id|nct_id|result_group_id|ctgov_group_code|period|reason|count
1313758|NCT03551743|4288588|P4|Overall Study|Withdrawal by Subject|0
1313759|NCT03551743|4288589|P3|Overall Study|Withdrawal by Subject|0
1313760|NCT03551743|4288590|P2|Overall Study|Withdrawal by Subject|0
1313761|NCT03551743|4288591|P1|Overall Study|Withdrawal by Subject|1
1313762|NCT03551743|4288588|P4|Overall Study|Adverse Event|0
1313763|NCT03551743|4288589|P3|Overall Study|Adverse Event|0
1313764|NCT03551743|4288590|P2|Overall Study|Adverse Event|0
1313765|NCT03551743|4288591|P1|Overall Study|Adverse Event|1
1313766|NCT03551730|4288637|P4|Overall Study|Adverse Event|0
1313767|NCT03551730|4288638|P3|Overall Study|Adverse Event|0
1313768|NCT03551730|4288639|P2|Overall Study|Adverse Event|0
1313769|NCT03551730|4288640|P1|Overall Study|Adverse Event|1
1313770|NCT03494985|4288728|P4|Overall Study|Other (Not specified)|0
1313771|NCT03494985|4288729|P3|Overall Study|Other (Not specified)|1
1313772|NCT03494985|4288730|P2|Overall Study|Other (Not specified)|1
1313773|NCT03494985|4288731|P1|Overall Study|Other (Not specified)|0
1313774|NCT03494985|4288728|P4|Overall Study|Other (Withdrawal of consent)|5
1313775|NCT03494985|4288729|P3|Overall Study|Other (Withdrawal of consent)|2
1313776|NCT03494985|4288730|P2|Overall Study|Other (Withdrawal of consent)|3
1313777|NCT03494985|4288731|P1|Overall Study|Other (Withdrawal of consent)|2
1313778|NCT03494985|4288728|P4|Overall Study|Adverse Event|0
1313779|NCT03494985|4288729|P3|Overall Study|Adverse Event|3
1313780|NCT03494985|4288730|P2|Overall Study|Adverse Event|2
1313781|NCT03494985|4288731|P1|Overall Study|Adverse Event|3
1313782|NCT03489551|4288765|P1|Overall Study|Withdrawal by Subject|2
1313783|NCT03478644|4288771|P2|Phase 2|Lost to Follow-up|0
1313784|NCT03478644|4288772|P1|Phase 2|Lost to Follow-up|1
1313785|NCT03478644|4288771|P2|Phase 2|Withdrawal by Subject|1
1313786|NCT03478644|4288772|P1|Phase 2|Withdrawal by Subject|2
1313787|NCT03407430|4288813|P2|Washout|Protocol Violation|0
1313788|NCT03407430|4288814|P1|Washout|Protocol Violation|1
1313789|NCT03405818|4288846|P1|Overall Study|Lost to Follow-up|4
1313790|NCT03405818|4288846|P1|Overall Study|Withdrawal by Subject|4
1313791|NCT03349099|4288954|P2|Overall Study|Stone migrated from the kidney|0
1313792|NCT03349099|4288955|P1|Overall Study|Stone migrated from the kidney|1
1313793|NCT03349099|4288954|P2|Overall Study|Physician Decision|4
1313794|NCT03349099|4288955|P1|Overall Study|Physician Decision|3
1313795|NCT03346759|4288967|P2|Second Menstrual Cycle|Lost to Follow-up|0
1313796|NCT03346759|4288968|P1|Second Menstrual Cycle|Lost to Follow-up|1
1313797|NCT03346759|4288967|P2|First Menstrual Cycle|Withdrawal by Subject|0
1313798|NCT03346759|4288968|P1|First Menstrual Cycle|Withdrawal by Subject|1
1313799|NCT03346759|4288967|P2|Enrollment to Baseline Data Collected|Lost to Follow-up|3
1313800|NCT03346759|4288968|P1|Enrollment to Baseline Data Collected|Lost to Follow-up|2
1313801|NCT03335566|4289004|P2|Overall Study|Other than specified above|2
1313802|NCT03335566|4289005|P1|Overall Study|Other than specified above|1
1313803|NCT03335566|4289004|P2|Overall Study|Protocol Violation|0
1313804|NCT03335566|4289005|P1|Overall Study|Protocol Violation|1
1313805|NCT03335566|4289004|P2|Overall Study|Technical Problems|0
1313806|NCT03335566|4289005|P1|Overall Study|Technical Problems|1
1313807|NCT03335566|4289004|P2|Overall Study|Lost to Follow-up|0
1313808|NCT03335566|4289005|P1|Overall Study|Lost to Follow-up|1
1313809|NCT03335566|4289004|P2|Overall Study|Adverse Event|1
1313810|NCT03335566|4289005|P1|Overall Study|Adverse Event|0
1313811|NCT03331315|4289019|P2|Overall Study|Physician Decision|14
1313812|NCT03331315|4289020|P1|Overall Study|Physician Decision|18
1313813|NCT03274453|4289131|P4|Overall Study|Surgery Cancelled|0
1313814|NCT03274453|4289132|P3|Overall Study|Surgery Cancelled|0
1313815|NCT03274453|4289133|P2|Overall Study|Surgery Cancelled|1
1313816|NCT03274453|4289134|P1|Overall Study|Surgery Cancelled|0
1313817|NCT03274453|4289131|P4|Overall Study|Physician Decision|3
1313818|NCT03274453|4289132|P3|Overall Study|Physician Decision|0
1313819|NCT03274453|4289133|P2|Overall Study|Physician Decision|0
1313820|NCT03274453|4289134|P1|Overall Study|Physician Decision|2
1313821|NCT03274453|4289131|P4|Overall Study|Lost to Follow-up|1
1313822|NCT03274453|4289132|P3|Overall Study|Lost to Follow-up|4
1313823|NCT03274453|4289133|P2|Overall Study|Lost to Follow-up|5
1313824|NCT03274453|4289134|P1|Overall Study|Lost to Follow-up|2
1313825|NCT03263806|4289161|P2|Overall Study|Study Termination|6
1313826|NCT03263806|4289162|P1|Overall Study|Study Termination|5
1313827|NCT03263806|4289161|P2|Overall Study|Withdrawal by Subject|1
1313828|NCT03263806|4289162|P1|Overall Study|Withdrawal by Subject|0
1313829|NCT03263806|4289161|P2|Overall Study|Elevated Troponin (failed screen)|0
1313830|NCT03263806|4289162|P1|Overall Study|Elevated Troponin (failed screen)|1
1313831|NCT03256552|4289174|P1|Overall Study|Withdrawal by Subject|2
1313832|NCT03256552|4289174|P1|Overall Study|Adverse Event|1
1313833|NCT03256552|4289174|P1|Overall Study|Physician Decision|1
1313834|NCT03256552|4289174|P1|Overall Study|Protocol Violation|1
1313835|NCT03255733|4289196|P1|Overall Study|Lost to Follow-up|4
1313836|NCT03255655|4289203|P2|Overall Study|Lost to Follow-up|4
1313837|NCT03255655|4289204|P1|Overall Study|Lost to Follow-up|7
1313838|NCT03254602|4289212|P1|Overall Study|Lost to Follow-up|4
1313839|NCT03238924|4289237|P2|Overall Study|Withdrawal by Subject|2
1313840|NCT03238924|4289238|P1|Overall Study|Withdrawal by Subject|2
1313841|NCT03238001|4289248|P1|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
1313842|NCT03238001|4289248|P1|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
1313843|NCT03238001|4289248|P1|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
1313844|NCT03238001|4289248|P1|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
1313845|NCT03238001|4289248|P1|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
1313846|NCT03238001|4289248|P1|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
1313847|NCT03238001|4289248|P1|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
1313848|NCT03238001|4289248|P1|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
1313849|NCT03231371|4289293|P1|Overall Study|chose or were ineligible to have MRI|12
1313850|NCT03231371|4289293|P1|Overall Study|Withdrawal by Subject|1
1313851|NCT03222141|4289303|P1|Overall Study|Lost to Follow-up|3
1313852|NCT03222141|4289303|P1|Overall Study|Death|15
1313853|NCT03218163|4289323|P1|Overall Study|Study termination|1
1313854|NCT03217968|4289327|P1|Overall Study|Protocol Violation|6
1313855|NCT03217968|4289327|P1|Overall Study|Lost to Follow-up|1
1313856|NCT03217968|4289327|P1|Overall Study|Withdrawal by Subject|4
1313857|NCT03196635|4289448|P1|Overall Study|Withdrawal by Subject|1
1313858|NCT03192306|4289468|P2|Overall Study|Protocol Violation|1
1313859|NCT03192306|4289469|P1|Overall Study|Protocol Violation|1
1313860|NCT03192306|4289468|P2|Overall Study|Lost to Follow-up|0
1313861|NCT03192306|4289469|P1|Overall Study|Lost to Follow-up|1
1313862|NCT03192306|4289468|P2|Overall Study|Withdrawal by Subject|1
1313863|NCT03192306|4289469|P1|Overall Study|Withdrawal by Subject|1
1313864|NCT03192306|4289468|P2|Overall Study|Did not treat cold sore during study|143
1313865|NCT03192306|4289469|P1|Overall Study|Did not treat cold sore during study|149
1313866|NCT03191552|4289490|P3|Overall Study|Undergone surgery (Progressive hip dyspl|0
1313867|NCT03191552|4289491|P2|Overall Study|Undergone surgery (Progressive hip dyspl|1
1313868|NCT03191552|4289492|P1|Overall Study|Undergone surgery (Progressive hip dyspl|0
1313869|NCT03191552|4289490|P3|Overall Study|Lost to Follow-up|0
1313870|NCT03191552|4289491|P2|Overall Study|Lost to Follow-up|0
1313871|NCT03191552|4289492|P1|Overall Study|Lost to Follow-up|1
1313872|NCT03184441|4289543|P1|Overall Study|Withdrawal by Subject|1
1313873|NCT03184077|4289553|P2|Overall Study|Lost to Follow-up|21
1313874|NCT03184077|4289554|P1|Overall Study|Lost to Follow-up|21
1313875|NCT03180138|4289583|P3|Overall Study|Found to be >24 mon after randomization|3
1313876|NCT03180138|4289584|P2|Overall Study|Found to be >24 mon after randomization|0
1313877|NCT03180138|4289585|P1|Overall Study|Found to be >24 mon after randomization|3
1313878|NCT03180138|4289583|P3|Overall Study|No prior immunization records|6
1313879|NCT03180138|4289584|P2|Overall Study|No prior immunization records|0
1313880|NCT03180138|4289585|P1|Overall Study|No prior immunization records|17
1313881|NCT03180138|4289583|P3|Overall Study|Mobile-phone could not be verified|15
1313882|NCT03180138|4289584|P2|Overall Study|Mobile-phone could not be verified|13
1313883|NCT03180138|4289585|P1|Overall Study|Mobile-phone could not be verified|2
1313884|NCT03151226|4289645|P1|Overall Study|not wear device correctly|1
1313885|NCT03151226|4289645|P1|Overall Study|Withdrawal by Subject|2
1313886|NCT03150485|4289649|P6|Overall Study|Unsatisfactory Lens Fitting|0
1313887|NCT03150485|4289650|P5|Overall Study|Unsatisfactory Lens Fitting|0
1313888|NCT03150485|4289651|P4|Overall Study|Unsatisfactory Lens Fitting|0
1313889|NCT03150485|4289652|P3|Overall Study|Unsatisfactory Lens Fitting|0
1313890|NCT03150485|4289653|P2|Overall Study|Unsatisfactory Lens Fitting|1
1313891|NCT03150485|4289654|P1|Overall Study|Unsatisfactory Lens Fitting|0
1313892|NCT03134183|4289711|P2|Overall Study|Withdrawal by Subject|1
1313893|NCT03134183|4289712|P1|Overall Study|Withdrawal by Subject|1
1313894|NCT03128723|4289745|P1|Overall Study|Withdrawal by Subject|2
1313895|NCT03128307|4289760|P1|Overall Study|Withdrawal by Subject|5
1313896|NCT03128307|4289760|P1|Overall Study|Lost to Follow-up|29
1313897|NCT03124784|4289807|P1|Overall Study|Computer/Equip Malfunction|1
1313898|NCT03124784|4289807|P1|Overall Study|Adverse Event|1
1313899|NCT03124199|4289823|P1|Overall Study|Lost to Follow-up|4
1313900|NCT03123354|4289851|P1|Overall Study|Physician Decision|6
1313901|NCT03118297|4289879|P2|Overall Study|Lost to Follow-up|2
1313902|NCT03118297|4289880|P1|Overall Study|Lost to Follow-up|0
1313903|NCT03110900|4290012|P2|Overall Study|Sponsor withdrew|1
1313904|NCT03110900|4290013|P1|Overall Study|Sponsor withdrew|1
1313905|NCT03099096|4290053|P1|Overall Study|Physician Decision|1
1313906|NCT03099096|4290053|P1|Overall Study|Adverse Event|1
1313907|NCT03097614|4290066|P1|Overall Study|Adverse Event|3
1313908|NCT03086447|4290092|P2|Overall Study|Lens Discomfort|1
1313909|NCT03086447|4290093|P1|Overall Study|Lens Discomfort|2
1313910|NCT03086447|4290092|P2|Overall Study|Adverse Event|0
1313911|NCT03086447|4290093|P1|Overall Study|Adverse Event|3
1313912|NCT03086447|4290092|P2|Overall Study|Lost to Follow-up|1
1313913|NCT03086447|4290093|P1|Overall Study|Lost to Follow-up|0
1313914|NCT03086447|4290092|P2|Overall Study|Protocol Violation|4
1313915|NCT03086447|4290093|P1|Overall Study|Protocol Violation|2
1313916|NCT03086447|4290092|P2|Overall Study|Test Article No Longer Available|0
1313917|NCT03086447|4290093|P1|Overall Study|Test Article No Longer Available|1
1313918|NCT03086447|4290092|P2|Overall Study|Unsatisfactory Lens Fitting|1
1313919|NCT03086447|4290093|P1|Overall Study|Unsatisfactory Lens Fitting|0
1313920|NCT03086447|4290092|P2|Overall Study|Lens Damage|6
1313921|NCT03086447|4290093|P1|Overall Study|Lens Damage|1
1313922|NCT03086447|4290092|P2|Overall Study|Product quality complaint|1
1313923|NCT03086447|4290093|P1|Overall Study|Product quality complaint|0
1313924|NCT03086447|4290092|P2|Overall Study|Lost Lens|5
1313925|NCT03086447|4290093|P1|Overall Study|Lost Lens|2
1313926|NCT03086447|4290092|P2|Overall Study|No Longer Meets Eligibility Criteria|1
1313927|NCT03086447|4290093|P1|Overall Study|No Longer Meets Eligibility Criteria|0
1313928|NCT03073798|4290122|P1|Overall Study|Withdrawal by Subject|1
1313929|NCT03073798|4290122|P1|Overall Study|Adverse Event|1
1313930|NCT03072875|4290133|P1|Overall Study|Lost to Follow-up|1
1313931|NCT03072719|4290140|P2|Overall Study|Adverse Event|1
1313932|NCT03072719|4290141|P1|Overall Study|Adverse Event|1
1313933|NCT03069313|4290287|P1|Overall Study|Adverse Event|5
1313934|NCT03065933|4290294|P1|Overall Study|study terminated|5
1313935|NCT03060512|4290311|P2|Overall Study|Non-compliance with study medication|2
1313936|NCT03060512|4290312|P1|Overall Study|Non-compliance with study medication|1
1313937|NCT03060512|4290311|P2|Overall Study|Withdrawal by Subject|0
1313938|NCT03060512|4290312|P1|Overall Study|Withdrawal by Subject|1
1313939|NCT03060512|4290311|P2|Overall Study|Lost to Follow-up|1
1313940|NCT03060512|4290312|P1|Overall Study|Lost to Follow-up|1
1313941|NCT03060512|4290311|P2|Overall Study|Adverse Event|6
1313942|NCT03060512|4290312|P1|Overall Study|Adverse Event|4
1313943|NCT03056352|4290342|P1|Overall Study|Lost to Follow-up|1
1313944|NCT03055221|4290348|P1|Overall Study|Study terminated by Sponsor|3
1313945|NCT03055221|4290348|P1|Overall Study|Physician Decision|1
1313946|NCT03055221|4290348|P1|Overall Study|Death|6
1313947|NCT03055221|4290348|P1|Overall Study|Withdrawal by Subject|4
1313948|NCT03055221|4290348|P1|Overall Study|Adverse Event|2
1313949|NCT03044431|4290601|P1|Overall Study|Lost to Follow-up|59
1313950|NCT03037307|4290684|P6|Period 1|Did Not Meet Study Criteria|0
1313951|NCT03037307|4290685|P5|Period 1|Did Not Meet Study Criteria|0
1313952|NCT03037307|4290686|P4|Period 1|Did Not Meet Study Criteria|1
1313953|NCT03037307|4290687|P3|Period 1|Did Not Meet Study Criteria|0
1313954|NCT03037307|4290688|P2|Period 1|Did Not Meet Study Criteria|0
1313955|NCT03037307|4290689|P1|Period 1|Did Not Meet Study Criteria|0
1313956|NCT03035916|4290724|P3|Overall Study|Puncture failed|0
1313957|NCT03035916|4290725|P2|Overall Study|Puncture failed|2
1313958|NCT03035916|4290726|P1|Overall Study|Puncture failed|0
1313959|NCT03034954|4290775|P2|Overall Study|Machine malfunction; did not reach 3 mA|0
1313960|NCT03034954|4290776|P1|Overall Study|Machine malfunction; did not reach 3 mA|1
1313961|NCT03031496|4290870|P2|Period 1|Withdrawal by Subject|2
1313962|NCT03031496|4290871|P1|Period 1|Withdrawal by Subject|0
1313963|NCT03031496|4290870|P2|Period 1|Adverse Event|0
1313964|NCT03031496|4290871|P1|Period 1|Adverse Event|2
1313965|NCT03029650|4290907|P2|Washout (1 Week)|Physician Decision|1
1313966|NCT03029650|4290908|P1|Washout (1 Week)|Physician Decision|0
1313967|NCT03029650|4290907|P2|Washout (1 Week)|Withdrawal by Subject|1
1313968|NCT03029650|4290908|P1|Washout (1 Week)|Withdrawal by Subject|1
1313969|NCT03026257|4290955|P6|Overall Study|Withdrawal by Subject|0
1313970|NCT03026257|4290956|P5|Overall Study|Withdrawal by Subject|0
1313971|NCT03026257|4290957|P4|Overall Study|Withdrawal by Subject|0
1313972|NCT03026257|4290958|P3|Overall Study|Withdrawal by Subject|0
1313973|NCT03026257|4290959|P2|Overall Study|Withdrawal by Subject|1
1313974|NCT03026257|4290960|P1|Overall Study|Withdrawal by Subject|1
1313975|NCT03026257|4290955|P6|Overall Study|Protocol Violation|0
1313976|NCT03026257|4290956|P5|Overall Study|Protocol Violation|1
1313977|NCT03026257|4290957|P4|Overall Study|Protocol Violation|1
1313978|NCT03026257|4290958|P3|Overall Study|Protocol Violation|0
1313979|NCT03026257|4290959|P2|Overall Study|Protocol Violation|0
1313980|NCT03026257|4290960|P1|Overall Study|Protocol Violation|1
1313981|NCT03026257|4290955|P6|Overall Study|Lost to Follow-up|0
1313982|NCT03026257|4290956|P5|Overall Study|Lost to Follow-up|0
1313983|NCT03026257|4290957|P4|Overall Study|Lost to Follow-up|0
1313984|NCT03026257|4290958|P3|Overall Study|Lost to Follow-up|0
1313985|NCT03026257|4290959|P2|Overall Study|Lost to Follow-up|0
1313986|NCT03026257|4290960|P1|Overall Study|Lost to Follow-up|1
1313987|NCT03026257|4290955|P6|Overall Study|Adverse Event|0
1313988|NCT03026257|4290956|P5|Overall Study|Adverse Event|0
1313989|NCT03026257|4290957|P4|Overall Study|Adverse Event|0
1313990|NCT03026257|4290958|P3|Overall Study|Adverse Event|0
1313991|NCT03026257|4290959|P2|Overall Study|Adverse Event|0
1313992|NCT03026257|4290960|P1|Overall Study|Adverse Event|3
1313993|NCT03023137|4291042|P2|Overall Study|Lost the baby in a car accident|0
1313994|NCT03023137|4291043|P1|Overall Study|Lost the baby in a car accident|1
1313995|NCT03023137|4291042|P2|Overall Study|Protocol Violation|4
1313996|NCT03023137|4291043|P1|Overall Study|Protocol Violation|0
1313997|NCT03023137|4291042|P2|Overall Study|Lost to Follow-up|1
1313998|NCT03023137|4291043|P1|Overall Study|Lost to Follow-up|1
1313999|NCT03023137|4291042|P2|Overall Study|Multiple pregnancy|4
1314000|NCT03023137|4291043|P1|Overall Study|Multiple pregnancy|2
1314001|NCT03022422|4291101|P6|Overall Study|3 subjects consented but not vaccinated|0
1314002|NCT03022422|4291102|P5|Overall Study|3 subjects consented but not vaccinated|0
1314003|NCT03022422|4291103|P4|Overall Study|3 subjects consented but not vaccinated|0
1314004|NCT03022422|4291104|P3|Overall Study|3 subjects consented but not vaccinated|3
1314005|NCT03022422|4291105|P2|Overall Study|3 subjects consented but not vaccinated|0
1314006|NCT03022422|4291106|P1|Overall Study|3 subjects consented but not vaccinated|0
1314007|NCT03021304|4291168|P1|Overall Study|Lack of Efficacy|1
1314008|NCT03020576|4291175|P2|Overall Study|Withdrawal by Subject|2
1314009|NCT03020576|4291176|P1|Overall Study|Withdrawal by Subject|1
1314010|NCT03018106|4291246|P2|Overall Study|Lost to Follow-up|1
1314011|NCT03018106|4291247|P1|Overall Study|Lost to Follow-up|0
1314012|NCT03017612|4291255|P1|Overall Study|Adverse Event|2
1314013|NCT03016078|4291263|P1|Overall Study|Protocol Violation|1
1314014|NCT03016078|4291263|P1|Overall Study|Protocol Violation|1
1314015|NCT03014674|4291277|P3|Overall Study|Withdrawal by Subject|0
1314016|NCT03014674|4291278|P2|Overall Study|Withdrawal by Subject|0
1314017|NCT03014674|4291279|P1|Overall Study|Withdrawal by Subject|1
1314018|NCT03011099|4291343|P2|Overall Study|Withdrawal by Subject|2
1314019|NCT03011099|4291344|P1|Overall Study|Withdrawal by Subject|0
1314020|NCT03005067|4291379|P2|Overall Study|Protocol Violation|1
1314021|NCT03005067|4291380|P1|Overall Study|Protocol Violation|0
1314022|NCT03005067|4291379|P2|Overall Study|Other (reason not specified)|1
1314023|NCT03005067|4291380|P1|Overall Study|Other (reason not specified)|3
1314024|NCT03005067|4291379|P2|Overall Study|Adverse Event|3
1314025|NCT03005067|4291380|P1|Overall Study|Adverse Event|4
1314026|NCT03005067|4291379|P2|Overall Study|Withdrawal by Subject|2
1314027|NCT03005067|4291380|P1|Overall Study|Withdrawal by Subject|3
1314028|NCT02990910|4291484|P2|Overall Study|Lack of Efficacy|10
1314029|NCT02990910|4291485|P1|Overall Study|Lack of Efficacy|6
1314030|NCT02988622|4291506|P1|Overall Study|Lost to Follow-up|17
1314031|NCT02988219|4291530|P2|Overall Study|Withdrawal by Subject|2
1314032|NCT02988219|4291531|P1|Overall Study|Withdrawal by Subject|0
1314033|NCT02988219|4291530|P2|Overall Study|Lack of Efficacy|1
1314034|NCT02988219|4291531|P1|Overall Study|Lack of Efficacy|1
1314035|NCT02987205|4291551|P1|Overall Study|Withdrawal by Subject|3
1314036|NCT02987205|4291551|P1|Overall Study|Adverse Event|1
1314037|NCT02986854|4291562|P3|Overall Study|Lost to Follow-up|2
1314038|NCT02986854|4291563|P2|Overall Study|Lost to Follow-up|11
1314039|NCT02986854|4291564|P1|Overall Study|Lost to Follow-up|3
1314040|NCT02986854|4291562|P3|Overall Study|Withdrawal by Subject|1
1314041|NCT02986854|4291563|P2|Overall Study|Withdrawal by Subject|1
1314042|NCT02986854|4291564|P1|Overall Study|Withdrawal by Subject|0
1314043|NCT02984267|4291657|P2|Overall Study|Withdrawal by Subject|1
1314044|NCT02984267|4291658|P1|Overall Study|Withdrawal by Subject|0
1314045|NCT02984267|4291657|P2|Overall Study|Protocol Violation|0
1314046|NCT02984267|4291658|P1|Overall Study|Protocol Violation|1
1314047|NCT02982018|4291691|P2|Overall Study|Withdrawal by Subject|1
1314048|NCT02982018|4291692|P1|Overall Study|Withdrawal by Subject|0
1314049|NCT02982018|4291691|P2|Overall Study|Lens Discomfort|0
1314050|NCT02982018|4291692|P1|Overall Study|Lens Discomfort|2
1314051|NCT02982018|4291691|P2|Overall Study|Adverse Event|1
1314052|NCT02982018|4291692|P1|Overall Study|Adverse Event|1
1314053|NCT02982018|4291691|P2|Overall Study|Protocol Violation|1
1314054|NCT02982018|4291692|P1|Overall Study|Protocol Violation|1
1314055|NCT02982018|4291691|P2|Overall Study|Incorrect Lens Dispensed|0
1314056|NCT02982018|4291692|P1|Overall Study|Incorrect Lens Dispensed|1
1314057|NCT02978833|4291708|P2|Overall Study|Study terminated|1
1314058|NCT02978833|4291709|P1|Overall Study|Study terminated|1
1314059|NCT02977572|4291727|P2|Overall Study|Exclusion criterion|2
1314060|NCT02977572|4291728|P1|Overall Study|Exclusion criterion|2
1314061|NCT02974543|4291752|P2|Overall Study|Withdrawal by Subject|0
1314062|NCT02974543|4291753|P1|Overall Study|Withdrawal by Subject|1
1314063|NCT02974114|4291776|P3|Overall Study|Other (Not specified)|2
1314064|NCT02974114|4291777|P2|Overall Study|Other (Not specified)|1
1314065|NCT02974114|4291778|P1|Overall Study|Other (Not specified)|0
1314066|NCT02973100|4291823|P4|Overall Study|Failed to attend Safety followup period|0
1314067|NCT02973100|4291824|P3|Overall Study|Failed to attend Safety followup period|1
1314068|NCT02973100|4291825|P2|Overall Study|Failed to attend Safety followup period|0
1314069|NCT02973100|4291826|P1|Overall Study|Failed to attend Safety followup period|0
1314070|NCT02973100|4291823|P4|Overall Study|Notification of change in address|1
1314071|NCT02973100|4291824|P3|Overall Study|Notification of change in address|0
1314072|NCT02973100|4291825|P2|Overall Study|Notification of change in address|0
1314073|NCT02973100|4291826|P1|Overall Study|Notification of change in address|0
1314074|NCT02973100|4291823|P4|Overall Study|Withdrawal by Subject|4
1314075|NCT02973100|4291824|P3|Overall Study|Withdrawal by Subject|1
1314076|NCT02973100|4291825|P2|Overall Study|Withdrawal by Subject|5
1314077|NCT02973100|4291826|P1|Overall Study|Withdrawal by Subject|3
1314078|NCT02973100|4291823|P4|Overall Study|Lost to Follow-up|0
1314079|NCT02973100|4291824|P3|Overall Study|Lost to Follow-up|1
1314080|NCT02973100|4291825|P2|Overall Study|Lost to Follow-up|1
1314081|NCT02973100|4291826|P1|Overall Study|Lost to Follow-up|3
1314082|NCT02973100|4291823|P4|Overall Study|Adverse Event|2
1314083|NCT02973100|4291824|P3|Overall Study|Adverse Event|1
1314084|NCT02973100|4291825|P2|Overall Study|Adverse Event|2
1314085|NCT02973100|4291826|P1|Overall Study|Adverse Event|1
1314086|NCT02971670|4291866|P4|Overall Study|Withdrawal by Subject|2
1314087|NCT02971670|4291867|P3|Overall Study|Withdrawal by Subject|1
1314088|NCT02971670|4291868|P2|Overall Study|Withdrawal by Subject|1
1314089|NCT02971670|4291869|P1|Overall Study|Withdrawal by Subject|4
1314090|NCT02969863|4291887|P6|Overall Study|Physician Decision|0
1314091|NCT02969863|4291888|P5|Overall Study|Physician Decision|0
1314092|NCT02969863|4291889|P4|Overall Study|Physician Decision|0
1314093|NCT02969863|4291890|P3|Overall Study|Physician Decision|0
1314094|NCT02969863|4291891|P2|Overall Study|Physician Decision|0
1314095|NCT02969863|4291892|P1|Overall Study|Physician Decision|1
1314096|NCT02968173|4291906|P1|Overall Study|Withdrawal by Subject|1
1314097|NCT02966509|4291993|P2|End of Life Utilization and Cost 15month|Patient Still Alive|48
1314098|NCT02966509|4291994|P1|End of Life Utilization and Cost 15month|Patient Still Alive|45
1314099|NCT02966509|4291993|P2|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
1314100|NCT02966509|4291994|P1|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
1314101|NCT02966509|4291993|P2|6 Month Satisfaction Survey|Refused to Answer|11
1314102|NCT02966509|4291994|P1|6 Month Satisfaction Survey|Refused to Answer|8
1314103|NCT02966509|4291993|P2|6 Month Satisfaction Survey|Lost to Follow-up|1
1314104|NCT02966509|4291994|P1|6 Month Satisfaction Survey|Lost to Follow-up|1
1314105|NCT02966509|4291993|P2|6 Month Satisfaction Survey|Withdrawal by Subject|3
1314106|NCT02966509|4291994|P1|6 Month Satisfaction Survey|Withdrawal by Subject|2
1314107|NCT02966509|4291993|P2|6 Month Satisfaction Survey|Death|33
1314108|NCT02966509|4291994|P1|6 Month Satisfaction Survey|Death|36
1314109|NCT02966509|4291993|P2|4-Month Satisfaction Decision Survey|Refused to Answer|2
1314110|NCT02966509|4291994|P1|4-Month Satisfaction Decision Survey|Refused to Answer|0
1314111|NCT02966509|4291993|P2|4-Month Satisfaction Decision Survey|Lost to Follow-up|1
1314112|NCT02966509|4291994|P1|4-Month Satisfaction Decision Survey|Lost to Follow-up|1
1314113|NCT02966509|4291993|P2|4-Month Satisfaction Decision Survey|Withdrawal by Subject|3
1314114|NCT02966509|4291994|P1|4-Month Satisfaction Decision Survey|Withdrawal by Subject|2
1314115|NCT02966509|4291993|P2|4-Month Satisfaction Decision Survey|Death|25
1314116|NCT02966509|4291994|P1|4-Month Satisfaction Decision Survey|Death|22
1314117|NCT02966509|4291993|P2|Baseline Satisfaction Survey|Refused to Answer|2
1314118|NCT02966509|4291994|P1|Baseline Satisfaction Survey|Refused to Answer|1
1314119|NCT02966509|4291993|P2|Baseline Satisfaction Survey|Lost to Follow-up|1
1314120|NCT02966509|4291994|P1|Baseline Satisfaction Survey|Lost to Follow-up|1
1314121|NCT02966509|4291993|P2|Baseline Satisfaction Survey|Death|1
1314122|NCT02966509|4291994|P1|Baseline Satisfaction Survey|Death|0
1314123|NCT02966509|4291993|P2|Baseline Satisfaction Survey|Withdrawal by Subject|3
1314124|NCT02966509|4291994|P1|Baseline Satisfaction Survey|Withdrawal by Subject|2
1314125|NCT02966015|4292020|P2|Inclusion Visit|did not answer questionnaire|3
1314126|NCT02966015|4292021|P1|Inclusion Visit|did not answer questionnaire|8
1314127|NCT02966002|4292027|P1|Overall Study|Lost to Follow-up|1
1314128|NCT02966002|4292027|P1|Overall Study|Adverse Event|1
1314129|NCT02966002|4292027|P1|Overall Study|Withdrawal by Subject|2
1314130|NCT02965833|4292034|P2|Period 2, Second 30 Days of Wear|Protocol Violation|0
1314131|NCT02965833|4292035|P1|Period 2, Second 30 Days of Wear|Protocol Violation|2
1314132|NCT02965833|4292034|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
1314133|NCT02965833|4292035|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
1314134|NCT02965833|4292034|P2|Period 1, First 30 Days of Wear|Protocol Violation|0
1314135|NCT02965833|4292035|P1|Period 1, First 30 Days of Wear|Protocol Violation|1
1314136|NCT02965833|4292034|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
1314137|NCT02965833|4292035|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
1314138|NCT02965833|4292034|P2|Period 1, First 30 Days of Wear|Adverse Event|1
1314139|NCT02965833|4292035|P1|Period 1, First 30 Days of Wear|Adverse Event|0
1314140|NCT02965820|4292041|P2|Period 2, Second 30 Days|Adverse Event|1
1314141|NCT02965820|4292042|P1|Period 2, Second 30 Days|Adverse Event|1
1314142|NCT02962882|4292058|P1|Overall Study|Transfer from ICU|32
1314143|NCT02962882|4292058|P1|Overall Study|Withdrawal by Subject|2
1314144|NCT02962882|4292058|P1|Overall Study|Adverse Event|2
1314145|NCT02961244|4292069|P2|Overall Study|İnadequate data|2
1314146|NCT02961244|4292070|P1|Overall Study|İnadequate data|0
1314147|NCT02961244|4292069|P2|Overall Study|Lost to Follow-up|2
1314148|NCT02961244|4292070|P1|Overall Study|Lost to Follow-up|0
1314149|NCT02961244|4292069|P2|Overall Study|Surgery plan change after study approval|2
1314150|NCT02961244|4292070|P1|Overall Study|Surgery plan change after study approval|0
1314151|NCT02961244|4292069|P2|Overall Study|Withdrawal by Subject|2
1314152|NCT02961244|4292070|P1|Overall Study|Withdrawal by Subject|1
1314153|NCT02961244|4292069|P2|Overall Study|Protocol Violation|1
1314154|NCT02961244|4292070|P1|Overall Study|Protocol Violation|0
1314155|NCT02956460|4292193|P2|Lens 1|Lost to Follow-up|0
1314156|NCT02956460|4292194|P1|Lens 1|Lost to Follow-up|1
1314157|NCT02954601|4292224|P4|First Intervention (Five Days)|Withdrawal by Subject|0
1314158|NCT02954601|4292225|P3|First Intervention (Five Days)|Withdrawal by Subject|1
1314159|NCT02954601|4292226|P2|First Intervention (Five Days)|Withdrawal by Subject|0
1314160|NCT02954601|4292227|P1|First Intervention (Five Days)|Withdrawal by Subject|0
1314161|NCT02951767|4292271|P1|Overall Study|Lost to Follow-up|1
1314162|NCT02951767|4292271|P1|Overall Study|Death|59
1314163|NCT02951767|4292271|P1|Overall Study|Withdrawal by Subject|5
1314164|NCT02951767|4292271|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
1314165|NCT02948582|4292450|P6|Washout Period 4|Adverse Event|0
1314166|NCT02948582|4292451|P5|Washout Period 4|Adverse Event|0
1314167|NCT02948582|4292452|P4|Washout Period 4|Adverse Event|0
1314168|NCT02948582|4292453|P3|Washout Period 4|Adverse Event|1
1314169|NCT02948582|4292454|P2|Washout Period 4|Adverse Event|0
1314170|NCT02948582|4292455|P1|Washout Period 4|Adverse Event|1
1314171|NCT02948582|4292450|P6|Washout Period 2|personal reasons|0
1314172|NCT02948582|4292451|P5|Washout Period 2|personal reasons|0
1314173|NCT02948582|4292452|P4|Washout Period 2|personal reasons|1
1314174|NCT02948582|4292453|P3|Washout Period 2|personal reasons|0
1314175|NCT02948582|4292454|P2|Washout Period 2|personal reasons|0
1314176|NCT02948582|4292455|P1|Washout Period 2|personal reasons|0
1314177|NCT02948582|4292450|P6|Washout Period 2|Adverse Event|0
1314178|NCT02948582|4292451|P5|Washout Period 2|Adverse Event|0
1314179|NCT02948582|4292452|P4|Washout Period 2|Adverse Event|0
1314180|NCT02948582|4292453|P3|Washout Period 2|Adverse Event|0
1314181|NCT02948582|4292454|P2|Washout Period 2|Adverse Event|1
1314182|NCT02948582|4292455|P1|Washout Period 2|Adverse Event|0
1314183|NCT02948582|4292450|P6|Washout Period 1|Protocol Violation|1
1314184|NCT02948582|4292451|P5|Washout Period 1|Protocol Violation|0
1314185|NCT02948582|4292452|P4|Washout Period 1|Protocol Violation|0
1314186|NCT02948582|4292453|P3|Washout Period 1|Protocol Violation|0
1314187|NCT02948582|4292454|P2|Washout Period 1|Protocol Violation|0
1314188|NCT02948582|4292455|P1|Washout Period 1|Protocol Violation|0
1314189|NCT02948582|4292450|P6|Washout Period 1|Adverse Event|0
1314190|NCT02948582|4292451|P5|Washout Period 1|Adverse Event|0
1314191|NCT02948582|4292452|P4|Washout Period 1|Adverse Event|0
1314192|NCT02948582|4292453|P3|Washout Period 1|Adverse Event|0
1314193|NCT02948582|4292454|P2|Washout Period 1|Adverse Event|2
1314194|NCT02948582|4292455|P1|Washout Period 1|Adverse Event|0
1314195|NCT02947022|4292563|P1|Overall Study|Study Stopped|1
1314196|NCT02945254|4292584|P2|Overall Study|Withdrawal by Subject|0
1314197|NCT02945254|4292585|P1|Overall Study|Withdrawal by Subject|1
1314198|NCT02945254|4292584|P2|Overall Study|Lost to Follow-up|0
1314199|NCT02945254|4292585|P1|Overall Study|Lost to Follow-up|1
1314200|NCT02937870|4292691|P1|Overall Study|Protocol Deviation|2
1314201|NCT02937870|4292691|P1|Overall Study|Adverse Event|1
1314202|NCT02935894|4292731|P1|Overall Study|Subject dismissed|1
1314203|NCT02927431|4292811|P3|Overall Study|Withdrawal by Subject|1
1314204|NCT02927431|4292812|P2|Overall Study|Withdrawal by Subject|0
1314205|NCT02927431|4292813|P1|Overall Study|Withdrawal by Subject|0
1314206|NCT02926573|4292891|P2|Overall Study|Delirium|1
1314207|NCT02926573|4292892|P1|Overall Study|Delirium|0
1314208|NCT02926573|4292891|P2|Overall Study|Return to operating room|2
1314209|NCT02926573|4292892|P1|Overall Study|Return to operating room|0
1314210|NCT02926573|4292891|P2|Overall Study|Withdrawal by Subject|2
1314211|NCT02926573|4292892|P1|Overall Study|Withdrawal by Subject|0
1314212|NCT02926573|4292891|P2|Overall Study|Change to outpatient status|1
1314213|NCT02926573|4292892|P1|Overall Study|Change to outpatient status|5
1314214|NCT02926573|4292891|P2|Overall Study|Change in surgery plan|1
1314215|NCT02926573|4292892|P1|Overall Study|Change in surgery plan|3
1314216|NCT02926573|4292891|P2|Overall Study|Remain intubated|2
1314217|NCT02926573|4292892|P1|Overall Study|Remain intubated|2
1314218|NCT02926573|4292891|P2|Overall Study|Nausea|0
1314219|NCT02926573|4292892|P1|Overall Study|Nausea|1
1314220|NCT02923245|4292925|P2|Overall Study|ultrasound order was cancelled|1
1314221|NCT02923245|4292926|P1|Overall Study|ultrasound order was cancelled|2
1314222|NCT02921425|4292977|P1|Overall Study|Protocol Violation|9
1314223|NCT02920957|4293047|P2|Second Intervention: 1 Month|Lost to Follow-up|1
1314224|NCT02920957|4293048|P1|Second Intervention: 1 Month|Lost to Follow-up|0
1314225|NCT02920957|4293047|P2|First Intervention : 1 Month|Adverse Event|0
1314226|NCT02920957|4293048|P1|First Intervention : 1 Month|Adverse Event|1
1314227|NCT02920957|4293047|P2|First Intervention : 1 Month|Lost to Follow-up|0
1314228|NCT02920957|4293048|P1|First Intervention : 1 Month|Lost to Follow-up|1
1314229|NCT02920957|4293047|P2|First Intervention : 1 Month|Withdrawal by Subject|0
1314230|NCT02920957|4293048|P1|First Intervention : 1 Month|Withdrawal by Subject|2
1314231|NCT02915978|4293186|P3|Overall Study|Adverse Event|0
1314232|NCT02915978|4293187|P2|Overall Study|Adverse Event|1
1314233|NCT02915978|4293188|P1|Overall Study|Adverse Event|2
1314234|NCT02915302|4293240|P2|Overall Study|Other|0
1314235|NCT02915302|4293241|P1|Overall Study|Other|1
1314236|NCT02915302|4293240|P2|Overall Study|Withdrawal by Subject|29
1314237|NCT02915302|4293241|P1|Overall Study|Withdrawal by Subject|22
1314238|NCT02915302|4293240|P2|Overall Study|Lost to Follow-up|22
1314239|NCT02915302|4293241|P1|Overall Study|Lost to Follow-up|19
1314240|NCT02915302|4293240|P2|Overall Study|Protocol Violation|27
1314241|NCT02915302|4293241|P1|Overall Study|Protocol Violation|20
1314242|NCT02915302|4293240|P2|Overall Study|Adverse Event|0
1314243|NCT02915302|4293241|P1|Overall Study|Adverse Event|3
1314244|NCT02914236|4293251|P1|Overall Study|Lost to Follow-up|1
1314245|NCT02912650|4293263|P4|Overall Study|Adverse Event|0
1314246|NCT02912650|4293264|P3|Overall Study|Adverse Event|1
1314247|NCT02912650|4293265|P2|Overall Study|Adverse Event|0
1314248|NCT02912650|4293266|P1|Overall Study|Adverse Event|0
1314249|NCT02912650|4293263|P4|Overall Study|Withdrawal by Subject|5
1314250|NCT02912650|4293264|P3|Overall Study|Withdrawal by Subject|1
1314251|NCT02912650|4293265|P2|Overall Study|Withdrawal by Subject|0
1314252|NCT02912650|4293266|P1|Overall Study|Withdrawal by Subject|1
1314253|NCT02907892|4293391|P2|Overall Study|Lost to Follow-up|40
1314254|NCT02907892|4293392|P1|Overall Study|Lost to Follow-up|27
1314255|NCT02905825|4293408|P1|Overall Study|Device Malfunction|1
1314256|NCT02905825|4293408|P1|Overall Study|Protocol Violation|11
1314257|NCT02903238|4293414|P1|Overall Study|Lost to Follow-up|4
1314258|NCT02901054|4293434|P1|Overall Study|Withdrawal by Subject|3
1314259|NCT02901054|4293434|P1|Overall Study|Physician Decision|1
1314260|NCT02898116|4293438|P1|Overall Study|Initiation of anticancer therapy|1
1314261|NCT02895347|4293446|P2|Overall Study|Withdrawal by Subject|1
1314262|NCT02895347|4293447|P1|Overall Study|Withdrawal by Subject|3
1314263|NCT02886715|4293506|P3|Overall Study|missing|2
1314264|NCT02886715|4293507|P2|Overall Study|missing|2
1314265|NCT02886715|4293508|P1|Overall Study|missing|7
1314266|NCT02886715|4293506|P3|Overall Study|Withdrawal by Subject|5
1314267|NCT02886715|4293507|P2|Overall Study|Withdrawal by Subject|18
1314268|NCT02886715|4293508|P1|Overall Study|Withdrawal by Subject|20
1314269|NCT02886715|4293506|P3|Overall Study|Protocol Violation|1
1314270|NCT02886715|4293507|P2|Overall Study|Protocol Violation|2
1314271|NCT02886715|4293508|P1|Overall Study|Protocol Violation|3
1314272|NCT02886715|4293506|P3|Overall Study|Pregnancy|1
1314273|NCT02886715|4293507|P2|Overall Study|Pregnancy|1
1314274|NCT02886715|4293508|P1|Overall Study|Pregnancy|1
1314275|NCT02886715|4293506|P3|Overall Study|Lost to Follow-up|10
1314276|NCT02886715|4293507|P2|Overall Study|Lost to Follow-up|26
1314277|NCT02886715|4293508|P1|Overall Study|Lost to Follow-up|29
1314278|NCT02886715|4293506|P3|Overall Study|Lack of Efficacy|1
1314279|NCT02886715|4293507|P2|Overall Study|Lack of Efficacy|2
1314280|NCT02886715|4293508|P1|Overall Study|Lack of Efficacy|0
1314281|NCT02886715|4293506|P3|Overall Study|Adverse Event|0
1314282|NCT02886715|4293507|P2|Overall Study|Adverse Event|2
1314283|NCT02886715|4293508|P1|Overall Study|Adverse Event|4
1314284|NCT02886715|4293506|P3|Overall Study|Non-Compliance With Study Drug|0
1314285|NCT02886715|4293507|P2|Overall Study|Non-Compliance With Study Drug|2
1314286|NCT02886715|4293508|P1|Overall Study|Non-Compliance With Study Drug|0
1314287|NCT02886702|4293525|P3|Overall Study|Administrative Reasons|1
1314288|NCT02886702|4293526|P2|Overall Study|Administrative Reasons|0
1314289|NCT02886702|4293527|P1|Overall Study|Administrative Reasons|0
1314290|NCT02886702|4293525|P3|Overall Study|Adverse Event|3
1314291|NCT02886702|4293526|P2|Overall Study|Adverse Event|9
1314292|NCT02886702|4293527|P1|Overall Study|Adverse Event|4
1314293|NCT02886702|4293525|P3|Overall Study|Lack of Efficacy|5
1314294|NCT02886702|4293526|P2|Overall Study|Lack of Efficacy|4
1314295|NCT02886702|4293527|P1|Overall Study|Lack of Efficacy|3
1314296|NCT02886702|4293525|P3|Overall Study|Lost to Follow-up|8
1314297|NCT02886702|4293526|P2|Overall Study|Lost to Follow-up|13
1314298|NCT02886702|4293527|P1|Overall Study|Lost to Follow-up|11
1314299|NCT02886702|4293525|P3|Overall Study|Non-Compliance With Study Drug|4
1314300|NCT02886702|4293526|P2|Overall Study|Non-Compliance With Study Drug|1
1314301|NCT02886702|4293527|P1|Overall Study|Non-Compliance With Study Drug|0
1314302|NCT02886702|4293525|P3|Overall Study|Protocol Violation|1
1314303|NCT02886702|4293526|P2|Overall Study|Protocol Violation|2
1314304|NCT02886702|4293527|P1|Overall Study|Protocol Violation|2
1314305|NCT02886702|4293525|P3|Overall Study|Significant Worsening of Condition|0
1314306|NCT02886702|4293526|P2|Overall Study|Significant Worsening of Condition|1
1314307|NCT02886702|4293527|P1|Overall Study|Significant Worsening of Condition|0
1314308|NCT02886702|4293525|P3|Overall Study|Withdrawal by Subject|22
1314309|NCT02886702|4293526|P2|Overall Study|Withdrawal by Subject|18
1314310|NCT02886702|4293527|P1|Overall Study|Withdrawal by Subject|24
1314311|NCT02886702|4293525|P3|Overall Study|Not Specified|9
1314312|NCT02886702|4293526|P2|Overall Study|Not Specified|3
1314313|NCT02886702|4293527|P1|Overall Study|Not Specified|4
1314314|NCT02886338|4293541|P1|Overall Study|Withdrawal by Subject|1
1314315|NCT02884089|4293564|P4|Follow-up Visit|Withdrawal by Subject|1
1314316|NCT02884089|4293565|P3|Follow-up Visit|Withdrawal by Subject|0
1314317|NCT02884089|4293566|P2|Follow-up Visit|Withdrawal by Subject|0
1314318|NCT02884089|4293567|P1|Follow-up Visit|Withdrawal by Subject|1
1314319|NCT02884089|4293564|P4|Period 4|Lost to Follow-up|0
1314320|NCT02884089|4293565|P3|Period 4|Lost to Follow-up|0
1314321|NCT02884089|4293566|P2|Period 4|Lost to Follow-up|0
1314322|NCT02884089|4293567|P1|Period 4|Lost to Follow-up|1
1314323|NCT02884089|4293564|P4|Period 4|Withdrawal by Subject|0
1314324|NCT02884089|4293565|P3|Period 4|Withdrawal by Subject|0
1314325|NCT02884089|4293566|P2|Period 4|Withdrawal by Subject|1
1314326|NCT02884089|4293567|P1|Period 4|Withdrawal by Subject|0
1314327|NCT02884089|4293564|P4|Washout Period 3|Lost to Follow-up|1
1314328|NCT02884089|4293565|P3|Washout Period 3|Lost to Follow-up|0
1314329|NCT02884089|4293566|P2|Washout Period 3|Lost to Follow-up|0
1314330|NCT02884089|4293567|P1|Washout Period 3|Lost to Follow-up|0
1314331|NCT02884089|4293564|P4|Washout Period 3|Withdrawal by Subject|0
1314332|NCT02884089|4293565|P3|Washout Period 3|Withdrawal by Subject|1
1314333|NCT02884089|4293566|P2|Washout Period 3|Withdrawal by Subject|0
1314334|NCT02884089|4293567|P1|Washout Period 3|Withdrawal by Subject|0
1314335|NCT02884089|4293564|P4|Period 3|Withdrawal by Subject|0
1314336|NCT02884089|4293565|P3|Period 3|Withdrawal by Subject|1
1314337|NCT02884089|4293566|P2|Period 3|Withdrawal by Subject|0
1314338|NCT02884089|4293567|P1|Period 3|Withdrawal by Subject|0
1314339|NCT02884089|4293564|P4|Period 2|Adverse Event|0
1314340|NCT02884089|4293565|P3|Period 2|Adverse Event|0
1314341|NCT02884089|4293566|P2|Period 2|Adverse Event|0
1314342|NCT02884089|4293567|P1|Period 2|Adverse Event|1
1314343|NCT02884089|4293564|P4|Washout Period 1|Withdrawal by Subject|0
1314344|NCT02884089|4293565|P3|Washout Period 1|Withdrawal by Subject|0
1314345|NCT02884089|4293566|P2|Washout Period 1|Withdrawal by Subject|1
1314346|NCT02884089|4293567|P1|Washout Period 1|Withdrawal by Subject|0
1314347|NCT02884089|4293564|P4|Washout Period 1|Lost to Follow-up|1
1314348|NCT02884089|4293565|P3|Washout Period 1|Lost to Follow-up|0
1314349|NCT02884089|4293566|P2|Washout Period 1|Lost to Follow-up|1
1314350|NCT02884089|4293567|P1|Washout Period 1|Lost to Follow-up|0
1314351|NCT02884089|4293564|P4|Period 1|Dosing error|0
1314352|NCT02884089|4293565|P3|Period 1|Dosing error|0
1314353|NCT02884089|4293566|P2|Period 1|Dosing error|2
1314354|NCT02884089|4293567|P1|Period 1|Dosing error|2
1314355|NCT02882152|4293583|P2|Overall Study|Lost to Follow-up|0
1314356|NCT02882152|4293584|P1|Overall Study|Lost to Follow-up|1
1314357|NCT02877082|4293648|P1|Overall Study|Trial was closed early|5
1314358|NCT02873754|4293680|P1|Overall Study|Couldn't complete study procedures|1
1314359|NCT02873754|4293680|P1|Overall Study|Lost to Follow-up|5
1314360|NCT02873429|4293715|P2|16 Weeks|Lost to Follow-up|0
1314361|NCT02873429|4293716|P1|16 Weeks|Lost to Follow-up|3
1314362|NCT02873429|4293715|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
1314363|NCT02873429|4293716|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
1314364|NCT02873429|4293715|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
1314365|NCT02873429|4293716|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
1314366|NCT02871375|4293741|P2|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
1314367|NCT02871375|4293742|P1|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
1314368|NCT02865083|4293796|P2|Overall Study|Early Termination|1
1314369|NCT02865083|4293797|P1|Overall Study|Early Termination|3
1314370|NCT02862730|4293852|P7|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1314371|NCT02862730|4293853|P6|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1314372|NCT02862730|4293854|P5|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1314373|NCT02862730|4293855|P4|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
1314374|NCT02862730|4293856|P3|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1314375|NCT02862730|4293857|P2|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1314376|NCT02862730|4293858|P1|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1314377|NCT02862730|4293852|P7|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1314378|NCT02862730|4293853|P6|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1314379|NCT02862730|4293854|P5|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
1314380|NCT02862730|4293855|P4|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1314381|NCT02862730|4293856|P3|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
1314382|NCT02862730|4293857|P2|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1314383|NCT02862730|4293858|P1|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1314384|NCT02862730|4293852|P7|Second Intervention (84 Hours)|Withdrawal by Subject|0
1314385|NCT02862730|4293853|P6|Second Intervention (84 Hours)|Withdrawal by Subject|0
1314386|NCT02862730|4293854|P5|Second Intervention (84 Hours)|Withdrawal by Subject|0
1314387|NCT02862730|4293855|P4|Second Intervention (84 Hours)|Withdrawal by Subject|0
1314388|NCT02862730|4293856|P3|Second Intervention (84 Hours)|Withdrawal by Subject|0
1314389|NCT02862730|4293857|P2|Second Intervention (84 Hours)|Withdrawal by Subject|0
1314390|NCT02862730|4293858|P1|Second Intervention (84 Hours)|Withdrawal by Subject|1
1314391|NCT02862730|4293852|P7|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1314392|NCT02862730|4293853|P6|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1314393|NCT02862730|4293854|P5|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1314394|NCT02862730|4293855|P4|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1314395|NCT02862730|4293856|P3|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
1314396|NCT02862730|4293857|P2|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1314397|NCT02862730|4293858|P1|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1314398|NCT02862600|4293913|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
1314399|NCT02862600|4293913|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
1314400|NCT02862600|4293913|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
1314401|NCT02862600|4293913|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
1314402|NCT02862574|4293923|P3|Open-Label Treatment Period|Study Terminated by Sponsor|1
1314403|NCT02862574|4293924|P2|Open-Label Treatment Period|Study Terminated by Sponsor|3
1314404|NCT02862574|4293925|P1|Open-Label Treatment Period|Study Terminated by Sponsor|2
1314405|NCT02862574|4293923|P3|Double-Blind Treatment Period|Study Terminated by Sponsor|4
1314406|NCT02862574|4293924|P2|Double-Blind Treatment Period|Study Terminated by Sponsor|1
1314407|NCT02862574|4293925|P1|Double-Blind Treatment Period|Study Terminated by Sponsor|3
1314408|NCT02862574|4293923|P3|Double-Blind Treatment Period|Adverse Event|0
1314409|NCT02862574|4293924|P2|Double-Blind Treatment Period|Adverse Event|1
1314410|NCT02862574|4293925|P1|Double-Blind Treatment Period|Adverse Event|0
1314411|NCT02862106|4293949|P2|Overall Study|Subjects moved to other city|0
1314412|NCT02862106|4293950|P1|Overall Study|Subjects moved to other city|1
1314413|NCT02862106|4293949|P2|Overall Study|Withdrawal by Subject|0
1314414|NCT02862106|4293950|P1|Overall Study|Withdrawal by Subject|2
1314415|NCT02862106|4293949|P2|Overall Study|Lost to Follow-up|5
1314416|NCT02862106|4293950|P1|Overall Study|Lost to Follow-up|15
1314417|NCT02862106|4293949|P2|Overall Study|Protocol Violation|1
1314418|NCT02862106|4293950|P1|Overall Study|Protocol Violation|16
1314419|NCT02862106|4293949|P2|Overall Study|Adverse Event|0
1314420|NCT02862106|4293950|P1|Overall Study|Adverse Event|4
1314421|NCT02861664|4294010|P2|Overall Study|Withdrawal of Consent|1
1314422|NCT02861664|4294011|P1|Overall Study|Withdrawal of Consent|0
1314423|NCT02856880|4294021|P1|Overall Study|Withdrawal of consent|1
1314424|NCT02855411|4294045|P1|Overall Study|Does not meet entrance criteria|14
1314425|NCT02855411|4294045|P1|Overall Study|Study terminated by sponsor|21
1314426|NCT02854527|4294086|P10|Overall Study|Lost to Follow-up|0
1314427|NCT02854527|4294087|P9|Overall Study|Lost to Follow-up|0
1314428|NCT02854527|4294088|P8|Overall Study|Lost to Follow-up|0
1314429|NCT02854527|4294089|P7|Overall Study|Lost to Follow-up|0
1314430|NCT02854527|4294090|P6|Overall Study|Lost to Follow-up|0
1314431|NCT02854527|4294091|P5|Overall Study|Lost to Follow-up|0
1314432|NCT02854527|4294092|P4|Overall Study|Lost to Follow-up|1
1314433|NCT02854527|4294093|P3|Overall Study|Lost to Follow-up|0
1314434|NCT02854527|4294094|P2|Overall Study|Lost to Follow-up|0
1314435|NCT02854527|4294095|P1|Overall Study|Lost to Follow-up|0
1314436|NCT02854527|4294086|P10|Overall Study|Adverse Event|0
1314437|NCT02854527|4294087|P9|Overall Study|Adverse Event|0
1314438|NCT02854527|4294088|P8|Overall Study|Adverse Event|0
1314439|NCT02854527|4294089|P7|Overall Study|Adverse Event|0
1314440|NCT02854527|4294090|P6|Overall Study|Adverse Event|0
1314441|NCT02854527|4294091|P5|Overall Study|Adverse Event|1
1314442|NCT02854527|4294092|P4|Overall Study|Adverse Event|0
1314443|NCT02854527|4294093|P3|Overall Study|Adverse Event|0
1314444|NCT02854527|4294094|P2|Overall Study|Adverse Event|0
1314445|NCT02854527|4294095|P1|Overall Study|Adverse Event|0
1314446|NCT02852434|4294128|P2|Overall Study|Unsuccessful Dilator Procedure|0
1314447|NCT02852434|4294129|P1|Overall Study|Unsuccessful Dilator Procedure|2
1314448|NCT02852434|4294128|P2|Overall Study|Withdrawal by Subject|1
1314449|NCT02852434|4294129|P1|Overall Study|Withdrawal by Subject|0
1314450|NCT02852265|4294145|P2|3-month Follow-up|Lost to Follow-up|1
1314451|NCT02852265|4294146|P1|3-month Follow-up|Lost to Follow-up|1
1314452|NCT02849678|4294173|P2|Overall Study|Protocol Violation|6
1314453|NCT02849678|4294174|P1|Overall Study|Protocol Violation|3
1314454|NCT02847260|4294205|P1|Overall Study|Physician Decision|1
1314455|NCT02847260|4294205|P1|Overall Study|Clinical Deterioration|1
1314456|NCT02847260|4294205|P1|Overall Study|Withdrawal by Subject|2
1314457|NCT02847260|4294205|P1|Overall Study|Adverse Event|3
1314458|NCT02846558|4294256|P4|Overall Study|Lost to Follow-up|0
1314459|NCT02846558|4294257|P3|Overall Study|Lost to Follow-up|0
1314460|NCT02846558|4294258|P2|Overall Study|Lost to Follow-up|0
1314461|NCT02846558|4294259|P1|Overall Study|Lost to Follow-up|2
1314462|NCT02846558|4294256|P4|Overall Study|Withdrawal by Subject|2
1314463|NCT02846558|4294257|P3|Overall Study|Withdrawal by Subject|2
1314464|NCT02846558|4294258|P2|Overall Study|Withdrawal by Subject|4
1314465|NCT02846558|4294259|P1|Overall Study|Withdrawal by Subject|5
1314466|NCT02846558|4294256|P4|Overall Study|Adverse Event|0
1314467|NCT02846558|4294257|P3|Overall Study|Adverse Event|0
1314468|NCT02846558|4294258|P2|Overall Study|Adverse Event|0
1314469|NCT02846558|4294259|P1|Overall Study|Adverse Event|1
1314470|NCT02844543|4294311|P1|Overall Study|Did not meet eligibility criteria|1
1314471|NCT02844543|4294311|P1|Overall Study|Withdrawal by Subject|4
1314472|NCT02840253|4294331|P1|Overall Study|Unsuccessful block|4
1314473|NCT02838901|4294378|P2|Overall Study|Lost to Follow-up|1
1314474|NCT02838901|4294379|P1|Overall Study|Lost to Follow-up|1
1314475|NCT02838901|4294378|P2|Overall Study|Withdrawal by Subject|1
1314476|NCT02838901|4294379|P1|Overall Study|Withdrawal by Subject|1
1314477|NCT02837952|4294409|P2|Overall Study|Medication Error|0
1314478|NCT02837952|4294410|P1|Overall Study|Medication Error|1
1314479|NCT02837952|4294409|P2|Overall Study|Withdrawal by Subject|5
1314480|NCT02837952|4294410|P1|Overall Study|Withdrawal by Subject|4
1314481|NCT02837952|4294409|P2|Overall Study|Adverse Event|1
1314482|NCT02837952|4294410|P1|Overall Study|Adverse Event|0
1314483|NCT02836249|4294424|P2|Overall Study|Still on Study|55
1314484|NCT02836249|4294425|P1|Overall Study|Still on Study|121
1314485|NCT02836249|4294424|P2|Overall Study|Lost to Follow-up|1
1314486|NCT02836249|4294425|P1|Overall Study|Lost to Follow-up|0
1314487|NCT02836249|4294424|P2|Overall Study|Withdrew Consent|1
1314488|NCT02836249|4294425|P1|Overall Study|Withdrew Consent|0
1314489|NCT02836249|4294424|P2|Overall Study|Pregnancy|0
1314490|NCT02836249|4294425|P1|Overall Study|Pregnancy|2
1314491|NCT02836249|4294424|P2|Overall Study|Randomized but Never Treated|1
1314492|NCT02836249|4294425|P1|Overall Study|Randomized but Never Treated|0
1314493|NCT02836236|4294443|P2|Overall Study|Still on Study|49
1314494|NCT02836236|4294444|P1|Overall Study|Still on Study|101
1314495|NCT02836236|4294443|P2|Overall Study|Investigator's Discretion|0
1314496|NCT02836236|4294444|P1|Overall Study|Investigator's Discretion|1
1314497|NCT02836236|4294443|P2|Overall Study|Adverse Event|1
1314498|NCT02836236|4294444|P1|Overall Study|Adverse Event|0
1314499|NCT02836236|4294443|P2|Overall Study|Withdrew Consent|0
1314500|NCT02836236|4294444|P1|Overall Study|Withdrew Consent|2
1314501|NCT02836236|4294443|P2|Overall Study|Randomized but Never Treated|0
1314502|NCT02836236|4294444|P1|Overall Study|Randomized but Never Treated|1
1314503|NCT02832375|4294482|P2|Overall Study|Withdrawal of Consent|0
1314504|NCT02832375|4294483|P1|Overall Study|Withdrawal of Consent|1
1314505|NCT02832375|4294482|P2|Overall Study|Lost to Follow-up|0
1314506|NCT02832375|4294483|P1|Overall Study|Lost to Follow-up|1
1314507|NCT02829996|4294507|P5|Overall Study|Withdrawal by Subject|0
1314508|NCT02829996|4294508|P4|Overall Study|Withdrawal by Subject|0
1314509|NCT02829996|4294509|P3|Overall Study|Withdrawal by Subject|0
1314510|NCT02829996|4294510|P2|Overall Study|Withdrawal by Subject|0
1314511|NCT02829996|4294511|P1|Overall Study|Withdrawal by Subject|1
1314512|NCT02829775|4294534|P1|Overall Study|Disease remission|1
1314513|NCT02829775|4294534|P1|Overall Study|Withdrawal by Subject|3
1314514|NCT02829775|4294534|P1|Overall Study|Death|1
1314515|NCT02829138|4294587|P2|Overall Study|Withdrawal by Subject|0
1314516|NCT02829138|4294588|P1|Overall Study|Withdrawal by Subject|1
1314517|NCT02826421|4294626|P4|Overall Study|Reason not given|0
1314518|NCT02826421|4294627|P3|Overall Study|Reason not given|1
1314519|NCT02826421|4294628|P2|Overall Study|Reason not given|0
1314520|NCT02826421|4294629|P1|Overall Study|Reason not given|1
1314521|NCT02826421|4294626|P4|Overall Study|Withdrawal by Subject|1
1314522|NCT02826421|4294627|P3|Overall Study|Withdrawal by Subject|1
1314523|NCT02826421|4294628|P2|Overall Study|Withdrawal by Subject|3
1314524|NCT02826421|4294629|P1|Overall Study|Withdrawal by Subject|1
1314525|NCT02826421|4294626|P4|Overall Study|Adverse Event|1
1314526|NCT02826421|4294627|P3|Overall Study|Adverse Event|0
1314527|NCT02826421|4294628|P2|Overall Study|Adverse Event|0
1314528|NCT02826421|4294629|P1|Overall Study|Adverse Event|1
1314529|NCT02825550|4294641|P1|Overall Study|Physician Decision|1
1314530|NCT02825251|4294649|P2|Overall Study|Unclassified|0
1314531|NCT02825251|4294650|P1|Overall Study|Unclassified|2
1314532|NCT02825251|4294649|P2|Overall Study|Withdrawal by Subject|4
1314533|NCT02825251|4294650|P1|Overall Study|Withdrawal by Subject|1
1314534|NCT02825251|4294649|P2|Overall Study|Lost to Follow-up|1
1314535|NCT02825251|4294650|P1|Overall Study|Lost to Follow-up|0
1314536|NCT02825251|4294649|P2|Overall Study|Adverse Event|1
1314537|NCT02825251|4294650|P1|Overall Study|Adverse Event|0
1314538|NCT02823964|4294851|P1|Overall Study|Withdrawal by Subject|1
1314539|NCT02823964|4294851|P1|Overall Study|Lack of Efficacy|1
1314540|NCT02823964|4294851|P1|Overall Study|Physician Decision|1
1314541|NCT02823964|4294851|P1|Overall Study|Adverse Event|2
1314542|NCT02822794|4294911|P2|Overall Study|Withdrew Consent|0
1314543|NCT02822794|4294912|P1|Overall Study|Withdrew Consent|1
1314544|NCT02815735|4295034|P2|Second Intervention (4 Weeks)|Protocol Violation|0
1314545|NCT02815735|4295035|P1|Second Intervention (4 Weeks)|Protocol Violation|1
1314546|NCT02815735|4295034|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
1314547|NCT02815735|4295035|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
1314548|NCT02815735|4295034|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
1314549|NCT02815735|4295035|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
1314550|NCT02815735|4295034|P2|First Intervention (4 Weeks)|Discomfort|0
1314551|NCT02815735|4295035|P1|First Intervention (4 Weeks)|Discomfort|1
1314552|NCT02815397|4295071|P1|Overall Study|Physician Decision|2
1314553|NCT02814643|4295080|P2|Overall Study|Withdrawal by Subject|2
1314554|NCT02814643|4295081|P1|Overall Study|Withdrawal by Subject|1
1314555|NCT02814643|4295080|P2|Overall Study|Lost to Follow-up|1
1314556|NCT02814643|4295081|P1|Overall Study|Lost to Follow-up|0
1314557|NCT02809833|4295180|P1|Overall Study|Missing Information|52
1314558|NCT02809833|4295180|P1|Overall Study|Not Specified|5
1314559|NCT02809833|4295180|P1|Overall Study|Adverse Event (AE)|24
1314560|NCT02809833|4295180|P1|Overall Study|Lost to Follow-up|35
1314561|NCT02809833|4295180|P1|Overall Study|Withdrawal by Subject|34
1314562|NCT02809833|4295180|P1|Overall Study|Noncompliance|1
1314563|NCT02809833|4295180|P1|Overall Study|Remission/Treatment No Longer Needed|3
1314564|NCT02809833|4295180|P1|Overall Study|Lack of Efficacy|89
1314565|NCT02809833|4295180|P1|Overall Study|Intolerance|54
1314566|NCT02809833|4295180|P1|Overall Study|Death|3
1314567|NCT02806505|4295315|P2|Overall Study|Insufficient therapeutic response|4
1314568|NCT02806505|4295316|P1|Overall Study|Insufficient therapeutic response|2
1314569|NCT02806505|4295315|P2|Overall Study|Failure to return|1
1314570|NCT02806505|4295316|P1|Overall Study|Failure to return|0
1314571|NCT02806505|4295315|P2|Overall Study|Did not cooperate/refused treatment|3
1314572|NCT02806505|4295316|P1|Overall Study|Did not cooperate/refused treatment|3
1314573|NCT02806505|4295315|P2|Overall Study|Death|0
1314574|NCT02806505|4295316|P1|Overall Study|Death|4
1314575|NCT02806505|4295315|P2|Overall Study|Adverse event/intercurrent illness|3
1314576|NCT02806505|4295316|P1|Overall Study|Adverse event/intercurrent illness|1
1314577|NCT02805907|4295328|P2|Overall Study|Lost to Follow-up|3
1314578|NCT02805907|4295329|P1|Overall Study|Lost to Follow-up|3
1314579|NCT02802878|4295343|P2|Overall Study|Protocol Violation|0
1314580|NCT02802878|4295344|P1|Overall Study|Protocol Violation|1
1314581|NCT02802878|4295343|P2|Overall Study|Withdrawal by Subject|3
1314582|NCT02802878|4295344|P1|Overall Study|Withdrawal by Subject|3
1314583|NCT02802592|4295358|P1|Overall Study|Study terminated due to loss of funding|4
1314584|NCT02801396|4295386|P6|Period 1|Withdrawal by Subject|0
1314585|NCT02801396|4295387|P5|Period 1|Withdrawal by Subject|1
1314586|NCT02801396|4295388|P4|Period 1|Withdrawal by Subject|0
1314587|NCT02801396|4295389|P3|Period 1|Withdrawal by Subject|0
1314588|NCT02801396|4295390|P2|Period 1|Withdrawal by Subject|0
1314589|NCT02801396|4295391|P1|Period 1|Withdrawal by Subject|0
1314590|NCT02799784|4295434|P2|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
1314591|NCT02799784|4295435|P1|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
1314592|NCT02799784|4295434|P2|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
1314593|NCT02799784|4295435|P1|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
1314594|NCT02799784|4295434|P2|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
1314595|NCT02799784|4295435|P1|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
1314596|NCT02799784|4295434|P2|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
1314597|NCT02799784|4295435|P1|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
1314598|NCT02799784|4295434|P2|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
1314599|NCT02799784|4295435|P1|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
1314600|NCT02799784|4295434|P2|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
1314601|NCT02799784|4295435|P1|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
1314602|NCT02799082|4295443|P2|Overall Study|Protocol Violation|1
1314603|NCT02799082|4295444|P1|Overall Study|Protocol Violation|0
1314604|NCT02799082|4295443|P2|Overall Study|Refused second PDT or withdraw consent|3
1314605|NCT02799082|4295444|P1|Overall Study|Refused second PDT or withdraw consent|4
1314606|NCT02799069|4295481|P3|Overall Study|Protocol Violation|2
1314607|NCT02799069|4295482|P2|Overall Study|Protocol Violation|0
1314608|NCT02799069|4295483|P1|Overall Study|Protocol Violation|1
1314609|NCT02799069|4295481|P3|Overall Study|Withdrawal by Subject|3
1314610|NCT02799069|4295482|P2|Overall Study|Withdrawal by Subject|4
1314611|NCT02799069|4295483|P1|Overall Study|Withdrawal by Subject|4
1314612|NCT02799069|4295481|P3|Overall Study|Lost to Follow-up|0
1314613|NCT02799069|4295482|P2|Overall Study|Lost to Follow-up|1
1314614|NCT02799069|4295483|P1|Overall Study|Lost to Follow-up|1
1314615|NCT02799069|4295481|P3|Overall Study|Lack of Efficacy|0
1314616|NCT02799069|4295482|P2|Overall Study|Lack of Efficacy|0
1314617|NCT02799069|4295483|P1|Overall Study|Lack of Efficacy|2
1314618|NCT02799069|4295481|P3|Overall Study|Adverse Event|2
1314619|NCT02799069|4295482|P2|Overall Study|Adverse Event|2
1314620|NCT02799069|4295483|P1|Overall Study|Adverse Event|0
1314621|NCT02797080|4295613|P1|Overall Study|Withdrawal by Subject|1
1314622|NCT02797080|4295613|P1|Overall Study|Lost to Follow-up|1
1314623|NCT02796963|4295655|P4|Overall Study|Lost to Follow-up|72
1314624|NCT02796963|4295656|P3|Overall Study|Lost to Follow-up|69
1314625|NCT02796963|4295657|P2|Overall Study|Lost to Follow-up|76
1314626|NCT02796963|4295658|P1|Overall Study|Lost to Follow-up|89
1314627|NCT02796651|4295720|P1|Overall Study|Not specified|10
1314628|NCT02796651|4295720|P1|Overall Study|Lack of Efficacy|1
1314629|NCT02796651|4295720|P1|Overall Study|Protocol Violation|4
1314630|NCT02796651|4295720|P1|Overall Study|Withdrawal by Subject|4
1314631|NCT02796651|4295720|P1|Overall Study|Lost to Follow-up|1
1314632|NCT02796651|4295720|P1|Overall Study|Adverse Event|6
1314633|NCT02794974|4295793|P2|Overall Study|Physician Decision|1
1314634|NCT02794974|4295794|P1|Overall Study|Physician Decision|0
1314635|NCT02794870|4295810|P2|Overall Study|Withdrawal by Subject|0
1314636|NCT02794870|4295811|P1|Overall Study|Withdrawal by Subject|2
1314637|NCT02794480|4295847|P4|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
1314638|NCT02794480|4295848|P3|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1314639|NCT02794480|4295849|P2|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1314640|NCT02794480|4295850|P1|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
1314641|NCT02794480|4295847|P4|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1314642|NCT02794480|4295848|P3|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1314643|NCT02794480|4295849|P2|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
1314644|NCT02794480|4295850|P1|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1314645|NCT02794480|4295847|P4|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
1314646|NCT02794480|4295848|P3|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
1314647|NCT02794480|4295849|P2|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
1314648|NCT02794480|4295850|P1|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
1314649|NCT02794480|4295847|P4|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
1314650|NCT02794480|4295848|P3|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
1314651|NCT02794480|4295849|P2|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
1314652|NCT02794480|4295850|P1|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
1314653|NCT02794480|4295847|P4|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
1314654|NCT02794480|4295848|P3|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
1314655|NCT02794480|4295849|P2|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
1314656|NCT02794480|4295850|P1|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
1314657|NCT02793947|4295870|P2|Overall Study|Physician Decision|5
1314658|NCT02793947|4295871|P1|Overall Study|Physician Decision|1
1314659|NCT02793947|4295870|P2|Overall Study|Death|0
1314660|NCT02793947|4295871|P1|Overall Study|Death|1
1314661|NCT02792062|4295973|P6|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1314662|NCT02792062|4295974|P5|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1314663|NCT02792062|4295975|P4|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1314664|NCT02792062|4295976|P3|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1314665|NCT02792062|4295977|P2|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1314666|NCT02792062|4295978|P1|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
1314667|NCT02791659|4296029|P2|Overall Study|Protocol Violation|1
1314668|NCT02791659|4296030|P1|Overall Study|Protocol Violation|0
1314669|NCT02791269|4296038|P2|Overall Study|Lost to Follow-up|1
1314670|NCT02791269|4296039|P1|Overall Study|Lost to Follow-up|0
1314671|NCT02788357|4296061|P2|Overall Study|Lost to Follow-up|0
1314672|NCT02788357|4296062|P1|Overall Study|Lost to Follow-up|3
1314673|NCT02786927|4296131|P1|Overall Study|Protocol Violation|4
1314674|NCT02786927|4296131|P1|Overall Study|Adverse Event|1
1314675|NCT02784106|4296216|P4|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
1314676|NCT02784106|4296217|P3|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
1314677|NCT02784106|4296218|P2|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
1314678|NCT02784106|4296219|P1|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
1314679|NCT02784106|4296216|P4|Open-Label Extension Period (26 Weeks)|Adverse Event|1
1314680|NCT02784106|4296217|P3|Open-Label Extension Period (26 Weeks)|Adverse Event|2
1314681|NCT02784106|4296218|P2|Open-Label Extension Period (26 Weeks)|Adverse Event|0
1314682|NCT02784106|4296219|P1|Open-Label Extension Period (26 Weeks)|Adverse Event|0
1314683|NCT02784106|4296216|P4|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1314684|NCT02784106|4296217|P3|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1314685|NCT02784106|4296218|P2|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1314686|NCT02784106|4296219|P1|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
1314687|NCT02784106|4296216|P4|Double-Blind Treatment Period (12 Weeks)|Not specified|0
1314688|NCT02784106|4296217|P3|Double-Blind Treatment Period (12 Weeks)|Not specified|0
1314689|NCT02784106|4296218|P2|Double-Blind Treatment Period (12 Weeks)|Not specified|0
1314690|NCT02784106|4296219|P1|Double-Blind Treatment Period (12 Weeks)|Not specified|2
1314691|NCT02784106|4296216|P4|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1314692|NCT02784106|4296217|P3|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1314693|NCT02784106|4296218|P2|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
1314694|NCT02784106|4296219|P1|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
1314695|NCT02784106|4296216|P4|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
1314696|NCT02784106|4296217|P3|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
1314697|NCT02784106|4296218|P2|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
1314698|NCT02784106|4296219|P1|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
1314699|NCT02782676|4296280|P2|Overall Study|Lost to Follow-up|1
1314700|NCT02782676|4296281|P1|Overall Study|Lost to Follow-up|0
1314701|NCT02782169|4296311|P2|Overall Study|Lost to Follow-up|2
1314702|NCT02782169|4296312|P1|Overall Study|Lost to Follow-up|1
1314703|NCT02781818|4296329|P3|Overall Study|Lost to Follow-up|1
1314704|NCT02781818|4296330|P2|Overall Study|Lost to Follow-up|2
1314705|NCT02781818|4296331|P1|Overall Study|Lost to Follow-up|4
1314706|NCT02780167|4296460|P5|Overall Study|Other|2
1314707|NCT02780167|4296461|P4|Overall Study|Other|1
1314708|NCT02780167|4296462|P3|Overall Study|Other|3
1314709|NCT02780167|4296463|P2|Overall Study|Other|0
1314710|NCT02780167|4296464|P1|Overall Study|Other|0
1314711|NCT02780167|4296460|P5|Overall Study|Withdrawal by Subject|4
1314712|NCT02780167|4296461|P4|Overall Study|Withdrawal by Subject|3
1314713|NCT02780167|4296462|P3|Overall Study|Withdrawal by Subject|4
1314714|NCT02780167|4296463|P2|Overall Study|Withdrawal by Subject|4
1314715|NCT02780167|4296464|P1|Overall Study|Withdrawal by Subject|6
1314716|NCT02780167|4296460|P5|Overall Study|Protocol Violation|2
1314717|NCT02780167|4296461|P4|Overall Study|Protocol Violation|1
1314718|NCT02780167|4296462|P3|Overall Study|Protocol Violation|1
1314719|NCT02780167|4296463|P2|Overall Study|Protocol Violation|5
1314720|NCT02780167|4296464|P1|Overall Study|Protocol Violation|5
1314721|NCT02780167|4296460|P5|Overall Study|No longer meets eligibility criteria|1
1314722|NCT02780167|4296461|P4|Overall Study|No longer meets eligibility criteria|1
1314723|NCT02780167|4296462|P3|Overall Study|No longer meets eligibility criteria|0
1314724|NCT02780167|4296463|P2|Overall Study|No longer meets eligibility criteria|0
1314725|NCT02780167|4296464|P1|Overall Study|No longer meets eligibility criteria|0
1314726|NCT02780167|4296460|P5|Overall Study|Does not meet entrance criteria|0
1314727|NCT02780167|4296461|P4|Overall Study|Does not meet entrance criteria|0
1314728|NCT02780167|4296462|P3|Overall Study|Does not meet entrance criteria|1
1314729|NCT02780167|4296463|P2|Overall Study|Does not meet entrance criteria|0
1314730|NCT02780167|4296464|P1|Overall Study|Does not meet entrance criteria|0
1314731|NCT02780167|4296460|P5|Overall Study|Lost to Follow-up|0
1314732|NCT02780167|4296461|P4|Overall Study|Lost to Follow-up|0
1314733|NCT02780167|4296462|P3|Overall Study|Lost to Follow-up|1
1314734|NCT02780167|4296463|P2|Overall Study|Lost to Follow-up|0
1314735|NCT02780167|4296464|P1|Overall Study|Lost to Follow-up|2
1314736|NCT02780167|4296460|P5|Overall Study|Lack of Efficacy|0
1314737|NCT02780167|4296461|P4|Overall Study|Lack of Efficacy|1
1314738|NCT02780167|4296462|P3|Overall Study|Lack of Efficacy|6
1314739|NCT02780167|4296463|P2|Overall Study|Lack of Efficacy|5
1314740|NCT02780167|4296464|P1|Overall Study|Lack of Efficacy|6
1314741|NCT02780167|4296460|P5|Overall Study|Adverse Event|8
1314742|NCT02780167|4296461|P4|Overall Study|Adverse Event|12
1314743|NCT02780167|4296462|P3|Overall Study|Adverse Event|8
1314744|NCT02780167|4296463|P2|Overall Study|Adverse Event|8
1314745|NCT02780167|4296464|P1|Overall Study|Adverse Event|9
1314746|NCT02777242|4296633|P1|Overall Study|Withdrawal by Subject|1
1314747|NCT02777242|4296633|P1|Overall Study|Sponsor's request|1
1314748|NCT02777242|4296633|P1|Overall Study|Multiple|1
1314749|NCT02777242|4296633|P1|Overall Study|Lost to Follow-up|1
1314750|NCT02777242|4296633|P1|Overall Study|Other|2
1314751|NCT02777125|4296639|P2|Overall Study|Protocol Violation|12
1314752|NCT02777125|4296640|P1|Overall Study|Protocol Violation|8
1314753|NCT02777125|4296639|P2|Overall Study|Assent form violation|23
1314754|NCT02777125|4296640|P1|Overall Study|Assent form violation|21
1314755|NCT02777125|4296639|P2|Overall Study|Consent form violation|12
1314756|NCT02777125|4296640|P1|Overall Study|Consent form violation|14
1314757|NCT02774278|4296693|P1|Overall Study|Protocol Violation|2
1314758|NCT02774278|4296693|P1|Overall Study|Withdrawal by Subject|3
1314759|NCT02774278|4296693|P1|Overall Study|Administrative reasons|6
1314760|NCT02774278|4296693|P1|Overall Study|Refused treatment/did not cooperate|9
1314761|NCT02774278|4296693|P1|Overall Study|Adverse event/intercurrent illness|16
1314762|NCT02774278|4296693|P1|Overall Study|Death|29
1314763|NCT02774278|4296693|P1|Overall Study|Lack of Efficacy|199
1314764|NCT02773446|4296750|P6|First Admission|Lost to Follow-up|0
1314765|NCT02773446|4296751|P5|First Admission|Lost to Follow-up|0
1314766|NCT02773446|4296752|P4|First Admission|Lost to Follow-up|0
1314767|NCT02773446|4296753|P3|First Admission|Lost to Follow-up|0
1314768|NCT02773446|4296754|P2|First Admission|Lost to Follow-up|0
1314769|NCT02773446|4296755|P1|First Admission|Lost to Follow-up|1
1314770|NCT02773446|4296750|P6|First Admission|Withdrawal by Subject|0
1314771|NCT02773446|4296751|P5|First Admission|Withdrawal by Subject|0
1314772|NCT02773446|4296752|P4|First Admission|Withdrawal by Subject|1
1314773|NCT02773446|4296753|P3|First Admission|Withdrawal by Subject|0
1314774|NCT02773446|4296754|P2|First Admission|Withdrawal by Subject|0
1314775|NCT02773446|4296755|P1|First Admission|Withdrawal by Subject|0
1314776|NCT02770248|4296814|P2|Overall Study|Randomized in error, prior to treatment|1
1314777|NCT02770248|4296815|P1|Overall Study|Randomized in error, prior to treatment|0
1314778|NCT02770248|4296814|P2|Overall Study|Adverse Event|1
1314779|NCT02770248|4296815|P1|Overall Study|Adverse Event|0
1314780|NCT02769858|4296827|P1|Overall Study|Withdrawal by Subject|2
1314781|NCT02768194|4296844|P6|Period 3|Other (Reason not specified)|0
1314782|NCT02768194|4296845|P5|Period 3|Other (Reason not specified)|0
1314783|NCT02768194|4296846|P4|Period 3|Other (Reason not specified)|0
1314784|NCT02768194|4296847|P3|Period 3|Other (Reason not specified)|0
1314785|NCT02768194|4296848|P2|Period 3|Other (Reason not specified)|1
1314786|NCT02768194|4296849|P1|Period 3|Other (Reason not specified)|0
1314787|NCT02768194|4296844|P6|Period 2|Other (Reason not specified)|0
1314788|NCT02768194|4296845|P5|Period 2|Other (Reason not specified)|0
1314789|NCT02768194|4296846|P4|Period 2|Other (Reason not specified)|0
1314790|NCT02768194|4296847|P3|Period 2|Other (Reason not specified)|0
1314791|NCT02768194|4296848|P2|Period 2|Other (Reason not specified)|0
1314792|NCT02768194|4296849|P1|Period 2|Other (Reason not specified)|1
1314793|NCT02768194|4296844|P6|Period 1|Adverse Event|0
1314794|NCT02768194|4296845|P5|Period 1|Adverse Event|0
1314795|NCT02768194|4296846|P4|Period 1|Adverse Event|1
1314796|NCT02768194|4296847|P3|Period 1|Adverse Event|0
1314797|NCT02768194|4296848|P2|Period 1|Adverse Event|0
1314798|NCT02768194|4296849|P1|Period 1|Adverse Event|0
1314799|NCT02767765|4296866|P1|Overall Study|Withdrawal by Subject|1
1314800|NCT02767765|4296866|P1|Overall Study|Non-Compliance|1
1314801|NCT02767765|4296866|P1|Overall Study|Investigator decision|1
1314802|NCT02767765|4296866|P1|Overall Study|Lost to Follow-up|2
1314803|NCT02767765|4296866|P1|Overall Study|Insufficient response|1
1314804|NCT02767765|4296866|P1|Overall Study|Death|1
1314805|NCT02767765|4296866|P1|Overall Study|Adverse Event|4
1314806|NCT02766400|4296877|P2|Overall Study|Withdrawal by Subject|0
1314807|NCT02766400|4296878|P1|Overall Study|Withdrawal by Subject|1
1314808|NCT02766400|4296877|P2|Overall Study|Death|2
1314809|NCT02766400|4296878|P1|Overall Study|Death|1
1314810|NCT02766283|4296884|P1|Overall Study|Lost to Follow-up|27
1314811|NCT02764697|4296947|P1|Overall Study|Lack of Efficacy|3
1314812|NCT02763189|4296954|P2|Overall Study|Device failure|2
1314813|NCT02763189|4296955|P1|Overall Study|Device failure|0
1314814|NCT02762370|4296965|P2|Overall Study|Protocol Violation|0
1314815|NCT02762370|4296966|P1|Overall Study|Protocol Violation|1
1314816|NCT02761733|4296988|P4|Overall Study|Cognitive Impairment|0
1314817|NCT02761733|4296989|P3|Overall Study|Cognitive Impairment|1
1314818|NCT02761733|4296990|P2|Overall Study|Cognitive Impairment|0
1314819|NCT02761733|4296991|P1|Overall Study|Cognitive Impairment|5
1314820|NCT02761733|4296988|P4|Overall Study|Discharged from Study Site|11
1314821|NCT02761733|4296989|P3|Overall Study|Discharged from Study Site|25
1314822|NCT02761733|4296990|P2|Overall Study|Discharged from Study Site|9
1314823|NCT02761733|4296991|P1|Overall Study|Discharged from Study Site|10
1314824|NCT02761733|4296988|P4|Overall Study|Withdrawal by Subject|0
1314825|NCT02761733|4296989|P3|Overall Study|Withdrawal by Subject|0
1314826|NCT02761733|4296990|P2|Overall Study|Withdrawal by Subject|0
1314827|NCT02761733|4296991|P1|Overall Study|Withdrawal by Subject|2
1314828|NCT02761733|4296988|P4|Overall Study|Physician Decision|0
1314829|NCT02761733|4296989|P3|Overall Study|Physician Decision|0
1314830|NCT02761733|4296990|P2|Overall Study|Physician Decision|0
1314831|NCT02761733|4296991|P1|Overall Study|Physician Decision|4
1314832|NCT02761733|4296988|P4|Overall Study|Lost to Follow-up|3
1314833|NCT02761733|4296989|P3|Overall Study|Lost to Follow-up|0
1314834|NCT02761733|4296990|P2|Overall Study|Lost to Follow-up|7
1314835|NCT02761733|4296991|P1|Overall Study|Lost to Follow-up|6
1314836|NCT02761733|4296988|P4|Overall Study|Death|1
1314837|NCT02761733|4296989|P3|Overall Study|Death|1
1314838|NCT02761733|4296990|P2|Overall Study|Death|5
1314839|NCT02761733|4296991|P1|Overall Study|Death|3
1314840|NCT02761642|4297021|P1|Overall Study|Reason Unspecified|21
1314841|NCT02761642|4297021|P1|Overall Study|Physician Decision|1
1314842|NCT02761642|4297021|P1|Overall Study|Lack of Efficacy|20
1314843|NCT02761642|4297021|P1|Overall Study|Death|3
1314844|NCT02761642|4297021|P1|Overall Study|Non-compliant|7
1314845|NCT02761642|4297021|P1|Overall Study|Withdrawal by Subject|2
1314846|NCT02761642|4297021|P1|Overall Study|Adverse Event|13
1314847|NCT02761642|4297021|P1|Overall Study|Did not Receive Study Treatment|3
1314848|NCT02761629|4297034|P2|Overall Study|Randomized But Not Treated|4
1314849|NCT02761629|4297035|P1|Overall Study|Randomized But Not Treated|8
1314850|NCT02761629|4297034|P2|Overall Study|Lost to Follow-up|1
1314851|NCT02761629|4297035|P1|Overall Study|Lost to Follow-up|4
1314852|NCT02761629|4297034|P2|Overall Study|Other|2
1314853|NCT02761629|4297035|P1|Overall Study|Other|0
1314854|NCT02761629|4297034|P2|Overall Study|Withdrawal by Subject|3
1314855|NCT02761629|4297035|P1|Overall Study|Withdrawal by Subject|0
1314856|NCT02761629|4297034|P2|Overall Study|Protocol Violation|2
1314857|NCT02761629|4297035|P1|Overall Study|Protocol Violation|2
1314858|NCT02761629|4297034|P2|Overall Study|Did not Cooperate/Refused Treatment|4
1314859|NCT02761629|4297035|P1|Overall Study|Did not Cooperate/Refused Treatment|2
1314860|NCT02761629|4297034|P2|Overall Study|Failure to Return|4
1314861|NCT02761629|4297035|P1|Overall Study|Failure to Return|2
1314862|NCT02761629|4297034|P2|Overall Study|Insufficient Therapeutic Response|7
1314863|NCT02761629|4297035|P1|Overall Study|Insufficient Therapeutic Response|2
1314864|NCT02761629|4297034|P2|Overall Study|Adverse Event/Intercurrent Illness|5
1314865|NCT02761629|4297035|P1|Overall Study|Adverse Event/Intercurrent Illness|7
1314866|NCT02760810|4297055|P1|Overall Study|Protocol Violation|1
1314867|NCT02760654|4297063|P2|Overall Study|Withdrawal by Subject|3
1314868|NCT02760654|4297064|P1|Overall Study|Withdrawal by Subject|4
1314869|NCT02760654|4297063|P2|Overall Study|Lost to Follow-up|3
1314870|NCT02760654|4297064|P1|Overall Study|Lost to Follow-up|3
1314871|NCT02760602|4297090|P2|Overall Study|Terminated by sponsor|13
1314872|NCT02760602|4297091|P1|Overall Study|Terminated by sponsor|12
1314873|NCT02760602|4297090|P2|Overall Study|Withdrawal by Subject|0
1314874|NCT02760602|4297091|P1|Overall Study|Withdrawal by Subject|1
1314875|NCT02759692|4297129|P2|Period 2|Test article no longer available|1
1314876|NCT02759692|4297130|P1|Period 2|Test article no longer available|0
1314877|NCT02759692|4297129|P2|Period 2|Lost to Follow-up|0
1314878|NCT02759692|4297130|P1|Period 2|Lost to Follow-up|1
1314879|NCT02759692|4297129|P2|Period 1|Miss-Randomized|1
1314880|NCT02759692|4297130|P1|Period 1|Miss-Randomized|1
1314881|NCT02759692|4297129|P2|Period 1|No longer meets eligibility criteria.|0
1314882|NCT02759692|4297130|P1|Period 1|No longer meets eligibility criteria.|1
1314883|NCT02759692|4297129|P2|Period 1|Test article no longer available|1
1314884|NCT02759692|4297130|P1|Period 1|Test article no longer available|1
1314885|NCT02759562|4297148|P2|Open-Label Treatment Period|Study Terminated by Sponsor|2
1314886|NCT02759562|4297149|P1|Open-Label Treatment Period|Study Terminated by Sponsor|1
1314887|NCT02759562|4297148|P2|Open-Label Treatment Period|Withdrew Consent|0
1314888|NCT02759562|4297149|P1|Open-Label Treatment Period|Withdrew Consent|1
1314889|NCT02759471|4297162|P1|Overall Study|discomfort|2
1314890|NCT02759315|4297177|P5|Overall Study|Study terminated prior to completion|1
1314891|NCT02759315|4297178|P4|Overall Study|Study terminated prior to completion|0
1314892|NCT02759315|4297179|P3|Overall Study|Study terminated prior to completion|5
1314893|NCT02759315|4297180|P2|Overall Study|Study terminated prior to completion|0
1314894|NCT02759315|4297181|P1|Overall Study|Study terminated prior to completion|2
1314895|NCT02759315|4297177|P5|Overall Study|Protocol Violation|0
1314896|NCT02759315|4297178|P4|Overall Study|Protocol Violation|0
1314897|NCT02759315|4297179|P3|Overall Study|Protocol Violation|0
1314898|NCT02759315|4297180|P2|Overall Study|Protocol Violation|1
1314899|NCT02759315|4297181|P1|Overall Study|Protocol Violation|0
1314900|NCT02759315|4297177|P5|Overall Study|Lost to Follow-up|0
1314901|NCT02759315|4297178|P4|Overall Study|Lost to Follow-up|0
1314902|NCT02759315|4297179|P3|Overall Study|Lost to Follow-up|4
1314903|NCT02759315|4297180|P2|Overall Study|Lost to Follow-up|0
1314904|NCT02759315|4297181|P1|Overall Study|Lost to Follow-up|2
1314905|NCT02759315|4297177|P5|Overall Study|Death|0
1314906|NCT02759315|4297178|P4|Overall Study|Death|0
1314907|NCT02759315|4297179|P3|Overall Study|Death|1
1314908|NCT02759315|4297180|P2|Overall Study|Death|0
1314909|NCT02759315|4297181|P1|Overall Study|Death|0
1314910|NCT02759315|4297177|P5|Overall Study|Adverse Event|0
1314911|NCT02759315|4297178|P4|Overall Study|Adverse Event|1
1314912|NCT02759315|4297179|P3|Overall Study|Adverse Event|0
1314913|NCT02759315|4297180|P2|Overall Study|Adverse Event|0
1314914|NCT02759315|4297181|P1|Overall Study|Adverse Event|0
1314915|NCT02758613|4297229|P4|Treatment|Withdrawal by Subject|0
1314916|NCT02758613|4297230|P3|Treatment|Withdrawal by Subject|1
1314917|NCT02758613|4297231|P2|Treatment|Withdrawal by Subject|0
1314918|NCT02758613|4297232|P1|Treatment|Withdrawal by Subject|1
1314919|NCT02758613|4297229|P4|Treatment|Physician and Sponsor Decision|0
1314920|NCT02758613|4297230|P3|Treatment|Physician and Sponsor Decision|0
1314921|NCT02758613|4297231|P2|Treatment|Physician and Sponsor Decision|0
1314922|NCT02758613|4297232|P1|Treatment|Physician and Sponsor Decision|1
1314923|NCT02758171|4297259|P2|Wash-out|Other reason|0
1314924|NCT02758171|4297260|P1|Wash-out|Other reason|1
1314925|NCT02758171|4297259|P2|Wash-out|Withdrawal by Subject|0
1314926|NCT02758171|4297260|P1|Wash-out|Withdrawal by Subject|1
1314927|NCT02756637|4297316|P2|Overall Study|Did not complete curative therapy|0
1314928|NCT02756637|4297317|P1|Overall Study|Did not complete curative therapy|33
1314929|NCT02756637|4297316|P2|Overall Study|No available NLR value|44
1314930|NCT02756637|4297317|P1|Overall Study|No available NLR value|44
1314931|NCT02756637|4297316|P2|Overall Study|Not eligible for initial SWOG study|10
1314932|NCT02756637|4297317|P1|Overall Study|Not eligible for initial SWOG study|10
1314933|NCT02755805|4297356|P2|Overall Study|Withdrawal by Subject|2
1314934|NCT02755805|4297357|P1|Overall Study|Withdrawal by Subject|0
1314935|NCT02755805|4297356|P2|Overall Study|Refused assessments|0
1314936|NCT02755805|4297357|P1|Overall Study|Refused assessments|1
1314937|NCT02755805|4297356|P2|Overall Study|Lost to Follow-up|2
1314938|NCT02755805|4297357|P1|Overall Study|Lost to Follow-up|1
1314939|NCT02755090|4297371|P2|Overall Study|equipment malfunction|0
1314940|NCT02755090|4297372|P1|Overall Study|equipment malfunction|1
1314941|NCT02754492|4297384|P4|Overall Study|Venous access issues not resulting in AE|4
1314942|NCT02754492|4297385|P3|Overall Study|Venous access issues not resulting in AE|0
1314943|NCT02754492|4297386|P2|Overall Study|Venous access issues not resulting in AE|0
1314944|NCT02754492|4297387|P1|Overall Study|Venous access issues not resulting in AE|0
1314945|NCT02754492|4297384|P4|Overall Study|Adverse Event|13
1314946|NCT02754492|4297385|P3|Overall Study|Adverse Event|0
1314947|NCT02754492|4297386|P2|Overall Study|Adverse Event|0
1314948|NCT02754492|4297387|P1|Overall Study|Adverse Event|0
1314949|NCT02754492|4297384|P4|Overall Study|Equipment malfuntion|5
1314950|NCT02754492|4297385|P3|Overall Study|Equipment malfuntion|2
1314951|NCT02754492|4297386|P2|Overall Study|Equipment malfuntion|0
1314952|NCT02754492|4297387|P1|Overall Study|Equipment malfuntion|0
1314953|NCT02754492|4297384|P4|Overall Study|Withdrawal by Subject|0
1314954|NCT02754492|4297385|P3|Overall Study|Withdrawal by Subject|0
1314955|NCT02754492|4297386|P2|Overall Study|Withdrawal by Subject|0
1314956|NCT02754492|4297387|P1|Overall Study|Withdrawal by Subject|2
1314957|NCT02754492|4297384|P4|Overall Study|Protocol Violation|1
1314958|NCT02754492|4297385|P3|Overall Study|Protocol Violation|0
1314959|NCT02754492|4297386|P2|Overall Study|Protocol Violation|2
1314960|NCT02754492|4297387|P1|Overall Study|Protocol Violation|2
1314961|NCT02754440|4297403|P4|Overall Study|Subject issues not resulting in AE|12
1314962|NCT02754440|4297404|P3|Overall Study|Subject issues not resulting in AE|0
1314963|NCT02754440|4297405|P2|Overall Study|Subject issues not resulting in AE|0
1314964|NCT02754440|4297406|P1|Overall Study|Subject issues not resulting in AE|0
1314965|NCT02754440|4297403|P4|Overall Study|Equipment failure|7
1314966|NCT02754440|4297404|P3|Overall Study|Equipment failure|5
1314967|NCT02754440|4297405|P2|Overall Study|Equipment failure|5
1314968|NCT02754440|4297406|P1|Overall Study|Equipment failure|0
1314969|NCT02754440|4297403|P4|Overall Study|Withdrawal by Subject|1
1314970|NCT02754440|4297404|P3|Overall Study|Withdrawal by Subject|0
1314971|NCT02754440|4297405|P2|Overall Study|Withdrawal by Subject|0
1314972|NCT02754440|4297406|P1|Overall Study|Withdrawal by Subject|0
1314973|NCT02754440|4297403|P4|Overall Study|Adverse Event|9
1314974|NCT02754440|4297404|P3|Overall Study|Adverse Event|0
1314975|NCT02754440|4297405|P2|Overall Study|Adverse Event|1
1314976|NCT02754440|4297406|P1|Overall Study|Adverse Event|3
1314977|NCT02754440|4297403|P4|Overall Study|Protocol Violation|6
1314978|NCT02754440|4297404|P3|Overall Study|Protocol Violation|2
1314979|NCT02754440|4297405|P2|Overall Study|Protocol Violation|2
1314980|NCT02754440|4297406|P1|Overall Study|Protocol Violation|3
1314981|NCT02753075|4297475|P3|Overall Study|Physician Decision|0
1314982|NCT02753075|4297476|P2|Overall Study|Physician Decision|1
1314983|NCT02753075|4297477|P1|Overall Study|Physician Decision|3
1314984|NCT02753075|4297475|P3|Overall Study|Withdrawal of Consent|3
1314985|NCT02753075|4297476|P2|Overall Study|Withdrawal of Consent|1
1314986|NCT02753075|4297477|P1|Overall Study|Withdrawal of Consent|1
1314987|NCT02753075|4297475|P3|Overall Study|Lost to Follow-up|0
1314988|NCT02753075|4297476|P2|Overall Study|Lost to Follow-up|0
1314989|NCT02753075|4297477|P1|Overall Study|Lost to Follow-up|2
1314990|NCT02753075|4297475|P3|Overall Study|Adverse Event|0
1314991|NCT02753075|4297476|P2|Overall Study|Adverse Event|1
1314992|NCT02753075|4297477|P1|Overall Study|Adverse Event|2
1314993|NCT02752958|4297502|P1|Overall Study|Other (Reason not specified)|2
1314994|NCT02752958|4297502|P1|Overall Study|Withdrawal by Subject|2
1314995|NCT02752958|4297502|P1|Overall Study|Protocol Violation|1
1314996|NCT02752958|4297502|P1|Overall Study|Lost to Follow-up|1
1314997|NCT02752958|4297502|P1|Overall Study|Adverse Event|3
1314998|NCT02752802|4297573|P2|Overall Study|Contrast Volume Not Collected|0
1314999|NCT02752802|4297574|P1|Overall Study|Contrast Volume Not Collected|1
1315000|NCT02752633|4297583|P1|Overall Study|Withdrawal by Subject|1
1315001|NCT02751450|4297612|P2|Overall Study|Adverse Event|0
1315002|NCT02751450|4297613|P1|Overall Study|Adverse Event|1
1315003|NCT02751320|4297625|P1|Overall Study|Withdrawal by Subject|1
1315004|NCT02751320|4297625|P1|Overall Study|Adverse Event|2
1315005|NCT02750943|4297663|P2|Overall Study|Withdrawal by Subject|7
1315006|NCT02750943|4297664|P1|Overall Study|Withdrawal by Subject|5
1315007|NCT02750943|4297663|P2|Overall Study|Lost to Follow-up|2
1315008|NCT02750943|4297664|P1|Overall Study|Lost to Follow-up|1
1315009|NCT02750930|4297678|P1|Overall Study|Study closed/terminated|8
1315010|NCT02750813|4297690|P2|Period 1, First 14 Days of Wear|Reason not given|1
1315011|NCT02750813|4297691|P1|Period 1, First 14 Days of Wear|Reason not given|0
1315012|NCT02750813|4297690|P2|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
1315013|NCT02750813|4297691|P1|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
1315014|NCT02750709|4297700|P6|Treatment Period 1|Adverse Event|1
1315015|NCT02750709|4297701|P5|Treatment Period 1|Adverse Event|0
1315016|NCT02750709|4297702|P4|Treatment Period 1|Adverse Event|0
1315017|NCT02750709|4297703|P3|Treatment Period 1|Adverse Event|0
1315018|NCT02750709|4297704|P2|Treatment Period 1|Adverse Event|0
1315019|NCT02750709|4297705|P1|Treatment Period 1|Adverse Event|0
1315020|NCT02750501|4297744|P1|Overall Study|Non-compliant use of PERT|1
1315021|NCT02750501|4297744|P1|Overall Study|G-tube came out|1
1315022|NCT02750501|4297744|P1|Overall Study|Protocol Violation|1
1315023|NCT02750501|4297744|P1|Overall Study|Physician Decision|1
1315024|NCT02750501|4297744|P1|Overall Study|Adverse Event|4
1315025|NCT02750345|4297756|P6|Intervention 1|Adverse Event|0
1315026|NCT02750345|4297757|P5|Intervention 1|Adverse Event|1
1315027|NCT02750345|4297758|P4|Intervention 1|Adverse Event|0
1315028|NCT02750345|4297759|P3|Intervention 1|Adverse Event|0
1315029|NCT02750345|4297760|P2|Intervention 1|Adverse Event|0
1315030|NCT02750345|4297761|P1|Intervention 1|Adverse Event|0
1315031|NCT02750332|4297787|P2|Treatment Period 1|Withdrawal by Subject|1
1315032|NCT02750332|4297788|P1|Treatment Period 1|Withdrawal by Subject|0
1315033|NCT02749370|4297847|P1|Overall Study|Lost to Follow-up|3
1315034|NCT02749370|4297847|P1|Overall Study|Withdrawal by Subject|11
1315035|NCT02748213|4297883|P2|Overall Study|Not Specified|29
1315036|NCT02748213|4297884|P1|Overall Study|Not Specified|30
1315037|NCT02748213|4297883|P2|Overall Study|Failure to Return|0
1315038|NCT02748213|4297884|P1|Overall Study|Failure to Return|1
1315039|NCT02748213|4297883|P2|Overall Study|Refused Treatment*|6
1315040|NCT02748213|4297884|P1|Overall Study|Refused Treatment*|6
1315041|NCT02748213|4297883|P2|Overall Study|Protocol Violation|4
1315042|NCT02748213|4297884|P1|Overall Study|Protocol Violation|6
1315043|NCT02748213|4297883|P2|Overall Study|Violation of Selection Criteria|0
1315044|NCT02748213|4297884|P1|Overall Study|Violation of Selection Criteria|2
1315045|NCT02748213|4297883|P2|Overall Study|Insufficient Therapeutic Response|57
1315046|NCT02748213|4297884|P1|Overall Study|Insufficient Therapeutic Response|56
1315047|NCT02748213|4297883|P2|Overall Study|Death|3
1315048|NCT02748213|4297884|P1|Overall Study|Death|5
1315049|NCT02748213|4297883|P2|Overall Study|Adverse Event or Intercurrent Illness|11
1315050|NCT02748213|4297884|P1|Overall Study|Adverse Event or Intercurrent Illness|5
1315051|NCT02748213|4297883|P2|Overall Study|Abnormal Laboratory Test|0
1315052|NCT02748213|4297884|P1|Overall Study|Abnormal Laboratory Test|1
1315053|NCT02748213|4297883|P2|Overall Study|Withdrawal Prior to Treatment|2
1315054|NCT02748213|4297884|P1|Overall Study|Withdrawal Prior to Treatment|1
1315055|NCT02746679|4297920|P2|Overall Study|Lost to Follow-up|6
1315056|NCT02746679|4297921|P1|Overall Study|Lost to Follow-up|4
1315057|NCT02745392|4298005|P4|Overall Study|Lost to Follow-up|0
1315058|NCT02745392|4298006|P3|Overall Study|Lost to Follow-up|0
1315059|NCT02745392|4298007|P2|Overall Study|Lost to Follow-up|1
1315060|NCT02745392|4298008|P1|Overall Study|Lost to Follow-up|0
1315061|NCT02743962|4298024|P2|Overall Study|Atrophic vaginitis diagnosed|0
1315062|NCT02743962|4298025|P1|Overall Study|Atrophic vaginitis diagnosed|1
1315063|NCT02743780|4298060|P5|Part 3 (7 Days)|Adverse Event|0
1315064|NCT02743780|4298061|P4|Part 3 (7 Days)|Adverse Event|0
1315065|NCT02743780|4298062|P3|Part 3 (7 Days)|Adverse Event|1
1315066|NCT02743780|4298063|P2|Part 3 (7 Days)|Adverse Event|0
1315067|NCT02743780|4298064|P1|Part 3 (7 Days)|Adverse Event|0
1315068|NCT02743117|4298120|P2|Overall Study|Other|0
1315069|NCT02743117|4298121|P1|Overall Study|Other|1
1315070|NCT02743117|4298120|P2|Overall Study|Lost to Follow-up|1
1315071|NCT02743117|4298121|P1|Overall Study|Lost to Follow-up|0
1315072|NCT02742818|4298146|P2|Overall Study|Protocol Violation|1
1315073|NCT02742818|4298147|P1|Overall Study|Protocol Violation|0
1315074|NCT02742818|4298146|P2|Overall Study|Adverse Event|1
1315075|NCT02742818|4298147|P1|Overall Study|Adverse Event|0
1315076|NCT02741713|4298163|P2|Overall Study|Surgery type changed intra-operatively|1
1315077|NCT02741713|4298164|P1|Overall Study|Surgery type changed intra-operatively|2
1315078|NCT02741245|4298209|P5|Overall Study|Withdrawal by Subject|0
1315079|NCT02741245|4298210|P4|Overall Study|Withdrawal by Subject|1
1315080|NCT02741245|4298211|P3|Overall Study|Withdrawal by Subject|0
1315081|NCT02741245|4298212|P2|Overall Study|Withdrawal by Subject|0
1315082|NCT02741245|4298213|P1|Overall Study|Withdrawal by Subject|0
1315083|NCT02741245|4298209|P5|Overall Study|Protocol Violation|0
1315084|NCT02741245|4298210|P4|Overall Study|Protocol Violation|1
1315085|NCT02741245|4298211|P3|Overall Study|Protocol Violation|0
1315086|NCT02741245|4298212|P2|Overall Study|Protocol Violation|1
1315087|NCT02741245|4298213|P1|Overall Study|Protocol Violation|0
1315088|NCT02741245|4298209|P5|Overall Study|Adverse Event|2
1315089|NCT02741245|4298210|P4|Overall Study|Adverse Event|2
1315090|NCT02741245|4298211|P3|Overall Study|Adverse Event|0
1315091|NCT02741245|4298212|P2|Overall Study|Adverse Event|0
1315092|NCT02741245|4298213|P1|Overall Study|Adverse Event|0
1315093|NCT02739997|4298315|P1|Overall Study|Withdrawal by Subject|1
1315094|NCT02739997|4298315|P1|Overall Study|Death|1
1315095|NCT02739984|4298329|P2|Overall Study|Lost to Follow-up|0
1315096|NCT02739984|4298330|P1|Overall Study|Lost to Follow-up|3
1315097|NCT02739984|4298329|P2|Overall Study|Death|1
1315098|NCT02739984|4298330|P1|Overall Study|Death|0
1315099|NCT02739984|4298329|P2|Overall Study|Withdrawal by Subject|1
1315100|NCT02739984|4298330|P1|Overall Study|Withdrawal by Subject|1
1315101|NCT02739984|4298329|P2|Overall Study|Sponsor Decision|0
1315102|NCT02739984|4298330|P1|Overall Study|Sponsor Decision|1
1315103|NCT02739594|4298389|P2|Overall Study|Not Specified|2
1315104|NCT02739594|4298390|P1|Overall Study|Not Specified|6
1315105|NCT02739594|4298389|P2|Overall Study|Elevated Serum Creatinine|1
1315106|NCT02739594|4298390|P1|Overall Study|Elevated Serum Creatinine|0
1315107|NCT02739594|4298389|P2|Overall Study|Lost to Follow-up|1
1315108|NCT02739594|4298390|P1|Overall Study|Lost to Follow-up|0
1315109|NCT02739594|4298389|P2|Overall Study|Withdrawal by Subject|1
1315110|NCT02739594|4298390|P1|Overall Study|Withdrawal by Subject|1
1315111|NCT02739594|4298389|P2|Overall Study|Administrative Reasons|3
1315112|NCT02739594|4298390|P1|Overall Study|Administrative Reasons|1
1315113|NCT02739594|4298389|P2|Overall Study|Renal Insufficiency|6
1315114|NCT02739594|4298390|P1|Overall Study|Renal Insufficiency|4
1315115|NCT02739594|4298389|P2|Overall Study|Death|2
1315116|NCT02739594|4298390|P1|Overall Study|Death|4
1315117|NCT02739594|4298389|P2|Overall Study|Protocol Violation|6
1315118|NCT02739594|4298390|P1|Overall Study|Protocol Violation|5
1315119|NCT02739594|4298389|P2|Overall Study|Violation of Eligibility Criteria|2
1315120|NCT02739594|4298390|P1|Overall Study|Violation of Eligibility Criteria|1
1315121|NCT02739594|4298389|P2|Overall Study|Undesired Event|4
1315122|NCT02739594|4298390|P1|Overall Study|Undesired Event|3
1315123|NCT02739321|4298422|P2|Overall Study|Withdrawal by Subject|2
1315124|NCT02739321|4298423|P1|Overall Study|Withdrawal by Subject|1
1315125|NCT02739321|4298422|P2|Overall Study|Lost to Follow-up|1
1315126|NCT02739321|4298423|P1|Overall Study|Lost to Follow-up|1
1315127|NCT02739321|4298422|P2|Overall Study|Lack of Efficacy|1
1315128|NCT02739321|4298423|P1|Overall Study|Lack of Efficacy|1
1315129|NCT02738333|4298486|P3|Overall Study|Lost to Follow-up|0
1315130|NCT02738333|4298487|P2|Overall Study|Lost to Follow-up|0
1315131|NCT02738333|4298488|P1|Overall Study|Lost to Follow-up|1
1315132|NCT02738333|4298486|P3|Overall Study|Death|0
1315133|NCT02738333|4298487|P2|Overall Study|Death|0
1315134|NCT02738333|4298488|P1|Overall Study|Death|1
1315135|NCT02738138|4298577|P2|Overall Study|Other - not further specified|0
1315136|NCT02738138|4298578|P1|Overall Study|Other - not further specified|1
1315137|NCT02738138|4298577|P2|Overall Study|Lost to Follow-up|0
1315138|NCT02738138|4298578|P1|Overall Study|Lost to Follow-up|2
1315139|NCT02738138|4298577|P2|Overall Study|Adverse Event|1
1315140|NCT02738138|4298578|P1|Overall Study|Adverse Event|0
1315141|NCT02737852|4298585|P1|Overall Study|Withdrawal by Subject|2
1315142|NCT02737618|4298595|P1|Overall Study|Withdrawal by Subject|9
1315143|NCT02737592|4298600|P1|Overall Study|Withdrawal by Subject|1
1315144|NCT02736721|4298619|P1|Overall Study|Other|5
1315145|NCT02736721|4298619|P1|Overall Study|Lost to Follow-up|3
1315146|NCT02736721|4298619|P1|Overall Study|Adverse Event|8
1315147|NCT02735200|4298641|P2|Overall Study|Withdrawal by Subject|0
1315148|NCT02735200|4298642|P1|Overall Study|Withdrawal by Subject|8
1315149|NCT02735200|4298641|P2|Overall Study|Lost to Follow-up|5
1315150|NCT02735200|4298642|P1|Overall Study|Lost to Follow-up|0
1315151|NCT02734810|4298675|P2|Overall Study|Lack of Efficacy|0
1315152|NCT02734810|4298676|P1|Overall Study|Lack of Efficacy|1
1315153|NCT02734810|4298675|P2|Overall Study|Adverse Event|0
1315154|NCT02734810|4298676|P1|Overall Study|Adverse Event|1
1315155|NCT02734212|4298717|P2|Overall Study|Lost to Follow-up|10
1315156|NCT02734212|4298718|P1|Overall Study|Lost to Follow-up|5
1315157|NCT02732639|4298748|P1|Overall Study|Lost to Follow-up|1
1315158|NCT02732561|4298761|P2|Overall Study|Withdrawal by Subject|0
1315159|NCT02732561|4298762|P1|Overall Study|Withdrawal by Subject|1
1315160|NCT02732561|4298761|P2|Overall Study|Lost to Follow-up|1
1315161|NCT02732561|4298762|P1|Overall Study|Lost to Follow-up|1
1315162|NCT02732327|4298772|P2|Overall Study|Protocol Violation|1
1315163|NCT02732327|4298773|P1|Overall Study|Protocol Violation|0
1315164|NCT02732210|4298781|P2|Overall Study|Missing|8
1315165|NCT02732210|4298782|P1|Overall Study|Missing|0
1315166|NCT02732210|4298781|P2|Overall Study|Other|103
1315167|NCT02732210|4298782|P1|Overall Study|Other|35
1315168|NCT02732210|4298781|P2|Overall Study|Death|15
1315169|NCT02732210|4298782|P1|Overall Study|Death|4
1315170|NCT02732210|4298781|P2|Overall Study|Lost to Follow-up|57
1315171|NCT02732210|4298782|P1|Overall Study|Lost to Follow-up|5
1315172|NCT02732210|4298781|P2|Overall Study|Withdrawal by Subject|87
1315173|NCT02732210|4298782|P1|Overall Study|Withdrawal by Subject|28
1315174|NCT02732210|4298781|P2|Overall Study|Study Ended|13
1315175|NCT02732210|4298782|P1|Overall Study|Study Ended|13
1315176|NCT02732210|4298781|P2|Overall Study|Site Closed|11
1315177|NCT02732210|4298782|P1|Overall Study|Site Closed|0
1315178|NCT02731131|4298834|P2|Overall Study|Refused Therapy|1
1315179|NCT02731131|4298835|P1|Overall Study|Refused Therapy|0
1315180|NCT02731131|4298834|P2|Overall Study|Psychiatric Disorder|1
1315181|NCT02731131|4298835|P1|Overall Study|Psychiatric Disorder|0
1315182|NCT02730819|4298851|P1|Overall Study|Lost to Follow-up|9
1315183|NCT02730728|4298860|P3|Overall Study|Lack of Efficacy|1
1315184|NCT02730728|4298861|P2|Overall Study|Lack of Efficacy|1
1315185|NCT02730728|4298862|P1|Overall Study|Lack of Efficacy|0
1315186|NCT02730728|4298860|P3|Overall Study|Withdrawal by Subject|0
1315187|NCT02730728|4298861|P2|Overall Study|Withdrawal by Subject|1
1315188|NCT02730728|4298862|P1|Overall Study|Withdrawal by Subject|0
1315189|NCT02730598|4298881|P2|Overall Study|Unrelated Injury affecting outcomes.|0
1315190|NCT02730598|4298882|P1|Overall Study|Unrelated Injury affecting outcomes.|1
1315191|NCT02730598|4298881|P2|Overall Study|Protocol Violation|1
1315192|NCT02730598|4298882|P1|Overall Study|Protocol Violation|0
1315193|NCT02730598|4298881|P2|Overall Study|Withdrawal by Subject|3
1315194|NCT02730598|4298882|P1|Overall Study|Withdrawal by Subject|3
1315195|NCT02730351|4298902|P2|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
1315196|NCT02730351|4298903|P1|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
1315197|NCT02730351|4298902|P2|Treatment Period 2 (2 Weeks)|Adverse Event|0
1315198|NCT02730351|4298903|P1|Treatment Period 2 (2 Weeks)|Adverse Event|1
1315199|NCT02730351|4298902|P2|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
1315200|NCT02730351|4298903|P1|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
1315201|NCT02730351|4298902|P2|Wash-out Period (2 Weeks)|Protocol Violation|1
1315202|NCT02730351|4298903|P1|Wash-out Period (2 Weeks)|Protocol Violation|0
1315203|NCT02730351|4298902|P2|Treatment Period 1 (2 Weeks)|Adverse Event|0
1315204|NCT02730351|4298903|P1|Treatment Period 1 (2 Weeks)|Adverse Event|1
1315205|NCT02726022|4298995|P1|Overall Study|Treatment Failure and Poor Compliance|1
1315206|NCT02726022|4298995|P1|Overall Study|Poor Compliance|13
1315207|NCT02726022|4298995|P1|Overall Study|Treatment Failure|8
1315208|NCT02726022|4298995|P1|Overall Study|Adverse Event|14
1315209|NCT02725788|4299006|P2|Overall Study|Protocol Violation|1
1315210|NCT02725788|4299007|P1|Overall Study|Protocol Violation|0
1315211|NCT02725788|4299006|P2|Overall Study|Lost to Follow-up|1
1315212|NCT02725788|4299007|P1|Overall Study|Lost to Follow-up|1
1315213|NCT02724644|4299015|P2|Overall Study|Administrative|0
1315214|NCT02724644|4299016|P1|Overall Study|Administrative|1
1315215|NCT02724644|4299015|P2|Overall Study|Withdrawal by Subject|1
1315216|NCT02724644|4299016|P1|Overall Study|Withdrawal by Subject|7
1315217|NCT02724644|4299015|P2|Overall Study|Lost to Follow-up|2
1315218|NCT02724644|4299016|P1|Overall Study|Lost to Follow-up|6
1315219|NCT02724644|4299015|P2|Overall Study|Adverse Event|1
1315220|NCT02724644|4299016|P1|Overall Study|Adverse Event|7
1315221|NCT02724111|4299050|P2|Overall Study|Protocol Violation|5
1315222|NCT02724111|4299051|P1|Overall Study|Protocol Violation|2
1315223|NCT02723201|4299074|P3|Second Intervention Period|Adverse Event|0
1315224|NCT02723201|4299075|P2|Second Intervention Period|Adverse Event|0
1315225|NCT02723201|4299076|P1|Second Intervention Period|Adverse Event|1
1315226|NCT02723201|4299074|P3|Second Intervention Period|Protocol Violation|0
1315227|NCT02723201|4299075|P2|Second Intervention Period|Protocol Violation|0
1315228|NCT02723201|4299076|P1|Second Intervention Period|Protocol Violation|1
1315229|NCT02723188|4299135|P3|Overall Study|Withdrawal by Subject|0
1315230|NCT02723188|4299136|P2|Overall Study|Withdrawal by Subject|0
1315231|NCT02723188|4299137|P1|Overall Study|Withdrawal by Subject|1
1315232|NCT02722967|4299151|P3|Overall Study|Non-adherence of the patch to the skin|2
1315233|NCT02722967|4299152|P2|Overall Study|Non-adherence of the patch to the skin|0
1315234|NCT02722967|4299153|P1|Overall Study|Non-adherence of the patch to the skin|0
1315235|NCT02722967|4299151|P3|Overall Study|Physician Decision|0
1315236|NCT02722967|4299152|P2|Overall Study|Physician Decision|0
1315237|NCT02722967|4299153|P1|Overall Study|Physician Decision|1
1315238|NCT02722967|4299151|P3|Overall Study|Withdrawal by Subject|1
1315239|NCT02722967|4299152|P2|Overall Study|Withdrawal by Subject|0
1315240|NCT02722967|4299153|P1|Overall Study|Withdrawal by Subject|1
1315241|NCT02722967|4299151|P3|Overall Study|Non-compliance with patch wearing|1
1315242|NCT02722967|4299152|P2|Overall Study|Non-compliance with patch wearing|1
1315243|NCT02722967|4299153|P1|Overall Study|Non-compliance with patch wearing|2
1315244|NCT02722967|4299151|P3|Overall Study|Lost to Follow-up|0
1315245|NCT02722967|4299152|P2|Overall Study|Lost to Follow-up|1
1315246|NCT02722967|4299153|P1|Overall Study|Lost to Follow-up|0
1315247|NCT02722967|4299151|P3|Overall Study|Adverse Event|0
1315248|NCT02722967|4299152|P2|Overall Study|Adverse Event|0
1315249|NCT02722967|4299153|P1|Overall Study|Adverse Event|1
1315250|NCT02722278|4299185|P2|Overall Study|Site closure not study related|1
1315251|NCT02722278|4299186|P1|Overall Study|Site closure not study related|0
1315252|NCT02722278|4299185|P2|Overall Study|Subject declined after tx assignment|1
1315253|NCT02722278|4299186|P1|Overall Study|Subject declined after tx assignment|0
1315254|NCT02722278|4299185|P2|Overall Study|High PSA pre-study/ not eligible|1
1315255|NCT02722278|4299186|P1|Overall Study|High PSA pre-study/ not eligible|0
1315256|NCT02722278|4299185|P2|Overall Study|Protocol Violation|0
1315257|NCT02722278|4299186|P1|Overall Study|Protocol Violation|1
1315258|NCT02722278|4299185|P2|Overall Study|Lost to Follow-up|0
1315259|NCT02722278|4299186|P1|Overall Study|Lost to Follow-up|2
1315260|NCT02722278|4299185|P2|Overall Study|Adverse Event|1
1315261|NCT02722278|4299186|P1|Overall Study|Adverse Event|4
1315262|NCT02722278|4299185|P2|Overall Study|Withdrawal by Subject|3
1315263|NCT02722278|4299186|P1|Overall Study|Withdrawal by Subject|5
1315264|NCT02722044|4299210|P1|Overall Study|Did Not Meet Criteria at Week 14|1
1315265|NCT02722044|4299210|P1|Overall Study|Withdrawal by Subject|1
1315266|NCT02722044|4299210|P1|Overall Study|Physician Decision|1
1315267|NCT02722044|4299210|P1|Overall Study|Adverse Event|2
1315268|NCT02721875|4299239|P2|Overall Study|Progressive disease/relapse|0
1315269|NCT02721875|4299240|P1|Overall Study|Progressive disease/relapse|1
1315270|NCT02720510|4299299|P2|Overall Study|Physician Decision|2
1315271|NCT02720510|4299300|P1|Overall Study|Physician Decision|1
1315272|NCT02720510|4299299|P2|Overall Study|Adverse Event|1
1315273|NCT02720510|4299300|P1|Overall Study|Adverse Event|0
1315274|NCT02720510|4299299|P2|Overall Study|Study Terminated by the sponsor|0
1315275|NCT02720510|4299300|P1|Overall Study|Study Terminated by the sponsor|2
1315276|NCT02720081|4299320|P2|Overall Study|Protocol Violation|1
1315277|NCT02720081|4299321|P1|Overall Study|Protocol Violation|4
1315278|NCT02720081|4299320|P2|Overall Study|Adverse Event|3
1315279|NCT02720081|4299321|P1|Overall Study|Adverse Event|0
1315280|NCT02718898|4299379|P2|Overall Study|Lost to Follow-up|0
1315281|NCT02718898|4299380|P1|Overall Study|Lost to Follow-up|2
1315282|NCT02718898|4299379|P2|Overall Study|Lack of Efficacy|0
1315283|NCT02718898|4299380|P1|Overall Study|Lack of Efficacy|1
1315284|NCT02718898|4299379|P2|Overall Study|Physician Decision|0
1315285|NCT02718898|4299380|P1|Overall Study|Physician Decision|1
1315286|NCT02718898|4299379|P2|Overall Study|Adverse Event|1
1315287|NCT02718898|4299380|P1|Overall Study|Adverse Event|5
1315288|NCT02717754|4299430|P6|Overall Study|Incorrect Infusion Duration|20
1315289|NCT02717754|4299431|P5|Overall Study|Incorrect Infusion Duration|20
1315290|NCT02717754|4299432|P4|Overall Study|Incorrect Infusion Duration|10
1315291|NCT02717754|4299433|P3|Overall Study|Incorrect Infusion Duration|0
1315292|NCT02717754|4299434|P2|Overall Study|Incorrect Infusion Duration|0
1315293|NCT02717754|4299435|P1|Overall Study|Incorrect Infusion Duration|0
1315294|NCT02716779|4299487|P3|Combination Therapy|Adverse Event|1
1315295|NCT02716779|4299488|P2|Combination Therapy|Adverse Event|2
1315296|NCT02716779|4299489|P1|Combination Therapy|Adverse Event|0
1315297|NCT02716779|4299487|P3|Monotherapy|Adverse Event|1
1315298|NCT02716779|4299488|P2|Monotherapy|Adverse Event|1
1315299|NCT02716779|4299489|P1|Monotherapy|Adverse Event|0
1315300|NCT02716298|4299562|P2|First Intervention (1 Month)|Lens discomfort|1
1315301|NCT02716298|4299563|P1|First Intervention (1 Month)|Lens discomfort|1
1315302|NCT02714062|4299581|P3|Overall Study|Protocol Violation|0
1315303|NCT02714062|4299582|P2|Overall Study|Protocol Violation|1
1315304|NCT02714062|4299583|P1|Overall Study|Protocol Violation|0
1315305|NCT02714062|4299581|P3|Overall Study|Withdrawal by Subject|1
1315306|NCT02714062|4299582|P2|Overall Study|Withdrawal by Subject|0
1315307|NCT02714062|4299583|P1|Overall Study|Withdrawal by Subject|1
1315308|NCT02714062|4299581|P3|Overall Study|Adverse Event|2
1315309|NCT02714062|4299582|P2|Overall Study|Adverse Event|0
1315310|NCT02714062|4299583|P1|Overall Study|Adverse Event|0
1315311|NCT02713594|4299629|P2|Overall Study|Lost to Follow-up|374
1315312|NCT02713594|4299630|P1|Overall Study|Lost to Follow-up|358
1315313|NCT02713594|4299629|P2|Overall Study|Withdrawal by Subject|22
1315314|NCT02713594|4299630|P1|Overall Study|Withdrawal by Subject|32
1315315|NCT02712333|4299648|P2|First Period|Withdrawal by Subject|2
1315316|NCT02712333|4299649|P1|First Period|Withdrawal by Subject|3
1315317|NCT02711995|4299699|P1|Washout (90 Days)|Conflicting medication|1
1315318|NCT02710292|4299774|P2|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
1315319|NCT02710292|4299775|P1|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
1315320|NCT02710292|4299774|P2|Period 1, First 10 Days of Wear|Adverse Event|1
1315321|NCT02710292|4299775|P1|Period 1, First 10 Days of Wear|Adverse Event|0
1315322|NCT02710136|4299784|P2|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
1315323|NCT02710136|4299785|P1|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
1315324|NCT02709577|4299810|P4|Overall Study|Withdrawal by Subject|0
1315325|NCT02709577|4299811|P3|Overall Study|Withdrawal by Subject|2
1315326|NCT02709577|4299812|P2|Overall Study|Withdrawal by Subject|3
1315327|NCT02709577|4299813|P1|Overall Study|Withdrawal by Subject|2
1315328|NCT02709577|4299810|P4|Overall Study|procedural complication|0
1315329|NCT02709577|4299811|P3|Overall Study|procedural complication|0
1315330|NCT02709577|4299812|P2|Overall Study|procedural complication|1
1315331|NCT02709577|4299813|P1|Overall Study|procedural complication|0
1315332|NCT02709577|4299810|P4|Overall Study|non-accommodating anatomy|0
1315333|NCT02709577|4299811|P3|Overall Study|non-accommodating anatomy|0
1315334|NCT02709577|4299812|P2|Overall Study|non-accommodating anatomy|1
1315335|NCT02709577|4299813|P1|Overall Study|non-accommodating anatomy|0
1315336|NCT02709096|4299827|P2|Overall Study|non-compliance|1
1315337|NCT02709096|4299828|P1|Overall Study|non-compliance|1
1315338|NCT02708524|4299838|P4|Overall Study|Subject lost study lens|0
1315339|NCT02708524|4299839|P3|Overall Study|Subject lost study lens|0
1315340|NCT02708524|4299840|P2|Overall Study|Subject lost study lens|0
1315341|NCT02708524|4299841|P1|Overall Study|Subject lost study lens|1
1315342|NCT02708524|4299838|P4|Overall Study|Did not wear lens at final visit|0
1315343|NCT02708524|4299839|P3|Overall Study|Did not wear lens at final visit|0
1315344|NCT02708524|4299840|P2|Overall Study|Did not wear lens at final visit|1
1315345|NCT02708524|4299841|P1|Overall Study|Did not wear lens at final visit|0
1315346|NCT02708524|4299838|P4|Overall Study|Dispensed incorrect study lens|0
1315347|NCT02708524|4299839|P3|Overall Study|Dispensed incorrect study lens|1
1315348|NCT02708524|4299840|P2|Overall Study|Dispensed incorrect study lens|1
1315349|NCT02708524|4299841|P1|Overall Study|Dispensed incorrect study lens|0
1315350|NCT02708524|4299838|P4|Overall Study|Withdrawal by Subject|0
1315351|NCT02708524|4299839|P3|Overall Study|Withdrawal by Subject|0
1315352|NCT02708524|4299840|P2|Overall Study|Withdrawal by Subject|1
1315353|NCT02708524|4299841|P1|Overall Study|Withdrawal by Subject|1
1315354|NCT02708524|4299838|P4|Overall Study|Protocol Violation|0
1315355|NCT02708524|4299839|P3|Overall Study|Protocol Violation|0
1315356|NCT02708524|4299840|P2|Overall Study|Protocol Violation|1
1315357|NCT02708524|4299841|P1|Overall Study|Protocol Violation|0
1315358|NCT02708524|4299838|P4|Overall Study|Lost to Follow-up|0
1315359|NCT02708524|4299839|P3|Overall Study|Lost to Follow-up|1
1315360|NCT02708524|4299840|P2|Overall Study|Lost to Follow-up|1
1315361|NCT02708524|4299841|P1|Overall Study|Lost to Follow-up|1
1315362|NCT02708524|4299838|P4|Overall Study|Lens Discomfort|0
1315363|NCT02708524|4299839|P3|Overall Study|Lens Discomfort|1
1315364|NCT02708524|4299840|P2|Overall Study|Lens Discomfort|0
1315365|NCT02708524|4299841|P1|Overall Study|Lens Discomfort|1
1315366|NCT02708524|4299838|P4|Overall Study|Adverse Event|0
1315367|NCT02708524|4299839|P3|Overall Study|Adverse Event|0
1315368|NCT02708524|4299840|P2|Overall Study|Adverse Event|1
1315369|NCT02708524|4299841|P1|Overall Study|Adverse Event|0
1315370|NCT02708355|4299890|P3|Overall Study|Adverse Event|0
1315371|NCT02708355|4299891|P2|Overall Study|Adverse Event|0
1315372|NCT02708355|4299892|P1|Overall Study|Adverse Event|1
1315373|NCT02708277|4299905|P2|Overall Study|Lost to Follow-up|4
1315374|NCT02708277|4299906|P1|Overall Study|Lost to Follow-up|7
1315375|NCT02707952|4299951|P4|Overall Study|Withdrawal by Subject|0
1315376|NCT02707952|4299952|P3|Overall Study|Withdrawal by Subject|2
1315377|NCT02707952|4299953|P2|Overall Study|Withdrawal by Subject|1
1315378|NCT02707952|4299954|P1|Overall Study|Withdrawal by Subject|0
1315379|NCT02707952|4299951|P4|Overall Study|Lost to Follow-up|0
1315380|NCT02707952|4299952|P3|Overall Study|Lost to Follow-up|0
1315381|NCT02707952|4299953|P2|Overall Study|Lost to Follow-up|0
1315382|NCT02707952|4299954|P1|Overall Study|Lost to Follow-up|1
1315383|NCT02707952|4299951|P4|Overall Study|Adverse Event|0
1315384|NCT02707952|4299952|P3|Overall Study|Adverse Event|0
1315385|NCT02707952|4299953|P2|Overall Study|Adverse Event|0
1315386|NCT02707952|4299954|P1|Overall Study|Adverse Event|1
1315387|NCT02707640|4299975|P2|Overall Study|Sponsor Discretion|0
1315388|NCT02707640|4299976|P1|Overall Study|Sponsor Discretion|1
1315389|NCT02707640|4299975|P2|Overall Study|Participant's Personal Decision|2
1315390|NCT02707640|4299976|P1|Overall Study|Participant's Personal Decision|1
1315391|NCT02707640|4299975|P2|Overall Study|Withdrawal by Subject|1
1315392|NCT02707640|4299976|P1|Overall Study|Withdrawal by Subject|0
1315393|NCT02707640|4299975|P2|Overall Study|Physician Decision|0
1315394|NCT02707640|4299976|P1|Overall Study|Physician Decision|2
1315395|NCT02707640|4299975|P2|Overall Study|Death|2
1315396|NCT02707640|4299976|P1|Overall Study|Death|1
1315397|NCT02707640|4299975|P2|Overall Study|Adverse Event|2
1315398|NCT02707640|4299976|P1|Overall Study|Adverse Event|4
1315399|NCT02706717|4300001|P2|Overall Study|Death|1
1315400|NCT02706717|4300002|P1|Overall Study|Death|0
1315401|NCT02706717|4300001|P2|Overall Study|Physician Decision|1
1315402|NCT02706717|4300002|P1|Overall Study|Physician Decision|0
1315403|NCT02706717|4300001|P2|Overall Study|Lost to Follow-up|1
1315404|NCT02706717|4300002|P1|Overall Study|Lost to Follow-up|0
1315405|NCT02706717|4300001|P2|Overall Study|Withdrawal by Subject|8
1315406|NCT02706717|4300002|P1|Overall Study|Withdrawal by Subject|1
1315407|NCT02706327|4300023|P3|Overall Study|Lost to Follow-up|2
1315408|NCT02706327|4300024|P2|Overall Study|Lost to Follow-up|1
1315409|NCT02706327|4300025|P1|Overall Study|Lost to Follow-up|1
1315410|NCT02705716|4300077|P2|Overall Study|Withdrawal of Consent|1
1315411|NCT02705716|4300078|P1|Overall Study|Withdrawal of Consent|1
1315412|NCT02705716|4300077|P2|Overall Study|Protocol Violation|0
1315413|NCT02705716|4300078|P1|Overall Study|Protocol Violation|3
1315414|NCT02705716|4300077|P2|Overall Study|Adverse Event|1
1315415|NCT02705716|4300078|P1|Overall Study|Adverse Event|0
1315416|NCT02704689|4300099|P1|Overall Study|Study device not implanted|2
1315417|NCT02704689|4300099|P1|Overall Study|Physician Decision|1
1315418|NCT02702011|4300191|P4|Overall Study|Withdrawal by Subject|0
1315419|NCT02702011|4300192|P3|Overall Study|Withdrawal by Subject|0
1315420|NCT02702011|4300193|P2|Overall Study|Withdrawal by Subject|1
1315421|NCT02702011|4300194|P1|Overall Study|Withdrawal by Subject|0
1315422|NCT02701985|4300206|P2|Overall Study|Adverse Event|5
1315423|NCT02701985|4300207|P1|Overall Study|Adverse Event|0
1315424|NCT02701985|4300206|P2|Overall Study|Death|0
1315425|NCT02701985|4300207|P1|Overall Study|Death|1
1315426|NCT02701985|4300206|P2|Overall Study|Lost to Follow-up|0
1315427|NCT02701985|4300207|P1|Overall Study|Lost to Follow-up|1
1315428|NCT02701985|4300206|P2|Overall Study|Withdrawal by Subject|1
1315429|NCT02701985|4300207|P1|Overall Study|Withdrawal by Subject|1
1315430|NCT02701361|4300265|P3|Overall Study|incarceration|1
1315431|NCT02701361|4300266|P2|Overall Study|incarceration|0
1315432|NCT02701361|4300267|P1|Overall Study|incarceration|0
1315433|NCT02701361|4300265|P3|Overall Study|timed out in rehab center|0
1315434|NCT02701361|4300266|P2|Overall Study|timed out in rehab center|1
1315435|NCT02701361|4300267|P1|Overall Study|timed out in rehab center|0
1315436|NCT02701361|4300265|P3|Overall Study|Withdrawal by Subject|0
1315437|NCT02701361|4300266|P2|Overall Study|Withdrawal by Subject|0
1315438|NCT02701361|4300267|P1|Overall Study|Withdrawal by Subject|4
1315439|NCT02701361|4300265|P3|Overall Study|Lost to Follow-up|1
1315440|NCT02701361|4300266|P2|Overall Study|Lost to Follow-up|2
1315441|NCT02701361|4300267|P1|Overall Study|Lost to Follow-up|5
1315442|NCT02701296|4300308|P2|Overall Study|Incomplete Data|2
1315443|NCT02701296|4300309|P1|Overall Study|Incomplete Data|0
1315444|NCT02699892|4300342|P1|Overall Study|Other|36
1315445|NCT02699684|4300347|P2|Period 2, Second 30 Days of Wear|Adverse Event|0
1315446|NCT02699684|4300348|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
1315447|NCT02699593|4300365|P2|Period 2|Torn Contact Lens|0
1315448|NCT02699593|4300366|P1|Period 2|Torn Contact Lens|1
1315449|NCT02699593|4300365|P2|Period 2|Lost Contact Lens|1
1315450|NCT02699593|4300366|P1|Period 2|Lost Contact Lens|0
1315451|NCT02699593|4300365|P2|Period 2|Adverse Event|1
1315452|NCT02699593|4300366|P1|Period 2|Adverse Event|1
1315453|NCT02699593|4300365|P2|Period 1|Adverse Event|1
1315454|NCT02699593|4300366|P1|Period 1|Adverse Event|1
1315455|NCT02699593|4300365|P2|Period 1|Withdrawal by Subject|1
1315456|NCT02699593|4300366|P1|Period 1|Withdrawal by Subject|0
1315457|NCT02699593|4300365|P2|Period 1|Protocol Violation|1
1315458|NCT02699593|4300366|P1|Period 1|Protocol Violation|0
1315459|NCT02699593|4300365|P2|Period 1|Torn Contact Len|3
1315460|NCT02699593|4300366|P1|Period 1|Torn Contact Len|4
1315461|NCT02699593|4300365|P2|Period 1|Unsatisfactory Visual Response|1
1315462|NCT02699593|4300366|P1|Period 1|Unsatisfactory Visual Response|0
1315463|NCT02698436|4300383|P2|Overall Study|Non-compliance with study regimen|0
1315464|NCT02698436|4300384|P1|Overall Study|Non-compliance with study regimen|1
1315465|NCT02698436|4300383|P2|Overall Study|Lost to Follow-up|4
1315466|NCT02698436|4300384|P1|Overall Study|Lost to Follow-up|2
1315467|NCT02698436|4300383|P2|Overall Study|Withdrawal by Subject|3
1315468|NCT02698436|4300384|P1|Overall Study|Withdrawal by Subject|3
1315469|NCT02698436|4300383|P2|Overall Study|Adverse Event|0
1315470|NCT02698436|4300384|P1|Overall Study|Adverse Event|1
1315471|NCT02698423|4300424|P2|Overall Study|Lost to Follow-up|24
1315472|NCT02698423|4300425|P1|Overall Study|Lost to Follow-up|19
1315473|NCT02696317|4300448|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
1315474|NCT02696317|4300449|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
1315475|NCT02696317|4300448|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
1315476|NCT02696317|4300449|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
1315477|NCT02696226|4300493|P4|Overall Study|Study terminated - lack of enrollment|0
1315478|NCT02696226|4300494|P3|Overall Study|Study terminated - lack of enrollment|2
1315479|NCT02696226|4300495|P2|Overall Study|Study terminated - lack of enrollment|0
1315480|NCT02696226|4300496|P1|Overall Study|Study terminated - lack of enrollment|1
1315481|NCT02694978|4300537|P2|Overall Study|Other-Withdrew prior to dosing|8
1315482|NCT02694978|4300538|P1|Overall Study|Other-Withdrew prior to dosing|9
1315483|NCT02694978|4300537|P2|Overall Study|Other-Personal reasons|3
1315484|NCT02694978|4300538|P1|Overall Study|Other-Personal reasons|3
1315485|NCT02694978|4300537|P2|Overall Study|Other-Protocol noncompliant|1
1315486|NCT02694978|4300538|P1|Overall Study|Other-Protocol noncompliant|2
1315487|NCT02694978|4300537|P2|Overall Study|Other-Unable to be reached|1
1315488|NCT02694978|4300538|P1|Overall Study|Other-Unable to be reached|0
1315489|NCT02694978|4300537|P2|Overall Study|Other-Investigator’s decision|0
1315490|NCT02694978|4300538|P1|Overall Study|Other-Investigator’s decision|1
1315491|NCT02694978|4300537|P2|Overall Study|Other-Decision of Participant|1
1315492|NCT02694978|4300538|P1|Overall Study|Other-Decision of Participant|6
1315493|NCT02694978|4300537|P2|Overall Study|Death|1
1315494|NCT02694978|4300538|P1|Overall Study|Death|4
1315495|NCT02694978|4300537|P2|Overall Study|Lost to Follow-up|17
1315496|NCT02694978|4300538|P1|Overall Study|Lost to Follow-up|14
1315497|NCT02694978|4300537|P2|Overall Study|Withdrawal by Subject|19
1315498|NCT02694978|4300538|P1|Overall Study|Withdrawal by Subject|22
1315499|NCT02694978|4300537|P2|Overall Study|Adverse Event|9
1315500|NCT02694978|4300538|P1|Overall Study|Adverse Event|10
1315501|NCT02694744|4300552|P2|Overall Study|Taking potassium supplement: exclusion 6|1
1315502|NCT02694744|4300553|P1|Overall Study|Taking potassium supplement: exclusion 6|0
1315503|NCT02694744|4300552|P2|Overall Study|Lost to Follow-up|0
1315504|NCT02694744|4300553|P1|Overall Study|Lost to Follow-up|1
1315505|NCT02694744|4300552|P2|Overall Study|Physician Decision|2
1315506|NCT02694744|4300553|P1|Overall Study|Physician Decision|1
1315507|NCT02694744|4300552|P2|Overall Study|Withdrawal by Subject|1
1315508|NCT02694744|4300553|P1|Overall Study|Withdrawal by Subject|2
1315509|NCT02694744|4300552|P2|Overall Study|Adverse Event|1
1315510|NCT02694744|4300553|P1|Overall Study|Adverse Event|2
1315511|NCT02694718|4300561|P1|Overall Study|Withdrawal by Subject|1
1315512|NCT02694718|4300561|P1|Overall Study|Death|1
1315513|NCT02694549|4300591|P1|Overall Study|screen failures|2
1315514|NCT02694536|4300597|P1|Overall Study|Not Specified|22
1315515|NCT02694536|4300597|P1|Overall Study|Death|8
1315516|NCT02694536|4300597|P1|Overall Study|Withdrawal by Subject|8
1315517|NCT02694536|4300597|P1|Overall Study|Study Drug-Related Adverse Event|1
1315518|NCT02694536|4300597|P1|Overall Study|Lost to Follow-up|1
1315519|NCT02694536|4300597|P1|Overall Study|Progressive Disease|40
1315520|NCT02693002|4300643|P2|Overall Study|Withdrawal by Subject|0
1315521|NCT02693002|4300644|P1|Overall Study|Withdrawal by Subject|1
1315522|NCT02692703|4300665|P1|Overall Study|Not Specified|1
1315523|NCT02692703|4300665|P1|Overall Study|Lost to Follow-up|1
1315524|NCT02692560|4300673|P2|Overall Study|Withdrawal by Subject|6
1315525|NCT02692560|4300674|P1|Overall Study|Withdrawal by Subject|0
1315526|NCT02691507|4300714|P2|Overall Study|Missed Visit 3|1
1315527|NCT02691507|4300715|P1|Overall Study|Missed Visit 3|0
1315528|NCT02690727|4300890|P2|Overall Study|Adverse Event|2
1315529|NCT02690727|4300891|P1|Overall Study|Adverse Event|2
1315530|NCT02689804|4300999|P2|Overall Study|Withdrawal by Subject|0
1315531|NCT02689804|4301000|P1|Overall Study|Withdrawal by Subject|2
1315532|NCT02689206|4301031|P5|Overall Study|Withdrawal by Subject|0
1315533|NCT02689206|4301032|P4|Overall Study|Withdrawal by Subject|0
1315534|NCT02689206|4301033|P3|Overall Study|Withdrawal by Subject|1
1315535|NCT02689206|4301034|P2|Overall Study|Withdrawal by Subject|0
1315536|NCT02689206|4301035|P1|Overall Study|Withdrawal by Subject|1
1315537|NCT02689206|4301031|P5|Overall Study|Physician Decision|0
1315538|NCT02689206|4301032|P4|Overall Study|Physician Decision|0
1315539|NCT02689206|4301033|P3|Overall Study|Physician Decision|0
1315540|NCT02689206|4301034|P2|Overall Study|Physician Decision|0
1315541|NCT02689206|4301035|P1|Overall Study|Physician Decision|1
1315542|NCT02689206|4301031|P5|Overall Study|Other: Reached stopping criteria|4
1315543|NCT02689206|4301032|P4|Overall Study|Other: Reached stopping criteria|3
1315544|NCT02689206|4301033|P3|Overall Study|Other: Reached stopping criteria|2
1315545|NCT02689206|4301034|P2|Overall Study|Other: Reached stopping criteria|1
1315546|NCT02689206|4301035|P1|Overall Study|Other: Reached stopping criteria|0
1315547|NCT02689206|4301031|P5|Overall Study|Protocol Violation|2
1315548|NCT02689206|4301032|P4|Overall Study|Protocol Violation|1
1315549|NCT02689206|4301033|P3|Overall Study|Protocol Violation|0
1315550|NCT02689206|4301034|P2|Overall Study|Protocol Violation|0
1315551|NCT02689206|4301035|P1|Overall Study|Protocol Violation|1
1315552|NCT02689206|4301031|P5|Overall Study|Adverse Event|2
1315553|NCT02689206|4301032|P4|Overall Study|Adverse Event|0
1315554|NCT02689206|4301033|P3|Overall Study|Adverse Event|1
1315555|NCT02689206|4301034|P2|Overall Study|Adverse Event|0
1315556|NCT02689206|4301035|P1|Overall Study|Adverse Event|0
1315557|NCT02688933|4301241|P2|Overall Study|Lost to Follow-up|5
1315558|NCT02688933|4301242|P1|Overall Study|Lost to Follow-up|1
1315559|NCT02688933|4301241|P2|Overall Study|Other than Specified|25
1315560|NCT02688933|4301242|P1|Overall Study|Other than Specified|14
1315561|NCT02688933|4301241|P2|Overall Study|Hypoglycemia|0
1315562|NCT02688933|4301242|P1|Overall Study|Hypoglycemia|2
1315563|NCT02688933|4301241|P2|Overall Study|Poor compliance to protocol|4
1315564|NCT02688933|4301242|P1|Overall Study|Poor compliance to protocol|7
1315565|NCT02688933|4301241|P2|Overall Study|Lack of Efficacy|2
1315566|NCT02688933|4301242|P1|Overall Study|Lack of Efficacy|2
1315567|NCT02688933|4301241|P2|Overall Study|Adverse Event|1
1315568|NCT02688933|4301242|P1|Overall Study|Adverse Event|3
1315569|NCT02688153|4301264|P2|Overall Study|Conversion to Commercial Valve|0
1315570|NCT02688153|4301265|P1|Overall Study|Conversion to Commercial Valve|3
1315571|NCT02688153|4301264|P2|Overall Study|Valve Explant|0
1315572|NCT02688153|4301265|P1|Overall Study|Valve Explant|1
1315573|NCT02688153|4301264|P2|Overall Study|Withdrawal by Subject|2
1315574|NCT02688153|4301265|P1|Overall Study|Withdrawal by Subject|4
1315575|NCT02688153|4301264|P2|Overall Study|Death|5
1315576|NCT02688153|4301265|P1|Overall Study|Death|7
1315577|NCT02685488|4301356|P2|Overall Study|Withdrawal by Subject|1
1315578|NCT02685488|4301357|P1|Overall Study|Withdrawal by Subject|0
1315579|NCT02685202|4301371|P1|Overall Study|Lost to Follow-up|9
1315580|NCT02683746|4301517|P2|Overall Study|Physician Decision|1
1315581|NCT02683746|4301518|P1|Overall Study|Physician Decision|2
1315582|NCT02683746|4301517|P2|Overall Study|Withdrawal by Subject|5
1315583|NCT02683746|4301518|P1|Overall Study|Withdrawal by Subject|6
1315584|NCT02683746|4301517|P2|Overall Study|Lost to Follow-up|6
1315585|NCT02683746|4301518|P1|Overall Study|Lost to Follow-up|5
1315586|NCT02683746|4301517|P2|Overall Study|Adverse Event|2
1315587|NCT02683746|4301518|P1|Overall Study|Adverse Event|3
1315588|NCT02683109|4301618|P2|Overall Study|Adverse Event|0
1315589|NCT02683109|4301619|P1|Overall Study|Adverse Event|1
1315590|NCT02681510|4301647|P1|Overall Study|Lost to Follow-up|9
1315591|NCT02681510|4301647|P1|Overall Study|Withdrawal by Subject|1
1315592|NCT02678923|4301680|P2|Overall Study|Did Not Return for Study Visits|0
1315593|NCT02678923|4301681|P1|Overall Study|Did Not Return for Study Visits|1
1315594|NCT02678923|4301680|P2|Overall Study|Lost to Follow-up|0
1315595|NCT02678923|4301681|P1|Overall Study|Lost to Follow-up|1
1315596|NCT02678923|4301680|P2|Overall Study|Withdrawal by Subject|2
1315597|NCT02678923|4301681|P1|Overall Study|Withdrawal by Subject|3
1315598|NCT02678923|4301680|P2|Overall Study|Protocol Deviation (Not Dosed)|3
1315599|NCT02678923|4301681|P1|Overall Study|Protocol Deviation (Not Dosed)|1
1315600|NCT02678676|4301697|P2|Overall Study|Unconfirmed for lost to follow-up|67
1315601|NCT02678676|4301698|P1|Overall Study|Unconfirmed for lost to follow-up|85
1315602|NCT02678676|4301697|P2|Overall Study|Lost to Follow-up|151
1315603|NCT02678676|4301698|P1|Overall Study|Lost to Follow-up|171
1315604|NCT02678676|4301697|P2|Overall Study|Withdrawal by Subject|5
1315605|NCT02678676|4301698|P1|Overall Study|Withdrawal by Subject|13
1315606|NCT02678676|4301697|P2|Overall Study|Death|649
1315607|NCT02678676|4301698|P1|Overall Study|Death|619
1315608|NCT02678286|4301708|P2|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
1315609|NCT02678286|4301709|P1|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
1315610|NCT02678286|4301708|P2|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
1315611|NCT02678286|4301709|P1|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
1315612|NCT02678286|4301708|P2|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
1315613|NCT02678286|4301709|P1|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
1315614|NCT02678286|4301708|P2|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
1315615|NCT02678286|4301709|P1|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
1315616|NCT02678286|4301708|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
1315617|NCT02678286|4301709|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
1315618|NCT02677844|4301758|P7|Period 3|Withdrawal by Subject|0
1315619|NCT02677844|4301759|P6|Period 3|Withdrawal by Subject|0
1315620|NCT02677844|4301760|P5|Period 3|Withdrawal by Subject|0
1315621|NCT02677844|4301761|P4|Period 3|Withdrawal by Subject|1
1315622|NCT02677844|4301762|P3|Period 3|Withdrawal by Subject|0
1315623|NCT02677844|4301763|P2|Period 3|Withdrawal by Subject|0
1315624|NCT02677844|4301764|P1|Period 3|Withdrawal by Subject|0
1315625|NCT02675907|4301827|P2|Study Overall|Lost to Follow-up|2
1315626|NCT02675907|4301828|P1|Study Overall|Lost to Follow-up|0
1315627|NCT02675907|4301827|P2|Study Overall|Withdrawal by Subject|2
1315628|NCT02675907|4301828|P1|Study Overall|Withdrawal by Subject|2
1315629|NCT02675907|4301827|P2|Study Overall|Lack of Efficacy|0
1315630|NCT02675907|4301828|P1|Study Overall|Lack of Efficacy|1
1315631|NCT02675907|4301827|P2|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
1315632|NCT02675907|4301828|P1|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
1315633|NCT02675907|4301827|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
1315634|NCT02675907|4301828|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
1315635|NCT02675634|4301873|P6|Test Period 2|Adverse Event|1
1315636|NCT02675634|4301874|P5|Test Period 2|Adverse Event|0
1315637|NCT02675634|4301875|P4|Test Period 2|Adverse Event|0
1315638|NCT02675634|4301876|P3|Test Period 2|Adverse Event|0
1315639|NCT02675634|4301877|P2|Test Period 2|Adverse Event|0
1315640|NCT02675634|4301878|P1|Test Period 2|Adverse Event|0
1315641|NCT02675634|4301873|P6|Test Period 2|Lack of Efficacy|0
1315642|NCT02675634|4301874|P5|Test Period 2|Lack of Efficacy|0
1315643|NCT02675634|4301875|P4|Test Period 2|Lack of Efficacy|0
1315644|NCT02675634|4301876|P3|Test Period 2|Lack of Efficacy|0
1315645|NCT02675634|4301877|P2|Test Period 2|Lack of Efficacy|0
1315646|NCT02675634|4301878|P1|Test Period 2|Lack of Efficacy|1
1315647|NCT02675634|4301873|P6|Test Period 1|Device deficiency that did not lead to A|0
1315648|NCT02675634|4301874|P5|Test Period 1|Device deficiency that did not lead to A|0
1315649|NCT02675634|4301875|P4|Test Period 1|Device deficiency that did not lead to A|0
1315650|NCT02675634|4301876|P3|Test Period 1|Device deficiency that did not lead to A|1
1315651|NCT02675634|4301877|P2|Test Period 1|Device deficiency that did not lead to A|0
1315652|NCT02675634|4301878|P1|Test Period 1|Device deficiency that did not lead to A|0
1315653|NCT02675634|4301873|P6|Test Period 1|Adverse Event|0
1315654|NCT02675634|4301874|P5|Test Period 1|Adverse Event|0
1315655|NCT02675634|4301875|P4|Test Period 1|Adverse Event|1
1315656|NCT02675634|4301876|P3|Test Period 1|Adverse Event|0
1315657|NCT02675634|4301877|P2|Test Period 1|Adverse Event|1
1315658|NCT02675634|4301878|P1|Test Period 1|Adverse Event|0
1315659|NCT02674334|4301908|P2|Overall Study|NIRS not recording|0
1315660|NCT02674334|4301909|P1|Overall Study|NIRS not recording|1
1315661|NCT02674334|4301908|P2|Overall Study|participant difficulty breathing|0
1315662|NCT02674334|4301909|P1|Overall Study|participant difficulty breathing|1
1315663|NCT02674334|4301908|P2|Overall Study|Lost to Follow-up|3
1315664|NCT02674334|4301909|P1|Overall Study|Lost to Follow-up|5
1315665|NCT02673619|4301926|P4|Overall Study|Lack of Efficacy|0
1315666|NCT02673619|4301927|P3|Overall Study|Lack of Efficacy|1
1315667|NCT02673619|4301928|P2|Overall Study|Lack of Efficacy|0
1315668|NCT02673619|4301929|P1|Overall Study|Lack of Efficacy|0
1315669|NCT02673619|4301926|P4|Overall Study|Adverse Event|0
1315670|NCT02673619|4301927|P3|Overall Study|Adverse Event|1
1315671|NCT02673619|4301928|P2|Overall Study|Adverse Event|0
1315672|NCT02673619|4301929|P1|Overall Study|Adverse Event|0
1315673|NCT02673619|4301926|P4|Overall Study|Withdrawal by Subject|0
1315674|NCT02673619|4301927|P3|Overall Study|Withdrawal by Subject|1
1315675|NCT02673619|4301928|P2|Overall Study|Withdrawal by Subject|1
1315676|NCT02673619|4301929|P1|Overall Study|Withdrawal by Subject|1
1315677|NCT02673619|4301926|P4|Overall Study|Lost to Follow-up|0
1315678|NCT02673619|4301927|P3|Overall Study|Lost to Follow-up|0
1315679|NCT02673619|4301928|P2|Overall Study|Lost to Follow-up|0
1315680|NCT02673619|4301929|P1|Overall Study|Lost to Follow-up|1
1315681|NCT02673489|4302021|P2|Follow Up Period|Unable to return for follow-up|1
1315682|NCT02673489|4302022|P1|Follow Up Period|Unable to return for follow-up|0
1315683|NCT02673489|4302021|P2|Follow Up Period|Unable to return for week 24 follow-up|1
1315684|NCT02673489|4302022|P1|Follow Up Period|Unable to return for week 24 follow-up|0
1315685|NCT02673489|4302021|P2|Treatment Period|Adverse Event|1
1315686|NCT02673489|4302022|P1|Treatment Period|Adverse Event|0
1315687|NCT02673489|4302021|P2|Treatment Period|Participant was incarcerated|1
1315688|NCT02673489|4302022|P1|Treatment Period|Participant was incarcerated|0
1315689|NCT02673489|4302021|P2|Treatment Period|Participant moved to another province|0
1315690|NCT02673489|4302022|P1|Treatment Period|Participant moved to another province|1
1315691|NCT02673489|4302021|P2|Treatment Period|Participant request to discontinue|1
1315692|NCT02673489|4302022|P1|Treatment Period|Participant request to discontinue|1
1315693|NCT02673489|4302021|P2|Treatment Period|Lost to Follow-up|0
1315694|NCT02673489|4302022|P1|Treatment Period|Lost to Follow-up|3
1315695|NCT02672423|4302047|P10|Period 3|Physician Decision|0
1315696|NCT02672423|4302048|P9|Period 3|Physician Decision|0
1315697|NCT02672423|4302049|P8|Period 3|Physician Decision|0
1315698|NCT02672423|4302050|P7|Period 3|Physician Decision|0
1315699|NCT02672423|4302051|P6|Period 3|Physician Decision|1
1315700|NCT02672423|4302052|P5|Period 3|Physician Decision|0
1315701|NCT02672423|4302053|P4|Period 3|Physician Decision|0
1315702|NCT02672423|4302054|P3|Period 3|Physician Decision|0
1315703|NCT02672423|4302055|P2|Period 3|Physician Decision|0
1315704|NCT02672423|4302056|P1|Period 3|Physician Decision|0
1315705|NCT02672423|4302047|P10|Period 3|Withdrawal by Subject|0
1315706|NCT02672423|4302048|P9|Period 3|Withdrawal by Subject|0
1315707|NCT02672423|4302049|P8|Period 3|Withdrawal by Subject|1
1315708|NCT02672423|4302050|P7|Period 3|Withdrawal by Subject|0
1315709|NCT02672423|4302051|P6|Period 3|Withdrawal by Subject|0
1315710|NCT02672423|4302052|P5|Period 3|Withdrawal by Subject|0
1315711|NCT02672423|4302053|P4|Period 3|Withdrawal by Subject|0
1315712|NCT02672423|4302054|P3|Period 3|Withdrawal by Subject|0
1315713|NCT02672423|4302055|P2|Period 3|Withdrawal by Subject|0
1315714|NCT02672423|4302056|P1|Period 3|Withdrawal by Subject|0
1315715|NCT02672423|4302047|P10|Period 2|Withdrawal by Subject|0
1315716|NCT02672423|4302048|P9|Period 2|Withdrawal by Subject|0
1315717|NCT02672423|4302049|P8|Period 2|Withdrawal by Subject|0
1315718|NCT02672423|4302050|P7|Period 2|Withdrawal by Subject|0
1315719|NCT02672423|4302051|P6|Period 2|Withdrawal by Subject|0
1315720|NCT02672423|4302052|P5|Period 2|Withdrawal by Subject|0
1315721|NCT02672423|4302053|P4|Period 2|Withdrawal by Subject|0
1315722|NCT02672423|4302054|P3|Period 2|Withdrawal by Subject|1
1315723|NCT02672423|4302055|P2|Period 2|Withdrawal by Subject|0
1315724|NCT02672423|4302056|P1|Period 2|Withdrawal by Subject|0
1315725|NCT02672423|4302047|P10|Period 1|Adverse Event|0
1315726|NCT02672423|4302048|P9|Period 1|Adverse Event|0
1315727|NCT02672423|4302049|P8|Period 1|Adverse Event|0
1315728|NCT02672423|4302050|P7|Period 1|Adverse Event|0
1315729|NCT02672423|4302051|P6|Period 1|Adverse Event|0
1315730|NCT02672423|4302052|P5|Period 1|Adverse Event|1
1315731|NCT02672423|4302053|P4|Period 1|Adverse Event|0
1315732|NCT02672423|4302054|P3|Period 1|Adverse Event|0
1315733|NCT02672423|4302055|P2|Period 1|Adverse Event|0
1315734|NCT02672423|4302056|P1|Period 1|Adverse Event|0
1315735|NCT02671760|4302079|P3|Overall Study|Lost to Follow-up|0
1315736|NCT02671760|4302080|P2|Overall Study|Lost to Follow-up|1
1315737|NCT02671760|4302081|P1|Overall Study|Lost to Follow-up|0
1315738|NCT02671461|4302110|P3|Follow-up|Administrative Reason by Sponsor|0
1315739|NCT02671461|4302111|P2|Follow-up|Administrative Reason by Sponsor|1
1315740|NCT02671461|4302112|P1|Follow-up|Administrative Reason by Sponsor|0
1315741|NCT02671461|4302110|P3|Follow-up|Lost to Follow-up|1
1315742|NCT02671461|4302111|P2|Follow-up|Lost to Follow-up|0
1315743|NCT02671461|4302112|P1|Follow-up|Lost to Follow-up|0
1315744|NCT02671461|4302110|P3|Follow-up|Withdrawal by Subject|0
1315745|NCT02671461|4302111|P2|Follow-up|Withdrawal by Subject|0
1315746|NCT02671461|4302112|P1|Follow-up|Withdrawal by Subject|1
1315747|NCT02671461|4302110|P3|Treatment|Lost to Follow-up|0
1315748|NCT02671461|4302111|P2|Treatment|Lost to Follow-up|0
1315749|NCT02671461|4302112|P1|Treatment|Lost to Follow-up|1
1315750|NCT02671461|4302110|P3|Treatment|Administrative Reason by Sponsor|4
1315751|NCT02671461|4302111|P2|Treatment|Administrative Reason by Sponsor|3
1315752|NCT02671461|4302112|P1|Treatment|Administrative Reason by Sponsor|1
1315753|NCT02671461|4302110|P3|Treatment|Adverse Event|1
1315754|NCT02671461|4302111|P2|Treatment|Adverse Event|0
1315755|NCT02671461|4302112|P1|Treatment|Adverse Event|0
1315756|NCT02670473|4302154|P1|Overall Study|Withdrawal by Subject|1
1315757|NCT02669095|4302213|P2|Overall Study|Visit 5 assessments not completed|1
1315758|NCT02669095|4302214|P1|Overall Study|Visit 5 assessments not completed|0
1315759|NCT02669095|4302213|P2|Overall Study|Torn Lens|1
1315760|NCT02669095|4302214|P1|Overall Study|Torn Lens|0
1315761|NCT02669095|4302213|P2|Overall Study|Unsatisfactory Lens Fitting|1
1315762|NCT02669095|4302214|P1|Overall Study|Unsatisfactory Lens Fitting|0
1315763|NCT02669095|4302213|P2|Overall Study|Adverse Event|0
1315764|NCT02669095|4302214|P1|Overall Study|Adverse Event|1
1315765|NCT02669043|4302222|P1|Overall Study|Didn't meet I/E criteria|4
1315766|NCT02668822|4302249|P2|Overall Study|Study Terminated by Sponsor|9
1315767|NCT02668822|4302250|P1|Overall Study|Study Terminated by Sponsor|7
1315768|NCT02668822|4302249|P2|Overall Study|Protocol Violation|0
1315769|NCT02668822|4302250|P1|Overall Study|Protocol Violation|2
1315770|NCT02668783|4302272|P2|Overall Study|Withdrawal by Subject|0
1315771|NCT02668783|4302273|P1|Overall Study|Withdrawal by Subject|1
1315772|NCT02668783|4302272|P2|Overall Study|Subject moved|0
1315773|NCT02668783|4302273|P1|Overall Study|Subject moved|1
1315774|NCT02668783|4302272|P2|Overall Study|Study terminated by sponsor|10
1315775|NCT02668783|4302273|P1|Overall Study|Study terminated by sponsor|9
1315776|NCT02668783|4302272|P2|Overall Study|Protocol Violation|1
1315777|NCT02668783|4302273|P1|Overall Study|Protocol Violation|2
1315778|NCT02668783|4302272|P2|Overall Study|Pregnancy|1
1315779|NCT02668783|4302273|P1|Overall Study|Pregnancy|0
1315780|NCT02667288|4302310|P1|Overall Study|Withdrawal by Subject|5
1315781|NCT02667288|4302310|P1|Overall Study|Lost to Follow-up|3
1315782|NCT02667288|4302310|P1|Overall Study|Protocol Violation|5
1315783|NCT02667275|4302317|P2|Overall Study|Discontinued early without completing|1
1315784|NCT02667275|4302318|P1|Overall Study|Discontinued early without completing|0
1315785|NCT02667275|4302317|P2|Overall Study|Withdrawal by Subject|5
1315786|NCT02667275|4302318|P1|Overall Study|Withdrawal by Subject|0
1315787|NCT02667275|4302317|P2|Overall Study|Lost to Follow-up|2
1315788|NCT02667275|4302318|P1|Overall Study|Lost to Follow-up|0
1315789|NCT02667275|4302317|P2|Overall Study|Protocol Violation|7
1315790|NCT02667275|4302318|P1|Overall Study|Protocol Violation|11
1315791|NCT02667236|4302328|P2|Overall Study|Withdrawal by Subject|0
1315792|NCT02667236|4302329|P1|Overall Study|Withdrawal by Subject|2
1315793|NCT02667236|4302328|P2|Overall Study|Adverse Event|1
1315794|NCT02667236|4302329|P1|Overall Study|Adverse Event|1
1315795|NCT02666222|4302354|P1|Overall Study|Death|2
1315796|NCT02665455|4302362|P1|Overall Study|Protocol Violation|1
1315797|NCT02665455|4302362|P1|Overall Study|Adverse Event|1
1315798|NCT02665455|4302362|P1|Overall Study|Lost to Follow-up|1
1315799|NCT02665455|4302362|P1|Overall Study|Withdrawal by Subject|6
1315800|NCT02665286|4302369|P3|Overall Study|Lost to Follow-up|1
1315801|NCT02665286|4302370|P2|Overall Study|Lost to Follow-up|2
1315802|NCT02665286|4302371|P1|Overall Study|Lost to Follow-up|3
1315803|NCT02663453|4302483|P2|Overall Study|Withdrawal by Subject|0
1315804|NCT02663453|4302484|P1|Overall Study|Withdrawal by Subject|1
1315805|NCT02663453|4302483|P2|Overall Study|Death|4
1315806|NCT02663453|4302484|P1|Overall Study|Death|4
1315807|NCT02662764|4302527|P1|Overall Study|Patient discharged prior to 24 hrs|5
1315808|NCT02662764|4302527|P1|Overall Study|Patient changed treatment|1
1315809|NCT02662764|4302527|P1|Overall Study|Device failure|4
1315810|NCT02662764|4302527|P1|Overall Study|Withdrawal by Subject|5
1315811|NCT02662764|4302527|P1|Overall Study|Protocol Violation|1
1315812|NCT02662764|4302527|P1|Overall Study|Lack of Efficacy|8
1315813|NCT02662764|4302527|P1|Overall Study|Adverse Event|6
1315814|NCT02662556|4302591|P1|Overall Study|Lack of Efficacy|4
1315815|NCT02662556|4302591|P1|Overall Study|Adverse Event|4
1315816|NCT02661594|4302613|P4|Overall Study|Protocol Violation|0
1315817|NCT02661594|4302614|P3|Overall Study|Protocol Violation|1
1315818|NCT02661594|4302615|P2|Overall Study|Protocol Violation|0
1315819|NCT02661594|4302616|P1|Overall Study|Protocol Violation|1
1315820|NCT02660242|4302626|P1|Glucagon Injection|Lost to Follow-up|1
1315821|NCT02660242|4302626|P1|Glucose Tabs|Lost to Follow-up|1
1315822|NCT02658149|4302713|P2|Overall Study|Physician Decision|0
1315823|NCT02658149|4302714|P1|Overall Study|Physician Decision|1
1315824|NCT02657031|4302759|P2|Overall Study|Adverse Event|2
1315825|NCT02657031|4302760|P1|Overall Study|Adverse Event|1
1315826|NCT02654145|4302806|P1|Overall Study|Withdrawal by Subject|5
1315827|NCT02654145|4302806|P1|Overall Study|Protocol Violation|1
1315828|NCT02654145|4302806|P1|Overall Study|Lack of Efficacy|1
1315829|NCT02653495|4302863|P2|Overall Study|Screening Failure|0
1315830|NCT02653495|4302864|P1|Overall Study|Screening Failure|10
1315831|NCT02653495|4302863|P2|Overall Study|Lost to Follow-up|0
1315832|NCT02653495|4302864|P1|Overall Study|Lost to Follow-up|2
1315833|NCT02651922|4302898|P1|Overall Study|due to exclusion criteria|2
1315834|NCT02651467|4302918|P3|Overall Study|Other (Not specified)|2
1315835|NCT02651467|4302919|P2|Overall Study|Other (Not specified)|0
1315836|NCT02651467|4302920|P1|Overall Study|Other (Not specified)|1
1315837|NCT02651467|4302918|P3|Overall Study|Withdrawal by Subject|2
1315838|NCT02651467|4302919|P2|Overall Study|Withdrawal by Subject|0
1315839|NCT02651467|4302920|P1|Overall Study|Withdrawal by Subject|0
1315840|NCT02651194|4302939|P1|Overall Study|Not Specified|2
1315841|NCT02651194|4302939|P1|Overall Study|Lost to Follow-up|3
1315842|NCT02651155|4302947|P2|Overall Study|Voluntary Withdrawal|0
1315843|NCT02651155|4302948|P1|Overall Study|Voluntary Withdrawal|5
1315844|NCT02651155|4302947|P2|Overall Study|Pretreatment Event/Adverse Event|2
1315845|NCT02651155|4302948|P1|Overall Study|Pretreatment Event/Adverse Event|1
1315846|NCT02649634|4302998|P2|Overall Study|Lost to Follow-up|1
1315847|NCT02649634|4302999|P1|Overall Study|Lost to Follow-up|0
1315848|NCT02649634|4302998|P2|Overall Study|Withdrawal by Subject|5
1315849|NCT02649634|4302999|P1|Overall Study|Withdrawal by Subject|3
1315850|NCT02648438|4303058|P3|Overall Study|Withdrawal by Subject|0
1315851|NCT02648438|4303059|P2|Overall Study|Withdrawal by Subject|1
1315852|NCT02648438|4303060|P1|Overall Study|Withdrawal by Subject|1
1315853|NCT02648438|4303058|P3|Overall Study|Protocol Violation|0
1315854|NCT02648438|4303059|P2|Overall Study|Protocol Violation|0
1315855|NCT02648438|4303060|P1|Overall Study|Protocol Violation|2
1315856|NCT02648438|4303058|P3|Overall Study|Eligibility criteria not fulfilled|0
1315857|NCT02648438|4303059|P2|Overall Study|Eligibility criteria not fulfilled|2
1315858|NCT02648438|4303060|P1|Overall Study|Eligibility criteria not fulfilled|0
1315859|NCT02648204|4303104|P4|Overall Study|Adverse Event|0
1315860|NCT02648204|4303105|P3|Overall Study|Adverse Event|1
1315861|NCT02648204|4303106|P2|Overall Study|Adverse Event|0
1315862|NCT02648204|4303107|P1|Overall Study|Adverse Event|0
1315863|NCT02648204|4303104|P4|Overall Study|Death|2
1315864|NCT02648204|4303105|P3|Overall Study|Death|2
1315865|NCT02648204|4303106|P2|Overall Study|Death|1
1315866|NCT02648204|4303107|P1|Overall Study|Death|1
1315867|NCT02648204|4303104|P4|Overall Study|Missing follow-up information|2
1315868|NCT02648204|4303105|P3|Overall Study|Missing follow-up information|4
1315869|NCT02648204|4303106|P2|Overall Study|Missing follow-up information|4
1315870|NCT02648204|4303107|P1|Overall Study|Missing follow-up information|4
1315871|NCT02648204|4303104|P4|Overall Study|Lost to Follow-up|6
1315872|NCT02648204|4303105|P3|Overall Study|Lost to Follow-up|4
1315873|NCT02648204|4303106|P2|Overall Study|Lost to Follow-up|8
1315874|NCT02648204|4303107|P1|Overall Study|Lost to Follow-up|5
1315875|NCT02648204|4303104|P4|Overall Study|Withdrawal by Subject|6
1315876|NCT02648204|4303105|P3|Overall Study|Withdrawal by Subject|2
1315877|NCT02648204|4303106|P2|Overall Study|Withdrawal by Subject|8
1315878|NCT02648204|4303107|P1|Overall Study|Withdrawal by Subject|12
1315879|NCT02647944|4303240|P2|Overall Study|Adverse Event|0
1315880|NCT02647944|4303241|P1|Overall Study|Adverse Event|2
1315881|NCT02647944|4303240|P2|Overall Study|Withdrawal by Subject|3
1315882|NCT02647944|4303241|P1|Overall Study|Withdrawal by Subject|0
1315883|NCT02647905|4303265|P1|Overall Study|Withdrawal by Subject|2
1315884|NCT02647905|4303265|P1|Overall Study|Lost to Follow-up|1
1315885|NCT02647320|4303275|P5|Overall Study|Disposition Missing Due to Fire at Site|4
1315886|NCT02647320|4303276|P4|Overall Study|Disposition Missing Due to Fire at Site|3
1315887|NCT02647320|4303277|P3|Overall Study|Disposition Missing Due to Fire at Site|4
1315888|NCT02647320|4303278|P2|Overall Study|Disposition Missing Due to Fire at Site|3
1315889|NCT02647320|4303279|P1|Overall Study|Disposition Missing Due to Fire at Site|2
1315890|NCT02647320|4303275|P5|Overall Study|Lack of Efficacy|0
1315891|NCT02647320|4303276|P4|Overall Study|Lack of Efficacy|1
1315892|NCT02647320|4303277|P3|Overall Study|Lack of Efficacy|0
1315893|NCT02647320|4303278|P2|Overall Study|Lack of Efficacy|0
1315894|NCT02647320|4303279|P1|Overall Study|Lack of Efficacy|0
1315895|NCT02647320|4303275|P5|Overall Study|Develop anemia|0
1315896|NCT02647320|4303276|P4|Overall Study|Develop anemia|0
1315897|NCT02647320|4303277|P3|Overall Study|Develop anemia|0
1315898|NCT02647320|4303278|P2|Overall Study|Develop anemia|0
1315899|NCT02647320|4303279|P1|Overall Study|Develop anemia|1
1315900|NCT02647320|4303275|P5|Overall Study|Lost to Follow-up|0
1315901|NCT02647320|4303276|P4|Overall Study|Lost to Follow-up|0
1315902|NCT02647320|4303277|P3|Overall Study|Lost to Follow-up|0
1315903|NCT02647320|4303278|P2|Overall Study|Lost to Follow-up|1
1315904|NCT02647320|4303279|P1|Overall Study|Lost to Follow-up|1
1315905|NCT02647320|4303275|P5|Overall Study|Reason not provided|2
1315906|NCT02647320|4303276|P4|Overall Study|Reason not provided|0
1315907|NCT02647320|4303277|P3|Overall Study|Reason not provided|1
1315908|NCT02647320|4303278|P2|Overall Study|Reason not provided|0
1315909|NCT02647320|4303279|P1|Overall Study|Reason not provided|0
1315910|NCT02647320|4303275|P5|Overall Study|Study terminated by sponsor|2
1315911|NCT02647320|4303276|P4|Overall Study|Study terminated by sponsor|1
1315912|NCT02647320|4303277|P3|Overall Study|Study terminated by sponsor|1
1315913|NCT02647320|4303278|P2|Overall Study|Study terminated by sponsor|1
1315914|NCT02647320|4303279|P1|Overall Study|Study terminated by sponsor|1
1315915|NCT02647320|4303275|P5|Overall Study|Persistent hyperglycemia|1
1315916|NCT02647320|4303276|P4|Overall Study|Persistent hyperglycemia|1
1315917|NCT02647320|4303277|P3|Overall Study|Persistent hyperglycemia|1
1315918|NCT02647320|4303278|P2|Overall Study|Persistent hyperglycemia|1
1315919|NCT02647320|4303279|P1|Overall Study|Persistent hyperglycemia|0
1315920|NCT02647320|4303275|P5|Overall Study|Withdrawal by Subject|7
1315921|NCT02647320|4303276|P4|Overall Study|Withdrawal by Subject|2
1315922|NCT02647320|4303277|P3|Overall Study|Withdrawal by Subject|2
1315923|NCT02647320|4303278|P2|Overall Study|Withdrawal by Subject|4
1315924|NCT02647320|4303279|P1|Overall Study|Withdrawal by Subject|7
1315925|NCT02647320|4303275|P5|Overall Study|Protocol Violation|0
1315926|NCT02647320|4303276|P4|Overall Study|Protocol Violation|0
1315927|NCT02647320|4303277|P3|Overall Study|Protocol Violation|3
1315928|NCT02647320|4303278|P2|Overall Study|Protocol Violation|0
1315929|NCT02647320|4303279|P1|Overall Study|Protocol Violation|0
1315930|NCT02647320|4303275|P5|Overall Study|Adverse Event|1
1315931|NCT02647320|4303276|P4|Overall Study|Adverse Event|2
1315932|NCT02647320|4303277|P3|Overall Study|Adverse Event|3
1315933|NCT02647320|4303278|P2|Overall Study|Adverse Event|1
1315934|NCT02647320|4303279|P1|Overall Study|Adverse Event|0
1315935|NCT02647281|4303370|P9|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
1315936|NCT02647281|4303371|P8|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1315937|NCT02647281|4303372|P7|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1315938|NCT02647281|4303373|P6|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1315939|NCT02647281|4303374|P5|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1315940|NCT02647281|4303375|P4|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1315941|NCT02647281|4303376|P3|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1315942|NCT02647281|4303377|P2|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1315943|NCT02647281|4303378|P1|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1315944|NCT02646124|4303569|P2|Overall Study|Lost to Follow-up|2
1315945|NCT02646124|4303570|P1|Overall Study|Lost to Follow-up|0
1315946|NCT02644356|4303747|P1|Overall Study|Withdrawal by Subject|2
1315947|NCT02644122|4303757|P1|Overall Study|Withdrawal by Subject|1
1315948|NCT02644109|4303767|P2|Overall Study|Adverse Event|4
1315949|NCT02644109|4303768|P1|Overall Study|Adverse Event|0
1315950|NCT02644096|4303776|P2|Overall Study|Withdrawal by Subject|25
1315951|NCT02644096|4303777|P1|Overall Study|Withdrawal by Subject|28
1315952|NCT02643394|4303811|P2|Overall Study|Protocol Violation|5
1315953|NCT02643394|4303812|P1|Overall Study|Protocol Violation|4
1315954|NCT02643251|4303822|P2|Overall Study|PI Decision to terminate patient|0
1315955|NCT02643251|4303823|P1|Overall Study|PI Decision to terminate patient|1
1315956|NCT02643251|4303822|P2|Overall Study|Protocol Violation|0
1315957|NCT02643251|4303823|P1|Overall Study|Protocol Violation|1
1315958|NCT02643251|4303822|P2|Overall Study|Lost to Follow-up|1
1315959|NCT02643251|4303823|P1|Overall Study|Lost to Follow-up|4
1315960|NCT02643251|4303822|P2|Overall Study|Withdrawal by Subject|0
1315961|NCT02643251|4303823|P1|Overall Study|Withdrawal by Subject|2
1315962|NCT02643251|4303822|P2|Overall Study|Adverse Event|1
1315963|NCT02643251|4303823|P1|Overall Study|Adverse Event|3
1315964|NCT02642679|4303905|P1|Overall Study|Physician Decision|1
1315965|NCT02642679|4303905|P1|Overall Study|Physician Decision|1
1315966|NCT02642679|4303905|P1|Overall Study|Withdrawal by Subject|1
1315967|NCT02642432|4303946|P1|Overall Study|Not Specified|3
1315968|NCT02642432|4303946|P1|Overall Study|Lost to Follow-up|2
1315969|NCT02642432|4303946|P1|Overall Study|Withdrew Consent|1
1315970|NCT02642432|4303946|P1|Overall Study|Adverse Event|2
1315971|NCT02642159|4303954|P2|Overall Study|Other than specified above|3
1315972|NCT02642159|4303955|P1|Overall Study|Other than specified above|10
1315973|NCT02642159|4303954|P2|Overall Study|Poor compliance to study protocol|0
1315974|NCT02642159|4303955|P1|Overall Study|Poor compliance to study protocol|1
1315975|NCT02642159|4303954|P2|Overall Study|Withdrawal by Subject|1
1315976|NCT02642159|4303955|P1|Overall Study|Withdrawal by Subject|9
1315977|NCT02642159|4303954|P2|Overall Study|Adverse Event|4
1315978|NCT02642159|4303955|P1|Overall Study|Adverse Event|10
1315979|NCT02642159|4303954|P2|Overall Study|Randomized but not treated|0
1315980|NCT02642159|4303955|P1|Overall Study|Randomized but not treated|1
1315981|NCT02641379|4304180|P11|Overall Study|PCR positive|0
1315982|NCT02641379|4304181|P10|Overall Study|PCR positive|0
1315983|NCT02641379|4304182|P9|Overall Study|PCR positive|0
1315984|NCT02641379|4304183|P8|Overall Study|PCR positive|0
1315985|NCT02641379|4304184|P7|Overall Study|PCR positive|1
1315986|NCT02641379|4304185|P6|Overall Study|PCR positive|0
1315987|NCT02641379|4304186|P5|Overall Study|PCR positive|0
1315988|NCT02641379|4304187|P4|Overall Study|PCR positive|0
1315989|NCT02641379|4304188|P3|Overall Study|PCR positive|0
1315990|NCT02641379|4304189|P2|Overall Study|PCR positive|0
1315991|NCT02641379|4304190|P1|Overall Study|PCR positive|0
1315992|NCT02641379|4304180|P11|Overall Study|Missing PCR result at Week 8|0
1315993|NCT02641379|4304181|P10|Overall Study|Missing PCR result at Week 8|1
1315994|NCT02641379|4304182|P9|Overall Study|Missing PCR result at Week 8|0
1315995|NCT02641379|4304183|P8|Overall Study|Missing PCR result at Week 8|0
1315996|NCT02641379|4304184|P7|Overall Study|Missing PCR result at Week 8|0
1315997|NCT02641379|4304185|P6|Overall Study|Missing PCR result at Week 8|0
1315998|NCT02641379|4304186|P5|Overall Study|Missing PCR result at Week 8|0
1315999|NCT02641379|4304187|P4|Overall Study|Missing PCR result at Week 8|0
1316000|NCT02641379|4304188|P3|Overall Study|Missing PCR result at Week 8|0
1316001|NCT02641379|4304189|P2|Overall Study|Missing PCR result at Week 8|0
1316002|NCT02641379|4304190|P1|Overall Study|Missing PCR result at Week 8|0
1316003|NCT02641379|4304180|P11|Overall Study|Participant treated after Week 24|0
1316004|NCT02641379|4304181|P10|Overall Study|Participant treated after Week 24|0
1316005|NCT02641379|4304182|P9|Overall Study|Participant treated after Week 24|1
1316006|NCT02641379|4304183|P8|Overall Study|Participant treated after Week 24|0
1316007|NCT02641379|4304184|P7|Overall Study|Participant treated after Week 24|0
1316008|NCT02641379|4304185|P6|Overall Study|Participant treated after Week 24|0
1316009|NCT02641379|4304186|P5|Overall Study|Participant treated after Week 24|0
1316010|NCT02641379|4304187|P4|Overall Study|Participant treated after Week 24|0
1316011|NCT02641379|4304188|P3|Overall Study|Participant treated after Week 24|0
1316012|NCT02641379|4304189|P2|Overall Study|Participant treated after Week 24|0
1316013|NCT02641379|4304190|P1|Overall Study|Participant treated after Week 24|0
1316014|NCT02641379|4304180|P11|Overall Study|Participant’s PCR high|0
1316015|NCT02641379|4304181|P10|Overall Study|Participant’s PCR high|0
1316016|NCT02641379|4304182|P9|Overall Study|Participant’s PCR high|0
1316017|NCT02641379|4304183|P8|Overall Study|Participant’s PCR high|1
1316018|NCT02641379|4304184|P7|Overall Study|Participant’s PCR high|0
1316019|NCT02641379|4304185|P6|Overall Study|Participant’s PCR high|0
1316020|NCT02641379|4304186|P5|Overall Study|Participant’s PCR high|0
1316021|NCT02641379|4304187|P4|Overall Study|Participant’s PCR high|0
1316022|NCT02641379|4304188|P3|Overall Study|Participant’s PCR high|0
1316023|NCT02641379|4304189|P2|Overall Study|Participant’s PCR high|0
1316024|NCT02641379|4304190|P1|Overall Study|Participant’s PCR high|0
1316025|NCT02641379|4304180|P11|Overall Study|Negative PCR result|0
1316026|NCT02641379|4304181|P10|Overall Study|Negative PCR result|1
1316027|NCT02641379|4304182|P9|Overall Study|Negative PCR result|0
1316028|NCT02641379|4304183|P8|Overall Study|Negative PCR result|0
1316029|NCT02641379|4304184|P7|Overall Study|Negative PCR result|0
1316030|NCT02641379|4304185|P6|Overall Study|Negative PCR result|0
1316031|NCT02641379|4304186|P5|Overall Study|Negative PCR result|0
1316032|NCT02641379|4304187|P4|Overall Study|Negative PCR result|0
1316033|NCT02641379|4304188|P3|Overall Study|Negative PCR result|0
1316034|NCT02641379|4304189|P2|Overall Study|Negative PCR result|0
1316035|NCT02641379|4304190|P1|Overall Study|Negative PCR result|0
1316036|NCT02641379|4304180|P11|Overall Study|No 2 Log drop at Week 12|1
1316037|NCT02641379|4304181|P10|Overall Study|No 2 Log drop at Week 12|0
1316038|NCT02641379|4304182|P9|Overall Study|No 2 Log drop at Week 12|0
1316039|NCT02641379|4304183|P8|Overall Study|No 2 Log drop at Week 12|0
1316040|NCT02641379|4304184|P7|Overall Study|No 2 Log drop at Week 12|0
1316041|NCT02641379|4304185|P6|Overall Study|No 2 Log drop at Week 12|0
1316042|NCT02641379|4304186|P5|Overall Study|No 2 Log drop at Week 12|0
1316043|NCT02641379|4304187|P4|Overall Study|No 2 Log drop at Week 12|0
1316044|NCT02641379|4304188|P3|Overall Study|No 2 Log drop at Week 12|0
1316045|NCT02641379|4304189|P2|Overall Study|No 2 Log drop at Week 12|0
1316046|NCT02641379|4304190|P1|Overall Study|No 2 Log drop at Week 12|0
1316047|NCT02641379|4304180|P11|Overall Study|Non-response Week 12|0
1316048|NCT02641379|4304181|P10|Overall Study|Non-response Week 12|0
1316049|NCT02641379|4304182|P9|Overall Study|Non-response Week 12|0
1316050|NCT02641379|4304183|P8|Overall Study|Non-response Week 12|1
1316051|NCT02641379|4304184|P7|Overall Study|Non-response Week 12|0
1316052|NCT02641379|4304185|P6|Overall Study|Non-response Week 12|0
1316053|NCT02641379|4304186|P5|Overall Study|Non-response Week 12|0
1316054|NCT02641379|4304187|P4|Overall Study|Non-response Week 12|0
1316055|NCT02641379|4304188|P3|Overall Study|Non-response Week 12|0
1316056|NCT02641379|4304189|P2|Overall Study|Non-response Week 12|0
1316057|NCT02641379|4304190|P1|Overall Study|Non-response Week 12|0
1316058|NCT02641379|4304180|P11|Overall Study|Participant showed weight reduction|0
1316059|NCT02641379|4304181|P10|Overall Study|Participant showed weight reduction|0
1316060|NCT02641379|4304182|P9|Overall Study|Participant showed weight reduction|0
1316061|NCT02641379|4304183|P8|Overall Study|Participant showed weight reduction|1
1316062|NCT02641379|4304184|P7|Overall Study|Participant showed weight reduction|0
1316063|NCT02641379|4304185|P6|Overall Study|Participant showed weight reduction|0
1316064|NCT02641379|4304186|P5|Overall Study|Participant showed weight reduction|0
1316065|NCT02641379|4304187|P4|Overall Study|Participant showed weight reduction|0
1316066|NCT02641379|4304188|P3|Overall Study|Participant showed weight reduction|0
1316067|NCT02641379|4304189|P2|Overall Study|Participant showed weight reduction|0
1316068|NCT02641379|4304190|P1|Overall Study|Participant showed weight reduction|0
1316069|NCT02641379|4304180|P11|Overall Study|Source data not found|0
1316070|NCT02641379|4304181|P10|Overall Study|Source data not found|0
1316071|NCT02641379|4304182|P9|Overall Study|Source data not found|0
1316072|NCT02641379|4304183|P8|Overall Study|Source data not found|0
1316073|NCT02641379|4304184|P7|Overall Study|Source data not found|0
1316074|NCT02641379|4304185|P6|Overall Study|Source data not found|1
1316075|NCT02641379|4304186|P5|Overall Study|Source data not found|0
1316076|NCT02641379|4304187|P4|Overall Study|Source data not found|0
1316077|NCT02641379|4304188|P3|Overall Study|Source data not found|0
1316078|NCT02641379|4304189|P2|Overall Study|Source data not found|0
1316079|NCT02641379|4304190|P1|Overall Study|Source data not found|0
1316080|NCT02641379|4304180|P11|Overall Study|Lost to Follow-up|0
1316081|NCT02641379|4304181|P10|Overall Study|Lost to Follow-up|0
1316082|NCT02641379|4304182|P9|Overall Study|Lost to Follow-up|1
1316083|NCT02641379|4304183|P8|Overall Study|Lost to Follow-up|0
1316084|NCT02641379|4304184|P7|Overall Study|Lost to Follow-up|0
1316085|NCT02641379|4304185|P6|Overall Study|Lost to Follow-up|0
1316086|NCT02641379|4304186|P5|Overall Study|Lost to Follow-up|0
1316087|NCT02641379|4304187|P4|Overall Study|Lost to Follow-up|0
1316088|NCT02641379|4304188|P3|Overall Study|Lost to Follow-up|0
1316089|NCT02641379|4304189|P2|Overall Study|Lost to Follow-up|0
1316090|NCT02641379|4304190|P1|Overall Study|Lost to Follow-up|0
1316091|NCT02641379|4304180|P11|Overall Study|Participation in sili rescue study|0
1316092|NCT02641379|4304181|P10|Overall Study|Participation in sili rescue study|0
1316093|NCT02641379|4304182|P9|Overall Study|Participation in sili rescue study|0
1316094|NCT02641379|4304183|P8|Overall Study|Participation in sili rescue study|0
1316095|NCT02641379|4304184|P7|Overall Study|Participation in sili rescue study|0
1316096|NCT02641379|4304185|P6|Overall Study|Participation in sili rescue study|1
1316097|NCT02641379|4304186|P5|Overall Study|Participation in sili rescue study|0
1316098|NCT02641379|4304187|P4|Overall Study|Participation in sili rescue study|0
1316099|NCT02641379|4304188|P3|Overall Study|Participation in sili rescue study|0
1316100|NCT02641379|4304189|P2|Overall Study|Participation in sili rescue study|0
1316101|NCT02641379|4304190|P1|Overall Study|Participation in sili rescue study|0
1316102|NCT02641379|4304180|P11|Overall Study|Protocol Violation|0
1316103|NCT02641379|4304181|P10|Overall Study|Protocol Violation|0
1316104|NCT02641379|4304182|P9|Overall Study|Protocol Violation|1
1316105|NCT02641379|4304183|P8|Overall Study|Protocol Violation|0
1316106|NCT02641379|4304184|P7|Overall Study|Protocol Violation|0
1316107|NCT02641379|4304185|P6|Overall Study|Protocol Violation|0
1316108|NCT02641379|4304186|P5|Overall Study|Protocol Violation|2
1316109|NCT02641379|4304187|P4|Overall Study|Protocol Violation|0
1316110|NCT02641379|4304188|P3|Overall Study|Protocol Violation|0
1316111|NCT02641379|4304189|P2|Overall Study|Protocol Violation|0
1316112|NCT02641379|4304190|P1|Overall Study|Protocol Violation|0
1316113|NCT02641379|4304180|P11|Overall Study|Blood could not be drawn|0
1316114|NCT02641379|4304181|P10|Overall Study|Blood could not be drawn|0
1316115|NCT02641379|4304182|P9|Overall Study|Blood could not be drawn|0
1316116|NCT02641379|4304183|P8|Overall Study|Blood could not be drawn|0
1316117|NCT02641379|4304184|P7|Overall Study|Blood could not be drawn|0
1316118|NCT02641379|4304185|P6|Overall Study|Blood could not be drawn|0
1316119|NCT02641379|4304186|P5|Overall Study|Blood could not be drawn|1
1316120|NCT02641379|4304187|P4|Overall Study|Blood could not be drawn|0
1316121|NCT02641379|4304188|P3|Overall Study|Blood could not be drawn|0
1316122|NCT02641379|4304189|P2|Overall Study|Blood could not be drawn|0
1316123|NCT02641379|4304190|P1|Overall Study|Blood could not be drawn|0
1316124|NCT02641379|4304180|P11|Overall Study|Baseline viral load unavailable|0
1316125|NCT02641379|4304181|P10|Overall Study|Baseline viral load unavailable|0
1316126|NCT02641379|4304182|P9|Overall Study|Baseline viral load unavailable|0
1316127|NCT02641379|4304183|P8|Overall Study|Baseline viral load unavailable|0
1316128|NCT02641379|4304184|P7|Overall Study|Baseline viral load unavailable|0
1316129|NCT02641379|4304185|P6|Overall Study|Baseline viral load unavailable|0
1316130|NCT02641379|4304186|P5|Overall Study|Baseline viral load unavailable|0
1316131|NCT02641379|4304187|P4|Overall Study|Baseline viral load unavailable|1
1316132|NCT02641379|4304188|P3|Overall Study|Baseline viral load unavailable|0
1316133|NCT02641379|4304189|P2|Overall Study|Baseline viral load unavailable|0
1316134|NCT02641379|4304190|P1|Overall Study|Baseline viral load unavailable|0
1316135|NCT02641379|4304180|P11|Overall Study|Inclusion criteria not fulfilled|0
1316136|NCT02641379|4304181|P10|Overall Study|Inclusion criteria not fulfilled|0
1316137|NCT02641379|4304182|P9|Overall Study|Inclusion criteria not fulfilled|0
1316138|NCT02641379|4304183|P8|Overall Study|Inclusion criteria not fulfilled|0
1316139|NCT02641379|4304184|P7|Overall Study|Inclusion criteria not fulfilled|0
1316140|NCT02641379|4304185|P6|Overall Study|Inclusion criteria not fulfilled|0
1316141|NCT02641379|4304186|P5|Overall Study|Inclusion criteria not fulfilled|0
1316142|NCT02641379|4304187|P4|Overall Study|Inclusion criteria not fulfilled|1
1316143|NCT02641379|4304188|P3|Overall Study|Inclusion criteria not fulfilled|0
1316144|NCT02641379|4304189|P2|Overall Study|Inclusion criteria not fulfilled|0
1316145|NCT02641379|4304190|P1|Overall Study|Inclusion criteria not fulfilled|0
1316146|NCT02641379|4304180|P11|Overall Study|PCR sample for Week 4 not drawn|0
1316147|NCT02641379|4304181|P10|Overall Study|PCR sample for Week 4 not drawn|0
1316148|NCT02641379|4304182|P9|Overall Study|PCR sample for Week 4 not drawn|0
1316149|NCT02641379|4304183|P8|Overall Study|PCR sample for Week 4 not drawn|0
1316150|NCT02641379|4304184|P7|Overall Study|PCR sample for Week 4 not drawn|0
1316151|NCT02641379|4304185|P6|Overall Study|PCR sample for Week 4 not drawn|0
1316152|NCT02641379|4304186|P5|Overall Study|PCR sample for Week 4 not drawn|0
1316153|NCT02641379|4304187|P4|Overall Study|PCR sample for Week 4 not drawn|1
1316154|NCT02641379|4304188|P3|Overall Study|PCR sample for Week 4 not drawn|0
1316155|NCT02641379|4304189|P2|Overall Study|PCR sample for Week 4 not drawn|0
1316156|NCT02641379|4304190|P1|Overall Study|PCR sample for Week 4 not drawn|0
1316157|NCT02641379|4304180|P11|Overall Study|PCR positive at Week 28|0
1316158|NCT02641379|4304181|P10|Overall Study|PCR positive at Week 28|0
1316159|NCT02641379|4304182|P9|Overall Study|PCR positive at Week 28|0
1316160|NCT02641379|4304183|P8|Overall Study|PCR positive at Week 28|0
1316161|NCT02641379|4304184|P7|Overall Study|PCR positive at Week 28|0
1316162|NCT02641379|4304185|P6|Overall Study|PCR positive at Week 28|0
1316163|NCT02641379|4304186|P5|Overall Study|PCR positive at Week 28|0
1316164|NCT02641379|4304187|P4|Overall Study|PCR positive at Week 28|0
1316165|NCT02641379|4304188|P3|Overall Study|PCR positive at Week 28|1
1316166|NCT02641379|4304189|P2|Overall Study|PCR positive at Week 28|0
1316167|NCT02641379|4304190|P1|Overall Study|PCR positive at Week 28|0
1316168|NCT02641379|4304180|P11|Overall Study|No PCR at baseline|0
1316169|NCT02641379|4304181|P10|Overall Study|No PCR at baseline|0
1316170|NCT02641379|4304182|P9|Overall Study|No PCR at baseline|0
1316171|NCT02641379|4304183|P8|Overall Study|No PCR at baseline|0
1316172|NCT02641379|4304184|P7|Overall Study|No PCR at baseline|0
1316173|NCT02641379|4304185|P6|Overall Study|No PCR at baseline|0
1316174|NCT02641379|4304186|P5|Overall Study|No PCR at baseline|0
1316175|NCT02641379|4304187|P4|Overall Study|No PCR at baseline|0
1316176|NCT02641379|4304188|P3|Overall Study|No PCR at baseline|1
1316177|NCT02641379|4304189|P2|Overall Study|No PCR at baseline|0
1316178|NCT02641379|4304190|P1|Overall Study|No PCR at baseline|0
1316179|NCT02641379|4304180|P11|Overall Study|PCR not performed at Week 12|0
1316180|NCT02641379|4304181|P10|Overall Study|PCR not performed at Week 12|0
1316181|NCT02641379|4304182|P9|Overall Study|PCR not performed at Week 12|0
1316182|NCT02641379|4304183|P8|Overall Study|PCR not performed at Week 12|0
1316183|NCT02641379|4304184|P7|Overall Study|PCR not performed at Week 12|0
1316184|NCT02641379|4304185|P6|Overall Study|PCR not performed at Week 12|0
1316185|NCT02641379|4304186|P5|Overall Study|PCR not performed at Week 12|0
1316186|NCT02641379|4304187|P4|Overall Study|PCR not performed at Week 12|0
1316187|NCT02641379|4304188|P3|Overall Study|PCR not performed at Week 12|1
1316188|NCT02641379|4304189|P2|Overall Study|PCR not performed at Week 12|0
1316189|NCT02641379|4304190|P1|Overall Study|PCR not performed at Week 12|0
1316190|NCT02641379|4304180|P11|Overall Study|PCR positive at Week 48|0
1316191|NCT02641379|4304181|P10|Overall Study|PCR positive at Week 48|0
1316192|NCT02641379|4304182|P9|Overall Study|PCR positive at Week 48|0
1316193|NCT02641379|4304183|P8|Overall Study|PCR positive at Week 48|0
1316194|NCT02641379|4304184|P7|Overall Study|PCR positive at Week 48|0
1316195|NCT02641379|4304185|P6|Overall Study|PCR positive at Week 48|0
1316196|NCT02641379|4304186|P5|Overall Study|PCR positive at Week 48|0
1316197|NCT02641379|4304187|P4|Overall Study|PCR positive at Week 48|0
1316198|NCT02641379|4304188|P3|Overall Study|PCR positive at Week 48|0
1316199|NCT02641379|4304189|P2|Overall Study|PCR positive at Week 48|1
1316200|NCT02641379|4304190|P1|Overall Study|PCR positive at Week 48|0
1316201|NCT02641379|4304180|P11|Overall Study|PCR positive at Week 68|0
1316202|NCT02641379|4304181|P10|Overall Study|PCR positive at Week 68|0
1316203|NCT02641379|4304182|P9|Overall Study|PCR positive at Week 68|0
1316204|NCT02641379|4304183|P8|Overall Study|PCR positive at Week 68|0
1316205|NCT02641379|4304184|P7|Overall Study|PCR positive at Week 68|0
1316206|NCT02641379|4304185|P6|Overall Study|PCR positive at Week 68|0
1316207|NCT02641379|4304186|P5|Overall Study|PCR positive at Week 68|0
1316208|NCT02641379|4304187|P4|Overall Study|PCR positive at Week 68|0
1316209|NCT02641379|4304188|P3|Overall Study|PCR positive at Week 68|0
1316210|NCT02641379|4304189|P2|Overall Study|PCR positive at Week 68|1
1316211|NCT02641379|4304190|P1|Overall Study|PCR positive at Week 68|0
1316212|NCT02641379|4304180|P11|Overall Study|Financial problems|0
1316213|NCT02641379|4304181|P10|Overall Study|Financial problems|0
1316214|NCT02641379|4304182|P9|Overall Study|Financial problems|0
1316215|NCT02641379|4304183|P8|Overall Study|Financial problems|0
1316216|NCT02641379|4304184|P7|Overall Study|Financial problems|0
1316217|NCT02641379|4304185|P6|Overall Study|Financial problems|0
1316218|NCT02641379|4304186|P5|Overall Study|Financial problems|0
1316219|NCT02641379|4304187|P4|Overall Study|Financial problems|0
1316220|NCT02641379|4304188|P3|Overall Study|Financial problems|0
1316221|NCT02641379|4304189|P2|Overall Study|Financial problems|1
1316222|NCT02641379|4304190|P1|Overall Study|Financial problems|0
1316223|NCT02641379|4304180|P11|Overall Study|Therapy stopped due to misunderstanding|0
1316224|NCT02641379|4304181|P10|Overall Study|Therapy stopped due to misunderstanding|0
1316225|NCT02641379|4304182|P9|Overall Study|Therapy stopped due to misunderstanding|0
1316226|NCT02641379|4304183|P8|Overall Study|Therapy stopped due to misunderstanding|0
1316227|NCT02641379|4304184|P7|Overall Study|Therapy stopped due to misunderstanding|0
1316228|NCT02641379|4304185|P6|Overall Study|Therapy stopped due to misunderstanding|0
1316229|NCT02641379|4304186|P5|Overall Study|Therapy stopped due to misunderstanding|0
1316230|NCT02641379|4304187|P4|Overall Study|Therapy stopped due to misunderstanding|0
1316231|NCT02641379|4304188|P3|Overall Study|Therapy stopped due to misunderstanding|0
1316232|NCT02641379|4304189|P2|Overall Study|Therapy stopped due to misunderstanding|0
1316233|NCT02641379|4304190|P1|Overall Study|Therapy stopped due to misunderstanding|1
1316234|NCT02641379|4304180|P11|Overall Study|Participant stopped study/treatment|0
1316235|NCT02641379|4304181|P10|Overall Study|Participant stopped study/treatment|0
1316236|NCT02641379|4304182|P9|Overall Study|Participant stopped study/treatment|1
1316237|NCT02641379|4304183|P8|Overall Study|Participant stopped study/treatment|0
1316238|NCT02641379|4304184|P7|Overall Study|Participant stopped study/treatment|2
1316239|NCT02641379|4304185|P6|Overall Study|Participant stopped study/treatment|1
1316240|NCT02641379|4304186|P5|Overall Study|Participant stopped study/treatment|0
1316241|NCT02641379|4304187|P4|Overall Study|Participant stopped study/treatment|0
1316242|NCT02641379|4304188|P3|Overall Study|Participant stopped study/treatment|1
1316243|NCT02641379|4304189|P2|Overall Study|Participant stopped study/treatment|3
1316244|NCT02641379|4304190|P1|Overall Study|Participant stopped study/treatment|1
1316245|NCT02641379|4304180|P11|Overall Study|Participant showed relapse|0
1316246|NCT02641379|4304181|P10|Overall Study|Participant showed relapse|0
1316247|NCT02641379|4304182|P9|Overall Study|Participant showed relapse|0
1316248|NCT02641379|4304183|P8|Overall Study|Participant showed relapse|0
1316249|NCT02641379|4304184|P7|Overall Study|Participant showed relapse|1
1316250|NCT02641379|4304185|P6|Overall Study|Participant showed relapse|0
1316251|NCT02641379|4304186|P5|Overall Study|Participant showed relapse|0
1316252|NCT02641379|4304187|P4|Overall Study|Participant showed relapse|0
1316253|NCT02641379|4304188|P3|Overall Study|Participant showed relapse|0
1316254|NCT02641379|4304189|P2|Overall Study|Participant showed relapse|0
1316255|NCT02641379|4304190|P1|Overall Study|Participant showed relapse|1
1316256|NCT02641379|4304180|P11|Overall Study|PCR positive at follow up 2|0
1316257|NCT02641379|4304181|P10|Overall Study|PCR positive at follow up 2|0
1316258|NCT02641379|4304182|P9|Overall Study|PCR positive at follow up 2|0
1316259|NCT02641379|4304183|P8|Overall Study|PCR positive at follow up 2|0
1316260|NCT02641379|4304184|P7|Overall Study|PCR positive at follow up 2|0
1316261|NCT02641379|4304185|P6|Overall Study|PCR positive at follow up 2|0
1316262|NCT02641379|4304186|P5|Overall Study|PCR positive at follow up 2|0
1316263|NCT02641379|4304187|P4|Overall Study|PCR positive at follow up 2|0
1316264|NCT02641379|4304188|P3|Overall Study|PCR positive at follow up 2|0
1316265|NCT02641379|4304189|P2|Overall Study|PCR positive at follow up 2|0
1316266|NCT02641379|4304190|P1|Overall Study|PCR positive at follow up 2|1
1316267|NCT02641379|4304180|P11|Overall Study|PCR positive at Week 24|0
1316268|NCT02641379|4304181|P10|Overall Study|PCR positive at Week 24|1
1316269|NCT02641379|4304182|P9|Overall Study|PCR positive at Week 24|0
1316270|NCT02641379|4304183|P8|Overall Study|PCR positive at Week 24|8
1316271|NCT02641379|4304184|P7|Overall Study|PCR positive at Week 24|3
1316272|NCT02641379|4304185|P6|Overall Study|PCR positive at Week 24|6
1316273|NCT02641379|4304186|P5|Overall Study|PCR positive at Week 24|0
1316274|NCT02641379|4304187|P4|Overall Study|PCR positive at Week 24|0
1316275|NCT02641379|4304188|P3|Overall Study|PCR positive at Week 24|62
1316276|NCT02641379|4304189|P2|Overall Study|PCR positive at Week 24|21
1316277|NCT02641379|4304190|P1|Overall Study|PCR positive at Week 24|15
1316278|NCT02641379|4304180|P11|Overall Study|Participant cannot be reached|1
1316279|NCT02641379|4304181|P10|Overall Study|Participant cannot be reached|2
1316280|NCT02641379|4304182|P9|Overall Study|Participant cannot be reached|0
1316281|NCT02641379|4304183|P8|Overall Study|Participant cannot be reached|1
1316282|NCT02641379|4304184|P7|Overall Study|Participant cannot be reached|0
1316283|NCT02641379|4304185|P6|Overall Study|Participant cannot be reached|1
1316284|NCT02641379|4304186|P5|Overall Study|Participant cannot be reached|2
1316285|NCT02641379|4304187|P4|Overall Study|Participant cannot be reached|8
1316286|NCT02641379|4304188|P3|Overall Study|Participant cannot be reached|0
1316287|NCT02641379|4304189|P2|Overall Study|Participant cannot be reached|4
1316288|NCT02641379|4304190|P1|Overall Study|Participant cannot be reached|4
1316289|NCT02641379|4304180|P11|Overall Study|Participant’s compliance|1
1316290|NCT02641379|4304181|P10|Overall Study|Participant’s compliance|1
1316291|NCT02641379|4304182|P9|Overall Study|Participant’s compliance|1
1316292|NCT02641379|4304183|P8|Overall Study|Participant’s compliance|0
1316293|NCT02641379|4304184|P7|Overall Study|Participant’s compliance|0
1316294|NCT02641379|4304185|P6|Overall Study|Participant’s compliance|2
1316295|NCT02641379|4304186|P5|Overall Study|Participant’s compliance|0
1316296|NCT02641379|4304187|P4|Overall Study|Participant’s compliance|1
1316297|NCT02641379|4304188|P3|Overall Study|Participant’s compliance|0
1316298|NCT02641379|4304189|P2|Overall Study|Participant’s compliance|1
1316299|NCT02641379|4304190|P1|Overall Study|Participant’s compliance|0
1316300|NCT02641379|4304180|P11|Overall Study|Participant unable to attend study visit|0
1316301|NCT02641379|4304181|P10|Overall Study|Participant unable to attend study visit|2
1316302|NCT02641379|4304182|P9|Overall Study|Participant unable to attend study visit|0
1316303|NCT02641379|4304183|P8|Overall Study|Participant unable to attend study visit|1
1316304|NCT02641379|4304184|P7|Overall Study|Participant unable to attend study visit|1
1316305|NCT02641379|4304185|P6|Overall Study|Participant unable to attend study visit|1
1316306|NCT02641379|4304186|P5|Overall Study|Participant unable to attend study visit|5
1316307|NCT02641379|4304187|P4|Overall Study|Participant unable to attend study visit|2
1316308|NCT02641379|4304188|P3|Overall Study|Participant unable to attend study visit|1
1316309|NCT02641379|4304189|P2|Overall Study|Participant unable to attend study visit|10
1316310|NCT02641379|4304190|P1|Overall Study|Participant unable to attend study visit|4
1316311|NCT02641379|4304180|P11|Overall Study|Lack of Efficacy|0
1316312|NCT02641379|4304181|P10|Overall Study|Lack of Efficacy|0
1316313|NCT02641379|4304182|P9|Overall Study|Lack of Efficacy|0
1316314|NCT02641379|4304183|P8|Overall Study|Lack of Efficacy|5
1316315|NCT02641379|4304184|P7|Overall Study|Lack of Efficacy|0
1316316|NCT02641379|4304185|P6|Overall Study|Lack of Efficacy|2
1316317|NCT02641379|4304186|P5|Overall Study|Lack of Efficacy|0
1316318|NCT02641379|4304187|P4|Overall Study|Lack of Efficacy|0
1316319|NCT02641379|4304188|P3|Overall Study|Lack of Efficacy|2
1316320|NCT02641379|4304189|P2|Overall Study|Lack of Efficacy|0
1316321|NCT02641379|4304190|P1|Overall Study|Lack of Efficacy|0
1316322|NCT02641379|4304180|P11|Overall Study|Adverse Event|5
1316323|NCT02641379|4304181|P10|Overall Study|Adverse Event|1
1316324|NCT02641379|4304182|P9|Overall Study|Adverse Event|1
1316325|NCT02641379|4304183|P8|Overall Study|Adverse Event|0
1316326|NCT02641379|4304184|P7|Overall Study|Adverse Event|5
1316327|NCT02641379|4304185|P6|Overall Study|Adverse Event|1
1316328|NCT02641379|4304186|P5|Overall Study|Adverse Event|5
1316329|NCT02641379|4304187|P4|Overall Study|Adverse Event|2
1316330|NCT02641379|4304188|P3|Overall Study|Adverse Event|2
1316331|NCT02641379|4304189|P2|Overall Study|Adverse Event|8
1316332|NCT02641379|4304190|P1|Overall Study|Adverse Event|7
1316333|NCT02641379|4304180|P11|Overall Study|Withdrawal of informed consent|0
1316334|NCT02641379|4304181|P10|Overall Study|Withdrawal of informed consent|0
1316335|NCT02641379|4304182|P9|Overall Study|Withdrawal of informed consent|0
1316336|NCT02641379|4304183|P8|Overall Study|Withdrawal of informed consent|1
1316337|NCT02641379|4304184|P7|Overall Study|Withdrawal of informed consent|0
1316338|NCT02641379|4304185|P6|Overall Study|Withdrawal of informed consent|0
1316339|NCT02641379|4304186|P5|Overall Study|Withdrawal of informed consent|0
1316340|NCT02641379|4304187|P4|Overall Study|Withdrawal of informed consent|0
1316341|NCT02641379|4304188|P3|Overall Study|Withdrawal of informed consent|0
1316342|NCT02641379|4304189|P2|Overall Study|Withdrawal of informed consent|1
1316343|NCT02641379|4304190|P1|Overall Study|Withdrawal of informed consent|0
1316344|NCT02641379|4304180|P11|Overall Study|Exclusion criterion during screening|0
1316345|NCT02641379|4304181|P10|Overall Study|Exclusion criterion during screening|0
1316346|NCT02641379|4304182|P9|Overall Study|Exclusion criterion during screening|0
1316347|NCT02641379|4304183|P8|Overall Study|Exclusion criterion during screening|0
1316348|NCT02641379|4304184|P7|Overall Study|Exclusion criterion during screening|0
1316349|NCT02641379|4304185|P6|Overall Study|Exclusion criterion during screening|0
1316350|NCT02641379|4304186|P5|Overall Study|Exclusion criterion during screening|2
1316351|NCT02641379|4304187|P4|Overall Study|Exclusion criterion during screening|1
1316352|NCT02641379|4304188|P3|Overall Study|Exclusion criterion during screening|0
1316353|NCT02641379|4304189|P2|Overall Study|Exclusion criterion during screening|0
1316354|NCT02641379|4304190|P1|Overall Study|Exclusion criterion during screening|1
1316355|NCT02640482|4304266|P2|Overall Study|Lost to Follow-up|0
1316356|NCT02640482|4304267|P1|Overall Study|Lost to Follow-up|3
1316357|NCT02640404|4304279|P2|Overall Study|Withdrawal by Subject|0
1316358|NCT02640404|4304280|P1|Overall Study|Withdrawal by Subject|1
1316359|NCT02640404|4304279|P2|Overall Study|Protocol Violation|0
1316360|NCT02640404|4304280|P1|Overall Study|Protocol Violation|1
1316361|NCT02640157|4304291|P3|Overall Study|Randomized in error; did not receive Tx|0
1316362|NCT02640157|4304292|P2|Overall Study|Randomized in error; did not receive Tx|1
1316363|NCT02640157|4304293|P1|Overall Study|Randomized in error; did not receive Tx|0
1316364|NCT02640157|4304291|P3|Overall Study|Lost to Follow-up|7
1316365|NCT02640157|4304292|P2|Overall Study|Lost to Follow-up|2
1316366|NCT02640157|4304293|P1|Overall Study|Lost to Follow-up|9
1316367|NCT02640157|4304291|P3|Overall Study|Withdrew consent|2
1316368|NCT02640157|4304292|P2|Overall Study|Withdrew consent|0
1316369|NCT02640157|4304293|P1|Overall Study|Withdrew consent|2
1316370|NCT02640157|4304291|P3|Overall Study|Adverse Event|1
1316371|NCT02640157|4304292|P2|Overall Study|Adverse Event|2
1316372|NCT02640157|4304293|P1|Overall Study|Adverse Event|2
1316373|NCT02639338|4304395|P2|Overall Study|Randomized but Not Treated|1
1316374|NCT02639338|4304396|P1|Overall Study|Randomized but Not Treated|0
1316375|NCT02639338|4304395|P2|Overall Study|Death|0
1316376|NCT02639338|4304396|P1|Overall Study|Death|1
1316377|NCT02639338|4304395|P2|Overall Study|Withdrew Consent|2
1316378|NCT02639338|4304396|P1|Overall Study|Withdrew Consent|1
1316379|NCT02639338|4304395|P2|Overall Study|Lost to Follow-up|2
1316380|NCT02639338|4304396|P1|Overall Study|Lost to Follow-up|2
1316381|NCT02639247|4304414|P2|Overall Study|Protocol Violation|0
1316382|NCT02639247|4304415|P1|Overall Study|Protocol Violation|1
1316383|NCT02639247|4304414|P2|Overall Study|Withdrew Consent|1
1316384|NCT02639247|4304415|P1|Overall Study|Withdrew Consent|0
1316385|NCT02639247|4304414|P2|Overall Study|Death|0
1316386|NCT02639247|4304415|P1|Overall Study|Death|2
1316387|NCT02639247|4304414|P2|Overall Study|Lost to Follow-up|1
1316388|NCT02639247|4304415|P1|Overall Study|Lost to Follow-up|2
1316389|NCT02639052|4304431|P1|Overall Study|Lost to Follow-up|1
1316390|NCT02638493|4304448|P3|Overall Study|Inability to provide semen samples|0
1316391|NCT02638493|4304449|P2|Overall Study|Inability to provide semen samples|0
1316392|NCT02638493|4304450|P1|Overall Study|Inability to provide semen samples|2
1316393|NCT02638259|4304481|P2|Treatment Period 2|Withdrawal by Subject|7
1316394|NCT02638259|4304482|P1|Treatment Period 2|Withdrawal by Subject|1
1316395|NCT02638259|4304481|P2|Treatment Period 2|Adverse Event|4
1316396|NCT02638259|4304482|P1|Treatment Period 2|Adverse Event|5
1316397|NCT02638259|4304481|P2|Treatment Period 1|Withdrawn per sponsor decision|2
1316398|NCT02638259|4304482|P1|Treatment Period 1|Withdrawn per sponsor decision|0
1316399|NCT02638259|4304481|P2|Treatment Period 1|Withdrawal by Subject|6
1316400|NCT02638259|4304482|P1|Treatment Period 1|Withdrawal by Subject|4
1316401|NCT02638259|4304481|P2|Treatment Period 1|Protocol Violation|3
1316402|NCT02638259|4304482|P1|Treatment Period 1|Protocol Violation|0
1316403|NCT02638259|4304481|P2|Treatment Period 1|Lack of Efficacy|1
1316404|NCT02638259|4304482|P1|Treatment Period 1|Lack of Efficacy|0
1316405|NCT02638259|4304481|P2|Treatment Period 1|Death|1
1316406|NCT02638259|4304482|P1|Treatment Period 1|Death|0
1316407|NCT02638259|4304481|P2|Treatment Period 1|Adverse Event|5
1316408|NCT02638259|4304482|P1|Treatment Period 1|Adverse Event|1
1316409|NCT02638129|4304494|P2|Overall Study|Study terminated|30
1316410|NCT02638129|4304495|P1|Overall Study|Study terminated|28
1316411|NCT02637323|4304668|P2|Overall Study|Protocol Violation|1
1316412|NCT02637323|4304669|P1|Overall Study|Protocol Violation|0
1316413|NCT02637323|4304668|P2|Overall Study|Lost to Follow-up|0
1316414|NCT02637323|4304669|P1|Overall Study|Lost to Follow-up|2
1316415|NCT02637063|4304680|P3|Overall Study|Withdrawal by Subject|3
1316416|NCT02637063|4304681|P2|Overall Study|Withdrawal by Subject|2
1316417|NCT02637063|4304682|P1|Overall Study|Withdrawal by Subject|2
1316418|NCT02637063|4304680|P3|Overall Study|Lost to Follow-up|3
1316419|NCT02637063|4304681|P2|Overall Study|Lost to Follow-up|2
1316420|NCT02637063|4304682|P1|Overall Study|Lost to Follow-up|3
1316421|NCT02637037|4304710|P2|Overall Study|Adverse Event|0
1316422|NCT02637037|4304711|P1|Overall Study|Adverse Event|1
1316423|NCT02637037|4304710|P2|Overall Study|Withdrawal by Subject|1
1316424|NCT02637037|4304711|P1|Overall Study|Withdrawal by Subject|2
1316425|NCT02637037|4304710|P2|Overall Study|Positive drug screen at admission|0
1316426|NCT02637037|4304711|P1|Overall Study|Positive drug screen at admission|1
1316427|NCT02636907|4304777|P1|Extension Phase|Lack of Efficacy|1
1316428|NCT02636907|4304777|P1|Extension Phase|Lost to Follow-up|2
1316429|NCT02636907|4304777|P1|Extension Phase|Physician Decision|1
1316430|NCT02636907|4304777|P1|Extension Phase|Withdrawal by Subject|4
1316431|NCT02636907|4304777|P1|Extension Phase|Adverse Event|2
1316432|NCT02636907|4304777|P1|Autoinjector Assessment Period|Withdrawal by Subject|2
1316433|NCT02636907|4304777|P1|Autoinjector Assessment Period|Adverse Event|2
1316434|NCT02636595|4304786|P1|Overall Study|Not specified|1
1316435|NCT02636595|4304786|P1|Overall Study|Lost to Follow-up|1
1316436|NCT02635984|4304794|P2|Overall Study|Study Arm Closed|0
1316437|NCT02635984|4304795|P1|Overall Study|Study Arm Closed|1
1316438|NCT02635984|4304794|P2|Overall Study|Lost to Follow-up|4
1316439|NCT02635984|4304795|P1|Overall Study|Lost to Follow-up|2
1316440|NCT02635204|4304864|P2|Overall Study|Lost to Follow-up|1
1316441|NCT02635204|4304865|P1|Overall Study|Lost to Follow-up|1
1316442|NCT02635204|4304864|P2|Overall Study|Adverse Event|0
1316443|NCT02635204|4304865|P1|Overall Study|Adverse Event|1
1316444|NCT02634801|4304878|P3|Overall Study|Withdrawal by Subject|3
1316445|NCT02634801|4304879|P2|Overall Study|Withdrawal by Subject|8
1316446|NCT02634801|4304880|P1|Overall Study|Withdrawal by Subject|1
1316447|NCT02634801|4304878|P3|Overall Study|Protocol Violation|1
1316448|NCT02634801|4304879|P2|Overall Study|Protocol Violation|0
1316449|NCT02634801|4304880|P1|Overall Study|Protocol Violation|0
1316450|NCT02634801|4304878|P3|Overall Study|Lost to Follow-up|1
1316451|NCT02634801|4304879|P2|Overall Study|Lost to Follow-up|1
1316452|NCT02634801|4304880|P1|Overall Study|Lost to Follow-up|2
1316453|NCT02634801|4304878|P3|Overall Study|Lack of Efficacy|0
1316454|NCT02634801|4304879|P2|Overall Study|Lack of Efficacy|2
1316455|NCT02634801|4304880|P1|Overall Study|Lack of Efficacy|0
1316456|NCT02634801|4304878|P3|Overall Study|Adverse Event|0
1316457|NCT02634801|4304879|P2|Overall Study|Adverse Event|20
1316458|NCT02634801|4304880|P1|Overall Study|Adverse Event|2
1316459|NCT02634788|4304976|P4|Overall Study|Withdrawal by Subject|0
1316460|NCT02634788|4304977|P3|Overall Study|Withdrawal by Subject|1
1316461|NCT02634788|4304978|P2|Overall Study|Withdrawal by Subject|1
1316462|NCT02634788|4304979|P1|Overall Study|Withdrawal by Subject|0
1316463|NCT02634788|4304976|P4|Overall Study|Lost to Follow-up|0
1316464|NCT02634788|4304977|P3|Overall Study|Lost to Follow-up|0
1316465|NCT02634788|4304978|P2|Overall Study|Lost to Follow-up|1
1316466|NCT02634788|4304979|P1|Overall Study|Lost to Follow-up|0
1316467|NCT02634788|4304976|P4|Overall Study|Lack of Efficacy|4
1316468|NCT02634788|4304977|P3|Overall Study|Lack of Efficacy|1
1316469|NCT02634788|4304978|P2|Overall Study|Lack of Efficacy|0
1316470|NCT02634788|4304979|P1|Overall Study|Lack of Efficacy|4
1316471|NCT02634788|4304976|P4|Overall Study|Adverse Event|1
1316472|NCT02634788|4304977|P3|Overall Study|Adverse Event|3
1316473|NCT02634788|4304978|P2|Overall Study|Adverse Event|8
1316474|NCT02634788|4304979|P1|Overall Study|Adverse Event|0
1316475|NCT02634580|4305049|P4|Overall Study|Subject Request|1
1316476|NCT02634580|4305050|P3|Overall Study|Subject Request|1
1316477|NCT02634580|4305051|P2|Overall Study|Subject Request|0
1316478|NCT02634580|4305052|P1|Overall Study|Subject Request|1
1316479|NCT02634346|4305109|P3|Overall Study|Protocol Violation|0
1316480|NCT02634346|4305110|P2|Overall Study|Protocol Violation|1
1316481|NCT02634346|4305111|P1|Overall Study|Protocol Violation|0
1316482|NCT02634346|4305109|P3|Overall Study|Lost to Follow-up|0
1316483|NCT02634346|4305110|P2|Overall Study|Lost to Follow-up|0
1316484|NCT02634346|4305111|P1|Overall Study|Lost to Follow-up|1
1316485|NCT02634346|4305109|P3|Overall Study|Lack of Efficacy|8
1316486|NCT02634346|4305110|P2|Overall Study|Lack of Efficacy|2
1316487|NCT02634346|4305111|P1|Overall Study|Lack of Efficacy|1
1316488|NCT02634346|4305109|P3|Overall Study|Adverse Event|7
1316489|NCT02634346|4305110|P2|Overall Study|Adverse Event|2
1316490|NCT02634346|4305111|P1|Overall Study|Adverse Event|2
1316491|NCT02634346|4305109|P3|Overall Study|Withdrawal by Subject|8
1316492|NCT02634346|4305110|P2|Overall Study|Withdrawal by Subject|9
1316493|NCT02634346|4305111|P1|Overall Study|Withdrawal by Subject|8
1316494|NCT02633787|4305239|P1|Overall Study|Withdrawal by Subject|1
1316495|NCT02633215|4305251|P2|Overall Study|Lost to Follow-up|3
1316496|NCT02633215|4305252|P1|Overall Study|Lost to Follow-up|2
1316497|NCT02632838|4305264|P2|Overall Study|Lost to Follow-up|2
1316498|NCT02632838|4305265|P1|Overall Study|Lost to Follow-up|0
1316499|NCT02632838|4305264|P2|Overall Study|Withdrawal by Subject|0
1316500|NCT02632838|4305265|P1|Overall Study|Withdrawal by Subject|3
1316501|NCT02632110|4305305|P10|Overall Study|Withdrawal by Subject|1
1316502|NCT02632110|4305306|P9|Overall Study|Withdrawal by Subject|1
1316503|NCT02632110|4305307|P8|Overall Study|Withdrawal by Subject|3
1316504|NCT02632110|4305308|P7|Overall Study|Withdrawal by Subject|3
1316505|NCT02632110|4305309|P6|Overall Study|Withdrawal by Subject|1
1316506|NCT02632110|4305310|P5|Overall Study|Withdrawal by Subject|1
1316507|NCT02632110|4305311|P4|Overall Study|Withdrawal by Subject|0
1316508|NCT02632110|4305312|P3|Overall Study|Withdrawal by Subject|0
1316509|NCT02632110|4305313|P2|Overall Study|Withdrawal by Subject|1
1316510|NCT02632110|4305314|P1|Overall Study|Withdrawal by Subject|1
1316511|NCT02631551|4305785|P4|Overall Study|Other|2
1316512|NCT02631551|4305786|P3|Overall Study|Other|2
1316513|NCT02631551|4305787|P2|Overall Study|Other|7
1316514|NCT02631551|4305788|P1|Overall Study|Other|5
1316515|NCT02631551|4305785|P4|Overall Study|Non-compliance with study drug|0
1316516|NCT02631551|4305786|P3|Overall Study|Non-compliance with study drug|0
1316517|NCT02631551|4305787|P2|Overall Study|Non-compliance with study drug|0
1316518|NCT02631551|4305788|P1|Overall Study|Non-compliance with study drug|1
1316519|NCT02631551|4305785|P4|Overall Study|Non-compliance with study procedures|1
1316520|NCT02631551|4305786|P3|Overall Study|Non-compliance with study procedures|1
1316521|NCT02631551|4305787|P2|Overall Study|Non-compliance with study procedures|0
1316522|NCT02631551|4305788|P1|Overall Study|Non-compliance with study procedures|0
1316523|NCT02631551|4305785|P4|Overall Study|Protocol deviation|0
1316524|NCT02631551|4305786|P3|Overall Study|Protocol deviation|3
1316525|NCT02631551|4305787|P2|Overall Study|Protocol deviation|6
1316526|NCT02631551|4305788|P1|Overall Study|Protocol deviation|3
1316527|NCT02631551|4305785|P4|Overall Study|Withdrawal by Subject|5
1316528|NCT02631551|4305786|P3|Overall Study|Withdrawal by Subject|0
1316529|NCT02631551|4305787|P2|Overall Study|Withdrawal by Subject|2
1316530|NCT02631551|4305788|P1|Overall Study|Withdrawal by Subject|2
1316531|NCT02631551|4305785|P4|Overall Study|Lost to Follow-up|3
1316532|NCT02631551|4305786|P3|Overall Study|Lost to Follow-up|0
1316533|NCT02631551|4305787|P2|Overall Study|Lost to Follow-up|2
1316534|NCT02631551|4305788|P1|Overall Study|Lost to Follow-up|1
1316535|NCT02631551|4305785|P4|Overall Study|Lack of Efficacy|0
1316536|NCT02631551|4305786|P3|Overall Study|Lack of Efficacy|1
1316537|NCT02631551|4305787|P2|Overall Study|Lack of Efficacy|0
1316538|NCT02631551|4305788|P1|Overall Study|Lack of Efficacy|0
1316539|NCT02631551|4305785|P4|Overall Study|Adverse Event|0
1316540|NCT02631551|4305786|P3|Overall Study|Adverse Event|4
1316541|NCT02631551|4305787|P2|Overall Study|Adverse Event|2
1316542|NCT02631551|4305788|P1|Overall Study|Adverse Event|1
1316543|NCT02630563|4305824|P1|Overall Study|Administrative|1
1316544|NCT02628938|4305866|P3|Overall Study|Failure to comply with the instructions|3
1316545|NCT02628938|4305867|P2|Overall Study|Failure to comply with the instructions|0
1316546|NCT02628938|4305868|P1|Overall Study|Failure to comply with the instructions|3
1316547|NCT02628938|4305866|P3|Overall Study|Did not attend the follow up recall|1
1316548|NCT02628938|4305867|P2|Overall Study|Did not attend the follow up recall|2
1316549|NCT02628938|4305868|P1|Overall Study|Did not attend the follow up recall|2
1316550|NCT02628418|4305884|P2|Overall Study|Lost to Follow-up|2
1316551|NCT02628418|4305885|P1|Overall Study|Lost to Follow-up|1
1316552|NCT02627144|4305960|P1|Overall Study|Other|17
1316553|NCT02627144|4305960|P1|Overall Study|Enrolled, not treated|6
1316554|NCT02627144|4305960|P1|Overall Study|Lost to Follow-up|8
1316555|NCT02627144|4305960|P1|Overall Study|Administrative reasons|65
1316556|NCT02627144|4305960|P1|Overall Study|Refusal of treatment / poor cooperation|38
1316557|NCT02627144|4305960|P1|Overall Study|Death from other cause|8
1316558|NCT02627144|4305960|P1|Overall Study|Death from cancer|20
1316559|NCT02627144|4305960|P1|Overall Study|Cancer progression|171
1316560|NCT02627144|4305960|P1|Overall Study|Serious adverse event|32
1316561|NCT02625259|4306058|P5|First Intervention (Day 1)|Withdrawal by Subject|0
1316562|NCT02625259|4306059|P4|First Intervention (Day 1)|Withdrawal by Subject|1
1316563|NCT02625259|4306060|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1316564|NCT02625259|4306061|P2|First Intervention (Day 1)|Withdrawal by Subject|0
1316565|NCT02625259|4306062|P1|First Intervention (Day 1)|Withdrawal by Subject|0
1316566|NCT02625259|4306058|P5|First Intervention (Day 1)|Adverse Event|0
1316567|NCT02625259|4306059|P4|First Intervention (Day 1)|Adverse Event|0
1316568|NCT02625259|4306060|P3|First Intervention (Day 1)|Adverse Event|0
1316569|NCT02625259|4306061|P2|First Intervention (Day 1)|Adverse Event|1
1316570|NCT02625259|4306062|P1|First Intervention (Day 1)|Adverse Event|2
1316571|NCT02625259|4306058|P5|First Intervention (Day 1)|Other|0
1316572|NCT02625259|4306059|P4|First Intervention (Day 1)|Other|0
1316573|NCT02625259|4306060|P3|First Intervention (Day 1)|Other|1
1316574|NCT02625259|4306061|P2|First Intervention (Day 1)|Other|0
1316575|NCT02625259|4306062|P1|First Intervention (Day 1)|Other|0
1316576|NCT02625233|4306099|P2|Overall Study|Adverse Event|0
1316577|NCT02625233|4306100|P1|Overall Study|Adverse Event|2
1316578|NCT02625220|4306108|P1|Overall Study|Study discontinued at site|2
1316579|NCT02625220|4306108|P1|Overall Study|Protocol Violation|1
1316580|NCT02625220|4306108|P1|Overall Study|Lost to Follow-up|2
1316581|NCT02625220|4306108|P1|Overall Study|Adverse Event|2
1316582|NCT02624791|4306208|P6|Overall Study|Withdrawal by Subject|0
1316583|NCT02624791|4306209|P5|Overall Study|Withdrawal by Subject|0
1316584|NCT02624791|4306210|P4|Overall Study|Withdrawal by Subject|0
1316585|NCT02624791|4306211|P3|Overall Study|Withdrawal by Subject|0
1316586|NCT02624791|4306212|P2|Overall Study|Withdrawal by Subject|0
1316587|NCT02624791|4306213|P1|Overall Study|Withdrawal by Subject|2
1316588|NCT02623361|4306220|P2|Overall Study|Withdrawal by Subject|1
1316589|NCT02623361|4306221|P1|Overall Study|Withdrawal by Subject|0
1316590|NCT02623361|4306220|P2|Overall Study|Protocol Violation|1
1316591|NCT02623361|4306221|P1|Overall Study|Protocol Violation|0
1316592|NCT02622568|4306233|P2|Overall Study|Lost to Follow-up|5
1316593|NCT02622568|4306234|P1|Overall Study|Lost to Follow-up|5
1316594|NCT02622321|4306244|P4|Overall Study|Withdrawal by Subject|0
1316595|NCT02622321|4306245|P3|Overall Study|Withdrawal by Subject|0
1316596|NCT02622321|4306246|P2|Overall Study|Withdrawal by Subject|0
1316597|NCT02622321|4306247|P1|Overall Study|Withdrawal by Subject|1
1316598|NCT02622321|4306244|P4|Overall Study|Ongoing treatment with emicizumab|7
1316599|NCT02622321|4306245|P3|Overall Study|Ongoing treatment with emicizumab|49
1316600|NCT02622321|4306246|P2|Overall Study|Ongoing treatment with emicizumab|13
1316601|NCT02622321|4306247|P1|Overall Study|Ongoing treatment with emicizumab|31
1316602|NCT02622321|4306244|P4|Overall Study|Ongoing in safety follow-up|0
1316603|NCT02622321|4306245|P3|Overall Study|Ongoing in safety follow-up|0
1316604|NCT02622321|4306246|P2|Overall Study|Ongoing in safety follow-up|0
1316605|NCT02622321|4306247|P1|Overall Study|Ongoing in safety follow-up|3
1316606|NCT02622321|4306244|P4|Overall Study|Ongoing treatment with no emicizumab|0
1316607|NCT02622321|4306245|P3|Overall Study|Ongoing treatment with no emicizumab|0
1316608|NCT02622321|4306246|P2|Overall Study|Ongoing treatment with no emicizumab|5
1316609|NCT02622321|4306247|P1|Overall Study|Ongoing treatment with no emicizumab|0
1316610|NCT02621047|4306293|P3|Overall Study|Adverse Event|1
1316611|NCT02621047|4306294|P2|Overall Study|Adverse Event|0
1316612|NCT02621047|4306295|P1|Overall Study|Adverse Event|0
1316613|NCT02621034|4306411|P3|Overall Study|Lost to Follow-up|5
1316614|NCT02621034|4306412|P2|Overall Study|Lost to Follow-up|2
1316615|NCT02621034|4306413|P1|Overall Study|Lost to Follow-up|3
1316616|NCT02619812|4306439|P4|Overall Study|Withdrawal by Subject|2
1316617|NCT02619812|4306440|P3|Overall Study|Withdrawal by Subject|1
1316618|NCT02619812|4306441|P2|Overall Study|Withdrawal by Subject|0
1316619|NCT02619812|4306442|P1|Overall Study|Withdrawal by Subject|0
1316620|NCT02615990|4306664|P2|Overall Study|study terminated|1
1316621|NCT02615990|4306665|P1|Overall Study|study terminated|1
1316622|NCT02614079|4306809|P1|Overall Study|Withdrawal by Subject|1
1316623|NCT02613910|4306813|P1|Overall Study|Termination of study|1
1316624|NCT02613871|4306862|P1|Overall Study|On Study|111
1316625|NCT02613403|4306881|P5|Overall Study|Withdrawal by Subject|0
1316626|NCT02613403|4306882|P4|Overall Study|Withdrawal by Subject|0
1316627|NCT02613403|4306883|P3|Overall Study|Withdrawal by Subject|0
1316628|NCT02613403|4306884|P2|Overall Study|Withdrawal by Subject|0
1316629|NCT02613403|4306885|P1|Overall Study|Withdrawal by Subject|2
1316630|NCT02613403|4306881|P5|Overall Study|Lost to Follow-up|0
1316631|NCT02613403|4306882|P4|Overall Study|Lost to Follow-up|0
1316632|NCT02613403|4306883|P3|Overall Study|Lost to Follow-up|0
1316633|NCT02613403|4306884|P2|Overall Study|Lost to Follow-up|1
1316634|NCT02613403|4306885|P1|Overall Study|Lost to Follow-up|0
1316635|NCT02612610|4306931|P4|Overall Study|Cough Improvement|0
1316636|NCT02612610|4306932|P3|Overall Study|Cough Improvement|1
1316637|NCT02612610|4306933|P2|Overall Study|Cough Improvement|0
1316638|NCT02612610|4306934|P1|Overall Study|Cough Improvement|0
1316639|NCT02612610|4306931|P4|Overall Study|Noncompliance|0
1316640|NCT02612610|4306932|P3|Overall Study|Noncompliance|0
1316641|NCT02612610|4306933|P2|Overall Study|Noncompliance|0
1316642|NCT02612610|4306934|P1|Overall Study|Noncompliance|1
1316643|NCT02612610|4306931|P4|Overall Study|Physician Decision|0
1316644|NCT02612610|4306932|P3|Overall Study|Physician Decision|0
1316645|NCT02612610|4306933|P2|Overall Study|Physician Decision|1
1316646|NCT02612610|4306934|P1|Overall Study|Physician Decision|0
1316647|NCT02612610|4306931|P4|Overall Study|Lack of Efficacy|1
1316648|NCT02612610|4306932|P3|Overall Study|Lack of Efficacy|0
1316649|NCT02612610|4306933|P2|Overall Study|Lack of Efficacy|2
1316650|NCT02612610|4306934|P1|Overall Study|Lack of Efficacy|1
1316651|NCT02612610|4306931|P4|Overall Study|Protocol Violation|0
1316652|NCT02612610|4306932|P3|Overall Study|Protocol Violation|1
1316653|NCT02612610|4306933|P2|Overall Study|Protocol Violation|1
1316654|NCT02612610|4306934|P1|Overall Study|Protocol Violation|0
1316655|NCT02612610|4306931|P4|Overall Study|Lost to Follow-up|0
1316656|NCT02612610|4306932|P3|Overall Study|Lost to Follow-up|0
1316657|NCT02612610|4306933|P2|Overall Study|Lost to Follow-up|1
1316658|NCT02612610|4306934|P1|Overall Study|Lost to Follow-up|0
1316659|NCT02612610|4306931|P4|Overall Study|Adverse Event|10
1316660|NCT02612610|4306932|P3|Overall Study|Adverse Event|3
1316661|NCT02612610|4306933|P2|Overall Study|Adverse Event|2
1316662|NCT02612610|4306934|P1|Overall Study|Adverse Event|2
1316663|NCT02612610|4306931|P4|Overall Study|Withdrawal by Subject|2
1316664|NCT02612610|4306932|P3|Overall Study|Withdrawal by Subject|0
1316665|NCT02612610|4306933|P2|Overall Study|Withdrawal by Subject|1
1316666|NCT02612610|4306934|P1|Overall Study|Withdrawal by Subject|1
1316667|NCT02612077|4307176|P1|Overall Study|Unknown reason|2
1316668|NCT02612077|4307176|P1|Overall Study|Disease Progression|3
1316669|NCT02612077|4307176|P1|Overall Study|Enrollment in a Clinical Trial|1
1316670|NCT02612077|4307176|P1|Overall Study|Moved or Changed Medical Team|23
1316671|NCT02612077|4307176|P1|Overall Study|Death|377
1316672|NCT02612077|4307176|P1|Overall Study|Lost to Follow-up|20
1316673|NCT02612077|4307176|P1|Overall Study|Protocol Violation|28
1316674|NCT02612077|4307176|P1|Overall Study|Withdrawal by Subject|9
1316675|NCT02612077|4307176|P1|Overall Study|Adverse Event|3
1316676|NCT02612064|4307188|P2|Overall Study|Not Specified|2
1316677|NCT02612064|4307189|P1|Overall Study|Not Specified|0
1316678|NCT02612064|4307188|P2|Overall Study|Withdrawal by Subject|1
1316679|NCT02612064|4307189|P1|Overall Study|Withdrawal by Subject|1
1316680|NCT02610816|4307229|P4|Phase 2|Pregnancy|1
1316681|NCT02610816|4307230|P3|Phase 2|Pregnancy|0
1316682|NCT02610816|4307231|P2|Phase 2|Pregnancy|0
1316683|NCT02610816|4307232|P1|Phase 2|Pregnancy|0
1316684|NCT02610816|4307229|P4|Phase 2|Physician Decision|2
1316685|NCT02610816|4307230|P3|Phase 2|Physician Decision|0
1316686|NCT02610816|4307231|P2|Phase 2|Physician Decision|0
1316687|NCT02610816|4307232|P1|Phase 2|Physician Decision|0
1316688|NCT02610816|4307229|P4|Phase 2|Lost to Follow-up|0
1316689|NCT02610816|4307230|P3|Phase 2|Lost to Follow-up|2
1316690|NCT02610816|4307231|P2|Phase 2|Lost to Follow-up|0
1316691|NCT02610816|4307232|P1|Phase 2|Lost to Follow-up|0
1316692|NCT02610816|4307229|P4|Phase 2|Withdrawal by Subject|3
1316693|NCT02610816|4307230|P3|Phase 2|Withdrawal by Subject|9
1316694|NCT02610816|4307231|P2|Phase 2|Withdrawal by Subject|0
1316695|NCT02610816|4307232|P1|Phase 2|Withdrawal by Subject|0
1316696|NCT02610816|4307229|P4|Phase 1|Physician Decision|0
1316697|NCT02610816|4307230|P3|Phase 1|Physician Decision|0
1316698|NCT02610816|4307231|P2|Phase 1|Physician Decision|1
1316699|NCT02610816|4307232|P1|Phase 1|Physician Decision|0
1316700|NCT02610816|4307229|P4|Phase 1|Lost to Follow-up|0
1316701|NCT02610816|4307230|P3|Phase 1|Lost to Follow-up|0
1316702|NCT02610816|4307231|P2|Phase 1|Lost to Follow-up|1
1316703|NCT02610816|4307232|P1|Phase 1|Lost to Follow-up|2
1316704|NCT02610816|4307229|P4|Phase 1|Withdrawal by Subject|0
1316705|NCT02610816|4307230|P3|Phase 1|Withdrawal by Subject|0
1316706|NCT02610816|4307231|P2|Phase 1|Withdrawal by Subject|6
1316707|NCT02610816|4307232|P1|Phase 1|Withdrawal by Subject|2
1316708|NCT02609672|4307272|P2|Overall Study|Lost to Follow-up|1
1316709|NCT02609672|4307273|P1|Overall Study|Lost to Follow-up|3
1316710|NCT02609659|4307307|P1|Overall Study|Not Specified|1
1316711|NCT02609659|4307307|P1|Overall Study|Lost to Follow-up|6
1316712|NCT02609659|4307307|P1|Overall Study|Adverse Event|1
1316713|NCT02609633|4307317|P2|Overall Study|Reason not Specified|1
1316714|NCT02609633|4307318|P1|Overall Study|Reason not Specified|2
1316715|NCT02609633|4307317|P2|Overall Study|Non-Compliant with Study Procedures|0
1316716|NCT02609633|4307318|P1|Overall Study|Non-Compliant with Study Procedures|2
1316717|NCT02609633|4307317|P2|Overall Study|Protocol Deviation|0
1316718|NCT02609633|4307318|P1|Overall Study|Protocol Deviation|1
1316719|NCT02609633|4307317|P2|Overall Study|Consent Withdrawn|1
1316720|NCT02609633|4307318|P1|Overall Study|Consent Withdrawn|0
1316721|NCT02609399|4307345|P2|Influenza Season 2016-2017|Found ineligible after randomization|0
1316722|NCT02609399|4307346|P1|Influenza Season 2016-2017|Found ineligible after randomization|1
1316723|NCT02609399|4307345|P2|Influenza Season 2016-2017|Lost to Follow-up|5
1316724|NCT02609399|4307346|P1|Influenza Season 2016-2017|Lost to Follow-up|8
1316725|NCT02609399|4307345|P2|Influenza Season 2015-2016|Lost to Follow-up|2
1316726|NCT02609399|4307346|P1|Influenza Season 2015-2016|Lost to Follow-up|3
1316727|NCT02609178|4307358|P6|First Crown|Withdrawal by Subject|0
1316728|NCT02609178|4307359|P5|First Crown|Withdrawal by Subject|0
1316729|NCT02609178|4307360|P4|First Crown|Withdrawal by Subject|1
1316730|NCT02609178|4307361|P3|First Crown|Withdrawal by Subject|1
1316731|NCT02609178|4307362|P2|First Crown|Withdrawal by Subject|0
1316732|NCT02609178|4307363|P1|First Crown|Withdrawal by Subject|0
1316733|NCT02607956|4307437|P2|Overall Study|Lost to Follow-up|5
1316734|NCT02607956|4307438|P1|Overall Study|Lost to Follow-up|8
1316735|NCT02607956|4307437|P2|Overall Study|Withdrawal by Subject|8
1316736|NCT02607956|4307438|P1|Overall Study|Withdrawal by Subject|7
1316737|NCT02607956|4307437|P2|Overall Study|Protocol Violation|1
1316738|NCT02607956|4307438|P1|Overall Study|Protocol Violation|2
1316739|NCT02607956|4307437|P2|Overall Study|Non-Compliance with Study Drug|1
1316740|NCT02607956|4307438|P1|Overall Study|Non-Compliance with Study Drug|0
1316741|NCT02607956|4307437|P2|Overall Study|Investigator's Decision|0
1316742|NCT02607956|4307438|P1|Overall Study|Investigator's Decision|3
1316743|NCT02607956|4307437|P2|Overall Study|Death|2
1316744|NCT02607956|4307438|P1|Overall Study|Death|1
1316745|NCT02607956|4307437|P2|Overall Study|Adverse Event|1
1316746|NCT02607956|4307438|P1|Overall Study|Adverse Event|3
1316747|NCT02607956|4307437|P2|Overall Study|Still on Study|307
1316748|NCT02607956|4307438|P1|Overall Study|Still on Study|296
1316749|NCT02607956|4307437|P2|Overall Study|Randomized and Never Treated|5
1316750|NCT02607956|4307438|P1|Overall Study|Randomized and Never Treated|7
1316751|NCT02607930|4307452|P2|Overall Study|Lost to Follow-up|6
1316752|NCT02607930|4307453|P1|Overall Study|Lost to Follow-up|9
1316753|NCT02607930|4307452|P2|Overall Study|Withdrawal by Subject|5
1316754|NCT02607930|4307453|P1|Overall Study|Withdrawal by Subject|3
1316755|NCT02607930|4307452|P2|Overall Study|Protocol Violation|0
1316756|NCT02607930|4307453|P1|Overall Study|Protocol Violation|1
1316757|NCT02607930|4307452|P2|Overall Study|Non-Compliance with Study Drug|0
1316758|NCT02607930|4307453|P1|Overall Study|Non-Compliance with Study Drug|2
1316759|NCT02607930|4307452|P2|Overall Study|Physician Decision|0
1316760|NCT02607930|4307453|P1|Overall Study|Physician Decision|3
1316761|NCT02607930|4307452|P2|Overall Study|Adverse Event|3
1316762|NCT02607930|4307453|P1|Overall Study|Adverse Event|0
1316763|NCT02607930|4307452|P2|Overall Study|Still in Study|301
1316764|NCT02607930|4307453|P1|Overall Study|Still in Study|296
1316765|NCT02607930|4307452|P2|Overall Study|Randomized and Never Treated|0
1316766|NCT02607930|4307453|P1|Overall Study|Randomized and Never Treated|2
1316767|NCT02607800|4307475|P2|Overall Study|Randomized/Enrolled but Not Treated|1
1316768|NCT02607800|4307476|P1|Overall Study|Randomized/Enrolled but Not Treated|1
1316769|NCT02607800|4307475|P2|Overall Study|Withdrew Consent|0
1316770|NCT02607800|4307476|P1|Overall Study|Withdrew Consent|2
1316771|NCT02607800|4307475|P2|Overall Study|Lost to Follow-up|10
1316772|NCT02607800|4307476|P1|Overall Study|Lost to Follow-up|7
1316773|NCT02607735|4307494|P3|Deferred Treatment Substudy|Withdrew Consent|1
1316774|NCT02607735|4307495|P2|Deferred Treatment Substudy|Withdrew Consent|0
1316775|NCT02607735|4307496|P1|Deferred Treatment Substudy|Withdrew Consent|0
1316776|NCT02607735|4307494|P3|Deferred Treatment Substudy|Lost to Follow-up|4
1316777|NCT02607735|4307495|P2|Deferred Treatment Substudy|Lost to Follow-up|0
1316778|NCT02607735|4307496|P1|Deferred Treatment Substudy|Lost to Follow-up|0
1316779|NCT02607735|4307494|P3|Primary Study|Withdrew Consent|0
1316780|NCT02607735|4307495|P2|Primary Study|Withdrew Consent|0
1316781|NCT02607735|4307496|P1|Primary Study|Withdrew Consent|2
1316782|NCT02607735|4307494|P3|Primary Study|Lost to Follow-up|0
1316783|NCT02607735|4307495|P2|Primary Study|Lost to Follow-up|0
1316784|NCT02607735|4307496|P1|Primary Study|Lost to Follow-up|4
1316785|NCT02607735|4307494|P3|Primary Study|Randomized but Never Treated|0
1316786|NCT02607735|4307495|P2|Primary Study|Randomized but Never Treated|0
1316787|NCT02607735|4307496|P1|Primary Study|Randomized but Never Treated|1
1316788|NCT02606279|4307541|P2|Overall Study|Lost to Follow-up|1
1316789|NCT02606279|4307542|P1|Overall Study|Lost to Follow-up|0
1316790|NCT02605954|4307556|P2|Overall Study|Randomized but not treated|1
1316791|NCT02605954|4307557|P1|Overall Study|Randomized but not treated|0
1316792|NCT02605954|4307556|P2|Overall Study|Lost to Follow-up|0
1316793|NCT02605954|4307557|P1|Overall Study|Lost to Follow-up|3
1316794|NCT02605954|4307556|P2|Overall Study|Withdrew Consent|2
1316795|NCT02605954|4307557|P1|Overall Study|Withdrew Consent|2
1316796|NCT02605954|4307556|P2|Overall Study|Non-Compliance with Study Drug|0
1316797|NCT02605954|4307557|P1|Overall Study|Non-Compliance with Study Drug|1
1316798|NCT02605954|4307556|P2|Overall Study|Investigator's Discretion|0
1316799|NCT02605954|4307557|P1|Overall Study|Investigator's Discretion|1
1316800|NCT02605954|4307556|P2|Overall Study|Adverse Event|1
1316801|NCT02605954|4307557|P1|Overall Study|Adverse Event|5
1316802|NCT02605928|4307574|P1|Overall Study|Lack of Efficacy|5
1316803|NCT02605928|4307574|P1|Overall Study|Model tuning phase|28
1316804|NCT02605174|4307671|P7|Overall Study|Randomization Failure|30
1316805|NCT02605174|4307672|P6|Overall Study|Randomization Failure|11
1316806|NCT02605174|4307673|P5|Overall Study|Randomization Failure|16
1316807|NCT02605174|4307674|P4|Overall Study|Randomization Failure|7
1316808|NCT02605174|4307675|P3|Overall Study|Randomization Failure|20
1316809|NCT02605174|4307676|P2|Overall Study|Randomization Failure|6
1316810|NCT02605174|4307677|P1|Overall Study|Randomization Failure|22
1316811|NCT02605174|4307671|P7|Overall Study|Physician Decision|3
1316812|NCT02605174|4307672|P6|Overall Study|Physician Decision|0
1316813|NCT02605174|4307673|P5|Overall Study|Physician Decision|0
1316814|NCT02605174|4307674|P4|Overall Study|Physician Decision|0
1316815|NCT02605174|4307675|P3|Overall Study|Physician Decision|0
1316816|NCT02605174|4307676|P2|Overall Study|Physician Decision|0
1316817|NCT02605174|4307677|P1|Overall Study|Physician Decision|2
1316818|NCT02605174|4307671|P7|Overall Study|Withdrawal by Subject|15
1316819|NCT02605174|4307672|P6|Overall Study|Withdrawal by Subject|4
1316820|NCT02605174|4307673|P5|Overall Study|Withdrawal by Subject|6
1316821|NCT02605174|4307674|P4|Overall Study|Withdrawal by Subject|11
1316822|NCT02605174|4307675|P3|Overall Study|Withdrawal by Subject|14
1316823|NCT02605174|4307676|P2|Overall Study|Withdrawal by Subject|6
1316824|NCT02605174|4307677|P1|Overall Study|Withdrawal by Subject|9
1316825|NCT02605174|4307671|P7|Overall Study|Pregnancy|0
1316826|NCT02605174|4307672|P6|Overall Study|Pregnancy|0
1316827|NCT02605174|4307673|P5|Overall Study|Pregnancy|0
1316828|NCT02605174|4307674|P4|Overall Study|Pregnancy|2
1316829|NCT02605174|4307675|P3|Overall Study|Pregnancy|0
1316830|NCT02605174|4307676|P2|Overall Study|Pregnancy|0
1316831|NCT02605174|4307677|P1|Overall Study|Pregnancy|1
1316832|NCT02605174|4307671|P7|Overall Study|Protocol Violation|12
1316833|NCT02605174|4307672|P6|Overall Study|Protocol Violation|7
1316834|NCT02605174|4307673|P5|Overall Study|Protocol Violation|7
1316835|NCT02605174|4307674|P4|Overall Study|Protocol Violation|6
1316836|NCT02605174|4307675|P3|Overall Study|Protocol Violation|14
1316837|NCT02605174|4307676|P2|Overall Study|Protocol Violation|4
1316838|NCT02605174|4307677|P1|Overall Study|Protocol Violation|10
1316839|NCT02605174|4307671|P7|Overall Study|Lost to Follow-up|29
1316840|NCT02605174|4307672|P6|Overall Study|Lost to Follow-up|10
1316841|NCT02605174|4307673|P5|Overall Study|Lost to Follow-up|20
1316842|NCT02605174|4307674|P4|Overall Study|Lost to Follow-up|10
1316843|NCT02605174|4307675|P3|Overall Study|Lost to Follow-up|27
1316844|NCT02605174|4307676|P2|Overall Study|Lost to Follow-up|7
1316845|NCT02605174|4307677|P1|Overall Study|Lost to Follow-up|20
1316846|NCT02605174|4307671|P7|Overall Study|Adverse Event|0
1316847|NCT02605174|4307672|P6|Overall Study|Adverse Event|0
1316848|NCT02605174|4307673|P5|Overall Study|Adverse Event|4
1316849|NCT02605174|4307674|P4|Overall Study|Adverse Event|0
1316850|NCT02605174|4307675|P3|Overall Study|Adverse Event|1
1316851|NCT02605174|4307676|P2|Overall Study|Adverse Event|0
1316852|NCT02605174|4307677|P1|Overall Study|Adverse Event|0
1316853|NCT02604589|4307740|P3|Overall Study|catheter dislodgement|1
1316854|NCT02604589|4307741|P2|Overall Study|catheter dislodgement|0
1316855|NCT02604589|4307742|P1|Overall Study|catheter dislodgement|0
1316856|NCT02604550|4307770|P2|Overall Study|Incomplete data using paper journal|19
1316857|NCT02604550|4307771|P1|Overall Study|Incomplete data using paper journal|18
1316858|NCT02604550|4307770|P2|Overall Study|Withdrawal by Subject|1
1316859|NCT02604550|4307771|P1|Overall Study|Withdrawal by Subject|0
1316860|NCT02604550|4307770|P2|Overall Study|Lost to Follow-up|6
1316861|NCT02604550|4307771|P1|Overall Study|Lost to Follow-up|7
1316862|NCT02604407|4307798|P3|Overall Study|Other|4
1316863|NCT02604407|4307799|P2|Overall Study|Other|1
1316864|NCT02604407|4307800|P1|Overall Study|Other|3
1316865|NCT02604407|4307798|P3|Overall Study|Lack of Efficacy|0
1316866|NCT02604407|4307799|P2|Overall Study|Lack of Efficacy|0
1316867|NCT02604407|4307800|P1|Overall Study|Lack of Efficacy|1
1316868|NCT02604407|4307798|P3|Overall Study|Lost to Follow-up|2
1316869|NCT02604407|4307799|P2|Overall Study|Lost to Follow-up|1
1316870|NCT02604407|4307800|P1|Overall Study|Lost to Follow-up|2
1316871|NCT02604407|4307798|P3|Overall Study|Withdrawal by Subject|5
1316872|NCT02604407|4307799|P2|Overall Study|Withdrawal by Subject|3
1316873|NCT02604407|4307800|P1|Overall Study|Withdrawal by Subject|3
1316874|NCT02604407|4307798|P3|Overall Study|Protocol Violation|0
1316875|NCT02604407|4307799|P2|Overall Study|Protocol Violation|0
1316876|NCT02604407|4307800|P1|Overall Study|Protocol Violation|2
1316877|NCT02604407|4307798|P3|Overall Study|Adverse Event|5
1316878|NCT02604407|4307799|P2|Overall Study|Adverse Event|7
1316879|NCT02604407|4307800|P1|Overall Study|Adverse Event|0
1316880|NCT02604342|4307813|P2|Overall Study|Ongoing|25
1316881|NCT02604342|4307814|P1|Overall Study|Ongoing|52
1316882|NCT02604342|4307813|P2|Overall Study|Withdrawal by Subject|3
1316883|NCT02604342|4307814|P1|Overall Study|Withdrawal by Subject|3
1316884|NCT02604342|4307813|P2|Overall Study|Progression of disease|0
1316885|NCT02604342|4307814|P1|Overall Study|Progression of disease|1
1316886|NCT02604342|4307813|P2|Overall Study|Death|7
1316887|NCT02604342|4307814|P1|Overall Study|Death|16
1316888|NCT02604264|4307866|P2|Overall Study|Had central venous catheter <21 days|242
1316889|NCT02604264|4307867|P1|Overall Study|Had central venous catheter <21 days|200
1316890|NCT02604017|4307894|P2|Overall Study|Not Specified|0
1316891|NCT02604017|4307895|P1|Overall Study|Not Specified|1
1316892|NCT02604017|4307894|P2|Overall Study|Lost to Follow-up|6
1316893|NCT02604017|4307895|P1|Overall Study|Lost to Follow-up|5
1316894|NCT02604017|4307894|P2|Overall Study|Withdrew Consent|2
1316895|NCT02604017|4307895|P1|Overall Study|Withdrew Consent|0
1316896|NCT02603952|4307924|P4|Overall Study|Received oseltamivir by error|1
1316897|NCT02603952|4307925|P3|Overall Study|Received oseltamivir by error|0
1316898|NCT02603952|4307926|P2|Overall Study|Received oseltamivir by error|0
1316899|NCT02603952|4307927|P1|Overall Study|Received oseltamivir by error|0
1316900|NCT02603952|4307924|P4|Overall Study|Withdrawal by Subject|0
1316901|NCT02603952|4307925|P3|Overall Study|Withdrawal by Subject|0
1316902|NCT02603952|4307926|P2|Overall Study|Withdrawal by Subject|0
1316903|NCT02603952|4307927|P1|Overall Study|Withdrawal by Subject|1
1316904|NCT02603120|4307974|P2|Overall Study|Lost to Follow-up|2
1316905|NCT02603120|4307975|P1|Overall Study|Lost to Follow-up|2
1316906|NCT02603120|4307974|P2|Overall Study|Withdrew Consent|7
1316907|NCT02603120|4307975|P1|Overall Study|Withdrew Consent|3
1316908|NCT02603120|4307974|P2|Overall Study|Pregnancy|1
1316909|NCT02603120|4307975|P1|Overall Study|Pregnancy|0
1316910|NCT02603120|4307974|P2|Overall Study|Death|0
1316911|NCT02603120|4307975|P1|Overall Study|Death|2
1316912|NCT02603120|4307974|P2|Overall Study|Adverse Event|2
1316913|NCT02603120|4307975|P1|Overall Study|Adverse Event|3
1316914|NCT02603120|4307974|P2|Overall Study|Still in Study|269
1316915|NCT02603120|4307975|P1|Overall Study|Still in Study|272
1316916|NCT02603120|4307974|P2|Overall Study|Randomized but Never Treated|2
1316917|NCT02603120|4307975|P1|Overall Study|Randomized but Never Treated|2
1316918|NCT02603107|4307995|P2|Optional Extension Phase|Still in Study|213
1316919|NCT02603107|4307996|P1|Optional Extension Phase|Still in Study|241
1316920|NCT02603107|4307995|P2|Randomized Phase|Lost to Follow-up|3
1316921|NCT02603107|4307996|P1|Randomized Phase|Lost to Follow-up|0
1316922|NCT02603107|4307995|P2|Randomized Phase|Withdrew Consent|14
1316923|NCT02603107|4307996|P1|Randomized Phase|Withdrew Consent|8
1316924|NCT02603107|4307995|P2|Randomized Phase|Protocol Violation|0
1316925|NCT02603107|4307996|P1|Randomized Phase|Protocol Violation|1
1316926|NCT02603107|4307995|P2|Randomized Phase|Non-Compliance with Study Drug|1
1316927|NCT02603107|4307996|P1|Randomized Phase|Non-Compliance with Study Drug|1
1316928|NCT02603107|4307995|P2|Randomized Phase|Investigator's Discretion|1
1316929|NCT02603107|4307996|P1|Randomized Phase|Investigator's Discretion|0
1316930|NCT02603107|4307995|P2|Randomized Phase|Death|1
1316931|NCT02603107|4307996|P1|Randomized Phase|Death|1
1316932|NCT02603107|4307995|P2|Randomized Phase|Adverse Event|0
1316933|NCT02603107|4307996|P1|Randomized Phase|Adverse Event|2
1316934|NCT02603107|4307995|P2|Randomized Phase|Still in Study|27
1316935|NCT02603107|4307996|P1|Randomized Phase|Still in Study|32
1316936|NCT02603107|4307995|P2|Randomized Phase|Randomized and Never Treated|1
1316937|NCT02603107|4307996|P1|Randomized Phase|Randomized and Never Treated|0
1316938|NCT02601573|4308027|P5|Overall Study|Withdrawal by Subject|0
1316939|NCT02601573|4308028|P4|Overall Study|Withdrawal by Subject|1
1316940|NCT02601573|4308029|P3|Overall Study|Withdrawal by Subject|0
1316941|NCT02601573|4308030|P2|Overall Study|Withdrawal by Subject|1
1316942|NCT02601573|4308031|P1|Overall Study|Withdrawal by Subject|0
1316943|NCT02601573|4308027|P5|Overall Study|Lost to Follow-up|2
1316944|NCT02601573|4308028|P4|Overall Study|Lost to Follow-up|0
1316945|NCT02601573|4308029|P3|Overall Study|Lost to Follow-up|1
1316946|NCT02601573|4308030|P2|Overall Study|Lost to Follow-up|3
1316947|NCT02601573|4308031|P1|Overall Study|Lost to Follow-up|0
1316948|NCT02601560|4308066|P8|Overall Study|Other|0
1316949|NCT02601560|4308067|P7|Overall Study|Other|1
1316950|NCT02601560|4308068|P6|Overall Study|Other|0
1316951|NCT02601560|4308069|P5|Overall Study|Other|0
1316952|NCT02601560|4308070|P4|Overall Study|Other|0
1316953|NCT02601560|4308071|P3|Overall Study|Other|0
1316954|NCT02601560|4308072|P2|Overall Study|Other|0
1316955|NCT02601560|4308073|P1|Overall Study|Other|0
1316956|NCT02600871|4308257|P2|Overall Study|Lost to Follow-up|10
1316957|NCT02600871|4308258|P1|Overall Study|Lost to Follow-up|13
1316958|NCT02600845|4308268|P1|Overall Study|Consent Withdrawal|5
1316959|NCT02600845|4308268|P1|Overall Study|Non-compliance with Study Procedures|10
1316960|NCT02600845|4308268|P1|Overall Study|Reason Not Specified|3
1316961|NCT02600351|4308330|P4|Overall Study|Randomized but Not Treated|3
1316962|NCT02600351|4308331|P3|Overall Study|Randomized but Not Treated|1
1316963|NCT02600351|4308332|P2|Overall Study|Randomized but Not Treated|0
1316964|NCT02600351|4308333|P1|Overall Study|Randomized but Not Treated|1
1316965|NCT02600351|4308330|P4|Overall Study|Lost to Follow-up|0
1316966|NCT02600351|4308331|P3|Overall Study|Lost to Follow-up|0
1316967|NCT02600351|4308332|P2|Overall Study|Lost to Follow-up|0
1316968|NCT02600351|4308333|P1|Overall Study|Lost to Follow-up|1
1316969|NCT02600351|4308330|P4|Overall Study|Lack of Efficacy|2
1316970|NCT02600351|4308331|P3|Overall Study|Lack of Efficacy|5
1316971|NCT02600351|4308332|P2|Overall Study|Lack of Efficacy|0
1316972|NCT02600351|4308333|P1|Overall Study|Lack of Efficacy|3
1316973|NCT02599129|4308365|P2|Overall Study|Withdrawal by Subject|1
1316974|NCT02599129|4308366|P1|Overall Study|Withdrawal by Subject|2
1316975|NCT02599129|4308365|P2|Overall Study|Lost to Follow-up|0
1316976|NCT02599129|4308366|P1|Overall Study|Lost to Follow-up|1
1316977|NCT02599129|4308365|P2|Overall Study|Lack of Efficacy|2
1316978|NCT02599129|4308366|P1|Overall Study|Lack of Efficacy|2
1316979|NCT02598934|4308382|P2|Overall Study|Protocol Violation|2
1316980|NCT02598934|4308383|P1|Overall Study|Protocol Violation|1
1316981|NCT02598934|4308382|P2|Overall Study|Administrative|1
1316982|NCT02598934|4308383|P1|Overall Study|Administrative|2
1316983|NCT02598934|4308382|P2|Overall Study|Withdrawal by Subject|3
1316984|NCT02598934|4308383|P1|Overall Study|Withdrawal by Subject|2
1316985|NCT02598934|4308382|P2|Overall Study|Failure to Return|3
1316986|NCT02598934|4308383|P1|Overall Study|Failure to Return|3
1316987|NCT02598934|4308382|P2|Overall Study|Adverse Event|13
1316988|NCT02598934|4308383|P1|Overall Study|Adverse Event|11
1316989|NCT02598622|4308395|P2|Overall Study|Physician Decision|0
1316990|NCT02598622|4308396|P1|Overall Study|Physician Decision|3
1316991|NCT02598622|4308395|P2|Overall Study|Withdrawal by Subject|0
1316992|NCT02598622|4308396|P1|Overall Study|Withdrawal by Subject|3
1316993|NCT02598193|4308423|P1|Overall Study|Does not want to take Nintedanib|1
1316994|NCT02598193|4308423|P1|Overall Study|Listed in active lung transplant list|1
1316995|NCT02598193|4308423|P1|Overall Study|Withdrawal by Subject|1
1316996|NCT02598193|4308423|P1|Overall Study|Adverse Event|13
1316997|NCT02598128|4308431|P4|Period A: Days -7 to -1|Adverse Event|0
1316998|NCT02598128|4308432|P3|Period A: Days -7 to -1|Adverse Event|0
1316999|NCT02598128|4308433|P2|Period A: Days -7 to -1|Adverse Event|0
1317000|NCT02598128|4308434|P1|Period A: Days -7 to -1|Adverse Event|1
1317001|NCT02597855|4308457|P2|Overall Study|Lost to Follow-up|1
1317002|NCT02597855|4308458|P1|Overall Study|Lost to Follow-up|2
1317003|NCT02597049|4308507|P3|Overall Study|Noncompliant with Study Visits|0
1317004|NCT02597049|4308508|P2|Overall Study|Noncompliant with Study Visits|0
1317005|NCT02597049|4308509|P1|Overall Study|Noncompliant with Study Visits|1
1317006|NCT02597049|4308507|P3|Overall Study|Death|0
1317007|NCT02597049|4308508|P2|Overall Study|Death|0
1317008|NCT02597049|4308509|P1|Overall Study|Death|2
1317009|NCT02597049|4308507|P3|Overall Study|Adverse Event|0
1317010|NCT02597049|4308508|P2|Overall Study|Adverse Event|0
1317011|NCT02597049|4308509|P1|Overall Study|Adverse Event|2
1317012|NCT02597049|4308507|P3|Overall Study|Withdrawal by Subject|1
1317013|NCT02597049|4308508|P2|Overall Study|Withdrawal by Subject|2
1317014|NCT02597049|4308509|P1|Overall Study|Withdrawal by Subject|2
1317015|NCT02597049|4308507|P3|Overall Study|Lost to Follow-up|2
1317016|NCT02597049|4308508|P2|Overall Study|Lost to Follow-up|3
1317017|NCT02597049|4308509|P1|Overall Study|Lost to Follow-up|0
1317018|NCT02596958|4308547|P1|Overall Study|Excluded Due to Second Line Treatment|9
1317019|NCT02596958|4308547|P1|Overall Study|Missing|32
1317020|NCT02596958|4308547|P1|Overall Study|Lost to Follow-up|33
1317021|NCT02596958|4308547|P1|Overall Study|Administrative Reasons/Other|231
1317022|NCT02596958|4308547|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
1317023|NCT02596958|4308547|P1|Overall Study|Death From Other Cause|33
1317024|NCT02596958|4308547|P1|Overall Study|Death From Cancer|112
1317025|NCT02596958|4308547|P1|Overall Study|Cancer Progression|441
1317026|NCT02596958|4308547|P1|Overall Study|Serious Adverse Drug Reactions|44
1317027|NCT02596945|4308559|P1|Overall Study|Missing|1
1317028|NCT02596945|4308559|P1|Overall Study|Withdrawal by Subject|1
1317029|NCT02596945|4308559|P1|Overall Study|Other Erythropoietin stimulating agent|4
1317030|NCT02596945|4308559|P1|Overall Study|Change to hemodialysis|15
1317031|NCT02596945|4308559|P1|Overall Study|Other|32
1317032|NCT02596945|4308559|P1|Overall Study|No documentation of study drug dosing|3
1317033|NCT02596854|4308570|P1|Overall Study|Withdrawn|8
1317034|NCT02596620|4308576|P2|Overall Study|Lost to Follow-up|1
1317035|NCT02596620|4308577|P1|Overall Study|Lost to Follow-up|1
1317036|NCT02596009|4308619|P6|Overall Study|Administrative problems|0
1317037|NCT02596009|4308620|P5|Overall Study|Administrative problems|0
1317038|NCT02596009|4308621|P4|Overall Study|Administrative problems|0
1317039|NCT02596009|4308622|P3|Overall Study|Administrative problems|0
1317040|NCT02596009|4308623|P2|Overall Study|Administrative problems|1
1317041|NCT02596009|4308624|P1|Overall Study|Administrative problems|0
1317042|NCT02595502|4308637|P2|Period 3|Received Incorrect Treatment at period 3|1
1317043|NCT02595502|4308638|P1|Period 3|Received Incorrect Treatment at period 3|0
1317044|NCT02595502|4308637|P2|Period 3|Lost to Follow-up|0
1317045|NCT02595502|4308638|P1|Period 3|Lost to Follow-up|1
1317046|NCT02595502|4308637|P2|Period 3|Protocol Violation|1
1317047|NCT02595502|4308638|P1|Period 3|Protocol Violation|0
1317048|NCT02595502|4308637|P2|Period 2|Received incorrect lens at Period 1|1
1317049|NCT02595502|4308638|P1|Period 2|Received incorrect lens at Period 1|0
1317050|NCT02595502|4308637|P2|Period 2|Adverse Event|1
1317051|NCT02595502|4308638|P1|Period 2|Adverse Event|1
1317052|NCT02595502|4308637|P2|Period 1|Lost to Follow-up|1
1317053|NCT02595502|4308638|P1|Period 1|Lost to Follow-up|0
1317054|NCT02595502|4308637|P2|Period 1|Withdrawal by Subject|0
1317055|NCT02595502|4308638|P1|Period 1|Withdrawal by Subject|1
1317056|NCT02595502|4308637|P2|Period 1|Adverse Event|1
1317057|NCT02595502|4308638|P1|Period 1|Adverse Event|0
1317058|NCT02595450|4308644|P1|Overall Study|Enrolled, but not treated|8
1317059|NCT02595450|4308644|P1|Overall Study|Unspecified (only completed 1 cycle)|73
1317060|NCT02593773|4308659|P1|Overall Study|Death|1
1317061|NCT02593773|4308659|P1|Overall Study|Study Terminated by Sponsor|31
1317062|NCT02593773|4308659|P1|Overall Study|Voluntary Withdrawal|3
1317063|NCT02591290|4308709|P1|Overall Study|Withdrawal by Subject|2
1317064|NCT02591238|4308719|P4|Overall Study|personal circumstances|0
1317065|NCT02591238|4308720|P3|Overall Study|personal circumstances|0
1317066|NCT02591238|4308721|P2|Overall Study|personal circumstances|1
1317067|NCT02591238|4308722|P1|Overall Study|personal circumstances|0
1317068|NCT02591238|4308719|P4|Overall Study|personal circumstances|1
1317069|NCT02591238|4308720|P3|Overall Study|personal circumstances|0
1317070|NCT02591238|4308721|P2|Overall Study|personal circumstances|0
1317071|NCT02591238|4308722|P1|Overall Study|personal circumstances|0
1317072|NCT02591238|4308719|P4|Overall Study|influenza|1
1317073|NCT02591238|4308720|P3|Overall Study|influenza|0
1317074|NCT02591238|4308721|P2|Overall Study|influenza|0
1317075|NCT02591238|4308722|P1|Overall Study|influenza|0
1317076|NCT02591238|4308719|P4|Overall Study|Withdrawal by Subject|1
1317077|NCT02591238|4308720|P3|Overall Study|Withdrawal by Subject|0
1317078|NCT02591238|4308721|P2|Overall Study|Withdrawal by Subject|0
1317079|NCT02591238|4308722|P1|Overall Study|Withdrawal by Subject|0
1317080|NCT02591238|4308719|P4|Overall Study|Pregnancy|0
1317081|NCT02591238|4308720|P3|Overall Study|Pregnancy|0
1317082|NCT02591238|4308721|P2|Overall Study|Pregnancy|0
1317083|NCT02591238|4308722|P1|Overall Study|Pregnancy|1
1317084|NCT02590939|4308758|P2|Overall Study|Failed the nociceptive test|1
1317085|NCT02590939|4308759|P1|Overall Study|Failed the nociceptive test|2
1317086|NCT02590939|4308758|P2|Overall Study|Withdrawal by Subject|1
1317087|NCT02590939|4308759|P1|Overall Study|Withdrawal by Subject|3
1317088|NCT02590588|4308779|P1|Overall Study|Adverse Event|1
1317089|NCT02590562|4308787|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
1317090|NCT02590003|4308846|P2|Overall Study|Death|2
1317091|NCT02590003|4308847|P1|Overall Study|Death|1
1317092|NCT02587819|4308894|P1|Overall Study|Lost to Follow-up|1
1317093|NCT02587819|4308894|P1|Overall Study|Adverse Event|1
1317094|NCT02587234|4308903|P2|Overall Study|Lost to Follow-up|2
1317095|NCT02587234|4308904|P1|Overall Study|Lost to Follow-up|0
1317096|NCT02587234|4308903|P2|Overall Study|Withdrawal by Subject|1
1317097|NCT02587234|4308904|P1|Overall Study|Withdrawal by Subject|1
1317098|NCT02586805|4308929|P4|Overall Study|Physician Decision|0
1317099|NCT02586805|4308930|P3|Overall Study|Physician Decision|0
1317100|NCT02586805|4308931|P2|Overall Study|Physician Decision|0
1317101|NCT02586805|4308932|P1|Overall Study|Physician Decision|1
1317102|NCT02586805|4308929|P4|Overall Study|Lost to Follow-up|0
1317103|NCT02586805|4308930|P3|Overall Study|Lost to Follow-up|1
1317104|NCT02586805|4308931|P2|Overall Study|Lost to Follow-up|0
1317105|NCT02586805|4308932|P1|Overall Study|Lost to Follow-up|0
1317106|NCT02586805|4308929|P4|Overall Study|Adverse Event|0
1317107|NCT02586805|4308930|P3|Overall Study|Adverse Event|1
1317108|NCT02586805|4308931|P2|Overall Study|Adverse Event|0
1317109|NCT02586805|4308932|P1|Overall Study|Adverse Event|2
1317110|NCT02586805|4308929|P4|Overall Study|Withdrawal by Subject|2
1317111|NCT02586805|4308930|P3|Overall Study|Withdrawal by Subject|1
1317112|NCT02586805|4308931|P2|Overall Study|Withdrawal by Subject|1
1317113|NCT02586805|4308932|P1|Overall Study|Withdrawal by Subject|3
1317114|NCT02586506|4308954|P1|Overall Study|Other Reason|2
1317115|NCT02586506|4308954|P1|Overall Study|Lost to Follow-up|1
1317116|NCT02586506|4308954|P1|Overall Study|Protocol Violation|6
1317117|NCT02586493|4308960|P1|Overall Study|Withdrawal by Subject|1
1317118|NCT02586493|4308960|P1|Overall Study|Lost to Follow-up|1
1317119|NCT02586493|4308960|P1|Overall Study|Protocol Violation|6
1317120|NCT02586493|4308960|P1|Overall Study|Adverse Event|4
1317121|NCT02585999|4308966|P1|Overall Study|Protocol Violation|1
1317122|NCT02585999|4308966|P1|Overall Study|Lost to Follow-up|1
1317123|NCT02585778|4308993|P2|Overall Study|Other than specified above|2
1317124|NCT02585778|4308994|P1|Overall Study|Other than specified above|6
1317125|NCT02585778|4308993|P2|Overall Study|Randomized but not treated|2
1317126|NCT02585778|4308994|P1|Overall Study|Randomized but not treated|1
1317127|NCT02585778|4308993|P2|Overall Study|Death|1
1317128|NCT02585778|4308994|P1|Overall Study|Death|0
1317129|NCT02585778|4308993|P2|Overall Study|Poor compliance to study protocol|2
1317130|NCT02585778|4308994|P1|Overall Study|Poor compliance to study protocol|0
1317131|NCT02585778|4308993|P2|Overall Study|Participant did not wish to continue|4
1317132|NCT02585778|4308994|P1|Overall Study|Participant did not wish to continue|9
1317133|NCT02585778|4308993|P2|Overall Study|Adverse Event|4
1317134|NCT02585778|4308994|P1|Overall Study|Adverse Event|17
1317135|NCT02584660|4309165|P2|Overall Study|Other|1
1317136|NCT02584660|4309166|P1|Overall Study|Other|0
1317137|NCT02584660|4309165|P2|Overall Study|Withdrawal by Subject|2
1317138|NCT02584660|4309166|P1|Overall Study|Withdrawal by Subject|0
1317139|NCT02584660|4309165|P2|Overall Study|Protocol Violation|1
1317140|NCT02584660|4309166|P1|Overall Study|Protocol Violation|0
1317141|NCT02584660|4309165|P2|Overall Study|Lost to Follow-up|4
1317142|NCT02584660|4309166|P1|Overall Study|Lost to Follow-up|3
1317143|NCT02584660|4309165|P2|Overall Study|Adverse Event|0
1317144|NCT02584660|4309166|P1|Overall Study|Adverse Event|4
1317145|NCT02584504|4309185|P3|Open-label Treatment|Entered but not treated|1
1317146|NCT02584504|4309186|P2|Open-label Treatment|Entered but not treated|1
1317147|NCT02584504|4309187|P1|Open-label Treatment|Entered but not treated|0
1317148|NCT02584504|4309185|P3|Open-label Treatment|Ongoing in the study|52
1317149|NCT02584504|4309186|P2|Open-label Treatment|Ongoing in the study|49
1317150|NCT02584504|4309187|P1|Open-label Treatment|Ongoing in the study|54
1317151|NCT02584504|4309185|P3|Open-label Treatment|Adverse Event|0
1317152|NCT02584504|4309186|P2|Open-label Treatment|Adverse Event|1
1317153|NCT02584504|4309187|P1|Open-label Treatment|Adverse Event|0
1317154|NCT02584504|4309185|P3|Open-label Treatment|Participant withdrew consent|2
1317155|NCT02584504|4309186|P2|Open-label Treatment|Participant withdrew consent|0
1317156|NCT02584504|4309187|P1|Open-label Treatment|Participant withdrew consent|0
1317157|NCT02584504|4309185|P3|Double-blind Treatment|Family Matter|0
1317158|NCT02584504|4309186|P2|Double-blind Treatment|Family Matter|1
1317159|NCT02584504|4309187|P1|Double-blind Treatment|Family Matter|0
1317160|NCT02584504|4309185|P3|Double-blind Treatment|Adverse Event|0
1317161|NCT02584504|4309186|P2|Double-blind Treatment|Adverse Event|1
1317162|NCT02584504|4309187|P1|Double-blind Treatment|Adverse Event|0
1317163|NCT02584504|4309185|P3|Double-blind Treatment|Participant withdrew consent|1
1317164|NCT02584504|4309186|P2|Double-blind Treatment|Participant withdrew consent|0
1317165|NCT02584504|4309187|P1|Double-blind Treatment|Participant withdrew consent|0
1317166|NCT02583425|4309238|P1|Treatment Period|Adverse Event|1
1317167|NCT02583425|4309238|P1|Baseline|Did not meet continued criteria|5
1317168|NCT02583425|4309238|P1|Screening|Did not meet entry criteria|12
1317169|NCT02582983|4309243|P1|Overall Study|Adverse Event|1
1317170|NCT02582983|4309243|P1|Overall Study|Withdrawal by Subject|2
1317171|NCT02582983|4309243|P1|Overall Study|Death|3
1317172|NCT02582684|4309258|P1|Overall Study|Found to be ineligible after enrollment|2
1317173|NCT02582684|4309258|P1|Overall Study|Subject withdrew consent|1
1317174|NCT02582684|4309258|P1|Overall Study|Subject not able to get to clinic|10
1317175|NCT02582684|4309258|P1|Overall Study|Unable to contact subject/parent|4
1317176|NCT02582632|4309277|P1|Overall Study|Not Specified|1
1317177|NCT02582242|4309292|P2|Overall Study|Unclassified|1
1317178|NCT02582242|4309293|P1|Overall Study|Unclassified|2
1317179|NCT02582242|4309292|P2|Overall Study|Withdrawal by Subject|11
1317180|NCT02582242|4309293|P1|Overall Study|Withdrawal by Subject|11
1317181|NCT02582242|4309292|P2|Overall Study|Lost to Follow-up|1
1317182|NCT02582242|4309293|P1|Overall Study|Lost to Follow-up|0
1317183|NCT02582242|4309292|P2|Overall Study|Protocol Violation|1
1317184|NCT02582242|4309293|P1|Overall Study|Protocol Violation|3
1317185|NCT02582242|4309292|P2|Overall Study|Adverse Event|3
1317186|NCT02582242|4309293|P1|Overall Study|Adverse Event|4
1317187|NCT02581488|4309335|P2|Overall Study|Protocol Violation|4
1317188|NCT02581488|4309336|P1|Overall Study|Protocol Violation|0
1317189|NCT02581488|4309335|P2|Overall Study|Non-Compliance|0
1317190|NCT02581488|4309336|P1|Overall Study|Non-Compliance|1
1317191|NCT02581488|4309335|P2|Overall Study|Withdrawal by Subject|0
1317192|NCT02581488|4309336|P1|Overall Study|Withdrawal by Subject|1
1317193|NCT02581488|4309335|P2|Overall Study|Lost to Follow-up|0
1317194|NCT02581488|4309336|P1|Overall Study|Lost to Follow-up|1
1317195|NCT02581488|4309335|P2|Overall Study|Adverse Event|7
1317196|NCT02581488|4309336|P1|Overall Study|Adverse Event|6
1317197|NCT02581410|4309367|P2|End of Study Phase|Other-transfer of subject not completed|1
1317198|NCT02581410|4309368|P1|End of Study Phase|Other-transfer of subject not completed|0
1317199|NCT02581410|4309367|P2|End of Study Phase|Lost to Follow-up|2
1317200|NCT02581410|4309368|P1|End of Study Phase|Lost to Follow-up|0
1317201|NCT02581410|4309367|P2|End of Study Phase|Migrated/moved from study area|3
1317202|NCT02581410|4309368|P1|End of Study Phase|Migrated/moved from study area|0
1317203|NCT02581410|4309367|P2|End of Study Phase|Withdrawal by Subject|2
1317204|NCT02581410|4309368|P1|End of Study Phase|Withdrawal by Subject|1
1317205|NCT02581410|4309367|P2|End of Study Phase|Adverse Event|3
1317206|NCT02581410|4309368|P1|End of Study Phase|Adverse Event|4
1317207|NCT02581410|4309367|P2|Vaccination Phase|Migrated/moved from study area|1
1317208|NCT02581410|4309368|P1|Vaccination Phase|Migrated/moved from study area|0
1317209|NCT02581410|4309367|P2|Vaccination Phase|Withdrawal by Subject|1
1317210|NCT02581410|4309368|P1|Vaccination Phase|Withdrawal by Subject|0
1317211|NCT02581410|4309367|P2|Vaccination Phase|Adverse Event|1
1317212|NCT02581410|4309368|P1|Vaccination Phase|Adverse Event|2
1317213|NCT02580357|4309421|P3|Overall Study|Protocol Violation|0
1317214|NCT02580357|4309422|P2|Overall Study|Protocol Violation|0
1317215|NCT02580357|4309423|P1|Overall Study|Protocol Violation|1
1317216|NCT02580357|4309421|P3|Overall Study|Lost to Follow-up|0
1317217|NCT02580357|4309422|P2|Overall Study|Lost to Follow-up|0
1317218|NCT02580357|4309423|P1|Overall Study|Lost to Follow-up|2
1317219|NCT02580240|4309440|P2|Overall Study|Physician Decision|0
1317220|NCT02580240|4309441|P1|Overall Study|Physician Decision|2
1317221|NCT02579772|4309458|P2|Overall Study|flu-like illness, orthopedic trauma|1
1317222|NCT02579772|4309459|P1|Overall Study|flu-like illness, orthopedic trauma|1
1317223|NCT02579772|4309458|P2|Overall Study|Usage of additional antioxidants|0
1317224|NCT02579772|4309459|P1|Overall Study|Usage of additional antioxidants|1
1317225|NCT02579772|4309458|P2|Overall Study|Withdrawal by Subject|1
1317226|NCT02579772|4309459|P1|Overall Study|Withdrawal by Subject|0
1317227|NCT02579603|4309479|P2|Overall Study|Other than stated|0
1317228|NCT02579603|4309480|P1|Overall Study|Other than stated|1
1317229|NCT02579603|4309479|P2|Overall Study|Adverse Event|2
1317230|NCT02579603|4309480|P1|Overall Study|Adverse Event|2
1317231|NCT02579603|4309479|P2|Overall Study|Not treated|0
1317232|NCT02579603|4309480|P1|Overall Study|Not treated|1
1317233|NCT02578992|4309506|P2|Overall Study|equipment not available or malfunction|3
1317234|NCT02578992|4309507|P1|Overall Study|equipment not available or malfunction|3
1317235|NCT02578706|4309522|P3|Overall Study|Physician Decision|0
1317236|NCT02578706|4309523|P2|Overall Study|Physician Decision|1
1317237|NCT02578706|4309524|P1|Overall Study|Physician Decision|0
1317238|NCT02578706|4309522|P3|Overall Study|Lost to Follow-up|0
1317239|NCT02578706|4309523|P2|Overall Study|Lost to Follow-up|4
1317240|NCT02578706|4309524|P1|Overall Study|Lost to Follow-up|0
1317241|NCT02578706|4309522|P3|Overall Study|Withdrawal by Subject|0
1317242|NCT02578706|4309523|P2|Overall Study|Withdrawal by Subject|0
1317243|NCT02578706|4309524|P1|Overall Study|Withdrawal by Subject|1
1317244|NCT02578316|4309601|P1|Extension Phase|Progression of disease|6
1317245|NCT02578186|4309630|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
1317246|NCT02578186|4309631|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
1317247|NCT02578186|4309630|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
1317248|NCT02578186|4309631|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
1317249|NCT02577718|4309637|P1|Overall Study|Withdrawal by Subject|2
1317250|NCT02577718|4309637|P1|Overall Study|Death|6
1317251|NCT02577315|4309672|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
1317252|NCT02577315|4309673|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1317253|NCT02577107|4309691|P2|Overall Study|Protocol deviation|1
1317254|NCT02577107|4309692|P1|Overall Study|Protocol deviation|0
1317255|NCT02577016|4309706|P2|Overall Study|Physician Decision|1
1317256|NCT02577016|4309707|P1|Overall Study|Physician Decision|0
1317257|NCT02577016|4309706|P2|Overall Study|Adverse Event|1
1317258|NCT02577016|4309707|P1|Overall Study|Adverse Event|2
1317259|NCT02577003|4309725|P2|Overall Study|Withdrawal by Subject|1
1317260|NCT02577003|4309726|P1|Overall Study|Withdrawal by Subject|0
1317261|NCT02577003|4309725|P2|Overall Study|Adverse Event|4
1317262|NCT02577003|4309726|P1|Overall Study|Adverse Event|2
1317263|NCT02576938|4309747|P3|Overall Study|Met Exclusion Criteria|0
1317264|NCT02576938|4309748|P2|Overall Study|Met Exclusion Criteria|1
1317265|NCT02576938|4309749|P1|Overall Study|Met Exclusion Criteria|0
1317266|NCT02576938|4309747|P3|Overall Study|Physician Decision|0
1317267|NCT02576938|4309748|P2|Overall Study|Physician Decision|1
1317268|NCT02576938|4309749|P1|Overall Study|Physician Decision|0
1317269|NCT02576938|4309747|P3|Overall Study|Lost to Follow-up|1
1317270|NCT02576938|4309748|P2|Overall Study|Lost to Follow-up|0
1317271|NCT02576938|4309749|P1|Overall Study|Lost to Follow-up|2
1317272|NCT02576938|4309747|P3|Overall Study|Lack of Efficacy|0
1317273|NCT02576938|4309748|P2|Overall Study|Lack of Efficacy|4
1317274|NCT02576938|4309749|P1|Overall Study|Lack of Efficacy|9
1317275|NCT02576938|4309747|P3|Overall Study|Withdrawal by Subject|4
1317276|NCT02576938|4309748|P2|Overall Study|Withdrawal by Subject|2
1317277|NCT02576938|4309749|P1|Overall Study|Withdrawal by Subject|3
1317278|NCT02576938|4309747|P3|Overall Study|Protocol Violation|1
1317279|NCT02576938|4309748|P2|Overall Study|Protocol Violation|1
1317280|NCT02576938|4309749|P1|Overall Study|Protocol Violation|1
1317281|NCT02576938|4309747|P3|Overall Study|Adverse Event|6
1317282|NCT02576938|4309748|P2|Overall Study|Adverse Event|3
1317283|NCT02576938|4309749|P1|Overall Study|Adverse Event|5
1317284|NCT02576639|4309782|P5|Overall Study|Physician Decision|1
1317285|NCT02576639|4309783|P4|Overall Study|Physician Decision|0
1317286|NCT02576639|4309784|P3|Overall Study|Physician Decision|0
1317287|NCT02576639|4309785|P2|Overall Study|Physician Decision|0
1317288|NCT02576639|4309786|P1|Overall Study|Physician Decision|0
1317289|NCT02576639|4309782|P5|Overall Study|Adverse Event|2
1317290|NCT02576639|4309783|P4|Overall Study|Adverse Event|1
1317291|NCT02576639|4309784|P3|Overall Study|Adverse Event|1
1317292|NCT02576639|4309785|P2|Overall Study|Adverse Event|0
1317293|NCT02576639|4309786|P1|Overall Study|Adverse Event|1
1317294|NCT02576639|4309782|P5|Overall Study|Withdrawal by Subject|1
1317295|NCT02576639|4309783|P4|Overall Study|Withdrawal by Subject|0
1317296|NCT02576639|4309784|P3|Overall Study|Withdrawal by Subject|1
1317297|NCT02576639|4309785|P2|Overall Study|Withdrawal by Subject|2
1317298|NCT02576639|4309786|P1|Overall Study|Withdrawal by Subject|1
1317299|NCT02576587|4309845|P2|Follow up Period (Case Only)|Controls not eligible for followup|155
1317300|NCT02576587|4309846|P1|Follow up Period (Case Only)|Controls not eligible for followup|0
1317301|NCT02576587|4309845|P2|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
1317302|NCT02576587|4309846|P1|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
1317303|NCT02576587|4309845|P2|Follow up Period (Case Only)|Withdrawal by Subject|0
1317304|NCT02576587|4309846|P1|Follow up Period (Case Only)|Withdrawal by Subject|25
1317305|NCT02576587|4309845|P2|Baseline|Equipment failure|1
1317306|NCT02576587|4309846|P1|Baseline|Equipment failure|0
1317307|NCT02576535|4309864|P1|Overall Study|Withdrawal by Subject|2
1317308|NCT02576145|4309888|P2|Overall Study|Tetanus Titers Decreased|1
1317309|NCT02576145|4309889|P1|Overall Study|Tetanus Titers Decreased|0
1317310|NCT02576145|4309888|P2|Overall Study|Acute rejection|0
1317311|NCT02576145|4309889|P1|Overall Study|Acute rejection|1
1317312|NCT02576145|4309888|P2|Overall Study|Withdrawal by Subject|0
1317313|NCT02576145|4309889|P1|Overall Study|Withdrawal by Subject|1
1317314|NCT02576145|4309888|P2|Overall Study|Adverse Event|0
1317315|NCT02576145|4309889|P1|Overall Study|Adverse Event|1
1317316|NCT02575911|4309931|P1|Overall Study|Lost to Follow-up|1
1317317|NCT02575833|4309951|P2|Overall Study|Lost to Follow-up|0
1317318|NCT02575833|4309952|P1|Overall Study|Lost to Follow-up|1
1317319|NCT02575833|4309951|P2|Overall Study|Withdrawal by Subject|1
1317320|NCT02575833|4309952|P1|Overall Study|Withdrawal by Subject|0
1317321|NCT02574845|4309973|P6|Overall Study|Adverse Event|1
1317322|NCT02574845|4309974|P5|Overall Study|Adverse Event|0
1317323|NCT02574845|4309975|P4|Overall Study|Adverse Event|0
1317324|NCT02574845|4309976|P3|Overall Study|Adverse Event|0
1317325|NCT02574845|4309977|P2|Overall Study|Adverse Event|1
1317326|NCT02574845|4309978|P1|Overall Study|Adverse Event|0
1317327|NCT02574845|4309973|P6|Overall Study|Consent withdrawn further participation|0
1317328|NCT02574845|4309974|P5|Overall Study|Consent withdrawn further participation|1
1317329|NCT02574845|4309975|P4|Overall Study|Consent withdrawn further participation|0
1317330|NCT02574845|4309976|P3|Overall Study|Consent withdrawn further participation|0
1317331|NCT02574845|4309977|P2|Overall Study|Consent withdrawn further participation|0
1317332|NCT02574845|4309978|P1|Overall Study|Consent withdrawn further participation|0
1317333|NCT02574260|4310008|P1|Overall Study|Disease Progression|1
1317334|NCT02574247|4310017|P3|Overall Study|Did not meet inclusion criteria|5
1317335|NCT02574247|4310018|P2|Overall Study|Did not meet inclusion criteria|3
1317336|NCT02574247|4310019|P1|Overall Study|Did not meet inclusion criteria|4
1317337|NCT02574247|4310017|P3|Overall Study|Withdrawal by Subject|0
1317338|NCT02574247|4310018|P2|Overall Study|Withdrawal by Subject|0
1317339|NCT02574247|4310019|P1|Overall Study|Withdrawal by Subject|1
1317340|NCT02573948|4310031|P1|Longitudinal Cohort|Incarcerated|25
1317341|NCT02573948|4310031|P1|Longitudinal Cohort|Lost to Follow-up|22
1317342|NCT02573948|4310031|P1|Longitudinal Cohort|Death|9
1317343|NCT02573870|4310041|P2|Overall Study|Other: Fail to Meet Visit|2
1317344|NCT02573870|4310042|P1|Overall Study|Other: Fail to Meet Visit|0
1317345|NCT02573870|4310041|P2|Overall Study|Lost to Follow-up|1
1317346|NCT02573870|4310042|P1|Overall Study|Lost to Follow-up|0
1317347|NCT02573870|4310041|P2|Overall Study|Other: Reached defined stopping criteria|1
1317348|NCT02573870|4310042|P1|Overall Study|Other: Reached defined stopping criteria|0
1317349|NCT02573870|4310041|P2|Overall Study|Lack of Efficacy|1
1317350|NCT02573870|4310042|P1|Overall Study|Lack of Efficacy|0
1317351|NCT02573870|4310041|P2|Overall Study|Adverse Event|2
1317352|NCT02573870|4310042|P1|Overall Study|Adverse Event|0
1317353|NCT02573467|4310052|P4|Post-treatment Follow up Epoch|Technical problems|0
1317354|NCT02573467|4310053|P3|Post-treatment Follow up Epoch|Technical problems|1
1317355|NCT02573467|4310054|P2|Post-treatment Follow up Epoch|Technical problems|0
1317356|NCT02573467|4310055|P1|Post-treatment Follow up Epoch|Technical problems|0
1317357|NCT02573467|4310052|P4|Post-treatment Follow up Epoch|Withdrawal by Subject|2
1317358|NCT02573467|4310053|P3|Post-treatment Follow up Epoch|Withdrawal by Subject|9
1317359|NCT02573467|4310054|P2|Post-treatment Follow up Epoch|Withdrawal by Subject|4
1317360|NCT02573467|4310055|P1|Post-treatment Follow up Epoch|Withdrawal by Subject|5
1317361|NCT02573467|4310052|P4|Post-treatment Follow up Epoch|Death|1
1317362|NCT02573467|4310053|P3|Post-treatment Follow up Epoch|Death|0
1317363|NCT02573467|4310054|P2|Post-treatment Follow up Epoch|Death|1
1317364|NCT02573467|4310055|P1|Post-treatment Follow up Epoch|Death|1
1317365|NCT02573467|4310052|P4|Double-blind Treatment Epoch|Study Terminated by sponsor|55
1317366|NCT02573467|4310053|P3|Double-blind Treatment Epoch|Study Terminated by sponsor|48
1317367|NCT02573467|4310054|P2|Double-blind Treatment Epoch|Study Terminated by sponsor|51
1317368|NCT02573467|4310055|P1|Double-blind Treatment Epoch|Study Terminated by sponsor|50
1317369|NCT02573467|4310052|P4|Double-blind Treatment Epoch|Withdrawal by Subject|0
1317370|NCT02573467|4310053|P3|Double-blind Treatment Epoch|Withdrawal by Subject|1
1317371|NCT02573467|4310054|P2|Double-blind Treatment Epoch|Withdrawal by Subject|1
1317372|NCT02573467|4310055|P1|Double-blind Treatment Epoch|Withdrawal by Subject|2
1317373|NCT02573467|4310052|P4|Double-blind Treatment Epoch|Adverse Event|0
1317374|NCT02573467|4310053|P3|Double-blind Treatment Epoch|Adverse Event|1
1317375|NCT02573467|4310054|P2|Double-blind Treatment Epoch|Adverse Event|0
1317376|NCT02573467|4310055|P1|Double-blind Treatment Epoch|Adverse Event|1
1317377|NCT02573467|4310052|P4|Double-blind Treatment Epoch|Lack of Efficacy|0
1317378|NCT02573467|4310053|P3|Double-blind Treatment Epoch|Lack of Efficacy|1
1317379|NCT02573467|4310054|P2|Double-blind Treatment Epoch|Lack of Efficacy|0
1317380|NCT02573467|4310055|P1|Double-blind Treatment Epoch|Lack of Efficacy|0
1317381|NCT02572076|4310134|P1|Overall Study|Protocol Violation|1
1317382|NCT02571244|4310175|P2|Overall Study|Unable to reach out post discharge|0
1317383|NCT02571244|4310176|P1|Overall Study|Unable to reach out post discharge|3
1317384|NCT02571244|4310175|P2|Overall Study|Lost to Follow-up|1
1317385|NCT02571244|4310176|P1|Overall Study|Lost to Follow-up|0
1317386|NCT02571049|4310221|P2|Randomization|No migraine attack|1
1317387|NCT02571049|4310222|P1|Randomization|No migraine attack|0
1317388|NCT02571049|4310221|P2|Screening|Did not meet entry criteria|2
1317389|NCT02571049|4310222|P1|Screening|Did not meet entry criteria|2
1317390|NCT02570165|4310310|P7|Overall Study|Withdrawal Request by GSK|0
1317391|NCT02570165|4310311|P6|Overall Study|Withdrawal Request by GSK|0
1317392|NCT02570165|4310312|P5|Overall Study|Withdrawal Request by GSK|0
1317393|NCT02570165|4310313|P4|Overall Study|Withdrawal Request by GSK|0
1317394|NCT02570165|4310314|P3|Overall Study|Withdrawal Request by GSK|2
1317395|NCT02570165|4310315|P2|Overall Study|Withdrawal Request by GSK|0
1317396|NCT02570165|4310316|P1|Overall Study|Withdrawal Request by GSK|0
1317397|NCT02570165|4310310|P7|Overall Study|Par. did not Meet Continuation Criteria|0
1317398|NCT02570165|4310311|P6|Overall Study|Par. did not Meet Continuation Criteria|1
1317399|NCT02570165|4310312|P5|Overall Study|Par. did not Meet Continuation Criteria|0
1317400|NCT02570165|4310313|P4|Overall Study|Par. did not Meet Continuation Criteria|0
1317401|NCT02570165|4310314|P3|Overall Study|Par. did not Meet Continuation Criteria|0
1317402|NCT02570165|4310315|P2|Overall Study|Par. did not Meet Continuation Criteria|0
1317403|NCT02570165|4310316|P1|Overall Study|Par. did not Meet Continuation Criteria|0
1317404|NCT02570165|4310310|P7|Overall Study|Withdrawal by Subject|0
1317405|NCT02570165|4310311|P6|Overall Study|Withdrawal by Subject|0
1317406|NCT02570165|4310312|P5|Overall Study|Withdrawal by Subject|1
1317407|NCT02570165|4310313|P4|Overall Study|Withdrawal by Subject|2
1317408|NCT02570165|4310314|P3|Overall Study|Withdrawal by Subject|0
1317409|NCT02570165|4310315|P2|Overall Study|Withdrawal by Subject|0
1317410|NCT02570165|4310316|P1|Overall Study|Withdrawal by Subject|0
1317411|NCT02570165|4310310|P7|Overall Study|Physician Decision|0
1317412|NCT02570165|4310311|P6|Overall Study|Physician Decision|0
1317413|NCT02570165|4310312|P5|Overall Study|Physician Decision|0
1317414|NCT02570165|4310313|P4|Overall Study|Physician Decision|0
1317415|NCT02570165|4310314|P3|Overall Study|Physician Decision|0
1317416|NCT02570165|4310315|P2|Overall Study|Physician Decision|1
1317417|NCT02570165|4310316|P1|Overall Study|Physician Decision|0
1317418|NCT02570165|4310310|P7|Overall Study|Lost to Follow-up|0
1317419|NCT02570165|4310311|P6|Overall Study|Lost to Follow-up|0
1317420|NCT02570165|4310312|P5|Overall Study|Lost to Follow-up|0
1317421|NCT02570165|4310313|P4|Overall Study|Lost to Follow-up|1
1317422|NCT02570165|4310314|P3|Overall Study|Lost to Follow-up|1
1317423|NCT02570165|4310315|P2|Overall Study|Lost to Follow-up|0
1317424|NCT02570165|4310316|P1|Overall Study|Lost to Follow-up|0
1317425|NCT02570165|4310310|P7|Overall Study|Par. Reached Stopping Criteria|0
1317426|NCT02570165|4310311|P6|Overall Study|Par. Reached Stopping Criteria|1
1317427|NCT02570165|4310312|P5|Overall Study|Par. Reached Stopping Criteria|1
1317428|NCT02570165|4310313|P4|Overall Study|Par. Reached Stopping Criteria|2
1317429|NCT02570165|4310314|P3|Overall Study|Par. Reached Stopping Criteria|0
1317430|NCT02570165|4310315|P2|Overall Study|Par. Reached Stopping Criteria|1
1317431|NCT02570165|4310316|P1|Overall Study|Par. Reached Stopping Criteria|1
1317432|NCT02570165|4310310|P7|Overall Study|Lack of Efficacy|0
1317433|NCT02570165|4310311|P6|Overall Study|Lack of Efficacy|0
1317434|NCT02570165|4310312|P5|Overall Study|Lack of Efficacy|4
1317435|NCT02570165|4310313|P4|Overall Study|Lack of Efficacy|0
1317436|NCT02570165|4310314|P3|Overall Study|Lack of Efficacy|0
1317437|NCT02570165|4310315|P2|Overall Study|Lack of Efficacy|1
1317438|NCT02570165|4310316|P1|Overall Study|Lack of Efficacy|0
1317439|NCT02570165|4310310|P7|Overall Study|Adverse Event|0
1317440|NCT02570165|4310311|P6|Overall Study|Adverse Event|0
1317441|NCT02570165|4310312|P5|Overall Study|Adverse Event|0
1317442|NCT02570165|4310313|P4|Overall Study|Adverse Event|0
1317443|NCT02570165|4310314|P3|Overall Study|Adverse Event|2
1317444|NCT02570165|4310315|P2|Overall Study|Adverse Event|0
1317445|NCT02570165|4310316|P1|Overall Study|Adverse Event|1
1317446|NCT02570126|4310341|P2|Overall Study|Withdrawal by Subject|7
1317447|NCT02570126|4310342|P1|Overall Study|Withdrawal by Subject|3
1317448|NCT02570126|4310341|P2|Overall Study|Protocol Violation|1
1317449|NCT02570126|4310342|P1|Overall Study|Protocol Violation|0
1317450|NCT02570126|4310341|P2|Overall Study|Violation Of Procedures GSK|1
1317451|NCT02570126|4310342|P1|Overall Study|Violation Of Procedures GSK|0
1317452|NCT02570126|4310341|P2|Overall Study|Unable To Arrange Visit 3|0
1317453|NCT02570126|4310342|P1|Overall Study|Unable To Arrange Visit 3|1
1317454|NCT02570126|4310341|P2|Overall Study|Lost to Follow-up|0
1317455|NCT02570126|4310342|P1|Overall Study|Lost to Follow-up|2
1317456|NCT02569996|4310377|P1|Overall Study|Unknown reason|1
1317457|NCT02569996|4310377|P1|Overall Study|Complete remission|7
1317458|NCT02569996|4310377|P1|Overall Study|Lost to Follow-up|5
1317459|NCT02569996|4310377|P1|Overall Study|Withdrawal by Subject|5
1317460|NCT02569996|4310377|P1|Overall Study|Non-compliance|9
1317461|NCT02569996|4310377|P1|Overall Study|New anti-lymphoma treatment|1
1317462|NCT02569996|4310377|P1|Overall Study|Progression of the disease|18
1317463|NCT02569996|4310377|P1|Overall Study|Physician Decision|3
1317464|NCT02569996|4310377|P1|Overall Study|Adverse Event|6
1317465|NCT02569957|4310389|P2|Overall Study|Withdrawal by Subject|1
1317466|NCT02569957|4310390|P1|Overall Study|Withdrawal by Subject|0
1317467|NCT02569853|4310422|P2|Overall Study|Physician Decision|1
1317468|NCT02569853|4310423|P1|Overall Study|Physician Decision|1
1317469|NCT02569853|4310422|P2|Overall Study|Did not experience migraine attack|7
1317470|NCT02569853|4310423|P1|Overall Study|Did not experience migraine attack|10
1317471|NCT02569853|4310422|P2|Overall Study|Protocol Violation|1
1317472|NCT02569853|4310423|P1|Overall Study|Protocol Violation|1
1317473|NCT02569853|4310422|P2|Overall Study|Lost to Follow-up|3
1317474|NCT02569853|4310423|P1|Overall Study|Lost to Follow-up|3
1317475|NCT02569853|4310422|P2|Overall Study|Withdrawal by Subject|2
1317476|NCT02569853|4310423|P1|Overall Study|Withdrawal by Subject|3
1317477|NCT02569853|4310422|P2|Overall Study|Adverse Event|0
1317478|NCT02569853|4310423|P1|Overall Study|Adverse Event|2
1317479|NCT02569437|4310452|P2|Overall Study|Lost to Follow-up|14
1317480|NCT02569437|4310453|P1|Overall Study|Lost to Follow-up|12
1317481|NCT02568384|4310517|P1|Overall Study|Mobile devices incompatible with App|2
1317482|NCT02568254|4310531|P6|Period 3|Unstatisfactory Lens fitting|0
1317483|NCT02568254|4310532|P5|Period 3|Unstatisfactory Lens fitting|1
1317484|NCT02568254|4310533|P4|Period 3|Unstatisfactory Lens fitting|0
1317485|NCT02568254|4310534|P3|Period 3|Unstatisfactory Lens fitting|0
1317486|NCT02568254|4310535|P2|Period 3|Unstatisfactory Lens fitting|0
1317487|NCT02568254|4310536|P1|Period 3|Unstatisfactory Lens fitting|0
1317488|NCT02568254|4310531|P6|Period 2|Adverse Event|0
1317489|NCT02568254|4310532|P5|Period 2|Adverse Event|0
1317490|NCT02568254|4310533|P4|Period 2|Adverse Event|0
1317491|NCT02568254|4310534|P3|Period 2|Adverse Event|1
1317492|NCT02568254|4310535|P2|Period 2|Adverse Event|0
1317493|NCT02568254|4310536|P1|Period 2|Adverse Event|0
1317494|NCT02567708|4310567|P2|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
1317495|NCT02567708|4310568|P1|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
1317496|NCT02567708|4310567|P2|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
1317497|NCT02567708|4310568|P1|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
1317498|NCT02567708|4310567|P2|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
1317499|NCT02567708|4310568|P1|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
1317500|NCT02567708|4310567|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
1317501|NCT02567708|4310568|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
1317502|NCT02567552|4310609|P2|Overall Study|Adverse Event|1
1317503|NCT02567552|4310610|P1|Overall Study|Adverse Event|0
1317504|NCT02567188|4310640|P1|Overall Study|Protocol Violation|5
1317505|NCT02567188|4310640|P1|Overall Study|Started Hemodialysis|2
1317506|NCT02567188|4310640|P1|Overall Study|Moved and Changed Clinic|1
1317507|NCT02567188|4310640|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
1317508|NCT02567188|4310640|P1|Overall Study|Withdrawal by Subject|1
1317509|NCT02567188|4310640|P1|Overall Study|Adverse Event|1
1317510|NCT02567188|4310640|P1|Overall Study|Lost to Follow-up|5
1317511|NCT02567188|4310640|P1|Overall Study|Terminated Mircera Treatment|9
1317512|NCT02567188|4310640|P1|Overall Study|Death|10
1317513|NCT02566759|4310686|P17|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
1317514|NCT02566759|4310687|P16|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317515|NCT02566759|4310688|P15|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317516|NCT02566759|4310689|P14|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317517|NCT02566759|4310690|P13|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317518|NCT02566759|4310691|P12|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317519|NCT02566759|4310692|P11|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317520|NCT02566759|4310693|P10|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317521|NCT02566759|4310694|P9|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317522|NCT02566759|4310695|P8|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317523|NCT02566759|4310696|P7|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317524|NCT02566759|4310697|P6|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317525|NCT02566759|4310698|P5|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317526|NCT02566759|4310699|P4|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317527|NCT02566759|4310700|P3|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317528|NCT02566759|4310701|P2|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317529|NCT02566759|4310702|P1|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1317530|NCT02566759|4310686|P17|All Parts|Other|0
1317531|NCT02566759|4310687|P16|All Parts|Other|0
1317532|NCT02566759|4310688|P15|All Parts|Other|0
1317533|NCT02566759|4310689|P14|All Parts|Other|2
1317534|NCT02566759|4310690|P13|All Parts|Other|0
1317535|NCT02566759|4310691|P12|All Parts|Other|0
1317536|NCT02566759|4310692|P11|All Parts|Other|0
1317537|NCT02566759|4310693|P10|All Parts|Other|0
1317538|NCT02566759|4310694|P9|All Parts|Other|0
1317539|NCT02566759|4310695|P8|All Parts|Other|0
1317540|NCT02566759|4310696|P7|All Parts|Other|0
1317541|NCT02566759|4310697|P6|All Parts|Other|0
1317542|NCT02566759|4310698|P5|All Parts|Other|0
1317543|NCT02566759|4310699|P4|All Parts|Other|0
1317544|NCT02566759|4310700|P3|All Parts|Other|0
1317545|NCT02566759|4310701|P2|All Parts|Other|0
1317546|NCT02566759|4310702|P1|All Parts|Other|0
1317547|NCT02566759|4310686|P17|All Parts|Adverse Event|0
1317548|NCT02566759|4310687|P16|All Parts|Adverse Event|0
1317549|NCT02566759|4310688|P15|All Parts|Adverse Event|0
1317550|NCT02566759|4310689|P14|All Parts|Adverse Event|3
1317551|NCT02566759|4310690|P13|All Parts|Adverse Event|1
1317552|NCT02566759|4310691|P12|All Parts|Adverse Event|0
1317553|NCT02566759|4310692|P11|All Parts|Adverse Event|0
1317554|NCT02566759|4310693|P10|All Parts|Adverse Event|0
1317555|NCT02566759|4310694|P9|All Parts|Adverse Event|0
1317556|NCT02566759|4310695|P8|All Parts|Adverse Event|0
1317557|NCT02566759|4310696|P7|All Parts|Adverse Event|0
1317558|NCT02566759|4310697|P6|All Parts|Adverse Event|0
1317559|NCT02566759|4310698|P5|All Parts|Adverse Event|0
1317560|NCT02566759|4310699|P4|All Parts|Adverse Event|0
1317561|NCT02566759|4310700|P3|All Parts|Adverse Event|0
1317562|NCT02566759|4310701|P2|All Parts|Adverse Event|0
1317563|NCT02566759|4310702|P1|All Parts|Adverse Event|0
1317564|NCT02566759|4310686|P17|All Parts|Withdrawal by Subject|0
1317565|NCT02566759|4310687|P16|All Parts|Withdrawal by Subject|0
1317566|NCT02566759|4310688|P15|All Parts|Withdrawal by Subject|0
1317567|NCT02566759|4310689|P14|All Parts|Withdrawal by Subject|0
1317568|NCT02566759|4310690|P13|All Parts|Withdrawal by Subject|0
1317569|NCT02566759|4310691|P12|All Parts|Withdrawal by Subject|0
1317570|NCT02566759|4310692|P11|All Parts|Withdrawal by Subject|0
1317571|NCT02566759|4310693|P10|All Parts|Withdrawal by Subject|0
1317572|NCT02566759|4310694|P9|All Parts|Withdrawal by Subject|0
1317573|NCT02566759|4310695|P8|All Parts|Withdrawal by Subject|0
1317574|NCT02566759|4310696|P7|All Parts|Withdrawal by Subject|0
1317575|NCT02566759|4310697|P6|All Parts|Withdrawal by Subject|0
1317576|NCT02566759|4310698|P5|All Parts|Withdrawal by Subject|0
1317577|NCT02566759|4310699|P4|All Parts|Withdrawal by Subject|0
1317578|NCT02566759|4310700|P3|All Parts|Withdrawal by Subject|0
1317579|NCT02566759|4310701|P2|All Parts|Withdrawal by Subject|1
1317580|NCT02566759|4310702|P1|All Parts|Withdrawal by Subject|0
1317581|NCT02566005|4310878|P2|Overall Study|labor after randomization|4
1317582|NCT02566005|4310879|P1|Overall Study|labor after randomization|0
1317583|NCT02566005|4310878|P2|Overall Study|did not receive foley|1
1317584|NCT02566005|4310879|P1|Overall Study|did not receive foley|0
1317585|NCT02566005|4310878|P2|Overall Study|received foley|0
1317586|NCT02566005|4310879|P1|Overall Study|received foley|8
1317587|NCT02566005|4310878|P2|Overall Study|vaginal bleeding|1
1317588|NCT02566005|4310879|P1|Overall Study|vaginal bleeding|0
1317589|NCT02565381|4310956|P3|Overall Study|Lost to Follow-up|1
1317590|NCT02565381|4310957|P2|Overall Study|Lost to Follow-up|0
1317591|NCT02565381|4310958|P1|Overall Study|Lost to Follow-up|1
1317592|NCT02565108|4310998|P2|Overall Study|Withdrew Consent|0
1317593|NCT02565108|4310999|P1|Overall Study|Withdrew Consent|1
1317594|NCT02565108|4310998|P2|Overall Study|Adverse Event|0
1317595|NCT02565108|4310999|P1|Overall Study|Adverse Event|1
1317596|NCT02564718|4311017|P2|Overall Study|Withdrew from treatment|1
1317597|NCT02564718|4311018|P1|Overall Study|Withdrew from treatment|0
1317598|NCT02564211|4311046|P1|Overall Study|Adverse Event|4
1317599|NCT02564055|4311058|P6|Overall Study|Withdrawal by Subject|10
1317600|NCT02564055|4311059|P5|Overall Study|Withdrawal by Subject|10
1317601|NCT02564055|4311060|P4|Overall Study|Withdrawal by Subject|3
1317602|NCT02564055|4311061|P3|Overall Study|Withdrawal by Subject|3
1317603|NCT02564055|4311062|P2|Overall Study|Withdrawal by Subject|4
1317604|NCT02564055|4311063|P1|Overall Study|Withdrawal by Subject|4
1317605|NCT02564055|4311058|P6|Overall Study|Physician Decision|0
1317606|NCT02564055|4311059|P5|Overall Study|Physician Decision|0
1317607|NCT02564055|4311060|P4|Overall Study|Physician Decision|0
1317608|NCT02564055|4311061|P3|Overall Study|Physician Decision|1
1317609|NCT02564055|4311062|P2|Overall Study|Physician Decision|0
1317610|NCT02564055|4311063|P1|Overall Study|Physician Decision|0
1317611|NCT02564055|4311058|P6|Overall Study|Lost to Follow-up|0
1317612|NCT02564055|4311059|P5|Overall Study|Lost to Follow-up|1
1317613|NCT02564055|4311060|P4|Overall Study|Lost to Follow-up|2
1317614|NCT02564055|4311061|P3|Overall Study|Lost to Follow-up|4
1317615|NCT02564055|4311062|P2|Overall Study|Lost to Follow-up|1
1317616|NCT02564055|4311063|P1|Overall Study|Lost to Follow-up|0
1317617|NCT02564055|4311058|P6|Overall Study|Reached stopping criteria|1
1317618|NCT02564055|4311059|P5|Overall Study|Reached stopping criteria|0
1317619|NCT02564055|4311060|P4|Overall Study|Reached stopping criteria|0
1317620|NCT02564055|4311061|P3|Overall Study|Reached stopping criteria|0
1317621|NCT02564055|4311062|P2|Overall Study|Reached stopping criteria|0
1317622|NCT02564055|4311063|P1|Overall Study|Reached stopping criteria|0
1317623|NCT02564055|4311058|P6|Overall Study|Protocol Violation|0
1317624|NCT02564055|4311059|P5|Overall Study|Protocol Violation|0
1317625|NCT02564055|4311060|P4|Overall Study|Protocol Violation|0
1317626|NCT02564055|4311061|P3|Overall Study|Protocol Violation|0
1317627|NCT02564055|4311062|P2|Overall Study|Protocol Violation|0
1317628|NCT02564055|4311063|P1|Overall Study|Protocol Violation|1
1317629|NCT02564055|4311058|P6|Overall Study|Adverse Event|1
1317630|NCT02564055|4311059|P5|Overall Study|Adverse Event|4
1317631|NCT02564055|4311060|P4|Overall Study|Adverse Event|1
1317632|NCT02564055|4311061|P3|Overall Study|Adverse Event|4
1317633|NCT02564055|4311062|P2|Overall Study|Adverse Event|0
1317634|NCT02564055|4311063|P1|Overall Study|Adverse Event|1
1317635|NCT02564042|4311317|P6|Overall Study|Withdrawal by Subject|12
1317636|NCT02564042|4311318|P5|Overall Study|Withdrawal by Subject|10
1317637|NCT02564042|4311319|P4|Overall Study|Withdrawal by Subject|2
1317638|NCT02564042|4311320|P3|Overall Study|Withdrawal by Subject|2
1317639|NCT02564042|4311321|P2|Overall Study|Withdrawal by Subject|3
1317640|NCT02564042|4311322|P1|Overall Study|Withdrawal by Subject|5
1317641|NCT02564042|4311317|P6|Overall Study|Physician Decision|0
1317642|NCT02564042|4311318|P5|Overall Study|Physician Decision|0
1317643|NCT02564042|4311319|P4|Overall Study|Physician Decision|1
1317644|NCT02564042|4311320|P3|Overall Study|Physician Decision|0
1317645|NCT02564042|4311321|P2|Overall Study|Physician Decision|0
1317646|NCT02564042|4311322|P1|Overall Study|Physician Decision|1
1317647|NCT02564042|4311317|P6|Overall Study|Lost to Follow-up|1
1317648|NCT02564042|4311318|P5|Overall Study|Lost to Follow-up|1
1317649|NCT02564042|4311319|P4|Overall Study|Lost to Follow-up|0
1317650|NCT02564042|4311320|P3|Overall Study|Lost to Follow-up|1
1317651|NCT02564042|4311321|P2|Overall Study|Lost to Follow-up|1
1317652|NCT02564042|4311322|P1|Overall Study|Lost to Follow-up|1
1317653|NCT02564042|4311317|P6|Overall Study|Adverse Event|1
1317654|NCT02564042|4311318|P5|Overall Study|Adverse Event|0
1317655|NCT02564042|4311319|P4|Overall Study|Adverse Event|0
1317656|NCT02564042|4311320|P3|Overall Study|Adverse Event|3
1317657|NCT02564042|4311321|P2|Overall Study|Adverse Event|4
1317658|NCT02564042|4311322|P1|Overall Study|Adverse Event|4
1317659|NCT02563899|4311579|P4|Overall Study|Withdrawal by Subject|0
1317660|NCT02563899|4311580|P3|Overall Study|Withdrawal by Subject|1
1317661|NCT02563899|4311581|P2|Overall Study|Withdrawal by Subject|0
1317662|NCT02563899|4311582|P1|Overall Study|Withdrawal by Subject|0
1317663|NCT02563899|4311579|P4|Overall Study|Protocol Violation|0
1317664|NCT02563899|4311580|P3|Overall Study|Protocol Violation|0
1317665|NCT02563899|4311581|P2|Overall Study|Protocol Violation|0
1317666|NCT02563899|4311582|P1|Overall Study|Protocol Violation|1
1317667|NCT02563106|4311644|P2|Overall Study|Other reason - not specified|1
1317668|NCT02563106|4311645|P1|Overall Study|Other reason - not specified|2
1317669|NCT02563106|4311644|P2|Overall Study|Physician Decision|1
1317670|NCT02563106|4311645|P1|Overall Study|Physician Decision|3
1317671|NCT02563106|4311644|P2|Overall Study|Lost to Follow-up|2
1317672|NCT02563106|4311645|P1|Overall Study|Lost to Follow-up|3
1317673|NCT02563106|4311644|P2|Overall Study|Use of non-permitted concurrent therapy|2
1317674|NCT02563106|4311645|P1|Overall Study|Use of non-permitted concurrent therapy|1
1317675|NCT02563106|4311644|P2|Overall Study|Protocol Violation|0
1317676|NCT02563106|4311645|P1|Overall Study|Protocol Violation|1
1317677|NCT02563106|4311644|P2|Overall Study|Adverse Event|15
1317678|NCT02563106|4311645|P1|Overall Study|Adverse Event|17
1317679|NCT02563106|4311644|P2|Overall Study|Withdrawal by Subject|8
1317680|NCT02563106|4311645|P1|Overall Study|Withdrawal by Subject|7
1317681|NCT02561806|4311731|P2|Overall Study|Withdrawal by Subject|2
1317682|NCT02561806|4311732|P1|Overall Study|Withdrawal by Subject|0
1317683|NCT02561806|4311731|P2|Overall Study|Adverse Event|2
1317684|NCT02561806|4311732|P1|Overall Study|Adverse Event|0
1317685|NCT02561806|4311731|P2|Overall Study|Protocol Violation|0
1317686|NCT02561806|4311732|P1|Overall Study|Protocol Violation|1
1317687|NCT02561572|4311795|P2|Overall Study|Protocol Violation|1
1317688|NCT02561572|4311796|P1|Overall Study|Protocol Violation|0
1317689|NCT02561572|4311795|P2|Overall Study|Inadequate time before surgery|1
1317690|NCT02561572|4311796|P1|Overall Study|Inadequate time before surgery|2
1317691|NCT02561195|4311818|P6|Overall Study|Randomized but not treated|0
1317692|NCT02561195|4311819|P5|Overall Study|Randomized but not treated|0
1317693|NCT02561195|4311820|P4|Overall Study|Randomized but not treated|0
1317694|NCT02561195|4311821|P3|Overall Study|Randomized but not treated|0
1317695|NCT02561195|4311822|P2|Overall Study|Randomized but not treated|0
1317696|NCT02561195|4311823|P1|Overall Study|Randomized but not treated|1
1317697|NCT02561195|4311818|P6|Overall Study|Withdrawal by Subject|0
1317698|NCT02561195|4311819|P5|Overall Study|Withdrawal by Subject|6
1317699|NCT02561195|4311820|P4|Overall Study|Withdrawal by Subject|2
1317700|NCT02561195|4311821|P3|Overall Study|Withdrawal by Subject|4
1317701|NCT02561195|4311822|P2|Overall Study|Withdrawal by Subject|4
1317702|NCT02561195|4311823|P1|Overall Study|Withdrawal by Subject|3
1317703|NCT02561195|4311818|P6|Overall Study|Death|0
1317704|NCT02561195|4311819|P5|Overall Study|Death|0
1317705|NCT02561195|4311820|P4|Overall Study|Death|2
1317706|NCT02561195|4311821|P3|Overall Study|Death|0
1317707|NCT02561195|4311822|P2|Overall Study|Death|1
1317708|NCT02561195|4311823|P1|Overall Study|Death|2
1317709|NCT02561195|4311818|P6|Overall Study|Protocol Violation|2
1317710|NCT02561195|4311819|P5|Overall Study|Protocol Violation|5
1317711|NCT02561195|4311820|P4|Overall Study|Protocol Violation|2
1317712|NCT02561195|4311821|P3|Overall Study|Protocol Violation|1
1317713|NCT02561195|4311822|P2|Overall Study|Protocol Violation|0
1317714|NCT02561195|4311823|P1|Overall Study|Protocol Violation|1
1317715|NCT02561195|4311818|P6|Overall Study|Other|1
1317716|NCT02561195|4311819|P5|Overall Study|Other|5
1317717|NCT02561195|4311820|P4|Overall Study|Other|7
1317718|NCT02561195|4311821|P3|Overall Study|Other|1
1317719|NCT02561195|4311822|P2|Overall Study|Other|3
1317720|NCT02561195|4311823|P1|Overall Study|Other|7
1317721|NCT02561195|4311818|P6|Overall Study|No longer willing to participate|3
1317722|NCT02561195|4311819|P5|Overall Study|No longer willing to participate|1
1317723|NCT02561195|4311820|P4|Overall Study|No longer willing to participate|4
1317724|NCT02561195|4311821|P3|Overall Study|No longer willing to participate|0
1317725|NCT02561195|4311822|P2|Overall Study|No longer willing to participate|4
1317726|NCT02561195|4311823|P1|Overall Study|No longer willing to participate|2
1317727|NCT02561195|4311818|P6|Overall Study|No longer meets eligibility criteria|1
1317728|NCT02561195|4311819|P5|Overall Study|No longer meets eligibility criteria|4
1317729|NCT02561195|4311820|P4|Overall Study|No longer meets eligibility criteria|4
1317730|NCT02561195|4311821|P3|Overall Study|No longer meets eligibility criteria|0
1317731|NCT02561195|4311822|P2|Overall Study|No longer meets eligibility criteria|1
1317732|NCT02561195|4311823|P1|Overall Study|No longer meets eligibility criteria|0
1317733|NCT02561195|4311818|P6|Overall Study|Lost to Follow-up|3
1317734|NCT02561195|4311819|P5|Overall Study|Lost to Follow-up|3
1317735|NCT02561195|4311820|P4|Overall Study|Lost to Follow-up|2
1317736|NCT02561195|4311821|P3|Overall Study|Lost to Follow-up|0
1317737|NCT02561195|4311822|P2|Overall Study|Lost to Follow-up|4
1317738|NCT02561195|4311823|P1|Overall Study|Lost to Follow-up|3
1317739|NCT02561195|4311818|P6|Overall Study|Adverse Event|0
1317740|NCT02561195|4311819|P5|Overall Study|Adverse Event|4
1317741|NCT02561195|4311820|P4|Overall Study|Adverse Event|3
1317742|NCT02561195|4311821|P3|Overall Study|Adverse Event|0
1317743|NCT02561195|4311822|P2|Overall Study|Adverse Event|5
1317744|NCT02561195|4311823|P1|Overall Study|Adverse Event|4
1317745|NCT02559622|4312015|P4|Overall Study|Patient/guardian decision|1
1317746|NCT02559622|4312016|P3|Overall Study|Patient/guardian decision|0
1317747|NCT02559622|4312017|P2|Overall Study|Patient/guardian decision|2
1317748|NCT02559622|4312018|P1|Overall Study|Patient/guardian decision|1
1317749|NCT02559622|4312015|P4|Overall Study|Adverse Event|2
1317750|NCT02559622|4312016|P3|Overall Study|Adverse Event|2
1317751|NCT02559622|4312017|P2|Overall Study|Adverse Event|2
1317752|NCT02559622|4312018|P1|Overall Study|Adverse Event|0
1317753|NCT02559622|4312015|P4|Overall Study|Progressive disease|0
1317754|NCT02559622|4312016|P3|Overall Study|Progressive disease|0
1317755|NCT02559622|4312017|P2|Overall Study|Progressive disease|1
1317756|NCT02559622|4312018|P1|Overall Study|Progressive disease|0
1317757|NCT02559414|4312100|P3|Overall Study|Other|1
1317758|NCT02559414|4312101|P2|Overall Study|Other|1
1317759|NCT02559414|4312102|P1|Overall Study|Other|0
1317760|NCT02559414|4312100|P3|Overall Study|Withdrawal by Subject|1
1317761|NCT02559414|4312101|P2|Overall Study|Withdrawal by Subject|0
1317762|NCT02559414|4312102|P1|Overall Study|Withdrawal by Subject|1
1317763|NCT02559414|4312100|P3|Overall Study|Lost to Follow-up|0
1317764|NCT02559414|4312101|P2|Overall Study|Lost to Follow-up|1
1317765|NCT02559414|4312102|P1|Overall Study|Lost to Follow-up|0
1317766|NCT02558894|4312124|P2|Overall Study|Closure of Part A|1
1317767|NCT02558894|4312125|P1|Overall Study|Closure of Part A|2
1317768|NCT02558894|4312124|P2|Overall Study|Withdrawal by Subject|1
1317769|NCT02558894|4312125|P1|Overall Study|Withdrawal by Subject|2
1317770|NCT02558894|4312124|P2|Overall Study|Death; any cause, entire study duration|31
1317771|NCT02558894|4312125|P1|Overall Study|Death; any cause, entire study duration|28
1317772|NCT02558790|4312186|P1|Overall Study|Screen Fail|3
1317773|NCT02558790|4312186|P1|Overall Study|Withdrawal by Subject|1
1317774|NCT02558790|4312186|P1|Overall Study|Physician Decision|1
1317775|NCT02558790|4312186|P1|Overall Study|Lost to Follow-up|2
1317776|NCT02557646|4312268|P1|Overall Study|Other|14
1317777|NCT02557646|4312268|P1|Overall Study|Lost to Follow-up|17
1317778|NCT02557646|4312268|P1|Overall Study|Withdrawal by Subject|18
1317779|NCT02557646|4312268|P1|Overall Study|Lack of Efficacy|186
1317780|NCT02557646|4312268|P1|Overall Study|Death|1
1317781|NCT02557646|4312268|P1|Overall Study|Adverse Event|40
1317782|NCT02557399|4312293|P2|Overall Study|Withdrawal by Subject|1
1317783|NCT02557399|4312294|P1|Overall Study|Withdrawal by Subject|1
1317784|NCT02557399|4312293|P2|Overall Study|Protocol-defined stopping criteria|1
1317785|NCT02557399|4312294|P1|Overall Study|Protocol-defined stopping criteria|0
1317786|NCT02557399|4312293|P2|Overall Study|Protocol Violation|1
1317787|NCT02557399|4312294|P1|Overall Study|Protocol Violation|0
1317788|NCT02557399|4312293|P2|Overall Study|Adverse Event|5
1317789|NCT02557399|4312294|P1|Overall Study|Adverse Event|6
1317790|NCT02556632|4312354|P3|Overall Study|Treatment or Change Delay|1
1317791|NCT02556632|4312355|P2|Overall Study|Treatment or Change Delay|0
1317792|NCT02556632|4312356|P1|Overall Study|Treatment or Change Delay|0
1317793|NCT02556632|4312354|P3|Overall Study|Disliked Study Procedures|1
1317794|NCT02556632|4312355|P2|Overall Study|Disliked Study Procedures|0
1317795|NCT02556632|4312356|P1|Overall Study|Disliked Study Procedures|0
1317796|NCT02556632|4312354|P3|Overall Study|Ineligible|0
1317797|NCT02556632|4312355|P2|Overall Study|Ineligible|1
1317798|NCT02556632|4312356|P1|Overall Study|Ineligible|0
1317799|NCT02556632|4312354|P3|Overall Study|Did Not Start RT|0
1317800|NCT02556632|4312355|P2|Overall Study|Did Not Start RT|1
1317801|NCT02556632|4312356|P1|Overall Study|Did Not Start RT|0
1317802|NCT02556632|4312354|P3|Overall Study|Possibly Related Adverse Event|1
1317803|NCT02556632|4312355|P2|Overall Study|Possibly Related Adverse Event|0
1317804|NCT02556632|4312356|P1|Overall Study|Possibly Related Adverse Event|0
1317805|NCT02556632|4312354|P3|Overall Study|Related Adverse Event|0
1317806|NCT02556632|4312355|P2|Overall Study|Related Adverse Event|1
1317807|NCT02556632|4312356|P1|Overall Study|Related Adverse Event|0
1317808|NCT02556632|4312354|P3|Overall Study|Unrelated Adverse Event|3
1317809|NCT02556632|4312355|P2|Overall Study|Unrelated Adverse Event|0
1317810|NCT02556632|4312356|P1|Overall Study|Unrelated Adverse Event|1
1317811|NCT02556632|4312354|P3|Overall Study|Withdrew (Unrelated Medical)|0
1317812|NCT02556632|4312355|P2|Overall Study|Withdrew (Unrelated Medical)|0
1317813|NCT02556632|4312356|P1|Overall Study|Withdrew (Unrelated Medical)|1
1317814|NCT02556632|4312354|P3|Overall Study|Changed Mind|0
1317815|NCT02556632|4312355|P2|Overall Study|Changed Mind|1
1317816|NCT02556632|4312356|P1|Overall Study|Changed Mind|0
1317817|NCT02556632|4312354|P3|Overall Study|Personal Issues|1
1317818|NCT02556632|4312355|P2|Overall Study|Personal Issues|1
1317819|NCT02556632|4312356|P1|Overall Study|Personal Issues|0
1317820|NCT02556632|4312354|P3|Overall Study|No Reason|1
1317821|NCT02556632|4312355|P2|Overall Study|No Reason|0
1317822|NCT02556632|4312356|P1|Overall Study|No Reason|1
1317823|NCT02556632|4312354|P3|Overall Study|Disliked Intervention|1
1317824|NCT02556632|4312355|P2|Overall Study|Disliked Intervention|1
1317825|NCT02556632|4312356|P1|Overall Study|Disliked Intervention|1
1317826|NCT02556632|4312354|P3|Overall Study|Lost to Follow-up|0
1317827|NCT02556632|4312355|P2|Overall Study|Lost to Follow-up|0
1317828|NCT02556632|4312356|P1|Overall Study|Lost to Follow-up|1
1317829|NCT02556307|4312374|P1|Overall Study|Enrolled but not treated|2
1317830|NCT02556307|4312374|P1|Overall Study|Change to triple therapy|4
1317831|NCT02556307|4312374|P1|Overall Study|Lost to Follow-up|36
1317832|NCT02556307|4312374|P1|Overall Study|Premature treatment interruption|11
1317833|NCT02556138|4312384|P1|Overall Study|Withdrawal by Subject|1
1317834|NCT02555722|4312392|P2|Month 2|Adverse Event|0
1317835|NCT02555722|4312393|P1|Month 2|Adverse Event|3
1317836|NCT02555722|4312392|P2|Month 1|Withdrawal by Subject|0
1317837|NCT02555722|4312393|P1|Month 1|Withdrawal by Subject|2
1317838|NCT02555722|4312392|P2|Week 2|Lens Discomfort|1
1317839|NCT02555722|4312393|P1|Week 2|Lens Discomfort|0
1317840|NCT02555722|4312392|P2|Week 1|Withdrawal by Subject|0
1317841|NCT02555722|4312393|P1|Week 1|Withdrawal by Subject|1
1317842|NCT02555618|4312560|P2|Overall Study|Sponsor's Circumstances|0
1317843|NCT02555618|4312561|P1|Overall Study|Sponsor's Circumstances|1
1317844|NCT02554981|4312618|P1|Overall Study|Other Miscellaneous Reasons|3
1317845|NCT02554981|4312618|P1|Overall Study|Administrative Reasons|1
1317846|NCT02554981|4312618|P1|Overall Study|Adverse Event|1
1317847|NCT02554877|4312646|P4|Overall Study|No longer willing to participate|0
1317848|NCT02554877|4312647|P3|Overall Study|No longer willing to participate|2
1317849|NCT02554877|4312648|P2|Overall Study|No longer willing to participate|2
1317850|NCT02554877|4312649|P1|Overall Study|No longer willing to participate|0
1317851|NCT02554877|4312646|P4|Overall Study|Insufficient clinical response|0
1317852|NCT02554877|4312647|P3|Overall Study|Insufficient clinical response|0
1317853|NCT02554877|4312648|P2|Overall Study|Insufficient clinical response|0
1317854|NCT02554877|4312649|P1|Overall Study|Insufficient clinical response|4
1317855|NCT02554877|4312646|P4|Overall Study|Other|3
1317856|NCT02554877|4312647|P3|Overall Study|Other|0
1317857|NCT02554877|4312648|P2|Overall Study|Other|3
1317858|NCT02554877|4312649|P1|Overall Study|Other|1
1317859|NCT02554877|4312646|P4|Overall Study|Protocol Violation|0
1317860|NCT02554877|4312647|P3|Overall Study|Protocol Violation|1
1317861|NCT02554877|4312648|P2|Overall Study|Protocol Violation|1
1317862|NCT02554877|4312649|P1|Overall Study|Protocol Violation|3
1317863|NCT02554877|4312646|P4|Overall Study|No longer met eligibility criteria|1
1317864|NCT02554877|4312647|P3|Overall Study|No longer met eligibility criteria|1
1317865|NCT02554877|4312648|P2|Overall Study|No longer met eligibility criteria|0
1317866|NCT02554877|4312649|P1|Overall Study|No longer met eligibility criteria|1
1317867|NCT02554877|4312646|P4|Overall Study|Did not meet entrance criteria|0
1317868|NCT02554877|4312647|P3|Overall Study|Did not meet entrance criteria|1
1317869|NCT02554877|4312648|P2|Overall Study|Did not meet entrance criteria|0
1317870|NCT02554877|4312649|P1|Overall Study|Did not meet entrance criteria|0
1317871|NCT02554877|4312646|P4|Overall Study|Lost to Follow-up|2
1317872|NCT02554877|4312647|P3|Overall Study|Lost to Follow-up|1
1317873|NCT02554877|4312648|P2|Overall Study|Lost to Follow-up|1
1317874|NCT02554877|4312649|P1|Overall Study|Lost to Follow-up|1
1317875|NCT02554877|4312646|P4|Overall Study|Adverse Event|1
1317876|NCT02554877|4312647|P3|Overall Study|Adverse Event|0
1317877|NCT02554877|4312648|P2|Overall Study|Adverse Event|0
1317878|NCT02554877|4312649|P1|Overall Study|Adverse Event|2
1317879|NCT02554279|4312748|P2|Overall Study|Other reason|6
1317880|NCT02554279|4312749|P1|Overall Study|Other reason|19
1317881|NCT02554279|4312748|P2|Overall Study|Protocol Violation|1
1317882|NCT02554279|4312749|P1|Overall Study|Protocol Violation|2
1317883|NCT02554279|4312748|P2|Overall Study|Withdrawal by Subject|4
1317884|NCT02554279|4312749|P1|Overall Study|Withdrawal by Subject|6
1317885|NCT02554279|4312748|P2|Overall Study|Lost to Follow-up|2
1317886|NCT02554279|4312749|P1|Overall Study|Lost to Follow-up|3
1317887|NCT02554279|4312748|P2|Overall Study|Adverse Event|5
1317888|NCT02554279|4312749|P1|Overall Study|Adverse Event|2
1317889|NCT02553772|4312783|P2|Overall Study|Other Miscellaneous Reasons|1
1317890|NCT02553772|4312784|P1|Overall Study|Other Miscellaneous Reasons|0
1317891|NCT02553772|4312783|P2|Overall Study|Lack of Efficacy|0
1317892|NCT02553772|4312784|P1|Overall Study|Lack of Efficacy|1
1317893|NCT02553772|4312783|P2|Overall Study|Withdrawal of Consent|1
1317894|NCT02553772|4312784|P1|Overall Study|Withdrawal of Consent|1
1317895|NCT02553772|4312783|P2|Overall Study|Lost to Follow-up|1
1317896|NCT02553772|4312784|P1|Overall Study|Lost to Follow-up|2
1317897|NCT02553772|4312783|P2|Overall Study|Adverse Event|3
1317898|NCT02553772|4312784|P1|Overall Study|Adverse Event|2
1317899|NCT02553629|4312800|P2|Overall Study|Logistic reasons|6
1317900|NCT02553629|4312801|P1|Overall Study|Logistic reasons|3
1317901|NCT02553538|4312817|P2|Overall Study|Died or Left Network|56
1317902|NCT02553538|4312818|P1|Overall Study|Died or Left Network|54
1317903|NCT02553538|4312817|P2|Overall Study|Could Not Reach by Telephone|0
1317904|NCT02553538|4312818|P1|Overall Study|Could Not Reach by Telephone|133
1317905|NCT02553421|4312840|P2|Overall Study|Improper Device Placement|0
1317906|NCT02553421|4312841|P1|Overall Study|Improper Device Placement|3
1317907|NCT02553421|4312840|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
1317908|NCT02553421|4312841|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
1317909|NCT02553421|4312840|P2|Overall Study|Lost to Follow-up|1
1317910|NCT02553421|4312841|P1|Overall Study|Lost to Follow-up|21
1317911|NCT02552303|4312872|P4|Follow-Up|ineligible|0
1317912|NCT02552303|4312873|P3|Follow-Up|ineligible|0
1317913|NCT02552303|4312874|P2|Follow-Up|ineligible|2
1317914|NCT02552303|4312875|P1|Follow-Up|ineligible|0
1317915|NCT02552303|4312872|P4|Follow-Up|Lost to Follow-up|0
1317916|NCT02552303|4312873|P3|Follow-Up|Lost to Follow-up|1
1317917|NCT02552303|4312874|P2|Follow-Up|Lost to Follow-up|0
1317918|NCT02552303|4312875|P1|Follow-Up|Lost to Follow-up|0
1317919|NCT02552303|4312872|P4|Allocation|ineligible|0
1317920|NCT02552303|4312873|P3|Allocation|ineligible|0
1317921|NCT02552303|4312874|P2|Allocation|ineligible|1
1317922|NCT02552303|4312875|P1|Allocation|ineligible|1
1317923|NCT02552303|4312872|P4|Allocation|Withdrawal by Subject|1
1317924|NCT02552303|4312873|P3|Allocation|Withdrawal by Subject|1
1317925|NCT02552303|4312874|P2|Allocation|Withdrawal by Subject|1
1317926|NCT02552303|4312875|P1|Allocation|Withdrawal by Subject|2
1317927|NCT02550288|4312943|P5|Overall Study|Withdrawal by Subject|0
1317928|NCT02550288|4312944|P4|Overall Study|Withdrawal by Subject|1
1317929|NCT02550288|4312945|P3|Overall Study|Withdrawal by Subject|0
1317930|NCT02550288|4312946|P2|Overall Study|Withdrawal by Subject|0
1317931|NCT02550288|4312947|P1|Overall Study|Withdrawal by Subject|0
1317932|NCT02550288|4312943|P5|Overall Study|Participant moved|0
1317933|NCT02550288|4312944|P4|Overall Study|Participant moved|1
1317934|NCT02550288|4312945|P3|Overall Study|Participant moved|0
1317935|NCT02550288|4312946|P2|Overall Study|Participant moved|0
1317936|NCT02550288|4312947|P1|Overall Study|Participant moved|0
1317937|NCT02550288|4312943|P5|Overall Study|Protocol Violation|3
1317938|NCT02550288|4312944|P4|Overall Study|Protocol Violation|0
1317939|NCT02550288|4312945|P3|Overall Study|Protocol Violation|1
1317940|NCT02550288|4312946|P2|Overall Study|Protocol Violation|2
1317941|NCT02550288|4312947|P1|Overall Study|Protocol Violation|2
1317942|NCT02550288|4312943|P5|Overall Study|Physician Decision|0
1317943|NCT02550288|4312944|P4|Overall Study|Physician Decision|1
1317944|NCT02550288|4312945|P3|Overall Study|Physician Decision|0
1317945|NCT02550288|4312946|P2|Overall Study|Physician Decision|0
1317946|NCT02550288|4312947|P1|Overall Study|Physician Decision|0
1317947|NCT02550288|4312943|P5|Overall Study|Adverse Event|0
1317948|NCT02550288|4312944|P4|Overall Study|Adverse Event|0
1317949|NCT02550288|4312945|P3|Overall Study|Adverse Event|0
1317950|NCT02550288|4312946|P2|Overall Study|Adverse Event|1
1317951|NCT02550288|4312947|P1|Overall Study|Adverse Event|0
1317952|NCT02549573|4313102|P2|Overall Study|Protocol Violation|1
1317953|NCT02549573|4313103|P1|Overall Study|Protocol Violation|0
1317954|NCT02549573|4313102|P2|Overall Study|Withdrawal by Subject|2
1317955|NCT02549573|4313103|P1|Overall Study|Withdrawal by Subject|0
1317956|NCT02549027|4313145|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1317957|NCT02549027|4313146|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
1317958|NCT02549027|4313147|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1317959|NCT02549027|4313148|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1317960|NCT02549027|4313149|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1317961|NCT02549027|4313150|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1317962|NCT02549027|4313145|P6|Washout After Period 4|Withdrawal by Subject|0
1317963|NCT02549027|4313146|P5|Washout After Period 4|Withdrawal by Subject|0
1317964|NCT02549027|4313147|P4|Washout After Period 4|Withdrawal by Subject|1
1317965|NCT02549027|4313148|P3|Washout After Period 4|Withdrawal by Subject|1
1317966|NCT02549027|4313149|P2|Washout After Period 4|Withdrawal by Subject|1
1317967|NCT02549027|4313150|P1|Washout After Period 4|Withdrawal by Subject|0
1317968|NCT02548455|4313290|P1|Overall Study|Visit not completed|173
1317969|NCT02548455|4313290|P1|Overall Study|Lost to Follow-up|14
1317970|NCT02548455|4313290|P1|Overall Study|Death|26
1317971|NCT02548455|4313290|P1|Overall Study|Withdrawal by Subject|27
1317972|NCT02548156|4313294|P6|Washout Period 1|Lost to Follow-up|0
1317973|NCT02548156|4313295|P5|Washout Period 1|Lost to Follow-up|1
1317974|NCT02548156|4313296|P4|Washout Period 1|Lost to Follow-up|0
1317975|NCT02548156|4313297|P3|Washout Period 1|Lost to Follow-up|0
1317976|NCT02548156|4313298|P2|Washout Period 1|Lost to Follow-up|0
1317977|NCT02548156|4313299|P1|Washout Period 1|Lost to Follow-up|0
1317978|NCT02548078|4313318|P2|Overall Study|Lost to Follow-up|3
1317979|NCT02548078|4313319|P1|Overall Study|Lost to Follow-up|1
1317980|NCT02548078|4313318|P2|Overall Study|Moved from study area|3
1317981|NCT02548078|4313319|P1|Overall Study|Moved from study area|3
1317982|NCT02548078|4313318|P2|Overall Study|Serious adverse event/Adverse event|0
1317983|NCT02548078|4313319|P1|Overall Study|Serious adverse event/Adverse event|1
1317984|NCT02547974|4313511|P4|Overall Study|Withdrawal by Subject|0
1317985|NCT02547974|4313512|P3|Overall Study|Withdrawal by Subject|0
1317986|NCT02547974|4313513|P2|Overall Study|Withdrawal by Subject|0
1317987|NCT02547974|4313514|P1|Overall Study|Withdrawal by Subject|1
1317988|NCT02547454|4313641|P1|Overall Study|No data|11
1317989|NCT02547454|4313641|P1|Overall Study|Other|39
1317990|NCT02547454|4313641|P1|Overall Study|Lost to Follow-up|26
1317991|NCT02547454|4313641|P1|Overall Study|Death|38
1317992|NCT02547454|4313641|P1|Overall Study|Due to no further need to treat|4
1317993|NCT02547454|4313641|P1|Overall Study|Due to transplantation|1
1317994|NCT02547454|4313641|P1|Overall Study|Due to hemodialysis|53
1317995|NCT02546986|4313700|P2|Survival Follow-Up Phase|Lost to Follow-up|2
1317996|NCT02546986|4313701|P1|Survival Follow-Up Phase|Lost to Follow-up|2
1317997|NCT02546986|4313700|P2|Survival Follow-Up Phase|Alive|16
1317998|NCT02546986|4313701|P1|Survival Follow-Up Phase|Alive|13
1317999|NCT02546986|4313700|P2|Survival Follow-Up Phase|Death|12
1318000|NCT02546986|4313701|P1|Survival Follow-Up Phase|Death|18
1318001|NCT02546986|4313700|P2|Survival Follow-Up Phase|Missing Status|5
1318002|NCT02546986|4313701|P1|Survival Follow-Up Phase|Missing Status|3
1318003|NCT02546986|4313700|P2|Treatment Period|Miscellaneous|9
1318004|NCT02546986|4313701|P1|Treatment Period|Miscellaneous|7
1318005|NCT02546986|4313700|P2|Treatment Period|Study Terminated by Sponsor|1
1318006|NCT02546986|4313701|P1|Treatment Period|Study Terminated by Sponsor|0
1318007|NCT02546986|4313700|P2|Treatment Period|Non-compliance with Study Drug|1
1318008|NCT02546986|4313701|P1|Treatment Period|Non-compliance with Study Drug|0
1318009|NCT02546986|4313700|P2|Treatment Period|Withdrawal by Subject|1
1318010|NCT02546986|4313701|P1|Treatment Period|Withdrawal by Subject|1
1318011|NCT02546986|4313700|P2|Treatment Period|Protocol Violation|0
1318012|NCT02546986|4313701|P1|Treatment Period|Protocol Violation|1
1318013|NCT02546986|4313700|P2|Treatment Period|Physician Decision|2
1318014|NCT02546986|4313701|P1|Treatment Period|Physician Decision|1
1318015|NCT02546986|4313700|P2|Treatment Period|Death|4
1318016|NCT02546986|4313701|P1|Treatment Period|Death|3
1318017|NCT02546986|4313700|P2|Treatment Period|Symptomatic Deterioration|3
1318018|NCT02546986|4313701|P1|Treatment Period|Symptomatic Deterioration|4
1318019|NCT02546986|4313700|P2|Treatment Period|Adverse Event|6
1318020|NCT02546986|4313701|P1|Treatment Period|Adverse Event|14
1318021|NCT02546986|4313700|P2|Treatment Period|Progressive Disease|22
1318022|NCT02546986|4313701|P1|Treatment Period|Progressive Disease|20
1318023|NCT02546609|4313727|P3|Overall Study|travel or work schedule restriction|2
1318024|NCT02546609|4313728|P2|Overall Study|travel or work schedule restriction|0
1318025|NCT02546609|4313729|P1|Overall Study|travel or work schedule restriction|0
1318026|NCT02546609|4313727|P3|Overall Study|Lost to Follow-up|1
1318027|NCT02546609|4313728|P2|Overall Study|Lost to Follow-up|3
1318028|NCT02546609|4313729|P1|Overall Study|Lost to Follow-up|2
1318029|NCT02546609|4313727|P3|Overall Study|Protocol Violation|1
1318030|NCT02546609|4313728|P2|Overall Study|Protocol Violation|1
1318031|NCT02546609|4313729|P1|Overall Study|Protocol Violation|0
1318032|NCT02546609|4313727|P3|Overall Study|Adverse Event|1
1318033|NCT02546609|4313728|P2|Overall Study|Adverse Event|6
1318034|NCT02546609|4313729|P1|Overall Study|Adverse Event|0
1318035|NCT02546609|4313727|P3|Overall Study|Withdrawal by Subject|2
1318036|NCT02546609|4313728|P2|Overall Study|Withdrawal by Subject|1
1318037|NCT02546609|4313729|P1|Overall Study|Withdrawal by Subject|0
1318038|NCT02545868|4313773|P3|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
1318039|NCT02545868|4313774|P2|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
1318040|NCT02545868|4313775|P1|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
1318041|NCT02545543|4313848|P2|Overall Study|Enrolment of subject at >1 study site|1
1318042|NCT02545543|4313849|P1|Overall Study|Enrolment of subject at >1 study site|1
1318043|NCT02545543|4313848|P2|Overall Study|Noncomplaince|0
1318044|NCT02545543|4313849|P1|Overall Study|Noncomplaince|1
1318045|NCT02545543|4313848|P2|Overall Study|Withdrawal by Subject|8
1318046|NCT02545543|4313849|P1|Overall Study|Withdrawal by Subject|9
1318047|NCT02545543|4313848|P2|Overall Study|Physician Decision|0
1318048|NCT02545543|4313849|P1|Overall Study|Physician Decision|3
1318049|NCT02545543|4313848|P2|Overall Study|Lost to Follow-up|25
1318050|NCT02545543|4313849|P1|Overall Study|Lost to Follow-up|67
1318051|NCT02545322|4313873|P1|Overall Study|Withdrawal by Subject|3
1318052|NCT02544074|4313929|P21|Overall Study|Tablet error|0
1318053|NCT02544074|4313930|P20|Overall Study|Tablet error|0
1318054|NCT02544074|4313931|P19|Overall Study|Tablet error|0
1318055|NCT02544074|4313932|P18|Overall Study|Tablet error|0
1318056|NCT02544074|4313933|P17|Overall Study|Tablet error|0
1318057|NCT02544074|4313934|P16|Overall Study|Tablet error|0
1318058|NCT02544074|4313935|P15|Overall Study|Tablet error|0
1318059|NCT02544074|4313936|P14|Overall Study|Tablet error|0
1318060|NCT02544074|4313937|P13|Overall Study|Tablet error|0
1318061|NCT02544074|4313938|P12|Overall Study|Tablet error|0
1318062|NCT02544074|4313939|P11|Overall Study|Tablet error|0
1318063|NCT02544074|4313940|P10|Overall Study|Tablet error|1
1318064|NCT02544074|4313941|P9|Overall Study|Tablet error|0
1318065|NCT02544074|4313942|P8|Overall Study|Tablet error|0
1318066|NCT02544074|4313943|P7|Overall Study|Tablet error|0
1318067|NCT02544074|4313944|P6|Overall Study|Tablet error|1
1318068|NCT02544074|4313945|P5|Overall Study|Tablet error|0
1318069|NCT02544074|4313946|P4|Overall Study|Tablet error|0
1318070|NCT02544074|4313947|P3|Overall Study|Tablet error|0
1318071|NCT02544074|4313948|P2|Overall Study|Tablet error|0
1318072|NCT02544074|4313949|P1|Overall Study|Tablet error|0
1318073|NCT02544074|4313929|P21|Overall Study|Withdrawal by Subject|0
1318074|NCT02544074|4313930|P20|Overall Study|Withdrawal by Subject|0
1318075|NCT02544074|4313931|P19|Overall Study|Withdrawal by Subject|0
1318076|NCT02544074|4313932|P18|Overall Study|Withdrawal by Subject|0
1318077|NCT02544074|4313933|P17|Overall Study|Withdrawal by Subject|0
1318078|NCT02544074|4313934|P16|Overall Study|Withdrawal by Subject|0
1318079|NCT02544074|4313935|P15|Overall Study|Withdrawal by Subject|0
1318080|NCT02544074|4313936|P14|Overall Study|Withdrawal by Subject|0
1318081|NCT02544074|4313937|P13|Overall Study|Withdrawal by Subject|0
1318082|NCT02544074|4313938|P12|Overall Study|Withdrawal by Subject|0
1318083|NCT02544074|4313939|P11|Overall Study|Withdrawal by Subject|0
1318084|NCT02544074|4313940|P10|Overall Study|Withdrawal by Subject|0
1318085|NCT02544074|4313941|P9|Overall Study|Withdrawal by Subject|0
1318086|NCT02544074|4313942|P8|Overall Study|Withdrawal by Subject|0
1318087|NCT02544074|4313943|P7|Overall Study|Withdrawal by Subject|0
1318088|NCT02544074|4313944|P6|Overall Study|Withdrawal by Subject|0
1318089|NCT02544074|4313945|P5|Overall Study|Withdrawal by Subject|0
1318090|NCT02544074|4313946|P4|Overall Study|Withdrawal by Subject|0
1318091|NCT02544074|4313947|P3|Overall Study|Withdrawal by Subject|0
1318092|NCT02544074|4313948|P2|Overall Study|Withdrawal by Subject|1
1318093|NCT02544074|4313949|P1|Overall Study|Withdrawal by Subject|0
1318094|NCT02543918|4313985|P2|Overall Study|Adverse Event|1
1318095|NCT02543918|4313986|P1|Overall Study|Adverse Event|1
1318096|NCT02543918|4313985|P2|Overall Study|Withdrawal by Subject|1
1318097|NCT02543918|4313986|P1|Overall Study|Withdrawal by Subject|1
1318098|NCT02543918|4313985|P2|Overall Study|Lost to Follow-up|1
1318099|NCT02543918|4313986|P1|Overall Study|Lost to Follow-up|1
1318100|NCT02543918|4313985|P2|Overall Study|Never treated|1
1318101|NCT02543918|4313986|P1|Overall Study|Never treated|0
1318102|NCT02543528|4313992|P5|Extended Wear Period|Withdrawal by Subject|0
1318103|NCT02543528|4313993|P4|Extended Wear Period|Withdrawal by Subject|5
1318104|NCT02543528|4313994|P3|Extended Wear Period|Withdrawal by Subject|10
1318105|NCT02543528|4313995|P2|Extended Wear Period|Withdrawal by Subject|9
1318106|NCT02543528|4313996|P1|Extended Wear Period|Withdrawal by Subject|4
1318107|NCT02543528|4313992|P5|Extended Wear Period|Lost to Follow-up|0
1318108|NCT02543528|4313993|P4|Extended Wear Period|Lost to Follow-up|1
1318109|NCT02543528|4313994|P3|Extended Wear Period|Lost to Follow-up|0
1318110|NCT02543528|4313995|P2|Extended Wear Period|Lost to Follow-up|1
1318111|NCT02543528|4313996|P1|Extended Wear Period|Lost to Follow-up|2
1318112|NCT02543528|4313992|P5|Extended Wear Period|Unsatisfactory Lens Fitting|0
1318113|NCT02543528|4313993|P4|Extended Wear Period|Unsatisfactory Lens Fitting|0
1318114|NCT02543528|4313994|P3|Extended Wear Period|Unsatisfactory Lens Fitting|1
1318115|NCT02543528|4313995|P2|Extended Wear Period|Unsatisfactory Lens Fitting|0
1318116|NCT02543528|4313996|P1|Extended Wear Period|Unsatisfactory Lens Fitting|0
1318117|NCT02543528|4313992|P5|Extended Wear Period|Missed too many scheduled visits|0
1318118|NCT02543528|4313993|P4|Extended Wear Period|Missed too many scheduled visits|3
1318119|NCT02543528|4313994|P3|Extended Wear Period|Missed too many scheduled visits|0
1318120|NCT02543528|4313995|P2|Extended Wear Period|Missed too many scheduled visits|0
1318121|NCT02543528|4313996|P1|Extended Wear Period|Missed too many scheduled visits|1
1318122|NCT02543528|4313992|P5|Extended Wear Period|Adverse Event|0
1318123|NCT02543528|4313993|P4|Extended Wear Period|Adverse Event|3
1318124|NCT02543528|4313994|P3|Extended Wear Period|Adverse Event|17
1318125|NCT02543528|4313995|P2|Extended Wear Period|Adverse Event|11
1318126|NCT02543528|4313996|P1|Extended Wear Period|Adverse Event|16
1318127|NCT02543528|4313992|P5|Adaptation Period|Adverse Event|2
1318128|NCT02543528|4313993|P4|Adaptation Period|Adverse Event|0
1318129|NCT02543528|4313994|P3|Adaptation Period|Adverse Event|0
1318130|NCT02543528|4313995|P2|Adaptation Period|Adverse Event|0
1318131|NCT02543528|4313996|P1|Adaptation Period|Adverse Event|0
1318132|NCT02543528|4313992|P5|Adaptation Period|Lost to Follow-up|14
1318133|NCT02543528|4313993|P4|Adaptation Period|Lost to Follow-up|0
1318134|NCT02543528|4313994|P3|Adaptation Period|Lost to Follow-up|0
1318135|NCT02543528|4313995|P2|Adaptation Period|Lost to Follow-up|0
1318136|NCT02543528|4313996|P1|Adaptation Period|Lost to Follow-up|0
1318137|NCT02543528|4313992|P5|Adaptation Period|Lens Handling Difficultes|8
1318138|NCT02543528|4313993|P4|Adaptation Period|Lens Handling Difficultes|0
1318139|NCT02543528|4313994|P3|Adaptation Period|Lens Handling Difficultes|0
1318140|NCT02543528|4313995|P2|Adaptation Period|Lens Handling Difficultes|0
1318141|NCT02543528|4313996|P1|Adaptation Period|Lens Handling Difficultes|0
1318142|NCT02543528|4313992|P5|Adaptation Period|Unsatisfactory Lens Fitting|2
1318143|NCT02543528|4313993|P4|Adaptation Period|Unsatisfactory Lens Fitting|0
1318144|NCT02543528|4313994|P3|Adaptation Period|Unsatisfactory Lens Fitting|0
1318145|NCT02543528|4313995|P2|Adaptation Period|Unsatisfactory Lens Fitting|0
1318146|NCT02543528|4313996|P1|Adaptation Period|Unsatisfactory Lens Fitting|0
1318147|NCT02542943|4314032|P3|Overall Study|Withdrawal by Subject|0
1318148|NCT02542943|4314033|P2|Overall Study|Withdrawal by Subject|1
1318149|NCT02542943|4314034|P1|Overall Study|Withdrawal by Subject|0
1318150|NCT02542943|4314032|P3|Overall Study|Lost to Follow-up|0
1318151|NCT02542943|4314033|P2|Overall Study|Lost to Follow-up|0
1318152|NCT02542943|4314034|P1|Overall Study|Lost to Follow-up|1
1318153|NCT02542072|4314108|P2|Second Intervention (1 Month)|Lens discomfort|0
1318154|NCT02542072|4314109|P1|Second Intervention (1 Month)|Lens discomfort|1
1318155|NCT02542072|4314108|P2|Second Intervention (1 Month)|Lost to Follow-up|0
1318156|NCT02542072|4314109|P1|Second Intervention (1 Month)|Lost to Follow-up|1
1318157|NCT02542072|4314108|P2|First Intervention (1 Month)|Protocol Violation|0
1318158|NCT02542072|4314109|P1|First Intervention (1 Month)|Protocol Violation|1
1318159|NCT02542072|4314108|P2|First Intervention (1 Month)|Lens discomfort|2
1318160|NCT02542072|4314109|P1|First Intervention (1 Month)|Lens discomfort|1
1318161|NCT02542072|4314108|P2|First Intervention (1 Month)|Lost to Follow-up|0
1318162|NCT02542072|4314109|P1|First Intervention (1 Month)|Lost to Follow-up|2
1318163|NCT02542072|4314108|P2|First Intervention (1 Month)|Adverse Event|1
1318164|NCT02542072|4314109|P1|First Intervention (1 Month)|Adverse Event|1
1318165|NCT02540850|4314228|P3|Overall Study|Lost to Follow-up|34
1318166|NCT02540850|4314229|P2|Overall Study|Lost to Follow-up|66
1318167|NCT02540850|4314230|P1|Overall Study|Lost to Follow-up|69
1318168|NCT02540356|4314301|P2|Overall Study|Terminated due to disease progression|0
1318169|NCT02540356|4314302|P1|Overall Study|Terminated due to disease progression|1
1318170|NCT02540265|4314336|P3|Overall Study|Lost to Follow-up|1
1318171|NCT02540265|4314337|P2|Overall Study|Lost to Follow-up|0
1318172|NCT02540265|4314338|P1|Overall Study|Lost to Follow-up|0
1318173|NCT02540213|4314358|P1|Overall Study|Enrolled but not treated|2
1318174|NCT02540213|4314358|P1|Overall Study|Consent withdrawn|7
1318175|NCT02540213|4314358|P1|Overall Study|Lack of Efficacy|6
1318176|NCT02540213|4314358|P1|Overall Study|Kidney transplant|3
1318177|NCT02540213|4314358|P1|Overall Study|Administrative reasons|3
1318178|NCT02540213|4314358|P1|Overall Study|Death/adverse event|18
1318179|NCT02539797|4314410|P3|Overall Study|Lost to Follow-up|0
1318180|NCT02539797|4314411|P2|Overall Study|Lost to Follow-up|1
1318181|NCT02539797|4314412|P1|Overall Study|Lost to Follow-up|0
1318182|NCT02539134|4314439|P6|Overall Study|Lost to Follow-up|0
1318183|NCT02539134|4314440|P5|Overall Study|Lost to Follow-up|0
1318184|NCT02539134|4314441|P4|Overall Study|Lost to Follow-up|0
1318185|NCT02539134|4314442|P3|Overall Study|Lost to Follow-up|0
1318186|NCT02539134|4314443|P2|Overall Study|Lost to Follow-up|0
1318187|NCT02539134|4314444|P1|Overall Study|Lost to Follow-up|1
1318188|NCT02538107|4314526|P1|Overall Study|Not recorded|7
1318189|NCT02538107|4314526|P1|Overall Study|Other|7
1318190|NCT02538107|4314526|P1|Overall Study|Surgery|1
1318191|NCT02538107|4314526|P1|Overall Study|Adverse Event|4
1318192|NCT02538107|4314526|P1|Overall Study|Administrative reason|5
1318193|NCT02538107|4314526|P1|Overall Study|Death|4
1318194|NCT02538107|4314526|P1|Overall Study|Withdrawal by Subject|17
1318195|NCT02538107|4314526|P1|Overall Study|No further treatment necessary|18
1318196|NCT02538107|4314526|P1|Overall Study|Administration of other ESA|11
1318197|NCT02538107|4314526|P1|Overall Study|Necessity of dialysis|20
1318198|NCT02538107|4314526|P1|Overall Study|Missing|5
1318199|NCT02538107|4314526|P1|Overall Study|Did not receive any Mircera dose|11
1318200|NCT02537522|4314559|P4|Phase II - Period 1 Bilateral|Adverse Event|1
1318201|NCT02537522|4314560|P3|Phase II - Period 1 Bilateral|Adverse Event|0
1318202|NCT02537522|4314561|P2|Phase II - Period 1 Bilateral|Adverse Event|0
1318203|NCT02537522|4314562|P1|Phase II - Period 1 Bilateral|Adverse Event|0
1318204|NCT02537522|4314559|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
1318205|NCT02537522|4314560|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
1318206|NCT02537522|4314561|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
1318207|NCT02537522|4314562|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
1318208|NCT02537522|4314559|P4|Phase I - Contralateral|incorrect randomization|0
1318209|NCT02537522|4314560|P3|Phase I - Contralateral|incorrect randomization|0
1318210|NCT02537522|4314561|P2|Phase I - Contralateral|incorrect randomization|1
1318211|NCT02537522|4314562|P1|Phase I - Contralateral|incorrect randomization|0
1318212|NCT02537522|4314559|P4|Phase I - Contralateral|Withdrawal by Subject|0
1318213|NCT02537522|4314560|P3|Phase I - Contralateral|Withdrawal by Subject|0
1318214|NCT02537522|4314561|P2|Phase I - Contralateral|Withdrawal by Subject|1
1318215|NCT02537522|4314562|P1|Phase I - Contralateral|Withdrawal by Subject|0
1318216|NCT02537522|4314559|P4|Phase I - Contralateral|Subject no longer eligible|0
1318217|NCT02537522|4314560|P3|Phase I - Contralateral|Subject no longer eligible|0
1318218|NCT02537522|4314561|P2|Phase I - Contralateral|Subject no longer eligible|7
1318219|NCT02537522|4314562|P1|Phase I - Contralateral|Subject no longer eligible|15
1318220|NCT02536781|4314572|P2|Overall Study|Lost to Follow-up|0
1318221|NCT02536781|4314573|P1|Overall Study|Lost to Follow-up|2
1318222|NCT02536664|4314583|P2|Overall Study|Missing|20
1318223|NCT02536664|4314584|P1|Overall Study|Missing|53
1318224|NCT02536664|4314583|P2|Overall Study|Other|24
1318225|NCT02536664|4314584|P1|Overall Study|Other|18
1318226|NCT02536664|4314583|P2|Overall Study|Withdrawal by Subject|5
1318227|NCT02536664|4314584|P1|Overall Study|Withdrawal by Subject|8
1318228|NCT02536664|4314583|P2|Overall Study|Intolerability|6
1318229|NCT02536664|4314584|P1|Overall Study|Intolerability|8
1318230|NCT02536664|4314583|P2|Overall Study|Death due to other reason|2
1318231|NCT02536664|4314584|P1|Overall Study|Death due to other reason|3
1318232|NCT02536664|4314583|P2|Overall Study|Death due to lymphoma|1
1318233|NCT02536664|4314584|P1|Overall Study|Death due to lymphoma|2
1318234|NCT02536664|4314583|P2|Overall Study|Progression|18
1318235|NCT02536664|4314584|P1|Overall Study|Progression|13
1318236|NCT02536664|4314583|P2|Overall Study|Inadequate completion of documentation|4
1318237|NCT02536664|4314584|P1|Overall Study|Inadequate completion of documentation|2
1318238|NCT02536313|4314604|P2|Overall Study|Lack of Efficacy|1
1318239|NCT02536313|4314605|P1|Overall Study|Lack of Efficacy|0
1318240|NCT02535741|4314621|P1|Overall Study|Missing data|6
1318241|NCT02535741|4314621|P1|Overall Study|Exclusion criteria: Bilateral implant|4
1318242|NCT02535741|4314621|P1|Overall Study|Lost to Follow-up|10
1318243|NCT02535741|4314621|P1|Overall Study|Withdrawal by Subject|9
1318244|NCT02535741|4314621|P1|Overall Study|Adverse Event|3
1318245|NCT02535416|4314638|P9|Overall Study|Family bereavement overseas|0
1318246|NCT02535416|4314639|P8|Overall Study|Family bereavement overseas|0
1318247|NCT02535416|4314640|P7|Overall Study|Family bereavement overseas|0
1318248|NCT02535416|4314641|P6|Overall Study|Family bereavement overseas|0
1318249|NCT02535416|4314642|P5|Overall Study|Family bereavement overseas|0
1318250|NCT02535416|4314643|P4|Overall Study|Family bereavement overseas|0
1318251|NCT02535416|4314644|P3|Overall Study|Family bereavement overseas|0
1318252|NCT02535416|4314645|P2|Overall Study|Family bereavement overseas|0
1318253|NCT02535416|4314646|P1|Overall Study|Family bereavement overseas|1
1318254|NCT02535364|4314698|P1|12-Month Follow-up Period|Subject transferred to hospice|1
1318255|NCT02535364|4314698|P1|12-Month Follow-up Period|Subject received alternative therapy|2
1318256|NCT02535364|4314698|P1|12-Month Follow-up Period|Underwent stem cell transplant|5
1318257|NCT02535364|4314698|P1|12-Month Follow-up Period|Death|5
1318258|NCT02535364|4314698|P1|12-Month Follow-up Period|Disease progression|22
1318259|NCT02535364|4314698|P1|Study Treatment|Study placed on clinical hold by FDA|1
1318260|NCT02535364|4314698|P1|Study Treatment|Death|1
1318261|NCT02535364|4314698|P1|Part B Screening|Change in diagnosis, no longer eligible|2
1318262|NCT02535364|4314698|P1|Part B Screening|Adverse Event|1
1318263|NCT02535364|4314698|P1|Part B Screening|Withdrawal by Subject|1
1318264|NCT02535364|4314698|P1|Part B Screening|Physician Decision|1
1318265|NCT02535364|4314698|P1|Part B Screening|Death|2
1318266|NCT02535364|4314698|P1|Part B Screening|Unable to manufacture JCAR015|3
1318267|NCT02535364|4314698|P1|Part B Screening|Study placed on clinical hold by FDA|7
1318268|NCT02535364|4314698|P1|Part A Screening Through Leukapheresis|Disease progression|1
1318269|NCT02535364|4314698|P1|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
1318270|NCT02535364|4314698|P1|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
1318271|NCT02534935|4314783|P3|Overall Study|Lost to Follow-up|1
1318272|NCT02534935|4314784|P2|Overall Study|Lost to Follow-up|1
1318273|NCT02534935|4314785|P1|Overall Study|Lost to Follow-up|0
1318274|NCT02534935|4314783|P3|Overall Study|Adverse Event|0
1318275|NCT02534935|4314784|P2|Overall Study|Adverse Event|2
1318276|NCT02534935|4314785|P1|Overall Study|Adverse Event|0
1318277|NCT02534935|4314783|P3|Overall Study|No longer meets the eligibility criteria|0
1318278|NCT02534935|4314784|P2|Overall Study|No longer meets the eligibility criteria|3
1318279|NCT02534935|4314785|P1|Overall Study|No longer meets the eligibility criteria|0
1318280|NCT02534935|4314783|P3|Overall Study|Withdrawal by Subject|3
1318281|NCT02534935|4314784|P2|Overall Study|Withdrawal by Subject|3
1318282|NCT02534935|4314785|P1|Overall Study|Withdrawal by Subject|0
1318283|NCT02534935|4314783|P3|Overall Study|No longer willing to participate|1
1318284|NCT02534935|4314784|P2|Overall Study|No longer willing to participate|1
1318285|NCT02534935|4314785|P1|Overall Study|No longer willing to participate|0
1318286|NCT02534883|4314945|P2|Overall Study|Early Termination|3
1318287|NCT02534883|4314946|P1|Overall Study|Early Termination|8
1318288|NCT02534493|4314962|P1|Overall Study|Withdrawal by Subject|1
1318289|NCT02534493|4314962|P1|Overall Study|Lost to Follow-up|1
1318290|NCT02534324|4314973|P2|Overall Study|Adverse Event|0
1318291|NCT02534324|4314974|P1|Overall Study|Adverse Event|1
1318292|NCT02534324|4314973|P2|Overall Study|Lost to Follow-up|7
1318293|NCT02534324|4314974|P1|Overall Study|Lost to Follow-up|20
1318294|NCT02534324|4314973|P2|Overall Study|Protocol Violation|1
1318295|NCT02534324|4314974|P1|Overall Study|Protocol Violation|4
1318296|NCT02533999|4314993|P2|Overall Study|Randomized but intervention not received|1
1318297|NCT02533999|4314994|P1|Overall Study|Randomized but intervention not received|0
1318298|NCT02533999|4314993|P2|Overall Study|Adverse Event|1
1318299|NCT02533999|4314994|P1|Overall Study|Adverse Event|0
1318300|NCT02533999|4314993|P2|Overall Study|Protocol Violation|0
1318301|NCT02533999|4314994|P1|Overall Study|Protocol Violation|3
1318302|NCT02533999|4314993|P2|Overall Study|Lost to Follow-up|5
1318303|NCT02533999|4314994|P1|Overall Study|Lost to Follow-up|3
1318304|NCT02533570|4315026|P3|Overall Study|Adverse Event|1
1318305|NCT02533570|4315027|P2|Overall Study|Adverse Event|1
1318306|NCT02533570|4315028|P1|Overall Study|Adverse Event|0
1318307|NCT02533531|4315039|P1|Overall Study|Device did not turn on|1
1318308|NCT02533401|4315102|P1|Overall Study|Violation of Selection Criteria|1
1318309|NCT02533401|4315102|P1|Overall Study|Lost to Follow-up|1
1318310|NCT02533401|4315102|P1|Overall Study|Insufficient Response/Progressed Disease|1
1318311|NCT02533401|4315102|P1|Overall Study|Death|5
1318312|NCT02533401|4315102|P1|Overall Study|Adverse Event/Intercurrent Disease|3
1318313|NCT02533258|4315110|P1|Overall Study|Lack of Efficacy|2
1318314|NCT02533258|4315110|P1|Overall Study|Progression of pleural effusion|1
1318315|NCT02533258|4315110|P1|Overall Study|Economic factor|1
1318316|NCT02533258|4315110|P1|Overall Study|Other|1
1318317|NCT02533258|4315110|P1|Overall Study|Death|2
1318318|NCT02533258|4315110|P1|Overall Study|Adverse Event|1
1318319|NCT02532374|4315213|P1|Overall Study|Physician Decision|1
1318320|NCT02532374|4315213|P1|Overall Study|Withdrawal by Subject|1
1318321|NCT02532179|4315237|P1|Overall Study|Subject received depot steroid injection|1
1318322|NCT02532179|4315237|P1|Overall Study|Pregnancy|1
1318323|NCT02532179|4315237|P1|Overall Study|Lost to Follow-up|1
1318324|NCT02531698|4315273|P2|Overall Study|Lost to Follow-up|0
1318325|NCT02531698|4315274|P1|Overall Study|Lost to Follow-up|1
1318326|NCT02531698|4315273|P2|Overall Study|Protocol Violation|0
1318327|NCT02531698|4315274|P1|Overall Study|Protocol Violation|2
1318328|NCT02531698|4315273|P2|Overall Study|Withdrawal by Subject|1
1318329|NCT02531698|4315274|P1|Overall Study|Withdrawal by Subject|6
1318330|NCT02531698|4315273|P2|Overall Study|Adverse Event|1
1318331|NCT02531698|4315274|P1|Overall Study|Adverse Event|2
1318332|NCT02531646|4315521|P3|Overall Study|equip. image processing issue|0
1318333|NCT02531646|4315522|P2|Overall Study|equip. image processing issue|1
1318334|NCT02531646|4315523|P1|Overall Study|equip. image processing issue|5
1318335|NCT02531373|4315546|P9|Overall Study|Withdrawal by Subject|0
1318336|NCT02531373|4315547|P8|Overall Study|Withdrawal by Subject|0
1318337|NCT02531373|4315548|P7|Overall Study|Withdrawal by Subject|0
1318338|NCT02531373|4315549|P6|Overall Study|Withdrawal by Subject|0
1318339|NCT02531373|4315550|P5|Overall Study|Withdrawal by Subject|3
1318340|NCT02531373|4315551|P4|Overall Study|Withdrawal by Subject|0
1318341|NCT02531373|4315552|P3|Overall Study|Withdrawal by Subject|0
1318342|NCT02531373|4315553|P2|Overall Study|Withdrawal by Subject|0
1318343|NCT02531373|4315554|P1|Overall Study|Withdrawal by Subject|0
1318344|NCT02531373|4315546|P9|Overall Study|Withdrawal by Parent/Guardian|3
1318345|NCT02531373|4315547|P8|Overall Study|Withdrawal by Parent/Guardian|1
1318346|NCT02531373|4315548|P7|Overall Study|Withdrawal by Parent/Guardian|4
1318347|NCT02531373|4315549|P6|Overall Study|Withdrawal by Parent/Guardian|3
1318348|NCT02531373|4315550|P5|Overall Study|Withdrawal by Parent/Guardian|0
1318349|NCT02531373|4315551|P4|Overall Study|Withdrawal by Parent/Guardian|0
1318350|NCT02531373|4315552|P3|Overall Study|Withdrawal by Parent/Guardian|0
1318351|NCT02531373|4315553|P2|Overall Study|Withdrawal by Parent/Guardian|0
1318352|NCT02531373|4315554|P1|Overall Study|Withdrawal by Parent/Guardian|0
1318353|NCT02531373|4315546|P9|Overall Study|Protocol Violation|1
1318354|NCT02531373|4315547|P8|Overall Study|Protocol Violation|0
1318355|NCT02531373|4315548|P7|Overall Study|Protocol Violation|1
1318356|NCT02531373|4315549|P6|Overall Study|Protocol Violation|1
1318357|NCT02531373|4315550|P5|Overall Study|Protocol Violation|0
1318358|NCT02531373|4315551|P4|Overall Study|Protocol Violation|0
1318359|NCT02531373|4315552|P3|Overall Study|Protocol Violation|0
1318360|NCT02531373|4315553|P2|Overall Study|Protocol Violation|0
1318361|NCT02531373|4315554|P1|Overall Study|Protocol Violation|0
1318362|NCT02531373|4315546|P9|Overall Study|Physician Decision|0
1318363|NCT02531373|4315547|P8|Overall Study|Physician Decision|0
1318364|NCT02531373|4315548|P7|Overall Study|Physician Decision|0
1318365|NCT02531373|4315549|P6|Overall Study|Physician Decision|1
1318366|NCT02531373|4315550|P5|Overall Study|Physician Decision|2
1318367|NCT02531373|4315551|P4|Overall Study|Physician Decision|0
1318368|NCT02531373|4315552|P3|Overall Study|Physician Decision|0
1318369|NCT02531373|4315553|P2|Overall Study|Physician Decision|0
1318370|NCT02531373|4315554|P1|Overall Study|Physician Decision|0
1318371|NCT02531373|4315546|P9|Overall Study|Lost to Follow-up|0
1318372|NCT02531373|4315547|P8|Overall Study|Lost to Follow-up|0
1318373|NCT02531373|4315548|P7|Overall Study|Lost to Follow-up|2
1318374|NCT02531373|4315549|P6|Overall Study|Lost to Follow-up|2
1318375|NCT02531373|4315550|P5|Overall Study|Lost to Follow-up|0
1318376|NCT02531373|4315551|P4|Overall Study|Lost to Follow-up|0
1318377|NCT02531373|4315552|P3|Overall Study|Lost to Follow-up|0
1318378|NCT02531373|4315553|P2|Overall Study|Lost to Follow-up|0
1318379|NCT02531373|4315554|P1|Overall Study|Lost to Follow-up|0
1318380|NCT02531373|4315546|P9|Overall Study|Lack of Efficacy|5
1318381|NCT02531373|4315547|P8|Overall Study|Lack of Efficacy|8
1318382|NCT02531373|4315548|P7|Overall Study|Lack of Efficacy|4
1318383|NCT02531373|4315549|P6|Overall Study|Lack of Efficacy|2
1318384|NCT02531373|4315550|P5|Overall Study|Lack of Efficacy|3
1318385|NCT02531373|4315551|P4|Overall Study|Lack of Efficacy|0
1318386|NCT02531373|4315552|P3|Overall Study|Lack of Efficacy|0
1318387|NCT02531373|4315553|P2|Overall Study|Lack of Efficacy|0
1318388|NCT02531373|4315554|P1|Overall Study|Lack of Efficacy|0
1318389|NCT02530671|4315617|P2|Overall Study|Withdrawal by Subject|0
1318390|NCT02530671|4315618|P1|Overall Study|Withdrawal by Subject|1
1318391|NCT02530671|4315617|P2|Overall Study|Lost to Follow-up|0
1318392|NCT02530671|4315618|P1|Overall Study|Lost to Follow-up|2
1318393|NCT02530125|4315679|P1|Followed for Survival for 2 Years|Early termination of study|3
1318394|NCT02530125|4315679|P1|Completed Treatment|Early termination of study|1
1318395|NCT02529995|4315693|P2|Part B|Discontinued Study|5
1318396|NCT02529995|4315694|P1|Part B|Discontinued Study|6
1318397|NCT02529995|4315693|P2|Part B|Ongoing Study at Data Cut-off|7
1318398|NCT02529995|4315694|P1|Part B|Ongoing Study at Data Cut-off|0
1318399|NCT02529995|4315693|P2|Part A|Discontinued Study|0
1318400|NCT02529995|4315694|P1|Part A|Discontinued Study|1
1318401|NCT02529995|4315693|P2|Part A|Ongoing Study at Data Cut-off|16
1318402|NCT02529995|4315694|P1|Part A|Ongoing Study at Data Cut-off|14
1318403|NCT02529488|4315728|P1|Overall Study|Death|3
1318404|NCT02529488|4315728|P1|Overall Study|Adverse Event|1
1318405|NCT02528331|4315757|P1|Overall Study|Withdrawal by Subject|2
1318406|NCT02528305|4315764|P1|Overall Study|Physician Decision|1
1318407|NCT02528305|4315764|P1|Overall Study|Adverse Event|1
1318408|NCT02528305|4315764|P1|Overall Study|Withdrawal by Subject|1
1318409|NCT02527161|4315817|P1|Overall Study|Consent violation|4
1318410|NCT02527161|4315817|P1|Overall Study|MRI contraindication|2
1318411|NCT02527161|4315817|P1|Overall Study|Delay in or unfit for surgery|5
1318412|NCT02527161|4315817|P1|Overall Study|Exclusion RA diagnosis|1
1318413|NCT02527161|4315817|P1|Overall Study|Exclusion for excessive deformity|1
1318414|NCT02527161|4315817|P1|Overall Study|Exclusion for BMI|2
1318415|NCT02527161|4315817|P1|Overall Study|Shape Match not used in surgery|2
1318416|NCT02527161|4315817|P1|Overall Study|Withdrawal by Subject|6
1318417|NCT02527161|4315817|P1|Overall Study|Failed MRI|39
1318418|NCT02527148|4315836|P2|Overall Study|Did not receive study intervention|0
1318419|NCT02527148|4315837|P1|Overall Study|Did not receive study intervention|1
1318420|NCT02526550|4315855|P1|Overall Study|Lost to Follow-up|1
1318421|NCT02526524|4315867|P6|Overall Study|Sponsor Decision|0
1318422|NCT02526524|4315868|P5|Overall Study|Sponsor Decision|0
1318423|NCT02526524|4315869|P4|Overall Study|Sponsor Decision|0
1318424|NCT02526524|4315870|P3|Overall Study|Sponsor Decision|0
1318425|NCT02526524|4315871|P2|Overall Study|Sponsor Decision|0
1318426|NCT02526524|4315872|P1|Overall Study|Sponsor Decision|1
1318427|NCT02526524|4315867|P6|Overall Study|Physician Decision|0
1318428|NCT02526524|4315868|P5|Overall Study|Physician Decision|1
1318429|NCT02526524|4315869|P4|Overall Study|Physician Decision|0
1318430|NCT02526524|4315870|P3|Overall Study|Physician Decision|0
1318431|NCT02526524|4315871|P2|Overall Study|Physician Decision|0
1318432|NCT02526524|4315872|P1|Overall Study|Physician Decision|0
1318433|NCT02526524|4315867|P6|Overall Study|Loss of Glucose Control|0
1318434|NCT02526524|4315868|P5|Overall Study|Loss of Glucose Control|2
1318435|NCT02526524|4315869|P4|Overall Study|Loss of Glucose Control|0
1318436|NCT02526524|4315870|P3|Overall Study|Loss of Glucose Control|3
1318437|NCT02526524|4315871|P2|Overall Study|Loss of Glucose Control|0
1318438|NCT02526524|4315872|P1|Overall Study|Loss of Glucose Control|0
1318439|NCT02526524|4315867|P6|Overall Study|Protocol Violation|3
1318440|NCT02526524|4315868|P5|Overall Study|Protocol Violation|4
1318441|NCT02526524|4315869|P4|Overall Study|Protocol Violation|3
1318442|NCT02526524|4315870|P3|Overall Study|Protocol Violation|5
1318443|NCT02526524|4315871|P2|Overall Study|Protocol Violation|1
1318444|NCT02526524|4315872|P1|Overall Study|Protocol Violation|3
1318445|NCT02526524|4315867|P6|Overall Study|Lost to Follow-up|5
1318446|NCT02526524|4315868|P5|Overall Study|Lost to Follow-up|2
1318447|NCT02526524|4315869|P4|Overall Study|Lost to Follow-up|1
1318448|NCT02526524|4315870|P3|Overall Study|Lost to Follow-up|8
1318449|NCT02526524|4315871|P2|Overall Study|Lost to Follow-up|3
1318450|NCT02526524|4315872|P1|Overall Study|Lost to Follow-up|2
1318451|NCT02526524|4315867|P6|Overall Study|Adverse Event|8
1318452|NCT02526524|4315868|P5|Overall Study|Adverse Event|6
1318453|NCT02526524|4315869|P4|Overall Study|Adverse Event|2
1318454|NCT02526524|4315870|P3|Overall Study|Adverse Event|4
1318455|NCT02526524|4315871|P2|Overall Study|Adverse Event|2
1318456|NCT02526524|4315872|P1|Overall Study|Adverse Event|3
1318457|NCT02526524|4315867|P6|Overall Study|Withdrawal by Subject|5
1318458|NCT02526524|4315868|P5|Overall Study|Withdrawal by Subject|9
1318459|NCT02526524|4315869|P4|Overall Study|Withdrawal by Subject|1
1318460|NCT02526524|4315870|P3|Overall Study|Withdrawal by Subject|6
1318461|NCT02526524|4315871|P2|Overall Study|Withdrawal by Subject|3
1318462|NCT02526524|4315872|P1|Overall Study|Withdrawal by Subject|3
1318463|NCT02526290|4315886|P1|Overall Study|Physician Decision|1
1318464|NCT02526290|4315886|P1|Overall Study|Withdrawal by Subject|4
1318465|NCT02526290|4315886|P1|Overall Study|Adverse Event|3
1318466|NCT02525094|4315971|P2|Overall Study|Not Treated|1
1318467|NCT02525094|4315972|P1|Overall Study|Not Treated|1
1318468|NCT02525094|4315971|P2|Overall Study|Withdrawal by Subject|6
1318469|NCT02525094|4315972|P1|Overall Study|Withdrawal by Subject|5
1318470|NCT02525094|4315971|P2|Overall Study|Lost to Follow-up|1
1318471|NCT02525094|4315972|P1|Overall Study|Lost to Follow-up|2
1318472|NCT02524665|4315999|P1|Overall Study|Lost to Follow-up|1
1318473|NCT02524288|4316050|P1|Overall Study|Physician Decision|2
1318474|NCT02524288|4316050|P1|Overall Study|Pregnancy|22
1318475|NCT02524288|4316050|P1|Overall Study|Withdrawal by Subject|76
1318476|NCT02524288|4316050|P1|Overall Study|Subject Moved|32
1318477|NCT02524288|4316050|P1|Overall Study|Study Terminated By Sponsor|1417
1318478|NCT02524288|4316050|P1|Overall Study|Site Discontinued Study Participation|1
1318479|NCT02524288|4316050|P1|Overall Study|Screen Failure|2
1318480|NCT02524288|4316050|P1|Overall Study|Protocol Violation|6
1318481|NCT02524288|4316050|P1|Overall Study|Pregnancy Wish|6
1318482|NCT02524288|4316050|P1|Overall Study|Non-Compliance With Study Drug|14
1318483|NCT02524288|4316050|P1|Overall Study|Non-Compliance With Protocol|32
1318484|NCT02524288|4316050|P1|Overall Study|Lost to Follow-up|216
1318485|NCT02524288|4316050|P1|Overall Study|Adverse Event|115
1318486|NCT02524158|4316060|P2|6-month Assessment|Lost to Follow-up|20
1318487|NCT02524158|4316061|P1|6-month Assessment|Lost to Follow-up|21
1318488|NCT02524158|4316060|P2|6-month Assessment|Withdrawal by Subject|1
1318489|NCT02524158|4316061|P1|6-month Assessment|Withdrawal by Subject|1
1318490|NCT02524158|4316060|P2|12-weeks Assessment|Lost to Follow-up|12
1318491|NCT02524158|4316061|P1|12-weeks Assessment|Lost to Follow-up|18
1318492|NCT02524158|4316060|P2|12-weeks Assessment|Withdrawal by Subject|1
1318493|NCT02524158|4316061|P1|12-weeks Assessment|Withdrawal by Subject|1
1318494|NCT02522624|4316128|P2|Overall Study|Technical failure|0
1318495|NCT02522624|4316129|P1|Overall Study|Technical failure|1
1318496|NCT02522286|4316149|P4|Overall Study|Withdrawal by Subject|3
1318497|NCT02522286|4316150|P3|Overall Study|Withdrawal by Subject|0
1318498|NCT02522286|4316151|P2|Overall Study|Withdrawal by Subject|0
1318499|NCT02522286|4316152|P1|Overall Study|Withdrawal by Subject|3
1318500|NCT02520726|4316180|P2|Overall Study|Lost to Follow-up|2
1318501|NCT02520726|4316181|P1|Overall Study|Lost to Follow-up|3
1318502|NCT02520089|4316195|P2|Overall Study|Lost to Follow-up|4
1318503|NCT02520089|4316196|P1|Overall Study|Lost to Follow-up|3
1318504|NCT02519855|4316206|P2|Overall Study|Lost to Follow-up|3
1318505|NCT02519855|4316207|P1|Overall Study|Lost to Follow-up|3
1318506|NCT02519855|4316206|P2|Overall Study|Adverse Event|1
1318507|NCT02519855|4316207|P1|Overall Study|Adverse Event|0
1318508|NCT02519842|4316225|P3|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
1318509|NCT02519842|4316226|P2|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
1318510|NCT02519842|4316227|P1|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
1318511|NCT02519842|4316225|P3|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
1318512|NCT02519842|4316226|P2|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
1318513|NCT02519842|4316227|P1|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
1318514|NCT02519842|4316225|P3|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
1318515|NCT02519842|4316226|P2|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
1318516|NCT02519842|4316227|P1|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
1318517|NCT02519842|4316225|P3|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
1318518|NCT02519842|4316226|P2|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
1318519|NCT02519842|4316227|P1|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
1318520|NCT02519842|4316225|P3|Optional Extension: Cycles 2-6|Death|1
1318521|NCT02519842|4316226|P2|Optional Extension: Cycles 2-6|Death|0
1318522|NCT02519842|4316227|P1|Optional Extension: Cycles 2-6|Death|0
1318523|NCT02519842|4316225|P3|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
1318524|NCT02519842|4316226|P2|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
1318525|NCT02519842|4316227|P1|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
1318526|NCT02519842|4316225|P3|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
1318527|NCT02519842|4316226|P2|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
1318528|NCT02519842|4316227|P1|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
1318529|NCT02519842|4316225|P3|Optional Extension: Cycles 2-6|Adverse Event|1
1318530|NCT02519842|4316226|P2|Optional Extension: Cycles 2-6|Adverse Event|0
1318531|NCT02519842|4316227|P1|Optional Extension: Cycles 2-6|Adverse Event|0
1318532|NCT02519842|4316225|P3|Optional Extension: Cycles 2-6|Physician Decision|5
1318533|NCT02519842|4316226|P2|Optional Extension: Cycles 2-6|Physician Decision|0
1318534|NCT02519842|4316227|P1|Optional Extension: Cycles 2-6|Physician Decision|0
1318535|NCT02519842|4316225|P3|Base Study: Cycle 1|Non-compliance with Study Drug|0
1318536|NCT02519842|4316226|P2|Base Study: Cycle 1|Non-compliance with Study Drug|1
1318537|NCT02519842|4316227|P1|Base Study: Cycle 1|Non-compliance with Study Drug|0
1318538|NCT02519842|4316225|P3|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
1318539|NCT02519842|4316226|P2|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
1318540|NCT02519842|4316227|P1|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
1318541|NCT02519842|4316225|P3|Base Study: Cycle 1|Adverse Event|0
1318542|NCT02519842|4316226|P2|Base Study: Cycle 1|Adverse Event|0
1318543|NCT02519842|4316227|P1|Base Study: Cycle 1|Adverse Event|1
1318544|NCT02519842|4316225|P3|Base Study: Cycle 1|Screening Failure|0
1318545|NCT02519842|4316226|P2|Base Study: Cycle 1|Screening Failure|1
1318546|NCT02519842|4316227|P1|Base Study: Cycle 1|Screening Failure|1
1318547|NCT02519712|4316246|P1|Overall Study|Accruals are donors|2
1318548|NCT02519712|4316246|P1|Overall Study|Disease Progression|1
1318549|NCT02519712|4316246|P1|Overall Study|Disease Relapse|1
1318550|NCT02519595|4316253|P3|Overall Study|Protocol Violation|16
1318551|NCT02519595|4316254|P2|Overall Study|Protocol Violation|22
1318552|NCT02519595|4316255|P1|Overall Study|Protocol Violation|8
1318553|NCT02518048|4316286|P1|Overall Study|Withdrawal by Subject|1
1318554|NCT02517515|4316315|P2|Overall Study|Not Specified|0
1318555|NCT02517515|4316316|P1|Overall Study|Not Specified|1
1318556|NCT02517515|4316315|P2|Overall Study|Lost to Follow-up|0
1318557|NCT02517515|4316316|P1|Overall Study|Lost to Follow-up|1
1318558|NCT02517515|4316315|P2|Overall Study|Withdrew Consent|1
1318559|NCT02517515|4316316|P1|Overall Study|Withdrew Consent|0
1318560|NCT02517515|4316315|P2|Overall Study|Adverse Event|1
1318561|NCT02517515|4316316|P1|Overall Study|Adverse Event|0
1318562|NCT02517463|4316333|P2|Overall Study|Lost to Follow-up|2
1318563|NCT02517463|4316334|P1|Overall Study|Lost to Follow-up|5
1318564|NCT02516410|4316380|P2|Overall Study|Withdrawal by Subject|1
1318565|NCT02516410|4316381|P1|Overall Study|Withdrawal by Subject|0
1318566|NCT02516410|4316380|P2|Overall Study|Adverse Event|1
1318567|NCT02516410|4316381|P1|Overall Study|Adverse Event|0
1318568|NCT02516306|4316410|P2|Period 2: Day 8 - 91|Protocol Violation|2
1318569|NCT02516306|4316411|P1|Period 2: Day 8 - 91|Protocol Violation|1
1318570|NCT02516202|4316420|P3|Overall Study|Stopped Follow-up|1
1318571|NCT02516202|4316421|P2|Overall Study|Stopped Follow-up|0
1318572|NCT02516202|4316422|P1|Overall Study|Stopped Follow-up|0
1318573|NCT02516202|4316420|P3|Overall Study|Lost to Follow-up|1
1318574|NCT02516202|4316421|P2|Overall Study|Lost to Follow-up|1
1318575|NCT02516202|4316422|P1|Overall Study|Lost to Follow-up|1
1318576|NCT02516202|4316420|P3|Overall Study|Withdrawal by Subject|1
1318577|NCT02516202|4316421|P2|Overall Study|Withdrawal by Subject|0
1318578|NCT02516202|4316422|P1|Overall Study|Withdrawal by Subject|1
1318579|NCT02516163|4316448|P1|Overall Study|MRI contraindication exclusion|6
1318580|NCT02516163|4316448|P1|Overall Study|Data not recorded|2
1318581|NCT02516163|4316448|P1|Overall Study|Use of incorrect measurement technique|5
1318582|NCT02516163|4316448|P1|Overall Study|Unfit/delay in surgery|3
1318583|NCT02516163|4316448|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
1318584|NCT02516163|4316448|P1|Overall Study|Withdrawal by Subject|1
1318585|NCT02516098|4316462|P2|Period 2|Withdrawal by Subject|1
1318586|NCT02516098|4316463|P1|Period 2|Withdrawal by Subject|0
1318587|NCT02516098|4316462|P2|Washout After Period 1|Adverse Event|1
1318588|NCT02516098|4316463|P1|Washout After Period 1|Adverse Event|0
1318589|NCT02516098|4316462|P2|Period 1|Protocol Violation|0
1318590|NCT02516098|4316463|P1|Period 1|Protocol Violation|1
1318591|NCT02515994|4316477|P2|Overall Study|Withdrawal by Subject|0
1318592|NCT02515994|4316478|P1|Overall Study|Withdrawal by Subject|2
1318593|NCT02515994|4316477|P2|Overall Study|Adverse Event|1
1318594|NCT02515994|4316478|P1|Overall Study|Adverse Event|3
1318595|NCT02515994|4316477|P2|Overall Study|No Longer Meets Eligibility Criteria|1
1318596|NCT02515994|4316478|P1|Overall Study|No Longer Meets Eligibility Criteria|2
1318597|NCT02515994|4316477|P2|Overall Study|Protocol Violation|5
1318598|NCT02515994|4316478|P1|Overall Study|Protocol Violation|3
1318599|NCT02515331|4316508|P3|Overall Study|Adverse Event|0
1318600|NCT02515331|4316509|P2|Overall Study|Adverse Event|0
1318601|NCT02515331|4316510|P1|Overall Study|Adverse Event|2
1318602|NCT02515331|4316508|P3|Overall Study|Protocol deviation|3
1318603|NCT02515331|4316509|P2|Overall Study|Protocol deviation|0
1318604|NCT02515331|4316510|P1|Overall Study|Protocol deviation|0
1318605|NCT02515331|4316508|P3|Overall Study|Withdrawal by Subject|1
1318606|NCT02515331|4316509|P2|Overall Study|Withdrawal by Subject|0
1318607|NCT02515331|4316510|P1|Overall Study|Withdrawal by Subject|0
1318608|NCT02515279|4316531|P1|Overall Study|Other|22
1318609|NCT02515279|4316531|P1|Overall Study|End-of-treatment visit not attended|17
1318610|NCT02515279|4316531|P1|Overall Study|Withdrawal by Subject|18
1318611|NCT02515279|4316531|P1|Overall Study|Lost to Follow-up|9
1318612|NCT02515279|4316531|P1|Overall Study|Lack of Efficacy|31
1318613|NCT02515279|4316531|P1|Overall Study|Adverse Event|7
1318614|NCT02515045|4316550|P3|Overall Study|Lost to Follow-up|1
1318615|NCT02515045|4316551|P2|Overall Study|Lost to Follow-up|1
1318616|NCT02515045|4316552|P1|Overall Study|Lost to Follow-up|0
1318617|NCT02515045|4316550|P3|Overall Study|Adverse Event|3
1318618|NCT02515045|4316551|P2|Overall Study|Adverse Event|3
1318619|NCT02515045|4316552|P1|Overall Study|Adverse Event|0
1318620|NCT02514772|4316589|P2|Overall Study|Withdrawal by Subject|1
1318621|NCT02514772|4316590|P1|Overall Study|Withdrawal by Subject|2
1318622|NCT02514772|4316589|P2|Overall Study|Death|1
1318623|NCT02514772|4316590|P1|Overall Study|Death|0
1318624|NCT02514772|4316589|P2|Overall Study|Adverse Event|0
1318625|NCT02514772|4316590|P1|Overall Study|Adverse Event|1
1318626|NCT02514473|4316604|P2|Overall Study|Other|1
1318627|NCT02514473|4316605|P1|Overall Study|Other|1
1318628|NCT02514473|4316604|P2|Overall Study|Lost to Follow-up|1
1318629|NCT02514473|4316605|P1|Overall Study|Lost to Follow-up|0
1318630|NCT02514473|4316604|P2|Overall Study|Withdrawal by Subject|1
1318631|NCT02514473|4316605|P1|Overall Study|Withdrawal by Subject|2
1318632|NCT02514473|4316604|P2|Overall Study|Adverse Event|2
1318633|NCT02514473|4316605|P1|Overall Study|Adverse Event|0
1318634|NCT02513771|4316662|P2|Overall Study|Not being able to get to clinic|0
1318635|NCT02513771|4316663|P1|Overall Study|Not being able to get to clinic|1
1318636|NCT02513771|4316662|P2|Overall Study|Lost to Follow-up|1
1318637|NCT02513771|4316663|P1|Overall Study|Lost to Follow-up|1
1318638|NCT02513550|4316702|P3|Overall Study|Death|2
1318639|NCT02513550|4316703|P2|Overall Study|Death|0
1318640|NCT02513550|4316704|P1|Overall Study|Death|1
1318641|NCT02513550|4316702|P3|Overall Study|Due to personal business|1
1318642|NCT02513550|4316703|P2|Overall Study|Due to personal business|0
1318643|NCT02513550|4316704|P1|Overall Study|Due to personal business|2
1318644|NCT02513550|4316702|P3|Overall Study|Met exclusion criteria and was not dosed|1
1318645|NCT02513550|4316703|P2|Overall Study|Met exclusion criteria and was not dosed|0
1318646|NCT02513550|4316704|P1|Overall Study|Met exclusion criteria and was not dosed|0
1318647|NCT02513550|4316702|P3|Overall Study|Site terminated by sponsor|3
1318648|NCT02513550|4316703|P2|Overall Study|Site terminated by sponsor|1
1318649|NCT02513550|4316704|P1|Overall Study|Site terminated by sponsor|1
1318650|NCT02513550|4316702|P3|Overall Study|Physician Decision|4
1318651|NCT02513550|4316703|P2|Overall Study|Physician Decision|0
1318652|NCT02513550|4316704|P1|Overall Study|Physician Decision|2
1318653|NCT02513550|4316702|P3|Overall Study|Protocol Violation|4
1318654|NCT02513550|4316703|P2|Overall Study|Protocol Violation|1
1318655|NCT02513550|4316704|P1|Overall Study|Protocol Violation|1
1318656|NCT02513550|4316702|P3|Overall Study|Lack of Efficacy|6
1318657|NCT02513550|4316703|P2|Overall Study|Lack of Efficacy|5
1318658|NCT02513550|4316704|P1|Overall Study|Lack of Efficacy|4
1318659|NCT02513550|4316702|P3|Overall Study|Lost to Follow-up|11
1318660|NCT02513550|4316703|P2|Overall Study|Lost to Follow-up|7
1318661|NCT02513550|4316704|P1|Overall Study|Lost to Follow-up|9
1318662|NCT02513550|4316702|P3|Overall Study|Adverse Event|17
1318663|NCT02513550|4316703|P2|Overall Study|Adverse Event|13
1318664|NCT02513550|4316704|P1|Overall Study|Adverse Event|5
1318665|NCT02513550|4316702|P3|Overall Study|Withdrawal by Subject|25
1318666|NCT02513550|4316703|P2|Overall Study|Withdrawal by Subject|11
1318667|NCT02513550|4316704|P1|Overall Study|Withdrawal by Subject|11
1318668|NCT02513160|4316771|P4|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
1318669|NCT02513160|4316772|P3|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
1318670|NCT02513160|4316773|P2|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
1318671|NCT02513160|4316774|P1|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
1318672|NCT02513160|4316771|P4|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
1318673|NCT02513160|4316772|P3|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
1318674|NCT02513160|4316773|P2|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
1318675|NCT02513160|4316774|P1|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
1318676|NCT02513160|4316771|P4|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
1318677|NCT02513160|4316772|P3|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
1318678|NCT02513160|4316773|P2|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
1318679|NCT02513160|4316774|P1|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
1318680|NCT02513160|4316771|P4|Treatment Period (Day 0 to Week 6)|Noncompliance|0
1318681|NCT02513160|4316772|P3|Treatment Period (Day 0 to Week 6)|Noncompliance|0
1318682|NCT02513160|4316773|P2|Treatment Period (Day 0 to Week 6)|Noncompliance|0
1318683|NCT02513160|4316774|P1|Treatment Period (Day 0 to Week 6)|Noncompliance|1
1318684|NCT02513160|4316771|P4|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
1318685|NCT02513160|4316772|P3|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
1318686|NCT02513160|4316773|P2|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
1318687|NCT02513160|4316774|P1|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
1318688|NCT02513160|4316771|P4|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
1318689|NCT02513160|4316772|P3|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
1318690|NCT02513160|4316773|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
1318691|NCT02513160|4316774|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
1318692|NCT02513160|4316771|P4|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
1318693|NCT02513160|4316772|P3|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
1318694|NCT02513160|4316773|P2|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
1318695|NCT02513160|4316774|P1|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
1318696|NCT02513160|4316771|P4|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
1318697|NCT02513160|4316772|P3|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
1318698|NCT02513160|4316773|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
1318699|NCT02513160|4316774|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
1318700|NCT02513160|4316771|P4|Run-In Period (Days -14 to Day -1)|Adverse Event|0
1318701|NCT02513160|4316772|P3|Run-In Period (Days -14 to Day -1)|Adverse Event|0
1318702|NCT02513160|4316773|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|0
1318703|NCT02513160|4316774|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|4
1318704|NCT02513160|4316771|P4|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
1318705|NCT02513160|4316772|P3|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
1318706|NCT02513160|4316773|P2|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
1318707|NCT02513160|4316774|P1|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
1318708|NCT02513160|4316771|P4|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
1318709|NCT02513160|4316772|P3|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
1318710|NCT02513160|4316773|P2|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
1318711|NCT02513160|4316774|P1|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
1318712|NCT02513160|4316771|P4|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
1318713|NCT02513160|4316772|P3|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
1318714|NCT02513160|4316773|P2|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
1318715|NCT02513160|4316774|P1|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
1318716|NCT02513095|4316811|P2|Overall Study|Stampede resulted in transfers out of ER|16
1318717|NCT02513095|4316812|P1|Overall Study|Stampede resulted in transfers out of ER|14
1318718|NCT02512861|4316854|P2|Overall Study|Withdrawal by Subject|1
1318719|NCT02512861|4316855|P1|Overall Study|Withdrawal by Subject|0
1318720|NCT02512861|4316854|P2|Overall Study|Physician Decision|1
1318721|NCT02512861|4316855|P1|Overall Study|Physician Decision|3
1318722|NCT02512861|4316854|P2|Overall Study|Protocol Violation|7
1318723|NCT02512861|4316855|P1|Overall Study|Protocol Violation|3
1318724|NCT02511782|4317002|P3|Overall Study|Withdrawal by Subject|0
1318725|NCT02511782|4317003|P2|Overall Study|Withdrawal by Subject|0
1318726|NCT02511782|4317004|P1|Overall Study|Withdrawal by Subject|1
1318727|NCT02511431|4317033|P6|Treatment|Lost to Follow-up|1
1318728|NCT02511431|4317034|P5|Treatment|Lost to Follow-up|0
1318729|NCT02511431|4317035|P4|Treatment|Lost to Follow-up|0
1318730|NCT02511431|4317036|P3|Treatment|Lost to Follow-up|1
1318731|NCT02511431|4317037|P2|Treatment|Lost to Follow-up|0
1318732|NCT02511431|4317038|P1|Treatment|Lost to Follow-up|0
1318733|NCT02510820|4317058|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
1318734|NCT02510820|4317059|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1318735|NCT02510820|4317058|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
1318736|NCT02510820|4317059|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
1318737|NCT02510014|4317099|P2|Treatment Period|Incarceration, pregnancy, misc|5
1318738|NCT02510014|4317100|P1|Treatment Period|Incarceration, pregnancy, misc|29
1318739|NCT02510014|4317099|P2|Treatment Period|Protocol Violation|4
1318740|NCT02510014|4317100|P1|Treatment Period|Protocol Violation|4
1318741|NCT02510014|4317099|P2|Treatment Period|Withdrawn by the investigator|1
1318742|NCT02510014|4317100|P1|Treatment Period|Withdrawn by the investigator|7
1318743|NCT02510014|4317099|P2|Treatment Period|Withdrawal by Subject|24
1318744|NCT02510014|4317100|P1|Treatment Period|Withdrawal by Subject|67
1318745|NCT02510014|4317099|P2|Treatment Period|Physician Decision|0
1318746|NCT02510014|4317100|P1|Treatment Period|Physician Decision|5
1318747|NCT02510014|4317099|P2|Treatment Period|Lost to Follow-up|19
1318748|NCT02510014|4317100|P1|Treatment Period|Lost to Follow-up|80
1318749|NCT02510014|4317099|P2|Treatment Period|Withdrawal symptoms|0
1318750|NCT02510014|4317100|P1|Treatment Period|Withdrawal symptoms|3
1318751|NCT02510014|4317099|P2|Treatment Period|Adverse Event|4
1318752|NCT02510014|4317100|P1|Treatment Period|Adverse Event|11
1318753|NCT02510014|4317099|P2|Run-In Period (Days -14 to Day -1)|Not specified|1
1318754|NCT02510014|4317100|P1|Run-In Period (Days -14 to Day -1)|Not specified|19
1318755|NCT02510014|4317099|P2|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
1318756|NCT02510014|4317100|P1|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
1318757|NCT02510014|4317099|P2|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
1318758|NCT02510014|4317100|P1|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
1318759|NCT02510014|4317099|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
1318760|NCT02510014|4317100|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
1318761|NCT02510014|4317099|P2|Run-In Period (Days -14 to Day -1)|Physician Decision|1
1318762|NCT02510014|4317100|P1|Run-In Period (Days -14 to Day -1)|Physician Decision|0
1318763|NCT02510014|4317099|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
1318764|NCT02510014|4317100|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
1318765|NCT02510014|4317099|P2|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
1318766|NCT02510014|4317100|P1|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
1318767|NCT02510014|4317099|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|1
1318768|NCT02510014|4317100|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|1
1318769|NCT02508194|4317246|P2|Overall Study|Principal Investigator Decision|2
1318770|NCT02508194|4317247|P1|Overall Study|Principal Investigator Decision|1
1318771|NCT02508194|4317246|P2|Overall Study|Error in Randomization|3
1318772|NCT02508194|4317247|P1|Overall Study|Error in Randomization|1
1318773|NCT02508194|4317246|P2|Overall Study|Withdrawal by Subject|18
1318774|NCT02508194|4317247|P1|Overall Study|Withdrawal by Subject|20
1318775|NCT02508194|4317246|P2|Overall Study|Lost to Follow-up|18
1318776|NCT02508194|4317247|P1|Overall Study|Lost to Follow-up|25
1318777|NCT02508194|4317246|P2|Overall Study|Death|3
1318778|NCT02508194|4317247|P1|Overall Study|Death|5
1318779|NCT02507752|4317300|P1|Overall Study|Participant didn't perform visit Week 24|1
1318780|NCT02507752|4317300|P1|Overall Study|Participant didn't perform visit Week 12|1
1318781|NCT02507752|4317300|P1|Overall Study|Infusion reaction at first infusion|1
1318782|NCT02507752|4317300|P1|Overall Study|Lost to Follow-up|7
1318783|NCT02507752|4317300|P1|Overall Study|Protocol Violation|6
1318784|NCT02507752|4317300|P1|Overall Study|Adverse Event|1
1318785|NCT02507375|4317344|P2|Overall Study|Adverse Event|1
1318786|NCT02507375|4317345|P1|Overall Study|Adverse Event|0
1318787|NCT02507375|4317344|P2|Overall Study|Refused treatment|1
1318788|NCT02507375|4317345|P1|Overall Study|Refused treatment|0
1318789|NCT02507375|4317344|P2|Overall Study|Death|1
1318790|NCT02507375|4317345|P1|Overall Study|Death|0
1318791|NCT02507375|4317344|P2|Overall Study|Progressive Disease|5
1318792|NCT02507375|4317345|P1|Overall Study|Progressive Disease|4
1318793|NCT02507219|4317362|P6|Overall Study|Withdrawal by Subject|0
1318794|NCT02507219|4317363|P5|Overall Study|Withdrawal by Subject|1
1318795|NCT02507219|4317364|P4|Overall Study|Withdrawal by Subject|0
1318796|NCT02507219|4317365|P3|Overall Study|Withdrawal by Subject|0
1318797|NCT02507219|4317366|P2|Overall Study|Withdrawal by Subject|0
1318798|NCT02507219|4317367|P1|Overall Study|Withdrawal by Subject|0
1318799|NCT02507219|4317362|P6|Overall Study|Physician Decision|0
1318800|NCT02507219|4317363|P5|Overall Study|Physician Decision|0
1318801|NCT02507219|4317364|P4|Overall Study|Physician Decision|0
1318802|NCT02507219|4317365|P3|Overall Study|Physician Decision|0
1318803|NCT02507219|4317366|P2|Overall Study|Physician Decision|0
1318804|NCT02507219|4317367|P1|Overall Study|Physician Decision|1
1318805|NCT02506881|4317379|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
1318806|NCT02506881|4317380|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
1318807|NCT02506881|4317381|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
1318808|NCT02506881|4317382|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
1318809|NCT02506881|4317379|P4|First Intervention (Day 1)|Withdrawal by Subject|0
1318810|NCT02506881|4317380|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1318811|NCT02506881|4317381|P2|First Intervention (Day 1)|Withdrawal by Subject|0
1318812|NCT02506881|4317382|P1|First Intervention (Day 1)|Withdrawal by Subject|1
1318813|NCT02506881|4317379|P4|First Intervention (Day 1)|Protocol Violation|0
1318814|NCT02506881|4317380|P3|First Intervention (Day 1)|Protocol Violation|1
1318815|NCT02506881|4317381|P2|First Intervention (Day 1)|Protocol Violation|0
1318816|NCT02506881|4317382|P1|First Intervention (Day 1)|Protocol Violation|0
1318817|NCT02506257|4317456|P4|Overall Study|Protocol Violation|0
1318818|NCT02506257|4317457|P3|Overall Study|Protocol Violation|1
1318819|NCT02506257|4317458|P2|Overall Study|Protocol Violation|0
1318820|NCT02506257|4317459|P1|Overall Study|Protocol Violation|0
1318821|NCT02506257|4317456|P4|Overall Study|Adverse Event|0
1318822|NCT02506257|4317457|P3|Overall Study|Adverse Event|3
1318823|NCT02506257|4317458|P2|Overall Study|Adverse Event|2
1318824|NCT02506257|4317459|P1|Overall Study|Adverse Event|0
1318825|NCT02506101|4317491|P2|Overall Study|No enrollment and staff unavailability|0
1318826|NCT02506101|4317492|P1|Overall Study|No enrollment and staff unavailability|1
1318827|NCT02506101|4317491|P2|Overall Study|Transportation issues|0
1318828|NCT02506101|4317492|P1|Overall Study|Transportation issues|1
1318829|NCT02505334|4317508|P2|Extension Treatment Period|Unclassified|0
1318830|NCT02505334|4317509|P1|Extension Treatment Period|Unclassified|3
1318831|NCT02505334|4317508|P2|Extension Treatment Period|Withdrawal by Subject|0
1318832|NCT02505334|4317509|P1|Extension Treatment Period|Withdrawal by Subject|6
1318833|NCT02505334|4317508|P2|Extension Treatment Period|Lack of Efficacy|0
1318834|NCT02505334|4317509|P1|Extension Treatment Period|Lack of Efficacy|4
1318835|NCT02505334|4317508|P2|Extension Treatment Period|Adverse Event|0
1318836|NCT02505334|4317509|P1|Extension Treatment Period|Adverse Event|5
1318837|NCT02505334|4317508|P2|Main Treatment Period|Unclassified|10
1318838|NCT02505334|4317509|P1|Main Treatment Period|Unclassified|4
1318839|NCT02505334|4317508|P2|Main Treatment Period|Withdrawal by Subject|8
1318840|NCT02505334|4317509|P1|Main Treatment Period|Withdrawal by Subject|1
1318841|NCT02505334|4317508|P2|Main Treatment Period|Protocol Violation|1
1318842|NCT02505334|4317509|P1|Main Treatment Period|Protocol Violation|0
1318843|NCT02505334|4317508|P2|Main Treatment Period|Lack of Efficacy|17
1318844|NCT02505334|4317509|P1|Main Treatment Period|Lack of Efficacy|7
1318845|NCT02505334|4317508|P2|Main Treatment Period|Adverse Event|3
1318846|NCT02505334|4317509|P1|Main Treatment Period|Adverse Event|3
1318847|NCT02504541|4317618|P1|Overall Study|Multiple|5
1318848|NCT02504541|4317618|P1|Overall Study|Other|2
1318849|NCT02504541|4317618|P1|Overall Study|Termination by Sponsor|1
1318850|NCT02504541|4317618|P1|Overall Study|Protocol Violation|2
1318851|NCT02504541|4317618|P1|Overall Study|Met Stopping Criteria|1
1318852|NCT02504541|4317618|P1|Overall Study|Lost to Follow-up|1
1318853|NCT02504541|4317618|P1|Overall Study|Withdrawal by Subject|4
1318854|NCT02504541|4317618|P1|Overall Study|Adverse Event|4
1318855|NCT02504502|4317624|P2|Crossover to Enhanced Report|Lost to Follow-up|0
1318856|NCT02504502|4317625|P1|Crossover to Enhanced Report|Lost to Follow-up|5
1318857|NCT02504502|4317624|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
1318858|NCT02504502|4317625|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
1318859|NCT02504320|4317635|P4|Treatment Period 3|Adverse Event|0
1318860|NCT02504320|4317636|P3|Treatment Period 3|Adverse Event|1
1318861|NCT02504320|4317637|P2|Treatment Period 3|Adverse Event|0
1318862|NCT02504320|4317638|P1|Treatment Period 3|Adverse Event|0
1318863|NCT02504320|4317635|P4|Treatment Period 3|Positive Drug Screen|1
1318864|NCT02504320|4317636|P3|Treatment Period 3|Positive Drug Screen|0
1318865|NCT02504320|4317637|P2|Treatment Period 3|Positive Drug Screen|0
1318866|NCT02504320|4317638|P1|Treatment Period 3|Positive Drug Screen|0
1318867|NCT02504320|4317635|P4|Treatment Period 2|Positive Drug Screen|0
1318868|NCT02504320|4317636|P3|Treatment Period 2|Positive Drug Screen|0
1318869|NCT02504320|4317637|P2|Treatment Period 2|Positive Drug Screen|1
1318870|NCT02504320|4317638|P1|Treatment Period 2|Positive Drug Screen|0
1318871|NCT02504320|4317635|P4|Treatment Period 1|Positive Drug Screen|0
1318872|NCT02504320|4317636|P3|Treatment Period 1|Positive Drug Screen|1
1318873|NCT02504320|4317637|P2|Treatment Period 1|Positive Drug Screen|0
1318874|NCT02504320|4317638|P1|Treatment Period 1|Positive Drug Screen|0
1318875|NCT02504294|4317658|P2|Overall Study|Lost to Follow-up|7
1318876|NCT02504294|4317659|P1|Overall Study|Lost to Follow-up|6
1318877|NCT02504294|4317658|P2|Overall Study|Physician Decision|2
1318878|NCT02504294|4317659|P1|Overall Study|Physician Decision|1
1318879|NCT02504294|4317658|P2|Overall Study|Protocol Violation|26
1318880|NCT02504294|4317659|P1|Overall Study|Protocol Violation|27
1318881|NCT02504294|4317658|P2|Overall Study|Withdrawal by Subject|1
1318882|NCT02504294|4317659|P1|Overall Study|Withdrawal by Subject|7
1318883|NCT02504294|4317658|P2|Overall Study|Adverse Event|12
1318884|NCT02504294|4317659|P1|Overall Study|Adverse Event|15
1318885|NCT02503865|4317688|P3|Overall Study|Refused treatment|2
1318886|NCT02503865|4317689|P2|Overall Study|Refused treatment|39
1318887|NCT02503865|4317690|P1|Overall Study|Refused treatment|4
1318888|NCT02503865|4317688|P3|Overall Study|Moved out of area|0
1318889|NCT02503865|4317689|P2|Overall Study|Moved out of area|8
1318890|NCT02503865|4317690|P1|Overall Study|Moved out of area|1
1318891|NCT02503787|4317710|P1|Implant to 3 Month Endpoint|Withdrawal by Subject|1
1318892|NCT02503787|4317710|P1|Implant to 3 Month Endpoint|Adverse Event|2
1318893|NCT02503787|4317710|P1|Successful Trial (≥50% Pain Relief)|Physician Decision|2
1318894|NCT02503787|4317710|P1|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
1318895|NCT02503787|4317710|P1|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
1318896|NCT02503787|4317710|P1|Device Trial (HD Programming Trial)|Lack of Efficacy|6
1318897|NCT02503787|4317710|P1|Enrollment|Unable to be programmed|1
1318898|NCT02503787|4317710|P1|Enrollment|Inability to implant system|1
1318899|NCT02503787|4317710|P1|Enrollment|Protocol Violation|1
1318900|NCT02503787|4317710|P1|Enrollment|Adverse Event|1
1318901|NCT02503787|4317710|P1|Enrollment|Study closure|1
1318902|NCT02503787|4317710|P1|Enrollment|Lost to Follow-up|1
1318903|NCT02503787|4317710|P1|Enrollment|Insurance issue|2
1318904|NCT02503787|4317710|P1|Enrollment|Physician Decision|2
1318905|NCT02503787|4317710|P1|Enrollment|Inclusion/exclusion criteria not met|4
1318906|NCT02503787|4317710|P1|Enrollment|Withdrawal by Subject|6
1318907|NCT02503215|4317733|P1|Overall Study|Unable to use positive airway pressure|2
1318908|NCT02503215|4317733|P1|Overall Study|Unable to wear compression stockings|1
1318909|NCT02503085|4317739|P4|Period 2: Washout (3 to 7 Days)|Adverse Event|0
1318910|NCT02503085|4317740|P3|Period 2: Washout (3 to 7 Days)|Adverse Event|1
1318911|NCT02503085|4317741|P2|Period 2: Washout (3 to 7 Days)|Adverse Event|0
1318912|NCT02503085|4317742|P1|Period 2: Washout (3 to 7 Days)|Adverse Event|1
1318913|NCT02502734|4317781|P2|Washout Period|Adverse Event|0
1318914|NCT02502734|4317782|P1|Washout Period|Adverse Event|1
1318915|NCT02502734|4317781|P2|Double-blind Treatment Period 1|Adverse Event|0
1318916|NCT02502734|4317782|P1|Double-blind Treatment Period 1|Adverse Event|1
1318917|NCT02502526|4317793|P3|Overall Study|Enrollment suspension|1
1318918|NCT02502526|4317794|P2|Overall Study|Enrollment suspension|1
1318919|NCT02502526|4317795|P1|Overall Study|Enrollment suspension|4
1318920|NCT02502526|4317793|P3|Overall Study|Disqualified due to cataract grading|1
1318921|NCT02502526|4317794|P2|Overall Study|Disqualified due to cataract grading|0
1318922|NCT02502526|4317795|P1|Overall Study|Disqualified due to cataract grading|0
1318923|NCT02502526|4317793|P3|Overall Study|Withdrawal by Subject|1
1318924|NCT02502526|4317794|P2|Overall Study|Withdrawal by Subject|1
1318925|NCT02502526|4317795|P1|Overall Study|Withdrawal by Subject|0
1318926|NCT02502526|4317793|P3|Overall Study|Lost to Follow-up|3
1318927|NCT02502526|4317794|P2|Overall Study|Lost to Follow-up|2
1318928|NCT02502526|4317795|P1|Overall Study|Lost to Follow-up|2
1318929|NCT02502149|4317881|P5|Intermediate|Discontinued prematurely|0
1318930|NCT02502149|4317882|P4|Intermediate|Discontinued prematurely|0
1318931|NCT02502149|4317883|P3|Intermediate|Discontinued prematurely|0
1318932|NCT02502149|4317884|P2|Intermediate|Discontinued prematurely|0
1318933|NCT02502149|4317885|P1|Intermediate|Discontinued prematurely|1
1318934|NCT02500758|4318029|P2|Second Intervention (2 Minutes)|Protocol Violation|1
1318935|NCT02500758|4318030|P1|Second Intervention (2 Minutes)|Protocol Violation|1
1318936|NCT02500758|4318029|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
1318937|NCT02500758|4318030|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
1318938|NCT02500758|4318029|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
1318939|NCT02500758|4318030|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
1318940|NCT02500758|4318029|P2|Washout (1 Week)|Lost to Follow-up|2
1318941|NCT02500758|4318030|P1|Washout (1 Week)|Lost to Follow-up|2
1318942|NCT02500758|4318029|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
1318943|NCT02500758|4318030|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
1318944|NCT02500706|4318041|P3|Overall Study|Unclassified|1
1318945|NCT02500706|4318042|P2|Overall Study|Unclassified|0
1318946|NCT02500706|4318043|P1|Overall Study|Unclassified|0
1318947|NCT02500706|4318041|P3|Overall Study|Withdrawal by Subject|4
1318948|NCT02500706|4318042|P2|Overall Study|Withdrawal by Subject|6
1318949|NCT02500706|4318043|P1|Overall Study|Withdrawal by Subject|4
1318950|NCT02500706|4318041|P3|Overall Study|Lost to Follow-up|1
1318951|NCT02500706|4318042|P2|Overall Study|Lost to Follow-up|1
1318952|NCT02500706|4318043|P1|Overall Study|Lost to Follow-up|0
1318953|NCT02500706|4318041|P3|Overall Study|Adverse Event|1
1318954|NCT02500706|4318042|P2|Overall Study|Adverse Event|0
1318955|NCT02500706|4318043|P1|Overall Study|Adverse Event|0
1318956|NCT02500537|4318210|P2|Overall Study|Withdrawal by Subject|0
1318957|NCT02500537|4318211|P1|Overall Study|Withdrawal by Subject|1
1318958|NCT02500537|4318210|P2|Overall Study|Lost to Follow-up|1
1318959|NCT02500537|4318211|P1|Overall Study|Lost to Follow-up|0
1318960|NCT02500537|4318210|P2|Overall Study|Death|0
1318961|NCT02500537|4318211|P1|Overall Study|Death|2
1318962|NCT02500056|4318280|P2|Overall Study|Death|1
1318963|NCT02500056|4318281|P1|Overall Study|Death|3
1318964|NCT02500056|4318280|P2|Overall Study|Recurrence|0
1318965|NCT02500056|4318281|P1|Overall Study|Recurrence|1
1318966|NCT02500056|4318280|P2|Overall Study|Lost to Follow-up|7
1318967|NCT02500056|4318281|P1|Overall Study|Lost to Follow-up|3
1318968|NCT02499952|4318291|P1|Overall Study|Death|9
1318969|NCT02499952|4318291|P1|Overall Study|Lost to Follow-up|1
1318970|NCT02499900|4318300|P2|Extension Study Period|Not specified|2
1318971|NCT02499900|4318301|P1|Extension Study Period|Not specified|0
1318972|NCT02499900|4318300|P2|Extension Study Period|Lost to Follow-up|5
1318973|NCT02499900|4318301|P1|Extension Study Period|Lost to Follow-up|2
1318974|NCT02499900|4318300|P2|Extension Study Period|Pregnancy|2
1318975|NCT02499900|4318301|P1|Extension Study Period|Pregnancy|1
1318976|NCT02499900|4318300|P2|Extension Study Period|Physician Decision|5
1318977|NCT02499900|4318301|P1|Extension Study Period|Physician Decision|2
1318978|NCT02499900|4318300|P2|Extension Study Period|Withdrawal by Subject|2
1318979|NCT02499900|4318301|P1|Extension Study Period|Withdrawal by Subject|5
1318980|NCT02499900|4318300|P2|Extension Study Period|Adverse Event|4
1318981|NCT02499900|4318301|P1|Extension Study Period|Adverse Event|2
1318982|NCT02499900|4318300|P2|Completed Core, Continue Into Extension|Personal motivation|0
1318983|NCT02499900|4318301|P1|Completed Core, Continue Into Extension|Personal motivation|1
1318984|NCT02499900|4318300|P2|Completed Core, Continue Into Extension|Did not wish to take injectables drugs|0
1318985|NCT02499900|4318301|P1|Completed Core, Continue Into Extension|Did not wish to take injectables drugs|1
1318986|NCT02499900|4318300|P2|Completed Core, Continue Into Extension|Withdrawal by Subject|2
1318987|NCT02499900|4318301|P1|Completed Core, Continue Into Extension|Withdrawal by Subject|0
1318988|NCT02499900|4318300|P2|Completed Core, Continue Into Extension|Physician Decision|0
1318989|NCT02499900|4318301|P1|Completed Core, Continue Into Extension|Physician Decision|1
1318990|NCT02499900|4318300|P2|Core Study Period|Death|1
1318991|NCT02499900|4318301|P1|Core Study Period|Death|0
1318992|NCT02499900|4318300|P2|Core Study Period|Adverse Event|14
1318993|NCT02499900|4318301|P1|Core Study Period|Adverse Event|18
1318994|NCT02499900|4318300|P2|Core Study Period|Withdrawal by Subject|10
1318995|NCT02499900|4318301|P1|Core Study Period|Withdrawal by Subject|11
1318996|NCT02499900|4318300|P2|Core Study Period|Protocol Violation|0
1318997|NCT02499900|4318301|P1|Core Study Period|Protocol Violation|3
1318998|NCT02499900|4318300|P2|Core Study Period|Pregnancy|0
1318999|NCT02499900|4318301|P1|Core Study Period|Pregnancy|1
1319000|NCT02499900|4318300|P2|Core Study Period|Per sponsor request|1
1319001|NCT02499900|4318301|P1|Core Study Period|Per sponsor request|0
1319002|NCT02499900|4318300|P2|Core Study Period|Lost to Follow-up|2
1319003|NCT02499900|4318301|P1|Core Study Period|Lost to Follow-up|1
1319004|NCT02499900|4318300|P2|Core Study Period|Not specified|4
1319005|NCT02499900|4318301|P1|Core Study Period|Not specified|1
1319006|NCT02499575|4318332|P2|Overall Study|Protocol Violation|1
1319007|NCT02499575|4318333|P1|Overall Study|Protocol Violation|0
1319008|NCT02499029|4318345|P2|Overall Study|Death|0
1319009|NCT02499029|4318346|P1|Overall Study|Death|1
1319010|NCT02499029|4318345|P2|Overall Study|Physician Decision|1
1319011|NCT02499029|4318346|P1|Overall Study|Physician Decision|2
1319012|NCT02499029|4318345|P2|Overall Study|Lost to Follow-up|2
1319013|NCT02499029|4318346|P1|Overall Study|Lost to Follow-up|2
1319014|NCT02498821|4318360|P2|Overall Study|Screen failure|5
1319015|NCT02498821|4318361|P1|Overall Study|Screen failure|3
1319016|NCT02498678|4318390|P2|Overall Study|interference from the surgical team|2
1319017|NCT02498678|4318391|P1|Overall Study|interference from the surgical team|0
1319018|NCT02498652|4318407|P2|Overall Study|Protocol Violation|1
1319019|NCT02498652|4318408|P1|Overall Study|Protocol Violation|0
1319020|NCT02497976|4318518|P2|Overall Study|Moved out of area|1
1319021|NCT02497976|4318519|P1|Overall Study|Moved out of area|0
1319022|NCT02497976|4318518|P2|Overall Study|Withdrawal by Subject|0
1319023|NCT02497976|4318519|P1|Overall Study|Withdrawal by Subject|2
1319024|NCT02497781|4318537|P2|Overall Study|Lost to Follow-up|1
1319025|NCT02497781|4318538|P1|Overall Study|Lost to Follow-up|1
1319026|NCT02497781|4318537|P2|Overall Study|Randomised but not treated|1
1319027|NCT02497781|4318538|P1|Overall Study|Randomised but not treated|1
1319028|NCT02497781|4318537|P2|Overall Study|Lack of Efficacy|1
1319029|NCT02497781|4318538|P1|Overall Study|Lack of Efficacy|0
1319030|NCT02497781|4318537|P2|Overall Study|Withdrawal by Subject|0
1319031|NCT02497781|4318538|P1|Overall Study|Withdrawal by Subject|2
1319032|NCT02497755|4318601|P2|Overall Study|Protocol Violation|0
1319033|NCT02497755|4318602|P1|Overall Study|Protocol Violation|1
1319034|NCT02496702|4318669|P2|Overall Study|Only partially tested|2
1319035|NCT02496702|4318670|P1|Overall Study|Only partially tested|0
1319036|NCT02496702|4318669|P2|Overall Study|Lost to Follow-up|6
1319037|NCT02496702|4318670|P1|Overall Study|Lost to Follow-up|8
1319038|NCT02496533|4318692|P2|Overall Study|Late for radiologic testing|2
1319039|NCT02496533|4318693|P1|Overall Study|Late for radiologic testing|0
1319040|NCT02496533|4318692|P2|Overall Study|Patient did not complete all measures|4
1319041|NCT02496533|4318693|P1|Overall Study|Patient did not complete all measures|0
1319042|NCT02496533|4318692|P2|Overall Study|Lack of data on outcome|0
1319043|NCT02496533|4318693|P1|Overall Study|Lack of data on outcome|3
1319044|NCT02496221|4318705|P2|Treatment Period 2 - 4 Days|Physician Decision|0
1319045|NCT02496221|4318706|P1|Treatment Period 2 - 4 Days|Physician Decision|1
1319046|NCT02496221|4318705|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
1319047|NCT02496221|4318706|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
1319048|NCT02496221|4318705|P2|Treatment Period 2 - 4 Days|Adverse Event|1
1319049|NCT02496221|4318706|P1|Treatment Period 2 - 4 Days|Adverse Event|0
1319050|NCT02496039|4318740|P1|Overall Study|Protocol Violation|1
1319051|NCT02496039|4318740|P1|Overall Study|Adverse Event|3
1319052|NCT02496000|4318755|P3|Overall Study|undetermined|0
1319053|NCT02496000|4318756|P2|Overall Study|undetermined|1
1319054|NCT02496000|4318757|P1|Overall Study|undetermined|0
1319055|NCT02496000|4318755|P3|Overall Study|Non-compliance or lack of cooperation|0
1319056|NCT02496000|4318756|P2|Overall Study|Non-compliance or lack of cooperation|2
1319057|NCT02496000|4318757|P1|Overall Study|Non-compliance or lack of cooperation|0
1319058|NCT02496000|4318755|P3|Overall Study|Protocol Violation|1
1319059|NCT02496000|4318756|P2|Overall Study|Protocol Violation|0
1319060|NCT02496000|4318757|P1|Overall Study|Protocol Violation|0
1319061|NCT02496000|4318755|P3|Overall Study|Lost to Follow-up|1
1319062|NCT02496000|4318756|P2|Overall Study|Lost to Follow-up|0
1319063|NCT02496000|4318757|P1|Overall Study|Lost to Follow-up|1
1319064|NCT02496000|4318755|P3|Overall Study|Withdrawal by Subject|0
1319065|NCT02496000|4318756|P2|Overall Study|Withdrawal by Subject|2
1319066|NCT02496000|4318757|P1|Overall Study|Withdrawal by Subject|1
1319067|NCT02495948|4318766|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
1319068|NCT02495948|4318767|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
1319069|NCT02495948|4318766|P2|Period 1, First 30 Days of Wear|Adverse Event|1
1319070|NCT02495948|4318767|P1|Period 1, First 30 Days of Wear|Adverse Event|0
1319071|NCT02494596|4318870|P3|Overall Study|Refused Treatment|0
1319072|NCT02494596|4318871|P2|Overall Study|Refused Treatment|1
1319073|NCT02494596|4318872|P1|Overall Study|Refused Treatment|0
1319074|NCT02494596|4318870|P3|Overall Study|Adverse Event|0
1319075|NCT02494596|4318871|P2|Overall Study|Adverse Event|1
1319076|NCT02494596|4318872|P1|Overall Study|Adverse Event|0
1319077|NCT02494596|4318870|P3|Overall Study|Insufficient Therapeutic Response|1
1319078|NCT02494596|4318871|P2|Overall Study|Insufficient Therapeutic Response|3
1319079|NCT02494596|4318872|P1|Overall Study|Insufficient Therapeutic Response|3
1319080|NCT02493855|4318924|P3|Overall Study|Withdrawal by Subject|0
1319081|NCT02493855|4318925|P2|Overall Study|Withdrawal by Subject|0
1319082|NCT02493855|4318926|P1|Overall Study|Withdrawal by Subject|1
1319083|NCT02493855|4318924|P3|Overall Study|Adverse Event|0
1319084|NCT02493855|4318925|P2|Overall Study|Adverse Event|1
1319085|NCT02493855|4318926|P1|Overall Study|Adverse Event|0
1319086|NCT02493855|4318924|P3|Overall Study|Non-compliance|0
1319087|NCT02493855|4318925|P2|Overall Study|Non-compliance|0
1319088|NCT02493855|4318926|P1|Overall Study|Non-compliance|1
1319089|NCT02493127|4318936|P2|Overall Study|Lost to Follow-up|1
1319090|NCT02493127|4318937|P1|Overall Study|Lost to Follow-up|1
1319091|NCT02492984|4318970|P2|Overall Study|Withdrawal by Subject|0
1319092|NCT02492984|4318971|P1|Overall Study|Withdrawal by Subject|1
1319093|NCT02492984|4318970|P2|Overall Study|Protocol Violation|0
1319094|NCT02492984|4318971|P1|Overall Study|Protocol Violation|1
1319095|NCT02492984|4318970|P2|Overall Study|Adverse Event|0
1319096|NCT02492984|4318971|P1|Overall Study|Adverse Event|1
1319097|NCT02492958|4318995|P4|Overall Study|Adverse Event|0
1319098|NCT02492958|4318996|P3|Overall Study|Adverse Event|1
1319099|NCT02492958|4318997|P2|Overall Study|Adverse Event|0
1319100|NCT02492958|4318998|P1|Overall Study|Adverse Event|1
1319101|NCT02492958|4318995|P4|Overall Study|Withdrawal by Subject|0
1319102|NCT02492958|4318996|P3|Overall Study|Withdrawal by Subject|1
1319103|NCT02492958|4318997|P2|Overall Study|Withdrawal by Subject|0
1319104|NCT02492958|4318998|P1|Overall Study|Withdrawal by Subject|0
1319105|NCT02492880|4319084|P1|Overall Study|Protocol Violation|1
1319106|NCT02492880|4319084|P1|Overall Study|Lost to Follow-up|1
1319107|NCT02492841|4319091|P3|Overall Study|Lost to Follow-up|35
1319108|NCT02492841|4319092|P2|Overall Study|Lost to Follow-up|31
1319109|NCT02492841|4319093|P1|Overall Study|Lost to Follow-up|34
1319110|NCT02492763|4319108|P4|Overall Study|Study Terminated by Sponsor|10
1319111|NCT02492763|4319109|P3|Overall Study|Study Terminated by Sponsor|6
1319112|NCT02492763|4319110|P2|Overall Study|Study Terminated by Sponsor|10
1319113|NCT02492763|4319111|P1|Overall Study|Study Terminated by Sponsor|13
1319114|NCT02492763|4319108|P4|Overall Study|Screen Failure|1
1319115|NCT02492763|4319109|P3|Overall Study|Screen Failure|0
1319116|NCT02492763|4319110|P2|Overall Study|Screen Failure|0
1319117|NCT02492763|4319111|P1|Overall Study|Screen Failure|0
1319118|NCT02492763|4319108|P4|Overall Study|Non-Compliance With Study Drug|0
1319119|NCT02492763|4319109|P3|Overall Study|Non-Compliance With Study Drug|0
1319120|NCT02492763|4319110|P2|Overall Study|Non-Compliance With Study Drug|1
1319121|NCT02492763|4319111|P1|Overall Study|Non-Compliance With Study Drug|0
1319122|NCT02492763|4319108|P4|Overall Study|Lost to Follow-up|0
1319123|NCT02492763|4319109|P3|Overall Study|Lost to Follow-up|1
1319124|NCT02492763|4319110|P2|Overall Study|Lost to Follow-up|0
1319125|NCT02492763|4319111|P1|Overall Study|Lost to Follow-up|0
1319126|NCT02492763|4319108|P4|Overall Study|Hyperglycemia Discontinuation Criteria|0
1319127|NCT02492763|4319109|P3|Overall Study|Hyperglycemia Discontinuation Criteria|0
1319128|NCT02492763|4319110|P2|Overall Study|Hyperglycemia Discontinuation Criteria|1
1319129|NCT02492763|4319111|P1|Overall Study|Hyperglycemia Discontinuation Criteria|0
1319130|NCT02492763|4319108|P4|Overall Study|Death|0
1319131|NCT02492763|4319109|P3|Overall Study|Death|1
1319132|NCT02492763|4319110|P2|Overall Study|Death|0
1319133|NCT02492763|4319111|P1|Overall Study|Death|0
1319134|NCT02492763|4319108|P4|Overall Study|Adverse Event|2
1319135|NCT02492763|4319109|P3|Overall Study|Adverse Event|1
1319136|NCT02492763|4319110|P2|Overall Study|Adverse Event|1
1319137|NCT02492763|4319111|P1|Overall Study|Adverse Event|3
1319138|NCT02492763|4319108|P4|Overall Study|Withdrawal by Subject|0
1319139|NCT02492763|4319109|P3|Overall Study|Withdrawal by Subject|1
1319140|NCT02492763|4319110|P2|Overall Study|Withdrawal by Subject|2
1319141|NCT02492763|4319111|P1|Overall Study|Withdrawal by Subject|0
1319142|NCT02492165|4319182|P4|Overall Study|Withdrawal by Subject|0
1319143|NCT02492165|4319183|P3|Overall Study|Withdrawal by Subject|0
1319144|NCT02492165|4319184|P2|Overall Study|Withdrawal by Subject|1
1319145|NCT02492165|4319185|P1|Overall Study|Withdrawal by Subject|0
1319146|NCT02491892|4319229|P2|Overall Study|Lost to Follow-up|0
1319147|NCT02491892|4319230|P1|Overall Study|Lost to Follow-up|1
1319148|NCT02491892|4319229|P2|Overall Study|Refused Treatment|0
1319149|NCT02491892|4319230|P1|Overall Study|Refused Treatment|1
1319150|NCT02491892|4319229|P2|Overall Study|Lack of Efficacy|36
1319151|NCT02491892|4319230|P1|Overall Study|Lack of Efficacy|37
1319152|NCT02491892|4319229|P2|Overall Study|Death|1
1319153|NCT02491892|4319230|P1|Overall Study|Death|1
1319154|NCT02491892|4319229|P2|Overall Study|Adverse Event|1
1319155|NCT02491892|4319230|P1|Overall Study|Adverse Event|1
1319156|NCT02491463|4319278|P4|Overall Study|Lost to Follow-up|0
1319157|NCT02491463|4319279|P3|Overall Study|Lost to Follow-up|3
1319158|NCT02491463|4319280|P2|Overall Study|Lost to Follow-up|3
1319159|NCT02491463|4319281|P1|Overall Study|Lost to Follow-up|0
1319160|NCT02491463|4319278|P4|Overall Study|Migrated/moved from study area|1
1319161|NCT02491463|4319279|P3|Overall Study|Migrated/moved from study area|1
1319162|NCT02491463|4319280|P2|Overall Study|Migrated/moved from study area|5
1319163|NCT02491463|4319281|P1|Overall Study|Migrated/moved from study area|1
1319164|NCT02491463|4319278|P4|Overall Study|Withdrawal by Subject|0
1319165|NCT02491463|4319279|P3|Overall Study|Withdrawal by Subject|0
1319166|NCT02491463|4319280|P2|Overall Study|Withdrawal by Subject|2
1319167|NCT02491463|4319281|P1|Overall Study|Withdrawal by Subject|1
1319168|NCT02491411|4319367|P1|Overall Study|Physician Decision|4
1319169|NCT02491073|4319379|P2|Overall Study|screen failure|0
1319170|NCT02491073|4319380|P1|Overall Study|screen failure|1
1319171|NCT02490475|4319421|P4|Period 2: Extension Phase|Adverse Event|0
1319172|NCT02490475|4319422|P3|Period 2: Extension Phase|Adverse Event|1
1319173|NCT02490475|4319423|P2|Period 2: Extension Phase|Adverse Event|0
1319174|NCT02490475|4319424|P1|Period 2: Extension Phase|Adverse Event|0
1319175|NCT02490475|4319421|P4|Period 2: Extension Phase|Refused Treatment|1
1319176|NCT02490475|4319422|P3|Period 2: Extension Phase|Refused Treatment|0
1319177|NCT02490475|4319423|P2|Period 2: Extension Phase|Refused Treatment|0
1319178|NCT02490475|4319424|P1|Period 2: Extension Phase|Refused Treatment|0
1319179|NCT02490475|4319421|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
1319180|NCT02490475|4319422|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
1319181|NCT02490475|4319423|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
1319182|NCT02490475|4319424|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
1319183|NCT02490475|4319421|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
1319184|NCT02490475|4319422|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
1319185|NCT02490475|4319423|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
1319186|NCT02490475|4319424|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
1319187|NCT02490475|4319421|P4|Period 1: First 6 Cycles|Refused Treatment|0
1319188|NCT02490475|4319422|P3|Period 1: First 6 Cycles|Refused Treatment|0
1319189|NCT02490475|4319423|P2|Period 1: First 6 Cycles|Refused Treatment|0
1319190|NCT02490475|4319424|P1|Period 1: First 6 Cycles|Refused Treatment|1
1319191|NCT02490475|4319421|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1319192|NCT02490475|4319422|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1319193|NCT02490475|4319423|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
1319194|NCT02490475|4319424|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1319195|NCT02490475|4319421|P4|Period 1: First 6 Cycles|Adverse Event|1
1319196|NCT02490475|4319422|P3|Period 1: First 6 Cycles|Adverse Event|0
1319197|NCT02490475|4319423|P2|Period 1: First 6 Cycles|Adverse Event|1
1319198|NCT02490475|4319424|P1|Period 1: First 6 Cycles|Adverse Event|2
1319199|NCT02489799|4319513|P2|Overall Study|Death|1
1319200|NCT02489799|4319514|P1|Overall Study|Death|0
1319201|NCT02489799|4319513|P2|Overall Study|Withdrawal by Subject|1
1319202|NCT02489799|4319514|P1|Overall Study|Withdrawal by Subject|1
1319203|NCT02489799|4319513|P2|Overall Study|Failure to Maintain Eligibility|6
1319204|NCT02489799|4319514|P1|Overall Study|Failure to Maintain Eligibility|4
1319205|NCT02489799|4319513|P2|Overall Study|Lost to Follow-up|1
1319206|NCT02489799|4319514|P1|Overall Study|Lost to Follow-up|4
1319207|NCT02489500|4319540|P2|Overall Study|Death|1
1319208|NCT02489500|4319541|P1|Overall Study|Death|1
1319209|NCT02488980|4319556|P3|Overall Study|Protocol Violation|2
1319210|NCT02488980|4319557|P2|Overall Study|Protocol Violation|2
1319211|NCT02488980|4319558|P1|Overall Study|Protocol Violation|2
1319212|NCT02488915|4319575|P1|Overall Study|Withdrawal by Subject|1
1319213|NCT02488915|4319575|P1|Overall Study|Lost to Follow-up|4
1319214|NCT02488915|4319575|P1|Overall Study|Death|21
1319215|NCT02488681|4319591|P1|Overall Study|Implant unsuccessful|7
1319216|NCT02487771|4319626|P2|Overall Study|Withdrawal by Subject|5
1319217|NCT02487771|4319627|P1|Overall Study|Withdrawal by Subject|3
1319218|NCT02487771|4319626|P2|Overall Study|Moved out of area|6
1319219|NCT02487771|4319627|P1|Overall Study|Moved out of area|5
1319220|NCT02487771|4319626|P2|Overall Study|Lost to Follow-up|3
1319221|NCT02487771|4319627|P1|Overall Study|Lost to Follow-up|2
1319222|NCT02487498|4319777|P2|Period: Period 2|Physician Decision|0
1319223|NCT02487498|4319778|P1|Period: Period 2|Physician Decision|1
1319224|NCT02487498|4319777|P2|Period: Period 2|Death|1
1319225|NCT02487498|4319778|P1|Period: Period 2|Death|0
1319226|NCT02487498|4319777|P2|Period: Period 2|Lost to Follow-up|1
1319227|NCT02487498|4319778|P1|Period: Period 2|Lost to Follow-up|1
1319228|NCT02487498|4319777|P2|Period: Period 2|Subject/guardian decision|1
1319229|NCT02487498|4319778|P1|Period: Period 2|Subject/guardian decision|2
1319230|NCT02487498|4319777|P2|Period: Period 2|Adverse Event|2
1319231|NCT02487498|4319778|P1|Period: Period 2|Adverse Event|2
1319232|NCT02487498|4319777|P2|Period: Washout|Non-compliance with study treatment|1
1319233|NCT02487498|4319778|P1|Period: Washout|Non-compliance with study treatment|0
1319234|NCT02487498|4319777|P2|Period: Washout|Physician Decision|0
1319235|NCT02487498|4319778|P1|Period: Washout|Physician Decision|1
1319236|NCT02487498|4319777|P2|Period: Washout|Lack of Efficacy|1
1319237|NCT02487498|4319778|P1|Period: Washout|Lack of Efficacy|1
1319238|NCT02487498|4319777|P2|Period: Washout|Subject/guardian decision|5
1319239|NCT02487498|4319778|P1|Period: Washout|Subject/guardian decision|0
1319240|NCT02487498|4319777|P2|Period: Period 1|Protocol deviation|0
1319241|NCT02487498|4319778|P1|Period: Period 1|Protocol deviation|1
1319242|NCT02487498|4319777|P2|Period: Period 1|Physician Decision|1
1319243|NCT02487498|4319778|P1|Period: Period 1|Physician Decision|0
1319244|NCT02487498|4319777|P2|Period: Period 1|Lack of Efficacy|0
1319245|NCT02487498|4319778|P1|Period: Period 1|Lack of Efficacy|1
1319246|NCT02487498|4319777|P2|Period: Period 1|Lost to Follow-up|2
1319247|NCT02487498|4319778|P1|Period: Period 1|Lost to Follow-up|0
1319248|NCT02487498|4319777|P2|Period: Period 1|Subject/guardian decision|4
1319249|NCT02487498|4319778|P1|Period: Period 1|Subject/guardian decision|2
1319250|NCT02487498|4319777|P2|Period: Period 1|Adverse Event|4
1319251|NCT02487498|4319778|P1|Period: Period 1|Adverse Event|2
1319252|NCT02487446|4319801|P2|Period 2|Adverse Event|2
1319253|NCT02487446|4319802|P1|Period 2|Adverse Event|6
1319254|NCT02487446|4319801|P2|Period 2|Withdrawal by Subject|1
1319255|NCT02487446|4319802|P1|Period 2|Withdrawal by Subject|1
1319256|NCT02487446|4319801|P2|Period 2|Lost to Follow-up|1
1319257|NCT02487446|4319802|P1|Period 2|Lost to Follow-up|1
1319258|NCT02487446|4319801|P2|Period 2|Protocol deviation|1
1319259|NCT02487446|4319802|P1|Period 2|Protocol deviation|0
1319260|NCT02487446|4319801|P2|Washout|Adverse Event|2
1319261|NCT02487446|4319802|P1|Washout|Adverse Event|2
1319262|NCT02487446|4319801|P2|Washout|Withdrawal by Subject|4
1319263|NCT02487446|4319802|P1|Washout|Withdrawal by Subject|1
1319264|NCT02487446|4319801|P2|Washout|Lost to Follow-up|2
1319265|NCT02487446|4319802|P1|Washout|Lost to Follow-up|0
1319266|NCT02487446|4319801|P2|Period 1|Adverse Event|5
1319267|NCT02487446|4319802|P1|Period 1|Adverse Event|5
1319268|NCT02487446|4319801|P2|Period 1|Withdrawal by Subject|0
1319269|NCT02487446|4319802|P1|Period 1|Withdrawal by Subject|2
1319270|NCT02487446|4319801|P2|Period 1|Lost to Follow-up|0
1319271|NCT02487446|4319802|P1|Period 1|Lost to Follow-up|2
1319272|NCT02487446|4319801|P2|Period 1|Protocol deviation|2
1319273|NCT02487446|4319802|P1|Period 1|Protocol deviation|3
1319274|NCT02487446|4319801|P2|Period 1|Lack of Efficacy|0
1319275|NCT02487446|4319802|P1|Period 1|Lack of Efficacy|1
1319276|NCT02487446|4319801|P2|Period 1|Physician Decision|1
1319277|NCT02487446|4319802|P1|Period 1|Physician Decision|0
1319278|NCT02487199|4319827|P2|Overall Study|Withdrew Consent|1
1319279|NCT02487199|4319828|P1|Overall Study|Withdrew Consent|0
1319280|NCT02487030|4319847|P7|Overall Study|Death|0
1319281|NCT02487030|4319848|P6|Overall Study|Death|0
1319282|NCT02487030|4319849|P5|Overall Study|Death|1
1319283|NCT02487030|4319850|P4|Overall Study|Death|0
1319284|NCT02487030|4319851|P3|Overall Study|Death|0
1319285|NCT02487030|4319852|P2|Overall Study|Death|0
1319286|NCT02487030|4319853|P1|Overall Study|Death|0
1319287|NCT02487030|4319847|P7|Overall Study|Adverse Event|0
1319288|NCT02487030|4319848|P6|Overall Study|Adverse Event|0
1319289|NCT02487030|4319849|P5|Overall Study|Adverse Event|0
1319290|NCT02487030|4319850|P4|Overall Study|Adverse Event|1
1319291|NCT02487030|4319851|P3|Overall Study|Adverse Event|0
1319292|NCT02487030|4319852|P2|Overall Study|Adverse Event|0
1319293|NCT02487030|4319853|P1|Overall Study|Adverse Event|0
1319294|NCT02487030|4319847|P7|Overall Study|Lost to Follow-up|0
1319295|NCT02487030|4319848|P6|Overall Study|Lost to Follow-up|1
1319296|NCT02487030|4319849|P5|Overall Study|Lost to Follow-up|0
1319297|NCT02487030|4319850|P4|Overall Study|Lost to Follow-up|1
1319298|NCT02487030|4319851|P3|Overall Study|Lost to Follow-up|1
1319299|NCT02487030|4319852|P2|Overall Study|Lost to Follow-up|0
1319300|NCT02487030|4319853|P1|Overall Study|Lost to Follow-up|0
1319301|NCT02487030|4319847|P7|Overall Study|Lack of Efficacy|0
1319302|NCT02487030|4319848|P6|Overall Study|Lack of Efficacy|0
1319303|NCT02487030|4319849|P5|Overall Study|Lack of Efficacy|1
1319304|NCT02487030|4319850|P4|Overall Study|Lack of Efficacy|0
1319305|NCT02487030|4319851|P3|Overall Study|Lack of Efficacy|1
1319306|NCT02487030|4319852|P2|Overall Study|Lack of Efficacy|4
1319307|NCT02487030|4319853|P1|Overall Study|Lack of Efficacy|2
1319308|NCT02486952|4319884|P1|Overall Study|Other|2
1319309|NCT02486952|4319884|P1|Overall Study|Lost to Follow-up|26
1319310|NCT02486952|4319884|P1|Overall Study|Lack of Efficacy|3
1319311|NCT02486952|4319884|P1|Overall Study|Death|15
1319312|NCT02486952|4319884|P1|Overall Study|Adverse Event|1
1319313|NCT02486952|4319884|P1|Overall Study|Not Started Induction Therapy|3
1319314|NCT02486796|4319891|P2|Overall Study|Physician Decision|0
1319315|NCT02486796|4319892|P1|Overall Study|Physician Decision|1
1319316|NCT02486796|4319891|P2|Overall Study|Withdrawal by Subject|1
1319317|NCT02486796|4319892|P1|Overall Study|Withdrawal by Subject|1
1319318|NCT02486627|4319906|P2|Overall Study|Lost to Follow-up|3
1319319|NCT02486627|4319907|P1|Overall Study|Lost to Follow-up|1
1319320|NCT02486627|4319906|P2|Overall Study|Significant Participant Noncompliance|1
1319321|NCT02486627|4319907|P1|Overall Study|Significant Participant Noncompliance|1
1319322|NCT02486627|4319906|P2|Overall Study|Consent Withdrawn by Participant|3
1319323|NCT02486627|4319907|P1|Overall Study|Consent Withdrawn by Participant|4
1319324|NCT02486627|4319906|P2|Overall Study|Other Unspecified|2
1319325|NCT02486627|4319907|P1|Overall Study|Other Unspecified|0
1319326|NCT02486627|4319906|P2|Overall Study|Death|0
1319327|NCT02486627|4319907|P1|Overall Study|Death|1
1319328|NCT02485925|4319924|P1|Overall Study|Lost to Follow-up|11
1319329|NCT02485925|4319924|P1|Overall Study|Death|1
1319330|NCT02485925|4319924|P1|Overall Study|Withdrawal by Subject|3
1319331|NCT02485483|4319934|P2|Overall Study|Discontinued after baseline|0
1319332|NCT02485483|4319935|P1|Overall Study|Discontinued after baseline|39
1319333|NCT02485483|4319934|P2|Overall Study|Depression at baseline|0
1319334|NCT02485483|4319935|P1|Overall Study|Depression at baseline|15
1319335|NCT02485353|4319950|P1|Overall Study|Disease Progression|1
1319336|NCT02485353|4319950|P1|Overall Study|Death|1
1319337|NCT02485301|4319957|P2|Overall Study|Other|4
1319338|NCT02485301|4319958|P1|Overall Study|Other|3
1319339|NCT02485301|4319957|P2|Overall Study|Lost to Follow-up|17
1319340|NCT02485301|4319958|P1|Overall Study|Lost to Follow-up|17
1319341|NCT02485301|4319957|P2|Overall Study|Migrated/moved from study area|19
1319342|NCT02485301|4319958|P1|Overall Study|Migrated/moved from study area|10
1319343|NCT02485301|4319957|P2|Overall Study|Withdrawal by Subject|7
1319344|NCT02485301|4319958|P1|Overall Study|Withdrawal by Subject|6
1319345|NCT02485301|4319957|P2|Overall Study|Protocol Violation|1
1319346|NCT02485301|4319958|P1|Overall Study|Protocol Violation|0
1319347|NCT02485301|4319957|P2|Overall Study|Serious Adverse Events|1
1319348|NCT02485301|4319958|P1|Overall Study|Serious Adverse Events|2
1319349|NCT02485158|4320008|P1|Overall Study|expected drug side effect|1
1319350|NCT02485158|4320008|P1|Overall Study|Withdrawal by Subject|3
1319351|NCT02484911|4320097|P2|Overall Study|Protocol Violation|1
1319352|NCT02484911|4320098|P1|Overall Study|Protocol Violation|2
1319353|NCT02484911|4320097|P2|Overall Study|Withdrawal by Subject|1
1319354|NCT02484911|4320098|P1|Overall Study|Withdrawal by Subject|2
1319355|NCT02484729|4320140|P10|Overall Study|Failure of IntelliCap Error|1
1319356|NCT02484729|4320141|P9|Overall Study|Failure of IntelliCap Error|0
1319357|NCT02484729|4320142|P8|Overall Study|Failure of IntelliCap Error|0
1319358|NCT02484729|4320143|P7|Overall Study|Failure of IntelliCap Error|0
1319359|NCT02484729|4320144|P6|Overall Study|Failure of IntelliCap Error|0
1319360|NCT02484729|4320145|P5|Overall Study|Failure of IntelliCap Error|0
1319361|NCT02484729|4320146|P4|Overall Study|Failure of IntelliCap Error|0
1319362|NCT02484729|4320147|P3|Overall Study|Failure of IntelliCap Error|0
1319363|NCT02484729|4320148|P2|Overall Study|Failure of IntelliCap Error|0
1319364|NCT02484729|4320149|P1|Overall Study|Failure of IntelliCap Error|0
1319365|NCT02483975|4320347|P2|Overall Study|Physician Decision|0
1319366|NCT02483975|4320348|P1|Overall Study|Physician Decision|2
1319367|NCT02483975|4320347|P2|Overall Study|Lost to Follow-up|1
1319368|NCT02483975|4320348|P1|Overall Study|Lost to Follow-up|0
1319369|NCT02483975|4320347|P2|Overall Study|Adverse Event|1
1319370|NCT02483975|4320348|P1|Overall Study|Adverse Event|0
1319371|NCT02483611|4320365|P3|Overall Study|Protocol Violation|1
1319372|NCT02483611|4320366|P2|Overall Study|Protocol Violation|0
1319373|NCT02483611|4320367|P1|Overall Study|Protocol Violation|0
1319374|NCT02483585|4320464|P2|Open-label Treatment Phase|Lost to Follow-up|5
1319375|NCT02483585|4320465|P1|Open-label Treatment Phase|Lost to Follow-up|3
1319376|NCT02483585|4320464|P2|Open-label Treatment Phase|Withdrawal by Subject|14
1319377|NCT02483585|4320465|P1|Open-label Treatment Phase|Withdrawal by Subject|18
1319378|NCT02483585|4320464|P2|Open-label Treatment Phase|Decision by Sponsor|1
1319379|NCT02483585|4320465|P1|Open-label Treatment Phase|Decision by Sponsor|0
1319380|NCT02483585|4320464|P2|Open-label Treatment Phase|Protocol-specified Criteria|5
1319381|NCT02483585|4320465|P1|Open-label Treatment Phase|Protocol-specified Criteria|6
1319382|NCT02483585|4320464|P2|Double-blind Treatment Phase|Lost to Follow-up|2
1319383|NCT02483585|4320465|P1|Double-blind Treatment Phase|Lost to Follow-up|3
1319384|NCT02483585|4320464|P2|Double-blind Treatment Phase|Withdrawal by Subject|12
1319385|NCT02483585|4320465|P1|Double-blind Treatment Phase|Withdrawal by Subject|12
1319386|NCT02483585|4320464|P2|Double-blind Treatment Phase|Decision by Sponsor|1
1319387|NCT02483585|4320465|P1|Double-blind Treatment Phase|Decision by Sponsor|1
1319388|NCT02482935|4320485|P2|Period 1|Withdrawal by Subject|0
1319389|NCT02482935|4320486|P1|Period 1|Withdrawal by Subject|1
1319390|NCT02482805|4320514|P3|Overall Study|Lost to Follow-up|0
1319391|NCT02482805|4320515|P2|Overall Study|Lost to Follow-up|4
1319392|NCT02482805|4320516|P1|Overall Study|Lost to Follow-up|4
1319393|NCT02482571|4320530|P1|Overall Study|Withdrawal by Subject|4
1319394|NCT02482571|4320530|P1|Overall Study|Scanner or Respiract failure|3
1319395|NCT02482571|4320530|P1|Overall Study|Adverse Event|1
1319396|NCT02482428|4320542|P5|Overall Study|subject/guardian decision|2
1319397|NCT02482428|4320543|P4|Overall Study|subject/guardian decision|0
1319398|NCT02482428|4320544|P3|Overall Study|subject/guardian decision|0
1319399|NCT02482428|4320545|P2|Overall Study|subject/guardian decision|2
1319400|NCT02482428|4320546|P1|Overall Study|subject/guardian decision|4
1319401|NCT02482428|4320542|P5|Overall Study|protocol deviation|0
1319402|NCT02482428|4320543|P4|Overall Study|protocol deviation|0
1319403|NCT02482428|4320544|P3|Overall Study|protocol deviation|0
1319404|NCT02482428|4320545|P2|Overall Study|protocol deviation|1
1319405|NCT02482428|4320546|P1|Overall Study|protocol deviation|1
1319406|NCT02482428|4320542|P5|Overall Study|Physician Decision|1
1319407|NCT02482428|4320543|P4|Overall Study|Physician Decision|0
1319408|NCT02482428|4320544|P3|Overall Study|Physician Decision|0
1319409|NCT02482428|4320545|P2|Overall Study|Physician Decision|0
1319410|NCT02482428|4320546|P1|Overall Study|Physician Decision|0
1319411|NCT02482428|4320542|P5|Overall Study|Lost to Follow-up|4
1319412|NCT02482428|4320543|P4|Overall Study|Lost to Follow-up|2
1319413|NCT02482428|4320544|P3|Overall Study|Lost to Follow-up|1
1319414|NCT02482428|4320545|P2|Overall Study|Lost to Follow-up|9
1319415|NCT02482428|4320546|P1|Overall Study|Lost to Follow-up|4
1319416|NCT02482298|4320569|P3|Overall Study|Lost to Follow-up|0
1319417|NCT02482298|4320570|P2|Overall Study|Lost to Follow-up|1
1319418|NCT02482298|4320571|P1|Overall Study|Lost to Follow-up|0
1319419|NCT02482298|4320569|P3|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
1319420|NCT02482298|4320570|P2|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
1319421|NCT02482298|4320571|P1|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
1319422|NCT02482298|4320569|P3|Overall Study|Did Not Fulfill Randomization Criteria|0
1319423|NCT02482298|4320570|P2|Overall Study|Did Not Fulfill Randomization Criteria|1
1319424|NCT02482298|4320571|P1|Overall Study|Did Not Fulfill Randomization Criteria|0
1319425|NCT02482298|4320569|P3|Overall Study|Withdrawal by Subject|2
1319426|NCT02482298|4320570|P2|Overall Study|Withdrawal by Subject|1
1319427|NCT02482298|4320571|P1|Overall Study|Withdrawal by Subject|2
1319428|NCT02482129|4320593|P2|Overall Study|Criteria not met|0
1319429|NCT02482129|4320594|P1|Overall Study|Criteria not met|1
1319430|NCT02482129|4320593|P2|Overall Study|Withdrawal by Subject|0
1319431|NCT02482129|4320594|P1|Overall Study|Withdrawal by Subject|2
1319432|NCT02482129|4320593|P2|Overall Study|Adverse Event|0
1319433|NCT02482129|4320594|P1|Overall Study|Adverse Event|1
1319434|NCT02482129|4320593|P2|Overall Study|Criteria not met-prior to treatment|0
1319435|NCT02482129|4320594|P1|Overall Study|Criteria not met-prior to treatment|1
1319436|NCT02482129|4320593|P2|Overall Study|Unable to draw blood-prior to treatment|0
1319437|NCT02482129|4320594|P1|Overall Study|Unable to draw blood-prior to treatment|1
1319438|NCT02482129|4320593|P2|Overall Study|Withdrawal by subject-prior to treatment|1
1319439|NCT02482129|4320594|P1|Overall Study|Withdrawal by subject-prior to treatment|0
1319440|NCT02482129|4320593|P2|Overall Study|Adverse Event-prior to treatment|1
1319441|NCT02482129|4320594|P1|Overall Study|Adverse Event-prior to treatment|0
1319442|NCT02481934|4320621|P1|Overall Study|Death|2
1319443|NCT02480712|4320700|P1|Overall Study|Lack of Efficacy|1
1319444|NCT02480712|4320700|P1|Overall Study|Death|1
1319445|NCT02480712|4320700|P1|Overall Study|Withdrew Consent|3
1319446|NCT02480712|4320700|P1|Overall Study|Lost to Follow-up|5
1319447|NCT02480712|4320700|P1|Overall Study|Enrolled but Never Treated|1
1319448|NCT02480621|4320719|P2|Follow Up|Lost to Follow-up|2
1319449|NCT02480621|4320720|P1|Follow Up|Lost to Follow-up|4
1319450|NCT02480621|4320719|P2|Randomization|Surgeon did not give intervention|1
1319451|NCT02480621|4320720|P1|Randomization|Surgeon did not give intervention|0
1319452|NCT02480621|4320719|P2|Randomization|Withdrawal by Subject|0
1319453|NCT02480621|4320720|P1|Randomization|Withdrawal by Subject|1
1319454|NCT02480153|4320797|P2|Overall Study|Randomized but not treated|1
1319455|NCT02480153|4320798|P1|Overall Study|Randomized but not treated|0
1319456|NCT02480153|4320797|P2|Overall Study|Withdrew treatment; continued in study|14
1319457|NCT02480153|4320798|P1|Overall Study|Withdrew treatment; continued in study|6
1319458|NCT02480153|4320797|P2|Overall Study|Discontinued from treatment and study|12
1319459|NCT02480153|4320798|P1|Overall Study|Discontinued from treatment and study|5
1319460|NCT02480010|4320806|P2|Overall Study|Refused Treatment|3
1319461|NCT02480010|4320807|P1|Overall Study|Refused Treatment|0
1319462|NCT02480010|4320806|P2|Overall Study|Insufficient therapeutic response|29
1319463|NCT02480010|4320807|P1|Overall Study|Insufficient therapeutic response|31
1319464|NCT02480010|4320806|P2|Overall Study|Death|0
1319465|NCT02480010|4320807|P1|Overall Study|Death|1
1319466|NCT02480010|4320806|P2|Overall Study|Adverse Event|1
1319467|NCT02480010|4320807|P1|Overall Study|Adverse Event|3
1319468|NCT02479412|4320869|P9|Overall Study|Randomization to wrong PK sampling group|0
1319469|NCT02479412|4320870|P8|Overall Study|Randomization to wrong PK sampling group|0
1319470|NCT02479412|4320871|P7|Overall Study|Randomization to wrong PK sampling group|0
1319471|NCT02479412|4320872|P6|Overall Study|Randomization to wrong PK sampling group|0
1319472|NCT02479412|4320873|P5|Overall Study|Randomization to wrong PK sampling group|1
1319473|NCT02479412|4320874|P4|Overall Study|Randomization to wrong PK sampling group|0
1319474|NCT02479412|4320875|P3|Overall Study|Randomization to wrong PK sampling group|0
1319475|NCT02479412|4320876|P2|Overall Study|Randomization to wrong PK sampling group|0
1319476|NCT02479412|4320877|P1|Overall Study|Randomization to wrong PK sampling group|0
1319477|NCT02479412|4320869|P9|Overall Study|Study-specific withdrawal criteria|1
1319478|NCT02479412|4320870|P8|Overall Study|Study-specific withdrawal criteria|1
1319479|NCT02479412|4320871|P7|Overall Study|Study-specific withdrawal criteria|0
1319480|NCT02479412|4320872|P6|Overall Study|Study-specific withdrawal criteria|0
1319481|NCT02479412|4320873|P5|Overall Study|Study-specific withdrawal criteria|0
1319482|NCT02479412|4320874|P4|Overall Study|Study-specific withdrawal criteria|1
1319483|NCT02479412|4320875|P3|Overall Study|Study-specific withdrawal criteria|1
1319484|NCT02479412|4320876|P2|Overall Study|Study-specific withdrawal criteria|0
1319485|NCT02479412|4320877|P1|Overall Study|Study-specific withdrawal criteria|0
1319486|NCT02479412|4320869|P9|Overall Study|Adverse Event|0
1319487|NCT02479412|4320870|P8|Overall Study|Adverse Event|0
1319488|NCT02479412|4320871|P7|Overall Study|Adverse Event|0
1319489|NCT02479412|4320872|P6|Overall Study|Adverse Event|0
1319490|NCT02479412|4320873|P5|Overall Study|Adverse Event|0
1319491|NCT02479412|4320874|P4|Overall Study|Adverse Event|0
1319492|NCT02479412|4320875|P3|Overall Study|Adverse Event|1
1319493|NCT02479412|4320876|P2|Overall Study|Adverse Event|0
1319494|NCT02479412|4320877|P1|Overall Study|Adverse Event|0
1319495|NCT02479139|4320954|P6|Overall Study|Other Miscellaneous Reasons|0
1319496|NCT02479139|4320955|P5|Overall Study|Other Miscellaneous Reasons|1
1319497|NCT02479139|4320956|P4|Overall Study|Other Miscellaneous Reasons|1
1319498|NCT02479139|4320957|P3|Overall Study|Other Miscellaneous Reasons|1
1319499|NCT02479139|4320958|P2|Overall Study|Other Miscellaneous Reasons|0
1319500|NCT02479139|4320959|P1|Overall Study|Other Miscellaneous Reasons|1
1319501|NCT02479139|4320954|P6|Overall Study|Treatment Failure/Lack of Efficacy|0
1319502|NCT02479139|4320955|P5|Overall Study|Treatment Failure/Lack of Efficacy|0
1319589|NCT02474082|4321438|P1|Overall Study|Dose tapering not achieved|0
1319503|NCT02479139|4320956|P4|Overall Study|Treatment Failure/Lack of Efficacy|0
1319504|NCT02479139|4320957|P3|Overall Study|Treatment Failure/Lack of Efficacy|1
1319505|NCT02479139|4320958|P2|Overall Study|Treatment Failure/Lack of Efficacy|0
1319506|NCT02479139|4320959|P1|Overall Study|Treatment Failure/Lack of Efficacy|0
1319507|NCT02479139|4320954|P6|Overall Study|Withdrew Consent|1
1319508|NCT02479139|4320955|P5|Overall Study|Withdrew Consent|1
1319509|NCT02479139|4320956|P4|Overall Study|Withdrew Consent|4
1319510|NCT02479139|4320957|P3|Overall Study|Withdrew Consent|1
1319511|NCT02479139|4320958|P2|Overall Study|Withdrew Consent|6
1319512|NCT02479139|4320959|P1|Overall Study|Withdrew Consent|5
1319513|NCT02479139|4320954|P6|Overall Study|Lost to Follow-up|5
1319514|NCT02479139|4320955|P5|Overall Study|Lost to Follow-up|3
1319515|NCT02479139|4320956|P4|Overall Study|Lost to Follow-up|2
1319516|NCT02479139|4320957|P3|Overall Study|Lost to Follow-up|4
1319517|NCT02479139|4320958|P2|Overall Study|Lost to Follow-up|4
1319518|NCT02479139|4320959|P1|Overall Study|Lost to Follow-up|2
1319519|NCT02478632|4320992|P2|Overall Study|Other (Withdrawal from parent study)|5
1319520|NCT02478632|4320993|P1|Overall Study|Other (Withdrawal from parent study)|4
1319521|NCT02478372|4321020|P2|Overall Study|Death|2
1319522|NCT02478372|4321021|P1|Overall Study|Death|0
1319523|NCT02478372|4321020|P2|Overall Study|Lost to Follow-up|4
1319524|NCT02478372|4321021|P1|Overall Study|Lost to Follow-up|1
1319525|NCT02478372|4321020|P2|Overall Study|Protocol Violation|8
1319526|NCT02478372|4321021|P1|Overall Study|Protocol Violation|12
1319527|NCT02478164|4321043|P1|Overall Study|Withdrawal by Subject|1
1319528|NCT02478164|4321043|P1|Overall Study|Adverse Event|1
1319529|NCT02478164|4321043|P1|Overall Study|Lack of Efficacy|13
1319530|NCT02477605|4321056|P2|Overall Study|Administered gas during surgery|1
1319531|NCT02477605|4321057|P1|Overall Study|Administered gas during surgery|0
1319532|NCT02477605|4321056|P2|Overall Study|Withdrawal by Subject|1
1319533|NCT02477605|4321057|P1|Overall Study|Withdrawal by Subject|0
1319534|NCT02477605|4321056|P2|Overall Study|Lost to Follow-up|2
1319535|NCT02477605|4321057|P1|Overall Study|Lost to Follow-up|0
1319536|NCT02477605|4321056|P2|Overall Study|Discontinued prior to treatment|0
1319537|NCT02477605|4321057|P1|Overall Study|Discontinued prior to treatment|1
1319538|NCT02477527|4321071|P1|Overall Study|Screen Failure|3
1319539|NCT02477527|4321071|P1|Overall Study|Withdrawal by Subject|1
1319540|NCT02477527|4321071|P1|Overall Study|Lost to Follow-up|2
1319541|NCT02477020|4321081|P2|Overall Study|Lack of Efficacy|5
1319542|NCT02477020|4321082|P1|Overall Study|Lack of Efficacy|14
1319543|NCT02477020|4321081|P2|Overall Study|Reason not Specified|1
1319544|NCT02477020|4321082|P1|Overall Study|Reason not Specified|3
1319545|NCT02477020|4321081|P2|Overall Study|Voluntary Withdrawal|16
1319546|NCT02477020|4321082|P1|Overall Study|Voluntary Withdrawal|7
1319547|NCT02477020|4321081|P2|Overall Study|Pretreatment Event/Adverse Event|6
1319548|NCT02477020|4321082|P1|Overall Study|Pretreatment Event/Adverse Event|6
1319549|NCT02476994|4321112|P2|Overall Study|Based on feedback from FDA|0
1319550|NCT02476994|4321113|P1|Overall Study|Based on feedback from FDA|1
1319551|NCT02476617|4321182|P1|Overall Study|Lost to Follow-up|1
1319552|NCT02476617|4321182|P1|Overall Study|Adverse Event|1
1319553|NCT02476422|4321211|P2|Overall Study|Subject/guardian decision|1
1319554|NCT02476422|4321212|P1|Overall Study|Subject/guardian decision|0
1319555|NCT02476175|4321242|P1|Overall Study|Adverse Event|2
1319556|NCT02475980|4321266|P1|Overall Study|Withdrawal by Subject|1
1319557|NCT02475980|4321266|P1|Overall Study|Lost to Follow-up|4
1319558|NCT02475733|4321277|P2|Overall Study|Physician Decision|0
1319559|NCT02475733|4321278|P1|Overall Study|Physician Decision|1
1319560|NCT02475733|4321277|P2|Overall Study|Withdrawal by Subject|0
1319561|NCT02475733|4321278|P1|Overall Study|Withdrawal by Subject|1
1319562|NCT02475564|4321335|P2|Overall Study|Intense Menstrual bleeding|0
1319563|NCT02475564|4321336|P1|Overall Study|Intense Menstrual bleeding|1
1319564|NCT02475564|4321335|P2|Overall Study|Lost to Follow-up|1
1319565|NCT02475564|4321336|P1|Overall Study|Lost to Follow-up|2
1319566|NCT02475564|4321335|P2|Overall Study|Withdrawal by Subject|0
1319567|NCT02475564|4321336|P1|Overall Study|Withdrawal by Subject|1
1319568|NCT02475395|4321348|P2|Overall Study|Protocol Violation|3
1319569|NCT02475395|4321349|P1|Overall Study|Protocol Violation|30
1319570|NCT02475278|4321359|P1|Overall Study|Reason Not Specified|1
1319571|NCT02475278|4321359|P1|Overall Study|Lost to Follow-up|1
1319572|NCT02474589|4321406|P2|Overall Study|Inability to complete study procedures|1
1319573|NCT02474589|4321407|P1|Overall Study|Inability to complete study procedures|5
1319574|NCT02474589|4321406|P2|Overall Study|Withdrawal by Subject|0
1319575|NCT02474589|4321407|P1|Overall Study|Withdrawal by Subject|4
1319576|NCT02474589|4321406|P2|Overall Study|Protocol Violation|1
1319577|NCT02474589|4321407|P1|Overall Study|Protocol Violation|4
1319578|NCT02474589|4321406|P2|Overall Study|Lost to Follow-up|1
1319579|NCT02474589|4321407|P1|Overall Study|Lost to Follow-up|6
1319580|NCT02474589|4321406|P2|Overall Study|Adverse Event|2
1319581|NCT02474589|4321407|P1|Overall Study|Adverse Event|6
1319582|NCT02474082|4321437|P2|Overall Study|Protocol deviation|1
1319583|NCT02474082|4321438|P1|Overall Study|Protocol deviation|0
1319584|NCT02474082|4321437|P2|Overall Study|Non-compliance with study treatment|2
1319585|NCT02474082|4321438|P1|Overall Study|Non-compliance with study treatment|0
1319586|NCT02474082|4321437|P2|Overall Study|Participant/guardian decision|2
1319587|NCT02474082|4321438|P1|Overall Study|Participant/guardian decision|1
1319588|NCT02474082|4321437|P2|Overall Study|Dose tapering not achieved|4
1319590|NCT02474082|4321437|P2|Overall Study|Lost to Follow-up|2
1319591|NCT02474082|4321438|P1|Overall Study|Lost to Follow-up|2
1319592|NCT02474082|4321437|P2|Overall Study|Withdrawal of informed consent|11
1319593|NCT02474082|4321438|P1|Overall Study|Withdrawal of informed consent|1
1319594|NCT02474082|4321437|P2|Overall Study|Adverse Event|32
1319595|NCT02474082|4321438|P1|Overall Study|Adverse Event|2
1319596|NCT02473640|4321512|P1|Treatment Period 1|Adverse Event|1
1319597|NCT02473523|4321521|P1|Overall Study|Lost to Follow-up|1
1319598|NCT02473523|4321521|P1|Overall Study|Death|1
1319599|NCT02473510|4321542|P2|Overall Study|Lost to Follow-up|2
1319600|NCT02473510|4321543|P1|Overall Study|Lost to Follow-up|1
1319601|NCT02473471|4321557|P1|Overall Study|Lost to Follow-up|1
1319602|NCT02473471|4321557|P1|Overall Study|poor oral hygiene|2
1319603|NCT02473445|4321588|P1|Overall Study|Sponsor Decision|20
1319604|NCT02473445|4321588|P1|Overall Study|Withdrawal by Subject|2
1319605|NCT02473367|4321594|P1|Period 4|Lost to Follow-up|1
1319606|NCT02473367|4321594|P1|Wait 1|Withdrawal by Subject|1
1319607|NCT02472977|4321615|P3|Overall Study|Subject request to discontinue treatment|0
1319608|NCT02472977|4321616|P2|Overall Study|Subject request to discontinue treatment|1
1319609|NCT02472977|4321617|P1|Overall Study|Subject request to discontinue treatment|0
1319610|NCT02472977|4321615|P3|Overall Study|Study drug toxicity|2
1319611|NCT02472977|4321616|P2|Overall Study|Study drug toxicity|0
1319612|NCT02472977|4321617|P1|Overall Study|Study drug toxicity|2
1319613|NCT02472977|4321615|P3|Overall Study|Withdrawal by Subject|0
1319614|NCT02472977|4321616|P2|Overall Study|Withdrawal by Subject|1
1319615|NCT02472977|4321617|P1|Overall Study|Withdrawal by Subject|0
1319616|NCT02472977|4321615|P3|Overall Study|Disease progression|6
1319617|NCT02472977|4321616|P2|Overall Study|Disease progression|25
1319618|NCT02472977|4321617|P1|Overall Study|Disease progression|4
1319619|NCT02472886|4321643|P3|Overall Study|Lack of Efficacy|1
1319620|NCT02472886|4321644|P2|Overall Study|Lack of Efficacy|2
1319621|NCT02472886|4321645|P1|Overall Study|Lack of Efficacy|0
1319622|NCT02472847|4321673|P2|Overall Study|Withdrawal by Subject|5
1319623|NCT02472847|4321674|P1|Overall Study|Withdrawal by Subject|1
1319624|NCT02472756|4321680|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
1319625|NCT02472756|4321680|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
1319626|NCT02472756|4321680|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
1319627|NCT02472756|4321680|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
1319628|NCT02472756|4321680|P1|Induction (Approximately 6 Months)|Adverse Event|1
1319629|NCT02472639|4321688|P2|Overall Study|Physician Decision|3
1319630|NCT02472639|4321689|P1|Overall Study|Physician Decision|4
1319631|NCT02472405|4321736|P1|Overall Study|Adverse Event|1
1319632|NCT02472405|4321736|P1|Overall Study|Lost to Follow-up|9
1319633|NCT02472366|4321744|P2|Overall Study|Lost to Follow-up|0
1319634|NCT02472366|4321745|P1|Overall Study|Lost to Follow-up|1
1319635|NCT02471755|4321761|P2|Overall Study|Lost to Follow-up|1
1319636|NCT02471755|4321762|P1|Overall Study|Lost to Follow-up|0
1319637|NCT02471755|4321761|P2|Overall Study|Withdrawal by Subject|0
1319638|NCT02471755|4321762|P1|Overall Study|Withdrawal by Subject|1
1319639|NCT02471612|4321778|P1|Overall Study|Lost to Follow-up|2
1319640|NCT02471183|4321800|P1|Extended Treatment Period|Lack of Efficacy|1
1319641|NCT02471183|4321800|P1|Main Treatment Period|Withdrawal by Subject|1
1319642|NCT02471183|4321800|P1|Main Treatment Period|Adverse Event|1
1319643|NCT02470429|4321836|P2|Overall Study|Withdrawal by Subject|0
1319644|NCT02470429|4321837|P1|Overall Study|Withdrawal by Subject|1
1319645|NCT02470429|4321836|P2|Overall Study|Adverse Event|0
1319646|NCT02470429|4321837|P1|Overall Study|Adverse Event|1
1319647|NCT02470403|4321855|P5|Overall Study|Subject/guardian decision|0
1319648|NCT02470403|4321856|P4|Overall Study|Subject/guardian decision|4
1319649|NCT02470403|4321857|P3|Overall Study|Subject/guardian decision|0
1319650|NCT02470403|4321858|P2|Overall Study|Subject/guardian decision|0
1319651|NCT02470403|4321859|P1|Overall Study|Subject/guardian decision|1
1319652|NCT02470403|4321855|P5|Overall Study|Lost to Follow-up|0
1319653|NCT02470403|4321856|P4|Overall Study|Lost to Follow-up|0
1319654|NCT02470403|4321857|P3|Overall Study|Lost to Follow-up|0
1319655|NCT02470403|4321858|P2|Overall Study|Lost to Follow-up|1
1319656|NCT02470403|4321859|P1|Overall Study|Lost to Follow-up|0
1319657|NCT02470403|4321855|P5|Overall Study|Adverse Event|0
1319658|NCT02470403|4321856|P4|Overall Study|Adverse Event|0
1319659|NCT02470403|4321857|P3|Overall Study|Adverse Event|0
1319660|NCT02470403|4321858|P2|Overall Study|Adverse Event|0
1319661|NCT02470403|4321859|P1|Overall Study|Adverse Event|1
1319662|NCT02469961|4321928|P2|Overall Study|Physician Decision|1
1319663|NCT02469961|4321929|P1|Overall Study|Physician Decision|4
1319664|NCT02469415|4321964|P1|Overall Study|Investigational agent placed on hold|2
1319665|NCT02469415|4321964|P1|Overall Study|Withdrawal by Subject|1
1319666|NCT02469298|4321972|P4|Overall Study|Withdrawal by Subject|1
1319667|NCT02469298|4321973|P3|Overall Study|Withdrawal by Subject|0
1319668|NCT02469298|4321974|P2|Overall Study|Withdrawal by Subject|0
1319669|NCT02469298|4321975|P1|Overall Study|Withdrawal by Subject|0
1319670|NCT02469298|4321972|P4|Overall Study|Physician Decision|1
1319671|NCT02469298|4321973|P3|Overall Study|Physician Decision|0
1319672|NCT02469298|4321974|P2|Overall Study|Physician Decision|0
1319673|NCT02469298|4321975|P1|Overall Study|Physician Decision|0
1319674|NCT02469298|4321972|P4|Overall Study|Lost to Follow-up|0
1319675|NCT02469298|4321973|P3|Overall Study|Lost to Follow-up|1
1319676|NCT02469298|4321974|P2|Overall Study|Lost to Follow-up|0
1319677|NCT02469298|4321975|P1|Overall Study|Lost to Follow-up|1
1319678|NCT02469298|4321972|P4|Overall Study|Protocol Violation|0
1319679|NCT02469298|4321973|P3|Overall Study|Protocol Violation|1
1319680|NCT02469298|4321974|P2|Overall Study|Protocol Violation|1
1319681|NCT02469298|4321975|P1|Overall Study|Protocol Violation|0
1319682|NCT02469246|4322115|P2|Overall Study|Lost to Follow-up|0
1319683|NCT02469246|4322116|P1|Overall Study|Lost to Follow-up|3
1319684|NCT02469246|4322115|P2|Overall Study|Withdrew Consent|6
1319685|NCT02469246|4322116|P1|Overall Study|Withdrew Consent|9
1319686|NCT02469246|4322115|P2|Overall Study|Protocol Violation|1
1319687|NCT02469246|4322116|P1|Overall Study|Protocol Violation|0
1319688|NCT02469246|4322115|P2|Overall Study|Non-Compliance with Study Drug|0
1319689|NCT02469246|4322116|P1|Overall Study|Non-Compliance with Study Drug|1
1319690|NCT02469246|4322115|P2|Overall Study|Investigator's Discretion|0
1319691|NCT02469246|4322116|P1|Overall Study|Investigator's Discretion|1
1319692|NCT02469246|4322115|P2|Overall Study|Lack of Efficacy|0
1319693|NCT02469246|4322116|P1|Overall Study|Lack of Efficacy|1
1319694|NCT02469246|4322115|P2|Overall Study|Death|0
1319695|NCT02469246|4322116|P1|Overall Study|Death|1
1319696|NCT02469246|4322115|P2|Overall Study|Adverse Event|5
1319697|NCT02469246|4322116|P1|Overall Study|Adverse Event|6
1319698|NCT02469246|4322115|P2|Overall Study|Still in Study up to the Data Cut Date|264
1319699|NCT02469246|4322116|P1|Overall Study|Still in Study up to the Data Cut Date|258
1319700|NCT02469246|4322115|P2|Overall Study|Randomized and Never Treated|6
1319701|NCT02469246|4322116|P1|Overall Study|Randomized and Never Treated|5
1319702|NCT02469168|4322134|P2|Overall Study|Trial closed|0
1319703|NCT02469168|4322135|P1|Overall Study|Trial closed|1
1319704|NCT02468414|4322217|P2|Overall Study|Screen Failure|0
1319705|NCT02468414|4322218|P1|Overall Study|Screen Failure|1
1319706|NCT02468414|4322217|P2|Overall Study|Poor in-vitro secreting TARGTs|0
1319707|NCT02468414|4322218|P1|Overall Study|Poor in-vitro secreting TARGTs|1
1319708|NCT02468414|4322217|P2|Overall Study|Early Study Termination by Sponsor|0
1319709|NCT02468414|4322218|P1|Overall Study|Early Study Termination by Sponsor|1
1319710|NCT02466659|4322278|P2|Overall Study|Lost to Follow-up|2
1319711|NCT02466659|4322279|P1|Overall Study|Lost to Follow-up|5
1319712|NCT02466425|4322289|P2|Overall Study|Withdrawal by Parent/Guardian|0
1319713|NCT02466425|4322290|P1|Overall Study|Withdrawal by Parent/Guardian|2
1319714|NCT02466425|4322289|P2|Overall Study|Other|3
1319715|NCT02466425|4322290|P1|Overall Study|Other|1
1319716|NCT02466425|4322289|P2|Overall Study|Withdrawal by Subject|1
1319717|NCT02466425|4322290|P1|Overall Study|Withdrawal by Subject|0
1319718|NCT02466425|4322289|P2|Overall Study|Protocol Violation|0
1319719|NCT02466425|4322290|P1|Overall Study|Protocol Violation|1
1319720|NCT02466425|4322289|P2|Overall Study|Lost to Follow-up|0
1319721|NCT02466425|4322290|P1|Overall Study|Lost to Follow-up|3
1319722|NCT02466425|4322289|P2|Overall Study|Lack of Efficacy|1
1319723|NCT02466425|4322290|P1|Overall Study|Lack of Efficacy|4
1319724|NCT02466425|4322289|P2|Overall Study|Adverse Event|11
1319725|NCT02466425|4322290|P1|Overall Study|Adverse Event|3
1319726|NCT02465866|4322310|P4|Period 3|Withdrawal by Subject|0
1319727|NCT02465866|4322311|P3|Period 3|Withdrawal by Subject|0
1319728|NCT02465866|4322312|P2|Period 3|Withdrawal by Subject|1
1319729|NCT02465866|4322313|P1|Period 3|Withdrawal by Subject|0
1319730|NCT02465489|4322399|P1|Overall Study|Adverse Event|5
1319731|NCT02465463|4322428|P2|Overall Study|Protocol Violation|0
1319732|NCT02465463|4322429|P1|Overall Study|Protocol Violation|1
1319733|NCT02465463|4322428|P2|Overall Study|Death|0
1319734|NCT02465463|4322429|P1|Overall Study|Death|1
1319735|NCT02465463|4322428|P2|Overall Study|Lost to Follow-up|1
1319736|NCT02465463|4322429|P1|Overall Study|Lost to Follow-up|2
1319737|NCT02465203|4322476|P3|Overall Study|Patient/guardian decision|1
1319738|NCT02465203|4322477|P2|Overall Study|Patient/guardian decision|1
1319739|NCT02465203|4322478|P1|Overall Study|Patient/guardian decision|1
1319740|NCT02465203|4322476|P3|Overall Study|New therapy for study indication|0
1319741|NCT02465203|4322477|P2|Overall Study|New therapy for study indication|0
1319742|NCT02465203|4322478|P1|Overall Study|New therapy for study indication|4
1319743|NCT02465203|4322476|P3|Overall Study|Study terminated by sponsor|11
1319744|NCT02465203|4322477|P2|Overall Study|Study terminated by sponsor|34
1319745|NCT02465203|4322478|P1|Overall Study|Study terminated by sponsor|50
1319746|NCT02465203|4322476|P3|Overall Study|Protocol Violation|1
1319747|NCT02465203|4322477|P2|Overall Study|Protocol Violation|1
1319748|NCT02465203|4322478|P1|Overall Study|Protocol Violation|1
1319749|NCT02463409|4322573|P1|Overall Study|Screen failure|1
1319750|NCT02463409|4322573|P1|Overall Study|Withdrawal by Subject|1
1319751|NCT02463331|4322581|P2|Overall Study|Physician Decision|0
1319752|NCT02463331|4322582|P1|Overall Study|Physician Decision|3
1319753|NCT02463331|4322581|P2|Overall Study|Lack of Efficacy|0
1319754|NCT02463331|4322582|P1|Overall Study|Lack of Efficacy|6
1319755|NCT02463331|4322581|P2|Overall Study|Pregnancy|3
1319756|NCT02463331|4322582|P1|Overall Study|Pregnancy|2
1319757|NCT02463331|4322581|P2|Overall Study|Lost to Follow-up|1
1319758|NCT02463331|4322582|P1|Overall Study|Lost to Follow-up|1
1319759|NCT02463331|4322581|P2|Overall Study|Adverse Event|2
1319760|NCT02463331|4322582|P1|Overall Study|Adverse Event|4
1319761|NCT02463097|4322598|P1|Overall Study|Withdrawal by Subject|1
1319762|NCT02462720|4322604|P2|Part 2|Protocol Violation|1
1319763|NCT02462720|4322605|P1|Part 2|Protocol Violation|0
1319764|NCT02462720|4322604|P2|Part 2|Withdrawal by Subject|0
1319765|NCT02462720|4322605|P1|Part 2|Withdrawal by Subject|1
1319766|NCT02462473|4322615|P1|Overall Study|Other|3
1319767|NCT02462473|4322615|P1|Overall Study|Death|1
1319768|NCT02461589|4322750|P10|Overall Study|Withdrawal from trial before exposure|1
1319769|NCT02461589|4322751|P9|Overall Study|Withdrawal from trial before exposure|0
1319770|NCT02461589|4322752|P8|Overall Study|Withdrawal from trial before exposure|0
1319771|NCT02461589|4322753|P7|Overall Study|Withdrawal from trial before exposure|0
1319772|NCT02461589|4322754|P6|Overall Study|Withdrawal from trial before exposure|0
1319773|NCT02461589|4322755|P5|Overall Study|Withdrawal from trial before exposure|0
1319774|NCT02461589|4322756|P4|Overall Study|Withdrawal from trial before exposure|0
1319775|NCT02461589|4322757|P3|Overall Study|Withdrawal from trial before exposure|0
1319776|NCT02461589|4322758|P2|Overall Study|Withdrawal from trial before exposure|0
1319777|NCT02461589|4322759|P1|Overall Study|Withdrawal from trial before exposure|0
1319778|NCT02461589|4322750|P10|Overall Study|Missing follow-up information|0
1319779|NCT02461589|4322751|P9|Overall Study|Missing follow-up information|0
1319780|NCT02461589|4322752|P8|Overall Study|Missing follow-up information|0
1319781|NCT02461589|4322753|P7|Overall Study|Missing follow-up information|1
1319782|NCT02461589|4322754|P6|Overall Study|Missing follow-up information|0
1319783|NCT02461589|4322755|P5|Overall Study|Missing follow-up information|0
1319784|NCT02461589|4322756|P4|Overall Study|Missing follow-up information|0
1319785|NCT02461589|4322757|P3|Overall Study|Missing follow-up information|0
1319786|NCT02461589|4322758|P2|Overall Study|Missing follow-up information|1
1319787|NCT02461589|4322759|P1|Overall Study|Missing follow-up information|1
1319788|NCT02461589|4322750|P10|Overall Study|Unclassified|2
1319789|NCT02461589|4322751|P9|Overall Study|Unclassified|0
1319790|NCT02461589|4322752|P8|Overall Study|Unclassified|0
1319791|NCT02461589|4322753|P7|Overall Study|Unclassified|1
1319792|NCT02461589|4322754|P6|Overall Study|Unclassified|0
1319793|NCT02461589|4322755|P5|Overall Study|Unclassified|0
1319794|NCT02461589|4322756|P4|Overall Study|Unclassified|0
1319795|NCT02461589|4322757|P3|Overall Study|Unclassified|0
1319796|NCT02461589|4322758|P2|Overall Study|Unclassified|0
1319797|NCT02461589|4322759|P1|Overall Study|Unclassified|0
1319798|NCT02461589|4322750|P10|Overall Study|Death|0
1319799|NCT02461589|4322751|P9|Overall Study|Death|0
1319800|NCT02461589|4322752|P8|Overall Study|Death|1
1319801|NCT02461589|4322753|P7|Overall Study|Death|0
1319802|NCT02461589|4322754|P6|Overall Study|Death|0
1319803|NCT02461589|4322755|P5|Overall Study|Death|0
1319804|NCT02461589|4322756|P4|Overall Study|Death|0
1319805|NCT02461589|4322757|P3|Overall Study|Death|0
1319806|NCT02461589|4322758|P2|Overall Study|Death|0
1319807|NCT02461589|4322759|P1|Overall Study|Death|0
1319808|NCT02461589|4322750|P10|Overall Study|Lost to Follow-up|1
1319809|NCT02461589|4322751|P9|Overall Study|Lost to Follow-up|3
1319810|NCT02461589|4322752|P8|Overall Study|Lost to Follow-up|1
1319811|NCT02461589|4322753|P7|Overall Study|Lost to Follow-up|3
1319812|NCT02461589|4322754|P6|Overall Study|Lost to Follow-up|1
1319813|NCT02461589|4322755|P5|Overall Study|Lost to Follow-up|1
1319814|NCT02461589|4322756|P4|Overall Study|Lost to Follow-up|3
1319815|NCT02461589|4322757|P3|Overall Study|Lost to Follow-up|2
1319816|NCT02461589|4322758|P2|Overall Study|Lost to Follow-up|0
1319817|NCT02461589|4322759|P1|Overall Study|Lost to Follow-up|0
1319818|NCT02461589|4322750|P10|Overall Study|Withdrawal by Subject|1
1319819|NCT02461589|4322751|P9|Overall Study|Withdrawal by Subject|3
1319820|NCT02461589|4322752|P8|Overall Study|Withdrawal by Subject|3
1319821|NCT02461589|4322753|P7|Overall Study|Withdrawal by Subject|1
1319822|NCT02461589|4322754|P6|Overall Study|Withdrawal by Subject|2
1319823|NCT02461589|4322755|P5|Overall Study|Withdrawal by Subject|1
1319824|NCT02461589|4322756|P4|Overall Study|Withdrawal by Subject|2
1319825|NCT02461589|4322757|P3|Overall Study|Withdrawal by Subject|3
1319826|NCT02461589|4322758|P2|Overall Study|Withdrawal by Subject|1
1319827|NCT02461589|4322759|P1|Overall Study|Withdrawal by Subject|5
1319828|NCT02461290|4322844|P1|Overall Study|Lost to Follow-up|3
1319829|NCT02461290|4322844|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
1319830|NCT02461134|4322851|P1|Overall Study|Adverse Event|1
1319831|NCT02460991|4322859|P2|Overall Study|Withdrawal by Subject|2
1319832|NCT02460991|4322860|P1|Overall Study|Withdrawal by Subject|0
1319833|NCT02460822|4322866|P1|Overall Study|Withdrawal by Subject|1
1319834|NCT02460159|4322883|P2|Overall Study|Withdrawal by Subject|0
1319835|NCT02460159|4322884|P1|Overall Study|Withdrawal by Subject|2
1319836|NCT02460159|4322883|P2|Overall Study|Adverse Event|1
1319837|NCT02460159|4322884|P1|Overall Study|Adverse Event|4
1319838|NCT02459418|4322914|P2|Overall Study|Abnormal Transvaginal Ultrasound|0
1319839|NCT02459418|4322915|P1|Overall Study|Abnormal Transvaginal Ultrasound|1
1319840|NCT02459418|4322914|P2|Overall Study|Elevated Creatine Kinase|0
1319841|NCT02459418|4322915|P1|Overall Study|Elevated Creatine Kinase|1
1319842|NCT02459418|4322914|P2|Overall Study|Withdrawal by Subject|1
1319843|NCT02459418|4322915|P1|Overall Study|Withdrawal by Subject|1
1319844|NCT02459418|4322914|P2|Overall Study|Adverse Event|1
1319845|NCT02459418|4322915|P1|Overall Study|Adverse Event|0
1319846|NCT02459418|4322914|P2|Overall Study|Endometrial thickness of >5 mm|0
1319847|NCT02459418|4322915|P1|Overall Study|Endometrial thickness of >5 mm|1
1319848|NCT02459418|4322914|P2|Overall Study|Physician Decision|2
1319849|NCT02459418|4322915|P1|Overall Study|Physician Decision|0
1319850|NCT02459418|4322914|P2|Overall Study|Protocol Violation|2
1319851|NCT02459418|4322915|P1|Overall Study|Protocol Violation|0
1319852|NCT02459418|4322914|P2|Overall Study|Exclusion Criteria|0
1319853|NCT02459418|4322915|P1|Overall Study|Exclusion Criteria|4
1319854|NCT02459093|4322937|P2|Overall Study|Lost to Follow-up|7
1319855|NCT02459093|4322938|P1|Overall Study|Lost to Follow-up|6
1319856|NCT02459093|4322937|P2|Overall Study|Protocol Violation|11
1319857|NCT02459093|4322938|P1|Overall Study|Protocol Violation|6
1319858|NCT02458287|4322982|P4|Overall Study|Relocated Out of State|1
1319859|NCT02458287|4322983|P3|Overall Study|Relocated Out of State|0
1319860|NCT02458287|4322984|P2|Overall Study|Relocated Out of State|0
1319861|NCT02458287|4322985|P1|Overall Study|Relocated Out of State|0
1319862|NCT02458287|4322982|P4|Overall Study|Withdrawal by Subject|1
1319863|NCT02458287|4322983|P3|Overall Study|Withdrawal by Subject|2
1319864|NCT02458287|4322984|P2|Overall Study|Withdrawal by Subject|2
1319865|NCT02458287|4322985|P1|Overall Study|Withdrawal by Subject|0
1319866|NCT02458287|4322982|P4|Overall Study|Protocol Violation|0
1319867|NCT02458287|4322983|P3|Overall Study|Protocol Violation|0
1319868|NCT02458287|4322984|P2|Overall Study|Protocol Violation|1
1319869|NCT02458287|4322985|P1|Overall Study|Protocol Violation|0
1319870|NCT02458287|4322982|P4|Overall Study|Lost to Follow-up|0
1319871|NCT02458287|4322983|P3|Overall Study|Lost to Follow-up|1
1319872|NCT02458287|4322984|P2|Overall Study|Lost to Follow-up|1
1319873|NCT02458287|4322985|P1|Overall Study|Lost to Follow-up|0
1319874|NCT02458287|4322982|P4|Overall Study|Adverse Event|1
1319875|NCT02458287|4322983|P3|Overall Study|Adverse Event|0
1319876|NCT02458287|4322984|P2|Overall Study|Adverse Event|0
1319877|NCT02458287|4322985|P1|Overall Study|Adverse Event|0
1319878|NCT02457793|4323036|P6|Overall Study|Physician Decision|3
1319879|NCT02457793|4323037|P5|Overall Study|Physician Decision|1
1319880|NCT02457793|4323038|P4|Overall Study|Physician Decision|1
1319881|NCT02457793|4323039|P3|Overall Study|Physician Decision|1
1319882|NCT02457793|4323040|P2|Overall Study|Physician Decision|0
1319883|NCT02457793|4323041|P1|Overall Study|Physician Decision|1
1319884|NCT02457793|4323036|P6|Overall Study|Adverse Event|0
1319885|NCT02457793|4323037|P5|Overall Study|Adverse Event|0
1319886|NCT02457793|4323038|P4|Overall Study|Adverse Event|1
1319887|NCT02457793|4323039|P3|Overall Study|Adverse Event|0
1319888|NCT02457793|4323040|P2|Overall Study|Adverse Event|0
1319889|NCT02457793|4323041|P1|Overall Study|Adverse Event|0
1319890|NCT02457793|4323036|P6|Overall Study|Withdrawal by Subject|2
1319891|NCT02457793|4323037|P5|Overall Study|Withdrawal by Subject|2
1319892|NCT02457793|4323038|P4|Overall Study|Withdrawal by Subject|2
1319893|NCT02457793|4323039|P3|Overall Study|Withdrawal by Subject|2
1319894|NCT02457793|4323040|P2|Overall Study|Withdrawal by Subject|4
1319895|NCT02457793|4323041|P1|Overall Study|Withdrawal by Subject|0
1319896|NCT02457793|4323036|P6|Overall Study|Reason not specified|1
1319897|NCT02457793|4323037|P5|Overall Study|Reason not specified|1
1319898|NCT02457793|4323038|P4|Overall Study|Reason not specified|1
1319899|NCT02457793|4323039|P3|Overall Study|Reason not specified|0
1319900|NCT02457793|4323040|P2|Overall Study|Reason not specified|0
1319901|NCT02457793|4323041|P1|Overall Study|Reason not specified|0
1319902|NCT02457611|4323185|P1|Overall Study|Lost to Follow-up|3
1319903|NCT02457247|4323244|P4|Period 2|Voluntary Withdrawal|0
1319904|NCT02457247|4323245|P3|Period 2|Voluntary Withdrawal|0
1319905|NCT02457247|4323246|P2|Period 2|Voluntary Withdrawal|1
1319906|NCT02457247|4323247|P1|Period 2|Voluntary Withdrawal|1
1319907|NCT02457247|4323244|P4|Period 2|Lost to Follow-up|0
1319908|NCT02457247|4323245|P3|Period 2|Lost to Follow-up|0
1319909|NCT02457247|4323246|P2|Period 2|Lost to Follow-up|1
1319910|NCT02457247|4323247|P1|Period 2|Lost to Follow-up|0
1319911|NCT02457247|4323244|P4|Period 2|Significant Protocol Deviation|0
1319912|NCT02457247|4323245|P3|Period 2|Significant Protocol Deviation|0
1319913|NCT02457247|4323246|P2|Period 2|Significant Protocol Deviation|0
1319914|NCT02457247|4323247|P1|Period 2|Significant Protocol Deviation|1
1319915|NCT02457247|4323244|P4|Period 2|Pretreatment Event/Adverse Event|0
1319916|NCT02457247|4323245|P3|Period 2|Pretreatment Event/Adverse Event|0
1319917|NCT02457247|4323246|P2|Period 2|Pretreatment Event/Adverse Event|1
1319918|NCT02457247|4323247|P1|Period 2|Pretreatment Event/Adverse Event|0
1319919|NCT02457247|4323244|P4|Period 1|Voluntary Withdrawal|0
1319920|NCT02457247|4323245|P3|Period 1|Voluntary Withdrawal|0
1319921|NCT02457247|4323246|P2|Period 1|Voluntary Withdrawal|0
1319922|NCT02457247|4323247|P1|Period 1|Voluntary Withdrawal|1
1319923|NCT02457247|4323244|P4|Period 1|Significant Protocol Deviation|0
1319924|NCT02457247|4323245|P3|Period 1|Significant Protocol Deviation|0
1319925|NCT02457247|4323246|P2|Period 1|Significant Protocol Deviation|1
1319926|NCT02457247|4323247|P1|Period 1|Significant Protocol Deviation|1
1319927|NCT02457247|4323244|P4|Period 1|Pretreatment Event/Adverse Event|0
1319928|NCT02457247|4323245|P3|Period 1|Pretreatment Event/Adverse Event|0
1319929|NCT02457247|4323246|P2|Period 1|Pretreatment Event/Adverse Event|1
1319930|NCT02457247|4323247|P1|Period 1|Pretreatment Event/Adverse Event|0
1319931|NCT02456740|4323270|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
1319932|NCT02456740|4323271|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
1319933|NCT02456740|4323272|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
1319934|NCT02456740|4323273|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
1319935|NCT02456740|4323274|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
1319936|NCT02456740|4323275|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
1319937|NCT02456740|4323276|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1319938|NCT02456740|4323277|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1319939|NCT02456740|4323278|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1319940|NCT02456740|4323270|P9|Active Treatment Phase (Weeks 24 - 52)|Death|0
1319941|NCT02456740|4323271|P8|Active Treatment Phase (Weeks 24 - 52)|Death|1
1319942|NCT02456740|4323272|P7|Active Treatment Phase (Weeks 24 - 52)|Death|0
1319943|NCT02456740|4323273|P6|Active Treatment Phase (Weeks 24 - 52)|Death|0
1319944|NCT02456740|4323274|P5|Active Treatment Phase (Weeks 24 - 52)|Death|0
1319945|NCT02456740|4323275|P4|Active Treatment Phase (Weeks 24 - 52)|Death|0
1319946|NCT02456740|4323276|P3|Active Treatment Phase (Weeks 24 - 52)|Death|0
1319947|NCT02456740|4323277|P2|Active Treatment Phase (Weeks 24 - 52)|Death|0
1319948|NCT02456740|4323278|P1|Active Treatment Phase (Weeks 24 - 52)|Death|0
1319949|NCT02456740|4323270|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
1319950|NCT02456740|4323271|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
1319951|NCT02456740|4323272|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
1319952|NCT02456740|4323273|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
1319953|NCT02456740|4323274|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
1319954|NCT02456740|4323275|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
1319955|NCT02456740|4323276|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1319956|NCT02456740|4323277|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1319957|NCT02456740|4323278|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1319958|NCT02456740|4323270|P9|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
1319959|NCT02456740|4323271|P8|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1319960|NCT02456740|4323272|P7|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1319961|NCT02456740|4323273|P6|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1319962|NCT02456740|4323274|P5|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
1319963|NCT02456740|4323275|P4|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
1319964|NCT02456740|4323276|P3|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1319965|NCT02456740|4323277|P2|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1319966|NCT02456740|4323278|P1|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1319967|NCT02456740|4323270|P9|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1319968|NCT02456740|4323271|P8|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1319969|NCT02456740|4323272|P7|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1319970|NCT02456740|4323273|P6|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1319971|NCT02456740|4323274|P5|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1319972|NCT02456740|4323275|P4|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1319973|NCT02456740|4323276|P3|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
1319974|NCT02456740|4323277|P2|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
1319975|NCT02456740|4323278|P1|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
1319976|NCT02456740|4323270|P9|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1319977|NCT02456740|4323271|P8|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1319978|NCT02456740|4323272|P7|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1319979|NCT02456740|4323273|P6|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1319980|NCT02456740|4323274|P5|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1319981|NCT02456740|4323275|P4|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1319982|NCT02456740|4323276|P3|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
1319983|NCT02456740|4323277|P2|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
1319984|NCT02456740|4323278|P1|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
1319985|NCT02456740|4323270|P9|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1319986|NCT02456740|4323271|P8|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1319987|NCT02456740|4323272|P7|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1319988|NCT02456740|4323273|P6|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1319989|NCT02456740|4323274|P5|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1319990|NCT02456740|4323275|P4|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1319991|NCT02456740|4323276|P3|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
1319992|NCT02456740|4323277|P2|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
1319993|NCT02456740|4323278|P1|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
1319994|NCT02455518|4323304|P4|Overall Study|Protocol Violation|3
1319995|NCT02455518|4323305|P3|Overall Study|Protocol Violation|1
1319996|NCT02455518|4323306|P2|Overall Study|Protocol Violation|1
1319997|NCT02455518|4323307|P1|Overall Study|Protocol Violation|0
1319998|NCT02455388|4323323|P3|Overall Study|Withdrawal by Subject|7
1319999|NCT02455388|4323324|P2|Overall Study|Withdrawal by Subject|0
1320000|NCT02455388|4323325|P1|Overall Study|Withdrawal by Subject|0
1320001|NCT02455388|4323323|P3|Overall Study|Protocol Violation|4
1320002|NCT02455388|4323324|P2|Overall Study|Protocol Violation|0
1320003|NCT02455388|4323325|P1|Overall Study|Protocol Violation|1
1320004|NCT02455050|4323336|P4|Treatment Period 2|Lost to Follow-up|1
1320005|NCT02455050|4323337|P3|Treatment Period 2|Lost to Follow-up|2
1320006|NCT02455050|4323338|P2|Treatment Period 2|Lost to Follow-up|0
1320007|NCT02455050|4323339|P1|Treatment Period 2|Lost to Follow-up|1
1320008|NCT02455050|4323336|P4|Treatment Period 1|Lost to Follow-up|2
1320009|NCT02455050|4323337|P3|Treatment Period 1|Lost to Follow-up|1
1320010|NCT02455050|4323338|P2|Treatment Period 1|Lost to Follow-up|1
1320011|NCT02455050|4323339|P1|Treatment Period 1|Lost to Follow-up|1
1320012|NCT02454959|4323403|P1|Overall Study|Adverse Event|2
1320013|NCT02454959|4323403|P1|Overall Study|Withdrawal by Subject|3
1320014|NCT02454959|4323403|P1|Overall Study|Physician Decision|1
1320015|NCT02454959|4323403|P1|Overall Study|Protocol-Specified Criteria|3
1320016|NCT02454933|4323423|P2|Overall Study|Withdrawal by Subject|2
1320017|NCT02454933|4323424|P1|Overall Study|Withdrawal by Subject|0
1320018|NCT02454933|4323423|P2|Overall Study|Adverse Event|1
1320019|NCT02454933|4323424|P1|Overall Study|Adverse Event|1
1320020|NCT02454933|4323423|P2|Overall Study|Progressive disease|5
1320021|NCT02454933|4323424|P1|Overall Study|Progressive disease|7
1320022|NCT02454608|4323432|P3|Open Label Period|Withdrawal by Subject|8
1320023|NCT02454608|4323433|P2|Open Label Period|Withdrawal by Subject|0
1320024|NCT02454608|4323434|P1|Open Label Period|Withdrawal by Subject|0
1320025|NCT02454608|4323432|P3|Open Label Period|Lost to Follow-up|11
1320026|NCT02454608|4323433|P2|Open Label Period|Lost to Follow-up|0
1320027|NCT02454608|4323434|P1|Open Label Period|Lost to Follow-up|0
1320028|NCT02454608|4323432|P3|Double-Blind Period|Lack of Efficacy|0
1320029|NCT02454608|4323433|P2|Double-Blind Period|Lack of Efficacy|2
1320030|NCT02454608|4323434|P1|Double-Blind Period|Lack of Efficacy|0
1320031|NCT02454101|4323526|P2|Overall Study|Lost to Follow-up|4
1320032|NCT02454101|4323527|P1|Overall Study|Lost to Follow-up|3
1320033|NCT02454101|4323526|P2|Overall Study|Adverse Event|3
1320034|NCT02454101|4323527|P1|Overall Study|Adverse Event|2
1320035|NCT02453321|4323587|P3|Overall Study|Deep Venous Thrombosis|0
1320036|NCT02453321|4323588|P2|Overall Study|Deep Venous Thrombosis|1
1320037|NCT02453321|4323589|P1|Overall Study|Deep Venous Thrombosis|0
1320038|NCT02453321|4323587|P3|Overall Study|Weakness|2
1320039|NCT02453321|4323588|P2|Overall Study|Weakness|1
1320040|NCT02453321|4323589|P1|Overall Study|Weakness|1
1320041|NCT02452892|4323621|P4|Follow-up|Subject left town on Day 42|0
1320042|NCT02452892|4323622|P3|Follow-up|Subject left town on Day 42|0
1320043|NCT02452892|4323623|P2|Follow-up|Subject left town on Day 42|0
1320044|NCT02452892|4323624|P1|Follow-up|Subject left town on Day 42|1
1320045|NCT02452892|4323621|P4|Follow-up|Withdrawal by Subject|1
1320046|NCT02452892|4323622|P3|Follow-up|Withdrawal by Subject|0
1320047|NCT02452892|4323623|P2|Follow-up|Withdrawal by Subject|0
1320048|NCT02452892|4323624|P1|Follow-up|Withdrawal by Subject|0
1320049|NCT02452892|4323621|P4|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
1320050|NCT02452892|4323622|P3|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
1320051|NCT02452892|4323623|P2|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
1320052|NCT02452892|4323624|P1|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
1320053|NCT02452892|4323621|P4|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
1320054|NCT02452892|4323622|P3|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
1320055|NCT02452892|4323623|P2|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
1320056|NCT02452892|4323624|P1|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
1320057|NCT02452892|4323621|P4|Week 1 Initial Randommization|Lost to Follow-up|0
1320058|NCT02452892|4323622|P3|Week 1 Initial Randommization|Lost to Follow-up|1
1320059|NCT02452892|4323623|P2|Week 1 Initial Randommization|Lost to Follow-up|0
1320060|NCT02452892|4323624|P1|Week 1 Initial Randommization|Lost to Follow-up|0
1320061|NCT02452892|4323621|P4|Week 1 Initial Randommization|Adverse Event|0
1320062|NCT02452892|4323622|P3|Week 1 Initial Randommization|Adverse Event|0
1320063|NCT02452892|4323623|P2|Week 1 Initial Randommization|Adverse Event|0
1320064|NCT02452892|4323624|P1|Week 1 Initial Randommization|Adverse Event|1
1320065|NCT02452320|4323696|P2|Overall Study|Adverse Event|1
1320066|NCT02452320|4323697|P1|Overall Study|Adverse Event|0
1320067|NCT02451917|4323709|P2|First Intervention (24 Weeks)|Adverse Event|2
1320068|NCT02451917|4323710|P1|First Intervention (24 Weeks)|Adverse Event|0
1320069|NCT02451917|4323709|P2|First Intervention (24 Weeks)|Death|1
1320070|NCT02451917|4323710|P1|First Intervention (24 Weeks)|Death|0
1320071|NCT02451917|4323709|P2|First Intervention (24 Weeks)|Lost to Follow-up|0
1320072|NCT02451917|4323710|P1|First Intervention (24 Weeks)|Lost to Follow-up|2
1320073|NCT02451358|4323732|P4|Overall Study|Protocol Violation|0
1320074|NCT02451358|4323733|P3|Overall Study|Protocol Violation|1
1320075|NCT02451358|4323734|P2|Overall Study|Protocol Violation|1
1320076|NCT02451358|4323735|P1|Overall Study|Protocol Violation|0
1320077|NCT02451358|4323732|P4|Overall Study|Withdrawal by Subject|0
1320078|NCT02451358|4323733|P3|Overall Study|Withdrawal by Subject|0
1320079|NCT02451358|4323734|P2|Overall Study|Withdrawal by Subject|1
1320080|NCT02451358|4323735|P1|Overall Study|Withdrawal by Subject|1
1320081|NCT02450539|4323841|P2|Overall Study|On study treatment/follow up|25
1320082|NCT02450539|4323842|P1|Overall Study|On study treatment/follow up|27
1320083|NCT02450539|4323841|P2|Overall Study|Lost to Follow-up|1
1320084|NCT02450539|4323842|P1|Overall Study|Lost to Follow-up|4
1320085|NCT02450539|4323841|P2|Overall Study|Withdrawal by Subject|7
1320086|NCT02450539|4323842|P1|Overall Study|Withdrawal by Subject|19
1320087|NCT02449915|4323879|P2|Overall Study|Abnormal preop lab|1
1320088|NCT02449915|4323880|P1|Overall Study|Abnormal preop lab|0
1320089|NCT02449915|4323879|P2|Overall Study|Intraoperative surgical findings|1
1320090|NCT02449915|4323880|P1|Overall Study|Intraoperative surgical findings|1
1320091|NCT02449915|4323879|P2|Overall Study|Withdrawal by Subject|2
1320092|NCT02449915|4323880|P1|Overall Study|Withdrawal by Subject|0
1320093|NCT02449915|4323879|P2|Overall Study|Exclusion criteria - drug use|0
1320094|NCT02449915|4323880|P1|Overall Study|Exclusion criteria - drug use|1
1320095|NCT02449902|4323888|P2|Overall Study|Withdrawal by Subject|1
1320096|NCT02449902|4323889|P1|Overall Study|Withdrawal by Subject|0
1320097|NCT02449902|4323888|P2|Overall Study|Adverse Event|1
1320098|NCT02449902|4323889|P1|Overall Study|Adverse Event|0
1320099|NCT02449044|4323944|P1|Overall Study|Sponsor Discontinued Trial|3
1320100|NCT02449044|4323944|P1|Overall Study|Physician Decision|9
1320101|NCT02449044|4323944|P1|Overall Study|Met Withdrawal Criteria|7
1320102|NCT02449044|4323944|P1|Overall Study|Adverse Event|30
1320103|NCT02449044|4323944|P1|Overall Study|Withdrawal by Subject|13
1320104|NCT02449044|4323944|P1|Overall Study|Lost to Follow-up|2
1320105|NCT02449018|4323965|P2|Overall Study|Patient decision|0
1320106|NCT02449018|4323966|P1|Overall Study|Patient decision|2
1320107|NCT02449018|4323965|P2|Overall Study|Protocol deviation|0
1320108|NCT02449018|4323966|P1|Overall Study|Protocol deviation|4
1320109|NCT02449018|4323965|P2|Overall Study|Adverse Event|1
1320110|NCT02449018|4323966|P1|Overall Study|Adverse Event|5
1320111|NCT02449018|4323965|P2|Overall Study|Administrative problems|0
1320112|NCT02449018|4323966|P1|Overall Study|Administrative problems|1
1320113|NCT02449018|4323965|P2|Overall Study|Abnormal laboratory value|1
1320114|NCT02449018|4323966|P1|Overall Study|Abnormal laboratory value|0
1320115|NCT02448810|4324035|P8|Overall Study|Other (unspecified)|0
1320116|NCT02448810|4324036|P7|Overall Study|Other (unspecified)|2
1320117|NCT02448810|4324037|P6|Overall Study|Other (unspecified)|0
1320118|NCT02448810|4324038|P5|Overall Study|Other (unspecified)|0
1320119|NCT02448810|4324039|P4|Overall Study|Other (unspecified)|0
1320120|NCT02448810|4324040|P3|Overall Study|Other (unspecified)|0
1320121|NCT02448810|4324041|P2|Overall Study|Other (unspecified)|0
1320122|NCT02448810|4324042|P1|Overall Study|Other (unspecified)|0
1320123|NCT02448810|4324035|P8|Overall Study|Lost to Follow-up|0
1320124|NCT02448810|4324036|P7|Overall Study|Lost to Follow-up|0
1320125|NCT02448810|4324037|P6|Overall Study|Lost to Follow-up|0
1320126|NCT02448810|4324038|P5|Overall Study|Lost to Follow-up|0
1320127|NCT02448810|4324039|P4|Overall Study|Lost to Follow-up|0
1320128|NCT02448810|4324040|P3|Overall Study|Lost to Follow-up|0
1320129|NCT02448810|4324041|P2|Overall Study|Lost to Follow-up|1
1320130|NCT02448810|4324042|P1|Overall Study|Lost to Follow-up|0
1320131|NCT02448810|4324035|P8|Overall Study|Other (Progressive disease)|5
1320132|NCT02448810|4324036|P7|Overall Study|Other (Progressive disease)|14
1320133|NCT02448810|4324037|P6|Overall Study|Other (Progressive disease)|9
1320134|NCT02448810|4324038|P5|Overall Study|Other (Progressive disease)|23
1320135|NCT02448810|4324039|P4|Overall Study|Other (Progressive disease)|3
1320136|NCT02448810|4324040|P3|Overall Study|Other (Progressive disease)|0
1320137|NCT02448810|4324041|P2|Overall Study|Other (Progressive disease)|2
1320138|NCT02448810|4324042|P1|Overall Study|Other (Progressive disease)|2
1320139|NCT02448810|4324035|P8|Overall Study|Death|0
1320140|NCT02448810|4324036|P7|Overall Study|Death|0
1320141|NCT02448810|4324037|P6|Overall Study|Death|0
1320142|NCT02448810|4324038|P5|Overall Study|Death|1
1320143|NCT02448810|4324039|P4|Overall Study|Death|0
1320144|NCT02448810|4324040|P3|Overall Study|Death|1
1320145|NCT02448810|4324041|P2|Overall Study|Death|0
1320146|NCT02448810|4324042|P1|Overall Study|Death|1
1320147|NCT02448810|4324035|P8|Overall Study|Other (study terminated by sponsor)|1
1320148|NCT02448810|4324036|P7|Overall Study|Other (study terminated by sponsor)|2
1320149|NCT02448810|4324037|P6|Overall Study|Other (study terminated by sponsor)|2
1320150|NCT02448810|4324038|P5|Overall Study|Other (study terminated by sponsor)|4
1320151|NCT02448810|4324039|P4|Overall Study|Other (study terminated by sponsor)|0
1320152|NCT02448810|4324040|P3|Overall Study|Other (study terminated by sponsor)|0
1320153|NCT02448810|4324041|P2|Overall Study|Other (study terminated by sponsor)|0
1320154|NCT02448810|4324042|P1|Overall Study|Other (study terminated by sponsor)|0
1320155|NCT02448810|4324035|P8|Overall Study|Withdrawal by Subject|2
1320156|NCT02448810|4324036|P7|Overall Study|Withdrawal by Subject|0
1320157|NCT02448810|4324037|P6|Overall Study|Withdrawal by Subject|5
1320158|NCT02448810|4324038|P5|Overall Study|Withdrawal by Subject|3
1320159|NCT02448810|4324039|P4|Overall Study|Withdrawal by Subject|0
1320160|NCT02448810|4324040|P3|Overall Study|Withdrawal by Subject|1
1320161|NCT02448810|4324041|P2|Overall Study|Withdrawal by Subject|0
1320162|NCT02448810|4324042|P1|Overall Study|Withdrawal by Subject|0
1320163|NCT02448810|4324035|P8|Overall Study|Adverse Event|0
1320164|NCT02448810|4324036|P7|Overall Study|Adverse Event|0
1320165|NCT02448810|4324037|P6|Overall Study|Adverse Event|0
1320166|NCT02448810|4324038|P5|Overall Study|Adverse Event|0
1320167|NCT02448810|4324039|P4|Overall Study|Adverse Event|0
1320168|NCT02448810|4324040|P3|Overall Study|Adverse Event|1
1320169|NCT02448810|4324041|P2|Overall Study|Adverse Event|0
1320170|NCT02448810|4324042|P1|Overall Study|Adverse Event|0
1320171|NCT02448563|4324112|P2|Overall Study|Withdrawal by Subject|1
1320172|NCT02448563|4324113|P1|Overall Study|Withdrawal by Subject|0
1320173|NCT02448563|4324112|P2|Overall Study|Lost to Follow-up|10
1320174|NCT02448563|4324113|P1|Overall Study|Lost to Follow-up|16
1320175|NCT02448537|4324135|P3|Overall Study|Withdrawal by Subject|1
1320176|NCT02448537|4324136|P2|Overall Study|Withdrawal by Subject|1
1320177|NCT02448537|4324137|P1|Overall Study|Withdrawal by Subject|1
1320178|NCT02447848|4324240|P1|Overall Study|Withdrawal by Subject|4
1320179|NCT02447848|4324240|P1|Overall Study|Lack of Efficacy|4
1320180|NCT02447848|4324240|P1|Overall Study|Patient discharged|3
1320181|NCT02447458|4324252|P6|Overall Study|Other|0
1320182|NCT02447458|4324253|P5|Overall Study|Other|0
1320183|NCT02447458|4324254|P4|Overall Study|Other|0
1320184|NCT02447458|4324255|P3|Overall Study|Other|1
1320185|NCT02447458|4324256|P2|Overall Study|Other|0
1320186|NCT02447458|4324257|P1|Overall Study|Other|0
1320187|NCT02447432|4324355|P2|Epoch 001|Lost to Follow-up|3
1320188|NCT02447432|4324356|P1|Epoch 001|Lost to Follow-up|1
1320189|NCT02447432|4324355|P2|Epoch 001|Migrated/moved from study area|5
1320190|NCT02447432|4324356|P1|Epoch 001|Migrated/moved from study area|3
1320191|NCT02447432|4324355|P2|Epoch 001|Withdrawal by Subject|4
1320192|NCT02447432|4324356|P1|Epoch 001|Withdrawal by Subject|0
1320193|NCT02447432|4324355|P2|Epoch 001|Adverse Event|1
1320194|NCT02447432|4324356|P1|Epoch 001|Adverse Event|1
1320195|NCT02447328|4324388|P1|Overall Study|Withdrawal by Subject|1
1320196|NCT02447029|4324400|P2|Overall Study|Withdrawal by Subject|2
1320197|NCT02447029|4324401|P1|Overall Study|Withdrawal by Subject|3
1320198|NCT02446990|4324421|P2|Overall Study|Withdrawal by Subject|199
1320199|NCT02446990|4324422|P1|Overall Study|Withdrawal by Subject|231
1320200|NCT02446990|4324421|P2|Overall Study|Physician Decision|0
1320201|NCT02446990|4324422|P1|Overall Study|Physician Decision|1
1320202|NCT02446990|4324421|P2|Overall Study|Lost to Follow-up|1
1320203|NCT02446990|4324422|P1|Overall Study|Lost to Follow-up|3
1320204|NCT02446990|4324421|P2|Overall Study|Death|458
1320205|NCT02446990|4324422|P1|Overall Study|Death|485
1320206|NCT02446743|4324456|P2|Overall Study|Other|3
1320207|NCT02446743|4324457|P1|Overall Study|Other|2
1320208|NCT02446743|4324456|P2|Overall Study|Adverse Event|1
1320209|NCT02446743|4324457|P1|Overall Study|Adverse Event|1
1320210|NCT02446743|4324456|P2|Overall Study|Lost to Follow-up|0
1320211|NCT02446743|4324457|P1|Overall Study|Lost to Follow-up|1
1320212|NCT02446743|4324456|P2|Overall Study|Withdrawal by Subject|1
1320213|NCT02446743|4324457|P1|Overall Study|Withdrawal by Subject|1
1320214|NCT02446717|4324589|P5|Overall Study|Withdrew consent|0
1320215|NCT02446717|4324590|P4|Overall Study|Withdrew consent|1
1320216|NCT02446717|4324591|P3|Overall Study|Withdrew consent|0
1320217|NCT02446717|4324592|P2|Overall Study|Withdrew consent|0
1320218|NCT02446717|4324593|P1|Overall Study|Withdrew consent|0
1320219|NCT02446717|4324589|P5|Overall Study|Lost to Follow-up|1
1320220|NCT02446717|4324590|P4|Overall Study|Lost to Follow-up|0
1320221|NCT02446717|4324591|P3|Overall Study|Lost to Follow-up|1
1320222|NCT02446717|4324592|P2|Overall Study|Lost to Follow-up|1
1320223|NCT02446717|4324593|P1|Overall Study|Lost to Follow-up|0
1320224|NCT02446717|4324589|P5|Overall Study|Adverse Event|0
1320225|NCT02446717|4324590|P4|Overall Study|Adverse Event|0
1320226|NCT02446717|4324591|P3|Overall Study|Adverse Event|1
1320227|NCT02446717|4324592|P2|Overall Study|Adverse Event|0
1320228|NCT02446717|4324593|P1|Overall Study|Adverse Event|0
1320229|NCT02446171|4324674|P4|Overall Study|Withdrawal by Subject|0
1320230|NCT02446171|4324675|P3|Overall Study|Withdrawal by Subject|2
1320231|NCT02446171|4324676|P2|Overall Study|Withdrawal by Subject|0
1320232|NCT02446171|4324677|P1|Overall Study|Withdrawal by Subject|0
1320233|NCT02446015|4324748|P2|Overall Study|Withdrawal by Subject|0
1320234|NCT02446015|4324749|P1|Overall Study|Withdrawal by Subject|1
1320235|NCT02446015|4324748|P2|Overall Study|Adverse Event|1
1320236|NCT02446015|4324749|P1|Overall Study|Adverse Event|0
1320237|NCT02445755|4324773|P1|Overall Study|Screen Failure|5
1320238|NCT02445755|4324773|P1|Overall Study|Protocol Violation|6
1320239|NCT02445755|4324773|P1|Overall Study|Withdrawal by Subject|2
1320240|NCT02445573|4324782|P2|Overall Study|Lost to Follow-up|1
1320241|NCT02445573|4324783|P1|Overall Study|Lost to Follow-up|0
1320242|NCT02445573|4324782|P2|Overall Study|Withdrawal by Subject|1
1320243|NCT02445573|4324783|P1|Overall Study|Withdrawal by Subject|1
1320244|NCT02444533|4324891|P2|Overall Study|Only gave post-procedure complications|2
1320245|NCT02444533|4324892|P1|Overall Study|Only gave post-procedure complications|2
1320246|NCT02444533|4324891|P2|Overall Study|Not able to complete forms|2
1320247|NCT02444533|4324892|P1|Overall Study|Not able to complete forms|0
1320248|NCT02444182|4324908|P2|Overall Study|Lost to Follow-up|4
1320249|NCT02444182|4324909|P1|Overall Study|Lost to Follow-up|0
1320250|NCT02444182|4324908|P2|Overall Study|non-compliance|1
1320251|NCT02444182|4324909|P1|Overall Study|non-compliance|2
1320252|NCT02443883|4324921|P4|Overall Study|Randomized, but never treated|1
1320253|NCT02443883|4324922|P3|Overall Study|Randomized, but never treated|1
1320254|NCT02443883|4324923|P2|Overall Study|Randomized, but never treated|0
1320255|NCT02443883|4324924|P1|Overall Study|Randomized, but never treated|2
1320256|NCT02443883|4324921|P4|Overall Study|Withdrawal by Subject|1
1320257|NCT02443883|4324922|P3|Overall Study|Withdrawal by Subject|2
1320258|NCT02443883|4324923|P2|Overall Study|Withdrawal by Subject|0
1320259|NCT02443883|4324924|P1|Overall Study|Withdrawal by Subject|1
1320260|NCT02443883|4324921|P4|Overall Study|Physician Decision|3
1320261|NCT02443883|4324922|P3|Overall Study|Physician Decision|0
1320262|NCT02443883|4324923|P2|Overall Study|Physician Decision|1
1320263|NCT02443883|4324924|P1|Overall Study|Physician Decision|2
1320264|NCT02443883|4324921|P4|Overall Study|Lost to Follow-up|0
1320265|NCT02443883|4324922|P3|Overall Study|Lost to Follow-up|0
1320266|NCT02443883|4324923|P2|Overall Study|Lost to Follow-up|2
1320267|NCT02443883|4324924|P1|Overall Study|Lost to Follow-up|1
1320268|NCT02443883|4324921|P4|Overall Study|Adverse Event|2
1320269|NCT02443883|4324922|P3|Overall Study|Adverse Event|1
1320270|NCT02443883|4324923|P2|Overall Study|Adverse Event|2
1320271|NCT02443883|4324924|P1|Overall Study|Adverse Event|0
1320272|NCT02443740|4324963|P11|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1320273|NCT02443740|4324964|P10|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1320274|NCT02443740|4324965|P9|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1320275|NCT02443740|4324966|P8|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1320276|NCT02443740|4324967|P7|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1320277|NCT02443740|4324968|P6|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
1320278|NCT02443740|4324969|P5|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1320279|NCT02443740|4324970|P4|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1320280|NCT02443740|4324971|P3|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1320281|NCT02443740|4324972|P2|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1320282|NCT02443740|4324973|P1|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1320283|NCT02443740|4324963|P11|Intervention Period 1 (3 Days)|Protocol Violation|0
1320284|NCT02443740|4324964|P10|Intervention Period 1 (3 Days)|Protocol Violation|0
1320285|NCT02443740|4324965|P9|Intervention Period 1 (3 Days)|Protocol Violation|0
1320286|NCT02443740|4324966|P8|Intervention Period 1 (3 Days)|Protocol Violation|0
1320287|NCT02443740|4324967|P7|Intervention Period 1 (3 Days)|Protocol Violation|1
1320288|NCT02443740|4324968|P6|Intervention Period 1 (3 Days)|Protocol Violation|0
1320289|NCT02443740|4324969|P5|Intervention Period 1 (3 Days)|Protocol Violation|0
1320290|NCT02443740|4324970|P4|Intervention Period 1 (3 Days)|Protocol Violation|0
1320291|NCT02443740|4324971|P3|Intervention Period 1 (3 Days)|Protocol Violation|0
1320292|NCT02443740|4324972|P2|Intervention Period 1 (3 Days)|Protocol Violation|0
1320293|NCT02443740|4324973|P1|Intervention Period 1 (3 Days)|Protocol Violation|1
1320294|NCT02443740|4324963|P11|Intervention Period 1 (3 Days)|Adverse Event|0
1320295|NCT02443740|4324964|P10|Intervention Period 1 (3 Days)|Adverse Event|0
1320296|NCT02443740|4324965|P9|Intervention Period 1 (3 Days)|Adverse Event|0
1320297|NCT02443740|4324966|P8|Intervention Period 1 (3 Days)|Adverse Event|0
1320298|NCT02443740|4324967|P7|Intervention Period 1 (3 Days)|Adverse Event|0
1320299|NCT02443740|4324968|P6|Intervention Period 1 (3 Days)|Adverse Event|1
1320300|NCT02443740|4324969|P5|Intervention Period 1 (3 Days)|Adverse Event|0
1320301|NCT02443740|4324970|P4|Intervention Period 1 (3 Days)|Adverse Event|0
1320302|NCT02443740|4324971|P3|Intervention Period 1 (3 Days)|Adverse Event|0
1320303|NCT02443740|4324972|P2|Intervention Period 1 (3 Days)|Adverse Event|0
1320304|NCT02443740|4324973|P1|Intervention Period 1 (3 Days)|Adverse Event|0
1320305|NCT02443402|4325154|P2|Overall Study|Screen Failure|2
1320306|NCT02443402|4325155|P1|Overall Study|Screen Failure|1
1320307|NCT02443402|4325154|P2|Overall Study|Withdrawal by Subject|1
1320308|NCT02443402|4325155|P1|Overall Study|Withdrawal by Subject|3
1320309|NCT02443103|4325215|P1|Overall Study|Noncompliance|1
1320310|NCT02443103|4325215|P1|Overall Study|Adverse Event|2
1320311|NCT02442830|4325222|P2|Overall Study|Technical Failure|1
1320312|NCT02442830|4325223|P1|Overall Study|Technical Failure|0
1320313|NCT02442804|4325233|P2|Overall Study|Adverse Event|0
1320314|NCT02442804|4325234|P1|Overall Study|Adverse Event|1
1320315|NCT02442804|4325233|P2|Overall Study|Withdrawal by Subject|1
1320316|NCT02442804|4325234|P1|Overall Study|Withdrawal by Subject|0
1320317|NCT02442349|4325273|P1|Overall Study|On-going Study at Data Cut-off|149
1320318|NCT02442349|4325273|P1|Overall Study|Withdrawal by Subject|8
1320319|NCT02442349|4325273|P1|Overall Study|Death|14
1320320|NCT02442310|4325278|P1|Overall Study|Withdrawal by Subject|1
1320321|NCT02442310|4325278|P1|Overall Study|Adverse Event|2
1320322|NCT02442284|4325300|P1|Overall Study|Not Specified|1
1320323|NCT02442284|4325300|P1|Overall Study|Lost to Follow-up|3
1320324|NCT02442284|4325300|P1|Overall Study|Withdrew Consent|2
1320325|NCT02442284|4325300|P1|Overall Study|Adverse Event|1
1320326|NCT02442271|4325307|P1|Overall Study|Not Specified|1
1320327|NCT02442271|4325307|P1|Overall Study|Lost to Follow-up|1
1320328|NCT02442271|4325307|P1|Overall Study|Withdrew Consent|1
1320329|NCT02442271|4325307|P1|Overall Study|Adverse Event|1
1320330|NCT02441946|4325334|P3|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
1320331|NCT02441946|4325335|P2|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
1320332|NCT02441946|4325336|P1|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
1320333|NCT02441946|4325334|P3|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
1320334|NCT02441946|4325335|P2|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
1320335|NCT02441946|4325336|P1|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
1320336|NCT02441946|4325334|P3|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
1320337|NCT02441946|4325335|P2|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
1320338|NCT02441946|4325336|P1|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
1320339|NCT02441946|4325334|P3|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
1320340|NCT02441946|4325335|P2|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
1320341|NCT02441946|4325336|P1|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
1320342|NCT02441946|4325334|P3|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
1320343|NCT02441946|4325335|P2|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
1320344|NCT02441946|4325336|P1|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
1320345|NCT02441946|4325334|P3|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
1320346|NCT02441946|4325335|P2|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
1320347|NCT02441946|4325336|P1|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
1320348|NCT02441946|4325334|P3|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
1320349|NCT02441946|4325335|P2|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
1320350|NCT02441946|4325336|P1|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
1320351|NCT02441946|4325334|P3|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
1320352|NCT02441946|4325335|P2|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
1320353|NCT02441946|4325336|P1|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
1320354|NCT02441946|4325334|P3|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
1320355|NCT02441946|4325335|P2|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
1320356|NCT02441946|4325336|P1|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
1320357|NCT02441517|4325348|P1|Overall Study|Study Terminated by Sponsor|1
1320358|NCT02441517|4325348|P1|Overall Study|Withdrawal by Subject|2
1320359|NCT02441517|4325348|P1|Overall Study|Lost to Follow-up|1
1320360|NCT02441218|4325360|P2|Overall Study|Lost to Follow-up|1
1320361|NCT02441218|4325361|P1|Overall Study|Lost to Follow-up|2
1320362|NCT02441218|4325360|P2|Overall Study|Withdrawal by Subject|58
1320363|NCT02441218|4325361|P1|Overall Study|Withdrawal by Subject|73
1320364|NCT02441218|4325360|P2|Overall Study|Death|553
1320365|NCT02441218|4325361|P1|Overall Study|Death|503
1320366|NCT02441179|4325387|P2|Overall Study|Withdrawal by Subject|1
1320367|NCT02441179|4325388|P1|Overall Study|Withdrawal by Subject|1
1320368|NCT02441114|4325406|P1|Washout2|Withdrawal by Subject|4
1320369|NCT02439138|4325469|P1|Overall Study|PI decision to terminate the study|2
1320370|NCT02439138|4325469|P1|Overall Study|Adverse Event|1
1320371|NCT02438280|4325525|P2|Overall Study|Physician Decision|0
1320372|NCT02438280|4325526|P1|Overall Study|Physician Decision|1
1320373|NCT02438137|4325536|P2|Overall Study|Physician Decision|1
1320374|NCT02438137|4325537|P1|Overall Study|Physician Decision|0
1320375|NCT02438137|4325536|P2|Overall Study|Withdrawal by Subject|3
1320376|NCT02438137|4325537|P1|Overall Study|Withdrawal by Subject|4
1320377|NCT02438137|4325536|P2|Overall Study|Adverse Event|0
1320378|NCT02438137|4325537|P1|Overall Study|Adverse Event|1
1320379|NCT02438137|4325536|P2|Overall Study|Lost to Follow-up|2
1320380|NCT02438137|4325537|P1|Overall Study|Lost to Follow-up|3
1320381|NCT02437903|4325545|P1|Overall Study|Lost to Follow-up|3
1320382|NCT02437903|4325545|P1|Overall Study|Withdrawal by Subject|1
1320383|NCT02437903|4325545|P1|Overall Study|Adverse Event|1
1320384|NCT02437864|4325555|P2|Overall Study|Protocol Violation|0
1320385|NCT02437864|4325556|P1|Overall Study|Protocol Violation|4
1320386|NCT02437513|4325570|P1|Overall Study|Withdrawal by Subject|2
1320387|NCT02437409|4325595|P1|Overall Study|Screening failure|12
1320388|NCT02437409|4325595|P1|Overall Study|Withdrawal by Subject|3
1320389|NCT02437305|4325610|P2|Overall Study|Lost to Follow-up|12
1320390|NCT02437305|4325611|P1|Overall Study|Lost to Follow-up|18
1320391|NCT02437162|4325639|P3|Overall Study|Randomized but not treated|1
1320392|NCT02437162|4325640|P2|Overall Study|Randomized but not treated|0
1320393|NCT02437162|4325641|P1|Overall Study|Randomized but not treated|0
1320394|NCT02437162|4325639|P3|Overall Study|Withdrawal by Subject|0
1320395|NCT02437162|4325640|P2|Overall Study|Withdrawal by Subject|0
1320396|NCT02437162|4325641|P1|Overall Study|Withdrawal by Subject|3
1320397|NCT02437162|4325639|P3|Overall Study|Protocol Violation|0
1320398|NCT02437162|4325640|P2|Overall Study|Protocol Violation|1
1320399|NCT02437162|4325641|P1|Overall Study|Protocol Violation|0
1320400|NCT02436811|4325652|P3|Overall Study|Lost to Follow-up|7
1320401|NCT02436811|4325653|P2|Overall Study|Lost to Follow-up|9
1320402|NCT02436811|4325654|P1|Overall Study|Lost to Follow-up|2
1320403|NCT02436577|4325668|P6|Overall Study|Protocol Deviation|0
1320404|NCT02436577|4325669|P5|Overall Study|Protocol Deviation|0
1320405|NCT02436577|4325670|P4|Overall Study|Protocol Deviation|0
1320406|NCT02436577|4325671|P3|Overall Study|Protocol Deviation|0
1320407|NCT02436577|4325672|P2|Overall Study|Protocol Deviation|1
1320408|NCT02436577|4325673|P1|Overall Study|Protocol Deviation|0
1320409|NCT02436330|4325728|P2|Cohort 6|Withdrawal by Subject|1
1320410|NCT02436330|4325729|P1|Cohort 6|Withdrawal by Subject|1
1320411|NCT02436330|4325728|P2|Cohort 6|Lost to Follow-up|0
1320412|NCT02436330|4325729|P1|Cohort 6|Lost to Follow-up|2
1320413|NCT02436330|4325728|P2|Cohort 5|Withdrawal by Subject|2
1320414|NCT02436330|4325729|P1|Cohort 5|Withdrawal by Subject|3
1320415|NCT02436330|4325728|P2|Cohort 5|Lost to Follow-up|2
1320416|NCT02436330|4325729|P1|Cohort 5|Lost to Follow-up|3
1320417|NCT02436330|4325728|P2|Cohort 4|Withdrawal by Subject|0
1320418|NCT02436330|4325729|P1|Cohort 4|Withdrawal by Subject|1
1320419|NCT02436330|4325728|P2|Cohort 4|Lost to Follow-up|0
1320420|NCT02436330|4325729|P1|Cohort 4|Lost to Follow-up|1
1320421|NCT02436330|4325728|P2|Cohort 3|Withdrawal by Subject|0
1320422|NCT02436330|4325729|P1|Cohort 3|Withdrawal by Subject|4
1320423|NCT02436330|4325728|P2|Cohort 3|Lost to Follow-up|0
1320424|NCT02436330|4325729|P1|Cohort 3|Lost to Follow-up|1
1320425|NCT02436330|4325728|P2|Cohort 2|Withdrawal by Subject|3
1320426|NCT02436330|4325729|P1|Cohort 2|Withdrawal by Subject|2
1320427|NCT02436330|4325728|P2|Cohort 2|Lost to Follow-up|0
1320428|NCT02436330|4325729|P1|Cohort 2|Lost to Follow-up|2
1320429|NCT02436330|4325728|P2|Cohort 1|Withdrawal by Subject|1
1320430|NCT02436330|4325729|P1|Cohort 1|Withdrawal by Subject|0
1320431|NCT02436330|4325728|P2|Cohort 1|Lost to Follow-up|2
1320432|NCT02436330|4325729|P1|Cohort 1|Lost to Follow-up|5
1320433|NCT02436304|4325774|P3|Overall Study|Randomized in error didn’t meet I/E crit|1
1320434|NCT02436304|4325775|P2|Overall Study|Randomized in error didn’t meet I/E crit|0
1320435|NCT02436304|4325776|P1|Overall Study|Randomized in error didn’t meet I/E crit|0
1320436|NCT02436304|4325774|P3|Overall Study|Withdrawal by Subject|0
1320437|NCT02436304|4325775|P2|Overall Study|Withdrawal by Subject|1
1320438|NCT02436304|4325776|P1|Overall Study|Withdrawal by Subject|0
1320439|NCT02436304|4325774|P3|Overall Study|Lost to Follow-up|0
1320440|NCT02436304|4325775|P2|Overall Study|Lost to Follow-up|1
1320441|NCT02436304|4325776|P1|Overall Study|Lost to Follow-up|0
1320442|NCT02435966|4325805|P3|Overall Study|Withdrawal by Subject|0
1320443|NCT02435966|4325806|P2|Overall Study|Withdrawal by Subject|1
1320444|NCT02435966|4325807|P1|Overall Study|Withdrawal by Subject|0
1320445|NCT02435836|4325815|P1|Overall Study|AE of Worsening Schizophrenia|96
1320446|NCT02435836|4325815|P1|Overall Study|Met Withdrawal Criteria|7
1320447|NCT02435836|4325815|P1|Overall Study|Protocol Violation|6
1320448|NCT02435836|4325815|P1|Overall Study|Noncompliance|27
1320449|NCT02435836|4325815|P1|Overall Study|Sponsor discontinued trial|167
1320450|NCT02435836|4325815|P1|Overall Study|Adverse Event|44
1320451|NCT02435836|4325815|P1|Overall Study|Insufficient Clinical Response|26
1320452|NCT02435836|4325815|P1|Overall Study|Withdrawal by Subject|236
1320453|NCT02435836|4325815|P1|Overall Study|Lack of Efficacy|1
1320454|NCT02435836|4325815|P1|Overall Study|Lost to Follow-up|21
1320455|NCT02435277|4325835|P4|Overall Study|Withdrawal by Subject|0
1320456|NCT02435277|4325836|P3|Overall Study|Withdrawal by Subject|0
1320457|NCT02435277|4325837|P2|Overall Study|Withdrawal by Subject|0
1320458|NCT02435277|4325838|P1|Overall Study|Withdrawal by Subject|1
1320459|NCT02435277|4325835|P4|Overall Study|Adverse Event|0
1320460|NCT02435277|4325836|P3|Overall Study|Adverse Event|0
1320461|NCT02435277|4325837|P2|Overall Study|Adverse Event|1
1320462|NCT02435277|4325838|P1|Overall Study|Adverse Event|1
1320463|NCT02434939|4325854|P2|Overall Study|Adverse Event|1
1320464|NCT02434939|4325855|P1|Overall Study|Adverse Event|0
1320465|NCT02434939|4325854|P2|Overall Study|Withdrawal by Subject|0
1320466|NCT02434939|4325855|P1|Overall Study|Withdrawal by Subject|3
1320467|NCT02434939|4325854|P2|Overall Study|Lack of Efficacy|48
1320468|NCT02434939|4325855|P1|Overall Study|Lack of Efficacy|34
1320469|NCT02434471|4325982|P1|Overall Study|Physician Decision|9
1320470|NCT02433834|4326001|P1|Overall Study|Physician Decision|1
1320471|NCT02433834|4326001|P1|Overall Study|Adverse Event|6
1320472|NCT02433834|4326001|P1|Overall Study|Withdrawal by Subject|14
1320473|NCT02433834|4326001|P1|Overall Study|Lost to Follow-up|6
1320474|NCT02433834|4326001|P1|Overall Study|Protocol Violation|3
1320475|NCT02433834|4326001|P1|Overall Study|Protocol-specified criteria|7
1320476|NCT02433483|4326094|P1|Overall Study|Other antineoplastic therapy/HSCT|1
1320477|NCT02433483|4326094|P1|Overall Study|Unacceptable toxicity|1
1320478|NCT02433340|4326121|P4|Overall Study|Not Specified|0
1320479|NCT02433340|4326122|P3|Overall Study|Not Specified|0
1320480|NCT02433340|4326123|P2|Overall Study|Not Specified|1
1320481|NCT02433340|4326124|P1|Overall Study|Not Specified|0
1320482|NCT02433340|4326121|P4|Overall Study|Required Alternative/Prohibited Therapy|0
1320483|NCT02433340|4326122|P3|Overall Study|Required Alternative/Prohibited Therapy|0
1320484|NCT02433340|4326123|P2|Overall Study|Required Alternative/Prohibited Therapy|0
1320485|NCT02433340|4326124|P1|Overall Study|Required Alternative/Prohibited Therapy|1
1320486|NCT02433340|4326121|P4|Overall Study|Lost to Follow-up|0
1320487|NCT02433340|4326122|P3|Overall Study|Lost to Follow-up|0
1320488|NCT02433340|4326123|P2|Overall Study|Lost to Follow-up|1
1320489|NCT02433340|4326124|P1|Overall Study|Lost to Follow-up|0
1320490|NCT02433340|4326121|P4|Overall Study|Withdrawal by Subject|2
1320491|NCT02433340|4326122|P3|Overall Study|Withdrawal by Subject|1
1320492|NCT02433340|4326123|P2|Overall Study|Withdrawal by Subject|0
1320493|NCT02433340|4326124|P1|Overall Study|Withdrawal by Subject|1
1320494|NCT02433340|4326121|P4|Overall Study|Adverse Event|0
1320495|NCT02433340|4326122|P3|Overall Study|Adverse Event|1
1320496|NCT02433340|4326123|P2|Overall Study|Adverse Event|0
1320497|NCT02433340|4326124|P1|Overall Study|Adverse Event|0
1320498|NCT02432105|4327037|P3|Overall Study|Randomized in error|2
1320499|NCT02432105|4327038|P2|Overall Study|Randomized in error|0
1320500|NCT02432105|4327039|P1|Overall Study|Randomized in error|0
1320501|NCT02432105|4327037|P3|Overall Study|Culture positive for yeast|0
1320502|NCT02432105|4327038|P2|Overall Study|Culture positive for yeast|1
1320503|NCT02432105|4327039|P1|Overall Study|Culture positive for yeast|0
1320504|NCT02432105|4327037|P3|Overall Study|Withdrawal by Subject|1
1320505|NCT02432105|4327038|P2|Overall Study|Withdrawal by Subject|0
1320506|NCT02432105|4327039|P1|Overall Study|Withdrawal by Subject|1
1320507|NCT02432105|4327037|P3|Overall Study|Lost to Follow-up|0
1320508|NCT02432105|4327038|P2|Overall Study|Lost to Follow-up|1
1320509|NCT02432105|4327039|P1|Overall Study|Lost to Follow-up|1
1320510|NCT02432040|4327056|P2|Overall Study|Physician Decision|1
1320511|NCT02432040|4327057|P1|Overall Study|Physician Decision|1
1320512|NCT02432040|4327056|P2|Overall Study|Lost to Follow-up|5
1320513|NCT02432040|4327057|P1|Overall Study|Lost to Follow-up|4
1320514|NCT02432040|4327056|P2|Overall Study|Lack of Efficacy|0
1320515|NCT02432040|4327057|P1|Overall Study|Lack of Efficacy|3
1320516|NCT02431468|4327134|P3|Overall Study|noncompliance, investigator termination,|2
1320517|NCT02431468|4327135|P2|Overall Study|noncompliance, investigator termination,|2
1320518|NCT02431468|4327136|P1|Overall Study|noncompliance, investigator termination,|2
1320519|NCT02431468|4327134|P3|Overall Study|Withdrawal by Subject|2
1320520|NCT02431468|4327135|P2|Overall Study|Withdrawal by Subject|12
1320521|NCT02431468|4327136|P1|Overall Study|Withdrawal by Subject|4
1320522|NCT02431468|4327134|P3|Overall Study|Adverse Event|5
1320523|NCT02431468|4327135|P2|Overall Study|Adverse Event|4
1320524|NCT02431468|4327136|P1|Overall Study|Adverse Event|2
1320525|NCT02430870|4327195|P8|Part 2|Other Reason Not Specified|1
1320526|NCT02430870|4327196|P7|Part 2|Other Reason Not Specified|0
1320527|NCT02430870|4327197|P6|Part 2|Other Reason Not Specified|0
1320528|NCT02430870|4327198|P5|Part 2|Other Reason Not Specified|0
1320529|NCT02430870|4327199|P4|Part 2|Other Reason Not Specified|0
1320530|NCT02430870|4327200|P3|Part 2|Other Reason Not Specified|0
1320531|NCT02430870|4327201|P2|Part 2|Other Reason Not Specified|0
1320532|NCT02430870|4327202|P1|Part 2|Other Reason Not Specified|0
1320533|NCT02430870|4327195|P8|Part 2|Voluntary Withdrawal|0
1320534|NCT02430870|4327196|P7|Part 2|Voluntary Withdrawal|1
1320535|NCT02430870|4327197|P6|Part 2|Voluntary Withdrawal|0
1320536|NCT02430870|4327198|P5|Part 2|Voluntary Withdrawal|0
1320537|NCT02430870|4327199|P4|Part 2|Voluntary Withdrawal|0
1320538|NCT02430870|4327200|P3|Part 2|Voluntary Withdrawal|0
1320539|NCT02430870|4327201|P2|Part 2|Voluntary Withdrawal|0
1320540|NCT02430870|4327202|P1|Part 2|Voluntary Withdrawal|0
1320541|NCT02430532|4327276|P2|Overall Study|Adverse Event|1
1320542|NCT02430532|4327277|P1|Overall Study|Adverse Event|0
1320543|NCT02430532|4327276|P2|Overall Study|Consent Withdrawn|2
1320544|NCT02430532|4327277|P1|Overall Study|Consent Withdrawn|0
1320545|NCT02430532|4327276|P2|Overall Study|Sponsor Decision to Stop Study Early|25
1320546|NCT02430532|4327277|P1|Overall Study|Sponsor Decision to Stop Study Early|30
1320547|NCT02429791|4327317|P2|Overall Study|Withdrawal by Subject|7
1320548|NCT02429791|4327318|P1|Overall Study|Withdrawal by Subject|3
1320549|NCT02429791|4327317|P2|Overall Study|Protocol Violation|4
1320550|NCT02429791|4327318|P1|Overall Study|Protocol Violation|1
1320551|NCT02429791|4327317|P2|Overall Study|Lost to Follow-up|2
1320552|NCT02429791|4327318|P1|Overall Study|Lost to Follow-up|1
1320553|NCT02429791|4327317|P2|Overall Study|Lack of Efficacy|1
1320554|NCT02429791|4327318|P1|Overall Study|Lack of Efficacy|2
1320555|NCT02429791|4327317|P2|Overall Study|Physician Decision|2
1320556|NCT02429791|4327318|P1|Overall Study|Physician Decision|0
1320557|NCT02429791|4327317|P2|Overall Study|Adverse Event|2
1320558|NCT02429791|4327318|P1|Overall Study|Adverse Event|6
1320559|NCT02429258|4327390|P2|Overall Study|Protocol Violation|1
1320560|NCT02429258|4327391|P1|Overall Study|Protocol Violation|0
1320561|NCT02429258|4327390|P2|Overall Study|Withdrawal by Subject|0
1320562|NCT02429258|4327391|P1|Overall Study|Withdrawal by Subject|2
1320563|NCT02428699|4327417|P2|Washout Period 1|Screen Failure|2
1320564|NCT02428699|4327418|P1|Washout Period 1|Screen Failure|1
1320565|NCT02428413|4327457|P2|Overall Study|Nurse Refusal|0
1320566|NCT02428413|4327458|P1|Overall Study|Nurse Refusal|1
1320567|NCT02428413|4327457|P2|Overall Study|Missed Cases|2
1320568|NCT02428413|4327458|P1|Overall Study|Missed Cases|1
1320569|NCT02428413|4327457|P2|Overall Study|Case Cancelled|0
1320570|NCT02428413|4327458|P1|Overall Study|Case Cancelled|2
1320571|NCT02428413|4327457|P2|Overall Study|Protocol Violation|2
1320572|NCT02428413|4327458|P1|Overall Study|Protocol Violation|1
1320573|NCT02428413|4327457|P2|Overall Study|Device to measure WAG malfunctioned|5
1320574|NCT02428413|4327458|P1|Overall Study|Device to measure WAG malfunctioned|3
1320575|NCT02428231|4327472|P2|Overall Study|Adverse Event|0
1320576|NCT02428231|4327473|P1|Overall Study|Adverse Event|3
1320577|NCT02428231|4327472|P2|Overall Study|Required Symptomatic Therapy|1
1320578|NCT02428231|4327473|P1|Overall Study|Required Symptomatic Therapy|0
1320579|NCT02428231|4327472|P2|Overall Study|Not Specified|16
1320580|NCT02428231|4327473|P1|Overall Study|Not Specified|10
1320581|NCT02427984|4327490|P3|Overall Study|Lost to Follow-up|18
1320582|NCT02427984|4327491|P2|Overall Study|Lost to Follow-up|5
1320583|NCT02427984|4327492|P1|Overall Study|Lost to Follow-up|13
1320584|NCT02427607|4327532|P1|Overall Study|Withdrawal by Subject|1
1320585|NCT02427477|4327538|P2|Period 1|Adverse Event|0
1320586|NCT02427477|4327539|P1|Period 1|Adverse Event|1
1320587|NCT02427399|4327552|P5|Overall Study|Protocol Violation|15
1320588|NCT02427399|4327553|P4|Overall Study|Protocol Violation|18
1320589|NCT02427399|4327554|P3|Overall Study|Protocol Violation|12
1320590|NCT02427399|4327555|P2|Overall Study|Protocol Violation|16
1320591|NCT02427399|4327556|P1|Overall Study|Protocol Violation|14
1320592|NCT02426541|4327580|P2|Overall Study|Protocol Violation|0
1320593|NCT02426541|4327581|P1|Overall Study|Protocol Violation|1
1320594|NCT02425826|4327598|P3|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
1320595|NCT02425826|4327599|P2|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
1320596|NCT02425826|4327600|P1|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
1320597|NCT02425826|4327598|P3|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
1320598|NCT02425826|4327599|P2|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
1320599|NCT02425826|4327600|P1|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
1320600|NCT02425826|4327598|P3|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
1320601|NCT02425826|4327599|P2|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
1320602|NCT02425826|4327600|P1|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
1320603|NCT02425826|4327598|P3|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
1320604|NCT02425826|4327599|P2|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
1320605|NCT02425826|4327600|P1|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
1320606|NCT02425826|4327598|P3|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
1320607|NCT02425826|4327599|P2|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
1320608|NCT02425826|4327600|P1|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
1320609|NCT02425826|4327598|P3|Placebo-controlled Phase (Week 0 - 16)|Other|0
1320610|NCT02425826|4327599|P2|Placebo-controlled Phase (Week 0 - 16)|Other|1
1320611|NCT02425826|4327600|P1|Placebo-controlled Phase (Week 0 - 16)|Other|3
1320612|NCT02425826|4327598|P3|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
1320613|NCT02425826|4327599|P2|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
1320614|NCT02425826|4327600|P1|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
1320615|NCT02425826|4327598|P3|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
1320616|NCT02425826|4327599|P2|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
1320617|NCT02425826|4327600|P1|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
1320618|NCT02425826|4327598|P3|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
1320619|NCT02425826|4327599|P2|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
1320620|NCT02425826|4327600|P1|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
1320621|NCT02425826|4327598|P3|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
1320622|NCT02425826|4327599|P2|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
1320623|NCT02425826|4327600|P1|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
1320624|NCT02424734|4327657|P3|Overall Study|Treatment stopped to be discharged home|0
1320625|NCT02424734|4327658|P2|Overall Study|Treatment stopped to be discharged home|2
1320626|NCT02424734|4327659|P1|Overall Study|Treatment stopped to be discharged home|2
1320627|NCT02424591|4327675|P2|Overall Study|Protocol Violation|3
1320628|NCT02424591|4327676|P1|Overall Study|Protocol Violation|2
1320629|NCT02424578|4327688|P2|Overall Study|Withdrawal by Subject|1
1320630|NCT02424578|4327689|P1|Overall Study|Withdrawal by Subject|0
1320631|NCT02424565|4327695|P2|Period 1 (D0)|Protocol Violation|1
1320632|NCT02424565|4327696|P1|Period 1 (D0)|Protocol Violation|0
1320633|NCT02424149|4327715|P2|Overall Study|Withdrawal by Subject|1
1320634|NCT02424149|4327716|P1|Overall Study|Withdrawal by Subject|0
1320635|NCT02424149|4327715|P2|Overall Study|surgery cancelled|0
1320636|NCT02424149|4327716|P1|Overall Study|surgery cancelled|2
1320637|NCT02423798|4327777|P1|Overall Study|Withdrawal by Subject|3
1320638|NCT02423291|4327843|P1|Overall Study|Adverse Event|1
1320639|NCT02423291|4327843|P1|Overall Study|Lack of Efficacy|14
1320640|NCT02423109|4327858|P2|Lens 1|Adverse Event|0
1320641|NCT02423109|4327859|P1|Lens 1|Adverse Event|1
1320642|NCT02422797|4327892|P2|Overall Study|Withdrawal by Subject|7
1320643|NCT02422797|4327893|P1|Overall Study|Withdrawal by Subject|2
1320644|NCT02422797|4327892|P2|Overall Study|Other; Reached stopping criteria|1
1320645|NCT02422797|4327893|P1|Overall Study|Other; Reached stopping criteria|1
1320646|NCT02422797|4327892|P2|Overall Study|Protocol Violation|3
1320647|NCT02422797|4327893|P1|Overall Study|Protocol Violation|0
1320648|NCT02422797|4327892|P2|Overall Study|Lost to Follow-up|1
1320649|NCT02422797|4327893|P1|Overall Study|Lost to Follow-up|1
1320650|NCT02422797|4327892|P2|Overall Study|Lack of Efficacy|2
1320651|NCT02422797|4327893|P1|Overall Study|Lack of Efficacy|1
1320652|NCT02422797|4327892|P2|Overall Study|Physician Decision|1
1320653|NCT02422797|4327893|P1|Overall Study|Physician Decision|0
1320654|NCT02422797|4327892|P2|Overall Study|Adverse Event|1
1320655|NCT02422797|4327893|P1|Overall Study|Adverse Event|11
1320656|NCT02422303|4327974|P2|Overall Study|Lost to Follow-up|1
1320657|NCT02422303|4327975|P1|Overall Study|Lost to Follow-up|1
1320658|NCT02421419|4327984|P3|Overall Study|Physician Decision|1
1320659|NCT02421419|4327985|P2|Overall Study|Physician Decision|0
1320660|NCT02421419|4327986|P1|Overall Study|Physician Decision|0
1320661|NCT02421120|4328071|P1|Overall Study|Adverse Event|1
1320662|NCT02420327|4328111|P1|Overall Study|Protocol Violation|1
1320663|NCT02420327|4328111|P1|Overall Study|Lost to Follow-up|1
1320664|NCT02420327|4328111|P1|Overall Study|Withdrawal by Subject|6
1320665|NCT02420327|4328111|P1|Overall Study|Pregnancy|1
1320666|NCT02420327|4328111|P1|Overall Study|Adverse Event|7
1320667|NCT02420262|4328147|P2|Overall Study|Unclassified|1
1320668|NCT02420262|4328148|P1|Overall Study|Unclassified|0
1320669|NCT02420262|4328147|P2|Overall Study|Withdrawal by Subject|4
1320670|NCT02420262|4328148|P1|Overall Study|Withdrawal by Subject|1
1320671|NCT02420262|4328147|P2|Overall Study|Adverse Event|0
1320672|NCT02420262|4328148|P1|Overall Study|Adverse Event|1
1320673|NCT02420093|4328174|P2|Overall Study|Withdrawal by Subject|1
1320674|NCT02420093|4328175|P1|Overall Study|Withdrawal by Subject|1
1320675|NCT02419937|4328218|P2|Overall Study|Lost to Follow-up|0
1320676|NCT02419937|4328219|P1|Overall Study|Lost to Follow-up|1
1320677|NCT02419755|4328227|P2|Overall Study|Withdrawal by Subject|0
1320678|NCT02419755|4328228|P1|Overall Study|Withdrawal by Subject|1
1320679|NCT02419755|4328227|P2|Overall Study|Ineligible|0
1320680|NCT02419755|4328228|P1|Overall Study|Ineligible|1
1320681|NCT02419755|4328227|P2|Overall Study|Relapse|1
1320682|NCT02419755|4328228|P1|Overall Study|Relapse|0
1320683|NCT02419755|4328227|P2|Overall Study|Death|3
1320684|NCT02419755|4328228|P1|Overall Study|Death|1
1320685|NCT02419469|4328264|P1|Overall Study|Withdrawal by Subject|1
1320686|NCT02419313|4328268|P2|Second Intervention|Lost to Follow-up|0
1320687|NCT02419313|4328269|P1|Second Intervention|Lost to Follow-up|1
1320688|NCT02419313|4328268|P2|First Intervention|Lost to Follow-up|0
1320689|NCT02419313|4328269|P1|First Intervention|Lost to Follow-up|2
1320690|NCT02419001|4328281|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
1320691|NCT02419001|4328282|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
1320692|NCT02418468|4328310|P2|Overall Study|Withdrawal of informed consent|1
1320693|NCT02418468|4328311|P1|Overall Study|Withdrawal of informed consent|1
1320694|NCT02418468|4328310|P2|Overall Study|Adverse Event|0
1320695|NCT02418468|4328311|P1|Overall Study|Adverse Event|1
1320696|NCT02417961|4328361|P1|Overall Study|Withdrawal by Subject|2
1320697|NCT02417961|4328361|P1|Overall Study|Lost to Follow-up|1
1320698|NCT02417961|4328361|P1|Overall Study|Adverse Event|1
1320699|NCT02417935|4328373|P2|Treatment Period|Physician Decision|1
1320700|NCT02417935|4328374|P1|Treatment Period|Physician Decision|3
1320701|NCT02417935|4328373|P2|Treatment Period|Withdrawal by Subject|3
1320702|NCT02417935|4328374|P1|Treatment Period|Withdrawal by Subject|3
1320703|NCT02417935|4328373|P2|Treatment Period|Protocol Violation|1
1320704|NCT02417935|4328374|P1|Treatment Period|Protocol Violation|2
1320705|NCT02417935|4328373|P2|Treatment Period|Entry Criteria not met|1
1320706|NCT02417935|4328374|P1|Treatment Period|Entry Criteria not met|0
1320707|NCT02417935|4328373|P2|Treatment Period|Lost to Follow-up|0
1320708|NCT02417935|4328374|P1|Treatment Period|Lost to Follow-up|1
1320709|NCT02417935|4328373|P2|Treatment Period|Adverse Event|10
1320710|NCT02417935|4328374|P1|Treatment Period|Adverse Event|12
1320711|NCT02417753|4328398|P1|Overall Study|Death|1
1320712|NCT02417532|4328408|P1|Overall Study|unable to complete exercises|4
1320713|NCT02417233|4328469|P3|Overall Study|Mentally unstable|0
1320714|NCT02417233|4328470|P2|Overall Study|Mentally unstable|1
1320715|NCT02417233|4328471|P1|Overall Study|Mentally unstable|0
1320716|NCT02417233|4328469|P3|Overall Study|Relocation out of study area|1
1320717|NCT02417233|4328470|P2|Overall Study|Relocation out of study area|0
1320718|NCT02417233|4328471|P1|Overall Study|Relocation out of study area|1
1320719|NCT02417233|4328469|P3|Overall Study|Withdrawal by Subject|8
1320720|NCT02417233|4328470|P2|Overall Study|Withdrawal by Subject|1
1320721|NCT02417233|4328471|P1|Overall Study|Withdrawal by Subject|2
1320722|NCT02417233|4328469|P3|Overall Study|Protocol Violation|2
1320723|NCT02417233|4328470|P2|Overall Study|Protocol Violation|0
1320724|NCT02417233|4328471|P1|Overall Study|Protocol Violation|2
1320725|NCT02417233|4328469|P3|Overall Study|Lost to Follow-up|34
1320726|NCT02417233|4328470|P2|Overall Study|Lost to Follow-up|39
1320727|NCT02417233|4328471|P1|Overall Study|Lost to Follow-up|27
1320728|NCT02417233|4328469|P3|Overall Study|Death|14
1320729|NCT02417233|4328470|P2|Overall Study|Death|10
1320730|NCT02417233|4328471|P1|Overall Study|Death|4
1320731|NCT02416934|4328520|P2|Overall Study|re-operation|0
1320732|NCT02416934|4328521|P1|Overall Study|re-operation|1
1320733|NCT02416934|4328520|P2|Overall Study|surgery started late|1
1320734|NCT02416934|4328521|P1|Overall Study|surgery started late|0
1320735|NCT02416934|4328520|P2|Overall Study|Protocol Violation|1
1320736|NCT02416934|4328521|P1|Overall Study|Protocol Violation|0
1320737|NCT02416934|4328520|P2|Overall Study|recruited during continuing renewal proc|1
1320738|NCT02416934|4328521|P1|Overall Study|recruited during continuing renewal proc|0
1320739|NCT02416934|4328520|P2|Overall Study|Withdrawal by Subject|0
1320740|NCT02416934|4328521|P1|Overall Study|Withdrawal by Subject|1
1320741|NCT02416934|4328520|P2|Overall Study|Lost to Follow-up|2
1320742|NCT02416934|4328521|P1|Overall Study|Lost to Follow-up|0
1320743|NCT02416934|4328520|P2|Overall Study|given steroids|2
1320744|NCT02416934|4328521|P1|Overall Study|given steroids|1
1320745|NCT02416180|4328531|P1|Overall Study|Withdrawal by Subject|1
1320746|NCT02415959|4328543|P5|Overall Study|Protocol Violation|0
1320747|NCT02415959|4328544|P4|Overall Study|Protocol Violation|1
1320748|NCT02415959|4328545|P3|Overall Study|Protocol Violation|0
1320749|NCT02415959|4328546|P2|Overall Study|Protocol Violation|0
1320750|NCT02415959|4328547|P1|Overall Study|Protocol Violation|0
1320751|NCT02415959|4328543|P5|Overall Study|Adverse Event|0
1320752|NCT02415959|4328544|P4|Overall Study|Adverse Event|0
1320753|NCT02415959|4328545|P3|Overall Study|Adverse Event|0
1320754|NCT02415959|4328546|P2|Overall Study|Adverse Event|1
1320755|NCT02415959|4328547|P1|Overall Study|Adverse Event|0
1320756|NCT02415127|4328693|P2|Overall Study|Adverse Event|0
1320757|NCT02415127|4328694|P1|Overall Study|Adverse Event|1
1320758|NCT02414828|4328712|P4|Overall Study|Lost to Follow-up|2
1320759|NCT02414828|4328713|P3|Overall Study|Lost to Follow-up|1
1320760|NCT02414828|4328714|P2|Overall Study|Lost to Follow-up|1
1320761|NCT02414828|4328715|P1|Overall Study|Lost to Follow-up|0
1320762|NCT02414152|4328764|P1|Overall Study|Lack of Efficacy|1
1320763|NCT02414152|4328764|P1|Overall Study|Withdrawal by Subject|1
1320764|NCT02413593|4328781|P1|Overall Study|Adverse Event|1
1320765|NCT02413593|4328781|P1|Overall Study|Lost to Follow-up|3
1320766|NCT02413489|4328793|P3|Overall Study|Study Terminated By Sponsor|1
1320767|NCT02413489|4328794|P2|Overall Study|Study Terminated By Sponsor|13
1320768|NCT02413489|4328795|P1|Overall Study|Study Terminated By Sponsor|2
1320769|NCT02413489|4328793|P3|Overall Study|Withdrawal by Subject|0
1320770|NCT02413489|4328794|P2|Overall Study|Withdrawal by Subject|0
1320771|NCT02413489|4328795|P1|Overall Study|Withdrawal by Subject|2
1320772|NCT02413489|4328793|P3|Overall Study|Death|4
1320773|NCT02413489|4328794|P2|Overall Study|Death|3
1320774|NCT02413489|4328795|P1|Overall Study|Death|11
1320775|NCT02413346|4328817|P2|Overall Study|Other Miscellaneous Reasons|3
1320776|NCT02413346|4328818|P1|Overall Study|Other Miscellaneous Reasons|4
1320777|NCT02413346|4328817|P2|Overall Study|Protocol Violation|0
1320778|NCT02413346|4328818|P1|Overall Study|Protocol Violation|2
1320779|NCT02413346|4328817|P2|Overall Study|Lost to Follow-up|21
1320780|NCT02413346|4328818|P1|Overall Study|Lost to Follow-up|17
1320781|NCT02413346|4328817|P2|Overall Study|Withdrawal by Subject|40
1320782|NCT02413346|4328818|P1|Overall Study|Withdrawal by Subject|30
1320783|NCT02413346|4328817|P2|Overall Study|Adverse Event|6
1320784|NCT02413346|4328818|P1|Overall Study|Adverse Event|6
1320785|NCT02413333|4328828|P2|Period 2|Protocol Deviation|0
1320786|NCT02413333|4328829|P1|Period 2|Protocol Deviation|1
1320787|NCT02413333|4328828|P2|Period 1|Reason Not Specified|1
1320788|NCT02413333|4328829|P1|Period 1|Reason Not Specified|0
1320789|NCT02413333|4328828|P2|Period 1|Adverse Event|0
1320790|NCT02413333|4328829|P1|Period 1|Adverse Event|1
1320791|NCT02413294|4328837|P1|Overall Study|Withdrawal by Subject|1
1320792|NCT02412657|4328892|P3|Overall Study|Protocol Violation|3
1320793|NCT02412657|4328893|P2|Overall Study|Protocol Violation|2
1320794|NCT02412657|4328894|P1|Overall Study|Protocol Violation|0
1320795|NCT02412657|4328892|P3|Overall Study|Lost to Follow-up|0
1320796|NCT02412657|4328893|P2|Overall Study|Lost to Follow-up|0
1320797|NCT02412657|4328894|P1|Overall Study|Lost to Follow-up|1
1320798|NCT02411747|4328943|P2|Overall Study|Protocol Violation|4
1320799|NCT02411747|4328944|P1|Overall Study|Protocol Violation|2
1320800|NCT02411747|4328943|P2|Overall Study|Withdrawal by Subject|0
1320801|NCT02411747|4328944|P1|Overall Study|Withdrawal by Subject|1
1320802|NCT02411578|4328952|P2|Crossover Trial Phase|Pregnancy|1
1320803|NCT02411578|4328953|P1|Crossover Trial Phase|Pregnancy|0
1320804|NCT02411539|4328995|P2|Overall Study|Confounding medical condition|1
1320805|NCT02411539|4328996|P1|Overall Study|Confounding medical condition|0
1320806|NCT02411539|4328995|P2|Overall Study|Lost to Follow-up|0
1320807|NCT02411539|4328996|P1|Overall Study|Lost to Follow-up|2
1320808|NCT02411292|4329084|P1|Overall Study|Lost to Follow-up|3
1320809|NCT02411292|4329084|P1|Overall Study|Death|2
1320810|NCT02411292|4329084|P1|Overall Study|Discharged before 3rd enoxaparin dose|16
1320811|NCT02411201|4329090|P1|Overall Study|Age group completed|2
1320812|NCT02411201|4329090|P1|Overall Study|Withdrawal by Subject|2
1320813|NCT02411201|4329090|P1|Overall Study|Adverse Event|2
1320814|NCT02411110|4329103|P2|Treatment Period 2|Personal Reasons|2
1320815|NCT02411110|4329104|P1|Treatment Period 2|Personal Reasons|0
1320816|NCT02411110|4329103|P2|Treatment Period 2|Lost to Follow-up|2
1320817|NCT02411110|4329104|P1|Treatment Period 2|Lost to Follow-up|0
1320818|NCT02411110|4329103|P2|Treatment Period 2|Adverse Event|0
1320819|NCT02411110|4329104|P1|Treatment Period 2|Adverse Event|1
1320820|NCT02411110|4329103|P2|Treatment Period 1|Other Miscellaneous Reasons|0
1320821|NCT02411110|4329104|P1|Treatment Period 1|Other Miscellaneous Reasons|2
1320822|NCT02411110|4329103|P2|Treatment Period 1|Personal Reasons|5
1320823|NCT02411110|4329104|P1|Treatment Period 1|Personal Reasons|2
1320824|NCT02411110|4329103|P2|Treatment Period 1|Lost to Follow-up|0
1320825|NCT02411110|4329104|P1|Treatment Period 1|Lost to Follow-up|1
1320826|NCT02411110|4329103|P2|Treatment Period 1|Adverse Event|2
1320827|NCT02411110|4329104|P1|Treatment Period 1|Adverse Event|4
1320828|NCT02410824|4329131|P2|First Intervention (One Week)|Headache|1
1320829|NCT02410824|4329132|P1|First Intervention (One Week)|Headache|0
1320830|NCT02410343|4329166|P2|Extension Period (12 Months)|Early termination of study by sponsor|1
1320831|NCT02410343|4329167|P1|Extension Period (12 Months)|Early termination of study by sponsor|0
1320832|NCT02410343|4329166|P2|Extension Period (12 Months)|Adverse Event|0
1320833|NCT02410343|4329167|P1|Extension Period (12 Months)|Adverse Event|1
1320834|NCT02410343|4329166|P2|Core Period (24 Weeks)|Early termination of study by sponsor|7
1320835|NCT02410343|4329167|P1|Core Period (24 Weeks)|Early termination of study by sponsor|4
1320836|NCT02410343|4329166|P2|Core Period (24 Weeks)|Adverse Event|0
1320837|NCT02410343|4329167|P1|Core Period (24 Weeks)|Adverse Event|1
1320838|NCT02410278|4329213|P3|Study Treatment Period|GSRS Threshold Not Met|0
1320839|NCT02410278|4329214|P2|Study Treatment Period|GSRS Threshold Not Met|1
1320840|NCT02410278|4329215|P1|Study Treatment Period|GSRS Threshold Not Met|0
1320841|NCT02410278|4329213|P3|Study Treatment Period|Other|0
1320842|NCT02410278|4329214|P2|Study Treatment Period|Other|3
1320843|NCT02410278|4329215|P1|Study Treatment Period|Other|0
1320844|NCT02410278|4329213|P3|Study Treatment Period|Withdrawal by Subject|0
1320845|NCT02410278|4329214|P2|Study Treatment Period|Withdrawal by Subject|1
1320846|NCT02410278|4329215|P1|Study Treatment Period|Withdrawal by Subject|0
1320847|NCT02410278|4329213|P3|Study Treatment Period|Physician Decision|1
1320848|NCT02410278|4329214|P2|Study Treatment Period|Physician Decision|0
1320849|NCT02410278|4329215|P1|Study Treatment Period|Physician Decision|0
1320850|NCT02410278|4329213|P3|Study Treatment Period|Adverse Event|3
1320851|NCT02410278|4329214|P2|Study Treatment Period|Adverse Event|6
1320852|NCT02410278|4329215|P1|Study Treatment Period|Adverse Event|0
1320853|NCT02410278|4329213|P3|Run-in Period|Pregnancy|0
1320854|NCT02410278|4329214|P2|Run-in Period|Pregnancy|0
1320855|NCT02410278|4329215|P1|Run-in Period|Pregnancy|1
1320856|NCT02410278|4329213|P3|Run-in Period|Withdrawal by Subject|0
1320857|NCT02410278|4329214|P2|Run-in Period|Withdrawal by Subject|0
1320858|NCT02410278|4329215|P1|Run-in Period|Withdrawal by Subject|1
1320859|NCT02410278|4329213|P3|Run-in Period|Lost to Follow-up|0
1320860|NCT02410278|4329214|P2|Run-in Period|Lost to Follow-up|0
1320861|NCT02410278|4329215|P1|Run-in Period|Lost to Follow-up|1
1320862|NCT02410278|4329213|P3|Run-in Period|GSRS Threshold Not Met|0
1320863|NCT02410278|4329214|P2|Run-in Period|GSRS Threshold Not Met|0
1320864|NCT02410278|4329215|P1|Run-in Period|GSRS Threshold Not Met|30
1320865|NCT02410278|4329213|P3|Run-in Period|Adverse Event|0
1320866|NCT02410278|4329214|P2|Run-in Period|Adverse Event|0
1320867|NCT02410278|4329215|P1|Run-in Period|Adverse Event|5
1320868|NCT02410252|4329240|P1|Overall Study|Physician Decision|2
1320869|NCT02410252|4329240|P1|Overall Study|Withdrawal by Subject|4
1320870|NCT02410200|4329253|P1|Overall Study|Adverse Event|2
1320871|NCT02408068|4329316|P6|Treatment 3 (1.5 Days)|Adverse Event|0
1320872|NCT02408068|4329317|P5|Treatment 3 (1.5 Days)|Adverse Event|0
1320873|NCT02408068|4329318|P4|Treatment 3 (1.5 Days)|Adverse Event|0
1320874|NCT02408068|4329319|P3|Treatment 3 (1.5 Days)|Adverse Event|1
1320875|NCT02408068|4329320|P2|Treatment 3 (1.5 Days)|Adverse Event|0
1320876|NCT02408068|4329321|P1|Treatment 3 (1.5 Days)|Adverse Event|0
1320877|NCT02407704|4329348|P4|Overall Study|Withdrawal by Subject|0
1320878|NCT02407704|4329349|P3|Overall Study|Withdrawal by Subject|1
1320879|NCT02407704|4329350|P2|Overall Study|Withdrawal by Subject|0
1320880|NCT02407704|4329351|P1|Overall Study|Withdrawal by Subject|0
1320881|NCT02407704|4329348|P4|Overall Study|Protocol Violation|1
1320882|NCT02407704|4329349|P3|Overall Study|Protocol Violation|0
1320883|NCT02407704|4329350|P2|Overall Study|Protocol Violation|0
1320884|NCT02407704|4329351|P1|Overall Study|Protocol Violation|0
1320885|NCT02407704|4329348|P4|Overall Study|Lost to Follow-up|2
1320886|NCT02407704|4329349|P3|Overall Study|Lost to Follow-up|0
1320887|NCT02407704|4329350|P2|Overall Study|Lost to Follow-up|0
1320888|NCT02407704|4329351|P1|Overall Study|Lost to Follow-up|0
1320889|NCT02406586|4329449|P3|Overall Study|Withdrawal by Subject|0
1320890|NCT02406586|4329450|P2|Overall Study|Withdrawal by Subject|0
1320891|NCT02406586|4329451|P1|Overall Study|Withdrawal by Subject|1
1320892|NCT02406586|4329449|P3|Overall Study|Lost to Follow-up|2
1320893|NCT02406586|4329450|P2|Overall Study|Lost to Follow-up|4
1320894|NCT02406586|4329451|P1|Overall Study|Lost to Follow-up|0
1320895|NCT02404649|4329585|P2|Overall Study|Adverse Event|2
1320896|NCT02404649|4329586|P1|Overall Study|Adverse Event|1
1320897|NCT02404545|4329594|P2|Overall Study|Sponsor Termination|6
1320898|NCT02404545|4329595|P1|Overall Study|Sponsor Termination|6
1320899|NCT02404493|4329614|P2|Overall Study|Adverse Event|1
1320900|NCT02404493|4329615|P1|Overall Study|Adverse Event|1
1320901|NCT02404389|4329860|P5|Overall Study|Subject/guardian decision|1
1320902|NCT02404389|4329861|P4|Overall Study|Subject/guardian decision|1
1320903|NCT02404389|4329862|P3|Overall Study|Subject/guardian decision|0
1320904|NCT02404389|4329863|P2|Overall Study|Subject/guardian decision|0
1320905|NCT02404389|4329864|P1|Overall Study|Subject/guardian decision|1
1320906|NCT02404389|4329860|P5|Overall Study|Adverse Event|2
1320907|NCT02404389|4329861|P4|Overall Study|Adverse Event|0
1320908|NCT02404389|4329862|P3|Overall Study|Adverse Event|1
1320909|NCT02404389|4329863|P2|Overall Study|Adverse Event|0
1320910|NCT02404389|4329864|P1|Overall Study|Adverse Event|1
1320911|NCT02404103|4329902|P2|Overall Study|Lost to Follow-up|3
1320912|NCT02404103|4329903|P1|Overall Study|Lost to Follow-up|3
1320913|NCT02404103|4329902|P2|Overall Study|Adverse Event|0
1320914|NCT02404103|4329903|P1|Overall Study|Adverse Event|1
1320915|NCT02403674|4329949|P2|Overall Study|Protocol Violation|2
1320916|NCT02403674|4329950|P1|Overall Study|Protocol Violation|4
1320917|NCT02403674|4329949|P2|Overall Study|Pregnancy|1
1320918|NCT02403674|4329950|P1|Overall Study|Pregnancy|1
1320919|NCT02403674|4329949|P2|Overall Study|Not treated with study drug|2
1320920|NCT02403674|4329950|P1|Overall Study|Not treated with study drug|4
1320921|NCT02403674|4329949|P2|Overall Study|Physician Decision|2
1320922|NCT02403674|4329950|P1|Overall Study|Physician Decision|2
1320923|NCT02403674|4329949|P2|Overall Study|Withdrawal by Subject|11
1320924|NCT02403674|4329950|P1|Overall Study|Withdrawal by Subject|8
1320925|NCT02403674|4329949|P2|Overall Study|Noncompliance with study drug|2
1320926|NCT02403674|4329950|P1|Overall Study|Noncompliance with study drug|1
1320927|NCT02403674|4329949|P2|Overall Study|Lost to Follow-up|7
1320928|NCT02403674|4329950|P1|Overall Study|Lost to Follow-up|6
1320929|NCT02403674|4329949|P2|Overall Study|Lack of Efficacy|10
1320930|NCT02403674|4329950|P1|Overall Study|Lack of Efficacy|18
1320931|NCT02403674|4329949|P2|Overall Study|Death|3
1320932|NCT02403674|4329950|P1|Overall Study|Death|1
1320933|NCT02403674|4329949|P2|Overall Study|Adverse Event|23
1320934|NCT02403674|4329950|P1|Overall Study|Adverse Event|10
1320935|NCT02403206|4329991|P2|Overall Study|Reason not given|4
1320936|NCT02403206|4329992|P1|Overall Study|Reason not given|2
1320937|NCT02403206|4329991|P2|Overall Study|Withdrawal by Subject|3
1320938|NCT02403206|4329992|P1|Overall Study|Withdrawal by Subject|3
1320939|NCT02403206|4329991|P2|Overall Study|Physician Decision|0
1320940|NCT02403206|4329992|P1|Overall Study|Physician Decision|2
1320941|NCT02403206|4329991|P2|Overall Study|Lost to Follow-up|3
1320942|NCT02403206|4329992|P1|Overall Study|Lost to Follow-up|4
1320943|NCT02403180|4330003|P2|Period 2 (5 Days)|Withdrawal by Subject|1
1320944|NCT02403180|4330004|P1|Period 2 (5 Days)|Withdrawal by Subject|0
1320945|NCT02403180|4330003|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
1320946|NCT02403180|4330004|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
1320947|NCT02402933|4330033|P1|Overall Study|Discontinued; Site Termination|10
1320948|NCT02402933|4330033|P1|Overall Study|Withdrawal by Subject|4
1320949|NCT02402322|4330051|P3|Follow-up|Withdrawal by Subject|24
1320950|NCT02402322|4330052|P2|Follow-up|Withdrawal by Subject|3
1320951|NCT02402322|4330053|P1|Follow-up|Withdrawal by Subject|6
1320952|NCT02402322|4330051|P3|Pretreatment|Withdrawal by Subject|1
1320953|NCT02402322|4330052|P2|Pretreatment|Withdrawal by Subject|1
1320954|NCT02402322|4330053|P1|Pretreatment|Withdrawal by Subject|3
1320955|NCT02401867|4330122|P1|Analysis|Cervical assay could not be conducted|9
1320956|NCT02401867|4330122|P1|Specimen Collection|Didn't receive 1 or more tests|10
1320957|NCT02401529|4330142|P2|Overall Study|Protocol Violation|0
1320958|NCT02401529|4330143|P1|Overall Study|Protocol Violation|5
1320959|NCT02401529|4330142|P2|Overall Study|Physician Decision|6
1320960|NCT02401529|4330143|P1|Overall Study|Physician Decision|2
1320961|NCT02401529|4330142|P2|Overall Study|Lost to Follow-up|1
1320962|NCT02401529|4330143|P1|Overall Study|Lost to Follow-up|2
1320963|NCT02401412|4330210|P2|Overall Study|Improper Enrollment per In/Ex Criteria|6
1320964|NCT02401412|4330211|P1|Overall Study|Improper Enrollment per In/Ex Criteria|10
1320965|NCT02401412|4330210|P2|Overall Study|Subject withdrawal prior to intervention|1
1320966|NCT02401412|4330211|P1|Overall Study|Subject withdrawal prior to intervention|0
1320967|NCT02401412|4330210|P2|Overall Study|Withdrawal by Subject|4
1320968|NCT02401412|4330211|P1|Overall Study|Withdrawal by Subject|4
1320969|NCT02401412|4330210|P2|Overall Study|Discontinued Intervention|21
1320970|NCT02401412|4330211|P1|Overall Study|Discontinued Intervention|15
1320971|NCT02401412|4330210|P2|Overall Study|Lost to Follow-up|0
1320972|NCT02401412|4330211|P1|Overall Study|Lost to Follow-up|1
1320973|NCT02401256|4330219|P1|Overall Study|Withdrawal by Subject|12
1320974|NCT02401256|4330219|P1|Overall Study|Adverse Event|5
1320975|NCT02401230|4330228|P3|Overall Study|Lost to Follow-up|3
1320976|NCT02401230|4330229|P2|Overall Study|Lost to Follow-up|3
1320977|NCT02401230|4330230|P1|Overall Study|Lost to Follow-up|1
1320978|NCT02401230|4330228|P3|Overall Study|Withdrawal by Subject|1
1320979|NCT02401230|4330229|P2|Overall Study|Withdrawal by Subject|1
1320980|NCT02401230|4330230|P1|Overall Study|Withdrawal by Subject|2
1320981|NCT02401230|4330228|P3|Overall Study|Adverse Event|0
1320982|NCT02401230|4330229|P2|Overall Study|Adverse Event|2
1320983|NCT02401230|4330230|P1|Overall Study|Adverse Event|3
1320984|NCT02400580|4330289|P2|Overall Study|Adverse Event|0
1320985|NCT02400580|4330290|P1|Overall Study|Adverse Event|1
1320986|NCT02400580|4330289|P2|Overall Study|Withdrawal by Subject|1
1320987|NCT02400580|4330290|P1|Overall Study|Withdrawal by Subject|1
1320988|NCT02400346|4330306|P1|Overall Study|Lost to Follow-up|1
1320989|NCT02400346|4330306|P1|Overall Study|Administrative or other reason(s)|2
1320990|NCT02400346|4330306|P1|Overall Study|Withdrawal by Subject|7
1320991|NCT02400346|4330306|P1|Overall Study|Non-compliance with IMP|1
1320992|NCT02400346|4330306|P1|Overall Study|Lack of Efficacy|9
1320993|NCT02400346|4330306|P1|Overall Study|Adverse Event|24
1320994|NCT02400333|4330314|P4|Overall Study|Protocol Violation|1
1320995|NCT02400333|4330315|P3|Overall Study|Protocol Violation|2
1320996|NCT02400333|4330316|P2|Overall Study|Protocol Violation|0
1320997|NCT02400333|4330317|P1|Overall Study|Protocol Violation|1
1320998|NCT02400333|4330314|P4|Overall Study|Withdrawal by Subject|1
1320999|NCT02400333|4330315|P3|Overall Study|Withdrawal by Subject|0
1321000|NCT02400333|4330316|P2|Overall Study|Withdrawal by Subject|1
1321001|NCT02400333|4330317|P1|Overall Study|Withdrawal by Subject|0
1321002|NCT02399163|4330381|P1|Overall Study|Withdrawal by Participant|5
1321003|NCT02399163|4330381|P1|Overall Study|Protocol Deviation|2
1321004|NCT02399163|4330381|P1|Overall Study|Adverse Event|2
1321005|NCT02398227|4330428|P2|Overall Study|Removed from treatment and dropped out|0
1321006|NCT02398227|4330429|P1|Overall Study|Removed from treatment and dropped out|1
1321007|NCT02398227|4330428|P2|Overall Study|Withdrawal by Subject|6
1321008|NCT02398227|4330429|P1|Overall Study|Withdrawal by Subject|5
1321009|NCT02398227|4330428|P2|Overall Study|Lost to Follow-up|12
1321010|NCT02398227|4330429|P1|Overall Study|Lost to Follow-up|21
1321011|NCT02397915|4330437|P4|Period 1|Physician Decision|0
1321012|NCT02397915|4330438|P3|Period 1|Physician Decision|0
1321013|NCT02397915|4330439|P2|Period 1|Physician Decision|0
1321014|NCT02397915|4330440|P1|Period 1|Physician Decision|1
1321015|NCT02397915|4330437|P4|Period 1|Protocol Violation|0
1321016|NCT02397915|4330438|P3|Period 1|Protocol Violation|0
1321017|NCT02397915|4330439|P2|Period 1|Protocol Violation|1
1321018|NCT02397915|4330440|P1|Period 1|Protocol Violation|0
1321019|NCT02397694|4330539|P2|Open Label Extension Phase|Withdrawal by Subject|0
1321020|NCT02397694|4330540|P1|Open Label Extension Phase|Withdrawal by Subject|1
1321021|NCT02397694|4330539|P2|Open Label Extension Phase|Still on Study Drug|30
1321022|NCT02397694|4330540|P1|Open Label Extension Phase|Still on Study Drug|61
1321023|NCT02397694|4330539|P2|Double-Blinded Phase|Lost to Follow-up|1
1321024|NCT02397694|4330540|P1|Double-Blinded Phase|Lost to Follow-up|1
1321025|NCT02397694|4330539|P2|Double-Blinded Phase|Withdrawal by Subject|0
1321026|NCT02397694|4330540|P1|Double-Blinded Phase|Withdrawal by Subject|1
1321027|NCT02397694|4330539|P2|Double-Blinded Phase|Non-compliance with study drug|2
1321028|NCT02397694|4330540|P1|Double-Blinded Phase|Non-compliance with study drug|0
1321029|NCT02397694|4330539|P2|Double-Blinded Phase|Adverse Event|0
1321030|NCT02397694|4330540|P1|Double-Blinded Phase|Adverse Event|1
1321031|NCT02397655|4330578|P1|Overall Study|data not completed|1301
1321032|NCT02396537|4330608|P2|Overall Study|Protocol Violation|1
1321033|NCT02396537|4330609|P1|Overall Study|Protocol Violation|0
1321034|NCT02396316|4330617|P2|Overall Study|Treatment unblinded|1
1321035|NCT02396316|4330618|P1|Overall Study|Treatment unblinded|0
1321036|NCT02396316|4330617|P2|Overall Study|Protocol Violation|1
1321037|NCT02396316|4330618|P1|Overall Study|Protocol Violation|0
1321038|NCT02396316|4330617|P2|Overall Study|Progressive disease|3
1321039|NCT02396316|4330618|P1|Overall Study|Progressive disease|6
1321040|NCT02396316|4330617|P2|Overall Study|Physician Decision|0
1321041|NCT02396316|4330618|P1|Overall Study|Physician Decision|1
1321042|NCT02395822|4330716|P1|Overall Study|Death|1
1321043|NCT02395822|4330716|P1|Overall Study|Withdrawal by Subject|1
1321044|NCT02395653|4330724|P1|Overall Study|Lost to Follow-up|1
1321045|NCT02395653|4330724|P1|Overall Study|Withdrawal by Subject|1
1321046|NCT02395653|4330724|P1|Overall Study|Inclusion Criteria Not Met at Screening|3
1321047|NCT02395653|4330724|P1|Overall Study|Investigator Decision at Screening|1
1321048|NCT02395653|4330724|P1|Overall Study|SSEC Application But With 0 Dose|1
1321049|NCT02395653|4330724|P1|Overall Study|Consent Withdrawn at Screening|1
1321050|NCT02395653|4330724|P1|Overall Study|Exclusion Criteria Met at Screening|4
1321051|NCT02395536|4330733|P2|Overall Study|Insurance issue|1
1321052|NCT02395536|4330734|P1|Overall Study|Insurance issue|0
1321053|NCT02395536|4330733|P2|Overall Study|Inclusion/Excusion Criteria Violation|2
1321054|NCT02395536|4330734|P1|Overall Study|Inclusion/Excusion Criteria Violation|1
1321055|NCT02395536|4330733|P2|Overall Study|Withdrawal by Subject|17
1321056|NCT02395536|4330734|P1|Overall Study|Withdrawal by Subject|9
1321057|NCT02395536|4330733|P2|Overall Study|Physician Decision|6
1321058|NCT02395536|4330734|P1|Overall Study|Physician Decision|4
1321059|NCT02395536|4330733|P2|Overall Study|Death|0
1321060|NCT02395536|4330734|P1|Overall Study|Death|2
1321061|NCT02395536|4330733|P2|Overall Study|Lost to Follow-up|4
1321062|NCT02395536|4330734|P1|Overall Study|Lost to Follow-up|4
1321063|NCT02395302|4330740|P1|Overall Study|Physician Decision|2
1321064|NCT02395302|4330740|P1|Overall Study|Withdrawal by Subject|2
1321065|NCT02395302|4330740|P1|Overall Study|Run In Failure|7
1321066|NCT02395302|4330740|P1|Overall Study|Screen Failure|3
1321067|NCT02395055|4330760|P2|Overall Study|Withdrawal by Subject|3
1321068|NCT02395055|4330761|P1|Overall Study|Withdrawal by Subject|7
1321069|NCT02394925|4330771|P1|Overall Study|Unsatisfactory Visual Response|5
1321070|NCT02394925|4330771|P1|Overall Study|No longer meet eligibility criteria|1
1321071|NCT02394925|4330771|P1|Overall Study|Protocol Violation|5
1321072|NCT02394925|4330771|P1|Overall Study|Lost to Follow-up|9
1321073|NCT02394925|4330771|P1|Overall Study|Lens handling difficulities|5
1321074|NCT02394925|4330771|P1|Overall Study|Lens Discomfort|3
1321075|NCT02394925|4330771|P1|Overall Study|Adverse Event|1
1321076|NCT02394808|4330779|P2|Period 2|Lost to Follow-up|0
1321077|NCT02394808|4330780|P1|Period 2|Lost to Follow-up|1
1321078|NCT02394808|4330779|P2|Period 1|Unsatisfactory lens fitting|1
1321079|NCT02394808|4330780|P1|Period 1|Unsatisfactory lens fitting|0
1321080|NCT02394756|4330788|P6|Period 2|Unsatisfactory Visual Response|0
1321081|NCT02394756|4330789|P5|Period 2|Unsatisfactory Visual Response|1
1321082|NCT02394756|4330790|P4|Period 2|Unsatisfactory Visual Response|0
1321083|NCT02394756|4330791|P3|Period 2|Unsatisfactory Visual Response|0
1321084|NCT02394756|4330792|P2|Period 2|Unsatisfactory Visual Response|0
1321085|NCT02394756|4330793|P1|Period 2|Unsatisfactory Visual Response|0
1321086|NCT02394756|4330788|P6|Period 1|Withdrawal by Subject|0
1321087|NCT02394756|4330789|P5|Period 1|Withdrawal by Subject|0
1321088|NCT02394756|4330790|P4|Period 1|Withdrawal by Subject|1
1321089|NCT02394756|4330791|P3|Period 1|Withdrawal by Subject|1
1321090|NCT02394756|4330792|P2|Period 1|Withdrawal by Subject|1
1321091|NCT02394756|4330793|P1|Period 1|Withdrawal by Subject|0
1321092|NCT02394756|4330788|P6|Period 1|Lens Discomfort|1
1321093|NCT02394756|4330789|P5|Period 1|Lens Discomfort|0
1321094|NCT02394756|4330790|P4|Period 1|Lens Discomfort|0
1321095|NCT02394756|4330791|P3|Period 1|Lens Discomfort|0
1321096|NCT02394756|4330792|P2|Period 1|Lens Discomfort|0
1321097|NCT02394756|4330793|P1|Period 1|Lens Discomfort|0
1321098|NCT02394665|4330807|P3|Overall Study|Physician Decision|0
1321099|NCT02394665|4330808|P2|Overall Study|Physician Decision|0
1321100|NCT02394665|4330809|P1|Overall Study|Physician Decision|1
1321101|NCT02394600|4330831|P2|Overall Study|Protocol Violation|0
1321102|NCT02394600|4330832|P1|Overall Study|Protocol Violation|1
1321103|NCT02394600|4330831|P2|Overall Study|Withdrawal by Subject|1
1321104|NCT02394600|4330832|P1|Overall Study|Withdrawal by Subject|0
1321105|NCT02394600|4330831|P2|Overall Study|Lost to Follow-up|1
1321106|NCT02394600|4330832|P1|Overall Study|Lost to Follow-up|0
1321107|NCT02394600|4330831|P2|Overall Study|Adverse Event|0
1321108|NCT02394600|4330832|P1|Overall Study|Adverse Event|3
1321109|NCT02393950|4330861|P2|Overall Study|Withdrawal by Subject|1
1321110|NCT02393950|4330862|P1|Overall Study|Withdrawal by Subject|0
1321111|NCT02393950|4330861|P2|Overall Study|Adverse Event|0
1321112|NCT02393950|4330862|P1|Overall Study|Adverse Event|1
1321113|NCT02393547|4330936|P1|Overall Study|Lost to Follow-up|1
1321114|NCT02393547|4330936|P1|Overall Study|Withdrawal by Subject|3
1321115|NCT02393547|4330936|P1|Overall Study|Adverse Event|2
1321116|NCT02393209|4330945|P4|Overall Study|Lost to Follow-up|0
1321117|NCT02393209|4330946|P3|Overall Study|Lost to Follow-up|0
1321118|NCT02393209|4330947|P2|Overall Study|Lost to Follow-up|1
1321119|NCT02393209|4330948|P1|Overall Study|Lost to Follow-up|0
1321120|NCT02393209|4330945|P4|Overall Study|Patient Seen by Another Oncologist|0
1321121|NCT02393209|4330946|P3|Overall Study|Patient Seen by Another Oncologist|0
1321122|NCT02393209|4330947|P2|Overall Study|Patient Seen by Another Oncologist|1
1321123|NCT02393209|4330948|P1|Overall Study|Patient Seen by Another Oncologist|0
1321124|NCT02393209|4330945|P4|Overall Study|Death from Legionella Infection|0
1321125|NCT02393209|4330946|P3|Overall Study|Death from Legionella Infection|0
1321126|NCT02393209|4330947|P2|Overall Study|Death from Legionella Infection|1
1321127|NCT02393209|4330948|P1|Overall Study|Death from Legionella Infection|0
1321128|NCT02393209|4330945|P4|Overall Study|Death due to Disease Progression|0
1321129|NCT02393209|4330946|P3|Overall Study|Death due to Disease Progression|0
1321130|NCT02393209|4330947|P2|Overall Study|Death due to Disease Progression|2
1321131|NCT02393209|4330948|P1|Overall Study|Death due to Disease Progression|2
1321132|NCT02393209|4330945|P4|Overall Study|Death|0
1321133|NCT02393209|4330946|P3|Overall Study|Death|0
1321134|NCT02393209|4330947|P2|Overall Study|Death|2
1321135|NCT02393209|4330948|P1|Overall Study|Death|2
1321136|NCT02393209|4330945|P4|Overall Study|Withdrawal by Patient|0
1321137|NCT02393209|4330946|P3|Overall Study|Withdrawal by Patient|0
1321138|NCT02393209|4330947|P2|Overall Study|Withdrawal by Patient|0
1321139|NCT02393209|4330948|P1|Overall Study|Withdrawal by Patient|1
1321140|NCT02393209|4330945|P4|Overall Study|Study Terminated by Sponsor|0
1321141|NCT02393209|4330946|P3|Overall Study|Study Terminated by Sponsor|0
1321142|NCT02393209|4330947|P2|Overall Study|Study Terminated by Sponsor|1
1321143|NCT02393209|4330948|P1|Overall Study|Study Terminated by Sponsor|1
1321144|NCT02392624|4331037|P3|Overall Study|Other|1
1321145|NCT02392624|4331038|P2|Overall Study|Other|1
1321146|NCT02392624|4331039|P1|Overall Study|Other|49
1321147|NCT02392624|4331037|P3|Overall Study|Sponsor/Investigator Decision|0
1321148|NCT02392624|4331038|P2|Overall Study|Sponsor/Investigator Decision|1
1321149|NCT02392624|4331039|P1|Overall Study|Sponsor/Investigator Decision|2
1321150|NCT02392624|4331037|P3|Overall Study|Protocol Violation|1
1321151|NCT02392624|4331038|P2|Overall Study|Protocol Violation|0
1321152|NCT02392624|4331039|P1|Overall Study|Protocol Violation|0
1321153|NCT02392624|4331037|P3|Overall Study|Pregnancy|0
1321154|NCT02392624|4331038|P2|Overall Study|Pregnancy|0
1321155|NCT02392624|4331039|P1|Overall Study|Pregnancy|1
1321156|NCT02392624|4331037|P3|Overall Study|Adverse Event|2
1321157|NCT02392624|4331038|P2|Overall Study|Adverse Event|1
1321158|NCT02392624|4331039|P1|Overall Study|Adverse Event|4
1321159|NCT02392624|4331037|P3|Overall Study|Withdrawal by Subject|9
1321160|NCT02392624|4331038|P2|Overall Study|Withdrawal by Subject|12
1321161|NCT02392624|4331039|P1|Overall Study|Withdrawal by Subject|15
1321162|NCT02392481|4331056|P4|Overall Study|Withdrawal by Subject|0
1321163|NCT02392481|4331057|P3|Overall Study|Withdrawal by Subject|1
1321164|NCT02392481|4331058|P2|Overall Study|Withdrawal by Subject|0
1321165|NCT02392481|4331059|P1|Overall Study|Withdrawal by Subject|0
1321166|NCT02392481|4331056|P4|Overall Study|Adverse Event|2
1321167|NCT02392481|4331057|P3|Overall Study|Adverse Event|1
1321168|NCT02392481|4331058|P2|Overall Study|Adverse Event|0
1321169|NCT02392481|4331059|P1|Overall Study|Adverse Event|0
1321170|NCT02392377|4331083|P2|Overall Study|Withdrawal by Subject|1
1321171|NCT02392377|4331084|P1|Overall Study|Withdrawal by Subject|0
1321172|NCT02392247|4331108|P1|Overall Study|Surgery cancelled; no data|1
1321173|NCT02392247|4331108|P1|Overall Study|Withdrawal by Subject|1
1321174|NCT02392234|4331119|P6|Treatment Period 2 (8 Weeks)|Adverse Event|0
1321175|NCT02392234|4331120|P5|Treatment Period 2 (8 Weeks)|Adverse Event|0
1321176|NCT02392234|4331121|P4|Treatment Period 2 (8 Weeks)|Adverse Event|0
1321177|NCT02392234|4331122|P3|Treatment Period 2 (8 Weeks)|Adverse Event|0
1321178|NCT02392234|4331123|P2|Treatment Period 2 (8 Weeks)|Adverse Event|0
1321179|NCT02392234|4331124|P1|Treatment Period 2 (8 Weeks)|Adverse Event|1
1321180|NCT02392234|4331119|P6|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1321181|NCT02392234|4331120|P5|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
1321182|NCT02392234|4331121|P4|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1321183|NCT02392234|4331122|P3|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
1321184|NCT02392234|4331123|P2|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1321185|NCT02392234|4331124|P1|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1321186|NCT02392234|4331119|P6|Treatment Period 1 (8 Weeks)|Other|0
1321187|NCT02392234|4331120|P5|Treatment Period 1 (8 Weeks)|Other|0
1321188|NCT02392234|4331121|P4|Treatment Period 1 (8 Weeks)|Other|0
1321189|NCT02392234|4331122|P3|Treatment Period 1 (8 Weeks)|Other|0
1321190|NCT02392234|4331123|P2|Treatment Period 1 (8 Weeks)|Other|0
1321191|NCT02392234|4331124|P1|Treatment Period 1 (8 Weeks)|Other|1
1321192|NCT02392234|4331119|P6|Treatment Period 1 (8 Weeks)|Noncompliance|1
1321193|NCT02392234|4331120|P5|Treatment Period 1 (8 Weeks)|Noncompliance|0
1321194|NCT02392234|4331121|P4|Treatment Period 1 (8 Weeks)|Noncompliance|0
1321195|NCT02392234|4331122|P3|Treatment Period 1 (8 Weeks)|Noncompliance|0
1321196|NCT02392234|4331123|P2|Treatment Period 1 (8 Weeks)|Noncompliance|0
1321197|NCT02392234|4331124|P1|Treatment Period 1 (8 Weeks)|Noncompliance|0
1321198|NCT02392234|4331119|P6|Treatment Period 1 (8 Weeks)|Pregnancy|0
1321199|NCT02392234|4331120|P5|Treatment Period 1 (8 Weeks)|Pregnancy|0
1321200|NCT02392234|4331121|P4|Treatment Period 1 (8 Weeks)|Pregnancy|1
1321201|NCT02392234|4331122|P3|Treatment Period 1 (8 Weeks)|Pregnancy|0
1321202|NCT02392234|4331123|P2|Treatment Period 1 (8 Weeks)|Pregnancy|0
1321203|NCT02392234|4331124|P1|Treatment Period 1 (8 Weeks)|Pregnancy|1
1321204|NCT02392234|4331119|P6|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
1321205|NCT02392234|4331120|P5|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1321206|NCT02392234|4331121|P4|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1321207|NCT02392234|4331122|P3|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1321208|NCT02392234|4331123|P2|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1321209|NCT02392234|4331124|P1|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1321210|NCT02392234|4331119|P6|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1321211|NCT02392234|4331120|P5|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
1321212|NCT02392234|4331121|P4|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1321213|NCT02392234|4331122|P3|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1321214|NCT02392234|4331123|P2|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1321215|NCT02392234|4331124|P1|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1321216|NCT02392234|4331119|P6|Treatment Period 1 (8 Weeks)|Adverse Event|1
1321217|NCT02392234|4331120|P5|Treatment Period 1 (8 Weeks)|Adverse Event|1
1321218|NCT02392234|4331121|P4|Treatment Period 1 (8 Weeks)|Adverse Event|0
1321219|NCT02392234|4331122|P3|Treatment Period 1 (8 Weeks)|Adverse Event|1
1321220|NCT02392234|4331123|P2|Treatment Period 1 (8 Weeks)|Adverse Event|0
1321221|NCT02392234|4331124|P1|Treatment Period 1 (8 Weeks)|Adverse Event|1
1321222|NCT02392000|4331156|P1|Overall Study|Lost to Follow-up|8
1321223|NCT02392000|4331156|P1|Overall Study|Withdrawal by Subject|1
1321224|NCT02392000|4331156|P1|Overall Study|Greater than mild sleep apnea exclusion|18
1321225|NCT02391311|4331179|P2|Overall Study|deemed ineligible after baseline|1
1321226|NCT02391311|4331180|P1|Overall Study|deemed ineligible after baseline|1
1321227|NCT02391311|4331179|P2|Overall Study|Lost to Follow-up|1
1321228|NCT02391311|4331180|P1|Overall Study|Lost to Follow-up|2
1321229|NCT02391116|4331188|P1|Survival Follow-up|Ongoing with Survival Follow-up|12
1321230|NCT02391116|4331188|P1|Survival Follow-up|Withdrawal by Subject|2
1321231|NCT02391116|4331188|P1|Active Follow-up|Switching to Other Therapy|2
1321232|NCT02391116|4331188|P1|Active Follow-up|Withdrawal by Subject|1
1321233|NCT02391116|4331188|P1|Safety Follow-up|Deterioration of General Conditions|3
1321234|NCT02391116|4331188|P1|Safety Follow-up|No Follow Up|1
1321235|NCT02391116|4331188|P1|Safety Follow-up|Switching to Other Therapy|4
1321236|NCT02391116|4331188|P1|Safety Follow-up|Withdrawal by Subject|4
1321237|NCT02391116|4331188|P1|Safety Follow-up|Adverse Event|1
1321238|NCT02391116|4331188|P1|Treatment|Ongoing with Treatment|1
1321239|NCT02391116|4331188|P1|Treatment|AE with Clinical PD|3
1321240|NCT02391116|4331188|P1|Treatment|Adverse Event (AE) Without Clinical PD|9
1321241|NCT02391116|4331188|P1|Treatment|Protocol Violation|1
1321242|NCT02391116|4331188|P1|Treatment|Withdrawal by Subject|1
1321243|NCT02391038|4331241|P3|Overall Study|Progressive disease|6
1321244|NCT02391038|4331242|P2|Overall Study|Progressive disease|3
1321245|NCT02391038|4331243|P1|Overall Study|Progressive disease|3
1321246|NCT02390219|4331357|P1|Overall Study|Other|2
1321247|NCT02390219|4331357|P1|Overall Study|Lost to Follow-up|2
1321248|NCT02390219|4331357|P1|Overall Study|Withdrawal by Subject|1
1321249|NCT02390219|4331357|P1|Overall Study|Adverse Event|6
1321250|NCT02390219|4331357|P1|Overall Study|Physician Decision|1
1321251|NCT02390219|4331357|P1|Overall Study|Death|1
1321252|NCT02390167|4331367|P1|Overall Study|Lost to Follow-up|1
1321253|NCT02389829|4331450|P2|Overall Study|Lost to Follow-up|1
1321254|NCT02389829|4331451|P1|Overall Study|Lost to Follow-up|0
1321255|NCT02389452|4331463|P1|Overall Study|Enrolled but Not Eligible for Study|6
1321256|NCT02389452|4331463|P1|Overall Study|Withdrawal by Subject|5
1321257|NCT02389452|4331463|P1|Overall Study|Adverse Event|1
1321258|NCT02389452|4331463|P1|Overall Study|Lost to Follow-up|13
1321259|NCT02388997|4331571|P2|Overall Study|Tested positive for virus during run-in|1
1321260|NCT02388997|4331572|P1|Overall Study|Tested positive for virus during run-in|0
1321261|NCT02388997|4331571|P2|Overall Study|Lung function exclusion criteria|2
1321262|NCT02388997|4331572|P1|Overall Study|Lung function exclusion criteria|0
1321263|NCT02388997|4331571|P2|Overall Study|Withdrawal by Subject|1
1321264|NCT02388997|4331572|P1|Overall Study|Withdrawal by Subject|2
1321265|NCT02388997|4331571|P2|Overall Study|Adverse Event|2
1321266|NCT02388997|4331572|P1|Overall Study|Adverse Event|1
1321267|NCT02388776|4331594|P1|Overall Study|Lost to Follow-up|1
1321268|NCT02388776|4331594|P1|Overall Study|Death|1
1321269|NCT02388763|4331599|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
1321270|NCT02388763|4331600|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
1321271|NCT02388763|4331599|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
1321272|NCT02388763|4331600|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
1321273|NCT02388347|4331635|P5|Overall Study|Withdrawal by Subject|0
1321274|NCT02388347|4331636|P4|Overall Study|Withdrawal by Subject|0
1321275|NCT02388347|4331637|P3|Overall Study|Withdrawal by Subject|1
1321276|NCT02388347|4331638|P2|Overall Study|Withdrawal by Subject|0
1321277|NCT02388347|4331639|P1|Overall Study|Withdrawal by Subject|0
1321278|NCT02388295|4331718|P3|Treatment Weeks 3 to 12|Adverse Event|0
1321279|NCT02388295|4331719|P2|Treatment Weeks 3 to 12|Adverse Event|1
1321280|NCT02388295|4331720|P1|Treatment Weeks 3 to 12|Adverse Event|1
1321281|NCT02388295|4331718|P3|Dose Escalation Week 2|Determined not eligible|1
1321282|NCT02388295|4331719|P2|Dose Escalation Week 2|Determined not eligible|1
1321283|NCT02388295|4331720|P1|Dose Escalation Week 2|Determined not eligible|1
1321284|NCT02388295|4331718|P3|Dose Escalation Week 2|Protocol Violation|0
1321285|NCT02388295|4331719|P2|Dose Escalation Week 2|Protocol Violation|1
1321286|NCT02388295|4331720|P1|Dose Escalation Week 2|Protocol Violation|0
1321287|NCT02388295|4331718|P3|Dose Escalation Week 1|Determined not eligible|1
1321288|NCT02388295|4331719|P2|Dose Escalation Week 1|Determined not eligible|1
1321289|NCT02388295|4331720|P1|Dose Escalation Week 1|Determined not eligible|1
1321290|NCT02388295|4331718|P3|Dose Escalation Week 1|Adverse Event|1
1321291|NCT02388295|4331719|P2|Dose Escalation Week 1|Adverse Event|2
1321292|NCT02388295|4331720|P1|Dose Escalation Week 1|Adverse Event|1
1321293|NCT02388269|4331738|P3|Overall Study|Screen Failure|10
1321294|NCT02388269|4331739|P2|Overall Study|Screen Failure|0
1321295|NCT02388269|4331740|P1|Overall Study|Screen Failure|0
1321296|NCT02388269|4331738|P3|Overall Study|Protocol Violation|0
1321297|NCT02388269|4331739|P2|Overall Study|Protocol Violation|0
1321298|NCT02388269|4331740|P1|Overall Study|Protocol Violation|2
1321299|NCT02388269|4331738|P3|Overall Study|no diary data|0
1321300|NCT02388269|4331739|P2|Overall Study|no diary data|0
1321301|NCT02388269|4331740|P1|Overall Study|no diary data|3
1321302|NCT02388269|4331738|P3|Overall Study|less than 50% stimulations|0
1321303|NCT02388269|4331739|P2|Overall Study|less than 50% stimulations|0
1321304|NCT02388269|4331740|P1|Overall Study|less than 50% stimulations|1
1321305|NCT02388269|4331738|P3|Overall Study|Withdrawal by Subject|0
1321306|NCT02388269|4331739|P2|Overall Study|Withdrawal by Subject|2
1321307|NCT02388269|4331740|P1|Overall Study|Withdrawal by Subject|1
1321308|NCT02388269|4331738|P3|Overall Study|Adverse Event|0
1321309|NCT02388269|4331739|P2|Overall Study|Adverse Event|0
1321310|NCT02388269|4331740|P1|Overall Study|Adverse Event|2
1321311|NCT02388191|4331772|P2|Overall Study|Patient did not receive IUD|0
1321312|NCT02388191|4331773|P1|Overall Study|Patient did not receive IUD|1
1321313|NCT02388074|4331787|P1|Overall Study|Sample Not Returned|1
1321314|NCT02388074|4331787|P1|Overall Study|Lost in Transit|2
1321315|NCT02387996|4331791|P1|Overall Study|Poor/Non-Compliance|1
1321316|NCT02387996|4331791|P1|Overall Study|Lost to Follow-up|1
1321317|NCT02387996|4331791|P1|Overall Study|Subject Withdrew Consent|1
1321318|NCT02387996|4331791|P1|Overall Study|Subject Request to Discontinue Treatment|9
1321319|NCT02387996|4331791|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
1321320|NCT02387996|4331791|P1|Overall Study|Study Drug Toxicity|14
1321321|NCT02387996|4331791|P1|Overall Study|Disease Progression|144
1321322|NCT02387983|4331802|P1|Overall Study|Withdrawal by Subject|2
1321323|NCT02387983|4331802|P1|Overall Study|Protocol Violation|1
1321324|NCT02387983|4331802|P1|Overall Study|Adverse Event|4
1321325|NCT02387580|4331861|P6|Overall Study|Withdrawal by Subject|0
1321326|NCT02387580|4331862|P5|Overall Study|Withdrawal by Subject|0
1321327|NCT02387580|4331863|P4|Overall Study|Withdrawal by Subject|1
1321328|NCT02387580|4331864|P3|Overall Study|Withdrawal by Subject|0
1321329|NCT02387580|4331865|P2|Overall Study|Withdrawal by Subject|0
1321330|NCT02387580|4331866|P1|Overall Study|Withdrawal by Subject|0
1321331|NCT02386098|4331967|P5|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
1321332|NCT02386098|4331968|P4|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
1321333|NCT02386098|4331969|P3|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
1321334|NCT02386098|4331970|P2|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
1321335|NCT02386098|4331971|P1|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
1321336|NCT02386098|4331967|P5|Stage 1 (96 Weeks)|Other|0
1321337|NCT02386098|4331968|P4|Stage 1 (96 Weeks)|Other|0
1321338|NCT02386098|4331969|P3|Stage 1 (96 Weeks)|Other|0
1321339|NCT02386098|4331970|P2|Stage 1 (96 Weeks)|Other|0
1321340|NCT02386098|4331971|P1|Stage 1 (96 Weeks)|Other|1
1321341|NCT02386098|4331967|P5|Stage 1 (96 Weeks)|Withdrawal by Subject|0
1321342|NCT02386098|4331968|P4|Stage 1 (96 Weeks)|Withdrawal by Subject|0
1321343|NCT02386098|4331969|P3|Stage 1 (96 Weeks)|Withdrawal by Subject|0
1321344|NCT02386098|4331970|P2|Stage 1 (96 Weeks)|Withdrawal by Subject|1
1321345|NCT02386098|4331971|P1|Stage 1 (96 Weeks)|Withdrawal by Subject|3
1321346|NCT02386098|4331967|P5|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
1321347|NCT02386098|4331968|P4|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
1321348|NCT02386098|4331969|P3|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
1321349|NCT02386098|4331970|P2|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
1321350|NCT02386098|4331971|P1|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
1321351|NCT02386098|4331967|P5|Stage 1 (96 Weeks)|Lost to Follow-up|0
1321352|NCT02386098|4331968|P4|Stage 1 (96 Weeks)|Lost to Follow-up|0
1321353|NCT02386098|4331969|P3|Stage 1 (96 Weeks)|Lost to Follow-up|0
1321354|NCT02386098|4331970|P2|Stage 1 (96 Weeks)|Lost to Follow-up|2
1321355|NCT02386098|4331971|P1|Stage 1 (96 Weeks)|Lost to Follow-up|2
1321356|NCT02386098|4331967|P5|Stage 1 (96 Weeks)|Adverse Event|0
1321357|NCT02386098|4331968|P4|Stage 1 (96 Weeks)|Adverse Event|0
1321358|NCT02386098|4331969|P3|Stage 1 (96 Weeks)|Adverse Event|0
1321359|NCT02386098|4331970|P2|Stage 1 (96 Weeks)|Adverse Event|1
1321360|NCT02386098|4331971|P1|Stage 1 (96 Weeks)|Adverse Event|2
1321361|NCT02386098|4331967|P5|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
1321362|NCT02386098|4331968|P4|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
1321363|NCT02386098|4331969|P3|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
1321364|NCT02386098|4331970|P2|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
1321365|NCT02386098|4331971|P1|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
1321366|NCT02385526|4332051|P3|Overall Study|Protocol Violation|0
1321367|NCT02385526|4332052|P2|Overall Study|Protocol Violation|0
1321368|NCT02385526|4332053|P1|Overall Study|Protocol Violation|1
1321369|NCT02385526|4332051|P3|Overall Study|Physician Decision|0
1321370|NCT02385526|4332052|P2|Overall Study|Physician Decision|0
1321371|NCT02385526|4332053|P1|Overall Study|Physician Decision|1
1321372|NCT02385526|4332051|P3|Overall Study|Lost to Follow-up|0
1321373|NCT02385526|4332052|P2|Overall Study|Lost to Follow-up|1
1321374|NCT02385526|4332053|P1|Overall Study|Lost to Follow-up|0
1321375|NCT02385526|4332051|P3|Overall Study|Withdrawal by Subject|0
1321376|NCT02385526|4332052|P2|Overall Study|Withdrawal by Subject|2
1321377|NCT02385526|4332053|P1|Overall Study|Withdrawal by Subject|0
1321378|NCT02384538|4332063|P2|Overall Study|Not Specified|3
1321379|NCT02384538|4332064|P1|Overall Study|Not Specified|1
1321380|NCT02384538|4332063|P2|Overall Study|Withdrew Consent|4
1321381|NCT02384538|4332064|P1|Overall Study|Withdrew Consent|0
1321382|NCT02384538|4332063|P2|Overall Study|Lack of Efficacy|4
1321383|NCT02384538|4332064|P1|Overall Study|Lack of Efficacy|4
1321384|NCT02384538|4332063|P2|Overall Study|Adverse Event|4
1321385|NCT02384538|4332064|P1|Overall Study|Adverse Event|1
1321386|NCT02383862|4332111|P2|3 Month Follow up|Lost to Follow-up|21
1321387|NCT02383862|4332112|P1|3 Month Follow up|Lost to Follow-up|23
1321388|NCT02383758|4332145|P2|Overall Study|Withdrawal by Subject|2
1321389|NCT02383758|4332146|P1|Overall Study|Withdrawal by Subject|0
1321390|NCT02383576|4332164|P2|Overall Study|Administrative/Other|4
1321391|NCT02383576|4332165|P1|Overall Study|Administrative/Other|2
1321392|NCT02383576|4332164|P2|Overall Study|Investigator's Decision|1
1321393|NCT02383576|4332165|P1|Overall Study|Investigator's Decision|0
1321394|NCT02383576|4332164|P2|Overall Study|Withdrew Consent|6
1321395|NCT02383576|4332165|P1|Overall Study|Withdrew Consent|1
1321396|NCT02383576|4332164|P2|Overall Study|Lost to Follow-up|1
1321397|NCT02383576|4332165|P1|Overall Study|Lost to Follow-up|7
1321398|NCT02383576|4332164|P2|Overall Study|Death|33
1321399|NCT02383576|4332165|P1|Overall Study|Death|53
1321400|NCT02383472|4332181|P2|Overall Study|Withdrawal by Subject|1
1321401|NCT02383472|4332182|P1|Overall Study|Withdrawal by Subject|1
1321402|NCT02382640|4332302|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
1321403|NCT02382640|4332303|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
1321404|NCT02382640|4332304|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
1321405|NCT02382640|4332305|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
1321406|NCT02382133|4332343|P1|Overall Study|pressure injury both sites|1
1321407|NCT02382133|4332343|P1|Overall Study|arterial catheter loss|4
1321408|NCT02382133|4332343|P1|Overall Study|Physician Decision|2
1321409|NCT02382133|4332343|P1|Overall Study|transfer out of ICU|4
1321410|NCT02382133|4332343|P1|Overall Study|Death|22
1321411|NCT02381795|4332348|P1|Overall Study|Study Terminated|2
1321412|NCT02381795|4332348|P1|Overall Study|Withdrawal by Subject|1
1321413|NCT02380742|4332419|P2|Overall Study|Withdrawal by Subject|0
1321414|NCT02380742|4332420|P1|Overall Study|Withdrawal by Subject|1
1321415|NCT02380287|4332440|P8|Overall Study|Adverse Event|0
1321416|NCT02380287|4332441|P7|Overall Study|Adverse Event|0
1321417|NCT02380287|4332442|P6|Overall Study|Adverse Event|0
1321418|NCT02380287|4332443|P5|Overall Study|Adverse Event|0
1321419|NCT02380287|4332444|P4|Overall Study|Adverse Event|0
1321420|NCT02380287|4332445|P3|Overall Study|Adverse Event|1
1321421|NCT02380287|4332446|P2|Overall Study|Adverse Event|0
1321422|NCT02380287|4332447|P1|Overall Study|Adverse Event|0
1321423|NCT02380248|4332463|P1|Overall Study|Withdrawal by Subject|3
1321424|NCT02380248|4332463|P1|Overall Study|Lost to Follow-up|11
1321425|NCT02379923|4332468|P1|Overall Study|Death|5
1321426|NCT02379637|4332484|P2|Overall Study|Withdrawal by Subject|0
1321427|NCT02379637|4332485|P1|Overall Study|Withdrawal by Subject|1
1321428|NCT02379637|4332484|P2|Overall Study|Adverse Event|0
1321429|NCT02379637|4332485|P1|Overall Study|Adverse Event|1
1321430|NCT02379637|4332484|P2|Overall Study|Protocol Violation|1
1321431|NCT02379637|4332485|P1|Overall Study|Protocol Violation|0
1321432|NCT02378961|4332522|P4|Overall Study|Death|0
1321433|NCT02378961|4332523|P3|Overall Study|Death|1
1321434|NCT02378961|4332524|P2|Overall Study|Death|0
1321435|NCT02378961|4332525|P1|Overall Study|Death|0
1321436|NCT02378961|4332522|P4|Overall Study|Lack of Efficacy|1
1321437|NCT02378961|4332523|P3|Overall Study|Lack of Efficacy|0
1321438|NCT02378961|4332524|P2|Overall Study|Lack of Efficacy|2
1321439|NCT02378961|4332525|P1|Overall Study|Lack of Efficacy|4
1321440|NCT02378935|4332562|P7|Overall Study|Death|0
1321441|NCT02378935|4332563|P6|Overall Study|Death|0
1321442|NCT02378935|4332564|P5|Overall Study|Death|0
1321443|NCT02378935|4332565|P4|Overall Study|Death|0
1321444|NCT02378935|4332566|P3|Overall Study|Death|1
1321445|NCT02378935|4332567|P2|Overall Study|Death|0
1321446|NCT02378935|4332568|P1|Overall Study|Death|0
1321447|NCT02378935|4332562|P7|Overall Study|Lack of Efficacy|0
1321448|NCT02378935|4332563|P6|Overall Study|Lack of Efficacy|0
1321449|NCT02378935|4332564|P5|Overall Study|Lack of Efficacy|0
1321450|NCT02378935|4332565|P4|Overall Study|Lack of Efficacy|6
1321451|NCT02378935|4332566|P3|Overall Study|Lack of Efficacy|2
1321452|NCT02378935|4332567|P2|Overall Study|Lack of Efficacy|0
1321453|NCT02378935|4332568|P1|Overall Study|Lack of Efficacy|10
1321454|NCT02378506|4332640|P1|Overall Study|Randomized But Not Treated|1
1321455|NCT02378506|4332640|P1|Overall Study|Adverse Event|14
1321456|NCT02378506|4332640|P1|Overall Study|Death|1
1321457|NCT02378506|4332640|P1|Overall Study|Protocol Violation|2
1321458|NCT02378506|4332640|P1|Overall Study|Withdrawal by Subject|4
1321459|NCT02378506|4332640|P1|Overall Study|Lack of Efficacy|3
1321460|NCT02378220|4332659|P2|Overall Study|Death|1
1321461|NCT02378220|4332660|P1|Overall Study|Death|6
1321462|NCT02377921|4332692|P2|Overall Study|Subject non-compliance|1
1321463|NCT02377921|4332693|P1|Overall Study|Subject non-compliance|1
1321464|NCT02377466|4332717|P2|Overall Study|Other: Randomized and not treated|2
1321465|NCT02377466|4332718|P1|Overall Study|Other: Randomized and not treated|0
1321466|NCT02377427|4332836|P5|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1321467|NCT02377427|4332837|P4|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1321468|NCT02377427|4332838|P3|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
1321469|NCT02377427|4332839|P2|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1321470|NCT02377427|4332840|P1|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1321471|NCT02377427|4332836|P5|Part A (Up to Week 20)|Withdrawal by Subject|0
1321472|NCT02377427|4332837|P4|Part A (Up to Week 20)|Withdrawal by Subject|0
1321473|NCT02377427|4332838|P3|Part A (Up to Week 20)|Withdrawal by Subject|0
1321474|NCT02377427|4332839|P2|Part A (Up to Week 20)|Withdrawal by Subject|0
1321475|NCT02377427|4332840|P1|Part A (Up to Week 20)|Withdrawal by Subject|2
1321476|NCT02377427|4332836|P5|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1321477|NCT02377427|4332837|P4|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1321478|NCT02377427|4332838|P3|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1321479|NCT02377427|4332839|P2|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1321480|NCT02377427|4332840|P1|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
1321481|NCT02377427|4332836|P5|Part A (Up to Week 20)|Physician Decision|0
1321482|NCT02377427|4332837|P4|Part A (Up to Week 20)|Physician Decision|0
1321483|NCT02377427|4332838|P3|Part A (Up to Week 20)|Physician Decision|0
1321484|NCT02377427|4332839|P2|Part A (Up to Week 20)|Physician Decision|0
1321485|NCT02377427|4332840|P1|Part A (Up to Week 20)|Physician Decision|1
1321486|NCT02376166|4332921|P1|Overall Study|Discontinued metformin early|2
1321487|NCT02376166|4332921|P1|Overall Study|Adverse Event|1
1321488|NCT02375971|4332949|P3|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
1321489|NCT02375971|4332950|P2|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
1321490|NCT02375971|4332951|P1|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
1321491|NCT02375971|4332949|P3|Follow-Up Phase (up to Day 169)|Death|4
1321492|NCT02375971|4332950|P2|Follow-Up Phase (up to Day 169)|Death|4
1321493|NCT02375971|4332951|P1|Follow-Up Phase (up to Day 169)|Death|4
1321494|NCT02375971|4332949|P3|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
1321495|NCT02375971|4332950|P2|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
1321496|NCT02375971|4332951|P1|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
1321497|NCT02375971|4332949|P3|Follow-Up Phase (up to Day 169)|Adverse Event|0
1321498|NCT02375971|4332950|P2|Follow-Up Phase (up to Day 169)|Adverse Event|0
1321499|NCT02375971|4332951|P1|Follow-Up Phase (up to Day 169)|Adverse Event|1
1321500|NCT02375971|4332949|P3|Treatment (Day 1 - Baseline)|Adverse Event|1
1321501|NCT02375971|4332950|P2|Treatment (Day 1 - Baseline)|Adverse Event|0
1321502|NCT02375971|4332951|P1|Treatment (Day 1 - Baseline)|Adverse Event|0
1321503|NCT02375971|4332949|P3|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
1321504|NCT02375971|4332950|P2|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
1321505|NCT02375971|4332951|P1|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
1321506|NCT02375971|4332949|P3|Treatment (Day 1 - Baseline)|Physician Decision|1
1321507|NCT02375971|4332950|P2|Treatment (Day 1 - Baseline)|Physician Decision|1
1321508|NCT02375971|4332951|P1|Treatment (Day 1 - Baseline)|Physician Decision|1
1321509|NCT02375971|4332949|P3|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
1321510|NCT02375971|4332950|P2|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
1321511|NCT02375971|4332951|P1|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
1321512|NCT02375724|4332993|P2|Overall Study|Adverse Event|4
1321513|NCT02375724|4332994|P1|Overall Study|Adverse Event|2
1321514|NCT02375724|4332993|P2|Overall Study|Protocol Violation|0
1321515|NCT02375724|4332994|P1|Overall Study|Protocol Violation|1
1321516|NCT02375724|4332993|P2|Overall Study|Lost to Follow-up|0
1321517|NCT02375724|4332994|P1|Overall Study|Lost to Follow-up|1
1321518|NCT02375724|4332993|P2|Overall Study|Withdrawal by Subject|1
1321519|NCT02375724|4332994|P1|Overall Study|Withdrawal by Subject|1
1321520|NCT02375724|4332993|P2|Overall Study|Lack of Efficacy|1
1321521|NCT02375724|4332994|P1|Overall Study|Lack of Efficacy|1
1321522|NCT02375373|4333004|P1|Overall Study|Withdrawal by Subject|11
1321523|NCT02375347|4333008|P1|Overall Study|Protocol Violation|1
1321524|NCT02374593|4333014|P2|Overall Study|non-compliant|0
1321525|NCT02374593|4333015|P1|Overall Study|non-compliant|2
1321526|NCT02374346|4333058|P1|Overall Study|operated or discharged during weekend|48
1321527|NCT02373202|4333090|P4|Overall Study|Not specified|0
1321528|NCT02373202|4333091|P3|Overall Study|Not specified|0
1321529|NCT02373202|4333092|P2|Overall Study|Not specified|1
1321530|NCT02373202|4333093|P1|Overall Study|Not specified|0
1321531|NCT02373202|4333090|P4|Overall Study|Lack of Efficacy|0
1321532|NCT02373202|4333091|P3|Overall Study|Lack of Efficacy|1
1321533|NCT02373202|4333092|P2|Overall Study|Lack of Efficacy|0
1321534|NCT02373202|4333093|P1|Overall Study|Lack of Efficacy|0
1321535|NCT02373202|4333090|P4|Overall Study|Adverse Event|1
1321536|NCT02373202|4333091|P3|Overall Study|Adverse Event|2
1321537|NCT02373202|4333092|P2|Overall Study|Adverse Event|5
1321538|NCT02373202|4333093|P1|Overall Study|Adverse Event|2
1321539|NCT02372071|4333188|P1|Overall Study|Protocol Violation|18
1321540|NCT02372058|4333193|P1|Overall Study|Withdrawal by Subject|3
1321541|NCT02371759|4333222|P8|Overall Study|Withdrawal by Subject|1
1321542|NCT02371759|4333223|P7|Overall Study|Withdrawal by Subject|0
1321543|NCT02371759|4333224|P6|Overall Study|Withdrawal by Subject|0
1321544|NCT02371759|4333225|P5|Overall Study|Withdrawal by Subject|0
1321545|NCT02371759|4333226|P4|Overall Study|Withdrawal by Subject|0
1321546|NCT02371759|4333227|P3|Overall Study|Withdrawal by Subject|0
1321547|NCT02371759|4333228|P2|Overall Study|Withdrawal by Subject|0
1321548|NCT02371759|4333229|P1|Overall Study|Withdrawal by Subject|0
1321549|NCT02371759|4333222|P8|Overall Study|Protocol Violation|3
1321550|NCT02371759|4333223|P7|Overall Study|Protocol Violation|0
1321551|NCT02371759|4333224|P6|Overall Study|Protocol Violation|1
1321552|NCT02371759|4333225|P5|Overall Study|Protocol Violation|3
1321553|NCT02371759|4333226|P4|Overall Study|Protocol Violation|0
1321554|NCT02371759|4333227|P3|Overall Study|Protocol Violation|1
1321555|NCT02371759|4333228|P2|Overall Study|Protocol Violation|1
1321556|NCT02371759|4333229|P1|Overall Study|Protocol Violation|3
1321557|NCT02371616|4333441|P2|Overall Study|Other (Not specified)|5
1321558|NCT02371616|4333442|P1|Overall Study|Other (Not specified)|1
1321559|NCT02371616|4333441|P2|Overall Study|Withdrawal of Consent|0
1321560|NCT02371616|4333442|P1|Overall Study|Withdrawal of Consent|1
1321561|NCT02371616|4333441|P2|Overall Study|Adverse Event|1
1321562|NCT02371616|4333442|P1|Overall Study|Adverse Event|0
1321563|NCT02371616|4333441|P2|Overall Study|Protocol Violation|1
1321564|NCT02371616|4333442|P1|Overall Study|Protocol Violation|2
1321565|NCT02370914|4333454|P1|Overall Study|Protocol Violation|2
1321566|NCT02370667|4333461|P3|Overall Study|Lost to Follow-up|0
1321567|NCT02370667|4333462|P2|Overall Study|Lost to Follow-up|1
1321568|NCT02370667|4333463|P1|Overall Study|Lost to Follow-up|0
1321569|NCT02370615|4333527|P2|Overall Study|Adverse Event|0
1321570|NCT02370615|4333528|P1|Overall Study|Adverse Event|1
1321571|NCT02370602|4333571|P6|Overall Study|Pretreatment Event/Adverse Event|0
1321572|NCT02370602|4333572|P5|Overall Study|Pretreatment Event/Adverse Event|0
1321573|NCT02370602|4333573|P4|Overall Study|Pretreatment Event/Adverse Event|0
1321574|NCT02370602|4333574|P3|Overall Study|Pretreatment Event/Adverse Event|0
1321575|NCT02370602|4333575|P2|Overall Study|Pretreatment Event/Adverse Event|0
1321576|NCT02370602|4333576|P1|Overall Study|Pretreatment Event/Adverse Event|1
1321577|NCT02370537|4333670|P3|Part B|Withdrawal by Subject|0
1321578|NCT02370537|4333671|P2|Part B|Withdrawal by Subject|1
1321579|NCT02370537|4333672|P1|Part B|Withdrawal by Subject|0
1321580|NCT02370537|4333670|P3|Part B|Not randomised to receive treatment|259
1321581|NCT02370537|4333671|P2|Part B|Not randomised to receive treatment|2
1321582|NCT02370537|4333672|P1|Part B|Not randomised to receive treatment|1
1321583|NCT02370537|4333670|P3|Part A (Open-label Recruitment)|Adverse Event|1
1321584|NCT02370537|4333671|P2|Part A (Open-label Recruitment)|Adverse Event|0
1321585|NCT02370537|4333672|P1|Part A (Open-label Recruitment)|Adverse Event|0
1321586|NCT02370537|4333670|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
1321587|NCT02370537|4333671|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
1321588|NCT02370537|4333672|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
1321589|NCT02370420|4333721|P2|Overall Study|Lost to Follow-up|9
1321590|NCT02370420|4333722|P1|Overall Study|Lost to Follow-up|11
1321591|NCT02370420|4333721|P2|Overall Study|Physician Decision|3
1321592|NCT02370420|4333722|P1|Overall Study|Physician Decision|3
1321593|NCT02370394|4333759|P2|Overall Study|Withdrawal by Subject|1
1321594|NCT02370394|4333760|P1|Overall Study|Withdrawal by Subject|0
1321595|NCT02370394|4333759|P2|Overall Study|Lost to Follow-up|1
1321596|NCT02370394|4333760|P1|Overall Study|Lost to Follow-up|2
1321597|NCT02370121|4333776|P2|Overall Study|Lost to Follow-up|1
1321598|NCT02370121|4333777|P1|Overall Study|Lost to Follow-up|1
1321599|NCT02369848|4333815|P1|Overall Study|Lost to Follow-up|1
1321600|NCT02369848|4333815|P1|Overall Study|Withdrawal by Subject|2
1321601|NCT02369848|4333815|P1|Overall Study|Death|1
1321602|NCT02369510|4333880|P3|Overall Study|Epidural Activation|5
1321603|NCT02369510|4333881|P2|Overall Study|Epidural Activation|1
1321604|NCT02369510|4333882|P1|Overall Study|Epidural Activation|1
1321605|NCT02369510|4333880|P3|Overall Study|Spilled Medication|1
1321606|NCT02369510|4333881|P2|Overall Study|Spilled Medication|2
1321607|NCT02369510|4333882|P1|Overall Study|Spilled Medication|1
1321608|NCT02369341|4333913|P2|Overall Study|Migrated/moved from study area|0
1321609|NCT02369341|4333914|P1|Overall Study|Migrated/moved from study area|1
1321610|NCT02368314|4333981|P2|Overall Study|Adverse Event|2
1321611|NCT02368314|4333982|P1|Overall Study|Adverse Event|1
1321612|NCT02368314|4333981|P2|Overall Study|Withdrawal by Subject|1
1321613|NCT02368314|4333982|P1|Overall Study|Withdrawal by Subject|2
1321614|NCT02367885|4334004|P3|Overall Study|Withdrawal by Subject|0
1321615|NCT02367885|4334005|P2|Overall Study|Withdrawal by Subject|0
1321616|NCT02367885|4334006|P1|Overall Study|Withdrawal by Subject|1
1321617|NCT02367885|4334004|P3|Overall Study|Lost to Follow-up|0
1321618|NCT02367885|4334005|P2|Overall Study|Lost to Follow-up|0
1321619|NCT02367885|4334006|P1|Overall Study|Lost to Follow-up|1
1321620|NCT02367521|4334241|P2|Overall Study|unable to find transportation|0
1321621|NCT02367521|4334242|P1|Overall Study|unable to find transportation|2
1321622|NCT02367521|4334241|P2|Overall Study|severe headache after intervention|0
1321623|NCT02367521|4334242|P1|Overall Study|severe headache after intervention|2
1321624|NCT02367131|4334328|P1|Overall Study|Other than stated above|20
1321625|NCT02367131|4334328|P1|Overall Study|No change/progressive disease|78
1321626|NCT02367131|4334328|P1|Overall Study|Improvement/remission|2
1321627|NCT02367131|4334328|P1|Overall Study|Request by patient|54
1321628|NCT02367131|4334328|P1|Overall Study|No visit since the first visit|4
1321629|NCT02367131|4334328|P1|Overall Study|Adverse Event|64
1321630|NCT02366936|4334395|P1|Overall Study|Physician Decision|2
1321631|NCT02366936|4334395|P1|Overall Study|Lost to Follow-up|4
1321632|NCT02366936|4334395|P1|Overall Study|Withdrawal by Subject|2
1321633|NCT02366923|4334400|P1|Overall Study|High Astigmatism|3
1321634|NCT02366923|4334400|P1|Overall Study|Positive Slit Lamp Findings|2
1321635|NCT02366923|4334400|P1|Overall Study|Withdrawal by Subject|1
1321636|NCT02366910|4334413|P1|Overall Study|Screen Failure|3
1321637|NCT02366910|4334413|P1|Overall Study|Withdrawal by Subject|2
1321638|NCT02366767|4334427|P2|Overall Study|left for home after 1 day at camp|0
1321639|NCT02366767|4334428|P1|Overall Study|left for home after 1 day at camp|1
1321640|NCT02366689|4334441|P3|Overall Study|Pregnancy|1
1321641|NCT02366689|4334442|P2|Overall Study|Pregnancy|1
1321642|NCT02366689|4334443|P1|Overall Study|Pregnancy|0
1321643|NCT02366689|4334441|P3|Overall Study|Lost to Follow-up|0
1321644|NCT02366689|4334442|P2|Overall Study|Lost to Follow-up|2
1321645|NCT02366689|4334443|P1|Overall Study|Lost to Follow-up|3
1321646|NCT02366689|4334441|P3|Overall Study|Withdrawal by Subject|1
1321647|NCT02366689|4334442|P2|Overall Study|Withdrawal by Subject|0
1321648|NCT02366689|4334443|P1|Overall Study|Withdrawal by Subject|1
1321649|NCT02366637|4334495|P2|Second Intervention Period|Study Terminated by Sponsor|1
1321650|NCT02366637|4334496|P1|Second Intervention Period|Study Terminated by Sponsor|1
1321651|NCT02366637|4334495|P2|First Intervention Period|Study Terminated by Sponsor|4
1321652|NCT02366637|4334496|P1|First Intervention Period|Study Terminated by Sponsor|6
1321653|NCT02366637|4334495|P2|First Intervention Period|Adverse Event|1
1321654|NCT02366637|4334496|P1|First Intervention Period|Adverse Event|0
1321655|NCT02366195|4334533|P1|Overall Study|Death|26
1321656|NCT02366195|4334533|P1|Overall Study|Lost to Follow-up|1
1321657|NCT02366195|4334533|P1|Overall Study|Withdrawal by Subject|6
1321658|NCT02366195|4334533|P1|Overall Study|Continuing Study|79
1321659|NCT02365519|4334563|P3|Randomized and Treated|Withdrawal by Subject|1
1321660|NCT02365519|4334564|P2|Randomized and Treated|Withdrawal by Subject|1
1321661|NCT02365519|4334565|P1|Randomized and Treated|Withdrawal by Subject|0
1321662|NCT02365519|4334563|P3|Randomized and Treated|Adverse Event|0
1321663|NCT02365519|4334564|P2|Randomized and Treated|Adverse Event|1
1321664|NCT02365519|4334565|P1|Randomized and Treated|Adverse Event|0
1321665|NCT02365298|4334586|P2|Period 2|Protocol Violation|1
1321666|NCT02365298|4334587|P1|Period 2|Protocol Violation|0
1321667|NCT02365298|4334586|P2|Period 2|Test Article longer available|1
1321668|NCT02365298|4334587|P1|Period 2|Test Article longer available|0
1321669|NCT02365298|4334586|P2|Period 2|Discontinued at request of Sponsor|0
1321670|NCT02365298|4334587|P1|Period 2|Discontinued at request of Sponsor|1
1321671|NCT02365298|4334586|P2|Period 2|incorrect Rx dispensed|0
1321672|NCT02365298|4334587|P1|Period 2|incorrect Rx dispensed|1
1321673|NCT02365233|4334606|P3|Overall Study|IRB withheld the data|2
1321674|NCT02365233|4334607|P2|Overall Study|IRB withheld the data|2
1321675|NCT02365233|4334608|P1|Overall Study|IRB withheld the data|1
1321676|NCT02364999|4334618|P2|Overall Study|Study ongoing|194
1321677|NCT02364999|4334619|P1|Overall Study|Study ongoing|179
1321678|NCT02364999|4334618|P2|Overall Study|Randomized but did not receive treatment|3
1321679|NCT02364999|4334619|P1|Overall Study|Randomized but did not receive treatment|2
1321680|NCT02364999|4334618|P2|Overall Study|Other|1
1321681|NCT02364999|4334619|P1|Overall Study|Other|1
1321682|NCT02364999|4334618|P2|Overall Study|Withdrawal by Subject|10
1321683|NCT02364999|4334619|P1|Overall Study|Withdrawal by Subject|13
1321684|NCT02364999|4334618|P2|Overall Study|Protocol Violation|2
1321685|NCT02364999|4334619|P1|Overall Study|Protocol Violation|2
1321686|NCT02364999|4334618|P2|Overall Study|Objective Progression Or Relapse|0
1321687|NCT02364999|4334619|P1|Overall Study|Objective Progression Or Relapse|3
1321688|NCT02364999|4334618|P2|Overall Study|Global Deterioration Of Health Status|2
1321689|NCT02364999|4334619|P1|Overall Study|Global Deterioration Of Health Status|0
1321690|NCT02364999|4334618|P2|Overall Study|Lost to Follow-up|11
1321691|NCT02364999|4334619|P1|Overall Study|Lost to Follow-up|9
1321692|NCT02364999|4334618|P2|Overall Study|Death|99
1321693|NCT02364999|4334619|P1|Overall Study|Death|109
1321694|NCT02364180|4334649|P1|Overall Study|Screen Fail|1
1321695|NCT02363946|4334666|P13|Overall Study|Lost to Follow-up|0
1321696|NCT02363946|4334667|P12|Overall Study|Lost to Follow-up|0
1321697|NCT02363946|4334668|P11|Overall Study|Lost to Follow-up|0
1321698|NCT02363946|4334669|P10|Overall Study|Lost to Follow-up|0
1321699|NCT02363946|4334670|P9|Overall Study|Lost to Follow-up|0
1321700|NCT02363946|4334671|P8|Overall Study|Lost to Follow-up|1
1321701|NCT02363946|4334672|P7|Overall Study|Lost to Follow-up|0
1321702|NCT02363946|4334673|P6|Overall Study|Lost to Follow-up|0
1321703|NCT02363946|4334674|P5|Overall Study|Lost to Follow-up|0
1321704|NCT02363946|4334675|P4|Overall Study|Lost to Follow-up|0
1321705|NCT02363946|4334676|P3|Overall Study|Lost to Follow-up|0
1321706|NCT02363946|4334677|P2|Overall Study|Lost to Follow-up|0
1321707|NCT02363946|4334678|P1|Overall Study|Lost to Follow-up|0
1321708|NCT02363478|4334873|P1|Overall Study|Adverse Event|4
1321709|NCT02363478|4334873|P1|Overall Study|Lost to Follow-up|4
1321710|NCT02363439|4334880|P1|Overall Study|Lack of Efficacy|4
1321711|NCT02362412|4334893|P2|Treatment Period III|Lost to Follow-up|1
1321712|NCT02362412|4334894|P1|Treatment Period III|Lost to Follow-up|0
1321713|NCT02362360|4334928|P2|Period 1|Withdrawal by Subject|1
1321714|NCT02362360|4334929|P1|Period 1|Withdrawal by Subject|2
1321715|NCT02362360|4334928|P2|Period 1|Lack of Efficacy|0
1321716|NCT02362360|4334929|P1|Period 1|Lack of Efficacy|1
1321717|NCT02361580|4334967|P2|Overall Study|Lost to Follow-up|3
1321718|NCT02361580|4334968|P1|Overall Study|Lost to Follow-up|6
1321719|NCT02360995|4334981|P3|Overall Study|Withdrawal by Subject|0
1321720|NCT02360995|4334982|P2|Overall Study|Withdrawal by Subject|1
1321721|NCT02360995|4334983|P1|Overall Study|Withdrawal by Subject|0
1321722|NCT02360995|4334981|P3|Overall Study|Lost to Follow-up|2
1321723|NCT02360995|4334982|P2|Overall Study|Lost to Follow-up|0
1321724|NCT02360995|4334983|P1|Overall Study|Lost to Follow-up|2
1321725|NCT02360475|4335025|P4|Overall Study|Migrated/moved from study area|1
1321726|NCT02360475|4335026|P3|Overall Study|Migrated/moved from study area|0
1321727|NCT02360475|4335027|P2|Overall Study|Migrated/moved from study area|0
1321728|NCT02360475|4335028|P1|Overall Study|Migrated/moved from study area|0
1321729|NCT02360475|4335025|P4|Overall Study|Withdrawal by Subject|0
1321730|NCT02360475|4335026|P3|Overall Study|Withdrawal by Subject|2
1321731|NCT02360475|4335027|P2|Overall Study|Withdrawal by Subject|1
1321732|NCT02360475|4335028|P1|Overall Study|Withdrawal by Subject|0
1321733|NCT02360475|4335025|P4|Overall Study|Lost to Follow-up|4
1321734|NCT02360475|4335026|P3|Overall Study|Lost to Follow-up|6
1321735|NCT02360475|4335027|P2|Overall Study|Lost to Follow-up|12
1321736|NCT02360475|4335028|P1|Overall Study|Lost to Follow-up|4
1321737|NCT02360228|4335089|P3|Overall Study|Unstable symptoms during screening|1
1321738|NCT02360228|4335090|P2|Overall Study|Unstable symptoms during screening|0
1321739|NCT02360228|4335091|P1|Overall Study|Unstable symptoms during screening|0
1321740|NCT02360228|4335089|P3|Overall Study|Self-discontinued medication|0
1321741|NCT02360228|4335090|P2|Overall Study|Self-discontinued medication|1
1321742|NCT02360228|4335091|P1|Overall Study|Self-discontinued medication|0
1321743|NCT02360228|4335089|P3|Overall Study|Withdrawal by Subject|0
1321744|NCT02360228|4335090|P2|Overall Study|Withdrawal by Subject|0
1321745|NCT02360228|4335091|P1|Overall Study|Withdrawal by Subject|1
1321746|NCT02359903|4335196|P2|Overall Study|Adverse Event|2
1321747|NCT02359903|4335197|P1|Overall Study|Adverse Event|0
1321748|NCT02359890|4335205|P1|Overall Study|Never treated with study catheter|6
1321749|NCT02359890|4335205|P1|Overall Study|Not meeting eligibility|4
1321750|NCT02359877|4335216|P4|Overall Study|Adverse Event|1
1321751|NCT02359877|4335217|P3|Overall Study|Adverse Event|0
1321752|NCT02359877|4335218|P2|Overall Study|Adverse Event|0
1321753|NCT02359877|4335219|P1|Overall Study|Adverse Event|0
1321754|NCT02359877|4335216|P4|Overall Study|Withdrawal by Subject|2
1321755|NCT02359877|4335217|P3|Overall Study|Withdrawal by Subject|0
1321756|NCT02359877|4335218|P2|Overall Study|Withdrawal by Subject|0
1321757|NCT02359877|4335219|P1|Overall Study|Withdrawal by Subject|1
1321758|NCT02359851|4335269|P1|Overall Study|Disease progression|1
1321759|NCT02359851|4335269|P1|Overall Study|Death|1
1321760|NCT02359435|4335279|P2|Overall Study|Lost to Follow-up|4
1321761|NCT02359435|4335280|P1|Overall Study|Lost to Follow-up|4
1321762|NCT02359045|4335340|P2|Overall Study|Adverse Event|1
1321763|NCT02359045|4335341|P1|Overall Study|Adverse Event|0
1321764|NCT02359045|4335340|P2|Overall Study|Lost to Follow-up|1
1321765|NCT02359045|4335341|P1|Overall Study|Lost to Follow-up|1
1321766|NCT02359045|4335340|P2|Overall Study|Eligibility criteria not fulfilled|1
1321767|NCT02359045|4335341|P1|Overall Study|Eligibility criteria not fulfilled|3
1321768|NCT02358863|4335578|P1|Overall Study|Physician Decision|3
1321769|NCT02358668|4335585|P3|Overall Study|Withdrawal by Subject|0
1321770|NCT02358668|4335586|P2|Overall Study|Withdrawal by Subject|1
1321771|NCT02358668|4335587|P1|Overall Study|Withdrawal by Subject|0
1321772|NCT02358668|4335585|P3|Overall Study|Adverse Event|0
1321773|NCT02358668|4335586|P2|Overall Study|Adverse Event|0
1321774|NCT02358668|4335587|P1|Overall Study|Adverse Event|2
1321775|NCT02358044|4335729|P2|Overall Study|Withdrawal by Subject|4
1321776|NCT02358044|4335730|P1|Overall Study|Withdrawal by Subject|0
1321777|NCT02358044|4335729|P2|Overall Study|Physician Decision|1
1321778|NCT02358044|4335730|P1|Overall Study|Physician Decision|0
1321779|NCT02358044|4335729|P2|Overall Study|Lost to Follow-up|1
1321780|NCT02358044|4335730|P1|Overall Study|Lost to Follow-up|2
1321781|NCT02358044|4335729|P2|Overall Study|Adverse Event|1
1321782|NCT02358044|4335730|P1|Overall Study|Adverse Event|0
1321783|NCT02357940|4335748|P2|Overall Study|Investigator's judgement|1
1321784|NCT02357940|4335749|P1|Overall Study|Investigator's judgement|0
1321785|NCT02357940|4335748|P2|Overall Study|Adverse Event|1
1321786|NCT02357940|4335749|P1|Overall Study|Adverse Event|0
1321787|NCT02357901|4335876|P4|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
1321788|NCT02357901|4335877|P3|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
1321789|NCT02357901|4335878|P2|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
1321790|NCT02357901|4335879|P1|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
1321791|NCT02357901|4335876|P4|Treatment Period (Day 1 to Week 24)|Physician Decision|1
1321792|NCT02357901|4335877|P3|Treatment Period (Day 1 to Week 24)|Physician Decision|1
1321793|NCT02357901|4335878|P2|Treatment Period (Day 1 to Week 24)|Physician Decision|0
1321794|NCT02357901|4335879|P1|Treatment Period (Day 1 to Week 24)|Physician Decision|0
1321795|NCT02357901|4335876|P4|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
1321796|NCT02357901|4335877|P3|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
1321797|NCT02357901|4335878|P2|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
1321798|NCT02357901|4335879|P1|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
1321799|NCT02357901|4335876|P4|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
1321800|NCT02357901|4335877|P3|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
1321801|NCT02357901|4335878|P2|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
1321802|NCT02357901|4335879|P1|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
1321803|NCT02357901|4335876|P4|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
1321804|NCT02357901|4335877|P3|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
1321805|NCT02357901|4335878|P2|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
1321806|NCT02357901|4335879|P1|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
1321807|NCT02357901|4335876|P4|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
1321808|NCT02357901|4335877|P3|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
1321809|NCT02357901|4335878|P2|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
1321810|NCT02357901|4335879|P1|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
1321811|NCT02357901|4335876|P4|Treatment Period (Day 1 to Week 24)|Adverse Event|2
1321812|NCT02357901|4335877|P3|Treatment Period (Day 1 to Week 24)|Adverse Event|10
1321813|NCT02357901|4335878|P2|Treatment Period (Day 1 to Week 24)|Adverse Event|6
1321814|NCT02357901|4335879|P1|Treatment Period (Day 1 to Week 24)|Adverse Event|0
1321815|NCT02357901|4335876|P4|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
1321816|NCT02357901|4335877|P3|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
1321817|NCT02357901|4335878|P2|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
1321818|NCT02357901|4335879|P1|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
1321819|NCT02357901|4335876|P4|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
1321820|NCT02357901|4335877|P3|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
1321821|NCT02357901|4335878|P2|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
1321822|NCT02357901|4335879|P1|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
1321823|NCT02357901|4335876|P4|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
1321824|NCT02357901|4335877|P3|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
1321825|NCT02357901|4335878|P2|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
1321826|NCT02357901|4335879|P1|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
1321827|NCT02357901|4335876|P4|Run-In Period (Days -14 to Day -1)|Run-In failures|0
1321828|NCT02357901|4335877|P3|Run-In Period (Days -14 to Day -1)|Run-In failures|0
1321829|NCT02357901|4335878|P2|Run-In Period (Days -14 to Day -1)|Run-In failures|0
1321830|NCT02357901|4335879|P1|Run-In Period (Days -14 to Day -1)|Run-In failures|161
1321831|NCT02357459|4335940|P3|Overall Study|Job Commitments|1
1321832|NCT02357459|4335941|P2|Overall Study|Job Commitments|0
1321833|NCT02357459|4335942|P1|Overall Study|Job Commitments|0
1321834|NCT02357459|4335940|P3|Overall Study|Pre-planned Knee surgery|2
1321835|NCT02357459|4335941|P2|Overall Study|Pre-planned Knee surgery|0
1321836|NCT02357459|4335942|P1|Overall Study|Pre-planned Knee surgery|0
1321837|NCT02357459|4335940|P3|Overall Study|Incarceration|1
1321838|NCT02357459|4335941|P2|Overall Study|Incarceration|0
1321839|NCT02357459|4335942|P1|Overall Study|Incarceration|0
1321840|NCT02357459|4335940|P3|Overall Study|Instruction from PCP|0
1321841|NCT02357459|4335941|P2|Overall Study|Instruction from PCP|0
1321842|NCT02357459|4335942|P1|Overall Study|Instruction from PCP|1
1321843|NCT02357459|4335940|P3|Overall Study|Patient Relocated|0
1321844|NCT02357459|4335941|P2|Overall Study|Patient Relocated|0
1321845|NCT02357459|4335942|P1|Overall Study|Patient Relocated|2
1321846|NCT02357459|4335940|P3|Overall Study|Lack of Efficacy|4
1321847|NCT02357459|4335941|P2|Overall Study|Lack of Efficacy|4
1321848|NCT02357459|4335942|P1|Overall Study|Lack of Efficacy|7
1321849|NCT02357459|4335940|P3|Overall Study|Lost to Follow-up|0
1321850|NCT02357459|4335941|P2|Overall Study|Lost to Follow-up|3
1321851|NCT02357459|4335942|P1|Overall Study|Lost to Follow-up|1
1321852|NCT02357459|4335940|P3|Overall Study|Protocol Violation|0
1321853|NCT02357459|4335941|P2|Overall Study|Protocol Violation|1
1321854|NCT02357459|4335942|P1|Overall Study|Protocol Violation|1
1321855|NCT02357459|4335940|P3|Overall Study|Physician Decision|0
1321856|NCT02357459|4335941|P2|Overall Study|Physician Decision|2
1321857|NCT02357459|4335942|P1|Overall Study|Physician Decision|0
1321858|NCT02357459|4335940|P3|Overall Study|Withdrawal by Subject|3
1321859|NCT02357459|4335941|P2|Overall Study|Withdrawal by Subject|3
1321860|NCT02357459|4335942|P1|Overall Study|Withdrawal by Subject|5
1321861|NCT02357459|4335940|P3|Overall Study|Adverse Event|1
1321862|NCT02357459|4335941|P2|Overall Study|Adverse Event|1
1321863|NCT02357459|4335942|P1|Overall Study|Adverse Event|0
1321864|NCT02357342|4335986|P2|First 6 Months|Death|0
1321865|NCT02357342|4335987|P1|First 6 Months|Death|2
1321866|NCT02356783|4336051|P2|Overall Study|Lost to Follow-up|3
1321867|NCT02356783|4336052|P1|Overall Study|Lost to Follow-up|1
1321868|NCT02356588|4336062|P2|Overall Study|Protocol Violation|1
1321869|NCT02356588|4336063|P1|Overall Study|Protocol Violation|0
1321870|NCT02356588|4336062|P2|Overall Study|Withdrawal by Subject|0
1321871|NCT02356588|4336063|P1|Overall Study|Withdrawal by Subject|1
1321872|NCT02356588|4336062|P2|Overall Study|Adverse Event|2
1321873|NCT02356588|4336063|P1|Overall Study|Adverse Event|0
1321874|NCT02356588|4336062|P2|Overall Study|Lack of Efficacy|10
1321875|NCT02356588|4336063|P1|Overall Study|Lack of Efficacy|4
1321876|NCT02356562|4336097|P2|Overall Study|site closure|0
1321877|NCT02356562|4336098|P1|Overall Study|site closure|1
1321878|NCT02356562|4336097|P2|Overall Study|Re-entered treatment in a previous study|0
1321879|NCT02356562|4336098|P1|Overall Study|Re-entered treatment in a previous study|1
1321880|NCT02356562|4336097|P2|Overall Study|Withdrawal by Subject|1
1321881|NCT02356562|4336098|P1|Overall Study|Withdrawal by Subject|0
1321882|NCT02355743|4336144|P1|Overall Study|Lost to Follow-up|1
1321883|NCT02355743|4336144|P1|Overall Study|Withdrawal by Subject|1
1321884|NCT02355691|4336152|P2|Overall Study|Loss of Research Personnel|9
1321885|NCT02355691|4336153|P1|Overall Study|Loss of Research Personnel|7
1321886|NCT02355028|4336172|P2|Overall Study|Deemed ineligible after randomization|4
1321887|NCT02355028|4336173|P1|Overall Study|Deemed ineligible after randomization|8
1321888|NCT02355028|4336172|P2|Overall Study|Withdrawal by Subject|1
1321889|NCT02355028|4336173|P1|Overall Study|Withdrawal by Subject|1
1321890|NCT02355028|4336172|P2|Overall Study|Adverse Event|0
1321891|NCT02355028|4336173|P1|Overall Study|Adverse Event|2
1321892|NCT02354599|4336240|P6|Overall Study|Withdrawal by Subject|0
1321893|NCT02354599|4336241|P5|Overall Study|Withdrawal by Subject|0
1321894|NCT02354599|4336242|P4|Overall Study|Withdrawal by Subject|0
1321895|NCT02354599|4336243|P3|Overall Study|Withdrawal by Subject|0
1321896|NCT02354599|4336244|P2|Overall Study|Withdrawal by Subject|1
1321897|NCT02354599|4336245|P1|Overall Study|Withdrawal by Subject|1
1321898|NCT02354599|4336240|P6|Overall Study|Pretreatment Event/Adverse Event|1
1321899|NCT02354599|4336241|P5|Overall Study|Pretreatment Event/Adverse Event|0
1321900|NCT02354599|4336242|P4|Overall Study|Pretreatment Event/Adverse Event|0
1321901|NCT02354599|4336243|P3|Overall Study|Pretreatment Event/Adverse Event|0
1321902|NCT02354599|4336244|P2|Overall Study|Pretreatment Event/Adverse Event|0
1321903|NCT02354599|4336245|P1|Overall Study|Pretreatment Event/Adverse Event|0
1321904|NCT02354235|4336317|P2|Overall Study|Conflict with the stopping criteria|1
1321905|NCT02354235|4336318|P1|Overall Study|Conflict with the stopping criteria|0
1321906|NCT02354235|4336317|P2|Overall Study|Withdrawal by Subject|3
1321907|NCT02354235|4336318|P1|Overall Study|Withdrawal by Subject|1
1321908|NCT02354235|4336317|P2|Overall Study|Physician Decision|1
1321909|NCT02354235|4336318|P1|Overall Study|Physician Decision|0
1321910|NCT02354235|4336317|P2|Overall Study|Adverse Event|2
1321911|NCT02354235|4336318|P1|Overall Study|Adverse Event|2
1321912|NCT02354222|4336334|P2|Overall Study|Conflict with the stopping criteria|4
1321913|NCT02354222|4336335|P1|Overall Study|Conflict with the stopping criteria|0
1321914|NCT02354222|4336334|P2|Overall Study|Withdrawal by Subject|3
1321915|NCT02354222|4336335|P1|Overall Study|Withdrawal by Subject|2
1321916|NCT02354222|4336334|P2|Overall Study|Pregnancy|0
1321917|NCT02354222|4336335|P1|Overall Study|Pregnancy|1
1321918|NCT02354222|4336334|P2|Overall Study|Physician Decision|1
1321919|NCT02354222|4336335|P1|Overall Study|Physician Decision|1
1321920|NCT02354222|4336334|P2|Overall Study|Adverse Event|3
1321921|NCT02354222|4336335|P1|Overall Study|Adverse Event|0
1321922|NCT02353871|4336351|P2|Overall Study|Lost to Follow-up|0
1321923|NCT02353871|4336352|P1|Overall Study|Lost to Follow-up|2
1321924|NCT02353871|4336351|P2|Overall Study|Consent withdrawn|8
1321925|NCT02353871|4336352|P1|Overall Study|Consent withdrawn|1
1321926|NCT02353871|4336351|P2|Overall Study|Protocol deviation|1
1321927|NCT02353871|4336352|P1|Overall Study|Protocol deviation|0
1321928|NCT02353572|4336385|P1|Overall Study|Study terminated|2
1321929|NCT02353572|4336385|P1|Overall Study|Withdrawal by Subject|1
1321930|NCT02353468|4336389|P1|Overall Study|Study terminated|3
1321931|NCT02353442|4336395|P2|Overall Study|Withdrawal by Subject|4
1321932|NCT02353442|4336396|P1|Overall Study|Withdrawal by Subject|3
1321933|NCT02352779|4336450|P3|Overall Study|No Reason|1
1321934|NCT02352779|4336451|P2|Overall Study|No Reason|0
1321935|NCT02352779|4336452|P1|Overall Study|No Reason|0
1321936|NCT02352779|4336450|P3|Overall Study|Other Medical Reason|1
1321937|NCT02352779|4336451|P2|Overall Study|Other Medical Reason|0
1321938|NCT02352779|4336452|P1|Overall Study|Other Medical Reason|0
1321939|NCT02352779|4336450|P3|Overall Study|Absence of Symptoms|0
1321940|NCT02352779|4336451|P2|Overall Study|Absence of Symptoms|0
1321941|NCT02352779|4336452|P1|Overall Study|Absence of Symptoms|1
1321942|NCT02352779|4336450|P3|Overall Study|Study Related Symptoms|0
1321943|NCT02352779|4336451|P2|Overall Study|Study Related Symptoms|0
1321944|NCT02352779|4336452|P1|Overall Study|Study Related Symptoms|1
1321945|NCT02352779|4336450|P3|Overall Study|Changed Mind|0
1321946|NCT02352779|4336451|P2|Overall Study|Changed Mind|0
1321947|NCT02352779|4336452|P1|Overall Study|Changed Mind|1
1321948|NCT02352779|4336450|P3|Overall Study|Disliked Intervention|0
1321949|NCT02352779|4336451|P2|Overall Study|Disliked Intervention|0
1321950|NCT02352779|4336452|P1|Overall Study|Disliked Intervention|1
1321951|NCT02352779|4336450|P3|Overall Study|Feeling Overwhelmed|0
1321952|NCT02352779|4336451|P2|Overall Study|Feeling Overwhelmed|0
1321953|NCT02352779|4336452|P1|Overall Study|Feeling Overwhelmed|1
1321954|NCT02352779|4336450|P3|Overall Study|Too Many Forms|0
1321955|NCT02352779|4336451|P2|Overall Study|Too Many Forms|0
1321956|NCT02352779|4336452|P1|Overall Study|Too Many Forms|2
1321957|NCT02352779|4336450|P3|Overall Study|Personal Issues|0
1321958|NCT02352779|4336451|P2|Overall Study|Personal Issues|1
1321959|NCT02352779|4336452|P1|Overall Study|Personal Issues|1
1321960|NCT02351960|4336482|P2|Overall Study|Significant Protocol Deviation|5
1321961|NCT02351960|4336483|P1|Overall Study|Significant Protocol Deviation|0
1321962|NCT02351960|4336482|P2|Overall Study|Voluntary Withdrawal|4
1321963|NCT02351960|4336483|P1|Overall Study|Voluntary Withdrawal|5
1321964|NCT02351960|4336482|P2|Overall Study|Pretreatment Event/Adverse Event|3
1321965|NCT02351960|4336483|P1|Overall Study|Pretreatment Event/Adverse Event|6
1321966|NCT02351934|4336504|P2|Follow-Up|2 ERAS Components Noncompliant|4
1321967|NCT02351934|4336505|P1|Follow-Up|2 ERAS Components Noncompliant|0
1321968|NCT02351934|4336504|P2|Follow-Up|1 ERAS Component Noncompliant|6
1321969|NCT02351934|4336505|P1|Follow-Up|1 ERAS Component Noncompliant|0
1321970|NCT02351934|4336504|P2|Follow-Up|No documentation|0
1321971|NCT02351934|4336505|P1|Follow-Up|No documentation|2
1321972|NCT02351934|4336504|P2|Follow-Up|Hypotension|0
1321973|NCT02351934|4336505|P1|Follow-Up|Hypotension|3
1321974|NCT02351934|4336504|P2|Follow-Up|Early dismissal|0
1321975|NCT02351934|4336505|P1|Follow-Up|Early dismissal|3
1321976|NCT02351934|4336504|P2|Follow-Up|Acute Kidney Injury|0
1321977|NCT02351934|4336505|P1|Follow-Up|Acute Kidney Injury|1
1321978|NCT02351934|4336504|P2|Follow-Up|POD weight<pre-op weight|0
1321979|NCT02351934|4336505|P1|Follow-Up|POD weight<pre-op weight|3
1321980|NCT02351934|4336504|P2|Allocation|Acute Kidney Injury on Post Op Day 1|0
1321981|NCT02351934|4336505|P1|Allocation|Acute Kidney Injury on Post Op Day 1|1
1321982|NCT02351934|4336504|P2|Allocation|Hypotension preventing administration|0
1321983|NCT02351934|4336505|P1|Allocation|Hypotension preventing administration|2
1321984|NCT02351934|4336504|P2|Allocation|POD weight<pre-op weight|0
1321985|NCT02351934|4336505|P1|Allocation|POD weight<pre-op weight|3
1321986|NCT02351817|4336521|P2|Period 2|Protocol Violation|0
1321987|NCT02351817|4336522|P1|Period 2|Protocol Violation|1
1321988|NCT02351817|4336521|P2|Period 2|Adverse Event|2
1321989|NCT02351817|4336522|P1|Period 2|Adverse Event|0
1321990|NCT02351817|4336521|P2|Period 1|Lack of Efficacy|1
1321991|NCT02351817|4336522|P1|Period 1|Lack of Efficacy|0
1321992|NCT02351817|4336521|P2|Period 1|Adverse Event|2
1321993|NCT02351817|4336522|P1|Period 1|Adverse Event|1
1321994|NCT02349711|4336602|P2|Overall Study|Lost to Follow-up|1
1321995|NCT02349711|4336603|P1|Overall Study|Lost to Follow-up|1
1321996|NCT02349711|4336602|P2|Overall Study|Withdrawal by Subject|1
1321997|NCT02349711|4336603|P1|Overall Study|Withdrawal by Subject|2
1321998|NCT02349542|4336636|P1|Overall Study|Withdrawal by Subject|5
1321999|NCT02349451|4336645|P4|Overall Study|Withdrawal by Subject|1
1322000|NCT02349451|4336646|P3|Overall Study|Withdrawal by Subject|2
1322001|NCT02349451|4336647|P2|Overall Study|Withdrawal by Subject|1
1322002|NCT02349451|4336648|P1|Overall Study|Withdrawal by Subject|0
1322003|NCT02349360|4336697|P2|Overall Study|Withdrawal by Subject|1
1322004|NCT02349360|4336698|P1|Overall Study|Withdrawal by Subject|0
1322005|NCT02349295|4336709|P5|IR (Week 16-24)|Lack of Efficacy|1
1322006|NCT02349295|4336710|P4|IR (Week 16-24)|Lack of Efficacy|0
1322007|NCT02349295|4336711|P3|IR (Week 16-24)|Lack of Efficacy|0
1322008|NCT02349295|4336712|P2|IR (Week 16-24)|Lack of Efficacy|0
1322009|NCT02349295|4336713|P1|IR (Week 16-24)|Lack of Efficacy|0
1322010|NCT02349295|4336709|P5|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1322011|NCT02349295|4336710|P4|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1322012|NCT02349295|4336711|P3|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1322013|NCT02349295|4336712|P2|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
1322014|NCT02349295|4336713|P1|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
1322015|NCT02349295|4336709|P5|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1322016|NCT02349295|4336710|P4|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1322017|NCT02349295|4336711|P3|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
1322018|NCT02349295|4336712|P2|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
1322019|NCT02349295|4336713|P1|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
1322020|NCT02349295|4336709|P5|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1322021|NCT02349295|4336710|P4|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1322022|NCT02349295|4336711|P3|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
1322023|NCT02349295|4336712|P2|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
1322024|NCT02349295|4336713|P1|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
1322025|NCT02349295|4336709|P5|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1322026|NCT02349295|4336710|P4|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1322027|NCT02349295|4336711|P3|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
1322028|NCT02349295|4336712|P2|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
1322029|NCT02349295|4336713|P1|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
1322030|NCT02349295|4336709|P5|Double Blind Treatment (Week 0-24)|Adverse Event|0
1322031|NCT02349295|4336710|P4|Double Blind Treatment (Week 0-24)|Adverse Event|0
1322032|NCT02349295|4336711|P3|Double Blind Treatment (Week 0-24)|Adverse Event|7
1322033|NCT02349295|4336712|P2|Double Blind Treatment (Week 0-24)|Adverse Event|5
1322034|NCT02349295|4336713|P1|Double Blind Treatment (Week 0-24)|Adverse Event|5
1322035|NCT02349061|4336816|P2|Overall Study|Other|1
1322036|NCT02349061|4336817|P1|Overall Study|Other|3
1322037|NCT02349061|4336816|P2|Overall Study|Physician Decision|0
1322038|NCT02349061|4336817|P1|Overall Study|Physician Decision|1
1322039|NCT02349061|4336816|P2|Overall Study|Lack of Efficacy|0
1322040|NCT02349061|4336817|P1|Overall Study|Lack of Efficacy|1
1322041|NCT02349061|4336816|P2|Overall Study|Adverse Event|3
1322042|NCT02349061|4336817|P1|Overall Study|Adverse Event|4
1322043|NCT02349048|4336825|P2|Overall Study|Lost to Follow-up|0
1322044|NCT02349048|4336826|P1|Overall Study|Lost to Follow-up|1
1322045|NCT02349048|4336825|P2|Overall Study|Withdrawal by Subject|0
1322046|NCT02349048|4336826|P1|Overall Study|Withdrawal by Subject|4
1322047|NCT02348723|4336848|P2|Overall Study|Adverse Event|1
1322048|NCT02348723|4336849|P1|Overall Study|Adverse Event|3
1322049|NCT02348723|4336848|P2|Overall Study|Reason other than specified|1
1322050|NCT02348723|4336849|P1|Overall Study|Reason other than specified|1
1322051|NCT02348723|4336848|P2|Overall Study|Consent withdrawn|3
1322052|NCT02348723|4336849|P1|Overall Study|Consent withdrawn|1
1322053|NCT02348723|4336848|P2|Overall Study|Lost to Follow-up|1
1322054|NCT02348723|4336849|P1|Overall Study|Lost to Follow-up|1
1322055|NCT02348723|4336848|P2|Overall Study|Non-compliant with Protocol|0
1322056|NCT02348723|4336849|P1|Overall Study|Non-compliant with Protocol|1
1322057|NCT02348723|4336848|P2|Overall Study|No ablation|20
1322058|NCT02348723|4336849|P1|Overall Study|No ablation|21
1322059|NCT02347774|4336916|P3|On Study Treatment|ranomized in error|1
1322060|NCT02347774|4336917|P2|On Study Treatment|ranomized in error|0
1322061|NCT02347774|4336918|P1|On Study Treatment|ranomized in error|0
1322062|NCT02347774|4336916|P3|On Study Treatment|Met Prolonged QT criteria|0
1322063|NCT02347774|4336917|P2|On Study Treatment|Met Prolonged QT criteria|0
1322064|NCT02347774|4336918|P1|On Study Treatment|Met Prolonged QT criteria|1
1322065|NCT02347774|4336916|P3|On Study Treatment|Lost to Follow-up|1
1322066|NCT02347774|4336917|P2|On Study Treatment|Lost to Follow-up|6
1322067|NCT02347774|4336918|P1|On Study Treatment|Lost to Follow-up|2
1322068|NCT02347774|4336916|P3|On Study Treatment|withdrew consent|12
1322069|NCT02347774|4336917|P2|On Study Treatment|withdrew consent|8
1322070|NCT02347774|4336918|P1|On Study Treatment|withdrew consent|9
1322071|NCT02347774|4336916|P3|On Study Treatment|Protocol Violation|1
1322072|NCT02347774|4336917|P2|On Study Treatment|Protocol Violation|0
1322073|NCT02347774|4336918|P1|On Study Treatment|Protocol Violation|0
1322074|NCT02347774|4336916|P3|On Study Treatment|non-complicance with study medication|0
1322075|NCT02347774|4336917|P2|On Study Treatment|non-complicance with study medication|2
1322076|NCT02347774|4336918|P1|On Study Treatment|non-complicance with study medication|0
1322077|NCT02347774|4336916|P3|On Study Treatment|Lack of Efficacy|2
1322078|NCT02347774|4336917|P2|On Study Treatment|Lack of Efficacy|0
1322079|NCT02347774|4336918|P1|On Study Treatment|Lack of Efficacy|3
1322080|NCT02347774|4336916|P3|On Study Treatment|Adverse Event|19
1322081|NCT02347774|4336917|P2|On Study Treatment|Adverse Event|15
1322082|NCT02347774|4336918|P1|On Study Treatment|Adverse Event|9
1322083|NCT02347774|4336916|P3|Study Participation|randomized in error|1
1322084|NCT02347774|4336917|P2|Study Participation|randomized in error|0
1322085|NCT02347774|4336918|P1|Study Participation|randomized in error|0
1322086|NCT02347774|4336916|P3|Study Participation|incarceration|0
1322087|NCT02347774|4336917|P2|Study Participation|incarceration|0
1322088|NCT02347774|4336918|P1|Study Participation|incarceration|1
1322089|NCT02347774|4336916|P3|Study Participation|non-compliance with study drug|0
1322090|NCT02347774|4336917|P2|Study Participation|non-compliance with study drug|1
1322091|NCT02347774|4336918|P1|Study Participation|non-compliance with study drug|0
1322092|NCT02347774|4336916|P3|Study Participation|Met Prolonged QT criteria|0
1322093|NCT02347774|4336917|P2|Study Participation|Met Prolonged QT criteria|0
1322094|NCT02347774|4336918|P1|Study Participation|Met Prolonged QT criteria|1
1322095|NCT02347774|4336916|P3|Study Participation|withdrew consent|1
1322096|NCT02347774|4336917|P2|Study Participation|withdrew consent|1
1322097|NCT02347774|4336918|P1|Study Participation|withdrew consent|1
1322098|NCT02347774|4336916|P3|Study Participation|Adverse Event|6
1322099|NCT02347774|4336917|P2|Study Participation|Adverse Event|4
1322100|NCT02347774|4336918|P1|Study Participation|Adverse Event|1
1322101|NCT02347774|4336916|P3|Study Participation|Withdrawal by Subject|15
1322102|NCT02347774|4336917|P2|Study Participation|Withdrawal by Subject|9
1322103|NCT02347774|4336918|P1|Study Participation|Withdrawal by Subject|8
1322104|NCT02347774|4336916|P3|Study Participation|Lost to Follow-up|2
1322105|NCT02347774|4336917|P2|Study Participation|Lost to Follow-up|6
1322106|NCT02347774|4336918|P1|Study Participation|Lost to Follow-up|3
1322107|NCT02347761|4336974|P3|On Study Treatment|Adverse Event|20
1322108|NCT02347761|4336975|P2|On Study Treatment|Adverse Event|8
1322109|NCT02347761|4336976|P1|On Study Treatment|Adverse Event|10
1322110|NCT02347761|4336974|P3|On Study Treatment|durg not working|1
1322111|NCT02347761|4336975|P2|On Study Treatment|durg not working|1
1322112|NCT02347761|4336976|P1|On Study Treatment|durg not working|0
1322113|NCT02347761|4336974|P3|On Study Treatment|investigator discretion|0
1322114|NCT02347761|4336975|P2|On Study Treatment|investigator discretion|0
1322115|NCT02347761|4336976|P1|On Study Treatment|investigator discretion|2
1322116|NCT02347761|4336974|P3|On Study Treatment|Lost to Follow-up|1
1322117|NCT02347761|4336975|P2|On Study Treatment|Lost to Follow-up|1
1322118|NCT02347761|4336976|P1|On Study Treatment|Lost to Follow-up|2
1322119|NCT02347761|4336974|P3|On Study Treatment|dissastisfaction with device|4
1322120|NCT02347761|4336975|P2|On Study Treatment|dissastisfaction with device|1
1322121|NCT02347761|4336976|P1|On Study Treatment|dissastisfaction with device|2
1322122|NCT02347761|4336974|P3|On Study Treatment|move/travel|5
1322123|NCT02347761|4336975|P2|On Study Treatment|move/travel|6
1322124|NCT02347761|4336976|P1|On Study Treatment|move/travel|2
1322125|NCT02347761|4336974|P3|On Study Treatment|Withdrawal by Subject|5
1322126|NCT02347761|4336975|P2|On Study Treatment|Withdrawal by Subject|3
1322127|NCT02347761|4336976|P1|On Study Treatment|Withdrawal by Subject|7
1322128|NCT02347761|4336974|P3|On Study Treatment|non-compliance with study medication|2
1322129|NCT02347761|4336975|P2|On Study Treatment|non-compliance with study medication|0
1322130|NCT02347761|4336976|P1|On Study Treatment|non-compliance with study medication|0
1322131|NCT02347761|4336974|P3|On Study Treatment|Lack of Efficacy|4
1322132|NCT02347761|4336975|P2|On Study Treatment|Lack of Efficacy|3
1322133|NCT02347761|4336976|P1|On Study Treatment|Lack of Efficacy|2
1322134|NCT02347761|4336974|P3|All Collected|moved/travel|0
1322135|NCT02347761|4336975|P2|All Collected|moved/travel|1
1322136|NCT02347761|4336976|P1|All Collected|moved/travel|0
1322137|NCT02347761|4336974|P3|All Collected|exacerbation of COPD|1
1322138|NCT02347761|4336975|P2|All Collected|exacerbation of COPD|0
1322139|NCT02347761|4336976|P1|All Collected|exacerbation of COPD|0
1322140|NCT02347761|4336974|P3|All Collected|instillation site pain|1
1322141|NCT02347761|4336975|P2|All Collected|instillation site pain|0
1322142|NCT02347761|4336976|P1|All Collected|instillation site pain|0
1322143|NCT02347761|4336974|P3|All Collected|invetigator disretion|0
1322144|NCT02347761|4336975|P2|All Collected|invetigator disretion|0
1322145|NCT02347761|4336976|P1|All Collected|invetigator disretion|2
1322146|NCT02347761|4336974|P3|All Collected|Withdrawal by Subject|22
1322147|NCT02347761|4336975|P2|All Collected|Withdrawal by Subject|11
1322148|NCT02347761|4336976|P1|All Collected|Withdrawal by Subject|11
1322149|NCT02347761|4336974|P3|All Collected|Lost to Follow-up|3
1322150|NCT02347761|4336975|P2|All Collected|Lost to Follow-up|2
1322151|NCT02347761|4336976|P1|All Collected|Lost to Follow-up|3
1322152|NCT02347761|4336974|P3|All Collected|Death|0
1322153|NCT02347761|4336975|P2|All Collected|Death|0
1322154|NCT02347761|4336976|P1|All Collected|Death|1
1322155|NCT02347657|4337037|P2|Overall Study|Other|3
1322156|NCT02347657|4337038|P1|Overall Study|Other|3
1322157|NCT02347657|4337037|P2|Overall Study|Randomized but not treated|0
1322158|NCT02347657|4337038|P1|Overall Study|Randomized but not treated|1
1322159|NCT02347657|4337037|P2|Overall Study|Withdrawal by Subject|7
1322160|NCT02347657|4337038|P1|Overall Study|Withdrawal by Subject|6
1322161|NCT02347657|4337037|P2|Overall Study|Adverse Event|4
1322162|NCT02347657|4337038|P1|Overall Study|Adverse Event|8
1322163|NCT02347657|4337037|P2|Overall Study|Physician Decision|1
1322164|NCT02347657|4337038|P1|Overall Study|Physician Decision|0
1322165|NCT02347189|4337095|P1|Overall Study|No primary outcome data available|2
1322166|NCT02347189|4337095|P1|Overall Study|No implant attempted of study device|9
1322167|NCT02347176|4337103|P4|Overall Study|Other|0
1322168|NCT02347176|4337104|P3|Overall Study|Other|2
1322169|NCT02347176|4337105|P2|Overall Study|Other|2
1322170|NCT02347176|4337106|P1|Overall Study|Other|1
1322171|NCT02347176|4337103|P4|Overall Study|Withdrawal by Subject|3
1322172|NCT02347176|4337104|P3|Overall Study|Withdrawal by Subject|5
1322173|NCT02347176|4337105|P2|Overall Study|Withdrawal by Subject|5
1322174|NCT02347176|4337106|P1|Overall Study|Withdrawal by Subject|9
1322175|NCT02347176|4337103|P4|Overall Study|Lost to Follow-up|1
1322176|NCT02347176|4337104|P3|Overall Study|Lost to Follow-up|1
1322177|NCT02347176|4337105|P2|Overall Study|Lost to Follow-up|3
1322178|NCT02347176|4337106|P1|Overall Study|Lost to Follow-up|2
1322179|NCT02347085|4337189|P1|Overall Study|Protocol Criteria|2
1322180|NCT02347085|4337189|P1|Overall Study|Lost to Follow-up|1
1322181|NCT02347085|4337189|P1|Overall Study|Withdrawal by Subject|4
1322182|NCT02347085|4337189|P1|Overall Study|Lack of Efficacy|1
1322183|NCT02347085|4337189|P1|Overall Study|Adverse Event|2
1322184|NCT02347072|4337211|P1|Overall Study|Disc due to Protocol-specified Criteria|6
1322185|NCT02347072|4337211|P1|Overall Study|Protocol Violation|1
1322186|NCT02347072|4337211|P1|Overall Study|Lost to Follow-up|2
1322187|NCT02347072|4337211|P1|Overall Study|Physician Decision|1
1322188|NCT02347072|4337211|P1|Overall Study|Withdrawal by Subject|6
1322189|NCT02347072|4337211|P1|Overall Study|Adverse Event|2
1322190|NCT02346877|4337245|P2|Overall Study|Missing|0
1322191|NCT02346877|4337246|P1|Overall Study|Missing|5
1322192|NCT02346877|4337245|P2|Overall Study|Sponsor Decision|0
1322193|NCT02346877|4337246|P1|Overall Study|Sponsor Decision|12
1322194|NCT02346877|4337245|P2|Overall Study|Administrative Decision|0
1322195|NCT02346877|4337246|P1|Overall Study|Administrative Decision|1
1322196|NCT02346877|4337245|P2|Overall Study|Adverse Event|0
1322197|NCT02346877|4337246|P1|Overall Study|Adverse Event|1
1322198|NCT02346721|4337256|P1|Overall Study|Lack of Efficacy|1
1322199|NCT02346721|4337256|P1|Overall Study|Withdrew Consent|3
1322200|NCT02346240|4337274|P17|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322201|NCT02346240|4337275|P16|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322202|NCT02346240|4337276|P15|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|1
1322203|NCT02346240|4337277|P14|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322204|NCT02346240|4337278|P13|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322205|NCT02346240|4337279|P12|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322206|NCT02346240|4337280|P11|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322207|NCT02346240|4337281|P10|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322208|NCT02346240|4337282|P9|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322209|NCT02346240|4337283|P8|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322210|NCT02346240|4337284|P7|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322211|NCT02346240|4337285|P6|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322212|NCT02346240|4337286|P5|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322213|NCT02346240|4337287|P4|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322214|NCT02346240|4337288|P3|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322215|NCT02346240|4337289|P2|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322216|NCT02346240|4337290|P1|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1322217|NCT02346240|4337274|P17|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322218|NCT02346240|4337275|P16|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322219|NCT02346240|4337276|P15|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322220|NCT02346240|4337277|P14|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322221|NCT02346240|4337278|P13|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322222|NCT02346240|4337279|P12|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322223|NCT02346240|4337280|P11|Finished Wk16 Entered Maintenance Period|Patient’s decisions|1
1322224|NCT02346240|4337281|P10|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322225|NCT02346240|4337282|P9|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322226|NCT02346240|4337283|P8|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322227|NCT02346240|4337284|P7|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322228|NCT02346240|4337285|P6|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322229|NCT02346240|4337286|P5|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322230|NCT02346240|4337287|P4|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322231|NCT02346240|4337288|P3|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322232|NCT02346240|4337289|P2|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322233|NCT02346240|4337290|P1|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1322234|NCT02346240|4337274|P17|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322235|NCT02346240|4337275|P16|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322236|NCT02346240|4337276|P15|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322237|NCT02346240|4337277|P14|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322238|NCT02346240|4337278|P13|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322239|NCT02346240|4337279|P12|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322240|NCT02346240|4337280|P11|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322241|NCT02346240|4337281|P10|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|1
1322242|NCT02346240|4337282|P9|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322243|NCT02346240|4337283|P8|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322244|NCT02346240|4337284|P7|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322245|NCT02346240|4337285|P6|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322246|NCT02346240|4337286|P5|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322247|NCT02346240|4337287|P4|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322248|NCT02346240|4337288|P3|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322249|NCT02346240|4337289|P2|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322250|NCT02346240|4337290|P1|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1322251|NCT02346240|4337274|P17|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1322252|NCT02346240|4337275|P16|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1322253|NCT02346240|4337276|P15|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
1322254|NCT02346240|4337277|P14|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
1322255|NCT02346240|4337278|P13|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1322256|NCT02346240|4337279|P12|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
1322257|NCT02346240|4337280|P11|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1322258|NCT02346240|4337281|P10|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1322259|NCT02346240|4337282|P9|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
1322260|NCT02346240|4337283|P8|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1322261|NCT02346240|4337284|P7|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1322262|NCT02346240|4337285|P6|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1322263|NCT02346240|4337286|P5|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1322264|NCT02346240|4337287|P4|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1322265|NCT02346240|4337288|P3|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1322266|NCT02346240|4337289|P2|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1322267|NCT02346240|4337290|P1|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1322268|NCT02346240|4337274|P17|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322269|NCT02346240|4337275|P16|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322270|NCT02346240|4337276|P15|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322271|NCT02346240|4337277|P14|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322272|NCT02346240|4337278|P13|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322273|NCT02346240|4337279|P12|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322274|NCT02346240|4337280|P11|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322275|NCT02346240|4337281|P10|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322276|NCT02346240|4337282|P9|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322277|NCT02346240|4337283|P8|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322278|NCT02346240|4337284|P7|Finished Wk16 Entered Maintenance Period|Moved out of state|1
1322279|NCT02346240|4337285|P6|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322280|NCT02346240|4337286|P5|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322281|NCT02346240|4337287|P4|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322282|NCT02346240|4337288|P3|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322283|NCT02346240|4337289|P2|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322284|NCT02346240|4337290|P1|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1322285|NCT02346240|4337274|P17|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|4
1322286|NCT02346240|4337275|P16|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|8
1322287|NCT02346240|4337276|P15|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|3
1322288|NCT02346240|4337277|P14|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|3
1322289|NCT02346240|4337278|P13|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1322290|NCT02346240|4337279|P12|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1322291|NCT02346240|4337280|P11|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1322292|NCT02346240|4337281|P10|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1322293|NCT02346240|4337282|P9|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1322294|NCT02346240|4337283|P8|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1322295|NCT02346240|4337284|P7|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1322296|NCT02346240|4337285|P6|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1322297|NCT02346240|4337286|P5|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1322298|NCT02346240|4337287|P4|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1322299|NCT02346240|4337288|P3|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1322300|NCT02346240|4337289|P2|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1322301|NCT02346240|4337290|P1|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1322302|NCT02346240|4337274|P17|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1322303|NCT02346240|4337275|P16|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1322304|NCT02346240|4337276|P15|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|4
1322305|NCT02346240|4337277|P14|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|2
1322306|NCT02346240|4337278|P13|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1322307|NCT02346240|4337279|P12|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|2
1322308|NCT02346240|4337280|P11|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1322309|NCT02346240|4337281|P10|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1322310|NCT02346240|4337282|P9|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1322311|NCT02346240|4337283|P8|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1322312|NCT02346240|4337284|P7|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1322313|NCT02346240|4337285|P6|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1322314|NCT02346240|4337286|P5|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1322315|NCT02346240|4337287|P4|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1322316|NCT02346240|4337288|P3|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1322317|NCT02346240|4337289|P2|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1322318|NCT02346240|4337290|P1|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1322319|NCT02346240|4337274|P17|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322320|NCT02346240|4337275|P16|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322321|NCT02346240|4337276|P15|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|1
1322322|NCT02346240|4337277|P14|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322323|NCT02346240|4337278|P13|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322324|NCT02346240|4337279|P12|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322325|NCT02346240|4337280|P11|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322326|NCT02346240|4337281|P10|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322327|NCT02346240|4337282|P9|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322328|NCT02346240|4337283|P8|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322329|NCT02346240|4337284|P7|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322330|NCT02346240|4337285|P6|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322331|NCT02346240|4337286|P5|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322332|NCT02346240|4337287|P4|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322333|NCT02346240|4337288|P3|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322334|NCT02346240|4337289|P2|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322335|NCT02346240|4337290|P1|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1322336|NCT02346240|4337274|P17|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322337|NCT02346240|4337275|P16|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|3
1322338|NCT02346240|4337276|P15|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322339|NCT02346240|4337277|P14|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322340|NCT02346240|4337278|P13|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322341|NCT02346240|4337279|P12|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322342|NCT02346240|4337280|P11|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322343|NCT02346240|4337281|P10|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322344|NCT02346240|4337282|P9|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322345|NCT02346240|4337283|P8|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322346|NCT02346240|4337284|P7|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322347|NCT02346240|4337285|P6|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322348|NCT02346240|4337286|P5|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322349|NCT02346240|4337287|P4|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322350|NCT02346240|4337288|P3|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322351|NCT02346240|4337289|P2|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322352|NCT02346240|4337290|P1|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1322353|NCT02346240|4337274|P17|Finished Wk16 Entered Maintenance Period|Adverse Event|2
1322354|NCT02346240|4337275|P16|Finished Wk16 Entered Maintenance Period|Adverse Event|1
1322355|NCT02346240|4337276|P15|Finished Wk16 Entered Maintenance Period|Adverse Event|4
1322356|NCT02346240|4337277|P14|Finished Wk16 Entered Maintenance Period|Adverse Event|1
1322357|NCT02346240|4337278|P13|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1322358|NCT02346240|4337279|P12|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1322359|NCT02346240|4337280|P11|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1322360|NCT02346240|4337281|P10|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1322361|NCT02346240|4337282|P9|Finished Wk16 Entered Maintenance Period|Adverse Event|2
1322362|NCT02346240|4337283|P8|Finished Wk16 Entered Maintenance Period|Adverse Event|1
1322363|NCT02346240|4337284|P7|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1322364|NCT02346240|4337285|P6|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1322365|NCT02346240|4337286|P5|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1322366|NCT02346240|4337287|P4|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1322367|NCT02346240|4337288|P3|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1322368|NCT02346240|4337289|P2|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1322369|NCT02346240|4337290|P1|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1322370|NCT02346240|4337274|P17|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322371|NCT02346240|4337275|P16|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322372|NCT02346240|4337276|P15|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322373|NCT02346240|4337277|P14|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322374|NCT02346240|4337278|P13|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322375|NCT02346240|4337279|P12|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322376|NCT02346240|4337280|P11|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322377|NCT02346240|4337281|P10|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322378|NCT02346240|4337282|P9|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322379|NCT02346240|4337283|P8|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322380|NCT02346240|4337284|P7|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322381|NCT02346240|4337285|P6|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322382|NCT02346240|4337286|P5|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322383|NCT02346240|4337287|P4|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322384|NCT02346240|4337288|P3|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
1322385|NCT02346240|4337289|P2|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322386|NCT02346240|4337290|P1|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1322387|NCT02346240|4337274|P17|Initial Period (Baseline to Week 16)|Non-compliance|0
1322388|NCT02346240|4337275|P16|Initial Period (Baseline to Week 16)|Non-compliance|0
1322389|NCT02346240|4337276|P15|Initial Period (Baseline to Week 16)|Non-compliance|0
1322390|NCT02346240|4337277|P14|Initial Period (Baseline to Week 16)|Non-compliance|0
1322391|NCT02346240|4337278|P13|Initial Period (Baseline to Week 16)|Non-compliance|0
1322392|NCT02346240|4337279|P12|Initial Period (Baseline to Week 16)|Non-compliance|0
1322393|NCT02346240|4337280|P11|Initial Period (Baseline to Week 16)|Non-compliance|0
1322394|NCT02346240|4337281|P10|Initial Period (Baseline to Week 16)|Non-compliance|0
1322395|NCT02346240|4337282|P9|Initial Period (Baseline to Week 16)|Non-compliance|0
1322396|NCT02346240|4337283|P8|Initial Period (Baseline to Week 16)|Non-compliance|0
1322397|NCT02346240|4337284|P7|Initial Period (Baseline to Week 16)|Non-compliance|0
1322398|NCT02346240|4337285|P6|Initial Period (Baseline to Week 16)|Non-compliance|0
1322399|NCT02346240|4337286|P5|Initial Period (Baseline to Week 16)|Non-compliance|0
1322400|NCT02346240|4337287|P4|Initial Period (Baseline to Week 16)|Non-compliance|1
1322401|NCT02346240|4337288|P3|Initial Period (Baseline to Week 16)|Non-compliance|0
1322402|NCT02346240|4337289|P2|Initial Period (Baseline to Week 16)|Non-compliance|1
1322403|NCT02346240|4337290|P1|Initial Period (Baseline to Week 16)|Non-compliance|0
1322404|NCT02346240|4337274|P17|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1322405|NCT02346240|4337275|P16|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1322406|NCT02346240|4337276|P15|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1322407|NCT02346240|4337277|P14|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1322408|NCT02346240|4337278|P13|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1322409|NCT02346240|4337279|P12|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1322410|NCT02346240|4337280|P11|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1322411|NCT02346240|4337281|P10|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1322412|NCT02346240|4337282|P9|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1322413|NCT02346240|4337283|P8|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1322414|NCT02346240|4337284|P7|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1322415|NCT02346240|4337285|P6|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1322416|NCT02346240|4337286|P5|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1322417|NCT02346240|4337287|P4|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
1322418|NCT02346240|4337288|P3|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
1322419|NCT02346240|4337289|P2|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
1322420|NCT02346240|4337290|P1|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
1322421|NCT02346240|4337274|P17|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1322422|NCT02346240|4337275|P16|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1322423|NCT02346240|4337276|P15|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1322424|NCT02346240|4337277|P14|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1322425|NCT02346240|4337278|P13|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1322426|NCT02346240|4337279|P12|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1322427|NCT02346240|4337280|P11|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1322428|NCT02346240|4337281|P10|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1322429|NCT02346240|4337282|P9|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1322430|NCT02346240|4337283|P8|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1322431|NCT02346240|4337284|P7|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1322432|NCT02346240|4337285|P6|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1322433|NCT02346240|4337286|P5|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1322434|NCT02346240|4337287|P4|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
1322435|NCT02346240|4337288|P3|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
1322436|NCT02346240|4337289|P2|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
1322437|NCT02346240|4337290|P1|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
1322438|NCT02346240|4337274|P17|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322439|NCT02346240|4337275|P16|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322440|NCT02346240|4337276|P15|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322441|NCT02346240|4337277|P14|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322442|NCT02346240|4337278|P13|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322443|NCT02346240|4337279|P12|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322444|NCT02346240|4337280|P11|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322445|NCT02346240|4337281|P10|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322446|NCT02346240|4337282|P9|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322447|NCT02346240|4337283|P8|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322448|NCT02346240|4337284|P7|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322449|NCT02346240|4337285|P6|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322450|NCT02346240|4337286|P5|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322451|NCT02346240|4337287|P4|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322452|NCT02346240|4337288|P3|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322453|NCT02346240|4337289|P2|Initial Period (Baseline to Week 16)|Protocol Violation|1
1322454|NCT02346240|4337290|P1|Initial Period (Baseline to Week 16)|Protocol Violation|0
1322455|NCT02346240|4337274|P17|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322456|NCT02346240|4337275|P16|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322457|NCT02346240|4337276|P15|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322458|NCT02346240|4337277|P14|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322459|NCT02346240|4337278|P13|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322460|NCT02346240|4337279|P12|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322461|NCT02346240|4337280|P11|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322462|NCT02346240|4337281|P10|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322463|NCT02346240|4337282|P9|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322464|NCT02346240|4337283|P8|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322465|NCT02346240|4337284|P7|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322466|NCT02346240|4337285|P6|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322467|NCT02346240|4337286|P5|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322468|NCT02346240|4337287|P4|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322469|NCT02346240|4337288|P3|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322470|NCT02346240|4337289|P2|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
1322471|NCT02346240|4337290|P1|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1322472|NCT02346240|4337274|P17|Initial Period (Baseline to Week 16)|Adverse Event|0
1322473|NCT02346240|4337275|P16|Initial Period (Baseline to Week 16)|Adverse Event|0
1322474|NCT02346240|4337276|P15|Initial Period (Baseline to Week 16)|Adverse Event|0
1322475|NCT02346240|4337277|P14|Initial Period (Baseline to Week 16)|Adverse Event|0
1322476|NCT02346240|4337278|P13|Initial Period (Baseline to Week 16)|Adverse Event|0
1322477|NCT02346240|4337279|P12|Initial Period (Baseline to Week 16)|Adverse Event|0
1322478|NCT02346240|4337280|P11|Initial Period (Baseline to Week 16)|Adverse Event|0
1322479|NCT02346240|4337281|P10|Initial Period (Baseline to Week 16)|Adverse Event|0
1322480|NCT02346240|4337282|P9|Initial Period (Baseline to Week 16)|Adverse Event|0
1322481|NCT02346240|4337283|P8|Initial Period (Baseline to Week 16)|Adverse Event|0
1322482|NCT02346240|4337284|P7|Initial Period (Baseline to Week 16)|Adverse Event|0
1322483|NCT02346240|4337285|P6|Initial Period (Baseline to Week 16)|Adverse Event|0
1322484|NCT02346240|4337286|P5|Initial Period (Baseline to Week 16)|Adverse Event|0
1322485|NCT02346240|4337287|P4|Initial Period (Baseline to Week 16)|Adverse Event|1
1322486|NCT02346240|4337288|P3|Initial Period (Baseline to Week 16)|Adverse Event|1
1322487|NCT02346240|4337289|P2|Initial Period (Baseline to Week 16)|Adverse Event|4
1322488|NCT02346240|4337290|P1|Initial Period (Baseline to Week 16)|Adverse Event|0
1322489|NCT02345330|4337369|P1|Overall Study|Progressive Disease|2
1322490|NCT02345330|4337369|P1|Overall Study|Death|1
1322491|NCT02345252|4337381|P2|Overall Study|Still in Study up to the Data Cut Date|300
1322492|NCT02345252|4337382|P1|Overall Study|Still in Study up to the Data Cut Date|304
1322493|NCT02345252|4337381|P2|Overall Study|Randomized but Never Treated|2
1322494|NCT02345252|4337382|P1|Overall Study|Randomized but Never Treated|0
1322495|NCT02345252|4337381|P2|Overall Study|Lost to Follow-up|3
1322496|NCT02345252|4337382|P1|Overall Study|Lost to Follow-up|2
1322497|NCT02345252|4337381|P2|Overall Study|Withdrew Consent|9
1322498|NCT02345252|4337382|P1|Overall Study|Withdrew Consent|7
1322499|NCT02345252|4337381|P2|Overall Study|Protocol Violation|0
1322500|NCT02345252|4337382|P1|Overall Study|Protocol Violation|1
1322501|NCT02345252|4337381|P2|Overall Study|Investigator's Discretion|1
1322502|NCT02345252|4337382|P1|Overall Study|Investigator's Discretion|0
1322503|NCT02345252|4337381|P2|Overall Study|Death|1
1322504|NCT02345252|4337382|P1|Overall Study|Death|1
1322505|NCT02345252|4337381|P2|Overall Study|Adverse Event|0
1322506|NCT02345252|4337382|P1|Overall Study|Adverse Event|1
1322507|NCT02345226|4337398|P2|Overall Study|Still in Study up to the Data Cut Date|409
1322508|NCT02345226|4337399|P1|Overall Study|Still in Study up to the Data Cut Date|405
1322509|NCT02345226|4337398|P2|Overall Study|Randomized but Never Treated|4
1322510|NCT02345226|4337399|P1|Overall Study|Randomized but Never Treated|2
1322511|NCT02345226|4337398|P2|Overall Study|Lost to Follow-up|6
1322512|NCT02345226|4337399|P1|Overall Study|Lost to Follow-up|7
1322513|NCT02345226|4337398|P2|Overall Study|Withdrew Consent|16
1322514|NCT02345226|4337399|P1|Overall Study|Withdrew Consent|18
1322515|NCT02345226|4337398|P2|Overall Study|Non-Compliance with Study Drug|0
1322516|NCT02345226|4337399|P1|Overall Study|Non-Compliance with Study Drug|1
1322517|NCT02345226|4337398|P2|Overall Study|Investigator's Discretion|1
1322518|NCT02345226|4337399|P1|Overall Study|Investigator's Discretion|3
1322519|NCT02345226|4337398|P2|Overall Study|Lack of Efficacy|0
1322520|NCT02345226|4337399|P1|Overall Study|Lack of Efficacy|1
1322521|NCT02345226|4337398|P2|Overall Study|Pregnancy|1
1322522|NCT02345226|4337399|P1|Overall Study|Pregnancy|0
1322523|NCT02345226|4337398|P2|Overall Study|Death|0
1322524|NCT02345226|4337399|P1|Overall Study|Death|1
1322525|NCT02345226|4337398|P2|Overall Study|Adverse Event|4
1322526|NCT02345226|4337399|P1|Overall Study|Adverse Event|2
1322527|NCT02345161|4337417|P2|Overall Study|Lost to Follow-up|1
1322528|NCT02345161|4337418|P1|Overall Study|Lost to Follow-up|0
1322529|NCT02345161|4337417|P2|Overall Study|Physician Decision|4
1322530|NCT02345161|4337418|P1|Overall Study|Physician Decision|4
1322531|NCT02345161|4337417|P2|Overall Study|Adverse Event|19
1322532|NCT02345161|4337418|P1|Overall Study|Adverse Event|16
1322533|NCT02345161|4337417|P2|Overall Study|Withdrawal by Subject|33
1322534|NCT02345161|4337418|P1|Overall Study|Withdrawal by Subject|25
1322535|NCT02344745|4337539|P2|Overall Study|Data collection sheets were lost|0
1322536|NCT02344745|4337540|P1|Overall Study|Data collection sheets were lost|2
1322537|NCT02344342|4337572|P4|Overall Study|Industry partner dropped out|10
1322538|NCT02344342|4337573|P3|Overall Study|Industry partner dropped out|14
1322539|NCT02344342|4337574|P2|Overall Study|Industry partner dropped out|9
1322540|NCT02344342|4337575|P1|Overall Study|Industry partner dropped out|11
1322541|NCT02343263|4337639|P3|Overall Study|Physician Decision|1
1322542|NCT02343263|4337640|P2|Overall Study|Physician Decision|3
1322543|NCT02343263|4337641|P1|Overall Study|Physician Decision|5
1322544|NCT02343159|4337670|P3|Overall Study|Enrollment Error|0
1322545|NCT02343159|4337671|P2|Overall Study|Enrollment Error|0
1322546|NCT02343159|4337672|P1|Overall Study|Enrollment Error|1
1322547|NCT02343159|4337670|P3|Overall Study|Sponsor Decision|0
1322548|NCT02343159|4337671|P2|Overall Study|Sponsor Decision|1
1322549|NCT02343159|4337672|P1|Overall Study|Sponsor Decision|0
1322550|NCT02343159|4337670|P3|Overall Study|Adverse Event|2
1322551|NCT02343159|4337671|P2|Overall Study|Adverse Event|4
1322552|NCT02343159|4337672|P1|Overall Study|Adverse Event|4
1322553|NCT02343159|4337670|P3|Overall Study|Lost to Follow-up|2
1322554|NCT02343159|4337671|P2|Overall Study|Lost to Follow-up|2
1322555|NCT02343159|4337672|P1|Overall Study|Lost to Follow-up|0
1322556|NCT02343159|4337670|P3|Overall Study|Withdrawal by Subject|2
1322557|NCT02343159|4337671|P2|Overall Study|Withdrawal by Subject|0
1322558|NCT02343159|4337672|P1|Overall Study|Withdrawal by Subject|3
1322559|NCT02343159|4337670|P3|Overall Study|Physician Decision|1
1322560|NCT02343159|4337671|P2|Overall Study|Physician Decision|0
1322561|NCT02343159|4337672|P1|Overall Study|Physician Decision|2
1322562|NCT02343159|4337670|P3|Overall Study|Early Study Termination|23
1322563|NCT02343159|4337671|P2|Overall Study|Early Study Termination|19
1322564|NCT02343159|4337672|P1|Overall Study|Early Study Termination|16
1322565|NCT02343003|4337716|P2|Overall Study|terminated by sponsor|0
1322566|NCT02343003|4337717|P1|Overall Study|terminated by sponsor|2
1322567|NCT02343003|4337716|P2|Overall Study|exclusion criteria met|1
1322568|NCT02343003|4337717|P1|Overall Study|exclusion criteria met|1
1322569|NCT02343003|4337716|P2|Overall Study|Death|1
1322570|NCT02343003|4337717|P1|Overall Study|Death|0
1322571|NCT02343003|4337716|P2|Overall Study|Protocol Violation|0
1322572|NCT02343003|4337717|P1|Overall Study|Protocol Violation|1
1322573|NCT02343003|4337716|P2|Overall Study|Lost to Follow-up|1
1322574|NCT02343003|4337717|P1|Overall Study|Lost to Follow-up|5
1322575|NCT02343003|4337716|P2|Overall Study|Withdrawal by Subject|4
1322576|NCT02343003|4337717|P1|Overall Study|Withdrawal by Subject|9
1322577|NCT02342704|4337735|P2|Overall Study|Adverse Event|3
1322578|NCT02342704|4337736|P1|Overall Study|Adverse Event|1
1322579|NCT02342704|4337735|P2|Overall Study|Lost to Follow-up|1
1322580|NCT02342704|4337736|P1|Overall Study|Lost to Follow-up|2
1322581|NCT02342704|4337735|P2|Overall Study|Withdrawal by Subject|0
1322582|NCT02342704|4337736|P1|Overall Study|Withdrawal by Subject|1
1322583|NCT02342704|4337735|P2|Overall Study|Not Specified|1
1322584|NCT02342704|4337736|P1|Overall Study|Not Specified|0
1322585|NCT02342704|4337735|P2|Overall Study|Sponsor Termination|43
1322586|NCT02342704|4337736|P1|Overall Study|Sponsor Termination|49
1322587|NCT02342704|4337735|P2|Overall Study|Physician Decision|3
1322588|NCT02342704|4337736|P1|Overall Study|Physician Decision|0
1322589|NCT02342548|4337773|P3|Overall Study|Other|1
1322590|NCT02342548|4337774|P2|Overall Study|Other|1
1322591|NCT02342548|4337775|P1|Overall Study|Other|1
1322592|NCT02342548|4337773|P3|Overall Study|Withdrawal by Subject|4
1322593|NCT02342548|4337774|P2|Overall Study|Withdrawal by Subject|3
1322594|NCT02342548|4337775|P1|Overall Study|Withdrawal by Subject|1
1322595|NCT02342548|4337773|P3|Overall Study|Protocol Violation|0
1322596|NCT02342548|4337774|P2|Overall Study|Protocol Violation|1
1322597|NCT02342548|4337775|P1|Overall Study|Protocol Violation|0
1322598|NCT02342548|4337773|P3|Overall Study|Study terminated by sponsor|25
1322599|NCT02342548|4337774|P2|Overall Study|Study terminated by sponsor|39
1322600|NCT02342548|4337775|P1|Overall Study|Study terminated by sponsor|20
1322601|NCT02342548|4337773|P3|Overall Study|Lost to Follow-up|0
1322602|NCT02342548|4337774|P2|Overall Study|Lost to Follow-up|1
1322603|NCT02342548|4337775|P1|Overall Study|Lost to Follow-up|0
1322604|NCT02342548|4337773|P3|Overall Study|Adverse Event|13
1322605|NCT02342548|4337774|P2|Overall Study|Adverse Event|17
1322606|NCT02342548|4337775|P1|Overall Study|Adverse Event|12
1322607|NCT02342418|4337819|P2|Overall Study|Adverse Event|1
1322608|NCT02342418|4337820|P1|Overall Study|Adverse Event|0
1322609|NCT02342288|4337830|P2|Overall Study|coordinator not available|2
1322610|NCT02342288|4337831|P1|Overall Study|coordinator not available|0
1322611|NCT02342288|4337830|P2|Overall Study|subject cannot tolerate numbing drops|1
1322612|NCT02342288|4337831|P1|Overall Study|subject cannot tolerate numbing drops|0
1322613|NCT02342288|4337830|P2|Overall Study|coordinator contaminated with blood|1
1322614|NCT02342288|4337831|P1|Overall Study|coordinator contaminated with blood|0
1322615|NCT02342288|4337830|P2|Overall Study|Withdrawal by Subject|0
1322616|NCT02342288|4337831|P1|Overall Study|Withdrawal by Subject|1
1322617|NCT02342288|4337830|P2|Overall Study|anesthesia leak in system|0
1322618|NCT02342288|4337831|P1|Overall Study|anesthesia leak in system|1
1322619|NCT02342288|4337830|P2|Overall Study|no protocol anesthesiologist available|2
1322620|NCT02342288|4337831|P1|Overall Study|no protocol anesthesiologist available|3
1322621|NCT02342223|4337837|P1|Overall Study|Lost to Follow-up|1
1322622|NCT02341482|4338009|P1|Overall Study|Adverse Event|1
1322623|NCT02341417|4338038|P3|Overall Study|Death|1
1322624|NCT02341417|4338039|P2|Overall Study|Death|0
1322625|NCT02341417|4338040|P1|Overall Study|Death|0
1322626|NCT02341417|4338038|P3|Overall Study|Decision by sponsor|0
1322627|NCT02341417|4338039|P2|Overall Study|Decision by sponsor|0
1322628|NCT02341417|4338040|P1|Overall Study|Decision by sponsor|2
1322629|NCT02341417|4338038|P3|Overall Study|Withdrawal by Subject|0
1322630|NCT02341417|4338039|P2|Overall Study|Withdrawal by Subject|2
1322631|NCT02341417|4338040|P1|Overall Study|Withdrawal by Subject|0
1322632|NCT02340663|4338105|P2|Overall Study|Withdrawal by Subject|1
1322633|NCT02340663|4338106|P1|Overall Study|Withdrawal by Subject|3
1322634|NCT02340663|4338105|P2|Overall Study|Protocol Violation|0
1322635|NCT02340663|4338106|P1|Overall Study|Protocol Violation|1
1322636|NCT02340663|4338105|P2|Overall Study|Lost to Follow-up|0
1322637|NCT02340663|4338106|P1|Overall Study|Lost to Follow-up|1
1322638|NCT02340520|4338162|P1|Overall Study|Withdrawal by Subject|1
1322639|NCT02340520|4338162|P1|Overall Study|Patient did not take drug as specified|1
1322640|NCT02340520|4338162|P1|Overall Study|Lost to Follow-up|1
1322641|NCT02340000|4338210|P2|Time Period 2|Lost to Follow-up|8
1322642|NCT02340000|4338211|P1|Time Period 2|Lost to Follow-up|10
1322643|NCT02340000|4338210|P2|Time Period 2|Withdrawal by Subject|7
1322644|NCT02340000|4338211|P1|Time Period 2|Withdrawal by Subject|9
1322645|NCT02340000|4338210|P2|Time Period 1|Lost to Follow-up|7
1322646|NCT02340000|4338211|P1|Time Period 1|Lost to Follow-up|6
1322647|NCT02340000|4338210|P2|Time Period 1|Withdrawal by Subject|8
1322648|NCT02340000|4338211|P1|Time Period 1|Withdrawal by Subject|6
1322649|NCT02339584|4338265|P2|Overall Study|Withdrawal by Subject|4
1322650|NCT02339584|4338266|P1|Overall Study|Withdrawal by Subject|2
1322651|NCT02339584|4338265|P2|Overall Study|Protocol Violation|1
1322652|NCT02339584|4338266|P1|Overall Study|Protocol Violation|1
1322653|NCT02339584|4338265|P2|Overall Study|Physician Decision|2
1322654|NCT02339584|4338266|P1|Overall Study|Physician Decision|1
1322655|NCT02339584|4338265|P2|Overall Study|Lack of Efficacy|1
1322656|NCT02339584|4338266|P1|Overall Study|Lack of Efficacy|0
1322657|NCT02339584|4338265|P2|Overall Study|Adverse Event|7
1322658|NCT02339584|4338266|P1|Overall Study|Adverse Event|11
1322659|NCT02339506|4338272|P2|Washout (Period 2)|Withdrawal by Subject|0
1322660|NCT02339506|4338273|P1|Washout (Period 2)|Withdrawal by Subject|2
1322661|NCT02339506|4338272|P2|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
1322662|NCT02339506|4338273|P1|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
1322663|NCT02339285|4338287|P3|Overall Study|Protocol Deviation|0
1322664|NCT02339285|4338288|P2|Overall Study|Protocol Deviation|1
1322665|NCT02339285|4338289|P1|Overall Study|Protocol Deviation|0
1322666|NCT02339285|4338287|P3|Overall Study|Lost to Follow-up|1
1322667|NCT02339285|4338288|P2|Overall Study|Lost to Follow-up|1
1322668|NCT02339285|4338289|P1|Overall Study|Lost to Follow-up|1
1322669|NCT02339285|4338287|P3|Overall Study|Withdrawal by Subject|1
1322670|NCT02339285|4338288|P2|Overall Study|Withdrawal by Subject|1
1322671|NCT02339285|4338289|P1|Overall Study|Withdrawal by Subject|0
1322672|NCT02339155|4338335|P2|Overall Study|Withdrawal by Subject|4
1322673|NCT02339155|4338336|P1|Overall Study|Withdrawal by Subject|4
1322674|NCT02339155|4338335|P2|Overall Study|Physician Decision|1
1322675|NCT02339155|4338336|P1|Overall Study|Physician Decision|2
1322676|NCT02339155|4338335|P2|Overall Study|Lost to Follow-up|9
1322677|NCT02339155|4338336|P1|Overall Study|Lost to Follow-up|8
1322678|NCT02339155|4338335|P2|Overall Study|Death|1
1322679|NCT02339155|4338336|P1|Overall Study|Death|1
1322680|NCT02339155|4338335|P2|Overall Study|Adverse Event|6
1322681|NCT02339155|4338336|P1|Overall Study|Adverse Event|0
1322682|NCT02338843|4338368|P2|Overall Study|Discontinued prior to randomizat|0
1322683|NCT02338843|4338369|P1|Overall Study|Discontinued prior to randomizat|1
1322684|NCT02338843|4338368|P2|Overall Study|Subject Recovered|2
1322685|NCT02338843|4338369|P1|Overall Study|Subject Recovered|0
1322686|NCT02338843|4338368|P2|Overall Study|Withdrawal by Subject|2
1322687|NCT02338843|4338369|P1|Overall Study|Withdrawal by Subject|0
1322688|NCT02338843|4338368|P2|Overall Study|Physician Decision|0
1322689|NCT02338843|4338369|P1|Overall Study|Physician Decision|1
1322690|NCT02338843|4338368|P2|Overall Study|Death|53
1322691|NCT02338843|4338369|P1|Overall Study|Death|40
1322692|NCT02338843|4338368|P2|Overall Study|Adverse Event|1
1322693|NCT02338843|4338369|P1|Overall Study|Adverse Event|2
1322694|NCT02338492|4338397|P1|Overall Study|Reason not captured above|6
1322695|NCT02338492|4338397|P1|Overall Study|Lost to Follow-up|4
1322696|NCT02338492|4338397|P1|Overall Study|Adverse Event|3
1322697|NCT02338492|4338397|P1|Overall Study|Death|32
1322698|NCT02337491|4338454|P2|Overall Study|On Treatment|0
1322699|NCT02337491|4338455|P1|Overall Study|On Treatment|2
1322700|NCT02337491|4338454|P2|Overall Study|Progressive Disease|28
1322701|NCT02337491|4338455|P1|Overall Study|Progressive Disease|44
1322702|NCT02337491|4338454|P2|Overall Study|Withdrawal by Subject|0
1322703|NCT02337491|4338455|P1|Overall Study|Withdrawal by Subject|3
1322704|NCT02337491|4338454|P2|Overall Study|Adverse Event|1
1322705|NCT02337491|4338455|P1|Overall Study|Adverse Event|0
1322706|NCT02337491|4338454|P2|Overall Study|Death|1
1322707|NCT02337491|4338455|P1|Overall Study|Death|1
1322708|NCT02336607|4338503|P4|Overall Study|Withdrawal by Subject|20
1322709|NCT02336607|4338504|P3|Overall Study|Withdrawal by Subject|0
1322710|NCT02336607|4338505|P2|Overall Study|Withdrawal by Subject|2
1322711|NCT02336607|4338506|P1|Overall Study|Withdrawal by Subject|0
1322712|NCT02336607|4338503|P4|Overall Study|Adverse Event|26
1322713|NCT02336607|4338504|P3|Overall Study|Adverse Event|2
1322714|NCT02336607|4338505|P2|Overall Study|Adverse Event|2
1322715|NCT02336607|4338506|P1|Overall Study|Adverse Event|0
1322716|NCT02336607|4338503|P4|Overall Study|Protocol Violation|3
1322717|NCT02336607|4338504|P3|Overall Study|Protocol Violation|1
1322718|NCT02336607|4338505|P2|Overall Study|Protocol Violation|1
1322719|NCT02336607|4338506|P1|Overall Study|Protocol Violation|0
1322720|NCT02336607|4338503|P4|Overall Study|Lost to Follow-up|21
1322721|NCT02336607|4338504|P3|Overall Study|Lost to Follow-up|0
1322722|NCT02336607|4338505|P2|Overall Study|Lost to Follow-up|1
1322723|NCT02336607|4338506|P1|Overall Study|Lost to Follow-up|2
1322724|NCT02336607|4338503|P4|Overall Study|Lack of Efficacy|2
1322725|NCT02336607|4338504|P3|Overall Study|Lack of Efficacy|0
1322726|NCT02336607|4338505|P2|Overall Study|Lack of Efficacy|0
1322727|NCT02336607|4338506|P1|Overall Study|Lack of Efficacy|1
1322728|NCT02336607|4338503|P4|Overall Study|Physician Decision|15
1322729|NCT02336607|4338504|P3|Overall Study|Physician Decision|3
1322730|NCT02336607|4338505|P2|Overall Study|Physician Decision|4
1322731|NCT02336607|4338506|P1|Overall Study|Physician Decision|1
1322732|NCT02336425|4338620|P4|Overall Study|Study terminated.|3
1322733|NCT02336425|4338621|P3|Overall Study|Study terminated.|3
1322734|NCT02336425|4338622|P2|Overall Study|Study terminated.|2
1322735|NCT02336425|4338623|P1|Overall Study|Study terminated.|2
1322736|NCT02336282|4338673|P1|Overall Study|Not enough time to complete sessions|2
1322737|NCT02336282|4338673|P1|Overall Study|Lost to Follow-up|1
1322738|NCT02336282|4338673|P1|Overall Study|Uncomfortable with technology|1
1322739|NCT02336282|4338673|P1|Overall Study|Unrelated illness|1
1322740|NCT02336178|4338697|P1|Overall Study|Other|1
1322741|NCT02336178|4338697|P1|Overall Study|Withdrawal by Subject|1
1322742|NCT02336178|4338697|P1|Overall Study|Protocol Violation|1
1322743|NCT02336178|4338697|P1|Overall Study|Lost to Follow-up|1
1322744|NCT02335489|4338811|P1|Overall Study|Lack of Efficacy|1
1322745|NCT02335489|4338811|P1|Overall Study|Physician Decision|2
1322746|NCT02335489|4338811|P1|Overall Study|Withdrawal by Subject|2
1322747|NCT02335489|4338811|P1|Overall Study|Lost to Follow-up|1
1322748|NCT02335489|4338811|P1|Overall Study|Sponsor terminated study|4
1322749|NCT02335346|4338815|P1|Overall Study|Withdrawal by Subject|1
1322750|NCT02335346|4338815|P1|Overall Study|Adverse Event|11
1322751|NCT02334384|4339095|P2|Overall Study|Lost to Follow-up|1
1322752|NCT02334384|4339096|P1|Overall Study|Lost to Follow-up|1
1322753|NCT02332889|4339135|P1|Overall Study|Physician Decision|1
1322754|NCT02332876|4339141|P2|Overall Study|Lost to Follow-up|1
1322755|NCT02332876|4339142|P1|Overall Study|Lost to Follow-up|1
1322756|NCT02332824|4339154|P6|Overall Study|Transfer|0
1322757|NCT02332824|4339155|P5|Overall Study|Transfer|0
1322758|NCT02332824|4339156|P4|Overall Study|Transfer|1
1322759|NCT02332824|4339157|P3|Overall Study|Transfer|1
1322760|NCT02332824|4339158|P2|Overall Study|Transfer|0
1322761|NCT02332824|4339159|P1|Overall Study|Transfer|0
1322762|NCT02332824|4339154|P6|Overall Study|Inconvenient schedule|0
1322763|NCT02332824|4339155|P5|Overall Study|Inconvenient schedule|0
1322764|NCT02332824|4339156|P4|Overall Study|Inconvenient schedule|0
1322765|NCT02332824|4339157|P3|Overall Study|Inconvenient schedule|0
1322766|NCT02332824|4339158|P2|Overall Study|Inconvenient schedule|1
1322767|NCT02332824|4339159|P1|Overall Study|Inconvenient schedule|1
1322768|NCT02332824|4339154|P6|Overall Study|Voluntary Withdrawal|0
1322769|NCT02332824|4339155|P5|Overall Study|Voluntary Withdrawal|0
1322770|NCT02332824|4339156|P4|Overall Study|Voluntary Withdrawal|0
1322771|NCT02332824|4339157|P3|Overall Study|Voluntary Withdrawal|0
1322772|NCT02332824|4339158|P2|Overall Study|Voluntary Withdrawal|0
1322773|NCT02332824|4339159|P1|Overall Study|Voluntary Withdrawal|1
1322774|NCT02332824|4339154|P6|Overall Study|Pretreatment Event/Adverse Event|1
1322775|NCT02332824|4339155|P5|Overall Study|Pretreatment Event/Adverse Event|4
1322776|NCT02332824|4339156|P4|Overall Study|Pretreatment Event/Adverse Event|1
1322777|NCT02332824|4339157|P3|Overall Study|Pretreatment Event/Adverse Event|1
1322778|NCT02332824|4339158|P2|Overall Study|Pretreatment Event/Adverse Event|0
1322779|NCT02332824|4339159|P1|Overall Study|Pretreatment Event/Adverse Event|4
1322780|NCT02332798|4339200|P3|Overall Study|Abnormal laboratory findings|0
1322781|NCT02332798|4339201|P2|Overall Study|Abnormal laboratory findings|0
1322782|NCT02332798|4339202|P1|Overall Study|Abnormal laboratory findings|1
1322783|NCT02332798|4339200|P3|Overall Study|Positive urine drug test|0
1322784|NCT02332798|4339201|P2|Overall Study|Positive urine drug test|1
1322785|NCT02332798|4339202|P1|Overall Study|Positive urine drug test|0
1322786|NCT02332798|4339200|P3|Overall Study|Unwilling to participate in study|1
1322787|NCT02332798|4339201|P2|Overall Study|Unwilling to participate in study|1
1322788|NCT02332798|4339202|P1|Overall Study|Unwilling to participate in study|0
1322789|NCT02332720|4339275|P23|Part A and Part B|Withdrawal by Subject|0
1322790|NCT02332720|4339276|P22|Part A and Part B|Withdrawal by Subject|0
1322791|NCT02332720|4339277|P21|Part A and Part B|Withdrawal by Subject|0
1322792|NCT02332720|4339278|P20|Part A and Part B|Withdrawal by Subject|1
1322793|NCT02332720|4339279|P19|Part A and Part B|Withdrawal by Subject|0
1322794|NCT02332720|4339280|P18|Part A and Part B|Withdrawal by Subject|0
1322795|NCT02332720|4339281|P17|Part A and Part B|Withdrawal by Subject|0
1322796|NCT02332720|4339282|P16|Part A and Part B|Withdrawal by Subject|0
1322797|NCT02332720|4339283|P15|Part A and Part B|Withdrawal by Subject|0
1322798|NCT02332720|4339284|P14|Part A and Part B|Withdrawal by Subject|0
1322799|NCT02332720|4339285|P13|Part A and Part B|Withdrawal by Subject|0
1322800|NCT02332720|4339286|P12|Part A and Part B|Withdrawal by Subject|0
1322801|NCT02332720|4339287|P11|Part A and Part B|Withdrawal by Subject|0
1322802|NCT02332720|4339288|P10|Part A and Part B|Withdrawal by Subject|0
1322803|NCT02332720|4339289|P9|Part A and Part B|Withdrawal by Subject|0
1322804|NCT02332720|4339290|P8|Part A and Part B|Withdrawal by Subject|0
1322805|NCT02332720|4339291|P7|Part A and Part B|Withdrawal by Subject|0
1322806|NCT02332720|4339292|P6|Part A and Part B|Withdrawal by Subject|1
1322807|NCT02332720|4339293|P5|Part A and Part B|Withdrawal by Subject|0
1322808|NCT02332720|4339294|P4|Part A and Part B|Withdrawal by Subject|0
1322809|NCT02332720|4339295|P3|Part A and Part B|Withdrawal by Subject|0
1322810|NCT02332720|4339296|P2|Part A and Part B|Withdrawal by Subject|0
1322811|NCT02332720|4339297|P1|Part A and Part B|Withdrawal by Subject|0
1322812|NCT02332720|4339275|P23|Part A and Part B|Physician Decision|0
1322813|NCT02332720|4339276|P22|Part A and Part B|Physician Decision|0
1322814|NCT02332720|4339277|P21|Part A and Part B|Physician Decision|0
1322815|NCT02332720|4339278|P20|Part A and Part B|Physician Decision|0
1322816|NCT02332720|4339279|P19|Part A and Part B|Physician Decision|1
1322817|NCT02332720|4339280|P18|Part A and Part B|Physician Decision|0
1322818|NCT02332720|4339281|P17|Part A and Part B|Physician Decision|0
1322819|NCT02332720|4339282|P16|Part A and Part B|Physician Decision|0
1322820|NCT02332720|4339283|P15|Part A and Part B|Physician Decision|0
1322821|NCT02332720|4339284|P14|Part A and Part B|Physician Decision|0
1322822|NCT02332720|4339285|P13|Part A and Part B|Physician Decision|0
1322823|NCT02332720|4339286|P12|Part A and Part B|Physician Decision|0
1322824|NCT02332720|4339287|P11|Part A and Part B|Physician Decision|0
1322825|NCT02332720|4339288|P10|Part A and Part B|Physician Decision|0
1322826|NCT02332720|4339289|P9|Part A and Part B|Physician Decision|0
1322827|NCT02332720|4339290|P8|Part A and Part B|Physician Decision|0
1322828|NCT02332720|4339291|P7|Part A and Part B|Physician Decision|0
1322829|NCT02332720|4339292|P6|Part A and Part B|Physician Decision|0
1322830|NCT02332720|4339293|P5|Part A and Part B|Physician Decision|0
1322831|NCT02332720|4339294|P4|Part A and Part B|Physician Decision|0
1322832|NCT02332720|4339295|P3|Part A and Part B|Physician Decision|0
1322833|NCT02332720|4339296|P2|Part A and Part B|Physician Decision|0
1322834|NCT02332720|4339297|P1|Part A and Part B|Physician Decision|0
1322835|NCT02332720|4339275|P23|Part A and Part B|Adverse Event|0
1322836|NCT02332720|4339276|P22|Part A and Part B|Adverse Event|0
1322837|NCT02332720|4339277|P21|Part A and Part B|Adverse Event|0
1322838|NCT02332720|4339278|P20|Part A and Part B|Adverse Event|0
1322839|NCT02332720|4339279|P19|Part A and Part B|Adverse Event|0
1322840|NCT02332720|4339280|P18|Part A and Part B|Adverse Event|1
1322841|NCT02332720|4339281|P17|Part A and Part B|Adverse Event|0
1322842|NCT02332720|4339282|P16|Part A and Part B|Adverse Event|0
1322843|NCT02332720|4339283|P15|Part A and Part B|Adverse Event|0
1322844|NCT02332720|4339284|P14|Part A and Part B|Adverse Event|0
1322845|NCT02332720|4339285|P13|Part A and Part B|Adverse Event|0
1322846|NCT02332720|4339286|P12|Part A and Part B|Adverse Event|0
1322847|NCT02332720|4339287|P11|Part A and Part B|Adverse Event|0
1322848|NCT02332720|4339288|P10|Part A and Part B|Adverse Event|0
1322849|NCT02332720|4339289|P9|Part A and Part B|Adverse Event|0
1322850|NCT02332720|4339290|P8|Part A and Part B|Adverse Event|0
1322851|NCT02332720|4339291|P7|Part A and Part B|Adverse Event|0
1322852|NCT02332720|4339292|P6|Part A and Part B|Adverse Event|0
1322853|NCT02332720|4339293|P5|Part A and Part B|Adverse Event|0
1322854|NCT02332720|4339294|P4|Part A and Part B|Adverse Event|0
1322855|NCT02332720|4339295|P3|Part A and Part B|Adverse Event|0
1322856|NCT02332720|4339296|P2|Part A and Part B|Adverse Event|0
1322857|NCT02332720|4339297|P1|Part A and Part B|Adverse Event|0
1322858|NCT02332720|4339275|P23|Part A and Part B|Lost to Follow-up|0
1322859|NCT02332720|4339276|P22|Part A and Part B|Lost to Follow-up|0
1322860|NCT02332720|4339277|P21|Part A and Part B|Lost to Follow-up|0
1322861|NCT02332720|4339278|P20|Part A and Part B|Lost to Follow-up|0
1322862|NCT02332720|4339279|P19|Part A and Part B|Lost to Follow-up|0
1322863|NCT02332720|4339280|P18|Part A and Part B|Lost to Follow-up|0
1322864|NCT02332720|4339281|P17|Part A and Part B|Lost to Follow-up|0
1322865|NCT02332720|4339282|P16|Part A and Part B|Lost to Follow-up|1
1322866|NCT02332720|4339283|P15|Part A and Part B|Lost to Follow-up|0
1322867|NCT02332720|4339284|P14|Part A and Part B|Lost to Follow-up|0
1322868|NCT02332720|4339285|P13|Part A and Part B|Lost to Follow-up|0
1322869|NCT02332720|4339286|P12|Part A and Part B|Lost to Follow-up|0
1322870|NCT02332720|4339287|P11|Part A and Part B|Lost to Follow-up|0
1322871|NCT02332720|4339288|P10|Part A and Part B|Lost to Follow-up|0
1322872|NCT02332720|4339289|P9|Part A and Part B|Lost to Follow-up|0
1322873|NCT02332720|4339290|P8|Part A and Part B|Lost to Follow-up|1
1322874|NCT02332720|4339291|P7|Part A and Part B|Lost to Follow-up|1
1322875|NCT02332720|4339292|P6|Part A and Part B|Lost to Follow-up|2
1322876|NCT02332720|4339293|P5|Part A and Part B|Lost to Follow-up|0
1322877|NCT02332720|4339294|P4|Part A and Part B|Lost to Follow-up|0
1322878|NCT02332720|4339295|P3|Part A and Part B|Lost to Follow-up|0
1322879|NCT02332720|4339296|P2|Part A and Part B|Lost to Follow-up|0
1322880|NCT02332720|4339297|P1|Part A and Part B|Lost to Follow-up|1
1322881|NCT02332707|4339433|P18|Overall Study|Withdrawal by Subject|0
1322882|NCT02332707|4339434|P17|Overall Study|Withdrawal by Subject|0
1322883|NCT02332707|4339435|P16|Overall Study|Withdrawal by Subject|0
1322884|NCT02332707|4339436|P15|Overall Study|Withdrawal by Subject|0
1322885|NCT02332707|4339437|P14|Overall Study|Withdrawal by Subject|0
1322886|NCT02332707|4339438|P13|Overall Study|Withdrawal by Subject|0
1322887|NCT02332707|4339439|P12|Overall Study|Withdrawal by Subject|0
1322888|NCT02332707|4339440|P11|Overall Study|Withdrawal by Subject|0
1322889|NCT02332707|4339441|P10|Overall Study|Withdrawal by Subject|3
1322890|NCT02332707|4339442|P9|Overall Study|Withdrawal by Subject|0
1322891|NCT02332707|4339443|P8|Overall Study|Withdrawal by Subject|0
1322892|NCT02332707|4339444|P7|Overall Study|Withdrawal by Subject|0
1322893|NCT02332707|4339445|P6|Overall Study|Withdrawal by Subject|0
1322894|NCT02332707|4339446|P5|Overall Study|Withdrawal by Subject|0
1322895|NCT02332707|4339447|P4|Overall Study|Withdrawal by Subject|0
1322896|NCT02332707|4339448|P3|Overall Study|Withdrawal by Subject|1
1322897|NCT02332707|4339449|P2|Overall Study|Withdrawal by Subject|0
1322898|NCT02332707|4339450|P1|Overall Study|Withdrawal by Subject|0
1322899|NCT02332707|4339433|P18|Overall Study|Physician Decision|0
1322900|NCT02332707|4339434|P17|Overall Study|Physician Decision|0
1322901|NCT02332707|4339435|P16|Overall Study|Physician Decision|0
1322902|NCT02332707|4339436|P15|Overall Study|Physician Decision|0
1322903|NCT02332707|4339437|P14|Overall Study|Physician Decision|0
1322904|NCT02332707|4339438|P13|Overall Study|Physician Decision|1
1322905|NCT02332707|4339439|P12|Overall Study|Physician Decision|0
1322906|NCT02332707|4339440|P11|Overall Study|Physician Decision|0
1322907|NCT02332707|4339441|P10|Overall Study|Physician Decision|0
1322908|NCT02332707|4339442|P9|Overall Study|Physician Decision|0
1322909|NCT02332707|4339443|P8|Overall Study|Physician Decision|0
1322910|NCT02332707|4339444|P7|Overall Study|Physician Decision|0
1322911|NCT02332707|4339445|P6|Overall Study|Physician Decision|0
1322912|NCT02332707|4339446|P5|Overall Study|Physician Decision|0
1322913|NCT02332707|4339447|P4|Overall Study|Physician Decision|1
1322914|NCT02332707|4339448|P3|Overall Study|Physician Decision|0
1322915|NCT02332707|4339449|P2|Overall Study|Physician Decision|0
1322916|NCT02332707|4339450|P1|Overall Study|Physician Decision|0
1322917|NCT02332707|4339433|P18|Overall Study|Lost to Follow-up|0
1322918|NCT02332707|4339434|P17|Overall Study|Lost to Follow-up|0
1322919|NCT02332707|4339435|P16|Overall Study|Lost to Follow-up|0
1322920|NCT02332707|4339436|P15|Overall Study|Lost to Follow-up|0
1322921|NCT02332707|4339437|P14|Overall Study|Lost to Follow-up|0
1322922|NCT02332707|4339438|P13|Overall Study|Lost to Follow-up|3
1322923|NCT02332707|4339439|P12|Overall Study|Lost to Follow-up|0
1322924|NCT02332707|4339440|P11|Overall Study|Lost to Follow-up|2
1322925|NCT02332707|4339441|P10|Overall Study|Lost to Follow-up|0
1322926|NCT02332707|4339442|P9|Overall Study|Lost to Follow-up|0
1322927|NCT02332707|4339443|P8|Overall Study|Lost to Follow-up|0
1322928|NCT02332707|4339444|P7|Overall Study|Lost to Follow-up|0
1322929|NCT02332707|4339445|P6|Overall Study|Lost to Follow-up|1
1322930|NCT02332707|4339446|P5|Overall Study|Lost to Follow-up|0
1322931|NCT02332707|4339447|P4|Overall Study|Lost to Follow-up|0
1322932|NCT02332707|4339448|P3|Overall Study|Lost to Follow-up|0
1322933|NCT02332707|4339449|P2|Overall Study|Lost to Follow-up|0
1322934|NCT02332707|4339450|P1|Overall Study|Lost to Follow-up|0
1322935|NCT02332707|4339433|P18|Overall Study|Adverse Event|0
1322936|NCT02332707|4339434|P17|Overall Study|Adverse Event|0
1322937|NCT02332707|4339435|P16|Overall Study|Adverse Event|0
1322938|NCT02332707|4339436|P15|Overall Study|Adverse Event|0
1322939|NCT02332707|4339437|P14|Overall Study|Adverse Event|0
1322940|NCT02332707|4339438|P13|Overall Study|Adverse Event|1
1322941|NCT02332707|4339439|P12|Overall Study|Adverse Event|0
1322942|NCT02332707|4339440|P11|Overall Study|Adverse Event|0
1322943|NCT02332707|4339441|P10|Overall Study|Adverse Event|0
1322944|NCT02332707|4339442|P9|Overall Study|Adverse Event|0
1322945|NCT02332707|4339443|P8|Overall Study|Adverse Event|0
1322946|NCT02332707|4339444|P7|Overall Study|Adverse Event|0
1322947|NCT02332707|4339445|P6|Overall Study|Adverse Event|0
1322948|NCT02332707|4339446|P5|Overall Study|Adverse Event|0
1322949|NCT02332707|4339447|P4|Overall Study|Adverse Event|0
1322950|NCT02332707|4339448|P3|Overall Study|Adverse Event|0
1322951|NCT02332707|4339449|P2|Overall Study|Adverse Event|0
1322952|NCT02332707|4339450|P1|Overall Study|Adverse Event|0
1322953|NCT02332590|4339544|P2|Overall Study|Other than specified above|5
1322954|NCT02332590|4339545|P1|Overall Study|Other than specified above|6
1322955|NCT02332590|4339544|P2|Overall Study|Randomized but not treated|0
1322956|NCT02332590|4339545|P1|Overall Study|Randomized but not treated|1
1322957|NCT02332590|4339544|P2|Overall Study|Poor compliance to protocol|1
1322958|NCT02332590|4339545|P1|Overall Study|Poor compliance to protocol|3
1322959|NCT02332590|4339544|P2|Overall Study|Lack of Efficacy|2
1322960|NCT02332590|4339545|P1|Overall Study|Lack of Efficacy|4
1322961|NCT02332590|4339544|P2|Overall Study|Adverse Event|11
1322962|NCT02332590|4339545|P1|Overall Study|Adverse Event|15
1322963|NCT02332239|4339609|P2|Overall Study|Lost to Follow-up|6
1322964|NCT02332239|4339610|P1|Overall Study|Lost to Follow-up|4
1322965|NCT02331446|4339657|P4|Overall Study|Lost before baseline analysis|0
1322966|NCT02331446|4339658|P3|Overall Study|Lost before baseline analysis|1
1322967|NCT02331446|4339659|P2|Overall Study|Lost before baseline analysis|1
1322968|NCT02331446|4339660|P1|Overall Study|Lost before baseline analysis|0
1322969|NCT02331446|4339657|P4|Overall Study|Physician Decision|1
1322970|NCT02331446|4339658|P3|Overall Study|Physician Decision|0
1322971|NCT02331446|4339659|P2|Overall Study|Physician Decision|1
1322972|NCT02331446|4339660|P1|Overall Study|Physician Decision|0
1322973|NCT02331446|4339657|P4|Overall Study|Disease|1
1322974|NCT02331446|4339658|P3|Overall Study|Disease|2
1322975|NCT02331446|4339659|P2|Overall Study|Disease|2
1322976|NCT02331446|4339660|P1|Overall Study|Disease|0
1322977|NCT02331446|4339657|P4|Overall Study|Personal Problem|0
1322978|NCT02331446|4339658|P3|Overall Study|Personal Problem|0
1322979|NCT02331446|4339659|P2|Overall Study|Personal Problem|0
1322980|NCT02331446|4339660|P1|Overall Study|Personal Problem|2
1322981|NCT02331446|4339657|P4|Overall Study|Lost to Follow-up|1
1322982|NCT02331446|4339658|P3|Overall Study|Lost to Follow-up|0
1322983|NCT02331446|4339659|P2|Overall Study|Lost to Follow-up|1
1322984|NCT02331446|4339660|P1|Overall Study|Lost to Follow-up|2
1322985|NCT02331368|4339730|P1|Overall Study|Withdrawal by Subject|3
1322986|NCT02330055|4339854|P2|Overall Study|participant did not sleep|1
1322987|NCT02330055|4339855|P1|Overall Study|participant did not sleep|0
1322988|NCT02330055|4339854|P2|Overall Study|data for less than 60 minutes|3
1322989|NCT02330055|4339855|P1|Overall Study|data for less than 60 minutes|3
1322990|NCT02330055|4339854|P2|Overall Study|participant forgot to wear device|5
1322991|NCT02330055|4339855|P1|Overall Study|participant forgot to wear device|5
1322992|NCT02330055|4339854|P2|Overall Study|technical issues|0
1322993|NCT02330055|4339855|P1|Overall Study|technical issues|2
1322994|NCT02329730|4339902|P12|Overall Study|Withdrawal by Subject|0
1322995|NCT02329730|4339903|P11|Overall Study|Withdrawal by Subject|0
1322996|NCT02329730|4339904|P10|Overall Study|Withdrawal by Subject|1
1322997|NCT02329730|4339905|P9|Overall Study|Withdrawal by Subject|1
1322998|NCT02329730|4339906|P8|Overall Study|Withdrawal by Subject|1
1322999|NCT02329730|4339907|P7|Overall Study|Withdrawal by Subject|1
1323000|NCT02329730|4339908|P6|Overall Study|Withdrawal by Subject|0
1323001|NCT02329730|4339909|P5|Overall Study|Withdrawal by Subject|1
1323002|NCT02329730|4339910|P4|Overall Study|Withdrawal by Subject|0
1323003|NCT02329730|4339911|P3|Overall Study|Withdrawal by Subject|0
1323004|NCT02329730|4339912|P2|Overall Study|Withdrawal by Subject|0
1323005|NCT02329730|4339913|P1|Overall Study|Withdrawal by Subject|0
1323006|NCT02329730|4339902|P12|Overall Study|Protocol Violation|0
1323007|NCT02329730|4339903|P11|Overall Study|Protocol Violation|0
1323008|NCT02329730|4339904|P10|Overall Study|Protocol Violation|0
1323009|NCT02329730|4339905|P9|Overall Study|Protocol Violation|0
1323010|NCT02329730|4339906|P8|Overall Study|Protocol Violation|0
1323011|NCT02329730|4339907|P7|Overall Study|Protocol Violation|0
1323012|NCT02329730|4339908|P6|Overall Study|Protocol Violation|2
1323013|NCT02329730|4339909|P5|Overall Study|Protocol Violation|2
1323014|NCT02329730|4339910|P4|Overall Study|Protocol Violation|0
1323015|NCT02329730|4339911|P3|Overall Study|Protocol Violation|0
1323016|NCT02329730|4339912|P2|Overall Study|Protocol Violation|0
1323017|NCT02329730|4339913|P1|Overall Study|Protocol Violation|0
1323018|NCT02329431|4340024|P2|Overall Study|Lost to Follow-up|13
1323019|NCT02329431|4340025|P1|Overall Study|Lost to Follow-up|20
1323020|NCT02329223|4340044|P3|Overall Study|Adverse Event|0
1323021|NCT02329223|4340045|P2|Overall Study|Adverse Event|1
1323022|NCT02329223|4340046|P1|Overall Study|Adverse Event|0
1323023|NCT02329223|4340044|P3|Overall Study|Physician Decision|1
1323024|NCT02329223|4340045|P2|Overall Study|Physician Decision|0
1323025|NCT02329223|4340046|P1|Overall Study|Physician Decision|0
1323026|NCT02329223|4340044|P3|Overall Study|Withdrawal by Subject|5
1323027|NCT02329223|4340045|P2|Overall Study|Withdrawal by Subject|2
1323028|NCT02329223|4340046|P1|Overall Study|Withdrawal by Subject|1
1323029|NCT02328937|4340096|P6|Period 2|Adverse Event|0
1323030|NCT02328937|4340097|P5|Period 2|Adverse Event|0
1323031|NCT02328937|4340098|P4|Period 2|Adverse Event|0
1323032|NCT02328937|4340099|P3|Period 2|Adverse Event|1
1323033|NCT02328937|4340100|P2|Period 2|Adverse Event|0
1323034|NCT02328937|4340101|P1|Period 2|Adverse Event|0
1323035|NCT02328937|4340096|P6|Period 1|Lost to Follow-up|0
1323036|NCT02328937|4340097|P5|Period 1|Lost to Follow-up|0
1323037|NCT02328937|4340098|P4|Period 1|Lost to Follow-up|1
1323038|NCT02328937|4340099|P3|Period 1|Lost to Follow-up|0
1323039|NCT02328937|4340100|P2|Period 1|Lost to Follow-up|0
1323040|NCT02328937|4340101|P1|Period 1|Lost to Follow-up|0
1323041|NCT02328105|4340149|P1|Overall Study|Still On Study in Follow-Up|4
1323042|NCT02328105|4340149|P1|Overall Study|Withdrawal by Subject|1
1323043|NCT02328105|4340149|P1|Overall Study|Death|6
1323044|NCT02328040|4340154|P2|First Intervention (2 Days)|Withdrawal by Subject|1
1323045|NCT02328040|4340155|P1|First Intervention (2 Days)|Withdrawal by Subject|1
1323046|NCT02327013|4340204|P5|Overall Study|Withdrawal before treatment|0
1323047|NCT02327013|4340205|P4|Overall Study|Withdrawal before treatment|0
1323048|NCT02327013|4340206|P3|Overall Study|Withdrawal before treatment|5
1323049|NCT02327013|4340207|P2|Overall Study|Withdrawal before treatment|1
1323050|NCT02327013|4340208|P1|Overall Study|Withdrawal before treatment|2
1323051|NCT02327013|4340204|P5|Overall Study|Protocol Violation|1
1323052|NCT02327013|4340205|P4|Overall Study|Protocol Violation|0
1323053|NCT02327013|4340206|P3|Overall Study|Protocol Violation|3
1323054|NCT02327013|4340207|P2|Overall Study|Protocol Violation|0
1323055|NCT02327013|4340208|P1|Overall Study|Protocol Violation|0
1323056|NCT02327013|4340204|P5|Overall Study|Administrative or other reason(s)|1
1323057|NCT02327013|4340205|P4|Overall Study|Administrative or other reason(s)|1
1323058|NCT02327013|4340206|P3|Overall Study|Administrative or other reason(s)|11
1323059|NCT02327013|4340207|P2|Overall Study|Administrative or other reason(s)|5
1323060|NCT02327013|4340208|P1|Overall Study|Administrative or other reason(s)|1
1323061|NCT02327013|4340204|P5|Overall Study|Lost to Follow-up|0
1323062|NCT02327013|4340205|P4|Overall Study|Lost to Follow-up|0
1323063|NCT02327013|4340206|P3|Overall Study|Lost to Follow-up|5
1323064|NCT02327013|4340207|P2|Overall Study|Lost to Follow-up|4
1323065|NCT02327013|4340208|P1|Overall Study|Lost to Follow-up|2
1323066|NCT02327013|4340204|P5|Overall Study|Withdrawal of Consent|0
1323067|NCT02327013|4340205|P4|Overall Study|Withdrawal of Consent|0
1323068|NCT02327013|4340206|P3|Overall Study|Withdrawal of Consent|3
1323069|NCT02327013|4340207|P2|Overall Study|Withdrawal of Consent|0
1323070|NCT02327013|4340208|P1|Overall Study|Withdrawal of Consent|1
1323071|NCT02327013|4340204|P5|Overall Study|Non-compliance with IMP|0
1323072|NCT02327013|4340205|P4|Overall Study|Non-compliance with IMP|0
1323073|NCT02327013|4340206|P3|Overall Study|Non-compliance with IMP|7
1323074|NCT02327013|4340207|P2|Overall Study|Non-compliance with IMP|2
1323075|NCT02327013|4340208|P1|Overall Study|Non-compliance with IMP|1
1323076|NCT02327013|4340204|P5|Overall Study|Lack of Efficacy|1
1323077|NCT02327013|4340205|P4|Overall Study|Lack of Efficacy|0
1323078|NCT02327013|4340206|P3|Overall Study|Lack of Efficacy|5
1323079|NCT02327013|4340207|P2|Overall Study|Lack of Efficacy|0
1323080|NCT02327013|4340208|P1|Overall Study|Lack of Efficacy|2
1323081|NCT02327013|4340204|P5|Overall Study|Adverse Event|1
1323082|NCT02327013|4340205|P4|Overall Study|Adverse Event|0
1323083|NCT02327013|4340206|P3|Overall Study|Adverse Event|3
1323084|NCT02327013|4340207|P2|Overall Study|Adverse Event|4
1323085|NCT02327013|4340208|P1|Overall Study|Adverse Event|4
1323086|NCT02326298|4340395|P10|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1323087|NCT02326298|4340396|P9|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1323088|NCT02326298|4340397|P8|Maintenance Period (Week 16 - Week 48)|Adverse Event|1
1323089|NCT02326298|4340398|P7|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1323090|NCT02326298|4340399|P6|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1323091|NCT02326298|4340400|P5|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1323092|NCT02326298|4340401|P4|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1323093|NCT02326298|4340402|P3|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1323094|NCT02326298|4340403|P2|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1323095|NCT02326298|4340404|P1|Maintenance Period (Week 16 - Week 48)|Adverse Event|0
1323096|NCT02326298|4340395|P10|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1323097|NCT02326298|4340396|P9|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1323098|NCT02326298|4340397|P8|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|2
1323099|NCT02326298|4340398|P7|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|1
1323100|NCT02326298|4340399|P6|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1323101|NCT02326298|4340400|P5|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1323102|NCT02326298|4340401|P4|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1323103|NCT02326298|4340402|P3|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1323104|NCT02326298|4340403|P2|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1323105|NCT02326298|4340404|P1|Maintenance Period (Week 16 - Week 48)|Lost to Follow-up|0
1323106|NCT02326298|4340395|P10|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1323107|NCT02326298|4340396|P9|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1323108|NCT02326298|4340397|P8|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|1
1323109|NCT02326298|4340398|P7|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1323110|NCT02326298|4340399|P6|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1323111|NCT02326298|4340400|P5|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1323112|NCT02326298|4340401|P4|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1323476|NCT02320721|4341031|P1|Overall Study|Poor compliance to protocol|3
1323113|NCT02326298|4340402|P3|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1323114|NCT02326298|4340403|P2|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1323115|NCT02326298|4340404|P1|Maintenance Period (Week 16 - Week 48)|No valid reason stated by patient|0
1323116|NCT02326298|4340395|P10|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1323117|NCT02326298|4340396|P9|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1323118|NCT02326298|4340397|P8|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1323119|NCT02326298|4340398|P7|Maintenance Period (Week 16 - Week 48)|Pregnancy|1
1323120|NCT02326298|4340399|P6|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1323121|NCT02326298|4340400|P5|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1323122|NCT02326298|4340401|P4|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1323123|NCT02326298|4340402|P3|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1323124|NCT02326298|4340403|P2|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1323125|NCT02326298|4340404|P1|Maintenance Period (Week 16 - Week 48)|Pregnancy|0
1323126|NCT02326298|4340395|P10|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1323127|NCT02326298|4340396|P9|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1323128|NCT02326298|4340397|P8|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1323129|NCT02326298|4340398|P7|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1323130|NCT02326298|4340399|P6|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1323131|NCT02326298|4340400|P5|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|1
1323132|NCT02326298|4340401|P4|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1323133|NCT02326298|4340402|P3|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1323134|NCT02326298|4340403|P2|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1323135|NCT02326298|4340404|P1|Maintenance Period (Week 16 - Week 48)|Patient cannot attend visits|0
1323136|NCT02326298|4340395|P10|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
1323137|NCT02326298|4340396|P9|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|4
1323138|NCT02326298|4340397|P8|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
1323139|NCT02326298|4340398|P7|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|2
1323140|NCT02326298|4340399|P6|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
1323141|NCT02326298|4340400|P5|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|1
1323142|NCT02326298|4340401|P4|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
1323143|NCT02326298|4340402|P3|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
1323144|NCT02326298|4340403|P2|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
1323145|NCT02326298|4340404|P1|Maintenance Period (Week 16 - Week 48)|Patient did not achieve PASI50 response|0
1323146|NCT02326298|4340395|P10|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|1
1323147|NCT02326298|4340396|P9|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|1
1323148|NCT02326298|4340397|P8|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|1
1323149|NCT02326298|4340398|P7|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|3
1323150|NCT02326298|4340399|P6|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|0
1323151|NCT02326298|4340400|P5|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|1
1323152|NCT02326298|4340401|P4|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|0
1323153|NCT02326298|4340402|P3|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|0
1323154|NCT02326298|4340403|P2|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|0
1323155|NCT02326298|4340404|P1|Maintenance Period (Week 16 - Week 48)|Withdrawal by Subject|0
1323156|NCT02326298|4340395|P10|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1323157|NCT02326298|4340396|P9|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1323158|NCT02326298|4340397|P8|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1323159|NCT02326298|4340398|P7|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1323160|NCT02326298|4340399|P6|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1323161|NCT02326298|4340400|P5|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1323162|NCT02326298|4340401|P4|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1323163|NCT02326298|4340402|P3|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|0
1323164|NCT02326298|4340403|P2|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|2
1323165|NCT02326298|4340404|P1|Initial Period (Week 0/Baseline - Wk 16)|Withdrawal by Subject|3
1323166|NCT02326298|4340395|P10|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1323167|NCT02326298|4340396|P9|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1323168|NCT02326298|4340397|P8|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1323169|NCT02326298|4340398|P7|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1323170|NCT02326298|4340399|P6|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1323171|NCT02326298|4340400|P5|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1323172|NCT02326298|4340401|P4|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1323173|NCT02326298|4340402|P3|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|0
1323174|NCT02326298|4340403|P2|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|1
1323175|NCT02326298|4340404|P1|Initial Period (Week 0/Baseline - Wk 16)|Lost to Follow-up|1
1323176|NCT02326298|4340395|P10|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1323177|NCT02326298|4340396|P9|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1323178|NCT02326298|4340397|P8|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1323179|NCT02326298|4340398|P7|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1323180|NCT02326298|4340399|P6|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1323181|NCT02326298|4340400|P5|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1323182|NCT02326298|4340401|P4|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1323183|NCT02326298|4340402|P3|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1323184|NCT02326298|4340403|P2|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|0
1323185|NCT02326298|4340404|P1|Initial Period (Week 0/Baseline - Wk 16)|Lack of Efficacy|1
1323186|NCT02326298|4340395|P10|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1323187|NCT02326298|4340396|P9|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1323188|NCT02326298|4340397|P8|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1323189|NCT02326298|4340398|P7|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1323190|NCT02326298|4340399|P6|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1323191|NCT02326298|4340400|P5|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1323192|NCT02326298|4340401|P4|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1323193|NCT02326298|4340402|P3|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|3
1323194|NCT02326298|4340403|P2|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1323195|NCT02326298|4340404|P1|Initial Period (Week 0/Baseline - Wk 16)|Adverse Event|0
1323196|NCT02326272|4340427|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1323197|NCT02326272|4340428|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
1323198|NCT02326272|4340429|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
1323199|NCT02326272|4340430|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
1323200|NCT02326272|4340431|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
1323201|NCT02326272|4340432|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1323202|NCT02326272|4340433|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1323203|NCT02326272|4340434|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1323204|NCT02326272|4340435|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1323205|NCT02326272|4340436|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1323206|NCT02326272|4340427|P10|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1323207|NCT02326272|4340428|P9|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
1323208|NCT02326272|4340429|P8|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1323209|NCT02326272|4340430|P7|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1323210|NCT02326272|4340431|P6|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1323211|NCT02326272|4340432|P5|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1323212|NCT02326272|4340433|P4|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1323213|NCT02326272|4340434|P3|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1323214|NCT02326272|4340435|P2|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1323215|NCT02326272|4340436|P1|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1323216|NCT02326272|4340427|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1323217|NCT02326272|4340428|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1323218|NCT02326272|4340429|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1323219|NCT02326272|4340430|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
1323220|NCT02326272|4340431|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1323221|NCT02326272|4340432|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1323222|NCT02326272|4340433|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1323223|NCT02326272|4340434|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1323224|NCT02326272|4340435|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1323225|NCT02326272|4340436|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1323226|NCT02326272|4340427|P10|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1323227|NCT02326272|4340428|P9|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1323228|NCT02326272|4340429|P8|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
1323229|NCT02326272|4340430|P7|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1323230|NCT02326272|4340431|P6|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1323231|NCT02326272|4340432|P5|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1323232|NCT02326272|4340433|P4|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1323233|NCT02326272|4340434|P3|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1323234|NCT02326272|4340435|P2|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1323235|NCT02326272|4340436|P1|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1323236|NCT02326272|4340427|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1323237|NCT02326272|4340428|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1323238|NCT02326272|4340429|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1323239|NCT02326272|4340430|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1323240|NCT02326272|4340431|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
1323241|NCT02326272|4340432|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1323242|NCT02326272|4340433|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1323243|NCT02326272|4340434|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1323244|NCT02326272|4340435|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1323245|NCT02326272|4340436|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1323246|NCT02326272|4340427|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1323247|NCT02326272|4340428|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1323248|NCT02326272|4340429|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
1323249|NCT02326272|4340430|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1323250|NCT02326272|4340431|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
1323251|NCT02326272|4340432|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1323252|NCT02326272|4340433|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1323253|NCT02326272|4340434|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1323254|NCT02326272|4340435|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1323255|NCT02326272|4340436|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1323256|NCT02326272|4340427|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
1323257|NCT02326272|4340428|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
1323258|NCT02326272|4340429|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1323259|NCT02326272|4340430|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
1323260|NCT02326272|4340431|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
1323261|NCT02326272|4340432|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1323262|NCT02326272|4340433|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1323263|NCT02326272|4340434|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1323264|NCT02326272|4340435|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1323265|NCT02326272|4340436|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1323266|NCT02326272|4340427|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1323267|NCT02326272|4340428|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
1323268|NCT02326272|4340429|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
1323269|NCT02326272|4340430|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
1323270|NCT02326272|4340431|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
1323271|NCT02326272|4340432|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
1323272|NCT02326272|4340433|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1323273|NCT02326272|4340434|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1323274|NCT02326272|4340435|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1323275|NCT02326272|4340436|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1323276|NCT02326272|4340427|P10|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1323277|NCT02326272|4340428|P9|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1323278|NCT02326272|4340429|P8|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1323279|NCT02326272|4340430|P7|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1323280|NCT02326272|4340431|P6|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1323281|NCT02326272|4340432|P5|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1323282|NCT02326272|4340433|P4|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1323283|NCT02326272|4340434|P3|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
1323284|NCT02326272|4340435|P2|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1323285|NCT02326272|4340436|P1|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1323286|NCT02326272|4340427|P10|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1323287|NCT02326272|4340428|P9|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1323288|NCT02326272|4340429|P8|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1323289|NCT02326272|4340430|P7|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1323290|NCT02326272|4340431|P6|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1323291|NCT02326272|4340432|P5|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1323292|NCT02326272|4340433|P4|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1323293|NCT02326272|4340434|P3|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
1323294|NCT02326272|4340435|P2|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1323295|NCT02326272|4340436|P1|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1323296|NCT02326272|4340427|P10|Initial Period (Week 0 to Week 16)|Missed two doses|0
1323297|NCT02326272|4340428|P9|Initial Period (Week 0 to Week 16)|Missed two doses|0
1323298|NCT02326272|4340429|P8|Initial Period (Week 0 to Week 16)|Missed two doses|0
1323299|NCT02326272|4340430|P7|Initial Period (Week 0 to Week 16)|Missed two doses|0
1323300|NCT02326272|4340431|P6|Initial Period (Week 0 to Week 16)|Missed two doses|0
1323301|NCT02326272|4340432|P5|Initial Period (Week 0 to Week 16)|Missed two doses|0
1323302|NCT02326272|4340433|P4|Initial Period (Week 0 to Week 16)|Missed two doses|0
1323303|NCT02326272|4340434|P3|Initial Period (Week 0 to Week 16)|Missed two doses|1
1323304|NCT02326272|4340435|P2|Initial Period (Week 0 to Week 16)|Missed two doses|0
1323305|NCT02326272|4340436|P1|Initial Period (Week 0 to Week 16)|Missed two doses|0
1323306|NCT02326272|4340427|P10|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1323307|NCT02326272|4340428|P9|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1323308|NCT02326272|4340429|P8|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1323309|NCT02326272|4340430|P7|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1323310|NCT02326272|4340431|P6|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1323311|NCT02326272|4340432|P5|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1323312|NCT02326272|4340433|P4|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1323313|NCT02326272|4340434|P3|Initial Period (Week 0 to Week 16)|Moved from the study area|1
1323314|NCT02326272|4340435|P2|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1323315|NCT02326272|4340436|P1|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1323316|NCT02326272|4340427|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1323317|NCT02326272|4340428|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1323318|NCT02326272|4340429|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1323319|NCT02326272|4340430|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1323320|NCT02326272|4340431|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1323321|NCT02326272|4340432|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1323322|NCT02326272|4340433|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1323323|NCT02326272|4340434|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
1323324|NCT02326272|4340435|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
1323325|NCT02326272|4340436|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
1323326|NCT02326272|4340427|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1323327|NCT02326272|4340428|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1323328|NCT02326272|4340429|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1323329|NCT02326272|4340430|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1323330|NCT02326272|4340431|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1323331|NCT02326272|4340432|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1323332|NCT02326272|4340433|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1323333|NCT02326272|4340434|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1323334|NCT02326272|4340435|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
1323335|NCT02326272|4340436|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
1323336|NCT02326272|4340427|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
1323337|NCT02326272|4340428|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
1323338|NCT02326272|4340429|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
1323339|NCT02326272|4340430|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
1323340|NCT02326272|4340431|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
1323341|NCT02326272|4340432|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
1323342|NCT02326272|4340433|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
1323343|NCT02326272|4340434|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
1323344|NCT02326272|4340435|P2|Initial Period (Week 0 to Week 16)|Adverse Event|3
1323345|NCT02326272|4340436|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
1323346|NCT02325713|4340483|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1323347|NCT02325713|4340484|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1323348|NCT02325713|4340485|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1323349|NCT02325713|4340486|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1323350|NCT02325713|4340487|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1323351|NCT02325713|4340488|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1323352|NCT02325713|4340489|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
1323353|NCT02325713|4340490|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1323354|NCT02325713|4340491|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1323355|NCT02325713|4340492|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1323356|NCT02325713|4340493|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1323357|NCT02325713|4340494|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1323358|NCT02325713|4340495|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1323359|NCT02325713|4340496|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1323360|NCT02325713|4340497|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1323361|NCT02325713|4340498|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1323362|NCT02325713|4340483|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1323363|NCT02325713|4340484|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1323364|NCT02325713|4340485|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1323365|NCT02325713|4340486|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1323366|NCT02325713|4340487|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1323367|NCT02325713|4340488|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1323368|NCT02325713|4340489|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1323369|NCT02325713|4340490|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1323370|NCT02325713|4340491|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1323371|NCT02325713|4340492|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1323372|NCT02325713|4340493|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1323373|NCT02325713|4340494|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1323374|NCT02325713|4340495|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1323375|NCT02325713|4340496|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1323376|NCT02325713|4340497|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1323377|NCT02325713|4340498|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
1323378|NCT02325713|4340483|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1323379|NCT02325713|4340484|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1323380|NCT02325713|4340485|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1323381|NCT02325713|4340486|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1323382|NCT02325713|4340487|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1323383|NCT02325713|4340488|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
1323384|NCT02325713|4340489|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1323385|NCT02325713|4340490|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1323386|NCT02325713|4340491|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1323387|NCT02325713|4340492|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1323388|NCT02325713|4340493|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1323389|NCT02325713|4340494|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1323390|NCT02325713|4340495|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1323391|NCT02325713|4340496|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1323392|NCT02325713|4340497|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1323393|NCT02325713|4340498|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1323394|NCT02325518|4340593|P2|Overall Study|Withdrawal by Subject|1
1323395|NCT02325518|4340594|P1|Overall Study|Withdrawal by Subject|0
1323396|NCT02325518|4340593|P2|Overall Study|Physician Decision|1
1323397|NCT02325518|4340594|P1|Overall Study|Physician Decision|0
1323398|NCT02325518|4340593|P2|Overall Study|Adverse Event|1
1323399|NCT02325518|4340594|P1|Overall Study|Adverse Event|4
1323400|NCT02324049|4340721|P1|Part C|Study terminated|11
1323401|NCT02322892|4340754|P2|Overall Study|Protocol Violation|0
1323402|NCT02322892|4340755|P1|Overall Study|Protocol Violation|1
1323403|NCT02322892|4340754|P2|Overall Study|Met exclusion criteria|1
1323404|NCT02322892|4340755|P1|Overall Study|Met exclusion criteria|0
1323405|NCT02322892|4340754|P2|Overall Study|Surgery cancelled|2
1323406|NCT02322892|4340755|P1|Overall Study|Surgery cancelled|1
1323407|NCT02322879|4340771|P2|First Intervention|Physician Decision|0
1323408|NCT02322879|4340772|P1|First Intervention|Physician Decision|1
1323409|NCT02322866|4340780|P2|Overall Study|Other Miscellaneous Reasons|6
1323410|NCT02322866|4340781|P1|Overall Study|Other Miscellaneous Reasons|6
1323411|NCT02322866|4340780|P2|Overall Study|Lack of Efficacy|1
1323412|NCT02322866|4340781|P1|Overall Study|Lack of Efficacy|3
1323413|NCT02322866|4340780|P2|Overall Study|Noncompliance with Treatment|4
1323414|NCT02322866|4340781|P1|Overall Study|Noncompliance with Treatment|3
1323415|NCT02322866|4340780|P2|Overall Study|Protocol Violation|0
1323416|NCT02322866|4340781|P1|Overall Study|Protocol Violation|1
1323417|NCT02322866|4340780|P2|Overall Study|Lost to Follow-up|39
1323418|NCT02322866|4340781|P1|Overall Study|Lost to Follow-up|36
1323419|NCT02322866|4340780|P2|Overall Study|Withdrawal of Consent|25
1323420|NCT02322866|4340781|P1|Overall Study|Withdrawal of Consent|16
1323421|NCT02322866|4340780|P2|Overall Study|Adverse Event|11
1323422|NCT02322866|4340781|P1|Overall Study|Adverse Event|6
1323423|NCT02322775|4340818|P2|Overall Study|Not willing to perform all FU visits|1
1323424|NCT02322775|4340819|P1|Overall Study|Not willing to perform all FU visits|0
1323425|NCT02322775|4340818|P2|Overall Study|Withdrawal by Subject|4
1323426|NCT02322775|4340819|P1|Overall Study|Withdrawal by Subject|3
1323427|NCT02322775|4340818|P2|Overall Study|Protocol Violation|0
1323428|NCT02322775|4340819|P1|Overall Study|Protocol Violation|1
1323429|NCT02322775|4340818|P2|Overall Study|Lost to Follow-up|1
1323430|NCT02322775|4340819|P1|Overall Study|Lost to Follow-up|0
1323431|NCT02322775|4340818|P2|Overall Study|Adverse Event|0
1323432|NCT02322775|4340819|P1|Overall Study|Adverse Event|1
1323433|NCT02322749|4340845|P6|Period 3|Withdrawal by Subject|0
1323434|NCT02322749|4340846|P5|Period 3|Withdrawal by Subject|0
1323435|NCT02322749|4340847|P4|Period 3|Withdrawal by Subject|0
1323436|NCT02322749|4340848|P3|Period 3|Withdrawal by Subject|1
1323437|NCT02322749|4340849|P2|Period 3|Withdrawal by Subject|0
1323438|NCT02322749|4340850|P1|Period 3|Withdrawal by Subject|0
1323439|NCT02322749|4340845|P6|Period 2|Withdrawal by Subject|0
1323440|NCT02322749|4340846|P5|Period 2|Withdrawal by Subject|0
1323441|NCT02322749|4340847|P4|Period 2|Withdrawal by Subject|1
1323442|NCT02322749|4340848|P3|Period 2|Withdrawal by Subject|0
1323443|NCT02322749|4340849|P2|Period 2|Withdrawal by Subject|0
1323444|NCT02322749|4340850|P1|Period 2|Withdrawal by Subject|0
1323445|NCT02322749|4340845|P6|Period 2|Adverse Event|0
1323446|NCT02322749|4340846|P5|Period 2|Adverse Event|0
1323447|NCT02322749|4340847|P4|Period 2|Adverse Event|1
1323448|NCT02322749|4340848|P3|Period 2|Adverse Event|0
1323449|NCT02322749|4340849|P2|Period 2|Adverse Event|0
1323450|NCT02322749|4340850|P1|Period 2|Adverse Event|0
1323451|NCT02322229|4340878|P1|Overall Study|Physician Decision|2
1323452|NCT02322216|4340890|P2|Overall Study|Withdrawal by Subject|4
1323453|NCT02322216|4340891|P1|Overall Study|Withdrawal by Subject|1
1323454|NCT02322216|4340890|P2|Overall Study|Adverse Event|0
1323455|NCT02322216|4340891|P1|Overall Study|Adverse Event|1
1323456|NCT02321436|4340904|P2|Overall Study|Lost to Follow-up|1
1323457|NCT02321436|4340905|P1|Overall Study|Lost to Follow-up|0
1323458|NCT02321436|4340904|P2|Overall Study|Withdrawal by Subject|0
1323459|NCT02321436|4340905|P1|Overall Study|Withdrawal by Subject|1
1323460|NCT02320903|4340924|P3|Overall Study|Lost to Follow-up|5
1323461|NCT02320903|4340925|P2|Overall Study|Lost to Follow-up|5
1323462|NCT02320903|4340926|P1|Overall Study|Lost to Follow-up|0
1323463|NCT02320903|4340924|P3|Overall Study|Exited therapy; no longer eligible|2
1323464|NCT02320903|4340925|P2|Overall Study|Exited therapy; no longer eligible|2
1323465|NCT02320903|4340926|P1|Overall Study|Exited therapy; no longer eligible|8
1323466|NCT02320903|4340924|P3|Overall Study|Withdrawal by Subject|9
1323467|NCT02320903|4340925|P2|Overall Study|Withdrawal by Subject|9
1323468|NCT02320903|4340926|P1|Overall Study|Withdrawal by Subject|0
1323469|NCT02320721|4341030|P2|Overall Study|Other than specified above|20
1323470|NCT02320721|4341031|P1|Overall Study|Other than specified above|15
1323471|NCT02320721|4341030|P2|Overall Study|Hypoglycemia|0
1323472|NCT02320721|4341031|P1|Overall Study|Hypoglycemia|1
1323473|NCT02320721|4341030|P2|Overall Study|Randomized but not treated|1
1323474|NCT02320721|4341031|P1|Overall Study|Randomized but not treated|0
1323475|NCT02320721|4341030|P2|Overall Study|Poor compliance to protocol|7
1323477|NCT02320721|4341030|P2|Overall Study|Lack of Efficacy|0
1323478|NCT02320721|4341031|P1|Overall Study|Lack of Efficacy|2
1323479|NCT02320721|4341030|P2|Overall Study|Adverse Event|6
1323480|NCT02320721|4341031|P1|Overall Study|Adverse Event|6
1323481|NCT02320487|4341086|P1|Overall Study|Adverse Event|11
1323482|NCT02320487|4341086|P1|Overall Study|Death|3
1323483|NCT02320487|4341086|P1|Overall Study|Withdrawal by Subject|1
1323484|NCT02320487|4341086|P1|Overall Study|Physician Decision|5
1323485|NCT02320487|4341086|P1|Overall Study|Reason not Specified|1
1323486|NCT02320396|4341106|P2|Overall Study|Withdrawal by Subject|0
1323487|NCT02320396|4341107|P1|Overall Study|Withdrawal by Subject|2
1323488|NCT02320396|4341106|P2|Overall Study|Protocol Violation|1
1323489|NCT02320396|4341107|P1|Overall Study|Protocol Violation|0
1323490|NCT02320396|4341106|P2|Overall Study|Pregnancy|1
1323491|NCT02320396|4341107|P1|Overall Study|Pregnancy|0
1323492|NCT02320396|4341106|P2|Overall Study|Adverse Event|2
1323493|NCT02320396|4341107|P1|Overall Study|Adverse Event|2
1323494|NCT02320149|4341149|P2|Overall Study|Other Miscellaneous Reasons|3
1323495|NCT02320149|4341150|P1|Overall Study|Other Miscellaneous Reasons|2
1323496|NCT02320149|4341149|P2|Overall Study|Lack of Efficacy|1
1323497|NCT02320149|4341150|P1|Overall Study|Lack of Efficacy|0
1323498|NCT02320149|4341149|P2|Overall Study|Noncompliance with Study Treatment|2
1323499|NCT02320149|4341150|P1|Overall Study|Noncompliance with Study Treatment|7
1323500|NCT02320149|4341149|P2|Overall Study|Protocol Violation|1
1323501|NCT02320149|4341150|P1|Overall Study|Protocol Violation|2
1323502|NCT02320149|4341149|P2|Overall Study|Lost to Follow-up|34
1323503|NCT02320149|4341150|P1|Overall Study|Lost to Follow-up|21
1323504|NCT02320149|4341149|P2|Overall Study|Withdrawal of Consent|32
1323505|NCT02320149|4341150|P1|Overall Study|Withdrawal of Consent|28
1323506|NCT02320149|4341149|P2|Overall Study|Adverse Event|7
1323507|NCT02320149|4341150|P1|Overall Study|Adverse Event|3
1323508|NCT02319668|4341196|P2|Overall Study|Other (Not specified)|2
1323509|NCT02319668|4341197|P1|Overall Study|Other (Not specified)|0
1323510|NCT02319525|4341211|P2|Overall Study|Withdrawal by Subject|1
1323511|NCT02319525|4341212|P1|Overall Study|Withdrawal by Subject|2
1323512|NCT02319148|4341248|P4|Second Intervention Period|Other|1
1323513|NCT02319148|4341249|P3|Second Intervention Period|Other|0
1323514|NCT02319148|4341250|P2|Second Intervention Period|Other|0
1323515|NCT02319148|4341251|P1|Second Intervention Period|Other|0
1323516|NCT02319148|4341248|P4|Second Intervention Period|No longer willing to participate|0
1323517|NCT02319148|4341249|P3|Second Intervention Period|No longer willing to participate|0
1323518|NCT02319148|4341250|P2|Second Intervention Period|No longer willing to participate|1
1323519|NCT02319148|4341251|P1|Second Intervention Period|No longer willing to participate|0
1323520|NCT02319148|4341248|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
1323521|NCT02319148|4341249|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
1323522|NCT02319148|4341250|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
1323523|NCT02319148|4341251|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
1323524|NCT02319044|4341314|P3|Overall Study|Not treated|2
1323525|NCT02319044|4341315|P2|Overall Study|Not treated|2
1323526|NCT02319044|4341316|P1|Overall Study|Not treated|0
1323527|NCT02319044|4341314|P3|Overall Study|Study specific discontinuation criteria|1
1323528|NCT02319044|4341315|P2|Overall Study|Study specific discontinuation criteria|2
1323529|NCT02319044|4341316|P1|Overall Study|Study specific discontinuation criteria|2
1323530|NCT02319044|4341314|P3|Overall Study|Adverse Event|8
1323531|NCT02319044|4341315|P2|Overall Study|Adverse Event|2
1323532|NCT02319044|4341316|P1|Overall Study|Adverse Event|17
1323533|NCT02319044|4341314|P3|Overall Study|Condition under investigation worsened|46
1323534|NCT02319044|4341315|P2|Overall Study|Condition under investigation worsened|50
1323535|NCT02319044|4341316|P1|Overall Study|Condition under investigation worsened|100
1323536|NCT02319044|4341314|P3|Overall Study|Withdrawal by Subject|6
1323537|NCT02319044|4341315|P2|Overall Study|Withdrawal by Subject|3
1323538|NCT02319044|4341316|P1|Overall Study|Withdrawal by Subject|3
1323539|NCT02319044|4341314|P3|Overall Study|Death, PI/sponsor decision, med history|4
1323540|NCT02319044|4341315|P2|Overall Study|Death, PI/sponsor decision, med history|1
1323541|NCT02319044|4341316|P1|Overall Study|Death, PI/sponsor decision, med history|0
1323542|NCT02319031|4341372|P2|Treatment Period|Death|0
1323543|NCT02319031|4341373|P1|Treatment Period|Death|1
1323544|NCT02318940|4341408|P2|Overall Study|lost the record|0
1323545|NCT02318940|4341409|P1|Overall Study|lost the record|1
1323546|NCT02318797|4341423|P2|Overall Study|Lost to Follow-up|96
1323547|NCT02318797|4341424|P1|Overall Study|Lost to Follow-up|85
1323548|NCT02318797|4341423|P2|Overall Study|Death|6
1323549|NCT02318797|4341424|P1|Overall Study|Death|3
1323550|NCT02318693|4341464|P2|Overall Study|Protocol Violation|1
1323551|NCT02318693|4341465|P1|Overall Study|Protocol Violation|0
1323552|NCT02318667|4341479|P1|Overall Study|Protocol Violation|2
1323553|NCT02318667|4341479|P1|Overall Study|Lack of Efficacy|6
1323554|NCT02318667|4341479|P1|Overall Study|Adverse Event|1
1323555|NCT02318602|4341496|P3|Overall Study|Guardian decision to withdraw|1
1323556|NCT02318602|4341497|P2|Overall Study|Guardian decision to withdraw|0
1323557|NCT02318602|4341498|P1|Overall Study|Guardian decision to withdraw|0
1323558|NCT02318602|4341496|P3|Overall Study|Death|0
1323559|NCT02318602|4341497|P2|Overall Study|Death|0
1323560|NCT02318602|4341498|P1|Overall Study|Death|1
1323561|NCT02318602|4341496|P3|Overall Study|Withdrawal by Subject|0
1323562|NCT02318602|4341497|P2|Overall Study|Withdrawal by Subject|3
1323563|NCT02318602|4341498|P1|Overall Study|Withdrawal by Subject|0
1323564|NCT02318602|4341496|P3|Overall Study|Adverse Event|1
1323565|NCT02318602|4341497|P2|Overall Study|Adverse Event|1
1323566|NCT02318602|4341498|P1|Overall Study|Adverse Event|0
1323567|NCT02317809|4341558|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
1323568|NCT02317809|4341559|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
1323569|NCT02317809|4341558|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
1323570|NCT02317809|4341559|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
1323571|NCT02317510|4341656|P2|Overall Study|Adverse Event|1
1323572|NCT02317510|4341657|P1|Overall Study|Adverse Event|0
1323573|NCT02317016|4341685|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
1323574|NCT02317016|4341685|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
1323575|NCT02317016|4341685|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
1323576|NCT02317016|4341685|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
1323577|NCT02317016|4341685|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
1323578|NCT02317016|4341685|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
1323579|NCT02317016|4341685|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
1323580|NCT02316847|4341713|P2|Overall Study|Withdrawn due to termination by Sponsor|67
1323581|NCT02316847|4341714|P1|Overall Study|Withdrawn due to termination by Sponsor|7
1323582|NCT02316847|4341713|P2|Overall Study|Noncompliance with study drug|3
1323583|NCT02316847|4341714|P1|Overall Study|Noncompliance with study drug|0
1323584|NCT02316847|4341713|P2|Overall Study|Withdrawal by Subject|9
1323585|NCT02316847|4341714|P1|Overall Study|Withdrawal by Subject|2
1323586|NCT02316847|4341713|P2|Overall Study|Pregnancy|1
1323587|NCT02316847|4341714|P1|Overall Study|Pregnancy|0
1323588|NCT02316847|4341713|P2|Overall Study|Physician Decision|1
1323589|NCT02316847|4341714|P1|Overall Study|Physician Decision|0
1323590|NCT02316847|4341713|P2|Overall Study|Lost to Follow-up|2
1323591|NCT02316847|4341714|P1|Overall Study|Lost to Follow-up|0
1323592|NCT02316847|4341713|P2|Overall Study|Adverse Event|3
1323593|NCT02316847|4341714|P1|Overall Study|Adverse Event|0
1323594|NCT02316769|4341725|P2|Overall Study|Withdrawal by Subject|0
1323595|NCT02316769|4341726|P1|Overall Study|Withdrawal by Subject|1
1323596|NCT02316769|4341725|P2|Overall Study|Physician Decision|0
1323597|NCT02316769|4341726|P1|Overall Study|Physician Decision|1
1323598|NCT02316613|4341743|P1|Overall Study|Did not met selection criteria|14
1323599|NCT02316613|4341743|P1|Overall Study|No data and duplicate cases|5
1323600|NCT02316613|4341743|P1|Overall Study|Participant moved/changed medical team|11
1323601|NCT02316613|4341743|P1|Overall Study|Lymphoma transformation|2
1323602|NCT02316613|4341743|P1|Overall Study|Lost to Follow-up|9
1323603|NCT02316613|4341743|P1|Overall Study|Death|63
1323604|NCT02316548|4341782|P2|Overall Study|Protocol Violation|1
1323605|NCT02316548|4341783|P1|Overall Study|Protocol Violation|0
1323606|NCT02315560|4341915|P1|Overall Study|noncompliance by subjects|3
1323607|NCT02314637|4341962|P2|Overall Study|Other Reason|0
1323608|NCT02314637|4341963|P1|Overall Study|Other Reason|1
1323609|NCT02314637|4341962|P2|Overall Study|Withdrawal by Subject|4
1323610|NCT02314637|4341963|P1|Overall Study|Withdrawal by Subject|5
1323611|NCT02314637|4341962|P2|Overall Study|Physician Decision|2
1323612|NCT02314637|4341963|P1|Overall Study|Physician Decision|5
1323613|NCT02314637|4341962|P2|Overall Study|Lack of Efficacy|0
1323614|NCT02314637|4341963|P1|Overall Study|Lack of Efficacy|1
1323615|NCT02314637|4341962|P2|Overall Study|Adverse Event|8
1323616|NCT02314637|4341963|P1|Overall Study|Adverse Event|4
1323617|NCT02314247|4342028|P3|Overall Study|Progression of Disease|0
1323618|NCT02314247|4342029|P2|Overall Study|Progression of Disease|2
1323619|NCT02314247|4342030|P1|Overall Study|Progression of Disease|6
1323620|NCT02314247|4342028|P3|Overall Study|Withdrawal by Subject|1
1323621|NCT02314247|4342029|P2|Overall Study|Withdrawal by Subject|3
1323622|NCT02314247|4342030|P1|Overall Study|Withdrawal by Subject|1
1323623|NCT02314247|4342028|P3|Overall Study|Adverse Event|0
1323624|NCT02314247|4342029|P2|Overall Study|Adverse Event|1
1323625|NCT02314247|4342030|P1|Overall Study|Adverse Event|2
1323626|NCT02314169|4342052|P1|Overall Study|Still on Study|1
1323627|NCT02314169|4342052|P1|Overall Study|Withdrawal by Subject|2
1323628|NCT02314169|4342052|P1|Overall Study|Physician Decision|4
1323629|NCT02314117|4342061|P2|Overall Study|No post-discontinuation follow-up|19
1323630|NCT02314117|4342062|P1|Overall Study|No post-discontinuation follow-up|21
1323631|NCT02314117|4342061|P2|Overall Study|Withdrawal by Subject|2
1323632|NCT02314117|4342062|P1|Overall Study|Withdrawal by Subject|2
1323633|NCT02314117|4342061|P2|Overall Study|On Treatment|6
1323634|NCT02314117|4342062|P1|Overall Study|On Treatment|10
1323635|NCT02314117|4342061|P2|Overall Study|Lost to Follow-up|11
1323636|NCT02314117|4342062|P1|Overall Study|Lost to Follow-up|8
1323637|NCT02313766|4342118|P3|Overall Study|Adverse Event|0
1323638|NCT02313766|4342119|P2|Overall Study|Adverse Event|1
1323639|NCT02313766|4342120|P1|Overall Study|Adverse Event|0
1323640|NCT02313766|4342118|P3|Overall Study|Lost to Follow-up|0
1323641|NCT02313766|4342119|P2|Overall Study|Lost to Follow-up|2
1323642|NCT02313766|4342120|P1|Overall Study|Lost to Follow-up|0
1323643|NCT02313766|4342118|P3|Overall Study|surgery cancelled|0
1323644|NCT02313766|4342119|P2|Overall Study|surgery cancelled|0
1323645|NCT02313766|4342120|P1|Overall Study|surgery cancelled|1
1323646|NCT02313558|4342157|P2|Overall Study|Lost to Follow-up|4
1323647|NCT02313558|4342158|P1|Overall Study|Lost to Follow-up|4
1323648|NCT02313558|4342157|P2|Overall Study|Withdrawal by Subject|0
1323649|NCT02313558|4342158|P1|Overall Study|Withdrawal by Subject|2
1323650|NCT02313233|4342172|P2|Overall Study|Administrative reason|1
1323651|NCT02313233|4342173|P1|Overall Study|Administrative reason|1
1323652|NCT02313233|4342172|P2|Overall Study|Withdrawal by Subject|2
1323653|NCT02313233|4342173|P1|Overall Study|Withdrawal by Subject|1
1323654|NCT02313155|4342195|P2|Overall Study|Lost to Follow-up|1
1323655|NCT02313155|4342196|P1|Overall Study|Lost to Follow-up|0
1323656|NCT02311881|4342391|P3|Overall Study|Serious Adverse Event|0
1323657|NCT02311881|4342392|P2|Overall Study|Serious Adverse Event|1
1323658|NCT02311881|4342393|P1|Overall Study|Serious Adverse Event|0
1323659|NCT02311881|4342391|P3|Overall Study|Participant taking another medication|1
1323660|NCT02311881|4342392|P2|Overall Study|Participant taking another medication|0
1323661|NCT02311881|4342393|P1|Overall Study|Participant taking another medication|0
1323662|NCT02311881|4342391|P3|Overall Study|Medical Monitor Discretion|1
1323663|NCT02311881|4342392|P2|Overall Study|Medical Monitor Discretion|0
1323664|NCT02311881|4342393|P1|Overall Study|Medical Monitor Discretion|0
1323665|NCT02311881|4342391|P3|Overall Study|Physician Decision|1
1323666|NCT02311881|4342392|P2|Overall Study|Physician Decision|0
1323667|NCT02311881|4342393|P1|Overall Study|Physician Decision|0
1323668|NCT02311881|4342391|P3|Overall Study|Non-Compliance|2
1323669|NCT02311881|4342392|P2|Overall Study|Non-Compliance|0
1323670|NCT02311881|4342393|P1|Overall Study|Non-Compliance|1
1323671|NCT02311881|4342391|P3|Overall Study|Protocol Deviation|0
1323672|NCT02311881|4342392|P2|Overall Study|Protocol Deviation|0
1323673|NCT02311881|4342393|P1|Overall Study|Protocol Deviation|1
1323674|NCT02311881|4342391|P3|Overall Study|Sponsor Decision|1
1323675|NCT02311881|4342392|P2|Overall Study|Sponsor Decision|1
1323676|NCT02311881|4342393|P1|Overall Study|Sponsor Decision|1
1323677|NCT02311881|4342391|P3|Overall Study|Withdrawal by Subject|4
1323678|NCT02311881|4342392|P2|Overall Study|Withdrawal by Subject|1
1323679|NCT02311881|4342393|P1|Overall Study|Withdrawal by Subject|3
1323680|NCT02311881|4342391|P3|Overall Study|Subject has border line pregnancy test|0
1323681|NCT02311881|4342392|P2|Overall Study|Subject has border line pregnancy test|0
1323682|NCT02311881|4342393|P1|Overall Study|Subject has border line pregnancy test|1
1323683|NCT02311881|4342391|P3|Overall Study|Lack of Efficacy|0
1323684|NCT02311881|4342392|P2|Overall Study|Lack of Efficacy|2
1323685|NCT02311881|4342393|P1|Overall Study|Lack of Efficacy|1
1323686|NCT02311881|4342391|P3|Overall Study|Not Specified|1
1323687|NCT02311881|4342392|P2|Overall Study|Not Specified|0
1323688|NCT02311881|4342393|P1|Overall Study|Not Specified|0
1323689|NCT02311881|4342391|P3|Overall Study|Withdrawal of consent|17
1323690|NCT02311881|4342392|P2|Overall Study|Withdrawal of consent|16
1323691|NCT02311881|4342393|P1|Overall Study|Withdrawal of consent|14
1323692|NCT02311881|4342391|P3|Overall Study|Protocol Violation|3
1323693|NCT02311881|4342392|P2|Overall Study|Protocol Violation|2
1323694|NCT02311881|4342393|P1|Overall Study|Protocol Violation|1
1323695|NCT02311881|4342391|P3|Overall Study|Lost to Follow-up|2
1323696|NCT02311881|4342392|P2|Overall Study|Lost to Follow-up|3
1323697|NCT02311881|4342393|P1|Overall Study|Lost to Follow-up|3
1323698|NCT02311881|4342391|P3|Overall Study|Adverse Event|8
1323699|NCT02311881|4342392|P2|Overall Study|Adverse Event|15
1323700|NCT02311881|4342393|P1|Overall Study|Adverse Event|7
1323701|NCT02311881|4342391|P3|Overall Study|Did not meet the study criteria|0
1323702|NCT02311881|4342392|P2|Overall Study|Did not meet the study criteria|2
1323703|NCT02311881|4342393|P1|Overall Study|Did not meet the study criteria|2
1323704|NCT02311153|4342446|P2|Overall Study|Lost to Follow-up|7
1323705|NCT02311153|4342447|P1|Overall Study|Lost to Follow-up|5
1323706|NCT02310789|4342463|P1|Overall Study|Adverse Event|1
1323707|NCT02310750|4342483|P16|HP Washout 2|Lost to Follow-up|0
1323708|NCT02310750|4342484|P15|HP Washout 2|Lost to Follow-up|0
1323709|NCT02310750|4342485|P14|HP Washout 2|Lost to Follow-up|0
1323710|NCT02310750|4342486|P13|HP Washout 2|Lost to Follow-up|0
1323711|NCT02310750|4342487|P12|HP Washout 2|Lost to Follow-up|0
1323712|NCT02310750|4342488|P11|HP Washout 2|Lost to Follow-up|0
1323713|NCT02310750|4342489|P10|HP Washout 2|Lost to Follow-up|0
1323714|NCT02310750|4342490|P9|HP Washout 2|Lost to Follow-up|0
1323715|NCT02310750|4342491|P8|HP Washout 2|Lost to Follow-up|0
1323716|NCT02310750|4342492|P7|HP Washout 2|Lost to Follow-up|7
1323717|NCT02310750|4342493|P6|HP Washout 2|Lost to Follow-up|0
1323718|NCT02310750|4342494|P5|HP Washout 2|Lost to Follow-up|1
1323719|NCT02310750|4342495|P4|HP Washout 2|Lost to Follow-up|0
1323720|NCT02310750|4342496|P3|HP Washout 2|Lost to Follow-up|0
1323721|NCT02310750|4342497|P2|HP Washout 2|Lost to Follow-up|0
1323722|NCT02310750|4342498|P1|HP Washout 2|Lost to Follow-up|0
1323723|NCT02310750|4342483|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1323724|NCT02310750|4342484|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1323725|NCT02310750|4342485|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1323726|NCT02310750|4342486|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1323727|NCT02310750|4342487|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1323728|NCT02310750|4342488|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1323729|NCT02310750|4342489|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1323730|NCT02310750|4342490|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
1323731|NCT02310750|4342491|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
1323732|NCT02310750|4342492|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1323810|NCT02310750|4342490|P9|HP Period 1|Withdrawal by Subject|0
1323733|NCT02310750|4342493|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1323734|NCT02310750|4342494|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1323735|NCT02310750|4342495|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1323736|NCT02310750|4342496|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1323737|NCT02310750|4342497|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1323738|NCT02310750|4342498|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1323739|NCT02310750|4342483|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1323740|NCT02310750|4342484|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1323741|NCT02310750|4342485|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1323742|NCT02310750|4342486|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1323743|NCT02310750|4342487|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1323744|NCT02310750|4342488|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1323745|NCT02310750|4342489|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
1323746|NCT02310750|4342490|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
1323747|NCT02310750|4342491|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
1323748|NCT02310750|4342492|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1323749|NCT02310750|4342493|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1323750|NCT02310750|4342494|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1323751|NCT02310750|4342495|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1323752|NCT02310750|4342496|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1323753|NCT02310750|4342497|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1323754|NCT02310750|4342498|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1323755|NCT02310750|4342483|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1323756|NCT02310750|4342484|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1323757|NCT02310750|4342485|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1323758|NCT02310750|4342486|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1323759|NCT02310750|4342487|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1323760|NCT02310750|4342488|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1323761|NCT02310750|4342489|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
1323762|NCT02310750|4342490|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1323763|NCT02310750|4342491|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1323764|NCT02310750|4342492|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1323765|NCT02310750|4342493|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1323766|NCT02310750|4342494|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1323767|NCT02310750|4342495|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1323768|NCT02310750|4342496|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1323769|NCT02310750|4342497|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1323770|NCT02310750|4342498|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1323771|NCT02310750|4342483|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1323772|NCT02310750|4342484|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1323773|NCT02310750|4342485|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1323774|NCT02310750|4342486|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1323775|NCT02310750|4342487|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1323776|NCT02310750|4342488|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1323777|NCT02310750|4342489|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
1323778|NCT02310750|4342490|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
1323779|NCT02310750|4342491|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1323780|NCT02310750|4342492|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1323781|NCT02310750|4342493|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
1323782|NCT02310750|4342494|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1323783|NCT02310750|4342495|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
1323784|NCT02310750|4342496|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1323785|NCT02310750|4342497|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1323786|NCT02310750|4342498|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1323787|NCT02310750|4342483|P16|HP Washout 1|Lost to Follow-up|0
1323788|NCT02310750|4342484|P15|HP Washout 1|Lost to Follow-up|0
1323789|NCT02310750|4342485|P14|HP Washout 1|Lost to Follow-up|0
1323790|NCT02310750|4342486|P13|HP Washout 1|Lost to Follow-up|0
1323791|NCT02310750|4342487|P12|HP Washout 1|Lost to Follow-up|0
1323792|NCT02310750|4342488|P11|HP Washout 1|Lost to Follow-up|0
1323793|NCT02310750|4342489|P10|HP Washout 1|Lost to Follow-up|0
1323794|NCT02310750|4342490|P9|HP Washout 1|Lost to Follow-up|0
1323795|NCT02310750|4342491|P8|HP Washout 1|Lost to Follow-up|0
1323796|NCT02310750|4342492|P7|HP Washout 1|Lost to Follow-up|3
1323797|NCT02310750|4342493|P6|HP Washout 1|Lost to Follow-up|2
1323798|NCT02310750|4342494|P5|HP Washout 1|Lost to Follow-up|2
1323799|NCT02310750|4342495|P4|HP Washout 1|Lost to Follow-up|1
1323800|NCT02310750|4342496|P3|HP Washout 1|Lost to Follow-up|1
1323801|NCT02310750|4342497|P2|HP Washout 1|Lost to Follow-up|0
1323802|NCT02310750|4342498|P1|HP Washout 1|Lost to Follow-up|0
1323803|NCT02310750|4342483|P16|HP Period 1|Withdrawal by Subject|0
1323804|NCT02310750|4342484|P15|HP Period 1|Withdrawal by Subject|0
1323805|NCT02310750|4342485|P14|HP Period 1|Withdrawal by Subject|0
1323806|NCT02310750|4342486|P13|HP Period 1|Withdrawal by Subject|0
1323807|NCT02310750|4342487|P12|HP Period 1|Withdrawal by Subject|0
1323808|NCT02310750|4342488|P11|HP Period 1|Withdrawal by Subject|0
1323809|NCT02310750|4342489|P10|HP Period 1|Withdrawal by Subject|0
1323811|NCT02310750|4342491|P8|HP Period 1|Withdrawal by Subject|0
1323812|NCT02310750|4342492|P7|HP Period 1|Withdrawal by Subject|0
1323813|NCT02310750|4342493|P6|HP Period 1|Withdrawal by Subject|0
1323814|NCT02310750|4342494|P5|HP Period 1|Withdrawal by Subject|0
1323815|NCT02310750|4342495|P4|HP Period 1|Withdrawal by Subject|1
1323816|NCT02310750|4342496|P3|HP Period 1|Withdrawal by Subject|0
1323817|NCT02310750|4342497|P2|HP Period 1|Withdrawal by Subject|0
1323818|NCT02310750|4342498|P1|HP Period 1|Withdrawal by Subject|1
1323819|NCT02310750|4342483|P16|HP Period 1|Lost to Follow-up|0
1323820|NCT02310750|4342484|P15|HP Period 1|Lost to Follow-up|0
1323821|NCT02310750|4342485|P14|HP Period 1|Lost to Follow-up|0
1323822|NCT02310750|4342486|P13|HP Period 1|Lost to Follow-up|0
1323823|NCT02310750|4342487|P12|HP Period 1|Lost to Follow-up|0
1323824|NCT02310750|4342488|P11|HP Period 1|Lost to Follow-up|0
1323825|NCT02310750|4342489|P10|HP Period 1|Lost to Follow-up|0
1323826|NCT02310750|4342490|P9|HP Period 1|Lost to Follow-up|0
1323827|NCT02310750|4342491|P8|HP Period 1|Lost to Follow-up|0
1323828|NCT02310750|4342492|P7|HP Period 1|Lost to Follow-up|1
1323829|NCT02310750|4342493|P6|HP Period 1|Lost to Follow-up|0
1323830|NCT02310750|4342494|P5|HP Period 1|Lost to Follow-up|0
1323831|NCT02310750|4342495|P4|HP Period 1|Lost to Follow-up|0
1323832|NCT02310750|4342496|P3|HP Period 1|Lost to Follow-up|0
1323833|NCT02310750|4342497|P2|HP Period 1|Lost to Follow-up|0
1323834|NCT02310750|4342498|P1|HP Period 1|Lost to Follow-up|0
1323835|NCT02310646|4342939|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
1323836|NCT02310646|4342940|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
1323837|NCT02310646|4342939|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
1323838|NCT02310646|4342940|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
1323839|NCT02310581|4342968|P4|Overall Study|Withdrawal by Subject|1
1323840|NCT02310581|4342969|P3|Overall Study|Withdrawal by Subject|0
1323841|NCT02310581|4342970|P2|Overall Study|Withdrawal by Subject|1
1323842|NCT02310581|4342971|P1|Overall Study|Withdrawal by Subject|2
1323843|NCT02310581|4342968|P4|Overall Study|Adverse Event|0
1323844|NCT02310581|4342969|P3|Overall Study|Adverse Event|1
1323845|NCT02310581|4342970|P2|Overall Study|Adverse Event|1
1323846|NCT02310581|4342971|P1|Overall Study|Adverse Event|1
1323847|NCT02310568|4343010|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
1323848|NCT02310568|4343011|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
1323849|NCT02310568|4343012|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
1323850|NCT02310568|4343013|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
1323851|NCT02310568|4343014|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
1323852|NCT02310568|4343010|P5|Stage 2 (4 Weeks)|Protocol Violation|0
1323853|NCT02310568|4343011|P4|Stage 2 (4 Weeks)|Protocol Violation|1
1323854|NCT02310568|4343012|P3|Stage 2 (4 Weeks)|Protocol Violation|0
1323855|NCT02310568|4343013|P2|Stage 2 (4 Weeks)|Protocol Violation|0
1323856|NCT02310568|4343014|P1|Stage 2 (4 Weeks)|Protocol Violation|0
1323857|NCT02310568|4343010|P5|Stage 2 (4 Weeks)|Adverse Event|1
1323858|NCT02310568|4343011|P4|Stage 2 (4 Weeks)|Adverse Event|1
1323859|NCT02310568|4343012|P3|Stage 2 (4 Weeks)|Adverse Event|0
1323860|NCT02310568|4343013|P2|Stage 2 (4 Weeks)|Adverse Event|0
1323861|NCT02310568|4343014|P1|Stage 2 (4 Weeks)|Adverse Event|0
1323862|NCT02310568|4343010|P5|Stage 2 (4 Weeks)|Other|0
1323863|NCT02310568|4343011|P4|Stage 2 (4 Weeks)|Other|0
1323864|NCT02310568|4343012|P3|Stage 2 (4 Weeks)|Other|1
1323865|NCT02310568|4343013|P2|Stage 2 (4 Weeks)|Other|1
1323866|NCT02310568|4343014|P1|Stage 2 (4 Weeks)|Other|0
1323867|NCT02310568|4343010|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
1323868|NCT02310568|4343011|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
1323869|NCT02310568|4343012|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
1323870|NCT02310568|4343013|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
1323871|NCT02310568|4343014|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
1323872|NCT02310568|4343010|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1323873|NCT02310568|4343011|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
1323874|NCT02310568|4343012|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1323875|NCT02310568|4343013|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1323876|NCT02310568|4343014|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1323877|NCT02310568|4343010|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1323878|NCT02310568|4343011|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
1323879|NCT02310568|4343012|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1323880|NCT02310568|4343013|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1323881|NCT02310568|4343014|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1323882|NCT02310568|4343010|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
1323883|NCT02310568|4343011|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
1323884|NCT02310568|4343012|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
1323885|NCT02310568|4343013|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
1323886|NCT02310568|4343014|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
1323887|NCT02310568|4343010|P5|Stage 1 ( 4 Weeks)|Other|0
1323888|NCT02310568|4343011|P4|Stage 1 ( 4 Weeks)|Other|0
1323889|NCT02310568|4343012|P3|Stage 1 ( 4 Weeks)|Other|0
1323890|NCT02310568|4343013|P2|Stage 1 ( 4 Weeks)|Other|1
1323891|NCT02310568|4343014|P1|Stage 1 ( 4 Weeks)|Other|1
1323892|NCT02310568|4343010|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1323893|NCT02310568|4343011|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1323894|NCT02310568|4343012|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1323895|NCT02310568|4343013|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1323896|NCT02310568|4343014|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
1323897|NCT02310568|4343010|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
1323898|NCT02310568|4343011|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1323899|NCT02310568|4343012|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1323900|NCT02310568|4343013|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1323901|NCT02310568|4343014|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1323902|NCT02310126|4343094|P2|Period 1 (15 Minutes)|Protocol Violation|1
1323903|NCT02310126|4343095|P1|Period 1 (15 Minutes)|Protocol Violation|0
1323904|NCT02310126|4343094|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
1323905|NCT02310126|4343095|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
1323906|NCT02309723|4343104|P3|Overall Study|Withdrawal by Subject|24
1323907|NCT02309723|4343105|P2|Overall Study|Withdrawal by Subject|23
1323908|NCT02309723|4343106|P1|Overall Study|Withdrawal by Subject|24
1323909|NCT02309411|4343123|P3|Overall Study|Withdrawal by Subject|0
1323910|NCT02309411|4343124|P2|Overall Study|Withdrawal by Subject|1
1323911|NCT02309411|4343125|P1|Overall Study|Withdrawal by Subject|1
1323912|NCT02309411|4343123|P3|Overall Study|Physician Decision|0
1323913|NCT02309411|4343124|P2|Overall Study|Physician Decision|0
1323914|NCT02309411|4343125|P1|Overall Study|Physician Decision|1
1323915|NCT02309294|4343144|P1|Overall Study|Withdrawal by Subject|2
1323916|NCT02309112|4343151|P3|Overall Study|Lost to Follow-up|0
1323917|NCT02309112|4343152|P2|Overall Study|Lost to Follow-up|1
1323918|NCT02309112|4343153|P1|Overall Study|Lost to Follow-up|0
1323919|NCT02309112|4343151|P3|Overall Study|Withdrawal by Subject|1
1323920|NCT02309112|4343152|P2|Overall Study|Withdrawal by Subject|0
1323921|NCT02309112|4343153|P1|Overall Study|Withdrawal by Subject|1
1323922|NCT02308748|4343189|P10|Period 5|Adverse Event|0
1323923|NCT02308748|4343190|P9|Period 5|Adverse Event|1
1323924|NCT02308748|4343191|P8|Period 5|Adverse Event|0
1323925|NCT02308748|4343192|P7|Period 5|Adverse Event|0
1323926|NCT02308748|4343193|P6|Period 5|Adverse Event|0
1323927|NCT02308748|4343194|P5|Period 5|Adverse Event|0
1323928|NCT02308748|4343195|P4|Period 5|Adverse Event|0
1323929|NCT02308748|4343196|P3|Period 5|Adverse Event|0
1323930|NCT02308748|4343197|P2|Period 5|Adverse Event|0
1323931|NCT02308748|4343198|P1|Period 5|Adverse Event|1
1323932|NCT02308748|4343189|P10|Period 3|Protocol Violation|1
1323933|NCT02308748|4343190|P9|Period 3|Protocol Violation|0
1323934|NCT02308748|4343191|P8|Period 3|Protocol Violation|0
1323935|NCT02308748|4343192|P7|Period 3|Protocol Violation|0
1323936|NCT02308748|4343193|P6|Period 3|Protocol Violation|0
1323937|NCT02308748|4343194|P5|Period 3|Protocol Violation|0
1323938|NCT02308748|4343195|P4|Period 3|Protocol Violation|0
1323939|NCT02308748|4343196|P3|Period 3|Protocol Violation|0
1323940|NCT02308748|4343197|P2|Period 3|Protocol Violation|0
1323941|NCT02308748|4343198|P1|Period 3|Protocol Violation|0
1323942|NCT02308748|4343189|P10|Period 2|Adverse Event|0
1323943|NCT02308748|4343190|P9|Period 2|Adverse Event|0
1323944|NCT02308748|4343191|P8|Period 2|Adverse Event|1
1323945|NCT02308748|4343192|P7|Period 2|Adverse Event|0
1323946|NCT02308748|4343193|P6|Period 2|Adverse Event|0
1323947|NCT02308748|4343194|P5|Period 2|Adverse Event|0
1323948|NCT02308748|4343195|P4|Period 2|Adverse Event|0
1323949|NCT02308748|4343196|P3|Period 2|Adverse Event|0
1323950|NCT02308748|4343197|P2|Period 2|Adverse Event|0
1323951|NCT02308748|4343198|P1|Period 2|Adverse Event|0
1323952|NCT02308748|4343189|P10|Period 1|Withdrawal by Subject|0
1323953|NCT02308748|4343190|P9|Period 1|Withdrawal by Subject|0
1323954|NCT02308748|4343191|P8|Period 1|Withdrawal by Subject|0
1323955|NCT02308748|4343192|P7|Period 1|Withdrawal by Subject|0
1323956|NCT02308748|4343193|P6|Period 1|Withdrawal by Subject|0
1323957|NCT02308748|4343194|P5|Period 1|Withdrawal by Subject|0
1323958|NCT02308748|4343195|P4|Period 1|Withdrawal by Subject|0
1323959|NCT02308748|4343196|P3|Period 1|Withdrawal by Subject|1
1323960|NCT02308748|4343197|P2|Period 1|Withdrawal by Subject|0
1323961|NCT02308748|4343198|P1|Period 1|Withdrawal by Subject|0
1323962|NCT02308124|4343249|P3|Overall Study|Adverse Event|2
1323963|NCT02308124|4343250|P2|Overall Study|Adverse Event|2
1323964|NCT02308124|4343251|P1|Overall Study|Adverse Event|0
1323965|NCT02308124|4343249|P3|Overall Study|Lost to Follow-up|6
1323966|NCT02308124|4343250|P2|Overall Study|Lost to Follow-up|6
1323967|NCT02308124|4343251|P1|Overall Study|Lost to Follow-up|6
1323968|NCT02307266|4343343|P3|Overall Study|Lost to Follow-up|0
1323969|NCT02307266|4343344|P2|Overall Study|Lost to Follow-up|0
1323970|NCT02307266|4343345|P1|Overall Study|Lost to Follow-up|3
1323971|NCT02307266|4343343|P3|Overall Study|Withdrawal by Subject|1
1323972|NCT02307266|4343344|P2|Overall Study|Withdrawal by Subject|0
1323973|NCT02307266|4343345|P1|Overall Study|Withdrawal by Subject|2
1323974|NCT02307266|4343343|P3|Overall Study|Adverse Event|5
1323975|NCT02307266|4343344|P2|Overall Study|Adverse Event|1
1323976|NCT02307266|4343345|P1|Overall Study|Adverse Event|3
1323977|NCT02305446|4343387|P1|Overall Study|Adverse Event|1
1323978|NCT02305381|4343395|P3|Overall Study|Unclassified|7
1323979|NCT02305381|4343396|P2|Overall Study|Unclassified|5
1323980|NCT02305381|4343397|P1|Overall Study|Unclassified|5
1323981|NCT02305238|4343510|P3|Overall Study|Randomized failure|8
1323982|NCT02305238|4343511|P2|Overall Study|Randomized failure|0
1323983|NCT02305238|4343512|P1|Overall Study|Randomized failure|0
1323984|NCT02305238|4343510|P3|Overall Study|Withdrawal by Subject|0
1323985|NCT02305238|4343511|P2|Overall Study|Withdrawal by Subject|2
1323986|NCT02305238|4343512|P1|Overall Study|Withdrawal by Subject|2
1323987|NCT02305238|4343510|P3|Overall Study|Adverse Event|0
1323988|NCT02305238|4343511|P2|Overall Study|Adverse Event|1
1323989|NCT02305238|4343512|P1|Overall Study|Adverse Event|3
1323990|NCT02305238|4343510|P3|Overall Study|Physician Decision|0
1323991|NCT02305238|4343511|P2|Overall Study|Physician Decision|0
1323992|NCT02305238|4343512|P1|Overall Study|Physician Decision|1
1323993|NCT02305238|4343510|P3|Overall Study|Protocol Violation|0
1323994|NCT02305238|4343511|P2|Overall Study|Protocol Violation|1
1323995|NCT02305238|4343512|P1|Overall Study|Protocol Violation|0
1323996|NCT02305238|4343510|P3|Overall Study|Logistical difficulties|0
1323997|NCT02305238|4343511|P2|Overall Study|Logistical difficulties|1
1323998|NCT02305238|4343512|P1|Overall Study|Logistical difficulties|1
1323999|NCT02305238|4343510|P3|Overall Study|Progressive disease|0
1324000|NCT02305238|4343511|P2|Overall Study|Progressive disease|2
1324001|NCT02305238|4343512|P1|Overall Study|Progressive disease|4
1324002|NCT02305238|4343510|P3|Overall Study|Death|0
1324003|NCT02305238|4343511|P2|Overall Study|Death|0
1324004|NCT02305238|4343512|P1|Overall Study|Death|2
1324005|NCT02304926|4343544|P2|Overall Study|Lost to Follow-up|1
1324006|NCT02304926|4343545|P1|Overall Study|Lost to Follow-up|2
1324007|NCT02303704|4343637|P2|Overall Study|Protocol Violation|9
1324008|NCT02303704|4343638|P1|Overall Study|Protocol Violation|5
1324009|NCT02302807|4343656|P2|Overall Study|Death|322
1324010|NCT02302807|4343657|P1|Overall Study|Death|345
1324011|NCT02302807|4343656|P2|Overall Study|Lost to Follow-up|3
1324012|NCT02302807|4343657|P1|Overall Study|Lost to Follow-up|3
1324013|NCT02302807|4343656|P2|Overall Study|Withdrawal by Subject|9
1324014|NCT02302807|4343657|P1|Overall Study|Withdrawal by Subject|27
1324015|NCT02302716|4343704|P2|Overall Study|Protocol Violation|1
1324016|NCT02302716|4343705|P1|Overall Study|Protocol Violation|0
1324017|NCT02302716|4343704|P2|Overall Study|Withdrawal by Subject|7
1324018|NCT02302716|4343705|P1|Overall Study|Withdrawal by Subject|13
1324019|NCT02302716|4343704|P2|Overall Study|Physician Decision|4
1324020|NCT02302716|4343705|P1|Overall Study|Physician Decision|3
1324021|NCT02302716|4343704|P2|Overall Study|Lost to Follow-up|4
1324022|NCT02302716|4343705|P1|Overall Study|Lost to Follow-up|2
1324023|NCT02302716|4343704|P2|Overall Study|Lack of Efficacy|1
1324024|NCT02302716|4343705|P1|Overall Study|Lack of Efficacy|0
1324025|NCT02302716|4343704|P2|Overall Study|Death|1
1324026|NCT02302716|4343705|P1|Overall Study|Death|0
1324027|NCT02302716|4343704|P2|Overall Study|Adverse Event|1
1324028|NCT02302716|4343705|P1|Overall Study|Adverse Event|1
1324029|NCT02301975|4343781|P3|Overall Study|Withdrawal by Subject|11
1324030|NCT02301975|4343782|P2|Overall Study|Withdrawal by Subject|12
1324031|NCT02301975|4343783|P1|Overall Study|Withdrawal by Subject|15
1324032|NCT02301975|4343781|P3|Overall Study|Physician Decision|3
1324033|NCT02301975|4343782|P2|Overall Study|Physician Decision|2
1324034|NCT02301975|4343783|P1|Overall Study|Physician Decision|4
1324035|NCT02301975|4343781|P3|Overall Study|Lost to Follow-up|2
1324036|NCT02301975|4343782|P2|Overall Study|Lost to Follow-up|2
1324037|NCT02301975|4343783|P1|Overall Study|Lost to Follow-up|0
1324038|NCT02301975|4343781|P3|Overall Study|Protocol Violation|3
1324039|NCT02301975|4343782|P2|Overall Study|Protocol Violation|5
1324040|NCT02301975|4343783|P1|Overall Study|Protocol Violation|3
1324041|NCT02301975|4343781|P3|Overall Study|Lack of Efficacy|1
1324042|NCT02301975|4343782|P2|Overall Study|Lack of Efficacy|1
1324043|NCT02301975|4343783|P1|Overall Study|Lack of Efficacy|1
1324044|NCT02301975|4343781|P3|Overall Study|Adverse Event|2
1324045|NCT02301975|4343782|P2|Overall Study|Adverse Event|3
1324046|NCT02301975|4343783|P1|Overall Study|Adverse Event|8
1324047|NCT02301936|4343811|P2|Overall Study|Lost to Follow-up|0
1324048|NCT02301936|4343812|P1|Overall Study|Lost to Follow-up|1
1324049|NCT02301429|4343834|P1|Overall Study|not acceptable vascular anatomy|3
1324050|NCT02301169|4343860|P2|Overall Study|Adverse Event|0
1324051|NCT02301169|4343861|P1|Overall Study|Adverse Event|1
1324052|NCT02300558|4343875|P1|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
1324053|NCT02300558|4343875|P1|Open-Label (OL) Extension Phase|Withdrew Consent|1
1324054|NCT02300558|4343875|P1|Open-Label (OL) Extension Phase|Lack of Efficacy|2
1324055|NCT02300558|4343875|P1|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
1324056|NCT02300311|4343888|P2|Overall Study|Refused to continue taking medication|0
1324057|NCT02300311|4343889|P1|Overall Study|Refused to continue taking medication|18
1324058|NCT02300311|4343888|P2|Overall Study|Other than the reason specified|0
1324059|NCT02300311|4343889|P1|Overall Study|Other than the reason specified|1
1324060|NCT02300298|4343901|P2|Disposition for Docetaxel|other adverse event|4
1324061|NCT02300298|4343902|P1|Disposition for Docetaxel|other adverse event|0
1324062|NCT02300298|4343901|P2|Disposition for Docetaxel|Progressive disease|6
1324063|NCT02300298|4343902|P1|Disposition for Docetaxel|Progressive disease|0
1324064|NCT02300298|4343901|P2|Disposition for Nintedanib|Progressive disease|0
1324065|NCT02300298|4343902|P1|Disposition for Nintedanib|Progressive disease|8
1324066|NCT02300129|4343912|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
1324067|NCT02300129|4343913|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
1324068|NCT02300129|4343914|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
1324069|NCT02300129|4343915|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
1324070|NCT02300129|4343912|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
1324071|NCT02300129|4343913|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
1324072|NCT02300129|4343914|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
1324073|NCT02300129|4343915|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
1324074|NCT02300129|4343912|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
1324075|NCT02300129|4343913|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
1324076|NCT02300129|4343914|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
1324077|NCT02300129|4343915|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
1324078|NCT02300103|4343925|P1|Overall Study|Withdrew Consent|2
1324079|NCT02300103|4343925|P1|Overall Study|Protocol Violation|1
1324080|NCT02300103|4343925|P1|Overall Study|Lack of Efficacy|3
1324081|NCT02299635|4344022|P1|Overall Study|Other|3
1324082|NCT02299635|4344022|P1|Overall Study|Withdrawal by Subject|2
1324083|NCT02299635|4344022|P1|Overall Study|Objective progression or relapse|10
1324084|NCT02299635|4344022|P1|Overall Study|Global deterioration of health status|1
1324085|NCT02299635|4344022|P1|Overall Study|Death|1
1324086|NCT02299635|4344022|P1|Overall Study|Adverse Event|2
1324087|NCT02299427|4344056|P2|Overall Study|not adherent to dog website use|0
1324088|NCT02299427|4344057|P1|Overall Study|not adherent to dog website use|21
1324089|NCT02299427|4344056|P2|Overall Study|Lost to Follow-up|3
1324090|NCT02299427|4344057|P1|Overall Study|Lost to Follow-up|1
1324091|NCT02299427|4344056|P2|Overall Study|Withdrawal by Subject|0
1324092|NCT02299427|4344057|P1|Overall Study|Withdrawal by Subject|1
1324093|NCT02299375|4344067|P2|Overall Study|Withdrawal by Subject|4
1324094|NCT02299375|4344068|P1|Overall Study|Withdrawal by Subject|1
1324095|NCT02299375|4344067|P2|Overall Study|Physician Decision|1
1324096|NCT02299375|4344068|P1|Overall Study|Physician Decision|1
1324097|NCT02299375|4344067|P2|Overall Study|Lost to Follow-up|2
1324098|NCT02299375|4344068|P1|Overall Study|Lost to Follow-up|0
1324099|NCT02299375|4344067|P2|Overall Study|Other: Study closed/terminated|55
1324100|NCT02299375|4344068|P1|Overall Study|Other: Study closed/terminated|66
1324101|NCT02299375|4344067|P2|Overall Study|Other: Met stopping criteria|0
1324102|NCT02299375|4344068|P1|Overall Study|Other: Met stopping criteria|1
1324103|NCT02299375|4344067|P2|Overall Study|Protocol Violation|3
1324104|NCT02299375|4344068|P1|Overall Study|Protocol Violation|1
1324105|NCT02299375|4344067|P2|Overall Study|Lack of Efficacy|3
1324106|NCT02299375|4344068|P1|Overall Study|Lack of Efficacy|1
1324107|NCT02299375|4344067|P2|Overall Study|Adverse Event, non-fatal|9
1324108|NCT02299375|4344068|P1|Overall Study|Adverse Event, non-fatal|8
1324109|NCT02299375|4344067|P2|Overall Study|Adverse Event, serious fatal|3
1324110|NCT02299375|4344068|P1|Overall Study|Adverse Event, serious fatal|1
1324111|NCT02299336|4344127|P1|Overall Study|Lost to Follow-up|1
1324112|NCT02299336|4344127|P1|Overall Study|Death|1
1324113|NCT02299336|4344127|P1|Overall Study|Adverse Event|1
1324114|NCT02299336|4344127|P1|Overall Study|Withdrawal by Subject|11
1324115|NCT02299206|4344151|P1|Overall Study|Withdrawal by Subject|1
1324116|NCT02299206|4344151|P1|Overall Study|Lost to Follow-up|1
1324117|NCT02299076|4344212|P2|Overall Study|Fraudulent Entries|14
1324118|NCT02299076|4344213|P1|Overall Study|Fraudulent Entries|20
1324119|NCT02298868|4344221|P1|Overall Study|Patient underwent transplant|1
1324120|NCT02298868|4344221|P1|Overall Study|Death|1
1324121|NCT02298868|4344221|P1|Overall Study|Adverse Event|1
1324122|NCT02298192|4344292|P2|Overall Study|Adverse Event|2
1324123|NCT02298192|4344293|P1|Overall Study|Adverse Event|6
1324124|NCT02298192|4344292|P2|Overall Study|Lost to Follow-up|1
1324125|NCT02298192|4344293|P1|Overall Study|Lost to Follow-up|2
1324126|NCT02298192|4344292|P2|Overall Study|Withdrawal by Subject|1
1324127|NCT02298192|4344293|P1|Overall Study|Withdrawal by Subject|6
1324128|NCT02298192|4344292|P2|Overall Study|Withdrawal criteria|0
1324129|NCT02298192|4344293|P1|Overall Study|Withdrawal criteria|2
1324130|NCT02298192|4344292|P2|Overall Study|Unclassified|2
1324131|NCT02298192|4344293|P1|Overall Study|Unclassified|3
1324132|NCT02298179|4344317|P12|Overall Study|Lost to Follow-up|0
1324133|NCT02298179|4344318|P11|Overall Study|Lost to Follow-up|0
1324134|NCT02298179|4344319|P10|Overall Study|Lost to Follow-up|0
1324135|NCT02298179|4344320|P9|Overall Study|Lost to Follow-up|0
1324136|NCT02298179|4344321|P8|Overall Study|Lost to Follow-up|1
1324137|NCT02298179|4344322|P7|Overall Study|Lost to Follow-up|0
1324138|NCT02298179|4344323|P6|Overall Study|Lost to Follow-up|0
1324139|NCT02298179|4344324|P5|Overall Study|Lost to Follow-up|0
1324140|NCT02298179|4344325|P4|Overall Study|Lost to Follow-up|0
1324141|NCT02298179|4344326|P3|Overall Study|Lost to Follow-up|1
1324142|NCT02298179|4344327|P2|Overall Study|Lost to Follow-up|0
1324143|NCT02298179|4344328|P1|Overall Study|Lost to Follow-up|0
1324144|NCT02297841|4344570|P1|Overall Study|Protocol Violation|7
1324145|NCT02297841|4344570|P1|Overall Study|Withdrawal by Subject|1
1324146|NCT02297815|4344576|P2|Overall Study|Lost to Follow-up|140
1324147|NCT02297815|4344577|P1|Overall Study|Lost to Follow-up|236
1324148|NCT02296931|4344642|P2|Overall Study|Protocol Violation|2
1324149|NCT02296931|4344643|P1|Overall Study|Protocol Violation|0
1324150|NCT02296840|4344651|P2|Overall Study|Lost to Follow-up|17
1324151|NCT02296840|4344652|P1|Overall Study|Lost to Follow-up|6
1324152|NCT02296840|4344651|P2|Overall Study|Protocol Violation|1
1324153|NCT02296840|4344652|P1|Overall Study|Protocol Violation|2
1324154|NCT02296840|4344651|P2|Overall Study|Adverse Event|1
1324155|NCT02296840|4344652|P1|Overall Study|Adverse Event|1
1324156|NCT02296476|4344667|P3|Overall Study|Disease Progression|2
1324157|NCT02296476|4344668|P2|Overall Study|Disease Progression|4
1324158|NCT02296476|4344669|P1|Overall Study|Disease Progression|6
1324159|NCT02296138|4344724|P2|Overall Study|Other than specified|13
1324160|NCT02296138|4344725|P1|Overall Study|Other than specified|15
1324161|NCT02296138|4344724|P2|Overall Study|Patients with data irregularities|11
1324334|NCT02291679|4345490|P2|Overall Study|Lost to Follow-up|10
1324162|NCT02296138|4344725|P1|Overall Study|Patients with data irregularities|10
1324163|NCT02296138|4344724|P2|Overall Study|Not Treated|1
1324164|NCT02296138|4344725|P1|Overall Study|Not Treated|1
1324165|NCT02296138|4344724|P2|Overall Study|Withdrawal by Subject|131
1324166|NCT02296138|4344725|P1|Overall Study|Withdrawal by Subject|184
1324167|NCT02296138|4344724|P2|Overall Study|Lost to Follow-up|12
1324168|NCT02296138|4344725|P1|Overall Study|Lost to Follow-up|9
1324169|NCT02296138|4344724|P2|Overall Study|Protocol Violation|36
1324170|NCT02296138|4344725|P1|Overall Study|Protocol Violation|35
1324171|NCT02296138|4344724|P2|Overall Study|Lack of Efficacy|37
1324172|NCT02296138|4344725|P1|Overall Study|Lack of Efficacy|59
1324173|NCT02296138|4344724|P2|Overall Study|Adverse Event|259
1324174|NCT02296138|4344725|P1|Overall Study|Adverse Event|348
1324175|NCT02295774|4344766|P1|Overall Study|Withdrawal by Subject|2
1324176|NCT02295774|4344766|P1|Overall Study|Lost to Follow-up|1
1324177|NCT02295644|4344774|P4|Overall Study|Did not meet inclusion criterion|2
1324178|NCT02295644|4344775|P3|Overall Study|Did not meet inclusion criterion|1
1324179|NCT02295644|4344776|P2|Overall Study|Did not meet inclusion criterion|0
1324180|NCT02295644|4344777|P1|Overall Study|Did not meet inclusion criterion|0
1324181|NCT02295280|4344797|P2|Overall Study|Adverse Event|1
1324182|NCT02295280|4344798|P1|Overall Study|Adverse Event|0
1324183|NCT02295020|4344806|P2|Overall Study|Withdrawal by Subject|2
1324184|NCT02295020|4344807|P1|Overall Study|Withdrawal by Subject|3
1324185|NCT02295020|4344806|P2|Overall Study|Adverse Event|1
1324186|NCT02295020|4344807|P1|Overall Study|Adverse Event|0
1324187|NCT02294773|4344839|P2|Overall Study|Withdrawal by Subject|2
1324188|NCT02294773|4344840|P1|Overall Study|Withdrawal by Subject|0
1324189|NCT02294734|4344856|P2|Overall Study|Withdrawal by Subject|2
1324190|NCT02294734|4344857|P1|Overall Study|Withdrawal by Subject|4
1324191|NCT02294734|4344856|P2|Overall Study|Physician Decision|1
1324192|NCT02294734|4344857|P1|Overall Study|Physician Decision|2
1324193|NCT02294734|4344856|P2|Overall Study|Lost to Follow-up|0
1324194|NCT02294734|4344857|P1|Overall Study|Lost to Follow-up|2
1324195|NCT02294734|4344856|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
1324196|NCT02294734|4344857|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
1324197|NCT02294734|4344856|P2|Overall Study|Adverse Event|5
1324198|NCT02294734|4344857|P1|Overall Study|Adverse Event|5
1324199|NCT02294682|4344909|P2|Overall Study|Could not swallow pills|0
1324200|NCT02294682|4344910|P1|Overall Study|Could not swallow pills|1
1324201|NCT02294604|4344953|P3|Overall Study|Culture contamination|0
1324202|NCT02294604|4344954|P2|Overall Study|Culture contamination|2
1324203|NCT02294604|4344955|P1|Overall Study|Culture contamination|1
1324204|NCT02294604|4344953|P3|Overall Study|Did not provide samples for culture|0
1324205|NCT02294604|4344954|P2|Overall Study|Did not provide samples for culture|1
1324206|NCT02294604|4344955|P1|Overall Study|Did not provide samples for culture|0
1324207|NCT02294474|4344974|P2|Overall Study|Other than specified above|12
1324208|NCT02294474|4344975|P1|Overall Study|Other than specified above|12
1324209|NCT02294474|4344974|P2|Overall Study|Protocol Violation|2
1324210|NCT02294474|4344975|P1|Overall Study|Protocol Violation|4
1324211|NCT02294474|4344974|P2|Overall Study|Lack of Efficacy|1
1324212|NCT02294474|4344975|P1|Overall Study|Lack of Efficacy|2
1324213|NCT02294474|4344974|P2|Overall Study|Adverse Event|7
1324214|NCT02294474|4344975|P1|Overall Study|Adverse Event|7
1324215|NCT02294461|4344999|P2|Overall Study|Miscellaneous|32
1324216|NCT02294461|4345000|P1|Overall Study|Miscellaneous|11
1324217|NCT02294461|4344999|P2|Overall Study|Adverse Event|10
1324218|NCT02294461|4345000|P1|Overall Study|Adverse Event|11
1324219|NCT02294461|4344999|P2|Overall Study|Disease Progression|39
1324220|NCT02294461|4345000|P1|Overall Study|Disease Progression|23
1324221|NCT02294461|4344999|P2|Overall Study|Withdrawal by Subject|45
1324222|NCT02294461|4345000|P1|Overall Study|Withdrawal by Subject|14
1324223|NCT02294461|4344999|P2|Overall Study|Protocol Violation|2
1324224|NCT02294461|4345000|P1|Overall Study|Protocol Violation|0
1324225|NCT02294461|4344999|P2|Overall Study|Death|3
1324226|NCT02294461|4345000|P1|Overall Study|Death|3
1324227|NCT02294019|4345052|P1|Overall Study|Withdrawal by Subject|1
1324228|NCT02294019|4345052|P1|Overall Study|Other|1
1324229|NCT02294019|4345052|P1|Overall Study|Lost to Follow-up|31
1324230|NCT02294019|4345052|P1|Overall Study|Protocol Violation|68
1324231|NCT02294019|4345052|P1|Overall Study|Adverse Event|2
1324232|NCT02293902|4345060|P5|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
1324233|NCT02293902|4345061|P4|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
1324234|NCT02293902|4345062|P3|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
1324235|NCT02293902|4345063|P2|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
1324236|NCT02293902|4345064|P1|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
1324237|NCT02293902|4345060|P5|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
1324238|NCT02293902|4345061|P4|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
1324239|NCT02293902|4345062|P3|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
1324240|NCT02293902|4345063|P2|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
1324241|NCT02293902|4345064|P1|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
1324242|NCT02293902|4345060|P5|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1324243|NCT02293902|4345061|P4|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1324244|NCT02293902|4345062|P3|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1324245|NCT02293902|4345063|P2|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1324246|NCT02293902|4345064|P1|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
1324247|NCT02293902|4345060|P5|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
1324248|NCT02293902|4345061|P4|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
1324249|NCT02293902|4345062|P3|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
1324250|NCT02293902|4345063|P2|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
1324251|NCT02293902|4345064|P1|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
1324252|NCT02293902|4345060|P5|Double-Blind Period (Up to Week 24)|Adverse Event|0
1324253|NCT02293902|4345061|P4|Double-Blind Period (Up to Week 24)|Adverse Event|0
1324254|NCT02293902|4345062|P3|Double-Blind Period (Up to Week 24)|Adverse Event|8
1324255|NCT02293902|4345063|P2|Double-Blind Period (Up to Week 24)|Adverse Event|6
1324256|NCT02293902|4345064|P1|Double-Blind Period (Up to Week 24)|Adverse Event|5
1324257|NCT02293863|4345126|P3|Overall Study|Reason Not Specified|2
1324258|NCT02293863|4345127|P2|Overall Study|Reason Not Specified|2
1324259|NCT02293863|4345128|P1|Overall Study|Reason Not Specified|0
1324260|NCT02293863|4345126|P3|Overall Study|Withdrawal by Subject|1
1324261|NCT02293863|4345127|P2|Overall Study|Withdrawal by Subject|3
1324262|NCT02293863|4345128|P1|Overall Study|Withdrawal by Subject|3
1324263|NCT02293863|4345126|P3|Overall Study|Lost to Follow-up|2
1324264|NCT02293863|4345127|P2|Overall Study|Lost to Follow-up|2
1324265|NCT02293863|4345128|P1|Overall Study|Lost to Follow-up|2
1324266|NCT02293863|4345126|P3|Overall Study|Death|4
1324267|NCT02293863|4345127|P2|Overall Study|Death|6
1324268|NCT02293863|4345128|P1|Overall Study|Death|4
1324269|NCT02293538|4345193|P2|Overall Study|Withdrawal by Subject|1
1324270|NCT02293538|4345194|P1|Overall Study|Withdrawal by Subject|0
1324271|NCT02293538|4345193|P2|Overall Study|Lost to Follow-up|0
1324272|NCT02293538|4345194|P1|Overall Study|Lost to Follow-up|1
1324273|NCT02293538|4345193|P2|Overall Study|Adverse Event|1
1324274|NCT02293538|4345194|P1|Overall Study|Adverse Event|0
1324275|NCT02293395|4345209|P2|Overall Study|Withdrawal by Subject|7
1324276|NCT02293395|4345210|P1|Overall Study|Withdrawal by Subject|8
1324277|NCT02293395|4345209|P2|Overall Study|Lost to Follow-up|0
1324278|NCT02293395|4345210|P1|Overall Study|Lost to Follow-up|1
1324279|NCT02292849|4345219|P3|Overall Study|Physician Decision|0
1324280|NCT02292849|4345220|P2|Overall Study|Physician Decision|0
1324281|NCT02292849|4345221|P1|Overall Study|Physician Decision|4
1324282|NCT02292849|4345219|P3|Overall Study|Lost to Follow-up|2
1324283|NCT02292849|4345220|P2|Overall Study|Lost to Follow-up|2
1324284|NCT02292849|4345221|P1|Overall Study|Lost to Follow-up|0
1324285|NCT02292719|4345235|P6|Overall Study|Subject enrolled in new study.|0
1324286|NCT02292719|4345236|P5|Overall Study|Subject enrolled in new study.|0
1324287|NCT02292719|4345237|P4|Overall Study|Subject enrolled in new study.|0
1324288|NCT02292719|4345238|P3|Overall Study|Subject enrolled in new study.|1
1324289|NCT02292719|4345239|P2|Overall Study|Subject enrolled in new study.|0
1324290|NCT02292719|4345240|P1|Overall Study|Subject enrolled in new study.|0
1324291|NCT02292719|4345235|P6|Overall Study|Withdrawal by Subject|0
1324292|NCT02292719|4345236|P5|Overall Study|Withdrawal by Subject|1
1324293|NCT02292719|4345237|P4|Overall Study|Withdrawal by Subject|1
1324294|NCT02292719|4345238|P3|Overall Study|Withdrawal by Subject|0
1324295|NCT02292719|4345239|P2|Overall Study|Withdrawal by Subject|0
1324296|NCT02292719|4345240|P1|Overall Study|Withdrawal by Subject|0
1324297|NCT02292212|4345379|P1|ViE Phase|Protocol Violation|2
1324298|NCT02292212|4345379|P1|ViE Phase|Withdrawal by Subject|1
1324299|NCT02291861|4345423|P4|Overall Study|Not specified|1
1324300|NCT02291861|4345424|P3|Overall Study|Not specified|0
1324301|NCT02291861|4345425|P2|Overall Study|Not specified|0
1324302|NCT02291861|4345426|P1|Overall Study|Not specified|0
1324303|NCT02291861|4345423|P4|Overall Study|Lost to Follow-up|0
1324304|NCT02291861|4345424|P3|Overall Study|Lost to Follow-up|4
1324305|NCT02291861|4345425|P2|Overall Study|Lost to Follow-up|1
1324306|NCT02291861|4345426|P1|Overall Study|Lost to Follow-up|2
1324307|NCT02291861|4345423|P4|Overall Study|Noncompliance|1
1324308|NCT02291861|4345424|P3|Overall Study|Noncompliance|2
1324309|NCT02291861|4345425|P2|Overall Study|Noncompliance|1
1324310|NCT02291861|4345426|P1|Overall Study|Noncompliance|1
1324311|NCT02291861|4345423|P4|Overall Study|Withdrawal by Subject|4
1324312|NCT02291861|4345424|P3|Overall Study|Withdrawal by Subject|1
1324313|NCT02291861|4345425|P2|Overall Study|Withdrawal by Subject|2
1324314|NCT02291861|4345426|P1|Overall Study|Withdrawal by Subject|1
1324315|NCT02291861|4345423|P4|Overall Study|Protocol Violation|1
1324316|NCT02291861|4345424|P3|Overall Study|Protocol Violation|0
1324317|NCT02291861|4345425|P2|Overall Study|Protocol Violation|0
1324318|NCT02291861|4345426|P1|Overall Study|Protocol Violation|1
1324319|NCT02291861|4345423|P4|Overall Study|Death|1
1324320|NCT02291861|4345424|P3|Overall Study|Death|1
1324321|NCT02291861|4345425|P2|Overall Study|Death|0
1324322|NCT02291861|4345426|P1|Overall Study|Death|0
1324323|NCT02291861|4345423|P4|Overall Study|Adverse Event|2
1324324|NCT02291861|4345424|P3|Overall Study|Adverse Event|1
1324325|NCT02291861|4345425|P2|Overall Study|Adverse Event|4
1324326|NCT02291861|4345426|P1|Overall Study|Adverse Event|2
1324327|NCT02291679|4345489|P3|Overall Study|Not Specified|2
1324328|NCT02291679|4345490|P2|Overall Study|Not Specified|4
1324329|NCT02291679|4345491|P1|Overall Study|Not Specified|2
1324330|NCT02291679|4345489|P3|Overall Study|Insufficient Therapeutic Response|7
1324331|NCT02291679|4345490|P2|Overall Study|Insufficient Therapeutic Response|5
1324332|NCT02291679|4345491|P1|Overall Study|Insufficient Therapeutic Response|5
1324333|NCT02291679|4345489|P3|Overall Study|Lost to Follow-up|9
1324335|NCT02291679|4345491|P1|Overall Study|Lost to Follow-up|12
1324336|NCT02291679|4345489|P3|Overall Study|Withdrew Consent|15
1324337|NCT02291679|4345490|P2|Overall Study|Withdrew Consent|10
1324338|NCT02291679|4345491|P1|Overall Study|Withdrew Consent|18
1324339|NCT02291679|4345489|P3|Overall Study|Protocol Violation|7
1324340|NCT02291679|4345490|P2|Overall Study|Protocol Violation|1
1324341|NCT02291679|4345491|P1|Overall Study|Protocol Violation|5
1324342|NCT02291679|4345489|P3|Overall Study|Adverse Event|19
1324343|NCT02291679|4345490|P2|Overall Study|Adverse Event|12
1324344|NCT02291679|4345491|P1|Overall Study|Adverse Event|2
1324345|NCT02291549|4345522|P2|Overall Study|Withdrawal by Subject|1
1324346|NCT02291549|4345523|P1|Overall Study|Withdrawal by Subject|0
1324347|NCT02291549|4345522|P2|Overall Study|Lost to Follow-up|0
1324348|NCT02291549|4345523|P1|Overall Study|Lost to Follow-up|1
1324349|NCT02291510|4345545|P4|Overall Study|Adverse Event|1
1324350|NCT02291510|4345546|P3|Overall Study|Adverse Event|0
1324351|NCT02291510|4345547|P2|Overall Study|Adverse Event|0
1324352|NCT02291510|4345548|P1|Overall Study|Adverse Event|0
1324353|NCT02291419|4345564|P2|Overall Study|Early study termination|5
1324354|NCT02291419|4345565|P1|Overall Study|Early study termination|1
1324355|NCT02291237|4345583|P2|Overall Study|Subject Required Prohibited Medication|0
1324356|NCT02291237|4345584|P1|Overall Study|Subject Required Prohibited Medication|2
1324357|NCT02291237|4345583|P2|Overall Study|Lost to Follow-up|2
1324358|NCT02291237|4345584|P1|Overall Study|Lost to Follow-up|0
1324359|NCT02291237|4345583|P2|Overall Study|Withdrew Consent|11
1324360|NCT02291237|4345584|P1|Overall Study|Withdrew Consent|11
1324361|NCT02291237|4345583|P2|Overall Study|Investigator's Discretion|3
1324362|NCT02291237|4345584|P1|Overall Study|Investigator's Discretion|0
1324363|NCT02291237|4345583|P2|Overall Study|Adverse Event|3
1324364|NCT02291237|4345584|P1|Overall Study|Adverse Event|1
1324365|NCT02291237|4345583|P2|Overall Study|Study Terminated by Sponsor|67
1324366|NCT02291237|4345584|P1|Overall Study|Study Terminated by Sponsor|72
1324367|NCT02290821|4345602|P2|Overall Study|Lost to Follow-up|2
1324368|NCT02290821|4345603|P1|Overall Study|Lost to Follow-up|3
1324369|NCT02290821|4345602|P2|Overall Study|Unable or unwilling to cooperate with|0
1324370|NCT02290821|4345603|P1|Overall Study|Unable or unwilling to cooperate with|2
1324371|NCT02290821|4345602|P2|Overall Study|Withdrawal by Subject|1
1324372|NCT02290821|4345603|P1|Overall Study|Withdrawal by Subject|1
1324373|NCT02290691|4345611|P2|Overall Study|Lost to Follow-up|7
1324374|NCT02290691|4345612|P1|Overall Study|Lost to Follow-up|7
1324375|NCT02290691|4345611|P2|Overall Study|Withdrawal by Subject|1
1324376|NCT02290691|4345612|P1|Overall Study|Withdrawal by Subject|1
1324377|NCT02290691|4345611|P2|Overall Study|Noncompliance|1
1324378|NCT02290691|4345612|P1|Overall Study|Noncompliance|0
1324379|NCT02289963|4345662|P2|Overall Study|Other than specified above|2
1324380|NCT02289963|4345663|P1|Overall Study|Other than specified above|0
1324381|NCT02289963|4345662|P2|Overall Study|End treatment visit outside visit window|4
1324382|NCT02289963|4345663|P1|Overall Study|End treatment visit outside visit window|0
1324383|NCT02289963|4345662|P2|Overall Study|Last injection missed|2
1324384|NCT02289963|4345663|P1|Overall Study|Last injection missed|2
1324385|NCT02289963|4345662|P2|Overall Study|Withdrawal by Subject|0
1324386|NCT02289963|4345663|P1|Overall Study|Withdrawal by Subject|1
1324387|NCT02289963|4345662|P2|Overall Study|Poor compliance to protocol|0
1324388|NCT02289963|4345663|P1|Overall Study|Poor compliance to protocol|1
1324389|NCT02289963|4345662|P2|Overall Study|Adverse Event|2
1324390|NCT02289963|4345663|P1|Overall Study|Adverse Event|1
1324391|NCT02289898|4345714|P3|Overall Study|Not specified|10
1324392|NCT02289898|4345715|P2|Overall Study|Not specified|7
1324393|NCT02289898|4345716|P1|Overall Study|Not specified|8
1324394|NCT02289898|4345714|P3|Overall Study|Use of another anticancer therapy|1
1324395|NCT02289898|4345715|P2|Overall Study|Use of another anticancer therapy|0
1324396|NCT02289898|4345716|P1|Overall Study|Use of another anticancer therapy|0
1324397|NCT02289898|4345714|P3|Overall Study|Disease progression|34
1324398|NCT02289898|4345715|P2|Overall Study|Disease progression|28
1324399|NCT02289898|4345716|P1|Overall Study|Disease progression|34
1324400|NCT02289898|4345714|P3|Overall Study|Adverse Event|5
1324401|NCT02289898|4345715|P2|Overall Study|Adverse Event|5
1324402|NCT02289898|4345716|P1|Overall Study|Adverse Event|3
1324403|NCT02289898|4345714|P3|Overall Study|Withdrawal by Subject|1
1324404|NCT02289898|4345715|P2|Overall Study|Withdrawal by Subject|4
1324405|NCT02289898|4345716|P1|Overall Study|Withdrawal by Subject|0
1324406|NCT02289898|4345714|P3|Overall Study|Physician Decision|2
1324407|NCT02289898|4345715|P2|Overall Study|Physician Decision|5
1324408|NCT02289898|4345716|P1|Overall Study|Physician Decision|2
1324409|NCT02289898|4345714|P3|Overall Study|Death|3
1324410|NCT02289898|4345715|P2|Overall Study|Death|4
1324411|NCT02289898|4345716|P1|Overall Study|Death|5
1324412|NCT02289833|4345725|P2|Overall Study|Death|8
1324413|NCT02289833|4345726|P1|Overall Study|Death|15
1324414|NCT02289833|4345725|P2|Overall Study|Lost to Follow-up|0
1324415|NCT02289833|4345726|P1|Overall Study|Lost to Follow-up|2
1324416|NCT02289833|4345725|P2|Overall Study|Disease Progression|3
1324417|NCT02289833|4345726|P1|Overall Study|Disease Progression|0
1324418|NCT02289833|4345725|P2|Overall Study|Clinical Progression|1
1324419|NCT02289833|4345726|P1|Overall Study|Clinical Progression|0
1324420|NCT02289833|4345725|P2|Overall Study|Continued Participation in Study|8
1324421|NCT02289833|4345726|P1|Overall Study|Continued Participation in Study|12
1324422|NCT02289820|4345764|P7|Overall Study|withdrawal of consent|0
1324423|NCT02289820|4345765|P6|Overall Study|withdrawal of consent|0
1324424|NCT02289820|4345766|P5|Overall Study|withdrawal of consent|0
1324425|NCT02289820|4345767|P4|Overall Study|withdrawal of consent|0
1324426|NCT02289820|4345768|P3|Overall Study|withdrawal of consent|0
1324427|NCT02289820|4345769|P2|Overall Study|withdrawal of consent|1
1324428|NCT02289820|4345770|P1|Overall Study|withdrawal of consent|0
1324429|NCT02289820|4345764|P7|Overall Study|Lost to Follow-up|1
1324430|NCT02289820|4345765|P6|Overall Study|Lost to Follow-up|1
1324431|NCT02289820|4345766|P5|Overall Study|Lost to Follow-up|0
1324432|NCT02289820|4345767|P4|Overall Study|Lost to Follow-up|1
1324433|NCT02289820|4345768|P3|Overall Study|Lost to Follow-up|3
1324434|NCT02289820|4345769|P2|Overall Study|Lost to Follow-up|0
1324435|NCT02289820|4345770|P1|Overall Study|Lost to Follow-up|0
1324436|NCT02289820|4345764|P7|Overall Study|Death|0
1324437|NCT02289820|4345765|P6|Overall Study|Death|0
1324438|NCT02289820|4345766|P5|Overall Study|Death|0
1324439|NCT02289820|4345767|P4|Overall Study|Death|0
1324440|NCT02289820|4345768|P3|Overall Study|Death|1
1324441|NCT02289820|4345769|P2|Overall Study|Death|0
1324442|NCT02289820|4345770|P1|Overall Study|Death|0
1324443|NCT02289820|4345764|P7|Overall Study|Withdrawal by Subject|1
1324444|NCT02289820|4345765|P6|Overall Study|Withdrawal by Subject|0
1324445|NCT02289820|4345766|P5|Overall Study|Withdrawal by Subject|0
1324446|NCT02289820|4345767|P4|Overall Study|Withdrawal by Subject|1
1324447|NCT02289820|4345768|P3|Overall Study|Withdrawal by Subject|2
1324448|NCT02289820|4345769|P2|Overall Study|Withdrawal by Subject|1
1324449|NCT02289820|4345770|P1|Overall Study|Withdrawal by Subject|2
1324450|NCT02289742|4345888|P4|Third Wear Period|Reason not given|1
1324451|NCT02289742|4345889|P3|Third Wear Period|Reason not given|0
1324452|NCT02289742|4345890|P2|Third Wear Period|Reason not given|0
1324453|NCT02289742|4345891|P1|Third Wear Period|Reason not given|0
1324454|NCT02289742|4345888|P4|Third Wear Period|Adverse Event|0
1324455|NCT02289742|4345889|P3|Third Wear Period|Adverse Event|0
1324456|NCT02289742|4345890|P2|Third Wear Period|Adverse Event|1
1324457|NCT02289742|4345891|P1|Third Wear Period|Adverse Event|0
1324458|NCT02289742|4345888|P4|First Wear Period|Other prior to treatment|1
1324459|NCT02289742|4345889|P3|First Wear Period|Other prior to treatment|0
1324460|NCT02289742|4345890|P2|First Wear Period|Other prior to treatment|0
1324461|NCT02289742|4345891|P1|First Wear Period|Other prior to treatment|0
1324462|NCT02289742|4345888|P4|First Wear Period|Adverse Event|0
1324463|NCT02289742|4345889|P3|First Wear Period|Adverse Event|1
1324464|NCT02289742|4345890|P2|First Wear Period|Adverse Event|0
1324465|NCT02289742|4345891|P1|First Wear Period|Adverse Event|0
1324466|NCT02289742|4345888|P4|First Wear Period|Adverse event prior to treatment|0
1324467|NCT02289742|4345889|P3|First Wear Period|Adverse event prior to treatment|0
1324468|NCT02289742|4345890|P2|First Wear Period|Adverse event prior to treatment|1
1324469|NCT02289742|4345891|P1|First Wear Period|Adverse event prior to treatment|0
1324470|NCT02289469|4345910|P2|Overall Study|Unable to match a control|0
1324471|NCT02289469|4345911|P1|Overall Study|Unable to match a control|6
1324472|NCT02289456|4345919|P1|Monotherapy Period|Miscellaneous|1
1324473|NCT02289456|4345919|P1|Monotherapy Period|Study Terminated by Sponsor|2
1324474|NCT02289456|4345919|P1|Monotherapy Period|Withdrawal by Subject|2
1324475|NCT02289456|4345919|P1|Monotherapy Period|Symptomatic Deterioration|1
1324476|NCT02289456|4345919|P1|Monotherapy Period|Progressive Disease (PD)|8
1324477|NCT02289456|4345919|P1|Monotherapy Period|Adverse Event|1
1324478|NCT02289456|4345919|P1|Monotherapy Period|Death|1
1324479|NCT02289456|4345919|P1|Induction Period|Miscellaneous|1
1324480|NCT02289456|4345919|P1|Induction Period|Withdrawal by Subject|2
1324481|NCT02289456|4345919|P1|Induction Period|Symptomatic Deterioration|4
1324482|NCT02289456|4345919|P1|Induction Period|Progressive Disease (PD)|4
1324483|NCT02289456|4345919|P1|Induction Period|Adverse Event|11
1324484|NCT02289456|4345919|P1|Induction Period|Death|2
1324485|NCT02289079|4345995|P2|Overall Study|Lost to Follow-up|1
1324486|NCT02289079|4345996|P1|Overall Study|Lost to Follow-up|0
1324487|NCT02289079|4345995|P2|Overall Study|Physician Decision|0
1324488|NCT02289079|4345996|P1|Overall Study|Physician Decision|2
1324489|NCT02288312|4346038|P3|Overall Study|Pregnancy|0
1324490|NCT02288312|4346039|P2|Overall Study|Pregnancy|0
1324491|NCT02288312|4346040|P1|Overall Study|Pregnancy|1
1324492|NCT02288091|4346078|P1|Overall Study|Screen fail|7
1324493|NCT02288091|4346078|P1|Overall Study|Lost to Follow-up|1
1324494|NCT02287883|4346088|P2|Overall Study|Non-response to survey|237
1324495|NCT02287883|4346089|P1|Overall Study|Non-response to survey|229
1324496|NCT02287883|4346088|P2|Overall Study|No longer eligible|182
1324497|NCT02287883|4346089|P1|Overall Study|No longer eligible|222
1324498|NCT02287883|4346088|P2|Overall Study|Death|7
1324499|NCT02287883|4346089|P1|Overall Study|Death|8
1324500|NCT02287623|4346254|P2|Overall Study|Protocol Violation|1
1324501|NCT02287623|4346255|P1|Overall Study|Protocol Violation|0
1324502|NCT02287610|4346271|P1|Overall Study|Excluded-investigator non-responsiveness|5
1324503|NCT02287610|4346271|P1|Overall Study|Withdrawal by Subject|8
1324504|NCT02287610|4346271|P1|Overall Study|Lost to Follow-up|3
1324505|NCT02287402|4346310|P1|Follow-up|Voluntary Withdrawal|2
1324506|NCT02287402|4346310|P1|Follow-up|Lost to Follow-up|1
1324507|NCT02287402|4346310|P1|Treatment Period|Voluntary Withdrawal|10
1324508|NCT02287402|4346310|P1|Treatment Period|Adverse Event|17
1324509|NCT02287025|4346415|P2|Overall Study|Screening failed|1
1324510|NCT02287025|4346416|P1|Overall Study|Screening failed|1
1324511|NCT02287025|4346415|P2|Overall Study|Withdrawal by Subject|2
1324512|NCT02287025|4346416|P1|Overall Study|Withdrawal by Subject|2
1324513|NCT02287025|4346415|P2|Overall Study|Adverse Event|4
1324514|NCT02287025|4346416|P1|Overall Study|Adverse Event|2
1324515|NCT02287025|4346415|P2|Overall Study|Progression of disease|2
1324516|NCT02287025|4346416|P1|Overall Study|Progression of disease|3
1324517|NCT02287025|4346415|P2|Overall Study|Not treated|0
1324518|NCT02287025|4346416|P1|Overall Study|Not treated|2
1324519|NCT02286466|4346594|P2|Overall Study|Declined Clinician Assessment|1
1324520|NCT02286466|4346595|P1|Overall Study|Declined Clinician Assessment|0
1324521|NCT02286466|4346594|P2|Overall Study|Lost to Follow-up|4
1324522|NCT02286466|4346595|P1|Overall Study|Lost to Follow-up|1
1324523|NCT02286466|4346594|P2|Overall Study|Withdrawal by Subject|2
1324524|NCT02286466|4346595|P1|Overall Study|Withdrawal by Subject|5
1324525|NCT02286466|4346594|P2|Overall Study|Death|3
1324526|NCT02286466|4346595|P1|Overall Study|Death|1
1324527|NCT02286193|4346607|P1|Overall Study|Referred: Declined service|38
1324528|NCT02286193|4346607|P1|Overall Study|Referred: unable to reach/resource sent|104
1324529|NCT02286193|4346607|P1|Overall Study|Referred: CRS unable to make contact|62
1324530|NCT02286102|4346614|P2|Overall Study|Screen Failure|1
1324531|NCT02286102|4346615|P1|Overall Study|Screen Failure|1
1324532|NCT02285998|4346627|P2|Overall Study|Other Reasons|10
1324533|NCT02285998|4346628|P1|Overall Study|Other Reasons|7
1324534|NCT02285998|4346627|P2|Overall Study|Withdrawal by Subject|61
1324535|NCT02285998|4346628|P1|Overall Study|Withdrawal by Subject|53
1324536|NCT02285998|4346627|P2|Overall Study|Lost to Follow-up|172
1324537|NCT02285998|4346628|P1|Overall Study|Lost to Follow-up|176
1324538|NCT02285998|4346627|P2|Overall Study|Physician Decision|2
1324539|NCT02285998|4346628|P1|Overall Study|Physician Decision|1
1324540|NCT02285998|4346627|P2|Overall Study|Adverse Event|8
1324541|NCT02285998|4346628|P1|Overall Study|Adverse Event|9
1324542|NCT02285777|4346680|P2|Overall Study|Lost to Follow-up|2
1324543|NCT02285777|4346681|P1|Overall Study|Lost to Follow-up|4
1324544|NCT02285777|4346680|P2|Overall Study|Withdrawal by Subject|1
1324545|NCT02285777|4346681|P1|Overall Study|Withdrawal by Subject|1
1324546|NCT02285270|4346713|P1|Overall Study|Determined to be ineligible|1
1324547|NCT02285270|4346713|P1|Overall Study|Physician Decision|3
1324548|NCT02285270|4346713|P1|Overall Study|Lost to Follow-up|1
1324549|NCT02284893|4346721|P2|52 Week (Long Term)|Non-Compliance|3
1324550|NCT02284893|4346722|P1|52 Week (Long Term)|Non-Compliance|2
1324551|NCT02284893|4346721|P2|52 Week (Long Term)|Lost to Follow-up|2
1324552|NCT02284893|4346722|P1|52 Week (Long Term)|Lost to Follow-up|2
1324553|NCT02284893|4346721|P2|52 Week (Long Term)|Withrawal of the consent by the subject|6
1324554|NCT02284893|4346722|P1|52 Week (Long Term)|Withrawal of the consent by the subject|4
1324555|NCT02284893|4346721|P2|52 Week (Long Term)|Subject no longer meets study criteria|1
1324556|NCT02284893|4346722|P1|52 Week (Long Term)|Subject no longer meets study criteria|0
1324557|NCT02284893|4346721|P2|52 Week (Long Term)|Adverse Event|1
1324558|NCT02284893|4346722|P1|52 Week (Long Term)|Adverse Event|3
1324559|NCT02284893|4346721|P2|26 Week (Short Term)|Other|1
1324560|NCT02284893|4346722|P1|26 Week (Short Term)|Other|1
1324561|NCT02284893|4346721|P2|26 Week (Short Term)|Subject no longer meets study criteria|8
1324562|NCT02284893|4346722|P1|26 Week (Short Term)|Subject no longer meets study criteria|5
1324563|NCT02284893|4346721|P2|26 Week (Short Term)|Lost to Follow-up|1
1324564|NCT02284893|4346722|P1|26 Week (Short Term)|Lost to Follow-up|3
1324565|NCT02284893|4346721|P2|26 Week (Short Term)|Withrawal of the consent by the subject|10
1324566|NCT02284893|4346722|P1|26 Week (Short Term)|Withrawal of the consent by the subject|7
1324567|NCT02284893|4346721|P2|26 Week (Short Term)|Discontinuation by the subject|2
1324568|NCT02284893|4346722|P1|26 Week (Short Term)|Discontinuation by the subject|2
1324569|NCT02284893|4346721|P2|26 Week (Short Term)|Adverse Event|9
1324570|NCT02284893|4346722|P1|26 Week (Short Term)|Adverse Event|1
1324571|NCT02284347|4346821|P1|Overall Study|Withdrawn prior to treatment|1
1324572|NCT02284347|4346821|P1|Overall Study|Lost to Follow-up|2
1324573|NCT02284243|4346829|P2|Overall Study|Adverse Event|0
1324574|NCT02284243|4346830|P1|Overall Study|Adverse Event|1
1324575|NCT02284243|4346829|P2|Overall Study|Lack of Efficacy|3
1324576|NCT02284243|4346830|P1|Overall Study|Lack of Efficacy|3
1324577|NCT02283788|4346926|P4|Overall Study|Withdrawal by Subject|1
1324578|NCT02283788|4346927|P3|Overall Study|Withdrawal by Subject|0
1324579|NCT02283788|4346928|P2|Overall Study|Withdrawal by Subject|1
1324580|NCT02283788|4346929|P1|Overall Study|Withdrawal by Subject|0
1324581|NCT02283788|4346926|P4|Overall Study|Adverse Event|1
1324582|NCT02283788|4346927|P3|Overall Study|Adverse Event|5
1324583|NCT02283788|4346928|P2|Overall Study|Adverse Event|3
1324584|NCT02283788|4346929|P1|Overall Study|Adverse Event|1
1324585|NCT02283411|4346945|P1|Overall Study|Screen Failed|28
1324586|NCT02283411|4346945|P1|Overall Study|Withdrawal by Subject|3
1324587|NCT02283268|4346953|P1|Overall Study|Withdrawal by Subject|1
1324588|NCT02282982|4347014|P1|Overall Study|Other, not specified|18
1324589|NCT02282982|4347014|P1|Overall Study|Palivizumab is ended|11
1324590|NCT02282982|4347014|P1|Overall Study|Lack of product|156
1324591|NCT02282982|4347014|P1|Overall Study|Death|4
1324592|NCT02282982|4347014|P1|Overall Study|Withdrew consent|2
1324593|NCT02282982|4347014|P1|Overall Study|Lost to Follow-up|15
1324594|NCT02282813|4347032|P3|Overall Study|Administrative reasons|0
1324595|NCT02282813|4347033|P2|Overall Study|Administrative reasons|1
1324596|NCT02282813|4347034|P1|Overall Study|Administrative reasons|0
1324597|NCT02282813|4347032|P3|Overall Study|Lack of Efficacy|0
1324598|NCT02282813|4347033|P2|Overall Study|Lack of Efficacy|0
1324599|NCT02282813|4347034|P1|Overall Study|Lack of Efficacy|1
1324600|NCT02282813|4347032|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
1324601|NCT02282813|4347033|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
1324602|NCT02282813|4347034|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
1324603|NCT02282813|4347032|P3|Overall Study|Lost to Follow-up|1
1324604|NCT02282813|4347033|P2|Overall Study|Lost to Follow-up|0
1324605|NCT02282813|4347034|P1|Overall Study|Lost to Follow-up|2
1324606|NCT02282813|4347032|P3|Overall Study|Physician Decision|1
1324607|NCT02282813|4347033|P2|Overall Study|Physician Decision|3
1324608|NCT02282813|4347034|P1|Overall Study|Physician Decision|0
1324609|NCT02282813|4347032|P3|Overall Study|Subject non-compliance|0
1324610|NCT02282813|4347033|P2|Overall Study|Subject non-compliance|4
1324611|NCT02282813|4347034|P1|Overall Study|Subject non-compliance|1
1324612|NCT02282813|4347032|P3|Overall Study|Adverse Event|1
1324613|NCT02282813|4347033|P2|Overall Study|Adverse Event|10
1324614|NCT02282813|4347034|P1|Overall Study|Adverse Event|3
1324615|NCT02282813|4347032|P3|Overall Study|Withdrawal by Subject|0
1324616|NCT02282813|4347033|P2|Overall Study|Withdrawal by Subject|5
1324617|NCT02282813|4347034|P1|Overall Study|Withdrawal by Subject|4
1324618|NCT02282631|4347080|P2|Overall Study|Lost to Follow-up|0
1324619|NCT02282631|4347081|P1|Overall Study|Lost to Follow-up|2
1324620|NCT02282605|4347122|P3|Overall Study|negative SA result on Day -1|0
1324621|NCT02282605|4347123|P2|Overall Study|negative SA result on Day -1|0
1324622|NCT02282605|4347124|P1|Overall Study|negative SA result on Day -1|3
1324623|NCT02282527|4347146|P2|Overall Study|Lack of home health aid|0
1324624|NCT02282527|4347147|P1|Overall Study|Lack of home health aid|1
1324625|NCT02282527|4347146|P2|Overall Study|Lost to Follow-up|1
1324626|NCT02282527|4347147|P1|Overall Study|Lost to Follow-up|0
1324627|NCT02281773|4347162|P5|Overall Study|Other Reason|1
1324628|NCT02281773|4347163|P4|Overall Study|Other Reason|3
1324629|NCT02281773|4347164|P3|Overall Study|Other Reason|2
1324630|NCT02281773|4347165|P2|Overall Study|Other Reason|4
1324631|NCT02281773|4347166|P1|Overall Study|Other Reason|0
1324632|NCT02281773|4347162|P5|Overall Study|Withdrawal by Subject|8
1324633|NCT02281773|4347163|P4|Overall Study|Withdrawal by Subject|6
1324634|NCT02281773|4347164|P3|Overall Study|Withdrawal by Subject|6
1324635|NCT02281773|4347165|P2|Overall Study|Withdrawal by Subject|8
1324636|NCT02281773|4347166|P1|Overall Study|Withdrawal by Subject|2
1324637|NCT02281773|4347162|P5|Overall Study|Lost to Follow-up|10
1324638|NCT02281773|4347163|P4|Overall Study|Lost to Follow-up|2
1324639|NCT02281773|4347164|P3|Overall Study|Lost to Follow-up|6
1324640|NCT02281773|4347165|P2|Overall Study|Lost to Follow-up|2
1324641|NCT02281773|4347166|P1|Overall Study|Lost to Follow-up|2
1324642|NCT02281773|4347162|P5|Overall Study|Protocol Violation|2
1324643|NCT02281773|4347163|P4|Overall Study|Protocol Violation|2
1324644|NCT02281773|4347164|P3|Overall Study|Protocol Violation|0
1324645|NCT02281773|4347165|P2|Overall Study|Protocol Violation|0
1324646|NCT02281773|4347166|P1|Overall Study|Protocol Violation|1
1324647|NCT02281773|4347162|P5|Overall Study|Adverse Event|9
1324648|NCT02281773|4347163|P4|Overall Study|Adverse Event|8
1324649|NCT02281773|4347164|P3|Overall Study|Adverse Event|4
1324650|NCT02281773|4347165|P2|Overall Study|Adverse Event|1
1324651|NCT02281773|4347166|P1|Overall Study|Adverse Event|6
1324652|NCT02281357|4347307|P2|Overall Study|Withdrawal by Subject|3
1324653|NCT02281357|4347308|P1|Overall Study|Withdrawal by Subject|4
1324654|NCT02281357|4347307|P2|Overall Study|Lost to Follow-up|0
1324655|NCT02281357|4347308|P1|Overall Study|Lost to Follow-up|1
1324656|NCT02281357|4347307|P2|Overall Study|Adverse Event|1
1324657|NCT02281357|4347308|P1|Overall Study|Adverse Event|2
1324658|NCT02281318|4347322|P2|Overall Study|Withdrawal by Subject|2
1324659|NCT02281318|4347323|P1|Overall Study|Withdrawal by Subject|6
1324660|NCT02281318|4347322|P2|Overall Study|Physician Decision|0
1324661|NCT02281318|4347323|P1|Overall Study|Physician Decision|2
1324662|NCT02281318|4347322|P2|Overall Study|Lost to Follow-up|1
1324663|NCT02281318|4347323|P1|Overall Study|Lost to Follow-up|2
1324664|NCT02281318|4347322|P2|Overall Study|Lack of Efficacy|0
1324665|NCT02281318|4347323|P1|Overall Study|Lack of Efficacy|2
1324666|NCT02281318|4347322|P2|Overall Study|Adverse Event|2
1324667|NCT02281318|4347323|P1|Overall Study|Adverse Event|2
1324668|NCT02280863|4347369|P2|Integrated Platform|Met stopping criteria|1
1324669|NCT02280863|4347370|P1|Integrated Platform|Met stopping criteria|0
1324670|NCT02280499|4347454|P1|Overall Study|Adverse Event|5
1324671|NCT02280499|4347454|P1|Overall Study|Lost to Follow-up|42
1324672|NCT02280499|4347454|P1|Overall Study|Death|14
1324673|NCT02280473|4347462|P2|Overall Study|Lost to Follow-up|1
1324674|NCT02280473|4347463|P1|Overall Study|Lost to Follow-up|0
1324675|NCT02280473|4347462|P2|Overall Study|Lack of Efficacy|1
1324676|NCT02280473|4347463|P1|Overall Study|Lack of Efficacy|0
1324677|NCT02280473|4347462|P2|Overall Study|Adverse Event|1
1324678|NCT02280473|4347463|P1|Overall Study|Adverse Event|1
1324679|NCT02280187|4347482|P1|Overall Study|Lost to Follow-up|218
1324680|NCT02279862|4347510|P2|Overall Study|Withdrawal by Subject|0
1324681|NCT02279862|4347511|P1|Overall Study|Withdrawal by Subject|1
1324682|NCT02279862|4347510|P2|Overall Study|Other|2
1324683|NCT02279862|4347511|P1|Overall Study|Other|1
1324684|NCT02279862|4347510|P2|Overall Study|Study closed by sponsor|13
1324685|NCT02279862|4347511|P1|Overall Study|Study closed by sponsor|16
1324686|NCT02279862|4347510|P2|Overall Study|Disease progression|2
1324687|NCT02279862|4347511|P1|Overall Study|Disease progression|5
1324688|NCT02279862|4347510|P2|Overall Study|Administrative reason by sponsor|1
1324689|NCT02279862|4347511|P1|Overall Study|Administrative reason by sponsor|0
1324690|NCT02279862|4347510|P2|Overall Study|No longer meets criteria|1
1324691|NCT02279862|4347511|P1|Overall Study|No longer meets criteria|0
1324692|NCT02279862|4347510|P2|Overall Study|Study drug toxicity|6
1324693|NCT02279862|4347511|P1|Overall Study|Study drug toxicity|3
1324694|NCT02279498|4347609|P2|Overall Study|Undefined|1
1324695|NCT02279498|4347610|P1|Overall Study|Undefined|2
1324696|NCT02279498|4347609|P2|Overall Study|Withdrawal by Subject|2
1324697|NCT02279498|4347610|P1|Overall Study|Withdrawal by Subject|9
1324698|NCT02279498|4347609|P2|Overall Study|Lost to Follow-up|1
1324699|NCT02279498|4347610|P1|Overall Study|Lost to Follow-up|0
1324700|NCT02279498|4347609|P2|Overall Study|Lack of Efficacy|0
1324701|NCT02279498|4347610|P1|Overall Study|Lack of Efficacy|4
1324702|NCT02279498|4347609|P2|Overall Study|Adverse Event|0
1324703|NCT02279498|4347610|P1|Overall Study|Adverse Event|3
1324704|NCT02279420|4347619|P1|Overall Study|Lost to Follow-up|23
1324705|NCT02279407|4347627|P4|Overall Study|Adverse Event|0
1324706|NCT02279407|4347628|P3|Overall Study|Adverse Event|2
1324707|NCT02279407|4347629|P2|Overall Study|Adverse Event|1
1324708|NCT02279407|4347630|P1|Overall Study|Adverse Event|1
1324709|NCT02279407|4347627|P4|Overall Study|Withdrawal by Subject|1
1324710|NCT02279407|4347628|P3|Overall Study|Withdrawal by Subject|1
1324711|NCT02279407|4347629|P2|Overall Study|Withdrawal by Subject|0
1324712|NCT02279407|4347630|P1|Overall Study|Withdrawal by Subject|1
1324713|NCT02279407|4347627|P4|Overall Study|Couldn't swallow IP; noncompliance|0
1324714|NCT02279407|4347628|P3|Overall Study|Couldn't swallow IP; noncompliance|2
1324715|NCT02279407|4347629|P2|Overall Study|Couldn't swallow IP; noncompliance|0
1324716|NCT02279407|4347630|P1|Overall Study|Couldn't swallow IP; noncompliance|0
1324717|NCT02278939|4347672|P2|Overall Study|family emergency unable to commit|0
1324718|NCT02278939|4347673|P1|Overall Study|family emergency unable to commit|2
1324719|NCT02278939|4347672|P2|Overall Study|death in family|0
1324720|NCT02278939|4347673|P1|Overall Study|death in family|1
1324721|NCT02278939|4347672|P2|Overall Study|Lost to Follow-up|1
1324722|NCT02278939|4347673|P1|Overall Study|Lost to Follow-up|1
1324723|NCT02278939|4347672|P2|Overall Study|lack of time|0
1324724|NCT02278939|4347673|P1|Overall Study|lack of time|1
1324725|NCT02278614|4347701|P2|Overall Study|left eye was not eligible|0
1324726|NCT02278614|4347702|P1|Overall Study|left eye was not eligible|1
1324727|NCT02278614|4347701|P2|Overall Study|Adverse Event|0
1324728|NCT02278614|4347702|P1|Overall Study|Adverse Event|1
1324729|NCT02278614|4347701|P2|Overall Study|Withdrawal by Subject|5
1324730|NCT02278614|4347702|P1|Overall Study|Withdrawal by Subject|3
1324731|NCT02278003|4347749|P2|Overall Study|Recognition task improperly completed|0
1324732|NCT02278003|4347750|P1|Overall Study|Recognition task improperly completed|7
1324733|NCT02278003|4347749|P2|Overall Study|Not Treated|0
1324734|NCT02278003|4347750|P1|Overall Study|Not Treated|1
1324735|NCT02278003|4347749|P2|Overall Study|Withdrawal by Subject|0
1324736|NCT02278003|4347750|P1|Overall Study|Withdrawal by Subject|11
1324737|NCT02277769|4347761|P3|Overall Study|Other than specified above|5
1324738|NCT02277769|4347762|P2|Overall Study|Other than specified above|8
1324739|NCT02277769|4347763|P1|Overall Study|Other than specified above|12
1324740|NCT02277769|4347761|P3|Overall Study|Adverse Event|4
1324741|NCT02277769|4347762|P2|Overall Study|Adverse Event|2
1324742|NCT02277769|4347763|P1|Overall Study|Adverse Event|14
1324743|NCT02277769|4347761|P3|Overall Study|Lack of Efficacy|4
1324744|NCT02277769|4347762|P2|Overall Study|Lack of Efficacy|0
1324745|NCT02277769|4347763|P1|Overall Study|Lack of Efficacy|17
1324746|NCT02277769|4347761|P3|Overall Study|Protocol Violation|5
1324747|NCT02277769|4347762|P2|Overall Study|Protocol Violation|3
1324748|NCT02277769|4347763|P1|Overall Study|Protocol Violation|3
1324749|NCT02277743|4347834|P3|Overall Study|Other than specified above|16
1324750|NCT02277743|4347835|P2|Overall Study|Other than specified above|5
1324751|NCT02277743|4347836|P1|Overall Study|Other than specified above|18
1324752|NCT02277743|4347834|P3|Overall Study|Lack of Efficacy|3
1324753|NCT02277743|4347835|P2|Overall Study|Lack of Efficacy|4
1324754|NCT02277743|4347836|P1|Overall Study|Lack of Efficacy|11
1324755|NCT02277743|4347834|P3|Overall Study|Adverse Event|6
1324756|NCT02277743|4347835|P2|Overall Study|Adverse Event|6
1324757|NCT02277743|4347836|P1|Overall Study|Adverse Event|10
1324758|NCT02277743|4347834|P3|Overall Study|Protocol Violation|1
1324759|NCT02277743|4347835|P2|Overall Study|Protocol Violation|1
1324760|NCT02277743|4347836|P1|Overall Study|Protocol Violation|1
1324761|NCT02277691|4347904|P1|Overall Study|Used Other Antihypertensive Drug|1
1324762|NCT02277691|4347904|P1|Overall Study|Lack of Efficacy|5
1324763|NCT02277691|4347904|P1|Overall Study|Voluntary Withdrawal|7
1324764|NCT02277691|4347904|P1|Overall Study|Pretreatment Event/Adverse Event|33
1324765|NCT02277119|4347950|P3|Overall Study|Protocol Violation|7
1324766|NCT02277119|4347951|P2|Overall Study|Protocol Violation|3
1324767|NCT02277119|4347952|P1|Overall Study|Protocol Violation|2
1324768|NCT02277119|4347950|P3|Overall Study|Lack of Efficacy|1
1324769|NCT02277119|4347951|P2|Overall Study|Lack of Efficacy|1
1324770|NCT02277119|4347952|P1|Overall Study|Lack of Efficacy|1
1324771|NCT02276612|4347979|P2|Overall Study|Lost to Follow-up|0
1324772|NCT02276612|4347980|P1|Overall Study|Lost to Follow-up|1
1324773|NCT02276612|4347979|P2|Overall Study|Withdrew Consent|0
1324774|NCT02276612|4347980|P1|Overall Study|Withdrew Consent|1
1324775|NCT02276612|4347979|P2|Overall Study|Pregnancy|0
1324776|NCT02276612|4347980|P1|Overall Study|Pregnancy|1
1324777|NCT02276612|4347979|P2|Overall Study|Death|0
1324778|NCT02276612|4347980|P1|Overall Study|Death|1
1324779|NCT02276560|4348003|P3|Overall Study|Adverse Event|0
1324780|NCT02276560|4348004|P2|Overall Study|Adverse Event|0
1324781|NCT02276560|4348005|P1|Overall Study|Adverse Event|1
1324782|NCT02276222|4348126|P2|Overall Study|subject withdrew after randomization|0
1324783|NCT02276222|4348127|P1|Overall Study|subject withdrew after randomization|1
1324784|NCT02276222|4348126|P2|Overall Study|sheduling conflict|0
1324785|NCT02276222|4348127|P1|Overall Study|sheduling conflict|1
1324786|NCT02276222|4348126|P2|Overall Study|Physician Decision|1
1324787|NCT02276222|4348127|P1|Overall Study|Physician Decision|2
1324788|NCT02276222|4348126|P2|Overall Study|Lost to Follow-up|5
1324789|NCT02276222|4348127|P1|Overall Study|Lost to Follow-up|15
1324790|NCT02276222|4348126|P2|Overall Study|sponsor decision|3
1324791|NCT02276222|4348127|P1|Overall Study|sponsor decision|0
1324792|NCT02276222|4348126|P2|Overall Study|non compliance with study medication|2
1324793|NCT02276222|4348127|P1|Overall Study|non compliance with study medication|6
1324794|NCT02276222|4348126|P2|Overall Study|Withdrawal by Subject|33
1324795|NCT02276222|4348127|P1|Overall Study|Withdrawal by Subject|79
1324796|NCT02276222|4348126|P2|Overall Study|Protocol Violation|2
1324797|NCT02276222|4348127|P1|Overall Study|Protocol Violation|3
1324798|NCT02276222|4348126|P2|Overall Study|Lack of Efficacy|3
1324799|NCT02276222|4348127|P1|Overall Study|Lack of Efficacy|13
1324800|NCT02276222|4348126|P2|Overall Study|Death|4
1324801|NCT02276222|4348127|P1|Overall Study|Death|3
1324802|NCT02276222|4348126|P2|Overall Study|Adverse Event|11
1324803|NCT02276222|4348127|P1|Overall Study|Adverse Event|62
1324804|NCT02276040|4348151|P1|Overall Study|Physician Decision|15
1324805|NCT02275611|4348175|P4|Inpatient Withdrawal|Withdrawal by Subject|0
1324806|NCT02275611|4348176|P3|Inpatient Withdrawal|Withdrawal by Subject|0
1324807|NCT02275611|4348177|P2|Inpatient Withdrawal|Withdrawal by Subject|0
1324808|NCT02275611|4348178|P1|Inpatient Withdrawal|Withdrawal by Subject|1
1324809|NCT02275546|4348190|P2|Treatment Period 2|Protocol Violation|1
1324810|NCT02275546|4348191|P1|Treatment Period 2|Protocol Violation|0
1324811|NCT02275546|4348190|P2|Treatment Period 2|Withdrawal by Subject|1
1324812|NCT02275546|4348191|P1|Treatment Period 2|Withdrawal by Subject|2
1324813|NCT02275481|4348201|P2|Overall Study|Physician Decision|1
1324814|NCT02275481|4348202|P1|Overall Study|Physician Decision|0
1324815|NCT02275481|4348201|P2|Overall Study|all other reasons combined|1
1324816|NCT02275481|4348202|P1|Overall Study|all other reasons combined|2
1324817|NCT02275481|4348201|P2|Overall Study|Withdrawal by Subject|0
1324818|NCT02275481|4348202|P1|Overall Study|Withdrawal by Subject|3
1324819|NCT02275481|4348201|P2|Overall Study|Lost to Follow-up|0
1324820|NCT02275481|4348202|P1|Overall Study|Lost to Follow-up|2
1324821|NCT02275481|4348201|P2|Overall Study|Death|1
1324822|NCT02275481|4348202|P1|Overall Study|Death|2
1324823|NCT02275364|4348208|P2|Period 1|Other reason|0
1324824|NCT02275364|4348209|P1|Period 1|Other reason|1
1324825|NCT02275364|4348208|P2|Period 1|Withdrawal by Subject|0
1324826|NCT02275364|4348209|P1|Period 1|Withdrawal by Subject|1
1324827|NCT02275052|4348270|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
1324828|NCT02275052|4348271|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1324829|NCT02275052|4348272|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1324830|NCT02275052|4348273|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1324831|NCT02275052|4348270|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
1324832|NCT02275052|4348271|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
1324833|NCT02275052|4348272|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
1324834|NCT02275052|4348273|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
1324835|NCT02275052|4348270|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
1324836|NCT02275052|4348271|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1324837|NCT02275052|4348272|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1324838|NCT02275052|4348273|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1324839|NCT02275052|4348270|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
1324840|NCT02275052|4348271|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
1324841|NCT02275052|4348272|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
1324842|NCT02275052|4348273|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
1324843|NCT02275052|4348270|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
1324844|NCT02275052|4348271|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
1324845|NCT02275052|4348272|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
1324846|NCT02275052|4348273|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
1324847|NCT02275052|4348270|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
1324848|NCT02275052|4348271|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
1324849|NCT02275052|4348272|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
1324850|NCT02275052|4348273|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
1324851|NCT02275052|4348270|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
1324852|NCT02275052|4348271|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
1324853|NCT02275052|4348272|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
1324854|NCT02275052|4348273|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
1324855|NCT02275052|4348270|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
1324856|NCT02275052|4348271|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
1324857|NCT02275052|4348272|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
1324858|NCT02275052|4348273|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
1324859|NCT02275052|4348270|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1324860|NCT02275052|4348271|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1324861|NCT02275052|4348272|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
1324862|NCT02275052|4348273|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
1324863|NCT02275052|4348270|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
1324864|NCT02275052|4348271|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
1324865|NCT02275052|4348272|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
1324866|NCT02275052|4348273|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
1324867|NCT02275052|4348270|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1324868|NCT02275052|4348271|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1324869|NCT02275052|4348272|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1324870|NCT02275052|4348273|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1324871|NCT02274948|4348287|P2|Overall Study|Left the area|3
1324872|NCT02274948|4348288|P1|Overall Study|Left the area|4
1324873|NCT02274948|4348287|P2|Overall Study|Stopped on family Practitioner advice|5
1324874|NCT02274948|4348288|P1|Overall Study|Stopped on family Practitioner advice|2
1324875|NCT02274948|4348287|P2|Overall Study|Withdrawal by Subject|58
1324876|NCT02274948|4348288|P1|Overall Study|Withdrawal by Subject|64
1324877|NCT02274948|4348287|P2|Overall Study|Lost to Follow-up|25
1324878|NCT02274948|4348288|P1|Overall Study|Lost to Follow-up|28
1324879|NCT02274792|4348329|P1|Overall Study|Sponsor Decision|2
1324880|NCT02274792|4348329|P1|Overall Study|Protocol Specified Criteria|2
1324881|NCT02274792|4348329|P1|Overall Study|Lost to Follow-up|8
1324882|NCT02274792|4348329|P1|Overall Study|Withdrawal by Subject|13
1324883|NCT02274766|4348339|P2|Overall Study|Adverse Event|1
1324884|NCT02274766|4348340|P1|Overall Study|Adverse Event|0
1324885|NCT02274766|4348339|P2|Overall Study|Subject Unwilling to Proceed|1
1324886|NCT02274766|4348340|P1|Overall Study|Subject Unwilling to Proceed|0
1324887|NCT02274766|4348339|P2|Overall Study|Did Not Receive Study Drug|1
1324888|NCT02274766|4348340|P1|Overall Study|Did Not Receive Study Drug|1
1324889|NCT02274766|4348339|P2|Overall Study|Withdrawal by Subject|6
1324890|NCT02274766|4348340|P1|Overall Study|Withdrawal by Subject|3
1324891|NCT02274558|4348386|P3|Overall Study|Physician Decision|1
1324892|NCT02274558|4348387|P2|Overall Study|Physician Decision|2
1324893|NCT02274558|4348388|P1|Overall Study|Physician Decision|0
1324894|NCT02274558|4348386|P3|Overall Study|Lost to Follow-up|1
1324895|NCT02274558|4348387|P2|Overall Study|Lost to Follow-up|1
1324896|NCT02274558|4348388|P1|Overall Study|Lost to Follow-up|2
1324897|NCT02274558|4348386|P3|Overall Study|Death|1
1324898|NCT02274558|4348387|P2|Overall Study|Death|0
1324899|NCT02274558|4348388|P1|Overall Study|Death|0
1324900|NCT02274558|4348386|P3|Overall Study|Withdrawal by Subject|4
1324901|NCT02274558|4348387|P2|Overall Study|Withdrawal by Subject|5
1324902|NCT02274558|4348388|P1|Overall Study|Withdrawal by Subject|1
1324903|NCT02274558|4348386|P3|Overall Study|Non-compliance|0
1324904|NCT02274558|4348387|P2|Overall Study|Non-compliance|1
1324905|NCT02274558|4348388|P1|Overall Study|Non-compliance|2
1324906|NCT02274558|4348386|P3|Overall Study|Adverse Event|2
1324907|NCT02274558|4348387|P2|Overall Study|Adverse Event|4
1324908|NCT02274558|4348388|P1|Overall Study|Adverse Event|2
1324909|NCT02273973|4348404|P2|Overall Study|Reason not specified|1
1324910|NCT02273973|4348405|P1|Overall Study|Reason not specified|0
1324911|NCT02273973|4348404|P2|Overall Study|Physician Decision|1
1324912|NCT02273973|4348405|P1|Overall Study|Physician Decision|0
1324913|NCT02273973|4348404|P2|Overall Study|Lost to Follow-up|1
1324914|NCT02273973|4348405|P1|Overall Study|Lost to Follow-up|0
1324915|NCT02273973|4348404|P2|Overall Study|Progression of disease|2
1324916|NCT02273973|4348405|P1|Overall Study|Progression of disease|0
1324917|NCT02273973|4348404|P2|Overall Study|Protocol Violation|0
1324918|NCT02273973|4348405|P1|Overall Study|Protocol Violation|1
1324919|NCT02273973|4348404|P2|Overall Study|Non-compliance|0
1324920|NCT02273973|4348405|P1|Overall Study|Non-compliance|1
1324921|NCT02273973|4348404|P2|Overall Study|Death|0
1324922|NCT02273973|4348405|P1|Overall Study|Death|1
1324923|NCT02273973|4348404|P2|Overall Study|Withdrawal by Subject|3
1324924|NCT02273973|4348405|P1|Overall Study|Withdrawal by Subject|2
1324925|NCT02273973|4348404|P2|Overall Study|Adverse Event|0
1324926|NCT02273973|4348405|P1|Overall Study|Adverse Event|4
1324927|NCT02273908|4348447|P2|Overall Study|Withdrawal by Subject|2
1324928|NCT02273908|4348448|P1|Overall Study|Withdrawal by Subject|4
1324929|NCT02273908|4348447|P2|Overall Study|Did not meet entrance criteria|2
1324930|NCT02273908|4348448|P1|Overall Study|Did not meet entrance criteria|3
1324931|NCT02273908|4348447|P2|Overall Study|Lost to Follow-up|1
1324932|NCT02273908|4348448|P1|Overall Study|Lost to Follow-up|10
1324933|NCT02273908|4348447|P2|Overall Study|Adverse Event|0
1324934|NCT02273908|4348448|P1|Overall Study|Adverse Event|16
1324935|NCT02273752|4348470|P1|Overall Study|Trial was terminated early|2
1324936|NCT02273180|4348514|P2|Overall Study|Other than specified above|10
1324937|NCT02273180|4348515|P1|Overall Study|Other than specified above|21
1324938|NCT02273180|4348514|P2|Overall Study|Hypoglycemia(not reported as serious AE)|0
1324939|NCT02273180|4348515|P1|Overall Study|Hypoglycemia(not reported as serious AE)|1
1324940|NCT02273180|4348514|P2|Overall Study|Randomized but not treated|0
1324941|NCT02273180|4348515|P1|Overall Study|Randomized but not treated|1
1324942|NCT02273180|4348514|P2|Overall Study|Protocol Violation|7
1324943|NCT02273180|4348515|P1|Overall Study|Protocol Violation|1
1324944|NCT02273180|4348514|P2|Overall Study|Lack of Efficacy|0
1324945|NCT02273180|4348515|P1|Overall Study|Lack of Efficacy|1
1324946|NCT02273180|4348514|P2|Overall Study|Adverse Event|2
1324947|NCT02273180|4348515|P1|Overall Study|Adverse Event|2
1324948|NCT02273167|4348540|P3|Overall Study|Various|8
1324949|NCT02273167|4348541|P2|Overall Study|Various|9
1324950|NCT02273167|4348542|P1|Overall Study|Various|10
1324951|NCT02273167|4348540|P3|Overall Study|Withdrawal by Subject|11
1324952|NCT02273167|4348541|P2|Overall Study|Withdrawal by Subject|12
1324953|NCT02273167|4348542|P1|Overall Study|Withdrawal by Subject|10
1324954|NCT02273167|4348540|P3|Overall Study|Lost to Follow-up|1
1324955|NCT02273167|4348541|P2|Overall Study|Lost to Follow-up|1
1324956|NCT02273167|4348542|P1|Overall Study|Lost to Follow-up|0
1324957|NCT02273167|4348540|P3|Overall Study|Protocol Violation|1
1324958|NCT02273167|4348541|P2|Overall Study|Protocol Violation|1
1324959|NCT02273167|4348542|P1|Overall Study|Protocol Violation|3
1324960|NCT02273167|4348540|P3|Overall Study|Adverse Event|0
1324961|NCT02273167|4348541|P2|Overall Study|Adverse Event|0
1324962|NCT02273167|4348542|P1|Overall Study|Adverse Event|1
1324963|NCT02273141|4348567|P2|Overall Study|Various|6
1324964|NCT02273141|4348568|P1|Overall Study|Various|6
1324965|NCT02273141|4348567|P2|Overall Study|Withdrawal by Subject|15
1324966|NCT02273141|4348568|P1|Overall Study|Withdrawal by Subject|10
1324967|NCT02273141|4348567|P2|Overall Study|Lost to Follow-up|3
1324968|NCT02273141|4348568|P1|Overall Study|Lost to Follow-up|1
1324969|NCT02273141|4348567|P2|Overall Study|Adverse Event|1
1324970|NCT02273141|4348568|P1|Overall Study|Adverse Event|0
1324971|NCT02273050|4348636|P3|Overall Study|Protocol Violation|4
1324972|NCT02273050|4348637|P2|Overall Study|Protocol Violation|1
1324973|NCT02273050|4348638|P1|Overall Study|Protocol Violation|3
1324974|NCT02273050|4348636|P3|Overall Study|Lost to Follow-up|3
1324975|NCT02273050|4348637|P2|Overall Study|Lost to Follow-up|2
1324976|NCT02273050|4348638|P1|Overall Study|Lost to Follow-up|0
1324977|NCT02273050|4348636|P3|Overall Study|Withdrawal by Subject|16
1324978|NCT02273050|4348637|P2|Overall Study|Withdrawal by Subject|14
1324979|NCT02273050|4348638|P1|Overall Study|Withdrawal by Subject|17
1324980|NCT02273050|4348636|P3|Overall Study|Lack of Efficacy|1
1324981|NCT02273050|4348637|P2|Overall Study|Lack of Efficacy|1
1324982|NCT02273050|4348638|P1|Overall Study|Lack of Efficacy|0
1324983|NCT02273050|4348636|P3|Overall Study|Dev. of study spec. withdrawal criteria|1
1324984|NCT02273050|4348637|P2|Overall Study|Dev. of study spec. withdrawal criteria|1
1324985|NCT02273050|4348638|P1|Overall Study|Dev. of study spec. withdrawal criteria|0
1324986|NCT02273050|4348636|P3|Overall Study|Death|1
1324987|NCT02273050|4348637|P2|Overall Study|Death|0
1324988|NCT02273050|4348638|P1|Overall Study|Death|0
1324989|NCT02273050|4348636|P3|Overall Study|Adverse Event|3
1324990|NCT02273050|4348637|P2|Overall Study|Adverse Event|3
1324991|NCT02273050|4348638|P1|Overall Study|Adverse Event|4
1324992|NCT02273037|4348666|P2|Overall Study|Other complication|0
1324993|NCT02273037|4348667|P1|Overall Study|Other complication|2
1324994|NCT02273037|4348666|P2|Overall Study|Multiple delivery|2
1324995|NCT02273037|4348667|P1|Overall Study|Multiple delivery|2
1324996|NCT02273037|4348666|P2|Overall Study|Breech delivery|3
1324997|NCT02273037|4348667|P1|Overall Study|Breech delivery|2
1324998|NCT02273037|4348666|P2|Overall Study|Delivered before monitoring initiated|3
1324999|NCT02273037|4348667|P1|Overall Study|Delivered before monitoring initiated|1
1325000|NCT02273037|4348666|P2|Overall Study|Lost to Follow-up|0
1325001|NCT02273037|4348667|P1|Overall Study|Lost to Follow-up|1
1325002|NCT02272803|4348679|P2|Overall Study|Withdrawal by Subject|0
1325003|NCT02272803|4348680|P1|Overall Study|Withdrawal by Subject|1
1325004|NCT02272803|4348679|P2|Overall Study|Poor/non-compliance|1
1325005|NCT02272803|4348680|P1|Overall Study|Poor/non-compliance|0
1325006|NCT02272803|4348679|P2|Overall Study|Subject moved to care facility|1
1325007|NCT02272803|4348680|P1|Overall Study|Subject moved to care facility|0
1325008|NCT02272803|4348679|P2|Overall Study|Maximum clinical benefit|1
1325009|NCT02272803|4348680|P1|Overall Study|Maximum clinical benefit|1
1325010|NCT02272803|4348679|P2|Overall Study|Subj request to discontinue study trt|4
1325011|NCT02272803|4348680|P1|Overall Study|Subj request to discontinue study trt|1
1325012|NCT02272803|4348679|P2|Overall Study|Study drug toxicity|4
1325013|NCT02272803|4348680|P1|Overall Study|Study drug toxicity|1
1325014|NCT02272803|4348679|P2|Overall Study|Adverse Event unrelated to study drug|4
1325015|NCT02272803|4348680|P1|Overall Study|Adverse Event unrelated to study drug|1
1325016|NCT02272803|4348679|P2|Overall Study|Disease progression|2
1325017|NCT02272803|4348680|P1|Overall Study|Disease progression|4
1325018|NCT02272725|4348693|P2|Overall Study|equipment malfunction|0
1325019|NCT02272725|4348694|P1|Overall Study|equipment malfunction|2
1325020|NCT02271984|4348704|P12|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1325021|NCT02271984|4348705|P11|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1325022|NCT02271984|4348706|P10|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1325023|NCT02271984|4348707|P9|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1325024|NCT02271984|4348708|P8|Washout Period 4 (7 Days)|Withdrawal by Subject|1
1325025|NCT02271984|4348709|P7|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1325026|NCT02271984|4348710|P6|Washout Period 4 (7 Days)|Withdrawal by Subject|1
1325027|NCT02271984|4348711|P5|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1325028|NCT02271984|4348712|P4|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1325029|NCT02271984|4348713|P3|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1325030|NCT02271984|4348714|P2|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1325031|NCT02271984|4348715|P1|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1325032|NCT02271945|4348804|P2|Overall Study|Other|1
1325033|NCT02271945|4348805|P1|Overall Study|Other|1
1325034|NCT02271945|4348804|P2|Overall Study|Withdrawal by Subject|1
1325035|NCT02271945|4348805|P1|Overall Study|Withdrawal by Subject|1
1325036|NCT02271945|4348804|P2|Overall Study|Death|3
1325037|NCT02271945|4348805|P1|Overall Study|Death|3
1325038|NCT02271880|4348843|P2|Overall Study|Premature discontinuation of study|4
1325039|NCT02271880|4348844|P1|Overall Study|Premature discontinuation of study|3
1325040|NCT02271854|4348850|P1|Overall Study|Lost to Follow-up|1
1325041|NCT02271854|4348850|P1|Overall Study|Unable or unwilling to cooperate with st|1
1325042|NCT02271854|4348850|P1|Overall Study|Withdrawal by Subject|2
1325043|NCT02271529|4348890|P1|Overall Study|Withdrawal by Subject|1
1325044|NCT02270944|4348927|P2|Overall Study|Withdrawal by Subject|1
1325045|NCT02270944|4348928|P1|Overall Study|Withdrawal by Subject|2
1325046|NCT02270944|4348927|P2|Overall Study|Lost to Follow-up|4
1325047|NCT02270944|4348928|P1|Overall Study|Lost to Follow-up|9
1325048|NCT02270684|4348944|P2|Overall Study|Study terminated|0
1325049|NCT02270684|4348945|P1|Overall Study|Study terminated|1
1325050|NCT02270684|4348944|P2|Overall Study|Lost to Follow-up|3
1325051|NCT02270684|4348945|P1|Overall Study|Lost to Follow-up|0
1325052|NCT02270515|4348951|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
1325053|NCT02270515|4348951|P1|Intervention Period 3: 12-18 Months|Death|3
1325054|NCT02270515|4348951|P1|Intervention Period 3: 12-18 Months|Received transplant|2
1325055|NCT02270515|4348951|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
1325056|NCT02270515|4348951|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
1325057|NCT02270515|4348951|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
1325058|NCT02270515|4348951|P1|Intervention Period 2: 6-12 Months|Death|5
1325059|NCT02270515|4348951|P1|Intervention Period 2: 6-12 Months|Received transplant|1
1325060|NCT02270515|4348951|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
1325061|NCT02270515|4348951|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
1325062|NCT02270515|4348951|P1|Intervention Period 1: 0-6 Months|Death|7
1325063|NCT02270515|4348951|P1|Intervention Period 1: 0-6 Months|Received transplant|3
1325064|NCT02270515|4348951|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
1325065|NCT02270515|4348951|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
1325066|NCT02269943|4348968|P2|Follow-Up Survival Period|Alive|8
1325067|NCT02269943|4348969|P1|Follow-Up Survival Period|Alive|2
1325068|NCT02269943|4348968|P2|Follow-Up Survival Period|Lost to Follow-up|2
1325069|NCT02269943|4348969|P1|Follow-Up Survival Period|Lost to Follow-up|0
1325070|NCT02269943|4348968|P2|Follow-Up Survival Period|Death|16
1325071|NCT02269943|4348969|P1|Follow-Up Survival Period|Death|3
1325072|NCT02269943|4348968|P2|Treatment Period|Symptomatic Deterioration|2
1325073|NCT02269943|4348969|P1|Treatment Period|Symptomatic Deterioration|0
1325074|NCT02269943|4348968|P2|Treatment Period|Progressive Disease|17
1325075|NCT02269943|4348969|P1|Treatment Period|Progressive Disease|5
1325076|NCT02269943|4348968|P2|Treatment Period|Adverse Event|10
1325077|NCT02269943|4348969|P1|Treatment Period|Adverse Event|1
1325078|NCT02269943|4348968|P2|Treatment Period|Death|1
1325079|NCT02269943|4348969|P1|Treatment Period|Death|0
1325080|NCT02269709|4348997|P1|Six Month Follow-up|Lost to Follow-up|12
1325081|NCT02269709|4348997|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
1325082|NCT02269709|4348997|P1|Time of Enrollment|Withdrawal by Subject|3
1325083|NCT02269657|4349002|P1|Overall Study|Protocol Violation|3
1325084|NCT02269475|4349022|P2|Overall Study|Withdrawal by Subject|1
1325085|NCT02269475|4349023|P1|Overall Study|Withdrawal by Subject|0
1325086|NCT02269475|4349022|P2|Overall Study|Meet Exclusion Criteria No. 17|0
1325087|NCT02269475|4349023|P1|Overall Study|Meet Exclusion Criteria No. 17|3
1325088|NCT02269098|4349036|P2|Overall Study|Lost to Follow-up|9
1325089|NCT02269098|4349037|P1|Overall Study|Lost to Follow-up|14
1325090|NCT02268864|4349084|P3|Overall Study|Death|0
1325091|NCT02268864|4349085|P2|Overall Study|Death|1
1325092|NCT02268864|4349086|P1|Overall Study|Death|0
1325093|NCT02268864|4349084|P3|Overall Study|Withdrawal by Subject|0
1325094|NCT02268864|4349085|P2|Overall Study|Withdrawal by Subject|0
1325095|NCT02268864|4349086|P1|Overall Study|Withdrawal by Subject|2
1325096|NCT02268526|4349111|P3|Overall Study|Subject/guardian decision|3
1325097|NCT02268526|4349112|P2|Overall Study|Subject/guardian decision|7
1325098|NCT02268526|4349113|P1|Overall Study|Subject/guardian decision|0
1325099|NCT02268526|4349111|P3|Overall Study|Physician Decision|1
1325100|NCT02268526|4349112|P2|Overall Study|Physician Decision|0
1325101|NCT02268526|4349113|P1|Overall Study|Physician Decision|0
1325102|NCT02268526|4349111|P3|Overall Study|protocol deviation|0
1325103|NCT02268526|4349112|P2|Overall Study|protocol deviation|1
1325104|NCT02268526|4349113|P1|Overall Study|protocol deviation|0
1325105|NCT02268526|4349111|P3|Overall Study|Death|0
1325106|NCT02268526|4349112|P2|Overall Study|Death|11
1325107|NCT02268526|4349113|P1|Overall Study|Death|1
1325108|NCT02268526|4349111|P3|Overall Study|Adverse Event|1
1325109|NCT02268526|4349112|P2|Overall Study|Adverse Event|2
1325110|NCT02268526|4349113|P1|Overall Study|Adverse Event|0
1325111|NCT02268396|4349134|P1|Overall Study|2 Subjects no Day 29 Assessment|2
1325112|NCT02268396|4349134|P1|Overall Study|Protocol-Specified Criteria|2
1325113|NCT02268396|4349134|P1|Overall Study|Lost to Follow-up|2
1325114|NCT02268396|4349134|P1|Overall Study|Withdrawal by Subject|1
1325115|NCT02268396|4349134|P1|Overall Study|Administrative|2
1325116|NCT02268396|4349134|P1|Overall Study|Adverse Event|3
1325117|NCT02268214|4349146|P3|Overall Study|Other reasons|3
1325118|NCT02268214|4349147|P2|Overall Study|Other reasons|2
1325119|NCT02268214|4349148|P1|Overall Study|Other reasons|3
1325120|NCT02268214|4349146|P3|Overall Study|Poor/non-compliance|2
1325121|NCT02268214|4349147|P2|Overall Study|Poor/non-compliance|0
1325122|NCT02268214|4349148|P1|Overall Study|Poor/non-compliance|2
1325123|NCT02268214|4349146|P3|Overall Study|Subject request to discontinue treatment|4
1325124|NCT02268214|4349147|P2|Overall Study|Subject request to discontinue treatment|5
1325125|NCT02268214|4349148|P1|Overall Study|Subject request to discontinue treatment|6
1325126|NCT02268214|4349146|P3|Overall Study|Withdrawal by Subject|6
1325127|NCT02268214|4349147|P2|Overall Study|Withdrawal by Subject|2
1325128|NCT02268214|4349148|P1|Overall Study|Withdrawal by Subject|3
1325129|NCT02268214|4349146|P3|Overall Study|Adverse Event|9
1325130|NCT02268214|4349147|P2|Overall Study|Adverse Event|8
1325131|NCT02268214|4349148|P1|Overall Study|Adverse Event|6
1325132|NCT02268214|4349146|P3|Overall Study|Lack of Efficacy|1
1325133|NCT02268214|4349147|P2|Overall Study|Lack of Efficacy|0
1325134|NCT02268214|4349148|P1|Overall Study|Lack of Efficacy|1
1325135|NCT02268214|4349146|P3|Overall Study|Lost to Follow-up|2
1325136|NCT02268214|4349147|P2|Overall Study|Lost to Follow-up|2
1325137|NCT02268214|4349148|P1|Overall Study|Lost to Follow-up|2
1325138|NCT02268214|4349146|P3|Overall Study|Pregnancy|1
1325139|NCT02268214|4349147|P2|Overall Study|Pregnancy|2
1325140|NCT02268214|4349148|P1|Overall Study|Pregnancy|1
1325141|NCT02268214|4349146|P3|Overall Study|Subject no longer meets study criteria|0
1325142|NCT02268214|4349147|P2|Overall Study|Subject no longer meets study criteria|2
1325143|NCT02268214|4349148|P1|Overall Study|Subject no longer meets study criteria|0
1325144|NCT02268058|4349178|P4|Overall Study|Protocol Violation|0
1325145|NCT02268058|4349179|P3|Overall Study|Protocol Violation|0
1325146|NCT02268058|4349180|P2|Overall Study|Protocol Violation|0
1325147|NCT02268058|4349181|P1|Overall Study|Protocol Violation|1
1325148|NCT02267824|4349223|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
1325149|NCT02267824|4349224|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
1325150|NCT02267824|4349223|P2|Overall Study|Protocol Violation|0
1325151|NCT02267824|4349224|P1|Overall Study|Protocol Violation|3
1325152|NCT02267824|4349223|P2|Overall Study|Lost to Follow-up|0
1325153|NCT02267824|4349224|P1|Overall Study|Lost to Follow-up|4
1325154|NCT02267824|4349223|P2|Overall Study|Pregnancy|1
1325155|NCT02267824|4349224|P1|Overall Study|Pregnancy|1
1325156|NCT02267187|4349267|P1|Overall Study|Screen fail|3
1325157|NCT02267187|4349267|P1|Overall Study|Physician Decision|2
1325158|NCT02267135|4349275|P2|Period 2 (Randomized Set)|Withdrawal by Subject|0
1325159|NCT02267135|4349276|P1|Period 2 (Randomized Set)|Withdrawal by Subject|1
1325160|NCT02267135|4349275|P2|Period 2 (Randomized Set)|Adverse Event|0
1325161|NCT02267135|4349276|P1|Period 2 (Randomized Set)|Adverse Event|2
1325162|NCT02267135|4349275|P2|Period 2 (Randomized Set)|Lost to Follow-up|1
1325163|NCT02267135|4349276|P1|Period 2 (Randomized Set)|Lost to Follow-up|1
1325164|NCT02267135|4349275|P2|Period 1 (Randomized Set)|Lost to Follow-up|1
1325165|NCT02267135|4349276|P1|Period 1 (Randomized Set)|Lost to Follow-up|0
1325166|NCT02267135|4349275|P2|Period 1 (Randomized Set)|Withdrawal by Subject|3
1325167|NCT02267135|4349276|P1|Period 1 (Randomized Set)|Withdrawal by Subject|1
1325168|NCT02266875|4349316|P2|Overall Study|Lost to Follow-up|0
1325169|NCT02266875|4349317|P1|Overall Study|Lost to Follow-up|2
1325170|NCT02266875|4349316|P2|Overall Study|Withdrawal by Subject|0
1325171|NCT02266875|4349317|P1|Overall Study|Withdrawal by Subject|9
1325172|NCT02266381|4349395|P3|Overall Study|Physician Decision|4
1325173|NCT02266381|4349396|P2|Overall Study|Physician Decision|5
1325174|NCT02266381|4349397|P1|Overall Study|Physician Decision|3
1325175|NCT02265796|4349464|P2|Overall Study|Withdrawal by Subject|1
1325176|NCT02265796|4349465|P1|Overall Study|Withdrawal by Subject|1
1325177|NCT02265796|4349464|P2|Overall Study|started on excluded medication|0
1325178|NCT02265796|4349465|P1|Overall Study|started on excluded medication|1
1325179|NCT02265796|4349464|P2|Overall Study|Death|0
1325180|NCT02265796|4349465|P1|Overall Study|Death|1
1325181|NCT02265237|4349483|P4|As Treated (Overall Study)|Other|1
1325182|NCT02265237|4349484|P3|As Treated (Overall Study)|Other|3
1325183|NCT02265237|4349485|P2|As Treated (Overall Study)|Other|0
1325184|NCT02265237|4349486|P1|As Treated (Overall Study)|Other|2
1325185|NCT02265237|4349483|P4|As Treated (Overall Study)|Lost to Follow-up|0
1325186|NCT02265237|4349484|P3|As Treated (Overall Study)|Lost to Follow-up|6
1325187|NCT02265237|4349485|P2|As Treated (Overall Study)|Lost to Follow-up|2
1325188|NCT02265237|4349486|P1|As Treated (Overall Study)|Lost to Follow-up|1
1325189|NCT02265237|4349483|P4|As Treated (Overall Study)|Withdrawal by Subject|0
1325190|NCT02265237|4349484|P3|As Treated (Overall Study)|Withdrawal by Subject|1
1325191|NCT02265237|4349485|P2|As Treated (Overall Study)|Withdrawal by Subject|0
1325192|NCT02265237|4349486|P1|As Treated (Overall Study)|Withdrawal by Subject|1
1325193|NCT02265237|4349483|P4|As Treated (Overall Study)|Adverse Event|0
1325194|NCT02265237|4349484|P3|As Treated (Overall Study)|Adverse Event|0
1325195|NCT02265237|4349485|P2|As Treated (Overall Study)|Adverse Event|1
1325196|NCT02265237|4349486|P1|As Treated (Overall Study)|Adverse Event|1
1325197|NCT02264821|4349516|P3|Overall Study|Protocol Violation|6
1325198|NCT02264821|4349517|P2|Overall Study|Protocol Violation|3
1325199|NCT02264821|4349518|P1|Overall Study|Protocol Violation|1
1325200|NCT02263365|4349580|P2|Overall Study|Physician Decision|18
1325201|NCT02263365|4349581|P1|Overall Study|Physician Decision|22
1325202|NCT02262754|4349636|P3|Overall Study|Other|2
1325203|NCT02262754|4349637|P2|Overall Study|Other|0
1325204|NCT02262754|4349638|P1|Overall Study|Other|4
1325205|NCT02262754|4349636|P3|Overall Study|Withdrawal by Subject|1
1325206|NCT02262754|4349637|P2|Overall Study|Withdrawal by Subject|0
1325207|NCT02262754|4349638|P1|Overall Study|Withdrawal by Subject|1
1325208|NCT02262754|4349636|P3|Overall Study|Protocol Violation|0
1325209|NCT02262754|4349637|P2|Overall Study|Protocol Violation|0
1325210|NCT02262754|4349638|P1|Overall Study|Protocol Violation|1
1325211|NCT02262754|4349636|P3|Overall Study|Study terminated by sponsor|4
1325212|NCT02262754|4349637|P2|Overall Study|Study terminated by sponsor|4
1325213|NCT02262754|4349638|P1|Overall Study|Study terminated by sponsor|5
1325214|NCT02262754|4349636|P3|Overall Study|No longer meets eligibility criteria|0
1325215|NCT02262754|4349637|P2|Overall Study|No longer meets eligibility criteria|1
1325216|NCT02262754|4349638|P1|Overall Study|No longer meets eligibility criteria|0
1325217|NCT02262754|4349636|P3|Overall Study|Lost to Follow-up|1
1325218|NCT02262754|4349637|P2|Overall Study|Lost to Follow-up|0
1325219|NCT02262754|4349638|P1|Overall Study|Lost to Follow-up|0
1325220|NCT02262754|4349636|P3|Overall Study|Lack of Efficacy|1
1325221|NCT02262754|4349637|P2|Overall Study|Lack of Efficacy|0
1325222|NCT02262754|4349638|P1|Overall Study|Lack of Efficacy|2
1325223|NCT02262754|4349636|P3|Overall Study|Adverse Event|0
1325224|NCT02262754|4349637|P2|Overall Study|Adverse Event|4
1325225|NCT02262754|4349638|P1|Overall Study|Adverse Event|3
1325226|NCT02261974|4349774|P2|Overall Study|Adverse Event|0
1325227|NCT02261974|4349775|P1|Overall Study|Adverse Event|1
1325228|NCT02261974|4349774|P2|Overall Study|Lost to Follow-up|0
1325229|NCT02261974|4349775|P1|Overall Study|Lost to Follow-up|2
1325230|NCT02261974|4349774|P2|Overall Study|Received partial treatment; FU to 1 mo|1
1325231|NCT02261974|4349775|P1|Overall Study|Received partial treatment; FU to 1 mo|3
1325232|NCT02261974|4349774|P2|Overall Study|Missed treatment cut-off date|3
1325233|NCT02261974|4349775|P1|Overall Study|Missed treatment cut-off date|6
1325234|NCT02261974|4349774|P2|Overall Study|Pregnancy|1
1325235|NCT02261974|4349775|P1|Overall Study|Pregnancy|0
1325236|NCT02261974|4349774|P2|Overall Study|Withdrawal by Subject|2
1325237|NCT02261974|4349775|P1|Overall Study|Withdrawal by Subject|3
1325238|NCT02261493|4349819|P3|Overall Study|Adverse Event|0
1325239|NCT02261493|4349820|P2|Overall Study|Adverse Event|1
1325240|NCT02261493|4349821|P1|Overall Study|Adverse Event|0
1325241|NCT02261493|4349819|P3|Overall Study|Lack of Efficacy|0
1325242|NCT02261493|4349820|P2|Overall Study|Lack of Efficacy|1
1325243|NCT02261493|4349821|P1|Overall Study|Lack of Efficacy|0
1325244|NCT02261493|4349819|P3|Overall Study|Pregnancy|0
1325245|NCT02261493|4349820|P2|Overall Study|Pregnancy|2
1325246|NCT02261493|4349821|P1|Overall Study|Pregnancy|1
1325247|NCT02261493|4349819|P3|Overall Study|Lost to Follow-up|8
1325248|NCT02261493|4349820|P2|Overall Study|Lost to Follow-up|27
1325249|NCT02261493|4349821|P1|Overall Study|Lost to Follow-up|14
1325250|NCT02261493|4349819|P3|Overall Study|Personal Reasons|16
1325251|NCT02261493|4349820|P2|Overall Study|Personal Reasons|14
1325252|NCT02261493|4349821|P1|Overall Study|Personal Reasons|14
1325253|NCT02261493|4349819|P3|Overall Study|Protocol Violation|0
1325254|NCT02261493|4349820|P2|Overall Study|Protocol Violation|0
1325255|NCT02261493|4349821|P1|Overall Study|Protocol Violation|1
1325256|NCT02261493|4349819|P3|Overall Study|Undisclosed alcohol abuse|0
1325257|NCT02261493|4349820|P2|Overall Study|Undisclosed alcohol abuse|1
1325258|NCT02261493|4349821|P1|Overall Study|Undisclosed alcohol abuse|0
1325259|NCT02261493|4349819|P3|Overall Study|Physician Decision|0
1325260|NCT02261493|4349820|P2|Overall Study|Physician Decision|1
1325261|NCT02261493|4349821|P1|Overall Study|Physician Decision|0
1325262|NCT02261493|4349819|P3|Overall Study|Noncompliance|2
1325263|NCT02261493|4349820|P2|Overall Study|Noncompliance|0
1325264|NCT02261493|4349821|P1|Overall Study|Noncompliance|0
1325265|NCT02261467|4349849|P2|Overall Study|Adverse Event|1
1325266|NCT02261467|4349850|P1|Overall Study|Adverse Event|1
1325267|NCT02261467|4349849|P2|Overall Study|Lost to Follow-up|13
1325268|NCT02261467|4349850|P1|Overall Study|Lost to Follow-up|2
1325269|NCT02261467|4349849|P2|Overall Study|Personal Reasons|22
1325270|NCT02261467|4349850|P1|Overall Study|Personal Reasons|17
1325271|NCT02261467|4349849|P2|Overall Study|Protocol Violation|1
1325272|NCT02261467|4349850|P1|Overall Study|Protocol Violation|0
1325273|NCT02261467|4349849|P2|Overall Study|Enrolled in Error|0
1325274|NCT02261467|4349850|P1|Overall Study|Enrolled in Error|1
1325275|NCT02260986|4349892|P3|Overall Study|Pregnancy|0
1325276|NCT02260986|4349893|P2|Overall Study|Pregnancy|0
1325277|NCT02260986|4349894|P1|Overall Study|Pregnancy|2
1325278|NCT02260986|4349892|P3|Overall Study|Lost to Follow-up|3
1325279|NCT02260986|4349893|P2|Overall Study|Lost to Follow-up|0
1325280|NCT02260986|4349894|P1|Overall Study|Lost to Follow-up|4
1325281|NCT02260986|4349892|P3|Overall Study|Lack of investigation product supply|1
1325282|NCT02260986|4349893|P2|Overall Study|Lack of investigation product supply|0
1325283|NCT02260986|4349894|P1|Overall Study|Lack of investigation product supply|2
1325284|NCT02260986|4349892|P3|Overall Study|Incorrect randomization|0
1325285|NCT02260986|4349893|P2|Overall Study|Incorrect randomization|1
1325286|NCT02260986|4349894|P1|Overall Study|Incorrect randomization|0
1325287|NCT02260986|4349892|P3|Overall Study|Withdrawal by Subject|9
1325288|NCT02260986|4349893|P2|Overall Study|Withdrawal by Subject|4
1325289|NCT02260986|4349894|P1|Overall Study|Withdrawal by Subject|17
1325290|NCT02260986|4349892|P3|Overall Study|Car accident|1
1325291|NCT02260986|4349893|P2|Overall Study|Car accident|0
1325292|NCT02260986|4349894|P1|Overall Study|Car accident|0
1325293|NCT02260986|4349892|P3|Overall Study|Protocol Violation|16
1325294|NCT02260986|4349893|P2|Overall Study|Protocol Violation|5
1325295|NCT02260986|4349894|P1|Overall Study|Protocol Violation|14
1325296|NCT02260986|4349892|P3|Overall Study|Lack of Efficacy|0
1325297|NCT02260986|4349893|P2|Overall Study|Lack of Efficacy|3
1325298|NCT02260986|4349894|P1|Overall Study|Lack of Efficacy|27
1325299|NCT02260986|4349892|P3|Overall Study|Adverse Event|11
1325300|NCT02260986|4349893|P2|Overall Study|Adverse Event|0
1325301|NCT02260986|4349894|P1|Overall Study|Adverse Event|24
1325302|NCT02260882|4350012|P2|Overall Study|Protocol Violation|1
1325303|NCT02260882|4350013|P1|Overall Study|Protocol Violation|0
1325304|NCT02260791|4350037|P2|Overall Study|Protocol deviation|3
1325305|NCT02260791|4350038|P1|Overall Study|Protocol deviation|2
1325306|NCT02260791|4350037|P2|Overall Study|Screen failure|1
1325307|NCT02260791|4350038|P1|Overall Study|Screen failure|0
1325308|NCT02260791|4350037|P2|Overall Study|Withdrawal by Subject|16
1325309|NCT02260791|4350038|P1|Overall Study|Withdrawal by Subject|11
1325310|NCT02260791|4350037|P2|Overall Study|Death|0
1325311|NCT02260791|4350038|P1|Overall Study|Death|1
1325312|NCT02260791|4350037|P2|Overall Study|Adverse Event|9
1325313|NCT02260791|4350038|P1|Overall Study|Adverse Event|13
1325314|NCT02260791|4350037|P2|Overall Study|Lack of Efficacy|1
1325315|NCT02260791|4350038|P1|Overall Study|Lack of Efficacy|2
1325316|NCT02260791|4350037|P2|Overall Study|Lost to Follow-up|4
1325317|NCT02260791|4350038|P1|Overall Study|Lost to Follow-up|4
1325318|NCT02260492|4350077|P3|Overall Study|Withdrawal by Subject|2
1325319|NCT02260492|4350078|P2|Overall Study|Withdrawal by Subject|2
1325320|NCT02260492|4350079|P1|Overall Study|Withdrawal by Subject|3
1325321|NCT02260492|4350077|P3|Overall Study|Physician Decision|1
1325322|NCT02260492|4350078|P2|Overall Study|Physician Decision|0
1325323|NCT02260492|4350079|P1|Overall Study|Physician Decision|2
1325324|NCT02260492|4350077|P3|Overall Study|Lost to Follow-up|0
1325325|NCT02260492|4350078|P2|Overall Study|Lost to Follow-up|9
1325326|NCT02260492|4350079|P1|Overall Study|Lost to Follow-up|12
1325327|NCT02260492|4350077|P3|Overall Study|Death|0
1325328|NCT02260492|4350078|P2|Overall Study|Death|1
1325329|NCT02260492|4350079|P1|Overall Study|Death|0
1325330|NCT02260492|4350077|P3|Overall Study|Adverse Event|2
1325331|NCT02260492|4350078|P2|Overall Study|Adverse Event|1
1325332|NCT02260492|4350079|P1|Overall Study|Adverse Event|6
1325333|NCT02260388|4350112|P4|Overall Study|Lost to Follow-up|4
1325334|NCT02260388|4350113|P3|Overall Study|Lost to Follow-up|3
1325335|NCT02260388|4350114|P2|Overall Study|Lost to Follow-up|8
1325336|NCT02260388|4350115|P1|Overall Study|Lost to Follow-up|2
1325337|NCT02259582|4350149|P3|Overall Study|Lack of Subject Adherence to Protocol|1
1325338|NCT02259582|4350150|P2|Overall Study|Lack of Subject Adherence to Protocol|1
1325339|NCT02259582|4350151|P1|Overall Study|Lack of Subject Adherence to Protocol|1
1325340|NCT02259582|4350149|P3|Overall Study|Disease progression|17
1325341|NCT02259582|4350150|P2|Overall Study|Disease progression|15
1325342|NCT02259582|4350151|P1|Overall Study|Disease progression|14
1325343|NCT02259582|4350149|P3|Overall Study|Withdrawal by Subject|1
1325344|NCT02259582|4350150|P2|Overall Study|Withdrawal by Subject|0
1325345|NCT02259582|4350151|P1|Overall Study|Withdrawal by Subject|0
1325346|NCT02259582|4350149|P3|Overall Study|Adverse Event|1
1325347|NCT02259582|4350150|P2|Overall Study|Adverse Event|0
1325348|NCT02259582|4350151|P1|Overall Study|Adverse Event|1
1325349|NCT02259582|4350149|P3|Overall Study|Death|1
1325350|NCT02259582|4350150|P2|Overall Study|Death|0
1325351|NCT02259582|4350151|P1|Overall Study|Death|0
1325352|NCT02259582|4350149|P3|Overall Study|Physician Decision|0
1325353|NCT02259582|4350150|P2|Overall Study|Physician Decision|1
1325354|NCT02259582|4350151|P1|Overall Study|Physician Decision|0
1325355|NCT02259400|4350161|P2|Overall Study|Death|2
1325356|NCT02259400|4350162|P1|Overall Study|Death|0
1325357|NCT02259348|4350194|P1|Overall Study|Death|4
1325358|NCT02259348|4350194|P1|Overall Study|Donors|6
1325359|NCT02258529|4350206|P1|Overall Study|Adverse Event|1
1325360|NCT02258529|4350206|P1|Overall Study|Study Terminated by Sponsor|9
1325361|NCT02258334|4350295|P4|Overall Study|Adverse Event|0
1325362|NCT02258334|4350296|P3|Overall Study|Adverse Event|0
1325363|NCT02258334|4350297|P2|Overall Study|Adverse Event|0
1325364|NCT02258334|4350298|P1|Overall Study|Adverse Event|1
1325365|NCT02257918|4350327|P3|Overall Study|Pregnancy|1
1325366|NCT02257918|4350328|P2|Overall Study|Pregnancy|0
1325367|NCT02257918|4350329|P1|Overall Study|Pregnancy|0
1325368|NCT02257918|4350327|P3|Overall Study|Withdrawal by Subject|1
1325369|NCT02257918|4350328|P2|Overall Study|Withdrawal by Subject|0
1325370|NCT02257918|4350329|P1|Overall Study|Withdrawal by Subject|0
1325371|NCT02257918|4350327|P3|Overall Study|Lost to Follow-up|0
1325372|NCT02257918|4350328|P2|Overall Study|Lost to Follow-up|1
1325373|NCT02257918|4350329|P1|Overall Study|Lost to Follow-up|4
1325374|NCT02257684|4350379|P1|Overall Study|Sponsor's Decision|1
1325375|NCT02257684|4350379|P1|Overall Study|Lack of Efficacy|1
1325376|NCT02257684|4350379|P1|Overall Study|Adverse Event|2
1325377|NCT02257385|4350389|P2|Overall Study|Withdrawal by Subject|4
1325378|NCT02257385|4350390|P1|Overall Study|Withdrawal by Subject|4
1325379|NCT02257385|4350389|P2|Overall Study|Lost to Follow-up|1
1325380|NCT02257385|4350390|P1|Overall Study|Lost to Follow-up|0
1325381|NCT02257385|4350389|P2|Overall Study|Protocol Violation|7
1325382|NCT02257385|4350390|P1|Overall Study|Protocol Violation|5
1325383|NCT02257385|4350389|P2|Overall Study|Lack of Efficacy|2
1325384|NCT02257385|4350390|P1|Overall Study|Lack of Efficacy|1
1325385|NCT02257385|4350389|P2|Overall Study|Adverse Event|8
1325386|NCT02257385|4350390|P1|Overall Study|Adverse Event|12
1325387|NCT02257372|4350400|P2|Overall Study|Withdrew consent|0
1325388|NCT02257372|4350401|P1|Overall Study|Withdrew consent|1
1325389|NCT02257372|4350400|P2|Overall Study|Lost to Follow-up|1
1325390|NCT02257372|4350401|P1|Overall Study|Lost to Follow-up|0
1325391|NCT02257372|4350400|P2|Overall Study|Protocol Violation|1
1325392|NCT02257372|4350401|P1|Overall Study|Protocol Violation|1
1325393|NCT02257372|4350400|P2|Overall Study|Lack of Efficacy|1
1325394|NCT02257372|4350401|P1|Overall Study|Lack of Efficacy|2
1325395|NCT02257372|4350400|P2|Overall Study|Adverse Event|7
1325396|NCT02257372|4350401|P1|Overall Study|Adverse Event|3
1325397|NCT02256982|4350411|P2|Overall Study|Disease Progression|1
1325398|NCT02256982|4350412|P1|Overall Study|Disease Progression|0
1325399|NCT02256969|4350421|P3|Overall Study|Screenfailed or withdrew|1
1325400|NCT02256969|4350422|P2|Overall Study|Screenfailed or withdrew|1
1325401|NCT02256969|4350423|P1|Overall Study|Screenfailed or withdrew|2
1325402|NCT02256891|4350442|P2|Overall Study|Equipment Malfunction|1
1325403|NCT02256891|4350443|P1|Overall Study|Equipment Malfunction|0
1325404|NCT02256891|4350442|P2|Overall Study|Screen Fail|4
1325405|NCT02256891|4350443|P1|Overall Study|Screen Fail|5
1325406|NCT02256891|4350442|P2|Overall Study|Physician Decision|3
1325407|NCT02256891|4350443|P1|Overall Study|Physician Decision|7
1325408|NCT02256891|4350442|P2|Overall Study|Lost to Follow-up|3
1325409|NCT02256891|4350443|P1|Overall Study|Lost to Follow-up|0
1325410|NCT02256891|4350442|P2|Overall Study|Death|2
1325411|NCT02256891|4350443|P1|Overall Study|Death|0
1325412|NCT02256553|4350467|P1|Period III|Adverse Event|3
1325413|NCT02256553|4350467|P1|Period II|Subject Moved|1
1325414|NCT02256553|4350467|P1|Period II|Adverse Event|1
1325415|NCT02256553|4350467|P1|Period I|Protocol Violation|1
1325416|NCT02256553|4350467|P1|Period I|Adverse Event|5
1325417|NCT02256488|4350480|P4|Overall Study|Withdrawal by Subject|2
1325418|NCT02256488|4350481|P3|Overall Study|Withdrawal by Subject|0
1325419|NCT02256488|4350482|P2|Overall Study|Withdrawal by Subject|0
1325420|NCT02256488|4350483|P1|Overall Study|Withdrawal by Subject|1
1325421|NCT02256488|4350480|P4|Overall Study|OTHER|1
1325422|NCT02256488|4350481|P3|Overall Study|OTHER|1
1325423|NCT02256488|4350482|P2|Overall Study|OTHER|0
1325424|NCT02256488|4350483|P1|Overall Study|OTHER|1
1325425|NCT02256488|4350480|P4|Overall Study|Lost to Follow-up|3
1325426|NCT02256488|4350481|P3|Overall Study|Lost to Follow-up|9
1325427|NCT02256488|4350482|P2|Overall Study|Lost to Follow-up|6
1325428|NCT02256488|4350483|P1|Overall Study|Lost to Follow-up|6
1325429|NCT02256436|4350499|P2|Overall Study|Ongoing in Study|67
1325430|NCT02256436|4350500|P1|Overall Study|Ongoing in Study|108
1325431|NCT02256436|4350499|P2|Overall Study|Withdrawal by Subject|30
1325432|NCT02256436|4350500|P1|Overall Study|Withdrawal by Subject|7
1325433|NCT02256436|4350499|P2|Overall Study|Protocol Violation|0
1325434|NCT02256436|4350500|P1|Overall Study|Protocol Violation|1
1325435|NCT02256436|4350499|P2|Overall Study|Physician Decision|3
1325436|NCT02256436|4350500|P1|Overall Study|Physician Decision|1
1325437|NCT02256436|4350499|P2|Overall Study|Lost to Follow-up|1
1325438|NCT02256436|4350500|P1|Overall Study|Lost to Follow-up|1
1325439|NCT02256436|4350499|P2|Overall Study|Death|158
1325440|NCT02256436|4350500|P1|Overall Study|Death|137
1325441|NCT02256436|4350499|P2|Overall Study|Adverse Event|13
1325442|NCT02256436|4350500|P1|Overall Study|Adverse Event|15
1325443|NCT02256267|4350560|P1|Period 2 (Day 7 to Day 14)|Adverse Event|1
1325444|NCT02256267|4350560|P1|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
1325445|NCT02255760|4350591|P5|Overall Study|Lost to Follow-up|0
1325446|NCT02255760|4350592|P4|Overall Study|Lost to Follow-up|0
1325447|NCT02255760|4350593|P3|Overall Study|Lost to Follow-up|0
1325448|NCT02255760|4350594|P2|Overall Study|Lost to Follow-up|1
1325449|NCT02255760|4350595|P1|Overall Study|Lost to Follow-up|0
1325450|NCT02255565|4350650|P3|Overall Study|Withdrawal by Subject|0
1325451|NCT02255565|4350651|P2|Overall Study|Withdrawal by Subject|1
1325452|NCT02255565|4350652|P1|Overall Study|Withdrawal by Subject|0
1325453|NCT02255279|4350713|P2|Overall Study|Withdrawal by Subject|6
1325454|NCT02255279|4350714|P1|Overall Study|Withdrawal by Subject|3
1325455|NCT02255279|4350713|P2|Overall Study|Protocol Violation|1
1325456|NCT02255279|4350714|P1|Overall Study|Protocol Violation|0
1325457|NCT02255279|4350713|P2|Overall Study|Lost to Follow-up|2
1325458|NCT02255279|4350714|P1|Overall Study|Lost to Follow-up|2
1325459|NCT02255149|4350740|P1|Overall Study|Implant Failure|1
1325460|NCT02255149|4350740|P1|Overall Study|Withdrawal by PI|1
1325461|NCT02255149|4350740|P1|Overall Study|Withdrawal by Subject|1
1325462|NCT02255149|4350740|P1|Overall Study|Lost to Follow-up|2
1325463|NCT02255097|4350744|P1|Overall Study|Treatment Ongoing|36
1325464|NCT02255097|4350744|P1|Overall Study|Allocated but not treated|1
1325465|NCT02255097|4350744|P1|Overall Study|Withdrawal by Subject|2
1325466|NCT02255097|4350744|P1|Overall Study|Progressive Disease|80
1325467|NCT02255097|4350744|P1|Overall Study|Physician Decision|1
1325468|NCT02255097|4350744|P1|Overall Study|Lost to Follow-up|1
1325469|NCT02255097|4350744|P1|Overall Study|Death|2
1325470|NCT02255097|4350744|P1|Overall Study|Excluded Medication|1
1325471|NCT02255097|4350744|P1|Overall Study|Complete Response|1
1325472|NCT02255097|4350744|P1|Overall Study|Clinical Progression|23
1325473|NCT02255097|4350744|P1|Overall Study|Adverse Event|24
1325474|NCT02254772|4350765|P1|Overall Study|Withdrawal by Subject|1
1325475|NCT02254772|4350765|P1|Overall Study|Ineligible|1
1325476|NCT02254551|4350771|P1|Dose Escalation|Dose-limiting toxicity|2
1325477|NCT02254551|4350771|P1|Dose Escalation|Physician Decision|1
1325478|NCT02254486|4350781|P2|Overall Study|Various|12
1325479|NCT02254486|4350782|P1|Overall Study|Various|12
1325480|NCT02254486|4350781|P2|Overall Study|GFR<60mL/min|21
1325481|NCT02254486|4350782|P1|Overall Study|GFR<60mL/min|16
1325482|NCT02254486|4350781|P2|Overall Study|Withdrawal by Subject|15
1325483|NCT02254486|4350782|P1|Overall Study|Withdrawal by Subject|17
1325484|NCT02254486|4350781|P2|Overall Study|Protocol Violation|2
1325485|NCT02254486|4350782|P1|Overall Study|Protocol Violation|1
1325486|NCT02254486|4350781|P2|Overall Study|Lost to Follow-up|4
1325487|NCT02254486|4350782|P1|Overall Study|Lost to Follow-up|2
1325488|NCT02254486|4350781|P2|Overall Study|Lack of Efficacy|0
1325489|NCT02254486|4350782|P1|Overall Study|Lack of Efficacy|1
1325490|NCT02254486|4350781|P2|Overall Study|Adverse Event|1
1325491|NCT02254486|4350782|P1|Overall Study|Adverse Event|1
1325492|NCT02254460|4350798|P2|Overall Study|Adverse Event|0
1325493|NCT02254460|4350799|P1|Overall Study|Adverse Event|1
1325494|NCT02254421|4350807|P2|Overall Study|Withdrew Consent|1
1325495|NCT02254421|4350808|P1|Overall Study|Withdrew Consent|1
1325496|NCT02254421|4350807|P2|Overall Study|Death|2
1325497|NCT02254421|4350808|P1|Overall Study|Death|0
1325498|NCT02254421|4350807|P2|Overall Study|Randomized but Not Treated|0
1325499|NCT02254421|4350808|P1|Overall Study|Randomized but Not Treated|1
1325500|NCT02254408|4350822|P2|Overall Study|Lost to Follow-up|0
1325501|NCT02254408|4350823|P1|Overall Study|Lost to Follow-up|1
1325502|NCT02254408|4350822|P2|Overall Study|Withdrawal by Subject|3
1325503|NCT02254408|4350823|P1|Overall Study|Withdrawal by Subject|3
1325504|NCT02254408|4350822|P2|Overall Study|Investigator's Discretion|1
1325505|NCT02254408|4350823|P1|Overall Study|Investigator's Discretion|0
1325506|NCT02254408|4350822|P2|Overall Study|Death|3
1325507|NCT02254408|4350823|P1|Overall Study|Death|2
1325508|NCT02254408|4350822|P2|Overall Study|Adverse Event|0
1325509|NCT02254408|4350823|P1|Overall Study|Adverse Event|1
1325510|NCT02254408|4350822|P2|Overall Study|Randomized But Not Treated|3
1325511|NCT02254408|4350823|P1|Overall Study|Randomized But Not Treated|1
1325512|NCT02254304|4350835|P2|Overall Study|Personal decision|0
1325513|NCT02254304|4350836|P1|Overall Study|Personal decision|1
1325514|NCT02254304|4350835|P2|Overall Study|Personal causes|1
1325515|NCT02254304|4350836|P1|Overall Study|Personal causes|4
1325516|NCT02254304|4350835|P2|Overall Study|Injection site pain and Injection fear|0
1325517|NCT02254304|4350836|P1|Overall Study|Injection site pain and Injection fear|1
1325518|NCT02254304|4350835|P2|Overall Study|Withdrawal by Subject|0
1325519|NCT02254304|4350836|P1|Overall Study|Withdrawal by Subject|3
1325520|NCT02254304|4350835|P2|Overall Study|Protocol Violation|0
1325521|NCT02254304|4350836|P1|Overall Study|Protocol Violation|1
1325522|NCT02254304|4350835|P2|Overall Study|Lost to Follow-up|2
1325523|NCT02254304|4350836|P1|Overall Study|Lost to Follow-up|2
1325524|NCT02254304|4350835|P2|Overall Study|Adverse Event|1
1325525|NCT02254304|4350836|P1|Overall Study|Adverse Event|2
1325526|NCT02253654|4350908|P2|Overall Study|Did Not Receive Study Treatment|1
1325527|NCT02253654|4350909|P1|Overall Study|Did Not Receive Study Treatment|4
1325528|NCT02253654|4350908|P2|Overall Study|Death|7
1325529|NCT02253654|4350909|P1|Overall Study|Death|4
1325530|NCT02253654|4350908|P2|Overall Study|Lost to Follow-up|5
1325531|NCT02253654|4350909|P1|Overall Study|Lost to Follow-up|2
1325532|NCT02253654|4350908|P2|Overall Study|Decision by Sponsor|1
1325533|NCT02253654|4350909|P1|Overall Study|Decision by Sponsor|1
1325534|NCT02253654|4350908|P2|Overall Study|Withdrawal by Subject|4
1325535|NCT02253654|4350909|P1|Overall Study|Withdrawal by Subject|12
1325536|NCT02253147|4351171|P1|Overall Study|Withdrawal by Subject|1
1325537|NCT02253147|4351171|P1|Overall Study|Lost to Follow-up|2
1325538|NCT02253147|4351171|P1|Overall Study|Conditional re-treatment at W52|5
1325539|NCT02253147|4351171|P1|Overall Study|Did not consent to study extension|9
1325540|NCT02253147|4351171|P1|Overall Study|Protocol Violation|30
1325541|NCT02252965|4351205|P2|Overall Study|Other|5
1325542|NCT02252965|4351206|P1|Overall Study|Other|4
1325543|NCT02252965|4351205|P2|Overall Study|Withdrawal by Subject|9
1325544|NCT02252965|4351206|P1|Overall Study|Withdrawal by Subject|7
1325545|NCT02252965|4351205|P2|Overall Study|Lack of Efficacy|2
1325546|NCT02252965|4351206|P1|Overall Study|Lack of Efficacy|0
1325547|NCT02252965|4351205|P2|Overall Study|Protocol Violation|5
1325548|NCT02252965|4351206|P1|Overall Study|Protocol Violation|4
1325549|NCT02252965|4351205|P2|Overall Study|Lost to Follow-up|8
1325550|NCT02252965|4351206|P1|Overall Study|Lost to Follow-up|16
1325551|NCT02252965|4351205|P2|Overall Study|Adverse Event|14
1325552|NCT02252965|4351206|P1|Overall Study|Adverse Event|9
1325553|NCT02252939|4351233|P1|Overall Study|Lost to Follow-up|3
1325554|NCT02252146|4351325|P1|Overall Study|Inability to travel to study site|1
1325555|NCT02252146|4351325|P1|Overall Study|Entered hospice care|1
1325556|NCT02252146|4351325|P1|Overall Study|Lack of Efficacy|4
1325557|NCT02252042|4351338|P2|Overall Study|Ongoing in study|35
1325558|NCT02252042|4351339|P1|Overall Study|Ongoing in study|64
1325559|NCT02252042|4351338|P2|Overall Study|Withdrawal by Subject|20
1325560|NCT02252042|4351339|P1|Overall Study|Withdrawal by Subject|13
1325561|NCT02252042|4351338|P2|Overall Study|Physician Decision|1
1325562|NCT02252042|4351339|P1|Overall Study|Physician Decision|0
1325563|NCT02252042|4351338|P2|Overall Study|Death|192
1325564|NCT02252042|4351339|P1|Overall Study|Death|170
1325565|NCT02252016|4351379|P2|Overall Study|Withdrawal by Subject|2
1325566|NCT02252016|4351380|P1|Overall Study|Withdrawal by Subject|0
1325567|NCT02252016|4351379|P2|Overall Study|Physician Decision|0
1325568|NCT02252016|4351380|P1|Overall Study|Physician Decision|1
1325569|NCT02252016|4351379|P2|Overall Study|Lost to Follow-up|1
1325570|NCT02252016|4351380|P1|Overall Study|Lost to Follow-up|2
1325571|NCT02251990|4351394|P2|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
1325572|NCT02251990|4351395|P1|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
1325573|NCT02251990|4351394|P2|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
1325574|NCT02251990|4351395|P1|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
1325575|NCT02251990|4351394|P2|Period 1 (Double-blind [DB])|Not Treated|0
1325576|NCT02251990|4351395|P1|Period 1 (Double-blind [DB])|Not Treated|1
1325577|NCT02251990|4351394|P2|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
1325578|NCT02251990|4351395|P1|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
1325579|NCT02251990|4351394|P2|Period 1 (Double-blind [DB])|Lack of Efficacy|0
1325580|NCT02251990|4351395|P1|Period 1 (Double-blind [DB])|Lack of Efficacy|5
1325581|NCT02251990|4351394|P2|Period 1 (Double-blind [DB])|Adverse Event|1
1325582|NCT02251990|4351395|P1|Period 1 (Double-blind [DB])|Adverse Event|1
1325583|NCT02251912|4351412|P2|Overall Study|Adverse Event|2
1325584|NCT02251912|4351413|P1|Overall Study|Adverse Event|0
1325585|NCT02251912|4351412|P2|Overall Study|Withdrawal by Subject|3
1325586|NCT02251912|4351413|P1|Overall Study|Withdrawal by Subject|2
1325587|NCT02251717|4351442|P2|Overall Study|Withdrew Consent|0
1325588|NCT02251717|4351443|P1|Overall Study|Withdrew Consent|1
1325589|NCT02251717|4351442|P2|Overall Study|Adverse Event|1
1325590|NCT02251717|4351443|P1|Overall Study|Adverse Event|0
1325591|NCT02251652|4351455|P1|Overall Study|Withdrawal by Subject|1
1325592|NCT02250443|4351506|P1|Overall Study|Adverse Event|3
1325593|NCT02250443|4351506|P1|Overall Study|Administrative problems|7
1325594|NCT02250326|4351535|P3|Follow-Up Period|Lost to Follow-up|3
1325595|NCT02250326|4351536|P2|Follow-Up Period|Lost to Follow-up|1
1325596|NCT02250326|4351537|P1|Follow-Up Period|Lost to Follow-up|1
1325597|NCT02250326|4351535|P3|Follow-Up Period|Unknown or Missing|3
1325598|NCT02250326|4351536|P2|Follow-Up Period|Unknown or Missing|3
1325599|NCT02250326|4351537|P1|Follow-Up Period|Unknown or Missing|2
1325600|NCT02250326|4351535|P3|Follow-Up Period|Death|32
1325601|NCT02250326|4351536|P2|Follow-Up Period|Death|26
1325602|NCT02250326|4351537|P1|Follow-Up Period|Death|46
1325603|NCT02250326|4351535|P3|Treatment Period|Randomized or assigned; not treated|1
1325604|NCT02250326|4351536|P2|Treatment Period|Randomized or assigned; not treated|1
1325605|NCT02250326|4351537|P1|Treatment Period|Randomized or assigned; not treated|2
1325606|NCT02250326|4351535|P3|Treatment Period|Miscellaneous|7
1325607|NCT02250326|4351536|P2|Treatment Period|Miscellaneous|2
1325608|NCT02250326|4351537|P1|Treatment Period|Miscellaneous|8
1325609|NCT02250326|4351535|P3|Treatment Period|Withdrawal by Subject|4
1325610|NCT02250326|4351536|P2|Treatment Period|Withdrawal by Subject|5
1325611|NCT02250326|4351537|P1|Treatment Period|Withdrawal by Subject|11
1325612|NCT02250326|4351535|P3|Treatment Period|Symptomatic Deterioration|10
1325613|NCT02250326|4351536|P2|Treatment Period|Symptomatic Deterioration|4
1325614|NCT02250326|4351537|P1|Treatment Period|Symptomatic Deterioration|9
1325615|NCT02250326|4351535|P3|Treatment Period|Progressive Disease|45
1325616|NCT02250326|4351536|P2|Treatment Period|Progressive Disease|36
1325617|NCT02250326|4351537|P1|Treatment Period|Progressive Disease|42
1325618|NCT02250326|4351535|P3|Treatment Period|Adverse Event|8
1325619|NCT02250326|4351536|P2|Treatment Period|Adverse Event|4
1325620|NCT02250326|4351537|P1|Treatment Period|Adverse Event|8
1325621|NCT02250326|4351535|P3|Treatment Period|Death|2
1325622|NCT02250326|4351536|P2|Treatment Period|Death|12
1325623|NCT02250326|4351537|P1|Treatment Period|Death|1
1325624|NCT02250274|4351570|P2|Overall Study|Insufficient blood draw amount|6
1325625|NCT02250274|4351571|P1|Overall Study|Insufficient blood draw amount|7
1325626|NCT02248818|4351673|P9|Randomised Study|Administrative - randomization error|0
1325627|NCT02248818|4351674|P8|Randomised Study|Administrative - randomization error|0
1325628|NCT02248818|4351675|P7|Randomised Study|Administrative - randomization error|0
1325629|NCT02248818|4351676|P6|Randomised Study|Administrative - randomization error|8
1325630|NCT02248818|4351677|P5|Randomised Study|Administrative - randomization error|0
1325631|NCT02248818|4351678|P4|Randomised Study|Administrative - randomization error|0
1325632|NCT02248818|4351679|P3|Randomised Study|Administrative - randomization error|0
1325633|NCT02248818|4351680|P2|Randomised Study|Administrative - randomization error|0
1325634|NCT02248818|4351681|P1|Randomised Study|Administrative - randomization error|0
1325635|NCT02248818|4351673|P9|Screening|Lost to Follow-up|7
1325636|NCT02248818|4351674|P8|Screening|Lost to Follow-up|0
1325637|NCT02248818|4351675|P7|Screening|Lost to Follow-up|0
1325638|NCT02248818|4351676|P6|Screening|Lost to Follow-up|0
1325639|NCT02248818|4351677|P5|Screening|Lost to Follow-up|0
1325640|NCT02248818|4351678|P4|Screening|Lost to Follow-up|0
1325641|NCT02248818|4351679|P3|Screening|Lost to Follow-up|0
1325642|NCT02248818|4351680|P2|Screening|Lost to Follow-up|0
1325643|NCT02248818|4351681|P1|Screening|Lost to Follow-up|0
1325644|NCT02248818|4351673|P9|Screening|Withdrawal by Subject|6
1325645|NCT02248818|4351674|P8|Screening|Withdrawal by Subject|0
1325646|NCT02248818|4351675|P7|Screening|Withdrawal by Subject|0
1325647|NCT02248818|4351676|P6|Screening|Withdrawal by Subject|0
1325648|NCT02248818|4351677|P5|Screening|Withdrawal by Subject|0
1325649|NCT02248818|4351678|P4|Screening|Withdrawal by Subject|0
1325650|NCT02248818|4351679|P3|Screening|Withdrawal by Subject|0
1325651|NCT02248818|4351680|P2|Screening|Withdrawal by Subject|0
1325652|NCT02248818|4351681|P1|Screening|Withdrawal by Subject|0
1325653|NCT02248818|4351673|P9|Screening|Physician Decision|73
1325654|NCT02248818|4351674|P8|Screening|Physician Decision|0
1325655|NCT02248818|4351675|P7|Screening|Physician Decision|0
1325656|NCT02248818|4351676|P6|Screening|Physician Decision|0
1325657|NCT02248818|4351677|P5|Screening|Physician Decision|0
1325658|NCT02248818|4351678|P4|Screening|Physician Decision|0
1325659|NCT02248818|4351679|P3|Screening|Physician Decision|0
1325660|NCT02248818|4351680|P2|Screening|Physician Decision|0
1325661|NCT02248818|4351681|P1|Screening|Physician Decision|0
1325662|NCT02248818|4351673|P9|Screening|Study fully enrolled|14
1325663|NCT02248818|4351674|P8|Screening|Study fully enrolled|0
1325664|NCT02248818|4351675|P7|Screening|Study fully enrolled|0
1325665|NCT02248818|4351676|P6|Screening|Study fully enrolled|0
1325666|NCT02248818|4351677|P5|Screening|Study fully enrolled|0
1325667|NCT02248818|4351678|P4|Screening|Study fully enrolled|0
1325668|NCT02248818|4351679|P3|Screening|Study fully enrolled|0
1325669|NCT02248818|4351680|P2|Screening|Study fully enrolled|0
1325670|NCT02248818|4351681|P1|Screening|Study fully enrolled|0
1325671|NCT02248818|4351673|P9|Screening|Protocol Violation|7
1325672|NCT02248818|4351674|P8|Screening|Protocol Violation|0
1325673|NCT02248818|4351675|P7|Screening|Protocol Violation|0
1325674|NCT02248818|4351676|P6|Screening|Protocol Violation|0
1325675|NCT02248818|4351677|P5|Screening|Protocol Violation|0
1325676|NCT02248818|4351678|P4|Screening|Protocol Violation|0
1325677|NCT02248818|4351679|P3|Screening|Protocol Violation|0
1325678|NCT02248818|4351680|P2|Screening|Protocol Violation|0
1325679|NCT02248818|4351681|P1|Screening|Protocol Violation|0
1325680|NCT02248675|4351844|P2|Overall Study|Lost to Follow-up|1
1325681|NCT02248675|4351845|P1|Overall Study|Lost to Follow-up|3
1325682|NCT02248480|4351872|P2|Overall Study|Other:Physician Decision|1
1325683|NCT02248480|4351873|P1|Overall Study|Other:Physician Decision|0
1325684|NCT02248480|4351872|P2|Overall Study|Entry Criteria Not Met|1
1325685|NCT02248480|4351873|P1|Overall Study|Entry Criteria Not Met|0
1325686|NCT02248480|4351872|P2|Overall Study|Withdrawal by Subject|4
1325687|NCT02248480|4351873|P1|Overall Study|Withdrawal by Subject|2
1325688|NCT02248480|4351872|P2|Overall Study|Adverse Event|2
1325689|NCT02248480|4351873|P1|Overall Study|Adverse Event|11
1325690|NCT02248480|4351872|P2|Overall Study|Lack of Efficacy|6
1325691|NCT02248480|4351873|P1|Overall Study|Lack of Efficacy|4
1325692|NCT02247960|4351940|P2|Catheter Removed|Lost to Follow-up|10
1325693|NCT02247960|4351941|P1|Catheter Removed|Lost to Follow-up|7
1325694|NCT02247960|4351940|P2|Patient Consent and Randomization|Withdrawal by Subject|4
1325695|NCT02247960|4351941|P1|Patient Consent and Randomization|Withdrawal by Subject|0
1325696|NCT02247960|4351940|P2|Patient Consent and Randomization|Physician Decision|2
1325697|NCT02247960|4351941|P1|Patient Consent and Randomization|Physician Decision|2
1325698|NCT02247401|4351980|P3|Overall Study|Lost to Follow-up|1
1325699|NCT02247401|4351981|P2|Overall Study|Lost to Follow-up|1
1325700|NCT02247401|4351982|P1|Overall Study|Lost to Follow-up|1
1325701|NCT02247401|4351980|P3|Overall Study|Withdrawal by Subject|1
1325702|NCT02247401|4351981|P2|Overall Study|Withdrawal by Subject|1
1325703|NCT02247401|4351982|P1|Overall Study|Withdrawal by Subject|4
1325704|NCT02247401|4351980|P3|Overall Study|Adverse Event|0
1325705|NCT02247401|4351981|P2|Overall Study|Adverse Event|0
1325706|NCT02247401|4351982|P1|Overall Study|Adverse Event|1
1325707|NCT02247011|4352012|P1|Overall Study|Poor quality of radiological results|125
1325708|NCT02246998|4352033|P4|Overall Study|Randomized but Never Dosed|1
1325709|NCT02246998|4352034|P3|Overall Study|Randomized but Never Dosed|2
1325710|NCT02246998|4352035|P2|Overall Study|Randomized but Never Dosed|2
1325711|NCT02246998|4352036|P1|Overall Study|Randomized but Never Dosed|1
1325712|NCT02246998|4352033|P4|Overall Study|Lost to Follow-up|1
1325713|NCT02246998|4352034|P3|Overall Study|Lost to Follow-up|0
1325714|NCT02246998|4352035|P2|Overall Study|Lost to Follow-up|0
1325715|NCT02246998|4352036|P1|Overall Study|Lost to Follow-up|1
1325716|NCT02246998|4352033|P4|Overall Study|Adverse Event|0
1325717|NCT02246998|4352034|P3|Overall Study|Adverse Event|1
1325718|NCT02246998|4352035|P2|Overall Study|Adverse Event|1
1325719|NCT02246998|4352036|P1|Overall Study|Adverse Event|0
1325720|NCT02246777|4352146|P1|Overall Study|Change of residence|1
1325721|NCT02246777|4352146|P1|Overall Study|Adverse Event|2
1325722|NCT02246764|4352162|P3|Overall Study|Protocol Violation|1
1325723|NCT02246764|4352163|P2|Overall Study|Protocol Violation|1
1325724|NCT02246764|4352164|P1|Overall Study|Protocol Violation|2
1325725|NCT02246764|4352162|P3|Overall Study|Physician Decision|1
1325726|NCT02246764|4352163|P2|Overall Study|Physician Decision|2
1325727|NCT02246764|4352164|P1|Overall Study|Physician Decision|0
1325896|NCT02243293|4352551|P9|Overall Study|Adverse Event|0
1325728|NCT02246764|4352162|P3|Overall Study|Disallowed Concomitant Medication|0
1325729|NCT02246764|4352163|P2|Overall Study|Disallowed Concomitant Medication|0
1325730|NCT02246764|4352164|P1|Overall Study|Disallowed Concomitant Medication|1
1325731|NCT02246764|4352162|P3|Overall Study|Withdrawal by Subject|1
1325732|NCT02246764|4352163|P2|Overall Study|Withdrawal by Subject|0
1325733|NCT02246764|4352164|P1|Overall Study|Withdrawal by Subject|0
1325734|NCT02246764|4352162|P3|Overall Study|Adverse Event|1
1325735|NCT02246764|4352163|P2|Overall Study|Adverse Event|29
1325736|NCT02246764|4352164|P1|Overall Study|Adverse Event|15
1325737|NCT02246673|4352177|P5|Overall Study|Protocol Violation|0
1325738|NCT02246673|4352178|P4|Overall Study|Protocol Violation|1
1325739|NCT02246673|4352179|P3|Overall Study|Protocol Violation|0
1325740|NCT02246673|4352180|P2|Overall Study|Protocol Violation|0
1325741|NCT02246673|4352181|P1|Overall Study|Protocol Violation|0
1325742|NCT02246673|4352177|P5|Overall Study|Lost to Follow-up|0
1325743|NCT02246673|4352178|P4|Overall Study|Lost to Follow-up|1
1325744|NCT02246673|4352179|P3|Overall Study|Lost to Follow-up|0
1325745|NCT02246673|4352180|P2|Overall Study|Lost to Follow-up|0
1325746|NCT02246673|4352181|P1|Overall Study|Lost to Follow-up|0
1325747|NCT02246673|4352177|P5|Overall Study|Withdrawal by Subject|1
1325748|NCT02246673|4352178|P4|Overall Study|Withdrawal by Subject|0
1325749|NCT02246673|4352179|P3|Overall Study|Withdrawal by Subject|0
1325750|NCT02246673|4352180|P2|Overall Study|Withdrawal by Subject|0
1325751|NCT02246673|4352181|P1|Overall Study|Withdrawal by Subject|0
1325752|NCT02246673|4352177|P5|Overall Study|Sponsor Decision|0
1325753|NCT02246673|4352178|P4|Overall Study|Sponsor Decision|0
1325754|NCT02246673|4352179|P3|Overall Study|Sponsor Decision|0
1325755|NCT02246673|4352180|P2|Overall Study|Sponsor Decision|0
1325756|NCT02246673|4352181|P1|Overall Study|Sponsor Decision|1
1325757|NCT02246660|4352289|P3|Overall Study|Death|1
1325758|NCT02246660|4352290|P2|Overall Study|Death|0
1325759|NCT02246660|4352291|P1|Overall Study|Death|0
1325760|NCT02246660|4352289|P3|Overall Study|Withdrawal by Subject|0
1325761|NCT02246660|4352290|P2|Overall Study|Withdrawal by Subject|1
1325762|NCT02246660|4352291|P1|Overall Study|Withdrawal by Subject|0
1325763|NCT02246621|4352301|P2|Overall Study|On Study Treatment/ Follow Up|133
1325764|NCT02246621|4352302|P1|Overall Study|On Study Treatment/ Follow Up|257
1325765|NCT02246621|4352301|P2|Overall Study|Lost to Follow-up|1
1325766|NCT02246621|4352302|P1|Overall Study|Lost to Follow-up|3
1325767|NCT02246621|4352301|P2|Overall Study|Withdrawal by Subject|14
1325768|NCT02246621|4352302|P1|Overall Study|Withdrawal by Subject|36
1325769|NCT02246582|4352339|P2|Overall Study|Withdrawal by Subject|4
1325770|NCT02246582|4352340|P1|Overall Study|Withdrawal by Subject|3
1325771|NCT02246166|4352361|P2|Overall Study|Protocol Violation|0
1325772|NCT02246166|4352362|P1|Overall Study|Protocol Violation|1
1325773|NCT02246114|4352398|P2|Overall Study|miscarriage|0
1325774|NCT02246114|4352399|P1|Overall Study|miscarriage|1
1325775|NCT02245412|4352433|P3|Overall Study|Other|0
1325776|NCT02245412|4352434|P2|Overall Study|Other|0
1325777|NCT02245412|4352435|P1|Overall Study|Other|1
1325778|NCT02245412|4352433|P3|Overall Study|Biopsy did not confirm GI GVHD|0
1325779|NCT02245412|4352434|P2|Overall Study|Biopsy did not confirm GI GVHD|0
1325780|NCT02245412|4352435|P1|Overall Study|Biopsy did not confirm GI GVHD|1
1325781|NCT02245412|4352433|P3|Overall Study|Withdrawal by Subject|0
1325782|NCT02245412|4352434|P2|Overall Study|Withdrawal by Subject|1
1325783|NCT02245412|4352435|P1|Overall Study|Withdrawal by Subject|1
1325784|NCT02245412|4352433|P3|Overall Study|Physician Decision|0
1325785|NCT02245412|4352434|P2|Overall Study|Physician Decision|1
1325786|NCT02245412|4352435|P1|Overall Study|Physician Decision|1
1325787|NCT02245412|4352433|P3|Overall Study|Death|0
1325788|NCT02245412|4352434|P2|Overall Study|Death|1
1325789|NCT02245412|4352435|P1|Overall Study|Death|1
1325790|NCT02244944|4352469|P1|Overall Study|Study Terminated|1
1325791|NCT02244944|4352469|P1|Overall Study|Withdrawal by Subject|1
1325792|NCT02244619|4352481|P2|Overall Study|Did not receive study intervention|21
1325793|NCT02244619|4352482|P1|Overall Study|Did not receive study intervention|8
1325794|NCT02244580|4352500|P1|Overall Study|No cancer tissues available|241
1325795|NCT02243293|4352538|P22|Overall Study|Randomized but did'nt receive study drug|0
1325796|NCT02243293|4352539|P21|Overall Study|Randomized but did'nt receive study drug|0
1325797|NCT02243293|4352540|P20|Overall Study|Randomized but did'nt receive study drug|1
1325798|NCT02243293|4352541|P19|Overall Study|Randomized but did'nt receive study drug|0
1325799|NCT02243293|4352542|P18|Overall Study|Randomized but did'nt receive study drug|0
1325800|NCT02243293|4352543|P17|Overall Study|Randomized but did'nt receive study drug|0
1325801|NCT02243293|4352544|P16|Overall Study|Randomized but did'nt receive study drug|0
1325802|NCT02243293|4352545|P15|Overall Study|Randomized but did'nt receive study drug|0
1325803|NCT02243293|4352546|P14|Overall Study|Randomized but did'nt receive study drug|0
1325804|NCT02243293|4352547|P13|Overall Study|Randomized but did'nt receive study drug|0
1325805|NCT02243293|4352548|P12|Overall Study|Randomized but did'nt receive study drug|0
1325806|NCT02243293|4352549|P11|Overall Study|Randomized but did'nt receive study drug|0
1325807|NCT02243293|4352550|P10|Overall Study|Randomized but did'nt receive study drug|1
1325808|NCT02243293|4352551|P9|Overall Study|Randomized but did'nt receive study drug|0
1325809|NCT02243293|4352552|P8|Overall Study|Randomized but did'nt receive study drug|0
1325810|NCT02243293|4352553|P7|Overall Study|Randomized but did'nt receive study drug|0
1325811|NCT02243293|4352554|P6|Overall Study|Randomized but did'nt receive study drug|0
1325812|NCT02243293|4352555|P5|Overall Study|Randomized but did'nt receive study drug|1
1325813|NCT02243293|4352556|P4|Overall Study|Randomized but did'nt receive study drug|0
1325814|NCT02243293|4352557|P3|Overall Study|Randomized but did'nt receive study drug|0
1325815|NCT02243293|4352558|P2|Overall Study|Randomized but did'nt receive study drug|0
1325816|NCT02243293|4352559|P1|Overall Study|Randomized but did'nt receive study drug|0
1325817|NCT02243293|4352538|P22|Overall Study|Enrolled into a Re-treatment Study|0
1325818|NCT02243293|4352539|P21|Overall Study|Enrolled into a Re-treatment Study|0
1325819|NCT02243293|4352540|P20|Overall Study|Enrolled into a Re-treatment Study|0
1325820|NCT02243293|4352541|P19|Overall Study|Enrolled into a Re-treatment Study|0
1325821|NCT02243293|4352542|P18|Overall Study|Enrolled into a Re-treatment Study|0
1325822|NCT02243293|4352543|P17|Overall Study|Enrolled into a Re-treatment Study|0
1325823|NCT02243293|4352544|P16|Overall Study|Enrolled into a Re-treatment Study|0
1325824|NCT02243293|4352545|P15|Overall Study|Enrolled into a Re-treatment Study|1
1325825|NCT02243293|4352546|P14|Overall Study|Enrolled into a Re-treatment Study|0
1325826|NCT02243293|4352547|P13|Overall Study|Enrolled into a Re-treatment Study|0
1325827|NCT02243293|4352548|P12|Overall Study|Enrolled into a Re-treatment Study|0
1325828|NCT02243293|4352549|P11|Overall Study|Enrolled into a Re-treatment Study|0
1325829|NCT02243293|4352550|P10|Overall Study|Enrolled into a Re-treatment Study|0
1325830|NCT02243293|4352551|P9|Overall Study|Enrolled into a Re-treatment Study|0
1325831|NCT02243293|4352552|P8|Overall Study|Enrolled into a Re-treatment Study|0
1325832|NCT02243293|4352553|P7|Overall Study|Enrolled into a Re-treatment Study|0
1325833|NCT02243293|4352554|P6|Overall Study|Enrolled into a Re-treatment Study|0
1325834|NCT02243293|4352555|P5|Overall Study|Enrolled into a Re-treatment Study|0
1325835|NCT02243293|4352556|P4|Overall Study|Enrolled into a Re-treatment Study|0
1325836|NCT02243293|4352557|P3|Overall Study|Enrolled into a Re-treatment Study|0
1325837|NCT02243293|4352558|P2|Overall Study|Enrolled into a Re-treatment Study|0
1325838|NCT02243293|4352559|P1|Overall Study|Enrolled into a Re-treatment Study|0
1325839|NCT02243293|4352538|P22|Overall Study|Lost to Follow-up|2
1325840|NCT02243293|4352539|P21|Overall Study|Lost to Follow-up|1
1325841|NCT02243293|4352540|P20|Overall Study|Lost to Follow-up|0
1325842|NCT02243293|4352541|P19|Overall Study|Lost to Follow-up|0
1325843|NCT02243293|4352542|P18|Overall Study|Lost to Follow-up|1
1325844|NCT02243293|4352543|P17|Overall Study|Lost to Follow-up|3
1325845|NCT02243293|4352544|P16|Overall Study|Lost to Follow-up|0
1325846|NCT02243293|4352545|P15|Overall Study|Lost to Follow-up|0
1325847|NCT02243293|4352546|P14|Overall Study|Lost to Follow-up|0
1325848|NCT02243293|4352547|P13|Overall Study|Lost to Follow-up|0
1325849|NCT02243293|4352548|P12|Overall Study|Lost to Follow-up|2
1325850|NCT02243293|4352549|P11|Overall Study|Lost to Follow-up|0
1325851|NCT02243293|4352550|P10|Overall Study|Lost to Follow-up|0
1325852|NCT02243293|4352551|P9|Overall Study|Lost to Follow-up|0
1325853|NCT02243293|4352552|P8|Overall Study|Lost to Follow-up|0
1325854|NCT02243293|4352553|P7|Overall Study|Lost to Follow-up|3
1325855|NCT02243293|4352554|P6|Overall Study|Lost to Follow-up|0
1325856|NCT02243293|4352555|P5|Overall Study|Lost to Follow-up|0
1325857|NCT02243293|4352556|P4|Overall Study|Lost to Follow-up|1
1325858|NCT02243293|4352557|P3|Overall Study|Lost to Follow-up|1
1325859|NCT02243293|4352558|P2|Overall Study|Lost to Follow-up|1
1325860|NCT02243293|4352559|P1|Overall Study|Lost to Follow-up|0
1325861|NCT02243293|4352538|P22|Overall Study|Withdrawal by Subject|1
1325862|NCT02243293|4352539|P21|Overall Study|Withdrawal by Subject|0
1325863|NCT02243293|4352540|P20|Overall Study|Withdrawal by Subject|0
1325864|NCT02243293|4352541|P19|Overall Study|Withdrawal by Subject|0
1325865|NCT02243293|4352542|P18|Overall Study|Withdrawal by Subject|0
1325866|NCT02243293|4352543|P17|Overall Study|Withdrawal by Subject|0
1325867|NCT02243293|4352544|P16|Overall Study|Withdrawal by Subject|0
1325868|NCT02243293|4352545|P15|Overall Study|Withdrawal by Subject|0
1325869|NCT02243293|4352546|P14|Overall Study|Withdrawal by Subject|0
1325870|NCT02243293|4352547|P13|Overall Study|Withdrawal by Subject|0
1325871|NCT02243293|4352548|P12|Overall Study|Withdrawal by Subject|1
1325872|NCT02243293|4352549|P11|Overall Study|Withdrawal by Subject|0
1325873|NCT02243293|4352550|P10|Overall Study|Withdrawal by Subject|1
1325874|NCT02243293|4352551|P9|Overall Study|Withdrawal by Subject|0
1325875|NCT02243293|4352552|P8|Overall Study|Withdrawal by Subject|0
1325876|NCT02243293|4352553|P7|Overall Study|Withdrawal by Subject|0
1325877|NCT02243293|4352554|P6|Overall Study|Withdrawal by Subject|0
1325878|NCT02243293|4352555|P5|Overall Study|Withdrawal by Subject|0
1325879|NCT02243293|4352556|P4|Overall Study|Withdrawal by Subject|0
1325880|NCT02243293|4352557|P3|Overall Study|Withdrawal by Subject|0
1325881|NCT02243293|4352558|P2|Overall Study|Withdrawal by Subject|0
1325882|NCT02243293|4352559|P1|Overall Study|Withdrawal by Subject|1
1325883|NCT02243293|4352538|P22|Overall Study|Adverse Event|0
1325884|NCT02243293|4352539|P21|Overall Study|Adverse Event|1
1325885|NCT02243293|4352540|P20|Overall Study|Adverse Event|0
1325886|NCT02243293|4352541|P19|Overall Study|Adverse Event|0
1325887|NCT02243293|4352542|P18|Overall Study|Adverse Event|0
1325888|NCT02243293|4352543|P17|Overall Study|Adverse Event|0
1325889|NCT02243293|4352544|P16|Overall Study|Adverse Event|1
1325890|NCT02243293|4352545|P15|Overall Study|Adverse Event|0
1325891|NCT02243293|4352546|P14|Overall Study|Adverse Event|0
1325892|NCT02243293|4352547|P13|Overall Study|Adverse Event|0
1325893|NCT02243293|4352548|P12|Overall Study|Adverse Event|0
1325894|NCT02243293|4352549|P11|Overall Study|Adverse Event|0
1325895|NCT02243293|4352550|P10|Overall Study|Adverse Event|0
1325897|NCT02243293|4352552|P8|Overall Study|Adverse Event|0
1325898|NCT02243293|4352553|P7|Overall Study|Adverse Event|0
1325899|NCT02243293|4352554|P6|Overall Study|Adverse Event|0
1325900|NCT02243293|4352555|P5|Overall Study|Adverse Event|0
1325901|NCT02243293|4352556|P4|Overall Study|Adverse Event|0
1325902|NCT02243293|4352557|P3|Overall Study|Adverse Event|0
1325903|NCT02243293|4352558|P2|Overall Study|Adverse Event|0
1325904|NCT02243293|4352559|P1|Overall Study|Adverse Event|1
1325905|NCT02243280|4352658|P11|Treated|Lost to Follow-up|2
1325906|NCT02243280|4352659|P10|Treated|Lost to Follow-up|0
1325907|NCT02243280|4352660|P9|Treated|Lost to Follow-up|1
1325908|NCT02243280|4352661|P8|Treated|Lost to Follow-up|0
1325909|NCT02243280|4352662|P7|Treated|Lost to Follow-up|0
1325910|NCT02243280|4352663|P6|Treated|Lost to Follow-up|0
1325911|NCT02243280|4352664|P5|Treated|Lost to Follow-up|0
1325912|NCT02243280|4352665|P4|Treated|Lost to Follow-up|0
1325913|NCT02243280|4352666|P3|Treated|Lost to Follow-up|0
1325914|NCT02243280|4352667|P2|Treated|Lost to Follow-up|0
1325915|NCT02243280|4352668|P1|Treated|Lost to Follow-up|0
1325916|NCT02243280|4352658|P11|Treated|Adverse Event|1
1325917|NCT02243280|4352659|P10|Treated|Adverse Event|0
1325918|NCT02243280|4352660|P9|Treated|Adverse Event|0
1325919|NCT02243280|4352661|P8|Treated|Adverse Event|0
1325920|NCT02243280|4352662|P7|Treated|Adverse Event|0
1325921|NCT02243280|4352663|P6|Treated|Adverse Event|0
1325922|NCT02243280|4352664|P5|Treated|Adverse Event|0
1325923|NCT02243280|4352665|P4|Treated|Adverse Event|0
1325924|NCT02243280|4352666|P3|Treated|Adverse Event|0
1325925|NCT02243280|4352667|P2|Treated|Adverse Event|0
1325926|NCT02243280|4352668|P1|Treated|Adverse Event|1
1325927|NCT02243202|4352723|P4|Overall Study|Randomized but not received treatment|1
1325928|NCT02243202|4352724|P3|Overall Study|Randomized but not received treatment|0
1325929|NCT02243202|4352725|P2|Overall Study|Randomized but not received treatment|0
1325930|NCT02243202|4352726|P1|Overall Study|Randomized but not received treatment|0
1325931|NCT02243202|4352723|P4|Overall Study|Other|2
1325932|NCT02243202|4352724|P3|Overall Study|Other|1
1325933|NCT02243202|4352725|P2|Overall Study|Other|3
1325934|NCT02243202|4352726|P1|Overall Study|Other|1
1325935|NCT02243202|4352723|P4|Overall Study|Withdrawal by Subject|4
1325936|NCT02243202|4352724|P3|Overall Study|Withdrawal by Subject|4
1325937|NCT02243202|4352725|P2|Overall Study|Withdrawal by Subject|6
1325938|NCT02243202|4352726|P1|Overall Study|Withdrawal by Subject|7
1325939|NCT02243202|4352723|P4|Overall Study|Protocol Violation|1
1325940|NCT02243202|4352724|P3|Overall Study|Protocol Violation|2
1325941|NCT02243202|4352725|P2|Overall Study|Protocol Violation|1
1325942|NCT02243202|4352726|P1|Overall Study|Protocol Violation|3
1325943|NCT02243202|4352723|P4|Overall Study|Lost to Follow-up|11
1325944|NCT02243202|4352724|P3|Overall Study|Lost to Follow-up|14
1325945|NCT02243202|4352725|P2|Overall Study|Lost to Follow-up|9
1325946|NCT02243202|4352726|P1|Overall Study|Lost to Follow-up|9
1325947|NCT02243202|4352723|P4|Overall Study|Adverse Event|4
1325948|NCT02243202|4352724|P3|Overall Study|Adverse Event|10
1325949|NCT02243202|4352725|P2|Overall Study|Adverse Event|6
1325950|NCT02243202|4352726|P1|Overall Study|Adverse Event|5
1325951|NCT02243176|4352762|P2|Overall Study|Adverse Event|2
1325952|NCT02243176|4352763|P1|Overall Study|Adverse Event|2
1325953|NCT02243176|4352762|P2|Overall Study|Withdrawal by Subject|7
1325954|NCT02243176|4352763|P1|Overall Study|Withdrawal by Subject|8
1325955|NCT02243176|4352762|P2|Overall Study|Protocol Violation|1
1325956|NCT02243176|4352763|P1|Overall Study|Protocol Violation|2
1325957|NCT02243176|4352762|P2|Overall Study|protocol specified withdrawal critera|3
1325958|NCT02243176|4352763|P1|Overall Study|protocol specified withdrawal critera|1
1325959|NCT02243176|4352762|P2|Overall Study|Other reason|2
1325960|NCT02243176|4352763|P1|Overall Study|Other reason|1
1325961|NCT02243046|4352788|P3|Overall Study|Lost to Follow-up|4
1325962|NCT02243046|4352789|P2|Overall Study|Lost to Follow-up|1
1325963|NCT02243046|4352790|P1|Overall Study|Lost to Follow-up|1
1325964|NCT02242643|4352845|P2|Overall Study|Withdrawal by subject at Visit 2|1
1325965|NCT02242643|4352846|P1|Overall Study|Withdrawal by subject at Visit 2|0
1325966|NCT02242643|4352845|P2|Overall Study|Language barrier|0
1325967|NCT02242643|4352846|P1|Overall Study|Language barrier|1
1325968|NCT02242643|4352845|P2|Overall Study|Protocol requirements not followed|0
1325969|NCT02242643|4352846|P1|Overall Study|Protocol requirements not followed|1
1325970|NCT02242643|4352845|P2|Overall Study|Consent withdrawal by parent|0
1325971|NCT02242643|4352846|P1|Overall Study|Consent withdrawal by parent|1
1325972|NCT02242643|4352845|P2|Overall Study|Non-compliance|0
1325973|NCT02242643|4352846|P1|Overall Study|Non-compliance|1
1325974|NCT02242643|4352845|P2|Overall Study|Child placed in foster care by family|1
1325975|NCT02242643|4352846|P1|Overall Study|Child placed in foster care by family|0
1325976|NCT02242643|4352845|P2|Overall Study|Lost to Follow-up|61
1325977|NCT02242643|4352846|P1|Overall Study|Lost to Follow-up|54
1325978|NCT02242643|4352845|P2|Overall Study|Migrated/moved from study area|3
1325979|NCT02242643|4352846|P1|Overall Study|Migrated/moved from study area|1
1325980|NCT02242643|4352845|P2|Overall Study|Withdrawal by Subject|10
1325981|NCT02242643|4352846|P1|Overall Study|Withdrawal by Subject|15
1325982|NCT02242643|4352845|P2|Overall Study|Protocol Violation|2
1325983|NCT02242643|4352846|P1|Overall Study|Protocol Violation|1
1325984|NCT02242305|4352901|P2|Overall Study|Lost to Follow-up|0
1325985|NCT02242305|4352902|P1|Overall Study|Lost to Follow-up|2
1325986|NCT02242305|4352901|P2|Overall Study|Subject withdraws inform consent|4
1325987|NCT02242305|4352902|P1|Overall Study|Subject withdraws inform consent|0
1325988|NCT02242305|4352901|P2|Overall Study|Non-compliance dosing regimen or visit|2
1325989|NCT02242305|4352902|P1|Overall Study|Non-compliance dosing regimen or visit|2
1325990|NCT02242305|4352901|P2|Overall Study|Adverse Event|0
1325991|NCT02242305|4352902|P1|Overall Study|Adverse Event|1
1325992|NCT02242305|4352901|P2|Overall Study|Without spasm-like pain during 3 weeks|4
1325993|NCT02242305|4352902|P1|Overall Study|Without spasm-like pain during 3 weeks|1
1325994|NCT02242201|4352923|P3|Overall Study|preoperative opioid consumption|0
1325995|NCT02242201|4352924|P2|Overall Study|preoperative opioid consumption|1
1325996|NCT02242201|4352925|P1|Overall Study|preoperative opioid consumption|0
1325997|NCT02242201|4352923|P3|Overall Study|postponed surgery|1
1325998|NCT02242201|4352924|P2|Overall Study|postponed surgery|0
1325999|NCT02242201|4352925|P1|Overall Study|postponed surgery|0
1326000|NCT02242201|4352923|P3|Overall Study|changed surgical procedure|0
1326001|NCT02242201|4352924|P2|Overall Study|changed surgical procedure|0
1326002|NCT02242201|4352925|P1|Overall Study|changed surgical procedure|1
1326003|NCT02242201|4352923|P3|Overall Study|planned post-op anticoagulation|0
1326004|NCT02242201|4352924|P2|Overall Study|planned post-op anticoagulation|0
1326005|NCT02242201|4352925|P1|Overall Study|planned post-op anticoagulation|1
1326006|NCT02242201|4352923|P3|Overall Study|preoperative identified neuropathy|0
1326007|NCT02242201|4352924|P2|Overall Study|preoperative identified neuropathy|0
1326008|NCT02242201|4352925|P1|Overall Study|preoperative identified neuropathy|2
1326009|NCT02241889|4352963|P6|Overall Study|Withdrawal by Subject|1
1326010|NCT02241889|4352964|P5|Overall Study|Withdrawal by Subject|0
1326011|NCT02241889|4352965|P4|Overall Study|Withdrawal by Subject|0
1326012|NCT02241889|4352966|P3|Overall Study|Withdrawal by Subject|0
1326013|NCT02241889|4352967|P2|Overall Study|Withdrawal by Subject|0
1326014|NCT02241889|4352968|P1|Overall Study|Withdrawal by Subject|0
1326015|NCT02241889|4352963|P6|Overall Study|device issues|0
1326016|NCT02241889|4352964|P5|Overall Study|device issues|0
1326017|NCT02241889|4352965|P4|Overall Study|device issues|0
1326018|NCT02241889|4352966|P3|Overall Study|device issues|1
1326019|NCT02241889|4352967|P2|Overall Study|device issues|0
1326020|NCT02241889|4352968|P1|Overall Study|device issues|0
1326021|NCT02241785|4353003|P1|Overall Study|Adverse Event|1
1326022|NCT02241785|4353003|P1|Overall Study|Lost to Follow-up|2
1326023|NCT02241785|4353003|P1|Overall Study|Withdrawal by Subject|1
1326024|NCT02241785|4353003|P1|Overall Study|Sponsor Termination|43
1326025|NCT02241551|4353017|P2|Overall Study|Adverse Event|0
1326026|NCT02241551|4353018|P1|Overall Study|Adverse Event|1
1326027|NCT02241187|4353042|P1|Overall Study|Protocol closed due to lack of accrual.|2
1326028|NCT02240680|4353049|P4|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
1326029|NCT02240680|4353050|P3|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
1326030|NCT02240680|4353051|P2|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
1326031|NCT02240680|4353052|P1|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
1326032|NCT02240680|4353049|P4|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
1326033|NCT02240680|4353050|P3|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
1326034|NCT02240680|4353051|P2|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
1326035|NCT02240680|4353052|P1|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
1326036|NCT02240680|4353049|P4|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
1326037|NCT02240680|4353050|P3|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
1326038|NCT02240680|4353051|P2|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
1326039|NCT02240680|4353052|P1|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
1326040|NCT02240680|4353049|P4|Overall Study (Up to 24 Weeks)|Other than specified|0
1326041|NCT02240680|4353050|P3|Overall Study (Up to 24 Weeks)|Other than specified|0
1326042|NCT02240680|4353051|P2|Overall Study (Up to 24 Weeks)|Other than specified|0
1326043|NCT02240680|4353052|P1|Overall Study (Up to 24 Weeks)|Other than specified|1
1326044|NCT02240680|4353049|P4|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
1326045|NCT02240680|4353050|P3|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
1326046|NCT02240680|4353051|P2|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
1326047|NCT02240680|4353052|P1|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
1326048|NCT02240680|4353049|P4|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
1326049|NCT02240680|4353050|P3|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
1326050|NCT02240680|4353051|P2|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
1326051|NCT02240680|4353052|P1|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
1326052|NCT02240680|4353049|P4|Overall Study (Up to 24 Weeks)|Protocol Violation|0
1326053|NCT02240680|4353050|P3|Overall Study (Up to 24 Weeks)|Protocol Violation|0
1326054|NCT02240680|4353051|P2|Overall Study (Up to 24 Weeks)|Protocol Violation|1
1326055|NCT02240680|4353052|P1|Overall Study (Up to 24 Weeks)|Protocol Violation|4
1326056|NCT02240680|4353049|P4|Overall Study (Up to 24 Weeks)|Adverse Event|0
1326057|NCT02240680|4353050|P3|Overall Study (Up to 24 Weeks)|Adverse Event|0
1326058|NCT02240680|4353051|P2|Overall Study (Up to 24 Weeks)|Adverse Event|6
1326059|NCT02240680|4353052|P1|Overall Study (Up to 24 Weeks)|Adverse Event|6
1326060|NCT02240628|4353093|P2|Overall Study|Physician Decision|5
1326061|NCT02240628|4353094|P1|Overall Study|Physician Decision|6
1326062|NCT02240368|4353128|P3|Overall Study|Entropy failed to detect more than 50%|1
1326063|NCT02240368|4353129|P2|Overall Study|Entropy failed to detect more than 50%|0
1326064|NCT02240368|4353130|P1|Overall Study|Entropy failed to detect more than 50%|0
1326065|NCT02240368|4353128|P3|Overall Study|Surgery lasted less then 20 minutes|0
1326066|NCT02240368|4353129|P2|Overall Study|Surgery lasted less then 20 minutes|0
1326067|NCT02240368|4353130|P1|Overall Study|Surgery lasted less then 20 minutes|1
1326068|NCT02239978|4353181|P2|Overall Study|Withdrawal by Subject|0
1326069|NCT02239978|4353182|P1|Overall Study|Withdrawal by Subject|2
1326070|NCT02239939|4353199|P2|Overall Study|Lost to Follow-up|1
1326071|NCT02239939|4353200|P1|Overall Study|Lost to Follow-up|0
1326072|NCT02239939|4353199|P2|Overall Study|Withdrawal by Subject|1
1326073|NCT02239939|4353200|P1|Overall Study|Withdrawal by Subject|1
1326074|NCT02239939|4353199|P2|Overall Study|Adverse Event|0
1326075|NCT02239939|4353200|P1|Overall Study|Adverse Event|1
1326076|NCT02239926|4353216|P2|Overall Study|Withdrawal by Subject|1
1326077|NCT02239926|4353217|P1|Overall Study|Withdrawal by Subject|0
1326078|NCT02239692|4353279|P2|Overall Study|Other reason|0
1326079|NCT02239692|4353280|P1|Overall Study|Other reason|1
1326080|NCT02239692|4353279|P2|Overall Study|Withdrawal by Subject|5
1326081|NCT02239692|4353280|P1|Overall Study|Withdrawal by Subject|3
1326082|NCT02239692|4353279|P2|Overall Study|Lost to Follow-up|4
1326083|NCT02239692|4353280|P1|Overall Study|Lost to Follow-up|1
1326084|NCT02239692|4353279|P2|Overall Study|Physician Decision|1
1326085|NCT02239692|4353280|P1|Overall Study|Physician Decision|0
1326086|NCT02239692|4353279|P2|Overall Study|Adverse Event|1
1326087|NCT02239692|4353280|P1|Overall Study|Adverse Event|0
1326088|NCT02239692|4353279|P2|Overall Study|Incomplete colonoscopy|2
1326089|NCT02239692|4353280|P1|Overall Study|Incomplete colonoscopy|1
1326090|NCT02239679|4353299|P3|Overall Study|Withdrawal by Subject|1
1326091|NCT02239679|4353300|P2|Overall Study|Withdrawal by Subject|3
1326092|NCT02239679|4353301|P1|Overall Study|Withdrawal by Subject|2
1326093|NCT02239679|4353299|P3|Overall Study|Lost to Follow-up|0
1326094|NCT02239679|4353300|P2|Overall Study|Lost to Follow-up|0
1326095|NCT02239679|4353301|P1|Overall Study|Lost to Follow-up|1
1326096|NCT02239094|4353532|P1|Overall Study|Remitted before started|1
1326097|NCT02239094|4353532|P1|Overall Study|Withdrawal by Subject|1
1326098|NCT02238483|4353560|P2|Overall Study|Illness in family member|0
1326099|NCT02238483|4353561|P1|Overall Study|Illness in family member|1
1326100|NCT02238483|4353560|P2|Overall Study|Completion status not recorded|1
1326101|NCT02238483|4353561|P1|Overall Study|Completion status not recorded|1
1326102|NCT02238483|4353560|P2|Overall Study|Withdrawn due to physician decision|0
1326103|NCT02238483|4353561|P1|Overall Study|Withdrawn due to physician decision|1
1326104|NCT02238483|4353560|P2|Overall Study|Adverse Event|3
1326105|NCT02238483|4353561|P1|Overall Study|Adverse Event|7
1326106|NCT02238483|4353560|P2|Overall Study|Death|0
1326107|NCT02238483|4353561|P1|Overall Study|Death|1
1326108|NCT02238483|4353560|P2|Overall Study|Protocol Violation|2
1326109|NCT02238483|4353561|P1|Overall Study|Protocol Violation|1
1326110|NCT02238483|4353560|P2|Overall Study|Lost to Follow-up|1
1326111|NCT02238483|4353561|P1|Overall Study|Lost to Follow-up|1
1326112|NCT02238483|4353560|P2|Overall Study|Withdrawal by Subject|7
1326113|NCT02238483|4353561|P1|Overall Study|Withdrawal by Subject|2
1326114|NCT02238379|4353599|P2|Overall Study|Lost to Follow-up|0
1326115|NCT02238379|4353600|P1|Overall Study|Lost to Follow-up|1
1326116|NCT02238080|4353626|P1|Overall Study|Other|4
1326117|NCT02238080|4353626|P1|Overall Study|Withdrawal by Subject|2
1326118|NCT02238080|4353626|P1|Overall Study|Treatment interrupted|6
1326119|NCT02238080|4353626|P1|Overall Study|Death|13
1326120|NCT02238067|4353640|P1|Overall Study|Not completed survey at Month 6|45
1326121|NCT02237118|4353685|P2|Overall Study|consent withdrawn|0
1326122|NCT02237118|4353686|P1|Overall Study|consent withdrawn|1
1326123|NCT02237118|4353685|P2|Overall Study|Protocol Violation|1
1326124|NCT02237118|4353686|P1|Overall Study|Protocol Violation|0
1326125|NCT02236611|4353723|P2|Overall Study|Withdrew consent|4
1326126|NCT02236611|4353724|P1|Overall Study|Withdrew consent|9
1326127|NCT02236611|4353723|P2|Overall Study|Protocol deviation|5
1326128|NCT02236611|4353724|P1|Overall Study|Protocol deviation|3
1326129|NCT02236611|4353723|P2|Overall Study|Lost to Follow-up|2
1326130|NCT02236611|4353724|P1|Overall Study|Lost to Follow-up|0
1326131|NCT02236611|4353723|P2|Overall Study|Lack of Efficacy|7
1326132|NCT02236611|4353724|P1|Overall Study|Lack of Efficacy|4
1326133|NCT02236611|4353723|P2|Overall Study|Adverse Event|16
1326134|NCT02236611|4353724|P1|Overall Study|Adverse Event|10
1326135|NCT02236598|4353732|P2|Overall Study|Withdrawal by Subject|1
1326136|NCT02236598|4353733|P1|Overall Study|Withdrawal by Subject|0
1326137|NCT02236598|4353732|P2|Overall Study|Adverse Event|1
1326138|NCT02236598|4353733|P1|Overall Study|Adverse Event|0
1326139|NCT02236130|4353769|P2|Overall Study|Lost to Follow-up|12
1326140|NCT02236130|4353770|P1|Overall Study|Lost to Follow-up|7
1326141|NCT02235454|4353820|P1|Overall Study|Withdrawal by Subject|2
1326142|NCT02235311|4353826|P2|Overall Study|Protocol Violation|1
1326143|NCT02235311|4353827|P1|Overall Study|Protocol Violation|0
1326144|NCT02235311|4353826|P2|Overall Study|Lost to Follow-up|1
1326145|NCT02235311|4353827|P1|Overall Study|Lost to Follow-up|0
1326146|NCT02235077|4353845|P2|Overall Study|Physician Decision|1
1326147|NCT02235077|4353846|P1|Overall Study|Physician Decision|0
1326148|NCT02235077|4353845|P2|Overall Study|Withdrawal by Subject|5
1326149|NCT02235077|4353846|P1|Overall Study|Withdrawal by Subject|8
1326150|NCT02235077|4353845|P2|Overall Study|Lost to Follow-up|6
1326151|NCT02235077|4353846|P1|Overall Study|Lost to Follow-up|5
1326152|NCT02235077|4353845|P2|Overall Study|Death|7
1326153|NCT02235077|4353846|P1|Overall Study|Death|5
1326154|NCT02234479|4353914|P2|Overall Study|Withdrawal by Subject|3
1326155|NCT02234479|4353915|P1|Overall Study|Withdrawal by Subject|1
1326156|NCT02234362|4353925|P1|Overall Study|Withdrawal by Subject|3
1326157|NCT02234362|4353925|P1|Overall Study|Lost to Follow-up|6
1326158|NCT02234362|4353925|P1|Overall Study|Not eligible after first screening visit|17
1326159|NCT02233803|4354006|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
1326160|NCT02233803|4354007|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
1326161|NCT02233803|4354006|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
1326162|NCT02233803|4354007|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
1326163|NCT02233803|4354006|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
1326164|NCT02233803|4354007|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
1326165|NCT02233803|4354006|P2|Washout Period (4-Wks)|Physician Decision|0
1326166|NCT02233803|4354007|P1|Washout Period (4-Wks)|Physician Decision|1
1326167|NCT02233803|4354006|P2|Washout Period (4-Wks)|Lost to Follow-up|1
1326168|NCT02233803|4354007|P1|Washout Period (4-Wks)|Lost to Follow-up|0
1326169|NCT02233803|4354006|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
1326170|NCT02233803|4354007|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
1326171|NCT02233803|4354006|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
1326172|NCT02233803|4354007|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
1326173|NCT02233803|4354006|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
1326174|NCT02233803|4354007|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
1326175|NCT02233803|4354006|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
1326176|NCT02233803|4354007|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
1326177|NCT02233647|4354017|P1|Overall Study|Adverse Event|1
1326178|NCT02233543|4354046|P2|Period 2|COPD exacerbation|0
1326179|NCT02233543|4354047|P1|Period 2|COPD exacerbation|1
1326180|NCT02233543|4354046|P2|Period 2|Participant required other treatment.|1
1326181|NCT02233543|4354047|P1|Period 2|Participant required other treatment.|0
1326182|NCT02233543|4354046|P2|Period 2|Adverse Event|0
1326183|NCT02233543|4354047|P1|Period 2|Adverse Event|1
1326184|NCT02233543|4354046|P2|Period 1|Participants required other treatment.|3
1326185|NCT02233543|4354047|P1|Period 1|Participants required other treatment.|2
1326186|NCT02233543|4354046|P2|Period 1|Withdrawal by Subject|0
1326187|NCT02233543|4354047|P1|Period 1|Withdrawal by Subject|1
1326188|NCT02233309|4354055|P1|Overall Study|Physician Decision|5
1326189|NCT02232880|4354089|P1|Overall Study|study stopped prior to randomization|1
1326190|NCT02232698|4354098|P2|Overall Study|Withdrawal by Subject|11
1326191|NCT02232698|4354099|P1|Overall Study|Withdrawal by Subject|0
1326192|NCT02232698|4354098|P2|Overall Study|Allocated to control group|3
1326193|NCT02232698|4354099|P1|Overall Study|Allocated to control group|0
1326194|NCT02232698|4354098|P2|Overall Study|Non-compliance with study device|4
1326195|NCT02232698|4354099|P1|Overall Study|Non-compliance with study device|1
1326196|NCT02232698|4354098|P2|Overall Study|Had device-associated symptoms|0
1326197|NCT02232698|4354099|P1|Overall Study|Had device-associated symptoms|7
1326198|NCT02232698|4354098|P2|Overall Study|Met exclusion criteria|1
1326199|NCT02232698|4354099|P1|Overall Study|Met exclusion criteria|1
1326200|NCT02232698|4354098|P2|Overall Study|Pregnancy|1
1326201|NCT02232698|4354099|P1|Overall Study|Pregnancy|1
1326202|NCT02232178|4354123|P3|Overall Study|surgical complication|0
1326203|NCT02232178|4354124|P2|Overall Study|surgical complication|0
1326204|NCT02232178|4354125|P1|Overall Study|surgical complication|1
1326205|NCT02232178|4354123|P3|Overall Study|ineligibility|1
1326206|NCT02232178|4354124|P2|Overall Study|ineligibility|0
1326207|NCT02232178|4354125|P1|Overall Study|ineligibility|0
1326208|NCT02232178|4354123|P3|Overall Study|Lost to Follow-up|0
1326209|NCT02232178|4354124|P2|Overall Study|Lost to Follow-up|1
1326210|NCT02232178|4354125|P1|Overall Study|Lost to Follow-up|0
1326211|NCT02231918|4354156|P3|Overall Study|Adverse Event|1
1326212|NCT02231918|4354157|P2|Overall Study|Adverse Event|0
1326213|NCT02231918|4354158|P1|Overall Study|Adverse Event|0
1326214|NCT02231918|4354156|P3|Overall Study|Withdrawal by Subject|0
1326215|NCT02231918|4354157|P2|Overall Study|Withdrawal by Subject|1
1326216|NCT02231918|4354158|P1|Overall Study|Withdrawal by Subject|0
1326217|NCT02231580|4354222|P2|Overall Study|Adverse Event|0
1326218|NCT02231580|4354223|P1|Overall Study|Adverse Event|5
1326219|NCT02231164|4354340|P2|Overall Study|Withdrawal by Subject|2
1326220|NCT02231164|4354341|P1|Overall Study|Withdrawal by Subject|1
1326221|NCT02231164|4354340|P2|Overall Study|Lack of Efficacy|3
1326222|NCT02231164|4354341|P1|Overall Study|Lack of Efficacy|4
1326223|NCT02231164|4354340|P2|Overall Study|Adverse Event|1
1326224|NCT02231164|4354341|P1|Overall Study|Adverse Event|1
1326225|NCT02230956|4354369|P3|Overall Study|Other Miscellaneous Reason|2
1326226|NCT02230956|4354370|P2|Overall Study|Other Miscellaneous Reason|1
1326227|NCT02230956|4354371|P1|Overall Study|Other Miscellaneous Reason|0
1326228|NCT02230956|4354369|P3|Overall Study|Protocol Violation|1
1326229|NCT02230956|4354370|P2|Overall Study|Protocol Violation|1
1326230|NCT02230956|4354371|P1|Overall Study|Protocol Violation|0
1326231|NCT02230956|4354369|P3|Overall Study|Personal Reasons|1
1326232|NCT02230956|4354370|P2|Overall Study|Personal Reasons|1
1326233|NCT02230956|4354371|P1|Overall Study|Personal Reasons|2
1326234|NCT02230956|4354369|P3|Overall Study|Lost to Follow-up|2
1326235|NCT02230956|4354370|P2|Overall Study|Lost to Follow-up|1
1326236|NCT02230956|4354371|P1|Overall Study|Lost to Follow-up|1
1326237|NCT02230956|4354369|P3|Overall Study|Lack of Efficacy|1
1326238|NCT02230956|4354370|P2|Overall Study|Lack of Efficacy|1
1326239|NCT02230956|4354371|P1|Overall Study|Lack of Efficacy|1
1326240|NCT02230956|4354369|P3|Overall Study|Adverse Event|0
1326241|NCT02230956|4354370|P2|Overall Study|Adverse Event|1
1326242|NCT02230956|4354371|P1|Overall Study|Adverse Event|1
1326243|NCT02230904|4354393|P2|Overall Study|Safety follow up could not take place|1
1326244|NCT02230904|4354394|P1|Overall Study|Safety follow up could not take place|0
1326245|NCT02230683|4354427|P1|Overall Study|Adverse Event|1
1326246|NCT02230670|4354444|P2|Overall Study|Progression to Child-Pugh C|2
1326247|NCT02230670|4354445|P1|Overall Study|Progression to Child-Pugh C|1
1326248|NCT02230670|4354444|P2|Overall Study|Protocol Violation|1
1326249|NCT02230670|4354445|P1|Overall Study|Protocol Violation|0
1326250|NCT02230670|4354444|P2|Overall Study|Physician Decision|1
1326251|NCT02230670|4354445|P1|Overall Study|Physician Decision|0
1326252|NCT02230670|4354444|P2|Overall Study|Withdrawal by Subject|2
1326253|NCT02230670|4354445|P1|Overall Study|Withdrawal by Subject|2
1326254|NCT02230670|4354444|P2|Overall Study|Adverse Event|2
1326255|NCT02230670|4354445|P1|Overall Study|Adverse Event|1
1326256|NCT02230384|4354484|P2|Phase 2 - Switch|Adverse Event|0
1326257|NCT02230384|4354485|P1|Phase 2 - Switch|Adverse Event|2
1326258|NCT02230384|4354484|P2|Phase 2 - Switch|Lost to Follow-up|0
1326259|NCT02230384|4354485|P1|Phase 2 - Switch|Lost to Follow-up|1
1326260|NCT02230384|4354484|P2|Phase 2 - Switch|Withdrawal by Subject|1
1326261|NCT02230384|4354485|P1|Phase 2 - Switch|Withdrawal by Subject|0
1326262|NCT02230384|4354484|P2|Phase 1|Physician Decision|1
1326263|NCT02230384|4354485|P1|Phase 1|Physician Decision|0
1326264|NCT02230384|4354484|P2|Phase 1|Lost to Follow-up|0
1326265|NCT02230384|4354485|P1|Phase 1|Lost to Follow-up|1
1326266|NCT02230332|4354493|P2|Overall Study|Protocol Violation|0
1326267|NCT02230332|4354494|P1|Overall Study|Protocol Violation|1
1326268|NCT02230332|4354493|P2|Overall Study|Lost to Follow-up|0
1326269|NCT02230332|4354494|P1|Overall Study|Lost to Follow-up|1
1326270|NCT02230332|4354493|P2|Overall Study|Adverse Event|1
1326271|NCT02230332|4354494|P1|Overall Study|Adverse Event|2
1326272|NCT02230306|4354510|P1|Overall Study|Did not receive study treatment|1
1326273|NCT02230085|4354521|P1|Overall Study|Withdrawal by Subject|3
1326274|NCT02230085|4354521|P1|Overall Study|Physician Decision|1
1326275|NCT02229864|4354525|P1|3 - Year Visit|Death|2
1326276|NCT02229864|4354525|P1|2 - Year Visit|Missed Visits|1
1326277|NCT02229539|4354580|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
1326278|NCT02229539|4354581|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
1326279|NCT02229539|4354582|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
1326280|NCT02229539|4354580|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
1326281|NCT02229539|4354581|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
1326282|NCT02229539|4354582|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
1326283|NCT02229539|4354580|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
1326284|NCT02229539|4354581|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
1326285|NCT02229539|4354582|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
1326286|NCT02229539|4354580|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
1326287|NCT02229539|4354581|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
1326288|NCT02229539|4354582|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
1326289|NCT02229539|4354580|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
1326290|NCT02229539|4354581|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
1326291|NCT02229539|4354582|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
1326292|NCT02229539|4354580|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
1326293|NCT02229539|4354581|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
1326294|NCT02229539|4354582|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
1326295|NCT02229539|4354580|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
1326296|NCT02229539|4354581|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
1326297|NCT02229539|4354582|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
1326298|NCT02229539|4354580|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
1326299|NCT02229539|4354581|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
1326300|NCT02229539|4354582|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
1326301|NCT02229539|4354580|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
1326302|NCT02229539|4354581|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
1326303|NCT02229539|4354582|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
1326304|NCT02229396|4354713|P3|Overall Study|Other Eligibility criteria|0
1326305|NCT02229396|4354714|P2|Overall Study|Other Eligibility criteria|2
1326306|NCT02229396|4354715|P1|Overall Study|Other Eligibility criteria|0
1326307|NCT02229396|4354713|P3|Overall Study|Withdrawal by Subject|16
1326308|NCT02229396|4354714|P2|Overall Study|Withdrawal by Subject|9
1326309|NCT02229396|4354715|P1|Overall Study|Withdrawal by Subject|15
1326310|NCT02229396|4354713|P3|Overall Study|Withdrew; no record on termination page|4
1326311|NCT02229396|4354714|P2|Overall Study|Withdrew; no record on termination page|5
1326312|NCT02229396|4354715|P1|Overall Study|Withdrew; no record on termination page|2
1326313|NCT02229396|4354713|P3|Overall Study|Patient was incorrectly randomized|1
1326314|NCT02229396|4354714|P2|Overall Study|Patient was incorrectly randomized|0
1326315|NCT02229396|4354715|P1|Overall Study|Patient was incorrectly randomized|0
1326316|NCT02229396|4354713|P3|Overall Study|Protocol deviation; compliance|0
1326317|NCT02229396|4354714|P2|Overall Study|Protocol deviation; compliance|0
1326318|NCT02229396|4354715|P1|Overall Study|Protocol deviation; compliance|1
1326319|NCT02229396|4354713|P3|Overall Study|Lost to Follow-up|11
1326320|NCT02229396|4354714|P2|Overall Study|Lost to Follow-up|5
1326321|NCT02229396|4354715|P1|Overall Study|Lost to Follow-up|4
1326322|NCT02229396|4354713|P3|Overall Study|Death|1
1326323|NCT02229396|4354714|P2|Overall Study|Death|3
1326324|NCT02229396|4354715|P1|Overall Study|Death|1
1326325|NCT02229396|4354713|P3|Overall Study|Adverse Event|5
1326326|NCT02229396|4354714|P2|Overall Study|Adverse Event|5
1326327|NCT02229396|4354715|P1|Overall Study|Adverse Event|2
1326328|NCT02229383|4354746|P2|Overall Study|Randomized in error|0
1326329|NCT02229383|4354747|P1|Overall Study|Randomized in error|1
1326330|NCT02229383|4354746|P2|Overall Study|Investigator decision|4
1326331|NCT02229383|4354747|P1|Overall Study|Investigator decision|1
1326332|NCT02229383|4354746|P2|Overall Study|Death|1
1326333|NCT02229383|4354747|P1|Overall Study|Death|0
1326334|NCT02229383|4354746|P2|Overall Study|Fire at the study center|4
1326335|NCT02229383|4354747|P1|Overall Study|Fire at the study center|2
1326336|NCT02229383|4354746|P2|Overall Study|Withdrawal by Subject|9
1326337|NCT02229383|4354747|P1|Overall Study|Withdrawal by Subject|5
1326338|NCT02229383|4354746|P2|Overall Study|Lost to Follow-up|2
1326339|NCT02229383|4354747|P1|Overall Study|Lost to Follow-up|4
1326340|NCT02229383|4354746|P2|Overall Study|Adverse Event|4
1326341|NCT02229383|4354747|P1|Overall Study|Adverse Event|9
1326342|NCT02229227|4354772|P2|Overall Study|Physician Decision|12
1326343|NCT02229227|4354773|P1|Overall Study|Physician Decision|5
1326344|NCT02229227|4354772|P2|Overall Study|Other|1
1326345|NCT02229227|4354773|P1|Overall Study|Other|0
1326346|NCT02229227|4354772|P2|Overall Study|Withdrawal by Subject|12
1326347|NCT02229227|4354773|P1|Overall Study|Withdrawal by Subject|8
1326348|NCT02229227|4354772|P2|Overall Study|Study terminated by sponsor|11
1326349|NCT02229227|4354773|P1|Overall Study|Study terminated by sponsor|11
1326350|NCT02229227|4354772|P2|Overall Study|Lost to Follow-up|3
1326351|NCT02229227|4354773|P1|Overall Study|Lost to Follow-up|3
1326352|NCT02229227|4354772|P2|Overall Study|Protocol defined stopping criteria|3
1326353|NCT02229227|4354773|P1|Overall Study|Protocol defined stopping criteria|1
1326354|NCT02229227|4354772|P2|Overall Study|Protocol Violation|8
1326355|NCT02229227|4354773|P1|Overall Study|Protocol Violation|6
1326356|NCT02229227|4354772|P2|Overall Study|Lack of Efficacy|3
1326357|NCT02229227|4354773|P1|Overall Study|Lack of Efficacy|3
1326358|NCT02229227|4354772|P2|Overall Study|Adverse Event|9
1326359|NCT02229227|4354773|P1|Overall Study|Adverse Event|14
1326360|NCT02229214|4354858|P2|Overall Study|Withdrawal by Subject|0
1326361|NCT02229214|4354859|P1|Overall Study|Withdrawal by Subject|4
1326362|NCT02229214|4354858|P2|Overall Study|Adverse Event|0
1326363|NCT02229214|4354859|P1|Overall Study|Adverse Event|2
1326364|NCT02228980|4354883|P4|Overall Study|Withdrawal by Subject|3
1326365|NCT02228980|4354884|P3|Overall Study|Withdrawal by Subject|2
1326366|NCT02228980|4354885|P2|Overall Study|Withdrawal by Subject|3
1326367|NCT02228980|4354886|P1|Overall Study|Withdrawal by Subject|3
1326368|NCT02228980|4354883|P4|Overall Study|Protocol Violation|0
1326369|NCT02228980|4354884|P3|Overall Study|Protocol Violation|0
1326370|NCT02228980|4354885|P2|Overall Study|Protocol Violation|0
1326371|NCT02228980|4354886|P1|Overall Study|Protocol Violation|7
1326372|NCT02228980|4354883|P4|Overall Study|Adverse Event|0
1326373|NCT02228980|4354884|P3|Overall Study|Adverse Event|0
1326374|NCT02228980|4354885|P2|Overall Study|Adverse Event|0
1326375|NCT02228980|4354886|P1|Overall Study|Adverse Event|14
1326376|NCT02228720|4354908|P1|Open Label - Day 30|Lost to Follow-up|1
1326377|NCT02228395|4354916|P3|First Intervention Period|Unable to comply with study dates|1
1326378|NCT02228395|4354917|P2|First Intervention Period|Unable to comply with study dates|1
1326379|NCT02228395|4354918|P1|First Intervention Period|Unable to comply with study dates|0
1326380|NCT02228395|4354916|P3|First Intervention Period|No longer willing to participate|0
1326381|NCT02228395|4354917|P2|First Intervention Period|No longer willing to participate|0
1326382|NCT02228395|4354918|P1|First Intervention Period|No longer willing to participate|1
1326383|NCT02227784|4355001|P5|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
1326384|NCT02227784|4355002|P4|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1326385|NCT02227784|4355003|P3|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1326386|NCT02227784|4355004|P2|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1326387|NCT02227784|4355005|P1|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1326388|NCT02227784|4355001|P5|Open-Label Extension Phase (OLE)|Sponsor Decision|243
1326389|NCT02227784|4355002|P4|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1326390|NCT02227784|4355003|P3|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1326391|NCT02227784|4355004|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1326392|NCT02227784|4355005|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1326393|NCT02227784|4355001|P5|Open-Label Extension Phase (OLE)|Death|1
1326394|NCT02227784|4355002|P4|Open-Label Extension Phase (OLE)|Death|0
1326395|NCT02227784|4355003|P3|Open-Label Extension Phase (OLE)|Death|0
1326396|NCT02227784|4355004|P2|Open-Label Extension Phase (OLE)|Death|0
1326397|NCT02227784|4355005|P1|Open-Label Extension Phase (OLE)|Death|0
1326398|NCT02227784|4355001|P5|Open-Label Extension Phase (OLE)|Adverse Event|1
1326399|NCT02227784|4355002|P4|Open-Label Extension Phase (OLE)|Adverse Event|0
1326400|NCT02227784|4355003|P3|Open-Label Extension Phase (OLE)|Adverse Event|0
1326401|NCT02227784|4355004|P2|Open-Label Extension Phase (OLE)|Adverse Event|0
1326402|NCT02227784|4355005|P1|Open-Label Extension Phase (OLE)|Adverse Event|0
1326403|NCT02227784|4355001|P5|Double-Blind Phase|Withdrawal by Subject|0
1326404|NCT02227784|4355002|P4|Double-Blind Phase|Withdrawal by Subject|2
1326405|NCT02227784|4355003|P3|Double-Blind Phase|Withdrawal by Subject|5
1326406|NCT02227784|4355004|P2|Double-Blind Phase|Withdrawal by Subject|1
1326407|NCT02227784|4355005|P1|Double-Blind Phase|Withdrawal by Subject|2
1326408|NCT02227784|4355001|P5|Double-Blind Phase|Sponsor Decision|0
1326409|NCT02227784|4355002|P4|Double-Blind Phase|Sponsor Decision|32
1326410|NCT02227784|4355003|P3|Double-Blind Phase|Sponsor Decision|14
1326411|NCT02227784|4355004|P2|Double-Blind Phase|Sponsor Decision|15
1326412|NCT02227784|4355005|P1|Double-Blind Phase|Sponsor Decision|34
1326413|NCT02227784|4355001|P5|Double-Blind Phase|Protocol Violation|0
1326414|NCT02227784|4355002|P4|Double-Blind Phase|Protocol Violation|1
1326415|NCT02227784|4355003|P3|Double-Blind Phase|Protocol Violation|1
1326416|NCT02227784|4355004|P2|Double-Blind Phase|Protocol Violation|0
1326417|NCT02227784|4355005|P1|Double-Blind Phase|Protocol Violation|0
1326418|NCT02227784|4355001|P5|Double-Blind Phase|Physician Decision|0
1326419|NCT02227784|4355002|P4|Double-Blind Phase|Physician Decision|1
1326420|NCT02227784|4355003|P3|Double-Blind Phase|Physician Decision|0
1326421|NCT02227784|4355004|P2|Double-Blind Phase|Physician Decision|0
1326422|NCT02227784|4355005|P1|Double-Blind Phase|Physician Decision|1
1326423|NCT02227784|4355001|P5|Double-Blind Phase|Adverse Event|0
1326424|NCT02227784|4355002|P4|Double-Blind Phase|Adverse Event|3
1326425|NCT02227784|4355003|P3|Double-Blind Phase|Adverse Event|1
1326426|NCT02227784|4355004|P2|Double-Blind Phase|Adverse Event|2
1326427|NCT02227784|4355005|P1|Double-Blind Phase|Adverse Event|3
1326428|NCT02227368|4355061|P2|Overall Study|Adverse Event|0
1326429|NCT02227368|4355062|P1|Overall Study|Adverse Event|1
1326430|NCT02227368|4355061|P2|Overall Study|Lost to Follow-up|0
1326431|NCT02227368|4355062|P1|Overall Study|Lost to Follow-up|1
1326432|NCT02227368|4355061|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
1326433|NCT02227368|4355062|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
1326434|NCT02227108|4355120|P1|Overall Study|Adverse Event|6
1326435|NCT02227108|4355120|P1|Overall Study|Investigator discretion|1
1326436|NCT02227108|4355120|P1|Overall Study|Initiation of alternative therapy|2
1326437|NCT02227108|4355120|P1|Overall Study|Progressive disease|17
1326438|NCT02227108|4355120|P1|Overall Study|Other|3
1326439|NCT02227108|4355120|P1|Overall Study|Did not receive treatment|2
1326440|NCT02226562|4355149|P2|Overall Study|Lost to Follow-up|1
1326441|NCT02226562|4355150|P1|Overall Study|Lost to Follow-up|0
1326442|NCT02226549|4355168|P2|Overall Study|Lost to Follow-up|1
1326443|NCT02226549|4355169|P1|Overall Study|Lost to Follow-up|0
1326444|NCT02226549|4355168|P2|Overall Study|Randomized but Never Treated|0
1326445|NCT02226549|4355169|P1|Overall Study|Randomized but Never Treated|1
1326446|NCT02226198|4355179|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
1326447|NCT02226198|4355180|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
1326448|NCT02226198|4355181|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
1326449|NCT02226198|4355179|P3|Lead-in Phase|Protocol Violation|0
1326450|NCT02226198|4355180|P2|Lead-in Phase|Protocol Violation|0
1326451|NCT02226198|4355181|P1|Lead-in Phase|Protocol Violation|1
1326452|NCT02226172|4355254|P1|Overall Study|Ongoing in study|3
1326453|NCT02226172|4355254|P1|Overall Study|Death|1
1326454|NCT02226172|4355254|P1|Overall Study|Other|4
1326455|NCT02226172|4355254|P1|Overall Study|Subject refused further follow-up|5
1326456|NCT02226003|4355276|P3|Overall Study|Withdrawal by Subject|3
1326457|NCT02226003|4355277|P2|Overall Study|Withdrawal by Subject|0
1326458|NCT02226003|4355278|P1|Overall Study|Withdrawal by Subject|0
1326459|NCT02226003|4355276|P3|Overall Study|Lost to Follow-up|3
1326460|NCT02226003|4355277|P2|Overall Study|Lost to Follow-up|1
1326461|NCT02226003|4355278|P1|Overall Study|Lost to Follow-up|2
1326462|NCT02224846|4355329|P2|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
1326463|NCT02224846|4355330|P1|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
1326464|NCT02224846|4355329|P2|Period 2 (Month 12 to Month 24)|Physician Decision|2
1326465|NCT02224846|4355330|P1|Period 2 (Month 12 to Month 24)|Physician Decision|0
1326466|NCT02224846|4355329|P2|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
1326467|NCT02224846|4355330|P1|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
1326468|NCT02224846|4355329|P2|Period 2 (Month 12 to Month 24)|Protocol Violation|11
1326469|NCT02224846|4355330|P1|Period 2 (Month 12 to Month 24)|Protocol Violation|4
1326470|NCT02224846|4355329|P2|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
1326471|NCT02224846|4355330|P1|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
1326472|NCT02224846|4355329|P2|Period 2 (Month 12 to Month 24)|Death|0
1326473|NCT02224846|4355330|P1|Period 2 (Month 12 to Month 24)|Death|1
1326474|NCT02224846|4355329|P2|Period 2 (Month 12 to Month 24)|Adverse Event|4
1326475|NCT02224846|4355330|P1|Period 2 (Month 12 to Month 24)|Adverse Event|3
1326476|NCT02224846|4355329|P2|Period 2 (Month 3 to Month 12)|Physician Decision|2
1326477|NCT02224846|4355330|P1|Period 2 (Month 3 to Month 12)|Physician Decision|0
1326478|NCT02224846|4355329|P2|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
1326479|NCT02224846|4355330|P1|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
1326480|NCT02224846|4355329|P2|Period 2 (Month 3 to Month 12)|Protocol Violation|3
1326481|NCT02224846|4355330|P1|Period 2 (Month 3 to Month 12)|Protocol Violation|0
1326482|NCT02224846|4355329|P2|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
1326483|NCT02224846|4355330|P1|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
1326484|NCT02224846|4355329|P2|Period 2 (Month 3 to Month 12)|Adverse Event|2
1326485|NCT02224846|4355330|P1|Period 2 (Month 3 to Month 12)|Adverse Event|1
1326486|NCT02224846|4355329|P2|Period 1 (Month 3)|Sponsor Decision|1
1326487|NCT02224846|4355330|P1|Period 1 (Month 3)|Sponsor Decision|2
1326488|NCT02224846|4355329|P2|Period 1 (Month 3)|Withdrawal by Subject|18
1326489|NCT02224846|4355330|P1|Period 1 (Month 3)|Withdrawal by Subject|8
1326490|NCT02224846|4355329|P2|Period 1 (Month 3)|Protocol Violation|8
1326491|NCT02224846|4355330|P1|Period 1 (Month 3)|Protocol Violation|4
1326492|NCT02224846|4355329|P2|Period 1 (Month 3)|Lost to Follow-up|8
1326493|NCT02224846|4355330|P1|Period 1 (Month 3)|Lost to Follow-up|3
1326494|NCT02224846|4355329|P2|Period 1 (Month 3)|Adverse Event|1
1326495|NCT02224846|4355330|P1|Period 1 (Month 3)|Adverse Event|2
1326496|NCT02224690|4355368|P2|Overall Study|Did not meet eligibility criteria|0
1326497|NCT02224690|4355369|P1|Overall Study|Did not meet eligibility criteria|1
1326498|NCT02224690|4355368|P2|Overall Study|Use of G-tube|0
1326499|NCT02224690|4355369|P1|Overall Study|Use of G-tube|1
1326500|NCT02224690|4355368|P2|Overall Study|Met Withdrawal Criteria|0
1326501|NCT02224690|4355369|P1|Overall Study|Met Withdrawal Criteria|4
1326502|NCT02224690|4355368|P2|Overall Study|Adverse Event|1
1326503|NCT02224690|4355369|P1|Overall Study|Adverse Event|8
1326504|NCT02224664|4355381|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
1326505|NCT02224664|4355382|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
1326506|NCT02224664|4355383|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
1326507|NCT02224664|4355384|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
1326508|NCT02224664|4355385|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
1326509|NCT02224664|4355381|P5|Dose Escalation Period (21 Days)|Adverse Event|7
1326510|NCT02224664|4355382|P4|Dose Escalation Period (21 Days)|Adverse Event|2
1326511|NCT02224664|4355383|P3|Dose Escalation Period (21 Days)|Adverse Event|2
1326512|NCT02224664|4355384|P2|Dose Escalation Period (21 Days)|Adverse Event|0
1326513|NCT02224664|4355385|P1|Dose Escalation Period (21 Days)|Adverse Event|0
1326514|NCT02224664|4355381|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1326515|NCT02224664|4355382|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1326516|NCT02224664|4355383|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1326517|NCT02224664|4355384|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1326518|NCT02224664|4355385|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
1326519|NCT02224625|4355465|P1|Sensitization|Adverse Event|55
1326520|NCT02224625|4355465|P1|Irritation|Adverse Event|6
1326521|NCT02224560|4355480|P3|Overall Study|Withdrawn by Investigator|0
1326522|NCT02224560|4355481|P2|Overall Study|Withdrawn by Investigator|1
1326523|NCT02224560|4355482|P1|Overall Study|Withdrawn by Investigator|1
1326524|NCT02224560|4355480|P3|Overall Study|Adverse Event|1
1326525|NCT02224560|4355481|P2|Overall Study|Adverse Event|1
1326526|NCT02224560|4355482|P1|Overall Study|Adverse Event|4
1326527|NCT02224560|4355480|P3|Overall Study|Met Withdrawal Criteria|0
1326528|NCT02224560|4355481|P2|Overall Study|Met Withdrawal Criteria|0
1326529|NCT02224560|4355482|P1|Overall Study|Met Withdrawal Criteria|1
1326530|NCT02224560|4355480|P3|Overall Study|Withdrawal by Subject|1
1326531|NCT02224560|4355481|P2|Overall Study|Withdrawal by Subject|0
1326532|NCT02224560|4355482|P1|Overall Study|Withdrawal by Subject|2
1326533|NCT02224560|4355480|P3|Overall Study|Protocol Deviation|0
1326534|NCT02224560|4355481|P2|Overall Study|Protocol Deviation|0
1326535|NCT02224560|4355482|P1|Overall Study|Protocol Deviation|1
1326536|NCT02224053|4355517|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
1326537|NCT02224053|4355517|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
1326538|NCT02224053|4355517|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
1326539|NCT02224053|4355517|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
1326540|NCT02224053|4355517|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
1326541|NCT02223754|4355563|P2|Period 2|Test Article No Longer Available|1
1326542|NCT02223754|4355564|P1|Period 2|Test Article No Longer Available|0
1326543|NCT02223754|4355563|P2|Period 2|Lost to Follow-up|0
1326544|NCT02223754|4355564|P1|Period 2|Lost to Follow-up|1
1326545|NCT02223754|4355563|P2|Period 2|Lens Discomfort|1
1326546|NCT02223754|4355564|P1|Period 2|Lens Discomfort|1
1326547|NCT02223754|4355563|P2|Period 2|Protocol Violation|0
1326548|NCT02223754|4355564|P1|Period 2|Protocol Violation|1
1326549|NCT02223754|4355563|P2|Period 2|Adverse Event|1
1326550|NCT02223754|4355564|P1|Period 2|Adverse Event|0
1326551|NCT02223754|4355563|P2|Period 1|Unsatisfactory Visual Response|1
1326552|NCT02223754|4355564|P1|Period 1|Unsatisfactory Visual Response|0
1326553|NCT02223754|4355563|P2|Period 1|Test Article No Longer Available|5
1326554|NCT02223754|4355564|P1|Period 1|Test Article No Longer Available|1
1326555|NCT02223754|4355563|P2|Period 1|Withdrawal by Subject|4
1326556|NCT02223754|4355564|P1|Period 1|Withdrawal by Subject|0
1326557|NCT02223754|4355563|P2|Period 1|Protocol Violation|4
1326558|NCT02223754|4355564|P1|Period 1|Protocol Violation|2
1326559|NCT02223754|4355563|P2|Period 1|Lost to Follow-up|1
1326560|NCT02223754|4355564|P1|Period 1|Lost to Follow-up|0
1326561|NCT02223754|4355563|P2|Period 1|Adverse Event|0
1326562|NCT02223754|4355564|P1|Period 1|Adverse Event|1
1326563|NCT02223715|4355584|P1|Overall Study|Lost to Follow-up|73
1326564|NCT02223715|4355584|P1|Overall Study|Death|31
1326565|NCT02223364|4355662|P3|Overall Study|Physician Decision|0
1326566|NCT02223364|4355663|P2|Overall Study|Physician Decision|0
1326567|NCT02223364|4355664|P1|Overall Study|Physician Decision|1
1326568|NCT02223364|4355662|P3|Overall Study|subject expired before surgery|0
1326569|NCT02223364|4355663|P2|Overall Study|subject expired before surgery|0
1326570|NCT02223364|4355664|P1|Overall Study|subject expired before surgery|1
1326571|NCT02223364|4355662|P3|Overall Study|Protocol Violation|3
1326572|NCT02223364|4355663|P2|Overall Study|Protocol Violation|0
1326573|NCT02223364|4355664|P1|Overall Study|Protocol Violation|3
1326574|NCT02222818|4355779|P2|Period 1|Eligibility criteria not met|3
1326575|NCT02222818|4355780|P1|Period 1|Eligibility criteria not met|0
1326576|NCT02222558|4355787|P6|Period 3|Withdrawal by Subject|1
1326577|NCT02222558|4355788|P5|Period 3|Withdrawal by Subject|0
1326578|NCT02222558|4355789|P4|Period 3|Withdrawal by Subject|0
1326579|NCT02222558|4355790|P3|Period 3|Withdrawal by Subject|0
1326580|NCT02222558|4355791|P2|Period 3|Withdrawal by Subject|0
1326581|NCT02222558|4355792|P1|Period 3|Withdrawal by Subject|0
1326582|NCT02222558|4355787|P6|Period 1: Single Dose|Withdrawal by Subject|0
1326583|NCT02222558|4355788|P5|Period 1: Single Dose|Withdrawal by Subject|0
1326584|NCT02222558|4355789|P4|Period 1: Single Dose|Withdrawal by Subject|0
1326585|NCT02222558|4355790|P3|Period 1: Single Dose|Withdrawal by Subject|0
1326586|NCT02222558|4355791|P2|Period 1: Single Dose|Withdrawal by Subject|0
1326587|NCT02222558|4355792|P1|Period 1: Single Dose|Withdrawal by Subject|4
1326588|NCT02222493|4355808|P2|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
1326589|NCT02222493|4355809|P1|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
1326590|NCT02222493|4355808|P2|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
1326591|NCT02222493|4355809|P1|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
1326592|NCT02222493|4355808|P2|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
1326593|NCT02222493|4355809|P1|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
1326594|NCT02222493|4355808|P2|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
1326595|NCT02222493|4355809|P1|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
1326596|NCT02222493|4355808|P2|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
1326597|NCT02222493|4355809|P1|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
1326598|NCT02222493|4355808|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
1326599|NCT02222493|4355809|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
1326600|NCT02222493|4355808|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
1326601|NCT02222493|4355809|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
1326602|NCT02222493|4355808|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
1326603|NCT02222493|4355809|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
1326604|NCT02222493|4355808|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
1326605|NCT02222493|4355809|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
1326606|NCT02222493|4355808|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
1326607|NCT02222493|4355809|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
1326608|NCT02222493|4355808|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
1326609|NCT02222493|4355809|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
1326610|NCT02222493|4355808|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
1326611|NCT02222493|4355809|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
1326612|NCT02222493|4355808|P2|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
1326613|NCT02222493|4355809|P1|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
1326614|NCT02222493|4355808|P2|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
1326615|NCT02222493|4355809|P1|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
1326616|NCT02222493|4355808|P2|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
1326617|NCT02222493|4355809|P1|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
1326618|NCT02222493|4355808|P2|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
1326619|NCT02222493|4355809|P1|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
1326620|NCT02222493|4355808|P2|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
1326621|NCT02222493|4355809|P1|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
1326622|NCT02222493|4355808|P2|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
1326623|NCT02222493|4355809|P1|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
1326624|NCT02222493|4355808|P2|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
1326625|NCT02222493|4355809|P1|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
1326626|NCT02222493|4355808|P2|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
1326627|NCT02222493|4355809|P1|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
1326628|NCT02222493|4355808|P2|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
1326629|NCT02222493|4355809|P1|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
1326630|NCT02222493|4355808|P2|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
1326631|NCT02222493|4355809|P1|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
1326632|NCT02222246|4355927|P2|Overall Study|Physician Decision|1
1326633|NCT02222246|4355928|P1|Overall Study|Physician Decision|0
1326634|NCT02222246|4355927|P2|Overall Study|No Emergency Department Visits|26
1326635|NCT02222246|4355928|P1|Overall Study|No Emergency Department Visits|27
1326636|NCT02222207|4355956|P1|Overall Study|Adverse Event|1
1326637|NCT02222207|4355956|P1|Overall Study|Other reasons|2
1326638|NCT02222207|4355956|P1|Overall Study|Death|1
1326639|NCT02221674|4356000|P3|Overall Study|Lost to Follow-up|0
1326640|NCT02221674|4356001|P2|Overall Study|Lost to Follow-up|0
1326641|NCT02221674|4356002|P1|Overall Study|Lost to Follow-up|1
1326642|NCT02221648|4356018|P2|Overall Study|Withdrawal by Subject|3
1326643|NCT02221648|4356019|P1|Overall Study|Withdrawal by Subject|3
1326644|NCT02220998|4356035|P2|Overall Study|Lost to Follow-up|4
1326645|NCT02220998|4356036|P1|Overall Study|Lost to Follow-up|4
1326646|NCT02220998|4356035|P2|Overall Study|Lack of Efficacy|5
1326647|NCT02220998|4356036|P1|Overall Study|Lack of Efficacy|0
1326648|NCT02220998|4356035|P2|Overall Study|Death|0
1326649|NCT02220998|4356036|P1|Overall Study|Death|2
1326650|NCT02220998|4356035|P2|Overall Study|Randomized but Never Treated|2
1326651|NCT02220998|4356036|P1|Overall Study|Randomized but Never Treated|1
1326652|NCT02220920|4356054|P2|Overall Study|Conflict with the stopping criteria|2
1326653|NCT02220920|4356055|P1|Overall Study|Conflict with the stopping criteria|1
1326654|NCT02220920|4356054|P2|Overall Study|Withdrawal by Subject|0
1326655|NCT02220920|4356055|P1|Overall Study|Withdrawal by Subject|1
1326656|NCT02220920|4356054|P2|Overall Study|Lack of Efficacy|1
1326657|NCT02220920|4356055|P1|Overall Study|Lack of Efficacy|0
1326658|NCT02220920|4356054|P2|Overall Study|Adverse Event|0
1326659|NCT02220920|4356055|P1|Overall Study|Adverse Event|1
1326660|NCT02220907|4356069|P1|Overall Study|Conflict with the stopping criteria|1
1326661|NCT02220907|4356069|P1|Overall Study|Withdrawal by Subject|2
1326662|NCT02220907|4356069|P1|Overall Study|Physician Decision|1
1326663|NCT02220907|4356069|P1|Overall Study|Adverse Event|7
1326664|NCT02220764|4356078|P2|Overall Study|Death|0
1326665|NCT02220764|4356079|P1|Overall Study|Death|1
1326666|NCT02220764|4356078|P2|Overall Study|Lost to Follow-up|1
1326667|NCT02220764|4356079|P1|Overall Study|Lost to Follow-up|3
1326668|NCT02220205|4356091|P2|Overall Study|Withdrawal by Subject|0
1326669|NCT02220205|4356092|P1|Overall Study|Withdrawal by Subject|1
1326670|NCT02219932|4356117|P2|Overall Study|Adverse Event|21
1326671|NCT02219932|4356118|P1|Overall Study|Adverse Event|23
1326672|NCT02219932|4356117|P2|Overall Study|Lost to Follow-up|2
1326673|NCT02219932|4356118|P1|Overall Study|Lost to Follow-up|4
1326674|NCT02219932|4356117|P2|Overall Study|Pregnancy|0
1326675|NCT02219932|4356118|P1|Overall Study|Pregnancy|1
1326676|NCT02219932|4356117|P2|Overall Study|Protocol Violation|6
1326677|NCT02219932|4356118|P1|Overall Study|Protocol Violation|10
1326678|NCT02219932|4356117|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
1326679|NCT02219932|4356118|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
1326680|NCT02219932|4356117|P2|Overall Study|Consent Withdrawn|7
1326681|NCT02219932|4356118|P1|Overall Study|Consent Withdrawn|11
1326682|NCT02219932|4356117|P2|Overall Study|Investigator Decision|1
1326683|NCT02219932|4356118|P1|Overall Study|Investigator Decision|0
1326684|NCT02219932|4356117|P2|Overall Study|Death|1
1326685|NCT02219932|4356118|P1|Overall Study|Death|1
1326686|NCT02219932|4356117|P2|Overall Study|Not Specified|11
1326687|NCT02219932|4356118|P1|Overall Study|Not Specified|5
1326688|NCT02219685|4356134|P2|Blinded Treatment Phase|Withdrew Consent|0
1326689|NCT02219685|4356135|P1|Blinded Treatment Phase|Withdrew Consent|1
1326690|NCT02219685|4356134|P2|Blinded Treatment Phase|Lost to Follow-up|0
1326691|NCT02219685|4356135|P1|Blinded Treatment Phase|Lost to Follow-up|1
1326692|NCT02219477|4356241|P3|Overall Study|Withdrawal by Subject|0
1326693|NCT02219477|4356242|P2|Overall Study|Withdrawal by Subject|1
1326694|NCT02219477|4356243|P1|Overall Study|Withdrawal by Subject|0
1326695|NCT02219477|4356241|P3|Overall Study|Adverse Event|1
1326696|NCT02219477|4356242|P2|Overall Study|Adverse Event|1
1326697|NCT02219477|4356243|P1|Overall Study|Adverse Event|0
1326698|NCT02219464|4356271|P2|Overall Study|catheter malfunction|0
1326699|NCT02219464|4356272|P1|Overall Study|catheter malfunction|1
1326700|NCT02219464|4356271|P2|Overall Study|case cancelled|0
1326701|NCT02219464|4356272|P1|Overall Study|case cancelled|1
1326702|NCT02219464|4356271|P2|Overall Study|Withdrawal by Subject|0
1326703|NCT02219464|4356272|P1|Overall Study|Withdrawal by Subject|1
1326704|NCT02219087|4356432|P2|Overall Study|Randomization envelope pulled out of seq|1
1326705|NCT02219087|4356433|P1|Overall Study|Randomization envelope pulled out of seq|0
1326706|NCT02219009|4356453|P2|Overall Study|Physician Decision|1
1326707|NCT02219009|4356454|P1|Overall Study|Physician Decision|0
1326708|NCT02219009|4356453|P2|Overall Study|Protocol deviation|0
1326709|NCT02219009|4356454|P1|Overall Study|Protocol deviation|1
1326710|NCT02219009|4356453|P2|Overall Study|Lost to Follow-up|2
1326711|NCT02219009|4356454|P1|Overall Study|Lost to Follow-up|2
1326712|NCT02219009|4356453|P2|Overall Study|Adverse Event|4
1326713|NCT02219009|4356454|P1|Overall Study|Adverse Event|2
1326714|NCT02219009|4356453|P2|Overall Study|Withdrawal by Subject|1
1326715|NCT02219009|4356454|P1|Overall Study|Withdrawal by Subject|5
1326716|NCT02218697|4356466|P2|Overall Study|Withdrawal by Subject|3
1326717|NCT02218697|4356467|P1|Overall Study|Withdrawal by Subject|2
1326718|NCT02218697|4356466|P2|Overall Study|Unwilling to be vaccinated in left arm|1
1326719|NCT02218697|4356467|P1|Overall Study|Unwilling to be vaccinated in left arm|0
1326720|NCT02218697|4356466|P2|Overall Study|Adverse Event|2
1326721|NCT02218697|4356467|P1|Overall Study|Adverse Event|0
1326722|NCT02218541|4356507|P2|Overall Study|Implant Failure|1
1326723|NCT02218541|4356508|P1|Overall Study|Implant Failure|4
1326724|NCT02218541|4356507|P2|Overall Study|Lost to Follow-up|1
1326725|NCT02218541|4356508|P1|Overall Study|Lost to Follow-up|2
1326726|NCT02218268|4356529|P2|24 Hour Washout|Physician Decision|9
1326727|NCT02218268|4356530|P1|24 Hour Washout|Physician Decision|11
1326728|NCT02218216|4356538|P3|Overall Study|Study terminated before completed|0
1326729|NCT02218216|4356539|P2|Overall Study|Study terminated before completed|0
1326730|NCT02218216|4356540|P1|Overall Study|Study terminated before completed|6
1326731|NCT02217982|4356579|P2|Overall Study|Adverse Event|1
1326732|NCT02217982|4356580|P1|Overall Study|Adverse Event|0
1326733|NCT02217982|4356579|P2|Overall Study|Trial discontinued|0
1326734|NCT02217982|4356580|P1|Overall Study|Trial discontinued|1
1326735|NCT02217878|4356590|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
1326736|NCT02217878|4356591|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
1326737|NCT02217878|4356590|P2|Overall Study|required morphine due to chest pain|2
1326738|NCT02217878|4356591|P1|Overall Study|required morphine due to chest pain|1
1326739|NCT02217527|4356685|P2|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
1326740|NCT02217527|4356686|P1|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
1326741|NCT02217527|4356685|P2|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
1326742|NCT02217527|4356686|P1|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
1326743|NCT02217280|4356696|P1|Overall Study|Post-consent sceen fail|2
1326744|NCT02217280|4356696|P1|Overall Study|Withdrawal by Subject|2
1326745|NCT02216591|4356712|P2|Overall Study|Lost to Follow-up|1
1326746|NCT02216591|4356713|P1|Overall Study|Lost to Follow-up|0
1326747|NCT02216526|4356726|P3|Overall Study|Hospitalization|3
1326748|NCT02216526|4356727|P2|Overall Study|Hospitalization|1
1326749|NCT02216526|4356728|P1|Overall Study|Hospitalization|2
1326750|NCT02216526|4356726|P3|Overall Study|Protocol Violation|2
1326751|NCT02216526|4356727|P2|Overall Study|Protocol Violation|0
1326752|NCT02216526|4356728|P1|Overall Study|Protocol Violation|2
1326753|NCT02216526|4356726|P3|Overall Study|Death|3
1326754|NCT02216526|4356727|P2|Overall Study|Death|1
1326755|NCT02216526|4356728|P1|Overall Study|Death|0
1326756|NCT02216526|4356726|P3|Overall Study|Adverse Event|0
1326757|NCT02216526|4356727|P2|Overall Study|Adverse Event|1
1326758|NCT02216526|4356728|P1|Overall Study|Adverse Event|1
1326759|NCT02216357|4356846|P2|Overall Study|Inclusion or exclusion criteria not met|1
1326760|NCT02216357|4356847|P1|Overall Study|Inclusion or exclusion criteria not met|2
1326761|NCT02216123|4356873|P2|Overall Study|Withdrawal by Subject|0
1326762|NCT02216123|4356874|P1|Overall Study|Withdrawal by Subject|2
1326763|NCT02216123|4356873|P2|Overall Study|Lost to Follow-up|2
1326764|NCT02216123|4356874|P1|Overall Study|Lost to Follow-up|4
1326765|NCT02215954|4356966|P3|Overall Study|Not exposed|3
1326766|NCT02215954|4356967|P2|Overall Study|Not exposed|1
1326767|NCT02215954|4356968|P1|Overall Study|Not exposed|1
1326768|NCT02215954|4356966|P3|Overall Study|Withdrawal by Subject|2
1326769|NCT02215954|4356967|P2|Overall Study|Withdrawal by Subject|0
1326770|NCT02215954|4356968|P1|Overall Study|Withdrawal by Subject|0
1326771|NCT02215954|4356966|P3|Overall Study|Adverse Event|1
1326772|NCT02215954|4356967|P2|Overall Study|Adverse Event|0
1326773|NCT02215954|4356968|P1|Overall Study|Adverse Event|0
1326774|NCT02215252|4356991|P3|Overall Study|Other|1
1326775|NCT02215252|4356992|P2|Overall Study|Other|1
1326776|NCT02215252|4356993|P1|Overall Study|Other|0
1326777|NCT02215252|4356991|P3|Overall Study|Withdrawal by Subject|0
1326778|NCT02215252|4356992|P2|Overall Study|Withdrawal by Subject|0
1326779|NCT02215252|4356993|P1|Overall Study|Withdrawal by Subject|1
1326780|NCT02215252|4356991|P3|Overall Study|Protocol Violation|0
1326781|NCT02215252|4356992|P2|Overall Study|Protocol Violation|1
1326782|NCT02215252|4356993|P1|Overall Study|Protocol Violation|0
1326783|NCT02215252|4356991|P3|Overall Study|Does not Meet Entrance Criteria|0
1326784|NCT02215252|4356992|P2|Overall Study|Does not Meet Entrance Criteria|1
1326785|NCT02215252|4356993|P1|Overall Study|Does not Meet Entrance Criteria|0
1326786|NCT02215252|4356991|P3|Overall Study|Lost to Follow-up|1
1326787|NCT02215252|4356992|P2|Overall Study|Lost to Follow-up|0
1326788|NCT02215252|4356993|P1|Overall Study|Lost to Follow-up|0
1326789|NCT02215252|4356991|P3|Overall Study|Adverse Event|2
1326790|NCT02215252|4356992|P2|Overall Study|Adverse Event|5
1326791|NCT02215252|4356993|P1|Overall Study|Adverse Event|1
1326792|NCT02214225|4357117|P3|Overall Study|randomized in error, not vaccinated|1
1326793|NCT02214225|4357118|P2|Overall Study|randomized in error, not vaccinated|1
1326794|NCT02214225|4357119|P1|Overall Study|randomized in error, not vaccinated|2
1326795|NCT02214225|4357117|P3|Overall Study|Death|1
1326796|NCT02214225|4357118|P2|Overall Study|Death|0
1326797|NCT02214225|4357119|P1|Overall Study|Death|5
1326798|NCT02214225|4357117|P3|Overall Study|Withdrawal by Subject|2
1326799|NCT02214225|4357118|P2|Overall Study|Withdrawal by Subject|0
1326800|NCT02214225|4357119|P1|Overall Study|Withdrawal by Subject|2
1326801|NCT02214225|4357117|P3|Overall Study|Lost to Follow-up|18
1326802|NCT02214225|4357118|P2|Overall Study|Lost to Follow-up|18
1326803|NCT02214225|4357119|P1|Overall Study|Lost to Follow-up|46
1326804|NCT02214186|4357178|P2|Overall Study|Protocol Violation|1
1326805|NCT02214186|4357179|P1|Overall Study|Protocol Violation|1
1326806|NCT02214186|4357178|P2|Overall Study|Lost to Follow-up|1
1326807|NCT02214186|4357179|P1|Overall Study|Lost to Follow-up|1
1326808|NCT02214121|4357204|P3|Part B|Lost to Follow-up|1
1326809|NCT02214121|4357205|P2|Part B|Lost to Follow-up|0
1326810|NCT02214121|4357206|P1|Part B|Lost to Follow-up|0
1326811|NCT02214121|4357204|P3|Part B|Dev. of study-specific withdrawal crit.|0
1326812|NCT02214121|4357205|P2|Part B|Dev. of study-specific withdrawal crit.|2
1326813|NCT02214121|4357206|P1|Part B|Dev. of study-specific withdrawal crit.|0
1326814|NCT02214121|4357204|P3|Part B|Patient decision|0
1326815|NCT02214121|4357205|P2|Part B|Patient decision|1
1326816|NCT02214121|4357206|P1|Part B|Patient decision|0
1326817|NCT02214121|4357204|P3|Part A|Other|0
1326818|NCT02214121|4357205|P2|Part A|Other|0
1326819|NCT02214121|4357206|P1|Part A|Other|1
1326820|NCT02214121|4357204|P3|Part A|Dev. of study-specific withdrawal crit.|0
1326821|NCT02214121|4357205|P2|Part A|Dev. of study-specific withdrawal crit.|0
1326822|NCT02214121|4357206|P1|Part A|Dev. of study-specific withdrawal crit.|4
1326823|NCT02214121|4357204|P3|Part A|Patient decision|0
1326824|NCT02214121|4357205|P2|Part A|Patient decision|0
1326825|NCT02214121|4357206|P1|Part A|Patient decision|2
1326826|NCT02213666|4357298|P1|Overall Study|Withdrawal by Subject|1
1326827|NCT02213510|4357304|P2|Overall Study|Lost to Follow-up|0
1326828|NCT02213510|4357305|P1|Overall Study|Lost to Follow-up|1
1326829|NCT02213510|4357304|P2|Overall Study|Death|1
1326830|NCT02213510|4357305|P1|Overall Study|Death|0
1326831|NCT02213198|4357363|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
1326832|NCT02213198|4357364|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
1326833|NCT02213198|4357363|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
1326834|NCT02213198|4357364|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
1326835|NCT02213198|4357363|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
1326836|NCT02213198|4357364|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
1326837|NCT02213198|4357363|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
1326838|NCT02213198|4357364|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
1326839|NCT02213198|4357363|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
1326840|NCT02213198|4357364|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
1326841|NCT02213198|4357363|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
1326842|NCT02213198|4357364|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
1326843|NCT02213198|4357363|P2|Baseline|incarcerated,violent|1
1326844|NCT02213198|4357364|P1|Baseline|incarcerated,violent|0
1326845|NCT02213198|4357363|P2|Baseline|Lost to Follow-up|21
1326846|NCT02213198|4357364|P1|Baseline|Lost to Follow-up|40
1326847|NCT02213198|4357363|P2|Baseline|transferred out of clinic|9
1326848|NCT02213198|4357364|P1|Baseline|transferred out of clinic|7
1326849|NCT02213198|4357363|P2|Baseline|Withdrawal by Subject|11
1326850|NCT02213198|4357364|P1|Baseline|Withdrawal by Subject|34
1326851|NCT02213198|4357363|P2|Baseline|No show for intake|9
1326852|NCT02213198|4357364|P1|Baseline|No show for intake|7
1326853|NCT02213055|4357374|P2|Overall Study|Did not Return to School|0
1326854|NCT02213055|4357375|P1|Overall Study|Did not Return to School|5
1326855|NCT02213055|4357374|P2|Overall Study|Did not meet Inclusion Criteria|0
1326856|NCT02213055|4357375|P1|Overall Study|Did not meet Inclusion Criteria|6
1326857|NCT02213055|4357374|P2|Overall Study|Had another Treatment during the Study|0
1326858|NCT02213055|4357375|P1|Overall Study|Had another Treatment during the Study|3
1326859|NCT02213055|4357374|P2|Overall Study|Did not have Live Lice|0
1326860|NCT02213055|4357375|P1|Overall Study|Did not have Live Lice|8
1326861|NCT02213055|4357374|P2|Overall Study|Documentation Issue during Study|0
1326862|NCT02213055|4357375|P1|Overall Study|Documentation Issue during Study|10
1326863|NCT02213055|4357374|P2|Overall Study|Documentation Issue at Enrollment|0
1326864|NCT02213055|4357375|P1|Overall Study|Documentation Issue at Enrollment|1
1326865|NCT02213055|4357374|P2|Overall Study|Protocol was not Followed during Study|0
1326866|NCT02213055|4357375|P1|Overall Study|Protocol was not Followed during Study|1
1326867|NCT02213055|4357374|P2|Overall Study|Protocol was not Followed at Enrollment|0
1326868|NCT02213055|4357375|P1|Overall Study|Protocol was not Followed at Enrollment|5
1326869|NCT02212457|4357413|P6|Overall Study|Other|1
1326870|NCT02212457|4357414|P5|Overall Study|Other|0
1326871|NCT02212457|4357415|P4|Overall Study|Other|1
1326872|NCT02212457|4357416|P3|Overall Study|Other|2
1326873|NCT02212457|4357417|P2|Overall Study|Other|1
1326874|NCT02212457|4357418|P1|Overall Study|Other|2
1326875|NCT02212457|4357413|P6|Overall Study|Protocol Violation|3
1326876|NCT02212457|4357414|P5|Overall Study|Protocol Violation|2
1326877|NCT02212457|4357415|P4|Overall Study|Protocol Violation|1
1326878|NCT02212457|4357416|P3|Overall Study|Protocol Violation|0
1326879|NCT02212457|4357417|P2|Overall Study|Protocol Violation|1
1326880|NCT02212457|4357418|P1|Overall Study|Protocol Violation|2
1326881|NCT02212457|4357413|P6|Overall Study|Lost to Follow-up|4
1326882|NCT02212457|4357414|P5|Overall Study|Lost to Follow-up|8
1326883|NCT02212457|4357415|P4|Overall Study|Lost to Follow-up|1
1326884|NCT02212457|4357416|P3|Overall Study|Lost to Follow-up|4
1326885|NCT02212457|4357417|P2|Overall Study|Lost to Follow-up|7
1326886|NCT02212457|4357418|P1|Overall Study|Lost to Follow-up|6
1326887|NCT02212457|4357413|P6|Overall Study|Withdrawal by Subject|4
1326888|NCT02212457|4357414|P5|Overall Study|Withdrawal by Subject|5
1326889|NCT02212457|4357415|P4|Overall Study|Withdrawal by Subject|6
1326890|NCT02212457|4357416|P3|Overall Study|Withdrawal by Subject|8
1326891|NCT02212457|4357417|P2|Overall Study|Withdrawal by Subject|10
1326892|NCT02212457|4357418|P1|Overall Study|Withdrawal by Subject|8
1326893|NCT02212457|4357413|P6|Overall Study|Adverse Event|1
1326894|NCT02212457|4357414|P5|Overall Study|Adverse Event|0
1326895|NCT02212457|4357415|P4|Overall Study|Adverse Event|2
1326896|NCT02212457|4357416|P3|Overall Study|Adverse Event|2
1326897|NCT02212457|4357417|P2|Overall Study|Adverse Event|2
1326898|NCT02212457|4357418|P1|Overall Study|Adverse Event|1
1326899|NCT02212301|4357456|P2|Period 1|Lost to Follow-up|1
1326900|NCT02212301|4357457|P1|Period 1|Lost to Follow-up|0
1326901|NCT02212197|4357468|P3|Overall Study|Need for radiotherapy|0
1326902|NCT02212197|4357469|P2|Overall Study|Need for radiotherapy|0
1326903|NCT02212197|4357470|P1|Overall Study|Need for radiotherapy|1
1326904|NCT02210208|4357546|P1|Period B (Donor Site)|7 subjects healed at or before Day 14|7
1326905|NCT02210208|4357546|P1|Period A (Graft Site)|Physician decided not to graft at OR|1
1326906|NCT02210208|4357546|P1|Period A (Graft Site)|Withdrawal by Subject|1
1326907|NCT02210091|4357566|P2|Overall Study|Withdrawal by Sponsor|1
1326908|NCT02210091|4357567|P1|Overall Study|Withdrawal by Sponsor|0
1326909|NCT02210091|4357566|P2|Overall Study|Physician Decision|1
1326910|NCT02210091|4357567|P1|Overall Study|Physician Decision|0
1326911|NCT02210000|4357645|P2|Overall Study|Physician Decision|1
1326912|NCT02210000|4357646|P1|Overall Study|Physician Decision|0
1326913|NCT02210000|4357645|P2|Overall Study|Lost to Follow-up|2
1326914|NCT02210000|4357646|P1|Overall Study|Lost to Follow-up|0
1326915|NCT02210000|4357645|P2|Overall Study|Adverse Event|5
1326916|NCT02210000|4357646|P1|Overall Study|Adverse Event|1
1326917|NCT02210000|4357645|P2|Overall Study|Withdrawal by Subject|1
1326918|NCT02210000|4357646|P1|Overall Study|Withdrawal by Subject|7
1326919|NCT02210000|4357645|P2|Overall Study|Study Terminated|12
1326920|NCT02210000|4357646|P1|Overall Study|Study Terminated|11
1326921|NCT02209766|4357672|P5|Overall Study|Withdrawal by Subject|0
1326922|NCT02209766|4357673|P4|Overall Study|Withdrawal by Subject|1
1326923|NCT02209766|4357674|P3|Overall Study|Withdrawal by Subject|0
1326924|NCT02209766|4357675|P2|Overall Study|Withdrawal by Subject|0
1326925|NCT02209766|4357676|P1|Overall Study|Withdrawal by Subject|0
1326926|NCT02209506|4357727|P5|Overall Study|Withdrawal by Subject|1
1326927|NCT02209506|4357728|P4|Overall Study|Withdrawal by Subject|0
1326928|NCT02209506|4357729|P3|Overall Study|Withdrawal by Subject|0
1326929|NCT02209506|4357730|P2|Overall Study|Withdrawal by Subject|0
1326930|NCT02209506|4357731|P1|Overall Study|Withdrawal by Subject|0
1326931|NCT02209454|4357806|P2|Second Period|Adverse Event|0
1326932|NCT02209454|4357807|P1|Second Period|Adverse Event|1
1326933|NCT02209181|4357844|P4|Overall Study|Withdrawal by Subject|0
1326934|NCT02209181|4357845|P3|Overall Study|Withdrawal by Subject|0
1326935|NCT02209181|4357846|P2|Overall Study|Withdrawal by Subject|1
1326936|NCT02209181|4357847|P1|Overall Study|Withdrawal by Subject|0
1326937|NCT02209181|4357844|P4|Overall Study|Adverse Event|0
1326938|NCT02209181|4357845|P3|Overall Study|Adverse Event|1
1326939|NCT02209181|4357846|P2|Overall Study|Adverse Event|0
1326940|NCT02209181|4357847|P1|Overall Study|Adverse Event|1
1326941|NCT02207907|4358075|P2|Overall Study|Pregnancy|1
1326942|NCT02207907|4358076|P1|Overall Study|Pregnancy|0
1326943|NCT02207907|4358075|P2|Overall Study|Did not meet study criteria|0
1326944|NCT02207907|4358076|P1|Overall Study|Did not meet study criteria|3
1326945|NCT02207907|4358075|P2|Overall Study|Withdrawal by Subject|6
1326946|NCT02207907|4358076|P1|Overall Study|Withdrawal by Subject|5
1326947|NCT02207907|4358075|P2|Overall Study|Lost to Follow-up|1
1326948|NCT02207907|4358076|P1|Overall Study|Lost to Follow-up|3
1326949|NCT02207829|4358094|P2|Overall Study|Withdrew consent|14
1326950|NCT02207829|4358095|P1|Overall Study|Withdrew consent|18
1326951|NCT02207829|4358094|P2|Overall Study|Protocol deviation|4
1326952|NCT02207829|4358095|P1|Overall Study|Protocol deviation|5
1326953|NCT02207829|4358094|P2|Overall Study|Lost to Follow-up|2
1326954|NCT02207829|4358095|P1|Overall Study|Lost to Follow-up|2
1326955|NCT02207829|4358094|P2|Overall Study|Lack of Efficacy|5
1326956|NCT02207829|4358095|P1|Overall Study|Lack of Efficacy|7
1326957|NCT02207829|4358094|P2|Overall Study|Adverse Event|9
1326958|NCT02207829|4358095|P1|Overall Study|Adverse Event|10
1326959|NCT02207634|4358114|P2|Overall Study|Lost to Follow-up|0
1326960|NCT02207634|4358115|P1|Overall Study|Lost to Follow-up|1
1326961|NCT02207634|4358114|P2|Overall Study|Withdrawal by Subject|31
1326962|NCT02207634|4358115|P1|Overall Study|Withdrawal by Subject|21
1326963|NCT02207621|4358130|P3|Overall Study|Other(Site,Sponsor and Subject request)|5
1326964|NCT02207621|4358131|P2|Overall Study|Other(Site,Sponsor and Subject request)|1
1326965|NCT02207621|4358132|P1|Overall Study|Other(Site,Sponsor and Subject request)|2
1326966|NCT02207621|4358130|P3|Overall Study|Death|0
1326967|NCT02207621|4358131|P2|Overall Study|Death|0
1326968|NCT02207621|4358132|P1|Overall Study|Death|2
1326969|NCT02207621|4358130|P3|Overall Study|Protocol Violation|6
1326970|NCT02207621|4358131|P2|Overall Study|Protocol Violation|10
1326971|NCT02207621|4358132|P1|Overall Study|Protocol Violation|4
1326972|NCT02207621|4358130|P3|Overall Study|Physician Decision|2
1326973|NCT02207621|4358131|P2|Overall Study|Physician Decision|2
1326974|NCT02207621|4358132|P1|Overall Study|Physician Decision|1
1326975|NCT02207621|4358130|P3|Overall Study|Disallowed Concurrent Medication|2
1326976|NCT02207621|4358131|P2|Overall Study|Disallowed Concurrent Medication|5
1326977|NCT02207621|4358132|P1|Overall Study|Disallowed Concurrent Medication|2
1326978|NCT02207621|4358130|P3|Overall Study|Lack of Efficacy|4
1326979|NCT02207621|4358131|P2|Overall Study|Lack of Efficacy|2
1326980|NCT02207621|4358132|P1|Overall Study|Lack of Efficacy|10
1326981|NCT02207621|4358130|P3|Overall Study|Lost to Follow-up|3
1326982|NCT02207621|4358131|P2|Overall Study|Lost to Follow-up|0
1326983|NCT02207621|4358132|P1|Overall Study|Lost to Follow-up|1
1326984|NCT02207621|4358130|P3|Overall Study|Non-Compliant|1
1326985|NCT02207621|4358131|P2|Overall Study|Non-Compliant|3
1326986|NCT02207621|4358132|P1|Overall Study|Non-Compliant|3
1326987|NCT02207621|4358130|P3|Overall Study|Withdrawal by Subject|13
1326988|NCT02207621|4358131|P2|Overall Study|Withdrawal by Subject|9
1326989|NCT02207621|4358132|P1|Overall Study|Withdrawal by Subject|9
1326990|NCT02207621|4358130|P3|Overall Study|Adverse Event|132
1326991|NCT02207621|4358131|P2|Overall Study|Adverse Event|15
1326992|NCT02207621|4358132|P1|Overall Study|Adverse Event|71
1326993|NCT02207608|4358145|P2|Overall Study|Adverse Event|0
1326994|NCT02207608|4358146|P1|Overall Study|Adverse Event|1
1326995|NCT02207530|4358170|P1|Overall Study|Adverse Event|8
1326996|NCT02207530|4358170|P1|Overall Study|Patient decision to stop study treatment|5
1326997|NCT02207530|4358170|P1|Overall Study|Worsening condition under investigation|78
1326998|NCT02207491|4358184|P2|Overall Study|Protocol Violation|5
1326999|NCT02207491|4358185|P1|Overall Study|Protocol Violation|3
1327000|NCT02207491|4358184|P2|Overall Study|Physician Decision|0
1327001|NCT02207491|4358185|P1|Overall Study|Physician Decision|2
1327002|NCT02207491|4358184|P2|Overall Study|Lack of Efficacy|0
1327003|NCT02207491|4358185|P1|Overall Study|Lack of Efficacy|3
1327004|NCT02207491|4358184|P2|Overall Study|Lost to Follow-up|1
1327005|NCT02207491|4358185|P1|Overall Study|Lost to Follow-up|0
1327006|NCT02207491|4358184|P2|Overall Study|Non-compliant|1
1327007|NCT02207491|4358185|P1|Overall Study|Non-compliant|0
1327008|NCT02207491|4358184|P2|Overall Study|Withdrawal by Subject|2
1327009|NCT02207491|4358185|P1|Overall Study|Withdrawal by Subject|3
1327010|NCT02207491|4358184|P2|Overall Study|Adverse Event|4
1327011|NCT02207491|4358185|P1|Overall Study|Adverse Event|20
1327012|NCT02207413|4358210|P6|Overall Study|Migrated/moved from study area|0
1327013|NCT02207413|4358211|P5|Overall Study|Migrated/moved from study area|1
1327014|NCT02207413|4358212|P4|Overall Study|Migrated/moved from study area|0
1327015|NCT02207413|4358213|P3|Overall Study|Migrated/moved from study area|0
1327016|NCT02207413|4358214|P2|Overall Study|Migrated/moved from study area|0
1327017|NCT02207413|4358215|P1|Overall Study|Migrated/moved from study area|0
1327018|NCT02207413|4358210|P6|Overall Study|Adverse Event|1
1327019|NCT02207413|4358211|P5|Overall Study|Adverse Event|2
1327020|NCT02207413|4358212|P4|Overall Study|Adverse Event|0
1327021|NCT02207413|4358213|P3|Overall Study|Adverse Event|0
1327022|NCT02207413|4358214|P2|Overall Study|Adverse Event|0
1327023|NCT02207413|4358215|P1|Overall Study|Adverse Event|0
1327024|NCT02207413|4358210|P6|Overall Study|Lost to Follow-up|5
1327025|NCT02207413|4358211|P5|Overall Study|Lost to Follow-up|1
1327026|NCT02207413|4358212|P4|Overall Study|Lost to Follow-up|1
1327027|NCT02207413|4358213|P3|Overall Study|Lost to Follow-up|0
1327028|NCT02207413|4358214|P2|Overall Study|Lost to Follow-up|0
1327029|NCT02207413|4358215|P1|Overall Study|Lost to Follow-up|0
1327030|NCT02207413|4358210|P6|Overall Study|Withdrawal by Subject|7
1327031|NCT02207413|4358211|P5|Overall Study|Withdrawal by Subject|3
1327032|NCT02207413|4358212|P4|Overall Study|Withdrawal by Subject|0
1327033|NCT02207413|4358213|P3|Overall Study|Withdrawal by Subject|0
1327034|NCT02207413|4358214|P2|Overall Study|Withdrawal by Subject|0
1327035|NCT02207413|4358215|P1|Overall Study|Withdrawal by Subject|1
1327036|NCT02207400|4358311|P2|Overall Study|Positive Urine Pregnancy Test|1
1327037|NCT02207400|4358312|P1|Overall Study|Positive Urine Pregnancy Test|0
1327038|NCT02207400|4358311|P2|Overall Study|Withdrawal by Subject|4
1327039|NCT02207400|4358312|P1|Overall Study|Withdrawal by Subject|8
1327040|NCT02207400|4358311|P2|Overall Study|Protocol Violation|1
1327041|NCT02207400|4358312|P1|Overall Study|Protocol Violation|1
1327042|NCT02207400|4358311|P2|Overall Study|Lost to Follow-up|7
1327043|NCT02207400|4358312|P1|Overall Study|Lost to Follow-up|6
1327044|NCT02207400|4358311|P2|Overall Study|Adverse Event|1
1327045|NCT02207400|4358312|P1|Overall Study|Adverse Event|1
1327046|NCT02207244|4358333|P9|Withdrawal, Retreatment Period:Week28-48|Other|0
1327047|NCT02207244|4358334|P8|Withdrawal, Retreatment Period:Week28-48|Other|1
1327048|NCT02207244|4358335|P7|Withdrawal, Retreatment Period:Week28-48|Other|0
1327049|NCT02207244|4358336|P6|Withdrawal, Retreatment Period:Week28-48|Other|0
1327050|NCT02207244|4358337|P5|Withdrawal, Retreatment Period:Week28-48|Other|0
1327051|NCT02207244|4358338|P4|Withdrawal, Retreatment Period:Week28-48|Other|0
1327052|NCT02207244|4358339|P3|Withdrawal, Retreatment Period:Week28-48|Other|0
1327053|NCT02207244|4358340|P2|Withdrawal, Retreatment Period:Week28-48|Other|0
1327054|NCT02207244|4358341|P1|Withdrawal, Retreatment Period:Week28-48|Other|0
1327055|NCT02207244|4358333|P9|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1327056|NCT02207244|4358334|P8|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1327057|NCT02207244|4358335|P7|Withdrawal, Retreatment Period:Week28-48|Non-compliance|1
1327058|NCT02207244|4358336|P6|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1327059|NCT02207244|4358337|P5|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1327060|NCT02207244|4358338|P4|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1327061|NCT02207244|4358339|P3|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1327062|NCT02207244|4358340|P2|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1327063|NCT02207244|4358341|P1|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1327064|NCT02207244|4358333|P9|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1327065|NCT02207244|4358334|P8|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1327066|NCT02207244|4358335|P7|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|1
1327067|NCT02207244|4358336|P6|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1327068|NCT02207244|4358337|P5|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1327069|NCT02207244|4358338|P4|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1327070|NCT02207244|4358339|P3|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1327071|NCT02207244|4358340|P2|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1327072|NCT02207244|4358341|P1|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1327073|NCT02207244|4358333|P9|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
1327074|NCT02207244|4358334|P8|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|2
1327075|NCT02207244|4358335|P7|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
1327076|NCT02207244|4358336|P6|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1327077|NCT02207244|4358337|P5|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1327078|NCT02207244|4358338|P4|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1327079|NCT02207244|4358339|P3|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1327080|NCT02207244|4358340|P2|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1327081|NCT02207244|4358341|P1|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1327082|NCT02207244|4358333|P9|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
1327083|NCT02207244|4358334|P8|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|5
1327084|NCT02207244|4358335|P7|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
1327085|NCT02207244|4358336|P6|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1327086|NCT02207244|4358337|P5|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1327087|NCT02207244|4358338|P4|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1327088|NCT02207244|4358339|P3|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1327089|NCT02207244|4358340|P2|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1327090|NCT02207244|4358341|P1|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1327091|NCT02207244|4358333|P9|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
1327092|NCT02207244|4358334|P8|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
1327093|NCT02207244|4358335|P7|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1327094|NCT02207244|4358336|P6|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1327095|NCT02207244|4358337|P5|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1327096|NCT02207244|4358338|P4|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1327097|NCT02207244|4358339|P3|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1327098|NCT02207244|4358340|P2|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1327099|NCT02207244|4358341|P1|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1327100|NCT02207244|4358333|P9|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1327101|NCT02207244|4358334|P8|Withdrawal, Retreatment Period:Week28-48|Pregnancy|2
1327102|NCT02207244|4358335|P7|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1327103|NCT02207244|4358336|P6|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1327104|NCT02207244|4358337|P5|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1327105|NCT02207244|4358338|P4|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1327106|NCT02207244|4358339|P3|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1327107|NCT02207244|4358340|P2|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1327108|NCT02207244|4358341|P1|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1327109|NCT02207244|4358333|P9|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
1327110|NCT02207244|4358334|P8|Withdrawal, Retreatment Period:Week28-48|Adverse Event|1
1327111|NCT02207244|4358335|P7|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
1327112|NCT02207244|4358336|P6|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1327113|NCT02207244|4358337|P5|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1327114|NCT02207244|4358338|P4|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1327115|NCT02207244|4358339|P3|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1327116|NCT02207244|4358340|P2|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1327117|NCT02207244|4358341|P1|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1327118|NCT02207244|4358333|P9|Placebo Crossover and ACP: Week 16 - 28|Other|0
1327119|NCT02207244|4358334|P8|Placebo Crossover and ACP: Week 16 - 28|Other|0
1327120|NCT02207244|4358335|P7|Placebo Crossover and ACP: Week 16 - 28|Other|0
1327121|NCT02207244|4358336|P6|Placebo Crossover and ACP: Week 16 - 28|Other|0
1327122|NCT02207244|4358337|P5|Placebo Crossover and ACP: Week 16 - 28|Other|0
1327123|NCT02207244|4358338|P4|Placebo Crossover and ACP: Week 16 - 28|Other|1
1327124|NCT02207244|4358339|P3|Placebo Crossover and ACP: Week 16 - 28|Other|0
1327125|NCT02207244|4358340|P2|Placebo Crossover and ACP: Week 16 - 28|Other|0
1327126|NCT02207244|4358341|P1|Placebo Crossover and ACP: Week 16 - 28|Other|0
1327127|NCT02207244|4358333|P9|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1327128|NCT02207244|4358334|P8|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1327129|NCT02207244|4358335|P7|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1327130|NCT02207244|4358336|P6|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
1327131|NCT02207244|4358337|P5|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1327132|NCT02207244|4358338|P4|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
1327133|NCT02207244|4358339|P3|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1327134|NCT02207244|4358340|P2|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1327135|NCT02207244|4358341|P1|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1327136|NCT02207244|4358333|P9|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1327137|NCT02207244|4358334|P8|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1327138|NCT02207244|4358335|P7|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1327139|NCT02207244|4358336|P6|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|2
1327140|NCT02207244|4358337|P5|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
1327141|NCT02207244|4358338|P4|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
1327142|NCT02207244|4358339|P3|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1327143|NCT02207244|4358340|P2|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1327144|NCT02207244|4358341|P1|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1327145|NCT02207244|4358333|P9|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1327146|NCT02207244|4358334|P8|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1327147|NCT02207244|4358335|P7|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1327148|NCT02207244|4358336|P6|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
1327149|NCT02207244|4358337|P5|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
1327150|NCT02207244|4358338|P4|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|1
1327151|NCT02207244|4358339|P3|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1327152|NCT02207244|4358340|P2|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1327153|NCT02207244|4358341|P1|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1327154|NCT02207244|4358333|P9|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1327155|NCT02207244|4358334|P8|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1327156|NCT02207244|4358335|P7|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1327157|NCT02207244|4358336|P6|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|2
1327158|NCT02207244|4358337|P5|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1327159|NCT02207244|4358338|P4|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1327160|NCT02207244|4358339|P3|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1327161|NCT02207244|4358340|P2|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1327162|NCT02207244|4358341|P1|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1327163|NCT02207244|4358333|P9|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1327164|NCT02207244|4358334|P8|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1327165|NCT02207244|4358335|P7|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1327166|NCT02207244|4358336|P6|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|2
1327167|NCT02207244|4358337|P5|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|3
1327168|NCT02207244|4358338|P4|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1327169|NCT02207244|4358339|P3|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1327170|NCT02207244|4358340|P2|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1327171|NCT02207244|4358341|P1|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1327172|NCT02207244|4358333|P9|Placebo Controlled Period: Week 0 - 16|Other|0
1327173|NCT02207244|4358334|P8|Placebo Controlled Period: Week 0 - 16|Other|0
1327174|NCT02207244|4358335|P7|Placebo Controlled Period: Week 0 - 16|Other|0
1327175|NCT02207244|4358336|P6|Placebo Controlled Period: Week 0 - 16|Other|0
1327176|NCT02207244|4358337|P5|Placebo Controlled Period: Week 0 - 16|Other|0
1327177|NCT02207244|4358338|P4|Placebo Controlled Period: Week 0 - 16|Other|0
1327178|NCT02207244|4358339|P3|Placebo Controlled Period: Week 0 - 16|Other|0
1327179|NCT02207244|4358340|P2|Placebo Controlled Period: Week 0 - 16|Other|1
1327180|NCT02207244|4358341|P1|Placebo Controlled Period: Week 0 - 16|Other|0
1327181|NCT02207244|4358333|P9|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1327182|NCT02207244|4358334|P8|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1327183|NCT02207244|4358335|P7|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1327184|NCT02207244|4358336|P6|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1327185|NCT02207244|4358337|P5|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1327186|NCT02207244|4358338|P4|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1327187|NCT02207244|4358339|P3|Placebo Controlled Period: Week 0 - 16|Non-Compliance|2
1327188|NCT02207244|4358340|P2|Placebo Controlled Period: Week 0 - 16|Non-Compliance|1
1327189|NCT02207244|4358341|P1|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1327190|NCT02207244|4358333|P9|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1327191|NCT02207244|4358334|P8|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1327192|NCT02207244|4358335|P7|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1327193|NCT02207244|4358336|P6|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1327194|NCT02207244|4358337|P5|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1327195|NCT02207244|4358338|P4|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1327196|NCT02207244|4358339|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
1327197|NCT02207244|4358340|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|3
1327198|NCT02207244|4358341|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
1327199|NCT02207244|4358333|P9|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1327200|NCT02207244|4358334|P8|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1327201|NCT02207244|4358335|P7|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1327202|NCT02207244|4358336|P6|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1327203|NCT02207244|4358337|P5|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1327204|NCT02207244|4358338|P4|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1327205|NCT02207244|4358339|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1327206|NCT02207244|4358340|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|1
1327207|NCT02207244|4358341|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|7
1327208|NCT02207244|4358333|P9|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1327209|NCT02207244|4358334|P8|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1327210|NCT02207244|4358335|P7|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1327211|NCT02207244|4358336|P6|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1327212|NCT02207244|4358337|P5|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1327213|NCT02207244|4358338|P4|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1327214|NCT02207244|4358339|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|2
1327215|NCT02207244|4358340|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|3
1327216|NCT02207244|4358341|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
1327217|NCT02207244|4358333|P9|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1327218|NCT02207244|4358334|P8|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1327219|NCT02207244|4358335|P7|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1327220|NCT02207244|4358336|P6|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1327221|NCT02207244|4358337|P5|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1327222|NCT02207244|4358338|P4|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1327223|NCT02207244|4358339|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
1327224|NCT02207244|4358340|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1327225|NCT02207244|4358341|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|4
1327226|NCT02207244|4358333|P9|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1327227|NCT02207244|4358334|P8|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1327228|NCT02207244|4358335|P7|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1327229|NCT02207244|4358336|P6|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1327230|NCT02207244|4358337|P5|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1327231|NCT02207244|4358338|P4|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1327232|NCT02207244|4358339|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
1327233|NCT02207244|4358340|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|9
1327234|NCT02207244|4358341|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
1327235|NCT02207231|4358382|P3|Active Controlled Period: Week 16 - 48|Non-compliance|3
1327236|NCT02207231|4358383|P2|Active Controlled Period: Week 16 - 48|Non-compliance|3
1327237|NCT02207231|4358384|P1|Active Controlled Period: Week 16 - 48|Non-compliance|0
1327238|NCT02207231|4358382|P3|Active Controlled Period: Week 16 - 48|Other|3
1327239|NCT02207231|4358383|P2|Active Controlled Period: Week 16 - 48|Other|2
1327240|NCT02207231|4358384|P1|Active Controlled Period: Week 16 - 48|Other|0
1327241|NCT02207231|4358382|P3|Active Controlled Period: Week 16 - 48|Protocol Violation|0
1327242|NCT02207231|4358383|P2|Active Controlled Period: Week 16 - 48|Protocol Violation|1
1327243|NCT02207231|4358384|P1|Active Controlled Period: Week 16 - 48|Protocol Violation|0
1327244|NCT02207231|4358382|P3|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
1327245|NCT02207231|4358383|P2|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
1327246|NCT02207231|4358384|P1|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
1327247|NCT02207231|4358382|P3|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
1327248|NCT02207231|4358383|P2|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
1327249|NCT02207231|4358384|P1|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
1327250|NCT02207231|4358382|P3|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
1327251|NCT02207231|4358383|P2|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
1327252|NCT02207231|4358384|P1|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
1327253|NCT02207231|4358382|P3|Active Controlled Period: Week 16 - 48|Pregnancy|1
1327254|NCT02207231|4358383|P2|Active Controlled Period: Week 16 - 48|Pregnancy|0
1327255|NCT02207231|4358384|P1|Active Controlled Period: Week 16 - 48|Pregnancy|0
1327256|NCT02207231|4358382|P3|Active Controlled Period: Week 16 - 48|Adverse Event|9
1327257|NCT02207231|4358383|P2|Active Controlled Period: Week 16 - 48|Adverse Event|6
1327258|NCT02207231|4358384|P1|Active Controlled Period: Week 16 - 48|Adverse Event|1
1327259|NCT02207231|4358382|P3|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
1327260|NCT02207231|4358383|P2|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
1327261|NCT02207231|4358384|P1|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
1327262|NCT02207231|4358382|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
1327263|NCT02207231|4358383|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1327264|NCT02207231|4358384|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1327265|NCT02207231|4358382|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
1327266|NCT02207231|4358383|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1327267|NCT02207231|4358384|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
1327268|NCT02207231|4358382|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
1327269|NCT02207231|4358383|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
1327270|NCT02207231|4358384|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
1327271|NCT02207231|4358382|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
1327272|NCT02207231|4358383|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1327273|NCT02207231|4358384|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
1327274|NCT02207231|4358382|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
1327275|NCT02207231|4358383|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
1327276|NCT02207231|4358384|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
1327277|NCT02207088|4358416|P1|Overall Study|Adverse Event|2
1327278|NCT02206607|4358431|P5|Second Intervention Period|Insufficient Clinical Response|0
1327279|NCT02206607|4358432|P4|Second Intervention Period|Insufficient Clinical Response|1
1327280|NCT02206607|4358433|P3|Second Intervention Period|Insufficient Clinical Response|0
1327281|NCT02206607|4358434|P2|Second Intervention Period|Insufficient Clinical Response|0
1327282|NCT02206607|4358435|P1|Second Intervention Period|Insufficient Clinical Response|0
1327283|NCT02206607|4358431|P5|Open-Label Run-In|Withdrawal by Subject|0
1327284|NCT02206607|4358432|P4|Open-Label Run-In|Withdrawal by Subject|0
1327285|NCT02206607|4358433|P3|Open-Label Run-In|Withdrawal by Subject|0
1327286|NCT02206607|4358434|P2|Open-Label Run-In|Withdrawal by Subject|0
1327287|NCT02206607|4358435|P1|Open-Label Run-In|Withdrawal by Subject|3
1327288|NCT02205814|4358491|P4|Overall Study|not compliant with study procedures|0
1327289|NCT02205814|4358492|P3|Overall Study|not compliant with study procedures|1
1327290|NCT02205814|4358493|P2|Overall Study|not compliant with study procedures|0
1327291|NCT02205814|4358494|P1|Overall Study|not compliant with study procedures|0
1327292|NCT02205814|4358491|P4|Overall Study|Withdrawal by Subject|1
1327293|NCT02205814|4358492|P3|Overall Study|Withdrawal by Subject|2
1327294|NCT02205814|4358493|P2|Overall Study|Withdrawal by Subject|1
1327295|NCT02205814|4358494|P1|Overall Study|Withdrawal by Subject|0
1327296|NCT02205814|4358491|P4|Overall Study|Protocol Violation|1
1327297|NCT02205814|4358492|P3|Overall Study|Protocol Violation|0
1327298|NCT02205814|4358493|P2|Overall Study|Protocol Violation|0
1327299|NCT02205814|4358494|P1|Overall Study|Protocol Violation|1
1327300|NCT02205814|4358491|P4|Overall Study|Physician Decision|0
1327301|NCT02205814|4358492|P3|Overall Study|Physician Decision|1
1327302|NCT02205814|4358493|P2|Overall Study|Physician Decision|0
1327303|NCT02205814|4358494|P1|Overall Study|Physician Decision|0
1327304|NCT02205814|4358491|P4|Overall Study|Lack of Efficacy|1
1327305|NCT02205814|4358492|P3|Overall Study|Lack of Efficacy|1
1327306|NCT02205814|4358493|P2|Overall Study|Lack of Efficacy|0
1327307|NCT02205814|4358494|P1|Overall Study|Lack of Efficacy|1
1327308|NCT02205814|4358491|P4|Overall Study|Lost to Follow-up|1
1327309|NCT02205814|4358492|P3|Overall Study|Lost to Follow-up|0
1327310|NCT02205814|4358493|P2|Overall Study|Lost to Follow-up|0
1327311|NCT02205814|4358494|P1|Overall Study|Lost to Follow-up|0
1327312|NCT02205476|4358547|P2|Overall Study|Study termination by Sponsor|3
1327313|NCT02205476|4358548|P1|Overall Study|Study termination by Sponsor|7
1327314|NCT02205333|4358587|P9|Overall Study|Withdrawal by Subject|0
1327315|NCT02205333|4358588|P8|Overall Study|Withdrawal by Subject|0
1327316|NCT02205333|4358589|P7|Overall Study|Withdrawal by Subject|2
1327317|NCT02205333|4358590|P6|Overall Study|Withdrawal by Subject|0
1327318|NCT02205333|4358591|P5|Overall Study|Withdrawal by Subject|0
1327319|NCT02205333|4358592|P4|Overall Study|Withdrawal by Subject|1
1327320|NCT02205333|4358593|P3|Overall Study|Withdrawal by Subject|0
1327321|NCT02205333|4358594|P2|Overall Study|Withdrawal by Subject|0
1327322|NCT02205333|4358595|P1|Overall Study|Withdrawal by Subject|1
1327323|NCT02205333|4358587|P9|Overall Study|Death|0
1327324|NCT02205333|4358588|P8|Overall Study|Death|2
1327325|NCT02205333|4358589|P7|Overall Study|Death|3
1327326|NCT02205333|4358590|P6|Overall Study|Death|3
1327327|NCT02205333|4358591|P5|Overall Study|Death|5
1327328|NCT02205333|4358592|P4|Overall Study|Death|6
1327329|NCT02205333|4358593|P3|Overall Study|Death|2
1327330|NCT02205333|4358594|P2|Overall Study|Death|6
1327331|NCT02205333|4358595|P1|Overall Study|Death|5
1327332|NCT02204579|4358791|P1|Overall Study|Screen failures|2
1327333|NCT02204449|4358845|P2|Overall Study|Withdrawal by Subject|1
1327334|NCT02204449|4358846|P1|Overall Study|Withdrawal by Subject|0
1327335|NCT02204449|4358845|P2|Overall Study|Death|1
1327336|NCT02204449|4358846|P1|Overall Study|Death|0
1327337|NCT02204449|4358845|P2|Overall Study|Lost to Follow-up|9
1327338|NCT02204449|4358846|P1|Overall Study|Lost to Follow-up|7
1327339|NCT02204410|4358856|P1|Overall Study|Withdrawal by Subject|3
1327340|NCT02204410|4358856|P1|Overall Study|Protocol Violation|1
1327341|NCT02204410|4358856|P1|Overall Study|Physician Decision|2
1327342|NCT02204410|4358856|P1|Overall Study|Lost to Follow-up|5
1327343|NCT02204371|4358861|P1|Overall Study|Adverse Event|1
1327344|NCT02204319|4358884|P1|Overall Study|Withdrawal by Subject|2
1327345|NCT02204319|4358884|P1|Overall Study|Pregnancy|1
1327346|NCT02204007|4358892|P2|Overall Study|Surgery Canceled|1
1327347|NCT02204007|4358893|P1|Overall Study|Surgery Canceled|1
1327348|NCT02203916|4358904|P3|Overall Study|Reason Not Specified|1
1327349|NCT02203916|4358905|P2|Overall Study|Reason Not Specified|2
1327350|NCT02203916|4358906|P1|Overall Study|Reason Not Specified|0
1327351|NCT02203916|4358904|P3|Overall Study|Lack of Efficacy|0
1327352|NCT02203916|4358905|P2|Overall Study|Lack of Efficacy|0
1327353|NCT02203916|4358906|P1|Overall Study|Lack of Efficacy|3
1327354|NCT02203916|4358904|P3|Overall Study|Voluntary Withdrawal|8
1327355|NCT02203916|4358905|P2|Overall Study|Voluntary Withdrawal|3
1327356|NCT02203916|4358906|P1|Overall Study|Voluntary Withdrawal|3
1327357|NCT02203916|4358904|P3|Overall Study|Lost to Follow-up|0
1327358|NCT02203916|4358905|P2|Overall Study|Lost to Follow-up|1
1327359|NCT02203916|4358906|P1|Overall Study|Lost to Follow-up|0
1327360|NCT02203916|4358904|P3|Overall Study|Major Protocol Deviation|0
1327361|NCT02203916|4358905|P2|Overall Study|Major Protocol Deviation|1
1327362|NCT02203916|4358906|P1|Overall Study|Major Protocol Deviation|1
1327363|NCT02203916|4358904|P3|Overall Study|Pretreatment Event/Adverse Event|2
1327364|NCT02203916|4358905|P2|Overall Study|Pretreatment Event/Adverse Event|3
1327365|NCT02203916|4358906|P1|Overall Study|Pretreatment Event/Adverse Event|1
1327366|NCT02203721|4358976|P2|Overall Study|Illness|1
1327367|NCT02203721|4358977|P1|Overall Study|Illness|0
1327368|NCT02203721|4358976|P2|Overall Study|Death|2
1327369|NCT02203721|4358977|P1|Overall Study|Death|0
1327370|NCT02203721|4358976|P2|Overall Study|Lost to Follow-up|0
1327371|NCT02203721|4358977|P1|Overall Study|Lost to Follow-up|1
1327372|NCT02203331|4359080|P6|Overall Study|Lost to Follow-up|0
1327373|NCT02203331|4359081|P5|Overall Study|Lost to Follow-up|1
1327374|NCT02203331|4359082|P4|Overall Study|Lost to Follow-up|0
1327375|NCT02203331|4359083|P3|Overall Study|Lost to Follow-up|0
1327376|NCT02203331|4359084|P2|Overall Study|Lost to Follow-up|0
1327377|NCT02203331|4359085|P1|Overall Study|Lost to Follow-up|0
1327378|NCT02203331|4359080|P6|Overall Study|Protocol Violation|0
1327379|NCT02203331|4359081|P5|Overall Study|Protocol Violation|1
1327380|NCT02203331|4359082|P4|Overall Study|Protocol Violation|1
1327381|NCT02203331|4359083|P3|Overall Study|Protocol Violation|0
1327382|NCT02203331|4359084|P2|Overall Study|Protocol Violation|2
1327383|NCT02203331|4359085|P1|Overall Study|Protocol Violation|0
1327384|NCT02203331|4359080|P6|Overall Study|Lack of Efficacy|1
1327385|NCT02203331|4359081|P5|Overall Study|Lack of Efficacy|0
1327386|NCT02203331|4359082|P4|Overall Study|Lack of Efficacy|0
1327387|NCT02203331|4359083|P3|Overall Study|Lack of Efficacy|1
1327388|NCT02203331|4359084|P2|Overall Study|Lack of Efficacy|2
1327389|NCT02203331|4359085|P1|Overall Study|Lack of Efficacy|0
1327390|NCT02203331|4359080|P6|Overall Study|Other Reasons|0
1327391|NCT02203331|4359081|P5|Overall Study|Other Reasons|0
1327392|NCT02203331|4359082|P4|Overall Study|Other Reasons|2
1327393|NCT02203331|4359083|P3|Overall Study|Other Reasons|0
1327394|NCT02203331|4359084|P2|Overall Study|Other Reasons|2
1327395|NCT02203331|4359085|P1|Overall Study|Other Reasons|1
1327396|NCT02203331|4359080|P6|Overall Study|Adverse Event|3
1327397|NCT02203331|4359081|P5|Overall Study|Adverse Event|3
1327398|NCT02203331|4359082|P4|Overall Study|Adverse Event|4
1327399|NCT02203331|4359083|P3|Overall Study|Adverse Event|3
1327400|NCT02203331|4359084|P2|Overall Study|Adverse Event|8
1327401|NCT02203331|4359085|P1|Overall Study|Adverse Event|4
1327402|NCT02203331|4359080|P6|Overall Study|Withdrawal by Subject|3
1327403|NCT02203331|4359081|P5|Overall Study|Withdrawal by Subject|0
1327404|NCT02203331|4359082|P4|Overall Study|Withdrawal by Subject|0
1327405|NCT02203331|4359083|P3|Overall Study|Withdrawal by Subject|1
1327406|NCT02203331|4359084|P2|Overall Study|Withdrawal by Subject|0
1327407|NCT02203331|4359085|P1|Overall Study|Withdrawal by Subject|1
1327408|NCT02203331|4359080|P6|Overall Study|Pregnancy|0
1327409|NCT02203331|4359081|P5|Overall Study|Pregnancy|2
1327410|NCT02203331|4359082|P4|Overall Study|Pregnancy|0
1327411|NCT02203331|4359083|P3|Overall Study|Pregnancy|0
1327412|NCT02203331|4359084|P2|Overall Study|Pregnancy|0
1327413|NCT02203331|4359085|P1|Overall Study|Pregnancy|1
1327414|NCT02203149|4359144|P5|Part 2|Adverse Event|1
1327415|NCT02203149|4359145|P4|Part 2|Adverse Event|1
1327416|NCT02203149|4359146|P3|Part 2|Adverse Event|0
1327417|NCT02203149|4359147|P2|Part 2|Adverse Event|0
1327418|NCT02203149|4359148|P1|Part 2|Adverse Event|0
1327419|NCT02203149|4359144|P5|Part 2|Withdrawal by Subject|0
1327420|NCT02203149|4359145|P4|Part 2|Withdrawal by Subject|1
1327421|NCT02203149|4359146|P3|Part 2|Withdrawal by Subject|0
1327422|NCT02203149|4359147|P2|Part 2|Withdrawal by Subject|0
1327423|NCT02203149|4359148|P1|Part 2|Withdrawal by Subject|0
1327424|NCT02203149|4359144|P5|Part 2|Death|0
1327425|NCT02203149|4359145|P4|Part 2|Death|1
1327426|NCT02203149|4359146|P3|Part 2|Death|1
1327427|NCT02203149|4359147|P2|Part 2|Death|0
1327428|NCT02203149|4359148|P1|Part 2|Death|0
1327429|NCT02203149|4359144|P5|Part 1|Adverse Event|0
1327430|NCT02203149|4359145|P4|Part 1|Adverse Event|0
1327431|NCT02203149|4359146|P3|Part 1|Adverse Event|0
1327432|NCT02203149|4359147|P2|Part 1|Adverse Event|1
1327433|NCT02203149|4359148|P1|Part 1|Adverse Event|0
1327434|NCT02203032|4359181|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
1327435|NCT02203032|4359182|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
1327436|NCT02203032|4359183|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
1327437|NCT02203032|4359184|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
1327438|NCT02203032|4359181|P4|Blinded Phase (Week 16 to Week 44)|Death|1
1327439|NCT02203032|4359182|P3|Blinded Phase (Week 16 to Week 44)|Death|0
1327440|NCT02203032|4359183|P2|Blinded Phase (Week 16 to Week 44)|Death|0
1327441|NCT02203032|4359184|P1|Blinded Phase (Week 16 to Week 44)|Death|0
1327442|NCT02203032|4359181|P4|Blinded Phase (Week 16 to Week 44)|Other|15
1327443|NCT02203032|4359182|P3|Blinded Phase (Week 16 to Week 44)|Other|1
1327444|NCT02203032|4359183|P2|Blinded Phase (Week 16 to Week 44)|Other|4
1327445|NCT02203032|4359184|P1|Blinded Phase (Week 16 to Week 44)|Other|0
1327446|NCT02203032|4359181|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
1327447|NCT02203032|4359182|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
1327448|NCT02203032|4359183|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
1327449|NCT02203032|4359184|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
1327450|NCT02203032|4359181|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
1327451|NCT02203032|4359182|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
1327452|NCT02203032|4359183|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
1327453|NCT02203032|4359184|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
1327454|NCT02203032|4359181|P4|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
1327455|NCT02203032|4359182|P3|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
1327456|NCT02203032|4359183|P2|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
1327457|NCT02203032|4359184|P1|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
1327458|NCT02203032|4359181|P4|Open Label Run-in (Week 0 to Week 16)|Other|0
1327459|NCT02203032|4359182|P3|Open Label Run-in (Week 0 to Week 16)|Other|0
1327460|NCT02203032|4359183|P2|Open Label Run-in (Week 0 to Week 16)|Other|0
1327461|NCT02203032|4359184|P1|Open Label Run-in (Week 0 to Week 16)|Other|2
1327462|NCT02203032|4359181|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
1327463|NCT02203032|4359182|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
1327464|NCT02203032|4359183|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
1327465|NCT02203032|4359184|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
1327466|NCT02203032|4359181|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
1327467|NCT02203032|4359182|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
1327468|NCT02203032|4359183|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
1327469|NCT02203032|4359184|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
1327470|NCT02203032|4359181|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
1327471|NCT02203032|4359182|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
1327472|NCT02203032|4359183|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
1327473|NCT02203032|4359184|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
1327474|NCT02203032|4359181|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
1327475|NCT02203032|4359182|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
1327476|NCT02203032|4359183|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
1327477|NCT02203032|4359184|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
1327478|NCT02203032|4359181|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
1327479|NCT02203032|4359182|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
1327480|NCT02203032|4359183|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
1327481|NCT02203032|4359184|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
1327482|NCT02202980|4359212|P14|Overall Study|Withdrew Consent|0
1327483|NCT02202980|4359213|P13|Overall Study|Withdrew Consent|0
1327484|NCT02202980|4359214|P12|Overall Study|Withdrew Consent|0
1327485|NCT02202980|4359215|P11|Overall Study|Withdrew Consent|0
1327486|NCT02202980|4359216|P10|Overall Study|Withdrew Consent|0
1327487|NCT02202980|4359217|P9|Overall Study|Withdrew Consent|1
1327488|NCT02202980|4359218|P8|Overall Study|Withdrew Consent|0
1327489|NCT02202980|4359219|P7|Overall Study|Withdrew Consent|0
1327490|NCT02202980|4359220|P6|Overall Study|Withdrew Consent|0
1327491|NCT02202980|4359221|P5|Overall Study|Withdrew Consent|0
1327492|NCT02202980|4359222|P4|Overall Study|Withdrew Consent|0
1327493|NCT02202980|4359223|P3|Overall Study|Withdrew Consent|2
1327494|NCT02202980|4359224|P2|Overall Study|Withdrew Consent|1
1327495|NCT02202980|4359225|P1|Overall Study|Withdrew Consent|0
1327496|NCT02202980|4359212|P14|Overall Study|Lost to Follow-up|0
1327497|NCT02202980|4359213|P13|Overall Study|Lost to Follow-up|1
1327498|NCT02202980|4359214|P12|Overall Study|Lost to Follow-up|0
1327499|NCT02202980|4359215|P11|Overall Study|Lost to Follow-up|0
1327500|NCT02202980|4359216|P10|Overall Study|Lost to Follow-up|0
1327501|NCT02202980|4359217|P9|Overall Study|Lost to Follow-up|1
1327502|NCT02202980|4359218|P8|Overall Study|Lost to Follow-up|1
1327503|NCT02202980|4359219|P7|Overall Study|Lost to Follow-up|0
1327504|NCT02202980|4359220|P6|Overall Study|Lost to Follow-up|0
1327505|NCT02202980|4359221|P5|Overall Study|Lost to Follow-up|0
1327506|NCT02202980|4359222|P4|Overall Study|Lost to Follow-up|1
1327507|NCT02202980|4359223|P3|Overall Study|Lost to Follow-up|1
1327508|NCT02202980|4359224|P2|Overall Study|Lost to Follow-up|1
1327509|NCT02202980|4359225|P1|Overall Study|Lost to Follow-up|0
1327510|NCT02202980|4359212|P14|Overall Study|Protocol Violation|0
1327511|NCT02202980|4359213|P13|Overall Study|Protocol Violation|0
1327512|NCT02202980|4359214|P12|Overall Study|Protocol Violation|0
1327513|NCT02202980|4359215|P11|Overall Study|Protocol Violation|0
1327514|NCT02202980|4359216|P10|Overall Study|Protocol Violation|0
1327515|NCT02202980|4359217|P9|Overall Study|Protocol Violation|0
1327516|NCT02202980|4359218|P8|Overall Study|Protocol Violation|0
1327517|NCT02202980|4359219|P7|Overall Study|Protocol Violation|0
1327518|NCT02202980|4359220|P6|Overall Study|Protocol Violation|0
1327519|NCT02202980|4359221|P5|Overall Study|Protocol Violation|3
1327520|NCT02202980|4359222|P4|Overall Study|Protocol Violation|3
1327521|NCT02202980|4359223|P3|Overall Study|Protocol Violation|0
1327522|NCT02202980|4359224|P2|Overall Study|Protocol Violation|0
1327523|NCT02202980|4359225|P1|Overall Study|Protocol Violation|0
1327524|NCT02202980|4359212|P14|Overall Study|Lack of Efficacy|0
1327525|NCT02202980|4359213|P13|Overall Study|Lack of Efficacy|10
1327526|NCT02202980|4359214|P12|Overall Study|Lack of Efficacy|3
1327527|NCT02202980|4359215|P11|Overall Study|Lack of Efficacy|0
1327528|NCT02202980|4359216|P10|Overall Study|Lack of Efficacy|0
1327529|NCT02202980|4359217|P9|Overall Study|Lack of Efficacy|2
1327530|NCT02202980|4359218|P8|Overall Study|Lack of Efficacy|2
1327531|NCT02202980|4359219|P7|Overall Study|Lack of Efficacy|11
1327532|NCT02202980|4359220|P6|Overall Study|Lack of Efficacy|1
1327533|NCT02202980|4359221|P5|Overall Study|Lack of Efficacy|3
1327534|NCT02202980|4359222|P4|Overall Study|Lack of Efficacy|0
1327535|NCT02202980|4359223|P3|Overall Study|Lack of Efficacy|7
1327536|NCT02202980|4359224|P2|Overall Study|Lack of Efficacy|0
1327537|NCT02202980|4359225|P1|Overall Study|Lack of Efficacy|1
1327538|NCT02202785|4359314|P3|Overall Study|Reason not Specified|13
1327539|NCT02202785|4359315|P2|Overall Study|Reason not Specified|7
1327540|NCT02202785|4359316|P1|Overall Study|Reason not Specified|10
1327541|NCT02202785|4359314|P3|Overall Study|Lost to Follow-up|0
1327542|NCT02202785|4359315|P2|Overall Study|Lost to Follow-up|1
1327543|NCT02202785|4359316|P1|Overall Study|Lost to Follow-up|0
1327544|NCT02202785|4359314|P3|Overall Study|Withdrawal by Subject|0
1327545|NCT02202785|4359315|P2|Overall Study|Withdrawal by Subject|1
1327546|NCT02202785|4359316|P1|Overall Study|Withdrawal by Subject|0
1327547|NCT02202785|4359314|P3|Overall Study|Study Terminated by Sponsor|4
1327548|NCT02202785|4359315|P2|Overall Study|Study Terminated by Sponsor|6
1327549|NCT02202785|4359316|P1|Overall Study|Study Terminated by Sponsor|1
1327550|NCT02202759|4359353|P3|Overall Study|Reason not Specified|10
1327551|NCT02202759|4359354|P2|Overall Study|Reason not Specified|11
1327552|NCT02202759|4359355|P1|Overall Study|Reason not Specified|4
1327553|NCT02202759|4359353|P3|Overall Study|Withdrawal by Subject|1
1327554|NCT02202759|4359354|P2|Overall Study|Withdrawal by Subject|1
1327555|NCT02202759|4359355|P1|Overall Study|Withdrawal by Subject|2
1327556|NCT02202759|4359353|P3|Overall Study|Study Terminated by Sponsor|3
1327557|NCT02202759|4359354|P2|Overall Study|Study Terminated by Sponsor|3
1327558|NCT02202759|4359355|P1|Overall Study|Study Terminated by Sponsor|3
1327559|NCT02202538|4359389|P1|Overall Study|Investigator Decision|1
1327560|NCT02202538|4359389|P1|Overall Study|Did not meet all inclusion criteria|2
1327561|NCT02202538|4359389|P1|Overall Study|Withdrawal by Subject|5
1327562|NCT02202317|4359400|P1|Overall Study|Lost to Follow-up|1
1327563|NCT02202161|4359427|P8|Overall Study|Withdrawal by Subject|0
1327564|NCT02202161|4359428|P7|Overall Study|Withdrawal by Subject|0
1327565|NCT02202161|4359429|P6|Overall Study|Withdrawal by Subject|0
1327566|NCT02202161|4359430|P5|Overall Study|Withdrawal by Subject|1
1327567|NCT02202161|4359431|P4|Overall Study|Withdrawal by Subject|0
1327568|NCT02202161|4359432|P3|Overall Study|Withdrawal by Subject|0
1327569|NCT02202161|4359433|P2|Overall Study|Withdrawal by Subject|0
1327570|NCT02202161|4359434|P1|Overall Study|Withdrawal by Subject|0
1327571|NCT02202161|4359427|P8|Overall Study|Physician Decision|3
1327572|NCT02202161|4359428|P7|Overall Study|Physician Decision|0
1327573|NCT02202161|4359429|P6|Overall Study|Physician Decision|0
1327574|NCT02202161|4359430|P5|Overall Study|Physician Decision|0
1327575|NCT02202161|4359431|P4|Overall Study|Physician Decision|0
1327576|NCT02202161|4359432|P3|Overall Study|Physician Decision|0
1327577|NCT02202161|4359433|P2|Overall Study|Physician Decision|0
1327578|NCT02202161|4359434|P1|Overall Study|Physician Decision|0
1327579|NCT02202161|4359427|P8|Overall Study|Did not meet continuation criteria|3
1327580|NCT02202161|4359428|P7|Overall Study|Did not meet continuation criteria|0
1327581|NCT02202161|4359429|P6|Overall Study|Did not meet continuation criteria|0
1327582|NCT02202161|4359430|P5|Overall Study|Did not meet continuation criteria|0
1327583|NCT02202161|4359431|P4|Overall Study|Did not meet continuation criteria|0
1327584|NCT02202161|4359432|P3|Overall Study|Did not meet continuation criteria|0
1327585|NCT02202161|4359433|P2|Overall Study|Did not meet continuation criteria|0
1327586|NCT02202161|4359434|P1|Overall Study|Did not meet continuation criteria|0
1327587|NCT02202161|4359427|P8|Overall Study|Adverse Event|0
1327588|NCT02202161|4359428|P7|Overall Study|Adverse Event|0
1327589|NCT02202161|4359429|P6|Overall Study|Adverse Event|1
1327590|NCT02202161|4359430|P5|Overall Study|Adverse Event|0
1327591|NCT02202161|4359431|P4|Overall Study|Adverse Event|0
1327592|NCT02202161|4359432|P3|Overall Study|Adverse Event|0
1327593|NCT02202161|4359433|P2|Overall Study|Adverse Event|1
1327594|NCT02202161|4359434|P1|Overall Study|Adverse Event|1
1327595|NCT02201953|4359594|P2|Overall Study|Death|3
1327596|NCT02201953|4359595|P1|Overall Study|Death|0
1327597|NCT02201953|4359594|P2|Overall Study|Adverse Event|5
1327598|NCT02201953|4359595|P1|Overall Study|Adverse Event|0
1327599|NCT02201953|4359594|P2|Overall Study|Withdrew Consent|5
1327600|NCT02201953|4359595|P1|Overall Study|Withdrew Consent|2
1327601|NCT02201953|4359594|P2|Overall Study|Lost to Follow-up|8
1327602|NCT02201953|4359595|P1|Overall Study|Lost to Follow-up|8
1327603|NCT02201953|4359594|P2|Overall Study|Lack of Efficacy|30
1327604|NCT02201953|4359595|P1|Overall Study|Lack of Efficacy|9
1327605|NCT02201953|4359594|P2|Overall Study|Randomized but Never Treated|5
1327606|NCT02201953|4359595|P1|Overall Study|Randomized but Never Treated|1
1327607|NCT02201940|4359613|P2|Overall Study|Adverse Event|1
1327608|NCT02201940|4359614|P1|Overall Study|Adverse Event|0
1327609|NCT02201940|4359613|P2|Overall Study|Death|0
1327610|NCT02201940|4359614|P1|Overall Study|Death|1
1327611|NCT02201940|4359613|P2|Overall Study|Investigator's Discretion|1
1327612|NCT02201940|4359614|P1|Overall Study|Investigator's Discretion|1
1327613|NCT02201940|4359613|P2|Overall Study|Withdrew Consent|1
1327614|NCT02201940|4359614|P1|Overall Study|Withdrew Consent|2
1327615|NCT02201940|4359613|P2|Overall Study|Lost to Follow-up|0
1327616|NCT02201940|4359614|P1|Overall Study|Lost to Follow-up|5
1327617|NCT02201940|4359613|P2|Overall Study|Lack of Efficacy|113
1327618|NCT02201940|4359614|P1|Overall Study|Lack of Efficacy|2
1327619|NCT02201940|4359613|P2|Overall Study|Randomized/Enrolled but Never Treated|0
1327620|NCT02201940|4359614|P1|Overall Study|Randomized/Enrolled but Never Treated|1
1327621|NCT02201901|4359633|P3|Overall Study|Adverse Event|0
1327622|NCT02201901|4359634|P2|Overall Study|Adverse Event|1
1327623|NCT02201901|4359635|P1|Overall Study|Adverse Event|1
1327624|NCT02201901|4359633|P3|Overall Study|Withdrew Consent|2
1327625|NCT02201901|4359634|P2|Overall Study|Withdrew Consent|0
1327626|NCT02201901|4359635|P1|Overall Study|Withdrew Consent|2
1327627|NCT02201901|4359633|P3|Overall Study|Lost to Follow-up|2
1327628|NCT02201901|4359634|P2|Overall Study|Lost to Follow-up|3
1327629|NCT02201901|4359635|P1|Overall Study|Lost to Follow-up|2
1327630|NCT02201901|4359633|P3|Overall Study|Death|3
1327631|NCT02201901|4359634|P2|Overall Study|Death|3
1327632|NCT02201901|4359635|P1|Overall Study|Death|3
1327633|NCT02201901|4359633|P3|Overall Study|Lack of Efficacy|6
1327634|NCT02201901|4359634|P2|Overall Study|Lack of Efficacy|1
1327635|NCT02201901|4359635|P1|Overall Study|Lack of Efficacy|7
1327636|NCT02201901|4359633|P3|Overall Study|Randomized but never treated|0
1327637|NCT02201901|4359634|P2|Overall Study|Randomized but never treated|1
1327638|NCT02201901|4359635|P1|Overall Study|Randomized but never treated|0
1327639|NCT02201784|4359666|P2|Overall Study|Failure to achieve adequate block|0
1327640|NCT02201784|4359667|P1|Overall Study|Failure to achieve adequate block|2
1327641|NCT02201524|4359685|P4|Overall Study|Other|0
1327642|NCT02201524|4359686|P3|Overall Study|Other|0
1327643|NCT02201524|4359687|P2|Overall Study|Other|1
1327644|NCT02201524|4359688|P1|Overall Study|Other|1
1327645|NCT02201524|4359685|P4|Overall Study|Withdrawal by Subject|1
1327646|NCT02201524|4359686|P3|Overall Study|Withdrawal by Subject|1
1327647|NCT02201524|4359687|P2|Overall Study|Withdrawal by Subject|0
1327648|NCT02201524|4359688|P1|Overall Study|Withdrawal by Subject|0
1327649|NCT02201524|4359685|P4|Overall Study|Protocol Violation|1
1327650|NCT02201524|4359686|P3|Overall Study|Protocol Violation|0
1327651|NCT02201524|4359687|P2|Overall Study|Protocol Violation|0
1327652|NCT02201524|4359688|P1|Overall Study|Protocol Violation|0
1327653|NCT02201524|4359685|P4|Overall Study|No longer meets eligibility criteria|2
1327654|NCT02201524|4359686|P3|Overall Study|No longer meets eligibility criteria|0
1327655|NCT02201524|4359687|P2|Overall Study|No longer meets eligibility criteria|0
1327656|NCT02201524|4359688|P1|Overall Study|No longer meets eligibility criteria|0
1327657|NCT02201524|4359685|P4|Overall Study|Lost to Follow-up|0
1327658|NCT02201524|4359686|P3|Overall Study|Lost to Follow-up|2
1327659|NCT02201524|4359687|P2|Overall Study|Lost to Follow-up|0
1327660|NCT02201524|4359688|P1|Overall Study|Lost to Follow-up|0
1327661|NCT02201524|4359685|P4|Overall Study|Insufficient clinical response|0
1327662|NCT02201524|4359686|P3|Overall Study|Insufficient clinical response|0
1327663|NCT02201524|4359687|P2|Overall Study|Insufficient clinical response|0
1327664|NCT02201524|4359688|P1|Overall Study|Insufficient clinical response|1
1327665|NCT02201524|4359685|P4|Overall Study|Adverse Event|0
1327666|NCT02201524|4359686|P3|Overall Study|Adverse Event|1
1327667|NCT02201524|4359687|P2|Overall Study|Adverse Event|2
1327668|NCT02201524|4359688|P1|Overall Study|Adverse Event|0
1327669|NCT02201329|4359813|P1|Overall Study|Withdrawal by Subject|2
1327670|NCT02201329|4359813|P1|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
1327671|NCT02200510|4359907|P2|Overall Study|potential COI - joined study team|0
1327672|NCT02200510|4359908|P1|Overall Study|potential COI - joined study team|1
1327673|NCT02200510|4359907|P2|Overall Study|Lost to Follow-up|1
1327674|NCT02200510|4359908|P1|Overall Study|Lost to Follow-up|7
1327675|NCT02200510|4359907|P2|Overall Study|Protocol Violation|1
1327676|NCT02200510|4359908|P1|Overall Study|Protocol Violation|0
1327677|NCT02200510|4359907|P2|Overall Study|Death|1
1327678|NCT02200510|4359908|P1|Overall Study|Death|1
1327679|NCT02199795|4359946|P2|Overall Study|withdrew due to shoulder pain|0
1327680|NCT02199795|4359947|P1|Overall Study|withdrew due to shoulder pain|1
1327681|NCT02199795|4359946|P2|Overall Study|no longer met inclusion criteria|0
1327682|NCT02199795|4359947|P1|Overall Study|no longer met inclusion criteria|1
1327683|NCT02199509|4359988|P2|Overall Study|Misunderstood titration schedule|0
1327684|NCT02199509|4359989|P1|Overall Study|Misunderstood titration schedule|1
1327685|NCT02199509|4359988|P2|Overall Study|Suicidal Ideation|1
1327686|NCT02199509|4359989|P1|Overall Study|Suicidal Ideation|0
1327687|NCT02198963|4360014|P1|Overall Study|Withdrawal by Subject|6
1327688|NCT02198963|4360014|P1|Overall Study|Adverse Event|1
1327689|NCT02198235|4360056|P3|Overall Study|Lost to Follow-up|2
1327690|NCT02198235|4360057|P2|Overall Study|Lost to Follow-up|2
1327691|NCT02198235|4360058|P1|Overall Study|Lost to Follow-up|3
1327692|NCT02198040|4360078|P3|Overall Study|Withdrawal by Subject|1
1327693|NCT02198040|4360079|P2|Overall Study|Withdrawal by Subject|0
1327694|NCT02198040|4360080|P1|Overall Study|Withdrawal by Subject|0
1327695|NCT02198040|4360078|P3|Overall Study|Work reasons|0
1327696|NCT02198040|4360079|P2|Overall Study|Work reasons|1
1327697|NCT02198040|4360080|P1|Overall Study|Work reasons|0
1327698|NCT02197806|4360110|P4|Overall Study|Adverse Event|1
1327699|NCT02197806|4360111|P3|Overall Study|Adverse Event|0
1327700|NCT02197806|4360112|P2|Overall Study|Adverse Event|1
1327701|NCT02197806|4360113|P1|Overall Study|Adverse Event|0
1327702|NCT02197247|4360164|P1|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
1327703|NCT02197247|4360164|P1|Part B: Day 78 to End Part B (AZD9291)|Death|1
1327704|NCT02197247|4360164|P1|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
1327705|NCT02197247|4360164|P1|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
1327706|NCT02197247|4360164|P1|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
1327707|NCT02197247|4360164|P1|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
1327708|NCT02197247|4360164|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
1327709|NCT02197247|4360164|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
1327710|NCT02197234|4360209|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
1327711|NCT02197234|4360209|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
1327712|NCT02197234|4360209|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
1327713|NCT02197234|4360209|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
1327714|NCT02197234|4360209|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
1327715|NCT02197234|4360209|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
1327716|NCT02197234|4360209|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
1327717|NCT02197130|4360231|P3|Overall Study|Other|3
1327718|NCT02197130|4360232|P2|Overall Study|Other|0
1327719|NCT02197130|4360233|P1|Overall Study|Other|1
1327720|NCT02197130|4360231|P3|Overall Study|Withdrawal by Subject|4
1327721|NCT02197130|4360232|P2|Overall Study|Withdrawal by Subject|3
1327722|NCT02197130|4360233|P1|Overall Study|Withdrawal by Subject|0
1327723|NCT02197130|4360231|P3|Overall Study|Does not meet entrance criteria|1
1327724|NCT02197130|4360232|P2|Overall Study|Does not meet entrance criteria|0
1327725|NCT02197130|4360233|P1|Overall Study|Does not meet entrance criteria|0
1327726|NCT02197130|4360231|P3|Overall Study|Lost to Follow-up|1
1327727|NCT02197130|4360232|P2|Overall Study|Lost to Follow-up|0
1327728|NCT02197130|4360233|P1|Overall Study|Lost to Follow-up|2
1327729|NCT02197130|4360231|P3|Overall Study|Death|0
1327730|NCT02197130|4360232|P2|Overall Study|Death|1
1327731|NCT02197130|4360233|P1|Overall Study|Death|0
1327732|NCT02197130|4360231|P3|Overall Study|Adverse Event|23
1327733|NCT02197130|4360232|P2|Overall Study|Adverse Event|4
1327734|NCT02197130|4360233|P1|Overall Study|Adverse Event|13
1327735|NCT02196714|4360325|P4|Overall Study|Protocol Violation|0
1327736|NCT02196714|4360326|P3|Overall Study|Protocol Violation|1
1327737|NCT02196714|4360327|P2|Overall Study|Protocol Violation|0
1327738|NCT02196714|4360328|P1|Overall Study|Protocol Violation|0
1327739|NCT02196701|4360450|P1|Overall Study|Non-adherence to Protocol|1
1327740|NCT02196701|4360450|P1|Overall Study|Lost to Follow-up|1
1327741|NCT02196701|4360450|P1|Overall Study|Adverse Event|1
1327742|NCT02196675|4360509|P3|Overall Study|Death|1
1327743|NCT02196675|4360510|P2|Overall Study|Death|0
1327744|NCT02196675|4360511|P1|Overall Study|Death|0
1327745|NCT02196675|4360509|P3|Overall Study|Protocol Violation|0
1327746|NCT02196675|4360510|P2|Overall Study|Protocol Violation|1
1327747|NCT02196675|4360511|P1|Overall Study|Protocol Violation|0
1327748|NCT02196675|4360509|P3|Overall Study|Intra-operative surgical exclusion|0
1327749|NCT02196675|4360510|P2|Overall Study|Intra-operative surgical exclusion|1
1327750|NCT02196675|4360511|P1|Overall Study|Intra-operative surgical exclusion|1
1327751|NCT02196675|4360509|P3|Overall Study|Withdrawal by Subject|0
1327752|NCT02196675|4360510|P2|Overall Study|Withdrawal by Subject|0
1327753|NCT02196675|4360511|P1|Overall Study|Withdrawal by Subject|1
1327754|NCT02196506|4360533|P4|Phase A+|Participant withdrawn by investigator|1
1327755|NCT02196506|4360534|P3|Phase A+|Participant withdrawn by investigator|0
1327756|NCT02196506|4360535|P2|Phase A+|Participant withdrawn by investigator|0
1327757|NCT02196506|4360536|P1|Phase A+|Participant withdrawn by investigator|0
1327758|NCT02196506|4360533|P4|Phase A+|Lost to Follow-up|6
1327759|NCT02196506|4360534|P3|Phase A+|Lost to Follow-up|0
1327760|NCT02196506|4360535|P2|Phase A+|Lost to Follow-up|0
1327761|NCT02196506|4360536|P1|Phase A+|Lost to Follow-up|0
1327762|NCT02196506|4360533|P4|Phase A+|Adverse Event|1
1327763|NCT02196506|4360534|P3|Phase A+|Adverse Event|0
1327764|NCT02196506|4360535|P2|Phase A+|Adverse Event|0
1327765|NCT02196506|4360536|P1|Phase A+|Adverse Event|0
1327766|NCT02196506|4360533|P4|Phase A+|Withdrawal by Participant|5
1327767|NCT02196506|4360534|P3|Phase A+|Withdrawal by Participant|0
1327768|NCT02196506|4360535|P2|Phase A+|Withdrawal by Participant|0
1327769|NCT02196506|4360536|P1|Phase A+|Withdrawal by Participant|0
1327770|NCT02196506|4360533|P4|Phase A+|Participant Met Withdrawal Criteria|1
1327771|NCT02196506|4360534|P3|Phase A+|Participant Met Withdrawal Criteria|0
1327772|NCT02196506|4360535|P2|Phase A+|Participant Met Withdrawal Criteria|0
1327773|NCT02196506|4360536|P1|Phase A+|Participant Met Withdrawal Criteria|0
1327774|NCT02196506|4360533|P4|Phase B|Lost to Follow-up|0
1327775|NCT02196506|4360534|P3|Phase B|Lost to Follow-up|1
1327776|NCT02196506|4360535|P2|Phase B|Lost to Follow-up|2
1327777|NCT02196506|4360536|P1|Phase B|Lost to Follow-up|0
1327778|NCT02196506|4360533|P4|Phase B|Adverse Event|0
1327779|NCT02196506|4360534|P3|Phase B|Adverse Event|1
1327780|NCT02196506|4360535|P2|Phase B|Adverse Event|4
1327781|NCT02196506|4360536|P1|Phase B|Adverse Event|0
1327782|NCT02196506|4360533|P4|Phase B|Withdrawal by Participant|0
1327783|NCT02196506|4360534|P3|Phase B|Withdrawal by Participant|1
1327784|NCT02196506|4360535|P2|Phase B|Withdrawal by Participant|8
1327785|NCT02196506|4360536|P1|Phase B|Withdrawal by Participant|0
1327786|NCT02196506|4360533|P4|Phase B|Lack of Efficacy|0
1327787|NCT02196506|4360534|P3|Phase B|Lack of Efficacy|2
1327788|NCT02196506|4360535|P2|Phase B|Lack of Efficacy|1
1327789|NCT02196506|4360536|P1|Phase B|Lack of Efficacy|0
1327790|NCT02196506|4360533|P4|Phase B|Participant Met Withdrawal Criteria|0
1327791|NCT02196506|4360534|P3|Phase B|Participant Met Withdrawal Criteria|1
1327792|NCT02196506|4360535|P2|Phase B|Participant Met Withdrawal Criteria|0
1327793|NCT02196506|4360536|P1|Phase B|Participant Met Withdrawal Criteria|0
1327794|NCT02196506|4360533|P4|Phase A|Participant withdrawn by investigator|0
1327795|NCT02196506|4360534|P3|Phase A|Participant withdrawn by investigator|0
1327796|NCT02196506|4360535|P2|Phase A|Participant withdrawn by investigator|0
1327797|NCT02196506|4360536|P1|Phase A|Participant withdrawn by investigator|10
1327798|NCT02196506|4360533|P4|Phase A|Protocol deviation|0
1327799|NCT02196506|4360534|P3|Phase A|Protocol deviation|0
1327800|NCT02196506|4360535|P2|Phase A|Protocol deviation|0
1327801|NCT02196506|4360536|P1|Phase A|Protocol deviation|12
1327802|NCT02196506|4360533|P4|Phase A|Lost to Follow-up|0
1327803|NCT02196506|4360534|P3|Phase A|Lost to Follow-up|0
1327804|NCT02196506|4360535|P2|Phase A|Lost to Follow-up|0
1327805|NCT02196506|4360536|P1|Phase A|Lost to Follow-up|9
1327806|NCT02196506|4360533|P4|Phase A|Adverse Event|0
1327807|NCT02196506|4360534|P3|Phase A|Adverse Event|0
1327808|NCT02196506|4360535|P2|Phase A|Adverse Event|0
1327809|NCT02196506|4360536|P1|Phase A|Adverse Event|22
1327810|NCT02196506|4360533|P4|Phase A|Withdrawal by Subject|0
1327811|NCT02196506|4360534|P3|Phase A|Withdrawal by Subject|0
1327812|NCT02196506|4360535|P2|Phase A|Withdrawal by Subject|0
1327813|NCT02196506|4360536|P1|Phase A|Withdrawal by Subject|34
1327814|NCT02196506|4360533|P4|Phase A|Participant Met Withdrawal Criteria|0
1327815|NCT02196506|4360534|P3|Phase A|Participant Met Withdrawal Criteria|0
1327816|NCT02196506|4360535|P2|Phase A|Participant Met Withdrawal Criteria|0
1327817|NCT02196506|4360536|P1|Phase A|Participant Met Withdrawal Criteria|34
1327818|NCT02196259|4360551|P3|Overall Study|Partial data analysis|0
1327819|NCT02196259|4360552|P2|Overall Study|Partial data analysis|3
1327820|NCT02196259|4360553|P1|Overall Study|Partial data analysis|0
1327821|NCT02196259|4360551|P3|Overall Study|Researcher choice|1
1327822|NCT02196259|4360552|P2|Overall Study|Researcher choice|0
1327823|NCT02196259|4360553|P1|Overall Study|Researcher choice|0
1327824|NCT02196077|4360581|P1|Overall Study|Protocol Violation|24
1327825|NCT02196077|4360581|P1|Overall Study|Lost to Follow-up|3
1327826|NCT02196077|4360581|P1|Overall Study|Physician Decision|1
1327827|NCT02196077|4360581|P1|Overall Study|Withdrawal by Subject|14
1327828|NCT02196077|4360581|P1|Overall Study|Lack of Efficacy|1
1327829|NCT02196077|4360581|P1|Overall Study|Adverse Event|4
1327830|NCT02195986|4360631|P3|Overall Study|Non-compliance|0
1327831|NCT02195986|4360632|P2|Overall Study|Non-compliance|1
1327832|NCT02195986|4360633|P1|Overall Study|Non-compliance|0
1327833|NCT02195986|4360631|P3|Overall Study|Protocol Violation|1
1327834|NCT02195986|4360632|P2|Overall Study|Protocol Violation|1
1327835|NCT02195986|4360633|P1|Overall Study|Protocol Violation|0
1327836|NCT02195986|4360631|P3|Overall Study|Family Emergency|1
1327837|NCT02195986|4360632|P2|Overall Study|Family Emergency|0
1327838|NCT02195986|4360633|P1|Overall Study|Family Emergency|0
1327839|NCT02195986|4360631|P3|Overall Study|Withdrawal by Subject|0
1327840|NCT02195986|4360632|P2|Overall Study|Withdrawal by Subject|3
1327841|NCT02195986|4360633|P1|Overall Study|Withdrawal by Subject|0
1327842|NCT02195986|4360631|P3|Overall Study|Adverse Event|0
1327843|NCT02195986|4360632|P2|Overall Study|Adverse Event|0
1327844|NCT02195986|4360633|P1|Overall Study|Adverse Event|3
1327845|NCT02195700|4360659|P2|Overall Study|Lost to Follow-up|1
1327846|NCT02195700|4360660|P1|Overall Study|Lost to Follow-up|1
1327847|NCT02195700|4360659|P2|Overall Study|Withdrawal by Subject|2
1327848|NCT02195700|4360660|P1|Overall Study|Withdrawal by Subject|3
1327849|NCT02195700|4360659|P2|Overall Study|Adverse Event|2
1327850|NCT02195700|4360660|P1|Overall Study|Adverse Event|1
1327851|NCT02195700|4360659|P2|Overall Study|Noncompliance|0
1327852|NCT02195700|4360660|P1|Overall Study|Noncompliance|1
1327853|NCT02195700|4360659|P2|Overall Study|Protocol Violation|2
1327854|NCT02195700|4360660|P1|Overall Study|Protocol Violation|0
1327855|NCT02195687|4360682|P2|Overall Study|Lost to Follow-up|1
1327856|NCT02195687|4360683|P1|Overall Study|Lost to Follow-up|4
1327857|NCT02195687|4360682|P2|Overall Study|Personal Reasons|1
1327858|NCT02195687|4360683|P1|Overall Study|Personal Reasons|1
1327859|NCT02195583|4360699|P1|Overall Study|Other Reason|2
1327860|NCT02195583|4360699|P1|Overall Study|Adverse Event|2
1327861|NCT02195583|4360699|P1|Overall Study|Withdrawal by Subject|4
1327862|NCT02195583|4360699|P1|Overall Study|Lost to Follow-up|1
1327863|NCT02195427|4360733|P2|Overall Study|Conditional re-treatment at W52|1
1327864|NCT02195427|4360734|P1|Overall Study|Conditional re-treatment at W52|2
1327865|NCT02195427|4360733|P2|Overall Study|Protocol Violation|14
1327866|NCT02195427|4360734|P1|Overall Study|Protocol Violation|7
1327867|NCT02195427|4360733|P2|Overall Study|Lost to Follow-up|1
1327868|NCT02195427|4360734|P1|Overall Study|Lost to Follow-up|0
1327869|NCT02195427|4360733|P2|Overall Study|Withdrawal by Subject|2
1327870|NCT02195427|4360734|P1|Overall Study|Withdrawal by Subject|4
1327871|NCT02195427|4360733|P2|Overall Study|Did not consent to study extension|9
1327872|NCT02195427|4360734|P1|Overall Study|Did not consent to study extension|13
1327873|NCT02195011|4360805|P2|Overall Study|Withdrawal by Subject|0
1327874|NCT02195011|4360806|P1|Overall Study|Withdrawal by Subject|3
1327875|NCT02195011|4360805|P2|Overall Study|Progressive Disease|1
1327876|NCT02195011|4360806|P1|Overall Study|Progressive Disease|18
1327877|NCT02195011|4360805|P2|Overall Study|Adverse Event|0
1327878|NCT02195011|4360806|P1|Overall Study|Adverse Event|4
1327879|NCT02194699|4360820|P2|With Potential to Receive 52 Weeks of IP|Other|16
1327880|NCT02194699|4360821|P1|With Potential to Receive 52 Weeks of IP|Other|24
1327881|NCT02194699|4360820|P2|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
1327882|NCT02194699|4360821|P1|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
1327883|NCT02194699|4360820|P2|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
1327884|NCT02194699|4360821|P1|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
1327885|NCT02194699|4360820|P2|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
1327886|NCT02194699|4360821|P1|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
1327887|NCT02194699|4360820|P2|With Potential to Receive 52 Weeks of IP|Death|3
1327888|NCT02194699|4360821|P1|With Potential to Receive 52 Weeks of IP|Death|1
1327889|NCT02194699|4360820|P2|With Potential to Receive 52 Weeks of IP|Adverse Event|3
1327890|NCT02194699|4360821|P1|With Potential to Receive 52 Weeks of IP|Adverse Event|4
1327891|NCT02194699|4360820|P2|Randomised|Duplicate patient|1
1327892|NCT02194699|4360821|P1|Randomised|Duplicate patient|2
1327893|NCT02194699|4360820|P2|Randomised|Without potential for 52 weeks of IP|5
1327894|NCT02194699|4360821|P1|Randomised|Without potential for 52 weeks of IP|5
1327895|NCT02194699|4360820|P2|Randomised|Did not receive treatment|5
1327896|NCT02194699|4360821|P1|Randomised|Did not receive treatment|1
1327897|NCT02194621|4360929|P3|Overall Study|Withdrawal by Subject|7
1327898|NCT02194621|4360930|P2|Overall Study|Withdrawal by Subject|4
1327899|NCT02194621|4360931|P1|Overall Study|Withdrawal by Subject|4
1327900|NCT02194621|4360929|P3|Overall Study|6 withdrew prior to randomization|2
1327901|NCT02194621|4360930|P2|Overall Study|6 withdrew prior to randomization|2
1327902|NCT02194621|4360931|P1|Overall Study|6 withdrew prior to randomization|2
1327903|NCT02194062|4360964|P3|Overall Study|Lost to Follow-up|5
1327904|NCT02194062|4360965|P2|Overall Study|Lost to Follow-up|2
1327905|NCT02194062|4360966|P1|Overall Study|Lost to Follow-up|2
1327906|NCT02193828|4360981|P4|Overall Study|Withdrawal by Subject|1
1327907|NCT02193828|4360982|P3|Overall Study|Withdrawal by Subject|1
1327908|NCT02193828|4360983|P2|Overall Study|Withdrawal by Subject|0
1327909|NCT02193828|4360984|P1|Overall Study|Withdrawal by Subject|0
1327910|NCT02193178|4361057|P1|Overall Study|Dry eyes|1
1327911|NCT02193178|4361057|P1|Overall Study|Lost to Follow-up|1
1327912|NCT02193165|4361107|P3|6 Week Product Use|Lost to Follow-up|0
1327913|NCT02193165|4361108|P2|6 Week Product Use|Lost to Follow-up|1
1327914|NCT02193165|4361109|P1|6 Week Product Use|Lost to Follow-up|0
1327915|NCT02193165|4361107|P3|4 Week Product Use|Lost to Follow-up|1
1327916|NCT02193165|4361108|P2|4 Week Product Use|Lost to Follow-up|1
1327917|NCT02193165|4361109|P1|4 Week Product Use|Lost to Follow-up|1
1327918|NCT02193087|4361136|P4|Overall Study|Did Not Receive Any Vaccination|1
1327919|NCT02193087|4361137|P3|Overall Study|Did Not Receive Any Vaccination|0
1327920|NCT02193087|4361138|P2|Overall Study|Did Not Receive Any Vaccination|3
1327921|NCT02193087|4361139|P1|Overall Study|Did Not Receive Any Vaccination|2
1327922|NCT02193087|4361136|P4|Overall Study|Other Reason Not Specified|9
1327923|NCT02193087|4361137|P3|Overall Study|Other Reason Not Specified|1
1327924|NCT02193087|4361138|P2|Overall Study|Other Reason Not Specified|2
1327925|NCT02193087|4361139|P1|Overall Study|Other Reason Not Specified|7
1327926|NCT02193087|4361136|P4|Overall Study|Withdrawal by Subject|19
1327927|NCT02193087|4361137|P3|Overall Study|Withdrawal by Subject|1
1327928|NCT02193087|4361138|P2|Overall Study|Withdrawal by Subject|3
1327929|NCT02193087|4361139|P1|Overall Study|Withdrawal by Subject|10
1327930|NCT02193087|4361136|P4|Overall Study|Protocol Violation|2
1327931|NCT02193087|4361137|P3|Overall Study|Protocol Violation|1
1327932|NCT02193087|4361138|P2|Overall Study|Protocol Violation|0
1327933|NCT02193087|4361139|P1|Overall Study|Protocol Violation|2
1327934|NCT02193087|4361136|P4|Overall Study|Lost to Follow-up|37
1327935|NCT02193087|4361137|P3|Overall Study|Lost to Follow-up|4
1327936|NCT02193087|4361138|P2|Overall Study|Lost to Follow-up|6
1327937|NCT02193087|4361139|P1|Overall Study|Lost to Follow-up|14
1327938|NCT02193087|4361136|P4|Overall Study|Adverse Event|11
1327939|NCT02193087|4361137|P3|Overall Study|Adverse Event|0
1327940|NCT02193087|4361138|P2|Overall Study|Adverse Event|0
1327941|NCT02193087|4361139|P1|Overall Study|Adverse Event|2
1327942|NCT02193074|4361184|P2|Overall Study|Adverse Event|13
1327943|NCT02193074|4361185|P1|Overall Study|Adverse Event|16
1327944|NCT02193074|4361184|P2|Overall Study|Withdrawal by Subject|2
1327945|NCT02193074|4361185|P1|Overall Study|Withdrawal by Subject|1
1327946|NCT02192905|4361217|P1|Overall Study|Lost to Follow-up|1
1327947|NCT02192606|4361281|P2|Overall Study|3D equipment rep unable to join|1
1327948|NCT02192606|4361282|P1|Overall Study|3D equipment rep unable to join|0
1327949|NCT02192606|4361281|P2|Overall Study|Physician Decision|2
1327950|NCT02192606|4361282|P1|Overall Study|Physician Decision|1
1327951|NCT02192606|4361281|P2|Overall Study|surgery type was changed|1
1327952|NCT02192606|4361282|P1|Overall Study|surgery type was changed|1
1327953|NCT02192164|4361313|P1|Overall Study|Did not meet the exclusion criteria|1
1327954|NCT02192164|4361313|P1|Overall Study|Physician Decision|4
1327955|NCT02192164|4361313|P1|Overall Study|Withdrawal by Subject|1
1327956|NCT02192164|4361313|P1|Overall Study|Other|8
1327957|NCT02191605|4361359|P5|Overall Study|Lost to Follow-up|4
1327958|NCT02191605|4361360|P4|Overall Study|Lost to Follow-up|3
1327959|NCT02191605|4361361|P3|Overall Study|Lost to Follow-up|7
1327960|NCT02191605|4361362|P2|Overall Study|Lost to Follow-up|4
1327961|NCT02191605|4361363|P1|Overall Study|Lost to Follow-up|9
1327962|NCT02191579|4361382|P2|Treatment 2|Multiple Reasons Specified|25
1327963|NCT02191579|4361383|P1|Treatment 2|Multiple Reasons Specified|0
1327964|NCT02191579|4361382|P2|Treatment 1|Multiple Reasons Specified|58
1327965|NCT02191579|4361383|P1|Treatment 1|Multiple Reasons Specified|27
1327966|NCT02191267|4361398|P3|Overall Study|Withdrawal by Subject|0
1327967|NCT02191267|4361399|P2|Overall Study|Withdrawal by Subject|0
1327968|NCT02191267|4361400|P1|Overall Study|Withdrawal by Subject|1
1327969|NCT02191137|4361411|P1|Follow-up|Adverse Event|1
1327970|NCT02191137|4361411|P1|Follow-up|Ongoing/unknown|2
1327971|NCT02191137|4361411|P1|Follow-up|Lost to Follow-up|2
1327972|NCT02191137|4361411|P1|Treatment|Other|1
1327973|NCT02191137|4361411|P1|Treatment|Adverse Event|2
1327974|NCT02191137|4361411|P1|Treatment|Withdrawal by Subject|3
1327975|NCT02191137|4361411|P1|Treatment|Death|4
1327976|NCT02191046|4361441|P2|Overall Study|low compliance|1
1327977|NCT02191046|4361442|P1|Overall Study|low compliance|5
1327978|NCT02190721|4361473|P3|Overall Study|Patient was out of the city|0
1327979|NCT02190721|4361474|P2|Overall Study|Patient was out of the city|1
1327980|NCT02190721|4361475|P1|Overall Study|Patient was out of the city|0
1327981|NCT02190604|4361598|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327982|NCT02190604|4361599|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327983|NCT02190604|4361600|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327984|NCT02190604|4361601|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327985|NCT02190604|4361602|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327986|NCT02190604|4361603|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
1327987|NCT02190604|4361604|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327988|NCT02190604|4361605|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327989|NCT02190604|4361606|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327990|NCT02190604|4361607|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327991|NCT02190604|4361608|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327992|NCT02190604|4361609|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327993|NCT02190604|4361610|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327994|NCT02190604|4361611|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327995|NCT02190604|4361612|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327996|NCT02190604|4361613|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327997|NCT02190604|4361614|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327998|NCT02190604|4361615|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1327999|NCT02190604|4361616|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1328000|NCT02190604|4361598|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328001|NCT02190604|4361599|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328002|NCT02190604|4361600|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328003|NCT02190604|4361601|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328004|NCT02190604|4361602|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
1328005|NCT02190604|4361603|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328006|NCT02190604|4361604|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328007|NCT02190604|4361605|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328008|NCT02190604|4361606|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328009|NCT02190604|4361607|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328010|NCT02190604|4361608|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328011|NCT02190604|4361609|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328012|NCT02190604|4361610|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328013|NCT02190604|4361611|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328014|NCT02190604|4361612|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328015|NCT02190604|4361613|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328016|NCT02190604|4361614|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328017|NCT02190604|4361615|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328018|NCT02190604|4361616|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1328019|NCT02190591|4361807|P2|Overall Study|face presentation so she was ineligible|1
1328020|NCT02190591|4361808|P1|Overall Study|face presentation so she was ineligible|0
1328021|NCT02190591|4361807|P2|Overall Study|did not use peanut ball as instructed|2
1328022|NCT02190591|4361808|P1|Overall Study|did not use peanut ball as instructed|0
1328023|NCT02190591|4361807|P2|Overall Study|Protocol Violation|0
1328024|NCT02190591|4361808|P1|Overall Study|Protocol Violation|1
1328025|NCT02190591|4361807|P2|Overall Study|Withdrawal by Subject|8
1328026|NCT02190591|4361808|P1|Overall Study|Withdrawal by Subject|1
1328027|NCT02190435|4361820|P2|Overall Study|3 consented screen fails|0
1328028|NCT02190435|4361821|P1|Overall Study|3 consented screen fails|3
1328029|NCT02190435|4361820|P2|Overall Study|First 12 patients were lead-ins|0
1328030|NCT02190435|4361821|P1|Overall Study|First 12 patients were lead-ins|12
1328031|NCT02189941|4361840|P3|Overall Study|Non-compliance|1
1328032|NCT02189941|4361841|P2|Overall Study|Non-compliance|0
1328033|NCT02189941|4361842|P1|Overall Study|Non-compliance|0
1328034|NCT02189863|4361870|P2|First 2 Weeks|Motion Sickness|2
1328035|NCT02189863|4361871|P1|First 2 Weeks|Motion Sickness|4
1328036|NCT02189837|4361886|P4|Overall Study|Sponsor Decision|1
1328037|NCT02189837|4361887|P3|Overall Study|Sponsor Decision|0
1328038|NCT02189837|4361888|P2|Overall Study|Sponsor Decision|0
1328039|NCT02189837|4361889|P1|Overall Study|Sponsor Decision|0
1328040|NCT02189837|4361886|P4|Overall Study|Withdrawal by Subject|1
1328041|NCT02189837|4361887|P3|Overall Study|Withdrawal by Subject|3
1328042|NCT02189837|4361888|P2|Overall Study|Withdrawal by Subject|1
1328043|NCT02189837|4361889|P1|Overall Study|Withdrawal by Subject|2
1328044|NCT02189759|4361919|P4|Overall Study|Lost to Follow-up|5
1328045|NCT02189759|4361920|P3|Overall Study|Lost to Follow-up|2
1328046|NCT02189759|4361921|P2|Overall Study|Lost to Follow-up|0
1328047|NCT02189759|4361922|P1|Overall Study|Lost to Follow-up|0
1328048|NCT02189252|4361979|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
1328049|NCT02189252|4361980|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
1328050|NCT02189252|4361981|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
1328051|NCT02189252|4361982|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
1328052|NCT02189252|4361979|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
1328053|NCT02189252|4361980|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
1328054|NCT02189252|4361981|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
1328055|NCT02189252|4361982|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
1328056|NCT02188849|4362041|P2|Overall Study|Lost to Follow-up|8
1328057|NCT02188849|4362042|P1|Overall Study|Lost to Follow-up|3
1328058|NCT02188784|4362056|P2|Overall Study|Physician Decision|3
1328059|NCT02188784|4362057|P1|Overall Study|Physician Decision|2
1328060|NCT02188784|4362056|P2|Overall Study|Withdrawal by Subject|9
1328061|NCT02188784|4362057|P1|Overall Study|Withdrawal by Subject|3
1328062|NCT02188784|4362056|P2|Overall Study|Lost to Follow-up|0
1328063|NCT02188784|4362057|P1|Overall Study|Lost to Follow-up|1
1328064|NCT02188784|4362056|P2|Overall Study|Death|1
1328065|NCT02188784|4362057|P1|Overall Study|Death|3
1328066|NCT02187861|4362093|P4|Overall Study|Alive in Study Follow-Up|31
1328067|NCT02187861|4362094|P3|Overall Study|Alive in Study Follow-Up|26
1328068|NCT02187861|4362095|P2|Overall Study|Alive in Study Follow-Up|10
1328069|NCT02187861|4362096|P1|Overall Study|Alive in Study Follow-Up|4
1328070|NCT02187861|4362093|P4|Overall Study|Other|1
1328071|NCT02187861|4362094|P3|Overall Study|Other|6
1328072|NCT02187861|4362095|P2|Overall Study|Other|2
1328073|NCT02187861|4362096|P1|Overall Study|Other|0
1328074|NCT02187861|4362093|P4|Overall Study|Withdrawal by Subject|3
1328075|NCT02187861|4362094|P3|Overall Study|Withdrawal by Subject|2
1328076|NCT02187861|4362095|P2|Overall Study|Withdrawal by Subject|0
1328077|NCT02187861|4362096|P1|Overall Study|Withdrawal by Subject|0
1328078|NCT02187861|4362093|P4|Overall Study|Progressive Disease|11
1328079|NCT02187861|4362094|P3|Overall Study|Progressive Disease|13
1328080|NCT02187861|4362095|P2|Overall Study|Progressive Disease|35
1328081|NCT02187861|4362096|P1|Overall Study|Progressive Disease|3
1328082|NCT02187861|4362093|P4|Overall Study|Physician Decision|3
1328083|NCT02187861|4362094|P3|Overall Study|Physician Decision|0
1328084|NCT02187861|4362095|P2|Overall Study|Physician Decision|1
1328085|NCT02187861|4362096|P1|Overall Study|Physician Decision|0
1328086|NCT02187861|4362093|P4|Overall Study|Lack of Efficacy|0
1328087|NCT02187861|4362094|P3|Overall Study|Lack of Efficacy|0
1328088|NCT02187861|4362095|P2|Overall Study|Lack of Efficacy|1
1328089|NCT02187861|4362096|P1|Overall Study|Lack of Efficacy|0
1328090|NCT02187861|4362093|P4|Overall Study|Death|2
1328091|NCT02187861|4362094|P3|Overall Study|Death|1
1328092|NCT02187861|4362095|P2|Overall Study|Death|3
1328093|NCT02187861|4362096|P1|Overall Study|Death|0
1328094|NCT02187861|4362093|P4|Overall Study|Adverse Event|0
1328095|NCT02187861|4362094|P3|Overall Study|Adverse Event|3
1328096|NCT02187861|4362095|P2|Overall Study|Adverse Event|1
1328097|NCT02187861|4362096|P1|Overall Study|Adverse Event|2
1328098|NCT02187809|4362192|P1|Overall Study|The study was terminated|3
1328099|NCT02187744|4362204|P2|Treatment|Participant refused continued treatment|1
1328100|NCT02187744|4362205|P1|Treatment|Participant refused continued treatment|1
1328101|NCT02187744|4362204|P2|Treatment|Not specified|0
1328102|NCT02187744|4362205|P1|Treatment|Not specified|2
1328103|NCT02187744|4362204|P2|Treatment|Lost to Follow-up|1
1328104|NCT02187744|4362205|P1|Treatment|Lost to Follow-up|0
1328105|NCT02187744|4362204|P2|Treatment|Related adverse event, not serious|2
1328106|NCT02187744|4362205|P1|Treatment|Related adverse event, not serious|0
1328107|NCT02187744|4362204|P2|Treatment|Related adverse event, serious non-fatal|1
1328108|NCT02187744|4362205|P1|Treatment|Related adverse event, serious non-fatal|0
1328109|NCT02187744|4362204|P2|Treatment|Death|0
1328110|NCT02187744|4362205|P1|Treatment|Death|1
1328111|NCT02187744|4362204|P2|Study|Related adverse event, serious non-fatal|1
1328112|NCT02187744|4362205|P1|Study|Related adverse event, serious non-fatal|0
1328113|NCT02187744|4362204|P2|Study|Death|0
1328114|NCT02187744|4362205|P1|Study|Death|1
1328115|NCT02187744|4362204|P2|Study|Related adverse event, not serious|2
1328116|NCT02187744|4362205|P1|Study|Related adverse event, not serious|0
1328117|NCT02187744|4362204|P2|Study|Lost to Follow-up|2
1328118|NCT02187744|4362205|P1|Study|Lost to Follow-up|0
1328119|NCT02187744|4362204|P2|Study|Not specified|1
1328120|NCT02187744|4362205|P1|Study|Not specified|2
1328121|NCT02187744|4362204|P2|Study|Participant refused further follow-up|0
1328122|NCT02187744|4362205|P1|Study|Participant refused further follow-up|1
1328123|NCT02187055|4362224|P3|Overall Study|Death|0
1328124|NCT02187055|4362225|P2|Overall Study|Death|0
1328125|NCT02187055|4362226|P1|Overall Study|Death|2
1328126|NCT02187055|4362224|P3|Overall Study|Adverse Event|36
1328127|NCT02187055|4362225|P2|Overall Study|Adverse Event|26
1328128|NCT02187055|4362226|P1|Overall Study|Adverse Event|21
1328129|NCT02187055|4362224|P3|Overall Study|Withdrawal by Subject|11
1328130|NCT02187055|4362225|P2|Overall Study|Withdrawal by Subject|11
1328131|NCT02187055|4362226|P1|Overall Study|Withdrawal by Subject|11
1328132|NCT02187055|4362224|P3|Overall Study|Pregnancy|0
1328133|NCT02187055|4362225|P2|Overall Study|Pregnancy|1
1328134|NCT02187055|4362226|P1|Overall Study|Pregnancy|3
1328135|NCT02187055|4362224|P3|Overall Study|Protocol Violation|4
1328136|NCT02187055|4362225|P2|Overall Study|Protocol Violation|9
1328137|NCT02187055|4362226|P1|Overall Study|Protocol Violation|9
1328138|NCT02187055|4362224|P3|Overall Study|Other|3
1328139|NCT02187055|4362225|P2|Overall Study|Other|6
1328140|NCT02187055|4362226|P1|Overall Study|Other|5
1328141|NCT02187055|4362224|P3|Overall Study|No longer willing to participate|10
1328142|NCT02187055|4362225|P2|Overall Study|No longer willing to participate|8
1328143|NCT02187055|4362226|P1|Overall Study|No longer willing to participate|6
1328144|NCT02187055|4362224|P3|Overall Study|No longer meets eligibility criteria|0
1328145|NCT02187055|4362225|P2|Overall Study|No longer meets eligibility criteria|2
1328146|NCT02187055|4362226|P1|Overall Study|No longer meets eligibility criteria|0
1328147|NCT02187055|4362224|P3|Overall Study|Lost to Follow-up|3
1328148|NCT02187055|4362225|P2|Overall Study|Lost to Follow-up|7
1328149|NCT02187055|4362226|P1|Overall Study|Lost to Follow-up|2
1328150|NCT02187055|4362224|P3|Overall Study|Lack of Efficacy|7
1328151|NCT02187055|4362225|P2|Overall Study|Lack of Efficacy|3
1328152|NCT02187055|4362226|P1|Overall Study|Lack of Efficacy|10
1328153|NCT02187029|4362328|P4|Overall Study|Withdrawal by Subject|0
1328154|NCT02187029|4362329|P3|Overall Study|Withdrawal by Subject|0
1328155|NCT02187029|4362330|P2|Overall Study|Withdrawal by Subject|0
1328156|NCT02187029|4362331|P1|Overall Study|Withdrawal by Subject|1
1328157|NCT02187029|4362328|P4|Overall Study|Study Terminated by Sponsor|3
1328158|NCT02187029|4362329|P3|Overall Study|Study Terminated by Sponsor|10
1328159|NCT02187029|4362330|P2|Overall Study|Study Terminated by Sponsor|0
1328160|NCT02187029|4362331|P1|Overall Study|Study Terminated by Sponsor|0
1328161|NCT02187029|4362328|P4|Overall Study|Adverse Event|0
1328162|NCT02187029|4362329|P3|Overall Study|Adverse Event|1
1328163|NCT02187029|4362330|P2|Overall Study|Adverse Event|1
1328164|NCT02187029|4362331|P1|Overall Study|Adverse Event|0
1328165|NCT02186873|4362453|P2|Overall Study|Withdrawal by Subject|2
1328166|NCT02186873|4362454|P1|Overall Study|Withdrawal by Subject|7
1328167|NCT02186873|4362453|P2|Overall Study|Lost to Follow-up|2
1328168|NCT02186873|4362454|P1|Overall Study|Lost to Follow-up|1
1328169|NCT02186873|4362453|P2|Overall Study|Lack of Efficacy|1
1328170|NCT02186873|4362454|P1|Overall Study|Lack of Efficacy|0
1328171|NCT02186873|4362453|P2|Overall Study|Adverse Event|3
1328172|NCT02186873|4362454|P1|Overall Study|Adverse Event|1
1328173|NCT02186223|4362499|P1|Overall Study|Device in place less than 48 hours|9
1328174|NCT02186223|4362499|P1|Overall Study|Death|3
1328175|NCT02186223|4362499|P1|Overall Study|Unable to obtain femoral access|3
1328176|NCT02186223|4362499|P1|Overall Study|Not eligible for device placement|6
1328177|NCT02185534|4362529|P6|First Washout Period|Protocol Violation|1
1328178|NCT02185534|4362530|P5|First Washout Period|Protocol Violation|0
1328179|NCT02185534|4362531|P4|First Washout Period|Protocol Violation|0
1328180|NCT02185534|4362532|P3|First Washout Period|Protocol Violation|0
1328181|NCT02185534|4362533|P2|First Washout Period|Protocol Violation|0
1328182|NCT02185534|4362534|P1|First Washout Period|Protocol Violation|0
1328183|NCT02185534|4362529|P6|First Washout Period|Withdrawal by Subject|0
1328184|NCT02185534|4362530|P5|First Washout Period|Withdrawal by Subject|1
1328185|NCT02185534|4362531|P4|First Washout Period|Withdrawal by Subject|0
1328186|NCT02185534|4362532|P3|First Washout Period|Withdrawal by Subject|0
1328187|NCT02185534|4362533|P2|First Washout Period|Withdrawal by Subject|0
1328188|NCT02185534|4362534|P1|First Washout Period|Withdrawal by Subject|1
1328189|NCT02185534|4362529|P6|First Period|Withdrawal by Subject|0
1328190|NCT02185534|4362530|P5|First Period|Withdrawal by Subject|0
1328191|NCT02185534|4362531|P4|First Period|Withdrawal by Subject|1
1328192|NCT02185534|4362532|P3|First Period|Withdrawal by Subject|0
1328193|NCT02185534|4362533|P2|First Period|Withdrawal by Subject|0
1328194|NCT02185534|4362534|P1|First Period|Withdrawal by Subject|0
1328195|NCT02184572|4362685|P2|Overall Study|Withdrawal by Subject|9
1328196|NCT02184572|4362686|P1|Overall Study|Withdrawal by Subject|14
1328197|NCT02184572|4362685|P2|Overall Study|Traveling Outside The Country|0
1328198|NCT02184572|4362686|P1|Overall Study|Traveling Outside The Country|1
1328199|NCT02184572|4362685|P2|Overall Study|2nd blooddraw & diary card incomplete|0
1328200|NCT02184572|4362686|P1|Overall Study|2nd blooddraw & diary card incomplete|1
1328201|NCT02184572|4362685|P2|Overall Study|Loss Of Kaiser Insurance|0
1328202|NCT02184572|4362686|P1|Overall Study|Loss Of Kaiser Insurance|1
1328203|NCT02184572|4362685|P2|Overall Study|Family Out Of Country Until 9/29/2015|0
1328204|NCT02184572|4362686|P1|Overall Study|Family Out Of Country Until 9/29/2015|1
1328205|NCT02184572|4362685|P2|Overall Study|Lost to Follow-up|21
1328206|NCT02184572|4362686|P1|Overall Study|Lost to Follow-up|29
1328207|NCT02184442|4362749|P2|Overall Study|Withdrawal by Subject|11
1328208|NCT02184442|4362750|P1|Overall Study|Withdrawal by Subject|3
1328209|NCT02184442|4362749|P2|Overall Study|Death|65
1328210|NCT02184442|4362750|P1|Overall Study|Death|61
1328211|NCT02183675|4362774|P6|Treatment Period 2 (10 Days)|Adverse Event|2
1328212|NCT02183675|4362775|P5|Treatment Period 2 (10 Days)|Adverse Event|0
1328213|NCT02183675|4362776|P4|Treatment Period 2 (10 Days)|Adverse Event|0
1328214|NCT02183675|4362777|P3|Treatment Period 2 (10 Days)|Adverse Event|0
1328215|NCT02183675|4362778|P2|Treatment Period 2 (10 Days)|Adverse Event|0
1328216|NCT02183675|4362779|P1|Treatment Period 2 (10 Days)|Adverse Event|0
1328217|NCT02183519|4362803|P2|Overall Study|Did not respond to cough inducter|3
1328218|NCT02183519|4362804|P1|Overall Study|Did not respond to cough inducter|0
1328219|NCT02183519|4362803|P2|Overall Study|computer error|0
1328220|NCT02183519|4362804|P1|Overall Study|computer error|3
1328221|NCT02182999|4362812|P2|Overall Study|Physician Decision|0
1328222|NCT02182999|4362813|P1|Overall Study|Physician Decision|1
1328223|NCT02182999|4362812|P2|Overall Study|Adverse Event|3
1328224|NCT02182999|4362813|P1|Overall Study|Adverse Event|4
1328225|NCT02182895|4362829|P2|Overall Study|Discharged from hospital within 24 hours|4
1328226|NCT02182895|4362830|P1|Overall Study|Discharged from hospital within 24 hours|2
1328227|NCT02182830|4362852|P2|Overall Study|Lost to Follow-up|3
1328228|NCT02182830|4362853|P1|Overall Study|Lost to Follow-up|3
1328229|NCT02182830|4362852|P2|Overall Study|Consent withdrawn|8
1328230|NCT02182830|4362853|P1|Overall Study|Consent withdrawn|8
1328231|NCT02182830|4362852|P2|Overall Study|Trial stopped, reason missing|3
1328232|NCT02182830|4362853|P1|Overall Study|Trial stopped, reason missing|3
1328233|NCT02182830|4362852|P2|Overall Study|Not Treated|1
1328234|NCT02182830|4362853|P1|Overall Study|Not Treated|1
1328235|NCT02181790|4362890|P2|Overall Study|study terminated|0
1328236|NCT02181790|4362891|P1|Overall Study|study terminated|2
1328237|NCT02181673|4362901|P3|Week 24-Week 60|Physician Decision|1
1328238|NCT02181673|4362902|P2|Week 24-Week 60|Physician Decision|0
1328239|NCT02181673|4362903|P1|Week 24-Week 60|Physician Decision|0
1328240|NCT02181673|4362901|P3|Week 24-Week 60|Lost to Follow-up|1
1328241|NCT02181673|4362902|P2|Week 24-Week 60|Lost to Follow-up|0
1328242|NCT02181673|4362903|P1|Week 24-Week 60|Lost to Follow-up|0
1328243|NCT02181673|4362901|P3|Week 24-Week 60|Lack of Efficacy|1
1328244|NCT02181673|4362902|P2|Week 24-Week 60|Lack of Efficacy|0
1328245|NCT02181673|4362903|P1|Week 24-Week 60|Lack of Efficacy|0
1328246|NCT02181673|4362901|P3|Week 24-Week 60|Pregnancy|1
1328247|NCT02181673|4362902|P2|Week 24-Week 60|Pregnancy|0
1328248|NCT02181673|4362903|P1|Week 24-Week 60|Pregnancy|0
1328249|NCT02181673|4362901|P3|Week 24-Week 60|Withdrawal by Subject|2
1328250|NCT02181673|4362902|P2|Week 24-Week 60|Withdrawal by Subject|2
1328251|NCT02181673|4362903|P1|Week 24-Week 60|Withdrawal by Subject|0
1328252|NCT02181673|4362901|P3|Week 24-Week 60|Other|1
1328253|NCT02181673|4362902|P2|Week 24-Week 60|Other|2
1328254|NCT02181673|4362903|P1|Week 24-Week 60|Other|0
1328255|NCT02181673|4362901|P3|Week 24-Week 60|Adverse Event|10
1328256|NCT02181673|4362902|P2|Week 24-Week 60|Adverse Event|4
1328257|NCT02181673|4362903|P1|Week 24-Week 60|Adverse Event|0
1328258|NCT02181673|4362901|P3|Up to Week 24|Randomized not Treated|1
1328259|NCT02181673|4362902|P2|Up to Week 24|Randomized not Treated|0
1328260|NCT02181673|4362903|P1|Up to Week 24|Randomized not Treated|0
1328261|NCT02181673|4362901|P3|Up to Week 24|Other|3
1328262|NCT02181673|4362902|P2|Up to Week 24|Other|0
1328263|NCT02181673|4362903|P1|Up to Week 24|Other|2
1328264|NCT02181673|4362901|P3|Up to Week 24|Withdrawal by Subject|1
1328265|NCT02181673|4362902|P2|Up to Week 24|Withdrawal by Subject|0
1328266|NCT02181673|4362903|P1|Up to Week 24|Withdrawal by Subject|10
1328267|NCT02181673|4362901|P3|Up to Week 24|Physician Decision|3
1328268|NCT02181673|4362902|P2|Up to Week 24|Physician Decision|0
1328269|NCT02181673|4362903|P1|Up to Week 24|Physician Decision|0
1328270|NCT02181673|4362901|P3|Up to Week 24|Lost to Follow-up|0
1328271|NCT02181673|4362902|P2|Up to Week 24|Lost to Follow-up|0
1328272|NCT02181673|4362903|P1|Up to Week 24|Lost to Follow-up|1
1328273|NCT02181673|4362901|P3|Up to Week 24|Lack of Efficacy|0
1328274|NCT02181673|4362902|P2|Up to Week 24|Lack of Efficacy|0
1328275|NCT02181673|4362903|P1|Up to Week 24|Lack of Efficacy|1
1328276|NCT02181673|4362901|P3|Up to Week 24|Death|0
1328277|NCT02181673|4362902|P2|Up to Week 24|Death|0
1328278|NCT02181673|4362903|P1|Up to Week 24|Death|1
1328279|NCT02181673|4362901|P3|Up to Week 24|Adverse Event|3
1328280|NCT02181673|4362902|P2|Up to Week 24|Adverse Event|0
1328281|NCT02181673|4362903|P1|Up to Week 24|Adverse Event|2
1328282|NCT02181634|4362930|P1|Overall Study|Patient opted to proceed to surgery|1
1328283|NCT02181634|4362930|P1|Overall Study|Symptomatic progression|1
1328284|NCT02181634|4362930|P1|Overall Study|Max number of dose reduction|1
1328285|NCT02181634|4362930|P1|Overall Study|Ineligible|1
1328286|NCT02181634|4362930|P1|Overall Study|Treatment delayed greater than 4 weeks|3
1328287|NCT02181634|4362930|P1|Overall Study|Death|2
1328288|NCT02181634|4362930|P1|Overall Study|Withdrawal by Subject|5
1328289|NCT02181634|4362930|P1|Overall Study|Physician Decision|8
1328290|NCT02181634|4362930|P1|Overall Study|Adverse Event|17
1328291|NCT02181634|4362930|P1|Overall Study|Lack of Efficacy|33
1328292|NCT02181504|4362979|P3|Overall Study|Adverse Event|1
1328293|NCT02181504|4362980|P2|Overall Study|Adverse Event|1
1328294|NCT02181504|4362981|P1|Overall Study|Adverse Event|1
1328295|NCT02180438|4363091|P1|Overall Study|Lost to Follow-up|1
1328296|NCT02180061|4363113|P2|Overall Study|Physician Decision|0
1328297|NCT02180061|4363114|P1|Overall Study|Physician Decision|1
1328298|NCT02180061|4363113|P2|Overall Study|Progressive Disease|5
1328299|NCT02180061|4363114|P1|Overall Study|Progressive Disease|15
1328300|NCT02180061|4363113|P2|Overall Study|Clinical Progression|1
1328301|NCT02180061|4363114|P1|Overall Study|Clinical Progression|5
1328302|NCT02180061|4363113|P2|Overall Study|Adverse Event|2
1328303|NCT02180061|4363114|P1|Overall Study|Adverse Event|4
1328304|NCT02179398|4363167|P2|Overall Study|Lost to Follow-up|1
1328305|NCT02179398|4363168|P1|Overall Study|Lost to Follow-up|0
1328306|NCT02179398|4363167|P2|Overall Study|Lack of obligatory data|3
1328307|NCT02179398|4363168|P1|Overall Study|Lack of obligatory data|3
1328308|NCT02178995|4363188|P9|Open Label|Adverse Event|0
1328309|NCT02178995|4363189|P8|Open Label|Adverse Event|0
1328310|NCT02178995|4363190|P7|Open Label|Adverse Event|0
1328311|NCT02178995|4363191|P6|Open Label|Adverse Event|0
1328312|NCT02178995|4363192|P5|Open Label|Adverse Event|0
1328313|NCT02178995|4363193|P4|Open Label|Adverse Event|0
1328314|NCT02178995|4363194|P3|Open Label|Adverse Event|0
1328315|NCT02178995|4363195|P2|Open Label|Adverse Event|0
1328316|NCT02178995|4363196|P1|Open Label|Adverse Event|2
1328317|NCT02178995|4363188|P9|Double Blind|Lost to Follow-up|0
1328318|NCT02178995|4363189|P8|Double Blind|Lost to Follow-up|1
1328319|NCT02178995|4363190|P7|Double Blind|Lost to Follow-up|0
1328320|NCT02178995|4363191|P6|Double Blind|Lost to Follow-up|0
1328321|NCT02178995|4363192|P5|Double Blind|Lost to Follow-up|0
1328322|NCT02178995|4363193|P4|Double Blind|Lost to Follow-up|0
1328323|NCT02178995|4363194|P3|Double Blind|Lost to Follow-up|0
1328324|NCT02178995|4363195|P2|Double Blind|Lost to Follow-up|1
1328325|NCT02178995|4363196|P1|Double Blind|Lost to Follow-up|0
1328326|NCT02178995|4363188|P9|Double Blind|Adverse Event|1
1328327|NCT02178995|4363189|P8|Double Blind|Adverse Event|1
1328328|NCT02178995|4363190|P7|Double Blind|Adverse Event|0
1328329|NCT02178995|4363191|P6|Double Blind|Adverse Event|1
1328330|NCT02178995|4363192|P5|Double Blind|Adverse Event|0
1328331|NCT02178995|4363193|P4|Double Blind|Adverse Event|0
1328332|NCT02178995|4363194|P3|Double Blind|Adverse Event|0
1328333|NCT02178995|4363195|P2|Double Blind|Adverse Event|0
1328334|NCT02178995|4363196|P1|Double Blind|Adverse Event|0
1328335|NCT02178787|4363278|P2|Overall Study|Physician Decision|0
1328336|NCT02178787|4363279|P1|Overall Study|Physician Decision|1
1328337|NCT02178787|4363278|P2|Overall Study|No TCD window|7
1328338|NCT02178787|4363279|P1|Overall Study|No TCD window|3
1328339|NCT02178787|4363278|P2|Overall Study|Withdrawal by Subject|2
1328340|NCT02178787|4363279|P1|Overall Study|Withdrawal by Subject|0
1328341|NCT02178787|4363278|P2|Overall Study|Lost to Follow-up|0
1328342|NCT02178787|4363279|P1|Overall Study|Lost to Follow-up|1
1328343|NCT02178475|4363308|P1|Overall Study|Protocol-specified Criteria|99
1328344|NCT02178475|4363308|P1|Overall Study|Death|13
1328345|NCT02178475|4363308|P1|Overall Study|Lost to Follow-up|10
1328346|NCT02178475|4363308|P1|Overall Study|Withdrawal by Subject|7
1328347|NCT02178059|4363328|P2|Washout|Physician Decision|0
1328348|NCT02178059|4363329|P1|Washout|Physician Decision|1
1328349|NCT02177266|4363347|P2|Overall Study|Withdrawal by Subject|0
1328350|NCT02177266|4363348|P1|Overall Study|Withdrawal by Subject|1
1328351|NCT02177266|4363347|P2|Overall Study|Adverse Event|1
1328352|NCT02177266|4363348|P1|Overall Study|Adverse Event|0
1328353|NCT02177136|4363370|P3|Overall Study|Protocol Violation|1
1328354|NCT02177136|4363371|P2|Overall Study|Protocol Violation|0
1328355|NCT02177136|4363372|P1|Overall Study|Protocol Violation|0
1328356|NCT02177136|4363370|P3|Overall Study|Adverse Event|3
1328357|NCT02177136|4363371|P2|Overall Study|Adverse Event|2
1328358|NCT02177136|4363372|P1|Overall Study|Adverse Event|3
1328359|NCT02177136|4363370|P3|Overall Study|Discontinued due to pruritus|0
1328360|NCT02177136|4363371|P2|Overall Study|Discontinued due to pruritus|3
1328361|NCT02177136|4363372|P1|Overall Study|Discontinued due to pruritus|1
1328362|NCT02177136|4363370|P3|Overall Study|Withdrawal by Subject|0
1328363|NCT02177136|4363371|P2|Overall Study|Withdrawal by Subject|0
1328364|NCT02177136|4363372|P1|Overall Study|Withdrawal by Subject|2
1328365|NCT02177032|4363405|P4|Overall Study|Withdrawal by Subject|0
1328366|NCT02177032|4363406|P3|Overall Study|Withdrawal by Subject|1
1328367|NCT02177032|4363407|P2|Overall Study|Withdrawal by Subject|0
1328368|NCT02177032|4363408|P1|Overall Study|Withdrawal by Subject|1
1328369|NCT02177032|4363405|P4|Overall Study|OTHER|0
1328370|NCT02177032|4363406|P3|Overall Study|OTHER|1
1328371|NCT02177032|4363407|P2|Overall Study|OTHER|0
1328372|NCT02177032|4363408|P1|Overall Study|OTHER|2
1328373|NCT02177032|4363405|P4|Overall Study|Lost to Follow-up|0
1328374|NCT02177032|4363406|P3|Overall Study|Lost to Follow-up|0
1328375|NCT02177032|4363407|P2|Overall Study|Lost to Follow-up|2
1328376|NCT02177032|4363408|P1|Overall Study|Lost to Follow-up|0
1328377|NCT02177032|4363405|P4|Overall Study|ADMINISTRATIVE REASON|0
1328378|NCT02177032|4363406|P3|Overall Study|ADMINISTRATIVE REASON|1
1328379|NCT02177032|4363407|P2|Overall Study|ADMINISTRATIVE REASON|0
1328380|NCT02177032|4363408|P1|Overall Study|ADMINISTRATIVE REASON|2
1328381|NCT02176655|4363446|P1|Overall Study|Subjects did not treat|6
1328382|NCT02176642|4363469|P2|Overall Study|Withdrawal by Subject|1
1328383|NCT02176642|4363470|P1|Overall Study|Withdrawal by Subject|0
1328384|NCT02176525|4363500|P8|Overall Study|not treated|0
1328385|NCT02176525|4363501|P7|Overall Study|not treated|0
1328386|NCT02176525|4363502|P6|Overall Study|not treated|1
1328387|NCT02176525|4363503|P5|Overall Study|not treated|0
1328388|NCT02176525|4363504|P4|Overall Study|not treated|0
1328389|NCT02176525|4363505|P3|Overall Study|not treated|0
1328390|NCT02176525|4363506|P2|Overall Study|not treated|0
1328391|NCT02176525|4363507|P1|Overall Study|not treated|1
1328392|NCT02176525|4363500|P8|Overall Study|Adverse Event|0
1328393|NCT02176525|4363501|P7|Overall Study|Adverse Event|1
1328394|NCT02176525|4363502|P6|Overall Study|Adverse Event|0
1328395|NCT02176525|4363503|P5|Overall Study|Adverse Event|1
1328396|NCT02176525|4363504|P4|Overall Study|Adverse Event|1
1328397|NCT02176525|4363505|P3|Overall Study|Adverse Event|0
1328398|NCT02176525|4363506|P2|Overall Study|Adverse Event|0
1328399|NCT02176525|4363507|P1|Overall Study|Adverse Event|0
1328400|NCT02176421|4363684|P1|Overall Study|Adverse Event|1
1328401|NCT02176421|4363684|P1|Overall Study|Lost to Follow-up|4
1328402|NCT02176356|4363693|P1|Overall Study|Other Miscellaneous Reasons|2
1328403|NCT02176356|4363693|P1|Overall Study|Personal Reasons|3
1328404|NCT02176356|4363693|P1|Overall Study|Lost to Follow-up|4
1328405|NCT02176356|4363693|P1|Overall Study|Screen Failure|14
1328406|NCT02176291|4363723|P2|Overall Study|Withdrawal by Subject|0
1328407|NCT02176291|4363724|P1|Overall Study|Withdrawal by Subject|2
1328408|NCT02176291|4363723|P2|Overall Study|non compliance with protocol|0
1328409|NCT02176291|4363724|P1|Overall Study|non compliance with protocol|2
1328410|NCT02176291|4363723|P2|Overall Study|Death|0
1328411|NCT02176291|4363724|P1|Overall Study|Death|1
1328412|NCT02176018|4363734|P2|Overall Study|Withdrawal by Subject|2
1328413|NCT02176018|4363735|P1|Overall Study|Withdrawal by Subject|1
1328414|NCT02176018|4363734|P2|Overall Study|Protocol Violation|1
1328415|NCT02176018|4363735|P1|Overall Study|Protocol Violation|1
1328416|NCT02176018|4363734|P2|Overall Study|Lost to Follow-up|1
1328417|NCT02176018|4363735|P1|Overall Study|Lost to Follow-up|3
1328418|NCT02176018|4363734|P2|Overall Study|Adverse Event|2
1328419|NCT02176018|4363735|P1|Overall Study|Adverse Event|0
1328420|NCT02175771|4363767|P9|Treatment Period|Not specified|0
1328421|NCT02175771|4363768|P8|Treatment Period|Not specified|2
1328422|NCT02175771|4363769|P7|Treatment Period|Not specified|0
1328423|NCT02175771|4363770|P6|Treatment Period|Not specified|0
1328424|NCT02175771|4363771|P5|Treatment Period|Not specified|1
1328425|NCT02175771|4363772|P4|Treatment Period|Not specified|3
1328426|NCT02175771|4363773|P3|Treatment Period|Not specified|0
1328427|NCT02175771|4363774|P2|Treatment Period|Not specified|1
1328428|NCT02175771|4363775|P1|Treatment Period|Not specified|0
1328429|NCT02175771|4363767|P9|Treatment Period|Lack of Efficacy|0
1328430|NCT02175771|4363768|P8|Treatment Period|Lack of Efficacy|1
1328431|NCT02175771|4363769|P7|Treatment Period|Lack of Efficacy|0
1328432|NCT02175771|4363770|P6|Treatment Period|Lack of Efficacy|1
1328433|NCT02175771|4363771|P5|Treatment Period|Lack of Efficacy|0
1328434|NCT02175771|4363772|P4|Treatment Period|Lack of Efficacy|0
1328435|NCT02175771|4363773|P3|Treatment Period|Lack of Efficacy|0
1328436|NCT02175771|4363774|P2|Treatment Period|Lack of Efficacy|0
1328437|NCT02175771|4363775|P1|Treatment Period|Lack of Efficacy|0
1328438|NCT02175771|4363767|P9|Treatment Period|Lost to Follow-up|2
1328439|NCT02175771|4363768|P8|Treatment Period|Lost to Follow-up|2
1328440|NCT02175771|4363769|P7|Treatment Period|Lost to Follow-up|1
1328441|NCT02175771|4363770|P6|Treatment Period|Lost to Follow-up|2
1328442|NCT02175771|4363771|P5|Treatment Period|Lost to Follow-up|1
1328443|NCT02175771|4363772|P4|Treatment Period|Lost to Follow-up|3
1328444|NCT02175771|4363773|P3|Treatment Period|Lost to Follow-up|1
1328445|NCT02175771|4363774|P2|Treatment Period|Lost to Follow-up|3
1328446|NCT02175771|4363775|P1|Treatment Period|Lost to Follow-up|0
1328447|NCT02175771|4363767|P9|Treatment Period|Disease progression|0
1328448|NCT02175771|4363768|P8|Treatment Period|Disease progression|2
1328449|NCT02175771|4363769|P7|Treatment Period|Disease progression|0
1328450|NCT02175771|4363770|P6|Treatment Period|Disease progression|0
1328451|NCT02175771|4363771|P5|Treatment Period|Disease progression|0
1328452|NCT02175771|4363772|P4|Treatment Period|Disease progression|0
1328453|NCT02175771|4363773|P3|Treatment Period|Disease progression|0
1328454|NCT02175771|4363774|P2|Treatment Period|Disease progression|0
1328455|NCT02175771|4363775|P1|Treatment Period|Disease progression|0
1328456|NCT02175771|4363767|P9|Treatment Period|Protocol Violation|0
1328457|NCT02175771|4363768|P8|Treatment Period|Protocol Violation|1
1328458|NCT02175771|4363769|P7|Treatment Period|Protocol Violation|0
1328459|NCT02175771|4363770|P6|Treatment Period|Protocol Violation|0
1328460|NCT02175771|4363771|P5|Treatment Period|Protocol Violation|0
1328461|NCT02175771|4363772|P4|Treatment Period|Protocol Violation|0
1328462|NCT02175771|4363773|P3|Treatment Period|Protocol Violation|0
1328463|NCT02175771|4363774|P2|Treatment Period|Protocol Violation|0
1328464|NCT02175771|4363775|P1|Treatment Period|Protocol Violation|0
1328465|NCT02175771|4363767|P9|Treatment Period|Noncompliance|1
1328466|NCT02175771|4363768|P8|Treatment Period|Noncompliance|0
1328467|NCT02175771|4363769|P7|Treatment Period|Noncompliance|0
1328468|NCT02175771|4363770|P6|Treatment Period|Noncompliance|0
1328469|NCT02175771|4363771|P5|Treatment Period|Noncompliance|0
1328470|NCT02175771|4363772|P4|Treatment Period|Noncompliance|0
1328471|NCT02175771|4363773|P3|Treatment Period|Noncompliance|2
1328472|NCT02175771|4363774|P2|Treatment Period|Noncompliance|1
1328473|NCT02175771|4363775|P1|Treatment Period|Noncompliance|0
1328474|NCT02175771|4363767|P9|Treatment Period|Withdrawal by Subject|2
1328475|NCT02175771|4363768|P8|Treatment Period|Withdrawal by Subject|9
1328476|NCT02175771|4363769|P7|Treatment Period|Withdrawal by Subject|2
1328477|NCT02175771|4363770|P6|Treatment Period|Withdrawal by Subject|4
1328478|NCT02175771|4363771|P5|Treatment Period|Withdrawal by Subject|2
1328479|NCT02175771|4363772|P4|Treatment Period|Withdrawal by Subject|6
1328480|NCT02175771|4363773|P3|Treatment Period|Withdrawal by Subject|3
1328481|NCT02175771|4363774|P2|Treatment Period|Withdrawal by Subject|9
1328482|NCT02175771|4363775|P1|Treatment Period|Withdrawal by Subject|0
1328483|NCT02175771|4363767|P9|Treatment Period|Adverse Event|1
1328484|NCT02175771|4363768|P8|Treatment Period|Adverse Event|0
1328485|NCT02175771|4363769|P7|Treatment Period|Adverse Event|2
1328486|NCT02175771|4363770|P6|Treatment Period|Adverse Event|3
1328487|NCT02175771|4363771|P5|Treatment Period|Adverse Event|1
1328488|NCT02175771|4363772|P4|Treatment Period|Adverse Event|1
1328489|NCT02175771|4363773|P3|Treatment Period|Adverse Event|1
1328490|NCT02175771|4363774|P2|Treatment Period|Adverse Event|2
1328491|NCT02175771|4363775|P1|Treatment Period|Adverse Event|0
1328492|NCT02175771|4363767|P9|Run-In Period (Pre-assignment)|Not specified|0
1328493|NCT02175771|4363768|P8|Run-In Period (Pre-assignment)|Not specified|0
1328494|NCT02175771|4363769|P7|Run-In Period (Pre-assignment)|Not specified|0
1328495|NCT02175771|4363770|P6|Run-In Period (Pre-assignment)|Not specified|0
1328496|NCT02175771|4363771|P5|Run-In Period (Pre-assignment)|Not specified|0
1328497|NCT02175771|4363772|P4|Run-In Period (Pre-assignment)|Not specified|0
1328498|NCT02175771|4363773|P3|Run-In Period (Pre-assignment)|Not specified|0
1328499|NCT02175771|4363774|P2|Run-In Period (Pre-assignment)|Not specified|0
1328500|NCT02175771|4363775|P1|Run-In Period (Pre-assignment)|Not specified|8
1328501|NCT02175771|4363767|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1328502|NCT02175771|4363768|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1328503|NCT02175771|4363769|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1328504|NCT02175771|4363770|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1328505|NCT02175771|4363771|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1328506|NCT02175771|4363772|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1328507|NCT02175771|4363773|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1328508|NCT02175771|4363774|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1328509|NCT02175771|4363775|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
1328510|NCT02175771|4363767|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1328511|NCT02175771|4363768|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1328512|NCT02175771|4363769|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1328513|NCT02175771|4363770|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1328514|NCT02175771|4363771|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1328515|NCT02175771|4363772|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1328516|NCT02175771|4363773|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1328517|NCT02175771|4363774|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1328518|NCT02175771|4363775|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
1328519|NCT02175771|4363767|P9|Run-In Period (Pre-assignment)|Adverse Event|0
1328520|NCT02175771|4363768|P8|Run-In Period (Pre-assignment)|Adverse Event|0
1328521|NCT02175771|4363769|P7|Run-In Period (Pre-assignment)|Adverse Event|0
1328522|NCT02175771|4363770|P6|Run-In Period (Pre-assignment)|Adverse Event|0
1328523|NCT02175771|4363771|P5|Run-In Period (Pre-assignment)|Adverse Event|0
1328524|NCT02175771|4363772|P4|Run-In Period (Pre-assignment)|Adverse Event|0
1328525|NCT02175771|4363773|P3|Run-In Period (Pre-assignment)|Adverse Event|0
1328526|NCT02175771|4363774|P2|Run-In Period (Pre-assignment)|Adverse Event|0
1328527|NCT02175771|4363775|P1|Run-In Period (Pre-assignment)|Adverse Event|9
1328528|NCT02175771|4363767|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1328529|NCT02175771|4363768|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1328530|NCT02175771|4363769|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1328531|NCT02175771|4363770|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1328532|NCT02175771|4363771|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1328533|NCT02175771|4363772|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1328534|NCT02175771|4363773|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1328535|NCT02175771|4363774|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1328536|NCT02175771|4363775|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
1328537|NCT02175771|4363767|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1328538|NCT02175771|4363768|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1328539|NCT02175771|4363769|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1328540|NCT02175771|4363770|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1328541|NCT02175771|4363771|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1328542|NCT02175771|4363772|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1328543|NCT02175771|4363773|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1328544|NCT02175771|4363774|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1328545|NCT02175771|4363775|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
1328546|NCT02175771|4363767|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1328547|NCT02175771|4363768|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1328548|NCT02175771|4363769|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1328549|NCT02175771|4363770|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1328550|NCT02175771|4363771|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1328551|NCT02175771|4363772|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1328552|NCT02175771|4363773|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1328553|NCT02175771|4363774|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1328554|NCT02175771|4363775|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
1328555|NCT02175745|4363833|P1|Overall Study|Not Eligible|1
1328556|NCT02175368|4363838|P1|Overall Study|Lost to Follow-up|1
1328557|NCT02175199|4363861|P2|Overall Study|Sponsor Decision|0
1328558|NCT02175199|4363862|P1|Overall Study|Sponsor Decision|1
1328559|NCT02175199|4363861|P2|Overall Study|Randomized in Error|0
1328560|NCT02175199|4363862|P1|Overall Study|Randomized in Error|1
1328561|NCT02175199|4363861|P2|Overall Study|Withdrawal by Subject|5
1328562|NCT02175199|4363862|P1|Overall Study|Withdrawal by Subject|1
1328563|NCT02175121|4363876|P5|Overall Study|Time issues|0
1328564|NCT02175121|4363877|P4|Overall Study|Time issues|0
1328565|NCT02175121|4363878|P3|Overall Study|Time issues|1
1328566|NCT02175121|4363879|P2|Overall Study|Time issues|0
1328567|NCT02175121|4363880|P1|Overall Study|Time issues|0
1328568|NCT02175121|4363876|P5|Overall Study|Schedule conflict|0
1328569|NCT02175121|4363877|P4|Overall Study|Schedule conflict|0
1328570|NCT02175121|4363878|P3|Overall Study|Schedule conflict|1
1328571|NCT02175121|4363879|P2|Overall Study|Schedule conflict|0
1328572|NCT02175121|4363880|P1|Overall Study|Schedule conflict|0
1328573|NCT02175121|4363876|P5|Overall Study|Personal emergency|1
1328574|NCT02175121|4363877|P4|Overall Study|Personal emergency|0
1328575|NCT02175121|4363878|P3|Overall Study|Personal emergency|0
1328576|NCT02175121|4363879|P2|Overall Study|Personal emergency|0
1328577|NCT02175121|4363880|P1|Overall Study|Personal emergency|0
1328578|NCT02175121|4363876|P5|Overall Study|Lost to Follow-up|0
1328579|NCT02175121|4363877|P4|Overall Study|Lost to Follow-up|1
1328580|NCT02175121|4363878|P3|Overall Study|Lost to Follow-up|0
1328581|NCT02175121|4363879|P2|Overall Study|Lost to Follow-up|1
1328582|NCT02175121|4363880|P1|Overall Study|Lost to Follow-up|0
1328583|NCT02175121|4363876|P5|Overall Study|Lack of Efficacy|0
1328584|NCT02175121|4363877|P4|Overall Study|Lack of Efficacy|0
1328585|NCT02175121|4363878|P3|Overall Study|Lack of Efficacy|0
1328586|NCT02175121|4363879|P2|Overall Study|Lack of Efficacy|0
1328587|NCT02175121|4363880|P1|Overall Study|Lack of Efficacy|1
1328588|NCT02174861|4364007|P1|Overall Study|Lost to Follow-up|26
1328589|NCT02174861|4364007|P1|Overall Study|Withdrawal by Subject|124
1328590|NCT02174861|4364007|P1|Overall Study|Decision by sponsor|8
1328591|NCT02173769|4364019|P1|Overall Study|Protocol Violation|4
1328592|NCT02173704|4364032|P2|Overall Study|Withdrawal by Subject|4
1328593|NCT02173704|4364033|P1|Overall Study|Withdrawal by Subject|9
1328594|NCT02173704|4364032|P2|Overall Study|Protocol Violation|0
1328595|NCT02173704|4364033|P1|Overall Study|Protocol Violation|1
1328596|NCT02173704|4364032|P2|Overall Study|Other|0
1328597|NCT02173704|4364033|P1|Overall Study|Other|1
1328598|NCT02173704|4364032|P2|Overall Study|Lost to Follow-up|0
1328599|NCT02173704|4364033|P1|Overall Study|Lost to Follow-up|1
1328600|NCT02173704|4364032|P2|Overall Study|Adverse Event|0
1328601|NCT02173704|4364033|P1|Overall Study|Adverse Event|1
1328602|NCT02173548|4364059|P2|Overall Study|Withdrawal by Subject|0
1328603|NCT02173548|4364060|P1|Overall Study|Withdrawal by Subject|1
1328604|NCT02173548|4364059|P2|Overall Study|Lost to Follow-up|2
1328605|NCT02173548|4364060|P1|Overall Study|Lost to Follow-up|0
1328606|NCT02173379|4364171|P2|Overall Study|Withdrawn by the physician|1
1328607|NCT02173379|4364172|P1|Overall Study|Withdrawn by the physician|0
1328608|NCT02173379|4364171|P2|Overall Study|Death|1
1328609|NCT02173379|4364172|P1|Overall Study|Death|1
1328610|NCT02173379|4364171|P2|Overall Study|Physician Decision|1
1328611|NCT02173379|4364172|P1|Overall Study|Physician Decision|4
1328612|NCT02173379|4364171|P2|Overall Study|Withdrawal by Subject|4
1328613|NCT02173379|4364172|P1|Overall Study|Withdrawal by Subject|1
1328614|NCT02173379|4364171|P2|Overall Study|Lost to Follow-up|0
1328615|NCT02173379|4364172|P1|Overall Study|Lost to Follow-up|3
1328616|NCT02173054|4364241|P3|Overall Study|Withdrawal by Subject|1
1328617|NCT02173054|4364242|P2|Overall Study|Withdrawal by Subject|0
1328618|NCT02173054|4364243|P1|Overall Study|Withdrawal by Subject|0
1328619|NCT02173054|4364241|P3|Overall Study|lack of compliance|0
1328620|NCT02173054|4364242|P2|Overall Study|lack of compliance|0
1328621|NCT02173054|4364243|P1|Overall Study|lack of compliance|1
1328622|NCT02172625|4364288|P2|Overall Study|car accident|1
1328623|NCT02172625|4364289|P1|Overall Study|car accident|0
1328624|NCT02172625|4364288|P2|Overall Study|Pregnancy|1
1328625|NCT02172625|4364289|P1|Overall Study|Pregnancy|0
1328626|NCT02172625|4364288|P2|Overall Study|Adverse Event|1
1328627|NCT02172625|4364289|P1|Overall Study|Adverse Event|0
1328628|NCT02172040|4364311|P4|Overall Study|Family emergency abroad|1
1328629|NCT02172040|4364312|P3|Overall Study|Family emergency abroad|0
1328630|NCT02172040|4364313|P2|Overall Study|Family emergency abroad|0
1328631|NCT02172040|4364314|P1|Overall Study|Family emergency abroad|0
1328632|NCT02172040|4364311|P4|Overall Study|Not available for Day 13 & 14 visits|0
1328633|NCT02172040|4364312|P3|Overall Study|Not available for Day 13 & 14 visits|1
1328634|NCT02172040|4364313|P2|Overall Study|Not available for Day 13 & 14 visits|0
1328635|NCT02172040|4364314|P1|Overall Study|Not available for Day 13 & 14 visits|0
1328636|NCT02172040|4364311|P4|Overall Study|Withdrawal by Subject|0
1328637|NCT02172040|4364312|P3|Overall Study|Withdrawal by Subject|1
1328638|NCT02172040|4364313|P2|Overall Study|Withdrawal by Subject|0
1328639|NCT02172040|4364314|P1|Overall Study|Withdrawal by Subject|0
1328640|NCT02172040|4364311|P4|Overall Study|Protocol Violation|0
1328641|NCT02172040|4364312|P3|Overall Study|Protocol Violation|0
1328642|NCT02172040|4364313|P2|Overall Study|Protocol Violation|1
1328643|NCT02172040|4364314|P1|Overall Study|Protocol Violation|0
1328644|NCT02172040|4364311|P4|Overall Study|Adverse Event|0
1328645|NCT02172040|4364312|P3|Overall Study|Adverse Event|0
1328646|NCT02172040|4364313|P2|Overall Study|Adverse Event|2
1328647|NCT02172040|4364314|P1|Overall Study|Adverse Event|0
1328648|NCT02170779|4364516|P2|Overall Study|Lost to Follow-up|1
1328649|NCT02170779|4364517|P1|Overall Study|Lost to Follow-up|0
1328650|NCT02170779|4364516|P2|Overall Study|Withdrawal by Subject|0
1328651|NCT02170779|4364517|P1|Overall Study|Withdrawal by Subject|1
1328652|NCT02170688|4364544|P5|Overall Study|Physician Decision|0
1328653|NCT02170688|4364545|P4|Overall Study|Physician Decision|0
1328654|NCT02170688|4364546|P3|Overall Study|Physician Decision|1
1328655|NCT02170688|4364547|P2|Overall Study|Physician Decision|0
1328656|NCT02170688|4364548|P1|Overall Study|Physician Decision|0
1328657|NCT02170688|4364544|P5|Overall Study|Full dose not received|0
1328658|NCT02170688|4364545|P4|Overall Study|Full dose not received|0
1328659|NCT02170688|4364546|P3|Overall Study|Full dose not received|0
1328660|NCT02170688|4364547|P2|Overall Study|Full dose not received|1
1328661|NCT02170688|4364548|P1|Overall Study|Full dose not received|0
1328662|NCT02170688|4364544|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
1328663|NCT02170688|4364545|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
1328664|NCT02170688|4364546|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
1328665|NCT02170688|4364547|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
1328666|NCT02170688|4364548|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
1328667|NCT02170207|4364721|P1|Overall Study|Case report forms unavailable|5
1328668|NCT02170077|4364732|P3|Overall Study|Exacerbation of seizures|1
1328669|NCT02170077|4364733|P2|Overall Study|Exacerbation of seizures|2
1328670|NCT02170077|4364734|P1|Overall Study|Exacerbation of seizures|0
1328671|NCT02170077|4364732|P3|Overall Study|Exclusion criteria|5
1328672|NCT02170077|4364733|P2|Overall Study|Exclusion criteria|2
1328673|NCT02170077|4364734|P1|Overall Study|Exclusion criteria|2
1328674|NCT02170077|4364732|P3|Overall Study|Lost to Follow-up|0
1328675|NCT02170077|4364733|P2|Overall Study|Lost to Follow-up|1
1328676|NCT02170077|4364734|P1|Overall Study|Lost to Follow-up|0
1328677|NCT02170077|4364732|P3|Overall Study|Adverse Event|4
1328678|NCT02170077|4364733|P2|Overall Study|Adverse Event|4
1328679|NCT02170077|4364734|P1|Overall Study|Adverse Event|4
1328680|NCT02170077|4364732|P3|Overall Study|Withdrawal by Subject|2
1328681|NCT02170077|4364733|P2|Overall Study|Withdrawal by Subject|4
1328682|NCT02170077|4364734|P1|Overall Study|Withdrawal by Subject|3
1328683|NCT02170064|4364745|P3|Overall Study|Physician Decision|0
1328684|NCT02170064|4364746|P2|Overall Study|Physician Decision|1
1328685|NCT02170064|4364747|P1|Overall Study|Physician Decision|1
1328686|NCT02170064|4364745|P3|Overall Study|Withdrawal by Subject|1
1328687|NCT02170064|4364746|P2|Overall Study|Withdrawal by Subject|1
1328688|NCT02170064|4364747|P1|Overall Study|Withdrawal by Subject|5
1328689|NCT02170025|4364763|P2|Overall Study|Adverse Event|0
1328690|NCT02170025|4364764|P1|Overall Study|Adverse Event|2
1328691|NCT02169414|4364912|P4|Overall Study|Adverse Event|0
1328692|NCT02169414|4364913|P3|Overall Study|Adverse Event|0
1328693|NCT02169414|4364914|P2|Overall Study|Adverse Event|1
1328694|NCT02169414|4364915|P1|Overall Study|Adverse Event|0
1328695|NCT02169414|4364912|P4|Overall Study|Withdrawal by Subject|0
1328696|NCT02169414|4364913|P3|Overall Study|Withdrawal by Subject|0
1328697|NCT02169414|4364914|P2|Overall Study|Withdrawal by Subject|0
1328698|NCT02169414|4364915|P1|Overall Study|Withdrawal by Subject|1
1328699|NCT02169336|4364956|P3|Overall Study|Subject declined to continue dosing|1
1328700|NCT02169336|4364957|P2|Overall Study|Subject declined to continue dosing|0
1328701|NCT02169336|4364958|P1|Overall Study|Subject declined to continue dosing|0
1328702|NCT02169336|4364956|P3|Overall Study|Physician Decision|1
1328703|NCT02169336|4364957|P2|Overall Study|Physician Decision|0
1328704|NCT02169336|4364958|P1|Overall Study|Physician Decision|0
1328705|NCT02169336|4364956|P3|Overall Study|Withdrawal by Subject|0
1328706|NCT02169336|4364957|P2|Overall Study|Withdrawal by Subject|0
1328707|NCT02169336|4364958|P1|Overall Study|Withdrawal by Subject|1
1328708|NCT02169336|4364956|P3|Overall Study|Adverse Event|1
1328709|NCT02169336|4364957|P2|Overall Study|Adverse Event|3
1328710|NCT02169336|4364958|P1|Overall Study|Adverse Event|2
1328711|NCT02169336|4364956|P3|Overall Study|Lack of Efficacy|0
1328712|NCT02169336|4364957|P2|Overall Study|Lack of Efficacy|1
1328713|NCT02169336|4364958|P1|Overall Study|Lack of Efficacy|1
1328714|NCT02169219|4364966|P1|Overall Study|Lack of Efficacy|6
1328715|NCT02168816|4364992|P2|Overall Study|Lost to Follow-up|2
1328716|NCT02168816|4364993|P1|Overall Study|Lost to Follow-up|2
1328717|NCT02168777|4365004|P3|Overall Study|Other reason|0
1328718|NCT02168777|4365005|P2|Overall Study|Other reason|1
1328719|NCT02168777|4365006|P1|Overall Study|Other reason|0
1328720|NCT02168777|4365004|P3|Overall Study|Clinical disease progression|2
1328721|NCT02168777|4365005|P2|Overall Study|Clinical disease progression|1
1328722|NCT02168777|4365006|P1|Overall Study|Clinical disease progression|0
1328723|NCT02168777|4365004|P3|Overall Study|Radiological disease progression|5
1328724|NCT02168777|4365005|P2|Overall Study|Radiological disease progression|5
1328725|NCT02168777|4365006|P1|Overall Study|Radiological disease progression|0
1328726|NCT02168777|4365004|P3|Overall Study|Disease recurrence|1
1328727|NCT02168777|4365005|P2|Overall Study|Disease recurrence|0
1328728|NCT02168777|4365006|P1|Overall Study|Disease recurrence|0
1328729|NCT02168777|4365004|P3|Overall Study|Adverse Event|1
1328730|NCT02168777|4365005|P2|Overall Study|Adverse Event|0
1328731|NCT02168777|4365006|P1|Overall Study|Adverse Event|1
1328732|NCT02168777|4365004|P3|Overall Study|Withdrawal by Subject|2
1328733|NCT02168777|4365005|P2|Overall Study|Withdrawal by Subject|0
1328734|NCT02168777|4365006|P1|Overall Study|Withdrawal by Subject|1
1328735|NCT02168491|4365083|P1|Overall Study|Withdrawal by Subject|1
1328736|NCT02168478|4365089|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
1328737|NCT02168478|4365089|P1|Overall Study|Did Not Consent to Participation|2
1328738|NCT02168478|4365089|P1|Overall Study|Withdrawal by Subject|1
1328739|NCT02168439|4365095|P2|Overall Study|Protocol Violation|2
1328740|NCT02168439|4365096|P1|Overall Study|Protocol Violation|0
1328741|NCT02168387|4365114|P2|Overall Study|Death|0
1328742|NCT02168387|4365115|P1|Overall Study|Death|1
1328743|NCT02168387|4365114|P2|Overall Study|Planned exubation|3
1328744|NCT02168387|4365115|P1|Overall Study|Planned exubation|6
1328745|NCT02168270|4365147|P1|Overall Study|Lack of Efficacy|4
1328746|NCT02167893|4365154|P1|Overall Study|Case report forms not collected|68
1328747|NCT02167893|4365154|P1|Overall Study|Investigator health reasons|10
1328748|NCT02167893|4365154|P1|Overall Study|Investigator transferred|85
1328749|NCT02167139|4365192|P4|Transition-extension|Lost to Follow-up|0
1328750|NCT02167139|4365193|P3|Transition-extension|Lost to Follow-up|0
1328751|NCT02167139|4365194|P2|Transition-extension|Lost to Follow-up|0
1328752|NCT02167139|4365195|P1|Transition-extension|Lost to Follow-up|1
1328753|NCT02167139|4365192|P4|Transition-extension|Other|0
1328754|NCT02167139|4365193|P3|Transition-extension|Other|1
1328755|NCT02167139|4365194|P2|Transition-extension|Other|0
1328756|NCT02167139|4365195|P1|Transition-extension|Other|1
1328757|NCT02167139|4365192|P4|Transition-extension|Lack of Efficacy|1
1328758|NCT02167139|4365193|P3|Transition-extension|Lack of Efficacy|1
1328759|NCT02167139|4365194|P2|Transition-extension|Lack of Efficacy|0
1328760|NCT02167139|4365195|P1|Transition-extension|Lack of Efficacy|0
1328761|NCT02167139|4365192|P4|Transition-extension|Withdrawal by Subject|1
1328762|NCT02167139|4365193|P3|Transition-extension|Withdrawal by Subject|4
1328763|NCT02167139|4365194|P2|Transition-extension|Withdrawal by Subject|0
1328764|NCT02167139|4365195|P1|Transition-extension|Withdrawal by Subject|2
1328765|NCT02167139|4365192|P4|Transition-extension|Adverse Event|3
1328766|NCT02167139|4365193|P3|Transition-extension|Adverse Event|2
1328767|NCT02167139|4365194|P2|Transition-extension|Adverse Event|0
1328768|NCT02167139|4365195|P1|Transition-extension|Adverse Event|2
1328769|NCT02167139|4365192|P4|Randomised, Double-blind|Other|0
1328770|NCT02167139|4365193|P3|Randomised, Double-blind|Other|0
1328771|NCT02167139|4365194|P2|Randomised, Double-blind|Other|0
1328772|NCT02167139|4365195|P1|Randomised, Double-blind|Other|3
1328773|NCT02167139|4365192|P4|Randomised, Double-blind|Lack of Efficacy|0
1328774|NCT02167139|4365193|P3|Randomised, Double-blind|Lack of Efficacy|0
1328775|NCT02167139|4365194|P2|Randomised, Double-blind|Lack of Efficacy|2
1328776|NCT02167139|4365195|P1|Randomised, Double-blind|Lack of Efficacy|1
1328777|NCT02167139|4365192|P4|Randomised, Double-blind|Adverse Event|0
1328778|NCT02167139|4365193|P3|Randomised, Double-blind|Adverse Event|0
1328779|NCT02167139|4365194|P2|Randomised, Double-blind|Adverse Event|9
1328780|NCT02167139|4365195|P1|Randomised, Double-blind|Adverse Event|2
1328781|NCT02167139|4365192|P4|Randomised, Double-blind|Withdrawal by Subject|0
1328782|NCT02167139|4365193|P3|Randomised, Double-blind|Withdrawal by Subject|0
1328783|NCT02167139|4365194|P2|Randomised, Double-blind|Withdrawal by Subject|8
1328784|NCT02167139|4365195|P1|Randomised, Double-blind|Withdrawal by Subject|11
1328785|NCT02166697|4365209|P1|Overall Study|Protocol Violation|347
1328786|NCT02166476|4365220|P2|Overall Study|Unable to Come for Visit|3
1328787|NCT02166476|4365221|P1|Overall Study|Unable to Come for Visit|0
1328788|NCT02166476|4365220|P2|Overall Study|Physician Decision|0
1328789|NCT02166476|4365221|P1|Overall Study|Physician Decision|1
1328790|NCT02166476|4365220|P2|Overall Study|Lost to Follow-up|10
1328791|NCT02166476|4365221|P1|Overall Study|Lost to Follow-up|5
1328792|NCT02166476|4365220|P2|Overall Study|Adverse Event|3
1328793|NCT02166476|4365221|P1|Overall Study|Adverse Event|3
1328794|NCT02166476|4365220|P2|Overall Study|Withdrawal by Subject|7
1328795|NCT02166476|4365221|P1|Overall Study|Withdrawal by Subject|5
1328796|NCT02165826|4365266|P3|Down-Titration Period|Reason Not Specified|2
1328797|NCT02165826|4365267|P2|Down-Titration Period|Reason Not Specified|0
1328798|NCT02165826|4365268|P1|Down-Titration Period|Reason Not Specified|1
1328799|NCT02165826|4365266|P3|Down-Titration Period|Voluntary Withdrawal|2
1328800|NCT02165826|4365267|P2|Down-Titration Period|Voluntary Withdrawal|1
1328801|NCT02165826|4365268|P1|Down-Titration Period|Voluntary Withdrawal|2
1328802|NCT02165826|4365266|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
1328803|NCT02165826|4365267|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
1328804|NCT02165826|4365268|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
1328805|NCT02165826|4365266|P3|Main Treatment Period|Did Not Receive Study Drug|0
1328806|NCT02165826|4365267|P2|Main Treatment Period|Did Not Receive Study Drug|2
1328807|NCT02165826|4365268|P1|Main Treatment Period|Did Not Receive Study Drug|0
1328808|NCT02165826|4365266|P3|Main Treatment Period|Reason Not Specified|16
1328809|NCT02165826|4365267|P2|Main Treatment Period|Reason Not Specified|5
1328810|NCT02165826|4365268|P1|Main Treatment Period|Reason Not Specified|8
1328811|NCT02165826|4365266|P3|Main Treatment Period|Lack of Efficacy|0
1328812|NCT02165826|4365267|P2|Main Treatment Period|Lack of Efficacy|0
1328813|NCT02165826|4365268|P1|Main Treatment Period|Lack of Efficacy|2
1328814|NCT02165826|4365266|P3|Main Treatment Period|Voluntary Withdrawal|21
1328815|NCT02165826|4365267|P2|Main Treatment Period|Voluntary Withdrawal|23
1328816|NCT02165826|4365268|P1|Main Treatment Period|Voluntary Withdrawal|23
1328817|NCT02165826|4365266|P3|Main Treatment Period|Lost to Follow-up|1
1328818|NCT02165826|4365267|P2|Main Treatment Period|Lost to Follow-up|2
1328819|NCT02165826|4365268|P1|Main Treatment Period|Lost to Follow-up|4
1328820|NCT02165826|4365266|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
1328821|NCT02165826|4365267|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
1328822|NCT02165826|4365268|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
1328823|NCT02165826|4365266|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
1328824|NCT02165826|4365267|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
1328825|NCT02165826|4365268|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
1328826|NCT02165202|4365368|P2|Injection Phase|Participant unwilling to comply|0
1328827|NCT02165202|4365369|P1|Injection Phase|Participant unwilling to comply|1
1328828|NCT02165202|4365368|P2|Injection Phase|No longer interested|1
1328829|NCT02165202|4365369|P1|Injection Phase|No longer interested|0
1328830|NCT02165202|4365368|P2|Injection Phase|Study Product related Toxicity|0
1328831|NCT02165202|4365369|P1|Injection Phase|Study Product related Toxicity|1
1328832|NCT02165202|4365368|P2|Injection Phase|End of Study|1
1328833|NCT02165202|4365369|P1|Injection Phase|End of Study|2
1328834|NCT02165202|4365368|P2|Injection Phase|QTcF>500 ms or increase of>60 ms|1
1328835|NCT02165202|4365369|P1|Injection Phase|QTcF>500 ms or increase of>60 ms|0
1328836|NCT02165202|4365368|P2|Injection Phase|Unable to attend within Visit Window|0
1328837|NCT02165202|4365369|P1|Injection Phase|Unable to attend within Visit Window|1
1328838|NCT02165202|4365368|P2|Injection Phase|Reactive HIV or HIV Suspected|2
1328839|NCT02165202|4365369|P1|Injection Phase|Reactive HIV or HIV Suspected|0
1328840|NCT02165202|4365368|P2|Injection Phase|Abnormal Lab Value|1
1328841|NCT02165202|4365369|P1|Injection Phase|Abnormal Lab Value|5
1328842|NCT02165202|4365368|P2|Oral Phase|Abnormal EKG|1
1328843|NCT02165202|4365369|P1|Oral Phase|Abnormal EKG|0
1328844|NCT02165202|4365368|P2|Oral Phase|Relocated, no follow-up planned|0
1328845|NCT02165202|4365369|P1|Oral Phase|Relocated, no follow-up planned|1
1328846|NCT02165202|4365368|P2|Oral Phase|CMC advised termination|0
1328847|NCT02165202|4365369|P1|Oral Phase|CMC advised termination|1
1328848|NCT02165202|4365368|P2|Oral Phase|QTcF>500 ms or increase of>60 ms|0
1328849|NCT02165202|4365369|P1|Oral Phase|QTcF>500 ms or increase of>60 ms|1
1328850|NCT02165202|4365368|P2|Oral Phase|Clinical reasons|0
1328851|NCT02165202|4365369|P1|Oral Phase|Clinical reasons|1
1328852|NCT02165202|4365368|P2|Oral Phase|Unable to contact Participant|1
1328853|NCT02165202|4365369|P1|Oral Phase|Unable to contact Participant|1
1328854|NCT02165202|4365368|P2|Oral Phase|Study product Related Toxicity|0
1328855|NCT02165202|4365369|P1|Oral Phase|Study product Related Toxicity|1
1328856|NCT02165202|4365368|P2|Oral Phase|Refused further participation|1
1328857|NCT02165202|4365369|P1|Oral Phase|Refused further participation|5
1328858|NCT02164929|4365403|P4|Overall Study|Failed regional block|0
1328859|NCT02164929|4365404|P3|Overall Study|Failed regional block|1
1328860|NCT02164929|4365405|P2|Overall Study|Failed regional block|0
1328861|NCT02164929|4365406|P1|Overall Study|Failed regional block|0
1328862|NCT02164929|4365403|P4|Overall Study|Converted to open procedure|2
1328863|NCT02164929|4365404|P3|Overall Study|Converted to open procedure|0
1328864|NCT02164929|4365405|P2|Overall Study|Converted to open procedure|0
1328865|NCT02164929|4365406|P1|Overall Study|Converted to open procedure|1
1328866|NCT02164916|4365450|P2|Overall Study|Not eligible|5
1328867|NCT02164916|4365451|P1|Overall Study|Not eligible|2
1328868|NCT02164916|4365450|P2|Overall Study|Reason under review|6
1328869|NCT02164916|4365451|P1|Overall Study|Reason under review|1
1328870|NCT02164916|4365450|P2|Overall Study|Not protocol specified|1
1328871|NCT02164916|4365451|P1|Overall Study|Not protocol specified|5
1328872|NCT02164916|4365450|P2|Overall Study|Progression|26
1328873|NCT02164916|4365451|P1|Overall Study|Progression|37
1328874|NCT02164916|4365450|P2|Overall Study|Refusal unrelated to adverse event|7
1328875|NCT02164916|4365451|P1|Overall Study|Refusal unrelated to adverse event|3
1328876|NCT02164916|4365450|P2|Overall Study|Death|1
1328877|NCT02164916|4365451|P1|Overall Study|Death|1
1328878|NCT02164916|4365450|P2|Overall Study|Adverse Event|8
1328879|NCT02164916|4365451|P1|Overall Study|Adverse Event|3
1328880|NCT02164864|4365471|P3|Overall Study|Other than stated|14
1328881|NCT02164864|4365472|P2|Overall Study|Other than stated|4
1328882|NCT02164864|4365473|P1|Overall Study|Other than stated|3
1328883|NCT02164864|4365471|P3|Overall Study|Consent withdrawn, not due to AE|56
1328884|NCT02164864|4365472|P2|Overall Study|Consent withdrawn, not due to AE|8
1328885|NCT02164864|4365473|P1|Overall Study|Consent withdrawn, not due to AE|21
1328886|NCT02164864|4365471|P3|Overall Study|Lost to Follow-up|2
1328887|NCT02164864|4365472|P2|Overall Study|Lost to Follow-up|3
1328888|NCT02164864|4365473|P1|Overall Study|Lost to Follow-up|4
1328889|NCT02164864|4365471|P3|Overall Study|Protocol Violation|1
1328890|NCT02164864|4365472|P2|Overall Study|Protocol Violation|4
1328891|NCT02164864|4365473|P1|Overall Study|Protocol Violation|2
1328892|NCT02164864|4365471|P3|Overall Study|Other Adverse Event (AE)|49
1328893|NCT02164864|4365472|P2|Overall Study|Other Adverse Event (AE)|32
1328894|NCT02164864|4365473|P1|Overall Study|Other Adverse Event (AE)|52
1328895|NCT02164864|4365471|P3|Overall Study|Other pre-existing disease worsening|9
1328896|NCT02164864|4365472|P2|Overall Study|Other pre-existing disease worsening|4
1328897|NCT02164864|4365473|P1|Overall Study|Other pre-existing disease worsening|6
1328898|NCT02164864|4365471|P3|Overall Study|Trial disease worsening|1
1328899|NCT02164864|4365472|P2|Overall Study|Trial disease worsening|5
1328900|NCT02164864|4365473|P1|Overall Study|Trial disease worsening|7
1328901|NCT02164539|4365538|P7|Treatment Phase C (1 Week)|Physician Decision|1
1328902|NCT02164539|4365539|P6|Treatment Phase C (1 Week)|Physician Decision|0
1328903|NCT02164539|4365540|P5|Treatment Phase C (1 Week)|Physician Decision|0
1328904|NCT02164539|4365541|P4|Treatment Phase C (1 Week)|Physician Decision|0
1328905|NCT02164539|4365542|P3|Treatment Phase C (1 Week)|Physician Decision|0
1328906|NCT02164539|4365543|P2|Treatment Phase C (1 Week)|Physician Decision|0
1328907|NCT02164539|4365544|P1|Treatment Phase C (1 Week)|Physician Decision|0
1328908|NCT02164539|4365538|P7|Treatment Phase C (1 Week)|Adverse Event|1
1328909|NCT02164539|4365539|P6|Treatment Phase C (1 Week)|Adverse Event|0
1328910|NCT02164539|4365540|P5|Treatment Phase C (1 Week)|Adverse Event|0
1328911|NCT02164539|4365541|P4|Treatment Phase C (1 Week)|Adverse Event|0
1328912|NCT02164539|4365542|P3|Treatment Phase C (1 Week)|Adverse Event|0
1328913|NCT02164539|4365543|P2|Treatment Phase C (1 Week)|Adverse Event|0
1328914|NCT02164539|4365544|P1|Treatment Phase C (1 Week)|Adverse Event|0
1328915|NCT02164539|4365538|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1328916|NCT02164539|4365539|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1328917|NCT02164539|4365540|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1328918|NCT02164539|4365541|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1328919|NCT02164539|4365542|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1328920|NCT02164539|4365543|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1328921|NCT02164539|4365544|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
1328922|NCT02164539|4365538|P7|Treatment Phase B (1 Week)|Physician Decision|1
1328923|NCT02164539|4365539|P6|Treatment Phase B (1 Week)|Physician Decision|0
1328924|NCT02164539|4365540|P5|Treatment Phase B (1 Week)|Physician Decision|1
1328925|NCT02164539|4365541|P4|Treatment Phase B (1 Week)|Physician Decision|0
1328926|NCT02164539|4365542|P3|Treatment Phase B (1 Week)|Physician Decision|0
1328927|NCT02164539|4365543|P2|Treatment Phase B (1 Week)|Physician Decision|0
1328928|NCT02164539|4365544|P1|Treatment Phase B (1 Week)|Physician Decision|0
1328929|NCT02164539|4365538|P7|Treatment Phase B (1 Week)|Adverse Event|0
1328930|NCT02164539|4365539|P6|Treatment Phase B (1 Week)|Adverse Event|0
1328931|NCT02164539|4365540|P5|Treatment Phase B (1 Week)|Adverse Event|2
1328932|NCT02164539|4365541|P4|Treatment Phase B (1 Week)|Adverse Event|0
1328933|NCT02164539|4365542|P3|Treatment Phase B (1 Week)|Adverse Event|0
1328934|NCT02164539|4365543|P2|Treatment Phase B (1 Week)|Adverse Event|0
1328935|NCT02164539|4365544|P1|Treatment Phase B (1 Week)|Adverse Event|0
1328936|NCT02164539|4365538|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
1328937|NCT02164539|4365539|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
1328938|NCT02164539|4365540|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
1328939|NCT02164539|4365541|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
1328940|NCT02164539|4365542|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
1328941|NCT02164539|4365543|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
1328942|NCT02164539|4365544|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
1328943|NCT02164318|4365606|P4|Overall Study|Withdrawal by Subject|1
1328944|NCT02164318|4365607|P3|Overall Study|Withdrawal by Subject|0
1328945|NCT02164318|4365608|P2|Overall Study|Withdrawal by Subject|1
1328946|NCT02164318|4365609|P1|Overall Study|Withdrawal by Subject|0
1328947|NCT02163915|4365632|P5|Overall Study|Physician Decision|0
1328948|NCT02163915|4365633|P4|Overall Study|Physician Decision|1
1328949|NCT02163915|4365634|P3|Overall Study|Physician Decision|0
1328950|NCT02163915|4365635|P2|Overall Study|Physician Decision|0
1328951|NCT02163915|4365636|P1|Overall Study|Physician Decision|0
1328952|NCT02163915|4365632|P5|Overall Study|Study termination|2
1328953|NCT02163915|4365633|P4|Overall Study|Study termination|0
1328954|NCT02163915|4365634|P3|Overall Study|Study termination|0
1328955|NCT02163915|4365635|P2|Overall Study|Study termination|0
1328956|NCT02163915|4365636|P1|Overall Study|Study termination|1
1328957|NCT02163915|4365632|P5|Overall Study|Withdrawal by Subject|2
1328958|NCT02163915|4365633|P4|Overall Study|Withdrawal by Subject|2
1328959|NCT02163915|4365634|P3|Overall Study|Withdrawal by Subject|2
1328960|NCT02163915|4365635|P2|Overall Study|Withdrawal by Subject|0
1328961|NCT02163915|4365636|P1|Overall Study|Withdrawal by Subject|2
1328962|NCT02163733|4365691|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
1328963|NCT02163733|4365692|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
1328964|NCT02163733|4365693|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
1328965|NCT02163733|4365691|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
1328966|NCT02163733|4365692|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
1328967|NCT02163733|4365693|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
1328968|NCT02163538|4365730|P2|Overall Study|Physician Decision|1
1328969|NCT02163538|4365731|P1|Overall Study|Physician Decision|0
1328970|NCT02163538|4365730|P2|Overall Study|Protocol Violation|0
1328971|NCT02163538|4365731|P1|Overall Study|Protocol Violation|1
1328972|NCT02163499|4365747|P1|Extended Dosing Phase: ZS|Various reasons|16
1328973|NCT02163499|4365747|P1|Extended Dosing Phase: ZS|Hyperkalemia|5
1328974|NCT02163499|4365747|P1|Extended Dosing Phase: ZS|Subject Compliance|17
1328975|NCT02163499|4365747|P1|Extended Dosing Phase: ZS|Death|8
1328976|NCT02163499|4365747|P1|Extended Dosing Phase: ZS|Protocol Violation|2
1328977|NCT02163499|4365747|P1|Extended Dosing Phase: ZS|Lost to Follow-up|31
1328978|NCT02163499|4365747|P1|Extended Dosing Phase: ZS|Physician Decision|8
1328979|NCT02163499|4365747|P1|Extended Dosing Phase: ZS|Withdrawal by Subject|81
1328980|NCT02163499|4365747|P1|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
1328981|NCT02163499|4365747|P1|Extended Dosing Phase: ZS|Sponsor's Decision|5
1328982|NCT02163499|4365747|P1|Extended Dosing Phase: ZS|Hypokalemia|9
1328983|NCT02163499|4365747|P1|Extended Dosing Phase: ZS|Expected Progression of CKD|40
1328984|NCT02163499|4365747|P1|Extended Dosing Phase: ZS|Adverse Event|51
1328985|NCT02163499|4365747|P1|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
1328986|NCT02163499|4365747|P1|Acute Phase: ZS 10 g TID|Physician Decision|1
1328987|NCT02163499|4365747|P1|Acute Phase: ZS 10 g TID|Protocol Violation|1
1328988|NCT02163499|4365747|P1|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
1328989|NCT02163499|4365747|P1|Acute Phase: ZS 10 g TID|Participant's Compliance|1
1328990|NCT02163395|4365769|P1|Overall Study|Adverse Event|1
1328991|NCT02163395|4365769|P1|Overall Study|Lost to Follow-up|3
1328992|NCT02163395|4365769|P1|Overall Study|Withdrawal by Subject|1
1328993|NCT02163187|4365778|P2|Overall Study|Progressive disease|0
1328994|NCT02163187|4365779|P1|Overall Study|Progressive disease|1
1328995|NCT02163187|4365778|P2|Overall Study|Device removed|0
1328996|NCT02163187|4365779|P1|Overall Study|Device removed|1
1328997|NCT02162862|4365803|P3|Overall Study|Subject did not feel the med was needed|4
1328998|NCT02162862|4365804|P2|Overall Study|Subject did not feel the med was needed|0
1328999|NCT02162862|4365805|P1|Overall Study|Subject did not feel the med was needed|0
1329000|NCT02162862|4365803|P3|Overall Study|Lost to Follow-up|0
1329001|NCT02162862|4365804|P2|Overall Study|Lost to Follow-up|11
1329002|NCT02162862|4365805|P1|Overall Study|Lost to Follow-up|0
1329003|NCT02162758|4365818|P2|Overall Study|Study termination|1
1329004|NCT02162758|4365819|P1|Overall Study|Study termination|0
1329005|NCT02161757|4365853|P3|Treatment Through Study Completion|Death|1
1329006|NCT02161757|4365854|P2|Treatment Through Study Completion|Death|1
1329007|NCT02161757|4365855|P1|Treatment Through Study Completion|Death|2
1329008|NCT02161757|4365853|P3|Treatment Through Study Completion|Other|12
1329009|NCT02161757|4365854|P2|Treatment Through Study Completion|Other|19
1329010|NCT02161757|4365855|P1|Treatment Through Study Completion|Other|20
1329011|NCT02161757|4365853|P3|Treatment Through Study Completion|Lost to Follow-up|4
1329012|NCT02161757|4365854|P2|Treatment Through Study Completion|Lost to Follow-up|2
1329013|NCT02161757|4365855|P1|Treatment Through Study Completion|Lost to Follow-up|7
1329014|NCT02161757|4365853|P3|Treatment Through Study Completion|Withdrawal by Subject|20
1329015|NCT02161757|4365854|P2|Treatment Through Study Completion|Withdrawal by Subject|19
1329016|NCT02161757|4365855|P1|Treatment Through Study Completion|Withdrawal by Subject|27
1329017|NCT02161757|4365853|P3|Treatment Through Study Completion|Protocol Violation|2
1329018|NCT02161757|4365854|P2|Treatment Through Study Completion|Protocol Violation|1
1329019|NCT02161757|4365855|P1|Treatment Through Study Completion|Protocol Violation|0
1329020|NCT02161757|4365853|P3|Treatment Through Study Completion|Adverse Event|0
1329021|NCT02161757|4365854|P2|Treatment Through Study Completion|Adverse Event|1
1329022|NCT02161757|4365855|P1|Treatment Through Study Completion|Adverse Event|1
1329023|NCT02161757|4365853|P3|Randomised Through Start Treatment|Did not receive treatment|0
1329024|NCT02161757|4365854|P2|Randomised Through Start Treatment|Did not receive treatment|2
1329025|NCT02161757|4365855|P1|Randomised Through Start Treatment|Did not receive treatment|3
1329026|NCT02161562|4365915|P2|Overall Study|Participant moved out of province|0
1329027|NCT02161562|4365916|P1|Overall Study|Participant moved out of province|1
1329028|NCT02161562|4365915|P2|Overall Study|Withdrew due to being out of the country|0
1329029|NCT02161562|4365916|P1|Overall Study|Withdrew due to being out of the country|1
1329030|NCT02161562|4365915|P2|Overall Study|Participant moved back to home country|0
1329031|NCT02161562|4365916|P1|Overall Study|Participant moved back to home country|1
1329032|NCT02161562|4365915|P2|Overall Study|Adverse Event|1
1329033|NCT02161562|4365916|P1|Overall Study|Adverse Event|1
1329034|NCT02161562|4365915|P2|Overall Study|Lack of Efficacy|1
1329035|NCT02161562|4365916|P1|Overall Study|Lack of Efficacy|4
1329036|NCT02161562|4365915|P2|Overall Study|Lost to Follow-up|1
1329037|NCT02161562|4365916|P1|Overall Study|Lost to Follow-up|3
1329038|NCT02161562|4365915|P2|Overall Study|Pregnancy|2
1329039|NCT02161562|4365916|P1|Overall Study|Pregnancy|1
1329040|NCT02161562|4365915|P2|Overall Study|Protocol Violation|4
1329041|NCT02161562|4365916|P1|Overall Study|Protocol Violation|9
1329042|NCT02161562|4365915|P2|Overall Study|Withdrawal by Subject|8
1329043|NCT02161562|4365916|P1|Overall Study|Withdrawal by Subject|5
1329044|NCT02161549|4365944|P2|Overall Study|Physician Decision|2
1329045|NCT02161549|4365945|P1|Overall Study|Physician Decision|6
1329046|NCT02161146|4365981|P5|Overall Study|Other Miscellaneous Reasons|0
1329047|NCT02161146|4365982|P4|Overall Study|Other Miscellaneous Reasons|0
1329048|NCT02161146|4365983|P3|Overall Study|Other Miscellaneous Reasons|0
1329049|NCT02161146|4365984|P2|Overall Study|Other Miscellaneous Reasons|1
1329050|NCT02161146|4365985|P1|Overall Study|Other Miscellaneous Reasons|0
1329051|NCT02161146|4365981|P5|Overall Study|Personal Reasons|1
1329052|NCT02161146|4365982|P4|Overall Study|Personal Reasons|2
1329053|NCT02161146|4365983|P3|Overall Study|Personal Reasons|0
1329054|NCT02161146|4365984|P2|Overall Study|Personal Reasons|1
1329055|NCT02161146|4365985|P1|Overall Study|Personal Reasons|0
1329056|NCT02161146|4365981|P5|Overall Study|Lost to Follow-up|0
1329057|NCT02161146|4365982|P4|Overall Study|Lost to Follow-up|0
1329058|NCT02161146|4365983|P3|Overall Study|Lost to Follow-up|0
1329059|NCT02161146|4365984|P2|Overall Study|Lost to Follow-up|1
1329060|NCT02161146|4365985|P1|Overall Study|Lost to Follow-up|0
1329061|NCT02161146|4365981|P5|Overall Study|Adverse Event|0
1329062|NCT02161146|4365982|P4|Overall Study|Adverse Event|1
1329063|NCT02161146|4365983|P3|Overall Study|Adverse Event|0
1329064|NCT02161146|4365984|P2|Overall Study|Adverse Event|1
1329065|NCT02161146|4365985|P1|Overall Study|Adverse Event|1
1329066|NCT02161016|4365998|P1|Overall Study|withdrawn by IRB|1
1329067|NCT02160977|4366029|P2|Six Months After Surgery|Lost to Follow-up|1
1329068|NCT02160977|4366030|P1|Six Months After Surgery|Lost to Follow-up|2
1329069|NCT02160977|4366029|P2|Three Months After Surgery|Lost to Follow-up|2
1329070|NCT02160977|4366030|P1|Three Months After Surgery|Lost to Follow-up|0
1329071|NCT02160977|4366029|P2|Six Weeks After Surgery|Lost to Follow-up|0
1329072|NCT02160977|4366030|P1|Six Weeks After Surgery|Lost to Follow-up|1
1329073|NCT02160314|4366057|P2|Overall Study|Lost to Follow-up|1
1329074|NCT02160314|4366058|P1|Overall Study|Lost to Follow-up|0
1329075|NCT02160314|4366057|P2|Overall Study|Withdrawal by Subject|2
1329076|NCT02160314|4366058|P1|Overall Study|Withdrawal by Subject|1
1329077|NCT02160314|4366057|P2|Overall Study|Protocol Violation|4
1329078|NCT02160314|4366058|P1|Overall Study|Protocol Violation|0
1329079|NCT02160314|4366057|P2|Overall Study|Adverse Event|6
1329080|NCT02160314|4366058|P1|Overall Study|Adverse Event|0
1329081|NCT02160145|4366066|P3|Randomized Double-blind Period|Physician Decision|5
1329082|NCT02160145|4366067|P2|Randomized Double-blind Period|Physician Decision|7
1329083|NCT02160145|4366068|P1|Randomized Double-blind Period|Physician Decision|0
1329084|NCT02160145|4366066|P3|Randomized Double-blind Period|Lost to Follow-up|3
1329085|NCT02160145|4366067|P2|Randomized Double-blind Period|Lost to Follow-up|1
1329086|NCT02160145|4366068|P1|Randomized Double-blind Period|Lost to Follow-up|0
1329087|NCT02160145|4366066|P3|Randomized Double-blind Period|Subject decision|20
1329088|NCT02160145|4366067|P2|Randomized Double-blind Period|Subject decision|21
1329089|NCT02160145|4366068|P1|Randomized Double-blind Period|Subject decision|0
1329090|NCT02160145|4366066|P3|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
1329091|NCT02160145|4366067|P2|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
1329092|NCT02160145|4366068|P1|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
1329093|NCT02160145|4366066|P3|Prerandomization Single-blind Period|Placebo run-in failure|0
1329094|NCT02160145|4366067|P2|Prerandomization Single-blind Period|Placebo run-in failure|0
1329095|NCT02160145|4366068|P1|Prerandomization Single-blind Period|Placebo run-in failure|23
1329096|NCT02160002|4366083|P2|Overall Study|Withdrawal by Subject|1
1329097|NCT02160002|4366084|P1|Overall Study|Withdrawal by Subject|2
1329098|NCT02159950|4366116|P2|Overall Study|Progression|1
1329099|NCT02159950|4366117|P1|Overall Study|Progression|0
1329100|NCT02159950|4366116|P2|Overall Study|Adverse Event|1
1329101|NCT02159950|4366117|P1|Overall Study|Adverse Event|0
1329102|NCT02159482|4366189|P1|Overall Study|Physician Decision|3
1329103|NCT02159482|4366189|P1|Overall Study|Withdrawal by Subject|2
1329104|NCT02159469|4366194|P1|Overall Study|Multiple|29
1329105|NCT02159469|4366194|P1|Overall Study|Other|1
1329106|NCT02159469|4366194|P1|Overall Study|Met Stopping Criteria|3
1329107|NCT02159469|4366194|P1|Overall Study|Sponsor's request|2
1329108|NCT02159469|4366194|P1|Overall Study|Lost to Follow-up|1
1329109|NCT02159469|4366194|P1|Overall Study|Withdrawal by Subject|9
1329110|NCT02159469|4366194|P1|Overall Study|Non-compliance|2
1329111|NCT02159469|4366194|P1|Overall Study|Adverse Event|5
1329112|NCT02159469|4366194|P1|Overall Study|Missing Completion status|1
1329113|NCT02159365|4366199|P1|Overall Study|Other|1
1329114|NCT02159365|4366199|P1|Overall Study|Subject Withdrew Consent|1
1329115|NCT02159365|4366199|P1|Overall Study|Subject Request to Discontinue Treatment|1
1329116|NCT02159365|4366199|P1|Overall Study|Study Drug Toxicity|1
1329117|NCT02159365|4366199|P1|Overall Study|Lost to Follow-up|1
1329118|NCT02159365|4366199|P1|Overall Study|Adverse Event Unrelated to Study Drug|6
1329119|NCT02159365|4366199|P1|Overall Study|Disease Progression|11
1329120|NCT02159352|4366205|P2|Overall Study|Withdrawal by Subject|1
1329121|NCT02159352|4366206|P1|Overall Study|Withdrawal by Subject|0
1329122|NCT02159352|4366205|P2|Overall Study|Adverse Event|1
1329123|NCT02159352|4366206|P1|Overall Study|Adverse Event|3
1329124|NCT02159040|4366281|P1|Overall Study|Death|1
1329125|NCT02158975|4366294|P1|Overall Study|Did not complete 1 cycle nor > 1dose|1
1329126|NCT02158936|4366304|P2|Overall Study|Lost to Follow-up|1
1329127|NCT02158936|4366305|P1|Overall Study|Lost to Follow-up|0
1329128|NCT02158936|4366304|P2|Overall Study|Physician Decision|13
1329129|NCT02158936|4366305|P1|Overall Study|Physician Decision|15
1329130|NCT02158936|4366304|P2|Overall Study|Withdrawal by Subject|16
1329131|NCT02158936|4366305|P1|Overall Study|Withdrawal by Subject|15
1329132|NCT02158936|4366304|P2|Overall Study|Adverse Event|24
1329133|NCT02158936|4366305|P1|Overall Study|Adverse Event|39
1329134|NCT02158936|4366304|P2|Overall Study|Azacitidine tx discontinued|46
1329135|NCT02158936|4366305|P1|Overall Study|Azacitidine tx discontinued|53
1329136|NCT02158936|4366304|P2|Overall Study|Study closed/ terminated|77
1329137|NCT02158936|4366305|P1|Overall Study|Study closed/ terminated|57
1329138|NCT02158728|4366347|P1|Overall Study|no qualified dataset|24
1329139|NCT02158728|4366347|P1|Overall Study|no procedure according to CIP done|3
1329140|NCT02158442|4366364|P2|Overall Study|Perfusion staff not available|0
1329141|NCT02158442|4366365|P1|Overall Study|Perfusion staff not available|1
1329142|NCT02158442|4366364|P2|Overall Study|Withdrawal by Subject|0
1329143|NCT02158442|4366365|P1|Overall Study|Withdrawal by Subject|1
1329144|NCT02158364|4366371|P1|Overall Study|Protocol Deviation|50
1329145|NCT02158364|4366371|P1|Overall Study|Case report forms uncollected|10
1329146|NCT02158247|4366389|P1|Overall Study|Invisible vocal cords|5
1329147|NCT02158039|4366405|P1|Overall Study|Screen Failure|9
1329148|NCT02158039|4366405|P1|Overall Study|Withdrawal by Subject|1
1329149|NCT02157948|4366412|P2|Overall Study|Decision by Sponsor|1
1329150|NCT02157948|4366413|P1|Overall Study|Decision by Sponsor|0
1329151|NCT02157948|4366412|P2|Overall Study|Protocol Specified Criteria|1
1329152|NCT02157948|4366413|P1|Overall Study|Protocol Specified Criteria|2
1329153|NCT02157948|4366412|P2|Overall Study|Lost to Follow-up|2
1329154|NCT02157948|4366413|P1|Overall Study|Lost to Follow-up|3
1329155|NCT02157948|4366412|P2|Overall Study|Withdrawal by Subject|5
1329156|NCT02157948|4366413|P1|Overall Study|Withdrawal by Subject|4
1329157|NCT02157935|4366425|P2|Overall Study|Adverse Event|5
1329158|NCT02157935|4366426|P1|Overall Study|Adverse Event|3
1329159|NCT02157935|4366425|P2|Overall Study|Death|4
1329160|NCT02157935|4366426|P1|Overall Study|Death|4
1329161|NCT02157935|4366425|P2|Overall Study|Lack of Efficacy|1
1329162|NCT02157935|4366426|P1|Overall Study|Lack of Efficacy|0
1329163|NCT02157935|4366425|P2|Overall Study|Other|12
1329164|NCT02157935|4366426|P1|Overall Study|Other|5
1329165|NCT02157935|4366425|P2|Overall Study|Progressive disease|2
1329166|NCT02157935|4366426|P1|Overall Study|Progressive disease|0
1329167|NCT02157935|4366425|P2|Overall Study|Protocol Violation|0
1329168|NCT02157935|4366426|P1|Overall Study|Protocol Violation|1
1329169|NCT02157935|4366425|P2|Overall Study|Screen failure|2
1329170|NCT02157935|4366426|P1|Overall Study|Screen failure|1
1329171|NCT02157935|4366425|P2|Overall Study|Withdrawal by Subject|39
1329172|NCT02157935|4366426|P1|Overall Study|Withdrawal by Subject|25
1329173|NCT02157883|4366452|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
1329174|NCT02157883|4366452|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
1329175|NCT02157883|4366452|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
1329176|NCT02157883|4366452|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
1329177|NCT02157883|4366452|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
1329178|NCT02157623|4366483|P2|Overall Study|Physician Decision|3
1329179|NCT02157623|4366484|P1|Overall Study|Physician Decision|4
1329180|NCT02157376|4366492|P2|Overall Study|Investigator's misjudgement|2
1329181|NCT02157376|4366493|P1|Overall Study|Investigator's misjudgement|1
1329182|NCT02157376|4366492|P2|Overall Study|Not treated|3
1329183|NCT02157376|4366493|P1|Overall Study|Not treated|8
1329184|NCT02157376|4366492|P2|Overall Study|Withdrawal by Subject|8
1329185|NCT02157376|4366493|P1|Overall Study|Withdrawal by Subject|3
1329186|NCT02157376|4366492|P2|Overall Study|Eligibility criteria not fulfilled|1
1329187|NCT02157376|4366493|P1|Overall Study|Eligibility criteria not fulfilled|0
1329188|NCT02157376|4366492|P2|Overall Study|Death|4
1329189|NCT02157376|4366493|P1|Overall Study|Death|10
1329190|NCT02157298|4366503|P2|Overall Study|Withdrawal by Subject|0
1329191|NCT02157298|4366504|P1|Overall Study|Withdrawal by Subject|1
1329192|NCT02157298|4366503|P2|Overall Study|Poor/Non-compliance|0
1329193|NCT02157298|4366504|P1|Overall Study|Poor/Non-compliance|1
1329194|NCT02157298|4366503|P2|Overall Study|Subject no longer meets study criteria|2
1329195|NCT02157298|4366504|P1|Overall Study|Subject no longer meets study criteria|1
1329196|NCT02157298|4366503|P2|Overall Study|Adverse Event|0
1329197|NCT02157298|4366504|P1|Overall Study|Adverse Event|1
1329198|NCT02157116|4366543|P1|Overall Study|Failed Screening|2
1329199|NCT02157116|4366543|P1|Overall Study|Physician Decision|3
1329200|NCT02157116|4366543|P1|Overall Study|Withdrawal by Subject|4
1329201|NCT02156466|4366563|P5|Overall Study|Quantiferon Positivity|0
1329202|NCT02156466|4366564|P4|Overall Study|Quantiferon Positivity|1
1329203|NCT02156466|4366565|P3|Overall Study|Quantiferon Positivity|0
1329204|NCT02156466|4366566|P2|Overall Study|Quantiferon Positivity|0
1329205|NCT02156466|4366567|P1|Overall Study|Quantiferon Positivity|0
1329206|NCT02156466|4366563|P5|Overall Study|Adverse Event|0
1329207|NCT02156466|4366564|P4|Overall Study|Adverse Event|1
1329208|NCT02156466|4366565|P3|Overall Study|Adverse Event|1
1329209|NCT02156466|4366566|P2|Overall Study|Adverse Event|0
1329210|NCT02156466|4366567|P1|Overall Study|Adverse Event|0
1329211|NCT02156271|4366748|P2|Overall Study|Physician Decision|3
1329212|NCT02156271|4366749|P1|Overall Study|Physician Decision|4
1329213|NCT02155985|4366788|P3|Overall Study|Lost to Follow-up|0
1329214|NCT02155985|4366789|P2|Overall Study|Lost to Follow-up|0
1329215|NCT02155985|4366790|P1|Overall Study|Lost to Follow-up|1
1329216|NCT02155985|4366788|P3|Overall Study|Withdrawal by Subject|1
1329217|NCT02155985|4366789|P2|Overall Study|Withdrawal by Subject|0
1329218|NCT02155985|4366790|P1|Overall Study|Withdrawal by Subject|0
1329219|NCT02155881|4366857|P2|Overall Study|Inappropriately randomized|2
1329220|NCT02155881|4366858|P1|Overall Study|Inappropriately randomized|2
1329221|NCT02155881|4366857|P2|Overall Study|Withdrawal by Subject|2
1329222|NCT02155881|4366858|P1|Overall Study|Withdrawal by Subject|0
1329223|NCT02155322|4366910|P1|Overall Study|Withdrawal by Subject|4
1329224|NCT02155322|4366910|P1|Overall Study|Relapse/Recurrence|8
1329225|NCT02155322|4366910|P1|Overall Study|Physician Decision|1
1329226|NCT02155322|4366910|P1|Overall Study|Adverse Event|1
1329227|NCT02155309|4366917|P3|Overall Study|Protocol Violation|1
1329228|NCT02155309|4366918|P2|Overall Study|Protocol Violation|0
1329229|NCT02155309|4366919|P1|Overall Study|Protocol Violation|0
1329230|NCT02155283|4366926|P1|Overall Study|Protocol Violation|3
1329231|NCT02155283|4366926|P1|Overall Study|Withdrawal by Subject|1
1329232|NCT02155283|4366926|P1|Overall Study|Lost to Follow-up|3
1329233|NCT02154425|4366953|P1|Screening Period|Adverse Event|1
1329234|NCT02154139|4367012|P1|Overall Study|Investigator transferred|3
1329235|NCT02154139|4367012|P1|Overall Study|Other|2
1329236|NCT02154139|4367012|P1|Overall Study|Injection not administered|2
1329237|NCT02154087|4367020|P1|Overall Study|Study Termination|1
1329238|NCT02154061|4367026|P2|Overall Study|enrolled but not vaccinated|0
1329239|NCT02154061|4367027|P1|Overall Study|enrolled but not vaccinated|1
1329240|NCT02154061|4367026|P2|Overall Study|Pregnancy|0
1329241|NCT02154061|4367027|P1|Overall Study|Pregnancy|1
1329242|NCT02153827|4367048|P2|Overall Study|Lost to Follow-up|9
1329243|NCT02153827|4367049|P1|Overall Study|Lost to Follow-up|3
1329244|NCT02153788|4367065|P2|Overall Study|Physician Decision|1
1329245|NCT02153788|4367066|P1|Overall Study|Physician Decision|2
1329246|NCT02153736|4367086|P2|Overall Study|Withdrawal by Subject|1
1329247|NCT02153736|4367087|P1|Overall Study|Withdrawal by Subject|0
1329248|NCT02153736|4367086|P2|Overall Study|Death|1
1329249|NCT02153736|4367087|P1|Overall Study|Death|0
1329250|NCT02153736|4367086|P2|Overall Study|Medical status change made ineligible|0
1329251|NCT02153736|4367087|P1|Overall Study|Medical status change made ineligible|1
1329252|NCT02153736|4367086|P2|Overall Study|Lost to Follow-up|0
1329253|NCT02153736|4367087|P1|Overall Study|Lost to Follow-up|1
1329254|NCT02153398|4367156|P5|Overall Study|Adverse Event|0
1329255|NCT02153398|4367157|P4|Overall Study|Adverse Event|1
1329256|NCT02153398|4367158|P3|Overall Study|Adverse Event|1
1329257|NCT02153398|4367159|P2|Overall Study|Adverse Event|0
1329258|NCT02153398|4367160|P1|Overall Study|Adverse Event|0
1329259|NCT02153398|4367156|P5|Overall Study|Withdrawal by Subject|0
1329260|NCT02153398|4367157|P4|Overall Study|Withdrawal by Subject|0
1329261|NCT02153398|4367158|P3|Overall Study|Withdrawal by Subject|0
1329262|NCT02153398|4367159|P2|Overall Study|Withdrawal by Subject|0
1329263|NCT02153398|4367160|P1|Overall Study|Withdrawal by Subject|1
1329264|NCT02153346|4367282|P1|Overall Study|Lost to Follow-up|11
1329265|NCT02153086|4367356|P1|Overall Study|Other|2
1329266|NCT02153086|4367356|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
1329267|NCT02152605|4367372|P2|Overall Study|Withdrew consent|2
1329268|NCT02152605|4367373|P1|Overall Study|Withdrew consent|4
1329269|NCT02152605|4367372|P2|Overall Study|Lost to Follow-up|0
1329270|NCT02152605|4367373|P1|Overall Study|Lost to Follow-up|1
1329271|NCT02152605|4367372|P2|Overall Study|Protocol deviation|4
1329272|NCT02152605|4367373|P1|Overall Study|Protocol deviation|1
1329273|NCT02152605|4367372|P2|Overall Study|Lack of Efficacy|4
1329274|NCT02152605|4367373|P1|Overall Study|Lack of Efficacy|7
1329275|NCT02152605|4367372|P2|Overall Study|Adverse Event|8
1329276|NCT02152605|4367373|P1|Overall Study|Adverse Event|6
1329277|NCT02152566|4367383|P1|Overall Study|Withdrawal by Subject|2
1329278|NCT02152566|4367383|P1|Overall Study|Lost to Follow-up|1
1329279|NCT02152371|4367389|P2|Overall Study|Reason Not Given|1
1329280|NCT02152371|4367390|P1|Overall Study|Reason Not Given|0
1329281|NCT02152371|4367389|P2|Overall Study|Physician Decision|2
1329282|NCT02152371|4367390|P1|Overall Study|Physician Decision|0
1329283|NCT02152371|4367389|P2|Overall Study|Lack of Efficacy|1
1329284|NCT02152371|4367390|P1|Overall Study|Lack of Efficacy|0
1329285|NCT02152371|4367389|P2|Overall Study|Lost to Follow-up|0
1329286|NCT02152371|4367390|P1|Overall Study|Lost to Follow-up|1
1329287|NCT02152371|4367389|P2|Overall Study|Protocol Violation|3
1329288|NCT02152371|4367390|P1|Overall Study|Protocol Violation|2
1329289|NCT02152371|4367389|P2|Overall Study|Withdrawal by Subject|7
1329290|NCT02152371|4367390|P1|Overall Study|Withdrawal by Subject|3
1329291|NCT02152371|4367389|P2|Overall Study|Adverse Event|2
1329292|NCT02152371|4367390|P1|Overall Study|Adverse Event|6
1329293|NCT02152007|4367426|P1|Overall Study|Withdrawal by Subject|1
1329294|NCT02151981|4367487|P2|Overall Study|Eligibility criteria not fulfilled|1
1329295|NCT02151981|4367488|P1|Overall Study|Eligibility criteria not fulfilled|0
1329296|NCT02151981|4367487|P2|Overall Study|Ongoing Study at Data Cut-off|95
1329297|NCT02151981|4367488|P1|Overall Study|Ongoing Study at Data Cut-off|224
1329298|NCT02151981|4367487|P2|Overall Study|Withdrawal by Subject|18
1329299|NCT02151981|4367488|P1|Overall Study|Withdrawal by Subject|19
1329300|NCT02151981|4367487|P2|Overall Study|Lost to Follow-up|0
1329301|NCT02151981|4367488|P1|Overall Study|Lost to Follow-up|1
1329302|NCT02151981|4367487|P2|Overall Study|Death|26
1329303|NCT02151981|4367488|P1|Overall Study|Death|35
1329304|NCT02151851|4367506|P2|Overall Study|Adverse Event|28
1329305|NCT02151851|4367507|P1|Overall Study|Adverse Event|6
1329306|NCT02151851|4367506|P2|Overall Study|Subject entered into study in error|1
1329307|NCT02151851|4367507|P1|Overall Study|Subject entered into study in error|0
1329308|NCT02151851|4367506|P2|Overall Study|Low compliance to study visits|1
1329309|NCT02151851|4367507|P1|Overall Study|Low compliance to study visits|0
1329310|NCT02151851|4367506|P2|Overall Study|Medical impairment|0
1329311|NCT02151851|4367507|P1|Overall Study|Medical impairment|1
1329312|NCT02151851|4367506|P2|Overall Study|Withdrawal by Subject|5
1329313|NCT02151851|4367507|P1|Overall Study|Withdrawal by Subject|2
1329314|NCT02151851|4367506|P2|Overall Study|Protocol Violation|1
1329315|NCT02151851|4367507|P1|Overall Study|Protocol Violation|0
1329316|NCT02151851|4367506|P2|Overall Study|Lack of Efficacy|94
1329317|NCT02151851|4367507|P1|Overall Study|Lack of Efficacy|67
1329318|NCT02151786|4367519|P1|Overall Study|Unavailability of Information|8
1329319|NCT02151786|4367519|P1|Overall Study|Randomized, not Treated|1
1329320|NCT02151786|4367519|P1|Overall Study|Outside the Contract Period|1
1329321|NCT02151786|4367519|P1|Overall Study|Unavailability of Case Report Form|26
1329322|NCT02151773|4367530|P1|Overall Study|Protocol Deviation|64
1329323|NCT02151643|4367540|P5|Overall Study|High Ferritin levels|1
1329324|NCT02151643|4367541|P4|Overall Study|High Ferritin levels|2
1329325|NCT02151643|4367542|P3|Overall Study|High Ferritin levels|2
1329326|NCT02151643|4367543|P2|Overall Study|High Ferritin levels|3
1329327|NCT02151643|4367544|P1|Overall Study|High Ferritin levels|3
1329328|NCT02151643|4367540|P5|Overall Study|Hyperphosphataemia|1
1329329|NCT02151643|4367541|P4|Overall Study|Hyperphosphataemia|0
1329330|NCT02151643|4367542|P3|Overall Study|Hyperphosphataemia|0
1329331|NCT02151643|4367543|P2|Overall Study|Hyperphosphataemia|0
1329332|NCT02151643|4367544|P1|Overall Study|Hyperphosphataemia|1
1329333|NCT02151643|4367540|P5|Overall Study|Withdrawal by Subject|1
1329334|NCT02151643|4367541|P4|Overall Study|Withdrawal by Subject|1
1329335|NCT02151643|4367542|P3|Overall Study|Withdrawal by Subject|1
1329336|NCT02151643|4367543|P2|Overall Study|Withdrawal by Subject|1
1329337|NCT02151643|4367544|P1|Overall Study|Withdrawal by Subject|0
1329338|NCT02151643|4367540|P5|Overall Study|Adverse Event|0
1329339|NCT02151643|4367541|P4|Overall Study|Adverse Event|4
1329340|NCT02151643|4367542|P3|Overall Study|Adverse Event|1
1329341|NCT02151643|4367543|P2|Overall Study|Adverse Event|0
1329342|NCT02151643|4367544|P1|Overall Study|Adverse Event|2
1329343|NCT02151461|4367585|P4|Overall Study|Treatment discontinuation|0
1329344|NCT02151461|4367586|P3|Overall Study|Treatment discontinuation|1
1329345|NCT02151461|4367587|P2|Overall Study|Treatment discontinuation|0
1329346|NCT02151461|4367588|P1|Overall Study|Treatment discontinuation|0
1329347|NCT02151461|4367585|P4|Overall Study|Withdrawal by Subject|1
1329348|NCT02151461|4367586|P3|Overall Study|Withdrawal by Subject|1
1329349|NCT02151461|4367587|P2|Overall Study|Withdrawal by Subject|0
1329350|NCT02151461|4367588|P1|Overall Study|Withdrawal by Subject|1
1329351|NCT02151461|4367585|P4|Overall Study|Lost to Follow-up|1
1329352|NCT02151461|4367586|P3|Overall Study|Lost to Follow-up|1
1329353|NCT02151461|4367587|P2|Overall Study|Lost to Follow-up|0
1329354|NCT02151461|4367588|P1|Overall Study|Lost to Follow-up|0
1329355|NCT02151461|4367585|P4|Overall Study|Adverse Event|2
1329356|NCT02151461|4367586|P3|Overall Study|Adverse Event|0
1329357|NCT02151461|4367587|P2|Overall Study|Adverse Event|1
1329358|NCT02151461|4367588|P1|Overall Study|Adverse Event|5
1329359|NCT02151058|4367644|P3|Overall Study|Lost to Follow-up|2
1329360|NCT02151058|4367645|P2|Overall Study|Lost to Follow-up|0
1329361|NCT02151058|4367646|P1|Overall Study|Lost to Follow-up|1
1329362|NCT02151058|4367644|P3|Overall Study|Withdrawal by Subject|3
1329363|NCT02151058|4367645|P2|Overall Study|Withdrawal by Subject|1
1329364|NCT02151058|4367646|P1|Overall Study|Withdrawal by Subject|1
1329365|NCT02150954|4367680|P2|Overall Study|Protocol Violation|0
1329366|NCT02150954|4367681|P1|Overall Study|Protocol Violation|1
1329367|NCT02150343|4367757|P4|Overall Study|Not specified|2
1329368|NCT02150343|4367758|P3|Overall Study|Not specified|0
1329369|NCT02150343|4367759|P2|Overall Study|Not specified|6
1329370|NCT02150343|4367760|P1|Overall Study|Not specified|2
1329371|NCT02150343|4367757|P4|Overall Study|Lost to Follow-up|3
1329372|NCT02150343|4367758|P3|Overall Study|Lost to Follow-up|2
1329373|NCT02150343|4367759|P2|Overall Study|Lost to Follow-up|4
1329374|NCT02150343|4367760|P1|Overall Study|Lost to Follow-up|4
1329375|NCT02150343|4367757|P4|Overall Study|Withdrawal by Subject|4
1329376|NCT02150343|4367758|P3|Overall Study|Withdrawal by Subject|9
1329377|NCT02150343|4367759|P2|Overall Study|Withdrawal by Subject|10
1329378|NCT02150343|4367760|P1|Overall Study|Withdrawal by Subject|13
1329379|NCT02150343|4367757|P4|Overall Study|Adverse Event|1
1329380|NCT02150343|4367758|P3|Overall Study|Adverse Event|1
1329381|NCT02150343|4367759|P2|Overall Study|Adverse Event|0
1329382|NCT02150343|4367760|P1|Overall Study|Adverse Event|2
1329383|NCT02150213|4367798|P1|Overall Study|Withdrawal by Subject|1
1329384|NCT02150213|4367798|P1|Overall Study|Lost to Follow-up|1
1329385|NCT02149875|4367824|P3|Overall Study|Physician Decision|2
1329386|NCT02149875|4367825|P2|Overall Study|Physician Decision|2
1329387|NCT02149875|4367826|P1|Overall Study|Physician Decision|1
1329388|NCT02149875|4367824|P3|Overall Study|Withdrawal by Subject|2
1329389|NCT02149875|4367825|P2|Overall Study|Withdrawal by Subject|2
1329390|NCT02149875|4367826|P1|Overall Study|Withdrawal by Subject|3
1329391|NCT02149875|4367824|P3|Overall Study|Lost to Follow-up|5
1329392|NCT02149875|4367825|P2|Overall Study|Lost to Follow-up|4
1329393|NCT02149875|4367826|P1|Overall Study|Lost to Follow-up|3
1329394|NCT02149264|4367855|P1|Overall Study|Protocol Violation|1
1329395|NCT02149264|4367855|P1|Overall Study|Physician Decision|3
1329396|NCT02149264|4367855|P1|Overall Study|Adverse Event|7
1329397|NCT02149264|4367855|P1|Overall Study|Withdrawal by Subject|9
1329398|NCT02149108|4367870|P2|Overall Study|Lost to Follow-up|0
1329399|NCT02149108|4367871|P1|Overall Study|Lost to Follow-up|1
1329400|NCT02149108|4367870|P2|Overall Study|Refusal to continue trial medication|11
1329401|NCT02149108|4367871|P1|Overall Study|Refusal to continue trial medication|15
1329402|NCT02149108|4367870|P2|Overall Study|Other not defined above|2
1329403|NCT02149108|4367871|P1|Overall Study|Other not defined above|0
1329404|NCT02149108|4367870|P2|Overall Study|Other Adverse Event (AE)|18
1329405|NCT02149108|4367871|P1|Overall Study|Other Adverse Event (AE)|8
1329406|NCT02149108|4367870|P2|Overall Study|Worsening/adverse event cancer disease|32
1329407|NCT02149108|4367871|P1|Overall Study|Worsening/adverse event cancer disease|31
1329408|NCT02149108|4367870|P2|Overall Study|Progressive Disease (PD)|318
1329409|NCT02149108|4367871|P1|Overall Study|Progressive Disease (PD)|324
1329410|NCT02149108|4367870|P2|Overall Study|Not treated|2
1329411|NCT02149108|4367871|P1|Overall Study|Not treated|1
1329412|NCT02148718|4367888|P1|Overall Study|Discontinued Study Prematurely|5
1329413|NCT02148718|4367888|P1|Overall Study|Protocol Violation|26
1329414|NCT02148445|4367936|P2|Overall Study|Death|3
1329415|NCT02148445|4367937|P1|Overall Study|Death|1
1329416|NCT02147691|4368012|P2|Overall Study|Lost to Follow-up|1
1329417|NCT02147691|4368013|P1|Overall Study|Lost to Follow-up|0
1329418|NCT02147691|4368012|P2|Overall Study|Adverse Event|0
1329419|NCT02147691|4368013|P1|Overall Study|Adverse Event|2
1329420|NCT02147691|4368012|P2|Overall Study|Withdrawal by Subject|0
1329421|NCT02147691|4368013|P1|Overall Study|Withdrawal by Subject|2
1329422|NCT02147587|4368059|P2|Overall Study|Lack of Efficacy|1
1329423|NCT02147587|4368060|P1|Overall Study|Lack of Efficacy|2
1329424|NCT02147587|4368059|P2|Overall Study|Adverse Event|4
1329425|NCT02147587|4368060|P1|Overall Study|Adverse Event|9
1329426|NCT02147561|4368080|P1|Overall Study|Subjects who didn’t receive BOTOX|1
1329427|NCT02147561|4368080|P1|Overall Study|Lost to Follow-up|3
1329428|NCT02147288|4368101|P10|Overall Study|complications from concurrent hernia rep|0
1329429|NCT02147288|4368102|P9|Overall Study|complications from concurrent hernia rep|0
1329430|NCT02147288|4368103|P8|Overall Study|complications from concurrent hernia rep|0
1329431|NCT02147288|4368104|P7|Overall Study|complications from concurrent hernia rep|0
1329432|NCT02147288|4368105|P6|Overall Study|complications from concurrent hernia rep|0
1329433|NCT02147288|4368106|P5|Overall Study|complications from concurrent hernia rep|0
1329434|NCT02147288|4368107|P4|Overall Study|complications from concurrent hernia rep|0
1329435|NCT02147288|4368108|P3|Overall Study|complications from concurrent hernia rep|0
1329436|NCT02147288|4368109|P2|Overall Study|complications from concurrent hernia rep|1
1329437|NCT02147288|4368110|P1|Overall Study|complications from concurrent hernia rep|0
1329438|NCT02147288|4368101|P10|Overall Study|post-operative hematoma|0
1329439|NCT02147288|4368102|P9|Overall Study|post-operative hematoma|0
1329440|NCT02147288|4368103|P8|Overall Study|post-operative hematoma|0
1329441|NCT02147288|4368104|P7|Overall Study|post-operative hematoma|0
1329442|NCT02147288|4368105|P6|Overall Study|post-operative hematoma|0
1329443|NCT02147288|4368106|P5|Overall Study|post-operative hematoma|0
1329444|NCT02147288|4368107|P4|Overall Study|post-operative hematoma|0
1329445|NCT02147288|4368108|P3|Overall Study|post-operative hematoma|0
1329446|NCT02147288|4368109|P2|Overall Study|post-operative hematoma|1
1329447|NCT02147288|4368110|P1|Overall Study|post-operative hematoma|1
1329448|NCT02147184|4368118|P2|Overall Study|Other|0
1329449|NCT02147184|4368119|P1|Overall Study|Other|1
1329450|NCT02147184|4368118|P2|Overall Study|Physician Decision|2
1329451|NCT02147184|4368119|P1|Overall Study|Physician Decision|0
1329452|NCT02147184|4368118|P2|Overall Study|Moved out of state|3
1329453|NCT02147184|4368119|P1|Overall Study|Moved out of state|3
1329454|NCT02147184|4368118|P2|Overall Study|Pregnancy|0
1329455|NCT02147184|4368119|P1|Overall Study|Pregnancy|6
1329456|NCT02147184|4368118|P2|Overall Study|Study Burden|7
1329457|NCT02147184|4368119|P1|Overall Study|Study Burden|11
1329458|NCT02147184|4368118|P2|Overall Study|Lost to Follow-up|15
1329459|NCT02147184|4368119|P1|Overall Study|Lost to Follow-up|28
1329460|NCT02147093|4368139|P2|Period 2|Protocol Violation|0
1329461|NCT02147093|4368140|P1|Period 2|Protocol Violation|2
1329462|NCT02147093|4368139|P2|Period 1|Lost to Follow-up|1
1329463|NCT02147093|4368140|P1|Period 1|Lost to Follow-up|0
1329464|NCT02146599|4368148|P1|Overall Study|Failed to meet inclusion criteria|5
1329465|NCT02146352|4368161|P1|Overall Study|Patient entered hospice care|1
1329466|NCT02146352|4368161|P1|Overall Study|Death|1
1329467|NCT02146326|4368179|P4|Overall Study|Unable to complete interview|6
1329468|NCT02146326|4368180|P3|Overall Study|Unable to complete interview|10
1329469|NCT02146326|4368181|P2|Overall Study|Unable to complete interview|0
1329470|NCT02146326|4368182|P1|Overall Study|Unable to complete interview|0
1329471|NCT02146326|4368179|P4|Overall Study|Death|4
1329472|NCT02146326|4368180|P3|Overall Study|Death|4
1329473|NCT02146326|4368181|P2|Overall Study|Death|0
1329474|NCT02146326|4368182|P1|Overall Study|Death|0
1329475|NCT02146326|4368179|P4|Overall Study|Incarcerated|8
1329476|NCT02146326|4368180|P3|Overall Study|Incarcerated|3
1329477|NCT02146326|4368181|P2|Overall Study|Incarcerated|0
1329478|NCT02146326|4368182|P1|Overall Study|Incarcerated|0
1329479|NCT02146326|4368179|P4|Overall Study|Separated from mental health center|0
1329480|NCT02146326|4368180|P3|Overall Study|Separated from mental health center|0
1329481|NCT02146326|4368181|P2|Overall Study|Separated from mental health center|33
1329482|NCT02146326|4368182|P1|Overall Study|Separated from mental health center|23
1329483|NCT02146326|4368179|P4|Overall Study|Withdrawal by Subject|11
1329484|NCT02146326|4368180|P3|Overall Study|Withdrawal by Subject|15
1329485|NCT02146326|4368181|P2|Overall Study|Withdrawal by Subject|1
1329486|NCT02146326|4368182|P1|Overall Study|Withdrawal by Subject|2
1329487|NCT02146326|4368179|P4|Overall Study|Lost to Follow-up|19
1329488|NCT02146326|4368180|P3|Overall Study|Lost to Follow-up|11
1329489|NCT02146326|4368181|P2|Overall Study|Lost to Follow-up|3
1329490|NCT02146326|4368182|P1|Overall Study|Lost to Follow-up|3
1329491|NCT02146248|4368344|P1|Overall Study|Withdrawal by Subject|2
1329492|NCT02146105|4368352|P1|Overall Study|Withdrawal by Subject|5
1329493|NCT02146105|4368352|P1|Overall Study|Adverse Event|1
1329494|NCT02145468|4368403|P2|Overall Study|Withdrawal by Subject|8
1329495|NCT02145468|4368404|P1|Overall Study|Withdrawal by Subject|5
1329496|NCT02145390|4368460|P1|Overall Study|Withdrawal by Subject|1
1329497|NCT02145156|4368501|P3|Overall Study|No match to vaccination records|41
1329498|NCT02145156|4368502|P2|Overall Study|No match to vaccination records|52
1329499|NCT02145156|4368503|P1|Overall Study|No match to vaccination records|60
1329500|NCT02144337|4368566|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
1329501|NCT02144337|4368567|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
1329502|NCT02144337|4368566|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
1329503|NCT02144337|4368567|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
1329504|NCT02144337|4368566|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
1329505|NCT02144337|4368567|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
1329506|NCT02144337|4368566|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
1329507|NCT02144337|4368567|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
1329508|NCT02144337|4368566|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
1329509|NCT02144337|4368567|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
1329510|NCT02144220|4368596|P1|Overall Study|Protocol Violation|1
1329511|NCT02144220|4368596|P1|Overall Study|Withdrawal by Subject|2
1329512|NCT02144220|4368596|P1|Overall Study|Physician Decision|3
1329513|NCT02144220|4368596|P1|Overall Study|Lack of Efficacy|4
1329514|NCT02144220|4368596|P1|Overall Study|technology incompatibility|9
1329515|NCT02144012|4368606|P2|Overall Study|Other|0
1329516|NCT02144012|4368607|P1|Overall Study|Other|3
1329517|NCT02144012|4368606|P2|Overall Study|Study Terminated by Sponsor|12
1329518|NCT02144012|4368607|P1|Overall Study|Study Terminated by Sponsor|18
1329519|NCT02144012|4368606|P2|Overall Study|Withdrawal by Subject|3
1329520|NCT02144012|4368607|P1|Overall Study|Withdrawal by Subject|11
1329521|NCT02144012|4368606|P2|Overall Study|Death|0
1329522|NCT02144012|4368607|P1|Overall Study|Death|1
1329523|NCT02144012|4368606|P2|Overall Study|Adverse Event|0
1329524|NCT02144012|4368607|P1|Overall Study|Adverse Event|1
1329525|NCT02143947|4368644|P2|Overall Study|Lost to Follow-up|2
1329526|NCT02143947|4368645|P1|Overall Study|Lost to Follow-up|4
1329527|NCT02143583|4368660|P3|Overall Study|husband illness|1
1329528|NCT02143583|4368661|P2|Overall Study|husband illness|0
1329529|NCT02143583|4368662|P1|Overall Study|husband illness|0
1329530|NCT02143583|4368660|P3|Overall Study|Withdrawal by Subject|1
1329531|NCT02143583|4368661|P2|Overall Study|Withdrawal by Subject|0
1329532|NCT02143583|4368662|P1|Overall Study|Withdrawal by Subject|1
1329533|NCT02143141|4368675|P2|Overall Study|pain scores at 24 hours not collected|0
1329534|NCT02143141|4368676|P1|Overall Study|pain scores at 24 hours not collected|1
1329535|NCT02143102|4368688|P2|Overall Study|Lost to Follow-up|0
1329536|NCT02143102|4368689|P1|Overall Study|Lost to Follow-up|11
1329537|NCT02142738|4368699|P2|Overall Study|Ongoing in Study|82
1329538|NCT02142738|4368700|P1|Overall Study|Ongoing in Study|107
1329539|NCT02142738|4368699|P2|Overall Study|Withdrawal by Subject|5
1329540|NCT02142738|4368700|P1|Overall Study|Withdrawal by Subject|5
1329541|NCT02142738|4368699|P2|Overall Study|Progressive Disease|1
1329542|NCT02142738|4368700|P1|Overall Study|Progressive Disease|0
1329543|NCT02142738|4368699|P2|Overall Study|Death|55
1329544|NCT02142738|4368700|P1|Overall Study|Death|33
1329545|NCT02142738|4368699|P2|Overall Study|Adverse Event|8
1329546|NCT02142738|4368700|P1|Overall Study|Adverse Event|9
1329547|NCT02142712|4368713|P4|Overall Study|Lost to Follow-up|0
1329548|NCT02142712|4368714|P3|Overall Study|Lost to Follow-up|1
1329549|NCT02142712|4368715|P2|Overall Study|Lost to Follow-up|1
1329550|NCT02142712|4368716|P1|Overall Study|Lost to Follow-up|1
1329551|NCT02142504|4368739|P3|Overall Study|Reason Not Specified|4
1329552|NCT02142504|4368740|P2|Overall Study|Reason Not Specified|5
1329553|NCT02142504|4368741|P1|Overall Study|Reason Not Specified|4
1329554|NCT02142504|4368739|P3|Overall Study|Physician Decision|3
1329555|NCT02142504|4368740|P2|Overall Study|Physician Decision|1
1329556|NCT02142504|4368741|P1|Overall Study|Physician Decision|0
1329557|NCT02142504|4368739|P3|Overall Study|Pregnancy|2
1329558|NCT02142504|4368740|P2|Overall Study|Pregnancy|4
1329559|NCT02142504|4368741|P1|Overall Study|Pregnancy|4
1329560|NCT02142504|4368739|P3|Overall Study|Withdrawal by Subject|11
1329561|NCT02142504|4368740|P2|Overall Study|Withdrawal by Subject|9
1329562|NCT02142504|4368741|P1|Overall Study|Withdrawal by Subject|7
1329563|NCT02142504|4368739|P3|Overall Study|Lost to Follow-up|17
1329564|NCT02142504|4368740|P2|Overall Study|Lost to Follow-up|19
1329565|NCT02142504|4368741|P1|Overall Study|Lost to Follow-up|12
1329566|NCT02142504|4368739|P3|Overall Study|Adverse Event|4
1329567|NCT02142504|4368740|P2|Overall Study|Adverse Event|3
1329568|NCT02142504|4368741|P1|Overall Study|Adverse Event|2
1329569|NCT02142504|4368739|P3|Overall Study|Protocol Violation|2
1329570|NCT02142504|4368740|P2|Overall Study|Protocol Violation|1
1329571|NCT02142504|4368741|P1|Overall Study|Protocol Violation|2
1329572|NCT02142283|4368930|P2|Overall Study|Withdrawal by Subject|3
1329573|NCT02142283|4368931|P1|Overall Study|Withdrawal by Subject|1
1329574|NCT02142283|4368930|P2|Overall Study|Death|18
1329575|NCT02142283|4368931|P1|Overall Study|Death|20
1329576|NCT02141997|4369006|P4|Overall Study|Not specified|0
1329577|NCT02141997|4369007|P3|Overall Study|Not specified|0
1329578|NCT02141997|4369008|P2|Overall Study|Not specified|4
1329579|NCT02141997|4369009|P1|Overall Study|Not specified|1
1329580|NCT02141997|4369006|P4|Overall Study|Withdrew consent|0
1329581|NCT02141997|4369007|P3|Overall Study|Withdrew consent|3
1329582|NCT02141997|4369008|P2|Overall Study|Withdrew consent|0
1329583|NCT02141997|4369009|P1|Overall Study|Withdrew consent|1
1329584|NCT02141997|4369006|P4|Overall Study|Participant noncompliance|0
1329585|NCT02141997|4369007|P3|Overall Study|Participant noncompliance|0
1329586|NCT02141997|4369008|P2|Overall Study|Participant noncompliance|0
1329587|NCT02141997|4369009|P1|Overall Study|Participant noncompliance|1
1329588|NCT02141997|4369006|P4|Overall Study|Adverse Event|1
1329589|NCT02141997|4369007|P3|Overall Study|Adverse Event|0
1329590|NCT02141997|4369008|P2|Overall Study|Adverse Event|2
1329591|NCT02141997|4369009|P1|Overall Study|Adverse Event|0
1329592|NCT02141984|4369047|P1|Overall Study|Lack of Efficacy|2
1329593|NCT02141854|4369066|P6|Treatment Period|Lost to Follow-up|1
1329594|NCT02141854|4369067|P5|Treatment Period|Lost to Follow-up|0
1329595|NCT02141854|4369068|P4|Treatment Period|Lost to Follow-up|1
1329596|NCT02141854|4369069|P3|Treatment Period|Lost to Follow-up|1
1329597|NCT02141854|4369070|P2|Treatment Period|Lost to Follow-up|1
1329598|NCT02141854|4369071|P1|Treatment Period|Lost to Follow-up|0
1329599|NCT02141854|4369066|P6|Treatment Period|Disease progression|18
1329600|NCT02141854|4369067|P5|Treatment Period|Disease progression|0
1329601|NCT02141854|4369068|P4|Treatment Period|Disease progression|3
1329602|NCT02141854|4369069|P3|Treatment Period|Disease progression|1
1329603|NCT02141854|4369070|P2|Treatment Period|Disease progression|2
1329604|NCT02141854|4369071|P1|Treatment Period|Disease progression|0
1329605|NCT02141854|4369066|P6|Treatment Period|Withdrawal by Subject|7
1329606|NCT02141854|4369067|P5|Treatment Period|Withdrawal by Subject|4
1329607|NCT02141854|4369068|P4|Treatment Period|Withdrawal by Subject|3
1329608|NCT02141854|4369069|P3|Treatment Period|Withdrawal by Subject|3
1329609|NCT02141854|4369070|P2|Treatment Period|Withdrawal by Subject|2
1329610|NCT02141854|4369071|P1|Treatment Period|Withdrawal by Subject|0
1329611|NCT02141854|4369066|P6|Treatment Period|Adverse Event|2
1329612|NCT02141854|4369067|P5|Treatment Period|Adverse Event|2
1329613|NCT02141854|4369068|P4|Treatment Period|Adverse Event|0
1329614|NCT02141854|4369069|P3|Treatment Period|Adverse Event|2
1329615|NCT02141854|4369070|P2|Treatment Period|Adverse Event|2
1329616|NCT02141854|4369071|P1|Treatment Period|Adverse Event|0
1329617|NCT02141854|4369066|P6|Treatment Period|Not specified|2
1329618|NCT02141854|4369067|P5|Treatment Period|Not specified|1
1329619|NCT02141854|4369068|P4|Treatment Period|Not specified|0
1329620|NCT02141854|4369069|P3|Treatment Period|Not specified|2
1329621|NCT02141854|4369070|P2|Treatment Period|Not specified|1
1329622|NCT02141854|4369071|P1|Treatment Period|Not specified|0
1329623|NCT02141854|4369066|P6|Treatment Period|Pregnancy|0
1329624|NCT02141854|4369067|P5|Treatment Period|Pregnancy|0
1329625|NCT02141854|4369068|P4|Treatment Period|Pregnancy|0
1329626|NCT02141854|4369069|P3|Treatment Period|Pregnancy|0
1329627|NCT02141854|4369070|P2|Treatment Period|Pregnancy|1
1329628|NCT02141854|4369071|P1|Treatment Period|Pregnancy|0
1329629|NCT02141854|4369066|P6|Treatment Period|Lack of Efficacy|7
1329630|NCT02141854|4369067|P5|Treatment Period|Lack of Efficacy|1
1329631|NCT02141854|4369068|P4|Treatment Period|Lack of Efficacy|1
1329632|NCT02141854|4369069|P3|Treatment Period|Lack of Efficacy|0
1329633|NCT02141854|4369070|P2|Treatment Period|Lack of Efficacy|0
1329634|NCT02141854|4369071|P1|Treatment Period|Lack of Efficacy|0
1329635|NCT02141854|4369066|P6|Treatment Period|Noncompliance|0
1329636|NCT02141854|4369067|P5|Treatment Period|Noncompliance|0
1329637|NCT02141854|4369068|P4|Treatment Period|Noncompliance|1
1329638|NCT02141854|4369069|P3|Treatment Period|Noncompliance|0
1329639|NCT02141854|4369070|P2|Treatment Period|Noncompliance|0
1329640|NCT02141854|4369071|P1|Treatment Period|Noncompliance|0
1329641|NCT02141854|4369066|P6|Treatment Period|Protocol Violation|1
1329642|NCT02141854|4369067|P5|Treatment Period|Protocol Violation|2
1329643|NCT02141854|4369068|P4|Treatment Period|Protocol Violation|2
1329644|NCT02141854|4369069|P3|Treatment Period|Protocol Violation|0
1329645|NCT02141854|4369070|P2|Treatment Period|Protocol Violation|1
1329646|NCT02141854|4369071|P1|Treatment Period|Protocol Violation|0
1329647|NCT02141854|4369066|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1329648|NCT02141854|4369067|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1329649|NCT02141854|4369068|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1329650|NCT02141854|4369069|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1329651|NCT02141854|4369070|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1329652|NCT02141854|4369071|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
1329653|NCT02141854|4369066|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1329654|NCT02141854|4369067|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1329655|NCT02141854|4369068|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1329656|NCT02141854|4369069|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1329657|NCT02141854|4369070|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1329658|NCT02141854|4369071|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
1329659|NCT02141854|4369066|P6|Run-In Period (Pre-assignment)|Adverse Event|0
1329660|NCT02141854|4369067|P5|Run-In Period (Pre-assignment)|Adverse Event|0
1329661|NCT02141854|4369068|P4|Run-In Period (Pre-assignment)|Adverse Event|0
1329662|NCT02141854|4369069|P3|Run-In Period (Pre-assignment)|Adverse Event|0
1329663|NCT02141854|4369070|P2|Run-In Period (Pre-assignment)|Adverse Event|0
1329664|NCT02141854|4369071|P1|Run-In Period (Pre-assignment)|Adverse Event|10
1329665|NCT02141854|4369066|P6|Run-In Period (Pre-assignment)|Not specified|0
1329666|NCT02141854|4369067|P5|Run-In Period (Pre-assignment)|Not specified|0
1329667|NCT02141854|4369068|P4|Run-In Period (Pre-assignment)|Not specified|0
1329668|NCT02141854|4369069|P3|Run-In Period (Pre-assignment)|Not specified|0
1329669|NCT02141854|4369070|P2|Run-In Period (Pre-assignment)|Not specified|0
1329670|NCT02141854|4369071|P1|Run-In Period (Pre-assignment)|Not specified|14
1329671|NCT02141854|4369066|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1329672|NCT02141854|4369067|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1329673|NCT02141854|4369068|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1329674|NCT02141854|4369069|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1329675|NCT02141854|4369070|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1329676|NCT02141854|4369071|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
1329677|NCT02141854|4369066|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1329678|NCT02141854|4369067|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1329679|NCT02141854|4369068|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1329680|NCT02141854|4369069|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1329681|NCT02141854|4369070|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1329682|NCT02141854|4369071|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
1329683|NCT02141854|4369066|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1329684|NCT02141854|4369067|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1329685|NCT02141854|4369068|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1329686|NCT02141854|4369069|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1329687|NCT02141854|4369070|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1329688|NCT02141854|4369071|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
1329689|NCT02141633|4369125|P2|Overall Study|Physician Decision|0
1329690|NCT02141633|4369126|P1|Overall Study|Physician Decision|1
1329691|NCT02141620|4369134|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
1329692|NCT02141620|4369135|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
1329693|NCT02141516|4369212|P3|Overall Study|Other|0
1329694|NCT02141516|4369213|P2|Overall Study|Other|3
1329695|NCT02141516|4369214|P1|Overall Study|Other|0
1329696|NCT02141516|4369212|P3|Overall Study|Lost to Follow-up|0
1329697|NCT02141516|4369213|P2|Overall Study|Lost to Follow-up|1
1329698|NCT02141516|4369214|P1|Overall Study|Lost to Follow-up|0
1329699|NCT02141516|4369212|P3|Overall Study|Adverse Event|0
1329700|NCT02141516|4369213|P2|Overall Study|Adverse Event|1
1329701|NCT02141516|4369214|P1|Overall Study|Adverse Event|0
1329702|NCT02141360|4369264|P3|Overall Study|Study Terminated before Visit|0
1329703|NCT02141360|4369265|P2|Overall Study|Study Terminated before Visit|0
1329704|NCT02141360|4369266|P1|Overall Study|Study Terminated before Visit|1
1329705|NCT02141360|4369264|P3|Overall Study|Withdrawal by Subject|0
1329706|NCT02141360|4369265|P2|Overall Study|Withdrawal by Subject|0
1329707|NCT02141360|4369266|P1|Overall Study|Withdrawal by Subject|6
1329708|NCT02141217|4369276|P2|Overall Study|Surgical Intervention|1
1329709|NCT02141217|4369277|P1|Overall Study|Surgical Intervention|1
1329710|NCT02141217|4369276|P2|Overall Study|Physician Decision|0
1329711|NCT02141217|4369277|P1|Overall Study|Physician Decision|1
1329712|NCT02141217|4369276|P2|Overall Study|Lost to Follow-up|1
1329713|NCT02141217|4369277|P1|Overall Study|Lost to Follow-up|1
1329714|NCT02141217|4369276|P2|Overall Study|Withdrawal by Subject|0
1329715|NCT02141217|4369277|P1|Overall Study|Withdrawal by Subject|6
1329716|NCT02141217|4369276|P2|Overall Study|Protocol Violation|4
1329717|NCT02141217|4369277|P1|Overall Study|Protocol Violation|1
1329718|NCT02141217|4369276|P2|Overall Study|Adverse Event|2
1329719|NCT02141217|4369277|P1|Overall Study|Adverse Event|1
1329720|NCT02140762|4369339|P2|Overall Study|Other|1
1329721|NCT02140762|4369340|P1|Overall Study|Other|0
1329722|NCT02140762|4369339|P2|Overall Study|Withdrawal by Subject|4
1329723|NCT02140762|4369340|P1|Overall Study|Withdrawal by Subject|6
1329724|NCT02140762|4369339|P2|Overall Study|Protocol Violation|1
1329725|NCT02140762|4369340|P1|Overall Study|Protocol Violation|1
1329726|NCT02140762|4369339|P2|Overall Study|Lost to Follow-up|5
1329727|NCT02140762|4369340|P1|Overall Study|Lost to Follow-up|9
1329728|NCT02140762|4369339|P2|Overall Study|Adverse Event|1
1329729|NCT02140762|4369340|P1|Overall Study|Adverse Event|1
1329730|NCT02140645|4369386|P6|Overall Study|Not linked|70896
1329731|NCT02140645|4369387|P5|Overall Study|Not linked|3286
1329732|NCT02140645|4369388|P4|Overall Study|Not linked|13833
1329733|NCT02140645|4369389|P3|Overall Study|Not linked|4236
1329734|NCT02140645|4369390|P2|Overall Study|Not linked|61654
1329735|NCT02140645|4369391|P1|Overall Study|Not linked|5489
1329736|NCT02140567|4369489|P1|Overall Study|Problems with recording equipment|6
1329737|NCT02140164|4369505|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
1329738|NCT02140060|4369526|P6|Overall Study|Lack of Efficacy|0
1329739|NCT02140060|4369527|P5|Overall Study|Lack of Efficacy|0
1329740|NCT02140060|4369528|P4|Overall Study|Lack of Efficacy|1
1329741|NCT02140060|4369529|P3|Overall Study|Lack of Efficacy|0
1329742|NCT02140060|4369530|P2|Overall Study|Lack of Efficacy|0
1329743|NCT02140060|4369531|P1|Overall Study|Lack of Efficacy|0
1329744|NCT02140060|4369526|P6|Overall Study|Adverse Event|1
1329745|NCT02140060|4369527|P5|Overall Study|Adverse Event|1
1329746|NCT02140060|4369528|P4|Overall Study|Adverse Event|1
1329747|NCT02140060|4369529|P3|Overall Study|Adverse Event|0
1329748|NCT02140060|4369530|P2|Overall Study|Adverse Event|0
1329749|NCT02140060|4369531|P1|Overall Study|Adverse Event|0
1329750|NCT02139982|4369556|P10|Overall Study|Lack of Efficacy|0
1329751|NCT02139982|4369557|P9|Overall Study|Lack of Efficacy|0
1329752|NCT02139982|4369558|P8|Overall Study|Lack of Efficacy|0
1329753|NCT02139982|4369559|P7|Overall Study|Lack of Efficacy|0
1329754|NCT02139982|4369560|P6|Overall Study|Lack of Efficacy|0
1329755|NCT02139982|4369561|P5|Overall Study|Lack of Efficacy|0
1329756|NCT02139982|4369562|P4|Overall Study|Lack of Efficacy|1
1329757|NCT02139982|4369563|P3|Overall Study|Lack of Efficacy|0
1329758|NCT02139982|4369564|P2|Overall Study|Lack of Efficacy|1
1329759|NCT02139982|4369565|P1|Overall Study|Lack of Efficacy|0
1329760|NCT02139943|4369610|P3|Overall Study|eGFR Withdrawal Criteria|1
1329761|NCT02139943|4369611|P2|Overall Study|eGFR Withdrawal Criteria|0
1329762|NCT02139943|4369612|P1|Overall Study|eGFR Withdrawal Criteria|0
1329763|NCT02139943|4369610|P3|Overall Study|Participant in Poor Compliance|1
1329764|NCT02139943|4369611|P2|Overall Study|Participant in Poor Compliance|0
1329765|NCT02139943|4369612|P1|Overall Study|Participant in Poor Compliance|1
1329766|NCT02139943|4369610|P3|Overall Study|Participant wishes to discontinue|0
1329767|NCT02139943|4369611|P2|Overall Study|Participant wishes to discontinue|0
1329768|NCT02139943|4369612|P1|Overall Study|Participant wishes to discontinue|2
1329769|NCT02139943|4369610|P3|Overall Study|Other|1
1329770|NCT02139943|4369611|P2|Overall Study|Other|0
1329771|NCT02139943|4369612|P1|Overall Study|Other|0
1329772|NCT02139943|4369610|P3|Overall Study|Withdrawal by Subject|0
1329773|NCT02139943|4369611|P2|Overall Study|Withdrawal by Subject|3
1329774|NCT02139943|4369612|P1|Overall Study|Withdrawal by Subject|4
1329775|NCT02139943|4369610|P3|Overall Study|Lost to Follow-up|2
1329776|NCT02139943|4369611|P2|Overall Study|Lost to Follow-up|2
1329777|NCT02139943|4369612|P1|Overall Study|Lost to Follow-up|3
1329778|NCT02139943|4369610|P3|Overall Study|Adverse Event|2
1329779|NCT02139943|4369611|P2|Overall Study|Adverse Event|1
1329780|NCT02139943|4369612|P1|Overall Study|Adverse Event|0
1329781|NCT02139644|4369637|P6|Treatment Period|Not specified|1
1329782|NCT02139644|4369638|P5|Treatment Period|Not specified|0
1329783|NCT02139644|4369639|P4|Treatment Period|Not specified|1
1329784|NCT02139644|4369640|P3|Treatment Period|Not specified|1
1329785|NCT02139644|4369641|P2|Treatment Period|Not specified|3
1329786|NCT02139644|4369642|P1|Treatment Period|Not specified|0
1329787|NCT02139644|4369637|P6|Treatment Period|Lack of Efficacy|4
1329788|NCT02139644|4369638|P5|Treatment Period|Lack of Efficacy|1
1329789|NCT02139644|4369639|P4|Treatment Period|Lack of Efficacy|0
1329790|NCT02139644|4369640|P3|Treatment Period|Lack of Efficacy|1
1329791|NCT02139644|4369641|P2|Treatment Period|Lack of Efficacy|0
1329792|NCT02139644|4369642|P1|Treatment Period|Lack of Efficacy|0
1329793|NCT02139644|4369637|P6|Treatment Period|Lost to Follow-up|1
1329794|NCT02139644|4369638|P5|Treatment Period|Lost to Follow-up|1
1329795|NCT02139644|4369639|P4|Treatment Period|Lost to Follow-up|1
1329796|NCT02139644|4369640|P3|Treatment Period|Lost to Follow-up|1
1329797|NCT02139644|4369641|P2|Treatment Period|Lost to Follow-up|0
1329798|NCT02139644|4369642|P1|Treatment Period|Lost to Follow-up|0
1329799|NCT02139644|4369637|P6|Treatment Period|Disease progression|2
1329800|NCT02139644|4369638|P5|Treatment Period|Disease progression|1
1329801|NCT02139644|4369639|P4|Treatment Period|Disease progression|1
1329802|NCT02139644|4369640|P3|Treatment Period|Disease progression|0
1329803|NCT02139644|4369641|P2|Treatment Period|Disease progression|0
1329804|NCT02139644|4369642|P1|Treatment Period|Disease progression|0
1329805|NCT02139644|4369637|P6|Treatment Period|Protocol Violation|1
1329806|NCT02139644|4369638|P5|Treatment Period|Protocol Violation|1
1329807|NCT02139644|4369639|P4|Treatment Period|Protocol Violation|1
1329808|NCT02139644|4369640|P3|Treatment Period|Protocol Violation|0
1329809|NCT02139644|4369641|P2|Treatment Period|Protocol Violation|0
1329810|NCT02139644|4369642|P1|Treatment Period|Protocol Violation|0
1329811|NCT02139644|4369637|P6|Treatment Period|Non-compliance|0
1329812|NCT02139644|4369638|P5|Treatment Period|Non-compliance|0
1329813|NCT02139644|4369639|P4|Treatment Period|Non-compliance|1
1329814|NCT02139644|4369640|P3|Treatment Period|Non-compliance|0
1329815|NCT02139644|4369641|P2|Treatment Period|Non-compliance|0
1329816|NCT02139644|4369642|P1|Treatment Period|Non-compliance|0
1329817|NCT02139644|4369637|P6|Treatment Period|Withdrawal by Subject|2
1329818|NCT02139644|4369638|P5|Treatment Period|Withdrawal by Subject|3
1329819|NCT02139644|4369639|P4|Treatment Period|Withdrawal by Subject|2
1329820|NCT02139644|4369640|P3|Treatment Period|Withdrawal by Subject|2
1329821|NCT02139644|4369641|P2|Treatment Period|Withdrawal by Subject|0
1329822|NCT02139644|4369642|P1|Treatment Period|Withdrawal by Subject|0
1329823|NCT02139644|4369637|P6|Treatment Period|Adverse Event|6
1329824|NCT02139644|4369638|P5|Treatment Period|Adverse Event|1
1329825|NCT02139644|4369639|P4|Treatment Period|Adverse Event|2
1329826|NCT02139644|4369640|P3|Treatment Period|Adverse Event|3
1329827|NCT02139644|4369641|P2|Treatment Period|Adverse Event|0
1329828|NCT02139644|4369642|P1|Treatment Period|Adverse Event|0
1329829|NCT02139644|4369637|P6|Run-In Period (Pre-assignment)|Not specified|0
1329830|NCT02139644|4369638|P5|Run-In Period (Pre-assignment)|Not specified|0
1329831|NCT02139644|4369639|P4|Run-In Period (Pre-assignment)|Not specified|0
1329832|NCT02139644|4369640|P3|Run-In Period (Pre-assignment)|Not specified|0
1329833|NCT02139644|4369641|P2|Run-In Period (Pre-assignment)|Not specified|0
1329834|NCT02139644|4369642|P1|Run-In Period (Pre-assignment)|Not specified|6
1329835|NCT02139644|4369637|P6|Run-In Period (Pre-assignment)|Adverse Event|0
1329836|NCT02139644|4369638|P5|Run-In Period (Pre-assignment)|Adverse Event|0
1329837|NCT02139644|4369639|P4|Run-In Period (Pre-assignment)|Adverse Event|0
1329838|NCT02139644|4369640|P3|Run-In Period (Pre-assignment)|Adverse Event|0
1329839|NCT02139644|4369641|P2|Run-In Period (Pre-assignment)|Adverse Event|0
1329840|NCT02139644|4369642|P1|Run-In Period (Pre-assignment)|Adverse Event|3
1329841|NCT02139644|4369637|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1329842|NCT02139644|4369638|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1329843|NCT02139644|4369639|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1329844|NCT02139644|4369640|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1329845|NCT02139644|4369641|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1329846|NCT02139644|4369642|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
1329847|NCT02139644|4369637|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1329848|NCT02139644|4369638|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1329849|NCT02139644|4369639|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1329850|NCT02139644|4369640|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1329851|NCT02139644|4369641|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1329852|NCT02139644|4369642|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
1329853|NCT02139644|4369637|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1329854|NCT02139644|4369638|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1329855|NCT02139644|4369639|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1329856|NCT02139644|4369640|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1329857|NCT02139644|4369641|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1329858|NCT02139644|4369642|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
1329859|NCT02139644|4369637|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1329860|NCT02139644|4369638|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1329861|NCT02139644|4369639|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1329862|NCT02139644|4369640|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1329863|NCT02139644|4369641|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1329864|NCT02139644|4369642|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
1329865|NCT02139644|4369637|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1329866|NCT02139644|4369638|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1329867|NCT02139644|4369639|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1329868|NCT02139644|4369640|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1329869|NCT02139644|4369641|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1329870|NCT02139644|4369642|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
1329871|NCT02139046|4369747|P5|Overall Study|Other Miscellaneous Reasons|12
1329872|NCT02139046|4369748|P4|Overall Study|Other Miscellaneous Reasons|9
1329873|NCT02139046|4369749|P3|Overall Study|Other Miscellaneous Reasons|4
1329874|NCT02139046|4369750|P2|Overall Study|Other Miscellaneous Reasons|9
1329875|NCT02139046|4369751|P1|Overall Study|Other Miscellaneous Reasons|10
1329876|NCT02139046|4369747|P5|Overall Study|Withdrawal due to a Gout Flare|1
1329877|NCT02139046|4369748|P4|Overall Study|Withdrawal due to a Gout Flare|0
1329878|NCT02139046|4369749|P3|Overall Study|Withdrawal due to a Gout Flare|1
1329879|NCT02139046|4369750|P2|Overall Study|Withdrawal due to a Gout Flare|1
1329880|NCT02139046|4369751|P1|Overall Study|Withdrawal due to a Gout Flare|1
1329881|NCT02139046|4369747|P5|Overall Study|Lack of Efficacy|2
1329882|NCT02139046|4369748|P4|Overall Study|Lack of Efficacy|1
1329883|NCT02139046|4369749|P3|Overall Study|Lack of Efficacy|2
1329884|NCT02139046|4369750|P2|Overall Study|Lack of Efficacy|1
1329885|NCT02139046|4369751|P1|Overall Study|Lack of Efficacy|0
1329886|NCT02139046|4369747|P5|Overall Study|Voluntary Withdrawal|16
1329887|NCT02139046|4369748|P4|Overall Study|Voluntary Withdrawal|15
1329888|NCT02139046|4369749|P3|Overall Study|Voluntary Withdrawal|10
1329889|NCT02139046|4369750|P2|Overall Study|Voluntary Withdrawal|8
1329890|NCT02139046|4369751|P1|Overall Study|Voluntary Withdrawal|20
1329891|NCT02139046|4369747|P5|Overall Study|Lost to Follow-up|13
1329892|NCT02139046|4369748|P4|Overall Study|Lost to Follow-up|18
1329893|NCT02139046|4369749|P3|Overall Study|Lost to Follow-up|16
1329894|NCT02139046|4369750|P2|Overall Study|Lost to Follow-up|16
1329895|NCT02139046|4369751|P1|Overall Study|Lost to Follow-up|13
1329896|NCT02139046|4369747|P5|Overall Study|Major Protocol Deviation|6
1329897|NCT02139046|4369748|P4|Overall Study|Major Protocol Deviation|12
1329898|NCT02139046|4369749|P3|Overall Study|Major Protocol Deviation|16
1329899|NCT02139046|4369750|P2|Overall Study|Major Protocol Deviation|10
1329900|NCT02139046|4369751|P1|Overall Study|Major Protocol Deviation|9
1329901|NCT02139046|4369747|P5|Overall Study|Pretreatment Event/Adverse Event|7
1329902|NCT02139046|4369748|P4|Overall Study|Pretreatment Event/Adverse Event|13
1329903|NCT02139046|4369749|P3|Overall Study|Pretreatment Event/Adverse Event|10
1329904|NCT02139046|4369750|P2|Overall Study|Pretreatment Event/Adverse Event|9
1329905|NCT02139046|4369751|P1|Overall Study|Pretreatment Event/Adverse Event|9
1329906|NCT02138838|4369791|P2|Overall Study|Withdrawal by Subject|5
1329907|NCT02138838|4369792|P1|Overall Study|Withdrawal by Subject|1
1329908|NCT02138838|4369791|P2|Overall Study|Study Closure|6
1329909|NCT02138838|4369792|P1|Overall Study|Study Closure|7
1329910|NCT02138825|4369810|P2|Safety Follow-up|withdrawn due to lung transplant|1
1329911|NCT02138825|4369811|P1|Safety Follow-up|withdrawn due to lung transplant|0
1329912|NCT02138825|4369810|P2|Safety Follow-up|treatment unblinded|1
1329913|NCT02138825|4369811|P1|Safety Follow-up|treatment unblinded|0
1329914|NCT02138825|4369810|P2|Safety Follow-up|too unwell to attend the visit|1
1329915|NCT02138825|4369811|P1|Safety Follow-up|too unwell to attend the visit|0
1329916|NCT02138825|4369810|P2|Safety Follow-up|progressive disease|2
1329917|NCT02138825|4369811|P1|Safety Follow-up|progressive disease|0
1329918|NCT02138825|4369810|P2|Safety Follow-up|logistical difficulties|1
1329919|NCT02138825|4369811|P1|Safety Follow-up|logistical difficulties|0
1329920|NCT02138825|4369810|P2|Safety Follow-up|withdrawal by PI|0
1329921|NCT02138825|4369811|P1|Safety Follow-up|withdrawal by PI|1
1329922|NCT02138825|4369810|P2|Safety Follow-up|clinic worsening|0
1329923|NCT02138825|4369811|P1|Safety Follow-up|clinic worsening|1
1329924|NCT02138825|4369810|P2|Safety Follow-up|Withdrawal by Subject|3
1329925|NCT02138825|4369811|P1|Safety Follow-up|Withdrawal by Subject|5
1329926|NCT02138825|4369810|P2|Safety Follow-up|Death|5
1329927|NCT02138825|4369811|P1|Safety Follow-up|Death|11
1329928|NCT02138825|4369810|P2|Safety Follow-up|Adverse Event|3
1329929|NCT02138825|4369811|P1|Safety Follow-up|Adverse Event|4
1329930|NCT02138825|4369810|P2|Long-term Extension|Study termination by sponsor|38
1329931|NCT02138825|4369811|P1|Long-term Extension|Study termination by sponsor|32
1329932|NCT02138825|4369810|P2|Main Study Treatment|Medical decision|0
1329933|NCT02138825|4369811|P1|Main Study Treatment|Medical decision|1
1329934|NCT02138825|4369810|P2|Main Study Treatment|Withdrawal by Subject|1
1329935|NCT02138825|4369811|P1|Main Study Treatment|Withdrawal by Subject|3
1329936|NCT02138825|4369810|P2|Main Study Treatment|Study terminated by sponsor|9
1329937|NCT02138825|4369811|P1|Main Study Treatment|Study terminated by sponsor|10
1329938|NCT02138825|4369810|P2|Main Study Treatment|Sponsor decision|18
1329939|NCT02138825|4369811|P1|Main Study Treatment|Sponsor decision|12
1329940|NCT02138825|4369810|P2|Main Study Treatment|Protocol Violation|2
1329941|NCT02138825|4369811|P1|Main Study Treatment|Protocol Violation|2
1329942|NCT02138825|4369810|P2|Main Study Treatment|Death|2
1329943|NCT02138825|4369811|P1|Main Study Treatment|Death|1
1329944|NCT02138825|4369810|P2|Main Study Treatment|Adverse Event|3
1329945|NCT02138825|4369811|P1|Main Study Treatment|Adverse Event|11
1329946|NCT02138747|4369829|P4|Treatment Period 2|Other - Miscellaneous|0
1329947|NCT02138747|4369830|P3|Treatment Period 2|Other - Miscellaneous|0
1329948|NCT02138747|4369831|P2|Treatment Period 2|Other - Miscellaneous|0
1329949|NCT02138747|4369832|P1|Treatment Period 2|Other - Miscellaneous|3
1329950|NCT02138747|4369829|P4|Treatment Period 2|Withdrawal by Subject|2
1329951|NCT02138747|4369830|P3|Treatment Period 2|Withdrawal by Subject|1
1329952|NCT02138747|4369831|P2|Treatment Period 2|Withdrawal by Subject|4
1329953|NCT02138747|4369832|P1|Treatment Period 2|Withdrawal by Subject|5
1329954|NCT02138747|4369829|P4|Treatment Period 2|Protocol Violation|0
1329955|NCT02138747|4369830|P3|Treatment Period 2|Protocol Violation|0
1329956|NCT02138747|4369831|P2|Treatment Period 2|Protocol Violation|0
1329957|NCT02138747|4369832|P1|Treatment Period 2|Protocol Violation|1
1329958|NCT02138747|4369829|P4|Treatment Period 2|Lost to Follow-up|0
1329959|NCT02138747|4369830|P3|Treatment Period 2|Lost to Follow-up|0
1329960|NCT02138747|4369831|P2|Treatment Period 2|Lost to Follow-up|0
1329961|NCT02138747|4369832|P1|Treatment Period 2|Lost to Follow-up|2
1329962|NCT02138747|4369829|P4|Treatment Period 2|Adverse Event|1
1329963|NCT02138747|4369830|P3|Treatment Period 2|Adverse Event|1
1329964|NCT02138747|4369831|P2|Treatment Period 2|Adverse Event|3
1329965|NCT02138747|4369832|P1|Treatment Period 2|Adverse Event|6
1329966|NCT02138747|4369829|P4|Treatment Period 1|Other - Miscellaneous|0
1329967|NCT02138747|4369830|P3|Treatment Period 1|Other - Miscellaneous|0
1329968|NCT02138747|4369831|P2|Treatment Period 1|Other - Miscellaneous|4
1329969|NCT02138747|4369832|P1|Treatment Period 1|Other - Miscellaneous|2
1329970|NCT02138747|4369829|P4|Treatment Period 1|Withdrawal by Subject|3
1329971|NCT02138747|4369830|P3|Treatment Period 1|Withdrawal by Subject|1
1329972|NCT02138747|4369831|P2|Treatment Period 1|Withdrawal by Subject|4
1329973|NCT02138747|4369832|P1|Treatment Period 1|Withdrawal by Subject|8
1329974|NCT02138747|4369829|P4|Treatment Period 1|Protocol Violation|0
1329975|NCT02138747|4369830|P3|Treatment Period 1|Protocol Violation|0
1329976|NCT02138747|4369831|P2|Treatment Period 1|Protocol Violation|2
1329977|NCT02138747|4369832|P1|Treatment Period 1|Protocol Violation|0
1329978|NCT02138747|4369829|P4|Treatment Period 1|Lost to Follow-up|0
1329979|NCT02138747|4369830|P3|Treatment Period 1|Lost to Follow-up|1
1329980|NCT02138747|4369831|P2|Treatment Period 1|Lost to Follow-up|1
1329981|NCT02138747|4369832|P1|Treatment Period 1|Lost to Follow-up|0
1329982|NCT02138747|4369829|P4|Treatment Period 1|Adverse Event|1
1329983|NCT02138747|4369830|P3|Treatment Period 1|Adverse Event|2
1329984|NCT02138747|4369831|P2|Treatment Period 1|Adverse Event|14
1329985|NCT02138747|4369832|P1|Treatment Period 1|Adverse Event|10
1329986|NCT02137785|4370160|P2|Overall Study|subject moved out of state|0
1329987|NCT02137785|4370161|P1|Overall Study|subject moved out of state|1
1329988|NCT02137785|4370160|P2|Overall Study|Withdrawal by Subject|4
1329989|NCT02137785|4370161|P1|Overall Study|Withdrawal by Subject|1
1329990|NCT02137785|4370160|P2|Overall Study|Lost to Follow-up|0
1329991|NCT02137785|4370161|P1|Overall Study|Lost to Follow-up|1
1329992|NCT02137772|4370269|P2|Overall Study|Not treated|2
1329993|NCT02137772|4370270|P1|Overall Study|Not treated|3
1329994|NCT02137772|4370269|P2|Overall Study|Non-compliance with study drug|0
1329995|NCT02137772|4370270|P1|Overall Study|Non-compliance with study drug|1
1329996|NCT02137772|4370269|P2|Overall Study|Withdrawal by Subject|17
1329997|NCT02137772|4370270|P1|Overall Study|Withdrawal by Subject|28
1329998|NCT02137772|4370269|P2|Overall Study|Physician Decision|5
1329999|NCT02137772|4370270|P1|Overall Study|Physician Decision|15
1330000|NCT02137772|4370269|P2|Overall Study|Lost to Follow-up|4
1330001|NCT02137772|4370270|P1|Overall Study|Lost to Follow-up|8
1330002|NCT02137772|4370269|P2|Overall Study|Death|44
1330003|NCT02137772|4370270|P1|Overall Study|Death|71
1330004|NCT02137772|4370269|P2|Overall Study|Adverse Event|3
1330005|NCT02137772|4370270|P1|Overall Study|Adverse Event|6
1330006|NCT02137226|4370347|P5|Period 2 (Re - Randomization)|Other Reason|1
1330007|NCT02137226|4370348|P4|Period 2 (Re - Randomization)|Other Reason|1
1330008|NCT02137226|4370349|P3|Period 2 (Re - Randomization)|Other Reason|1
1330009|NCT02137226|4370350|P2|Period 2 (Re - Randomization)|Other Reason|0
1330010|NCT02137226|4370351|P1|Period 2 (Re - Randomization)|Other Reason|0
1330011|NCT02137226|4370347|P5|Period 2 (Re - Randomization)|Lack of Efficacy|0
1330012|NCT02137226|4370348|P4|Period 2 (Re - Randomization)|Lack of Efficacy|0
1330013|NCT02137226|4370349|P3|Period 2 (Re - Randomization)|Lack of Efficacy|2
1330014|NCT02137226|4370350|P2|Period 2 (Re - Randomization)|Lack of Efficacy|0
1330015|NCT02137226|4370351|P1|Period 2 (Re - Randomization)|Lack of Efficacy|0
1330016|NCT02137226|4370347|P5|Period 2 (Re - Randomization)|Lost to Follow-up|0
1330017|NCT02137226|4370348|P4|Period 2 (Re - Randomization)|Lost to Follow-up|0
1330018|NCT02137226|4370349|P3|Period 2 (Re - Randomization)|Lost to Follow-up|3
1330019|NCT02137226|4370350|P2|Period 2 (Re - Randomization)|Lost to Follow-up|0
1330020|NCT02137226|4370351|P1|Period 2 (Re - Randomization)|Lost to Follow-up|0
1330021|NCT02137226|4370347|P5|Period 2 (Re - Randomization)|Physician Decision|0
1330022|NCT02137226|4370348|P4|Period 2 (Re - Randomization)|Physician Decision|1
1330023|NCT02137226|4370349|P3|Period 2 (Re - Randomization)|Physician Decision|0
1330024|NCT02137226|4370350|P2|Period 2 (Re - Randomization)|Physician Decision|0
1330025|NCT02137226|4370351|P1|Period 2 (Re - Randomization)|Physician Decision|0
1330026|NCT02137226|4370347|P5|Period 2 (Re - Randomization)|Withdrawal by Subject|4
1330027|NCT02137226|4370348|P4|Period 2 (Re - Randomization)|Withdrawal by Subject|5
1330028|NCT02137226|4370349|P3|Period 2 (Re - Randomization)|Withdrawal by Subject|8
1330029|NCT02137226|4370350|P2|Period 2 (Re - Randomization)|Withdrawal by Subject|0
1330030|NCT02137226|4370351|P1|Period 2 (Re - Randomization)|Withdrawal by Subject|0
1330031|NCT02137226|4370347|P5|Period 2 (Re - Randomization)|Adverse Event|4
1330032|NCT02137226|4370348|P4|Period 2 (Re - Randomization)|Adverse Event|1
1330033|NCT02137226|4370349|P3|Period 2 (Re - Randomization)|Adverse Event|3
1330034|NCT02137226|4370350|P2|Period 2 (Re - Randomization)|Adverse Event|0
1330035|NCT02137226|4370351|P1|Period 2 (Re - Randomization)|Adverse Event|0
1330036|NCT02137226|4370347|P5|Period 1 (Initial Randomization)|Other Reason|0
1330037|NCT02137226|4370348|P4|Period 1 (Initial Randomization)|Other Reason|0
1330038|NCT02137226|4370349|P3|Period 1 (Initial Randomization)|Other Reason|0
1330039|NCT02137226|4370350|P2|Period 1 (Initial Randomization)|Other Reason|3
1330040|NCT02137226|4370351|P1|Period 1 (Initial Randomization)|Other Reason|1
1330041|NCT02137226|4370347|P5|Period 1 (Initial Randomization)|Lack of Efficacy|0
1330042|NCT02137226|4370348|P4|Period 1 (Initial Randomization)|Lack of Efficacy|0
1330043|NCT02137226|4370349|P3|Period 1 (Initial Randomization)|Lack of Efficacy|0
1330044|NCT02137226|4370350|P2|Period 1 (Initial Randomization)|Lack of Efficacy|0
1330045|NCT02137226|4370351|P1|Period 1 (Initial Randomization)|Lack of Efficacy|1
1330046|NCT02137226|4370347|P5|Period 1 (Initial Randomization)|Lost to Follow-up|0
1330047|NCT02137226|4370348|P4|Period 1 (Initial Randomization)|Lost to Follow-up|0
1330048|NCT02137226|4370349|P3|Period 1 (Initial Randomization)|Lost to Follow-up|0
1330049|NCT02137226|4370350|P2|Period 1 (Initial Randomization)|Lost to Follow-up|2
1330050|NCT02137226|4370351|P1|Period 1 (Initial Randomization)|Lost to Follow-up|3
1330051|NCT02137226|4370347|P5|Period 1 (Initial Randomization)|Physician Decision|0
1330052|NCT02137226|4370348|P4|Period 1 (Initial Randomization)|Physician Decision|0
1330053|NCT02137226|4370349|P3|Period 1 (Initial Randomization)|Physician Decision|0
1330054|NCT02137226|4370350|P2|Period 1 (Initial Randomization)|Physician Decision|3
1330055|NCT02137226|4370351|P1|Period 1 (Initial Randomization)|Physician Decision|1
1330056|NCT02137226|4370347|P5|Period 1 (Initial Randomization)|Withdrawal by Subject|0
1330057|NCT02137226|4370348|P4|Period 1 (Initial Randomization)|Withdrawal by Subject|0
1330058|NCT02137226|4370349|P3|Period 1 (Initial Randomization)|Withdrawal by Subject|0
1330059|NCT02137226|4370350|P2|Period 1 (Initial Randomization)|Withdrawal by Subject|5
1330060|NCT02137226|4370351|P1|Period 1 (Initial Randomization)|Withdrawal by Subject|11
1330061|NCT02137226|4370347|P5|Period 1 (Initial Randomization)|Adverse Event|0
1330062|NCT02137226|4370348|P4|Period 1 (Initial Randomization)|Adverse Event|0
1330063|NCT02137226|4370349|P3|Period 1 (Initial Randomization)|Adverse Event|0
1330064|NCT02137226|4370350|P2|Period 1 (Initial Randomization)|Adverse Event|3
1330065|NCT02137226|4370351|P1|Period 1 (Initial Randomization)|Adverse Event|3
1330066|NCT02136914|4370365|P2|Overall Study|Death|1
1330067|NCT02136914|4370366|P1|Overall Study|Death|0
1330068|NCT02136914|4370365|P2|Overall Study|Lack of Efficacy|0
1330069|NCT02136914|4370366|P1|Overall Study|Lack of Efficacy|1
1330070|NCT02136914|4370365|P2|Overall Study|Did Not Receive Study Drug|0
1330071|NCT02136914|4370366|P1|Overall Study|Did Not Receive Study Drug|2
1330072|NCT02136914|4370365|P2|Overall Study|Lost to Follow-up|1
1330073|NCT02136914|4370366|P1|Overall Study|Lost to Follow-up|1
1330074|NCT02136914|4370365|P2|Overall Study|Subject Unwilling to Proceed|2
1330075|NCT02136914|4370366|P1|Overall Study|Subject Unwilling to Proceed|7
1330076|NCT02136914|4370365|P2|Overall Study|Withdrawal by Subject|10
1330077|NCT02136914|4370366|P1|Overall Study|Withdrawal by Subject|3
1330078|NCT02136914|4370365|P2|Overall Study|Sponsor's Decision to Stop the Study|7
1330079|NCT02136914|4370366|P1|Overall Study|Sponsor's Decision to Stop the Study|7
1330080|NCT02136134|4370441|P2|Overall Study|Subjects randomized but not treated|8
1330081|NCT02136134|4370442|P1|Overall Study|Subjects randomized but not treated|10
1330082|NCT02136134|4370441|P2|Overall Study|Ongoing|207
1330083|NCT02136134|4370442|P1|Overall Study|Ongoing|185
1330084|NCT02136134|4370441|P2|Overall Study|Other|3
1330085|NCT02136134|4370442|P1|Overall Study|Other|3
1330086|NCT02136134|4370441|P2|Overall Study|Withdrawal by Subject|4
1330087|NCT02136134|4370442|P1|Overall Study|Withdrawal by Subject|14
1330088|NCT02136134|4370441|P2|Overall Study|Death|29
1330089|NCT02136134|4370442|P1|Overall Study|Death|35
1330090|NCT02135848|4370480|P2|Overall Study|Withdrawal by Subject|1
1330091|NCT02135848|4370481|P1|Overall Study|Withdrawal by Subject|1
1330092|NCT02135848|4370480|P2|Overall Study|Adverse Event|0
1330093|NCT02135848|4370481|P1|Overall Study|Adverse Event|2
1330094|NCT02135692|4370539|P1|Overall Study|Withdrawal by Subject|15
1330095|NCT02135692|4370539|P1|Overall Study|Lost to Follow-up|4
1330096|NCT02135692|4370539|P1|Overall Study|Study closed/terminated|153
1330097|NCT02135692|4370539|P1|Overall Study|Product commercially available|159
1330098|NCT02135692|4370539|P1|Overall Study|Subject met Liver Stopping Criteria|1
1330099|NCT02135692|4370539|P1|Overall Study|Protocol Violation|2
1330100|NCT02135692|4370539|P1|Overall Study|Lack of Efficacy|2
1330101|NCT02135692|4370539|P1|Overall Study|Adverse Event|3
1330102|NCT02135614|4370558|P2|Overall Study|Lost to Follow-up|0
1330103|NCT02135614|4370559|P1|Overall Study|Lost to Follow-up|3
1330104|NCT02135614|4370558|P2|Overall Study|Withdrew Consent|2
1330105|NCT02135614|4370559|P1|Overall Study|Withdrew Consent|2
1330106|NCT02135614|4370558|P2|Overall Study|Investigator's Discretion|1
1330107|NCT02135614|4370559|P1|Overall Study|Investigator's Discretion|0
1330108|NCT02135614|4370558|P2|Overall Study|Death|0
1330109|NCT02135614|4370559|P1|Overall Study|Death|1
1330110|NCT02135614|4370558|P2|Overall Study|Adverse Event|1
1330111|NCT02135614|4370559|P1|Overall Study|Adverse Event|0
1330112|NCT02135614|4370558|P2|Overall Study|Randomized but Not Treated|1
1330113|NCT02135614|4370559|P1|Overall Study|Randomized but Not Treated|2
1330114|NCT02135445|4370573|P2|Overall Study|Withdrawal by Subject|0
1330115|NCT02135445|4370574|P1|Overall Study|Withdrawal by Subject|1
1330116|NCT02135445|4370573|P2|Overall Study|Lost to Follow-up|0
1330117|NCT02135445|4370574|P1|Overall Study|Lost to Follow-up|1
1330118|NCT02135029|4370658|P3|Overall Study|Death|0
1330119|NCT02135029|4370659|P2|Overall Study|Death|1
1330120|NCT02135029|4370660|P1|Overall Study|Death|0
1330121|NCT02135029|4370658|P3|Overall Study|Other|0
1330122|NCT02135029|4370659|P2|Overall Study|Other|1
1330123|NCT02135029|4370660|P1|Overall Study|Other|0
1330124|NCT02135029|4370658|P3|Overall Study|Withdrawal by Subject|1
1330125|NCT02135029|4370659|P2|Overall Study|Withdrawal by Subject|0
1330126|NCT02135029|4370660|P1|Overall Study|Withdrawal by Subject|2
1330127|NCT02135029|4370658|P3|Overall Study|Lost to Follow-up|0
1330128|NCT02135029|4370659|P2|Overall Study|Lost to Follow-up|1
1330129|NCT02135029|4370660|P1|Overall Study|Lost to Follow-up|0
1330130|NCT02135029|4370658|P3|Overall Study|Adverse Event|2
1330131|NCT02135029|4370659|P2|Overall Study|Adverse Event|2
1330132|NCT02135029|4370660|P1|Overall Study|Adverse Event|2
1330133|NCT02134977|4370765|P1|Overall Study|Protocol Deviation|102
1330134|NCT02134925|4370799|P2|Overall Study|Cancel|6
1330135|NCT02134925|4370800|P1|Overall Study|Cancel|1
1330136|NCT02134925|4370799|P2|Overall Study|Withdrawal by Subject|0
1330137|NCT02134925|4370800|P1|Overall Study|Withdrawal by Subject|1
1330138|NCT02134587|4370814|P1|Overall Study|Did not completed all meetings|30
1330139|NCT02134015|4370920|P2|Overall Study|Withdrawal by Subject|7
1330140|NCT02134015|4370921|P1|Overall Study|Withdrawal by Subject|3
1330141|NCT02134015|4370920|P2|Overall Study|Adverse Event|10
1330142|NCT02134015|4370921|P1|Overall Study|Adverse Event|9
1330143|NCT02134015|4370920|P2|Overall Study|Study terminated by sponsor|3
1330144|NCT02134015|4370921|P1|Overall Study|Study terminated by sponsor|2
1330145|NCT02134015|4370920|P2|Overall Study|Progressive disease (per RECIST 1.1)|43
1330146|NCT02134015|4370921|P1|Overall Study|Progressive disease (per RECIST 1.1)|40
1330147|NCT02134015|4370920|P2|Overall Study|Clinical progression|7
1330148|NCT02134015|4370921|P1|Overall Study|Clinical progression|14
1330149|NCT02134015|4370920|P2|Overall Study|Reason not provided|2
1330150|NCT02134015|4370921|P1|Overall Study|Reason not provided|1
1330151|NCT02134015|4370920|P2|Overall Study|Death|1
1330152|NCT02134015|4370921|P1|Overall Study|Death|2
1330153|NCT02134015|4370920|P2|Overall Study|Protocol Violation|1
1330154|NCT02134015|4370921|P1|Overall Study|Protocol Violation|0
1330155|NCT02133664|4370959|P2|Overall Study|Adverse Event|6
1330156|NCT02133664|4370960|P1|Overall Study|Adverse Event|3
1330157|NCT02133664|4370959|P2|Overall Study|Lost to Follow-up|1
1330158|NCT02133664|4370960|P1|Overall Study|Lost to Follow-up|2
1330159|NCT02133508|4370976|P1|Overall Study|Lost to Follow-up|2
1330160|NCT02133508|4370976|P1|Overall Study|Death|12
1330161|NCT02133508|4370976|P1|Overall Study|Decision of Investigator or Sponsor|1
1330162|NCT02133352|4370984|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
1330163|NCT02133131|4371015|P7|Overall Study|Protocol Violation|1
1330164|NCT02133131|4371016|P6|Overall Study|Protocol Violation|0
1330165|NCT02133131|4371017|P5|Overall Study|Protocol Violation|0
1330166|NCT02133131|4371018|P4|Overall Study|Protocol Violation|0
1330167|NCT02133131|4371019|P3|Overall Study|Protocol Violation|0
1330168|NCT02133131|4371020|P2|Overall Study|Protocol Violation|0
1330169|NCT02133131|4371021|P1|Overall Study|Protocol Violation|0
1330170|NCT02133131|4371015|P7|Overall Study|Ongoing in study|11
1330171|NCT02133131|4371016|P6|Overall Study|Ongoing in study|14
1330172|NCT02133131|4371017|P5|Overall Study|Ongoing in study|15
1330173|NCT02133131|4371018|P4|Overall Study|Ongoing in study|0
1330174|NCT02133131|4371019|P3|Overall Study|Ongoing in study|0
1330175|NCT02133131|4371020|P2|Overall Study|Ongoing in study|0
1330176|NCT02133131|4371021|P1|Overall Study|Ongoing in study|0
1330177|NCT02133131|4371015|P7|Overall Study|Status not recorded|0
1330178|NCT02133131|4371016|P6|Overall Study|Status not recorded|0
1330179|NCT02133131|4371017|P5|Overall Study|Status not recorded|0
1330180|NCT02133131|4371018|P4|Overall Study|Status not recorded|4
1330181|NCT02133131|4371019|P3|Overall Study|Status not recorded|1
1330182|NCT02133131|4371020|P2|Overall Study|Status not recorded|5
1330183|NCT02133131|4371021|P1|Overall Study|Status not recorded|4
1330184|NCT02133131|4371015|P7|Overall Study|Lost to Follow-up|0
1330185|NCT02133131|4371016|P6|Overall Study|Lost to Follow-up|0
1330186|NCT02133131|4371017|P5|Overall Study|Lost to Follow-up|0
1330187|NCT02133131|4371018|P4|Overall Study|Lost to Follow-up|1
1330188|NCT02133131|4371019|P3|Overall Study|Lost to Follow-up|0
1330189|NCT02133131|4371020|P2|Overall Study|Lost to Follow-up|0
1330190|NCT02133131|4371021|P1|Overall Study|Lost to Follow-up|1
1330191|NCT02133131|4371015|P7|Overall Study|Adverse Event|0
1330192|NCT02133131|4371016|P6|Overall Study|Adverse Event|0
1330193|NCT02133131|4371017|P5|Overall Study|Adverse Event|0
1330194|NCT02133131|4371018|P4|Overall Study|Adverse Event|1
1330195|NCT02133131|4371019|P3|Overall Study|Adverse Event|0
1330196|NCT02133131|4371020|P2|Overall Study|Adverse Event|0
1330197|NCT02133131|4371021|P1|Overall Study|Adverse Event|0
1330198|NCT02132949|4371075|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
1330199|NCT02132949|4371076|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
1330200|NCT02132949|4371075|P2|Adjuvant Treatment Period|Protocol Deviation|0
1330201|NCT02132949|4371076|P1|Adjuvant Treatment Period|Protocol Deviation|1
1330202|NCT02132949|4371075|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
1330203|NCT02132949|4371076|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
1330204|NCT02132949|4371075|P2|Adjuvant Treatment Period|Physician Decision|0
1330205|NCT02132949|4371076|P1|Adjuvant Treatment Period|Physician Decision|1
1330206|NCT02132949|4371075|P2|Adjuvant Treatment Period|Disease Relapse|1
1330207|NCT02132949|4371076|P1|Adjuvant Treatment Period|Disease Relapse|0
1330208|NCT02132949|4371075|P2|Adjuvant Treatment Period|Disease Progression|1
1330209|NCT02132949|4371076|P1|Adjuvant Treatment Period|Disease Progression|0
1330210|NCT02132949|4371075|P2|Adjuvant Treatment Period|Reason unspecified|1
1330211|NCT02132949|4371076|P1|Adjuvant Treatment Period|Reason unspecified|0
1330212|NCT02132949|4371075|P2|Adjuvant Treatment Period|Adverse Event|6
1330213|NCT02132949|4371076|P1|Adjuvant Treatment Period|Adverse Event|4
1330214|NCT02132949|4371075|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
1330215|NCT02132949|4371076|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
1330216|NCT02132949|4371075|P2|Neoadjuvant Treatment Period|Adverse Event|3
1330217|NCT02132949|4371076|P1|Neoadjuvant Treatment Period|Adverse Event|6
1330218|NCT02132949|4371075|P2|Neoadjuvant Treatment Period|Disease Progression|1
1330219|NCT02132949|4371076|P1|Neoadjuvant Treatment Period|Disease Progression|1
1330220|NCT02132949|4371075|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
1330221|NCT02132949|4371076|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
1330222|NCT02132949|4371075|P2|Neoadjuvant Treatment Period|Physician Decision|0
1330223|NCT02132949|4371076|P1|Neoadjuvant Treatment Period|Physician Decision|2
1330224|NCT02132949|4371075|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
1330225|NCT02132949|4371076|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
1330226|NCT02132949|4371075|P2|Neoadjuvant Treatment Period|Reason unspecified|1
1330227|NCT02132949|4371076|P1|Neoadjuvant Treatment Period|Reason unspecified|3
1330228|NCT02132949|4371075|P2|Neoadjuvant Treatment Period|Early surgery|3
1330229|NCT02132949|4371076|P1|Neoadjuvant Treatment Period|Early surgery|4
1330230|NCT02132767|4371169|P2|Overall Study|Lost to Follow-up|4
1330231|NCT02132767|4371170|P1|Overall Study|Lost to Follow-up|4
1330232|NCT02132767|4371169|P2|Overall Study|Withdrawal by Subject|9
1330233|NCT02132767|4371170|P1|Overall Study|Withdrawal by Subject|10
1330234|NCT02132767|4371169|P2|Overall Study|Death|2
1330235|NCT02132767|4371170|P1|Overall Study|Death|3
1330236|NCT02132637|4371192|P2|Study Period 2 (Crossover)|Physician Decision|0
1330237|NCT02132637|4371193|P1|Study Period 2 (Crossover)|Physician Decision|2
1330238|NCT02132637|4371192|P2|Study Period 2 (Crossover)|Adverse Event|1
1330239|NCT02132637|4371193|P1|Study Period 2 (Crossover)|Adverse Event|0
1330240|NCT02132637|4371192|P2|Study Period 1|Physician Decision|0
1330241|NCT02132637|4371193|P1|Study Period 1|Physician Decision|1
1330242|NCT02132637|4371192|P2|Study Period 1|Withdrawal by Subject|4
1330243|NCT02132637|4371193|P1|Study Period 1|Withdrawal by Subject|0
1330244|NCT02132611|4371217|P1|Overall Study|Death|2
1330245|NCT02132247|4371235|P2|Overall Study|Protocol Violation|0
1330246|NCT02132247|4371236|P1|Overall Study|Protocol Violation|1
1330247|NCT02132117|4371265|P2|Overall Study|Other Miscellaneous Reasons|0
1330248|NCT02132117|4371266|P1|Overall Study|Other Miscellaneous Reasons|2
1330249|NCT02132117|4371265|P2|Overall Study|Personal Reasons|2
1330250|NCT02132117|4371266|P1|Overall Study|Personal Reasons|1
1330251|NCT02132117|4371265|P2|Overall Study|Lost to Follow-up|2
1330252|NCT02132117|4371266|P1|Overall Study|Lost to Follow-up|2
1330253|NCT02132117|4371265|P2|Overall Study|Adverse Event|1
1330254|NCT02132117|4371266|P1|Overall Study|Adverse Event|6
1330255|NCT02131662|4371287|P5|Overall Study|Not treated|3
1330256|NCT02131662|4371288|P4|Overall Study|Not treated|2
1330257|NCT02131662|4371289|P3|Overall Study|Not treated|2
1330258|NCT02131662|4371290|P2|Overall Study|Not treated|0
1330259|NCT02131662|4371291|P1|Overall Study|Not treated|2
1330260|NCT02131662|4371287|P5|Overall Study|Lost to Follow-up|0
1330261|NCT02131662|4371288|P4|Overall Study|Lost to Follow-up|9
1330262|NCT02131662|4371289|P3|Overall Study|Lost to Follow-up|0
1330263|NCT02131662|4371290|P2|Overall Study|Lost to Follow-up|3
1330264|NCT02131662|4371291|P1|Overall Study|Lost to Follow-up|1
1330265|NCT02131662|4371287|P5|Overall Study|Withdrawal by Subject|6
1330266|NCT02131662|4371288|P4|Overall Study|Withdrawal by Subject|5
1330267|NCT02131662|4371289|P3|Overall Study|Withdrawal by Subject|1
1330268|NCT02131662|4371290|P2|Overall Study|Withdrawal by Subject|5
1330269|NCT02131662|4371291|P1|Overall Study|Withdrawal by Subject|1
1330270|NCT02131662|4371287|P5|Overall Study|Lack of Efficacy|1
1330271|NCT02131662|4371288|P4|Overall Study|Lack of Efficacy|0
1330272|NCT02131662|4371289|P3|Overall Study|Lack of Efficacy|0
1330273|NCT02131662|4371290|P2|Overall Study|Lack of Efficacy|0
1330274|NCT02131662|4371291|P1|Overall Study|Lack of Efficacy|1
1330275|NCT02131662|4371287|P5|Overall Study|Wish for pregnancy|1
1330276|NCT02131662|4371288|P4|Overall Study|Wish for pregnancy|0
1330277|NCT02131662|4371289|P3|Overall Study|Wish for pregnancy|0
1330278|NCT02131662|4371290|P2|Overall Study|Wish for pregnancy|0
1330279|NCT02131662|4371291|P1|Overall Study|Wish for pregnancy|0
1330280|NCT02131662|4371287|P5|Overall Study|Pregnancy|0
1330281|NCT02131662|4371288|P4|Overall Study|Pregnancy|1
1330282|NCT02131662|4371289|P3|Overall Study|Pregnancy|0
1330283|NCT02131662|4371290|P2|Overall Study|Pregnancy|1
1330284|NCT02131662|4371291|P1|Overall Study|Pregnancy|0
1330285|NCT02131662|4371287|P5|Overall Study|Adverse Event|3
1330286|NCT02131662|4371288|P4|Overall Study|Adverse Event|1
1330287|NCT02131662|4371289|P3|Overall Study|Adverse Event|1
1330288|NCT02131662|4371290|P2|Overall Study|Adverse Event|1
1330289|NCT02131662|4371291|P1|Overall Study|Adverse Event|0
1330290|NCT02131662|4371287|P5|Overall Study|Other|4
1330291|NCT02131662|4371288|P4|Overall Study|Other|3
1330292|NCT02131662|4371289|P3|Overall Study|Other|3
1330293|NCT02131662|4371290|P2|Overall Study|Other|4
1330294|NCT02131662|4371291|P1|Overall Study|Other|2
1330295|NCT02131662|4371287|P5|Overall Study|Protocol Violation|0
1330296|NCT02131662|4371288|P4|Overall Study|Protocol Violation|0
1330297|NCT02131662|4371289|P3|Overall Study|Protocol Violation|0
1330298|NCT02131662|4371290|P2|Overall Study|Protocol Violation|0
1330299|NCT02131662|4371291|P1|Overall Study|Protocol Violation|1
1330300|NCT02131636|4371337|P2|Overall Study|Adverse Event|1
1330301|NCT02131636|4371338|P1|Overall Study|Adverse Event|4
1330302|NCT02131636|4371337|P2|Overall Study|Lost to Follow-up|0
1330303|NCT02131636|4371338|P1|Overall Study|Lost to Follow-up|4
1330304|NCT02131636|4371337|P2|Overall Study|Personal Reasons|4
1330305|NCT02131636|4371338|P1|Overall Study|Personal Reasons|4
1330306|NCT02131532|4371354|P1|Overall Study|Other health conditions|2
1330307|NCT02131532|4371354|P1|Overall Study|Physician Decision|1
1330308|NCT02131532|4371354|P1|Overall Study|Withdrawal by Subject|1
1330309|NCT02131324|4371446|P2|Overall Study|Lost to Follow-up|1
1330310|NCT02131324|4371447|P1|Overall Study|Lost to Follow-up|1
1330311|NCT02131324|4371446|P2|Overall Study|Withdrawal by Subject|2
1330312|NCT02131324|4371447|P1|Overall Study|Withdrawal by Subject|1
1330313|NCT02131311|4371453|P1|Overall Study|Lost to Follow-up|1
1330314|NCT02131311|4371453|P1|Overall Study|Protocol Violation|1
1330315|NCT02131311|4371453|P1|Overall Study|Adverse Event|2
1330316|NCT02131272|4371465|P2|Overall Study|Withdrawal Criteria|0
1330317|NCT02131272|4371466|P1|Overall Study|Withdrawal Criteria|1
1330318|NCT02131272|4371465|P2|Overall Study|Withdrawal by Subject|1
1330319|NCT02131272|4371466|P1|Overall Study|Withdrawal by Subject|0
1330320|NCT02131272|4371465|P2|Overall Study|Withdrawal by parent|1
1330321|NCT02131272|4371466|P1|Overall Study|Withdrawal by parent|0
1330322|NCT02131233|4371486|P2|Overall Study|Withdrawal by Subject|11
1330323|NCT02131233|4371487|P1|Overall Study|Withdrawal by Subject|18
1330324|NCT02131233|4371486|P2|Overall Study|Pregnancy|0
1330325|NCT02131233|4371487|P1|Overall Study|Pregnancy|4
1330326|NCT02131233|4371486|P2|Overall Study|Physician Decision|0
1330327|NCT02131233|4371487|P1|Overall Study|Physician Decision|7
1330328|NCT02131233|4371486|P2|Overall Study|Non-Compliance With Study Drug|5
1330329|NCT02131233|4371487|P1|Overall Study|Non-Compliance With Study Drug|8
1330330|NCT02131233|4371486|P2|Overall Study|Lost to Follow-up|13
1330331|NCT02131233|4371487|P1|Overall Study|Lost to Follow-up|14
1330332|NCT02131233|4371486|P2|Overall Study|Lack of Efficacy|3
1330333|NCT02131233|4371487|P1|Overall Study|Lack of Efficacy|6
1330334|NCT02131233|4371486|P2|Overall Study|Death|1
1330335|NCT02131233|4371487|P1|Overall Study|Death|0
1330336|NCT02131233|4371486|P2|Overall Study|Adverse Event|6
1330337|NCT02131233|4371487|P1|Overall Study|Adverse Event|7
1330338|NCT02131233|4371486|P2|Overall Study|Not Treated|3
1330339|NCT02131233|4371487|P1|Overall Study|Not Treated|2
1330340|NCT02131064|4371521|P2|Overall Study|Other|0
1330341|NCT02131064|4371522|P1|Overall Study|Other|1
1330342|NCT02131064|4371521|P2|Overall Study|Ongoing|207
1330343|NCT02131064|4371522|P1|Overall Study|Ongoing|214
1330344|NCT02131064|4371521|P2|Overall Study|Withdrawal by Subject|14
1330345|NCT02131064|4371522|P1|Overall Study|Withdrawal by Subject|6
1330346|NCT02131064|4371521|P2|Overall Study|Lost to Follow-up|1
1330347|NCT02131064|4371522|P1|Overall Study|Lost to Follow-up|0
1330348|NCT02131064|4371521|P2|Overall Study|Death|1
1330349|NCT02131064|4371522|P1|Overall Study|Death|0
1330350|NCT02130284|4371785|P1|Overall Study|Screen Failure|1
1330351|NCT02130284|4371785|P1|Overall Study|Subject was screened as backup for study|3
1330352|NCT02130284|4371785|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
1330353|NCT02130284|4371785|P1|Overall Study|Subject Withdrew Consent|1
1330354|NCT02130284|4371785|P1|Overall Study|Withdrawal by Subject|3
1330355|NCT02130193|4371811|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
1330356|NCT02130193|4371812|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
1330357|NCT02130193|4371813|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
1330358|NCT02130193|4371811|P3|Part B: 52-week Double-blind Period|Physician Decision|1
1330359|NCT02130193|4371812|P2|Part B: 52-week Double-blind Period|Physician Decision|0
1330360|NCT02130193|4371813|P1|Part B: 52-week Double-blind Period|Physician Decision|0
1330361|NCT02130193|4371811|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
1330362|NCT02130193|4371812|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
1330363|NCT02130193|4371813|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
1330364|NCT02130193|4371811|P3|Part B: 52-week Double-blind Period|Adverse Event|3
1330365|NCT02130193|4371812|P2|Part B: 52-week Double-blind Period|Adverse Event|5
1330366|NCT02130193|4371813|P1|Part B: 52-week Double-blind Period|Adverse Event|0
1330367|NCT02129777|4371897|P7|Open-Label Period|Study Termination|39
1330368|NCT02129777|4371898|P6|Open-Label Period|Study Termination|10
1330369|NCT02129777|4371899|P5|Open-Label Period|Study Termination|0
1330370|NCT02129777|4371900|P4|Open-Label Period|Study Termination|0
1330371|NCT02129777|4371901|P3|Open-Label Period|Study Termination|0
1330372|NCT02129777|4371902|P2|Open-Label Period|Study Termination|0
1330373|NCT02129777|4371903|P1|Open-Label Period|Study Termination|0
1330374|NCT02129777|4371897|P7|Open-Label Period|Withdrawal by Subject|3
1330375|NCT02129777|4371898|P6|Open-Label Period|Withdrawal by Subject|1
1330376|NCT02129777|4371899|P5|Open-Label Period|Withdrawal by Subject|0
1330377|NCT02129777|4371900|P4|Open-Label Period|Withdrawal by Subject|0
1330378|NCT02129777|4371901|P3|Open-Label Period|Withdrawal by Subject|0
1330379|NCT02129777|4371902|P2|Open-Label Period|Withdrawal by Subject|0
1330380|NCT02129777|4371903|P1|Open-Label Period|Withdrawal by Subject|0
1330381|NCT02129777|4371897|P7|Open-Label Period|Lost to Follow-up|1
1330382|NCT02129777|4371898|P6|Open-Label Period|Lost to Follow-up|1
1330383|NCT02129777|4371899|P5|Open-Label Period|Lost to Follow-up|0
1330384|NCT02129777|4371900|P4|Open-Label Period|Lost to Follow-up|0
1330385|NCT02129777|4371901|P3|Open-Label Period|Lost to Follow-up|0
1330386|NCT02129777|4371902|P2|Open-Label Period|Lost to Follow-up|0
1330387|NCT02129777|4371903|P1|Open-Label Period|Lost to Follow-up|0
1330388|NCT02129777|4371897|P7|Open-Label Period|Lack of Efficacy|5
1330389|NCT02129777|4371898|P6|Open-Label Period|Lack of Efficacy|0
1330390|NCT02129777|4371899|P5|Open-Label Period|Lack of Efficacy|0
1330391|NCT02129777|4371900|P4|Open-Label Period|Lack of Efficacy|0
1330392|NCT02129777|4371901|P3|Open-Label Period|Lack of Efficacy|0
1330393|NCT02129777|4371902|P2|Open-Label Period|Lack of Efficacy|0
1330394|NCT02129777|4371903|P1|Open-Label Period|Lack of Efficacy|0
1330395|NCT02129777|4371897|P7|Double-Blind Period|Other|0
1330396|NCT02129777|4371898|P6|Double-Blind Period|Other|0
1330397|NCT02129777|4371899|P5|Double-Blind Period|Other|0
1330398|NCT02129777|4371900|P4|Double-Blind Period|Other|0
1330399|NCT02129777|4371901|P3|Double-Blind Period|Other|0
1330400|NCT02129777|4371902|P2|Double-Blind Period|Other|2
1330401|NCT02129777|4371903|P1|Double-Blind Period|Other|1
1330402|NCT02129777|4371897|P7|Double-Blind Period|Lack of Efficacy|0
1330403|NCT02129777|4371898|P6|Double-Blind Period|Lack of Efficacy|0
1330404|NCT02129777|4371899|P5|Double-Blind Period|Lack of Efficacy|2
1330405|NCT02129777|4371900|P4|Double-Blind Period|Lack of Efficacy|3
1330406|NCT02129777|4371901|P3|Double-Blind Period|Lack of Efficacy|0
1330407|NCT02129777|4371902|P2|Double-Blind Period|Lack of Efficacy|1
1330408|NCT02129777|4371903|P1|Double-Blind Period|Lack of Efficacy|3
1330409|NCT02129777|4371897|P7|Double-Blind Period|Pregnancy|0
1330410|NCT02129777|4371898|P6|Double-Blind Period|Pregnancy|0
1330411|NCT02129777|4371899|P5|Double-Blind Period|Pregnancy|1
1330412|NCT02129777|4371900|P4|Double-Blind Period|Pregnancy|0
1330413|NCT02129777|4371901|P3|Double-Blind Period|Pregnancy|0
1330414|NCT02129777|4371902|P2|Double-Blind Period|Pregnancy|0
1330415|NCT02129777|4371903|P1|Double-Blind Period|Pregnancy|0
1330416|NCT02129777|4371897|P7|Double-Blind Period|Withdrawal by Subject|0
1330417|NCT02129777|4371898|P6|Double-Blind Period|Withdrawal by Subject|0
1330418|NCT02129777|4371899|P5|Double-Blind Period|Withdrawal by Subject|3
1330419|NCT02129777|4371900|P4|Double-Blind Period|Withdrawal by Subject|2
1330420|NCT02129777|4371901|P3|Double-Blind Period|Withdrawal by Subject|3
1330421|NCT02129777|4371902|P2|Double-Blind Period|Withdrawal by Subject|4
1330422|NCT02129777|4371903|P1|Double-Blind Period|Withdrawal by Subject|2
1330423|NCT02129777|4371897|P7|Double-Blind Period|Lost to Follow-up|0
1330424|NCT02129777|4371898|P6|Double-Blind Period|Lost to Follow-up|0
1330425|NCT02129777|4371899|P5|Double-Blind Period|Lost to Follow-up|0
1330426|NCT02129777|4371900|P4|Double-Blind Period|Lost to Follow-up|2
1330427|NCT02129777|4371901|P3|Double-Blind Period|Lost to Follow-up|1
1330428|NCT02129777|4371902|P2|Double-Blind Period|Lost to Follow-up|1
1330429|NCT02129777|4371903|P1|Double-Blind Period|Lost to Follow-up|1
1330430|NCT02129777|4371897|P7|Double-Blind Period|Adverse Event|0
1330431|NCT02129777|4371898|P6|Double-Blind Period|Adverse Event|0
1330432|NCT02129777|4371899|P5|Double-Blind Period|Adverse Event|1
1330433|NCT02129777|4371900|P4|Double-Blind Period|Adverse Event|0
1330434|NCT02129777|4371901|P3|Double-Blind Period|Adverse Event|0
1330435|NCT02129777|4371902|P2|Double-Blind Period|Adverse Event|0
1330436|NCT02129777|4371903|P1|Double-Blind Period|Adverse Event|0
1330437|NCT02129608|4372019|P3|Overall Study|Withdrawal by Subject|2
1330438|NCT02129608|4372020|P2|Overall Study|Withdrawal by Subject|0
1330439|NCT02129608|4372021|P1|Overall Study|Withdrawal by Subject|0
1330440|NCT02129608|4372019|P3|Overall Study|Lost to Follow-up|1
1330441|NCT02129608|4372020|P2|Overall Study|Lost to Follow-up|1
1330442|NCT02129608|4372021|P1|Overall Study|Lost to Follow-up|0
1330443|NCT02129192|4372034|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
1330444|NCT02129192|4372035|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
1330445|NCT02129062|4372052|P1|Overall Study|Disease Progression|2
1330446|NCT02129062|4372052|P1|Overall Study|Death|1
1330447|NCT02128997|4372059|P2|Overall Study|Lost to Follow-up|11
1330448|NCT02128997|4372060|P1|Overall Study|Lost to Follow-up|6
1330449|NCT02128932|4372075|P3|Overall Study|No reason for withdrawal|7
1330450|NCT02128932|4372076|P2|Overall Study|No reason for withdrawal|11
1330451|NCT02128932|4372077|P1|Overall Study|No reason for withdrawal|12
1330452|NCT02128932|4372075|P3|Overall Study|Lost to Follow-up|1
1330453|NCT02128932|4372076|P2|Overall Study|Lost to Follow-up|1
1330454|NCT02128932|4372077|P1|Overall Study|Lost to Follow-up|2
1330455|NCT02128932|4372075|P3|Overall Study|Death|2
1330456|NCT02128932|4372076|P2|Overall Study|Death|0
1330457|NCT02128932|4372077|P1|Overall Study|Death|2
1330458|NCT02128932|4372075|P3|Overall Study|Withdrawal by Subject|8
1330459|NCT02128932|4372076|P2|Overall Study|Withdrawal by Subject|7
1330460|NCT02128932|4372077|P1|Overall Study|Withdrawal by Subject|11
1330461|NCT02128542|4372134|P2|Overall Study|Withdrew Consent|0
1330462|NCT02128542|4372135|P1|Overall Study|Withdrew Consent|1
1330463|NCT02128542|4372134|P2|Overall Study|Lost to Follow-up|0
1330464|NCT02128542|4372135|P1|Overall Study|Lost to Follow-up|3
1330465|NCT02128490|4372153|P5|Overall Study|Other Miscellaneous Reasons|1
1330466|NCT02128490|4372154|P4|Overall Study|Other Miscellaneous Reasons|1
1330467|NCT02128490|4372155|P3|Overall Study|Other Miscellaneous Reasons|2
1330468|NCT02128490|4372156|P2|Overall Study|Other Miscellaneous Reasons|0
1330469|NCT02128490|4372157|P1|Overall Study|Other Miscellaneous Reasons|0
1330470|NCT02128490|4372153|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
1330471|NCT02128490|4372154|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
1330472|NCT02128490|4372155|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
1330473|NCT02128490|4372156|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
1330474|NCT02128490|4372157|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
1330475|NCT02128490|4372153|P5|Overall Study|Lack of Efficacy|0
1330476|NCT02128490|4372154|P4|Overall Study|Lack of Efficacy|0
1330477|NCT02128490|4372155|P3|Overall Study|Lack of Efficacy|0
1330478|NCT02128490|4372156|P2|Overall Study|Lack of Efficacy|1
1330479|NCT02128490|4372157|P1|Overall Study|Lack of Efficacy|0
1330480|NCT02128490|4372153|P5|Overall Study|Voluntary Withdrawal|2
1330481|NCT02128490|4372154|P4|Overall Study|Voluntary Withdrawal|1
1330482|NCT02128490|4372155|P3|Overall Study|Voluntary Withdrawal|1
1330483|NCT02128490|4372156|P2|Overall Study|Voluntary Withdrawal|3
1330484|NCT02128490|4372157|P1|Overall Study|Voluntary Withdrawal|3
1330485|NCT02128490|4372153|P5|Overall Study|Lost to Follow-up|1
1330486|NCT02128490|4372154|P4|Overall Study|Lost to Follow-up|1
1330487|NCT02128490|4372155|P3|Overall Study|Lost to Follow-up|1
1330488|NCT02128490|4372156|P2|Overall Study|Lost to Follow-up|0
1330489|NCT02128490|4372157|P1|Overall Study|Lost to Follow-up|0
1330490|NCT02128490|4372153|P5|Overall Study|Major Protocol Deviation|2
1330491|NCT02128490|4372154|P4|Overall Study|Major Protocol Deviation|2
1330492|NCT02128490|4372155|P3|Overall Study|Major Protocol Deviation|0
1330493|NCT02128490|4372156|P2|Overall Study|Major Protocol Deviation|2
1330494|NCT02128490|4372157|P1|Overall Study|Major Protocol Deviation|1
1330495|NCT02128490|4372153|P5|Overall Study|Pretreatment Event/Adverse Event|0
1330496|NCT02128490|4372154|P4|Overall Study|Pretreatment Event/Adverse Event|1
1330497|NCT02128490|4372155|P3|Overall Study|Pretreatment Event/Adverse Event|1
1330498|NCT02128490|4372156|P2|Overall Study|Pretreatment Event/Adverse Event|0
1330499|NCT02128490|4372157|P1|Overall Study|Pretreatment Event/Adverse Event|1
1330500|NCT02128269|4372179|P1|Treatment Period|Physician Decision|1
1330501|NCT02128269|4372179|P1|Treatment Period|Adverse Event|1
1330502|NCT02128217|4372185|P2|Overall Study|Lost to Follow-up|1
1330503|NCT02128217|4372186|P1|Overall Study|Lost to Follow-up|0
1330504|NCT02127970|4372234|P2|Overall Study|Subject Withdrew Consent|3
1330505|NCT02127970|4372235|P1|Overall Study|Subject Withdrew Consent|5
1330506|NCT02127970|4372234|P2|Overall Study|Pregnancy|1
1330507|NCT02127970|4372235|P1|Overall Study|Pregnancy|0
1330508|NCT02127970|4372234|P2|Overall Study|Reason not Specified|7
1330509|NCT02127970|4372235|P1|Overall Study|Reason not Specified|4
1330510|NCT02127970|4372234|P2|Overall Study|Lost to Follow-up|14
1330511|NCT02127970|4372235|P1|Overall Study|Lost to Follow-up|14
1330512|NCT02127970|4372234|P2|Overall Study|Death|1
1330513|NCT02127970|4372235|P1|Overall Study|Death|1
1330514|NCT02127970|4372234|P2|Overall Study|Adverse Event|1
1330515|NCT02127970|4372235|P1|Overall Study|Adverse Event|2
1330516|NCT02127372|4372370|P2|Overall Study|Withdrawal by Subject|0
1330517|NCT02127372|4372371|P1|Overall Study|Withdrawal by Subject|1
1330518|NCT02127307|4372381|P1|Overall Study|Other than specified above|169
1330519|NCT02127307|4372381|P1|Overall Study|Death|101
1330520|NCT02127307|4372381|P1|Overall Study|Lost to Follow-up|2
1330521|NCT02127307|4372381|P1|Overall Study|Protocol Violation|36
1330522|NCT02127281|4372387|P2|Overall Study|Lost to Follow-up|0
1330523|NCT02127281|4372388|P1|Overall Study|Lost to Follow-up|1
1330524|NCT02126839|4372416|P2|Overall Study|Not specified|5
1330525|NCT02126839|4372417|P1|Overall Study|Not specified|5
1330526|NCT02126839|4372416|P2|Overall Study|Lost to Follow-up|4
1330527|NCT02126839|4372417|P1|Overall Study|Lost to Follow-up|1
1330528|NCT02126839|4372416|P2|Overall Study|Sponsor request|1
1330529|NCT02126839|4372417|P1|Overall Study|Sponsor request|0
1330530|NCT02126839|4372416|P2|Overall Study|Protocol Violation|3
1330531|NCT02126839|4372417|P1|Overall Study|Protocol Violation|2
1330532|NCT02126839|4372416|P2|Overall Study|Withdrawal by parent/guardian|0
1330533|NCT02126839|4372417|P1|Overall Study|Withdrawal by parent/guardian|1
1330534|NCT02126839|4372416|P2|Overall Study|Withdrawal by Subject|0
1330535|NCT02126839|4372417|P1|Overall Study|Withdrawal by Subject|1
1330536|NCT02126839|4372416|P2|Overall Study|Adverse Event|1
1330537|NCT02126839|4372417|P1|Overall Study|Adverse Event|0
1330538|NCT02126670|4372444|P4|Overall Study|Withdrawal by Subject|1
1330539|NCT02126670|4372445|P3|Overall Study|Withdrawal by Subject|0
1330540|NCT02126670|4372446|P2|Overall Study|Withdrawal by Subject|0
1330541|NCT02126670|4372447|P1|Overall Study|Withdrawal by Subject|1
1330542|NCT02125877|4372499|P2|Overall Study|Adverse Event|4
1330543|NCT02125877|4372500|P1|Overall Study|Adverse Event|6
1330544|NCT02125877|4372499|P2|Overall Study|Protocol deviation|1
1330545|NCT02125877|4372500|P1|Overall Study|Protocol deviation|4
1330546|NCT02125877|4372499|P2|Overall Study|Withdrawal by Subject|1
1330547|NCT02125877|4372500|P1|Overall Study|Withdrawal by Subject|2
1330548|NCT02125877|4372499|P2|Overall Study|Participant/guardian decision|2
1330549|NCT02125877|4372500|P1|Overall Study|Participant/guardian decision|0
1330550|NCT02125877|4372499|P2|Overall Study|Administrative problems|1
1330551|NCT02125877|4372500|P1|Overall Study|Administrative problems|0
1330552|NCT02125877|4372499|P2|Overall Study|Death|1
1330553|NCT02125877|4372500|P1|Overall Study|Death|0
1330554|NCT02125877|4372499|P2|Overall Study|Physician Decision|0
1330555|NCT02125877|4372500|P1|Overall Study|Physician Decision|1
1330556|NCT02125838|4372530|P2|Overall Study|Lost to Follow-up|4
1330557|NCT02125838|4372531|P1|Overall Study|Lost to Follow-up|4
1330558|NCT02125734|4372549|P2|Period 2|Adverse Event|1
1330559|NCT02125734|4372550|P1|Period 2|Adverse Event|0
1330560|NCT02125604|4372560|P1|Overall Study|Adverse Event|20
1330561|NCT02125604|4372560|P1|Overall Study|Consent Withdrawn|4
1330562|NCT02125604|4372560|P1|Overall Study|Lost to Follow-up|2
1330563|NCT02125604|4372560|P1|Overall Study|Investigator Decision|1
1330564|NCT02125604|4372560|P1|Overall Study|Not Specified|4
1330565|NCT02124811|4372608|P2|Overall Study|Withdrawal by Subject|0
1330566|NCT02124811|4372609|P1|Overall Study|Withdrawal by Subject|1
1330567|NCT02124811|4372608|P2|Overall Study|Early termination|2
1330568|NCT02124811|4372609|P1|Overall Study|Early termination|2
1330569|NCT02124798|4372627|P1|Overall Study|Lost to Follow-up|1
1330570|NCT02124798|4372627|P1|Overall Study|Adverse Event|3
1330571|NCT02124161|4372685|P2|Overall Study|Lost to Follow-up|4
1330572|NCT02124161|4372686|P1|Overall Study|Lost to Follow-up|3
1330573|NCT02124161|4372685|P2|Overall Study|No longer meets eligibility criteria|4
1330574|NCT02124161|4372686|P1|Overall Study|No longer meets eligibility criteria|5
1330575|NCT02124161|4372685|P2|Overall Study|Does not meet entrance criteria|3
1330576|NCT02124161|4372686|P1|Overall Study|Does not meet entrance criteria|2
1330577|NCT02124161|4372685|P2|Overall Study|Adverse Event|0
1330578|NCT02124161|4372686|P1|Overall Study|Adverse Event|2
1330579|NCT02124161|4372685|P2|Overall Study|Withdrawal by Subject|2
1330580|NCT02124161|4372686|P1|Overall Study|Withdrawal by Subject|1
1330581|NCT02124161|4372685|P2|Overall Study|Protocol Violation|1
1330582|NCT02124161|4372686|P1|Overall Study|Protocol Violation|2
1330583|NCT02124161|4372685|P2|Overall Study|Death|0
1330584|NCT02124161|4372686|P1|Overall Study|Death|1
1330585|NCT02124161|4372685|P2|Overall Study|Other unspecified|1
1330586|NCT02124161|4372686|P1|Overall Study|Other unspecified|0
1330587|NCT02123966|4372745|P1|Overall Study|Intercurrent Illness|1
1330588|NCT02123472|4372785|P2|Period 2 (7 Days)|Withdrawal by Subject|1
1330589|NCT02123472|4372786|P1|Period 2 (7 Days)|Withdrawal by Subject|0
1330590|NCT02123459|4372796|P2|Washout Period (1 Day)|Adverse Event|0
1330591|NCT02123459|4372797|P1|Washout Period (1 Day)|Adverse Event|1
1330592|NCT02123446|4372807|P2|Washout Period (1 Day)|Physician Decision|0
1330593|NCT02123446|4372808|P1|Washout Period (1 Day)|Physician Decision|1
1330594|NCT02122146|4372906|P8|Part 1: Dose Escalation|Other|2
1330595|NCT02122146|4372907|P7|Part 1: Dose Escalation|Other|1
1330596|NCT02122146|4372908|P6|Part 1: Dose Escalation|Other|1
1330597|NCT02122146|4372909|P5|Part 1: Dose Escalation|Other|0
1330598|NCT02122146|4372910|P4|Part 1: Dose Escalation|Other|0
1330599|NCT02122146|4372911|P3|Part 1: Dose Escalation|Other|0
1330600|NCT02122146|4372912|P2|Part 1: Dose Escalation|Other|0
1330601|NCT02122146|4372913|P1|Part 1: Dose Escalation|Other|1
1330602|NCT02122146|4372906|P8|Part 1: Dose Escalation|Withdrawal by Subject|0
1330603|NCT02122146|4372907|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
1330604|NCT02122146|4372908|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
1330605|NCT02122146|4372909|P5|Part 1: Dose Escalation|Withdrawal by Subject|0
1330606|NCT02122146|4372910|P4|Part 1: Dose Escalation|Withdrawal by Subject|1
1330607|NCT02122146|4372911|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
1330608|NCT02122146|4372912|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
1330609|NCT02122146|4372913|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
1330610|NCT02122146|4372906|P8|Part 1: Dose Escalation|Lost to Follow-up|0
1330611|NCT02122146|4372907|P7|Part 1: Dose Escalation|Lost to Follow-up|0
1330612|NCT02122146|4372908|P6|Part 1: Dose Escalation|Lost to Follow-up|0
1330613|NCT02122146|4372909|P5|Part 1: Dose Escalation|Lost to Follow-up|1
1330614|NCT02122146|4372910|P4|Part 1: Dose Escalation|Lost to Follow-up|0
1330615|NCT02122146|4372911|P3|Part 1: Dose Escalation|Lost to Follow-up|1
1330616|NCT02122146|4372912|P2|Part 1: Dose Escalation|Lost to Follow-up|0
1330617|NCT02122146|4372913|P1|Part 1: Dose Escalation|Lost to Follow-up|0
1330618|NCT02122146|4372906|P8|Part 1: Dose Escalation|Death|0
1330619|NCT02122146|4372907|P7|Part 1: Dose Escalation|Death|0
1330620|NCT02122146|4372908|P6|Part 1: Dose Escalation|Death|0
1330621|NCT02122146|4372909|P5|Part 1: Dose Escalation|Death|0
1330622|NCT02122146|4372910|P4|Part 1: Dose Escalation|Death|0
1330623|NCT02122146|4372911|P3|Part 1: Dose Escalation|Death|1
1330624|NCT02122146|4372912|P2|Part 1: Dose Escalation|Death|1
1330625|NCT02122146|4372913|P1|Part 1: Dose Escalation|Death|0
1330626|NCT02121847|4373174|P1|Overall Study|Adverse Event|2
1330627|NCT02121847|4373174|P1|Overall Study|Administrative Reasons|1
1330628|NCT02121834|4373200|P7|Overall Study|Lost to Follow-up|0
1330629|NCT02121834|4373201|P6|Overall Study|Lost to Follow-up|0
1330630|NCT02121834|4373202|P5|Overall Study|Lost to Follow-up|0
1330631|NCT02121834|4373203|P4|Overall Study|Lost to Follow-up|0
1330632|NCT02121834|4373204|P3|Overall Study|Lost to Follow-up|1
1330633|NCT02121834|4373205|P2|Overall Study|Lost to Follow-up|0
1330634|NCT02121834|4373206|P1|Overall Study|Lost to Follow-up|0
1330635|NCT02121834|4373200|P7|Overall Study|Withdrawal by Subject|0
1330636|NCT02121834|4373201|P6|Overall Study|Withdrawal by Subject|0
1330637|NCT02121834|4373202|P5|Overall Study|Withdrawal by Subject|0
1330638|NCT02121834|4373203|P4|Overall Study|Withdrawal by Subject|0
1330639|NCT02121834|4373204|P3|Overall Study|Withdrawal by Subject|1
1330640|NCT02121834|4373205|P2|Overall Study|Withdrawal by Subject|1
1330641|NCT02121834|4373206|P1|Overall Study|Withdrawal by Subject|0
1330642|NCT02121834|4373200|P7|Overall Study|Protocol Violation|0
1330643|NCT02121834|4373201|P6|Overall Study|Protocol Violation|0
1330644|NCT02121834|4373202|P5|Overall Study|Protocol Violation|0
1330645|NCT02121834|4373203|P4|Overall Study|Protocol Violation|0
1330646|NCT02121834|4373204|P3|Overall Study|Protocol Violation|0
1330647|NCT02121834|4373205|P2|Overall Study|Protocol Violation|1
1330648|NCT02121834|4373206|P1|Overall Study|Protocol Violation|0
1330649|NCT02121808|4373232|P1|Overall Study|Technical problem|3
1330650|NCT02121795|4373243|P2|Overall Study|Still in Study up to the Data Cut Date|316
1330651|NCT02121795|4373244|P1|Overall Study|Still in Study up to the Data Cut Date|315
1330652|NCT02121795|4373243|P2|Overall Study|Lost to Follow-up|1
1330653|NCT02121795|4373244|P1|Overall Study|Lost to Follow-up|2
1330654|NCT02121795|4373243|P2|Overall Study|Withdrew Consent|10
1330655|NCT02121795|4373244|P1|Overall Study|Withdrew Consent|10
1330656|NCT02121795|4373243|P2|Overall Study|Protocol Violation|2
1330657|NCT02121795|4373244|P1|Overall Study|Protocol Violation|0
1330658|NCT02121795|4373243|P2|Overall Study|Non-Compliance with Study Drug|1
1330659|NCT02121795|4373244|P1|Overall Study|Non-Compliance with Study Drug|1
1330660|NCT02121795|4373243|P2|Overall Study|Investigator's Discretion|0
1330661|NCT02121795|4373244|P1|Overall Study|Investigator's Discretion|1
1330662|NCT02121795|4373243|P2|Overall Study|Adverse Event|0
1330663|NCT02121795|4373244|P1|Overall Study|Adverse Event|4
1330664|NCT02121795|4373243|P2|Overall Study|Randomized but Never Treated|4
1330665|NCT02121795|4373244|P1|Overall Study|Randomized but Never Treated|1
1330666|NCT02121535|4373260|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
1330667|NCT02121535|4373261|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
1330668|NCT02121535|4373260|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
1330669|NCT02121535|4373261|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
1330670|NCT02121522|4373284|P1|Overall Study|Adverse Event|1
1330671|NCT02121509|4373291|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
1330672|NCT02121509|4373292|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
1330673|NCT02121509|4373293|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
1330674|NCT02121509|4373294|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
1330675|NCT02121509|4373291|P4|Washout Period (35 Days)|Withdrawal by Subject|0
1330676|NCT02121509|4373292|P3|Washout Period (35 Days)|Withdrawal by Subject|0
1330677|NCT02121509|4373293|P2|Washout Period (35 Days)|Withdrawal by Subject|3
1330678|NCT02121509|4373294|P1|Washout Period (35 Days)|Withdrawal by Subject|0
1330679|NCT02121509|4373291|P4|Washout Period (35 Days)|Adverse Event|0
1330680|NCT02121509|4373292|P3|Washout Period (35 Days)|Adverse Event|0
1330681|NCT02121509|4373293|P2|Washout Period (35 Days)|Adverse Event|1
1330682|NCT02121509|4373294|P1|Washout Period (35 Days)|Adverse Event|1
1330683|NCT02121210|4373365|P2|Overall Study|Other than specified above|2
1330684|NCT02121210|4373366|P1|Overall Study|Other than specified above|0
1330685|NCT02121210|4373365|P2|Overall Study|Lack of Efficacy|0
1330686|NCT02121210|4373366|P1|Overall Study|Lack of Efficacy|2
1330687|NCT02121210|4373365|P2|Overall Study|Adverse Event|7
1330688|NCT02121210|4373366|P1|Overall Study|Adverse Event|5
1330689|NCT02120833|4373391|P2|Overall Study|Lost to Follow-up|1
1330690|NCT02120833|4373392|P1|Overall Study|Lost to Follow-up|1
1330691|NCT02120833|4373391|P2|Overall Study|Withdrawal by Subject|0
1330692|NCT02120833|4373392|P1|Overall Study|Withdrawal by Subject|2
1330693|NCT02120833|4373391|P2|Overall Study|Adverse Event|0
1330694|NCT02120833|4373392|P1|Overall Study|Adverse Event|1
1330695|NCT02120794|4373546|P1|Overall Study|Due to insurance coverage|1
1330696|NCT02120794|4373546|P1|Overall Study|Physician Decision|4
1330697|NCT02120794|4373546|P1|Overall Study|Adverse Event|10
1330698|NCT02120794|4373546|P1|Overall Study|Withdrawal by Subject|43
1330699|NCT02120664|4373558|P5|Overall Study|Withdrawal by Subject|0
1330700|NCT02120664|4373559|P4|Overall Study|Withdrawal by Subject|1
1330701|NCT02120664|4373560|P3|Overall Study|Withdrawal by Subject|0
1330702|NCT02120664|4373561|P2|Overall Study|Withdrawal by Subject|0
1330703|NCT02120664|4373562|P1|Overall Study|Withdrawal by Subject|0
1330704|NCT02120625|4373580|P1|Overall Study|Physician Decision|2
1330705|NCT02120417|4373595|P2|Overall Study|Other unspecified|4
1330706|NCT02120417|4373596|P1|Overall Study|Other unspecified|5
1330707|NCT02120417|4373595|P2|Overall Study|Physician Decision|3
1330708|NCT02120417|4373596|P1|Overall Study|Physician Decision|2
1330709|NCT02120417|4373595|P2|Overall Study|Noncompliance with study treatment|2
1330710|NCT02120417|4373596|P1|Overall Study|Noncompliance with study treatment|0
1330711|NCT02120417|4373595|P2|Overall Study|Disease progression|45
1330712|NCT02120417|4373596|P1|Overall Study|Disease progression|41
1330713|NCT02120417|4373595|P2|Overall Study|Participant decision|4
1330714|NCT02120417|4373596|P1|Overall Study|Participant decision|4
1330715|NCT02120417|4373595|P2|Overall Study|Adverse Event|9
1330716|NCT02120417|4373596|P1|Overall Study|Adverse Event|3
1330717|NCT02120417|4373595|P2|Overall Study|Death|1
1330718|NCT02120417|4373596|P1|Overall Study|Death|5
1330719|NCT02120300|4373618|P4|Overall Study|Lost to Follow-up|0
1330720|NCT02120300|4373619|P3|Overall Study|Lost to Follow-up|0
1330721|NCT02120300|4373620|P2|Overall Study|Lost to Follow-up|0
1330722|NCT02120300|4373621|P1|Overall Study|Lost to Follow-up|1
1330723|NCT02120300|4373618|P4|Overall Study|Lack of Efficacy|1
1330724|NCT02120300|4373619|P3|Overall Study|Lack of Efficacy|0
1330725|NCT02120300|4373620|P2|Overall Study|Lack of Efficacy|0
1330726|NCT02120300|4373621|P1|Overall Study|Lack of Efficacy|0
1330727|NCT02120300|4373618|P4|Overall Study|Enrolled but Never Treated|0
1330728|NCT02120300|4373619|P3|Overall Study|Enrolled but Never Treated|0
1330729|NCT02120300|4373620|P2|Overall Study|Enrolled but Never Treated|0
1330730|NCT02120300|4373621|P1|Overall Study|Enrolled but Never Treated|2
1330731|NCT02120027|4373659|P2|Overall Study|Withdrawal by Subject|25
1330732|NCT02120027|4373660|P1|Overall Study|Withdrawal by Subject|33
1330733|NCT02120027|4373659|P2|Overall Study|Study terminated by Sponsor|47
1330734|NCT02120027|4373660|P1|Overall Study|Study terminated by Sponsor|45
1330735|NCT02120027|4373659|P2|Overall Study|Protocol Violation|21
1330736|NCT02120027|4373660|P1|Overall Study|Protocol Violation|18
1330737|NCT02120027|4373659|P2|Overall Study|Physician Decision|3
1330738|NCT02120027|4373660|P1|Overall Study|Physician Decision|4
1330739|NCT02120027|4373659|P2|Overall Study|Other|0
1330740|NCT02120027|4373660|P1|Overall Study|Other|4
1330741|NCT02120027|4373659|P2|Overall Study|Lost to Follow-up|13
1330742|NCT02120027|4373660|P1|Overall Study|Lost to Follow-up|5
1330743|NCT02120027|4373659|P2|Overall Study|Lack of Efficacy|5
1330744|NCT02120027|4373660|P1|Overall Study|Lack of Efficacy|3
1330745|NCT02120027|4373659|P2|Overall Study|Adverse Event|5
1330746|NCT02120027|4373660|P1|Overall Study|Adverse Event|4
1330747|NCT02119936|4373685|P1|Overall Study|Lost to Follow-up|10
1330748|NCT02119676|4373719|P4|Overall Study|Did not receive study med|5
1330749|NCT02119676|4373720|P3|Overall Study|Did not receive study med|4
1330750|NCT02119676|4373721|P2|Overall Study|Did not receive study med|2
1330751|NCT02119676|4373722|P1|Overall Study|Did not receive study med|2
1330752|NCT02119676|4373719|P4|Overall Study|Other, unspecified|4
1330753|NCT02119676|4373720|P3|Overall Study|Other, unspecified|3
1330754|NCT02119676|4373721|P2|Overall Study|Other, unspecified|1
1330755|NCT02119676|4373722|P1|Overall Study|Other, unspecified|2
1330756|NCT02119676|4373719|P4|Overall Study|Protocol deviation|0
1330757|NCT02119676|4373720|P3|Overall Study|Protocol deviation|1
1330758|NCT02119676|4373721|P2|Overall Study|Protocol deviation|0
1330759|NCT02119676|4373722|P1|Overall Study|Protocol deviation|0
1330760|NCT02119676|4373719|P4|Overall Study|Lost to Follow-up|0
1330761|NCT02119676|4373720|P3|Overall Study|Lost to Follow-up|1
1330762|NCT02119676|4373721|P2|Overall Study|Lost to Follow-up|0
1330763|NCT02119676|4373722|P1|Overall Study|Lost to Follow-up|0
1330764|NCT02119676|4373719|P4|Overall Study|Noncompliance|0
1330765|NCT02119676|4373720|P3|Overall Study|Noncompliance|0
1330766|NCT02119676|4373721|P2|Overall Study|Noncompliance|1
1330767|NCT02119676|4373722|P1|Overall Study|Noncompliance|0
1330768|NCT02119676|4373719|P4|Overall Study|Death|1
1330769|NCT02119676|4373720|P3|Overall Study|Death|2
1330770|NCT02119676|4373721|P2|Overall Study|Death|3
1330771|NCT02119676|4373722|P1|Overall Study|Death|9
1330772|NCT02119676|4373719|P4|Overall Study|Physician Decision|2
1330773|NCT02119676|4373720|P3|Overall Study|Physician Decision|3
1330774|NCT02119676|4373721|P2|Overall Study|Physician Decision|2
1330775|NCT02119676|4373722|P1|Overall Study|Physician Decision|4
1330776|NCT02119676|4373719|P4|Overall Study|Patient decision, inc. consent withdrawn|6
1330777|NCT02119676|4373720|P3|Overall Study|Patient decision, inc. consent withdrawn|5
1330778|NCT02119676|4373721|P2|Overall Study|Patient decision, inc. consent withdrawn|5
1330779|NCT02119676|4373722|P1|Overall Study|Patient decision, inc. consent withdrawn|4
1330780|NCT02119676|4373719|P4|Overall Study|Disease progression|73
1330781|NCT02119676|4373720|P3|Overall Study|Disease progression|68
1330782|NCT02119676|4373721|P2|Overall Study|Disease progression|55
1330783|NCT02119676|4373722|P1|Overall Study|Disease progression|53
1330784|NCT02119676|4373719|P4|Overall Study|Adverse Event|10
1330785|NCT02119676|4373720|P3|Overall Study|Adverse Event|10
1330786|NCT02119676|4373721|P2|Overall Study|Adverse Event|17
1330787|NCT02119676|4373722|P1|Overall Study|Adverse Event|9
1330788|NCT02119663|4373754|P2|Overall Study|Study Terminated by the Sponsor|4
1330789|NCT02119663|4373755|P1|Overall Study|Study Terminated by the Sponsor|3
1330790|NCT02119663|4373754|P2|Overall Study|Subject decision|1
1330791|NCT02119663|4373755|P1|Overall Study|Subject decision|0
1330792|NCT02119663|4373754|P2|Overall Study|Other unspecified|0
1330793|NCT02119663|4373755|P1|Overall Study|Other unspecified|2
1330794|NCT02119663|4373754|P2|Overall Study|Physician Decision|2
1330795|NCT02119663|4373755|P1|Overall Study|Physician Decision|1
1330796|NCT02119663|4373754|P2|Overall Study|Death|2
1330797|NCT02119663|4373755|P1|Overall Study|Death|3
1330798|NCT02119663|4373754|P2|Overall Study|Adverse Event|5
1330799|NCT02119663|4373755|P1|Overall Study|Adverse Event|5
1330800|NCT02119663|4373754|P2|Overall Study|Disease progression|27
1330801|NCT02119663|4373755|P1|Overall Study|Disease progression|26
1330802|NCT02119650|4373773|P2|Overall Study|Multiple reasons for termination|1
1330803|NCT02119650|4373774|P1|Overall Study|Multiple reasons for termination|2
1330804|NCT02119650|4373773|P2|Overall Study|Physician Decision|2
1330805|NCT02119650|4373774|P1|Overall Study|Physician Decision|0
1330806|NCT02119650|4373773|P2|Overall Study|Study terminated by the sponsor|0
1330807|NCT02119650|4373774|P1|Overall Study|Study terminated by the sponsor|1
1330808|NCT02119650|4373773|P2|Overall Study|Noncompliance with study treatment|1
1330809|NCT02119650|4373774|P1|Overall Study|Noncompliance with study treatment|1
1330810|NCT02119650|4373773|P2|Overall Study|Death|1
1330811|NCT02119650|4373774|P1|Overall Study|Death|5
1330812|NCT02119650|4373773|P2|Overall Study|Disease progression|14
1330813|NCT02119650|4373774|P1|Overall Study|Disease progression|11
1330814|NCT02119650|4373773|P2|Overall Study|Subject decision|3
1330815|NCT02119650|4373774|P1|Overall Study|Subject decision|2
1330816|NCT02119650|4373773|P2|Overall Study|Adverse Event|4
1330817|NCT02119650|4373774|P1|Overall Study|Adverse Event|3
1330818|NCT02119325|4373788|P2|Washout Period 1|Adverse Event|1
1330819|NCT02119325|4373789|P1|Washout Period 1|Adverse Event|0
1330820|NCT02119299|4373833|P1|Overall Study|Pregnancy|1
1330821|NCT02119299|4373833|P1|Overall Study|Lack of Efficacy|1
1330822|NCT02119299|4373833|P1|Overall Study|Withdrawal by Subject|7
1330823|NCT02119286|4373847|P3|Overall Study|Withdrawal by Subject|0
1330824|NCT02119286|4373848|P2|Overall Study|Withdrawal by Subject|1
1330825|NCT02119286|4373849|P1|Overall Study|Withdrawal by Subject|4
1330826|NCT02119286|4373847|P3|Overall Study|Lost to Follow-up|1
1330827|NCT02119286|4373848|P2|Overall Study|Lost to Follow-up|0
1330828|NCT02119286|4373849|P1|Overall Study|Lost to Follow-up|2
1330829|NCT02119286|4373847|P3|Overall Study|Lack of Efficacy|4
1330830|NCT02119286|4373848|P2|Overall Study|Lack of Efficacy|3
1330831|NCT02119286|4373849|P1|Overall Study|Lack of Efficacy|11
1330832|NCT02119286|4373847|P3|Overall Study|Adverse Event|2
1330833|NCT02119286|4373848|P2|Overall Study|Adverse Event|7
1330834|NCT02119286|4373849|P1|Overall Study|Adverse Event|9
1330835|NCT02119104|4373860|P1|Overall Study|Protocol Violation|16
1330836|NCT02118961|4373866|P2|Overall Study|Withdrawal by Subject|0
1330837|NCT02118961|4373867|P1|Overall Study|Withdrawal by Subject|1
1330838|NCT02118896|4373895|P10|Overall Study|Miscellaneous|0
1330839|NCT02118896|4373896|P9|Overall Study|Miscellaneous|0
1330840|NCT02118896|4373897|P8|Overall Study|Miscellaneous|0
1330841|NCT02118896|4373898|P7|Overall Study|Miscellaneous|0
1330842|NCT02118896|4373899|P6|Overall Study|Miscellaneous|4
1330843|NCT02118896|4373900|P5|Overall Study|Miscellaneous|0
1330844|NCT02118896|4373901|P4|Overall Study|Miscellaneous|2
1330845|NCT02118896|4373902|P3|Overall Study|Miscellaneous|0
1330846|NCT02118896|4373903|P2|Overall Study|Miscellaneous|2
1330847|NCT02118896|4373904|P1|Overall Study|Miscellaneous|1
1330848|NCT02118896|4373895|P10|Overall Study|Prohibited medication|0
1330849|NCT02118896|4373896|P9|Overall Study|Prohibited medication|0
1330850|NCT02118896|4373897|P8|Overall Study|Prohibited medication|0
1330851|NCT02118896|4373898|P7|Overall Study|Prohibited medication|0
1330852|NCT02118896|4373899|P6|Overall Study|Prohibited medication|3
1330853|NCT02118896|4373900|P5|Overall Study|Prohibited medication|1
1330854|NCT02118896|4373901|P4|Overall Study|Prohibited medication|0
1330855|NCT02118896|4373902|P3|Overall Study|Prohibited medication|0
1330856|NCT02118896|4373903|P2|Overall Study|Prohibited medication|0
1330857|NCT02118896|4373904|P1|Overall Study|Prohibited medication|0
1330858|NCT02118896|4373895|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
1330859|NCT02118896|4373896|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
1330860|NCT02118896|4373897|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
1330861|NCT02118896|4373898|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
1330862|NCT02118896|4373899|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
1330863|NCT02118896|4373900|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
1330864|NCT02118896|4373901|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
1330865|NCT02118896|4373902|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
1330866|NCT02118896|4373903|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
1330867|NCT02118896|4373904|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
1330868|NCT02118896|4373895|P10|Overall Study|Lost to Follow-up|0
1330869|NCT02118896|4373896|P9|Overall Study|Lost to Follow-up|0
1330870|NCT02118896|4373897|P8|Overall Study|Lost to Follow-up|0
1330871|NCT02118896|4373898|P7|Overall Study|Lost to Follow-up|0
1330872|NCT02118896|4373899|P6|Overall Study|Lost to Follow-up|1
1330873|NCT02118896|4373900|P5|Overall Study|Lost to Follow-up|2
1330874|NCT02118896|4373901|P4|Overall Study|Lost to Follow-up|0
1330875|NCT02118896|4373902|P3|Overall Study|Lost to Follow-up|1
1330876|NCT02118896|4373903|P2|Overall Study|Lost to Follow-up|2
1330877|NCT02118896|4373904|P1|Overall Study|Lost to Follow-up|1
1330878|NCT02118896|4373895|P10|Overall Study|Pregnancy|0
1330879|NCT02118896|4373896|P9|Overall Study|Pregnancy|0
1330880|NCT02118896|4373897|P8|Overall Study|Pregnancy|0
1330881|NCT02118896|4373898|P7|Overall Study|Pregnancy|1
1330882|NCT02118896|4373899|P6|Overall Study|Pregnancy|3
1330883|NCT02118896|4373900|P5|Overall Study|Pregnancy|1
1330884|NCT02118896|4373901|P4|Overall Study|Pregnancy|0
1330885|NCT02118896|4373902|P3|Overall Study|Pregnancy|0
1330886|NCT02118896|4373903|P2|Overall Study|Pregnancy|1
1330887|NCT02118896|4373904|P1|Overall Study|Pregnancy|1
1330888|NCT02118896|4373895|P10|Overall Study|Non-compliance|0
1330889|NCT02118896|4373896|P9|Overall Study|Non-compliance|0
1330890|NCT02118896|4373897|P8|Overall Study|Non-compliance|1
1330891|NCT02118896|4373898|P7|Overall Study|Non-compliance|0
1330892|NCT02118896|4373899|P6|Overall Study|Non-compliance|1
1330893|NCT02118896|4373900|P5|Overall Study|Non-compliance|0
1330894|NCT02118896|4373901|P4|Overall Study|Non-compliance|5
1330895|NCT02118896|4373902|P3|Overall Study|Non-compliance|1
1330896|NCT02118896|4373903|P2|Overall Study|Non-compliance|1
1330897|NCT02118896|4373904|P1|Overall Study|Non-compliance|2
1330898|NCT02118896|4373895|P10|Overall Study|Consent withdrawn|0
1330899|NCT02118896|4373896|P9|Overall Study|Consent withdrawn|0
1330900|NCT02118896|4373897|P8|Overall Study|Consent withdrawn|0
1330901|NCT02118896|4373898|P7|Overall Study|Consent withdrawn|0
1330902|NCT02118896|4373899|P6|Overall Study|Consent withdrawn|4
1330903|NCT02118896|4373900|P5|Overall Study|Consent withdrawn|1
1330904|NCT02118896|4373901|P4|Overall Study|Consent withdrawn|4
1330905|NCT02118896|4373902|P3|Overall Study|Consent withdrawn|3
1330906|NCT02118896|4373903|P2|Overall Study|Consent withdrawn|0
1330907|NCT02118896|4373904|P1|Overall Study|Consent withdrawn|2
1330908|NCT02118896|4373895|P10|Overall Study|Adverse Event|0
1330909|NCT02118896|4373896|P9|Overall Study|Adverse Event|4
1330910|NCT02118896|4373897|P8|Overall Study|Adverse Event|1
1330911|NCT02118896|4373898|P7|Overall Study|Adverse Event|1
1330912|NCT02118896|4373899|P6|Overall Study|Adverse Event|9
1330913|NCT02118896|4373900|P5|Overall Study|Adverse Event|5
1330914|NCT02118896|4373901|P4|Overall Study|Adverse Event|5
1330915|NCT02118896|4373902|P3|Overall Study|Adverse Event|4
1330916|NCT02118896|4373903|P2|Overall Study|Adverse Event|4
1330917|NCT02118896|4373904|P1|Overall Study|Adverse Event|5
1330918|NCT02118896|4373895|P10|Overall Study|Death|0
1330919|NCT02118896|4373896|P9|Overall Study|Death|0
1330920|NCT02118896|4373897|P8|Overall Study|Death|0
1330921|NCT02118896|4373898|P7|Overall Study|Death|0
1330922|NCT02118896|4373899|P6|Overall Study|Death|1
1330923|NCT02118896|4373900|P5|Overall Study|Death|3
1330924|NCT02118896|4373901|P4|Overall Study|Death|6
1330925|NCT02118896|4373902|P3|Overall Study|Death|4
1330926|NCT02118896|4373903|P2|Overall Study|Death|0
1330927|NCT02118896|4373904|P1|Overall Study|Death|4
1330928|NCT02118792|4373994|P2|Overall Study|Randomised but not treated|0
1330929|NCT02118792|4373995|P1|Overall Study|Randomised but not treated|1
1330930|NCT02118792|4373994|P2|Overall Study|Other|6
1330931|NCT02118792|4373995|P1|Overall Study|Other|1
1330932|NCT02118792|4373994|P2|Overall Study|Withdrawal by parent/guardian|20
1330933|NCT02118792|4373995|P1|Overall Study|Withdrawal by parent/guardian|14
1330934|NCT02118792|4373994|P2|Overall Study|Adverse Event|4
1330935|NCT02118792|4373995|P1|Overall Study|Adverse Event|5
1330936|NCT02118792|4373994|P2|Overall Study|Lost to Follow-up|4
1330937|NCT02118792|4373995|P1|Overall Study|Lost to Follow-up|4
1330938|NCT02118792|4373994|P2|Overall Study|Withdrawal by Subject|3
1330939|NCT02118792|4373995|P1|Overall Study|Withdrawal by Subject|6
1330940|NCT02118766|4374037|P2|Overall Study|Other|1
1330941|NCT02118766|4374038|P1|Overall Study|Other|3
1330942|NCT02118766|4374037|P2|Overall Study|Withdrawal by parent/guardian|18
1330943|NCT02118766|4374038|P1|Overall Study|Withdrawal by parent/guardian|12
1330944|NCT02118766|4374037|P2|Overall Study|Lost to Follow-up|4
1330945|NCT02118766|4374038|P1|Overall Study|Lost to Follow-up|5
1330946|NCT02118766|4374037|P2|Overall Study|Withdrawal by Subject|6
1330947|NCT02118766|4374038|P1|Overall Study|Withdrawal by Subject|3
1330948|NCT02118766|4374037|P2|Overall Study|Adverse Event|2
1330949|NCT02118766|4374038|P1|Overall Study|Adverse Event|7
1330950|NCT02118597|4374060|P1|Overall Study|Investigator's decision|1
1330951|NCT02118597|4374060|P1|Overall Study|Serious Adverse Event|1
1330952|NCT02118597|4374060|P1|Overall Study|Sponsor terminated the study|14
1330953|NCT02117687|4374102|P2|Overall Study|Other Reasons|1
1330954|NCT02117687|4374103|P1|Overall Study|Other Reasons|1
1330955|NCT02117687|4374102|P2|Overall Study|Adverse Event|2
1330956|NCT02117687|4374103|P1|Overall Study|Adverse Event|0
1330957|NCT02117687|4374102|P2|Overall Study|Lost to Follow-up|1
1330958|NCT02117687|4374103|P1|Overall Study|Lost to Follow-up|0
1330959|NCT02117648|4374135|P1|Abemaciclib Safety-Extension Phase|Adverse Event|2
1330960|NCT02117648|4374135|P1|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
1330961|NCT02117648|4374135|P1|Abemaciclib Safety-Extension Phase|Death|3
1330962|NCT02117648|4374135|P1|Abemaciclib Safety-Extension Phase|Physician Decision|1
1330963|NCT02117648|4374135|P1|Abemaciclib Safety-Extension Phase|Progressive Disease|12
1330964|NCT02117648|4374135|P1|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
1330965|NCT02117648|4374135|P1|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
1330966|NCT02117648|4374135|P1|Abemaciclib + Clarithromycin Period 2|Death|1
1330967|NCT02117648|4374135|P1|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
1330968|NCT02117648|4374135|P1|Abemaciclib Alone Period 1|Adverse Event|1
1330969|NCT02117648|4374135|P1|Abemaciclib Alone Period 1|Withdrawal by Subject|1
1330970|NCT02117570|4374148|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
1330971|NCT02117570|4374149|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
1330972|NCT02117570|4374150|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
1330973|NCT02117570|4374148|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
1330974|NCT02117570|4374149|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
1330975|NCT02117570|4374150|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
1330976|NCT02117570|4374148|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
1330977|NCT02117570|4374149|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
1330978|NCT02117570|4374150|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
1330979|NCT02117570|4374148|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
1330980|NCT02117570|4374149|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
1330981|NCT02117570|4374150|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
1330982|NCT02117570|4374148|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
1330983|NCT02117570|4374149|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
1330984|NCT02117570|4374150|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
1330985|NCT02117570|4374148|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
1330986|NCT02117570|4374149|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
1330987|NCT02117570|4374150|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
1330988|NCT02117570|4374148|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
1330989|NCT02117570|4374149|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
1330990|NCT02117570|4374150|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
1330991|NCT02117544|4374200|P2|Period 1|Lost to follow-up (prior to treatment)|0
1330992|NCT02117544|4374201|P1|Period 1|Lost to follow-up (prior to treatment)|2
1330993|NCT02117479|4374216|P2|Overall Study|Other unspecified|7
1330994|NCT02117479|4374217|P1|Overall Study|Other unspecified|11
1330995|NCT02117479|4374216|P2|Overall Study|Physician Decision|2
1330996|NCT02117479|4374217|P1|Overall Study|Physician Decision|7
1330997|NCT02117479|4374216|P2|Overall Study|Study terminated by the sponsor|6
1330998|NCT02117479|4374217|P1|Overall Study|Study terminated by the sponsor|4
1330999|NCT02117479|4374216|P2|Overall Study|Noncompliance with study treatment|0
1331000|NCT02117479|4374217|P1|Overall Study|Noncompliance with study treatment|1
1331001|NCT02117479|4374216|P2|Overall Study|Disease progression|108
1331002|NCT02117479|4374217|P1|Overall Study|Disease progression|104
1331003|NCT02117479|4374216|P2|Overall Study|Subject decision|9
1331004|NCT02117479|4374217|P1|Overall Study|Subject decision|8
1331005|NCT02117479|4374216|P2|Overall Study|Adverse Event|16
1331006|NCT02117479|4374217|P1|Overall Study|Adverse Event|8
1331007|NCT02117479|4374216|P2|Overall Study|Death|8
1331008|NCT02117479|4374217|P1|Overall Study|Death|13
1331009|NCT02117414|4374235|P2|Overall Study|Withdrawal by Subject|4
1331010|NCT02117414|4374236|P1|Overall Study|Withdrawal by Subject|10
1331011|NCT02117414|4374235|P2|Overall Study|Death|2
1331012|NCT02117414|4374236|P1|Overall Study|Death|5
1331013|NCT02117050|4374280|P1|Overall Study|Subject Enrolled but not Dosed|1
1331014|NCT02116972|4374295|P3|Overall Study|scheduling conflicts and relocation|6
1331015|NCT02116972|4374296|P2|Overall Study|scheduling conflicts and relocation|3
1331016|NCT02116972|4374297|P1|Overall Study|scheduling conflicts and relocation|3
1331017|NCT02116972|4374295|P3|Overall Study|Lack of Efficacy|5
1331018|NCT02116972|4374296|P2|Overall Study|Lack of Efficacy|6
1331019|NCT02116972|4374297|P1|Overall Study|Lack of Efficacy|6
1331020|NCT02116972|4374295|P3|Overall Study|Lost to Follow-up|1
1331021|NCT02116972|4374296|P2|Overall Study|Lost to Follow-up|3
1331022|NCT02116972|4374297|P1|Overall Study|Lost to Follow-up|4
1331023|NCT02116972|4374295|P3|Overall Study|Protocol Violation|1
1331024|NCT02116972|4374296|P2|Overall Study|Protocol Violation|0
1331025|NCT02116972|4374297|P1|Overall Study|Protocol Violation|1
1331026|NCT02116972|4374295|P3|Overall Study|Withdrawal by Subject|5
1331027|NCT02116972|4374296|P2|Overall Study|Withdrawal by Subject|1
1331028|NCT02116972|4374297|P1|Overall Study|Withdrawal by Subject|1
1331029|NCT02116972|4374295|P3|Overall Study|Adverse Event|1
1331030|NCT02116972|4374296|P2|Overall Study|Adverse Event|4
1331031|NCT02116972|4374297|P1|Overall Study|Adverse Event|4
1331032|NCT02116803|4374329|P2|Overall Study|Death|0
1331033|NCT02116803|4374330|P1|Overall Study|Death|1
1331034|NCT02116803|4374329|P2|Overall Study|Study terminated by sponsor|1
1331035|NCT02116803|4374330|P1|Overall Study|Study terminated by sponsor|2
1331036|NCT02116803|4374329|P2|Overall Study|Progressive disease|0
1331037|NCT02116803|4374330|P1|Overall Study|Progressive disease|4
1331038|NCT02116803|4374329|P2|Overall Study|Physician Decision|0
1331039|NCT02116803|4374330|P1|Overall Study|Physician Decision|1
1331040|NCT02116803|4374329|P2|Overall Study|Adverse Event|1
1331041|NCT02116803|4374330|P1|Overall Study|Adverse Event|2
1331042|NCT02116621|4374338|P2|Twelve Month Follow-up|Enrolled within 12 months of study end|8
1331043|NCT02116621|4374339|P1|Twelve Month Follow-up|Enrolled within 12 months of study end|14
1331044|NCT02116621|4374338|P2|Twelve Month Follow-up|Did not complete follow-up survey|3
1331045|NCT02116621|4374339|P1|Twelve Month Follow-up|Did not complete follow-up survey|1
1331046|NCT02116621|4374338|P2|Twelve Month Follow-up|Lost to Follow-up|1
1331047|NCT02116621|4374339|P1|Twelve Month Follow-up|Lost to Follow-up|0
1331048|NCT02116621|4374338|P2|Twelve Month Follow-up|Withdrawal by Subject|0
1331049|NCT02116621|4374339|P1|Twelve Month Follow-up|Withdrawal by Subject|1
1331050|NCT02116621|4374338|P2|Six Month Follow-up|Did not complete follow-up survey|1
1331051|NCT02116621|4374339|P1|Six Month Follow-up|Did not complete follow-up survey|1
1331052|NCT02116621|4374338|P2|Six Month Follow-up|Lost to Follow-up|1
1331053|NCT02116621|4374339|P1|Six Month Follow-up|Lost to Follow-up|2
1331054|NCT02116621|4374338|P2|Six Month Follow-up|Withdrawal by Subject|1
1331055|NCT02116621|4374339|P1|Six Month Follow-up|Withdrawal by Subject|1
1331056|NCT02116621|4374338|P2|Three Month Follow-up|Did not complete follow-up survey|4
1331057|NCT02116621|4374339|P1|Three Month Follow-up|Did not complete follow-up survey|14
1331058|NCT02116621|4374338|P2|Three Month Follow-up|Lost to Follow-up|1
1331059|NCT02116621|4374339|P1|Three Month Follow-up|Lost to Follow-up|0
1331060|NCT02116621|4374338|P2|Three Month Follow-up|Withdrawal by Subject|1
1331061|NCT02116621|4374339|P1|Three Month Follow-up|Withdrawal by Subject|4
1331062|NCT02116621|4374338|P2|Three Month Follow-up|Death|1
1331063|NCT02116621|4374339|P1|Three Month Follow-up|Death|1
1331064|NCT02116621|4374338|P2|Baseline|Withdrawal by Subject|4
1331065|NCT02116621|4374339|P1|Baseline|Withdrawal by Subject|0
1331066|NCT02116582|4374427|P1|Overall Study|Other: Transitioned to 9785-CL-0123|12
1331067|NCT02116582|4374427|P1|Overall Study|Lost to Follow-up|1
1331068|NCT02116582|4374427|P1|Overall Study|Other: Miscellaneous|11
1331069|NCT02116582|4374427|P1|Overall Study|Withdrawal by Subject|8
1331070|NCT02116582|4374427|P1|Overall Study|Protocol Violation|3
1331071|NCT02116582|4374427|P1|Overall Study|Progressive Disease|148
1331072|NCT02116582|4374427|P1|Overall Study|Death|9
1331073|NCT02116582|4374427|P1|Overall Study|Adverse Event|22
1331074|NCT02116582|4374427|P1|Overall Study|Enrolled but Never Received Study Drug|1
1331075|NCT02116530|4374437|P2|Overall Study|Other Medical Problems|2
1331076|NCT02116530|4374438|P1|Overall Study|Other Medical Problems|2
1331077|NCT02116530|4374437|P2|Overall Study|Lost to Follow-up|0
1331078|NCT02116530|4374438|P1|Overall Study|Lost to Follow-up|1
1331079|NCT02116530|4374437|P2|Overall Study|Physician Decision|0
1331080|NCT02116530|4374438|P1|Overall Study|Physician Decision|1
1331081|NCT02116530|4374437|P2|Overall Study|Adverse Event|0
1331082|NCT02116530|4374438|P1|Overall Study|Adverse Event|4
1331083|NCT02116530|4374437|P2|Overall Study|Withdrawal by Subject|2
1331084|NCT02116530|4374438|P1|Overall Study|Withdrawal by Subject|1
1331085|NCT02116361|4374456|P4|Overall Study|Investigator Decision - Relapse|5
1331086|NCT02116361|4374457|P3|Overall Study|Investigator Decision - Relapse|8
1331087|NCT02116361|4374458|P2|Overall Study|Investigator Decision - Relapse|7
1331088|NCT02116361|4374459|P1|Overall Study|Investigator Decision - Relapse|9
1331089|NCT02116361|4374456|P4|Overall Study|Personal Reasons|9
1331090|NCT02116361|4374457|P3|Overall Study|Personal Reasons|4
1331091|NCT02116361|4374458|P2|Overall Study|Personal Reasons|6
1331092|NCT02116361|4374459|P1|Overall Study|Personal Reasons|6
1331093|NCT02116361|4374456|P4|Overall Study|Lost to Follow-up|5
1331094|NCT02116361|4374457|P3|Overall Study|Lost to Follow-up|7
1331095|NCT02116361|4374458|P2|Overall Study|Lost to Follow-up|5
1331096|NCT02116361|4374459|P1|Overall Study|Lost to Follow-up|4
1331097|NCT02116361|4374456|P4|Overall Study|Lack of Efficacy|3
1331098|NCT02116361|4374457|P3|Overall Study|Lack of Efficacy|4
1331099|NCT02116361|4374458|P2|Overall Study|Lack of Efficacy|7
1331100|NCT02116361|4374459|P1|Overall Study|Lack of Efficacy|5
1331101|NCT02116361|4374456|P4|Overall Study|Other Reasons|3
1331102|NCT02116361|4374457|P3|Overall Study|Other Reasons|3
1331103|NCT02116361|4374458|P2|Overall Study|Other Reasons|3
1331104|NCT02116361|4374459|P1|Overall Study|Other Reasons|3
1331105|NCT02116361|4374456|P4|Overall Study|Adverse Event|3
1331106|NCT02116361|4374457|P3|Overall Study|Adverse Event|0
1331107|NCT02116361|4374458|P2|Overall Study|Adverse Event|0
1331108|NCT02116361|4374459|P1|Overall Study|Adverse Event|1
1331109|NCT02116361|4374456|P4|Overall Study|Physician Decision|0
1331110|NCT02116361|4374457|P3|Overall Study|Physician Decision|0
1331111|NCT02116361|4374458|P2|Overall Study|Physician Decision|3
1331112|NCT02116361|4374459|P1|Overall Study|Physician Decision|2
1331113|NCT02116361|4374456|P4|Overall Study|Protocol Violation|2
1331114|NCT02116361|4374457|P3|Overall Study|Protocol Violation|0
1331115|NCT02116361|4374458|P2|Overall Study|Protocol Violation|0
1331116|NCT02116361|4374459|P1|Overall Study|Protocol Violation|1
1331117|NCT02116361|4374456|P4|Overall Study|Pregnancy|1
1331118|NCT02116361|4374457|P3|Overall Study|Pregnancy|0
1331119|NCT02116361|4374458|P2|Overall Study|Pregnancy|0
1331120|NCT02116361|4374459|P1|Overall Study|Pregnancy|0
1331121|NCT02116309|4374496|P2|Overall Study|Lost to Follow-up|1
1331122|NCT02116309|4374497|P1|Overall Study|Lost to Follow-up|0
1331123|NCT02115815|4374529|P7|Overall Study|Missed appointment, randomized in error|0
1331124|NCT02115815|4374530|P6|Overall Study|Missed appointment, randomized in error|1
1331125|NCT02115815|4374531|P5|Overall Study|Missed appointment, randomized in error|0
1331126|NCT02115815|4374532|P4|Overall Study|Missed appointment, randomized in error|0
1331127|NCT02115815|4374533|P3|Overall Study|Missed appointment, randomized in error|0
1331128|NCT02115815|4374534|P2|Overall Study|Missed appointment, randomized in error|0
1331129|NCT02115815|4374535|P1|Overall Study|Missed appointment, randomized in error|0
1331130|NCT02115815|4374529|P7|Overall Study|Not enough drug to dose participant|0
1331131|NCT02115815|4374530|P6|Overall Study|Not enough drug to dose participant|1
1331132|NCT02115815|4374531|P5|Overall Study|Not enough drug to dose participant|0
1331133|NCT02115815|4374532|P4|Overall Study|Not enough drug to dose participant|0
1331134|NCT02115815|4374533|P3|Overall Study|Not enough drug to dose participant|0
1331135|NCT02115815|4374534|P2|Overall Study|Not enough drug to dose participant|0
1331136|NCT02115815|4374535|P1|Overall Study|Not enough drug to dose participant|0
1331137|NCT02115815|4374529|P7|Overall Study|Withdrawal by Subject|0
1331138|NCT02115815|4374530|P6|Overall Study|Withdrawal by Subject|0
1331139|NCT02115815|4374531|P5|Overall Study|Withdrawal by Subject|0
1331140|NCT02115815|4374532|P4|Overall Study|Withdrawal by Subject|0
1331141|NCT02115815|4374533|P3|Overall Study|Withdrawal by Subject|0
1331142|NCT02115815|4374534|P2|Overall Study|Withdrawal by Subject|0
1331143|NCT02115815|4374535|P1|Overall Study|Withdrawal by Subject|2
1331144|NCT02115321|4374678|P2|Overall Study|Death|0
1331145|NCT02115321|4374679|P1|Overall Study|Death|1
1331146|NCT02115269|4374699|P1|Overall Study|Didn't take study drug|2
1331147|NCT02115269|4374699|P1|Overall Study|Withdrawal by Subject|2
1331148|NCT02115269|4374699|P1|Overall Study|Moved to another city|7
1331149|NCT02115269|4374699|P1|Overall Study|Did not complete patient diary|3
1331150|NCT02115269|4374699|P1|Overall Study|Lost to Follow-up|43
1331151|NCT02115256|4374719|P2|Overall Study|Withdrawal by Subject|1
1331152|NCT02115256|4374720|P1|Overall Study|Withdrawal by Subject|0
1331153|NCT02114931|4374734|P2|Overall Study|Other|1
1331154|NCT02114931|4374735|P1|Overall Study|Other|2
1331155|NCT02114931|4374734|P2|Overall Study|Physician Decision|2
1331156|NCT02114931|4374735|P1|Overall Study|Physician Decision|1
1331157|NCT02114931|4374734|P2|Overall Study|Lost to Follow-up|3
1331158|NCT02114931|4374735|P1|Overall Study|Lost to Follow-up|3
1331159|NCT02114931|4374734|P2|Overall Study|Adverse Event|6
1331160|NCT02114931|4374735|P1|Overall Study|Adverse Event|4
1331161|NCT02114931|4374734|P2|Overall Study|Withdrawal by Subject|18
1331162|NCT02114931|4374735|P1|Overall Study|Withdrawal by Subject|15
1331163|NCT02114892|4374751|P2|Overall Study|Lost to Follow-up|2
1331164|NCT02114892|4374752|P1|Overall Study|Lost to Follow-up|1
1331165|NCT02114697|4374788|P2|Overall Study|Study terminated|4
1331166|NCT02114697|4374789|P1|Overall Study|Study terminated|5
1331167|NCT02114268|4374801|P6|Overall Study|Withdrawn by site due to noncompliance|0
1331168|NCT02114268|4374802|P5|Overall Study|Withdrawn by site due to noncompliance|0
1331169|NCT02114268|4374803|P4|Overall Study|Withdrawn by site due to noncompliance|0
1331170|NCT02114268|4374804|P3|Overall Study|Withdrawn by site due to noncompliance|0
1331171|NCT02114268|4374805|P2|Overall Study|Withdrawn by site due to noncompliance|0
1331172|NCT02114268|4374806|P1|Overall Study|Withdrawn by site due to noncompliance|1
1331173|NCT02114268|4374801|P6|Overall Study|Withdrawal by Subject|1
1331174|NCT02114268|4374802|P5|Overall Study|Withdrawal by Subject|0
1331175|NCT02114268|4374803|P4|Overall Study|Withdrawal by Subject|0
1331176|NCT02114268|4374804|P3|Overall Study|Withdrawal by Subject|0
1331177|NCT02114268|4374805|P2|Overall Study|Withdrawal by Subject|0
1331178|NCT02114268|4374806|P1|Overall Study|Withdrawal by Subject|1
1331179|NCT02114268|4374801|P6|Overall Study|Lost to Follow-up|2
1331180|NCT02114268|4374802|P5|Overall Study|Lost to Follow-up|0
1331181|NCT02114268|4374803|P4|Overall Study|Lost to Follow-up|0
1331182|NCT02114268|4374804|P3|Overall Study|Lost to Follow-up|1
1331183|NCT02114268|4374805|P2|Overall Study|Lost to Follow-up|1
1331184|NCT02114268|4374806|P1|Overall Study|Lost to Follow-up|4
1331185|NCT02114203|4374875|P3|Overall Study|Withdrawal by Subject|0
1331186|NCT02114203|4374876|P2|Overall Study|Withdrawal by Subject|1
1331187|NCT02114203|4374877|P1|Overall Study|Withdrawal by Subject|0
1331188|NCT02114203|4374875|P3|Overall Study|Adverse Event|0
1331189|NCT02114203|4374876|P2|Overall Study|Adverse Event|1
1331190|NCT02114203|4374877|P1|Overall Study|Adverse Event|0
1331191|NCT02114177|4374911|P2|Overall Study|Other|1
1331192|NCT02114177|4374912|P1|Overall Study|Other|2
1331193|NCT02114177|4374911|P2|Overall Study|Withdrawal by Subject|1
1331194|NCT02114177|4374912|P1|Overall Study|Withdrawal by Subject|6
1331195|NCT02114177|4374911|P2|Overall Study|Lost to Follow-up|2
1331196|NCT02114177|4374912|P1|Overall Study|Lost to Follow-up|1
1331197|NCT02114151|4374936|P1|Overall Study|Withdrawal by Subject|5
1331198|NCT02114151|4374936|P1|Overall Study|Lost to Follow-up|1
1331199|NCT02114151|4374936|P1|Overall Study|Death|1
1331200|NCT02113579|4374953|P2|Overall Study|Lost to Follow-up|2
1331201|NCT02113579|4374954|P1|Overall Study|Lost to Follow-up|6
1331202|NCT02113579|4374953|P2|Overall Study|Withdrawal by Subject|2
1331203|NCT02113579|4374954|P1|Overall Study|Withdrawal by Subject|3
1331204|NCT02113579|4374953|P2|Overall Study|Adverse Event|0
1331205|NCT02113579|4374954|P1|Overall Study|Adverse Event|1
1331206|NCT02113449|4374978|P1|Overall Study|Adverse Event|4
1331207|NCT02113436|4374994|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
1331208|NCT02113436|4374995|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
1331209|NCT02113436|4374996|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
1331210|NCT02113436|4374997|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
1331211|NCT02113436|4374994|P4|Period 2: 16 Weeks|Physician Decision|0
1331212|NCT02113436|4374995|P3|Period 2: 16 Weeks|Physician Decision|2
1331213|NCT02113436|4374996|P2|Period 2: 16 Weeks|Physician Decision|0
1331214|NCT02113436|4374997|P1|Period 2: 16 Weeks|Physician Decision|0
1331215|NCT02113436|4374994|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
1331216|NCT02113436|4374995|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
1331217|NCT02113436|4374996|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
1331218|NCT02113436|4374997|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
1331219|NCT02113436|4374994|P4|Period 2: 16 Weeks|Adverse Event|5
1331220|NCT02113436|4374995|P3|Period 2: 16 Weeks|Adverse Event|4
1331221|NCT02113436|4374996|P2|Period 2: 16 Weeks|Adverse Event|0
1331222|NCT02113436|4374997|P1|Period 2: 16 Weeks|Adverse Event|0
1331223|NCT02113436|4374994|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
1331224|NCT02113436|4374995|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
1331225|NCT02113436|4374996|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
1331226|NCT02113436|4374997|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
1331227|NCT02113436|4374994|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
1331228|NCT02113436|4374995|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
1331229|NCT02113436|4374996|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
1331230|NCT02113436|4374997|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
1331231|NCT02113436|4374994|P4|Period 1: 8 Weeks|Protocol Violation|0
1331232|NCT02113436|4374995|P3|Period 1: 8 Weeks|Protocol Violation|0
1331233|NCT02113436|4374996|P2|Period 1: 8 Weeks|Protocol Violation|0
1331234|NCT02113436|4374997|P1|Period 1: 8 Weeks|Protocol Violation|1
1331235|NCT02113436|4374994|P4|Period 1: 8 Weeks|Adverse Event|0
1331236|NCT02113436|4374995|P3|Period 1: 8 Weeks|Adverse Event|0
1331237|NCT02113436|4374996|P2|Period 1: 8 Weeks|Adverse Event|0
1331238|NCT02113436|4374997|P1|Period 1: 8 Weeks|Adverse Event|1
1331239|NCT02113124|4375020|P2|Overall Study|Unable to retrieve blood sample|1
1331240|NCT02113124|4375021|P1|Overall Study|Unable to retrieve blood sample|1
1331241|NCT02113007|4375027|P1|Overall Study|Progressive disease|2
1331242|NCT02112448|4375035|P2|Overall Study|required heparin so could not use ketoro|0
1331243|NCT02112448|4375036|P1|Overall Study|required heparin so could not use ketoro|1
1331244|NCT02112448|4375035|P2|Overall Study|Physician Decision|6
1331245|NCT02112448|4375036|P1|Overall Study|Physician Decision|4
1331246|NCT02112448|4375035|P2|Overall Study|Protocol Violation|2
1331247|NCT02112448|4375036|P1|Overall Study|Protocol Violation|1
1331248|NCT02112448|4375035|P2|Overall Study|lab values precluding use of ketorolac|2
1331249|NCT02112448|4375036|P1|Overall Study|lab values precluding use of ketorolac|2
1331250|NCT02111603|4375084|P1|Overall Study|Withdrawal by Subject|1
1331251|NCT02111369|4375093|P1|Overall Study|Withdrawal by Subject|1
1331252|NCT02111369|4375093|P1|Overall Study|Lost to Follow-up|2
1331253|NCT02111174|4375138|P2|Secondary Outcomes (2 and 3 Month f/u)|Death|1
1331254|NCT02111174|4375139|P1|Secondary Outcomes (2 and 3 Month f/u)|Death|0
1331255|NCT02111174|4375138|P2|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
1331256|NCT02111174|4375139|P1|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
1331257|NCT02111174|4375138|P2|Treatment and Primary Outcome|Withdrawal by Subject|2
1331258|NCT02111174|4375139|P1|Treatment and Primary Outcome|Withdrawal by Subject|2
1331259|NCT02111174|4375138|P2|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
1331260|NCT02111174|4375139|P1|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
1331261|NCT02111096|4375168|P3|Overall Study|Withdrawal by Subject|8
1331262|NCT02111096|4375169|P2|Overall Study|Withdrawal by Subject|2
1331263|NCT02111096|4375170|P1|Overall Study|Withdrawal by Subject|4
1331264|NCT02111096|4375168|P3|Overall Study|Terminated by Sponsor|54
1331265|NCT02111096|4375169|P2|Overall Study|Terminated by Sponsor|35
1331266|NCT02111096|4375170|P1|Overall Study|Terminated by Sponsor|53
1331267|NCT02111096|4375168|P3|Overall Study|Protocol Violation|1
1331268|NCT02111096|4375169|P2|Overall Study|Protocol Violation|0
1331269|NCT02111096|4375170|P1|Overall Study|Protocol Violation|1
1331270|NCT02111096|4375168|P3|Overall Study|Physician Decision|0
1331271|NCT02111096|4375169|P2|Overall Study|Physician Decision|1
1331272|NCT02111096|4375170|P1|Overall Study|Physician Decision|0
1331273|NCT02111096|4375168|P3|Overall Study|Lost to Follow Up|1
1331274|NCT02111096|4375169|P2|Overall Study|Lost to Follow Up|1
1331275|NCT02111096|4375170|P1|Overall Study|Lost to Follow Up|1
1331276|NCT02111096|4375168|P3|Overall Study|Non-Compliance with Study Drug|0
1331277|NCT02111096|4375169|P2|Overall Study|Non-Compliance with Study Drug|1
1331278|NCT02111096|4375170|P1|Overall Study|Non-Compliance with Study Drug|1
1331279|NCT02111096|4375168|P3|Overall Study|Adverse Event|2
1331280|NCT02111096|4375169|P2|Overall Study|Adverse Event|1
1331281|NCT02111096|4375170|P1|Overall Study|Adverse Event|4
1331282|NCT02111083|4375218|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
1331283|NCT02111083|4375219|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
1331284|NCT02110693|4375237|P2|Overall Study|Other|0
1331285|NCT02110693|4375238|P1|Overall Study|Other|1
1331286|NCT02110693|4375237|P2|Overall Study|technical difficulties|4
1331287|NCT02110693|4375238|P1|Overall Study|technical difficulties|6
1331288|NCT02110693|4375237|P2|Overall Study|skipped assessment|18
1331289|NCT02110693|4375238|P1|Overall Study|skipped assessment|15
1331290|NCT02110693|4375237|P2|Overall Study|Withdrawal by Subject|7
1331291|NCT02110693|4375238|P1|Overall Study|Withdrawal by Subject|6
1331292|NCT02110238|4375284|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
1331293|NCT02110238|4375285|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
1331294|NCT02110238|4375284|P2|14 Week Blinded Extension Phase|Protocol Violation|3
1331295|NCT02110238|4375285|P1|14 Week Blinded Extension Phase|Protocol Violation|2
1331296|NCT02110238|4375284|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
1331297|NCT02110238|4375285|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
1331298|NCT02110238|4375284|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
1331299|NCT02110238|4375285|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
1331300|NCT02110238|4375284|P2|14 Week Blinded Extension Phase|Adverse Event|1
1331301|NCT02110238|4375285|P1|14 Week Blinded Extension Phase|Adverse Event|1
1331302|NCT02110238|4375284|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
1331303|NCT02110238|4375285|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
1331304|NCT02110238|4375284|P2|12 Week Pivotal Phase|Protocol Violation|1
1331305|NCT02110238|4375285|P1|12 Week Pivotal Phase|Protocol Violation|0
1331306|NCT02110238|4375284|P2|12 Week Pivotal Phase|Physician Decision|2
1331307|NCT02110238|4375285|P1|12 Week Pivotal Phase|Physician Decision|0
1331308|NCT02110238|4375284|P2|12 Week Pivotal Phase|Lost to Follow-up|0
1331309|NCT02110238|4375285|P1|12 Week Pivotal Phase|Lost to Follow-up|2
1331310|NCT02110238|4375284|P2|12 Week Pivotal Phase|Lack of Efficacy|3
1331311|NCT02110238|4375285|P1|12 Week Pivotal Phase|Lack of Efficacy|2
1331312|NCT02110238|4375284|P2|12 Week Pivotal Phase|Adverse Event|0
1331313|NCT02110238|4375285|P1|12 Week Pivotal Phase|Adverse Event|3
1331314|NCT02109484|4375327|P8|Overall Study|Moved away from study area|1
1331315|NCT02109484|4375328|P7|Overall Study|Moved away from study area|1
1331316|NCT02109484|4375329|P6|Overall Study|Moved away from study area|0
1331317|NCT02109484|4375330|P5|Overall Study|Moved away from study area|0
1331318|NCT02109484|4375331|P4|Overall Study|Moved away from study area|0
1331319|NCT02109484|4375332|P3|Overall Study|Moved away from study area|0
1331320|NCT02109484|4375333|P2|Overall Study|Moved away from study area|0
1331321|NCT02109484|4375334|P1|Overall Study|Moved away from study area|0
1331322|NCT02109484|4375327|P8|Overall Study|Death|2
1331323|NCT02109484|4375328|P7|Overall Study|Death|0
1331324|NCT02109484|4375329|P6|Overall Study|Death|0
1331325|NCT02109484|4375330|P5|Overall Study|Death|0
1331326|NCT02109484|4375331|P4|Overall Study|Death|0
1331327|NCT02109484|4375332|P3|Overall Study|Death|0
1331328|NCT02109484|4375333|P2|Overall Study|Death|0
1331329|NCT02109484|4375334|P1|Overall Study|Death|0
1331330|NCT02109484|4375327|P8|Overall Study|Physician Decision|0
1331331|NCT02109484|4375328|P7|Overall Study|Physician Decision|0
1331332|NCT02109484|4375329|P6|Overall Study|Physician Decision|0
1331333|NCT02109484|4375330|P5|Overall Study|Physician Decision|2
1331334|NCT02109484|4375331|P4|Overall Study|Physician Decision|0
1331335|NCT02109484|4375332|P3|Overall Study|Physician Decision|0
1331336|NCT02109484|4375333|P2|Overall Study|Physician Decision|0
1331337|NCT02109484|4375334|P1|Overall Study|Physician Decision|0
1331338|NCT02109484|4375327|P8|Overall Study|Withdrawal by Subject|0
1331339|NCT02109484|4375328|P7|Overall Study|Withdrawal by Subject|1
1331340|NCT02109484|4375329|P6|Overall Study|Withdrawal by Subject|1
1331341|NCT02109484|4375330|P5|Overall Study|Withdrawal by Subject|1
1331342|NCT02109484|4375331|P4|Overall Study|Withdrawal by Subject|0
1331343|NCT02109484|4375332|P3|Overall Study|Withdrawal by Subject|0
1331344|NCT02109484|4375333|P2|Overall Study|Withdrawal by Subject|0
1331345|NCT02109484|4375334|P1|Overall Study|Withdrawal by Subject|0
1331346|NCT02109484|4375327|P8|Overall Study|Lost to Follow-up|0
1331347|NCT02109484|4375328|P7|Overall Study|Lost to Follow-up|1
1331348|NCT02109484|4375329|P6|Overall Study|Lost to Follow-up|0
1331349|NCT02109484|4375330|P5|Overall Study|Lost to Follow-up|1
1331350|NCT02109484|4375331|P4|Overall Study|Lost to Follow-up|1
1331351|NCT02109484|4375332|P3|Overall Study|Lost to Follow-up|0
1331352|NCT02109484|4375333|P2|Overall Study|Lost to Follow-up|0
1331353|NCT02109484|4375334|P1|Overall Study|Lost to Follow-up|0
1331354|NCT02109445|4375390|P1|Overall Study|Adverse Event|1
1331355|NCT02109445|4375390|P1|Overall Study|Symptomatic deterioration|2
1331356|NCT02109172|4375423|P6|Overall Study|Death|0
1331357|NCT02109172|4375424|P5|Overall Study|Death|1
1331358|NCT02109172|4375425|P4|Overall Study|Death|0
1331359|NCT02109172|4375426|P3|Overall Study|Death|0
1331360|NCT02109172|4375427|P2|Overall Study|Death|0
1331361|NCT02109172|4375428|P1|Overall Study|Death|0
1331362|NCT02109172|4375423|P6|Overall Study|Adverse Event|1
1331363|NCT02109172|4375424|P5|Overall Study|Adverse Event|0
1331364|NCT02109172|4375425|P4|Overall Study|Adverse Event|0
1331365|NCT02109172|4375426|P3|Overall Study|Adverse Event|1
1331366|NCT02109172|4375427|P2|Overall Study|Adverse Event|0
1331367|NCT02109172|4375428|P1|Overall Study|Adverse Event|0
1331368|NCT02109172|4375423|P6|Overall Study|Withdrawal by Subject|0
1331369|NCT02109172|4375424|P5|Overall Study|Withdrawal by Subject|0
1331370|NCT02109172|4375425|P4|Overall Study|Withdrawal by Subject|1
1331371|NCT02109172|4375426|P3|Overall Study|Withdrawal by Subject|0
1331372|NCT02109172|4375427|P2|Overall Study|Withdrawal by Subject|0
1331373|NCT02109172|4375428|P1|Overall Study|Withdrawal by Subject|1
1331374|NCT02109133|4375449|P2|Overall Study|Lost to Follow-up|0
1331375|NCT02109133|4375450|P1|Overall Study|Lost to Follow-up|1
1331376|NCT02109107|4375462|P1|Overall Study|Lost to Follow-up|2
1331377|NCT02109042|4375469|P1|Overall Study|Sponsor Decision|15
1331378|NCT02108951|4375490|P1|Overall Study|Study Terminated by Sponsor|14
1331379|NCT02108951|4375490|P1|Overall Study|Patient's/guardian's decision|1
1331380|NCT02108951|4375490|P1|Overall Study|Lost to Follow-up|1
1331381|NCT02108652|4375528|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
1331382|NCT02108652|4375528|P1|Overall Study|Withdrawal by Subject|8
1331383|NCT02108652|4375528|P1|Overall Study|Lost to Follow-up|2
1331384|NCT02108652|4375528|P1|Overall Study|Death|226
1331385|NCT02107898|4375697|P2|Overall Study|Randomized but not treated|1
1331386|NCT02107898|4375698|P1|Overall Study|Randomized but not treated|0
1331387|NCT02107898|4375697|P2|Overall Study|Consent withdrawn by participant|1
1331388|NCT02107898|4375698|P1|Overall Study|Consent withdrawn by participant|2
1331389|NCT02107898|4375697|P2|Overall Study|Participant moved|2
1331390|NCT02107898|4375698|P1|Overall Study|Participant moved|0
1331391|NCT02107898|4375697|P2|Overall Study|Poor compliance to protocol|1
1331392|NCT02107898|4375698|P1|Overall Study|Poor compliance to protocol|0
1331393|NCT02107898|4375697|P2|Overall Study|Adverse Event|7
1331394|NCT02107898|4375698|P1|Overall Study|Adverse Event|4
1331395|NCT02107703|4375752|P2|Overall Study|On study treatment/follow up|152
1331396|NCT02107703|4375753|P1|Overall Study|On study treatment/follow up|319
1331397|NCT02107703|4375752|P2|Overall Study|Lost to Follow-up|4
1331398|NCT02107703|4375753|P1|Overall Study|Lost to Follow-up|6
1331399|NCT02107703|4375752|P2|Overall Study|Withdrawal by Subject|19
1331400|NCT02107703|4375753|P1|Overall Study|Withdrawal by Subject|36
1331401|NCT02107482|4375785|P1|Overall Study|Lack of Efficacy|1
1331402|NCT02107482|4375785|P1|Overall Study|Lost to Follow-up|1
1331403|NCT02107482|4375785|P1|Overall Study|inconveinence|2
1331404|NCT02107443|4375793|P2|Overall Study|Withdrawal: Personal Issues|3
1331405|NCT02107443|4375794|P1|Overall Study|Withdrawal: Personal Issues|0
1331406|NCT02107443|4375793|P2|Overall Study|Withdrawal: Disease Progression|2
1331407|NCT02107443|4375794|P1|Overall Study|Withdrawal: Disease Progression|4
1331408|NCT02107443|4375793|P2|Overall Study|Withdrawal: Other Medical|5
1331409|NCT02107443|4375794|P1|Overall Study|Withdrawal: Other Medical|9
1331410|NCT02107443|4375793|P2|Overall Study|Withdrawal: Feeling Overwhelmed|1
1331411|NCT02107443|4375794|P1|Overall Study|Withdrawal: Feeling Overwhelmed|2
1331412|NCT02107443|4375793|P2|Overall Study|Withdrawal: Too Time Consuming|6
1331413|NCT02107443|4375794|P1|Overall Study|Withdrawal: Too Time Consuming|3
1331414|NCT02107443|4375793|P2|Overall Study|Withdrawal: Too Many Forms|1
1331415|NCT02107443|4375794|P1|Overall Study|Withdrawal: Too Many Forms|3
1331416|NCT02107443|4375793|P2|Overall Study|Withdrawal: Changed MD/Facility|3
1331417|NCT02107443|4375794|P1|Overall Study|Withdrawal: Changed MD/Facility|1
1331418|NCT02107443|4375793|P2|Overall Study|Withdrawal: Changed Mind|0
1331419|NCT02107443|4375794|P1|Overall Study|Withdrawal: Changed Mind|2
1331420|NCT02107443|4375793|P2|Overall Study|Withdrawal: Disliked Study Procedures|2
1331421|NCT02107443|4375794|P1|Overall Study|Withdrawal: Disliked Study Procedures|1
1331422|NCT02107443|4375793|P2|Overall Study|Withdrawal: Hospitalization/Hospice|28
1331423|NCT02107443|4375794|P1|Overall Study|Withdrawal: Hospitalization/Hospice|28
1331424|NCT02107443|4375793|P2|Overall Study|Registered but Not Eligible|1
1331425|NCT02107443|4375794|P1|Overall Study|Registered but Not Eligible|0
1331426|NCT02107443|4375793|P2|Overall Study|Study Protocol Violation|1
1331427|NCT02107443|4375794|P1|Overall Study|Study Protocol Violation|3
1331428|NCT02107443|4375793|P2|Overall Study|Death|30
1331429|NCT02107443|4375794|P1|Overall Study|Death|42
1331430|NCT02107313|4375833|P2|Overall Study|One participant did not do the FED cohor|1
1331431|NCT02107313|4375834|P1|Overall Study|One participant did not do the FED cohor|0
1331432|NCT02107274|4375844|P2|Control Phase|Adverse Event|1
1331433|NCT02107274|4375845|P1|Control Phase|Adverse Event|0
1331434|NCT02107274|4375844|P2|Control Phase|Death|0
1331435|NCT02107274|4375845|P1|Control Phase|Death|2
1331436|NCT02107274|4375844|P2|Control Phase|Lost to Follow-up|1
1331437|NCT02107274|4375845|P1|Control Phase|Lost to Follow-up|1
1331438|NCT02107274|4375844|P2|Treatment vs. Placebo|Lost to Follow-up|2
1331439|NCT02107274|4375845|P1|Treatment vs. Placebo|Lost to Follow-up|0
1331440|NCT02107274|4375844|P2|Treatment vs. Placebo|Adverse Event|0
1331441|NCT02107274|4375845|P1|Treatment vs. Placebo|Adverse Event|3
1331442|NCT02107196|4375859|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
1331443|NCT02107196|4375860|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
1331444|NCT02107196|4375859|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
1331445|NCT02107196|4375860|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
1331446|NCT02107196|4375859|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
1331447|NCT02107196|4375860|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
1331448|NCT02107196|4375859|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
1331449|NCT02107196|4375860|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
1331450|NCT02107196|4375859|P2|12-week Treatment Period|Reason Missing|8
1331451|NCT02107196|4375860|P1|12-week Treatment Period|Reason Missing|11
1331452|NCT02107196|4375859|P2|12-week Treatment Period|Protocol Violation|8
1331453|NCT02107196|4375860|P1|12-week Treatment Period|Protocol Violation|7
1331454|NCT02107196|4375859|P2|12-week Treatment Period|Withdrawal by Subject|12
1331455|NCT02107196|4375860|P1|12-week Treatment Period|Withdrawal by Subject|15
1331456|NCT02107196|4375859|P2|12-week Treatment Period|Physician Decision|1
1331457|NCT02107196|4375860|P1|12-week Treatment Period|Physician Decision|0
1331458|NCT02107196|4375859|P2|12-week Treatment Period|Lost to Follow-up|6
1331459|NCT02107196|4375860|P1|12-week Treatment Period|Lost to Follow-up|3
1331460|NCT02107196|4375859|P2|12-week Treatment Period|Lack of Efficacy|1
1331461|NCT02107196|4375860|P1|12-week Treatment Period|Lack of Efficacy|2
1331462|NCT02107196|4375859|P2|12-week Treatment Period|Adverse Event|3
1331463|NCT02107196|4375860|P1|12-week Treatment Period|Adverse Event|6
1331464|NCT02107092|4375873|P1|Overall Study|Expected progression of CKD|12
1331465|NCT02107092|4375873|P1|Overall Study|Adverse Event|7
1331466|NCT02107092|4375873|P1|Overall Study|Withdrawal by Subject|9
1331467|NCT02107092|4375873|P1|Overall Study|Lost to Follow-up|2
1331468|NCT02107092|4375873|P1|Overall Study|Physician Decision|3
1331469|NCT02107092|4375873|P1|Overall Study|Met ECG withdrawal criteria|3
1331470|NCT02107092|4375873|P1|Overall Study|Hypo-or hyperkalemia|2
1331471|NCT02107092|4375873|P1|Overall Study|Subject compliance|3
1331472|NCT02107092|4375873|P1|Overall Study|Miscellaneous|3
1331473|NCT02107014|4375878|P1|Overall Study|Withdrew before drug: moving interstate|1
1331474|NCT02106923|4375960|P6|Overall Study|Protocol Violation|1
1331475|NCT02106923|4375961|P5|Overall Study|Protocol Violation|0
1331476|NCT02106923|4375962|P4|Overall Study|Protocol Violation|0
1331477|NCT02106923|4375963|P3|Overall Study|Protocol Violation|0
1331478|NCT02106923|4375964|P2|Overall Study|Protocol Violation|0
1331479|NCT02106923|4375965|P1|Overall Study|Protocol Violation|0
1331480|NCT02106832|4376013|P4|Overall Study|Technical problems|0
1331481|NCT02106832|4376014|P3|Overall Study|Technical problems|0
1331482|NCT02106832|4376015|P2|Overall Study|Technical problems|1
1331483|NCT02106832|4376016|P1|Overall Study|Technical problems|0
1331484|NCT02106832|4376013|P4|Overall Study|Withdrawal by Subject|7
1331485|NCT02106832|4376014|P3|Overall Study|Withdrawal by Subject|10
1331486|NCT02106832|4376015|P2|Overall Study|Withdrawal by Subject|17
1331487|NCT02106832|4376016|P1|Overall Study|Withdrawal by Subject|17
1331488|NCT02106832|4376013|P4|Overall Study|Protocol Violation|1
1331489|NCT02106832|4376014|P3|Overall Study|Protocol Violation|0
1331490|NCT02106832|4376015|P2|Overall Study|Protocol Violation|0
1331491|NCT02106832|4376016|P1|Overall Study|Protocol Violation|0
1331492|NCT02106832|4376013|P4|Overall Study|Physician Decision|0
1331493|NCT02106832|4376014|P3|Overall Study|Physician Decision|0
1331494|NCT02106832|4376015|P2|Overall Study|Physician Decision|0
1331495|NCT02106832|4376016|P1|Overall Study|Physician Decision|1
1331496|NCT02106832|4376013|P4|Overall Study|Lost to Follow-up|3
1331497|NCT02106832|4376014|P3|Overall Study|Lost to Follow-up|1
1331498|NCT02106832|4376015|P2|Overall Study|Lost to Follow-up|1
1331499|NCT02106832|4376016|P1|Overall Study|Lost to Follow-up|0
1331500|NCT02106832|4376013|P4|Overall Study|Deterioration of general conditions|0
1331501|NCT02106832|4376014|P3|Overall Study|Deterioration of general conditions|1
1331502|NCT02106832|4376015|P2|Overall Study|Deterioration of general conditions|0
1331503|NCT02106832|4376016|P1|Overall Study|Deterioration of general conditions|0
1331504|NCT02106832|4376013|P4|Overall Study|Death|4
1331505|NCT02106832|4376014|P3|Overall Study|Death|1
1331506|NCT02106832|4376015|P2|Overall Study|Death|4
1331507|NCT02106832|4376016|P1|Overall Study|Death|4
1331508|NCT02106832|4376013|P4|Overall Study|Adverse Event|0
1331509|NCT02106832|4376014|P3|Overall Study|Adverse Event|3
1331510|NCT02106832|4376015|P2|Overall Study|Adverse Event|2
1331511|NCT02106832|4376016|P1|Overall Study|Adverse Event|1
1331512|NCT02106403|4376083|P6|Follow-Up Visit 3|Other Reason|1
1331513|NCT02106403|4376084|P5|Follow-Up Visit 3|Other Reason|0
1331514|NCT02106403|4376085|P4|Follow-Up Visit 3|Other Reason|0
1331515|NCT02106403|4376086|P3|Follow-Up Visit 3|Other Reason|0
1331516|NCT02106403|4376087|P2|Follow-Up Visit 3|Other Reason|0
1331517|NCT02106403|4376088|P1|Follow-Up Visit 3|Other Reason|0
1331518|NCT02106390|4376111|P3|Overall Study|Protocol Violation|0
1331519|NCT02106390|4376112|P2|Overall Study|Protocol Violation|1
1331520|NCT02106390|4376113|P1|Overall Study|Protocol Violation|0
1331521|NCT02106390|4376111|P3|Overall Study|Adverse Event|1
1331522|NCT02106390|4376112|P2|Overall Study|Adverse Event|2
1331523|NCT02106390|4376113|P1|Overall Study|Adverse Event|0
1331524|NCT02106390|4376111|P3|Overall Study|Other: Unspecified|2
1331525|NCT02106390|4376112|P2|Overall Study|Other: Unspecified|4
1331526|NCT02106390|4376113|P1|Overall Study|Other: Unspecified|1
1331527|NCT02106390|4376111|P3|Overall Study|Other: Administrative Reason|12
1331528|NCT02106390|4376112|P2|Overall Study|Other: Administrative Reason|5
1331529|NCT02106390|4376113|P1|Overall Study|Other: Administrative Reason|8
1331530|NCT02106390|4376111|P3|Overall Study|Lost to Follow-up|13
1331531|NCT02106390|4376112|P2|Overall Study|Lost to Follow-up|20
1331532|NCT02106390|4376113|P1|Overall Study|Lost to Follow-up|25
1331533|NCT02106390|4376111|P3|Overall Study|Withdrawal by Subject|15
1331534|NCT02106390|4376112|P2|Overall Study|Withdrawal by Subject|16
1331535|NCT02106390|4376113|P1|Overall Study|Withdrawal by Subject|15
1331536|NCT02106156|4376190|P3|Overall Study|Relocation/Change of Physician|0
1331537|NCT02106156|4376191|P2|Overall Study|Relocation/Change of Physician|1
1331538|NCT02106156|4376192|P1|Overall Study|Relocation/Change of Physician|40
1331539|NCT02106156|4376190|P3|Overall Study|Hospitalization/Surgical Intervention|0
1331540|NCT02106156|4376191|P2|Overall Study|Hospitalization/Surgical Intervention|0
1331541|NCT02106156|4376192|P1|Overall Study|Hospitalization/Surgical Intervention|6
1331542|NCT02106156|4376190|P3|Overall Study|Change of Laboratory Parameter|0
1331543|NCT02106156|4376191|P2|Overall Study|Change of Laboratory Parameter|0
1331544|NCT02106156|4376192|P1|Overall Study|Change of Laboratory Parameter|10
1331545|NCT02106156|4376190|P3|Overall Study|Unplanned Event|0
1331546|NCT02106156|4376191|P2|Overall Study|Unplanned Event|2
1331547|NCT02106156|4376192|P1|Overall Study|Unplanned Event|82
1331548|NCT02106156|4376190|P3|Overall Study|Lost to Follow-up|0
1331549|NCT02106156|4376191|P2|Overall Study|Lost to Follow-up|8
1331550|NCT02106156|4376192|P1|Overall Study|Lost to Follow-up|451
1331551|NCT02106156|4376190|P3|Overall Study|Patients Request|0
1331552|NCT02106156|4376191|P2|Overall Study|Patients Request|9
1331553|NCT02106156|4376192|P1|Overall Study|Patients Request|307
1331554|NCT02106156|4376190|P3|Overall Study|Lack of Compliance|0
1331555|NCT02106156|4376191|P2|Overall Study|Lack of Compliance|7
1331556|NCT02106156|4376192|P1|Overall Study|Lack of Compliance|211
1331557|NCT02106156|4376190|P3|Overall Study|Concomitant Disease|0
1331558|NCT02106156|4376191|P2|Overall Study|Concomitant Disease|2
1331559|NCT02106156|4376192|P1|Overall Study|Concomitant Disease|74
1331560|NCT02106156|4376190|P3|Overall Study|Lack of Virological Response|0
1331561|NCT02106156|4376191|P2|Overall Study|Lack of Virological Response|8
1331562|NCT02106156|4376192|P1|Overall Study|Lack of Virological Response|1044
1331563|NCT02106156|4376190|P3|Overall Study|Lack of Tolerability|0
1331564|NCT02106156|4376191|P2|Overall Study|Lack of Tolerability|3
1331565|NCT02106156|4376192|P1|Overall Study|Lack of Tolerability|305
1331566|NCT02106156|4376190|P3|Overall Study|Patient Died|0
1331567|NCT02106156|4376191|P2|Overall Study|Patient Died|0
1331568|NCT02106156|4376192|P1|Overall Study|Patient Died|19
1331569|NCT02105987|4376216|P6|Continuation Phase|Protocol Violation|0
1331570|NCT02105987|4376217|P5|Continuation Phase|Protocol Violation|1
1331571|NCT02105987|4376218|P4|Continuation Phase|Protocol Violation|0
1331572|NCT02105987|4376219|P3|Continuation Phase|Protocol Violation|0
1331573|NCT02105987|4376220|P2|Continuation Phase|Protocol Violation|0
1331574|NCT02105987|4376221|P1|Continuation Phase|Protocol Violation|0
1331575|NCT02105987|4376216|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
1331576|NCT02105987|4376217|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
1331577|NCT02105987|4376218|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
1331578|NCT02105987|4376219|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
1331579|NCT02105987|4376220|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
1331580|NCT02105987|4376221|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
1331581|NCT02105987|4376216|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1331582|NCT02105987|4376217|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1331583|NCT02105987|4376218|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
1331584|NCT02105987|4376219|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1331585|NCT02105987|4376220|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1331586|NCT02105987|4376221|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1331587|NCT02105987|4376216|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
1331588|NCT02105987|4376217|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
1331589|NCT02105987|4376218|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
1331590|NCT02105987|4376219|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
1331591|NCT02105987|4376220|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
1331592|NCT02105987|4376221|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
1331593|NCT02105987|4376216|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1331594|NCT02105987|4376217|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1331595|NCT02105987|4376218|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
1331596|NCT02105987|4376219|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
1331597|NCT02105987|4376220|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1331598|NCT02105987|4376221|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1331599|NCT02105987|4376216|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1331600|NCT02105987|4376217|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1331601|NCT02105987|4376218|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
1331602|NCT02105987|4376219|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
1331603|NCT02105987|4376220|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1331604|NCT02105987|4376221|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1331605|NCT02105987|4376216|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
1331606|NCT02105987|4376217|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
1331607|NCT02105987|4376218|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
1331608|NCT02105987|4376219|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
1331609|NCT02105987|4376220|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
1331610|NCT02105987|4376221|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
1331611|NCT02105987|4376216|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
1331612|NCT02105987|4376217|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
1331613|NCT02105987|4376218|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
1331614|NCT02105987|4376219|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
1331615|NCT02105987|4376220|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
1331616|NCT02105987|4376221|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
1331617|NCT02105987|4376216|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1331618|NCT02105987|4376217|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1331619|NCT02105987|4376218|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1331620|NCT02105987|4376219|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1331621|NCT02105987|4376220|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
1331622|NCT02105987|4376221|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1331623|NCT02105987|4376216|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
1331624|NCT02105987|4376217|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
1331625|NCT02105987|4376218|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
1331626|NCT02105987|4376219|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
1331627|NCT02105987|4376220|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
1331628|NCT02105987|4376221|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
1331629|NCT02105987|4376216|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1331630|NCT02105987|4376217|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1331631|NCT02105987|4376218|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1331632|NCT02105987|4376219|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1331633|NCT02105987|4376220|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
1331634|NCT02105987|4376221|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
1331635|NCT02105987|4376216|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1331636|NCT02105987|4376217|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1331637|NCT02105987|4376218|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1331638|NCT02105987|4376219|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1331639|NCT02105987|4376220|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
1331640|NCT02105987|4376221|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
1331641|NCT02105987|4376216|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
1331642|NCT02105987|4376217|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
1331643|NCT02105987|4376218|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
1331644|NCT02105987|4376219|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
1331645|NCT02105987|4376220|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
1331646|NCT02105987|4376221|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
1331647|NCT02105987|4376216|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
1331648|NCT02105987|4376217|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
1331649|NCT02105987|4376218|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
1331650|NCT02105987|4376219|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
1331651|NCT02105987|4376220|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
1331652|NCT02105987|4376221|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
1331653|NCT02105974|4376275|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
1331654|NCT02105974|4376276|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
1331655|NCT02105974|4376277|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
1331656|NCT02105974|4376275|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
1331657|NCT02105974|4376276|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
1331658|NCT02105974|4376277|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
1331659|NCT02105974|4376275|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
1331660|NCT02105974|4376276|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
1331661|NCT02105974|4376277|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
1331662|NCT02105974|4376275|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
1331663|NCT02105974|4376276|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
1331664|NCT02105974|4376277|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
1331665|NCT02105974|4376275|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
1331666|NCT02105974|4376276|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
1331667|NCT02105974|4376277|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
1331668|NCT02105974|4376275|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
1331669|NCT02105974|4376276|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
1331670|NCT02105974|4376277|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
1331671|NCT02105974|4376275|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
1331672|NCT02105974|4376276|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
1331673|NCT02105974|4376277|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
1331674|NCT02105974|4376275|P3|2 Week Run-in Period|Investigator discretion|0
1331675|NCT02105974|4376276|P2|2 Week Run-in Period|Investigator discretion|0
1331676|NCT02105974|4376277|P1|2 Week Run-in Period|Investigator discretion|8
1331677|NCT02105974|4376275|P3|2 Week Run-in Period|Withdrew consent|0
1331678|NCT02105974|4376276|P2|2 Week Run-in Period|Withdrew consent|0
1331679|NCT02105974|4376277|P1|2 Week Run-in Period|Withdrew consent|23
1331680|NCT02105974|4376275|P3|2 Week Run-in Period|Lost to Follow-up|0
1331681|NCT02105974|4376276|P2|2 Week Run-in Period|Lost to Follow-up|0
1331682|NCT02105974|4376277|P1|2 Week Run-in Period|Lost to Follow-up|2
1331683|NCT02105974|4376275|P3|2 Week Run-in Period|Study closed/terminated|0
1331684|NCT02105974|4376276|P2|2 Week Run-in Period|Study closed/terminated|0
1331685|NCT02105974|4376277|P1|2 Week Run-in Period|Study closed/terminated|1
1331686|NCT02105974|4376275|P3|2 Week Run-in Period|Adverse Event|0
1331687|NCT02105974|4376276|P2|2 Week Run-in Period|Adverse Event|0
1331688|NCT02105974|4376277|P1|2 Week Run-in Period|Adverse Event|6
1331689|NCT02105974|4376275|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
1331690|NCT02105974|4376276|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
1331691|NCT02105974|4376277|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
1331692|NCT02105974|4376275|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
1331693|NCT02105974|4376276|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
1331694|NCT02105974|4376277|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
1331695|NCT02105961|4376290|P3|Overall Study|Withdrawal by Subject|11
1331696|NCT02105961|4376291|P2|Overall Study|Withdrawal by Subject|7
1331697|NCT02105961|4376292|P1|Overall Study|Withdrawal by Subject|15
1331698|NCT02105961|4376290|P3|Overall Study|Physician Decision|2
1331699|NCT02105961|4376291|P2|Overall Study|Physician Decision|3
1331700|NCT02105961|4376292|P1|Overall Study|Physician Decision|3
1331701|NCT02105961|4376290|P3|Overall Study|Lost to Follow-up|1
1331702|NCT02105961|4376291|P2|Overall Study|Lost to Follow-up|0
1331703|NCT02105961|4376292|P1|Overall Study|Lost to Follow-up|2
1331704|NCT02105961|4376290|P3|Overall Study|Lack of Efficacy|3
1331705|NCT02105961|4376291|P2|Overall Study|Lack of Efficacy|0
1331706|NCT02105961|4376292|P1|Overall Study|Lack of Efficacy|3
1331707|NCT02105961|4376290|P3|Overall Study|Adverse Event|13
1331708|NCT02105961|4376291|P2|Overall Study|Adverse Event|7
1331709|NCT02105961|4376292|P1|Overall Study|Adverse Event|18
1331710|NCT02105948|4376316|P4|Overall Study|Withdrawal by Subject|11
1331711|NCT02105948|4376317|P3|Overall Study|Withdrawal by Subject|10
1331712|NCT02105948|4376318|P2|Overall Study|Withdrawal by Subject|10
1331713|NCT02105948|4376319|P1|Overall Study|Withdrawal by Subject|15
1331714|NCT02105948|4376316|P4|Overall Study|Physician Decision|2
1331715|NCT02105948|4376317|P3|Overall Study|Physician Decision|2
1331716|NCT02105948|4376318|P2|Overall Study|Physician Decision|2
1331717|NCT02105948|4376319|P1|Overall Study|Physician Decision|2
1331718|NCT02105948|4376316|P4|Overall Study|Lost to Follow-up|1
1331719|NCT02105948|4376317|P3|Overall Study|Lost to Follow-up|2
1331720|NCT02105948|4376318|P2|Overall Study|Lost to Follow-up|0
1331721|NCT02105948|4376319|P1|Overall Study|Lost to Follow-up|0
1331722|NCT02105948|4376316|P4|Overall Study|Lack of Efficacy|2
1331723|NCT02105948|4376317|P3|Overall Study|Lack of Efficacy|3
1331724|NCT02105948|4376318|P2|Overall Study|Lack of Efficacy|1
1331725|NCT02105948|4376319|P1|Overall Study|Lack of Efficacy|0
1331726|NCT02105948|4376316|P4|Overall Study|Adverse Event|11
1331727|NCT02105948|4376317|P3|Overall Study|Adverse Event|11
1331728|NCT02105948|4376318|P2|Overall Study|Adverse Event|7
1331729|NCT02105948|4376319|P1|Overall Study|Adverse Event|10
1331730|NCT02105701|4376360|P4|Overall Study|Death|0
1331731|NCT02105701|4376361|P3|Overall Study|Death|0
1331732|NCT02105701|4376362|P2|Overall Study|Death|0
1331733|NCT02105701|4376363|P1|Overall Study|Death|1
1331734|NCT02105701|4376360|P4|Overall Study|Withdrawal by Subject|1
1331735|NCT02105701|4376361|P3|Overall Study|Withdrawal by Subject|0
1331736|NCT02105701|4376362|P2|Overall Study|Withdrawal by Subject|1
1331737|NCT02105701|4376363|P1|Overall Study|Withdrawal by Subject|2
1331738|NCT02105701|4376360|P4|Overall Study|Protocol Violation|0
1331739|NCT02105701|4376361|P3|Overall Study|Protocol Violation|1
1331740|NCT02105701|4376362|P2|Overall Study|Protocol Violation|0
1331741|NCT02105701|4376363|P1|Overall Study|Protocol Violation|0
1331742|NCT02105701|4376360|P4|Overall Study|Lost to Follow-up|1
1331743|NCT02105701|4376361|P3|Overall Study|Lost to Follow-up|2
1331744|NCT02105701|4376362|P2|Overall Study|Lost to Follow-up|0
1331745|NCT02105701|4376363|P1|Overall Study|Lost to Follow-up|1
1331746|NCT02105688|4376387|P2|Overall Study|Withdrawal by Subject|2
1331747|NCT02105688|4376388|P1|Overall Study|Withdrawal by Subject|4
1331748|NCT02105688|4376387|P2|Overall Study|Protocol Violation|1
1331749|NCT02105688|4376388|P1|Overall Study|Protocol Violation|0
1331750|NCT02105688|4376387|P2|Overall Study|Physician Decision|1
1331751|NCT02105688|4376388|P1|Overall Study|Physician Decision|0
1331752|NCT02105688|4376387|P2|Overall Study|Lost to Follow-up|4
1331753|NCT02105688|4376388|P1|Overall Study|Lost to Follow-up|9
1331754|NCT02105688|4376387|P2|Overall Study|Adverse Event|1
1331755|NCT02105688|4376388|P1|Overall Study|Adverse Event|1
1331756|NCT02105688|4376387|P2|Overall Study|Ongoing|90
1331757|NCT02105688|4376388|P1|Overall Study|Ongoing|12
1331758|NCT02105662|4376398|P1|Overall Study|Withdrawal by Subject|1
1331759|NCT02105662|4376398|P1|Overall Study|Lost to Follow-up|5
1331760|NCT02105636|4376407|P2|Overall Study|Not Reported|0
1331761|NCT02105636|4376408|P1|Overall Study|Not Reported|3
1331762|NCT02105636|4376407|P2|Overall Study|Reason Not Specified|2
1331763|NCT02105636|4376408|P1|Overall Study|Reason Not Specified|0
1331764|NCT02105636|4376407|P2|Overall Study|Poor/Non-compliance|1
1331765|NCT02105636|4376408|P1|Overall Study|Poor/Non-compliance|0
1331766|NCT02105636|4376407|P2|Overall Study|Maximum Clinical Benefit|1
1331767|NCT02105636|4376408|P1|Overall Study|Maximum Clinical Benefit|1
1331768|NCT02105636|4376407|P2|Overall Study|Subject Withdrew Consent|1
1331769|NCT02105636|4376408|P1|Overall Study|Subject Withdrew Consent|4
1331770|NCT02105636|4376407|P2|Overall Study|Subject Request to Discontinue Treatment|6
1331771|NCT02105636|4376408|P1|Overall Study|Subject Request to Discontinue Treatment|4
1331772|NCT02105636|4376407|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
1331773|NCT02105636|4376408|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
1331774|NCT02105636|4376407|P2|Overall Study|Study Drug Toxicity|11
1331775|NCT02105636|4376408|P1|Overall Study|Study Drug Toxicity|9
1331776|NCT02105636|4376407|P2|Overall Study|Disease Progression|83
1331777|NCT02105636|4376408|P1|Overall Study|Disease Progression|162
1331778|NCT02105467|4376451|P2|Period 3|Lost to Follow-up|1
1331779|NCT02105467|4376452|P1|Period 3|Lost to Follow-up|0
1331780|NCT02105467|4376451|P2|Period 2|Withdrawal by Subject|2
1331781|NCT02105467|4376452|P1|Period 2|Withdrawal by Subject|0
1331782|NCT02105467|4376451|P2|Period 2|Death|0
1331783|NCT02105467|4376452|P1|Period 2|Death|1
1331784|NCT02105467|4376451|P2|Period 2|Lost to Follow-up|0
1331785|NCT02105467|4376452|P1|Period 2|Lost to Follow-up|1
1331786|NCT02105467|4376451|P2|Period 1|Death|0
1331787|NCT02105467|4376452|P1|Period 1|Death|1
1331788|NCT02105467|4376451|P2|Period 1|Lost to Follow-up|0
1331789|NCT02105467|4376452|P1|Period 1|Lost to Follow-up|1
1331790|NCT02105454|4376464|P1|Overall Study|Withdrawal by Subject|1
1331791|NCT02105285|4376551|P3|Overall Study|Withdrawal by Subject|0
1331792|NCT02105285|4376552|P2|Overall Study|Withdrawal by Subject|0
1331793|NCT02105285|4376553|P1|Overall Study|Withdrawal by Subject|1
1331794|NCT02105285|4376551|P3|Overall Study|Protocol Violation|0
1331795|NCT02105285|4376552|P2|Overall Study|Protocol Violation|1
1331796|NCT02105285|4376553|P1|Overall Study|Protocol Violation|0
1331797|NCT02105285|4376551|P3|Overall Study|Adverse Event|0
1331798|NCT02105285|4376552|P2|Overall Study|Adverse Event|1
1331799|NCT02105285|4376553|P1|Overall Study|Adverse Event|1
1331800|NCT02105272|4376572|P2|Overall Study|Withdrawal by Subject|0
1331801|NCT02105272|4376573|P1|Overall Study|Withdrawal by Subject|2
1331802|NCT02105272|4376572|P2|Overall Study|Protocol Violation|0
1331803|NCT02105272|4376573|P1|Overall Study|Protocol Violation|2
1331804|NCT02105272|4376572|P2|Overall Study|Physician Decision|1
1331805|NCT02105272|4376573|P1|Overall Study|Physician Decision|0
1331806|NCT02105272|4376572|P2|Overall Study|Adverse Event|2
1331807|NCT02105272|4376573|P1|Overall Study|Adverse Event|1
1331808|NCT02105116|4376589|P1|Overall Study|Death|1
1331809|NCT02105116|4376589|P1|Overall Study|not eligible for step 2 of trial|5
1331810|NCT02105012|4376596|P1|Overall Study|Lack of Efficacy|1
1331811|NCT02105012|4376596|P1|Overall Study|Adverse Event|1
1331812|NCT02105012|4376596|P1|Overall Study|Physician Decision|3
1331813|NCT02105012|4376596|P1|Overall Study|Protocol Violation|4
1331814|NCT02105012|4376596|P1|Overall Study|Lost to Follow-up|4
1331815|NCT02105012|4376596|P1|Overall Study|Protocol Specified Criteria|9
1331816|NCT02105012|4376596|P1|Overall Study|Withdrawal by Subject|11
1331817|NCT02104947|4376630|P2|Overall Study|Other than stated above|3
1331818|NCT02104947|4376631|P1|Overall Study|Other than stated above|2
1331819|NCT02104947|4376630|P2|Overall Study|Adverse Event|38
1331820|NCT02104947|4376631|P1|Overall Study|Adverse Event|57
1331821|NCT02104947|4376630|P2|Overall Study|Protocol Violation|8
1331822|NCT02104947|4376631|P1|Overall Study|Protocol Violation|6
1331823|NCT02104947|4376630|P2|Overall Study|Lost to Follow-up|4
1331824|NCT02104947|4376631|P1|Overall Study|Lost to Follow-up|4
1331825|NCT02104947|4376630|P2|Overall Study|Withdrawal by Subject|3
1331826|NCT02104947|4376631|P1|Overall Study|Withdrawal by Subject|10
1331827|NCT02104895|4376649|P2|Overall Study|Withdrawal by Subject|14
1331828|NCT02104895|4376650|P1|Overall Study|Withdrawal by Subject|0
1331829|NCT02104804|4376690|P2|Overall Study|Withdrawal by Subject|12
1331830|NCT02104804|4376691|P1|Overall Study|Withdrawal by Subject|4
1331831|NCT02104804|4376690|P2|Overall Study|Adverse Event|3
1331832|NCT02104804|4376691|P1|Overall Study|Adverse Event|4
1331833|NCT02104804|4376690|P2|Overall Study|Protocol Violation|1
1331834|NCT02104804|4376691|P1|Overall Study|Protocol Violation|0
1331835|NCT02104804|4376690|P2|Overall Study|Other listed|1
1331836|NCT02104804|4376691|P1|Overall Study|Other listed|2
1331837|NCT02104804|4376690|P2|Overall Study|Study specific discontinuation criteria|1
1331838|NCT02104804|4376691|P1|Overall Study|Study specific discontinuation criteria|6
1331839|NCT02104804|4376690|P2|Overall Study|Did not take study medication|1
1331840|NCT02104804|4376691|P1|Overall Study|Did not take study medication|0
1331841|NCT02104505|4376773|P2|Second Intervention (14 Days)|Adverse Event|0
1331842|NCT02104505|4376774|P1|Second Intervention (14 Days)|Adverse Event|2
1331843|NCT02104505|4376773|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
1331844|NCT02104505|4376774|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
1331845|NCT02104505|4376773|P2|First Intervention (14 Days)|exclusionary condition|1
1331846|NCT02104505|4376774|P1|First Intervention (14 Days)|exclusionary condition|0
1331847|NCT02104505|4376773|P2|First Intervention (14 Days)|Lost to Follow-up|1
1331848|NCT02104505|4376774|P1|First Intervention (14 Days)|Lost to Follow-up|0
1331849|NCT02104505|4376773|P2|First Intervention (14 Days)|Withdrawal by Subject|1
1331850|NCT02104505|4376774|P1|First Intervention (14 Days)|Withdrawal by Subject|0
1331851|NCT02104505|4376773|P2|First Intervention (14 Days)|Adverse Event|0
1331852|NCT02104505|4376774|P1|First Intervention (14 Days)|Adverse Event|2
1331853|NCT02103439|4376826|P2|Overall Study|Withdrawal by Subject|1
1331854|NCT02103439|4376827|P1|Overall Study|Withdrawal by Subject|3
1331855|NCT02103439|4376826|P2|Overall Study|Adverse Event|2
1331856|NCT02103439|4376827|P1|Overall Study|Adverse Event|0
1331857|NCT02103062|4376919|P2|Overall Study|Death|1
1331858|NCT02103062|4376920|P1|Overall Study|Death|0
1331859|NCT02103062|4376919|P2|Overall Study|Progressive Disease|20
1331860|NCT02103062|4376920|P1|Overall Study|Progressive Disease|17
1331861|NCT02103062|4376919|P2|Overall Study|Adverse Event|2
1331862|NCT02103062|4376920|P1|Overall Study|Adverse Event|1
1331863|NCT02102490|4377011|P1|Overall Study|Lost to Follow-up|1
1331864|NCT02102490|4377011|P1|Overall Study|Death|5
1331865|NCT02102490|4377011|P1|Overall Study|Adverse Event|3
1331866|NCT02102464|4377025|P3|Randomized Study|Withdrawal by Subject|0
1331867|NCT02102464|4377026|P2|Randomized Study|Withdrawal by Subject|1
1331868|NCT02102464|4377027|P1|Randomized Study|Withdrawal by Subject|0
1331869|NCT02102399|4377046|P2|Overall Study|Withdrawal by Subject|4
1331870|NCT02102399|4377047|P1|Overall Study|Withdrawal by Subject|6
1331871|NCT02102204|4377095|P1|Overall Study|Ongoing|5
1331872|NCT02102204|4377095|P1|Overall Study|Sponsor Decision|5
1331873|NCT02102204|4377095|P1|Overall Study|Lost to Follow-up|65
1331874|NCT02102204|4377095|P1|Overall Study|Death|92
1331875|NCT02102204|4377095|P1|Overall Study|Withdrawal by Subject|137
1331876|NCT02101983|4377106|P2|Overall Study|Physician Decision|0
1331877|NCT02101983|4377107|P1|Overall Study|Physician Decision|1
1331878|NCT02101359|4377119|P2|Overall Study|Protocol Violation|2
1331879|NCT02101359|4377120|P1|Overall Study|Protocol Violation|0
1331880|NCT02101359|4377119|P2|Overall Study|Lost to Follow-up|0
1331881|NCT02101359|4377120|P1|Overall Study|Lost to Follow-up|1
1331882|NCT02101359|4377119|P2|Overall Study|Withdrawal by Subject|4
1331883|NCT02101359|4377120|P1|Overall Study|Withdrawal by Subject|5
1331884|NCT02101359|4377119|P2|Overall Study|Not included|13
1331885|NCT02101359|4377120|P1|Overall Study|Not included|23
1331886|NCT02101294|4377126|P1|Overall Study|Lost to Follow-up|6
1331887|NCT02101294|4377126|P1|Overall Study|Withdrawal by Subject|5
1331888|NCT02101112|4377146|P6|Overall Study|Withdrawal by Subject|0
1331889|NCT02101112|4377147|P5|Overall Study|Withdrawal by Subject|1
1331890|NCT02101112|4377148|P4|Overall Study|Withdrawal by Subject|0
1331891|NCT02101112|4377149|P3|Overall Study|Withdrawal by Subject|0
1331892|NCT02101112|4377150|P2|Overall Study|Withdrawal by Subject|0
1331893|NCT02101112|4377151|P1|Overall Study|Withdrawal by Subject|0
1331894|NCT02101112|4377146|P6|Overall Study|Adverse Event|0
1331895|NCT02101112|4377147|P5|Overall Study|Adverse Event|0
1331896|NCT02101112|4377148|P4|Overall Study|Adverse Event|0
1331897|NCT02101112|4377149|P3|Overall Study|Adverse Event|1
1331898|NCT02101112|4377150|P2|Overall Study|Adverse Event|0
1331899|NCT02101112|4377151|P1|Overall Study|Adverse Event|0
1331900|NCT02101021|4377181|P5|Overall Study|Study Terminated by Sponsor|1
1331901|NCT02101021|4377182|P4|Overall Study|Study Terminated by Sponsor|1
1331902|NCT02101021|4377183|P3|Overall Study|Study Terminated by Sponsor|1
1331903|NCT02101021|4377184|P2|Overall Study|Study Terminated by Sponsor|0
1331904|NCT02101021|4377185|P1|Overall Study|Study Terminated by Sponsor|1
1331905|NCT02101021|4377181|P5|Overall Study|Lost to Follow-up|0
1331906|NCT02101021|4377182|P4|Overall Study|Lost to Follow-up|0
1331907|NCT02101021|4377183|P3|Overall Study|Lost to Follow-up|0
1331908|NCT02101021|4377184|P2|Overall Study|Lost to Follow-up|0
1331909|NCT02101021|4377185|P1|Overall Study|Lost to Follow-up|1
1331910|NCT02101021|4377181|P5|Overall Study|Withdrew Consent from study|0
1331911|NCT02101021|4377182|P4|Overall Study|Withdrew Consent from study|2
1331912|NCT02101021|4377183|P3|Overall Study|Withdrew Consent from study|0
1331913|NCT02101021|4377184|P2|Overall Study|Withdrew Consent from study|1
1331914|NCT02101021|4377185|P1|Overall Study|Withdrew Consent from study|1
1331915|NCT02101021|4377181|P5|Overall Study|Death|3
1331916|NCT02101021|4377182|P4|Overall Study|Death|0
1331917|NCT02101021|4377183|P3|Overall Study|Death|6
1331918|NCT02101021|4377184|P2|Overall Study|Death|3
1331919|NCT02101021|4377185|P1|Overall Study|Death|4
1331920|NCT02100839|4377234|P2|Multiple Ascending Dose|Withdrawal by Subject|0
1331921|NCT02100839|4377235|P1|Multiple Ascending Dose|Withdrawal by Subject|2
1331922|NCT02100839|4377234|P2|Multiple Ascending Dose|Adverse Event|0
1331923|NCT02100839|4377235|P1|Multiple Ascending Dose|Adverse Event|2
1331924|NCT02100670|4377262|P4|Overall Study|Withdrawal by Subject|0
1331925|NCT02100670|4377263|P3|Overall Study|Withdrawal by Subject|0
1331926|NCT02100670|4377264|P2|Overall Study|Withdrawal by Subject|0
1331927|NCT02100670|4377265|P1|Overall Study|Withdrawal by Subject|1
1331928|NCT02100670|4377262|P4|Overall Study|Physician Decision|0
1331929|NCT02100670|4377263|P3|Overall Study|Physician Decision|0
1331930|NCT02100670|4377264|P2|Overall Study|Physician Decision|1
1331931|NCT02100670|4377265|P1|Overall Study|Physician Decision|0
1331932|NCT02100670|4377262|P4|Overall Study|Poor Efficacy|0
1331933|NCT02100670|4377263|P3|Overall Study|Poor Efficacy|0
1331934|NCT02100670|4377264|P2|Overall Study|Poor Efficacy|1
1331935|NCT02100670|4377265|P1|Overall Study|Poor Efficacy|0
1331936|NCT02100670|4377262|P4|Overall Study|No swelling no pain|0
1331937|NCT02100670|4377263|P3|Overall Study|No swelling no pain|0
1331938|NCT02100670|4377264|P2|Overall Study|No swelling no pain|0
1331939|NCT02100670|4377265|P1|Overall Study|No swelling no pain|1
1331940|NCT02100670|4377262|P4|Overall Study|Withdrawal of Consent|0
1331941|NCT02100670|4377263|P3|Overall Study|Withdrawal of Consent|1
1331942|NCT02100670|4377264|P2|Overall Study|Withdrawal of Consent|1
1331943|NCT02100670|4377265|P1|Overall Study|Withdrawal of Consent|0
1331944|NCT02100670|4377262|P4|Overall Study|Protocol Violation|1
1331945|NCT02100670|4377263|P3|Overall Study|Protocol Violation|0
1331946|NCT02100670|4377264|P2|Overall Study|Protocol Violation|1
1331947|NCT02100670|4377265|P1|Overall Study|Protocol Violation|0
1331948|NCT02100670|4377262|P4|Overall Study|Lost to Follow-up|0
1331949|NCT02100670|4377263|P3|Overall Study|Lost to Follow-up|0
1331950|NCT02100670|4377264|P2|Overall Study|Lost to Follow-up|0
1331951|NCT02100670|4377265|P1|Overall Study|Lost to Follow-up|1
1331952|NCT02100670|4377262|P4|Overall Study|Adverse Event|0
1331953|NCT02100670|4377263|P3|Overall Study|Adverse Event|3
1331954|NCT02100670|4377264|P2|Overall Study|Adverse Event|3
1331955|NCT02100670|4377265|P1|Overall Study|Adverse Event|10
1331956|NCT02100644|4377325|P3|LTG Escalation Phase|Withdrawal by Subject|0
1331957|NCT02100644|4377326|P2|LTG Escalation Phase|Withdrawal by Subject|0
1331958|NCT02100644|4377327|P1|LTG Escalation Phase|Withdrawal by Subject|3
1331959|NCT02100644|4377325|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
1331960|NCT02100644|4377326|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
1331961|NCT02100644|4377327|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
1331962|NCT02100644|4377325|P3|LTG Escalation Phase|Adverse Event|0
1331963|NCT02100644|4377326|P2|LTG Escalation Phase|Adverse Event|0
1331964|NCT02100644|4377327|P1|LTG Escalation Phase|Adverse Event|9
1331965|NCT02100514|4377352|P5|Extension Period|Withdrew consent|0
1331966|NCT02100514|4377353|P4|Extension Period|Withdrew consent|0
1331967|NCT02100514|4377354|P3|Extension Period|Withdrew consent|2
1331968|NCT02100514|4377355|P2|Extension Period|Withdrew consent|0
1331969|NCT02100514|4377356|P1|Extension Period|Withdrew consent|0
1331970|NCT02100514|4377352|P5|Treatment Period|Other|0
1331971|NCT02100514|4377353|P4|Treatment Period|Other|0
1331972|NCT02100514|4377354|P3|Treatment Period|Other|0
1331973|NCT02100514|4377355|P2|Treatment Period|Other|11
1331974|NCT02100514|4377356|P1|Treatment Period|Other|9
1331975|NCT02100514|4377352|P5|Treatment Period|Withdrawal by Subject|0
1331976|NCT02100514|4377353|P4|Treatment Period|Withdrawal by Subject|0
1331977|NCT02100514|4377354|P3|Treatment Period|Withdrawal by Subject|0
1331978|NCT02100514|4377355|P2|Treatment Period|Withdrawal by Subject|37
1331979|NCT02100514|4377356|P1|Treatment Period|Withdrawal by Subject|12
1331980|NCT02100514|4377352|P5|Treatment Period|Protocol Violation|0
1331981|NCT02100514|4377353|P4|Treatment Period|Protocol Violation|0
1331982|NCT02100514|4377354|P3|Treatment Period|Protocol Violation|0
1331983|NCT02100514|4377355|P2|Treatment Period|Protocol Violation|1
1331984|NCT02100514|4377356|P1|Treatment Period|Protocol Violation|1
1331985|NCT02100514|4377352|P5|Treatment Period|Did Not Meet Entrance Criteria|0
1331986|NCT02100514|4377353|P4|Treatment Period|Did Not Meet Entrance Criteria|0
1331987|NCT02100514|4377354|P3|Treatment Period|Did Not Meet Entrance Criteria|0
1331988|NCT02100514|4377355|P2|Treatment Period|Did Not Meet Entrance Criteria|1
1331989|NCT02100514|4377356|P1|Treatment Period|Did Not Meet Entrance Criteria|0
1331990|NCT02100514|4377352|P5|Treatment Period|Lost to Follow-up|0
1331991|NCT02100514|4377353|P4|Treatment Period|Lost to Follow-up|0
1331992|NCT02100514|4377354|P3|Treatment Period|Lost to Follow-up|0
1331993|NCT02100514|4377355|P2|Treatment Period|Lost to Follow-up|17
1331994|NCT02100514|4377356|P1|Treatment Period|Lost to Follow-up|5
1331995|NCT02100514|4377352|P5|Treatment Period|Death|0
1331996|NCT02100514|4377353|P4|Treatment Period|Death|0
1331997|NCT02100514|4377354|P3|Treatment Period|Death|0
1331998|NCT02100514|4377355|P2|Treatment Period|Death|2
1331999|NCT02100514|4377356|P1|Treatment Period|Death|2
1332000|NCT02100514|4377352|P5|Treatment Period|Adverse Event|0
1332001|NCT02100514|4377353|P4|Treatment Period|Adverse Event|0
1332002|NCT02100514|4377354|P3|Treatment Period|Adverse Event|0
1332003|NCT02100514|4377355|P2|Treatment Period|Adverse Event|5
1332004|NCT02100514|4377356|P1|Treatment Period|Adverse Event|0
1332005|NCT02100475|4377424|P2|Overall Study|Withdrawal criteria|0
1332006|NCT02100475|4377425|P1|Overall Study|Withdrawal criteria|1
1332007|NCT02100475|4377424|P2|Overall Study|Unclassified|2
1332008|NCT02100475|4377425|P1|Overall Study|Unclassified|1
1332009|NCT02100228|4377475|P2|Overall Study|Death|1
1332010|NCT02100228|4377476|P1|Overall Study|Death|1
1332011|NCT02100228|4377475|P2|Overall Study|Adverse Event|12
1332012|NCT02100228|4377476|P1|Overall Study|Adverse Event|16
1332013|NCT02100228|4377475|P2|Overall Study|Withdrawal by Subject|37
1332014|NCT02100228|4377476|P1|Overall Study|Withdrawal by Subject|27
1332015|NCT02100228|4377475|P2|Overall Study|Lost to Follow-up|1
1332016|NCT02100228|4377476|P1|Overall Study|Lost to Follow-up|0
1332017|NCT02100228|4377475|P2|Overall Study|Non-compliance|3
1332018|NCT02100228|4377476|P1|Overall Study|Non-compliance|0
1332019|NCT02100228|4377475|P2|Overall Study|Inclusion/Exclusion criteria not met|16
1332020|NCT02100228|4377476|P1|Overall Study|Inclusion/Exclusion criteria not met|12
1332021|NCT02100228|4377475|P2|Overall Study|Administrative reason|1
1332022|NCT02100228|4377476|P1|Overall Study|Administrative reason|0
1332023|NCT02100228|4377475|P2|Overall Study|Other|19
1332024|NCT02100228|4377476|P1|Overall Study|Other|19
1332025|NCT02100124|4377512|P3|Overall Study|Withdrawal by Subject|0
1332026|NCT02100124|4377513|P2|Overall Study|Withdrawal by Subject|0
1332027|NCT02100124|4377514|P1|Overall Study|Withdrawal by Subject|1
1332028|NCT02100124|4377512|P3|Overall Study|Lost to Follow-up|3
1332029|NCT02100124|4377513|P2|Overall Study|Lost to Follow-up|11
1332030|NCT02100124|4377514|P1|Overall Study|Lost to Follow-up|5
1332031|NCT02099838|4377544|P2|Overall Study|Withdrawal by Subject|1
1332032|NCT02099838|4377545|P1|Overall Study|Withdrawal by Subject|0
1332033|NCT02099838|4377544|P2|Overall Study|Lost to Follow-up|1
1332034|NCT02099838|4377545|P1|Overall Study|Lost to Follow-up|3
1332035|NCT02099838|4377544|P2|Overall Study|Death|0
1332036|NCT02099838|4377545|P1|Overall Study|Death|1
1332037|NCT02099708|4377575|P1|Overall Study|Other|29
1332038|NCT02099708|4377575|P1|Overall Study|Lost to Follow-up|141
1332039|NCT02099708|4377575|P1|Overall Study|Data Not Available|30
1332040|NCT02099682|4377586|P1|Overall Study|Other|29
1332041|NCT02099682|4377586|P1|Overall Study|Lost to Follow-up|31
1332042|NCT02099682|4377586|P1|Overall Study|Data Not Available|51
1332043|NCT02099344|4377612|P2|Overall Study|Physician Decision|0
1332044|NCT02099344|4377613|P1|Overall Study|Physician Decision|1
1332045|NCT02099110|4377650|P5|Overall Study|Physician Decision|1
1332046|NCT02099110|4377651|P4|Overall Study|Physician Decision|2
1332047|NCT02099110|4377652|P3|Overall Study|Physician Decision|1
1332048|NCT02099110|4377653|P2|Overall Study|Physician Decision|0
1332049|NCT02099110|4377654|P1|Overall Study|Physician Decision|3
1332050|NCT02099110|4377650|P5|Overall Study|Non-compliance with study drug|1
1332051|NCT02099110|4377651|P4|Overall Study|Non-compliance with study drug|0
1332052|NCT02099110|4377652|P3|Overall Study|Non-compliance with study drug|0
1332053|NCT02099110|4377653|P2|Overall Study|Non-compliance with study drug|0
1332054|NCT02099110|4377654|P1|Overall Study|Non-compliance with study drug|2
1332055|NCT02099110|4377650|P5|Overall Study|Screen failure|1
1332056|NCT02099110|4377651|P4|Overall Study|Screen failure|0
1332057|NCT02099110|4377652|P3|Overall Study|Screen failure|0
1332058|NCT02099110|4377653|P2|Overall Study|Screen failure|0
1332059|NCT02099110|4377654|P1|Overall Study|Screen failure|0
1332060|NCT02099110|4377650|P5|Overall Study|Death|0
1332061|NCT02099110|4377651|P4|Overall Study|Death|0
1332062|NCT02099110|4377652|P3|Overall Study|Death|0
1332063|NCT02099110|4377653|P2|Overall Study|Death|1
1332064|NCT02099110|4377654|P1|Overall Study|Death|0
1332065|NCT02099110|4377650|P5|Overall Study|Lost to Follow-up|6
1332066|NCT02099110|4377651|P4|Overall Study|Lost to Follow-up|5
1332067|NCT02099110|4377652|P3|Overall Study|Lost to Follow-up|11
1332068|NCT02099110|4377653|P2|Overall Study|Lost to Follow-up|12
1332069|NCT02099110|4377654|P1|Overall Study|Lost to Follow-up|6
1332070|NCT02099110|4377650|P5|Overall Study|Adverse Event|2
1332071|NCT02099110|4377651|P4|Overall Study|Adverse Event|3
1332072|NCT02099110|4377652|P3|Overall Study|Adverse Event|2
1332073|NCT02099110|4377653|P2|Overall Study|Adverse Event|5
1332074|NCT02099110|4377654|P1|Overall Study|Adverse Event|3
1332075|NCT02099110|4377650|P5|Overall Study|Withdrawal by Subject|13
1332076|NCT02099110|4377651|P4|Overall Study|Withdrawal by Subject|9
1332077|NCT02099110|4377652|P3|Overall Study|Withdrawal by Subject|13
1332078|NCT02099110|4377653|P2|Overall Study|Withdrawal by Subject|11
1332079|NCT02099110|4377654|P1|Overall Study|Withdrawal by Subject|7
1332080|NCT02099110|4377650|P5|Overall Study|Participant moved|2
1332081|NCT02099110|4377651|P4|Overall Study|Participant moved|0
1332082|NCT02099110|4377652|P3|Overall Study|Participant moved|1
1332083|NCT02099110|4377653|P2|Overall Study|Participant moved|1
1332084|NCT02099110|4377654|P1|Overall Study|Participant moved|1
1332085|NCT02099110|4377650|P5|Overall Study|Protocol Violation|1
1332086|NCT02099110|4377651|P4|Overall Study|Protocol Violation|3
1332087|NCT02099110|4377652|P3|Overall Study|Protocol Violation|0
1332088|NCT02099110|4377653|P2|Overall Study|Protocol Violation|1
1332089|NCT02099110|4377654|P1|Overall Study|Protocol Violation|2
1332090|NCT02098746|4377728|P1|Overall Study|Data Not Available After Treatment|1
1332091|NCT02098746|4377728|P1|Overall Study|Enrolled 15 Days After the First Dose|1
1332092|NCT02098746|4377728|P1|Overall Study|Other Miscellaneous Reasons|1
1332093|NCT02098746|4377728|P1|Overall Study|Changes of Investigator|2
1332094|NCT02098733|4377736|P1|Overall Study|Lost to Follow-up|5
1332095|NCT02098733|4377736|P1|Overall Study|Data Not Available|5
1332096|NCT02098395|4377750|P4|Overall Study|Unclassified|2
1332097|NCT02098395|4377751|P3|Overall Study|Unclassified|3
1332098|NCT02098395|4377752|P2|Overall Study|Unclassified|0
1332099|NCT02098395|4377753|P1|Overall Study|Unclassified|0
1332100|NCT02098395|4377750|P4|Overall Study|Lost to Follow-up|3
1332101|NCT02098395|4377751|P3|Overall Study|Lost to Follow-up|0
1332102|NCT02098395|4377752|P2|Overall Study|Lost to Follow-up|1
1332103|NCT02098395|4377753|P1|Overall Study|Lost to Follow-up|2
1332104|NCT02098395|4377750|P4|Overall Study|Adverse Event|2
1332105|NCT02098395|4377751|P3|Overall Study|Adverse Event|34
1332106|NCT02098395|4377752|P2|Overall Study|Adverse Event|19
1332107|NCT02098395|4377753|P1|Overall Study|Adverse Event|12
1332108|NCT02098395|4377750|P4|Overall Study|Withdrawal by Subject|13
1332109|NCT02098395|4377751|P3|Overall Study|Withdrawal by Subject|5
1332110|NCT02098395|4377752|P2|Overall Study|Withdrawal by Subject|10
1332111|NCT02098395|4377753|P1|Overall Study|Withdrawal by Subject|10
1332112|NCT02098395|4377750|P4|Overall Study|Protocol Violation|7
1332113|NCT02098395|4377751|P3|Overall Study|Protocol Violation|0
1332114|NCT02098395|4377752|P2|Overall Study|Protocol Violation|2
1332115|NCT02098395|4377753|P1|Overall Study|Protocol Violation|2
1332116|NCT02098369|4377774|P3|Overall Study|Other|1
1332117|NCT02098369|4377775|P2|Overall Study|Other|2
1332118|NCT02098369|4377776|P1|Overall Study|Other|0
1332119|NCT02098369|4377774|P3|Overall Study|Death|1
1332120|NCT02098369|4377775|P2|Overall Study|Death|1
1332121|NCT02098369|4377776|P1|Overall Study|Death|1
1332122|NCT02098369|4377774|P3|Overall Study|Lost to Follow-up|3
1332123|NCT02098369|4377775|P2|Overall Study|Lost to Follow-up|1
1332124|NCT02098369|4377776|P1|Overall Study|Lost to Follow-up|5
1332125|NCT02098369|4377774|P3|Overall Study|Withdrawal by Subject|0
1332126|NCT02098369|4377775|P2|Overall Study|Withdrawal by Subject|5
1332127|NCT02098369|4377776|P1|Overall Study|Withdrawal by Subject|1
1332128|NCT02098109|4377814|P2|Overall Study|Protocol Violation|0
1332129|NCT02098109|4377815|P1|Overall Study|Protocol Violation|3
1332130|NCT02097823|4377893|P2|Overall Study|Withdrawal by Subject|1
1332131|NCT02097823|4377894|P1|Overall Study|Withdrawal by Subject|1
1332132|NCT02097745|4377909|P1|Overall Study|Reason Not Specified|96
1332133|NCT02097745|4377909|P1|Overall Study|Administrative/Other|27
1332134|NCT02097745|4377909|P1|Overall Study|Failure to Return|14
1332135|NCT02097745|4377909|P1|Overall Study|Death|16
1332136|NCT02097745|4377909|P1|Overall Study|Adverse Event|25
1332137|NCT02097719|4377945|P2|Overall Study|Adverse Event|0
1332138|NCT02097719|4377946|P1|Overall Study|Adverse Event|2
1332139|NCT02097719|4377945|P2|Overall Study|Lost to Follow-up|1
1332140|NCT02097719|4377946|P1|Overall Study|Lost to Follow-up|0
1332141|NCT02097719|4377945|P2|Overall Study|Subject Withdrew Consent|0
1332142|NCT02097719|4377946|P1|Overall Study|Subject Withdrew Consent|1
1332143|NCT02097472|4377966|P8|Received Vaccination 2|Adverse Event|0
1332144|NCT02097472|4377967|P7|Received Vaccination 2|Adverse Event|1
1332145|NCT02097472|4377968|P6|Received Vaccination 2|Adverse Event|0
1332146|NCT02097472|4377969|P5|Received Vaccination 2|Adverse Event|0
1332147|NCT02097472|4377970|P4|Received Vaccination 2|Adverse Event|0
1332148|NCT02097472|4377971|P3|Received Vaccination 2|Adverse Event|0
1332149|NCT02097472|4377972|P2|Received Vaccination 2|Adverse Event|0
1332150|NCT02097472|4377973|P1|Received Vaccination 2|Adverse Event|0
1332151|NCT02097290|4378404|P1|Overall Study|Attempt|8
1332152|NCT02097290|4378404|P1|Overall Study|Total Withdrawals|3
1332153|NCT02097290|4378404|P1|Overall Study|Death|6
1332154|NCT02097238|4378414|P1|Overall Study|Progressive Disease|17
1332155|NCT02097238|4378414|P1|Overall Study|Physician Decision|1
1332156|NCT02097238|4378414|P1|Overall Study|Death|1
1332157|NCT02097134|4378420|P1|Overall Study|Refusal of Further Protocol Therapy|1
1332158|NCT02097134|4378420|P1|Overall Study|Progressive Disease|3
1332159|NCT02097134|4378420|P1|Overall Study|Non-Protocol Therapy|1
1332160|NCT02097134|4378420|P1|Overall Study|Physician Decision|4
1332161|NCT02097108|4378424|P1|Overall Study|patient was abroad for 6 months|1
1332162|NCT02097108|4378424|P1|Overall Study|Adverse Event|1
1332163|NCT02097056|4378431|P1|Overall Study|Not specified|2
1332164|NCT02097056|4378431|P1|Overall Study|Adverse Event|37
1332165|NCT02097056|4378431|P1|Overall Study|Lost to Follow-up|2
1332166|NCT02097056|4378431|P1|Overall Study|Withdrawal by Subject|15
1332167|NCT02097056|4378431|P1|Overall Study|Protocol Violation|2
1332168|NCT02097030|4378439|P2|First Intervention (3 Days)|Visual Acuity|1
1332169|NCT02097030|4378440|P1|First Intervention (3 Days)|Visual Acuity|0
1332170|NCT02097030|4378439|P2|First Intervention (3 Days)|Lost to Follow-up|0
1332171|NCT02097030|4378440|P1|First Intervention (3 Days)|Lost to Follow-up|1
1332172|NCT02096952|4378501|P1|Overall Study|Adverse Event|1
1332173|NCT02096900|4378507|P2|Overall Study|Surgery cancelled- medication received|1
1332174|NCT02096900|4378508|P1|Overall Study|Surgery cancelled- medication received|1
1332175|NCT02096900|4378507|P2|Overall Study|Did not receive medication|1
1332176|NCT02096900|4378508|P1|Overall Study|Did not receive medication|3
1332177|NCT02096835|4378560|P3|Overall Study|Lost to Follow-up|1
1332178|NCT02096835|4378561|P2|Overall Study|Lost to Follow-up|0
1332179|NCT02096835|4378562|P1|Overall Study|Lost to Follow-up|1
1332180|NCT02096835|4378560|P3|Overall Study|converted to open procedures|0
1332181|NCT02096835|4378561|P2|Overall Study|converted to open procedures|0
1332182|NCT02096835|4378562|P1|Overall Study|converted to open procedures|1
1332183|NCT02096835|4378560|P3|Overall Study|Withdrawal by Subject|0
1332184|NCT02096835|4378561|P2|Overall Study|Withdrawal by Subject|0
1332185|NCT02096835|4378562|P1|Overall Study|Withdrawal by Subject|1
1332186|NCT02096744|4378579|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
1332187|NCT02096744|4378580|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
1332188|NCT02096744|4378579|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
1332189|NCT02096744|4378580|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
1332190|NCT02096744|4378579|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
1332191|NCT02096744|4378580|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
1332192|NCT02096705|4378634|P2|Follow-up|Subjects not reporting status|2
1332193|NCT02096705|4378635|P1|Follow-up|Subjects not reporting status|1
1332194|NCT02096705|4378634|P2|Follow-up|Adverse Event|2
1332195|NCT02096705|4378635|P1|Follow-up|Adverse Event|2
1332196|NCT02096705|4378634|P2|Follow-up|Withdrawal by Subject|0
1332197|NCT02096705|4378635|P1|Follow-up|Withdrawal by Subject|1
1332198|NCT02096705|4378634|P2|Treatment|Other|1
1332199|NCT02096705|4378635|P1|Treatment|Other|1
1332200|NCT02096705|4378634|P2|Treatment|Withdrawal by Subject|0
1332201|NCT02096705|4378635|P1|Treatment|Withdrawal by Subject|1
1332202|NCT02096705|4378634|P2|Treatment|Subject request to discontinue treatment|1
1332203|NCT02096705|4378635|P1|Treatment|Subject request to discontinue treatment|1
1332204|NCT02096705|4378634|P2|Treatment|Adverse Event|3
1332205|NCT02096705|4378635|P1|Treatment|Adverse Event|6
1332206|NCT02096263|4378701|P3|Overall Study|Withdrawal by Subject|8
1332207|NCT02096263|4378702|P2|Overall Study|Withdrawal by Subject|7
1332208|NCT02096263|4378703|P1|Overall Study|Withdrawal by Subject|5
1332209|NCT02096263|4378701|P3|Overall Study|Protocol Violation|8
1332210|NCT02096263|4378702|P2|Overall Study|Protocol Violation|2
1332211|NCT02096263|4378703|P1|Overall Study|Protocol Violation|7
1332212|NCT02096263|4378701|P3|Overall Study|Sponsor study termination|1
1332213|NCT02096263|4378702|P2|Overall Study|Sponsor study termination|0
1332214|NCT02096263|4378703|P1|Overall Study|Sponsor study termination|0
1332215|NCT02096263|4378701|P3|Overall Study|Other|6
1332216|NCT02096263|4378702|P2|Overall Study|Other|9
1332217|NCT02096263|4378703|P1|Overall Study|Other|7
1332218|NCT02096263|4378701|P3|Overall Study|Lost to Follow-up|15
1332219|NCT02096263|4378702|P2|Overall Study|Lost to Follow-up|18
1332220|NCT02096263|4378703|P1|Overall Study|Lost to Follow-up|14
1332221|NCT02096263|4378701|P3|Overall Study|Adverse Event|1
1332222|NCT02096263|4378702|P2|Overall Study|Adverse Event|0
1332223|NCT02096263|4378703|P1|Overall Study|Adverse Event|1
1332224|NCT02096042|4378891|P3|Overall Study|Disease Progression|0
1332225|NCT02096042|4378892|P2|Overall Study|Disease Progression|0
1332226|NCT02096042|4378893|P1|Overall Study|Disease Progression|1
1332227|NCT02095873|4378902|P2|Second Intervention (8 Weeks)|Protocol Violation|0
1332228|NCT02095873|4378903|P1|Second Intervention (8 Weeks)|Protocol Violation|1
1332229|NCT02095873|4378902|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
1332230|NCT02095873|4378903|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
1332231|NCT02095873|4378902|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
1332232|NCT02095873|4378903|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
1332233|NCT02095691|4378915|P1|Overall Study|Physician Decision|1
1332234|NCT02095535|4378947|P1|Recruitment|Protocol Violation|2
1332235|NCT02095223|4378953|P2|Overall Study|Withdrawal by Subject|0
1332236|NCT02095223|4378954|P1|Overall Study|Withdrawal by Subject|1
1332237|NCT02095197|4378964|P2|Overall Study|Lost to Follow-up|3
1332238|NCT02095197|4378965|P1|Overall Study|Lost to Follow-up|0
1332239|NCT02095158|4378977|P1|Overall Study|Other Miscellaneous Reasons|1
1332240|NCT02095158|4378977|P1|Overall Study|Protocol Violation|1
1332241|NCT02095158|4378977|P1|Overall Study|Personal Reasons|35
1332242|NCT02095158|4378977|P1|Overall Study|Lost to Follow-up|20
1332243|NCT02095158|4378977|P1|Overall Study|Pregnancy|1
1332244|NCT02095158|4378977|P1|Overall Study|Lack of Efficacy|3
1332245|NCT02095158|4378977|P1|Overall Study|Adverse Event|14
1332246|NCT02095106|4378984|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
1332247|NCT02095106|4378985|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
1332248|NCT02094937|4379001|P4|12 Weeks in Period 2|Randomized incorrectly|0
1332249|NCT02094937|4379002|P3|12 Weeks in Period 2|Randomized incorrectly|0
1332250|NCT02094937|4379003|P2|12 Weeks in Period 2|Randomized incorrectly|1
1332251|NCT02094937|4379004|P1|12 Weeks in Period 2|Randomized incorrectly|0
1332252|NCT02094937|4379001|P4|12 Weeks in Period 2|Withdrawal by Subject|0
1332253|NCT02094937|4379002|P3|12 Weeks in Period 2|Withdrawal by Subject|2
1332254|NCT02094937|4379003|P2|12 Weeks in Period 2|Withdrawal by Subject|2
1332255|NCT02094937|4379004|P1|12 Weeks in Period 2|Withdrawal by Subject|0
1332256|NCT02094937|4379001|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
1332257|NCT02094937|4379002|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
1332258|NCT02094937|4379003|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
1332259|NCT02094937|4379004|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
1332260|NCT02094937|4379001|P4|12 Weeks in Period 2|Lack of Efficacy|0
1332261|NCT02094937|4379002|P3|12 Weeks in Period 2|Lack of Efficacy|0
1332262|NCT02094937|4379003|P2|12 Weeks in Period 2|Lack of Efficacy|1
1332263|NCT02094937|4379004|P1|12 Weeks in Period 2|Lack of Efficacy|0
1332264|NCT02094937|4379001|P4|12 Weeks in Period 2|Adverse Event|1
1332265|NCT02094937|4379002|P3|12 Weeks in Period 2|Adverse Event|4
1332266|NCT02094937|4379003|P2|12 Weeks in Period 2|Adverse Event|2
1332267|NCT02094937|4379004|P1|12 Weeks in Period 2|Adverse Event|0
1332268|NCT02094937|4379001|P4|8 Weeks in Period 1|Withdrawal by Subject|0
1332269|NCT02094937|4379002|P3|8 Weeks in Period 1|Withdrawal by Subject|0
1332270|NCT02094937|4379003|P2|8 Weeks in Period 1|Withdrawal by Subject|0
1332271|NCT02094937|4379004|P1|8 Weeks in Period 1|Withdrawal by Subject|4
1332272|NCT02094937|4379001|P4|8 Weeks in Period 1|Physician Decision|0
1332273|NCT02094937|4379002|P3|8 Weeks in Period 1|Physician Decision|0
1332274|NCT02094937|4379003|P2|8 Weeks in Period 1|Physician Decision|0
1332275|NCT02094937|4379004|P1|8 Weeks in Period 1|Physician Decision|1
1332276|NCT02094937|4379001|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
1332277|NCT02094937|4379002|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
1332278|NCT02094937|4379003|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
1332279|NCT02094937|4379004|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
1332280|NCT02094937|4379001|P4|8 Weeks in Period 1|Protocol Violation|0
1332281|NCT02094937|4379002|P3|8 Weeks in Period 1|Protocol Violation|0
1332282|NCT02094937|4379003|P2|8 Weeks in Period 1|Protocol Violation|0
1332283|NCT02094937|4379004|P1|8 Weeks in Period 1|Protocol Violation|2
1332284|NCT02094937|4379001|P4|8 Weeks in Period 1|Lack of Efficacy|0
1332285|NCT02094937|4379002|P3|8 Weeks in Period 1|Lack of Efficacy|0
1332286|NCT02094937|4379003|P2|8 Weeks in Period 1|Lack of Efficacy|0
1332287|NCT02094937|4379004|P1|8 Weeks in Period 1|Lack of Efficacy|3
1332288|NCT02094937|4379001|P4|8 Weeks in Period 1|Adverse Event|0
1332289|NCT02094937|4379002|P3|8 Weeks in Period 1|Adverse Event|0
1332290|NCT02094937|4379003|P2|8 Weeks in Period 1|Adverse Event|0
1332291|NCT02094937|4379004|P1|8 Weeks in Period 1|Adverse Event|9
1332292|NCT02094898|4379034|P1|Overall Study|Lack of Efficacy|1
1332293|NCT02094898|4379034|P1|Overall Study|Adverse Event|2
1332294|NCT02094898|4379034|P1|Overall Study|Clinical Worsening|2
1332295|NCT02094885|4379081|P2|Overall Study|Withdrawn due to age|0
1332296|NCT02094885|4379082|P1|Overall Study|Withdrawn due to age|1
1332297|NCT02094885|4379081|P2|Overall Study|Death|5
1332298|NCT02094885|4379082|P1|Overall Study|Death|1
1332299|NCT02094677|4379096|P2|Overall Study|Screening|1
1332300|NCT02094677|4379097|P1|Overall Study|Screening|3
1332301|NCT02094612|4379176|P2|Overall Study|Never started ADHD medication|23
1332302|NCT02094612|4379177|P1|Overall Study|Never started ADHD medication|32
1332303|NCT02094612|4379176|P2|Overall Study|Lost to Follow-up|47
1332304|NCT02094612|4379177|P1|Overall Study|Lost to Follow-up|47
1332305|NCT02094573|4379197|P2|Overall Study|Ongoing|76
1332306|NCT02094573|4379198|P1|Overall Study|Ongoing|64
1332307|NCT02094573|4379197|P2|Overall Study|Randomized but not treated|0
1332308|NCT02094573|4379198|P1|Overall Study|Randomized but not treated|3
1332309|NCT02094573|4379197|P2|Overall Study|Withdrawal by Subject|4
1332310|NCT02094573|4379198|P1|Overall Study|Withdrawal by Subject|2
1332311|NCT02094573|4379197|P2|Overall Study|Non-compliance with study drug|1
1332312|NCT02094573|4379198|P1|Overall Study|Non-compliance with study drug|0
1332313|NCT02094573|4379197|P2|Overall Study|Death|1
1332314|NCT02094573|4379198|P1|Overall Study|Death|7
1332315|NCT02094573|4379197|P2|Overall Study|Adverse Event|9
1332316|NCT02094573|4379198|P1|Overall Study|Adverse Event|3
1332317|NCT02094573|4379197|P2|Overall Study|Clinical Progressive Disease|3
1332318|NCT02094573|4379198|P1|Overall Study|Clinical Progressive Disease|4
1332319|NCT02094573|4379197|P2|Overall Study|Documented Progressive Disease|16
1332320|NCT02094573|4379198|P1|Overall Study|Documented Progressive Disease|29
1332321|NCT02094300|4379280|P1|Overall Study|Still be eligible for follow-up|3
1332322|NCT02094300|4379280|P1|Overall Study|Lost to Follow-up|10
1332323|NCT02094300|4379280|P1|Overall Study|Death|7
1332324|NCT02094261|4379284|P1|Overall Study|Ongoing Study at Data Cut-off|181
1332325|NCT02094261|4379284|P1|Overall Study|Withdrawal by Subject|4
1332326|NCT02094261|4379284|P1|Overall Study|Lost to Follow-up|1
1332327|NCT02094261|4379284|P1|Overall Study|Death|24
1332328|NCT02093923|4379326|P5|Overall Study|Screen failure after randomization|0
1332329|NCT02093923|4379327|P4|Overall Study|Screen failure after randomization|1
1332330|NCT02093923|4379328|P3|Overall Study|Screen failure after randomization|0
1332331|NCT02093923|4379329|P2|Overall Study|Screen failure after randomization|0
1332332|NCT02093923|4379330|P1|Overall Study|Screen failure after randomization|0
1332333|NCT02093923|4379326|P5|Overall Study|Lost to Follow-up|0
1332334|NCT02093923|4379327|P4|Overall Study|Lost to Follow-up|1
1332335|NCT02093923|4379328|P3|Overall Study|Lost to Follow-up|0
1332336|NCT02093923|4379329|P2|Overall Study|Lost to Follow-up|0
1332337|NCT02093923|4379330|P1|Overall Study|Lost to Follow-up|0
1332338|NCT02093897|4379385|P1|Overall Study|Adverse event, non-fatal|1
1332339|NCT02093897|4379385|P1|Overall Study|Planned age group closure - no's reached|17
1332340|NCT02093897|4379385|P1|Overall Study|Physician Decision|1
1332341|NCT02093689|4379488|P3|Overall Study|Physician Decision|0
1332342|NCT02093689|4379489|P2|Overall Study|Physician Decision|0
1332343|NCT02093689|4379490|P1|Overall Study|Physician Decision|4
1332344|NCT02093520|4379498|P2|Overall Study|Not treated|22
1332345|NCT02093520|4379499|P1|Overall Study|Not treated|6
1332346|NCT02093390|4379511|P2|Overall Study|Withdrawal by Subject|1
1332347|NCT02093390|4379512|P1|Overall Study|Withdrawal by Subject|0
1332348|NCT02093351|4379551|P3|Overall Study|Death|0
1332349|NCT02093351|4379552|P2|Overall Study|Death|1
1332350|NCT02093351|4379553|P1|Overall Study|Death|0
1332351|NCT02093351|4379551|P3|Overall Study|Condition under investigation worsened|2
1332352|NCT02093351|4379552|P2|Overall Study|Condition under investigation worsened|0
1332353|NCT02093351|4379553|P1|Overall Study|Condition under investigation worsened|2
1332354|NCT02093351|4379551|P3|Overall Study|Adverse Event|1
1332355|NCT02093351|4379552|P2|Overall Study|Adverse Event|1
1332356|NCT02093351|4379553|P1|Overall Study|Adverse Event|0
1332357|NCT02093221|4379609|P5|Overall Study|Study termination|7
1332358|NCT02093221|4379610|P4|Overall Study|Study termination|6
1332359|NCT02093221|4379611|P3|Overall Study|Study termination|4
1332360|NCT02093221|4379612|P2|Overall Study|Study termination|5
1332361|NCT02093221|4379613|P1|Overall Study|Study termination|6
1332362|NCT02093221|4379609|P5|Overall Study|Protocol Violation|0
1332363|NCT02093221|4379610|P4|Overall Study|Protocol Violation|0
1332364|NCT02093221|4379611|P3|Overall Study|Protocol Violation|0
1332365|NCT02093221|4379612|P2|Overall Study|Protocol Violation|1
1332366|NCT02093221|4379613|P1|Overall Study|Protocol Violation|0
1332367|NCT02093221|4379609|P5|Overall Study|Death|0
1332368|NCT02093221|4379610|P4|Overall Study|Death|0
1332369|NCT02093221|4379611|P3|Overall Study|Death|0
1332370|NCT02093221|4379612|P2|Overall Study|Death|1
1332371|NCT02093221|4379613|P1|Overall Study|Death|0
1332372|NCT02093221|4379609|P5|Overall Study|Lost to Follow-up|0
1332373|NCT02093221|4379610|P4|Overall Study|Lost to Follow-up|1
1332374|NCT02093221|4379611|P3|Overall Study|Lost to Follow-up|1
1332375|NCT02093221|4379612|P2|Overall Study|Lost to Follow-up|0
1332376|NCT02093221|4379613|P1|Overall Study|Lost to Follow-up|2
1332377|NCT02093221|4379609|P5|Overall Study|Withdrawal by Subject|1
1332378|NCT02093221|4379610|P4|Overall Study|Withdrawal by Subject|1
1332379|NCT02093221|4379611|P3|Overall Study|Withdrawal by Subject|4
1332380|NCT02093221|4379612|P2|Overall Study|Withdrawal by Subject|1
1332381|NCT02093221|4379613|P1|Overall Study|Withdrawal by Subject|1
1332382|NCT02093221|4379609|P5|Overall Study|Adverse Event|0
1332383|NCT02093221|4379610|P4|Overall Study|Adverse Event|0
1332384|NCT02093221|4379611|P3|Overall Study|Adverse Event|0
1332385|NCT02093221|4379612|P2|Overall Study|Adverse Event|0
1332386|NCT02093221|4379613|P1|Overall Study|Adverse Event|1
1332387|NCT02093026|4379650|P1|Overall Study|Other|157
1332388|NCT02093026|4379650|P1|Overall Study|Death|10
1332389|NCT02093026|4379650|P1|Overall Study|Adverse Event|26
1332390|NCT02092961|4379672|P3|Overall Study|Adverse Event|0
1332391|NCT02092961|4379673|P2|Overall Study|Adverse Event|4
1332392|NCT02092961|4379674|P1|Overall Study|Adverse Event|2
1332393|NCT02092961|4379672|P3|Overall Study|Dev. of study specific discont. criteria|0
1332394|NCT02092961|4379673|P2|Overall Study|Dev. of study specific discont. criteria|0
1332395|NCT02092961|4379674|P1|Overall Study|Dev. of study specific discont. criteria|3
1332396|NCT02092961|4379672|P3|Overall Study|Lack of therapeutic response|3
1332397|NCT02092961|4379673|P2|Overall Study|Lack of therapeutic response|1
1332398|NCT02092961|4379674|P1|Overall Study|Lack of therapeutic response|2
1332399|NCT02092961|4379672|P3|Overall Study|Study stopped|12
1332400|NCT02092961|4379673|P2|Overall Study|Study stopped|9
1332401|NCT02092961|4379674|P1|Overall Study|Study stopped|13
1332402|NCT02092961|4379672|P3|Overall Study|Not reported|1
1332403|NCT02092961|4379673|P2|Overall Study|Not reported|0
1332404|NCT02092961|4379674|P1|Overall Study|Not reported|1
1332405|NCT02092662|4379710|P2|Overall Study|Lost to Follow-up|0
1332406|NCT02092662|4379711|P1|Overall Study|Lost to Follow-up|13
1332407|NCT02092389|4379770|P1|Overall Study|Not specified|5
1332408|NCT02092389|4379770|P1|Overall Study|Adverse Event|1
1332409|NCT02092350|4379782|P2|Overall Study|Withdrawal by Subject|2
1332410|NCT02092350|4379783|P1|Overall Study|Withdrawal by Subject|2
1332411|NCT02092350|4379782|P2|Overall Study|Screen Failure|0
1332412|NCT02092350|4379783|P1|Overall Study|Screen Failure|1
1332413|NCT02092350|4379782|P2|Overall Study|Physician Decision|1
1332414|NCT02092350|4379783|P1|Overall Study|Physician Decision|1
1332415|NCT02092350|4379782|P2|Overall Study|Protocol Violation|0
1332416|NCT02092350|4379783|P1|Overall Study|Protocol Violation|1
1332417|NCT02092350|4379782|P2|Overall Study|Lost to Follow-up|1
1332418|NCT02092350|4379783|P1|Overall Study|Lost to Follow-up|3
1332419|NCT02092350|4379782|P2|Overall Study|Death|5
1332420|NCT02092350|4379783|P1|Overall Study|Death|2
1332421|NCT02092350|4379782|P2|Overall Study|Adverse Event|3
1332422|NCT02092350|4379783|P1|Overall Study|Adverse Event|0
1332423|NCT02092285|4379811|P1|Maintenance Phase & Follow-up|Lack of Efficacy|23
1332424|NCT02092285|4379811|P1|Maintenance Phase & Follow-up|Withdrawal by Subject|11
1332425|NCT02092285|4379811|P1|Maintenance Phase & Follow-up|Relapse/recurrence|29
1332426|NCT02092285|4379811|P1|Maintenance Phase & Follow-up|Protocol Violation|11
1332427|NCT02092285|4379811|P1|Maintenance Phase & Follow-up|Pregnancy|1
1332428|NCT02092285|4379811|P1|Maintenance Phase & Follow-up|Physician Decision|10
1332429|NCT02092285|4379811|P1|Maintenance Phase & Follow-up|Non-compliance with study drug|2
1332430|NCT02092285|4379811|P1|Maintenance Phase & Follow-up|Lost to Follow-up|1
1332431|NCT02092285|4379811|P1|Maintenance Phase & Follow-up|Adverse Event|22
1332432|NCT02092285|4379811|P1|Induction Phase|Lack of Efficacy|14
1332433|NCT02092285|4379811|P1|Induction Phase|Withdrawal by Subject|2
1332434|NCT02092285|4379811|P1|Induction Phase|Relapse/Recurrence|7
1332435|NCT02092285|4379811|P1|Induction Phase|Pregnancy|1
1332436|NCT02092285|4379811|P1|Induction Phase|Physician Decision|4
1332437|NCT02092285|4379811|P1|Induction Phase|Adverse Event|7
1332438|NCT02092220|4379815|P2|Period 2|Nausea, Anxiety, Inconvenience|1
1332439|NCT02092220|4379816|P1|Period 2|Nausea, Anxiety, Inconvenience|0
1332440|NCT02092220|4379815|P2|Period 2|Severe Hypoglycaemia|0
1332441|NCT02092220|4379816|P1|Period 2|Severe Hypoglycaemia|1
1332442|NCT02092220|4379815|P2|Period 1|Unrelated Illness|2
1332443|NCT02092220|4379816|P1|Period 1|Unrelated Illness|0
1332444|NCT02092116|4379889|P2|Overall Study|Adverse Event|1
1332445|NCT02092116|4379890|P1|Overall Study|Adverse Event|0
1332446|NCT02092116|4379889|P2|Overall Study|Withdrawal by Subject|3
1332447|NCT02092116|4379890|P1|Overall Study|Withdrawal by Subject|0
1332448|NCT02091986|4379902|P3|Overall Study|Adverse Event|2
1332449|NCT02091986|4379903|P2|Overall Study|Adverse Event|0
1332450|NCT02091986|4379904|P1|Overall Study|Adverse Event|0
1332451|NCT02091986|4379902|P3|Overall Study|Withdrawal by Subject|3
1332452|NCT02091986|4379903|P2|Overall Study|Withdrawal by Subject|8
1332453|NCT02091986|4379904|P1|Overall Study|Withdrawal by Subject|4
1332454|NCT02091986|4379902|P3|Overall Study|Lost to Follow-up|0
1332455|NCT02091986|4379903|P2|Overall Study|Lost to Follow-up|0
1332456|NCT02091986|4379904|P1|Overall Study|Lost to Follow-up|1
1332457|NCT02091986|4379902|P3|Overall Study|7 rand in error 1 patient decision|3
1332458|NCT02091986|4379903|P2|Overall Study|7 rand in error 1 patient decision|3
1332459|NCT02091986|4379904|P1|Overall Study|7 rand in error 1 patient decision|2
1332460|NCT02091960|4379951|P1|Overall Study|On Study at Data Cut-off|12
1332461|NCT02091960|4379951|P1|Overall Study|Miscellaneous Reasons|31
1332462|NCT02091960|4379951|P1|Overall Study|Withdrawal by Subject|1
1332463|NCT02091960|4379951|P1|Overall Study|Death|7
1332464|NCT02091869|4379964|P2|Overall Study|Withdrawal by Subject|3
1332465|NCT02091869|4379965|P1|Overall Study|Withdrawal by Subject|0
1332466|NCT02091752|4380006|P1|Overall Study|Adverse Event|1
1332467|NCT02091752|4380006|P1|Overall Study|Study terminated by Sponsor|2
1332468|NCT02091739|4380020|P5|EP: 48 Weeks|Withdrawal by Subject|6
1332469|NCT02091739|4380021|P4|EP: 48 Weeks|Withdrawal by Subject|2
1332470|NCT02091739|4380022|P3|EP: 48 Weeks|Withdrawal by Subject|0
1332471|NCT02091739|4380023|P2|EP: 48 Weeks|Withdrawal by Subject|0
1332472|NCT02091739|4380024|P1|EP: 48 Weeks|Withdrawal by Subject|0
1332473|NCT02091739|4380020|P5|EP: 48 Weeks|Adverse Event|6
1332474|NCT02091739|4380021|P4|EP: 48 Weeks|Adverse Event|2
1332475|NCT02091739|4380022|P3|EP: 48 Weeks|Adverse Event|0
1332476|NCT02091739|4380023|P2|EP: 48 Weeks|Adverse Event|0
1332477|NCT02091739|4380024|P1|EP: 48 Weeks|Adverse Event|0
1332478|NCT02091739|4380020|P5|EP: 48 Weeks|Death|2
1332479|NCT02091739|4380021|P4|EP: 48 Weeks|Death|3
1332480|NCT02091739|4380022|P3|EP: 48 Weeks|Death|0
1332481|NCT02091739|4380023|P2|EP: 48 Weeks|Death|0
1332482|NCT02091739|4380024|P1|EP: 48 Weeks|Death|0
1332483|NCT02091739|4380020|P5|EP: 48 Weeks|Other|0
1332484|NCT02091739|4380021|P4|EP: 48 Weeks|Other|1
1332485|NCT02091739|4380022|P3|EP: 48 Weeks|Other|0
1332486|NCT02091739|4380023|P2|EP: 48 Weeks|Other|0
1332487|NCT02091739|4380024|P1|EP: 48 Weeks|Other|0
1332488|NCT02091739|4380020|P5|MP: 16 Weeks|Lost to Follow-up|0
1332489|NCT02091739|4380021|P4|MP: 16 Weeks|Lost to Follow-up|0
1332490|NCT02091739|4380022|P3|MP: 16 Weeks|Lost to Follow-up|1
1332491|NCT02091739|4380023|P2|MP: 16 Weeks|Lost to Follow-up|0
1332492|NCT02091739|4380024|P1|MP: 16 Weeks|Lost to Follow-up|0
1332493|NCT02091739|4380020|P5|MP: 16 Weeks|Withdrawal by Subject|0
1332494|NCT02091739|4380021|P4|MP: 16 Weeks|Withdrawal by Subject|0
1332495|NCT02091739|4380022|P3|MP: 16 Weeks|Withdrawal by Subject|0
1332496|NCT02091739|4380023|P2|MP: 16 Weeks|Withdrawal by Subject|4
1332497|NCT02091739|4380024|P1|MP: 16 Weeks|Withdrawal by Subject|3
1332498|NCT02091739|4380020|P5|MP: 16 Weeks|Adverse Event|0
1332499|NCT02091739|4380021|P4|MP: 16 Weeks|Adverse Event|0
1332500|NCT02091739|4380022|P3|MP: 16 Weeks|Adverse Event|1
1332501|NCT02091739|4380023|P2|MP: 16 Weeks|Adverse Event|1
1332502|NCT02091739|4380024|P1|MP: 16 Weeks|Adverse Event|1
1332503|NCT02091726|4380043|P1|Overall Study|Lost to Follow-up|6
1332504|NCT02091414|4380060|P1|Overall Study|Death|2
1332505|NCT02091414|4380060|P1|Overall Study|Withdrawal by Subject|2
1332506|NCT02091375|4380074|P2|Overall Study|Withdrawn by the investigator|0
1332507|NCT02091375|4380075|P1|Overall Study|Withdrawn by the investigator|1
1332508|NCT02091375|4380074|P2|Overall Study|Withdrawal by Subject|1
1332509|NCT02091375|4380075|P1|Overall Study|Withdrawal by Subject|0
1332510|NCT02091375|4380074|P2|Overall Study|Lost to Follow-up|1
1332511|NCT02091375|4380075|P1|Overall Study|Lost to Follow-up|0
1332512|NCT02091375|4380074|P2|Overall Study|Adverse Event|1
1332513|NCT02091375|4380075|P1|Overall Study|Adverse Event|8
1332514|NCT02091362|4380105|P2|Period 2|Withdrawal by Subject|1
1332515|NCT02091362|4380106|P1|Period 2|Withdrawal by Subject|1
1332516|NCT02091362|4380105|P2|Period 2|Lost to Follow-up|1
1332517|NCT02091362|4380106|P1|Period 2|Lost to Follow-up|0
1332518|NCT02091362|4380105|P2|Period 2|Adverse Event|0
1332519|NCT02091362|4380106|P1|Period 2|Adverse Event|1
1332520|NCT02091362|4380105|P2|Wash-out|Withdrawal by Subject|2
1332521|NCT02091362|4380106|P1|Wash-out|Withdrawal by Subject|0
1332522|NCT02091362|4380105|P2|Wash-out|Lost to Follow-up|1
1332523|NCT02091362|4380106|P1|Wash-out|Lost to Follow-up|1
1332524|NCT02091362|4380105|P2|Period 1|Adverse Event|0
1332525|NCT02091362|4380106|P1|Period 1|Adverse Event|2
1332526|NCT02091362|4380105|P2|Period 1|Lost to Follow-up|1
1332527|NCT02091362|4380106|P1|Period 1|Lost to Follow-up|0
1332528|NCT02091362|4380105|P2|Period 1|Withdrawal by Subject|3
1332529|NCT02091362|4380106|P1|Period 1|Withdrawal by Subject|2
1332530|NCT02091362|4380105|P2|Period 1|Protocol Violation|0
1332531|NCT02091362|4380106|P1|Period 1|Protocol Violation|1
1332532|NCT02091206|4380130|P4|Taper Period|Lost to Follow-up|1
1332533|NCT02091206|4380131|P3|Taper Period|Lost to Follow-up|0
1332534|NCT02091206|4380132|P2|Taper Period|Lost to Follow-up|0
1332535|NCT02091206|4380133|P1|Taper Period|Lost to Follow-up|0
1332536|NCT02091206|4380130|P4|Taper Period|Participant refused study drug|1
1332537|NCT02091206|4380131|P3|Taper Period|Participant refused study drug|0
1332538|NCT02091206|4380132|P2|Taper Period|Participant refused study drug|0
1332539|NCT02091206|4380133|P1|Taper Period|Participant refused study drug|1
1332540|NCT02091206|4380130|P4|Treatment Period|Met withdrawal criteria|0
1332541|NCT02091206|4380131|P3|Treatment Period|Met withdrawal criteria|1
1332542|NCT02091206|4380132|P2|Treatment Period|Met withdrawal criteria|0
1332543|NCT02091206|4380133|P1|Treatment Period|Met withdrawal criteria|0
1332544|NCT02091206|4380130|P4|Treatment Period|Adverse Event|0
1332545|NCT02091206|4380131|P3|Treatment Period|Adverse Event|0
1332546|NCT02091206|4380132|P2|Treatment Period|Adverse Event|1
1332547|NCT02091206|4380133|P1|Treatment Period|Adverse Event|0
1332548|NCT02090855|4380155|P1|Overall Study|no evaluable Standard of Truth results|2
1332549|NCT02090764|4380168|P2|Overall Study|Lost to Follow-up|2
1332550|NCT02090764|4380169|P1|Overall Study|Lost to Follow-up|2
1332551|NCT02090764|4380168|P2|Overall Study|Intercurrent illness and other|1
1332552|NCT02090764|4380169|P1|Overall Study|Intercurrent illness and other|1
1332553|NCT02090764|4380168|P2|Overall Study|Withdrawal by Subject|1
1332554|NCT02090764|4380169|P1|Overall Study|Withdrawal by Subject|2
1332555|NCT02090764|4380168|P2|Overall Study|Lack of Efficacy|13
1332556|NCT02090764|4380169|P1|Overall Study|Lack of Efficacy|0
1332557|NCT02090764|4380168|P2|Overall Study|Adverse Event|3
1332558|NCT02090764|4380169|P1|Overall Study|Adverse Event|1
1332559|NCT02090413|4380178|P3|Overall Study|Lost to Follow-up|0
1332560|NCT02090413|4380179|P2|Overall Study|Lost to Follow-up|1
1332561|NCT02090413|4380180|P1|Overall Study|Lost to Follow-up|1
1332562|NCT02090413|4380178|P3|Overall Study|Not Specified|0
1332563|NCT02090413|4380179|P2|Overall Study|Not Specified|1
1332564|NCT02090413|4380180|P1|Overall Study|Not Specified|2
1332565|NCT02090413|4380178|P3|Overall Study|Investigator Decision|0
1332566|NCT02090413|4380179|P2|Overall Study|Investigator Decision|1
1332567|NCT02090413|4380180|P1|Overall Study|Investigator Decision|1
1332568|NCT02090413|4380178|P3|Overall Study|Withdrawal by Subject|2
1332569|NCT02090413|4380179|P2|Overall Study|Withdrawal by Subject|2
1332570|NCT02090413|4380180|P1|Overall Study|Withdrawal by Subject|2
1332571|NCT02090413|4380178|P3|Overall Study|Flushing event|1
1332572|NCT02090413|4380179|P2|Overall Study|Flushing event|0
1332573|NCT02090413|4380180|P1|Overall Study|Flushing event|2
1332574|NCT02090413|4380178|P3|Overall Study|Adverse Event|20
1332575|NCT02090413|4380179|P2|Overall Study|Adverse Event|15
1332576|NCT02090413|4380180|P1|Overall Study|Adverse Event|11
1332577|NCT02089737|4380266|P1|Overall Study|Not treated|1
1332578|NCT02089737|4380266|P1|Overall Study|Survey form not completed|5
1332579|NCT02089347|4380275|P2|Overall Study|Protocol Violation|0
1332580|NCT02089347|4380276|P1|Overall Study|Protocol Violation|1
1332581|NCT02088957|4380316|P2|Overall Study|Lack of Efficacy|0
1332582|NCT02088957|4380317|P1|Overall Study|Lack of Efficacy|1
1332583|NCT02088177|4380333|P1|Overall Study|Lost to Follow-up|3
1332584|NCT02087943|4380345|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
1332585|NCT02087943|4380346|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
1332586|NCT02087943|4380347|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
1332587|NCT02087943|4380348|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
1332588|NCT02087943|4380349|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
1332589|NCT02087943|4380345|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
1332590|NCT02087943|4380346|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1332591|NCT02087943|4380347|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1332592|NCT02087943|4380348|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1332593|NCT02087943|4380349|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1332594|NCT02087943|4380345|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1332595|NCT02087943|4380346|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1332596|NCT02087943|4380347|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
1332597|NCT02087943|4380348|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1332598|NCT02087943|4380349|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1332599|NCT02087943|4380345|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
1332600|NCT02087943|4380346|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
1332601|NCT02087943|4380347|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
1332602|NCT02087943|4380348|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
1332603|NCT02087943|4380349|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
1332604|NCT02087943|4380345|P5|Active Treatment Phase Week 12-24|Adverse Event|1
1332605|NCT02087943|4380346|P4|Active Treatment Phase Week 12-24|Adverse Event|0
1332606|NCT02087943|4380347|P3|Active Treatment Phase Week 12-24|Adverse Event|2
1332607|NCT02087943|4380348|P2|Active Treatment Phase Week 12-24|Adverse Event|1
1332608|NCT02087943|4380349|P1|Active Treatment Phase Week 12-24|Adverse Event|0
1332609|NCT02087943|4380345|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1332610|NCT02087943|4380346|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1332611|NCT02087943|4380347|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1332612|NCT02087943|4380348|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
1332613|NCT02087943|4380349|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1332614|NCT02087943|4380345|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
1332615|NCT02087943|4380346|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
1332616|NCT02087943|4380347|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
1332617|NCT02087943|4380348|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
1332618|NCT02087943|4380349|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
1332619|NCT02087943|4380345|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
1332620|NCT02087943|4380346|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
1332621|NCT02087943|4380347|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
1332622|NCT02087943|4380348|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
1332623|NCT02087943|4380349|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
1332624|NCT02087943|4380345|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
1332625|NCT02087943|4380346|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
1332626|NCT02087943|4380347|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
1332627|NCT02087943|4380348|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
1332628|NCT02087943|4380349|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
1332629|NCT02087943|4380345|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
1332630|NCT02087943|4380346|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
1332631|NCT02087943|4380347|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
1332632|NCT02087943|4380348|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
1332633|NCT02087943|4380349|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
1332634|NCT02087774|4380375|P2|Overall Study|Were absent day of data collection|20
1332635|NCT02087774|4380376|P1|Overall Study|Were absent day of data collection|8
1332636|NCT02087670|4380396|P2|Overall Study|Withdrawal by Subject|2
1332637|NCT02087670|4380397|P1|Overall Study|Withdrawal by Subject|3
1332638|NCT02087423|4380433|P3|Overall Study|Ongoing treatment at data cutoff|18
1332639|NCT02087423|4380434|P2|Overall Study|Ongoing treatment at data cutoff|0
1332640|NCT02087423|4380435|P1|Overall Study|Ongoing treatment at data cutoff|10
1332641|NCT02087423|4380433|P3|Overall Study|Adverse Event|3
1332642|NCT02087423|4380434|P2|Overall Study|Adverse Event|24
1332643|NCT02087423|4380435|P1|Overall Study|Adverse Event|2
1332644|NCT02087423|4380433|P3|Overall Study|Withdrawal by Subject|2
1332645|NCT02087423|4380434|P2|Overall Study|Withdrawal by Subject|7
1332646|NCT02087423|4380435|P1|Overall Study|Withdrawal by Subject|5
1332647|NCT02087423|4380433|P3|Overall Study|Physician Decision|35
1332648|NCT02087423|4380434|P2|Overall Study|Physician Decision|174
1332649|NCT02087423|4380435|P1|Overall Study|Physician Decision|86
1332650|NCT02087241|4380459|P4|Overall Study|Study Terminated by Sponsor|4
1332651|NCT02087241|4380460|P3|Overall Study|Study Terminated by Sponsor|0
1332652|NCT02087241|4380461|P2|Overall Study|Study Terminated by Sponsor|2
1332653|NCT02087241|4380462|P1|Overall Study|Study Terminated by Sponsor|0
1332654|NCT02087241|4380459|P4|Overall Study|Progressive Disease|1
1332655|NCT02087241|4380460|P3|Overall Study|Progressive Disease|0
1332656|NCT02087241|4380461|P2|Overall Study|Progressive Disease|0
1332657|NCT02087241|4380462|P1|Overall Study|Progressive Disease|0
1332658|NCT02087241|4380459|P4|Overall Study|Withdrawal by Subject|1
1332659|NCT02087241|4380460|P3|Overall Study|Withdrawal by Subject|0
1332660|NCT02087241|4380461|P2|Overall Study|Withdrawal by Subject|0
1332661|NCT02087241|4380462|P1|Overall Study|Withdrawal by Subject|1
1332662|NCT02087241|4380459|P4|Overall Study|Death|1
1332663|NCT02087241|4380460|P3|Overall Study|Death|1
1332664|NCT02087241|4380461|P2|Overall Study|Death|1
1332665|NCT02087241|4380462|P1|Overall Study|Death|2
1332666|NCT02087176|4380488|P1|Overall Study|Study Terminated by Sponsor|2
1332667|NCT02087176|4380488|P1|Overall Study|Censored|19
1332668|NCT02087176|4380488|P1|Overall Study|Death|10
1332669|NCT02087176|4380488|P1|Overall Study|Withdrawal by Subject|1
1332670|NCT02087059|4380493|P1|Overall Study|Lost to Follow-up|1
1332671|NCT02087059|4380493|P1|Overall Study|Adverse Event|5
1332672|NCT02087059|4380493|P1|Overall Study|Disease Progression|1
1332673|NCT02086591|4380540|P1|Overall Study|protocol terminated|3
1332674|NCT02086591|4380540|P1|Overall Study|Withdrawal by Subject|1
1332675|NCT02086591|4380540|P1|Overall Study|Adverse Event|1
1332676|NCT02085785|4380548|P2|Overall Study|Lost to Follow-up|1
1332677|NCT02085785|4380549|P1|Overall Study|Lost to Follow-up|0
1332678|NCT02085785|4380548|P2|Overall Study|Withdrawal by Subject|1
1332679|NCT02085785|4380549|P1|Overall Study|Withdrawal by Subject|2
1332680|NCT02085161|4380573|P4|Overall Study|Other Reason|1
1332681|NCT02085161|4380574|P3|Overall Study|Other Reason|1
1332682|NCT02085161|4380575|P2|Overall Study|Other Reason|0
1332683|NCT02085161|4380576|P1|Overall Study|Other Reason|1
1332684|NCT02085161|4380573|P4|Overall Study|Withdrawal by Subject|3
1332685|NCT02085161|4380574|P3|Overall Study|Withdrawal by Subject|0
1332686|NCT02085161|4380575|P2|Overall Study|Withdrawal by Subject|4
1332687|NCT02085161|4380576|P1|Overall Study|Withdrawal by Subject|2
1332688|NCT02085161|4380573|P4|Overall Study|Protocol Violation|1
1332689|NCT02085161|4380574|P3|Overall Study|Protocol Violation|0
1332690|NCT02085161|4380575|P2|Overall Study|Protocol Violation|1
1332691|NCT02085161|4380576|P1|Overall Study|Protocol Violation|0
1332692|NCT02085161|4380573|P4|Overall Study|Adverse Event|5
1332693|NCT02085161|4380574|P3|Overall Study|Adverse Event|4
1332694|NCT02085161|4380575|P2|Overall Study|Adverse Event|5
1332695|NCT02085161|4380576|P1|Overall Study|Adverse Event|8
1332696|NCT02085161|4380573|P4|Overall Study|Not Treated|0
1332697|NCT02085161|4380574|P3|Overall Study|Not Treated|0
1332698|NCT02085161|4380575|P2|Overall Study|Not Treated|0
1332699|NCT02085161|4380576|P1|Overall Study|Not Treated|1
1332700|NCT02084238|4380644|P1|Overall Study|Lost to Follow-up|2
1332701|NCT02084134|4380657|P2|Overall Study|Death|1
1332702|NCT02084134|4380658|P1|Overall Study|Death|0
1332703|NCT02084134|4380657|P2|Overall Study|Protocol Violation|2
1332704|NCT02084134|4380658|P1|Overall Study|Protocol Violation|4
1332705|NCT02084082|4380668|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
1332706|NCT02084082|4380669|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1332707|NCT02084082|4380670|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1332708|NCT02084082|4380671|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1332709|NCT02084082|4380668|P4|Washout Period 1 (35 Days)|Adverse Event|1
1332710|NCT02084082|4380669|P3|Washout Period 1 (35 Days)|Adverse Event|1
1332711|NCT02084082|4380670|P2|Washout Period 1 (35 Days)|Adverse Event|0
1332712|NCT02084082|4380671|P1|Washout Period 1 (35 Days)|Adverse Event|0
1332713|NCT02084056|4380712|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1332714|NCT02084056|4380713|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1332715|NCT02084056|4380714|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1332716|NCT02084056|4380715|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
1332717|NCT02084056|4380712|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1332718|NCT02084056|4380713|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1332719|NCT02084056|4380714|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1332720|NCT02084056|4380715|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
1332721|NCT02083965|4380747|P2|Treatment Period|Not Specified|0
1332722|NCT02083965|4380748|P1|Treatment Period|Not Specified|1
1332723|NCT02083380|4380865|P3|Overall Study|Other|6
1332724|NCT02083380|4380866|P2|Overall Study|Other|4
1332725|NCT02083380|4380867|P1|Overall Study|Other|8
1332726|NCT02083380|4380865|P3|Overall Study|Lost to Follow-up|3
1332727|NCT02083380|4380866|P2|Overall Study|Lost to Follow-up|3
1332728|NCT02083380|4380867|P1|Overall Study|Lost to Follow-up|5
1332729|NCT02083380|4380865|P3|Overall Study|Adverse Event|1
1332730|NCT02083380|4380866|P2|Overall Study|Adverse Event|0
1332731|NCT02083380|4380867|P1|Overall Study|Adverse Event|0
1332732|NCT02083380|4380865|P3|Overall Study|Physician Decision|3
1332733|NCT02083380|4380866|P2|Overall Study|Physician Decision|6
1332734|NCT02083380|4380867|P1|Overall Study|Physician Decision|1
1332735|NCT02083380|4380865|P3|Overall Study|Withdrawal by Subject|7
1332736|NCT02083380|4380866|P2|Overall Study|Withdrawal by Subject|3
1332737|NCT02083380|4380867|P1|Overall Study|Withdrawal by Subject|9
1332738|NCT02083380|4380865|P3|Overall Study|Lack of Efficacy|64
1332739|NCT02083380|4380866|P2|Overall Study|Lack of Efficacy|79
1332740|NCT02083380|4380867|P1|Overall Study|Lack of Efficacy|68
1332741|NCT02083185|4380972|P3|Overall Study|Did not Receive Study Drug|0
1332742|NCT02083185|4380973|P2|Overall Study|Did not Receive Study Drug|2
1332743|NCT02083185|4380974|P1|Overall Study|Did not Receive Study Drug|0
1332744|NCT02083185|4380972|P3|Overall Study|Study Terminated by Sponsor|0
1332745|NCT02083185|4380973|P2|Overall Study|Study Terminated by Sponsor|1
1332746|NCT02083185|4380974|P1|Overall Study|Study Terminated by Sponsor|0
1332747|NCT02083185|4380972|P3|Overall Study|Reason not Specified|5
1332748|NCT02083185|4380973|P2|Overall Study|Reason not Specified|6
1332749|NCT02083185|4380974|P1|Overall Study|Reason not Specified|9
1332750|NCT02083185|4380972|P3|Overall Study|Death|1
1332751|NCT02083185|4380973|P2|Overall Study|Death|2
1332752|NCT02083185|4380974|P1|Overall Study|Death|2
1332753|NCT02083185|4380972|P3|Overall Study|Withdrawal by Subject|1
1332754|NCT02083185|4380973|P2|Overall Study|Withdrawal by Subject|15
1332755|NCT02083185|4380974|P1|Overall Study|Withdrawal by Subject|9
1332756|NCT02083185|4380972|P3|Overall Study|Lost to Follow-up|0
1332757|NCT02083185|4380973|P2|Overall Study|Lost to Follow-up|3
1332758|NCT02083185|4380974|P1|Overall Study|Lost to Follow-up|0
1332759|NCT02082912|4381071|P2|Overall Study|Physician Decision|1
1332760|NCT02082912|4381072|P1|Overall Study|Physician Decision|0
1332761|NCT02082262|4381136|P1|Overall Study|Adverse Event|48
1332762|NCT02082262|4381136|P1|Overall Study|Withdrawal by Subject|3
1332763|NCT02082184|4381142|P2|Overall Study|Subject non-compliance|1
1332764|NCT02082184|4381143|P1|Overall Study|Subject non-compliance|0
1332765|NCT02082184|4381142|P2|Overall Study|Lost to Follow-up|2
1332766|NCT02082184|4381143|P1|Overall Study|Lost to Follow-up|0
1332767|NCT02082184|4381142|P2|Overall Study|Protocol Violation|6
1332768|NCT02082184|4381143|P1|Overall Study|Protocol Violation|0
1332769|NCT02082184|4381142|P2|Overall Study|Withdrawal by Subject|2
1332770|NCT02082184|4381143|P1|Overall Study|Withdrawal by Subject|3
1332771|NCT02082184|4381142|P2|Overall Study|Device associated symptoms|0
1332772|NCT02082184|4381143|P1|Overall Study|Device associated symptoms|5
1332773|NCT02082184|4381142|P2|Overall Study|Medical diagnosis|2
1332774|NCT02082184|4381143|P1|Overall Study|Medical diagnosis|1
1332775|NCT02082184|4381142|P2|Overall Study|Adverse Event|0
1332776|NCT02082184|4381143|P1|Overall Study|Adverse Event|1
1332777|NCT02082158|4381168|P6|Overall Study|Failed Fit-testing|7
1332778|NCT02082158|4381169|P5|Overall Study|Failed Fit-testing|3
1332779|NCT02082158|4381170|P4|Overall Study|Failed Fit-testing|4
1332780|NCT02082158|4381171|P3|Overall Study|Failed Fit-testing|14
1332781|NCT02082158|4381172|P2|Overall Study|Failed Fit-testing|8
1332782|NCT02082158|4381173|P1|Overall Study|Failed Fit-testing|8
1332783|NCT02082158|4381168|P6|Overall Study|Withdrawal by Subject|0
1332784|NCT02082158|4381169|P5|Overall Study|Withdrawal by Subject|1
1332785|NCT02082158|4381170|P4|Overall Study|Withdrawal by Subject|0
1332786|NCT02082158|4381171|P3|Overall Study|Withdrawal by Subject|0
1332787|NCT02082158|4381172|P2|Overall Study|Withdrawal by Subject|0
1332788|NCT02082158|4381173|P1|Overall Study|Withdrawal by Subject|0
1332789|NCT02081859|4381195|P2|Overall Study|Other reasons|0
1332790|NCT02081859|4381196|P1|Overall Study|Other reasons|2
1332791|NCT02081859|4381195|P2|Overall Study|< 4 embryos|23
1332792|NCT02081859|4381196|P1|Overall Study|< 4 embryos|27
1332793|NCT02081859|4381195|P2|Overall Study|Unanticipated freeze all cycle|6
1332794|NCT02081859|4381196|P1|Overall Study|Unanticipated freeze all cycle|2
1332795|NCT02081859|4381195|P2|Overall Study|No sperm|0
1332796|NCT02081859|4381196|P1|Overall Study|No sperm|1
1332797|NCT02081859|4381195|P2|Overall Study|No fertilization|2
1332798|NCT02081859|4381196|P1|Overall Study|No fertilization|2
1332799|NCT02081690|4381204|P1|Overall Study|Withdrawal by Subject|1
1332800|NCT02081690|4381204|P1|Overall Study|Physician Decision|3
1332801|NCT02081690|4381204|P1|Overall Study|Death|3
1332802|NCT02081677|4381215|P4|Overall Study|Unsatisfactory Lens Fitting|0
1332803|NCT02081677|4381216|P3|Overall Study|Unsatisfactory Lens Fitting|0
1332804|NCT02081677|4381217|P2|Overall Study|Unsatisfactory Lens Fitting|1
1332805|NCT02081677|4381218|P1|Overall Study|Unsatisfactory Lens Fitting|0
1332806|NCT02081677|4381215|P4|Overall Study|Not comfortable with lens care system|0
1332807|NCT02081677|4381216|P3|Overall Study|Not comfortable with lens care system|0
1332808|NCT02081677|4381217|P2|Overall Study|Not comfortable with lens care system|0
1332809|NCT02081677|4381218|P1|Overall Study|Not comfortable with lens care system|1
1332810|NCT02081677|4381215|P4|Overall Study|No Longer Meets Eligibility Criteria|0
1332811|NCT02081677|4381216|P3|Overall Study|No Longer Meets Eligibility Criteria|1
1332812|NCT02081677|4381217|P2|Overall Study|No Longer Meets Eligibility Criteria|0
1332813|NCT02081677|4381218|P1|Overall Study|No Longer Meets Eligibility Criteria|0
1332814|NCT02081677|4381215|P4|Overall Study|Adverse Event|0
1332815|NCT02081677|4381216|P3|Overall Study|Adverse Event|1
1332816|NCT02081677|4381217|P2|Overall Study|Adverse Event|0
1332817|NCT02081677|4381218|P1|Overall Study|Adverse Event|0
1332818|NCT02081599|4381310|P2|Period 2：Open-label Period|Withdrawal by Subject|0
1332819|NCT02081599|4381311|P1|Period 2：Open-label Period|Withdrawal by Subject|2
1332820|NCT02081599|4381310|P2|Period 2：Open-label Period|Physician Decision|0
1332821|NCT02081599|4381311|P1|Period 2：Open-label Period|Physician Decision|1
1332822|NCT02081599|4381310|P2|Period 2：Open-label Period|Lack of Efficacy|4
1332823|NCT02081599|4381311|P1|Period 2：Open-label Period|Lack of Efficacy|2
1332824|NCT02081599|4381310|P2|Period 2：Open-label Period|Adverse Event|0
1332825|NCT02081599|4381311|P1|Period 2：Open-label Period|Adverse Event|1
1332826|NCT02081599|4381310|P2|Period 1：Double-blind Period|stopping criteria|0
1332827|NCT02081599|4381311|P1|Period 1：Double-blind Period|stopping criteria|1
1332828|NCT02081599|4381310|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
1332829|NCT02081599|4381311|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
1332830|NCT02081599|4381310|P2|Period 1：Double-blind Period|Protocol Violation|1
1332831|NCT02081599|4381311|P1|Period 1：Double-blind Period|Protocol Violation|0
1332832|NCT02081599|4381310|P2|Period 1：Double-blind Period|Physician Decision|0
1332833|NCT02081599|4381311|P1|Period 1：Double-blind Period|Physician Decision|1
1332834|NCT02081599|4381310|P2|Period 1：Double-blind Period|Lack of Efficacy|1
1332835|NCT02081599|4381311|P1|Period 1：Double-blind Period|Lack of Efficacy|2
1332836|NCT02081599|4381310|P2|Period 1：Double-blind Period|Adverse Event|0
1332837|NCT02081599|4381311|P1|Period 1：Double-blind Period|Adverse Event|3
1332838|NCT02081586|4381329|P4|Overall Study|Head injury not related to study|0
1332839|NCT02081586|4381330|P3|Overall Study|Head injury not related to study|1
1332840|NCT02081586|4381331|P2|Overall Study|Head injury not related to study|0
1332841|NCT02081586|4381332|P1|Overall Study|Head injury not related to study|0
1332842|NCT02081586|4381329|P4|Overall Study|Lost to Follow-up|1
1332843|NCT02081586|4381330|P3|Overall Study|Lost to Follow-up|0
1332844|NCT02081586|4381331|P2|Overall Study|Lost to Follow-up|1
1332845|NCT02081586|4381332|P1|Overall Study|Lost to Follow-up|0
1332846|NCT02081183|4381423|P2|Overall Study|Not specified|3
1332847|NCT02081183|4381424|P1|Overall Study|Not specified|3
1332848|NCT02081183|4381423|P2|Overall Study|Protocol Violation|0
1332849|NCT02081183|4381424|P1|Overall Study|Protocol Violation|1
1332850|NCT02081183|4381423|P2|Overall Study|Lost to Follow-up|1
1332851|NCT02081183|4381424|P1|Overall Study|Lost to Follow-up|0
1332852|NCT02081079|4381440|P2|Overall Study|Lost to Follow-up|0
1332853|NCT02081079|4381441|P1|Overall Study|Lost to Follow-up|1
1332854|NCT02081079|4381440|P2|Overall Study|Lack of Efficacy|2
1332855|NCT02081079|4381441|P1|Overall Study|Lack of Efficacy|3
1332856|NCT02081001|4381514|P12|Overall Study|Adverse Event|0
1332857|NCT02081001|4381515|P11|Overall Study|Adverse Event|0
1332858|NCT02081001|4381516|P10|Overall Study|Adverse Event|0
1332859|NCT02081001|4381517|P9|Overall Study|Adverse Event|0
1332860|NCT02081001|4381518|P8|Overall Study|Adverse Event|0
1332861|NCT02081001|4381519|P7|Overall Study|Adverse Event|0
1332862|NCT02081001|4381520|P6|Overall Study|Adverse Event|0
1332863|NCT02081001|4381521|P5|Overall Study|Adverse Event|1
1332864|NCT02081001|4381522|P4|Overall Study|Adverse Event|0
1332865|NCT02081001|4381523|P3|Overall Study|Adverse Event|0
1332866|NCT02081001|4381524|P2|Overall Study|Adverse Event|0
1332867|NCT02081001|4381525|P1|Overall Study|Adverse Event|0
1332868|NCT02080871|4381589|P1|Overall Study|Lost to Follow-up|1
1332869|NCT02080871|4381589|P1|Overall Study|Death|1
1332870|NCT02080832|4381634|P3|Overall Study|Lost to Follow-up|2
1332871|NCT02080832|4381635|P2|Overall Study|Lost to Follow-up|2
1332872|NCT02080832|4381636|P1|Overall Study|Lost to Follow-up|0
1332873|NCT02080832|4381634|P3|Overall Study|Excluded from analysis by MRI|14
1332874|NCT02080832|4381635|P2|Overall Study|Excluded from analysis by MRI|10
1332875|NCT02080832|4381636|P1|Overall Study|Excluded from analysis by MRI|9
1332876|NCT02080481|4381694|P2|Overall Study|Never received a block.|0
1332877|NCT02080481|4381695|P1|Overall Study|Never received a block.|1
1332878|NCT02080091|4381713|P1|Overall Study|Other|1
1332879|NCT02080091|4381713|P1|Overall Study|Withdrawal by Subject|1
1332880|NCT02080091|4381713|P1|Overall Study|Death|1
1332881|NCT02080091|4381713|P1|Overall Study|Study Terminated|22
1332882|NCT02079909|4381722|P3|Overall Study|Relocation etc.|3
1332883|NCT02079909|4381723|P2|Overall Study|Relocation etc.|2
1332884|NCT02079909|4381724|P1|Overall Study|Relocation etc.|2
1332885|NCT02079909|4381722|P3|Overall Study|Physician Decision|1
1332886|NCT02079909|4381723|P2|Overall Study|Physician Decision|1
1332887|NCT02079909|4381724|P1|Overall Study|Physician Decision|0
1332888|NCT02079909|4381722|P3|Overall Study|Protocol Violation|1
1332889|NCT02079909|4381723|P2|Overall Study|Protocol Violation|1
1332890|NCT02079909|4381724|P1|Overall Study|Protocol Violation|0
1332891|NCT02079909|4381722|P3|Overall Study|Lack of Efficacy|1
1332892|NCT02079909|4381723|P2|Overall Study|Lack of Efficacy|0
1332893|NCT02079909|4381724|P1|Overall Study|Lack of Efficacy|0
1332894|NCT02079909|4381722|P3|Overall Study|Death|0
1332895|NCT02079909|4381723|P2|Overall Study|Death|2
1332896|NCT02079909|4381724|P1|Overall Study|Death|2
1332897|NCT02079909|4381722|P3|Overall Study|Lost to Follow-up|1
1332898|NCT02079909|4381723|P2|Overall Study|Lost to Follow-up|3
1332899|NCT02079909|4381724|P1|Overall Study|Lost to Follow-up|2
1332900|NCT02079909|4381722|P3|Overall Study|Withdrawal by Subject|4
1332901|NCT02079909|4381723|P2|Overall Study|Withdrawal by Subject|17
1332902|NCT02079909|4381724|P1|Overall Study|Withdrawal by Subject|9
1332903|NCT02079909|4381722|P3|Overall Study|Adverse Event|7
1332904|NCT02079909|4381723|P2|Overall Study|Adverse Event|23
1332905|NCT02079909|4381724|P1|Overall Study|Adverse Event|23
1332906|NCT02079844|4381741|P3|Treatment Period 2|Voluntary Withdrawal|0
1332907|NCT02079844|4381742|P2|Treatment Period 2|Voluntary Withdrawal|1
1332908|NCT02079844|4381743|P1|Treatment Period 2|Voluntary Withdrawal|0
1332909|NCT02079844|4381741|P3|Treatment Period 1|Voluntary Withdrawal|2
1332910|NCT02079844|4381742|P2|Treatment Period 1|Voluntary Withdrawal|0
1332911|NCT02079844|4381743|P1|Treatment Period 1|Voluntary Withdrawal|0
1332912|NCT02079805|4381801|P2|Overall Study|Voluntary Withdrawal|1
1332913|NCT02079805|4381802|P1|Overall Study|Voluntary Withdrawal|0
1332914|NCT02079805|4381801|P2|Overall Study|Pretreatment Event/Adverse Event|1
1332915|NCT02079805|4381802|P1|Overall Study|Pretreatment Event/Adverse Event|0
1332916|NCT02079649|4381824|P4|Overall Study|Randomization error (prior to treatment)|0
1332917|NCT02079649|4381825|P3|Overall Study|Randomization error (prior to treatment)|1
1332918|NCT02079649|4381826|P2|Overall Study|Randomization error (prior to treatment)|0
1332919|NCT02079649|4381827|P1|Overall Study|Randomization error (prior to treatment)|1
1332920|NCT02079649|4381824|P4|Overall Study|Withdrawal by Subject|1
1332921|NCT02079649|4381825|P3|Overall Study|Withdrawal by Subject|0
1332922|NCT02079649|4381826|P2|Overall Study|Withdrawal by Subject|0
1332923|NCT02079649|4381827|P1|Overall Study|Withdrawal by Subject|0
1332924|NCT02079649|4381824|P4|Overall Study|Lost to Follow-up|1
1332925|NCT02079649|4381825|P3|Overall Study|Lost to Follow-up|0
1332926|NCT02079649|4381826|P2|Overall Study|Lost to Follow-up|0
1332927|NCT02079649|4381827|P1|Overall Study|Lost to Follow-up|0
1332928|NCT02079610|4381844|P2|Overall Study|Withdrawal by Subject|1
1332929|NCT02079610|4381845|P1|Overall Study|Withdrawal by Subject|1
1332930|NCT02079532|4381855|P1|Overall Study|Not specified|3
1332931|NCT02079532|4381855|P1|Overall Study|Inclusion into ReFIRST|3
1332932|NCT02079532|4381855|P1|Overall Study|Administrative problems|1
1332933|NCT02079532|4381855|P1|Overall Study|Withdrawal by Subject|1
1332934|NCT02079532|4381855|P1|Overall Study|Protocol Violation|3
1332935|NCT02079532|4381855|P1|Overall Study|Lack of Efficacy|9
1332936|NCT02079532|4381855|P1|Overall Study|Additional or changed therapy|2
1332937|NCT02079532|4381855|P1|Overall Study|Adverse Event|7
1332938|NCT02079519|4381877|P1|Overall Study|Adverse Event|1
1332939|NCT02079519|4381877|P1|Overall Study|Disease Progression|9
1332940|NCT02079246|4381890|P2|OLEX-MEM|Other: Moved to nursing home|3
1332941|NCT02079246|4381891|P1|OLEX-MEM|Other: Moved to nursing home|0
1332942|NCT02079246|4381890|P2|OLEX-MEM|Lost to Follow-up|1
1332943|NCT02079246|4381891|P1|OLEX-MEM|Lost to Follow-up|0
1332944|NCT02079246|4381890|P2|OLEX-MEM|Protocol Violation|2
1332945|NCT02079246|4381891|P1|OLEX-MEM|Protocol Violation|0
1332946|NCT02079246|4381890|P2|OLEX-MEM|Withdrawal by Subject|7
1332947|NCT02079246|4381891|P1|OLEX-MEM|Withdrawal by Subject|0
1332948|NCT02079246|4381890|P2|OLEX-MEM|Adverse Event|6
1332949|NCT02079246|4381891|P1|OLEX-MEM|Adverse Event|0
1332950|NCT02079246|4381890|P2|OLEX|Other: Withdrawal of caregiver consent|0
1332951|NCT02079246|4381891|P1|OLEX|Other: Withdrawal of caregiver consent|1
1332952|NCT02079246|4381890|P2|OLEX|Other: Moved to nursing home|0
1332953|NCT02079246|4381891|P1|OLEX|Other: Moved to nursing home|1
1332954|NCT02079246|4381890|P2|OLEX|Other: Worsening of condition|0
1332955|NCT02079246|4381891|P1|OLEX|Other: Worsening of condition|1
1332956|NCT02079246|4381890|P2|OLEX|Other: Coordinator decision|0
1332957|NCT02079246|4381891|P1|OLEX|Other: Coordinator decision|1
1332958|NCT02079246|4381890|P2|OLEX|Other: Caregiver unavailable|0
1332959|NCT02079246|4381891|P1|OLEX|Other: Caregiver unavailable|3
1332960|NCT02079246|4381890|P2|OLEX|Other: Insufficient compliance|0
1332961|NCT02079246|4381891|P1|OLEX|Other: Insufficient compliance|2
1332962|NCT02079246|4381890|P2|OLEX|Other: Disallowed medication|0
1332963|NCT02079246|4381891|P1|OLEX|Other: Disallowed medication|8
1332964|NCT02079246|4381890|P2|OLEX|Results of the lead-in studies|0
1332965|NCT02079246|4381891|P1|OLEX|Results of the lead-in studies|58
1332966|NCT02079246|4381890|P2|OLEX|Lack of Efficacy|0
1332967|NCT02079246|4381891|P1|OLEX|Lack of Efficacy|3
1332968|NCT02079246|4381890|P2|OLEX|Protocol Violation|0
1332969|NCT02079246|4381891|P1|OLEX|Protocol Violation|6
1332970|NCT02079246|4381890|P2|OLEX|Lost to Follow-up|0
1332971|NCT02079246|4381891|P1|OLEX|Lost to Follow-up|6
1332972|NCT02079246|4381890|P2|OLEX|Withdrawal by Subject|0
1332973|NCT02079246|4381891|P1|OLEX|Withdrawal by Subject|60
1332974|NCT02079246|4381890|P2|OLEX|Adverse Event|0
1332975|NCT02079246|4381891|P1|OLEX|Adverse Event|66
1332976|NCT02079246|4381890|P2|OLEX|Death|0
1332977|NCT02079246|4381891|P1|OLEX|Death|11
1332978|NCT02079246|4381890|P2|OLEX|Withdrawal before treatment|0
1332979|NCT02079246|4381891|P1|OLEX|Withdrawal before treatment|1
1332980|NCT02077374|4381953|P2|Overall Study|Protocol Violation|1
1332981|NCT02077374|4381954|P1|Overall Study|Protocol Violation|0
1332982|NCT02077374|4381953|P2|Overall Study|Withdrawal by Subject|1
1332983|NCT02077374|4381954|P1|Overall Study|Withdrawal by Subject|0
1332984|NCT02077140|4381975|P5|Overall Study|Withdrawal by Subject|2
1332985|NCT02077140|4381976|P4|Overall Study|Withdrawal by Subject|2
1332986|NCT02077140|4381977|P3|Overall Study|Withdrawal by Subject|0
1332987|NCT02077140|4381978|P2|Overall Study|Withdrawal by Subject|1
1332988|NCT02077140|4381979|P1|Overall Study|Withdrawal by Subject|0
1332989|NCT02077140|4381975|P5|Overall Study|Lost to Follow-up|3
1332990|NCT02077140|4381976|P4|Overall Study|Lost to Follow-up|2
1332991|NCT02077140|4381977|P3|Overall Study|Lost to Follow-up|2
1332992|NCT02077140|4381978|P2|Overall Study|Lost to Follow-up|1
1332993|NCT02077140|4381979|P1|Overall Study|Lost to Follow-up|4
1332994|NCT02076334|4382202|P4|Overall Study|muscle soreness|1
1332995|NCT02076334|4382203|P3|Overall Study|muscle soreness|0
1332996|NCT02076334|4382204|P2|Overall Study|muscle soreness|0
1332997|NCT02076334|4382205|P1|Overall Study|muscle soreness|0
1332998|NCT02076334|4382202|P4|Overall Study|Lost to Follow-up|0
1332999|NCT02076334|4382203|P3|Overall Study|Lost to Follow-up|1
1333000|NCT02076334|4382204|P2|Overall Study|Lost to Follow-up|1
1333001|NCT02076334|4382205|P1|Overall Study|Lost to Follow-up|0
1333002|NCT02076334|4382202|P4|Overall Study|Protocol Violation|0
1333003|NCT02076334|4382203|P3|Overall Study|Protocol Violation|0
1333004|NCT02076334|4382204|P2|Overall Study|Protocol Violation|0
1333005|NCT02076334|4382205|P1|Overall Study|Protocol Violation|1
1333006|NCT02076178|4382238|P2|Injection Phase|Lost to Follow-up|1
1333007|NCT02076178|4382239|P1|Injection Phase|Lost to Follow-up|0
1333008|NCT02076178|4382238|P2|Injection Phase|Physician Decision|3
1333009|NCT02076178|4382239|P1|Injection Phase|Physician Decision|0
1333010|NCT02076178|4382238|P2|Injection Phase|Withdrawal by Subject|3
1333011|NCT02076178|4382239|P1|Injection Phase|Withdrawal by Subject|0
1333012|NCT02076178|4382238|P2|Injection Phase|Protocol defined stopping criteria|0
1333013|NCT02076178|4382239|P1|Injection Phase|Protocol defined stopping criteria|1
1333014|NCT02076178|4382238|P2|Oral Phase|Physician Decision|1
1333015|NCT02076178|4382239|P1|Oral Phase|Physician Decision|0
1333016|NCT02076178|4382238|P2|Oral Phase|Withdrawal by Subject|4
1333017|NCT02076178|4382239|P1|Oral Phase|Withdrawal by Subject|0
1333018|NCT02076178|4382238|P2|Oral Phase|Adverse Event|7
1333019|NCT02076178|4382239|P1|Oral Phase|Adverse Event|0
1333020|NCT02076009|4382273|P2|Overall Study|Subjects randomized but not treated|3
1333021|NCT02076009|4382274|P1|Overall Study|Subjects randomized but not treated|2
1333022|NCT02076009|4382273|P2|Overall Study|Ongoing|249
1333023|NCT02076009|4382274|P1|Overall Study|Ongoing|226
1333024|NCT02076009|4382273|P2|Overall Study|Progressive disease|0
1333025|NCT02076009|4382274|P1|Overall Study|Progressive disease|1
1333026|NCT02076009|4382273|P2|Overall Study|Lost to Follow-up|1
1333027|NCT02076009|4382274|P1|Overall Study|Lost to Follow-up|1
1333028|NCT02076009|4382273|P2|Overall Study|Withdrawal by Subject|3
1333029|NCT02076009|4382274|P1|Overall Study|Withdrawal by Subject|9
1333030|NCT02076009|4382273|P2|Overall Study|Death|30
1333031|NCT02076009|4382274|P1|Overall Study|Death|44
1333032|NCT02075840|4382296|P2|Overall Study|Ongoing at CCOD|82
1333033|NCT02075840|4382297|P1|Overall Study|Ongoing at CCOD|99
1333034|NCT02075840|4382296|P2|Overall Study|Physician Decision|3
1333035|NCT02075840|4382297|P1|Overall Study|Physician Decision|1
1333036|NCT02075840|4382296|P2|Overall Study|Lost to Follow-up|2
1333037|NCT02075840|4382297|P1|Overall Study|Lost to Follow-up|3
1333038|NCT02075840|4382296|P2|Overall Study|Death|40
1333039|NCT02075840|4382297|P1|Overall Study|Death|35
1333040|NCT02075840|4382296|P2|Overall Study|Adverse Event|2
1333041|NCT02075840|4382297|P1|Overall Study|Adverse Event|0
1333042|NCT02075840|4382296|P2|Overall Study|Reason not specified|0
1333043|NCT02075840|4382297|P1|Overall Study|Reason not specified|1
1333044|NCT02075840|4382296|P2|Overall Study|Withdrawal by Subject|22
1333045|NCT02075840|4382297|P1|Overall Study|Withdrawal by Subject|13
1333046|NCT02075658|4382353|P2|Overall Study|Physician Decision|2
1333047|NCT02075658|4382354|P1|Overall Study|Physician Decision|2
1333048|NCT02075632|4382364|P2|Overall Study|Withdrawal by Subject|1
1333049|NCT02075632|4382365|P1|Overall Study|Withdrawal by Subject|0
1333050|NCT02075632|4382364|P2|Overall Study|Lost to Follow-up|3
1333051|NCT02075632|4382365|P1|Overall Study|Lost to Follow-up|0
1333052|NCT02075632|4382364|P2|Overall Study|Adverse Event|1
1333053|NCT02075632|4382365|P1|Overall Study|Adverse Event|1
1333054|NCT02075541|4382377|P2|Overall Study|Other- unable to perform study procedure|0
1333055|NCT02075541|4382378|P1|Overall Study|Other- unable to perform study procedure|1
1333056|NCT02075541|4382377|P2|Overall Study|Sponsor study termination|1
1333057|NCT02075541|4382378|P1|Overall Study|Sponsor study termination|0
1333058|NCT02075541|4382377|P2|Overall Study|Withdrawal by Subject|3
1333059|NCT02075541|4382378|P1|Overall Study|Withdrawal by Subject|1
1333060|NCT02075541|4382377|P2|Overall Study|Protocol Violation|0
1333061|NCT02075541|4382378|P1|Overall Study|Protocol Violation|1
1333062|NCT02075541|4382377|P2|Overall Study|Serious Adverse Event|4
1333063|NCT02075541|4382378|P1|Overall Study|Serious Adverse Event|1
1333064|NCT02075515|4382427|P3|Overall Study|Lost to Follow-up|6
1333065|NCT02075515|4382428|P2|Overall Study|Lost to Follow-up|3
1333066|NCT02075515|4382429|P1|Overall Study|Lost to Follow-up|1
1333067|NCT02075515|4382427|P3|Overall Study|Withdrawal by Subject|1
1333068|NCT02075515|4382428|P2|Overall Study|Withdrawal by Subject|0
1333069|NCT02075515|4382429|P1|Overall Study|Withdrawal by Subject|2
1333070|NCT02075515|4382427|P3|Overall Study|Non-Serious Adverse Event|0
1333071|NCT02075515|4382428|P2|Overall Study|Non-Serious Adverse Event|1
1333072|NCT02075515|4382429|P1|Overall Study|Non-Serious Adverse Event|0
1333073|NCT02075515|4382427|P3|Overall Study|Serious Adverse Event|1
1333074|NCT02075515|4382428|P2|Overall Study|Serious Adverse Event|1
1333075|NCT02075515|4382429|P1|Overall Study|Serious Adverse Event|1
1333076|NCT02075463|4382464|P1|Overall Study|Withdrawal by Subject|1
1333077|NCT02075463|4382464|P1|Overall Study|Par. reached stopping criteria|4
1333078|NCT02075463|4382464|P1|Overall Study|Adverse Event|3
1333079|NCT02075320|4382514|P1|Overall Study|Withdrawal by Subject|2
1333080|NCT02075255|4382524|P3|Overall Study|Death|0
1333081|NCT02075255|4382525|P2|Overall Study|Death|2
1333082|NCT02075255|4382526|P1|Overall Study|Death|0
1333083|NCT02075255|4382524|P3|Overall Study|Adverse Event|1
1333084|NCT02075255|4382525|P2|Overall Study|Adverse Event|0
1333085|NCT02075255|4382526|P1|Overall Study|Adverse Event|0
1333086|NCT02075255|4382524|P3|Overall Study|Lost to Follow-up|1
1333087|NCT02075255|4382525|P2|Overall Study|Lost to Follow-up|0
1333088|NCT02075255|4382526|P1|Overall Study|Lost to Follow-up|0
1333089|NCT02075255|4382524|P3|Overall Study|Withdrawal by Subject|0
1333090|NCT02075255|4382525|P2|Overall Study|Withdrawal by Subject|1
1333091|NCT02075255|4382526|P1|Overall Study|Withdrawal by Subject|4
1333092|NCT02075255|4382524|P3|Overall Study|Study specific withdrawal criteria|1
1333093|NCT02075255|4382525|P2|Overall Study|Study specific withdrawal criteria|1
1333094|NCT02075255|4382526|P1|Overall Study|Study specific withdrawal criteria|0
1333095|NCT02075073|4382657|P3|Overall Study|Withdrawal by Subject|0
1333096|NCT02075073|4382658|P2|Overall Study|Withdrawal by Subject|1
1333097|NCT02075073|4382659|P1|Overall Study|Withdrawal by Subject|0
1333098|NCT02075008|4382681|P1|Overall Study|Study terminated by Sponsor|159
1333099|NCT02075008|4382681|P1|Overall Study|Withdrawal by Subject|6
1333100|NCT02075008|4382681|P1|Overall Study|Adverse Event|5
1333101|NCT02075008|4382681|P1|Overall Study|Death|1
1333102|NCT02075008|4382681|P1|Overall Study|Lack of Efficacy|1
1333103|NCT02075008|4382681|P1|Overall Study|Lost to Follow-up|1
1333104|NCT02075008|4382681|P1|Overall Study|Physician Decision|1
1333105|NCT02075008|4382681|P1|Overall Study|Pregnancy|1
1333106|NCT02075008|4382681|P1|Overall Study|Technical problems|1
1333107|NCT02074982|4382704|P2|Overall Study|Death|2
1333108|NCT02074982|4382705|P1|Overall Study|Death|0
1333109|NCT02074982|4382704|P2|Overall Study|Subject/guardian decision|24
1333110|NCT02074982|4382705|P1|Overall Study|Subject/guardian decision|15
1333111|NCT02074982|4382704|P2|Overall Study|Technical problems|2
1333112|NCT02074982|4382705|P1|Overall Study|Technical problems|0
1333113|NCT02074982|4382704|P2|Overall Study|Protocol deviation|3
1333114|NCT02074982|4382705|P1|Overall Study|Protocol deviation|4
1333115|NCT02074982|4382704|P2|Overall Study|Pregnancy|2
1333116|NCT02074982|4382705|P1|Overall Study|Pregnancy|1
1333117|NCT02074982|4382704|P2|Overall Study|Physician Decision|1
1333118|NCT02074982|4382705|P1|Overall Study|Physician Decision|1
1333119|NCT02074982|4382704|P2|Overall Study|Non-compliance with study treatment|2
1333120|NCT02074982|4382705|P1|Overall Study|Non-compliance with study treatment|0
1333121|NCT02074982|4382704|P2|Overall Study|Lost to Follow-up|10
1333122|NCT02074982|4382705|P1|Overall Study|Lost to Follow-up|9
1333123|NCT02074982|4382704|P2|Overall Study|Lack of Efficacy|1
1333124|NCT02074982|4382705|P1|Overall Study|Lack of Efficacy|6
1333125|NCT02074982|4382704|P2|Overall Study|Adverse Event|7
1333126|NCT02074982|4382705|P1|Overall Study|Adverse Event|15
1333127|NCT02074553|4382752|P8|Washout Period 3|Physician Decision|1
1333128|NCT02074553|4382753|P7|Washout Period 3|Physician Decision|0
1333129|NCT02074553|4382754|P6|Washout Period 3|Physician Decision|0
1333130|NCT02074553|4382755|P5|Washout Period 3|Physician Decision|0
1333131|NCT02074553|4382756|P4|Washout Period 3|Physician Decision|0
1333132|NCT02074553|4382757|P3|Washout Period 3|Physician Decision|0
1333133|NCT02074553|4382758|P2|Washout Period 3|Physician Decision|0
1333134|NCT02074553|4382759|P1|Washout Period 3|Physician Decision|0
1333135|NCT02074553|4382752|P8|Washout Period 2|Lost to Follow-up|0
1333136|NCT02074553|4382753|P7|Washout Period 2|Lost to Follow-up|0
1333137|NCT02074553|4382754|P6|Washout Period 2|Lost to Follow-up|0
1333138|NCT02074553|4382755|P5|Washout Period 2|Lost to Follow-up|0
1333139|NCT02074553|4382756|P4|Washout Period 2|Lost to Follow-up|0
1333140|NCT02074553|4382757|P3|Washout Period 2|Lost to Follow-up|1
1333141|NCT02074553|4382758|P2|Washout Period 2|Lost to Follow-up|0
1333142|NCT02074553|4382759|P1|Washout Period 2|Lost to Follow-up|0
1333143|NCT02074553|4382752|P8|Washout Period 2|Physician Decision|0
1333144|NCT02074553|4382753|P7|Washout Period 2|Physician Decision|0
1333145|NCT02074553|4382754|P6|Washout Period 2|Physician Decision|1
1333146|NCT02074553|4382755|P5|Washout Period 2|Physician Decision|0
1333147|NCT02074553|4382756|P4|Washout Period 2|Physician Decision|0
1333148|NCT02074553|4382757|P3|Washout Period 2|Physician Decision|0
1333149|NCT02074553|4382758|P2|Washout Period 2|Physician Decision|0
1333150|NCT02074553|4382759|P1|Washout Period 2|Physician Decision|0
1333151|NCT02074553|4382752|P8|Washout Period 2|Adverse Event|0
1333152|NCT02074553|4382753|P7|Washout Period 2|Adverse Event|1
1333153|NCT02074553|4382754|P6|Washout Period 2|Adverse Event|0
1333154|NCT02074553|4382755|P5|Washout Period 2|Adverse Event|0
1333155|NCT02074553|4382756|P4|Washout Period 2|Adverse Event|0
1333156|NCT02074553|4382757|P3|Washout Period 2|Adverse Event|0
1333157|NCT02074553|4382758|P2|Washout Period 2|Adverse Event|0
1333158|NCT02074553|4382759|P1|Washout Period 2|Adverse Event|0
1333159|NCT02074553|4382752|P8|Washout Period 1|Other|0
1333160|NCT02074553|4382753|P7|Washout Period 1|Other|0
1333161|NCT02074553|4382754|P6|Washout Period 1|Other|1
1333162|NCT02074553|4382755|P5|Washout Period 1|Other|0
1333163|NCT02074553|4382756|P4|Washout Period 1|Other|0
1333164|NCT02074553|4382757|P3|Washout Period 1|Other|0
1333165|NCT02074553|4382758|P2|Washout Period 1|Other|0
1333166|NCT02074553|4382759|P1|Washout Period 1|Other|0
1333167|NCT02074553|4382752|P8|Washout Period 1|Physician Decision|0
1333168|NCT02074553|4382753|P7|Washout Period 1|Physician Decision|0
1333169|NCT02074553|4382754|P6|Washout Period 1|Physician Decision|0
1333170|NCT02074553|4382755|P5|Washout Period 1|Physician Decision|0
1333171|NCT02074553|4382756|P4|Washout Period 1|Physician Decision|1
1333172|NCT02074553|4382757|P3|Washout Period 1|Physician Decision|0
1333173|NCT02074553|4382758|P2|Washout Period 1|Physician Decision|0
1333174|NCT02074553|4382759|P1|Washout Period 1|Physician Decision|0
1333175|NCT02074553|4382752|P8|Washout Period 1|Adverse Event|0
1333176|NCT02074553|4382753|P7|Washout Period 1|Adverse Event|0
1333177|NCT02074553|4382754|P6|Washout Period 1|Adverse Event|0
1333178|NCT02074553|4382755|P5|Washout Period 1|Adverse Event|0
1333179|NCT02074553|4382756|P4|Washout Period 1|Adverse Event|0
1333180|NCT02074553|4382757|P3|Washout Period 1|Adverse Event|0
1333181|NCT02074553|4382758|P2|Washout Period 1|Adverse Event|0
1333182|NCT02074553|4382759|P1|Washout Period 1|Adverse Event|1
1333183|NCT02074553|4382752|P8|Intervention Period 1|Family Emergency|0
1333184|NCT02074553|4382753|P7|Intervention Period 1|Family Emergency|0
1333185|NCT02074553|4382754|P6|Intervention Period 1|Family Emergency|0
1333186|NCT02074553|4382755|P5|Intervention Period 1|Family Emergency|0
1333187|NCT02074553|4382756|P4|Intervention Period 1|Family Emergency|1
1333188|NCT02074553|4382757|P3|Intervention Period 1|Family Emergency|0
1333189|NCT02074553|4382758|P2|Intervention Period 1|Family Emergency|0
1333190|NCT02074553|4382759|P1|Intervention Period 1|Family Emergency|0
1333191|NCT02074514|4382941|P2|Overall Study|Withdrew Consent|1
1333192|NCT02074514|4382942|P1|Overall Study|Withdrew Consent|0
1333193|NCT02074514|4382941|P2|Overall Study|Lost to Follow-up|1
1333194|NCT02074514|4382942|P1|Overall Study|Lost to Follow-up|0
1333195|NCT02074514|4382941|P2|Overall Study|Lack of Efficacy|2
1333196|NCT02074514|4382942|P1|Overall Study|Lack of Efficacy|3
1333197|NCT02074059|4383083|P6|Overall Study|Death|1
1333198|NCT02074059|4383084|P5|Overall Study|Death|1
1333199|NCT02074059|4383085|P4|Overall Study|Death|0
1333200|NCT02074059|4383086|P3|Overall Study|Death|0
1333201|NCT02074059|4383087|P2|Overall Study|Death|0
1333202|NCT02074059|4383088|P1|Overall Study|Death|0
1333203|NCT02073656|4383135|P1|Primary Study|Withdrew Consent|1
1333204|NCT02073656|4383135|P1|Primary Study|Death|1
1333205|NCT02073656|4383135|P1|Primary Study|Lost to Follow-up|6
1333206|NCT02072980|4383213|P2|Period 2, Second Wear|Adverse Event|1
1333207|NCT02072980|4383214|P1|Period 2, Second Wear|Adverse Event|0
1333208|NCT02072226|4383234|P2|Overall Study|Patient Withdrawal of Consent|0
1333209|NCT02072226|4383235|P1|Overall Study|Patient Withdrawal of Consent|1
1333210|NCT02072226|4383234|P2|Overall Study|Death|0
1333211|NCT02072226|4383235|P1|Overall Study|Death|1
1333212|NCT02072226|4383234|P2|Overall Study|Patient Non-compliance|3
1333213|NCT02072226|4383235|P1|Overall Study|Patient Non-compliance|2
1333214|NCT02072226|4383234|P2|Overall Study|Lost to Follow-up|7
1333215|NCT02072226|4383235|P1|Overall Study|Lost to Follow-up|11
1333216|NCT02072096|4383265|P2|Overall Study|Lost to Follow-up|0
1333217|NCT02072096|4383266|P1|Overall Study|Lost to Follow-up|1
1333218|NCT02072096|4383265|P2|Overall Study|Study Terminated by Sponsor|30
1333219|NCT02072096|4383266|P1|Overall Study|Study Terminated by Sponsor|43
1333220|NCT02072096|4383265|P2|Overall Study|Physician Decision|1
1333221|NCT02072096|4383266|P1|Overall Study|Physician Decision|0
1333222|NCT02072096|4383265|P2|Overall Study|Death|0
1333223|NCT02072096|4383266|P1|Overall Study|Death|2
1333224|NCT02072096|4383265|P2|Overall Study|No Reason Provided|2
1333225|NCT02072096|4383266|P1|Overall Study|No Reason Provided|4
1333226|NCT02072096|4383265|P2|Overall Study|Adverse Event|2
1333227|NCT02072096|4383266|P1|Overall Study|Adverse Event|5
1333228|NCT02072096|4383265|P2|Overall Study|Withdrawal by Subject|7
1333229|NCT02072096|4383266|P1|Overall Study|Withdrawal by Subject|5
1333230|NCT02072096|4383265|P2|Overall Study|Protocol Violation|7
1333231|NCT02072096|4383266|P1|Overall Study|Protocol Violation|7
1333232|NCT02072096|4383265|P2|Overall Study|Lack of Efficacy|29
1333233|NCT02072096|4383266|P1|Overall Study|Lack of Efficacy|18
1333234|NCT02071849|4383288|P1|2-year Extended Follow-up|Adverse Event|1
1333235|NCT02071849|4383288|P1|6-month Primary Endpoint|Adverse Event|1
1333236|NCT02071849|4383288|P1|6-month Primary Endpoint|Did not receive device|4
1333237|NCT02071771|4383354|P2|Period 1: First 10 Days|Unavailable lens power|0
1333238|NCT02071771|4383355|P1|Period 1: First 10 Days|Unavailable lens power|1
1333239|NCT02071771|4383354|P2|Period 1: First 10 Days|Unacceptable lens fit|0
1333240|NCT02071771|4383355|P1|Period 1: First 10 Days|Unacceptable lens fit|1
1333241|NCT02071082|4383410|P2|Overall Study|Lost to Follow-up|1
1333242|NCT02071082|4383411|P1|Overall Study|Lost to Follow-up|1
1333243|NCT02071082|4383410|P2|Overall Study|Withdrew Consent|4
1333244|NCT02071082|4383411|P1|Overall Study|Withdrew Consent|0
1333245|NCT02071082|4383410|P2|Overall Study|Adverse Event|1
1333246|NCT02071082|4383411|P1|Overall Study|Adverse Event|0
1333247|NCT02071082|4383410|P2|Overall Study|Enrolled and Never Treated|1
1333248|NCT02071082|4383411|P1|Overall Study|Enrolled and Never Treated|1
1333249|NCT02070965|4383442|P3|Overall Study|Subject moved|0
1333250|NCT02070965|4383443|P2|Overall Study|Subject moved|0
1333251|NCT02070965|4383444|P1|Overall Study|Subject moved|1
1333252|NCT02070965|4383442|P3|Overall Study|Withdrawal by Subject|1
1333253|NCT02070965|4383443|P2|Overall Study|Withdrawal by Subject|1
1333254|NCT02070965|4383444|P1|Overall Study|Withdrawal by Subject|1
1333255|NCT02070965|4383442|P3|Overall Study|Lost to Follow-up|0
1333256|NCT02070965|4383443|P2|Overall Study|Lost to Follow-up|1
1333257|NCT02070965|4383444|P1|Overall Study|Lost to Follow-up|0
1333258|NCT02070744|4383456|P5|OLE Phase (48 Weeks)|Other|1
1333259|NCT02070744|4383457|P4|OLE Phase (48 Weeks)|Other|0
1333260|NCT02070744|4383458|P3|OLE Phase (48 Weeks)|Other|0
1333261|NCT02070744|4383459|P2|OLE Phase (48 Weeks)|Other|0
1333262|NCT02070744|4383460|P1|OLE Phase (48 Weeks)|Other|0
1333263|NCT02070744|4383456|P5|OLE Phase (48 Weeks)|Withdrawal by Subject|2
1333264|NCT02070744|4383457|P4|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1333265|NCT02070744|4383458|P3|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1333266|NCT02070744|4383459|P2|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1333267|NCT02070744|4383460|P1|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1333268|NCT02070744|4383456|P5|PC Phase (12 Weeks)|Randomized, but not treated|0
1333269|NCT02070744|4383457|P4|PC Phase (12 Weeks)|Randomized, but not treated|1
1333270|NCT02070744|4383458|P3|PC Phase (12 Weeks)|Randomized, but not treated|0
1333271|NCT02070744|4383459|P2|PC Phase (12 Weeks)|Randomized, but not treated|0
1333272|NCT02070744|4383460|P1|PC Phase (12 Weeks)|Randomized, but not treated|0
1333273|NCT02070588|4383543|P3|Overall Study|Adverse Event|0
1333274|NCT02070588|4383544|P2|Overall Study|Adverse Event|0
1333275|NCT02070588|4383545|P1|Overall Study|Adverse Event|1
1333276|NCT02070588|4383543|P3|Overall Study|Writhdrawal due to early termination|0
1333277|NCT02070588|4383544|P2|Overall Study|Writhdrawal due to early termination|0
1333278|NCT02070588|4383545|P1|Overall Study|Writhdrawal due to early termination|9
1333279|NCT02070588|4383543|P3|Overall Study|Withdrawal by Subject|0
1333280|NCT02070588|4383544|P2|Overall Study|Withdrawal by Subject|1
1333281|NCT02070588|4383545|P1|Overall Study|Withdrawal by Subject|29
1333282|NCT02070484|4383561|P2|Overall Study|Withdrawal by Subject|0
1333283|NCT02070484|4383562|P1|Overall Study|Withdrawal by Subject|1
1333284|NCT02070380|4383574|P4|Second Injection|Protocol Violation|5
1333285|NCT02070380|4383575|P3|Second Injection|Protocol Violation|1
1333286|NCT02070380|4383576|P2|Second Injection|Protocol Violation|1
1333287|NCT02070380|4383577|P1|Second Injection|Protocol Violation|0
1333288|NCT02070380|4383574|P4|Second Injection|Image sets missing or technically inadeq|0
1333289|NCT02070380|4383575|P3|Second Injection|Image sets missing or technically inadeq|0
1333290|NCT02070380|4383576|P2|Second Injection|Image sets missing or technically inadeq|1
1333291|NCT02070380|4383577|P1|Second Injection|Image sets missing or technically inadeq|0
1333292|NCT02070380|4383574|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
1333293|NCT02070380|4383575|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
1333294|NCT02070380|4383576|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
1333295|NCT02070380|4383577|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
1333296|NCT02069093|4383655|P1|Overall Study|Adverse Event|10
1333297|NCT02069093|4383655|P1|Overall Study|Abnormal laboratory values|1
1333298|NCT02069093|4383655|P1|Overall Study|Withdrawal by Subject|2
1333299|NCT02069093|4383655|P1|Overall Study|Administrative problems|1
1333300|NCT02069093|4383655|P1|Overall Study|Death|1
1333301|NCT02069093|4383655|P1|Overall Study|New cancer therapy|1
1333302|NCT02069093|4383655|P1|Overall Study|Disease progression|14
1333303|NCT02068547|4383666|P2|Overall Study|Physician Decision|0
1333304|NCT02068547|4383667|P1|Overall Study|Physician Decision|1
1333305|NCT02068547|4383666|P2|Overall Study|Lost to Follow-up|3
1333306|NCT02068547|4383667|P1|Overall Study|Lost to Follow-up|3
1333307|NCT02068495|4383677|P1|Overall Study|Protocol Deviation|49
1333308|NCT02068495|4383677|P1|Overall Study|Case Report Forms Uncollected|60
1333309|NCT02068443|4383689|P3|Overall Study|Other Reason Not Specified|0
1333310|NCT02068443|4383690|P2|Overall Study|Other Reason Not Specified|0
1333311|NCT02068443|4383691|P1|Overall Study|Other Reason Not Specified|1
1333312|NCT02068443|4383689|P3|Overall Study|Lack of Efficacy|0
1333313|NCT02068443|4383690|P2|Overall Study|Lack of Efficacy|1
1333314|NCT02068443|4383691|P1|Overall Study|Lack of Efficacy|2
1333315|NCT02068443|4383689|P3|Overall Study|Voluntary Withdrawal|1
1333316|NCT02068443|4383690|P2|Overall Study|Voluntary Withdrawal|0
1333317|NCT02068443|4383691|P1|Overall Study|Voluntary Withdrawal|4
1333318|NCT02068443|4383689|P3|Overall Study|Pretreatment Event/Adverse Event|2
1333319|NCT02068443|4383690|P2|Overall Study|Pretreatment Event/Adverse Event|5
1333320|NCT02068443|4383691|P1|Overall Study|Pretreatment Event/Adverse Event|0
1333321|NCT02068222|4383726|P1|Overall Study|Lost to Follow-up|1
1333322|NCT02067728|4383757|P2|6 Month Measurements|Unable to attend|97
1333323|NCT02067728|4383758|P1|6 Month Measurements|Unable to attend|114
1333324|NCT02067728|4383757|P2|6 Month Follow up Survey|Lost to Follow-up|60
1333325|NCT02067728|4383758|P1|6 Month Follow up Survey|Lost to Follow-up|48
1333326|NCT02067728|4383757|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
1333327|NCT02067728|4383758|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
1333328|NCT02067676|4383792|P6|Overall Study|Withdrawal by Subject|0
1333329|NCT02067676|4383793|P5|Overall Study|Withdrawal by Subject|0
1333330|NCT02067676|4383794|P4|Overall Study|Withdrawal by Subject|0
1333331|NCT02067676|4383795|P3|Overall Study|Withdrawal by Subject|0
1333332|NCT02067676|4383796|P2|Overall Study|Withdrawal by Subject|0
1333333|NCT02067676|4383797|P1|Overall Study|Withdrawal by Subject|1
1333334|NCT02067533|4383914|P2|Overall Study|Lost to Follow-up|2
1333335|NCT02067533|4383915|P1|Overall Study|Lost to Follow-up|4
1333336|NCT02066922|4383930|P1|Overall Study|Adverse Event|1
1333337|NCT02066415|4383985|P3|Overall Study|Lost to Follow-up|2
1333338|NCT02066415|4383986|P2|Overall Study|Lost to Follow-up|2
1333339|NCT02066415|4383987|P1|Overall Study|Lost to Follow-up|7
1333340|NCT02066415|4383985|P3|Overall Study|Withdrawal by Subject|4
1333341|NCT02066415|4383986|P2|Overall Study|Withdrawal by Subject|1
1333342|NCT02066415|4383987|P1|Overall Study|Withdrawal by Subject|9
1333343|NCT02066415|4383985|P3|Overall Study|Decision by Sponsor|2
1333344|NCT02066415|4383986|P2|Overall Study|Decision by Sponsor|4
1333345|NCT02066415|4383987|P1|Overall Study|Decision by Sponsor|5
1333346|NCT02066402|4384012|P2|Overall Study|Protocol driven decision point|1
1333347|NCT02066402|4384013|P1|Overall Study|Protocol driven decision point|0
1333348|NCT02066402|4384012|P2|Overall Study|Progressive disease-clinical progression|1
1333349|NCT02066402|4384013|P1|Overall Study|Progressive disease-clinical progression|0
1333350|NCT02066402|4384012|P2|Overall Study|Withdrawal by Subject|11
1333351|NCT02066402|4384013|P1|Overall Study|Withdrawal by Subject|14
1333352|NCT02066402|4384012|P2|Overall Study|Lost to Follow-up|8
1333353|NCT02066402|4384013|P1|Overall Study|Lost to Follow-up|11
1333354|NCT02066402|4384012|P2|Overall Study|Adverse Event|2
1333355|NCT02066402|4384013|P1|Overall Study|Adverse Event|1
1333356|NCT02066233|4384041|P2|EG Scan II (Day 1)|difficulty intubating subject|6
1333357|NCT02066233|4384042|P1|EG Scan II (Day 1)|difficulty intubating subject|6
1333358|NCT02066129|4384052|P2|Overall Study|Physician Decision|1
1333359|NCT02066129|4384053|P1|Overall Study|Physician Decision|1
1333360|NCT02066129|4384052|P2|Overall Study|Lack of Efficacy|10
1333361|NCT02066129|4384053|P1|Overall Study|Lack of Efficacy|8
1333362|NCT02066129|4384052|P2|Overall Study|Withdrawal by Subject|10
1333363|NCT02066129|4384053|P1|Overall Study|Withdrawal by Subject|7
1333364|NCT02066129|4384052|P2|Overall Study|Lost to Follow-up|12
1333365|NCT02066129|4384053|P1|Overall Study|Lost to Follow-up|13
1333366|NCT02066051|4384067|P1|Overall Study|Subject developed active GVHD|1
1333367|NCT02065895|4384072|P6|Overall Study|Scheduling conflicts|0
1333368|NCT02065895|4384073|P5|Overall Study|Scheduling conflicts|0
1333369|NCT02065895|4384074|P4|Overall Study|Scheduling conflicts|0
1333370|NCT02065895|4384075|P3|Overall Study|Scheduling conflicts|0
1333371|NCT02065895|4384076|P2|Overall Study|Scheduling conflicts|1
1333372|NCT02065895|4384077|P1|Overall Study|Scheduling conflicts|0
1333373|NCT02065895|4384072|P6|Overall Study|Protocol Violation|0
1333374|NCT02065895|4384073|P5|Overall Study|Protocol Violation|0
1333375|NCT02065895|4384074|P4|Overall Study|Protocol Violation|1
1333376|NCT02065895|4384075|P3|Overall Study|Protocol Violation|0
1333377|NCT02065895|4384076|P2|Overall Study|Protocol Violation|0
1333378|NCT02065895|4384077|P1|Overall Study|Protocol Violation|1
1333379|NCT02064920|4384270|P2|Overall Study|Withdrawal by Subject|3
1333380|NCT02064920|4384271|P1|Overall Study|Withdrawal by Subject|1
1333381|NCT02064920|4384270|P2|Overall Study|Technical Problems|1
1333382|NCT02064920|4384271|P1|Overall Study|Technical Problems|0
1333383|NCT02064920|4384270|P2|Overall Study|Physician Decision|1
1333384|NCT02064920|4384271|P1|Overall Study|Physician Decision|0
1333385|NCT02064920|4384270|P2|Overall Study|Adverse Event|4
1333386|NCT02064920|4384271|P1|Overall Study|Adverse Event|0
1333387|NCT02064894|4384301|P3|Overall Study|Withdrawal by Subject|115
1333388|NCT02064894|4384302|P2|Overall Study|Withdrawal by Subject|102
1333389|NCT02064894|4384303|P1|Overall Study|Withdrawal by Subject|43
1333390|NCT02064439|4384317|P3|Overall Study|Other|7
1333391|NCT02064439|4384318|P2|Overall Study|Other|2
1333392|NCT02064439|4384319|P1|Overall Study|Other|2
1333393|NCT02064439|4384317|P3|Overall Study|Safety outcome reached|10
1333394|NCT02064439|4384318|P2|Overall Study|Safety outcome reached|20
1333395|NCT02064439|4384319|P1|Overall Study|Safety outcome reached|12
1333396|NCT02064439|4384317|P3|Overall Study|Efficacy outcome reached|57
1333397|NCT02064439|4384318|P2|Overall Study|Efficacy outcome reached|16
1333398|NCT02064439|4384319|P1|Overall Study|Efficacy outcome reached|18
1333399|NCT02064439|4384317|P3|Overall Study|Logistical difficulties|2
1333400|NCT02064439|4384318|P2|Overall Study|Logistical difficulties|5
1333401|NCT02064439|4384319|P1|Overall Study|Logistical difficulties|6
1333402|NCT02064439|4384317|P3|Overall Study|Physician Decision|1
1333403|NCT02064439|4384318|P2|Overall Study|Physician Decision|1
1333404|NCT02064439|4384319|P1|Overall Study|Physician Decision|0
1333405|NCT02064439|4384317|P3|Overall Study|Non-compliance with study medication|23
1333406|NCT02064439|4384318|P2|Overall Study|Non-compliance with study medication|19
1333407|NCT02064439|4384319|P1|Overall Study|Non-compliance with study medication|21
1333408|NCT02064439|4384317|P3|Overall Study|Lost to Follow-up|4
1333409|NCT02064439|4384318|P2|Overall Study|Lost to Follow-up|3
1333410|NCT02064439|4384319|P1|Overall Study|Lost to Follow-up|1
1333411|NCT02064439|4384317|P3|Overall Study|Protocol Violation|3
1333412|NCT02064439|4384318|P2|Overall Study|Protocol Violation|5
1333413|NCT02064439|4384319|P1|Overall Study|Protocol Violation|3
1333414|NCT02064439|4384317|P3|Overall Study|Withdrawal by Subject|26
1333415|NCT02064439|4384318|P2|Overall Study|Withdrawal by Subject|18
1333416|NCT02064439|4384319|P1|Overall Study|Withdrawal by Subject|29
1333417|NCT02064439|4384317|P3|Overall Study|Death|3
1333418|NCT02064439|4384318|P2|Overall Study|Death|2
1333419|NCT02064439|4384319|P1|Overall Study|Death|0
1333420|NCT02064439|4384317|P3|Overall Study|Adverse Event|46
1333421|NCT02064439|4384318|P2|Overall Study|Adverse Event|47
1333422|NCT02064439|4384319|P1|Overall Study|Adverse Event|51
1333423|NCT02064231|4384354|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
1333424|NCT02064231|4384355|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
1333425|NCT02064231|4384356|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
1333426|NCT02064231|4384357|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
1333427|NCT02064231|4384354|P4|First Test Period (Test A or Test C)|Adverse Event|0
1333428|NCT02064231|4384355|P3|First Test Period (Test A or Test C)|Adverse Event|1
1333429|NCT02064231|4384356|P2|First Test Period (Test A or Test C)|Adverse Event|0
1333430|NCT02064231|4384357|P1|First Test Period (Test A or Test C)|Adverse Event|1
1333431|NCT02064231|4384354|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
1333432|NCT02064231|4384355|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
1333433|NCT02064231|4384356|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
1333434|NCT02064231|4384357|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
1333435|NCT02064231|4384354|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
1333436|NCT02064231|4384355|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
1333437|NCT02064231|4384356|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
1333438|NCT02064231|4384357|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
1333439|NCT02064205|4384369|P1|Overall Study|Withdrawal by Subject|1
1333440|NCT02063880|4384387|P2|Overall Study|Ineligible|2
1333441|NCT02063880|4384388|P1|Overall Study|Ineligible|0
1333442|NCT02063880|4384387|P2|Overall Study|Lost to Follow-up|7
1333443|NCT02063880|4384388|P1|Overall Study|Lost to Follow-up|7
1333444|NCT02063880|4384387|P2|Overall Study|Death|18
1333445|NCT02063880|4384388|P1|Overall Study|Death|21
1333446|NCT02063854|4384405|P7|Overall Study|Did Not Receive Study Drug|0
1333447|NCT02063854|4384406|P6|Overall Study|Did Not Receive Study Drug|1
1333448|NCT02063854|4384407|P5|Overall Study|Did Not Receive Study Drug|0
1333449|NCT02063854|4384408|P4|Overall Study|Did Not Receive Study Drug|0
1333450|NCT02063854|4384409|P3|Overall Study|Did Not Receive Study Drug|0
1333451|NCT02063854|4384410|P2|Overall Study|Did Not Receive Study Drug|0
1333452|NCT02063854|4384411|P1|Overall Study|Did Not Receive Study Drug|0
1333453|NCT02063854|4384405|P7|Overall Study|Reason Not Specified|0
1333454|NCT02063854|4384406|P6|Overall Study|Reason Not Specified|0
1333455|NCT02063854|4384407|P5|Overall Study|Reason Not Specified|0
1333456|NCT02063854|4384408|P4|Overall Study|Reason Not Specified|0
1333457|NCT02063854|4384409|P3|Overall Study|Reason Not Specified|0
1333458|NCT02063854|4384410|P2|Overall Study|Reason Not Specified|0
1333459|NCT02063854|4384411|P1|Overall Study|Reason Not Specified|1
1333460|NCT02063854|4384405|P7|Overall Study|Surgical Dental Work Performed/Planned|1
1333461|NCT02063854|4384406|P6|Overall Study|Surgical Dental Work Performed/Planned|6
1333462|NCT02063854|4384407|P5|Overall Study|Surgical Dental Work Performed/Planned|1
1333463|NCT02063854|4384408|P4|Overall Study|Surgical Dental Work Performed/Planned|1
1333464|NCT02063854|4384409|P3|Overall Study|Surgical Dental Work Performed/Planned|6
1333465|NCT02063854|4384410|P2|Overall Study|Surgical Dental Work Performed/Planned|2
1333466|NCT02063854|4384411|P1|Overall Study|Surgical Dental Work Performed/Planned|5
1333467|NCT02063854|4384405|P7|Overall Study|Voluntary Withdrawal|1
1333468|NCT02063854|4384406|P6|Overall Study|Voluntary Withdrawal|6
1333469|NCT02063854|4384407|P5|Overall Study|Voluntary Withdrawal|3
1333470|NCT02063854|4384408|P4|Overall Study|Voluntary Withdrawal|1
1333471|NCT02063854|4384409|P3|Overall Study|Voluntary Withdrawal|8
1333472|NCT02063854|4384410|P2|Overall Study|Voluntary Withdrawal|0
1333473|NCT02063854|4384411|P1|Overall Study|Voluntary Withdrawal|2
1333474|NCT02063854|4384405|P7|Overall Study|Major Protocol Deviation|0
1333475|NCT02063854|4384406|P6|Overall Study|Major Protocol Deviation|0
1333476|NCT02063854|4384407|P5|Overall Study|Major Protocol Deviation|0
1333477|NCT02063854|4384408|P4|Overall Study|Major Protocol Deviation|0
1333478|NCT02063854|4384409|P3|Overall Study|Major Protocol Deviation|3
1333479|NCT02063854|4384410|P2|Overall Study|Major Protocol Deviation|0
1333480|NCT02063854|4384411|P1|Overall Study|Major Protocol Deviation|0
1333481|NCT02063854|4384405|P7|Overall Study|Pretreatment Event/Adverse Event|4
1333482|NCT02063854|4384406|P6|Overall Study|Pretreatment Event/Adverse Event|18
1333483|NCT02063854|4384407|P5|Overall Study|Pretreatment Event/Adverse Event|7
1333484|NCT02063854|4384408|P4|Overall Study|Pretreatment Event/Adverse Event|8
1333485|NCT02063854|4384409|P3|Overall Study|Pretreatment Event/Adverse Event|13
1333486|NCT02063854|4384410|P2|Overall Study|Pretreatment Event/Adverse Event|10
1333487|NCT02063854|4384411|P1|Overall Study|Pretreatment Event/Adverse Event|13
1333488|NCT02063737|4384495|P2|Overall Study|Lost to Follow-up|4
1333489|NCT02063737|4384496|P1|Overall Study|Lost to Follow-up|11
1333490|NCT02063672|4384530|P2|Overall Study|Withdrawal by Subject|2
1333491|NCT02063672|4384531|P1|Overall Study|Withdrawal by Subject|2
1333492|NCT02063672|4384530|P2|Overall Study|Lost to Follow-up|3
1333493|NCT02063672|4384531|P1|Overall Study|Lost to Follow-up|1
1333494|NCT02063672|4384530|P2|Overall Study|Death|3
1333495|NCT02063672|4384531|P1|Overall Study|Death|5
1333496|NCT02063672|4384530|P2|Overall Study|Ongoing Follow-up|14
1333497|NCT02063672|4384531|P1|Overall Study|Ongoing Follow-up|27
1333498|NCT02063659|4384578|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
1333499|NCT02063659|4384579|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
1333500|NCT02063659|4384580|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
1333501|NCT02063659|4384581|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
1333502|NCT02063659|4384578|P4|Open-Label Extension Period (OLE)|Adverse Event|7
1333503|NCT02063659|4384579|P3|Open-Label Extension Period (OLE)|Adverse Event|0
1333504|NCT02063659|4384580|P2|Open-Label Extension Period (OLE)|Adverse Event|0
1333505|NCT02063659|4384581|P1|Open-Label Extension Period (OLE)|Adverse Event|0
1333506|NCT02063659|4384578|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|1
1333507|NCT02063659|4384579|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1333508|NCT02063659|4384580|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1333509|NCT02063659|4384581|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1333510|NCT02063659|4384578|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
1333511|NCT02063659|4384579|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1333512|NCT02063659|4384580|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1333513|NCT02063659|4384581|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1333514|NCT02063659|4384578|P4|Open-Label Extension Period (OLE)|Physician Decision|1
1333515|NCT02063659|4384579|P3|Open-Label Extension Period (OLE)|Physician Decision|0
1333516|NCT02063659|4384580|P2|Open-Label Extension Period (OLE)|Physician Decision|0
1333517|NCT02063659|4384581|P1|Open-Label Extension Period (OLE)|Physician Decision|0
1333518|NCT02063659|4384578|P4|Double-Blind Treatment Period|Withdrawal of consent|0
1333519|NCT02063659|4384579|P3|Double-Blind Treatment Period|Withdrawal of consent|3
1333520|NCT02063659|4384580|P2|Double-Blind Treatment Period|Withdrawal of consent|1
1333521|NCT02063659|4384581|P1|Double-Blind Treatment Period|Withdrawal of consent|0
1333522|NCT02063659|4384578|P4|Double-Blind Treatment Period|Physician Decision|0
1333523|NCT02063659|4384579|P3|Double-Blind Treatment Period|Physician Decision|0
1333524|NCT02063659|4384580|P2|Double-Blind Treatment Period|Physician Decision|0
1333525|NCT02063659|4384581|P1|Double-Blind Treatment Period|Physician Decision|1
1333526|NCT02063659|4384578|P4|Double-Blind Treatment Period|Adverse Event|0
1333527|NCT02063659|4384579|P3|Double-Blind Treatment Period|Adverse Event|0
1333528|NCT02063659|4384580|P2|Double-Blind Treatment Period|Adverse Event|2
1333529|NCT02063659|4384581|P1|Double-Blind Treatment Period|Adverse Event|1
1333530|NCT02063217|4384664|P3|Overall Study|Withdrawal by Subject|0
1333531|NCT02063217|4384665|P2|Overall Study|Withdrawal by Subject|0
1333532|NCT02063217|4384666|P1|Overall Study|Withdrawal by Subject|1
1333533|NCT02062879|4384702|P2|Overall Study|Withdrawal by Subject|1
1333534|NCT02062879|4384703|P1|Overall Study|Withdrawal by Subject|4
1333535|NCT02062658|4384739|P1|Overall Study|Lack of Efficacy|1
1333536|NCT02062658|4384739|P1|Overall Study|Withdrawal by Subject|1
1333537|NCT02062645|4384743|P1|Overall Study|Lost to Follow-up|5
1333538|NCT02062645|4384743|P1|Overall Study|Protocol Violation|8
1333539|NCT02062645|4384743|P1|Overall Study|Adverse Event|2
1333540|NCT02062450|4384785|P1|Overall Study|No follow-up visit|124
1333541|NCT02062437|4384799|P1|Overall Study|Pt. couldn't come due to med. condition|1
1333542|NCT02062437|4384799|P1|Overall Study|Death|2
1333543|NCT02062437|4384799|P1|Overall Study|Patient not available for the 2y visit|18
1333544|NCT02062437|4384799|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
1333545|NCT02062385|4384812|P4|Overall Study|Lost to Follow-up|0
1333546|NCT02062385|4384813|P3|Overall Study|Lost to Follow-up|1
1333547|NCT02062385|4384814|P2|Overall Study|Lost to Follow-up|0
1333548|NCT02062385|4384815|P1|Overall Study|Lost to Follow-up|0
1333549|NCT02062385|4384812|P4|Overall Study|Death|1
1333550|NCT02062385|4384813|P3|Overall Study|Death|0
1333551|NCT02062385|4384814|P2|Overall Study|Death|0
1333552|NCT02062385|4384815|P1|Overall Study|Death|0
1333553|NCT02062385|4384812|P4|Overall Study|Withdrawn by parent/guardian|8
1333554|NCT02062385|4384813|P3|Overall Study|Withdrawn by parent/guardian|9
1333555|NCT02062385|4384814|P2|Overall Study|Withdrawn by parent/guardian|41
1333556|NCT02062385|4384815|P1|Overall Study|Withdrawn by parent/guardian|46
1333557|NCT02062385|4384812|P4|Overall Study|Moved|0
1333558|NCT02062385|4384813|P3|Overall Study|Moved|1
1333559|NCT02062385|4384814|P2|Overall Study|Moved|11
1333560|NCT02062385|4384815|P1|Overall Study|Moved|10
1333561|NCT02062385|4384812|P4|Overall Study|Incomplete EPI by database lock|0
1333562|NCT02062385|4384813|P3|Overall Study|Incomplete EPI by database lock|0
1333563|NCT02062385|4384814|P2|Overall Study|Incomplete EPI by database lock|0
1333564|NCT02062385|4384815|P1|Overall Study|Incomplete EPI by database lock|2
1333565|NCT02062385|4384812|P4|Overall Study|Protocol Violation|0
1333566|NCT02062385|4384813|P3|Overall Study|Protocol Violation|0
1333567|NCT02062385|4384814|P2|Overall Study|Protocol Violation|0
1333568|NCT02062385|4384815|P1|Overall Study|Protocol Violation|1
1333569|NCT02062385|4384812|P4|Overall Study|Adverse Event|0
1333570|NCT02062385|4384813|P3|Overall Study|Adverse Event|1
1333571|NCT02062385|4384814|P2|Overall Study|Adverse Event|13
1333572|NCT02062385|4384815|P1|Overall Study|Adverse Event|19
1333573|NCT02061592|4384999|P2|Period 2|Lost to Follow-up|1
1333574|NCT02061592|4385000|P1|Period 2|Lost to Follow-up|0
1333575|NCT02061592|4384999|P2|Period 1|Protocol Violation|0
1333576|NCT02061592|4385000|P1|Period 1|Protocol Violation|1
1333577|NCT02061592|4384999|P2|Period 1|Withdrawal by Subject|0
1333578|NCT02061592|4385000|P1|Period 1|Withdrawal by Subject|1
1333579|NCT02061540|4385012|P1|Overall Study|Withdrawal by Subject|2
1333580|NCT02061540|4385012|P1|Overall Study|Adverse Event|2
1333581|NCT02061280|4385180|P2|Overall Study|Lost to Follow-up|1
1333582|NCT02061280|4385181|P1|Overall Study|Lost to Follow-up|5
1333583|NCT02061280|4385180|P2|Overall Study|Withdrawal by Subject|2
1333584|NCT02061280|4385181|P1|Overall Study|Withdrawal by Subject|1
1333585|NCT02061280|4385180|P2|Overall Study|moved out of state|1
1333586|NCT02061280|4385181|P1|Overall Study|moved out of state|0
1333587|NCT02061280|4385180|P2|Overall Study|Protocol Violation|8
1333588|NCT02061280|4385181|P1|Overall Study|Protocol Violation|12
1333589|NCT02059395|4385357|P2|Overall Study|Lost to Follow-up|4
1333590|NCT02059395|4385358|P1|Overall Study|Lost to Follow-up|2
1333591|NCT02059291|4385373|P25|Epoch 4|Lack of Efficacy|0
1333592|NCT02059291|4385374|P24|Epoch 4|Lack of Efficacy|1
1333593|NCT02059291|4385375|P23|Epoch 4|Lack of Efficacy|0
1333594|NCT02059291|4385376|P22|Epoch 4|Lack of Efficacy|0
1333595|NCT02059291|4385377|P21|Epoch 4|Lack of Efficacy|0
1333596|NCT02059291|4385378|P20|Epoch 4|Lack of Efficacy|0
1333597|NCT02059291|4385379|P19|Epoch 4|Lack of Efficacy|0
1333598|NCT02059291|4385380|P18|Epoch 4|Lack of Efficacy|0
1333599|NCT02059291|4385381|P17|Epoch 4|Lack of Efficacy|0
1333600|NCT02059291|4385382|P16|Epoch 4|Lack of Efficacy|0
1333601|NCT02059291|4385383|P15|Epoch 4|Lack of Efficacy|0
1333602|NCT02059291|4385384|P14|Epoch 4|Lack of Efficacy|0
1333603|NCT02059291|4385385|P13|Epoch 4|Lack of Efficacy|0
1333604|NCT02059291|4385386|P12|Epoch 4|Lack of Efficacy|0
1333605|NCT02059291|4385387|P11|Epoch 4|Lack of Efficacy|0
1333606|NCT02059291|4385388|P10|Epoch 4|Lack of Efficacy|0
1333607|NCT02059291|4385389|P9|Epoch 4|Lack of Efficacy|0
1333608|NCT02059291|4385390|P8|Epoch 4|Lack of Efficacy|0
1333609|NCT02059291|4385391|P7|Epoch 4|Lack of Efficacy|0
1333610|NCT02059291|4385392|P6|Epoch 4|Lack of Efficacy|0
1333611|NCT02059291|4385393|P5|Epoch 4|Lack of Efficacy|0
1333612|NCT02059291|4385394|P4|Epoch 4|Lack of Efficacy|0
1333613|NCT02059291|4385395|P3|Epoch 4|Lack of Efficacy|0
1333614|NCT02059291|4385396|P2|Epoch 4|Lack of Efficacy|0
1333615|NCT02059291|4385397|P1|Epoch 4|Lack of Efficacy|0
1333616|NCT02059291|4385373|P25|Epoch 4|Withdrawal by Subject|0
1333617|NCT02059291|4385374|P24|Epoch 4|Withdrawal by Subject|0
1333618|NCT02059291|4385375|P23|Epoch 4|Withdrawal by Subject|0
1333619|NCT02059291|4385376|P22|Epoch 4|Withdrawal by Subject|0
1333620|NCT02059291|4385377|P21|Epoch 4|Withdrawal by Subject|1
1333621|NCT02059291|4385378|P20|Epoch 4|Withdrawal by Subject|0
1333622|NCT02059291|4385379|P19|Epoch 4|Withdrawal by Subject|0
1333623|NCT02059291|4385380|P18|Epoch 4|Withdrawal by Subject|0
1333624|NCT02059291|4385381|P17|Epoch 4|Withdrawal by Subject|0
1333625|NCT02059291|4385382|P16|Epoch 4|Withdrawal by Subject|0
1333626|NCT02059291|4385383|P15|Epoch 4|Withdrawal by Subject|0
1333627|NCT02059291|4385384|P14|Epoch 4|Withdrawal by Subject|0
1333628|NCT02059291|4385385|P13|Epoch 4|Withdrawal by Subject|0
1333629|NCT02059291|4385386|P12|Epoch 4|Withdrawal by Subject|0
1333630|NCT02059291|4385387|P11|Epoch 4|Withdrawal by Subject|0
1333631|NCT02059291|4385388|P10|Epoch 4|Withdrawal by Subject|0
1333632|NCT02059291|4385389|P9|Epoch 4|Withdrawal by Subject|0
1333633|NCT02059291|4385390|P8|Epoch 4|Withdrawal by Subject|0
1333634|NCT02059291|4385391|P7|Epoch 4|Withdrawal by Subject|0
1333635|NCT02059291|4385392|P6|Epoch 4|Withdrawal by Subject|0
1333636|NCT02059291|4385393|P5|Epoch 4|Withdrawal by Subject|0
1333637|NCT02059291|4385394|P4|Epoch 4|Withdrawal by Subject|0
1333638|NCT02059291|4385395|P3|Epoch 4|Withdrawal by Subject|0
1333639|NCT02059291|4385396|P2|Epoch 4|Withdrawal by Subject|0
1333640|NCT02059291|4385397|P1|Epoch 4|Withdrawal by Subject|0
1333641|NCT02059291|4385373|P25|Epoch 4|Pregnancy|0
1333642|NCT02059291|4385374|P24|Epoch 4|Pregnancy|0
1333643|NCT02059291|4385375|P23|Epoch 4|Pregnancy|0
1333644|NCT02059291|4385376|P22|Epoch 4|Pregnancy|0
1333645|NCT02059291|4385377|P21|Epoch 4|Pregnancy|0
1333646|NCT02059291|4385378|P20|Epoch 4|Pregnancy|0
1333647|NCT02059291|4385379|P19|Epoch 4|Pregnancy|0
1333648|NCT02059291|4385380|P18|Epoch 4|Pregnancy|0
1333649|NCT02059291|4385381|P17|Epoch 4|Pregnancy|1
1333650|NCT02059291|4385382|P16|Epoch 4|Pregnancy|0
1333651|NCT02059291|4385383|P15|Epoch 4|Pregnancy|0
1333652|NCT02059291|4385384|P14|Epoch 4|Pregnancy|0
1333653|NCT02059291|4385385|P13|Epoch 4|Pregnancy|0
1333654|NCT02059291|4385386|P12|Epoch 4|Pregnancy|0
1333655|NCT02059291|4385387|P11|Epoch 4|Pregnancy|0
1333656|NCT02059291|4385388|P10|Epoch 4|Pregnancy|0
1333657|NCT02059291|4385389|P9|Epoch 4|Pregnancy|0
1333658|NCT02059291|4385390|P8|Epoch 4|Pregnancy|0
1333659|NCT02059291|4385391|P7|Epoch 4|Pregnancy|0
1333660|NCT02059291|4385392|P6|Epoch 4|Pregnancy|0
1333661|NCT02059291|4385393|P5|Epoch 4|Pregnancy|0
1333662|NCT02059291|4385394|P4|Epoch 4|Pregnancy|0
1333663|NCT02059291|4385395|P3|Epoch 4|Pregnancy|0
1333664|NCT02059291|4385396|P2|Epoch 4|Pregnancy|0
1333665|NCT02059291|4385397|P1|Epoch 4|Pregnancy|0
1333666|NCT02059291|4385373|P25|Epoch 4|Adverse Event|0
1333667|NCT02059291|4385374|P24|Epoch 4|Adverse Event|0
1333668|NCT02059291|4385375|P23|Epoch 4|Adverse Event|1
1333669|NCT02059291|4385376|P22|Epoch 4|Adverse Event|0
1333670|NCT02059291|4385377|P21|Epoch 4|Adverse Event|0
1333671|NCT02059291|4385378|P20|Epoch 4|Adverse Event|0
1333672|NCT02059291|4385379|P19|Epoch 4|Adverse Event|0
1333673|NCT02059291|4385380|P18|Epoch 4|Adverse Event|0
1333674|NCT02059291|4385381|P17|Epoch 4|Adverse Event|1
1333675|NCT02059291|4385382|P16|Epoch 4|Adverse Event|0
1333676|NCT02059291|4385383|P15|Epoch 4|Adverse Event|0
1333677|NCT02059291|4385384|P14|Epoch 4|Adverse Event|0
1333678|NCT02059291|4385385|P13|Epoch 4|Adverse Event|0
1333679|NCT02059291|4385386|P12|Epoch 4|Adverse Event|0
1333680|NCT02059291|4385387|P11|Epoch 4|Adverse Event|0
1333681|NCT02059291|4385388|P10|Epoch 4|Adverse Event|0
1333682|NCT02059291|4385389|P9|Epoch 4|Adverse Event|0
1333683|NCT02059291|4385390|P8|Epoch 4|Adverse Event|0
1333684|NCT02059291|4385391|P7|Epoch 4|Adverse Event|0
1333685|NCT02059291|4385392|P6|Epoch 4|Adverse Event|0
1333686|NCT02059291|4385393|P5|Epoch 4|Adverse Event|0
1333687|NCT02059291|4385394|P4|Epoch 4|Adverse Event|0
1333688|NCT02059291|4385395|P3|Epoch 4|Adverse Event|0
1333689|NCT02059291|4385396|P2|Epoch 4|Adverse Event|0
1333690|NCT02059291|4385397|P1|Epoch 4|Adverse Event|0
1333691|NCT02059291|4385373|P25|Epoch 3|Withdrawal by Subject|0
1333692|NCT02059291|4385374|P24|Epoch 3|Withdrawal by Subject|0
1333693|NCT02059291|4385375|P23|Epoch 3|Withdrawal by Subject|0
1333694|NCT02059291|4385376|P22|Epoch 3|Withdrawal by Subject|0
1333695|NCT02059291|4385377|P21|Epoch 3|Withdrawal by Subject|0
1333696|NCT02059291|4385378|P20|Epoch 3|Withdrawal by Subject|0
1333697|NCT02059291|4385379|P19|Epoch 3|Withdrawal by Subject|0
1333698|NCT02059291|4385380|P18|Epoch 3|Withdrawal by Subject|0
1333699|NCT02059291|4385381|P17|Epoch 3|Withdrawal by Subject|0
1333700|NCT02059291|4385382|P16|Epoch 3|Withdrawal by Subject|1
1333701|NCT02059291|4385383|P15|Epoch 3|Withdrawal by Subject|0
1333702|NCT02059291|4385384|P14|Epoch 3|Withdrawal by Subject|0
1333703|NCT02059291|4385385|P13|Epoch 3|Withdrawal by Subject|0
1333704|NCT02059291|4385386|P12|Epoch 3|Withdrawal by Subject|0
1333705|NCT02059291|4385387|P11|Epoch 3|Withdrawal by Subject|0
1333706|NCT02059291|4385388|P10|Epoch 3|Withdrawal by Subject|0
1333707|NCT02059291|4385389|P9|Epoch 3|Withdrawal by Subject|0
1333708|NCT02059291|4385390|P8|Epoch 3|Withdrawal by Subject|0
1333709|NCT02059291|4385391|P7|Epoch 3|Withdrawal by Subject|0
1333710|NCT02059291|4385392|P6|Epoch 3|Withdrawal by Subject|0
1333711|NCT02059291|4385393|P5|Epoch 3|Withdrawal by Subject|0
1333712|NCT02059291|4385394|P4|Epoch 3|Withdrawal by Subject|0
1333713|NCT02059291|4385395|P3|Epoch 3|Withdrawal by Subject|0
1333714|NCT02059291|4385396|P2|Epoch 3|Withdrawal by Subject|0
1333715|NCT02059291|4385397|P1|Epoch 3|Withdrawal by Subject|0
1333716|NCT02059291|4385373|P25|Epoch 3|Lack of Efficacy|0
1333717|NCT02059291|4385374|P24|Epoch 3|Lack of Efficacy|0
1333718|NCT02059291|4385375|P23|Epoch 3|Lack of Efficacy|0
1333719|NCT02059291|4385376|P22|Epoch 3|Lack of Efficacy|0
1333720|NCT02059291|4385377|P21|Epoch 3|Lack of Efficacy|0
1333721|NCT02059291|4385378|P20|Epoch 3|Lack of Efficacy|0
1333722|NCT02059291|4385379|P19|Epoch 3|Lack of Efficacy|0
1333723|NCT02059291|4385380|P18|Epoch 3|Lack of Efficacy|0
1333724|NCT02059291|4385381|P17|Epoch 3|Lack of Efficacy|0
1333725|NCT02059291|4385382|P16|Epoch 3|Lack of Efficacy|3
1333726|NCT02059291|4385383|P15|Epoch 3|Lack of Efficacy|0
1333727|NCT02059291|4385384|P14|Epoch 3|Lack of Efficacy|0
1333728|NCT02059291|4385385|P13|Epoch 3|Lack of Efficacy|0
1333729|NCT02059291|4385386|P12|Epoch 3|Lack of Efficacy|0
1333730|NCT02059291|4385387|P11|Epoch 3|Lack of Efficacy|0
1333731|NCT02059291|4385388|P10|Epoch 3|Lack of Efficacy|0
1333732|NCT02059291|4385389|P9|Epoch 3|Lack of Efficacy|0
1333733|NCT02059291|4385390|P8|Epoch 3|Lack of Efficacy|0
1333734|NCT02059291|4385391|P7|Epoch 3|Lack of Efficacy|0
1333735|NCT02059291|4385392|P6|Epoch 3|Lack of Efficacy|0
1333736|NCT02059291|4385393|P5|Epoch 3|Lack of Efficacy|0
1333737|NCT02059291|4385394|P4|Epoch 3|Lack of Efficacy|0
1333738|NCT02059291|4385395|P3|Epoch 3|Lack of Efficacy|0
1333739|NCT02059291|4385396|P2|Epoch 3|Lack of Efficacy|0
1333740|NCT02059291|4385397|P1|Epoch 3|Lack of Efficacy|0
1333741|NCT02059291|4385373|P25|Epoch 3|Adverse Event|0
1333742|NCT02059291|4385374|P24|Epoch 3|Adverse Event|0
1333743|NCT02059291|4385375|P23|Epoch 3|Adverse Event|0
1333744|NCT02059291|4385376|P22|Epoch 3|Adverse Event|0
1333745|NCT02059291|4385377|P21|Epoch 3|Adverse Event|0
1333746|NCT02059291|4385378|P20|Epoch 3|Adverse Event|0
1333747|NCT02059291|4385379|P19|Epoch 3|Adverse Event|0
1333748|NCT02059291|4385380|P18|Epoch 3|Adverse Event|0
1333749|NCT02059291|4385381|P17|Epoch 3|Adverse Event|0
1333750|NCT02059291|4385382|P16|Epoch 3|Adverse Event|1
1333751|NCT02059291|4385383|P15|Epoch 3|Adverse Event|0
1333752|NCT02059291|4385384|P14|Epoch 3|Adverse Event|0
1333753|NCT02059291|4385385|P13|Epoch 3|Adverse Event|0
1333754|NCT02059291|4385386|P12|Epoch 3|Adverse Event|0
1333755|NCT02059291|4385387|P11|Epoch 3|Adverse Event|0
1333756|NCT02059291|4385388|P10|Epoch 3|Adverse Event|0
1333757|NCT02059291|4385389|P9|Epoch 3|Adverse Event|0
1333758|NCT02059291|4385390|P8|Epoch 3|Adverse Event|0
1333759|NCT02059291|4385391|P7|Epoch 3|Adverse Event|0
1333760|NCT02059291|4385392|P6|Epoch 3|Adverse Event|0
1333761|NCT02059291|4385393|P5|Epoch 3|Adverse Event|0
1333762|NCT02059291|4385394|P4|Epoch 3|Adverse Event|0
1333763|NCT02059291|4385395|P3|Epoch 3|Adverse Event|0
1333764|NCT02059291|4385396|P2|Epoch 3|Adverse Event|0
1333765|NCT02059291|4385397|P1|Epoch 3|Adverse Event|0
1333766|NCT02059291|4385373|P25|Epoch 3|Physician Decision|0
1333767|NCT02059291|4385374|P24|Epoch 3|Physician Decision|0
1333768|NCT02059291|4385375|P23|Epoch 3|Physician Decision|0
1333769|NCT02059291|4385376|P22|Epoch 3|Physician Decision|0
1333770|NCT02059291|4385377|P21|Epoch 3|Physician Decision|0
1333771|NCT02059291|4385378|P20|Epoch 3|Physician Decision|0
1333772|NCT02059291|4385379|P19|Epoch 3|Physician Decision|0
1333773|NCT02059291|4385380|P18|Epoch 3|Physician Decision|0
1333774|NCT02059291|4385381|P17|Epoch 3|Physician Decision|0
1333775|NCT02059291|4385382|P16|Epoch 3|Physician Decision|1
1333776|NCT02059291|4385383|P15|Epoch 3|Physician Decision|0
1333777|NCT02059291|4385384|P14|Epoch 3|Physician Decision|1
1333778|NCT02059291|4385385|P13|Epoch 3|Physician Decision|0
1333779|NCT02059291|4385386|P12|Epoch 3|Physician Decision|0
1333780|NCT02059291|4385387|P11|Epoch 3|Physician Decision|0
1333781|NCT02059291|4385388|P10|Epoch 3|Physician Decision|0
1333782|NCT02059291|4385389|P9|Epoch 3|Physician Decision|0
1333783|NCT02059291|4385390|P8|Epoch 3|Physician Decision|0
1333784|NCT02059291|4385391|P7|Epoch 3|Physician Decision|0
1333785|NCT02059291|4385392|P6|Epoch 3|Physician Decision|0
1333786|NCT02059291|4385393|P5|Epoch 3|Physician Decision|0
1333787|NCT02059291|4385394|P4|Epoch 3|Physician Decision|0
1333788|NCT02059291|4385395|P3|Epoch 3|Physician Decision|0
1333789|NCT02059291|4385396|P2|Epoch 3|Physician Decision|0
1333790|NCT02059291|4385397|P1|Epoch 3|Physician Decision|0
1333791|NCT02059291|4385373|P25|Epoch 2|Withdrawal by Subject|0
1333792|NCT02059291|4385374|P24|Epoch 2|Withdrawal by Subject|0
1333793|NCT02059291|4385375|P23|Epoch 2|Withdrawal by Subject|0
1333794|NCT02059291|4385376|P22|Epoch 2|Withdrawal by Subject|0
1333795|NCT02059291|4385377|P21|Epoch 2|Withdrawal by Subject|0
1333796|NCT02059291|4385378|P20|Epoch 2|Withdrawal by Subject|0
1333797|NCT02059291|4385379|P19|Epoch 2|Withdrawal by Subject|0
1333798|NCT02059291|4385380|P18|Epoch 2|Withdrawal by Subject|0
1333799|NCT02059291|4385381|P17|Epoch 2|Withdrawal by Subject|0
1333800|NCT02059291|4385382|P16|Epoch 2|Withdrawal by Subject|0
1333801|NCT02059291|4385383|P15|Epoch 2|Withdrawal by Subject|0
1333802|NCT02059291|4385384|P14|Epoch 2|Withdrawal by Subject|0
1333803|NCT02059291|4385385|P13|Epoch 2|Withdrawal by Subject|0
1333804|NCT02059291|4385386|P12|Epoch 2|Withdrawal by Subject|0
1333805|NCT02059291|4385387|P11|Epoch 2|Withdrawal by Subject|0
1333806|NCT02059291|4385388|P10|Epoch 2|Withdrawal by Subject|0
1333807|NCT02059291|4385389|P9|Epoch 2|Withdrawal by Subject|1
1333808|NCT02059291|4385390|P8|Epoch 2|Withdrawal by Subject|0
1333809|NCT02059291|4385391|P7|Epoch 2|Withdrawal by Subject|0
1333810|NCT02059291|4385392|P6|Epoch 2|Withdrawal by Subject|1
1333811|NCT02059291|4385393|P5|Epoch 2|Withdrawal by Subject|0
1333812|NCT02059291|4385394|P4|Epoch 2|Withdrawal by Subject|0
1333813|NCT02059291|4385395|P3|Epoch 2|Withdrawal by Subject|0
1333814|NCT02059291|4385396|P2|Epoch 2|Withdrawal by Subject|1
1333815|NCT02059291|4385397|P1|Epoch 2|Withdrawal by Subject|0
1333816|NCT02059291|4385373|P25|Epoch 2|Adverse Event|0
1333817|NCT02059291|4385374|P24|Epoch 2|Adverse Event|0
1333818|NCT02059291|4385375|P23|Epoch 2|Adverse Event|0
1333819|NCT02059291|4385376|P22|Epoch 2|Adverse Event|0
1333820|NCT02059291|4385377|P21|Epoch 2|Adverse Event|0
1333821|NCT02059291|4385378|P20|Epoch 2|Adverse Event|0
1333822|NCT02059291|4385379|P19|Epoch 2|Adverse Event|0
1333823|NCT02059291|4385380|P18|Epoch 2|Adverse Event|0
1333824|NCT02059291|4385381|P17|Epoch 2|Adverse Event|0
1333825|NCT02059291|4385382|P16|Epoch 2|Adverse Event|0
1333826|NCT02059291|4385383|P15|Epoch 2|Adverse Event|0
1333827|NCT02059291|4385384|P14|Epoch 2|Adverse Event|0
1333828|NCT02059291|4385385|P13|Epoch 2|Adverse Event|0
1333829|NCT02059291|4385386|P12|Epoch 2|Adverse Event|0
1333830|NCT02059291|4385387|P11|Epoch 2|Adverse Event|0
1333831|NCT02059291|4385388|P10|Epoch 2|Adverse Event|0
1333832|NCT02059291|4385389|P9|Epoch 2|Adverse Event|1
1333833|NCT02059291|4385390|P8|Epoch 2|Adverse Event|1
1333834|NCT02059291|4385391|P7|Epoch 2|Adverse Event|0
1333835|NCT02059291|4385392|P6|Epoch 2|Adverse Event|0
1333836|NCT02059291|4385393|P5|Epoch 2|Adverse Event|0
1333837|NCT02059291|4385394|P4|Epoch 2|Adverse Event|1
1333838|NCT02059291|4385395|P3|Epoch 2|Adverse Event|1
1333839|NCT02059291|4385396|P2|Epoch 2|Adverse Event|0
1333840|NCT02059291|4385397|P1|Epoch 2|Adverse Event|0
1333841|NCT02059291|4385373|P25|Epoch 2|Lack of Efficacy|0
1333842|NCT02059291|4385374|P24|Epoch 2|Lack of Efficacy|0
1333843|NCT02059291|4385375|P23|Epoch 2|Lack of Efficacy|0
1333844|NCT02059291|4385376|P22|Epoch 2|Lack of Efficacy|0
1333845|NCT02059291|4385377|P21|Epoch 2|Lack of Efficacy|0
1333846|NCT02059291|4385378|P20|Epoch 2|Lack of Efficacy|0
1333847|NCT02059291|4385379|P19|Epoch 2|Lack of Efficacy|0
1333848|NCT02059291|4385380|P18|Epoch 2|Lack of Efficacy|0
1333849|NCT02059291|4385381|P17|Epoch 2|Lack of Efficacy|0
1333850|NCT02059291|4385382|P16|Epoch 2|Lack of Efficacy|0
1333851|NCT02059291|4385383|P15|Epoch 2|Lack of Efficacy|0
1333852|NCT02059291|4385384|P14|Epoch 2|Lack of Efficacy|0
1333853|NCT02059291|4385385|P13|Epoch 2|Lack of Efficacy|0
1333854|NCT02059291|4385386|P12|Epoch 2|Lack of Efficacy|0
1333855|NCT02059291|4385387|P11|Epoch 2|Lack of Efficacy|0
1333856|NCT02059291|4385388|P10|Epoch 2|Lack of Efficacy|0
1333857|NCT02059291|4385389|P9|Epoch 2|Lack of Efficacy|0
1333858|NCT02059291|4385390|P8|Epoch 2|Lack of Efficacy|0
1333859|NCT02059291|4385391|P7|Epoch 2|Lack of Efficacy|0
1333860|NCT02059291|4385392|P6|Epoch 2|Lack of Efficacy|1
1333861|NCT02059291|4385393|P5|Epoch 2|Lack of Efficacy|0
1333862|NCT02059291|4385394|P4|Epoch 2|Lack of Efficacy|1
1333863|NCT02059291|4385395|P3|Epoch 2|Lack of Efficacy|0
1333864|NCT02059291|4385396|P2|Epoch 2|Lack of Efficacy|0
1333865|NCT02059291|4385397|P1|Epoch 2|Lack of Efficacy|0
1333866|NCT02059278|4385451|P2|Overall Study|Ran out of IP and decided to discontinue|0
1333867|NCT02059278|4385452|P1|Overall Study|Ran out of IP and decided to discontinue|1
1333868|NCT02059278|4385451|P2|Overall Study|Withdrawal by Subject|3
1333869|NCT02059278|4385452|P1|Overall Study|Withdrawal by Subject|0
1333870|NCT02059278|4385451|P2|Overall Study|Lost to Follow-up|0
1333871|NCT02059278|4385452|P1|Overall Study|Lost to Follow-up|1
1333872|NCT02059278|4385451|P2|Overall Study|Adverse Event|1
1333873|NCT02059278|4385452|P1|Overall Study|Adverse Event|1
1333874|NCT02059187|4385468|P2|Overall Study|Withdrawal by Subject|8
1333875|NCT02059187|4385469|P1|Overall Study|Withdrawal by Subject|12
1333876|NCT02059187|4385468|P2|Overall Study|Protocol Violation|0
1333877|NCT02059187|4385469|P1|Overall Study|Protocol Violation|1
1333878|NCT02059187|4385468|P2|Overall Study|Physician Decision|2
1333879|NCT02059187|4385469|P1|Overall Study|Physician Decision|1
1333880|NCT02059187|4385468|P2|Overall Study|Non-compliance with study drug|0
1333881|NCT02059187|4385469|P1|Overall Study|Non-compliance with study drug|1
1333882|NCT02059187|4385468|P2|Overall Study|Lost to Follow-up|8
1333883|NCT02059187|4385469|P1|Overall Study|Lost to Follow-up|9
1333884|NCT02059187|4385468|P2|Overall Study|Death|1
1333885|NCT02059187|4385469|P1|Overall Study|Death|1
1333886|NCT02059187|4385468|P2|Overall Study|Adverse Event|3
1333887|NCT02059187|4385469|P1|Overall Study|Adverse Event|0
1333888|NCT02059174|4385495|P2|Period 3|Physician Decision|0
1333889|NCT02059174|4385496|P1|Period 3|Physician Decision|1
1333890|NCT02059174|4385495|P2|Period 2|Protocol Violation|0
1333891|NCT02059174|4385496|P1|Period 2|Protocol Violation|1
1333892|NCT02059174|4385495|P2|Period 2|Withdrawal by Subject|2
1333893|NCT02059174|4385496|P1|Period 2|Withdrawal by Subject|0
1333894|NCT02059174|4385495|P2|Period 1|Withdrawal by Subject|2
1333895|NCT02059174|4385496|P1|Period 1|Withdrawal by Subject|0
1333896|NCT02059161|4385520|P2|Overall Study|Non-compliance with study drug|2
1333897|NCT02059161|4385521|P1|Overall Study|Non-compliance with study drug|6
1333898|NCT02059161|4385520|P2|Overall Study|Randomized in error, no study drug|1
1333899|NCT02059161|4385521|P1|Overall Study|Randomized in error, no study drug|0
1333900|NCT02059161|4385520|P2|Overall Study|Withdrawal by Subject|13
1333901|NCT02059161|4385521|P1|Overall Study|Withdrawal by Subject|16
1333902|NCT02059161|4385520|P2|Overall Study|Protocol Violation|1
1333903|NCT02059161|4385521|P1|Overall Study|Protocol Violation|1
1333904|NCT02059161|4385520|P2|Overall Study|Physician Decision|4
1333905|NCT02059161|4385521|P1|Overall Study|Physician Decision|4
1333906|NCT02059161|4385520|P2|Overall Study|Lost to Follow-up|12
1333907|NCT02059161|4385521|P1|Overall Study|Lost to Follow-up|20
1333908|NCT02059161|4385520|P2|Overall Study|Adverse Event|6
1333909|NCT02059161|4385521|P1|Overall Study|Adverse Event|2
1333910|NCT02059161|4385520|P2|Overall Study|Pregnancy|2
1333911|NCT02059161|4385521|P1|Overall Study|Pregnancy|0
1333912|NCT02059148|4385581|P6|Treatment 1|Protocol Violation|1
1333913|NCT02059148|4385582|P5|Treatment 1|Protocol Violation|0
1333914|NCT02059148|4385583|P4|Treatment 1|Protocol Violation|0
1333915|NCT02059148|4385584|P3|Treatment 1|Protocol Violation|0
1333916|NCT02059148|4385585|P2|Treatment 1|Protocol Violation|0
1333917|NCT02059148|4385586|P1|Treatment 1|Protocol Violation|0
1333918|NCT02059135|4385605|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
1333919|NCT02059135|4385606|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
1333920|NCT02059135|4385605|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
1333921|NCT02059135|4385606|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
1333922|NCT02059135|4385605|P2|Neonatal Follow-up (Safety Population)|Death|2
1333923|NCT02059135|4385606|P1|Neonatal Follow-up (Safety Population)|Death|3
1333924|NCT02059135|4385605|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
1333925|NCT02059135|4385606|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
1333926|NCT02059135|4385605|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
1333927|NCT02059135|4385606|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
1333928|NCT02059135|4385605|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
1333929|NCT02059135|4385606|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
1333930|NCT02059135|4385605|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
1333931|NCT02059135|4385606|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
1333932|NCT02059135|4385605|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
1333933|NCT02059135|4385606|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
1333934|NCT02059005|4385635|P2|Overall Study|Inpatient|1
1333935|NCT02059005|4385636|P1|Overall Study|Inpatient|0
1333936|NCT02059005|4385635|P2|Overall Study|Incarceration|1
1333937|NCT02059005|4385636|P1|Overall Study|Incarceration|0
1333938|NCT02059005|4385635|P2|Overall Study|Lost to Follow-up|19
1333939|NCT02059005|4385636|P1|Overall Study|Lost to Follow-up|19
1333940|NCT02059005|4385635|P2|Overall Study|Death|3
1333941|NCT02059005|4385636|P1|Overall Study|Death|1
1333942|NCT02058992|4385646|P1|Overall Study|CRF Uncollected|20
1333943|NCT02058992|4385646|P1|Overall Study|Protocol Violation|92
1333944|NCT02058992|4385646|P1|Overall Study|Lost to Follow-up|4
1333945|NCT02058940|4385655|P1|Overall Study|Discharged from Critical Care Unit|1
1333946|NCT02058836|4385679|P2|Overall Study|Withdrawal by Subject|1
1333947|NCT02058836|4385680|P1|Overall Study|Withdrawal by Subject|1
1333948|NCT02058628|4385710|P2|Overall Study|Non compliance|0
1333949|NCT02058628|4385711|P1|Overall Study|Non compliance|1
1333950|NCT02058628|4385710|P2|Overall Study|A lot of time for study for participant|0
1333951|NCT02058628|4385711|P1|Overall Study|A lot of time for study for participant|1
1333952|NCT02058628|4385710|P2|Overall Study|The visit date was not in timeline|1
1333953|NCT02058628|4385711|P1|Overall Study|The visit date was not in timeline|0
1333954|NCT02058628|4385710|P2|Overall Study|Not in time schedule|1
1333955|NCT02058628|4385711|P1|Overall Study|Not in time schedule|0
1333956|NCT02058628|4385710|P2|Overall Study|Lost to Follow-up|4
1333957|NCT02058628|4385711|P1|Overall Study|Lost to Follow-up|2
1333958|NCT02058628|4385710|P2|Overall Study|Withdrawal by Subject|2
1333959|NCT02058628|4385711|P1|Overall Study|Withdrawal by Subject|2
1333960|NCT02058628|4385710|P2|Overall Study|Adverse Event|0
1333961|NCT02058628|4385711|P1|Overall Study|Adverse Event|1
1333962|NCT02058589|4385743|P2|Overall Study|Withdrawal by Subject|1
1333963|NCT02058589|4385744|P1|Overall Study|Withdrawal by Subject|0
1333964|NCT02058589|4385743|P2|Overall Study|Non-Serious Adverse Event|0
1333965|NCT02058589|4385744|P1|Overall Study|Non-Serious Adverse Event|1
1333966|NCT02058589|4385743|P2|Overall Study|Serious Adverse Event|1
1333967|NCT02058589|4385744|P1|Overall Study|Serious Adverse Event|1
1333968|NCT02058563|4385786|P2|Overall Study|Other (patient incarcerated)|1
1333969|NCT02058563|4385787|P1|Overall Study|Other (patient incarcerated)|0
1333970|NCT02058563|4385786|P2|Overall Study|Consent Withdrawal|1
1333971|NCT02058563|4385787|P1|Overall Study|Consent Withdrawal|1
1333972|NCT02058563|4385786|P2|Overall Study|Other (vaccinated later as new subject)|0
1333973|NCT02058563|4385787|P1|Overall Study|Other (vaccinated later as new subject)|1
1333974|NCT02058563|4385786|P2|Overall Study|Lost to Follow-up|22
1333975|NCT02058563|4385787|P1|Overall Study|Lost to Follow-up|26
1333976|NCT02058537|4385823|P1|Overall Study|Withdrawal by Subject|1
1333977|NCT02058498|4385829|P1|Overall Study|Withdrawal by Subject|4
1333978|NCT02058290|4385837|P2|Overall Study|Withdrawal by Subject|1
1333979|NCT02058290|4385838|P1|Overall Study|Withdrawal by Subject|0
1333980|NCT02058290|4385837|P2|Overall Study|Didn't meet intraoperative criteria|7
1333981|NCT02058290|4385838|P1|Overall Study|Didn't meet intraoperative criteria|8
1333982|NCT02058290|4385837|P2|Overall Study|Physician Decision|0
1333983|NCT02058290|4385838|P1|Overall Study|Physician Decision|1
1333984|NCT02058290|4385837|P2|Overall Study|Protocol Violation|1
1333985|NCT02058290|4385838|P1|Overall Study|Protocol Violation|2
1333986|NCT02058160|4385854|P2|Overall Study|Other than specified above|6
1333987|NCT02058160|4385855|P1|Overall Study|Other than specified above|12
1333988|NCT02058160|4385854|P2|Overall Study|Lost to Follow-up|0
1333989|NCT02058160|4385855|P1|Overall Study|Lost to Follow-up|1
1333990|NCT02058160|4385854|P2|Overall Study|Adverse Event|3
1333991|NCT02058160|4385855|P1|Overall Study|Adverse Event|12
1333992|NCT02058160|4385854|P2|Overall Study|Poor compliance to protocol|1
1333993|NCT02058160|4385855|P1|Overall Study|Poor compliance to protocol|4
1333994|NCT02058160|4385854|P2|Overall Study|Randomized but not treated|4
1333995|NCT02058160|4385855|P1|Overall Study|Randomized but not treated|2
1333996|NCT02058147|4385892|P3|Overall Study|Other than specified|0
1333997|NCT02058147|4385893|P2|Overall Study|Other than specified|9
1333998|NCT02058147|4385894|P1|Overall Study|Other than specified|8
1333999|NCT02058147|4385892|P3|Overall Study|Poor compliance to protocol|4
1334000|NCT02058147|4385893|P2|Overall Study|Poor compliance to protocol|9
1334001|NCT02058147|4385894|P1|Overall Study|Poor compliance to protocol|8
1334002|NCT02058147|4385892|P3|Overall Study|Lack of Efficacy|3
1334003|NCT02058147|4385893|P2|Overall Study|Lack of Efficacy|0
1334004|NCT02058147|4385894|P1|Overall Study|Lack of Efficacy|1
1334005|NCT02058147|4385892|P3|Overall Study|Adverse Event|21
1334006|NCT02058147|4385893|P2|Overall Study|Adverse Event|9
1334007|NCT02058147|4385894|P1|Overall Study|Adverse Event|12
1334008|NCT02058147|4385892|P3|Overall Study|Randomized but not treated|1
1334009|NCT02058147|4385893|P2|Overall Study|Randomized but not treated|0
1334010|NCT02058147|4385894|P1|Overall Study|Randomized but not treated|0
1334011|NCT02058069|4385943|P1|Overall Study|Withdrawal by Subject|6
1334012|NCT02058069|4385943|P1|Overall Study|Exclusion due to implant size|5
1334013|NCT02057874|4385992|P1|Overall Study|participant did not return for scan|1
1334014|NCT02057835|4386010|P10|Overall Study|Withdrawal by Subject|0
1334015|NCT02057835|4386011|P9|Overall Study|Withdrawal by Subject|0
1334016|NCT02057835|4386012|P8|Overall Study|Withdrawal by Subject|0
1334017|NCT02057835|4386013|P7|Overall Study|Withdrawal by Subject|0
1334018|NCT02057835|4386014|P6|Overall Study|Withdrawal by Subject|0
1334019|NCT02057835|4386015|P5|Overall Study|Withdrawal by Subject|0
1334020|NCT02057835|4386016|P4|Overall Study|Withdrawal by Subject|0
1334021|NCT02057835|4386017|P3|Overall Study|Withdrawal by Subject|0
1334022|NCT02057835|4386018|P2|Overall Study|Withdrawal by Subject|2
1334023|NCT02057835|4386019|P1|Overall Study|Withdrawal by Subject|0
1334024|NCT02057757|4386098|P2|Overall Study|Non-compliance|0
1334025|NCT02057757|4386099|P1|Overall Study|Non-compliance|1
1334026|NCT02057757|4386098|P2|Overall Study|Lost to Follow-up|3
1334027|NCT02057757|4386099|P1|Overall Study|Lost to Follow-up|8
1334028|NCT02057757|4386098|P2|Overall Study|Death|0
1334029|NCT02057757|4386099|P1|Overall Study|Death|2
1334030|NCT02057757|4386098|P2|Overall Study|Withdrawal by Subject|5
1334031|NCT02057757|4386099|P1|Overall Study|Withdrawal by Subject|3
1334032|NCT02057692|4386153|P4|Overall Study|Lost to Follow-up|1
1334033|NCT02057692|4386154|P3|Overall Study|Lost to Follow-up|0
1334034|NCT02057692|4386155|P2|Overall Study|Lost to Follow-up|0
1334035|NCT02057692|4386156|P1|Overall Study|Lost to Follow-up|0
1334036|NCT02057692|4386153|P4|Overall Study|Adverse Event|0
1334037|NCT02057692|4386154|P3|Overall Study|Adverse Event|0
1334038|NCT02057692|4386155|P2|Overall Study|Adverse Event|0
1334039|NCT02057692|4386156|P1|Overall Study|Adverse Event|1
1334040|NCT02057549|4386182|P2|Overall Study|Withdrawal by Subject|0
1334041|NCT02057549|4386183|P1|Overall Study|Withdrawal by Subject|1
1334042|NCT02057549|4386182|P2|Overall Study|Physician Decision|0
1334043|NCT02057549|4386183|P1|Overall Study|Physician Decision|1
1334044|NCT02057549|4386182|P2|Overall Study|Lost to Follow-up|0
1334045|NCT02057549|4386183|P1|Overall Study|Lost to Follow-up|1
1334046|NCT02057406|4386206|P3|Overall Study|Patient transportation issues|1
1334047|NCT02057406|4386207|P2|Overall Study|Patient transportation issues|0
1334048|NCT02057406|4386208|P1|Overall Study|Patient transportation issues|0
1334049|NCT02057406|4386206|P3|Overall Study|Protocol Violation|0
1334050|NCT02057406|4386207|P2|Overall Study|Protocol Violation|1
1334051|NCT02057406|4386208|P1|Overall Study|Protocol Violation|0
1334052|NCT02057406|4386206|P3|Overall Study|Death|0
1334053|NCT02057406|4386207|P2|Overall Study|Death|0
1334054|NCT02057406|4386208|P1|Overall Study|Death|1
1334055|NCT02057406|4386206|P3|Overall Study|Lost to Follow-up|1
1334056|NCT02057406|4386207|P2|Overall Study|Lost to Follow-up|0
1334057|NCT02057406|4386208|P1|Overall Study|Lost to Follow-up|0
1334058|NCT02057406|4386206|P3|Overall Study|Withdrawal by Subject|0
1334059|NCT02057406|4386207|P2|Overall Study|Withdrawal by Subject|2
1334060|NCT02057406|4386208|P1|Overall Study|Withdrawal by Subject|0
1334061|NCT02057406|4386206|P3|Overall Study|Physician Decision|2
1334062|NCT02057406|4386207|P2|Overall Study|Physician Decision|0
1334063|NCT02057406|4386208|P1|Overall Study|Physician Decision|0
1334064|NCT02057393|4386219|P1|Overall Study|Patient did not meet criteria|1
1334065|NCT02057393|4386219|P1|Overall Study|Withdrawal by Subject|1
1334066|NCT02057250|4386240|P5|Extension Phase|Other than specified above|7
1334067|NCT02057250|4386241|P4|Extension Phase|Other than specified above|0
1334068|NCT02057250|4386242|P3|Extension Phase|Other than specified above|0
1334069|NCT02057250|4386243|P2|Extension Phase|Other than specified above|0
1334070|NCT02057250|4386244|P1|Extension Phase|Other than specified above|0
1334071|NCT02057250|4386240|P5|Extension Phase|Entered in this period but not treated|4
1334072|NCT02057250|4386241|P4|Extension Phase|Entered in this period but not treated|0
1334073|NCT02057250|4386242|P3|Extension Phase|Entered in this period but not treated|0
1334074|NCT02057250|4386243|P2|Extension Phase|Entered in this period but not treated|0
1334075|NCT02057250|4386244|P1|Extension Phase|Entered in this period but not treated|0
1334076|NCT02057250|4386240|P5|Extension Phase|Lack of Efficacy|10
1334077|NCT02057250|4386241|P4|Extension Phase|Lack of Efficacy|0
1334078|NCT02057250|4386242|P3|Extension Phase|Lack of Efficacy|0
1334079|NCT02057250|4386243|P2|Extension Phase|Lack of Efficacy|0
1334080|NCT02057250|4386244|P1|Extension Phase|Lack of Efficacy|0
1334081|NCT02057250|4386240|P5|Extension Phase|Adverse Event|15
1334082|NCT02057250|4386241|P4|Extension Phase|Adverse Event|0
1334083|NCT02057250|4386242|P3|Extension Phase|Adverse Event|0
1334084|NCT02057250|4386243|P2|Extension Phase|Adverse Event|0
1334085|NCT02057250|4386244|P1|Extension Phase|Adverse Event|0
1334086|NCT02057250|4386240|P5|AID Assessment Phase|Other than specified above|0
1334087|NCT02057250|4386241|P4|AID Assessment Phase|Other than specified above|1
1334088|NCT02057250|4386242|P3|AID Assessment Phase|Other than specified above|1
1334089|NCT02057250|4386243|P2|AID Assessment Phase|Other than specified above|1
1334090|NCT02057250|4386244|P1|AID Assessment Phase|Other than specified above|1
1334091|NCT02057250|4386240|P5|AID Assessment Phase|Adverse Event|0
1334092|NCT02057250|4386241|P4|AID Assessment Phase|Adverse Event|1
1334093|NCT02057250|4386242|P3|AID Assessment Phase|Adverse Event|6
1334094|NCT02057250|4386243|P2|AID Assessment Phase|Adverse Event|2
1334095|NCT02057250|4386244|P1|AID Assessment Phase|Adverse Event|3
1334096|NCT02057068|4386264|P2|Overall Study|Lost to Follow-up|2
1334097|NCT02057068|4386265|P1|Overall Study|Lost to Follow-up|2
1334098|NCT02057068|4386264|P2|Overall Study|Carepartner (CP) Health|2
1334099|NCT02057068|4386265|P1|Overall Study|Carepartner (CP) Health|4
1334100|NCT02057068|4386264|P2|Overall Study|Caregiver (CG) Health|2
1334101|NCT02057068|4386265|P1|Overall Study|Caregiver (CG) Health|0
1334102|NCT02057068|4386264|P2|Overall Study|Withdrawal by Subject|2
1334103|NCT02057068|4386265|P1|Overall Study|Withdrawal by Subject|2
1334104|NCT02056834|4386275|P1|Overall Study|Lost to Follow-up|7
1334105|NCT02056652|4386296|P2|Overall Study|Lost to Follow-up|3
1334106|NCT02056652|4386297|P1|Overall Study|Lost to Follow-up|0
1334107|NCT02056652|4386296|P2|Overall Study|Withdrawal by Subject|0
1334108|NCT02056652|4386297|P1|Overall Study|Withdrawal by Subject|1
1334109|NCT02056392|4386347|P6|Overall Study|Withdrawal by Subject|0
1334110|NCT02056392|4386348|P5|Overall Study|Withdrawal by Subject|1
1334111|NCT02056392|4386349|P4|Overall Study|Withdrawal by Subject|0
1334112|NCT02056392|4386350|P3|Overall Study|Withdrawal by Subject|0
1334113|NCT02056392|4386351|P2|Overall Study|Withdrawal by Subject|0
1334114|NCT02056392|4386352|P1|Overall Study|Withdrawal by Subject|1
1334115|NCT02056392|4386347|P6|Overall Study|Protocol Violation|0
1334116|NCT02056392|4386348|P5|Overall Study|Protocol Violation|0
1334117|NCT02056392|4386349|P4|Overall Study|Protocol Violation|0
1334118|NCT02056392|4386350|P3|Overall Study|Protocol Violation|1
1334119|NCT02056392|4386351|P2|Overall Study|Protocol Violation|0
1334120|NCT02056392|4386352|P1|Overall Study|Protocol Violation|1
1334121|NCT02056392|4386347|P6|Overall Study|Lost to Follow-up|0
1334122|NCT02056392|4386348|P5|Overall Study|Lost to Follow-up|0
1334123|NCT02056392|4386349|P4|Overall Study|Lost to Follow-up|0
1334124|NCT02056392|4386350|P3|Overall Study|Lost to Follow-up|2
1334125|NCT02056392|4386351|P2|Overall Study|Lost to Follow-up|1
1334126|NCT02056392|4386352|P1|Overall Study|Lost to Follow-up|0
1334127|NCT02055365|4386422|P1|Overall Study|Prematurely Withdrawn|1
1334128|NCT02055352|4386435|P2|Overall Study|Reason unknown|5
1334129|NCT02055352|4386436|P1|Overall Study|Reason unknown|1
1334130|NCT02055352|4386435|P2|Overall Study|Withdrawal of informed consent|0
1334131|NCT02055352|4386436|P1|Overall Study|Withdrawal of informed consent|1
1334132|NCT02055352|4386435|P2|Overall Study|AE, study drug would be detrimental|3
1334133|NCT02055352|4386436|P1|Overall Study|AE, study drug would be detrimental|1
1334134|NCT02055352|4386435|P2|Overall Study|Use of prohibited treatment|3
1334135|NCT02055352|4386436|P1|Overall Study|Use of prohibited treatment|0
1334136|NCT02055352|4386435|P2|Overall Study|Patient decision|1
1334137|NCT02055352|4386436|P1|Overall Study|Patient decision|1
1334138|NCT02055352|4386435|P2|Overall Study|Death|2
1334139|NCT02055352|4386436|P1|Overall Study|Death|1
1334140|NCT02055352|4386435|P2|Overall Study|Poor compliance|1
1334141|NCT02055352|4386436|P1|Overall Study|Poor compliance|1
1334142|NCT02055352|4386435|P2|Overall Study|Non-eligible|1
1334143|NCT02055352|4386436|P1|Overall Study|Non-eligible|0
1334144|NCT02055352|4386435|P2|Overall Study|Adverse Event|1
1334145|NCT02055352|4386436|P1|Overall Study|Adverse Event|0
1334146|NCT02054910|4386452|P2|Overall Study|Lost to Follow-up|1
1334147|NCT02054910|4386453|P1|Overall Study|Lost to Follow-up|4
1334148|NCT02054897|4386472|P3|Overall Study|Randomized but not exposed|0
1334149|NCT02054897|4386473|P2|Overall Study|Randomized but not exposed|0
1334150|NCT02054897|4386474|P1|Overall Study|Randomized but not exposed|1
1334151|NCT02054897|4386472|P3|Overall Study|Lost to Follow-up|7
1334152|NCT02054897|4386473|P2|Overall Study|Lost to Follow-up|2
1334153|NCT02054897|4386474|P1|Overall Study|Lost to Follow-up|4
1334154|NCT02054897|4386472|P3|Overall Study|Missing follow-up information|3
1334155|NCT02054897|4386473|P2|Overall Study|Missing follow-up information|5
1334156|NCT02054897|4386474|P1|Overall Study|Missing follow-up information|3
1334157|NCT02054897|4386472|P3|Overall Study|Withdrawal by Subject|2
1334158|NCT02054897|4386473|P2|Overall Study|Withdrawal by Subject|0
1334159|NCT02054897|4386474|P1|Overall Study|Withdrawal by Subject|2
1334160|NCT02054715|4386521|P2|Follow-up 2|Treatment Change or Delay|0
1334161|NCT02054715|4386522|P1|Follow-up 2|Treatment Change or Delay|1
1334162|NCT02054715|4386521|P2|Follow-up 2|No Reason|0
1334163|NCT02054715|4386522|P1|Follow-up 2|No Reason|2
1334164|NCT02054715|4386521|P2|Follow-up 2|Changed Mind|1
1334165|NCT02054715|4386522|P1|Follow-up 2|Changed Mind|0
1334166|NCT02054715|4386521|P2|Follow-up 2|Changed MD/Facility|1
1334167|NCT02054715|4386522|P1|Follow-up 2|Changed MD/Facility|0
1334168|NCT02054715|4386521|P2|Follow-up 2|Hospitalization|2
1334169|NCT02054715|4386522|P1|Follow-up 2|Hospitalization|0
1334170|NCT02054715|4386521|P2|Follow-up 2|Death|3
1334171|NCT02054715|4386522|P1|Follow-up 2|Death|3
1334172|NCT02054715|4386521|P2|Follow-up 2|Ineligible|5
1334173|NCT02054715|4386522|P1|Follow-up 2|Ineligible|4
1334174|NCT02054715|4386521|P2|Follow-up 2|Followup Not Completed|4
1334175|NCT02054715|4386522|P1|Follow-up 2|Followup Not Completed|3
1334176|NCT02054715|4386521|P2|Follow-up 2|Refused|2
1334177|NCT02054715|4386522|P1|Follow-up 2|Refused|3
1334178|NCT02054715|4386521|P2|Follow-up 2|Lost to Followup|1
1334179|NCT02054715|4386522|P1|Follow-up 2|Lost to Followup|3
1334180|NCT02054715|4386521|P2|Baseline/Follow-up 1|Changed Mind|0
1334181|NCT02054715|4386522|P1|Baseline/Follow-up 1|Changed Mind|1
1334182|NCT02054715|4386521|P2|Baseline/Follow-up 1|Hospitalization|0
1334183|NCT02054715|4386522|P1|Baseline/Follow-up 1|Hospitalization|1
1334184|NCT02054715|4386521|P2|Baseline/Follow-up 1|Ineligible|0
1334185|NCT02054715|4386522|P1|Baseline/Follow-up 1|Ineligible|3
1334186|NCT02054715|4386521|P2|Baseline/Follow-up 1|Overwhelmed|0
1334187|NCT02054715|4386522|P1|Baseline/Follow-up 1|Overwhelmed|2
1334188|NCT02054715|4386521|P2|Baseline/Follow-up 1|No Reason|1
1334189|NCT02054715|4386522|P1|Baseline/Follow-up 1|No Reason|0
1334190|NCT02054715|4386521|P2|Baseline/Follow-up 1|Disliked Procedure|1
1334191|NCT02054715|4386522|P1|Baseline/Follow-up 1|Disliked Procedure|0
1334192|NCT02054715|4386521|P2|Baseline/Follow-up 1|Changed MD/Facility|1
1334193|NCT02054715|4386522|P1|Baseline/Follow-up 1|Changed MD/Facility|0
1334194|NCT02054715|4386521|P2|Baseline/Follow-up 1|Medical|1
1334195|NCT02054715|4386522|P1|Baseline/Follow-up 1|Medical|0
1334196|NCT02054715|4386521|P2|Baseline/Follow-up 1|Refused|3
1334197|NCT02054715|4386522|P1|Baseline/Follow-up 1|Refused|1
1334198|NCT02054702|4386536|P2|Overall Study|Withdrawal by Subject|4
1334199|NCT02054702|4386537|P1|Overall Study|Withdrawal by Subject|14
1334200|NCT02054702|4386536|P2|Overall Study|Physician Decision|1
1334201|NCT02054702|4386537|P1|Overall Study|Physician Decision|0
1334202|NCT02054702|4386536|P2|Overall Study|Met Withdrawal Criteria|1
1334203|NCT02054702|4386537|P1|Overall Study|Met Withdrawal Criteria|4
1334204|NCT02054702|4386536|P2|Overall Study|Adverse Event|1
1334205|NCT02054702|4386537|P1|Overall Study|Adverse Event|3
1334206|NCT02054702|4386536|P2|Overall Study|Lost to Follow-up|5
1334207|NCT02054702|4386537|P1|Overall Study|Lost to Follow-up|3
1334208|NCT02054481|4386592|P4|Overall Study|Other reason|0
1334209|NCT02054481|4386593|P3|Overall Study|Other reason|2
1334210|NCT02054481|4386594|P2|Overall Study|Other reason|1
1334211|NCT02054481|4386595|P1|Overall Study|Other reason|2
1334212|NCT02054481|4386592|P4|Overall Study|Lost to Follow-up|0
1334213|NCT02054481|4386593|P3|Overall Study|Lost to Follow-up|0
1334214|NCT02054481|4386594|P2|Overall Study|Lost to Follow-up|0
1334215|NCT02054481|4386595|P1|Overall Study|Lost to Follow-up|1
1334216|NCT02054481|4386592|P4|Overall Study|Adverse Event|1
1334217|NCT02054481|4386593|P3|Overall Study|Adverse Event|0
1334218|NCT02054481|4386594|P2|Overall Study|Adverse Event|1
1334219|NCT02054481|4386595|P1|Overall Study|Adverse Event|1
1334220|NCT02054325|4386643|P2|Overall Study|Lost to Follow-up|5
1334221|NCT02054325|4386644|P1|Overall Study|Lost to Follow-up|8
1334222|NCT02053753|4386654|P2|Overall Study|Lost to Follow-up|3
1334223|NCT02053753|4386655|P1|Overall Study|Lost to Follow-up|4
1334224|NCT02053753|4386654|P2|Overall Study|Decision by Sponsor|1
1334225|NCT02053753|4386655|P1|Overall Study|Decision by Sponsor|1
1334226|NCT02053753|4386654|P2|Overall Study|Withdrawal by Subject|4
1334227|NCT02053753|4386655|P1|Overall Study|Withdrawal by Subject|2
1334228|NCT02053610|4386679|P2|Overall Study|Failure to Return|3
1334229|NCT02053610|4386680|P1|Overall Study|Failure to Return|4
1334230|NCT02053610|4386679|P2|Overall Study|Did not Receive Treatment|2
1334231|NCT02053610|4386680|P1|Overall Study|Did not Receive Treatment|0
1334232|NCT02053610|4386679|P2|Overall Study|Refused treatment/Did not cooperate|0
1334233|NCT02053610|4386680|P1|Overall Study|Refused treatment/Did not cooperate|3
1334234|NCT02053610|4386679|P2|Overall Study|Disease Progression|94
1334235|NCT02053610|4386680|P1|Overall Study|Disease Progression|148
1334236|NCT02053610|4386679|P2|Overall Study|Administrative/Other|27
1334237|NCT02053610|4386680|P1|Overall Study|Administrative/Other|34
1334238|NCT02053610|4386679|P2|Overall Study|Death|25
1334239|NCT02053610|4386680|P1|Overall Study|Death|31
1334240|NCT02053610|4386679|P2|Overall Study|Withdrew Consent|14
1334241|NCT02053610|4386680|P1|Overall Study|Withdrew Consent|12
1334242|NCT02053610|4386679|P2|Overall Study|Adverse Event/Intercurrent Illness|9
1334243|NCT02053610|4386680|P1|Overall Study|Adverse Event/Intercurrent Illness|3
1334244|NCT02053493|4386712|P2|Overall Study|Withdrawal by Subject|1
1334245|NCT02053493|4386713|P1|Overall Study|Withdrawal by Subject|1
1334246|NCT02053168|4386751|P1|Overall Study|Lost to Follow-up|1
1334247|NCT02053168|4386751|P1|Overall Study|Physician Decision|1
1334248|NCT02053168|4386751|P1|Overall Study|Withdrawal by Subject|1
1334249|NCT02052596|4386830|P2|Safety Phase|Lost due to Crohn`s disease|1
1334250|NCT02052596|4386831|P1|Safety Phase|Lost due to Crohn`s disease|0
1334251|NCT02052596|4386830|P2|Safety Phase|Enrolled in error|0
1334252|NCT02052596|4386831|P1|Safety Phase|Enrolled in error|1
1334253|NCT02052596|4386830|P2|Safety Phase|Withdrawal by Subject|11
1334254|NCT02052596|4386831|P1|Safety Phase|Withdrawal by Subject|8
1334255|NCT02052596|4386830|P2|Safety Phase|Protocol Violation|2
1334256|NCT02052596|4386831|P1|Safety Phase|Protocol Violation|1
1334257|NCT02052596|4386830|P2|Safety Phase|Lost to Follow-up|18
1334258|NCT02052596|4386831|P1|Safety Phase|Lost to Follow-up|11
1334259|NCT02052596|4386830|P2|Safety Phase|Adverse Event|3
1334260|NCT02052596|4386831|P1|Safety Phase|Adverse Event|6
1334261|NCT02052596|4386830|P2|Active Phase|Lost due to Crohn`s disease|1
1334262|NCT02052596|4386831|P1|Active Phase|Lost due to Crohn`s disease|0
1334263|NCT02052596|4386830|P2|Active Phase|Enrolled in error|0
1334264|NCT02052596|4386831|P1|Active Phase|Enrolled in error|1
1334265|NCT02052596|4386830|P2|Active Phase|Withdrawal by Subject|4
1334266|NCT02052596|4386831|P1|Active Phase|Withdrawal by Subject|3
1334267|NCT02052596|4386830|P2|Active Phase|Protocol Violation|2
1334268|NCT02052596|4386831|P1|Active Phase|Protocol Violation|1
1334269|NCT02052596|4386830|P2|Active Phase|Lost to Follow-up|11
1334270|NCT02052596|4386831|P1|Active Phase|Lost to Follow-up|8
1334271|NCT02052596|4386830|P2|Active Phase|Adverse Event|2
1334272|NCT02052596|4386831|P1|Active Phase|Adverse Event|3
1334273|NCT02052466|4386861|P1|Overall Study|Acromial fracture|1
1334274|NCT02052466|4386861|P1|Overall Study|Withdrawal by Subject|1
1334275|NCT02052440|4386878|P2|Overall Study|Withdrawal by Subject|1
1334276|NCT02052440|4386879|P1|Overall Study|Withdrawal by Subject|0
1334277|NCT02052414|4386891|P1|Overall Study|Withdrawal by Subject|3
1334278|NCT02052414|4386891|P1|Overall Study|Lack of Efficacy|2
1334279|NCT02052414|4386891|P1|Overall Study|Adverse Event|12
1334280|NCT02052011|4386926|P2|Overall Study|Withdrawal by Subject|2
1334281|NCT02052011|4386927|P1|Overall Study|Withdrawal by Subject|1
1334282|NCT02052011|4386926|P2|Overall Study|Lost to Follow-up|0
1334283|NCT02052011|4386927|P1|Overall Study|Lost to Follow-up|3
1334284|NCT02051296|4387069|P2|Overall Study|withdraw prior to treatment|7
1334285|NCT02051296|4387070|P1|Overall Study|withdraw prior to treatment|7
1334286|NCT02051296|4387069|P2|Overall Study|Lost to Follow-up|2
1334287|NCT02051296|4387070|P1|Overall Study|Lost to Follow-up|1
1334288|NCT02050321|4387087|P1|Overall Study|Adverse Event|1
1334289|NCT02050321|4387087|P1|Overall Study|Withdrawal by Subject|1
1334290|NCT02050048|4387094|P2|Overall Study|Ineligible after ERCP|1
1334291|NCT02050048|4387095|P1|Overall Study|Ineligible after ERCP|4
1334292|NCT02050048|4387094|P2|Overall Study|Death|0
1334293|NCT02050048|4387095|P1|Overall Study|Death|1
1334294|NCT02050048|4387094|P2|Overall Study|Lost to Follow-up|1
1334295|NCT02050048|4387095|P1|Overall Study|Lost to Follow-up|0
1334296|NCT02049450|4387126|P1|Overall Study|Patients/guardian decision|1
1334297|NCT02049450|4387126|P1|Overall Study|Withdrawal by Subject|1
1334298|NCT02049450|4387126|P1|Overall Study|Adverse Event|2
1334299|NCT02048904|4387164|P1|Overall Study|Physician Decision|70
1334300|NCT02048904|4387164|P1|Overall Study|Withdrawal by Subject|7
1334301|NCT02048241|4387179|P2|Overall Study|Withdrawal by Subject|1
1334302|NCT02048241|4387180|P1|Overall Study|Withdrawal by Subject|0
1334303|NCT02048072|4387186|P1|Overall Study|Lost to Follow-up|1
1334304|NCT02048072|4387186|P1|Overall Study|Adverse Event|3
1334305|NCT02047227|4387201|P2|Overall Study|Other|9
1334306|NCT02047227|4387202|P1|Overall Study|Other|10
1334307|NCT02047227|4387201|P2|Overall Study|All embryos discarded|11
1334308|NCT02047227|4387202|P1|Overall Study|All embryos discarded|12
1334309|NCT02047227|4387201|P2|Overall Study|Intention to freeze all embryos|0
1334310|NCT02047227|4387202|P1|Overall Study|Intention to freeze all embryos|1
1334311|NCT02047227|4387201|P2|Overall Study|No fertilization|51
1334312|NCT02047227|4387202|P1|Overall Study|No fertilization|61
1334313|NCT02047227|4387201|P2|Overall Study|No oocytes retrieved|20
1334314|NCT02047227|4387202|P1|Overall Study|No oocytes retrieved|21
1334315|NCT02047227|4387201|P2|Overall Study|Lack of ovarian response to stimulation|32
1334316|NCT02047227|4387202|P1|Overall Study|Lack of ovarian response to stimulation|35
1334317|NCT02047227|4387201|P2|Overall Study|Spontaneous pregnancy|0
1334318|NCT02047227|4387202|P1|Overall Study|Spontaneous pregnancy|1
1334319|NCT02047227|4387201|P2|Overall Study|Protocol Violation|0
1334320|NCT02047227|4387202|P1|Overall Study|Protocol Violation|1
1334321|NCT02047227|4387201|P2|Overall Study|Lost to Follow-up|3
1334322|NCT02047227|4387202|P1|Overall Study|Lost to Follow-up|0
1334323|NCT02047227|4387201|P2|Overall Study|Adverse Event|4
1334324|NCT02047227|4387202|P1|Overall Study|Adverse Event|2
1334325|NCT02046993|4387220|P2|Overall Study|Lost to Follow-up|1
1334326|NCT02046993|4387221|P1|Overall Study|Lost to Follow-up|1
1334327|NCT02046993|4387220|P2|Overall Study|Withdrawal by Subject|10
1334328|NCT02046993|4387221|P1|Overall Study|Withdrawal by Subject|2
1334329|NCT02046616|4387271|P1|8-Week FU Period|Lost to Follow-up|1
1334330|NCT02046616|4387271|P1|24-Week Treatment Period|Not Specified|1
1334331|NCT02046616|4387271|P1|24-Week Treatment Period|Physician Decision|3
1334332|NCT02046616|4387271|P1|24-Week Treatment Period|Insufficient Therapeutic Response|1
1334333|NCT02046616|4387271|P1|24-Week Treatment Period|Any Other Adverse Event|13
1334334|NCT02046616|4387271|P1|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
1334335|NCT02046564|4387293|P2|Overall Study|Subject met withdrawal criteria|5
1334336|NCT02046564|4387294|P1|Overall Study|Subject met withdrawal criteria|2
1334337|NCT02046564|4387293|P2|Overall Study|Withdrawal by Subject|10
1334338|NCT02046564|4387294|P1|Overall Study|Withdrawal by Subject|4
1334339|NCT02046564|4387293|P2|Overall Study|Protocol Violation|1
1334340|NCT02046564|4387294|P1|Overall Study|Protocol Violation|3
1334341|NCT02046564|4387293|P2|Overall Study|Physician Decision|1
1334342|NCT02046564|4387294|P1|Overall Study|Physician Decision|0
1334343|NCT02046564|4387293|P2|Overall Study|Adverse Event|3
1334344|NCT02046564|4387294|P1|Overall Study|Adverse Event|6
1334345|NCT02046369|4387333|P2|Overall Study|non compliance|0
1334346|NCT02046369|4387334|P1|Overall Study|non compliance|1
1334347|NCT02046369|4387333|P2|Overall Study|never received study drug|1
1334348|NCT02046369|4387334|P1|Overall Study|never received study drug|0
1334349|NCT02046369|4387333|P2|Overall Study|Withdrawal by Subject|6
1334350|NCT02046369|4387334|P1|Overall Study|Withdrawal by Subject|3
1334351|NCT02046369|4387333|P2|Overall Study|Protocol Violation|2
1334352|NCT02046369|4387334|P1|Overall Study|Protocol Violation|1
1334353|NCT02046369|4387333|P2|Overall Study|Lost to Follow-up|3
1334354|NCT02046369|4387334|P1|Overall Study|Lost to Follow-up|3
1334355|NCT02046369|4387333|P2|Overall Study|Lack of Efficacy|3
1334356|NCT02046369|4387334|P1|Overall Study|Lack of Efficacy|3
1334357|NCT02046369|4387333|P2|Overall Study|Adverse Event|3
1334358|NCT02046369|4387334|P1|Overall Study|Adverse Event|3
1334359|NCT02046226|4387367|P1|Overall Study|Lost to Follow-up|7
1334360|NCT02046148|4387415|P2|Overall Study|Withdrawal by Subject|2
1334361|NCT02046148|4387416|P1|Overall Study|Withdrawal by Subject|0
1334362|NCT02046148|4387415|P2|Overall Study|Lost to Follow-up|1
1334363|NCT02046148|4387416|P1|Overall Study|Lost to Follow-up|1
1334364|NCT02046122|4387460|P1|Overall Study|Withdrawal by Subject|1
1334365|NCT02046122|4387460|P1|Overall Study|Physician Decision|8
1334366|NCT02045979|4387482|P3|Overall Study|not specified above|0
1334367|NCT02045979|4387483|P2|Overall Study|not specified above|1
1334368|NCT02045979|4387484|P1|Overall Study|not specified above|0
1334369|NCT02045979|4387482|P3|Overall Study|Informed Consent Withdrawn|1
1334370|NCT02045979|4387483|P2|Overall Study|Informed Consent Withdrawn|0
1334371|NCT02045979|4387484|P1|Overall Study|Informed Consent Withdrawn|2
1334372|NCT02045875|4387521|P2|Overall Study|Withdrawal by Subject|3
1334373|NCT02045875|4387522|P1|Overall Study|Withdrawal by Subject|4
1334374|NCT02045875|4387521|P2|Overall Study|Lost to Follow-up|0
1334375|NCT02045875|4387522|P1|Overall Study|Lost to Follow-up|3
1334376|NCT02045862|4387533|P3|Overall Study|Lost to Follow-up|6
1334377|NCT02045862|4387534|P2|Overall Study|Lost to Follow-up|2
1334378|NCT02045862|4387535|P1|Overall Study|Lost to Follow-up|1
1334379|NCT02045862|4387533|P3|Overall Study|Adverse Event|27
1334380|NCT02045862|4387534|P2|Overall Study|Adverse Event|5
1334381|NCT02045862|4387535|P1|Overall Study|Adverse Event|7
1334382|NCT02045862|4387533|P3|Overall Study|Randomized but not Received Study Drug|8
1334383|NCT02045862|4387534|P2|Overall Study|Randomized but not Received Study Drug|2
1334384|NCT02045862|4387535|P1|Overall Study|Randomized but not Received Study Drug|0
1334385|NCT02045862|4387533|P3|Overall Study|Lack of Efficacy|13
1334386|NCT02045862|4387534|P2|Overall Study|Lack of Efficacy|4
1334387|NCT02045862|4387535|P1|Overall Study|Lack of Efficacy|8
1334388|NCT02045862|4387533|P3|Overall Study|Protocol Violation|6
1334389|NCT02045862|4387534|P2|Overall Study|Protocol Violation|0
1334390|NCT02045862|4387535|P1|Overall Study|Protocol Violation|0
1334391|NCT02045862|4387533|P3|Overall Study|Withdrawal by Patient|57
1334392|NCT02045862|4387534|P2|Overall Study|Withdrawal by Patient|27
1334393|NCT02045862|4387535|P1|Overall Study|Withdrawal by Patient|18
1334394|NCT02045862|4387533|P3|Overall Study|Miscellaneous|8
1334395|NCT02045862|4387534|P2|Overall Study|Miscellaneous|0
1334396|NCT02045862|4387535|P1|Overall Study|Miscellaneous|5
1334397|NCT02045862|4387533|P3|Overall Study|Death|1
1334398|NCT02045862|4387534|P2|Overall Study|Death|0
1334399|NCT02045862|4387535|P1|Overall Study|Death|0
1334400|NCT02045836|4387716|P2|Overall Study|Migrated from study area|2
1334401|NCT02045836|4387717|P1|Overall Study|Migrated from study area|0
1334402|NCT02045836|4387716|P2|Overall Study|Lost to Follow-up|7
1334403|NCT02045836|4387717|P1|Overall Study|Lost to Follow-up|4
1334404|NCT02045836|4387716|P2|Overall Study|Withdrawal by Subject|1
1334405|NCT02045836|4387717|P1|Overall Study|Withdrawal by Subject|1
1334406|NCT02045836|4387716|P2|Overall Study|Adverse Event|4
1334407|NCT02045836|4387717|P1|Overall Study|Adverse Event|4
1334408|NCT02045797|4387749|P3|Overall Study|Withdrawal by Subject|0
1334409|NCT02045797|4387750|P2|Overall Study|Withdrawal by Subject|2
1334410|NCT02045797|4387751|P1|Overall Study|Withdrawal by Subject|1
1334411|NCT02045797|4387749|P3|Overall Study|Physician Decision|0
1334412|NCT02045797|4387750|P2|Overall Study|Physician Decision|1
1334413|NCT02045797|4387751|P1|Overall Study|Physician Decision|0
1334414|NCT02045797|4387749|P3|Overall Study|Lost to Follow-up|1
1334415|NCT02045797|4387750|P2|Overall Study|Lost to Follow-up|3
1334416|NCT02045797|4387751|P1|Overall Study|Lost to Follow-up|2
1334417|NCT02045797|4387749|P3|Overall Study|Lack of Efficacy|0
1334418|NCT02045797|4387750|P2|Overall Study|Lack of Efficacy|0
1334419|NCT02045797|4387751|P1|Overall Study|Lack of Efficacy|1
1334420|NCT02045797|4387749|P3|Overall Study|Adverse Event|0
1334421|NCT02045797|4387750|P2|Overall Study|Adverse Event|1
1334422|NCT02045797|4387751|P1|Overall Study|Adverse Event|3
1334423|NCT02045732|4387896|P2|Overall Study|At the discretion of the investigator|1
1334424|NCT02045732|4387897|P1|Overall Study|At the discretion of the investigator|1
1334425|NCT02044848|4388028|P2|Overall Study|Administrative Problems|3
1334426|NCT02044848|4388029|P1|Overall Study|Administrative Problems|2
1334427|NCT02044822|4388035|P1|Overall Study|Lost to Follow-up|1
1334428|NCT02044822|4388035|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
1334429|NCT02044822|4388035|P1|Overall Study|Withdrew Consent|3
1334430|NCT02044822|4388035|P1|Overall Study|Investigator's Discretion|10
1334431|NCT02044822|4388035|P1|Overall Study|Study Terminated by Sponsor|77
1334432|NCT02044458|4388047|P2|Overall Study|Protocol Violation|8
1334433|NCT02044458|4388048|P1|Overall Study|Protocol Violation|3
1334434|NCT02044302|4388134|P2|Overall Study|study terminated|0
1334435|NCT02044302|4388135|P1|Overall Study|study terminated|2
1334436|NCT02044094|4388141|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
1334437|NCT02044094|4388141|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
1334438|NCT02044094|4388141|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
1334439|NCT02044094|4388141|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
1334440|NCT02044094|4388141|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
1334441|NCT02044094|4388141|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
1334442|NCT02044094|4388141|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
1334443|NCT02044094|4388141|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
1334444|NCT02043938|4388198|P1|Overall Study|Investigator decision|1
1334445|NCT02043938|4388198|P1|Overall Study|No show by subject|1
1334446|NCT02043938|4388198|P1|Overall Study|Unable to place EEG sensors on patient|1
1334447|NCT02043938|4388198|P1|Overall Study|Withdrawal by Subject|7
1334448|NCT02043782|4388249|P6|Period 1|Adverse Event|0
1334449|NCT02043782|4388250|P5|Period 1|Adverse Event|0
1334450|NCT02043782|4388251|P4|Period 1|Adverse Event|0
1334451|NCT02043782|4388252|P3|Period 1|Adverse Event|1
1334452|NCT02043782|4388253|P2|Period 1|Adverse Event|0
1334453|NCT02043782|4388254|P1|Period 1|Adverse Event|0
1334454|NCT02043366|4388365|P6|Overall Study|Lost to Follow-up|2
1334455|NCT02043366|4388366|P5|Overall Study|Lost to Follow-up|2
1334456|NCT02043366|4388367|P4|Overall Study|Lost to Follow-up|2
1334457|NCT02043366|4388368|P3|Overall Study|Lost to Follow-up|2
1334458|NCT02043366|4388369|P2|Overall Study|Lost to Follow-up|2
1334459|NCT02043366|4388370|P1|Overall Study|Lost to Follow-up|2
1334460|NCT02043132|4388408|P2|Overall Study|screen failures|8
1334461|NCT02043132|4388409|P1|Overall Study|screen failures|4
1334462|NCT02043132|4388408|P2|Overall Study|Lost to Follow-up|1
1334463|NCT02043132|4388409|P1|Overall Study|Lost to Follow-up|1
1334464|NCT02043015|4388429|P1|Overall Study|Incarceration|1
1334465|NCT02043015|4388429|P1|Overall Study|Participant moved away from study city|4
1334466|NCT02043015|4388429|P1|Overall Study|Removed once target enrollment reached|15
1334467|NCT02043015|4388429|P1|Overall Study|Withdrawal by Subject|4
1334468|NCT02043015|4388429|P1|Overall Study|Lost to Follow-up|4
1334469|NCT02042924|4388442|P1|Overall Study|Early Death|1
1334470|NCT02042443|4388490|P2|Overall Study|Not eligible/not analyzable|6
1334471|NCT02042443|4388491|P1|Overall Study|Not eligible/not analyzable|3
1334472|NCT02042443|4388490|P2|Overall Study|not protocol specified|1
1334473|NCT02042443|4388491|P1|Overall Study|not protocol specified|1
1334474|NCT02042443|4388490|P2|Overall Study|Progression|17
1334475|NCT02042443|4388491|P1|Overall Study|Progression|21
1334476|NCT02042443|4388490|P2|Overall Study|Withdrawal by Subject|1
1334477|NCT02042443|4388491|P1|Overall Study|Withdrawal by Subject|0
1334478|NCT02042443|4388490|P2|Overall Study|Adverse Event|1
1334479|NCT02042443|4388491|P1|Overall Study|Adverse Event|2
1334480|NCT02042404|4388503|P2|Overall Study|Inability to meet time requirements|0
1334481|NCT02042404|4388504|P1|Overall Study|Inability to meet time requirements|1
1334482|NCT02042404|4388503|P2|Overall Study|Unrelated Adverse Event|0
1334483|NCT02042404|4388504|P1|Overall Study|Unrelated Adverse Event|3
1334484|NCT02042404|4388503|P2|Overall Study|Death|0
1334485|NCT02042404|4388504|P1|Overall Study|Death|1
1334486|NCT02041533|4388544|P2|Overall Study|Randomized, not treated|7
1334487|NCT02041533|4388545|P1|Overall Study|Randomized, not treated|4
1334488|NCT02041533|4388544|P2|Overall Study|Completed max number of chemo cycles|29
1334489|NCT02041533|4388545|P1|Overall Study|Completed max number of chemo cycles|0
1334490|NCT02041533|4388544|P2|Overall Study|Other reasons|1
1334491|NCT02041533|4388545|P1|Overall Study|Other reasons|0
1334492|NCT02041533|4388544|P2|Overall Study|Poor/non-compliance|0
1334493|NCT02041533|4388545|P1|Overall Study|Poor/non-compliance|1
1334494|NCT02041533|4388544|P2|Overall Study|Maximum clinical benefit|18
1334495|NCT02041533|4388545|P1|Overall Study|Maximum clinical benefit|0
1334496|NCT02041533|4388544|P2|Overall Study|Withdrawal by Subject|1
1334497|NCT02041533|4388545|P1|Overall Study|Withdrawal by Subject|2
1334498|NCT02041533|4388544|P2|Overall Study|Subject request to discontinue treatment|9
1334499|NCT02041533|4388545|P1|Overall Study|Subject request to discontinue treatment|5
1334500|NCT02041533|4388544|P2|Overall Study|Adverse Event unrelated to study drug|21
1334501|NCT02041533|4388545|P1|Overall Study|Adverse Event unrelated to study drug|20
1334502|NCT02041533|4388544|P2|Overall Study|Death|0
1334503|NCT02041533|4388545|P1|Overall Study|Death|1
1334504|NCT02041533|4388544|P2|Overall Study|Study drug toxicity|30
1334505|NCT02041533|4388545|P1|Overall Study|Study drug toxicity|27
1334506|NCT02041533|4388544|P2|Overall Study|Disease Progression|142
1334507|NCT02041533|4388545|P1|Overall Study|Disease Progression|168
1334508|NCT02041520|4388567|P2|Overall Study|Hypothiroidism identified during follow-|1
1334509|NCT02041520|4388568|P1|Overall Study|Hypothiroidism identified during follow-|0
1334510|NCT02041520|4388567|P2|Overall Study|Lost to Follow-up|1
1334511|NCT02041520|4388568|P1|Overall Study|Lost to Follow-up|0
1334512|NCT02041520|4388567|P2|Overall Study|Protocol Violation|0
1334513|NCT02041520|4388568|P1|Overall Study|Protocol Violation|1
1334514|NCT02041520|4388567|P2|Overall Study|Withdrawal by Subject|4
1334515|NCT02041520|4388568|P1|Overall Study|Withdrawal by Subject|3
1334516|NCT02041520|4388567|P2|Overall Study|Adverse Event|1
1334517|NCT02041520|4388568|P1|Overall Study|Adverse Event|2
1334518|NCT02041286|4388611|P1|Overall Study|Adverse Event|1
1334519|NCT02041091|4388646|P2|Optional Safety Extension Period|Lost to Follow-up|3
1334520|NCT02041091|4388647|P1|Optional Safety Extension Period|Lost to Follow-up|2
1334521|NCT02041091|4388646|P2|Optional Safety Extension Period|Sponsor Decision|74
1334522|NCT02041091|4388647|P1|Optional Safety Extension Period|Sponsor Decision|70
1334523|NCT02041091|4388646|P2|Optional Safety Extension Period|Physician Decision|1
1334524|NCT02041091|4388647|P1|Optional Safety Extension Period|Physician Decision|2
1334525|NCT02041091|4388646|P2|Optional Safety Extension Period|Protocol Violation|0
1334526|NCT02041091|4388647|P1|Optional Safety Extension Period|Protocol Violation|2
1334527|NCT02041091|4388646|P2|Optional Safety Extension Period|Withdrawal by Subject|2
1334528|NCT02041091|4388647|P1|Optional Safety Extension Period|Withdrawal by Subject|5
1334529|NCT02041091|4388646|P2|Optional Safety Extension Period|Adverse Event|2
1334530|NCT02041091|4388647|P1|Optional Safety Extension Period|Adverse Event|4
1334531|NCT02041091|4388646|P2|Treatment|Lost to Follow-up|0
1334532|NCT02041091|4388647|P1|Treatment|Lost to Follow-up|1
1334533|NCT02041091|4388646|P2|Treatment|Sponsor Decision|16
1334534|NCT02041091|4388647|P1|Treatment|Sponsor Decision|15
1334535|NCT02041091|4388646|P2|Treatment|Physician Decision|0
1334536|NCT02041091|4388647|P1|Treatment|Physician Decision|1
1334537|NCT02041091|4388646|P2|Treatment|Withdrawal by Subject|4
1334538|NCT02041091|4388647|P1|Treatment|Withdrawal by Subject|2
1334539|NCT02041091|4388646|P2|Treatment|Adverse Event|3
1334540|NCT02041091|4388647|P1|Treatment|Adverse Event|3
1334541|NCT02040844|4388672|P3|Overall Study|Concomitant medication|1
1334542|NCT02040844|4388673|P2|Overall Study|Concomitant medication|3
1334543|NCT02040844|4388674|P1|Overall Study|Concomitant medication|1
1334544|NCT02040844|4388672|P3|Overall Study|Non-specified|5
1334545|NCT02040844|4388673|P2|Overall Study|Non-specified|2
1334546|NCT02040844|4388674|P1|Overall Study|Non-specified|8
1334547|NCT02040844|4388672|P3|Overall Study|Missing|2
1334548|NCT02040844|4388673|P2|Overall Study|Missing|3
1334549|NCT02040844|4388674|P1|Overall Study|Missing|13
1334550|NCT02040844|4388672|P3|Overall Study|Lost to Follow-up|13
1334551|NCT02040844|4388673|P2|Overall Study|Lost to Follow-up|9
1334552|NCT02040844|4388674|P1|Overall Study|Lost to Follow-up|12
1334553|NCT02040844|4388672|P3|Overall Study|Withdrawal by Subject|25
1334554|NCT02040844|4388673|P2|Overall Study|Withdrawal by Subject|22
1334555|NCT02040844|4388674|P1|Overall Study|Withdrawal by Subject|16
1334556|NCT02040844|4388672|P3|Overall Study|Adverse Event|1
1334557|NCT02040844|4388673|P2|Overall Study|Adverse Event|0
1334558|NCT02040844|4388674|P1|Overall Study|Adverse Event|0
1334559|NCT02040779|4388721|P3|Overall Study|Lack of Efficacy|0
1334560|NCT02040779|4388722|P2|Overall Study|Lack of Efficacy|2
1334561|NCT02040779|4388723|P1|Overall Study|Lack of Efficacy|4
1334562|NCT02040779|4388721|P3|Overall Study|Lost to Follow-up|1
1334563|NCT02040779|4388722|P2|Overall Study|Lost to Follow-up|2
1334564|NCT02040779|4388723|P1|Overall Study|Lost to Follow-up|1
1334565|NCT02040779|4388721|P3|Overall Study|Protocol Violation|0
1334566|NCT02040779|4388722|P2|Overall Study|Protocol Violation|1
1334567|NCT02040779|4388723|P1|Overall Study|Protocol Violation|2
1334568|NCT02040779|4388721|P3|Overall Study|Non-compliance|0
1334569|NCT02040779|4388722|P2|Overall Study|Non-compliance|1
1334570|NCT02040779|4388723|P1|Overall Study|Non-compliance|0
1334571|NCT02040779|4388721|P3|Overall Study|Withdrawal by Subject|3
1334572|NCT02040779|4388722|P2|Overall Study|Withdrawal by Subject|1
1334573|NCT02040779|4388723|P1|Overall Study|Withdrawal by Subject|4
1334574|NCT02040779|4388721|P3|Overall Study|Adverse Event|0
1334575|NCT02040779|4388722|P2|Overall Study|Adverse Event|0
1334576|NCT02040779|4388723|P1|Overall Study|Adverse Event|1
1334577|NCT02040766|4388763|P5|Overall Study|Lack of Efficacy|5
1334578|NCT02040766|4388764|P4|Overall Study|Lack of Efficacy|6
1334579|NCT02040766|4388765|P3|Overall Study|Lack of Efficacy|4
1334580|NCT02040766|4388766|P2|Overall Study|Lack of Efficacy|3
1334581|NCT02040766|4388767|P1|Overall Study|Lack of Efficacy|6
1334582|NCT02040766|4388763|P5|Overall Study|Not reported|0
1334583|NCT02040766|4388764|P4|Overall Study|Not reported|0
1334584|NCT02040766|4388765|P3|Overall Study|Not reported|0
1334585|NCT02040766|4388766|P2|Overall Study|Not reported|0
1334586|NCT02040766|4388767|P1|Overall Study|Not reported|1
1334587|NCT02040766|4388763|P5|Overall Study|Lost to Follow-up|4
1334588|NCT02040766|4388764|P4|Overall Study|Lost to Follow-up|1
1334589|NCT02040766|4388765|P3|Overall Study|Lost to Follow-up|3
1334590|NCT02040766|4388766|P2|Overall Study|Lost to Follow-up|1
1334591|NCT02040766|4388767|P1|Overall Study|Lost to Follow-up|4
1334592|NCT02040766|4388763|P5|Overall Study|Protocol Violation|0
1334593|NCT02040766|4388764|P4|Overall Study|Protocol Violation|3
1334594|NCT02040766|4388765|P3|Overall Study|Protocol Violation|2
1334595|NCT02040766|4388766|P2|Overall Study|Protocol Violation|1
1334596|NCT02040766|4388767|P1|Overall Study|Protocol Violation|2
1334597|NCT02040766|4388763|P5|Overall Study|Non-compliance|0
1334598|NCT02040766|4388764|P4|Overall Study|Non-compliance|0
1334599|NCT02040766|4388765|P3|Overall Study|Non-compliance|0
1334600|NCT02040766|4388766|P2|Overall Study|Non-compliance|1
1334601|NCT02040766|4388767|P1|Overall Study|Non-compliance|0
1334602|NCT02040766|4388763|P5|Overall Study|Withdrawal by Subject|2
1334603|NCT02040766|4388764|P4|Overall Study|Withdrawal by Subject|3
1334604|NCT02040766|4388765|P3|Overall Study|Withdrawal by Subject|2
1334605|NCT02040766|4388766|P2|Overall Study|Withdrawal by Subject|3
1334606|NCT02040766|4388767|P1|Overall Study|Withdrawal by Subject|4
1334607|NCT02040766|4388763|P5|Overall Study|Adverse Event|2
1334608|NCT02040766|4388764|P4|Overall Study|Adverse Event|0
1334609|NCT02040766|4388765|P3|Overall Study|Adverse Event|1
1334610|NCT02040766|4388766|P2|Overall Study|Adverse Event|1
1334611|NCT02040766|4388767|P1|Overall Study|Adverse Event|1
1334612|NCT02040532|4388818|P1|Overall Study|Withdrawal by Subject|3
1334613|NCT02040532|4388818|P1|Overall Study|Adverse Event|4
1334614|NCT02040532|4388818|P1|Overall Study|Physician Decision|4
1334615|NCT02040532|4388818|P1|Overall Study|Lost to Follow-up|1
1334616|NCT02040428|4388831|P2|Overall Study|Withdrawal by Subject|1
1334617|NCT02040428|4388832|P1|Overall Study|Withdrawal by Subject|1
1334618|NCT02040428|4388831|P2|Overall Study|Death|3
1334619|NCT02040428|4388832|P1|Overall Study|Death|4
1334620|NCT02039778|4388880|P1|Overall Study|Never started the protocol treatment|1
1334621|NCT02039778|4388880|P1|Overall Study|Withdrawal by Subject|1
1334622|NCT02039778|4388880|P1|Overall Study|Death|2
1334623|NCT02039687|4388892|P4|Overall Study|treatment assignment could not be confir|0
1334624|NCT02039687|4388893|P3|Overall Study|treatment assignment could not be confir|2
1334625|NCT02039687|4388894|P2|Overall Study|treatment assignment could not be confir|0
1334626|NCT02039687|4388895|P1|Overall Study|treatment assignment could not be confir|0
1334627|NCT02039687|4388892|P4|Overall Study|Withdrawal by Subject|0
1334628|NCT02039687|4388893|P3|Overall Study|Withdrawal by Subject|0
1334629|NCT02039687|4388894|P2|Overall Study|Withdrawal by Subject|1
1334630|NCT02039687|4388895|P1|Overall Study|Withdrawal by Subject|0
1334631|NCT02039687|4388892|P4|Overall Study|Adverse Event|0
1334632|NCT02039687|4388893|P3|Overall Study|Adverse Event|1
1334633|NCT02039687|4388894|P2|Overall Study|Adverse Event|0
1334634|NCT02039687|4388895|P1|Overall Study|Adverse Event|0
1334635|NCT02039674|4388930|P9|Overall Study|Ongoing in Study|4
1334636|NCT02039674|4388931|P8|Overall Study|Ongoing in Study|33
1334637|NCT02039674|4388932|P7|Overall Study|Ongoing in Study|34
1334638|NCT02039674|4388933|P6|Overall Study|Ongoing in Study|1
1334639|NCT02039674|4388934|P5|Overall Study|Ongoing in Study|6
1334640|NCT02039674|4388935|P4|Overall Study|Ongoing in Study|2
1334641|NCT02039674|4388936|P3|Overall Study|Ongoing in Study|5
1334642|NCT02039674|4388937|P2|Overall Study|Ongoing in Study|5
1334643|NCT02039674|4388938|P1|Overall Study|Ongoing in Study|7
1334644|NCT02039674|4388930|P9|Overall Study|Withdrawal by Subject|2
1334645|NCT02039674|4388931|P8|Overall Study|Withdrawal by Subject|5
1334646|NCT02039674|4388932|P7|Overall Study|Withdrawal by Subject|3
1334647|NCT02039674|4388933|P6|Overall Study|Withdrawal by Subject|1
1334648|NCT02039674|4388934|P5|Overall Study|Withdrawal by Subject|2
1334649|NCT02039674|4388935|P4|Overall Study|Withdrawal by Subject|0
1334650|NCT02039674|4388936|P3|Overall Study|Withdrawal by Subject|1
1334651|NCT02039674|4388937|P2|Overall Study|Withdrawal by Subject|1
1334652|NCT02039674|4388938|P1|Overall Study|Withdrawal by Subject|2
1334653|NCT02039674|4388930|P9|Overall Study|Progressive Disease|23
1334654|NCT02039674|4388931|P8|Overall Study|Progressive Disease|18
1334655|NCT02039674|4388932|P7|Overall Study|Progressive Disease|17
1334656|NCT02039674|4388933|P6|Overall Study|Progressive Disease|0
1334657|NCT02039674|4388934|P5|Overall Study|Progressive Disease|2
1334658|NCT02039674|4388935|P4|Overall Study|Progressive Disease|4
1334659|NCT02039674|4388936|P3|Overall Study|Progressive Disease|15
1334660|NCT02039674|4388937|P2|Overall Study|Progressive Disease|13
1334661|NCT02039674|4388938|P1|Overall Study|Progressive Disease|13
1334662|NCT02039674|4388930|P9|Overall Study|Physician Decision|0
1334663|NCT02039674|4388931|P8|Overall Study|Physician Decision|0
1334664|NCT02039674|4388932|P7|Overall Study|Physician Decision|1
1334665|NCT02039674|4388933|P6|Overall Study|Physician Decision|0
1334666|NCT02039674|4388934|P5|Overall Study|Physician Decision|0
1334667|NCT02039674|4388935|P4|Overall Study|Physician Decision|0
1334668|NCT02039674|4388936|P3|Overall Study|Physician Decision|0
1334669|NCT02039674|4388937|P2|Overall Study|Physician Decision|0
1334670|NCT02039674|4388938|P1|Overall Study|Physician Decision|0
1334671|NCT02039674|4388930|P9|Overall Study|Lost to Follow-up|0
1334672|NCT02039674|4388931|P8|Overall Study|Lost to Follow-up|1
1334673|NCT02039674|4388932|P7|Overall Study|Lost to Follow-up|0
1334674|NCT02039674|4388933|P6|Overall Study|Lost to Follow-up|0
1334675|NCT02039674|4388934|P5|Overall Study|Lost to Follow-up|0
1334676|NCT02039674|4388935|P4|Overall Study|Lost to Follow-up|0
1334677|NCT02039674|4388936|P3|Overall Study|Lost to Follow-up|0
1334678|NCT02039674|4388937|P2|Overall Study|Lost to Follow-up|0
1334679|NCT02039674|4388938|P1|Overall Study|Lost to Follow-up|0
1334680|NCT02039674|4388930|P9|Overall Study|Excluded Medication|5
1334681|NCT02039674|4388931|P8|Overall Study|Excluded Medication|4
1334682|NCT02039674|4388932|P7|Overall Study|Excluded Medication|2
1334683|NCT02039674|4388933|P6|Overall Study|Excluded Medication|4
1334684|NCT02039674|4388934|P5|Overall Study|Excluded Medication|2
1334685|NCT02039674|4388935|P4|Overall Study|Excluded Medication|0
1334686|NCT02039674|4388936|P3|Overall Study|Excluded Medication|2
1334687|NCT02039674|4388937|P2|Overall Study|Excluded Medication|1
1334688|NCT02039674|4388938|P1|Overall Study|Excluded Medication|2
1334689|NCT02039674|4388930|P9|Overall Study|Death|8
1334690|NCT02039674|4388931|P8|Overall Study|Death|0
1334691|NCT02039674|4388932|P7|Overall Study|Death|1
1334692|NCT02039674|4388933|P6|Overall Study|Death|1
1334693|NCT02039674|4388934|P5|Overall Study|Death|0
1334694|NCT02039674|4388935|P4|Overall Study|Death|0
1334695|NCT02039674|4388936|P3|Overall Study|Death|0
1334696|NCT02039674|4388937|P2|Overall Study|Death|3
1334697|NCT02039674|4388938|P1|Overall Study|Death|0
1334698|NCT02039674|4388930|P9|Overall Study|Adverse Event|3
1334699|NCT02039674|4388931|P8|Overall Study|Adverse Event|2
1334700|NCT02039674|4388932|P7|Overall Study|Adverse Event|2
1334701|NCT02039674|4388933|P6|Overall Study|Adverse Event|0
1334702|NCT02039674|4388934|P5|Overall Study|Adverse Event|0
1334703|NCT02039674|4388935|P4|Overall Study|Adverse Event|0
1334704|NCT02039674|4388936|P3|Overall Study|Adverse Event|1
1334705|NCT02039674|4388937|P2|Overall Study|Adverse Event|2
1334706|NCT02039674|4388938|P1|Overall Study|Adverse Event|0
1334707|NCT02039427|4388974|P4|Overall Study|Steroid Use|0
1334708|NCT02039427|4388975|P3|Overall Study|Steroid Use|0
1334709|NCT02039427|4388976|P2|Overall Study|Steroid Use|0
1334710|NCT02039427|4388977|P1|Overall Study|Steroid Use|1
1334711|NCT02039427|4388974|P4|Overall Study|Loss of follow - up|4
1334712|NCT02039427|4388975|P3|Overall Study|Loss of follow - up|2
1334713|NCT02039427|4388976|P2|Overall Study|Loss of follow - up|0
1334714|NCT02039427|4388977|P1|Overall Study|Loss of follow - up|1
1334715|NCT02039427|4388974|P4|Overall Study|Cancellation of surgery|0
1334716|NCT02039427|4388975|P3|Overall Study|Cancellation of surgery|1
1334717|NCT02039427|4388976|P2|Overall Study|Cancellation of surgery|0
1334718|NCT02039427|4388977|P1|Overall Study|Cancellation of surgery|0
1334719|NCT02039427|4388974|P4|Overall Study|Withdrawal on concent|1
1334720|NCT02039427|4388975|P3|Overall Study|Withdrawal on concent|0
1334721|NCT02039427|4388976|P2|Overall Study|Withdrawal on concent|0
1334722|NCT02039427|4388977|P1|Overall Study|Withdrawal on concent|0
1334723|NCT02039427|4388974|P4|Overall Study|Duration of surgery > 3h|0
1334724|NCT02039427|4388975|P3|Overall Study|Duration of surgery > 3h|0
1334725|NCT02039427|4388976|P2|Overall Study|Duration of surgery > 3h|1
1334726|NCT02039427|4388977|P1|Overall Study|Duration of surgery > 3h|1
1334727|NCT02039414|4388997|P2|Overall Study|Protocol Violation|1
1334728|NCT02039414|4388998|P1|Overall Study|Protocol Violation|3
1334729|NCT02039414|4388997|P2|Overall Study|Lost to Follow-up|0
1334730|NCT02039414|4388998|P1|Overall Study|Lost to Follow-up|2
1334731|NCT02039414|4388997|P2|Overall Study|Delivered|1
1334732|NCT02039414|4388998|P1|Overall Study|Delivered|1
1334733|NCT02038959|4389021|P2|Overall Study|Withdrawal by Subject|8
1334734|NCT02038959|4389022|P1|Overall Study|Withdrawal by Subject|6
1334735|NCT02038946|4389048|P1|Overall Study|Other reasons|1
1334736|NCT02038946|4389048|P1|Overall Study|Lost to Follow-up|2
1334737|NCT02038946|4389048|P1|Overall Study|Withdrawal by Subject|3
1334738|NCT02038946|4389048|P1|Overall Study|Death|5
1334739|NCT02038933|4389059|P1|Follow-up|Disease Progression|2
1334740|NCT02038933|4389059|P1|Follow-up|Withdrawal by Subject|1
1334741|NCT02038933|4389059|P1|Follow-up|Lost to Follow-up|1
1334742|NCT02038933|4389059|P1|Follow-up|Adverse event unrelated to study drug|4
1334743|NCT02038933|4389059|P1|Follow-up|Death|11
1334744|NCT02038933|4389059|P1|Treatment|Withdrawal by Subject|1
1334745|NCT02038933|4389059|P1|Treatment|Disease Progression|101
1334746|NCT02038933|4389059|P1|Treatment|Study Drug Toxicity|4
1334747|NCT02038933|4389059|P1|Treatment|Adverse Event Unrelated to Study Drug|6
1334748|NCT02038933|4389059|P1|Treatment|Lost to Follow-up|1
1334749|NCT02038933|4389059|P1|Treatment|No longer meets study criteria|1
1334750|NCT02038907|4389092|P14|Overall Study|Withdrawal by Subject|0
1334751|NCT02038907|4389093|P13|Overall Study|Withdrawal by Subject|0
1334752|NCT02038907|4389094|P12|Overall Study|Withdrawal by Subject|0
1334753|NCT02038907|4389095|P11|Overall Study|Withdrawal by Subject|1
1334754|NCT02038907|4389096|P10|Overall Study|Withdrawal by Subject|0
1334755|NCT02038907|4389097|P9|Overall Study|Withdrawal by Subject|0
1334756|NCT02038907|4389098|P8|Overall Study|Withdrawal by Subject|0
1334757|NCT02038907|4389099|P7|Overall Study|Withdrawal by Subject|0
1334758|NCT02038907|4389100|P6|Overall Study|Withdrawal by Subject|0
1334759|NCT02038907|4389101|P5|Overall Study|Withdrawal by Subject|0
1334760|NCT02038907|4389102|P4|Overall Study|Withdrawal by Subject|0
1334761|NCT02038907|4389103|P3|Overall Study|Withdrawal by Subject|0
1334762|NCT02038907|4389104|P2|Overall Study|Withdrawal by Subject|0
1334763|NCT02038907|4389105|P1|Overall Study|Withdrawal by Subject|0
1334764|NCT02038907|4389092|P14|Overall Study|Protocol Violation|0
1334765|NCT02038907|4389093|P13|Overall Study|Protocol Violation|0
1334766|NCT02038907|4389094|P12|Overall Study|Protocol Violation|0
1334767|NCT02038907|4389095|P11|Overall Study|Protocol Violation|1
1334768|NCT02038907|4389096|P10|Overall Study|Protocol Violation|0
1334769|NCT02038907|4389097|P9|Overall Study|Protocol Violation|0
1334770|NCT02038907|4389098|P8|Overall Study|Protocol Violation|0
1334771|NCT02038907|4389099|P7|Overall Study|Protocol Violation|0
1334772|NCT02038907|4389100|P6|Overall Study|Protocol Violation|0
1334773|NCT02038907|4389101|P5|Overall Study|Protocol Violation|0
1334774|NCT02038907|4389102|P4|Overall Study|Protocol Violation|0
1334775|NCT02038907|4389103|P3|Overall Study|Protocol Violation|0
1334776|NCT02038907|4389104|P2|Overall Study|Protocol Violation|0
1334777|NCT02038907|4389105|P1|Overall Study|Protocol Violation|0
1334778|NCT02038829|4389633|P12|Treatment Period 6|Adverse Event|0
1334779|NCT02038829|4389634|P11|Treatment Period 6|Adverse Event|0
1334780|NCT02038829|4389635|P10|Treatment Period 6|Adverse Event|0
1334781|NCT02038829|4389636|P9|Treatment Period 6|Adverse Event|0
1334782|NCT02038829|4389637|P8|Treatment Period 6|Adverse Event|0
1334783|NCT02038829|4389638|P7|Treatment Period 6|Adverse Event|0
1334784|NCT02038829|4389639|P6|Treatment Period 6|Adverse Event|0
1334785|NCT02038829|4389640|P5|Treatment Period 6|Adverse Event|0
1334786|NCT02038829|4389641|P4|Treatment Period 6|Adverse Event|0
1334787|NCT02038829|4389642|P3|Treatment Period 6|Adverse Event|1
1334788|NCT02038829|4389643|P2|Treatment Period 6|Adverse Event|0
1334789|NCT02038829|4389644|P1|Treatment Period 6|Adverse Event|0
1334790|NCT02038829|4389633|P12|Washout Period 4|Adverse Event|0
1334791|NCT02038829|4389634|P11|Washout Period 4|Adverse Event|0
1334792|NCT02038829|4389635|P10|Washout Period 4|Adverse Event|0
1334793|NCT02038829|4389636|P9|Washout Period 4|Adverse Event|0
1334794|NCT02038829|4389637|P8|Washout Period 4|Adverse Event|0
1334795|NCT02038829|4389638|P7|Washout Period 4|Adverse Event|1
1334796|NCT02038829|4389639|P6|Washout Period 4|Adverse Event|0
1334797|NCT02038829|4389640|P5|Washout Period 4|Adverse Event|0
1334798|NCT02038829|4389641|P4|Washout Period 4|Adverse Event|0
1334799|NCT02038829|4389642|P3|Washout Period 4|Adverse Event|0
1334800|NCT02038829|4389643|P2|Washout Period 4|Adverse Event|0
1334801|NCT02038829|4389644|P1|Washout Period 4|Adverse Event|0
1334802|NCT02038829|4389633|P12|Treatment Period 4|Adverse Event|0
1334803|NCT02038829|4389634|P11|Treatment Period 4|Adverse Event|0
1334804|NCT02038829|4389635|P10|Treatment Period 4|Adverse Event|0
1334805|NCT02038829|4389636|P9|Treatment Period 4|Adverse Event|0
1334806|NCT02038829|4389637|P8|Treatment Period 4|Adverse Event|0
1334807|NCT02038829|4389638|P7|Treatment Period 4|Adverse Event|0
1334808|NCT02038829|4389639|P6|Treatment Period 4|Adverse Event|0
1334809|NCT02038829|4389640|P5|Treatment Period 4|Adverse Event|0
1334810|NCT02038829|4389641|P4|Treatment Period 4|Adverse Event|0
1334811|NCT02038829|4389642|P3|Treatment Period 4|Adverse Event|0
1334812|NCT02038829|4389643|P2|Treatment Period 4|Adverse Event|1
1334813|NCT02038829|4389644|P1|Treatment Period 4|Adverse Event|0
1334814|NCT02038829|4389633|P12|Washout Period 2|Withdrawal by Subject|0
1334815|NCT02038829|4389634|P11|Washout Period 2|Withdrawal by Subject|0
1334816|NCT02038829|4389635|P10|Washout Period 2|Withdrawal by Subject|0
1334817|NCT02038829|4389636|P9|Washout Period 2|Withdrawal by Subject|0
1334818|NCT02038829|4389637|P8|Washout Period 2|Withdrawal by Subject|0
1334819|NCT02038829|4389638|P7|Washout Period 2|Withdrawal by Subject|0
1334820|NCT02038829|4389639|P6|Washout Period 2|Withdrawal by Subject|1
1334821|NCT02038829|4389640|P5|Washout Period 2|Withdrawal by Subject|0
1334822|NCT02038829|4389641|P4|Washout Period 2|Withdrawal by Subject|0
1334823|NCT02038829|4389642|P3|Washout Period 2|Withdrawal by Subject|0
1334824|NCT02038829|4389643|P2|Washout Period 2|Withdrawal by Subject|0
1334825|NCT02038829|4389644|P1|Washout Period 2|Withdrawal by Subject|0
1334826|NCT02038829|4389633|P12|Washout Period 2|Adverse Event|0
1334827|NCT02038829|4389634|P11|Washout Period 2|Adverse Event|0
1334828|NCT02038829|4389635|P10|Washout Period 2|Adverse Event|0
1334829|NCT02038829|4389636|P9|Washout Period 2|Adverse Event|1
1334830|NCT02038829|4389637|P8|Washout Period 2|Adverse Event|0
1334831|NCT02038829|4389638|P7|Washout Period 2|Adverse Event|0
1334832|NCT02038829|4389639|P6|Washout Period 2|Adverse Event|0
1334833|NCT02038829|4389640|P5|Washout Period 2|Adverse Event|0
1334834|NCT02038829|4389641|P4|Washout Period 2|Adverse Event|0
1334835|NCT02038829|4389642|P3|Washout Period 2|Adverse Event|0
1334836|NCT02038829|4389643|P2|Washout Period 2|Adverse Event|0
1334837|NCT02038829|4389644|P1|Washout Period 2|Adverse Event|0
1334838|NCT02038829|4389633|P12|Treatment Period 2|Withdrawal by Subject|0
1334839|NCT02038829|4389634|P11|Treatment Period 2|Withdrawal by Subject|0
1334840|NCT02038829|4389635|P10|Treatment Period 2|Withdrawal by Subject|0
1334841|NCT02038829|4389636|P9|Treatment Period 2|Withdrawal by Subject|0
1334842|NCT02038829|4389637|P8|Treatment Period 2|Withdrawal by Subject|0
1334843|NCT02038829|4389638|P7|Treatment Period 2|Withdrawal by Subject|0
1334844|NCT02038829|4389639|P6|Treatment Period 2|Withdrawal by Subject|0
1334845|NCT02038829|4389640|P5|Treatment Period 2|Withdrawal by Subject|0
1334846|NCT02038829|4389641|P4|Treatment Period 2|Withdrawal by Subject|0
1334847|NCT02038829|4389642|P3|Treatment Period 2|Withdrawal by Subject|0
1334848|NCT02038829|4389643|P2|Treatment Period 2|Withdrawal by Subject|0
1334849|NCT02038829|4389644|P1|Treatment Period 2|Withdrawal by Subject|1
1334850|NCT02038829|4389633|P12|Treatment Period 2|Adverse Event|0
1334851|NCT02038829|4389634|P11|Treatment Period 2|Adverse Event|1
1334852|NCT02038829|4389635|P10|Treatment Period 2|Adverse Event|0
1334853|NCT02038829|4389636|P9|Treatment Period 2|Adverse Event|0
1334854|NCT02038829|4389637|P8|Treatment Period 2|Adverse Event|0
1334855|NCT02038829|4389638|P7|Treatment Period 2|Adverse Event|0
1334856|NCT02038829|4389639|P6|Treatment Period 2|Adverse Event|0
1334857|NCT02038829|4389640|P5|Treatment Period 2|Adverse Event|0
1334858|NCT02038829|4389641|P4|Treatment Period 2|Adverse Event|0
1334859|NCT02038829|4389642|P3|Treatment Period 2|Adverse Event|0
1334860|NCT02038829|4389643|P2|Treatment Period 2|Adverse Event|0
1334861|NCT02038829|4389644|P1|Treatment Period 2|Adverse Event|0
1334862|NCT02038829|4389633|P12|Washout Period 1|Death|0
1334863|NCT02038829|4389634|P11|Washout Period 1|Death|0
1334864|NCT02038829|4389635|P10|Washout Period 1|Death|0
1334865|NCT02038829|4389636|P9|Washout Period 1|Death|0
1334866|NCT02038829|4389637|P8|Washout Period 1|Death|0
1334867|NCT02038829|4389638|P7|Washout Period 1|Death|0
1334868|NCT02038829|4389639|P6|Washout Period 1|Death|0
1334869|NCT02038829|4389640|P5|Washout Period 1|Death|1
1334870|NCT02038829|4389641|P4|Washout Period 1|Death|0
1334871|NCT02038829|4389642|P3|Washout Period 1|Death|0
1334872|NCT02038829|4389643|P2|Washout Period 1|Death|0
1334873|NCT02038829|4389644|P1|Washout Period 1|Death|0
1334874|NCT02038790|4389678|P2|Day 0 - First Treatment|Withdrawal by Subject|1
1334875|NCT02038790|4389679|P1|Day 0 - First Treatment|Withdrawal by Subject|1
1334876|NCT02038764|4389715|P5|Overall Study|Other|0
1334877|NCT02038764|4389716|P4|Overall Study|Other|0
1334878|NCT02038764|4389717|P3|Overall Study|Other|1
1334879|NCT02038764|4389718|P2|Overall Study|Other|0
1334880|NCT02038764|4389719|P1|Overall Study|Other|1
1334881|NCT02038764|4389715|P5|Overall Study|Withdrawal by Subject|1
1334882|NCT02038764|4389716|P4|Overall Study|Withdrawal by Subject|0
1334883|NCT02038764|4389717|P3|Overall Study|Withdrawal by Subject|0
1334884|NCT02038764|4389718|P2|Overall Study|Withdrawal by Subject|0
1334885|NCT02038764|4389719|P1|Overall Study|Withdrawal by Subject|0
1334886|NCT02038764|4389715|P5|Overall Study|Lost to Follow-up|0
1334887|NCT02038764|4389716|P4|Overall Study|Lost to Follow-up|0
1334888|NCT02038764|4389717|P3|Overall Study|Lost to Follow-up|0
1334889|NCT02038764|4389718|P2|Overall Study|Lost to Follow-up|1
1334890|NCT02038764|4389719|P1|Overall Study|Lost to Follow-up|0
1334891|NCT02038764|4389715|P5|Overall Study|Adverse Event|0
1334892|NCT02038764|4389716|P4|Overall Study|Adverse Event|0
1334893|NCT02038764|4389717|P3|Overall Study|Adverse Event|1
1334894|NCT02038764|4389718|P2|Overall Study|Adverse Event|0
1334895|NCT02038764|4389719|P1|Overall Study|Adverse Event|0
1334896|NCT02038543|4389823|P4|Overall Study|Withdrawal by Subject|1
1334897|NCT02038543|4389824|P3|Overall Study|Withdrawal by Subject|0
1334898|NCT02038543|4389825|P2|Overall Study|Withdrawal by Subject|0
1334899|NCT02038543|4389826|P1|Overall Study|Withdrawal by Subject|0
1334900|NCT02038543|4389823|P4|Overall Study|Screen Failure|1
1334901|NCT02038543|4389824|P3|Overall Study|Screen Failure|0
1334902|NCT02038543|4389825|P2|Overall Study|Screen Failure|0
1334903|NCT02038543|4389826|P1|Overall Study|Screen Failure|0
1334904|NCT02038075|4389842|P2|Overall Study|Withdrawal by Subject|0
1334905|NCT02038075|4389843|P1|Overall Study|Withdrawal by Subject|3
1334906|NCT02037568|4389938|P2|Overall Study|Patient did not receive transplant|1
1334907|NCT02037568|4389939|P1|Overall Study|Patient did not receive transplant|0
1334908|NCT02037568|4389938|P2|Overall Study|Screen Failure|1
1334909|NCT02037568|4389939|P1|Overall Study|Screen Failure|3
1334910|NCT02037568|4389938|P2|Overall Study|Lost to Follow-up|13
1334911|NCT02037568|4389939|P1|Overall Study|Lost to Follow-up|16
1334912|NCT02037568|4389938|P2|Overall Study|Withdrawal by Subject|24
1334913|NCT02037568|4389939|P1|Overall Study|Withdrawal by Subject|17
1334914|NCT02037477|4389965|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
1334915|NCT02037477|4389966|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
1334916|NCT02037477|4389967|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
1334917|NCT02037477|4389968|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
1334918|NCT02036775|4390046|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
1334919|NCT02036775|4390047|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1334920|NCT02036775|4390048|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1334921|NCT02036775|4390049|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1334922|NCT02036775|4390050|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1334923|NCT02036775|4390051|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1334924|NCT02036580|4390092|P3|Overall Study|Adverse Event|0
1334925|NCT02036580|4390093|P2|Overall Study|Adverse Event|0
1334926|NCT02036580|4390094|P1|Overall Study|Adverse Event|1
1334927|NCT02036580|4390092|P3|Overall Study|Withdrawal by Subject|0
1334928|NCT02036580|4390093|P2|Overall Study|Withdrawal by Subject|1
1334929|NCT02036580|4390094|P1|Overall Study|Withdrawal by Subject|0
1334930|NCT02036515|4390115|P3|Overall Study|Hyperglycemia|1
1334931|NCT02036515|4390116|P2|Overall Study|Hyperglycemia|0
1334932|NCT02036515|4390117|P1|Overall Study|Hyperglycemia|0
1334933|NCT02036515|4390115|P3|Overall Study|Withdrawal by Subject|9
1334934|NCT02036515|4390116|P2|Overall Study|Withdrawal by Subject|7
1334935|NCT02036515|4390117|P1|Overall Study|Withdrawal by Subject|4
1334936|NCT02036515|4390115|P3|Overall Study|Screen failure|0
1334937|NCT02036515|4390116|P2|Overall Study|Screen failure|2
1334938|NCT02036515|4390117|P1|Overall Study|Screen failure|0
1334939|NCT02036515|4390115|P3|Overall Study|Non-compliance with study drug|2
1334940|NCT02036515|4390116|P2|Overall Study|Non-compliance with study drug|0
1334941|NCT02036515|4390117|P1|Overall Study|Non-compliance with study drug|0
1334942|NCT02036515|4390115|P3|Overall Study|Lost to Follow-up|0
1334943|NCT02036515|4390116|P2|Overall Study|Lost to Follow-up|2
1334944|NCT02036515|4390117|P1|Overall Study|Lost to Follow-up|0
1334945|NCT02036515|4390115|P3|Overall Study|Adverse Event|2
1334946|NCT02036515|4390116|P2|Overall Study|Adverse Event|1
1334947|NCT02036515|4390117|P1|Overall Study|Adverse Event|1
1334948|NCT02035748|4390216|P1|Overall Study|Progressive Disease|1
1334949|NCT02035748|4390216|P1|Overall Study|Withdrawal by Subject|6
1334950|NCT02035748|4390216|P1|Overall Study|Physician Decision|3
1334951|NCT02035748|4390216|P1|Overall Study|Lost to Follow-up|2
1334952|NCT02035748|4390216|P1|Overall Study|Death|3
1334953|NCT02035748|4390216|P1|Overall Study|Adverse Event|5
1334954|NCT02035696|4390230|P4|Overall Study|Withdrawal by Subject|1
1334955|NCT02035696|4390231|P3|Overall Study|Withdrawal by Subject|2
1334956|NCT02035696|4390232|P2|Overall Study|Withdrawal by Subject|0
1334957|NCT02035696|4390233|P1|Overall Study|Withdrawal by Subject|3
1334958|NCT02035696|4390230|P4|Overall Study|Lost to Follow-up|2
1334959|NCT02035696|4390231|P3|Overall Study|Lost to Follow-up|1
1334960|NCT02035696|4390232|P2|Overall Study|Lost to Follow-up|3
1334961|NCT02035696|4390233|P1|Overall Study|Lost to Follow-up|0
1334962|NCT02035553|4390289|P2|Overall Study|Other Reason|4
1334963|NCT02035553|4390290|P1|Overall Study|Other Reason|0
1334964|NCT02035553|4390289|P2|Overall Study|Lost to Follow-up|1
1334965|NCT02035553|4390290|P1|Overall Study|Lost to Follow-up|0
1334966|NCT02035553|4390289|P2|Overall Study|Non-compliance with Study Drug|1
1334967|NCT02035553|4390290|P1|Overall Study|Non-compliance with Study Drug|0
1334968|NCT02035553|4390289|P2|Overall Study|Withdrawal by Subject|7
1334969|NCT02035553|4390290|P1|Overall Study|Withdrawal by Subject|4
1334970|NCT02035553|4390289|P2|Overall Study|Lack of Efficacy|1
1334971|NCT02035553|4390290|P1|Overall Study|Lack of Efficacy|1
1334972|NCT02035553|4390289|P2|Overall Study|Physician Decision|2
1334973|NCT02035553|4390290|P1|Overall Study|Physician Decision|3
1334974|NCT02035553|4390289|P2|Overall Study|Adverse Event|6
1334975|NCT02035553|4390290|P1|Overall Study|Adverse Event|10
1334976|NCT02035553|4390289|P2|Overall Study|Death (See All-Cause Mortality Table)|1
1334977|NCT02035553|4390290|P1|Overall Study|Death (See All-Cause Mortality Table)|0
1334978|NCT02035475|4390296|P1|Overall Study|Equipment Error|1
1334979|NCT02035475|4390296|P1|Overall Study|Physician Decision|1
1334980|NCT02035475|4390296|P1|Overall Study|Withdrawal by Subject|4
1334981|NCT02035332|4390307|P1|Overall Study|Procedure Aborted due to Uterine Width|1
1334982|NCT02034916|4390315|P2|Overall Study|Ongoing as of data cutoff (01 Sep 2016)|20
1334983|NCT02034916|4390316|P1|Overall Study|Ongoing as of data cutoff (01 Sep 2016)|15
1334984|NCT02034916|4390315|P2|Overall Study|Lost to Follow-up|1
1334985|NCT02034916|4390316|P1|Overall Study|Lost to Follow-up|1
1334986|NCT02034916|4390315|P2|Overall Study|Withdrawal by Subject|1
1334987|NCT02034916|4390316|P1|Overall Study|Withdrawal by Subject|1
1334988|NCT02034916|4390315|P2|Overall Study|Death|13
1334989|NCT02034916|4390316|P1|Overall Study|Death|32
1334990|NCT02034877|4390351|P2|Overall Study|No Longer Willing to Participate|3
1334991|NCT02034877|4390352|P1|Overall Study|No Longer Willing to Participate|0
1334992|NCT02034877|4390351|P2|Overall Study|Lost to Follow-up|3
1334993|NCT02034877|4390352|P1|Overall Study|Lost to Follow-up|0
1334994|NCT02034799|4390370|P2|Overall Study|Death|1
1334995|NCT02034799|4390371|P1|Overall Study|Death|2
1334996|NCT02034799|4390370|P2|Overall Study|Lost to Follow-up|1
1334997|NCT02034799|4390371|P1|Overall Study|Lost to Follow-up|0
1334998|NCT02034799|4390370|P2|Overall Study|Withdrawal by Subject|2
1334999|NCT02034799|4390371|P1|Overall Study|Withdrawal by Subject|0
1335000|NCT02034708|4390385|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
1335001|NCT02034708|4390386|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
1335002|NCT02034708|4390385|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
1335003|NCT02034708|4390386|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
1335004|NCT02034708|4390385|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
1335005|NCT02034708|4390386|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
1335006|NCT02034708|4390385|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
1335007|NCT02034708|4390386|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
1335008|NCT02034591|4390397|P6|Overall Study|Withdrawal by Subject|0
1335009|NCT02034591|4390398|P5|Overall Study|Withdrawal by Subject|1
1335010|NCT02034591|4390399|P4|Overall Study|Withdrawal by Subject|0
1335011|NCT02034591|4390400|P3|Overall Study|Withdrawal by Subject|0
1335012|NCT02034591|4390401|P2|Overall Study|Withdrawal by Subject|0
1335013|NCT02034591|4390402|P1|Overall Study|Withdrawal by Subject|0
1335014|NCT02034565|4390457|P2|Overall Study|Adverse Event|0
1335015|NCT02034565|4390458|P1|Overall Study|Adverse Event|1
1335016|NCT02034552|4390475|P3|Overall Study|Non-compliance with study drug|1
1335017|NCT02034552|4390476|P2|Overall Study|Non-compliance with study drug|0
1335018|NCT02034552|4390477|P1|Overall Study|Non-compliance with study drug|0
1335019|NCT02034552|4390475|P3|Overall Study|Withdrawal by Subject|1
1335020|NCT02034552|4390476|P2|Overall Study|Withdrawal by Subject|0
1335021|NCT02034552|4390477|P1|Overall Study|Withdrawal by Subject|2
1335022|NCT02034552|4390475|P3|Overall Study|AE associated with disease progression|0
1335023|NCT02034552|4390476|P2|Overall Study|AE associated with disease progression|1
1335024|NCT02034552|4390477|P1|Overall Study|AE associated with disease progression|0
1335025|NCT02034552|4390475|P3|Overall Study|AE not assoc. with disease progression|2
1335026|NCT02034552|4390476|P2|Overall Study|AE not assoc. with disease progression|3
1335027|NCT02034552|4390477|P1|Overall Study|AE not assoc. with disease progression|1
1335028|NCT02034552|4390475|P3|Overall Study|Ongoing with treatment|11
1335029|NCT02034552|4390476|P2|Overall Study|Ongoing with treatment|11
1335030|NCT02034552|4390477|P1|Overall Study|Ongoing with treatment|0
1335031|NCT02034552|4390475|P3|Overall Study|Never treated|0
1335032|NCT02034552|4390476|P2|Overall Study|Never treated|2
1335033|NCT02034552|4390477|P1|Overall Study|Never treated|3
1335034|NCT02034513|4390502|P2|Overall Study|Unclassified|1
1335035|NCT02034513|4390503|P1|Overall Study|Unclassified|0
1335036|NCT02034513|4390502|P2|Overall Study|Withdrawal by Subject|25
1335037|NCT02034513|4390503|P1|Overall Study|Withdrawal by Subject|25
1335038|NCT02034513|4390502|P2|Overall Study|Protocol Violation|10
1335039|NCT02034513|4390503|P1|Overall Study|Protocol Violation|7
1335040|NCT02034513|4390502|P2|Overall Study|Pregnancy|3
1335041|NCT02034513|4390503|P1|Overall Study|Pregnancy|0
1335042|NCT02034513|4390502|P2|Overall Study|Lost to Follow-up|7
1335043|NCT02034513|4390503|P1|Overall Study|Lost to Follow-up|6
1335044|NCT02034513|4390502|P2|Overall Study|Lack of Efficacy|1
1335045|NCT02034513|4390503|P1|Overall Study|Lack of Efficacy|0
1335046|NCT02034513|4390502|P2|Overall Study|Adverse Event|10
1335047|NCT02034513|4390503|P1|Overall Study|Adverse Event|11
1335048|NCT02034162|4390521|P3|Double-blind|Withdrawal by Subject|0
1335049|NCT02034162|4390522|P2|Double-blind|Withdrawal by Subject|7
1335050|NCT02034162|4390523|P1|Double-blind|Withdrawal by Subject|5
1335051|NCT02034162|4390521|P3|Double-blind|Protocol Violation|0
1335052|NCT02034162|4390522|P2|Double-blind|Protocol Violation|1
1335053|NCT02034162|4390523|P1|Double-blind|Protocol Violation|0
1335054|NCT02034162|4390521|P3|Double-blind|Physician Decision|0
1335055|NCT02034162|4390522|P2|Double-blind|Physician Decision|0
1335056|NCT02034162|4390523|P1|Double-blind|Physician Decision|1
1335057|NCT02034162|4390521|P3|Double-blind|Lost to Follow-up|0
1335058|NCT02034162|4390522|P2|Double-blind|Lost to Follow-up|0
1335059|NCT02034162|4390523|P1|Double-blind|Lost to Follow-up|3
1335060|NCT02033369|4390596|P2|Overall Study|Protocol Violation|0
1335061|NCT02033369|4390597|P1|Overall Study|Protocol Violation|2
1335062|NCT02033369|4390596|P2|Overall Study|Lost to Follow-up|0
1335063|NCT02033369|4390597|P1|Overall Study|Lost to Follow-up|1
1335064|NCT02033369|4390596|P2|Overall Study|Withdrawal by Subject|1
1335065|NCT02033369|4390597|P1|Overall Study|Withdrawal by Subject|1
1335066|NCT02033369|4390596|P2|Overall Study|Not a good demographic match|2
1335067|NCT02033369|4390597|P1|Overall Study|Not a good demographic match|0
1335068|NCT02033369|4390596|P2|Overall Study|Physician Decision|2
1335069|NCT02033369|4390597|P1|Overall Study|Physician Decision|1
1335070|NCT02032901|4390663|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
1335071|NCT02032901|4390664|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
1335072|NCT02032901|4390663|P2|Treatment Period (12 Weeks)|Pregnancy|0
1335073|NCT02032901|4390664|P1|Treatment Period (12 Weeks)|Pregnancy|1
1335074|NCT02032888|4390688|P3|Follow-up Period|Not specified|0
1335075|NCT02032888|4390689|P2|Follow-up Period|Not specified|0
1335076|NCT02032888|4390690|P1|Follow-up Period|Not specified|1
1335077|NCT02032888|4390688|P3|Follow-up Period|Death|0
1335078|NCT02032888|4390689|P2|Follow-up Period|Death|1
1335079|NCT02032888|4390690|P1|Follow-up Period|Death|1
1335080|NCT02032888|4390688|P3|Follow-up Period|Lost to Follow-up|0
1335081|NCT02032888|4390689|P2|Follow-up Period|Lost to Follow-up|1
1335082|NCT02032888|4390690|P1|Follow-up Period|Lost to Follow-up|1
1335083|NCT02032888|4390688|P3|Treatment Period|Not specified|0
1335084|NCT02032888|4390689|P2|Treatment Period|Not specified|1
1335085|NCT02032888|4390690|P1|Treatment Period|Not specified|1
1335086|NCT02032888|4390688|P3|Treatment Period|Poor compliance/noncompliance|0
1335087|NCT02032888|4390689|P2|Treatment Period|Poor compliance/noncompliance|1
1335088|NCT02032888|4390690|P1|Treatment Period|Poor compliance/noncompliance|1
1335089|NCT02032875|4390721|P2|Follow-up Period|Virologic Relapse|10
1335090|NCT02032875|4390722|P1|Follow-up Period|Virologic Relapse|3
1335091|NCT02032875|4390721|P2|Follow-up Period|Death|1
1335092|NCT02032875|4390722|P1|Follow-up Period|Death|0
1335093|NCT02032875|4390721|P2|Treatment Period|Liver transplant, Treatment extension|3
1335094|NCT02032875|4390722|P1|Treatment Period|Liver transplant, Treatment extension|0
1335095|NCT02032875|4390721|P2|Treatment Period|Liver transplant, No extension needed|1
1335096|NCT02032875|4390722|P1|Treatment Period|Liver transplant, No extension needed|0
1335097|NCT02032875|4390721|P2|Treatment Period|Adverse Event|0
1335098|NCT02032875|4390722|P1|Treatment Period|Adverse Event|1
1335099|NCT02032706|4390751|P1|Overall Study|Protocol Violation|1
1335100|NCT02032706|4390751|P1|Overall Study|Did not qualify|5
1335101|NCT02032407|4390808|P1|Overall Study|Other Miscellaneous Reasons|2
1335102|NCT02032407|4390808|P1|Overall Study|Pregnancy|1
1335103|NCT02032407|4390808|P1|Overall Study|Lost to Follow-up|2
1335104|NCT02032238|4390821|P2|Overall Study|Lost to Follow-up|0
1335105|NCT02032238|4390822|P1|Overall Study|Lost to Follow-up|2
1335106|NCT02031679|4390863|P2|Overall Study|Lack of Efficacy|1
1335107|NCT02031679|4390864|P1|Overall Study|Lack of Efficacy|0
1335108|NCT02031679|4390863|P2|Overall Study|Protocol Violation|1
1335109|NCT02031679|4390864|P1|Overall Study|Protocol Violation|0
1335110|NCT02031640|4390879|P6|Double-blind Treatment Period|Lost to Follow-up|0
1335111|NCT02031640|4390880|P5|Double-blind Treatment Period|Lost to Follow-up|1
1335112|NCT02031640|4390881|P4|Double-blind Treatment Period|Lost to Follow-up|0
1335113|NCT02031640|4390882|P3|Double-blind Treatment Period|Lost to Follow-up|0
1335114|NCT02031640|4390883|P2|Double-blind Treatment Period|Lost to Follow-up|3
1335115|NCT02031640|4390884|P1|Double-blind Treatment Period|Lost to Follow-up|0
1335116|NCT02031640|4390879|P6|Double-blind Treatment Period|Withdrawal by Subject|1
1335117|NCT02031640|4390880|P5|Double-blind Treatment Period|Withdrawal by Subject|1
1335118|NCT02031640|4390881|P4|Double-blind Treatment Period|Withdrawal by Subject|1
1335119|NCT02031640|4390882|P3|Double-blind Treatment Period|Withdrawal by Subject|3
1335120|NCT02031640|4390883|P2|Double-blind Treatment Period|Withdrawal by Subject|2
1335121|NCT02031640|4390884|P1|Double-blind Treatment Period|Withdrawal by Subject|0
1335122|NCT02031640|4390879|P6|Double-blind Treatment Period|Adverse Event|0
1335123|NCT02031640|4390880|P5|Double-blind Treatment Period|Adverse Event|0
1335124|NCT02031640|4390881|P4|Double-blind Treatment Period|Adverse Event|2
1335125|NCT02031640|4390882|P3|Double-blind Treatment Period|Adverse Event|0
1335126|NCT02031640|4390883|P2|Double-blind Treatment Period|Adverse Event|0
1335127|NCT02031640|4390884|P1|Double-blind Treatment Period|Adverse Event|0
1335128|NCT02031640|4390879|P6|Double-blind Treatment Period|Non-compliance|0
1335129|NCT02031640|4390880|P5|Double-blind Treatment Period|Non-compliance|1
1335130|NCT02031640|4390881|P4|Double-blind Treatment Period|Non-compliance|1
1335131|NCT02031640|4390882|P3|Double-blind Treatment Period|Non-compliance|0
1335132|NCT02031640|4390883|P2|Double-blind Treatment Period|Non-compliance|1
1335133|NCT02031640|4390884|P1|Double-blind Treatment Period|Non-compliance|0
1335134|NCT02031640|4390879|P6|Double-blind Treatment Period|Lack of Efficacy|1
1335135|NCT02031640|4390880|P5|Double-blind Treatment Period|Lack of Efficacy|5
1335136|NCT02031640|4390881|P4|Double-blind Treatment Period|Lack of Efficacy|2
1335137|NCT02031640|4390882|P3|Double-blind Treatment Period|Lack of Efficacy|3
1335138|NCT02031640|4390883|P2|Double-blind Treatment Period|Lack of Efficacy|14
1335139|NCT02031640|4390884|P1|Double-blind Treatment Period|Lack of Efficacy|0
1335140|NCT02031640|4390879|P6|Double-blind Treatment Period|Protocol deviation|1
1335141|NCT02031640|4390880|P5|Double-blind Treatment Period|Protocol deviation|3
1335142|NCT02031640|4390881|P4|Double-blind Treatment Period|Protocol deviation|1
1335143|NCT02031640|4390882|P3|Double-blind Treatment Period|Protocol deviation|0
1335144|NCT02031640|4390883|P2|Double-blind Treatment Period|Protocol deviation|2
1335145|NCT02031640|4390884|P1|Double-blind Treatment Period|Protocol deviation|0
1335146|NCT02031640|4390879|P6|Run-In Period|Various administrative reasons|0
1335147|NCT02031640|4390880|P5|Run-In Period|Various administrative reasons|0
1335148|NCT02031640|4390881|P4|Run-In Period|Various administrative reasons|0
1335149|NCT02031640|4390882|P3|Run-In Period|Various administrative reasons|0
1335150|NCT02031640|4390883|P2|Run-In Period|Various administrative reasons|0
1335151|NCT02031640|4390884|P1|Run-In Period|Various administrative reasons|17
1335152|NCT02031640|4390879|P6|Run-In Period|Randomization criteria not met|0
1335153|NCT02031640|4390880|P5|Run-In Period|Randomization criteria not met|0
1335154|NCT02031640|4390881|P4|Run-In Period|Randomization criteria not met|0
1335155|NCT02031640|4390882|P3|Run-In Period|Randomization criteria not met|0
1335156|NCT02031640|4390883|P2|Run-In Period|Randomization criteria not met|0
1335157|NCT02031640|4390884|P1|Run-In Period|Randomization criteria not met|85
1335158|NCT02031640|4390879|P6|Run-In Period|Exclusion criteria met|0
1335159|NCT02031640|4390880|P5|Run-In Period|Exclusion criteria met|0
1335160|NCT02031640|4390881|P4|Run-In Period|Exclusion criteria met|0
1335161|NCT02031640|4390882|P3|Run-In Period|Exclusion criteria met|0
1335162|NCT02031640|4390883|P2|Run-In Period|Exclusion criteria met|0
1335163|NCT02031640|4390884|P1|Run-In Period|Exclusion criteria met|8
1335164|NCT02031640|4390879|P6|Run-In Period|Inclusion criteria not met|0
1335165|NCT02031640|4390880|P5|Run-In Period|Inclusion criteria not met|0
1335166|NCT02031640|4390881|P4|Run-In Period|Inclusion criteria not met|0
1335167|NCT02031640|4390882|P3|Run-In Period|Inclusion criteria not met|0
1335168|NCT02031640|4390883|P2|Run-In Period|Inclusion criteria not met|0
1335169|NCT02031640|4390884|P1|Run-In Period|Inclusion criteria not met|38
1335170|NCT02031640|4390879|P6|Run-In Period|Withdrawal by Subject|0
1335171|NCT02031640|4390880|P5|Run-In Period|Withdrawal by Subject|0
1335172|NCT02031640|4390881|P4|Run-In Period|Withdrawal by Subject|0
1335173|NCT02031640|4390882|P3|Run-In Period|Withdrawal by Subject|0
1335174|NCT02031640|4390883|P2|Run-In Period|Withdrawal by Subject|0
1335175|NCT02031640|4390884|P1|Run-In Period|Withdrawal by Subject|17
1335176|NCT02031640|4390879|P6|Run-In Period|Adverse Event|0
1335177|NCT02031640|4390880|P5|Run-In Period|Adverse Event|0
1335178|NCT02031640|4390881|P4|Run-In Period|Adverse Event|0
1335179|NCT02031640|4390882|P3|Run-In Period|Adverse Event|0
1335180|NCT02031640|4390883|P2|Run-In Period|Adverse Event|0
1335181|NCT02031640|4390884|P1|Run-In Period|Adverse Event|4
1335182|NCT02031640|4390879|P6|Screening Period|Enrollment closed|0
1335183|NCT02031640|4390880|P5|Screening Period|Enrollment closed|0
1335184|NCT02031640|4390881|P4|Screening Period|Enrollment closed|0
1335185|NCT02031640|4390882|P3|Screening Period|Enrollment closed|0
1335186|NCT02031640|4390883|P2|Screening Period|Enrollment closed|0
1335187|NCT02031640|4390884|P1|Screening Period|Enrollment closed|26
1335188|NCT02031640|4390879|P6|Screening Period|Lost to Follow-up|0
1335189|NCT02031640|4390880|P5|Screening Period|Lost to Follow-up|0
1335190|NCT02031640|4390881|P4|Screening Period|Lost to Follow-up|0
1335191|NCT02031640|4390882|P3|Screening Period|Lost to Follow-up|0
1335192|NCT02031640|4390883|P2|Screening Period|Lost to Follow-up|0
1335193|NCT02031640|4390884|P1|Screening Period|Lost to Follow-up|14
1335194|NCT02031640|4390879|P6|Screening Period|Exclusion criteria met|0
1335195|NCT02031640|4390880|P5|Screening Period|Exclusion criteria met|0
1335196|NCT02031640|4390881|P4|Screening Period|Exclusion criteria met|0
1335197|NCT02031640|4390882|P3|Screening Period|Exclusion criteria met|0
1335198|NCT02031640|4390883|P2|Screening Period|Exclusion criteria met|0
1335199|NCT02031640|4390884|P1|Screening Period|Exclusion criteria met|30
1335200|NCT02031640|4390879|P6|Screening Period|Inclusion criteria not met|0
1335201|NCT02031640|4390880|P5|Screening Period|Inclusion criteria not met|0
1335202|NCT02031640|4390881|P4|Screening Period|Inclusion criteria not met|0
1335203|NCT02031640|4390882|P3|Screening Period|Inclusion criteria not met|0
1335204|NCT02031640|4390883|P2|Screening Period|Inclusion criteria not met|0
1335205|NCT02031640|4390884|P1|Screening Period|Inclusion criteria not met|312
1335206|NCT02031640|4390879|P6|Screening Period|Withdrawal by Subject|0
1335207|NCT02031640|4390880|P5|Screening Period|Withdrawal by Subject|0
1335208|NCT02031640|4390881|P4|Screening Period|Withdrawal by Subject|0
1335209|NCT02031640|4390882|P3|Screening Period|Withdrawal by Subject|0
1335210|NCT02031640|4390883|P2|Screening Period|Withdrawal by Subject|0
1335211|NCT02031640|4390884|P1|Screening Period|Withdrawal by Subject|29
1335212|NCT02031640|4390879|P6|Screening Period|Adverse Event|0
1335213|NCT02031640|4390880|P5|Screening Period|Adverse Event|0
1335214|NCT02031640|4390881|P4|Screening Period|Adverse Event|0
1335215|NCT02031640|4390882|P3|Screening Period|Adverse Event|0
1335216|NCT02031640|4390883|P2|Screening Period|Adverse Event|0
1335217|NCT02031640|4390884|P1|Screening Period|Adverse Event|1
1335218|NCT02031471|4390927|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
1335219|NCT02031471|4390927|P1|Long Term Extension (LTE) Period|Adverse Event|1
1335220|NCT02031471|4390927|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
1335221|NCT02031471|4390927|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
1335222|NCT02031471|4390927|P1|24 Week Treatment Period|Protocol Violation|1
1335223|NCT02031471|4390927|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
1335224|NCT02031471|4390927|P1|24 Week Treatment Period|Adverse Event|6
1335225|NCT02031458|4390960|P3|Overall Study|Lost to Follow-up|2
1335226|NCT02031458|4390961|P2|Overall Study|Lost to Follow-up|1
1335227|NCT02031458|4390962|P1|Overall Study|Lost to Follow-up|1
1335228|NCT02031458|4390960|P3|Overall Study|On Treatment|73
1335229|NCT02031458|4390961|P2|Overall Study|On Treatment|81
1335230|NCT02031458|4390962|P1|Overall Study|On Treatment|43
1335231|NCT02031458|4390960|P3|Overall Study|On Survival Follow-Up|73
1335232|NCT02031458|4390961|P2|Overall Study|On Survival Follow-Up|83
1335233|NCT02031458|4390962|P1|Overall Study|On Survival Follow-Up|46
1335234|NCT02031458|4390960|P3|Overall Study|Withdrawal by Subject|3
1335235|NCT02031458|4390961|P2|Overall Study|Withdrawal by Subject|9
1335236|NCT02031458|4390962|P1|Overall Study|Withdrawal by Subject|6
1335237|NCT02031458|4390960|P3|Overall Study|Unknown Reason|2
1335238|NCT02031458|4390961|P2|Overall Study|Unknown Reason|1
1335239|NCT02031458|4390962|P1|Overall Study|Unknown Reason|0
1335240|NCT02031458|4390960|P3|Overall Study|Physician Decision|0
1335241|NCT02031458|4390961|P2|Overall Study|Physician Decision|1
1335242|NCT02031458|4390962|P1|Overall Study|Physician Decision|0
1335243|NCT02031458|4390960|P3|Overall Study|Protocol Violation|0
1335244|NCT02031458|4390961|P2|Overall Study|Protocol Violation|4
1335245|NCT02031458|4390962|P1|Overall Study|Protocol Violation|7
1335246|NCT02031458|4390960|P3|Overall Study|Death|100
1335247|NCT02031458|4390961|P2|Overall Study|Death|87
1335248|NCT02031458|4390962|P1|Overall Study|Death|36
1335249|NCT02030600|4391058|P2|Treatment Period 2|Unclassified|0
1335250|NCT02030600|4391059|P1|Treatment Period 2|Unclassified|1
1335251|NCT02030600|4391058|P2|Treatment Period 2|Withdrawal by Subject|9
1335252|NCT02030600|4391059|P1|Treatment Period 2|Withdrawal by Subject|13
1335253|NCT02030600|4391058|P2|Treatment Period 2|Protocol Violation|2
1335254|NCT02030600|4391059|P1|Treatment Period 2|Protocol Violation|1
1335255|NCT02030600|4391058|P2|Treatment Period 2|Lost to Follow-up|2
1335256|NCT02030600|4391059|P1|Treatment Period 2|Lost to Follow-up|4
1335257|NCT02030600|4391058|P2|Treatment Period 2|Lack of Efficacy|1
1335258|NCT02030600|4391059|P1|Treatment Period 2|Lack of Efficacy|2
1335259|NCT02030600|4391058|P2|Treatment Period 2|Adverse Event|4
1335260|NCT02030600|4391059|P1|Treatment Period 2|Adverse Event|4
1335261|NCT02030600|4391058|P2|Treatment Period 1|Unclassified|0
1335262|NCT02030600|4391059|P1|Treatment Period 1|Unclassified|1
1335263|NCT02030600|4391058|P2|Treatment Period 1|Casebook Unsigned|0
1335264|NCT02030600|4391059|P1|Treatment Period 1|Casebook Unsigned|1
1335265|NCT02030600|4391058|P2|Treatment Period 1|Withdrawal by Subject|17
1335266|NCT02030600|4391059|P1|Treatment Period 1|Withdrawal by Subject|13
1335267|NCT02030600|4391058|P2|Treatment Period 1|Protocol Violation|17
1335268|NCT02030600|4391059|P1|Treatment Period 1|Protocol Violation|22
1335269|NCT02030600|4391058|P2|Treatment Period 1|Lost to Follow-up|3
1335270|NCT02030600|4391059|P1|Treatment Period 1|Lost to Follow-up|11
1335271|NCT02030600|4391058|P2|Treatment Period 1|Lack of Efficacy|1
1335272|NCT02030600|4391059|P1|Treatment Period 1|Lack of Efficacy|0
1335273|NCT02030600|4391058|P2|Treatment Period 1|Adverse Event|7
1335274|NCT02030600|4391059|P1|Treatment Period 1|Adverse Event|5
1335275|NCT02030535|4391080|P1|Washout Period 1 (21 Days)|Adverse Event|1
1335276|NCT02030405|4391148|P1|Overall Study|Lost to Follow-up|1
1335277|NCT02030405|4391148|P1|Overall Study|Withdrawal by Subject|1
1335278|NCT02030119|4391157|P4|Overall Study|Ineligible (see Pre-assignment Details)|0
1335279|NCT02030119|4391158|P3|Overall Study|Ineligible (see Pre-assignment Details)|1
1335280|NCT02030119|4391159|P2|Overall Study|Ineligible (see Pre-assignment Details)|1
1335281|NCT02030119|4391160|P1|Overall Study|Ineligible (see Pre-assignment Details)|0
1335282|NCT02030119|4391157|P4|Overall Study|Withdrawal by Subject|3
1335283|NCT02030119|4391158|P3|Overall Study|Withdrawal by Subject|5
1335284|NCT02030119|4391159|P2|Overall Study|Withdrawal by Subject|1
1335285|NCT02030119|4391160|P1|Overall Study|Withdrawal by Subject|3
1335286|NCT02030041|4391198|P3|Overall Study|Withdrawal by Subject|1
1335287|NCT02030041|4391199|P2|Overall Study|Withdrawal by Subject|2
1335288|NCT02030041|4391200|P1|Overall Study|Withdrawal by Subject|2
1335289|NCT02029989|4391213|P2|Overall Study|Protocol Violation|0
1335290|NCT02029989|4391214|P1|Overall Study|Protocol Violation|1
1335291|NCT02029989|4391213|P2|Overall Study|Death|1
1335292|NCT02029989|4391214|P1|Overall Study|Death|0
1335293|NCT02029989|4391213|P2|Overall Study|Lost to Follow-up|7
1335294|NCT02029989|4391214|P1|Overall Study|Lost to Follow-up|9
1335295|NCT02029989|4391213|P2|Overall Study|Physician Decision|0
1335296|NCT02029989|4391214|P1|Overall Study|Physician Decision|2
1335297|NCT02029989|4391213|P2|Overall Study|Change of location|3
1335298|NCT02029989|4391214|P1|Overall Study|Change of location|2
1335299|NCT02029989|4391213|P2|Overall Study|Withdrawal: Fear of needles|0
1335300|NCT02029989|4391214|P1|Overall Study|Withdrawal: Fear of needles|1
1335301|NCT02029989|4391213|P2|Overall Study|Withdrawal by Subject|0
1335302|NCT02029989|4391214|P1|Overall Study|Withdrawal by Subject|1
1335303|NCT02029846|4391237|P2|Overall Study|n=1 each arm|1
1335304|NCT02029846|4391238|P1|Overall Study|n=1 each arm|1
1335305|NCT02029521|4391275|P2|Overall Study|Withdrawal by Subject|1
1335306|NCT02029521|4391276|P1|Overall Study|Withdrawal by Subject|1
1335307|NCT02029521|4391275|P2|Overall Study|Protocol Violation|0
1335308|NCT02029521|4391276|P1|Overall Study|Protocol Violation|1
1335309|NCT02029417|4391374|P1|Overall Study|Adverse Event|1
1335310|NCT02029417|4391374|P1|Overall Study|Death|1
1335311|NCT02028767|4391478|P2|Treatment Period 2|Reason other than those specified above|0
1335312|NCT02028767|4391479|P1|Treatment Period 2|Reason other than those specified above|1
1335313|NCT02028767|4391478|P2|Treatment Period 2|Non compliant with protocol|0
1335314|NCT02028767|4391479|P1|Treatment Period 2|Non compliant with protocol|1
1335315|NCT02028169|4391704|P1|Overall Study|Concomitant Medication Usage|1
1335316|NCT02028169|4391704|P1|Overall Study|Cessation of Drug|1
1335317|NCT02028169|4391704|P1|Overall Study|Adverse Event|1
1335318|NCT02028169|4391704|P1|Overall Study|Withdrawal by Subject|2
1335319|NCT02028169|4391704|P1|Overall Study|Lack of Efficacy|2
1335320|NCT02028169|4391704|P1|Overall Study|Lost to Follow-up|21
1335321|NCT02028065|4391730|P3|Treatment Through Study Completion|Adverse Event|5
1335322|NCT02028065|4391731|P2|Treatment Through Study Completion|Adverse Event|3
1335323|NCT02028065|4391732|P1|Treatment Through Study Completion|Adverse Event|3
1335324|NCT02028065|4391730|P3|Treatment Through Study Completion|Withdrawal by Subject|3
1335325|NCT02028065|4391731|P2|Treatment Through Study Completion|Withdrawal by Subject|4
1335326|NCT02028065|4391732|P1|Treatment Through Study Completion|Withdrawal by Subject|5
1335327|NCT02028065|4391730|P3|Treatment Through Study Completion|Protocol Violation|0
1335328|NCT02028065|4391731|P2|Treatment Through Study Completion|Protocol Violation|4
1335329|NCT02028065|4391732|P1|Treatment Through Study Completion|Protocol Violation|1
1335330|NCT02028065|4391730|P3|Treatment Through Study Completion|Physician Decision|0
1335331|NCT02028065|4391731|P2|Treatment Through Study Completion|Physician Decision|0
1335332|NCT02028065|4391732|P1|Treatment Through Study Completion|Physician Decision|1
1335333|NCT02028065|4391730|P3|Treatment Through Study Completion|Lost to Follow-up|6
1335334|NCT02028065|4391731|P2|Treatment Through Study Completion|Lost to Follow-up|4
1335335|NCT02028065|4391732|P1|Treatment Through Study Completion|Lost to Follow-up|2
1335336|NCT02028065|4391730|P3|Randomization Through Start Treatment|Not treated|3
1335337|NCT02028065|4391731|P2|Randomization Through Start Treatment|Not treated|3
1335338|NCT02028065|4391732|P1|Randomization Through Start Treatment|Not treated|1
1335339|NCT02027844|4391759|P3|Overall Study|Incomlete data|0
1335340|NCT02027844|4391760|P2|Overall Study|Incomlete data|0
1335341|NCT02027844|4391761|P1|Overall Study|Incomlete data|2
1335342|NCT02027844|4391759|P3|Overall Study|Protocol Violation|0
1335343|NCT02027844|4391760|P2|Overall Study|Protocol Violation|2
1335344|NCT02027844|4391761|P1|Overall Study|Protocol Violation|0
1335345|NCT02027844|4391759|P3|Overall Study|Lost to Follow-up|1
1335346|NCT02027844|4391760|P2|Overall Study|Lost to Follow-up|2
1335347|NCT02027844|4391761|P1|Overall Study|Lost to Follow-up|0
1335348|NCT02027844|4391759|P3|Overall Study|Withdrawal by Subject|1
1335349|NCT02027844|4391760|P2|Overall Study|Withdrawal by Subject|2
1335350|NCT02027844|4391761|P1|Overall Study|Withdrawal by Subject|3
1335351|NCT02027402|4391780|P2|Overall Study|Withdrawal by Subject|1
1335352|NCT02027402|4391781|P1|Overall Study|Withdrawal by Subject|4
1335353|NCT02027311|4391795|P2|Overall Study|Protocol Violation|2
1335354|NCT02027311|4391796|P1|Overall Study|Protocol Violation|3
1335355|NCT02026258|4391831|P2|Recieved Allocated Intervention|Lost to Follow-up|1
1335356|NCT02026258|4391832|P1|Recieved Allocated Intervention|Lost to Follow-up|0
1335357|NCT02026258|4391831|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
1335358|NCT02026258|4391832|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
1335359|NCT02026258|4391831|P2|Randomized|Presence of periodontal disease|1
1335360|NCT02026258|4391832|P1|Randomized|Presence of periodontal disease|1
1335361|NCT02026258|4391831|P2|Randomized|Change in treatment plan|0
1335362|NCT02026258|4391832|P1|Randomized|Change in treatment plan|1
1335363|NCT02026258|4391831|P2|Randomized|Did not start treatment|1
1335364|NCT02026258|4391832|P1|Randomized|Did not start treatment|2
1335365|NCT02026141|4391866|P2|Overall Study|Protocol Violation|1
1335366|NCT02026141|4391867|P1|Overall Study|Protocol Violation|0
1335367|NCT02025907|4391875|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
1335368|NCT02025907|4391876|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
1335369|NCT02025907|4391875|P2|Overall Study|Adverse Event|1
1335370|NCT02025907|4391876|P1|Overall Study|Adverse Event|3
1335371|NCT02025907|4391875|P2|Overall Study|Lost to Follow-up|2
1335372|NCT02025907|4391876|P1|Overall Study|Lost to Follow-up|2
1335373|NCT02025907|4391875|P2|Overall Study|Physician Decision|0
1335374|NCT02025907|4391876|P1|Overall Study|Physician Decision|2
1335375|NCT02025907|4391875|P2|Overall Study|Protocol Violation|0
1335376|NCT02025907|4391876|P1|Overall Study|Protocol Violation|2
1335377|NCT02025907|4391875|P2|Overall Study|Withdrawal by Subject|8
1335378|NCT02025907|4391876|P1|Overall Study|Withdrawal by Subject|15
1335379|NCT02025907|4391875|P2|Overall Study|Lack of Efficacy|0
1335380|NCT02025907|4391876|P1|Overall Study|Lack of Efficacy|1
1335381|NCT02025621|4391933|P2|Overall Study|Surgery initiated before infusion|3
1335382|NCT02025621|4391934|P1|Overall Study|Surgery initiated before infusion|3
1335383|NCT02025621|4391933|P2|Overall Study|No longer eligible|15
1335384|NCT02025621|4391934|P1|Overall Study|No longer eligible|10
1335385|NCT02025621|4391933|P2|Overall Study|Death|1
1335386|NCT02025621|4391934|P1|Overall Study|Death|0
1335387|NCT02025621|4391933|P2|Overall Study|Withdrawal by Subject|0
1335388|NCT02025621|4391934|P1|Overall Study|Withdrawal by Subject|1
1335389|NCT02024971|4391979|P1|Overall Study|Lost to Follow-up|6
1335390|NCT02024971|4391979|P1|Overall Study|Data Not Available|30
1335391|NCT02024932|4391992|P6|Overall Study|Abnormal laboratory value|0
1335392|NCT02024932|4391993|P5|Overall Study|Abnormal laboratory value|0
1335393|NCT02024932|4391994|P4|Overall Study|Abnormal laboratory value|2
1335394|NCT02024932|4391995|P3|Overall Study|Abnormal laboratory value|0
1335395|NCT02024932|4391996|P2|Overall Study|Abnormal laboratory value|0
1335396|NCT02024932|4391997|P1|Overall Study|Abnormal laboratory value|0
1335397|NCT02024932|4391992|P6|Overall Study|Adverse Event|0
1335398|NCT02024932|4391993|P5|Overall Study|Adverse Event|2
1335399|NCT02024932|4391994|P4|Overall Study|Adverse Event|0
1335400|NCT02024932|4391995|P3|Overall Study|Adverse Event|0
1335401|NCT02024932|4391996|P2|Overall Study|Adverse Event|3
1335402|NCT02024932|4391997|P1|Overall Study|Adverse Event|2
1335403|NCT02024867|4392056|P2|Overall Study|Lost to Follow-up|4
1335404|NCT02024867|4392057|P1|Overall Study|Lost to Follow-up|6
1335405|NCT02024867|4392056|P2|Overall Study|Protocol Violation|3
1335406|NCT02024867|4392057|P1|Overall Study|Protocol Violation|3
1335407|NCT02024698|4392082|P2|First Intervention (7 Days)|Withdrawal by Subject|1
1335408|NCT02024698|4392083|P1|First Intervention (7 Days)|Withdrawal by Subject|0
1335409|NCT02023879|4392161|P3|Extension Open Label Treatment|Other than specified above|2
1335410|NCT02023879|4392162|P2|Extension Open Label Treatment|Other than specified above|7
1335411|NCT02023879|4392163|P1|Extension Open Label Treatment|Other than specified above|2
1335412|NCT02023879|4392161|P3|Extension Open Label Treatment|Participant moved|0
1335413|NCT02023879|4392162|P2|Extension Open Label Treatment|Participant moved|2
1335414|NCT02023879|4392163|P1|Extension Open Label Treatment|Participant moved|1
1335415|NCT02023879|4392161|P3|Extension Open Label Treatment|Poor compliance to protocol|0
1335416|NCT02023879|4392162|P2|Extension Open Label Treatment|Poor compliance to protocol|1
1335417|NCT02023879|4392163|P1|Extension Open Label Treatment|Poor compliance to protocol|1
1335418|NCT02023879|4392161|P3|Extension Open Label Treatment|Adverse Event|3
1335419|NCT02023879|4392162|P2|Extension Open Label Treatment|Adverse Event|7
1335420|NCT02023879|4392163|P1|Extension Open Label Treatment|Adverse Event|1
1335421|NCT02023879|4392161|P3|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
1335422|NCT02023879|4392162|P2|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
1335423|NCT02023879|4392163|P1|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
1335424|NCT02023879|4392161|P3|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
1335425|NCT02023879|4392162|P2|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
1335426|NCT02023879|4392163|P1|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
1335427|NCT02023879|4392161|P3|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
1335428|NCT02023879|4392162|P2|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
1335429|NCT02023879|4392163|P1|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
1335430|NCT02023879|4392161|P3|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
1335431|NCT02023879|4392162|P2|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
1335432|NCT02023879|4392163|P1|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
1335433|NCT02023879|4392161|P3|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
1335434|NCT02023879|4392162|P2|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
1335435|NCT02023879|4392163|P1|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
1335436|NCT02023879|4392161|P3|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
1335437|NCT02023879|4392162|P2|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
1335438|NCT02023879|4392163|P1|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
1335439|NCT02023866|4392252|P1|Overall Study|Withdrawal by Subject|1
1335440|NCT02023866|4392252|P1|Overall Study|Adverse Event|3
1335441|NCT02023866|4392252|P1|Overall Study|Non-compliance|2
1335442|NCT02023697|4392274|P3|Active Follow-up Period|PD - radiological progression|1
1335443|NCT02023697|4392275|P2|Active Follow-up Period|PD - radiological progression|0
1335444|NCT02023697|4392276|P1|Active Follow-up Period|PD - radiological progression|0
1335445|NCT02023697|4392274|P3|Active Follow-up Period|Progressive disease-clinical progression|1
1335446|NCT02023697|4392275|P2|Active Follow-up Period|Progressive disease-clinical progression|2
1335447|NCT02023697|4392276|P1|Active Follow-up Period|Progressive disease-clinical progression|0
1335448|NCT02023697|4392274|P3|Active Follow-up Period|Other unspecified|2
1335449|NCT02023697|4392275|P2|Active Follow-up Period|Other unspecified|0
1335450|NCT02023697|4392276|P1|Active Follow-up Period|Other unspecified|3
1335451|NCT02023697|4392274|P3|Active Follow-up Period|Lost to Follow-up|0
1335452|NCT02023697|4392275|P2|Active Follow-up Period|Lost to Follow-up|1
1335453|NCT02023697|4392276|P1|Active Follow-up Period|Lost to Follow-up|0
1335454|NCT02023697|4392274|P3|Active Follow-up Period|Death|75
1335455|NCT02023697|4392275|P2|Active Follow-up Period|Death|73
1335456|NCT02023697|4392276|P1|Active Follow-up Period|Death|76
1335457|NCT02023697|4392274|P3|Active Follow-up Period|Withdrawal by Subject|6
1335458|NCT02023697|4392275|P2|Active Follow-up Period|Withdrawal by Subject|12
1335459|NCT02023697|4392276|P1|Active Follow-up Period|Withdrawal by Subject|3
1335460|NCT02023697|4392274|P3|Active Follow-up Period|Ongoing active follow-up|31
1335461|NCT02023697|4392275|P2|Active Follow-up Period|Ongoing active follow-up|31
1335462|NCT02023697|4392276|P1|Active Follow-up Period|Ongoing active follow-up|35
1335463|NCT02023697|4392274|P3|Treatment Period|Withdrawal by Subject|10
1335464|NCT02023697|4392275|P2|Treatment Period|Withdrawal by Subject|4
1335465|NCT02023697|4392276|P1|Treatment Period|Withdrawal by Subject|4
1335466|NCT02023697|4392274|P3|Treatment Period|Progressive disease-clinical progression|28
1335467|NCT02023697|4392275|P2|Treatment Period|Progressive disease-clinical progression|8
1335468|NCT02023697|4392276|P1|Treatment Period|Progressive disease-clinical progression|10
1335469|NCT02023697|4392274|P3|Treatment Period|Other unspecified|5
1335470|NCT02023697|4392275|P2|Treatment Period|Other unspecified|3
1335471|NCT02023697|4392276|P1|Treatment Period|Other unspecified|1
1335472|NCT02023697|4392274|P3|Treatment Period|Adverse Event|23
1335473|NCT02023697|4392275|P2|Treatment Period|Adverse Event|25
1335474|NCT02023697|4392276|P1|Treatment Period|Adverse Event|13
1335475|NCT02023697|4392274|P3|Treatment Period|Never Treated|10
1335476|NCT02023697|4392275|P2|Treatment Period|Never Treated|6
1335477|NCT02023697|4392276|P1|Treatment Period|Never Treated|5
1335478|NCT02023697|4392274|P3|Treatment Period|PD - radiological progression|26
1335479|NCT02023697|4392275|P2|Treatment Period|PD - radiological progression|17
1335480|NCT02023697|4392276|P1|Treatment Period|PD - radiological progression|13
1335481|NCT02023268|4392389|P2|Overall Study|Withdrawal by Subject|1
1335482|NCT02023268|4392390|P1|Overall Study|Withdrawal by Subject|0
1335483|NCT02023268|4392389|P2|Overall Study|Adverse Event|2
1335484|NCT02023268|4392390|P1|Overall Study|Adverse Event|0
1335485|NCT02023268|4392389|P2|Overall Study|Lack of Efficacy|1
1335486|NCT02023268|4392390|P1|Overall Study|Lack of Efficacy|0
1335487|NCT02023151|4392396|P1|Overall Study|Lost to Follow-up|4
1335488|NCT02023112|4392466|P2|Overall Study|Withdrawal by Subject|1
1335489|NCT02023112|4392467|P1|Overall Study|Withdrawal by Subject|2
1335490|NCT02023099|4392488|P3|Overall Study|Non-treatment-emergent Fatal AE|1
1335491|NCT02023099|4392489|P2|Overall Study|Non-treatment-emergent Fatal AE|0
1335492|NCT02023099|4392490|P1|Overall Study|Non-treatment-emergent Fatal AE|0
1335493|NCT02023099|4392488|P3|Overall Study|Withdrawn Consent|1
1335494|NCT02023099|4392489|P2|Overall Study|Withdrawn Consent|0
1335495|NCT02023099|4392490|P1|Overall Study|Withdrawn Consent|3
1335496|NCT02023099|4392488|P3|Overall Study|Non-fatal Adverse Event (AE)|1
1335497|NCT02023099|4392489|P2|Overall Study|Non-fatal Adverse Event (AE)|0
1335498|NCT02023099|4392490|P1|Overall Study|Non-fatal Adverse Event (AE)|0
1335499|NCT02022748|4392513|P3|Overall Study|Withdrawal by Subject|0
1335500|NCT02022748|4392514|P2|Overall Study|Withdrawal by Subject|1
1335501|NCT02022748|4392515|P1|Overall Study|Withdrawal by Subject|0
1335502|NCT02022748|4392513|P3|Overall Study|Adverse Event|0
1335503|NCT02022748|4392514|P2|Overall Study|Adverse Event|1
1335504|NCT02022748|4392515|P1|Overall Study|Adverse Event|1
1335505|NCT02022670|4392541|P3|Overall Study|Adverse Event|1
1335506|NCT02022670|4392542|P2|Overall Study|Adverse Event|0
1335507|NCT02022670|4392543|P1|Overall Study|Adverse Event|1
1335508|NCT02022007|4392587|P3|Overall Study|Noncompliant|1
1335509|NCT02022007|4392588|P2|Overall Study|Noncompliant|0
1335510|NCT02022007|4392589|P1|Overall Study|Noncompliant|0
1335511|NCT02022007|4392587|P3|Overall Study|Withdrawal by Subject|1
1335512|NCT02022007|4392588|P2|Overall Study|Withdrawal by Subject|1
1335513|NCT02022007|4392589|P1|Overall Study|Withdrawal by Subject|1
1335514|NCT02021643|4392654|P4|Overall Study|Withdrew Consent|0
1335515|NCT02021643|4392655|P3|Overall Study|Withdrew Consent|0
1335516|NCT02021643|4392656|P2|Overall Study|Withdrew Consent|1
1335517|NCT02021643|4392657|P1|Overall Study|Withdrew Consent|0
1335518|NCT02021643|4392654|P4|Overall Study|Lost to Follow-up|0
1335519|NCT02021643|4392655|P3|Overall Study|Lost to Follow-up|0
1335520|NCT02021643|4392656|P2|Overall Study|Lost to Follow-up|1
1335521|NCT02021643|4392657|P1|Overall Study|Lost to Follow-up|0
1335522|NCT02021643|4392654|P4|Overall Study|Lack of Efficacy|12
1335523|NCT02021643|4392655|P3|Overall Study|Lack of Efficacy|0
1335524|NCT02021643|4392656|P2|Overall Study|Lack of Efficacy|6
1335525|NCT02021643|4392657|P1|Overall Study|Lack of Efficacy|7
1335526|NCT02021643|4392654|P4|Overall Study|Investigator's Discretion|0
1335527|NCT02021643|4392655|P3|Overall Study|Investigator's Discretion|0
1335528|NCT02021643|4392656|P2|Overall Study|Investigator's Discretion|0
1335529|NCT02021643|4392657|P1|Overall Study|Investigator's Discretion|1
1335530|NCT02021643|4392654|P4|Overall Study|Death|0
1335531|NCT02021643|4392655|P3|Overall Study|Death|0
1335532|NCT02021643|4392656|P2|Overall Study|Death|1
1335533|NCT02021643|4392657|P1|Overall Study|Death|0
1335534|NCT02021643|4392654|P4|Overall Study|Adverse Event|0
1335535|NCT02021643|4392655|P3|Overall Study|Adverse Event|0
1335536|NCT02021643|4392656|P2|Overall Study|Adverse Event|1
1335537|NCT02021643|4392657|P1|Overall Study|Adverse Event|0
1335538|NCT02021643|4392654|P4|Overall Study|Enrolled but Never Treated|0
1335539|NCT02021643|4392655|P3|Overall Study|Enrolled but Never Treated|0
1335540|NCT02021643|4392656|P2|Overall Study|Enrolled but Never Treated|0
1335541|NCT02021643|4392657|P1|Overall Study|Enrolled but Never Treated|1
1335542|NCT02021565|4392699|P2|3-month Follow-up|Protocol Violation|2
1335543|NCT02021565|4392700|P1|3-month Follow-up|Protocol Violation|3
1335544|NCT02021565|4392699|P2|3-month Follow-up|Withdrawal by Subject|0
1335545|NCT02021565|4392700|P1|3-month Follow-up|Withdrawal by Subject|4
1335546|NCT02021565|4392699|P2|3-month Follow-up|Death|0
1335547|NCT02021565|4392700|P1|3-month Follow-up|Death|3
1335548|NCT02021565|4392699|P2|Baseline Through Intervention|Lost to Follow-up|2
1335549|NCT02021565|4392700|P1|Baseline Through Intervention|Lost to Follow-up|4
1335550|NCT02021565|4392699|P2|Baseline Through Intervention|Protocol Violation|7
1335551|NCT02021565|4392700|P1|Baseline Through Intervention|Protocol Violation|0
1335552|NCT02021565|4392699|P2|Baseline Through Intervention|Withdrawal by Subject|8
1335553|NCT02021565|4392700|P1|Baseline Through Intervention|Withdrawal by Subject|8
1335554|NCT02021565|4392699|P2|Baseline Through Intervention|Death|1
1335555|NCT02021565|4392700|P1|Baseline Through Intervention|Death|0
1335556|NCT02021331|4392720|P2|Overall Study|Adverse Event|2
1335557|NCT02021331|4392721|P1|Overall Study|Adverse Event|0
1335558|NCT02021292|4392733|P2|Overall Study|Death|1
1335559|NCT02021292|4392734|P1|Overall Study|Death|0
1335560|NCT02021292|4392733|P2|Overall Study|Lost to Follow-up|1
1335561|NCT02021292|4392734|P1|Overall Study|Lost to Follow-up|0
1335562|NCT02021292|4392733|P2|Overall Study|Physician Decision|1
1335563|NCT02021292|4392734|P1|Overall Study|Physician Decision|0
1335564|NCT02020941|4392760|P1|Overall Study|Disease Progression|4
1335565|NCT02020941|4392760|P1|Overall Study|Withdrawal by Subject|1
1335566|NCT02020941|4392760|P1|Overall Study|Physician Decision|2
1335567|NCT02020941|4392760|P1|Overall Study|Adverse Event|1
1335568|NCT02020889|4392771|P2|Overall Study|Withdrawal by Subject|2
1335569|NCT02020889|4392772|P1|Overall Study|Withdrawal by Subject|3
1335570|NCT02020889|4392771|P2|Overall Study|Physician Decision|0
1335571|NCT02020889|4392772|P1|Overall Study|Physician Decision|2
1335572|NCT02020889|4392771|P2|Overall Study|Lost to Follow-up|0
1335573|NCT02020889|4392772|P1|Overall Study|Lost to Follow-up|1
1335574|NCT02020889|4392771|P2|Overall Study|Lack of Efficacy|0
1335575|NCT02020889|4392772|P1|Overall Study|Lack of Efficacy|1
1335576|NCT02020889|4392771|P2|Overall Study|Adverse Event|1
1335577|NCT02020889|4392772|P1|Overall Study|Adverse Event|0
1335578|NCT02020863|4392826|P1|Overall Study|Team chose not to place an a line|1
1335579|NCT02020863|4392826|P1|Overall Study|Discovery of Metastatic disease|4
1335580|NCT02020616|4392841|P7|Overall Study|Lack of Efficacy|0
1335581|NCT02020616|4392842|P6|Overall Study|Lack of Efficacy|0
1335582|NCT02020616|4392843|P5|Overall Study|Lack of Efficacy|1
1335583|NCT02020616|4392844|P4|Overall Study|Lack of Efficacy|0
1335584|NCT02020616|4392845|P3|Overall Study|Lack of Efficacy|0
1335585|NCT02020616|4392846|P2|Overall Study|Lack of Efficacy|0
1335586|NCT02020616|4392847|P1|Overall Study|Lack of Efficacy|0
1335587|NCT02020616|4392841|P7|Overall Study|Randomized in Error|0
1335588|NCT02020616|4392842|P6|Overall Study|Randomized in Error|0
1335589|NCT02020616|4392843|P5|Overall Study|Randomized in Error|0
1335590|NCT02020616|4392844|P4|Overall Study|Randomized in Error|1
1335591|NCT02020616|4392845|P3|Overall Study|Randomized in Error|0
1335592|NCT02020616|4392846|P2|Overall Study|Randomized in Error|0
1335593|NCT02020616|4392847|P1|Overall Study|Randomized in Error|0
1335594|NCT02020616|4392841|P7|Overall Study|Early Termination Criteria Met|0
1335595|NCT02020616|4392842|P6|Overall Study|Early Termination Criteria Met|1
1335596|NCT02020616|4392843|P5|Overall Study|Early Termination Criteria Met|0
1335597|NCT02020616|4392844|P4|Overall Study|Early Termination Criteria Met|0
1335598|NCT02020616|4392845|P3|Overall Study|Early Termination Criteria Met|1
1335599|NCT02020616|4392846|P2|Overall Study|Early Termination Criteria Met|0
1335600|NCT02020616|4392847|P1|Overall Study|Early Termination Criteria Met|0
1335601|NCT02020616|4392841|P7|Overall Study|Lost to Follow-up|0
1335602|NCT02020616|4392842|P6|Overall Study|Lost to Follow-up|1
1335603|NCT02020616|4392843|P5|Overall Study|Lost to Follow-up|1
1335604|NCT02020616|4392844|P4|Overall Study|Lost to Follow-up|1
1335605|NCT02020616|4392845|P3|Overall Study|Lost to Follow-up|0
1335606|NCT02020616|4392846|P2|Overall Study|Lost to Follow-up|1
1335607|NCT02020616|4392847|P1|Overall Study|Lost to Follow-up|0
1335608|NCT02020616|4392841|P7|Overall Study|Withdrawal by Subject|1
1335609|NCT02020616|4392842|P6|Overall Study|Withdrawal by Subject|1
1335610|NCT02020616|4392843|P5|Overall Study|Withdrawal by Subject|0
1335611|NCT02020616|4392844|P4|Overall Study|Withdrawal by Subject|0
1335612|NCT02020616|4392845|P3|Overall Study|Withdrawal by Subject|1
1335613|NCT02020616|4392846|P2|Overall Study|Withdrawal by Subject|0
1335614|NCT02020616|4392847|P1|Overall Study|Withdrawal by Subject|0
1335615|NCT02020616|4392841|P7|Overall Study|Physician Decision|2
1335616|NCT02020616|4392842|P6|Overall Study|Physician Decision|1
1335617|NCT02020616|4392843|P5|Overall Study|Physician Decision|0
1335618|NCT02020616|4392844|P4|Overall Study|Physician Decision|0
1335619|NCT02020616|4392845|P3|Overall Study|Physician Decision|0
1335620|NCT02020616|4392846|P2|Overall Study|Physician Decision|0
1335621|NCT02020616|4392847|P1|Overall Study|Physician Decision|0
1335622|NCT02020616|4392841|P7|Overall Study|Adverse Event|1
1335623|NCT02020616|4392842|P6|Overall Study|Adverse Event|1
1335624|NCT02020616|4392843|P5|Overall Study|Adverse Event|0
1335625|NCT02020616|4392844|P4|Overall Study|Adverse Event|0
1335626|NCT02020616|4392845|P3|Overall Study|Adverse Event|0
1335627|NCT02020616|4392846|P2|Overall Study|Adverse Event|0
1335628|NCT02020616|4392847|P1|Overall Study|Adverse Event|0
1335629|NCT02020577|4392940|P2|Overall Study|Other than stated above|1
1335630|NCT02020577|4392941|P1|Overall Study|Other than stated above|0
1335631|NCT02020577|4392940|P2|Overall Study|Withdrawal by Subject|1
1335632|NCT02020577|4392941|P1|Overall Study|Withdrawal by Subject|0
1335633|NCT02020577|4392940|P2|Overall Study|Other AE or clinical progression|15
1335634|NCT02020577|4392941|P1|Overall Study|Other AE or clinical progression|0
1335635|NCT02020577|4392940|P2|Overall Study|Progressive disease|38
1335636|NCT02020577|4392941|P1|Overall Study|Progressive disease|3
1335637|NCT02020512|4392968|P1|Overall Study|Protocol Violation|4
1335638|NCT02020512|4392968|P1|Overall Study|Lost to Follow-up|3
1335639|NCT02020512|4392968|P1|Overall Study|Adverse Event|1
1335640|NCT02020031|4393020|P2|Overall Study|Physician Decision|1
1335641|NCT02020031|4393021|P1|Overall Study|Physician Decision|1
1335642|NCT02019979|4393029|P1|Overall Study|study terminated|14
1335643|NCT02019719|4393040|P5|Overall Study|Physician Decision|0
1335644|NCT02019719|4393041|P4|Overall Study|Physician Decision|0
1335645|NCT02019719|4393042|P3|Overall Study|Physician Decision|0
1335646|NCT02019719|4393043|P2|Overall Study|Physician Decision|0
1335647|NCT02019719|4393044|P1|Overall Study|Physician Decision|2
1335648|NCT02019719|4393040|P5|Overall Study|Protocol defined stopping criteria|1
1335649|NCT02019719|4393041|P4|Overall Study|Protocol defined stopping criteria|1
1335650|NCT02019719|4393042|P3|Overall Study|Protocol defined stopping criteria|0
1335651|NCT02019719|4393043|P2|Overall Study|Protocol defined stopping criteria|0
1335652|NCT02019719|4393044|P1|Overall Study|Protocol defined stopping criteria|2
1335653|NCT02019719|4393040|P5|Overall Study|Protocol Violation|0
1335654|NCT02019719|4393041|P4|Overall Study|Protocol Violation|0
1335655|NCT02019719|4393042|P3|Overall Study|Protocol Violation|0
1335656|NCT02019719|4393043|P2|Overall Study|Protocol Violation|1
1335657|NCT02019719|4393044|P1|Overall Study|Protocol Violation|1
1335658|NCT02019719|4393040|P5|Overall Study|Adverse Event|1
1335659|NCT02019719|4393041|P4|Overall Study|Adverse Event|1
1335660|NCT02019719|4393042|P3|Overall Study|Adverse Event|0
1335661|NCT02019719|4393043|P2|Overall Study|Adverse Event|0
1335662|NCT02019719|4393044|P1|Overall Study|Adverse Event|1
1335663|NCT02019550|4393160|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
1335664|NCT02019550|4393161|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
1335665|NCT02019472|4393202|P3|Overall Study|Other|6
1335666|NCT02019472|4393203|P2|Overall Study|Other|8
1335667|NCT02019472|4393204|P1|Overall Study|Other|3
1335668|NCT02019472|4393202|P3|Overall Study|Withdrawal by Subject|11
1335669|NCT02019472|4393203|P2|Overall Study|Withdrawal by Subject|10
1335670|NCT02019472|4393204|P1|Overall Study|Withdrawal by Subject|11
1335671|NCT02019472|4393202|P3|Overall Study|Pregnancy|2
1335672|NCT02019472|4393203|P2|Overall Study|Pregnancy|2
1335673|NCT02019472|4393204|P1|Overall Study|Pregnancy|1
1335674|NCT02019472|4393202|P3|Overall Study|Physician Decision|0
1335675|NCT02019472|4393203|P2|Overall Study|Physician Decision|2
1335676|NCT02019472|4393204|P1|Overall Study|Physician Decision|1
1335677|NCT02019472|4393202|P3|Overall Study|Lost to Follow-up|1
1335678|NCT02019472|4393203|P2|Overall Study|Lost to Follow-up|2
1335679|NCT02019472|4393204|P1|Overall Study|Lost to Follow-up|0
1335680|NCT02019472|4393202|P3|Overall Study|Lack of Efficacy|4
1335681|NCT02019472|4393203|P2|Overall Study|Lack of Efficacy|4
1335682|NCT02019472|4393204|P1|Overall Study|Lack of Efficacy|7
1335683|NCT02019472|4393202|P3|Overall Study|Death|1
1335684|NCT02019472|4393203|P2|Overall Study|Death|1
1335685|NCT02019472|4393204|P1|Overall Study|Death|0
1335686|NCT02019472|4393202|P3|Overall Study|Adverse Event|17
1335687|NCT02019472|4393203|P2|Overall Study|Adverse Event|23
1335688|NCT02019472|4393204|P1|Overall Study|Adverse Event|14
1335689|NCT02019277|4393225|P1|Overall Study|Adverse Event|1
1335690|NCT02019277|4393225|P1|Overall Study|Did no Cooperate|1
1335691|NCT02019277|4393225|P1|Overall Study|Death|7
1335692|NCT02019277|4393225|P1|Overall Study|Withdrawal by Subject|3
1335693|NCT02018822|4393244|P3|Overall Study|Lost to Follow-up|5
1335694|NCT02018822|4393245|P2|Overall Study|Lost to Follow-up|6
1335695|NCT02018822|4393246|P1|Overall Study|Lost to Follow-up|6
1335696|NCT02018822|4393244|P3|Overall Study|Physician Decision|1
1335697|NCT02018822|4393245|P2|Overall Study|Physician Decision|1
1335698|NCT02018822|4393246|P1|Overall Study|Physician Decision|0
1335699|NCT02018822|4393244|P3|Overall Study|filling replaced by crown|0
1335700|NCT02018822|4393245|P2|Overall Study|filling replaced by crown|1
1335701|NCT02018822|4393246|P1|Overall Study|filling replaced by crown|0
1335702|NCT02018562|4393301|P2|Overall Study|Discharged prior to study completion|0
1335703|NCT02018562|4393302|P1|Overall Study|Discharged prior to study completion|1
1335704|NCT02018562|4393301|P2|Overall Study|Withdrawal by Subject|0
1335705|NCT02018562|4393302|P1|Overall Study|Withdrawal by Subject|2
1335706|NCT02017522|4393331|P1|Overall Study|Withdrawal by Subject|1
1335707|NCT02017015|4393347|P1|Overall Study|Physician Decision|2
1335708|NCT02017015|4393347|P1|Overall Study|Non-compliance with study drug|2
1335709|NCT02017015|4393347|P1|Overall Study|Progressive Disease|31
1335710|NCT02017015|4393347|P1|Overall Study|Death|4
1335711|NCT02017015|4393347|P1|Overall Study|Withdrawal by Subject|21
1335712|NCT02017015|4393347|P1|Overall Study|Adverse Event|9
1335713|NCT02016898|4393372|P2|Overall Study|Lost to Follow-up|4
1335714|NCT02016898|4393373|P1|Overall Study|Lost to Follow-up|4
1335715|NCT02016898|4393372|P2|Overall Study|Death|1
1335716|NCT02016898|4393373|P1|Overall Study|Death|1
1335717|NCT02016690|4393381|P1|Overall Study|Hospitalized for RSV at study start|3
1335718|NCT02016690|4393381|P1|Overall Study|Did not meet inclusion criteria|13
1335719|NCT02016690|4393381|P1|Overall Study|Excluded from SAS: Ineligible for study|2
1335720|NCT02016690|4393381|P1|Overall Study|Excluded from SAS: Early treatment|2
1335721|NCT02016690|4393381|P1|Overall Study|Excluded from SAS: Duplication|2
1335722|NCT02016690|4393381|P1|Overall Study|Excluded from SAS: Enrollment violation|2
1335723|NCT02016625|4393394|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
1335724|NCT02016625|4393395|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
1335725|NCT02016625|4393394|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
1335726|NCT02016625|4393395|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
1335727|NCT02016625|4393394|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
1335728|NCT02016625|4393395|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
1335729|NCT02016482|4393450|P2|Period B|Required Alternative/Prohibited Therapy|2
1335730|NCT02016482|4393451|P1|Period B|Required Alternative/Prohibited Therapy|0
1335731|NCT02016482|4393450|P2|Period B|Not Specified|0
1335732|NCT02016482|4393451|P1|Period B|Not Specified|4
1335733|NCT02016482|4393450|P2|Period B|Lack of Efficacy|4
1335734|NCT02016482|4393451|P1|Period B|Lack of Efficacy|6
1335735|NCT02016482|4393450|P2|Period B|Lost to Follow-up|0
1335736|NCT02016482|4393451|P1|Period B|Lost to Follow-up|2
1335737|NCT02016482|4393450|P2|Period B|Withdrawal by Subject|1
1335738|NCT02016482|4393451|P1|Period B|Withdrawal by Subject|1
1335739|NCT02016482|4393450|P2|Period A|Required Alternative/Prohibited Therapy|1
1335740|NCT02016482|4393451|P1|Period A|Required Alternative/Prohibited Therapy|0
1335741|NCT02016482|4393450|P2|Period A|Protocol Violation|1
1335742|NCT02016482|4393451|P1|Period A|Protocol Violation|0
1335743|NCT02016482|4393450|P2|Period A|Not Specified|0
1335744|NCT02016482|4393451|P1|Period A|Not Specified|3
1335745|NCT02016482|4393450|P2|Period A|Lack of Efficacy|1
1335746|NCT02016482|4393451|P1|Period A|Lack of Efficacy|2
1335747|NCT02016482|4393450|P2|Period A|Lost to Follow-up|3
1335748|NCT02016482|4393451|P1|Period A|Lost to Follow-up|3
1335749|NCT02016482|4393450|P2|Period A|Withdrawal by Subject|4
1335750|NCT02016482|4393451|P1|Period A|Withdrawal by Subject|3
1335751|NCT02016482|4393450|P2|Period A|Adverse Event|5
1335752|NCT02016482|4393451|P1|Period A|Adverse Event|3
1335753|NCT02016170|4393542|P3|Overall Study|Protocol Violation|0
1335754|NCT02016170|4393543|P2|Overall Study|Protocol Violation|0
1335755|NCT02016170|4393544|P1|Overall Study|Protocol Violation|1
1335756|NCT02016170|4393542|P3|Overall Study|Adverse Event|0
1335757|NCT02016170|4393543|P2|Overall Study|Adverse Event|1
1335758|NCT02016170|4393544|P1|Overall Study|Adverse Event|1
1335759|NCT02016105|4393555|P6|EXTENSION PERIOD|Lost to Follow-up|2
1335760|NCT02016105|4393556|P5|EXTENSION PERIOD|Lost to Follow-up|0
1335761|NCT02016105|4393557|P4|EXTENSION PERIOD|Lost to Follow-up|0
1335762|NCT02016105|4393558|P3|EXTENSION PERIOD|Lost to Follow-up|0
1335763|NCT02016105|4393559|P2|EXTENSION PERIOD|Lost to Follow-up|0
1335764|NCT02016105|4393560|P1|EXTENSION PERIOD|Lost to Follow-up|0
1335765|NCT02016105|4393555|P6|EXTENSION PERIOD|Non-compliance with study indication|0
1335766|NCT02016105|4393556|P5|EXTENSION PERIOD|Non-compliance with study indication|1
1335767|NCT02016105|4393557|P4|EXTENSION PERIOD|Non-compliance with study indication|0
1335768|NCT02016105|4393558|P3|EXTENSION PERIOD|Non-compliance with study indication|0
1335769|NCT02016105|4393559|P2|EXTENSION PERIOD|Non-compliance with study indication|0
1335770|NCT02016105|4393560|P1|EXTENSION PERIOD|Non-compliance with study indication|0
1335771|NCT02016105|4393555|P6|EXTENSION PERIOD|Withdrawal by Subject|2
1335772|NCT02016105|4393556|P5|EXTENSION PERIOD|Withdrawal by Subject|2
1335773|NCT02016105|4393557|P4|EXTENSION PERIOD|Withdrawal by Subject|2
1335774|NCT02016105|4393558|P3|EXTENSION PERIOD|Withdrawal by Subject|2
1335775|NCT02016105|4393559|P2|EXTENSION PERIOD|Withdrawal by Subject|0
1335776|NCT02016105|4393560|P1|EXTENSION PERIOD|Withdrawal by Subject|0
1335777|NCT02016105|4393555|P6|EXTENSION PERIOD|Adverse Event|0
1335778|NCT02016105|4393556|P5|EXTENSION PERIOD|Adverse Event|1
1335779|NCT02016105|4393557|P4|EXTENSION PERIOD|Adverse Event|0
1335780|NCT02016105|4393558|P3|EXTENSION PERIOD|Adverse Event|2
1335781|NCT02016105|4393559|P2|EXTENSION PERIOD|Adverse Event|0
1335782|NCT02016105|4393560|P1|EXTENSION PERIOD|Adverse Event|0
1335783|NCT02016105|4393555|P6|EXTENSION PERIOD|Lack of Efficacy|1
1335784|NCT02016105|4393556|P5|EXTENSION PERIOD|Lack of Efficacy|1
1335785|NCT02016105|4393557|P4|EXTENSION PERIOD|Lack of Efficacy|3
1335786|NCT02016105|4393558|P3|EXTENSION PERIOD|Lack of Efficacy|1
1335787|NCT02016105|4393559|P2|EXTENSION PERIOD|Lack of Efficacy|0
1335788|NCT02016105|4393560|P1|EXTENSION PERIOD|Lack of Efficacy|0
1335789|NCT02016105|4393555|P6|EXTENSION PERIOD|New therapy for study indication|1
1335790|NCT02016105|4393556|P5|EXTENSION PERIOD|New therapy for study indication|1
1335791|NCT02016105|4393557|P4|EXTENSION PERIOD|New therapy for study indication|0
1335792|NCT02016105|4393558|P3|EXTENSION PERIOD|New therapy for study indication|0
1335793|NCT02016105|4393559|P2|EXTENSION PERIOD|New therapy for study indication|0
1335794|NCT02016105|4393560|P1|EXTENSION PERIOD|New therapy for study indication|0
1335795|NCT02016105|4393555|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
1335796|NCT02016105|4393556|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
1335797|NCT02016105|4393557|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
1335798|NCT02016105|4393558|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
1335799|NCT02016105|4393559|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
1335800|NCT02016105|4393560|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
1335801|NCT02016105|4393555|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
1335802|NCT02016105|4393556|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
1335803|NCT02016105|4393557|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
1335804|NCT02016105|4393558|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
1335805|NCT02016105|4393559|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
1335806|NCT02016105|4393560|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
1335807|NCT02016105|4393555|P6|TREATMENT PERIOD 2|Adverse Event|1
1335808|NCT02016105|4393556|P5|TREATMENT PERIOD 2|Adverse Event|0
1335809|NCT02016105|4393557|P4|TREATMENT PERIOD 2|Adverse Event|4
1335810|NCT02016105|4393558|P3|TREATMENT PERIOD 2|Adverse Event|0
1335811|NCT02016105|4393559|P2|TREATMENT PERIOD 2|Adverse Event|0
1335812|NCT02016105|4393560|P1|TREATMENT PERIOD 2|Adverse Event|0
1335813|NCT02016105|4393555|P6|TREATMENT PERIOD 2|Death|1
1335814|NCT02016105|4393556|P5|TREATMENT PERIOD 2|Death|0
1335815|NCT02016105|4393557|P4|TREATMENT PERIOD 2|Death|0
1335816|NCT02016105|4393558|P3|TREATMENT PERIOD 2|Death|0
1335817|NCT02016105|4393559|P2|TREATMENT PERIOD 2|Death|0
1335818|NCT02016105|4393560|P1|TREATMENT PERIOD 2|Death|0
1335819|NCT02016105|4393555|P6|TREATMENT PERIOD 2|Pregnancy|1
1335820|NCT02016105|4393556|P5|TREATMENT PERIOD 2|Pregnancy|0
1335821|NCT02016105|4393557|P4|TREATMENT PERIOD 2|Pregnancy|0
1335822|NCT02016105|4393558|P3|TREATMENT PERIOD 2|Pregnancy|0
1335823|NCT02016105|4393559|P2|TREATMENT PERIOD 2|Pregnancy|0
1335824|NCT02016105|4393560|P1|TREATMENT PERIOD 2|Pregnancy|0
1335825|NCT02016105|4393555|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
1335826|NCT02016105|4393556|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
1335827|NCT02016105|4393557|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
1335828|NCT02016105|4393558|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
1335829|NCT02016105|4393559|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
1335830|NCT02016105|4393560|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
1335831|NCT02016105|4393555|P6|TREATMENT PERIOD 2|Non compliance study medication|1
1335832|NCT02016105|4393556|P5|TREATMENT PERIOD 2|Non compliance study medication|0
1335833|NCT02016105|4393557|P4|TREATMENT PERIOD 2|Non compliance study medication|0
1335834|NCT02016105|4393558|P3|TREATMENT PERIOD 2|Non compliance study medication|0
1335835|NCT02016105|4393559|P2|TREATMENT PERIOD 2|Non compliance study medication|0
1335836|NCT02016105|4393560|P1|TREATMENT PERIOD 2|Non compliance study medication|0
1335837|NCT02016105|4393555|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
1335838|NCT02016105|4393556|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
1335839|NCT02016105|4393557|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
1335840|NCT02016105|4393558|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
1335841|NCT02016105|4393559|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
1335842|NCT02016105|4393560|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
1335843|NCT02016105|4393555|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
1335844|NCT02016105|4393556|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
1335845|NCT02016105|4393557|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
1335846|NCT02016105|4393558|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
1335847|NCT02016105|4393559|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
1335848|NCT02016105|4393560|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
1335849|NCT02016105|4393555|P6|TREATMENT PERIOD 1|Adverse Event|0
1335850|NCT02016105|4393556|P5|TREATMENT PERIOD 1|Adverse Event|0
1335851|NCT02016105|4393557|P4|TREATMENT PERIOD 1|Adverse Event|0
1335852|NCT02016105|4393558|P3|TREATMENT PERIOD 1|Adverse Event|0
1335853|NCT02016105|4393559|P2|TREATMENT PERIOD 1|Adverse Event|5
1335854|NCT02016105|4393560|P1|TREATMENT PERIOD 1|Adverse Event|3
1335855|NCT02016105|4393555|P6|TREATMENT PERIOD 1|Pregnancy|0
1335856|NCT02016105|4393556|P5|TREATMENT PERIOD 1|Pregnancy|0
1335857|NCT02016105|4393557|P4|TREATMENT PERIOD 1|Pregnancy|0
1335858|NCT02016105|4393558|P3|TREATMENT PERIOD 1|Pregnancy|0
1335859|NCT02016105|4393559|P2|TREATMENT PERIOD 1|Pregnancy|1
1335860|NCT02016105|4393560|P1|TREATMENT PERIOD 1|Pregnancy|0
1335861|NCT02016105|4393555|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
1335862|NCT02016105|4393556|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
1335863|NCT02016105|4393557|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
1335864|NCT02016105|4393558|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
1335865|NCT02016105|4393559|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
1335866|NCT02016105|4393560|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
1335867|NCT02016105|4393555|P6|TREATMENT PERIOD 1|Physician Decision|0
1335868|NCT02016105|4393556|P5|TREATMENT PERIOD 1|Physician Decision|0
1335869|NCT02016105|4393557|P4|TREATMENT PERIOD 1|Physician Decision|0
1335870|NCT02016105|4393558|P3|TREATMENT PERIOD 1|Physician Decision|0
1335871|NCT02016105|4393559|P2|TREATMENT PERIOD 1|Physician Decision|2
1335872|NCT02016105|4393560|P1|TREATMENT PERIOD 1|Physician Decision|0
1335873|NCT02016105|4393555|P6|TREATMENT PERIOD 1|Protocol Violation|0
1335874|NCT02016105|4393556|P5|TREATMENT PERIOD 1|Protocol Violation|0
1335875|NCT02016105|4393557|P4|TREATMENT PERIOD 1|Protocol Violation|0
1335876|NCT02016105|4393558|P3|TREATMENT PERIOD 1|Protocol Violation|0
1335877|NCT02016105|4393559|P2|TREATMENT PERIOD 1|Protocol Violation|8
1335878|NCT02016105|4393560|P1|TREATMENT PERIOD 1|Protocol Violation|2
1335879|NCT02015793|4393619|P2|Overall Study|Withdrawal by Subject|1
1335880|NCT02015793|4393620|P1|Overall Study|Withdrawal by Subject|1
1335881|NCT02015793|4393619|P2|Overall Study|Adverse Event|3
1335882|NCT02015793|4393620|P1|Overall Study|Adverse Event|3
1335883|NCT02015754|4393650|P1|Overall Study|Lost to Follow-up|1
1335884|NCT02015754|4393650|P1|Overall Study|Change in treatment modality|5
1335885|NCT02015754|4393650|P1|Overall Study|Disease progression|5
1335886|NCT02015676|4393670|P3|Overall Study|Disease progression|1
1335887|NCT02015676|4393671|P2|Overall Study|Disease progression|1
1335888|NCT02015676|4393672|P1|Overall Study|Disease progression|3
1335889|NCT02015676|4393670|P3|Overall Study|Death|0
1335890|NCT02015676|4393671|P2|Overall Study|Death|1
1335891|NCT02015676|4393672|P1|Overall Study|Death|0
1335892|NCT02015676|4393670|P3|Overall Study|Administrative reasons|1
1335893|NCT02015676|4393671|P2|Overall Study|Administrative reasons|3
1335894|NCT02015676|4393672|P1|Overall Study|Administrative reasons|0
1335895|NCT02015676|4393670|P3|Overall Study|Withdrawal by Subject|1
1335896|NCT02015676|4393671|P2|Overall Study|Withdrawal by Subject|7
1335897|NCT02015676|4393672|P1|Overall Study|Withdrawal by Subject|1
1335898|NCT02015676|4393670|P3|Overall Study|Protocol Violation|0
1335899|NCT02015676|4393671|P2|Overall Study|Protocol Violation|0
1335900|NCT02015676|4393672|P1|Overall Study|Protocol Violation|1
1335901|NCT02015676|4393670|P3|Overall Study|Lack of Efficacy|0
1335902|NCT02015676|4393671|P2|Overall Study|Lack of Efficacy|4
1335903|NCT02015676|4393672|P1|Overall Study|Lack of Efficacy|2
1335904|NCT02015676|4393670|P3|Overall Study|Adverse Event|0
1335905|NCT02015676|4393671|P2|Overall Study|Adverse Event|18
1335906|NCT02015676|4393672|P1|Overall Study|Adverse Event|2
1335907|NCT02015663|4393688|P2|Overall Study|Administrative problems|11
1335908|NCT02015663|4393689|P1|Overall Study|Administrative problems|10
1335909|NCT02015663|4393688|P2|Overall Study|Adverse Event|0
1335910|NCT02015663|4393689|P1|Overall Study|Adverse Event|3
1335911|NCT02015663|4393688|P2|Overall Study|Protocol Violation|1
1335912|NCT02015663|4393689|P1|Overall Study|Protocol Violation|0
1335913|NCT02015663|4393688|P2|Overall Study|Withdrawal by Subject|0
1335914|NCT02015663|4393689|P1|Overall Study|Withdrawal by Subject|1
1335915|NCT02015663|4393688|P2|Overall Study|unsatisfactory therapeutic effect|0
1335916|NCT02015663|4393689|P1|Overall Study|unsatisfactory therapeutic effect|1
1335917|NCT02015637|4393720|P2|Overall Study|Did not take study drug|0
1335918|NCT02015637|4393721|P1|Overall Study|Did not take study drug|2
1335919|NCT02015637|4393720|P2|Overall Study|Adverse Event|0
1335920|NCT02015637|4393721|P1|Overall Study|Adverse Event|3
1335921|NCT02015637|4393720|P2|Overall Study|Lost to Follow-up|5
1335922|NCT02015637|4393721|P1|Overall Study|Lost to Follow-up|3
1335923|NCT02015546|4393732|P3|Overall Study|Screem Failure|3
1335924|NCT02015546|4393733|P2|Overall Study|Screem Failure|1
1335925|NCT02015546|4393734|P1|Overall Study|Screem Failure|2
1335926|NCT02015546|4393732|P3|Overall Study|Withdrawal by Subject|1
1335927|NCT02015546|4393733|P2|Overall Study|Withdrawal by Subject|1
1335928|NCT02015546|4393734|P1|Overall Study|Withdrawal by Subject|1
1335929|NCT02015481|4393766|P1|Overall Study|Death|1
1335930|NCT02015221|4393790|P2|Overall Study|Lost to Follow-up|0
1335931|NCT02015221|4393791|P1|Overall Study|Lost to Follow-up|1
1335932|NCT02015221|4393790|P2|Overall Study|Withdrawal by Subject|6
1335933|NCT02015221|4393791|P1|Overall Study|Withdrawal by Subject|8
1335934|NCT02015195|4393804|P7|Overall Study|Adverse Event|0
1335935|NCT02015195|4393805|P6|Overall Study|Adverse Event|0
1335936|NCT02015195|4393806|P5|Overall Study|Adverse Event|0
1335937|NCT02015195|4393807|P4|Overall Study|Adverse Event|1
1335938|NCT02015195|4393808|P3|Overall Study|Adverse Event|0
1335939|NCT02015195|4393809|P2|Overall Study|Adverse Event|0
1335940|NCT02015195|4393810|P1|Overall Study|Adverse Event|0
1335941|NCT02015039|4393833|P2|Overall Study|Not eligible|1
1335942|NCT02015039|4393834|P1|Overall Study|Not eligible|0
1335943|NCT02014740|4393854|P2|Overall Study|Withdrawal by Subject|1
1335944|NCT02014740|4393855|P1|Overall Study|Withdrawal by Subject|2
1335945|NCT02014740|4393854|P2|Overall Study|Lost to Follow-up|4
1335946|NCT02014740|4393855|P1|Overall Study|Lost to Follow-up|4
1335947|NCT02014584|4393863|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1335948|NCT02014584|4393864|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
1335949|NCT02014584|4393865|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1335950|NCT02014584|4393866|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1335951|NCT02014584|4393867|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1335952|NCT02014584|4393868|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1335953|NCT02014584|4393863|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1335954|NCT02014584|4393864|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1335955|NCT02014584|4393865|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
1335956|NCT02014584|4393866|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
1335957|NCT02014584|4393867|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1335958|NCT02014584|4393868|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1335959|NCT02014584|4393863|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1335960|NCT02014584|4393864|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1335961|NCT02014584|4393865|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1335962|NCT02014584|4393866|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
1335963|NCT02014584|4393867|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1335964|NCT02014584|4393868|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1335965|NCT02014584|4393863|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1335966|NCT02014584|4393864|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1335967|NCT02014584|4393865|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1335968|NCT02014584|4393866|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1335969|NCT02014584|4393867|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
1335970|NCT02014584|4393868|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
1335971|NCT02014584|4393863|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
1335972|NCT02014584|4393864|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
1335973|NCT02014584|4393865|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
1335974|NCT02014584|4393866|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
1335975|NCT02014584|4393867|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
1335976|NCT02014584|4393868|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
1335977|NCT02014480|4393985|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
1335978|NCT02014480|4393986|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1335979|NCT02014480|4393987|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1335980|NCT02014480|4393988|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1335981|NCT02014480|4393989|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1335982|NCT02014480|4393990|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1335983|NCT02014480|4393985|P6|Treatment Period 3 (14 Days)|Adverse Event|1
1335984|NCT02014480|4393986|P5|Treatment Period 3 (14 Days)|Adverse Event|0
1335985|NCT02014480|4393987|P4|Treatment Period 3 (14 Days)|Adverse Event|0
1335986|NCT02014480|4393988|P3|Treatment Period 3 (14 Days)|Adverse Event|1
1335987|NCT02014480|4393989|P2|Treatment Period 3 (14 Days)|Adverse Event|0
1335988|NCT02014480|4393990|P1|Treatment Period 3 (14 Days)|Adverse Event|0
1335989|NCT02014480|4393985|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1335990|NCT02014480|4393986|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1335991|NCT02014480|4393987|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1335992|NCT02014480|4393988|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1335993|NCT02014480|4393989|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
1335994|NCT02014480|4393990|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1335995|NCT02014480|4393985|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
1335996|NCT02014480|4393986|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
1335997|NCT02014480|4393987|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
1335998|NCT02014480|4393988|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
1335999|NCT02014480|4393989|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
1336000|NCT02014480|4393990|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
1336001|NCT02014480|4393985|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1336002|NCT02014480|4393986|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1336003|NCT02014480|4393987|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1336004|NCT02014480|4393988|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
1336005|NCT02014480|4393989|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1336006|NCT02014480|4393990|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1336007|NCT02014480|4393985|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1336008|NCT02014480|4393986|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1336009|NCT02014480|4393987|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
1336010|NCT02014480|4393988|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1336011|NCT02014480|4393989|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1336012|NCT02014480|4393990|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1336013|NCT02014480|4393985|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1336014|NCT02014480|4393986|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1336015|NCT02014480|4393987|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1336016|NCT02014480|4393988|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
1336017|NCT02014480|4393989|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1336018|NCT02014480|4393990|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1336019|NCT02014467|4394009|P2|Overall Study|Withdrawal by Subject|4
1336020|NCT02014467|4394010|P1|Overall Study|Withdrawal by Subject|16
1336021|NCT02014467|4394009|P2|Overall Study|Physician Decision|3
1336022|NCT02014467|4394010|P1|Overall Study|Physician Decision|2
1336023|NCT02014467|4394009|P2|Overall Study|Protocol Violation|0
1336024|NCT02014467|4394010|P1|Overall Study|Protocol Violation|3
1336025|NCT02014467|4394009|P2|Overall Study|Adverse Event|0
1336026|NCT02014467|4394010|P1|Overall Study|Adverse Event|4
1336027|NCT02014441|4394070|P1|Overall Study|Continuing in Study|21
1336028|NCT02014441|4394070|P1|Overall Study|Withdrawal by Subject|9
1336029|NCT02014402|4394166|P4|Overall Study|Lost to Follow-up|2
1336030|NCT02014402|4394167|P3|Overall Study|Lost to Follow-up|1
1336031|NCT02014402|4394168|P2|Overall Study|Lost to Follow-up|0
1336032|NCT02014402|4394169|P1|Overall Study|Lost to Follow-up|0
1336033|NCT02014402|4394166|P4|Overall Study|Subject did not have transportation|0
1336034|NCT02014402|4394167|P3|Overall Study|Subject did not have transportation|0
1336035|NCT02014402|4394168|P2|Overall Study|Subject did not have transportation|1
1336036|NCT02014402|4394169|P1|Overall Study|Subject did not have transportation|0
1336037|NCT02014402|4394166|P4|Overall Study|Withdrawal by Subject|1
1336038|NCT02014402|4394167|P3|Overall Study|Withdrawal by Subject|2
1336039|NCT02014402|4394168|P2|Overall Study|Withdrawal by Subject|2
1336040|NCT02014402|4394169|P1|Overall Study|Withdrawal by Subject|1
1336041|NCT02014402|4394166|P4|Overall Study|Adverse Event|0
1336042|NCT02014402|4394167|P3|Overall Study|Adverse Event|0
1336043|NCT02014402|4394168|P2|Overall Study|Adverse Event|0
1336044|NCT02014402|4394169|P1|Overall Study|Adverse Event|1
1336045|NCT02014272|4394209|P2|Intervention Period 1|Adverse Event|1
1336046|NCT02014272|4394210|P1|Intervention Period 1|Adverse Event|0
1336047|NCT02014272|4394209|P2|Intervention Period 1|Withdrawal by Subject|0
1336048|NCT02014272|4394210|P1|Intervention Period 1|Withdrawal by Subject|1
1336049|NCT02013830|4394242|P1|Overall Study|Refused treatment|1
1336050|NCT02013830|4394242|P1|Overall Study|Insufficient therapeutic response|25
1336051|NCT02013830|4394242|P1|Overall Study|Death|1
1336052|NCT02013830|4394242|P1|Overall Study|Adverse Event|3
1336053|NCT02013817|4394253|P1|Overall Study|Not specified|9
1336054|NCT02013817|4394253|P1|Overall Study|Death|2
1336055|NCT02013817|4394253|P1|Overall Study|Withdrawal by Subject|4
1336056|NCT02013817|4394253|P1|Overall Study|Adverse Event|12
1336057|NCT02013791|4394271|P9|Period 1|Other Miscellaneous Reasons|0
1336058|NCT02013791|4394272|P8|Period 1|Other Miscellaneous Reasons|0
1336059|NCT02013791|4394273|P7|Period 1|Other Miscellaneous Reasons|0
1336060|NCT02013791|4394274|P6|Period 1|Other Miscellaneous Reasons|0
1336061|NCT02013791|4394275|P5|Period 1|Other Miscellaneous Reasons|0
1336062|NCT02013791|4394276|P4|Period 1|Other Miscellaneous Reasons|0
1336063|NCT02013791|4394277|P3|Period 1|Other Miscellaneous Reasons|0
1336064|NCT02013791|4394278|P2|Period 1|Other Miscellaneous Reasons|2
1336065|NCT02013791|4394279|P1|Period 1|Other Miscellaneous Reasons|0
1336066|NCT02013791|4394271|P9|Period 1|Lost to Follow-up|0
1336067|NCT02013791|4394272|P8|Period 1|Lost to Follow-up|1
1336068|NCT02013791|4394273|P7|Period 1|Lost to Follow-up|1
1336069|NCT02013791|4394274|P6|Period 1|Lost to Follow-up|0
1336070|NCT02013791|4394275|P5|Period 1|Lost to Follow-up|0
1336071|NCT02013791|4394276|P4|Period 1|Lost to Follow-up|1
1336072|NCT02013791|4394277|P3|Period 1|Lost to Follow-up|0
1336073|NCT02013791|4394278|P2|Period 1|Lost to Follow-up|0
1336074|NCT02013791|4394279|P1|Period 1|Lost to Follow-up|0
1336075|NCT02013765|4394300|P1|Overall Study|Trial was terminated by sponsor|1
1336076|NCT02013687|4394314|P4|Overall Study|Missed visits due to patient travel|0
1336077|NCT02013687|4394315|P3|Overall Study|Missed visits due to patient travel|1
1336078|NCT02013687|4394316|P2|Overall Study|Missed visits due to patient travel|0
1336079|NCT02013687|4394317|P1|Overall Study|Missed visits due to patient travel|0
1336080|NCT02013687|4394314|P4|Overall Study|Withdrawal by Subject|1
1336081|NCT02013687|4394315|P3|Overall Study|Withdrawal by Subject|0
1336082|NCT02013687|4394316|P2|Overall Study|Withdrawal by Subject|0
1336083|NCT02013687|4394317|P1|Overall Study|Withdrawal by Subject|0
1336084|NCT02013687|4394314|P4|Overall Study|Protocol Violation|1
1336085|NCT02013687|4394315|P3|Overall Study|Protocol Violation|0
1336086|NCT02013687|4394316|P2|Overall Study|Protocol Violation|0
1336087|NCT02013687|4394317|P1|Overall Study|Protocol Violation|0
1336088|NCT02013687|4394314|P4|Overall Study|Lost to Follow-up|0
1336089|NCT02013687|4394315|P3|Overall Study|Lost to Follow-up|1
1336090|NCT02013687|4394316|P2|Overall Study|Lost to Follow-up|0
1336091|NCT02013687|4394317|P1|Overall Study|Lost to Follow-up|0
1336092|NCT02013622|4394347|P1|Overall Study|Lack of Efficacy|1
1336093|NCT02013622|4394347|P1|Overall Study|Protocol Deviation|1
1336094|NCT02013622|4394347|P1|Overall Study|Withdrawal by Subject|6
1336095|NCT02013622|4394347|P1|Overall Study|Met Withdrawal Criteria|3
1336096|NCT02013622|4394347|P1|Overall Study|Adverse Event|3
1336097|NCT02013622|4394347|P1|Overall Study|Lost to Follow-up|10
1336098|NCT02013609|4394367|P1|Overall Study|Met Withdrawal Criteria|3
1336099|NCT02013609|4394367|P1|Overall Study|Adverse Event|3
1336100|NCT02013609|4394367|P1|Overall Study|Lost to Follow-up|3
1336101|NCT02013609|4394367|P1|Overall Study|Withdrawal by Subject|9
1336102|NCT02013544|4394392|P2|Overall Study|Entry criteria not met/non-compliance|3
1336103|NCT02013544|4394393|P1|Overall Study|Entry criteria not met/non-compliance|2
1336104|NCT02013544|4394392|P2|Overall Study|Physician Decision|1
1336105|NCT02013544|4394393|P1|Overall Study|Physician Decision|0
1336106|NCT02013544|4394392|P2|Overall Study|Withdrawal by Subject|8
1336107|NCT02013544|4394393|P1|Overall Study|Withdrawal by Subject|2
1336108|NCT02013544|4394392|P2|Overall Study|Lost to Follow-up|3
1336109|NCT02013544|4394393|P1|Overall Study|Lost to Follow-up|2
1336110|NCT02013544|4394392|P2|Overall Study|Adverse Event|5
1336111|NCT02013544|4394393|P1|Overall Study|Adverse Event|5
1336112|NCT02013531|4394415|P1|Overall Study|Withdrawal by Subject|1
1336113|NCT02013531|4394415|P1|Overall Study|Met Withdrawal Criteria|1
1336114|NCT02013531|4394415|P1|Overall Study|Lost to Follow-up|3
1336115|NCT02013388|4394445|P8|Overall Study|work emergency|0
1336116|NCT02013388|4394446|P7|Overall Study|work emergency|0
1336117|NCT02013388|4394447|P6|Overall Study|work emergency|0
1336118|NCT02013388|4394448|P5|Overall Study|work emergency|1
1336119|NCT02013388|4394449|P4|Overall Study|work emergency|0
1336120|NCT02013388|4394450|P3|Overall Study|work emergency|0
1336121|NCT02013388|4394451|P2|Overall Study|work emergency|0
1336122|NCT02013388|4394452|P1|Overall Study|work emergency|1
1336123|NCT02013206|4394509|P2|Overall Study|Other reasons off treatment|2
1336124|NCT02013206|4394510|P1|Overall Study|Other reasons off treatment|5
1336125|NCT02013206|4394509|P2|Overall Study|Death|2
1336126|NCT02013206|4394510|P1|Overall Study|Death|1
1336127|NCT02013206|4394509|P2|Overall Study|Patient non-compliance|0
1336128|NCT02013206|4394510|P1|Overall Study|Patient non-compliance|1
1336129|NCT02013206|4394509|P2|Overall Study|Patient refusal|0
1336130|NCT02013206|4394510|P1|Overall Study|Patient refusal|2
1336131|NCT02013206|4394509|P2|Overall Study|Adverse Event|0
1336132|NCT02013206|4394510|P1|Overall Study|Adverse Event|1
1336133|NCT02013206|4394509|P2|Overall Study|Symptomatic deterioration|1
1336134|NCT02013206|4394510|P1|Overall Study|Symptomatic deterioration|3
1336135|NCT02013206|4394509|P2|Overall Study|Progressive disease (PD)|17
1336136|NCT02013206|4394510|P1|Overall Study|Progressive disease (PD)|14
1336137|NCT02013167|4394532|P2|Overall Study|Death|160
1336138|NCT02013167|4394533|P1|Overall Study|Death|85
1336139|NCT02013167|4394532|P2|Overall Study|Lost to Follow-up|1
1336140|NCT02013167|4394533|P1|Overall Study|Lost to Follow-up|0
1336141|NCT02013167|4394532|P2|Overall Study|Sponsor Decision|3
1336142|NCT02013167|4394533|P1|Overall Study|Sponsor Decision|1
1336143|NCT02013167|4394532|P2|Overall Study|Withdrawal by Subject|14
1336144|NCT02013167|4394533|P1|Overall Study|Withdrawal by Subject|15
1336145|NCT02012959|4394609|P5|Treatment Phase A|Adverse Event|0
1336146|NCT02012959|4394610|P4|Treatment Phase A|Adverse Event|0
1336147|NCT02012959|4394611|P3|Treatment Phase A|Adverse Event|0
1336148|NCT02012959|4394612|P2|Treatment Phase A|Adverse Event|0
1336149|NCT02012959|4394613|P1|Treatment Phase A|Adverse Event|2
1336150|NCT02012686|4394626|P2|Overall Study|electrocardiography monitoring noise|1
1336151|NCT02012686|4394627|P1|Overall Study|electrocardiography monitoring noise|0
1336152|NCT02012686|4394626|P2|Overall Study|muscle contraction|1
1336153|NCT02012686|4394627|P1|Overall Study|muscle contraction|0
1336154|NCT02012452|4394674|P2|Overall Study|Withdrawal by Subject|0
1336155|NCT02012452|4394675|P1|Overall Study|Withdrawal by Subject|4
1336156|NCT02012452|4394674|P2|Overall Study|Lost to Follow-up|1
1336157|NCT02012452|4394675|P1|Overall Study|Lost to Follow-up|2
1336158|NCT02012218|4394688|P5|Overall Study|Protocol Deviation|0
1336159|NCT02012218|4394689|P4|Overall Study|Protocol Deviation|0
1336160|NCT02012218|4394690|P3|Overall Study|Protocol Deviation|0
1336161|NCT02012218|4394691|P2|Overall Study|Protocol Deviation|0
1336162|NCT02012218|4394692|P1|Overall Study|Protocol Deviation|1
1336163|NCT02012218|4394688|P5|Overall Study|Protocol Specified|0
1336164|NCT02012218|4394689|P4|Overall Study|Protocol Specified|0
1336165|NCT02012218|4394690|P3|Overall Study|Protocol Specified|0
1336166|NCT02012218|4394691|P2|Overall Study|Protocol Specified|0
1336167|NCT02012218|4394692|P1|Overall Study|Protocol Specified|1
1336168|NCT02012218|4394688|P5|Overall Study|Lost to Follow-up|0
1336169|NCT02012218|4394689|P4|Overall Study|Lost to Follow-up|0
1336170|NCT02012218|4394690|P3|Overall Study|Lost to Follow-up|1
1336171|NCT02012218|4394691|P2|Overall Study|Lost to Follow-up|1
1336172|NCT02012218|4394692|P1|Overall Study|Lost to Follow-up|0
1336173|NCT02012218|4394688|P5|Overall Study|Adverse Event|0
1336174|NCT02012218|4394689|P4|Overall Study|Adverse Event|1
1336175|NCT02012218|4394690|P3|Overall Study|Adverse Event|0
1336176|NCT02012218|4394691|P2|Overall Study|Adverse Event|0
1336177|NCT02012218|4394692|P1|Overall Study|Adverse Event|1
1336178|NCT02012218|4394688|P5|Overall Study|Withdrawal by Subject|1
1336179|NCT02012218|4394689|P4|Overall Study|Withdrawal by Subject|1
1336180|NCT02012218|4394690|P3|Overall Study|Withdrawal by Subject|1
1336181|NCT02012218|4394691|P2|Overall Study|Withdrawal by Subject|0
1336182|NCT02012218|4394692|P1|Overall Study|Withdrawal by Subject|1
1336183|NCT02011893|4394704|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
1336184|NCT02011893|4394705|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
1336185|NCT02011893|4394706|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
1336186|NCT02011893|4394704|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
1336187|NCT02011893|4394705|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
1336188|NCT02011893|4394706|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
1336189|NCT02011893|4394704|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
1336190|NCT02011893|4394705|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
1336191|NCT02011893|4394706|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
1336192|NCT02011893|4394704|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
1336193|NCT02011893|4394705|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
1336194|NCT02011893|4394706|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
1336195|NCT02011893|4394704|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
1336196|NCT02011893|4394705|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
1336197|NCT02011893|4394706|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
1336198|NCT02011893|4394704|P3|Enrollment to Randomization|Screening Failure|0
1336199|NCT02011893|4394705|P2|Enrollment to Randomization|Screening Failure|0
1336200|NCT02011893|4394706|P1|Enrollment to Randomization|Screening Failure|29
1336201|NCT02011893|4394704|P3|Enrollment to Randomization|Withdrawal by Subject|0
1336202|NCT02011893|4394705|P2|Enrollment to Randomization|Withdrawal by Subject|0
1336203|NCT02011893|4394706|P1|Enrollment to Randomization|Withdrawal by Subject|21
1336204|NCT02011893|4394704|P3|Enrollment to Randomization|Physician Decision|0
1336205|NCT02011893|4394705|P2|Enrollment to Randomization|Physician Decision|0
1336206|NCT02011893|4394706|P1|Enrollment to Randomization|Physician Decision|10
1336207|NCT02011893|4394704|P3|Enrollment to Randomization|Adverse Event|0
1336208|NCT02011893|4394705|P2|Enrollment to Randomization|Adverse Event|0
1336209|NCT02011893|4394706|P1|Enrollment to Randomization|Adverse Event|2
1336210|NCT02011542|4394717|P1|Overall Study|Physician Decision|1
1336211|NCT02011113|4394848|P1|Overall Study|Study terminated by sponsor|11
1336212|NCT02011113|4394848|P1|Overall Study|Investigator's judgement- DP|3
1336213|NCT02011113|4394848|P1|Overall Study|Insufficient effect of Pomalidomide|1
1336214|NCT02011113|4394848|P1|Overall Study|Death|1
1336215|NCT02011113|4394848|P1|Overall Study|Disease Progression (DP)|16
1336216|NCT02011113|4394848|P1|Overall Study|Adverse Event|4
1336217|NCT02010684|4394877|P2|Overall Study|Withdrawal by Subject|5
1336218|NCT02010684|4394878|P1|Overall Study|Withdrawal by Subject|4
1336219|NCT02010684|4394877|P2|Overall Study|Lost to Follow-up|18
1336220|NCT02010684|4394878|P1|Overall Study|Lost to Follow-up|8
1336221|NCT02010632|4394896|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
1336222|NCT02010632|4394897|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
1336223|NCT02010567|4394908|P5|Overall Study|Adverse Event|1
1336224|NCT02010567|4394909|P4|Overall Study|Adverse Event|0
1336225|NCT02010567|4394910|P3|Overall Study|Adverse Event|1
1336226|NCT02010567|4394911|P2|Overall Study|Adverse Event|0
1336227|NCT02010567|4394912|P1|Overall Study|Adverse Event|0
1336228|NCT02010255|4394937|P14|Overall Study|Randomized but Not Treated|1
1336229|NCT02010255|4394938|P13|Overall Study|Randomized but Not Treated|0
1336230|NCT02010255|4394939|P12|Overall Study|Randomized but Not Treated|0
1336231|NCT02010255|4394940|P11|Overall Study|Randomized but Not Treated|0
1336232|NCT02010255|4394941|P10|Overall Study|Randomized but Not Treated|0
1336233|NCT02010255|4394942|P9|Overall Study|Randomized but Not Treated|0
1336234|NCT02010255|4394943|P8|Overall Study|Randomized but Not Treated|0
1336235|NCT02010255|4394944|P7|Overall Study|Randomized but Not Treated|0
1336236|NCT02010255|4394945|P6|Overall Study|Randomized but Not Treated|0
1336237|NCT02010255|4394946|P5|Overall Study|Randomized but Not Treated|0
1336238|NCT02010255|4394947|P4|Overall Study|Randomized but Not Treated|0
1336239|NCT02010255|4394948|P3|Overall Study|Randomized but Not Treated|0
1336240|NCT02010255|4394949|P2|Overall Study|Randomized but Not Treated|0
1336241|NCT02010255|4394950|P1|Overall Study|Randomized but Not Treated|0
1336242|NCT02010255|4394937|P14|Overall Study|Lost to Follow-up|0
1336243|NCT02010255|4394938|P13|Overall Study|Lost to Follow-up|0
1336244|NCT02010255|4394939|P12|Overall Study|Lost to Follow-up|0
1336245|NCT02010255|4394940|P11|Overall Study|Lost to Follow-up|0
1336246|NCT02010255|4394941|P10|Overall Study|Lost to Follow-up|0
1336247|NCT02010255|4394942|P9|Overall Study|Lost to Follow-up|0
1336248|NCT02010255|4394943|P8|Overall Study|Lost to Follow-up|0
1336249|NCT02010255|4394944|P7|Overall Study|Lost to Follow-up|0
1336250|NCT02010255|4394945|P6|Overall Study|Lost to Follow-up|0
1336251|NCT02010255|4394946|P5|Overall Study|Lost to Follow-up|1
1336252|NCT02010255|4394947|P4|Overall Study|Lost to Follow-up|0
1336253|NCT02010255|4394948|P3|Overall Study|Lost to Follow-up|1
1336254|NCT02010255|4394949|P2|Overall Study|Lost to Follow-up|0
1336255|NCT02010255|4394950|P1|Overall Study|Lost to Follow-up|0
1336256|NCT02010255|4394937|P14|Overall Study|Adverse Event|0
1336257|NCT02010255|4394938|P13|Overall Study|Adverse Event|0
1336258|NCT02010255|4394939|P12|Overall Study|Adverse Event|0
1336259|NCT02010255|4394940|P11|Overall Study|Adverse Event|0
1336260|NCT02010255|4394941|P10|Overall Study|Adverse Event|0
1336261|NCT02010255|4394942|P9|Overall Study|Adverse Event|0
1336262|NCT02010255|4394943|P8|Overall Study|Adverse Event|0
1336263|NCT02010255|4394944|P7|Overall Study|Adverse Event|0
1336264|NCT02010255|4394945|P6|Overall Study|Adverse Event|0
1336265|NCT02010255|4394946|P5|Overall Study|Adverse Event|0
1336266|NCT02010255|4394947|P4|Overall Study|Adverse Event|0
1336267|NCT02010255|4394948|P3|Overall Study|Adverse Event|0
1336268|NCT02010255|4394949|P2|Overall Study|Adverse Event|0
1336269|NCT02010255|4394950|P1|Overall Study|Adverse Event|1
1336270|NCT02010255|4394937|P14|Overall Study|Withdrew Consent|0
1336271|NCT02010255|4394938|P13|Overall Study|Withdrew Consent|0
1336272|NCT02010255|4394939|P12|Overall Study|Withdrew Consent|0
1336273|NCT02010255|4394940|P11|Overall Study|Withdrew Consent|0
1336274|NCT02010255|4394941|P10|Overall Study|Withdrew Consent|0
1336275|NCT02010255|4394942|P9|Overall Study|Withdrew Consent|0
1336276|NCT02010255|4394943|P8|Overall Study|Withdrew Consent|0
1336277|NCT02010255|4394944|P7|Overall Study|Withdrew Consent|0
1336278|NCT02010255|4394945|P6|Overall Study|Withdrew Consent|0
1336279|NCT02010255|4394946|P5|Overall Study|Withdrew Consent|0
1336280|NCT02010255|4394947|P4|Overall Study|Withdrew Consent|1
1336281|NCT02010255|4394948|P3|Overall Study|Withdrew Consent|0
1336282|NCT02010255|4394949|P2|Overall Study|Withdrew Consent|0
1336283|NCT02010255|4394950|P1|Overall Study|Withdrew Consent|1
1336284|NCT02010255|4394937|P14|Overall Study|Lack of Efficacy|0
1336285|NCT02010255|4394938|P13|Overall Study|Lack of Efficacy|0
1336286|NCT02010255|4394939|P12|Overall Study|Lack of Efficacy|0
1336287|NCT02010255|4394940|P11|Overall Study|Lack of Efficacy|1
1336288|NCT02010255|4394941|P10|Overall Study|Lack of Efficacy|0
1336289|NCT02010255|4394942|P9|Overall Study|Lack of Efficacy|0
1336290|NCT02010255|4394943|P8|Overall Study|Lack of Efficacy|0
1336291|NCT02010255|4394944|P7|Overall Study|Lack of Efficacy|0
1336292|NCT02010255|4394945|P6|Overall Study|Lack of Efficacy|0
1336293|NCT02010255|4394946|P5|Overall Study|Lack of Efficacy|1
1336294|NCT02010255|4394947|P4|Overall Study|Lack of Efficacy|1
1336295|NCT02010255|4394948|P3|Overall Study|Lack of Efficacy|2
1336296|NCT02010255|4394949|P2|Overall Study|Lack of Efficacy|1
1336297|NCT02010255|4394950|P1|Overall Study|Lack of Efficacy|4
1336298|NCT02010255|4394937|P14|Overall Study|Death|0
1336299|NCT02010255|4394938|P13|Overall Study|Death|0
1336300|NCT02010255|4394939|P12|Overall Study|Death|1
1336301|NCT02010255|4394940|P11|Overall Study|Death|1
1336302|NCT02010255|4394941|P10|Overall Study|Death|0
1336303|NCT02010255|4394942|P9|Overall Study|Death|1
1336304|NCT02010255|4394943|P8|Overall Study|Death|1
1336305|NCT02010255|4394944|P7|Overall Study|Death|1
1336306|NCT02010255|4394945|P6|Overall Study|Death|0
1336307|NCT02010255|4394946|P5|Overall Study|Death|2
1336308|NCT02010255|4394947|P4|Overall Study|Death|4
1336309|NCT02010255|4394948|P3|Overall Study|Death|4
1336310|NCT02010255|4394949|P2|Overall Study|Death|1
1336311|NCT02010255|4394950|P1|Overall Study|Death|0
1336312|NCT02009878|4395294|P3|Overall Study|Participant Met Withdrawal Criteria|0
1336313|NCT02009878|4395295|P2|Overall Study|Participant Met Withdrawal Criteria|1
1336314|NCT02009878|4395296|P1|Overall Study|Participant Met Withdrawal Criteria|0
1336315|NCT02009865|4395330|P2|Overall Study|Withdrawal by Subject|1
1336316|NCT02009865|4395331|P1|Overall Study|Withdrawal by Subject|1
1336317|NCT02009865|4395330|P2|Overall Study|Protocol Violation|2
1336318|NCT02009865|4395331|P1|Overall Study|Protocol Violation|0
1336319|NCT02009865|4395330|P2|Overall Study|Adverse Event|2
1336320|NCT02009865|4395331|P1|Overall Study|Adverse Event|0
1336321|NCT02009722|4395347|P2|Overall Study|Did not receive intervention|1
1336322|NCT02009722|4395348|P1|Overall Study|Did not receive intervention|0
1336323|NCT02009722|4395347|P2|Overall Study|Protocol Violation|2
1336324|NCT02009722|4395348|P1|Overall Study|Protocol Violation|1
1336325|NCT02009696|4395372|P1|Overall Study|Withdrawal by Subject|2
1336326|NCT02009163|4395380|P3|Randomized-withdrawal Period|Not specified|5
1336327|NCT02009163|4395381|P2|Randomized-withdrawal Period|Not specified|9
1336328|NCT02009163|4395382|P1|Randomized-withdrawal Period|Not specified|0
1336329|NCT02009163|4395380|P3|Randomized-withdrawal Period|Pregnancy|2
1336330|NCT02009163|4395381|P2|Randomized-withdrawal Period|Pregnancy|0
1336331|NCT02009163|4395382|P1|Randomized-withdrawal Period|Pregnancy|0
1336332|NCT02009163|4395380|P3|Randomized-withdrawal Period|Protocol Violation|2
1336333|NCT02009163|4395381|P2|Randomized-withdrawal Period|Protocol Violation|1
1336334|NCT02009163|4395382|P1|Randomized-withdrawal Period|Protocol Violation|0
1336335|NCT02009163|4395380|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
1336336|NCT02009163|4395381|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
1336337|NCT02009163|4395382|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
1336338|NCT02009163|4395380|P3|Randomized-withdrawal Period|Adverse Event|6
1336339|NCT02009163|4395381|P2|Randomized-withdrawal Period|Adverse Event|0
1336340|NCT02009163|4395382|P1|Randomized-withdrawal Period|Adverse Event|0
1336341|NCT02009163|4395380|P3|Randomized-withdrawal Period|Lost to Follow-up|6
1336342|NCT02009163|4395381|P2|Randomized-withdrawal Period|Lost to Follow-up|13
1336343|NCT02009163|4395382|P1|Randomized-withdrawal Period|Lost to Follow-up|0
1336344|NCT02009163|4395380|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
1336345|NCT02009163|4395381|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
1336346|NCT02009163|4395382|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
1336347|NCT02009163|4395380|P3|Open-label Period (Non-randomized)|Not specified|0
1336348|NCT02009163|4395381|P2|Open-label Period (Non-randomized)|Not specified|0
1336349|NCT02009163|4395382|P1|Open-label Period (Non-randomized)|Not specified|13
1336350|NCT02009163|4395380|P3|Open-label Period (Non-randomized)|Pregnancy|0
1336351|NCT02009163|4395381|P2|Open-label Period (Non-randomized)|Pregnancy|0
1336352|NCT02009163|4395382|P1|Open-label Period (Non-randomized)|Pregnancy|1
1336353|NCT02009163|4395380|P3|Open-label Period (Non-randomized)|Protocol Violation|0
1336354|NCT02009163|4395381|P2|Open-label Period (Non-randomized)|Protocol Violation|0
1336355|NCT02009163|4395382|P1|Open-label Period (Non-randomized)|Protocol Violation|10
1336356|NCT02009163|4395380|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
1336357|NCT02009163|4395381|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
1336358|NCT02009163|4395382|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
1336359|NCT02009163|4395380|P3|Open-label Period (Non-randomized)|Adverse Event|0
1336360|NCT02009163|4395381|P2|Open-label Period (Non-randomized)|Adverse Event|0
1336361|NCT02009163|4395382|P1|Open-label Period (Non-randomized)|Adverse Event|22
1336362|NCT02009163|4395380|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
1336363|NCT02009163|4395381|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
1336364|NCT02009163|4395382|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
1336365|NCT02009163|4395380|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
1336366|NCT02009163|4395381|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
1336367|NCT02009163|4395382|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
1336368|NCT02008526|4395459|P3|Overall Study|Lost to Follow-up|6
1336369|NCT02008526|4395460|P2|Overall Study|Lost to Follow-up|9
1336370|NCT02008526|4395461|P1|Overall Study|Lost to Follow-up|5
1336371|NCT02008526|4395459|P3|Overall Study|Withdrawal by Subject|2
1336372|NCT02008526|4395460|P2|Overall Study|Withdrawal by Subject|3
1336373|NCT02008526|4395461|P1|Overall Study|Withdrawal by Subject|3
1336374|NCT02008526|4395459|P3|Overall Study|Death|1
1336375|NCT02008526|4395460|P2|Overall Study|Death|2
1336376|NCT02008526|4395461|P1|Overall Study|Death|0
1336377|NCT02008227|4395474|P2|Overall Study|Ongoing Survival Follow-up|106
1336378|NCT02008227|4395475|P1|Overall Study|Ongoing Survival Follow-up|135
1336379|NCT02008227|4395474|P2|Overall Study|Ongoing on Study Treatment|85
1336380|NCT02008227|4395475|P1|Overall Study|Ongoing on Study Treatment|4
1336381|NCT02008227|4395474|P2|Overall Study|Withdrawal by Subject|34
1336382|NCT02008227|4395475|P1|Overall Study|Withdrawal by Subject|63
1336383|NCT02008227|4395474|P2|Overall Study|Death|383
1336384|NCT02008227|4395475|P1|Overall Study|Death|407
1336385|NCT02008227|4395474|P2|Overall Study|Lost to Follow-up|5
1336386|NCT02008227|4395475|P1|Overall Study|Lost to Follow-up|3
1336387|NCT02007954|4395536|P1|Overall Study|Death|1
1336388|NCT02007954|4395536|P1|Overall Study|Disease progression and unrelated AE|1
1336389|NCT02007954|4395536|P1|Overall Study|Switch in treatment modality|2
1336390|NCT02007954|4395536|P1|Overall Study|Received liver transplant|3
1336391|NCT02007577|4395555|P2|Overall Study|Withdrawal by Subject|1
1336392|NCT02007577|4395556|P1|Overall Study|Withdrawal by Subject|0
1336393|NCT02007577|4395555|P2|Overall Study|Adverse Event|0
1336394|NCT02007577|4395556|P1|Overall Study|Adverse Event|1
1336395|NCT02007512|4395568|P4|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
1336396|NCT02007512|4395569|P3|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
1336397|NCT02007512|4395570|P2|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
1336398|NCT02007512|4395571|P1|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
1336399|NCT02007512|4395568|P4|Open Label Treatment Period|Disease progression|11
1336400|NCT02007512|4395569|P3|Open Label Treatment Period|Disease progression|0
1336401|NCT02007512|4395570|P2|Open Label Treatment Period|Disease progression|17
1336402|NCT02007512|4395571|P1|Open Label Treatment Period|Disease progression|0
1336403|NCT02007512|4395568|P4|Open Label Treatment Period|Other|1
1336404|NCT02007512|4395569|P3|Open Label Treatment Period|Other|0
1336405|NCT02007512|4395570|P2|Open Label Treatment Period|Other|0
1336406|NCT02007512|4395571|P1|Open Label Treatment Period|Other|0
1336407|NCT02007512|4395568|P4|Open Label Treatment Period|Adverse Event|0
1336408|NCT02007512|4395569|P3|Open Label Treatment Period|Adverse Event|0
1336409|NCT02007512|4395570|P2|Open Label Treatment Period|Adverse Event|1
1336410|NCT02007512|4395571|P1|Open Label Treatment Period|Adverse Event|0
1336411|NCT02007512|4395568|P4|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
1336412|NCT02007512|4395569|P3|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
1336413|NCT02007512|4395570|P2|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
1336414|NCT02007512|4395571|P1|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
1336415|NCT02007512|4395568|P4|Double Blind Treatment Period|Other|2
1336416|NCT02007512|4395569|P3|Double Blind Treatment Period|Other|1
1336417|NCT02007512|4395570|P2|Double Blind Treatment Period|Other|0
1336418|NCT02007512|4395571|P1|Double Blind Treatment Period|Other|0
1336419|NCT02007512|4395568|P4|Double Blind Treatment Period|Protocol Violation|1
1336420|NCT02007512|4395569|P3|Double Blind Treatment Period|Protocol Violation|0
1336421|NCT02007512|4395570|P2|Double Blind Treatment Period|Protocol Violation|0
1336422|NCT02007512|4395571|P1|Double Blind Treatment Period|Protocol Violation|0
1336423|NCT02007512|4395568|P4|Double Blind Treatment Period|Withdrawal by Subject|3
1336424|NCT02007512|4395569|P3|Double Blind Treatment Period|Withdrawal by Subject|3
1336425|NCT02007512|4395570|P2|Double Blind Treatment Period|Withdrawal by Subject|2
1336426|NCT02007512|4395571|P1|Double Blind Treatment Period|Withdrawal by Subject|4
1336427|NCT02007512|4395568|P4|Double Blind Treatment Period|Disease progression|51
1336428|NCT02007512|4395569|P3|Double Blind Treatment Period|Disease progression|45
1336429|NCT02007512|4395570|P2|Double Blind Treatment Period|Disease progression|49
1336430|NCT02007512|4395571|P1|Double Blind Treatment Period|Disease progression|44
1336431|NCT02007512|4395568|P4|Double Blind Treatment Period|Death|0
1336432|NCT02007512|4395569|P3|Double Blind Treatment Period|Death|0
1336433|NCT02007512|4395570|P2|Double Blind Treatment Period|Death|0
1336434|NCT02007512|4395571|P1|Double Blind Treatment Period|Death|1
1336435|NCT02007512|4395568|P4|Double Blind Treatment Period|Adverse Event|2
1336436|NCT02007512|4395569|P3|Double Blind Treatment Period|Adverse Event|6
1336437|NCT02007512|4395570|P2|Double Blind Treatment Period|Adverse Event|2
1336438|NCT02007512|4395571|P1|Double Blind Treatment Period|Adverse Event|4
1336439|NCT02007434|4395641|P8|Overall Study|Non-compliance|0
1336440|NCT02007434|4395642|P7|Overall Study|Non-compliance|0
1336441|NCT02007434|4395643|P6|Overall Study|Non-compliance|0
1336442|NCT02007434|4395644|P5|Overall Study|Non-compliance|0
1336443|NCT02007434|4395645|P4|Overall Study|Non-compliance|0
1336444|NCT02007434|4395646|P3|Overall Study|Non-compliance|1
1336445|NCT02007434|4395647|P2|Overall Study|Non-compliance|0
1336446|NCT02007434|4395648|P1|Overall Study|Non-compliance|1
1336447|NCT02007434|4395641|P8|Overall Study|Lost to Follow-up|0
1336448|NCT02007434|4395642|P7|Overall Study|Lost to Follow-up|0
1336449|NCT02007434|4395643|P6|Overall Study|Lost to Follow-up|0
1336450|NCT02007434|4395644|P5|Overall Study|Lost to Follow-up|0
1336451|NCT02007434|4395645|P4|Overall Study|Lost to Follow-up|0
1336452|NCT02007434|4395646|P3|Overall Study|Lost to Follow-up|0
1336453|NCT02007434|4395647|P2|Overall Study|Lost to Follow-up|1
1336454|NCT02007434|4395648|P1|Overall Study|Lost to Follow-up|0
1336455|NCT02007278|4395779|P2|Overall Study|Mis-randomization|1
1336456|NCT02007278|4395780|P1|Overall Study|Mis-randomization|1
1336457|NCT02007278|4395779|P2|Overall Study|Incorrect medication administration|0
1336458|NCT02007278|4395780|P1|Overall Study|Incorrect medication administration|1
1336459|NCT02007278|4395779|P2|Overall Study|Ingestion of drugs not allowed in study|1
1336460|NCT02007278|4395780|P1|Overall Study|Ingestion of drugs not allowed in study|0
1336461|NCT02007278|4395779|P2|Overall Study|Failure to comply with an eligibility|1
1336462|NCT02007278|4395780|P1|Overall Study|Failure to comply with an eligibility|0
1336463|NCT02007252|4395802|P2|Overall Study|Adverse Event|4
1336464|NCT02007252|4395803|P1|Overall Study|Adverse Event|7
1336465|NCT02007252|4395802|P2|Overall Study|Abnormal laboratory value(s)|0
1336466|NCT02007252|4395803|P1|Overall Study|Abnormal laboratory value(s)|1
1336467|NCT02007252|4395802|P2|Overall Study|Administrative problems|7
1336468|NCT02007252|4395803|P1|Overall Study|Administrative problems|3
1336469|NCT02007096|4395818|P2|Overall Study|no mesh placed|1
1336470|NCT02007096|4395819|P1|Overall Study|no mesh placed|0
1336471|NCT02007096|4395818|P2|Overall Study|converted to open surgery|1
1336472|NCT02007096|4395819|P1|Overall Study|converted to open surgery|1
1336473|NCT02007096|4395818|P2|Overall Study|did not follow postoperative protocol|11
1336474|NCT02007096|4395819|P1|Overall Study|did not follow postoperative protocol|8
1336475|NCT02007096|4395818|P2|Overall Study|did not inject saline|3
1336476|NCT02007096|4395819|P1|Overall Study|did not inject saline|0
1336477|NCT02007096|4395818|P2|Overall Study|medication not available|0
1336478|NCT02007096|4395819|P1|Overall Study|medication not available|2
1336479|NCT02007070|4395831|P1|Overall Study|Progressive Disease|21
1336480|NCT02007070|4395831|P1|Overall Study|Physician Decision|1
1336481|NCT02007070|4395831|P1|Overall Study|Protocol Violation|2
1336482|NCT02007070|4395831|P1|Overall Study|Death|1
1336483|NCT02007070|4395831|P1|Overall Study|Clinical Progression|4
1336484|NCT02007070|4395831|P1|Overall Study|Adverse Event|4
1336485|NCT02006732|4395888|P4|Overall Study|Withdrawal by Subject|1
1336486|NCT02006732|4395889|P3|Overall Study|Withdrawal by Subject|4
1336487|NCT02006732|4395890|P2|Overall Study|Withdrawal by Subject|0
1336488|NCT02006732|4395891|P1|Overall Study|Withdrawal by Subject|3
1336489|NCT02006732|4395888|P4|Overall Study|Lost to Follow-up|0
1336490|NCT02006732|4395889|P3|Overall Study|Lost to Follow-up|0
1336491|NCT02006732|4395890|P2|Overall Study|Lost to Follow-up|1
1336492|NCT02006732|4395891|P1|Overall Study|Lost to Follow-up|0
1336493|NCT02006732|4395888|P4|Overall Study|Protocol Violation|0
1336494|NCT02006732|4395889|P3|Overall Study|Protocol Violation|0
1336495|NCT02006732|4395890|P2|Overall Study|Protocol Violation|1
1336496|NCT02006732|4395891|P1|Overall Study|Protocol Violation|1
1336497|NCT02006732|4395888|P4|Overall Study|Lack of Efficacy|1
1336498|NCT02006732|4395889|P3|Overall Study|Lack of Efficacy|1
1336499|NCT02006732|4395890|P2|Overall Study|Lack of Efficacy|3
1336500|NCT02006732|4395891|P1|Overall Study|Lack of Efficacy|6
1336501|NCT02006732|4395888|P4|Overall Study|Adverse Event|2
1336502|NCT02006732|4395889|P3|Overall Study|Adverse Event|4
1336503|NCT02006732|4395890|P2|Overall Study|Adverse Event|7
1336504|NCT02006732|4395891|P1|Overall Study|Adverse Event|10
1336505|NCT02006719|4395931|P2|Overall Study|Other/Unknown|1
1336506|NCT02006719|4395932|P1|Overall Study|Other/Unknown|0
1336507|NCT02006719|4395931|P2|Overall Study|Adverse Event|1
1336508|NCT02006719|4395932|P1|Overall Study|Adverse Event|1
1336509|NCT02006719|4395931|P2|Overall Study|Protocol Violation|0
1336510|NCT02006719|4395932|P1|Overall Study|Protocol Violation|2
1336511|NCT02006719|4395931|P2|Overall Study|Lost to Follow-up|1
1336512|NCT02006719|4395932|P1|Overall Study|Lost to Follow-up|5
1336513|NCT02006719|4395931|P2|Overall Study|Withdrawal by Subject|2
1336514|NCT02006719|4395932|P1|Overall Study|Withdrawal by Subject|10
1336515|NCT02006706|4395962|P1|Overall Study|Lost to Follow-up|1
1336516|NCT02006667|4395967|P1|Overall Study|Withdrawal by Subject|1
1336517|NCT02006667|4395967|P1|Overall Study|Death|2
1336518|NCT02006667|4395967|P1|Overall Study|Adverse Event|3
1336519|NCT02006654|4395979|P2|Overall Study|moving out of state|1
1336520|NCT02006654|4395980|P1|Overall Study|moving out of state|0
1336521|NCT02006654|4395979|P2|Overall Study|disallowed medication|0
1336522|NCT02006654|4395980|P1|Overall Study|disallowed medication|1
1336523|NCT02006654|4395979|P2|Overall Study|mood disorder|1
1336524|NCT02006654|4395980|P1|Overall Study|mood disorder|0
1336525|NCT02006654|4395979|P2|Overall Study|faecal incontinence|1
1336526|NCT02006654|4395980|P1|Overall Study|faecal incontinence|0
1336527|NCT02006654|4395979|P2|Overall Study|worsening cognitive condition|1
1336528|NCT02006654|4395980|P1|Overall Study|worsening cognitive condition|0
1336529|NCT02006654|4395979|P2|Overall Study|insufficient compliance|0
1336530|NCT02006654|4395980|P1|Overall Study|insufficient compliance|1
1336531|NCT02006654|4395979|P2|Overall Study|patient's will|1
1336532|NCT02006654|4395980|P1|Overall Study|patient's will|2
1336533|NCT02006654|4395979|P2|Overall Study|Lost to Follow-up|0
1336534|NCT02006654|4395980|P1|Overall Study|Lost to Follow-up|1
1336535|NCT02006654|4395979|P2|Overall Study|Protocol Violation|8
1336536|NCT02006654|4395980|P1|Overall Study|Protocol Violation|5
1336537|NCT02006654|4395979|P2|Overall Study|Withdrawal by Subject|12
1336538|NCT02006654|4395980|P1|Overall Study|Withdrawal by Subject|14
1336539|NCT02006654|4395979|P2|Overall Study|Death|0
1336540|NCT02006654|4395980|P1|Overall Study|Death|1
1336541|NCT02006654|4395979|P2|Overall Study|Adverse Event|17
1336542|NCT02006654|4395980|P1|Overall Study|Adverse Event|16
1336543|NCT02006654|4395979|P2|Overall Study|Withdrawal before treatment|2
1336544|NCT02006654|4395980|P1|Overall Study|Withdrawal before treatment|4
1336545|NCT02006641|4396009|P3|Overall Study|Other reason: protocol non-compliance|1
1336546|NCT02006641|4396010|P2|Overall Study|Other reason: protocol non-compliance|0
1336547|NCT02006641|4396011|P1|Overall Study|Other reason: protocol non-compliance|0
1336548|NCT02006641|4396009|P3|Overall Study|Other reason: caregiver impossibility|1
1336549|NCT02006641|4396010|P2|Overall Study|Other reason: caregiver impossibility|0
1336550|NCT02006641|4396011|P1|Overall Study|Other reason: caregiver impossibility|0
1336551|NCT02006641|4396009|P3|Overall Study|Other reason: hospitalisation|0
1336552|NCT02006641|4396010|P2|Overall Study|Other reason: hospitalisation|1
1336553|NCT02006641|4396011|P1|Overall Study|Other reason: hospitalisation|0
1336554|NCT02006641|4396009|P3|Overall Study|Other reason: patient's wife has died|1
1336555|NCT02006641|4396010|P2|Overall Study|Other reason: patient's wife has died|0
1336556|NCT02006641|4396011|P1|Overall Study|Other reason: patient's wife has died|0
1336557|NCT02006641|4396009|P3|Overall Study|Other reason: caregiver in hospital|0
1336558|NCT02006641|4396010|P2|Overall Study|Other reason: caregiver in hospital|1
1336559|NCT02006641|4396011|P1|Overall Study|Other reason: caregiver in hospital|0
1336560|NCT02006641|4396009|P3|Overall Study|Other reason: patient has moved|1
1336561|NCT02006641|4396010|P2|Overall Study|Other reason: patient has moved|0
1336562|NCT02006641|4396011|P1|Overall Study|Other reason: patient has moved|1
1336563|NCT02006641|4396009|P3|Overall Study|Other reason:patient didn't want to come|1
1336564|NCT02006641|4396010|P2|Overall Study|Other reason:patient didn't want to come|0
1336565|NCT02006641|4396011|P1|Overall Study|Other reason:patient didn't want to come|0
1336566|NCT02006641|4396009|P3|Overall Study|Other reason: patient didn't show up|0
1336567|NCT02006641|4396010|P2|Overall Study|Other reason: patient didn't show up|0
1336568|NCT02006641|4396011|P1|Overall Study|Other reason: patient didn't show up|1
1336569|NCT02006641|4396009|P3|Overall Study|Withdrawal by Subject|11
1336570|NCT02006641|4396010|P2|Overall Study|Withdrawal by Subject|12
1336571|NCT02006641|4396011|P1|Overall Study|Withdrawal by Subject|7
1336572|NCT02006641|4396009|P3|Overall Study|Lost to Follow-up|0
1336573|NCT02006641|4396010|P2|Overall Study|Lost to Follow-up|1
1336574|NCT02006641|4396011|P1|Overall Study|Lost to Follow-up|0
1336575|NCT02006641|4396009|P3|Overall Study|Protocol Violation|2
1336576|NCT02006641|4396010|P2|Overall Study|Protocol Violation|2
1336577|NCT02006641|4396011|P1|Overall Study|Protocol Violation|0
1336578|NCT02006641|4396009|P3|Overall Study|Adverse Event|15
1336579|NCT02006641|4396010|P2|Overall Study|Adverse Event|11
1336580|NCT02006641|4396011|P1|Overall Study|Adverse Event|15
1336581|NCT02006641|4396009|P3|Overall Study|Withdrawal before treatment|3
1336582|NCT02006641|4396010|P2|Overall Study|Withdrawal before treatment|5
1336583|NCT02006641|4396011|P1|Overall Study|Withdrawal before treatment|2
1336584|NCT02005692|4396110|P1|Overall Study|Discharged earlier than anticipated|5
1336585|NCT02005692|4396110|P1|Overall Study|Withdrawal by Subject|1
1336586|NCT02005692|4396110|P1|Overall Study|Protocol Violation|1
1336587|NCT02005562|4396130|P2|Overall Study|Physician Decision|1
1336588|NCT02005562|4396131|P1|Overall Study|Physician Decision|0
1336589|NCT02005562|4396130|P2|Overall Study|No transplant|4
1336590|NCT02005562|4396131|P1|Overall Study|No transplant|1
1336591|NCT02005562|4396130|P2|Overall Study|Withdrawal by Subject|2
1336592|NCT02005562|4396131|P1|Overall Study|Withdrawal by Subject|2
1336593|NCT02005562|4396130|P2|Overall Study|Graft loss|6
1336594|NCT02005562|4396131|P1|Overall Study|Graft loss|7
1336595|NCT02005562|4396130|P2|Overall Study|Death|2
1336596|NCT02005562|4396131|P1|Overall Study|Death|2
1336597|NCT02005484|4396173|P1|Overall Study|Sponsor decision|1
1336598|NCT02005484|4396173|P1|Overall Study|Changed to a Different Study|1
1336599|NCT02005484|4396173|P1|Overall Study|Disease progression|1
1336600|NCT02005484|4396173|P1|Overall Study|Death|1
1336601|NCT02005211|4396194|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1336602|NCT02005211|4396195|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1336603|NCT02005211|4396196|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
1336604|NCT02005211|4396197|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1336605|NCT02005211|4396198|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1336606|NCT02005211|4396199|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1336607|NCT02005211|4396200|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1336608|NCT02005029|4396235|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
1336609|NCT02005029|4396236|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
1336610|NCT02004886|4396288|P4|Overall Study|Unable to attend future visits|0
1336611|NCT02004886|4396289|P3|Overall Study|Unable to attend future visits|0
1336612|NCT02004886|4396290|P2|Overall Study|Unable to attend future visits|0
1336613|NCT02004886|4396291|P1|Overall Study|Unable to attend future visits|1
1336614|NCT02004886|4396288|P4|Overall Study|Adverse Event|0
1336615|NCT02004886|4396289|P3|Overall Study|Adverse Event|0
1336616|NCT02004886|4396290|P2|Overall Study|Adverse Event|1
1336617|NCT02004886|4396291|P1|Overall Study|Adverse Event|0
1336618|NCT02004873|4396341|P1|Overall Study|Withdrawal by Subject|1
1336619|NCT02004873|4396341|P1|Overall Study|Death|23
1336620|NCT02004873|4396341|P1|Overall Study|Missed 6-month visit|4
1336621|NCT02004873|4396341|P1|Overall Study|Awaiting 6-month visit|390
1336622|NCT02004873|4396341|P1|Overall Study|Implant unsuccessful|6
1336623|NCT02004847|4396350|P2|Overall Study|Protocol Violation|1
1336624|NCT02004847|4396351|P1|Overall Study|Protocol Violation|1
1336625|NCT02004262|4396401|P6|Overall Study|Study Terminated by Sponsor|5
1336626|NCT02004262|4396402|P5|Overall Study|Study Terminated by Sponsor|1
1336627|NCT02004262|4396403|P4|Overall Study|Study Terminated by Sponsor|1
1336628|NCT02004262|4396404|P3|Overall Study|Study Terminated by Sponsor|2
1336629|NCT02004262|4396405|P2|Overall Study|Study Terminated by Sponsor|3
1336630|NCT02004262|4396406|P1|Overall Study|Study Terminated by Sponsor|4
1336631|NCT02004262|4396401|P6|Overall Study|Lost to Follow-up|0
1336632|NCT02004262|4396402|P5|Overall Study|Lost to Follow-up|0
1336633|NCT02004262|4396403|P4|Overall Study|Lost to Follow-up|0
1336634|NCT02004262|4396404|P3|Overall Study|Lost to Follow-up|0
1336635|NCT02004262|4396405|P2|Overall Study|Lost to Follow-up|1
1336636|NCT02004262|4396406|P1|Overall Study|Lost to Follow-up|1
1336637|NCT02004262|4396401|P6|Overall Study|Withdrawal by Subject|3
1336638|NCT02004262|4396402|P5|Overall Study|Withdrawal by Subject|1
1336639|NCT02004262|4396403|P4|Overall Study|Withdrawal by Subject|0
1336640|NCT02004262|4396404|P3|Overall Study|Withdrawal by Subject|4
1336641|NCT02004262|4396405|P2|Overall Study|Withdrawal by Subject|0
1336642|NCT02004262|4396406|P1|Overall Study|Withdrawal by Subject|1
1336643|NCT02004262|4396401|P6|Overall Study|Death|22
1336644|NCT02004262|4396402|P5|Overall Study|Death|29
1336645|NCT02004262|4396403|P4|Overall Study|Death|28
1336646|NCT02004262|4396404|P3|Overall Study|Death|66
1336647|NCT02004262|4396405|P2|Overall Study|Death|64
1336648|NCT02004262|4396406|P1|Overall Study|Death|67
1336649|NCT02004236|4396426|P3|Overall Study|Lack of Efficacy|16
1336650|NCT02004236|4396427|P2|Overall Study|Lack of Efficacy|0
1336651|NCT02004236|4396428|P1|Overall Study|Lack of Efficacy|0
1336652|NCT02004093|4396488|P2|Overall Study|Not specified|1
1336653|NCT02004093|4396489|P1|Overall Study|Not specified|3
1336654|NCT02004093|4396488|P2|Overall Study|Withdrawal by Subject|7
1336655|NCT02004093|4396489|P1|Overall Study|Withdrawal by Subject|3
1336656|NCT02004093|4396488|P2|Overall Study|Lost to Follow-up|1
1336657|NCT02004093|4396489|P1|Overall Study|Lost to Follow-up|0
1336658|NCT02004093|4396488|P2|Overall Study|Protocol Violation|1
1336659|NCT02004093|4396489|P1|Overall Study|Protocol Violation|0
1336660|NCT02004093|4396488|P2|Overall Study|Lack of Efficacy|62
1336661|NCT02004093|4396489|P1|Overall Study|Lack of Efficacy|66
1336662|NCT02004093|4396488|P2|Overall Study|Death|1
1336663|NCT02004093|4396489|P1|Overall Study|Death|2
1336664|NCT02003963|4396521|P2|Overall Study|Lost to Follow-up|1
1336665|NCT02003963|4396522|P1|Overall Study|Lost to Follow-up|2
1336666|NCT02003924|4396544|P2|Overall Study|Adverse Event|29
1336667|NCT02003924|4396545|P1|Overall Study|Adverse Event|91
1336668|NCT02003924|4396544|P2|Overall Study|Withdrawal by Subject|34
1336669|NCT02003924|4396545|P1|Overall Study|Withdrawal by Subject|49
1336670|NCT02003924|4396544|P2|Overall Study|Other than specified|19
1336671|NCT02003924|4396545|P1|Overall Study|Other than specified|18
1336672|NCT02003924|4396544|P2|Overall Study|Lost to Follow-up|1
1336673|NCT02003924|4396545|P1|Overall Study|Lost to Follow-up|2
1336674|NCT02003924|4396544|P2|Overall Study|Protocol Violation|2
1336675|NCT02003924|4396545|P1|Overall Study|Protocol Violation|1
1336676|NCT02003924|4396544|P2|Overall Study|Disease progression|207
1336677|NCT02003924|4396545|P1|Overall Study|Disease progression|138
1336678|NCT02003924|4396544|P2|Overall Study|Ongoing in study|176
1336679|NCT02003924|4396545|P1|Overall Study|Ongoing in study|634
1336680|NCT02003638|4396645|P2|Overall Study|Withdrawal by Subject|0
1336681|NCT02003638|4396646|P1|Overall Study|Withdrawal by Subject|1
1336682|NCT02003534|4396652|P1|Overall Study|Lost to Follow-up|47
1336683|NCT02003391|4396664|P2|Overall Study|Adverse Event|0
1336684|NCT02003391|4396665|P1|Overall Study|Adverse Event|1
1336685|NCT02003391|4396664|P2|Overall Study|Protocol Violation|1
1336686|NCT02003391|4396665|P1|Overall Study|Protocol Violation|0
1336687|NCT02003391|4396664|P2|Overall Study|Withdrawal by Subject|1
1336688|NCT02003391|4396665|P1|Overall Study|Withdrawal by Subject|2
1336689|NCT02003365|4396678|P3|Overall Study|Lost to Follow-up|1
1336690|NCT02003365|4396679|P2|Overall Study|Lost to Follow-up|0
1336691|NCT02003365|4396680|P1|Overall Study|Lost to Follow-up|0
1336692|NCT02003014|4396704|P1|Overall Study|Investigator's transfer|4
1336693|NCT02003014|4396704|P1|Overall Study|Patient did not visit the study site|5
1336694|NCT02003014|4396704|P1|Overall Study|Treatment started after contract period|1
1336695|NCT02003014|4396704|P1|Overall Study|Case report forms uncollected|9
1336696|NCT02002689|4396786|P1|Overall Study|Adverse Event|3
1336697|NCT02002689|4396786|P1|Overall Study|Disease Progression|7
1336698|NCT02002533|4396805|P2|Overall Study|Lost to Follow-up|1
1336699|NCT02002533|4396806|P1|Overall Study|Lost to Follow-up|0
1336700|NCT02002533|4396805|P2|Overall Study|Adverse Event|3
1336701|NCT02002533|4396806|P1|Overall Study|Adverse Event|0
1336702|NCT02002533|4396805|P2|Overall Study|Protocol Violation|1
1336703|NCT02002533|4396806|P1|Overall Study|Protocol Violation|0
1336704|NCT02002533|4396805|P2|Overall Study|Withdrawal by Subject|13
1336705|NCT02002533|4396806|P1|Overall Study|Withdrawal by Subject|6
1336706|NCT02002221|4396831|P2|Overall Study|Patient withdrew consent|1
1336707|NCT02002221|4396832|P1|Overall Study|Patient withdrew consent|0
1336708|NCT02002221|4396831|P2|Overall Study|Unsatisfactory therapeutic effect|1
1336709|NCT02002221|4396832|P1|Overall Study|Unsatisfactory therapeutic effect|0
1336710|NCT02002221|4396831|P2|Overall Study|Adverse Event|1
1336711|NCT02002221|4396832|P1|Overall Study|Adverse Event|2
1336712|NCT02001181|4396868|P2|Overall Study|Withdrawal by Subject|1
1336713|NCT02001181|4396869|P1|Overall Study|Withdrawal by Subject|0
1336714|NCT02001181|4396868|P2|Overall Study|Lost to Follow-up|0
1336715|NCT02001181|4396869|P1|Overall Study|Lost to Follow-up|1
1336716|NCT02001181|4396868|P2|Overall Study|Adverse Event|2
1336717|NCT02001181|4396869|P1|Overall Study|Adverse Event|0
1336718|NCT02001051|4396885|P2|Overall Study|Deemed not eligible following enrollment|1
1336719|NCT02001051|4396886|P1|Overall Study|Deemed not eligible following enrollment|0
1336720|NCT02000921|4396938|P3|Overall Study|Physician Decision|0
1336721|NCT02000921|4396939|P2|Overall Study|Physician Decision|2
1336722|NCT02000921|4396940|P1|Overall Study|Physician Decision|0
1336723|NCT02000921|4396938|P3|Overall Study|Lost to Follow-up|5
1336724|NCT02000921|4396939|P2|Overall Study|Lost to Follow-up|4
1336725|NCT02000921|4396940|P1|Overall Study|Lost to Follow-up|2
1336726|NCT02000921|4396938|P3|Overall Study|Withdrawal by Subject|5
1336727|NCT02000921|4396939|P2|Overall Study|Withdrawal by Subject|10
1336728|NCT02000921|4396940|P1|Overall Study|Withdrawal by Subject|3
1336729|NCT02000752|4396959|P2|Overall Study|Shift Changes|5
1336730|NCT02000752|4396960|P1|Overall Study|Shift Changes|12
1336731|NCT02000752|4396959|P2|Overall Study|Dystocic delivery|8
1336732|NCT02000752|4396960|P1|Overall Study|Dystocic delivery|19
1336733|NCT02000622|4396974|P2|Overall Study|Withdrawal by Subject|7
1336734|NCT02000622|4396975|P1|Overall Study|Withdrawal by Subject|5
1336735|NCT02000622|4396974|P2|Overall Study|Death|46
1336736|NCT02000622|4396975|P1|Overall Study|Death|94
1336737|NCT02000622|4396974|P2|Overall Study|Lost to Follow-up|0
1336738|NCT02000622|4396975|P1|Overall Study|Lost to Follow-up|1
1336739|NCT02000622|4396974|P2|Overall Study|Withdrawn due to site closure|0
1336740|NCT02000622|4396975|P1|Overall Study|Withdrawn due to site closure|1
1336741|NCT02000531|4396997|P2|Overall Study|Discontinued due to data cut-off|8
1336742|NCT02000531|4396998|P1|Overall Study|Discontinued due to data cut-off|3
1336743|NCT02000531|4396997|P2|Overall Study|Lost to Follow-up|0
1336744|NCT02000531|4396998|P1|Overall Study|Lost to Follow-up|1
1336745|NCT02000440|4397006|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
1336746|NCT02000440|4397006|P1|Overall Study|Adverse Event|3
1336747|NCT02000427|4397026|P1|Overall Study|Death|22
1336748|NCT01999894|4397083|P1|Overall Study|Inclusion/exclusion criteria not met|1
1336749|NCT01999894|4397083|P1|Overall Study|Other Reason|3
1336750|NCT01999894|4397083|P1|Overall Study|Lost to Follow-up|10
1336751|NCT01999894|4397083|P1|Overall Study|Withdrawal by Subject|7
1336752|NCT01999894|4397083|P1|Overall Study|Protocol Violation|1
1336753|NCT01999894|4397083|P1|Overall Study|Lack of Efficacy|5
1336754|NCT01999894|4397083|P1|Overall Study|Adverse Event|9
1336755|NCT01999322|4397125|P2|Overall Study|Adverse Event|0
1336756|NCT01999322|4397126|P1|Overall Study|Adverse Event|1
1336757|NCT01999218|4397178|P3|Overall Study|Treated but excluded at 1 trial site|2
1336758|NCT01999218|4397179|P2|Overall Study|Treated but excluded at 1 trial site|5
1336759|NCT01999218|4397180|P1|Overall Study|Treated but excluded at 1 trial site|3
1336760|NCT01999218|4397178|P3|Overall Study|Adverse Event|7
1336761|NCT01999218|4397179|P2|Overall Study|Adverse Event|7
1336762|NCT01999218|4397180|P1|Overall Study|Adverse Event|9
1336763|NCT01999218|4397178|P3|Overall Study|Excluded Medication|2
1336764|NCT01999218|4397179|P2|Overall Study|Excluded Medication|1
1336765|NCT01999218|4397180|P1|Overall Study|Excluded Medication|1
1336766|NCT01999218|4397178|P3|Overall Study|Death|2
1336767|NCT01999218|4397179|P2|Overall Study|Death|1
1336768|NCT01999218|4397180|P1|Overall Study|Death|7
1336769|NCT01999218|4397178|P3|Overall Study|Creatinine/eGFR|1
1336770|NCT01999218|4397179|P2|Overall Study|Creatinine/eGFR|0
1336771|NCT01999218|4397180|P1|Overall Study|Creatinine/eGFR|0
1336772|NCT01999218|4397178|P3|Overall Study|Withdrawal by Subject|34
1336773|NCT01999218|4397179|P2|Overall Study|Withdrawal by Subject|29
1336774|NCT01999218|4397180|P1|Overall Study|Withdrawal by Subject|28
1336775|NCT01999218|4397178|P3|Overall Study|Participant moves|3
1336776|NCT01999218|4397179|P2|Overall Study|Participant moves|5
1336777|NCT01999218|4397180|P1|Overall Study|Participant moves|2
1336778|NCT01999218|4397178|P3|Overall Study|Study Terminated By Sponsor|12
1336779|NCT01999218|4397179|P2|Overall Study|Study Terminated By Sponsor|5
1336780|NCT01999218|4397180|P1|Overall Study|Study Terminated By Sponsor|7
1336781|NCT01999218|4397178|P3|Overall Study|Screen failure|0
1336782|NCT01999218|4397179|P2|Overall Study|Screen failure|1
1336783|NCT01999218|4397180|P1|Overall Study|Screen failure|0
1336784|NCT01999218|4397178|P3|Overall Study|Protocol Violation|4
1336785|NCT01999218|4397179|P2|Overall Study|Protocol Violation|5
1336786|NCT01999218|4397180|P1|Overall Study|Protocol Violation|4
1336787|NCT01999218|4397178|P3|Overall Study|Physician Decision|6
1336788|NCT01999218|4397179|P2|Overall Study|Physician Decision|4
1336789|NCT01999218|4397180|P1|Overall Study|Physician Decision|1
1336790|NCT01999218|4397178|P3|Overall Study|Non-Compliance With Study Drug|1
1336791|NCT01999218|4397179|P2|Overall Study|Non-Compliance With Study Drug|4
1336792|NCT01999218|4397180|P1|Overall Study|Non-Compliance With Study Drug|6
1336793|NCT01999218|4397178|P3|Overall Study|Lost to Follow-up|18
1336794|NCT01999218|4397179|P2|Overall Study|Lost to Follow-up|17
1336795|NCT01999218|4397180|P1|Overall Study|Lost to Follow-up|22
1336796|NCT01999218|4397178|P3|Overall Study|Lack of Efficacy|1
1336797|NCT01999218|4397179|P2|Overall Study|Lack of Efficacy|0
1336798|NCT01999218|4397180|P1|Overall Study|Lack of Efficacy|1
1336799|NCT01999218|4397178|P3|Overall Study|Hyperglycemia|17
1336800|NCT01999218|4397179|P2|Overall Study|Hyperglycemia|17
1336801|NCT01999218|4397180|P1|Overall Study|Hyperglycemia|18
1336802|NCT01998919|4397222|P2|Overall Study|Not specified|2
1336803|NCT01998919|4397223|P1|Overall Study|Not specified|5
1336804|NCT01998919|4397222|P2|Overall Study|Lost to Follow-up|0
1336805|NCT01998919|4397223|P1|Overall Study|Lost to Follow-up|2
1336806|NCT01998919|4397222|P2|Overall Study|Withdrawal by Subject|4
1336807|NCT01998919|4397223|P1|Overall Study|Withdrawal by Subject|2
1336808|NCT01998919|4397222|P2|Overall Study|Disease progression|22
1336809|NCT01998919|4397223|P1|Overall Study|Disease progression|31
1336810|NCT01998919|4397222|P2|Overall Study|Adverse Event|5
1336811|NCT01998919|4397223|P1|Overall Study|Adverse Event|0
1336812|NCT01998919|4397222|P2|Overall Study|Death|2
1336813|NCT01998919|4397223|P1|Overall Study|Death|2
1336814|NCT01998906|4397244|P3|Overall Study|Not specified|4
1336815|NCT01998906|4397245|P2|Overall Study|Not specified|8
1336816|NCT01998906|4397246|P1|Overall Study|Not specified|3
1336817|NCT01998906|4397244|P3|Overall Study|Administrative/Other|3
1336818|NCT01998906|4397245|P2|Overall Study|Administrative/Other|1
1336819|NCT01998906|4397246|P1|Overall Study|Administrative/Other|2
1336820|NCT01998906|4397244|P3|Overall Study|Withdrawal by Subject|3
1336821|NCT01998906|4397245|P2|Overall Study|Withdrawal by Subject|4
1336822|NCT01998906|4397246|P1|Overall Study|Withdrawal by Subject|1
1336823|NCT01998906|4397244|P3|Overall Study|Violation of Selection Criteria|1
1336824|NCT01998906|4397245|P2|Overall Study|Violation of Selection Criteria|0
1336825|NCT01998906|4397246|P1|Overall Study|Violation of Selection Criteria|0
1336826|NCT01998906|4397244|P3|Overall Study|Failure to return|4
1336827|NCT01998906|4397245|P2|Overall Study|Failure to return|2
1336828|NCT01998906|4397246|P1|Overall Study|Failure to return|0
1336829|NCT01998906|4397244|P3|Overall Study|Lack of Efficacy|8
1336830|NCT01998906|4397245|P2|Overall Study|Lack of Efficacy|9
1336831|NCT01998906|4397246|P1|Overall Study|Lack of Efficacy|10
1336832|NCT01998906|4397244|P3|Overall Study|Death|17
1336833|NCT01998906|4397245|P2|Overall Study|Death|30
1336834|NCT01998906|4397246|P1|Overall Study|Death|21
1336835|NCT01998906|4397244|P3|Overall Study|Participants ongoing in follow−up|58
1336836|NCT01998906|4397245|P2|Overall Study|Participants ongoing in follow−up|60
1336837|NCT01998906|4397246|P1|Overall Study|Participants ongoing in follow−up|77
1336838|NCT01998893|4397290|P1|Overall Study|Transformation to high-grade lymphoma|1
1336839|NCT01998893|4397290|P1|Overall Study|Withdrawal by Subject|1
1336840|NCT01998893|4397290|P1|Overall Study|Protocol Violation|2
1336841|NCT01998893|4397290|P1|Overall Study|Physician Decision|2
1336842|NCT01998893|4397290|P1|Overall Study|Lost to Follow-up|8
1336843|NCT01998893|4397290|P1|Overall Study|Death|1
1336844|NCT01998893|4397290|P1|Overall Study|Adverse Event|2
1336845|NCT01998880|4397302|P2|Overall Study|Violation of Selection Criteria at Entry|1
1336846|NCT01998880|4397303|P1|Overall Study|Violation of Selection Criteria at Entry|1
1336847|NCT01998880|4397302|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
1336848|NCT01998880|4397303|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
1336849|NCT01998880|4397302|P2|Overall Study|Other Protocol Violation|1
1336850|NCT01998880|4397303|P1|Overall Study|Other Protocol Violation|0
1336851|NCT01998880|4397302|P2|Overall Study|Administrative/Other|1
1336852|NCT01998880|4397303|P1|Overall Study|Administrative/Other|3
1336853|NCT01998880|4397302|P2|Overall Study|Insufficient Therapeutic Response|5
1336854|NCT01998880|4397303|P1|Overall Study|Insufficient Therapeutic Response|1
1336855|NCT01998880|4397302|P2|Overall Study|Death|6
1336856|NCT01998880|4397303|P1|Overall Study|Death|3
1336857|NCT01998880|4397302|P2|Overall Study|Withdrew Consent|2
1336858|NCT01998880|4397303|P1|Overall Study|Withdrew Consent|2
1336859|NCT01998880|4397302|P2|Overall Study|Progression of Disease|8
1336860|NCT01998880|4397303|P1|Overall Study|Progression of Disease|2
1336861|NCT01998880|4397302|P2|Overall Study|Adverse Events or Intercurrent Illness|16
1336862|NCT01998880|4397303|P1|Overall Study|Adverse Events or Intercurrent Illness|16
1336863|NCT01998737|4397321|P2|Overall Study|Corrupted database|0
1336864|NCT01998737|4397322|P1|Overall Study|Corrupted database|23
1336865|NCT01998633|4397334|P1|Overall Study|Death|1
1336866|NCT01998581|4397352|P2|Overall Study|Randomized but withdrew before treatment|0
1336867|NCT01998581|4397353|P1|Overall Study|Randomized but withdrew before treatment|1
1336868|NCT01998581|4397352|P2|Overall Study|Other reasons|2
1336869|NCT01998581|4397353|P1|Overall Study|Other reasons|3
1336870|NCT01998581|4397352|P2|Overall Study|Adverse Event|1
1336871|NCT01998581|4397353|P1|Overall Study|Adverse Event|1
1336872|NCT01998581|4397352|P2|Overall Study|Lost to Follow-up|4
1336873|NCT01998581|4397353|P1|Overall Study|Lost to Follow-up|12
1336874|NCT01998581|4397352|P2|Overall Study|Withdrawal by Subject|1
1336875|NCT01998581|4397353|P1|Overall Study|Withdrawal by Subject|8
1336876|NCT01998581|4397352|P2|Overall Study|Protocol Violation|0
1336877|NCT01998581|4397353|P1|Overall Study|Protocol Violation|1
1336878|NCT01998581|4397352|P2|Overall Study|Refused repeat treatment|4
1336879|NCT01998581|4397353|P1|Overall Study|Refused repeat treatment|20
1336880|NCT01998477|4397365|P2|Overall Study|Withdrawal by Subject|0
1336881|NCT01998477|4397366|P1|Overall Study|Withdrawal by Subject|6
1336882|NCT01998477|4397365|P2|Overall Study|Lost to Follow-up|5
1336883|NCT01998477|4397366|P1|Overall Study|Lost to Follow-up|4
1336884|NCT01998399|4397412|P2|Overall Study|Withdrawal by Subject|1
1336885|NCT01998399|4397413|P1|Overall Study|Withdrawal by Subject|0
1336886|NCT01998399|4397412|P2|Overall Study|Study stopped before dosing completed|3
1336887|NCT01998399|4397413|P1|Overall Study|Study stopped before dosing completed|3
1336888|NCT01998399|4397412|P2|Overall Study|Death|2
1336889|NCT01998399|4397413|P1|Overall Study|Death|4
1336890|NCT01998399|4397412|P2|Overall Study|Lost to Follow-up|3
1336891|NCT01998399|4397413|P1|Overall Study|Lost to Follow-up|1
1336892|NCT01997892|4397475|P1|Overall Study|Study completion data not recorded|35
1336893|NCT01997892|4397475|P1|Overall Study|Other|3
1336894|NCT01997892|4397475|P1|Overall Study|Renal transplant|8
1336895|NCT01997892|4397475|P1|Overall Study|Death|14
1336896|NCT01997892|4397475|P1|Overall Study|Lost to Follow-up|6
1336897|NCT01997892|4397475|P1|Overall Study|Physician Decision|2
1336898|NCT01996904|4397642|P2|Overall Study|Lost to Follow-up|27
1336899|NCT01996904|4397643|P1|Overall Study|Lost to Follow-up|38
1336900|NCT01996748|4397662|P2|Overall Study|Lost to Follow-up|1
1336901|NCT01996748|4397663|P1|Overall Study|Lost to Follow-up|4
1336902|NCT01996748|4397662|P2|Overall Study|Withdrawal by Subject|1
1336903|NCT01996748|4397663|P1|Overall Study|Withdrawal by Subject|0
1336904|NCT01996748|4397662|P2|Overall Study|Adverse Event|4
1336905|NCT01996748|4397663|P1|Overall Study|Adverse Event|1
1336906|NCT01996748|4397662|P2|Overall Study|Physician Decision|0
1336907|NCT01996748|4397663|P1|Overall Study|Physician Decision|2
1336908|NCT01996748|4397662|P2|Overall Study|Personal reason|0
1336909|NCT01996748|4397663|P1|Overall Study|Personal reason|1
1336910|NCT01996709|4397677|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
1336911|NCT01996709|4397678|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
1336912|NCT01996709|4397677|P2|Overall Study|Subject Non-Compliant|0
1336913|NCT01996709|4397678|P1|Overall Study|Subject Non-Compliant|1
1336914|NCT01996709|4397677|P2|Overall Study|Lost to Follow-up|0
1336915|NCT01996709|4397678|P1|Overall Study|Lost to Follow-up|3
1336916|NCT01996709|4397677|P2|Overall Study|Withdrawal by Subject|0
1336917|NCT01996709|4397678|P1|Overall Study|Withdrawal by Subject|1
1336918|NCT01996592|4397725|P1|Overall Study|change in mode of delivery|4
1336919|NCT01996592|4397725|P1|Overall Study|Withdrawal by Subject|5
1336920|NCT01996592|4397725|P1|Overall Study|change in surgical date|4
1336921|NCT01996592|4397725|P1|Overall Study|no response to text/no diary entry|32
1336922|NCT01996332|4397761|P1|Overall Study|Lost to Follow-up|34
1336923|NCT01996332|4397761|P1|Overall Study|Physician Decision|17
1336924|NCT01996332|4397761|P1|Overall Study|Clinical Deterioration|28
1336925|NCT01996332|4397761|P1|Overall Study|Other|20
1336926|NCT01996332|4397761|P1|Overall Study|Withdrawal by Subject|71
1336927|NCT01996332|4397761|P1|Overall Study|Protocol Violation|9
1336928|NCT01996332|4397761|P1|Overall Study|Death|264
1336929|NCT01996332|4397761|P1|Overall Study|Lack of Efficacy|1245
1336930|NCT01996332|4397761|P1|Overall Study|Adverse Event|117
1336931|NCT01996319|4397769|P2|Overall Study|Adverse Event|2
1336932|NCT01996319|4397770|P1|Overall Study|Adverse Event|2
1336933|NCT01996319|4397769|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
1336934|NCT01996319|4397770|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
1336935|NCT01996319|4397769|P2|Overall Study|Protocol Violation|0
1336936|NCT01996319|4397770|P1|Overall Study|Protocol Violation|1
1336937|NCT01995513|4397790|P3|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
1336938|NCT01995513|4397791|P2|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
1337019|NCT01995201|4397868|P3|From Week 24 Until Week 48|Lost to Follow-up|0
1336939|NCT01995513|4397792|P1|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
1336940|NCT01995513|4397790|P3|Double Blind Treatment Period|Disease Progression|93
1336941|NCT01995513|4397791|P2|Double Blind Treatment Period|Disease Progression|82
1336942|NCT01995513|4397792|P1|Double Blind Treatment Period|Disease Progression|0
1336943|NCT01995513|4397790|P3|Double Blind Treatment Period|Death|1
1336944|NCT01995513|4397791|P2|Double Blind Treatment Period|Death|0
1336945|NCT01995513|4397792|P1|Double Blind Treatment Period|Death|0
1336946|NCT01995513|4397790|P3|Double Blind Treatment Period|Withdrawal by Subject|6
1336947|NCT01995513|4397791|P2|Double Blind Treatment Period|Withdrawal by Subject|4
1336948|NCT01995513|4397792|P1|Double Blind Treatment Period|Withdrawal by Subject|0
1336949|NCT01995513|4397790|P3|Double Blind Treatment Period|Other|2
1336950|NCT01995513|4397791|P2|Double Blind Treatment Period|Other|1
1336951|NCT01995513|4397792|P1|Double Blind Treatment Period|Other|0
1336952|NCT01995513|4397790|P3|Double Blind Treatment Period|Adverse Event|5
1336953|NCT01995513|4397791|P2|Double Blind Treatment Period|Adverse Event|12
1336954|NCT01995513|4397792|P1|Double Blind Treatment Period|Adverse Event|0
1336955|NCT01995513|4397790|P3|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
1336956|NCT01995513|4397791|P2|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
1336957|NCT01995513|4397792|P1|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
1336958|NCT01995513|4397790|P3|Open Label Treatment Period|Death|0
1336959|NCT01995513|4397791|P2|Open Label Treatment Period|Death|0
1336960|NCT01995513|4397792|P1|Open Label Treatment Period|Death|8
1336961|NCT01995513|4397790|P3|Open Label Treatment Period|Adverse Event|0
1336962|NCT01995513|4397791|P2|Open Label Treatment Period|Adverse Event|0
1336963|NCT01995513|4397792|P1|Open Label Treatment Period|Adverse Event|35
1336964|NCT01995513|4397790|P3|Open Label Treatment Period|No PSA response at week 13|0
1336965|NCT01995513|4397791|P2|Open Label Treatment Period|No PSA response at week 13|0
1336966|NCT01995513|4397792|P1|Open Label Treatment Period|No PSA response at week 13|43
1336967|NCT01995513|4397790|P3|Open Label Treatment Period|Disease Progression|0
1336968|NCT01995513|4397791|P2|Open Label Treatment Period|Disease Progression|0
1336969|NCT01995513|4397792|P1|Open Label Treatment Period|Disease Progression|64
1336970|NCT01995513|4397790|P3|Open Label Treatment Period|Protocol Violation|0
1336971|NCT01995513|4397791|P2|Open Label Treatment Period|Protocol Violation|0
1336972|NCT01995513|4397792|P1|Open Label Treatment Period|Protocol Violation|1
1336973|NCT01995513|4397790|P3|Open Label Treatment Period|Withdrawal by Subject|0
1336974|NCT01995513|4397791|P2|Open Label Treatment Period|Withdrawal by Subject|0
1336975|NCT01995513|4397792|P1|Open Label Treatment Period|Withdrawal by Subject|14
1336976|NCT01995513|4397790|P3|Open Label Treatment Period|Other|0
1336977|NCT01995513|4397791|P2|Open Label Treatment Period|Other|0
1336978|NCT01995513|4397792|P1|Open Label Treatment Period|Other|9
1336979|NCT01995461|4397835|P1|Overall Study|Withdrawal by Subject|2
1336980|NCT01995461|4397835|P1|Overall Study|Lost to Follow-up|2
1336981|NCT01995461|4397835|P1|Overall Study|Death|1
1336982|NCT01995357|4397841|P6|Period 5|Adverse Event|0
1336983|NCT01995357|4397842|P5|Period 5|Adverse Event|0
1336984|NCT01995357|4397843|P4|Period 5|Adverse Event|0
1336985|NCT01995357|4397844|P3|Period 5|Adverse Event|1
1336986|NCT01995357|4397845|P2|Period 5|Adverse Event|0
1336987|NCT01995357|4397846|P1|Period 5|Adverse Event|1
1336988|NCT01995357|4397841|P6|Period 5|Lack of Efficacy|0
1336989|NCT01995357|4397842|P5|Period 5|Lack of Efficacy|0
1336990|NCT01995357|4397843|P4|Period 5|Lack of Efficacy|0
1336991|NCT01995357|4397844|P3|Period 5|Lack of Efficacy|0
1336992|NCT01995357|4397845|P2|Period 5|Lack of Efficacy|0
1336993|NCT01995357|4397846|P1|Period 5|Lack of Efficacy|1
1336994|NCT01995201|4397864|P7|From Week 24 Until Week 48|Protocol Violation|0
1336995|NCT01995201|4397865|P6|From Week 24 Until Week 48|Protocol Violation|0
1336996|NCT01995201|4397866|P5|From Week 24 Until Week 48|Protocol Violation|2
1336997|NCT01995201|4397867|P4|From Week 24 Until Week 48|Protocol Violation|0
1336998|NCT01995201|4397868|P3|From Week 24 Until Week 48|Protocol Violation|1
1336999|NCT01995201|4397869|P2|From Week 24 Until Week 48|Protocol Violation|0
1337000|NCT01995201|4397870|P1|From Week 24 Until Week 48|Protocol Violation|0
1337001|NCT01995201|4397864|P7|From Week 24 Until Week 48|Physician Decision|0
1337002|NCT01995201|4397865|P6|From Week 24 Until Week 48|Physician Decision|0
1337003|NCT01995201|4397866|P5|From Week 24 Until Week 48|Physician Decision|1
1337004|NCT01995201|4397867|P4|From Week 24 Until Week 48|Physician Decision|0
1337005|NCT01995201|4397868|P3|From Week 24 Until Week 48|Physician Decision|0
1337006|NCT01995201|4397869|P2|From Week 24 Until Week 48|Physician Decision|0
1337007|NCT01995201|4397870|P1|From Week 24 Until Week 48|Physician Decision|0
1337008|NCT01995201|4397864|P7|From Week 24 Until Week 48|Withdrawal by Subject|0
1337009|NCT01995201|4397865|P6|From Week 24 Until Week 48|Withdrawal by Subject|0
1337010|NCT01995201|4397866|P5|From Week 24 Until Week 48|Withdrawal by Subject|1
1337011|NCT01995201|4397867|P4|From Week 24 Until Week 48|Withdrawal by Subject|0
1337012|NCT01995201|4397868|P3|From Week 24 Until Week 48|Withdrawal by Subject|1
1337013|NCT01995201|4397869|P2|From Week 24 Until Week 48|Withdrawal by Subject|0
1337014|NCT01995201|4397870|P1|From Week 24 Until Week 48|Withdrawal by Subject|0
1337015|NCT01995201|4397864|P7|From Week 24 Until Week 48|Lost to Follow-up|0
1337016|NCT01995201|4397865|P6|From Week 24 Until Week 48|Lost to Follow-up|1
1337017|NCT01995201|4397866|P5|From Week 24 Until Week 48|Lost to Follow-up|1
1337018|NCT01995201|4397867|P4|From Week 24 Until Week 48|Lost to Follow-up|0
1337020|NCT01995201|4397869|P2|From Week 24 Until Week 48|Lost to Follow-up|0
1337021|NCT01995201|4397870|P1|From Week 24 Until Week 48|Lost to Follow-up|0
1337022|NCT01995201|4397864|P7|From Week 24 Until Week 48|Lack of Efficacy|1
1337023|NCT01995201|4397865|P6|From Week 24 Until Week 48|Lack of Efficacy|2
1337024|NCT01995201|4397866|P5|From Week 24 Until Week 48|Lack of Efficacy|0
1337025|NCT01995201|4397867|P4|From Week 24 Until Week 48|Lack of Efficacy|0
1337026|NCT01995201|4397868|P3|From Week 24 Until Week 48|Lack of Efficacy|1
1337027|NCT01995201|4397869|P2|From Week 24 Until Week 48|Lack of Efficacy|0
1337028|NCT01995201|4397870|P1|From Week 24 Until Week 48|Lack of Efficacy|0
1337029|NCT01995201|4397864|P7|From Week 24 Until Week 48|Death|0
1337030|NCT01995201|4397865|P6|From Week 24 Until Week 48|Death|2
1337031|NCT01995201|4397866|P5|From Week 24 Until Week 48|Death|0
1337032|NCT01995201|4397867|P4|From Week 24 Until Week 48|Death|0
1337033|NCT01995201|4397868|P3|From Week 24 Until Week 48|Death|0
1337034|NCT01995201|4397869|P2|From Week 24 Until Week 48|Death|0
1337035|NCT01995201|4397870|P1|From Week 24 Until Week 48|Death|0
1337036|NCT01995201|4397864|P7|From Week 24 Until Week 48|Adverse Event|1
1337037|NCT01995201|4397865|P6|From Week 24 Until Week 48|Adverse Event|3
1337038|NCT01995201|4397866|P5|From Week 24 Until Week 48|Adverse Event|1
1337039|NCT01995201|4397867|P4|From Week 24 Until Week 48|Adverse Event|1
1337040|NCT01995201|4397868|P3|From Week 24 Until Week 48|Adverse Event|2
1337041|NCT01995201|4397869|P2|From Week 24 Until Week 48|Adverse Event|0
1337042|NCT01995201|4397870|P1|From Week 24 Until Week 48|Adverse Event|0
1337043|NCT01995201|4397864|P7|From Baseline Until Week 24|Protocol Violation|0
1337044|NCT01995201|4397865|P6|From Baseline Until Week 24|Protocol Violation|0
1337045|NCT01995201|4397866|P5|From Baseline Until Week 24|Protocol Violation|0
1337046|NCT01995201|4397867|P4|From Baseline Until Week 24|Protocol Violation|0
1337047|NCT01995201|4397868|P3|From Baseline Until Week 24|Protocol Violation|0
1337048|NCT01995201|4397869|P2|From Baseline Until Week 24|Protocol Violation|9
1337049|NCT01995201|4397870|P1|From Baseline Until Week 24|Protocol Violation|0
1337050|NCT01995201|4397864|P7|From Baseline Until Week 24|Physician Decision|0
1337051|NCT01995201|4397865|P6|From Baseline Until Week 24|Physician Decision|0
1337052|NCT01995201|4397866|P5|From Baseline Until Week 24|Physician Decision|0
1337053|NCT01995201|4397867|P4|From Baseline Until Week 24|Physician Decision|0
1337054|NCT01995201|4397868|P3|From Baseline Until Week 24|Physician Decision|0
1337055|NCT01995201|4397869|P2|From Baseline Until Week 24|Physician Decision|2
1337056|NCT01995201|4397870|P1|From Baseline Until Week 24|Physician Decision|0
1337057|NCT01995201|4397864|P7|From Baseline Until Week 24|Withdrawal by Subject|0
1337058|NCT01995201|4397865|P6|From Baseline Until Week 24|Withdrawal by Subject|0
1337059|NCT01995201|4397866|P5|From Baseline Until Week 24|Withdrawal by Subject|0
1337060|NCT01995201|4397867|P4|From Baseline Until Week 24|Withdrawal by Subject|0
1337061|NCT01995201|4397868|P3|From Baseline Until Week 24|Withdrawal by Subject|0
1337062|NCT01995201|4397869|P2|From Baseline Until Week 24|Withdrawal by Subject|8
1337063|NCT01995201|4397870|P1|From Baseline Until Week 24|Withdrawal by Subject|2
1337064|NCT01995201|4397864|P7|From Baseline Until Week 24|Lost to Follow-up|0
1337065|NCT01995201|4397865|P6|From Baseline Until Week 24|Lost to Follow-up|0
1337066|NCT01995201|4397866|P5|From Baseline Until Week 24|Lost to Follow-up|0
1337067|NCT01995201|4397867|P4|From Baseline Until Week 24|Lost to Follow-up|0
1337068|NCT01995201|4397868|P3|From Baseline Until Week 24|Lost to Follow-up|0
1337069|NCT01995201|4397869|P2|From Baseline Until Week 24|Lost to Follow-up|3
1337070|NCT01995201|4397870|P1|From Baseline Until Week 24|Lost to Follow-up|2
1337071|NCT01995201|4397864|P7|From Baseline Until Week 24|Lack of Efficacy|0
1337072|NCT01995201|4397865|P6|From Baseline Until Week 24|Lack of Efficacy|0
1337073|NCT01995201|4397866|P5|From Baseline Until Week 24|Lack of Efficacy|0
1337074|NCT01995201|4397867|P4|From Baseline Until Week 24|Lack of Efficacy|0
1337075|NCT01995201|4397868|P3|From Baseline Until Week 24|Lack of Efficacy|0
1337076|NCT01995201|4397869|P2|From Baseline Until Week 24|Lack of Efficacy|5
1337077|NCT01995201|4397870|P1|From Baseline Until Week 24|Lack of Efficacy|2
1337078|NCT01995201|4397864|P7|From Baseline Until Week 24|Death|0
1337079|NCT01995201|4397865|P6|From Baseline Until Week 24|Death|0
1337080|NCT01995201|4397866|P5|From Baseline Until Week 24|Death|0
1337081|NCT01995201|4397867|P4|From Baseline Until Week 24|Death|0
1337082|NCT01995201|4397868|P3|From Baseline Until Week 24|Death|0
1337083|NCT01995201|4397869|P2|From Baseline Until Week 24|Death|1
1337084|NCT01995201|4397870|P1|From Baseline Until Week 24|Death|0
1337085|NCT01995201|4397864|P7|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1337086|NCT01995201|4397865|P6|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1337087|NCT01995201|4397866|P5|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1337088|NCT01995201|4397867|P4|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1337089|NCT01995201|4397868|P3|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1337090|NCT01995201|4397869|P2|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
1337091|NCT01995201|4397870|P1|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1337092|NCT01995201|4397864|P7|From Baseline Until Week 24|Adverse Event|0
1337093|NCT01995201|4397865|P6|From Baseline Until Week 24|Adverse Event|0
1337094|NCT01995201|4397866|P5|From Baseline Until Week 24|Adverse Event|0
1337095|NCT01995201|4397867|P4|From Baseline Until Week 24|Adverse Event|0
1337096|NCT01995201|4397868|P3|From Baseline Until Week 24|Adverse Event|0
1337097|NCT01995201|4397869|P2|From Baseline Until Week 24|Adverse Event|15
1337098|NCT01995201|4397870|P1|From Baseline Until Week 24|Adverse Event|4
1337099|NCT01995136|4397979|P1|Overall Study|Change in residence|1
1337100|NCT01995071|4397995|P12|Overall Study|Incarcerated|0
1337101|NCT01995071|4397996|P11|Overall Study|Incarcerated|0
1337102|NCT01995071|4397997|P10|Overall Study|Incarcerated|0
1337103|NCT01995071|4397998|P9|Overall Study|Incarcerated|0
1337104|NCT01995071|4397999|P8|Overall Study|Incarcerated|1
1337105|NCT01995071|4398000|P7|Overall Study|Incarcerated|0
1337106|NCT01995071|4398001|P6|Overall Study|Incarcerated|0
1337107|NCT01995071|4398002|P5|Overall Study|Incarcerated|0
1337108|NCT01995071|4398003|P4|Overall Study|Incarcerated|0
1337109|NCT01995071|4398004|P3|Overall Study|Incarcerated|0
1337110|NCT01995071|4398005|P2|Overall Study|Incarcerated|0
1337111|NCT01995071|4398006|P1|Overall Study|Incarcerated|0
1337112|NCT01995071|4397995|P12|Overall Study|Lost to Follow-up|0
1337113|NCT01995071|4397996|P11|Overall Study|Lost to Follow-up|0
1337114|NCT01995071|4397997|P10|Overall Study|Lost to Follow-up|0
1337115|NCT01995071|4397998|P9|Overall Study|Lost to Follow-up|1
1337116|NCT01995071|4397999|P8|Overall Study|Lost to Follow-up|1
1337117|NCT01995071|4398000|P7|Overall Study|Lost to Follow-up|0
1337118|NCT01995071|4398001|P6|Overall Study|Lost to Follow-up|0
1337119|NCT01995071|4398002|P5|Overall Study|Lost to Follow-up|0
1337120|NCT01995071|4398003|P4|Overall Study|Lost to Follow-up|0
1337121|NCT01995071|4398004|P3|Overall Study|Lost to Follow-up|0
1337122|NCT01995071|4398005|P2|Overall Study|Lost to Follow-up|0
1337123|NCT01995071|4398006|P1|Overall Study|Lost to Follow-up|1
1337124|NCT01995071|4397995|P12|Overall Study|Moved|0
1337125|NCT01995071|4397996|P11|Overall Study|Moved|1
1337126|NCT01995071|4397997|P10|Overall Study|Moved|0
1337127|NCT01995071|4397998|P9|Overall Study|Moved|0
1337128|NCT01995071|4397999|P8|Overall Study|Moved|0
1337129|NCT01995071|4398000|P7|Overall Study|Moved|0
1337130|NCT01995071|4398001|P6|Overall Study|Moved|0
1337131|NCT01995071|4398002|P5|Overall Study|Moved|1
1337132|NCT01995071|4398003|P4|Overall Study|Moved|0
1337133|NCT01995071|4398004|P3|Overall Study|Moved|1
1337134|NCT01995071|4398005|P2|Overall Study|Moved|0
1337135|NCT01995071|4398006|P1|Overall Study|Moved|0
1337136|NCT01995071|4397995|P12|Overall Study|Adverse Event|0
1337137|NCT01995071|4397996|P11|Overall Study|Adverse Event|0
1337138|NCT01995071|4397997|P10|Overall Study|Adverse Event|0
1337139|NCT01995071|4397998|P9|Overall Study|Adverse Event|0
1337140|NCT01995071|4397999|P8|Overall Study|Adverse Event|0
1337141|NCT01995071|4398000|P7|Overall Study|Adverse Event|1
1337142|NCT01995071|4398001|P6|Overall Study|Adverse Event|0
1337143|NCT01995071|4398002|P5|Overall Study|Adverse Event|0
1337144|NCT01995071|4398003|P4|Overall Study|Adverse Event|0
1337145|NCT01995071|4398004|P3|Overall Study|Adverse Event|0
1337146|NCT01995071|4398005|P2|Overall Study|Adverse Event|0
1337147|NCT01995071|4398006|P1|Overall Study|Adverse Event|0
1337148|NCT01994902|4398141|P2|Test Period 2|Other|3
1337149|NCT01994902|4398142|P1|Test Period 2|Other|0
1337150|NCT01994902|4398141|P2|Test Period 2|Lack of Efficacy|1
1337151|NCT01994902|4398142|P1|Test Period 2|Lack of Efficacy|0
1337152|NCT01994902|4398141|P2|Test Period 2|Withdrawal by Subject|2
1337153|NCT01994902|4398142|P1|Test Period 2|Withdrawal by Subject|0
1337154|NCT01994902|4398141|P2|Test Period 1|bag too small|0
1337155|NCT01994902|4398142|P1|Test Period 1|bag too small|1
1337156|NCT01994902|4398141|P2|Test Period 1|Lack of Efficacy|1
1337157|NCT01994902|4398142|P1|Test Period 1|Lack of Efficacy|0
1337158|NCT01994902|4398141|P2|Test Period 1|Adverse Event|1
1337159|NCT01994902|4398142|P1|Test Period 1|Adverse Event|2
1337160|NCT01994902|4398141|P2|Test Period 1|device deficiency with adverse event|1
1337161|NCT01994902|4398142|P1|Test Period 1|device deficiency with adverse event|0
1337162|NCT01994902|4398141|P2|Test Period 1|Withdrawal by Subject|0
1337163|NCT01994902|4398142|P1|Test Period 1|Withdrawal by Subject|3
1337164|NCT01994876|4398148|P2|Test Period 2|Protocol Violation|1
1337165|NCT01994876|4398149|P1|Test Period 2|Protocol Violation|0
1337166|NCT01994876|4398148|P2|Test Period 2|Adverse Event|0
1337167|NCT01994876|4398149|P1|Test Period 2|Adverse Event|1
1337168|NCT01994876|4398148|P2|Test Period 1|Adverse Event|1
1337169|NCT01994876|4398149|P1|Test Period 1|Adverse Event|0
1337170|NCT01994876|4398148|P2|Test Period 1|Withdrawal by Subject|1
1337171|NCT01994876|4398149|P1|Test Period 1|Withdrawal by Subject|0
1337172|NCT01994863|4398157|P2|Period 2|Withdrawal by Subject|1
1337173|NCT01994863|4398158|P1|Period 2|Withdrawal by Subject|1
1337174|NCT01994863|4398157|P2|Period 2|Lack of Efficacy|2
1337175|NCT01994863|4398158|P1|Period 2|Lack of Efficacy|0
1337176|NCT01994863|4398157|P2|Period 2|Adverse Event|1
1337177|NCT01994863|4398158|P1|Period 2|Adverse Event|0
1337178|NCT01994863|4398157|P2|Period 1|Lack of Efficacy|0
1337179|NCT01994863|4398158|P1|Period 1|Lack of Efficacy|1
1337180|NCT01994863|4398157|P2|Period 1|Trial stopped by sponsor|3
1337181|NCT01994863|4398158|P1|Period 1|Trial stopped by sponsor|1
1337182|NCT01994863|4398157|P2|Period 1|Withdrawal by Subject|0
1337183|NCT01994863|4398158|P1|Period 1|Withdrawal by Subject|1
1337184|NCT01994863|4398157|P2|Period 1|Adverse Event|0
1337185|NCT01994863|4398158|P1|Period 1|Adverse Event|4
1337186|NCT01994837|4398164|P1|Overall Study|Removed from study due to no response|1
1337187|NCT01994837|4398164|P1|Overall Study|Proceeded to transplant|1
1337188|NCT01994837|4398164|P1|Overall Study|Chose palliative care|1
1337189|NCT01994837|4398164|P1|Overall Study|Adverse event not related to progression|1
1337190|NCT01994837|4398164|P1|Overall Study|Fatal progressive disease|2
1337191|NCT01994837|4398164|P1|Overall Study|Adv event related to progressive disease|3
1337192|NCT01994837|4398164|P1|Overall Study|Progressive disease per protocol|23
1337193|NCT01994720|4398221|P2|Overall Study|Withdrawal by Subject|56
1337194|NCT01994720|4398222|P1|Overall Study|Withdrawal by Subject|46
1337195|NCT01994629|4398264|P2|Overall Study|Lost to Follow-up|3
1337196|NCT01994629|4398265|P1|Overall Study|Lost to Follow-up|0
1337197|NCT01994629|4398264|P2|Overall Study|Withdrawal by Subject|0
1337198|NCT01994629|4398265|P1|Overall Study|Withdrawal by Subject|1
1337199|NCT01994395|4398300|P2|Overall Study|Withdrawal by Subject|2
1337200|NCT01994395|4398301|P1|Overall Study|Withdrawal by Subject|1
1337201|NCT01994291|4398326|P3|Overall Study|Other|0
1337202|NCT01994291|4398327|P2|Overall Study|Other|2
1337203|NCT01994291|4398328|P1|Overall Study|Other|1
1337204|NCT01994291|4398326|P3|Overall Study|Withdrawal by Subject|5
1337205|NCT01994291|4398327|P2|Overall Study|Withdrawal by Subject|3
1337206|NCT01994291|4398328|P1|Overall Study|Withdrawal by Subject|6
1337207|NCT01994291|4398326|P3|Overall Study|Protocol Violation|0
1337208|NCT01994291|4398327|P2|Overall Study|Protocol Violation|0
1337209|NCT01994291|4398328|P1|Overall Study|Protocol Violation|1
1337210|NCT01994291|4398326|P3|Overall Study|Medication error without associated AE|1
1337211|NCT01994291|4398327|P2|Overall Study|Medication error without associated AE|0
1337212|NCT01994291|4398328|P1|Overall Study|Medication error without associated AE|1
1337213|NCT01994291|4398326|P3|Overall Study|Does not meet entrance criteria|0
1337214|NCT01994291|4398327|P2|Overall Study|Does not meet entrance criteria|0
1337215|NCT01994291|4398328|P1|Overall Study|Does not meet entrance criteria|1
1337216|NCT01994291|4398326|P3|Overall Study|Lost to Follow-up|0
1337217|NCT01994291|4398327|P2|Overall Study|Lost to Follow-up|1
1337218|NCT01994291|4398328|P1|Overall Study|Lost to Follow-up|1
1337219|NCT01994291|4398326|P3|Overall Study|Adverse Event|3
1337220|NCT01994291|4398327|P2|Overall Study|Adverse Event|1
1337221|NCT01994291|4398328|P1|Overall Study|Adverse Event|4
1337222|NCT01994226|4398384|P2|Overall Study|Early Cessation of treatment|11
1337223|NCT01994226|4398385|P1|Overall Study|Early Cessation of treatment|6
1337224|NCT01994226|4398384|P2|Overall Study|Protocol Violation|10
1337225|NCT01994226|4398385|P1|Overall Study|Protocol Violation|13
1337226|NCT01993940|4398393|P2|Overall Study|Other - Miscellaneous|1
1337227|NCT01993940|4398394|P1|Overall Study|Other - Miscellaneous|1
1337228|NCT01993940|4398393|P2|Overall Study|Death|0
1337229|NCT01993940|4398394|P1|Overall Study|Death|1
1337230|NCT01993940|4398393|P2|Overall Study|Protocol Violation|8
1337231|NCT01993940|4398394|P1|Overall Study|Protocol Violation|5
1337232|NCT01993940|4398393|P2|Overall Study|Lost to Follow-up|5
1337233|NCT01993940|4398394|P1|Overall Study|Lost to Follow-up|2
1337234|NCT01993940|4398393|P2|Overall Study|Withdrawal by Subject|19
1337235|NCT01993940|4398394|P1|Overall Study|Withdrawal by Subject|15
1337236|NCT01993940|4398393|P2|Overall Study|Adverse Event|11
1337237|NCT01993940|4398394|P1|Overall Study|Adverse Event|16
1337238|NCT01993888|4398410|P2|Overall Study|Withdrawal by Subject|1
1337239|NCT01993888|4398411|P1|Overall Study|Withdrawal by Subject|0
1337240|NCT01993888|4398410|P2|Overall Study|Lost to Follow-up|1
1337241|NCT01993888|4398411|P1|Overall Study|Lost to Follow-up|1
1337242|NCT01993888|4398410|P2|Overall Study|Death|1
1337243|NCT01993888|4398411|P1|Overall Study|Death|1
1337244|NCT01993823|4398429|P2|Overall Study|Lost to Follow-up|4
1337245|NCT01993823|4398430|P1|Overall Study|Lost to Follow-up|1
1337246|NCT01993823|4398429|P2|Overall Study|Protocol Violation|1
1337247|NCT01993823|4398430|P1|Overall Study|Protocol Violation|0
1337248|NCT01993823|4398429|P2|Overall Study|Requested by the patient|11
1337249|NCT01993823|4398430|P1|Overall Study|Requested by the patient|6
1337250|NCT01993030|4398477|P2|Overall Study|Adverse Event|4
1337251|NCT01993030|4398478|P1|Overall Study|Adverse Event|0
1337252|NCT01992536|4398532|P10|Overall Study|Withdrawal by Subject|0
1337253|NCT01992536|4398533|P9|Overall Study|Withdrawal by Subject|0
1337254|NCT01992536|4398534|P8|Overall Study|Withdrawal by Subject|0
1337255|NCT01992536|4398535|P7|Overall Study|Withdrawal by Subject|0
1337256|NCT01992536|4398536|P6|Overall Study|Withdrawal by Subject|0
1337257|NCT01992536|4398537|P5|Overall Study|Withdrawal by Subject|0
1337258|NCT01992536|4398538|P4|Overall Study|Withdrawal by Subject|2
1337259|NCT01992536|4398539|P3|Overall Study|Withdrawal by Subject|0
1337260|NCT01992536|4398540|P2|Overall Study|Withdrawal by Subject|1
1337261|NCT01992536|4398541|P1|Overall Study|Withdrawal by Subject|0
1337262|NCT01992536|4398532|P10|Overall Study|Lost to Follow-up|1
1337263|NCT01992536|4398533|P9|Overall Study|Lost to Follow-up|1
1337264|NCT01992536|4398534|P8|Overall Study|Lost to Follow-up|0
1337265|NCT01992536|4398535|P7|Overall Study|Lost to Follow-up|0
1337266|NCT01992536|4398536|P6|Overall Study|Lost to Follow-up|1
1337267|NCT01992536|4398537|P5|Overall Study|Lost to Follow-up|0
1337268|NCT01992536|4398538|P4|Overall Study|Lost to Follow-up|0
1337269|NCT01992536|4398539|P3|Overall Study|Lost to Follow-up|1
1337270|NCT01992536|4398540|P2|Overall Study|Lost to Follow-up|2
1337271|NCT01992536|4398541|P1|Overall Study|Lost to Follow-up|4
1337272|NCT01992536|4398532|P10|Overall Study|Administrative Reason|0
1337273|NCT01992536|4398533|P9|Overall Study|Administrative Reason|0
1337274|NCT01992536|4398534|P8|Overall Study|Administrative Reason|0
1337275|NCT01992536|4398535|P7|Overall Study|Administrative Reason|7
1337276|NCT01992536|4398536|P6|Overall Study|Administrative Reason|0
1337277|NCT01992536|4398537|P5|Overall Study|Administrative Reason|0
1337278|NCT01992536|4398538|P4|Overall Study|Administrative Reason|0
1337279|NCT01992536|4398539|P3|Overall Study|Administrative Reason|0
1337280|NCT01992536|4398540|P2|Overall Study|Administrative Reason|0
1337281|NCT01992536|4398541|P1|Overall Study|Administrative Reason|0
1337282|NCT01992107|4398792|P3|Overall Study|Withdrawal by Subject|8
1337283|NCT01992107|4398793|P2|Overall Study|Withdrawal by Subject|7
1337284|NCT01992107|4398794|P1|Overall Study|Withdrawal by Subject|13
1337285|NCT01992107|4398792|P3|Overall Study|noncompliance and were unavailable|2
1337286|NCT01992107|4398793|P2|Overall Study|noncompliance and were unavailable|3
1337287|NCT01992107|4398794|P1|Overall Study|noncompliance and were unavailable|7
1337288|NCT01992107|4398792|P3|Overall Study|Lost to Follow-up|26
1337289|NCT01992107|4398793|P2|Overall Study|Lost to Follow-up|22
1337290|NCT01992107|4398794|P1|Overall Study|Lost to Follow-up|46
1337291|NCT01992107|4398792|P3|Overall Study|Adverse Event|0
1337292|NCT01992107|4398793|P2|Overall Study|Adverse Event|1
1337293|NCT01992107|4398794|P1|Overall Study|Adverse Event|0
1337294|NCT01992107|4398792|P3|Overall Study|Administrative reasons|0
1337295|NCT01992107|4398793|P2|Overall Study|Administrative reasons|0
1337296|NCT01992107|4398794|P1|Overall Study|Administrative reasons|2
1337297|NCT01992094|4398850|P3|Overall Study|Withdrawal by Subject|4
1337298|NCT01992094|4398851|P2|Overall Study|Withdrawal by Subject|3
1337299|NCT01992094|4398852|P1|Overall Study|Withdrawal by Subject|7
1337300|NCT01992094|4398850|P3|Overall Study|Protocol Violation|1
1337301|NCT01992094|4398851|P2|Overall Study|Protocol Violation|0
1337302|NCT01992094|4398852|P1|Overall Study|Protocol Violation|1
1337303|NCT01992094|4398850|P3|Overall Study|OTHER|0
1337304|NCT01992094|4398851|P2|Overall Study|OTHER|0
1337305|NCT01992094|4398852|P1|Overall Study|OTHER|4
1337306|NCT01992094|4398850|P3|Overall Study|Lost to Follow-up|13
1337307|NCT01992094|4398851|P2|Overall Study|Lost to Follow-up|9
1337308|NCT01992094|4398852|P1|Overall Study|Lost to Follow-up|26
1337309|NCT01992094|4398850|P3|Overall Study|Death|2
1337310|NCT01992094|4398851|P2|Overall Study|Death|5
1337311|NCT01992094|4398852|P1|Overall Study|Death|5
1337312|NCT01992094|4398850|P3|Overall Study|Adverse Event|0
1337313|NCT01992094|4398851|P2|Overall Study|Adverse Event|0
1337314|NCT01992094|4398852|P1|Overall Study|Adverse Event|1
1337315|NCT01992094|4398850|P3|Overall Study|ADMINISTRATIVE REASON|1
1337316|NCT01992094|4398851|P2|Overall Study|ADMINISTRATIVE REASON|7
1337317|NCT01992094|4398852|P1|Overall Study|ADMINISTRATIVE REASON|6
1337318|NCT01991314|4398966|P2|Overall Study|Lost to Follow-up|10
1337319|NCT01991314|4398967|P1|Overall Study|Lost to Follow-up|6
1337320|NCT01991314|4398966|P2|Overall Study|Adverse Event|1
1337321|NCT01991314|4398967|P1|Overall Study|Adverse Event|5
1337322|NCT01990859|4398989|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
1337323|NCT01990859|4398989|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
1337324|NCT01990742|4399114|P2|Overall Study|Facility closed|270
1337325|NCT01990742|4399115|P1|Overall Study|Facility closed|0
1337326|NCT01990742|4399114|P2|Overall Study|Withdrawal by facility|1083
1337327|NCT01990742|4399115|P1|Overall Study|Withdrawal by facility|407
1337328|NCT01990664|4399151|P2|Overall Study|Unsatisfactory Visual Response|1
1337329|NCT01990664|4399152|P1|Overall Study|Unsatisfactory Visual Response|0
1337330|NCT01990664|4399151|P2|Overall Study|Lens Handling Difficulties|0
1337331|NCT01990664|4399152|P1|Overall Study|Lens Handling Difficulties|1
1337332|NCT01990664|4399151|P2|Overall Study|Lens Discomfort|1
1337333|NCT01990664|4399152|P1|Overall Study|Lens Discomfort|1
1337334|NCT01990664|4399151|P2|Overall Study|Protocol Violation|0
1337335|NCT01990664|4399152|P1|Overall Study|Protocol Violation|1
1337336|NCT01990664|4399151|P2|Overall Study|Withdrawal by Subject|3
1337337|NCT01990664|4399152|P1|Overall Study|Withdrawal by Subject|2
1337338|NCT01990664|4399151|P2|Overall Study|Lost to Follow-up|6
1337339|NCT01990664|4399152|P1|Overall Study|Lost to Follow-up|2
1337340|NCT01990560|4399158|P1|Overall Study|Withdrawal by Subject|1
1337341|NCT01990534|4399172|P1|Overall Study|Overall Survival Follow-up|25
1337342|NCT01990534|4399172|P1|Overall Study|Progression Free Survival Follow-up|11
1337343|NCT01990534|4399172|P1|Overall Study|Reason Not Specified|2
1337344|NCT01990534|4399172|P1|Overall Study|Withdrawal by Subject|3
1337345|NCT01990534|4399172|P1|Overall Study|Symptomatic Deterioration|1
1337346|NCT01990534|4399172|P1|Overall Study|Withdrawal of Informed Consent|2
1337347|NCT01990534|4399172|P1|Overall Study|Protocol Violation|1
1337348|NCT01990534|4399172|P1|Overall Study|Progressive disease|3
1337349|NCT01990534|4399172|P1|Overall Study|Death|12
1337350|NCT01990339|4399188|P1|Overall Study|Lost to Follow-up|861
1337351|NCT01990339|4399188|P1|Overall Study|Voluntary Withdrawal|1402
1337352|NCT01990339|4399188|P1|Overall Study|Data Not Available|49
1337353|NCT01990313|4399193|P1|Overall Study|Lost to Follow-up|1
1337354|NCT01990261|4399198|P1|Overall Study|Lost to Follow-up|2
1337355|NCT01990261|4399198|P1|Overall Study|Dossier not Approved|1
1337356|NCT01990261|4399198|P1|Overall Study|PD Before Treatment Start|1
1337357|NCT01990261|4399198|P1|Overall Study|Disease Progression (PD)|8
1337358|NCT01990261|4399198|P1|Overall Study|Death From other Causes|1
1337359|NCT01990261|4399198|P1|Overall Study|Death due to Disease Progression (PD)|10
1337360|NCT01990261|4399198|P1|Overall Study|Death Before Treatment Start|2
1337361|NCT01989689|4399235|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
1337362|NCT01989689|4399236|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
1337363|NCT01989689|4399235|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
1337364|NCT01989689|4399236|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
1337365|NCT01989676|4399248|P2|Overall Study|Discontinued|68
1337366|NCT01989676|4399249|P1|Overall Study|Discontinued|59
1337367|NCT01989676|4399248|P2|Overall Study|Ongoing at data cutoff|279
1337368|NCT01989676|4399249|P1|Overall Study|Ongoing at data cutoff|279
1337369|NCT01989572|4399275|P6|Overall Study|alternative therapy|3
1337370|NCT01989572|4399276|P5|Overall Study|alternative therapy|1
1337371|NCT01989572|4399277|P4|Overall Study|alternative therapy|0
1337372|NCT01989572|4399278|P3|Overall Study|alternative therapy|0
1337373|NCT01989572|4399279|P2|Overall Study|alternative therapy|0
1337374|NCT01989572|4399280|P1|Overall Study|alternative therapy|3
1337375|NCT01989572|4399275|P6|Overall Study|not start protocol therapy|18
1337376|NCT01989572|4399276|P5|Overall Study|not start protocol therapy|4
1337377|NCT01989572|4399277|P4|Overall Study|not start protocol therapy|3
1337378|NCT01989572|4399278|P3|Overall Study|not start protocol therapy|2
1337379|NCT01989572|4399279|P2|Overall Study|not start protocol therapy|1
1337380|NCT01989572|4399280|P1|Overall Study|not start protocol therapy|5
1337381|NCT01989572|4399275|P6|Overall Study|unknown/not specify|5
1337382|NCT01989572|4399276|P5|Overall Study|unknown/not specify|3
1337383|NCT01989572|4399277|P4|Overall Study|unknown/not specify|3
1337384|NCT01989572|4399278|P3|Overall Study|unknown/not specify|1
1337385|NCT01989572|4399279|P2|Overall Study|unknown/not specify|4
1337386|NCT01989572|4399280|P1|Overall Study|unknown/not specify|3
1337387|NCT01989572|4399275|P6|Overall Study|maximum dose reached|0
1337388|NCT01989572|4399276|P5|Overall Study|maximum dose reached|1
1337389|NCT01989572|4399277|P4|Overall Study|maximum dose reached|0
1337390|NCT01989572|4399278|P3|Overall Study|maximum dose reached|0
1337391|NCT01989572|4399279|P2|Overall Study|maximum dose reached|1
1337392|NCT01989572|4399280|P1|Overall Study|maximum dose reached|0
1337393|NCT01989572|4399275|P6|Overall Study|error|1
1337394|NCT01989572|4399276|P5|Overall Study|error|1
1337395|NCT01989572|4399277|P4|Overall Study|error|1
1337396|NCT01989572|4399278|P3|Overall Study|error|1
1337397|NCT01989572|4399279|P2|Overall Study|error|1
1337398|NCT01989572|4399280|P1|Overall Study|error|2
1337399|NCT01989572|4399275|P6|Overall Study|complicating disease|0
1337400|NCT01989572|4399276|P5|Overall Study|complicating disease|1
1337401|NCT01989572|4399277|P4|Overall Study|complicating disease|0
1337402|NCT01989572|4399278|P3|Overall Study|complicating disease|2
1337403|NCT01989572|4399279|P2|Overall Study|complicating disease|1
1337404|NCT01989572|4399280|P1|Overall Study|complicating disease|1
1337405|NCT01989572|4399275|P6|Overall Study|Withdrawal by Subject|4
1337406|NCT01989572|4399276|P5|Overall Study|Withdrawal by Subject|12
1337407|NCT01989572|4399277|P4|Overall Study|Withdrawal by Subject|1
1337408|NCT01989572|4399278|P3|Overall Study|Withdrawal by Subject|5
1337409|NCT01989572|4399279|P2|Overall Study|Withdrawal by Subject|1
1337410|NCT01989572|4399280|P1|Overall Study|Withdrawal by Subject|4
1337411|NCT01989572|4399275|P6|Overall Study|Death|0
1337412|NCT01989572|4399276|P5|Overall Study|Death|1
1337413|NCT01989572|4399277|P4|Overall Study|Death|0
1337414|NCT01989572|4399278|P3|Overall Study|Death|0
1337415|NCT01989572|4399279|P2|Overall Study|Death|0
1337416|NCT01989572|4399280|P1|Overall Study|Death|0
1337417|NCT01989572|4399275|P6|Overall Study|Adverse Event|0
1337418|NCT01989572|4399276|P5|Overall Study|Adverse Event|3
1337419|NCT01989572|4399277|P4|Overall Study|Adverse Event|0
1337420|NCT01989572|4399278|P3|Overall Study|Adverse Event|3
1337421|NCT01989572|4399279|P2|Overall Study|Adverse Event|1
1337422|NCT01989572|4399280|P1|Overall Study|Adverse Event|2
1337423|NCT01989572|4399275|P6|Overall Study|Lack of Efficacy|79
1337424|NCT01989572|4399276|P5|Overall Study|Lack of Efficacy|71
1337425|NCT01989572|4399277|P4|Overall Study|Lack of Efficacy|43
1337426|NCT01989572|4399278|P3|Overall Study|Lack of Efficacy|48
1337427|NCT01989572|4399279|P2|Overall Study|Lack of Efficacy|48
1337428|NCT01989572|4399280|P1|Overall Study|Lack of Efficacy|35
1337429|NCT01989455|4399313|P5|Overall Study|Technical problems with infusion|1
1337430|NCT01989455|4399314|P4|Overall Study|Technical problems with infusion|0
1337431|NCT01989455|4399315|P3|Overall Study|Technical problems with infusion|1
1337432|NCT01989455|4399316|P2|Overall Study|Technical problems with infusion|0
1337433|NCT01989455|4399317|P1|Overall Study|Technical problems with infusion|0
1337434|NCT01989455|4399313|P5|Overall Study|Withdrawal by Subject|0
1337435|NCT01989455|4399314|P4|Overall Study|Withdrawal by Subject|0
1337436|NCT01989455|4399315|P3|Overall Study|Withdrawal by Subject|0
1337437|NCT01989455|4399316|P2|Overall Study|Withdrawal by Subject|1
1337438|NCT01989455|4399317|P1|Overall Study|Withdrawal by Subject|0
1337439|NCT01989455|4399313|P5|Overall Study|Adverse Event|0
1337440|NCT01989455|4399314|P4|Overall Study|Adverse Event|0
1337441|NCT01989455|4399315|P3|Overall Study|Adverse Event|0
1337442|NCT01989455|4399316|P2|Overall Study|Adverse Event|1
1337443|NCT01989455|4399317|P1|Overall Study|Adverse Event|0
1337444|NCT01989169|4399361|P2|Period 2|Adverse Event|1
1337445|NCT01989169|4399362|P1|Period 2|Adverse Event|0
1337446|NCT01989156|4399375|P3|End of Study (Population at Day 90)|Employment Conflict|0
1337447|NCT01989156|4399376|P2|End of Study (Population at Day 90)|Employment Conflict|1
1337448|NCT01989156|4399377|P1|End of Study (Population at Day 90)|Employment Conflict|0
1337449|NCT01989156|4399375|P3|End of Study (Population at Day 90)|Moved out of state|0
1337450|NCT01989156|4399376|P2|End of Study (Population at Day 90)|Moved out of state|0
1337451|NCT01989156|4399377|P1|End of Study (Population at Day 90)|Moved out of state|1
1337452|NCT01989156|4399375|P3|End of Study (Population at Day 90)|Physician Decision|1
1337453|NCT01989156|4399376|P2|End of Study (Population at Day 90)|Physician Decision|0
1337454|NCT01989156|4399377|P1|End of Study (Population at Day 90)|Physician Decision|1
1337455|NCT01989156|4399375|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
1337456|NCT01989156|4399376|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
1337457|NCT01989156|4399377|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
1337458|NCT01989156|4399375|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
1337459|NCT01989156|4399376|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
1337460|NCT01989156|4399377|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
1337461|NCT01989156|4399375|P3|Confinement Period (Population at Day 5)|Adverse Event|1
1337462|NCT01989156|4399376|P2|Confinement Period (Population at Day 5)|Adverse Event|0
1337463|NCT01989156|4399377|P1|Confinement Period (Population at Day 5)|Adverse Event|0
1337464|NCT01989156|4399375|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
1337465|NCT01989156|4399376|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
1337466|NCT01989156|4399377|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
1337467|NCT01989156|4399375|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
1337468|NCT01989156|4399376|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1337469|NCT01989156|4399377|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
1337470|NCT01988662|4399437|P2|Overall Study|Adverse Event|1
1337471|NCT01988662|4399438|P1|Overall Study|Adverse Event|3
1337472|NCT01988662|4399437|P2|Overall Study|Subject/guardian decision|1
1337473|NCT01988662|4399438|P1|Overall Study|Subject/guardian decision|1
1337474|NCT01988402|4399465|P2|Overall Study|Withdrawal by Subject|0
1337475|NCT01988402|4399466|P1|Overall Study|Withdrawal by Subject|1
1337476|NCT01988402|4399465|P2|Overall Study|Adverse Event|2
1337477|NCT01988402|4399466|P1|Overall Study|Adverse Event|1
1337478|NCT01988012|4399508|P1|Overall Study|Protocol Violation|1
1337479|NCT01988012|4399508|P1|Overall Study|Physician Decision|1
1337480|NCT01988012|4399508|P1|Overall Study|Lost to Follow-up|1
1337481|NCT01988012|4399508|P1|Overall Study|Patient Withdrawal of Consent|4
1337482|NCT01988012|4399508|P1|Overall Study|Insufficient Therapeutic Response|3
1337483|NCT01988012|4399508|P1|Overall Study|Adverse Event|5
1337484|NCT01987986|4399534|P4|Overall Study|Adverse Event|0
1337485|NCT01987986|4399535|P3|Overall Study|Adverse Event|2
1337486|NCT01987986|4399536|P2|Overall Study|Adverse Event|0
1337487|NCT01987986|4399537|P1|Overall Study|Adverse Event|1
1337488|NCT01987986|4399534|P4|Overall Study|Lost to Follow-up|0
1337489|NCT01987986|4399535|P3|Overall Study|Lost to Follow-up|0
1337490|NCT01987986|4399536|P2|Overall Study|Lost to Follow-up|0
1337491|NCT01987986|4399537|P1|Overall Study|Lost to Follow-up|1
1337492|NCT01987960|4399577|P4|Period 3|Administrative or other reason|43
1337493|NCT01987960|4399578|P3|Period 3|Administrative or other reason|0
1337494|NCT01987960|4399579|P2|Period 3|Administrative or other reason|0
1337495|NCT01987960|4399580|P1|Period 3|Administrative or other reason|0
1337496|NCT01987960|4399577|P4|Period 3|Lost to Follow-up|5
1337497|NCT01987960|4399578|P3|Period 3|Lost to Follow-up|0
1337498|NCT01987960|4399579|P2|Period 3|Lost to Follow-up|0
1337499|NCT01987960|4399580|P1|Period 3|Lost to Follow-up|0
1337500|NCT01987960|4399577|P4|Period 3|Withdrawal by Subject|9
1337501|NCT01987960|4399578|P3|Period 3|Withdrawal by Subject|0
1337502|NCT01987960|4399579|P2|Period 3|Withdrawal by Subject|0
1337503|NCT01987960|4399580|P1|Period 3|Withdrawal by Subject|0
1337504|NCT01987960|4399577|P4|Period 3|Protocol Violation|6
1337505|NCT01987960|4399578|P3|Period 3|Protocol Violation|0
1337506|NCT01987960|4399579|P2|Period 3|Protocol Violation|0
1337507|NCT01987960|4399580|P1|Period 3|Protocol Violation|0
1337508|NCT01987960|4399577|P4|Period 3|Non-compliance with IMP|1
1337509|NCT01987960|4399578|P3|Period 3|Non-compliance with IMP|0
1337510|NCT01987960|4399579|P2|Period 3|Non-compliance with IMP|0
1337511|NCT01987960|4399580|P1|Period 3|Non-compliance with IMP|0
1337512|NCT01987960|4399577|P4|Period 3|Adverse Event|7
1337513|NCT01987960|4399578|P3|Period 3|Adverse Event|0
1337514|NCT01987960|4399579|P2|Period 3|Adverse Event|0
1337515|NCT01987960|4399580|P1|Period 3|Adverse Event|0
1337516|NCT01987960|4399577|P4|Period 2|Administrative or other reason|0
1337517|NCT01987960|4399578|P3|Period 2|Administrative or other reason|7
1337518|NCT01987960|4399579|P2|Period 2|Administrative or other reason|5
1337519|NCT01987960|4399580|P1|Period 2|Administrative or other reason|0
1337520|NCT01987960|4399577|P4|Period 2|Withdrawal by Subject|0
1337521|NCT01987960|4399578|P3|Period 2|Withdrawal by Subject|1
1337522|NCT01987960|4399579|P2|Period 2|Withdrawal by Subject|0
1337523|NCT01987960|4399580|P1|Period 2|Withdrawal by Subject|0
1337524|NCT01987960|4399577|P4|Period 2|Adverse Event|0
1337525|NCT01987960|4399578|P3|Period 2|Adverse Event|1
1337526|NCT01987960|4399579|P2|Period 2|Adverse Event|0
1337527|NCT01987960|4399580|P1|Period 2|Adverse Event|0
1337528|NCT01987960|4399577|P4|Period 1|Withdrawal of consent before treatment|0
1337529|NCT01987960|4399578|P3|Period 1|Withdrawal of consent before treatment|0
1337530|NCT01987960|4399579|P2|Period 1|Withdrawal of consent before treatment|0
1337531|NCT01987960|4399580|P1|Period 1|Withdrawal of consent before treatment|4
1337532|NCT01987960|4399577|P4|Period 1|administrative or other reason|0
1337533|NCT01987960|4399578|P3|Period 1|administrative or other reason|0
1337534|NCT01987960|4399579|P2|Period 1|administrative or other reason|0
1337535|NCT01987960|4399580|P1|Period 1|administrative or other reason|75
1337536|NCT01987960|4399577|P4|Period 1|Lost to Follow-up|0
1337537|NCT01987960|4399578|P3|Period 1|Lost to Follow-up|0
1337538|NCT01987960|4399579|P2|Period 1|Lost to Follow-up|0
1337539|NCT01987960|4399580|P1|Period 1|Lost to Follow-up|40
1337540|NCT01987960|4399577|P4|Period 1|Withdrawal by Subject|0
1337541|NCT01987960|4399578|P3|Period 1|Withdrawal by Subject|0
1337542|NCT01987960|4399579|P2|Period 1|Withdrawal by Subject|0
1337543|NCT01987960|4399580|P1|Period 1|Withdrawal by Subject|21
1337544|NCT01987960|4399577|P4|Period 1|Protocol Violation|0
1337545|NCT01987960|4399578|P3|Period 1|Protocol Violation|0
1337546|NCT01987960|4399579|P2|Period 1|Protocol Violation|0
1337547|NCT01987960|4399580|P1|Period 1|Protocol Violation|12
1337548|NCT01987960|4399577|P4|Period 1|Non-compliance with IMP|0
1337549|NCT01987960|4399578|P3|Period 1|Non-compliance with IMP|0
1337550|NCT01987960|4399579|P2|Period 1|Non-compliance with IMP|0
1337551|NCT01987960|4399580|P1|Period 1|Non-compliance with IMP|6
1337552|NCT01987960|4399577|P4|Period 1|Lack of Efficacy|0
1337553|NCT01987960|4399578|P3|Period 1|Lack of Efficacy|0
1337554|NCT01987960|4399579|P2|Period 1|Lack of Efficacy|0
1337555|NCT01987960|4399580|P1|Period 1|Lack of Efficacy|4
1337556|NCT01987960|4399577|P4|Period 1|Adverse Event|0
1337557|NCT01987960|4399578|P3|Period 1|Adverse Event|0
1337558|NCT01987960|4399579|P2|Period 1|Adverse Event|0
1337559|NCT01987960|4399580|P1|Period 1|Adverse Event|24
1337560|NCT01987908|4399592|P3|Post-Treatment Observation Period|Other: Bad Veins|0
1337561|NCT01987908|4399593|P2|Post-Treatment Observation Period|Other: Bad Veins|1
1337562|NCT01987908|4399594|P1|Post-Treatment Observation Period|Other: Bad Veins|0
1337563|NCT01987908|4399592|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
1337564|NCT01987908|4399593|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
1337565|NCT01987908|4399594|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
1337566|NCT01987908|4399592|P3|Treatment Period|Adverse Event|1
1337567|NCT01987908|4399593|P2|Treatment Period|Adverse Event|1
1337568|NCT01987908|4399594|P1|Treatment Period|Adverse Event|0
1337569|NCT01987908|4399592|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
1337570|NCT01987908|4399593|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
1337571|NCT01987908|4399594|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
1337572|NCT01987908|4399592|P3|Placebo Lead-in Period|Withdrawal by Subject|0
1337573|NCT01987908|4399593|P2|Placebo Lead-in Period|Withdrawal by Subject|0
1337574|NCT01987908|4399594|P1|Placebo Lead-in Period|Withdrawal by Subject|1
1337575|NCT01987908|4399592|P3|Placebo Lead-in Period|Physician Decision|0
1337576|NCT01987908|4399593|P2|Placebo Lead-in Period|Physician Decision|0
1337577|NCT01987908|4399594|P1|Placebo Lead-in Period|Physician Decision|2
1337578|NCT01987908|4399592|P3|Placebo Lead-in Period|Adverse Event|0
1337579|NCT01987908|4399593|P2|Placebo Lead-in Period|Adverse Event|0
1337580|NCT01987908|4399594|P1|Placebo Lead-in Period|Adverse Event|2
1337581|NCT01987895|4399677|P2|Overall Study|randomized before giving IC|1
1337582|NCT01987895|4399678|P1|Overall Study|randomized before giving IC|0
1337583|NCT01987895|4399677|P2|Overall Study|Lost to Follow-up|5
1337584|NCT01987895|4399678|P1|Overall Study|Lost to Follow-up|3
1337585|NCT01987895|4399677|P2|Overall Study|Death|7
1337586|NCT01987895|4399678|P1|Overall Study|Death|7
1337587|NCT01987895|4399677|P2|Overall Study|Physician Decision|10
1337588|NCT01987895|4399678|P1|Overall Study|Physician Decision|8
1337589|NCT01987895|4399677|P2|Overall Study|Withdrawal by Subject|7
1337590|NCT01987895|4399678|P1|Overall Study|Withdrawal by Subject|12
1337591|NCT01987765|4399702|P1|Overall Study|Lost to Follow-up|37
1337592|NCT01987765|4399702|P1|Overall Study|Protocol Violation|65
1337593|NCT01987557|4399726|P3|Overall Study|Adverse Event|0
1337594|NCT01987557|4399727|P2|Overall Study|Adverse Event|2
1337595|NCT01987557|4399728|P1|Overall Study|Adverse Event|0
1337596|NCT01987557|4399726|P3|Overall Study|Withdrawal by Subject|2
1337597|NCT01987557|4399727|P2|Overall Study|Withdrawal by Subject|1
1337598|NCT01987557|4399728|P1|Overall Study|Withdrawal by Subject|2
1337599|NCT01987557|4399726|P3|Overall Study|Protocol Violation|1
1337600|NCT01987557|4399727|P2|Overall Study|Protocol Violation|0
1337601|NCT01987557|4399728|P1|Overall Study|Protocol Violation|1
1337602|NCT01987505|4399738|P1|Overall Study|Death|4
1337603|NCT01987505|4399738|P1|Overall Study|Investigator Decision|2
1337604|NCT01987505|4399738|P1|Overall Study|Lost to Follow-up|15
1337605|NCT01987505|4399738|P1|Overall Study|Other Reason|2
1337606|NCT01987505|4399738|P1|Overall Study|Withdrawal by Subject|2
1337607|NCT01987505|4399738|P1|Overall Study|Other|9
1337608|NCT01987479|4399768|P1|Overall Study|Adverse Event|7
1337609|NCT01987479|4399768|P1|Overall Study|Lost to Follow-up|1
1337610|NCT01987479|4399768|P1|Overall Study|Other|5
1337611|NCT01987479|4399768|P1|Overall Study|Participant/legal guardian decision|1
1337612|NCT01987479|4399768|P1|Overall Study|Physician Decision|2
1337613|NCT01987479|4399768|P1|Overall Study|Protocol Violation|1
1337614|NCT01987453|4399796|P3|Overall Study|Lack of Efficacy|0
1337615|NCT01987453|4399797|P2|Overall Study|Lack of Efficacy|12
1337616|NCT01987453|4399798|P1|Overall Study|Lack of Efficacy|1
1337617|NCT01987453|4399796|P3|Overall Study|Death|1
1337618|NCT01987453|4399797|P2|Overall Study|Death|0
1337619|NCT01987453|4399798|P1|Overall Study|Death|0
1337620|NCT01987232|4399867|P5|Overall Study|Ongoing in Study|0
1337621|NCT01987232|4399868|P4|Overall Study|Ongoing in Study|1
1337622|NCT01987232|4399869|P3|Overall Study|Ongoing in Study|0
1337623|NCT01987232|4399870|P2|Overall Study|Ongoing in Study|0
1337624|NCT01987232|4399871|P1|Overall Study|Ongoing in Study|0
1337625|NCT01986985|4399958|P1|Overall Study|Scan not completed due to malfunction|3
1337626|NCT01986985|4399958|P1|Overall Study|Withdrawal by Subject|4
1337627|NCT01986855|4399998|P3|Overall Study|Withdrawal by Subject|5
1337628|NCT01986855|4399999|P2|Overall Study|Withdrawal by Subject|8
1337629|NCT01986855|4400000|P1|Overall Study|Withdrawal by Subject|7
1337630|NCT01986855|4399998|P3|Overall Study|Participant Moved|2
1337631|NCT01986855|4399999|P2|Overall Study|Participant Moved|0
1337632|NCT01986855|4400000|P1|Overall Study|Participant Moved|0
1337633|NCT01986855|4399998|P3|Overall Study|Screen Failure|0
1337634|NCT01986855|4399999|P2|Overall Study|Screen Failure|1
1337635|NCT01986855|4400000|P1|Overall Study|Screen Failure|0
1337636|NCT01986855|4399998|P3|Overall Study|Lost to Follow-up|0
1337637|NCT01986855|4399999|P2|Overall Study|Lost to Follow-up|1
1337638|NCT01986855|4400000|P1|Overall Study|Lost to Follow-up|2
1337639|NCT01986855|4399998|P3|Overall Study|Death|4
1337640|NCT01986855|4399999|P2|Overall Study|Death|4
1337641|NCT01986855|4400000|P1|Overall Study|Death|3
1337642|NCT01986855|4399998|P3|Overall Study|Adverse Event|0
1337643|NCT01986855|4399999|P2|Overall Study|Adverse Event|0
1337644|NCT01986855|4400000|P1|Overall Study|Adverse Event|1
1337645|NCT01986751|4400050|P2|Overall Study|improperly consented|2
1337646|NCT01986751|4400051|P1|Overall Study|improperly consented|10
1337647|NCT01986231|4400105|P1|Overall Study|Adverse Event|1
1337648|NCT01986062|4400112|P2|Overall Study|Lost to Follow-up|1
1337649|NCT01986062|4400113|P1|Overall Study|Lost to Follow-up|1
1337650|NCT01985321|4400186|P2|Overall Study|Subject treated wrong type of sore|0
1337651|NCT01985321|4400187|P1|Overall Study|Subject treated wrong type of sore|1
1337652|NCT01985321|4400186|P2|Overall Study|Lost to Follow-up|2
1337653|NCT01985321|4400187|P1|Overall Study|Lost to Follow-up|5
1337654|NCT01985321|4400186|P2|Overall Study|Withdrawal by Subject|0
1337655|NCT01985321|4400187|P1|Overall Study|Withdrawal by Subject|1
1337656|NCT01985321|4400186|P2|Overall Study|Protocol Violation|3
1337657|NCT01985321|4400187|P1|Overall Study|Protocol Violation|4
1337658|NCT01985126|4400197|P2|Overall Study|Withdrawal by Subject|7
1337659|NCT01985126|4400198|P1|Overall Study|Withdrawal by Subject|2
1337660|NCT01985126|4400197|P2|Overall Study|Study Terminated By Sponsor|22
1337661|NCT01985126|4400198|P1|Overall Study|Study Terminated By Sponsor|1
1337662|NCT01985126|4400197|P2|Overall Study|Lost to Follow-up|8
1337663|NCT01985126|4400198|P1|Overall Study|Lost to Follow-up|0
1337664|NCT01985126|4400197|P2|Overall Study|Death|69
1337665|NCT01985126|4400198|P1|Overall Study|Death|15
1337666|NCT01984892|4400216|P1|Overall Study|Progressive disease|7
1337667|NCT01984697|4400227|P5|Overall Study|Pregnancy|1
1337668|NCT01984697|4400228|P4|Overall Study|Pregnancy|0
1337669|NCT01984697|4400229|P3|Overall Study|Pregnancy|1
1337670|NCT01984697|4400230|P2|Overall Study|Pregnancy|0
1337671|NCT01984697|4400231|P1|Overall Study|Pregnancy|2
1337672|NCT01984697|4400227|P5|Overall Study|Death|0
1337673|NCT01984697|4400228|P4|Overall Study|Death|1
1337674|NCT01984697|4400229|P3|Overall Study|Death|0
1337675|NCT01984697|4400230|P2|Overall Study|Death|0
1337676|NCT01984697|4400231|P1|Overall Study|Death|0
1337677|NCT01984697|4400227|P5|Overall Study|Missed last follow-up visit|0
1337678|NCT01984697|4400228|P4|Overall Study|Missed last follow-up visit|0
1337679|NCT01984697|4400229|P3|Overall Study|Missed last follow-up visit|0
1337680|NCT01984697|4400230|P2|Overall Study|Missed last follow-up visit|0
1337681|NCT01984697|4400231|P1|Overall Study|Missed last follow-up visit|1
1337682|NCT01984697|4400227|P5|Overall Study|Withdrawal by Subject|13
1337683|NCT01984697|4400228|P4|Overall Study|Withdrawal by Subject|11
1337684|NCT01984697|4400229|P3|Overall Study|Withdrawal by Subject|13
1337685|NCT01984697|4400230|P2|Overall Study|Withdrawal by Subject|21
1337686|NCT01984697|4400231|P1|Overall Study|Withdrawal by Subject|15
1337687|NCT01984697|4400227|P5|Overall Study|Protocol Violation|0
1337688|NCT01984697|4400228|P4|Overall Study|Protocol Violation|2
1337689|NCT01984697|4400229|P3|Overall Study|Protocol Violation|3
1337690|NCT01984697|4400230|P2|Overall Study|Protocol Violation|5
1337691|NCT01984697|4400231|P1|Overall Study|Protocol Violation|8
1337692|NCT01984697|4400227|P5|Overall Study|Physician Decision|0
1337693|NCT01984697|4400228|P4|Overall Study|Physician Decision|1
1337694|NCT01984697|4400229|P3|Overall Study|Physician Decision|0
1337695|NCT01984697|4400230|P2|Overall Study|Physician Decision|0
1337696|NCT01984697|4400231|P1|Overall Study|Physician Decision|3
1337697|NCT01984697|4400227|P5|Overall Study|Lost to Follow-up|21
1337698|NCT01984697|4400228|P4|Overall Study|Lost to Follow-up|6
1337699|NCT01984697|4400229|P3|Overall Study|Lost to Follow-up|10
1337700|NCT01984697|4400230|P2|Overall Study|Lost to Follow-up|5
1337701|NCT01984697|4400231|P1|Overall Study|Lost to Follow-up|14
1337702|NCT01984697|4400227|P5|Overall Study|Adverse Event|0
1337703|NCT01984697|4400228|P4|Overall Study|Adverse Event|0
1337704|NCT01984697|4400229|P3|Overall Study|Adverse Event|2
1337705|NCT01984697|4400230|P2|Overall Study|Adverse Event|0
1337706|NCT01984697|4400231|P1|Overall Study|Adverse Event|0
1337707|NCT01984684|4400350|P2|Overall Study|Subject had inadequate IV access|1
1337708|NCT01984684|4400351|P1|Overall Study|Subject had inadequate IV access|0
1337709|NCT01984684|4400350|P2|Overall Study|Study drug not available at site|1
1337710|NCT01984684|4400351|P1|Overall Study|Study drug not available at site|1
1337711|NCT01984684|4400350|P2|Overall Study|Subject incarcerated|0
1337712|NCT01984684|4400351|P1|Overall Study|Subject incarcerated|1
1337713|NCT01984684|4400350|P2|Overall Study|Noncompliance with study drug|1
1337714|NCT01984684|4400351|P1|Overall Study|Noncompliance with study drug|2
1337715|NCT01984684|4400350|P2|Overall Study|Death|1
1337716|NCT01984684|4400351|P1|Overall Study|Death|0
1337717|NCT01984684|4400350|P2|Overall Study|Protocol Violation|2
1337718|NCT01984684|4400351|P1|Overall Study|Protocol Violation|4
1337719|NCT01984684|4400350|P2|Overall Study|Physician Decision|2
1337720|NCT01984684|4400351|P1|Overall Study|Physician Decision|4
1337721|NCT01984684|4400350|P2|Overall Study|Lack of Efficacy|6
1337722|NCT01984684|4400351|P1|Overall Study|Lack of Efficacy|3
1337723|NCT01984684|4400350|P2|Overall Study|Withdrawal by Subject|9
1337724|NCT01984684|4400351|P1|Overall Study|Withdrawal by Subject|9
1337725|NCT01984684|4400350|P2|Overall Study|Adverse Event|12
1337726|NCT01984684|4400351|P1|Overall Study|Adverse Event|8
1337727|NCT01984684|4400350|P2|Overall Study|Lost to Follow-up|24
1337728|NCT01984684|4400351|P1|Overall Study|Lost to Follow-up|25
1337729|NCT01984424|4400369|P2|Overall Study|Lost to Follow-up|1
1337730|NCT01984424|4400370|P1|Overall Study|Lost to Follow-up|0
1337731|NCT01984424|4400369|P2|Overall Study|Sponsor Decision|1
1337732|NCT01984424|4400370|P1|Overall Study|Sponsor Decision|0
1337733|NCT01984424|4400369|P2|Overall Study|Withdrawal by Subject|5
1337734|NCT01984424|4400370|P1|Overall Study|Withdrawal by Subject|3
1337735|NCT01984294|4400425|P3|Overall Study|Adverse Event|0
1337736|NCT01984294|4400426|P2|Overall Study|Adverse Event|1
1337737|NCT01984294|4400427|P1|Overall Study|Adverse Event|0
1337738|NCT01984294|4400425|P3|Overall Study|Lack of Efficacy|6
1337739|NCT01984294|4400426|P2|Overall Study|Lack of Efficacy|2
1337740|NCT01984294|4400427|P1|Overall Study|Lack of Efficacy|4
1337741|NCT01984294|4400425|P3|Overall Study|Randomized but Never Treated|1
1337742|NCT01984294|4400426|P2|Overall Study|Randomized but Never Treated|0
1337743|NCT01984294|4400427|P1|Overall Study|Randomized but Never Treated|0
1337744|NCT01984242|4400450|P3|Overall Study|Ongoing in Study|61
1337745|NCT01984242|4400451|P2|Overall Study|Ongoing in Study|65
1337746|NCT01984242|4400452|P1|Overall Study|Ongoing in Study|60
1337747|NCT01984242|4400450|P3|Overall Study|Randomized, but not treated|1
1337748|NCT01984242|4400451|P2|Overall Study|Randomized, but not treated|0
1337749|NCT01984242|4400452|P1|Overall Study|Randomized, but not treated|0
1337750|NCT01984242|4400450|P3|Overall Study|Other|1
1337751|NCT01984242|4400451|P2|Overall Study|Other|0
1337752|NCT01984242|4400452|P1|Overall Study|Other|1
1337753|NCT01984242|4400450|P3|Overall Study|Lost to Follow-up|1
1337754|NCT01984242|4400451|P2|Overall Study|Lost to Follow-up|0
1337755|NCT01984242|4400452|P1|Overall Study|Lost to Follow-up|0
1337756|NCT01984242|4400450|P3|Overall Study|Physician Decision|2
1337757|NCT01984242|4400451|P2|Overall Study|Physician Decision|0
1337758|NCT01984242|4400452|P1|Overall Study|Physician Decision|1
1337759|NCT01984242|4400450|P3|Overall Study|Withdrawal by Subject|5
1337760|NCT01984242|4400451|P2|Overall Study|Withdrawal by Subject|2
1337761|NCT01984242|4400452|P1|Overall Study|Withdrawal by Subject|2
1337762|NCT01984242|4400450|P3|Overall Study|Death|30
1337763|NCT01984242|4400451|P2|Overall Study|Death|36
1337764|NCT01984242|4400452|P1|Overall Study|Death|37
1337765|NCT01984229|4400602|P2|Safety Follow-up Period|Lost to Follow-up|0
1337766|NCT01984229|4400603|P1|Safety Follow-up Period|Lost to Follow-up|1
1337767|NCT01984229|4400602|P2|Safety Follow-up Period|Adverse Event|1
1337768|NCT01984229|4400603|P1|Safety Follow-up Period|Adverse Event|1
1337769|NCT01983683|4400694|P2|Overall Study|Sponsor Decision|1
1337770|NCT01983683|4400695|P1|Overall Study|Sponsor Decision|1
1337771|NCT01983683|4400694|P2|Overall Study|Lost to Follow-up|8
1337772|NCT01983683|4400695|P1|Overall Study|Lost to Follow-up|4
1337773|NCT01983683|4400694|P2|Overall Study|Physician Decision|9
1337774|NCT01983683|4400695|P1|Overall Study|Physician Decision|8
1337775|NCT01983683|4400694|P2|Overall Study|Death|15
1337776|NCT01983683|4400695|P1|Overall Study|Death|11
1337777|NCT01983683|4400694|P2|Overall Study|Withdrawal by Subject|18
1337778|NCT01983683|4400695|P1|Overall Study|Withdrawal by Subject|14
1337779|NCT01983254|4400747|P2|Overall Study|too ill|8
1337780|NCT01983254|4400748|P1|Overall Study|too ill|11
1337781|NCT01983254|4400747|P2|Overall Study|Lost to Follow-up|16
1337782|NCT01983254|4400748|P1|Overall Study|Lost to Follow-up|17
1337783|NCT01983254|4400747|P2|Overall Study|Death|6
1337784|NCT01983254|4400748|P1|Overall Study|Death|6
1337785|NCT01983111|4400760|P2|Overall Study|Protocol Violation|1
1337786|NCT01983111|4400761|P1|Overall Study|Protocol Violation|0
1337787|NCT01983111|4400760|P2|Overall Study|Adverse Event|0
1337788|NCT01983111|4400761|P1|Overall Study|Adverse Event|4
1337789|NCT01983111|4400760|P2|Overall Study|Withdrawal by Subject|6
1337790|NCT01983111|4400761|P1|Overall Study|Withdrawal by Subject|8
1337791|NCT01982812|4400796|P2|Overall Study|Adverse Event|5
1337792|NCT01982812|4400797|P1|Overall Study|Adverse Event|0
1337793|NCT01982812|4400796|P2|Overall Study|Death|5
1337794|NCT01982812|4400797|P1|Overall Study|Death|1
1337795|NCT01982773|4400811|P2|Overall Study|Lost to Follow-up|1
1337796|NCT01982773|4400812|P1|Overall Study|Lost to Follow-up|7
1337797|NCT01982773|4400811|P2|Overall Study|Withdrawal by Subject|3
1337798|NCT01982773|4400812|P1|Overall Study|Withdrawal by Subject|1
1337799|NCT01982682|4400833|P1|Overall Study|Physician Decision|1
1337800|NCT01982435|4400847|P2|Overall Study|Adverse Event|0
1337801|NCT01982435|4400848|P1|Overall Study|Adverse Event|1
1337802|NCT01982292|4400887|P2|Overall Study|Technical Problems|0
1337803|NCT01982292|4400888|P1|Overall Study|Technical Problems|2
1337804|NCT01982292|4400887|P2|Overall Study|Patient/Guardian Decision|1
1337805|NCT01982292|4400888|P1|Overall Study|Patient/Guardian Decision|3
1337806|NCT01982292|4400887|P2|Overall Study|Protocol Deviation|0
1337807|NCT01982292|4400888|P1|Overall Study|Protocol Deviation|1
1337808|NCT01982292|4400887|P2|Overall Study|Non-Compliance With Study Treatment|0
1337809|NCT01982292|4400888|P1|Overall Study|Non-Compliance With Study Treatment|1
1337810|NCT01982292|4400887|P2|Overall Study|Lost to Follow-up|0
1337811|NCT01982292|4400888|P1|Overall Study|Lost to Follow-up|2
1337812|NCT01982292|4400887|P2|Overall Study|Death|0
1337813|NCT01982292|4400888|P1|Overall Study|Death|1
1337814|NCT01982292|4400887|P2|Overall Study|Adverse Event|0
1337815|NCT01982292|4400888|P1|Overall Study|Adverse Event|2
1337816|NCT01982253|4400909|P3|Overall Study|Study terminated by sponsor|4
1337817|NCT01982253|4400910|P2|Overall Study|Study terminated by sponsor|4
1337818|NCT01982253|4400911|P1|Overall Study|Study terminated by sponsor|1
1337819|NCT01982253|4400909|P3|Overall Study|Withdrawal by Subject|0
1337820|NCT01982253|4400910|P2|Overall Study|Withdrawal by Subject|0
1337821|NCT01982253|4400911|P1|Overall Study|Withdrawal by Subject|1
1337822|NCT01981954|4400935|P1|Fixed-Dose Assessment Period|Lack of Efficacy|1
1337823|NCT01981954|4400935|P1|Titration Period|Protocol Deviation|1
1337824|NCT01981616|4401004|P2|Overall Study|Protocol Violation|0
1337825|NCT01981616|4401005|P1|Overall Study|Protocol Violation|1
1337826|NCT01981616|4401004|P2|Overall Study|Adverse Event|1
1337827|NCT01981616|4401005|P1|Overall Study|Adverse Event|0
1337828|NCT01981473|4401031|P3|Overall Study|Received treatment for >24 months|6
1337829|NCT01981473|4401032|P2|Overall Study|Received treatment for >24 months|0
1337830|NCT01981473|4401033|P1|Overall Study|Received treatment for >24 months|2
1337831|NCT01981473|4401031|P3|Overall Study|Received treatment for < 6 months|1
1337832|NCT01981473|4401032|P2|Overall Study|Received treatment for < 6 months|0
1337833|NCT01981473|4401033|P1|Overall Study|Received treatment for < 6 months|0
1337834|NCT01981473|4401031|P3|Overall Study|Incorrect diagnosis of RA|1
1337835|NCT01981473|4401032|P2|Overall Study|Incorrect diagnosis of RA|0
1337836|NCT01981473|4401033|P1|Overall Study|Incorrect diagnosis of RA|0
1337837|NCT01981356|4401074|P2|Overall Study|Protocol Violation|0
1337838|NCT01981356|4401075|P1|Overall Study|Protocol Violation|2
1337839|NCT01981356|4401074|P2|Overall Study|Withdrawal by Subject|1
1337840|NCT01981356|4401075|P1|Overall Study|Withdrawal by Subject|1
1337841|NCT01981356|4401074|P2|Overall Study|Lost to Follow-up|1
1337842|NCT01981356|4401075|P1|Overall Study|Lost to Follow-up|4
1337843|NCT01980992|4401111|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
1337844|NCT01980992|4401112|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
1337845|NCT01980992|4401111|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
1337846|NCT01980992|4401112|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
1337847|NCT01980992|4401111|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
1337848|NCT01980992|4401112|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
1337849|NCT01980992|4401111|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
1337850|NCT01980992|4401112|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
1337851|NCT01980992|4401111|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
1337852|NCT01980992|4401112|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
1337853|NCT01980992|4401111|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
1337854|NCT01980992|4401112|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
1337855|NCT01980940|4401137|P8|Overall Study|Protocol Violation|0
1337856|NCT01980940|4401138|P7|Overall Study|Protocol Violation|0
1337857|NCT01980940|4401139|P6|Overall Study|Protocol Violation|2
1337858|NCT01980940|4401140|P5|Overall Study|Protocol Violation|0
1337859|NCT01980940|4401141|P4|Overall Study|Protocol Violation|0
1337860|NCT01980940|4401142|P3|Overall Study|Protocol Violation|0
1337861|NCT01980940|4401143|P2|Overall Study|Protocol Violation|0
1337862|NCT01980940|4401144|P1|Overall Study|Protocol Violation|0
1337863|NCT01980888|4401198|P2|Overall Study|Non-Compliance with Study Drug|2
1337864|NCT01980888|4401199|P1|Overall Study|Non-Compliance with Study Drug|3
1337865|NCT01980888|4401198|P2|Overall Study|Investigator's Discretion|3
1337866|NCT01980888|4401199|P1|Overall Study|Investigator's Discretion|8
1337867|NCT01980888|4401198|P2|Overall Study|Withdrew Consent|6
1337868|NCT01980888|4401199|P1|Overall Study|Withdrew Consent|17
1337869|NCT01980888|4401198|P2|Overall Study|Study Terminated by Sponsor|122
1337870|NCT01980888|4401199|P1|Overall Study|Study Terminated by Sponsor|116
1337871|NCT01980875|4401218|P3|Overall Study|Lost to Follow-up|1
1337872|NCT01980875|4401219|P2|Overall Study|Lost to Follow-up|0
1337873|NCT01980875|4401220|P1|Overall Study|Lost to Follow-up|0
1337874|NCT01980875|4401218|P3|Overall Study|Study Terminated by Sponsor|22
1337875|NCT01980875|4401219|P2|Overall Study|Study Terminated by Sponsor|24
1337876|NCT01980875|4401220|P1|Overall Study|Study Terminated by Sponsor|7
1337877|NCT01980875|4401218|P3|Overall Study|Withdrew Consent|1
1337878|NCT01980875|4401219|P2|Overall Study|Withdrew Consent|1
1337879|NCT01980875|4401220|P1|Overall Study|Withdrew Consent|1
1337880|NCT01980095|4401291|P2|Overall Study|Study drug discontinued|0
1337881|NCT01980095|4401292|P1|Overall Study|Study drug discontinued|1
1337882|NCT01980095|4401291|P2|Overall Study|Safety issue|1
1337883|NCT01980095|4401292|P1|Overall Study|Safety issue|0
1337884|NCT01980095|4401291|P2|Overall Study|Poor compliance|0
1337885|NCT01980095|4401292|P1|Overall Study|Poor compliance|5
1337886|NCT01980095|4401291|P2|Overall Study|Withdrawal by Subject|3
1337887|NCT01980095|4401292|P1|Overall Study|Withdrawal by Subject|2
1337888|NCT01980095|4401291|P2|Overall Study|Lost to Follow-up|7
1337889|NCT01980095|4401292|P1|Overall Study|Lost to Follow-up|6
1337890|NCT01979952|4401302|P2|Overall Study|Other than specified above|0
1337891|NCT01979952|4401303|P1|Overall Study|Other than specified above|1
1337892|NCT01979952|4401302|P2|Overall Study|Withdrawal by Subject|1
1337893|NCT01979952|4401303|P1|Overall Study|Withdrawal by Subject|2
1337894|NCT01979952|4401302|P2|Overall Study|Protocol Violation|0
1337895|NCT01979952|4401303|P1|Overall Study|Protocol Violation|1
1337896|NCT01979952|4401302|P2|Overall Study|Adverse Event|5
1337897|NCT01979952|4401303|P1|Overall Study|Adverse Event|4
1337898|NCT01979185|4401370|P2|Period 2|Not specified|1
1337899|NCT01979185|4401371|P1|Period 2|Not specified|0
1337900|NCT01978236|4401536|P1|Overall Study|Discontinued due to study close|2
1337901|NCT01978145|4401555|P2|Treatment Period 2|Par. reached defined stopping criteria|5
1337902|NCT01978145|4401556|P1|Treatment Period 2|Par. reached defined stopping criteria|8
1337903|NCT01978145|4401555|P2|Treatment Period 2|Withdrawal by Subject|4
1337904|NCT01978145|4401556|P1|Treatment Period 2|Withdrawal by Subject|7
1337905|NCT01978145|4401555|P2|Treatment Period 2|Lost to Follow-up|1
1337906|NCT01978145|4401556|P1|Treatment Period 2|Lost to Follow-up|1
1337907|NCT01978145|4401555|P2|Treatment Period 2|Protocol Violation|1
1337908|NCT01978145|4401556|P1|Treatment Period 2|Protocol Violation|0
1337909|NCT01978145|4401555|P2|Treatment Period 2|Adverse Event|3
1337910|NCT01978145|4401556|P1|Treatment Period 2|Adverse Event|3
1337911|NCT01978145|4401555|P2|Washout Period 1|Par. reached defined stopping criteria|1
1337912|NCT01978145|4401556|P1|Washout Period 1|Par. reached defined stopping criteria|0
1337913|NCT01978145|4401555|P2|Washout Period 1|Withdrawal by Subject|1
1337914|NCT01978145|4401556|P1|Washout Period 1|Withdrawal by Subject|1
1337915|NCT01978145|4401555|P2|Washout Period 1|Adverse Event|1
1337916|NCT01978145|4401556|P1|Washout Period 1|Adverse Event|0
1337917|NCT01978145|4401555|P2|Treatment Period 1|Par. reached defined stopping criteria|3
1337918|NCT01978145|4401556|P1|Treatment Period 1|Par. reached defined stopping criteria|2
1337919|NCT01978145|4401555|P2|Treatment Period 1|Withdrawal by Subject|4
1337920|NCT01978145|4401556|P1|Treatment Period 1|Withdrawal by Subject|5
1337921|NCT01978145|4401555|P2|Treatment Period 1|Physician Decision|0
1337922|NCT01978145|4401556|P1|Treatment Period 1|Physician Decision|1
1337923|NCT01978145|4401555|P2|Treatment Period 1|Adverse Event|9
1337924|NCT01978145|4401556|P1|Treatment Period 1|Adverse Event|1
1337925|NCT01978119|4401572|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
1337926|NCT01978119|4401573|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1337927|NCT01978119|4401572|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1337928|NCT01978119|4401573|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1337929|NCT01978119|4401572|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
1337930|NCT01978119|4401573|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
1337931|NCT01978093|4401599|P2|Overall Study|N/A for vaccine administration|1
1337932|NCT01978093|4401600|P1|Overall Study|N/A for vaccine administration|0
1337933|NCT01978093|4401599|P2|Overall Study|Child was in care of grandmother|1
1337934|NCT01978093|4401600|P1|Overall Study|Child was in care of grandmother|0
1337935|NCT01978093|4401599|P2|Overall Study|Mother lost custody of child|1
1337936|NCT01978093|4401600|P1|Overall Study|Mother lost custody of child|0
1337937|NCT01978093|4401599|P2|Overall Study|Lost kaiser health plan unable to contac|0
1337938|NCT01978093|4401600|P1|Overall Study|Lost kaiser health plan unable to contac|1
1337939|NCT01978093|4401599|P2|Overall Study|Loss of kaiser coverage|10
1337940|NCT01978093|4401600|P1|Overall Study|Loss of kaiser coverage|4
1337941|NCT01978093|4401599|P2|Overall Study|Migrated/moved from study area|13
1337942|NCT01978093|4401600|P1|Overall Study|Migrated/moved from study area|11
1337943|NCT01978093|4401599|P2|Overall Study|Lost to Follow-up|15
1337944|NCT01978093|4401600|P1|Overall Study|Lost to Follow-up|11
1337945|NCT01978093|4401599|P2|Overall Study|Withdrawal by Subject|25
1337946|NCT01978093|4401600|P1|Overall Study|Withdrawal by Subject|29
1337947|NCT01978093|4401599|P2|Overall Study|Protocol Violation|2
1337948|NCT01978093|4401600|P1|Overall Study|Protocol Violation|8
1337949|NCT01978093|4401599|P2|Overall Study|Adverse Event|5
1337950|NCT01978093|4401600|P1|Overall Study|Adverse Event|0
1337951|NCT01978093|4401599|P2|Overall Study|Death|0
1337952|NCT01978093|4401600|P1|Overall Study|Death|1
1337953|NCT01977820|4401644|P2|Overall Study|Sponsor terminated the study|1
1337954|NCT01977820|4401645|P1|Overall Study|Sponsor terminated the study|1
1337955|NCT01977794|4401653|P2|Overall Study|Other|1
1337956|NCT01977794|4401654|P1|Overall Study|Other|0
1337957|NCT01977794|4401653|P2|Overall Study|Withdrew consent|1
1337958|NCT01977794|4401654|P1|Overall Study|Withdrew consent|2
1337959|NCT01977794|4401653|P2|Overall Study|Death|1
1337960|NCT01977794|4401654|P1|Overall Study|Death|1
1337961|NCT01977794|4401653|P2|Overall Study|Protocol Violation|0
1337962|NCT01977794|4401654|P1|Overall Study|Protocol Violation|1
1337963|NCT01977794|4401653|P2|Overall Study|Lost to Follow-up|1
1337964|NCT01977794|4401654|P1|Overall Study|Lost to Follow-up|2
1337965|NCT01977794|4401653|P2|Overall Study|Adverse Event|2
1337966|NCT01977794|4401654|P1|Overall Study|Adverse Event|2
1337967|NCT01977729|4401689|P1|Overall Study|Study terminated|1
1337968|NCT01977690|4401701|P2|Overall Study|Withdrawal by Subject|4
1337969|NCT01977690|4401702|P1|Overall Study|Withdrawal by Subject|0
1337970|NCT01977677|4401711|P3|Overall Study|Unrelated Adverse Event|1
1337971|NCT01977677|4401712|P2|Overall Study|Unrelated Adverse Event|0
1337972|NCT01977677|4401713|P1|Overall Study|Unrelated Adverse Event|0
1337973|NCT01977625|4401724|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
1337974|NCT01977625|4401725|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1337975|NCT01977625|4401724|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
1337976|NCT01977625|4401725|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
1337977|NCT01977612|4401735|P2|Overall Study|Lost to Follow-up|1
1337978|NCT01977612|4401736|P1|Overall Study|Lost to Follow-up|1
1337979|NCT01977573|4401758|P4|Overall Study|Withdrawal by Subject|1
1337980|NCT01977573|4401759|P3|Overall Study|Withdrawal by Subject|1
1337981|NCT01977573|4401760|P2|Overall Study|Withdrawal by Subject|1
1337982|NCT01977573|4401761|P1|Overall Study|Withdrawal by Subject|6
1337983|NCT01977573|4401758|P4|Overall Study|Reached Defined Stopping Criteria|0
1337984|NCT01977573|4401759|P3|Overall Study|Reached Defined Stopping Criteria|1
1337985|NCT01977573|4401760|P2|Overall Study|Reached Defined Stopping Criteria|1
1337986|NCT01977573|4401761|P1|Overall Study|Reached Defined Stopping Criteria|2
1337987|NCT01977573|4401758|P4|Overall Study|Protocol Violation|0
1337988|NCT01977573|4401759|P3|Overall Study|Protocol Violation|0
1337989|NCT01977573|4401760|P2|Overall Study|Protocol Violation|1
1337990|NCT01977573|4401761|P1|Overall Study|Protocol Violation|3
1337991|NCT01977573|4401758|P4|Overall Study|Physician Decision|0
1337992|NCT01977573|4401759|P3|Overall Study|Physician Decision|0
1337993|NCT01977573|4401760|P2|Overall Study|Physician Decision|0
1337994|NCT01977573|4401761|P1|Overall Study|Physician Decision|1
1337995|NCT01977573|4401758|P4|Overall Study|Lost to Follow-up|1
1337996|NCT01977573|4401759|P3|Overall Study|Lost to Follow-up|0
1337997|NCT01977573|4401760|P2|Overall Study|Lost to Follow-up|0
1337998|NCT01977573|4401761|P1|Overall Study|Lost to Follow-up|1
1337999|NCT01977573|4401758|P4|Overall Study|Adverse Event|1
1338000|NCT01977573|4401759|P3|Overall Study|Adverse Event|2
1338001|NCT01977573|4401760|P2|Overall Study|Adverse Event|0
1338002|NCT01977573|4401761|P1|Overall Study|Adverse Event|7
1338003|NCT01977482|4401875|P6|Overall Study|Withdrawal by Subject|5
1338004|NCT01977482|4401876|P5|Overall Study|Withdrawal by Subject|1
1338005|NCT01977482|4401877|P4|Overall Study|Withdrawal by Subject|3
1338006|NCT01977482|4401878|P3|Overall Study|Withdrawal by Subject|1
1338007|NCT01977482|4401879|P2|Overall Study|Withdrawal by Subject|4
1338008|NCT01977482|4401880|P1|Overall Study|Withdrawal by Subject|2
1338009|NCT01977482|4401875|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
1338010|NCT01977482|4401876|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
1338011|NCT01977482|4401877|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
1338012|NCT01977482|4401878|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
1338013|NCT01977482|4401879|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
1338014|NCT01977482|4401880|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
1338015|NCT01977482|4401875|P6|Overall Study|Protocol Violation|0
1338016|NCT01977482|4401876|P5|Overall Study|Protocol Violation|0
1338017|NCT01977482|4401877|P4|Overall Study|Protocol Violation|0
1338018|NCT01977482|4401878|P3|Overall Study|Protocol Violation|1
1338019|NCT01977482|4401879|P2|Overall Study|Protocol Violation|0
1338020|NCT01977482|4401880|P1|Overall Study|Protocol Violation|0
1338021|NCT01977482|4401875|P6|Overall Study|Physician Decision|0
1338022|NCT01977482|4401876|P5|Overall Study|Physician Decision|0
1338023|NCT01977482|4401877|P4|Overall Study|Physician Decision|0
1338024|NCT01977482|4401878|P3|Overall Study|Physician Decision|0
1338025|NCT01977482|4401879|P2|Overall Study|Physician Decision|1
1338026|NCT01977482|4401880|P1|Overall Study|Physician Decision|0
1338027|NCT01977482|4401875|P6|Overall Study|Lost to Follow-up|0
1338028|NCT01977482|4401876|P5|Overall Study|Lost to Follow-up|0
1338029|NCT01977482|4401877|P4|Overall Study|Lost to Follow-up|0
1338030|NCT01977482|4401878|P3|Overall Study|Lost to Follow-up|0
1338031|NCT01977482|4401879|P2|Overall Study|Lost to Follow-up|0
1338032|NCT01977482|4401880|P1|Overall Study|Lost to Follow-up|1
1338033|NCT01977482|4401875|P6|Overall Study|Adverse Event|0
1338034|NCT01977482|4401876|P5|Overall Study|Adverse Event|2
1338035|NCT01977482|4401877|P4|Overall Study|Adverse Event|0
1338036|NCT01977482|4401878|P3|Overall Study|Adverse Event|1
1338037|NCT01977482|4401879|P2|Overall Study|Adverse Event|1
1338038|NCT01977482|4401880|P1|Overall Study|Adverse Event|0
1338039|NCT01977456|4401995|P1|Overall Study|Death|5
1338040|NCT01977352|4402004|P2|Overall Study|Lost to Follow-up|2
1338041|NCT01977352|4402005|P1|Overall Study|Lost to Follow-up|1
1338042|NCT01977222|4402023|P1|Overall Study|Withdrawal by Subject|1
1338043|NCT01977092|4402036|P2|Overall Study|In prison|11
1338044|NCT01977092|4402037|P1|Overall Study|In prison|3
1338045|NCT01977092|4402036|P2|Overall Study|Withdrawal by Subject|1
1338046|NCT01977092|4402037|P1|Overall Study|Withdrawal by Subject|2
1338047|NCT01977092|4402036|P2|Overall Study|Lost to Follow-up|14
1338048|NCT01977092|4402037|P1|Overall Study|Lost to Follow-up|23
1338049|NCT01977092|4402036|P2|Overall Study|Death|4
1338050|NCT01977092|4402037|P1|Overall Study|Death|3
1338051|NCT01976845|4402078|P3|Overall Study|Physician Decision|3
1338052|NCT01976845|4402079|P2|Overall Study|Physician Decision|8
1338053|NCT01976845|4402080|P1|Overall Study|Physician Decision|8
1338054|NCT01976806|4402105|P2|Overall Study|Withdrawal by Subject|1
1338055|NCT01976806|4402106|P1|Overall Study|Withdrawal by Subject|1
1338056|NCT01976806|4402105|P2|Overall Study|Adverse Event|1
1338057|NCT01976806|4402106|P1|Overall Study|Adverse Event|1
1338058|NCT01976806|4402105|P2|Overall Study|Lost to Follow-up|4
1338059|NCT01976806|4402106|P1|Overall Study|Lost to Follow-up|1
1338060|NCT01976663|4402134|P1|Overall Study|Lost to Follow-up|3
1338061|NCT01976663|4402134|P1|Overall Study|Adverse Event|2
1338062|NCT01976663|4402134|P1|Overall Study|Screen Failure|3
1338063|NCT01976663|4402134|P1|Overall Study|Withdrawal by Subject|4
1338064|NCT01976663|4402134|P1|Overall Study|Personal Reasons|6
1338065|NCT01976663|4402134|P1|Overall Study|Completed 18 mos but no repeat treatment|24
1338066|NCT01976624|4402153|P1|Overall Study|Participants age less than 19 years|12
1338067|NCT01976624|4402153|P1|Overall Study|Participants contraindicated|2
1338068|NCT01976507|4402181|P1|Overall Study|ablation not done, drug not given|1
1338069|NCT01976507|4402181|P1|Overall Study|Adverse Event|6
1338070|NCT01976338|4402205|P2|Overall Study|Adverse Event|1
1338071|NCT01976338|4402206|P1|Overall Study|Adverse Event|5
1338072|NCT01976338|4402205|P2|Overall Study|Withdrawal by Subject|2
1338073|NCT01976338|4402206|P1|Overall Study|Withdrawal by Subject|5
1338074|NCT01976338|4402205|P2|Overall Study|Lost to Follow-up|0
1338075|NCT01976338|4402206|P1|Overall Study|Lost to Follow-up|3
1338076|NCT01976338|4402205|P2|Overall Study|Physician Decision|1
1338077|NCT01976338|4402206|P1|Overall Study|Physician Decision|0
1338078|NCT01976312|4402233|P2|Overall Study|Protocol Violation|0
1338079|NCT01976312|4402234|P1|Overall Study|Protocol Violation|2
1338080|NCT01976312|4402233|P2|Overall Study|Adverse Event|6
1338081|NCT01976312|4402234|P1|Overall Study|Adverse Event|6
1338082|NCT01976312|4402233|P2|Overall Study|Withdrawal by Subject|2
1338083|NCT01976312|4402234|P1|Overall Study|Withdrawal by Subject|7
1338084|NCT01976312|4402233|P2|Overall Study|Lost to Follow-up|0
1338085|NCT01976312|4402234|P1|Overall Study|Lost to Follow-up|2
1338086|NCT01976312|4402233|P2|Overall Study|Pregnancy|1
1338087|NCT01976312|4402234|P1|Overall Study|Pregnancy|0
1338088|NCT01976299|4402255|P2|Overall Study|See clarification above in comments|2
1338089|NCT01976299|4402256|P1|Overall Study|See clarification above in comments|9
1338090|NCT01976299|4402255|P2|Overall Study|Lost to Follow-up|1
1338091|NCT01976299|4402256|P1|Overall Study|Lost to Follow-up|7
1338092|NCT01976299|4402255|P2|Overall Study|Death|2
1338093|NCT01976299|4402256|P1|Overall Study|Death|4
1338094|NCT01976299|4402255|P2|Overall Study|Withdrawal by Subject|1
1338095|NCT01976299|4402256|P1|Overall Study|Withdrawal by Subject|3
1338096|NCT01976104|4402283|P4|Overall Study|Other|0
1338097|NCT01976104|4402284|P3|Overall Study|Other|0
1338098|NCT01976104|4402285|P2|Overall Study|Other|1
1338099|NCT01976104|4402286|P1|Overall Study|Other|0
1338100|NCT01976104|4402283|P4|Overall Study|Withdrawal by Subject|1
1338101|NCT01976104|4402284|P3|Overall Study|Withdrawal by Subject|0
1338102|NCT01976104|4402285|P2|Overall Study|Withdrawal by Subject|0
1338103|NCT01976104|4402286|P1|Overall Study|Withdrawal by Subject|3
1338104|NCT01976104|4402283|P4|Overall Study|Subject Choice|1
1338105|NCT01976104|4402284|P3|Overall Study|Subject Choice|0
1338106|NCT01976104|4402285|P2|Overall Study|Subject Choice|1
1338107|NCT01976104|4402286|P1|Overall Study|Subject Choice|0
1338108|NCT01976104|4402283|P4|Overall Study|Lost to Follow-up|1
1338109|NCT01976104|4402284|P3|Overall Study|Lost to Follow-up|1
1338110|NCT01976104|4402285|P2|Overall Study|Lost to Follow-up|0
1338111|NCT01976104|4402286|P1|Overall Study|Lost to Follow-up|3
1338112|NCT01976104|4402283|P4|Overall Study|Adverse Event|0
1338113|NCT01976104|4402284|P3|Overall Study|Adverse Event|1
1338114|NCT01976104|4402285|P2|Overall Study|Adverse Event|0
1338115|NCT01976104|4402286|P1|Overall Study|Adverse Event|0
1338116|NCT01975948|4402320|P4|Overall Study|Withdrawal by Subject|6
1338117|NCT01975948|4402321|P3|Overall Study|Withdrawal by Subject|7
1338118|NCT01975948|4402322|P2|Overall Study|Withdrawal by Subject|21
1338119|NCT01975948|4402323|P1|Overall Study|Withdrawal by Subject|17
1338120|NCT01975675|4402394|P4|Overall Study|Death|0
1338121|NCT01975675|4402395|P3|Overall Study|Death|0
1338122|NCT01975675|4402396|P2|Overall Study|Death|1
1338123|NCT01975675|4402397|P1|Overall Study|Death|0
1338124|NCT01975389|4402430|P2|Overall Study|Randomized, not treated|5
1338125|NCT01975389|4402431|P1|Overall Study|Randomized, not treated|4
1338126|NCT01975389|4402430|P2|Overall Study|Other|9
1338127|NCT01975389|4402431|P1|Overall Study|Other|6
1338128|NCT01975389|4402430|P2|Overall Study|Withdrawal by Subject|76
1338129|NCT01975389|4402431|P1|Overall Study|Withdrawal by Subject|90
1338130|NCT01975389|4402430|P2|Overall Study|Lost to Follow-up|86
1338131|NCT01975389|4402431|P1|Overall Study|Lost to Follow-up|81
1338132|NCT01975389|4402430|P2|Overall Study|Death|54
1338133|NCT01975389|4402431|P1|Overall Study|Death|61
1338134|NCT01975389|4402430|P2|Overall Study|Adverse Event|6
1338135|NCT01975389|4402431|P1|Overall Study|Adverse Event|10
1338136|NCT01975376|4402491|P2|Overall Study|Randomized, Not Treated|8
1338137|NCT01975376|4402492|P1|Overall Study|Randomized, Not Treated|16
1338138|NCT01975376|4402491|P2|Overall Study|Other|4
1338139|NCT01975376|4402492|P1|Overall Study|Other|2
1338140|NCT01975376|4402491|P2|Overall Study|Withdrew consent|62
1338141|NCT01975376|4402492|P1|Overall Study|Withdrew consent|68
1338142|NCT01975376|4402491|P2|Overall Study|Lost to Follow-up|66
1338143|NCT01975376|4402492|P1|Overall Study|Lost to Follow-up|70
1338144|NCT01975376|4402491|P2|Overall Study|Death|72
1338145|NCT01975376|4402492|P1|Overall Study|Death|65
1338146|NCT01975376|4402491|P2|Overall Study|Adverse Event|5
1338147|NCT01975376|4402492|P1|Overall Study|Adverse Event|5
1338148|NCT01975285|4402552|P2|Overall Study|Failed Block and follow up|2
1338149|NCT01975285|4402553|P1|Overall Study|Failed Block and follow up|2
1338150|NCT01975246|4402569|P2|Overall Study|Other than stated|1
1338151|NCT01975246|4402570|P1|Overall Study|Other than stated|0
1338152|NCT01975246|4402569|P2|Overall Study|Protocol Violation|0
1338153|NCT01975246|4402570|P1|Overall Study|Protocol Violation|1
1338154|NCT01975246|4402569|P2|Overall Study|Lack of Efficacy|0
1338155|NCT01975246|4402570|P1|Overall Study|Lack of Efficacy|1
1338156|NCT01975246|4402569|P2|Overall Study|Adverse Event|1
1338157|NCT01975246|4402570|P1|Overall Study|Adverse Event|2
1338158|NCT01975220|4402583|P6|Test Period 1|Not treated|0
1338159|NCT01975220|4402584|P5|Test Period 1|Not treated|0
1338160|NCT01975220|4402585|P4|Test Period 1|Not treated|0
1338161|NCT01975220|4402586|P3|Test Period 1|Not treated|0
1338162|NCT01975220|4402587|P2|Test Period 1|Not treated|1
1338163|NCT01975220|4402588|P1|Test Period 1|Not treated|0
1338164|NCT01974895|4402644|P2|Overall Study|Other (Reason unknown)|8
1338165|NCT01974895|4402645|P1|Overall Study|Other (Reason unknown)|9
1338166|NCT01974895|4402644|P2|Overall Study|Other (Missed Visit)|0
1338167|NCT01974895|4402645|P1|Overall Study|Other (Missed Visit)|1
1338168|NCT01974895|4402644|P2|Overall Study|Withdrawal by Subject|1
1338169|NCT01974895|4402645|P1|Overall Study|Withdrawal by Subject|0
1338170|NCT01974895|4402644|P2|Overall Study|Lost to Follow-up|6
1338171|NCT01974895|4402645|P1|Overall Study|Lost to Follow-up|4
1338172|NCT01974895|4402644|P2|Overall Study|Protocol Violation|0
1338173|NCT01974895|4402645|P1|Overall Study|Protocol Violation|1
1338174|NCT01974817|4402675|P1|Overall Study|Protocol Violation|2
1338175|NCT01974817|4402675|P1|Overall Study|Lost to Follow-up|2
1338176|NCT01974817|4402675|P1|Overall Study|Death|4
1338177|NCT01974752|4402681|P2|Overall Study|Other Eligibility Criteria|1
1338178|NCT01974752|4402682|P1|Overall Study|Other Eligibility Criteria|0
1338179|NCT01974752|4402681|P2|Overall Study|Withdrawal by Subject|3
1338180|NCT01974752|4402682|P1|Overall Study|Withdrawal by Subject|2
1338181|NCT01974752|4402681|P2|Overall Study|Lost to Follow-up|0
1338182|NCT01974752|4402682|P1|Overall Study|Lost to Follow-up|2
1338183|NCT01974752|4402681|P2|Overall Study|Death|11
1338184|NCT01974752|4402682|P1|Overall Study|Death|33
1338185|NCT01974323|4402709|P2|Overall Study|Adverse Event|2
1338186|NCT01974323|4402710|P1|Overall Study|Adverse Event|2
1338187|NCT01974323|4402709|P2|Overall Study|Lack of Efficacy|1
1338188|NCT01974323|4402710|P1|Overall Study|Lack of Efficacy|1
1338189|NCT01974323|4402709|P2|Overall Study|Pregnancy|1
1338190|NCT01974323|4402710|P1|Overall Study|Pregnancy|2
1338191|NCT01974323|4402709|P2|Overall Study|Lost to Follow-up|40
1338192|NCT01974323|4402710|P1|Overall Study|Lost to Follow-up|45
1338193|NCT01974323|4402709|P2|Overall Study|Personal Reasons|19
1338194|NCT01974323|4402710|P1|Overall Study|Personal Reasons|15
1338195|NCT01974323|4402709|P2|Overall Study|Protocol Violation|2
1338196|NCT01974323|4402710|P1|Overall Study|Protocol Violation|2
1338197|NCT01974323|4402709|P2|Overall Study|Other Reasons|28
1338198|NCT01974323|4402710|P1|Overall Study|Other Reasons|25
1338199|NCT01974141|4402743|P2|Overall Study|Adverse Event|5
1338200|NCT01974141|4402744|P1|Overall Study|Adverse Event|4
1338201|NCT01974141|4402743|P2|Overall Study|Lack of Efficacy|1
1338202|NCT01974141|4402744|P1|Overall Study|Lack of Efficacy|0
1338203|NCT01974141|4402743|P2|Overall Study|Pregnancy|3
1338204|NCT01974141|4402744|P1|Overall Study|Pregnancy|3
1338205|NCT01974141|4402743|P2|Overall Study|Lost to Follow-up|29
1338206|NCT01974141|4402744|P1|Overall Study|Lost to Follow-up|38
1338207|NCT01974141|4402743|P2|Overall Study|Personal Reasons|20
1338208|NCT01974141|4402744|P1|Overall Study|Personal Reasons|21
1338209|NCT01974141|4402743|P2|Overall Study|Protocol Violation|6
1338210|NCT01974141|4402744|P1|Overall Study|Protocol Violation|2
1338211|NCT01974141|4402743|P2|Overall Study|Other Reasons|18
1338212|NCT01974141|4402744|P1|Overall Study|Other Reasons|28
1338213|NCT01973595|4402808|P4|Washout|Withdrawal by Subject|0
1338214|NCT01973595|4402809|P3|Washout|Withdrawal by Subject|1
1338215|NCT01973595|4402810|P2|Washout|Withdrawal by Subject|0
1338216|NCT01973595|4402811|P1|Washout|Withdrawal by Subject|1
1338217|NCT01973491|4402825|P1|Treatment Period (16 Weeks)|Adverse Event|1
1338218|NCT01973491|4402825|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
1338219|NCT01973491|4402825|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
1338220|NCT01973439|4402841|P1|Overall Study|PK curve incomplete|2
1338221|NCT01973439|4402841|P1|Overall Study|Vomiting after commencing once daily|1
1338222|NCT01973439|4402841|P1|Overall Study|Lost samples from one PK Day|2
1338223|NCT01973387|4402863|P2|Overall Study|Randomized, not treated|2
1338224|NCT01973387|4402864|P1|Overall Study|Randomized, not treated|2
1338225|NCT01973387|4402863|P2|Overall Study|Death|3
1338226|NCT01973387|4402864|P1|Overall Study|Death|4
1338227|NCT01973387|4402863|P2|Overall Study|Progressive disease or relapse|5
1338228|NCT01973387|4402864|P1|Overall Study|Progressive disease or relapse|16
1338229|NCT01973387|4402863|P2|Overall Study|Study terminated by sponsor|0
1338230|NCT01973387|4402864|P1|Overall Study|Study terminated by sponsor|63
1338231|NCT01973387|4402863|P2|Overall Study|Withdrawal by Subject|4
1338232|NCT01973387|4402864|P1|Overall Study|Withdrawal by Subject|7
1338233|NCT01973387|4402863|P2|Overall Study|Adverse Event|4
1338234|NCT01973387|4402864|P1|Overall Study|Adverse Event|14
1338235|NCT01973231|4402905|P2|Overall Study|Withdrawal by Subject|9
1338236|NCT01973231|4402906|P1|Overall Study|Withdrawal by Subject|7
1338237|NCT01973231|4402905|P2|Overall Study|unclassified|1
1338238|NCT01973231|4402906|P1|Overall Study|unclassified|2
1338239|NCT01973231|4402905|P2|Overall Study|Lost to Follow-up|1
1338240|NCT01973231|4402906|P1|Overall Study|Lost to Follow-up|1
1338241|NCT01973231|4402905|P2|Overall Study|Protocol Violation|1
1338242|NCT01973231|4402906|P1|Overall Study|Protocol Violation|1
1338243|NCT01973218|4402926|P2|Overall Study|Withdrawal by Subject|0
1338244|NCT01973218|4402927|P1|Overall Study|Withdrawal by Subject|1
1338245|NCT01973218|4402926|P2|Overall Study|Adverse Event|0
1338246|NCT01973218|4402927|P1|Overall Study|Adverse Event|1
1338247|NCT01972841|4402977|P6|Overall Study|Did not have end of treatment page|0
1338248|NCT01972841|4402978|P5|Overall Study|Did not have end of treatment page|1
1338249|NCT01972841|4402979|P4|Overall Study|Did not have end of treatment page|0
1338250|NCT01972841|4402980|P3|Overall Study|Did not have end of treatment page|0
1338251|NCT01972841|4402981|P2|Overall Study|Did not have end of treatment page|0
1338252|NCT01972841|4402982|P1|Overall Study|Did not have end of treatment page|0
1338253|NCT01972841|4402977|P6|Overall Study|Miscellaneous|4
1338254|NCT01972841|4402978|P5|Overall Study|Miscellaneous|0
1338255|NCT01972841|4402979|P4|Overall Study|Miscellaneous|1
1338256|NCT01972841|4402980|P3|Overall Study|Miscellaneous|4
1338257|NCT01972841|4402981|P2|Overall Study|Miscellaneous|0
1338258|NCT01972841|4402982|P1|Overall Study|Miscellaneous|0
1338259|NCT01972841|4402977|P6|Overall Study|Withdrawal by participants|34
1338260|NCT01972841|4402978|P5|Overall Study|Withdrawal by participants|33
1338261|NCT01972841|4402979|P4|Overall Study|Withdrawal by participants|16
1338262|NCT01972841|4402980|P3|Overall Study|Withdrawal by participants|23
1338263|NCT01972841|4402981|P2|Overall Study|Withdrawal by participants|27
1338264|NCT01972841|4402982|P1|Overall Study|Withdrawal by participants|21
1338265|NCT01972841|4402977|P6|Overall Study|Protocol Violation|4
1338266|NCT01972841|4402978|P5|Overall Study|Protocol Violation|9
1338267|NCT01972841|4402979|P4|Overall Study|Protocol Violation|5
1338268|NCT01972841|4402980|P3|Overall Study|Protocol Violation|3
1338269|NCT01972841|4402981|P2|Overall Study|Protocol Violation|2
1338270|NCT01972841|4402982|P1|Overall Study|Protocol Violation|2
1338271|NCT01972841|4402977|P6|Overall Study|Lost to Follow-up|3
1338272|NCT01972841|4402978|P5|Overall Study|Lost to Follow-up|9
1338273|NCT01972841|4402979|P4|Overall Study|Lost to Follow-up|2
1338274|NCT01972841|4402980|P3|Overall Study|Lost to Follow-up|4
1338275|NCT01972841|4402981|P2|Overall Study|Lost to Follow-up|2
1338276|NCT01972841|4402982|P1|Overall Study|Lost to Follow-up|4
1338277|NCT01972841|4402977|P6|Overall Study|Lack of Efficacy|1
1338278|NCT01972841|4402978|P5|Overall Study|Lack of Efficacy|4
1338279|NCT01972841|4402979|P4|Overall Study|Lack of Efficacy|2
1338280|NCT01972841|4402980|P3|Overall Study|Lack of Efficacy|0
1338281|NCT01972841|4402981|P2|Overall Study|Lack of Efficacy|0
1338282|NCT01972841|4402982|P1|Overall Study|Lack of Efficacy|1
1338283|NCT01972841|4402977|P6|Overall Study|Adverse Event|26
1338284|NCT01972841|4402978|P5|Overall Study|Adverse Event|21
1338285|NCT01972841|4402979|P4|Overall Study|Adverse Event|9
1338286|NCT01972841|4402980|P3|Overall Study|Adverse Event|12
1338287|NCT01972841|4402981|P2|Overall Study|Adverse Event|8
1338288|NCT01972841|4402982|P1|Overall Study|Adverse Event|13
1338289|NCT01972841|4402977|P6|Overall Study|Randomized but Never Received Treatment|13
1338290|NCT01972841|4402978|P5|Overall Study|Randomized but Never Received Treatment|6
1338291|NCT01972841|4402979|P4|Overall Study|Randomized but Never Received Treatment|2
1338292|NCT01972841|4402980|P3|Overall Study|Randomized but Never Received Treatment|4
1338293|NCT01972841|4402981|P2|Overall Study|Randomized but Never Received Treatment|5
1338294|NCT01972841|4402982|P1|Overall Study|Randomized but Never Received Treatment|2
1338295|NCT01972776|4403416|P6|Part 2|Administrative problems|7
1338296|NCT01972776|4403417|P5|Part 2|Administrative problems|10
1338297|NCT01972776|4403418|P4|Part 2|Administrative problems|0
1338298|NCT01972776|4403419|P3|Part 2|Administrative problems|0
1338299|NCT01972776|4403420|P2|Part 2|Administrative problems|0
1338300|NCT01972776|4403421|P1|Part 2|Administrative problems|0
1338301|NCT01972776|4403416|P6|Part 2|Adverse Event|0
1338302|NCT01972776|4403417|P5|Part 2|Adverse Event|3
1338303|NCT01972776|4403418|P4|Part 2|Adverse Event|0
1338304|NCT01972776|4403419|P3|Part 2|Adverse Event|0
1338305|NCT01972776|4403420|P2|Part 2|Adverse Event|0
1338306|NCT01972776|4403421|P1|Part 2|Adverse Event|0
1338307|NCT01972776|4403416|P6|Part 1|Adverse Event|0
1338308|NCT01972776|4403417|P5|Part 1|Adverse Event|0
1338309|NCT01972776|4403418|P4|Part 1|Adverse Event|1
1338310|NCT01972776|4403419|P3|Part 1|Adverse Event|1
1338311|NCT01972776|4403420|P2|Part 1|Adverse Event|0
1338312|NCT01972776|4403421|P1|Part 1|Adverse Event|0
1338313|NCT01972776|4403416|P6|Part 1|Withdrawal by Subject|0
1338314|NCT01972776|4403417|P5|Part 1|Withdrawal by Subject|0
1338315|NCT01972776|4403418|P4|Part 1|Withdrawal by Subject|0
1338316|NCT01972776|4403419|P3|Part 1|Withdrawal by Subject|1
1338317|NCT01972776|4403420|P2|Part 1|Withdrawal by Subject|0
1338318|NCT01972776|4403421|P1|Part 1|Withdrawal by Subject|0
1338319|NCT01972724|4403492|P3|Open-Label|Significant Protocol Deviation|2
1338320|NCT01972724|4403493|P2|Open-Label|Significant Protocol Deviation|0
1338321|NCT01972724|4403494|P1|Open-Label|Significant Protocol Deviation|0
1338322|NCT01972724|4403492|P3|Open-Label|Withdrew Consent|3
1338323|NCT01972724|4403493|P2|Open-Label|Withdrew Consent|0
1338324|NCT01972724|4403494|P1|Open-Label|Withdrew Consent|0
1338325|NCT01972724|4403492|P3|Double-Blind|Significant Protocol Deviation|0
1338326|NCT01972724|4403493|P2|Double-Blind|Significant Protocol Deviation|8
1338327|NCT01972724|4403494|P1|Double-Blind|Significant Protocol Deviation|5
1338328|NCT01972724|4403492|P3|Double-Blind|Withdrawal of Consent|0
1338329|NCT01972724|4403493|P2|Double-Blind|Withdrawal of Consent|1
1338330|NCT01972724|4403494|P1|Double-Blind|Withdrawal of Consent|2
1338331|NCT01972724|4403492|P3|Double-Blind|Adverse Event|0
1338332|NCT01972724|4403493|P2|Double-Blind|Adverse Event|0
1338333|NCT01972724|4403494|P1|Double-Blind|Adverse Event|1
1338334|NCT01972724|4403492|P3|Double-Blind|Rescue Criteria Met|0
1338335|NCT01972724|4403493|P2|Double-Blind|Rescue Criteria Met|0
1338336|NCT01972724|4403494|P1|Double-Blind|Rescue Criteria Met|1
1338337|NCT01972659|4403507|P2|Overall Study|problems realted to acceleromyograph|1
1338338|NCT01972659|4403508|P1|Overall Study|problems realted to acceleromyograph|2
1338339|NCT01972659|4403507|P2|Overall Study|Protocol Violation|2
1338340|NCT01972659|4403508|P1|Overall Study|Protocol Violation|2
1338341|NCT01972568|4403517|P3|Overall Study|Adverse Event|5
1338342|NCT01972568|4403518|P2|Overall Study|Adverse Event|6
1338343|NCT01972568|4403519|P1|Overall Study|Adverse Event|5
1338344|NCT01972568|4403517|P3|Overall Study|Lost to Follow-up|0
1338345|NCT01972568|4403518|P2|Overall Study|Lost to Follow-up|0
1338346|NCT01972568|4403519|P1|Overall Study|Lost to Follow-up|1
1338347|NCT01972568|4403517|P3|Overall Study|Withdrawal by Subject|7
1338348|NCT01972568|4403518|P2|Overall Study|Withdrawal by Subject|3
1338349|NCT01972568|4403519|P1|Overall Study|Withdrawal by Subject|6
1338350|NCT01972568|4403517|P3|Overall Study|Protocol Violation|2
1338351|NCT01972568|4403518|P2|Overall Study|Protocol Violation|2
1338352|NCT01972568|4403519|P1|Overall Study|Protocol Violation|1
1338353|NCT01972568|4403517|P3|Overall Study|Lack of Efficacy|2
1338354|NCT01972568|4403518|P2|Overall Study|Lack of Efficacy|1
1338355|NCT01972568|4403519|P1|Overall Study|Lack of Efficacy|0
1338356|NCT01972568|4403517|P3|Overall Study|Other events|0
1338357|NCT01972568|4403518|P2|Overall Study|Other events|0
1338358|NCT01972568|4403519|P1|Overall Study|Other events|3
1338359|NCT01972529|4403558|P4|Overall Study|Not treated|1
1338360|NCT01972529|4403559|P3|Overall Study|Not treated|2
1338361|NCT01972529|4403560|P2|Overall Study|Not treated|1
1338362|NCT01972529|4403561|P1|Overall Study|Not treated|0
1338363|NCT01972529|4403558|P4|Overall Study|Not Specified|2
1338364|NCT01972529|4403559|P3|Overall Study|Not Specified|0
1338365|NCT01972529|4403560|P2|Overall Study|Not Specified|0
1338366|NCT01972529|4403561|P1|Overall Study|Not Specified|0
1338367|NCT01972529|4403558|P4|Overall Study|Withdrawl of Consent|1
1338368|NCT01972529|4403559|P3|Overall Study|Withdrawl of Consent|0
1338369|NCT01972529|4403560|P2|Overall Study|Withdrawl of Consent|2
1338370|NCT01972529|4403561|P1|Overall Study|Withdrawl of Consent|1
1338371|NCT01972529|4403558|P4|Overall Study|Participant Choice|0
1338372|NCT01972529|4403559|P3|Overall Study|Participant Choice|0
1338373|NCT01972529|4403560|P2|Overall Study|Participant Choice|1
1338374|NCT01972529|4403561|P1|Overall Study|Participant Choice|0
1338375|NCT01972529|4403558|P4|Overall Study|Lost to Follow-up|0
1338376|NCT01972529|4403559|P3|Overall Study|Lost to Follow-up|0
1338377|NCT01972529|4403560|P2|Overall Study|Lost to Follow-up|0
1338378|NCT01972529|4403561|P1|Overall Study|Lost to Follow-up|1
1338379|NCT01972529|4403558|P4|Overall Study|Adverse Event|0
1338380|NCT01972529|4403559|P3|Overall Study|Adverse Event|0
1338381|NCT01972529|4403560|P2|Overall Study|Adverse Event|1
1338382|NCT01972529|4403561|P1|Overall Study|Adverse Event|0
1338383|NCT01972464|4403606|P2|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
1338384|NCT01972464|4403607|P1|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
1338385|NCT01972464|4403606|P2|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
1338386|NCT01972464|4403607|P1|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
1338387|NCT01972464|4403606|P2|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
1338388|NCT01972464|4403607|P1|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
1338389|NCT01972464|4403606|P2|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
1338390|NCT01972464|4403607|P1|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
1338391|NCT01972438|4403623|P2|Post Month 12 Study Period|Early Study Closure|4
1338392|NCT01972438|4403624|P1|Post Month 12 Study Period|Early Study Closure|3
1338393|NCT01972438|4403623|P2|Months 6-12 Study Period|Early Study Closure|2
1338394|NCT01972438|4403624|P1|Months 6-12 Study Period|Early Study Closure|2
1338395|NCT01972438|4403623|P2|Months 6-12 Study Period|Death|0
1338396|NCT01972438|4403624|P1|Months 6-12 Study Period|Death|1
1338397|NCT01972438|4403623|P2|Months 3-6 Crossover Period|Early Study Closure|1
1338398|NCT01972438|4403624|P1|Months 3-6 Crossover Period|Early Study Closure|0
1338399|NCT01972438|4403623|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
1338400|NCT01972438|4403624|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
1338401|NCT01972438|4403623|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
1338402|NCT01972438|4403624|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
1338403|NCT01972438|4403623|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
1338404|NCT01972438|4403624|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
1338405|NCT01972438|4403623|P2|Baseline-Month 3 Crossover Period|Death|0
1338406|NCT01972438|4403624|P1|Baseline-Month 3 Crossover Period|Death|1
1338407|NCT01972308|4403678|P2|Overall Study|Death|1
1338408|NCT01972308|4403679|P1|Overall Study|Death|4
1338409|NCT01972308|4403678|P2|Overall Study|Lost to Follow-up|6
1338410|NCT01972308|4403679|P1|Overall Study|Lost to Follow-up|4
1338411|NCT01972308|4403678|P2|Overall Study|Withdrawal by Subject|1
1338412|NCT01972308|4403679|P1|Overall Study|Withdrawal by Subject|0
1338413|NCT01972152|4403695|P6|Second Treatment Visit|Protocol Violation|0
1338414|NCT01972152|4403696|P5|Second Treatment Visit|Protocol Violation|0
1338415|NCT01972152|4403697|P4|Second Treatment Visit|Protocol Violation|0
1338416|NCT01972152|4403698|P3|Second Treatment Visit|Protocol Violation|0
1338417|NCT01972152|4403699|P2|Second Treatment Visit|Protocol Violation|1
1338418|NCT01972152|4403700|P1|Second Treatment Visit|Protocol Violation|0
1338419|NCT01972152|4403695|P6|First Treatment Visit|Lost to Follow-up|0
1338420|NCT01972152|4403696|P5|First Treatment Visit|Lost to Follow-up|0
1338421|NCT01972152|4403697|P4|First Treatment Visit|Lost to Follow-up|0
1338422|NCT01972152|4403698|P3|First Treatment Visit|Lost to Follow-up|0
1338423|NCT01972152|4403699|P2|First Treatment Visit|Lost to Follow-up|1
1338424|NCT01972152|4403700|P1|First Treatment Visit|Lost to Follow-up|0
1338425|NCT01971723|4403737|P2|Overall Study|Protocol Violation|2
1338426|NCT01971723|4403738|P1|Overall Study|Protocol Violation|1
1338427|NCT01971723|4403737|P2|Overall Study|Withdrawal by Subject|1
1338428|NCT01971723|4403738|P1|Overall Study|Withdrawal by Subject|1
1338429|NCT01971645|4403771|P3|Overall Study|Protocol Violation|1
1338430|NCT01971645|4403772|P2|Overall Study|Protocol Violation|0
1338431|NCT01971645|4403773|P1|Overall Study|Protocol Violation|0
1338432|NCT01971645|4403771|P3|Overall Study|Lost to Follow-up|1
1338433|NCT01971645|4403772|P2|Overall Study|Lost to Follow-up|0
1338434|NCT01971645|4403773|P1|Overall Study|Lost to Follow-up|1
1338435|NCT01971645|4403771|P3|Overall Study|Adverse Event|0
1338436|NCT01971645|4403772|P2|Overall Study|Adverse Event|0
1338437|NCT01971645|4403773|P1|Overall Study|Adverse Event|1
1338438|NCT01971567|4403807|P2|Overall Study|Lost to Follow-up|0
1338439|NCT01971567|4403808|P1|Overall Study|Lost to Follow-up|1
1338440|NCT01971567|4403807|P2|Overall Study|Withdrawal by Subject|2
1338441|NCT01971567|4403808|P1|Overall Study|Withdrawal by Subject|3
1338442|NCT01971554|4403834|P4|Overall Study|Lost to Follow-up|0
1338443|NCT01971554|4403835|P3|Overall Study|Lost to Follow-up|0
1338444|NCT01971554|4403836|P2|Overall Study|Lost to Follow-up|0
1338445|NCT01971554|4403837|P1|Overall Study|Lost to Follow-up|1
1338446|NCT01971476|4403874|P3|Cohort 2: 12 to <18 Years|Adverse Event|0
1338447|NCT01971476|4403875|P2|Cohort 2: 12 to <18 Years|Adverse Event|1
1338448|NCT01971476|4403876|P1|Cohort 2: 12 to <18 Years|Adverse Event|0
1338449|NCT01971476|4403874|P3|Cohort 2: 12 to <18 Years|Other not defined|0
1338450|NCT01971476|4403875|P2|Cohort 2: 12 to <18 Years|Other not defined|3
1338451|NCT01971476|4403876|P1|Cohort 2: 12 to <18 Years|Other not defined|6
1338452|NCT01971476|4403874|P3|Cohort 1: 2 to <12 Years|Other not defined|6
1338453|NCT01971476|4403875|P2|Cohort 1: 2 to <12 Years|Other not defined|3
1338454|NCT01971476|4403876|P1|Cohort 1: 2 to <12 Years|Other not defined|3
1338455|NCT01971203|4403986|P2|Overall Study|Adverse Event|0
1338456|NCT01971203|4403987|P1|Overall Study|Adverse Event|1
1338457|NCT01971203|4403986|P2|Overall Study|Withdrawal by Subject|6
1338458|NCT01971203|4403987|P1|Overall Study|Withdrawal by Subject|5
1338459|NCT01971203|4403986|P2|Overall Study|Protocol Violation|2
1338460|NCT01971203|4403987|P1|Overall Study|Protocol Violation|3
1338461|NCT01970995|4404014|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
1338462|NCT01970995|4404015|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
1338463|NCT01970995|4404016|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
1338464|NCT01970995|4404014|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1338465|NCT01970995|4404015|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1338466|NCT01970995|4404016|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1338467|NCT01970982|4404039|P3|Overall Study|Withdrawal by Subject|2
1338468|NCT01970982|4404040|P2|Overall Study|Withdrawal by Subject|0
1338469|NCT01970982|4404041|P1|Overall Study|Withdrawal by Subject|0
1338470|NCT01970878|4404063|P4|Overall Study|No Completion Status|0
1338471|NCT01970878|4404064|P3|Overall Study|No Completion Status|0
1338472|NCT01970878|4404065|P2|Overall Study|No Completion Status|1
1338473|NCT01970878|4404066|P1|Overall Study|No Completion Status|0
1338474|NCT01970878|4404063|P4|Overall Study|Physician Decision|0
1338475|NCT01970878|4404064|P3|Overall Study|Physician Decision|1
1338476|NCT01970878|4404065|P2|Overall Study|Physician Decision|1
1338477|NCT01970878|4404066|P1|Overall Study|Physician Decision|0
1338478|NCT01970878|4404063|P4|Overall Study|Protocol Specified Criteria|6
1338479|NCT01970878|4404064|P3|Overall Study|Protocol Specified Criteria|3
1338480|NCT01970878|4404065|P2|Overall Study|Protocol Specified Criteria|4
1338481|NCT01970878|4404066|P1|Overall Study|Protocol Specified Criteria|10
1338482|NCT01970878|4404063|P4|Overall Study|Adverse Event|3
1338483|NCT01970878|4404064|P3|Overall Study|Adverse Event|4
1338484|NCT01970878|4404065|P2|Overall Study|Adverse Event|7
1338485|NCT01970878|4404066|P1|Overall Study|Adverse Event|12
1338486|NCT01970878|4404063|P4|Overall Study|Lack of Efficacy|0
1338487|NCT01970878|4404064|P3|Overall Study|Lack of Efficacy|2
1338488|NCT01970878|4404065|P2|Overall Study|Lack of Efficacy|1
1338489|NCT01970878|4404066|P1|Overall Study|Lack of Efficacy|2
1338490|NCT01970878|4404063|P4|Overall Study|Administrative Reasons|4
1338491|NCT01970878|4404064|P3|Overall Study|Administrative Reasons|0
1338492|NCT01970878|4404065|P2|Overall Study|Administrative Reasons|0
1338493|NCT01970878|4404066|P1|Overall Study|Administrative Reasons|1
1338494|NCT01970878|4404063|P4|Overall Study|Lost to Follow-up|4
1338495|NCT01970878|4404064|P3|Overall Study|Lost to Follow-up|2
1338496|NCT01970878|4404065|P2|Overall Study|Lost to Follow-up|3
1338497|NCT01970878|4404066|P1|Overall Study|Lost to Follow-up|1
1338498|NCT01970878|4404063|P4|Overall Study|Withdrawal by Subject|7
1338499|NCT01970878|4404064|P3|Overall Study|Withdrawal by Subject|14
1338500|NCT01970878|4404065|P2|Overall Study|Withdrawal by Subject|10
1338501|NCT01970878|4404066|P1|Overall Study|Withdrawal by Subject|11
1338502|NCT01970865|4404109|P17|Overall Study|Study ongoing|2
1338503|NCT01970865|4404110|P16|Overall Study|Study ongoing|29
1338504|NCT01970865|4404111|P15|Overall Study|Study ongoing|29
1338505|NCT01970865|4404112|P14|Overall Study|Study ongoing|41
1338506|NCT01970865|4404113|P13|Overall Study|Study ongoing|43
1338507|NCT01970865|4404114|P12|Overall Study|Study ongoing|22
1338508|NCT01970865|4404115|P11|Overall Study|Study ongoing|29
1338509|NCT01970865|4404116|P10|Overall Study|Study ongoing|3
1338510|NCT01970865|4404117|P9|Overall Study|Study ongoing|1
1338511|NCT01970865|4404118|P8|Overall Study|Study ongoing|0
1338512|NCT01970865|4404119|P7|Overall Study|Study ongoing|2
1338513|NCT01970865|4404120|P6|Overall Study|Study ongoing|0
1338514|NCT01970865|4404121|P5|Overall Study|Study ongoing|8
1338515|NCT01970865|4404122|P4|Overall Study|Study ongoing|6
1338516|NCT01970865|4404123|P3|Overall Study|Study ongoing|0
1338517|NCT01970865|4404124|P2|Overall Study|Study ongoing|2
1338518|NCT01970865|4404125|P1|Overall Study|Study ongoing|0
1338519|NCT01970865|4404109|P17|Overall Study|Other|0
1338520|NCT01970865|4404110|P16|Overall Study|Other|1
1338521|NCT01970865|4404111|P15|Overall Study|Other|0
1338522|NCT01970865|4404112|P14|Overall Study|Other|1
1338523|NCT01970865|4404113|P13|Overall Study|Other|0
1338524|NCT01970865|4404114|P12|Overall Study|Other|0
1338525|NCT01970865|4404115|P11|Overall Study|Other|0
1338526|NCT01970865|4404116|P10|Overall Study|Other|0
1338527|NCT01970865|4404117|P9|Overall Study|Other|0
1338528|NCT01970865|4404118|P8|Overall Study|Other|0
1338529|NCT01970865|4404119|P7|Overall Study|Other|0
1338530|NCT01970865|4404120|P6|Overall Study|Other|0
1338531|NCT01970865|4404121|P5|Overall Study|Other|0
1338532|NCT01970865|4404122|P4|Overall Study|Other|1
1338533|NCT01970865|4404123|P3|Overall Study|Other|0
1338534|NCT01970865|4404124|P2|Overall Study|Other|0
1338535|NCT01970865|4404125|P1|Overall Study|Other|0
1338536|NCT01970865|4404109|P17|Overall Study|Withdrawal by Subject|0
1338537|NCT01970865|4404110|P16|Overall Study|Withdrawal by Subject|7
1338538|NCT01970865|4404111|P15|Overall Study|Withdrawal by Subject|2
1338539|NCT01970865|4404112|P14|Overall Study|Withdrawal by Subject|5
1338540|NCT01970865|4404113|P13|Overall Study|Withdrawal by Subject|2
1338541|NCT01970865|4404114|P12|Overall Study|Withdrawal by Subject|1
1338542|NCT01970865|4404115|P11|Overall Study|Withdrawal by Subject|0
1338543|NCT01970865|4404116|P10|Overall Study|Withdrawal by Subject|0
1338544|NCT01970865|4404117|P9|Overall Study|Withdrawal by Subject|0
1338545|NCT01970865|4404118|P8|Overall Study|Withdrawal by Subject|0
1338546|NCT01970865|4404119|P7|Overall Study|Withdrawal by Subject|0
1338547|NCT01970865|4404120|P6|Overall Study|Withdrawal by Subject|0
1338548|NCT01970865|4404121|P5|Overall Study|Withdrawal by Subject|2
1338549|NCT01970865|4404122|P4|Overall Study|Withdrawal by Subject|1
1338550|NCT01970865|4404123|P3|Overall Study|Withdrawal by Subject|0
1338551|NCT01970865|4404124|P2|Overall Study|Withdrawal by Subject|0
1338552|NCT01970865|4404125|P1|Overall Study|Withdrawal by Subject|0
1338553|NCT01970865|4404109|P17|Overall Study|Lost to Follow-up|0
1338554|NCT01970865|4404110|P16|Overall Study|Lost to Follow-up|0
1338555|NCT01970865|4404111|P15|Overall Study|Lost to Follow-up|0
1338556|NCT01970865|4404112|P14|Overall Study|Lost to Follow-up|0
1338557|NCT01970865|4404113|P13|Overall Study|Lost to Follow-up|1
1338558|NCT01970865|4404114|P12|Overall Study|Lost to Follow-up|0
1338559|NCT01970865|4404115|P11|Overall Study|Lost to Follow-up|0
1338560|NCT01970865|4404116|P10|Overall Study|Lost to Follow-up|0
1338561|NCT01970865|4404117|P9|Overall Study|Lost to Follow-up|0
1338562|NCT01970865|4404118|P8|Overall Study|Lost to Follow-up|0
1338563|NCT01970865|4404119|P7|Overall Study|Lost to Follow-up|0
1338564|NCT01970865|4404120|P6|Overall Study|Lost to Follow-up|0
1338565|NCT01970865|4404121|P5|Overall Study|Lost to Follow-up|1
1338566|NCT01970865|4404122|P4|Overall Study|Lost to Follow-up|1
1338567|NCT01970865|4404123|P3|Overall Study|Lost to Follow-up|0
1338568|NCT01970865|4404124|P2|Overall Study|Lost to Follow-up|0
1338569|NCT01970865|4404125|P1|Overall Study|Lost to Follow-up|0
1338570|NCT01970865|4404109|P17|Overall Study|Death|1
1338571|NCT01970865|4404110|P16|Overall Study|Death|10
1338572|NCT01970865|4404111|P15|Overall Study|Death|15
1338573|NCT01970865|4404112|P14|Overall Study|Death|19
1338574|NCT01970865|4404113|P13|Overall Study|Death|14
1338575|NCT01970865|4404114|P12|Overall Study|Death|4
1338576|NCT01970865|4404115|P11|Overall Study|Death|1
1338577|NCT01970865|4404116|P10|Overall Study|Death|1
1338578|NCT01970865|4404117|P9|Overall Study|Death|2
1338579|NCT01970865|4404118|P8|Overall Study|Death|3
1338580|NCT01970865|4404119|P7|Overall Study|Death|1
1338581|NCT01970865|4404120|P6|Overall Study|Death|3
1338582|NCT01970865|4404121|P5|Overall Study|Death|6
1338583|NCT01970865|4404122|P4|Overall Study|Death|4
1338584|NCT01970865|4404123|P3|Overall Study|Death|3
1338585|NCT01970865|4404124|P2|Overall Study|Death|1
1338586|NCT01970865|4404125|P1|Overall Study|Death|3
1338587|NCT01970488|4404559|P5|Part 2: Post Week 16|Lost to Follow-up|2
1338588|NCT01970488|4404560|P4|Part 2: Post Week 16|Lost to Follow-up|1
1338589|NCT01970488|4404561|P3|Part 2: Post Week 16|Lost to Follow-up|1
1338590|NCT01970488|4404562|P2|Part 2: Post Week 16|Lost to Follow-up|0
1338591|NCT01970488|4404563|P1|Part 2: Post Week 16|Lost to Follow-up|0
1338592|NCT01970488|4404559|P5|Part 2: Post Week 16|Withdrawal by Subject|3
1338593|NCT01970488|4404560|P4|Part 2: Post Week 16|Withdrawal by Subject|3
1338594|NCT01970488|4404561|P3|Part 2: Post Week 16|Withdrawal by Subject|8
1338595|NCT01970488|4404562|P2|Part 2: Post Week 16|Withdrawal by Subject|0
1338596|NCT01970488|4404563|P1|Part 2: Post Week 16|Withdrawal by Subject|0
1338597|NCT01970488|4404559|P5|Part 2: Post Week 16|Adverse Event|1
1338598|NCT01970488|4404560|P4|Part 2: Post Week 16|Adverse Event|1
1338599|NCT01970488|4404561|P3|Part 2: Post Week 16|Adverse Event|5
1338600|NCT01970488|4404562|P2|Part 2: Post Week 16|Adverse Event|0
1338601|NCT01970488|4404563|P1|Part 2: Post Week 16|Adverse Event|0
1338602|NCT01970488|4404559|P5|Part 2: Post Week 16|Lack of Efficacy|1
1338603|NCT01970488|4404560|P4|Part 2: Post Week 16|Lack of Efficacy|3
1338604|NCT01970488|4404561|P3|Part 2: Post Week 16|Lack of Efficacy|2
1338605|NCT01970488|4404562|P2|Part 2: Post Week 16|Lack of Efficacy|0
1338606|NCT01970488|4404563|P1|Part 2: Post Week 16|Lack of Efficacy|0
1338607|NCT01970488|4404559|P5|Part 2: Post Week 16|Non-compliance|0
1338608|NCT01970488|4404560|P4|Part 2: Post Week 16|Non-compliance|0
1338609|NCT01970488|4404561|P3|Part 2: Post Week 16|Non-compliance|1
1338610|NCT01970488|4404562|P2|Part 2: Post Week 16|Non-compliance|0
1338611|NCT01970488|4404563|P1|Part 2: Post Week 16|Non-compliance|0
1338612|NCT01970488|4404559|P5|Part 2: Post Week 16|Physician Decision|1
1338613|NCT01970488|4404560|P4|Part 2: Post Week 16|Physician Decision|0
1338614|NCT01970488|4404561|P3|Part 2: Post Week 16|Physician Decision|0
1338615|NCT01970488|4404562|P2|Part 2: Post Week 16|Physician Decision|0
1338616|NCT01970488|4404563|P1|Part 2: Post Week 16|Physician Decision|0
1338617|NCT01970488|4404559|P5|Part 1: Through Week 16|Lost to Follow-up|0
1338618|NCT01970488|4404560|P4|Part 1: Through Week 16|Lost to Follow-up|0
1338619|NCT01970488|4404561|P3|Part 1: Through Week 16|Lost to Follow-up|0
1338620|NCT01970488|4404562|P2|Part 1: Through Week 16|Lost to Follow-up|2
1338621|NCT01970488|4404563|P1|Part 1: Through Week 16|Lost to Follow-up|0
1338622|NCT01970488|4404559|P5|Part 1: Through Week 16|Withdrawal by Subject|0
1338623|NCT01970488|4404560|P4|Part 1: Through Week 16|Withdrawal by Subject|0
1338624|NCT01970488|4404561|P3|Part 1: Through Week 16|Withdrawal by Subject|0
1338625|NCT01970488|4404562|P2|Part 1: Through Week 16|Withdrawal by Subject|2
1338626|NCT01970488|4404563|P1|Part 1: Through Week 16|Withdrawal by Subject|3
1338627|NCT01970488|4404559|P5|Part 1: Through Week 16|Adverse Event|0
1338628|NCT01970488|4404560|P4|Part 1: Through Week 16|Adverse Event|0
1338629|NCT01970488|4404561|P3|Part 1: Through Week 16|Adverse Event|0
1338630|NCT01970488|4404562|P2|Part 1: Through Week 16|Adverse Event|5
1338631|NCT01970488|4404563|P1|Part 1: Through Week 16|Adverse Event|6
1338632|NCT01970488|4404559|P5|Part 1: Through Week 16|Protocol Violation|0
1338633|NCT01970488|4404560|P4|Part 1: Through Week 16|Protocol Violation|0
1338634|NCT01970488|4404561|P3|Part 1: Through Week 16|Protocol Violation|0
1338635|NCT01970488|4404562|P2|Part 1: Through Week 16|Protocol Violation|2
1338636|NCT01970488|4404563|P1|Part 1: Through Week 16|Protocol Violation|1
1338637|NCT01970488|4404559|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
1338638|NCT01970488|4404560|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
1338639|NCT01970488|4404561|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
1338640|NCT01970488|4404562|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
1338641|NCT01970488|4404563|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
1338642|NCT01970475|4404630|P2|Overall Study|Protocol Violation|0
1338643|NCT01970475|4404631|P1|Overall Study|Protocol Violation|1
1338644|NCT01970475|4404630|P2|Overall Study|Lost to Follow-up|2
1338645|NCT01970475|4404631|P1|Overall Study|Lost to Follow-up|2
1338646|NCT01970475|4404630|P2|Overall Study|Adverse Event|3
1338647|NCT01970475|4404631|P1|Overall Study|Adverse Event|7
1338648|NCT01970475|4404630|P2|Overall Study|Withdrawal by Subject|6
1338649|NCT01970475|4404631|P1|Overall Study|Withdrawal by Subject|11
1338650|NCT01970462|4404651|P2|Overall Study|Lost to Follow-up|2
1338651|NCT01970462|4404652|P1|Overall Study|Lost to Follow-up|0
1338652|NCT01970397|4404666|P2|Overall Study|Protocol Violation|1
1338653|NCT01970397|4404667|P1|Overall Study|Protocol Violation|1
1338654|NCT01970397|4404666|P2|Overall Study|Personal Reasons|2
1338655|NCT01970397|4404667|P1|Overall Study|Personal Reasons|1
1338656|NCT01970397|4404666|P2|Overall Study|Lost to Follow-up|1
1338657|NCT01970397|4404667|P1|Overall Study|Lost to Follow-up|0
1338658|NCT01970397|4404666|P2|Overall Study|Adverse Event|1
1338659|NCT01970397|4404667|P1|Overall Study|Adverse Event|0
1338660|NCT01969799|4404679|P2|Overall Study|Physician Decision|0
1338661|NCT01969799|4404680|P1|Overall Study|Physician Decision|1
1338662|NCT01969799|4404679|P2|Overall Study|Lost to Follow-up|2
1338663|NCT01969799|4404680|P1|Overall Study|Lost to Follow-up|0
1338664|NCT01969799|4404679|P2|Overall Study|Death|11
1338665|NCT01969799|4404680|P1|Overall Study|Death|16
1338666|NCT01969799|4404679|P2|Overall Study|Adverse Event|1
1338667|NCT01969799|4404680|P1|Overall Study|Adverse Event|0
1338668|NCT01969721|4404717|P4|Overall Study|Discontinued during washout periods.|2
1338669|NCT01969721|4404718|P3|Overall Study|Discontinued during washout periods.|1
1338670|NCT01969721|4404719|P2|Overall Study|Discontinued during washout periods.|1
1338671|NCT01969721|4404720|P1|Overall Study|Discontinued during washout periods.|0
1338672|NCT01969721|4404717|P4|Overall Study|Other not defined above|0
1338673|NCT01969721|4404718|P3|Overall Study|Other not defined above|0
1338674|NCT01969721|4404719|P2|Overall Study|Other not defined above|2
1338675|NCT01969721|4404720|P1|Overall Study|Other not defined above|0
1338676|NCT01969721|4404717|P4|Overall Study|Non compliant with protocol|2
1338677|NCT01969721|4404718|P3|Overall Study|Non compliant with protocol|0
1338678|NCT01969721|4404719|P2|Overall Study|Non compliant with protocol|1
1338679|NCT01969721|4404720|P1|Overall Study|Non compliant with protocol|1
1338680|NCT01969721|4404717|P4|Overall Study|Lack of Efficacy|0
1338681|NCT01969721|4404718|P3|Overall Study|Lack of Efficacy|1
1338682|NCT01969721|4404719|P2|Overall Study|Lack of Efficacy|0
1338683|NCT01969721|4404720|P1|Overall Study|Lack of Efficacy|0
1338684|NCT01969721|4404717|P4|Overall Study|Adverse Event|2
1338685|NCT01969721|4404718|P3|Overall Study|Adverse Event|3
1338686|NCT01969721|4404719|P2|Overall Study|Adverse Event|8
1338687|NCT01969721|4404720|P1|Overall Study|Adverse Event|3
1338688|NCT01969565|4404765|P1|Overall Study|Withdrawal by Subject|1
1338689|NCT01969084|4404846|P2|Overall Study|Adverse Event|1
1338690|NCT01969084|4404847|P1|Overall Study|Adverse Event|0
1338691|NCT01969058|4404863|P2|Overall Study|Adverse Event|0
1338692|NCT01969058|4404864|P1|Overall Study|Adverse Event|1
1338693|NCT01969058|4404863|P2|Overall Study|Withdrawal by Subject|0
1338694|NCT01969058|4404864|P1|Overall Study|Withdrawal by Subject|2
1338695|NCT01968980|4404900|P2|Overall Study|Other unspecified|2
1338696|NCT01968980|4404901|P1|Overall Study|Other unspecified|1
1338697|NCT01968980|4404900|P2|Overall Study|Withdrawal by Subject|5
1338698|NCT01968980|4404901|P1|Overall Study|Withdrawal by Subject|13
1338699|NCT01968980|4404900|P2|Overall Study|Does not meet entry criteria|3
1338700|NCT01968980|4404901|P1|Overall Study|Does not meet entry criteria|1
1338701|NCT01968980|4404900|P2|Overall Study|Adverse Event|3
1338702|NCT01968980|4404901|P1|Overall Study|Adverse Event|1
1338703|NCT01968980|4404900|P2|Overall Study|Death|1
1338704|NCT01968980|4404901|P1|Overall Study|Death|0
1338705|NCT01968967|4404963|P5|Extension Period|Withdrew Consent|5
1338706|NCT01968967|4404964|P4|Extension Period|Withdrew Consent|0
1338707|NCT01968967|4404965|P3|Extension Period|Withdrew Consent|2
1338708|NCT01968967|4404966|P2|Extension Period|Withdrew Consent|0
1338709|NCT01968967|4404967|P1|Extension Period|Withdrew Consent|0
1338710|NCT01968967|4404963|P5|Treatment Period|Randomized Not Treated|0
1338711|NCT01968967|4404964|P4|Treatment Period|Randomized Not Treated|0
1338712|NCT01968967|4404965|P3|Treatment Period|Randomized Not Treated|0
1338713|NCT01968967|4404966|P2|Treatment Period|Randomized Not Treated|5
1338714|NCT01968967|4404967|P1|Treatment Period|Randomized Not Treated|6
1338715|NCT01968967|4404963|P5|Treatment Period|Death|0
1338716|NCT01968967|4404964|P4|Treatment Period|Death|0
1338717|NCT01968967|4404965|P3|Treatment Period|Death|0
1338718|NCT01968967|4404966|P2|Treatment Period|Death|2
1338719|NCT01968967|4404967|P1|Treatment Period|Death|9
1338720|NCT01968967|4404963|P5|Treatment Period|Adverse Event|0
1338721|NCT01968967|4404964|P4|Treatment Period|Adverse Event|0
1338722|NCT01968967|4404965|P3|Treatment Period|Adverse Event|0
1338723|NCT01968967|4404966|P2|Treatment Period|Adverse Event|8
1338724|NCT01968967|4404967|P1|Treatment Period|Adverse Event|9
1338725|NCT01968967|4404963|P5|Treatment Period|Protocol Violation|0
1338726|NCT01968967|4404964|P4|Treatment Period|Protocol Violation|0
1338727|NCT01968967|4404965|P3|Treatment Period|Protocol Violation|0
1338728|NCT01968967|4404966|P2|Treatment Period|Protocol Violation|2
1338729|NCT01968967|4404967|P1|Treatment Period|Protocol Violation|1
1338730|NCT01968967|4404963|P5|Treatment Period|Lost to Follow-up|0
1338731|NCT01968967|4404964|P4|Treatment Period|Lost to Follow-up|0
1338732|NCT01968967|4404965|P3|Treatment Period|Lost to Follow-up|0
1338733|NCT01968967|4404966|P2|Treatment Period|Lost to Follow-up|31
1338734|NCT01968967|4404967|P1|Treatment Period|Lost to Follow-up|26
1338735|NCT01968967|4404963|P5|Treatment Period|Did Not Meet Entrance Criteria|0
1338736|NCT01968967|4404964|P4|Treatment Period|Did Not Meet Entrance Criteria|0
1338737|NCT01968967|4404965|P3|Treatment Period|Did Not Meet Entrance Criteria|0
1338738|NCT01968967|4404966|P2|Treatment Period|Did Not Meet Entrance Criteria|3
1338739|NCT01968967|4404967|P1|Treatment Period|Did Not Meet Entrance Criteria|2
1338740|NCT01968967|4404963|P5|Treatment Period|Withdrawal by Subject|0
1338741|NCT01968967|4404964|P4|Treatment Period|Withdrawal by Subject|0
1338742|NCT01968967|4404965|P3|Treatment Period|Withdrawal by Subject|0
1338743|NCT01968967|4404966|P2|Treatment Period|Withdrawal by Subject|61
1338744|NCT01968967|4404967|P1|Treatment Period|Withdrawal by Subject|71
1338745|NCT01968967|4404963|P5|Treatment Period|Other|0
1338746|NCT01968967|4404964|P4|Treatment Period|Other|0
1338747|NCT01968967|4404965|P3|Treatment Period|Other|0
1338748|NCT01968967|4404966|P2|Treatment Period|Other|22
1338749|NCT01968967|4404967|P1|Treatment Period|Other|22
1338750|NCT01968954|4405036|P2|Overall Study|Did not met inclusion criteria|2
1338751|NCT01968954|4405037|P1|Overall Study|Did not met inclusion criteria|0
1338752|NCT01968954|4405036|P2|Overall Study|Protocol Violation|1
1338753|NCT01968954|4405037|P1|Overall Study|Protocol Violation|0
1338754|NCT01968954|4405036|P2|Overall Study|Other|8
1338755|NCT01968954|4405037|P1|Overall Study|Other|7
1338756|NCT01968954|4405036|P2|Overall Study|Withdrawal by Subject|23
1338757|NCT01968954|4405037|P1|Overall Study|Withdrawal by Subject|20
1338758|NCT01968954|4405036|P2|Overall Study|Lost to Follow-up|4
1338759|NCT01968954|4405037|P1|Overall Study|Lost to Follow-up|6
1338760|NCT01968954|4405036|P2|Overall Study|Death|2
1338761|NCT01968954|4405037|P1|Overall Study|Death|1
1338762|NCT01968954|4405036|P2|Overall Study|Adverse Event|3
1338763|NCT01968954|4405037|P1|Overall Study|Adverse Event|6
1338764|NCT01968811|4405101|P1|Overall Study|post op.ref. of subject to other hospita|1
1338765|NCT01968811|4405101|P1|Overall Study|Protocol Violation|4
1338766|NCT01968694|4405108|P2|Washout (1 Month)|Lost to Follow-up|1
1338767|NCT01968694|4405109|P1|Washout (1 Month)|Lost to Follow-up|0
1338768|NCT01968551|4405126|P3|Extension Phase|Lost to Follow-up|1
1338769|NCT01968551|4405127|P2|Extension Phase|Lost to Follow-up|0
1338770|NCT01968551|4405128|P1|Extension Phase|Lost to Follow-up|1
1338771|NCT01968551|4405126|P3|Extension Phase|Withdrew Consent|1
1338772|NCT01968551|4405127|P2|Extension Phase|Withdrew Consent|0
1338773|NCT01968551|4405128|P1|Extension Phase|Withdrew Consent|0
1338774|NCT01968551|4405126|P3|Extension Phase|Death|0
1338775|NCT01968551|4405127|P2|Extension Phase|Death|1
1338776|NCT01968551|4405128|P1|Extension Phase|Death|0
1338777|NCT01968551|4405126|P3|Extension Phase|Adverse Event|2
1338778|NCT01968551|4405127|P2|Extension Phase|Adverse Event|0
1338779|NCT01968551|4405128|P1|Extension Phase|Adverse Event|0
1338780|NCT01968551|4405126|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
1338781|NCT01968551|4405127|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
1338782|NCT01968551|4405128|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
1338783|NCT01968551|4405126|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
1338784|NCT01968551|4405127|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
1338785|NCT01968551|4405128|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
1338786|NCT01968551|4405126|P3|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
1338787|NCT01968551|4405127|P2|Open Label Phase (48 Weeks)|Investigator’s Discretion|1
1338788|NCT01968551|4405128|P1|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
1338789|NCT01968551|4405126|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
1338790|NCT01968551|4405127|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
1338791|NCT01968551|4405128|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
1338792|NCT01968434|4405144|P2|Overall Study|Lost to Follow-up|6
1338793|NCT01968434|4405145|P1|Overall Study|Lost to Follow-up|3
1338794|NCT01968226|4405155|P1|Overall Study|[F-18] RDG-K5 was not available|2
1338795|NCT01968213|4405161|P2|Overall Study|Ongoing|9
1338796|NCT01968213|4405162|P1|Overall Study|Ongoing|90
1338797|NCT01967940|4405199|P4|Part 2|Unknown Reason|1
1338798|NCT01967940|4405200|P3|Part 2|Unknown Reason|0
1338799|NCT01967940|4405201|P2|Part 2|Unknown Reason|0
1338800|NCT01967940|4405202|P1|Part 2|Unknown Reason|0
1338801|NCT01967940|4405199|P4|Part 2|Adverse Event|1
1338802|NCT01967940|4405200|P3|Part 2|Adverse Event|0
1338803|NCT01967940|4405201|P2|Part 2|Adverse Event|0
1338804|NCT01967940|4405202|P1|Part 2|Adverse Event|0
1338805|NCT01967940|4405199|P4|Part 2|Enrolled in Part 2 and Never Treated|1
1338806|NCT01967940|4405200|P3|Part 2|Enrolled in Part 2 and Never Treated|0
1338807|NCT01967940|4405201|P2|Part 2|Enrolled in Part 2 and Never Treated|0
1338808|NCT01967940|4405202|P1|Part 2|Enrolled in Part 2 and Never Treated|0
1338809|NCT01967732|4405244|P4|First Intervention (Day 1)|Poor venous access|0
1338810|NCT01967732|4405245|P3|First Intervention (Day 1)|Poor venous access|0
1338811|NCT01967732|4405246|P2|First Intervention (Day 1)|Poor venous access|1
1338812|NCT01967732|4405247|P1|First Intervention (Day 1)|Poor venous access|0
1338813|NCT01967732|4405244|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
1338814|NCT01967732|4405245|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
1338815|NCT01967732|4405246|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
1338816|NCT01967732|4405247|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
1338817|NCT01967719|4405261|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
1338818|NCT01967719|4405262|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
1338819|NCT01967719|4405263|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
1338820|NCT01967719|4405264|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
1338821|NCT01967719|4405261|P4|First Intervention (Day 1)|Withdrawal by Subject|1
1338822|NCT01967719|4405262|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1338823|NCT01967719|4405263|P2|First Intervention (Day 1)|Withdrawal by Subject|1
1338824|NCT01967719|4405264|P1|First Intervention (Day 1)|Withdrawal by Subject|0
1338825|NCT01967706|4405279|P4|First Intervention (Day 1)|Withdrawal by Subject|0
1338826|NCT01967706|4405280|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1338827|NCT01967706|4405281|P2|First Intervention (Day 1)|Withdrawal by Subject|0
1338828|NCT01967706|4405282|P1|First Intervention (Day 1)|Withdrawal by Subject|1
1338829|NCT01967628|4405303|P2|Overall Study|Low protein concentration in sample|25
1338830|NCT01967628|4405304|P1|Overall Study|Low protein concentration in sample|20
1338831|NCT01967628|4405303|P2|Overall Study|Lost to Follow-up|0
1338832|NCT01967628|4405304|P1|Overall Study|Lost to Follow-up|1
1338833|NCT01967628|4405303|P2|Overall Study|Unable to complete bronchoscopy|6
1338834|NCT01967628|4405304|P1|Overall Study|Unable to complete bronchoscopy|4
1338835|NCT01967628|4405303|P2|Overall Study|Withdrawal by Subject|0
1338836|NCT01967628|4405304|P1|Overall Study|Withdrawal by Subject|2
1338837|NCT01967550|4405312|P2|Overall Study|Non Compliance|1
1338838|NCT01967550|4405313|P1|Overall Study|Non Compliance|0
1338839|NCT01967550|4405312|P2|Overall Study|Protocol Violation|1
1338840|NCT01967550|4405313|P1|Overall Study|Protocol Violation|2
1338841|NCT01967550|4405312|P2|Overall Study|Adverse Event|0
1338842|NCT01967550|4405313|P1|Overall Study|Adverse Event|2
1338843|NCT01967550|4405312|P2|Overall Study|Withdrawal by Subject|0
1338844|NCT01967550|4405313|P1|Overall Study|Withdrawal by Subject|1
1338845|NCT01967277|4405343|P2|Overall Study|Unrelated illness|1
1338846|NCT01967277|4405344|P1|Overall Study|Unrelated illness|0
1338847|NCT01967277|4405343|P2|Overall Study|Lost to Follow-up|2
1338848|NCT01967277|4405344|P1|Overall Study|Lost to Follow-up|1
1338849|NCT01967147|4405354|P2|Overall Study|Other|5
1338850|NCT01967147|4405355|P1|Overall Study|Other|4
1338851|NCT01967147|4405354|P2|Overall Study|Non-compliance with Study Drug|3
1338852|NCT01967147|4405355|P1|Overall Study|Non-compliance with Study Drug|0
1338853|NCT01967147|4405354|P2|Overall Study|Withdrawal by Subject|4
1338854|NCT01967147|4405355|P1|Overall Study|Withdrawal by Subject|2
1338855|NCT01967147|4405354|P2|Overall Study|Lost to Follow-up|2
1338856|NCT01967147|4405355|P1|Overall Study|Lost to Follow-up|1
1338857|NCT01967147|4405354|P2|Overall Study|Lack of Efficacy|4
1338858|NCT01967147|4405355|P1|Overall Study|Lack of Efficacy|1
1338859|NCT01967147|4405354|P2|Overall Study|Adverse Event|2
1338860|NCT01967147|4405355|P1|Overall Study|Adverse Event|5
1338861|NCT01967069|4405385|P2|Overall Study|Lack of Efficacy|1
1338862|NCT01967069|4405386|P1|Overall Study|Lack of Efficacy|0
1338863|NCT01967069|4405385|P2|Overall Study|Withdrawal by Subject|3
1338864|NCT01967069|4405386|P1|Overall Study|Withdrawal by Subject|1
1338865|NCT01967069|4405385|P2|Overall Study|Lost to Follow-up|2
1338866|NCT01967069|4405386|P1|Overall Study|Lost to Follow-up|5
1338867|NCT01967069|4405385|P2|Overall Study|Adverse Event|2
1338868|NCT01967069|4405386|P1|Overall Study|Adverse Event|2
1338869|NCT01966432|4405543|P3|Overall Study|SBIRT program ended|20
1338870|NCT01966432|4405544|P2|Overall Study|SBIRT program ended|8
1338871|NCT01966432|4405545|P1|Overall Study|SBIRT program ended|1
1338872|NCT01966432|4405543|P3|Overall Study|Subject Incarcerated|1
1338873|NCT01966432|4405544|P2|Overall Study|Subject Incarcerated|0
1338874|NCT01966432|4405545|P1|Overall Study|Subject Incarcerated|0
1338875|NCT01966432|4405543|P3|Overall Study|Withdrawal by Subject|0
1338876|NCT01966432|4405544|P2|Overall Study|Withdrawal by Subject|3
1338877|NCT01966432|4405545|P1|Overall Study|Withdrawal by Subject|1
1338878|NCT01966432|4405543|P3|Overall Study|Lost to Follow-up|5
1338879|NCT01966432|4405544|P2|Overall Study|Lost to Follow-up|2
1338880|NCT01966432|4405545|P1|Overall Study|Lost to Follow-up|3
1338881|NCT01966120|4405615|P2|Overall Study|Lost to Follow-up|1
1338882|NCT01966120|4405616|P1|Overall Study|Lost to Follow-up|1
1338883|NCT01966120|4405615|P2|Overall Study|Withdrawal by Subject|5
1338884|NCT01966120|4405616|P1|Overall Study|Withdrawal by Subject|0
1338885|NCT01966068|4405640|P1|Overall Study|Lost to Follow-up|81
1338886|NCT01966068|4405640|P1|Overall Study|Withdrawal by Subject|57
1338887|NCT01966042|4405645|P1|Overall Study|Death|2
1338888|NCT01966003|4405654|P2|Overall Study|Other|1
1338889|NCT01966003|4405655|P1|Overall Study|Other|1
1338890|NCT01966003|4405654|P2|Overall Study|Plan to Receive Commercial Bevacizumab|67
1338891|NCT01966003|4405655|P1|Overall Study|Plan to Receive Commercial Bevacizumab|44
1338892|NCT01966003|4405654|P2|Overall Study|Plan to Receive Other Anticancer Therapy|127
1338893|NCT01966003|4405655|P1|Overall Study|Plan to Receive Other Anticancer Therapy|131
1338894|NCT01966003|4405654|P2|Overall Study|Withdrawal by Subject|19
1338895|NCT01966003|4405655|P1|Overall Study|Withdrawal by Subject|29
1338896|NCT01966003|4405654|P2|Overall Study|Physician Decision|13
1338897|NCT01966003|4405655|P1|Overall Study|Physician Decision|12
1338898|NCT01966003|4405654|P2|Overall Study|Lost to Follow-up|3
1338899|NCT01966003|4405655|P1|Overall Study|Lost to Follow-up|4
1338900|NCT01966003|4405654|P2|Overall Study|Protocol Violation|4
1338901|NCT01966003|4405655|P1|Overall Study|Protocol Violation|6
1338902|NCT01966003|4405654|P2|Overall Study|Death|36
1338903|NCT01966003|4405655|P1|Overall Study|Death|43
1338904|NCT01965938|4405673|P2|Overall Study|Withdrawal by Subject|0
1338905|NCT01965938|4405674|P1|Overall Study|Withdrawal by Subject|1
1338906|NCT01965834|4405705|P1|Overall Study|Lack of Efficacy|4
1338907|NCT01965652|4405746|P2|Overall Study|Pregnancy|1
1338908|NCT01965652|4405747|P1|Overall Study|Pregnancy|0
1338909|NCT01965652|4405746|P2|Overall Study|Other - Miscellaneous|21
1338910|NCT01965652|4405747|P1|Overall Study|Other - Miscellaneous|18
1338911|NCT01965652|4405746|P2|Overall Study|Death|4
1338912|NCT01965652|4405747|P1|Overall Study|Death|3
1338913|NCT01965652|4405746|P2|Overall Study|Protocol Violation|38
1338914|NCT01965652|4405747|P1|Overall Study|Protocol Violation|34
1338915|NCT01965652|4405746|P2|Overall Study|Lost to Follow-up|40
1338916|NCT01965652|4405747|P1|Overall Study|Lost to Follow-up|53
1338917|NCT01965652|4405746|P2|Overall Study|Withdrawal by Subject|69
1338918|NCT01965652|4405747|P1|Overall Study|Withdrawal by Subject|62
1338919|NCT01965652|4405746|P2|Overall Study|Adverse Event|37
1338920|NCT01965652|4405747|P1|Overall Study|Adverse Event|40
1338921|NCT01965600|4405777|P4|Second Intervention|Study terminated by Sponsor|2
1338922|NCT01965600|4405778|P3|Second Intervention|Study terminated by Sponsor|2
1338923|NCT01965600|4405779|P2|Second Intervention|Study terminated by Sponsor|0
1338924|NCT01965600|4405780|P1|Second Intervention|Study terminated by Sponsor|0
1338925|NCT01965600|4405777|P4|Washout Period of Approximately 15 Days|Adverse Event|1
1338926|NCT01965600|4405778|P3|Washout Period of Approximately 15 Days|Adverse Event|0
1338927|NCT01965600|4405779|P2|Washout Period of Approximately 15 Days|Adverse Event|0
1338928|NCT01965600|4405780|P1|Washout Period of Approximately 15 Days|Adverse Event|0
1338929|NCT01965600|4405777|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
1338930|NCT01965600|4405778|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
1338931|NCT01965600|4405779|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
1338932|NCT01965600|4405780|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
1338933|NCT01965600|4405777|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
1338934|NCT01965600|4405778|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
1338935|NCT01965600|4405779|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
1338936|NCT01965600|4405780|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
1338937|NCT01965600|4405777|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
1338938|NCT01965600|4405778|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
1338939|NCT01965600|4405779|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
1338940|NCT01965600|4405780|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
1338941|NCT01965535|4405837|P2|Overall Study|Lack of Efficacy|1
1338942|NCT01965535|4405838|P1|Overall Study|Lack of Efficacy|2
1338943|NCT01965431|4405852|P6|Overall Study|Other than stated above|6
1338944|NCT01965431|4405853|P5|Overall Study|Other than stated above|6
1338945|NCT01965431|4405854|P4|Overall Study|Other than stated above|6
1338946|NCT01965431|4405855|P3|Overall Study|Other than stated above|6
1338947|NCT01965431|4405856|P2|Overall Study|Other than stated above|5
1338948|NCT01965431|4405857|P1|Overall Study|Other than stated above|6
1338949|NCT01965431|4405852|P6|Overall Study|Adverse Event|0
1338950|NCT01965431|4405853|P5|Overall Study|Adverse Event|0
1338951|NCT01965431|4405854|P4|Overall Study|Adverse Event|0
1338952|NCT01965431|4405855|P3|Overall Study|Adverse Event|0
1338953|NCT01965431|4405856|P2|Overall Study|Adverse Event|1
1338954|NCT01965431|4405857|P1|Overall Study|Adverse Event|0
1338955|NCT01965327|4405881|P1|Overall Study|Physician Decision|2
1338956|NCT01965262|4406095|P2|Second Intervention (7 Days)|Poor visual acuity|0
1338957|NCT01965262|4406096|P1|Second Intervention (7 Days)|Poor visual acuity|1
1338958|NCT01965262|4406095|P2|Second Intervention (7 Days)|Poor lens fit|9
1338959|NCT01965262|4406096|P1|Second Intervention (7 Days)|Poor lens fit|0
1338960|NCT01965262|4406095|P2|Second Intervention (7 Days)|Discontinued|1
1338961|NCT01965262|4406096|P1|Second Intervention (7 Days)|Discontinued|0
1338962|NCT01965158|4406160|P2|Overall Study|Other - Miscellaneous|0
1338963|NCT01965158|4406161|P1|Overall Study|Other - Miscellaneous|3
1338964|NCT01965158|4406160|P2|Overall Study|Protocol Violation|1
1338965|NCT01965158|4406161|P1|Overall Study|Protocol Violation|1
1338966|NCT01965158|4406160|P2|Overall Study|Lost to Follow-up|5
1338967|NCT01965158|4406161|P1|Overall Study|Lost to Follow-up|7
1338968|NCT01965158|4406160|P2|Overall Study|Withdrawal by Subject|24
1338969|NCT01965158|4406161|P1|Overall Study|Withdrawal by Subject|16
1338970|NCT01965158|4406160|P2|Overall Study|Adverse Event|5
1338971|NCT01965158|4406161|P1|Overall Study|Adverse Event|14
1338972|NCT01964976|4406202|P1|Overall Study|Protocol Violation|31
1338973|NCT01964950|4406216|P1|Overall Study|Protocol Violation|25
1338974|NCT01964898|4406230|P2|Overall Study|Withdrawal by Subject|0
1338975|NCT01964898|4406231|P1|Overall Study|Withdrawal by Subject|1
1338976|NCT01964898|4406230|P2|Overall Study|Lost to Follow-up|5
1338977|NCT01964898|4406231|P1|Overall Study|Lost to Follow-up|3
1338978|NCT01964898|4406230|P2|Overall Study|did not receive the allocated interventi|1
1338979|NCT01964898|4406231|P1|Overall Study|did not receive the allocated interventi|2
1338980|NCT01964898|4406230|P2|Overall Study|ineligible post-randomization|1
1338981|NCT01964898|4406231|P1|Overall Study|ineligible post-randomization|1
1338982|NCT01964716|4406253|P2|Overall Study|Death|0
1338983|NCT01964716|4406254|P1|Overall Study|Death|1
1338984|NCT01964716|4406253|P2|Overall Study|No longer met eligibility criteria|1
1338985|NCT01964716|4406254|P1|Overall Study|No longer met eligibility criteria|1
1338986|NCT01964716|4406253|P2|Overall Study|Lost to Follow-up|2
1338987|NCT01964716|4406254|P1|Overall Study|Lost to Follow-up|1
1338988|NCT01964716|4406253|P2|Overall Study|Withdrawal by Subject|3
1338989|NCT01964716|4406254|P1|Overall Study|Withdrawal by Subject|2
1338990|NCT01964547|4406292|P2|Overall Study|Withdrawal by Investigator|1
1338991|NCT01964547|4406293|P1|Overall Study|Withdrawal by Investigator|0
1338992|NCT01964547|4406292|P2|Overall Study|Lost to Follow-up|1
1338993|NCT01964547|4406293|P1|Overall Study|Lost to Follow-up|0
1338994|NCT01964547|4406292|P2|Overall Study|Withdrawal by Subject|7
1338995|NCT01964547|4406293|P1|Overall Study|Withdrawal by Subject|4
1338996|NCT01964547|4406292|P2|Overall Study|Adverse Event|2
1338997|NCT01964547|4406293|P1|Overall Study|Adverse Event|8
1338998|NCT01964521|4406317|P1|Overall Study|Lost to Follow-up|4
1338999|NCT01964352|4406326|P4|Overall Study|Other than stated above|2
1339000|NCT01964352|4406327|P3|Overall Study|Other than stated above|1
1339001|NCT01964352|4406328|P2|Overall Study|Other than stated above|2
1339002|NCT01964352|4406329|P1|Overall Study|Other than stated above|0
1339003|NCT01964352|4406326|P4|Overall Study|Withdrawal by Subject|0
1339004|NCT01964352|4406327|P3|Overall Study|Withdrawal by Subject|1
1339005|NCT01964352|4406328|P2|Overall Study|Withdrawal by Subject|2
1339006|NCT01964352|4406329|P1|Overall Study|Withdrawal by Subject|4
1339007|NCT01964352|4406326|P4|Overall Study|Lost to Follow-up|1
1339008|NCT01964352|4406327|P3|Overall Study|Lost to Follow-up|0
1339009|NCT01964352|4406328|P2|Overall Study|Lost to Follow-up|0
1339010|NCT01964352|4406329|P1|Overall Study|Lost to Follow-up|1
1339011|NCT01964352|4406326|P4|Overall Study|Protocol Violation|2
1339012|NCT01964352|4406327|P3|Overall Study|Protocol Violation|0
1339013|NCT01964352|4406328|P2|Overall Study|Protocol Violation|4
1339014|NCT01964352|4406329|P1|Overall Study|Protocol Violation|2
1339015|NCT01964352|4406326|P4|Overall Study|Lack of Efficacy|0
1339016|NCT01964352|4406327|P3|Overall Study|Lack of Efficacy|0
1339017|NCT01964352|4406328|P2|Overall Study|Lack of Efficacy|0
1339018|NCT01964352|4406329|P1|Overall Study|Lack of Efficacy|6
1339019|NCT01964352|4406326|P4|Overall Study|Adverse Event|3
1339020|NCT01964352|4406327|P3|Overall Study|Adverse Event|4
1339021|NCT01964352|4406328|P2|Overall Study|Adverse Event|3
1339022|NCT01964352|4406329|P1|Overall Study|Adverse Event|13
1339023|NCT01964326|4406359|P1|Overall Study|Did not meet eligibility criteria|1
1339024|NCT01964326|4406359|P1|Overall Study|Other|9
1339025|NCT01964326|4406359|P1|Overall Study|Investigator Discretion|1
1339026|NCT01964326|4406359|P1|Overall Study|Physician Decision|55
1339027|NCT01964326|4406359|P1|Overall Study|No Longer Meets Eligibility Criteria|1
1339028|NCT01964326|4406359|P1|Overall Study|Pregnancy|1
1339029|NCT01964326|4406359|P1|Overall Study|Withdrawal by Subject|87
1339030|NCT01964326|4406359|P1|Overall Study|Lost to Follow-up|88
1339031|NCT01964326|4406359|P1|Overall Study|Protocol Violation|4
1339032|NCT01964326|4406359|P1|Overall Study|Death|2
1339033|NCT01964326|4406359|P1|Overall Study|Adverse Event|48
1339034|NCT01964222|4406368|P2|Overall Study|Screening Failure|0
1339035|NCT01964222|4406369|P1|Overall Study|Screening Failure|2
1339036|NCT01964222|4406368|P2|Overall Study|Withdrawal by Subject|6
1339037|NCT01964222|4406369|P1|Overall Study|Withdrawal by Subject|6
1339038|NCT01964222|4406368|P2|Overall Study|Lost to Follow-up|5
1339039|NCT01964222|4406369|P1|Overall Study|Lost to Follow-up|7
1339040|NCT01964105|4406386|P3|Overall Study|Lost to Follow-up|0
1339041|NCT01964105|4406387|P2|Overall Study|Lost to Follow-up|13
1339042|NCT01964105|4406388|P1|Overall Study|Lost to Follow-up|2
1339043|NCT01963767|4406415|P2|Overall Study|Adverse Event|0
1339044|NCT01963767|4406416|P1|Overall Study|Adverse Event|2
1339045|NCT01963767|4406415|P2|Overall Study|Withdrawal by Subject|2
1339046|NCT01963767|4406416|P1|Overall Study|Withdrawal by Subject|4
1339047|NCT01963676|4406426|P2|Overall Study|Withdrawal by Subject|0
1339048|NCT01963676|4406427|P1|Overall Study|Withdrawal by Subject|1
1339049|NCT01963611|4406440|P5|Overall Study|Other|45
1339050|NCT01963611|4406441|P4|Overall Study|Other|45
1339051|NCT01963611|4406442|P3|Overall Study|Other|48
1339052|NCT01963611|4406443|P2|Overall Study|Other|46
1339053|NCT01963611|4406444|P1|Overall Study|Other|47
1339054|NCT01963611|4406440|P5|Overall Study|Withdrawal by Subject|3
1339055|NCT01963611|4406441|P4|Overall Study|Withdrawal by Subject|1
1339056|NCT01963611|4406442|P3|Overall Study|Withdrawal by Subject|1
1339057|NCT01963611|4406443|P2|Overall Study|Withdrawal by Subject|2
1339058|NCT01963611|4406444|P1|Overall Study|Withdrawal by Subject|3
1339059|NCT01963611|4406440|P5|Overall Study|Lack of Efficacy|0
1339060|NCT01963611|4406441|P4|Overall Study|Lack of Efficacy|1
1339061|NCT01963611|4406442|P3|Overall Study|Lack of Efficacy|0
1339062|NCT01963611|4406443|P2|Overall Study|Lack of Efficacy|0
1339063|NCT01963611|4406444|P1|Overall Study|Lack of Efficacy|0
1339064|NCT01963611|4406440|P5|Overall Study|Protocol Violation|0
1339065|NCT01963611|4406441|P4|Overall Study|Protocol Violation|1
1339066|NCT01963611|4406442|P3|Overall Study|Protocol Violation|0
1339067|NCT01963611|4406443|P2|Overall Study|Protocol Violation|0
1339068|NCT01963611|4406444|P1|Overall Study|Protocol Violation|0
1339069|NCT01963611|4406440|P5|Overall Study|Adverse Event|3
1339070|NCT01963611|4406441|P4|Overall Study|Adverse Event|4
1339071|NCT01963611|4406442|P3|Overall Study|Adverse Event|3
1339072|NCT01963611|4406443|P2|Overall Study|Adverse Event|1
1339073|NCT01963611|4406444|P1|Overall Study|Adverse Event|1
1339074|NCT01963403|4406503|P2|Overall Study|Implant removal|1
1339075|NCT01963403|4406504|P1|Overall Study|Implant removal|0
1339076|NCT01963403|4406503|P2|Overall Study|Lost to Follow-up|3
1339077|NCT01963403|4406504|P1|Overall Study|Lost to Follow-up|2
1339078|NCT01963260|4406526|P10|Overall Study|Withdrawal by Subject|0
1339079|NCT01963260|4406527|P9|Overall Study|Withdrawal by Subject|0
1339080|NCT01963260|4406528|P8|Overall Study|Withdrawal by Subject|0
1339081|NCT01963260|4406529|P7|Overall Study|Withdrawal by Subject|0
1339082|NCT01963260|4406530|P6|Overall Study|Withdrawal by Subject|0
1339083|NCT01963260|4406531|P5|Overall Study|Withdrawal by Subject|2
1339084|NCT01963260|4406532|P4|Overall Study|Withdrawal by Subject|1
1339085|NCT01963260|4406533|P3|Overall Study|Withdrawal by Subject|0
1339086|NCT01963260|4406534|P2|Overall Study|Withdrawal by Subject|0
1339087|NCT01963260|4406535|P1|Overall Study|Withdrawal by Subject|2
1339088|NCT01962974|4406643|P1|Overall Study|Study termination|7
1339089|NCT01962922|4406670|P2|Extendion Portion (up to Month 6)|Physician Decision|0
1339090|NCT01962922|4406671|P1|Extendion Portion (up to Month 6)|Physician Decision|1
1339091|NCT01962922|4406670|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
1339092|NCT01962922|4406671|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
1339093|NCT01962922|4406670|P2|PK Portion Day 7|non-compliance|0
1339094|NCT01962922|4406671|P1|PK Portion Day 7|non-compliance|1
1339095|NCT01962922|4406670|P2|PK Portion Day 7|Withdrawal by Subject|0
1339096|NCT01962922|4406671|P1|PK Portion Day 7|Withdrawal by Subject|3
1339097|NCT01962493|4406748|P2|Overall Study|Withdrawal by Subject|2
1339098|NCT01962493|4406749|P1|Overall Study|Withdrawal by Subject|4
1339099|NCT01962493|4406748|P2|Overall Study|Protocol Violation|1
1339100|NCT01962493|4406749|P1|Overall Study|Protocol Violation|0
1339101|NCT01962493|4406748|P2|Overall Study|Adverse Event|2
1339102|NCT01962493|4406749|P1|Overall Study|Adverse Event|1
1339103|NCT01962441|4406772|P3|Retreatment Substudy|Lost to Follow-up|0
1339104|NCT01962441|4406773|P2|Retreatment Substudy|Lost to Follow-up|0
1339105|NCT01962441|4406774|P1|Retreatment Substudy|Lost to Follow-up|1
1339106|NCT01962441|4406772|P3|Retreatment Substudy|Lack of Efficacy|0
1339107|NCT01962441|4406773|P2|Retreatment Substudy|Lack of Efficacy|0
1339108|NCT01962441|4406774|P1|Retreatment Substudy|Lack of Efficacy|1
1339109|NCT01962441|4406772|P3|Randomized Period|Protocol Violation|0
1339110|NCT01962441|4406773|P2|Randomized Period|Protocol Violation|1
1339111|NCT01962441|4406774|P1|Randomized Period|Protocol Violation|0
1339112|NCT01962441|4406772|P3|Randomized Period|Death|2
1339113|NCT01962441|4406773|P2|Randomized Period|Death|0
1339114|NCT01962441|4406774|P1|Randomized Period|Death|0
1339115|NCT01962441|4406772|P3|Randomized Period|Adverse Event|0
1339116|NCT01962441|4406773|P2|Randomized Period|Adverse Event|1
1339117|NCT01962441|4406774|P1|Randomized Period|Adverse Event|1
1339118|NCT01962441|4406772|P3|Randomized Period|Withdrew Consent|2
1339119|NCT01962441|4406773|P2|Randomized Period|Withdrew Consent|3
1339120|NCT01962441|4406774|P1|Randomized Period|Withdrew Consent|3
1339121|NCT01962441|4406772|P3|Randomized Period|Lost to Follow-up|4
1339122|NCT01962441|4406773|P2|Randomized Period|Lost to Follow-up|4
1339123|NCT01962441|4406774|P1|Randomized Period|Lost to Follow-up|2
1339124|NCT01962441|4406772|P3|Randomized Period|Randomized but Never Treated|3
1339125|NCT01962441|4406773|P2|Randomized Period|Randomized but Never Treated|2
1339126|NCT01962441|4406774|P1|Randomized Period|Randomized but Never Treated|4
1339127|NCT01961544|4406813|P1|Overall Study|Aggravation of Steral Pain|1
1339128|NCT01961544|4406813|P1|Overall Study|Poor Tolerance|1
1339129|NCT01961544|4406813|P1|Overall Study|Physician Decision|2
1339130|NCT01961544|4406813|P1|Overall Study|Adverse Event|1
1339131|NCT01961544|4406813|P1|Overall Study|Withdrawal by Subject|7
1339132|NCT01961544|4406813|P1|Overall Study|Protocol Violation|1
1339133|NCT01961349|4406821|P3|Overall Study|registration error, personal reason etc|1
1339134|NCT01961349|4406822|P2|Overall Study|registration error, personal reason etc|2
1339135|NCT01961349|4406823|P1|Overall Study|registration error, personal reason etc|2
1339136|NCT01961349|4406821|P3|Overall Study|Adverse Event|1
1339137|NCT01961349|4406822|P2|Overall Study|Adverse Event|0
1339138|NCT01961349|4406823|P1|Overall Study|Adverse Event|0
1339139|NCT01961349|4406821|P3|Overall Study|Withdrawal by Subject|0
1339140|NCT01961349|4406822|P2|Overall Study|Withdrawal by Subject|4
1339141|NCT01961349|4406823|P1|Overall Study|Withdrawal by Subject|1
1339142|NCT01961323|4406834|P1|Overall Study|screen failure|34
1339143|NCT01961323|4406834|P1|Overall Study|Lost to Follow-up|8
1339144|NCT01961323|4406834|P1|Overall Study|Withdrawal by Subject|7
1339145|NCT01961297|4406842|P2|Overall Study|unconfirmed diagnosis of SD|1
1339146|NCT01961297|4406843|P1|Overall Study|unconfirmed diagnosis of SD|2
1339147|NCT01961115|4406869|P3|Overall Study|Adverse Event|1
1339148|NCT01961115|4406870|P2|Overall Study|Adverse Event|0
1339149|NCT01961115|4406871|P1|Overall Study|Adverse Event|1
1339150|NCT01961115|4406869|P3|Overall Study|Disease Progression|3
1339151|NCT01961115|4406870|P2|Overall Study|Disease Progression|0
1339152|NCT01961115|4406871|P1|Overall Study|Disease Progression|1
1339153|NCT01960907|4406914|P2|Overall Study|Withdrawal by Subject|42
1339154|NCT01960907|4406915|P1|Overall Study|Withdrawal by Subject|32
1339155|NCT01960907|4406914|P2|Overall Study|Death|3
1339156|NCT01960907|4406915|P1|Overall Study|Death|4
1339157|NCT01960855|4406930|P5|Overall Study|Lost to Follow-up|2
1339158|NCT01960855|4406931|P4|Overall Study|Lost to Follow-up|0
1339159|NCT01960855|4406932|P3|Overall Study|Lost to Follow-up|0
1339160|NCT01960855|4406933|P2|Overall Study|Lost to Follow-up|1
1339161|NCT01960855|4406934|P1|Overall Study|Lost to Follow-up|2
1339162|NCT01960855|4406930|P5|Overall Study|Consent withdrawn by subject|1
1339163|NCT01960855|4406931|P4|Overall Study|Consent withdrawn by subject|1
1339164|NCT01960855|4406932|P3|Overall Study|Consent withdrawn by subject|2
1339165|NCT01960855|4406933|P2|Overall Study|Consent withdrawn by subject|1
1339166|NCT01960855|4406934|P1|Overall Study|Consent withdrawn by subject|3
1339167|NCT01960855|4406930|P5|Overall Study|Not specified|0
1339168|NCT01960855|4406931|P4|Overall Study|Not specified|1
1339169|NCT01960855|4406932|P3|Overall Study|Not specified|1
1339170|NCT01960855|4406933|P2|Overall Study|Not specified|1
1339171|NCT01960855|4406934|P1|Overall Study|Not specified|2
1339172|NCT01960855|4406930|P5|Overall Study|Lack of Efficacy|0
1339173|NCT01960855|4406931|P4|Overall Study|Lack of Efficacy|0
1339174|NCT01960855|4406932|P3|Overall Study|Lack of Efficacy|0
1339175|NCT01960855|4406933|P2|Overall Study|Lack of Efficacy|1
1339176|NCT01960855|4406934|P1|Overall Study|Lack of Efficacy|1
1339177|NCT01960855|4406930|P5|Overall Study|Adverse Event|2
1339178|NCT01960855|4406931|P4|Overall Study|Adverse Event|2
1339179|NCT01960855|4406932|P3|Overall Study|Adverse Event|6
1339180|NCT01960855|4406933|P2|Overall Study|Adverse Event|0
1339181|NCT01960855|4406934|P1|Overall Study|Adverse Event|2
1339182|NCT01960855|4406930|P5|Overall Study|Subject noncompliant|0
1339183|NCT01960855|4406931|P4|Overall Study|Subject noncompliant|0
1339184|NCT01960855|4406932|P3|Overall Study|Subject noncompliant|0
1339185|NCT01960855|4406933|P2|Overall Study|Subject noncompliant|0
1339186|NCT01960855|4406934|P1|Overall Study|Subject noncompliant|1
1339187|NCT01960842|4406966|P1|Overall Study|Withdrawal by Subject|2
1339188|NCT01960842|4406966|P1|Overall Study|Adverse Event|1
1339189|NCT01960816|4406989|P1|Overall Study|Lost to Follow-up|1
1339190|NCT01960725|4406997|P2|Overall Study|unable to obtain blood sample|2
1339191|NCT01960725|4406998|P1|Overall Study|unable to obtain blood sample|1
1339192|NCT01960725|4406997|P2|Overall Study|Withdrawal by Subject|0
1339193|NCT01960725|4406998|P1|Overall Study|Withdrawal by Subject|1
1339194|NCT01960725|4406997|P2|Overall Study|Lost to Follow-up|3
1339195|NCT01960725|4406998|P1|Overall Study|Lost to Follow-up|4
1339196|NCT01960296|4407077|P2|Overall Study|Received different procedure|3
1339197|NCT01960296|4407078|P1|Overall Study|Received different procedure|1
1339198|NCT01960296|4407077|P2|Overall Study|Postponed surgery|0
1339199|NCT01960296|4407078|P1|Overall Study|Postponed surgery|1
1339200|NCT01960140|4407098|P1|Period 2 (Days 3-18)|Adverse Event|2
1339201|NCT01960114|4407109|P2|Overall Study|Could not swallow study medication|1
1339202|NCT01960114|4407110|P1|Overall Study|Could not swallow study medication|0
1339203|NCT01960114|4407109|P2|Overall Study|Adverse Event|0
1339204|NCT01960114|4407110|P1|Overall Study|Adverse Event|1
1339205|NCT01959932|4407156|P3|Overall Study|Withdrawal by Subject|0
1339206|NCT01959932|4407157|P2|Overall Study|Withdrawal by Subject|0
1339207|NCT01959932|4407158|P1|Overall Study|Withdrawal by Subject|1
1339208|NCT01959880|4407180|P4|Overall Study|Study completed early-FDA approved|152
1339209|NCT01959880|4407181|P3|Overall Study|Study completed early-FDA approved|179
1339210|NCT01959880|4407182|P2|Overall Study|Study completed early-FDA approved|311
1339211|NCT01959880|4407183|P1|Overall Study|Study completed early-FDA approved|1003
1339212|NCT01959880|4407180|P4|Overall Study|Explantation w/o study device reimplant.|12
1339213|NCT01959880|4407181|P3|Overall Study|Explantation w/o study device reimplant.|5
1339214|NCT01959880|4407182|P2|Overall Study|Explantation w/o study device reimplant.|17
1339215|NCT01959880|4407183|P1|Overall Study|Explantation w/o study device reimplant.|22
1339216|NCT01959880|4407180|P4|Overall Study|Lost to Follow-up|8
1339217|NCT01959880|4407181|P3|Overall Study|Lost to Follow-up|15
1339218|NCT01959880|4407182|P2|Overall Study|Lost to Follow-up|18
1339219|NCT01959880|4407183|P1|Overall Study|Lost to Follow-up|95
1339220|NCT01959880|4407180|P4|Overall Study|Death|2
1339221|NCT01959880|4407181|P3|Overall Study|Death|1
1339222|NCT01959880|4407182|P2|Overall Study|Death|10
1339223|NCT01959880|4407183|P1|Overall Study|Death|1
1339224|NCT01959880|4407180|P4|Overall Study|Withdrawal by Subject|7
1339225|NCT01959880|4407181|P3|Overall Study|Withdrawal by Subject|8
1339226|NCT01959880|4407182|P2|Overall Study|Withdrawal by Subject|13
1339227|NCT01959880|4407183|P1|Overall Study|Withdrawal by Subject|11
1339228|NCT01959607|4407212|P4|First Intervention (Day 1)|Withdrawal by Subject|0
1339229|NCT01959607|4407213|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1339230|NCT01959607|4407214|P2|First Intervention (Day 1)|Withdrawal by Subject|1
1339231|NCT01959607|4407215|P1|First Intervention (Day 1)|Withdrawal by Subject|1
1339232|NCT01959581|4407228|P1|Overall Study|Lost to Follow-up|5
1339233|NCT01959529|4407234|P2|Overall Study|Lack of glycaemic control|1
1339234|NCT01959529|4407235|P1|Overall Study|Lack of glycaemic control|1
1339235|NCT01959529|4407234|P2|Overall Study|Hypoglycaemia|1
1339236|NCT01959529|4407235|P1|Overall Study|Hypoglycaemia|1
1339237|NCT01959529|4407234|P2|Overall Study|Other|68
1339238|NCT01959529|4407235|P1|Overall Study|Other|70
1339239|NCT01959529|4407234|P2|Overall Study|Lost to Follow-up|1
1339240|NCT01959529|4407235|P1|Overall Study|Lost to Follow-up|4
1339241|NCT01959529|4407234|P2|Overall Study|Adverse event (not hypoglycaemia)|1
1339242|NCT01959529|4407235|P1|Overall Study|Adverse event (not hypoglycaemia)|0
1339243|NCT01959516|4407247|P2|Epoch 2|Moderate or severe COPD exacerbation|1
1339244|NCT01959516|4407248|P1|Epoch 2|Moderate or severe COPD exacerbation|0
1339245|NCT01959516|4407247|P2|Epoch 2|Subject withdrew consent|0
1339246|NCT01959516|4407248|P1|Epoch 2|Subject withdrew consent|1
1339247|NCT01959516|4407247|P2|Epoch 2|unsatisfactory therapeutic effect|0
1339248|NCT01959516|4407248|P1|Epoch 2|unsatisfactory therapeutic effect|1
1339249|NCT01959516|4407247|P2|Epoch 1|Protocol deviation|1
1339250|NCT01959516|4407248|P1|Epoch 1|Protocol deviation|0
1339251|NCT01959516|4407247|P2|Epoch 1|Moderate or severe COPD exacerbation|1
1339252|NCT01959516|4407248|P1|Epoch 1|Moderate or severe COPD exacerbation|0
1339253|NCT01959516|4407247|P2|Epoch 1|Use of prohibited treatment|0
1339254|NCT01959516|4407248|P1|Epoch 1|Use of prohibited treatment|1
1339255|NCT01959516|4407247|P2|Epoch 1|Administrative problems|0
1339256|NCT01959516|4407248|P1|Epoch 1|Administrative problems|1
1339257|NCT01959516|4407247|P2|Epoch 1|Subject withdrew consent|2
1339258|NCT01959516|4407248|P1|Epoch 1|Subject withdrew consent|3
1339259|NCT01959516|4407247|P2|Epoch 1|unsatisfactory therapeutic effect|0
1339260|NCT01959516|4407248|P1|Epoch 1|unsatisfactory therapeutic effect|1
1339261|NCT01959516|4407247|P2|Epoch 1|Adverse Event|1
1339262|NCT01959516|4407248|P1|Epoch 1|Adverse Event|4
1339263|NCT01959503|4407258|P2|Overall Study|Randomized but not treated|1
1339264|NCT01959503|4407259|P1|Overall Study|Randomized but not treated|1
1339265|NCT01959503|4407258|P2|Overall Study|Death|1
1339266|NCT01959503|4407259|P1|Overall Study|Death|2
1339267|NCT01959412|4407279|P6|Overall Study|Adverse Event|0
1339268|NCT01959412|4407280|P5|Overall Study|Adverse Event|0
1339269|NCT01959412|4407281|P4|Overall Study|Adverse Event|1
1339270|NCT01959412|4407282|P3|Overall Study|Adverse Event|0
1339271|NCT01959412|4407283|P2|Overall Study|Adverse Event|0
1339272|NCT01959412|4407284|P1|Overall Study|Adverse Event|0
1339273|NCT01959412|4407279|P6|Overall Study|Protocol deviation|0
1339274|NCT01959412|4407280|P5|Overall Study|Protocol deviation|3
1339275|NCT01959412|4407281|P4|Overall Study|Protocol deviation|1
1339276|NCT01959412|4407282|P3|Overall Study|Protocol deviation|0
1339277|NCT01959412|4407283|P2|Overall Study|Protocol deviation|1
1339278|NCT01959412|4407284|P1|Overall Study|Protocol deviation|1
1339279|NCT01959035|4407322|P1|Overall Study|Other (no primary reason given)|1
1339280|NCT01959035|4407322|P1|Overall Study|Lost to Follow-up|1
1339281|NCT01959035|4407322|P1|Overall Study|Withdrawal by Subject|4
1339282|NCT01959035|4407322|P1|Overall Study|Adverse Event|5
1339283|NCT01958827|4407348|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
1339284|NCT01958827|4407348|P1|Overall Study|Lack of Efficacy|6
1339285|NCT01958827|4407348|P1|Overall Study|Adverse Event|3
1339286|NCT01958671|4407379|P3|Overall Study|Withdrawal by Subject|13
1339287|NCT01958671|4407380|P2|Overall Study|Withdrawal by Subject|10
1339288|NCT01958671|4407381|P1|Overall Study|Withdrawal by Subject|8
1339289|NCT01958671|4407379|P3|Overall Study|Participant moved|1
1339290|NCT01958671|4407380|P2|Overall Study|Participant moved|0
1339291|NCT01958671|4407381|P1|Overall Study|Participant moved|0
1339292|NCT01958671|4407379|P3|Overall Study|Study site terminated by sponsor|1
1339293|NCT01958671|4407380|P2|Overall Study|Study site terminated by sponsor|0
1339294|NCT01958671|4407381|P1|Overall Study|Study site terminated by sponsor|1
1339295|NCT01958671|4407379|P3|Overall Study|Protocol Violation|0
1339296|NCT01958671|4407380|P2|Overall Study|Protocol Violation|1
1339297|NCT01958671|4407381|P1|Overall Study|Protocol Violation|0
1339298|NCT01958671|4407379|P3|Overall Study|Pregnancy|1
1339299|NCT01958671|4407380|P2|Overall Study|Pregnancy|0
1339300|NCT01958671|4407381|P1|Overall Study|Pregnancy|0
1339301|NCT01958671|4407379|P3|Overall Study|Non-compliance with study drug|1
1339302|NCT01958671|4407380|P2|Overall Study|Non-compliance with study drug|1
1339303|NCT01958671|4407381|P1|Overall Study|Non-compliance with study drug|1
1339304|NCT01958671|4407379|P3|Overall Study|Lost to Follow-up|7
1339305|NCT01958671|4407380|P2|Overall Study|Lost to Follow-up|11
1339306|NCT01958671|4407381|P1|Overall Study|Lost to Follow-up|7
1339307|NCT01958671|4407379|P3|Overall Study|Hyperglycemia|2
1339308|NCT01958671|4407380|P2|Overall Study|Hyperglycemia|0
1339309|NCT01958671|4407381|P1|Overall Study|Hyperglycemia|0
1339310|NCT01958671|4407379|P3|Overall Study|Excluded medication|1
1339311|NCT01958671|4407380|P2|Overall Study|Excluded medication|0
1339312|NCT01958671|4407381|P1|Overall Study|Excluded medication|0
1339313|NCT01958671|4407379|P3|Overall Study|Death|0
1339314|NCT01958671|4407380|P2|Overall Study|Death|0
1339315|NCT01958671|4407381|P1|Overall Study|Death|1
1339316|NCT01958671|4407379|P3|Overall Study|Adverse Event|5
1339317|NCT01958671|4407380|P2|Overall Study|Adverse Event|1
1339318|NCT01958671|4407381|P1|Overall Study|Adverse Event|1
1339319|NCT01958619|4407455|P4|Overall Study|Protocol Violation|0
1339320|NCT01958619|4407456|P3|Overall Study|Protocol Violation|1
1339321|NCT01958619|4407457|P2|Overall Study|Protocol Violation|0
1339322|NCT01958619|4407458|P1|Overall Study|Protocol Violation|2
1339323|NCT01958437|4407521|P4|Overall Study|Incidental MRI findings|1
1339324|NCT01958437|4407522|P3|Overall Study|Incidental MRI findings|1
1339325|NCT01958437|4407523|P2|Overall Study|Incidental MRI findings|0
1339326|NCT01958437|4407524|P1|Overall Study|Incidental MRI findings|0
1339327|NCT01958281|4407560|P3|Overall Study|Withdrew Consent|0
1339328|NCT01958281|4407561|P2|Overall Study|Withdrew Consent|0
1339329|NCT01958281|4407562|P1|Overall Study|Withdrew Consent|1
1339330|NCT01958281|4407560|P3|Overall Study|Adverse Event|0
1339331|NCT01958281|4407561|P2|Overall Study|Adverse Event|2
1339332|NCT01958281|4407562|P1|Overall Study|Adverse Event|0
1339333|NCT01958281|4407560|P3|Overall Study|Lack of Efficacy|0
1339334|NCT01958281|4407561|P2|Overall Study|Lack of Efficacy|2
1339335|NCT01958281|4407562|P1|Overall Study|Lack of Efficacy|5
1339336|NCT01958164|4407638|P2|Overall Study|Lost to Follow-up|3
1339337|NCT01958164|4407639|P1|Overall Study|Lost to Follow-up|2
1339338|NCT01958164|4407638|P2|Overall Study|Adverse Event|2
1339339|NCT01958164|4407639|P1|Overall Study|Adverse Event|0
1339340|NCT01958060|4407658|P6|Overall Study|Not treated|0
1339341|NCT01958060|4407659|P5|Overall Study|Not treated|1
1339342|NCT01958060|4407660|P4|Overall Study|Not treated|0
1339343|NCT01958060|4407661|P3|Overall Study|Not treated|0
1339344|NCT01958060|4407662|P2|Overall Study|Not treated|0
1339345|NCT01958060|4407663|P1|Overall Study|Not treated|2
1339346|NCT01958021|4407688|P2|Overall Study|Death|0
1339347|NCT01958021|4407689|P1|Overall Study|Death|2
1339348|NCT01958021|4407688|P2|Overall Study|Protocol Violation|1
1339349|NCT01958021|4407689|P1|Overall Study|Protocol Violation|3
1339350|NCT01958021|4407688|P2|Overall Study|Physician Decision|13
1339351|NCT01958021|4407689|P1|Overall Study|Physician Decision|10
1339352|NCT01958021|4407688|P2|Overall Study|Subject/guardian decision|13
1339353|NCT01958021|4407689|P1|Overall Study|Subject/guardian decision|12
1339354|NCT01958021|4407688|P2|Overall Study|Adverse Event|7
1339355|NCT01958021|4407689|P1|Overall Study|Adverse Event|25
1339356|NCT01958021|4407688|P2|Overall Study|Progressive disease|146
1339357|NCT01958021|4407689|P1|Overall Study|Progressive disease|87
1339358|NCT01958008|4407701|P4|Overall Study|Other adverse event|0
1339359|NCT01958008|4407702|P3|Overall Study|Other adverse event|0
1339360|NCT01958008|4407703|P2|Overall Study|Other adverse event|0
1339361|NCT01958008|4407704|P1|Overall Study|Other adverse event|1
1339362|NCT01958008|4407701|P4|Overall Study|Worsening of disease under study|0
1339363|NCT01958008|4407702|P3|Overall Study|Worsening of disease under study|1
1339364|NCT01958008|4407703|P2|Overall Study|Worsening of disease under study|0
1339365|NCT01958008|4407704|P1|Overall Study|Worsening of disease under study|0
1339366|NCT01957865|4407744|P3|Overall Study|Lost to Follow-up|2
1339367|NCT01957865|4407745|P2|Overall Study|Lost to Follow-up|2
1339368|NCT01957865|4407746|P1|Overall Study|Lost to Follow-up|0
1339369|NCT01957865|4407744|P3|Overall Study|Found HIV negative|1
1339370|NCT01957865|4407745|P2|Overall Study|Found HIV negative|0
1339371|NCT01957865|4407746|P1|Overall Study|Found HIV negative|0
1339372|NCT01957579|4407779|P4|Overall Study|Death|0
1339373|NCT01957579|4407780|P3|Overall Study|Death|2
1339374|NCT01957579|4407781|P2|Overall Study|Death|0
1339375|NCT01957579|4407782|P1|Overall Study|Death|0
1339376|NCT01957579|4407779|P4|Overall Study|Withdrawal of concent|0
1339377|NCT01957579|4407780|P3|Overall Study|Withdrawal of concent|0
1339378|NCT01957579|4407781|P2|Overall Study|Withdrawal of concent|1
1339379|NCT01957579|4407782|P1|Overall Study|Withdrawal of concent|0
1339380|NCT01957553|4407849|P2|Test Period 2 (21 +- 1 Days)|Other|0
1339381|NCT01957553|4407850|P1|Test Period 2 (21 +- 1 Days)|Other|1
1339382|NCT01957553|4407849|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
1339383|NCT01957553|4407850|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
1339384|NCT01957553|4407849|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
1339385|NCT01957553|4407850|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
1339386|NCT01957553|4407849|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
1339387|NCT01957553|4407850|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
1339388|NCT01957553|4407849|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
1339389|NCT01957553|4407850|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
1339390|NCT01957553|4407849|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
1339391|NCT01957553|4407850|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
1339392|NCT01957553|4407849|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
1339393|NCT01957553|4407850|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
1339394|NCT01957553|4407849|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
1339395|NCT01957553|4407850|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
1339396|NCT01957553|4407849|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
1339397|NCT01957553|4407850|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
1339398|NCT01957488|4407856|P6|Test Period 3|Lack of Efficacy|0
1339399|NCT01957488|4407857|P5|Test Period 3|Lack of Efficacy|0
1339400|NCT01957488|4407858|P4|Test Period 3|Lack of Efficacy|0
1339401|NCT01957488|4407859|P3|Test Period 3|Lack of Efficacy|0
1339402|NCT01957488|4407860|P2|Test Period 3|Lack of Efficacy|1
1339403|NCT01957488|4407861|P1|Test Period 3|Lack of Efficacy|0
1339404|NCT01957488|4407856|P6|Test Period 3|Withdrawal by Subject|0
1339405|NCT01957488|4407857|P5|Test Period 3|Withdrawal by Subject|0
1339406|NCT01957488|4407858|P4|Test Period 3|Withdrawal by Subject|0
1339407|NCT01957488|4407859|P3|Test Period 3|Withdrawal by Subject|0
1339408|NCT01957488|4407860|P2|Test Period 3|Withdrawal by Subject|0
1339409|NCT01957488|4407861|P1|Test Period 3|Withdrawal by Subject|1
1339410|NCT01957488|4407856|P6|Test Period 2|Discontinue due to personal problems|1
1339411|NCT01957488|4407857|P5|Test Period 2|Discontinue due to personal problems|0
1339412|NCT01957488|4407858|P4|Test Period 2|Discontinue due to personal problems|0
1339413|NCT01957488|4407859|P3|Test Period 2|Discontinue due to personal problems|0
1339414|NCT01957488|4407860|P2|Test Period 2|Discontinue due to personal problems|0
1339415|NCT01957488|4407861|P1|Test Period 2|Discontinue due to personal problems|0
1339416|NCT01957488|4407856|P6|Test Period 2|Adverse Event|0
1339417|NCT01957488|4407857|P5|Test Period 2|Adverse Event|2
1339418|NCT01957488|4407858|P4|Test Period 2|Adverse Event|0
1339419|NCT01957488|4407859|P3|Test Period 2|Adverse Event|0
1339420|NCT01957488|4407860|P2|Test Period 2|Adverse Event|0
1339421|NCT01957488|4407861|P1|Test Period 2|Adverse Event|0
1339422|NCT01957488|4407856|P6|Test Period 2|Withdrawal by Subject|0
1339423|NCT01957488|4407857|P5|Test Period 2|Withdrawal by Subject|0
1339424|NCT01957488|4407858|P4|Test Period 2|Withdrawal by Subject|0
1339425|NCT01957488|4407859|P3|Test Period 2|Withdrawal by Subject|0
1339426|NCT01957488|4407860|P2|Test Period 2|Withdrawal by Subject|1
1339427|NCT01957488|4407861|P1|Test Period 2|Withdrawal by Subject|0
1339428|NCT01957488|4407856|P6|Test Period 2|Other|0
1339429|NCT01957488|4407857|P5|Test Period 2|Other|0
1339430|NCT01957488|4407858|P4|Test Period 2|Other|0
1339431|NCT01957488|4407859|P3|Test Period 2|Other|0
1339432|NCT01957488|4407860|P2|Test Period 2|Other|0
1339433|NCT01957488|4407861|P1|Test Period 2|Other|1
1339434|NCT01957488|4407856|P6|Test Period 2|Protocol Violation|0
1339435|NCT01957488|4407857|P5|Test Period 2|Protocol Violation|0
1339436|NCT01957488|4407858|P4|Test Period 2|Protocol Violation|1
1339437|NCT01957488|4407859|P3|Test Period 2|Protocol Violation|1
1339438|NCT01957488|4407860|P2|Test Period 2|Protocol Violation|0
1339439|NCT01957488|4407861|P1|Test Period 2|Protocol Violation|2
1339440|NCT01957488|4407856|P6|Test Period 1|screen failure|1
1339441|NCT01957488|4407857|P5|Test Period 1|screen failure|0
1339442|NCT01957488|4407858|P4|Test Period 1|screen failure|0
1339443|NCT01957488|4407859|P3|Test Period 1|screen failure|0
1339444|NCT01957488|4407860|P2|Test Period 1|screen failure|0
1339445|NCT01957488|4407861|P1|Test Period 1|screen failure|0
1339446|NCT01957488|4407856|P6|Test Period 1|subject did not want to wait for cut bag|0
1339447|NCT01957488|4407857|P5|Test Period 1|subject did not want to wait for cut bag|1
1339448|NCT01957488|4407858|P4|Test Period 1|subject did not want to wait for cut bag|0
1339449|NCT01957488|4407859|P3|Test Period 1|subject did not want to wait for cut bag|0
1339450|NCT01957488|4407860|P2|Test Period 1|subject did not want to wait for cut bag|0
1339451|NCT01957488|4407861|P1|Test Period 1|subject did not want to wait for cut bag|0
1339452|NCT01957488|4407856|P6|Test Period 1|Withdrawal by Subject|2
1339453|NCT01957488|4407857|P5|Test Period 1|Withdrawal by Subject|1
1339454|NCT01957488|4407858|P4|Test Period 1|Withdrawal by Subject|1
1339455|NCT01957488|4407859|P3|Test Period 1|Withdrawal by Subject|0
1339456|NCT01957488|4407860|P2|Test Period 1|Withdrawal by Subject|0
1339457|NCT01957488|4407861|P1|Test Period 1|Withdrawal by Subject|0
1339458|NCT01957488|4407856|P6|Test Period 1|Adverse Event|0
1339459|NCT01957488|4407857|P5|Test Period 1|Adverse Event|1
1339460|NCT01957488|4407858|P4|Test Period 1|Adverse Event|0
1339461|NCT01957488|4407859|P3|Test Period 1|Adverse Event|1
1339462|NCT01957488|4407860|P2|Test Period 1|Adverse Event|1
1339463|NCT01957488|4407861|P1|Test Period 1|Adverse Event|0
1339464|NCT01957488|4407856|P6|Test Period 1|Protocol Violation|3
1339465|NCT01957488|4407857|P5|Test Period 1|Protocol Violation|0
1339466|NCT01957488|4407858|P4|Test Period 1|Protocol Violation|1
1339467|NCT01957488|4407859|P3|Test Period 1|Protocol Violation|2
1339468|NCT01957488|4407860|P2|Test Period 1|Protocol Violation|2
1339469|NCT01957488|4407861|P1|Test Period 1|Protocol Violation|1
1339470|NCT01957488|4407856|P6|Test Period 1|Lost to Follow-up|0
1339471|NCT01957488|4407857|P5|Test Period 1|Lost to Follow-up|0
1339472|NCT01957488|4407858|P4|Test Period 1|Lost to Follow-up|1
1339473|NCT01957488|4407859|P3|Test Period 1|Lost to Follow-up|1
1339474|NCT01957488|4407860|P2|Test Period 1|Lost to Follow-up|0
1339475|NCT01957488|4407861|P1|Test Period 1|Lost to Follow-up|2
1339476|NCT01957475|4407869|P2|Test Period 2|Adverse Event|0
1339477|NCT01957475|4407870|P1|Test Period 2|Adverse Event|1
1339478|NCT01957475|4407869|P2|Test Period 1|Lack of Efficacy|1
1339479|NCT01957475|4407870|P1|Test Period 1|Lack of Efficacy|0
1339480|NCT01957475|4407869|P2|Test Period 1|Other|0
1339481|NCT01957475|4407870|P1|Test Period 1|Other|1
1339482|NCT01957475|4407869|P2|Test Period 1|Withdrawal by Subject|0
1339483|NCT01957475|4407870|P1|Test Period 1|Withdrawal by Subject|1
1339484|NCT01957462|4407876|P2|Test Period 1|Adverse Event|0
1339485|NCT01957462|4407877|P1|Test Period 1|Adverse Event|1
1339486|NCT01957462|4407876|P2|Test Period 1|Withdrawal by Subject|0
1339487|NCT01957462|4407877|P1|Test Period 1|Withdrawal by Subject|1
1339488|NCT01957397|4407888|P2|Test Period 3|the adhesive did not work|0
1339489|NCT01957397|4407889|P1|Test Period 3|the adhesive did not work|1
1339490|NCT01957397|4407888|P2|Test Period 3|Adverse Event|2
1339491|NCT01957397|4407889|P1|Test Period 3|Adverse Event|1
1339492|NCT01957397|4407888|P2|Test Period 2|Adverse Event|1
1339493|NCT01957397|4407889|P1|Test Period 2|Adverse Event|0
1339494|NCT01957397|4407888|P2|Test Period 1|Withdrawal by Subject|0
1339495|NCT01957397|4407889|P1|Test Period 1|Withdrawal by Subject|1
1339496|NCT01957397|4407888|P2|Test Period 1|sudden leakage/small bag|1
1339497|NCT01957397|4407889|P1|Test Period 1|sudden leakage/small bag|1
1339498|NCT01957215|4407914|P2|Overall Study|Withdrawal by Subject|5
1339499|NCT01957215|4407915|P1|Overall Study|Withdrawal by Subject|7
1339500|NCT01957215|4407914|P2|Overall Study|Protocol Violation|2
1339501|NCT01957215|4407915|P1|Overall Study|Protocol Violation|1
1339502|NCT01957215|4407914|P2|Overall Study|Lost to Follow-up|3
1339503|NCT01957215|4407915|P1|Overall Study|Lost to Follow-up|3
1339504|NCT01957215|4407914|P2|Overall Study|Adverse Event|2
1339505|NCT01957215|4407915|P1|Overall Study|Adverse Event|2
1339506|NCT01957202|4407943|P18|Treatment Period 3 (8 Days)|Adverse Event|0
1339507|NCT01957202|4407944|P17|Treatment Period 3 (8 Days)|Adverse Event|1
1339508|NCT01957202|4407945|P16|Treatment Period 3 (8 Days)|Adverse Event|0
1339509|NCT01957202|4407946|P15|Treatment Period 3 (8 Days)|Adverse Event|0
1339510|NCT01957202|4407947|P14|Treatment Period 3 (8 Days)|Adverse Event|0
1339511|NCT01957202|4407948|P13|Treatment Period 3 (8 Days)|Adverse Event|0
1339512|NCT01957202|4407949|P12|Treatment Period 3 (8 Days)|Adverse Event|0
1339513|NCT01957202|4407950|P11|Treatment Period 3 (8 Days)|Adverse Event|0
1339514|NCT01957202|4407951|P10|Treatment Period 3 (8 Days)|Adverse Event|0
1339515|NCT01957202|4407952|P9|Treatment Period 3 (8 Days)|Adverse Event|0
1339516|NCT01957202|4407953|P8|Treatment Period 3 (8 Days)|Adverse Event|0
1339517|NCT01957202|4407954|P7|Treatment Period 3 (8 Days)|Adverse Event|0
1339518|NCT01957202|4407955|P6|Treatment Period 3 (8 Days)|Adverse Event|0
1339519|NCT01957202|4407956|P5|Treatment Period 3 (8 Days)|Adverse Event|0
1339520|NCT01957202|4407957|P4|Treatment Period 3 (8 Days)|Adverse Event|0
1339521|NCT01957202|4407958|P3|Treatment Period 3 (8 Days)|Adverse Event|0
1339522|NCT01957202|4407959|P2|Treatment Period 3 (8 Days)|Adverse Event|0
1339523|NCT01957202|4407960|P1|Treatment Period 3 (8 Days)|Adverse Event|0
1339524|NCT01957202|4407943|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339525|NCT01957202|4407944|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
1339526|NCT01957202|4407945|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339527|NCT01957202|4407946|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339528|NCT01957202|4407947|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339529|NCT01957202|4407948|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339530|NCT01957202|4407949|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339531|NCT01957202|4407950|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339532|NCT01957202|4407951|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339533|NCT01957202|4407952|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339534|NCT01957202|4407953|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339535|NCT01957202|4407954|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339536|NCT01957202|4407955|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339537|NCT01957202|4407956|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339538|NCT01957202|4407957|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339539|NCT01957202|4407958|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339540|NCT01957202|4407959|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
1339541|NCT01957202|4407960|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1339542|NCT01957163|4407985|P3|Overall Study|Withdrawal by Subject|4
1339543|NCT01957163|4407986|P2|Overall Study|Withdrawal by Subject|2
1339544|NCT01957163|4407987|P1|Overall Study|Withdrawal by Subject|4
1339545|NCT01957163|4407985|P3|Overall Study|Lost to Follow-up|0
1339546|NCT01957163|4407986|P2|Overall Study|Lost to Follow-up|1
1339547|NCT01957163|4407987|P1|Overall Study|Lost to Follow-up|0
1339548|NCT01957163|4407985|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
1339549|NCT01957163|4407986|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
1339550|NCT01957163|4407987|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
1339551|NCT01957163|4407985|P3|Overall Study|Protocol Violation|0
1339552|NCT01957163|4407986|P2|Overall Study|Protocol Violation|2
1339553|NCT01957163|4407987|P1|Overall Study|Protocol Violation|1
1339554|NCT01957163|4407985|P3|Overall Study|Lack of Efficacy|9
1339555|NCT01957163|4407986|P2|Overall Study|Lack of Efficacy|4
1339556|NCT01957163|4407987|P1|Overall Study|Lack of Efficacy|5
1339557|NCT01957163|4407985|P3|Overall Study|Adverse Event|4
1339558|NCT01957163|4407986|P2|Overall Study|Adverse Event|2
1339559|NCT01957163|4407987|P1|Overall Study|Adverse Event|5
1339560|NCT01957137|4407998|P1|Randomized Portion|Withdrawal by Subject|1
1339561|NCT01957137|4407998|P1|Randomized Portion|Adverse Event|1
1339562|NCT01957111|4408028|P2|Overall Study|Withdrawal by Subject|1
1339563|NCT01957111|4408029|P1|Overall Study|Withdrawal by Subject|1
1339564|NCT01956240|4408047|P2|Overall Study|Adverse Event|4
1339565|NCT01956240|4408048|P1|Overall Study|Adverse Event|17
1339566|NCT01956240|4408047|P2|Overall Study|Lost to Follow-up|20
1339567|NCT01956240|4408048|P1|Overall Study|Lost to Follow-up|6
1339568|NCT01955733|4408137|P3|Period 2|Other not defined above|2
1339569|NCT01955733|4408138|P2|Period 2|Other not defined above|2
1339570|NCT01955733|4408139|P1|Period 2|Other not defined above|0
1339571|NCT01955733|4408137|P3|Period 2|Lost to Follow-up|0
1339572|NCT01955733|4408138|P2|Period 2|Lost to Follow-up|0
1339573|NCT01955733|4408139|P1|Period 2|Lost to Follow-up|2
1339574|NCT01955733|4408137|P3|Period 2|Study terminated by sponsor|16
1339575|NCT01955733|4408138|P2|Period 2|Study terminated by sponsor|14
1339576|NCT01955733|4408139|P1|Period 2|Study terminated by sponsor|8
1339577|NCT01955733|4408137|P3|Period 2|Withdrawal by Subject|2
1339578|NCT01955733|4408138|P2|Period 2|Withdrawal by Subject|3
1339579|NCT01955733|4408139|P1|Period 2|Withdrawal by Subject|1
1339580|NCT01955733|4408137|P3|Period 2|Physician Decision|1
1339581|NCT01955733|4408138|P2|Period 2|Physician Decision|0
1339582|NCT01955733|4408139|P1|Period 2|Physician Decision|0
1339583|NCT01955733|4408137|P3|Period 2|Adverse Event|0
1339584|NCT01955733|4408138|P2|Period 2|Adverse Event|0
1339585|NCT01955733|4408139|P1|Period 2|Adverse Event|1
1339586|NCT01955733|4408137|P3|Period 1|Lost to Follow-up|0
1339587|NCT01955733|4408138|P2|Period 1|Lost to Follow-up|0
1339588|NCT01955733|4408139|P1|Period 1|Lost to Follow-up|1
1339589|NCT01955707|4408232|P2|Overall Study|Not Specified|2
1339590|NCT01955707|4408233|P1|Overall Study|Not Specified|4
1339591|NCT01955707|4408232|P2|Overall Study|Death|14
1339592|NCT01955707|4408233|P1|Overall Study|Death|13
1339593|NCT01955707|4408232|P2|Overall Study|Withdrawal by Subject|3
1339594|NCT01955707|4408233|P1|Overall Study|Withdrawal by Subject|0
1339595|NCT01955707|4408232|P2|Overall Study|Lost to Follow-up|1
1339596|NCT01955707|4408233|P1|Overall Study|Lost to Follow-up|2
1339597|NCT01955707|4408232|P2|Overall Study|Adverse Event|2
1339598|NCT01955707|4408233|P1|Overall Study|Adverse Event|1
1339599|NCT01955161|4408501|P3|Overall Study|Other reason: patient's will|1
1339600|NCT01955161|4408502|P2|Overall Study|Other reason: patient's will|0
1339601|NCT01955161|4408503|P1|Overall Study|Other reason: patient's will|0
1339602|NCT01955161|4408501|P3|Overall Study|Other reason: primary biliary cirrhosis|0
1339603|NCT01955161|4408502|P2|Overall Study|Other reason: primary biliary cirrhosis|0
1339604|NCT01955161|4408503|P1|Overall Study|Other reason: primary biliary cirrhosis|1
1339605|NCT01955161|4408501|P3|Overall Study|Other reason: insufficient compliance|1
1339606|NCT01955161|4408502|P2|Overall Study|Other reason: insufficient compliance|0
1339607|NCT01955161|4408503|P1|Overall Study|Other reason: insufficient compliance|0
1339608|NCT01955161|4408501|P3|Overall Study|Other reason: moved to nursing home|0
1339609|NCT01955161|4408502|P2|Overall Study|Other reason: moved to nursing home|1
1339610|NCT01955161|4408503|P1|Overall Study|Other reason: moved to nursing home|0
1339611|NCT01955161|4408501|P3|Overall Study|Other reason: caregiver unavailable|0
1339612|NCT01955161|4408502|P2|Overall Study|Other reason: caregiver unavailable|0
1339613|NCT01955161|4408503|P1|Overall Study|Other reason: caregiver unavailable|1
1339614|NCT01955161|4408501|P3|Overall Study|Other reason: disallowed medication|1
1339615|NCT01955161|4408502|P2|Overall Study|Other reason: disallowed medication|0
1339616|NCT01955161|4408503|P1|Overall Study|Other reason: disallowed medication|1
1339617|NCT01955161|4408501|P3|Overall Study|Other reason: physician decision|1
1339618|NCT01955161|4408502|P2|Overall Study|Other reason: physician decision|1
1339619|NCT01955161|4408503|P1|Overall Study|Other reason: physician decision|0
1339620|NCT01955161|4408501|P3|Overall Study|Protocol Violation|0
1339621|NCT01955161|4408502|P2|Overall Study|Protocol Violation|0
1339622|NCT01955161|4408503|P1|Overall Study|Protocol Violation|2
1339623|NCT01955161|4408501|P3|Overall Study|Withdrawal by Subject|12
1339624|NCT01955161|4408502|P2|Overall Study|Withdrawal by Subject|8
1339625|NCT01955161|4408503|P1|Overall Study|Withdrawal by Subject|9
1339626|NCT01955161|4408501|P3|Overall Study|Death|3
1339627|NCT01955161|4408502|P2|Overall Study|Death|1
1339628|NCT01955161|4408503|P1|Overall Study|Death|1
1339629|NCT01955161|4408501|P3|Overall Study|Adverse Event|15
1339630|NCT01955161|4408502|P2|Overall Study|Adverse Event|14
1339631|NCT01955161|4408503|P1|Overall Study|Adverse Event|10
1339632|NCT01955161|4408501|P3|Overall Study|Withdrawal before treatment|1
1339633|NCT01955161|4408502|P2|Overall Study|Withdrawal before treatment|0
1339634|NCT01955161|4408503|P1|Overall Study|Withdrawal before treatment|2
1339635|NCT01955122|4408543|P2|Overall Study|Physician Decision|5
1339636|NCT01955122|4408544|P1|Overall Study|Physician Decision|5
1339637|NCT01955083|4408564|P2|Overall Study|Lost to Follow-up|1
1339638|NCT01955083|4408565|P1|Overall Study|Lost to Follow-up|1
1339639|NCT01955044|4408598|P3|Overall Study|Death|0
1339640|NCT01955044|4408599|P2|Overall Study|Death|1
1339641|NCT01955044|4408600|P1|Overall Study|Death|1
1339642|NCT01955005|4408613|P2|Overall Study|Withdrawal by Subject|5
1339643|NCT01955005|4408614|P1|Overall Study|Withdrawal by Subject|3
1339644|NCT01954771|4408627|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
1339645|NCT01954771|4408628|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
1339646|NCT01954771|4408629|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
1339647|NCT01954771|4408627|P3|Overall Study|Missing CGMS of end-point|0
1339648|NCT01954771|4408628|P2|Overall Study|Missing CGMS of end-point|1
1339649|NCT01954771|4408629|P1|Overall Study|Missing CGMS of end-point|1
1339650|NCT01954771|4408627|P3|Overall Study|Missing HbA1c of end-point|0
1339651|NCT01954771|4408628|P2|Overall Study|Missing HbA1c of end-point|1
1339652|NCT01954771|4408629|P1|Overall Study|Missing HbA1c of end-point|1
1339653|NCT01954745|4408646|P1|Overall Study|Death|1
1339654|NCT01954745|4408646|P1|Overall Study|Adverse Event|2
1339655|NCT01954745|4408646|P1|Overall Study|Clinical Progression|5
1339656|NCT01954745|4408646|P1|Overall Study|Radiological Progression|11
1339657|NCT01954394|4408677|P2|Overall Study|Other than specified above|21
1339658|NCT01954394|4408678|P1|Overall Study|Other than specified above|10
1339659|NCT01954394|4408677|P2|Overall Study|Related to Study Drug administration|2
1339660|NCT01954394|4408678|P1|Overall Study|Related to Study Drug administration|2
1339661|NCT01954394|4408677|P2|Overall Study|Participant Moved|4
1339662|NCT01954394|4408678|P1|Overall Study|Participant Moved|0
1339663|NCT01954394|4408677|P2|Overall Study|Poor compliance to protocol|7
1339664|NCT01954394|4408678|P1|Overall Study|Poor compliance to protocol|7
1339665|NCT01954394|4408677|P2|Overall Study|Adverse Event|23
1339666|NCT01954394|4408678|P1|Overall Study|Adverse Event|10
1339667|NCT01954394|4408677|P2|Overall Study|Enrolled but not treated|0
1339668|NCT01954394|4408678|P1|Overall Study|Enrolled but not treated|1
1339669|NCT01954251|4408730|P2|Overall Study|Withdrawal by Subject|6
1339670|NCT01954251|4408731|P1|Overall Study|Withdrawal by Subject|2
1339671|NCT01954251|4408730|P2|Overall Study|Lost to Follow-up|6
1339672|NCT01954251|4408731|P1|Overall Study|Lost to Follow-up|6
1339673|NCT01954251|4408730|P2|Overall Study|Adverse Event|7
1339674|NCT01954251|4408731|P1|Overall Study|Adverse Event|5
1339675|NCT01954121|4408828|P2|Overall Study|Subject did not follow instructions|2
1339676|NCT01954121|4408829|P1|Overall Study|Subject did not follow instructions|0
1339677|NCT01954121|4408828|P2|Overall Study|Non-compliant patient|1
1339678|NCT01954121|4408829|P1|Overall Study|Non-compliant patient|1
1339679|NCT01954121|4408828|P2|Overall Study|Non-compliant with study procedures|0
1339680|NCT01954121|4408829|P1|Overall Study|Non-compliant with study procedures|1
1339681|NCT01954121|4408828|P2|Overall Study|SAE, non-fatal|4
1339682|NCT01954121|4408829|P1|Overall Study|SAE, non-fatal|1
1339683|NCT01954121|4408828|P2|Overall Study|AE, non-serious non-fatal|22
1339684|NCT01954121|4408829|P1|Overall Study|AE, non-serious non-fatal|5
1339685|NCT01954121|4408828|P2|Overall Study|AE, serious fatal|0
1339686|NCT01954121|4408829|P1|Overall Study|AE, serious fatal|1
1339687|NCT01954121|4408828|P2|Overall Study|Pregnancy|1
1339688|NCT01954121|4408829|P1|Overall Study|Pregnancy|1
1339689|NCT01954121|4408828|P2|Overall Study|Withdrawal by Subject|12
1339690|NCT01954121|4408829|P1|Overall Study|Withdrawal by Subject|18
1339691|NCT01954121|4408828|P2|Overall Study|Lost to Follow-up|6
1339692|NCT01954121|4408829|P1|Overall Study|Lost to Follow-up|5
1339693|NCT01954121|4408828|P2|Overall Study|Protocol Violation|2
1339694|NCT01954121|4408829|P1|Overall Study|Protocol Violation|0
1339695|NCT01954121|4408828|P2|Overall Study|Lack of Efficacy|41
1339696|NCT01954121|4408829|P1|Overall Study|Lack of Efficacy|94
1339697|NCT01953354|4408891|P2|Overall Study|Disease Exacerbation|0
1339698|NCT01953354|4408892|P1|Overall Study|Disease Exacerbation|1
1339699|NCT01953354|4408891|P2|Overall Study|Decision of Sponsor|1
1339700|NCT01953354|4408892|P1|Overall Study|Decision of Sponsor|0
1339701|NCT01953354|4408891|P2|Overall Study|Withdrawal by Subject|1
1339702|NCT01953354|4408892|P1|Overall Study|Withdrawal by Subject|0
1339703|NCT01953328|4408920|P8|Overall Study|Lost to Follow-up|0
1339704|NCT01953328|4408921|P7|Overall Study|Lost to Follow-up|0
1339705|NCT01953328|4408922|P6|Overall Study|Lost to Follow-up|0
1339706|NCT01953328|4408923|P5|Overall Study|Lost to Follow-up|1
1339707|NCT01953328|4408924|P4|Overall Study|Lost to Follow-up|0
1339708|NCT01953328|4408925|P3|Overall Study|Lost to Follow-up|0
1339709|NCT01953328|4408926|P2|Overall Study|Lost to Follow-up|0
1339710|NCT01953328|4408927|P1|Overall Study|Lost to Follow-up|0
1339711|NCT01953328|4408920|P8|Overall Study|Withdrawal by Subject|0
1339712|NCT01953328|4408921|P7|Overall Study|Withdrawal by Subject|0
1339713|NCT01953328|4408922|P6|Overall Study|Withdrawal by Subject|0
1339714|NCT01953328|4408923|P5|Overall Study|Withdrawal by Subject|1
1339715|NCT01953328|4408924|P4|Overall Study|Withdrawal by Subject|0
1339716|NCT01953328|4408925|P3|Overall Study|Withdrawal by Subject|0
1339717|NCT01953328|4408926|P2|Overall Study|Withdrawal by Subject|0
1339718|NCT01953328|4408927|P1|Overall Study|Withdrawal by Subject|0
1339719|NCT01953224|4409140|P2|Overall Study|Withdrawal by Subject|2
1339720|NCT01953224|4409141|P1|Overall Study|Withdrawal by Subject|1
1339721|NCT01953224|4409140|P2|Overall Study|Lost to Follow-up|1
1339722|NCT01953224|4409141|P1|Overall Study|Lost to Follow-up|1
1339723|NCT01952834|4409176|P1|Overall Study|Adverse Event|1
1339724|NCT01952691|4409183|P1|Overall Study|Lost to Follow-up|2
1339725|NCT01952665|4409210|P2|Overall Study|Protocol Violation|1
1339726|NCT01952665|4409211|P1|Overall Study|Protocol Violation|0
1339727|NCT01952665|4409210|P2|Overall Study|Adverse Event|1
1339728|NCT01952665|4409211|P1|Overall Study|Adverse Event|2
1339729|NCT01952665|4409210|P2|Overall Study|Lost to Follow-up|2
1339730|NCT01952665|4409211|P1|Overall Study|Lost to Follow-up|1
1339731|NCT01952665|4409210|P2|Overall Study|Physician Decision|2
1339732|NCT01952665|4409211|P1|Overall Study|Physician Decision|3
1339733|NCT01952574|4409366|P4|Overall Study|Lost to Follow-up|0
1339734|NCT01952574|4409367|P3|Overall Study|Lost to Follow-up|1
1339735|NCT01952574|4409368|P2|Overall Study|Lost to Follow-up|0
1339736|NCT01952574|4409369|P1|Overall Study|Lost to Follow-up|2
1339737|NCT01952574|4409366|P4|Overall Study|Sponsor Decision|2
1339738|NCT01952574|4409367|P3|Overall Study|Sponsor Decision|5
1339739|NCT01952574|4409368|P2|Overall Study|Sponsor Decision|0
1339740|NCT01952574|4409369|P1|Overall Study|Sponsor Decision|6
1339741|NCT01952574|4409366|P4|Overall Study|Withdrawal by Subject|4
1339742|NCT01952574|4409367|P3|Overall Study|Withdrawal by Subject|3
1339743|NCT01952574|4409368|P2|Overall Study|Withdrawal by Subject|3
1339744|NCT01952574|4409369|P1|Overall Study|Withdrawal by Subject|9
1339745|NCT01952366|4409402|P1|Overall Study|Withdrawal by Subject|9
1339746|NCT01952366|4409402|P1|Overall Study|Death|22
1339747|NCT01952145|4409417|P2|Overall Study|Unclassified|1
1339748|NCT01952145|4409418|P1|Overall Study|Unclassified|1
1339749|NCT01952145|4409417|P2|Overall Study|Withdrawal Criteria|11
1339750|NCT01952145|4409418|P1|Overall Study|Withdrawal Criteria|16
1339751|NCT01952145|4409417|P2|Overall Study|Adverse Event|0
1339752|NCT01952145|4409418|P1|Overall Study|Adverse Event|9
1339753|NCT01952145|4409417|P2|Overall Study|Death|1
1339754|NCT01952145|4409418|P1|Overall Study|Death|0
1339755|NCT01952145|4409417|P2|Overall Study|Protocol Violation|1
1339756|NCT01952145|4409418|P1|Overall Study|Protocol Violation|2
1339757|NCT01952080|4409432|P4|Overall Study|Protocol Non-compliance|0
1339758|NCT01952080|4409433|P3|Overall Study|Protocol Non-compliance|0
1339759|NCT01952080|4409434|P2|Overall Study|Protocol Non-compliance|1
1339760|NCT01952080|4409435|P1|Overall Study|Protocol Non-compliance|0
1339761|NCT01952080|4409432|P4|Overall Study|Withdrawal by Subject|1
1339762|NCT01952080|4409433|P3|Overall Study|Withdrawal by Subject|0
1339763|NCT01952080|4409434|P2|Overall Study|Withdrawal by Subject|0
1339764|NCT01952080|4409435|P1|Overall Study|Withdrawal by Subject|0
1339765|NCT01951703|4409514|P2|Second Intervention|Unsatisfactory Lens fitting|1
1339766|NCT01951703|4409515|P1|Second Intervention|Unsatisfactory Lens fitting|0
1339767|NCT01951703|4409514|P2|Second Intervention|Protocol Violation|1
1339768|NCT01951703|4409515|P1|Second Intervention|Protocol Violation|0
1339769|NCT01951703|4409514|P2|First Intervention|Physician Decision|0
1339770|NCT01951703|4409515|P1|First Intervention|Physician Decision|1
1339771|NCT01951703|4409514|P2|First Intervention|Subject was not compliant|1
1339772|NCT01951703|4409515|P1|First Intervention|Subject was not compliant|1
1339773|NCT01951703|4409514|P2|First Intervention|Withdrawal by Subject|0
1339774|NCT01951703|4409515|P1|First Intervention|Withdrawal by Subject|1
1339775|NCT01951586|4409540|P2|Overall Study|Withdrawal by Subject|13
1339776|NCT01951586|4409541|P1|Overall Study|Withdrawal by Subject|7
1339777|NCT01951586|4409540|P2|Overall Study|Death|100
1339778|NCT01951586|4409541|P1|Overall Study|Death|52
1339779|NCT01951573|4409565|P2|Washout Period|Adverse Event|1
1339780|NCT01951573|4409566|P1|Washout Period|Adverse Event|0
1339781|NCT01951417|4409576|P1|Overall Study|Lost to Follow-up|6
1339782|NCT01951417|4409576|P1|Overall Study|Protocol Violation|2
1339783|NCT01951417|4409576|P1|Overall Study|Withdrawal by Subject|1
1339784|NCT01951170|4409599|P1|Overall Study|Investigator decision|1
1339785|NCT01951092|4409622|P1|Overall Study|Transfer of Care|1
1339786|NCT01951092|4409622|P1|Overall Study|Incarceration|1
1339787|NCT01951092|4409622|P1|Overall Study|Lost to Follow-up|10
1339788|NCT01950741|4409633|P1|Overall Study|Withdrawal by Subject|1
1339789|NCT01950741|4409633|P1|Overall Study|Death|1
1339790|NCT01950741|4409633|P1|Overall Study|Lost to Follow-up|1
1339791|NCT01950364|4409648|P2|Overall Study|Protocol Violation|1
1339792|NCT01950364|4409649|P1|Overall Study|Protocol Violation|0
1339793|NCT01950364|4409648|P2|Overall Study|Withdrawal by Subject|1
1339794|NCT01950364|4409649|P1|Overall Study|Withdrawal by Subject|0
1339795|NCT01950364|4409648|P2|Overall Study|Disease Progression|2
1339796|NCT01950364|4409649|P1|Overall Study|Disease Progression|5
1339797|NCT01950364|4409648|P2|Overall Study|Stem Cell Transplant|6
1339798|NCT01950364|4409649|P1|Overall Study|Stem Cell Transplant|2
1339799|NCT01950364|4409648|P2|Overall Study|Adverse Event|0
1339800|NCT01950364|4409649|P1|Overall Study|Adverse Event|3
1339801|NCT01949870|4409758|P1|Overall Study|Eligibility requirements not fulfilled|2
1339802|NCT01949870|4409758|P1|Overall Study|Study termination|1
1339803|NCT01949870|4409758|P1|Overall Study|Adverse Event|1
1339804|NCT01949870|4409758|P1|Overall Study|Lack of Efficacy|2
1339805|NCT01949532|4409921|P2|Overall Study|On-study at the Data Cut-off Date|3
1339806|NCT01949532|4409922|P1|Overall Study|On-study at the Data Cut-off Date|3
1339807|NCT01949155|4409997|P2|Overall Study|Protocol Violation|0
1339808|NCT01949155|4409998|P1|Overall Study|Protocol Violation|1
1339809|NCT01949155|4409997|P2|Overall Study|Lost to Follow-up|0
1339810|NCT01949155|4409998|P1|Overall Study|Lost to Follow-up|1
1339811|NCT01949142|4410010|P2|Overall Study|Parent changed their mind|0
1339812|NCT01949142|4410011|P1|Overall Study|Parent changed their mind|1
1339813|NCT01949142|4410010|P2|Overall Study|Lost to Follow-up|1
1339814|NCT01949142|4410011|P1|Overall Study|Lost to Follow-up|1
1339815|NCT01949142|4410010|P2|Overall Study|Withdrawal of consent|0
1339816|NCT01949142|4410011|P1|Overall Study|Withdrawal of consent|1
1339817|NCT01949116|4410023|P2|Overall Study|Withdrawal by Subject|3
1339818|NCT01949116|4410024|P1|Overall Study|Withdrawal by Subject|5
1339819|NCT01949116|4410023|P2|Overall Study|Lost to Follow-up|3
1339820|NCT01949116|4410024|P1|Overall Study|Lost to Follow-up|1
1339821|NCT01949116|4410023|P2|Overall Study|Death|0
1339822|NCT01949116|4410024|P1|Overall Study|Death|2
1339823|NCT01949090|4410061|P5|Overall Study|Lost to Follow-up|1
1339824|NCT01949090|4410062|P4|Overall Study|Lost to Follow-up|1
1339825|NCT01949090|4410063|P3|Overall Study|Lost to Follow-up|0
1339826|NCT01949090|4410064|P2|Overall Study|Lost to Follow-up|1
1339827|NCT01949090|4410065|P1|Overall Study|Lost to Follow-up|2
1339828|NCT01949090|4410061|P5|Overall Study|Protocol non-compliance|1
1339829|NCT01949090|4410062|P4|Overall Study|Protocol non-compliance|0
1339830|NCT01949090|4410063|P3|Overall Study|Protocol non-compliance|0
1339831|NCT01949090|4410064|P2|Overall Study|Protocol non-compliance|0
1339832|NCT01949090|4410065|P1|Overall Study|Protocol non-compliance|0
1339833|NCT01949090|4410061|P5|Overall Study|Withdrawal by Subject|1
1339834|NCT01949090|4410062|P4|Overall Study|Withdrawal by Subject|0
1339835|NCT01949090|4410063|P3|Overall Study|Withdrawal by Subject|0
1339836|NCT01949090|4410064|P2|Overall Study|Withdrawal by Subject|0
1339837|NCT01949090|4410065|P1|Overall Study|Withdrawal by Subject|2
1339838|NCT01949090|4410061|P5|Overall Study|Serious Adverse Event|1
1339839|NCT01949090|4410062|P4|Overall Study|Serious Adverse Event|0
1339840|NCT01949090|4410063|P3|Overall Study|Serious Adverse Event|2
1339841|NCT01949090|4410064|P2|Overall Study|Serious Adverse Event|1
1339842|NCT01949090|4410065|P1|Overall Study|Serious Adverse Event|0
1339843|NCT01949051|4410242|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1339844|NCT01949051|4410243|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1339845|NCT01949051|4410244|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1339846|NCT01949051|4410245|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
1339847|NCT01949051|4410246|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1339848|NCT01949051|4410247|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1339849|NCT01949051|4410242|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1339850|NCT01949051|4410243|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1339851|NCT01949051|4410244|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1339852|NCT01949051|4410245|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1339853|NCT01949051|4410246|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
1339854|NCT01949051|4410247|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1339855|NCT01949051|4410242|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
1339856|NCT01949051|4410243|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
1339857|NCT01949051|4410244|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
1339858|NCT01949051|4410245|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
1339859|NCT01949051|4410246|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
1339860|NCT01949051|4410247|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
1339861|NCT01949051|4410242|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1339862|NCT01949051|4410243|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1339863|NCT01949051|4410244|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1339864|NCT01949051|4410245|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1339865|NCT01949051|4410246|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1339866|NCT01949051|4410247|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
1339867|NCT01949051|4410242|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
1339868|NCT01949051|4410243|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
1339869|NCT01949051|4410244|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
1339870|NCT01949051|4410245|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
1339871|NCT01949051|4410246|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
1339872|NCT01949051|4410247|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
1339873|NCT01948908|4410276|P3|Overall Study|Protocol Violation|2
1339874|NCT01948908|4410277|P2|Overall Study|Protocol Violation|0
1339875|NCT01948908|4410278|P1|Overall Study|Protocol Violation|1
1339876|NCT01948830|4410294|P2|Overall Study|Death|4
1339877|NCT01948830|4410295|P1|Overall Study|Death|3
1339878|NCT01948830|4410294|P2|Overall Study|Adverse Event|2
1339879|NCT01948830|4410295|P1|Overall Study|Adverse Event|9
1339880|NCT01948830|4410294|P2|Overall Study|Withdrawal by Subject|17
1339881|NCT01948830|4410295|P1|Overall Study|Withdrawal by Subject|14
1339882|NCT01948830|4410294|P2|Overall Study|Lost to Follow-up|4
1339883|NCT01948830|4410295|P1|Overall Study|Lost to Follow-up|5
1339884|NCT01948830|4410294|P2|Overall Study|Protocol deviation|2
1339885|NCT01948830|4410295|P1|Overall Study|Protocol deviation|1
1339886|NCT01948830|4410294|P2|Overall Study|Physician Decision|3
1339887|NCT01948830|4410295|P1|Overall Study|Physician Decision|1
1339888|NCT01948791|4410327|P1|Overall Study|Screening failure|35
1339889|NCT01948791|4410327|P1|Overall Study|Others|7
1339890|NCT01948791|4410327|P1|Overall Study|Management issues|1
1339891|NCT01948791|4410327|P1|Overall Study|Lost to Follow-up|6
1339892|NCT01948791|4410327|P1|Overall Study|Withdrawal by Subject|5
1339893|NCT01948791|4410327|P1|Overall Study|Protocol Violation|2
1339894|NCT01948791|4410327|P1|Overall Study|Lack of Efficacy|3
1339895|NCT01948791|4410327|P1|Overall Study|Adverse Event|12
1339896|NCT01948193|4410370|P1|Overall Study|Lost to Follow-up|7
1339897|NCT01948193|4410370|P1|Overall Study|Serious event|2
1339898|NCT01948076|4410392|P2|Overall Study|Withdrawal by Subject|1
1339899|NCT01948076|4410393|P1|Overall Study|Withdrawal by Subject|0
1339900|NCT01948063|4410403|P2|Overall Study|Blood samples were accidentally thawed|0
1339901|NCT01948063|4410404|P1|Overall Study|Blood samples were accidentally thawed|1
1339902|NCT01948063|4410403|P2|Overall Study|Discovered an enrollment in other study|1
1339903|NCT01948063|4410404|P1|Overall Study|Discovered an enrollment in other study|0
1339904|NCT01948063|4410403|P2|Overall Study|Boston MCI halted research protocol|1
1339905|NCT01948063|4410404|P1|Overall Study|Boston MCI halted research protocol|0
1339906|NCT01948050|4410412|P2|Overall Study|Withdrawal by Subject|1
1339907|NCT01948050|4410413|P1|Overall Study|Withdrawal by Subject|0
1339908|NCT01947855|4410481|P3|Overall Study|Withdrawal by Subject|0
1339909|NCT01947855|4410482|P2|Overall Study|Withdrawal by Subject|0
1339910|NCT01947855|4410483|P1|Overall Study|Withdrawal by Subject|1
1339911|NCT01947582|4410491|P1|Overall Study|Withdrawal by Subject|1
1339912|NCT01947517|4410500|P2|Overall Study|Withdrawal by Subject|1
1339913|NCT01947517|4410501|P1|Overall Study|Withdrawal by Subject|1
1339914|NCT01947491|4410519|P4|Overall Study|Adverse Event|2
1339915|NCT01947491|4410520|P3|Overall Study|Adverse Event|0
1339916|NCT01947491|4410521|P2|Overall Study|Adverse Event|1
1339917|NCT01947491|4410522|P1|Overall Study|Adverse Event|0
1339918|NCT01947491|4410519|P4|Overall Study|Worsening of condition|0
1339919|NCT01947491|4410520|P3|Overall Study|Worsening of condition|0
1339920|NCT01947491|4410521|P2|Overall Study|Worsening of condition|1
1339921|NCT01947491|4410522|P1|Overall Study|Worsening of condition|0
1339922|NCT01947491|4410519|P4|Overall Study|Withdrawal by Subject|0
1339923|NCT01947491|4410520|P3|Overall Study|Withdrawal by Subject|1
1339924|NCT01947491|4410521|P2|Overall Study|Withdrawal by Subject|1
1339925|NCT01947491|4410522|P1|Overall Study|Withdrawal by Subject|1
1339926|NCT01947491|4410519|P4|Overall Study|Protocol Violation|0
1339927|NCT01947491|4410520|P3|Overall Study|Protocol Violation|0
1339928|NCT01947491|4410521|P2|Overall Study|Protocol Violation|0
1339929|NCT01947491|4410522|P1|Overall Study|Protocol Violation|1
1339930|NCT01947491|4410519|P4|Overall Study|Lack of Efficacy|1
1339931|NCT01947491|4410520|P3|Overall Study|Lack of Efficacy|0
1339932|NCT01947491|4410521|P2|Overall Study|Lack of Efficacy|0
1339933|NCT01947491|4410522|P1|Overall Study|Lack of Efficacy|1
1339934|NCT01947491|4410519|P4|Overall Study|Lost to Follow-up|2
1339935|NCT01947491|4410520|P3|Overall Study|Lost to Follow-up|1
1339936|NCT01947491|4410521|P2|Overall Study|Lost to Follow-up|3
1339937|NCT01947491|4410522|P1|Overall Study|Lost to Follow-up|5
1339938|NCT01947127|4410566|P2|Overall Study|Data loss|4
1339939|NCT01947127|4410567|P1|Overall Study|Data loss|4
1339940|NCT01947127|4410566|P2|Overall Study|Withdrawal by Subject|1
1339941|NCT01947127|4410567|P1|Overall Study|Withdrawal by Subject|1
1339942|NCT01947127|4410566|P2|Overall Study|Protocol Violation|38
1339943|NCT01947127|4410567|P1|Overall Study|Protocol Violation|18
1339944|NCT01946529|4410591|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
1339945|NCT01946529|4410592|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
1339946|NCT01946529|4410593|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
1339947|NCT01946529|4410591|P3|End of Window Therapy (2 Courses)|Physician Decision|0
1339948|NCT01946529|4410592|P2|End of Window Therapy (2 Courses)|Physician Decision|1
1339949|NCT01946529|4410593|P1|End of Window Therapy (2 Courses)|Physician Decision|0
1339950|NCT01946438|4410604|P4|Overall Study|Withdrawal by Subject|0
1339951|NCT01946438|4410605|P3|Overall Study|Withdrawal by Subject|0
1339952|NCT01946438|4410606|P2|Overall Study|Withdrawal by Subject|0
1339953|NCT01946438|4410607|P1|Overall Study|Withdrawal by Subject|1
1339954|NCT01946438|4410604|P4|Overall Study|Protocol Violation|0
1339955|NCT01946438|4410605|P3|Overall Study|Protocol Violation|1
1339956|NCT01946438|4410606|P2|Overall Study|Protocol Violation|0
1339957|NCT01946438|4410607|P1|Overall Study|Protocol Violation|0
1339958|NCT01946438|4410604|P4|Overall Study|Serious Adverse event|0
1339959|NCT01946438|4410605|P3|Overall Study|Serious Adverse event|0
1339960|NCT01946438|4410606|P2|Overall Study|Serious Adverse event|0
1339961|NCT01946438|4410607|P1|Overall Study|Serious Adverse event|1
1339962|NCT01946438|4410604|P4|Overall Study|Adverse Event|1
1339963|NCT01946438|4410605|P3|Overall Study|Adverse Event|0
1339964|NCT01946438|4410606|P2|Overall Study|Adverse Event|0
1339965|NCT01946438|4410607|P1|Overall Study|Adverse Event|0
1339966|NCT01946425|4410635|P2|Overall Study|Withdrawal by Subject|0
1339967|NCT01946425|4410636|P1|Overall Study|Withdrawal by Subject|1
1339968|NCT01946425|4410635|P2|Overall Study|Protocol Violation|0
1339969|NCT01946425|4410636|P1|Overall Study|Protocol Violation|1
1339970|NCT01946412|4410650|P1|Overall Study|Difficulty in swallowing|1
1339971|NCT01946412|4410650|P1|Overall Study|Continued with commercial Kalydeco|2
1339972|NCT01946412|4410650|P1|Overall Study|Non-Compliance|1
1339973|NCT01946412|4410650|P1|Overall Study|Adverse Event|1
1339974|NCT01946204|4410695|P2|Overall Study|Other|3
1339975|NCT01946204|4410696|P1|Overall Study|Other|7
1339976|NCT01946204|4410695|P2|Overall Study|Ongoing|687
1339977|NCT01946204|4410696|P1|Overall Study|Ongoing|316
1339978|NCT01946204|4410695|P2|Overall Study|Lost to Follow-up|7
1339979|NCT01946204|4410696|P1|Overall Study|Lost to Follow-up|3
1339980|NCT01946204|4410695|P2|Overall Study|Withdrawal by Subject|50
1339981|NCT01946204|4410696|P1|Overall Study|Withdrawal by Subject|37
1339982|NCT01946204|4410695|P2|Overall Study|Death|59
1339983|NCT01946204|4410696|P1|Overall Study|Death|38
1339984|NCT01946178|4410712|P1|Overall Study|Lost to Follow-up|1
1339985|NCT01946178|4410712|P1|Overall Study|Pregnancy|1
1339986|NCT01945944|4410781|P2|Overall Study|Withdrawal by Subject|1
1339987|NCT01945944|4410782|P1|Overall Study|Withdrawal by Subject|0
1339988|NCT01945944|4410781|P2|Overall Study|Physician Decision|0
1339989|NCT01945944|4410782|P1|Overall Study|Physician Decision|1
1339990|NCT01945944|4410781|P2|Overall Study|Adverse Event|2
1339991|NCT01945944|4410782|P1|Overall Study|Adverse Event|0
1339992|NCT01945489|4410806|P2|Cycle 2|Lost to Follow-up|1
1339993|NCT01945489|4410807|P1|Cycle 2|Lost to Follow-up|0
1339994|NCT01945489|4410806|P2|Cycle 2|Adverse Event|0
1339995|NCT01945489|4410807|P1|Cycle 2|Adverse Event|1
1339996|NCT01945489|4410806|P2|Cycle 1|Other Miscellaneous Reasons|1
1339997|NCT01945489|4410807|P1|Cycle 1|Other Miscellaneous Reasons|3
1339998|NCT01945489|4410806|P2|Cycle 1|Protocol Violation|1
1339999|NCT01945489|4410807|P1|Cycle 1|Protocol Violation|0
1340000|NCT01945489|4410806|P2|Cycle 1|Personal Reasons|2
1340001|NCT01945489|4410807|P1|Cycle 1|Personal Reasons|4
1340002|NCT01945489|4410806|P2|Cycle 1|Lost to Follow-up|0
1340003|NCT01945489|4410807|P1|Cycle 1|Lost to Follow-up|4
1340004|NCT01945489|4410806|P2|Cycle 1|Adverse Event|0
1340005|NCT01945489|4410807|P1|Cycle 1|Adverse Event|2
1340006|NCT01945281|4410861|P2|Overall Study|Technical Problems|0
1340007|NCT01945281|4410862|P1|Overall Study|Technical Problems|1
1340008|NCT01945281|4410861|P2|Overall Study|Physician Decision|1
1340009|NCT01945281|4410862|P1|Overall Study|Physician Decision|1
1340010|NCT01945281|4410861|P2|Overall Study|Death|3
1340011|NCT01945281|4410862|P1|Overall Study|Death|3
1340012|NCT01945281|4410861|P2|Overall Study|Adverse Event|0
1340013|NCT01945281|4410862|P1|Overall Study|Adverse Event|1
1340014|NCT01945242|4410874|P2|Overall Study|Physician Decision|3
1340015|NCT01945242|4410875|P1|Overall Study|Physician Decision|3
1340016|NCT01945086|4410933|P3|Overall Study|Adverse Event|1
1340017|NCT01945086|4410934|P2|Overall Study|Adverse Event|0
1340018|NCT01945086|4410935|P1|Overall Study|Adverse Event|0
1340019|NCT01945086|4410933|P3|Overall Study|Withdrawal by Subject|1
1340020|NCT01945086|4410934|P2|Overall Study|Withdrawal by Subject|0
1340021|NCT01945086|4410935|P1|Overall Study|Withdrawal by Subject|1
1340022|NCT01945034|4410979|P3|Overall Study|Protocol Violation|1
1340023|NCT01945034|4410980|P2|Overall Study|Protocol Violation|0
1340024|NCT01945034|4410981|P1|Overall Study|Protocol Violation|1
1340025|NCT01945034|4410979|P3|Overall Study|Lost to Follow-up|2
1340026|NCT01945034|4410980|P2|Overall Study|Lost to Follow-up|0
1340027|NCT01945034|4410981|P1|Overall Study|Lost to Follow-up|0
1340028|NCT01945034|4410979|P3|Overall Study|Other|3
1340029|NCT01945034|4410980|P2|Overall Study|Other|1
1340030|NCT01945034|4410981|P1|Overall Study|Other|0
1340031|NCT01945034|4410979|P3|Overall Study|Withdrawal by Subject|1
1340032|NCT01945034|4410980|P2|Overall Study|Withdrawal by Subject|3
1340033|NCT01945034|4410981|P1|Overall Study|Withdrawal by Subject|0
1340034|NCT01945034|4410979|P3|Overall Study|Medication Error|0
1340035|NCT01945034|4410980|P2|Overall Study|Medication Error|1
1340036|NCT01945034|4410981|P1|Overall Study|Medication Error|0
1340037|NCT01945021|4411031|P1|Overall Study|Non-RECIST disease progression|1
1340038|NCT01945021|4411031|P1|Overall Study|Withdrawal of consent|3
1340039|NCT01945021|4411031|P1|Overall Study|Withdrawal by Subject|2
1340040|NCT01945021|4411031|P1|Overall Study|Global deterioration of health-related s|1
1340041|NCT01945021|4411031|P1|Overall Study|Disease progression by RECIST v1.1|30
1340042|NCT01945021|4411031|P1|Overall Study|Pregnancy|1
1340043|NCT01945021|4411031|P1|Overall Study|Death|1
1340044|NCT01945021|4411031|P1|Overall Study|Adverse Event|8
1340045|NCT01944969|4411045|P1|Overall Study|Administrative or other reasons|23
1340046|NCT01944969|4411045|P1|Overall Study|Non-compliance with IMP|1
1340047|NCT01944969|4411045|P1|Overall Study|Lack of Efficacy|1
1340048|NCT01944969|4411045|P1|Overall Study|Adverse Event|1
1340049|NCT01944839|4411069|P2|Overall Study|Subject non-compliance|3
1340050|NCT01944839|4411070|P1|Overall Study|Subject non-compliance|0
1340051|NCT01944839|4411069|P2|Overall Study|Lost to Follow-up|0
1340052|NCT01944839|4411070|P1|Overall Study|Lost to Follow-up|1
1340053|NCT01944839|4411069|P2|Overall Study|Withdrawal by Subject|17
1340054|NCT01944839|4411070|P1|Overall Study|Withdrawal by Subject|9
1340055|NCT01944839|4411069|P2|Overall Study|Adverse Event|5
1340056|NCT01944839|4411070|P1|Overall Study|Adverse Event|10
1340057|NCT01944839|4411069|P2|Overall Study|Protocol Violation|1
1340058|NCT01944839|4411070|P1|Overall Study|Protocol Violation|0
1340059|NCT01944839|4411069|P2|Overall Study|Physician Decision|2
1340060|NCT01944839|4411070|P1|Overall Study|Physician Decision|2
1340061|NCT01944774|4411079|P3|Overall Study|Lost to Follow-up|0
1340062|NCT01944774|4411080|P2|Overall Study|Lost to Follow-up|1
1340063|NCT01944774|4411081|P1|Overall Study|Lost to Follow-up|0
1340064|NCT01944774|4411079|P3|Overall Study|Lack of Efficacy|2
1340065|NCT01944774|4411080|P2|Overall Study|Lack of Efficacy|2
1340066|NCT01944774|4411081|P1|Overall Study|Lack of Efficacy|1
1340067|NCT01944774|4411079|P3|Overall Study|Adverse Event|3
1340068|NCT01944774|4411080|P2|Overall Study|Adverse Event|2
1340069|NCT01944774|4411081|P1|Overall Study|Adverse Event|3
1340070|NCT01944774|4411079|P3|Overall Study|Withdrawal by Subject|3
1340071|NCT01944774|4411080|P2|Overall Study|Withdrawal by Subject|3
1340072|NCT01944774|4411081|P1|Overall Study|Withdrawal by Subject|2
1340073|NCT01944722|4411124|P1|Overall Study|>ASCUS Cytology|1122
1340074|NCT01944722|4411124|P1|Overall Study|Unsatisfactory Cytology Result|63
1340075|NCT01944722|4411124|P1|Overall Study|NILM Subjects <30 years old|8106
1340076|NCT01944722|4411124|P1|Overall Study|Withdrawal by Subject|8
1340077|NCT01944722|4411124|P1|Overall Study|Specimens Mislabeled|2
1340078|NCT01944722|4411124|P1|Overall Study|Missing Specimens|3
1340079|NCT01944722|4411124|P1|Overall Study|Insufficient Volume for Test|1
1340080|NCT01944722|4411124|P1|Overall Study|Improper Storage/Transport|5
1340081|NCT01944722|4411124|P1|Overall Study|Specimen Shipping Issues|34
1340082|NCT01944722|4411124|P1|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
1340083|NCT01944670|4411158|P1|Overall Study|Lost to Follow-up|2
1340084|NCT01944631|4411165|P2|Overall Study|Withdrawal by Subject|1
1340085|NCT01944631|4411166|P1|Overall Study|Withdrawal by Subject|0
1340086|NCT01944631|4411165|P2|Overall Study|Lost to Follow-up|1
1340087|NCT01944631|4411166|P1|Overall Study|Lost to Follow-up|3
1340088|NCT01944631|4411165|P2|Overall Study|Adverse Event|0
1340089|NCT01944631|4411166|P1|Overall Study|Adverse Event|1
1340090|NCT01944462|4411182|P1|PPPP Educational Program|Lost to Follow-up|60
1340091|NCT01944098|4411212|P2|Overall Study|Physician Decision|0
1340092|NCT01944098|4411213|P1|Overall Study|Physician Decision|1
1340093|NCT01944059|4411225|P1|Overall Study|Adverse Event|2
1340094|NCT01944059|4411225|P1|Overall Study|Withdrawal by Subject|1
1340095|NCT01944059|4411225|P1|Overall Study|Physician Decision|3
1340096|NCT01944059|4411225|P1|Overall Study|Lost to Follow-up|1
1340097|NCT01943552|4411298|P2|Overall Study|Other Reasons|17
1340098|NCT01943552|4411299|P1|Overall Study|Other Reasons|16
1340099|NCT01943552|4411298|P2|Overall Study|Withdrawal by Subject|6
1340100|NCT01943552|4411299|P1|Overall Study|Withdrawal by Subject|6
1340101|NCT01943552|4411298|P2|Overall Study|Adverse Event|2
1340102|NCT01943552|4411299|P1|Overall Study|Adverse Event|3
1340103|NCT01943539|4411315|P2|Overall Study|Non-compliance with at-home intervention|0
1340104|NCT01943539|4411316|P1|Overall Study|Non-compliance with at-home intervention|4
1340105|NCT01943435|4411352|P3|6 Month Follow up|Lost to Follow-up|15
1340106|NCT01943435|4411353|P2|6 Month Follow up|Lost to Follow-up|7
1340107|NCT01943435|4411354|P1|6 Month Follow up|Lost to Follow-up|12
1340108|NCT01943435|4411352|P3|2 Month Follow up|Lost to Follow-up|0
1340109|NCT01943435|4411353|P2|2 Month Follow up|Lost to Follow-up|3
1340110|NCT01943435|4411354|P1|2 Month Follow up|Lost to Follow-up|2
1340111|NCT01943435|4411352|P3|Intervention Period|Withdrawal by Subject|4
1340112|NCT01943435|4411353|P2|Intervention Period|Withdrawal by Subject|3
1340113|NCT01943435|4411354|P1|Intervention Period|Withdrawal by Subject|3
1340114|NCT01943435|4411352|P3|Baseline Eligibility and Randomization|Withdrawal by Subject|3
1340115|NCT01943435|4411353|P2|Baseline Eligibility and Randomization|Withdrawal by Subject|12
1340116|NCT01943435|4411354|P1|Baseline Eligibility and Randomization|Withdrawal by Subject|4
1340117|NCT01943292|4411375|P3|Overall Study|Withdrawal by Subject|0
1340118|NCT01943292|4411376|P2|Overall Study|Withdrawal by Subject|0
1340119|NCT01943292|4411377|P1|Overall Study|Withdrawal by Subject|1
1340120|NCT01942785|4411404|P1|Overall Study|Protocol Violation|1
1340121|NCT01942785|4411404|P1|Overall Study|Withdrawal by Subject|1
1340122|NCT01942785|4411404|P1|Overall Study|Adverse Event|2
1340123|NCT01942733|4411433|P1|Overall Study|Administrative|1
1340124|NCT01942733|4411433|P1|Overall Study|Non-compliance with IMP|1
1340125|NCT01942733|4411433|P1|Overall Study|Lost to Follow-up|1
1340126|NCT01942590|4411485|P2|Overall Study|Adverse Event|0
1340127|NCT01942590|4411486|P1|Overall Study|Adverse Event|1
1340128|NCT01942590|4411485|P2|Overall Study|Withdrawal by Subject|1
1340129|NCT01942590|4411486|P1|Overall Study|Withdrawal by Subject|0
1340130|NCT01942161|4411519|P3|Overall Study|Withdrawal by Subject|1
1340131|NCT01942161|4411520|P2|Overall Study|Withdrawal by Subject|3
1340132|NCT01942161|4411521|P1|Overall Study|Withdrawal by Subject|3
1340133|NCT01942161|4411519|P3|Overall Study|Protocol Violation|0
1340134|NCT01942161|4411520|P2|Overall Study|Protocol Violation|0
1340135|NCT01942161|4411521|P1|Overall Study|Protocol Violation|1
1340136|NCT01942161|4411519|P3|Overall Study|Physician Decision|0
1340137|NCT01942161|4411520|P2|Overall Study|Physician Decision|1
1340138|NCT01942161|4411521|P1|Overall Study|Physician Decision|3
1340139|NCT01942161|4411519|P3|Overall Study|Adverse Event|5
1340140|NCT01942161|4411520|P2|Overall Study|Adverse Event|2
1340141|NCT01942161|4411521|P1|Overall Study|Adverse Event|1
1340142|NCT01942148|4411541|P1|Overall Study|Use of the prohibition medicine|1
1340143|NCT01942148|4411541|P1|Overall Study|Withdrawal by Subject|8
1340144|NCT01942148|4411541|P1|Overall Study|Protocol Violation|1
1340145|NCT01942148|4411541|P1|Overall Study|Physician Decision|11
1340146|NCT01942148|4411541|P1|Overall Study|Lack of Efficacy|2
1340147|NCT01942148|4411541|P1|Overall Study|Adverse Event|4
1340148|NCT01942135|4411549|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
1340149|NCT01942135|4411550|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
1340150|NCT01942135|4411549|P2|Overall Study|Withdrawal by Subject|2
1340151|NCT01942135|4411550|P1|Overall Study|Withdrawal by Subject|4
1340152|NCT01942135|4411549|P2|Overall Study|Participant Refused toContinue Treatment|1
1340153|NCT01942135|4411550|P1|Overall Study|Participant Refused toContinue Treatment|1
1340154|NCT01942135|4411549|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
1340155|NCT01942135|4411550|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
1340156|NCT01942135|4411549|P2|Overall Study|Death|1
1340157|NCT01942135|4411550|P1|Overall Study|Death|0
1340158|NCT01942135|4411549|P2|Overall Study|Randomized Not Treated|2
1340159|NCT01942135|4411550|P1|Overall Study|Randomized Not Treated|2
1340160|NCT01942135|4411549|P2|Overall Study|Global deterioration of health status|3
1340161|NCT01942135|4411550|P1|Overall Study|Global deterioration of health status|8
1340162|NCT01942135|4411549|P2|Overall Study|Adverse Event|3
1340163|NCT01942135|4411550|P1|Overall Study|Adverse Event|9
1340164|NCT01941940|4411587|P1|Overall Study|Other|1
1340165|NCT01941940|4411587|P1|Overall Study|Other|1
1340166|NCT01941940|4411587|P1|Overall Study|Death|1
1340167|NCT01941940|4411587|P1|Overall Study|Withdrawal by Subject|15
1340168|NCT01941940|4411587|P1|Overall Study|Physician Decision|2
1340169|NCT01941940|4411587|P1|Overall Study|Lost to Follow-up|2
1340170|NCT01941940|4411587|P1|Overall Study|Adverse Event|11
1340171|NCT01941498|4411636|P1|Overall Study|Relocated out of state|1
1340172|NCT01941186|4411754|P2|Follow-up|Lost to Follow-up|0
1340173|NCT01941186|4411755|P1|Follow-up|Lost to Follow-up|1
1340174|NCT01940900|4411783|P2|Overall Study|other|0
1340175|NCT01940900|4411784|P1|Overall Study|other|1
1340176|NCT01940900|4411783|P2|Overall Study|subject non-compliance|1
1340177|NCT01940900|4411784|P1|Overall Study|subject non-compliance|1
1340178|NCT01940900|4411783|P2|Overall Study|Sponsor Decision|0
1340179|NCT01940900|4411784|P1|Overall Study|Sponsor Decision|1
1340180|NCT01940900|4411783|P2|Overall Study|Lost to Follow-up|0
1340181|NCT01940900|4411784|P1|Overall Study|Lost to Follow-up|1
1340182|NCT01940900|4411783|P2|Overall Study|Withdrawal by Subject|15
1340183|NCT01940900|4411784|P1|Overall Study|Withdrawal by Subject|11
1340184|NCT01940900|4411783|P2|Overall Study|Adverse Event|15
1340185|NCT01940900|4411784|P1|Overall Study|Adverse Event|10
1340186|NCT01940900|4411783|P2|Overall Study|Physician Decision|0
1340187|NCT01940900|4411784|P1|Overall Study|Physician Decision|4
1340188|NCT01940497|4411834|P2|Overall Study|Ongoing at data cut-off|117
1340189|NCT01940497|4411835|P1|Overall Study|Ongoing at data cut-off|116
1340190|NCT01940497|4411834|P2|Overall Study|Withdrawal by Subject|0
1340191|NCT01940497|4411835|P1|Overall Study|Withdrawal by Subject|2
1340192|NCT01940497|4411834|P2|Overall Study|Protocol Violation|0
1340193|NCT01940497|4411835|P1|Overall Study|Protocol Violation|1
1340194|NCT01940497|4411834|P2|Overall Study|Failure to return|1
1340195|NCT01940497|4411835|P1|Overall Study|Failure to return|0
1340196|NCT01940497|4411834|P2|Overall Study|Adverse event/Intercurrent illness|0
1340197|NCT01940497|4411835|P1|Overall Study|Adverse event/Intercurrent illness|1
1340198|NCT01940484|4411874|P1|Overall Study|Adverse Event|1
1340199|NCT01940484|4411874|P1|Overall Study|Death|2
1340200|NCT01940484|4411874|P1|Overall Study|Underwent transplantation|4
1340201|NCT01940484|4411874|P1|Overall Study|Withdrawal by Subject|3
1340202|NCT01940471|4411894|P2|Open-Label Extension|Still on Open-Label Treatment|8
1340203|NCT01940471|4411895|P1|Open-Label Extension|Still on Open-Label Treatment|14
1340204|NCT01940471|4411894|P2|Double-Blind Phase|Still on Double-Blind Treatment|270
1340205|NCT01940471|4411895|P1|Double-Blind Phase|Still on Double-Blind Treatment|537
1340206|NCT01940471|4411894|P2|Double-Blind Phase|HBsAg Seroconversion|0
1340207|NCT01940471|4411895|P1|Double-Blind Phase|HBsAg Seroconversion|1
1340208|NCT01940471|4411894|P2|Double-Blind Phase|Protocol Violation|1
1340209|NCT01940471|4411895|P1|Double-Blind Phase|Protocol Violation|0
1340210|NCT01940471|4411894|P2|Double-Blind Phase|Lack of Efficacy|0
1340211|NCT01940471|4411895|P1|Double-Blind Phase|Lack of Efficacy|1
1340212|NCT01940471|4411894|P2|Double-Blind Phase|Death|0
1340213|NCT01940471|4411895|P1|Double-Blind Phase|Death|1
1340214|NCT01940471|4411894|P2|Double-Blind Phase|Protocol-Specified Criteria|0
1340215|NCT01940471|4411895|P1|Double-Blind Phase|Protocol-Specified Criteria|2
1340216|NCT01940471|4411894|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
1340217|NCT01940471|4411895|P1|Double-Blind Phase|Non-Compliance with Study Drug|2
1340218|NCT01940471|4411894|P2|Double-Blind Phase|Investigator's Discretion|1
1340219|NCT01940471|4411895|P1|Double-Blind Phase|Investigator's Discretion|2
1340220|NCT01940471|4411894|P2|Double-Blind Phase|Pregnancy|1
1340221|NCT01940471|4411895|P1|Double-Blind Phase|Pregnancy|2
1340222|NCT01940471|4411894|P2|Double-Blind Phase|Lost to Follow-up|2
1340223|NCT01940471|4411895|P1|Double-Blind Phase|Lost to Follow-up|2
1340224|NCT01940471|4411894|P2|Double-Blind Phase|Adverse Event|3
1340225|NCT01940471|4411895|P1|Double-Blind Phase|Adverse Event|6
1340226|NCT01940471|4411894|P2|Double-Blind Phase|Withdrew Consent|5
1340227|NCT01940471|4411895|P1|Double-Blind Phase|Withdrew Consent|11
1340228|NCT01940471|4411894|P2|Double-Blind Phase|Randomized but Never Treated|1
1340229|NCT01940471|4411895|P1|Double-Blind Phase|Randomized but Never Treated|1
1340230|NCT01940354|4411913|P2|Overall Study|Withdrawal by Subject|2
1340231|NCT01940354|4411914|P1|Overall Study|Withdrawal by Subject|4
1340232|NCT01940341|4411926|P2|Open-label Extension Phase|Still on Study|1
1340233|NCT01940341|4411927|P1|Open-label Extension Phase|Still on Study|4
1340234|NCT01940341|4411926|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
1340235|NCT01940341|4411927|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
1340236|NCT01940341|4411926|P2|Double-Blind Phase|Protocol Specified Criteria|0
1340237|NCT01940341|4411927|P1|Double-Blind Phase|Protocol Specified Criteria|1
1340238|NCT01940341|4411926|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
1340239|NCT01940341|4411927|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
1340240|NCT01940341|4411926|P2|Double-Blind Phase|Investigator's Discretion|0
1340241|NCT01940341|4411927|P1|Double-Blind Phase|Investigator's Discretion|1
1340242|NCT01940341|4411926|P2|Double-Blind Phase|Pregnancy|1
1340243|NCT01940341|4411927|P1|Double-Blind Phase|Pregnancy|0
1340244|NCT01940341|4411926|P2|Double-Blind Phase|Lost to Follow-up|1
1340245|NCT01940341|4411927|P1|Double-Blind Phase|Lost to Follow-up|4
1340246|NCT01940341|4411926|P2|Double-Blind Phase|Withdrew Consent|2
1340247|NCT01940341|4411927|P1|Double-Blind Phase|Withdrew Consent|3
1340248|NCT01940341|4411926|P2|Double-Blind Phase|Adverse Event|2
1340249|NCT01940341|4411927|P1|Double-Blind Phase|Adverse Event|3
1340250|NCT01940341|4411926|P2|Double-Blind Phase|Randomized but Never Treated|1
1340251|NCT01940341|4411927|P1|Double-Blind Phase|Randomized but Never Treated|0
1340252|NCT01940120|4411958|P1|Overall Study|Withdrawal by Subject|8
1340253|NCT01940120|4411958|P1|Overall Study|Death|40
1340254|NCT01939548|4412121|P3|Overall Study|Did not complete follow-up|0
1340255|NCT01939548|4412122|P2|Overall Study|Did not complete follow-up|1
1340256|NCT01939548|4412123|P1|Overall Study|Did not complete follow-up|0
1340257|NCT01939548|4412121|P3|Overall Study|Participant withdrew consent|0
1340258|NCT01939548|4412122|P2|Overall Study|Participant withdrew consent|2
1340259|NCT01939548|4412123|P1|Overall Study|Participant withdrew consent|0
1340260|NCT01939548|4412121|P3|Overall Study|Participant unwilling to continue|0
1340261|NCT01939548|4412122|P2|Overall Study|Participant unwilling to continue|1
1340262|NCT01939548|4412123|P1|Overall Study|Participant unwilling to continue|0
1340263|NCT01939548|4412121|P3|Overall Study|Participant dropped|1
1340264|NCT01939548|4412122|P2|Overall Study|Participant dropped|0
1340265|NCT01939548|4412123|P1|Overall Study|Participant dropped|0
1340266|NCT01939548|4412121|P3|Overall Study|Death|1
1340267|NCT01939548|4412122|P2|Overall Study|Death|0
1340268|NCT01939548|4412123|P1|Overall Study|Death|0
1340269|NCT01939548|4412121|P3|Overall Study|Adverse Event|7
1340270|NCT01939548|4412122|P2|Overall Study|Adverse Event|9
1340271|NCT01939548|4412123|P1|Overall Study|Adverse Event|2
1340272|NCT01939548|4412121|P3|Overall Study|Lost to Follow-up|3
1340273|NCT01939548|4412122|P2|Overall Study|Lost to Follow-up|5
1340274|NCT01939548|4412123|P1|Overall Study|Lost to Follow-up|5
1340275|NCT01939548|4412121|P3|Overall Study|Protocol Violation|5
1340276|NCT01939548|4412122|P2|Overall Study|Protocol Violation|6
1340277|NCT01939548|4412123|P1|Overall Study|Protocol Violation|7
1340278|NCT01939548|4412121|P3|Overall Study|Withdrawal by Subject|1
1340279|NCT01939548|4412122|P2|Overall Study|Withdrawal by Subject|4
1340280|NCT01939548|4412123|P1|Overall Study|Withdrawal by Subject|4
1340281|NCT01939548|4412121|P3|Overall Study|Did Not Meet Entrance Criteria|0
1340282|NCT01939548|4412122|P2|Overall Study|Did Not Meet Entrance Criteria|0
1340283|NCT01939548|4412123|P1|Overall Study|Did Not Meet Entrance Criteria|1
1340284|NCT01939548|4412121|P3|Overall Study|Insufficient Clinical Response|0
1340285|NCT01939548|4412122|P2|Overall Study|Insufficient Clinical Response|0
1340286|NCT01939548|4412123|P1|Overall Study|Insufficient Clinical Response|1
1340287|NCT01939548|4412121|P3|Overall Study|Study Terminated by Sponsor|12
1340288|NCT01939548|4412122|P2|Overall Study|Study Terminated by Sponsor|19
1340289|NCT01939548|4412123|P1|Overall Study|Study Terminated by Sponsor|17
1340290|NCT01939548|4412121|P3|Overall Study|Non compliance|0
1340291|NCT01939548|4412122|P2|Overall Study|Non compliance|2
1340292|NCT01939548|4412123|P1|Overall Study|Non compliance|0
1340293|NCT01939496|4412197|P3|Overall Study|Other|1
1340294|NCT01939496|4412198|P2|Overall Study|Other|0
1340295|NCT01939496|4412199|P1|Overall Study|Other|2
1340296|NCT01939496|4412197|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
1340297|NCT01939496|4412198|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
1340298|NCT01939496|4412199|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
1340299|NCT01939496|4412197|P3|Overall Study|Withdrawal by Subject|1
1340300|NCT01939496|4412198|P2|Overall Study|Withdrawal by Subject|1
1340301|NCT01939496|4412199|P1|Overall Study|Withdrawal by Subject|0
1340302|NCT01939496|4412197|P3|Overall Study|Protocol Violation|0
1340303|NCT01939496|4412198|P2|Overall Study|Protocol Violation|0
1340304|NCT01939496|4412199|P1|Overall Study|Protocol Violation|3
1340305|NCT01939496|4412197|P3|Overall Study|Physician Decision|0
1340306|NCT01939496|4412198|P2|Overall Study|Physician Decision|0
1340307|NCT01939496|4412199|P1|Overall Study|Physician Decision|1
1340308|NCT01939496|4412197|P3|Overall Study|Lost to Follow-up|0
1340309|NCT01939496|4412198|P2|Overall Study|Lost to Follow-up|1
1340310|NCT01939496|4412199|P1|Overall Study|Lost to Follow-up|1
1340311|NCT01939496|4412197|P3|Overall Study|Adverse Event|0
1340312|NCT01939496|4412198|P2|Overall Study|Adverse Event|0
1340313|NCT01939496|4412199|P1|Overall Study|Adverse Event|2
1340314|NCT01939314|4412266|P2|Overall Study|Lost to Follow-up|6
1340315|NCT01939314|4412267|P1|Overall Study|Lost to Follow-up|5
1340316|NCT01939314|4412266|P2|Overall Study|Pregnancy|1
1340317|NCT01939314|4412267|P1|Overall Study|Pregnancy|0
1340318|NCT01939314|4412266|P2|Overall Study|Protocol Violation|0
1340319|NCT01939314|4412267|P1|Overall Study|Protocol Violation|1
1340320|NCT01939314|4412266|P2|Overall Study|Withdrawal by Subject|1
1340321|NCT01939314|4412267|P1|Overall Study|Withdrawal by Subject|3
1340322|NCT01939223|4412288|P2|Overall Study|Withdrawal by Subject|0
1340323|NCT01939223|4412289|P1|Overall Study|Withdrawal by Subject|6
1340324|NCT01939223|4412288|P2|Overall Study|Study stopped by Sponsor|7
1340325|NCT01939223|4412289|P1|Overall Study|Study stopped by Sponsor|5
1340326|NCT01939223|4412288|P2|Overall Study|Disease recurrence (radiological)|3
1340327|NCT01939223|4412289|P1|Overall Study|Disease recurrence (radiological)|1
1340328|NCT01939223|4412288|P2|Overall Study|AE not assoc. with disease recurrence|1
1340329|NCT01939223|4412289|P1|Overall Study|AE not assoc. with disease recurrence|1
1340330|NCT01939197|4412304|P7|Overall Study|Lost to Follow-up|2
1340331|NCT01939197|4412305|P6|Overall Study|Lost to Follow-up|1
1340332|NCT01939197|4412306|P5|Overall Study|Lost to Follow-up|3
1340333|NCT01939197|4412307|P4|Overall Study|Lost to Follow-up|1
1340334|NCT01939197|4412308|P3|Overall Study|Lost to Follow-up|0
1340335|NCT01939197|4412309|P2|Overall Study|Lost to Follow-up|1
1340336|NCT01939197|4412310|P1|Overall Study|Lost to Follow-up|0
1340337|NCT01939197|4412304|P7|Overall Study|Withdrawal by Subject|0
1340338|NCT01939197|4412305|P6|Overall Study|Withdrawal by Subject|0
1340339|NCT01939197|4412306|P5|Overall Study|Withdrawal by Subject|1
1340340|NCT01939197|4412307|P4|Overall Study|Withdrawal by Subject|0
1340341|NCT01939197|4412308|P3|Overall Study|Withdrawal by Subject|0
1340342|NCT01939197|4412309|P2|Overall Study|Withdrawal by Subject|0
1340343|NCT01939197|4412310|P1|Overall Study|Withdrawal by Subject|1
1340344|NCT01939002|4412381|P2|Overall Study|Not Specified|2
1340345|NCT01939002|4412382|P1|Overall Study|Not Specified|1
1340346|NCT01939002|4412381|P2|Overall Study|Withdrawal by Subject|3
1340347|NCT01939002|4412382|P1|Overall Study|Withdrawal by Subject|5
1340348|NCT01939002|4412381|P2|Overall Study|Adverse Event|13
1340349|NCT01939002|4412382|P1|Overall Study|Adverse Event|13
1340350|NCT01938573|4412463|P2|Overall Study|Operation at other hospital|0
1340351|NCT01938573|4412464|P1|Overall Study|Operation at other hospital|1
1340352|NCT01938573|4412463|P2|Overall Study|Lack of Efficacy|0
1340353|NCT01938573|4412464|P1|Overall Study|Lack of Efficacy|1
1340354|NCT01938430|4412484|P14|Overall Study|Withdrew Consent|0
1340355|NCT01938430|4412485|P13|Overall Study|Withdrew Consent|0
1340356|NCT01938430|4412486|P12|Overall Study|Withdrew Consent|0
1340357|NCT01938430|4412487|P11|Overall Study|Withdrew Consent|0
1340358|NCT01938430|4412488|P10|Overall Study|Withdrew Consent|0
1340359|NCT01938430|4412489|P9|Overall Study|Withdrew Consent|1
1340360|NCT01938430|4412490|P8|Overall Study|Withdrew Consent|0
1340361|NCT01938430|4412491|P7|Overall Study|Withdrew Consent|0
1340362|NCT01938430|4412492|P6|Overall Study|Withdrew Consent|0
1340363|NCT01938430|4412493|P5|Overall Study|Withdrew Consent|0
1340364|NCT01938430|4412494|P4|Overall Study|Withdrew Consent|0
1340365|NCT01938430|4412495|P3|Overall Study|Withdrew Consent|0
1340366|NCT01938430|4412496|P2|Overall Study|Withdrew Consent|0
1340367|NCT01938430|4412497|P1|Overall Study|Withdrew Consent|0
1340368|NCT01938430|4412484|P14|Overall Study|Lost to Follow-up|0
1340369|NCT01938430|4412485|P13|Overall Study|Lost to Follow-up|0
1340370|NCT01938430|4412486|P12|Overall Study|Lost to Follow-up|0
1340371|NCT01938430|4412487|P11|Overall Study|Lost to Follow-up|0
1340372|NCT01938430|4412488|P10|Overall Study|Lost to Follow-up|0
1340373|NCT01938430|4412489|P9|Overall Study|Lost to Follow-up|0
1340374|NCT01938430|4412490|P8|Overall Study|Lost to Follow-up|0
1340375|NCT01938430|4412491|P7|Overall Study|Lost to Follow-up|0
1340376|NCT01938430|4412492|P6|Overall Study|Lost to Follow-up|1
1340377|NCT01938430|4412493|P5|Overall Study|Lost to Follow-up|0
1340378|NCT01938430|4412494|P4|Overall Study|Lost to Follow-up|0
1340379|NCT01938430|4412495|P3|Overall Study|Lost to Follow-up|1
1340380|NCT01938430|4412496|P2|Overall Study|Lost to Follow-up|0
1340381|NCT01938430|4412497|P1|Overall Study|Lost to Follow-up|0
1340382|NCT01938430|4412484|P14|Overall Study|Lack of Efficacy|0
1340383|NCT01938430|4412485|P13|Overall Study|Lack of Efficacy|0
1340384|NCT01938430|4412486|P12|Overall Study|Lack of Efficacy|1
1340385|NCT01938430|4412487|P11|Overall Study|Lack of Efficacy|2
1340386|NCT01938430|4412488|P10|Overall Study|Lack of Efficacy|0
1340387|NCT01938430|4412489|P9|Overall Study|Lack of Efficacy|1
1340388|NCT01938430|4412490|P8|Overall Study|Lack of Efficacy|0
1340389|NCT01938430|4412491|P7|Overall Study|Lack of Efficacy|0
1340390|NCT01938430|4412492|P6|Overall Study|Lack of Efficacy|0
1340391|NCT01938430|4412493|P5|Overall Study|Lack of Efficacy|0
1340392|NCT01938430|4412494|P4|Overall Study|Lack of Efficacy|1
1340393|NCT01938430|4412495|P3|Overall Study|Lack of Efficacy|1
1340394|NCT01938430|4412496|P2|Overall Study|Lack of Efficacy|1
1340395|NCT01938430|4412497|P1|Overall Study|Lack of Efficacy|3
1340396|NCT01938430|4412484|P14|Overall Study|Investigator's Discretion|0
1340397|NCT01938430|4412485|P13|Overall Study|Investigator's Discretion|0
1340398|NCT01938430|4412486|P12|Overall Study|Investigator's Discretion|0
1340399|NCT01938430|4412487|P11|Overall Study|Investigator's Discretion|0
1340400|NCT01938430|4412488|P10|Overall Study|Investigator's Discretion|0
1340401|NCT01938430|4412489|P9|Overall Study|Investigator's Discretion|0
1340402|NCT01938430|4412490|P8|Overall Study|Investigator's Discretion|0
1340403|NCT01938430|4412491|P7|Overall Study|Investigator's Discretion|0
1340404|NCT01938430|4412492|P6|Overall Study|Investigator's Discretion|0
1340405|NCT01938430|4412493|P5|Overall Study|Investigator's Discretion|0
1340406|NCT01938430|4412494|P4|Overall Study|Investigator's Discretion|0
1340407|NCT01938430|4412495|P3|Overall Study|Investigator's Discretion|1
1340408|NCT01938430|4412496|P2|Overall Study|Investigator's Discretion|0
1340409|NCT01938430|4412497|P1|Overall Study|Investigator's Discretion|0
1340410|NCT01938430|4412484|P14|Overall Study|Death|0
1340411|NCT01938430|4412485|P13|Overall Study|Death|0
1340412|NCT01938430|4412486|P12|Overall Study|Death|0
1340413|NCT01938430|4412487|P11|Overall Study|Death|0
1340414|NCT01938430|4412488|P10|Overall Study|Death|3
1340415|NCT01938430|4412489|P9|Overall Study|Death|2
1340416|NCT01938430|4412490|P8|Overall Study|Death|1
1340417|NCT01938430|4412491|P7|Overall Study|Death|1
1340418|NCT01938430|4412492|P6|Overall Study|Death|0
1340419|NCT01938430|4412493|P5|Overall Study|Death|0
1340420|NCT01938430|4412494|P4|Overall Study|Death|1
1340421|NCT01938430|4412495|P3|Overall Study|Death|2
1340422|NCT01938430|4412496|P2|Overall Study|Death|2
1340423|NCT01938430|4412497|P1|Overall Study|Death|1
1340424|NCT01938430|4412484|P14|Overall Study|Adverse Event|0
1340425|NCT01938430|4412485|P13|Overall Study|Adverse Event|0
1340426|NCT01938430|4412486|P12|Overall Study|Adverse Event|0
1340427|NCT01938430|4412487|P11|Overall Study|Adverse Event|0
1340428|NCT01938430|4412488|P10|Overall Study|Adverse Event|0
1340429|NCT01938430|4412489|P9|Overall Study|Adverse Event|0
1340430|NCT01938430|4412490|P8|Overall Study|Adverse Event|0
1340431|NCT01938430|4412491|P7|Overall Study|Adverse Event|1
1340432|NCT01938430|4412492|P6|Overall Study|Adverse Event|0
1340433|NCT01938430|4412493|P5|Overall Study|Adverse Event|0
1340434|NCT01938430|4412494|P4|Overall Study|Adverse Event|0
1340435|NCT01938430|4412495|P3|Overall Study|Adverse Event|0
1340436|NCT01938430|4412496|P2|Overall Study|Adverse Event|0
1340437|NCT01938430|4412497|P1|Overall Study|Adverse Event|0
1340438|NCT01938430|4412484|P14|Overall Study|Randomized but Not Treated|1
1340439|NCT01938430|4412485|P13|Overall Study|Randomized but Not Treated|0
1340440|NCT01938430|4412486|P12|Overall Study|Randomized but Not Treated|0
1340441|NCT01938430|4412487|P11|Overall Study|Randomized but Not Treated|1
1340442|NCT01938430|4412488|P10|Overall Study|Randomized but Not Treated|0
1340443|NCT01938430|4412489|P9|Overall Study|Randomized but Not Treated|0
1340444|NCT01938430|4412490|P8|Overall Study|Randomized but Not Treated|0
1340445|NCT01938430|4412491|P7|Overall Study|Randomized but Not Treated|0
1340446|NCT01938430|4412492|P6|Overall Study|Randomized but Not Treated|0
1340447|NCT01938430|4412493|P5|Overall Study|Randomized but Not Treated|0
1340448|NCT01938430|4412494|P4|Overall Study|Randomized but Not Treated|0
1340449|NCT01938430|4412495|P3|Overall Study|Randomized but Not Treated|0
1340450|NCT01938430|4412496|P2|Overall Study|Randomized but Not Treated|0
1340451|NCT01938430|4412497|P1|Overall Study|Randomized but Not Treated|0
1340452|NCT01938391|4412822|P1|12 Month Follow up|Withdrawal by Subject|1
1340453|NCT01938391|4412822|P1|12 Month Follow up|Physician Decision|1
1340454|NCT01938391|4412822|P1|6 Month Follow up|Withdrawal by Subject|1
1340455|NCT01937871|4412941|P3|Overall Study|Entry Criteria Not Met|1
1340456|NCT01937871|4412942|P2|Overall Study|Entry Criteria Not Met|2
1340457|NCT01937871|4412943|P1|Overall Study|Entry Criteria Not Met|1
1340458|NCT01937871|4412941|P3|Overall Study|Physician Decision|0
1340459|NCT01937871|4412942|P2|Overall Study|Physician Decision|1
1340460|NCT01937871|4412943|P1|Overall Study|Physician Decision|0
1340461|NCT01937871|4412941|P3|Overall Study|Withdrawal by Subject|4
1340462|NCT01937871|4412942|P2|Overall Study|Withdrawal by Subject|6
1340463|NCT01937871|4412943|P1|Overall Study|Withdrawal by Subject|9
1340464|NCT01937871|4412941|P3|Overall Study|Lost to Follow-up|4
1340465|NCT01937871|4412942|P2|Overall Study|Lost to Follow-up|2
1340466|NCT01937871|4412943|P1|Overall Study|Lost to Follow-up|8
1340467|NCT01937871|4412941|P3|Overall Study|Adverse Event|2
1340468|NCT01937871|4412942|P2|Overall Study|Adverse Event|6
1340469|NCT01937871|4412943|P1|Overall Study|Adverse Event|6
1340470|NCT01937715|4413019|P5|Overall Study|Other|0
1340471|NCT01937715|4413020|P4|Overall Study|Other|3
1340472|NCT01937715|4413021|P3|Overall Study|Other|0
1340473|NCT01937715|4413022|P2|Overall Study|Other|0
1340474|NCT01937715|4413023|P1|Overall Study|Other|0
1340475|NCT01937715|4413019|P5|Overall Study|Withdrawal by Subject|2
1340476|NCT01937715|4413020|P4|Overall Study|Withdrawal by Subject|0
1340477|NCT01937715|4413021|P3|Overall Study|Withdrawal by Subject|0
1340478|NCT01937715|4413022|P2|Overall Study|Withdrawal by Subject|1
1340479|NCT01937715|4413023|P1|Overall Study|Withdrawal by Subject|0
1340480|NCT01937715|4413019|P5|Overall Study|Death|0
1340481|NCT01937715|4413020|P4|Overall Study|Death|1
1340482|NCT01937715|4413021|P3|Overall Study|Death|0
1340483|NCT01937715|4413022|P2|Overall Study|Death|0
1340484|NCT01937715|4413023|P1|Overall Study|Death|0
1340485|NCT01937390|4413214|P1|Overall Study|Fail to return|21
1340486|NCT01937390|4413214|P1|Overall Study|Withdrawal by Subject|5
1340487|NCT01937390|4413214|P1|Overall Study|Lost to Follow-up|7
1340488|NCT01937390|4413214|P1|Overall Study|Death|2
1340489|NCT01937364|4413224|P2|Overall Study|Adverse Event|1
1340490|NCT01937364|4413225|P1|Overall Study|Adverse Event|2
1340491|NCT01937351|4413237|P2|Overall Study|Not treated w device, per protocol fail|0
1340492|NCT01937351|4413238|P1|Overall Study|Not treated w device, per protocol fail|4
1340493|NCT01937351|4413237|P2|Overall Study|Death|0
1340494|NCT01937351|4413238|P1|Overall Study|Death|1
1340495|NCT01937351|4413237|P2|Overall Study|Withdrawal by Subject|2
1340496|NCT01937351|4413238|P1|Overall Study|Withdrawal by Subject|4
1340497|NCT01937312|4413246|P2|Overall Study|Withdrawal of subject prior to treatment|1
1340498|NCT01937312|4413247|P1|Overall Study|Withdrawal of subject prior to treatment|1
1340499|NCT01937312|4413246|P2|Overall Study|Lack of Efficacy|1
1340500|NCT01937312|4413247|P1|Overall Study|Lack of Efficacy|0
1340501|NCT01937312|4413246|P2|Overall Study|Adverse Event|1
1340502|NCT01937312|4413247|P1|Overall Study|Adverse Event|10
1340503|NCT01937299|4413262|P2|Overall Study|Withdrawal by Subject|0
1340504|NCT01937299|4413263|P1|Overall Study|Withdrawal by Subject|1
1340505|NCT01937299|4413262|P2|Overall Study|Lack of Efficacy|4
1340506|NCT01937299|4413263|P1|Overall Study|Lack of Efficacy|0
1340507|NCT01937299|4413262|P2|Overall Study|Adverse Event|0
1340508|NCT01937299|4413263|P1|Overall Study|Adverse Event|13
1340509|NCT01937130|4413298|P4|Overall Study|Patient lost to FU due to death|0
1340510|NCT01937130|4413299|P3|Overall Study|Patient lost to FU due to death|0
1340511|NCT01937130|4413300|P2|Overall Study|Patient lost to FU due to death|0
1340512|NCT01937130|4413301|P1|Overall Study|Patient lost to FU due to death|2
1340513|NCT01937130|4413298|P4|Overall Study|Patients unable to swallow|0
1340514|NCT01937130|4413299|P3|Overall Study|Patients unable to swallow|0
1340515|NCT01937130|4413300|P2|Overall Study|Patients unable to swallow|1
1340516|NCT01937130|4413301|P1|Overall Study|Patients unable to swallow|0
1340517|NCT01937130|4413298|P4|Overall Study|Physician Decision|0
1340518|NCT01937130|4413299|P3|Overall Study|Physician Decision|0
1340519|NCT01937130|4413300|P2|Overall Study|Physician Decision|1
1340520|NCT01937130|4413301|P1|Overall Study|Physician Decision|0
1340521|NCT01937130|4413298|P4|Overall Study|Lost to Follow-up|0
1340522|NCT01937130|4413299|P3|Overall Study|Lost to Follow-up|2
1340523|NCT01937130|4413300|P2|Overall Study|Lost to Follow-up|0
1340524|NCT01937130|4413301|P1|Overall Study|Lost to Follow-up|2
1340525|NCT01937130|4413298|P4|Overall Study|Death|0
1340526|NCT01937130|4413299|P3|Overall Study|Death|1
1340527|NCT01937130|4413300|P2|Overall Study|Death|1
1340528|NCT01937130|4413301|P1|Overall Study|Death|1
1340529|NCT01937130|4413298|P4|Overall Study|Adverse Event|1
1340530|NCT01937130|4413299|P3|Overall Study|Adverse Event|0
1340531|NCT01937130|4413300|P2|Overall Study|Adverse Event|1
1340532|NCT01937130|4413301|P1|Overall Study|Adverse Event|0
1340533|NCT01937130|4413298|P4|Overall Study|Withdrawal by Subject|1
1340534|NCT01937130|4413299|P3|Overall Study|Withdrawal by Subject|0
1340535|NCT01937130|4413300|P2|Overall Study|Withdrawal by Subject|0
1340536|NCT01937130|4413301|P1|Overall Study|Withdrawal by Subject|0
1340537|NCT01936974|4413339|P2|Overall Study|Physician Decision|5
1340538|NCT01936974|4413340|P1|Overall Study|Physician Decision|2
1340539|NCT01936870|4413370|P1|Overall Study|No Drug Administration|1
1340540|NCT01936870|4413370|P1|Overall Study|Protocol Violation|12
1340541|NCT01936870|4413370|P1|Overall Study|No Visit After Treatment|176
1340542|NCT01936649|4413407|P1|Overall Study|Other than specified above|5
1340543|NCT01936649|4413407|P1|Overall Study|Protocol Violation|2
1340544|NCT01936649|4413407|P1|Overall Study|Physician Decision|2
1340545|NCT01936649|4413407|P1|Overall Study|Withdrawal by Subject|4
1340546|NCT01936623|4413414|P2|Overall Study|Lost to Follow-up|5
1340547|NCT01936623|4413415|P1|Overall Study|Lost to Follow-up|0
1340548|NCT01936363|4413459|P2|Overall Study|Ongoing|5
1340549|NCT01936363|4413460|P1|Overall Study|Ongoing|7
1340550|NCT01936181|4413486|P4|Transition-extension|Withdrawal by Subject|1
1340551|NCT01936181|4413487|P3|Transition-extension|Withdrawal by Subject|2
1340552|NCT01936181|4413488|P2|Transition-extension|Withdrawal by Subject|0
1340553|NCT01936181|4413489|P1|Transition-extension|Withdrawal by Subject|7
1340554|NCT01936181|4413486|P4|Transition-extension|Physician Decision|1
1340555|NCT01936181|4413487|P3|Transition-extension|Physician Decision|0
1340556|NCT01936181|4413488|P2|Transition-extension|Physician Decision|0
1340557|NCT01936181|4413489|P1|Transition-extension|Physician Decision|2
1340558|NCT01936181|4413486|P4|Transition-extension|Lost to Follow-up|2
1340559|NCT01936181|4413487|P3|Transition-extension|Lost to Follow-up|1
1340560|NCT01936181|4413488|P2|Transition-extension|Lost to Follow-up|0
1340561|NCT01936181|4413489|P1|Transition-extension|Lost to Follow-up|3
1340562|NCT01936181|4413486|P4|Transition-extension|Adverse Event|1
1340563|NCT01936181|4413487|P3|Transition-extension|Adverse Event|3
1340564|NCT01936181|4413488|P2|Transition-extension|Adverse Event|0
1340565|NCT01936181|4413489|P1|Transition-extension|Adverse Event|3
1340566|NCT01936181|4413486|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
1340567|NCT01936181|4413487|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
1340568|NCT01936181|4413488|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
1340569|NCT01936181|4413489|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
1340570|NCT01936181|4413486|P4|Randomised, Double-blind|Withdrawal by Subject|0
1340571|NCT01936181|4413487|P3|Randomised, Double-blind|Withdrawal by Subject|0
1340572|NCT01936181|4413488|P2|Randomised, Double-blind|Withdrawal by Subject|26
1340573|NCT01936181|4413489|P1|Randomised, Double-blind|Withdrawal by Subject|23
1340574|NCT01936181|4413486|P4|Randomised, Double-blind|Physician Decision|0
1340575|NCT01936181|4413487|P3|Randomised, Double-blind|Physician Decision|0
1340576|NCT01936181|4413488|P2|Randomised, Double-blind|Physician Decision|4
1340577|NCT01936181|4413489|P1|Randomised, Double-blind|Physician Decision|4
1340578|NCT01936181|4413486|P4|Randomised, Double-blind|Pregnancy|0
1340579|NCT01936181|4413487|P3|Randomised, Double-blind|Pregnancy|0
1340580|NCT01936181|4413488|P2|Randomised, Double-blind|Pregnancy|1
1340581|NCT01936181|4413489|P1|Randomised, Double-blind|Pregnancy|0
1340582|NCT01936181|4413486|P4|Randomised, Double-blind|Lost to Follow-up|0
1340583|NCT01936181|4413487|P3|Randomised, Double-blind|Lost to Follow-up|0
1340584|NCT01936181|4413488|P2|Randomised, Double-blind|Lost to Follow-up|1
1340585|NCT01936181|4413489|P1|Randomised, Double-blind|Lost to Follow-up|0
1340586|NCT01936181|4413486|P4|Randomised, Double-blind|Lack of Efficacy|0
1340587|NCT01936181|4413487|P3|Randomised, Double-blind|Lack of Efficacy|0
1340588|NCT01936181|4413488|P2|Randomised, Double-blind|Lack of Efficacy|6
1340589|NCT01936181|4413489|P1|Randomised, Double-blind|Lack of Efficacy|5
1340590|NCT01936181|4413486|P4|Randomised, Double-blind|Protocol Violation|0
1340591|NCT01936181|4413487|P3|Randomised, Double-blind|Protocol Violation|0
1340592|NCT01936181|4413488|P2|Randomised, Double-blind|Protocol Violation|5
1340593|NCT01936181|4413489|P1|Randomised, Double-blind|Protocol Violation|1
1340594|NCT01936181|4413486|P4|Randomised, Double-blind|Adverse Event|0
1340595|NCT01936181|4413487|P3|Randomised, Double-blind|Adverse Event|0
1340596|NCT01936181|4413488|P2|Randomised, Double-blind|Adverse Event|21
1340597|NCT01936181|4413489|P1|Randomised, Double-blind|Adverse Event|27
1340598|NCT01935947|4413503|P3|Overall Study|Death|0
1340599|NCT01935947|4413504|P2|Overall Study|Death|0
1340600|NCT01935947|4413505|P1|Overall Study|Death|1
1340601|NCT01935947|4413503|P3|Overall Study|Diease Progression|2
1340602|NCT01935947|4413504|P2|Overall Study|Diease Progression|2
1340603|NCT01935947|4413505|P1|Overall Study|Diease Progression|2
1340604|NCT01935947|4413503|P3|Overall Study|Adverse Event|0
1340605|NCT01935947|4413504|P2|Overall Study|Adverse Event|2
1340606|NCT01935947|4413505|P1|Overall Study|Adverse Event|0
1340607|NCT01934894|4413564|P2|Overall Study|Progressive Disease|2
1340608|NCT01934894|4413565|P1|Overall Study|Progressive Disease|3
1340609|NCT01934894|4413564|P2|Overall Study|Withdrawal by Subject|1
1340610|NCT01934894|4413565|P1|Overall Study|Withdrawal by Subject|0
1340611|NCT01934894|4413564|P2|Overall Study|Death|0
1340612|NCT01934894|4413565|P1|Overall Study|Death|2
1340613|NCT01934894|4413564|P2|Overall Study|Adverse Event|2
1340614|NCT01934894|4413565|P1|Overall Study|Adverse Event|1
1340615|NCT01934790|4413580|P1|Active Follow up|Other reason|1
1340616|NCT01934790|4413580|P1|Active Follow up|Progressive disease|1
1340617|NCT01934790|4413580|P1|Active Follow up|Physician Decision|2
1340618|NCT01934790|4413580|P1|Active Follow up|Death|20
1340619|NCT01934790|4413580|P1|Treatment|Study drug never administered|1
1340620|NCT01934790|4413580|P1|Treatment|Withdrawal by Subject|2
1340621|NCT01934790|4413580|P1|Treatment|Radiological progression|4
1340622|NCT01934790|4413580|P1|Treatment|Clinical progression|6
1340623|NCT01934790|4413580|P1|Treatment|Adverse Event|3
1340624|NCT01934504|4413634|P4|Overall Study|Study Terminated by Sponsor|5
1340625|NCT01934504|4413635|P3|Overall Study|Study Terminated by Sponsor|5
1340626|NCT01934504|4413636|P2|Overall Study|Study Terminated by Sponsor|0
1340627|NCT01934504|4413637|P1|Overall Study|Study Terminated by Sponsor|1
1340628|NCT01934504|4413634|P4|Overall Study|Protocol Deviation|2
1340629|NCT01934504|4413635|P3|Overall Study|Protocol Deviation|0
1340630|NCT01934504|4413636|P2|Overall Study|Protocol Deviation|0
1340631|NCT01934504|4413637|P1|Overall Study|Protocol Deviation|0
1340632|NCT01934218|4413670|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
1340633|NCT01934218|4413671|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
1340634|NCT01934218|4413670|P2|Open-Label Phase|Noncompliance with Study Protocol|2
1340635|NCT01934218|4413671|P1|Open-Label Phase|Noncompliance with Study Protocol|4
1340636|NCT01934218|4413670|P2|Open-Label Phase|Withdrawal by Subject|11
1340637|NCT01934218|4413671|P1|Open-Label Phase|Withdrawal by Subject|13
1340638|NCT01934218|4413670|P2|Open-Label Phase|Protocol Violation|0
1340639|NCT01934218|4413671|P1|Open-Label Phase|Protocol Violation|1
1340640|NCT01934218|4413670|P2|Open-Label Phase|Physician Decision|0
1340641|NCT01934218|4413671|P1|Open-Label Phase|Physician Decision|1
1340642|NCT01934218|4413670|P2|Open-Label Phase|Lost to Follow-up|2
1340643|NCT01934218|4413671|P1|Open-Label Phase|Lost to Follow-up|4
1340644|NCT01934218|4413670|P2|Open-Label Phase|Lack of Efficacy|4
1340645|NCT01934218|4413671|P1|Open-Label Phase|Lack of Efficacy|1
1340646|NCT01934218|4413670|P2|Open-Label Phase|Adverse Event|4
1340647|NCT01934218|4413671|P1|Open-Label Phase|Adverse Event|2
1340648|NCT01934218|4413670|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
1340649|NCT01934218|4413671|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
1340650|NCT01934218|4413670|P2|Double-blind Phase|Noncompliance with Study Protocol|8
1340651|NCT01934218|4413671|P1|Double-blind Phase|Noncompliance with Study Protocol|5
1340652|NCT01934218|4413670|P2|Double-blind Phase|Withdrawal by Subject|13
1340653|NCT01934218|4413671|P1|Double-blind Phase|Withdrawal by Subject|16
1340654|NCT01934218|4413670|P2|Double-blind Phase|Protocol Violation|0
1340655|NCT01934218|4413671|P1|Double-blind Phase|Protocol Violation|4
1340656|NCT01934218|4413670|P2|Double-blind Phase|Physician Decision|2
1340657|NCT01934218|4413671|P1|Double-blind Phase|Physician Decision|1
1340658|NCT01934218|4413670|P2|Double-blind Phase|Lost to Follow-up|14
1340659|NCT01934218|4413671|P1|Double-blind Phase|Lost to Follow-up|7
1340660|NCT01934218|4413670|P2|Double-blind Phase|Lack of Efficacy|7
1340661|NCT01934218|4413671|P1|Double-blind Phase|Lack of Efficacy|6
1340662|NCT01934218|4413670|P2|Double-blind Phase|Adverse Event|8
1340663|NCT01934218|4413671|P1|Double-blind Phase|Adverse Event|8
1340664|NCT01934192|4413682|P4|Overall Study|Physician Decision|0
1340665|NCT01934192|4413683|P3|Overall Study|Physician Decision|0
1340666|NCT01934192|4413684|P2|Overall Study|Physician Decision|2
1340667|NCT01934192|4413685|P1|Overall Study|Physician Decision|3
1340668|NCT01934192|4413682|P4|Overall Study|Other: reached stopping criteria|0
1340669|NCT01934192|4413683|P3|Overall Study|Other: reached stopping criteria|1
1340670|NCT01934192|4413684|P2|Overall Study|Other: reached stopping criteria|5
1340671|NCT01934192|4413685|P1|Overall Study|Other: reached stopping criteria|6
1340672|NCT01934192|4413682|P4|Overall Study|Protocol Violation|1
1340673|NCT01934192|4413683|P3|Overall Study|Protocol Violation|0
1340674|NCT01934192|4413684|P2|Overall Study|Protocol Violation|0
1340675|NCT01934192|4413685|P1|Overall Study|Protocol Violation|0
1340676|NCT01934010|4413822|P3|Overall Study|Lost to Follow-up|0
1340677|NCT01934010|4413823|P2|Overall Study|Lost to Follow-up|4
1340678|NCT01934010|4413824|P1|Overall Study|Lost to Follow-up|7
1340679|NCT01934010|4413822|P3|Overall Study|Withdrawal by Subject|2
1340680|NCT01934010|4413823|P2|Overall Study|Withdrawal by Subject|6
1340681|NCT01934010|4413824|P1|Overall Study|Withdrawal by Subject|15
1340682|NCT01934010|4413822|P3|Overall Study|Adverse Event|0
1340683|NCT01934010|4413823|P2|Overall Study|Adverse Event|1
1340684|NCT01934010|4413824|P1|Overall Study|Adverse Event|1
1340685|NCT01933932|4413843|P2|Overall Study|Eligibility criteria not fulfilled|1
1340686|NCT01933932|4413844|P1|Overall Study|Eligibility criteria not fulfilled|0
1340687|NCT01933932|4413843|P2|Overall Study|Withdrawal by Subject|14
1340688|NCT01933932|4413844|P1|Overall Study|Withdrawal by Subject|11
1340689|NCT01933932|4413843|P2|Overall Study|Death|163
1340690|NCT01933932|4413844|P1|Overall Study|Death|173
1340691|NCT01933919|4413862|P2|Open-label Long-term Phase|Other|2
1340692|NCT01933919|4413863|P1|Open-label Long-term Phase|Other|1
1340693|NCT01933919|4413862|P2|Open-label Long-term Phase|Lost to Follow-up|0
1340694|NCT01933919|4413863|P1|Open-label Long-term Phase|Lost to Follow-up|1
1340695|NCT01933919|4413862|P2|Open-label Long-term Phase|Withdrawal by Subject|4
1340696|NCT01933919|4413863|P1|Open-label Long-term Phase|Withdrawal by Subject|3
1340697|NCT01933919|4413862|P2|Open-label Long-term Phase|Adverse Event|0
1340698|NCT01933919|4413863|P1|Open-label Long-term Phase|Adverse Event|2
1340699|NCT01933919|4413862|P2|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
1340700|NCT01933919|4413863|P1|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
1340701|NCT01933919|4413862|P2|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
1340702|NCT01933919|4413863|P1|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
1340703|NCT01933919|4413862|P2|Double-blind Placebo-controlled Phase|Adverse Event|1
1340704|NCT01933919|4413863|P1|Double-blind Placebo-controlled Phase|Adverse Event|0
1340705|NCT01933880|4413899|P2|Overall Study|Protocol Violation|0
1340706|NCT01933880|4413900|P1|Overall Study|Protocol Violation|1
1340707|NCT01933880|4413899|P2|Overall Study|Other|0
1340708|NCT01933880|4413900|P1|Overall Study|Other|4
1340709|NCT01933880|4413899|P2|Overall Study|Followup exceeded 4 days to visit window|0
1340710|NCT01933880|4413900|P1|Overall Study|Followup exceeded 4 days to visit window|19
1340711|NCT01933880|4413899|P2|Overall Study|Concomitant medication Interference|1
1340712|NCT01933880|4413900|P1|Overall Study|Concomitant medication Interference|0
1340713|NCT01933880|4413899|P2|Overall Study|Lack of Efficacy|0
1340714|NCT01933880|4413900|P1|Overall Study|Lack of Efficacy|1
1340715|NCT01933880|4413899|P2|Overall Study|Withdrawal by Subject|0
1340716|NCT01933880|4413900|P1|Overall Study|Withdrawal by Subject|5
1340717|NCT01933672|4413976|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1340718|NCT01933672|4413977|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1340719|NCT01933672|4413978|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1340720|NCT01933672|4413979|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1340721|NCT01933672|4413980|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1340722|NCT01933672|4413981|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
1340723|NCT01933672|4413982|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1340724|NCT01933672|4413976|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1340725|NCT01933672|4413977|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1340726|NCT01933672|4413978|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1340727|NCT01933672|4413979|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
1340728|NCT01933672|4413980|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1340729|NCT01933672|4413981|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1340730|NCT01933672|4413982|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1340731|NCT01933672|4413976|P7|Second Intervention Period (12-16 Days)|Other|0
1340732|NCT01933672|4413977|P6|Second Intervention Period (12-16 Days)|Other|0
1340733|NCT01933672|4413978|P5|Second Intervention Period (12-16 Days)|Other|0
1340734|NCT01933672|4413979|P4|Second Intervention Period (12-16 Days)|Other|0
1340735|NCT01933672|4413980|P3|Second Intervention Period (12-16 Days)|Other|1
1340736|NCT01933672|4413981|P2|Second Intervention Period (12-16 Days)|Other|1
1340737|NCT01933672|4413982|P1|Second Intervention Period (12-16 Days)|Other|0
1340738|NCT01933672|4413976|P7|First Intervention Period (12-16 Days)|Other|0
1340739|NCT01933672|4413977|P6|First Intervention Period (12-16 Days)|Other|1
1340740|NCT01933672|4413978|P5|First Intervention Period (12-16 Days)|Other|0
1340741|NCT01933672|4413979|P4|First Intervention Period (12-16 Days)|Other|0
1340742|NCT01933672|4413980|P3|First Intervention Period (12-16 Days)|Other|1
1340743|NCT01933672|4413981|P2|First Intervention Period (12-16 Days)|Other|0
1340744|NCT01933672|4413982|P1|First Intervention Period (12-16 Days)|Other|0
1340745|NCT01933672|4413976|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1340746|NCT01933672|4413977|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1340747|NCT01933672|4413978|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
1340748|NCT01933672|4413979|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1340749|NCT01933672|4413980|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1340750|NCT01933672|4413981|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1340751|NCT01933672|4413982|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1340752|NCT01933672|4413976|P7|Metformin Run-in Period|Other|0
1340753|NCT01933672|4413977|P6|Metformin Run-in Period|Other|0
1340754|NCT01933672|4413978|P5|Metformin Run-in Period|Other|0
1340755|NCT01933672|4413979|P4|Metformin Run-in Period|Other|0
1340756|NCT01933672|4413980|P3|Metformin Run-in Period|Other|0
1340757|NCT01933672|4413981|P2|Metformin Run-in Period|Other|0
1340758|NCT01933672|4413982|P1|Metformin Run-in Period|Other|5
1340846|NCT01931839|4414382|P1|Overall Study|Withdrawal of consent|0
1340759|NCT01933672|4413976|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
1340760|NCT01933672|4413977|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
1340761|NCT01933672|4413978|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
1340762|NCT01933672|4413979|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
1340763|NCT01933672|4413980|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
1340764|NCT01933672|4413981|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
1340765|NCT01933672|4413982|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
1340766|NCT01933672|4413976|P7|Metformin Run-in Period|Adverse Event|0
1340767|NCT01933672|4413977|P6|Metformin Run-in Period|Adverse Event|0
1340768|NCT01933672|4413978|P5|Metformin Run-in Period|Adverse Event|0
1340769|NCT01933672|4413979|P4|Metformin Run-in Period|Adverse Event|0
1340770|NCT01933672|4413980|P3|Metformin Run-in Period|Adverse Event|0
1340771|NCT01933672|4413981|P2|Metformin Run-in Period|Adverse Event|0
1340772|NCT01933672|4413982|P1|Metformin Run-in Period|Adverse Event|1
1340773|NCT01933334|4414057|P2|Overall Study|Withdrawal by Subject|1
1340774|NCT01933334|4414058|P1|Overall Study|Withdrawal by Subject|0
1340775|NCT01933334|4414057|P2|Overall Study|Adverse Event|1
1340776|NCT01933334|4414058|P1|Overall Study|Adverse Event|5
1340777|NCT01933048|4414087|P2|Overall Study|unknown reasons|1
1340778|NCT01933048|4414088|P1|Overall Study|unknown reasons|1
1340779|NCT01933048|4414087|P2|Overall Study|Physician Decision|0
1340780|NCT01933048|4414088|P1|Overall Study|Physician Decision|1
1340781|NCT01933048|4414087|P2|Overall Study|Protocol Violation|8
1340782|NCT01933048|4414088|P1|Overall Study|Protocol Violation|7
1340783|NCT01933048|4414087|P2|Overall Study|personal reasons|1
1340784|NCT01933048|4414088|P1|Overall Study|personal reasons|1
1340785|NCT01933048|4414087|P2|Overall Study|Lost to Follow-up|18
1340786|NCT01933048|4414088|P1|Overall Study|Lost to Follow-up|15
1340787|NCT01932970|4414101|P1|Overall Study|Protocol Specified Criteria|10
1340788|NCT01932970|4414101|P1|Overall Study|Lost to Follow-up|2
1340789|NCT01932970|4414101|P1|Overall Study|Death|1
1340790|NCT01932970|4414101|P1|Overall Study|Withdrawal by Subject|5
1340791|NCT01932762|4414113|P4|Overall Study|Physician Decision|0
1340792|NCT01932762|4414114|P3|Overall Study|Physician Decision|0
1340793|NCT01932762|4414115|P2|Overall Study|Physician Decision|0
1340794|NCT01932762|4414116|P1|Overall Study|Physician Decision|1
1340795|NCT01932762|4414113|P4|Overall Study|Lost to Follow-up|1
1340796|NCT01932762|4414114|P3|Overall Study|Lost to Follow-up|0
1340797|NCT01932762|4414115|P2|Overall Study|Lost to Follow-up|0
1340798|NCT01932762|4414116|P1|Overall Study|Lost to Follow-up|4
1340799|NCT01932762|4414113|P4|Overall Study|Withdrawal by Subject|0
1340800|NCT01932762|4414114|P3|Overall Study|Withdrawal by Subject|0
1340801|NCT01932762|4414115|P2|Overall Study|Withdrawal by Subject|2
1340802|NCT01932762|4414116|P1|Overall Study|Withdrawal by Subject|1
1340803|NCT01931865|4414363|P1|Overall Study|Withdrawal by Subject|2
1340804|NCT01931865|4414363|P1|Overall Study|Lost to Follow-up|2
1340805|NCT01931839|4414376|P7|Overall Study|Other|0
1340806|NCT01931839|4414377|P6|Overall Study|Other|0
1340807|NCT01931839|4414378|P5|Overall Study|Other|0
1340808|NCT01931839|4414379|P4|Overall Study|Other|0
1340809|NCT01931839|4414380|P3|Overall Study|Other|6
1340810|NCT01931839|4414381|P2|Overall Study|Other|2
1340811|NCT01931839|4414382|P1|Overall Study|Other|4
1340812|NCT01931839|4414376|P7|Overall Study|Lost to Follow-up|0
1340813|NCT01931839|4414377|P6|Overall Study|Lost to Follow-up|0
1340814|NCT01931839|4414378|P5|Overall Study|Lost to Follow-up|0
1340815|NCT01931839|4414379|P4|Overall Study|Lost to Follow-up|5
1340816|NCT01931839|4414380|P3|Overall Study|Lost to Follow-up|4
1340817|NCT01931839|4414381|P2|Overall Study|Lost to Follow-up|2
1340818|NCT01931839|4414382|P1|Overall Study|Lost to Follow-up|1
1340819|NCT01931839|4414376|P7|Overall Study|Other non-compliance|0
1340820|NCT01931839|4414377|P6|Overall Study|Other non-compliance|3
1340821|NCT01931839|4414378|P5|Overall Study|Other non-compliance|0
1340822|NCT01931839|4414379|P4|Overall Study|Other non-compliance|3
1340823|NCT01931839|4414380|P3|Overall Study|Other non-compliance|12
1340824|NCT01931839|4414381|P2|Overall Study|Other non-compliance|9
1340825|NCT01931839|4414382|P1|Overall Study|Other non-compliance|15
1340826|NCT01931839|4414376|P7|Overall Study|Withdrawal of consent (not due to AE)|2
1340827|NCT01931839|4414377|P6|Overall Study|Withdrawal of consent (not due to AE)|2
1340828|NCT01931839|4414378|P5|Overall Study|Withdrawal of consent (not due to AE)|0
1340829|NCT01931839|4414379|P4|Overall Study|Withdrawal of consent (not due to AE)|3
1340830|NCT01931839|4414380|P3|Overall Study|Withdrawal of consent (not due to AE)|13
1340831|NCT01931839|4414381|P2|Overall Study|Withdrawal of consent (not due to AE)|8
1340832|NCT01931839|4414382|P1|Overall Study|Withdrawal of consent (not due to AE)|11
1340833|NCT01931839|4414376|P7|Overall Study|Adverse Event|1
1340834|NCT01931839|4414377|P6|Overall Study|Adverse Event|0
1340835|NCT01931839|4414378|P5|Overall Study|Adverse Event|0
1340836|NCT01931839|4414379|P4|Overall Study|Adverse Event|3
1340837|NCT01931839|4414380|P3|Overall Study|Adverse Event|1
1340838|NCT01931839|4414381|P2|Overall Study|Adverse Event|4
1340839|NCT01931839|4414382|P1|Overall Study|Adverse Event|9
1340840|NCT01931839|4414376|P7|Overall Study|Withdrawal of consent|0
1340841|NCT01931839|4414377|P6|Overall Study|Withdrawal of consent|0
1340842|NCT01931839|4414378|P5|Overall Study|Withdrawal of consent|1
1340843|NCT01931839|4414379|P4|Overall Study|Withdrawal of consent|0
1340844|NCT01931839|4414380|P3|Overall Study|Withdrawal of consent|0
1340845|NCT01931839|4414381|P2|Overall Study|Withdrawal of consent|0
1340847|NCT01931839|4414376|P7|Overall Study|Physician Decision|1
1340848|NCT01931839|4414377|P6|Overall Study|Physician Decision|0
1340849|NCT01931839|4414378|P5|Overall Study|Physician Decision|0
1340850|NCT01931839|4414379|P4|Overall Study|Physician Decision|0
1340851|NCT01931839|4414380|P3|Overall Study|Physician Decision|1
1340852|NCT01931839|4414381|P2|Overall Study|Physician Decision|0
1340853|NCT01931839|4414382|P1|Overall Study|Physician Decision|1
1340854|NCT01931839|4414376|P7|Overall Study|Death|0
1340855|NCT01931839|4414377|P6|Overall Study|Death|0
1340856|NCT01931839|4414378|P5|Overall Study|Death|0
1340857|NCT01931839|4414379|P4|Overall Study|Death|0
1340858|NCT01931839|4414380|P3|Overall Study|Death|2
1340859|NCT01931839|4414381|P2|Overall Study|Death|1
1340860|NCT01931839|4414382|P1|Overall Study|Death|0
1340861|NCT01931475|4414485|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
1340862|NCT01931475|4414486|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
1340863|NCT01931475|4414485|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
1340864|NCT01931475|4414486|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
1340865|NCT01931475|4414485|P2|Period 2: Extension Treatment Phase|Physician Decision|1
1340866|NCT01931475|4414486|P1|Period 2: Extension Treatment Phase|Physician Decision|1
1340867|NCT01931475|4414485|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
1340868|NCT01931475|4414486|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
1340869|NCT01931475|4414485|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
1340870|NCT01931475|4414486|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
1340871|NCT01931475|4414485|P2|Period 2: Extension Treatment Phase|Adverse Event|8
1340872|NCT01931475|4414486|P1|Period 2: Extension Treatment Phase|Adverse Event|0
1340873|NCT01931475|4414485|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
1340874|NCT01931475|4414486|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
1340875|NCT01931475|4414485|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
1340876|NCT01931475|4414486|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
1340877|NCT01931475|4414485|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
1340878|NCT01931475|4414486|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
1340879|NCT01931475|4414485|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
1340880|NCT01931475|4414486|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
1340881|NCT01931475|4414485|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
1340882|NCT01931475|4414486|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
1340883|NCT01931462|4414513|P1|Overall Study|Withdrawal by Subject|1
1340884|NCT01931397|4414524|P1|Overall Study|moved out of state|1
1340885|NCT01931397|4414524|P1|Overall Study|Withdrawal by Subject|8
1340886|NCT01931397|4414524|P1|Overall Study|Physician Decision|2
1340887|NCT01931150|4414535|P2|Overall Study|Withdrawal by Subject|2
1340888|NCT01931150|4414536|P1|Overall Study|Withdrawal by Subject|1
1340889|NCT01931059|4414544|P2|Day3|Lost to Follow-up|0
1340890|NCT01931059|4414545|P1|Day3|Lost to Follow-up|1
1340891|NCT01931059|4414544|P2|Day 1|Pregnancy|1
1340892|NCT01931059|4414545|P1|Day 1|Pregnancy|0
1340893|NCT01930890|4414561|P4|Overall Study|Adverse Event|0
1340894|NCT01930890|4414562|P3|Overall Study|Adverse Event|0
1340895|NCT01930890|4414563|P2|Overall Study|Adverse Event|1
1340896|NCT01930890|4414564|P1|Overall Study|Adverse Event|0
1340897|NCT01930890|4414561|P4|Overall Study|Consent Withdrawn|1
1340898|NCT01930890|4414562|P3|Overall Study|Consent Withdrawn|0
1340899|NCT01930890|4414563|P2|Overall Study|Consent Withdrawn|3
1340900|NCT01930890|4414564|P1|Overall Study|Consent Withdrawn|0
1340901|NCT01930890|4414561|P4|Overall Study|Investigator Decision|0
1340902|NCT01930890|4414562|P3|Overall Study|Investigator Decision|0
1340903|NCT01930890|4414563|P2|Overall Study|Investigator Decision|1
1340904|NCT01930890|4414564|P1|Overall Study|Investigator Decision|0
1340905|NCT01930890|4414561|P4|Overall Study|Death|1
1340906|NCT01930890|4414562|P3|Overall Study|Death|0
1340907|NCT01930890|4414563|P2|Overall Study|Death|0
1340908|NCT01930890|4414564|P1|Overall Study|Death|0
1340909|NCT01930890|4414561|P4|Overall Study|Study Termination|25
1340910|NCT01930890|4414562|P3|Overall Study|Study Termination|13
1340911|NCT01930890|4414563|P2|Overall Study|Study Termination|28
1340912|NCT01930890|4414564|P1|Overall Study|Study Termination|14
1340913|NCT01930799|4414578|P1|Overall Study|Lost to Follow-up|5
1340914|NCT01930799|4414578|P1|Overall Study|Withdrawal by Subject|3
1340915|NCT01930162|4414686|P1|Overall Study|Death|1
1340916|NCT01930162|4414686|P1|Overall Study|Abnormal test procedure result(s)|4
1340917|NCT01930045|4414722|P6|Pause (up to 37 Days)|Protocol Violation|1
1340918|NCT01930045|4414723|P5|Pause (up to 37 Days)|Protocol Violation|0
1340919|NCT01930045|4414724|P4|Pause (up to 37 Days)|Protocol Violation|0
1340920|NCT01930045|4414725|P3|Pause (up to 37 Days)|Protocol Violation|0
1340921|NCT01930045|4414726|P2|Pause (up to 37 Days)|Protocol Violation|0
1340922|NCT01930045|4414727|P1|Pause (up to 37 Days)|Protocol Violation|0
1340923|NCT01930045|4414722|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
1340924|NCT01930045|4414723|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
1340925|NCT01930045|4414724|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
1340926|NCT01930045|4414725|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
1340927|NCT01930045|4414726|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
1340928|NCT01930045|4414727|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
1340929|NCT01929993|4414754|P2|Overall Study|Absent CIN, invasion present or artifact|22
1340930|NCT01929993|4414755|P1|Overall Study|Absent CIN, invasion present or artifact|26
1340931|NCT01929993|4414754|P2|Overall Study|Protocol Violation|6
1340932|NCT01929993|4414755|P1|Overall Study|Protocol Violation|4
1340933|NCT01929980|4414761|P1|Overall Study|Physician Decision|1
1340934|NCT01929876|4414769|P1|Period 2|Non-Compliance|1
1340935|NCT01929863|4414782|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
1340936|NCT01929863|4414783|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
1340937|NCT01929863|4414782|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
1340938|NCT01929863|4414783|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
1340939|NCT01929863|4414782|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
1340940|NCT01929863|4414783|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
1340941|NCT01929707|4414838|P8|Intervention Period 2|Withdrawal by Subject|0
1340942|NCT01929707|4414839|P7|Intervention Period 2|Withdrawal by Subject|0
1340943|NCT01929707|4414840|P6|Intervention Period 2|Withdrawal by Subject|2
1340944|NCT01929707|4414841|P5|Intervention Period 2|Withdrawal by Subject|0
1340945|NCT01929707|4414842|P4|Intervention Period 2|Withdrawal by Subject|0
1340946|NCT01929707|4414843|P3|Intervention Period 2|Withdrawal by Subject|0
1340947|NCT01929707|4414844|P2|Intervention Period 2|Withdrawal by Subject|0
1340948|NCT01929707|4414845|P1|Intervention Period 2|Withdrawal by Subject|0
1340949|NCT01929707|4414838|P8|Intervention Period 1|Withdrawal by Subject|0
1340950|NCT01929707|4414839|P7|Intervention Period 1|Withdrawal by Subject|0
1340951|NCT01929707|4414840|P6|Intervention Period 1|Withdrawal by Subject|0
1340952|NCT01929707|4414841|P5|Intervention Period 1|Withdrawal by Subject|0
1340953|NCT01929707|4414842|P4|Intervention Period 1|Withdrawal by Subject|2
1340954|NCT01929707|4414843|P3|Intervention Period 1|Withdrawal by Subject|0
1340955|NCT01929707|4414844|P2|Intervention Period 1|Withdrawal by Subject|0
1340956|NCT01929707|4414845|P1|Intervention Period 1|Withdrawal by Subject|0
1340957|NCT01929707|4414838|P8|Intervention Period 1|Lost to Follow-up|0
1340958|NCT01929707|4414839|P7|Intervention Period 1|Lost to Follow-up|0
1340959|NCT01929707|4414840|P6|Intervention Period 1|Lost to Follow-up|0
1340960|NCT01929707|4414841|P5|Intervention Period 1|Lost to Follow-up|0
1340961|NCT01929707|4414842|P4|Intervention Period 1|Lost to Follow-up|1
1340962|NCT01929707|4414843|P3|Intervention Period 1|Lost to Follow-up|0
1340963|NCT01929707|4414844|P2|Intervention Period 1|Lost to Follow-up|0
1340964|NCT01929707|4414845|P1|Intervention Period 1|Lost to Follow-up|0
1340965|NCT01929681|4414877|P2|Overall Study|Physician Decision|1
1340966|NCT01929681|4414878|P1|Overall Study|Physician Decision|1
1340967|NCT01929681|4414877|P2|Overall Study|Withdrawal by Subject|0
1340968|NCT01929681|4414878|P1|Overall Study|Withdrawal by Subject|1
1340969|NCT01929317|4414923|P2|Long-term Phase|Study Closed/Terminated|3
1340970|NCT01929317|4414924|P1|Long-term Phase|Study Closed/Terminated|5
1340971|NCT01929317|4414923|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
1340972|NCT01929317|4414924|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
1340973|NCT01929317|4414923|P2|Long-term Phase|Protocol Violation|0
1340974|NCT01929317|4414924|P1|Long-term Phase|Protocol Violation|1
1340975|NCT01929317|4414923|P2|Long-term Phase|Withdrawal by Subject|0
1340976|NCT01929317|4414924|P1|Long-term Phase|Withdrawal by Subject|4
1340977|NCT01929317|4414923|P2|Long-term Phase|Physician Decision|0
1340978|NCT01929317|4414924|P1|Long-term Phase|Physician Decision|3
1340979|NCT01929317|4414923|P2|Long-term Phase|Adverse Event|1
1340980|NCT01929317|4414924|P1|Long-term Phase|Adverse Event|5
1340981|NCT01929317|4414923|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
1340982|NCT01929317|4414924|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
1340983|NCT01929317|4414923|P2|Dose Increase Effect Verification Phase|Physician Decision|0
1340984|NCT01929317|4414924|P1|Dose Increase Effect Verification Phase|Physician Decision|1
1340985|NCT01929317|4414923|P2|Dose Increase Effect Verification Phase|Adverse Event|1
1340986|NCT01929317|4414924|P1|Dose Increase Effect Verification Phase|Adverse Event|5
1340987|NCT01929135|4414993|P2|Overall Study|Lost to Follow-up|1
1340988|NCT01929135|4414994|P1|Overall Study|Lost to Follow-up|1
1340989|NCT01929083|4415008|P2|Intervention 2|Adverse Event|1
1340990|NCT01929083|4415009|P1|Intervention 2|Adverse Event|0
1340991|NCT01929083|4415008|P2|Intervention 1|Nonadherent to study medications|0
1340992|NCT01929083|4415009|P1|Intervention 1|Nonadherent to study medications|1
1340993|NCT01929083|4415008|P2|Intervention 1|Lost to Follow-up|0
1340994|NCT01929083|4415009|P1|Intervention 1|Lost to Follow-up|2
1340995|NCT01929044|4415035|P2|Overall Study|Not Treated|3
1340996|NCT01929044|4415036|P1|Overall Study|Not Treated|1
1340997|NCT01929044|4415035|P2|Overall Study|Protocol Violation|14
1340998|NCT01929044|4415036|P1|Overall Study|Protocol Violation|9
1340999|NCT01929044|4415035|P2|Overall Study|Adverse Event|0
1341000|NCT01929044|4415036|P1|Overall Study|Adverse Event|1
1341001|NCT01929031|4415058|P6|Overall Study|Reason other than specified above|0
1341002|NCT01929031|4415059|P5|Overall Study|Reason other than specified above|1
1341003|NCT01929031|4415060|P4|Overall Study|Reason other than specified above|0
1341004|NCT01929031|4415061|P3|Overall Study|Reason other than specified above|0
1341005|NCT01929031|4415062|P2|Overall Study|Reason other than specified above|1
1341006|NCT01929031|4415063|P1|Overall Study|Reason other than specified above|0
1341007|NCT01929031|4415058|P6|Overall Study|Protocol Violation|1
1341008|NCT01929031|4415059|P5|Overall Study|Protocol Violation|0
1341009|NCT01929031|4415060|P4|Overall Study|Protocol Violation|0
1341010|NCT01929031|4415061|P3|Overall Study|Protocol Violation|0
1341011|NCT01929031|4415062|P2|Overall Study|Protocol Violation|0
1341012|NCT01929031|4415063|P1|Overall Study|Protocol Violation|1
1341013|NCT01929031|4415058|P6|Overall Study|Adverse Event|0
1341014|NCT01929031|4415059|P5|Overall Study|Adverse Event|0
1341015|NCT01929031|4415060|P4|Overall Study|Adverse Event|0
1341016|NCT01929031|4415061|P3|Overall Study|Adverse Event|1
1341017|NCT01929031|4415062|P2|Overall Study|Adverse Event|1
1341018|NCT01929031|4415063|P1|Overall Study|Adverse Event|3
1341019|NCT01928940|4415087|P2|Overall Study|Adverse Event|1
1341020|NCT01928940|4415088|P1|Overall Study|Adverse Event|0
1341021|NCT01928927|4415131|P2|Overall Study|Withdrawal by Subject|1
1341022|NCT01928927|4415132|P1|Overall Study|Withdrawal by Subject|1
1341023|NCT01928927|4415131|P2|Overall Study|Lost to Follow-up|0
1341024|NCT01928927|4415132|P1|Overall Study|Lost to Follow-up|1
1341025|NCT01928862|4415259|P5|Overall Study|Lost to Follow-up|1
1341026|NCT01928862|4415260|P4|Overall Study|Lost to Follow-up|0
1341027|NCT01928862|4415261|P3|Overall Study|Lost to Follow-up|0
1341028|NCT01928862|4415262|P2|Overall Study|Lost to Follow-up|0
1341029|NCT01928862|4415263|P1|Overall Study|Lost to Follow-up|1
1341030|NCT01928771|4415316|P3|Overall Study|Severe Non-Compliance to Protocol|2
1341031|NCT01928771|4415317|P2|Overall Study|Severe Non-Compliance to Protocol|2
1341032|NCT01928771|4415318|P1|Overall Study|Severe Non-Compliance to Protocol|4
1341033|NCT01928771|4415316|P3|Overall Study|Other Reasons|14
1341034|NCT01928771|4415317|P2|Overall Study|Other Reasons|9
1341035|NCT01928771|4415318|P1|Overall Study|Other Reasons|9
1341036|NCT01928771|4415316|P3|Overall Study|Study-Specific Withdrawal Criteria|1
1341037|NCT01928771|4415317|P2|Overall Study|Study-Specific Withdrawal Criteria|1
1341038|NCT01928771|4415318|P1|Overall Study|Study-Specific Withdrawal Criteria|0
1341039|NCT01928771|4415316|P3|Overall Study|Withdrawal by Subject|17
1341040|NCT01928771|4415317|P2|Overall Study|Withdrawal by Subject|15
1341041|NCT01928771|4415318|P1|Overall Study|Withdrawal by Subject|20
1341042|NCT01928771|4415316|P3|Overall Study|Lost to Follow-up|3
1341043|NCT01928771|4415317|P2|Overall Study|Lost to Follow-up|6
1341044|NCT01928771|4415318|P1|Overall Study|Lost to Follow-up|5
1341045|NCT01928771|4415316|P3|Overall Study|Death|2
1341046|NCT01928771|4415317|P2|Overall Study|Death|2
1341047|NCT01928771|4415318|P1|Overall Study|Death|2
1341048|NCT01928771|4415316|P3|Overall Study|Adverse Event|1
1341049|NCT01928771|4415317|P2|Overall Study|Adverse Event|5
1341050|NCT01928771|4415318|P1|Overall Study|Adverse Event|6
1341051|NCT01928615|4415430|P1|Overall Study|Study Terminated by Sponsor|2
1341052|NCT01928472|4415449|P4|Overall Study|Unclassified|0
1341053|NCT01928472|4415450|P3|Overall Study|Unclassified|1
1341054|NCT01928472|4415451|P2|Overall Study|Unclassified|0
1341055|NCT01928472|4415452|P1|Overall Study|Unclassified|0
1341056|NCT01928472|4415449|P4|Overall Study|Administrative Reason|0
1341057|NCT01928472|4415450|P3|Overall Study|Administrative Reason|0
1341058|NCT01928472|4415451|P2|Overall Study|Administrative Reason|1
1341059|NCT01928472|4415452|P1|Overall Study|Administrative Reason|2
1341060|NCT01928472|4415449|P4|Overall Study|Lost to Follow-up|0
1341061|NCT01928472|4415450|P3|Overall Study|Lost to Follow-up|4
1341062|NCT01928472|4415451|P2|Overall Study|Lost to Follow-up|3
1341063|NCT01928472|4415452|P1|Overall Study|Lost to Follow-up|2
1341064|NCT01928472|4415449|P4|Overall Study|Withdrawal by Subject|2
1341065|NCT01928472|4415450|P3|Overall Study|Withdrawal by Subject|1
1341066|NCT01928472|4415451|P2|Overall Study|Withdrawal by Subject|4
1341067|NCT01928472|4415452|P1|Overall Study|Withdrawal by Subject|4
1341068|NCT01928472|4415449|P4|Overall Study|Death|0
1341069|NCT01928472|4415450|P3|Overall Study|Death|1
1341070|NCT01928472|4415451|P2|Overall Study|Death|0
1341071|NCT01928472|4415452|P1|Overall Study|Death|0
1341072|NCT01928433|4415522|P3|Overall Study|Other reasons|4
1341073|NCT01928433|4415523|P2|Overall Study|Other reasons|3
1341074|NCT01928433|4415524|P1|Overall Study|Other reasons|3
1341075|NCT01928433|4415522|P3|Overall Study|Lost to Follow-up|3
1341076|NCT01928433|4415523|P2|Overall Study|Lost to Follow-up|2
1341077|NCT01928433|4415524|P1|Overall Study|Lost to Follow-up|0
1341078|NCT01928433|4415522|P3|Overall Study|Negative screening urine culture|10
1341079|NCT01928433|4415523|P2|Overall Study|Negative screening urine culture|6
1341080|NCT01928433|4415524|P1|Overall Study|Negative screening urine culture|7
1341081|NCT01928433|4415522|P3|Overall Study|Withdrawal by Subject|0
1341082|NCT01928433|4415523|P2|Overall Study|Withdrawal by Subject|4
1341083|NCT01928433|4415524|P1|Overall Study|Withdrawal by Subject|0
1341084|NCT01928433|4415522|P3|Overall Study|Lack of Efficacy|4
1341085|NCT01928433|4415523|P2|Overall Study|Lack of Efficacy|4
1341086|NCT01928433|4415524|P1|Overall Study|Lack of Efficacy|5
1341087|NCT01928433|4415522|P3|Overall Study|Protocol Violation|2
1341088|NCT01928433|4415523|P2|Overall Study|Protocol Violation|0
1341089|NCT01928433|4415524|P1|Overall Study|Protocol Violation|0
1341090|NCT01928433|4415522|P3|Overall Study|Adverse Event|5
1341091|NCT01928433|4415523|P2|Overall Study|Adverse Event|2
1341092|NCT01928433|4415524|P1|Overall Study|Adverse Event|5
1341093|NCT01928381|4415547|P7|Part 2 - Post Third Intervention|Protocol Violation|0
1341094|NCT01928381|4415548|P6|Part 2 - Post Third Intervention|Protocol Violation|0
1341095|NCT01928381|4415549|P5|Part 2 - Post Third Intervention|Protocol Violation|0
1341096|NCT01928381|4415550|P4|Part 2 - Post Third Intervention|Protocol Violation|0
1341097|NCT01928381|4415551|P3|Part 2 - Post Third Intervention|Protocol Violation|1
1341098|NCT01928381|4415552|P2|Part 2 - Post Third Intervention|Protocol Violation|0
1341099|NCT01928381|4415553|P1|Part 2 - Post Third Intervention|Protocol Violation|0
1341100|NCT01928381|4415547|P7|Part 2 - Second Intervention|Lost to Follow-up|0
1341101|NCT01928381|4415548|P6|Part 2 - Second Intervention|Lost to Follow-up|0
1341102|NCT01928381|4415549|P5|Part 2 - Second Intervention|Lost to Follow-up|0
1341103|NCT01928381|4415550|P4|Part 2 - Second Intervention|Lost to Follow-up|1
1341104|NCT01928381|4415551|P3|Part 2 - Second Intervention|Lost to Follow-up|0
1341105|NCT01928381|4415552|P2|Part 2 - Second Intervention|Lost to Follow-up|1
1341106|NCT01928381|4415553|P1|Part 2 - Second Intervention|Lost to Follow-up|0
1341107|NCT01928381|4415547|P7|Washout First Intervention|Protocol Violation|0
1341108|NCT01928381|4415548|P6|Washout First Intervention|Protocol Violation|0
1341109|NCT01928381|4415549|P5|Washout First Intervention|Protocol Violation|1
1341110|NCT01928381|4415550|P4|Washout First Intervention|Protocol Violation|0
1341111|NCT01928381|4415551|P3|Washout First Intervention|Protocol Violation|0
1341112|NCT01928381|4415552|P2|Washout First Intervention|Protocol Violation|0
1341113|NCT01928381|4415553|P1|Washout First Intervention|Protocol Violation|0
1341114|NCT01928381|4415547|P7|Part 2 - First Intervention|Lost to Follow-up|0
1341115|NCT01928381|4415548|P6|Part 2 - First Intervention|Lost to Follow-up|0
1341116|NCT01928381|4415549|P5|Part 2 - First Intervention|Lost to Follow-up|0
1341117|NCT01928381|4415550|P4|Part 2 - First Intervention|Lost to Follow-up|1
1341118|NCT01928381|4415551|P3|Part 2 - First Intervention|Lost to Follow-up|0
1341119|NCT01928381|4415552|P2|Part 2 - First Intervention|Lost to Follow-up|0
1341120|NCT01928381|4415553|P1|Part 2 - First Intervention|Lost to Follow-up|0
1341121|NCT01928381|4415547|P7|Part 2 - First Intervention|Eligibility criterion not met|1
1341122|NCT01928381|4415548|P6|Part 2 - First Intervention|Eligibility criterion not met|1
1341123|NCT01928381|4415549|P5|Part 2 - First Intervention|Eligibility criterion not met|0
1341124|NCT01928381|4415550|P4|Part 2 - First Intervention|Eligibility criterion not met|0
1341125|NCT01928381|4415551|P3|Part 2 - First Intervention|Eligibility criterion not met|0
1341126|NCT01928381|4415552|P2|Part 2 - First Intervention|Eligibility criterion not met|0
1341127|NCT01928381|4415553|P1|Part 2 - First Intervention|Eligibility criterion not met|0
1341128|NCT01928381|4415547|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
1341129|NCT01928381|4415548|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
1341130|NCT01928381|4415549|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
1341131|NCT01928381|4415550|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
1341132|NCT01928381|4415551|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
1341133|NCT01928381|4415552|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
1341134|NCT01928381|4415553|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
1341135|NCT01928381|4415547|P7|Part 2 - First Intervention|Withdrawal by Subject|0
1341136|NCT01928381|4415548|P6|Part 2 - First Intervention|Withdrawal by Subject|0
1341137|NCT01928381|4415549|P5|Part 2 - First Intervention|Withdrawal by Subject|0
1341138|NCT01928381|4415550|P4|Part 2 - First Intervention|Withdrawal by Subject|0
1341139|NCT01928381|4415551|P3|Part 2 - First Intervention|Withdrawal by Subject|1
1341140|NCT01928381|4415552|P2|Part 2 - First Intervention|Withdrawal by Subject|0
1341141|NCT01928381|4415553|P1|Part 2 - First Intervention|Withdrawal by Subject|0
1341142|NCT01928381|4415547|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1341143|NCT01928381|4415548|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1341144|NCT01928381|4415549|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1341145|NCT01928381|4415550|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1341146|NCT01928381|4415551|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1341147|NCT01928381|4415552|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1341148|NCT01928381|4415553|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
1341149|NCT01928381|4415547|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1341150|NCT01928381|4415548|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1341151|NCT01928381|4415549|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1341152|NCT01928381|4415550|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1341153|NCT01928381|4415551|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1341154|NCT01928381|4415552|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1341155|NCT01928381|4415553|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
1341156|NCT01928381|4415547|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1341157|NCT01928381|4415548|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1341158|NCT01928381|4415549|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1341159|NCT01928381|4415550|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1341160|NCT01928381|4415551|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1341161|NCT01928381|4415552|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1341162|NCT01928381|4415553|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
1341163|NCT01928381|4415547|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1341164|NCT01928381|4415548|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1341165|NCT01928381|4415549|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1341166|NCT01928381|4415550|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1341167|NCT01928381|4415551|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1341168|NCT01928381|4415552|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1341169|NCT01928381|4415553|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
1341170|NCT01928381|4415547|P7|Part 1 - Pain Training|Protocol Violation|0
1341171|NCT01928381|4415548|P6|Part 1 - Pain Training|Protocol Violation|0
1341172|NCT01928381|4415549|P5|Part 1 - Pain Training|Protocol Violation|0
1341173|NCT01928381|4415550|P4|Part 1 - Pain Training|Protocol Violation|0
1341174|NCT01928381|4415551|P3|Part 1 - Pain Training|Protocol Violation|0
1341175|NCT01928381|4415552|P2|Part 1 - Pain Training|Protocol Violation|0
1341176|NCT01928381|4415553|P1|Part 1 - Pain Training|Protocol Violation|1
1341177|NCT01928381|4415547|P7|Part 1 - Pain Training|Lost to Follow-up|0
1341178|NCT01928381|4415548|P6|Part 1 - Pain Training|Lost to Follow-up|0
1341179|NCT01928381|4415549|P5|Part 1 - Pain Training|Lost to Follow-up|0
1341180|NCT01928381|4415550|P4|Part 1 - Pain Training|Lost to Follow-up|0
1341181|NCT01928381|4415551|P3|Part 1 - Pain Training|Lost to Follow-up|0
1341182|NCT01928381|4415552|P2|Part 1 - Pain Training|Lost to Follow-up|0
1341183|NCT01928381|4415553|P1|Part 1 - Pain Training|Lost to Follow-up|4
1341184|NCT01928381|4415547|P7|Part 1 - Pain Training|Withdrawal by Subject|0
1341185|NCT01928381|4415548|P6|Part 1 - Pain Training|Withdrawal by Subject|0
1341186|NCT01928381|4415549|P5|Part 1 - Pain Training|Withdrawal by Subject|0
1341187|NCT01928381|4415550|P4|Part 1 - Pain Training|Withdrawal by Subject|0
1341188|NCT01928381|4415551|P3|Part 1 - Pain Training|Withdrawal by Subject|0
1341189|NCT01928381|4415552|P2|Part 1 - Pain Training|Withdrawal by Subject|0
1341190|NCT01928381|4415553|P1|Part 1 - Pain Training|Withdrawal by Subject|1
1341191|NCT01928381|4415547|P7|Part 1 - Pain Training|Pain training criteria not met|0
1341192|NCT01928381|4415548|P6|Part 1 - Pain Training|Pain training criteria not met|0
1341193|NCT01928381|4415549|P5|Part 1 - Pain Training|Pain training criteria not met|0
1341194|NCT01928381|4415550|P4|Part 1 - Pain Training|Pain training criteria not met|0
1341195|NCT01928381|4415551|P3|Part 1 - Pain Training|Pain training criteria not met|0
1341196|NCT01928381|4415552|P2|Part 1 - Pain Training|Pain training criteria not met|0
1341197|NCT01928381|4415553|P1|Part 1 - Pain Training|Pain training criteria not met|29
1341198|NCT01928381|4415547|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1341199|NCT01928381|4415548|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1341200|NCT01928381|4415549|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1341201|NCT01928381|4415550|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1341202|NCT01928381|4415551|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1341203|NCT01928381|4415552|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1341204|NCT01928381|4415553|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
1341205|NCT01928082|4415580|P1|Overall Study|Study terminated.|1
1341206|NCT01927757|4415598|P1|Overall Study|Ethical Reasons|4
1341207|NCT01927757|4415598|P1|Overall Study|Other|1
1341208|NCT01927757|4415598|P1|Overall Study|Decision by Sponsor|2
1341209|NCT01927757|4415598|P1|Overall Study|Lost to Follow-up|2
1341210|NCT01927757|4415598|P1|Overall Study|Withdrawal by Subject|14
1341211|NCT01927419|4415626|P2|Overall Study|Not reported|0
1341212|NCT01927419|4415627|P1|Overall Study|Not reported|1
1341213|NCT01927419|4415626|P2|Overall Study|Not specified|1
1341214|NCT01927419|4415627|P1|Overall Study|Not specified|2
1341215|NCT01927419|4415626|P2|Overall Study|Withdrawal by Subject|1
1341216|NCT01927419|4415627|P1|Overall Study|Withdrawal by Subject|3
1341217|NCT01927419|4415626|P2|Overall Study|Adverse event unrelated to study drug|1
1341218|NCT01927419|4415627|P1|Overall Study|Adverse event unrelated to study drug|6
1341219|NCT01927419|4415626|P2|Overall Study|Death|1
1341220|NCT01927419|4415627|P1|Overall Study|Death|0
1341221|NCT01927419|4415626|P2|Overall Study|Study drug toxicity|7
1341222|NCT01927419|4415627|P1|Overall Study|Study drug toxicity|43
1341223|NCT01927419|4415626|P2|Overall Study|Disease progression|17
1341224|NCT01927419|4415627|P1|Overall Study|Disease progression|15
1341225|NCT01927055|4415661|P3|Double-Blind|Extended Vacation|0
1341226|NCT01927055|4415662|P2|Double-Blind|Extended Vacation|1
1341227|NCT01927055|4415663|P1|Double-Blind|Extended Vacation|0
1341228|NCT01927055|4415661|P3|Double-Blind|Supine Hypertension|1
1341229|NCT01927055|4415662|P2|Double-Blind|Supine Hypertension|0
1341230|NCT01927055|4415663|P1|Double-Blind|Supine Hypertension|0
1341231|NCT01927055|4415661|P3|Double-Blind|Study Stopped|7
1341232|NCT01927055|4415662|P2|Double-Blind|Study Stopped|7
1341233|NCT01927055|4415663|P1|Double-Blind|Study Stopped|0
1341234|NCT01927055|4415661|P3|Double-Blind|Withdrawal by Subject|3
1341235|NCT01927055|4415662|P2|Double-Blind|Withdrawal by Subject|2
1341236|NCT01927055|4415663|P1|Double-Blind|Withdrawal by Subject|0
1341237|NCT01927055|4415661|P3|Double-Blind|Protocol Violation|1
1341238|NCT01927055|4415662|P2|Double-Blind|Protocol Violation|0
1341239|NCT01927055|4415663|P1|Double-Blind|Protocol Violation|0
1341240|NCT01927055|4415661|P3|Double-Blind|Adverse Event|1
1341241|NCT01927055|4415662|P2|Double-Blind|Adverse Event|1
1341242|NCT01927055|4415663|P1|Double-Blind|Adverse Event|0
1341243|NCT01927055|4415661|P3|Open-label|Difficulty attending study visits|0
1341244|NCT01927055|4415662|P2|Open-label|Difficulty attending study visits|0
1341245|NCT01927055|4415663|P1|Open-label|Difficulty attending study visits|1
1341246|NCT01927055|4415661|P3|Open-label|Supine Hypertension|0
1341247|NCT01927055|4415662|P2|Open-label|Supine Hypertension|0
1341248|NCT01927055|4415663|P1|Open-label|Supine Hypertension|4
1341249|NCT01927055|4415661|P3|Open-label|Study Stopped|0
1341250|NCT01927055|4415662|P2|Open-label|Study Stopped|0
1341251|NCT01927055|4415663|P1|Open-label|Study Stopped|4
1341252|NCT01927055|4415661|P3|Open-label|Withdrawal by Subject|0
1341253|NCT01927055|4415662|P2|Open-label|Withdrawal by Subject|0
1341254|NCT01927055|4415663|P1|Open-label|Withdrawal by Subject|1
1341255|NCT01927055|4415661|P3|Open-label|Adverse Event|0
1341256|NCT01927055|4415662|P2|Open-label|Adverse Event|0
1341257|NCT01927055|4415663|P1|Open-label|Adverse Event|6
1341258|NCT01926782|4415687|P6|Overall Study|Related to study drug administration|2
1341259|NCT01926782|4415688|P5|Overall Study|Related to study drug administration|0
1341260|NCT01926782|4415689|P4|Overall Study|Related to study drug administration|0
1341261|NCT01926782|4415690|P3|Overall Study|Related to study drug administration|0
1341262|NCT01926782|4415691|P2|Overall Study|Related to study drug administration|0
1341263|NCT01926782|4415692|P1|Overall Study|Related to study drug administration|0
1341264|NCT01926782|4415687|P6|Overall Study|Withdrawal by Subject|5
1341265|NCT01926782|4415688|P5|Overall Study|Withdrawal by Subject|0
1341266|NCT01926782|4415689|P4|Overall Study|Withdrawal by Subject|1
1341267|NCT01926782|4415690|P3|Overall Study|Withdrawal by Subject|8
1341268|NCT01926782|4415691|P2|Overall Study|Withdrawal by Subject|1
1341269|NCT01926782|4415692|P1|Overall Study|Withdrawal by Subject|6
1341270|NCT01926782|4415687|P6|Overall Study|Randomized and not treated|0
1341271|NCT01926782|4415688|P5|Overall Study|Randomized and not treated|0
1341272|NCT01926782|4415689|P4|Overall Study|Randomized and not treated|1
1341273|NCT01926782|4415690|P3|Overall Study|Randomized and not treated|0
1341274|NCT01926782|4415691|P2|Overall Study|Randomized and not treated|0
1341275|NCT01926782|4415692|P1|Overall Study|Randomized and not treated|0
1341276|NCT01926782|4415687|P6|Overall Study|Poor compliance to protocol|6
1341277|NCT01926782|4415688|P5|Overall Study|Poor compliance to protocol|1
1341278|NCT01926782|4415689|P4|Overall Study|Poor compliance to protocol|0
1341279|NCT01926782|4415690|P3|Overall Study|Poor compliance to protocol|8
1341280|NCT01926782|4415691|P2|Overall Study|Poor compliance to protocol|3
1341281|NCT01926782|4415692|P1|Overall Study|Poor compliance to protocol|5
1341282|NCT01926782|4415687|P6|Overall Study|Adverse Event|14
1341283|NCT01926782|4415688|P5|Overall Study|Adverse Event|3
1341284|NCT01926782|4415689|P4|Overall Study|Adverse Event|4
1341285|NCT01926782|4415690|P3|Overall Study|Adverse Event|17
1341286|NCT01926782|4415691|P2|Overall Study|Adverse Event|4
1341287|NCT01926782|4415692|P1|Overall Study|Adverse Event|13
1341288|NCT01926782|4415687|P6|Overall Study|Other than specified|11
1341289|NCT01926782|4415688|P5|Overall Study|Other than specified|4
1341290|NCT01926782|4415689|P4|Overall Study|Other than specified|12
1341291|NCT01926782|4415690|P3|Overall Study|Other than specified|5
1341292|NCT01926782|4415691|P2|Overall Study|Other than specified|3
1341293|NCT01926782|4415692|P1|Overall Study|Other than specified|2
1341294|NCT01926782|4415687|P6|Overall Study|Physician Decision|0
1341295|NCT01926782|4415688|P5|Overall Study|Physician Decision|0
1341296|NCT01926782|4415689|P4|Overall Study|Physician Decision|1
1341297|NCT01926782|4415690|P3|Overall Study|Physician Decision|1
1341298|NCT01926782|4415691|P2|Overall Study|Physician Decision|2
1341299|NCT01926782|4415692|P1|Overall Study|Physician Decision|0
1341300|NCT01926782|4415687|P6|Overall Study|Participant moved|3
1341301|NCT01926782|4415688|P5|Overall Study|Participant moved|0
1341302|NCT01926782|4415689|P4|Overall Study|Participant moved|1
1341303|NCT01926782|4415690|P3|Overall Study|Participant moved|1
1341304|NCT01926782|4415691|P2|Overall Study|Participant moved|0
1341305|NCT01926782|4415692|P1|Overall Study|Participant moved|2
1341306|NCT01926626|4415841|P1|Overall Study|Lost to Follow-up|7
1341307|NCT01926626|4415841|P1|Overall Study|Withdrawal by Subject|15
1341308|NCT01926119|4415851|P1|Overall Study|Withdrawal by Subject|1
1341309|NCT01926028|4415864|P3|Overall Study|Non compliance or other reasons|0
1341310|NCT01926028|4415865|P2|Overall Study|Non compliance or other reasons|2
1341311|NCT01926028|4415866|P1|Overall Study|Non compliance or other reasons|4
1341312|NCT01926028|4415864|P3|Overall Study|Withdrawal by Subject|2
1341313|NCT01926028|4415865|P2|Overall Study|Withdrawal by Subject|9
1341314|NCT01926028|4415866|P1|Overall Study|Withdrawal by Subject|9
1341315|NCT01926028|4415864|P3|Overall Study|Physician Decision|0
1341316|NCT01926028|4415865|P2|Overall Study|Physician Decision|5
1341317|NCT01926028|4415866|P1|Overall Study|Physician Decision|1
1341318|NCT01926028|4415864|P3|Overall Study|Lost to Follow-up|0
1341319|NCT01926028|4415865|P2|Overall Study|Lost to Follow-up|6
1341320|NCT01926028|4415866|P1|Overall Study|Lost to Follow-up|7
1341321|NCT01926015|4415902|P2|Overall Study|Randomized not treated|0
1341322|NCT01926015|4415903|P1|Overall Study|Randomized not treated|2
1341323|NCT01926015|4415902|P2|Overall Study|Withdrawal by parent/guardian|1
1341324|NCT01926015|4415903|P1|Overall Study|Withdrawal by parent/guardian|0
1341325|NCT01925768|4415946|P2|Overall Study|Non-compliance with study drug|1
1341326|NCT01925768|4415947|P1|Overall Study|Non-compliance with study drug|0
1341327|NCT01925768|4415946|P2|Overall Study|Withdrawal by Subject|4
1341328|NCT01925768|4415947|P1|Overall Study|Withdrawal by Subject|1
1341329|NCT01925768|4415946|P2|Overall Study|Lack of Efficacy|6
1341330|NCT01925768|4415947|P1|Overall Study|Lack of Efficacy|3
1341331|NCT01925768|4415946|P2|Overall Study|Adverse Event|10
1341332|NCT01925768|4415947|P1|Overall Study|Adverse Event|5
1341333|NCT01925768|4415946|P2|Overall Study|Protocol Violation|2
1341334|NCT01925768|4415947|P1|Overall Study|Protocol Violation|1
1341335|NCT01925768|4415946|P2|Overall Study|Lost to Follow-up|0
1341336|NCT01925768|4415947|P1|Overall Study|Lost to Follow-up|1
1341337|NCT01925703|4415955|P1|Overall Study|Discharge prior to full iron repletion|1
1341338|NCT01925703|4415955|P1|Overall Study|Lost to Follow-up|2
1341339|NCT01925703|4415955|P1|Overall Study|Physician Decision|1
1341340|NCT01925612|4415966|P5|Overall Study|Adverse Event|2
1341341|NCT01925612|4415967|P4|Overall Study|Adverse Event|1
1341342|NCT01925612|4415968|P3|Overall Study|Adverse Event|0
1341343|NCT01925612|4415969|P2|Overall Study|Adverse Event|3
1341344|NCT01925612|4415970|P1|Overall Study|Adverse Event|3
1341345|NCT01925612|4415966|P5|Overall Study|Progressive Disease|0
1341346|NCT01925612|4415967|P4|Overall Study|Progressive Disease|0
1341347|NCT01925612|4415968|P3|Overall Study|Progressive Disease|1
1341348|NCT01925612|4415969|P2|Overall Study|Progressive Disease|1
1341349|NCT01925612|4415970|P1|Overall Study|Progressive Disease|1
1341350|NCT01925417|4416020|P1|Overall Study|Death|1
1341351|NCT01925417|4416020|P1|Overall Study|Withdrawal by Subject|2
1341352|NCT01925274|4416051|P3|Overall Study|Protocol amendment|6
1341353|NCT01925274|4416052|P2|Overall Study|Protocol amendment|3
1341354|NCT01925274|4416053|P1|Overall Study|Protocol amendment|1
1341355|NCT01925274|4416051|P3|Overall Study|Study terminated by sponsor|0
1341356|NCT01925274|4416052|P2|Overall Study|Study terminated by sponsor|0
1341357|NCT01925274|4416053|P1|Overall Study|Study terminated by sponsor|4
1341358|NCT01925274|4416051|P3|Overall Study|Withdrawal by Subject|0
1341359|NCT01925274|4416052|P2|Overall Study|Withdrawal by Subject|2
1341360|NCT01925274|4416053|P1|Overall Study|Withdrawal by Subject|1
1341361|NCT01925274|4416051|P3|Overall Study|Lost to Follow-up|0
1341362|NCT01925274|4416052|P2|Overall Study|Lost to Follow-up|1
1341363|NCT01925274|4416053|P1|Overall Study|Lost to Follow-up|0
1341364|NCT01925274|4416051|P3|Overall Study|Death|0
1341365|NCT01925274|4416052|P2|Overall Study|Death|0
1341366|NCT01925274|4416053|P1|Overall Study|Death|1
1341367|NCT01925209|4416134|P4|Follow-up|Withdrawal by Subject|2
1341368|NCT01925209|4416135|P3|Follow-up|Withdrawal by Subject|0
1341369|NCT01925209|4416136|P2|Follow-up|Withdrawal by Subject|2
1341370|NCT01925209|4416137|P1|Follow-up|Withdrawal by Subject|0
1341371|NCT01925209|4416134|P4|Follow-up|Non-compliance with study treatment|1
1341372|NCT01925209|4416135|P3|Follow-up|Non-compliance with study treatment|0
1341373|NCT01925209|4416136|P2|Follow-up|Non-compliance with study treatment|0
1341374|NCT01925209|4416137|P1|Follow-up|Non-compliance with study treatment|0
1341375|NCT01925209|4416134|P4|Follow-up|Physician Decision|0
1341376|NCT01925209|4416135|P3|Follow-up|Physician Decision|1
1341377|NCT01925209|4416136|P2|Follow-up|Physician Decision|0
1341378|NCT01925209|4416137|P1|Follow-up|Physician Decision|0
1341379|NCT01925209|4416134|P4|Follow-up|Adverse Event|1
1341380|NCT01925209|4416135|P3|Follow-up|Adverse Event|0
1341381|NCT01925209|4416136|P2|Follow-up|Adverse Event|4
1341382|NCT01925209|4416137|P1|Follow-up|Adverse Event|1
1341383|NCT01925209|4416134|P4|Maintenance Treatment Epoch|Adverse Event|0
1341384|NCT01925209|4416135|P3|Maintenance Treatment Epoch|Adverse Event|1
1341385|NCT01925209|4416136|P2|Maintenance Treatment Epoch|Adverse Event|0
1341386|NCT01925209|4416137|P1|Maintenance Treatment Epoch|Adverse Event|0
1341387|NCT01925209|4416134|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
1341388|NCT01925209|4416135|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
1341389|NCT01925209|4416136|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
1341390|NCT01925209|4416137|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
1341391|NCT01925209|4416134|P4|Treatment Epoch|Adverse Event|1
1341392|NCT01925209|4416135|P3|Treatment Epoch|Adverse Event|3
1341393|NCT01925209|4416136|P2|Treatment Epoch|Adverse Event|5
1341394|NCT01925209|4416137|P1|Treatment Epoch|Adverse Event|3
1341395|NCT01925209|4416134|P4|Treatment Epoch|Withdrawal by Subject|2
1341396|NCT01925209|4416135|P3|Treatment Epoch|Withdrawal by Subject|3
1341397|NCT01925209|4416136|P2|Treatment Epoch|Withdrawal by Subject|3
1341398|NCT01925209|4416137|P1|Treatment Epoch|Withdrawal by Subject|4
1341399|NCT01925209|4416134|P4|Treatment Epoch|Protocol deviation|1
1341400|NCT01925209|4416135|P3|Treatment Epoch|Protocol deviation|1
1341401|NCT01925209|4416136|P2|Treatment Epoch|Protocol deviation|0
1341402|NCT01925209|4416137|P1|Treatment Epoch|Protocol deviation|0
1341403|NCT01925209|4416134|P4|Treatment Epoch|Death|0
1341404|NCT01925209|4416135|P3|Treatment Epoch|Death|0
1341405|NCT01925209|4416136|P2|Treatment Epoch|Death|0
1341406|NCT01925209|4416137|P1|Treatment Epoch|Death|1
1341407|NCT01925209|4416134|P4|Treatment Epoch|Non-compliance with study treatment|1
1341408|NCT01925209|4416135|P3|Treatment Epoch|Non-compliance with study treatment|0
1341409|NCT01925209|4416136|P2|Treatment Epoch|Non-compliance with study treatment|0
1341410|NCT01925209|4416137|P1|Treatment Epoch|Non-compliance with study treatment|0
1341411|NCT01925209|4416134|P4|Treatment Epoch|Physician Decision|0
1341412|NCT01925209|4416135|P3|Treatment Epoch|Physician Decision|0
1341413|NCT01925209|4416136|P2|Treatment Epoch|Physician Decision|0
1341414|NCT01925209|4416137|P1|Treatment Epoch|Physician Decision|1
1341415|NCT01925183|4416169|P2|Overall Study|Adverse Event|0
1341416|NCT01925183|4416170|P1|Overall Study|Adverse Event|1
1341417|NCT01925170|4416178|P1|Overall Study|Unverified cancer status|53
1341418|NCT01924845|4416238|P1|Overall Study|Protocol Violation|1
1341419|NCT01924845|4416238|P1|Overall Study|Withdrawal by Subject|2
1341420|NCT01924845|4416238|P1|Overall Study|Adverse Event|3
1341421|NCT01924767|4416251|P5|Overall Study|Adverse Event|0
1341422|NCT01924767|4416252|P4|Overall Study|Adverse Event|0
1341423|NCT01924767|4416253|P3|Overall Study|Adverse Event|1
1341424|NCT01924767|4416254|P2|Overall Study|Adverse Event|0
1341425|NCT01924767|4416255|P1|Overall Study|Adverse Event|1
1341426|NCT01924429|4416371|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
1341427|NCT01924429|4416372|P1|Washout Period (2 Weeks)|Withdrawal by Subject|3
1341428|NCT01924364|4416415|P1|Overall Study|Physician Decision|3
1341429|NCT01924299|4416432|P2|Period 2|Adverse Event|1
1341430|NCT01924299|4416433|P1|Period 2|Adverse Event|0
1341431|NCT01924299|4416432|P2|Period 2|Withdrawal by Subject|0
1341432|NCT01924299|4416433|P1|Period 2|Withdrawal by Subject|1
1341433|NCT01924182|4416455|P2|Overall Study|Withdrawal by Subject|0
1341434|NCT01924182|4416456|P1|Overall Study|Withdrawal by Subject|1
1341435|NCT01923896|4416475|P2|Overall Study|Adverse Event|0
1341436|NCT01923896|4416476|P1|Overall Study|Adverse Event|1
1341437|NCT01923740|4416499|P2|3 Year Clinical Follow-up|Death|0
1341438|NCT01923740|4416500|P1|3 Year Clinical Follow-up|Death|1
1341439|NCT01923740|4416499|P2|2 Year Clinical Follow-up|ICF withdrawal|0
1341440|NCT01923740|4416500|P1|2 Year Clinical Follow-up|ICF withdrawal|1
1341441|NCT01923740|4416499|P2|2 Year Clinical Follow-up|Lost to Follow-up|2
1341442|NCT01923740|4416500|P1|2 Year Clinical Follow-up|Lost to Follow-up|0
1341443|NCT01923740|4416499|P2|2 Year Clinical Follow-up|Death|1
1341444|NCT01923740|4416500|P1|2 Year Clinical Follow-up|Death|1
1341445|NCT01923740|4416499|P2|1 Year Clinical Follow-up|Lost to Follow-up|0
1341446|NCT01923740|4416500|P1|1 Year Clinical Follow-up|Lost to Follow-up|1
1341447|NCT01923740|4416499|P2|270-day Clinical Follow-up|Death|4
1341448|NCT01923740|4416500|P1|270-day Clinical Follow-up|Death|0
1341449|NCT01923467|4416877|P1|Overall Study|Subject non-interest|479
1341450|NCT01923467|4416877|P1|Overall Study|Lost to Follow-up|62
1341451|NCT01923389|4416883|P2|Overall Study|Protocol Violation|0
1341452|NCT01923389|4416884|P1|Overall Study|Protocol Violation|1
1341453|NCT01923311|4416908|P2|Overall Study|Study Terminated by Sponsor|0
1341454|NCT01923311|4416909|P1|Overall Study|Study Terminated by Sponsor|12
1341455|NCT01923311|4416908|P2|Overall Study|Withdrew Consent|0
1341456|NCT01923311|4416909|P1|Overall Study|Withdrew Consent|1
1341457|NCT01923311|4416908|P2|Overall Study|Non-Compliance with Study Drug|1
1341458|NCT01923311|4416909|P1|Overall Study|Non-Compliance with Study Drug|2
1341459|NCT01923311|4416908|P2|Overall Study|Investigator's Discretion|0
1341460|NCT01923311|4416909|P1|Overall Study|Investigator's Discretion|1
1341461|NCT01923311|4416908|P2|Overall Study|Pregnancy|0
1341462|NCT01923311|4416909|P1|Overall Study|Pregnancy|1
1341463|NCT01922934|4416967|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
1341464|NCT01922934|4416968|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
1341465|NCT01922934|4416967|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
1341466|NCT01922934|4416968|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
1341467|NCT01922934|4416967|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
1341468|NCT01922934|4416968|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
1341469|NCT01922934|4416967|P2|Eligible Patients|Did not meet inclusion criteria|81
1341470|NCT01922934|4416968|P1|Eligible Patients|Did not meet inclusion criteria|36
1341471|NCT01922934|4416967|P2|Eligible Patients|Physician Decision|0
1341472|NCT01922934|4416968|P1|Eligible Patients|Physician Decision|17
1341473|NCT01922934|4416967|P2|Eligible Patients|Death|7
1341474|NCT01922934|4416968|P1|Eligible Patients|Death|0
1341475|NCT01922739|4416980|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
1341476|NCT01922739|4416980|P1|Open-label Treatment Period|Physician Decision|1
1341477|NCT01922739|4416980|P1|Open-label Treatment Period|Lost to Follow-up|2
1341478|NCT01922739|4416980|P1|Open-label Treatment Period|Noncompliance to study procedures|1
1341479|NCT01922739|4416980|P1|Open-label Treatment Period|Pregnancy|1
1341480|NCT01922739|4416980|P1|Open-label Treatment Period|Protocol Violation|5
1341481|NCT01922739|4416980|P1|Open-label Treatment Period|Noncompliance to study medication|3
1341482|NCT01922739|4416980|P1|Open-label Treatment Period|Withdrawal by Subject|14
1341483|NCT01922739|4416980|P1|Open-label Treatment Period|Adverse Event|6
1341484|NCT01922739|4416980|P1|Titration/Adjustment Period|Lack of Efficacy|3
1341485|NCT01922739|4416980|P1|Titration/Adjustment Period|Lost to Follow-up|1
1341486|NCT01922739|4416980|P1|Titration/Adjustment Period|Withdrawal by Subject|5
1341487|NCT01922739|4416980|P1|Titration/Adjustment Period|Adverse Event|3
1341488|NCT01922349|4417009|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
1341489|NCT01922349|4417010|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
1341490|NCT01922349|4417011|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
1341491|NCT01922349|4417012|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
1341492|NCT01922271|4417119|P2|WASHOUT Period|Withdrawal by Subject|0
1341493|NCT01922271|4417120|P1|WASHOUT Period|Withdrawal by Subject|1
1341494|NCT01922089|4417161|P2|Overall Study|Lost to Follow-up|1
1341495|NCT01922089|4417162|P1|Overall Study|Lost to Follow-up|0
1341496|NCT01922089|4417161|P2|Overall Study|Death|1
1341497|NCT01922089|4417162|P1|Overall Study|Death|2
1341498|NCT01922089|4417161|P2|Overall Study|Physician Decision|3
1341499|NCT01922089|4417162|P1|Overall Study|Physician Decision|2
1341500|NCT01922089|4417161|P2|Overall Study|administrative problems|1
1341501|NCT01922089|4417162|P1|Overall Study|administrative problems|4
1341502|NCT01922089|4417161|P2|Overall Study|Withdrawal by Subject|4
1341503|NCT01922089|4417162|P1|Overall Study|Withdrawal by Subject|3
1341504|NCT01922089|4417161|P2|Overall Study|Protocol Deviation|7
1341505|NCT01922089|4417162|P1|Overall Study|Protocol Deviation|10
1341506|NCT01922089|4417161|P2|Overall Study|Adverse Event|13
1341507|NCT01922089|4417162|P1|Overall Study|Adverse Event|18
1341508|NCT01922037|4417174|P2|Overall Study|Other unspecified|66
1341509|NCT01922037|4417175|P1|Overall Study|Other unspecified|2
1341510|NCT01922037|4417174|P2|Overall Study|Investigator/Sponsor decision|4
1341511|NCT01922037|4417175|P1|Overall Study|Investigator/Sponsor decision|1
1341512|NCT01922037|4417174|P2|Overall Study|Participant non-compliance|46
1341513|NCT01922037|4417175|P1|Overall Study|Participant non-compliance|4
1341514|NCT01922037|4417174|P2|Overall Study|Pregnancy|2
1341515|NCT01922037|4417175|P1|Overall Study|Pregnancy|0
1341516|NCT01922037|4417174|P2|Overall Study|Death|5
1341517|NCT01922037|4417175|P1|Overall Study|Death|0
1341518|NCT01922037|4417174|P2|Overall Study|Adverse Event|7
1341519|NCT01922037|4417175|P1|Overall Study|Adverse Event|1
1341520|NCT01922037|4417174|P2|Overall Study|Withdrawal by Subject|44
1341521|NCT01922037|4417175|P1|Overall Study|Withdrawal by Subject|2
1341522|NCT01922011|4417269|P2|Overall Study|Randomized in error|0
1341523|NCT01922011|4417270|P1|Overall Study|Randomized in error|1
1341524|NCT01922011|4417269|P2|Overall Study|Lack of willing home health agency|0
1341525|NCT01922011|4417270|P1|Overall Study|Lack of willing home health agency|1
1341526|NCT01922011|4417269|P2|Overall Study|Not Treated|0
1341527|NCT01922011|4417270|P1|Overall Study|Not Treated|1
1341528|NCT01922011|4417269|P2|Overall Study|Missed Test-of-Cure Visit|2
1341529|NCT01922011|4417270|P1|Overall Study|Missed Test-of-Cure Visit|0
1341530|NCT01922011|4417269|P2|Overall Study|Lost to Follow-up|1
1341531|NCT01922011|4417270|P1|Overall Study|Lost to Follow-up|0
1341532|NCT01922011|4417269|P2|Overall Study|Parent/Guardian Decision|0
1341533|NCT01922011|4417270|P1|Overall Study|Parent/Guardian Decision|3
1341534|NCT01922011|4417269|P2|Overall Study|Physician Decision|1
1341535|NCT01922011|4417270|P1|Overall Study|Physician Decision|0
1341536|NCT01922011|4417269|P2|Overall Study|Protocol Violation|1
1341537|NCT01922011|4417270|P1|Overall Study|Protocol Violation|0
1341538|NCT01921829|4417337|P2|Overall Study|Withdrawal by Subject|1
1341539|NCT01921829|4417338|P1|Overall Study|Withdrawal by Subject|0
1341540|NCT01921348|4417414|P2|Overall Study|Lost to Follow-up|2
1341541|NCT01921348|4417415|P1|Overall Study|Lost to Follow-up|0
1341542|NCT01921348|4417414|P2|Overall Study|Withdrawal by Subject|0
1341543|NCT01921348|4417415|P1|Overall Study|Withdrawal by Subject|1
1341544|NCT01921270|4417444|P1|Overall Study|Withdrawal by Subject|1
1341545|NCT01921257|4417460|P1|Overall Study|Withdrawal by Subject|1
1341546|NCT01921257|4417460|P1|Overall Study|Protocol Violation|1
1341547|NCT01921257|4417460|P1|Overall Study|Adverse Event|1
1341548|NCT01921205|4417467|P2|Overall Study|Non Compliance Of Child|1
1341549|NCT01921205|4417468|P1|Overall Study|Non Compliance Of Child|0
1341550|NCT01921205|4417467|P2|Overall Study|Non Compliance Of The Parent|1
1341551|NCT01921205|4417468|P1|Overall Study|Non Compliance Of The Parent|0
1341552|NCT01921205|4417467|P2|Overall Study|The Excessive Use Of Rescue Medication|1
1341553|NCT01921205|4417468|P1|Overall Study|The Excessive Use Of Rescue Medication|0
1341554|NCT01921205|4417467|P2|Overall Study|Use Of Prohibited Medication|1
1341555|NCT01921205|4417468|P1|Overall Study|Use Of Prohibited Medication|0
1341556|NCT01921205|4417467|P2|Overall Study|Withdrawal by Subject|5
1341557|NCT01921205|4417468|P1|Overall Study|Withdrawal by Subject|6
1341558|NCT01921205|4417467|P2|Overall Study|Lost to Follow-up|1
1341559|NCT01921205|4417468|P1|Overall Study|Lost to Follow-up|1
1341560|NCT01921205|4417467|P2|Overall Study|Protocol Violation|3
1341561|NCT01921205|4417468|P1|Overall Study|Protocol Violation|1
1341562|NCT01921205|4417467|P2|Overall Study|Lack of Efficacy|0
1341563|NCT01921205|4417468|P1|Overall Study|Lack of Efficacy|1
1341564|NCT01921205|4417467|P2|Overall Study|Adverse Event|7
1341565|NCT01921205|4417468|P1|Overall Study|Adverse Event|12
1341566|NCT01921101|4417509|P2|Overall Study|Death|6
1341567|NCT01921101|4417510|P1|Overall Study|Death|16
1341568|NCT01920958|4417518|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
1341569|NCT01920893|4417536|P2|Overall Study|Lack of Efficacy|0
1341570|NCT01920893|4417537|P1|Overall Study|Lack of Efficacy|2
1341571|NCT01920893|4417536|P2|Overall Study|Adverse Event|2
1341572|NCT01920893|4417537|P1|Overall Study|Adverse Event|5
1341573|NCT01920854|4417570|P7|Overall Study|Withdrawal by Subject|1
1341574|NCT01920854|4417571|P6|Overall Study|Withdrawal by Subject|0
1341575|NCT01920854|4417572|P5|Overall Study|Withdrawal by Subject|1
1341576|NCT01920854|4417573|P4|Overall Study|Withdrawal by Subject|0
1341577|NCT01920854|4417574|P3|Overall Study|Withdrawal by Subject|0
1341578|NCT01920854|4417575|P2|Overall Study|Withdrawal by Subject|0
1341579|NCT01920854|4417576|P1|Overall Study|Withdrawal by Subject|1
1341580|NCT01920594|4417736|P2|Overall Study|Investigator discretion|1
1341581|NCT01920594|4417737|P1|Overall Study|Investigator discretion|0
1341582|NCT01920594|4417736|P2|Overall Study|Recovery|0
1341583|NCT01920594|4417737|P1|Overall Study|Recovery|2
1341584|NCT01920594|4417736|P2|Overall Study|Lost to Follow-up|0
1341585|NCT01920594|4417737|P1|Overall Study|Lost to Follow-up|1
1341586|NCT01920594|4417736|P2|Overall Study|Adverse Event|2
1341587|NCT01920594|4417737|P1|Overall Study|Adverse Event|4
1341588|NCT01920568|4417787|P2|Overall Study|Death due to disease progression|12
1341589|NCT01920568|4417788|P1|Overall Study|Death due to disease progression|25
1341590|NCT01920568|4417787|P2|Overall Study|Withdrawal by Subject|55
1341591|NCT01920568|4417788|P1|Overall Study|Withdrawal by Subject|79
1341592|NCT01920568|4417787|P2|Overall Study|Physician Decision|4
1341593|NCT01920568|4417788|P1|Overall Study|Physician Decision|13
1341594|NCT01920568|4417787|P2|Overall Study|Lost to Follow-up|2
1341595|NCT01920568|4417788|P1|Overall Study|Lost to Follow-up|2
1341596|NCT01920568|4417787|P2|Overall Study|Protocol Violation|3
1341597|NCT01920568|4417788|P1|Overall Study|Protocol Violation|5
1341598|NCT01920568|4417787|P2|Overall Study|Adverse Event|8
1341599|NCT01920568|4417788|P1|Overall Study|Adverse Event|27
1341600|NCT01920555|4417814|P5|Overall Study|Lost to Follow-up|0
1341601|NCT01920555|4417815|P4|Overall Study|Lost to Follow-up|1
1341602|NCT01920555|4417816|P3|Overall Study|Lost to Follow-up|0
1341603|NCT01920555|4417817|P2|Overall Study|Lost to Follow-up|1
1341604|NCT01920555|4417818|P1|Overall Study|Lost to Follow-up|0
1341605|NCT01920555|4417814|P5|Overall Study|Travel Difficulties|1
1341606|NCT01920555|4417815|P4|Overall Study|Travel Difficulties|0
1341607|NCT01920555|4417816|P3|Overall Study|Travel Difficulties|0
1341608|NCT01920555|4417817|P2|Overall Study|Travel Difficulties|1
1341609|NCT01920555|4417818|P1|Overall Study|Travel Difficulties|1
1341610|NCT01920555|4417814|P5|Overall Study|Lack of Efficacy|0
1341611|NCT01920555|4417815|P4|Overall Study|Lack of Efficacy|0
1341612|NCT01920555|4417816|P3|Overall Study|Lack of Efficacy|0
1341613|NCT01920555|4417817|P2|Overall Study|Lack of Efficacy|0
1341614|NCT01920555|4417818|P1|Overall Study|Lack of Efficacy|2
1341615|NCT01920555|4417814|P5|Overall Study|Physician Decision|0
1341616|NCT01920555|4417815|P4|Overall Study|Physician Decision|2
1341617|NCT01920555|4417816|P3|Overall Study|Physician Decision|1
1341618|NCT01920555|4417817|P2|Overall Study|Physician Decision|2
1341619|NCT01920555|4417818|P1|Overall Study|Physician Decision|1
1341620|NCT01920178|4417893|P2|Overall Study|Lost to Follow-up|1
1341621|NCT01920178|4417894|P1|Overall Study|Lost to Follow-up|2
1341622|NCT01919801|4417912|P2|Overall Study|Other|1
1341623|NCT01919801|4417913|P1|Overall Study|Other|0
1341624|NCT01919801|4417912|P2|Overall Study|Lost to Follow-up|1
1341625|NCT01919801|4417913|P1|Overall Study|Lost to Follow-up|0
1341626|NCT01919801|4417912|P2|Overall Study|Physician Decision|1
1341627|NCT01919801|4417913|P1|Overall Study|Physician Decision|0
1341628|NCT01919801|4417912|P2|Overall Study|Withdrawal by Subject|0
1341629|NCT01919801|4417913|P1|Overall Study|Withdrawal by Subject|1
1341630|NCT01919723|4417938|P2|Overall Study|Blood Samples Hemolyzed|2
1341631|NCT01919723|4417939|P1|Overall Study|Blood Samples Hemolyzed|2
1341632|NCT01919307|4417979|P1|Overall Study|Withdrawal by Subject|9
1341633|NCT01919229|4417989|P3|Overall Study|Subject/guardian decision|1
1341634|NCT01919229|4417990|P2|Overall Study|Subject/guardian decision|0
1341635|NCT01919229|4417991|P1|Overall Study|Subject/guardian decision|0
1341636|NCT01918371|4418056|P2|Overall Study|Missing Data|1
1341637|NCT01918371|4418057|P1|Overall Study|Missing Data|1
1341638|NCT01918332|4418135|P4|Overall Study|lipid result by central lab did not meet|0
1341639|NCT01918332|4418136|P3|Overall Study|lipid result by central lab did not meet|1
1341640|NCT01918332|4418137|P2|Overall Study|lipid result by central lab did not meet|0
1341641|NCT01918332|4418138|P1|Overall Study|lipid result by central lab did not meet|0
1341642|NCT01918332|4418135|P4|Overall Study|Protocol Violation|3
1341643|NCT01918332|4418136|P3|Overall Study|Protocol Violation|6
1341644|NCT01918332|4418137|P2|Overall Study|Protocol Violation|2
1341645|NCT01918332|4418138|P1|Overall Study|Protocol Violation|6
1341646|NCT01918332|4418135|P4|Overall Study|Withdrawal by Subject|3
1341647|NCT01918332|4418136|P3|Overall Study|Withdrawal by Subject|2
1341648|NCT01918332|4418137|P2|Overall Study|Withdrawal by Subject|3
1341649|NCT01918332|4418138|P1|Overall Study|Withdrawal by Subject|2
1341650|NCT01918332|4418135|P4|Overall Study|Adverse Event|1
1341651|NCT01918332|4418136|P3|Overall Study|Adverse Event|0
1341652|NCT01918332|4418137|P2|Overall Study|Adverse Event|0
1341653|NCT01918332|4418138|P1|Overall Study|Adverse Event|0
1341654|NCT01918306|4418150|P4|Overall Study|progress disease, crossover|0
1341655|NCT01918306|4418151|P3|Overall Study|progress disease, crossover|1
1341656|NCT01918306|4418152|P2|Overall Study|progress disease, crossover|0
1341657|NCT01918306|4418153|P1|Overall Study|progress disease, crossover|0
1341658|NCT01918306|4418150|P4|Overall Study|Lack of Efficacy|0
1341659|NCT01918306|4418151|P3|Overall Study|Lack of Efficacy|0
1341660|NCT01918306|4418152|P2|Overall Study|Lack of Efficacy|0
1341661|NCT01918306|4418153|P1|Overall Study|Lack of Efficacy|1
1341662|NCT01918306|4418150|P4|Overall Study|neutropenia|0
1341663|NCT01918306|4418151|P3|Overall Study|neutropenia|0
1341664|NCT01918306|4418152|P2|Overall Study|neutropenia|0
1341665|NCT01918306|4418153|P1|Overall Study|neutropenia|1
1341666|NCT01918306|4418150|P4|Overall Study|Withdrawal by Subject|2
1341667|NCT01918306|4418151|P3|Overall Study|Withdrawal by Subject|0
1341668|NCT01918306|4418152|P2|Overall Study|Withdrawal by Subject|0
1341669|NCT01918306|4418153|P1|Overall Study|Withdrawal by Subject|0
1341670|NCT01918306|4418150|P4|Overall Study|progresive disease|1
1341671|NCT01918306|4418151|P3|Overall Study|progresive disease|1
1341672|NCT01918306|4418152|P2|Overall Study|progresive disease|0
1341673|NCT01918306|4418153|P1|Overall Study|progresive disease|4
1341674|NCT01918085|4418175|P2|Test Period 1: Strata Strip|Adverse Event|1
1341675|NCT01918085|4418176|P1|Test Period 1: Strata Strip|Adverse Event|0
1341676|NCT01918033|4418187|P3|Overall Study|Withdrawal by Subject|0
1341677|NCT01918033|4418188|P2|Overall Study|Withdrawal by Subject|1
1341678|NCT01918033|4418189|P1|Overall Study|Withdrawal by Subject|2
1341679|NCT01918033|4418187|P3|Overall Study|Protocol Violation|1
1341680|NCT01918033|4418188|P2|Overall Study|Protocol Violation|0
1341681|NCT01918033|4418189|P1|Overall Study|Protocol Violation|2
1341682|NCT01918033|4418187|P3|Overall Study|Lost to Follow-up|0
1341683|NCT01918033|4418188|P2|Overall Study|Lost to Follow-up|1
1341684|NCT01918033|4418189|P1|Overall Study|Lost to Follow-up|0
1341685|NCT01918033|4418187|P3|Overall Study|Adverse Event|2
1341686|NCT01918033|4418188|P2|Overall Study|Adverse Event|0
1341687|NCT01918033|4418189|P1|Overall Study|Adverse Event|1
1341688|NCT01917656|4418260|P2|Overall Study|Lost to Follow-up|4
1341689|NCT01917656|4418261|P1|Overall Study|Lost to Follow-up|3
1341690|NCT01917656|4418260|P2|Overall Study|Withdrawal by Subject|3
1341691|NCT01917656|4418261|P1|Overall Study|Withdrawal by Subject|4
1341692|NCT01917656|4418260|P2|Overall Study|Unclassified|3
1341693|NCT01917656|4418261|P1|Overall Study|Unclassified|0
1341694|NCT01917656|4418260|P2|Overall Study|Withdrawal criteria|14
1341695|NCT01917656|4418261|P1|Overall Study|Withdrawal criteria|8
1341696|NCT01917656|4418260|P2|Overall Study|Adverse Event|0
1341697|NCT01917656|4418261|P1|Overall Study|Adverse Event|11
1341698|NCT01917526|4418287|P2|Overall Study|Protocol Violation|1
1341699|NCT01917526|4418288|P1|Overall Study|Protocol Violation|1
1341700|NCT01917344|4418305|P1|Overall Study|Withdrawal by Subject|1
1341701|NCT01916980|4418320|P2|Overall Study|Withdrawal by Subject|0
1341702|NCT01916980|4418321|P1|Overall Study|Withdrawal by Subject|1
1341703|NCT01916980|4418320|P2|Overall Study|Lack of Efficacy|2
1341704|NCT01916980|4418321|P1|Overall Study|Lack of Efficacy|2
1341705|NCT01916980|4418320|P2|Overall Study|Adverse Event|2
1341706|NCT01916980|4418321|P1|Overall Study|Adverse Event|4
1341707|NCT01916967|4418340|P3|Overall Study|Protocol Violation|0
1341708|NCT01916967|4418341|P2|Overall Study|Protocol Violation|1
1341709|NCT01916967|4418342|P1|Overall Study|Protocol Violation|0
1341710|NCT01916967|4418340|P3|Overall Study|Physician Decision|1
1341711|NCT01916967|4418341|P2|Overall Study|Physician Decision|0
1341712|NCT01916967|4418342|P1|Overall Study|Physician Decision|0
1341713|NCT01916967|4418340|P3|Overall Study|Lack of Efficacy|6
1341714|NCT01916967|4418341|P2|Overall Study|Lack of Efficacy|0
1341715|NCT01916967|4418342|P1|Overall Study|Lack of Efficacy|0
1341716|NCT01916967|4418340|P3|Overall Study|Adverse Event|2
1341717|NCT01916967|4418341|P2|Overall Study|Adverse Event|0
1341718|NCT01916967|4418342|P1|Overall Study|Adverse Event|0
1341719|NCT01916824|4418398|P2|Overall Study|Withdrawal by Subject|3
1341720|NCT01916824|4418399|P1|Overall Study|Withdrawal by Subject|2
1341721|NCT01916824|4418398|P2|Overall Study|Physician Decision|0
1341722|NCT01916824|4418399|P1|Overall Study|Physician Decision|2
1341723|NCT01916824|4418398|P2|Overall Study|Lost to Follow-up|6
1341724|NCT01916824|4418399|P1|Overall Study|Lost to Follow-up|3
1341725|NCT01916304|4418468|P1|Overall Study|Screening failure|17
1341726|NCT01916226|4418480|P4|Overall Study|Physician Decision|1
1341727|NCT01916226|4418481|P3|Overall Study|Physician Decision|0
1341728|NCT01916226|4418482|P2|Overall Study|Physician Decision|0
1341729|NCT01916226|4418483|P1|Overall Study|Physician Decision|0
1341730|NCT01916226|4418480|P4|Overall Study|Protocol Violation|1
1341731|NCT01916226|4418481|P3|Overall Study|Protocol Violation|0
1341732|NCT01916226|4418482|P2|Overall Study|Protocol Violation|1
1341733|NCT01916226|4418483|P1|Overall Study|Protocol Violation|0
1341734|NCT01916226|4418480|P4|Overall Study|Lack of Efficacy|1
1341735|NCT01916226|4418481|P3|Overall Study|Lack of Efficacy|2
1341736|NCT01916226|4418482|P2|Overall Study|Lack of Efficacy|0
1341737|NCT01916226|4418483|P1|Overall Study|Lack of Efficacy|0
1341738|NCT01916226|4418480|P4|Overall Study|Adverse Event|1
1341739|NCT01916226|4418481|P3|Overall Study|Adverse Event|1
1341740|NCT01916226|4418482|P2|Overall Study|Adverse Event|0
1341741|NCT01916226|4418483|P1|Overall Study|Adverse Event|1
1341742|NCT01916109|4418517|P1|Overall Study|Withdrawal by Subject|1
1341743|NCT01915940|4418523|P3|Treatment Period|Other Miscellaneous Reasons|0
1341744|NCT01915940|4418524|P2|Treatment Period|Other Miscellaneous Reasons|1
1341745|NCT01915940|4418525|P1|Treatment Period|Other Miscellaneous Reasons|0
1341746|NCT01915940|4418523|P3|Treatment Period|Adverse Event|1
1341747|NCT01915940|4418524|P2|Treatment Period|Adverse Event|9
1341748|NCT01915940|4418525|P1|Treatment Period|Adverse Event|0
1341749|NCT01915940|4418523|P3|Treatment Period|Decision of Participant|3
1341750|NCT01915940|4418524|P2|Treatment Period|Decision of Participant|1
1341751|NCT01915940|4418525|P1|Treatment Period|Decision of Participant|0
1341752|NCT01915940|4418523|P3|Pre-randomization Washout Period|Not Qualified for Randomization|0
1341753|NCT01915940|4418524|P2|Pre-randomization Washout Period|Not Qualified for Randomization|0
1341754|NCT01915940|4418525|P1|Pre-randomization Washout Period|Not Qualified for Randomization|39
1341755|NCT01915914|4418541|P4|Follow-up Phase|Physician Decision|1
1341756|NCT01915914|4418542|P3|Follow-up Phase|Physician Decision|0
1341757|NCT01915914|4418543|P2|Follow-up Phase|Physician Decision|0
1341758|NCT01915914|4418544|P1|Follow-up Phase|Physician Decision|0
1341759|NCT01915914|4418541|P4|Follow-up Phase|Withdrawal by Subject|1
1341760|NCT01915914|4418542|P3|Follow-up Phase|Withdrawal by Subject|0
1341761|NCT01915914|4418543|P2|Follow-up Phase|Withdrawal by Subject|0
1341762|NCT01915914|4418544|P1|Follow-up Phase|Withdrawal by Subject|0
1341763|NCT01915914|4418541|P4|Maintenance Phase|Missing|0
1341764|NCT01915914|4418542|P3|Maintenance Phase|Missing|0
1341765|NCT01915914|4418543|P2|Maintenance Phase|Missing|1
1341766|NCT01915914|4418544|P1|Maintenance Phase|Missing|0
1341767|NCT01915914|4418541|P4|Maintenance Phase|Lost to Follow-up|0
1341768|NCT01915914|4418542|P3|Maintenance Phase|Lost to Follow-up|1
1341769|NCT01915914|4418543|P2|Maintenance Phase|Lost to Follow-up|4
1341770|NCT01915914|4418544|P1|Maintenance Phase|Lost to Follow-up|0
1341771|NCT01915914|4418541|P4|Maintenance Phase|Withdrawal by Subject|0
1341772|NCT01915914|4418542|P3|Maintenance Phase|Withdrawal by Subject|1
1341773|NCT01915914|4418543|P2|Maintenance Phase|Withdrawal by Subject|1
1341774|NCT01915914|4418544|P1|Maintenance Phase|Withdrawal by Subject|0
1341775|NCT01915914|4418541|P4|Acute Phase|Missing|0
1341776|NCT01915914|4418542|P3|Acute Phase|Missing|0
1341777|NCT01915914|4418543|P2|Acute Phase|Missing|0
1341778|NCT01915914|4418544|P1|Acute Phase|Missing|1
1341779|NCT01915914|4418541|P4|Acute Phase|"Not Achieved treatment success"|0
1341780|NCT01915914|4418542|P3|Acute Phase|"Not Achieved treatment success"|0
1341781|NCT01915914|4418543|P2|Acute Phase|"Not Achieved treatment success"|0
1341782|NCT01915914|4418544|P1|Acute Phase|"Not Achieved treatment success"|1
1341783|NCT01915914|4418541|P4|Acute Phase|Accepted Other Topic Therapies|0
1341784|NCT01915914|4418542|P3|Acute Phase|Accepted Other Topic Therapies|0
1341785|NCT01915914|4418543|P2|Acute Phase|Accepted Other Topic Therapies|0
1341786|NCT01915914|4418544|P1|Acute Phase|Accepted Other Topic Therapies|1
1341787|NCT01915914|4418541|P4|Acute Phase|Physician Decision|0
1341788|NCT01915914|4418542|P3|Acute Phase|Physician Decision|0
1341789|NCT01915914|4418543|P2|Acute Phase|Physician Decision|0
1341790|NCT01915914|4418544|P1|Acute Phase|Physician Decision|1
1341791|NCT01915914|4418541|P4|Acute Phase|Lost to Follow-up|0
1341792|NCT01915914|4418542|P3|Acute Phase|Lost to Follow-up|0
1341793|NCT01915914|4418543|P2|Acute Phase|Lost to Follow-up|0
1341794|NCT01915914|4418544|P1|Acute Phase|Lost to Follow-up|4
1341795|NCT01915914|4418541|P4|Acute Phase|Withdrawal by Subject|0
1341796|NCT01915914|4418542|P3|Acute Phase|Withdrawal by Subject|0
1341797|NCT01915914|4418543|P2|Acute Phase|Withdrawal by Subject|0
1341798|NCT01915914|4418544|P1|Acute Phase|Withdrawal by Subject|4
1341799|NCT01915849|4418576|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1341800|NCT01915849|4418577|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1341801|NCT01915849|4418578|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1341802|NCT01915849|4418579|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
1341803|NCT01915849|4418576|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
1341804|NCT01915849|4418577|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
1341805|NCT01915849|4418578|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
1341806|NCT01915849|4418579|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
1341807|NCT01915732|4418604|P2|Overall Study|Poor Conscious Effect|1
1341808|NCT01915732|4418605|P1|Overall Study|Poor Conscious Effect|0
1341809|NCT01915732|4418604|P2|Overall Study|Improper Facial Procedure|1
1341810|NCT01915732|4418605|P1|Overall Study|Improper Facial Procedure|0
1341811|NCT01915732|4418604|P2|Overall Study|Job Transfer|1
1341812|NCT01915732|4418605|P1|Overall Study|Job Transfer|0
1341813|NCT01915732|4418604|P2|Overall Study|Par. Refused to Hospital Visits|1
1341814|NCT01915732|4418605|P1|Overall Study|Par. Refused to Hospital Visits|0
1341815|NCT01915732|4418604|P2|Overall Study|Par. not Willing to Continue Treatment|1
1341816|NCT01915732|4418605|P1|Overall Study|Par. not Willing to Continue Treatment|0
1341817|NCT01915732|4418604|P2|Overall Study|Got Well|1
1341818|NCT01915732|4418605|P1|Overall Study|Got Well|0
1341819|NCT01915732|4418604|P2|Overall Study|Par. Unable to Come to the Hospital|1
1341820|NCT01915732|4418605|P1|Overall Study|Par. Unable to Come to the Hospital|0
1341821|NCT01915732|4418604|P2|Overall Study|Poor Perceived Efficacy|0
1341822|NCT01915732|4418605|P1|Overall Study|Poor Perceived Efficacy|1
1341823|NCT01915732|4418604|P2|Overall Study|Pregnancy|0
1341824|NCT01915732|4418605|P1|Overall Study|Pregnancy|1
1341825|NCT01915732|4418604|P2|Overall Study|Recovered|0
1341826|NCT01915732|4418605|P1|Overall Study|Recovered|1
1341827|NCT01915732|4418604|P2|Overall Study|Drug Release Error|0
1341828|NCT01915732|4418605|P1|Overall Study|Drug Release Error|1
1341829|NCT01915732|4418604|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
1341830|NCT01915732|4418605|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
1341831|NCT01915732|4418604|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
1341832|NCT01915732|4418605|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
1341833|NCT01915732|4418604|P2|Overall Study|Lost to Follow-up|26
1341834|NCT01915732|4418605|P1|Overall Study|Lost to Follow-up|22
1341835|NCT01915732|4418604|P2|Overall Study|Lack of Efficacy|11
1341836|NCT01915732|4418605|P1|Overall Study|Lack of Efficacy|6
1341837|NCT01915732|4418604|P2|Overall Study|Protocol Violation|5
1341838|NCT01915732|4418605|P1|Overall Study|Protocol Violation|5
1341839|NCT01915732|4418604|P2|Overall Study|Adverse Event|4
1341840|NCT01915732|4418605|P1|Overall Study|Adverse Event|12
1341841|NCT01915732|4418604|P2|Overall Study|Failure to Meet Randomization Criteria|0
1341842|NCT01915732|4418605|P1|Overall Study|Failure to Meet Randomization Criteria|1
1341843|NCT01915732|4418604|P2|Overall Study|Withdrawal by Subject|18
1341844|NCT01915732|4418605|P1|Overall Study|Withdrawal by Subject|18
1341845|NCT01914926|4418673|P2|Overall Study|uncooperative, agitated and removed|1
1341846|NCT01914926|4418674|P1|Overall Study|uncooperative, agitated and removed|0
1341847|NCT01914926|4418673|P2|Overall Study|Adverse Event|0
1341848|NCT01914926|4418674|P1|Overall Study|Adverse Event|1
1341849|NCT01914757|4418683|P3|Overall Study|Other reasons|4
1341850|NCT01914757|4418684|P2|Overall Study|Other reasons|9
1341851|NCT01914757|4418685|P1|Overall Study|Other reasons|5
1341852|NCT01914757|4418683|P3|Overall Study|Eligibility criteria not fulfilled|2
1341853|NCT01914757|4418684|P2|Overall Study|Eligibility criteria not fulfilled|0
1341854|NCT01914757|4418685|P1|Overall Study|Eligibility criteria not fulfilled|2
1341855|NCT01914757|4418683|P3|Overall Study|Study specific withdrawal criteria|0
1341856|NCT01914757|4418684|P2|Overall Study|Study specific withdrawal criteria|1
1341857|NCT01914757|4418685|P1|Overall Study|Study specific withdrawal criteria|0
1341858|NCT01914757|4418683|P3|Overall Study|Adverse Event|4
1341859|NCT01914757|4418684|P2|Overall Study|Adverse Event|3
1341860|NCT01914757|4418685|P1|Overall Study|Adverse Event|4
1341861|NCT01914757|4418683|P3|Overall Study|Death|1
1341862|NCT01914757|4418684|P2|Overall Study|Death|2
1341863|NCT01914757|4418685|P1|Overall Study|Death|2
1341864|NCT01914757|4418683|P3|Overall Study|Withdrawal by Subject|19
1341865|NCT01914757|4418684|P2|Overall Study|Withdrawal by Subject|27
1341866|NCT01914757|4418685|P1|Overall Study|Withdrawal by Subject|15
1341867|NCT01914757|4418683|P3|Overall Study|Lost to Follow-up|6
1341868|NCT01914757|4418684|P2|Overall Study|Lost to Follow-up|8
1341869|NCT01914757|4418685|P1|Overall Study|Lost to Follow-up|5
1341870|NCT01914757|4418683|P3|Overall Study|Severe non-compliance to protocol|2
1341871|NCT01914757|4418684|P2|Overall Study|Severe non-compliance to protocol|1
1341872|NCT01914757|4418685|P1|Overall Study|Severe non-compliance to protocol|3
1341873|NCT01914679|4418759|P1|Overall Study|Sponsor terminated study|4
1341874|NCT01914679|4418759|P1|Overall Study|Lack of Efficacy|1
1341875|NCT01914666|4418766|P3|Treatment Period|Physician Decision|2
1341876|NCT01914666|4418767|P2|Treatment Period|Physician Decision|0
1341877|NCT01914666|4418768|P1|Treatment Period|Physician Decision|0
1341878|NCT01914666|4418766|P3|Treatment Period|Withdrawal by Subject|2
1341879|NCT01914666|4418767|P2|Treatment Period|Withdrawal by Subject|2
1341880|NCT01914666|4418768|P1|Treatment Period|Withdrawal by Subject|3
1341881|NCT01914666|4418766|P3|Treatment Period|Adverse Event|2
1341882|NCT01914666|4418767|P2|Treatment Period|Adverse Event|4
1341883|NCT01914666|4418768|P1|Treatment Period|Adverse Event|10
1341884|NCT01914666|4418766|P3|Treatment Period|Lack of Efficacy|2
1341885|NCT01914666|4418767|P2|Treatment Period|Lack of Efficacy|0
1341886|NCT01914666|4418768|P1|Treatment Period|Lack of Efficacy|0
1341887|NCT01913483|4418890|P2|Overall Study|Death|17
1341888|NCT01913483|4418891|P1|Overall Study|Death|14
1341889|NCT01913483|4418890|P2|Overall Study|Lost to Follow-up|3
1341890|NCT01913483|4418891|P1|Overall Study|Lost to Follow-up|6
1341891|NCT01913483|4418890|P2|Overall Study|Withdrawal by Subject|2
1341892|NCT01913483|4418891|P1|Overall Study|Withdrawal by Subject|1
1341893|NCT01913470|4418903|P2|Overall Study|Withdrawal by Subject|1
1341894|NCT01913470|4418904|P1|Overall Study|Withdrawal by Subject|0
1341895|NCT01913470|4418903|P2|Overall Study|Physician Decision|1
1341896|NCT01913470|4418904|P1|Overall Study|Physician Decision|0
1341897|NCT01913470|4418903|P2|Overall Study|Lost to Follow-up|1
1341898|NCT01913470|4418904|P1|Overall Study|Lost to Follow-up|0
1341899|NCT01913405|4418922|P1|Overall Study|Adverse Event|1
1341900|NCT01913405|4418922|P1|Overall Study|Withdrawal by Subject|1
1341901|NCT01913041|4418989|P1|Overall Study|Physician Decision|1
1341902|NCT01913041|4418989|P1|Overall Study|Withdrawal by Subject|3
1341903|NCT01913041|4418989|P1|Overall Study|Protocol Violation|35
1341904|NCT01912781|4418995|P2|Overall Study|Withdrawal by Subject|0
1341905|NCT01912781|4418996|P1|Overall Study|Withdrawal by Subject|2
1341906|NCT01912768|4419027|P2|Overall Study|Randomized in error|0
1341907|NCT01912768|4419028|P1|Overall Study|Randomized in error|1
1341908|NCT01912768|4419027|P2|Overall Study|Withdrawal by Subject|3
1341909|NCT01912768|4419028|P1|Overall Study|Withdrawal by Subject|5
1341910|NCT01912768|4419027|P2|Overall Study|Lost to Follow-up|1
1341911|NCT01912768|4419028|P1|Overall Study|Lost to Follow-up|2
1341912|NCT01912768|4419027|P2|Overall Study|Adverse Event|0
1341913|NCT01912768|4419028|P1|Overall Study|Adverse Event|2
1341914|NCT01912599|4419059|P2|Overall Study|Withdrawal by Subject|1
1341915|NCT01912599|4419060|P1|Overall Study|Withdrawal by Subject|0
1341916|NCT01912404|4419085|P2|Overall Study|Due to personal reasons|0
1341917|NCT01912404|4419086|P1|Overall Study|Due to personal reasons|1
1341918|NCT01912339|4419099|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
1341919|NCT01912339|4419100|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
1341920|NCT01912339|4419101|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
1341921|NCT01912339|4419099|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
1341922|NCT01912339|4419100|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
1341923|NCT01912339|4419101|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
1341924|NCT01912339|4419099|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
1341925|NCT01912339|4419100|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
1341926|NCT01912339|4419101|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
1341927|NCT01912339|4419099|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
1341928|NCT01912339|4419100|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
1341929|NCT01912339|4419101|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
1341930|NCT01912339|4419099|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
1341931|NCT01912339|4419100|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
1341932|NCT01912339|4419101|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
1341933|NCT01912339|4419099|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
1341934|NCT01912339|4419100|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
1341935|NCT01912339|4419101|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
1341936|NCT01912339|4419099|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
1341937|NCT01912339|4419100|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
1341938|NCT01912339|4419101|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
1341939|NCT01912339|4419099|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
1341940|NCT01912339|4419100|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
1341941|NCT01912339|4419101|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
1342024|NCT01911429|4419276|P3|Overall Study|Lack of Efficacy|4
1341942|NCT01912339|4419099|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
1341943|NCT01912339|4419100|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
1341944|NCT01912339|4419101|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
1341945|NCT01912339|4419099|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
1341946|NCT01912339|4419100|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
1341947|NCT01912339|4419101|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
1341948|NCT01912339|4419099|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
1341949|NCT01912339|4419100|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
1341950|NCT01912339|4419101|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
1341951|NCT01912339|4419099|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
1341952|NCT01912339|4419100|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
1341953|NCT01912339|4419101|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
1341954|NCT01912339|4419099|P3|Blinded (0 to 3 Months)|Declined to participate|0
1341955|NCT01912339|4419100|P2|Blinded (0 to 3 Months)|Declined to participate|0
1341956|NCT01912339|4419101|P1|Blinded (0 to 3 Months)|Declined to participate|1
1341957|NCT01912222|4419118|P3|Part B: Treatment Period|Withdrawal by Subject|2
1341958|NCT01912222|4419119|P2|Part B: Treatment Period|Withdrawal by Subject|1
1341959|NCT01912222|4419120|P1|Part B: Treatment Period|Withdrawal by Subject|2
1341960|NCT01912222|4419118|P3|Part B: Treatment Period|Adverse Event|3
1341961|NCT01912222|4419119|P2|Part B: Treatment Period|Adverse Event|2
1341962|NCT01912222|4419120|P1|Part B: Treatment Period|Adverse Event|1
1341963|NCT01912222|4419118|P3|Part B: Treatment Period|Progressive disease|15
1341964|NCT01912222|4419119|P2|Part B: Treatment Period|Progressive disease|12
1341965|NCT01912222|4419120|P1|Part B: Treatment Period|Progressive disease|10
1341966|NCT01912222|4419118|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
1341967|NCT01912222|4419119|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
1341968|NCT01912222|4419120|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
1341969|NCT01911845|4419143|P1|Overall Study|Other (not specified)|3
1341970|NCT01911845|4419143|P1|Overall Study|Lost to Follow-up|1
1341971|NCT01911845|4419143|P1|Overall Study|Adverse Event|2
1341972|NCT01911819|4419160|P3|Overall Study|Withdrawal by Subject|0
1341973|NCT01911819|4419161|P2|Overall Study|Withdrawal by Subject|1
1341974|NCT01911819|4419162|P1|Overall Study|Withdrawal by Subject|1
1341975|NCT01911819|4419160|P3|Overall Study|Adverse Event|0
1341976|NCT01911819|4419161|P2|Overall Study|Adverse Event|1
1341977|NCT01911819|4419162|P1|Overall Study|Adverse Event|0
1341978|NCT01911793|4419175|P2|Overall Study|Physician Decision|5
1341979|NCT01911793|4419176|P1|Overall Study|Physician Decision|1
1341980|NCT01911780|4419200|P2|Extension Period (52 Weeks)|Personal reason|1
1341981|NCT01911780|4419201|P1|Extension Period (52 Weeks)|Personal reason|1
1341982|NCT01911780|4419200|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
1341983|NCT01911780|4419201|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
1341984|NCT01911780|4419200|P2|Extension Period (52 Weeks)|Adverse Event|0
1341985|NCT01911780|4419201|P1|Extension Period (52 Weeks)|Adverse Event|3
1341986|NCT01911780|4419200|P2|Double-blind Period (8 Weeks)|Personal reason|0
1341987|NCT01911780|4419201|P1|Double-blind Period (8 Weeks)|Personal reason|1
1341988|NCT01911780|4419200|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
1341989|NCT01911780|4419201|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
1341990|NCT01911780|4419200|P2|Double-blind Period (8 Weeks)|Adverse Event|2
1341991|NCT01911780|4419201|P1|Double-blind Period (8 Weeks)|Adverse Event|1
1341992|NCT01911546|4419235|P1|Overall Study|Everolimus was discontinued|5
1341993|NCT01911546|4419235|P1|Overall Study|Lost to Follow-up|1
1341994|NCT01911442|4419245|P3|Overall Study|Mother's Work Schedule|0
1341995|NCT01911442|4419246|P2|Overall Study|Mother's Work Schedule|1
1341996|NCT01911442|4419247|P1|Overall Study|Mother's Work Schedule|0
1341997|NCT01911442|4419245|P3|Overall Study|Withdrawal by Subject|6
1341998|NCT01911442|4419246|P2|Overall Study|Withdrawal by Subject|0
1341999|NCT01911442|4419247|P1|Overall Study|Withdrawal by Subject|1
1342000|NCT01911442|4419245|P3|Overall Study|Lost to Follow-up|1
1342001|NCT01911442|4419246|P2|Overall Study|Lost to Follow-up|0
1342002|NCT01911442|4419247|P1|Overall Study|Lost to Follow-up|2
1342003|NCT01911442|4419245|P3|Overall Study|Lack of Efficacy|1
1342004|NCT01911442|4419246|P2|Overall Study|Lack of Efficacy|1
1342005|NCT01911442|4419247|P1|Overall Study|Lack of Efficacy|1
1342006|NCT01911442|4419245|P3|Overall Study|Adverse Event|4
1342007|NCT01911442|4419246|P2|Overall Study|Adverse Event|2
1342008|NCT01911442|4419247|P1|Overall Study|Adverse Event|2
1342009|NCT01911429|4419276|P3|Overall Study|subject left study|0
1342010|NCT01911429|4419277|P2|Overall Study|subject left study|0
1342011|NCT01911429|4419278|P1|Overall Study|subject left study|1
1342012|NCT01911429|4419276|P3|Overall Study|Accidental randomization|1
1342013|NCT01911429|4419277|P2|Overall Study|Accidental randomization|0
1342014|NCT01911429|4419278|P1|Overall Study|Accidental randomization|0
1342015|NCT01911429|4419276|P3|Overall Study|Withdrawal by Subject|4
1342016|NCT01911429|4419277|P2|Overall Study|Withdrawal by Subject|5
1342017|NCT01911429|4419278|P1|Overall Study|Withdrawal by Subject|5
1342018|NCT01911429|4419276|P3|Overall Study|Protocol Violation|1
1342019|NCT01911429|4419277|P2|Overall Study|Protocol Violation|0
1342020|NCT01911429|4419278|P1|Overall Study|Protocol Violation|0
1342021|NCT01911429|4419276|P3|Overall Study|Lost to Follow-up|1
1342022|NCT01911429|4419277|P2|Overall Study|Lost to Follow-up|0
1342023|NCT01911429|4419278|P1|Overall Study|Lost to Follow-up|0
1342025|NCT01911429|4419277|P2|Overall Study|Lack of Efficacy|2
1342026|NCT01911429|4419278|P1|Overall Study|Lack of Efficacy|1
1342027|NCT01911429|4419276|P3|Overall Study|Adverse Event|9
1342028|NCT01911429|4419277|P2|Overall Study|Adverse Event|3
1342029|NCT01911429|4419278|P1|Overall Study|Adverse Event|5
1342030|NCT01911273|4419370|P2|Overall Study|Withdrawal by Subject|2
1342031|NCT01911273|4419371|P1|Overall Study|Withdrawal by Subject|0
1342032|NCT01911273|4419370|P2|Overall Study|Progression of Disease|0
1342033|NCT01911273|4419371|P1|Overall Study|Progression of Disease|1
1342034|NCT01911260|4419405|P4|Follow-up Period|transference or evasion of school|12
1342035|NCT01911260|4419406|P3|Follow-up Period|transference or evasion of school|15
1342036|NCT01911260|4419407|P2|Follow-up Period|transference or evasion of school|20
1342037|NCT01911260|4419408|P1|Follow-up Period|transference or evasion of school|13
1342038|NCT01911260|4419405|P4|Supplementation Period|less than 12 weeks supplementation|2
1342039|NCT01911260|4419406|P3|Supplementation Period|less than 12 weeks supplementation|1
1342040|NCT01911260|4419407|P2|Supplementation Period|less than 12 weeks supplementation|3
1342041|NCT01911260|4419408|P1|Supplementation Period|less than 12 weeks supplementation|0
1342042|NCT01911260|4419405|P4|Supplementation Period|refused to receive supplement|0
1342043|NCT01911260|4419406|P3|Supplementation Period|refused to receive supplement|1
1342044|NCT01911260|4419407|P2|Supplementation Period|refused to receive supplement|0
1342045|NCT01911260|4419408|P1|Supplementation Period|refused to receive supplement|1
1342046|NCT01911260|4419405|P4|Supplementation Period|Adverse Event|0
1342047|NCT01911260|4419406|P3|Supplementation Period|Adverse Event|1
1342048|NCT01911260|4419407|P2|Supplementation Period|Adverse Event|0
1342049|NCT01911260|4419408|P1|Supplementation Period|Adverse Event|2
1342050|NCT01911260|4419405|P4|Supplementation Period|transference or evasion of school|6
1342051|NCT01911260|4419406|P3|Supplementation Period|transference or evasion of school|7
1342052|NCT01911260|4419407|P2|Supplementation Period|transference or evasion of school|9
1342053|NCT01911260|4419408|P1|Supplementation Period|transference or evasion of school|7
1342054|NCT01910441|4419494|P2|Overall Study|Physician Decision|1
1342055|NCT01910441|4419495|P1|Overall Study|Physician Decision|0
1342056|NCT01910441|4419494|P2|Overall Study|Adverse Event|0
1342057|NCT01910441|4419495|P1|Overall Study|Adverse Event|1
1342058|NCT01910441|4419494|P2|Overall Study|Non-compliance|1
1342059|NCT01910441|4419495|P1|Overall Study|Non-compliance|0
1342060|NCT01910441|4419494|P2|Overall Study|Withdrawal by Subject|1
1342061|NCT01910441|4419495|P1|Overall Study|Withdrawal by Subject|0
1342062|NCT01910441|4419494|P2|Overall Study|Lost to Follow-up|5
1342063|NCT01910441|4419495|P1|Overall Study|Lost to Follow-up|6
1342064|NCT01910441|4419494|P2|Overall Study|Sponsor decision|2
1342065|NCT01910441|4419495|P1|Overall Study|Sponsor decision|0
1342066|NCT01910402|4419503|P2|Continuation Phase|Withdrawal by Subject|0
1342067|NCT01910402|4419504|P1|Continuation Phase|Withdrawal by Subject|2
1342068|NCT01910402|4419503|P2|Continuation Phase|Protocol Violation|0
1342069|NCT01910402|4419504|P1|Continuation Phase|Protocol Violation|3
1342070|NCT01910402|4419503|P2|Continuation Phase|Adverse Event|0
1342071|NCT01910402|4419504|P1|Continuation Phase|Adverse Event|1
1342072|NCT01910402|4419503|P2|Continuation Phase|Ongoing|0
1342073|NCT01910402|4419504|P1|Continuation Phase|Ongoing|84
1342074|NCT01910402|4419503|P2|Randomized Phase|Withdrawal by Subject|7
1342075|NCT01910402|4419504|P1|Randomized Phase|Withdrawal by Subject|5
1342076|NCT01910402|4419503|P2|Randomized Phase|Protocol Violation|13
1342077|NCT01910402|4419504|P1|Randomized Phase|Protocol Violation|10
1342078|NCT01910402|4419503|P2|Randomized Phase|Lost to Follow-up|13
1342079|NCT01910402|4419504|P1|Randomized Phase|Lost to Follow-up|11
1342080|NCT01910402|4419503|P2|Randomized Phase|Lack of Efficacy|4
1342081|NCT01910402|4419504|P1|Randomized Phase|Lack of Efficacy|5
1342082|NCT01910402|4419503|P2|Randomized Phase|Physician Decision|0
1342083|NCT01910402|4419504|P1|Randomized Phase|Physician Decision|1
1342084|NCT01910402|4419503|P2|Randomized Phase|Adverse Event|18
1342085|NCT01910402|4419504|P1|Randomized Phase|Adverse Event|10
1342086|NCT01910389|4419574|P2|Overall Study|Study Closed|8
1342087|NCT01910389|4419575|P1|Overall Study|Study Closed|13
1342088|NCT01910389|4419574|P2|Overall Study|Withdrawal by Subject|0
1342089|NCT01910389|4419575|P1|Overall Study|Withdrawal by Subject|2
1342090|NCT01910181|4419616|P1|Overall Study|Alive in Follow-Up|12
1342091|NCT01910181|4419616|P1|Overall Study|Alive on Treatment|14
1342092|NCT01910181|4419616|P1|Overall Study|Death|20
1342093|NCT01910116|4419643|P2|Overall Study|incomplete data|1
1342094|NCT01910116|4419644|P1|Overall Study|incomplete data|0
1342095|NCT01910116|4419643|P2|Overall Study|uncertain allocation|3
1342096|NCT01910116|4419644|P1|Overall Study|uncertain allocation|1
1342097|NCT01910116|4419643|P2|Overall Study|Withdrawal by Subject|3
1342098|NCT01910116|4419644|P1|Overall Study|Withdrawal by Subject|8
1342099|NCT01910116|4419643|P2|Overall Study|Protocol Violation|2
1342100|NCT01910116|4419644|P1|Overall Study|Protocol Violation|1
1342101|NCT01910116|4419643|P2|Overall Study|Lost to Follow-up|0
1342102|NCT01910116|4419644|P1|Overall Study|Lost to Follow-up|1
1342103|NCT01910116|4419643|P2|Overall Study|Lack of Efficacy|4
1342104|NCT01910116|4419644|P1|Overall Study|Lack of Efficacy|3
1342105|NCT01910116|4419643|P2|Overall Study|Adverse Event|3
1342106|NCT01910116|4419644|P1|Overall Study|Adverse Event|0
1342107|NCT01909804|4419741|P12|Overall Study|Protocol Violation|1
1342108|NCT01909804|4419742|P11|Overall Study|Protocol Violation|0
1342109|NCT01909804|4419743|P10|Overall Study|Protocol Violation|0
1342110|NCT01909804|4419744|P9|Overall Study|Protocol Violation|0
1342111|NCT01909804|4419745|P8|Overall Study|Protocol Violation|0
1342112|NCT01909804|4419746|P7|Overall Study|Protocol Violation|0
1342113|NCT01909804|4419747|P6|Overall Study|Protocol Violation|0
1342114|NCT01909804|4419748|P5|Overall Study|Protocol Violation|0
1342115|NCT01909804|4419749|P4|Overall Study|Protocol Violation|0
1342116|NCT01909804|4419750|P3|Overall Study|Protocol Violation|0
1342117|NCT01909804|4419751|P2|Overall Study|Protocol Violation|0
1342118|NCT01909804|4419752|P1|Overall Study|Protocol Violation|0
1342119|NCT01909804|4419741|P12|Overall Study|Withdrew Consent|0
1342120|NCT01909804|4419742|P11|Overall Study|Withdrew Consent|0
1342121|NCT01909804|4419743|P10|Overall Study|Withdrew Consent|0
1342122|NCT01909804|4419744|P9|Overall Study|Withdrew Consent|0
1342123|NCT01909804|4419745|P8|Overall Study|Withdrew Consent|0
1342124|NCT01909804|4419746|P7|Overall Study|Withdrew Consent|0
1342125|NCT01909804|4419747|P6|Overall Study|Withdrew Consent|1
1342126|NCT01909804|4419748|P5|Overall Study|Withdrew Consent|1
1342127|NCT01909804|4419749|P4|Overall Study|Withdrew Consent|0
1342128|NCT01909804|4419750|P3|Overall Study|Withdrew Consent|0
1342129|NCT01909804|4419751|P2|Overall Study|Withdrew Consent|0
1342130|NCT01909804|4419752|P1|Overall Study|Withdrew Consent|0
1342131|NCT01909804|4419741|P12|Overall Study|Lack of Efficacy|1
1342132|NCT01909804|4419742|P11|Overall Study|Lack of Efficacy|0
1342133|NCT01909804|4419743|P10|Overall Study|Lack of Efficacy|1
1342134|NCT01909804|4419744|P9|Overall Study|Lack of Efficacy|0
1342135|NCT01909804|4419745|P8|Overall Study|Lack of Efficacy|1
1342136|NCT01909804|4419746|P7|Overall Study|Lack of Efficacy|1
1342137|NCT01909804|4419747|P6|Overall Study|Lack of Efficacy|3
1342138|NCT01909804|4419748|P5|Overall Study|Lack of Efficacy|7
1342139|NCT01909804|4419749|P4|Overall Study|Lack of Efficacy|0
1342140|NCT01909804|4419750|P3|Overall Study|Lack of Efficacy|0
1342141|NCT01909804|4419751|P2|Overall Study|Lack of Efficacy|1
1342142|NCT01909804|4419752|P1|Overall Study|Lack of Efficacy|4
1342143|NCT01909804|4419741|P12|Overall Study|Death|0
1342144|NCT01909804|4419742|P11|Overall Study|Death|1
1342145|NCT01909804|4419743|P10|Overall Study|Death|0
1342146|NCT01909804|4419744|P9|Overall Study|Death|0
1342147|NCT01909804|4419745|P8|Overall Study|Death|0
1342148|NCT01909804|4419746|P7|Overall Study|Death|0
1342149|NCT01909804|4419747|P6|Overall Study|Death|0
1342150|NCT01909804|4419748|P5|Overall Study|Death|0
1342151|NCT01909804|4419749|P4|Overall Study|Death|0
1342152|NCT01909804|4419750|P3|Overall Study|Death|0
1342153|NCT01909804|4419751|P2|Overall Study|Death|0
1342154|NCT01909804|4419752|P1|Overall Study|Death|0
1342155|NCT01909804|4419741|P12|Overall Study|Randomized but Never Treated|1
1342156|NCT01909804|4419742|P11|Overall Study|Randomized but Never Treated|0
1342157|NCT01909804|4419743|P10|Overall Study|Randomized but Never Treated|0
1342158|NCT01909804|4419744|P9|Overall Study|Randomized but Never Treated|0
1342159|NCT01909804|4419745|P8|Overall Study|Randomized but Never Treated|0
1342160|NCT01909804|4419746|P7|Overall Study|Randomized but Never Treated|1
1342161|NCT01909804|4419747|P6|Overall Study|Randomized but Never Treated|0
1342162|NCT01909804|4419748|P5|Overall Study|Randomized but Never Treated|0
1342163|NCT01909804|4419749|P4|Overall Study|Randomized but Never Treated|0
1342164|NCT01909804|4419750|P3|Overall Study|Randomized but Never Treated|0
1342165|NCT01909804|4419751|P2|Overall Study|Randomized but Never Treated|0
1342166|NCT01909804|4419752|P1|Overall Study|Randomized but Never Treated|0
1342167|NCT01909778|4419798|P1|Overall Study|failed screening|1
1342168|NCT01909674|4419877|P2|Overall Study|Withdrawal by Subject|2
1342169|NCT01909674|4419878|P1|Overall Study|Withdrawal by Subject|5
1342170|NCT01909466|4419897|P2|Overall Study|Lack of Efficacy|0
1342171|NCT01909466|4419898|P1|Overall Study|Lack of Efficacy|1
1342172|NCT01909466|4419897|P2|Overall Study|Withdrawal by Subject|9
1342173|NCT01909466|4419898|P1|Overall Study|Withdrawal by Subject|11
1342174|NCT01909466|4419897|P2|Overall Study|Physician Decision|0
1342175|NCT01909466|4419898|P1|Overall Study|Physician Decision|2
1342176|NCT01909466|4419897|P2|Overall Study|Met Withdrawal Criteria|3
1342177|NCT01909466|4419898|P1|Overall Study|Met Withdrawal Criteria|0
1342178|NCT01909466|4419897|P2|Overall Study|Adverse Event|4
1342179|NCT01909466|4419898|P1|Overall Study|Adverse Event|3
1342180|NCT01909466|4419897|P2|Overall Study|Lost to Follow-up|7
1342181|NCT01909466|4419898|P1|Overall Study|Lost to Follow-up|5
1342182|NCT01909336|4419921|P3|Overall Study|Physician Decision|1
1342183|NCT01909336|4419922|P2|Overall Study|Physician Decision|1
1342184|NCT01909336|4419923|P1|Overall Study|Physician Decision|0
1342185|NCT01909336|4419921|P3|Overall Study|Lost to Follow-up|2
1342186|NCT01909336|4419922|P2|Overall Study|Lost to Follow-up|2
1342187|NCT01909336|4419923|P1|Overall Study|Lost to Follow-up|4
1342188|NCT01908907|4419975|P2|Overall Study|Protocol Violation|0
1342189|NCT01908907|4419976|P1|Overall Study|Protocol Violation|1
1342190|NCT01908907|4419975|P2|Overall Study|Physician Decision|0
1342191|NCT01908907|4419976|P1|Overall Study|Physician Decision|1
1342192|NCT01908829|4420020|P3|Overall Study|Withdrawal by Subject|22
1342193|NCT01908829|4420021|P2|Overall Study|Withdrawal by Subject|29
1342194|NCT01908829|4420022|P1|Overall Study|Withdrawal by Subject|26
1342195|NCT01908829|4420020|P3|Overall Study|Lack of Efficacy|2
1342196|NCT01908829|4420021|P2|Overall Study|Lack of Efficacy|3
1342197|NCT01908829|4420022|P1|Overall Study|Lack of Efficacy|1
1342198|NCT01908829|4420020|P3|Overall Study|Protocol Violation|0
1342199|NCT01908829|4420021|P2|Overall Study|Protocol Violation|2
1342200|NCT01908829|4420022|P1|Overall Study|Protocol Violation|2
1342201|NCT01908829|4420020|P3|Overall Study|Miscellaneous|0
1342202|NCT01908829|4420021|P2|Overall Study|Miscellaneous|2
1342203|NCT01908829|4420022|P1|Overall Study|Miscellaneous|0
1342204|NCT01908829|4420020|P3|Overall Study|Discontinued (no EoT page)|0
1342205|NCT01908829|4420021|P2|Overall Study|Discontinued (no EoT page)|0
1342206|NCT01908829|4420022|P1|Overall Study|Discontinued (no EoT page)|2
1342207|NCT01908829|4420020|P3|Overall Study|Randomized no double-blind drug received|1
1342208|NCT01908829|4420021|P2|Overall Study|Randomized no double-blind drug received|0
1342209|NCT01908829|4420022|P1|Overall Study|Randomized no double-blind drug received|1
1342210|NCT01908829|4420020|P3|Overall Study|Lost to Follow-up|1
1342211|NCT01908829|4420021|P2|Overall Study|Lost to Follow-up|2
1342212|NCT01908829|4420022|P1|Overall Study|Lost to Follow-up|4
1342213|NCT01908829|4420020|P3|Overall Study|Adverse Event|13
1342214|NCT01908829|4420021|P2|Overall Study|Adverse Event|11
1342215|NCT01908829|4420022|P1|Overall Study|Adverse Event|13
1342216|NCT01908803|4420137|P2|Overall Study|Adverse Event (pre-treatment)|0
1342217|NCT01908803|4420138|P1|Overall Study|Adverse Event (pre-treatment)|1
1342218|NCT01908803|4420137|P2|Overall Study|Randomization Error|0
1342219|NCT01908803|4420138|P1|Overall Study|Randomization Error|1
1342220|NCT01908803|4420137|P2|Overall Study|Withdrawal by Subject|0
1342221|NCT01908803|4420138|P1|Overall Study|Withdrawal by Subject|1
1342222|NCT01908803|4420137|P2|Overall Study|Physician Decision|1
1342223|NCT01908803|4420138|P1|Overall Study|Physician Decision|0
1342224|NCT01908803|4420137|P2|Overall Study|Adverse Event|0
1342225|NCT01908803|4420138|P1|Overall Study|Adverse Event|1
1342226|NCT01908140|4420151|P2|Overall Study|Adverse Event|23
1342227|NCT01908140|4420152|P1|Overall Study|Adverse Event|22
1342228|NCT01908140|4420151|P2|Overall Study|Protocol Violation|9
1342229|NCT01908140|4420152|P1|Overall Study|Protocol Violation|8
1342230|NCT01908140|4420151|P2|Overall Study|Lost to Follow-up|6
1342231|NCT01908140|4420152|P1|Overall Study|Lost to Follow-up|1
1342232|NCT01908140|4420151|P2|Overall Study|Withdrawal by Subject|24
1342233|NCT01908140|4420152|P1|Overall Study|Withdrawal by Subject|23
1342234|NCT01908140|4420151|P2|Overall Study|Lack of Efficacy|5
1342235|NCT01908140|4420152|P1|Overall Study|Lack of Efficacy|7
1342236|NCT01908140|4420151|P2|Overall Study|Other or Progressive Disease|12
1342237|NCT01908140|4420152|P1|Overall Study|Other or Progressive Disease|5
1342238|NCT01907906|4420173|P2|Overall Study|Physician Decision|1
1342239|NCT01907906|4420174|P1|Overall Study|Physician Decision|3
1342240|NCT01907906|4420173|P2|Overall Study|Withdrawal by Subject|0
1342241|NCT01907906|4420174|P1|Overall Study|Withdrawal by Subject|1
1342242|NCT01907854|4420254|P2|Overall Study|Unclassified|3
1342243|NCT01907854|4420255|P1|Overall Study|Unclassified|4
1342244|NCT01907854|4420254|P2|Overall Study|Lost to Follow-up|2
1342245|NCT01907854|4420255|P1|Overall Study|Lost to Follow-up|2
1342246|NCT01907854|4420254|P2|Overall Study|Withdrawal by Subject|7
1342247|NCT01907854|4420255|P1|Overall Study|Withdrawal by Subject|9
1342248|NCT01907854|4420254|P2|Overall Study|Protocol Violation|1
1342249|NCT01907854|4420255|P1|Overall Study|Protocol Violation|1
1342250|NCT01907815|4420275|P2|Overall Study|Withdrawal by Subject|0
1342251|NCT01907815|4420276|P1|Overall Study|Withdrawal by Subject|1
1342252|NCT01907516|4420292|P2|First Intervention (3 Weeks)|Developed DKA during study|0
1342253|NCT01907516|4420293|P1|First Intervention (3 Weeks)|Developed DKA during study|1
1342254|NCT01907516|4420292|P2|First Intervention (3 Weeks)|Delivered before second arm|4
1342255|NCT01907516|4420293|P1|First Intervention (3 Weeks)|Delivered before second arm|3
1342256|NCT01907516|4420292|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
1342257|NCT01907516|4420293|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
1342258|NCT01907516|4420292|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
1342259|NCT01907516|4420293|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
1342260|NCT01907087|4420428|P1|Overall Study|Withdrawal by Subject|1
1342261|NCT01906372|4420477|P1|Overall Study|Withdrawal by Subject|2
1342262|NCT01905683|4420507|P1|Overall Study|Lost to Follow-up|4
1342263|NCT01905683|4420507|P1|Overall Study|Adverse Event|4
1342264|NCT01905683|4420507|P1|Overall Study|Withdrawal by Subject|20
1342265|NCT01905683|4420507|P1|Overall Study|Lack of Efficacy|8
1342266|NCT01905683|4420507|P1|Overall Study|Physician Decision|1
1342267|NCT01905683|4420507|P1|Overall Study|Re-injection criteria not met; others|13
1342268|NCT01905683|4420507|P1|Overall Study|Protocol Violation|1
1342269|NCT01905657|4420523|P3|Overall Study|Excluded from Efficacy Analysis|0
1342270|NCT01905657|4420524|P2|Overall Study|Excluded from Efficacy Analysis|0
1342271|NCT01905657|4420525|P1|Overall Study|Excluded from Efficacy Analysis|1
1342272|NCT01905657|4420523|P3|Overall Study|Continuing in Study|11
1342273|NCT01905657|4420524|P2|Overall Study|Continuing in Study|74
1342274|NCT01905657|4420525|P1|Overall Study|Continuing in Study|74
1342275|NCT01905657|4420523|P3|Overall Study|Withdrawal by Subject|45
1342276|NCT01905657|4420524|P2|Overall Study|Withdrawal by Subject|10
1342277|NCT01905657|4420525|P1|Overall Study|Withdrawal by Subject|5
1342278|NCT01905657|4420523|P3|Overall Study|Protocol Violation|1
1342279|NCT01905657|4420524|P2|Overall Study|Protocol Violation|1
1342280|NCT01905657|4420525|P1|Overall Study|Protocol Violation|2
1342281|NCT01905657|4420523|P3|Overall Study|Progressive Disease|89
1342282|NCT01905657|4420524|P2|Overall Study|Progressive Disease|126
1342283|NCT01905657|4420525|P1|Overall Study|Progressive Disease|124
1342284|NCT01905657|4420523|P3|Overall Study|Physician Decision|113
1342285|NCT01905657|4420524|P2|Overall Study|Physician Decision|74
1342286|NCT01905657|4420525|P1|Overall Study|Physician Decision|82
1342287|NCT01905657|4420523|P3|Overall Study|Other|1
1342288|NCT01905657|4420524|P2|Overall Study|Other|7
1342289|NCT01905657|4420525|P1|Overall Study|Other|3
1342290|NCT01905657|4420523|P3|Overall Study|Death|21
1342291|NCT01905657|4420524|P2|Overall Study|Death|21
1342292|NCT01905657|4420525|P1|Overall Study|Death|21
1342293|NCT01905657|4420523|P3|Overall Study|Adverse Event|47
1342294|NCT01905657|4420524|P2|Overall Study|Adverse Event|32
1342295|NCT01905657|4420525|P1|Overall Study|Adverse Event|33
1342296|NCT01905657|4420523|P3|Overall Study|Not Treated|0
1342297|NCT01905657|4420524|P2|Overall Study|Not Treated|1
1342298|NCT01905657|4420525|P1|Overall Study|Not Treated|0
1342299|NCT01905553|4420550|P2|Period 2|Adverse Event|0
1342300|NCT01905553|4420551|P1|Period 2|Adverse Event|1
1342301|NCT01905540|4420565|P4|Period 3|Not specified|1
1342302|NCT01905540|4420566|P3|Period 3|Not specified|1
1342303|NCT01905540|4420567|P2|Period 3|Not specified|0
1342304|NCT01905540|4420568|P1|Period 3|Not specified|1
1342305|NCT01905267|4420603|P2|Overall Study|Physician Decision|2
1342306|NCT01905267|4420604|P1|Overall Study|Physician Decision|2
1342307|NCT01904773|4420625|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1342308|NCT01904773|4420626|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1342309|NCT01904773|4420627|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1342310|NCT01904773|4420628|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1342311|NCT01904773|4420629|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1342312|NCT01904773|4420630|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1342313|NCT01904773|4420631|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1342314|NCT01904773|4420632|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
1342315|NCT01904773|4420633|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1342316|NCT01904773|4420625|P9|Fifth Intervention|Adverse Event|0
1342317|NCT01904773|4420626|P8|Fifth Intervention|Adverse Event|1
1342318|NCT01904773|4420627|P7|Fifth Intervention|Adverse Event|0
1342319|NCT01904773|4420628|P6|Fifth Intervention|Adverse Event|0
1342320|NCT01904773|4420629|P5|Fifth Intervention|Adverse Event|0
1342321|NCT01904773|4420630|P4|Fifth Intervention|Adverse Event|0
1342322|NCT01904773|4420631|P3|Fifth Intervention|Adverse Event|0
1342323|NCT01904773|4420632|P2|Fifth Intervention|Adverse Event|0
1342324|NCT01904773|4420633|P1|Fifth Intervention|Adverse Event|0
1342325|NCT01904773|4420625|P9|Placebo Washout First Intervention|Condition worsened|0
1342326|NCT01904773|4420626|P8|Placebo Washout First Intervention|Condition worsened|0
1342327|NCT01904773|4420627|P7|Placebo Washout First Intervention|Condition worsened|0
1342328|NCT01904773|4420628|P6|Placebo Washout First Intervention|Condition worsened|0
1342329|NCT01904773|4420629|P5|Placebo Washout First Intervention|Condition worsened|0
1342330|NCT01904773|4420630|P4|Placebo Washout First Intervention|Condition worsened|0
1342331|NCT01904773|4420631|P3|Placebo Washout First Intervention|Condition worsened|0
1342332|NCT01904773|4420632|P2|Placebo Washout First Intervention|Condition worsened|1
1342333|NCT01904773|4420633|P1|Placebo Washout First Intervention|Condition worsened|0
1342334|NCT01904773|4420625|P9|First Intervention|Adverse Event|0
1342335|NCT01904773|4420626|P8|First Intervention|Adverse Event|0
1342336|NCT01904773|4420627|P7|First Intervention|Adverse Event|1
1342337|NCT01904773|4420628|P6|First Intervention|Adverse Event|0
1342338|NCT01904773|4420629|P5|First Intervention|Adverse Event|0
1342339|NCT01904773|4420630|P4|First Intervention|Adverse Event|0
1342340|NCT01904773|4420631|P3|First Intervention|Adverse Event|0
1342341|NCT01904773|4420632|P2|First Intervention|Adverse Event|0
1342342|NCT01904773|4420633|P1|First Intervention|Adverse Event|0
1342343|NCT01904773|4420625|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1342344|NCT01904773|4420626|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1342345|NCT01904773|4420627|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1342346|NCT01904773|4420628|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1342347|NCT01904773|4420629|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1342348|NCT01904773|4420630|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1342349|NCT01904773|4420631|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1342350|NCT01904773|4420632|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1342351|NCT01904773|4420633|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
1342352|NCT01904773|4420625|P9|Screen|Withdrawal by Subject|0
1342353|NCT01904773|4420626|P8|Screen|Withdrawal by Subject|0
1342354|NCT01904773|4420627|P7|Screen|Withdrawal by Subject|0
1342355|NCT01904773|4420628|P6|Screen|Withdrawal by Subject|0
1342356|NCT01904773|4420629|P5|Screen|Withdrawal by Subject|0
1342357|NCT01904773|4420630|P4|Screen|Withdrawal by Subject|0
1342358|NCT01904773|4420631|P3|Screen|Withdrawal by Subject|0
1342359|NCT01904773|4420632|P2|Screen|Withdrawal by Subject|0
1342360|NCT01904773|4420633|P1|Screen|Withdrawal by Subject|1
1342361|NCT01904773|4420625|P9|Screen|Screen failure|0
1342362|NCT01904773|4420626|P8|Screen|Screen failure|0
1342363|NCT01904773|4420627|P7|Screen|Screen failure|0
1342364|NCT01904773|4420628|P6|Screen|Screen failure|0
1342365|NCT01904773|4420629|P5|Screen|Screen failure|0
1342366|NCT01904773|4420630|P4|Screen|Screen failure|0
1342367|NCT01904773|4420631|P3|Screen|Screen failure|0
1342368|NCT01904773|4420632|P2|Screen|Screen failure|0
1342369|NCT01904773|4420633|P1|Screen|Screen failure|3
1342370|NCT01904760|4420650|P2|Overall Study|Protocol Violation|0
1342371|NCT01904760|4420651|P1|Overall Study|Protocol Violation|1
1342372|NCT01904721|4420666|P7|Overall Study|Adverse Event|0
1342373|NCT01904721|4420667|P6|Overall Study|Adverse Event|1
1342374|NCT01904721|4420668|P5|Overall Study|Adverse Event|3
1342375|NCT01904721|4420669|P4|Overall Study|Adverse Event|0
1342376|NCT01904721|4420670|P3|Overall Study|Adverse Event|0
1342377|NCT01904721|4420671|P2|Overall Study|Adverse Event|0
1342378|NCT01904721|4420672|P1|Overall Study|Adverse Event|0
1342379|NCT01904721|4420666|P7|Overall Study|Lack of Efficacy|1
1342380|NCT01904721|4420667|P6|Overall Study|Lack of Efficacy|0
1342381|NCT01904721|4420668|P5|Overall Study|Lack of Efficacy|0
1342382|NCT01904721|4420669|P4|Overall Study|Lack of Efficacy|0
1342383|NCT01904721|4420670|P3|Overall Study|Lack of Efficacy|0
1342384|NCT01904721|4420671|P2|Overall Study|Lack of Efficacy|0
1342385|NCT01904721|4420672|P1|Overall Study|Lack of Efficacy|0
1342386|NCT01904721|4420666|P7|Overall Study|Lost to Follow-up|1
1342387|NCT01904721|4420667|P6|Overall Study|Lost to Follow-up|3
1342388|NCT01904721|4420668|P5|Overall Study|Lost to Follow-up|1
1342389|NCT01904721|4420669|P4|Overall Study|Lost to Follow-up|0
1342390|NCT01904721|4420670|P3|Overall Study|Lost to Follow-up|0
1342391|NCT01904721|4420671|P2|Overall Study|Lost to Follow-up|0
1342392|NCT01904721|4420672|P1|Overall Study|Lost to Follow-up|0
1342393|NCT01904721|4420666|P7|Overall Study|Personal Reasons|3
1342394|NCT01904721|4420667|P6|Overall Study|Personal Reasons|3
1342395|NCT01904721|4420668|P5|Overall Study|Personal Reasons|2
1342396|NCT01904721|4420669|P4|Overall Study|Personal Reasons|0
1342397|NCT01904721|4420670|P3|Overall Study|Personal Reasons|0
1342398|NCT01904721|4420671|P2|Overall Study|Personal Reasons|0
1342399|NCT01904721|4420672|P1|Overall Study|Personal Reasons|0
1342400|NCT01904721|4420666|P7|Overall Study|Other Reasons|2
1342401|NCT01904721|4420667|P6|Overall Study|Other Reasons|2
1342402|NCT01904721|4420668|P5|Overall Study|Other Reasons|2
1342403|NCT01904721|4420669|P4|Overall Study|Other Reasons|1
1342404|NCT01904721|4420670|P3|Overall Study|Other Reasons|1
1342405|NCT01904721|4420671|P2|Overall Study|Other Reasons|0
1342406|NCT01904721|4420672|P1|Overall Study|Other Reasons|0
1342407|NCT01904604|4420702|P3|Overall Study|Unrelated illness|0
1342408|NCT01904604|4420703|P2|Overall Study|Unrelated illness|1
1342409|NCT01904604|4420704|P1|Overall Study|Unrelated illness|0
1342410|NCT01904604|4420702|P3|Overall Study|Increased syncope|0
1342411|NCT01904604|4420703|P2|Overall Study|Increased syncope|1
1342412|NCT01904604|4420704|P1|Overall Study|Increased syncope|0
1342413|NCT01904604|4420702|P3|Overall Study|Patch site reactions|0
1342414|NCT01904604|4420703|P2|Overall Study|Patch site reactions|1
1342415|NCT01904604|4420704|P1|Overall Study|Patch site reactions|0
1342416|NCT01904604|4420702|P3|Overall Study|Anxiety about OFC/Refused OFC|0
1342417|NCT01904604|4420703|P2|Overall Study|Anxiety about OFC/Refused OFC|0
1342418|NCT01904604|4420704|P1|Overall Study|Anxiety about OFC/Refused OFC|2
1342419|NCT01904604|4420702|P3|Overall Study|Non-compliance|0
1342420|NCT01904604|4420703|P2|Overall Study|Non-compliance|0
1342421|NCT01904604|4420704|P1|Overall Study|Non-compliance|1
1342422|NCT01904604|4420702|P3|Overall Study|Withdrew before receiving dosing|0
1342423|NCT01904604|4420703|P2|Overall Study|Withdrew before receiving dosing|1
1342424|NCT01904604|4420704|P1|Overall Study|Withdrew before receiving dosing|0
1342425|NCT01904279|4420758|P2|Overall Study|Withdrawal by Subject|0
1342426|NCT01904279|4420759|P1|Overall Study|Withdrawal by Subject|1
1342427|NCT01904279|4420758|P2|Overall Study|Lack of Efficacy|3
1342428|NCT01904279|4420759|P1|Overall Study|Lack of Efficacy|2
1342429|NCT01904149|4420785|P6|Overall Study|non compliance with study drug|0
1342430|NCT01904149|4420786|P5|Overall Study|non compliance with study drug|0
1342431|NCT01904149|4420787|P4|Overall Study|non compliance with study drug|0
1342432|NCT01904149|4420788|P3|Overall Study|non compliance with study drug|0
1342433|NCT01904149|4420789|P2|Overall Study|non compliance with study drug|0
1342434|NCT01904149|4420790|P1|Overall Study|non compliance with study drug|1
1342435|NCT01904149|4420785|P6|Overall Study|Protocol Violation|0
1342436|NCT01904149|4420786|P5|Overall Study|Protocol Violation|0
1342437|NCT01904149|4420787|P4|Overall Study|Protocol Violation|0
1342438|NCT01904149|4420788|P3|Overall Study|Protocol Violation|0
1342439|NCT01904149|4420789|P2|Overall Study|Protocol Violation|1
1342440|NCT01904149|4420790|P1|Overall Study|Protocol Violation|0
1342441|NCT01904149|4420785|P6|Overall Study|Withdrawal by Subject|0
1342442|NCT01904149|4420786|P5|Overall Study|Withdrawal by Subject|1
1342443|NCT01904149|4420787|P4|Overall Study|Withdrawal by Subject|0
1342444|NCT01904149|4420788|P3|Overall Study|Withdrawal by Subject|1
1342445|NCT01904149|4420789|P2|Overall Study|Withdrawal by Subject|3
1342446|NCT01904149|4420790|P1|Overall Study|Withdrawal by Subject|1
1342447|NCT01904149|4420785|P6|Overall Study|Lack of Efficacy|1
1342448|NCT01904149|4420786|P5|Overall Study|Lack of Efficacy|3
1342449|NCT01904149|4420787|P4|Overall Study|Lack of Efficacy|3
1342450|NCT01904149|4420788|P3|Overall Study|Lack of Efficacy|1
1342451|NCT01904149|4420789|P2|Overall Study|Lack of Efficacy|3
1342452|NCT01904149|4420790|P1|Overall Study|Lack of Efficacy|0
1342453|NCT01904149|4420785|P6|Overall Study|Adverse Event|2
1342454|NCT01904149|4420786|P5|Overall Study|Adverse Event|1
1342455|NCT01904149|4420787|P4|Overall Study|Adverse Event|1
1342456|NCT01904149|4420788|P3|Overall Study|Adverse Event|0
1342457|NCT01904149|4420789|P2|Overall Study|Adverse Event|4
1342458|NCT01904149|4420790|P1|Overall Study|Adverse Event|3
1342459|NCT01904058|4420841|P4|Overall Study|Pregnancy|1
1342460|NCT01904058|4420842|P3|Overall Study|Pregnancy|0
1342461|NCT01904058|4420843|P2|Overall Study|Pregnancy|0
1342462|NCT01904058|4420844|P1|Overall Study|Pregnancy|0
1342463|NCT01904058|4420841|P4|Overall Study|Withdrawal by Subject|0
1342464|NCT01904058|4420842|P3|Overall Study|Withdrawal by Subject|1
1342465|NCT01904058|4420843|P2|Overall Study|Withdrawal by Subject|0
1342466|NCT01904058|4420844|P1|Overall Study|Withdrawal by Subject|1
1342467|NCT01904058|4420841|P4|Overall Study|Adverse Event|0
1342468|NCT01904058|4420842|P3|Overall Study|Adverse Event|0
1342469|NCT01904058|4420843|P2|Overall Study|Adverse Event|0
1342470|NCT01904058|4420844|P1|Overall Study|Adverse Event|2
1342471|NCT01903993|4420884|P2|Overall Study|Lost to Follow-up|1
1342472|NCT01903993|4420885|P1|Overall Study|Lost to Follow-up|2
1342473|NCT01903993|4420884|P2|Overall Study|Withdrawal by Subject|5
1342474|NCT01903993|4420885|P1|Overall Study|Withdrawal by Subject|13
1342475|NCT01903993|4420884|P2|Overall Study|Death|89
1342476|NCT01903993|4420885|P1|Overall Study|Death|108
1342477|NCT01903876|4420902|P2|Six-Month Follow-up Period|Lost to Follow-up|145
1342478|NCT01903876|4420903|P1|Six-Month Follow-up Period|Lost to Follow-up|91
1342479|NCT01903876|4420902|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
1342480|NCT01903876|4420903|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
1342481|NCT01903863|4420913|P2|Overall Study|Physician Decision|0
1342482|NCT01903863|4420914|P1|Overall Study|Physician Decision|2
1342483|NCT01903720|4420934|P1|Overall Study|Treatment with alternative drug|1
1342484|NCT01903720|4420934|P1|Overall Study|Lost to Follow-up|2
1342485|NCT01903720|4420934|P1|Overall Study|Rescinding of informed consent|2
1342486|NCT01903720|4420934|P1|Overall Study|Adverse Event|1
1342487|NCT01903720|4420934|P1|Overall Study|Inclusion / exclusion criteria not met|6
1342488|NCT01903460|4420972|P4|Overall Study|Adverse Event|1
1342489|NCT01903460|4420973|P3|Overall Study|Adverse Event|0
1342490|NCT01903460|4420974|P2|Overall Study|Adverse Event|0
1342491|NCT01903460|4420975|P1|Overall Study|Adverse Event|0
1342492|NCT01903252|4421011|P6|Maintenance, Open-Label|Other|2
1342493|NCT01903252|4421012|P5|Maintenance, Open-Label|Other|6
1342494|NCT01903252|4421013|P4|Maintenance, Open-Label|Other|2
1342495|NCT01903252|4421014|P3|Maintenance, Open-Label|Other|0
1342496|NCT01903252|4421015|P2|Maintenance, Open-Label|Other|0
1342497|NCT01903252|4421016|P1|Maintenance, Open-Label|Other|0
1342498|NCT01903252|4421011|P6|Maintenance, Open-Label|Withdrawal by Subject|2
1342499|NCT01903252|4421012|P5|Maintenance, Open-Label|Withdrawal by Subject|6
1342500|NCT01903252|4421013|P4|Maintenance, Open-Label|Withdrawal by Subject|1
1342501|NCT01903252|4421014|P3|Maintenance, Open-Label|Withdrawal by Subject|0
1342502|NCT01903252|4421015|P2|Maintenance, Open-Label|Withdrawal by Subject|0
1342503|NCT01903252|4421016|P1|Maintenance, Open-Label|Withdrawal by Subject|0
1342504|NCT01903252|4421011|P6|Maintenance, Open-Label|Adverse Event|14
1342505|NCT01903252|4421012|P5|Maintenance, Open-Label|Adverse Event|9
1342506|NCT01903252|4421013|P4|Maintenance, Open-Label|Adverse Event|3
1342507|NCT01903252|4421014|P3|Maintenance, Open-Label|Adverse Event|0
1342508|NCT01903252|4421015|P2|Maintenance, Open-Label|Adverse Event|0
1342509|NCT01903252|4421016|P1|Maintenance, Open-Label|Adverse Event|0
1342510|NCT01903252|4421011|P6|Extended Induction, Open-Label|Physician Decision|0
1342511|NCT01903252|4421012|P5|Extended Induction, Open-Label|Physician Decision|0
1342512|NCT01903252|4421013|P4|Extended Induction, Open-Label|Physician Decision|0
1342513|NCT01903252|4421014|P3|Extended Induction, Open-Label|Physician Decision|1
1342514|NCT01903252|4421015|P2|Extended Induction, Open-Label|Physician Decision|0
1342515|NCT01903252|4421016|P1|Extended Induction, Open-Label|Physician Decision|0
1342516|NCT01903252|4421011|P6|Extended Induction, Open-Label|Withdrawal by Subject|0
1342517|NCT01903252|4421012|P5|Extended Induction, Open-Label|Withdrawal by Subject|0
1342518|NCT01903252|4421013|P4|Extended Induction, Open-Label|Withdrawal by Subject|0
1342519|NCT01903252|4421014|P3|Extended Induction, Open-Label|Withdrawal by Subject|5
1342520|NCT01903252|4421015|P2|Extended Induction, Open-Label|Withdrawal by Subject|0
1342521|NCT01903252|4421016|P1|Extended Induction, Open-Label|Withdrawal by Subject|0
1342522|NCT01903252|4421011|P6|Extended Induction, Open-Label|Adverse Event|0
1342523|NCT01903252|4421012|P5|Extended Induction, Open-Label|Adverse Event|0
1342524|NCT01903252|4421013|P4|Extended Induction, Open-Label|Adverse Event|0
1342525|NCT01903252|4421014|P3|Extended Induction, Open-Label|Adverse Event|17
1342526|NCT01903252|4421015|P2|Extended Induction, Open-Label|Adverse Event|0
1342527|NCT01903252|4421016|P1|Extended Induction, Open-Label|Adverse Event|0
1342528|NCT01903252|4421011|P6|Double-Blind Induction|non-compliance,|0
1342529|NCT01903252|4421012|P5|Double-Blind Induction|non-compliance,|0
1342530|NCT01903252|4421013|P4|Double-Blind Induction|non-compliance,|0
1342531|NCT01903252|4421014|P3|Double-Blind Induction|non-compliance,|0
1342532|NCT01903252|4421015|P2|Double-Blind Induction|non-compliance,|7
1342533|NCT01903252|4421016|P1|Double-Blind Induction|non-compliance,|7
1342534|NCT01903252|4421011|P6|Double-Blind Induction|Physician Decision|0
1342535|NCT01903252|4421012|P5|Double-Blind Induction|Physician Decision|0
1342536|NCT01903252|4421013|P4|Double-Blind Induction|Physician Decision|0
1342537|NCT01903252|4421014|P3|Double-Blind Induction|Physician Decision|0
1342538|NCT01903252|4421015|P2|Double-Blind Induction|Physician Decision|3
1342539|NCT01903252|4421016|P1|Double-Blind Induction|Physician Decision|2
1342540|NCT01903252|4421011|P6|Double-Blind Induction|Withdrawal by Subject|0
1342541|NCT01903252|4421012|P5|Double-Blind Induction|Withdrawal by Subject|0
1342542|NCT01903252|4421013|P4|Double-Blind Induction|Withdrawal by Subject|0
1342543|NCT01903252|4421014|P3|Double-Blind Induction|Withdrawal by Subject|0
1342544|NCT01903252|4421015|P2|Double-Blind Induction|Withdrawal by Subject|13
1342545|NCT01903252|4421016|P1|Double-Blind Induction|Withdrawal by Subject|10
1342546|NCT01903252|4421011|P6|Double-Blind Induction|Adverse Event|0
1342547|NCT01903252|4421012|P5|Double-Blind Induction|Adverse Event|0
1342548|NCT01903252|4421013|P4|Double-Blind Induction|Adverse Event|0
1342549|NCT01903252|4421014|P3|Double-Blind Induction|Adverse Event|0
1342550|NCT01903252|4421015|P2|Double-Blind Induction|Adverse Event|18
1342551|NCT01903252|4421016|P1|Double-Blind Induction|Adverse Event|20
1342552|NCT01903031|4421129|P3|Overall Study|NuvaRing removed prior to Day 21 visit|1
1342553|NCT01903031|4421130|P2|Overall Study|NuvaRing removed prior to Day 21 visit|0
1342554|NCT01903031|4421131|P1|Overall Study|NuvaRing removed prior to Day 21 visit|0
1342555|NCT01903031|4421129|P3|Overall Study|Lost to Follow-up|1
1342556|NCT01903031|4421130|P2|Overall Study|Lost to Follow-up|0
1342557|NCT01903031|4421131|P1|Overall Study|Lost to Follow-up|0
1342558|NCT01903031|4421129|P3|Overall Study|Protocol Violation|2
1342559|NCT01903031|4421130|P2|Overall Study|Protocol Violation|0
1342560|NCT01903031|4421131|P1|Overall Study|Protocol Violation|0
1342561|NCT01903031|4421129|P3|Overall Study|Withdrawal by Subject|1
1342562|NCT01903031|4421130|P2|Overall Study|Withdrawal by Subject|1
1342563|NCT01903031|4421131|P1|Overall Study|Withdrawal by Subject|0
1342564|NCT01903031|4421129|P3|Overall Study|Adverse Event|0
1342565|NCT01903031|4421130|P2|Overall Study|Adverse Event|1
1342566|NCT01903031|4421131|P1|Overall Study|Adverse Event|0
1342567|NCT01903031|4421129|P3|Overall Study|Missed Day 21 Primary Endpoint Visit|0
1342568|NCT01903031|4421130|P2|Overall Study|Missed Day 21 Primary Endpoint Visit|0
1342569|NCT01903031|4421131|P1|Overall Study|Missed Day 21 Primary Endpoint Visit|1
1342570|NCT01903031|4421129|P3|Overall Study|Not Able to Attend Clinic|0
1342571|NCT01903031|4421130|P2|Overall Study|Not Able to Attend Clinic|1
1342572|NCT01903031|4421131|P1|Overall Study|Not Able to Attend Clinic|1
1342573|NCT01902888|4421187|P1|Overall Study|Study Terminated|3
1342574|NCT01902628|4421201|P1|Overall Study|Lost to Follow-up|35
1342575|NCT01902628|4421201|P1|Overall Study|Adverse Event|41
1342576|NCT01902628|4421201|P1|Overall Study|Withdrawal of participant's consent|7
1342577|NCT01902303|4421229|P2|Overall Study|Did not develop a cold sore|19
1342578|NCT01902303|4421230|P1|Overall Study|Did not develop a cold sore|21
1342579|NCT01902303|4421229|P2|Overall Study|subject lost investigational product|1
1342580|NCT01902303|4421230|P1|Overall Study|subject lost investigational product|0
1342581|NCT01902303|4421229|P2|Overall Study|Protocol Violation|2
1342582|NCT01902303|4421230|P1|Overall Study|Protocol Violation|2
1342583|NCT01902303|4421229|P2|Overall Study|Lost to Follow-up|1
1342584|NCT01902303|4421230|P1|Overall Study|Lost to Follow-up|0
1342585|NCT01902303|4421229|P2|Overall Study|Adverse Event|1
1342586|NCT01902303|4421230|P1|Overall Study|Adverse Event|0
1342587|NCT01902134|4421244|P6|Overall Study|not specified|0
1342588|NCT01902134|4421245|P5|Overall Study|not specified|1
1342589|NCT01902134|4421246|P4|Overall Study|not specified|0
1342590|NCT01902134|4421247|P3|Overall Study|not specified|2
1342591|NCT01902134|4421248|P2|Overall Study|not specified|1
1342592|NCT01902134|4421249|P1|Overall Study|not specified|0
1342593|NCT01902134|4421244|P6|Overall Study|no compliance|0
1342594|NCT01902134|4421245|P5|Overall Study|no compliance|0
1342595|NCT01902134|4421246|P4|Overall Study|no compliance|0
1342596|NCT01902134|4421247|P3|Overall Study|no compliance|0
1342597|NCT01902134|4421248|P2|Overall Study|no compliance|0
1342598|NCT01902134|4421249|P1|Overall Study|no compliance|1
1342599|NCT01902134|4421244|P6|Overall Study|Withdrawal by Subject|4
1342600|NCT01902134|4421245|P5|Overall Study|Withdrawal by Subject|5
1342601|NCT01902134|4421246|P4|Overall Study|Withdrawal by Subject|1
1342602|NCT01902134|4421247|P3|Overall Study|Withdrawal by Subject|9
1342603|NCT01902134|4421248|P2|Overall Study|Withdrawal by Subject|8
1342604|NCT01902134|4421249|P1|Overall Study|Withdrawal by Subject|4
1342605|NCT01902134|4421244|P6|Overall Study|Protocol Violation|1
1342606|NCT01902134|4421245|P5|Overall Study|Protocol Violation|0
1342607|NCT01902134|4421246|P4|Overall Study|Protocol Violation|0
1342608|NCT01902134|4421247|P3|Overall Study|Protocol Violation|0
1342609|NCT01902134|4421248|P2|Overall Study|Protocol Violation|0
1342610|NCT01902134|4421249|P1|Overall Study|Protocol Violation|0
1342611|NCT01902134|4421244|P6|Overall Study|Physician Decision|0
1342612|NCT01902134|4421245|P5|Overall Study|Physician Decision|0
1342613|NCT01902134|4421246|P4|Overall Study|Physician Decision|0
1342614|NCT01902134|4421247|P3|Overall Study|Physician Decision|0
1342615|NCT01902134|4421248|P2|Overall Study|Physician Decision|1
1342616|NCT01902134|4421249|P1|Overall Study|Physician Decision|0
1342617|NCT01902134|4421244|P6|Overall Study|Lack of Efficacy|1
1342618|NCT01902134|4421245|P5|Overall Study|Lack of Efficacy|0
1342619|NCT01902134|4421246|P4|Overall Study|Lack of Efficacy|0
1342620|NCT01902134|4421247|P3|Overall Study|Lack of Efficacy|2
1342621|NCT01902134|4421248|P2|Overall Study|Lack of Efficacy|0
1342622|NCT01902134|4421249|P1|Overall Study|Lack of Efficacy|0
1342623|NCT01902134|4421244|P6|Overall Study|Adverse Event|3
1342624|NCT01902134|4421245|P5|Overall Study|Adverse Event|1
1342625|NCT01902134|4421246|P4|Overall Study|Adverse Event|1
1342626|NCT01902134|4421247|P3|Overall Study|Adverse Event|2
1342627|NCT01902134|4421248|P2|Overall Study|Adverse Event|1
1342628|NCT01902134|4421249|P1|Overall Study|Adverse Event|3
1342629|NCT01901653|4421305|P13|Overall Study|Alive at Study Termination by Sponsor|1
1342630|NCT01901653|4421306|P12|Overall Study|Alive at Study Termination by Sponsor|1
1342631|NCT01901653|4421307|P11|Overall Study|Alive at Study Termination by Sponsor|0
1342632|NCT01901653|4421308|P10|Overall Study|Alive at Study Termination by Sponsor|2
1342633|NCT01901653|4421309|P9|Overall Study|Alive at Study Termination by Sponsor|0
1342634|NCT01901653|4421310|P8|Overall Study|Alive at Study Termination by Sponsor|0
1342635|NCT01901653|4421311|P7|Overall Study|Alive at Study Termination by Sponsor|0
1342636|NCT01901653|4421312|P6|Overall Study|Alive at Study Termination by Sponsor|0
1342637|NCT01901653|4421313|P5|Overall Study|Alive at Study Termination by Sponsor|0
1342638|NCT01901653|4421314|P4|Overall Study|Alive at Study Termination by Sponsor|0
1342639|NCT01901653|4421315|P3|Overall Study|Alive at Study Termination by Sponsor|1
1342640|NCT01901653|4421316|P2|Overall Study|Alive at Study Termination by Sponsor|0
1342641|NCT01901653|4421317|P1|Overall Study|Alive at Study Termination by Sponsor|0
1342642|NCT01901653|4421305|P13|Overall Study|Withdrawal by Subject|0
1342643|NCT01901653|4421306|P12|Overall Study|Withdrawal by Subject|0
1342644|NCT01901653|4421307|P11|Overall Study|Withdrawal by Subject|0
1342645|NCT01901653|4421308|P10|Overall Study|Withdrawal by Subject|0
1342646|NCT01901653|4421309|P9|Overall Study|Withdrawal by Subject|0
1342647|NCT01901653|4421310|P8|Overall Study|Withdrawal by Subject|0
1342648|NCT01901653|4421311|P7|Overall Study|Withdrawal by Subject|1
1342649|NCT01901653|4421312|P6|Overall Study|Withdrawal by Subject|0
1342650|NCT01901653|4421313|P5|Overall Study|Withdrawal by Subject|0
1342651|NCT01901653|4421314|P4|Overall Study|Withdrawal by Subject|0
1342652|NCT01901653|4421315|P3|Overall Study|Withdrawal by Subject|0
1342653|NCT01901653|4421316|P2|Overall Study|Withdrawal by Subject|0
1342654|NCT01901653|4421317|P1|Overall Study|Withdrawal by Subject|0
1342655|NCT01901653|4421305|P13|Overall Study|Lost to Follow-up|0
1342656|NCT01901653|4421306|P12|Overall Study|Lost to Follow-up|0
1342657|NCT01901653|4421307|P11|Overall Study|Lost to Follow-up|0
1342658|NCT01901653|4421308|P10|Overall Study|Lost to Follow-up|0
1342659|NCT01901653|4421309|P9|Overall Study|Lost to Follow-up|0
1342660|NCT01901653|4421310|P8|Overall Study|Lost to Follow-up|1
1342661|NCT01901653|4421311|P7|Overall Study|Lost to Follow-up|0
1342662|NCT01901653|4421312|P6|Overall Study|Lost to Follow-up|1
1342663|NCT01901653|4421313|P5|Overall Study|Lost to Follow-up|0
1342664|NCT01901653|4421314|P4|Overall Study|Lost to Follow-up|0
1342665|NCT01901653|4421315|P3|Overall Study|Lost to Follow-up|2
1342666|NCT01901653|4421316|P2|Overall Study|Lost to Follow-up|0
1342667|NCT01901653|4421317|P1|Overall Study|Lost to Follow-up|1
1342668|NCT01901653|4421305|P13|Overall Study|Death|4
1342669|NCT01901653|4421306|P12|Overall Study|Death|15
1342670|NCT01901653|4421307|P11|Overall Study|Death|2
1342671|NCT01901653|4421308|P10|Overall Study|Death|16
1342672|NCT01901653|4421309|P9|Overall Study|Death|1
1342673|NCT01901653|4421310|P8|Overall Study|Death|9
1342674|NCT01901653|4421311|P7|Overall Study|Death|6
1342675|NCT01901653|4421312|P6|Overall Study|Death|2
1342676|NCT01901653|4421313|P5|Overall Study|Death|2
1342677|NCT01901653|4421314|P4|Overall Study|Death|3
1342678|NCT01901653|4421315|P3|Overall Study|Death|8
1342679|NCT01901653|4421316|P2|Overall Study|Death|1
1342680|NCT01901653|4421317|P1|Overall Study|Death|2
1342681|NCT01901393|4421385|P2|Overall Study|Adverse Event|0
1342682|NCT01901393|4421386|P1|Overall Study|Adverse Event|1
1342683|NCT01901341|4421404|P2|Overall Study|Withdrawal by Subject|1
1342684|NCT01901341|4421405|P1|Overall Study|Withdrawal by Subject|1
1342685|NCT01901341|4421404|P2|Overall Study|Study Terminated by Sponsor|15
1342686|NCT01901341|4421405|P1|Overall Study|Study Terminated by Sponsor|13
1342687|NCT01901341|4421404|P2|Overall Study|Protocol Violation|0
1342688|NCT01901341|4421405|P1|Overall Study|Protocol Violation|2
1342689|NCT01901341|4421404|P2|Overall Study|Lost to Follow-up|1
1342690|NCT01901341|4421405|P1|Overall Study|Lost to Follow-up|0
1342691|NCT01901341|4421404|P2|Overall Study|Lack of Efficacy|2
1342692|NCT01901341|4421405|P1|Overall Study|Lack of Efficacy|0
1342693|NCT01901341|4421404|P2|Overall Study|Adverse Event|2
1342694|NCT01901341|4421405|P1|Overall Study|Adverse Event|4
1342695|NCT01901328|4421419|P2|Overall Study|Lack of Efficacy|1
1342696|NCT01901328|4421420|P1|Overall Study|Lack of Efficacy|0
1342697|NCT01901328|4421419|P2|Overall Study|Withdrawal by Subject|2
1342698|NCT01901328|4421420|P1|Overall Study|Withdrawal by Subject|1
1342699|NCT01901328|4421419|P2|Overall Study|Study Terminated by Sponsor|16
1342700|NCT01901328|4421420|P1|Overall Study|Study Terminated by Sponsor|19
1342701|NCT01901328|4421419|P2|Overall Study|Protocol Violation|1
1342702|NCT01901328|4421420|P1|Overall Study|Protocol Violation|1
1342703|NCT01901328|4421419|P2|Overall Study|Physician Decision|1
1342704|NCT01901328|4421420|P1|Overall Study|Physician Decision|0
1342705|NCT01901328|4421419|P2|Overall Study|Lost to Follow-up|0
1342706|NCT01901328|4421420|P1|Overall Study|Lost to Follow-up|1
1342707|NCT01901302|4421434|P2|Overall Study|Withdrawal by Subject|0
1342708|NCT01901302|4421435|P1|Overall Study|Withdrawal by Subject|2
1342709|NCT01901302|4421434|P2|Overall Study|Study Terminated by Sponsor|20
1342710|NCT01901302|4421435|P1|Overall Study|Study Terminated by Sponsor|23
1342711|NCT01901302|4421434|P2|Overall Study|Lack of Efficacy|2
1342712|NCT01901302|4421435|P1|Overall Study|Lack of Efficacy|0
1342713|NCT01901302|4421434|P2|Overall Study|Adverse Event|1
1342714|NCT01901302|4421435|P1|Overall Study|Adverse Event|2
1342715|NCT01901185|4421486|P1|Overall Study|Withdrawal by Subject|2
1342716|NCT01900665|4421495|P2|Open Label Period|Withdrawal by Subject|28
1342717|NCT01900665|4421496|P1|Open Label Period|Withdrawal by Subject|20
1342718|NCT01900665|4421495|P2|Open Label Period|Sponsor Decision|765
1342719|NCT01900665|4421496|P1|Open Label Period|Sponsor Decision|802
1342720|NCT01900665|4421495|P2|Open Label Period|Protocol Violation|1
1342721|NCT01900665|4421496|P1|Open Label Period|Protocol Violation|0
1342722|NCT01900665|4421495|P2|Open Label Period|Physician Decision|4
1342723|NCT01900665|4421496|P1|Open Label Period|Physician Decision|4
1342724|NCT01900665|4421495|P2|Open Label Period|Parent/Caregiver Decision|34
1342725|NCT01900665|4421496|P1|Open Label Period|Parent/Caregiver Decision|33
1342726|NCT01900665|4421495|P2|Open Label Period|Lost to Follow-up|1
1342727|NCT01900665|4421496|P1|Open Label Period|Lost to Follow-up|1
1342728|NCT01900665|4421495|P2|Open Label Period|Death|6
1342729|NCT01900665|4421496|P1|Open Label Period|Death|5
1342730|NCT01900665|4421495|P2|Open Label Period|Adverse Event|20
1342731|NCT01900665|4421496|P1|Open Label Period|Adverse Event|16
1342732|NCT01900665|4421495|P2|Placebo Controlled Period|Entry Criteria Not Met|9
1342733|NCT01900665|4421496|P1|Placebo Controlled Period|Entry Criteria Not Met|5
1342734|NCT01900665|4421495|P2|Placebo Controlled Period|Caregiver Decision|41
1342735|NCT01900665|4421496|P1|Placebo Controlled Period|Caregiver Decision|33
1342736|NCT01900665|4421495|P2|Placebo Controlled Period|Lost to Follow-up|0
1342737|NCT01900665|4421496|P1|Placebo Controlled Period|Lost to Follow-up|3
1342738|NCT01900665|4421495|P2|Placebo Controlled Period|Physician Decision|7
1342739|NCT01900665|4421496|P1|Placebo Controlled Period|Physician Decision|11
1342740|NCT01900665|4421495|P2|Placebo Controlled Period|Withdrawal by Subject|45
1342741|NCT01900665|4421496|P1|Placebo Controlled Period|Withdrawal by Subject|33
1342742|NCT01900665|4421495|P2|Placebo Controlled Period|Protocol Violation|7
1342743|NCT01900665|4421496|P1|Placebo Controlled Period|Protocol Violation|1
1342744|NCT01900665|4421495|P2|Placebo Controlled Period|Adverse Event|39
1342745|NCT01900665|4421496|P1|Placebo Controlled Period|Adverse Event|48
1342746|NCT01900665|4421495|P2|Placebo Controlled Period|Death|16
1342747|NCT01900665|4421496|P1|Placebo Controlled Period|Death|9
1342748|NCT01900652|4421539|P2|Overall Study|Physician Decision|1
1342749|NCT01900652|4421540|P1|Overall Study|Physician Decision|1
1342750|NCT01900652|4421539|P2|Overall Study|Adverse Event|1
1342751|NCT01900652|4421540|P1|Overall Study|Adverse Event|2
1342752|NCT01900652|4421539|P2|Overall Study|Death|0
1342753|NCT01900652|4421540|P1|Overall Study|Death|3
1342754|NCT01900652|4421539|P2|Overall Study|Consent withdrawn by subject|1
1342755|NCT01900652|4421540|P1|Overall Study|Consent withdrawn by subject|1
1342756|NCT01900652|4421539|P2|Overall Study|Progressive Disease|0
1342757|NCT01900652|4421540|P1|Overall Study|Progressive Disease|1
1342758|NCT01900444|4421574|P1|Overall Study|Lost to Follow-up|1
1342759|NCT01900444|4421574|P1|Overall Study|Protocol Violation|2
1342760|NCT01900431|4421587|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
1342761|NCT01900431|4421588|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
1342762|NCT01900431|4421589|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
1342763|NCT01900431|4421587|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
1342764|NCT01900431|4421588|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
1342765|NCT01900431|4421589|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
1342766|NCT01900431|4421587|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
1342767|NCT01900431|4421588|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
1342768|NCT01900431|4421589|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
1342769|NCT01900431|4421587|P3|Extended Treatment Period (Part B)|Other than specified above|0
1342770|NCT01900431|4421588|P2|Extended Treatment Period (Part B)|Other than specified above|1
1342771|NCT01900431|4421589|P1|Extended Treatment Period (Part B)|Other than specified above|0
1342772|NCT01900431|4421587|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
1342773|NCT01900431|4421588|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
1342774|NCT01900431|4421589|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
1342775|NCT01900431|4421587|P3|Extended Treatment Period (Part B)|Adverse Event|0
1342776|NCT01900431|4421588|P2|Extended Treatment Period (Part B)|Adverse Event|2
1342777|NCT01900431|4421589|P1|Extended Treatment Period (Part B)|Adverse Event|0
1342778|NCT01900431|4421587|P3|Principal Treatment Period (Part A)|Other than specified above|0
1342779|NCT01900431|4421588|P2|Principal Treatment Period (Part A)|Other than specified above|1
1342780|NCT01900431|4421589|P1|Principal Treatment Period (Part A)|Other than specified above|0
1342781|NCT01900431|4421587|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
1342782|NCT01900431|4421588|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
1342783|NCT01900431|4421589|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
1342784|NCT01900431|4421587|P3|Principal Treatment Period (Part A)|Adverse Event|0
1342785|NCT01900431|4421588|P2|Principal Treatment Period (Part A)|Adverse Event|3
1342786|NCT01900431|4421589|P1|Principal Treatment Period (Part A)|Adverse Event|1
1342787|NCT01900314|4421615|P2|Overall Study|Withdrawal by Subject|3
1342788|NCT01900314|4421616|P1|Overall Study|Withdrawal by Subject|3
1342789|NCT01900314|4421615|P2|Overall Study|Protocol Violation|1
1342790|NCT01900314|4421616|P1|Overall Study|Protocol Violation|0
1342791|NCT01900314|4421615|P2|Overall Study|Lost to Follow-up|0
1342792|NCT01900314|4421616|P1|Overall Study|Lost to Follow-up|1
1342793|NCT01900054|4421646|P1|Overall Study|Withdrawal by Subject|1
1342794|NCT01900054|4421646|P1|Overall Study|Physician Decision|1
1342795|NCT01899768|4421655|P1|Part B|Withdrawal by Subject|1
1342796|NCT01899768|4421655|P1|Part B|Adverse Event|1
1342797|NCT01899768|4421655|P1|Part A|Withdrawal by Subject|1
1342798|NCT01899768|4421655|P1|Part A|Adverse Event|2
1342799|NCT01899742|4421729|P2|Overall Study|Withdrawal by Subject|5
1342800|NCT01899742|4421730|P1|Overall Study|Withdrawal by Subject|9
1342801|NCT01899742|4421729|P2|Overall Study|Protocol Violation|2
1342802|NCT01899742|4421730|P1|Overall Study|Protocol Violation|2
1342803|NCT01899742|4421729|P2|Overall Study|Lack of Efficacy|5
1342804|NCT01899742|4421730|P1|Overall Study|Lack of Efficacy|1
1342805|NCT01899742|4421729|P2|Overall Study|Adverse Event|4
1342806|NCT01899742|4421730|P1|Overall Study|Adverse Event|5
1342807|NCT01899144|4421769|P1|Treatment Period 5|Not specified|1
1342808|NCT01899144|4421769|P1|Treatment Period 3|Not specified|2
1342809|NCT01899144|4421769|P1|Treatment Period 2|Not specified|1
1342810|NCT01898884|4421796|P9|Multiple Dose Period|Randomized Not Treated|1
1342811|NCT01898884|4421797|P8|Multiple Dose Period|Randomized Not Treated|0
1342812|NCT01898884|4421798|P7|Multiple Dose Period|Randomized Not Treated|0
1342813|NCT01898884|4421799|P6|Multiple Dose Period|Randomized Not Treated|0
1342814|NCT01898884|4421800|P5|Multiple Dose Period|Randomized Not Treated|0
1342815|NCT01898884|4421801|P4|Multiple Dose Period|Randomized Not Treated|0
1342816|NCT01898884|4421802|P3|Multiple Dose Period|Randomized Not Treated|0
1342817|NCT01898884|4421803|P2|Multiple Dose Period|Randomized Not Treated|0
1342818|NCT01898884|4421804|P1|Multiple Dose Period|Randomized Not Treated|0
1342819|NCT01898884|4421796|P9|Multiple Dose Period|Adverse Event|0
1342820|NCT01898884|4421797|P8|Multiple Dose Period|Adverse Event|0
1342821|NCT01898884|4421798|P7|Multiple Dose Period|Adverse Event|1
1342822|NCT01898884|4421799|P6|Multiple Dose Period|Adverse Event|0
1342823|NCT01898884|4421800|P5|Multiple Dose Period|Adverse Event|0
1342824|NCT01898884|4421801|P4|Multiple Dose Period|Adverse Event|0
1342825|NCT01898884|4421802|P3|Multiple Dose Period|Adverse Event|0
1342826|NCT01898884|4421803|P2|Multiple Dose Period|Adverse Event|0
1342827|NCT01898884|4421804|P1|Multiple Dose Period|Adverse Event|0
1342828|NCT01898598|4421956|P2|Overall Study|Other|1
1342829|NCT01898598|4421957|P1|Overall Study|Other|0
1342830|NCT01898598|4421956|P2|Overall Study|Lost to Follow-up|1
1342831|NCT01898598|4421957|P1|Overall Study|Lost to Follow-up|0
1342832|NCT01898598|4421956|P2|Overall Study|Withdrawal by Subject|0
1342833|NCT01898598|4421957|P1|Overall Study|Withdrawal by Subject|3
1342834|NCT01898598|4421956|P2|Overall Study|Adverse Event|0
1342835|NCT01898598|4421957|P1|Overall Study|Adverse Event|1
1342836|NCT01898442|4421976|P3|Overall Study|Patient vomited pills|1
1342837|NCT01898442|4421977|P2|Overall Study|Patient vomited pills|0
1342838|NCT01898442|4421978|P1|Overall Study|Patient vomited pills|0
1342839|NCT01898442|4421976|P3|Overall Study|Hemolysis/technical problems|2
1342840|NCT01898442|4421977|P2|Overall Study|Hemolysis/technical problems|2
1342841|NCT01898442|4421978|P1|Overall Study|Hemolysis/technical problems|1
1342842|NCT01898286|4422007|P1|Overall Study|Lost to Follow-up|1
1342843|NCT01898286|4422007|P1|Overall Study|Protocol Violation|1
1342844|NCT01898286|4422007|P1|Overall Study|Withdrawal by Subject|1
1342845|NCT01898208|4422017|P3|Overall Study|Lost to Follow-up|1
1342846|NCT01898208|4422018|P2|Overall Study|Lost to Follow-up|1
1342847|NCT01898208|4422019|P1|Overall Study|Lost to Follow-up|3
1342848|NCT01898208|4422017|P3|Overall Study|System/Technical Error|3
1342849|NCT01898208|4422018|P2|Overall Study|System/Technical Error|2
1342850|NCT01898208|4422019|P1|Overall Study|System/Technical Error|1
1342851|NCT01898208|4422017|P3|Overall Study|Non-Blood Specimens in Bottles|4
1342852|NCT01898208|4422018|P2|Overall Study|Non-Blood Specimens in Bottles|5
1342853|NCT01898208|4422019|P1|Overall Study|Non-Blood Specimens in Bottles|3
1342854|NCT01898208|4422017|P3|Overall Study|Negative Gram Stain|6
1342855|NCT01898208|4422018|P2|Overall Study|Negative Gram Stain|9
1342856|NCT01898208|4422019|P1|Overall Study|Negative Gram Stain|6
1342857|NCT01898208|4422017|P3|Overall Study|Death/comfort care within 24 hours|8
1342858|NCT01898208|4422018|P2|Overall Study|Death/comfort care within 24 hours|9
1342859|NCT01898208|4422019|P1|Overall Study|Death/comfort care within 24 hours|10
1342860|NCT01898208|4422017|P3|Overall Study|Positive blood culture|15
1342861|NCT01898208|4422018|P2|Overall Study|Positive blood culture|23
1342862|NCT01898208|4422019|P1|Overall Study|Positive blood culture|17
1342863|NCT01898195|4422066|P3|Smoking Abstinence|Did not have good measurements|36
1342864|NCT01898195|4422067|P2|Smoking Abstinence|Did not have good measurements|38
1342865|NCT01898195|4422068|P1|Smoking Abstinence|Did not have good measurements|35
1342866|NCT01898091|4422081|P2|Overall Study|Withdrawal by Subject|5
1342867|NCT01898091|4422082|P1|Overall Study|Withdrawal by Subject|1
1342868|NCT01898091|4422081|P2|Overall Study|Lost to Follow-up|1
1342869|NCT01898091|4422082|P1|Overall Study|Lost to Follow-up|1
1342870|NCT01897727|4422117|P2|Overall Study|Exclusion: central sleep apnea|1
1342871|NCT01897727|4422118|P1|Overall Study|Exclusion: central sleep apnea|0
1342872|NCT01897233|4422147|P1|Part B (24 Weeks)|Physician Decision|1
1342873|NCT01897233|4422147|P1|Part B (24 Weeks)|Withdrawal by Subject|2
1342874|NCT01897233|4422147|P1|Part B (24 Weeks)|Adverse Event|1
1342875|NCT01896986|4422199|P2|Overall Study|samples lost|23
1342876|NCT01896986|4422200|P1|Overall Study|samples lost|14
1342877|NCT01896934|4422206|P1|Overall Study|Withdrawal by Subject|1
1342878|NCT01896934|4422206|P1|Overall Study|Adverse Event|1
1342879|NCT01896895|4422215|P4|Double-blind MP|Lost to Follow-up|0
1342880|NCT01896895|4422216|P3|Double-blind MP|Lost to Follow-up|1
1342881|NCT01896895|4422217|P2|Double-blind MP|Lost to Follow-up|0
1342882|NCT01896895|4422218|P1|Double-blind MP|Lost to Follow-up|1
1342883|NCT01896895|4422215|P4|Double-blind MP|Withdrawal by Subject|0
1342884|NCT01896895|4422216|P3|Double-blind MP|Withdrawal by Subject|1
1342885|NCT01896895|4422217|P2|Double-blind MP|Withdrawal by Subject|2
1342886|NCT01896895|4422218|P1|Double-blind MP|Withdrawal by Subject|0
1342887|NCT01896895|4422215|P4|Double-blind MP|Physician Decision|0
1342888|NCT01896895|4422216|P3|Double-blind MP|Physician Decision|1
1342889|NCT01896895|4422217|P2|Double-blind MP|Physician Decision|0
1342890|NCT01896895|4422218|P1|Double-blind MP|Physician Decision|0
1342891|NCT01896726|4422233|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
1342892|NCT01896726|4422233|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
1342893|NCT01896700|4422248|P2|Overall Study|Withdrawal by Subject|1
1342894|NCT01896700|4422249|P1|Overall Study|Withdrawal by Subject|0
1342895|NCT01896700|4422248|P2|Overall Study|Adverse Event|5
1342896|NCT01896700|4422249|P1|Overall Study|Adverse Event|4
1342897|NCT01896557|4422280|P2|Clopidogrel + GI Protector|Reading error|3
1342898|NCT01896557|4422281|P1|Clopidogrel + GI Protector|Reading error|1
1342899|NCT01896557|4422280|P2|Clopidogrel + GI Protector|low adherence|1
1342900|NCT01896557|4422281|P1|Clopidogrel + GI Protector|low adherence|1
1342901|NCT01896557|4422280|P2|Clopidogrel Alone|Adverse Event|0
1342902|NCT01896557|4422281|P1|Clopidogrel Alone|Adverse Event|1
1342903|NCT01896297|4422318|P1|Overall Study|Died in post treatment phase|1
1342904|NCT01896232|4422325|P2|Overall Study|Lost to Follow-up|12
1342905|NCT01896232|4422326|P1|Overall Study|Lost to Follow-up|9
1342906|NCT01896232|4422325|P2|Overall Study|Sponsor Decision|0
1342907|NCT01896232|4422326|P1|Overall Study|Sponsor Decision|2
1342908|NCT01896232|4422325|P2|Overall Study|Withdrawal by Subject|31
1342909|NCT01896232|4422326|P1|Overall Study|Withdrawal by Subject|32
1342910|NCT01896232|4422325|P2|Overall Study|Death|10
1342911|NCT01896232|4422326|P1|Overall Study|Death|6
1342912|NCT01896193|4422354|P2|Overall Study|Withdrew Consent|0
1342913|NCT01896193|4422355|P1|Overall Study|Withdrew Consent|1
1342914|NCT01896193|4422354|P2|Overall Study|Protocol Violation|1
1342915|NCT01896193|4422355|P1|Overall Study|Protocol Violation|0
1342916|NCT01896193|4422354|P2|Overall Study|Lack of Efficacy|11
1342917|NCT01896193|4422355|P1|Overall Study|Lack of Efficacy|20
1342918|NCT01896050|4422407|P2|Overall Study|Death|0
1342919|NCT01896050|4422408|P1|Overall Study|Death|1
1342920|NCT01896050|4422407|P2|Overall Study|Adverse Event|2
1342921|NCT01896050|4422408|P1|Overall Study|Adverse Event|37
1342922|NCT01895608|4422456|P4|Overall Study|Withdrawal by Subject|0
1342923|NCT01895608|4422457|P3|Overall Study|Withdrawal by Subject|2
1342924|NCT01895608|4422458|P2|Overall Study|Withdrawal by Subject|0
1342925|NCT01895608|4422459|P1|Overall Study|Withdrawal by Subject|0
1342926|NCT01895608|4422456|P4|Overall Study|change in health status|0
1342927|NCT01895608|4422457|P3|Overall Study|change in health status|1
1342928|NCT01895608|4422458|P2|Overall Study|change in health status|1
1342929|NCT01895608|4422459|P1|Overall Study|change in health status|0
1342930|NCT01895543|4422489|P1|Overall Study|Other (Not fulfilling above criteria)|24
1342931|NCT01895543|4422489|P1|Overall Study|Physician Decision|2
1342932|NCT01895543|4422489|P1|Overall Study|Protocol Violation|1
1342933|NCT01895543|4422489|P1|Overall Study|Subject's substantial non-compliance|6
1342934|NCT01895543|4422489|P1|Overall Study|Adverse Event|28
1342935|NCT01895543|4422489|P1|Overall Study|Lost to Follow-up|25
1342936|NCT01895543|4422489|P1|Overall Study|Withdrawal by Subject|43
1342937|NCT01895452|4422505|P2|Overall Study|Noncompliance with study drug|1
1342938|NCT01895452|4422506|P1|Overall Study|Noncompliance with study drug|0
1342939|NCT01895452|4422505|P2|Overall Study|Underlying disease|3
1342940|NCT01895452|4422506|P1|Overall Study|Underlying disease|0
1342941|NCT01895452|4422505|P2|Overall Study|Withdrawal by Subject|14
1342942|NCT01895452|4422506|P1|Overall Study|Withdrawal by Subject|2
1342943|NCT01895452|4422505|P2|Overall Study|Pregnancy|1
1342944|NCT01895452|4422506|P1|Overall Study|Pregnancy|0
1342945|NCT01895452|4422505|P2|Overall Study|Lost to Follow-up|5
1342946|NCT01895452|4422506|P1|Overall Study|Lost to Follow-up|1
1342947|NCT01895452|4422505|P2|Overall Study|Adverse Event|4
1342948|NCT01895452|4422506|P1|Overall Study|Adverse Event|1
1342949|NCT01895335|4422516|P1|Overall Study|Other than Specified Above|44
1342950|NCT01895335|4422516|P1|Overall Study|Included But Not treated|1
1342951|NCT01895335|4422516|P1|Overall Study|Poor Compliance to Protocol|11
1342952|NCT01895335|4422516|P1|Overall Study|Lack of Efficacy|53
1342953|NCT01895335|4422516|P1|Overall Study|Adverse Event|106
1342954|NCT01895322|4422533|P1|Overall Study|Protocol Violation|10
1342955|NCT01895322|4422533|P1|Overall Study|Withdrawal by Subject|2
1342956|NCT01895322|4422533|P1|Overall Study|Adverse Event|1
1342957|NCT01895309|4422542|P2|Overall Study|Withdrawal by Subject|18
1342958|NCT01895309|4422543|P1|Overall Study|Withdrawal by Subject|9
1342959|NCT01895309|4422542|P2|Overall Study|Physician Decision|10
1342960|NCT01895309|4422543|P1|Overall Study|Physician Decision|15
1342961|NCT01895309|4422542|P2|Overall Study|Lost to Follow-up|3
1342962|NCT01895309|4422543|P1|Overall Study|Lost to Follow-up|1
1342963|NCT01895309|4422542|P2|Overall Study|Lack of Efficacy|3
1342964|NCT01895309|4422543|P1|Overall Study|Lack of Efficacy|1
1342965|NCT01895309|4422542|P2|Overall Study|Protocol Violation|0
1342966|NCT01895309|4422543|P1|Overall Study|Protocol Violation|1
1342967|NCT01895309|4422542|P2|Overall Study|Adverse Event|17
1342968|NCT01895309|4422543|P1|Overall Study|Adverse Event|13
1342969|NCT01895270|4422557|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
1342970|NCT01895270|4422558|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
1342971|NCT01895270|4422557|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
1342972|NCT01895270|4422558|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
1342973|NCT01895270|4422557|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
1342974|NCT01895270|4422558|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
1342975|NCT01895270|4422557|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
1342976|NCT01895270|4422558|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
1342977|NCT01895270|4422557|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
1342978|NCT01895270|4422558|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
1342979|NCT01895270|4422557|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
1342980|NCT01895270|4422558|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
1342981|NCT01895270|4422557|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
1342982|NCT01895270|4422558|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
1342983|NCT01895101|4422577|P3|Overall Study|coagulation disorder|0
1342984|NCT01895101|4422578|P2|Overall Study|coagulation disorder|1
1342985|NCT01895101|4422579|P1|Overall Study|coagulation disorder|0
1342986|NCT01895101|4422577|P3|Overall Study|Death|0
1342987|NCT01895101|4422578|P2|Overall Study|Death|1
1342988|NCT01895101|4422579|P1|Overall Study|Death|0
1342989|NCT01895101|4422577|P3|Overall Study|another study, enrolled in other study|0
1342990|NCT01895101|4422578|P2|Overall Study|another study, enrolled in other study|1
1342991|NCT01895101|4422579|P1|Overall Study|another study, enrolled in other study|0
1342992|NCT01895101|4422577|P3|Overall Study|Withdrawal by Subject|2
1342993|NCT01895101|4422578|P2|Overall Study|Withdrawal by Subject|1
1342994|NCT01895101|4422579|P1|Overall Study|Withdrawal by Subject|0
1342995|NCT01895101|4422577|P3|Overall Study|OPCAB procedure|3
1342996|NCT01895101|4422578|P2|Overall Study|OPCAB procedure|1
1342997|NCT01895101|4422579|P1|Overall Study|OPCAB procedure|1
1342998|NCT01894984|4422614|P2|Overall Study|Other|175
1342999|NCT01894984|4422615|P1|Overall Study|Other|314
1343000|NCT01894620|4422672|P2|Overall Study|Withdrawal by Subject|1
1343001|NCT01894620|4422673|P1|Overall Study|Withdrawal by Subject|0
1343002|NCT01894607|4422681|P1|Overall Study|Ineligible|1
1343003|NCT01894581|4422688|P2|Overall Study|Screen Failure|4
1343004|NCT01894581|4422689|P1|Overall Study|Screen Failure|3
1343005|NCT01894581|4422688|P2|Overall Study|Withdrawal by Subject|3
1343006|NCT01894581|4422689|P1|Overall Study|Withdrawal by Subject|2
1343007|NCT01894477|4422706|P2|Overall Study|protocol changed due SC changed to cord|1
1343008|NCT01894477|4422707|P1|Overall Study|protocol changed due SC changed to cord|0
1343009|NCT01894477|4422706|P2|Overall Study|Protocol Violation|1
1343010|NCT01894477|4422707|P1|Overall Study|Protocol Violation|0
1343011|NCT01894256|4422718|P3|Part B|Lack of Efficacy|13
1343012|NCT01894256|4422719|P2|Part B|Lack of Efficacy|12
1343013|NCT01894256|4422720|P1|Part B|Lack of Efficacy|15
1343014|NCT01894256|4422718|P3|Part B|Withdrawal by Subject|0
1343015|NCT01894256|4422719|P2|Part B|Withdrawal by Subject|1
1343016|NCT01894256|4422720|P1|Part B|Withdrawal by Subject|0
1343017|NCT01894256|4422718|P3|Part B|Death|1
1343018|NCT01894256|4422719|P2|Part B|Death|1
1343019|NCT01894256|4422720|P1|Part B|Death|0
1343020|NCT01894256|4422718|P3|Part A|Adverse Event|0
1343021|NCT01894256|4422719|P2|Part A|Adverse Event|1
1343022|NCT01894256|4422720|P1|Part A|Adverse Event|0
1343023|NCT01894230|4422766|P2|Overall Study|Death|0
1343024|NCT01894230|4422767|P1|Overall Study|Death|1
1343025|NCT01894230|4422766|P2|Overall Study|Non-adherent|1
1343026|NCT01894230|4422767|P1|Overall Study|Non-adherent|0
1343027|NCT01894230|4422766|P2|Overall Study|Withdrawal by Subject|4
1343028|NCT01894230|4422767|P1|Overall Study|Withdrawal by Subject|4
1343029|NCT01894230|4422766|P2|Overall Study|Lost to Follow-up|2
1343030|NCT01894230|4422767|P1|Overall Study|Lost to Follow-up|2
1343031|NCT01894100|4422793|P2|Overall Study|Withdrawal by Subject|0
1343032|NCT01894100|4422794|P1|Overall Study|Withdrawal by Subject|3
1343033|NCT01894100|4422793|P2|Overall Study|Lost to Follow-up|1
1343034|NCT01894100|4422794|P1|Overall Study|Lost to Follow-up|0
1343035|NCT01894022|4422819|P2|Overall Study|Study Closed/terminated|10
1343036|NCT01894022|4422820|P1|Overall Study|Study Closed/terminated|7
1343037|NCT01894022|4422819|P2|Overall Study|Adverse Event, non-fatal|0
1343038|NCT01894022|4422820|P1|Overall Study|Adverse Event, non-fatal|1
1343039|NCT01894022|4422819|P2|Overall Study|Death|0
1343040|NCT01894022|4422820|P1|Overall Study|Death|1
1343041|NCT01893905|4422874|P2|Overall Study|Other reason|3
1343042|NCT01893905|4422875|P1|Overall Study|Other reason|1
1343043|NCT01893905|4422874|P2|Overall Study|Lack of adherence to treatment|0
1343044|NCT01893905|4422875|P1|Overall Study|Lack of adherence to treatment|2
1343045|NCT01893905|4422874|P2|Overall Study|Protocol Violation|1
1343046|NCT01893905|4422875|P1|Overall Study|Protocol Violation|6
1343047|NCT01893905|4422874|P2|Overall Study|Lost to Follow-up|0
1343048|NCT01893905|4422875|P1|Overall Study|Lost to Follow-up|1
1343049|NCT01893905|4422874|P2|Overall Study|Lack of Efficacy|7
1343050|NCT01893905|4422875|P1|Overall Study|Lack of Efficacy|5
1343051|NCT01893905|4422874|P2|Overall Study|Adverse Event|3
1343052|NCT01893905|4422875|P1|Overall Study|Adverse Event|9
1343053|NCT01893905|4422874|P2|Overall Study|Withdrawal by Subject|0
1343054|NCT01893905|4422875|P1|Overall Study|Withdrawal by Subject|1
1343055|NCT01893411|4422906|P3|Overall Study|Lost to Follow-up|1
1343056|NCT01893411|4422907|P2|Overall Study|Lost to Follow-up|0
1343057|NCT01893411|4422908|P1|Overall Study|Lost to Follow-up|2
1343058|NCT01893411|4422906|P3|Overall Study|Withdrawal by Subject|3
1343059|NCT01893411|4422907|P2|Overall Study|Withdrawal by Subject|4
1343060|NCT01893411|4422908|P1|Overall Study|Withdrawal by Subject|7
1343061|NCT01893411|4422906|P3|Overall Study|Adverse Event|0
1343062|NCT01893411|4422907|P2|Overall Study|Adverse Event|0
1343063|NCT01893411|4422908|P1|Overall Study|Adverse Event|1
1343064|NCT01893411|4422906|P3|Overall Study|Not Specified|3
1343065|NCT01893411|4422907|P2|Overall Study|Not Specified|1
1343066|NCT01893411|4422908|P1|Overall Study|Not Specified|3
1343067|NCT01893411|4422906|P3|Overall Study|Lack of Efficacy|0
1343068|NCT01893411|4422907|P2|Overall Study|Lack of Efficacy|1
1343069|NCT01893411|4422908|P1|Overall Study|Lack of Efficacy|2
1343070|NCT01893411|4422906|P3|Overall Study|Physician Decision|2
1343071|NCT01893411|4422907|P2|Overall Study|Physician Decision|1
1343072|NCT01893411|4422908|P1|Overall Study|Physician Decision|1
1343073|NCT01893411|4422906|P3|Overall Study|Protocol Violation|0
1343074|NCT01893411|4422907|P2|Overall Study|Protocol Violation|0
1343075|NCT01893411|4422908|P1|Overall Study|Protocol Violation|1
1343076|NCT01893346|4422990|P4|Overall Study|Withdrawal by Subject|0
1343077|NCT01893346|4422991|P3|Overall Study|Withdrawal by Subject|0
1343078|NCT01893346|4422992|P2|Overall Study|Withdrawal by Subject|0
1343079|NCT01893346|4422993|P1|Overall Study|Withdrawal by Subject|2
1343080|NCT01893346|4422990|P4|Overall Study|Protocol Violation|0
1343081|NCT01893346|4422991|P3|Overall Study|Protocol Violation|0
1343082|NCT01893346|4422992|P2|Overall Study|Protocol Violation|0
1343083|NCT01893346|4422993|P1|Overall Study|Protocol Violation|1
1343084|NCT01893346|4422990|P4|Overall Study|Lost to Follow-up|0
1343085|NCT01893346|4422991|P3|Overall Study|Lost to Follow-up|0
1343086|NCT01893346|4422992|P2|Overall Study|Lost to Follow-up|1
1343087|NCT01893346|4422993|P1|Overall Study|Lost to Follow-up|0
1343088|NCT01893281|4423007|P1|Overall Study|Withdrawal by Subject|1
1343089|NCT01893281|4423007|P1|Overall Study|Protocol Violation|1
1343090|NCT01893281|4423007|P1|Overall Study|Adverse Event|1
1343091|NCT01893203|4423014|P1|Overall Study|Withdrawal by Subject|1
1343092|NCT01892657|4423046|P1|Overall Study|Protocol Violation|12
1343093|NCT01892657|4423046|P1|Overall Study|Withdrawal by Subject|6
1343094|NCT01892293|4423085|P1|Overall Study|Apheresed but not treated|4
1343095|NCT01892189|4423129|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1343096|NCT01892189|4423130|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1343097|NCT01892189|4423131|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1343098|NCT01892189|4423132|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
1343099|NCT01892189|4423133|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1343100|NCT01892189|4423134|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1343101|NCT01892189|4423135|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1343102|NCT01892189|4423136|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1343103|NCT01892189|4423137|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1343104|NCT01892189|4423129|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1343105|NCT01892189|4423130|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1343106|NCT01892189|4423131|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1343107|NCT01892189|4423132|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1343108|NCT01892189|4423133|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1343109|NCT01892189|4423134|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1343110|NCT01892189|4423135|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
1343111|NCT01892189|4423136|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1343112|NCT01892189|4423137|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1343113|NCT01892189|4423129|P9|Washout Period 1 (7 Days)|Adverse Event|1
1343114|NCT01892189|4423130|P8|Washout Period 1 (7 Days)|Adverse Event|0
1343115|NCT01892189|4423131|P7|Washout Period 1 (7 Days)|Adverse Event|0
1343116|NCT01892189|4423132|P6|Washout Period 1 (7 Days)|Adverse Event|0
1343117|NCT01892189|4423133|P5|Washout Period 1 (7 Days)|Adverse Event|0
1343118|NCT01892189|4423134|P4|Washout Period 1 (7 Days)|Adverse Event|0
1343119|NCT01892189|4423135|P3|Washout Period 1 (7 Days)|Adverse Event|0
1343120|NCT01892189|4423136|P2|Washout Period 1 (7 Days)|Adverse Event|0
1343121|NCT01892189|4423137|P1|Washout Period 1 (7 Days)|Adverse Event|0
1343122|NCT01892163|4423179|P2|Overall Study|Lost to Follow-up|0
1343123|NCT01892163|4423180|P1|Overall Study|Lost to Follow-up|1
1343124|NCT01892163|4423179|P2|Overall Study|Death|1
1343125|NCT01892163|4423180|P1|Overall Study|Death|1
1343126|NCT01892020|4423192|P2|Period 2|Protocol Violation|0
1343127|NCT01892020|4423193|P1|Period 2|Protocol Violation|1
1343128|NCT01892020|4423192|P2|Period 1|Unclassified|1
1343129|NCT01892020|4423193|P1|Period 1|Unclassified|0
1343130|NCT01892020|4423192|P2|Period 1|Protocol Violation|4
1343131|NCT01892020|4423193|P1|Period 1|Protocol Violation|2
1343132|NCT01892020|4423192|P2|Period 1|Adverse Event|1
1343133|NCT01892020|4423193|P1|Period 1|Adverse Event|1
1343134|NCT01891890|4423218|P3|Overall Study|Study ended before endpoint reached|6
1343135|NCT01891890|4423219|P2|Overall Study|Study ended before endpoint reached|3
1343136|NCT01891890|4423220|P1|Overall Study|Study ended before endpoint reached|7
1343137|NCT01891890|4423218|P3|Overall Study|Lost to Follow-up|1
1343138|NCT01891890|4423219|P2|Overall Study|Lost to Follow-up|0
1343139|NCT01891890|4423220|P1|Overall Study|Lost to Follow-up|0
1343140|NCT01891864|4423263|P6|Extension Period|Lost to Follow-up|0
1343141|NCT01891864|4423264|P5|Extension Period|Lost to Follow-up|0
1343142|NCT01891864|4423265|P4|Extension Period|Lost to Follow-up|0
1343143|NCT01891864|4423266|P3|Extension Period|Lost to Follow-up|2
1343144|NCT01891864|4423267|P2|Extension Period|Lost to Follow-up|0
1343145|NCT01891864|4423268|P1|Extension Period|Lost to Follow-up|0
1343146|NCT01891864|4423263|P6|Extension Period|Withdrawal by Subject|0
1343147|NCT01891864|4423264|P5|Extension Period|Withdrawal by Subject|4
1343148|NCT01891864|4423265|P4|Extension Period|Withdrawal by Subject|2
1343149|NCT01891864|4423266|P3|Extension Period|Withdrawal by Subject|1
1343150|NCT01891864|4423267|P2|Extension Period|Withdrawal by Subject|0
1343151|NCT01891864|4423268|P1|Extension Period|Withdrawal by Subject|0
1343152|NCT01891864|4423263|P6|Extension Period|Adverse Event|0
1343153|NCT01891864|4423264|P5|Extension Period|Adverse Event|2
1343154|NCT01891864|4423265|P4|Extension Period|Adverse Event|2
1343155|NCT01891864|4423266|P3|Extension Period|Adverse Event|4
1343156|NCT01891864|4423267|P2|Extension Period|Adverse Event|0
1343157|NCT01891864|4423268|P1|Extension Period|Adverse Event|0
1343158|NCT01891864|4423263|P6|Extension Period|Pregnancy|0
1343159|NCT01891864|4423264|P5|Extension Period|Pregnancy|0
1343160|NCT01891864|4423265|P4|Extension Period|Pregnancy|0
1343161|NCT01891864|4423266|P3|Extension Period|Pregnancy|1
1343162|NCT01891864|4423267|P2|Extension Period|Pregnancy|0
1343163|NCT01891864|4423268|P1|Extension Period|Pregnancy|0
1343164|NCT01891864|4423263|P6|Extension Period|Lack of Efficacy|0
1343165|NCT01891864|4423264|P5|Extension Period|Lack of Efficacy|1
1343166|NCT01891864|4423265|P4|Extension Period|Lack of Efficacy|1
1343167|NCT01891864|4423266|P3|Extension Period|Lack of Efficacy|0
1343168|NCT01891864|4423267|P2|Extension Period|Lack of Efficacy|0
1343169|NCT01891864|4423268|P1|Extension Period|Lack of Efficacy|0
1343170|NCT01891864|4423263|P6|Treatment Period 2|Withdrawal by Subject|1
1343171|NCT01891864|4423264|P5|Treatment Period 2|Withdrawal by Subject|1
1343172|NCT01891864|4423265|P4|Treatment Period 2|Withdrawal by Subject|4
1343173|NCT01891864|4423266|P3|Treatment Period 2|Withdrawal by Subject|3
1343174|NCT01891864|4423267|P2|Treatment Period 2|Withdrawal by Subject|0
1343175|NCT01891864|4423268|P1|Treatment Period 2|Withdrawal by Subject|0
1343176|NCT01891864|4423263|P6|Treatment Period 2|Termination of Site|0
1343177|NCT01891864|4423264|P5|Treatment Period 2|Termination of Site|2
1343178|NCT01891864|4423265|P4|Treatment Period 2|Termination of Site|0
1343179|NCT01891864|4423266|P3|Treatment Period 2|Termination of Site|0
1343180|NCT01891864|4423267|P2|Treatment Period 2|Termination of Site|0
1343181|NCT01891864|4423268|P1|Treatment Period 2|Termination of Site|0
1343182|NCT01891864|4423263|P6|Treatment Period 2|Adverse Event|4
1343183|NCT01891864|4423264|P5|Treatment Period 2|Adverse Event|0
1343184|NCT01891864|4423265|P4|Treatment Period 2|Adverse Event|2
1343185|NCT01891864|4423266|P3|Treatment Period 2|Adverse Event|1
1343186|NCT01891864|4423267|P2|Treatment Period 2|Adverse Event|0
1343187|NCT01891864|4423268|P1|Treatment Period 2|Adverse Event|0
1343188|NCT01891864|4423263|P6|Treatment Period 2|Lack of Efficacy|0
1343189|NCT01891864|4423264|P5|Treatment Period 2|Lack of Efficacy|1
1343190|NCT01891864|4423265|P4|Treatment Period 2|Lack of Efficacy|0
1343191|NCT01891864|4423266|P3|Treatment Period 2|Lack of Efficacy|1
1343192|NCT01891864|4423267|P2|Treatment Period 2|Lack of Efficacy|0
1343193|NCT01891864|4423268|P1|Treatment Period 2|Lack of Efficacy|0
1343194|NCT01891864|4423263|P6|Treatment Period 2|Site Termination|0
1343195|NCT01891864|4423264|P5|Treatment Period 2|Site Termination|0
1343196|NCT01891864|4423265|P4|Treatment Period 2|Site Termination|2
1343197|NCT01891864|4423266|P3|Treatment Period 2|Site Termination|1
1343198|NCT01891864|4423267|P2|Treatment Period 2|Site Termination|0
1343199|NCT01891864|4423268|P1|Treatment Period 2|Site Termination|0
1343200|NCT01891864|4423263|P6|Treatment Period 2|Physician Decision|0
1343201|NCT01891864|4423264|P5|Treatment Period 2|Physician Decision|0
1343202|NCT01891864|4423265|P4|Treatment Period 2|Physician Decision|0
1343203|NCT01891864|4423266|P3|Treatment Period 2|Physician Decision|1
1343204|NCT01891864|4423267|P2|Treatment Period 2|Physician Decision|0
1343205|NCT01891864|4423268|P1|Treatment Period 2|Physician Decision|0
1343206|NCT01891864|4423263|P6|Treatment Period 2|Protocol Violation|0
1343207|NCT01891864|4423264|P5|Treatment Period 2|Protocol Violation|0
1343208|NCT01891864|4423265|P4|Treatment Period 2|Protocol Violation|1
1343209|NCT01891864|4423266|P3|Treatment Period 2|Protocol Violation|0
1343210|NCT01891864|4423267|P2|Treatment Period 2|Protocol Violation|0
1343211|NCT01891864|4423268|P1|Treatment Period 2|Protocol Violation|0
1343212|NCT01891864|4423263|P6|Treatment Period 1|Lost to Follow-up|0
1343213|NCT01891864|4423264|P5|Treatment Period 1|Lost to Follow-up|0
1343214|NCT01891864|4423265|P4|Treatment Period 1|Lost to Follow-up|0
1343215|NCT01891864|4423266|P3|Treatment Period 1|Lost to Follow-up|0
1343216|NCT01891864|4423267|P2|Treatment Period 1|Lost to Follow-up|0
1343217|NCT01891864|4423268|P1|Treatment Period 1|Lost to Follow-up|1
1343218|NCT01891864|4423263|P6|Treatment Period 1|Withdrawal by Subject|0
1343219|NCT01891864|4423264|P5|Treatment Period 1|Withdrawal by Subject|0
1343220|NCT01891864|4423265|P4|Treatment Period 1|Withdrawal by Subject|0
1343221|NCT01891864|4423266|P3|Treatment Period 1|Withdrawal by Subject|0
1343222|NCT01891864|4423267|P2|Treatment Period 1|Withdrawal by Subject|5
1343223|NCT01891864|4423268|P1|Treatment Period 1|Withdrawal by Subject|2
1343224|NCT01891864|4423263|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1343225|NCT01891864|4423264|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1343226|NCT01891864|4423265|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1343227|NCT01891864|4423266|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1343228|NCT01891864|4423267|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
1343229|NCT01891864|4423268|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
1343230|NCT01891864|4423263|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
1343231|NCT01891864|4423264|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
1343232|NCT01891864|4423265|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
1343233|NCT01891864|4423266|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
1343234|NCT01891864|4423267|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
1343235|NCT01891864|4423268|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
1343236|NCT01891864|4423263|P6|Treatment Period 1|Physician Decision|0
1343237|NCT01891864|4423264|P5|Treatment Period 1|Physician Decision|0
1343238|NCT01891864|4423265|P4|Treatment Period 1|Physician Decision|0
1343239|NCT01891864|4423266|P3|Treatment Period 1|Physician Decision|0
1343240|NCT01891864|4423267|P2|Treatment Period 1|Physician Decision|1
1343241|NCT01891864|4423268|P1|Treatment Period 1|Physician Decision|0
1343242|NCT01891864|4423263|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1343243|NCT01891864|4423264|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1343244|NCT01891864|4423265|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1343245|NCT01891864|4423266|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1343246|NCT01891864|4423267|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
1343247|NCT01891864|4423268|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
1343248|NCT01891669|4423311|P10|Overall Study|Other|0
1343249|NCT01891669|4423312|P9|Overall Study|Other|0
1343250|NCT01891669|4423313|P8|Overall Study|Other|1
1343251|NCT01891669|4423314|P7|Overall Study|Other|0
1343252|NCT01891669|4423315|P6|Overall Study|Other|0
1343253|NCT01891669|4423316|P5|Overall Study|Other|0
1343254|NCT01891669|4423317|P4|Overall Study|Other|0
1343255|NCT01891669|4423318|P3|Overall Study|Other|0
1343256|NCT01891669|4423319|P2|Overall Study|Other|0
1343257|NCT01891669|4423320|P1|Overall Study|Other|1
1343258|NCT01891669|4423311|P10|Overall Study|Withdrawal by Subject|1
1343259|NCT01891669|4423312|P9|Overall Study|Withdrawal by Subject|1
1343260|NCT01891669|4423313|P8|Overall Study|Withdrawal by Subject|2
1343261|NCT01891669|4423314|P7|Overall Study|Withdrawal by Subject|1
1343262|NCT01891669|4423315|P6|Overall Study|Withdrawal by Subject|0
1343263|NCT01891669|4423316|P5|Overall Study|Withdrawal by Subject|0
1343264|NCT01891669|4423317|P4|Overall Study|Withdrawal by Subject|0
1343265|NCT01891669|4423318|P3|Overall Study|Withdrawal by Subject|0
1343266|NCT01891669|4423319|P2|Overall Study|Withdrawal by Subject|1
1343267|NCT01891669|4423320|P1|Overall Study|Withdrawal by Subject|1
1343268|NCT01891669|4423311|P10|Overall Study|Death|1
1343269|NCT01891669|4423312|P9|Overall Study|Death|0
1343270|NCT01891669|4423313|P8|Overall Study|Death|1
1343271|NCT01891669|4423314|P7|Overall Study|Death|0
1343272|NCT01891669|4423315|P6|Overall Study|Death|0
1343273|NCT01891669|4423316|P5|Overall Study|Death|0
1343274|NCT01891669|4423317|P4|Overall Study|Death|0
1343275|NCT01891669|4423318|P3|Overall Study|Death|0
1343276|NCT01891669|4423319|P2|Overall Study|Death|0
1343277|NCT01891669|4423320|P1|Overall Study|Death|0
1343278|NCT01890967|4423511|P6|Overall Study|Withdrawal by Subject|1
1343279|NCT01890967|4423512|P5|Overall Study|Withdrawal by Subject|3
1343280|NCT01890967|4423513|P4|Overall Study|Withdrawal by Subject|3
1343281|NCT01890967|4423514|P3|Overall Study|Withdrawal by Subject|2
1343282|NCT01890967|4423515|P2|Overall Study|Withdrawal by Subject|4
1343283|NCT01890967|4423516|P1|Overall Study|Withdrawal by Subject|3
1343284|NCT01890967|4423511|P6|Overall Study|Sponsor Decision|3
1343285|NCT01890967|4423512|P5|Overall Study|Sponsor Decision|2
1343286|NCT01890967|4423513|P4|Overall Study|Sponsor Decision|3
1343287|NCT01890967|4423514|P3|Overall Study|Sponsor Decision|1
1343288|NCT01890967|4423515|P2|Overall Study|Sponsor Decision|0
1343289|NCT01890967|4423516|P1|Overall Study|Sponsor Decision|2
1343290|NCT01890967|4423511|P6|Overall Study|Protocol Violation|1
1343291|NCT01890967|4423512|P5|Overall Study|Protocol Violation|4
1343292|NCT01890967|4423513|P4|Overall Study|Protocol Violation|2
1343293|NCT01890967|4423514|P3|Overall Study|Protocol Violation|3
1343294|NCT01890967|4423515|P2|Overall Study|Protocol Violation|3
1343295|NCT01890967|4423516|P1|Overall Study|Protocol Violation|0
1343296|NCT01890967|4423511|P6|Overall Study|Lost to Follow-up|1
1343297|NCT01890967|4423512|P5|Overall Study|Lost to Follow-up|0
1343298|NCT01890967|4423513|P4|Overall Study|Lost to Follow-up|1
1343299|NCT01890967|4423514|P3|Overall Study|Lost to Follow-up|1
1343300|NCT01890967|4423515|P2|Overall Study|Lost to Follow-up|1
1343301|NCT01890967|4423516|P1|Overall Study|Lost to Follow-up|1
1343302|NCT01890967|4423511|P6|Overall Study|Death|0
1343303|NCT01890967|4423512|P5|Overall Study|Death|0
1343304|NCT01890967|4423513|P4|Overall Study|Death|0
1343305|NCT01890967|4423514|P3|Overall Study|Death|0
1343306|NCT01890967|4423515|P2|Overall Study|Death|0
1343307|NCT01890967|4423516|P1|Overall Study|Death|1
1343308|NCT01890967|4423511|P6|Overall Study|Adverse Event|7
1343309|NCT01890967|4423512|P5|Overall Study|Adverse Event|1
1343310|NCT01890967|4423513|P4|Overall Study|Adverse Event|2
1343311|NCT01890967|4423514|P3|Overall Study|Adverse Event|3
1343312|NCT01890967|4423515|P2|Overall Study|Adverse Event|3
1343313|NCT01890967|4423516|P1|Overall Study|Adverse Event|3
1343314|NCT01890915|4423594|P2|Overall Study|Equipment Malfunction|1
1343315|NCT01890915|4423595|P1|Overall Study|Equipment Malfunction|0
1343316|NCT01890915|4423594|P2|Overall Study|Protocol Violation|0
1343317|NCT01890915|4423595|P1|Overall Study|Protocol Violation|2
1343318|NCT01890915|4423594|P2|Overall Study|Adverse Event|0
1343319|NCT01890915|4423595|P1|Overall Study|Adverse Event|1
1343320|NCT01890785|4423611|P6|Third Intervention|Withdrawal by Subject|0
1343321|NCT01890785|4423612|P5|Third Intervention|Withdrawal by Subject|0
1343322|NCT01890785|4423613|P4|Third Intervention|Withdrawal by Subject|0
1343323|NCT01890785|4423614|P3|Third Intervention|Withdrawal by Subject|0
1343324|NCT01890785|4423615|P2|Third Intervention|Withdrawal by Subject|1
1343325|NCT01890785|4423616|P1|Third Intervention|Withdrawal by Subject|0
1343326|NCT01890759|4423635|P2|Overall Study|Withdrawal by Subject|8
1343327|NCT01890759|4423636|P1|Overall Study|Withdrawal by Subject|2
1343328|NCT01890759|4423635|P2|Overall Study|Lost to Follow-up|2
1343329|NCT01890759|4423636|P1|Overall Study|Lost to Follow-up|0
1343330|NCT01890759|4423635|P2|Overall Study|Protocol Violation|2
1343331|NCT01890759|4423636|P1|Overall Study|Protocol Violation|0
1343332|NCT01890746|4423670|P2|Overall Study|Ongoing|50
1343333|NCT01890746|4423671|P1|Overall Study|Ongoing|44
1343334|NCT01890746|4423670|P2|Overall Study|Death|14
1343335|NCT01890746|4423671|P1|Overall Study|Death|23
1343336|NCT01890746|4423670|P2|Overall Study|Withdrawal by Subject|8
1343337|NCT01890746|4423671|P1|Overall Study|Withdrawal by Subject|4
1343338|NCT01890746|4423670|P2|Overall Study|Physician Decision|2
1343339|NCT01890746|4423671|P1|Overall Study|Physician Decision|2
1343340|NCT01890746|4423670|P2|Overall Study|Adverse Event|0
1343341|NCT01890746|4423671|P1|Overall Study|Adverse Event|1
1343342|NCT01890512|4423768|P1|Overall Study|Protocol Violation|1
1343343|NCT01890512|4423768|P1|Overall Study|Withdrawal by Subject|1
1343344|NCT01890512|4423768|P1|Overall Study|Physician Decision|1
1343345|NCT01890473|4423774|P2|Overall Study|Poor/non-compliance|0
1343346|NCT01890473|4423775|P1|Overall Study|Poor/non-compliance|1
1343347|NCT01890473|4423774|P2|Overall Study|Lost to Follow-up|0
1343348|NCT01890473|4423775|P1|Overall Study|Lost to Follow-up|1
1343349|NCT01890434|4423801|P1|Overall Study|Withdrawal by PI for ICA not performed|2
1343350|NCT01890434|4423801|P1|Overall Study|Unable to contact|1
1343351|NCT01890434|4423801|P1|Overall Study|Moved out of position|1
1343352|NCT01890434|4423801|P1|Overall Study|Uncontactable by phone|1
1343353|NCT01890434|4423801|P1|Overall Study|Participant didn't complete MRI|1
1343354|NCT01890434|4423801|P1|Overall Study|GSPECT at rest was not done|1
1343355|NCT01890434|4423801|P1|Overall Study|Decline to return for GSPECT|1
1343356|NCT01890434|4423801|P1|Overall Study|Could not get whole set of images|1
1343357|NCT01890434|4423801|P1|Overall Study|CRC didn't contact participant for FU|1
1343358|NCT01890434|4423801|P1|Overall Study|Assessment discrepancy|1
1343359|NCT01890434|4423801|P1|Overall Study|PCI at external hospital|1
1343360|NCT01890434|4423801|P1|Overall Study|Adverse Event|8
1343361|NCT01890421|4423831|P1|Overall Study|Other reason|10
1343362|NCT01890421|4423831|P1|Overall Study|Adverse Event|1
1343363|NCT01890148|4423870|P1|Overall Study|Adverse Event|1
1343364|NCT01890122|4423890|P4|Overall Study|Randomized but not Treated|0
1343365|NCT01890122|4423891|P3|Overall Study|Randomized but not Treated|0
1343366|NCT01890122|4423892|P2|Overall Study|Randomized but not Treated|1
1343367|NCT01890122|4423893|P1|Overall Study|Randomized but not Treated|1
1343368|NCT01890122|4423890|P4|Overall Study|Reason not Specified|2
1343369|NCT01890122|4423891|P3|Overall Study|Reason not Specified|1
1343370|NCT01890122|4423892|P2|Overall Study|Reason not Specified|1
1343371|NCT01890122|4423893|P1|Overall Study|Reason not Specified|0
1343372|NCT01890122|4423890|P4|Overall Study|Lack of Efficacy|41
1343373|NCT01890122|4423891|P3|Overall Study|Lack of Efficacy|7
1343374|NCT01890122|4423892|P2|Overall Study|Lack of Efficacy|24
1343375|NCT01890122|4423893|P1|Overall Study|Lack of Efficacy|14
1343376|NCT01890122|4423890|P4|Overall Study|Voluntary Withdrawal|11
1343377|NCT01890122|4423891|P3|Overall Study|Voluntary Withdrawal|2
1343378|NCT01890122|4423892|P2|Overall Study|Voluntary Withdrawal|8
1343379|NCT01890122|4423893|P1|Overall Study|Voluntary Withdrawal|8
1343380|NCT01890122|4423890|P4|Overall Study|Lost to Follow-up|2
1343381|NCT01890122|4423891|P3|Overall Study|Lost to Follow-up|2
1343382|NCT01890122|4423892|P2|Overall Study|Lost to Follow-up|1
1343383|NCT01890122|4423893|P1|Overall Study|Lost to Follow-up|0
1343384|NCT01890122|4423890|P4|Overall Study|Major Protocol Deviation|1
1343385|NCT01890122|4423891|P3|Overall Study|Major Protocol Deviation|0
1343386|NCT01890122|4423892|P2|Overall Study|Major Protocol Deviation|1
1343387|NCT01890122|4423893|P1|Overall Study|Major Protocol Deviation|3
1343388|NCT01890122|4423890|P4|Overall Study|Adverse Event|2
1343389|NCT01890122|4423891|P3|Overall Study|Adverse Event|1
1343390|NCT01890122|4423892|P2|Overall Study|Adverse Event|1
1343391|NCT01890122|4423893|P1|Overall Study|Adverse Event|1
1343392|NCT01889251|4424044|P2|Overall Study|Adverse Event|0
1343393|NCT01889251|4424045|P1|Overall Study|Adverse Event|1
1343394|NCT01889238|4424051|P1|Overall Study|Treatment ongoing|9
1343395|NCT01888965|4424068|P1|Overall Study|Lack of Efficacy|4
1343396|NCT01888965|4424068|P1|Overall Study|Adverse Event|5
1343397|NCT01888900|4424080|P2|Overall Study|failed treatment|2
1343398|NCT01888900|4424081|P1|Overall Study|failed treatment|0
1343399|NCT01888367|4424104|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
1343400|NCT01888367|4424105|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
1343401|NCT01888367|4424106|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
1343402|NCT01888367|4424104|P3|Overall Study|Protocol Violation|1
1343403|NCT01888367|4424105|P2|Overall Study|Protocol Violation|0
1343404|NCT01888367|4424106|P1|Overall Study|Protocol Violation|0
1343405|NCT01888367|4424104|P3|Overall Study|Lost to Follow-up|0
1343406|NCT01888367|4424105|P2|Overall Study|Lost to Follow-up|1
1343407|NCT01888367|4424106|P1|Overall Study|Lost to Follow-up|1
1343408|NCT01888367|4424104|P3|Overall Study|Withdrawal by Subject|1
1343409|NCT01888367|4424105|P2|Overall Study|Withdrawal by Subject|0
1343410|NCT01888367|4424106|P1|Overall Study|Withdrawal by Subject|1
1343411|NCT01888367|4424104|P3|Overall Study|Death|1
1343412|NCT01888367|4424105|P2|Overall Study|Death|0
1343413|NCT01888367|4424106|P1|Overall Study|Death|2
1343414|NCT01888367|4424104|P3|Overall Study|Physician Decision|2
1343415|NCT01888367|4424105|P2|Overall Study|Physician Decision|4
1343416|NCT01888367|4424106|P1|Overall Study|Physician Decision|3
1343417|NCT01888003|4424126|P3|Overall Study|Study Terminated|40
1343418|NCT01888003|4424127|P2|Overall Study|Study Terminated|6
1343419|NCT01888003|4424128|P1|Overall Study|Study Terminated|5
1343420|NCT01887678|4424168|P2|Overall Study|Specified|2
1343421|NCT01887678|4424169|P1|Overall Study|Specified|1
1343422|NCT01887678|4424168|P2|Overall Study|Non-compliance|3
1343423|NCT01887678|4424169|P1|Overall Study|Non-compliance|0
1343424|NCT01887678|4424168|P2|Overall Study|Lack of Efficacy|2
1343425|NCT01887678|4424169|P1|Overall Study|Lack of Efficacy|1
1343426|NCT01887678|4424168|P2|Overall Study|Deterioration of clinical condition|4
1343427|NCT01887678|4424169|P1|Overall Study|Deterioration of clinical condition|0
1343428|NCT01887678|4424168|P2|Overall Study|Lost to Follow-up|2
1343429|NCT01887678|4424169|P1|Overall Study|Lost to Follow-up|4
1343430|NCT01887678|4424168|P2|Overall Study|Withdrawal of consent|4
1343431|NCT01887678|4424169|P1|Overall Study|Withdrawal of consent|3
1343432|NCT01887678|4424168|P2|Overall Study|Exceeded rescue medication dosage|5
1343433|NCT01887678|4424169|P1|Overall Study|Exceeded rescue medication dosage|4
1343434|NCT01887678|4424168|P2|Overall Study|Adverse Event|6
1343435|NCT01887678|4424169|P1|Overall Study|Adverse Event|4
1343436|NCT01887418|4424237|P3|Overall Study|Travelling difficulties|1
1343437|NCT01887418|4424238|P2|Overall Study|Travelling difficulties|0
1343438|NCT01887418|4424239|P1|Overall Study|Travelling difficulties|0
1343439|NCT01887353|4424258|P2|Overall Study|Study stopped early|3
1343440|NCT01887353|4424259|P1|Overall Study|Study stopped early|4
1343441|NCT01887288|4424265|P1|Overall Study|The study was terminated and the PI has|16
1343442|NCT01886833|4424302|P1|Overall Study|IgA not available from both periods|204
1343443|NCT01886781|4424325|P2|Overall Study|Worsening of symptoms|1
1343444|NCT01886781|4424326|P1|Overall Study|Worsening of symptoms|1
1343445|NCT01886781|4424325|P2|Overall Study|Withdrawal by Subject|1
1343446|NCT01886781|4424326|P1|Overall Study|Withdrawal by Subject|2
1343447|NCT01886781|4424325|P2|Overall Study|Lost to Follow-up|0
1343448|NCT01886781|4424326|P1|Overall Study|Lost to Follow-up|5
1343449|NCT01886781|4424325|P2|Overall Study|Adverse Event|0
1343450|NCT01886781|4424326|P1|Overall Study|Adverse Event|1
1343451|NCT01886781|4424325|P2|Overall Study|Protocol Violation|0
1343452|NCT01886781|4424326|P1|Overall Study|Protocol Violation|5
1343453|NCT01886716|4424336|P4|Week 3|Lost to Follow-up|1
1343454|NCT01886716|4424337|P3|Week 3|Lost to Follow-up|0
1343455|NCT01886716|4424338|P2|Week 3|Lost to Follow-up|1
1343456|NCT01886716|4424339|P1|Week 3|Lost to Follow-up|1
1343457|NCT01886716|4424336|P4|Week 2|Lost to Follow-up|3
1343458|NCT01886716|4424337|P3|Week 2|Lost to Follow-up|1
1343459|NCT01886716|4424338|P2|Week 2|Lost to Follow-up|2
1343460|NCT01886716|4424339|P1|Week 2|Lost to Follow-up|3
1343461|NCT01886716|4424336|P4|Week 1|Lost to Follow-up|2
1343462|NCT01886716|4424337|P3|Week 1|Lost to Follow-up|2
1343463|NCT01886716|4424338|P2|Week 1|Lost to Follow-up|0
1343464|NCT01886716|4424339|P1|Week 1|Lost to Follow-up|0
1343465|NCT01886690|4424355|P2|Overall Study|Personal Reasons|1
1343466|NCT01886690|4424356|P1|Overall Study|Personal Reasons|0
1343467|NCT01886690|4424355|P2|Overall Study|Protocol Violation|1
1343468|NCT01886690|4424356|P1|Overall Study|Protocol Violation|0
1343469|NCT01886313|4424372|P2|Overall Study|Adverse Event|1
1343470|NCT01886313|4424373|P1|Overall Study|Adverse Event|1
1343471|NCT01886300|4424379|P1|Overall Study|Trial terminated by sponsor|16
1343472|NCT01886287|4424390|P1|Overall Study|Clinical progression due to disease|1
1343473|NCT01886287|4424390|P1|Overall Study|Radiographic disease progression|1
1343474|NCT01885936|4424408|P2|Overall Study|Withdrawal by Subject|0
1343475|NCT01885936|4424409|P1|Overall Study|Withdrawal by Subject|1
1343476|NCT01885559|4424443|P2|Overall Study|Protocol Violation|1
1343477|NCT01885559|4424444|P1|Overall Study|Protocol Violation|0
1343478|NCT01885559|4424443|P2|Overall Study|Less than full participation|19
1343479|NCT01885559|4424444|P1|Overall Study|Less than full participation|9
1343480|NCT01885559|4424443|P2|Overall Study|Lost to Follow-up|16
1343481|NCT01885559|4424444|P1|Overall Study|Lost to Follow-up|15
1343482|NCT01885208|4424466|P2|Overall Study|Unclassified|38
1343483|NCT01885208|4424467|P1|Overall Study|Unclassified|32
1343484|NCT01885104|4424508|P2|Overall Study|Physician Decision|0
1343485|NCT01885104|4424509|P1|Overall Study|Physician Decision|1
1343486|NCT01885104|4424508|P2|Overall Study|Lost to Follow-up|1
1343487|NCT01885104|4424509|P1|Overall Study|Lost to Follow-up|0
1343488|NCT01885104|4424508|P2|Overall Study|Withdrawal of Consent|0
1343489|NCT01885104|4424509|P1|Overall Study|Withdrawal of Consent|1
1343490|NCT01885000|4424519|P2|Overall Study|Protocol Violation|1
1343491|NCT01885000|4424520|P1|Overall Study|Protocol Violation|0
1343492|NCT01885000|4424519|P2|Overall Study|Withdrawal by Subject|1
1343493|NCT01885000|4424520|P1|Overall Study|Withdrawal by Subject|1
1343494|NCT01885000|4424519|P2|Overall Study|Adverse Event|0
1343495|NCT01885000|4424520|P1|Overall Study|Adverse Event|1
1343496|NCT01884688|4424541|P1|Overall Study|Screen Failure|2
1343497|NCT01884675|4424547|P2|Overall Study|Study closed/terminated|2
1343498|NCT01884675|4424548|P1|Overall Study|Study closed/terminated|3
1343499|NCT01884597|4424591|P3|Overall Study|Death|0
1343500|NCT01884597|4424592|P2|Overall Study|Death|1
1343501|NCT01884597|4424593|P1|Overall Study|Death|0
1343502|NCT01884597|4424591|P3|Overall Study|Lack of Efficacy|0
1343503|NCT01884597|4424592|P2|Overall Study|Lack of Efficacy|0
1343504|NCT01884597|4424593|P1|Overall Study|Lack of Efficacy|1
1343505|NCT01884597|4424591|P3|Overall Study|Adverse Event|1
1343506|NCT01884597|4424592|P2|Overall Study|Adverse Event|0
1343507|NCT01884597|4424593|P1|Overall Study|Adverse Event|0
1343508|NCT01884571|4424622|P1|Overall Study|Disease progression|3
1343509|NCT01884571|4424622|P1|Overall Study|Withdrawal by Subject|2
1343510|NCT01884571|4424622|P1|Overall Study|Death|2
1343511|NCT01884571|4424622|P1|Overall Study|Adverse Event|1
1343512|NCT01884545|4424637|P4|Overall Study|Non-adherence|0
1343513|NCT01884545|4424638|P3|Overall Study|Non-adherence|0
1343514|NCT01884545|4424639|P2|Overall Study|Non-adherence|2
1343515|NCT01884545|4424640|P1|Overall Study|Non-adherence|0
1343516|NCT01884545|4424637|P4|Overall Study|Patient withdrawn|5
1343517|NCT01884545|4424638|P3|Overall Study|Patient withdrawn|5
1343518|NCT01884545|4424639|P2|Overall Study|Patient withdrawn|12
1343519|NCT01884545|4424640|P1|Overall Study|Patient withdrawn|7
1343520|NCT01884545|4424637|P4|Overall Study|Lost to Follow-up|4
1343521|NCT01884545|4424638|P3|Overall Study|Lost to Follow-up|9
1343522|NCT01884545|4424639|P2|Overall Study|Lost to Follow-up|4
1343523|NCT01884545|4424640|P1|Overall Study|Lost to Follow-up|6
1343524|NCT01883895|4424832|P1|Overall Study|Lost to Follow-up|2
1343525|NCT01883635|4424846|P2|Overall Study|Withdrawal by Subject|0
1343526|NCT01883635|4424847|P1|Overall Study|Withdrawal by Subject|4
1343527|NCT01883453|4424861|P2|Overall Study|No episode of common cold|23
1343528|NCT01883453|4424862|P1|Overall Study|No episode of common cold|25
1343529|NCT01882985|4424888|P1|Overall Study|Withdrawal by Subject|1
1343530|NCT01882985|4424888|P1|Overall Study|Lost to Follow-up|1
1343531|NCT01882907|4424897|P2|Overall Study|Withdrawal by Subject|6
1343532|NCT01882907|4424898|P1|Overall Study|Withdrawal by Subject|0
1343533|NCT01882907|4424897|P2|Overall Study|Protocol Violation|14
1343534|NCT01882907|4424898|P1|Overall Study|Protocol Violation|10
1343535|NCT01882907|4424897|P2|Overall Study|Lost to Follow-up|4
1343536|NCT01882907|4424898|P1|Overall Study|Lost to Follow-up|1
1343537|NCT01882907|4424897|P2|Overall Study|Lack of Efficacy|3
1343538|NCT01882907|4424898|P1|Overall Study|Lack of Efficacy|0
1343539|NCT01882907|4424897|P2|Overall Study|Adverse Event|1
1343540|NCT01882907|4424898|P1|Overall Study|Adverse Event|3
1343541|NCT01882829|4424934|P1|Overall Study|Withdrawal by Subject|1
1343542|NCT01882829|4424934|P1|Overall Study|Protocol Violation|1
1343543|NCT01882829|4424934|P1|Overall Study|Adverse Event|4
1343544|NCT01882647|4424955|P2|Overall Study|Withdrawal by Subject|4
1343545|NCT01882647|4424956|P1|Overall Study|Withdrawal by Subject|0
1343546|NCT01882647|4424955|P2|Overall Study|Lost to Follow-up|2
1343547|NCT01882647|4424956|P1|Overall Study|Lost to Follow-up|2
1343548|NCT01882465|4424996|P7|Period 2|Protocol Violation|0
1343549|NCT01882465|4424997|P6|Period 2|Protocol Violation|0
1343550|NCT01882465|4424998|P5|Period 2|Protocol Violation|1
1343551|NCT01882465|4424999|P4|Period 2|Protocol Violation|0
1343552|NCT01882465|4425000|P3|Period 2|Protocol Violation|0
1343553|NCT01882465|4425001|P2|Period 2|Protocol Violation|0
1343554|NCT01882465|4425002|P1|Period 2|Protocol Violation|0
1343555|NCT01882465|4424996|P7|Period 1|Withdrawal by Subject|1
1343556|NCT01882465|4424997|P6|Period 1|Withdrawal by Subject|0
1343557|NCT01882465|4424998|P5|Period 1|Withdrawal by Subject|0
1343558|NCT01882465|4424999|P4|Period 1|Withdrawal by Subject|0
1343559|NCT01882465|4425000|P3|Period 1|Withdrawal by Subject|0
1343560|NCT01882465|4425001|P2|Period 1|Withdrawal by Subject|0
1343561|NCT01882465|4425002|P1|Period 1|Withdrawal by Subject|0
1343562|NCT01882465|4424996|P7|Period 1|Lens Discomfort|0
1343563|NCT01882465|4424997|P6|Period 1|Lens Discomfort|0
1343564|NCT01882465|4424998|P5|Period 1|Lens Discomfort|0
1343565|NCT01882465|4424999|P4|Period 1|Lens Discomfort|1
1343566|NCT01882465|4425000|P3|Period 1|Lens Discomfort|0
1343567|NCT01882465|4425001|P2|Period 1|Lens Discomfort|0
1343568|NCT01882465|4425002|P1|Period 1|Lens Discomfort|0
1343569|NCT01882439|4425014|P4|Overall Study|Adverse event unrelated to study drug|1
1343570|NCT01882439|4425015|P3|Overall Study|Adverse event unrelated to study drug|1
1343571|NCT01882439|4425016|P2|Overall Study|Adverse event unrelated to study drug|2
1343572|NCT01882439|4425017|P1|Overall Study|Adverse event unrelated to study drug|2
1343573|NCT01882439|4425014|P4|Overall Study|Insufficient clinical response|2
1343574|NCT01882439|4425015|P3|Overall Study|Insufficient clinical response|4
1343575|NCT01882439|4425016|P2|Overall Study|Insufficient clinical response|4
1343576|NCT01882439|4425017|P1|Overall Study|Insufficient clinical response|1
1343577|NCT01882439|4425014|P4|Overall Study|Medication error with no associated AE|0
1343578|NCT01882439|4425015|P3|Overall Study|Medication error with no associated AE|2
1343579|NCT01882439|4425016|P2|Overall Study|Medication error with no associated AE|0
1343580|NCT01882439|4425017|P1|Overall Study|Medication error with no associated AE|0
1343581|NCT01882439|4425014|P4|Overall Study|No longer willing to participate|3
1343582|NCT01882439|4425015|P3|Overall Study|No longer willing to participate|2
1343583|NCT01882439|4425016|P2|Overall Study|No longer willing to participate|4
1343670|NCT01880515|4425520|P1|Overall Study|Disease Progression|5
1343584|NCT01882439|4425017|P1|Overall Study|No longer willing to participate|1
1343585|NCT01882439|4425014|P4|Overall Study|Protocol Violation|1
1343586|NCT01882439|4425015|P3|Overall Study|Protocol Violation|0
1343587|NCT01882439|4425016|P2|Overall Study|Protocol Violation|2
1343588|NCT01882439|4425017|P1|Overall Study|Protocol Violation|2
1343589|NCT01882439|4425014|P4|Overall Study|Pregnancy|0
1343590|NCT01882439|4425015|P3|Overall Study|Pregnancy|0
1343591|NCT01882439|4425016|P2|Overall Study|Pregnancy|1
1343592|NCT01882439|4425017|P1|Overall Study|Pregnancy|0
1343593|NCT01882439|4425014|P4|Overall Study|Adverse event related to study drug|2
1343594|NCT01882439|4425015|P3|Overall Study|Adverse event related to study drug|1
1343595|NCT01882439|4425016|P2|Overall Study|Adverse event related to study drug|8
1343596|NCT01882439|4425017|P1|Overall Study|Adverse event related to study drug|3
1343597|NCT01882257|4425214|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
1343598|NCT01882257|4425215|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
1343599|NCT01882257|4425216|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
1343600|NCT01882257|4425214|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
1343601|NCT01882257|4425215|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
1343602|NCT01882257|4425216|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
1343603|NCT01881776|4425248|P3|Overall Study|Protocol Violation|1
1343604|NCT01881776|4425249|P2|Overall Study|Protocol Violation|2
1343605|NCT01881776|4425250|P1|Overall Study|Protocol Violation|0
1343606|NCT01881776|4425248|P3|Overall Study|Lost to Follow-up|1
1343607|NCT01881776|4425249|P2|Overall Study|Lost to Follow-up|2
1343608|NCT01881776|4425250|P1|Overall Study|Lost to Follow-up|1
1343609|NCT01881737|4425276|P1|Overall Study|Worsening of baseline behavior|1
1343610|NCT01881737|4425276|P1|Overall Study|Withdrawal by Subject|1
1343611|NCT01881737|4425276|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
1343612|NCT01881230|4425288|P3|Overall Study|Untreated: Withdrawal Before Study Start|0
1343613|NCT01881230|4425289|P2|Overall Study|Untreated: Withdrawal Before Study Start|0
1343614|NCT01881230|4425290|P1|Overall Study|Untreated: Withdrawal Before Study Start|1
1343615|NCT01881230|4425288|P3|Overall Study|Untreated: Death|1
1343616|NCT01881230|4425289|P2|Overall Study|Untreated: Death|0
1343617|NCT01881230|4425290|P1|Overall Study|Untreated: Death|0
1343618|NCT01881230|4425288|P3|Overall Study|Untreated: Other|1
1343619|NCT01881230|4425289|P2|Overall Study|Untreated: Other|0
1343620|NCT01881230|4425290|P1|Overall Study|Untreated: Other|0
1343621|NCT01881230|4425288|P3|Overall Study|Miscellaneous|0
1343622|NCT01881230|4425289|P2|Overall Study|Miscellaneous|3
1343623|NCT01881230|4425290|P1|Overall Study|Miscellaneous|3
1343624|NCT01881230|4425288|P3|Overall Study|Protocol Violation|0
1343625|NCT01881230|4425289|P2|Overall Study|Protocol Violation|1
1343626|NCT01881230|4425290|P1|Overall Study|Protocol Violation|1
1343627|NCT01881230|4425288|P3|Overall Study|Given Commercially Available Drug|2
1343628|NCT01881230|4425289|P2|Overall Study|Given Commercially Available Drug|0
1343629|NCT01881230|4425290|P1|Overall Study|Given Commercially Available Drug|0
1343630|NCT01881230|4425288|P3|Overall Study|Non-Compliance with Study Drug|0
1343631|NCT01881230|4425289|P2|Overall Study|Non-Compliance with Study Drug|2
1343632|NCT01881230|4425290|P1|Overall Study|Non-Compliance with Study Drug|1
1343633|NCT01881230|4425288|P3|Overall Study|Physician Decision|6
1343634|NCT01881230|4425289|P2|Overall Study|Physician Decision|3
1343635|NCT01881230|4425290|P1|Overall Study|Physician Decision|4
1343636|NCT01881230|4425288|P3|Overall Study|Withdrawal by Subject|6
1343637|NCT01881230|4425289|P2|Overall Study|Withdrawal by Subject|4
1343638|NCT01881230|4425290|P1|Overall Study|Withdrawal by Subject|6
1343639|NCT01881230|4425288|P3|Overall Study|Symptomatic Deterioration|1
1343640|NCT01881230|4425289|P2|Overall Study|Symptomatic Deterioration|3
1343641|NCT01881230|4425290|P1|Overall Study|Symptomatic Deterioration|3
1343642|NCT01881230|4425288|P3|Overall Study|Progressive Disease|36
1343643|NCT01881230|4425289|P2|Overall Study|Progressive Disease|35
1343644|NCT01881230|4425290|P1|Overall Study|Progressive Disease|31
1343645|NCT01881230|4425288|P3|Overall Study|Adverse Event|12
1343646|NCT01881230|4425289|P2|Overall Study|Adverse Event|13
1343647|NCT01881230|4425290|P1|Overall Study|Adverse Event|9
1343648|NCT01881230|4425288|P3|Overall Study|Death|1
1343649|NCT01881230|4425289|P2|Overall Study|Death|0
1343650|NCT01881230|4425290|P1|Overall Study|Death|2
1343651|NCT01881126|4425318|P2|Overall Study|Adverse Event|1
1343652|NCT01881126|4425319|P1|Overall Study|Adverse Event|0
1343653|NCT01881126|4425318|P2|Overall Study|Non-compliance|1
1343654|NCT01881126|4425319|P1|Overall Study|Non-compliance|1
1343655|NCT01880736|4425411|P4|Overall Study|Withdrawal Criteria|5
1343656|NCT01880736|4425412|P3|Overall Study|Withdrawal Criteria|1
1343657|NCT01880736|4425413|P2|Overall Study|Withdrawal Criteria|2
1343658|NCT01880736|4425414|P1|Overall Study|Withdrawal Criteria|1
1343659|NCT01880736|4425411|P4|Overall Study|Adverse Event|1
1343660|NCT01880736|4425412|P3|Overall Study|Adverse Event|0
1343661|NCT01880736|4425413|P2|Overall Study|Adverse Event|0
1343662|NCT01880736|4425414|P1|Overall Study|Adverse Event|0
1343663|NCT01880593|4425498|P2|Overall Study|Withdrawal by Subject|1
1343664|NCT01880593|4425499|P1|Overall Study|Withdrawal by Subject|6
1343665|NCT01880593|4425498|P2|Overall Study|Lack of Efficacy|5
1343666|NCT01880593|4425499|P1|Overall Study|Lack of Efficacy|1
1343667|NCT01880593|4425498|P2|Overall Study|Adverse Event|0
1343668|NCT01880593|4425499|P1|Overall Study|Adverse Event|1
1343669|NCT01880515|4425519|P2|Overall Study|Disease Progression|7
1343671|NCT01880515|4425519|P2|Overall Study|Lost to Follow-up|2
1343672|NCT01880515|4425520|P1|Overall Study|Lost to Follow-up|3
1343673|NCT01880437|4425531|P3|Overall Study|Study terminated by Sponsor|2
1343674|NCT01880437|4425532|P2|Overall Study|Study terminated by Sponsor|0
1343675|NCT01880437|4425533|P1|Overall Study|Study terminated by Sponsor|3
1343676|NCT01880437|4425531|P3|Overall Study|Death|17
1343677|NCT01880437|4425532|P2|Overall Study|Death|4
1343678|NCT01880437|4425533|P1|Overall Study|Death|12
1343679|NCT01880424|4425559|P2|Overall Study|Not specified|0
1343680|NCT01880424|4425560|P1|Overall Study|Not specified|1
1343681|NCT01880424|4425559|P2|Overall Study|Withdrawal by Subject|30
1343682|NCT01880424|4425560|P1|Overall Study|Withdrawal by Subject|10
1343683|NCT01880424|4425559|P2|Overall Study|Protocol Violation|13
1343684|NCT01880424|4425560|P1|Overall Study|Protocol Violation|11
1343685|NCT01880424|4425559|P2|Overall Study|Lost to Follow-up|2
1343686|NCT01880424|4425560|P1|Overall Study|Lost to Follow-up|3
1343687|NCT01880424|4425559|P2|Overall Study|Lack of Efficacy|4
1343688|NCT01880424|4425560|P1|Overall Study|Lack of Efficacy|1
1343689|NCT01880424|4425559|P2|Overall Study|Adverse Event|6
1343690|NCT01880424|4425560|P1|Overall Study|Adverse Event|7
1343691|NCT01880086|4425616|P2|Overall Study|Lost to Follow-up|1
1343692|NCT01880086|4425617|P1|Overall Study|Lost to Follow-up|1
1343693|NCT01879852|4425637|P2|Overall Study|Withdrawal by Subject|0
1343694|NCT01879852|4425638|P1|Overall Study|Withdrawal by Subject|2
1343695|NCT01879722|4425682|P10|Overall Study|Voluntary Withdrawal|0
1343696|NCT01879722|4425683|P9|Overall Study|Voluntary Withdrawal|1
1343697|NCT01879722|4425684|P8|Overall Study|Voluntary Withdrawal|0
1343698|NCT01879722|4425685|P7|Overall Study|Voluntary Withdrawal|0
1343699|NCT01879722|4425686|P6|Overall Study|Voluntary Withdrawal|0
1343700|NCT01879722|4425687|P5|Overall Study|Voluntary Withdrawal|0
1343701|NCT01879722|4425688|P4|Overall Study|Voluntary Withdrawal|0
1343702|NCT01879722|4425689|P3|Overall Study|Voluntary Withdrawal|0
1343703|NCT01879722|4425690|P2|Overall Study|Voluntary Withdrawal|0
1343704|NCT01879722|4425691|P1|Overall Study|Voluntary Withdrawal|0
1343705|NCT01879722|4425682|P10|Overall Study|Pretreatment Event/Adverse Event|0
1343706|NCT01879722|4425683|P9|Overall Study|Pretreatment Event/Adverse Event|1
1343707|NCT01879722|4425684|P8|Overall Study|Pretreatment Event/Adverse Event|1
1343708|NCT01879722|4425685|P7|Overall Study|Pretreatment Event/Adverse Event|0
1343709|NCT01879722|4425686|P6|Overall Study|Pretreatment Event/Adverse Event|0
1343710|NCT01879722|4425687|P5|Overall Study|Pretreatment Event/Adverse Event|1
1343711|NCT01879722|4425688|P4|Overall Study|Pretreatment Event/Adverse Event|1
1343712|NCT01879722|4425689|P3|Overall Study|Pretreatment Event/Adverse Event|0
1343713|NCT01879722|4425690|P2|Overall Study|Pretreatment Event/Adverse Event|1
1343714|NCT01879722|4425691|P1|Overall Study|Pretreatment Event/Adverse Event|0
1343715|NCT01879683|4425839|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
1343716|NCT01879618|4425846|P1|Overall Study|Adverse Event|5
1343717|NCT01879618|4425846|P1|Overall Study|Protocol Violation|6
1343718|NCT01879618|4425846|P1|Overall Study|Surgery;changed schedule; not available|8
1343719|NCT01879618|4425846|P1|Overall Study|Withdrawal by Subject|1
1343720|NCT01879618|4425846|P1|Overall Study|Does not meet entrance criteria|1
1343721|NCT01879579|4425853|P2|Overall Study|Discontinued insulin - possible allergy|1
1343722|NCT01879579|4425854|P1|Overall Study|Discontinued insulin - possible allergy|0
1343723|NCT01879579|4425853|P2|Overall Study|Phenotypic type 1 diabetes|1
1343724|NCT01879579|4425854|P1|Overall Study|Phenotypic type 1 diabetes|0
1343725|NCT01879579|4425853|P2|Overall Study|Did not initiate insulin treatment|0
1343726|NCT01879579|4425854|P1|Overall Study|Did not initiate insulin treatment|1
1343727|NCT01879579|4425853|P2|Overall Study|Did not enroll in texting platform|0
1343728|NCT01879579|4425854|P1|Overall Study|Did not enroll in texting platform|1
1343729|NCT01879579|4425853|P2|Overall Study|Phone incompatible with texting platform|0
1343730|NCT01879579|4425854|P1|Overall Study|Phone incompatible with texting platform|3
1343731|NCT01879553|4425884|P2|Overall Study|Withdrawal by Subject|0
1343732|NCT01879553|4425885|P1|Overall Study|Withdrawal by Subject|1
1343733|NCT01879410|4425919|P2|Overall Study|Randomised in Error|2
1343734|NCT01879410|4425920|P1|Overall Study|Randomised in Error|1
1343735|NCT01879410|4425919|P2|Overall Study|Withdrawal by Subject|8
1343736|NCT01879410|4425920|P1|Overall Study|Withdrawal by Subject|7
1343737|NCT01879410|4425919|P2|Overall Study|Lost to Follow-up|1
1343738|NCT01879410|4425920|P1|Overall Study|Lost to Follow-up|2
1343739|NCT01879410|4425919|P2|Overall Study|Protocol Violation|7
1343740|NCT01879410|4425920|P1|Overall Study|Protocol Violation|1
1343741|NCT01879410|4425919|P2|Overall Study|Lack of Efficacy|6
1343742|NCT01879410|4425920|P1|Overall Study|Lack of Efficacy|4
1343743|NCT01879410|4425919|P2|Overall Study|Adverse Event|14
1343744|NCT01879410|4425920|P1|Overall Study|Adverse Event|9
1343745|NCT01879319|4425987|P2|Overall Study|Lost to Follow-up|5
1343746|NCT01879319|4425988|P1|Overall Study|Lost to Follow-up|1
1343747|NCT01879319|4425987|P2|Overall Study|Withdrawal by Subject|0
1343748|NCT01879319|4425988|P1|Overall Study|Withdrawal by Subject|1
1343749|NCT01879072|4426005|P1|Overall Study|Withdrawal by Subject|48
1343750|NCT01878214|4426130|P2|Overall Study|Lost to Follow-up|36
1343751|NCT01878214|4426131|P1|Overall Study|Lost to Follow-up|35
1343752|NCT01878214|4426130|P2|Overall Study|Death|1
1343753|NCT01878214|4426131|P1|Overall Study|Death|0
1343754|NCT01878214|4426130|P2|Overall Study|Withdrawal by Subject|7
1343755|NCT01878214|4426131|P1|Overall Study|Withdrawal by Subject|18
1343756|NCT01878175|4426145|P1|Overall Study|Developed contraindicated health problem|2
1343757|NCT01878149|4426164|P2|Overall Study|Did Not Meet Eligibility Criteria|2
1343758|NCT01878149|4426165|P1|Overall Study|Did Not Meet Eligibility Criteria|2
1343759|NCT01878097|4426173|P2|Implementation Year 4|Surveys not fully completed|3007
1343760|NCT01878097|4426174|P1|Implementation Year 4|Surveys not fully completed|3604
1343761|NCT01878097|4426173|P2|Implementation Year 3|Surveys not fully completed|2980
1343762|NCT01878097|4426174|P1|Implementation Year 3|Surveys not fully completed|3494
1343763|NCT01878097|4426173|P2|Implementation Year 2|Surveys not fully completed|2841
1343764|NCT01878097|4426174|P1|Implementation Year 2|Surveys not fully completed|3281
1343765|NCT01878097|4426173|P2|Implementation Year 1|Surveys not fully completed|2549
1343766|NCT01878097|4426174|P1|Implementation Year 1|Surveys not fully completed|3202
1343767|NCT01878097|4426173|P2|Baseline|Surveys not fully completed|1800
1343768|NCT01878097|4426174|P1|Baseline|Surveys not fully completed|2497
1343769|NCT01877720|4426190|P2|Overall Study|Adverse Event|0
1343770|NCT01877720|4426191|P1|Overall Study|Adverse Event|1
1343771|NCT01877668|4426220|P5|Overall Study|Adverse event unrelated to study drug|1
1343772|NCT01877668|4426221|P4|Overall Study|Adverse event unrelated to study drug|0
1343773|NCT01877668|4426222|P3|Overall Study|Adverse event unrelated to study drug|2
1343774|NCT01877668|4426223|P2|Overall Study|Adverse event unrelated to study drug|1
1343775|NCT01877668|4426224|P1|Overall Study|Adverse event unrelated to study drug|4
1343776|NCT01877668|4426220|P5|Overall Study|Adverse event related to study drug|1
1343777|NCT01877668|4426221|P4|Overall Study|Adverse event related to study drug|2
1343778|NCT01877668|4426222|P3|Overall Study|Adverse event related to study drug|2
1343779|NCT01877668|4426223|P2|Overall Study|Adverse event related to study drug|2
1343780|NCT01877668|4426224|P1|Overall Study|Adverse event related to study drug|2
1343781|NCT01877668|4426220|P5|Overall Study|Protocol Violation|3
1343782|NCT01877668|4426221|P4|Overall Study|Protocol Violation|0
1343783|NCT01877668|4426222|P3|Overall Study|Protocol Violation|0
1343784|NCT01877668|4426223|P2|Overall Study|Protocol Violation|1
1343785|NCT01877668|4426224|P1|Overall Study|Protocol Violation|1
1343786|NCT01877668|4426220|P5|Overall Study|Not specified|3
1343787|NCT01877668|4426221|P4|Overall Study|Not specified|1
1343788|NCT01877668|4426222|P3|Overall Study|Not specified|1
1343789|NCT01877668|4426223|P2|Overall Study|Not specified|1
1343790|NCT01877668|4426224|P1|Overall Study|Not specified|1
1343791|NCT01877668|4426220|P5|Overall Study|Withdrawal by Subject|2
1343792|NCT01877668|4426221|P4|Overall Study|Withdrawal by Subject|2
1343793|NCT01877668|4426222|P3|Overall Study|Withdrawal by Subject|3
1343794|NCT01877668|4426223|P2|Overall Study|Withdrawal by Subject|0
1343795|NCT01877668|4426224|P1|Overall Study|Withdrawal by Subject|2
1343796|NCT01877668|4426220|P5|Overall Study|Lost to Follow-up|0
1343797|NCT01877668|4426221|P4|Overall Study|Lost to Follow-up|0
1343798|NCT01877668|4426222|P3|Overall Study|Lost to Follow-up|1
1343799|NCT01877668|4426223|P2|Overall Study|Lost to Follow-up|2
1343800|NCT01877668|4426224|P1|Overall Study|Lost to Follow-up|0
1343801|NCT01877668|4426220|P5|Overall Study|Insufficient clinical response|0
1343802|NCT01877668|4426221|P4|Overall Study|Insufficient clinical response|2
1343803|NCT01877668|4426222|P3|Overall Study|Insufficient clinical response|2
1343804|NCT01877668|4426223|P2|Overall Study|Insufficient clinical response|1
1343805|NCT01877668|4426224|P1|Overall Study|Insufficient clinical response|0
1343806|NCT01877668|4426220|P5|Overall Study|No longer met study criteria|0
1343807|NCT01877668|4426221|P4|Overall Study|No longer met study criteria|0
1343808|NCT01877668|4426222|P3|Overall Study|No longer met study criteria|1
1343809|NCT01877668|4426223|P2|Overall Study|No longer met study criteria|0
1343810|NCT01877668|4426224|P1|Overall Study|No longer met study criteria|1
1343811|NCT01877668|4426220|P5|Overall Study|Death|0
1343812|NCT01877668|4426221|P4|Overall Study|Death|1
1343813|NCT01877668|4426222|P3|Overall Study|Death|0
1343814|NCT01877668|4426223|P2|Overall Study|Death|0
1343815|NCT01877668|4426224|P1|Overall Study|Death|0
1343816|NCT01877421|4426528|P18|Phase 2|Protocol Violation|0
1343817|NCT01877421|4426529|P17|Phase 2|Protocol Violation|0
1343818|NCT01877421|4426530|P16|Phase 2|Protocol Violation|0
1343819|NCT01877421|4426531|P15|Phase 2|Protocol Violation|0
1343820|NCT01877421|4426532|P14|Phase 2|Protocol Violation|0
1343821|NCT01877421|4426533|P13|Phase 2|Protocol Violation|0
1343822|NCT01877421|4426534|P12|Phase 2|Protocol Violation|0
1343823|NCT01877421|4426535|P11|Phase 2|Protocol Violation|1
1343824|NCT01877421|4426536|P10|Phase 2|Protocol Violation|0
1343825|NCT01877421|4426537|P9|Phase 2|Protocol Violation|0
1343826|NCT01877421|4426538|P8|Phase 2|Protocol Violation|0
1343827|NCT01877421|4426539|P7|Phase 2|Protocol Violation|0
1343828|NCT01877421|4426540|P6|Phase 2|Protocol Violation|0
1343829|NCT01877421|4426541|P5|Phase 2|Protocol Violation|0
1343830|NCT01877421|4426542|P4|Phase 2|Protocol Violation|0
1343831|NCT01877421|4426543|P3|Phase 2|Protocol Violation|0
1343832|NCT01877421|4426544|P2|Phase 2|Protocol Violation|0
1343833|NCT01877421|4426545|P1|Phase 2|Protocol Violation|0
1343834|NCT01877421|4426528|P18|Phase 2|Withdrawal by Subject|0
1343835|NCT01877421|4426529|P17|Phase 2|Withdrawal by Subject|0
1343836|NCT01877421|4426530|P16|Phase 2|Withdrawal by Subject|1
1343837|NCT01877421|4426531|P15|Phase 2|Withdrawal by Subject|0
1343838|NCT01877421|4426532|P14|Phase 2|Withdrawal by Subject|0
1343839|NCT01877421|4426533|P13|Phase 2|Withdrawal by Subject|1
1343840|NCT01877421|4426534|P12|Phase 2|Withdrawal by Subject|0
1343841|NCT01877421|4426535|P11|Phase 2|Withdrawal by Subject|1
1343842|NCT01877421|4426536|P10|Phase 2|Withdrawal by Subject|0
1343843|NCT01877421|4426537|P9|Phase 2|Withdrawal by Subject|1
1343844|NCT01877421|4426538|P8|Phase 2|Withdrawal by Subject|0
1343845|NCT01877421|4426539|P7|Phase 2|Withdrawal by Subject|0
1343846|NCT01877421|4426540|P6|Phase 2|Withdrawal by Subject|0
1343847|NCT01877421|4426541|P5|Phase 2|Withdrawal by Subject|0
1343848|NCT01877421|4426542|P4|Phase 2|Withdrawal by Subject|0
1343849|NCT01877421|4426543|P3|Phase 2|Withdrawal by Subject|0
1343850|NCT01877421|4426544|P2|Phase 2|Withdrawal by Subject|0
1343851|NCT01877421|4426545|P1|Phase 2|Withdrawal by Subject|0
1343852|NCT01877421|4426528|P18|Phase 2|Lost to Follow-up|0
1343853|NCT01877421|4426529|P17|Phase 2|Lost to Follow-up|0
1343854|NCT01877421|4426530|P16|Phase 2|Lost to Follow-up|0
1343855|NCT01877421|4426531|P15|Phase 2|Lost to Follow-up|0
1343856|NCT01877421|4426532|P14|Phase 2|Lost to Follow-up|0
1343857|NCT01877421|4426533|P13|Phase 2|Lost to Follow-up|0
1343858|NCT01877421|4426534|P12|Phase 2|Lost to Follow-up|0
1343859|NCT01877421|4426535|P11|Phase 2|Lost to Follow-up|0
1343860|NCT01877421|4426536|P10|Phase 2|Lost to Follow-up|0
1343861|NCT01877421|4426537|P9|Phase 2|Lost to Follow-up|0
1343862|NCT01877421|4426538|P8|Phase 2|Lost to Follow-up|0
1343863|NCT01877421|4426539|P7|Phase 2|Lost to Follow-up|1
1343864|NCT01877421|4426540|P6|Phase 2|Lost to Follow-up|0
1343865|NCT01877421|4426541|P5|Phase 2|Lost to Follow-up|0
1343866|NCT01877421|4426542|P4|Phase 2|Lost to Follow-up|0
1343867|NCT01877421|4426543|P3|Phase 2|Lost to Follow-up|0
1343868|NCT01877421|4426544|P2|Phase 2|Lost to Follow-up|0
1343869|NCT01877421|4426545|P1|Phase 2|Lost to Follow-up|0
1343870|NCT01877408|4426655|P2|Overall Study|Lost to Follow-up|2
1343871|NCT01877408|4426656|P1|Overall Study|Lost to Follow-up|0
1343872|NCT01877278|4426689|P2|Overall Study|Lost to Follow-up|3
1343873|NCT01877278|4426690|P1|Overall Study|Lost to Follow-up|3
1343874|NCT01876979|4426738|P2|Overall Study|Physician Decision|3
1343875|NCT01876979|4426739|P1|Overall Study|Physician Decision|2
1343876|NCT01876823|4426745|P1|Overall Study|Patients moved|2
1343877|NCT01876823|4426745|P1|Overall Study|Physician Decision|2
1343878|NCT01876823|4426745|P1|Overall Study|Withdrawal by Subject|5
1343879|NCT01876810|4426758|P2|Overall Study|Physician Decision|1
1343880|NCT01876810|4426759|P1|Overall Study|Physician Decision|0
1343881|NCT01876784|4426771|P2|Overall Study|Ongoing|40
1343882|NCT01876784|4426772|P1|Overall Study|Ongoing|41
1343883|NCT01876784|4426771|P2|Overall Study|Other than specified above|6
1343884|NCT01876784|4426772|P1|Overall Study|Other than specified above|5
1343885|NCT01876784|4426771|P2|Overall Study|Randomized but not treated|1
1343886|NCT01876784|4426772|P1|Overall Study|Randomized but not treated|2
1343887|NCT01876784|4426771|P2|Overall Study|Death|0
1343888|NCT01876784|4426772|P1|Overall Study|Death|1
1343889|NCT01876784|4426771|P2|Overall Study|Lost to Follow-up|1
1343890|NCT01876784|4426772|P1|Overall Study|Lost to Follow-up|0
1343891|NCT01876784|4426771|P2|Overall Study|Disease progression|67
1343892|NCT01876784|4426772|P1|Overall Study|Disease progression|37
1343893|NCT01876784|4426771|P2|Overall Study|Protocol Violation|0
1343894|NCT01876784|4426772|P1|Overall Study|Protocol Violation|1
1343895|NCT01876784|4426771|P2|Overall Study|Adverse Event|2
1343896|NCT01876784|4426772|P1|Overall Study|Adverse Event|15
1343897|NCT01876784|4426771|P2|Overall Study|Withdrawal by Subject|2
1343898|NCT01876784|4426772|P1|Overall Study|Withdrawal by Subject|17
1343899|NCT01876732|4426778|P1|Overall Study|MMA was not over 800mg/dL|75
1343900|NCT01876706|4426783|P1|Overall Study|Lost to Follow-up|2
1343901|NCT01876706|4426783|P1|Overall Study|BPH Intervention|2
1343902|NCT01876420|4426800|P1|Overall Study|Missed 30 day visit|1
1343903|NCT01876381|4426812|P1|Overall Study|Withdrawal by Subject|1
1343904|NCT01876381|4426812|P1|Overall Study|Physician Decision|1
1343905|NCT01876381|4426812|P1|Overall Study|Lack of Efficacy|5
1343906|NCT01876368|4426819|P2|Overall Study|Subject/guardian decision|1
1343907|NCT01876368|4426820|P1|Overall Study|Subject/guardian decision|3
1343908|NCT01876368|4426819|P2|Overall Study|Protocol deviation|3
1343909|NCT01876368|4426820|P1|Overall Study|Protocol deviation|3
1343910|NCT01876368|4426819|P2|Overall Study|Physician Decision|2
1343911|NCT01876368|4426820|P1|Overall Study|Physician Decision|0
1343912|NCT01876368|4426819|P2|Overall Study|Non-compliance with study treatment|1
1343913|NCT01876368|4426820|P1|Overall Study|Non-compliance with study treatment|0
1343914|NCT01876368|4426819|P2|Overall Study|Lost to Follow-up|1
1343915|NCT01876368|4426820|P1|Overall Study|Lost to Follow-up|0
1343916|NCT01876368|4426819|P2|Overall Study|Lack of Efficacy|0
1343917|NCT01876368|4426820|P1|Overall Study|Lack of Efficacy|1
1343918|NCT01876368|4426819|P2|Overall Study|Adverse Event|5
1343919|NCT01876368|4426820|P1|Overall Study|Adverse Event|2
1343920|NCT01875991|4426864|P2|Overall Study|Sponsor Decision|0
1343921|NCT01875991|4426865|P1|Overall Study|Sponsor Decision|1
1343922|NCT01875991|4426864|P2|Overall Study|Withdrawal by Subject|6
1343923|NCT01875991|4426865|P1|Overall Study|Withdrawal by Subject|6
1343924|NCT01875874|4426901|P1|Overall Study|Death|3
1343925|NCT01875848|4426908|P2|Overall Study|Withdrawal by Subject|0
1343926|NCT01875848|4426909|P1|Overall Study|Withdrawal by Subject|2
1343927|NCT01875731|4426926|P2|Overall Study|Fail to obtain lab sample|0
1343928|NCT01875731|4426927|P1|Overall Study|Fail to obtain lab sample|1
1343929|NCT01875471|4426946|P2|Overall Study|Unsatisfactory Lens Fitting|0
1343930|NCT01875471|4426947|P1|Overall Study|Unsatisfactory Lens Fitting|1
1343931|NCT01875471|4426946|P2|Overall Study|Adverse Event|1
1343932|NCT01875471|4426947|P1|Overall Study|Adverse Event|0
1343933|NCT01875445|4426955|P2|Overall Study|Withdrawal by Subject|0
1343934|NCT01875445|4426956|P1|Overall Study|Withdrawal by Subject|2
1343935|NCT01875445|4426955|P2|Overall Study|Lost to Follow-up|0
1343936|NCT01875445|4426956|P1|Overall Study|Lost to Follow-up|5
1343937|NCT01875185|4426966|P2|Overall Study|study was terminated|48
1343938|NCT01875185|4426967|P1|Overall Study|study was terminated|52
1343939|NCT01874665|4427015|P2|Overall Study|Other|0
1343940|NCT01874665|4427016|P1|Overall Study|Other|2
1343941|NCT01874665|4427015|P2|Overall Study|Documented Progressive Disease|7
1343942|NCT01874665|4427016|P1|Overall Study|Documented Progressive Disease|11
1343943|NCT01874665|4427015|P2|Overall Study|Study Terminated by Sponsor|2
1343944|NCT01874665|4427016|P1|Overall Study|Study Terminated by Sponsor|0
1343945|NCT01874665|4427015|P2|Overall Study|Clinical Progressive Disease|3
1343946|NCT01874665|4427016|P1|Overall Study|Clinical Progressive Disease|4
1343947|NCT01874665|4427015|P2|Overall Study|Physician Decision|0
1343948|NCT01874665|4427016|P1|Overall Study|Physician Decision|3
1343949|NCT01874665|4427015|P2|Overall Study|Withdrawal by Subject|1
1343950|NCT01874665|4427016|P1|Overall Study|Withdrawal by Subject|4
1343951|NCT01874665|4427015|P2|Overall Study|Adverse Event|2
1343952|NCT01874665|4427016|P1|Overall Study|Adverse Event|6
1343953|NCT01874353|4427044|P2|Overall Study|Withdrawal by Subject|9
1343954|NCT01874353|4427045|P1|Overall Study|Withdrawal by Subject|7
1343955|NCT01874353|4427044|P2|Overall Study|Death|27
1343956|NCT01874353|4427045|P1|Overall Study|Death|45
1343957|NCT01874353|4427044|P2|Overall Study|Lost to Follow-up|1
1343958|NCT01874353|4427045|P1|Overall Study|Lost to Follow-up|1
1343959|NCT01874353|4427044|P2|Overall Study|Other|0
1343960|NCT01874353|4427045|P1|Overall Study|Other|2
1343961|NCT01874340|4427072|P4|Overall Study|Withdrawal by Subject|1
1343962|NCT01874340|4427073|P3|Overall Study|Withdrawal by Subject|0
1343963|NCT01874340|4427074|P2|Overall Study|Withdrawal by Subject|0
1343964|NCT01874340|4427075|P1|Overall Study|Withdrawal by Subject|0
1343965|NCT01874340|4427072|P4|Overall Study|Study terminated by Sponsor|4
1343966|NCT01874340|4427073|P3|Overall Study|Study terminated by Sponsor|8
1343967|NCT01874340|4427074|P2|Overall Study|Study terminated by Sponsor|8
1343968|NCT01874340|4427075|P1|Overall Study|Study terminated by Sponsor|6
1343969|NCT01874275|4427103|P2|Overall Study|Lost to Follow-up|0
1343970|NCT01874275|4427104|P1|Overall Study|Lost to Follow-up|1
1343971|NCT01874145|4427127|P2|Extension Period|Lost to Follow-up|1
1343972|NCT01874145|4427128|P1|Extension Period|Lost to Follow-up|1
1343973|NCT01874145|4427127|P2|Extension Period|Withdrawal by Subject|1
1343974|NCT01874145|4427128|P1|Extension Period|Withdrawal by Subject|2
1343975|NCT01874145|4427127|P2|Extension Period|Adverse Event|2
1343976|NCT01874145|4427128|P1|Extension Period|Adverse Event|3
1343977|NCT01874145|4427127|P2|Core Period|Withdrawal by Subject|4
1343978|NCT01874145|4427128|P1|Core Period|Withdrawal by Subject|0
1343979|NCT01874145|4427127|P2|Core Period|Adverse Event|1
1343980|NCT01874145|4427128|P1|Core Period|Adverse Event|0
1343981|NCT01874145|4427127|P2|Core Period|Physician Decision|1
1343982|NCT01874145|4427128|P1|Core Period|Physician Decision|1
1343983|NCT01874145|4427127|P2|Core Period|Protocol Violation|1
1343984|NCT01874145|4427128|P1|Core Period|Protocol Violation|1
1343985|NCT01874145|4427127|P2|Core Period|Non-compliance|0
1343986|NCT01874145|4427128|P1|Core Period|Non-compliance|1
1343987|NCT01874054|4427187|P1|Follow-up Period|Continuing in Follow-up|48
1343988|NCT01874054|4427187|P1|Follow-up Period|Withdrawal by Subject|1
1343989|NCT01874054|4427187|P1|Treatment Period|Non-AE related|2
1343990|NCT01874054|4427187|P1|Treatment Period|Withdrawal by Subject|6
1343991|NCT01874054|4427187|P1|Treatment Period|Physician Decision|3
1343992|NCT01874054|4427187|P1|Treatment Period|Adverse Event|20
1343993|NCT01874054|4427187|P1|Treatment Period|Progressive Disease|7
1343994|NCT01873950|4427209|P5|Period 5|Withdrawal by Subject|0
1343995|NCT01873950|4427210|P4|Period 5|Withdrawal by Subject|1
1343996|NCT01873950|4427211|P3|Period 5|Withdrawal by Subject|0
1343997|NCT01873950|4427212|P2|Period 5|Withdrawal by Subject|0
1343998|NCT01873950|4427213|P1|Period 5|Withdrawal by Subject|0
1343999|NCT01873859|4427250|P2|Overall Study|Withdrawal by Subject|4
1344000|NCT01873859|4427251|P1|Overall Study|Withdrawal by Subject|0
1344001|NCT01873729|4427259|P1|Overall Study|Withdrawal by Subject|1
1344002|NCT01873417|4427264|P1|Overall Study|Physician Decision|3
1344003|NCT01873417|4427264|P1|Overall Study|Withdrawal by Subject|2
1344004|NCT01873417|4427264|P1|Overall Study|Lost to Follow-up|2
1344005|NCT01873417|4427264|P1|Overall Study|Adverse Event|24
1344006|NCT01873417|4427264|P1|Overall Study|Did Not Receive Any Study Drug|4
1344007|NCT01872910|4427281|P6|Overall Study|Lost to Follow-up|0
1344008|NCT01872910|4427282|P5|Overall Study|Lost to Follow-up|0
1344009|NCT01872910|4427283|P4|Overall Study|Lost to Follow-up|0
1344010|NCT01872910|4427284|P3|Overall Study|Lost to Follow-up|2
1344011|NCT01872910|4427285|P2|Overall Study|Lost to Follow-up|0
1344012|NCT01872910|4427286|P1|Overall Study|Lost to Follow-up|2
1344013|NCT01872715|4427331|P1|Overall Study|Withdrawal by Subject|2
1344014|NCT01872715|4427331|P1|Overall Study|Protocol Violation|1
1344015|NCT01872715|4427331|P1|Overall Study|Adverse Event|1
1344016|NCT01872689|4427350|P4|Open-Label Period (Only For Monotherapy)|Adverse Event|0
1344017|NCT01872689|4427351|P3|Open-Label Period (Only For Monotherapy)|Adverse Event|0
1344018|NCT01872689|4427352|P2|Open-Label Period (Only For Monotherapy)|Adverse Event|1
1344019|NCT01872689|4427353|P1|Open-Label Period (Only For Monotherapy)|Adverse Event|2
1344096|NCT01872078|4427452|P4|Overall Study|Protocol Violation|0
1344020|NCT01872689|4427350|P4|Open-Label Period (Only For Monotherapy)|Death|0
1344021|NCT01872689|4427351|P3|Open-Label Period (Only For Monotherapy)|Death|0
1344022|NCT01872689|4427352|P2|Open-Label Period (Only For Monotherapy)|Death|3
1344023|NCT01872689|4427353|P1|Open-Label Period (Only For Monotherapy)|Death|5
1344024|NCT01872689|4427350|P4|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
1344025|NCT01872689|4427351|P3|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
1344026|NCT01872689|4427352|P2|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
1344027|NCT01872689|4427353|P1|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
1344028|NCT01872689|4427350|P4|Open-Label Period (Only For Monotherapy)|Physician Decision|0
1344029|NCT01872689|4427351|P3|Open-Label Period (Only For Monotherapy)|Physician Decision|0
1344030|NCT01872689|4427352|P2|Open-Label Period (Only For Monotherapy)|Physician Decision|1
1344031|NCT01872689|4427353|P1|Open-Label Period (Only For Monotherapy)|Physician Decision|0
1344032|NCT01872689|4427350|P4|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
1344033|NCT01872689|4427351|P3|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
1344034|NCT01872689|4427352|P2|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
1344035|NCT01872689|4427353|P1|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
1344036|NCT01872689|4427350|P4|Open-Label Period (Only For Monotherapy)|Other|0
1344037|NCT01872689|4427351|P3|Open-Label Period (Only For Monotherapy)|Other|0
1344038|NCT01872689|4427352|P2|Open-Label Period (Only For Monotherapy)|Other|3
1344039|NCT01872689|4427353|P1|Open-Label Period (Only For Monotherapy)|Other|2
1344040|NCT01872689|4427350|P4|Double-Blind/Placebo-Controlled Period|Adverse Event|7
1344041|NCT01872689|4427351|P3|Double-Blind/Placebo-Controlled Period|Adverse Event|10
1344042|NCT01872689|4427352|P2|Double-Blind/Placebo-Controlled Period|Adverse Event|3
1344043|NCT01872689|4427353|P1|Double-Blind/Placebo-Controlled Period|Adverse Event|6
1344044|NCT01872689|4427350|P4|Double-Blind/Placebo-Controlled Period|Death|9
1344045|NCT01872689|4427351|P3|Double-Blind/Placebo-Controlled Period|Death|14
1344046|NCT01872689|4427352|P2|Double-Blind/Placebo-Controlled Period|Death|4
1344047|NCT01872689|4427353|P1|Double-Blind/Placebo-Controlled Period|Death|3
1344048|NCT01872689|4427350|P4|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
1344049|NCT01872689|4427351|P3|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
1344050|NCT01872689|4427352|P2|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
1344051|NCT01872689|4427353|P1|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
1344052|NCT01872689|4427350|P4|Double-Blind/Placebo-Controlled Period|Physician Decision|1
1344053|NCT01872689|4427351|P3|Double-Blind/Placebo-Controlled Period|Physician Decision|3
1344054|NCT01872689|4427352|P2|Double-Blind/Placebo-Controlled Period|Physician Decision|3
1344055|NCT01872689|4427353|P1|Double-Blind/Placebo-Controlled Period|Physician Decision|0
1344056|NCT01872689|4427350|P4|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
1344057|NCT01872689|4427351|P3|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
1344058|NCT01872689|4427352|P2|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
1344059|NCT01872689|4427353|P1|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
1344060|NCT01872689|4427350|P4|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
1344061|NCT01872689|4427351|P3|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
1344062|NCT01872689|4427352|P2|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
1344063|NCT01872689|4427353|P1|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
1344064|NCT01872689|4427350|P4|Double-Blind/Placebo-Controlled Period|Other|3
1344065|NCT01872689|4427351|P3|Double-Blind/Placebo-Controlled Period|Other|6
1344066|NCT01872689|4427352|P2|Double-Blind/Placebo-Controlled Period|Other|1
1344067|NCT01872689|4427353|P1|Double-Blind/Placebo-Controlled Period|Other|1
1344068|NCT01872689|4427350|P4|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
1344069|NCT01872689|4427351|P3|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
1344070|NCT01872689|4427352|P2|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
1344071|NCT01872689|4427353|P1|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
1344072|NCT01872611|4427429|P2|Overall Study|Reason not provided|6
1344073|NCT01872611|4427430|P1|Overall Study|Reason not provided|6
1344074|NCT01872611|4427429|P2|Overall Study|Withdrawal by Subject|1
1344075|NCT01872611|4427430|P1|Overall Study|Withdrawal by Subject|6
1344076|NCT01872611|4427429|P2|Overall Study|Physician Decision|0
1344077|NCT01872611|4427430|P1|Overall Study|Physician Decision|1
1344078|NCT01872611|4427429|P2|Overall Study|Lost to Follow-up|1
1344079|NCT01872611|4427430|P1|Overall Study|Lost to Follow-up|8
1344080|NCT01872611|4427429|P2|Overall Study|Death, prior to treatment|1
1344081|NCT01872611|4427430|P1|Overall Study|Death, prior to treatment|0
1344082|NCT01872611|4427429|P2|Overall Study|Death|1
1344083|NCT01872611|4427430|P1|Overall Study|Death|0
1344084|NCT01872611|4427429|P2|Overall Study|Adverse Event, prior to treatment|1
1344085|NCT01872611|4427430|P1|Overall Study|Adverse Event, prior to treatment|0
1344086|NCT01872611|4427429|P2|Overall Study|Adverse Event|1
1344087|NCT01872611|4427430|P1|Overall Study|Adverse Event|3
1344088|NCT01872078|4427452|P4|Overall Study|Patient met exclusion criterion 16.|1
1344089|NCT01872078|4427453|P3|Overall Study|Patient met exclusion criterion 16.|0
1344090|NCT01872078|4427454|P2|Overall Study|Patient met exclusion criterion 16.|0
1344091|NCT01872078|4427455|P1|Overall Study|Patient met exclusion criterion 16.|0
1344092|NCT01872078|4427452|P4|Overall Study|Withdrawal by Subject|0
1344093|NCT01872078|4427453|P3|Overall Study|Withdrawal by Subject|1
1344094|NCT01872078|4427454|P2|Overall Study|Withdrawal by Subject|0
1344095|NCT01872078|4427455|P1|Overall Study|Withdrawal by Subject|0
1344097|NCT01872078|4427453|P3|Overall Study|Protocol Violation|1
1344098|NCT01872078|4427454|P2|Overall Study|Protocol Violation|0
1344099|NCT01872078|4427455|P1|Overall Study|Protocol Violation|0
1344100|NCT01872078|4427452|P4|Overall Study|Dose administration non-compliance|1
1344101|NCT01872078|4427453|P3|Overall Study|Dose administration non-compliance|0
1344102|NCT01872078|4427454|P2|Overall Study|Dose administration non-compliance|0
1344103|NCT01872078|4427455|P1|Overall Study|Dose administration non-compliance|0
1344104|NCT01872078|4427452|P4|Overall Study|Adverse Event|0
1344105|NCT01872078|4427453|P3|Overall Study|Adverse Event|1
1344106|NCT01872078|4427454|P2|Overall Study|Adverse Event|0
1344107|NCT01872078|4427455|P1|Overall Study|Adverse Event|0
1344108|NCT01871870|4427465|P1|Overall Study|hyperglycemia|2
1344109|NCT01871870|4427465|P1|Overall Study|Hardware issues|7
1344110|NCT01871805|4427476|P6|Phase II|Lost to Follow-up|13
1344111|NCT01871805|4427477|P5|Phase II|Lost to Follow-up|0
1344112|NCT01871805|4427478|P4|Phase II|Lost to Follow-up|0
1344113|NCT01871805|4427479|P3|Phase II|Lost to Follow-up|0
1344114|NCT01871805|4427480|P2|Phase II|Lost to Follow-up|0
1344115|NCT01871805|4427481|P1|Phase II|Lost to Follow-up|0
1344116|NCT01871805|4427476|P6|Phase II|Alive in Survival Follow-up|29
1344117|NCT01871805|4427477|P5|Phase II|Alive in Survival Follow-up|0
1344118|NCT01871805|4427478|P4|Phase II|Alive in Survival Follow-up|0
1344119|NCT01871805|4427479|P3|Phase II|Alive in Survival Follow-up|0
1344120|NCT01871805|4427480|P2|Phase II|Alive in Survival Follow-up|0
1344121|NCT01871805|4427481|P1|Phase II|Alive in Survival Follow-up|0
1344122|NCT01871805|4427476|P6|Phase II|Death|45
1344123|NCT01871805|4427477|P5|Phase II|Death|0
1344124|NCT01871805|4427478|P4|Phase II|Death|0
1344125|NCT01871805|4427479|P3|Phase II|Death|0
1344126|NCT01871805|4427480|P2|Phase II|Death|0
1344127|NCT01871805|4427481|P1|Phase II|Death|0
1344128|NCT01871805|4427476|P6|Phase I|Lost to Follow-up|0
1344129|NCT01871805|4427477|P5|Phase I|Lost to Follow-up|0
1344130|NCT01871805|4427478|P4|Phase I|Lost to Follow-up|0
1344131|NCT01871805|4427479|P3|Phase I|Lost to Follow-up|3
1344132|NCT01871805|4427480|P2|Phase I|Lost to Follow-up|1
1344133|NCT01871805|4427481|P1|Phase I|Lost to Follow-up|0
1344134|NCT01871805|4427476|P6|Phase I|Alive in Survival Follow-up|0
1344135|NCT01871805|4427477|P5|Phase I|Alive in Survival Follow-up|4
1344136|NCT01871805|4427478|P4|Phase I|Alive in Survival Follow-up|5
1344137|NCT01871805|4427479|P3|Phase I|Alive in Survival Follow-up|4
1344138|NCT01871805|4427480|P2|Phase I|Alive in Survival Follow-up|2
1344139|NCT01871805|4427481|P1|Phase I|Alive in Survival Follow-up|0
1344140|NCT01871805|4427476|P6|Phase I|Death|0
1344141|NCT01871805|4427477|P5|Phase I|Death|9
1344142|NCT01871805|4427478|P4|Phase I|Death|2
1344143|NCT01871805|4427479|P3|Phase I|Death|6
1344144|NCT01871805|4427480|P2|Phase I|Death|4
1344145|NCT01871805|4427481|P1|Phase I|Death|7
1344146|NCT01871558|4427553|P2|Overall Study|Withdrawal by Subject|0
1344147|NCT01871558|4427554|P1|Overall Study|Withdrawal by Subject|2
1344148|NCT01871558|4427553|P2|Overall Study|antidiabetic drug prematurely stopped|1
1344149|NCT01871558|4427554|P1|Overall Study|antidiabetic drug prematurely stopped|1
1344150|NCT01871558|4427553|P2|Overall Study|Other reason|1
1344151|NCT01871558|4427554|P1|Overall Study|Other reason|0
1344152|NCT01871532|4427574|P2|Overall Study|Withdrawal by Subject|2
1344153|NCT01871532|4427575|P1|Overall Study|Withdrawal by Subject|1
1344154|NCT01871519|4427609|P1|Overall Study|Withdrawal by Subject|49
1344155|NCT01871519|4427609|P1|Overall Study|Lost to Follow-up|15
1344156|NCT01871519|4427609|P1|Overall Study|Death|26
1344157|NCT01871402|4427639|P2|Overall Study|Non-compliance|1
1344158|NCT01871402|4427640|P1|Overall Study|Non-compliance|0
1344159|NCT01871402|4427639|P2|Overall Study|Withdrawal by Subject|2
1344160|NCT01871402|4427640|P1|Overall Study|Withdrawal by Subject|0
1344161|NCT01871402|4427639|P2|Overall Study|Lost to Follow-up|0
1344162|NCT01871402|4427640|P1|Overall Study|Lost to Follow-up|1
1344163|NCT01871285|4427658|P4|First Intervention (1 Day)|Lost to Follow-up|0
1344164|NCT01871285|4427659|P3|First Intervention (1 Day)|Lost to Follow-up|1
1344165|NCT01871285|4427660|P2|First Intervention (1 Day)|Lost to Follow-up|1
1344166|NCT01871285|4427661|P1|First Intervention (1 Day)|Lost to Follow-up|0
1344167|NCT01871285|4427658|P4|First Intervention (1 Day)|Adverse Event|0
1344168|NCT01871285|4427659|P3|First Intervention (1 Day)|Adverse Event|0
1344169|NCT01871285|4427660|P2|First Intervention (1 Day)|Adverse Event|0
1344170|NCT01871285|4427661|P1|First Intervention (1 Day)|Adverse Event|1
1344171|NCT01871142|4427687|P1|Overall Study|Adverse Event|1
1344172|NCT01871090|4427703|P2|Overall Study|Subject Non-Compliance|1
1344173|NCT01871090|4427704|P1|Overall Study|Subject Non-Compliance|0
1344174|NCT01871090|4427703|P2|Overall Study|Interrogation not completed correctly|0
1344175|NCT01871090|4427704|P1|Overall Study|Interrogation not completed correctly|1
1344176|NCT01871090|4427703|P2|Overall Study|Interrogation not done in Emergency Room|22
1344177|NCT01871090|4427704|P1|Overall Study|Interrogation not done in Emergency Room|1
1344178|NCT01870999|4427717|P3|Overall Study|Protocol Violation|1
1344179|NCT01870999|4427718|P2|Overall Study|Protocol Violation|0
1344180|NCT01870999|4427719|P1|Overall Study|Protocol Violation|0
1344181|NCT01870999|4427717|P3|Overall Study|Withdrawal by Subject|5
1344182|NCT01870999|4427718|P2|Overall Study|Withdrawal by Subject|2
1344183|NCT01870999|4427719|P1|Overall Study|Withdrawal by Subject|0
1344184|NCT01870999|4427717|P3|Overall Study|Subject withdrawn by Investigator|0
1344185|NCT01870999|4427718|P2|Overall Study|Subject withdrawn by Investigator|0
1344186|NCT01870999|4427719|P1|Overall Study|Subject withdrawn by Investigator|1
1344187|NCT01870999|4427717|P3|Overall Study|Subject met withdrawal criteria|0
1344188|NCT01870999|4427718|P2|Overall Study|Subject met withdrawal criteria|2
1344189|NCT01870999|4427719|P1|Overall Study|Subject met withdrawal criteria|3
1344190|NCT01870999|4427717|P3|Overall Study|Adverse Event|1
1344191|NCT01870999|4427718|P2|Overall Study|Adverse Event|4
1344192|NCT01870999|4427719|P1|Overall Study|Adverse Event|0
1344193|NCT01870973|4427777|P2|Overall Study|Lost to Follow-up|3
1344194|NCT01870973|4427778|P1|Overall Study|Lost to Follow-up|10
1344195|NCT01870921|4427784|P1|Overall Study|Other|1
1344196|NCT01870921|4427784|P1|Overall Study|Subject Lost to Follow up|2
1344197|NCT01870921|4427784|P1|Overall Study|Severe non-compliance to protocol|7
1344198|NCT01870921|4427784|P1|Overall Study|Subject decision|80
1344199|NCT01870843|4427803|P1|Overall Study|Withdrawal by Subject|18
1344200|NCT01870843|4427803|P1|Overall Study|Death|1
1344201|NCT01870843|4427803|P1|Overall Study|Lost to Follow-up|24
1344202|NCT01870843|4427803|P1|Overall Study|Adverse Event|10
1344203|NCT01870778|4427818|P2|Overall Study|Lost to Follow-up|2
1344204|NCT01870778|4427819|P1|Overall Study|Lost to Follow-up|0
1344205|NCT01870778|4427818|P2|Overall Study|Withdrawal by Subject|7
1344206|NCT01870778|4427819|P1|Overall Study|Withdrawal by Subject|8
1344207|NCT01870739|4427845|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
1344208|NCT01870739|4427846|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
1344209|NCT01870739|4427845|P2|Add-on Period (40 Weeks)|Protocol deviation|1
1344210|NCT01870739|4427846|P1|Add-on Period (40 Weeks)|Protocol deviation|1
1344211|NCT01870739|4427845|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
1344212|NCT01870739|4427846|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
1344213|NCT01870739|4427845|P2|Add-on Period (40 Weeks)|Adverse Event|1
1344214|NCT01870739|4427846|P1|Add-on Period (40 Weeks)|Adverse Event|0
1344215|NCT01870739|4427845|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
1344216|NCT01870739|4427846|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
1344217|NCT01870739|4427845|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
1344218|NCT01870739|4427846|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
1344219|NCT01870739|4427845|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
1344220|NCT01870739|4427846|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
1344221|NCT01870726|4427885|P7|Overall Study|Progressive disease|10
1344222|NCT01870726|4427886|P6|Overall Study|Progressive disease|4
1344223|NCT01870726|4427887|P5|Overall Study|Progressive disease|6
1344224|NCT01870726|4427888|P4|Overall Study|Progressive disease|5
1344225|NCT01870726|4427889|P3|Overall Study|Progressive disease|4
1344226|NCT01870726|4427890|P2|Overall Study|Progressive disease|5
1344227|NCT01870726|4427891|P1|Overall Study|Progressive disease|5
1344228|NCT01870726|4427885|P7|Overall Study|Adverse Event|0
1344229|NCT01870726|4427886|P6|Overall Study|Adverse Event|1
1344230|NCT01870726|4427887|P5|Overall Study|Adverse Event|1
1344231|NCT01870726|4427888|P4|Overall Study|Adverse Event|0
1344232|NCT01870726|4427889|P3|Overall Study|Adverse Event|0
1344233|NCT01870726|4427890|P2|Overall Study|Adverse Event|0
1344234|NCT01870726|4427891|P1|Overall Study|Adverse Event|0
1344235|NCT01870726|4427885|P7|Overall Study|Withdrawal by Subject|0
1344236|NCT01870726|4427886|P6|Overall Study|Withdrawal by Subject|0
1344237|NCT01870726|4427887|P5|Overall Study|Withdrawal by Subject|0
1344238|NCT01870726|4427888|P4|Overall Study|Withdrawal by Subject|0
1344239|NCT01870726|4427889|P3|Overall Study|Withdrawal by Subject|0
1344240|NCT01870726|4427890|P2|Overall Study|Withdrawal by Subject|1
1344241|NCT01870726|4427891|P1|Overall Study|Withdrawal by Subject|0
1344242|NCT01870726|4427885|P7|Overall Study|Withdrawal of informed consent|0
1344243|NCT01870726|4427886|P6|Overall Study|Withdrawal of informed consent|0
1344244|NCT01870726|4427887|P5|Overall Study|Withdrawal of informed consent|0
1344245|NCT01870726|4427888|P4|Overall Study|Withdrawal of informed consent|1
1344246|NCT01870726|4427889|P3|Overall Study|Withdrawal of informed consent|0
1344247|NCT01870726|4427890|P2|Overall Study|Withdrawal of informed consent|0
1344248|NCT01870726|4427891|P1|Overall Study|Withdrawal of informed consent|0
1344249|NCT01870583|4427986|P3|Overall Study|Lost to Follow-up|5
1344250|NCT01870583|4427987|P2|Overall Study|Lost to Follow-up|13
1344251|NCT01870583|4427988|P1|Overall Study|Lost to Follow-up|11
1344252|NCT01870583|4427986|P3|Overall Study|Protocol Violation|3
1344253|NCT01870583|4427987|P2|Overall Study|Protocol Violation|5
1344254|NCT01870583|4427988|P1|Overall Study|Protocol Violation|0
1344255|NCT01870076|4428011|P4|Overall Study|Withdrawal by Subject|0
1344256|NCT01870076|4428012|P3|Overall Study|Withdrawal by Subject|1
1344257|NCT01870076|4428013|P2|Overall Study|Withdrawal by Subject|0
1344258|NCT01870076|4428014|P1|Overall Study|Withdrawal by Subject|1
1344259|NCT01869959|4428032|P5|Treatment Period|Withdrawal by Subject|0
1344260|NCT01869959|4428033|P4|Treatment Period|Withdrawal by Subject|0
1344261|NCT01869959|4428034|P3|Treatment Period|Withdrawal by Subject|0
1344262|NCT01869959|4428035|P2|Treatment Period|Withdrawal by Subject|1
1344263|NCT01869959|4428036|P1|Treatment Period|Withdrawal by Subject|0
1344264|NCT01869959|4428032|P5|Treatment Period|Sponsor decision|0
1344265|NCT01869959|4428033|P4|Treatment Period|Sponsor decision|1
1344266|NCT01869959|4428034|P3|Treatment Period|Sponsor decision|0
1344267|NCT01869959|4428035|P2|Treatment Period|Sponsor decision|1
1344268|NCT01869959|4428036|P1|Treatment Period|Sponsor decision|0
1344269|NCT01869959|4428032|P5|Treatment Period|Adverse Event|0
1344270|NCT01869959|4428033|P4|Treatment Period|Adverse Event|1
1344271|NCT01869959|4428034|P3|Treatment Period|Adverse Event|3
1344272|NCT01869959|4428035|P2|Treatment Period|Adverse Event|0
1344273|NCT01869959|4428036|P1|Treatment Period|Adverse Event|1
1344274|NCT01869959|4428032|P5|Randomization Period|Physician Decision|1
1344275|NCT01869959|4428033|P4|Randomization Period|Physician Decision|0
1344276|NCT01869959|4428034|P3|Randomization Period|Physician Decision|0
1344277|NCT01869959|4428035|P2|Randomization Period|Physician Decision|0
1344278|NCT01869959|4428036|P1|Randomization Period|Physician Decision|0
1344279|NCT01869699|4428106|P2|Overall Study|Withdrawal by Subject|0
1344280|NCT01869699|4428107|P1|Overall Study|Withdrawal by Subject|1
1344281|NCT01869348|4428170|P2|Overall Study|Withdrawal by Subject|1
1344282|NCT01869348|4428171|P1|Overall Study|Withdrawal by Subject|1
1344283|NCT01868997|4428204|P2|Overall Study|Not Specified|1
1344284|NCT01868997|4428205|P1|Overall Study|Not Specified|3
1344285|NCT01868997|4428204|P2|Overall Study|Lack of Efficacy|0
1344286|NCT01868997|4428205|P1|Overall Study|Lack of Efficacy|2
1344287|NCT01868997|4428204|P2|Overall Study|Adverse Event|5
1344288|NCT01868997|4428205|P1|Overall Study|Adverse Event|2
1344289|NCT01868893|4428221|P1|Overall Study|Neutropenia|1
1344290|NCT01868893|4428221|P1|Overall Study|Commercial availability of study drug|17
1344291|NCT01868893|4428221|P1|Overall Study|Adverse Event|2
1344292|NCT01868542|4428267|P2|Overall Study|Unclassified|1
1344293|NCT01868542|4428268|P1|Overall Study|Unclassified|0
1344294|NCT01868542|4428267|P2|Overall Study|Protocol Violation|1
1344295|NCT01868542|4428268|P1|Overall Study|Protocol Violation|0
1344296|NCT01868503|4428286|P1|Overall Study|Protocol Violation|1
1344297|NCT01868503|4428286|P1|Overall Study|Withdrawal by Subject|1
1344298|NCT01868243|4428341|P2|Overall Study|Death|1
1344299|NCT01868243|4428342|P1|Overall Study|Death|0
1344300|NCT01868074|4428352|P2|Overall Study|Withdrawal by Subject|2
1344301|NCT01868074|4428353|P1|Overall Study|Withdrawal by Subject|4
1344302|NCT01868074|4428352|P2|Overall Study|Lost to Follow-up|2
1344303|NCT01868074|4428353|P1|Overall Study|Lost to Follow-up|3
1344304|NCT01868035|4428363|P1|Overall Study|Non-compliance|1
1344305|NCT01868035|4428363|P1|Overall Study|Progressive Disease|2
1344306|NCT01868035|4428363|P1|Overall Study|Withdrawal by Subject|1
1344307|NCT01868035|4428363|P1|Overall Study|Lost to Follow-up|3
1344308|NCT01868009|4428379|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
1344309|NCT01868009|4428380|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
1344310|NCT01868009|4428379|P2|Period 2 (5-9 Days)|Adverse Event|0
1344311|NCT01868009|4428380|P1|Period 2 (5-9 Days)|Adverse Event|1
1344312|NCT01868009|4428379|P2|Period 1 (5-9 Days)|Adverse Event|2
1344313|NCT01868009|4428380|P1|Period 1 (5-9 Days)|Adverse Event|0
1344314|NCT01867710|4428394|P4|Overall Study|Other|0
1344315|NCT01867710|4428395|P3|Overall Study|Other|0
1344316|NCT01867710|4428396|P2|Overall Study|Other|1
1344317|NCT01867710|4428397|P1|Overall Study|Other|0
1344318|NCT01867710|4428394|P4|Overall Study|Eligible Criteria Not Met|0
1344319|NCT01867710|4428395|P3|Overall Study|Eligible Criteria Not Met|1
1344320|NCT01867710|4428396|P2|Overall Study|Eligible Criteria Not Met|0
1344321|NCT01867710|4428397|P1|Overall Study|Eligible Criteria Not Met|0
1344322|NCT01867710|4428394|P4|Overall Study|Withdrawal by Subject|0
1344323|NCT01867710|4428395|P3|Overall Study|Withdrawal by Subject|0
1344324|NCT01867710|4428396|P2|Overall Study|Withdrawal by Subject|1
1344325|NCT01867710|4428397|P1|Overall Study|Withdrawal by Subject|0
1344326|NCT01867710|4428394|P4|Overall Study|Protocol Violation|1
1344327|NCT01867710|4428395|P3|Overall Study|Protocol Violation|0
1344328|NCT01867710|4428396|P2|Overall Study|Protocol Violation|0
1344329|NCT01867710|4428397|P1|Overall Study|Protocol Violation|1
1344330|NCT01867710|4428394|P4|Overall Study|Physician Decision|0
1344331|NCT01867710|4428395|P3|Overall Study|Physician Decision|1
1344332|NCT01867710|4428396|P2|Overall Study|Physician Decision|0
1344333|NCT01867710|4428397|P1|Overall Study|Physician Decision|0
1344334|NCT01867710|4428394|P4|Overall Study|Death|0
1344335|NCT01867710|4428395|P3|Overall Study|Death|1
1344336|NCT01867710|4428396|P2|Overall Study|Death|1
1344337|NCT01867710|4428397|P1|Overall Study|Death|0
1344338|NCT01867710|4428394|P4|Overall Study|Other Adverse Events|3
1344339|NCT01867710|4428395|P3|Overall Study|Other Adverse Events|1
1344340|NCT01867710|4428396|P2|Overall Study|Other Adverse Events|0
1344341|NCT01867710|4428397|P1|Overall Study|Other Adverse Events|1
1344342|NCT01867710|4428394|P4|Overall Study|Palliative Radiation Required|1
1344343|NCT01867710|4428395|P3|Overall Study|Palliative Radiation Required|1
1344344|NCT01867710|4428396|P2|Overall Study|Palliative Radiation Required|0
1344345|NCT01867710|4428397|P1|Overall Study|Palliative Radiation Required|0
1344346|NCT01867710|4428394|P4|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
1344347|NCT01867710|4428395|P3|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
1344348|NCT01867710|4428396|P2|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
1344349|NCT01867710|4428397|P1|Overall Study|Adverse Event Sustained Toxicity>Grade 1|1
1344350|NCT01867710|4428394|P4|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
1344351|NCT01867710|4428395|P3|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
1344352|NCT01867710|4428396|P2|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|2
1344353|NCT01867710|4428397|P1|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
1344354|NCT01867710|4428394|P4|Overall Study|Disease Progression|2
1344355|NCT01867710|4428395|P3|Overall Study|Disease Progression|4
1344356|NCT01867710|4428396|P2|Overall Study|Disease Progression|2
1344357|NCT01867710|4428397|P1|Overall Study|Disease Progression|5
1344358|NCT01867658|4428411|P1|Overall Study|Subject could not be contacted|1
1344359|NCT01867658|4428411|P1|Overall Study|Death|2
1344360|NCT01867658|4428411|P1|Overall Study|Withdrawal by Subject|6
1344361|NCT01867580|4428435|P2|Overall Study|Wound recurrence|1
1344362|NCT01867580|4428436|P1|Overall Study|Wound recurrence|0
1344363|NCT01867580|4428435|P2|Overall Study|Continuation of therapy|1
1344364|NCT01867580|4428436|P1|Overall Study|Continuation of therapy|0
1344365|NCT01867580|4428435|P2|Overall Study|Osteomyelitis|1
1344366|NCT01867580|4428436|P1|Overall Study|Osteomyelitis|0
1344367|NCT01867580|4428435|P2|Overall Study|Interruption to therapy|0
1344368|NCT01867580|4428436|P1|Overall Study|Interruption to therapy|3
1344369|NCT01867580|4428435|P2|Overall Study|Missed follow-up assessment|1
1344370|NCT01867580|4428436|P1|Overall Study|Missed follow-up assessment|2
1344371|NCT01867580|4428435|P2|Overall Study|Sponsor terminated study|0
1344372|NCT01867580|4428436|P1|Overall Study|Sponsor terminated study|1
1344373|NCT01867580|4428435|P2|Overall Study|Lost to Follow-up|5
1344374|NCT01867580|4428436|P1|Overall Study|Lost to Follow-up|3
1344375|NCT01867580|4428435|P2|Overall Study|Physician Decision|12
1344376|NCT01867580|4428436|P1|Overall Study|Physician Decision|17
1344377|NCT01867580|4428435|P2|Overall Study|Withdrawal by Subject|3
1344378|NCT01867580|4428436|P1|Overall Study|Withdrawal by Subject|2
1344379|NCT01867424|4428461|P2|Overall Study|Patient noncompliance|1
1344380|NCT01867424|4428462|P1|Overall Study|Patient noncompliance|2
1344381|NCT01867307|4428476|P2|Overall Study|Other Adverse Event|3
1344382|NCT01867307|4428477|P1|Overall Study|Other Adverse Event|1
1344383|NCT01867307|4428476|P2|Overall Study|Protocol Violation|0
1344384|NCT01867307|4428477|P1|Overall Study|Protocol Violation|2
1344385|NCT01867216|4428490|P7|Overall Study|Unable to Place Catheter for Blood Draws|0
1344386|NCT01867216|4428491|P6|Overall Study|Unable to Place Catheter for Blood Draws|0
1344387|NCT01867216|4428492|P5|Overall Study|Unable to Place Catheter for Blood Draws|0
1344388|NCT01867216|4428493|P4|Overall Study|Unable to Place Catheter for Blood Draws|0
1344389|NCT01867216|4428494|P3|Overall Study|Unable to Place Catheter for Blood Draws|0
1344390|NCT01867216|4428495|P2|Overall Study|Unable to Place Catheter for Blood Draws|0
1344391|NCT01867216|4428496|P1|Overall Study|Unable to Place Catheter for Blood Draws|1
1344392|NCT01867216|4428490|P7|Overall Study|Physician Decision|0
1344393|NCT01867216|4428491|P6|Overall Study|Physician Decision|0
1344394|NCT01867216|4428492|P5|Overall Study|Physician Decision|0
1344395|NCT01867216|4428493|P4|Overall Study|Physician Decision|0
1344396|NCT01867216|4428494|P3|Overall Study|Physician Decision|0
1344397|NCT01867216|4428495|P2|Overall Study|Physician Decision|0
1344398|NCT01867216|4428496|P1|Overall Study|Physician Decision|1
1344399|NCT01867216|4428490|P7|Overall Study|Withdrawal by Subject|1
1344400|NCT01867216|4428491|P6|Overall Study|Withdrawal by Subject|0
1344401|NCT01867216|4428492|P5|Overall Study|Withdrawal by Subject|1
1344402|NCT01867216|4428493|P4|Overall Study|Withdrawal by Subject|0
1344403|NCT01867216|4428494|P3|Overall Study|Withdrawal by Subject|0
1344404|NCT01867216|4428495|P2|Overall Study|Withdrawal by Subject|0
1344405|NCT01867216|4428496|P1|Overall Study|Withdrawal by Subject|2
1344406|NCT01867086|4428568|P1|Overall Study|Disease Progression|1
1344407|NCT01867047|4428577|P2|Overall Study|surgery not indicated in protocol|2
1344408|NCT01867047|4428578|P1|Overall Study|surgery not indicated in protocol|1
1344409|NCT01867047|4428577|P2|Overall Study|Physician Decision|0
1344410|NCT01867047|4428578|P1|Overall Study|Physician Decision|2
1344411|NCT01867047|4428577|P2|Overall Study|Withdrawal by Subject|0
1344412|NCT01867047|4428578|P1|Overall Study|Withdrawal by Subject|2
1344413|NCT01867047|4428577|P2|Overall Study|Lost to Follow-up|3
1344414|NCT01867047|4428578|P1|Overall Study|Lost to Follow-up|3
1344415|NCT01867021|4428598|P2|Overall Study|Withdrawal by Subject|6
1344416|NCT01867021|4428599|P1|Overall Study|Withdrawal by Subject|1
1344417|NCT01867021|4428598|P2|Overall Study|Lost to Follow-up|2
1344418|NCT01867021|4428599|P1|Overall Study|Lost to Follow-up|0
1344419|NCT01867021|4428598|P2|Overall Study|Death|0
1344420|NCT01867021|4428599|P1|Overall Study|Death|1
1344421|NCT01867021|4428598|P2|Overall Study|Not Eligible|1
1344422|NCT01867021|4428599|P1|Overall Study|Not Eligible|0
1344423|NCT01867021|4428598|P2|Overall Study|Adverse Event|1
1344424|NCT01867021|4428599|P1|Overall Study|Adverse Event|0
1344425|NCT01866709|4428630|P2|Overall Study|Adverse Event|0
1344426|NCT01866709|4428631|P1|Overall Study|Adverse Event|1
1344427|NCT01866423|4428672|P1|Overall Study|Sponsor Decision|1
1344428|NCT01866423|4428672|P1|Overall Study|Lack of Efficacy|3
1344429|NCT01866319|4428685|P3|Overall Study|Remain on study|176
1344430|NCT01866319|4428686|P2|Overall Study|Remain on study|190
1344431|NCT01866319|4428687|P1|Overall Study|Remain on study|131
1344432|NCT01866319|4428685|P3|Overall Study|Withdrawal by Subject|6
1344433|NCT01866319|4428686|P2|Overall Study|Withdrawal by Subject|9
1344434|NCT01866319|4428687|P1|Overall Study|Withdrawal by Subject|31
1344435|NCT01866319|4428685|P3|Overall Study|Physician Decision|0
1344436|NCT01866319|4428686|P2|Overall Study|Physician Decision|0
1344437|NCT01866319|4428687|P1|Overall Study|Physician Decision|1
1344438|NCT01866319|4428685|P3|Overall Study|Lost to Follow-up|6
1344439|NCT01866319|4428686|P2|Overall Study|Lost to Follow-up|0
1344440|NCT01866319|4428687|P1|Overall Study|Lost to Follow-up|3
1344441|NCT01866319|4428685|P3|Overall Study|Death|77
1344442|NCT01866319|4428686|P2|Overall Study|Death|74
1344443|NCT01866319|4428687|P1|Overall Study|Death|97
1344444|NCT01866319|4428685|P3|Overall Study|Clinical progression|0
1344445|NCT01866319|4428686|P2|Overall Study|Clinical progression|0
1344446|NCT01866319|4428687|P1|Overall Study|Clinical progression|1
1344447|NCT01866319|4428685|P3|Overall Study|Adverse Event|12
1344448|NCT01866319|4428686|P2|Overall Study|Adverse Event|6
1344449|NCT01866319|4428687|P1|Overall Study|Adverse Event|13
1344450|NCT01866293|4428786|P1|Overall Study|Adverse Event|2
1344451|NCT01865812|4428828|P1|Overall Study|Adverse Event|2
1344452|NCT01865747|4428836|P2|Primary Intent to Treat (PITT)|Other|1
1344453|NCT01865747|4428837|P1|Primary Intent to Treat (PITT)|Other|0
1344454|NCT01865747|4428836|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
1344455|NCT01865747|4428837|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
1344456|NCT01865747|4428836|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
1344457|NCT01865747|4428837|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
1344458|NCT01865747|4428836|P2|Primary Intent to Treat (PITT)|Physician Decision|2
1344459|NCT01865747|4428837|P1|Primary Intent to Treat (PITT)|Physician Decision|4
1344460|NCT01865747|4428836|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
1344461|NCT01865747|4428837|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
1344462|NCT01865747|4428836|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
1344463|NCT01865747|4428837|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
1344464|NCT01865747|4428836|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
1344465|NCT01865747|4428837|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
1344466|NCT01865747|4428836|P2|Primary Intent to Treat (PITT)|Adverse Event|20
1344467|NCT01865747|4428837|P1|Primary Intent to Treat (PITT)|Adverse Event|21
1344468|NCT01865747|4428836|P2|Overall Study (ITT)|Reason Not Provided|1
1344469|NCT01865747|4428837|P1|Overall Study (ITT)|Reason Not Provided|0
1344470|NCT01865747|4428836|P2|Overall Study (ITT)|Progressive Disease|158
1344471|NCT01865747|4428837|P1|Overall Study (ITT)|Progressive Disease|122
1344472|NCT01865747|4428836|P2|Overall Study (ITT)|Sponsor Decision|1
1344473|NCT01865747|4428837|P1|Overall Study (ITT)|Sponsor Decision|0
1344474|NCT01865747|4428836|P2|Overall Study (ITT)|Withdrawal by Subject|11
1344475|NCT01865747|4428837|P1|Overall Study (ITT)|Withdrawal by Subject|6
1344476|NCT01865747|4428836|P2|Overall Study (ITT)|Physician Decision|2
1344477|NCT01865747|4428837|P1|Overall Study (ITT)|Physician Decision|5
1344478|NCT01865747|4428836|P2|Overall Study (ITT)|Protocol Violation|1
1344479|NCT01865747|4428837|P1|Overall Study (ITT)|Protocol Violation|1
1344480|NCT01865747|4428836|P2|Overall Study (ITT)|Lack of Efficacy|0
1344481|NCT01865747|4428837|P1|Overall Study (ITT)|Lack of Efficacy|3
1344482|NCT01865747|4428836|P2|Overall Study (ITT)|Clinical Deterioration|50
1344483|NCT01865747|4428837|P1|Overall Study (ITT)|Clinical Deterioration|29
1344484|NCT01865747|4428836|P2|Overall Study (ITT)|Adverse Event|31
1344485|NCT01865747|4428837|P1|Overall Study (ITT)|Adverse Event|32
1344486|NCT01865084|4428855|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
1344487|NCT01865084|4428856|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
1344488|NCT01865084|4428857|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
1344489|NCT01865084|4428855|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
1344490|NCT01865084|4428856|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
1344491|NCT01865084|4428857|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
1344492|NCT01865084|4428855|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
1344493|NCT01865084|4428856|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
1344494|NCT01865084|4428857|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
1344495|NCT01865084|4428855|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
1344496|NCT01865084|4428856|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
1344497|NCT01865084|4428857|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
1344498|NCT01865084|4428855|P3|Open Label Extension (OLE) Period|Adverse Event|1
1344499|NCT01865084|4428856|P2|Open Label Extension (OLE) Period|Adverse Event|0
1344500|NCT01865084|4428857|P1|Open Label Extension (OLE) Period|Adverse Event|0
1344501|NCT01865084|4428855|P3|Double Blind Period (DB)|Withdrawal by Subject|0
1344502|NCT01865084|4428856|P2|Double Blind Period (DB)|Withdrawal by Subject|0
1344503|NCT01865084|4428857|P1|Double Blind Period (DB)|Withdrawal by Subject|1
1344504|NCT01865084|4428855|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
1344505|NCT01865084|4428856|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
1344506|NCT01865084|4428857|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
1344507|NCT01865084|4428855|P3|Double Blind Period (DB)|Protocol Violation|1
1344508|NCT01865084|4428856|P2|Double Blind Period (DB)|Protocol Violation|0
1344509|NCT01865084|4428857|P1|Double Blind Period (DB)|Protocol Violation|0
1344510|NCT01865084|4428855|P3|Double Blind Period (DB)|Adverse Event|1
1344511|NCT01865084|4428856|P2|Double Blind Period (DB)|Adverse Event|2
1344512|NCT01865084|4428857|P1|Double Blind Period (DB)|Adverse Event|2
1344513|NCT01864525|4428889|P2|Overall Study|Adverse Event|0
1344514|NCT01864525|4428890|P1|Overall Study|Adverse Event|1
1344515|NCT01864200|4428913|P2|Overall Study|Protocol Violation|0
1344516|NCT01864200|4428914|P1|Overall Study|Protocol Violation|1
1344517|NCT01864200|4428913|P2|Overall Study|Lost to Follow-up|3
1344518|NCT01864200|4428914|P1|Overall Study|Lost to Follow-up|1
1344519|NCT01864174|4428922|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
1344520|NCT01864174|4428923|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
1344521|NCT01864174|4428922|P2|Off Treatment Follow-Up|Other|0
1344522|NCT01864174|4428923|P1|Off Treatment Follow-Up|Other|2
1344523|NCT01864174|4428922|P2|Double Blind - Compliant Randomized|Other|10
1344524|NCT01864174|4428923|P1|Double Blind - Compliant Randomized|Other|6
1344525|NCT01864174|4428922|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
1344526|NCT01864174|4428923|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
1344527|NCT01864174|4428922|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
1344528|NCT01864174|4428923|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
1344529|NCT01864174|4428922|P2|Double Blind - Compliant Randomized|Death|0
1344530|NCT01864174|4428923|P1|Double Blind - Compliant Randomized|Death|1
1344531|NCT01864174|4428922|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
1344532|NCT01864174|4428923|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
1344533|NCT01864174|4428922|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
1344534|NCT01864174|4428923|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
1344535|NCT01864174|4428922|P2|Double Blind - Compliant Randomized|Adverse Event|1
1344536|NCT01864174|4428923|P1|Double Blind - Compliant Randomized|Adverse Event|6
1344537|NCT01864174|4428922|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
1344538|NCT01864174|4428923|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
1344539|NCT01864148|4428942|P5|Overall Study|Not Dosed|0
1344540|NCT01864148|4428943|P4|Overall Study|Not Dosed|1
1344541|NCT01864148|4428944|P3|Overall Study|Not Dosed|0
1344542|NCT01864148|4428945|P2|Overall Study|Not Dosed|0
1344543|NCT01864148|4428946|P1|Overall Study|Not Dosed|0
1344544|NCT01864148|4428942|P5|Overall Study|Adverse Event|7
1344545|NCT01864148|4428943|P4|Overall Study|Adverse Event|7
1344546|NCT01864148|4428944|P3|Overall Study|Adverse Event|4
1344547|NCT01864148|4428945|P2|Overall Study|Adverse Event|2
1344548|NCT01864148|4428946|P1|Overall Study|Adverse Event|4
1344549|NCT01864148|4428942|P5|Overall Study|Lost to Follow-up|1
1344550|NCT01864148|4428943|P4|Overall Study|Lost to Follow-up|2
1344551|NCT01864148|4428944|P3|Overall Study|Lost to Follow-up|0
1344552|NCT01864148|4428945|P2|Overall Study|Lost to Follow-up|0
1344553|NCT01864148|4428946|P1|Overall Study|Lost to Follow-up|0
1344554|NCT01864148|4428942|P5|Overall Study|Withdrawal by Subject|8
1344555|NCT01864148|4428943|P4|Overall Study|Withdrawal by Subject|8
1344556|NCT01864148|4428944|P3|Overall Study|Withdrawal by Subject|6
1344557|NCT01864148|4428945|P2|Overall Study|Withdrawal by Subject|2
1344558|NCT01864148|4428946|P1|Overall Study|Withdrawal by Subject|9
1344559|NCT01864148|4428942|P5|Overall Study|Investigator Decision|6
1344560|NCT01864148|4428943|P4|Overall Study|Investigator Decision|4
1344561|NCT01864148|4428944|P3|Overall Study|Investigator Decision|0
1344562|NCT01864148|4428945|P2|Overall Study|Investigator Decision|0
1344563|NCT01864148|4428946|P1|Overall Study|Investigator Decision|5
1344564|NCT01864148|4428942|P5|Overall Study|Death|0
1344565|NCT01864148|4428943|P4|Overall Study|Death|1
1344566|NCT01864148|4428944|P3|Overall Study|Death|0
1344567|NCT01864148|4428945|P2|Overall Study|Death|0
1344568|NCT01864148|4428946|P1|Overall Study|Death|0
1344569|NCT01864148|4428942|P5|Overall Study|Not Specified|1
1344570|NCT01864148|4428943|P4|Overall Study|Not Specified|3
1344571|NCT01864148|4428944|P3|Overall Study|Not Specified|1
1344572|NCT01864148|4428945|P2|Overall Study|Not Specified|1
1344573|NCT01864148|4428946|P1|Overall Study|Not Specified|2
1344574|NCT01864005|4428975|P2|Overall Study|Need GP IIb/IIIa|3
1344575|NCT01864005|4428976|P1|Overall Study|Need GP IIb/IIIa|1
1344576|NCT01864005|4428975|P2|Overall Study|Disease need|1
1344577|NCT01864005|4428976|P1|Overall Study|Disease need|1
1344578|NCT01864005|4428975|P2|Overall Study|Incorrect enrolment|0
1344579|NCT01864005|4428976|P1|Overall Study|Incorrect enrolment|1
1344580|NCT01864005|4428975|P2|Overall Study|Withdrawal by Subject|1
1344581|NCT01864005|4428976|P1|Overall Study|Withdrawal by Subject|0
1344582|NCT01864005|4428975|P2|Overall Study|Protocol Violation|1
1344583|NCT01864005|4428976|P1|Overall Study|Protocol Violation|0
1344584|NCT01863953|4428993|P3|Overall Study|Adverse Event|1
1344585|NCT01863953|4428994|P2|Overall Study|Adverse Event|0
1344586|NCT01863953|4428995|P1|Overall Study|Adverse Event|0
1344587|NCT01863771|4429009|P4|Maintenance Phase|Withdrawal by Subject|3
1344588|NCT01863771|4429010|P3|Maintenance Phase|Withdrawal by Subject|2
1344589|NCT01863771|4429011|P2|Maintenance Phase|Withdrawal by Subject|1
1344590|NCT01863771|4429012|P1|Maintenance Phase|Withdrawal by Subject|0
1344591|NCT01863771|4429009|P4|Maintenance Phase|Pregnancy|0
1344592|NCT01863771|4429010|P3|Maintenance Phase|Pregnancy|0
1344593|NCT01863771|4429011|P2|Maintenance Phase|Pregnancy|1
1344594|NCT01863771|4429012|P1|Maintenance Phase|Pregnancy|0
1344595|NCT01863771|4429009|P4|Maintenance Phase|Physician Decision|1
1344596|NCT01863771|4429010|P3|Maintenance Phase|Physician Decision|2
1344597|NCT01863771|4429011|P2|Maintenance Phase|Physician Decision|0
1344598|NCT01863771|4429012|P1|Maintenance Phase|Physician Decision|0
1344599|NCT01863771|4429009|P4|Maintenance Phase|Lack of Efficacy|38
1344600|NCT01863771|4429010|P3|Maintenance Phase|Lack of Efficacy|7
1344601|NCT01863771|4429011|P2|Maintenance Phase|Lack of Efficacy|3
1344602|NCT01863771|4429012|P1|Maintenance Phase|Lack of Efficacy|0
1344603|NCT01863771|4429009|P4|Maintenance Phase|Adverse Event|1
1344604|NCT01863771|4429010|P3|Maintenance Phase|Adverse Event|1
1344605|NCT01863771|4429011|P2|Maintenance Phase|Adverse Event|0
1344606|NCT01863771|4429012|P1|Maintenance Phase|Adverse Event|0
1344607|NCT01863771|4429009|P4|Induction Phase|Withdrawal by Subject|0
1344608|NCT01863771|4429010|P3|Induction Phase|Withdrawal by Subject|0
1344609|NCT01863771|4429011|P2|Induction Phase|Withdrawal by Subject|0
1344610|NCT01863771|4429012|P1|Induction Phase|Withdrawal by Subject|2
1344611|NCT01863771|4429009|P4|Induction Phase|Lack of Efficacy|0
1344612|NCT01863771|4429010|P3|Induction Phase|Lack of Efficacy|0
1344613|NCT01863771|4429011|P2|Induction Phase|Lack of Efficacy|0
1344614|NCT01863771|4429012|P1|Induction Phase|Lack of Efficacy|10
1344615|NCT01863771|4429009|P4|Induction Phase|Adverse Event|0
1344616|NCT01863771|4429010|P3|Induction Phase|Adverse Event|0
1344617|NCT01863771|4429011|P2|Induction Phase|Adverse Event|0
1344618|NCT01863771|4429012|P1|Induction Phase|Adverse Event|9
1344619|NCT01863758|4429024|P1|Prophylactic Treatment-Phase II|Lost to Follow-up|1
1344620|NCT01863758|4429024|P1|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
1344621|NCT01863680|4429032|P1|Overall Study|Other|6
1344622|NCT01863680|4429032|P1|Overall Study|Did not undergo IVF/ET|14
1344623|NCT01863680|4429032|P1|Overall Study|Withdrawal by Subject|1
1344624|NCT01863680|4429032|P1|Overall Study|Spontaneous pregnancy|2
1344625|NCT01863680|4429032|P1|Overall Study|Risk of OHSS|17
1344626|NCT01863680|4429032|P1|Overall Study|Adverse Event|17
1344627|NCT01863667|4429040|P2|Overall Study|Withdrawal by Subject|2
1344628|NCT01863667|4429041|P1|Overall Study|Withdrawal by Subject|2
1344629|NCT01863667|4429040|P2|Overall Study|Study terminated by Sponsor|30
1344630|NCT01863667|4429041|P1|Overall Study|Study terminated by Sponsor|30
1344631|NCT01863667|4429040|P2|Overall Study|Adverse Event|0
1344632|NCT01863667|4429041|P1|Overall Study|Adverse Event|1
1344633|NCT01863433|4429065|P1|Overall Study|Protocol Violation|1
1344634|NCT01863368|4429075|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
1344635|NCT01863368|4429076|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
1344636|NCT01863368|4429075|P2|Phase II, Day 35 to Day 90|Adverse Event|0
1344637|NCT01863368|4429076|P1|Phase II, Day 35 to Day 90|Adverse Event|1
1344638|NCT01863368|4429075|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
1344639|NCT01863368|4429076|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
1344640|NCT01863368|4429075|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
1344641|NCT01863368|4429076|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
1344642|NCT01863368|4429075|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
1344643|NCT01863368|4429076|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
1344644|NCT01863368|4429075|P2|Phase I, Day 0 to Day 35|Adverse Event|4
1344645|NCT01863368|4429076|P1|Phase I, Day 0 to Day 35|Adverse Event|2
1344646|NCT01862991|4429101|P3|Overall Study|Protocol Violation|0
1344647|NCT01862991|4429102|P2|Overall Study|Protocol Violation|0
1344648|NCT01862991|4429103|P1|Overall Study|Protocol Violation|1
1344649|NCT01862991|4429101|P3|Overall Study|Lost to Follow-up|1
1344650|NCT01862991|4429102|P2|Overall Study|Lost to Follow-up|1
1344651|NCT01862991|4429103|P1|Overall Study|Lost to Follow-up|2
1344652|NCT01862874|4429116|P2|Overall Study|Death|1
1344653|NCT01862874|4429117|P1|Overall Study|Death|0
1344654|NCT01862874|4429116|P2|Overall Study|Withdrawal by Subject|40
1344655|NCT01862874|4429117|P1|Overall Study|Withdrawal by Subject|46
1344656|NCT01862874|4429116|P2|Overall Study|Withdrawn by parent/guardian|1
1344657|NCT01862874|4429117|P1|Overall Study|Withdrawn by parent/guardian|1
1344658|NCT01862874|4429116|P2|Overall Study|Physician Decision|3
1344659|NCT01862874|4429117|P1|Overall Study|Physician Decision|5
1344660|NCT01862874|4429116|P2|Overall Study|Lost to Follow-up|29
1344661|NCT01862874|4429117|P1|Overall Study|Lost to Follow-up|26
1344662|NCT01862874|4429116|P2|Overall Study|Adverse Event|3
1344663|NCT01862874|4429117|P1|Overall Study|Adverse Event|0
1344664|NCT01862874|4429116|P2|Overall Study|Randomized not treated|0
1344665|NCT01862874|4429117|P1|Overall Study|Randomized not treated|1
1344666|NCT01862484|4429135|P2|Overall Study|Withdrawal by Subject|3
1344667|NCT01862484|4429136|P1|Overall Study|Withdrawal by Subject|0
1344668|NCT01862484|4429135|P2|Overall Study|Protocol Violation|2
1344669|NCT01862484|4429136|P1|Overall Study|Protocol Violation|0
1344670|NCT01862484|4429135|P2|Overall Study|Lost to Follow-up|2
1344671|NCT01862484|4429136|P1|Overall Study|Lost to Follow-up|1
1344672|NCT01862484|4429135|P2|Overall Study|Lack of Efficacy|1
1344673|NCT01862484|4429136|P1|Overall Study|Lack of Efficacy|1
1344674|NCT01862250|4429155|P1|Overall Study|Adverse Event|4
1344675|NCT01861522|4429274|P2|Overall Study|Withdrawal by Subject|0
1344676|NCT01861522|4429275|P1|Overall Study|Withdrawal by Subject|2
1344677|NCT01861522|4429274|P2|Overall Study|Adverse Event|0
1344678|NCT01861522|4429275|P1|Overall Study|Adverse Event|1
1344679|NCT01860989|4429299|P1|Overall Study|Unsatisfactory therapeutic|5
1344680|NCT01860976|4429305|P2|Long Term Extension|Ongoing treatment at time of analysis|100
1344681|NCT01860976|4429306|P1|Long Term Extension|Ongoing treatment at time of analysis|106
1344682|NCT01860976|4429305|P2|Long Term Extension|Withdrawal by Subject|0
1344683|NCT01860976|4429306|P1|Long Term Extension|Withdrawal by Subject|1
1344684|NCT01860976|4429305|P2|Long Term Extension|Subject request to discontinue treatment|0
1344685|NCT01860976|4429306|P1|Long Term Extension|Subject request to discontinue treatment|2
1344686|NCT01860976|4429305|P2|Long Term Extension|Lack of Efficacy|7
1344687|NCT01860976|4429306|P1|Long Term Extension|Lack of Efficacy|3
1344688|NCT01860976|4429305|P2|Long Term Extension|Adverse Event|0
1344689|NCT01860976|4429306|P1|Long Term Extension|Adverse Event|1
1344690|NCT01860976|4429305|P2|Open-Label|Ongoing OL treatment at time of analysis|45
1344691|NCT01860976|4429306|P1|Open-Label|Ongoing OL treatment at time of analysis|46
1344692|NCT01860976|4429305|P2|Open-Label|Other Reasons|1
1344693|NCT01860976|4429306|P1|Open-Label|Other Reasons|1
1344694|NCT01860976|4429305|P2|Open-Label|Withdrawal by Subject|1
1344695|NCT01860976|4429306|P1|Open-Label|Withdrawal by Subject|4
1344696|NCT01860976|4429305|P2|Open-Label|Subject request discontinue treatment|3
1344697|NCT01860976|4429306|P1|Open-Label|Subject request discontinue treatment|4
1344698|NCT01860976|4429305|P2|Open-Label|Lost to Follow-up|2
1344699|NCT01860976|4429306|P1|Open-Label|Lost to Follow-up|1
1344700|NCT01860976|4429305|P2|Open-Label|Lack of Efficacy|8
1344701|NCT01860976|4429306|P1|Open-Label|Lack of Efficacy|16
1344702|NCT01860976|4429305|P2|Open-Label|Adverse Event|4
1344703|NCT01860976|4429306|P1|Open-Label|Adverse Event|2
1344704|NCT01860976|4429305|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
1344705|NCT01860976|4429306|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
1344706|NCT01860976|4429305|P2|Blinded Treatment|Entered Open-Label in error|1
1344707|NCT01860976|4429306|P1|Blinded Treatment|Entered Open-Label in error|0
1344708|NCT01860976|4429305|P2|Blinded Treatment|Subject no longer met criteria|0
1344709|NCT01860976|4429306|P1|Blinded Treatment|Subject no longer met criteria|1
1344710|NCT01860976|4429305|P2|Blinded Treatment|Withdrawal by Subject|5
1344711|NCT01860976|4429306|P1|Blinded Treatment|Withdrawal by Subject|3
1344712|NCT01860976|4429305|P2|Blinded Treatment|Subject request to discontinue treatment|3
1344713|NCT01860976|4429306|P1|Blinded Treatment|Subject request to discontinue treatment|2
1344714|NCT01860976|4429305|P2|Blinded Treatment|Lack of Efficacy|12
1344715|NCT01860976|4429306|P1|Blinded Treatment|Lack of Efficacy|5
1344716|NCT01860976|4429305|P2|Blinded Treatment|Adverse Event|3
1344717|NCT01860976|4429306|P1|Blinded Treatment|Adverse Event|1
1344718|NCT01860846|4429328|P1|Overall Study|Lost to Follow-up|33
1344719|NCT01860703|4429339|P4|Overall Study|Personal reason|0
1344720|NCT01860703|4429340|P3|Overall Study|Personal reason|1
1344721|NCT01860703|4429341|P2|Overall Study|Personal reason|0
1344722|NCT01860703|4429342|P1|Overall Study|Personal reason|1
1344723|NCT01860703|4429339|P4|Overall Study|Withdrawal by Subject|0
1344724|NCT01860703|4429340|P3|Overall Study|Withdrawal by Subject|0
1344725|NCT01860703|4429341|P2|Overall Study|Withdrawal by Subject|1
1344726|NCT01860703|4429342|P1|Overall Study|Withdrawal by Subject|0
1344727|NCT01860703|4429339|P4|Overall Study|Adverse Event|2
1344728|NCT01860703|4429340|P3|Overall Study|Adverse Event|0
1344729|NCT01860703|4429341|P2|Overall Study|Adverse Event|4
1344730|NCT01860703|4429342|P1|Overall Study|Adverse Event|1
1344731|NCT01860677|4429374|P2|Second Intervention (1 Day)|Lost to Follow-up|0
1344732|NCT01860677|4429375|P1|Second Intervention (1 Day)|Lost to Follow-up|7
1344733|NCT01860534|4429413|P2|ROP #2|discharged prior to ROP #2|0
1344734|NCT01860534|4429414|P1|ROP #2|discharged prior to ROP #2|1
1344735|NCT01860534|4429413|P2|ROP #1|Needed treatment for ROP|1
1344736|NCT01860534|4429414|P1|ROP #1|Needed treatment for ROP|0
1344737|NCT01860079|4429462|P2|Overall Study|Physician Decision|22
1344738|NCT01860079|4429463|P1|Overall Study|Physician Decision|14
1344739|NCT01860040|4429471|P2|Overall Study|Withdrawal by Subject|0
1344740|NCT01860040|4429472|P1|Overall Study|Withdrawal by Subject|1
1344741|NCT01859988|4429483|P6|Overall Study|Other than specified above|3
1344742|NCT01859988|4429484|P5|Overall Study|Other than specified above|5
1344743|NCT01859988|4429485|P4|Overall Study|Other than specified above|3
1344744|NCT01859988|4429486|P3|Overall Study|Other than specified above|11
1344745|NCT01859988|4429487|P2|Overall Study|Other than specified above|2
1344746|NCT01859988|4429488|P1|Overall Study|Other than specified above|0
1344747|NCT01859988|4429483|P6|Overall Study|Protocol Violation|0
1344748|NCT01859988|4429484|P5|Overall Study|Protocol Violation|0
1344749|NCT01859988|4429485|P4|Overall Study|Protocol Violation|0
1344750|NCT01859988|4429486|P3|Overall Study|Protocol Violation|1
1344751|NCT01859988|4429487|P2|Overall Study|Protocol Violation|0
1344752|NCT01859988|4429488|P1|Overall Study|Protocol Violation|0
1344753|NCT01859988|4429483|P6|Overall Study|Lost to Follow-up|2
1344754|NCT01859988|4429484|P5|Overall Study|Lost to Follow-up|3
1344755|NCT01859988|4429485|P4|Overall Study|Lost to Follow-up|0
1344756|NCT01859988|4429486|P3|Overall Study|Lost to Follow-up|3
1344757|NCT01859988|4429487|P2|Overall Study|Lost to Follow-up|2
1344758|NCT01859988|4429488|P1|Overall Study|Lost to Follow-up|1
1344759|NCT01859988|4429483|P6|Overall Study|Adverse Event|2
1344760|NCT01859988|4429484|P5|Overall Study|Adverse Event|2
1344761|NCT01859988|4429485|P4|Overall Study|Adverse Event|1
1344762|NCT01859988|4429486|P3|Overall Study|Adverse Event|3
1344763|NCT01859988|4429487|P2|Overall Study|Adverse Event|1
1344764|NCT01859988|4429488|P1|Overall Study|Adverse Event|2
1344765|NCT01859988|4429483|P6|Overall Study|Physician Decision|1
1344766|NCT01859988|4429484|P5|Overall Study|Physician Decision|4
1344767|NCT01859988|4429485|P4|Overall Study|Physician Decision|3
1344768|NCT01859988|4429486|P3|Overall Study|Physician Decision|1
1344769|NCT01859988|4429487|P2|Overall Study|Physician Decision|3
1344770|NCT01859988|4429488|P1|Overall Study|Physician Decision|1
1344771|NCT01859988|4429483|P6|Overall Study|Lack of Efficacy|9
1344772|NCT01859988|4429484|P5|Overall Study|Lack of Efficacy|7
1344773|NCT01859988|4429485|P4|Overall Study|Lack of Efficacy|0
1344774|NCT01859988|4429486|P3|Overall Study|Lack of Efficacy|5
1344775|NCT01859988|4429487|P2|Overall Study|Lack of Efficacy|1
1344776|NCT01859988|4429488|P1|Overall Study|Lack of Efficacy|1
1344777|NCT01859988|4429483|P6|Overall Study|Withdrawal by Subject|2
1344778|NCT01859988|4429484|P5|Overall Study|Withdrawal by Subject|2
1344779|NCT01859988|4429485|P4|Overall Study|Withdrawal by Subject|3
1344780|NCT01859988|4429486|P3|Overall Study|Withdrawal by Subject|4
1344781|NCT01859988|4429487|P2|Overall Study|Withdrawal by Subject|3
1344782|NCT01859988|4429488|P1|Overall Study|Withdrawal by Subject|6
1344783|NCT01859949|4429582|P2|Overall Study|Adverse Event|1
1344784|NCT01859949|4429583|P1|Overall Study|Adverse Event|0
1344785|NCT01859949|4429582|P2|Overall Study|Protocol Violation|1
1344786|NCT01859949|4429583|P1|Overall Study|Protocol Violation|1
1344787|NCT01859949|4429582|P2|Overall Study|Withdrawal by Subject|10
1344788|NCT01859949|4429583|P1|Overall Study|Withdrawal by Subject|11
1344789|NCT01859949|4429582|P2|Overall Study|Physician Decision|4
1344790|NCT01859949|4429583|P1|Overall Study|Physician Decision|2
1344791|NCT01859949|4429582|P2|Overall Study|Family Matters|1
1344792|NCT01859949|4429583|P1|Overall Study|Family Matters|0
1344793|NCT01859793|4429601|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
1344794|NCT01859793|4429602|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
1344795|NCT01859793|4429601|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
1344796|NCT01859793|4429602|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
1344797|NCT01859793|4429601|P2|First Intervention (8 Weeks)|Adverse Event|0
1344798|NCT01859793|4429602|P1|First Intervention (8 Weeks)|Adverse Event|1
1344799|NCT01859793|4429601|P2|First Intervention (8 Weeks)|Protocol Violation|0
1344800|NCT01859793|4429602|P1|First Intervention (8 Weeks)|Protocol Violation|2
1344801|NCT01859715|4429615|P3|Overall Study|No 2nd VAS|23
1344802|NCT01859715|4429616|P2|Overall Study|No 2nd VAS|8
1344803|NCT01859715|4429617|P1|Overall Study|No 2nd VAS|16
1344804|NCT01859702|4429628|P1|Overall Study|Adverse Event|2
1344805|NCT01859702|4429628|P1|Overall Study|Protocol deviation|3
1344806|NCT01859598|4429642|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
1344807|NCT01859507|4429650|P1|Overall Study|left the country|4
1344808|NCT01859494|4429655|P1|Overall Study|Adverse Event|1
1344809|NCT01859390|4429666|P2|Overall Study|Shipment Error|1
1344810|NCT01859390|4429667|P1|Overall Study|Shipment Error|0
1344811|NCT01859390|4429666|P2|Overall Study|Tube Cracked|2
1344812|NCT01859390|4429667|P1|Overall Study|Tube Cracked|0
1344813|NCT01859390|4429666|P2|Overall Study|Sample Missing Collection Date|1
1344814|NCT01859390|4429667|P1|Overall Study|Sample Missing Collection Date|0
1344815|NCT01859390|4429666|P2|Overall Study|Insufficient Sputum Collected|3
1344816|NCT01859390|4429667|P1|Overall Study|Insufficient Sputum Collected|1
1344817|NCT01859143|4429801|P2|Overall Study|Lost to Follow-up|0
1344818|NCT01859143|4429802|P1|Overall Study|Lost to Follow-up|2
1344819|NCT01858766|4429858|P19|Overall Study|Withdrew Consent|0
1344820|NCT01858766|4429859|P18|Overall Study|Withdrew Consent|0
1344821|NCT01858766|4429860|P17|Overall Study|Withdrew Consent|0
1344822|NCT01858766|4429861|P16|Overall Study|Withdrew Consent|0
1344823|NCT01858766|4429862|P15|Overall Study|Withdrew Consent|0
1344824|NCT01858766|4429863|P14|Overall Study|Withdrew Consent|0
1344825|NCT01858766|4429864|P13|Overall Study|Withdrew Consent|0
1344826|NCT01858766|4429865|P12|Overall Study|Withdrew Consent|1
1344827|NCT01858766|4429866|P11|Overall Study|Withdrew Consent|0
1344828|NCT01858766|4429867|P10|Overall Study|Withdrew Consent|0
1344829|NCT01858766|4429868|P9|Overall Study|Withdrew Consent|0
1344830|NCT01858766|4429869|P8|Overall Study|Withdrew Consent|0
1344831|NCT01858766|4429870|P7|Overall Study|Withdrew Consent|0
1344832|NCT01858766|4429871|P6|Overall Study|Withdrew Consent|0
1344833|NCT01858766|4429872|P5|Overall Study|Withdrew Consent|0
1344834|NCT01858766|4429873|P4|Overall Study|Withdrew Consent|0
1344835|NCT01858766|4429874|P3|Overall Study|Withdrew Consent|0
1344836|NCT01858766|4429875|P2|Overall Study|Withdrew Consent|0
1344837|NCT01858766|4429876|P1|Overall Study|Withdrew Consent|0
1344838|NCT01858766|4429858|P19|Overall Study|Lost to Follow-up|1
1344839|NCT01858766|4429859|P18|Overall Study|Lost to Follow-up|0
1344840|NCT01858766|4429860|P17|Overall Study|Lost to Follow-up|1
1344841|NCT01858766|4429861|P16|Overall Study|Lost to Follow-up|1
1344842|NCT01858766|4429862|P15|Overall Study|Lost to Follow-up|3
1344843|NCT01858766|4429863|P14|Overall Study|Lost to Follow-up|0
1344844|NCT01858766|4429864|P13|Overall Study|Lost to Follow-up|0
1344845|NCT01858766|4429865|P12|Overall Study|Lost to Follow-up|1
1344846|NCT01858766|4429866|P11|Overall Study|Lost to Follow-up|0
1344847|NCT01858766|4429867|P10|Overall Study|Lost to Follow-up|0
1344848|NCT01858766|4429868|P9|Overall Study|Lost to Follow-up|0
1344849|NCT01858766|4429869|P8|Overall Study|Lost to Follow-up|2
1344850|NCT01858766|4429870|P7|Overall Study|Lost to Follow-up|0
1344851|NCT01858766|4429871|P6|Overall Study|Lost to Follow-up|1
1344852|NCT01858766|4429872|P5|Overall Study|Lost to Follow-up|0
1344853|NCT01858766|4429873|P4|Overall Study|Lost to Follow-up|0
1344854|NCT01858766|4429874|P3|Overall Study|Lost to Follow-up|0
1344855|NCT01858766|4429875|P2|Overall Study|Lost to Follow-up|0
1344856|NCT01858766|4429876|P1|Overall Study|Lost to Follow-up|0
1344857|NCT01858766|4429858|P19|Overall Study|Lack of Efficacy|3
1344858|NCT01858766|4429859|P18|Overall Study|Lack of Efficacy|3
1344859|NCT01858766|4429860|P17|Overall Study|Lack of Efficacy|2
1344860|NCT01858766|4429861|P16|Overall Study|Lack of Efficacy|5
1344861|NCT01858766|4429862|P15|Overall Study|Lack of Efficacy|5
1344862|NCT01858766|4429863|P14|Overall Study|Lack of Efficacy|3
1344863|NCT01858766|4429864|P13|Overall Study|Lack of Efficacy|5
1344864|NCT01858766|4429865|P12|Overall Study|Lack of Efficacy|3
1344865|NCT01858766|4429866|P11|Overall Study|Lack of Efficacy|0
1344866|NCT01858766|4429867|P10|Overall Study|Lack of Efficacy|0
1344867|NCT01858766|4429868|P9|Overall Study|Lack of Efficacy|0
1344868|NCT01858766|4429869|P8|Overall Study|Lack of Efficacy|0
1344869|NCT01858766|4429870|P7|Overall Study|Lack of Efficacy|0
1344870|NCT01858766|4429871|P6|Overall Study|Lack of Efficacy|2
1344871|NCT01858766|4429872|P5|Overall Study|Lack of Efficacy|1
1344872|NCT01858766|4429873|P4|Overall Study|Lack of Efficacy|0
1344873|NCT01858766|4429874|P3|Overall Study|Lack of Efficacy|0
1344874|NCT01858766|4429875|P2|Overall Study|Lack of Efficacy|0
1344875|NCT01858766|4429876|P1|Overall Study|Lack of Efficacy|1
1344876|NCT01858766|4429858|P19|Overall Study|Death|0
1344877|NCT01858766|4429859|P18|Overall Study|Death|0
1344878|NCT01858766|4429860|P17|Overall Study|Death|0
1344879|NCT01858766|4429861|P16|Overall Study|Death|0
1344880|NCT01858766|4429862|P15|Overall Study|Death|0
1344881|NCT01858766|4429863|P14|Overall Study|Death|0
1344882|NCT01858766|4429864|P13|Overall Study|Death|0
1344883|NCT01858766|4429865|P12|Overall Study|Death|0
1344884|NCT01858766|4429866|P11|Overall Study|Death|0
1344885|NCT01858766|4429867|P10|Overall Study|Death|0
1344886|NCT01858766|4429868|P9|Overall Study|Death|0
1344887|NCT01858766|4429869|P8|Overall Study|Death|0
1344888|NCT01858766|4429870|P7|Overall Study|Death|0
1344889|NCT01858766|4429871|P6|Overall Study|Death|0
1344890|NCT01858766|4429872|P5|Overall Study|Death|0
1344891|NCT01858766|4429873|P4|Overall Study|Death|0
1344892|NCT01858766|4429874|P3|Overall Study|Death|1
1344893|NCT01858766|4429875|P2|Overall Study|Death|0
1344894|NCT01858766|4429876|P1|Overall Study|Death|0
1344895|NCT01858766|4429858|P19|Overall Study|Randomized but Never Treated|0
1344896|NCT01858766|4429859|P18|Overall Study|Randomized but Never Treated|1
1344897|NCT01858766|4429860|P17|Overall Study|Randomized but Never Treated|0
1344898|NCT01858766|4429861|P16|Overall Study|Randomized but Never Treated|0
1344899|NCT01858766|4429862|P15|Overall Study|Randomized but Never Treated|0
1344900|NCT01858766|4429863|P14|Overall Study|Randomized but Never Treated|0
1344901|NCT01858766|4429864|P13|Overall Study|Randomized but Never Treated|0
1344902|NCT01858766|4429865|P12|Overall Study|Randomized but Never Treated|0
1344903|NCT01858766|4429866|P11|Overall Study|Randomized but Never Treated|0
1344904|NCT01858766|4429867|P10|Overall Study|Randomized but Never Treated|0
1344905|NCT01858766|4429868|P9|Overall Study|Randomized but Never Treated|0
1344906|NCT01858766|4429869|P8|Overall Study|Randomized but Never Treated|0
1344907|NCT01858766|4429870|P7|Overall Study|Randomized but Never Treated|0
1344908|NCT01858766|4429871|P6|Overall Study|Randomized but Never Treated|1
1344909|NCT01858766|4429872|P5|Overall Study|Randomized but Never Treated|0
1344910|NCT01858766|4429873|P4|Overall Study|Randomized but Never Treated|0
1344911|NCT01858766|4429874|P3|Overall Study|Randomized but Never Treated|0
1344912|NCT01858766|4429875|P2|Overall Study|Randomized but Never Treated|0
1344913|NCT01858766|4429876|P1|Overall Study|Randomized but Never Treated|0
1344914|NCT01858701|4429947|P2|Period 2, Second 30 Days of Wear|Comfort|1
1344915|NCT01858701|4429948|P1|Period 2, Second 30 Days of Wear|Comfort|0
1344916|NCT01858701|4429947|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
1344917|NCT01858701|4429948|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
1344918|NCT01858701|4429947|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
1344919|NCT01858701|4429948|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
1344920|NCT01858701|4429947|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
1344921|NCT01858701|4429948|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
1344922|NCT01858636|4429954|P1|Overall Study|Withdrawal by Subject|1
1344923|NCT01858636|4429954|P1|Overall Study|Lost to Follow-up|1
1344924|NCT01858636|4429954|P1|Overall Study|Death|1
1344925|NCT01858636|4429954|P1|Overall Study|Physician Decision|1
1344926|NCT01858636|4429954|P1|Overall Study|No Device Deployment Attempted|24
1344927|NCT01858389|4430007|P2|Overall Study|Did not receive treatment|3
1344928|NCT01858389|4430008|P1|Overall Study|Did not receive treatment|0
1344929|NCT01858389|4430007|P2|Overall Study|Adverse Event|1
1344930|NCT01858389|4430008|P1|Overall Study|Adverse Event|3
1344931|NCT01858389|4430007|P2|Overall Study|Not specified|4
1344932|NCT01858389|4430008|P1|Overall Study|Not specified|2
1344933|NCT01858389|4430007|P2|Overall Study|Progressive disease|11
1344934|NCT01858389|4430008|P1|Overall Study|Progressive disease|10
1344935|NCT01858389|4430007|P2|Overall Study|Withdrawal by Subject|1
1344936|NCT01858389|4430008|P1|Overall Study|Withdrawal by Subject|0
1344937|NCT01858389|4430007|P2|Overall Study|Study terminated by sponsor|2
1344938|NCT01858389|4430008|P1|Overall Study|Study terminated by sponsor|0
1344939|NCT01858389|4430007|P2|Overall Study|Death|3
1344940|NCT01858389|4430008|P1|Overall Study|Death|1
1344941|NCT01858376|4430023|P1|Overall Study|Dropped d/t lab work not fitting criter|4
1344942|NCT01857622|4430062|P3|Overall Study|Withdrawal by Subject|0
1344943|NCT01857622|4430063|P2|Overall Study|Withdrawal by Subject|0
1344944|NCT01857622|4430064|P1|Overall Study|Withdrawal by Subject|1
1344945|NCT01857622|4430062|P3|Overall Study|Protocol Violation|0
1344946|NCT01857622|4430063|P2|Overall Study|Protocol Violation|1
1344947|NCT01857622|4430064|P1|Overall Study|Protocol Violation|4
1344948|NCT01857622|4430062|P3|Overall Study|Physician Decision|0
1344949|NCT01857622|4430063|P2|Overall Study|Physician Decision|0
1344950|NCT01857622|4430064|P1|Overall Study|Physician Decision|1
1344951|NCT01857622|4430062|P3|Overall Study|Adverse Event|2
1344952|NCT01857622|4430063|P2|Overall Study|Adverse Event|0
1344953|NCT01857622|4430064|P1|Overall Study|Adverse Event|5
1344954|NCT01857583|4430076|P4|Overall Study|Withdrawal by Subject|2
1344955|NCT01857583|4430077|P3|Overall Study|Withdrawal by Subject|1
1344956|NCT01857583|4430078|P2|Overall Study|Withdrawal by Subject|0
1344957|NCT01857583|4430079|P1|Overall Study|Withdrawal by Subject|1
1344958|NCT01857583|4430076|P4|Overall Study|Physician Decision|1
1344959|NCT01857583|4430077|P3|Overall Study|Physician Decision|0
1344960|NCT01857583|4430078|P2|Overall Study|Physician Decision|0
1344961|NCT01857583|4430079|P1|Overall Study|Physician Decision|0
1344962|NCT01857583|4430076|P4|Overall Study|Death|0
1344963|NCT01857583|4430077|P3|Overall Study|Death|1
1344964|NCT01857583|4430078|P2|Overall Study|Death|1
1344965|NCT01857583|4430079|P1|Overall Study|Death|0
1344966|NCT01857583|4430076|P4|Overall Study|Adverse Event|1
1344967|NCT01857583|4430077|P3|Overall Study|Adverse Event|1
1344968|NCT01857583|4430078|P2|Overall Study|Adverse Event|0
1344969|NCT01857583|4430079|P1|Overall Study|Adverse Event|0
1344970|NCT01857531|4430089|P1|Overall Study|Withdrawal by Subject|4
1344971|NCT01857323|4430107|P1|Overall Study|Did not complete 180 doses|48
1344972|NCT01857323|4430107|P1|Overall Study|Not specified|4
1344973|NCT01857323|4430107|P1|Overall Study|Lost to Follow-up|1
1344974|NCT01857323|4430107|P1|Overall Study|Protocol Violation|6
1344975|NCT01857323|4430107|P1|Overall Study|Non-compliance|1
1344976|NCT01857323|4430107|P1|Overall Study|Withdrawal by Subject|3
1344977|NCT01857323|4430107|P1|Overall Study|Adverse Event|1
1344978|NCT01857206|4430156|P2|Overall Study|Withdrawal by Subject|0
1344979|NCT01857206|4430157|P1|Overall Study|Withdrawal by Subject|1
1344980|NCT01857206|4430156|P2|Overall Study|Unclassified|3
1344981|NCT01857206|4430157|P1|Overall Study|Unclassified|3
1344982|NCT01857206|4430156|P2|Overall Study|Lost to Follow-up|6
1344983|NCT01857206|4430157|P1|Overall Study|Lost to Follow-up|9
1344984|NCT01857206|4430156|P2|Overall Study|ADMINISTRATIVE REASON|1
1344985|NCT01857206|4430157|P1|Overall Study|ADMINISTRATIVE REASON|0
1344986|NCT01857102|4430175|P2|Period 2|Unsatisfactory Lens Fit|0
1344987|NCT01857102|4430176|P1|Period 2|Unsatisfactory Lens Fit|1
1344988|NCT01857102|4430175|P2|Period 2|Lens Discomfort|0
1344989|NCT01857102|4430176|P1|Period 2|Lens Discomfort|1
1344990|NCT01857102|4430175|P2|Period 1|Physician Decision|0
1344991|NCT01857102|4430176|P1|Period 1|Physician Decision|1
1344992|NCT01857102|4430175|P2|Period 1|Unsatisfactory Visual Response|0
1344993|NCT01857102|4430176|P1|Period 1|Unsatisfactory Visual Response|1
1344994|NCT01857102|4430175|P2|Period 1|Unsatisfactory Lens Fit|0
1344995|NCT01857102|4430176|P1|Period 1|Unsatisfactory Lens Fit|1
1344996|NCT01857102|4430175|P2|Period 1|Lost to Follow-up|3
1344997|NCT01857102|4430176|P1|Period 1|Lost to Follow-up|0
1344998|NCT01857102|4430175|P2|Period 1|No longer meets Eligibility Criteria|2
1344999|NCT01857102|4430176|P1|Period 1|No longer meets Eligibility Criteria|0
1345000|NCT01857063|4430186|P2|Period 2 (7 Days)|Withdrawal by Subject|0
1345001|NCT01857063|4430187|P1|Period 2 (7 Days)|Withdrawal by Subject|1
1345002|NCT01857063|4430186|P2|Period 2 (7 Days)|Physician Decision|1
1345003|NCT01857063|4430187|P1|Period 2 (7 Days)|Physician Decision|1
1345004|NCT01857063|4430186|P2|Period 2 (7 Days)|Adverse Event|1
1345005|NCT01857063|4430187|P1|Period 2 (7 Days)|Adverse Event|2
1345006|NCT01857063|4430186|P2|Period 1 (7 Days)|Withdrawal by Subject|3
1345007|NCT01857063|4430187|P1|Period 1 (7 Days)|Withdrawal by Subject|1
1345008|NCT01857063|4430186|P2|Period 1 (7 Days)|Physician Decision|0
1345009|NCT01857063|4430187|P1|Period 1 (7 Days)|Physician Decision|1
1345010|NCT01857063|4430186|P2|Period 1 (7 Days)|Adverse Event|1
1345011|NCT01857063|4430187|P1|Period 1 (7 Days)|Adverse Event|0
1345012|NCT01856907|4430220|P3|Overall Study|Withdrawal by Subject|0
1345013|NCT01856907|4430221|P2|Overall Study|Withdrawal by Subject|1
1345014|NCT01856907|4430222|P1|Overall Study|Withdrawal by Subject|0
1345015|NCT01856907|4430220|P3|Overall Study|Pregnancy|0
1345016|NCT01856907|4430221|P2|Overall Study|Pregnancy|1
1345017|NCT01856907|4430222|P1|Overall Study|Pregnancy|0
1345018|NCT01856907|4430220|P3|Overall Study|Pregnancy|0
1345019|NCT01856907|4430221|P2|Overall Study|Pregnancy|1
1345020|NCT01856907|4430222|P1|Overall Study|Pregnancy|0
1345021|NCT01856686|4430275|P2|Overall Study|Lost to Follow-up|11
1345022|NCT01856686|4430276|P1|Overall Study|Lost to Follow-up|5
1345023|NCT01856673|4430319|P3|Overall Study|Protocol Violation|1
1345024|NCT01856673|4430320|P2|Overall Study|Protocol Violation|0
1345025|NCT01856673|4430321|P1|Overall Study|Protocol Violation|1
1345026|NCT01856673|4430319|P3|Overall Study|Death|0
1345027|NCT01856673|4430320|P2|Overall Study|Death|1
1345028|NCT01856673|4430321|P1|Overall Study|Death|2
1345029|NCT01856673|4430319|P3|Overall Study|Paperwork errors|0
1345030|NCT01856673|4430320|P2|Overall Study|Paperwork errors|0
1345031|NCT01856673|4430321|P1|Overall Study|Paperwork errors|4
1345032|NCT01856673|4430319|P3|Overall Study|Psychologist decision|0
1345033|NCT01856673|4430320|P2|Overall Study|Psychologist decision|0
1345034|NCT01856673|4430321|P1|Overall Study|Psychologist decision|3
1345035|NCT01856673|4430319|P3|Overall Study|Unknown reasons|0
1345036|NCT01856673|4430320|P2|Overall Study|Unknown reasons|0
1345037|NCT01856673|4430321|P1|Overall Study|Unknown reasons|20
1345038|NCT01856673|4430319|P3|Overall Study|Lost to Follow-up|0
1345039|NCT01856673|4430320|P2|Overall Study|Lost to Follow-up|34
1345040|NCT01856673|4430321|P1|Overall Study|Lost to Follow-up|22
1345041|NCT01856673|4430319|P3|Overall Study|Withdrawal by Subject|33
1345042|NCT01856673|4430320|P2|Overall Study|Withdrawal by Subject|50
1345043|NCT01856673|4430321|P1|Overall Study|Withdrawal by Subject|46
1345044|NCT01856569|4430332|P1|Overall Study|Did not met inclusion criteria|8
1345045|NCT01856569|4430332|P1|Overall Study|Lost to Follow-up|3
1345046|NCT01856569|4430332|P1|Overall Study|Changed Site/Structure|1
1345047|NCT01856569|4430332|P1|Overall Study|Other|1
1345048|NCT01856322|4430387|P3|Overall Study|off study due to lack of accrual|3
1345049|NCT01856322|4430388|P2|Overall Study|off study due to lack of accrual|0
1345050|NCT01856322|4430389|P1|Overall Study|off study due to lack of accrual|0
1345051|NCT01856257|4430422|P4|Overall Study|Donor complication|1
1345052|NCT01856257|4430423|P3|Overall Study|Donor complication|0
1345053|NCT01856257|4430424|P2|Overall Study|Donor complication|0
1345054|NCT01856257|4430425|P1|Overall Study|Donor complication|0
1345055|NCT01856257|4430422|P4|Overall Study|Withdrawal by Subject|0
1345056|NCT01856257|4430423|P3|Overall Study|Withdrawal by Subject|0
1345057|NCT01856257|4430424|P2|Overall Study|Withdrawal by Subject|1
1345058|NCT01856257|4430425|P1|Overall Study|Withdrawal by Subject|1
1345059|NCT01856257|4430422|P4|Overall Study|Physician Decision|1
1345060|NCT01856257|4430423|P3|Overall Study|Physician Decision|0
1345061|NCT01856257|4430424|P2|Overall Study|Physician Decision|0
1345062|NCT01856257|4430425|P1|Overall Study|Physician Decision|0
1345063|NCT01856257|4430422|P4|Overall Study|Death|0
1345064|NCT01856257|4430423|P3|Overall Study|Death|0
1345065|NCT01856257|4430424|P2|Overall Study|Death|0
1345066|NCT01856257|4430425|P1|Overall Study|Death|2
1345067|NCT01855958|4430593|P2|Overall Study|Withdrawal by Subject|0
1345068|NCT01855958|4430594|P1|Overall Study|Withdrawal by Subject|1
1345069|NCT01855945|4430624|P12|Overall Study|Withdrawal by Subject|1
1345070|NCT01855945|4430625|P11|Overall Study|Withdrawal by Subject|4
1345071|NCT01855945|4430626|P10|Overall Study|Withdrawal by Subject|2
1345072|NCT01855945|4430627|P9|Overall Study|Withdrawal by Subject|0
1345073|NCT01855945|4430628|P8|Overall Study|Withdrawal by Subject|0
1345074|NCT01855945|4430629|P7|Overall Study|Withdrawal by Subject|1
1345075|NCT01855945|4430630|P6|Overall Study|Withdrawal by Subject|0
1345076|NCT01855945|4430631|P5|Overall Study|Withdrawal by Subject|1
1345077|NCT01855945|4430632|P4|Overall Study|Withdrawal by Subject|1
1345078|NCT01855945|4430633|P3|Overall Study|Withdrawal by Subject|4
1345079|NCT01855945|4430634|P2|Overall Study|Withdrawal by Subject|0
1345080|NCT01855945|4430635|P1|Overall Study|Withdrawal by Subject|4
1345081|NCT01855945|4430624|P12|Overall Study|Other - Unclassified|0
1345082|NCT01855945|4430625|P11|Overall Study|Other - Unclassified|1
1345083|NCT01855945|4430626|P10|Overall Study|Other - Unclassified|0
1345084|NCT01855945|4430627|P9|Overall Study|Other - Unclassified|0
1345085|NCT01855945|4430628|P8|Overall Study|Other - Unclassified|1
1345086|NCT01855945|4430629|P7|Overall Study|Other - Unclassified|2
1345087|NCT01855945|4430630|P6|Overall Study|Other - Unclassified|0
1345088|NCT01855945|4430631|P5|Overall Study|Other - Unclassified|0
1345089|NCT01855945|4430632|P4|Overall Study|Other - Unclassified|0
1345090|NCT01855945|4430633|P3|Overall Study|Other - Unclassified|1
1345091|NCT01855945|4430634|P2|Overall Study|Other - Unclassified|1
1345092|NCT01855945|4430635|P1|Overall Study|Other - Unclassified|1
1345093|NCT01855945|4430624|P12|Overall Study|Lost to Follow-up|2
1345094|NCT01855945|4430625|P11|Overall Study|Lost to Follow-up|0
1345095|NCT01855945|4430626|P10|Overall Study|Lost to Follow-up|0
1345096|NCT01855945|4430627|P9|Overall Study|Lost to Follow-up|2
1345097|NCT01855945|4430628|P8|Overall Study|Lost to Follow-up|7
1345098|NCT01855945|4430629|P7|Overall Study|Lost to Follow-up|4
1345099|NCT01855945|4430630|P6|Overall Study|Lost to Follow-up|3
1345100|NCT01855945|4430631|P5|Overall Study|Lost to Follow-up|0
1345101|NCT01855945|4430632|P4|Overall Study|Lost to Follow-up|3
1345102|NCT01855945|4430633|P3|Overall Study|Lost to Follow-up|7
1345103|NCT01855945|4430634|P2|Overall Study|Lost to Follow-up|10
1345104|NCT01855945|4430635|P1|Overall Study|Lost to Follow-up|11
1345105|NCT01855945|4430624|P12|Overall Study|Death|0
1345106|NCT01855945|4430625|P11|Overall Study|Death|0
1345107|NCT01855945|4430626|P10|Overall Study|Death|0
1345108|NCT01855945|4430627|P9|Overall Study|Death|0
1345109|NCT01855945|4430628|P8|Overall Study|Death|0
1345110|NCT01855945|4430629|P7|Overall Study|Death|2
1345111|NCT01855945|4430630|P6|Overall Study|Death|0
1345112|NCT01855945|4430631|P5|Overall Study|Death|0
1345113|NCT01855945|4430632|P4|Overall Study|Death|0
1345114|NCT01855945|4430633|P3|Overall Study|Death|0
1345115|NCT01855945|4430634|P2|Overall Study|Death|0
1345116|NCT01855945|4430635|P1|Overall Study|Death|0
1345117|NCT01855945|4430624|P12|Overall Study|Adverse Event|0
1345118|NCT01855945|4430625|P11|Overall Study|Adverse Event|0
1345119|NCT01855945|4430626|P10|Overall Study|Adverse Event|0
1345120|NCT01855945|4430627|P9|Overall Study|Adverse Event|0
1345121|NCT01855945|4430628|P8|Overall Study|Adverse Event|0
1345122|NCT01855945|4430629|P7|Overall Study|Adverse Event|1
1345123|NCT01855945|4430630|P6|Overall Study|Adverse Event|0
1345124|NCT01855945|4430631|P5|Overall Study|Adverse Event|0
1345125|NCT01855945|4430632|P4|Overall Study|Adverse Event|0
1345126|NCT01855945|4430633|P3|Overall Study|Adverse Event|0
1345127|NCT01855945|4430634|P2|Overall Study|Adverse Event|0
1345128|NCT01855945|4430635|P1|Overall Study|Adverse Event|0
1345129|NCT01855919|4430771|P2|Overall Study|Protocol Violation|4
1345130|NCT01855919|4430772|P1|Overall Study|Protocol Violation|1
1345131|NCT01855919|4430771|P2|Overall Study|Entry Criteria Not Met|1
1345132|NCT01855919|4430772|P1|Overall Study|Entry Criteria Not Met|1
1345133|NCT01855919|4430771|P2|Overall Study|Withdrawal by Subject|10
1345134|NCT01855919|4430772|P1|Overall Study|Withdrawal by Subject|4
1345135|NCT01855919|4430771|P2|Overall Study|Lack of Efficacy|3
1345136|NCT01855919|4430772|P1|Overall Study|Lack of Efficacy|1
1345137|NCT01855919|4430771|P2|Overall Study|Adverse Event|8
1345138|NCT01855919|4430772|P1|Overall Study|Adverse Event|16
1345139|NCT01855789|4430804|P4|2) Week 24 up to End of Study|Other|1
1345140|NCT01855789|4430805|P3|2) Week 24 up to End of Study|Other|0
1345141|NCT01855789|4430806|P2|2) Week 24 up to End of Study|Other|0
1345142|NCT01855789|4430807|P1|2) Week 24 up to End of Study|Other|0
1345143|NCT01855789|4430804|P4|2) Week 24 up to End of Study|Sponsor Decision|1
1345144|NCT01855789|4430805|P3|2) Week 24 up to End of Study|Sponsor Decision|0
1345145|NCT01855789|4430806|P2|2) Week 24 up to End of Study|Sponsor Decision|0
1345146|NCT01855789|4430807|P1|2) Week 24 up to End of Study|Sponsor Decision|0
1345147|NCT01855789|4430804|P4|2) Week 24 up to End of Study|Participant Non-compliance|1
1345148|NCT01855789|4430805|P3|2) Week 24 up to End of Study|Participant Non-compliance|0
1345149|NCT01855789|4430806|P2|2) Week 24 up to End of Study|Participant Non-compliance|1
1345150|NCT01855789|4430807|P1|2) Week 24 up to End of Study|Participant Non-compliance|0
1345151|NCT01855789|4430804|P4|2) Week 24 up to End of Study|Physician Decision|4
1345152|NCT01855789|4430805|P3|2) Week 24 up to End of Study|Physician Decision|2
1345153|NCT01855789|4430806|P2|2) Week 24 up to End of Study|Physician Decision|0
1345154|NCT01855789|4430807|P1|2) Week 24 up to End of Study|Physician Decision|0
1345155|NCT01855789|4430804|P4|2) Week 24 up to End of Study|Withdrawal by Subject|8
1345156|NCT01855789|4430805|P3|2) Week 24 up to End of Study|Withdrawal by Subject|5
1345157|NCT01855789|4430806|P2|2) Week 24 up to End of Study|Withdrawal by Subject|7
1345158|NCT01855789|4430807|P1|2) Week 24 up to End of Study|Withdrawal by Subject|0
1345159|NCT01855789|4430804|P4|2) Week 24 up to End of Study|Protocol Violation|1
1345160|NCT01855789|4430805|P3|2) Week 24 up to End of Study|Protocol Violation|0
1345161|NCT01855789|4430806|P2|2) Week 24 up to End of Study|Protocol Violation|0
1345162|NCT01855789|4430807|P1|2) Week 24 up to End of Study|Protocol Violation|0
1345163|NCT01855789|4430804|P4|2) Week 24 up to End of Study|Lost to Follow-up|4
1345164|NCT01855789|4430805|P3|2) Week 24 up to End of Study|Lost to Follow-up|1
1345165|NCT01855789|4430806|P2|2) Week 24 up to End of Study|Lost to Follow-up|1
1345166|NCT01855789|4430807|P1|2) Week 24 up to End of Study|Lost to Follow-up|0
1345167|NCT01855789|4430804|P4|2) Week 24 up to End of Study|Lack of Efficacy|16
1345168|NCT01855789|4430805|P3|2) Week 24 up to End of Study|Lack of Efficacy|5
1345169|NCT01855789|4430806|P2|2) Week 24 up to End of Study|Lack of Efficacy|2
1345170|NCT01855789|4430807|P1|2) Week 24 up to End of Study|Lack of Efficacy|0
1345171|NCT01855789|4430804|P4|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
1345172|NCT01855789|4430805|P3|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
1345173|NCT01855789|4430806|P2|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
1345174|NCT01855789|4430807|P1|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
1345175|NCT01855789|4430804|P4|2) Week 24 up to End of Study|Adverse Event|21
1345176|NCT01855789|4430805|P3|2) Week 24 up to End of Study|Adverse Event|5
1345177|NCT01855789|4430806|P2|2) Week 24 up to End of Study|Adverse Event|4
1345178|NCT01855789|4430807|P1|2) Week 24 up to End of Study|Adverse Event|0
1345179|NCT01855789|4430804|P4|1) Baseline up to Week 24|Other|0
1345180|NCT01855789|4430805|P3|1) Baseline up to Week 24|Other|0
1345181|NCT01855789|4430806|P2|1) Baseline up to Week 24|Other|0
1345182|NCT01855789|4430807|P1|1) Baseline up to Week 24|Other|4
1345183|NCT01855789|4430804|P4|1) Baseline up to Week 24|Sponsor Decision|0
1345184|NCT01855789|4430805|P3|1) Baseline up to Week 24|Sponsor Decision|0
1345185|NCT01855789|4430806|P2|1) Baseline up to Week 24|Sponsor Decision|0
1345186|NCT01855789|4430807|P1|1) Baseline up to Week 24|Sponsor Decision|3
1345187|NCT01855789|4430804|P4|1) Baseline up to Week 24|Participant Non-compliance|0
1345188|NCT01855789|4430805|P3|1) Baseline up to Week 24|Participant Non-compliance|0
1345189|NCT01855789|4430806|P2|1) Baseline up to Week 24|Participant Non-compliance|0
1345190|NCT01855789|4430807|P1|1) Baseline up to Week 24|Participant Non-compliance|3
1345191|NCT01855789|4430804|P4|1) Baseline up to Week 24|Pregnancy|0
1345192|NCT01855789|4430805|P3|1) Baseline up to Week 24|Pregnancy|0
1345193|NCT01855789|4430806|P2|1) Baseline up to Week 24|Pregnancy|0
1345194|NCT01855789|4430807|P1|1) Baseline up to Week 24|Pregnancy|1
1345195|NCT01855789|4430804|P4|1) Baseline up to Week 24|Physician Decision|0
1345196|NCT01855789|4430805|P3|1) Baseline up to Week 24|Physician Decision|0
1345197|NCT01855789|4430806|P2|1) Baseline up to Week 24|Physician Decision|0
1345198|NCT01855789|4430807|P1|1) Baseline up to Week 24|Physician Decision|4
1345199|NCT01855789|4430804|P4|1) Baseline up to Week 24|Withdrawal by Subject|0
1345200|NCT01855789|4430805|P3|1) Baseline up to Week 24|Withdrawal by Subject|0
1345201|NCT01855789|4430806|P2|1) Baseline up to Week 24|Withdrawal by Subject|0
1345202|NCT01855789|4430807|P1|1) Baseline up to Week 24|Withdrawal by Subject|31
1345203|NCT01855789|4430804|P4|1) Baseline up to Week 24|Protocol Violation|0
1345204|NCT01855789|4430805|P3|1) Baseline up to Week 24|Protocol Violation|0
1345205|NCT01855789|4430806|P2|1) Baseline up to Week 24|Protocol Violation|0
1345206|NCT01855789|4430807|P1|1) Baseline up to Week 24|Protocol Violation|4
1345207|NCT01855789|4430804|P4|1) Baseline up to Week 24|Lost to Follow-up|0
1345208|NCT01855789|4430805|P3|1) Baseline up to Week 24|Lost to Follow-up|0
1345209|NCT01855789|4430806|P2|1) Baseline up to Week 24|Lost to Follow-up|0
1345210|NCT01855789|4430807|P1|1) Baseline up to Week 24|Lost to Follow-up|11
1345211|NCT01855789|4430804|P4|1) Baseline up to Week 24|Lack of Efficacy|0
1345212|NCT01855789|4430805|P3|1) Baseline up to Week 24|Lack of Efficacy|0
1345213|NCT01855789|4430806|P2|1) Baseline up to Week 24|Lack of Efficacy|0
1345214|NCT01855789|4430807|P1|1) Baseline up to Week 24|Lack of Efficacy|16
1345215|NCT01855789|4430804|P4|1) Baseline up to Week 24|Death|0
1345216|NCT01855789|4430805|P3|1) Baseline up to Week 24|Death|0
1345217|NCT01855789|4430806|P2|1) Baseline up to Week 24|Death|0
1345218|NCT01855789|4430807|P1|1) Baseline up to Week 24|Death|2
1345219|NCT01855789|4430804|P4|1) Baseline up to Week 24|Adverse Event|0
1345220|NCT01855789|4430805|P3|1) Baseline up to Week 24|Adverse Event|0
1345221|NCT01855789|4430806|P2|1) Baseline up to Week 24|Adverse Event|0
1345222|NCT01855789|4430807|P1|1) Baseline up to Week 24|Adverse Event|37
1345223|NCT01855425|4430829|P1|Overall Study|Physician Decision|20
1345224|NCT01855074|4430833|P1|Overall Study|Started but not treated|1
1345225|NCT01855074|4430833|P1|Overall Study|Withdrawal by Subject|8
1345226|NCT01855074|4430833|P1|Overall Study|Lost to Follow-up|4
1345227|NCT01855074|4430833|P1|Overall Study|Adverse Event|1
1345228|NCT01854944|4430845|P3|Overall Study|Withdrawal by Subject|1
1345229|NCT01854944|4430846|P2|Overall Study|Withdrawal by Subject|0
1345230|NCT01854944|4430847|P1|Overall Study|Withdrawal by Subject|0
1345231|NCT01854827|4430901|P1|Overall Study|Death|1
1345232|NCT01854710|4430913|P6|Overall Study|CRI procedural error|2
1345233|NCT01854710|4430914|P5|Overall Study|CRI procedural error|2
1345234|NCT01854710|4430915|P4|Overall Study|CRI procedural error|2
1345235|NCT01854710|4430916|P3|Overall Study|CRI procedural error|2
1345236|NCT01854710|4430917|P2|Overall Study|CRI procedural error|2
1345237|NCT01854710|4430918|P1|Overall Study|CRI procedural error|2
1345238|NCT01854710|4430913|P6|Overall Study|Withdrawal by Subject|0
1345239|NCT01854710|4430914|P5|Overall Study|Withdrawal by Subject|0
1345240|NCT01854710|4430915|P4|Overall Study|Withdrawal by Subject|0
1345241|NCT01854710|4430916|P3|Overall Study|Withdrawal by Subject|0
1345242|NCT01854710|4430917|P2|Overall Study|Withdrawal by Subject|1
1345243|NCT01854710|4430918|P1|Overall Study|Withdrawal by Subject|2
1345244|NCT01854697|4430939|P5|Overall Study|Not Specified|0
1345245|NCT01854697|4430940|P4|Overall Study|Not Specified|0
1345246|NCT01854697|4430941|P3|Overall Study|Not Specified|1
1345247|NCT01854697|4430942|P2|Overall Study|Not Specified|1
1345248|NCT01854697|4430943|P1|Overall Study|Not Specified|0
1345249|NCT01854697|4430939|P5|Overall Study|Withdrew Consent|0
1345250|NCT01854697|4430940|P4|Overall Study|Withdrew Consent|1
1345251|NCT01854697|4430941|P3|Overall Study|Withdrew Consent|0
1345252|NCT01854697|4430942|P2|Overall Study|Withdrew Consent|1
1345253|NCT01854697|4430943|P1|Overall Study|Withdrew Consent|0
1345254|NCT01854697|4430939|P5|Overall Study|To enter another AbbVie study|1
1345255|NCT01854697|4430940|P4|Overall Study|To enter another AbbVie study|0
1345256|NCT01854697|4430941|P3|Overall Study|To enter another AbbVie study|0
1345257|NCT01854697|4430942|P2|Overall Study|To enter another AbbVie study|0
1345258|NCT01854697|4430943|P1|Overall Study|To enter another AbbVie study|1
1345259|NCT01854697|4430939|P5|Overall Study|Lost to Follow-up|0
1345260|NCT01854697|4430940|P4|Overall Study|Lost to Follow-up|2
1345261|NCT01854697|4430941|P3|Overall Study|Lost to Follow-up|1
1345262|NCT01854697|4430942|P2|Overall Study|Lost to Follow-up|1
1345263|NCT01854697|4430943|P1|Overall Study|Lost to Follow-up|4
1345264|NCT01854697|4430939|P5|Overall Study|Adverse Event|1
1345265|NCT01854697|4430940|P4|Overall Study|Adverse Event|0
1345266|NCT01854697|4430941|P3|Overall Study|Adverse Event|0
1345267|NCT01854697|4430942|P2|Overall Study|Adverse Event|0
1345268|NCT01854697|4430943|P1|Overall Study|Adverse Event|1
1345269|NCT01854658|4430987|P4|Overall Study|Administrative reasons|2
1345270|NCT01854658|4430988|P3|Overall Study|Administrative reasons|2
1345271|NCT01854658|4430989|P2|Overall Study|Administrative reasons|1
1345272|NCT01854658|4430990|P1|Overall Study|Administrative reasons|5
1345273|NCT01854658|4430987|P4|Overall Study|Adverse Event|19
1345274|NCT01854658|4430988|P3|Overall Study|Adverse Event|23
1345275|NCT01854658|4430989|P2|Overall Study|Adverse Event|14
1345276|NCT01854658|4430990|P1|Overall Study|Adverse Event|21
1345277|NCT01854658|4430987|P4|Overall Study|Lack of Efficacy|7
1345278|NCT01854658|4430988|P3|Overall Study|Lack of Efficacy|4
1345279|NCT01854658|4430989|P2|Overall Study|Lack of Efficacy|8
1345280|NCT01854658|4430990|P1|Overall Study|Lack of Efficacy|3
1345281|NCT01854658|4430987|P4|Overall Study|Protocol-specified criteria|7
1345282|NCT01854658|4430988|P3|Overall Study|Protocol-specified criteria|10
1345283|NCT01854658|4430989|P2|Overall Study|Protocol-specified criteria|15
1345284|NCT01854658|4430990|P1|Overall Study|Protocol-specified criteria|15
1345285|NCT01854658|4430987|P4|Overall Study|Withdrawal by Subject|15
1345286|NCT01854658|4430988|P3|Overall Study|Withdrawal by Subject|29
1345287|NCT01854658|4430989|P2|Overall Study|Withdrawal by Subject|21
1345288|NCT01854658|4430990|P1|Overall Study|Withdrawal by Subject|28
1345289|NCT01854658|4430987|P4|Overall Study|Lost to Follow-up|4
1345290|NCT01854658|4430988|P3|Overall Study|Lost to Follow-up|8
1345291|NCT01854658|4430989|P2|Overall Study|Lost to Follow-up|9
1345292|NCT01854658|4430990|P1|Overall Study|Lost to Follow-up|8
1345293|NCT01854658|4430987|P4|Overall Study|Physician Decision|4
1345294|NCT01854658|4430988|P3|Overall Study|Physician Decision|2
1345295|NCT01854658|4430989|P2|Overall Study|Physician Decision|5
1345296|NCT01854658|4430990|P1|Overall Study|Physician Decision|7
1345297|NCT01854658|4430987|P4|Overall Study|Protocol Violation|1
1345298|NCT01854658|4430988|P3|Overall Study|Protocol Violation|2
1345299|NCT01854658|4430989|P2|Overall Study|Protocol Violation|2
1345300|NCT01854658|4430990|P1|Overall Study|Protocol Violation|6
1345301|NCT01854645|4431025|P5|Overall Study|Adverse Event|11
1345302|NCT01854645|4431026|P4|Overall Study|Adverse Event|20
1345303|NCT01854645|4431027|P3|Overall Study|Adverse Event|19
1345304|NCT01854645|4431028|P2|Overall Study|Adverse Event|31
1345305|NCT01854645|4431029|P1|Overall Study|Adverse Event|33
1345306|NCT01854645|4431025|P5|Overall Study|Lack of Efficacy|9
1345307|NCT01854645|4431026|P4|Overall Study|Lack of Efficacy|3
1345308|NCT01854645|4431027|P3|Overall Study|Lack of Efficacy|9
1345309|NCT01854645|4431028|P2|Overall Study|Lack of Efficacy|12
1345310|NCT01854645|4431029|P1|Overall Study|Lack of Efficacy|7
1345311|NCT01854645|4431025|P5|Overall Study|Withdrawal by Subject|24
1345312|NCT01854645|4431026|P4|Overall Study|Withdrawal by Subject|21
1345313|NCT01854645|4431027|P3|Overall Study|Withdrawal by Subject|30
1345314|NCT01854645|4431028|P2|Overall Study|Withdrawal by Subject|41
1345315|NCT01854645|4431029|P1|Overall Study|Withdrawal by Subject|31
1345316|NCT01854645|4431025|P5|Overall Study|Physician Decision|7
1345317|NCT01854645|4431026|P4|Overall Study|Physician Decision|3
1345318|NCT01854645|4431027|P3|Overall Study|Physician Decision|3
1345319|NCT01854645|4431028|P2|Overall Study|Physician Decision|5
1345320|NCT01854645|4431029|P1|Overall Study|Physician Decision|1
1345321|NCT01854645|4431025|P5|Overall Study|Lost to Follow-up|0
1345322|NCT01854645|4431026|P4|Overall Study|Lost to Follow-up|5
1345323|NCT01854645|4431027|P3|Overall Study|Lost to Follow-up|8
1345324|NCT01854645|4431028|P2|Overall Study|Lost to Follow-up|7
1345325|NCT01854645|4431029|P1|Overall Study|Lost to Follow-up|10
1345326|NCT01854645|4431025|P5|Overall Study|Protocol Violation|1
1345327|NCT01854645|4431026|P4|Overall Study|Protocol Violation|4
1345328|NCT01854645|4431027|P3|Overall Study|Protocol Violation|5
1345329|NCT01854645|4431028|P2|Overall Study|Protocol Violation|0
1345330|NCT01854645|4431029|P1|Overall Study|Protocol Violation|3
1345331|NCT01854645|4431025|P5|Overall Study|Administrative Reasons / Missing|1
1345332|NCT01854645|4431026|P4|Overall Study|Administrative Reasons / Missing|1
1345333|NCT01854645|4431027|P3|Overall Study|Administrative Reasons / Missing|0
1345334|NCT01854645|4431028|P2|Overall Study|Administrative Reasons / Missing|0
1345335|NCT01854645|4431029|P1|Overall Study|Administrative Reasons / Missing|0
1345336|NCT01854645|4431025|P5|Overall Study|Protocol-Specified Criteria|7
1345337|NCT01854645|4431026|P4|Overall Study|Protocol-Specified Criteria|5
1345338|NCT01854645|4431027|P3|Overall Study|Protocol-Specified Criteria|8
1345339|NCT01854645|4431028|P2|Overall Study|Protocol-Specified Criteria|10
1345340|NCT01854645|4431029|P1|Overall Study|Protocol-Specified Criteria|13
1345341|NCT01854528|4431110|P2|Overall Study|Virologic Failure|9
1345342|NCT01854528|4431111|P1|Overall Study|Virologic Failure|0
1345343|NCT01854528|4431110|P2|Overall Study|Withdrawal by Subject|2
1345344|NCT01854528|4431111|P1|Overall Study|Withdrawal by Subject|0
1345345|NCT01854528|4431110|P2|Overall Study|Adverse Event|4
1345346|NCT01854528|4431111|P1|Overall Study|Adverse Event|0
1345347|NCT01854047|4431174|P5|Overall Study|Other than specified above|8
1345348|NCT01854047|4431175|P4|Overall Study|Other than specified above|5
1345349|NCT01854047|4431176|P3|Overall Study|Other than specified above|3
1345350|NCT01854047|4431177|P2|Overall Study|Other than specified above|3
1345351|NCT01854047|4431178|P1|Overall Study|Other than specified above|3
1345352|NCT01854047|4431174|P5|Overall Study|Randomized but not treated|4
1345353|NCT01854047|4431175|P4|Overall Study|Randomized but not treated|0
1345354|NCT01854047|4431176|P3|Overall Study|Randomized but not treated|2
1345355|NCT01854047|4431177|P2|Overall Study|Randomized but not treated|1
1345356|NCT01854047|4431178|P1|Overall Study|Randomized but not treated|0
1345357|NCT01854047|4431174|P5|Overall Study|Adverse Event|7
1345358|NCT01854047|4431175|P4|Overall Study|Adverse Event|10
1345359|NCT01854047|4431176|P3|Overall Study|Adverse Event|6
1345360|NCT01854047|4431177|P2|Overall Study|Adverse Event|4
1345361|NCT01854047|4431178|P1|Overall Study|Adverse Event|5
1345362|NCT01854047|4431174|P5|Overall Study|Poor compliance to protocol|0
1345363|NCT01854047|4431175|P4|Overall Study|Poor compliance to protocol|0
1345364|NCT01854047|4431176|P3|Overall Study|Poor compliance to protocol|2
1345365|NCT01854047|4431177|P2|Overall Study|Poor compliance to protocol|0
1345366|NCT01854047|4431178|P1|Overall Study|Poor compliance to protocol|3
1345367|NCT01854047|4431174|P5|Overall Study|Lack of Efficacy|0
1345368|NCT01854047|4431175|P4|Overall Study|Lack of Efficacy|0
1345369|NCT01854047|4431176|P3|Overall Study|Lack of Efficacy|0
1345370|NCT01854047|4431177|P2|Overall Study|Lack of Efficacy|0
1345371|NCT01854047|4431178|P1|Overall Study|Lack of Efficacy|1
1345372|NCT01853982|4431309|P2|Overall Study|Lost to Follow-up|1
1345373|NCT01853982|4431310|P1|Overall Study|Lost to Follow-up|0
1345374|NCT01853982|4431309|P2|Overall Study|Death|0
1345375|NCT01853982|4431310|P1|Overall Study|Death|1
1345376|NCT01853982|4431309|P2|Overall Study|Withdrawal by Subject|0
1345377|NCT01853982|4431310|P1|Overall Study|Withdrawal by Subject|1
1345378|NCT01853839|4431316|P1|Overall Study|Lost to follow-up or no valid BP measure|336
1345379|NCT01853839|4431316|P1|Overall Study|End of treatment visit too early|33
1345380|NCT01853839|4431316|P1|Overall Study|Not meet ITT population definition|58
1345381|NCT01853839|4431316|P1|Overall Study|Violated inclusion criteria|2
1345382|NCT01853696|4431338|P2|Overall Study|Lost to Follow-up|4
1345383|NCT01853696|4431339|P1|Overall Study|Lost to Follow-up|5
1345384|NCT01853696|4431338|P2|Overall Study|Withdrawal by Subject|1
1345385|NCT01853696|4431339|P1|Overall Study|Withdrawal by Subject|1
1345386|NCT01853475|4431375|P3|Overall Study|Withdrawal by Subject|0
1345387|NCT01853475|4431376|P2|Overall Study|Withdrawal by Subject|1
1345388|NCT01853475|4431377|P1|Overall Study|Withdrawal by Subject|0
1345389|NCT01853397|4431398|P4|Overall Study|Subject Noncompliance|1
1345390|NCT01853397|4431399|P3|Overall Study|Subject Noncompliance|0
1345391|NCT01853397|4431400|P2|Overall Study|Subject Noncompliance|0
1345392|NCT01853397|4431401|P1|Overall Study|Subject Noncompliance|0
1345393|NCT01853397|4431398|P4|Overall Study|Withdrawal by Subject|1
1345394|NCT01853397|4431399|P3|Overall Study|Withdrawal by Subject|0
1345395|NCT01853397|4431400|P2|Overall Study|Withdrawal by Subject|0
1345396|NCT01853397|4431401|P1|Overall Study|Withdrawal by Subject|0
1345397|NCT01853384|4431429|P2|Completed Follow up Visit 2|Lost to Follow-up|1
1345398|NCT01853384|4431430|P1|Completed Follow up Visit 2|Lost to Follow-up|0
1345399|NCT01853384|4431429|P2|Completed Follow up Visit 2|Death|0
1345400|NCT01853384|4431430|P1|Completed Follow up Visit 2|Death|1
1345401|NCT01853384|4431429|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
1345402|NCT01853384|4431430|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
1345403|NCT01853384|4431429|P2|Completed Follow up Visit 2|Adverse Event|0
1345404|NCT01853384|4431430|P1|Completed Follow up Visit 2|Adverse Event|1
1345405|NCT01853384|4431429|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
1345406|NCT01853384|4431430|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
1345407|NCT01853384|4431429|P2|Completed Follow up Visit 1|Early Termination|9
1345408|NCT01853384|4431430|P1|Completed Follow up Visit 1|Early Termination|13
1345409|NCT01853384|4431429|P2|Randomized|Other|3
1345410|NCT01853384|4431430|P1|Randomized|Other|3
1345411|NCT01853384|4431429|P2|Randomized|Sponsor Decision|34
1345412|NCT01853384|4431430|P1|Randomized|Sponsor Decision|47
1345413|NCT01853384|4431429|P2|Randomized|Withdrawal by Subject|3
1345414|NCT01853384|4431430|P1|Randomized|Withdrawal by Subject|5
1345415|NCT01853384|4431429|P2|Randomized|Lost to Follow-up|1
1345416|NCT01853384|4431430|P1|Randomized|Lost to Follow-up|1
1345417|NCT01853384|4431429|P2|Randomized|Death|2
1345418|NCT01853384|4431430|P1|Randomized|Death|1
1345419|NCT01853384|4431429|P2|Randomized|Adverse Event|3
1345420|NCT01853384|4431430|P1|Randomized|Adverse Event|5
1345421|NCT01853280|4431470|P2|Overall Study|Ineligible|1
1345422|NCT01853280|4431471|P1|Overall Study|Ineligible|0
1345423|NCT01853280|4431470|P2|Overall Study|Withdrawal by Subject|1
1345424|NCT01853280|4431471|P1|Overall Study|Withdrawal by Subject|0
1345425|NCT01853280|4431470|P2|Overall Study|Physician Decision|1
1345426|NCT01853280|4431471|P1|Overall Study|Physician Decision|0
1345427|NCT01853280|4431470|P2|Overall Study|Lost to Follow-up|1
1345428|NCT01853280|4431471|P1|Overall Study|Lost to Follow-up|0
1345429|NCT01853280|4431470|P2|Overall Study|Lack of Efficacy|2
1345430|NCT01853280|4431471|P1|Overall Study|Lack of Efficacy|2
1345431|NCT01853254|4431477|P1|Overall Study|Administrative/Other|16
1345432|NCT01853254|4431477|P1|Overall Study|Withdrawal of Consent|16
1345433|NCT01853254|4431477|P1|Overall Study|Other Protocol Violation|1
1345434|NCT01853254|4431477|P1|Overall Study|Refusal of Treatment|1
1345435|NCT01853254|4431477|P1|Overall Study|Insufficient Therapeutic Response|22
1345436|NCT01853254|4431477|P1|Overall Study|Failure to Return|43
1345437|NCT01853254|4431477|P1|Overall Study|Death|1
1345438|NCT01853254|4431477|P1|Overall Study|Adverse Event/Intercurrent Illness|3
1345439|NCT01853254|4431477|P1|Overall Study|Abnormal Laboratory Test|1
1345440|NCT01853176|4431494|P2|Overall Study|Study terminated|0
1345441|NCT01853176|4431495|P1|Overall Study|Study terminated|4
1345442|NCT01853072|4431514|P2|Overall Study|Reason not specified|6
1345443|NCT01853072|4431515|P1|Overall Study|Reason not specified|9
1345444|NCT01853072|4431514|P2|Overall Study|Withdrawal by Subject|2
1345445|NCT01853072|4431515|P1|Overall Study|Withdrawal by Subject|1
1345446|NCT01853072|4431514|P2|Overall Study|Physician Decision|1
1345447|NCT01853072|4431515|P1|Overall Study|Physician Decision|1
1345448|NCT01853072|4431514|P2|Overall Study|Non-compliance with study drug|1
1345449|NCT01853072|4431515|P1|Overall Study|Non-compliance with study drug|0
1345450|NCT01853072|4431514|P2|Overall Study|Lost to Follow-up|3
1345451|NCT01853072|4431515|P1|Overall Study|Lost to Follow-up|0
1345452|NCT01853072|4431514|P2|Overall Study|Death|4
1345453|NCT01853072|4431515|P1|Overall Study|Death|1
1345454|NCT01853072|4431514|P2|Overall Study|Adverse Event|3
1345455|NCT01853072|4431515|P1|Overall Study|Adverse Event|0
1345456|NCT01853072|4431514|P2|Overall Study|Adverse event prior to treatment|1
1345457|NCT01853072|4431515|P1|Overall Study|Adverse event prior to treatment|0
1345458|NCT01853046|4431535|P2|Overall Study|Disease progression|3
1345459|NCT01853046|4431536|P1|Overall Study|Disease progression|13
1345460|NCT01853046|4431535|P2|Overall Study|Adverse Event|2
1345461|NCT01853046|4431536|P1|Overall Study|Adverse Event|4
1345462|NCT01853046|4431535|P2|Overall Study|Withdrawal by Subject|1
1345463|NCT01853046|4431536|P1|Overall Study|Withdrawal by Subject|1
1345464|NCT01852825|4431604|P3|Overall Study|Withdrawal by Subject|0
1345465|NCT01852825|4431605|P2|Overall Study|Withdrawal by Subject|0
1345466|NCT01852825|4431606|P1|Overall Study|Withdrawal by Subject|2
1345467|NCT01852812|4431632|P3|Overall Study|Non-compliance With Study Drug|0
1345468|NCT01852812|4431633|P2|Overall Study|Non-compliance With Study Drug|1
1345469|NCT01852812|4431634|P1|Overall Study|Non-compliance With Study Drug|0
1345470|NCT01852812|4431632|P3|Overall Study|Adverse Event|1
1345471|NCT01852812|4431633|P2|Overall Study|Adverse Event|0
1345472|NCT01852812|4431634|P1|Overall Study|Adverse Event|0
1345473|NCT01852591|4431672|P1|Overall Study|Not Evaluable at Time of Analysis|1
1345474|NCT01852591|4431672|P1|Overall Study|Withdrawal by Subject|2
1345475|NCT01852292|4431713|P2|Overall Study|Progressive disease|52
1345476|NCT01852292|4431714|P1|Overall Study|Progressive disease|42
1345477|NCT01852292|4431713|P2|Overall Study|Study terminated by Sponsor|1
1345478|NCT01852292|4431714|P1|Overall Study|Study terminated by Sponsor|0
1345479|NCT01852292|4431713|P2|Overall Study|Non-compliance with study treatment|0
1345480|NCT01852292|4431714|P1|Overall Study|Non-compliance with study treatment|1
1345481|NCT01852292|4431713|P2|Overall Study|Protocol Violation|0
1345482|NCT01852292|4431714|P1|Overall Study|Protocol Violation|2
1345483|NCT01852292|4431713|P2|Overall Study|Physician Decision|2
1345484|NCT01852292|4431714|P1|Overall Study|Physician Decision|6
1345485|NCT01852292|4431713|P2|Overall Study|Adverse Event|11
1345486|NCT01852292|4431714|P1|Overall Study|Adverse Event|8
1345487|NCT01852292|4431713|P2|Overall Study|Patient/guardian decision|4
1345488|NCT01852292|4431714|P1|Overall Study|Patient/guardian decision|8
1345489|NCT01852292|4431713|P2|Overall Study|Death|8
1345490|NCT01852292|4431714|P1|Overall Study|Death|9
1345491|NCT01852292|4431713|P2|Overall Study|Untreated - did not receive study drug|1
1345492|NCT01852292|4431714|P1|Overall Study|Untreated - did not receive study drug|3
1345493|NCT01852214|4431738|P2|Washout Period|Withdrawal by Subject|1
1345494|NCT01852214|4431739|P1|Washout Period|Withdrawal by Subject|0
1345495|NCT01852214|4431738|P2|Period 1|Withdrawal by Subject|1
1345496|NCT01852214|4431739|P1|Period 1|Withdrawal by Subject|0
1345497|NCT01852214|4431738|P2|Period 1|Adverse Event|2
1345498|NCT01852214|4431739|P1|Period 1|Adverse Event|1
1345499|NCT01852162|4431766|P2|Overall Study|Withdrawal by Subject|1
1345500|NCT01852162|4431767|P1|Overall Study|Withdrawal by Subject|3
1345501|NCT01852162|4431766|P2|Overall Study|Adverse Event|0
1345502|NCT01852162|4431767|P1|Overall Study|Adverse Event|1
1345503|NCT01852110|4431783|P6|Overall Study|Withdrawal by Subject|0
1345504|NCT01852110|4431784|P5|Overall Study|Withdrawal by Subject|0
1345505|NCT01852110|4431785|P4|Overall Study|Withdrawal by Subject|0
1345506|NCT01852110|4431786|P3|Overall Study|Withdrawal by Subject|0
1345507|NCT01852110|4431787|P2|Overall Study|Withdrawal by Subject|4
1345508|NCT01852110|4431788|P1|Overall Study|Withdrawal by Subject|4
1345509|NCT01852110|4431783|P6|Overall Study|Study Terminated by Sponsor|0
1345510|NCT01852110|4431784|P5|Overall Study|Study Terminated by Sponsor|0
1345511|NCT01852110|4431785|P4|Overall Study|Study Terminated by Sponsor|0
1345512|NCT01852110|4431786|P3|Overall Study|Study Terminated by Sponsor|0
1345513|NCT01852110|4431787|P2|Overall Study|Study Terminated by Sponsor|32
1345514|NCT01852110|4431788|P1|Overall Study|Study Terminated by Sponsor|30
1345515|NCT01852110|4431783|P6|Overall Study|Protocol Violation|0
1345516|NCT01852110|4431784|P5|Overall Study|Protocol Violation|0
1345517|NCT01852110|4431785|P4|Overall Study|Protocol Violation|0
1345518|NCT01852110|4431786|P3|Overall Study|Protocol Violation|0
1345519|NCT01852110|4431787|P2|Overall Study|Protocol Violation|1
1345520|NCT01852110|4431788|P1|Overall Study|Protocol Violation|0
1345521|NCT01852110|4431783|P6|Overall Study|Physician Decision|0
1345522|NCT01852110|4431784|P5|Overall Study|Physician Decision|0
1345523|NCT01852110|4431785|P4|Overall Study|Physician Decision|0
1345524|NCT01852110|4431786|P3|Overall Study|Physician Decision|0
1345525|NCT01852110|4431787|P2|Overall Study|Physician Decision|0
1345526|NCT01852110|4431788|P1|Overall Study|Physician Decision|1
1345527|NCT01852110|4431783|P6|Overall Study|Non-compliance with Study Drug|0
1345528|NCT01852110|4431784|P5|Overall Study|Non-compliance with Study Drug|0
1345529|NCT01852110|4431785|P4|Overall Study|Non-compliance with Study Drug|0
1345530|NCT01852110|4431786|P3|Overall Study|Non-compliance with Study Drug|0
1345531|NCT01852110|4431787|P2|Overall Study|Non-compliance with Study Drug|1
1345532|NCT01852110|4431788|P1|Overall Study|Non-compliance with Study Drug|2
1345533|NCT01852110|4431783|P6|Overall Study|Lost to Follow-up|0
1345534|NCT01852110|4431784|P5|Overall Study|Lost to Follow-up|0
1345535|NCT01852110|4431785|P4|Overall Study|Lost to Follow-up|0
1345536|NCT01852110|4431786|P3|Overall Study|Lost to Follow-up|0
1345537|NCT01852110|4431787|P2|Overall Study|Lost to Follow-up|3
1345538|NCT01852110|4431788|P1|Overall Study|Lost to Follow-up|1
1345539|NCT01852110|4431783|P6|Overall Study|Adverse Event|0
1345540|NCT01852110|4431784|P5|Overall Study|Adverse Event|0
1345541|NCT01852110|4431785|P4|Overall Study|Adverse Event|0
1345542|NCT01852110|4431786|P3|Overall Study|Adverse Event|0
1345543|NCT01852110|4431787|P2|Overall Study|Adverse Event|5
1345544|NCT01852110|4431788|P1|Overall Study|Adverse Event|12
1345545|NCT01851863|4431862|P4|Overall Study|Lost to Follow-up|3
1345546|NCT01851863|4431863|P3|Overall Study|Lost to Follow-up|2
1345547|NCT01851863|4431864|P2|Overall Study|Lost to Follow-up|4
1345548|NCT01851863|4431865|P1|Overall Study|Lost to Follow-up|3
1345549|NCT01851863|4431862|P4|Overall Study|Did not receive study medication|0
1345550|NCT01851863|4431863|P3|Overall Study|Did not receive study medication|3
1345551|NCT01851863|4431864|P2|Overall Study|Did not receive study medication|5
1345552|NCT01851863|4431865|P1|Overall Study|Did not receive study medication|2
1345553|NCT01851720|4431894|P2|Overall Study|Lost to Follow-up|1
1345554|NCT01851720|4431895|P1|Overall Study|Lost to Follow-up|0
1345555|NCT01851590|4431925|P3|Overall Study|Lack of Efficacy|0
1345556|NCT01851590|4431926|P2|Overall Study|Lack of Efficacy|1
1345557|NCT01851590|4431927|P1|Overall Study|Lack of Efficacy|0
1345558|NCT01851590|4431925|P3|Overall Study|Adverse Event|2
1345559|NCT01851590|4431926|P2|Overall Study|Adverse Event|0
1345560|NCT01851590|4431927|P1|Overall Study|Adverse Event|0
1345561|NCT01851590|4431925|P3|Overall Study|Withdrawal by Subject|1
1345562|NCT01851590|4431926|P2|Overall Study|Withdrawal by Subject|0
1345563|NCT01851590|4431927|P1|Overall Study|Withdrawal by Subject|0
1345564|NCT01851330|4431950|P3|Overall Study|Investigator’s Discretion|1
1345565|NCT01851330|4431951|P2|Overall Study|Investigator’s Discretion|0
1345566|NCT01851330|4431952|P1|Overall Study|Investigator’s Discretion|0
1345567|NCT01851330|4431950|P3|Overall Study|Withdrew Consent|0
1345568|NCT01851330|4431951|P2|Overall Study|Withdrew Consent|1
1345569|NCT01851330|4431952|P1|Overall Study|Withdrew Consent|2
1345570|NCT01851330|4431950|P3|Overall Study|Lost to Follow-up|9
1345571|NCT01851330|4431951|P2|Overall Study|Lost to Follow-up|6
1345572|NCT01851330|4431952|P1|Overall Study|Lost to Follow-up|1
1345573|NCT01851330|4431950|P3|Overall Study|Lack of Efficacy|2
1345574|NCT01851330|4431951|P2|Overall Study|Lack of Efficacy|9
1345575|NCT01851330|4431952|P1|Overall Study|Lack of Efficacy|10
1345576|NCT01850615|4432007|P2|Overall Study|Unclassified|1
1345577|NCT01850615|4432008|P1|Overall Study|Unclassified|0
1345578|NCT01850615|4432007|P2|Overall Study|Lost to Follow-up|1
1345579|NCT01850615|4432008|P1|Overall Study|Lost to Follow-up|0
1345580|NCT01850615|4432007|P2|Overall Study|Withdrawal by Subject|1
1345581|NCT01850615|4432008|P1|Overall Study|Withdrawal by Subject|3
1345582|NCT01850615|4432007|P2|Overall Study|Adverse Event|1
1345583|NCT01850615|4432008|P1|Overall Study|Adverse Event|2
1345584|NCT01850615|4432007|P2|Overall Study|Protocol Violation|1
1345585|NCT01850615|4432008|P1|Overall Study|Protocol Violation|4
1345586|NCT01850589|4432026|P2|Overall Study|Withdrawal by Subject|0
1345587|NCT01850589|4432027|P1|Overall Study|Withdrawal by Subject|8
1345588|NCT01850030|4432092|P2|Overall Study|pregnancy not confirmed at visit 4|249
1345589|NCT01850030|4432093|P1|Overall Study|pregnancy not confirmed at visit 4|248
1345590|NCT01850030|4432092|P2|Overall Study|Protocol Violation|28
1345591|NCT01850030|4432093|P1|Overall Study|Protocol Violation|24
1345592|NCT01850030|4432092|P2|Overall Study|Withdrawal by Subject|4
1345593|NCT01850030|4432093|P1|Overall Study|Withdrawal by Subject|3
1345594|NCT01850030|4432092|P2|Overall Study|Lost to Follow-up|5
1345595|NCT01850030|4432093|P1|Overall Study|Lost to Follow-up|5
1345596|NCT01850030|4432092|P2|Overall Study|Lack of Efficacy|1
1345597|NCT01850030|4432093|P1|Overall Study|Lack of Efficacy|3
1345598|NCT01850030|4432092|P2|Overall Study|Adverse Event|82
1345599|NCT01850030|4432093|P1|Overall Study|Adverse Event|64
1345600|NCT01849848|4432105|P1|Overall Study|Progression of the primary disease|3
1345601|NCT01849848|4432105|P1|Overall Study|Physician Decision|1
1345602|NCT01849588|4432203|P1|Overall Study|Lack of Efficacy|3
1345603|NCT01849562|4432213|P3|Overall Study|Non-compliance with Study Drug|0
1345604|NCT01849562|4432214|P2|Overall Study|Non-compliance with Study Drug|0
1345605|NCT01849562|4432215|P1|Overall Study|Non-compliance with Study Drug|1
1345606|NCT01849562|4432213|P3|Overall Study|Lost to Follow-up|0
1345607|NCT01849562|4432214|P2|Overall Study|Lost to Follow-up|0
1345608|NCT01849562|4432215|P1|Overall Study|Lost to Follow-up|1
1345609|NCT01849497|4432228|P2|Overall Study|Lost to Follow-up|1
1345610|NCT01849497|4432229|P1|Overall Study|Lost to Follow-up|0
1345611|NCT01849497|4432228|P2|Overall Study|Sponsor Decision|1
1345612|NCT01849497|4432229|P1|Overall Study|Sponsor Decision|0
1345613|NCT01849497|4432228|P2|Overall Study|Withdrawal by Subject|2
1345614|NCT01849497|4432229|P1|Overall Study|Withdrawal by Subject|1
1345615|NCT01849458|4432237|P1|Overall Study|Lost to Follow-up|4
1345616|NCT01849289|4432276|P2|Overall Study|Unclassified|18
1345617|NCT01849289|4432277|P1|Overall Study|Unclassified|25
1345618|NCT01849289|4432276|P2|Overall Study|Withdrawal criteria|0
1345619|NCT01849289|4432277|P1|Overall Study|Withdrawal criteria|1
1345620|NCT01849289|4432276|P2|Overall Study|Protocol Violation|3
1345621|NCT01849289|4432277|P1|Overall Study|Protocol Violation|3
1345622|NCT01849289|4432276|P2|Overall Study|Adverse Event|3
1345623|NCT01849289|4432277|P1|Overall Study|Adverse Event|3
1345624|NCT01848990|4432321|P3|Overall Study|Death|0
1345625|NCT01848990|4432322|P2|Overall Study|Death|0
1345626|NCT01848990|4432323|P1|Overall Study|Death|1
1345627|NCT01848990|4432321|P3|Overall Study|Non Compliance|0
1345628|NCT01848990|4432322|P2|Overall Study|Non Compliance|0
1345629|NCT01848990|4432323|P1|Overall Study|Non Compliance|1
1345630|NCT01848990|4432321|P3|Overall Study|Physician Decision|0
1345631|NCT01848990|4432322|P2|Overall Study|Physician Decision|0
1345632|NCT01848990|4432323|P1|Overall Study|Physician Decision|1
1345633|NCT01848990|4432321|P3|Overall Study|Withdrawal by Subject|9
1345634|NCT01848990|4432322|P2|Overall Study|Withdrawal by Subject|6
1345635|NCT01848990|4432323|P1|Overall Study|Withdrawal by Subject|20
1345636|NCT01848990|4432321|P3|Overall Study|Protocol Violation|0
1345637|NCT01848990|4432322|P2|Overall Study|Protocol Violation|1
1345638|NCT01848990|4432323|P1|Overall Study|Protocol Violation|0
1345639|NCT01848990|4432321|P3|Overall Study|Lost to Follow-up|2
1345640|NCT01848990|4432322|P2|Overall Study|Lost to Follow-up|1
1345641|NCT01848990|4432323|P1|Overall Study|Lost to Follow-up|6
1345642|NCT01848990|4432321|P3|Overall Study|Adverse Event|0
1345643|NCT01848990|4432322|P2|Overall Study|Adverse Event|1
1345644|NCT01848990|4432323|P1|Overall Study|Adverse Event|4
1345645|NCT01848938|4432349|P2|Overall Study|Lost to Follow-up|1
1345646|NCT01848938|4432350|P1|Overall Study|Lost to Follow-up|1
1345647|NCT01848834|4432399|P5|Overall Study|Not Treated|0
1345648|NCT01848834|4432400|P4|Overall Study|Not Treated|0
1345649|NCT01848834|4432401|P3|Overall Study|Not Treated|0
1345650|NCT01848834|4432402|P2|Overall Study|Not Treated|1
1345651|NCT01848834|4432403|P1|Overall Study|Not Treated|0
1345652|NCT01848834|4432399|P5|Overall Study|Withdrawal by Subject|7
1345653|NCT01848834|4432400|P4|Overall Study|Withdrawal by Subject|0
1345654|NCT01848834|4432401|P3|Overall Study|Withdrawal by Subject|3
1345655|NCT01848834|4432402|P2|Overall Study|Withdrawal by Subject|2
1345656|NCT01848834|4432403|P1|Overall Study|Withdrawal by Subject|0
1345657|NCT01848834|4432399|P5|Overall Study|Protocol Violation|2
1345658|NCT01848834|4432400|P4|Overall Study|Protocol Violation|0
1345659|NCT01848834|4432401|P3|Overall Study|Protocol Violation|1
1345660|NCT01848834|4432402|P2|Overall Study|Protocol Violation|0
1345661|NCT01848834|4432403|P1|Overall Study|Protocol Violation|0
1345662|NCT01848834|4432399|P5|Overall Study|Progressive Disease|78
1345663|NCT01848834|4432400|P4|Overall Study|Progressive Disease|36
1345664|NCT01848834|4432401|P3|Overall Study|Progressive Disease|21
1345665|NCT01848834|4432402|P2|Overall Study|Progressive Disease|41
1345666|NCT01848834|4432403|P1|Overall Study|Progressive Disease|27
1345667|NCT01848834|4432399|P5|Overall Study|Death|3
1345668|NCT01848834|4432400|P4|Overall Study|Death|0
1345669|NCT01848834|4432401|P3|Overall Study|Death|0
1345670|NCT01848834|4432402|P2|Overall Study|Death|1
1345671|NCT01848834|4432403|P1|Overall Study|Death|0
1345672|NCT01848834|4432399|P5|Overall Study|Complete Response|0
1345673|NCT01848834|4432400|P4|Overall Study|Complete Response|0
1345674|NCT01848834|4432401|P3|Overall Study|Complete Response|0
1345675|NCT01848834|4432402|P2|Overall Study|Complete Response|1
1345676|NCT01848834|4432403|P1|Overall Study|Complete Response|0
1345677|NCT01848834|4432399|P5|Overall Study|Adverse Event|15
1345678|NCT01848834|4432400|P4|Overall Study|Adverse Event|1
1345679|NCT01848834|4432401|P3|Overall Study|Adverse Event|6
1345680|NCT01848834|4432402|P2|Overall Study|Adverse Event|8
1345681|NCT01848834|4432403|P1|Overall Study|Adverse Event|3
1345682|NCT01848834|4432399|P5|Overall Study|Physician Decision|1
1345683|NCT01848834|4432400|P4|Overall Study|Physician Decision|0
1345684|NCT01848834|4432401|P3|Overall Study|Physician Decision|0
1345685|NCT01848834|4432402|P2|Overall Study|Physician Decision|0
1345686|NCT01848834|4432403|P1|Overall Study|Physician Decision|0
1345687|NCT01848834|4432399|P5|Overall Study|Ongoing in Study|26
1345688|NCT01848834|4432400|P4|Overall Study|Ongoing in Study|0
1345689|NCT01848834|4432401|P3|Overall Study|Ongoing in Study|1
1345690|NCT01848834|4432402|P2|Overall Study|Ongoing in Study|6
1345691|NCT01848834|4432403|P1|Overall Study|Ongoing in Study|0
1345692|NCT01848756|4432438|P1|Overall Study|Enrolled in Error|1
1345693|NCT01848756|4432438|P1|Overall Study|Withdrawal by Subject|1
1345694|NCT01848756|4432438|P1|Overall Study|Adverse Event|1
1345695|NCT01848288|4432452|P1|Overall Study|Withdrawal by Subject|1
1345696|NCT01848288|4432452|P1|Overall Study|Protocol Violation|1
1345697|NCT01848288|4432452|P1|Overall Study|Death|1
1345698|NCT01848210|4432463|P2|Overall Study|Administrative|0
1345699|NCT01848210|4432464|P1|Overall Study|Administrative|1
1345700|NCT01848210|4432463|P2|Overall Study|Chronic Venous Insufficiency Course|2
1345701|NCT01848210|4432464|P1|Overall Study|Chronic Venous Insufficiency Course|1
1345702|NCT01848210|4432463|P2|Overall Study|Hepatic Function Alteration|0
1345703|NCT01848210|4432464|P1|Overall Study|Hepatic Function Alteration|4
1345704|NCT01848210|4432463|P2|Overall Study|Hypesensitivity|0
1345705|NCT01848210|4432464|P1|Overall Study|Hypesensitivity|1
1345706|NCT01848210|4432463|P2|Overall Study|Discontinuation Criterion|7
1345707|NCT01848210|4432464|P1|Overall Study|Discontinuation Criterion|5
1345708|NCT01848210|4432463|P2|Overall Study|Adverse Event|9
1345709|NCT01848210|4432464|P1|Overall Study|Adverse Event|7
1345710|NCT01848210|4432463|P2|Overall Study|Impedition Condition|9
1345711|NCT01848210|4432464|P1|Overall Study|Impedition Condition|5
1345712|NCT01848210|4432463|P2|Overall Study|Use of Forbidden Drugs|10
1345713|NCT01848210|4432464|P1|Overall Study|Use of Forbidden Drugs|9
1345714|NCT01848210|4432463|P2|Overall Study|Protocol Violation|5
1345715|NCT01848210|4432464|P1|Overall Study|Protocol Violation|3
1345716|NCT01848210|4432463|P2|Overall Study|Lost to Follow-up|12
1345717|NCT01848210|4432464|P1|Overall Study|Lost to Follow-up|24
1345718|NCT01848210|4432463|P2|Overall Study|Informed Consent Form Withdrawal|24
1345719|NCT01848210|4432464|P1|Overall Study|Informed Consent Form Withdrawal|28
1345720|NCT01848145|4432486|P1|Subsequent Infusions: Weeks 3-8|Death|1
1345721|NCT01848145|4432486|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
1345722|NCT01848145|4432486|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
1345723|NCT01848145|4432486|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
1345724|NCT01848145|4432486|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
1345725|NCT01848145|4432486|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
1345726|NCT01848145|4432486|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
1345727|NCT01847885|4432526|P3|Randomization|Screen Failure|0
1345728|NCT01847885|4432527|P2|Randomization|Screen Failure|3
1345729|NCT01847885|4432528|P1|Randomization|Screen Failure|0
1345730|NCT01847885|4432526|P3|Randomization|Withdrawal by Subject|2
1345731|NCT01847885|4432527|P2|Randomization|Withdrawal by Subject|0
1345732|NCT01847885|4432528|P1|Randomization|Withdrawal by Subject|0
1345733|NCT01847885|4432526|P3|Randomization|Protocol Violation|0
1345734|NCT01847885|4432527|P2|Randomization|Protocol Violation|1
1345735|NCT01847885|4432528|P1|Randomization|Protocol Violation|0
1345736|NCT01847885|4432526|P3|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
1345737|NCT01847885|4432527|P2|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
1345738|NCT01847885|4432528|P1|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
1345739|NCT01847885|4432526|P3|Initial Enrollment (Consented)|Screen failure|0
1345740|NCT01847885|4432527|P2|Initial Enrollment (Consented)|Screen failure|0
1345741|NCT01847885|4432528|P1|Initial Enrollment (Consented)|Screen failure|39
1345742|NCT01847885|4432526|P3|Initial Enrollment (Consented)|Withdrawal by Subject|0
1345743|NCT01847885|4432527|P2|Initial Enrollment (Consented)|Withdrawal by Subject|0
1345744|NCT01847885|4432528|P1|Initial Enrollment (Consented)|Withdrawal by Subject|2
1345745|NCT01847885|4432526|P3|Initial Enrollment (Consented)|Protocol Violation|0
1345746|NCT01847885|4432527|P2|Initial Enrollment (Consented)|Protocol Violation|0
1345747|NCT01847885|4432528|P1|Initial Enrollment (Consented)|Protocol Violation|1
1345748|NCT01847443|4432605|P4|Washout Period Before Study Period 4|Positive alcohol test|0
1345749|NCT01847443|4432606|P3|Washout Period Before Study Period 4|Positive alcohol test|0
1345750|NCT01847443|4432607|P2|Washout Period Before Study Period 4|Positive alcohol test|0
1345751|NCT01847443|4432608|P1|Washout Period Before Study Period 4|Positive alcohol test|1
1345752|NCT01847443|4432605|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
1345753|NCT01847443|4432606|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
1345754|NCT01847443|4432607|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
1345755|NCT01847443|4432608|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
1345756|NCT01847443|4432605|P4|Washout Period Before Study Period 3|Other reason|0
1345757|NCT01847443|4432606|P3|Washout Period Before Study Period 3|Other reason|0
1345758|NCT01847443|4432607|P2|Washout Period Before Study Period 3|Other reason|0
1345759|NCT01847443|4432608|P1|Washout Period Before Study Period 3|Other reason|1
1345760|NCT01847443|4432605|P4|Washout Period Before Study Period 2|Other reason|0
1345761|NCT01847443|4432606|P3|Washout Period Before Study Period 2|Other reason|0
1345762|NCT01847443|4432607|P2|Washout Period Before Study Period 2|Other reason|0
1345763|NCT01847443|4432608|P1|Washout Period Before Study Period 2|Other reason|1
1345764|NCT01847443|4432605|P4|Washout Period Before Study Period 2|Adverse Event|0
1345765|NCT01847443|4432606|P3|Washout Period Before Study Period 2|Adverse Event|0
1345766|NCT01847443|4432607|P2|Washout Period Before Study Period 2|Adverse Event|1
1345767|NCT01847443|4432608|P1|Washout Period Before Study Period 2|Adverse Event|1
1345768|NCT01847443|4432605|P4|Study Period 1|Withdrawal by Subject|0
1345769|NCT01847443|4432606|P3|Study Period 1|Withdrawal by Subject|0
1345770|NCT01847443|4432607|P2|Study Period 1|Withdrawal by Subject|1
1345771|NCT01847443|4432608|P1|Study Period 1|Withdrawal by Subject|0
1345772|NCT01846741|4432669|P1|Baseline Visit|Subject did not meet entry criteria|2
1345773|NCT01846507|4432817|P1|Overall Study|Missing data|2
1345774|NCT01846507|4432817|P1|Overall Study|Protocol Violation|1
1345775|NCT01846507|4432817|P1|Overall Study|Lost to Follow-up|4
1345776|NCT01846442|4432904|P4|Overall Study|Left the city/Lost medication|1
1345777|NCT01846442|4432905|P3|Overall Study|Left the city/Lost medication|1
1345778|NCT01846442|4432906|P2|Overall Study|Left the city/Lost medication|0
1345779|NCT01846442|4432907|P1|Overall Study|Left the city/Lost medication|1
1345780|NCT01846442|4432904|P4|Overall Study|Withdrawal by Subject|1
1345781|NCT01846442|4432905|P3|Overall Study|Withdrawal by Subject|0
1345782|NCT01846442|4432906|P2|Overall Study|Withdrawal by Subject|2
1345783|NCT01846442|4432907|P1|Overall Study|Withdrawal by Subject|3
1345784|NCT01846442|4432904|P4|Overall Study|Lost to Follow-up|0
1345785|NCT01846442|4432905|P3|Overall Study|Lost to Follow-up|1
1345786|NCT01846442|4432906|P2|Overall Study|Lost to Follow-up|0
1345787|NCT01846442|4432907|P1|Overall Study|Lost to Follow-up|0
1345788|NCT01846442|4432904|P4|Overall Study|Adverse Event|1
1345789|NCT01846442|4432905|P3|Overall Study|Adverse Event|2
1345790|NCT01846442|4432906|P2|Overall Study|Adverse Event|4
1345791|NCT01846442|4432907|P1|Overall Study|Adverse Event|2
1345792|NCT01846416|4432948|P3|Overall Study|Lost to Follow-up|1
1345793|NCT01846416|4432949|P2|Overall Study|Lost to Follow-up|2
1345794|NCT01846416|4432950|P1|Overall Study|Lost to Follow-up|0
1345795|NCT01846416|4432948|P3|Overall Study|Ongoing as of 7 January 2015|3
1345796|NCT01846416|4432949|P2|Overall Study|Ongoing as of 7 January 2015|41
1345797|NCT01846416|4432950|P1|Overall Study|Ongoing as of 7 January 2015|21
1345798|NCT01846416|4432948|P3|Overall Study|Other|0
1345799|NCT01846416|4432949|P2|Overall Study|Other|0
1345800|NCT01846416|4432950|P1|Overall Study|Other|1
1345801|NCT01846416|4432948|P3|Overall Study|Withdrawal by Subject|0
1345802|NCT01846416|4432949|P2|Overall Study|Withdrawal by Subject|7
1345803|NCT01846416|4432950|P1|Overall Study|Withdrawal by Subject|1
1345804|NCT01846416|4432948|P3|Overall Study|Death|9
1345805|NCT01846416|4432949|P2|Overall Study|Death|43
1345806|NCT01846416|4432950|P1|Overall Study|Death|8
1345807|NCT01846299|4432995|P2|Overall Study|Adverse Event|0
1345808|NCT01846299|4432996|P1|Overall Study|Adverse Event|2
1345809|NCT01846299|4432995|P2|Overall Study|Withdrawal by Subject|6
1345810|NCT01846299|4432996|P1|Overall Study|Withdrawal by Subject|1
1345811|NCT01846299|4432995|P2|Overall Study|Lost to Follow-up|0
1345812|NCT01846299|4432996|P1|Overall Study|Lost to Follow-up|3
1345813|NCT01846299|4432995|P2|Overall Study|Death|2
1345814|NCT01846299|4432996|P1|Overall Study|Death|1
1345815|NCT01846299|4432995|P2|Overall Study|Protocol deviation|0
1345816|NCT01846299|4432996|P1|Overall Study|Protocol deviation|1
1345817|NCT01846299|4432995|P2|Overall Study|Physician Decision|2
1345818|NCT01846299|4432996|P1|Overall Study|Physician Decision|4
1345819|NCT01846221|4433034|P2|Overall Study|Age Exclusion|0
1345820|NCT01846221|4433035|P1|Overall Study|Age Exclusion|1
1345821|NCT01846221|4433034|P2|Overall Study|Catheter Failure|0
1345822|NCT01846221|4433035|P1|Overall Study|Catheter Failure|2
1345823|NCT01846104|4433049|P1|Overall Study|Withdrawal by Subject|1
1345824|NCT01846039|4433055|P1|Overall Study|Subject Withdrew Consent|1
1345825|NCT01846039|4433055|P1|Overall Study|Protocol Violation|1
1345826|NCT01845974|4433067|P2|Overall Study|screen failure|0
1345827|NCT01845974|4433068|P1|Overall Study|screen failure|1
1345828|NCT01845831|4433076|P5|Inpatient Phase|Withdrawal by Subject|0
1345829|NCT01845831|4433077|P4|Inpatient Phase|Withdrawal by Subject|0
1345830|NCT01845831|4433078|P3|Inpatient Phase|Withdrawal by Subject|0
1345831|NCT01845831|4433079|P2|Inpatient Phase|Withdrawal by Subject|1
1345832|NCT01845831|4433080|P1|Inpatient Phase|Withdrawal by Subject|1
1345833|NCT01845077|4433152|P6|Washout Period|Protocol Violation|0
1345834|NCT01845077|4433153|P5|Washout Period|Protocol Violation|1
1345835|NCT01845077|4433154|P4|Washout Period|Protocol Violation|1
1345836|NCT01845077|4433155|P3|Washout Period|Protocol Violation|0
1345837|NCT01845077|4433156|P2|Washout Period|Protocol Violation|0
1345838|NCT01845077|4433157|P1|Washout Period|Protocol Violation|0
1345839|NCT01845077|4433152|P6|Washout Period|elevated lab values (not clinic. sign.)|0
1345840|NCT01845077|4433153|P5|Washout Period|elevated lab values (not clinic. sign.)|0
1345841|NCT01845077|4433154|P4|Washout Period|elevated lab values (not clinic. sign.)|0
1345842|NCT01845077|4433155|P3|Washout Period|elevated lab values (not clinic. sign.)|1
1345843|NCT01845077|4433156|P2|Washout Period|elevated lab values (not clinic. sign.)|0
1345844|NCT01845077|4433157|P1|Washout Period|elevated lab values (not clinic. sign.)|0
1345845|NCT01845077|4433152|P6|Washout Period|Adverse Event|0
1345846|NCT01845077|4433153|P5|Washout Period|Adverse Event|0
1345847|NCT01845077|4433154|P4|Washout Period|Adverse Event|0
1345848|NCT01845077|4433155|P3|Washout Period|Adverse Event|0
1345849|NCT01845077|4433156|P2|Washout Period|Adverse Event|0
1345850|NCT01845077|4433157|P1|Washout Period|Adverse Event|1
1345851|NCT01845077|4433152|P6|Washout Period|Lost to Follow-up|1
1345852|NCT01845077|4433153|P5|Washout Period|Lost to Follow-up|0
1345853|NCT01845077|4433154|P4|Washout Period|Lost to Follow-up|1
1345854|NCT01845077|4433155|P3|Washout Period|Lost to Follow-up|0
1345855|NCT01845077|4433156|P2|Washout Period|Lost to Follow-up|1
1345856|NCT01845077|4433157|P1|Washout Period|Lost to Follow-up|0
1345857|NCT01845025|4433203|P2|Overall Study|Missing|1
1345858|NCT01845025|4433204|P1|Overall Study|Missing|1
1345859|NCT01845025|4433203|P2|Overall Study|Protocol deviation|6
1345860|NCT01845025|4433204|P1|Overall Study|Protocol deviation|3
1345861|NCT01845025|4433203|P2|Overall Study|Death|0
1345862|NCT01845025|4433204|P1|Overall Study|Death|2
1345863|NCT01845025|4433203|P2|Overall Study|Administrative problems|8
1345864|NCT01845025|4433204|P1|Overall Study|Administrative problems|8
1345865|NCT01845025|4433203|P2|Overall Study|Lost to Follow-up|13
1345866|NCT01845025|4433204|P1|Overall Study|Lost to Follow-up|13
1345867|NCT01845025|4433203|P2|Overall Study|Withdrawal by Subject|44
1345868|NCT01845025|4433204|P1|Overall Study|Withdrawal by Subject|48
1345869|NCT01845025|4433203|P2|Overall Study|Unsatisfactory therapeutic effect|2
1345870|NCT01845025|4433204|P1|Overall Study|Unsatisfactory therapeutic effect|4
1345871|NCT01845025|4433203|P2|Overall Study|Adverse Event|3
1345872|NCT01845025|4433204|P1|Overall Study|Adverse Event|6
1345873|NCT01844895|4433226|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
1345874|NCT01844895|4433226|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
1345875|NCT01844895|4433226|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
1345876|NCT01844895|4433226|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
1345877|NCT01844895|4433226|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
1345878|NCT01844895|4433226|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
1345879|NCT01844895|4433226|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
1345880|NCT01844856|4433244|P2|Overall Study|Randomized but was a Screen Failure|1
1345881|NCT01844856|4433245|P1|Overall Study|Randomized but was a Screen Failure|0
1345882|NCT01844856|4433244|P2|Overall Study|Inadvertently Not Scheduled|0
1345883|NCT01844856|4433245|P1|Overall Study|Inadvertently Not Scheduled|1
1345884|NCT01844856|4433244|P2|Overall Study|Enterococcus Resistant|1
1345885|NCT01844856|4433245|P1|Overall Study|Enterococcus Resistant|0
1345886|NCT01844856|4433244|P2|Overall Study|Noncompliance|3
1345887|NCT01844856|4433245|P1|Overall Study|Noncompliance|2
1345888|NCT01844856|4433244|P2|Overall Study|Withdrawal by Subject|2
1345889|NCT01844856|4433245|P1|Overall Study|Withdrawal by Subject|3
1345890|NCT01844856|4433244|P2|Overall Study|Adverse Event|6
1345891|NCT01844856|4433245|P1|Overall Study|Adverse Event|3
1345892|NCT01844856|4433244|P2|Overall Study|Lost to Follow-up|3
1345893|NCT01844856|4433245|P1|Overall Study|Lost to Follow-up|15
1345894|NCT01844830|4433257|P2|Overall Study|Withdrawal by Subject|0
1345895|NCT01844830|4433258|P1|Overall Study|Withdrawal by Subject|1
1345896|NCT01844817|4433288|P2|Treatment|Other|3
1345897|NCT01844817|4433289|P1|Treatment|Other|0
1345898|NCT01844817|4433288|P2|Treatment|Lost to Follow-up|1
1345899|NCT01844817|4433289|P1|Treatment|Lost to Follow-up|0
1345900|NCT01844817|4433288|P2|Treatment|Death|8
1345901|NCT01844817|4433289|P1|Treatment|Death|10
1345902|NCT01844817|4433288|P2|Treatment|Withdrawal by Subject|6
1345903|NCT01844817|4433289|P1|Treatment|Withdrawal by Subject|10
1345904|NCT01844817|4433288|P2|Treatment|Adverse Event|9
1345905|NCT01844817|4433289|P1|Treatment|Adverse Event|17
1345906|NCT01844817|4433288|P2|Treatment|Progressive Disease|36
1345907|NCT01844817|4433289|P1|Treatment|Progressive Disease|27
1345908|NCT01844817|4433288|P2|Enrolled and Randomized|Withdrawal by Subject|3
1345909|NCT01844817|4433289|P1|Enrolled and Randomized|Withdrawal by Subject|2
1345910|NCT01844778|4433302|P3|Overall Study|Adverse Event|2
1345911|NCT01844778|4433303|P2|Overall Study|Adverse Event|2
1345912|NCT01844778|4433304|P1|Overall Study|Adverse Event|0
1345913|NCT01844778|4433302|P3|Overall Study|Withdrawal by Subject|0
1345914|NCT01844778|4433303|P2|Overall Study|Withdrawal by Subject|0
1345915|NCT01844778|4433304|P1|Overall Study|Withdrawal by Subject|2
1345916|NCT01844778|4433302|P3|Overall Study|Protocol deviation|2
1345917|NCT01844778|4433303|P2|Overall Study|Protocol deviation|1
1345918|NCT01844778|4433304|P1|Overall Study|Protocol deviation|0
1345919|NCT01844765|4433330|P2|Overall Study|Untreated|0
1345920|NCT01844765|4433331|P1|Overall Study|Untreated|1
1345921|NCT01844765|4433330|P2|Overall Study|Protocol Violation|0
1345922|NCT01844765|4433331|P1|Overall Study|Protocol Violation|1
1345923|NCT01844765|4433330|P2|Overall Study|Disease progression|0
1345924|NCT01844765|4433331|P1|Overall Study|Disease progression|1
1345925|NCT01844765|4433330|P2|Overall Study|Administrative problems|1
1345926|NCT01844765|4433331|P1|Overall Study|Administrative problems|1
1345927|NCT01844765|4433330|P2|Overall Study|Withdrawal by Subject|1
1345928|NCT01844765|4433331|P1|Overall Study|Withdrawal by Subject|0
1345929|NCT01844765|4433330|P2|Overall Study|Adverse Event|4
1345930|NCT01844765|4433331|P1|Overall Study|Adverse Event|5
1345931|NCT01844700|4433351|P2|Overall Study|stopped taking meds|1
1345932|NCT01844700|4433352|P1|Overall Study|stopped taking meds|0
1345933|NCT01844700|4433351|P2|Overall Study|Withdrawal by Subject|0
1345934|NCT01844700|4433352|P1|Overall Study|Withdrawal by Subject|1
1345935|NCT01844700|4433351|P2|Overall Study|refused medication switch|0
1345936|NCT01844700|4433352|P1|Overall Study|refused medication switch|1
1345937|NCT01844700|4433351|P2|Overall Study|Lack of Efficacy|0
1345938|NCT01844700|4433352|P1|Overall Study|Lack of Efficacy|1
1345939|NCT01844687|4433364|P1|Visit 4|Withdrawal by Subject|2
1345940|NCT01844687|4433364|P1|Visit 4|Lost to Follow-up|1
1345941|NCT01844687|4433364|P1|Visit 4|Pregnancy|1
1345942|NCT01844687|4433364|P1|Visit 3|child care problems|1
1345943|NCT01844687|4433364|P1|Visit 3|Withdrawal by Subject|3
1345944|NCT01844687|4433364|P1|Visit 3|Lost to Follow-up|1
1345945|NCT01844687|4433364|P1|Visit 2|Protocol Violation|1
1345946|NCT01844687|4433364|P1|Visit 2|Withdrawal by Subject|1
1345947|NCT01844687|4433364|P1|Visit 1|Lost to Follow-up|5
1345948|NCT01844687|4433364|P1|Visit 1|Protocol Violation|3
1345949|NCT01844531|4433427|P4|Overall Study|Withdrawal by Subject|0
1345950|NCT01844531|4433428|P3|Overall Study|Withdrawal by Subject|0
1345951|NCT01844531|4433429|P2|Overall Study|Withdrawal by Subject|1
1345952|NCT01844531|4433430|P1|Overall Study|Withdrawal by Subject|0
1345953|NCT01844518|4433460|P1|Long-Term Extension|Still in On-Going Study|149
1345954|NCT01844518|4433460|P1|Long-Term Extension|No Longer Met Study Criteria|1
1345955|NCT01844518|4433460|P1|Long-Term Extension|Adverse Event|1
1345956|NCT01844518|4433460|P1|Long-Term Extension|Lack of Efficacy|6
1345957|NCT01844518|4433460|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
1345958|NCT01844518|4433460|P1|Short-Term (ST) Period|Withdrawal of Consent|2
1345959|NCT01844518|4433460|P1|Short-Term (ST) Period|Lack of Efficacy|3
1345960|NCT01844518|4433460|P1|Short-Term (ST) Period|Adverse Event|3
1345961|NCT01844505|4433477|P3|Overall Study|Not Reported|1
1345962|NCT01844505|4433478|P2|Overall Study|Not Reported|0
1345963|NCT01844505|4433479|P1|Overall Study|Not Reported|0
1345964|NCT01844505|4433477|P3|Overall Study|Other Reasons|2
1345965|NCT01844505|4433478|P2|Overall Study|Other Reasons|2
1345966|NCT01844505|4433479|P1|Overall Study|Other Reasons|4
1345967|NCT01844505|4433477|P3|Overall Study|Subject no longer meets criteria|0
1345968|NCT01844505|4433478|P2|Overall Study|Subject no longer meets criteria|1
1345969|NCT01844505|4433479|P1|Overall Study|Subject no longer meets criteria|0
1345970|NCT01844505|4433477|P3|Overall Study|Poor/non-compliance|1
1345971|NCT01844505|4433478|P2|Overall Study|Poor/non-compliance|1
1345972|NCT01844505|4433479|P1|Overall Study|Poor/non-compliance|1
1345973|NCT01844505|4433477|P3|Overall Study|Maximum clinical benefit|2
1345974|NCT01844505|4433478|P2|Overall Study|Maximum clinical benefit|11
1345975|NCT01844505|4433479|P1|Overall Study|Maximum clinical benefit|8
1345976|NCT01844505|4433477|P3|Overall Study|Lost to Follow-up|0
1345977|NCT01844505|4433478|P2|Overall Study|Lost to Follow-up|0
1345978|NCT01844505|4433479|P1|Overall Study|Lost to Follow-up|1
1345979|NCT01844505|4433477|P3|Overall Study|Withdrawal by Subject|0
1345980|NCT01844505|4433478|P2|Overall Study|Withdrawal by Subject|3
1345981|NCT01844505|4433479|P1|Overall Study|Withdrawal by Subject|0
1345982|NCT01844505|4433477|P3|Overall Study|Subject request discontinue treatment|8
1345983|NCT01844505|4433478|P2|Overall Study|Subject request discontinue treatment|14
1345984|NCT01844505|4433479|P1|Overall Study|Subject request discontinue treatment|17
1345985|NCT01844505|4433477|P3|Overall Study|Adverse event unrelated to study drug|6
1345986|NCT01844505|4433478|P2|Overall Study|Adverse event unrelated to study drug|15
1345987|NCT01844505|4433479|P1|Overall Study|Adverse event unrelated to study drug|7
1345988|NCT01844505|4433477|P3|Overall Study|Death|1
1345989|NCT01844505|4433478|P2|Overall Study|Death|3
1345990|NCT01844505|4433479|P1|Overall Study|Death|1
1345991|NCT01844505|4433477|P3|Overall Study|Study drug toxicity|50
1345992|NCT01844505|4433478|P2|Overall Study|Study drug toxicity|131
1345993|NCT01844505|4433479|P1|Overall Study|Study drug toxicity|40
1345994|NCT01844505|4433477|P3|Overall Study|Disease progression|224
1345995|NCT01844505|4433478|P2|Overall Study|Disease progression|88
1345996|NCT01844505|4433479|P1|Overall Study|Disease progression|170
1345997|NCT01843972|4433590|P10|Overall Study|Withdrawal by Subject|0
1345998|NCT01843972|4433591|P9|Overall Study|Withdrawal by Subject|0
1345999|NCT01843972|4433592|P8|Overall Study|Withdrawal by Subject|0
1346000|NCT01843972|4433593|P7|Overall Study|Withdrawal by Subject|0
1346001|NCT01843972|4433594|P6|Overall Study|Withdrawal by Subject|0
1346002|NCT01843972|4433595|P5|Overall Study|Withdrawal by Subject|1
1346003|NCT01843972|4433596|P4|Overall Study|Withdrawal by Subject|0
1346004|NCT01843972|4433597|P3|Overall Study|Withdrawal by Subject|0
1346005|NCT01843972|4433598|P2|Overall Study|Withdrawal by Subject|0
1346006|NCT01843972|4433599|P1|Overall Study|Withdrawal by Subject|0
1346007|NCT01843933|4433669|P2|Overall Study|Data lost|4
1346008|NCT01843933|4433670|P1|Overall Study|Data lost|6
1346009|NCT01843842|4433689|P2|Overall Study|Do not meet inclusion criteria|1
1346010|NCT01843842|4433690|P1|Overall Study|Do not meet inclusion criteria|1
1346011|NCT01843777|4433712|P2|Overall Study|Withdrawal by Subject|0
1346012|NCT01843777|4433713|P1|Overall Study|Withdrawal by Subject|1
1346013|NCT01843673|4433721|P1|Overall Study|Withdrawal by Subject|4
1346014|NCT01843673|4433721|P1|Overall Study|Lack of Efficacy|2
1346015|NCT01843660|4433733|P1|Overall Study|Other|30
1346016|NCT01843374|4433757|P2|Overall Study|Withdrawing due to Other reason|46
1346017|NCT01843374|4433758|P1|Overall Study|Withdrawing due to Other reason|20
1346018|NCT01843374|4433757|P2|Overall Study|Withdrawal by Subject|20
1346019|NCT01843374|4433758|P1|Overall Study|Withdrawal by Subject|14
1346020|NCT01843374|4433757|P2|Overall Study|Death|313
1346021|NCT01843374|4433758|P1|Overall Study|Death|155
1346022|NCT01843348|4433785|P3|Overall Study|Various reasons|6
1346023|NCT01843348|4433786|P2|Overall Study|Various reasons|9
1346024|NCT01843348|4433787|P1|Overall Study|Various reasons|4
1346025|NCT01843348|4433785|P3|Overall Study|Graft loss/retransplantation|11
1346026|NCT01843348|4433786|P2|Overall Study|Graft loss/retransplantation|8
1346027|NCT01843348|4433787|P1|Overall Study|Graft loss/retransplantation|5
1346028|NCT01843348|4433785|P3|Overall Study|Death|4
1346029|NCT01843348|4433786|P2|Overall Study|Death|3
1346030|NCT01843348|4433787|P1|Overall Study|Death|5
1346031|NCT01843348|4433785|P3|Overall Study|Lost to Follow-up|2
1346032|NCT01843348|4433786|P2|Overall Study|Lost to Follow-up|4
1346033|NCT01843348|4433787|P1|Overall Study|Lost to Follow-up|5
1346034|NCT01843348|4433785|P3|Overall Study|Withdrawal by Subject|18
1346035|NCT01843348|4433786|P2|Overall Study|Withdrawal by Subject|16
1346036|NCT01843348|4433787|P1|Overall Study|Withdrawal by Subject|4
1346037|NCT01843205|4433827|P2|First Treatment (11 Days)|Withdrawal by Subject|0
1346038|NCT01843205|4433828|P1|First Treatment (11 Days)|Withdrawal by Subject|1
1346039|NCT01843192|4433889|P3|Overall Study|Intra-operative exclusions per protocol|2
1346040|NCT01843192|4433890|P2|Overall Study|Intra-operative exclusions per protocol|6
1346041|NCT01843192|4433891|P1|Overall Study|Intra-operative exclusions per protocol|2
1346042|NCT01842958|4433922|P2|Overall Study|Lost to Follow-up|1
1346043|NCT01842958|4433923|P1|Overall Study|Lost to Follow-up|1
1346044|NCT01842633|4433996|P3|Overall Study|Technical issues|0
1346045|NCT01842633|4433997|P2|Overall Study|Technical issues|0
1346046|NCT01842633|4433998|P1|Overall Study|Technical issues|1
1346047|NCT01842633|4433996|P3|Overall Study|Withdrawal by Subject|0
1346048|NCT01842633|4433997|P2|Overall Study|Withdrawal by Subject|1
1346049|NCT01842633|4433998|P1|Overall Study|Withdrawal by Subject|0
1346050|NCT01842633|4433996|P3|Overall Study|Adverse Event|0
1346051|NCT01842633|4433997|P2|Overall Study|Adverse Event|1
1346052|NCT01842633|4433998|P1|Overall Study|Adverse Event|1
1346053|NCT01842633|4433996|P3|Overall Study|Screen Failure|0
1346054|NCT01842633|4433997|P2|Overall Study|Screen Failure|0
1346055|NCT01842633|4433998|P1|Overall Study|Screen Failure|1
1346056|NCT01842620|4434045|P2|Period 1|Withdrawal by Subject|0
1346057|NCT01842620|4434046|P1|Period 1|Withdrawal by Subject|1
1346058|NCT01842607|4434062|P1|Overall Study|Withdrawal by Subject|14
1346059|NCT01842607|4434062|P1|Overall Study|Physician Decision|9
1346060|NCT01842607|4434062|P1|Overall Study|Lost to Follow-up|3
1346061|NCT01842607|4434062|P1|Overall Study|Protocol defined stopping criteria|2
1346062|NCT01842607|4434062|P1|Overall Study|Protocol Violation|8
1346063|NCT01842607|4434062|P1|Overall Study|Lack of Efficacy|19
1346064|NCT01842607|4434062|P1|Overall Study|Adverse Event|11
1346065|NCT01842438|4434094|P2|T2: 6month Follow-up|Death|1
1346066|NCT01842438|4434095|P1|T2: 6month Follow-up|Death|0
1346067|NCT01842438|4434094|P2|T2: 6month Follow-up|Withdrawal by Subject|3
1346068|NCT01842438|4434095|P1|T2: 6month Follow-up|Withdrawal by Subject|4
1346069|NCT01842438|4434094|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
1346070|NCT01842438|4434095|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
1346071|NCT01842334|4434109|P2|Overall Study|Moved away mid-study|1
1346072|NCT01842334|4434110|P1|Overall Study|Moved away mid-study|0
1346073|NCT01842334|4434109|P2|Overall Study|Withdrawal by Subject|3
1346074|NCT01842334|4434110|P1|Overall Study|Withdrawal by Subject|3
1346075|NCT01841970|4434116|P1|Overall Study|Lost to Follow-up|8
1346076|NCT01841970|4434116|P1|Overall Study|Physician Decision|2
1346077|NCT01841970|4434116|P1|Overall Study|Withdrawal by Subject|1
1346078|NCT01841697|4434142|P2|Overall Study|Withdrawal by Subject|16
1346079|NCT01841697|4434143|P1|Overall Study|Withdrawal by Subject|16
1346080|NCT01841697|4434142|P2|Overall Study|Lost to Follow-up|1
1346081|NCT01841697|4434143|P1|Overall Study|Lost to Follow-up|4
1346082|NCT01841697|4434142|P2|Overall Study|Death|1
1346083|NCT01841697|4434143|P1|Overall Study|Death|0
1346084|NCT01841593|4434183|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
1346085|NCT01841593|4434184|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
1346086|NCT01841593|4434183|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
1346087|NCT01841593|4434184|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
1346088|NCT01841567|4434200|P1|Overall Study|Adverse Event|3
1346089|NCT01840943|4434228|P2|Overall Study|Lost to Follow-up|4
1346090|NCT01840943|4434229|P1|Overall Study|Lost to Follow-up|4
1346091|NCT01840943|4434228|P2|Overall Study|Physician Decision|2
1346092|NCT01840943|4434229|P1|Overall Study|Physician Decision|4
1346093|NCT01840943|4434228|P2|Overall Study|Withdrawal by Subject|6
1346094|NCT01840943|4434229|P1|Overall Study|Withdrawal by Subject|5
1346095|NCT01840605|4434265|P2|Overall Study|Physician Decision|1
1346096|NCT01840605|4434266|P1|Overall Study|Physician Decision|2
1346097|NCT01840605|4434265|P2|Overall Study|Adverse Event|1
1346098|NCT01840605|4434266|P1|Overall Study|Adverse Event|0
1346099|NCT01840410|4434280|P2|Overall Study|Adverse Event|1
1346100|NCT01840410|4434281|P1|Overall Study|Adverse Event|1
1346101|NCT01840410|4434280|P2|Overall Study|Withdrawal by Subject|1
1346102|NCT01840410|4434281|P1|Overall Study|Withdrawal by Subject|2
1346103|NCT01840410|4434280|P2|Overall Study|Lost to Follow-up|0
1346104|NCT01840410|4434281|P1|Overall Study|Lost to Follow-up|1
1346105|NCT01840410|4434280|P2|Overall Study|Protocol deviation|0
1346106|NCT01840410|4434281|P1|Overall Study|Protocol deviation|1
1346107|NCT01840410|4434280|P2|Overall Study|Pregnancy|0
1346108|NCT01840410|4434281|P1|Overall Study|Pregnancy|1
1346109|NCT01840410|4434280|P2|Overall Study|Physician Decision|2
1346110|NCT01840410|4434281|P1|Overall Study|Physician Decision|1
1346111|NCT01840163|4434330|P2|Overall Study|Lost to Follow-up|16
1346112|NCT01840163|4434331|P1|Overall Study|Lost to Follow-up|19
1346113|NCT01839279|4434476|P3|Overall Study|Classified as 'Other'|0
1346114|NCT01839279|4434477|P2|Overall Study|Classified as 'Other'|0
1346115|NCT01839279|4434478|P1|Overall Study|Classified as 'Other'|5
1346116|NCT01839279|4434476|P3|Overall Study|Withdrawal by Subject|1
1346117|NCT01839279|4434477|P2|Overall Study|Withdrawal by Subject|1
1346118|NCT01839279|4434478|P1|Overall Study|Withdrawal by Subject|4
1346119|NCT01839279|4434476|P3|Overall Study|Adverse Event|1
1346120|NCT01839279|4434477|P2|Overall Study|Adverse Event|1
1346121|NCT01839279|4434478|P1|Overall Study|Adverse Event|4
1346122|NCT01838941|4434510|P1|Overall Study|Withdrawal by Subject|1
1346123|NCT01838941|4434510|P1|Overall Study|Adverse Event|1
1346124|NCT01838694|4434611|P2|Overall Study|Adverse Event|1
1346125|NCT01838694|4434612|P1|Overall Study|Adverse Event|0
1346126|NCT01838681|4434621|P4|Period B/A+|Administrative or other reasons|28
1346127|NCT01838681|4434622|P3|Period B/A+|Administrative or other reasons|10
1346128|NCT01838681|4434623|P2|Period B/A+|Administrative or other reasons|6
1346129|NCT01838681|4434624|P1|Period B/A+|Administrative or other reasons|0
1346130|NCT01838681|4434621|P4|Period B/A+|Withdrawal before treatment|0
1346131|NCT01838681|4434622|P3|Period B/A+|Withdrawal before treatment|0
1346132|NCT01838681|4434623|P2|Period B/A+|Withdrawal before treatment|1
1346133|NCT01838681|4434624|P1|Period B/A+|Withdrawal before treatment|0
1346134|NCT01838681|4434621|P4|Period B/A+|Lost to Follow-up|11
1346135|NCT01838681|4434622|P3|Period B/A+|Lost to Follow-up|5
1346136|NCT01838681|4434623|P2|Period B/A+|Lost to Follow-up|2
1346137|NCT01838681|4434624|P1|Period B/A+|Lost to Follow-up|0
1346138|NCT01838681|4434621|P4|Period B/A+|Non-compliance with IMP|3
1346139|NCT01838681|4434622|P3|Period B/A+|Non-compliance with IMP|3
1346140|NCT01838681|4434623|P2|Period B/A+|Non-compliance with IMP|2
1346141|NCT01838681|4434624|P1|Period B/A+|Non-compliance with IMP|0
1346142|NCT01838681|4434621|P4|Period B/A+|Protocol Violation|6
1346143|NCT01838681|4434622|P3|Period B/A+|Protocol Violation|4
1346144|NCT01838681|4434623|P2|Period B/A+|Protocol Violation|1
1346145|NCT01838681|4434624|P1|Period B/A+|Protocol Violation|0
1346146|NCT01838681|4434621|P4|Period B/A+|Withdrawal by Subject|47
1346147|NCT01838681|4434622|P3|Period B/A+|Withdrawal by Subject|35
1346148|NCT01838681|4434623|P2|Period B/A+|Withdrawal by Subject|28
1346149|NCT01838681|4434624|P1|Period B/A+|Withdrawal by Subject|0
1346150|NCT01838681|4434621|P4|Period B/A+|Lack of Efficacy|6
1346151|NCT01838681|4434622|P3|Period B/A+|Lack of Efficacy|11
1346152|NCT01838681|4434623|P2|Period B/A+|Lack of Efficacy|9
1346153|NCT01838681|4434624|P1|Period B/A+|Lack of Efficacy|0
1346154|NCT01838681|4434621|P4|Period B/A+|Adverse Event|16
1346155|NCT01838681|4434622|P3|Period B/A+|Adverse Event|27
1346156|NCT01838681|4434623|P2|Period B/A+|Adverse Event|13
1346157|NCT01838681|4434624|P1|Period B/A+|Adverse Event|0
1346158|NCT01838681|4434621|P4|Period A|Administrative or other reasons|0
1346159|NCT01838681|4434622|P3|Period A|Administrative or other reasons|0
1346160|NCT01838681|4434623|P2|Period A|Administrative or other reasons|0
1346161|NCT01838681|4434624|P1|Period A|Administrative or other reasons|17
1346162|NCT01838681|4434621|P4|Period A|Withdrawal before treatment|0
1346163|NCT01838681|4434622|P3|Period A|Withdrawal before treatment|0
1346164|NCT01838681|4434623|P2|Period A|Withdrawal before treatment|0
1346165|NCT01838681|4434624|P1|Period A|Withdrawal before treatment|4
1346166|NCT01838681|4434621|P4|Period A|Lost to Follow-up|0
1346167|NCT01838681|4434622|P3|Period A|Lost to Follow-up|0
1346168|NCT01838681|4434623|P2|Period A|Lost to Follow-up|0
1346169|NCT01838681|4434624|P1|Period A|Lost to Follow-up|4
1346170|NCT01838681|4434621|P4|Period A|Non-compliance with IMP|0
1346171|NCT01838681|4434622|P3|Period A|Non-compliance with IMP|0
1346172|NCT01838681|4434623|P2|Period A|Non-compliance with IMP|0
1346173|NCT01838681|4434624|P1|Period A|Non-compliance with IMP|6
1346174|NCT01838681|4434621|P4|Period A|Protocol Violation|0
1346175|NCT01838681|4434622|P3|Period A|Protocol Violation|0
1346176|NCT01838681|4434623|P2|Period A|Protocol Violation|0
1346177|NCT01838681|4434624|P1|Period A|Protocol Violation|16
1346178|NCT01838681|4434621|P4|Period A|Withdrawal by Subject|0
1346179|NCT01838681|4434622|P3|Period A|Withdrawal by Subject|0
1346180|NCT01838681|4434623|P2|Period A|Withdrawal by Subject|0
1346181|NCT01838681|4434624|P1|Period A|Withdrawal by Subject|70
1346182|NCT01838681|4434621|P4|Period A|Early response|0
1346183|NCT01838681|4434622|P3|Period A|Early response|0
1346184|NCT01838681|4434623|P2|Period A|Early response|0
1346185|NCT01838681|4434624|P1|Period A|Early response|148
1346186|NCT01838681|4434621|P4|Period A|Lack of Efficacy|0
1346187|NCT01838681|4434622|P3|Period A|Lack of Efficacy|0
1346188|NCT01838681|4434623|P2|Period A|Lack of Efficacy|0
1346189|NCT01838681|4434624|P1|Period A|Lack of Efficacy|21
1346190|NCT01838681|4434621|P4|Period A|Adverse Event|0
1346191|NCT01838681|4434622|P3|Period A|Adverse Event|0
1346192|NCT01838681|4434623|P2|Period A|Adverse Event|0
1346193|NCT01838681|4434624|P1|Period A|Adverse Event|39
1346194|NCT01838642|4434732|P1|Overall Study|Died on study|1
1346195|NCT01838616|4434745|P2|Pick-up Arm|Technical problems|0
1346196|NCT01838616|4434746|P1|Pick-up Arm|Technical problems|1
1346197|NCT01838616|4434745|P2|Pick-up Arm|Withdrawal by Subject|0
1346198|NCT01838616|4434746|P1|Pick-up Arm|Withdrawal by Subject|1
1346199|NCT01838616|4434745|P2|Pick-up Arm|Adverse Event|0
1346200|NCT01838616|4434746|P1|Pick-up Arm|Adverse Event|9
1346201|NCT01838616|4434745|P2|Pick-up Arm|Lack of Efficacy|0
1346202|NCT01838616|4434746|P1|Pick-up Arm|Lack of Efficacy|4
1346203|NCT01838616|4434745|P2|Continuation Period|Technical problems|1
1346204|NCT01838616|4434746|P1|Continuation Period|Technical problems|0
1346205|NCT01838616|4434745|P2|Continuation Period|Withdrawal by Subject|4
1346206|NCT01838616|4434746|P1|Continuation Period|Withdrawal by Subject|0
1346207|NCT01838616|4434745|P2|Continuation Period|Lost to Follow-up|0
1346208|NCT01838616|4434746|P1|Continuation Period|Lost to Follow-up|1
1346209|NCT01838616|4434745|P2|Continuation Period|Protocol Violation|0
1346210|NCT01838616|4434746|P1|Continuation Period|Protocol Violation|2
1346211|NCT01838616|4434745|P2|Continuation Period|Adverse Event|4
1346212|NCT01838616|4434746|P1|Continuation Period|Adverse Event|8
1346213|NCT01838616|4434745|P2|Continuation Period|Lack of Efficacy|5
1346214|NCT01838616|4434746|P1|Continuation Period|Lack of Efficacy|3
1346215|NCT01838616|4434745|P2|Titration Period|Protocol Violation|1
1346216|NCT01838616|4434746|P1|Titration Period|Protocol Violation|0
1346217|NCT01838616|4434745|P2|Titration Period|Not specified|0
1346218|NCT01838616|4434746|P1|Titration Period|Not specified|1
1346219|NCT01838616|4434745|P2|Titration Period|Technical problems|0
1346220|NCT01838616|4434746|P1|Titration Period|Technical problems|1
1346221|NCT01838616|4434745|P2|Titration Period|Withdrawal by Subject|5
1346222|NCT01838616|4434746|P1|Titration Period|Withdrawal by Subject|5
1346223|NCT01838616|4434745|P2|Titration Period|Lack of Efficacy|12
1346224|NCT01838616|4434746|P1|Titration Period|Lack of Efficacy|5
1346225|NCT01838616|4434745|P2|Titration Period|Adverse Event|48
1346226|NCT01838616|4434746|P1|Titration Period|Adverse Event|18
1346227|NCT01838590|4434817|P2|Overall Study|Lost to Follow-up|1
1346228|NCT01838590|4434818|P1|Overall Study|Lost to Follow-up|0
1346229|NCT01838590|4434817|P2|Overall Study|Lack of Efficacy|4
1346230|NCT01838590|4434818|P1|Overall Study|Lack of Efficacy|12
1346231|NCT01838499|4434842|P2|Overall Study|Withdrawal by Subject|9
1346232|NCT01838499|4434843|P1|Overall Study|Withdrawal by Subject|19
1346233|NCT01838499|4434842|P2|Overall Study|Adverse Event|1
1346234|NCT01838499|4434843|P1|Overall Study|Adverse Event|2
1346235|NCT01838499|4434842|P2|Overall Study|Lack of Efficacy|2
1346236|NCT01838499|4434843|P1|Overall Study|Lack of Efficacy|1
1346237|NCT01838499|4434842|P2|Overall Study|Lost to Follow-up|4
1346238|NCT01838499|4434843|P1|Overall Study|Lost to Follow-up|2
1346239|NCT01838499|4434842|P2|Overall Study|Protocol Violation|1
1346240|NCT01838499|4434843|P1|Overall Study|Protocol Violation|0
1346241|NCT01838213|4434870|P2|Overall Study|Ineligible|191
1346242|NCT01838213|4434871|P1|Overall Study|Ineligible|166
1346243|NCT01838044|4434879|P2|Overall Study|Lost to Follow-up|2
1346244|NCT01838044|4434880|P1|Overall Study|Lost to Follow-up|0
1346245|NCT01838044|4434879|P2|Overall Study|Medication error without associated AE|1
1346246|NCT01838044|4434880|P1|Overall Study|Medication error without associated AE|0
1346247|NCT01838044|4434879|P2|Overall Study|Insufficient clinical response|2
1346248|NCT01838044|4434880|P1|Overall Study|Insufficient clinical response|1
1346249|NCT01838044|4434879|P2|Overall Study|Withdrawal by Subject|2
1346250|NCT01838044|4434880|P1|Overall Study|Withdrawal by Subject|0
1346251|NCT01838044|4434879|P2|Overall Study|Protocol Violation|3
1346252|NCT01838044|4434880|P1|Overall Study|Protocol Violation|3
1346253|NCT01838044|4434879|P2|Overall Study|Adverse Event|6
1346254|NCT01838044|4434880|P1|Overall Study|Adverse Event|4
1346255|NCT01837966|4434913|P2|Overall Study|Withdrawal by Subject|1
1346256|NCT01837966|4434914|P1|Overall Study|Withdrawal by Subject|2
1346257|NCT01837823|4434920|P1|Overall Study|Lost to Follow-up|6
1346258|NCT01837797|4434951|P5|Period 3|Other|2
1346259|NCT01837797|4434952|P4|Period 3|Other|0
1346260|NCT01837797|4434953|P3|Period 3|Other|0
1346261|NCT01837797|4434954|P2|Period 3|Other|0
1346262|NCT01837797|4434955|P1|Period 3|Other|0
1346263|NCT01837797|4434951|P5|Period 3|Administrative reasons|20
1346264|NCT01837797|4434952|P4|Period 3|Administrative reasons|0
1346265|NCT01837797|4434953|P3|Period 3|Administrative reasons|0
1346266|NCT01837797|4434954|P2|Period 3|Administrative reasons|0
1346267|NCT01837797|4434955|P1|Period 3|Administrative reasons|0
1346268|NCT01837797|4434951|P5|Period 3|Adverse Event|1
1346269|NCT01837797|4434952|P4|Period 3|Adverse Event|0
1346270|NCT01837797|4434953|P3|Period 3|Adverse Event|0
1346271|NCT01837797|4434954|P2|Period 3|Adverse Event|0
1346272|NCT01837797|4434955|P1|Period 3|Adverse Event|0
1346273|NCT01837797|4434951|P5|Period 2|Adverse Event|0
1346274|NCT01837797|4434952|P4|Period 2|Adverse Event|1
1346275|NCT01837797|4434953|P3|Period 2|Adverse Event|0
1346276|NCT01837797|4434954|P2|Period 2|Adverse Event|0
1346277|NCT01837797|4434955|P1|Period 2|Adverse Event|0
1346278|NCT01837797|4434951|P5|Period 2|Administrative or other reasons|0
1346279|NCT01837797|4434952|P4|Period 2|Administrative or other reasons|4
1346280|NCT01837797|4434953|P3|Period 2|Administrative or other reasons|2
1346281|NCT01837797|4434954|P2|Period 2|Administrative or other reasons|5
1346282|NCT01837797|4434955|P1|Period 2|Administrative or other reasons|0
1346283|NCT01837797|4434951|P5|Period 1|Other|0
1346284|NCT01837797|4434952|P4|Period 1|Other|0
1346285|NCT01837797|4434953|P3|Period 1|Other|0
1346286|NCT01837797|4434954|P2|Period 1|Other|0
1346287|NCT01837797|4434955|P1|Period 1|Other|10
1346288|NCT01837797|4434951|P5|Period 1|Withdrawal of consent before treatment|0
1346289|NCT01837797|4434952|P4|Period 1|Withdrawal of consent before treatment|0
1346290|NCT01837797|4434953|P3|Period 1|Withdrawal of consent before treatment|0
1346291|NCT01837797|4434954|P2|Period 1|Withdrawal of consent before treatment|0
1346292|NCT01837797|4434955|P1|Period 1|Withdrawal of consent before treatment|1
1346293|NCT01837797|4434951|P5|Period 1|Administrative reasons|0
1346294|NCT01837797|4434952|P4|Period 1|Administrative reasons|0
1346295|NCT01837797|4434953|P3|Period 1|Administrative reasons|0
1346296|NCT01837797|4434954|P2|Period 1|Administrative reasons|0
1346297|NCT01837797|4434955|P1|Period 1|Administrative reasons|76
1346298|NCT01837797|4434951|P5|Period 1|Withdrawal by Subject|0
1346299|NCT01837797|4434952|P4|Period 1|Withdrawal by Subject|0
1346300|NCT01837797|4434953|P3|Period 1|Withdrawal by Subject|0
1346301|NCT01837797|4434954|P2|Period 1|Withdrawal by Subject|0
1346302|NCT01837797|4434955|P1|Period 1|Withdrawal by Subject|6
1346303|NCT01837797|4434951|P5|Period 1|Adverse Event|0
1346304|NCT01837797|4434952|P4|Period 1|Adverse Event|0
1346305|NCT01837797|4434953|P3|Period 1|Adverse Event|0
1346306|NCT01837797|4434954|P2|Period 1|Adverse Event|0
1346307|NCT01837797|4434955|P1|Period 1|Adverse Event|9
1346308|NCT01837719|4434990|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
1346309|NCT01837719|4434990|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
1346310|NCT01837680|4435059|P2|Overall Study|switched to oral hypoglycemic or diet|4
1346311|NCT01837680|4435060|P1|Overall Study|switched to oral hypoglycemic or diet|2
1346312|NCT01837680|4435059|P2|Overall Study|allergic reaction|0
1346313|NCT01837680|4435060|P1|Overall Study|allergic reaction|6
1346314|NCT01837680|4435059|P2|Overall Study|lack of insurance|2
1346315|NCT01837680|4435060|P1|Overall Study|lack of insurance|0
1346316|NCT01837680|4435059|P2|Overall Study|Lost to Follow-up|2
1346317|NCT01837680|4435060|P1|Overall Study|Lost to Follow-up|2
1346318|NCT01836549|4435168|P7|Overall Study|Patient inevaluable to start therapy|1
1346319|NCT01836549|4435169|P6|Overall Study|Patient inevaluable to start therapy|0
1346320|NCT01836549|4435170|P5|Overall Study|Patient inevaluable to start therapy|0
1346321|NCT01836549|4435171|P4|Overall Study|Patient inevaluable to start therapy|0
1346322|NCT01836549|4435172|P3|Overall Study|Patient inevaluable to start therapy|0
1346323|NCT01836549|4435173|P2|Overall Study|Patient inevaluable to start therapy|0
1346324|NCT01836549|4435174|P1|Overall Study|Patient inevaluable to start therapy|0
1346325|NCT01836549|4435168|P7|Overall Study|Patient declared ineligible|0
1346326|NCT01836549|4435169|P6|Overall Study|Patient declared ineligible|0
1346327|NCT01836549|4435170|P5|Overall Study|Patient declared ineligible|0
1346328|NCT01836549|4435171|P4|Overall Study|Patient declared ineligible|1
1346329|NCT01836549|4435172|P3|Overall Study|Patient declared ineligible|0
1346330|NCT01836549|4435173|P2|Overall Study|Patient declared ineligible|0
1346331|NCT01836549|4435174|P1|Overall Study|Patient declared ineligible|0
1346332|NCT01836549|4435168|P7|Overall Study|Did not receive study drug|0
1346333|NCT01836549|4435169|P6|Overall Study|Did not receive study drug|0
1346334|NCT01836549|4435170|P5|Overall Study|Did not receive study drug|0
1346335|NCT01836549|4435171|P4|Overall Study|Did not receive study drug|0
1346336|NCT01836549|4435172|P3|Overall Study|Did not receive study drug|1
1346337|NCT01836549|4435173|P2|Overall Study|Did not receive study drug|0
1346338|NCT01836549|4435174|P1|Overall Study|Did not receive study drug|0
1346339|NCT01836523|4435198|P4|Overall Study|Unclassified|29
1346340|NCT01836523|4435199|P3|Overall Study|Unclassified|19
1346341|NCT01836523|4435200|P2|Overall Study|Unclassified|28
1346342|NCT01836523|4435201|P1|Overall Study|Unclassified|17
1346343|NCT01836523|4435198|P4|Overall Study|Met Withdrawal Criteria|27
1346344|NCT01836523|4435199|P3|Overall Study|Met Withdrawal Criteria|21
1346345|NCT01836523|4435200|P2|Overall Study|Met Withdrawal Criteria|13
1346346|NCT01836523|4435201|P1|Overall Study|Met Withdrawal Criteria|13
1346347|NCT01836523|4435198|P4|Overall Study|Protocol Violation|4
1346348|NCT01836523|4435199|P3|Overall Study|Protocol Violation|2
1346349|NCT01836523|4435200|P2|Overall Study|Protocol Violation|3
1346350|NCT01836523|4435201|P1|Overall Study|Protocol Violation|6
1346351|NCT01836523|4435198|P4|Overall Study|Adverse Event|14
1346352|NCT01836523|4435199|P3|Overall Study|Adverse Event|49
1346353|NCT01836523|4435200|P2|Overall Study|Adverse Event|41
1346354|NCT01836523|4435201|P1|Overall Study|Adverse Event|15
1346355|NCT01836471|4435228|P5|Overall Study|Non compliance with tx|0
1346356|NCT01836471|4435229|P4|Overall Study|Non compliance with tx|0
1346357|NCT01836471|4435230|P3|Overall Study|Non compliance with tx|0
1346358|NCT01836471|4435231|P2|Overall Study|Non compliance with tx|1
1346359|NCT01836471|4435232|P1|Overall Study|Non compliance with tx|1
1346360|NCT01836471|4435228|P5|Overall Study|Adverse Event|2
1346361|NCT01836471|4435229|P4|Overall Study|Adverse Event|1
1346362|NCT01836471|4435230|P3|Overall Study|Adverse Event|1
1346363|NCT01836471|4435231|P2|Overall Study|Adverse Event|3
1346364|NCT01836471|4435232|P1|Overall Study|Adverse Event|6
1346365|NCT01836471|4435228|P5|Overall Study|Lost to Follow-up|1
1346366|NCT01836471|4435229|P4|Overall Study|Lost to Follow-up|1
1346367|NCT01836471|4435230|P3|Overall Study|Lost to Follow-up|0
1346368|NCT01836471|4435231|P2|Overall Study|Lost to Follow-up|0
1346369|NCT01836471|4435232|P1|Overall Study|Lost to Follow-up|0
1346370|NCT01836471|4435228|P5|Overall Study|Physician Decision|0
1346371|NCT01836471|4435229|P4|Overall Study|Physician Decision|0
1346372|NCT01836471|4435230|P3|Overall Study|Physician Decision|0
1346373|NCT01836471|4435231|P2|Overall Study|Physician Decision|1
1346374|NCT01836471|4435232|P1|Overall Study|Physician Decision|0
1346375|NCT01836471|4435228|P5|Overall Study|Withdrawal by Subject|2
1346376|NCT01836471|4435229|P4|Overall Study|Withdrawal by Subject|0
1346377|NCT01836471|4435230|P3|Overall Study|Withdrawal by Subject|1
1346378|NCT01836471|4435231|P2|Overall Study|Withdrawal by Subject|4
1346379|NCT01836471|4435232|P1|Overall Study|Withdrawal by Subject|3
1346380|NCT01836471|4435228|P5|Overall Study|Pregnancy|0
1346381|NCT01836471|4435229|P4|Overall Study|Pregnancy|0
1346382|NCT01836471|4435230|P3|Overall Study|Pregnancy|0
1346383|NCT01836471|4435231|P2|Overall Study|Pregnancy|0
1346384|NCT01836471|4435232|P1|Overall Study|Pregnancy|1
1346385|NCT01836458|4435261|P4|Overall Study|Unsatisfactory therapeutic effect|6
1346386|NCT01836458|4435262|P3|Overall Study|Unsatisfactory therapeutic effect|5
1346387|NCT01836458|4435263|P2|Overall Study|Unsatisfactory therapeutic effect|2
1346388|NCT01836458|4435264|P1|Overall Study|Unsatisfactory therapeutic effect|3
1346389|NCT01835899|4435387|P3|Overall Study|Other than stated above|0
1346390|NCT01835899|4435388|P2|Overall Study|Other than stated above|1
1346391|NCT01835899|4435389|P1|Overall Study|Other than stated above|0
1346392|NCT01835899|4435387|P3|Overall Study|Adverse Event|1
1346393|NCT01835899|4435388|P2|Overall Study|Adverse Event|0
1346394|NCT01835899|4435389|P1|Overall Study|Adverse Event|0
1346395|NCT01835548|4435433|P3|Double-Blind Treatment Period|Withdrawal by Subject|0
1346396|NCT01835548|4435434|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
1346397|NCT01835548|4435435|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
1346398|NCT01835548|4435433|P3|Double-Blind Treatment Period|Adverse Event|0
1346399|NCT01835548|4435434|P2|Double-Blind Treatment Period|Adverse Event|1
1346400|NCT01835548|4435435|P1|Double-Blind Treatment Period|Adverse Event|0
1346401|NCT01835548|4435433|P3|Dose Optimization Period|Withdrawal by Subject|1
1346402|NCT01835548|4435434|P2|Dose Optimization Period|Withdrawal by Subject|0
1346403|NCT01835548|4435435|P1|Dose Optimization Period|Withdrawal by Subject|0
1346404|NCT01835548|4435433|P3|Dose Optimization Period|Adverse Event|1
1346405|NCT01835548|4435434|P2|Dose Optimization Period|Adverse Event|0
1346406|NCT01835548|4435435|P1|Dose Optimization Period|Adverse Event|0
1346407|NCT01835470|4435464|P1|Long Term Treatment Period|Lack of Efficacy|1
1346408|NCT01835470|4435464|P1|Long Term Treatment Period|Subject Request to Discontinue|1
1346409|NCT01835431|4435476|P2|Overall Study|Protocol Violation|0
1346410|NCT01835431|4435477|P1|Overall Study|Protocol Violation|1
1346411|NCT01835431|4435476|P2|Overall Study|Withdrawal by Subject|10
1346412|NCT01835431|4435477|P1|Overall Study|Withdrawal by Subject|6
1346413|NCT01835431|4435476|P2|Overall Study|other|2
1346414|NCT01835431|4435477|P1|Overall Study|other|0
1346415|NCT01835431|4435476|P2|Overall Study|Adverse Event|0
1346416|NCT01835431|4435477|P1|Overall Study|Adverse Event|1
1346417|NCT01835132|4435515|P1|Initial Phase|Insufficient Therapeutic Response|2
1346418|NCT01835015|4435560|P5|Overall Study|Adverse Event|0
1346419|NCT01835015|4435561|P4|Overall Study|Adverse Event|0
1346420|NCT01835015|4435562|P3|Overall Study|Adverse Event|1
1346421|NCT01835015|4435563|P2|Overall Study|Adverse Event|0
1346422|NCT01835015|4435564|P1|Overall Study|Adverse Event|0
1346423|NCT01834586|4435647|P1|Overall Study|Adverse Event|1
1346424|NCT01834274|4435687|P2|Overall Study|Other|1
1346425|NCT01834274|4435688|P1|Overall Study|Other|2
1346426|NCT01834274|4435687|P2|Overall Study|Lost to Follow-up|1
1346427|NCT01834274|4435688|P1|Overall Study|Lost to Follow-up|3
1346428|NCT01834274|4435687|P2|Overall Study|Withdrawal by Subject|1
1346429|NCT01834274|4435688|P1|Overall Study|Withdrawal by Subject|1
1346430|NCT01834274|4435687|P2|Overall Study|Study Termination|38
1346431|NCT01834274|4435688|P1|Overall Study|Study Termination|41
1346432|NCT01834222|4435711|P1|Overall Study|Not meet inclusion/exclusion criteria|1
1346433|NCT01833897|4435797|P1|Overall Study|Lack of Efficacy|1
1346434|NCT01833533|4435824|P2|Overall Study|Not Specified|7
1346435|NCT01833533|4435825|P1|Overall Study|Not Specified|2
1346436|NCT01833533|4435824|P2|Overall Study|To Enter an Extension Study|4
1346437|NCT01833533|4435825|P1|Overall Study|To Enter an Extension Study|0
1346438|NCT01833533|4435824|P2|Overall Study|Lost to Follow-up|9
1346439|NCT01833533|4435825|P1|Overall Study|Lost to Follow-up|4
1346440|NCT01833533|4435824|P2|Overall Study|Adverse Event|1
1346441|NCT01833533|4435825|P1|Overall Study|Adverse Event|0
1346442|NCT01833169|4435869|P1|Overall Study|Physician Decision|2
1346443|NCT01833169|4435869|P1|Overall Study|Death|3
1346444|NCT01833169|4435869|P1|Overall Study|Withdrawal by Subject|9
1346445|NCT01833169|4435869|P1|Overall Study|Adverse Event|33
1346446|NCT01833169|4435869|P1|Overall Study|Disease Progression|99
1346447|NCT01833065|4435938|P5|Overall Study|Others|4
1346448|NCT01833065|4435939|P4|Overall Study|Others|1
1346449|NCT01833065|4435940|P3|Overall Study|Others|1
1346450|NCT01833065|4435941|P2|Overall Study|Others|1
1346451|NCT01833065|4435942|P1|Overall Study|Others|2
1346452|NCT01833065|4435938|P5|Overall Study|Trial terminated by sponsor|13
1346453|NCT01833065|4435939|P4|Overall Study|Trial terminated by sponsor|3
1346454|NCT01833065|4435940|P3|Overall Study|Trial terminated by sponsor|7
1346455|NCT01833065|4435941|P2|Overall Study|Trial terminated by sponsor|8
1346456|NCT01833065|4435942|P1|Overall Study|Trial terminated by sponsor|8
1346457|NCT01833065|4435938|P5|Overall Study|Subject's substantial non-compliance|0
1346458|NCT01833065|4435939|P4|Overall Study|Subject's substantial non-compliance|0
1346459|NCT01833065|4435940|P3|Overall Study|Subject's substantial non-compliance|0
1346460|NCT01833065|4435941|P2|Overall Study|Subject's substantial non-compliance|1
1346461|NCT01833065|4435942|P1|Overall Study|Subject's substantial non-compliance|0
1346462|NCT01833065|4435938|P5|Overall Study|Withdrawal by Subject|11
1346463|NCT01833065|4435939|P4|Overall Study|Withdrawal by Subject|3
1346464|NCT01833065|4435940|P3|Overall Study|Withdrawal by Subject|4
1346465|NCT01833065|4435941|P2|Overall Study|Withdrawal by Subject|2
1346466|NCT01833065|4435942|P1|Overall Study|Withdrawal by Subject|6
1346467|NCT01833065|4435938|P5|Overall Study|Lost to Follow-up|3
1346468|NCT01833065|4435939|P4|Overall Study|Lost to Follow-up|0
1346469|NCT01833065|4435940|P3|Overall Study|Lost to Follow-up|0
1346470|NCT01833065|4435941|P2|Overall Study|Lost to Follow-up|0
1346471|NCT01833065|4435942|P1|Overall Study|Lost to Follow-up|1
1346472|NCT01833065|4435938|P5|Overall Study|Protocol Violation|2
1346473|NCT01833065|4435939|P4|Overall Study|Protocol Violation|0
1346474|NCT01833065|4435940|P3|Overall Study|Protocol Violation|0
1346475|NCT01833065|4435941|P2|Overall Study|Protocol Violation|0
1346476|NCT01833065|4435942|P1|Overall Study|Protocol Violation|1
1346477|NCT01833065|4435938|P5|Overall Study|Adverse Event|3
1346478|NCT01833065|4435939|P4|Overall Study|Adverse Event|2
1346479|NCT01833065|4435940|P3|Overall Study|Adverse Event|0
1346480|NCT01833065|4435941|P2|Overall Study|Adverse Event|1
1346481|NCT01833065|4435942|P1|Overall Study|Adverse Event|6
1346482|NCT01832766|4435973|P2|Washout|Lost to Follow-up|1
1346483|NCT01832766|4435974|P1|Washout|Lost to Follow-up|0
1346484|NCT01832493|4436040|P1|Overall Study|Unable to place LV lead|2
1346485|NCT01832493|4436040|P1|Overall Study|Protocol Violation|4
1346486|NCT01832493|4436040|P1|Overall Study|Physician Decision|2
1346487|NCT01832155|4436060|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
1346488|NCT01832155|4436061|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
1346489|NCT01832155|4436060|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
1346490|NCT01832155|4436061|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
1346491|NCT01831817|4436166|P4|Overall Study|Withdrawl of Consent|0
1346492|NCT01831817|4436167|P3|Overall Study|Withdrawl of Consent|0
1346493|NCT01831817|4436168|P2|Overall Study|Withdrawl of Consent|0
1346494|NCT01831817|4436169|P1|Overall Study|Withdrawl of Consent|3
1346495|NCT01831817|4436166|P4|Overall Study|Lost to Follow-up|0
1346496|NCT01831817|4436167|P3|Overall Study|Lost to Follow-up|0
1346497|NCT01831817|4436168|P2|Overall Study|Lost to Follow-up|0
1346498|NCT01831817|4436169|P1|Overall Study|Lost to Follow-up|1
1346499|NCT01831791|4436207|P1|Overall Study|Withdrawal by Subject|10
1346500|NCT01831765|4436236|P3|Overall Study|Lost to Follow-up|3
1346501|NCT01831765|4436237|P2|Overall Study|Lost to Follow-up|3
1346502|NCT01831765|4436238|P1|Overall Study|Lost to Follow-up|2
1346503|NCT01831765|4436236|P3|Overall Study|Withdrawal criteria|16
1346504|NCT01831765|4436237|P2|Overall Study|Withdrawal criteria|10
1346505|NCT01831765|4436238|P1|Overall Study|Withdrawal criteria|12
1346506|NCT01831765|4436236|P3|Overall Study|Withdrawal by Subject|17
1346507|NCT01831765|4436237|P2|Overall Study|Withdrawal by Subject|7
1346508|NCT01831765|4436238|P1|Overall Study|Withdrawal by Subject|22
1346509|NCT01831765|4436236|P3|Overall Study|Adverse Event|3
1346510|NCT01831765|4436237|P2|Overall Study|Adverse Event|3
1346511|NCT01831765|4436238|P1|Overall Study|Adverse Event|5
1346512|NCT01831765|4436236|P3|Overall Study|Other, site closed|0
1346513|NCT01831765|4436237|P2|Overall Study|Other, site closed|1
1346514|NCT01831765|4436238|P1|Overall Study|Other, site closed|1
1346515|NCT01831765|4436236|P3|Overall Study|Death|1
1346516|NCT01831765|4436237|P2|Overall Study|Death|1
1346517|NCT01831765|4436238|P1|Overall Study|Death|0
1346518|NCT01831765|4436236|P3|Overall Study|Pregnancy|2
1346519|NCT01831765|4436237|P2|Overall Study|Pregnancy|1
1346520|NCT01831765|4436238|P1|Overall Study|Pregnancy|1
1346521|NCT01831765|4436236|P3|Overall Study|Other, sponsor withdrew subject|0
1346522|NCT01831765|4436237|P2|Overall Study|Other, sponsor withdrew subject|1
1346523|NCT01831765|4436238|P1|Overall Study|Other, sponsor withdrew subject|0
1346524|NCT01831765|4436236|P3|Overall Study|Lack of Efficacy|0
1346525|NCT01831765|4436237|P2|Overall Study|Lack of Efficacy|0
1346526|NCT01831765|4436238|P1|Overall Study|Lack of Efficacy|1
1346527|NCT01831726|4436264|P1|Overall Study|Subject/guardian decision|7
1346528|NCT01831726|4436264|P1|Overall Study|Physician Decision|1
1346529|NCT01831726|4436264|P1|Overall Study|Disease Progression|49
1346530|NCT01831726|4436264|P1|Overall Study|Death|7
1346531|NCT01831726|4436264|P1|Overall Study|Adverse Event|16
1346532|NCT01831466|4436283|P12|Overall Study|Adverse Event|2
1346533|NCT01831466|4436284|P11|Overall Study|Adverse Event|0
1346534|NCT01831466|4436285|P10|Overall Study|Adverse Event|1
1346535|NCT01831466|4436286|P9|Overall Study|Adverse Event|1
1346536|NCT01831466|4436287|P8|Overall Study|Adverse Event|1
1346537|NCT01831466|4436288|P7|Overall Study|Adverse Event|0
1346538|NCT01831466|4436289|P6|Overall Study|Adverse Event|7
1346539|NCT01831466|4436290|P5|Overall Study|Adverse Event|3
1346540|NCT01831466|4436291|P4|Overall Study|Adverse Event|6
1346541|NCT01831466|4436292|P3|Overall Study|Adverse Event|4
1346542|NCT01831466|4436293|P2|Overall Study|Adverse Event|0
1346543|NCT01831466|4436294|P1|Overall Study|Adverse Event|0
1346544|NCT01831466|4436283|P12|Overall Study|Lack of Efficacy|0
1346545|NCT01831466|4436284|P11|Overall Study|Lack of Efficacy|2
1346546|NCT01831466|4436285|P10|Overall Study|Lack of Efficacy|2
1346547|NCT01831466|4436286|P9|Overall Study|Lack of Efficacy|2
1346548|NCT01831466|4436287|P8|Overall Study|Lack of Efficacy|1
1346549|NCT01831466|4436288|P7|Overall Study|Lack of Efficacy|1
1346550|NCT01831466|4436289|P6|Overall Study|Lack of Efficacy|8
1346551|NCT01831466|4436290|P5|Overall Study|Lack of Efficacy|9
1346552|NCT01831466|4436291|P4|Overall Study|Lack of Efficacy|6
1346553|NCT01831466|4436292|P3|Overall Study|Lack of Efficacy|7
1346554|NCT01831466|4436293|P2|Overall Study|Lack of Efficacy|8
1346555|NCT01831466|4436294|P1|Overall Study|Lack of Efficacy|5
1346556|NCT01831466|4436283|P12|Overall Study|Lost to Follow-up|1
1346557|NCT01831466|4436284|P11|Overall Study|Lost to Follow-up|0
1346558|NCT01831466|4436285|P10|Overall Study|Lost to Follow-up|1
1346559|NCT01831466|4436286|P9|Overall Study|Lost to Follow-up|0
1346560|NCT01831466|4436287|P8|Overall Study|Lost to Follow-up|0
1346561|NCT01831466|4436288|P7|Overall Study|Lost to Follow-up|0
1346562|NCT01831466|4436289|P6|Overall Study|Lost to Follow-up|3
1346563|NCT01831466|4436290|P5|Overall Study|Lost to Follow-up|0
1346564|NCT01831466|4436291|P4|Overall Study|Lost to Follow-up|2
1346565|NCT01831466|4436292|P3|Overall Study|Lost to Follow-up|4
1346566|NCT01831466|4436293|P2|Overall Study|Lost to Follow-up|1
1346567|NCT01831466|4436294|P1|Overall Study|Lost to Follow-up|0
1346568|NCT01831466|4436283|P12|Overall Study|Withdrawal by Subject|1
1346569|NCT01831466|4436284|P11|Overall Study|Withdrawal by Subject|0
1346570|NCT01831466|4436285|P10|Overall Study|Withdrawal by Subject|1
1346571|NCT01831466|4436286|P9|Overall Study|Withdrawal by Subject|0
1346572|NCT01831466|4436287|P8|Overall Study|Withdrawal by Subject|0
1346573|NCT01831466|4436288|P7|Overall Study|Withdrawal by Subject|0
1346574|NCT01831466|4436289|P6|Overall Study|Withdrawal by Subject|5
1346575|NCT01831466|4436290|P5|Overall Study|Withdrawal by Subject|3
1346576|NCT01831466|4436291|P4|Overall Study|Withdrawal by Subject|3
1346577|NCT01831466|4436292|P3|Overall Study|Withdrawal by Subject|3
1346578|NCT01831466|4436293|P2|Overall Study|Withdrawal by Subject|3
1346579|NCT01831466|4436294|P1|Overall Study|Withdrawal by Subject|6
1346580|NCT01831466|4436283|P12|Overall Study|Death|0
1346581|NCT01831466|4436284|P11|Overall Study|Death|0
1346582|NCT01831466|4436285|P10|Overall Study|Death|0
1346583|NCT01831466|4436286|P9|Overall Study|Death|0
1346584|NCT01831466|4436287|P8|Overall Study|Death|0
1346585|NCT01831466|4436288|P7|Overall Study|Death|0
1346586|NCT01831466|4436289|P6|Overall Study|Death|0
1346587|NCT01831466|4436290|P5|Overall Study|Death|0
1346588|NCT01831466|4436291|P4|Overall Study|Death|0
1346589|NCT01831466|4436292|P3|Overall Study|Death|0
1346590|NCT01831466|4436293|P2|Overall Study|Death|1
1346591|NCT01831466|4436294|P1|Overall Study|Death|0
1346592|NCT01831466|4436283|P12|Overall Study|Non-compliance with study treatment|0
1346593|NCT01831466|4436284|P11|Overall Study|Non-compliance with study treatment|0
1346594|NCT01831466|4436285|P10|Overall Study|Non-compliance with study treatment|0
1346595|NCT01831466|4436286|P9|Overall Study|Non-compliance with study treatment|0
1346596|NCT01831466|4436287|P8|Overall Study|Non-compliance with study treatment|0
1346597|NCT01831466|4436288|P7|Overall Study|Non-compliance with study treatment|0
1346598|NCT01831466|4436289|P6|Overall Study|Non-compliance with study treatment|1
1346599|NCT01831466|4436290|P5|Overall Study|Non-compliance with study treatment|0
1346600|NCT01831466|4436291|P4|Overall Study|Non-compliance with study treatment|0
1346601|NCT01831466|4436292|P3|Overall Study|Non-compliance with study treatment|1
1346602|NCT01831466|4436293|P2|Overall Study|Non-compliance with study treatment|1
1346603|NCT01831466|4436294|P1|Overall Study|Non-compliance with study treatment|2
1346604|NCT01831466|4436283|P12|Overall Study|Not specified|0
1346605|NCT01831466|4436284|P11|Overall Study|Not specified|0
1346606|NCT01831466|4436285|P10|Overall Study|Not specified|0
1346607|NCT01831466|4436286|P9|Overall Study|Not specified|0
1346608|NCT01831466|4436287|P8|Overall Study|Not specified|0
1346609|NCT01831466|4436288|P7|Overall Study|Not specified|0
1346610|NCT01831466|4436289|P6|Overall Study|Not specified|1
1346611|NCT01831466|4436290|P5|Overall Study|Not specified|2
1346612|NCT01831466|4436291|P4|Overall Study|Not specified|2
1346613|NCT01831466|4436292|P3|Overall Study|Not specified|2
1346614|NCT01831466|4436293|P2|Overall Study|Not specified|3
1346615|NCT01831466|4436294|P1|Overall Study|Not specified|2
1346616|NCT01831466|4436283|P12|Overall Study|Protocol Violation|0
1346617|NCT01831466|4436284|P11|Overall Study|Protocol Violation|0
1346618|NCT01831466|4436285|P10|Overall Study|Protocol Violation|0
1346619|NCT01831466|4436286|P9|Overall Study|Protocol Violation|0
1346620|NCT01831466|4436287|P8|Overall Study|Protocol Violation|0
1346621|NCT01831466|4436288|P7|Overall Study|Protocol Violation|0
1346622|NCT01831466|4436289|P6|Overall Study|Protocol Violation|1
1346623|NCT01831466|4436290|P5|Overall Study|Protocol Violation|0
1346624|NCT01831466|4436291|P4|Overall Study|Protocol Violation|0
1346625|NCT01831466|4436292|P3|Overall Study|Protocol Violation|2
1346626|NCT01831466|4436293|P2|Overall Study|Protocol Violation|1
1346627|NCT01831466|4436294|P1|Overall Study|Protocol Violation|1
1346628|NCT01831258|4436416|P2|Overall Study|Lost to Follow-up|2
1346629|NCT01831258|4436417|P1|Overall Study|Lost to Follow-up|3
1346630|NCT01831258|4436416|P2|Overall Study|Withdrawal by Subject|1
1346631|NCT01831258|4436417|P1|Overall Study|Withdrawal by Subject|2
1346632|NCT01830972|4436503|P2|Part IV|Non-Compliance|0
1346633|NCT01830972|4436504|P1|Part IV|Non-Compliance|1
1346634|NCT01830972|4436503|P2|Part IV|Withdrawal by Subject|1
1346635|NCT01830972|4436504|P1|Part IV|Withdrawal by Subject|2
1346636|NCT01830972|4436503|P2|Part III|Noncompliance|0
1346637|NCT01830972|4436504|P1|Part III|Noncompliance|1
1346638|NCT01830972|4436503|P2|Part III|Withdrawal by Subject|0
1346639|NCT01830972|4436504|P1|Part III|Withdrawal by Subject|1
1346640|NCT01830972|4436503|P2|Part II|Withdrawal by Subject|2
1346641|NCT01830972|4436504|P1|Part II|Withdrawal by Subject|2
1346642|NCT01830920|4436548|P5|Overall Study|Not specified|3
1346643|NCT01830920|4436549|P4|Overall Study|Not specified|5
1346644|NCT01830920|4436550|P3|Overall Study|Not specified|1
1346645|NCT01830920|4436551|P2|Overall Study|Not specified|1
1346646|NCT01830920|4436552|P1|Overall Study|Not specified|15
1346647|NCT01830920|4436548|P5|Overall Study|Death|4
1346648|NCT01830920|4436549|P4|Overall Study|Death|4
1346649|NCT01830920|4436550|P3|Overall Study|Death|5
1346650|NCT01830920|4436551|P2|Overall Study|Death|3
1346651|NCT01830920|4436552|P1|Overall Study|Death|3
1346652|NCT01830920|4436548|P5|Overall Study|Withdrawal by Subject|1
1346653|NCT01830920|4436549|P4|Overall Study|Withdrawal by Subject|7
1346654|NCT01830920|4436550|P3|Overall Study|Withdrawal by Subject|1
1346655|NCT01830920|4436551|P2|Overall Study|Withdrawal by Subject|2
1346656|NCT01830920|4436552|P1|Overall Study|Withdrawal by Subject|2
1346657|NCT01830920|4436548|P5|Overall Study|Adverse Event|0
1346658|NCT01830920|4436549|P4|Overall Study|Adverse Event|0
1346659|NCT01830920|4436550|P3|Overall Study|Adverse Event|1
1346660|NCT01830920|4436551|P2|Overall Study|Adverse Event|0
1346661|NCT01830920|4436552|P1|Overall Study|Adverse Event|1
1346662|NCT01830881|4436591|P2|Overall Study|Changed decision to have an abortion|1
1346663|NCT01830881|4436592|P1|Overall Study|Changed decision to have an abortion|0
1346664|NCT01830855|4436640|P4|Overall Study|Lost to Follow-up|33
1346665|NCT01830855|4436641|P3|Overall Study|Lost to Follow-up|23
1346666|NCT01830855|4436642|P2|Overall Study|Lost to Follow-up|20
1346667|NCT01830855|4436643|P1|Overall Study|Lost to Follow-up|47
1346668|NCT01830855|4436640|P4|Overall Study|No longer willing to participate|17
1346669|NCT01830855|4436641|P3|Overall Study|No longer willing to participate|12
1346670|NCT01830855|4436642|P2|Overall Study|No longer willing to participate|13
1346671|NCT01830855|4436643|P1|Overall Study|No longer willing to participate|32
1346672|NCT01830855|4436640|P4|Overall Study|Withdrawal by Subject|12
1346673|NCT01830855|4436641|P3|Overall Study|Withdrawal by Subject|10
1346674|NCT01830855|4436642|P2|Overall Study|Withdrawal by Subject|14
1346675|NCT01830855|4436643|P1|Overall Study|Withdrawal by Subject|33
1346676|NCT01830855|4436640|P4|Overall Study|Protocol deviation|6
1346677|NCT01830855|4436641|P3|Overall Study|Protocol deviation|6
1346678|NCT01830855|4436642|P2|Overall Study|Protocol deviation|5
1346679|NCT01830855|4436643|P1|Overall Study|Protocol deviation|10
1346680|NCT01830855|4436640|P4|Overall Study|Adverse Event|3
1346681|NCT01830855|4436641|P3|Overall Study|Adverse Event|6
1346682|NCT01830855|4436642|P2|Overall Study|Adverse Event|5
1346683|NCT01830855|4436643|P1|Overall Study|Adverse Event|11
1346684|NCT01830855|4436640|P4|Overall Study|No longer meets eligibility criteria|5
1346685|NCT01830855|4436641|P3|Overall Study|No longer meets eligibility criteria|3
1346686|NCT01830855|4436642|P2|Overall Study|No longer meets eligibility criteria|2
1346687|NCT01830855|4436643|P1|Overall Study|No longer meets eligibility criteria|11
1346688|NCT01830855|4436640|P4|Overall Study|Pregnancy|1
1346689|NCT01830855|4436641|P3|Overall Study|Pregnancy|2
1346690|NCT01830855|4436642|P2|Overall Study|Pregnancy|1
1346691|NCT01830855|4436643|P1|Overall Study|Pregnancy|3
1346692|NCT01830855|4436640|P4|Overall Study|Medication error without associated AE|1
1346693|NCT01830855|4436641|P3|Overall Study|Medication error without associated AE|0
1346694|NCT01830855|4436642|P2|Overall Study|Medication error without associated AE|0
1346695|NCT01830855|4436643|P1|Overall Study|Medication error without associated AE|1
1346696|NCT01830855|4436640|P4|Overall Study|Other|4
1346697|NCT01830855|4436641|P3|Overall Study|Other|4
1346698|NCT01830855|4436642|P2|Overall Study|Other|1
1346699|NCT01830855|4436643|P1|Overall Study|Other|7
1346700|NCT01830543|4436783|P3|Overall Study|Other|37
1346701|NCT01830543|4436784|P2|Overall Study|Other|17
1346702|NCT01830543|4436785|P1|Overall Study|Other|12
1346703|NCT01830543|4436783|P3|Overall Study|Withdrawal by consent|3
1346704|NCT01830543|4436784|P2|Overall Study|Withdrawal by consent|3
1346705|NCT01830543|4436785|P1|Overall Study|Withdrawal by consent|3
1346706|NCT01830543|4436783|P3|Overall Study|Physician Decision|12
1346707|NCT01830543|4436784|P2|Overall Study|Physician Decision|5
1346708|NCT01830543|4436785|P1|Overall Study|Physician Decision|11
1346709|NCT01830543|4436783|P3|Overall Study|Protocol Violation|7
1346710|NCT01830543|4436784|P2|Overall Study|Protocol Violation|7
1346711|NCT01830543|4436785|P1|Overall Study|Protocol Violation|3
1346712|NCT01830543|4436783|P3|Overall Study|Death|22
1346713|NCT01830543|4436784|P2|Overall Study|Death|22
1346714|NCT01830543|4436785|P1|Overall Study|Death|20
1346715|NCT01830543|4436783|P3|Overall Study|Adverse Event|76
1346716|NCT01830543|4436784|P2|Overall Study|Adverse Event|77
1346717|NCT01830543|4436785|P1|Overall Study|Adverse Event|91
1346718|NCT01830543|4436783|P3|Overall Study|Subject Decision|57
1346719|NCT01830543|4436784|P2|Overall Study|Subject Decision|21
1346720|NCT01830543|4436785|P1|Overall Study|Subject Decision|19
1346721|NCT01830127|4436917|P2|Overall Study|Other reason not defined above|2
1346722|NCT01830127|4436918|P1|Overall Study|Other reason not defined above|0
1346723|NCT01830127|4436917|P2|Overall Study|Withdrawal by Subject|1
1346724|NCT01830127|4436918|P1|Overall Study|Withdrawal by Subject|1
1346725|NCT01830127|4436917|P2|Overall Study|Lack of Efficacy|0
1346726|NCT01830127|4436918|P1|Overall Study|Lack of Efficacy|3
1346727|NCT01830127|4436917|P2|Overall Study|Adverse Event|6
1346728|NCT01830127|4436918|P1|Overall Study|Adverse Event|1
1346729|NCT01829711|4436942|P1|Overall Study|Still in Follow Up|50
1346730|NCT01829711|4436942|P1|Overall Study|Death|3
1346731|NCT01829711|4436942|P1|Overall Study|Withdrawal by Subject|2
1346732|NCT01829711|4436942|P1|Overall Study|Lost to Follow-up|1
1346733|NCT01829711|4436942|P1|Overall Study|Not specified|24
1346734|NCT01829477|4436997|P2|Overall Study|Withdrawal by Subject|0
1346735|NCT01829477|4436998|P1|Overall Study|Withdrawal by Subject|1
1346736|NCT01829477|4436997|P2|Overall Study|Study Terminated by Sponsor|15
1346737|NCT01829477|4436998|P1|Overall Study|Study Terminated by Sponsor|15
1346738|NCT01829464|4437011|P3|Overall Study|Lack of Efficacy|0
1346739|NCT01829464|4437012|P2|Overall Study|Lack of Efficacy|1
1346740|NCT01829464|4437013|P1|Overall Study|Lack of Efficacy|0
1346741|NCT01829464|4437011|P3|Overall Study|Study terminated by sponsor|25
1346742|NCT01829464|4437012|P2|Overall Study|Study terminated by sponsor|28
1346743|NCT01829464|4437013|P1|Overall Study|Study terminated by sponsor|25
1346744|NCT01829464|4437011|P3|Overall Study|Withdrawal by Subject|0
1346745|NCT01829464|4437012|P2|Overall Study|Withdrawal by Subject|0
1346746|NCT01829464|4437013|P1|Overall Study|Withdrawal by Subject|2
1346747|NCT01829464|4437011|P3|Overall Study|Lost to Follow-up|1
1346748|NCT01829464|4437012|P2|Overall Study|Lost to Follow-up|0
1346749|NCT01829464|4437013|P1|Overall Study|Lost to Follow-up|0
1346750|NCT01829464|4437011|P3|Overall Study|Adverse Event|0
1346751|NCT01829464|4437012|P2|Overall Study|Adverse Event|0
1346752|NCT01829464|4437013|P1|Overall Study|Adverse Event|1
1346753|NCT01829243|4437038|P2|First Intervention|Screen Failure|2
1346754|NCT01829243|4437039|P1|First Intervention|Screen Failure|4
1346755|NCT01829230|4437053|P2|Overall Study|Lost to Follow-up|1
1346756|NCT01829230|4437054|P1|Overall Study|Lost to Follow-up|1
1346757|NCT01829230|4437053|P2|Overall Study|Withdrawal by Subject|1
1346758|NCT01829230|4437054|P1|Overall Study|Withdrawal by Subject|0
1346759|NCT01829230|4437053|P2|Overall Study|Protocol Violation|2
1346760|NCT01829230|4437054|P1|Overall Study|Protocol Violation|0
1346761|NCT01829191|4437064|P2|Overall Study|Subject was fit for ortho - k|1
1346762|NCT01829191|4437065|P1|Overall Study|Subject was fit for ortho - k|0
1346763|NCT01829191|4437064|P2|Overall Study|Lost to Follow-up|1
1346764|NCT01829191|4437065|P1|Overall Study|Lost to Follow-up|0
1346765|NCT01829191|4437064|P2|Overall Study|Withdrawal by Subject|3
1346766|NCT01829191|4437065|P1|Overall Study|Withdrawal by Subject|2
1346767|NCT01829191|4437064|P2|Overall Study|Protocol Violation|1
1346768|NCT01829191|4437065|P1|Overall Study|Protocol Violation|4
1346769|NCT01829191|4437064|P2|Overall Study|Lens handling difficulty|4
1346770|NCT01829191|4437065|P1|Overall Study|Lens handling difficulty|1
1346771|NCT01829191|4437064|P2|Overall Study|Lens discomfort|3
1346772|NCT01829191|4437065|P1|Overall Study|Lens discomfort|0
1346773|NCT01829191|4437064|P2|Overall Study|Relocation|1
1346774|NCT01829191|4437065|P1|Overall Study|Relocation|0
1346775|NCT01829165|4437074|P2|Overall Study|Did not complete intervention|0
1346776|NCT01829165|4437075|P1|Overall Study|Did not complete intervention|2
1346777|NCT01829113|4437083|P2|Overall Study|Physician Decision|1
1346778|NCT01829113|4437084|P1|Overall Study|Physician Decision|1
1346779|NCT01829113|4437083|P2|Overall Study|No Study Treatment Received|2
1346780|NCT01829113|4437084|P1|Overall Study|No Study Treatment Received|3
1346781|NCT01829113|4437083|P2|Overall Study|Sponsor Decision|1
1346782|NCT01829113|4437084|P1|Overall Study|Sponsor Decision|1
1346783|NCT01829113|4437083|P2|Overall Study|Death|6
1346784|NCT01829113|4437084|P1|Overall Study|Death|4
1346785|NCT01829113|4437083|P2|Overall Study|Withdrawal by Subject|10
1346786|NCT01829113|4437084|P1|Overall Study|Withdrawal by Subject|17
1346787|NCT01829113|4437083|P2|Overall Study|Adverse Event|10
1346788|NCT01829113|4437084|P1|Overall Study|Adverse Event|14
1346789|NCT01829113|4437083|P2|Overall Study|Disease Progression|48
1346790|NCT01829113|4437084|P1|Overall Study|Disease Progression|37
1346791|NCT01829048|4437101|P5|Overall Study|Withdrawal by Subject|0
1346792|NCT01829048|4437102|P4|Overall Study|Withdrawal by Subject|2
1346793|NCT01829048|4437103|P3|Overall Study|Withdrawal by Subject|0
1346794|NCT01829048|4437104|P2|Overall Study|Withdrawal by Subject|0
1346795|NCT01829048|4437105|P1|Overall Study|Withdrawal by Subject|0
1346796|NCT01828281|4437248|P2|Overall Study|Withdrawal by Subject|0
1346797|NCT01828281|4437249|P1|Overall Study|Withdrawal by Subject|1
1346798|NCT01828112|4437282|P2|Overall Study|Subject/guardian decision|8
1346799|NCT01828112|4437283|P1|Overall Study|Subject/guardian decision|6
1346800|NCT01828112|4437282|P2|Overall Study|Progressive disease|82
1346801|NCT01828112|4437283|P1|Overall Study|Progressive disease|56
1346802|NCT01828112|4437282|P2|Overall Study|Physician Decision|5
1346803|NCT01828112|4437283|P1|Overall Study|Physician Decision|5
1346804|NCT01828112|4437282|P2|Overall Study|Death|5
1346805|NCT01828112|4437283|P1|Overall Study|Death|9
1346806|NCT01828112|4437282|P2|Overall Study|Adverse Event|8
1346807|NCT01828112|4437283|P1|Overall Study|Adverse Event|6
1346808|NCT01828099|4437291|P2|Overall Study|Subject/guardian decision|23
1346809|NCT01828099|4437292|P1|Overall Study|Subject/guardian decision|7
1346810|NCT01828099|4437291|P2|Overall Study|Protocol Violation|0
1346811|NCT01828099|4437292|P1|Overall Study|Protocol Violation|1
1346812|NCT01828099|4437291|P2|Overall Study|Progressive disease|94
1346813|NCT01828099|4437292|P1|Overall Study|Progressive disease|51
1346814|NCT01828099|4437291|P2|Overall Study|Physician Decision|11
1346815|NCT01828099|4437292|P1|Overall Study|Physician Decision|7
1346816|NCT01828099|4437291|P2|Overall Study|Non-compliance with study treatment|0
1346817|NCT01828099|4437292|P1|Overall Study|Non-compliance with study treatment|2
1346818|NCT01828099|4437291|P2|Overall Study|Lost to Follow-up|0
1346819|NCT01828099|4437292|P1|Overall Study|Lost to Follow-up|2
1346820|NCT01828099|4437291|P2|Overall Study|Death|11
1346821|NCT01828099|4437292|P1|Overall Study|Death|9
1346822|NCT01828099|4437291|P2|Overall Study|Adverse Event|18
1346823|NCT01828099|4437292|P1|Overall Study|Adverse Event|15
1346824|NCT01827839|4437298|P1|Overall Study|Consent Withdrawal|2
1346825|NCT01827839|4437298|P1|Overall Study|Adverse Event|1
1346826|NCT01827670|4437322|P2|Overall Study|Lost to Follow-up|1
1346827|NCT01827670|4437323|P1|Overall Study|Lost to Follow-up|0
1346828|NCT01827670|4437322|P2|Overall Study|Withdrawal of Consent|2
1346829|NCT01827670|4437323|P1|Overall Study|Withdrawal of Consent|3
1346830|NCT01827592|4437342|P3|Overall Study|Others|3
1346831|NCT01827592|4437343|P2|Overall Study|Others|1
1346832|NCT01827592|4437344|P1|Overall Study|Others|0
1346833|NCT01827592|4437342|P3|Overall Study|Trial terminated by Sponsor|51
1346834|NCT01827592|4437343|P2|Overall Study|Trial terminated by Sponsor|53
1346835|NCT01827592|4437344|P1|Overall Study|Trial terminated by Sponsor|47
1346836|NCT01827592|4437342|P3|Overall Study|Patient's substantial non-compliance|6
1346837|NCT01827592|4437343|P2|Overall Study|Patient's substantial non-compliance|1
1346838|NCT01827592|4437344|P1|Overall Study|Patient's substantial non-compliance|1
1346839|NCT01827592|4437342|P3|Overall Study|Withdrawal by Subject|11
1346840|NCT01827592|4437343|P2|Overall Study|Withdrawal by Subject|11
1346841|NCT01827592|4437344|P1|Overall Study|Withdrawal by Subject|12
1346842|NCT01827592|4437342|P3|Overall Study|Lost to Follow-up|2
1346843|NCT01827592|4437343|P2|Overall Study|Lost to Follow-up|2
1346844|NCT01827592|4437344|P1|Overall Study|Lost to Follow-up|1
1346845|NCT01827592|4437342|P3|Overall Study|Protocol Violation|0
1346846|NCT01827592|4437343|P2|Overall Study|Protocol Violation|1
1346847|NCT01827592|4437344|P1|Overall Study|Protocol Violation|2
1346848|NCT01827592|4437342|P3|Overall Study|Physician Decision|1
1346849|NCT01827592|4437343|P2|Overall Study|Physician Decision|2
1346850|NCT01827592|4437344|P1|Overall Study|Physician Decision|0
1346851|NCT01827592|4437342|P3|Overall Study|Adverse Event|2
1346852|NCT01827592|4437343|P2|Overall Study|Adverse Event|9
1346853|NCT01827592|4437344|P1|Overall Study|Adverse Event|11
1346854|NCT01827371|4437409|P4|Overall Study|Temporary study halt to vaccinations|13
1346855|NCT01827371|4437410|P3|Overall Study|Temporary study halt to vaccinations|5
1346856|NCT01827371|4437411|P2|Overall Study|Temporary study halt to vaccinations|2
1346857|NCT01827371|4437412|P1|Overall Study|Temporary study halt to vaccinations|11
1346858|NCT01827371|4437409|P4|Overall Study|Physician Decision|1
1346859|NCT01827371|4437410|P3|Overall Study|Physician Decision|0
1346860|NCT01827371|4437411|P2|Overall Study|Physician Decision|1
1346861|NCT01827371|4437412|P1|Overall Study|Physician Decision|0
1346862|NCT01827371|4437409|P4|Overall Study|Withdrawal by Subject|3
1346863|NCT01827371|4437410|P3|Overall Study|Withdrawal by Subject|2
1346864|NCT01827371|4437411|P2|Overall Study|Withdrawal by Subject|2
1346865|NCT01827371|4437412|P1|Overall Study|Withdrawal by Subject|1
1346866|NCT01827371|4437409|P4|Overall Study|Protocol Violation|0
1346867|NCT01827371|4437410|P3|Overall Study|Protocol Violation|0
1346868|NCT01827371|4437411|P2|Overall Study|Protocol Violation|0
1346869|NCT01827371|4437412|P1|Overall Study|Protocol Violation|1
1346870|NCT01827371|4437409|P4|Overall Study|Lost to Follow-up|4
1346871|NCT01827371|4437410|P3|Overall Study|Lost to Follow-up|0
1346872|NCT01827371|4437411|P2|Overall Study|Lost to Follow-up|2
1346873|NCT01827371|4437412|P1|Overall Study|Lost to Follow-up|0
1346874|NCT01827371|4437409|P4|Overall Study|Adverse Event|2
1346875|NCT01827371|4437410|P3|Overall Study|Adverse Event|4
1346876|NCT01827371|4437411|P2|Overall Study|Adverse Event|0
1346877|NCT01827371|4437412|P1|Overall Study|Adverse Event|0
1346878|NCT01827332|4437471|P2|Overall Study|Lost to Follow-up|1
1346879|NCT01827332|4437472|P1|Overall Study|Lost to Follow-up|2
1346880|NCT01827319|4437480|P1|Overall Study|Lost to Follow-up|3
1346881|NCT01827267|4437503|P2|Overall Study|Still on study|2
1346882|NCT01827267|4437504|P1|Overall Study|Still on study|0
1346883|NCT01827267|4437503|P2|Overall Study|Sponsor Discontinued Study|8
1346884|NCT01827267|4437504|P1|Overall Study|Sponsor Discontinued Study|2
1346885|NCT01827267|4437503|P2|Overall Study|Disease Progression|1
1346886|NCT01827267|4437504|P1|Overall Study|Disease Progression|1
1346887|NCT01827267|4437503|P2|Overall Study|Physician Decision|0
1346888|NCT01827267|4437504|P1|Overall Study|Physician Decision|1
1346889|NCT01827267|4437503|P2|Overall Study|Did not receive study drug|1
1346890|NCT01827267|4437504|P1|Overall Study|Did not receive study drug|1
1346891|NCT01827254|4437519|P1|Overall Study|Intolerance to treatment|4
1346892|NCT01827254|4437519|P1|Overall Study|Disease progression|36
1346893|NCT01827254|4437519|P1|Overall Study|Did not complete re-challenge|1
1346894|NCT01827254|4437519|P1|Overall Study|Discontinued prior initiation: sunitinib|1
1346895|NCT01827254|4437519|P1|Overall Study|Invalidated centre|3
1346896|NCT01827254|4437519|P1|Overall Study|Case report form not completed|4
1346897|NCT01827254|4437519|P1|Overall Study|Death|10
1346898|NCT01826981|4437544|P15|Overall Study|Enrolled/Randomized but Not Treated|0
1346899|NCT01826981|4437545|P14|Overall Study|Enrolled/Randomized but Not Treated|0
1346900|NCT01826981|4437546|P13|Overall Study|Enrolled/Randomized but Not Treated|0
1346901|NCT01826981|4437547|P12|Overall Study|Enrolled/Randomized but Not Treated|0
1346902|NCT01826981|4437548|P11|Overall Study|Enrolled/Randomized but Not Treated|0
1346903|NCT01826981|4437549|P10|Overall Study|Enrolled/Randomized but Not Treated|0
1346904|NCT01826981|4437550|P9|Overall Study|Enrolled/Randomized but Not Treated|0
1346905|NCT01826981|4437551|P8|Overall Study|Enrolled/Randomized but Not Treated|1
1346906|NCT01826981|4437552|P7|Overall Study|Enrolled/Randomized but Not Treated|0
1346907|NCT01826981|4437553|P6|Overall Study|Enrolled/Randomized but Not Treated|0
1346908|NCT01826981|4437554|P5|Overall Study|Enrolled/Randomized but Not Treated|0
1346909|NCT01826981|4437555|P4|Overall Study|Enrolled/Randomized but Not Treated|0
1346910|NCT01826981|4437556|P3|Overall Study|Enrolled/Randomized but Not Treated|0
1346911|NCT01826981|4437557|P2|Overall Study|Enrolled/Randomized but Not Treated|0
1346912|NCT01826981|4437558|P1|Overall Study|Enrolled/Randomized but Not Treated|0
1346913|NCT01826981|4437544|P15|Overall Study|Upper G-I Haemorrhage|0
1346914|NCT01826981|4437545|P14|Overall Study|Upper G-I Haemorrhage|1
1346915|NCT01826981|4437546|P13|Overall Study|Upper G-I Haemorrhage|0
1346916|NCT01826981|4437547|P12|Overall Study|Upper G-I Haemorrhage|0
1346917|NCT01826981|4437548|P11|Overall Study|Upper G-I Haemorrhage|0
1346918|NCT01826981|4437549|P10|Overall Study|Upper G-I Haemorrhage|0
1346919|NCT01826981|4437550|P9|Overall Study|Upper G-I Haemorrhage|0
1346920|NCT01826981|4437551|P8|Overall Study|Upper G-I Haemorrhage|0
1346921|NCT01826981|4437552|P7|Overall Study|Upper G-I Haemorrhage|0
1346922|NCT01826981|4437553|P6|Overall Study|Upper G-I Haemorrhage|0
1346923|NCT01826981|4437554|P5|Overall Study|Upper G-I Haemorrhage|0
1346924|NCT01826981|4437555|P4|Overall Study|Upper G-I Haemorrhage|0
1346925|NCT01826981|4437556|P3|Overall Study|Upper G-I Haemorrhage|0
1346926|NCT01826981|4437557|P2|Overall Study|Upper G-I Haemorrhage|0
1346927|NCT01826981|4437558|P1|Overall Study|Upper G-I Haemorrhage|0
1346928|NCT01826981|4437544|P15|Overall Study|Adverse Event|0
1346929|NCT01826981|4437545|P14|Overall Study|Adverse Event|0
1346930|NCT01826981|4437546|P13|Overall Study|Adverse Event|0
1346931|NCT01826981|4437547|P12|Overall Study|Adverse Event|0
1346932|NCT01826981|4437548|P11|Overall Study|Adverse Event|0
1346933|NCT01826981|4437549|P10|Overall Study|Adverse Event|0
1346934|NCT01826981|4437550|P9|Overall Study|Adverse Event|0
1346935|NCT01826981|4437551|P8|Overall Study|Adverse Event|0
1346936|NCT01826981|4437552|P7|Overall Study|Adverse Event|0
1346937|NCT01826981|4437553|P6|Overall Study|Adverse Event|0
1346938|NCT01826981|4437554|P5|Overall Study|Adverse Event|1
1346939|NCT01826981|4437555|P4|Overall Study|Adverse Event|0
1346940|NCT01826981|4437556|P3|Overall Study|Adverse Event|0
1346941|NCT01826981|4437557|P2|Overall Study|Adverse Event|0
1346942|NCT01826981|4437558|P1|Overall Study|Adverse Event|0
1346943|NCT01826981|4437544|P15|Overall Study|Withdrew Consent|0
1346944|NCT01826981|4437545|P14|Overall Study|Withdrew Consent|1
1346945|NCT01826981|4437546|P13|Overall Study|Withdrew Consent|0
1346946|NCT01826981|4437547|P12|Overall Study|Withdrew Consent|1
1346947|NCT01826981|4437548|P11|Overall Study|Withdrew Consent|0
1346948|NCT01826981|4437549|P10|Overall Study|Withdrew Consent|0
1346949|NCT01826981|4437550|P9|Overall Study|Withdrew Consent|0
1346950|NCT01826981|4437551|P8|Overall Study|Withdrew Consent|1
1346951|NCT01826981|4437552|P7|Overall Study|Withdrew Consent|1
1346952|NCT01826981|4437553|P6|Overall Study|Withdrew Consent|0
1346953|NCT01826981|4437554|P5|Overall Study|Withdrew Consent|0
1346954|NCT01826981|4437555|P4|Overall Study|Withdrew Consent|0
1346955|NCT01826981|4437556|P3|Overall Study|Withdrew Consent|0
1346956|NCT01826981|4437557|P2|Overall Study|Withdrew Consent|0
1346957|NCT01826981|4437558|P1|Overall Study|Withdrew Consent|0
1346958|NCT01826981|4437544|P15|Overall Study|Lost to Follow-up|0
1346959|NCT01826981|4437545|P14|Overall Study|Lost to Follow-up|0
1346960|NCT01826981|4437546|P13|Overall Study|Lost to Follow-up|1
1346961|NCT01826981|4437547|P12|Overall Study|Lost to Follow-up|1
1346962|NCT01826981|4437548|P11|Overall Study|Lost to Follow-up|1
1346963|NCT01826981|4437549|P10|Overall Study|Lost to Follow-up|1
1346964|NCT01826981|4437550|P9|Overall Study|Lost to Follow-up|0
1346965|NCT01826981|4437551|P8|Overall Study|Lost to Follow-up|1
1346966|NCT01826981|4437552|P7|Overall Study|Lost to Follow-up|0
1346967|NCT01826981|4437553|P6|Overall Study|Lost to Follow-up|1
1346968|NCT01826981|4437554|P5|Overall Study|Lost to Follow-up|1
1346969|NCT01826981|4437555|P4|Overall Study|Lost to Follow-up|0
1346970|NCT01826981|4437556|P3|Overall Study|Lost to Follow-up|0
1346971|NCT01826981|4437557|P2|Overall Study|Lost to Follow-up|0
1346972|NCT01826981|4437558|P1|Overall Study|Lost to Follow-up|0
1346973|NCT01826981|4437544|P15|Overall Study|Lack of Efficacy|0
1346974|NCT01826981|4437545|P14|Overall Study|Lack of Efficacy|3
1346975|NCT01826981|4437546|P13|Overall Study|Lack of Efficacy|0
1346976|NCT01826981|4437547|P12|Overall Study|Lack of Efficacy|0
1346977|NCT01826981|4437548|P11|Overall Study|Lack of Efficacy|1
1346978|NCT01826981|4437549|P10|Overall Study|Lack of Efficacy|0
1346979|NCT01826981|4437550|P9|Overall Study|Lack of Efficacy|7
1346980|NCT01826981|4437551|P8|Overall Study|Lack of Efficacy|8
1346981|NCT01826981|4437552|P7|Overall Study|Lack of Efficacy|0
1346982|NCT01826981|4437553|P6|Overall Study|Lack of Efficacy|0
1346983|NCT01826981|4437554|P5|Overall Study|Lack of Efficacy|5
1346984|NCT01826981|4437555|P4|Overall Study|Lack of Efficacy|0
1346985|NCT01826981|4437556|P3|Overall Study|Lack of Efficacy|0
1346986|NCT01826981|4437557|P2|Overall Study|Lack of Efficacy|1
1346987|NCT01826981|4437558|P1|Overall Study|Lack of Efficacy|0
1346988|NCT01826604|4437744|P2|Overall Study|Lost to Follow-up|9
1346989|NCT01826604|4437745|P1|Overall Study|Lost to Follow-up|8
1346990|NCT01826422|4437789|P2|Overall Study|Withdrawal by Subject|3
1346991|NCT01826422|4437790|P1|Overall Study|Withdrawal by Subject|1
1346992|NCT01826370|4437834|P1|Overall Study|Other reason not defined above|2
1346993|NCT01826370|4437834|P1|Overall Study|Lost to Follow-up|12
1346994|NCT01826370|4437834|P1|Overall Study|Protocol Violation|6
1346995|NCT01826214|4437846|P2|Overall Study|Subject/guardian decision|3
1346996|NCT01826214|4437847|P1|Overall Study|Subject/guardian decision|2
1346997|NCT01826214|4437846|P2|Overall Study|Study terminated by Sponsor|1
1346998|NCT01826214|4437847|P1|Overall Study|Study terminated by Sponsor|0
1346999|NCT01826214|4437846|P2|Overall Study|Progressive disease|21
1347000|NCT01826214|4437847|P1|Overall Study|Progressive disease|22
1347001|NCT01826214|4437846|P2|Overall Study|Physician Decision|2
1347002|NCT01826214|4437847|P1|Overall Study|Physician Decision|0
1347003|NCT01826214|4437846|P2|Overall Study|Lost to Follow-up|0
1347004|NCT01826214|4437847|P1|Overall Study|Lost to Follow-up|1
1347005|NCT01826214|4437846|P2|Overall Study|Death|1
1347006|NCT01826214|4437847|P1|Overall Study|Death|3
1347007|NCT01826214|4437846|P2|Overall Study|Adverse Event|6
1347008|NCT01826214|4437847|P1|Overall Study|Adverse Event|7
1347009|NCT01826201|4437865|P1|Overall Study|Non compliance with protocol|4
1347010|NCT01825941|4437873|P2|Overall Study|Lost to Follow-up|1
1347011|NCT01825941|4437874|P1|Overall Study|Lost to Follow-up|4
1347012|NCT01825837|4437884|P4|PART II|reason unspecified|0
1347013|NCT01825837|4437885|P3|PART II|reason unspecified|2
1347014|NCT01825837|4437886|P2|PART II|reason unspecified|2
1347015|NCT01825837|4437887|P1|PART II|reason unspecified|2
1347016|NCT01825837|4437884|P4|PART II|Treatment failure|0
1347017|NCT01825837|4437885|P3|PART II|Treatment failure|5
1347018|NCT01825837|4437886|P2|PART II|Treatment failure|4
1347019|NCT01825837|4437887|P1|PART II|Treatment failure|6
1347020|NCT01825837|4437884|P4|PART II|Adverse Event|0
1347021|NCT01825837|4437885|P3|PART II|Adverse Event|1
1347022|NCT01825837|4437886|P2|PART II|Adverse Event|3
1347023|NCT01825837|4437887|P1|PART II|Adverse Event|3
1347024|NCT01825837|4437884|P4|PART II|Patient non-compliance|0
1347025|NCT01825837|4437885|P3|PART II|Patient non-compliance|4
1347026|NCT01825837|4437886|P2|PART II|Patient non-compliance|2
1347027|NCT01825837|4437887|P1|PART II|Patient non-compliance|5
1347028|NCT01825837|4437884|P4|PART II|Withdrawal by Subject|0
1347029|NCT01825837|4437885|P3|PART II|Withdrawal by Subject|7
1347030|NCT01825837|4437886|P2|PART II|Withdrawal by Subject|3
1347031|NCT01825837|4437887|P1|PART II|Withdrawal by Subject|3
1347032|NCT01825837|4437884|P4|PART I|reason unspecified|3
1347033|NCT01825837|4437885|P3|PART I|reason unspecified|0
1347034|NCT01825837|4437886|P2|PART I|reason unspecified|0
1347035|NCT01825837|4437887|P1|PART I|reason unspecified|0
1347036|NCT01825837|4437884|P4|PART I|Treatment failure|7
1347037|NCT01825837|4437885|P3|PART I|Treatment failure|0
1347038|NCT01825837|4437886|P2|PART I|Treatment failure|0
1347039|NCT01825837|4437887|P1|PART I|Treatment failure|0
1347040|NCT01825837|4437884|P4|PART I|Patient non-compliance|1
1347041|NCT01825837|4437885|P3|PART I|Patient non-compliance|0
1347042|NCT01825837|4437886|P2|PART I|Patient non-compliance|0
1347043|NCT01825837|4437887|P1|PART I|Patient non-compliance|0
1347044|NCT01825837|4437884|P4|PART I|Withdrawal by Subject|6
1347045|NCT01825837|4437885|P3|PART I|Withdrawal by Subject|0
1347046|NCT01825837|4437886|P2|PART I|Withdrawal by Subject|0
1347047|NCT01825837|4437887|P1|PART I|Withdrawal by Subject|0
1347048|NCT01825798|4437897|P2|Overall Study|Lost to Follow-up|0
1347049|NCT01825798|4437898|P1|Overall Study|Lost to Follow-up|1
1347050|NCT01825798|4437897|P2|Overall Study|Adverse Event|5
1347051|NCT01825798|4437898|P1|Overall Study|Adverse Event|1
1347052|NCT01825577|4437926|P1|Overall Study|Lack of Efficacy|3
1347053|NCT01825577|4437926|P1|Overall Study|Withdrawn by family members|2
1347054|NCT01825577|4437926|P1|Overall Study|Withdrawal by Subject|1
1347055|NCT01825577|4437926|P1|Overall Study|Physician Decision|2
1347056|NCT01825200|4437950|P2|Overall Study|Withdrawal by Subject|1
1347057|NCT01825200|4437951|P1|Overall Study|Withdrawal by Subject|0
1347058|NCT01825200|4437950|P2|Overall Study|Lost to Follow-up|6
1347059|NCT01825200|4437951|P1|Overall Study|Lost to Follow-up|5
1347060|NCT01824979|4437974|P2|Overall Study|Protocol Violation|13
1347061|NCT01824979|4437975|P1|Overall Study|Protocol Violation|6
1347062|NCT01824979|4437974|P2|Overall Study|Physician Decision|0
1347063|NCT01824979|4437975|P1|Overall Study|Physician Decision|2
1347064|NCT01824979|4437974|P2|Overall Study|Withdrawal by Subject|0
1347065|NCT01824979|4437975|P1|Overall Study|Withdrawal by Subject|5
1347066|NCT01824823|4437992|P2|Overall Study|Off-treatment reason not submitted|0
1347067|NCT01824823|4437993|P1|Overall Study|Off-treatment reason not submitted|1
1347068|NCT01824823|4437992|P2|Overall Study|Lack of Efficacy|1
1347069|NCT01824823|4437993|P1|Overall Study|Lack of Efficacy|1
1347070|NCT01824602|4438003|P4|Overall Study|Treatment failure|1
1347071|NCT01824602|4438004|P3|Overall Study|Treatment failure|0
1347072|NCT01824602|4438005|P2|Overall Study|Treatment failure|0
1347073|NCT01824602|4438006|P1|Overall Study|Treatment failure|0
1347074|NCT01824602|4438003|P4|Overall Study|Adverse Event|2
1347075|NCT01824602|4438004|P3|Overall Study|Adverse Event|2
1347076|NCT01824602|4438005|P2|Overall Study|Adverse Event|0
1347077|NCT01824602|4438006|P1|Overall Study|Adverse Event|1
1347078|NCT01824602|4438003|P4|Overall Study|Patient non-compliance|0
1347079|NCT01824602|4438004|P3|Overall Study|Patient non-compliance|1
1347080|NCT01824602|4438005|P2|Overall Study|Patient non-compliance|0
1347081|NCT01824602|4438006|P1|Overall Study|Patient non-compliance|0
1347082|NCT01824602|4438003|P4|Overall Study|Withdrawal by Subject|2
1347083|NCT01824602|4438004|P3|Overall Study|Withdrawal by Subject|1
1347084|NCT01824602|4438005|P2|Overall Study|Withdrawal by Subject|0
1347085|NCT01824602|4438006|P1|Overall Study|Withdrawal by Subject|0
1347086|NCT01824576|4438045|P1|Overall Study|Device deficiency|2
1347087|NCT01824498|4438063|P6|Washout (8 Weeks)|Withdrawal by Subject|0
1347088|NCT01824498|4438064|P5|Washout (8 Weeks)|Withdrawal by Subject|1
1347089|NCT01824498|4438065|P4|Washout (8 Weeks)|Withdrawal by Subject|1
1347090|NCT01824498|4438066|P3|Washout (8 Weeks)|Withdrawal by Subject|2
1347091|NCT01824498|4438067|P2|Washout (8 Weeks)|Withdrawal by Subject|0
1347092|NCT01824498|4438068|P1|Washout (8 Weeks)|Withdrawal by Subject|2
1347093|NCT01824355|4438099|P1|Overall Study|unevaluable reference method results per|1
1347094|NCT01824355|4438099|P1|Overall Study|Adverse Event|2
1347095|NCT01824342|4438110|P2|Overall Study|Death|0
1347096|NCT01824342|4438111|P1|Overall Study|Death|2
1347097|NCT01824342|4438110|P2|Overall Study|Physician Decision|0
1347098|NCT01824342|4438111|P1|Overall Study|Physician Decision|5
1347099|NCT01824342|4438110|P2|Overall Study|Disease Progression|1
1347100|NCT01824342|4438111|P1|Overall Study|Disease Progression|1
1347101|NCT01824342|4438110|P2|Overall Study|Adverse Event|1
1347102|NCT01824342|4438111|P1|Overall Study|Adverse Event|1
1347103|NCT01824342|4438110|P2|Overall Study|Withdrawal by Subject|3
1347104|NCT01824342|4438111|P1|Overall Study|Withdrawal by Subject|0
1347105|NCT01824303|4438125|P2|Randomized Study|Other Miscellaneous Reasons|0
1347106|NCT01824303|4438126|P1|Randomized Study|Other Miscellaneous Reasons|1
1347107|NCT01824303|4438125|P2|Randomized Study|Withdrawal by Subject|1
1347108|NCT01824303|4438126|P1|Randomized Study|Withdrawal by Subject|1
1347109|NCT01823679|4438154|P1|Overall Study|Death|1
1347110|NCT01823536|4438207|P6|Overall Study|Subject moved out of the state|0
1347111|NCT01823536|4438208|P5|Overall Study|Subject moved out of the state|1
1347112|NCT01823536|4438209|P4|Overall Study|Subject moved out of the state|0
1347113|NCT01823536|4438210|P3|Overall Study|Subject moved out of the state|0
1347114|NCT01823536|4438211|P2|Overall Study|Subject moved out of the state|0
1347115|NCT01823536|4438212|P1|Overall Study|Subject moved out of the state|0
1347116|NCT01823536|4438207|P6|Overall Study|Met exclusion criterion No 6|0
1347117|NCT01823536|4438208|P5|Overall Study|Met exclusion criterion No 6|0
1347118|NCT01823536|4438209|P4|Overall Study|Met exclusion criterion No 6|1
1347119|NCT01823536|4438210|P3|Overall Study|Met exclusion criterion No 6|0
1347120|NCT01823536|4438211|P2|Overall Study|Met exclusion criterion No 6|0
1347121|NCT01823536|4438212|P1|Overall Study|Met exclusion criterion No 6|0
1347122|NCT01823536|4438207|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
1347123|NCT01823536|4438208|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
1347124|NCT01823536|4438209|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
1347125|NCT01823536|4438210|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
1347126|NCT01823536|4438211|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
1347127|NCT01823536|4438212|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
1347128|NCT01823536|4438207|P6|Overall Study|Withdrawal by Subject|0
1347129|NCT01823536|4438208|P5|Overall Study|Withdrawal by Subject|0
1347130|NCT01823536|4438209|P4|Overall Study|Withdrawal by Subject|0
1347131|NCT01823536|4438210|P3|Overall Study|Withdrawal by Subject|0
1347132|NCT01823536|4438211|P2|Overall Study|Withdrawal by Subject|1
1347133|NCT01823536|4438212|P1|Overall Study|Withdrawal by Subject|1
1347134|NCT01823536|4438207|P6|Overall Study|Protocol Violation|0
1347135|NCT01823536|4438208|P5|Overall Study|Protocol Violation|0
1347136|NCT01823536|4438209|P4|Overall Study|Protocol Violation|0
1347137|NCT01823536|4438210|P3|Overall Study|Protocol Violation|0
1347138|NCT01823536|4438211|P2|Overall Study|Protocol Violation|1
1347139|NCT01823536|4438212|P1|Overall Study|Protocol Violation|0
1347140|NCT01823536|4438207|P6|Overall Study|Lost to Follow-up|0
1347141|NCT01823536|4438208|P5|Overall Study|Lost to Follow-up|1
1347142|NCT01823536|4438209|P4|Overall Study|Lost to Follow-up|1
1347143|NCT01823536|4438210|P3|Overall Study|Lost to Follow-up|0
1347144|NCT01823536|4438211|P2|Overall Study|Lost to Follow-up|0
1347145|NCT01823536|4438212|P1|Overall Study|Lost to Follow-up|1
1347146|NCT01823341|4438263|P1|Overall Study|Adverse Event|1
1347147|NCT01823341|4438263|P1|Overall Study|Withdrawal by Subject|7
1347148|NCT01823341|4438263|P1|Overall Study|Failed run-in|7
1347149|NCT01823289|4438306|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
1347150|NCT01823289|4438306|P1|Overall Study|Drug affected efficacy and safety|1
1347151|NCT01823289|4438306|P1|Overall Study|Transaminase increased more than 3 times|1
1347152|NCT01823289|4438306|P1|Overall Study|Administered contraindicated medicine|1
1347153|NCT01823289|4438306|P1|Overall Study|Physician Decision|9
1347154|NCT01823289|4438306|P1|Overall Study|Lack of Efficacy|1
1347155|NCT01823289|4438306|P1|Overall Study|Adverse Event|5
1347156|NCT01823289|4438306|P1|Overall Study|Lost to Follow-up|5
1347157|NCT01823224|4438314|P2|Overall Study|Withdrawal by Subject|1
1347158|NCT01823224|4438315|P1|Overall Study|Withdrawal by Subject|0
1347159|NCT01823224|4438314|P2|Overall Study|missed med dose|1
1347160|NCT01823224|4438315|P1|Overall Study|missed med dose|0
1347161|NCT01823224|4438314|P2|Overall Study|pharmacy error|1
1347162|NCT01823224|4438315|P1|Overall Study|pharmacy error|0
1347163|NCT01823224|4438314|P2|Overall Study|didn't qualify|2
1347164|NCT01823224|4438315|P1|Overall Study|didn't qualify|1
1347165|NCT01823224|4438314|P2|Overall Study|Lost to Follow-up|6
1347166|NCT01823224|4438315|P1|Overall Study|Lost to Follow-up|5
1347167|NCT01823146|4438325|P2|Overall Study|Lost to Follow-up|1
1347168|NCT01823146|4438326|P1|Overall Study|Lost to Follow-up|2
1347169|NCT01823146|4438325|P2|Overall Study|Withdrawal by Subject|1
1347170|NCT01823146|4438326|P1|Overall Study|Withdrawal by Subject|0
1347171|NCT01822899|4438338|P2|Overall Study|Withdrawal by Subject|7
1347172|NCT01822899|4438339|P1|Overall Study|Withdrawal by Subject|5
1347173|NCT01822899|4438338|P2|Overall Study|Lost to Follow-up|0
1347174|NCT01822899|4438339|P1|Overall Study|Lost to Follow-up|1
1347175|NCT01822899|4438338|P2|Overall Study|Protocol Violation|3
1347176|NCT01822899|4438339|P1|Overall Study|Protocol Violation|6
1347177|NCT01822899|4438338|P2|Overall Study|Lack of Efficacy|3
1347178|NCT01822899|4438339|P1|Overall Study|Lack of Efficacy|6
1347179|NCT01822899|4438338|P2|Overall Study|Adverse Event|5
1347180|NCT01822899|4438339|P1|Overall Study|Adverse Event|6
1347181|NCT01822821|4438349|P2|Overall Study|Other reasons|0
1347182|NCT01822821|4438350|P1|Overall Study|Other reasons|1
1347183|NCT01822821|4438349|P2|Overall Study|Eligible surgery cancelled|1
1347184|NCT01822821|4438350|P1|Overall Study|Eligible surgery cancelled|1
1347185|NCT01822756|4438379|P5|Overall Study|disease progression & patient preference|0
1347186|NCT01822756|4438380|P4|Overall Study|disease progression & patient preference|0
1347187|NCT01822756|4438381|P3|Overall Study|disease progression & patient preference|1
1347188|NCT01822756|4438382|P2|Overall Study|disease progression & patient preference|0
1347189|NCT01822756|4438383|P1|Overall Study|disease progression & patient preference|2
1347190|NCT01822756|4438379|P5|Overall Study|Physician Decision|0
1347191|NCT01822756|4438380|P4|Overall Study|Physician Decision|0
1347192|NCT01822756|4438381|P3|Overall Study|Physician Decision|0
1347193|NCT01822756|4438382|P2|Overall Study|Physician Decision|1
1347194|NCT01822756|4438383|P1|Overall Study|Physician Decision|0
1347195|NCT01822756|4438379|P5|Overall Study|Lost to Follow-up|1
1347196|NCT01822756|4438380|P4|Overall Study|Lost to Follow-up|0
1347197|NCT01822756|4438381|P3|Overall Study|Lost to Follow-up|1
1347198|NCT01822756|4438382|P2|Overall Study|Lost to Follow-up|0
1347199|NCT01822756|4438383|P1|Overall Study|Lost to Follow-up|1
1347200|NCT01822756|4438379|P5|Overall Study|Death|0
1347201|NCT01822756|4438380|P4|Overall Study|Death|0
1347202|NCT01822756|4438381|P3|Overall Study|Death|1
1347203|NCT01822756|4438382|P2|Overall Study|Death|2
1347204|NCT01822756|4438383|P1|Overall Study|Death|2
1347205|NCT01822756|4438379|P5|Overall Study|Disease progression|6
1347206|NCT01822756|4438380|P4|Overall Study|Disease progression|2
1347207|NCT01822756|4438381|P3|Overall Study|Disease progression|7
1347208|NCT01822756|4438382|P2|Overall Study|Disease progression|1
1347209|NCT01822756|4438383|P1|Overall Study|Disease progression|11
1347210|NCT01822756|4438379|P5|Overall Study|Adverse Event|0
1347211|NCT01822756|4438380|P4|Overall Study|Adverse Event|2
1347212|NCT01822756|4438381|P3|Overall Study|Adverse Event|0
1347213|NCT01822756|4438382|P2|Overall Study|Adverse Event|0
1347214|NCT01822756|4438383|P1|Overall Study|Adverse Event|0
1347215|NCT01822691|4438425|P1|Overall Study|Withdrawal by Subject|2
1347216|NCT01822678|4438436|P3|Overall Study|Lost to Follow-up|1
1347217|NCT01822678|4438437|P2|Overall Study|Lost to Follow-up|2
1347218|NCT01822678|4438438|P1|Overall Study|Lost to Follow-up|0
1347219|NCT01822678|4438436|P3|Overall Study|Lack of Efficacy|5
1347220|NCT01822678|4438437|P2|Overall Study|Lack of Efficacy|6
1347221|NCT01822678|4438438|P1|Overall Study|Lack of Efficacy|3
1347222|NCT01822678|4438436|P3|Overall Study|Adverse Event|1
1347223|NCT01822678|4438437|P2|Overall Study|Adverse Event|3
1347224|NCT01822678|4438438|P1|Overall Study|Adverse Event|4
1347225|NCT01822678|4438436|P3|Overall Study|Withdrawal by Subject|4
1347226|NCT01822678|4438437|P2|Overall Study|Withdrawal by Subject|4
1347227|NCT01822678|4438438|P1|Overall Study|Withdrawal by Subject|5
1347228|NCT01822665|4438446|P1|Overall Study|Other Reason|5
1347229|NCT01822665|4438446|P1|Overall Study|Adverse Event|3
1347230|NCT01822561|4438489|P1|Overall Study|Withdrawal by Subject|2
1347231|NCT01822535|4438510|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
1347232|NCT01822535|4438511|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
1347233|NCT01822535|4438510|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
1347234|NCT01822535|4438511|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
1347235|NCT01822535|4438510|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
1347236|NCT01822535|4438511|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
1347237|NCT01822223|4438535|P2|Overall Study|Death|1
1347238|NCT01822223|4438536|P1|Overall Study|Death|0
1347239|NCT01821963|4438581|P1|Overall Study|Adverse Event|1
1347240|NCT01821937|4438587|P2|Overall Study|Adverse Event|3
1347241|NCT01821937|4438588|P1|Overall Study|Adverse Event|0
1347242|NCT01821807|4438612|P2|Overall Study|Lost to Follow-up|1
1347243|NCT01821807|4438613|P1|Overall Study|Lost to Follow-up|3
1347244|NCT01821118|4438701|P2|Overall Study|Death|1
1347245|NCT01821118|4438702|P1|Overall Study|Death|0
1347246|NCT01820585|4438753|P4|Overall Study|Pregnancy|0
1347247|NCT01820585|4438754|P3|Overall Study|Pregnancy|0
1347248|NCT01820585|4438755|P2|Overall Study|Pregnancy|1
1347249|NCT01820585|4438756|P1|Overall Study|Pregnancy|0
1347250|NCT01820585|4438753|P4|Overall Study|at sponsor request|0
1347251|NCT01820585|4438754|P3|Overall Study|at sponsor request|1
1347252|NCT01820585|4438755|P2|Overall Study|at sponsor request|0
1347253|NCT01820585|4438756|P1|Overall Study|at sponsor request|0
1347254|NCT01820585|4438753|P4|Overall Study|Subject non-compliance|2
1347255|NCT01820585|4438754|P3|Overall Study|Subject non-compliance|1
1347256|NCT01820585|4438755|P2|Overall Study|Subject non-compliance|0
1347257|NCT01820585|4438756|P1|Overall Study|Subject non-compliance|0
1347258|NCT01820585|4438753|P4|Overall Study|Protocol Violation|1
1347259|NCT01820585|4438754|P3|Overall Study|Protocol Violation|1
1347260|NCT01820585|4438755|P2|Overall Study|Protocol Violation|1
1347261|NCT01820585|4438756|P1|Overall Study|Protocol Violation|3
1347262|NCT01820585|4438753|P4|Overall Study|Lost to Follow-up|3
1347263|NCT01820585|4438754|P3|Overall Study|Lost to Follow-up|0
1347264|NCT01820585|4438755|P2|Overall Study|Lost to Follow-up|3
1347265|NCT01820585|4438756|P1|Overall Study|Lost to Follow-up|3
1347266|NCT01820585|4438753|P4|Overall Study|Withdrawal by Subject|8
1347267|NCT01820585|4438754|P3|Overall Study|Withdrawal by Subject|3
1347268|NCT01820585|4438755|P2|Overall Study|Withdrawal by Subject|7
1347269|NCT01820585|4438756|P1|Overall Study|Withdrawal by Subject|3
1347270|NCT01820585|4438753|P4|Overall Study|Lack of Efficacy|1
1347271|NCT01820585|4438754|P3|Overall Study|Lack of Efficacy|5
1347272|NCT01820585|4438755|P2|Overall Study|Lack of Efficacy|7
1347273|NCT01820585|4438756|P1|Overall Study|Lack of Efficacy|9
1347274|NCT01820585|4438753|P4|Overall Study|Adverse Event|34
1347275|NCT01820585|4438754|P3|Overall Study|Adverse Event|23
1347276|NCT01820585|4438755|P2|Overall Study|Adverse Event|13
1347277|NCT01820585|4438756|P1|Overall Study|Adverse Event|9
1347278|NCT01820559|4438769|P3|Overall Study|Lack of Efficacy|3
1347279|NCT01820559|4438770|P2|Overall Study|Lack of Efficacy|2
1347280|NCT01820559|4438771|P1|Overall Study|Lack of Efficacy|3
1347281|NCT01820559|4438769|P3|Overall Study|At sponsor request|1
1347282|NCT01820559|4438770|P2|Overall Study|At sponsor request|0
1347283|NCT01820559|4438771|P1|Overall Study|At sponsor request|0
1347284|NCT01820559|4438769|P3|Overall Study|Lost to Follow-up|2
1347285|NCT01820559|4438770|P2|Overall Study|Lost to Follow-up|2
1347286|NCT01820559|4438771|P1|Overall Study|Lost to Follow-up|3
1347287|NCT01820559|4438769|P3|Overall Study|Subject's non-compliance|2
1347288|NCT01820559|4438770|P2|Overall Study|Subject's non-compliance|0
1347289|NCT01820559|4438771|P1|Overall Study|Subject's non-compliance|1
1347290|NCT01820559|4438769|P3|Overall Study|Protocol Violation|3
1347291|NCT01820559|4438770|P2|Overall Study|Protocol Violation|1
1347292|NCT01820559|4438771|P1|Overall Study|Protocol Violation|2
1347293|NCT01820559|4438769|P3|Overall Study|Withdrawal by Subject|5
1347294|NCT01820559|4438770|P2|Overall Study|Withdrawal by Subject|2
1347295|NCT01820559|4438771|P1|Overall Study|Withdrawal by Subject|1
1347296|NCT01820559|4438769|P3|Overall Study|Adverse Event|13
1347297|NCT01820559|4438770|P2|Overall Study|Adverse Event|6
1347298|NCT01820559|4438771|P1|Overall Study|Adverse Event|4
1347299|NCT01820364|4438792|P2|Part II: LGX818 + MEK162|Study Termination|1
1347300|NCT01820364|4438793|P1|Part II: LGX818 + MEK162|Study Termination|0
1347301|NCT01820364|4438792|P2|Part I: LGX818|Disease Progression|0
1347302|NCT01820364|4438793|P1|Part I: LGX818|Disease Progression|4
1347303|NCT01820364|4438792|P2|Part I: LGX818|Adverse Event|0
1347304|NCT01820364|4438793|P1|Part I: LGX818|Adverse Event|6
1347305|NCT01820364|4438792|P2|Part I: LGX818|Administrative Problems|0
1347306|NCT01820364|4438793|P1|Part I: LGX818|Administrative Problems|3
1347307|NCT01820364|4438792|P2|Part I: LGX818|Death|0
1347308|NCT01820364|4438793|P1|Part I: LGX818|Death|1
1347309|NCT01819272|4438977|P6|Overall Study|Loss of Glucose Control|0
1347310|NCT01819272|4438978|P5|Overall Study|Loss of Glucose Control|2
1347311|NCT01819272|4438979|P4|Overall Study|Loss of Glucose Control|1
1347312|NCT01819272|4438980|P3|Overall Study|Loss of Glucose Control|0
1347313|NCT01819272|4438981|P2|Overall Study|Loss of Glucose Control|1
1347314|NCT01819272|4438982|P1|Overall Study|Loss of Glucose Control|2
1347315|NCT01819272|4438977|P6|Overall Study|Withdrawal of Consent|1
1347316|NCT01819272|4438978|P5|Overall Study|Withdrawal of Consent|0
1347317|NCT01819272|4438979|P4|Overall Study|Withdrawal of Consent|1
1347318|NCT01819272|4438980|P3|Overall Study|Withdrawal of Consent|2
1347319|NCT01819272|4438981|P2|Overall Study|Withdrawal of Consent|1
1347320|NCT01819272|4438982|P1|Overall Study|Withdrawal of Consent|0
1347321|NCT01819272|4438977|P6|Overall Study|Physician Decision|0
1347322|NCT01819272|4438978|P5|Overall Study|Physician Decision|0
1347323|NCT01819272|4438979|P4|Overall Study|Physician Decision|0
1347324|NCT01819272|4438980|P3|Overall Study|Physician Decision|0
1347325|NCT01819272|4438981|P2|Overall Study|Physician Decision|1
1347326|NCT01819272|4438982|P1|Overall Study|Physician Decision|0
1347327|NCT01819272|4438977|P6|Overall Study|Protocol Violation|3
1347328|NCT01819272|4438978|P5|Overall Study|Protocol Violation|2
1347329|NCT01819272|4438979|P4|Overall Study|Protocol Violation|1
1347330|NCT01819272|4438980|P3|Overall Study|Protocol Violation|0
1347331|NCT01819272|4438981|P2|Overall Study|Protocol Violation|0
1347332|NCT01819272|4438982|P1|Overall Study|Protocol Violation|0
1347333|NCT01819272|4438977|P6|Overall Study|Lost to Follow-up|3
1347334|NCT01819272|4438978|P5|Overall Study|Lost to Follow-up|0
1347335|NCT01819272|4438979|P4|Overall Study|Lost to Follow-up|0
1347336|NCT01819272|4438980|P3|Overall Study|Lost to Follow-up|1
1347337|NCT01819272|4438981|P2|Overall Study|Lost to Follow-up|0
1347338|NCT01819272|4438982|P1|Overall Study|Lost to Follow-up|3
1347339|NCT01819272|4438977|P6|Overall Study|Adverse Event|0
1347340|NCT01819272|4438978|P5|Overall Study|Adverse Event|0
1347341|NCT01819272|4438979|P4|Overall Study|Adverse Event|2
1347342|NCT01819272|4438980|P3|Overall Study|Adverse Event|0
1347343|NCT01819272|4438981|P2|Overall Study|Adverse Event|0
1347344|NCT01819272|4438982|P1|Overall Study|Adverse Event|1
1347345|NCT01819194|4439008|P1|Overall Study|Loss of study articles|2
1347346|NCT01819129|4439015|P2|Overall Study|Withdrawal Criteria|15
1347347|NCT01819129|4439016|P1|Overall Study|Withdrawal Criteria|20
1347348|NCT01819129|4439015|P2|Overall Study|Death|1
1347349|NCT01819129|4439016|P1|Overall Study|Death|1
1347350|NCT01819129|4439015|P2|Overall Study|Adverse Event|4
1347351|NCT01819129|4439016|P1|Overall Study|Adverse Event|1
1347352|NCT01819129|4439015|P2|Overall Study|Lack of Efficacy|1
1347353|NCT01819129|4439016|P1|Overall Study|Lack of Efficacy|0
1347354|NCT01819129|4439015|P2|Overall Study|Lost to Follow-up|2
1347355|NCT01819129|4439016|P1|Overall Study|Lost to Follow-up|5
1347356|NCT01819129|4439015|P2|Overall Study|Withdrawal by Subject|15
1347357|NCT01819129|4439016|P1|Overall Study|Withdrawal by Subject|15
1347358|NCT01819129|4439015|P2|Overall Study|Other, Subject moved out of the country|1
1347359|NCT01819129|4439016|P1|Overall Study|Other, Subject moved out of the country|0
1347360|NCT01819129|4439015|P2|Overall Study|Other, weight gain, hypoglycaemic events|0
1347361|NCT01819129|4439016|P1|Overall Study|Other, weight gain, hypoglycaemic events|1
1347362|NCT01819129|4439015|P2|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
1347363|NCT01819129|4439016|P1|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
1347364|NCT01818752|4439030|P2|Overall Study|Randomized but not Dosed|4
1347365|NCT01818752|4439031|P1|Overall Study|Randomized but not Dosed|7
1347366|NCT01818752|4439030|P2|Overall Study|Continuing Treatment|4
1347367|NCT01818752|4439031|P1|Overall Study|Continuing Treatment|1
1347368|NCT01818752|4439030|P2|Overall Study|Other|8
1347369|NCT01818752|4439031|P1|Overall Study|Other|7
1347370|NCT01818752|4439030|P2|Overall Study|Disease Progression|48
1347371|NCT01818752|4439031|P1|Overall Study|Disease Progression|54
1347372|NCT01818752|4439030|P2|Overall Study|Physician Decision|8
1347373|NCT01818752|4439031|P1|Overall Study|Physician Decision|9
1347374|NCT01818752|4439030|P2|Overall Study|Withdrawal by Subject|14
1347375|NCT01818752|4439031|P1|Overall Study|Withdrawal by Subject|15
1347376|NCT01818752|4439030|P2|Overall Study|Non-compliance|20
1347377|NCT01818752|4439031|P1|Overall Study|Non-compliance|16
1347378|NCT01818752|4439030|P2|Overall Study|Death|18
1347379|NCT01818752|4439031|P1|Overall Study|Death|14
1347380|NCT01818752|4439030|P2|Overall Study|Adverse Event|74
1347381|NCT01818752|4439031|P1|Overall Study|Adverse Event|64
1347382|NCT01818700|4439049|P1|Overall Study|Other|1
1347383|NCT01818700|4439049|P1|Overall Study|Protocol Violation|2
1347384|NCT01818700|4439049|P1|Overall Study|Withdrawal by Subject|27
1347385|NCT01818700|4439049|P1|Overall Study|Lost to Follow-up|5
1347386|NCT01818700|4439049|P1|Overall Study|Lack of Efficacy|2
1347387|NCT01818700|4439049|P1|Overall Study|Adverse Event|67
1347388|NCT01818596|4439060|P2|Overall Study|Still on Study|6
1347389|NCT01818596|4439061|P1|Overall Study|Still on Study|232
1347390|NCT01818596|4439060|P2|Overall Study|Lost to Follow-up|0
1347391|NCT01818596|4439061|P1|Overall Study|Lost to Follow-up|2
1347392|NCT01818596|4439060|P2|Overall Study|Protocol Violation|0
1347393|NCT01818596|4439061|P1|Overall Study|Protocol Violation|1
1347394|NCT01818596|4439060|P2|Overall Study|Withdrew Consent|0
1347395|NCT01818596|4439061|P1|Overall Study|Withdrew Consent|3
1347396|NCT01818596|4439060|P2|Overall Study|Adverse Event|0
1347397|NCT01818596|4439061|P1|Overall Study|Adverse Event|4
1347398|NCT01818596|4439060|P2|Overall Study|Enrolled but Not Treated|0
1347399|NCT01818596|4439061|P1|Overall Study|Enrolled but Not Treated|4
1347400|NCT01818336|4439109|P2|Overall Study|Lost to Follow-up|1
1347401|NCT01818336|4439110|P1|Overall Study|Lost to Follow-up|0
1347402|NCT01818336|4439109|P2|Overall Study|Declined retest visit|11
1347403|NCT01818336|4439110|P1|Overall Study|Declined retest visit|0
1347404|NCT01818297|4439118|P2|Open Label Phase (3-12 Months)|Early study closure|10
1347405|NCT01818297|4439119|P1|Open Label Phase (3-12 Months)|Early study closure|17
1347406|NCT01818297|4439118|P2|Open Label Phase (3-12 Months)|Physician Decision|0
1347407|NCT01818297|4439119|P1|Open Label Phase (3-12 Months)|Physician Decision|1
1347408|NCT01818297|4439118|P2|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
1347409|NCT01818297|4439119|P1|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
1347410|NCT01818141|4439137|P2|Overall Study|Lost to Follow-up|2
1347411|NCT01818141|4439138|P1|Overall Study|Lost to Follow-up|0
1347412|NCT01818141|4439137|P2|Overall Study|No baseline C.diff colonies|1
1347413|NCT01818141|4439138|P1|Overall Study|No baseline C.diff colonies|1
1347414|NCT01818141|4439137|P2|Overall Study|Withdrawal by Subject|0
1347415|NCT01818141|4439138|P1|Overall Study|Withdrawal by Subject|2
1347416|NCT01817790|4439203|P2|Overall Study|Other: Could not attend appointment|1
1347417|NCT01817790|4439204|P1|Overall Study|Other: Could not attend appointment|1
1347418|NCT01817790|4439203|P2|Overall Study|Withdrawal by Subject|3
1347419|NCT01817790|4439204|P1|Overall Study|Withdrawal by Subject|1
1347420|NCT01817790|4439203|P2|Overall Study|Protocol Violation|1
1347421|NCT01817790|4439204|P1|Overall Study|Protocol Violation|2
1347422|NCT01817790|4439203|P2|Overall Study|Lost to Follow-up|1
1347423|NCT01817790|4439204|P1|Overall Study|Lost to Follow-up|0
1347424|NCT01817790|4439203|P2|Overall Study|Adverse Event|2
1347425|NCT01817790|4439204|P1|Overall Study|Adverse Event|0
1347426|NCT01817777|4439248|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
1347427|NCT01817777|4439249|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
1347428|NCT01817777|4439250|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
1347429|NCT01817777|4439248|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
1347430|NCT01817777|4439249|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
1347431|NCT01817777|4439250|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
1347432|NCT01817777|4439248|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
1347433|NCT01817777|4439249|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
1347434|NCT01817777|4439250|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
1347435|NCT01817777|4439248|P3|Observational Phase (8 Weeks)|Early Study Termination|0
1347436|NCT01817777|4439249|P2|Observational Phase (8 Weeks)|Early Study Termination|0
1347437|NCT01817777|4439250|P1|Observational Phase (8 Weeks)|Early Study Termination|2
1347438|NCT01817777|4439248|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
1347439|NCT01817777|4439249|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
1347440|NCT01817777|4439250|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
1347441|NCT01817764|4439274|P2|Overall Study|Withdrawal by Subject|12
1347442|NCT01817764|4439275|P1|Overall Study|Withdrawal by Subject|10
1347443|NCT01817764|4439274|P2|Overall Study|Lost to Follow-up|4
1347444|NCT01817764|4439275|P1|Overall Study|Lost to Follow-up|1
1347445|NCT01817764|4439274|P2|Overall Study|Protocol Violation|5
1347446|NCT01817764|4439275|P1|Overall Study|Protocol Violation|7
1347447|NCT01817764|4439274|P2|Overall Study|Lack of Efficacy|7
1347448|NCT01817764|4439275|P1|Overall Study|Lack of Efficacy|9
1347449|NCT01817764|4439274|P2|Overall Study|Adverse Event|10
1347450|NCT01817764|4439275|P1|Overall Study|Adverse Event|7
1347451|NCT01817725|4439283|P1|Overall Study|Withdrawal by Subject|1
1347452|NCT01816893|4439351|P2|Washout Period|Withdrawal by Subject|0
1347453|NCT01816893|4439352|P1|Washout Period|Withdrawal by Subject|2
1347454|NCT01816685|4439387|P2|Overall Study|Surgery Cancelled|2
1347455|NCT01816685|4439388|P1|Overall Study|Surgery Cancelled|3
1347456|NCT01816685|4439387|P2|Overall Study|Lost to Follow-up|9
1347457|NCT01816685|4439388|P1|Overall Study|Lost to Follow-up|7
1347458|NCT01816477|4439398|P2|Overall Study|Unable to tolerate catheter placement|0
1347459|NCT01816477|4439399|P1|Overall Study|Unable to tolerate catheter placement|3
1347460|NCT01816477|4439398|P2|Overall Study|Withdrawal by Subject|1
1347461|NCT01816477|4439399|P1|Overall Study|Withdrawal by Subject|13
1347462|NCT01816295|4439453|P2|OLE Phase|Lack of Efficacy|7
1347463|NCT01816295|4439454|P1|OLE Phase|Lack of Efficacy|3
1347464|NCT01816295|4439453|P2|OLE Phase|Withdrawal by Subject|10
1347465|NCT01816295|4439454|P1|OLE Phase|Withdrawal by Subject|10
1347466|NCT01816295|4439453|P2|OLE Phase|Sponsor Decision|9
1347467|NCT01816295|4439454|P1|OLE Phase|Sponsor Decision|7
1347468|NCT01816295|4439453|P2|OLE Phase|Protocol Violation|4
1347469|NCT01816295|4439454|P1|OLE Phase|Protocol Violation|4
1347470|NCT01816295|4439453|P2|OLE Phase|Physician Decision|1
1347471|NCT01816295|4439454|P1|OLE Phase|Physician Decision|3
1347472|NCT01816295|4439453|P2|OLE Phase|Lost to Follow-up|5
1347473|NCT01816295|4439454|P1|OLE Phase|Lost to Follow-up|5
1347474|NCT01816295|4439453|P2|OLE Phase|Entry Criteria Not Met|5
1347475|NCT01816295|4439454|P1|OLE Phase|Entry Criteria Not Met|3
1347476|NCT01816295|4439453|P2|OLE Phase|Death|0
1347477|NCT01816295|4439454|P1|OLE Phase|Death|1
1347478|NCT01816295|4439453|P2|OLE Phase|Adverse Event|15
1347479|NCT01816295|4439454|P1|OLE Phase|Adverse Event|17
1347480|NCT01816295|4439453|P2|Double Blind Phase|Withdrawal by Subject|20
1347481|NCT01816295|4439454|P1|Double Blind Phase|Withdrawal by Subject|22
1347482|NCT01816295|4439453|P2|Double Blind Phase|Sponsor Decision|8
1347483|NCT01816295|4439454|P1|Double Blind Phase|Sponsor Decision|8
1347484|NCT01816295|4439453|P2|Double Blind Phase|Protocol Violation|11
1347485|NCT01816295|4439454|P1|Double Blind Phase|Protocol Violation|17
1347486|NCT01816295|4439453|P2|Double Blind Phase|Physician Decision|2
1347487|NCT01816295|4439454|P1|Double Blind Phase|Physician Decision|2
1347488|NCT01816295|4439453|P2|Double Blind Phase|Lost to Follow-up|5
1347489|NCT01816295|4439454|P1|Double Blind Phase|Lost to Follow-up|3
1347490|NCT01816295|4439453|P2|Double Blind Phase|Entry Criteria Not Met|2
1347491|NCT01816295|4439454|P1|Double Blind Phase|Entry Criteria Not Met|0
1347492|NCT01816295|4439453|P2|Double Blind Phase|Adverse Event|8
1347493|NCT01816295|4439454|P1|Double Blind Phase|Adverse Event|11
1347494|NCT01816243|4439469|P1|Overall Study|Amputation|3
1347495|NCT01816243|4439469|P1|Overall Study|Not eligible for the study|1
1347496|NCT01816243|4439469|P1|Overall Study|Lack of Efficacy|1
1347497|NCT01816243|4439469|P1|Overall Study|Lost to Follow-up|1
1347498|NCT01816243|4439469|P1|Overall Study|Adverse Event|6
1347499|NCT01816074|4439480|P4|Phase 2|Withdrawal by Subject|0
1347500|NCT01816074|4439481|P3|Phase 2|Withdrawal by Subject|0
1347501|NCT01816074|4439482|P2|Phase 2|Withdrawal by Subject|0
1347502|NCT01816074|4439483|P1|Phase 2|Withdrawal by Subject|1
1347503|NCT01816074|4439480|P4|Phase 2|Physician Decision|1
1347504|NCT01816074|4439481|P3|Phase 2|Physician Decision|0
1347505|NCT01816074|4439482|P2|Phase 2|Physician Decision|0
1347506|NCT01816074|4439483|P1|Phase 2|Physician Decision|0
1347507|NCT01816074|4439480|P4|Phase 2|Unsatisfied with Randomization assignmen|0
1347508|NCT01816074|4439481|P3|Phase 2|Unsatisfied with Randomization assignmen|0
1347509|NCT01816074|4439482|P2|Phase 2|Unsatisfied with Randomization assignmen|0
1347510|NCT01816074|4439483|P1|Phase 2|Unsatisfied with Randomization assignmen|1
1347511|NCT01816074|4439480|P4|Phase 2|Time commitment Issues|0
1347512|NCT01816074|4439481|P3|Phase 2|Time commitment Issues|0
1347513|NCT01816074|4439482|P2|Phase 2|Time commitment Issues|2
1347514|NCT01816074|4439483|P1|Phase 2|Time commitment Issues|0
1347515|NCT01816074|4439480|P4|Phase 1|Time commitment issues|0
1347516|NCT01816074|4439481|P3|Phase 1|Time commitment issues|1
1347517|NCT01816074|4439482|P2|Phase 1|Time commitment issues|0
1347518|NCT01816074|4439483|P1|Phase 1|Time commitment issues|0
1347519|NCT01816048|4439511|P1|Overall Study|Disease Progression|3
1347520|NCT01816048|4439511|P1|Overall Study|Withdrawal by Subject|1
1347521|NCT01816048|4439511|P1|Overall Study|Death|1
1347522|NCT01816048|4439511|P1|Overall Study|Adverse Event|1
1347523|NCT01815918|4439526|P2|Overall Study|Lack of Efficacy|15
1347524|NCT01815918|4439527|P1|Overall Study|Lack of Efficacy|15
1347525|NCT01815918|4439526|P2|Overall Study|Patient samples not analyzable|4
1347526|NCT01815918|4439527|P1|Overall Study|Patient samples not analyzable|3
1347527|NCT01815840|4439543|P2|Overall Study|Sponsor Termination Treatment|0
1347528|NCT01815840|4439544|P1|Overall Study|Sponsor Termination Treatment|1
1347529|NCT01815840|4439543|P2|Overall Study|Refused Treatment|1
1347530|NCT01815840|4439544|P1|Overall Study|Refused Treatment|5
1347531|NCT01815840|4439543|P2|Overall Study|Lost to Follow-up|6
1347532|NCT01815840|4439544|P1|Overall Study|Lost to Follow-up|3
1347533|NCT01815840|4439543|P2|Overall Study|Investigators Decision|3
1347534|NCT01815840|4439544|P1|Overall Study|Investigators Decision|2
1347535|NCT01815840|4439543|P2|Overall Study|Disease progression|2
1347536|NCT01815840|4439544|P1|Overall Study|Disease progression|3
1347537|NCT01815840|4439543|P2|Overall Study|Death|2
1347538|NCT01815840|4439544|P1|Overall Study|Death|2
1347539|NCT01815840|4439543|P2|Overall Study|Adverse Event|16
1347540|NCT01815840|4439544|P1|Overall Study|Adverse Event|10
1347541|NCT01815840|4439543|P2|Overall Study|Administrative/Other|3
1347542|NCT01815840|4439544|P1|Overall Study|Administrative/Other|1
1347543|NCT01815840|4439543|P2|Overall Study|Withdrew Consent|30
1347544|NCT01815840|4439544|P1|Overall Study|Withdrew Consent|31
1347545|NCT01815840|4439543|P2|Overall Study|Missing|0
1347546|NCT01815840|4439544|P1|Overall Study|Missing|1
1347547|NCT01815736|4439574|P2|Overall Study|Still on Study|449
1347548|NCT01815736|4439575|P1|Overall Study|Still on Study|929
1347549|NCT01815736|4439574|P2|Overall Study|Lost to Follow-up|7
1347550|NCT01815736|4439575|P1|Overall Study|Lost to Follow-up|6
1347551|NCT01815736|4439574|P2|Overall Study|Withdrew Consent|15
1347552|NCT01815736|4439575|P1|Overall Study|Withdrew Consent|7
1347553|NCT01815736|4439574|P2|Overall Study|Investigator's Discretion|0
1347554|NCT01815736|4439575|P1|Overall Study|Investigator's Discretion|4
1347555|NCT01815736|4439574|P2|Overall Study|Death|0
1347556|NCT01815736|4439575|P1|Overall Study|Death|4
1347557|NCT01815736|4439574|P2|Overall Study|Adverse Event|4
1347558|NCT01815736|4439575|P1|Overall Study|Adverse Event|7
1347559|NCT01815736|4439574|P2|Overall Study|Randomized but Not Treated|3
1347560|NCT01815736|4439575|P1|Overall Study|Randomized but Not Treated|4
1347561|NCT01815138|4439628|P2|Overall Study|Physician Decision|5
1347562|NCT01815138|4439629|P1|Overall Study|Physician Decision|8
1347563|NCT01815138|4439628|P2|Overall Study|Withdrawal by Subject|1
1347564|NCT01815138|4439629|P1|Overall Study|Withdrawal by Subject|0
1347565|NCT01815099|4439641|P1|Overall Study|unable to attend study visits|1
1347566|NCT01815099|4439641|P1|Overall Study|Lack of Efficacy|1
1347567|NCT01814878|4439655|P2|Overall Study|Other|0
1347568|NCT01814878|4439656|P1|Overall Study|Other|2
1347569|NCT01814878|4439655|P2|Overall Study|Screening failure (drop-out)|3
1347570|NCT01814878|4439656|P1|Overall Study|Screening failure (drop-out)|0
1347571|NCT01814878|4439655|P2|Overall Study|Physician Decision|1
1347572|NCT01814878|4439656|P1|Overall Study|Physician Decision|3
1347573|NCT01814878|4439655|P2|Overall Study|Protocol Violation|5
1347574|NCT01814878|4439656|P1|Overall Study|Protocol Violation|5
1347575|NCT01814878|4439655|P2|Overall Study|Withdrawal by Subject|16
1347576|NCT01814878|4439656|P1|Overall Study|Withdrawal by Subject|20
1347577|NCT01814878|4439655|P2|Overall Study|Adverse Event|5
1347578|NCT01814878|4439656|P1|Overall Study|Adverse Event|16
1347579|NCT01814800|4439676|P1|Overall Study|Subject relocation|1
1347580|NCT01814800|4439676|P1|Overall Study|Sponsor decision|1
1347581|NCT01814800|4439676|P1|Overall Study|Pregnancy|1
1347582|NCT01814800|4439676|P1|Overall Study|Adverse Event|2
1347583|NCT01814761|4439736|P2|Overall Study|Lost to Follow-up|5
1347584|NCT01814761|4439737|P1|Overall Study|Lost to Follow-up|1
1347585|NCT01814761|4439736|P2|Overall Study|Ocular Adverse Event|15
1347586|NCT01814761|4439737|P1|Overall Study|Ocular Adverse Event|6
1347587|NCT01814761|4439736|P2|Overall Study|Other Reasons|10
1347588|NCT01814761|4439737|P1|Overall Study|Other Reasons|1
1347589|NCT01814748|4439751|P2|Overall Study|Withdrawal by Subject|4
1347590|NCT01814748|4439752|P1|Overall Study|Withdrawal by Subject|6
1347591|NCT01814748|4439751|P2|Overall Study|Study site terminated by sponsor|1
1347592|NCT01814748|4439752|P1|Overall Study|Study site terminated by sponsor|1
1347593|NCT01814748|4439751|P2|Overall Study|Lost to Follow-up|2
1347594|NCT01814748|4439752|P1|Overall Study|Lost to Follow-up|1
1347595|NCT01814696|4439796|P2|Overall Study|Randomized to wrong group|0
1347596|NCT01814696|4439797|P1|Overall Study|Randomized to wrong group|1
1347597|NCT01814696|4439796|P2|Overall Study|Withdrawal by Subject|0
1347598|NCT01814696|4439797|P1|Overall Study|Withdrawal by Subject|1
1347599|NCT01814670|4439815|P1|Overall Study|Protocol Violation|12
1347600|NCT01814553|4439825|P2|Overall Study|Other than stated|8
1347601|NCT01814553|4439826|P1|Overall Study|Other than stated|7
1347602|NCT01814553|4439825|P2|Overall Study|Withdrawal by Subject|1
1347603|NCT01814553|4439826|P1|Overall Study|Withdrawal by Subject|1
1347604|NCT01814553|4439825|P2|Overall Study|Other Adverse Event|5
1347605|NCT01814553|4439826|P1|Overall Study|Other Adverse Event|4
1347606|NCT01814553|4439825|P2|Overall Study|PD per clinical progression|8
1347607|NCT01814553|4439826|P1|Overall Study|PD per clinical progression|6
1347608|NCT01814397|4439840|P1|Overall Study|Withdrawal by Subject|7
1347609|NCT01814397|4439840|P1|Overall Study|Adverse Event|7
1347610|NCT01814332|4439849|P2|Overall Study|Lost to Follow-up|1
1347611|NCT01814332|4439850|P1|Overall Study|Lost to Follow-up|5
1347612|NCT01814332|4439849|P2|Overall Study|Protocol Violation|4
1347613|NCT01814332|4439850|P1|Overall Study|Protocol Violation|0
1347614|NCT01814332|4439849|P2|Overall Study|Withdrawal by Subject|8
1347615|NCT01814332|4439850|P1|Overall Study|Withdrawal by Subject|3
1347616|NCT01814332|4439849|P2|Overall Study|Adverse Event|3
1347617|NCT01814332|4439850|P1|Overall Study|Adverse Event|8
1347618|NCT01814137|4439872|P2|Overall Study|Unclassified|1
1347619|NCT01814137|4439873|P1|Overall Study|Unclassified|2
1347620|NCT01814137|4439872|P2|Overall Study|Physician Decision|1
1347621|NCT01814137|4439873|P1|Overall Study|Physician Decision|1
1347622|NCT01814137|4439872|P2|Overall Study|Withdrawal by Subject|2
1347623|NCT01814137|4439873|P1|Overall Study|Withdrawal by Subject|2
1347624|NCT01814137|4439872|P2|Overall Study|Adverse Event|1
1347625|NCT01814137|4439873|P1|Overall Study|Adverse Event|0
1347626|NCT01814046|4439889|P3|Drug Administration|Death due to complications of RSV|0
1347627|NCT01814046|4439890|P2|Drug Administration|Death due to complications of RSV|0
1347628|NCT01814046|4439891|P1|Drug Administration|Death due to complications of RSV|1
1347629|NCT01813890|4439905|P3|Overall Study|Lack of Efficacy|2
1347630|NCT01813890|4439906|P2|Overall Study|Lack of Efficacy|1
1347631|NCT01813890|4439907|P1|Overall Study|Lack of Efficacy|9
1347632|NCT01813890|4439905|P3|Overall Study|Adverse Event|4
1347633|NCT01813890|4439906|P2|Overall Study|Adverse Event|3
1347634|NCT01813890|4439907|P1|Overall Study|Adverse Event|0
1347635|NCT01813721|4439936|P1|Overall Study|Withdrawal by Subject|1
1347636|NCT01813721|4439936|P1|Overall Study|Ineligibility determined|63
1347637|NCT01813474|4439991|P3|Overall Study|Death|1
1347638|NCT01813474|4439992|P2|Overall Study|Death|0
1347639|NCT01813474|4439993|P1|Overall Study|Death|0
1347640|NCT01813474|4439991|P3|Overall Study|Lack of Efficacy|9
1347641|NCT01813474|4439992|P2|Overall Study|Lack of Efficacy|6
1347642|NCT01813474|4439993|P1|Overall Study|Lack of Efficacy|2
1347643|NCT01813474|4439991|P3|Overall Study|Adverse Event|0
1347644|NCT01813474|4439992|P2|Overall Study|Adverse Event|1
1347645|NCT01813474|4439993|P1|Overall Study|Adverse Event|1
1347646|NCT01813474|4439991|P3|Overall Study|Withdrawal by Subject|1
1347647|NCT01813474|4439992|P2|Overall Study|Withdrawal by Subject|0
1347648|NCT01813474|4439993|P1|Overall Study|Withdrawal by Subject|0
1347649|NCT01813422|4440017|P2|Overall Study|Lost to Follow-up|4
1347650|NCT01813422|4440018|P1|Overall Study|Lost to Follow-up|2
1347651|NCT01813422|4440017|P2|Overall Study|Sponsor Decision|1
1347652|NCT01813422|4440018|P1|Overall Study|Sponsor Decision|2
1347653|NCT01813422|4440017|P2|Overall Study|Death|3
1347654|NCT01813422|4440018|P1|Overall Study|Death|2
1347655|NCT01813422|4440017|P2|Overall Study|Withdrawal by Subject|8
1347656|NCT01813422|4440018|P1|Overall Study|Withdrawal by Subject|14
1347657|NCT01813019|4440043|P2|Overall Study|Protocol Deviation|1
1347658|NCT01813019|4440044|P1|Overall Study|Protocol Deviation|2
1347659|NCT01813019|4440043|P2|Overall Study|administrative problems|0
1347660|NCT01813019|4440044|P1|Overall Study|administrative problems|2
1347661|NCT01813019|4440043|P2|Overall Study|Withdrawal by Subject|2
1347662|NCT01813019|4440044|P1|Overall Study|Withdrawal by Subject|3
1347663|NCT01813019|4440043|P2|Overall Study|Adverse Event|3
1347664|NCT01813019|4440044|P1|Overall Study|Adverse Event|0
1347665|NCT01812837|4440055|P3|Overall Study|Protocol Violation|0
1347666|NCT01812837|4440056|P2|Overall Study|Protocol Violation|0
1347667|NCT01812837|4440057|P1|Overall Study|Protocol Violation|1
1347668|NCT01812837|4440055|P3|Overall Study|Lost to Follow-up|0
1347669|NCT01812837|4440056|P2|Overall Study|Lost to Follow-up|1
1347670|NCT01812837|4440057|P1|Overall Study|Lost to Follow-up|1
1347671|NCT01812707|4440069|P4|Overall Study|Consent withdrawn by participant|0
1347672|NCT01812707|4440070|P3|Overall Study|Consent withdrawn by participant|0
1347673|NCT01812707|4440071|P2|Overall Study|Consent withdrawn by participant|0
1347674|NCT01812707|4440072|P1|Overall Study|Consent withdrawn by participant|1
1347675|NCT01812707|4440069|P4|Overall Study|Poor compliance to protocol|0
1347676|NCT01812707|4440070|P3|Overall Study|Poor compliance to protocol|0
1347677|NCT01812707|4440071|P2|Overall Study|Poor compliance to protocol|0
1347678|NCT01812707|4440072|P1|Overall Study|Poor compliance to protocol|1
1347679|NCT01812707|4440069|P4|Overall Study|Adverse Event|2
1347680|NCT01812707|4440070|P3|Overall Study|Adverse Event|0
1347681|NCT01812707|4440071|P2|Overall Study|Adverse Event|0
1347682|NCT01812707|4440072|P1|Overall Study|Adverse Event|0
1347683|NCT01812655|4440120|P3|Overall Study|Protocol Violation|0
1347684|NCT01812655|4440121|P2|Overall Study|Protocol Violation|1
1347685|NCT01812655|4440122|P1|Overall Study|Protocol Violation|1
1347686|NCT01812057|4440147|P2|Overall Study|Physician Decision|0
1347687|NCT01812057|4440148|P1|Overall Study|Physician Decision|1
1347688|NCT01812057|4440147|P2|Overall Study|Protocol Violation|0
1347689|NCT01812057|4440148|P1|Overall Study|Protocol Violation|1
1347690|NCT01811953|4440251|P6|Overall Study|Protocol Violation|0
1347691|NCT01811953|4440252|P5|Overall Study|Protocol Violation|1
1347692|NCT01811953|4440253|P4|Overall Study|Protocol Violation|0
1347693|NCT01811953|4440254|P3|Overall Study|Protocol Violation|0
1347694|NCT01811953|4440255|P2|Overall Study|Protocol Violation|0
1347695|NCT01811953|4440256|P1|Overall Study|Protocol Violation|0
1347696|NCT01811953|4440251|P6|Overall Study|Adverse Event|1
1347697|NCT01811953|4440252|P5|Overall Study|Adverse Event|0
1347698|NCT01811953|4440253|P4|Overall Study|Adverse Event|1
1347699|NCT01811953|4440254|P3|Overall Study|Adverse Event|0
1347700|NCT01811953|4440255|P2|Overall Study|Adverse Event|0
1347701|NCT01811953|4440256|P1|Overall Study|Adverse Event|0
1347702|NCT01811732|4440302|P2|Overall Study|Correct study drug not available on site|0
1347703|NCT01811732|4440303|P1|Overall Study|Correct study drug not available on site|1
1347704|NCT01811732|4440302|P2|Overall Study|Admitted to another facility|0
1347705|NCT01811732|4440303|P1|Overall Study|Admitted to another facility|1
1347706|NCT01811732|4440302|P2|Overall Study|Subject incarcerated|2
1347707|NCT01811732|4440303|P1|Overall Study|Subject incarcerated|1
1347708|NCT01811732|4440302|P2|Overall Study|Protocol Violation|1
1347709|NCT01811732|4440303|P1|Overall Study|Protocol Violation|0
1347710|NCT01811732|4440302|P2|Overall Study|Insufficient venous access|1
1347711|NCT01811732|4440303|P1|Overall Study|Insufficient venous access|0
1347712|NCT01811732|4440302|P2|Overall Study|Death|1
1347713|NCT01811732|4440303|P1|Overall Study|Death|1
1347714|NCT01811732|4440302|P2|Overall Study|Physician Decision|0
1347715|NCT01811732|4440303|P1|Overall Study|Physician Decision|2
1347716|NCT01811732|4440302|P2|Overall Study|Non-compliance with study drug/procedure|3
1347717|NCT01811732|4440303|P1|Overall Study|Non-compliance with study drug/procedure|3
1347718|NCT01811732|4440302|P2|Overall Study|Lack of Efficacy|1
1347719|NCT01811732|4440303|P1|Overall Study|Lack of Efficacy|3
1347720|NCT01811732|4440302|P2|Overall Study|Adverse Event|9
1347721|NCT01811732|4440303|P1|Overall Study|Adverse Event|3
1347722|NCT01811732|4440302|P2|Overall Study|Withdrawal by Subject|10
1347723|NCT01811732|4440303|P1|Overall Study|Withdrawal by Subject|16
1347724|NCT01811732|4440302|P2|Overall Study|Lost to Follow-up|30
1347725|NCT01811732|4440303|P1|Overall Study|Lost to Follow-up|24
1347726|NCT01811706|4440313|P2|First Intervention ( 4 Weeks)|Adverse Event|0
1347727|NCT01811706|4440314|P1|First Intervention ( 4 Weeks)|Adverse Event|1
1347728|NCT01811563|4440331|P2|Overall Study|Incorrect Randomization procedure|1
1347729|NCT01811563|4440332|P1|Overall Study|Incorrect Randomization procedure|0
1347730|NCT01811563|4440331|P2|Overall Study|Lost to Follow-up|2
1347731|NCT01811563|4440332|P1|Overall Study|Lost to Follow-up|5
1347732|NCT01811485|4440361|P3|Overall Study|Protocol Deviation|0
1347733|NCT01811485|4440362|P2|Overall Study|Protocol Deviation|1
1347734|NCT01811485|4440363|P1|Overall Study|Protocol Deviation|0
1347735|NCT01811485|4440361|P3|Overall Study|Administrative problems|0
1347736|NCT01811485|4440362|P2|Overall Study|Administrative problems|0
1347737|NCT01811485|4440363|P1|Overall Study|Administrative problems|1
1347738|NCT01811485|4440361|P3|Overall Study|Unsatisfactory therapeutic effect|3
1347739|NCT01811485|4440362|P2|Overall Study|Unsatisfactory therapeutic effect|0
1347740|NCT01811485|4440363|P1|Overall Study|Unsatisfactory therapeutic effect|0
1347741|NCT01811485|4440361|P3|Overall Study|Adverse Event|2
1347742|NCT01811485|4440362|P2|Overall Study|Adverse Event|3
1347743|NCT01811485|4440363|P1|Overall Study|Adverse Event|1
1347744|NCT01811472|4440383|P3|Overall Study|Subject/guardian decision|0
1347745|NCT01811472|4440384|P2|Overall Study|Subject/guardian decision|0
1347746|NCT01811472|4440385|P1|Overall Study|Subject/guardian decision|1
1347747|NCT01811472|4440383|P3|Overall Study|Lost to Follow-up|1
1347748|NCT01811472|4440384|P2|Overall Study|Lost to Follow-up|0
1347749|NCT01811472|4440385|P1|Overall Study|Lost to Follow-up|0
1347750|NCT01811472|4440383|P3|Overall Study|Adverse Event|4
1347751|NCT01811472|4440384|P2|Overall Study|Adverse Event|0
1347752|NCT01811472|4440385|P1|Overall Study|Adverse Event|1
1347753|NCT01811238|4440472|P1|Overall Study|subject refused study medication|6
1347754|NCT01811238|4440472|P1|Overall Study|Lack of Efficacy|4
1347755|NCT01811238|4440472|P1|Overall Study|Protocol Violation|4
1347756|NCT01811238|4440472|P1|Overall Study|Adverse Event|25
1347757|NCT01811238|4440472|P1|Overall Study|Withdrawal by Subject|42
1347758|NCT01811186|4440496|P2|Overall Study|Lost to Follow-up|2
1347759|NCT01811186|4440497|P1|Overall Study|Lost to Follow-up|4
1347760|NCT01811186|4440496|P2|Overall Study|Lack of Efficacy|6
1347761|NCT01811186|4440497|P1|Overall Study|Lack of Efficacy|3
1347762|NCT01811186|4440496|P2|Overall Study|Withdrawal by Subject|10
1347763|NCT01811186|4440497|P1|Overall Study|Withdrawal by Subject|5
1347764|NCT01811186|4440496|P2|Overall Study|Protocol Violation|6
1347765|NCT01811186|4440497|P1|Overall Study|Protocol Violation|5
1347766|NCT01811186|4440496|P2|Overall Study|Adverse Event|38
1347767|NCT01811186|4440497|P1|Overall Study|Adverse Event|54
1347768|NCT01810939|4440530|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
1347769|NCT01810939|4440531|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
1347770|NCT01810939|4440532|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
1347771|NCT01810939|4440530|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
1347772|NCT01810939|4440531|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
1347773|NCT01810939|4440532|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
1347774|NCT01810939|4440530|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
1347775|NCT01810939|4440531|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
1347776|NCT01810939|4440532|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
1347777|NCT01810939|4440530|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
1347778|NCT01810939|4440531|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
1347779|NCT01810939|4440532|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
1347780|NCT01810939|4440530|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
1347781|NCT01810939|4440531|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
1347782|NCT01810939|4440532|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
1347783|NCT01810939|4440530|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
1347784|NCT01810939|4440531|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
1347785|NCT01810939|4440532|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
1347786|NCT01810939|4440530|P3|Part B Placebo-Controlled Withdrawal|Death|1
1347787|NCT01810939|4440531|P2|Part B Placebo-Controlled Withdrawal|Death|0
1347788|NCT01810939|4440532|P1|Part B Placebo-Controlled Withdrawal|Death|0
1347789|NCT01810939|4440530|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
1347790|NCT01810939|4440531|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
1347791|NCT01810939|4440532|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
1347792|NCT01810939|4440530|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
1347793|NCT01810939|4440531|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
1347794|NCT01810939|4440532|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
1347795|NCT01810939|4440530|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
1347796|NCT01810939|4440531|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
1347797|NCT01810939|4440532|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
1347798|NCT01810939|4440530|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
1347799|NCT01810939|4440531|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
1347800|NCT01810939|4440532|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
1347801|NCT01810939|4440530|P3|Part A Treatment Period|Protocol-specified (High K+)|0
1347802|NCT01810939|4440531|P2|Part A Treatment Period|Protocol-specified (High K+)|0
1347803|NCT01810939|4440532|P1|Part A Treatment Period|Protocol-specified (High K+)|3
1347804|NCT01810939|4440530|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
1347805|NCT01810939|4440531|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
1347806|NCT01810939|4440532|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
1347807|NCT01810939|4440530|P3|Part A Treatment Period|Withdrawal by Subject|0
1347808|NCT01810939|4440531|P2|Part A Treatment Period|Withdrawal by Subject|0
1347809|NCT01810939|4440532|P1|Part A Treatment Period|Withdrawal by Subject|5
1347810|NCT01810939|4440530|P3|Part A Treatment Period|Adverse Event|0
1347811|NCT01810939|4440531|P2|Part A Treatment Period|Adverse Event|0
1347812|NCT01810939|4440532|P1|Part A Treatment Period|Adverse Event|10
1347813|NCT01810939|4440530|P3|Part A Treatment Period|Protocol Violation|0
1347814|NCT01810939|4440531|P2|Part A Treatment Period|Protocol Violation|0
1347815|NCT01810939|4440532|P1|Part A Treatment Period|Protocol Violation|2
1347816|NCT01810939|4440530|P3|Part A Treatment Period|Non-compliance with Study Drug|0
1347817|NCT01810939|4440531|P2|Part A Treatment Period|Non-compliance with Study Drug|0
1347818|NCT01810939|4440532|P1|Part A Treatment Period|Non-compliance with Study Drug|1
1347819|NCT01810783|4440545|P1|Overall Study|Enrolled, not treated|1
1347820|NCT01810783|4440545|P1|Overall Study|Adminstrative or other reason(s)|23
1347821|NCT01810783|4440545|P1|Overall Study|Non-compliance with IMP|4
1347822|NCT01810783|4440545|P1|Overall Study|Protocol Violation|5
1347823|NCT01810783|4440545|P1|Overall Study|Lost to Follow-up|10
1347824|NCT01810783|4440545|P1|Overall Study|Lack of Efficacy|12
1347825|NCT01810783|4440545|P1|Overall Study|Withdrawal by Subject|22
1347826|NCT01810783|4440545|P1|Overall Study|Adverse Event|32
1347827|NCT01810380|4440573|P3|Overall Study|Administrative or other reasons|9
1347828|NCT01810380|4440574|P2|Overall Study|Administrative or other reasons|13
1347829|NCT01810380|4440575|P1|Overall Study|Administrative or other reasons|11
1347830|NCT01810380|4440573|P3|Overall Study|Withdrawal by Subject|6
1347831|NCT01810380|4440574|P2|Overall Study|Withdrawal by Subject|0
1347832|NCT01810380|4440575|P1|Overall Study|Withdrawal by Subject|6
1347833|NCT01810380|4440573|P3|Overall Study|Protocol Violation|1
1347834|NCT01810380|4440574|P2|Overall Study|Protocol Violation|0
1347835|NCT01810380|4440575|P1|Overall Study|Protocol Violation|1
1347836|NCT01810380|4440573|P3|Overall Study|Lack of Efficacy|11
1347837|NCT01810380|4440574|P2|Overall Study|Lack of Efficacy|10
1347838|NCT01810380|4440575|P1|Overall Study|Lack of Efficacy|24
1347839|NCT01810380|4440573|P3|Overall Study|Adverse Event|4
1347840|NCT01810380|4440574|P2|Overall Study|Adverse Event|14
1347841|NCT01810380|4440575|P1|Overall Study|Adverse Event|11
1347842|NCT01810380|4440573|P3|Overall Study|Randomised not treated|1
1347843|NCT01810380|4440574|P2|Overall Study|Randomised not treated|1
1347844|NCT01810380|4440575|P1|Overall Study|Randomised not treated|2
1347845|NCT01810302|4440636|P2|Overall Study|Physician Decision|1
1347846|NCT01810302|4440637|P1|Overall Study|Physician Decision|0
1347847|NCT01810302|4440636|P2|Overall Study|Death|0
1347848|NCT01810302|4440637|P1|Overall Study|Death|1
1347849|NCT01810263|4440656|P2|Overall Study|Lost to Follow-up|7
1347850|NCT01810263|4440657|P1|Overall Study|Lost to Follow-up|8
1347851|NCT01810042|4440663|P1|Overall Study|Lost to Follow-up|10
1347852|NCT01809327|4440729|P5|Overall Study|Other|9
1347853|NCT01809327|4440730|P4|Overall Study|Other|4
1347854|NCT01809327|4440731|P3|Overall Study|Other|7
1347855|NCT01809327|4440732|P2|Overall Study|Other|15
1347856|NCT01809327|4440733|P1|Overall Study|Other|14
1347857|NCT01809327|4440729|P5|Overall Study|Pregnancy|0
1347858|NCT01809327|4440730|P4|Overall Study|Pregnancy|0
1347859|NCT01809327|4440731|P3|Overall Study|Pregnancy|0
1347860|NCT01809327|4440732|P2|Overall Study|Pregnancy|0
1347861|NCT01809327|4440733|P1|Overall Study|Pregnancy|1
1347862|NCT01809327|4440729|P5|Overall Study|Physician Decision|0
1347863|NCT01809327|4440730|P4|Overall Study|Physician Decision|0
1347864|NCT01809327|4440731|P3|Overall Study|Physician Decision|0
1347865|NCT01809327|4440732|P2|Overall Study|Physician Decision|1
1347866|NCT01809327|4440733|P1|Overall Study|Physician Decision|1
1347867|NCT01809327|4440729|P5|Overall Study|Protocol Violation|0
1347868|NCT01809327|4440730|P4|Overall Study|Protocol Violation|0
1347869|NCT01809327|4440731|P3|Overall Study|Protocol Violation|0
1347870|NCT01809327|4440732|P2|Overall Study|Protocol Violation|1
1347871|NCT01809327|4440733|P1|Overall Study|Protocol Violation|0
1347872|NCT01809327|4440729|P5|Overall Study|Death|0
1347873|NCT01809327|4440730|P4|Overall Study|Death|0
1347874|NCT01809327|4440731|P3|Overall Study|Death|0
1347875|NCT01809327|4440732|P2|Overall Study|Death|0
1347876|NCT01809327|4440733|P1|Overall Study|Death|1
1347877|NCT01809327|4440729|P5|Overall Study|Adverse Event|8
1347878|NCT01809327|4440730|P4|Overall Study|Adverse Event|4
1347879|NCT01809327|4440731|P3|Overall Study|Adverse Event|7
1347880|NCT01809327|4440732|P2|Overall Study|Adverse Event|3
1347881|NCT01809327|4440733|P1|Overall Study|Adverse Event|4
1347882|NCT01809327|4440729|P5|Overall Study|Withdrawal by Subject|5
1347883|NCT01809327|4440730|P4|Overall Study|Withdrawal by Subject|2
1347884|NCT01809327|4440731|P3|Overall Study|Withdrawal by Subject|4
1347885|NCT01809327|4440732|P2|Overall Study|Withdrawal by Subject|4
1347886|NCT01809327|4440733|P1|Overall Study|Withdrawal by Subject|6
1347887|NCT01809327|4440729|P5|Overall Study|Lost to Follow-up|3
1347888|NCT01809327|4440730|P4|Overall Study|Lost to Follow-up|2
1347889|NCT01809327|4440731|P3|Overall Study|Lost to Follow-up|4
1347890|NCT01809327|4440732|P2|Overall Study|Lost to Follow-up|2
1347891|NCT01809327|4440733|P1|Overall Study|Lost to Follow-up|5
1347892|NCT01809314|4440775|P1|Overall Study|Lost to Follow-up|724
1347893|NCT01809314|4440775|P1|Overall Study|Insufficient Therapeutic Response|14
1347894|NCT01809314|4440775|P1|Overall Study|Adverse Event|6
1347895|NCT01809314|4440775|P1|Overall Study|Withdrawal Prior to Treatment|1
1347896|NCT01809262|4440781|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
1347897|NCT01809262|4440782|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
1347898|NCT01809262|4440783|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
1347899|NCT01809262|4440784|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
1347900|NCT01809262|4440785|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
1347901|NCT01809262|4440786|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
1347902|NCT01809262|4440787|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
1347903|NCT01809262|4440788|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
1347904|NCT01809262|4440789|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
1347905|NCT01809262|4440790|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
1347906|NCT01809262|4440781|P10|Period 1 (First Dose + Washout)|Adverse Event|0
1347907|NCT01809262|4440782|P9|Period 1 (First Dose + Washout)|Adverse Event|0
1347908|NCT01809262|4440783|P8|Period 1 (First Dose + Washout)|Adverse Event|0
1347909|NCT01809262|4440784|P7|Period 1 (First Dose + Washout)|Adverse Event|0
1347910|NCT01809262|4440785|P6|Period 1 (First Dose + Washout)|Adverse Event|0
1347911|NCT01809262|4440786|P5|Period 1 (First Dose + Washout)|Adverse Event|1
1347912|NCT01809262|4440787|P4|Period 1 (First Dose + Washout)|Adverse Event|0
1347913|NCT01809262|4440788|P3|Period 1 (First Dose + Washout)|Adverse Event|0
1347914|NCT01809262|4440789|P2|Period 1 (First Dose + Washout)|Adverse Event|0
1347915|NCT01809262|4440790|P1|Period 1 (First Dose + Washout)|Adverse Event|0
1347916|NCT01809210|4440864|P7|Overall Study|Death|1
1347917|NCT01809210|4440865|P6|Overall Study|Death|3
1347918|NCT01809210|4440866|P5|Overall Study|Death|1
1347919|NCT01809210|4440867|P4|Overall Study|Death|0
1347920|NCT01809210|4440868|P3|Overall Study|Death|2
1347921|NCT01809210|4440869|P2|Overall Study|Death|1
1347922|NCT01809210|4440870|P1|Overall Study|Death|1
1347923|NCT01809210|4440864|P7|Overall Study|Withdrawal by Subject|4
1347924|NCT01809210|4440865|P6|Overall Study|Withdrawal by Subject|0
1347925|NCT01809210|4440866|P5|Overall Study|Withdrawal by Subject|1
1347926|NCT01809210|4440867|P4|Overall Study|Withdrawal by Subject|1
1347927|NCT01809210|4440868|P3|Overall Study|Withdrawal by Subject|1
1347928|NCT01809210|4440869|P2|Overall Study|Withdrawal by Subject|0
1347929|NCT01809210|4440870|P1|Overall Study|Withdrawal by Subject|0
1347930|NCT01809197|4440944|P2|Overall Study|Product not available|1
1347931|NCT01809197|4440945|P1|Overall Study|Product not available|0
1347932|NCT01809197|4440944|P2|Overall Study|Withdrawal by Subject|1
1347933|NCT01809197|4440945|P1|Overall Study|Withdrawal by Subject|1
1347934|NCT01809197|4440944|P2|Overall Study|Decision Unrelated to an Adverse Event|0
1347935|NCT01809197|4440945|P1|Overall Study|Decision Unrelated to an Adverse Event|1
1347936|NCT01809197|4440944|P2|Overall Study|Non-Compliance|1
1347937|NCT01809197|4440945|P1|Overall Study|Non-Compliance|1
1347938|NCT01809197|4440944|P2|Overall Study|Failed slit lamp exam|0
1347939|NCT01809197|4440945|P1|Overall Study|Failed slit lamp exam|1
1347940|NCT01809197|4440944|P2|Overall Study|Adverse Event|3
1347941|NCT01809197|4440945|P1|Overall Study|Adverse Event|2
1347942|NCT01809197|4440944|P2|Overall Study|Lost to Follow-up|2
1347943|NCT01809197|4440945|P1|Overall Study|Lost to Follow-up|4
1347944|NCT01808651|4441016|P3|Study Period 1|Participant Decision|3
1347945|NCT01808651|4441017|P2|Study Period 1|Participant Decision|7
1347946|NCT01808651|4441018|P1|Study Period 1|Participant Decision|9
1347947|NCT01808651|4441016|P3|Study Period 1|Adverse Event|1
1347948|NCT01808651|4441017|P2|Study Period 1|Adverse Event|4
1347949|NCT01808651|4441018|P1|Study Period 1|Adverse Event|10
1347950|NCT01808651|4441016|P3|Study Period 1|Lack of Efficacy|0
1347951|NCT01808651|4441017|P2|Study Period 1|Lack of Efficacy|1
1347952|NCT01808651|4441018|P1|Study Period 1|Lack of Efficacy|2
1347953|NCT01808651|4441016|P3|Study Period 1|Physician Decision|0
1347954|NCT01808651|4441017|P2|Study Period 1|Physician Decision|2
1347955|NCT01808651|4441018|P1|Study Period 1|Physician Decision|3
1347956|NCT01808651|4441016|P3|Study Period 1|Protocol Violation|1
1347957|NCT01808651|4441017|P2|Study Period 1|Protocol Violation|0
1347958|NCT01808651|4441018|P1|Study Period 1|Protocol Violation|1
1347959|NCT01808651|4441016|P3|Study Period 1|Lost to Follow-up|0
1347960|NCT01808651|4441017|P2|Study Period 1|Lost to Follow-up|3
1347961|NCT01808651|4441018|P1|Study Period 1|Lost to Follow-up|1
1347962|NCT01808612|4441053|P3|Discontinuation Period|Lost to Follow-up|0
1347963|NCT01808612|4441054|P2|Discontinuation Period|Lost to Follow-up|1
1347964|NCT01808612|4441055|P1|Discontinuation Period|Lost to Follow-up|0
1347965|NCT01808612|4441053|P3|Discontinuation Period|Physician Decision|0
1347966|NCT01808612|4441054|P2|Discontinuation Period|Physician Decision|0
1347967|NCT01808612|4441055|P1|Discontinuation Period|Physician Decision|1
1347968|NCT01808612|4441053|P3|Discontinuation Period|Adverse Event|0
1347969|NCT01808612|4441054|P2|Discontinuation Period|Adverse Event|0
1347970|NCT01808612|4441055|P1|Discontinuation Period|Adverse Event|1
1347971|NCT01808612|4441053|P3|Treatment Period|Lack of Efficacy|2
1347972|NCT01808612|4441054|P2|Treatment Period|Lack of Efficacy|1
1347973|NCT01808612|4441055|P1|Treatment Period|Lack of Efficacy|1
1347974|NCT01808612|4441053|P3|Treatment Period|Sponsor Decision|0
1347975|NCT01808612|4441054|P2|Treatment Period|Sponsor Decision|0
1347976|NCT01808612|4441055|P1|Treatment Period|Sponsor Decision|1
1347977|NCT01808612|4441053|P3|Treatment Period|Physician Decision|4
1347978|NCT01808612|4441054|P2|Treatment Period|Physician Decision|0
1347979|NCT01808612|4441055|P1|Treatment Period|Physician Decision|1
1347980|NCT01808612|4441053|P3|Treatment Period|Withdrawal by Subject|4
1347981|NCT01808612|4441054|P2|Treatment Period|Withdrawal by Subject|0
1347982|NCT01808612|4441055|P1|Treatment Period|Withdrawal by Subject|1
1347983|NCT01808612|4441053|P3|Treatment Period|Protocol Violation|0
1347984|NCT01808612|4441054|P2|Treatment Period|Protocol Violation|0
1347985|NCT01808612|4441055|P1|Treatment Period|Protocol Violation|1
1347986|NCT01808612|4441053|P3|Treatment Period|Lost to Follow-up|1
1347987|NCT01808612|4441054|P2|Treatment Period|Lost to Follow-up|2
1347988|NCT01808612|4441055|P1|Treatment Period|Lost to Follow-up|2
1347989|NCT01808612|4441053|P3|Treatment Period|Adverse Event|3
1347990|NCT01808612|4441054|P2|Treatment Period|Adverse Event|4
1347991|NCT01808612|4441055|P1|Treatment Period|Adverse Event|8
1347992|NCT01808534|4441121|P1|Overall Study|Physician Decision|1
1347993|NCT01808534|4441121|P1|Overall Study|Disease progression|3
1347994|NCT01808508|4441132|P3|Overall Study|Lost to Follow-up|0
1347995|NCT01808508|4441133|P2|Overall Study|Lost to Follow-up|0
1347996|NCT01808508|4441134|P1|Overall Study|Lost to Follow-up|1
1347997|NCT01808339|4441151|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1347998|NCT01808339|4441152|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1347999|NCT01808339|4441153|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1348000|NCT01808339|4441154|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
1348001|NCT01808339|4441155|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1348002|NCT01808339|4441156|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1348003|NCT01808339|4441151|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1348004|NCT01808339|4441152|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1348005|NCT01808339|4441153|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1348006|NCT01808339|4441154|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1348007|NCT01808339|4441155|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1348008|NCT01808339|4441156|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1348009|NCT01808339|4441151|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
1348010|NCT01808339|4441152|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
1348011|NCT01808339|4441153|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
1348012|NCT01808339|4441154|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
1348013|NCT01808339|4441155|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
1348014|NCT01808339|4441156|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
1348015|NCT01808313|4441200|P1|Overall Study|Physician Decision|1
1348016|NCT01808313|4441200|P1|Overall Study|Lost to Follow-up|1
1348017|NCT01808313|4441200|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
1348018|NCT01808313|4441200|P1|Overall Study|Protocol Violation|2
1348019|NCT01808313|4441200|P1|Overall Study|Adverse Event|5
1348020|NCT01808261|4441230|P2|Overall Study|Lost to Follow-up|1
1348021|NCT01808261|4441231|P1|Overall Study|Lost to Follow-up|3
1348022|NCT01808261|4441230|P2|Overall Study|Consent withdrawn by subject|7
1348023|NCT01808261|4441231|P1|Overall Study|Consent withdrawn by subject|6
1348024|NCT01808261|4441230|P2|Overall Study|Adverse event, non-fatal|0
1348025|NCT01808261|4441231|P1|Overall Study|Adverse event, non-fatal|2
1348026|NCT01808261|4441230|P2|Overall Study|Study Closed/Terminated|23
1348027|NCT01808261|4441231|P1|Overall Study|Study Closed/Terminated|25
1348028|NCT01808261|4441230|P2|Overall Study|Physician Decision|2
1348029|NCT01808261|4441231|P1|Overall Study|Physician Decision|0
1348030|NCT01808248|4441287|P1|Overall Study|Lost to Follow-up|1
1348031|NCT01808248|4441287|P1|Overall Study|Withdrawal by Subject|1
1348032|NCT01808248|4441287|P1|Overall Study|Lack of Efficacy|3
1348033|NCT01808209|4441301|P2|Overall Study|Lost to Follow-up|1
1348034|NCT01808209|4441302|P1|Overall Study|Lost to Follow-up|0
1348035|NCT01808144|4441346|P2|Overall Study|Adverse Event|15
1348036|NCT01808144|4441347|P1|Overall Study|Adverse Event|11
1348037|NCT01808144|4441346|P2|Overall Study|Gout flare|1
1348038|NCT01808144|4441347|P1|Overall Study|Gout flare|0
1348039|NCT01808144|4441346|P2|Overall Study|Protocol Violation|6
1348040|NCT01808144|4441347|P1|Overall Study|Protocol Violation|6
1348041|NCT01808144|4441346|P2|Overall Study|Lost to Follow-up|3
1348042|NCT01808144|4441347|P1|Overall Study|Lost to Follow-up|6
1348043|NCT01808144|4441346|P2|Overall Study|Withdrawal by Subject|23
1348044|NCT01808144|4441347|P1|Overall Study|Withdrawal by Subject|16
1348045|NCT01808144|4441346|P2|Overall Study|Death|0
1348046|NCT01808144|4441347|P1|Overall Study|Death|1
1348047|NCT01808118|4441355|P3|Period 2|Switched to other therapy|0
1348048|NCT01808118|4441356|P2|Period 2|Switched to other therapy|1
1348049|NCT01808118|4441357|P1|Period 2|Switched to other therapy|0
1348050|NCT01808118|4441355|P3|Period 2|Investigator no longer conducting trials|0
1348051|NCT01808118|4441356|P2|Period 2|Investigator no longer conducting trials|1
1348052|NCT01808118|4441357|P1|Period 2|Investigator no longer conducting trials|0
1348053|NCT01808118|4441355|P3|Period 2|Lost to Follow-up|2
1348054|NCT01808118|4441356|P2|Period 2|Lost to Follow-up|0
1348055|NCT01808118|4441357|P1|Period 2|Lost to Follow-up|0
1348056|NCT01808118|4441355|P3|Period 2|Withdrew consent|6
1348057|NCT01808118|4441356|P2|Period 2|Withdrew consent|7
1348058|NCT01808118|4441357|P1|Period 2|Withdrew consent|0
1348059|NCT01808118|4441355|P3|Period 2|Adverse Event|0
1348060|NCT01808118|4441356|P2|Period 2|Adverse Event|4
1348061|NCT01808118|4441357|P1|Period 2|Adverse Event|0
1348062|NCT01808118|4441355|P3|Period 1|Lack of Efficacy|0
1348063|NCT01808118|4441356|P2|Period 1|Lack of Efficacy|0
1348064|NCT01808118|4441357|P1|Period 1|Lack of Efficacy|1
1348065|NCT01808118|4441355|P3|Period 1|Non-compliance per sponsor|0
1348066|NCT01808118|4441356|P2|Period 1|Non-compliance per sponsor|0
1348067|NCT01808118|4441357|P1|Period 1|Non-compliance per sponsor|1
1348068|NCT01808118|4441355|P3|Period 1|Investigator decision: site closure|0
1348069|NCT01808118|4441356|P2|Period 1|Investigator decision: site closure|0
1348070|NCT01808118|4441357|P1|Period 1|Investigator decision: site closure|2
1348071|NCT01808118|4441355|P3|Period 1|Non-conformance with inclusion criteria|0
1348072|NCT01808118|4441356|P2|Period 1|Non-conformance with inclusion criteria|0
1348073|NCT01808118|4441357|P1|Period 1|Non-conformance with inclusion criteria|3
1348074|NCT01808118|4441355|P3|Period 1|Did not meet inclusion criteria|0
1348075|NCT01808118|4441356|P2|Period 1|Did not meet inclusion criteria|0
1348076|NCT01808118|4441357|P1|Period 1|Did not meet inclusion criteria|3
1348077|NCT01808118|4441355|P3|Period 1|Enrolled in error|0
1348078|NCT01808118|4441356|P2|Period 1|Enrolled in error|0
1348079|NCT01808118|4441357|P1|Period 1|Enrolled in error|7
1348080|NCT01808118|4441355|P3|Period 1|Did not meet criteria for remission|0
1348081|NCT01808118|4441356|P2|Period 1|Did not meet criteria for remission|0
1348082|NCT01808118|4441357|P1|Period 1|Did not meet criteria for remission|303
1348083|NCT01808118|4441355|P3|Period 1|Lost to Follow-up|0
1348084|NCT01808118|4441356|P2|Period 1|Lost to Follow-up|0
1348085|NCT01808118|4441357|P1|Period 1|Lost to Follow-up|9
1348086|NCT01808118|4441355|P3|Period 1|Withdrew consent|0
1348087|NCT01808118|4441356|P2|Period 1|Withdrew consent|0
1348088|NCT01808118|4441357|P1|Period 1|Withdrew consent|24
1348089|NCT01808118|4441355|P3|Period 1|Adverse Event|0
1348090|NCT01808118|4441356|P2|Period 1|Adverse Event|0
1348091|NCT01808118|4441357|P1|Period 1|Adverse Event|15
1348092|NCT01808092|4441420|P2|Overall Study|Other Eligibility criteria|5
1348093|NCT01808092|4441421|P1|Overall Study|Other Eligibility criteria|3
1348094|NCT01808092|4441420|P2|Overall Study|Withdrawal by Subject|4
1348095|NCT01808092|4441421|P1|Overall Study|Withdrawal by Subject|9
1348096|NCT01808092|4441420|P2|Overall Study|Lost to Follow-up|7
1348097|NCT01808092|4441421|P1|Overall Study|Lost to Follow-up|3
1348098|NCT01808092|4441420|P2|Overall Study|Death|29
1348099|NCT01808092|4441421|P1|Overall Study|Death|39
1348100|NCT01808066|4441523|P1|Overall Study|Withdrawal by Subject|15
1348101|NCT01807949|4441530|P3|Overall Study|Randomized But Not Treated|2
1348102|NCT01807949|4441531|P2|Overall Study|Randomized But Not Treated|2
1348103|NCT01807949|4441532|P1|Overall Study|Randomized But Not Treated|0
1348104|NCT01807949|4441530|P3|Overall Study|Undefined|2
1348105|NCT01807949|4441531|P2|Overall Study|Undefined|1
1348106|NCT01807949|4441532|P1|Overall Study|Undefined|0
1348107|NCT01807949|4441530|P3|Overall Study|Non-Compliance|1
1348108|NCT01807949|4441531|P2|Overall Study|Non-Compliance|0
1348109|NCT01807949|4441532|P1|Overall Study|Non-Compliance|0
1348110|NCT01807949|4441530|P3|Overall Study|Withdrawal by Subject|2
1348111|NCT01807949|4441531|P2|Overall Study|Withdrawal by Subject|2
1348112|NCT01807949|4441532|P1|Overall Study|Withdrawal by Subject|1
1348113|NCT01807949|4441530|P3|Overall Study|Adverse Event|2
1348114|NCT01807949|4441531|P2|Overall Study|Adverse Event|2
1348115|NCT01807949|4441532|P1|Overall Study|Adverse Event|1
1348116|NCT01807923|4441584|P3|Overall Study|Randomized But Not Treated|5
1348117|NCT01807923|4441585|P2|Overall Study|Randomized But Not Treated|2
1348118|NCT01807923|4441586|P1|Overall Study|Randomized But Not Treated|3
1348119|NCT01807923|4441584|P3|Overall Study|Not Eligible (Genotype)|1
1348120|NCT01807923|4441585|P2|Overall Study|Not Eligible (Genotype)|0
1348121|NCT01807923|4441586|P1|Overall Study|Not Eligible (Genotype)|0
1348122|NCT01807923|4441584|P3|Overall Study|Physician Decision|1
1348123|NCT01807923|4441585|P2|Overall Study|Physician Decision|0
1348124|NCT01807923|4441586|P1|Overall Study|Physician Decision|0
1348125|NCT01807923|4441584|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
1348126|NCT01807923|4441585|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
1348127|NCT01807923|4441586|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
1348128|NCT01807923|4441584|P3|Overall Study|Adverse Event|2
1348129|NCT01807923|4441585|P2|Overall Study|Adverse Event|1
1348130|NCT01807923|4441586|P1|Overall Study|Adverse Event|2
1348131|NCT01807650|4441648|P1|Overall Study|Other|2
1348132|NCT01807650|4441648|P1|Overall Study|Adverse Event|5
1348133|NCT01807650|4441648|P1|Overall Study|Lack of Full Wound Closure at Day 28|13
1348134|NCT01807520|4441736|P7|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
1348135|NCT01807520|4441737|P6|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
1348136|NCT01807520|4441738|P5|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1348137|NCT01807520|4441739|P4|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1348138|NCT01807520|4441740|P3|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1348139|NCT01807520|4441741|P2|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1348140|NCT01807520|4441742|P1|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1348141|NCT01807520|4441736|P7|Follow-up Period (132-140 Weeks)|Study terminated|0
1348142|NCT01807520|4441737|P6|Follow-up Period (132-140 Weeks)|Study terminated|1
1348143|NCT01807520|4441738|P5|Follow-up Period (132-140 Weeks)|Study terminated|0
1348144|NCT01807520|4441739|P4|Follow-up Period (132-140 Weeks)|Study terminated|0
1348145|NCT01807520|4441740|P3|Follow-up Period (132-140 Weeks)|Study terminated|0
1348146|NCT01807520|4441741|P2|Follow-up Period (132-140 Weeks)|Study terminated|0
1348147|NCT01807520|4441742|P1|Follow-up Period (132-140 Weeks)|Study terminated|0
1348148|NCT01807520|4441736|P7|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1348149|NCT01807520|4441737|P6|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
1348150|NCT01807520|4441738|P5|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1348151|NCT01807520|4441739|P4|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1348152|NCT01807520|4441740|P3|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1348153|NCT01807520|4441741|P2|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1348154|NCT01807520|4441742|P1|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1348155|NCT01807520|4441736|P7|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
1348156|NCT01807520|4441737|P6|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
1348157|NCT01807520|4441738|P5|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
1348158|NCT01807520|4441739|P4|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
1348159|NCT01807520|4441740|P3|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
1348160|NCT01807520|4441741|P2|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
1348161|NCT01807520|4441742|P1|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
1348162|NCT01807520|4441736|P7|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1348163|NCT01807520|4441737|P6|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1348164|NCT01807520|4441738|P5|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1348165|NCT01807520|4441739|P4|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
1348166|NCT01807520|4441740|P3|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1348167|NCT01807520|4441741|P2|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
1348168|NCT01807520|4441742|P1|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
1348169|NCT01807520|4441736|P7|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1348170|NCT01807520|4441737|P6|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1348171|NCT01807520|4441738|P5|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
1348172|NCT01807520|4441739|P4|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1348173|NCT01807520|4441740|P3|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1348174|NCT01807520|4441741|P2|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
1348175|NCT01807520|4441742|P1|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
1348176|NCT01807520|4441736|P7|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1348177|NCT01807520|4441737|P6|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1348178|NCT01807520|4441738|P5|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1348179|NCT01807520|4441739|P4|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
1348180|NCT01807520|4441740|P3|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1348181|NCT01807520|4441741|P2|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1348182|NCT01807520|4441742|P1|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
1348183|NCT01807520|4441736|P7|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1348184|NCT01807520|4441737|P6|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1348185|NCT01807520|4441738|P5|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1348186|NCT01807520|4441739|P4|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1348187|NCT01807520|4441740|P3|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1348188|NCT01807520|4441741|P2|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
1348189|NCT01807520|4441742|P1|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1348190|NCT01807520|4441736|P7|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1348191|NCT01807520|4441737|P6|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1348192|NCT01807520|4441738|P5|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1348193|NCT01807520|4441739|P4|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1348194|NCT01807520|4441740|P3|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1348195|NCT01807520|4441741|P2|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1348196|NCT01807520|4441742|P1|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
1348197|NCT01807520|4441736|P7|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1348198|NCT01807520|4441737|P6|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1348199|NCT01807520|4441738|P5|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1348200|NCT01807520|4441739|P4|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
1348201|NCT01807520|4441740|P3|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1348202|NCT01807520|4441741|P2|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1348203|NCT01807520|4441742|P1|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1348204|NCT01807520|4441736|P7|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1348205|NCT01807520|4441737|P6|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1348206|NCT01807520|4441738|P5|Treatment Period 2 (16-132 Weeks)|Study terminated|2
1348207|NCT01807520|4441739|P4|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1348208|NCT01807520|4441740|P3|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1348209|NCT01807520|4441741|P2|Treatment Period 2 (16-132 Weeks)|Study terminated|4
1348210|NCT01807520|4441742|P1|Treatment Period 2 (16-132 Weeks)|Study terminated|7
1348211|NCT01807520|4441736|P7|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1348212|NCT01807520|4441737|P6|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1348213|NCT01807520|4441738|P5|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1348214|NCT01807520|4441739|P4|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1348215|NCT01807520|4441740|P3|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1348216|NCT01807520|4441741|P2|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1348217|NCT01807520|4441742|P1|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
1348218|NCT01807520|4441736|P7|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1348219|NCT01807520|4441737|P6|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1348220|NCT01807520|4441738|P5|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1348221|NCT01807520|4441739|P4|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1348222|NCT01807520|4441740|P3|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
1348223|NCT01807520|4441741|P2|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1348224|NCT01807520|4441742|P1|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1348225|NCT01807520|4441736|P7|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1348226|NCT01807520|4441737|P6|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1348227|NCT01807520|4441738|P5|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1348228|NCT01807520|4441739|P4|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1348229|NCT01807520|4441740|P3|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1348230|NCT01807520|4441741|P2|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1348231|NCT01807520|4441742|P1|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
1348232|NCT01807520|4441736|P7|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1348233|NCT01807520|4441737|P6|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1348234|NCT01807520|4441738|P5|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1348235|NCT01807520|4441739|P4|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1348236|NCT01807520|4441740|P3|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
1348237|NCT01807520|4441741|P2|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1348238|NCT01807520|4441742|P1|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1348239|NCT01807520|4441736|P7|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1348240|NCT01807520|4441737|P6|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1348241|NCT01807520|4441738|P5|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1348242|NCT01807520|4441739|P4|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1348243|NCT01807520|4441740|P3|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
1348244|NCT01807520|4441741|P2|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1348245|NCT01807520|4441742|P1|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
1348246|NCT01807520|4441736|P7|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1348247|NCT01807520|4441737|P6|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1348248|NCT01807520|4441738|P5|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1348249|NCT01807520|4441739|P4|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1348250|NCT01807520|4441740|P3|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
1348251|NCT01807520|4441741|P2|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
1348252|NCT01807520|4441742|P1|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1348253|NCT01807234|4441775|P6|Overall Study|Lack of Efficacy|1
1348254|NCT01807234|4441776|P5|Overall Study|Lack of Efficacy|1
1348255|NCT01807234|4441777|P4|Overall Study|Lack of Efficacy|0
1348256|NCT01807234|4441778|P3|Overall Study|Lack of Efficacy|0
1348257|NCT01807234|4441779|P2|Overall Study|Lack of Efficacy|0
1348258|NCT01807234|4441780|P1|Overall Study|Lack of Efficacy|0
1348259|NCT01807234|4441775|P6|Overall Study|Withdrawal by Subject|1
1348260|NCT01807234|4441776|P5|Overall Study|Withdrawal by Subject|2
1348261|NCT01807234|4441777|P4|Overall Study|Withdrawal by Subject|1
1348262|NCT01807234|4441778|P3|Overall Study|Withdrawal by Subject|1
1348263|NCT01807234|4441779|P2|Overall Study|Withdrawal by Subject|1
1348264|NCT01807234|4441780|P1|Overall Study|Withdrawal by Subject|3
1348265|NCT01807234|4441775|P6|Overall Study|Lost to Follow-up|2
1348266|NCT01807234|4441776|P5|Overall Study|Lost to Follow-up|1
1348267|NCT01807234|4441777|P4|Overall Study|Lost to Follow-up|1
1348268|NCT01807234|4441778|P3|Overall Study|Lost to Follow-up|1
1348269|NCT01807234|4441779|P2|Overall Study|Lost to Follow-up|5
1348270|NCT01807234|4441780|P1|Overall Study|Lost to Follow-up|2
1348271|NCT01807156|4441815|P1|Overall Study|Physician Decision|1
1348272|NCT01806961|4441839|P1|Overall Study|sponsor decision|16
1348273|NCT01806896|4441845|P2|Overall Study|Other|0
1348274|NCT01806896|4441846|P1|Overall Study|Other|1
1348275|NCT01806896|4441845|P2|Overall Study|Adverse Event|0
1348276|NCT01806896|4441846|P1|Overall Study|Adverse Event|2
1348277|NCT01806779|4441913|P3|Overall Study|Withdrawal by Subject|22
1348278|NCT01806779|4441914|P2|Overall Study|Withdrawal by Subject|23
1348279|NCT01806779|4441915|P1|Overall Study|Withdrawal by Subject|20
1348280|NCT01806779|4441913|P3|Overall Study|Lost to Follow-up|0
1348281|NCT01806779|4441914|P2|Overall Study|Lost to Follow-up|20
1348282|NCT01806779|4441915|P1|Overall Study|Lost to Follow-up|19
1348283|NCT01806779|4441913|P3|Overall Study|Lack of Efficacy|0
1348284|NCT01806779|4441914|P2|Overall Study|Lack of Efficacy|1
1348285|NCT01806779|4441915|P1|Overall Study|Lack of Efficacy|1
1348286|NCT01806779|4441913|P3|Overall Study|Physician Decision|1
1348287|NCT01806779|4441914|P2|Overall Study|Physician Decision|0
1348288|NCT01806779|4441915|P1|Overall Study|Physician Decision|2
1348289|NCT01806714|4441930|P2|Overall Study|No functioning phone number|170
1348290|NCT01806714|4441931|P1|Overall Study|No functioning phone number|200
1348291|NCT01806662|4441941|P2|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
1348292|NCT01806662|4441942|P1|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
1348293|NCT01806662|4441941|P2|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
1348294|NCT01806662|4441942|P1|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
1348295|NCT01806662|4441941|P2|First Intervention (Weeks 0-16)|Adverse Event|1
1348296|NCT01806662|4441942|P1|First Intervention (Weeks 0-16)|Adverse Event|0
1348297|NCT01806662|4441941|P2|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
1348298|NCT01806662|4441942|P1|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
1348299|NCT01806623|4441948|P1|Overall Study|Did not meet the inclusion criteria|56
1348300|NCT01806623|4441948|P1|Overall Study|Adverse Event|1
1348301|NCT01806623|4441948|P1|Overall Study|Withdrawal by Subject|1
1348302|NCT01806597|4441968|P6|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
1348303|NCT01806597|4441969|P5|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1348304|NCT01806597|4441970|P4|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1348305|NCT01806597|4441971|P3|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1348306|NCT01806597|4441972|P2|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1348307|NCT01806597|4441973|P1|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1348308|NCT01806597|4441968|P6|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
1348309|NCT01806597|4441969|P5|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1348310|NCT01806597|4441970|P4|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1348311|NCT01806597|4441971|P3|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1348312|NCT01806597|4441972|P2|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1348313|NCT01806597|4441973|P1|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1348314|NCT01806597|4441968|P6|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
1348315|NCT01806597|4441969|P5|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1348316|NCT01806597|4441970|P4|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1348317|NCT01806597|4441971|P3|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1348318|NCT01806597|4441972|P2|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1348319|NCT01806597|4441973|P1|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1348320|NCT01806597|4441968|P6|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
1348321|NCT01806597|4441969|P5|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1348322|NCT01806597|4441970|P4|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1348323|NCT01806597|4441971|P3|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1348324|NCT01806597|4441972|P2|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1348325|NCT01806597|4441973|P1|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1348326|NCT01806597|4441968|P6|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
1348327|NCT01806597|4441969|P5|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1348328|NCT01806597|4441970|P4|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1348329|NCT01806597|4441971|P3|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1348330|NCT01806597|4441972|P2|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1348331|NCT01806597|4441973|P1|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1348332|NCT01806597|4441968|P6|Treatment Period 2 (Week 16 to Week 132)|Death|0
1348333|NCT01806597|4441969|P5|Treatment Period 2 (Week 16 to Week 132)|Death|0
1348334|NCT01806597|4441970|P4|Treatment Period 2 (Week 16 to Week 132)|Death|0
1348335|NCT01806597|4441971|P3|Treatment Period 2 (Week 16 to Week 132)|Death|0
1348336|NCT01806597|4441972|P2|Treatment Period 2 (Week 16 to Week 132)|Death|0
1348337|NCT01806597|4441973|P1|Treatment Period 2 (Week 16 to Week 132)|Death|1
1348338|NCT01806597|4441968|P6|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
1348339|NCT01806597|4441969|P5|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
1348340|NCT01806597|4441970|P4|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
1348341|NCT01806597|4441971|P3|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
1348342|NCT01806597|4441972|P2|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
1348343|NCT01806597|4441973|P1|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
1348344|NCT01806597|4441968|P6|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
1348345|NCT01806597|4441969|P5|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
1348346|NCT01806597|4441970|P4|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
1348347|NCT01806597|4441971|P3|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
1348348|NCT01806597|4441972|P2|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
1348349|NCT01806597|4441973|P1|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
1348350|NCT01806597|4441968|P6|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1348351|NCT01806597|4441969|P5|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1348352|NCT01806597|4441970|P4|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
1348353|NCT01806597|4441971|P3|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1348354|NCT01806597|4441972|P2|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
1348355|NCT01806597|4441973|P1|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1348356|NCT01806597|4441968|P6|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1348357|NCT01806597|4441969|P5|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1348358|NCT01806597|4441970|P4|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1348359|NCT01806597|4441971|P3|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1348360|NCT01806597|4441972|P2|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1348361|NCT01806597|4441973|P1|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
1348362|NCT01806597|4441968|P6|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1348363|NCT01806597|4441969|P5|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1348364|NCT01806597|4441970|P4|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1348365|NCT01806597|4441971|P3|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1348366|NCT01806597|4441972|P2|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
1348367|NCT01806597|4441973|P1|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
1348368|NCT01806597|4441968|P6|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1348369|NCT01806597|4441969|P5|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1348370|NCT01806597|4441970|P4|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1348371|NCT01806597|4441971|P3|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1348372|NCT01806597|4441972|P2|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1348373|NCT01806597|4441973|P1|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
1348374|NCT01806597|4441968|P6|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
1348375|NCT01806597|4441969|P5|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
1348376|NCT01806597|4441970|P4|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
1348377|NCT01806597|4441971|P3|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
1348378|NCT01806597|4441972|P2|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
1348379|NCT01806597|4441973|P1|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
1348380|NCT01806597|4441968|P6|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
1348381|NCT01806597|4441969|P5|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
1348382|NCT01806597|4441970|P4|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
1348383|NCT01806597|4441971|P3|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
1348384|NCT01806597|4441972|P2|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
1348385|NCT01806597|4441973|P1|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
1348386|NCT01806597|4441968|P6|Period 1 (Baseline to Week 16)|Physician Decision|0
1348387|NCT01806597|4441969|P5|Period 1 (Baseline to Week 16)|Physician Decision|0
1348388|NCT01806597|4441970|P4|Period 1 (Baseline to Week 16)|Physician Decision|0
1348389|NCT01806597|4441971|P3|Period 1 (Baseline to Week 16)|Physician Decision|0
1348390|NCT01806597|4441972|P2|Period 1 (Baseline to Week 16)|Physician Decision|1
1348391|NCT01806597|4441973|P1|Period 1 (Baseline to Week 16)|Physician Decision|0
1348392|NCT01806597|4441968|P6|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
1348393|NCT01806597|4441969|P5|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
1348394|NCT01806597|4441970|P4|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
1348395|NCT01806597|4441971|P3|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
1348396|NCT01806597|4441972|P2|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
1348397|NCT01806597|4441973|P1|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
1348398|NCT01806597|4441968|P6|Period 1 (Baseline to Week 16)|Protocol Violation|0
1348399|NCT01806597|4441969|P5|Period 1 (Baseline to Week 16)|Protocol Violation|0
1348400|NCT01806597|4441970|P4|Period 1 (Baseline to Week 16)|Protocol Violation|0
1348401|NCT01806597|4441971|P3|Period 1 (Baseline to Week 16)|Protocol Violation|0
1348402|NCT01806597|4441972|P2|Period 1 (Baseline to Week 16)|Protocol Violation|1
1348403|NCT01806597|4441973|P1|Period 1 (Baseline to Week 16)|Protocol Violation|0
1348404|NCT01806597|4441968|P6|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1348405|NCT01806597|4441969|P5|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
1348406|NCT01806597|4441970|P4|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1348407|NCT01806597|4441971|P3|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1348408|NCT01806597|4441972|P2|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1348409|NCT01806597|4441973|P1|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
1348410|NCT01806597|4441968|P6|Period 1 (Baseline to Week 16)|Adverse Event|0
1348411|NCT01806597|4441969|P5|Period 1 (Baseline to Week 16)|Adverse Event|2
1348412|NCT01806597|4441970|P4|Period 1 (Baseline to Week 16)|Adverse Event|0
1348413|NCT01806597|4441971|P3|Period 1 (Baseline to Week 16)|Adverse Event|0
1348414|NCT01806597|4441972|P2|Period 1 (Baseline to Week 16)|Adverse Event|1
1348415|NCT01806597|4441973|P1|Period 1 (Baseline to Week 16)|Adverse Event|1
1348416|NCT01806584|4442009|P2|Overall Study|Other unspecified|0
1348417|NCT01806584|4442010|P1|Overall Study|Other unspecified|1
1348418|NCT01806584|4442009|P2|Overall Study|Withdrawal by Subject|1
1348419|NCT01806584|4442010|P1|Overall Study|Withdrawal by Subject|1
1348420|NCT01806584|4442009|P2|Overall Study|Study terminated by sponsor|14
1348421|NCT01806584|4442010|P1|Overall Study|Study terminated by sponsor|9
1348422|NCT01806584|4442009|P2|Overall Study|Lost to Follow-up|2
1348423|NCT01806584|4442010|P1|Overall Study|Lost to Follow-up|0
1348424|NCT01806584|4442009|P2|Overall Study|Death|0
1348425|NCT01806584|4442010|P1|Overall Study|Death|1
1348426|NCT01806584|4442009|P2|Overall Study|Adverse Event|1
1348427|NCT01806584|4442010|P1|Overall Study|Adverse Event|2
1348428|NCT01806545|4442024|P2|Overall Study|Withdrawal by Subject|2
1348429|NCT01806545|4442025|P1|Overall Study|Withdrawal by Subject|3
1348430|NCT01806545|4442024|P2|Overall Study|Lost to Follow-up|0
1348431|NCT01806545|4442025|P1|Overall Study|Lost to Follow-up|1
1348432|NCT01806545|4442024|P2|Overall Study|Adverse Event|3
1348433|NCT01806545|4442025|P1|Overall Study|Adverse Event|2
1348434|NCT01806389|4442047|P1|Overall Study|Withdrawal by Subject|4
1348435|NCT01806298|4442061|P1|Overall Study|Other|5
1348436|NCT01806298|4442061|P1|Overall Study|Withdrawal by Subject|1
1348437|NCT01806298|4442061|P1|Overall Study|Protocol Non-compliance|1
1348438|NCT01806298|4442061|P1|Overall Study|Adverse Event|3
1348439|NCT01806051|4442071|P1|Overall Study|Withdrawal by Subject|6
1348440|NCT01805180|4442169|P3|Lead-in Donor Phase|screen failure|0
1348441|NCT01805180|4442170|P2|Lead-in Donor Phase|screen failure|0
1348442|NCT01805180|4442171|P1|Lead-in Donor Phase|screen failure|1
1348443|NCT01804946|4442209|P2|Overall Study|Do not meet inclusion criteria|2
1348444|NCT01804946|4442210|P1|Overall Study|Do not meet inclusion criteria|1
1348445|NCT01804946|4442209|P2|Overall Study|Insufficient data available|1
1348446|NCT01804946|4442210|P1|Overall Study|Insufficient data available|0
1348447|NCT01804946|4442209|P2|Overall Study|Adverse Event|1
1348448|NCT01804946|4442210|P1|Overall Study|Adverse Event|0
1348449|NCT01804946|4442209|P2|Overall Study|Protocol Violation|0
1348450|NCT01804946|4442210|P1|Overall Study|Protocol Violation|1
1348451|NCT01804842|4442248|P3|Overall Study|Personal Reason|1
1348452|NCT01804842|4442249|P2|Overall Study|Personal Reason|0
1348453|NCT01804842|4442250|P1|Overall Study|Personal Reason|0
1348454|NCT01804842|4442248|P3|Overall Study|Non-Compliance|0
1348455|NCT01804842|4442249|P2|Overall Study|Non-Compliance|1
1348456|NCT01804842|4442250|P1|Overall Study|Non-Compliance|1
1348457|NCT01804842|4442248|P3|Overall Study|Lost to Follow-up|0
1348458|NCT01804842|4442249|P2|Overall Study|Lost to Follow-up|0
1348459|NCT01804842|4442250|P1|Overall Study|Lost to Follow-up|1
1348460|NCT01804842|4442248|P3|Overall Study|Adverse Event|0
1348461|NCT01804842|4442249|P2|Overall Study|Adverse Event|1
1348462|NCT01804842|4442250|P1|Overall Study|Adverse Event|1
1348463|NCT01804673|4442267|P1|Overall Study|Other|4
1348464|NCT01804673|4442267|P1|Overall Study|Use of Prohibited Medication|1
1348465|NCT01804673|4442267|P1|Overall Study|No Further Therapy Required|84
1348466|NCT01804673|4442267|P1|Overall Study|Change to Oral Therapy|37
1348467|NCT01804673|4442267|P1|Overall Study|Lack of Efficacy|9
1348468|NCT01804673|4442267|P1|Overall Study|Withdrawal by Subject|1
1348469|NCT01804673|4442267|P1|Overall Study|Adverse Event|4
1348470|NCT01804140|4442287|P1|Overall Study|No sampling or biopsy procedures done|114
1348471|NCT01803737|4442356|P2|Overall Study|Lost to Follow-up|2
1348472|NCT01803737|4442357|P1|Overall Study|Lost to Follow-up|0
1348473|NCT01803737|4442356|P2|Overall Study|Medical Reason|1
1348474|NCT01803737|4442357|P1|Overall Study|Medical Reason|0
1348475|NCT01803737|4442356|P2|Overall Study|Lack of Time|0
1348476|NCT01803737|4442357|P1|Overall Study|Lack of Time|1
1348477|NCT01803711|4442381|P2|Overall Study|Adverse Event|1
1348478|NCT01803711|4442382|P1|Overall Study|Adverse Event|1
1348479|NCT01803646|4442400|P2|Overall Study|Lost to Follow-up|1
1348480|NCT01803646|4442401|P1|Overall Study|Lost to Follow-up|5
1348481|NCT01803646|4442400|P2|Overall Study|Randomization error|2
1348482|NCT01803646|4442401|P1|Overall Study|Randomization error|1
1348483|NCT01803646|4442400|P2|Overall Study|Withdrawal by Subject|6
1348484|NCT01803646|4442401|P1|Overall Study|Withdrawal by Subject|9
1348485|NCT01803646|4442400|P2|Overall Study|Adverse Event|1
1348486|NCT01803646|4442401|P1|Overall Study|Adverse Event|1
1348487|NCT01803646|4442400|P2|Overall Study|Protocol Violation|0
1348488|NCT01803646|4442401|P1|Overall Study|Protocol Violation|1
1348489|NCT01803607|4442413|P2|Overall Study|Withdrawal by Subject|5
1348490|NCT01803607|4442414|P1|Overall Study|Withdrawal by Subject|6
1348491|NCT01803607|4442413|P2|Overall Study|Study terminated by sponsor|56
1348492|NCT01803607|4442414|P1|Overall Study|Study terminated by sponsor|54
1348493|NCT01803607|4442413|P2|Overall Study|Protocol Violation|2
1348494|NCT01803607|4442414|P1|Overall Study|Protocol Violation|3
1348495|NCT01803607|4442413|P2|Overall Study|Lack of Efficacy|1
1348496|NCT01803607|4442414|P1|Overall Study|Lack of Efficacy|0
1348497|NCT01803607|4442413|P2|Overall Study|Adverse Event|3
1348498|NCT01803607|4442414|P1|Overall Study|Adverse Event|5
1348499|NCT01803464|4442438|P4|Overall Study|Withdrawal by Subject|0
1348500|NCT01803464|4442439|P3|Overall Study|Withdrawal by Subject|0
1348501|NCT01803464|4442440|P2|Overall Study|Withdrawal by Subject|0
1348502|NCT01803464|4442441|P1|Overall Study|Withdrawal by Subject|1
1348503|NCT01803464|4442438|P4|Overall Study|Incomplete data|0
1348504|NCT01803464|4442439|P3|Overall Study|Incomplete data|4
1348505|NCT01803464|4442440|P2|Overall Study|Incomplete data|0
1348506|NCT01803464|4442441|P1|Overall Study|Incomplete data|0
1348507|NCT01802775|4442461|P2|Overall Study|Lost to Follow-up|2
1348508|NCT01802775|4442462|P1|Overall Study|Lost to Follow-up|1
1348509|NCT01802775|4442461|P2|Overall Study|Withdrawal by Subject|5
1348510|NCT01802775|4442462|P1|Overall Study|Withdrawal by Subject|3
1348511|NCT01802775|4442461|P2|Overall Study|Adverse Event|1
1348512|NCT01802775|4442462|P1|Overall Study|Adverse Event|1
1348513|NCT01802775|4442461|P2|Overall Study|Physician Decision|0
1348514|NCT01802775|4442462|P1|Overall Study|Physician Decision|1
1348515|NCT01802775|4442461|P2|Overall Study|Reason not provided|1
1348516|NCT01802775|4442462|P1|Overall Study|Reason not provided|0
1348517|NCT01802775|4442461|P2|Overall Study|Death|3
1348518|NCT01802775|4442462|P1|Overall Study|Death|0
1348519|NCT01802632|4442484|P6|Overall Study|Other (not specified)|1
1348520|NCT01802632|4442485|P5|Overall Study|Other (not specified)|0
1348521|NCT01802632|4442486|P4|Overall Study|Other (not specified)|1
1348522|NCT01802632|4442487|P3|Overall Study|Other (not specified)|7
1348523|NCT01802632|4442488|P2|Overall Study|Other (not specified)|0
1348524|NCT01802632|4442489|P1|Overall Study|Other (not specified)|0
1348525|NCT01802632|4442484|P6|Overall Study|Ongoing Study at Data Cut-off|22
1348526|NCT01802632|4442485|P5|Overall Study|Ongoing Study at Data Cut-off|6
1348527|NCT01802632|4442486|P4|Overall Study|Ongoing Study at Data Cut-off|50
1348528|NCT01802632|4442487|P3|Overall Study|Ongoing Study at Data Cut-off|115
1348529|NCT01802632|4442488|P2|Overall Study|Ongoing Study at Data Cut-off|16
1348530|NCT01802632|4442489|P1|Overall Study|Ongoing Study at Data Cut-off|168
1348531|NCT01802632|4442484|P6|Overall Study|Objective Disease Progression|4
1348532|NCT01802632|4442485|P5|Overall Study|Objective Disease Progression|4
1348533|NCT01802632|4442486|P4|Overall Study|Objective Disease Progression|6
1348534|NCT01802632|4442487|P3|Overall Study|Objective Disease Progression|104
1348535|NCT01802632|4442488|P2|Overall Study|Objective Disease Progression|12
1348536|NCT01802632|4442489|P1|Overall Study|Objective Disease Progression|1
1348537|NCT01802632|4442484|P6|Overall Study|Withdrawal by Subject|1
1348538|NCT01802632|4442485|P5|Overall Study|Withdrawal by Subject|0
1348539|NCT01802632|4442486|P4|Overall Study|Withdrawal by Subject|3
1348540|NCT01802632|4442487|P3|Overall Study|Withdrawal by Subject|7
1348541|NCT01802632|4442488|P2|Overall Study|Withdrawal by Subject|2
1348542|NCT01802632|4442489|P1|Overall Study|Withdrawal by Subject|4
1348543|NCT01802632|4442484|P6|Overall Study|Death|0
1348544|NCT01802632|4442485|P5|Overall Study|Death|2
1348545|NCT01802632|4442486|P4|Overall Study|Death|0
1348546|NCT01802632|4442487|P3|Overall Study|Death|38
1348547|NCT01802632|4442488|P2|Overall Study|Death|1
1348548|NCT01802632|4442489|P1|Overall Study|Death|28
1348549|NCT01802515|4442523|P3|Overall Study|Withdrawal by Subject|0
1348550|NCT01802515|4442524|P2|Overall Study|Withdrawal by Subject|0
1348551|NCT01802515|4442525|P1|Overall Study|Withdrawal by Subject|3
1348552|NCT01802320|4442536|P1|Overall Study|Withdrawal by Subject|1
1348553|NCT01802320|4442536|P1|Overall Study|Death|1
1348554|NCT01801982|4442610|P1|Overall Study|Lost to Follow-up|1
1348555|NCT01801917|4442624|P4|Period 1 - Randomized|Adverse Event|0
1348556|NCT01801917|4442625|P3|Period 1 - Randomized|Adverse Event|1
1348557|NCT01801917|4442626|P2|Period 1 - Randomized|Adverse Event|0
1348558|NCT01801917|4442627|P1|Period 1 - Randomized|Adverse Event|1
1348559|NCT01801735|4442647|P1|Overall Study|Other, including site closure|19
1348560|NCT01801735|4442647|P1|Overall Study|Death|1
1348561|NCT01801735|4442647|P1|Overall Study|Physician Decision|3
1348562|NCT01801735|4442647|P1|Overall Study|Non-compliance with Trial Drug|13
1348563|NCT01801735|4442647|P1|Overall Study|Lost to Follow-up|15
1348564|NCT01801735|4442647|P1|Overall Study|Protocol Violation|25
1348565|NCT01801735|4442647|P1|Overall Study|Withdrawal by Subject|27
1348566|NCT01801735|4442647|P1|Overall Study|Lack of Efficacy|28
1348567|NCT01801735|4442647|P1|Overall Study|Adverse Event|79
1348568|NCT01801475|4442654|P5|Overall Study|Withdrawal by Subject|1
1348569|NCT01801475|4442655|P4|Overall Study|Withdrawal by Subject|0
1348570|NCT01801475|4442656|P3|Overall Study|Withdrawal by Subject|0
1348571|NCT01801475|4442657|P2|Overall Study|Withdrawal by Subject|0
1348572|NCT01801475|4442658|P1|Overall Study|Withdrawal by Subject|0
1348573|NCT01801436|4442683|P1|Overall Study|Progressive disease|4
1348574|NCT01801436|4442683|P1|Overall Study|Adverse Event|2
1348575|NCT01801436|4442683|P1|Overall Study|Withdrawal by Subject|3
1348576|NCT01801358|4442721|P6|Overall Study|Withdrawal by Subject|2
1348577|NCT01801358|4442722|P5|Overall Study|Withdrawal by Subject|0
1348578|NCT01801358|4442723|P4|Overall Study|Withdrawal by Subject|1
1348579|NCT01801358|4442724|P3|Overall Study|Withdrawal by Subject|0
1348580|NCT01801358|4442725|P2|Overall Study|Withdrawal by Subject|0
1348581|NCT01801358|4442726|P1|Overall Study|Withdrawal by Subject|0
1348582|NCT01801358|4442721|P6|Overall Study|Progressive Disease|5
1348583|NCT01801358|4442722|P5|Overall Study|Progressive Disease|6
1348584|NCT01801358|4442723|P4|Overall Study|Progressive Disease|5
1348585|NCT01801358|4442724|P3|Overall Study|Progressive Disease|4
1348586|NCT01801358|4442725|P2|Overall Study|Progressive Disease|4
1348587|NCT01801358|4442726|P1|Overall Study|Progressive Disease|6
1348588|NCT01801358|4442721|P6|Overall Study|Physician Decision|0
1348589|NCT01801358|4442722|P5|Overall Study|Physician Decision|0
1348590|NCT01801358|4442723|P4|Overall Study|Physician Decision|0
1348591|NCT01801358|4442724|P3|Overall Study|Physician Decision|1
1348592|NCT01801358|4442725|P2|Overall Study|Physician Decision|0
1348593|NCT01801358|4442726|P1|Overall Study|Physician Decision|0
1348594|NCT01801358|4442721|P6|Overall Study|Adverse Event|1
1348595|NCT01801358|4442722|P5|Overall Study|Adverse Event|0
1348596|NCT01801358|4442723|P4|Overall Study|Adverse Event|0
1348597|NCT01801358|4442724|P3|Overall Study|Adverse Event|1
1348598|NCT01801358|4442725|P2|Overall Study|Adverse Event|2
1348599|NCT01801358|4442726|P1|Overall Study|Adverse Event|0
1348600|NCT01801280|4442848|P4|Period 4|Protocol Violation|0
1348601|NCT01801280|4442849|P3|Period 4|Protocol Violation|1
1348602|NCT01801280|4442850|P2|Period 4|Protocol Violation|0
1348603|NCT01801280|4442851|P1|Period 4|Protocol Violation|0
1348604|NCT01801280|4442848|P4|Period 2|Withdrawal by Subject|0
1348605|NCT01801280|4442849|P3|Period 2|Withdrawal by Subject|0
1348606|NCT01801280|4442850|P2|Period 2|Withdrawal by Subject|0
1348607|NCT01801280|4442851|P1|Period 2|Withdrawal by Subject|1
1348608|NCT01801280|4442848|P4|Period 1|Withdrawal by Subject|0
1348609|NCT01801280|4442849|P3|Period 1|Withdrawal by Subject|0
1348610|NCT01801280|4442850|P2|Period 1|Withdrawal by Subject|1
1348611|NCT01801280|4442851|P1|Period 1|Withdrawal by Subject|0
1348612|NCT01801111|4442866|P1|Overall Study|On-going Survival Follow up|25
1348613|NCT01801111|4442866|P1|Overall Study|Death|24
1348614|NCT01801111|4442866|P1|Overall Study|Treatment On-going|89
1348615|NCT01800968|4442891|P2|Overall Study|Physician Decision|0
1348616|NCT01800968|4442892|P1|Overall Study|Physician Decision|1
1348617|NCT01800968|4442891|P2|Overall Study|Withdrawal by Subject|9
1348618|NCT01800968|4442892|P1|Overall Study|Withdrawal by Subject|7
1348619|NCT01800968|4442891|P2|Overall Study|Lost to Follow-up|7
1348620|NCT01800968|4442892|P1|Overall Study|Lost to Follow-up|5
1348621|NCT01800968|4442891|P2|Overall Study|Death|16
1348622|NCT01800968|4442892|P1|Overall Study|Death|23
1348623|NCT01800916|4442934|P9|Test Period 1 (1 Week)|Adverse Event|0
1348624|NCT01800916|4442935|P8|Test Period 1 (1 Week)|Adverse Event|0
1348625|NCT01800916|4442936|P7|Test Period 1 (1 Week)|Adverse Event|0
1348626|NCT01800916|4442937|P6|Test Period 1 (1 Week)|Adverse Event|0
1348627|NCT01800916|4442938|P5|Test Period 1 (1 Week)|Adverse Event|1
1348628|NCT01800916|4442939|P4|Test Period 1 (1 Week)|Adverse Event|0
1348629|NCT01800916|4442940|P3|Test Period 1 (1 Week)|Adverse Event|0
1348630|NCT01800916|4442941|P2|Test Period 1 (1 Week)|Adverse Event|0
1348631|NCT01800916|4442942|P1|Test Period 1 (1 Week)|Adverse Event|0
1348632|NCT01800916|4442934|P9|Test Period 1 (1 Week)|Convex product user|0
1348633|NCT01800916|4442935|P8|Test Period 1 (1 Week)|Convex product user|0
1348634|NCT01800916|4442936|P7|Test Period 1 (1 Week)|Convex product user|0
1348635|NCT01800916|4442937|P6|Test Period 1 (1 Week)|Convex product user|0
1348636|NCT01800916|4442938|P5|Test Period 1 (1 Week)|Convex product user|0
1348637|NCT01800916|4442939|P4|Test Period 1 (1 Week)|Convex product user|1
1348638|NCT01800916|4442940|P3|Test Period 1 (1 Week)|Convex product user|0
1348639|NCT01800916|4442941|P2|Test Period 1 (1 Week)|Convex product user|0
1348640|NCT01800916|4442942|P1|Test Period 1 (1 Week)|Convex product user|0
1348641|NCT01800903|4442952|P6|Second Test Period|unable to catheterise|0
1348642|NCT01800903|4442953|P5|Second Test Period|unable to catheterise|0
1348643|NCT01800903|4442954|P4|Second Test Period|unable to catheterise|0
1348644|NCT01800903|4442955|P3|Second Test Period|unable to catheterise|0
1348645|NCT01800903|4442956|P2|Second Test Period|unable to catheterise|0
1348646|NCT01800903|4442957|P1|Second Test Period|unable to catheterise|1
1348647|NCT01799993|4443054|P2|Overall Study|Subject didn't return for follow-up|1
1348648|NCT01799993|4443055|P1|Overall Study|Subject didn't return for follow-up|0
1348649|NCT01799993|4443054|P2|Overall Study|Other|0
1348650|NCT01799993|4443055|P1|Overall Study|Other|1
1348651|NCT01799993|4443054|P2|Overall Study|Withdrawal by parent/guardian|1
1348652|NCT01799993|4443055|P1|Overall Study|Withdrawal by parent/guardian|0
1348653|NCT01799993|4443054|P2|Overall Study|Non-compliance with medical device|0
1348654|NCT01799993|4443055|P1|Overall Study|Non-compliance with medical device|1
1348655|NCT01799993|4443054|P2|Overall Study|Protocol deviation|0
1348656|NCT01799993|4443055|P1|Overall Study|Protocol deviation|1
1348657|NCT01799993|4443054|P2|Overall Study|Logistical difficulties|0
1348658|NCT01799993|4443055|P1|Overall Study|Logistical difficulties|1
1348659|NCT01799993|4443054|P2|Overall Study|Recovery|1
1348660|NCT01799993|4443055|P1|Overall Study|Recovery|0
1348661|NCT01799993|4443054|P2|Overall Study|Lack of Efficacy|0
1348662|NCT01799993|4443055|P1|Overall Study|Lack of Efficacy|1
1348663|NCT01799993|4443054|P2|Overall Study|Adverse Event|0
1348664|NCT01799993|4443055|P1|Overall Study|Adverse Event|1
1348665|NCT01799993|4443054|P2|Overall Study|Screen failure|1
1348666|NCT01799993|4443055|P1|Overall Study|Screen failure|0
1348667|NCT01799993|4443054|P2|Overall Study|Deterioration of general conditions|0
1348668|NCT01799993|4443055|P1|Overall Study|Deterioration of general conditions|2
1348669|NCT01799993|4443054|P2|Overall Study|Protocol Violation|1
1348670|NCT01799993|4443055|P1|Overall Study|Protocol Violation|1
1348671|NCT01799993|4443054|P2|Overall Study|Protocol driven decision point|3
1348672|NCT01799993|4443055|P1|Overall Study|Protocol driven decision point|0
1348673|NCT01799993|4443054|P2|Overall Study|Withdrawal by parent/guardian/LAR|3
1348674|NCT01799993|4443055|P1|Overall Study|Withdrawal by parent/guardian/LAR|5
1348675|NCT01799993|4443054|P2|Overall Study|Lost to Follow-up|8
1348676|NCT01799993|4443055|P1|Overall Study|Lost to Follow-up|5
1348677|NCT01799993|4443054|P2|Overall Study|Withdrawal by Subject|24
1348678|NCT01799993|4443055|P1|Overall Study|Withdrawal by Subject|23
1348679|NCT01799993|4443054|P2|Overall Study|Death|45
1348680|NCT01799993|4443055|P1|Overall Study|Death|61
1348681|NCT01799993|4443054|P2|Overall Study|"Didn't complete CRF page End of FU"|40
1348682|NCT01799993|4443055|P1|Overall Study|"Didn't complete CRF page End of FU"|30
1348683|NCT01799941|4443087|P1|Overall Study|Not Specified|15
1348684|NCT01799941|4443087|P1|Overall Study|Lost to Follow-up|17
1348685|NCT01799941|4443087|P1|Overall Study|Lack of Efficacy|3
1348686|NCT01799941|4443087|P1|Overall Study|Investigator Decision|4
1348687|NCT01799941|4443087|P1|Overall Study|Death|2
1348688|NCT01799941|4443087|P1|Overall Study|Withdrawal by Subject|21
1348689|NCT01799941|4443087|P1|Overall Study|Adverse Event|34
1348690|NCT01799720|4443144|P3|Overall Study|Pregnancy|1
1348691|NCT01799720|4443145|P2|Overall Study|Pregnancy|0
1348692|NCT01799720|4443146|P1|Overall Study|Pregnancy|0
1348693|NCT01799720|4443144|P3|Overall Study|Protocol Violation|0
1348694|NCT01799720|4443145|P2|Overall Study|Protocol Violation|1
1348695|NCT01799720|4443146|P1|Overall Study|Protocol Violation|0
1348696|NCT01799720|4443144|P3|Overall Study|Withdrawal by Subject|0
1348697|NCT01799720|4443145|P2|Overall Study|Withdrawal by Subject|0
1348698|NCT01799720|4443146|P1|Overall Study|Withdrawal by Subject|3
1348699|NCT01799590|4443184|P3|Overall Study|Other|1
1348700|NCT01799590|4443185|P2|Overall Study|Other|0
1348701|NCT01799590|4443186|P1|Overall Study|Other|3
1348702|NCT01799590|4443184|P3|Overall Study|Use of prohibited concomitant drugs|0
1348703|NCT01799590|4443185|P2|Overall Study|Use of prohibited concomitant drugs|0
1348704|NCT01799590|4443186|P1|Overall Study|Use of prohibited concomitant drugs|1
1348705|NCT01799590|4443184|P3|Overall Study|Using drugs with restricted days of use|2
1348706|NCT01799590|4443185|P2|Overall Study|Using drugs with restricted days of use|3
1348707|NCT01799590|4443186|P1|Overall Study|Using drugs with restricted days of use|0
1348708|NCT01799590|4443184|P3|Overall Study|Aggravation of complications|1
1348709|NCT01799590|4443185|P2|Overall Study|Aggravation of complications|1
1348710|NCT01799590|4443186|P1|Overall Study|Aggravation of complications|0
1348711|NCT01799590|4443184|P3|Overall Study|Participants convenience|2
1348712|NCT01799590|4443185|P2|Overall Study|Participants convenience|4
1348713|NCT01799590|4443186|P1|Overall Study|Participants convenience|4
1348714|NCT01799590|4443184|P3|Overall Study|Lack of Efficacy|3
1348715|NCT01799590|4443185|P2|Overall Study|Lack of Efficacy|1
1348716|NCT01799590|4443186|P1|Overall Study|Lack of Efficacy|3
1348717|NCT01799590|4443184|P3|Overall Study|Pregnancy|0
1348718|NCT01799590|4443185|P2|Overall Study|Pregnancy|0
1348719|NCT01799590|4443186|P1|Overall Study|Pregnancy|2
1348720|NCT01799590|4443184|P3|Overall Study|Adverse Event|5
1348721|NCT01799590|4443185|P2|Overall Study|Adverse Event|7
1348722|NCT01799590|4443186|P1|Overall Study|Adverse Event|13
1348723|NCT01799239|4443229|P2|Period 2 (7 Days)|Protocol Violation|0
1348724|NCT01799239|4443230|P1|Period 2 (7 Days)|Protocol Violation|1
1348725|NCT01799239|4443229|P2|Period 2 (7 Days)|Withdrawal by Subject|1
1348726|NCT01799239|4443230|P1|Period 2 (7 Days)|Withdrawal by Subject|1
1348727|NCT01799239|4443229|P2|Period 1 (7 Days)|Protocol Violation|1
1348728|NCT01799239|4443230|P1|Period 1 (7 Days)|Protocol Violation|0
1348729|NCT01799239|4443229|P2|Period 1 (7 Days)|Withdrawal by Subject|0
1348730|NCT01799239|4443230|P1|Period 1 (7 Days)|Withdrawal by Subject|2
1348731|NCT01799239|4443229|P2|Period 1 (7 Days)|Lack of Efficacy|0
1348732|NCT01799239|4443230|P1|Period 1 (7 Days)|Lack of Efficacy|1
1348733|NCT01799226|4443238|P2|Overall Study|Disqualified at Day 14|0
1348734|NCT01799226|4443239|P1|Overall Study|Disqualified at Day 14|1
1348735|NCT01799226|4443238|P2|Overall Study|Withdrawal by Subject|0
1348736|NCT01799226|4443239|P1|Overall Study|Withdrawal by Subject|1
1348737|NCT01798992|4443251|P4|Overall Study|Insufficient biopsy tissue|0
1348738|NCT01798992|4443252|P3|Overall Study|Insufficient biopsy tissue|1
1348739|NCT01798992|4443253|P2|Overall Study|Insufficient biopsy tissue|0
1348740|NCT01798992|4443254|P1|Overall Study|Insufficient biopsy tissue|0
1348741|NCT01798992|4443251|P4|Overall Study|Lost to Follow-up|0
1348742|NCT01798992|4443252|P3|Overall Study|Lost to Follow-up|1
1348743|NCT01798992|4443253|P2|Overall Study|Lost to Follow-up|1
1348744|NCT01798992|4443254|P1|Overall Study|Lost to Follow-up|0
1348745|NCT01798992|4443251|P4|Overall Study|Administrative withdrawal|1
1348746|NCT01798992|4443252|P3|Overall Study|Administrative withdrawal|0
1348747|NCT01798992|4443253|P2|Overall Study|Administrative withdrawal|1
1348748|NCT01798992|4443254|P1|Overall Study|Administrative withdrawal|0
1348749|NCT01798927|4443274|P1|Overall Study|Withdrawal by Subject|1
1348750|NCT01798706|4443282|P2|Overall Study|Other than specified above|9
1348751|NCT01798706|4443283|P1|Overall Study|Other than specified above|5
1348752|NCT01798706|4443282|P2|Overall Study|Poor compliance to protocol|0
1348753|NCT01798706|4443283|P1|Overall Study|Poor compliance to protocol|1
1348754|NCT01798706|4443282|P2|Overall Study|Lack of Efficacy|2
1348755|NCT01798706|4443283|P1|Overall Study|Lack of Efficacy|0
1348756|NCT01798706|4443282|P2|Overall Study|Adverse Event|10
1348757|NCT01798706|4443283|P1|Overall Study|Adverse Event|15
1348758|NCT01798485|4443328|P2|Overall Study|Clinical Progression|24
1348759|NCT01798485|4443329|P1|Overall Study|Clinical Progression|35
1348760|NCT01798485|4443328|P2|Overall Study|Sponsor Decision|54
1348761|NCT01798485|4443329|P1|Overall Study|Sponsor Decision|61
1348762|NCT01798485|4443328|P2|Overall Study|Death|22
1348763|NCT01798485|4443329|P1|Overall Study|Death|25
1348764|NCT01798485|4443328|P2|Overall Study|Objective Disease Progression|106
1348765|NCT01798485|4443329|P1|Overall Study|Objective Disease Progression|152
1348766|NCT01798485|4443328|P2|Overall Study|Physician Decision|10
1348767|NCT01798485|4443329|P1|Overall Study|Physician Decision|14
1348768|NCT01798485|4443328|P2|Overall Study|Lost to Follow-up|3
1348769|NCT01798485|4443329|P1|Overall Study|Lost to Follow-up|0
1348770|NCT01798485|4443328|P2|Overall Study|Withdrawal by Subject|31
1348771|NCT01798485|4443329|P1|Overall Study|Withdrawal by Subject|27
1348772|NCT01798485|4443328|P2|Overall Study|Adverse Event|40
1348773|NCT01798485|4443329|P1|Overall Study|Adverse Event|32
1348774|NCT01798134|4443455|P1|Overall Study|Liver transplant/surgery|4
1348775|NCT01798134|4443455|P1|Overall Study|Physician Decision|3
1348776|NCT01798134|4443455|P1|Overall Study|Adverse Event|3
1348777|NCT01798134|4443455|P1|Overall Study|Death|2
1348778|NCT01798134|4443455|P1|Overall Study|Withdrawal by Subject|3
1348779|NCT01798134|4443455|P1|Overall Study|Lost to Follow-up|1
1348780|NCT01798056|4443464|P2|Overall Study|Other|2
1348781|NCT01798056|4443465|P1|Overall Study|Other|0
1348782|NCT01798056|4443464|P2|Overall Study|Lost to Follow-up|1
1348783|NCT01798056|4443465|P1|Overall Study|Lost to Follow-up|1
1348784|NCT01798056|4443464|P2|Overall Study|Migrated/moved from study area|1
1348785|NCT01798056|4443465|P1|Overall Study|Migrated/moved from study area|1
1348786|NCT01798056|4443464|P2|Overall Study|Withdrawal by Subject|9
1348787|NCT01798056|4443465|P1|Overall Study|Withdrawal by Subject|12
1348788|NCT01798056|4443464|P2|Overall Study|Serious Adverse Event|12
1348789|NCT01798056|4443465|P1|Overall Study|Serious Adverse Event|13
1348790|NCT01798004|4443499|P1|Overall Study|Enrollment another COG therapeutic trial|32
1348791|NCT01798004|4443499|P1|Overall Study|Initiation of other non-protocol therapy|5
1348792|NCT01798004|4443499|P1|Overall Study|Patient/parent refusal|7
1348793|NCT01798004|4443499|P1|Overall Study|Ineligible|4
1348794|NCT01798004|4443499|P1|Overall Study|Withdrawal by Subject|4
1348795|NCT01798004|4443499|P1|Overall Study|Physician Decision|25
1348796|NCT01798004|4443499|P1|Overall Study|Lack of Efficacy|8
1348797|NCT01798004|4443499|P1|Overall Study|Death|2
1348798|NCT01797783|4443505|P2|Overall Study|Withdrawal by Subject|0
1348799|NCT01797783|4443506|P1|Overall Study|Withdrawal by Subject|1
1348800|NCT01797783|4443505|P2|Overall Study|Adverse Event|1
1348801|NCT01797783|4443506|P1|Overall Study|Adverse Event|1
1348802|NCT01797731|4443530|P2|Overall Study|Didn't have proper radiographs required|3
1348803|NCT01797731|4443531|P1|Overall Study|Didn't have proper radiographs required|3
1348804|NCT01797705|4443539|P1|Overall Study|Withdrawal by Subject|1
1348805|NCT01797705|4443539|P1|Overall Study|Equipment anomalies during sleep studies|4
1348806|NCT01797536|4443604|P4|Overall Study|Adverse Event|0
1348807|NCT01797536|4443605|P3|Overall Study|Adverse Event|0
1348808|NCT01797536|4443606|P2|Overall Study|Adverse Event|1
1348809|NCT01797536|4443607|P1|Overall Study|Adverse Event|0
1348810|NCT01797445|4443679|P2|Overall Study|Still on Study|383
1348811|NCT01797445|4443680|P1|Overall Study|Still on Study|381
1348812|NCT01797445|4443679|P2|Overall Study|Lost to Follow-up|15
1348813|NCT01797445|4443680|P1|Overall Study|Lost to Follow-up|22
1348814|NCT01797445|4443679|P2|Overall Study|Withdrew Consent|19
1348815|NCT01797445|4443680|P1|Overall Study|Withdrew Consent|12
1348816|NCT01797445|4443679|P2|Overall Study|Protocol Violation|1
1348817|NCT01797445|4443680|P1|Overall Study|Protocol Violation|0
1348818|NCT01797445|4443679|P2|Overall Study|Noncompliance with Study Drug|1
1348819|NCT01797445|4443680|P1|Overall Study|Noncompliance with Study Drug|3
1348820|NCT01797445|4443679|P2|Overall Study|Investigator's Discretion|12
1348821|NCT01797445|4443680|P1|Overall Study|Investigator's Discretion|8
1348822|NCT01797445|4443679|P2|Overall Study|Lack of Efficacy|2
1348823|NCT01797445|4443680|P1|Overall Study|Lack of Efficacy|1
1348824|NCT01797445|4443679|P2|Overall Study|Death|2
1348825|NCT01797445|4443680|P1|Overall Study|Death|1
1348826|NCT01797445|4443679|P2|Overall Study|Adverse Event|0
1348827|NCT01797445|4443680|P1|Overall Study|Adverse Event|3
1348828|NCT01797445|4443679|P2|Overall Study|Randomized but Not Treated|2
1348829|NCT01797445|4443680|P1|Overall Study|Randomized but Not Treated|4
1348830|NCT01797120|4443738|P2|Overall Study|never start protocol therapy|0
1348831|NCT01797120|4443739|P1|Overall Study|never start protocol therapy|2
1348832|NCT01797120|4443738|P2|Overall Study|still on treatment|4
1348833|NCT01797120|4443739|P1|Overall Study|still on treatment|2
1348834|NCT01797120|4443738|P2|Overall Study|Physician Decision|0
1348835|NCT01797120|4443739|P1|Overall Study|Physician Decision|3
1348836|NCT01797120|4443738|P2|Overall Study|Non-compliance|0
1348837|NCT01797120|4443739|P1|Overall Study|Non-compliance|1
1348838|NCT01797120|4443738|P2|Overall Study|Symptomatic progression|1
1348839|NCT01797120|4443739|P1|Overall Study|Symptomatic progression|2
1348840|NCT01797120|4443738|P2|Overall Study|Withdrawal by Subject|6
1348841|NCT01797120|4443739|P1|Overall Study|Withdrawal by Subject|6
1348842|NCT01797120|4443738|P2|Overall Study|Adverse Event|5
1348843|NCT01797120|4443739|P1|Overall Study|Adverse Event|13
1348844|NCT01797120|4443738|P2|Overall Study|Disesae progression|49
1348845|NCT01797120|4443739|P1|Overall Study|Disesae progression|37
1348846|NCT01797094|4443753|P2|Overall Study|Other Miscellaneous Reasons|0
1348847|NCT01797094|4443754|P1|Overall Study|Other Miscellaneous Reasons|1
1348848|NCT01797094|4443753|P2|Overall Study|Protocol Violation|1
1348849|NCT01797094|4443754|P1|Overall Study|Protocol Violation|0
1348850|NCT01797094|4443753|P2|Overall Study|Personal Reasons|0
1348851|NCT01797094|4443754|P1|Overall Study|Personal Reasons|4
1348852|NCT01797094|4443753|P2|Overall Study|Adverse Event|1
1348853|NCT01797094|4443754|P1|Overall Study|Adverse Event|1
1348854|NCT01797081|4443776|P4|Overall Study|Protocol Violation|1
1348855|NCT01797081|4443777|P3|Overall Study|Protocol Violation|0
1348856|NCT01797081|4443778|P2|Overall Study|Protocol Violation|0
1348857|NCT01797081|4443779|P1|Overall Study|Protocol Violation|0
1348858|NCT01797081|4443776|P4|Overall Study|Personal Reasons|8
1348859|NCT01797081|4443777|P3|Overall Study|Personal Reasons|4
1348860|NCT01797081|4443778|P2|Overall Study|Personal Reasons|4
1348861|NCT01797081|4443779|P1|Overall Study|Personal Reasons|12
1348862|NCT01797081|4443776|P4|Overall Study|Pregnancy|0
1348863|NCT01797081|4443777|P3|Overall Study|Pregnancy|0
1348864|NCT01797081|4443778|P2|Overall Study|Pregnancy|0
1348865|NCT01797081|4443779|P1|Overall Study|Pregnancy|1
1348866|NCT01797081|4443776|P4|Overall Study|Adverse Event|0
1348867|NCT01797081|4443777|P3|Overall Study|Adverse Event|1
1348868|NCT01797081|4443778|P2|Overall Study|Adverse Event|0
1348869|NCT01797081|4443779|P1|Overall Study|Adverse Event|1
1348870|NCT01796964|4443820|P2|Overall Study|Withdrawal by Subject|1
1348871|NCT01796964|4443821|P1|Overall Study|Withdrawal by Subject|1
1348872|NCT01796964|4443820|P2|Overall Study|Protocol Violation|1
1348873|NCT01796964|4443821|P1|Overall Study|Protocol Violation|0
1348874|NCT01796964|4443820|P2|Overall Study|Death|0
1348875|NCT01796964|4443821|P1|Overall Study|Death|1
1348876|NCT01796964|4443820|P2|Overall Study|Adverse Event|1
1348877|NCT01796964|4443821|P1|Overall Study|Adverse Event|1
1348878|NCT01796860|4443843|P1|Overall Study|Withdrawal by Subject|3
1348879|NCT01796548|4443849|P1|Overall Study|Other|2
1348880|NCT01796548|4443849|P1|Overall Study|Lost to Follow-up|1
1348881|NCT01795937|4443883|P3|Overall Study|Physician Decision|0
1348882|NCT01795937|4443884|P2|Overall Study|Physician Decision|1
1348883|NCT01795937|4443885|P1|Overall Study|Physician Decision|0
1348884|NCT01795937|4443883|P3|Overall Study|Withdrawal by Subject|0
1348885|NCT01795937|4443884|P2|Overall Study|Withdrawal by Subject|0
1348886|NCT01795937|4443885|P1|Overall Study|Withdrawal by Subject|1
1348887|NCT01795898|4443914|P1|Overall Study|Physician Decision|1
1348888|NCT01795898|4443914|P1|Overall Study|Withdrew consent & had adverse events|3
1348889|NCT01795898|4443914|P1|Overall Study|Death|1
1348890|NCT01795898|4443914|P1|Overall Study|No pain|1
1348891|NCT01795898|4443914|P1|Overall Study|Diagnosed with metastasis|1
1348892|NCT01795898|4443914|P1|Overall Study|Withdrawal of consent|6
1348893|NCT01795898|4443914|P1|Overall Study|Lost to Follow-up|20
1348894|NCT01795898|4443914|P1|Overall Study|Adverse Event|27
1348895|NCT01795547|4443950|P2|Overall Study|Not stated|1
1348896|NCT01795547|4443951|P1|Overall Study|Not stated|0
1348897|NCT01795547|4443950|P2|Overall Study|Others|1
1348898|NCT01795547|4443951|P1|Overall Study|Others|4
1348899|NCT01795547|4443950|P2|Overall Study|Non-compliance with IMP|1
1348900|NCT01795547|4443951|P1|Overall Study|Non-compliance with IMP|1
1348901|NCT01795547|4443950|P2|Overall Study|Not Treated|10
1348902|NCT01795547|4443951|P1|Overall Study|Not Treated|4
1348903|NCT01795547|4443950|P2|Overall Study|Withdrawal of consent|12
1348904|NCT01795547|4443951|P1|Overall Study|Withdrawal of consent|7
1348905|NCT01795547|4443950|P2|Overall Study|Lost to Follow-up|5
1348906|NCT01795547|4443951|P1|Overall Study|Lost to Follow-up|2
1348907|NCT01795547|4443950|P2|Overall Study|Protocol Violation|4
1348908|NCT01795547|4443951|P1|Overall Study|Protocol Violation|6
1348909|NCT01795547|4443950|P2|Overall Study|Lack of Efficacy|3
1348910|NCT01795547|4443951|P1|Overall Study|Lack of Efficacy|8
1348911|NCT01795547|4443950|P2|Overall Study|Adverse Event|27
1348912|NCT01795547|4443951|P1|Overall Study|Adverse Event|16
1348913|NCT01795495|4443983|P3|Overall Study|Physician Decision|1
1348914|NCT01795495|4443984|P2|Overall Study|Physician Decision|0
1348915|NCT01795495|4443985|P1|Overall Study|Physician Decision|0
1348916|NCT01795495|4443983|P3|Overall Study|Protocol Violation|1
1348917|NCT01795495|4443984|P2|Overall Study|Protocol Violation|0
1348918|NCT01795495|4443985|P1|Overall Study|Protocol Violation|1
1348919|NCT01794949|4443998|P2|Overall Study|Lost to Follow-up|0
1348920|NCT01794949|4443999|P1|Overall Study|Lost to Follow-up|1
1348921|NCT01794845|4444010|P1|Overall Study|Withdrawal by Subject|1
1348922|NCT01794000|4444073|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1348923|NCT01794000|4444074|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
1348924|NCT01794000|4444073|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
1348925|NCT01794000|4444074|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
1348926|NCT01794000|4444073|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
1348927|NCT01794000|4444074|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
1348928|NCT01794000|4444073|P2|Double-Blind Phase (DBP)|Physician Decision|0
1348929|NCT01794000|4444074|P1|Double-Blind Phase (DBP)|Physician Decision|2
1348930|NCT01794000|4444073|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
1348931|NCT01794000|4444074|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
1348932|NCT01794000|4444073|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
1348933|NCT01794000|4444074|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
1348934|NCT01794000|4444073|P2|Double-Blind Phase (DBP)|Death|2
1348935|NCT01794000|4444074|P1|Double-Blind Phase (DBP)|Death|1
1348936|NCT01794000|4444073|P2|Double-Blind Phase (DBP)|Adverse Event|2
1348937|NCT01794000|4444074|P1|Double-Blind Phase (DBP)|Adverse Event|5
1348938|NCT01793935|4444107|P2|Overall Study|Lost to Follow-up|1
1348939|NCT01793935|4444108|P1|Overall Study|Lost to Follow-up|0
1348940|NCT01793935|4444107|P2|Overall Study|Patient did not take study medication|1
1348941|NCT01793935|4444108|P1|Overall Study|Patient did not take study medication|1
1348942|NCT01793935|4444107|P2|Overall Study|Adverse Event|0
1348943|NCT01793935|4444108|P1|Overall Study|Adverse Event|2
1348944|NCT01793935|4444107|P2|Overall Study|Protocol Violation|1
1348945|NCT01793935|4444108|P1|Overall Study|Protocol Violation|2
1348946|NCT01793935|4444107|P2|Overall Study|Pregnancy|0
1348947|NCT01793935|4444108|P1|Overall Study|Pregnancy|1
1348948|NCT01793883|4444145|P3|Overall Study|Respiratory distress during spirometry|1
1348949|NCT01793883|4444146|P2|Overall Study|Respiratory distress during spirometry|0
1348950|NCT01793883|4444147|P1|Overall Study|Respiratory distress during spirometry|0
1348951|NCT01793883|4444145|P3|Overall Study|Dosing error|0
1348952|NCT01793883|4444146|P2|Overall Study|Dosing error|1
1348953|NCT01793883|4444147|P1|Overall Study|Dosing error|0
1348954|NCT01793883|4444145|P3|Overall Study|Met exclusion criteria|0
1348955|NCT01793883|4444146|P2|Overall Study|Met exclusion criteria|0
1348956|NCT01793883|4444147|P1|Overall Study|Met exclusion criteria|1
1348957|NCT01793883|4444145|P3|Overall Study|Unable to complete measurements|0
1348958|NCT01793883|4444146|P2|Overall Study|Unable to complete measurements|0
1348959|NCT01793883|4444147|P1|Overall Study|Unable to complete measurements|1
1348960|NCT01793883|4444145|P3|Overall Study|Unable to complete spriometry|0
1348961|NCT01793883|4444146|P2|Overall Study|Unable to complete spriometry|0
1348962|NCT01793883|4444147|P1|Overall Study|Unable to complete spriometry|1
1348963|NCT01793883|4444145|P3|Overall Study|Randomized in error|0
1348964|NCT01793883|4444146|P2|Overall Study|Randomized in error|0
1348965|NCT01793883|4444147|P1|Overall Study|Randomized in error|1
1348966|NCT01793883|4444145|P3|Overall Study|Lost to Follow-up|3
1348967|NCT01793883|4444146|P2|Overall Study|Lost to Follow-up|1
1348968|NCT01793883|4444147|P1|Overall Study|Lost to Follow-up|5
1348969|NCT01793883|4444145|P3|Overall Study|Subject noncompliance|1
1348970|NCT01793883|4444146|P2|Overall Study|Subject noncompliance|1
1348971|NCT01793883|4444147|P1|Overall Study|Subject noncompliance|0
1348972|NCT01793883|4444145|P3|Overall Study|Withdrawal by Subject|3
1348973|NCT01793883|4444146|P2|Overall Study|Withdrawal by Subject|7
1348974|NCT01793883|4444147|P1|Overall Study|Withdrawal by Subject|3
1348975|NCT01793688|4444155|P1|Overall Study|Protocol Violation|2
1348976|NCT01792830|4444201|P11|Overall Study|Adverse Event|0
1348977|NCT01792830|4444202|P10|Overall Study|Adverse Event|0
1348978|NCT01792830|4444203|P9|Overall Study|Adverse Event|1
1348979|NCT01792830|4444204|P8|Overall Study|Adverse Event|0
1348980|NCT01792830|4444205|P7|Overall Study|Adverse Event|0
1348981|NCT01792830|4444206|P6|Overall Study|Adverse Event|0
1348982|NCT01792830|4444207|P5|Overall Study|Adverse Event|0
1348983|NCT01792830|4444208|P4|Overall Study|Adverse Event|0
1348984|NCT01792830|4444209|P3|Overall Study|Adverse Event|0
1348985|NCT01792830|4444210|P2|Overall Study|Adverse Event|0
1348986|NCT01792830|4444211|P1|Overall Study|Adverse Event|0
1348987|NCT01792830|4444201|P11|Overall Study|Death|1
1348988|NCT01792830|4444202|P10|Overall Study|Death|0
1348989|NCT01792830|4444203|P9|Overall Study|Death|1
1348990|NCT01792830|4444204|P8|Overall Study|Death|0
1348991|NCT01792830|4444205|P7|Overall Study|Death|1
1348992|NCT01792830|4444206|P6|Overall Study|Death|0
1348993|NCT01792830|4444207|P5|Overall Study|Death|0
1348994|NCT01792830|4444208|P4|Overall Study|Death|1
1348995|NCT01792830|4444209|P3|Overall Study|Death|0
1348996|NCT01792830|4444210|P2|Overall Study|Death|0
1348997|NCT01792830|4444211|P1|Overall Study|Death|3
1348998|NCT01792830|4444201|P11|Overall Study|Withdrawal by Subject|2
1348999|NCT01792830|4444202|P10|Overall Study|Withdrawal by Subject|0
1349000|NCT01792830|4444203|P9|Overall Study|Withdrawal by Subject|7
1349001|NCT01792830|4444204|P8|Overall Study|Withdrawal by Subject|1
1349002|NCT01792830|4444205|P7|Overall Study|Withdrawal by Subject|1
1349003|NCT01792830|4444206|P6|Overall Study|Withdrawal by Subject|1
1349004|NCT01792830|4444207|P5|Overall Study|Withdrawal by Subject|1
1349005|NCT01792830|4444208|P4|Overall Study|Withdrawal by Subject|2
1349006|NCT01792830|4444209|P3|Overall Study|Withdrawal by Subject|0
1349007|NCT01792830|4444210|P2|Overall Study|Withdrawal by Subject|0
1349008|NCT01792830|4444211|P1|Overall Study|Withdrawal by Subject|22
1349009|NCT01792635|4444298|P3|Part B|Study terminated|3
1349010|NCT01792635|4444299|P2|Part B|Study terminated|4
1349011|NCT01792635|4444300|P1|Part B|Study terminated|0
1349012|NCT01792635|4444298|P3|Part B|Adverse Event|1
1349013|NCT01792635|4444299|P2|Part B|Adverse Event|0
1349014|NCT01792635|4444300|P1|Part B|Adverse Event|0
1349015|NCT01792518|4444328|P2|Overall Study|Other Reason|1
1349016|NCT01792518|4444329|P1|Overall Study|Other Reason|0
1349017|NCT01792518|4444328|P2|Overall Study|Withdrawal by Subject|0
1349018|NCT01792518|4444329|P1|Overall Study|Withdrawal by Subject|2
1349019|NCT01792518|4444328|P2|Overall Study|Lost to Follow-up|1
1349020|NCT01792518|4444329|P1|Overall Study|Lost to Follow-up|3
1349021|NCT01792518|4444328|P2|Overall Study|Protocol Violation|1
1349022|NCT01792518|4444329|P1|Overall Study|Protocol Violation|0
1349023|NCT01792518|4444328|P2|Overall Study|Adverse Event|4
1349024|NCT01792518|4444329|P1|Overall Study|Adverse Event|3
1349025|NCT01792284|4444339|P3|Randomization Period 2|Withdrawal by Subject|0
1349026|NCT01792284|4444340|P2|Randomization Period 2|Withdrawal by Subject|2
1349027|NCT01792284|4444341|P1|Randomization Period 2|Withdrawal by Subject|0
1349028|NCT01792284|4444339|P3|Randomization Period 2|Protocol Violation|0
1349029|NCT01792284|4444340|P2|Randomization Period 2|Protocol Violation|1
1349030|NCT01792284|4444341|P1|Randomization Period 2|Protocol Violation|0
1349031|NCT01792284|4444339|P3|Randomization Period 1|Lost to Follow-up|1
1349032|NCT01792284|4444340|P2|Randomization Period 1|Lost to Follow-up|0
1349033|NCT01792284|4444341|P1|Randomization Period 1|Lost to Follow-up|0
1349034|NCT01792284|4444339|P3|Randomization Period 1|Adverse Event|2
1349035|NCT01792284|4444340|P2|Randomization Period 1|Adverse Event|0
1349036|NCT01792284|4444341|P1|Randomization Period 1|Adverse Event|0
1349037|NCT01792284|4444339|P3|Randomization Period 1|Physician Decision|1
1349038|NCT01792284|4444340|P2|Randomization Period 1|Physician Decision|1
1349039|NCT01792284|4444341|P1|Randomization Period 1|Physician Decision|0
1349040|NCT01792284|4444339|P3|Randomization Period 1|Withdrawal by Subject|1
1349041|NCT01792284|4444340|P2|Randomization Period 1|Withdrawal by Subject|1
1349042|NCT01792284|4444341|P1|Randomization Period 1|Withdrawal by Subject|0
1349043|NCT01792284|4444339|P3|Lead-in Period|Protocol Required Discontinuation|0
1349044|NCT01792284|4444340|P2|Lead-in Period|Protocol Required Discontinuation|0
1349045|NCT01792284|4444341|P1|Lead-in Period|Protocol Required Discontinuation|1
1349046|NCT01792284|4444339|P3|Lead-in Period|Physician Decision|0
1349047|NCT01792284|4444340|P2|Lead-in Period|Physician Decision|0
1349048|NCT01792284|4444341|P1|Lead-in Period|Physician Decision|1
1349049|NCT01792284|4444339|P3|Lead-in Period|Withdrawal by Subject|0
1349050|NCT01792284|4444340|P2|Lead-in Period|Withdrawal by Subject|0
1349051|NCT01792284|4444341|P1|Lead-in Period|Withdrawal by Subject|10
1349052|NCT01792284|4444339|P3|Lead-in Period|Protocol Violation|0
1349053|NCT01792284|4444340|P2|Lead-in Period|Protocol Violation|0
1349054|NCT01792284|4444341|P1|Lead-in Period|Protocol Violation|1
1349055|NCT01792284|4444339|P3|Lead-in Period|Lost to Follow-up|0
1349056|NCT01792284|4444340|P2|Lead-in Period|Lost to Follow-up|0
1349057|NCT01792284|4444341|P1|Lead-in Period|Lost to Follow-up|2
1349058|NCT01792284|4444339|P3|Lead-in Period|Adverse Event|0
1349059|NCT01792284|4444340|P2|Lead-in Period|Adverse Event|0
1349060|NCT01792284|4444341|P1|Lead-in Period|Adverse Event|15
1349061|NCT01791894|4444400|P1|Overall Study|Adverse Event|1
1349062|NCT01791803|4444411|P4|Overall Study|Death|2
1349063|NCT01791803|4444412|P3|Overall Study|Death|2
1349064|NCT01791803|4444413|P2|Overall Study|Death|0
1349065|NCT01791803|4444414|P1|Overall Study|Death|0
1349066|NCT01791803|4444411|P4|Overall Study|Physician Decision|1
1349067|NCT01791803|4444412|P3|Overall Study|Physician Decision|0
1349068|NCT01791803|4444413|P2|Overall Study|Physician Decision|2
1349069|NCT01791803|4444414|P1|Overall Study|Physician Decision|0
1349070|NCT01791803|4444411|P4|Overall Study|Withdrawal by Subject|2
1349071|NCT01791803|4444412|P3|Overall Study|Withdrawal by Subject|0
1349072|NCT01791803|4444413|P2|Overall Study|Withdrawal by Subject|0
1349073|NCT01791803|4444414|P1|Overall Study|Withdrawal by Subject|0
1349074|NCT01791725|4444432|P3|Overall Study|Withdrawal by Subject|0
1349075|NCT01791725|4444433|P2|Overall Study|Withdrawal by Subject|1
1349076|NCT01791725|4444434|P1|Overall Study|Withdrawal by Subject|0
1349077|NCT01791517|4444457|P12|Phase II|Pre-Existing Ocular Issue|1
1349078|NCT01791517|4444458|P11|Phase II|Pre-Existing Ocular Issue|0
1349079|NCT01791517|4444459|P10|Phase II|Pre-Existing Ocular Issue|0
1349080|NCT01791517|4444460|P9|Phase II|Pre-Existing Ocular Issue|0
1349081|NCT01791517|4444461|P8|Phase II|Pre-Existing Ocular Issue|0
1349082|NCT01791517|4444462|P7|Phase II|Pre-Existing Ocular Issue|0
1349083|NCT01791517|4444463|P6|Phase II|Pre-Existing Ocular Issue|0
1349084|NCT01791517|4444464|P5|Phase II|Pre-Existing Ocular Issue|0
1349085|NCT01791517|4444465|P4|Phase II|Pre-Existing Ocular Issue|0
1349086|NCT01791517|4444466|P3|Phase II|Pre-Existing Ocular Issue|0
1349087|NCT01791517|4444467|P2|Phase II|Pre-Existing Ocular Issue|0
1349088|NCT01791517|4444468|P1|Phase II|Pre-Existing Ocular Issue|0
1349089|NCT01791517|4444457|P12|Phase II|Unsatisfactory Lens Fitting|0
1349090|NCT01791517|4444458|P11|Phase II|Unsatisfactory Lens Fitting|0
1349091|NCT01791517|4444459|P10|Phase II|Unsatisfactory Lens Fitting|1
1349092|NCT01791517|4444460|P9|Phase II|Unsatisfactory Lens Fitting|0
1349093|NCT01791517|4444461|P8|Phase II|Unsatisfactory Lens Fitting|0
1349094|NCT01791517|4444462|P7|Phase II|Unsatisfactory Lens Fitting|0
1349095|NCT01791517|4444463|P6|Phase II|Unsatisfactory Lens Fitting|0
1349096|NCT01791517|4444464|P5|Phase II|Unsatisfactory Lens Fitting|0
1349097|NCT01791517|4444465|P4|Phase II|Unsatisfactory Lens Fitting|0
1349098|NCT01791517|4444466|P3|Phase II|Unsatisfactory Lens Fitting|0
1349099|NCT01791517|4444467|P2|Phase II|Unsatisfactory Lens Fitting|0
1349100|NCT01791517|4444468|P1|Phase II|Unsatisfactory Lens Fitting|0
1349101|NCT01791517|4444457|P12|Phase II|Lens Handling Difficulties|0
1349102|NCT01791517|4444458|P11|Phase II|Lens Handling Difficulties|0
1349103|NCT01791517|4444459|P10|Phase II|Lens Handling Difficulties|0
1349104|NCT01791517|4444460|P9|Phase II|Lens Handling Difficulties|1
1349105|NCT01791517|4444461|P8|Phase II|Lens Handling Difficulties|0
1349106|NCT01791517|4444462|P7|Phase II|Lens Handling Difficulties|0
1349107|NCT01791517|4444463|P6|Phase II|Lens Handling Difficulties|0
1349108|NCT01791517|4444464|P5|Phase II|Lens Handling Difficulties|0
1349109|NCT01791517|4444465|P4|Phase II|Lens Handling Difficulties|0
1349110|NCT01791517|4444466|P3|Phase II|Lens Handling Difficulties|0
1349111|NCT01791517|4444467|P2|Phase II|Lens Handling Difficulties|0
1349112|NCT01791517|4444468|P1|Phase II|Lens Handling Difficulties|0
1349113|NCT01791517|4444457|P12|Phase II|Adverse Event|0
1349114|NCT01791517|4444458|P11|Phase II|Adverse Event|0
1349115|NCT01791517|4444459|P10|Phase II|Adverse Event|1
1349116|NCT01791517|4444460|P9|Phase II|Adverse Event|0
1349117|NCT01791517|4444461|P8|Phase II|Adverse Event|1
1349118|NCT01791517|4444462|P7|Phase II|Adverse Event|2
1349119|NCT01791517|4444463|P6|Phase II|Adverse Event|0
1349120|NCT01791517|4444464|P5|Phase II|Adverse Event|0
1349121|NCT01791517|4444465|P4|Phase II|Adverse Event|0
1349122|NCT01791517|4444466|P3|Phase II|Adverse Event|0
1349123|NCT01791517|4444467|P2|Phase II|Adverse Event|0
1349124|NCT01791517|4444468|P1|Phase II|Adverse Event|0
1349125|NCT01791517|4444457|P12|Phase II|Lack of Efficacy|0
1349126|NCT01791517|4444458|P11|Phase II|Lack of Efficacy|0
1349127|NCT01791517|4444459|P10|Phase II|Lack of Efficacy|0
1349128|NCT01791517|4444460|P9|Phase II|Lack of Efficacy|0
1349129|NCT01791517|4444461|P8|Phase II|Lack of Efficacy|0
1349130|NCT01791517|4444462|P7|Phase II|Lack of Efficacy|0
1349131|NCT01791517|4444463|P6|Phase II|Lack of Efficacy|0
1349132|NCT01791517|4444464|P5|Phase II|Lack of Efficacy|1
1349133|NCT01791517|4444465|P4|Phase II|Lack of Efficacy|0
1349134|NCT01791517|4444466|P3|Phase II|Lack of Efficacy|0
1349135|NCT01791517|4444467|P2|Phase II|Lack of Efficacy|0
1349136|NCT01791517|4444468|P1|Phase II|Lack of Efficacy|0
1349137|NCT01791517|4444457|P12|Phase II|Withdrawal by Subject|0
1349138|NCT01791517|4444458|P11|Phase II|Withdrawal by Subject|1
1349139|NCT01791517|4444459|P10|Phase II|Withdrawal by Subject|0
1349140|NCT01791517|4444460|P9|Phase II|Withdrawal by Subject|0
1349141|NCT01791517|4444461|P8|Phase II|Withdrawal by Subject|1
1349142|NCT01791517|4444462|P7|Phase II|Withdrawal by Subject|0
1349143|NCT01791517|4444463|P6|Phase II|Withdrawal by Subject|2
1349144|NCT01791517|4444464|P5|Phase II|Withdrawal by Subject|0
1349145|NCT01791517|4444465|P4|Phase II|Withdrawal by Subject|0
1349146|NCT01791517|4444466|P3|Phase II|Withdrawal by Subject|0
1349147|NCT01791517|4444467|P2|Phase II|Withdrawal by Subject|0
1349148|NCT01791517|4444468|P1|Phase II|Withdrawal by Subject|1
1349149|NCT01791517|4444457|P12|Phase II|Lost to Follow-up|0
1349150|NCT01791517|4444458|P11|Phase II|Lost to Follow-up|0
1349151|NCT01791517|4444459|P10|Phase II|Lost to Follow-up|1
1349152|NCT01791517|4444460|P9|Phase II|Lost to Follow-up|1
1349153|NCT01791517|4444461|P8|Phase II|Lost to Follow-up|1
1349154|NCT01791517|4444462|P7|Phase II|Lost to Follow-up|0
1349155|NCT01791517|4444463|P6|Phase II|Lost to Follow-up|2
1349156|NCT01791517|4444464|P5|Phase II|Lost to Follow-up|1
1349157|NCT01791517|4444465|P4|Phase II|Lost to Follow-up|0
1349158|NCT01791517|4444466|P3|Phase II|Lost to Follow-up|1
1349159|NCT01791517|4444467|P2|Phase II|Lost to Follow-up|0
1349160|NCT01791517|4444468|P1|Phase II|Lost to Follow-up|1
1349161|NCT01791517|4444457|P12|Phase I: Period 3|Adverse Event|0
1349162|NCT01791517|4444458|P11|Phase I: Period 3|Adverse Event|0
1349163|NCT01791517|4444459|P10|Phase I: Period 3|Adverse Event|0
1349164|NCT01791517|4444460|P9|Phase I: Period 3|Adverse Event|0
1349165|NCT01791517|4444461|P8|Phase I: Period 3|Adverse Event|0
1349166|NCT01791517|4444462|P7|Phase I: Period 3|Adverse Event|0
1349167|NCT01791517|4444463|P6|Phase I: Period 3|Adverse Event|0
1349168|NCT01791517|4444464|P5|Phase I: Period 3|Adverse Event|0
1349169|NCT01791517|4444465|P4|Phase I: Period 3|Adverse Event|1
1349170|NCT01791517|4444466|P3|Phase I: Period 3|Adverse Event|0
1349171|NCT01791517|4444467|P2|Phase I: Period 3|Adverse Event|0
1349172|NCT01791517|4444468|P1|Phase I: Period 3|Adverse Event|0
1349173|NCT01791517|4444457|P12|Phase I: Period 3|Lost to Follow-up|0
1349174|NCT01791517|4444458|P11|Phase I: Period 3|Lost to Follow-up|0
1349175|NCT01791517|4444459|P10|Phase I: Period 3|Lost to Follow-up|0
1349176|NCT01791517|4444460|P9|Phase I: Period 3|Lost to Follow-up|0
1349177|NCT01791517|4444461|P8|Phase I: Period 3|Lost to Follow-up|0
1349178|NCT01791517|4444462|P7|Phase I: Period 3|Lost to Follow-up|0
1349179|NCT01791517|4444463|P6|Phase I: Period 3|Lost to Follow-up|0
1349180|NCT01791517|4444464|P5|Phase I: Period 3|Lost to Follow-up|1
1349181|NCT01791517|4444465|P4|Phase I: Period 3|Lost to Follow-up|0
1349182|NCT01791517|4444466|P3|Phase I: Period 3|Lost to Follow-up|0
1349183|NCT01791517|4444467|P2|Phase I: Period 3|Lost to Follow-up|1
1349184|NCT01791517|4444468|P1|Phase I: Period 3|Lost to Follow-up|0
1349185|NCT01791517|4444457|P12|Phase I: Period 3|Lens Discomfort|1
1349186|NCT01791517|4444458|P11|Phase I: Period 3|Lens Discomfort|0
1349187|NCT01791517|4444459|P10|Phase I: Period 3|Lens Discomfort|0
1349188|NCT01791517|4444460|P9|Phase I: Period 3|Lens Discomfort|0
1349189|NCT01791517|4444461|P8|Phase I: Period 3|Lens Discomfort|0
1349190|NCT01791517|4444462|P7|Phase I: Period 3|Lens Discomfort|0
1349191|NCT01791517|4444463|P6|Phase I: Period 3|Lens Discomfort|0
1349192|NCT01791517|4444464|P5|Phase I: Period 3|Lens Discomfort|0
1349193|NCT01791517|4444465|P4|Phase I: Period 3|Lens Discomfort|0
1349194|NCT01791517|4444466|P3|Phase I: Period 3|Lens Discomfort|0
1349195|NCT01791517|4444467|P2|Phase I: Period 3|Lens Discomfort|0
1349196|NCT01791517|4444468|P1|Phase I: Period 3|Lens Discomfort|0
1349197|NCT01791517|4444457|P12|Phase I: Period 2|Lost to Follow-up|0
1349198|NCT01791517|4444458|P11|Phase I: Period 2|Lost to Follow-up|0
1349199|NCT01791517|4444459|P10|Phase I: Period 2|Lost to Follow-up|0
1349200|NCT01791517|4444460|P9|Phase I: Period 2|Lost to Follow-up|0
1349201|NCT01791517|4444461|P8|Phase I: Period 2|Lost to Follow-up|0
1349202|NCT01791517|4444462|P7|Phase I: Period 2|Lost to Follow-up|0
1349203|NCT01791517|4444463|P6|Phase I: Period 2|Lost to Follow-up|0
1349204|NCT01791517|4444464|P5|Phase I: Period 2|Lost to Follow-up|0
1349205|NCT01791517|4444465|P4|Phase I: Period 2|Lost to Follow-up|0
1349206|NCT01791517|4444466|P3|Phase I: Period 2|Lost to Follow-up|2
1349207|NCT01791517|4444467|P2|Phase I: Period 2|Lost to Follow-up|3
1349208|NCT01791517|4444468|P1|Phase I: Period 2|Lost to Follow-up|0
1349209|NCT01791517|4444457|P12|Phase I: Period 2|Lens Discomfort|0
1349210|NCT01791517|4444458|P11|Phase I: Period 2|Lens Discomfort|0
1349211|NCT01791517|4444459|P10|Phase I: Period 2|Lens Discomfort|0
1349212|NCT01791517|4444460|P9|Phase I: Period 2|Lens Discomfort|0
1349213|NCT01791517|4444461|P8|Phase I: Period 2|Lens Discomfort|0
1349214|NCT01791517|4444462|P7|Phase I: Period 2|Lens Discomfort|0
1349215|NCT01791517|4444463|P6|Phase I: Period 2|Lens Discomfort|1
1349216|NCT01791517|4444464|P5|Phase I: Period 2|Lens Discomfort|0
1349217|NCT01791517|4444465|P4|Phase I: Period 2|Lens Discomfort|0
1349218|NCT01791517|4444466|P3|Phase I: Period 2|Lens Discomfort|0
1349219|NCT01791517|4444467|P2|Phase I: Period 2|Lens Discomfort|0
1349220|NCT01791517|4444468|P1|Phase I: Period 2|Lens Discomfort|0
1349221|NCT01791517|4444457|P12|Phase I: Period 2|Unsatisfactory Visual Response|0
1349222|NCT01791517|4444458|P11|Phase I: Period 2|Unsatisfactory Visual Response|1
1349223|NCT01791517|4444459|P10|Phase I: Period 2|Unsatisfactory Visual Response|0
1349224|NCT01791517|4444460|P9|Phase I: Period 2|Unsatisfactory Visual Response|0
1349225|NCT01791517|4444461|P8|Phase I: Period 2|Unsatisfactory Visual Response|0
1349226|NCT01791517|4444462|P7|Phase I: Period 2|Unsatisfactory Visual Response|0
1349227|NCT01791517|4444463|P6|Phase I: Period 2|Unsatisfactory Visual Response|0
1349228|NCT01791517|4444464|P5|Phase I: Period 2|Unsatisfactory Visual Response|0
1349229|NCT01791517|4444465|P4|Phase I: Period 2|Unsatisfactory Visual Response|0
1349230|NCT01791517|4444466|P3|Phase I: Period 2|Unsatisfactory Visual Response|0
1349231|NCT01791517|4444467|P2|Phase I: Period 2|Unsatisfactory Visual Response|0
1349232|NCT01791517|4444468|P1|Phase I: Period 2|Unsatisfactory Visual Response|0
1349233|NCT01791517|4444457|P12|Phase I: Period 2|Withdrawal by Subject|0
1349234|NCT01791517|4444458|P11|Phase I: Period 2|Withdrawal by Subject|1
1349235|NCT01791517|4444459|P10|Phase I: Period 2|Withdrawal by Subject|1
1349236|NCT01791517|4444460|P9|Phase I: Period 2|Withdrawal by Subject|0
1349237|NCT01791517|4444461|P8|Phase I: Period 2|Withdrawal by Subject|0
1349238|NCT01791517|4444462|P7|Phase I: Period 2|Withdrawal by Subject|0
1349239|NCT01791517|4444463|P6|Phase I: Period 2|Withdrawal by Subject|0
1349240|NCT01791517|4444464|P5|Phase I: Period 2|Withdrawal by Subject|0
1349241|NCT01791517|4444465|P4|Phase I: Period 2|Withdrawal by Subject|0
1349242|NCT01791517|4444466|P3|Phase I: Period 2|Withdrawal by Subject|0
1349243|NCT01791517|4444467|P2|Phase I: Period 2|Withdrawal by Subject|0
1349244|NCT01791517|4444468|P1|Phase I: Period 2|Withdrawal by Subject|0
1349245|NCT01791517|4444457|P12|Phase I: Period 2|Protocol Violation|0
1349246|NCT01791517|4444458|P11|Phase I: Period 2|Protocol Violation|0
1349247|NCT01791517|4444459|P10|Phase I: Period 2|Protocol Violation|0
1349248|NCT01791517|4444460|P9|Phase I: Period 2|Protocol Violation|0
1349249|NCT01791517|4444461|P8|Phase I: Period 2|Protocol Violation|0
1349250|NCT01791517|4444462|P7|Phase I: Period 2|Protocol Violation|0
1349251|NCT01791517|4444463|P6|Phase I: Period 2|Protocol Violation|0
1349252|NCT01791517|4444464|P5|Phase I: Period 2|Protocol Violation|0
1349253|NCT01791517|4444465|P4|Phase I: Period 2|Protocol Violation|1
1349254|NCT01791517|4444466|P3|Phase I: Period 2|Protocol Violation|0
1349255|NCT01791517|4444467|P2|Phase I: Period 2|Protocol Violation|0
1349256|NCT01791517|4444468|P1|Phase I: Period 2|Protocol Violation|0
1349257|NCT01791517|4444457|P12|Phase I: Period 2|Unsatisfactory Lens Fit|0
1349258|NCT01791517|4444458|P11|Phase I: Period 2|Unsatisfactory Lens Fit|0
1349259|NCT01791517|4444459|P10|Phase I: Period 2|Unsatisfactory Lens Fit|0
1349260|NCT01791517|4444460|P9|Phase I: Period 2|Unsatisfactory Lens Fit|0
1349261|NCT01791517|4444461|P8|Phase I: Period 2|Unsatisfactory Lens Fit|0
1349262|NCT01791517|4444462|P7|Phase I: Period 2|Unsatisfactory Lens Fit|0
1349263|NCT01791517|4444463|P6|Phase I: Period 2|Unsatisfactory Lens Fit|0
1349264|NCT01791517|4444464|P5|Phase I: Period 2|Unsatisfactory Lens Fit|0
1349265|NCT01791517|4444465|P4|Phase I: Period 2|Unsatisfactory Lens Fit|0
1349266|NCT01791517|4444466|P3|Phase I: Period 2|Unsatisfactory Lens Fit|0
1349267|NCT01791517|4444467|P2|Phase I: Period 2|Unsatisfactory Lens Fit|0
1349268|NCT01791517|4444468|P1|Phase I: Period 2|Unsatisfactory Lens Fit|1
1349269|NCT01791517|4444457|P12|Phase I: Period 1|Lens Handling DIfficulties|1
1349270|NCT01791517|4444458|P11|Phase I: Period 1|Lens Handling DIfficulties|0
1349271|NCT01791517|4444459|P10|Phase I: Period 1|Lens Handling DIfficulties|0
1349272|NCT01791517|4444460|P9|Phase I: Period 1|Lens Handling DIfficulties|0
1349273|NCT01791517|4444461|P8|Phase I: Period 1|Lens Handling DIfficulties|0
1349274|NCT01791517|4444462|P7|Phase I: Period 1|Lens Handling DIfficulties|0
1349275|NCT01791517|4444463|P6|Phase I: Period 1|Lens Handling DIfficulties|0
1349276|NCT01791517|4444464|P5|Phase I: Period 1|Lens Handling DIfficulties|0
1349277|NCT01791517|4444465|P4|Phase I: Period 1|Lens Handling DIfficulties|0
1349278|NCT01791517|4444466|P3|Phase I: Period 1|Lens Handling DIfficulties|0
1349279|NCT01791517|4444467|P2|Phase I: Period 1|Lens Handling DIfficulties|0
1349280|NCT01791517|4444468|P1|Phase I: Period 1|Lens Handling DIfficulties|0
1349281|NCT01791517|4444457|P12|Phase I: Period 1|Lost to Follow-up|0
1349282|NCT01791517|4444458|P11|Phase I: Period 1|Lost to Follow-up|0
1349283|NCT01791517|4444459|P10|Phase I: Period 1|Lost to Follow-up|1
1349284|NCT01791517|4444460|P9|Phase I: Period 1|Lost to Follow-up|1
1349285|NCT01791517|4444461|P8|Phase I: Period 1|Lost to Follow-up|0
1349286|NCT01791517|4444462|P7|Phase I: Period 1|Lost to Follow-up|1
1349287|NCT01791517|4444463|P6|Phase I: Period 1|Lost to Follow-up|0
1349288|NCT01791517|4444464|P5|Phase I: Period 1|Lost to Follow-up|0
1349289|NCT01791517|4444465|P4|Phase I: Period 1|Lost to Follow-up|1
1349290|NCT01791517|4444466|P3|Phase I: Period 1|Lost to Follow-up|0
1349291|NCT01791517|4444467|P2|Phase I: Period 1|Lost to Follow-up|0
1349292|NCT01791517|4444468|P1|Phase I: Period 1|Lost to Follow-up|0
1349293|NCT01791517|4444457|P12|Phase I: Period 1|Protocol Violation|0
1349294|NCT01791517|4444458|P11|Phase I: Period 1|Protocol Violation|0
1349295|NCT01791517|4444459|P10|Phase I: Period 1|Protocol Violation|0
1349296|NCT01791517|4444460|P9|Phase I: Period 1|Protocol Violation|0
1349297|NCT01791517|4444461|P8|Phase I: Period 1|Protocol Violation|0
1349298|NCT01791517|4444462|P7|Phase I: Period 1|Protocol Violation|0
1349299|NCT01791517|4444463|P6|Phase I: Period 1|Protocol Violation|0
1349300|NCT01791517|4444464|P5|Phase I: Period 1|Protocol Violation|0
1349301|NCT01791517|4444465|P4|Phase I: Period 1|Protocol Violation|0
1349302|NCT01791517|4444466|P3|Phase I: Period 1|Protocol Violation|0
1349303|NCT01791517|4444467|P2|Phase I: Period 1|Protocol Violation|1
1349304|NCT01791517|4444468|P1|Phase I: Period 1|Protocol Violation|0
1349305|NCT01791517|4444457|P12|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1349306|NCT01791517|4444458|P11|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1349307|NCT01791517|4444459|P10|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1349308|NCT01791517|4444460|P9|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1349309|NCT01791517|4444461|P8|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1349310|NCT01791517|4444462|P7|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1349311|NCT01791517|4444463|P6|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1349312|NCT01791517|4444464|P5|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1349313|NCT01791517|4444465|P4|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1349314|NCT01791517|4444466|P3|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1349315|NCT01791517|4444467|P2|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1349316|NCT01791517|4444468|P1|Phase I: Period 1|Unsatisfactory Lens Fitting|1
1349317|NCT01791517|4444457|P12|Phase I: Period 1|Adverse Event|0
1349318|NCT01791517|4444458|P11|Phase I: Period 1|Adverse Event|0
1349319|NCT01791517|4444459|P10|Phase I: Period 1|Adverse Event|0
1349320|NCT01791517|4444460|P9|Phase I: Period 1|Adverse Event|0
1349321|NCT01791517|4444461|P8|Phase I: Period 1|Adverse Event|0
1349322|NCT01791517|4444462|P7|Phase I: Period 1|Adverse Event|0
1349323|NCT01791517|4444463|P6|Phase I: Period 1|Adverse Event|0
1349324|NCT01791517|4444464|P5|Phase I: Period 1|Adverse Event|0
1349325|NCT01791517|4444465|P4|Phase I: Period 1|Adverse Event|1
1349326|NCT01791517|4444466|P3|Phase I: Period 1|Adverse Event|1
1349327|NCT01791517|4444467|P2|Phase I: Period 1|Adverse Event|0
1349328|NCT01791517|4444468|P1|Phase I: Period 1|Adverse Event|0
1349329|NCT01791517|4444457|P12|Phase I: Period 1|Withdrawal by Subject|0
1349330|NCT01791517|4444458|P11|Phase I: Period 1|Withdrawal by Subject|0
1349331|NCT01791517|4444459|P10|Phase I: Period 1|Withdrawal by Subject|0
1349332|NCT01791517|4444460|P9|Phase I: Period 1|Withdrawal by Subject|0
1349333|NCT01791517|4444461|P8|Phase I: Period 1|Withdrawal by Subject|0
1349334|NCT01791517|4444462|P7|Phase I: Period 1|Withdrawal by Subject|0
1349335|NCT01791517|4444463|P6|Phase I: Period 1|Withdrawal by Subject|1
1349336|NCT01791517|4444464|P5|Phase I: Period 1|Withdrawal by Subject|1
1349337|NCT01791517|4444465|P4|Phase I: Period 1|Withdrawal by Subject|0
1349338|NCT01791517|4444466|P3|Phase I: Period 1|Withdrawal by Subject|1
1349339|NCT01791517|4444467|P2|Phase I: Period 1|Withdrawal by Subject|1
1349340|NCT01791517|4444468|P1|Phase I: Period 1|Withdrawal by Subject|0
1349341|NCT01791413|4444532|P2|Overall Study|Lost to Follow-up|1
1349342|NCT01791413|4444533|P1|Overall Study|Lost to Follow-up|5
1349343|NCT01791244|4444542|P2|Overall Study|Laboratory Abnormality|1
1349344|NCT01791244|4444543|P1|Overall Study|Laboratory Abnormality|0
1349345|NCT01791244|4444542|P2|Overall Study|Insufficient clinical response|10
1349346|NCT01791244|4444543|P1|Overall Study|Insufficient clinical response|10
1349347|NCT01791244|4444542|P2|Overall Study|Adverse Event|7
1349348|NCT01791244|4444543|P1|Overall Study|Adverse Event|5
1349349|NCT01791205|4444579|P2|Phase II|Physician’s decision|0
1349350|NCT01791205|4444580|P1|Phase II|Physician’s decision|1
1349351|NCT01791205|4444579|P2|Phase II|Remission of disease|0
1349352|NCT01791205|4444580|P1|Phase II|Remission of disease|1
1349353|NCT01791205|4444579|P2|Phase II|Lost to Follow-up|0
1349354|NCT01791205|4444580|P1|Phase II|Lost to Follow-up|1
1349355|NCT01791205|4444579|P2|Phase II|Safety|0
1349356|NCT01791205|4444580|P1|Phase II|Safety|1
1349357|NCT01791205|4444579|P2|Phase II|Adverse Event|0
1349358|NCT01791205|4444580|P1|Phase II|Adverse Event|2
1349359|NCT01791205|4444579|P2|Phase II|Lack of Efficacy|0
1349360|NCT01791205|4444580|P1|Phase II|Lack of Efficacy|6
1349361|NCT01791153|4444664|P4|Overall Study|Withdrawal by Subject|1
1349362|NCT01791153|4444665|P3|Overall Study|Withdrawal by Subject|2
1349363|NCT01791153|4444666|P2|Overall Study|Withdrawal by Subject|2
1349364|NCT01791153|4444667|P1|Overall Study|Withdrawal by Subject|6
1349365|NCT01791153|4444664|P4|Overall Study|Protocol Violation|1
1349366|NCT01791153|4444665|P3|Overall Study|Protocol Violation|0
1349367|NCT01791153|4444666|P2|Overall Study|Protocol Violation|0
1349368|NCT01791153|4444667|P1|Overall Study|Protocol Violation|0
1349369|NCT01791153|4444664|P4|Overall Study|Physician Decision|1
1349370|NCT01791153|4444665|P3|Overall Study|Physician Decision|0
1349371|NCT01791153|4444666|P2|Overall Study|Physician Decision|0
1349372|NCT01791153|4444667|P1|Overall Study|Physician Decision|0
1349373|NCT01791153|4444664|P4|Overall Study|Non-Compliance|0
1349374|NCT01791153|4444665|P3|Overall Study|Non-Compliance|0
1349375|NCT01791153|4444666|P2|Overall Study|Non-Compliance|0
1349376|NCT01791153|4444667|P1|Overall Study|Non-Compliance|1
1349377|NCT01791153|4444664|P4|Overall Study|Lack of Efficacy|2
1349378|NCT01791153|4444665|P3|Overall Study|Lack of Efficacy|2
1349379|NCT01791153|4444666|P2|Overall Study|Lack of Efficacy|3
1349380|NCT01791153|4444667|P1|Overall Study|Lack of Efficacy|1
1349381|NCT01791153|4444664|P4|Overall Study|Adverse Event|0
1349382|NCT01791153|4444665|P3|Overall Study|Adverse Event|2
1349383|NCT01791153|4444666|P2|Overall Study|Adverse Event|3
1349384|NCT01791153|4444667|P1|Overall Study|Adverse Event|7
1349385|NCT01790828|4444723|P1|Overall Study|Not specified|34
1349386|NCT01790633|4444781|P2|Overall Study|RT failure and no follow-up ELISA|3
1349387|NCT01790633|4444782|P1|Overall Study|RT failure and no follow-up ELISA|0
1349388|NCT01790633|4444781|P2|Overall Study|Did not have serology performed|0
1349389|NCT01790633|4444782|P1|Overall Study|Did not have serology performed|47
1349390|NCT01790633|4444781|P2|Overall Study|Protocol Violation|2
1349391|NCT01790633|4444782|P1|Overall Study|Protocol Violation|1
1349392|NCT01790594|4444795|P3|Overall Study|Terminated prior to week 76|0
1349393|NCT01790594|4444796|P2|Overall Study|Terminated prior to week 76|2
1349394|NCT01790594|4444797|P1|Overall Study|Terminated prior to week 76|0
1349395|NCT01790594|4444795|P3|Overall Study|Transplant was not done|3
1349396|NCT01790594|4444796|P2|Overall Study|Transplant was not done|0
1349397|NCT01790594|4444797|P1|Overall Study|Transplant was not done|0
1349398|NCT01790594|4444795|P3|Overall Study|Withdrawal by Subject|0
1349399|NCT01790594|4444796|P2|Overall Study|Withdrawal by Subject|0
1349400|NCT01790594|4444797|P1|Overall Study|Withdrawal by Subject|2
1349401|NCT01790594|4444795|P3|Overall Study|Physician Decision|0
1349402|NCT01790594|4444796|P2|Overall Study|Physician Decision|1
1349403|NCT01790594|4444797|P1|Overall Study|Physician Decision|2
1349404|NCT01790594|4444795|P3|Overall Study|Death|0
1349405|NCT01790594|4444796|P2|Overall Study|Death|0
1349406|NCT01790594|4444797|P1|Overall Study|Death|1
1349407|NCT01790568|4444874|P2|Overall Study|Progression prior to transplant|1
1349408|NCT01790568|4444875|P1|Overall Study|Progression prior to transplant|0
1349409|NCT01790516|4444883|P2|Overall Study|Physician Decision|0
1349410|NCT01790516|4444884|P1|Overall Study|Physician Decision|1
1349411|NCT01790438|4444908|P2|Overall Study|Protocol Required Discontinuation|1
1349412|NCT01790438|4444909|P1|Overall Study|Protocol Required Discontinuation|7
1349413|NCT01790438|4444908|P2|Overall Study|Sponsor Decision|3
1349414|NCT01790438|4444909|P1|Overall Study|Sponsor Decision|0
1349415|NCT01790438|4444908|P2|Overall Study|Physician Decision|1
1349416|NCT01790438|4444909|P1|Overall Study|Physician Decision|3
1349417|NCT01790438|4444908|P2|Overall Study|Withdrawal by Subject|2
1349418|NCT01790438|4444909|P1|Overall Study|Withdrawal by Subject|13
1349419|NCT01790438|4444908|P2|Overall Study|Lost to Follow-up|2
1349420|NCT01790438|4444909|P1|Overall Study|Lost to Follow-up|5
1349421|NCT01790438|4444908|P2|Overall Study|Death|0
1349422|NCT01790438|4444909|P1|Overall Study|Death|4
1349423|NCT01790438|4444908|P2|Overall Study|Adverse Event|2
1349424|NCT01790438|4444909|P1|Overall Study|Adverse Event|3
1349425|NCT01789970|4444978|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
1349426|NCT01789970|4444979|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
1349427|NCT01789970|4444980|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
1349428|NCT01789970|4444978|P3|Double-blind Treatment Period (12 Weeks)|Not specified|3
1349429|NCT01789970|4444979|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
1349430|NCT01789970|4444980|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
1349431|NCT01789970|4444978|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
1349432|NCT01789970|4444979|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
1349433|NCT01789970|4444980|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
1349434|NCT01789970|4444978|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
1349435|NCT01789970|4444979|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
1349436|NCT01789970|4444980|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
1349437|NCT01789970|4444978|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
1349438|NCT01789970|4444979|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
1349439|NCT01789970|4444980|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
1349440|NCT01789970|4444978|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
1349441|NCT01789970|4444979|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
1349442|NCT01789970|4444980|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
1349443|NCT01789970|4444978|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
1349444|NCT01789970|4444979|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
1349445|NCT01789970|4444980|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
1349446|NCT01789970|4444978|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
1349447|NCT01789970|4444979|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
1349448|NCT01789970|4444980|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1349449|NCT01789970|4444978|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
1349450|NCT01789970|4444979|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
1349451|NCT01789970|4444980|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1349452|NCT01789970|4444978|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
1349453|NCT01789970|4444979|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
1349454|NCT01789970|4444980|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
1349455|NCT01789970|4444978|P3|Open-label Titration Period|Dropped out prior to dosing|0
1349456|NCT01789970|4444979|P2|Open-label Titration Period|Dropped out prior to dosing|0
1349457|NCT01789970|4444980|P1|Open-label Titration Period|Dropped out prior to dosing|2
1349458|NCT01789970|4444978|P3|Open-label Titration Period|Not specified|0
1349459|NCT01789970|4444979|P2|Open-label Titration Period|Not specified|0
1349460|NCT01789970|4444980|P1|Open-label Titration Period|Not specified|76
1349461|NCT01789970|4444978|P3|Open-label Titration Period|Pregnancy|0
1349462|NCT01789970|4444979|P2|Open-label Titration Period|Pregnancy|0
1349463|NCT01789970|4444980|P1|Open-label Titration Period|Pregnancy|2
1349464|NCT01789970|4444978|P3|Open-label Titration Period|Noncompliance with study procedures|0
1349465|NCT01789970|4444979|P2|Open-label Titration Period|Noncompliance with study procedures|0
1349466|NCT01789970|4444980|P1|Open-label Titration Period|Noncompliance with study procedures|8
1349467|NCT01789970|4444978|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
1349468|NCT01789970|4444979|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
1349469|NCT01789970|4444980|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
1349470|NCT01789970|4444978|P3|Open-label Titration Period|Noncompliance to study drug admin|0
1349471|NCT01789970|4444979|P2|Open-label Titration Period|Noncompliance to study drug admin|0
1349472|NCT01789970|4444980|P1|Open-label Titration Period|Noncompliance to study drug admin|11
1349473|NCT01789970|4444978|P3|Open-label Titration Period|Lost to Follow-up|0
1349474|NCT01789970|4444979|P2|Open-label Titration Period|Lost to Follow-up|0
1349475|NCT01789970|4444980|P1|Open-label Titration Period|Lost to Follow-up|5
1349476|NCT01789970|4444978|P3|Open-label Titration Period|Protocol Violation|0
1349477|NCT01789970|4444979|P2|Open-label Titration Period|Protocol Violation|0
1349478|NCT01789970|4444980|P1|Open-label Titration Period|Protocol Violation|18
1349479|NCT01789970|4444978|P3|Open-label Titration Period|Withdrawal by Subject|0
1349480|NCT01789970|4444979|P2|Open-label Titration Period|Withdrawal by Subject|0
1349481|NCT01789970|4444980|P1|Open-label Titration Period|Withdrawal by Subject|31
1349482|NCT01789970|4444978|P3|Open-label Titration Period|Lack of Efficacy|0
1349483|NCT01789970|4444979|P2|Open-label Titration Period|Lack of Efficacy|0
1349484|NCT01789970|4444980|P1|Open-label Titration Period|Lack of Efficacy|31
1349485|NCT01789970|4444978|P3|Open-label Titration Period|Adverse Event|0
1349486|NCT01789970|4444979|P2|Open-label Titration Period|Adverse Event|0
1349487|NCT01789970|4444980|P1|Open-label Titration Period|Adverse Event|68
1349488|NCT01789606|4445032|P2|Overall Study|Ineligible or not Willing to Continue|348
1349489|NCT01789606|4445033|P1|Overall Study|Ineligible or not Willing to Continue|0
1349490|NCT01789606|4445032|P2|Overall Study|Lost to Follow-up|14
1349491|NCT01789606|4445033|P1|Overall Study|Lost to Follow-up|0
1349492|NCT01789606|4445032|P2|Overall Study|Adverse Event|3
1349493|NCT01789606|4445033|P1|Overall Study|Adverse Event|0
1349494|NCT01789606|4445032|P2|Overall Study|Protocol Violation|55
1349495|NCT01789606|4445033|P1|Overall Study|Protocol Violation|0
1349496|NCT01789606|4445032|P2|Overall Study|No Study Medication Taken|1
1349497|NCT01789606|4445033|P1|Overall Study|No Study Medication Taken|0
1349498|NCT01789606|4445032|P2|Overall Study|Administrative Reasons|6
1349499|NCT01789606|4445033|P1|Overall Study|Administrative Reasons|17
1349500|NCT01789606|4445032|P2|Overall Study|Ineligible|2
1349501|NCT01789606|4445033|P1|Overall Study|Ineligible|6
1349502|NCT01789606|4445032|P2|Overall Study|Withdrawal by Subject|1
1349503|NCT01789606|4445033|P1|Overall Study|Withdrawal by Subject|0
1349504|NCT01789606|4445032|P2|Overall Study|Participant not Purchased the Product|20
1349505|NCT01789606|4445033|P1|Overall Study|Participant not Purchased the Product|0
1349506|NCT01789567|4445051|P1|Overall Study|Death|6
1349507|NCT01789476|4445060|P2|Overall Study|Unable to get IV access|0
1349508|NCT01789476|4445061|P1|Overall Study|Unable to get IV access|1
1349509|NCT01789476|4445060|P2|Overall Study|Adverse Event|0
1349510|NCT01789476|4445061|P1|Overall Study|Adverse Event|1
1349511|NCT01789476|4445060|P2|Overall Study|Lack of Efficacy|2
1349512|NCT01789476|4445061|P1|Overall Study|Lack of Efficacy|6
1349513|NCT01788943|4445094|P2|Overall Study|Withdrawal by Subject|0
1349514|NCT01788943|4445095|P1|Overall Study|Withdrawal by Subject|1
1349515|NCT01788566|4445124|P1|Overall Study|Clinical Progressive Disease|3
1349516|NCT01788566|4445124|P1|Overall Study|Adverse Event|1
1349517|NCT01788566|4445124|P1|Overall Study|Death|4
1349518|NCT01788358|4445134|P1|Overall Study|Adverse Event|51
1349519|NCT01788358|4445134|P1|Overall Study|Lack of Efficacy|1
1349520|NCT01788358|4445134|P1|Overall Study|Withdrawal by Subject|26
1349521|NCT01788358|4445134|P1|Overall Study|Protocol Violation|3
1349522|NCT01788358|4445134|P1|Overall Study|Lost to Follow-up|5
1349523|NCT01788358|4445134|P1|Overall Study|Logistical difficulties|1
1349524|NCT01788358|4445134|P1|Overall Study|Other|11
1349525|NCT01788228|4445148|P2|Overall Study|Migrated/moved from study area|0
1349526|NCT01788228|4445149|P1|Overall Study|Migrated/moved from study area|1
1349527|NCT01788215|4445168|P2|Overall Study|Lost to Follow-up|0
1349528|NCT01788215|4445169|P1|Overall Study|Lost to Follow-up|2
1349529|NCT01788215|4445168|P2|Overall Study|Withdrawal by Subject|1
1349530|NCT01788215|4445169|P1|Overall Study|Withdrawal by Subject|0
1349531|NCT01788163|4445198|P9|Overall Study|Withdrawal by Subject|1
1349532|NCT01788163|4445199|P8|Overall Study|Withdrawal by Subject|0
1349533|NCT01788163|4445200|P7|Overall Study|Withdrawal by Subject|0
1349534|NCT01788163|4445201|P6|Overall Study|Withdrawal by Subject|0
1349535|NCT01788163|4445202|P5|Overall Study|Withdrawal by Subject|0
1349536|NCT01788163|4445203|P4|Overall Study|Withdrawal by Subject|0
1349537|NCT01788163|4445204|P3|Overall Study|Withdrawal by Subject|0
1349538|NCT01788163|4445205|P2|Overall Study|Withdrawal by Subject|0
1349539|NCT01788163|4445206|P1|Overall Study|Withdrawal by Subject|2
1349540|NCT01788163|4445198|P9|Overall Study|Other|15
1349541|NCT01788163|4445199|P8|Overall Study|Other|48
1349542|NCT01788163|4445200|P7|Overall Study|Other|1
1349543|NCT01788163|4445201|P6|Overall Study|Other|7
1349544|NCT01788163|4445202|P5|Overall Study|Other|0
1349545|NCT01788163|4445203|P4|Overall Study|Other|0
1349546|NCT01788163|4445204|P3|Overall Study|Other|0
1349547|NCT01788163|4445205|P2|Overall Study|Other|0
1349548|NCT01788163|4445206|P1|Overall Study|Other|53
1349549|NCT01788046|4445369|P2|Overall Study|Protocol Specified Criteria|1
1349550|NCT01788046|4445370|P1|Overall Study|Protocol Specified Criteria|25
1349551|NCT01788046|4445369|P2|Overall Study|Death|5
1349552|NCT01788046|4445370|P1|Overall Study|Death|7
1349553|NCT01788046|4445369|P2|Overall Study|Lost to Follow-up|19
1349554|NCT01788046|4445370|P1|Overall Study|Lost to Follow-up|12
1349555|NCT01788046|4445369|P2|Overall Study|Withdrawal by Subject|12
1349556|NCT01788046|4445370|P1|Overall Study|Withdrawal by Subject|12
1349557|NCT01787838|4445393|P1|Overall Study|refused|1413
1349558|NCT01787825|4445397|P2|Overall Study|Data Not Analyzable|1
1349559|NCT01787825|4445398|P1|Overall Study|Data Not Analyzable|5
1349560|NCT01787825|4445397|P2|Overall Study|Subject Did Not Ingest Capsules|0
1349561|NCT01787825|4445398|P1|Overall Study|Subject Did Not Ingest Capsules|1
1349562|NCT01787760|4445416|P3|Overall Study|Near vision blur|0
1349563|NCT01787760|4445417|P2|Overall Study|Near vision blur|0
1349564|NCT01787760|4445418|P1|Overall Study|Near vision blur|1
1349565|NCT01787760|4445416|P3|Overall Study|Unsatisfactory visual response|0
1349566|NCT01787760|4445417|P2|Overall Study|Unsatisfactory visual response|1
1349567|NCT01787760|4445418|P1|Overall Study|Unsatisfactory visual response|1
1349568|NCT01787760|4445416|P3|Overall Study|Unsatisfactory physiological response|0
1349569|NCT01787760|4445417|P2|Overall Study|Unsatisfactory physiological response|4
1349570|NCT01787760|4445418|P1|Overall Study|Unsatisfactory physiological response|2
1349571|NCT01787760|4445416|P3|Overall Study|Unsatisfactory lens fitting performance|0
1349572|NCT01787760|4445417|P2|Overall Study|Unsatisfactory lens fitting performance|6
1349573|NCT01787760|4445418|P1|Overall Study|Unsatisfactory lens fitting performance|3
1349574|NCT01787760|4445416|P3|Overall Study|Stroke|0
1349575|NCT01787760|4445417|P2|Overall Study|Stroke|0
1349576|NCT01787760|4445418|P1|Overall Study|Stroke|1
1349577|NCT01787760|4445416|P3|Overall Study|Lost to Follow-up|1
1349578|NCT01787760|4445417|P2|Overall Study|Lost to Follow-up|0
1349579|NCT01787760|4445418|P1|Overall Study|Lost to Follow-up|1
1349580|NCT01787760|4445416|P3|Overall Study|Withdrawal by Subject|2
1349581|NCT01787760|4445417|P2|Overall Study|Withdrawal by Subject|1
1349582|NCT01787760|4445418|P1|Overall Study|Withdrawal by Subject|5
1349583|NCT01787760|4445416|P3|Overall Study|Protocol Violation|1
1349584|NCT01787760|4445417|P2|Overall Study|Protocol Violation|0
1349585|NCT01787760|4445418|P1|Overall Study|Protocol Violation|6
1349586|NCT01787760|4445416|P3|Overall Study|Lens handling difficulty|0
1349587|NCT01787760|4445417|P2|Overall Study|Lens handling difficulty|2
1349588|NCT01787760|4445418|P1|Overall Study|Lens handling difficulty|1
1349589|NCT01787760|4445416|P3|Overall Study|Lens discomfort|0
1349590|NCT01787760|4445417|P2|Overall Study|Lens discomfort|0
1349591|NCT01787760|4445418|P1|Overall Study|Lens discomfort|3
1349592|NCT01787760|4445416|P3|Overall Study|Relocation|0
1349593|NCT01787760|4445417|P2|Overall Study|Relocation|1
1349594|NCT01787760|4445418|P1|Overall Study|Relocation|1
1349595|NCT01787760|4445416|P3|Overall Study|Dryness|0
1349596|NCT01787760|4445417|P2|Overall Study|Dryness|1
1349597|NCT01787760|4445418|P1|Overall Study|Dryness|0
1349598|NCT01787760|4445416|P3|Overall Study|Decompensated on left exotropia|1
1349599|NCT01787760|4445417|P2|Overall Study|Decompensated on left exotropia|0
1349600|NCT01787760|4445418|P1|Overall Study|Decompensated on left exotropia|0
1349601|NCT01787760|4445416|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
1349602|NCT01787760|4445417|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
1349603|NCT01787760|4445418|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
1349604|NCT01787591|4445432|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
1349605|NCT01787591|4445433|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
1349606|NCT01787591|4445434|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
1349607|NCT01787591|4445435|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
1349608|NCT01787461|4445463|P2|Overall Study|Protocol Violation|0
1349609|NCT01787461|4445464|P1|Overall Study|Protocol Violation|3
1349610|NCT01787461|4445463|P2|Overall Study|Withdrawal by Subject|4
1349611|NCT01787461|4445464|P1|Overall Study|Withdrawal by Subject|3
1349612|NCT01787461|4445463|P2|Overall Study|No longer met eligibility criteria|0
1349613|NCT01787461|4445464|P1|Overall Study|No longer met eligibility criteria|1
1349614|NCT01787461|4445463|P2|Overall Study|Lost to Follow-up|2
1349615|NCT01787461|4445464|P1|Overall Study|Lost to Follow-up|3
1349616|NCT01787461|4445463|P2|Overall Study|Adverse Event|3
1349617|NCT01787461|4445464|P1|Overall Study|Adverse Event|4
1349618|NCT01787279|4445513|P1|Overall Study|Lack of Efficacy|1
1349619|NCT01787279|4445513|P1|Overall Study|Lost to Follow-up|2
1349620|NCT01787188|4445539|P3|Overall Study|Other, including patient moved|0
1349621|NCT01787188|4445540|P2|Overall Study|Other, including patient moved|3
1349622|NCT01787188|4445541|P1|Overall Study|Other, including patient moved|0
1349623|NCT01787188|4445539|P3|Overall Study|Lost to Follow-up|2
1349624|NCT01787188|4445540|P2|Overall Study|Lost to Follow-up|2
1349625|NCT01787188|4445541|P1|Overall Study|Lost to Follow-up|1
1349626|NCT01787188|4445539|P3|Overall Study|Protocol Violation|3
1349627|NCT01787188|4445540|P2|Overall Study|Protocol Violation|2
1349628|NCT01787188|4445541|P1|Overall Study|Protocol Violation|3
1349629|NCT01787188|4445539|P3|Overall Study|Withdrawal by Subject|2
1349630|NCT01787188|4445540|P2|Overall Study|Withdrawal by Subject|3
1349631|NCT01787188|4445541|P1|Overall Study|Withdrawal by Subject|4
1349632|NCT01787188|4445539|P3|Overall Study|Non-compliance with Study Drug|0
1349633|NCT01787188|4445540|P2|Overall Study|Non-compliance with Study Drug|1
1349634|NCT01787188|4445541|P1|Overall Study|Non-compliance with Study Drug|0
1349635|NCT01787188|4445539|P3|Overall Study|Lack of Efficacy|5
1349636|NCT01787188|4445540|P2|Overall Study|Lack of Efficacy|3
1349637|NCT01787188|4445541|P1|Overall Study|Lack of Efficacy|7
1349638|NCT01787188|4445539|P3|Overall Study|Adverse Event|6
1349639|NCT01787188|4445540|P2|Overall Study|Adverse Event|4
1349640|NCT01787188|4445541|P1|Overall Study|Adverse Event|2
1349641|NCT01787032|4445613|P6|Overall Study|Protocol Violation|1
1349642|NCT01787032|4445614|P5|Overall Study|Protocol Violation|1
1349643|NCT01787032|4445615|P4|Overall Study|Protocol Violation|0
1349644|NCT01787032|4445616|P3|Overall Study|Protocol Violation|0
1349645|NCT01787032|4445617|P2|Overall Study|Protocol Violation|0
1349646|NCT01787032|4445618|P1|Overall Study|Protocol Violation|0
1349647|NCT01786993|4445642|P2|Overall Study|Hospice Admission|0
1349648|NCT01786993|4445643|P1|Overall Study|Hospice Admission|1
1349649|NCT01786993|4445642|P2|Overall Study|System Explant|0
1349650|NCT01786993|4445643|P1|Overall Study|System Explant|1
1349651|NCT01786993|4445642|P2|Overall Study|Subject Non-Compliance|0
1349652|NCT01786993|4445643|P1|Overall Study|Subject Non-Compliance|1
1349653|NCT01786993|4445642|P2|Overall Study|Lost to Follow-up|1
1349654|NCT01786993|4445643|P1|Overall Study|Lost to Follow-up|0
1349655|NCT01786993|4445642|P2|Overall Study|Withdrawal by Subject|2
1349656|NCT01786993|4445643|P1|Overall Study|Withdrawal by Subject|3
1349657|NCT01786993|4445642|P2|Overall Study|Death|7
1349658|NCT01786993|4445643|P1|Overall Study|Death|6
1349659|NCT01786707|4445693|P2|Overall Study|Lost to Follow-up|1
1349660|NCT01786707|4445694|P1|Overall Study|Lost to Follow-up|1
1349661|NCT01786668|4445706|P4|Overall Study|Lost to Follow-up|0
1349662|NCT01786668|4445707|P3|Overall Study|Lost to Follow-up|1
1349663|NCT01786668|4445708|P2|Overall Study|Lost to Follow-up|0
1349664|NCT01786668|4445709|P1|Overall Study|Lost to Follow-up|1
1349665|NCT01786668|4445706|P4|Overall Study|Pregnancy|1
1349666|NCT01786668|4445707|P3|Overall Study|Pregnancy|0
1349667|NCT01786668|4445708|P2|Overall Study|Pregnancy|0
1349668|NCT01786668|4445709|P1|Overall Study|Pregnancy|0
1349669|NCT01786668|4445706|P4|Overall Study|Withdrawal by Subject|1
1349670|NCT01786668|4445707|P3|Overall Study|Withdrawal by Subject|3
1349671|NCT01786668|4445708|P2|Overall Study|Withdrawal by Subject|0
1349672|NCT01786668|4445709|P1|Overall Study|Withdrawal by Subject|0
1349673|NCT01786668|4445706|P4|Overall Study|Adverse Event|2
1349674|NCT01786668|4445707|P3|Overall Study|Adverse Event|1
1349675|NCT01786668|4445708|P2|Overall Study|Adverse Event|1
1349676|NCT01786668|4445709|P1|Overall Study|Adverse Event|0
1349677|NCT01786629|4445809|P2|Overall Study|Adverse Event|1
1349678|NCT01786629|4445810|P1|Overall Study|Adverse Event|0
1349679|NCT01786629|4445809|P2|Overall Study|Lack of Efficacy|4
1349680|NCT01786629|4445810|P1|Overall Study|Lack of Efficacy|0
1349681|NCT01786551|4445816|P1|Overall Study|Participant withdrew consent|2
1349682|NCT01786330|4445824|P2|Overall Study|Protocol Violation|0
1349683|NCT01786330|4445825|P1|Overall Study|Protocol Violation|1
1349684|NCT01786330|4445824|P2|Overall Study|Excluded intraoperatively|1
1349685|NCT01786330|4445825|P1|Overall Study|Excluded intraoperatively|0
1349686|NCT01786330|4445824|P2|Overall Study|Lost to Follow-up|1
1349687|NCT01786330|4445825|P1|Overall Study|Lost to Follow-up|0
1349688|NCT01786330|4445824|P2|Overall Study|Withdrawal by Subject|1
1349689|NCT01786330|4445825|P1|Overall Study|Withdrawal by Subject|0
1349690|NCT01786174|4445863|P2|Overall Study|Discontinued Study Drug|0
1349691|NCT01786174|4445864|P1|Overall Study|Discontinued Study Drug|2
1349692|NCT01786109|4445894|P3|Overall Study|adverse effects colon preparation|1
1349693|NCT01786109|4445895|P2|Overall Study|adverse effects colon preparation|0
1349694|NCT01786109|4445896|P1|Overall Study|adverse effects colon preparation|0
1349695|NCT01786109|4445894|P3|Overall Study|unrelated illness|1
1349696|NCT01786109|4445895|P2|Overall Study|unrelated illness|0
1349697|NCT01786109|4445896|P1|Overall Study|unrelated illness|0
1349698|NCT01786109|4445894|P3|Overall Study|fail manometry barostat tube placement|0
1349699|NCT01786109|4445895|P2|Overall Study|fail manometry barostat tube placement|0
1349700|NCT01786109|4445896|P1|Overall Study|fail manometry barostat tube placement|1
1349701|NCT01785875|4445925|P3|Overall Study|Missing|3
1349702|NCT01785875|4445926|P2|Overall Study|Missing|1
1349703|NCT01785875|4445927|P1|Overall Study|Missing|0
1349704|NCT01785875|4445925|P3|Overall Study|Protocol Specified Criteria|55
1349705|NCT01785875|4445926|P2|Overall Study|Protocol Specified Criteria|214
1349706|NCT01785875|4445927|P1|Overall Study|Protocol Specified Criteria|207
1349707|NCT01785875|4445925|P3|Overall Study|Sponsor Decision|0
1349708|NCT01785875|4445926|P2|Overall Study|Sponsor Decision|2
1349709|NCT01785875|4445927|P1|Overall Study|Sponsor Decision|0
1349710|NCT01785875|4445925|P3|Overall Study|Death|7
1349711|NCT01785875|4445926|P2|Overall Study|Death|16
1349712|NCT01785875|4445927|P1|Overall Study|Death|27
1349713|NCT01785875|4445925|P3|Overall Study|Lost to Follow-up|6
1349714|NCT01785875|4445926|P2|Overall Study|Lost to Follow-up|22
1349715|NCT01785875|4445927|P1|Overall Study|Lost to Follow-up|19
1349716|NCT01785875|4445925|P3|Overall Study|Withdrawal by Subject|36
1349717|NCT01785875|4445926|P2|Overall Study|Withdrawal by Subject|34
1349718|NCT01785875|4445927|P1|Overall Study|Withdrawal by Subject|41
1349719|NCT01785849|4445996|P2|Overall Study|Lost to Follow-up|11
1349720|NCT01785849|4445997|P1|Overall Study|Lost to Follow-up|10
1349721|NCT01785849|4445996|P2|Overall Study|Sponsor Decision|1
1349722|NCT01785849|4445997|P1|Overall Study|Sponsor Decision|0
1349723|NCT01785849|4445996|P2|Overall Study|Withdrawal by Subject|12
1349724|NCT01785849|4445997|P1|Overall Study|Withdrawal by Subject|15
1349725|NCT01785849|4445996|P2|Overall Study|Protocol Specified Criteria|1
1349726|NCT01785849|4445997|P1|Overall Study|Protocol Specified Criteria|29
1349727|NCT01785849|4445996|P2|Overall Study|Death|9
1349728|NCT01785849|4445997|P1|Overall Study|Death|7
1349729|NCT01785628|4446015|P2|Overall Study|Lost to Follow-up|3
1349730|NCT01785628|4446016|P1|Overall Study|Lost to Follow-up|2
1349731|NCT01785615|4446039|P4|Dietary Phase|Lost to Follow-up|24
1349732|NCT01785615|4446040|P3|Dietary Phase|Lost to Follow-up|0
1349733|NCT01785615|4446041|P2|Dietary Phase|Lost to Follow-up|0
1349734|NCT01785615|4446042|P1|Dietary Phase|Lost to Follow-up|0
1349735|NCT01785602|4446114|P2|Overall Study|Administrative problems|3
1349736|NCT01785602|4446115|P1|Overall Study|Administrative problems|7
1349737|NCT01785602|4446114|P2|Overall Study|Adverse Event|5
1349738|NCT01785602|4446115|P1|Overall Study|Adverse Event|3
1349739|NCT01785602|4446114|P2|Overall Study|Lost to Follow-up|1
1349740|NCT01785602|4446115|P1|Overall Study|Lost to Follow-up|1
1349741|NCT01785602|4446114|P2|Overall Study|Withdrawal by Subject|0
1349742|NCT01785602|4446115|P1|Overall Study|Withdrawal by Subject|2
1349743|NCT01785524|4446125|P2|Overall Study|Withdrawal by Subject|2
1349744|NCT01785524|4446126|P1|Overall Study|Withdrawal by Subject|2
1349745|NCT01785472|4446145|P3|Overall Study|Technical problems|1
1349746|NCT01785472|4446146|P2|Overall Study|Technical problems|0
1349747|NCT01785472|4446147|P1|Overall Study|Technical problems|0
1349748|NCT01785472|4446145|P3|Overall Study|Subject/guardian decision|11
1349749|NCT01785472|4446146|P2|Overall Study|Subject/guardian decision|10
1349750|NCT01785472|4446147|P1|Overall Study|Subject/guardian decision|15
1349751|NCT01785472|4446145|P3|Overall Study|Protocol deviation|2
1349752|NCT01785472|4446146|P2|Overall Study|Protocol deviation|2
1349753|NCT01785472|4446147|P1|Overall Study|Protocol deviation|0
1349754|NCT01785472|4446145|P3|Overall Study|Physician Decision|1
1349755|NCT01785472|4446146|P2|Overall Study|Physician Decision|1
1349756|NCT01785472|4446147|P1|Overall Study|Physician Decision|1
1349757|NCT01785472|4446145|P3|Overall Study|Lost to Follow-up|0
1349758|NCT01785472|4446146|P2|Overall Study|Lost to Follow-up|2
1349759|NCT01785472|4446147|P1|Overall Study|Lost to Follow-up|1
1349760|NCT01785472|4446145|P3|Overall Study|Lack of Efficacy|1
1349761|NCT01785472|4446146|P2|Overall Study|Lack of Efficacy|0
1349762|NCT01785472|4446147|P1|Overall Study|Lack of Efficacy|2
1349763|NCT01785472|4446145|P3|Overall Study|Adverse Event|6
1349764|NCT01785472|4446146|P2|Overall Study|Adverse Event|4
1349765|NCT01785472|4446147|P1|Overall Study|Adverse Event|5
1349766|NCT01785160|4446220|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
1349767|NCT01785160|4446220|P1|Treatment Period 1: Raltegravir|Not treated|1
1349768|NCT01784965|4446255|P2|Overall Study|Adverse Event|8
1349769|NCT01784965|4446256|P1|Overall Study|Adverse Event|0
1349770|NCT01784965|4446255|P2|Overall Study|Withdrawal by Subject|3
1349771|NCT01784965|4446256|P1|Overall Study|Withdrawal by Subject|6
1349772|NCT01783938|4446331|P2|Overall Study|Not Specified|0
1349773|NCT01783938|4446332|P1|Overall Study|Not Specified|1
1349774|NCT01783938|4446331|P2|Overall Study|Withdrew Consent|0
1349775|NCT01783938|4446332|P1|Overall Study|Withdrew Consent|3
1349776|NCT01783938|4446331|P2|Overall Study|Request to Discontinue Study Treatment|2
1349777|NCT01783938|4446332|P1|Overall Study|Request to Discontinue Study Treatment|1
1349778|NCT01783938|4446331|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
1349779|NCT01783938|4446332|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
1349780|NCT01783938|4446331|P2|Overall Study|Study Drug Toxicity|10
1349781|NCT01783938|4446332|P1|Overall Study|Study Drug Toxicity|22
1349782|NCT01783938|4446331|P2|Overall Study|Disease Progression|39
1349783|NCT01783938|4446332|P1|Overall Study|Disease Progression|18
1349784|NCT01783886|4446360|P3|Overall Study|Adverse Event|4
1349785|NCT01783886|4446361|P2|Overall Study|Adverse Event|5
1349786|NCT01783886|4446362|P1|Overall Study|Adverse Event|4
1349787|NCT01783886|4446360|P3|Overall Study|Withdrawal of consent by participant|4
1349788|NCT01783886|4446361|P2|Overall Study|Withdrawal of consent by participant|3
1349789|NCT01783886|4446362|P1|Overall Study|Withdrawal of consent by participant|1
1349790|NCT01783886|4446360|P3|Overall Study|Protocol deviation|2
1349791|NCT01783886|4446361|P2|Overall Study|Protocol deviation|0
1349792|NCT01783886|4446362|P1|Overall Study|Protocol deviation|0
1349793|NCT01783886|4446360|P3|Overall Study|Lost to Follow-up|0
1349794|NCT01783886|4446361|P2|Overall Study|Lost to Follow-up|3
1349795|NCT01783886|4446362|P1|Overall Study|Lost to Follow-up|0
1349796|NCT01783821|4446409|P2|Overall Study|Screen Failure|1
1349797|NCT01783821|4446410|P1|Overall Study|Screen Failure|1
1349798|NCT01783743|4446428|P2|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
1349799|NCT01783743|4446429|P1|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
1349800|NCT01783743|4446428|P2|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
1349801|NCT01783743|4446429|P1|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
1349802|NCT01783743|4446428|P2|Screening of Subjects by CTA During MDA|Absent at MDA|4439
1349803|NCT01783743|4446429|P1|Screening of Subjects by CTA During MDA|Absent at MDA|3427
1349804|NCT01783730|4446443|P1|Overall Study|Failed to meet inclusion criteria|6
1349805|NCT01783678|4446468|P6|Overall Study|Withdrew Consent|0
1349806|NCT01783678|4446469|P5|Overall Study|Withdrew Consent|0
1349807|NCT01783678|4446470|P4|Overall Study|Withdrew Consent|2
1349808|NCT01783678|4446471|P3|Overall Study|Withdrew Consent|0
1349809|NCT01783678|4446472|P2|Overall Study|Withdrew Consent|1
1349810|NCT01783678|4446473|P1|Overall Study|Withdrew Consent|1
1349811|NCT01783678|4446468|P6|Overall Study|Lost to Follow-up|0
1349812|NCT01783678|4446469|P5|Overall Study|Lost to Follow-up|1
1349813|NCT01783678|4446470|P4|Overall Study|Lost to Follow-up|2
1349814|NCT01783678|4446471|P3|Overall Study|Lost to Follow-up|0
1349815|NCT01783678|4446472|P2|Overall Study|Lost to Follow-up|4
1349816|NCT01783678|4446473|P1|Overall Study|Lost to Follow-up|0
1349817|NCT01783678|4446468|P6|Overall Study|Lack of Efficacy|5
1349818|NCT01783678|4446469|P5|Overall Study|Lack of Efficacy|6
1349819|NCT01783678|4446470|P4|Overall Study|Lack of Efficacy|3
1349820|NCT01783678|4446471|P3|Overall Study|Lack of Efficacy|1
1349821|NCT01783678|4446472|P2|Overall Study|Lack of Efficacy|13
1349822|NCT01783678|4446473|P1|Overall Study|Lack of Efficacy|1
1349823|NCT01783678|4446468|P6|Overall Study|Randomized but Not Treated|0
1349824|NCT01783678|4446469|P5|Overall Study|Randomized but Not Treated|0
1349825|NCT01783678|4446470|P4|Overall Study|Randomized but Not Treated|1
1349826|NCT01783678|4446471|P3|Overall Study|Randomized but Not Treated|0
1349827|NCT01783678|4446472|P2|Overall Study|Randomized but Not Treated|0
1349828|NCT01783678|4446473|P1|Overall Study|Randomized but Not Treated|0
1349829|NCT01783548|4446575|P2|Overall Study|Lack of Efficacy|1
1349830|NCT01783548|4446576|P1|Overall Study|Lack of Efficacy|1
1349831|NCT01783548|4446575|P2|Overall Study|Lost to Follow-up|3
1349832|NCT01783548|4446576|P1|Overall Study|Lost to Follow-up|8
1349833|NCT01783548|4446575|P2|Overall Study|Protocol Violation|2
1349834|NCT01783548|4446576|P1|Overall Study|Protocol Violation|2
1349835|NCT01783548|4446575|P2|Overall Study|Non-compliance|0
1349836|NCT01783548|4446576|P1|Overall Study|Non-compliance|4
1349837|NCT01783548|4446575|P2|Overall Study|Withdrawal by Subject|8
1349838|NCT01783548|4446576|P1|Overall Study|Withdrawal by Subject|11
1349839|NCT01783548|4446575|P2|Overall Study|Adverse Event|4
1349840|NCT01783548|4446576|P1|Overall Study|Adverse Event|8
1349841|NCT01783496|4446594|P6|Overall Study|Withdrawal by Subject|0
1349842|NCT01783496|4446595|P5|Overall Study|Withdrawal by Subject|0
1349843|NCT01783496|4446596|P4|Overall Study|Withdrawal by Subject|0
1349844|NCT01783496|4446597|P3|Overall Study|Withdrawal by Subject|0
1349845|NCT01783496|4446598|P2|Overall Study|Withdrawal by Subject|0
1349846|NCT01783496|4446599|P1|Overall Study|Withdrawal by Subject|1
1349847|NCT01783496|4446594|P6|Overall Study|Lost to Follow-up|1
1349848|NCT01783496|4446595|P5|Overall Study|Lost to Follow-up|0
1349849|NCT01783496|4446596|P4|Overall Study|Lost to Follow-up|2
1349850|NCT01783496|4446597|P3|Overall Study|Lost to Follow-up|0
1349851|NCT01783496|4446598|P2|Overall Study|Lost to Follow-up|0
1349852|NCT01783496|4446599|P1|Overall Study|Lost to Follow-up|0
1349853|NCT01783483|4446627|P2|Overall Study|Physician Decision|1
1349854|NCT01783483|4446628|P1|Overall Study|Physician Decision|1
1349855|NCT01783483|4446627|P2|Overall Study|Withdrawal by Subject|1
1349856|NCT01783483|4446628|P1|Overall Study|Withdrawal by Subject|2
1349857|NCT01783483|4446627|P2|Overall Study|Lost to Follow-up|10
1349858|NCT01783483|4446628|P1|Overall Study|Lost to Follow-up|14
1349859|NCT01783483|4446627|P2|Overall Study|Death|3
1349860|NCT01783483|4446628|P1|Overall Study|Death|3
1349861|NCT01783418|4446666|P2|Overall Study|Withdrawal by Subject|0
1349862|NCT01783418|4446667|P1|Overall Study|Withdrawal by Subject|1
1349863|NCT01783015|4446720|P3|Open Label Treatment|Study Terminated by Sponsor|6
1349864|NCT01783015|4446721|P2|Open Label Treatment|Study Terminated by Sponsor|0
1349865|NCT01783015|4446722|P1|Open Label Treatment|Study Terminated by Sponsor|0
1349866|NCT01783015|4446720|P3|Blinded Treatment|Study Terminated by Sponsor|0
1349867|NCT01783015|4446721|P2|Blinded Treatment|Study Terminated by Sponsor|0
1349868|NCT01783015|4446722|P1|Blinded Treatment|Study Terminated by Sponsor|2
1349869|NCT01783015|4446720|P3|Blinded Treatment|Withdrawal by Subject|0
1349870|NCT01783015|4446721|P2|Blinded Treatment|Withdrawal by Subject|1
1349871|NCT01783015|4446722|P1|Blinded Treatment|Withdrawal by Subject|0
1349872|NCT01783015|4446720|P3|Blinded Treatment|Protocol Violation|0
1349873|NCT01783015|4446721|P2|Blinded Treatment|Protocol Violation|1
1349874|NCT01783015|4446722|P1|Blinded Treatment|Protocol Violation|0
1349875|NCT01783015|4446720|P3|Blinded Treatment|Adverse Event|0
1349876|NCT01783015|4446721|P2|Blinded Treatment|Adverse Event|1
1349877|NCT01783015|4446722|P1|Blinded Treatment|Adverse Event|0
1349878|NCT01782885|4446831|P2|Overall Study|Lost to Follow-up|6
1349879|NCT01782885|4446832|P1|Overall Study|Lost to Follow-up|4
1349880|NCT01782872|4446858|P4|Overall Study|Withdrawal by Subject|0
1349881|NCT01782872|4446859|P3|Overall Study|Withdrawal by Subject|0
1349882|NCT01782872|4446860|P2|Overall Study|Withdrawal by Subject|1
1349883|NCT01782872|4446861|P1|Overall Study|Withdrawal by Subject|0
1349884|NCT01782872|4446858|P4|Overall Study|Protocol Violation|1
1349885|NCT01782872|4446859|P3|Overall Study|Protocol Violation|0
1349886|NCT01782872|4446860|P2|Overall Study|Protocol Violation|0
1349887|NCT01782872|4446861|P1|Overall Study|Protocol Violation|0
1349888|NCT01782859|4446885|P2|Overall Study|Withdrawal by Subject|1
1349889|NCT01782859|4446886|P1|Overall Study|Withdrawal by Subject|0
1349890|NCT01782859|4446885|P2|Overall Study|Protocol Violation|6
1349891|NCT01782859|4446886|P1|Overall Study|Protocol Violation|6
1349892|NCT01782742|4446902|P2|Double-blind Treatment Phase|Adverse Event|0
1349893|NCT01782742|4446903|P1|Double-blind Treatment Phase|Adverse Event|1
1349894|NCT01782690|4446936|P1|Overall Study|Study completion unknown|7
1349895|NCT01782690|4446936|P1|Overall Study|Death|133
1349896|NCT01782690|4446936|P1|Overall Study|Tumor progression|74
1349897|NCT01782690|4446936|P1|Overall Study|Patient's wish|21
1349898|NCT01782690|4446936|P1|Overall Study|Physician Decision|13
1349899|NCT01782690|4446936|P1|Overall Study|Absent rash|9
1349900|NCT01782690|4446936|P1|Overall Study|Withdrawal of informed consent|2
1349901|NCT01782690|4446936|P1|Overall Study|Lost to Follow-up|31
1349902|NCT01782690|4446936|P1|Overall Study|Toxicity of erlotinib|1
1349903|NCT01782690|4446936|P1|Overall Study|Toxicity of gemcitabine|1
1349904|NCT01782690|4446936|P1|Overall Study|Not reported|7
1349905|NCT01782664|4446958|P6|Overall Study|Withdrawal by Subject|0
1349906|NCT01782664|4446959|P5|Overall Study|Withdrawal by Subject|0
1349907|NCT01782664|4446960|P4|Overall Study|Withdrawal by Subject|0
1349908|NCT01782664|4446961|P3|Overall Study|Withdrawal by Subject|0
1349909|NCT01782664|4446962|P2|Overall Study|Withdrawal by Subject|2
1349910|NCT01782664|4446963|P1|Overall Study|Withdrawal by Subject|2
1349911|NCT01782664|4446958|P6|Overall Study|Protocol Violation|0
1349912|NCT01782664|4446959|P5|Overall Study|Protocol Violation|0
1349913|NCT01782664|4446960|P4|Overall Study|Protocol Violation|1
1349914|NCT01782664|4446961|P3|Overall Study|Protocol Violation|0
1349915|NCT01782664|4446962|P2|Overall Study|Protocol Violation|1
1349916|NCT01782664|4446963|P1|Overall Study|Protocol Violation|0
1349917|NCT01782664|4446958|P6|Overall Study|Lack of Efficacy|0
1349918|NCT01782664|4446959|P5|Overall Study|Lack of Efficacy|0
1349919|NCT01782664|4446960|P4|Overall Study|Lack of Efficacy|2
1349920|NCT01782664|4446961|P3|Overall Study|Lack of Efficacy|2
1349921|NCT01782664|4446962|P2|Overall Study|Lack of Efficacy|0
1349922|NCT01782664|4446963|P1|Overall Study|Lack of Efficacy|2
1349923|NCT01782664|4446958|P6|Overall Study|Adverse Event|0
1349924|NCT01782664|4446959|P5|Overall Study|Adverse Event|0
1349925|NCT01782664|4446960|P4|Overall Study|Adverse Event|2
1349926|NCT01782664|4446961|P3|Overall Study|Adverse Event|2
1349927|NCT01782664|4446962|P2|Overall Study|Adverse Event|2
1349928|NCT01782664|4446963|P1|Overall Study|Adverse Event|2
1349929|NCT01782495|4447120|P11|Overall Study|Withdrew Consent|0
1349930|NCT01782495|4447121|P10|Overall Study|Withdrew Consent|0
1349931|NCT01782495|4447122|P9|Overall Study|Withdrew Consent|0
1349932|NCT01782495|4447123|P8|Overall Study|Withdrew Consent|1
1349933|NCT01782495|4447124|P7|Overall Study|Withdrew Consent|0
1349934|NCT01782495|4447125|P6|Overall Study|Withdrew Consent|0
1349935|NCT01782495|4447126|P5|Overall Study|Withdrew Consent|0
1349936|NCT01782495|4447127|P4|Overall Study|Withdrew Consent|0
1349937|NCT01782495|4447128|P3|Overall Study|Withdrew Consent|0
1349938|NCT01782495|4447129|P2|Overall Study|Withdrew Consent|1
1349939|NCT01782495|4447130|P1|Overall Study|Withdrew Consent|0
1349940|NCT01782495|4447120|P11|Overall Study|Adverse Event|0
1349941|NCT01782495|4447121|P10|Overall Study|Adverse Event|0
1349942|NCT01782495|4447122|P9|Overall Study|Adverse Event|0
1349943|NCT01782495|4447123|P8|Overall Study|Adverse Event|2
1349944|NCT01782495|4447124|P7|Overall Study|Adverse Event|0
1349945|NCT01782495|4447125|P6|Overall Study|Adverse Event|0
1349946|NCT01782495|4447126|P5|Overall Study|Adverse Event|0
1349947|NCT01782495|4447127|P4|Overall Study|Adverse Event|0
1349948|NCT01782495|4447128|P3|Overall Study|Adverse Event|0
1349949|NCT01782495|4447129|P2|Overall Study|Adverse Event|0
1349950|NCT01782495|4447130|P1|Overall Study|Adverse Event|0
1349951|NCT01782482|4447189|P2|Overall Study|Habitually wearing toric lens OS|1
1349952|NCT01782482|4447190|P1|Overall Study|Habitually wearing toric lens OS|0
1349953|NCT01782482|4447189|P2|Overall Study|Randomized in Error|2
1349954|NCT01782482|4447190|P1|Overall Study|Randomized in Error|2
1349955|NCT01782482|4447189|P2|Overall Study|Withdrawal by Subject|3
1349956|NCT01782482|4447190|P1|Overall Study|Withdrawal by Subject|2
1349957|NCT01782482|4447189|P2|Overall Study|Protocol Violation|0
1349958|NCT01782482|4447190|P1|Overall Study|Protocol Violation|1
1349959|NCT01782482|4447189|P2|Overall Study|Physician Decision|0
1349960|NCT01782482|4447190|P1|Overall Study|Physician Decision|1
1349961|NCT01782482|4447189|P2|Overall Study|Lost to Follow-up|3
1349962|NCT01782482|4447190|P1|Overall Study|Lost to Follow-up|2
1349963|NCT01782482|4447189|P2|Overall Study|Adverse Event|1
1349964|NCT01782482|4447190|P1|Overall Study|Adverse Event|2
1349965|NCT01782469|4447198|P1|Overall Study|Lost to Follow-up|1
1349966|NCT01782326|4447208|P2|Double-blind Treatment|Technical problems|5
1349967|NCT01782326|4447209|P1|Double-blind Treatment|Technical problems|0
1349968|NCT01782326|4447208|P2|Double-blind Treatment|Protocol deviation|7
1349969|NCT01782326|4447209|P1|Double-blind Treatment|Protocol deviation|8
1349970|NCT01782326|4447208|P2|Double-blind Treatment|Physician Decision|16
1349971|NCT01782326|4447209|P1|Double-blind Treatment|Physician Decision|13
1349972|NCT01782326|4447208|P2|Double-blind Treatment|Lack of Efficacy|22
1349973|NCT01782326|4447209|P1|Double-blind Treatment|Lack of Efficacy|17
1349974|NCT01782326|4447208|P2|Double-blind Treatment|Subject/guardian decision|125
1349975|NCT01782326|4447209|P1|Double-blind Treatment|Subject/guardian decision|111
1349976|NCT01782326|4447208|P2|Double-blind Treatment|Adverse Event|145
1349977|NCT01782326|4447209|P1|Double-blind Treatment|Adverse Event|129
1349978|NCT01782326|4447208|P2|Planned Treatment Epoch|Technical problems|4
1349979|NCT01782326|4447209|P1|Planned Treatment Epoch|Technical problems|0
1349980|NCT01782326|4447208|P2|Planned Treatment Epoch|Lost to Follow-up|4
1349981|NCT01782326|4447209|P1|Planned Treatment Epoch|Lost to Follow-up|4
1349982|NCT01782326|4447208|P2|Planned Treatment Epoch|Protocol deviation|3
1349983|NCT01782326|4447209|P1|Planned Treatment Epoch|Protocol deviation|2
1349984|NCT01782326|4447208|P2|Planned Treatment Epoch|Physician Decision|16
1349985|NCT01782326|4447209|P1|Planned Treatment Epoch|Physician Decision|18
1349986|NCT01782326|4447208|P2|Planned Treatment Epoch|Death|30
1349987|NCT01782326|4447209|P1|Planned Treatment Epoch|Death|29
1349988|NCT01782326|4447208|P2|Planned Treatment Epoch|Subject/guardian decision|151
1349989|NCT01782326|4447209|P1|Planned Treatment Epoch|Subject/guardian decision|149
1349990|NCT01782313|4447269|P1|Survival Follow up|Lost to Follow-up|1
1349991|NCT01782313|4447269|P1|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
1349992|NCT01782313|4447269|P1|Continued Treatment After 16 Weeks|Progressive Disease|6
1349993|NCT01782313|4447269|P1|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
1349994|NCT01782313|4447269|P1|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
1349995|NCT01782313|4447269|P1|Treated Cycle 3|Progressive Disease|21
1349996|NCT01782313|4447269|P1|Reached First Response/Completed 2 Cycle|Progressive Disease|3
1349997|NCT01782313|4447269|P1|Reached First Response/Completed 2 Cycle|Adverse Event|3
1349998|NCT01782222|4447283|P3|Overall Study|Moved to other state|0
1349999|NCT01782222|4447284|P2|Overall Study|Moved to other state|1
1350000|NCT01782222|4447285|P1|Overall Study|Moved to other state|0
1350001|NCT01782222|4447283|P3|Overall Study|Withdrawal by Subject|1
1350002|NCT01782222|4447284|P2|Overall Study|Withdrawal by Subject|4
1350003|NCT01782222|4447285|P1|Overall Study|Withdrawal by Subject|1
1350004|NCT01782222|4447283|P3|Overall Study|Protocol Violation|0
1350005|NCT01782222|4447284|P2|Overall Study|Protocol Violation|0
1350006|NCT01782222|4447285|P1|Overall Study|Protocol Violation|1
1350007|NCT01782222|4447283|P3|Overall Study|Lack of Efficacy|0
1350008|NCT01782222|4447284|P2|Overall Study|Lack of Efficacy|1
1350009|NCT01782222|4447285|P1|Overall Study|Lack of Efficacy|2
1350010|NCT01782222|4447283|P3|Overall Study|Adverse Event|3
1350011|NCT01782222|4447284|P2|Overall Study|Adverse Event|5
1350012|NCT01782222|4447285|P1|Overall Study|Adverse Event|4
1350013|NCT01781975|4447319|P2|Overall Study|Withdrawal by Subject|1
1350014|NCT01781975|4447320|P1|Overall Study|Withdrawal by Subject|1
1350015|NCT01781975|4447319|P2|Overall Study|Death|0
1350016|NCT01781975|4447320|P1|Overall Study|Death|1
1350017|NCT01781962|4447326|P1|Overall Study|Other Miscellaneous Reasons|5
1350018|NCT01781832|4447332|P1|Overall Study|Withdrawal by Subject|1
1350019|NCT01781637|4447352|P2|Overall Study|Withdrawal by Subject|0
1350020|NCT01781637|4447353|P1|Overall Study|Withdrawal by Subject|1
1350021|NCT01781637|4447352|P2|Overall Study|Lack of Efficacy|6
1350022|NCT01781637|4447353|P1|Overall Study|Lack of Efficacy|2
1350023|NCT01781637|4447352|P2|Overall Study|Adverse Event|0
1350024|NCT01781637|4447353|P1|Overall Study|Adverse Event|1
1350025|NCT01781299|4447440|P2|Overall Study|Withdrawal by Subject|1
1350026|NCT01781299|4447441|P1|Overall Study|Withdrawal by Subject|0
1350027|NCT01781286|4447449|P6|Overall Study|Noncompliance|0
1350028|NCT01781286|4447450|P5|Overall Study|Noncompliance|0
1350029|NCT01781286|4447451|P4|Overall Study|Noncompliance|1
1350030|NCT01781286|4447452|P3|Overall Study|Noncompliance|0
1350031|NCT01781286|4447453|P2|Overall Study|Noncompliance|0
1350032|NCT01781286|4447454|P1|Overall Study|Noncompliance|0
1350033|NCT01781286|4447449|P6|Overall Study|Time Constraints|0
1350034|NCT01781286|4447450|P5|Overall Study|Time Constraints|0
1350035|NCT01781286|4447451|P4|Overall Study|Time Constraints|0
1350036|NCT01781286|4447452|P3|Overall Study|Time Constraints|2
1350037|NCT01781286|4447453|P2|Overall Study|Time Constraints|0
1350038|NCT01781286|4447454|P1|Overall Study|Time Constraints|2
1350039|NCT01781286|4447449|P6|Overall Study|Lost to Follow-up|1
1350040|NCT01781286|4447450|P5|Overall Study|Lost to Follow-up|0
1350041|NCT01781286|4447451|P4|Overall Study|Lost to Follow-up|0
1350042|NCT01781286|4447452|P3|Overall Study|Lost to Follow-up|0
1350043|NCT01781286|4447453|P2|Overall Study|Lost to Follow-up|0
1350044|NCT01781286|4447454|P1|Overall Study|Lost to Follow-up|0
1350045|NCT01781026|4447505|P1|Overall Study|Lack of Efficacy|2
1350046|NCT01780987|4447511|P2|Overall Study|Not Receiving any Study Medication|1
1350047|NCT01780987|4447512|P1|Overall Study|Not Receiving any Study Medication|0
1350048|NCT01780987|4447511|P2|Overall Study|Changing Residence|0
1350049|NCT01780987|4447512|P1|Overall Study|Changing Residence|1
1350050|NCT01780987|4447511|P2|Overall Study|Request of Changing Hospital|1
1350051|NCT01780987|4447512|P1|Overall Study|Request of Changing Hospital|0
1350052|NCT01780987|4447511|P2|Overall Study|Withdrawal by Subject|0
1350053|NCT01780987|4447512|P1|Overall Study|Withdrawal by Subject|2
1350054|NCT01780987|4447511|P2|Overall Study|Adverse Event|4
1350055|NCT01780987|4447512|P1|Overall Study|Adverse Event|0
1350056|NCT01780974|4447530|P2|Overall Study|Adverse Event|3
1350057|NCT01780974|4447531|P1|Overall Study|Adverse Event|1
1350058|NCT01780974|4447530|P2|Overall Study|Death|0
1350059|NCT01780974|4447531|P1|Overall Study|Death|1
1350060|NCT01780935|4447541|P2|Overall Study|Patient withdrew consent|9
1350061|NCT01780935|4447542|P1|Overall Study|Patient withdrew consent|8
1350062|NCT01780935|4447541|P2|Overall Study|Protocol deviation|1
1350063|NCT01780935|4447542|P1|Overall Study|Protocol deviation|0
1350064|NCT01780935|4447541|P2|Overall Study|Physician Decision|1
1350065|NCT01780935|4447542|P1|Overall Study|Physician Decision|1
1350066|NCT01780935|4447541|P2|Overall Study|Lost to Follow-up|6
1350067|NCT01780935|4447542|P1|Overall Study|Lost to Follow-up|2
1350068|NCT01780935|4447541|P2|Overall Study|Death|6
1350069|NCT01780935|4447542|P1|Overall Study|Death|1
1350070|NCT01780935|4447541|P2|Overall Study|Adverse Event|4
1350071|NCT01780935|4447542|P1|Overall Study|Adverse Event|2
1350072|NCT01780935|4447541|P2|Overall Study|Admin problems due to early termination|309
1350073|NCT01780935|4447542|P1|Overall Study|Admin problems due to early termination|321
1350074|NCT01780584|4447646|P3|Overall Study|Protocol Violation|1
1350075|NCT01780584|4447647|P2|Overall Study|Protocol Violation|0
1350076|NCT01780584|4447648|P1|Overall Study|Protocol Violation|0
1350077|NCT01780584|4447646|P3|Overall Study|Adverse Event|0
1350078|NCT01780584|4447647|P2|Overall Study|Adverse Event|1
1350079|NCT01780584|4447648|P1|Overall Study|Adverse Event|0
1350080|NCT01780584|4447646|P3|Overall Study|Death|1
1350081|NCT01780584|4447647|P2|Overall Study|Death|0
1350082|NCT01780584|4447648|P1|Overall Study|Death|1
1350083|NCT01780545|4447670|P2|Overall Study|Lost to Follow-up|1
1350084|NCT01780545|4447671|P1|Overall Study|Lost to Follow-up|1
1350085|NCT01780545|4447670|P2|Overall Study|Withdrawal by Subject|1
1350086|NCT01780545|4447671|P1|Overall Study|Withdrawal by Subject|3
1350087|NCT01780506|4447689|P2|Overall Study|Still on Study|388
1350088|NCT01780506|4447690|P1|Overall Study|Still on Study|401
1350089|NCT01780506|4447689|P2|Overall Study|Lost to Follow-up|14
1350090|NCT01780506|4447690|P1|Overall Study|Lost to Follow-up|10
1350091|NCT01780506|4447689|P2|Overall Study|Withdrew Consent|15
1350092|NCT01780506|4447690|P1|Overall Study|Withdrew Consent|13
1350093|NCT01780506|4447689|P2|Overall Study|Protocol Violation|3
1350094|NCT01780506|4447690|P1|Overall Study|Protocol Violation|3
1350095|NCT01780506|4447689|P2|Overall Study|Non-Compliance with Study Drug|1
1350096|NCT01780506|4447690|P1|Overall Study|Non-Compliance with Study Drug|1
1350097|NCT01780506|4447689|P2|Overall Study|Investigator's Discretion|1
1350098|NCT01780506|4447690|P1|Overall Study|Investigator's Discretion|2
1350099|NCT01780506|4447689|P2|Overall Study|Lack of Efficacy|1
1350100|NCT01780506|4447690|P1|Overall Study|Lack of Efficacy|1
1350101|NCT01780506|4447689|P2|Overall Study|Pregnancy|0
1350102|NCT01780506|4447690|P1|Overall Study|Pregnancy|1
1350103|NCT01780506|4447689|P2|Overall Study|Death|1
1350104|NCT01780506|4447690|P1|Overall Study|Death|0
1350105|NCT01780506|4447689|P2|Overall Study|Adverse Event|8
1350106|NCT01780506|4447690|P1|Overall Study|Adverse Event|3
1350107|NCT01780506|4447689|P2|Overall Study|Randomized but not Treated|2
1350108|NCT01780506|4447690|P1|Overall Study|Randomized but not Treated|3
1350109|NCT01780389|4447728|P1|Overall Study|Adverse Event|1
1350110|NCT01779869|4447766|P1|Overall Study|Physician Decision|2
1350111|NCT01779648|4447772|P2|Overall Study|Protocol Violation|0
1350112|NCT01779648|4447773|P1|Overall Study|Protocol Violation|1
1350113|NCT01779440|4447803|P2|Overall Study|Withdrawal by Subject|5
1350114|NCT01779440|4447804|P1|Overall Study|Withdrawal by Subject|3
1350115|NCT01778985|4447845|P2|Overall Study|Protocol Violation|1
1350116|NCT01778985|4447846|P1|Overall Study|Protocol Violation|4
1350117|NCT01778985|4447845|P2|Overall Study|Physician Decision|2
1350118|NCT01778985|4447846|P1|Overall Study|Physician Decision|2
1350119|NCT01778985|4447845|P2|Overall Study|Lost to Follow-up|0
1350120|NCT01778985|4447846|P1|Overall Study|Lost to Follow-up|1
1350121|NCT01778855|4447892|P2|Overall Study|Death|1
1350122|NCT01778855|4447893|P1|Overall Study|Death|0
1350123|NCT01778751|4447901|P2|Overall Study|Transfered care|0
1350124|NCT01778751|4447902|P1|Overall Study|Transfered care|1
1350125|NCT01778751|4447901|P2|Overall Study|Withdrawal by Subject|2
1350126|NCT01778751|4447902|P1|Overall Study|Withdrawal by Subject|0
1350127|NCT01778751|4447901|P2|Overall Study|Lost to Follow-up|0
1350128|NCT01778751|4447902|P1|Overall Study|Lost to Follow-up|1
1350129|NCT01778530|4447953|P1|Overall Study|Adverse event/side effect|1
1350130|NCT01778530|4447953|P1|Overall Study|Progression on study|1
1350131|NCT01778127|4447965|P3|Overall Study|Withdrawal by Subject|4
1350132|NCT01778127|4447966|P2|Overall Study|Withdrawal by Subject|1
1350133|NCT01778127|4447967|P1|Overall Study|Withdrawal by Subject|3
1350134|NCT01778127|4447965|P3|Overall Study|Lost to Follow-up|2
1350135|NCT01778127|4447966|P2|Overall Study|Lost to Follow-up|1
1350136|NCT01778127|4447967|P1|Overall Study|Lost to Follow-up|5
1350137|NCT01778062|4448010|P2|Overall Study|major protocol deviation|3
1350138|NCT01778062|4448011|P1|Overall Study|major protocol deviation|4
1350139|NCT01778062|4448010|P2|Overall Study|Consent Withdrawal|5
1350140|NCT01778062|4448011|P1|Overall Study|Consent Withdrawal|1
1350141|NCT01778062|4448010|P2|Overall Study|Adverse Event|3
1350142|NCT01778062|4448011|P1|Overall Study|Adverse Event|1
1350143|NCT01778049|4448025|P6|Double Blind Treatment Period|Other reason not defined above|1
1350144|NCT01778049|4448026|P5|Double Blind Treatment Period|Other reason not defined above|2
1350145|NCT01778049|4448027|P4|Double Blind Treatment Period|Other reason not defined above|2
1350146|NCT01778049|4448028|P3|Double Blind Treatment Period|Other reason not defined above|4
1350147|NCT01778049|4448029|P2|Double Blind Treatment Period|Other reason not defined above|0
1350148|NCT01778049|4448030|P1|Double Blind Treatment Period|Other reason not defined above|0
1350149|NCT01778049|4448025|P6|Double Blind Treatment Period|Not treated|0
1350150|NCT01778049|4448026|P5|Double Blind Treatment Period|Not treated|2
1350151|NCT01778049|4448027|P4|Double Blind Treatment Period|Not treated|2
1350152|NCT01778049|4448028|P3|Double Blind Treatment Period|Not treated|0
1350153|NCT01778049|4448029|P2|Double Blind Treatment Period|Not treated|0
1350154|NCT01778049|4448030|P1|Double Blind Treatment Period|Not treated|0
1350155|NCT01778049|4448025|P6|Double Blind Treatment Period|Withdrawal by Subject|1
1350156|NCT01778049|4448026|P5|Double Blind Treatment Period|Withdrawal by Subject|0
1350157|NCT01778049|4448027|P4|Double Blind Treatment Period|Withdrawal by Subject|2
1350158|NCT01778049|4448028|P3|Double Blind Treatment Period|Withdrawal by Subject|1
1350159|NCT01778049|4448029|P2|Double Blind Treatment Period|Withdrawal by Subject|0
1350160|NCT01778049|4448030|P1|Double Blind Treatment Period|Withdrawal by Subject|0
1350161|NCT01778049|4448025|P6|Double Blind Treatment Period|Lost to Follow-up|2
1350162|NCT01778049|4448026|P5|Double Blind Treatment Period|Lost to Follow-up|5
1350163|NCT01778049|4448027|P4|Double Blind Treatment Period|Lost to Follow-up|1
1350164|NCT01778049|4448028|P3|Double Blind Treatment Period|Lost to Follow-up|4
1350165|NCT01778049|4448029|P2|Double Blind Treatment Period|Lost to Follow-up|0
1350166|NCT01778049|4448030|P1|Double Blind Treatment Period|Lost to Follow-up|0
1350167|NCT01778049|4448025|P6|Double Blind Treatment Period|Protocol Violation|0
1350168|NCT01778049|4448026|P5|Double Blind Treatment Period|Protocol Violation|0
1350169|NCT01778049|4448027|P4|Double Blind Treatment Period|Protocol Violation|0
1350170|NCT01778049|4448028|P3|Double Blind Treatment Period|Protocol Violation|2
1350171|NCT01778049|4448029|P2|Double Blind Treatment Period|Protocol Violation|0
1350172|NCT01778049|4448030|P1|Double Blind Treatment Period|Protocol Violation|0
1350173|NCT01778049|4448025|P6|Double Blind Treatment Period|Lack of Efficacy|1
1350174|NCT01778049|4448026|P5|Double Blind Treatment Period|Lack of Efficacy|0
1350175|NCT01778049|4448027|P4|Double Blind Treatment Period|Lack of Efficacy|0
1350176|NCT01778049|4448028|P3|Double Blind Treatment Period|Lack of Efficacy|0
1350177|NCT01778049|4448029|P2|Double Blind Treatment Period|Lack of Efficacy|0
1350178|NCT01778049|4448030|P1|Double Blind Treatment Period|Lack of Efficacy|0
1350179|NCT01778049|4448025|P6|Double Blind Treatment Period|Adverse Event|2
1350180|NCT01778049|4448026|P5|Double Blind Treatment Period|Adverse Event|3
1350181|NCT01778049|4448027|P4|Double Blind Treatment Period|Adverse Event|5
1350182|NCT01778049|4448028|P3|Double Blind Treatment Period|Adverse Event|4
1350183|NCT01778049|4448029|P2|Double Blind Treatment Period|Adverse Event|0
1350184|NCT01778049|4448030|P1|Double Blind Treatment Period|Adverse Event|0
1350185|NCT01778049|4448025|P6|Open Label Treatment Period|Other reason not defined above|0
1350186|NCT01778049|4448026|P5|Open Label Treatment Period|Other reason not defined above|0
1350187|NCT01778049|4448027|P4|Open Label Treatment Period|Other reason not defined above|0
1350188|NCT01778049|4448028|P3|Open Label Treatment Period|Other reason not defined above|0
1350189|NCT01778049|4448029|P2|Open Label Treatment Period|Other reason not defined above|94
1350190|NCT01778049|4448030|P1|Open Label Treatment Period|Other reason not defined above|77
1350191|NCT01778049|4448025|P6|Open Label Treatment Period|Not treated|0
1350192|NCT01778049|4448026|P5|Open Label Treatment Period|Not treated|0
1350193|NCT01778049|4448027|P4|Open Label Treatment Period|Not treated|0
1350194|NCT01778049|4448028|P3|Open Label Treatment Period|Not treated|0
1350195|NCT01778049|4448029|P2|Open Label Treatment Period|Not treated|1
1350196|NCT01778049|4448030|P1|Open Label Treatment Period|Not treated|2
1350197|NCT01778049|4448025|P6|Open Label Treatment Period|Withdrawal by Subject|0
1350198|NCT01778049|4448026|P5|Open Label Treatment Period|Withdrawal by Subject|0
1350199|NCT01778049|4448027|P4|Open Label Treatment Period|Withdrawal by Subject|0
1350200|NCT01778049|4448028|P3|Open Label Treatment Period|Withdrawal by Subject|0
1350201|NCT01778049|4448029|P2|Open Label Treatment Period|Withdrawal by Subject|10
1350202|NCT01778049|4448030|P1|Open Label Treatment Period|Withdrawal by Subject|4
1350203|NCT01778049|4448025|P6|Open Label Treatment Period|Lost to Follow-up|0
1350204|NCT01778049|4448026|P5|Open Label Treatment Period|Lost to Follow-up|0
1350205|NCT01778049|4448027|P4|Open Label Treatment Period|Lost to Follow-up|0
1350206|NCT01778049|4448028|P3|Open Label Treatment Period|Lost to Follow-up|0
1350207|NCT01778049|4448029|P2|Open Label Treatment Period|Lost to Follow-up|3
1350208|NCT01778049|4448030|P1|Open Label Treatment Period|Lost to Follow-up|4
1350209|NCT01778049|4448025|P6|Open Label Treatment Period|Protocol Violation|0
1350210|NCT01778049|4448026|P5|Open Label Treatment Period|Protocol Violation|0
1350211|NCT01778049|4448027|P4|Open Label Treatment Period|Protocol Violation|0
1350212|NCT01778049|4448028|P3|Open Label Treatment Period|Protocol Violation|0
1350213|NCT01778049|4448029|P2|Open Label Treatment Period|Protocol Violation|5
1350214|NCT01778049|4448030|P1|Open Label Treatment Period|Protocol Violation|5
1350215|NCT01778049|4448025|P6|Open Label Treatment Period|Lack of Efficacy|0
1350216|NCT01778049|4448026|P5|Open Label Treatment Period|Lack of Efficacy|0
1350217|NCT01778049|4448027|P4|Open Label Treatment Period|Lack of Efficacy|0
1350218|NCT01778049|4448028|P3|Open Label Treatment Period|Lack of Efficacy|0
1350219|NCT01778049|4448029|P2|Open Label Treatment Period|Lack of Efficacy|1
1350220|NCT01778049|4448030|P1|Open Label Treatment Period|Lack of Efficacy|1
1350221|NCT01778049|4448025|P6|Open Label Treatment Period|Adverse Event|0
1350222|NCT01778049|4448026|P5|Open Label Treatment Period|Adverse Event|0
1350223|NCT01778049|4448027|P4|Open Label Treatment Period|Adverse Event|0
1350224|NCT01778049|4448028|P3|Open Label Treatment Period|Adverse Event|0
1350225|NCT01778049|4448029|P2|Open Label Treatment Period|Adverse Event|15
1350226|NCT01778049|4448030|P1|Open Label Treatment Period|Adverse Event|5
1350227|NCT01778023|4448048|P2|Overall Study|Withdrawal by Subject|3
1350228|NCT01778023|4448049|P1|Overall Study|Withdrawal by Subject|0
1350229|NCT01778010|4448066|P1|Overall Study|rash while on placebo|1
1350230|NCT01778010|4448066|P1|Overall Study|Arrested|1
1350231|NCT01778010|4448066|P1|Overall Study|abnormal ECG before meds|1
1350232|NCT01778010|4448066|P1|Overall Study|Withdrawal by Subject|2
1350233|NCT01777997|4448107|P1|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
1350234|NCT01777997|4448107|P1|Weeks 48 to 72/96 on ART|Death|1
1350235|NCT01777997|4448107|P1|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
1350236|NCT01777997|4448107|P1|12 Week lead-in of no ART|Severe debilitation|2
1350237|NCT01777932|4448129|P1|Overall Study|Patient refused further treatment|10
1350238|NCT01777932|4448129|P1|Overall Study|Reimbursement limit|9
1350239|NCT01777932|4448129|P1|Overall Study|Investigator decision|10
1350240|NCT01777932|4448129|P1|Overall Study|Lost to Follow-up|3
1350241|NCT01777932|4448129|P1|Overall Study|Adverse Event|34
1350242|NCT01777932|4448129|P1|Overall Study|Death|3
1350243|NCT01777932|4448129|P1|Overall Study|Disease progression|136
1350244|NCT01777776|4448147|P4|Overall Study|Withdrawal by Subject|1
1350245|NCT01777776|4448148|P3|Overall Study|Withdrawal by Subject|0
1350246|NCT01777776|4448149|P2|Overall Study|Withdrawal by Subject|0
1350247|NCT01777776|4448150|P1|Overall Study|Withdrawal by Subject|0
1350248|NCT01777776|4448147|P4|Overall Study|Disease Progression|3
1350249|NCT01777776|4448148|P3|Overall Study|Disease Progression|6
1350250|NCT01777776|4448149|P2|Overall Study|Disease Progression|8
1350251|NCT01777776|4448150|P1|Overall Study|Disease Progression|4
1350252|NCT01777776|4448147|P4|Overall Study|Adverse Event|0
1350253|NCT01777776|4448148|P3|Overall Study|Adverse Event|0
1350254|NCT01777776|4448149|P2|Overall Study|Adverse Event|4
1350255|NCT01777776|4448150|P1|Overall Study|Adverse Event|2
1350256|NCT01777763|4448209|P2|Overall Study|Treatment Failure|6
1350257|NCT01777763|4448210|P1|Overall Study|Treatment Failure|1
1350258|NCT01777763|4448209|P2|Overall Study|Withdrawal by Subject|2
1350259|NCT01777763|4448210|P1|Overall Study|Withdrawal by Subject|0
1350260|NCT01777763|4448209|P2|Overall Study|Protocol Violation|7
1350261|NCT01777763|4448210|P1|Overall Study|Protocol Violation|1
1350262|NCT01777763|4448209|P2|Overall Study|Adverse Event|32
1350263|NCT01777763|4448210|P1|Overall Study|Adverse Event|2
1350264|NCT01777620|4448234|P2|Overall Study|Subject Withdrawal|0
1350265|NCT01777620|4448235|P1|Overall Study|Subject Withdrawal|1
1350266|NCT01777581|4448261|P2|Overall Study|Lack of Efficacy|1
1350267|NCT01777581|4448262|P1|Overall Study|Lack of Efficacy|0
1350268|NCT01777581|4448261|P2|Overall Study|Adverse Event|0
1350269|NCT01777581|4448262|P1|Overall Study|Adverse Event|2
1350270|NCT01777581|4448261|P2|Overall Study|Lost to Follow-up|1
1350271|NCT01777581|4448262|P1|Overall Study|Lost to Follow-up|1
1350272|NCT01777542|4448280|P2|Second Intervention (20 Weeks)|Adverse Event|1
1350273|NCT01777542|4448281|P1|Second Intervention (20 Weeks)|Adverse Event|0
1350274|NCT01777334|4448349|P2|Overall Study|Withdrawal by Subject|11
1350275|NCT01777334|4448350|P1|Overall Study|Withdrawal by Subject|14
1350276|NCT01777334|4448349|P2|Overall Study|Lost to Follow-up|2
1350277|NCT01777334|4448350|P1|Overall Study|Lost to Follow-up|3
1350278|NCT01777334|4448349|P2|Overall Study|Protocol Violation|7
1350279|NCT01777334|4448350|P1|Overall Study|Protocol Violation|3
1350280|NCT01777334|4448349|P2|Overall Study|Lack of Efficacy|29
1350281|NCT01777334|4448350|P1|Overall Study|Lack of Efficacy|15
1350282|NCT01777334|4448349|P2|Overall Study|Adverse Event|14
1350283|NCT01777334|4448350|P1|Overall Study|Adverse Event|18
1350284|NCT01777321|4448360|P2|Overall Study|Withdrawal by Subject|1
1350285|NCT01777321|4448361|P1|Overall Study|Withdrawal by Subject|0
1350286|NCT01777282|4448402|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
1350287|NCT01777282|4448403|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
1350288|NCT01777282|4448404|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
1350289|NCT01777282|4448405|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
1350290|NCT01777282|4448406|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
1350291|NCT01777282|4448402|P5|Overall Study|Protocol Violation|2
1350292|NCT01777282|4448403|P4|Overall Study|Protocol Violation|0
1350293|NCT01777282|4448404|P3|Overall Study|Protocol Violation|1
1350294|NCT01777282|4448405|P2|Overall Study|Protocol Violation|0
1350295|NCT01777282|4448406|P1|Overall Study|Protocol Violation|2
1350296|NCT01777282|4448402|P5|Overall Study|Withdrawal by Subject|2
1350297|NCT01777282|4448403|P4|Overall Study|Withdrawal by Subject|1
1350298|NCT01777282|4448404|P3|Overall Study|Withdrawal by Subject|0
1350299|NCT01777282|4448405|P2|Overall Study|Withdrawal by Subject|0
1350300|NCT01777282|4448406|P1|Overall Study|Withdrawal by Subject|4
1350301|NCT01777282|4448402|P5|Overall Study|Adverse Event|3
1350302|NCT01777282|4448403|P4|Overall Study|Adverse Event|1
1350303|NCT01777282|4448404|P3|Overall Study|Adverse Event|2
1350304|NCT01777282|4448405|P2|Overall Study|Adverse Event|4
1350305|NCT01777282|4448406|P1|Overall Study|Adverse Event|4
1350306|NCT01777282|4448402|P5|Overall Study|New Antidiabetic Medication|0
1350307|NCT01777282|4448403|P4|Overall Study|New Antidiabetic Medication|0
1350308|NCT01777282|4448404|P3|Overall Study|New Antidiabetic Medication|1
1350309|NCT01777282|4448405|P2|Overall Study|New Antidiabetic Medication|0
1350310|NCT01777282|4448406|P1|Overall Study|New Antidiabetic Medication|0
1350311|NCT01777282|4448402|P5|Overall Study|Persistent Hyperglycemia|0
1350312|NCT01777282|4448403|P4|Overall Study|Persistent Hyperglycemia|0
1350313|NCT01777282|4448404|P3|Overall Study|Persistent Hyperglycemia|1
1350314|NCT01777282|4448405|P2|Overall Study|Persistent Hyperglycemia|0
1350315|NCT01777282|4448406|P1|Overall Study|Persistent Hyperglycemia|0
1350316|NCT01777269|4448450|P2|Overall Study|Withdrawal by Subject|9
1350317|NCT01777269|4448451|P1|Overall Study|Withdrawal by Subject|9
1350318|NCT01777269|4448450|P2|Overall Study|Physician Decision|2
1350319|NCT01777269|4448451|P1|Overall Study|Physician Decision|5
1350320|NCT01777269|4448450|P2|Overall Study|Lost to Follow-up|0
1350321|NCT01777269|4448451|P1|Overall Study|Lost to Follow-up|4
1350322|NCT01777269|4448450|P2|Overall Study|Participants reached stopping criteria|1
1350323|NCT01777269|4448451|P1|Overall Study|Participants reached stopping criteria|1
1350324|NCT01777269|4448450|P2|Overall Study|Protocol Violation|4
1350325|NCT01777269|4448451|P1|Overall Study|Protocol Violation|4
1350326|NCT01777269|4448450|P2|Overall Study|Lack of Efficacy|10
1350327|NCT01777269|4448451|P1|Overall Study|Lack of Efficacy|8
1350328|NCT01777269|4448450|P2|Overall Study|Adverse Event|33
1350329|NCT01777269|4448451|P1|Overall Study|Adverse Event|24
1350330|NCT01777191|4448488|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
1350331|NCT01777191|4448489|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
1350332|NCT01777191|4448488|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
1350333|NCT01777191|4448489|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
1350334|NCT01777191|4448488|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
1350335|NCT01777191|4448489|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
1350336|NCT01777191|4448488|P2|Safety Extension Per (Week 12-Week 48)|Death|1
1350337|NCT01777191|4448489|P1|Safety Extension Per (Week 12-Week 48)|Death|0
1350338|NCT01777191|4448488|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
1350339|NCT01777191|4448489|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
1350340|NCT01777191|4448488|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
1350341|NCT01777191|4448489|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
1350342|NCT01777191|4448488|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
1350343|NCT01777191|4448489|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
1350344|NCT01777191|4448488|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
1350345|NCT01777191|4448489|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
1350346|NCT01777191|4448488|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
1350347|NCT01777191|4448489|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
1350348|NCT01777191|4448488|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
1350349|NCT01777191|4448489|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
1350350|NCT01777191|4448488|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
1350351|NCT01777191|4448489|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
1350352|NCT01776554|4448552|P2|Overall Study|Unclassified|1
1350353|NCT01776554|4448553|P1|Overall Study|Unclassified|4
1350354|NCT01776554|4448552|P2|Overall Study|Protocol Violation|0
1350355|NCT01776554|4448553|P1|Overall Study|Protocol Violation|1
1350356|NCT01776554|4448552|P2|Overall Study|Administrative Reason|5
1350357|NCT01776554|4448553|P1|Overall Study|Administrative Reason|2
1350358|NCT01776554|4448552|P2|Overall Study|Lost to Follow-up|9
1350359|NCT01776554|4448553|P1|Overall Study|Lost to Follow-up|6
1350360|NCT01776554|4448552|P2|Overall Study|Withdrawal by Subject|8
1350361|NCT01776554|4448553|P1|Overall Study|Withdrawal by Subject|3
1350362|NCT01776554|4448552|P2|Overall Study|Adverse Event|0
1350363|NCT01776554|4448553|P1|Overall Study|Adverse Event|1
1350364|NCT01776541|4448596|P2|Overall Study|Withdrawal by Subject|20
1350365|NCT01776541|4448597|P1|Overall Study|Withdrawal by Subject|12
1350366|NCT01776541|4448596|P2|Overall Study|Protocol Violation|1
1350367|NCT01776541|4448597|P1|Overall Study|Protocol Violation|2
1350368|NCT01776541|4448596|P2|Overall Study|Unclassified|4
1350369|NCT01776541|4448597|P1|Overall Study|Unclassified|5
1350370|NCT01776541|4448596|P2|Overall Study|Lost to Follow-up|48
1350371|NCT01776541|4448597|P1|Overall Study|Lost to Follow-up|27
1350372|NCT01776541|4448596|P2|Overall Study|Death|0
1350373|NCT01776541|4448597|P1|Overall Study|Death|4
1350374|NCT01776541|4448596|P2|Overall Study|Administrative Reason|2
1350375|NCT01776541|4448597|P1|Overall Study|Administrative Reason|6
1350376|NCT01776008|4448627|P1|Overall Study|ineligible|2
1350377|NCT01775995|4448641|P2|Overall Study|Lost to Follow-up|1
1350378|NCT01775995|4448642|P1|Overall Study|Lost to Follow-up|1
1350379|NCT01775787|4448736|P2|Second 7-10 Days|concerns with using IV|1
1350380|NCT01775787|4448737|P1|Second 7-10 Days|concerns with using IV|0
1350381|NCT01775787|4448736|P2|Second 7-10 Days|time commitment|1
1350382|NCT01775787|4448737|P1|Second 7-10 Days|time commitment|0
1350383|NCT01775787|4448736|P2|First 7-10 Days|concerns with using IV|2
1350384|NCT01775787|4448737|P1|First 7-10 Days|concerns with using IV|1
1350385|NCT01775787|4448736|P2|First 7-10 Days|time commitment|2
1350386|NCT01775787|4448737|P1|First 7-10 Days|time commitment|0
1350387|NCT01775787|4448736|P2|First 7-10 Days|family emergency|1
1350388|NCT01775787|4448737|P1|First 7-10 Days|family emergency|0
1350389|NCT01775787|4448736|P2|First 7-10 Days|Adverse Event|1
1350390|NCT01775787|4448737|P1|First 7-10 Days|Adverse Event|0
1350391|NCT01775670|4448784|P2|Overall Study|Lost to Follow-up|1
1350392|NCT01775670|4448785|P1|Overall Study|Lost to Follow-up|1
1350393|NCT01775553|4448811|P1|Overall Study|Disease Progression|12
1350394|NCT01775553|4448811|P1|Overall Study|Adverse Event|1
1350395|NCT01775189|4448819|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
1350396|NCT01775189|4448820|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
1350397|NCT01775189|4448821|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
1350398|NCT01775189|4448822|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
1350399|NCT01775189|4448823|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
1350400|NCT01775189|4448824|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
1350401|NCT01775189|4448825|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
1350402|NCT01775189|4448819|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
1350403|NCT01775189|4448820|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
1350404|NCT01775189|4448821|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
1350405|NCT01775189|4448822|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
1350406|NCT01775189|4448823|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
1350407|NCT01775189|4448824|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
1350408|NCT01775189|4448825|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
1350409|NCT01775189|4448819|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
1350410|NCT01775189|4448820|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
1350411|NCT01775189|4448821|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
1350412|NCT01775189|4448822|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
1350413|NCT01775189|4448823|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
1350414|NCT01775189|4448824|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
1350415|NCT01775189|4448825|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
1350416|NCT01775189|4448819|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1350417|NCT01775189|4448820|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1350418|NCT01775189|4448821|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1350419|NCT01775189|4448822|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1350420|NCT01775189|4448823|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
1350421|NCT01775189|4448824|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
1350422|NCT01775189|4448825|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1350423|NCT01775189|4448819|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
1350424|NCT01775189|4448820|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
1350425|NCT01775189|4448821|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
1350426|NCT01775189|4448822|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
1350427|NCT01775189|4448823|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
1350428|NCT01775189|4448824|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
1350429|NCT01775189|4448825|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
1350430|NCT01775189|4448819|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
1350431|NCT01775189|4448820|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
1350432|NCT01775189|4448821|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
1350433|NCT01775189|4448822|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
1350434|NCT01775189|4448823|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
1350435|NCT01775189|4448824|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
1350436|NCT01775189|4448825|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
1350437|NCT01775137|4449044|P1|Overall Study|Withdrawal by participants|5
1350438|NCT01775137|4449044|P1|Overall Study|Adverse Event|1
1350439|NCT01775137|4449044|P1|Overall Study|Unsatisfactory therapeutic effect|2
1350440|NCT01775137|4449044|P1|Overall Study|Protocol deviation|2
1350441|NCT01775137|4449044|P1|Overall Study|Death|1
1350442|NCT01775124|4449071|P2|Extension Period|Withdrawal by Subject|12
1350443|NCT01775124|4449072|P1|Extension Period|Withdrawal by Subject|9
1350444|NCT01775124|4449071|P2|Extension Period|Lost to Follow-up|1
1350445|NCT01775124|4449072|P1|Extension Period|Lost to Follow-up|0
1350446|NCT01775124|4449071|P2|Extension Period|Administrative problems|1
1350447|NCT01775124|4449072|P1|Extension Period|Administrative problems|0
1350448|NCT01775124|4449071|P2|Extension Period|Physician Decision|2
1350449|NCT01775124|4449072|P1|Extension Period|Physician Decision|0
1350450|NCT01775124|4449071|P2|Extension Period|Adverse Event|2
1350451|NCT01775124|4449072|P1|Extension Period|Adverse Event|3
1350452|NCT01775124|4449071|P2|Core Period|Adverse Event|5
1350453|NCT01775124|4449072|P1|Core Period|Adverse Event|5
1350454|NCT01775124|4449071|P2|Core Period|Withdrawal by Subject|2
1350455|NCT01775124|4449072|P1|Core Period|Withdrawal by Subject|4
1350456|NCT01775124|4449071|P2|Core Period|Administrative problems|0
1350457|NCT01775124|4449072|P1|Core Period|Administrative problems|1
1350458|NCT01775124|4449071|P2|Core Period|Death|1
1350459|NCT01775124|4449072|P1|Core Period|Death|0
1350460|NCT01775124|4449071|P2|Core Period|Physician Decision|1
1350461|NCT01775124|4449072|P1|Core Period|Physician Decision|1
1350462|NCT01775124|4449071|P2|Core Period|Disease Progression|1
1350463|NCT01775124|4449072|P1|Core Period|Disease Progression|0
1350464|NCT01774981|4449107|P8|Overall Study|Death|0
1350465|NCT01774981|4449108|P7|Overall Study|Death|0
1350466|NCT01774981|4449109|P6|Overall Study|Death|0
1350467|NCT01774981|4449110|P5|Overall Study|Death|1
1350468|NCT01774981|4449111|P4|Overall Study|Death|0
1350469|NCT01774981|4449112|P3|Overall Study|Death|0
1350470|NCT01774981|4449113|P2|Overall Study|Death|0
1350471|NCT01774981|4449114|P1|Overall Study|Death|0
1350472|NCT01774981|4449107|P8|Overall Study|Withdrawal by Subject|1
1350473|NCT01774981|4449108|P7|Overall Study|Withdrawal by Subject|0
1350474|NCT01774981|4449109|P6|Overall Study|Withdrawal by Subject|0
1350475|NCT01774981|4449110|P5|Overall Study|Withdrawal by Subject|0
1350476|NCT01774981|4449111|P4|Overall Study|Withdrawal by Subject|0
1350477|NCT01774981|4449112|P3|Overall Study|Withdrawal by Subject|0
1350478|NCT01774981|4449113|P2|Overall Study|Withdrawal by Subject|0
1350479|NCT01774981|4449114|P1|Overall Study|Withdrawal by Subject|0
1350480|NCT01774981|4449107|P8|Overall Study|Adverse Event|0
1350481|NCT01774981|4449108|P7|Overall Study|Adverse Event|0
1350482|NCT01774981|4449109|P6|Overall Study|Adverse Event|1
1350483|NCT01774981|4449110|P5|Overall Study|Adverse Event|0
1350484|NCT01774981|4449111|P4|Overall Study|Adverse Event|0
1350485|NCT01774981|4449112|P3|Overall Study|Adverse Event|0
1350486|NCT01774981|4449113|P2|Overall Study|Adverse Event|0
1350487|NCT01774981|4449114|P1|Overall Study|Adverse Event|0
1350488|NCT01774968|4449146|P2|Overall Study|Withdrawal by Subject|11
1350489|NCT01774968|4449147|P1|Overall Study|Withdrawal by Subject|6
1350490|NCT01774968|4449146|P2|Overall Study|Sponsor Decision|2
1350491|NCT01774968|4449147|P1|Overall Study|Sponsor Decision|0
1350492|NCT01774968|4449146|P2|Overall Study|Protocol Violation|13
1350493|NCT01774968|4449147|P1|Overall Study|Protocol Violation|14
1350494|NCT01774968|4449146|P2|Overall Study|Physician Decision|1
1350495|NCT01774968|4449147|P1|Overall Study|Physician Decision|5
1350496|NCT01774968|4449146|P2|Overall Study|Lost to Follow-up|3
1350497|NCT01774968|4449147|P1|Overall Study|Lost to Follow-up|1
1350498|NCT01774968|4449146|P2|Overall Study|Death|1
1350499|NCT01774968|4449147|P1|Overall Study|Death|0
1350500|NCT01774968|4449146|P2|Overall Study|Adverse Event|4
1350501|NCT01774968|4449147|P1|Overall Study|Adverse Event|4
1350502|NCT01774929|4449181|P1|Overall Study|Adverse Event|3
1350503|NCT01774903|4449187|P1|Overall Study|Ineligible to continue the trial|1
1350504|NCT01774903|4449187|P1|Overall Study|Lack of Efficacy|1
1350505|NCT01774903|4449187|P1|Overall Study|Withdrawal by Subject|2
1350506|NCT01774903|4449187|P1|Overall Study|Adverse Event|7
1350507|NCT01774786|4449205|P2|Overall Study|Ineligible for Study|3
1350508|NCT01774786|4449206|P1|Overall Study|Ineligible for Study|1
1350509|NCT01774786|4449205|P2|Overall Study|Physician Decision|0
1350510|NCT01774786|4449206|P1|Overall Study|Physician Decision|1
1350511|NCT01774786|4449205|P2|Overall Study|Withdrawal by Subject|12
1350512|NCT01774786|4449206|P1|Overall Study|Withdrawal by Subject|15
1350513|NCT01774786|4449205|P2|Overall Study|Lost to Follow-up|4
1350514|NCT01774786|4449206|P1|Overall Study|Lost to Follow-up|3
1350515|NCT01774786|4449205|P2|Overall Study|Death|262
1350516|NCT01774786|4449206|P1|Overall Study|Death|242
1350517|NCT01774786|4449205|P2|Overall Study|In Follow-up|62
1350518|NCT01774786|4449206|P1|Overall Study|In Follow-up|65
1350519|NCT01774786|4449205|P2|Overall Study|Between Treatment and Follow-up|2
1350520|NCT01774786|4449206|P1|Overall Study|Between Treatment and Follow-up|6
1350521|NCT01774786|4449205|P2|Overall Study|On Treatment|47
1350522|NCT01774786|4449206|P1|Overall Study|On Treatment|55
1350523|NCT01774591|4449257|P2|Overall Study|Adverse Event|2
1350524|NCT01774591|4449258|P1|Overall Study|Adverse Event|0
1350525|NCT01774591|4449257|P2|Overall Study|Withdrawal by Subject|1
1350526|NCT01774591|4449258|P1|Overall Study|Withdrawal by Subject|0
1350527|NCT01774591|4449257|P2|Overall Study|Physician Decision|1
1350528|NCT01774591|4449258|P1|Overall Study|Physician Decision|1
1350529|NCT01774344|4449270|P2|Overall Study|Non-compliance with study drug|2
1350530|NCT01774344|4449271|P1|Overall Study|Non-compliance with study drug|0
1350531|NCT01774344|4449270|P2|Overall Study|Physician Decision|1
1350532|NCT01774344|4449271|P1|Overall Study|Physician Decision|0
1350533|NCT01774344|4449270|P2|Overall Study|Adverse event (AE)|1
1350534|NCT01774344|4449271|P1|Overall Study|Adverse event (AE)|0
1350535|NCT01774344|4449270|P2|Overall Study|AE not related to disease progression|47
1350536|NCT01774344|4449271|P1|Overall Study|AE not related to disease progression|12
1350537|NCT01774344|4449270|P2|Overall Study|Ongoing with treatment|65
1350538|NCT01774344|4449271|P1|Overall Study|Ongoing with treatment|10
1350539|NCT01774344|4449270|P2|Overall Study|Other|0
1350540|NCT01774344|4449271|P1|Overall Study|Other|1
1350541|NCT01774344|4449270|P2|Overall Study|Study drug never administered|5
1350542|NCT01774344|4449271|P1|Overall Study|Study drug never administered|1
1350543|NCT01774344|4449270|P2|Overall Study|Withdrawal by Subject|26
1350544|NCT01774344|4449271|P1|Overall Study|Withdrawal by Subject|5
1350545|NCT01774344|4449270|P2|Overall Study|Protocol Violation|1
1350546|NCT01774344|4449271|P1|Overall Study|Protocol Violation|3
1350547|NCT01774305|4449287|P2|Overall Study|Physician Decision|0
1350548|NCT01774305|4449288|P1|Overall Study|Physician Decision|1
1350549|NCT01774253|4449296|P1|Overall Study|Death|1
1350550|NCT01774253|4449296|P1|Overall Study|Withdrawal by Subject|2
1350551|NCT01774253|4449296|P1|Overall Study|Physician Decision|2
1350552|NCT01774253|4449296|P1|Overall Study|Lack of Efficacy|4
1350553|NCT01774110|4449315|P1|Overall Study|Lost to Follow-up|7
1350554|NCT01774097|4449323|P2|Overall Study|Adverse Event|1
1350555|NCT01774097|4449324|P1|Overall Study|Adverse Event|1
1350556|NCT01774097|4449323|P2|Overall Study|Withdrawal by Subject|1
1350557|NCT01774097|4449324|P1|Overall Study|Withdrawal by Subject|1
1350558|NCT01774084|4449354|P2|Overall Study|Personal reasons|0
1350559|NCT01774084|4449355|P1|Overall Study|Personal reasons|1
1350560|NCT01773889|4449385|P1|Overall Study|lack of funding|2
1350561|NCT01773473|4449391|P2|Overall Study|Lost to Follow-up|0
1350562|NCT01773473|4449392|P1|Overall Study|Lost to Follow-up|2
1350563|NCT01773473|4449391|P2|Overall Study|Withdrawal by Subject|3
1350564|NCT01773473|4449392|P1|Overall Study|Withdrawal by Subject|5
1350565|NCT01773473|4449391|P2|Overall Study|Non-Compliance with study drug|4
1350566|NCT01773473|4449392|P1|Overall Study|Non-Compliance with study drug|1
1350567|NCT01773473|4449391|P2|Overall Study|Lack of Efficacy|1
1350568|NCT01773473|4449392|P1|Overall Study|Lack of Efficacy|0
1350569|NCT01773473|4449391|P2|Overall Study|Sponsor Decision|0
1350570|NCT01773473|4449392|P1|Overall Study|Sponsor Decision|2
1350571|NCT01773473|4449391|P2|Overall Study|Physician Decision|5
1350572|NCT01773473|4449392|P1|Overall Study|Physician Decision|3
1350573|NCT01773473|4449391|P2|Overall Study|Protocol Violation|4
1350574|NCT01773473|4449392|P1|Overall Study|Protocol Violation|0
1350575|NCT01773473|4449391|P2|Overall Study|Adverse Event|2
1350576|NCT01773473|4449392|P1|Overall Study|Adverse Event|3
1350577|NCT01773291|4449413|P3|Overall Study|Withdrawal by Subject|1
1350578|NCT01773291|4449414|P2|Overall Study|Withdrawal by Subject|0
1350579|NCT01773291|4449415|P1|Overall Study|Withdrawal by Subject|0
1350580|NCT01773291|4449413|P3|Overall Study|Protocol Violation|0
1350581|NCT01773291|4449414|P2|Overall Study|Protocol Violation|0
1350582|NCT01773291|4449415|P1|Overall Study|Protocol Violation|1
1350583|NCT01773226|4449426|P1|Overall Study|Withdrawal by Subject|1
1350584|NCT01773122|4449445|P4|Overall Study|Due to amended age eligibility criteria|1
1350585|NCT01773122|4449446|P3|Overall Study|Due to amended age eligibility criteria|0
1350586|NCT01773122|4449447|P2|Overall Study|Due to amended age eligibility criteria|1
1350587|NCT01773122|4449448|P1|Overall Study|Due to amended age eligibility criteria|3
1350588|NCT01773070|4449462|P1|Overall Study|Death (unrelated to study procedures)|3
1350589|NCT01773070|4449462|P1|Overall Study|Other|15
1350590|NCT01773070|4449462|P1|Overall Study|Lost to Follow-up|39
1350591|NCT01773070|4449462|P1|Overall Study|Withdrawal by Subject|24
1350592|NCT01772823|4449472|P2|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
1350593|NCT01772823|4449473|P1|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
1350594|NCT01772823|4449472|P2|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
1350595|NCT01772823|4449473|P1|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
1350596|NCT01772823|4449472|P2|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
1350597|NCT01772823|4449473|P1|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
1350598|NCT01772823|4449472|P2|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
1350599|NCT01772823|4449473|P1|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
1350600|NCT01772823|4449472|P2|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
1350601|NCT01772823|4449473|P1|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
1350602|NCT01772823|4449472|P2|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
1350603|NCT01772823|4449473|P1|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
1350604|NCT01772823|4449472|P2|Treatment Phase (Week 0- Week 48)|Incarcerated|0
1350605|NCT01772823|4449473|P1|Treatment Phase (Week 0- Week 48)|Incarcerated|1
1350606|NCT01772823|4449472|P2|Treatment Phase (Week 0- Week 48)|Moved out of area|3
1350607|NCT01772823|4449473|P1|Treatment Phase (Week 0- Week 48)|Moved out of area|4
1350608|NCT01772823|4449472|P2|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
1350609|NCT01772823|4449473|P1|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
1350610|NCT01772823|4449472|P2|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
1350611|NCT01772823|4449473|P1|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
1350612|NCT01772823|4449472|P2|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
1350613|NCT01772823|4449473|P1|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
1350614|NCT01772823|4449472|P2|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
1350615|NCT01772823|4449473|P1|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
1350616|NCT01772823|4449472|P2|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
1350617|NCT01772823|4449473|P1|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
1350618|NCT01772823|4449472|P2|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
1350619|NCT01772823|4449473|P1|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
1350620|NCT01772823|4449472|P2|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
1350621|NCT01772823|4449473|P1|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
1350622|NCT01772823|4449472|P2|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
1350623|NCT01772823|4449473|P1|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
1350624|NCT01772576|4449595|P1|Overall Study|Withdrawal by Subject|6
1350625|NCT01772576|4449595|P1|Overall Study|Adverse Event|6
1350626|NCT01772576|4449595|P1|Overall Study|Study device not used|3
1350627|NCT01772576|4449595|P1|Overall Study|Lost to Follow-up|3
1350628|NCT01772576|4449595|P1|Overall Study|Protocol Violation|1
1350629|NCT01772576|4449595|P1|Overall Study|Death|15
1350630|NCT01772550|4449607|P3|Overall Study|Adverse Event|1
1350631|NCT01772550|4449608|P2|Overall Study|Adverse Event|0
1350632|NCT01772550|4449609|P1|Overall Study|Adverse Event|0
1350633|NCT01772550|4449607|P3|Overall Study|Unable to insert IV in antecubital vein|5
1350634|NCT01772550|4449608|P2|Overall Study|Unable to insert IV in antecubital vein|1
1350635|NCT01772550|4449609|P1|Overall Study|Unable to insert IV in antecubital vein|1
1350636|NCT01772537|4449650|P3|Overall Study|unsuccessful lumbar drain placement|0
1350637|NCT01772537|4449651|P2|Overall Study|unsuccessful lumbar drain placement|0
1350638|NCT01772537|4449652|P1|Overall Study|unsuccessful lumbar drain placement|1
1350639|NCT01772368|4449666|P1|Overall Study|Not specified|1
1350640|NCT01772368|4449666|P1|Overall Study|Protocol Violation|2
1350641|NCT01772368|4449666|P1|Overall Study|Withdrawal by Subject|3
1350642|NCT01772368|4449666|P1|Overall Study|Adverse Event|1
1350643|NCT01772316|4449712|P1|Overall Study|Withdrawn by sponsor decision|5
1350644|NCT01772316|4449712|P1|Overall Study|Inform consent withdrawn|1
1350645|NCT01772316|4449712|P1|Overall Study|Serious adverse event|1
1350646|NCT01772147|4449733|P3|Overall Study|Lack of Efficacy|6
1350647|NCT01772147|4449734|P2|Overall Study|Lack of Efficacy|6
1350648|NCT01772147|4449735|P1|Overall Study|Lack of Efficacy|8
1350649|NCT01772147|4449733|P3|Overall Study|Protocol Deviation|1
1350650|NCT01772147|4449734|P2|Overall Study|Protocol Deviation|1
1350651|NCT01772147|4449735|P1|Overall Study|Protocol Deviation|2
1350652|NCT01772147|4449733|P3|Overall Study|Lost to Follow-up|1
1350653|NCT01772147|4449734|P2|Overall Study|Lost to Follow-up|0
1350654|NCT01772147|4449735|P1|Overall Study|Lost to Follow-up|1
1350655|NCT01772147|4449733|P3|Overall Study|Withdrew Consent|4
1350656|NCT01772147|4449734|P2|Overall Study|Withdrew Consent|8
1350657|NCT01772147|4449735|P1|Overall Study|Withdrew Consent|7
1350658|NCT01772147|4449733|P3|Overall Study|Adverse Event|6
1350659|NCT01772147|4449734|P2|Overall Study|Adverse Event|10
1350660|NCT01772147|4449735|P1|Overall Study|Adverse Event|13
1350661|NCT01772134|4449755|P3|Overall Study|Randomized Study Medication Not Received|1
1350662|NCT01772134|4449756|P2|Overall Study|Randomized Study Medication Not Received|0
1350663|NCT01772134|4449757|P1|Overall Study|Randomized Study Medication Not Received|2
1350664|NCT01772134|4449755|P3|Overall Study|Protocol-defined Stopping Criteria|0
1350665|NCT01772134|4449756|P2|Overall Study|Protocol-defined Stopping Criteria|0
1350666|NCT01772134|4449757|P1|Overall Study|Protocol-defined Stopping Criteria|1
1350667|NCT01772134|4449755|P3|Overall Study|Lack of Efficacy|3
1350668|NCT01772134|4449756|P2|Overall Study|Lack of Efficacy|5
1350669|NCT01772134|4449757|P1|Overall Study|Lack of Efficacy|11
1350670|NCT01772134|4449755|P3|Overall Study|Protocol Deviation|3
1350671|NCT01772134|4449756|P2|Overall Study|Protocol Deviation|3
1350672|NCT01772134|4449757|P1|Overall Study|Protocol Deviation|4
1350673|NCT01772134|4449755|P3|Overall Study|Lost to Follow-up|0
1350674|NCT01772134|4449756|P2|Overall Study|Lost to Follow-up|0
1350675|NCT01772134|4449757|P1|Overall Study|Lost to Follow-up|2
1350676|NCT01772134|4449755|P3|Overall Study|Withdrew Consent|5
1350677|NCT01772134|4449756|P2|Overall Study|Withdrew Consent|1
1350678|NCT01772134|4449757|P1|Overall Study|Withdrew Consent|3
1350679|NCT01772134|4449755|P3|Overall Study|Adverse Event|10
1350680|NCT01772134|4449756|P2|Overall Study|Adverse Event|5
1350681|NCT01772134|4449757|P1|Overall Study|Adverse Event|6
1350682|NCT01771913|4449794|P2|Overall Study|Withdrawal by Subject|0
1350683|NCT01771913|4449795|P1|Overall Study|Withdrawal by Subject|1
1350684|NCT01770860|4449814|P1|Overall Study|Administrative decision made by the PI|1
1350685|NCT01770860|4449814|P1|Overall Study|Lost to Follow-up|1
1350686|NCT01770860|4449814|P1|Overall Study|Withdrawal by Subject|4
1350687|NCT01770743|4449862|P5|Overall Study|Moving Out of State|0
1350688|NCT01770743|4449863|P4|Overall Study|Moving Out of State|0
1350689|NCT01770743|4449864|P3|Overall Study|Moving Out of State|0
1350690|NCT01770743|4449865|P2|Overall Study|Moving Out of State|1
1350691|NCT01770743|4449866|P1|Overall Study|Moving Out of State|0
1350692|NCT01770743|4449862|P5|Overall Study|Sponsor Terminated Subject|0
1350693|NCT01770743|4449863|P4|Overall Study|Sponsor Terminated Subject|1
1350694|NCT01770743|4449864|P3|Overall Study|Sponsor Terminated Subject|0
1350695|NCT01770743|4449865|P2|Overall Study|Sponsor Terminated Subject|0
1350696|NCT01770743|4449866|P1|Overall Study|Sponsor Terminated Subject|1
1350697|NCT01770743|4449862|P5|Overall Study|Lost to Follow-up|1
1350698|NCT01770743|4449863|P4|Overall Study|Lost to Follow-up|0
1350699|NCT01770743|4449864|P3|Overall Study|Lost to Follow-up|0
1350700|NCT01770743|4449865|P2|Overall Study|Lost to Follow-up|2
1350701|NCT01770743|4449866|P1|Overall Study|Lost to Follow-up|0
1350702|NCT01770743|4449862|P5|Overall Study|Withdrawal by Subject|1
1350703|NCT01770743|4449863|P4|Overall Study|Withdrawal by Subject|1
1350704|NCT01770743|4449864|P3|Overall Study|Withdrawal by Subject|1
1350705|NCT01770743|4449865|P2|Overall Study|Withdrawal by Subject|0
1350706|NCT01770743|4449866|P1|Overall Study|Withdrawal by Subject|0
1350707|NCT01770743|4449862|P5|Overall Study|Adverse Event|0
1350708|NCT01770743|4449863|P4|Overall Study|Adverse Event|0
1350709|NCT01770743|4449864|P3|Overall Study|Adverse Event|0
1350710|NCT01770743|4449865|P2|Overall Study|Adverse Event|0
1350711|NCT01770743|4449866|P1|Overall Study|Adverse Event|1
1350712|NCT01770509|4449968|P2|Overall Study|Lost to Follow-up|2
1350713|NCT01770509|4449969|P1|Overall Study|Lost to Follow-up|1
1350714|NCT01770509|4449968|P2|Overall Study|Injury|1
1350715|NCT01770509|4449969|P1|Overall Study|Injury|0
1350716|NCT01770392|4450005|P1|Washout Period of at Least 14 Days|Adverse Event|1
1350717|NCT01770379|4450020|P3|Overall Study|Adverse Event|2
1350718|NCT01770379|4450021|P2|Overall Study|Adverse Event|3
1350719|NCT01770379|4450022|P1|Overall Study|Adverse Event|1
1350720|NCT01770379|4450020|P3|Overall Study|Lack of Efficacy|6
1350721|NCT01770379|4450021|P2|Overall Study|Lack of Efficacy|6
1350722|NCT01770379|4450022|P1|Overall Study|Lack of Efficacy|8
1350723|NCT01770379|4450020|P3|Overall Study|Lost to Follow-up|2
1350724|NCT01770379|4450021|P2|Overall Study|Lost to Follow-up|0
1350725|NCT01770379|4450022|P1|Overall Study|Lost to Follow-up|0
1350726|NCT01770379|4450020|P3|Overall Study|Physician Decision|2
1350727|NCT01770379|4450021|P2|Overall Study|Physician Decision|1
1350728|NCT01770379|4450022|P1|Overall Study|Physician Decision|0
1350729|NCT01770379|4450020|P3|Overall Study|Protocol Violation|1
1350730|NCT01770379|4450021|P2|Overall Study|Protocol Violation|1
1350731|NCT01770379|4450022|P1|Overall Study|Protocol Violation|0
1350732|NCT01770379|4450020|P3|Overall Study|study terminated by sponsor|22
1350733|NCT01770379|4450021|P2|Overall Study|study terminated by sponsor|23
1350734|NCT01770379|4450022|P1|Overall Study|study terminated by sponsor|22
1350735|NCT01770379|4450020|P3|Overall Study|Withdrawal by Subject|7
1350736|NCT01770379|4450021|P2|Overall Study|Withdrawal by Subject|10
1350737|NCT01770379|4450022|P1|Overall Study|Withdrawal by Subject|7
1350738|NCT01770379|4450020|P3|Overall Study|Technical issues|0
1350739|NCT01770379|4450021|P2|Overall Study|Technical issues|0
1350740|NCT01770379|4450022|P1|Overall Study|Technical issues|1
1350741|NCT01770145|4450059|P1|Treatment|Withdrawal by Subject|1
1350742|NCT01770145|4450059|P1|Treatment|Adverse Event|3
1350743|NCT01770145|4450059|P1|Baseline|Unable to define optimal dose|4
1350744|NCT01770145|4450059|P1|Baseline|Lost to Follow-up|1
1350745|NCT01770145|4450059|P1|Baseline|Withdrawal by Subject|1
1350746|NCT01770145|4450059|P1|Baseline|Adverse Event|20
1350747|NCT01769508|4450079|P1|Overall Study|Lost to Follow-up|1
1350748|NCT01769508|4450079|P1|Overall Study|Adverse Event|1
1350749|NCT01769508|4450079|P1|Overall Study|Withdrawal by Subject|1
1350750|NCT01769508|4450079|P1|Overall Study|Death|3
1350751|NCT01769456|4450088|P1|Overall Study|Parental request to youth to withdraw|1
1350752|NCT01769456|4450088|P1|Overall Study|No wk 0 visit w/in 30 days of screening|5
1350753|NCT01769456|4450088|P1|Overall Study|Moved out of the area|3
1350754|NCT01769456|4450088|P1|Overall Study|Did not receive PCC intervention|6
1350755|NCT01769456|4450088|P1|Overall Study|Withdrawal by Subject|3
1350756|NCT01769456|4450088|P1|Overall Study|Lost to Follow-up|19
1350757|NCT01769443|4450109|P2|Overall Study|Study closure|0
1350758|NCT01769443|4450110|P1|Overall Study|Study closure|1
1350759|NCT01769391|4450154|P2|Overall Study|Investigator Decision|0
1350760|NCT01769391|4450155|P1|Overall Study|Investigator Decision|2
1350761|NCT01769391|4450154|P2|Overall Study|Withdrawal by Subject|3
1350762|NCT01769391|4450155|P1|Overall Study|Withdrawal by Subject|4
1350763|NCT01769391|4450154|P2|Overall Study|Progressive Disease|2
1350764|NCT01769391|4450155|P1|Overall Study|Progressive Disease|1
1350765|NCT01769391|4450154|P2|Overall Study|Adverse Event|3
1350766|NCT01769391|4450155|P1|Overall Study|Adverse Event|0
1350767|NCT01769391|4450154|P2|Overall Study|Death|1
1350768|NCT01769391|4450155|P1|Overall Study|Death|10
1350769|NCT01769378|4450174|P2|Overall Study|Lost to Follow-up|0
1350770|NCT01769378|4450175|P1|Overall Study|Lost to Follow-up|2
1350771|NCT01769378|4450174|P2|Overall Study|Sponsor Decision|0
1350772|NCT01769378|4450175|P1|Overall Study|Sponsor Decision|1
1350773|NCT01769378|4450174|P2|Overall Study|Withdrawal by Subject|3
1350774|NCT01769378|4450175|P1|Overall Study|Withdrawal by Subject|10
1350775|NCT01769378|4450174|P2|Overall Study|Protocol Violation|1
1350776|NCT01769378|4450175|P1|Overall Study|Protocol Violation|1
1350777|NCT01769378|4450174|P2|Overall Study|Entry criteria not met|0
1350778|NCT01769378|4450175|P1|Overall Study|Entry criteria not met|1
1350779|NCT01769378|4450174|P2|Overall Study|Adverse Event|0
1350780|NCT01769378|4450175|P1|Overall Study|Adverse Event|10
1350781|NCT01769339|4450255|P1|Overall Study|Adverse Event|1
1350782|NCT01769339|4450255|P1|Overall Study|Lost to Follow-up|42
1350783|NCT01769326|4450266|P4|Overall Study|Got sick and could not complete study|0
1350784|NCT01769326|4450267|P3|Overall Study|Got sick and could not complete study|1
1350785|NCT01769326|4450268|P2|Overall Study|Got sick and could not complete study|0
1350786|NCT01769326|4450269|P1|Overall Study|Got sick and could not complete study|0
1350787|NCT01769326|4450266|P4|Overall Study|got a job|0
1350788|NCT01769326|4450267|P3|Overall Study|got a job|0
1350789|NCT01769326|4450268|P2|Overall Study|got a job|1
1350790|NCT01769326|4450269|P1|Overall Study|got a job|0
1350791|NCT01769326|4450266|P4|Overall Study|unrelated injry|0
1350792|NCT01769326|4450267|P3|Overall Study|unrelated injry|0
1350793|NCT01769326|4450268|P2|Overall Study|unrelated injry|1
1350794|NCT01769326|4450269|P1|Overall Study|unrelated injry|1
1350795|NCT01769326|4450266|P4|Overall Study|Lost to Follow-up|0
1350796|NCT01769326|4450267|P3|Overall Study|Lost to Follow-up|0
1350797|NCT01769326|4450268|P2|Overall Study|Lost to Follow-up|2
1350798|NCT01769326|4450269|P1|Overall Study|Lost to Follow-up|1
1350799|NCT01769196|4450311|P2|Overall Study|Withdrew consent|40
1350800|NCT01769196|4450312|P1|Overall Study|Withdrew consent|36
1350801|NCT01769196|4450311|P2|Overall Study|Participant never dosed with study drug|0
1350802|NCT01769196|4450312|P1|Overall Study|Participant never dosed with study drug|1
1350803|NCT01769196|4450311|P2|Overall Study|Study terminated by sponsor|161
1350804|NCT01769196|4450312|P1|Overall Study|Study terminated by sponsor|160
1350805|NCT01769196|4450311|P2|Overall Study|Protocol Violation|3
1350806|NCT01769196|4450312|P1|Overall Study|Protocol Violation|0
1350807|NCT01769196|4450311|P2|Overall Study|Protocol defined criteria for withdrawal|11
1350808|NCT01769196|4450312|P1|Overall Study|Protocol defined criteria for withdrawal|9
1350809|NCT01769196|4450311|P2|Overall Study|Progressive disease|6
1350810|NCT01769196|4450312|P1|Overall Study|Progressive disease|11
1350811|NCT01769196|4450311|P2|Overall Study|Lack of Efficacy|2
1350812|NCT01769196|4450312|P1|Overall Study|Lack of Efficacy|3
1350813|NCT01769196|4450311|P2|Overall Study|Investigator Discretion|3
1350814|NCT01769196|4450312|P1|Overall Study|Investigator Discretion|7
1350815|NCT01769196|4450311|P2|Overall Study|Death|26
1350816|NCT01769196|4450312|P1|Overall Study|Death|21
1350817|NCT01769196|4450311|P2|Overall Study|Adverse Event|20
1350818|NCT01769196|4450312|P1|Overall Study|Adverse Event|24
1350819|NCT01769105|4450342|P2|Cross-over|Lost to Follow-up|0
1350820|NCT01769105|4450343|P1|Cross-over|Lost to Follow-up|5
1350821|NCT01769105|4450342|P2|First Intervention|Protocol Violation|2
1350822|NCT01769105|4450343|P1|First Intervention|Protocol Violation|2
1350823|NCT01768676|4450364|P2|Overall Study|Withdrawal by Subject|10
1350824|NCT01768676|4450365|P1|Overall Study|Withdrawal by Subject|3
1350825|NCT01768676|4450364|P2|Overall Study|Physician Decision|1
1350826|NCT01768676|4450365|P1|Overall Study|Physician Decision|4
1350827|NCT01768676|4450364|P2|Overall Study|Protocol Violation|1
1350828|NCT01768676|4450365|P1|Overall Study|Protocol Violation|1
1350829|NCT01768676|4450364|P2|Overall Study|Lost to Follow-up|16
1350830|NCT01768676|4450365|P1|Overall Study|Lost to Follow-up|13
1350831|NCT01768676|4450364|P2|Overall Study|Adverse Event|3
1350832|NCT01768676|4450365|P1|Overall Study|Adverse Event|3
1350833|NCT01768572|4450382|P3|Overall Study|Other, Not due to an adverse event|1
1350834|NCT01768572|4450383|P2|Overall Study|Other, Not due to an adverse event|1
1350835|NCT01768572|4450384|P1|Overall Study|Other, Not due to an adverse event|1
1350836|NCT01768572|4450382|P3|Overall Study|Lack of Efficacy|1
1350837|NCT01768572|4450383|P2|Overall Study|Lack of Efficacy|3
1350838|NCT01768572|4450384|P1|Overall Study|Lack of Efficacy|1
1350839|NCT01768572|4450382|P3|Overall Study|Adverse Event|4
1350840|NCT01768572|4450383|P2|Overall Study|Adverse Event|8
1350841|NCT01768572|4450384|P1|Overall Study|Adverse Event|7
1350842|NCT01768559|4450395|P3|Overall Study|Other than specified|5
1350843|NCT01768559|4450396|P2|Overall Study|Other than specified|8
1350844|NCT01768559|4450397|P1|Overall Study|Other than specified|9
1350845|NCT01768559|4450395|P3|Overall Study|Poor compliance to protocol|2
1350846|NCT01768559|4450396|P2|Overall Study|Poor compliance to protocol|3
1350847|NCT01768559|4450397|P1|Overall Study|Poor compliance to protocol|0
1350848|NCT01768559|4450395|P3|Overall Study|Lack of Efficacy|0
1350849|NCT01768559|4450396|P2|Overall Study|Lack of Efficacy|4
1350850|NCT01768559|4450397|P1|Overall Study|Lack of Efficacy|6
1350851|NCT01768559|4450395|P3|Overall Study|Adverse Event|5
1350852|NCT01768559|4450396|P2|Overall Study|Adverse Event|2
1350853|NCT01768559|4450397|P1|Overall Study|Adverse Event|15
1350854|NCT01768559|4450395|P3|Overall Study|Randomized but not treated|1
1350855|NCT01768559|4450396|P2|Overall Study|Randomized but not treated|0
1350856|NCT01768559|4450397|P1|Overall Study|Randomized but not treated|0
1350857|NCT01768286|4450462|P4|Overall Study|Withdrew Consent|0
1350858|NCT01768286|4450463|P3|Overall Study|Withdrew Consent|1
1350859|NCT01768286|4450464|P2|Overall Study|Withdrew Consent|0
1350860|NCT01768286|4450465|P1|Overall Study|Withdrew Consent|0
1350861|NCT01768286|4450462|P4|Overall Study|Lack of Efficacy|1
1350862|NCT01768286|4450463|P3|Overall Study|Lack of Efficacy|0
1350863|NCT01768286|4450464|P2|Overall Study|Lack of Efficacy|4
1350864|NCT01768286|4450465|P1|Overall Study|Lack of Efficacy|7
1350865|NCT01768286|4450462|P4|Overall Study|Randomized But Not Treated|0
1350866|NCT01768286|4450463|P3|Overall Study|Randomized But Not Treated|1
1350867|NCT01768286|4450464|P2|Overall Study|Randomized But Not Treated|0
1350868|NCT01768286|4450465|P1|Overall Study|Randomized But Not Treated|0
1350869|NCT01768117|4450527|P1|Overall Study|Protocol Violation|3
1350870|NCT01768117|4450527|P1|Overall Study|Withdrawal by Subject|2
1350871|NCT01768117|4450527|P1|Overall Study|Lost to Follow-up|1
1350872|NCT01767987|4450591|P2|Overall Study|Physician Decision|1
1350873|NCT01767987|4450592|P1|Overall Study|Physician Decision|4
1350874|NCT01767597|4450658|P2|Overall Study|Withdrawal by Subject|0
1350875|NCT01767597|4450659|P1|Overall Study|Withdrawal by Subject|1
1350876|NCT01767597|4450658|P2|Overall Study|Incomplete intervention|1
1350877|NCT01767597|4450659|P1|Overall Study|Incomplete intervention|3
1350878|NCT01767519|4450668|P3|Overall Study|Adverse Event|1
1350879|NCT01767519|4450669|P2|Overall Study|Adverse Event|5
1350880|NCT01767519|4450670|P1|Overall Study|Adverse Event|5
1350881|NCT01767519|4450668|P3|Overall Study|Lack of Efficacy|0
1350882|NCT01767519|4450669|P2|Overall Study|Lack of Efficacy|0
1350883|NCT01767519|4450670|P1|Overall Study|Lack of Efficacy|1
1350884|NCT01767519|4450668|P3|Overall Study|Lost to Follow-up|2
1350885|NCT01767519|4450669|P2|Overall Study|Lost to Follow-up|1
1350886|NCT01767519|4450670|P1|Overall Study|Lost to Follow-up|3
1350887|NCT01767519|4450668|P3|Overall Study|Personal Reasons|0
1350888|NCT01767519|4450669|P2|Overall Study|Personal Reasons|0
1350889|NCT01767519|4450670|P1|Overall Study|Personal Reasons|1
1350890|NCT01767519|4450668|P3|Overall Study|Protocol Violation|0
1350891|NCT01767519|4450669|P2|Overall Study|Protocol Violation|3
1350892|NCT01767519|4450670|P1|Overall Study|Protocol Violation|0
1350893|NCT01767519|4450668|P3|Overall Study|Other Reasons|2
1350894|NCT01767519|4450669|P2|Overall Study|Other Reasons|4
1350895|NCT01767519|4450670|P1|Overall Study|Other Reasons|4
1350896|NCT01767467|4450711|P2|End of Study Phase (up to Month 13)|Subject Unavailable|2
1350897|NCT01767467|4450712|P1|End of Study Phase (up to Month 13)|Subject Unavailable|0
1350898|NCT01767467|4450711|P2|End of Study Phase (up to Month 13)|Physician Decision|0
1350899|NCT01767467|4450712|P1|End of Study Phase (up to Month 13)|Physician Decision|1
1350900|NCT01767467|4450711|P2|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
1350901|NCT01767467|4450712|P1|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
1350902|NCT01767467|4450711|P2|End of Study Phase (up to Month 13)|Lost to Follow-up|4
1350903|NCT01767467|4450712|P1|End of Study Phase (up to Month 13)|Lost to Follow-up|6
1350904|NCT01767467|4450711|P2|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
1350905|NCT01767467|4450712|P1|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
1350906|NCT01767467|4450711|P2|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
1350907|NCT01767467|4450712|P1|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
1350908|NCT01767467|4450711|P2|End of Study Phase (up to Month 13)|Protocol Violation|0
1350909|NCT01767467|4450712|P1|End of Study Phase (up to Month 13)|Protocol Violation|2
1350910|NCT01767467|4450711|P2|End of Study Phase (up to Month 13)|Adverse Event|39
1350911|NCT01767467|4450712|P1|End of Study Phase (up to Month 13)|Adverse Event|29
1350912|NCT01767467|4450711|P2|Vaccination Phase (up to Month 2)|Subject unavailable|1
1350913|NCT01767467|4450712|P1|Vaccination Phase (up to Month 2)|Subject unavailable|0
1350914|NCT01767467|4450711|P2|Vaccination Phase (up to Month 2)|Physician Decision|0
1350915|NCT01767467|4450712|P1|Vaccination Phase (up to Month 2)|Physician Decision|1
1350916|NCT01767467|4450711|P2|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
1350917|NCT01767467|4450712|P1|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
1350918|NCT01767467|4450711|P2|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
1350919|NCT01767467|4450712|P1|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
1350920|NCT01767467|4450711|P2|Vaccination Phase (up to Month 2)|Protocol Violation|0
1350921|NCT01767467|4450712|P1|Vaccination Phase (up to Month 2)|Protocol Violation|1
1350922|NCT01767467|4450711|P2|Vaccination Phase (up to Month 2)|Adverse Event|8
1350923|NCT01767467|4450712|P1|Vaccination Phase (up to Month 2)|Adverse Event|8
1350924|NCT01767376|4450763|P3|Overall Study|Withdrawal by Subject|0
1350925|NCT01767376|4450764|P2|Overall Study|Withdrawal by Subject|1
1350926|NCT01767376|4450765|P1|Overall Study|Withdrawal by Subject|1
1350927|NCT01767376|4450763|P3|Overall Study|Lost to Follow-up|0
1350928|NCT01767376|4450764|P2|Overall Study|Lost to Follow-up|2
1350929|NCT01767376|4450765|P1|Overall Study|Lost to Follow-up|3
1350930|NCT01767116|4450846|P2|Overall Study|Lost to Follow-up|2
1350931|NCT01767116|4450847|P1|Overall Study|Lost to Follow-up|2
1350932|NCT01766921|4450905|P2|Overall Study|Withdrawal by Subject|5
1350933|NCT01766921|4450906|P1|Overall Study|Withdrawal by Subject|14
1350934|NCT01766921|4450905|P2|Overall Study|Protocol Violation|1
1350935|NCT01766921|4450906|P1|Overall Study|Protocol Violation|1
1350936|NCT01766921|4450905|P2|Overall Study|Unclassified|2
1350937|NCT01766921|4450906|P1|Overall Study|Unclassified|2
1350938|NCT01766921|4450905|P2|Overall Study|Lost to Follow-up|3
1350939|NCT01766921|4450906|P1|Overall Study|Lost to Follow-up|1
1350940|NCT01766921|4450905|P2|Overall Study|Death|1
1350941|NCT01766921|4450906|P1|Overall Study|Death|1
1350942|NCT01766921|4450905|P2|Overall Study|Administrative Reason|5
1350943|NCT01766921|4450906|P1|Overall Study|Administrative Reason|5
1350944|NCT01766778|4450927|P2|Overall Study|Withdrawal by Subject|0
1350945|NCT01766778|4450928|P1|Overall Study|Withdrawal by Subject|1
1350946|NCT01766778|4450927|P2|Overall Study|Adverse Event|4
1350947|NCT01766778|4450928|P1|Overall Study|Adverse Event|4
1350948|NCT01766336|4450982|P2|Overall Study|Withdrawal by Subject|15
1350949|NCT01766336|4450983|P1|Overall Study|Withdrawal by Subject|18
1350950|NCT01766336|4450982|P2|Overall Study|Sponsor Decision|43
1350951|NCT01766336|4450983|P1|Overall Study|Sponsor Decision|52
1350952|NCT01766336|4450982|P2|Overall Study|Protocol Violation|1
1350953|NCT01766336|4450983|P1|Overall Study|Protocol Violation|0
1350954|NCT01766336|4450982|P2|Overall Study|Physician Decision|2
1350955|NCT01766336|4450983|P1|Overall Study|Physician Decision|4
1350956|NCT01766336|4450982|P2|Overall Study|Lost to Follow-up|3
1350957|NCT01766336|4450983|P1|Overall Study|Lost to Follow-up|1
1350958|NCT01766336|4450982|P2|Overall Study|Death|3
1350959|NCT01766336|4450983|P1|Overall Study|Death|4
1350960|NCT01766336|4450982|P2|Overall Study|Adverse Event|8
1350961|NCT01766336|4450983|P1|Overall Study|Adverse Event|11
1350962|NCT01766310|4450991|P2|Overall Study|Lost to Follow-up|3
1350963|NCT01766310|4450992|P1|Overall Study|Lost to Follow-up|1
1350964|NCT01766050|4451020|P1|Overall Study|Withdrawal by Subject|2
1350965|NCT01766050|4451020|P1|Overall Study|Lost to Follow-up|1
1350966|NCT01766050|4451020|P1|Overall Study|Adverse Event|1
1350967|NCT01766037|4451155|P2|Overall Study|nausea / discomfort|0
1350968|NCT01766037|4451156|P1|Overall Study|nausea / discomfort|3
1350969|NCT01766037|4451155|P2|Overall Study|medical - unrelated|2
1350970|NCT01766037|4451156|P1|Overall Study|medical - unrelated|1
1350971|NCT01766037|4451155|P2|Overall Study|Moved from area|0
1350972|NCT01766037|4451156|P1|Overall Study|Moved from area|5
1350973|NCT01766037|4451155|P2|Overall Study|Withdrawal by Subject|16
1350974|NCT01766037|4451156|P1|Overall Study|Withdrawal by Subject|18
1350975|NCT01766037|4451155|P2|Overall Study|Physician Decision|1
1350976|NCT01766037|4451156|P1|Overall Study|Physician Decision|0
1350977|NCT01766037|4451155|P2|Overall Study|Lost to Follow-up|10
1350978|NCT01766037|4451156|P1|Overall Study|Lost to Follow-up|0
1350979|NCT01766037|4451155|P2|Overall Study|Lack of Efficacy|0
1350980|NCT01766037|4451156|P1|Overall Study|Lack of Efficacy|1
1350981|NCT01766037|4451155|P2|Overall Study|Adverse Event|0
1350982|NCT01766037|4451156|P1|Overall Study|Adverse Event|1
1350983|NCT01765764|4451225|P3|Treatment Period|Other Miscellaneous Reasons|2
1350984|NCT01765764|4451226|P2|Treatment Period|Other Miscellaneous Reasons|2
1350985|NCT01765764|4451227|P1|Treatment Period|Other Miscellaneous Reasons|1
1350986|NCT01765764|4451225|P3|Treatment Period|Personal Reasons|1
1350987|NCT01765764|4451226|P2|Treatment Period|Personal Reasons|2
1350988|NCT01765764|4451227|P1|Treatment Period|Personal Reasons|1
1350989|NCT01765764|4451225|P3|Treatment Period|Lost to Follow-up|2
1350990|NCT01765764|4451226|P2|Treatment Period|Lost to Follow-up|3
1350991|NCT01765764|4451227|P1|Treatment Period|Lost to Follow-up|0
1350992|NCT01765764|4451225|P3|Treatment Period|Adverse Event|1
1350993|NCT01765764|4451226|P2|Treatment Period|Adverse Event|2
1350994|NCT01765764|4451227|P1|Treatment Period|Adverse Event|1
1350995|NCT01765751|4451247|P3|Overall Study|Lost to Follow-up|1
1350996|NCT01765751|4451248|P2|Overall Study|Lost to Follow-up|2
1350997|NCT01765751|4451249|P1|Overall Study|Lost to Follow-up|0
1350998|NCT01765673|4451281|P1|Overall Study|No transportation for 2nd/3rd visits|1
1350999|NCT01765582|4451307|P3|Overall Study|Withdrawal of Consent|10
1351000|NCT01765582|4451308|P2|Overall Study|Withdrawal of Consent|6
1351001|NCT01765582|4451309|P1|Overall Study|Withdrawal of Consent|11
1351002|NCT01765582|4451307|P3|Overall Study|Sponsor Decision|42
1351003|NCT01765582|4451308|P2|Overall Study|Sponsor Decision|42
1351004|NCT01765582|4451309|P1|Overall Study|Sponsor Decision|46
1351005|NCT01765582|4451307|P3|Overall Study|Death|33
1351006|NCT01765582|4451308|P2|Overall Study|Death|36
1351007|NCT01765582|4451309|P1|Overall Study|Death|31
1351008|NCT01765582|4451307|P3|Overall Study|Lost to Follow-up|1
1351009|NCT01765582|4451308|P2|Overall Study|Lost to Follow-up|2
1351010|NCT01765582|4451309|P1|Overall Study|Lost to Follow-up|2
1351011|NCT01765582|4451307|P3|Overall Study|Other|9
1351012|NCT01765582|4451308|P2|Overall Study|Other|6
1351013|NCT01765582|4451309|P1|Overall Study|Other|3
1351014|NCT01765569|4451342|P1|Period C|Death|1
1351015|NCT01765569|4451342|P1|Period B|Withdrawal by Subject|1
1351016|NCT01765543|4451363|P1|Overall Study|Withdrawal by Subject|2
1351017|NCT01765543|4451363|P1|Overall Study|Death|1
1351018|NCT01765426|4451415|P4|Overall Study|Lost to Follow-up|0
1351019|NCT01765426|4451416|P3|Overall Study|Lost to Follow-up|0
1351020|NCT01765426|4451417|P2|Overall Study|Lost to Follow-up|1
1351021|NCT01765426|4451418|P1|Overall Study|Lost to Follow-up|0
1351022|NCT01765270|4451474|P2|Overall Study|Withdrawal by Subject|1
1351023|NCT01765270|4451475|P1|Overall Study|Withdrawal by Subject|0
1351024|NCT01765270|4451474|P2|Overall Study|Physician Decision|0
1351025|NCT01765270|4451475|P1|Overall Study|Physician Decision|1
1351026|NCT01765192|4451497|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
1351027|NCT01765192|4451498|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
1351028|NCT01765192|4451497|P2|Treatment Period 2|Reason not specified|2
1351029|NCT01765192|4451498|P1|Treatment Period 2|Reason not specified|0
1351030|NCT01765192|4451497|P2|Washout Period|Reason not specified|0
1351031|NCT01765192|4451498|P1|Washout Period|Reason not specified|1
1351032|NCT01765192|4451497|P2|Washout Period|Voluntary Withdrawal|1
1351033|NCT01765192|4451498|P1|Washout Period|Voluntary Withdrawal|1
1351034|NCT01765192|4451497|P2|Treatment Period 1|Adverse Event|1
1351035|NCT01765192|4451498|P1|Treatment Period 1|Adverse Event|0
1351036|NCT01765179|4451516|P1|Overall Study|Ca elevated 10.6|1
1351037|NCT01765179|4451516|P1|Overall Study|work conflict|1
1351038|NCT01765179|4451516|P1|Overall Study|lack of venous access|1
1351039|NCT01765179|4451516|P1|Overall Study|Out of country unable to finish study|1
1351040|NCT01765179|4451516|P1|Overall Study|prohibited med|1
1351041|NCT01765179|4451516|P1|Overall Study|Hematocrit >54%|3
1351042|NCT01765179|4451516|P1|Overall Study|Withdrawal by Subject|8
1351043|NCT01765179|4451516|P1|Overall Study|Protocol Violation|1
1351044|NCT01765179|4451516|P1|Overall Study|Non-compliance with study drug|2
1351045|NCT01765179|4451516|P1|Overall Study|Lost to Follow-up|5
1351046|NCT01765179|4451516|P1|Overall Study|Adverse Event|3
1351047|NCT01765153|4451523|P2|Rest Phase 2|Lost to Follow-up|1
1351048|NCT01765153|4451524|P1|Rest Phase 2|Lost to Follow-up|2
1351049|NCT01765153|4451523|P2|Training Phase 2|Withdrawal by Subject|1
1351050|NCT01765153|4451524|P1|Training Phase 2|Withdrawal by Subject|0
1351051|NCT01765153|4451523|P2|Rest Phase 1|Withdrawal by Subject|1
1351052|NCT01765153|4451524|P1|Rest Phase 1|Withdrawal by Subject|0
1351053|NCT01765153|4451523|P2|Training Phase 1|Poor participation in intervention|1
1351054|NCT01765153|4451524|P1|Training Phase 1|Poor participation in intervention|0
1351055|NCT01765153|4451523|P2|Training Phase 1|Format of intervention differed|0
1351056|NCT01765153|4451524|P1|Training Phase 1|Format of intervention differed|1
1351057|NCT01764997|4451631|P5|Study Drug Treatment Period|Other than specified above|10
1351058|NCT01764997|4451632|P4|Study Drug Treatment Period|Other than specified above|0
1351059|NCT01764997|4451633|P3|Study Drug Treatment Period|Other than specified above|0
1351060|NCT01764997|4451634|P2|Study Drug Treatment Period|Other than specified above|0
1351061|NCT01764997|4451635|P1|Study Drug Treatment Period|Other than specified above|0
1351062|NCT01764997|4451631|P5|Study Drug Treatment Period|Lack of Efficacy|2
1351063|NCT01764997|4451632|P4|Study Drug Treatment Period|Lack of Efficacy|0
1351064|NCT01764997|4451633|P3|Study Drug Treatment Period|Lack of Efficacy|0
1351065|NCT01764997|4451634|P2|Study Drug Treatment Period|Lack of Efficacy|0
1351066|NCT01764997|4451635|P1|Study Drug Treatment Period|Lack of Efficacy|0
1351067|NCT01764997|4451631|P5|Study Drug Treatment Period|Adverse Event|24
1351068|NCT01764997|4451632|P4|Study Drug Treatment Period|Adverse Event|0
1351069|NCT01764997|4451633|P3|Study Drug Treatment Period|Adverse Event|0
1351070|NCT01764997|4451634|P2|Study Drug Treatment Period|Adverse Event|1
1351071|NCT01764997|4451635|P1|Study Drug Treatment Period|Adverse Event|0
1351072|NCT01764997|4451631|P5|Run-in Period|Other than specified above|0
1351073|NCT01764997|4451632|P4|Run-in Period|Other than specified above|0
1351074|NCT01764997|4451633|P3|Run-in Period|Other than specified above|0
1351075|NCT01764997|4451634|P2|Run-in Period|Other than specified above|0
1351076|NCT01764997|4451635|P1|Run-in Period|Other than specified above|17
1351077|NCT01764997|4451631|P5|Run-in Period|Poor compliance to protocol|0
1351078|NCT01764997|4451632|P4|Run-in Period|Poor compliance to protocol|0
1351079|NCT01764997|4451633|P3|Run-in Period|Poor compliance to protocol|0
1351080|NCT01764997|4451634|P2|Run-in Period|Poor compliance to protocol|0
1351081|NCT01764997|4451635|P1|Run-in Period|Poor compliance to protocol|1
1351082|NCT01764997|4451631|P5|Run-in Period|Lack of Efficacy|0
1351083|NCT01764997|4451632|P4|Run-in Period|Lack of Efficacy|0
1351084|NCT01764997|4451633|P3|Run-in Period|Lack of Efficacy|0
1351085|NCT01764997|4451634|P2|Run-in Period|Lack of Efficacy|0
1351086|NCT01764997|4451635|P1|Run-in Period|Lack of Efficacy|5
1351087|NCT01764997|4451631|P5|Run-in Period|Adverse Event|0
1351088|NCT01764997|4451632|P4|Run-in Period|Adverse Event|0
1351089|NCT01764997|4451633|P3|Run-in Period|Adverse Event|0
1351090|NCT01764997|4451634|P2|Run-in Period|Adverse Event|0
1351091|NCT01764997|4451635|P1|Run-in Period|Adverse Event|15
1351092|NCT01764945|4451662|P8|Overall Study|Adverse Event|0
1351093|NCT01764945|4451663|P7|Overall Study|Adverse Event|1
1351094|NCT01764945|4451664|P6|Overall Study|Adverse Event|0
1351095|NCT01764945|4451665|P5|Overall Study|Adverse Event|0
1351096|NCT01764945|4451666|P4|Overall Study|Adverse Event|0
1351097|NCT01764945|4451667|P3|Overall Study|Adverse Event|0
1351098|NCT01764945|4451668|P2|Overall Study|Adverse Event|1
1351099|NCT01764945|4451669|P1|Overall Study|Adverse Event|0
1351100|NCT01764841|4451715|P4|Overall Study|Lost to Follow-up|0
1351101|NCT01764841|4451716|P3|Overall Study|Lost to Follow-up|1
1351102|NCT01764841|4451717|P2|Overall Study|Lost to Follow-up|0
1351103|NCT01764841|4451718|P1|Overall Study|Lost to Follow-up|3
1351104|NCT01764841|4451715|P4|Overall Study|Withdrawal by Subject|15
1351105|NCT01764841|4451716|P3|Overall Study|Withdrawal by Subject|11
1351106|NCT01764841|4451717|P2|Overall Study|Withdrawal by Subject|24
1351107|NCT01764841|4451718|P1|Overall Study|Withdrawal by Subject|16
1351108|NCT01764841|4451715|P4|Overall Study|Protocol Violation|0
1351109|NCT01764841|4451716|P3|Overall Study|Protocol Violation|0
1351110|NCT01764841|4451717|P2|Overall Study|Protocol Violation|1
1351111|NCT01764841|4451718|P1|Overall Study|Protocol Violation|0
1351112|NCT01764841|4451715|P4|Overall Study|No Follow Up|0
1351113|NCT01764841|4451716|P3|Overall Study|No Follow Up|1
1351114|NCT01764841|4451717|P2|Overall Study|No Follow Up|0
1351115|NCT01764841|4451718|P1|Overall Study|No Follow Up|1
1351116|NCT01764841|4451715|P4|Overall Study|Death|4
1351117|NCT01764841|4451716|P3|Overall Study|Death|1
1351118|NCT01764841|4451717|P2|Overall Study|Death|0
1351119|NCT01764841|4451718|P1|Overall Study|Death|3
1351120|NCT01764841|4451715|P4|Overall Study|Logistical Difficulties|0
1351121|NCT01764841|4451716|P3|Overall Study|Logistical Difficulties|0
1351122|NCT01764841|4451717|P2|Overall Study|Logistical Difficulties|1
1351123|NCT01764841|4451718|P1|Overall Study|Logistical Difficulties|0
1351124|NCT01764633|4451761|P2|Overall Study|Lost to Follow-up|5
1351125|NCT01764633|4451762|P1|Overall Study|Lost to Follow-up|13
1351126|NCT01764633|4451761|P2|Overall Study|Withdrawal by Subject|88
1351127|NCT01764633|4451762|P1|Overall Study|Withdrawal by Subject|105
1351128|NCT01764386|4451791|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
1351129|NCT01764386|4451792|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
1351130|NCT01764386|4451791|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
1351131|NCT01764386|4451792|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
1351132|NCT01764386|4451791|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
1351133|NCT01764386|4451792|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
1351134|NCT01764386|4451791|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
1351135|NCT01764386|4451792|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
1351136|NCT01764386|4451791|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
1351137|NCT01764386|4451792|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
1351138|NCT01764386|4451791|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
1351139|NCT01764386|4451792|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
1351140|NCT01764386|4451791|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
1351141|NCT01764386|4451792|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
1351142|NCT01764386|4451791|P2|Controlled Treatment Period (CTP)|Adverse Event|0
1351143|NCT01764386|4451792|P1|Controlled Treatment Period (CTP)|Adverse Event|35
1351144|NCT01764022|4451835|P2|Overall Study|Protocol Violation|0
1351145|NCT01764022|4451836|P1|Overall Study|Protocol Violation|1
1351146|NCT01764022|4451835|P2|Overall Study|Physician Decision|2
1351147|NCT01764022|4451836|P1|Overall Study|Physician Decision|2
1351148|NCT01764022|4451835|P2|Overall Study|Lack of Efficacy|5
1351149|NCT01764022|4451836|P1|Overall Study|Lack of Efficacy|10
1351150|NCT01764022|4451835|P2|Overall Study|Withdrawal by Subject|4
1351151|NCT01764022|4451836|P1|Overall Study|Withdrawal by Subject|5
1351152|NCT01764022|4451835|P2|Overall Study|Death|1
1351153|NCT01764022|4451836|P1|Overall Study|Death|3
1351154|NCT01763996|4451864|P2|Treatment Period 2|Adverse Event|1
1351155|NCT01763996|4451865|P1|Treatment Period 2|Adverse Event|0
1351156|NCT01763918|4451895|P4|Overall Study|Sponsor Decision|0
1351157|NCT01763918|4451896|P3|Overall Study|Sponsor Decision|9
1351158|NCT01763918|4451897|P2|Overall Study|Sponsor Decision|0
1351159|NCT01763918|4451898|P1|Overall Study|Sponsor Decision|4
1351160|NCT01763918|4451895|P4|Overall Study|Withdrawal by Subject|2
1351161|NCT01763918|4451896|P3|Overall Study|Withdrawal by Subject|1
1351162|NCT01763918|4451897|P2|Overall Study|Withdrawal by Subject|1
1351163|NCT01763918|4451898|P1|Overall Study|Withdrawal by Subject|2
1351164|NCT01763905|4451996|P4|Overall Study|Lost to Follow-up|0
1351165|NCT01763905|4451997|P3|Overall Study|Lost to Follow-up|1
1351166|NCT01763905|4451998|P2|Overall Study|Lost to Follow-up|0
1351167|NCT01763905|4451999|P1|Overall Study|Lost to Follow-up|0
1351168|NCT01763905|4451996|P4|Overall Study|Decision by sponsor|0
1351169|NCT01763905|4451997|P3|Overall Study|Decision by sponsor|8
1351170|NCT01763905|4451998|P2|Overall Study|Decision by sponsor|0
1351171|NCT01763905|4451999|P1|Overall Study|Decision by sponsor|5
1351172|NCT01763905|4451996|P4|Overall Study|Withdrawal by Subject|1
1351173|NCT01763905|4451997|P3|Overall Study|Withdrawal by Subject|0
1351174|NCT01763905|4451998|P2|Overall Study|Withdrawal by Subject|1
1351175|NCT01763905|4451999|P1|Overall Study|Withdrawal by Subject|1
1351176|NCT01763866|4452117|P24|Overall Study|Death|0
1351177|NCT01763866|4452118|P23|Overall Study|Death|0
1351178|NCT01763866|4452119|P22|Overall Study|Death|0
1351179|NCT01763866|4452120|P21|Overall Study|Death|0
1351180|NCT01763866|4452121|P20|Overall Study|Death|0
1351181|NCT01763866|4452122|P19|Overall Study|Death|0
1351182|NCT01763866|4452123|P18|Overall Study|Death|0
1351183|NCT01763866|4452124|P17|Overall Study|Death|1
1351184|NCT01763866|4452125|P16|Overall Study|Death|0
1351185|NCT01763866|4452126|P15|Overall Study|Death|0
1351186|NCT01763866|4452127|P14|Overall Study|Death|0
1351187|NCT01763866|4452128|P13|Overall Study|Death|0
1351188|NCT01763866|4452129|P12|Overall Study|Death|0
1351189|NCT01763866|4452130|P11|Overall Study|Death|0
1351190|NCT01763866|4452131|P10|Overall Study|Death|0
1351191|NCT01763866|4452132|P9|Overall Study|Death|0
1351192|NCT01763866|4452133|P8|Overall Study|Death|0
1351193|NCT01763866|4452134|P7|Overall Study|Death|0
1351194|NCT01763866|4452135|P6|Overall Study|Death|0
1351195|NCT01763866|4452136|P5|Overall Study|Death|0
1351196|NCT01763866|4452137|P4|Overall Study|Death|0
1351197|NCT01763866|4452138|P3|Overall Study|Death|0
1351198|NCT01763866|4452139|P2|Overall Study|Death|0
1351199|NCT01763866|4452140|P1|Overall Study|Death|0
1351200|NCT01763866|4452117|P24|Overall Study|Lost to Follow-up|1
1351201|NCT01763866|4452118|P23|Overall Study|Lost to Follow-up|0
1351202|NCT01763866|4452119|P22|Overall Study|Lost to Follow-up|0
1351203|NCT01763866|4452120|P21|Overall Study|Lost to Follow-up|0
1351204|NCT01763866|4452121|P20|Overall Study|Lost to Follow-up|1
1351205|NCT01763866|4452122|P19|Overall Study|Lost to Follow-up|1
1351206|NCT01763866|4452123|P18|Overall Study|Lost to Follow-up|0
1351207|NCT01763866|4452124|P17|Overall Study|Lost to Follow-up|0
1351208|NCT01763866|4452125|P16|Overall Study|Lost to Follow-up|0
1351209|NCT01763866|4452126|P15|Overall Study|Lost to Follow-up|1
1351210|NCT01763866|4452127|P14|Overall Study|Lost to Follow-up|0
1351211|NCT01763866|4452128|P13|Overall Study|Lost to Follow-up|1
1351212|NCT01763866|4452129|P12|Overall Study|Lost to Follow-up|0
1351213|NCT01763866|4452130|P11|Overall Study|Lost to Follow-up|0
1351214|NCT01763866|4452131|P10|Overall Study|Lost to Follow-up|0
1351215|NCT01763866|4452132|P9|Overall Study|Lost to Follow-up|0
1351216|NCT01763866|4452133|P8|Overall Study|Lost to Follow-up|0
1351217|NCT01763866|4452134|P7|Overall Study|Lost to Follow-up|1
1351218|NCT01763866|4452135|P6|Overall Study|Lost to Follow-up|0
1351219|NCT01763866|4452136|P5|Overall Study|Lost to Follow-up|0
1351220|NCT01763866|4452137|P4|Overall Study|Lost to Follow-up|0
1351221|NCT01763866|4452138|P3|Overall Study|Lost to Follow-up|0
1351222|NCT01763866|4452139|P2|Overall Study|Lost to Follow-up|0
1351223|NCT01763866|4452140|P1|Overall Study|Lost to Follow-up|0
1351224|NCT01763866|4452117|P24|Overall Study|Decision by sponsor|0
1351225|NCT01763866|4452118|P23|Overall Study|Decision by sponsor|1
1351226|NCT01763866|4452119|P22|Overall Study|Decision by sponsor|0
1351227|NCT01763866|4452120|P21|Overall Study|Decision by sponsor|2
1351228|NCT01763866|4452121|P20|Overall Study|Decision by sponsor|0
1351229|NCT01763866|4452122|P19|Overall Study|Decision by sponsor|4
1351230|NCT01763866|4452123|P18|Overall Study|Decision by sponsor|0
1351231|NCT01763866|4452124|P17|Overall Study|Decision by sponsor|0
1351232|NCT01763866|4452125|P16|Overall Study|Decision by sponsor|0
1351233|NCT01763866|4452126|P15|Overall Study|Decision by sponsor|5
1351234|NCT01763866|4452127|P14|Overall Study|Decision by sponsor|0
1351235|NCT01763866|4452128|P13|Overall Study|Decision by sponsor|1
1351236|NCT01763866|4452129|P12|Overall Study|Decision by sponsor|0
1351237|NCT01763866|4452130|P11|Overall Study|Decision by sponsor|6
1351238|NCT01763866|4452131|P10|Overall Study|Decision by sponsor|0
1351239|NCT01763866|4452132|P9|Overall Study|Decision by sponsor|2
1351240|NCT01763866|4452133|P8|Overall Study|Decision by sponsor|0
1351241|NCT01763866|4452134|P7|Overall Study|Decision by sponsor|2
1351242|NCT01763866|4452135|P6|Overall Study|Decision by sponsor|0
1351243|NCT01763866|4452136|P5|Overall Study|Decision by sponsor|2
1351244|NCT01763866|4452137|P4|Overall Study|Decision by sponsor|0
1351245|NCT01763866|4452138|P3|Overall Study|Decision by sponsor|1
1351246|NCT01763866|4452139|P2|Overall Study|Decision by sponsor|0
1351247|NCT01763866|4452140|P1|Overall Study|Decision by sponsor|0
1351248|NCT01763866|4452117|P24|Overall Study|Withdrawal by Subject|1
1351249|NCT01763866|4452118|P23|Overall Study|Withdrawal by Subject|2
1351250|NCT01763866|4452119|P22|Overall Study|Withdrawal by Subject|1
1351251|NCT01763866|4452120|P21|Overall Study|Withdrawal by Subject|2
1351252|NCT01763866|4452121|P20|Overall Study|Withdrawal by Subject|1
1351253|NCT01763866|4452122|P19|Overall Study|Withdrawal by Subject|1
1351254|NCT01763866|4452123|P18|Overall Study|Withdrawal by Subject|1
1351255|NCT01763866|4452124|P17|Overall Study|Withdrawal by Subject|0
1351256|NCT01763866|4452125|P16|Overall Study|Withdrawal by Subject|3
1351257|NCT01763866|4452126|P15|Overall Study|Withdrawal by Subject|6
1351258|NCT01763866|4452127|P14|Overall Study|Withdrawal by Subject|0
1351259|NCT01763866|4452128|P13|Overall Study|Withdrawal by Subject|2
1351260|NCT01763866|4452129|P12|Overall Study|Withdrawal by Subject|2
1351261|NCT01763866|4452130|P11|Overall Study|Withdrawal by Subject|2
1351262|NCT01763866|4452131|P10|Overall Study|Withdrawal by Subject|1
1351263|NCT01763866|4452132|P9|Overall Study|Withdrawal by Subject|1
1351264|NCT01763866|4452133|P8|Overall Study|Withdrawal by Subject|0
1351265|NCT01763866|4452134|P7|Overall Study|Withdrawal by Subject|4
1351266|NCT01763866|4452135|P6|Overall Study|Withdrawal by Subject|3
1351267|NCT01763866|4452136|P5|Overall Study|Withdrawal by Subject|0
1351268|NCT01763866|4452137|P4|Overall Study|Withdrawal by Subject|0
1351269|NCT01763866|4452138|P3|Overall Study|Withdrawal by Subject|4
1351270|NCT01763866|4452139|P2|Overall Study|Withdrawal by Subject|1
1351271|NCT01763866|4452140|P1|Overall Study|Withdrawal by Subject|2
1351272|NCT01763827|4452700|P6|Overall Study|Lost to Follow-up|1
1351273|NCT01763827|4452701|P5|Overall Study|Lost to Follow-up|2
1351274|NCT01763827|4452702|P4|Overall Study|Lost to Follow-up|1
1351275|NCT01763827|4452703|P3|Overall Study|Lost to Follow-up|1
1351276|NCT01763827|4452704|P2|Overall Study|Lost to Follow-up|1
1351277|NCT01763827|4452705|P1|Overall Study|Lost to Follow-up|0
1351278|NCT01763827|4452700|P6|Overall Study|Decision by sponsor|1
1351279|NCT01763827|4452701|P5|Overall Study|Decision by sponsor|2
1351280|NCT01763827|4452702|P4|Overall Study|Decision by sponsor|0
1351281|NCT01763827|4452703|P3|Overall Study|Decision by sponsor|3
1351282|NCT01763827|4452704|P2|Overall Study|Decision by sponsor|0
1351283|NCT01763827|4452705|P1|Overall Study|Decision by sponsor|2
1351284|NCT01763827|4452700|P6|Overall Study|Withdrawal by Subject|0
1351285|NCT01763827|4452701|P5|Overall Study|Withdrawal by Subject|2
1351286|NCT01763827|4452702|P4|Overall Study|Withdrawal by Subject|0
1351287|NCT01763827|4452703|P3|Overall Study|Withdrawal by Subject|0
1351288|NCT01763827|4452704|P2|Overall Study|Withdrawal by Subject|0
1351289|NCT01763827|4452705|P1|Overall Study|Withdrawal by Subject|1
1351290|NCT01763047|4452876|P2|Period 2|Unsatisfactory lens Fitting|1
1351291|NCT01763047|4452877|P1|Period 2|Unsatisfactory lens Fitting|0
1351292|NCT01763047|4452876|P2|Period 2|Protocol Violation|2
1351293|NCT01763047|4452877|P1|Period 2|Protocol Violation|0
1351294|NCT01763047|4452876|P2|Period 2|Unsatisfactory Visual Response|1
1351295|NCT01763047|4452877|P1|Period 2|Unsatisfactory Visual Response|1
1351296|NCT01763047|4452876|P2|Period 2|Study Site office Closed|1
1351297|NCT01763047|4452877|P1|Period 2|Study Site office Closed|1
1351298|NCT01763047|4452876|P2|Period 2|No longer meets Eligibility Criteria|0
1351299|NCT01763047|4452877|P1|Period 2|No longer meets Eligibility Criteria|1
1351300|NCT01763047|4452876|P2|Period 2|Lens Discomfort|0
1351301|NCT01763047|4452877|P1|Period 2|Lens Discomfort|1
1351302|NCT01763047|4452876|P2|Period 1|Study Site office Closed|1
1351303|NCT01763047|4452877|P1|Period 1|Study Site office Closed|0
1351304|NCT01763047|4452876|P2|Period 1|Lens Power Not Available|1
1351305|NCT01763047|4452877|P1|Period 1|Lens Power Not Available|0
1351306|NCT01763047|4452876|P2|Period 1|Unsatisfactory Visual Response|3
1351307|NCT01763047|4452877|P1|Period 1|Unsatisfactory Visual Response|0
1351308|NCT01763047|4452876|P2|Period 1|Adverse Event|1
1351309|NCT01763047|4452877|P1|Period 1|Adverse Event|0
1351310|NCT01763047|4452876|P2|Period 1|No Longer Meets Eligibility criteria|0
1351311|NCT01763047|4452877|P1|Period 1|No Longer Meets Eligibility criteria|1
1351312|NCT01763047|4452876|P2|Period 1|Protocol Violation|4
1351313|NCT01763047|4452877|P1|Period 1|Protocol Violation|4
1351314|NCT01763047|4452876|P2|Period 1|Test Article Not Available|1
1351315|NCT01763047|4452877|P1|Period 1|Test Article Not Available|4
1351316|NCT01762943|4452916|P2|Overall Study|Withdrawal by Subject|1
1351317|NCT01762943|4452917|P1|Overall Study|Withdrawal by Subject|2
1351318|NCT01762943|4452916|P2|Overall Study|Protocol Violation|0
1351319|NCT01762943|4452917|P1|Overall Study|Protocol Violation|1
1351320|NCT01762943|4452916|P2|Overall Study|Physician Decision|1
1351321|NCT01762943|4452917|P1|Overall Study|Physician Decision|1
1351322|NCT01762800|4452934|P2|Overall Study|Withdrawal by Subject|4
1351323|NCT01762800|4452935|P1|Overall Study|Withdrawal by Subject|7
1351324|NCT01762800|4452934|P2|Overall Study|Physician Decision|1
1351325|NCT01762800|4452935|P1|Overall Study|Physician Decision|1
1351326|NCT01762800|4452934|P2|Overall Study|Study Closed/Terminated|1
1351327|NCT01762800|4452935|P1|Overall Study|Study Closed/Terminated|0
1351328|NCT01762800|4452934|P2|Overall Study|Lack of Efficacy|2
1351329|NCT01762800|4452935|P1|Overall Study|Lack of Efficacy|3
1351330|NCT01762800|4452934|P2|Overall Study|Adverse Event|13
1351331|NCT01762800|4452935|P1|Overall Study|Adverse Event|8
1351332|NCT01762761|4453009|P2|Overall Study|Physician Decision|1
1351333|NCT01762761|4453010|P1|Overall Study|Physician Decision|0
1351334|NCT01762761|4453009|P2|Overall Study|Protocol Violation|1
1351335|NCT01762761|4453010|P1|Overall Study|Protocol Violation|0
1351336|NCT01762761|4453009|P2|Overall Study|Lack of Efficacy|0
1351337|NCT01762761|4453010|P1|Overall Study|Lack of Efficacy|1
1351338|NCT01762761|4453009|P2|Overall Study|Adverse Event|2
1351339|NCT01762761|4453010|P1|Overall Study|Adverse Event|1
1351340|NCT01762345|4453088|P1|Overall Study|Protocol Violation|2
1351341|NCT01762345|4453088|P1|Overall Study|Adverse Event|5
1351342|NCT01761565|4453136|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
1351343|NCT01761162|4453189|P1|Overall Study|Withdrawal by Subject|3
1351344|NCT01760876|4453281|P1|Overall Study|Very poor baseline OCT quality|2
1351345|NCT01760876|4453281|P1|Overall Study|Major depression|1
1351346|NCT01760876|4453281|P1|Overall Study|Impaired renal function|1
1351347|NCT01760876|4453281|P1|Overall Study|Carcinoma of prostate|1
1351348|NCT01760876|4453281|P1|Overall Study|Non-cardiac death (head injury)|1
1351349|NCT01759511|4453336|P1|Overall Study|Withdrawal by Subject|3
1351350|NCT01759511|4453336|P1|Overall Study|Study Terminated by Sponsor|13
1351351|NCT01759511|4453336|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
1351352|NCT01759511|4453336|P1|Overall Study|Progressive Disease|5
1351353|NCT01759511|4453336|P1|Overall Study|Physician Decision|1
1351354|NCT01759511|4453336|P1|Overall Study|Lack of Efficacy|2
1351355|NCT01759511|4453336|P1|Overall Study|Death|2
1351356|NCT01759511|4453336|P1|Overall Study|Adverse Event|4
1351357|NCT01759420|4453344|P1|Overall Study|Inaccurate EKG machine readings|1
1351358|NCT01759420|4453344|P1|Overall Study|Screen failure|5
1351359|NCT01759407|4453351|P2|Overall Study|Protocol Violation|2
1351360|NCT01759407|4453352|P1|Overall Study|Protocol Violation|0
1351361|NCT01759381|4453364|P2|Overall Study|Death|0
1351362|NCT01759381|4453365|P1|Overall Study|Death|1
1351363|NCT01759368|4453373|P2|Overall Study|Lost to Follow-up|0
1351364|NCT01759368|4453374|P1|Overall Study|Lost to Follow-up|1
1351365|NCT01759290|4453392|P1|Overall Study|Unknown reason|4
1351366|NCT01759290|4453392|P1|Overall Study|Lost to Follow-up|53
1351367|NCT01759290|4453392|P1|Overall Study|Death|17
1351368|NCT01759290|4453392|P1|Overall Study|Physician Decision|2
1351369|NCT01759290|4453392|P1|Overall Study|Subjects withdrawn consent|5
1351370|NCT01759264|4453452|P1|Overall Study|Discontinued Humira Due to Business Trip|1
1351371|NCT01759264|4453452|P1|Overall Study|Withdrawal by Subject|3
1351372|NCT01759264|4453452|P1|Overall Study|Lost to Follow-up|2
1351373|NCT01759264|4453452|P1|Overall Study|Not Specified|2
1351374|NCT01759264|4453452|P1|Overall Study|Adverse Event|1
1351375|NCT01759264|4453452|P1|Overall Study|Serious Adverse Events (SAEs)|1
1351376|NCT01758900|4453480|P2|Overall Study|difficulty for further intubation|8
1351377|NCT01758900|4453481|P1|Overall Study|difficulty for further intubation|7
1351378|NCT01758289|4453597|P1|Overall Study|Adverse Event|9
1351379|NCT01758289|4453597|P1|Overall Study|Premature Study Termination|44
1351380|NCT01757847|4453623|P2|Overall Study|Withdrawal by Subject|4
1351381|NCT01757847|4453624|P1|Overall Study|Withdrawal by Subject|3
1351382|NCT01757821|4453632|P1|Overall Study|Adverse Event|1
1351383|NCT01757704|4453647|P2|Overall Study|Protocol Violation|3
1351384|NCT01757704|4453648|P1|Overall Study|Protocol Violation|1
1351385|NCT01757691|4453666|P2|Overall Study|Administrative problems|0
1351386|NCT01757691|4453667|P1|Overall Study|Administrative problems|2
1351387|NCT01757405|4453715|P2|Overall Study|Withdrawal by Subject|1
1351388|NCT01757405|4453716|P1|Overall Study|Withdrawal by Subject|0
1351389|NCT01757405|4453715|P2|Overall Study|Lost to Follow-up|1
1351390|NCT01757405|4453716|P1|Overall Study|Lost to Follow-up|1
1351391|NCT01757275|4453734|P2|Overall Study|Not treated|4
1351392|NCT01757275|4453735|P1|Overall Study|Not treated|3
1351393|NCT01757275|4453734|P2|Overall Study|Withdrawal by Subject|4
1351394|NCT01757275|4453735|P1|Overall Study|Withdrawal by Subject|2
1351395|NCT01757275|4453734|P2|Overall Study|Adverse Event|3
1351396|NCT01757275|4453735|P1|Overall Study|Adverse Event|3
1351397|NCT01757275|4453734|P2|Overall Study|Lost to Follow-up|2
1351398|NCT01757275|4453735|P1|Overall Study|Lost to Follow-up|1
1351399|NCT01757197|4453757|P1|Overall Study|Death|2
1351400|NCT01757184|4453766|P2|Double-Blind Period|Adverse Event|0
1351401|NCT01757184|4453767|P1|Double-Blind Period|Adverse Event|1
1351402|NCT01757171|4453791|P2|Overall Study|ECOG decline|0
1351403|NCT01757171|4453792|P1|Overall Study|ECOG decline|1
1351404|NCT01757171|4453791|P2|Overall Study|Hospitalization|0
1351405|NCT01757171|4453792|P1|Overall Study|Hospitalization|1
1351406|NCT01757171|4453791|P2|Overall Study|Disease Progression|0
1351407|NCT01757171|4453792|P1|Overall Study|Disease Progression|1
1351408|NCT01757171|4453791|P2|Overall Study|Adverse Event|1
1351409|NCT01757171|4453792|P1|Overall Study|Adverse Event|5
1351410|NCT01756300|4453826|P1|Overall Study|Withdrawal by Subject|1
1351411|NCT01756300|4453826|P1|Overall Study|Death|1
1351412|NCT01756274|4453848|P1|Overall Study|Laboratory error|1
1351413|NCT01756274|4453848|P1|Overall Study|Protocol Violation|2
1351414|NCT01756235|4453855|P1|Overall Study|Adalimumab Treatment was not Documented|2
1351415|NCT01756157|4453876|P2|First Intervention Period|Lost to Follow-up|2
1351416|NCT01756157|4453877|P1|First Intervention Period|Lost to Follow-up|0
1351417|NCT01756157|4453876|P2|First Intervention Period|Withdrawal by Subject|0
1351418|NCT01756157|4453877|P1|First Intervention Period|Withdrawal by Subject|1
1351419|NCT01756079|4453891|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
1351420|NCT01756079|4453891|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
1351421|NCT01756079|4453891|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
1351422|NCT01756079|4453891|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
1351423|NCT01756079|4453891|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
1351424|NCT01756053|4453897|P2|Period 2 (10 Days)|Protocol Violation|2
1351425|NCT01756053|4453898|P1|Period 2 (10 Days)|Protocol Violation|0
1351426|NCT01756053|4453897|P2|Period 1 (10 Days)|Protocol Violation|1
1351427|NCT01756053|4453898|P1|Period 1 (10 Days)|Protocol Violation|1
1351428|NCT01755702|4453918|P1|Washout Period II|Other Reason|5
1351429|NCT01755702|4453918|P1|Wash Out Period I|Other Reason|3
1351430|NCT01755689|4453965|P5|Overall Study|Pregnancy|2
1351431|NCT01755689|4453966|P4|Overall Study|Pregnancy|4
1351432|NCT01755689|4453967|P3|Overall Study|Pregnancy|2
1351433|NCT01755689|4453968|P2|Overall Study|Pregnancy|1
1351434|NCT01755689|4453969|P1|Overall Study|Pregnancy|1
1351435|NCT01755689|4453965|P5|Overall Study|Lost to Follow-up|2
1351436|NCT01755689|4453966|P4|Overall Study|Lost to Follow-up|0
1351437|NCT01755689|4453967|P3|Overall Study|Lost to Follow-up|1
1351438|NCT01755689|4453968|P2|Overall Study|Lost to Follow-up|0
1351439|NCT01755689|4453969|P1|Overall Study|Lost to Follow-up|1
1351440|NCT01755689|4453965|P5|Overall Study|Migrated/moved from study area|1
1351441|NCT01755689|4453966|P4|Overall Study|Migrated/moved from study area|1
1351442|NCT01755689|4453967|P3|Overall Study|Migrated/moved from study area|1
1351443|NCT01755689|4453968|P2|Overall Study|Migrated/moved from study area|1
1351444|NCT01755689|4453969|P1|Overall Study|Migrated/moved from study area|0
1351445|NCT01755689|4453965|P5|Overall Study|Withdrawal by Subject|1
1351446|NCT01755689|4453966|P4|Overall Study|Withdrawal by Subject|1
1351447|NCT01755689|4453967|P3|Overall Study|Withdrawal by Subject|2
1351448|NCT01755689|4453968|P2|Overall Study|Withdrawal by Subject|3
1351449|NCT01755689|4453969|P1|Overall Study|Withdrawal by Subject|1
1351450|NCT01755637|4454044|P2|Period 1|Adverse Event|1
1351451|NCT01755637|4454045|P1|Period 1|Adverse Event|0
1351452|NCT01755416|4454076|P2|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
1351453|NCT01755416|4454077|P1|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
1351454|NCT01755234|4454085|P2|Overall Study|unblinded|0
1351455|NCT01755234|4454086|P1|Overall Study|unblinded|1
1351456|NCT01755234|4454085|P2|Overall Study|Withdrawal by Subject|1
1351457|NCT01755234|4454086|P1|Overall Study|Withdrawal by Subject|0
1351458|NCT01755234|4454085|P2|Overall Study|case cancelled|0
1351459|NCT01755234|4454086|P1|Overall Study|case cancelled|1
1351460|NCT01755234|4454085|P2|Overall Study|Change in surgical case|1
1351461|NCT01755234|4454086|P1|Overall Study|Change in surgical case|2
1351462|NCT01755234|4454085|P2|Overall Study|Lost to Follow-up|6
1351463|NCT01755234|4454086|P1|Overall Study|Lost to Follow-up|11
1351464|NCT01755156|4454117|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
1351465|NCT01755156|4454118|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
1351466|NCT01755156|4454117|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
1351467|NCT01755156|4454118|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
1351468|NCT01755156|4454117|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
1351469|NCT01755156|4454118|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
1351470|NCT01755156|4454117|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
1351471|NCT01755156|4454118|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
1351472|NCT01755156|4454117|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
1351473|NCT01755156|4454118|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
1351474|NCT01755156|4454117|P2|Phase A (Weeks 0-24)|Protocol Violation|1
1351475|NCT01755156|4454118|P1|Phase A (Weeks 0-24)|Protocol Violation|1
1351476|NCT01755156|4454117|P2|Phase A (Weeks 0-24)|Physician Decision|1
1351477|NCT01755156|4454118|P1|Phase A (Weeks 0-24)|Physician Decision|0
1351478|NCT01755156|4454117|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
1351479|NCT01755156|4454118|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
1351480|NCT01755156|4454117|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
1351481|NCT01755156|4454118|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
1351482|NCT01755156|4454117|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
1351483|NCT01755156|4454118|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
1351484|NCT01755156|4454117|P2|Phase A (Weeks 0-24)|Adverse Event|3
1351485|NCT01755156|4454118|P1|Phase A (Weeks 0-24)|Adverse Event|2
1351486|NCT01755091|4454182|P3|Overall Study|Physician Decision|2
1351487|NCT01755091|4454183|P2|Overall Study|Physician Decision|1
1351488|NCT01755091|4454184|P1|Overall Study|Physician Decision|1
1351489|NCT01755091|4454182|P3|Overall Study|Lost to Follow-up|1
1351490|NCT01755091|4454183|P2|Overall Study|Lost to Follow-up|0
1351491|NCT01755091|4454184|P1|Overall Study|Lost to Follow-up|1
1351492|NCT01755091|4454182|P3|Overall Study|Adverse Event|1
1351493|NCT01755091|4454183|P2|Overall Study|Adverse Event|1
1351494|NCT01755091|4454184|P1|Overall Study|Adverse Event|1
1351495|NCT01755091|4454182|P3|Overall Study|Withdrawal by Subject|3
1351496|NCT01755091|4454183|P2|Overall Study|Withdrawal by Subject|1
1351497|NCT01755091|4454184|P1|Overall Study|Withdrawal by Subject|6
1351498|NCT01755026|4454209|P2|Overall Study|Withdrawal by Subject|1
1351499|NCT01755026|4454210|P1|Overall Study|Withdrawal by Subject|1
1351500|NCT01755026|4454209|P2|Overall Study|Adverse Event|0
1351501|NCT01755026|4454210|P1|Overall Study|Adverse Event|1
1351502|NCT01754922|4454233|P2|Overall Study|Adverse Event|1
1351503|NCT01754922|4454234|P1|Overall Study|Adverse Event|0
1351504|NCT01754766|4454247|P3|Overall Study|Personal reasons|0
1351505|NCT01754766|4454248|P2|Overall Study|Personal reasons|1
1351506|NCT01754766|4454249|P1|Overall Study|Personal reasons|1
1351507|NCT01754727|4454263|P1|Overall Study|Adalimumab Treatment was not Documented|2
1351508|NCT01754493|4454390|P1|Overall Study|Scheduling conflict|1
1351509|NCT01754493|4454390|P1|Overall Study|Moved out of town|1
1351510|NCT01754493|4454390|P1|Overall Study|Withdrawal by Subject|1
1351511|NCT01754493|4454390|P1|Overall Study|Lost to Follow-up|3
1351512|NCT01754493|4454390|P1|Overall Study|Adverse Event|1
1351513|NCT01754467|4454415|P1|Overall Study|Lost to Follow-up|1
1351514|NCT01754402|4454425|P3|Overall Study|Lack of Efficacy|1
1351515|NCT01754402|4454426|P2|Overall Study|Lack of Efficacy|0
1351516|NCT01754402|4454427|P1|Overall Study|Lack of Efficacy|0
1351517|NCT01754402|4454425|P3|Overall Study|Withdrawal by Subject|1
1351518|NCT01754402|4454426|P2|Overall Study|Withdrawal by Subject|0
1351519|NCT01754402|4454427|P1|Overall Study|Withdrawal by Subject|0
1351520|NCT01754402|4454425|P3|Overall Study|Adverse Event|1
1351521|NCT01754402|4454426|P2|Overall Study|Adverse Event|2
1351522|NCT01754402|4454427|P1|Overall Study|Adverse Event|2
1351523|NCT01754402|4454425|P3|Overall Study|Death|1
1351524|NCT01754402|4454426|P2|Overall Study|Death|0
1351525|NCT01754402|4454427|P1|Overall Study|Death|0
1351526|NCT01754376|4454461|P1|Overall Study|Lack of Efficacy|2
1351527|NCT01754376|4454461|P1|Overall Study|Adverse Event|1
1351528|NCT01754259|4454472|P2|Overall Study|Lost to Follow-up|1
1351529|NCT01754259|4454473|P1|Overall Study|Lost to Follow-up|0
1351530|NCT01754259|4454472|P2|Overall Study|Adverse Event|1
1351531|NCT01754259|4454473|P1|Overall Study|Adverse Event|3
1351532|NCT01754259|4454472|P2|Overall Study|Withdrawal by Subject|4
1351533|NCT01754259|4454473|P1|Overall Study|Withdrawal by Subject|2
1351534|NCT01754194|4454483|P2|Overall Study|Not Specified|8
1351535|NCT01754194|4454484|P1|Overall Study|Not Specified|9
1351536|NCT01754194|4454483|P2|Overall Study|Withdrawal by Subject|5
1351537|NCT01754194|4454484|P1|Overall Study|Withdrawal by Subject|4
1351538|NCT01754194|4454483|P2|Overall Study|Lost to Follow-up|14
1351539|NCT01754194|4454484|P1|Overall Study|Lost to Follow-up|39
1351540|NCT01754129|4454504|P1|Overall Study|Inclusion/exclusion criteria violation|3
1351541|NCT01754129|4454504|P1|Overall Study|Withdrew consent|1
1351542|NCT01754129|4454504|P1|Overall Study|Lost to Follow-up|7
1351543|NCT01754129|4454504|P1|Overall Study|Duodopa discontinuation|9
1351544|NCT01754129|4454504|P1|Overall Study|Death|13
1351545|NCT01753999|4454527|P2|Period 2 -Cross to Alternate Arm|Physician Decision|2
1351546|NCT01753999|4454528|P1|Period 2 -Cross to Alternate Arm|Physician Decision|0
1351547|NCT01753999|4454527|P2|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|4
1351548|NCT01753999|4454528|P1|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|2
1351549|NCT01753999|4454527|P2|Period 2 -Cross to Alternate Arm|Lost to Follow-up|20
1351550|NCT01753999|4454528|P1|Period 2 -Cross to Alternate Arm|Lost to Follow-up|15
1351551|NCT01753999|4454527|P2|Period 1 - Initial Assignment|Lost to Follow-up|27
1351552|NCT01753999|4454528|P1|Period 1 - Initial Assignment|Lost to Follow-up|17
1351553|NCT01753999|4454527|P2|Period 1 - Initial Assignment|Withdrawal by Subject|20
1351554|NCT01753999|4454528|P1|Period 1 - Initial Assignment|Withdrawal by Subject|21
1351555|NCT01753999|4454527|P2|Period 1 - Initial Assignment|Physician Decision|3
1351556|NCT01753999|4454528|P1|Period 1 - Initial Assignment|Physician Decision|1
1351557|NCT01753856|4454538|P2|Overall Study|Sponsor Decision|0
1351558|NCT01753856|4454539|P1|Overall Study|Sponsor Decision|2
1351559|NCT01753856|4454538|P2|Overall Study|Withdrawal by Subject|2
1351560|NCT01753856|4454539|P1|Overall Study|Withdrawal by Subject|0
1351561|NCT01753856|4454538|P2|Overall Study|Adverse Event|0
1351562|NCT01753856|4454539|P1|Overall Study|Adverse Event|1
1351563|NCT01753518|4454629|P2|Postpartum Follow-up|Lost to Follow-up|15
1351564|NCT01753518|4454630|P1|Postpartum Follow-up|Lost to Follow-up|22
1351565|NCT01753518|4454629|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
1351566|NCT01753518|4454630|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
1351567|NCT01753518|4454629|P2|Intention-to-Treat Analysis|Multifetal gestation|3
1351568|NCT01753518|4454630|P1|Intention-to-Treat Analysis|Multifetal gestation|2
1351569|NCT01753518|4454629|P2|Intention-to-Treat Analysis|Missing consent form|3
1351570|NCT01753518|4454630|P1|Intention-to-Treat Analysis|Missing consent form|5
1351571|NCT01753336|4454652|P1|Overall Study|Withdrawal by Subject|1
1351572|NCT01753336|4454652|P1|Overall Study|Sponsor's decision|2
1351573|NCT01753336|4454652|P1|Overall Study|Physician Decision|2
1351574|NCT01753336|4454652|P1|Overall Study|Lost to Follow-up|3
1351575|NCT01753336|4454652|P1|Overall Study|Patient decision|12
1351576|NCT01753323|4454664|P3|Overall Study|Adverse Event|1
1351577|NCT01753323|4454665|P2|Overall Study|Adverse Event|0
1351578|NCT01753323|4454666|P1|Overall Study|Adverse Event|0
1351579|NCT01753323|4454664|P3|Overall Study|Protocol deviation|0
1351580|NCT01753323|4454665|P2|Overall Study|Protocol deviation|0
1351581|NCT01753323|4454666|P1|Overall Study|Protocol deviation|1
1351582|NCT01753323|4454664|P3|Overall Study|Lack of Efficacy|8
1351583|NCT01753323|4454665|P2|Overall Study|Lack of Efficacy|0
1351584|NCT01753323|4454666|P1|Overall Study|Lack of Efficacy|0
1351585|NCT01753310|4454704|P2|Overall Study|Withdrawal by Subject|0
1351586|NCT01753310|4454705|P1|Overall Study|Withdrawal by Subject|1
1351587|NCT01753310|4454704|P2|Overall Study|Sponsor decision|0
1351588|NCT01753310|4454705|P1|Overall Study|Sponsor decision|1
1351589|NCT01753310|4454704|P2|Overall Study|Subject decision|2
1351590|NCT01753310|4454705|P1|Overall Study|Subject decision|2
1351591|NCT01753310|4454704|P2|Overall Study|Lost to Follow-up|0
1351592|NCT01753310|4454705|P1|Overall Study|Lost to Follow-up|2
1351593|NCT01753310|4454704|P2|Overall Study|Adverse Event|0
1351594|NCT01753310|4454705|P1|Overall Study|Adverse Event|1
1351595|NCT01753310|4454704|P2|Overall Study|Entered into open label extension study|22
1351596|NCT01753310|4454705|P1|Overall Study|Entered into open label extension study|25
1351597|NCT01753115|4454728|P3|Overall Study|Used excluded drug|0
1351598|NCT01753115|4454729|P2|Overall Study|Used excluded drug|1
1351599|NCT01753115|4454730|P1|Overall Study|Used excluded drug|0
1351600|NCT01753115|4454728|P3|Overall Study|Subject non-compliant|0
1351601|NCT01753115|4454729|P2|Overall Study|Subject non-compliant|3
1351602|NCT01753115|4454730|P1|Overall Study|Subject non-compliant|3
1351603|NCT01753115|4454728|P3|Overall Study|Withdrawal by Subject|6
1351604|NCT01753115|4454729|P2|Overall Study|Withdrawal by Subject|5
1351605|NCT01753115|4454730|P1|Overall Study|Withdrawal by Subject|6
1351606|NCT01753115|4454728|P3|Overall Study|Lost to Follow-up|8
1351607|NCT01753115|4454729|P2|Overall Study|Lost to Follow-up|6
1351608|NCT01753115|4454730|P1|Overall Study|Lost to Follow-up|3
1351609|NCT01753076|4454740|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
1351610|NCT01753076|4454741|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
1351611|NCT01753076|4454740|P2|Overall Study|Withdrawal by Subject|24
1351612|NCT01753076|4454741|P1|Overall Study|Withdrawal by Subject|14
1351613|NCT01753076|4454740|P2|Overall Study|Physician Decision|2
1351614|NCT01753076|4454741|P1|Overall Study|Physician Decision|4
1351615|NCT01753076|4454740|P2|Overall Study|Lost to Follow-up|1
1351616|NCT01753076|4454741|P1|Overall Study|Lost to Follow-up|2
1351617|NCT01753076|4454740|P2|Overall Study|Lack of Efficacy|1
1351618|NCT01753076|4454741|P1|Overall Study|Lack of Efficacy|3
1351619|NCT01753076|4454740|P2|Overall Study|Adverse Event|18
1351620|NCT01753076|4454741|P1|Overall Study|Adverse Event|17
1351621|NCT01752907|4454767|P2|Overall Study|Decision by Sponsor|9
1351622|NCT01752907|4454768|P1|Overall Study|Decision by Sponsor|6
1351623|NCT01752907|4454767|P2|Overall Study|Lost to Follow-up|1
1351624|NCT01752907|4454768|P1|Overall Study|Lost to Follow-up|2
1351625|NCT01752907|4454767|P2|Overall Study|Withdrawal by Subject|10
1351626|NCT01752907|4454768|P1|Overall Study|Withdrawal by Subject|4
1351627|NCT01752855|4454788|P2|Overall Study|Lack of Efficacy|2
1351628|NCT01752855|4454789|P1|Overall Study|Lack of Efficacy|0
1351629|NCT01752855|4454788|P2|Overall Study|Withdrew Consent|2
1351630|NCT01752855|4454789|P1|Overall Study|Withdrew Consent|0
1351631|NCT01752855|4454788|P2|Overall Study|Adverse Event|0
1351632|NCT01752855|4454789|P1|Overall Study|Adverse Event|1
1351633|NCT01752023|4454835|P2|Overall Study|Physician Decision|1
1351634|NCT01752023|4454836|P1|Overall Study|Physician Decision|2
1351635|NCT01751867|4455023|P2|Overall Study|Randomized but not treated.|1
1351636|NCT01751867|4455024|P1|Overall Study|Randomized but not treated.|2
1351637|NCT01751867|4455023|P2|Overall Study|Other|37
1351638|NCT01751867|4455024|P1|Overall Study|Other|11
1351639|NCT01751867|4455023|P2|Overall Study|Death|5
1351640|NCT01751867|4455024|P1|Overall Study|Death|0
1351641|NCT01751867|4455023|P2|Overall Study|Protocol Violation|2
1351642|NCT01751867|4455024|P1|Overall Study|Protocol Violation|0
1351643|NCT01751867|4455023|P2|Overall Study|Physician Decision|7
1351644|NCT01751867|4455024|P1|Overall Study|Physician Decision|4
1351645|NCT01751867|4455023|P2|Overall Study|Withdrawal by Subject|1
1351646|NCT01751867|4455024|P1|Overall Study|Withdrawal by Subject|3
1351647|NCT01751867|4455023|P2|Overall Study|Poor Compliance|5
1351648|NCT01751867|4455024|P1|Overall Study|Poor Compliance|0
1351649|NCT01751867|4455023|P2|Overall Study|Adverse Event|15
1351650|NCT01751867|4455024|P1|Overall Study|Adverse Event|8
1351651|NCT01751867|4455023|P2|Overall Study|Diease Progression|18
1351652|NCT01751867|4455024|P1|Overall Study|Diease Progression|4
1351653|NCT01751867|4455023|P2|Overall Study|Completed treatment,dropped in follow-up|8
1351654|NCT01751867|4455024|P1|Overall Study|Completed treatment,dropped in follow-up|4
1351655|NCT01751802|4455044|P2|Overall Study|Adverse Event|2
1351656|NCT01751802|4455045|P1|Overall Study|Adverse Event|4
1351657|NCT01751724|4455059|P2|Overall Study|withdrawn by parent|2
1351658|NCT01751724|4455060|P1|Overall Study|withdrawn by parent|0
1351659|NCT01751724|4455059|P2|Overall Study|extubated bef.start assigned treatment|0
1351660|NCT01751724|4455060|P1|Overall Study|extubated bef.start assigned treatment|1
1351661|NCT01751412|4455086|P1|Overall Study|Disease Progression Before Treatment|1
1351662|NCT01751178|4455154|P3|Overall Study|Other Reason (unknown)|2
1351663|NCT01751178|4455155|P2|Overall Study|Other Reason (unknown)|0
1351664|NCT01751178|4455156|P1|Overall Study|Other Reason (unknown)|1
1351665|NCT01751178|4455154|P3|Overall Study|Adverse Event|0
1351666|NCT01751178|4455155|P2|Overall Study|Adverse Event|0
1351667|NCT01751178|4455156|P1|Overall Study|Adverse Event|2
1351668|NCT01751165|4455176|P3|Overall Study|Lost to Follow-up|1
1351669|NCT01751165|4455177|P2|Overall Study|Lost to Follow-up|1
1351670|NCT01751165|4455178|P1|Overall Study|Lost to Follow-up|1
1351671|NCT01751165|4455176|P3|Overall Study|Serious adverse event|0
1351672|NCT01751165|4455177|P2|Overall Study|Serious adverse event|2
1351673|NCT01751165|4455178|P1|Overall Study|Serious adverse event|0
1351674|NCT01751165|4455176|P3|Overall Study|Withdrawal by Subject|1
1351675|NCT01751165|4455177|P2|Overall Study|Withdrawal by Subject|0
1351676|NCT01751165|4455178|P1|Overall Study|Withdrawal by Subject|0
1351677|NCT01751165|4455176|P3|Overall Study|Adverse event, serious fatal|1
1351678|NCT01751165|4455177|P2|Overall Study|Adverse event, serious fatal|0
1351679|NCT01751165|4455178|P1|Overall Study|Adverse event, serious fatal|1
1351680|NCT01751113|4455218|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
1351681|NCT01751113|4455219|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
1351682|NCT01751113|4455220|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
1351683|NCT01751113|4455221|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
1351684|NCT01751113|4455222|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
1351685|NCT01751113|4455223|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
1351686|NCT01751113|4455218|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
1351687|NCT01751113|4455219|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
1351688|NCT01751113|4455220|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
1351689|NCT01751113|4455221|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
1351690|NCT01751113|4455222|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
1351691|NCT01751113|4455223|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
1351692|NCT01751087|4455264|P3|Overall Study|Physician Decision|1
1351693|NCT01751087|4455265|P2|Overall Study|Physician Decision|0
1351694|NCT01751087|4455266|P1|Overall Study|Physician Decision|0
1351695|NCT01751087|4455264|P3|Overall Study|Withdrawal by Subject|0
1351696|NCT01751087|4455265|P2|Overall Study|Withdrawal by Subject|0
1351697|NCT01751087|4455266|P1|Overall Study|Withdrawal by Subject|1
1351698|NCT01750840|4455354|P1|Overall Study|Lost to Follow-up|4
1351699|NCT01750684|4455361|P2|Overall Study|Protocol Violation|0
1351700|NCT01750684|4455362|P1|Overall Study|Protocol Violation|1
1351701|NCT01750684|4455361|P2|Overall Study|Withdrawn by Sponsor|1
1351702|NCT01750684|4455362|P1|Overall Study|Withdrawn by Sponsor|0
1351703|NCT01750684|4455361|P2|Overall Study|Non-compliance with Study Drug|1
1351704|NCT01750684|4455362|P1|Overall Study|Non-compliance with Study Drug|0
1351705|NCT01750684|4455361|P2|Overall Study|Death|0
1351706|NCT01750684|4455362|P1|Overall Study|Death|1
1351707|NCT01750346|4455397|P3|Overall Study|Adverse Event|0
1351708|NCT01750346|4455398|P2|Overall Study|Adverse Event|0
1351709|NCT01750346|4455399|P1|Overall Study|Adverse Event|1
1351710|NCT01750294|4455425|P1|Overall Study|Safety Endpoint|1
1351711|NCT01750294|4455425|P1|Overall Study|Withdrawal by Subject|1
1351712|NCT01750281|4455432|P3|Overall Study|Did not receive treatment|0
1351713|NCT01750281|4455433|P2|Overall Study|Did not receive treatment|1
1351714|NCT01750281|4455434|P1|Overall Study|Did not receive treatment|0
1351715|NCT01750281|4455432|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
1351716|NCT01750281|4455433|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
1351717|NCT01750281|4455434|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
1351718|NCT01750281|4455432|P3|Overall Study|Discontinued Selumetinib/Placebo|75
1351719|NCT01750281|4455433|P2|Overall Study|Discontinued Selumetinib/Placebo|77
1351720|NCT01750281|4455434|P1|Overall Study|Discontinued Selumetinib/Placebo|37
1351721|NCT01750242|4455464|P1|Overall Study|Unreadable Images|3
1351722|NCT01750229|4455469|P1|Long-term Follow-up Phase|Withdrawal by Subject|1
1351723|NCT01750229|4455469|P1|Long-term Follow-up Phase|Adverse Event|2
1351724|NCT01750229|4455469|P1|Randomized Crossover Phase|Withdrawal by Subject|1
1351725|NCT01750229|4455469|P1|Randomized Crossover Phase|Adverse Event|1
1351726|NCT01749982|4455492|P4|Overall Study|Withdrawal by Subject|1
1351727|NCT01749982|4455493|P3|Overall Study|Withdrawal by Subject|0
1351728|NCT01749982|4455494|P2|Overall Study|Withdrawal by Subject|0
1351729|NCT01749982|4455495|P1|Overall Study|Withdrawal by Subject|0
1351730|NCT01749982|4455492|P4|Overall Study|Lost to Follow-up|1
1351731|NCT01749982|4455493|P3|Overall Study|Lost to Follow-up|0
1351732|NCT01749982|4455494|P2|Overall Study|Lost to Follow-up|0
1351733|NCT01749982|4455495|P1|Overall Study|Lost to Follow-up|0
1351734|NCT01749982|4455492|P4|Overall Study|Physician Decision|1
1351735|NCT01749982|4455493|P3|Overall Study|Physician Decision|0
1351736|NCT01749982|4455494|P2|Overall Study|Physician Decision|0
1351737|NCT01749982|4455495|P1|Overall Study|Physician Decision|0
1351738|NCT01749800|4455526|P3|Overall Study|Withdrawal by Subject|0
1351739|NCT01749800|4455527|P2|Overall Study|Withdrawal by Subject|1
1351740|NCT01749800|4455528|P1|Overall Study|Withdrawal by Subject|0
1351741|NCT01749800|4455526|P3|Overall Study|not meeting inclusion criteria|0
1351742|NCT01749800|4455527|P2|Overall Study|not meeting inclusion criteria|0
1351743|NCT01749800|4455528|P1|Overall Study|not meeting inclusion criteria|3
1351744|NCT01749735|4455538|P2|Overall Study|Withdrawal by Subject|0
1351745|NCT01749735|4455539|P1|Overall Study|Withdrawal by Subject|1
1351746|NCT01748890|4455628|P1|Overall Study|Insufficient recruitment for analysis|4
1351747|NCT01748760|4455683|P2|Overall Study|Lost to Follow-up|1
1351748|NCT01748760|4455684|P1|Overall Study|Lost to Follow-up|5
1351749|NCT01748760|4455683|P2|Overall Study|Withdrawal by Subject|1
1351750|NCT01748760|4455684|P1|Overall Study|Withdrawal by Subject|1
1351751|NCT01748292|4455720|P2|Overall Study|Withdrawal by Subject|2
1351752|NCT01748292|4455721|P1|Overall Study|Withdrawal by Subject|0
1351753|NCT01748292|4455720|P2|Overall Study|Death|3
1351754|NCT01748292|4455721|P1|Overall Study|Death|0
1351755|NCT01748292|4455720|P2|Overall Study|Lost to Follow-up|3
1351756|NCT01748292|4455721|P1|Overall Study|Lost to Follow-up|0
1351757|NCT01748292|4455720|P2|Overall Study|Adverse Event|4
1351758|NCT01748292|4455721|P1|Overall Study|Adverse Event|2
1351759|NCT01748162|4455751|P2|Overall Study|reasons not available|2
1351760|NCT01748162|4455752|P1|Overall Study|reasons not available|3
1351761|NCT01748162|4455751|P2|Overall Study|participant consented but did not begin|1
1351762|NCT01748162|4455752|P1|Overall Study|participant consented but did not begin|0
1351763|NCT01748162|4455751|P2|Overall Study|no additional croup episodes to evaluate|2
1351764|NCT01748162|4455752|P1|Overall Study|no additional croup episodes to evaluate|2
1351765|NCT01748071|4455763|P3|Overall Study|Adverse Event|0
1351766|NCT01748071|4455764|P2|Overall Study|Adverse Event|2
1351767|NCT01748071|4455765|P1|Overall Study|Adverse Event|2
1351768|NCT01747811|4456052|P2|Overall Study|Lack of Efficacy|4
1351769|NCT01747811|4456053|P1|Overall Study|Lack of Efficacy|2
1351770|NCT01747772|4456069|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
1351771|NCT01747655|4456077|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
1351772|NCT01747655|4456078|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
1351773|NCT01747655|4456077|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
1351774|NCT01747655|4456078|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
1351775|NCT01747655|4456077|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
1351776|NCT01747655|4456078|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
1351777|NCT01747629|4456108|P2|Overall Study|Not specified|1
1351778|NCT01747629|4456109|P1|Overall Study|Not specified|2
1351779|NCT01747629|4456108|P2|Overall Study|Not treated|0
1351780|NCT01747629|4456109|P1|Overall Study|Not treated|1
1351781|NCT01747629|4456108|P2|Overall Study|Inclusion criteria not met|0
1351782|NCT01747629|4456109|P1|Overall Study|Inclusion criteria not met|1
1351783|NCT01747629|4456108|P2|Overall Study|Noncompliance|1
1351784|NCT01747629|4456109|P1|Overall Study|Noncompliance|1
1351785|NCT01747629|4456108|P2|Overall Study|Withdrawal by Subject|2
1351786|NCT01747629|4456109|P1|Overall Study|Withdrawal by Subject|2
1351787|NCT01747629|4456108|P2|Overall Study|Adverse Event|2
1351788|NCT01747629|4456109|P1|Overall Study|Adverse Event|1
1351789|NCT01747551|4456143|P2|Overall Study|Other|0
1351790|NCT01747551|4456144|P1|Overall Study|Other|2
1351791|NCT01747551|4456143|P2|Overall Study|Physician Decision|1
1351792|NCT01747551|4456144|P1|Overall Study|Physician Decision|2
1351793|NCT01747551|4456143|P2|Overall Study|Withdrawal by Subject|1
1351794|NCT01747551|4456144|P1|Overall Study|Withdrawal by Subject|3
1351795|NCT01747551|4456143|P2|Overall Study|Prolonged Treatment Delay|0
1351796|NCT01747551|4456144|P1|Overall Study|Prolonged Treatment Delay|2
1351797|NCT01747551|4456143|P2|Overall Study|Adverse Event|1
1351798|NCT01747551|4456144|P1|Overall Study|Adverse Event|7
1351799|NCT01747551|4456143|P2|Overall Study|Death|1
1351800|NCT01747551|4456144|P1|Overall Study|Death|3
1351801|NCT01747551|4456143|P2|Overall Study|Progressive Disease|17
1351802|NCT01747551|4456144|P1|Overall Study|Progressive Disease|24
1351803|NCT01746862|4456202|P2|Overall Study|Entered puberty during the study|0
1351804|NCT01746862|4456203|P1|Overall Study|Entered puberty during the study|1
1351805|NCT01746862|4456202|P2|Overall Study|Consent withdrawal by parent’s guardian|2
1351806|NCT01746862|4456203|P1|Overall Study|Consent withdrawal by parent’s guardian|5
1351807|NCT01746862|4456202|P2|Overall Study|Protocol Violation|0
1351808|NCT01746862|4456203|P1|Overall Study|Protocol Violation|1
1351809|NCT01746862|4456202|P2|Overall Study|Withdrawal by Subject|1
1351810|NCT01746862|4456203|P1|Overall Study|Withdrawal by Subject|1
1351811|NCT01746368|4456273|P2|Overall Study|Withdrawal by Subject|1
1351812|NCT01746368|4456274|P1|Overall Study|Withdrawal by Subject|0
1351813|NCT01746368|4456273|P2|Overall Study|Lost to Follow-up|0
1351814|NCT01746368|4456274|P1|Overall Study|Lost to Follow-up|2
1351815|NCT01746173|4456301|P1|Overall Study|Disease Progression|2
1351816|NCT01746108|4456309|P3|Overall Study|Lost to Follow-up|0
1351817|NCT01746108|4456310|P2|Overall Study|Lost to Follow-up|1
1351818|NCT01746108|4456311|P1|Overall Study|Lost to Follow-up|0
1351819|NCT01746108|4456309|P3|Overall Study|Withdrawal by Subject|0
1351820|NCT01746108|4456310|P2|Overall Study|Withdrawal by Subject|1
1351821|NCT01746108|4456311|P1|Overall Study|Withdrawal by Subject|0
1351822|NCT01746108|4456309|P3|Overall Study|Adverse event, non-fatal|0
1351823|NCT01746108|4456310|P2|Overall Study|Adverse event, non-fatal|1
1351824|NCT01746108|4456311|P1|Overall Study|Adverse event, non-fatal|0
1351825|NCT01746108|4456309|P3|Overall Study|Migrated /moved from study area|0
1351826|NCT01746108|4456310|P2|Overall Study|Migrated /moved from study area|1
1351827|NCT01746108|4456311|P1|Overall Study|Migrated /moved from study area|0
1351828|NCT01745848|4456409|P1|Overall Study|Adverse Event|6
1351829|NCT01745393|4456416|P2|12-month Follow-up|Lost to Follow-up|5
1351830|NCT01745393|4456417|P1|12-month Follow-up|Lost to Follow-up|6
1351831|NCT01745393|4456416|P2|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
1351832|NCT01745393|4456417|P1|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
1351833|NCT01745393|4456416|P2|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
1351834|NCT01745393|4456417|P1|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
1351835|NCT01745380|4456429|P2|Overall Study|Lack of Efficacy|1
1351836|NCT01745380|4456430|P1|Overall Study|Lack of Efficacy|0
1351837|NCT01745380|4456429|P2|Overall Study|Lost to Follow-up|0
1351838|NCT01745380|4456430|P1|Overall Study|Lost to Follow-up|1
1351839|NCT01745094|4456483|P4|Overall Study|Untenable Due to Recurrent Cystitis|0
1351840|NCT01745094|4456484|P3|Overall Study|Untenable Due to Recurrent Cystitis|0
1351841|NCT01745094|4456485|P2|Overall Study|Untenable Due to Recurrent Cystitis|0
1351842|NCT01745094|4456486|P1|Overall Study|Untenable Due to Recurrent Cystitis|1
1351843|NCT01745094|4456483|P4|Overall Study|Show no Stable Solifenacin Intake|0
1351844|NCT01745094|4456484|P3|Overall Study|Show no Stable Solifenacin Intake|1
1351845|NCT01745094|4456485|P2|Overall Study|Show no Stable Solifenacin Intake|0
1351846|NCT01745094|4456486|P1|Overall Study|Show no Stable Solifenacin Intake|0
1351847|NCT01745094|4456483|P4|Overall Study|Need Further Examinations Due to Biopsy|0
1351848|NCT01745094|4456484|P3|Overall Study|Need Further Examinations Due to Biopsy|1
1351849|NCT01745094|4456485|P2|Overall Study|Need Further Examinations Due to Biopsy|0
1351850|NCT01745094|4456486|P1|Overall Study|Need Further Examinations Due to Biopsy|0
1351851|NCT01745094|4456483|P4|Overall Study|Protocol Violation|1
1351852|NCT01745094|4456484|P3|Overall Study|Protocol Violation|3
1351853|NCT01745094|4456485|P2|Overall Study|Protocol Violation|0
1351854|NCT01745094|4456486|P1|Overall Study|Protocol Violation|1
1351855|NCT01745094|4456483|P4|Overall Study|Withdrawal by Subject|2
1351856|NCT01745094|4456484|P3|Overall Study|Withdrawal by Subject|1
1351857|NCT01745094|4456485|P2|Overall Study|Withdrawal by Subject|0
1351858|NCT01745094|4456486|P1|Overall Study|Withdrawal by Subject|2
1351859|NCT01745094|4456483|P4|Overall Study|Adverse Event|0
1351860|NCT01745094|4456484|P3|Overall Study|Adverse Event|3
1351861|NCT01745094|4456485|P2|Overall Study|Adverse Event|0
1351862|NCT01745094|4456486|P1|Overall Study|Adverse Event|0
1351863|NCT01745094|4456483|P4|Overall Study|Not Meeting the Eligibility Criteria|0
1351864|NCT01745094|4456484|P3|Overall Study|Not Meeting the Eligibility Criteria|3
1351865|NCT01745094|4456485|P2|Overall Study|Not Meeting the Eligibility Criteria|0
1351866|NCT01745094|4456486|P1|Overall Study|Not Meeting the Eligibility Criteria|1
1351867|NCT01744977|4456587|P2|Overall Study|No longer meets inclusion|0
1351868|NCT01744977|4456588|P1|Overall Study|No longer meets inclusion|6
1351869|NCT01744977|4456587|P2|Overall Study|Lost to Follow-up|0
1351870|NCT01744977|4456588|P1|Overall Study|Lost to Follow-up|2
1351871|NCT01744977|4456587|P2|Overall Study|Death|3
1351872|NCT01744977|4456588|P1|Overall Study|Death|2
1351873|NCT01744977|4456587|P2|Overall Study|Withdrawal by Subject|2
1351874|NCT01744977|4456588|P1|Overall Study|Withdrawal by Subject|1
1351875|NCT01744782|4456659|P1|Overall Study|Death|1
1351876|NCT01744691|4456719|P1|Overall Study|Physician Decision|4
1351877|NCT01744691|4456719|P1|Overall Study|Withdrawal of consent for treatment|3
1351878|NCT01744691|4456719|P1|Overall Study|Unacceptable toxicity, AE or death|18
1351879|NCT01744691|4456719|P1|Overall Study|Progressive Disease|18
1351880|NCT01744496|4456726|P2|Maintenance Period|Subject left town|0
1351881|NCT01744496|4456727|P1|Maintenance Period|Subject left town|1
1351882|NCT01744496|4456726|P2|Maintenance Period|Withdrawal by Subject|1
1351883|NCT01744496|4456727|P1|Maintenance Period|Withdrawal by Subject|1
1351884|NCT01744496|4456726|P2|Maintenance Period|Protocol Violation|0
1351885|NCT01744496|4456727|P1|Maintenance Period|Protocol Violation|1
1351886|NCT01744496|4456726|P2|Maintenance Period|Adverse Event|3
1351887|NCT01744496|4456727|P1|Maintenance Period|Adverse Event|1
1351888|NCT01744496|4456726|P2|Titration Period|Personal reasons|1
1351889|NCT01744496|4456727|P1|Titration Period|Personal reasons|0
1351890|NCT01744496|4456726|P2|Titration Period|Adverse Event|1
1351891|NCT01744496|4456727|P1|Titration Period|Adverse Event|2
1351892|NCT01744483|4456748|P3|Overall Study|Routed to OSH|1
1351893|NCT01744483|4456749|P2|Overall Study|Routed to OSH|0
1351894|NCT01744483|4456750|P1|Overall Study|Routed to OSH|2
1351895|NCT01744483|4456748|P3|Overall Study|No ICU Admit|2
1351896|NCT01744483|4456749|P2|Overall Study|No ICU Admit|1
1351897|NCT01744483|4456750|P1|Overall Study|No ICU Admit|5
1351898|NCT01744483|4456748|P3|Overall Study|Withdrawal by Subject|2
1351899|NCT01744483|4456749|P2|Overall Study|Withdrawal by Subject|6
1351900|NCT01744483|4456750|P1|Overall Study|Withdrawal by Subject|4
1351901|NCT01744483|4456748|P3|Overall Study|Protocol Violation|1
1351902|NCT01744483|4456749|P2|Overall Study|Protocol Violation|2
1351903|NCT01744483|4456750|P1|Overall Study|Protocol Violation|1
1351904|NCT01744483|4456748|P3|Overall Study|Lost to Follow-up|11
1351905|NCT01744483|4456749|P2|Overall Study|Lost to Follow-up|9
1351906|NCT01744483|4456750|P1|Overall Study|Lost to Follow-up|8
1351907|NCT01744483|4456748|P3|Overall Study|Death|11
1351908|NCT01744483|4456749|P2|Overall Study|Death|4
1351909|NCT01744483|4456750|P1|Overall Study|Death|9
1351910|NCT01744392|4456758|P1|Overall Study|Physician Decision|1
1351911|NCT01744197|4456798|P2|Overall Study|No patch received|2
1351912|NCT01744197|4456799|P1|Overall Study|No patch received|2
1351913|NCT01744197|4456798|P2|Overall Study|Received 1 patch|1
1351914|NCT01744197|4456799|P1|Overall Study|Received 1 patch|2
1351915|NCT01743469|4456890|P4|Follow-up Period - Post-Treatment|Lost to Follow-up|0
1351916|NCT01743469|4456891|P3|Follow-up Period - Post-Treatment|Lost to Follow-up|0
1351917|NCT01743469|4456892|P2|Follow-up Period - Post-Treatment|Lost to Follow-up|1
1351918|NCT01743469|4456893|P1|Follow-up Period - Post-Treatment|Lost to Follow-up|1
1351919|NCT01743469|4456890|P4|Follow-up Period - Post-Treatment|Death|16
1351920|NCT01743469|4456891|P3|Follow-up Period - Post-Treatment|Death|22
1351921|NCT01743469|4456892|P2|Follow-up Period - Post-Treatment|Death|47
1351922|NCT01743469|4456893|P1|Follow-up Period - Post-Treatment|Death|43
1351923|NCT01743469|4456890|P4|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
1351924|NCT01743469|4456891|P3|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
1351925|NCT01743469|4456892|P2|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
1351926|NCT01743469|4456893|P1|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
1351927|NCT01743469|4456890|P4|Active Treatment Phase|Missing|0
1351928|NCT01743469|4456891|P3|Active Treatment Phase|Missing|0
1351929|NCT01743469|4456892|P2|Active Treatment Phase|Missing|0
1351930|NCT01743469|4456893|P1|Active Treatment Phase|Missing|1
1351931|NCT01743469|4456890|P4|Active Treatment Phase|Withdrawal by Subject|0
1351932|NCT01743469|4456891|P3|Active Treatment Phase|Withdrawal by Subject|0
1351933|NCT01743469|4456892|P2|Active Treatment Phase|Withdrawal by Subject|3
1351934|NCT01743469|4456893|P1|Active Treatment Phase|Withdrawal by Subject|2
1351935|NCT01743469|4456890|P4|Active Treatment Phase|Disease Progression|20
1351936|NCT01743469|4456891|P3|Active Treatment Phase|Disease Progression|30
1351937|NCT01743469|4456892|P2|Active Treatment Phase|Disease Progression|47
1351938|NCT01743469|4456893|P1|Active Treatment Phase|Disease Progression|40
1351939|NCT01743469|4456890|P4|Active Treatment Phase|Adverse Event|1
1351940|NCT01743469|4456891|P3|Active Treatment Phase|Adverse Event|8
1351941|NCT01743469|4456892|P2|Active Treatment Phase|Adverse Event|5
1351942|NCT01743469|4456893|P1|Active Treatment Phase|Adverse Event|10
1351943|NCT01743092|4456933|P2|Overall Study|Lost to Follow-up|15
1351944|NCT01743092|4456934|P1|Overall Study|Lost to Follow-up|14
1351945|NCT01743027|4456946|P4|Overall Study|Withdrawal by Subject|1
1351946|NCT01743027|4456947|P3|Overall Study|Withdrawal by Subject|3
1351947|NCT01743027|4456948|P2|Overall Study|Withdrawal by Subject|0
1351948|NCT01743027|4456949|P1|Overall Study|Withdrawal by Subject|1
1351949|NCT01743027|4456946|P4|Overall Study|Protocol Violation|0
1351950|NCT01743027|4456947|P3|Overall Study|Protocol Violation|1
1351951|NCT01743027|4456948|P2|Overall Study|Protocol Violation|1
1351952|NCT01743027|4456949|P1|Overall Study|Protocol Violation|1
1351953|NCT01743027|4456946|P4|Overall Study|Progressive Disease|0
1351954|NCT01743027|4456947|P3|Overall Study|Progressive Disease|3
1351955|NCT01743027|4456948|P2|Overall Study|Progressive Disease|4
1351956|NCT01743027|4456949|P1|Overall Study|Progressive Disease|1
1351957|NCT01743027|4456946|P4|Overall Study|Lost to Follow-up|0
1351958|NCT01743027|4456947|P3|Overall Study|Lost to Follow-up|2
1351959|NCT01743027|4456948|P2|Overall Study|Lost to Follow-up|0
1351960|NCT01743027|4456949|P1|Overall Study|Lost to Follow-up|0
1351961|NCT01743027|4456946|P4|Overall Study|Adverse Event|0
1351962|NCT01743027|4456947|P3|Overall Study|Adverse Event|0
1351963|NCT01743027|4456948|P2|Overall Study|Adverse Event|0
1351964|NCT01743027|4456949|P1|Overall Study|Adverse Event|2
1351965|NCT01743001|4456989|P2|Overall Study|Death|0
1351966|NCT01743001|4456990|P1|Overall Study|Death|1
1351967|NCT01743001|4456989|P2|Overall Study|Pregnancy|0
1351968|NCT01743001|4456990|P1|Overall Study|Pregnancy|1
1351969|NCT01743001|4456989|P2|Overall Study|Physician Decision|0
1351970|NCT01743001|4456990|P1|Overall Study|Physician Decision|1
1351971|NCT01742897|4457013|P1|Overall Study|Other|1
1351972|NCT01742897|4457013|P1|Overall Study|Withdrawal by Subject|1
1351973|NCT01742897|4457013|P1|Overall Study|Adverse Event|3
1351974|NCT01742091|4457065|P6|Overall Study|Lost to Follow-up|1
1351975|NCT01742091|4457066|P5|Overall Study|Lost to Follow-up|0
1351976|NCT01742091|4457067|P4|Overall Study|Lost to Follow-up|0
1351977|NCT01742091|4457068|P3|Overall Study|Lost to Follow-up|0
1351978|NCT01742091|4457069|P2|Overall Study|Lost to Follow-up|0
1351979|NCT01742091|4457070|P1|Overall Study|Lost to Follow-up|0
1351980|NCT01742091|4457065|P6|Overall Study|Withdrawal by Subject|0
1351981|NCT01742091|4457066|P5|Overall Study|Withdrawal by Subject|0
1351982|NCT01742091|4457067|P4|Overall Study|Withdrawal by Subject|1
1351983|NCT01742091|4457068|P3|Overall Study|Withdrawal by Subject|0
1351984|NCT01742091|4457069|P2|Overall Study|Withdrawal by Subject|0
1351985|NCT01742091|4457070|P1|Overall Study|Withdrawal by Subject|0
1351986|NCT01742091|4457065|P6|Overall Study|Physician Decision|1
1351987|NCT01742091|4457066|P5|Overall Study|Physician Decision|0
1351988|NCT01742091|4457067|P4|Overall Study|Physician Decision|0
1351989|NCT01742091|4457068|P3|Overall Study|Physician Decision|0
1351990|NCT01742091|4457069|P2|Overall Study|Physician Decision|0
1351991|NCT01742091|4457070|P1|Overall Study|Physician Decision|0
1351992|NCT01742091|4457065|P6|Overall Study|Adverse Event|0
1351993|NCT01742091|4457066|P5|Overall Study|Adverse Event|1
1351994|NCT01742091|4457067|P4|Overall Study|Adverse Event|0
1351995|NCT01742091|4457068|P3|Overall Study|Adverse Event|0
1351996|NCT01742091|4457069|P2|Overall Study|Adverse Event|0
1351997|NCT01742091|4457070|P1|Overall Study|Adverse Event|0
1351998|NCT01741792|4457110|P3|Overall Study|Death|12
1351999|NCT01741792|4457111|P2|Overall Study|Death|1
1352000|NCT01741792|4457112|P1|Overall Study|Death|6
1352001|NCT01741701|4457179|P2|Overall Study|Withdrawal by Subject|1
1352002|NCT01741701|4457180|P1|Overall Study|Withdrawal by Subject|0
1352003|NCT01741701|4457179|P2|Overall Study|Adverse Event|1
1352004|NCT01741701|4457180|P1|Overall Study|Adverse Event|5
1352005|NCT01741688|4457196|P1|Overall Study|Withdrawal by Subject|1
1352006|NCT01741688|4457196|P1|Overall Study|Lack of insurance coverage|2
1352007|NCT01741259|4457378|P2|Overall Study|Withdrawal by Subject|2
1352008|NCT01741259|4457379|P1|Overall Study|Withdrawal by Subject|0
1352009|NCT01741259|4457378|P2|Overall Study|Protocol Violation|4
1352010|NCT01741259|4457379|P1|Overall Study|Protocol Violation|6
1352011|NCT01740440|4457498|P1|Overall Study|Lost to Follow-up|3
1352012|NCT01740427|4457506|P2|Overall Study|Study terminated by Sponsor|0
1352013|NCT01740427|4457507|P1|Overall Study|Study terminated by Sponsor|1
1352014|NCT01740427|4457506|P2|Overall Study|Lost to Follow-up|0
1352015|NCT01740427|4457507|P1|Overall Study|Lost to Follow-up|1
1352016|NCT01740427|4457506|P2|Overall Study|Protocol Violation|3
1352017|NCT01740427|4457507|P1|Overall Study|Protocol Violation|5
1352018|NCT01740427|4457506|P2|Overall Study|Death|2
1352019|NCT01740427|4457507|P1|Overall Study|Death|6
1352020|NCT01740427|4457506|P2|Overall Study|Unspecified reasons|4
1352021|NCT01740427|4457507|P1|Overall Study|Unspecified reasons|6
1352022|NCT01740427|4457506|P2|Overall Study|Subject refused continued treatment|9
1352023|NCT01740427|4457507|P1|Overall Study|Subject refused continued treatment|12
1352024|NCT01740427|4457506|P2|Overall Study|Global deterioration of health status|9
1352025|NCT01740427|4457507|P1|Overall Study|Global deterioration of health status|16
1352026|NCT01740427|4457506|P2|Overall Study|Adverse Event|9
1352027|NCT01740427|4457507|P1|Overall Study|Adverse Event|20
1352028|NCT01740427|4457506|P2|Overall Study|Objective progression or relapse|125
1352029|NCT01740427|4457507|P1|Overall Study|Objective progression or relapse|172
1352030|NCT01740427|4457506|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
1352031|NCT01740427|4457507|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
1352032|NCT01740401|4457559|P1|Overall Study|Did not reach primary endpoint|2
1352033|NCT01740401|4457559|P1|Overall Study|Adverse Event|2
1352034|NCT01740401|4457559|P1|Overall Study|Progression of disease|6
1352035|NCT01740388|4457568|P2|Overall Study|Subjects missing data, completed|36
1352036|NCT01740388|4457569|P1|Overall Study|Subjects missing data, completed|41
1352037|NCT01740388|4457568|P2|Overall Study|Physician Decision|6
1352038|NCT01740388|4457569|P1|Overall Study|Physician Decision|2
1352039|NCT01740388|4457568|P2|Overall Study|Lost to Follow-up|0
1352040|NCT01740388|4457569|P1|Overall Study|Lost to Follow-up|2
1352041|NCT01740388|4457568|P2|Overall Study|Withdrawal by Subject|2
1352042|NCT01740388|4457569|P1|Overall Study|Withdrawal by Subject|1
1352043|NCT01740297|4457621|P3|Overall Study|Sponsor Decision|0
1352044|NCT01740297|4457622|P2|Overall Study|Sponsor Decision|1
1352045|NCT01740297|4457623|P1|Overall Study|Sponsor Decision|0
1352046|NCT01740297|4457621|P3|Overall Study|Death|19
1352047|NCT01740297|4457622|P2|Overall Study|Death|23
1352048|NCT01740297|4457623|P1|Overall Study|Death|8
1352049|NCT01740297|4457621|P3|Overall Study|Withdrawal by Subject|11
1352050|NCT01740297|4457622|P2|Overall Study|Withdrawal by Subject|9
1352051|NCT01740297|4457623|P1|Overall Study|Withdrawal by Subject|1
1352052|NCT01740297|4457621|P3|Overall Study|Continuing Study|68
1352053|NCT01740297|4457622|P2|Overall Study|Continuing Study|67
1352054|NCT01740297|4457623|P1|Overall Study|Continuing Study|10
1352055|NCT01740128|4457674|P2|Overall Study|Insufficient protocol compliance|2
1352056|NCT01740128|4457675|P1|Overall Study|Insufficient protocol compliance|2
1352057|NCT01740128|4457674|P2|Overall Study|Withdrawal by Subject|0
1352058|NCT01740128|4457675|P1|Overall Study|Withdrawal by Subject|1
1352059|NCT01740128|4457674|P2|Overall Study|Lost to Follow-up|2
1352060|NCT01740128|4457675|P1|Overall Study|Lost to Follow-up|2
1352061|NCT01740128|4457674|P2|Overall Study|Protocol Violation|2
1352062|NCT01740128|4457675|P1|Overall Study|Protocol Violation|1
1352063|NCT01740128|4457674|P2|Overall Study|Pregnancy|1
1352064|NCT01740128|4457675|P1|Overall Study|Pregnancy|0
1352065|NCT01740089|4457704|P3|After 12 Weeks|Withdrawal by Subject|1
1352066|NCT01740089|4457705|P2|After 12 Weeks|Withdrawal by Subject|1
1352067|NCT01740089|4457706|P1|After 12 Weeks|Withdrawal by Subject|1
1352068|NCT01740089|4457704|P3|After 12 Weeks|Protocol Violation|1
1352069|NCT01740089|4457705|P2|After 12 Weeks|Protocol Violation|1
1352070|NCT01740089|4457706|P1|After 12 Weeks|Protocol Violation|1
1352071|NCT01740089|4457704|P3|After 12 Weeks|Adverse Event|5
1352072|NCT01740089|4457705|P2|After 12 Weeks|Adverse Event|0
1352073|NCT01740089|4457706|P1|After 12 Weeks|Adverse Event|2
1352074|NCT01740089|4457704|P3|After 12 Weeks|Lack of Efficacy|4
1352075|NCT01740089|4457705|P2|After 12 Weeks|Lack of Efficacy|1
1352076|NCT01740089|4457706|P1|After 12 Weeks|Lack of Efficacy|3
1352077|NCT01740089|4457704|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
1352078|NCT01740089|4457705|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
1352079|NCT01740089|4457706|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
1352080|NCT01740089|4457704|P3|First 12 Weeks of Treatment|Adverse Event|2
1352081|NCT01740089|4457705|P2|First 12 Weeks of Treatment|Adverse Event|1
1352082|NCT01740089|4457706|P1|First 12 Weeks of Treatment|Adverse Event|0
1352083|NCT01739803|4457724|P2|Overall Study|Lost to Follow-up|6
1352084|NCT01739803|4457725|P1|Overall Study|Lost to Follow-up|9
1352085|NCT01739790|4457737|P2|Overall Study|Early Trial Termination|4
1352086|NCT01739790|4457738|P1|Overall Study|Early Trial Termination|2
1352087|NCT01739595|4457747|P3|Overall Study|Drug discrepancy|0
1352088|NCT01739595|4457748|P2|Overall Study|Drug discrepancy|0
1352089|NCT01739595|4457749|P1|Overall Study|Drug discrepancy|1
1352090|NCT01739595|4457747|P3|Overall Study|Lab assessment|0
1352091|NCT01739595|4457748|P2|Overall Study|Lab assessment|0
1352092|NCT01739595|4457749|P1|Overall Study|Lab assessment|1
1352093|NCT01739595|4457747|P3|Overall Study|Protocol Violation|0
1352094|NCT01739595|4457748|P2|Overall Study|Protocol Violation|0
1352095|NCT01739595|4457749|P1|Overall Study|Protocol Violation|1
1352096|NCT01739595|4457747|P3|Overall Study|Eligibility issue|0
1352097|NCT01739595|4457748|P2|Overall Study|Eligibility issue|0
1352098|NCT01739595|4457749|P1|Overall Study|Eligibility issue|3
1352099|NCT01739595|4457747|P3|Overall Study|Withdrawal by Subject|2
1352100|NCT01739595|4457748|P2|Overall Study|Withdrawal by Subject|1
1352101|NCT01739595|4457749|P1|Overall Study|Withdrawal by Subject|2
1352102|NCT01739595|4457747|P3|Overall Study|Lost to Follow-up|0
1352103|NCT01739595|4457748|P2|Overall Study|Lost to Follow-up|0
1352104|NCT01739595|4457749|P1|Overall Study|Lost to Follow-up|2
1352105|NCT01739595|4457747|P3|Overall Study|Adverse Event|0
1352106|NCT01739595|4457748|P2|Overall Study|Adverse Event|0
1352107|NCT01739595|4457749|P1|Overall Study|Adverse Event|3
1352108|NCT01739348|4457774|P4|Part II (Extension Study)|Withdrawal by Subject|7
1352109|NCT01739348|4457775|P3|Part II (Extension Study)|Withdrawal by Subject|4
1352110|NCT01739348|4457776|P2|Part II (Extension Study)|Withdrawal by Subject|2
1352111|NCT01739348|4457777|P1|Part II (Extension Study)|Withdrawal by Subject|5
1352112|NCT01739348|4457774|P4|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
1352113|NCT01739348|4457775|P3|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
1352114|NCT01739348|4457776|P2|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
1352115|NCT01739348|4457777|P1|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
1352116|NCT01739348|4457774|P4|Part II (Extension Study)|Participant Moved|3
1352117|NCT01739348|4457775|P3|Part II (Extension Study)|Participant Moved|0
1352118|NCT01739348|4457776|P2|Part II (Extension Study)|Participant Moved|3
1352119|NCT01739348|4457777|P1|Part II (Extension Study)|Participant Moved|3
1352120|NCT01739348|4457774|P4|Part II (Extension Study)|Study Terminated by Sponsor|323
1352121|NCT01739348|4457775|P3|Part II (Extension Study)|Study Terminated by Sponsor|34
1352122|NCT01739348|4457776|P2|Part II (Extension Study)|Study Terminated by Sponsor|315
1352123|NCT01739348|4457777|P1|Part II (Extension Study)|Study Terminated by Sponsor|329
1352124|NCT01739348|4457774|P4|Part II (Extension Study)|Physician Decision|12
1352125|NCT01739348|4457775|P3|Part II (Extension Study)|Physician Decision|6
1352126|NCT01739348|4457776|P2|Part II (Extension Study)|Physician Decision|11
1352127|NCT01739348|4457777|P1|Part II (Extension Study)|Physician Decision|7
1352128|NCT01739348|4457774|P4|Part II (Extension Study)|Non-Compliance with Study Drug|1
1352129|NCT01739348|4457775|P3|Part II (Extension Study)|Non-Compliance with Study Drug|0
1352130|NCT01739348|4457776|P2|Part II (Extension Study)|Non-Compliance with Study Drug|0
1352131|NCT01739348|4457777|P1|Part II (Extension Study)|Non-Compliance with Study Drug|0
1352132|NCT01739348|4457774|P4|Part II (Extension Study)|Lost to Follow-up|1
1352133|NCT01739348|4457775|P3|Part II (Extension Study)|Lost to Follow-up|0
1352134|NCT01739348|4457776|P2|Part II (Extension Study)|Lost to Follow-up|4
1352135|NCT01739348|4457777|P1|Part II (Extension Study)|Lost to Follow-up|3
1352136|NCT01739348|4457774|P4|Part II (Extension Study)|Lack of Efficacy|1
1352137|NCT01739348|4457775|P3|Part II (Extension Study)|Lack of Efficacy|0
1352138|NCT01739348|4457776|P2|Part II (Extension Study)|Lack of Efficacy|5
1352139|NCT01739348|4457777|P1|Part II (Extension Study)|Lack of Efficacy|1
1352140|NCT01739348|4457774|P4|Part II (Extension Study)|Death|6
1352141|NCT01739348|4457775|P3|Part II (Extension Study)|Death|2
1352142|NCT01739348|4457776|P2|Part II (Extension Study)|Death|3
1352143|NCT01739348|4457777|P1|Part II (Extension Study)|Death|3
1352144|NCT01739348|4457774|P4|Part II (Extension Study)|Adverse Event|26
1352145|NCT01739348|4457775|P3|Part II (Extension Study)|Adverse Event|7
1352146|NCT01739348|4457776|P2|Part II (Extension Study)|Adverse Event|11
1352147|NCT01739348|4457777|P1|Part II (Extension Study)|Adverse Event|10
1352148|NCT01739348|4457774|P4|Part I (Base Study)|Withdrawal by Subject|20
1352149|NCT01739348|4457775|P3|Part I (Base Study)|Withdrawal by Subject|7
1352150|NCT01739348|4457776|P2|Part I (Base Study)|Withdrawal by Subject|21
1352151|NCT01739348|4457777|P1|Part I (Base Study)|Withdrawal by Subject|23
1352152|NCT01739348|4457774|P4|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
1352153|NCT01739348|4457775|P3|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
1352154|NCT01739348|4457776|P2|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
1352155|NCT01739348|4457777|P1|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
1352156|NCT01739348|4457774|P4|Part I (Base Study)|Participant Moved|7
1352157|NCT01739348|4457775|P3|Part I (Base Study)|Participant Moved|1
1352158|NCT01739348|4457776|P2|Part I (Base Study)|Participant Moved|3
1352159|NCT01739348|4457777|P1|Part I (Base Study)|Participant Moved|4
1352160|NCT01739348|4457774|P4|Part I (Base Study)|Study Terminated by Sponsor|86
1352161|NCT01739348|4457775|P3|Part I (Base Study)|Study Terminated by Sponsor|0
1352162|NCT01739348|4457776|P2|Part I (Base Study)|Study Terminated by Sponsor|73
1352163|NCT01739348|4457777|P1|Part I (Base Study)|Study Terminated by Sponsor|72
1352164|NCT01739348|4457774|P4|Part I (Base Study)|Site Discontinued Study Participation|0
1352165|NCT01739348|4457775|P3|Part I (Base Study)|Site Discontinued Study Participation|0
1352166|NCT01739348|4457776|P2|Part I (Base Study)|Site Discontinued Study Participation|3
1352167|NCT01739348|4457777|P1|Part I (Base Study)|Site Discontinued Study Participation|1
1352168|NCT01739348|4457774|P4|Part I (Base Study)|Screen Failure|0
1352169|NCT01739348|4457775|P3|Part I (Base Study)|Screen Failure|0
1352170|NCT01739348|4457776|P2|Part I (Base Study)|Screen Failure|0
1352171|NCT01739348|4457777|P1|Part I (Base Study)|Screen Failure|2
1352172|NCT01739348|4457774|P4|Part I (Base Study)|Protocol Violation|2
1352173|NCT01739348|4457775|P3|Part I (Base Study)|Protocol Violation|1
1352174|NCT01739348|4457776|P2|Part I (Base Study)|Protocol Violation|0
1352175|NCT01739348|4457777|P1|Part I (Base Study)|Protocol Violation|2
1352176|NCT01739348|4457774|P4|Part I (Base Study)|Physician Decision|4
1352177|NCT01739348|4457775|P3|Part I (Base Study)|Physician Decision|1
1352178|NCT01739348|4457776|P2|Part I (Base Study)|Physician Decision|7
1352179|NCT01739348|4457777|P1|Part I (Base Study)|Physician Decision|10
1352180|NCT01739348|4457774|P4|Part I (Base Study)|Non-Compliance with Study Drug|0
1352181|NCT01739348|4457775|P3|Part I (Base Study)|Non-Compliance with Study Drug|0
1352182|NCT01739348|4457776|P2|Part I (Base Study)|Non-Compliance with Study Drug|2
1352183|NCT01739348|4457777|P1|Part I (Base Study)|Non-Compliance with Study Drug|3
1352184|NCT01739348|4457774|P4|Part I (Base Study)|Lost to Follow-up|4
1352185|NCT01739348|4457775|P3|Part I (Base Study)|Lost to Follow-up|4
1352186|NCT01739348|4457776|P2|Part I (Base Study)|Lost to Follow-up|2
1352187|NCT01739348|4457777|P1|Part I (Base Study)|Lost to Follow-up|4
1352188|NCT01739348|4457774|P4|Part I (Base Study)|Lack of Efficacy|7
1352189|NCT01739348|4457775|P3|Part I (Base Study)|Lack of Efficacy|0
1352190|NCT01739348|4457776|P2|Part I (Base Study)|Lack of Efficacy|8
1352191|NCT01739348|4457777|P1|Part I (Base Study)|Lack of Efficacy|3
1352192|NCT01739348|4457774|P4|Part I (Base Study)|Death|8
1352193|NCT01739348|4457775|P3|Part I (Base Study)|Death|2
1352194|NCT01739348|4457776|P2|Part I (Base Study)|Death|7
1352195|NCT01739348|4457777|P1|Part I (Base Study)|Death|10
1352196|NCT01739348|4457774|P4|Part I (Base Study)|Adverse Event|33
1352197|NCT01739348|4457775|P3|Part I (Base Study)|Adverse Event|8
1352198|NCT01739348|4457776|P2|Part I (Base Study)|Adverse Event|52
1352199|NCT01739348|4457777|P1|Part I (Base Study)|Adverse Event|41
1352200|NCT01739335|4457849|P2|Overall Study|Ineligible patient randomized|1
1352201|NCT01739335|4457850|P1|Overall Study|Ineligible patient randomized|0
1352202|NCT01739335|4457849|P2|Overall Study|Lost to Follow-up|4
1352203|NCT01739335|4457850|P1|Overall Study|Lost to Follow-up|7
1352204|NCT01738984|4457884|P2|Overall Study|Lost to Follow-up|39
1352205|NCT01738984|4457885|P1|Overall Study|Lost to Follow-up|59
1352206|NCT01738984|4457884|P2|Overall Study|Withdrawal by Subject|0
1352207|NCT01738984|4457885|P1|Overall Study|Withdrawal by Subject|1
1352208|NCT01738984|4457884|P2|Overall Study|Pregnancy|0
1352209|NCT01738984|4457885|P1|Overall Study|Pregnancy|4
1352210|NCT01738971|4457898|P3|Overall Study|Lost to Follow-up|17
1352211|NCT01738971|4457899|P2|Overall Study|Lost to Follow-up|30
1352212|NCT01738971|4457900|P1|Overall Study|Lost to Follow-up|19
1352213|NCT01738919|4457916|P2|Overall Study|Not treated in accordance to guidelines|1
1352214|NCT01738919|4457917|P1|Overall Study|Not treated in accordance to guidelines|0
1352215|NCT01738919|4457916|P2|Overall Study|Withdrawal by Subject|1
1352216|NCT01738919|4457917|P1|Overall Study|Withdrawal by Subject|0
1352217|NCT01738919|4457916|P2|Overall Study|Immigrated|1
1352218|NCT01738919|4457917|P1|Overall Study|Immigrated|0
1352219|NCT01738919|4457916|P2|Overall Study|Lost to Follow-up|0
1352220|NCT01738919|4457917|P1|Overall Study|Lost to Follow-up|1
1352221|NCT01738646|4458067|P1|Overall Study|Still Receiving Treatment|2
1352222|NCT01738581|4458077|P2|Overall Study|Lost to Follow-up|0
1352223|NCT01738581|4458078|P1|Overall Study|Lost to Follow-up|1
1352224|NCT01738503|4458102|P7|PET Imaging Sub-study|Scheduling issues with imaging facility|1
1352225|NCT01738503|4458103|P6|PET Imaging Sub-study|Scheduling issues with imaging facility|1
1352226|NCT01738503|4458104|P5|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1352227|NCT01738503|4458105|P4|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1352228|NCT01738503|4458106|P3|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1352229|NCT01738503|4458107|P2|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1352230|NCT01738503|4458108|P1|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1352231|NCT01738503|4458102|P7|PET Imaging Sub-study|Adverse Event|0
1352232|NCT01738503|4458103|P6|PET Imaging Sub-study|Adverse Event|1
1352233|NCT01738503|4458104|P5|PET Imaging Sub-study|Adverse Event|0
1352234|NCT01738503|4458105|P4|PET Imaging Sub-study|Adverse Event|0
1352235|NCT01738503|4458106|P3|PET Imaging Sub-study|Adverse Event|0
1352236|NCT01738503|4458107|P2|PET Imaging Sub-study|Adverse Event|0
1352237|NCT01738503|4458108|P1|PET Imaging Sub-study|Adverse Event|0
1352238|NCT01738503|4458102|P7|Treatment Period|Not specified|0
1352239|NCT01738503|4458103|P6|Treatment Period|Not specified|0
1352240|NCT01738503|4458104|P5|Treatment Period|Not specified|0
1352241|NCT01738503|4458105|P4|Treatment Period|Not specified|0
1352242|NCT01738503|4458106|P3|Treatment Period|Not specified|1
1352243|NCT01738503|4458107|P2|Treatment Period|Not specified|0
1352244|NCT01738503|4458108|P1|Treatment Period|Not specified|0
1352245|NCT01738503|4458102|P7|Treatment Period|Protocol Violation|0
1352246|NCT01738503|4458103|P6|Treatment Period|Protocol Violation|2
1352247|NCT01738503|4458104|P5|Treatment Period|Protocol Violation|4
1352248|NCT01738503|4458105|P4|Treatment Period|Protocol Violation|0
1352249|NCT01738503|4458106|P3|Treatment Period|Protocol Violation|1
1352250|NCT01738503|4458107|P2|Treatment Period|Protocol Violation|3
1352251|NCT01738503|4458108|P1|Treatment Period|Protocol Violation|0
1352252|NCT01738503|4458102|P7|Treatment Period|Withdrawal by Subject|1
1352253|NCT01738503|4458103|P6|Treatment Period|Withdrawal by Subject|1
1352254|NCT01738503|4458104|P5|Treatment Period|Withdrawal by Subject|1
1352255|NCT01738503|4458105|P4|Treatment Period|Withdrawal by Subject|1
1352256|NCT01738503|4458106|P3|Treatment Period|Withdrawal by Subject|0
1352257|NCT01738503|4458107|P2|Treatment Period|Withdrawal by Subject|1
1352258|NCT01738503|4458108|P1|Treatment Period|Withdrawal by Subject|0
1352259|NCT01738503|4458102|P7|Treatment Period|Lost to Follow-up|5
1352260|NCT01738503|4458103|P6|Treatment Period|Lost to Follow-up|1
1352261|NCT01738503|4458104|P5|Treatment Period|Lost to Follow-up|1
1352262|NCT01738503|4458105|P4|Treatment Period|Lost to Follow-up|4
1352263|NCT01738503|4458106|P3|Treatment Period|Lost to Follow-up|3
1352264|NCT01738503|4458107|P2|Treatment Period|Lost to Follow-up|0
1352265|NCT01738503|4458108|P1|Treatment Period|Lost to Follow-up|0
1352266|NCT01738503|4458102|P7|Treatment Period|Adverse Event|2
1352267|NCT01738503|4458103|P6|Treatment Period|Adverse Event|2
1352268|NCT01738503|4458104|P5|Treatment Period|Adverse Event|2
1352269|NCT01738503|4458105|P4|Treatment Period|Adverse Event|1
1352270|NCT01738503|4458106|P3|Treatment Period|Adverse Event|0
1352271|NCT01738503|4458107|P2|Treatment Period|Adverse Event|1
1352272|NCT01738503|4458108|P1|Treatment Period|Adverse Event|0
1352273|NCT01738503|4458102|P7|Induction/Stabilization (Days -14 to -1)|Not specified|0
1352274|NCT01738503|4458103|P6|Induction/Stabilization (Days -14 to -1)|Not specified|0
1352275|NCT01738503|4458104|P5|Induction/Stabilization (Days -14 to -1)|Not specified|0
1352276|NCT01738503|4458105|P4|Induction/Stabilization (Days -14 to -1)|Not specified|0
1352277|NCT01738503|4458106|P3|Induction/Stabilization (Days -14 to -1)|Not specified|0
1352278|NCT01738503|4458107|P2|Induction/Stabilization (Days -14 to -1)|Not specified|0
1352279|NCT01738503|4458108|P1|Induction/Stabilization (Days -14 to -1)|Not specified|35
1352280|NCT01738477|4458306|P2|Overall Study|Lost to Follow-up|4
1352281|NCT01738477|4458307|P1|Overall Study|Lost to Follow-up|1
1352282|NCT01738438|4458335|P1|Overall Study|Adverse Event|3
1352283|NCT01738438|4458335|P1|Overall Study|Disease Progression|32
1352284|NCT01738191|4458352|P2|Overall Study|Withdrawal by Subject|1
1352285|NCT01738191|4458353|P1|Overall Study|Withdrawal by Subject|4
1352286|NCT01737996|4458376|P3|Overall Study|Withdrawal by Subject|1
1352287|NCT01737996|4458377|P2|Overall Study|Withdrawal by Subject|0
1352288|NCT01737996|4458378|P1|Overall Study|Withdrawal by Subject|0
1352289|NCT01737996|4458376|P3|Overall Study|Adverse Event|1
1352290|NCT01737996|4458377|P2|Overall Study|Adverse Event|1
1352291|NCT01737996|4458378|P1|Overall Study|Adverse Event|0
1352292|NCT01737931|4458440|P3|Overall Study|Physician Decision|0
1352293|NCT01737931|4458441|P2|Overall Study|Physician Decision|1
1352294|NCT01737931|4458442|P1|Overall Study|Physician Decision|0
1352295|NCT01737931|4458440|P3|Overall Study|Withdrawal by Subject|1
1352296|NCT01737931|4458441|P2|Overall Study|Withdrawal by Subject|1
1352297|NCT01737931|4458442|P1|Overall Study|Withdrawal by Subject|0
1352298|NCT01737879|4458457|P1|Overall Study|Sponsor decision|40
1352299|NCT01737879|4458457|P1|Overall Study|Death|1
1352300|NCT01737840|4458466|P2|Overall Study|Diagnosed with an other pathology|2
1352301|NCT01737840|4458467|P1|Overall Study|Diagnosed with an other pathology|2
1352302|NCT01737762|4458477|P2|Overall Study|Trial termination|9
1352303|NCT01737762|4458478|P1|Overall Study|Trial termination|11
1352304|NCT01737762|4458477|P2|Overall Study|Moved from area|1
1352305|NCT01737762|4458478|P1|Overall Study|Moved from area|2
1352306|NCT01737762|4458477|P2|Overall Study|Physician Decision|1
1352307|NCT01737762|4458478|P1|Overall Study|Physician Decision|1
1352308|NCT01737762|4458477|P2|Overall Study|Progressive disease|2
1352309|NCT01737762|4458478|P1|Overall Study|Progressive disease|1
1352310|NCT01737762|4458477|P2|Overall Study|Withdrawal by Subject|2
1352311|NCT01737762|4458478|P1|Overall Study|Withdrawal by Subject|2
1352312|NCT01737762|4458477|P2|Overall Study|Lost to Follow-up|0
1352313|NCT01737762|4458478|P1|Overall Study|Lost to Follow-up|1
1352314|NCT01737762|4458477|P2|Overall Study|Adverse Event|2
1352315|NCT01737762|4458478|P1|Overall Study|Adverse Event|2
1352316|NCT01737710|4458491|P5|Overall Study|Vaccinated in Error/Ineligible|0
1352317|NCT01737710|4458492|P4|Overall Study|Vaccinated in Error/Ineligible|0
1352318|NCT01737710|4458493|P3|Overall Study|Vaccinated in Error/Ineligible|0
1352319|NCT01737710|4458494|P2|Overall Study|Vaccinated in Error/Ineligible|1
1352320|NCT01737710|4458495|P1|Overall Study|Vaccinated in Error/Ineligible|1
1352321|NCT01737710|4458491|P5|Overall Study|Withdrawal by Subject|0
1352322|NCT01737710|4458492|P4|Overall Study|Withdrawal by Subject|0
1352323|NCT01737710|4458493|P3|Overall Study|Withdrawal by Subject|1
1352324|NCT01737710|4458494|P2|Overall Study|Withdrawal by Subject|1
1352325|NCT01737710|4458495|P1|Overall Study|Withdrawal by Subject|1
1352326|NCT01737710|4458491|P5|Overall Study|Lost to Follow-up|0
1352327|NCT01737710|4458492|P4|Overall Study|Lost to Follow-up|0
1352328|NCT01737710|4458493|P3|Overall Study|Lost to Follow-up|2
1352329|NCT01737710|4458494|P2|Overall Study|Lost to Follow-up|2
1352330|NCT01737710|4458495|P1|Overall Study|Lost to Follow-up|0
1352331|NCT01737268|4458586|P1|Overall Study|In consideration of the patient’s safety|1
1352332|NCT01737268|4458586|P1|Overall Study|Worsening of Target Disease|2
1352333|NCT01737268|4458586|P1|Overall Study|Adverse Event|6
1352334|NCT01737021|4458600|P2|Overall Study|Lost to Follow-up|3
1352335|NCT01737021|4458601|P1|Overall Study|Lost to Follow-up|5
1352336|NCT01736917|4458647|P1|Overall Study|Protocol Violation|10
1352337|NCT01736917|4458647|P1|Overall Study|Adverse Event|1
1352338|NCT01736696|4458661|P7|Overall Study|Withdrawal by Subject|0
1352339|NCT01736696|4458662|P6|Overall Study|Withdrawal by Subject|0
1352340|NCT01736696|4458663|P5|Overall Study|Withdrawal by Subject|0
1352341|NCT01736696|4458664|P4|Overall Study|Withdrawal by Subject|0
1352342|NCT01736696|4458665|P3|Overall Study|Withdrawal by Subject|1
1352343|NCT01736696|4458666|P2|Overall Study|Withdrawal by Subject|0
1352344|NCT01736696|4458667|P1|Overall Study|Withdrawal by Subject|0
1352345|NCT01736657|4458984|P1|Overall Study|insufficient vascular access|1
1352346|NCT01736579|4458993|P2|Overall Study|Termination of Study by Sponsor|2
1352347|NCT01736579|4458994|P1|Overall Study|Termination of Study by Sponsor|2
1352348|NCT01736553|4459030|P2|Overall Study|Lost to Follow-up|2
1352349|NCT01736553|4459031|P1|Overall Study|Lost to Follow-up|2
1352350|NCT01736553|4459030|P2|Overall Study|Withdrawal by Subject|2
1352351|NCT01736553|4459031|P1|Overall Study|Withdrawal by Subject|5
1352352|NCT01736553|4459030|P2|Overall Study|Death|0
1352353|NCT01736553|4459031|P1|Overall Study|Death|12
1352354|NCT01736540|4459082|P1|Overall Study|Unable to make MRI appointment|3
1352355|NCT01736540|4459082|P1|Overall Study|No show for MRI appointment|1
1352356|NCT01736540|4459082|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
1352357|NCT01736540|4459082|P1|Overall Study|Protocol Violation|1
1352358|NCT01736540|4459082|P1|Overall Study|Withdrawal by Subject|5
1352359|NCT01736540|4459082|P1|Overall Study|Abnormal test procedure|1
1352360|NCT01736540|4459082|P1|Overall Study|Death|1
1352361|NCT01736540|4459082|P1|Overall Study|Did not complete scan within 45 days|2
1352362|NCT01736475|4459148|P2|Overall Study|Other - Surgical procedure|0
1352363|NCT01736475|4459149|P1|Overall Study|Other - Surgical procedure|1
1352364|NCT01736475|4459148|P2|Overall Study|Other - Screen failure|0
1352365|NCT01736475|4459149|P1|Overall Study|Other - Screen failure|1
1352366|NCT01736475|4459148|P2|Overall Study|Protocol Violation|0
1352367|NCT01736475|4459149|P1|Overall Study|Protocol Violation|4
1352368|NCT01736475|4459148|P2|Overall Study|Withdrawal by Subject|0
1352369|NCT01736475|4459149|P1|Overall Study|Withdrawal by Subject|2
1352370|NCT01736475|4459148|P2|Overall Study|Adverse Event|0
1352371|NCT01736475|4459149|P1|Overall Study|Adverse Event|4
1352372|NCT01736397|4459204|P2|Overall Study|Not stated|4
1352373|NCT01736397|4459205|P1|Overall Study|Not stated|1
1352374|NCT01736397|4459204|P2|Overall Study|Adverse Event|3
1352375|NCT01736397|4459205|P1|Overall Study|Adverse Event|6
1352376|NCT01736397|4459204|P2|Overall Study|Lost to Follow-up|1
1352377|NCT01736397|4459205|P1|Overall Study|Lost to Follow-up|0
1352378|NCT01736397|4459204|P2|Overall Study|Withdrawal by Subject|5
1352379|NCT01736397|4459205|P1|Overall Study|Withdrawal by Subject|6
1352380|NCT01736397|4459204|P2|Overall Study|Lack of Efficacy|11
1352381|NCT01736397|4459205|P1|Overall Study|Lack of Efficacy|1
1352382|NCT01736215|4459265|P1|Overall Study|Insufficient data to perform analysis|8
1352383|NCT01736215|4459265|P1|Overall Study|Progressive disease stop chemotherapy|1
1352384|NCT01736215|4459265|P1|Overall Study|Adverse Event|4
1352385|NCT01736215|4459265|P1|Overall Study|Early termination of erythropoietin use|1
1352386|NCT01736176|4459277|P1|Overall Study|Unable to Complete PEG Placement|1
1352387|NCT01736176|4459277|P1|Overall Study|Lack of Efficacy|3
1352388|NCT01736176|4459277|P1|Overall Study|Withdrawal by Subject|4
1352389|NCT01736176|4459277|P1|Overall Study|Adverse Event|3
1352390|NCT01735916|4459324|P3|Overall Study|Withdrawal by Subject|0
1352391|NCT01735916|4459325|P2|Overall Study|Withdrawal by Subject|0
1352392|NCT01735916|4459326|P1|Overall Study|Withdrawal by Subject|3
1352393|NCT01735916|4459324|P3|Overall Study|Early termination of study by sponsor|7
1352394|NCT01735916|4459325|P2|Overall Study|Early termination of study by sponsor|19
1352395|NCT01735916|4459326|P1|Overall Study|Early termination of study by sponsor|4
1352396|NCT01735916|4459324|P3|Overall Study|Subject not eligible to be randomized|0
1352397|NCT01735916|4459325|P2|Overall Study|Subject not eligible to be randomized|0
1352398|NCT01735916|4459326|P1|Overall Study|Subject not eligible to be randomized|11
1352399|NCT01735630|4459364|P2|Overall Study|Withdrawal by Subject|9
1352400|NCT01735630|4459365|P1|Overall Study|Withdrawal by Subject|7
1352401|NCT01735630|4459364|P2|Overall Study|Sponsor Decision|1
1352402|NCT01735630|4459365|P1|Overall Study|Sponsor Decision|2
1352403|NCT01735630|4459364|P2|Overall Study|Physician Decision|1
1352404|NCT01735630|4459365|P1|Overall Study|Physician Decision|0
1352405|NCT01735630|4459364|P2|Overall Study|Lost to Follow-up|0
1352406|NCT01735630|4459365|P1|Overall Study|Lost to Follow-up|1
1352407|NCT01735630|4459364|P2|Overall Study|Adverse Event|7
1352408|NCT01735630|4459365|P1|Overall Study|Adverse Event|8
1352409|NCT01735396|4459392|P1|Overall Study|not evaluable|1
1352410|NCT01735201|4459421|P8|Overall Study|Other Miscellaneous Reasons|1
1352411|NCT01735201|4459422|P7|Overall Study|Other Miscellaneous Reasons|1
1352412|NCT01735201|4459423|P6|Overall Study|Other Miscellaneous Reasons|2
1352413|NCT01735201|4459424|P5|Overall Study|Other Miscellaneous Reasons|0
1352414|NCT01735201|4459425|P4|Overall Study|Other Miscellaneous Reasons|1
1352415|NCT01735201|4459426|P3|Overall Study|Other Miscellaneous Reasons|0
1352416|NCT01735201|4459427|P2|Overall Study|Other Miscellaneous Reasons|0
1352417|NCT01735201|4459428|P1|Overall Study|Other Miscellaneous Reasons|0
1352418|NCT01735201|4459421|P8|Overall Study|Protocol Violation|0
1352419|NCT01735201|4459422|P7|Overall Study|Protocol Violation|0
1352420|NCT01735201|4459423|P6|Overall Study|Protocol Violation|0
1352421|NCT01735201|4459424|P5|Overall Study|Protocol Violation|0
1352422|NCT01735201|4459425|P4|Overall Study|Protocol Violation|0
1352423|NCT01735201|4459426|P3|Overall Study|Protocol Violation|0
1352424|NCT01735201|4459427|P2|Overall Study|Protocol Violation|0
1352425|NCT01735201|4459428|P1|Overall Study|Protocol Violation|1
1352426|NCT01735201|4459421|P8|Overall Study|Personal Reasons|0
1352427|NCT01735201|4459422|P7|Overall Study|Personal Reasons|0
1352428|NCT01735201|4459423|P6|Overall Study|Personal Reasons|0
1352429|NCT01735201|4459424|P5|Overall Study|Personal Reasons|0
1352430|NCT01735201|4459425|P4|Overall Study|Personal Reasons|0
1352431|NCT01735201|4459426|P3|Overall Study|Personal Reasons|0
1352432|NCT01735201|4459427|P2|Overall Study|Personal Reasons|0
1352433|NCT01735201|4459428|P1|Overall Study|Personal Reasons|1
1352434|NCT01735201|4459421|P8|Overall Study|Adverse Event|1
1352435|NCT01735201|4459422|P7|Overall Study|Adverse Event|2
1352436|NCT01735201|4459423|P6|Overall Study|Adverse Event|3
1352437|NCT01735201|4459424|P5|Overall Study|Adverse Event|1
1352438|NCT01735201|4459425|P4|Overall Study|Adverse Event|1
1352439|NCT01735201|4459426|P3|Overall Study|Adverse Event|0
1352440|NCT01735201|4459427|P2|Overall Study|Adverse Event|1
1352441|NCT01735201|4459428|P1|Overall Study|Adverse Event|1
1352442|NCT01735175|4459464|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
1352443|NCT01735175|4459465|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
1352444|NCT01735175|4459464|P2|Overall Study|Death|2
1352445|NCT01735175|4459465|P1|Overall Study|Death|3
1352446|NCT01735175|4459464|P2|Overall Study|Lost to Follow-up|2
1352447|NCT01735175|4459465|P1|Overall Study|Lost to Follow-up|4
1352448|NCT01735175|4459464|P2|Overall Study|Withdrawal by Subject|2
1352449|NCT01735175|4459465|P1|Overall Study|Withdrawal by Subject|9
1352450|NCT01734993|4459485|P1|Overall Study|Lack of Efficacy|1
1352451|NCT01734993|4459485|P1|Overall Study|Adverse Event|1
1352452|NCT01734785|4459522|P4|Double−Blind Period|Not treated|0
1352453|NCT01734785|4459523|P3|Double−Blind Period|Not treated|0
1352454|NCT01734785|4459524|P2|Double−Blind Period|Not treated|0
1352455|NCT01734785|4459525|P1|Double−Blind Period|Not treated|1
1352456|NCT01734785|4459522|P4|Double−Blind Period|Withdrawal by Subject|0
1352457|NCT01734785|4459523|P3|Double−Blind Period|Withdrawal by Subject|0
1352458|NCT01734785|4459524|P2|Double−Blind Period|Withdrawal by Subject|0
1352459|NCT01734785|4459525|P1|Double−Blind Period|Withdrawal by Subject|2
1352460|NCT01734785|4459522|P4|Double−Blind Period|Lost to Follow-up|0
1352461|NCT01734785|4459523|P3|Double−Blind Period|Lost to Follow-up|2
1352462|NCT01734785|4459524|P2|Double−Blind Period|Lost to Follow-up|4
1352463|NCT01734785|4459525|P1|Double−Blind Period|Lost to Follow-up|2
1352464|NCT01734785|4459522|P4|Double−Blind Period|Protocol Violation|0
1352465|NCT01734785|4459523|P3|Double−Blind Period|Protocol Violation|1
1352466|NCT01734785|4459524|P2|Double−Blind Period|Protocol Violation|1
1352467|NCT01734785|4459525|P1|Double−Blind Period|Protocol Violation|0
1352468|NCT01734785|4459522|P4|Double−Blind Period|Lack of Efficacy|0
1352469|NCT01734785|4459523|P3|Double−Blind Period|Lack of Efficacy|0
1352470|NCT01734785|4459524|P2|Double−Blind Period|Lack of Efficacy|1
1352471|NCT01734785|4459525|P1|Double−Blind Period|Lack of Efficacy|0
1352472|NCT01734785|4459522|P4|Double−Blind Period|Adverse Event|0
1352473|NCT01734785|4459523|P3|Double−Blind Period|Adverse Event|2
1352474|NCT01734785|4459524|P2|Double−Blind Period|Adverse Event|3
1352475|NCT01734785|4459525|P1|Double−Blind Period|Adverse Event|0
1352476|NCT01734785|4459522|P4|Open−Label Period|Other Reasons|224
1352477|NCT01734785|4459523|P3|Open−Label Period|Other Reasons|0
1352478|NCT01734785|4459524|P2|Open−Label Period|Other Reasons|0
1352479|NCT01734785|4459525|P1|Open−Label Period|Other Reasons|0
1352480|NCT01734785|4459522|P4|Open−Label Period|Withdrawal by Subject|12
1352481|NCT01734785|4459523|P3|Open−Label Period|Withdrawal by Subject|0
1352482|NCT01734785|4459524|P2|Open−Label Period|Withdrawal by Subject|0
1352483|NCT01734785|4459525|P1|Open−Label Period|Withdrawal by Subject|0
1352484|NCT01734785|4459522|P4|Open−Label Period|Lost to Follow-up|14
1352485|NCT01734785|4459523|P3|Open−Label Period|Lost to Follow-up|0
1352486|NCT01734785|4459524|P2|Open−Label Period|Lost to Follow-up|0
1352487|NCT01734785|4459525|P1|Open−Label Period|Lost to Follow-up|0
1352488|NCT01734785|4459522|P4|Open−Label Period|Protocol Violation|13
1352489|NCT01734785|4459523|P3|Open−Label Period|Protocol Violation|0
1352490|NCT01734785|4459524|P2|Open−Label Period|Protocol Violation|0
1352491|NCT01734785|4459525|P1|Open−Label Period|Protocol Violation|0
1352492|NCT01734785|4459522|P4|Open−Label Period|Lack of Efficacy|1
1352493|NCT01734785|4459523|P3|Open−Label Period|Lack of Efficacy|0
1352494|NCT01734785|4459524|P2|Open−Label Period|Lack of Efficacy|0
1352495|NCT01734785|4459525|P1|Open−Label Period|Lack of Efficacy|0
1352496|NCT01734785|4459522|P4|Open−Label Period|Adverse Event|9
1352497|NCT01734785|4459523|P3|Open−Label Period|Adverse Event|0
1352498|NCT01734785|4459524|P2|Open−Label Period|Adverse Event|0
1352499|NCT01734785|4459525|P1|Open−Label Period|Adverse Event|0
1352500|NCT01734772|4459542|P2|Overall Study|Withdrawal by Subject|1
1352501|NCT01734772|4459543|P1|Overall Study|Withdrawal by Subject|0
1352502|NCT01734772|4459542|P2|Overall Study|Adverse Event|2
1352503|NCT01734772|4459543|P1|Overall Study|Adverse Event|1
1352504|NCT01734395|4459584|P1|Overall Study|Missing the reasons for not completed|3
1352505|NCT01734395|4459584|P1|Overall Study|Withdrawal by Subject|10
1352506|NCT01734395|4459584|P1|Overall Study|Adverse Event|40
1352507|NCT01734395|4459584|P1|Overall Study|Lack of Efficacy|5
1352508|NCT01734395|4459584|P1|Overall Study|Lost to Follow-up|287
1352509|NCT01734395|4459584|P1|Overall Study|Not specified|65
1352510|NCT01733758|4459642|P4|Overall Study|Inv Decision, HbA1c not controlled|1
1352511|NCT01733758|4459643|P3|Overall Study|Inv Decision, HbA1c not controlled|0
1352512|NCT01733758|4459644|P2|Overall Study|Inv Decision, HbA1c not controlled|1
1352513|NCT01733758|4459645|P1|Overall Study|Inv Decision, HbA1c not controlled|1
1352514|NCT01733758|4459642|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
1352515|NCT01733758|4459643|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
1352516|NCT01733758|4459644|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
1352517|NCT01733758|4459645|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
1352518|NCT01733758|4459642|P4|Overall Study|Non-compliance|0
1352519|NCT01733758|4459643|P3|Overall Study|Non-compliance|0
1352520|NCT01733758|4459644|P2|Overall Study|Non-compliance|0
1352521|NCT01733758|4459645|P1|Overall Study|Non-compliance|1
1352522|NCT01733758|4459642|P4|Overall Study|Protocol Violation|2
1352523|NCT01733758|4459643|P3|Overall Study|Protocol Violation|2
1352524|NCT01733758|4459644|P2|Overall Study|Protocol Violation|1
1352525|NCT01733758|4459645|P1|Overall Study|Protocol Violation|0
1352526|NCT01733758|4459642|P4|Overall Study|Persistent Hyperglycemia|0
1352527|NCT01733758|4459643|P3|Overall Study|Persistent Hyperglycemia|0
1352528|NCT01733758|4459644|P2|Overall Study|Persistent Hyperglycemia|2
1352529|NCT01733758|4459645|P1|Overall Study|Persistent Hyperglycemia|3
1352530|NCT01733758|4459642|P4|Overall Study|Withdrawal by Subject|3
1352531|NCT01733758|4459643|P3|Overall Study|Withdrawal by Subject|5
1352532|NCT01733758|4459644|P2|Overall Study|Withdrawal by Subject|1
1352533|NCT01733758|4459645|P1|Overall Study|Withdrawal by Subject|1
1352534|NCT01733758|4459642|P4|Overall Study|Adverse Event|1
1352535|NCT01733758|4459643|P3|Overall Study|Adverse Event|8
1352536|NCT01733758|4459644|P2|Overall Study|Adverse Event|7
1352537|NCT01733758|4459645|P1|Overall Study|Adverse Event|5
1352538|NCT01733732|4459711|P2|Overall Study|Did not attend all study visits|0
1352539|NCT01733732|4459712|P1|Overall Study|Did not attend all study visits|1
1352540|NCT01733732|4459711|P2|Overall Study|Adverse Event|0
1352541|NCT01733732|4459712|P1|Overall Study|Adverse Event|1
1352542|NCT01733680|4459748|P2|Overall Study|Withdrawal by Subject|1
1352543|NCT01733680|4459749|P1|Overall Study|Withdrawal by Subject|0
1352544|NCT01733329|4459769|P2|Overall Study|Uterine artery injury|0
1352545|NCT01733329|4459770|P1|Overall Study|Uterine artery injury|1
1352546|NCT01733329|4459769|P2|Overall Study|Protocol Violation|1
1352547|NCT01733329|4459770|P1|Overall Study|Protocol Violation|1
1352548|NCT01733316|4459782|P1|Long Term Extension Phase|Sponsor Decision|2
1352549|NCT01733316|4459782|P1|Long Term Extension Phase|Consent Withdrawn by Subject|2
1352550|NCT01733316|4459782|P1|Long Term Extension Phase|Adverse Event|1
1352551|NCT01733316|4459782|P1|RP103 Phase|Non-compliance|1
1352552|NCT01733121|4459820|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
1352553|NCT01733121|4459821|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
1352554|NCT01733121|4459820|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
1352555|NCT01733121|4459821|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
1352556|NCT01733121|4459820|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
1352557|NCT01733121|4459821|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
1352558|NCT01733121|4459820|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
1352559|NCT01733121|4459821|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
1352560|NCT01732926|4459863|P2|Overall Study|Blind Broken by Subject or Study Site|1
1352561|NCT01732926|4459864|P1|Overall Study|Blind Broken by Subject or Study Site|1
1352562|NCT01732926|4459863|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
1352563|NCT01732926|4459864|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
1352564|NCT01732926|4459863|P2|Overall Study|Other Reason|4
1352565|NCT01732926|4459864|P1|Overall Study|Other Reason|21
1352566|NCT01732926|4459863|P2|Overall Study|Physician Decision|11
1352567|NCT01732926|4459864|P1|Overall Study|Physician Decision|24
1352568|NCT01732926|4459863|P2|Overall Study|Withdrawal by Subject|8
1352569|NCT01732926|4459864|P1|Overall Study|Withdrawal by Subject|46
1352570|NCT01732926|4459863|P2|Overall Study|Study Terminated by Sponsor|80
1352571|NCT01732926|4459864|P1|Overall Study|Study Terminated by Sponsor|168
1352572|NCT01732913|4459880|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
1352573|NCT01732913|4459881|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
1352574|NCT01732913|4459880|P2|Overall Study|Other|1
1352575|NCT01732913|4459881|P1|Overall Study|Other|7
1352576|NCT01732913|4459880|P2|Overall Study|Physician Decision|7
1352577|NCT01732913|4459881|P1|Overall Study|Physician Decision|14
1352578|NCT01732913|4459880|P2|Overall Study|Withdrawal by Subject|4
1352579|NCT01732913|4459881|P1|Overall Study|Withdrawal by Subject|27
1352580|NCT01732913|4459880|P2|Overall Study|Study Terminated by Sponsor|55
1352581|NCT01732913|4459881|P1|Overall Study|Study Terminated by Sponsor|105
1352582|NCT01732835|4459895|P1|2-year Extended Follow-up|Death|1
1352583|NCT01732835|4459895|P1|2-year Extended Follow-up|Adverse Event|3
1352584|NCT01732835|4459895|P1|2-year Extended Follow-up|Withdrawal by Subject|1
1352585|NCT01732835|4459895|P1|6-month Primary Endpoint|Adverse Event|3
1352586|NCT01732835|4459895|P1|6-month Primary Endpoint|Withdrawal by Subject|2
1352587|NCT01732835|4459895|P1|6-month Primary Endpoint|Did not receive device|19
1352588|NCT01732822|4459928|P2|Overall Study|Withdrawal by Subject|113
1352589|NCT01732822|4459929|P1|Overall Study|Withdrawal by Subject|123
1352590|NCT01732796|4460002|P3|Overall Study|Other reason not defined above|2
1352591|NCT01732796|4460003|P2|Overall Study|Other reason not defined above|0
1352592|NCT01732796|4460004|P1|Overall Study|Other reason not defined above|1
1352593|NCT01732796|4460002|P3|Overall Study|Withdrawal by Subject|2
1352594|NCT01732796|4460003|P2|Overall Study|Withdrawal by Subject|8
1352595|NCT01732796|4460004|P1|Overall Study|Withdrawal by Subject|6
1352596|NCT01732796|4460002|P3|Overall Study|Lost to Follow-up|0
1352597|NCT01732796|4460003|P2|Overall Study|Lost to Follow-up|0
1352598|NCT01732796|4460004|P1|Overall Study|Lost to Follow-up|2
1352599|NCT01732796|4460002|P3|Overall Study|Lack of Efficacy|5
1352600|NCT01732796|4460003|P2|Overall Study|Lack of Efficacy|18
1352601|NCT01732796|4460004|P1|Overall Study|Lack of Efficacy|21
1352602|NCT01732796|4460002|P3|Overall Study|Adverse Event|4
1352603|NCT01732796|4460003|P2|Overall Study|Adverse Event|16
1352604|NCT01732796|4460004|P1|Overall Study|Adverse Event|16
1352605|NCT01732783|4460023|P3|Overall Study|Withdrawal by Subject|0
1352606|NCT01732783|4460024|P2|Overall Study|Withdrawal by Subject|0
1352607|NCT01732783|4460025|P1|Overall Study|Withdrawal by Subject|1
1352608|NCT01732783|4460023|P3|Overall Study|Administrative Decision|1
1352609|NCT01732783|4460024|P2|Overall Study|Administrative Decision|2
1352610|NCT01732783|4460025|P1|Overall Study|Administrative Decision|8
1352611|NCT01732783|4460023|P3|Overall Study|Lost to Follow-up|1
1352612|NCT01732783|4460024|P2|Overall Study|Lost to Follow-up|1
1352613|NCT01732783|4460025|P1|Overall Study|Lost to Follow-up|7
1352614|NCT01732783|4460023|P3|Overall Study|Death|1
1352615|NCT01732783|4460024|P2|Overall Study|Death|4
1352616|NCT01732783|4460025|P1|Overall Study|Death|13
1352617|NCT01732783|4460023|P3|Overall Study|Discontinued Panitumumab Treatment|7
1352618|NCT01732783|4460024|P2|Overall Study|Discontinued Panitumumab Treatment|25
1352619|NCT01732783|4460025|P1|Overall Study|Discontinued Panitumumab Treatment|106
1352620|NCT01732770|4460089|P2|Overall Study|Death|0
1352621|NCT01732770|4460090|P1|Overall Study|Death|1
1352622|NCT01732770|4460089|P2|Overall Study|Decision by Sponsor|2
1352623|NCT01732770|4460090|P1|Overall Study|Decision by Sponsor|2
1352624|NCT01732770|4460089|P2|Overall Study|Withdrawal by Subject|3
1352625|NCT01732770|4460090|P1|Overall Study|Withdrawal by Subject|5
1352626|NCT01732770|4460089|P2|Overall Study|Lost to Follow-up|3
1352627|NCT01732770|4460090|P1|Overall Study|Lost to Follow-up|2
1352628|NCT01732757|4460105|P3|Overall Study|Lost to Follow-up|0
1352629|NCT01732757|4460106|P2|Overall Study|Lost to Follow-up|0
1352630|NCT01732757|4460107|P1|Overall Study|Lost to Follow-up|1
1352631|NCT01732692|4460147|P2|Overall Study|Adverse Event|1
1352632|NCT01732692|4460148|P1|Overall Study|Adverse Event|0
1352633|NCT01732640|4460162|P2|Overall Study|Death|1
1352634|NCT01732640|4460163|P1|Overall Study|Death|0
1352635|NCT01732640|4460162|P2|Overall Study|Adverse Event|1
1352636|NCT01732640|4460163|P1|Overall Study|Adverse Event|0
1352637|NCT01732588|4460181|P3|First Intervention (7 Days)|Adverse Event|0
1352638|NCT01732588|4460182|P2|First Intervention (7 Days)|Adverse Event|1
1352639|NCT01732588|4460183|P1|First Intervention (7 Days)|Adverse Event|0
1352640|NCT01732549|4460199|P2|Overall Study|Not Specified|14
1352641|NCT01732549|4460200|P1|Overall Study|Not Specified|8
1352642|NCT01732549|4460199|P2|Overall Study|Disease progression|50
1352643|NCT01732549|4460200|P1|Overall Study|Disease progression|37
1352644|NCT01732549|4460199|P2|Overall Study|Consent withdrawn|6
1352645|NCT01732549|4460200|P1|Overall Study|Consent withdrawn|13
1352646|NCT01732549|4460199|P2|Overall Study|Adverse Event|3
1352647|NCT01732549|4460200|P1|Overall Study|Adverse Event|13
1352648|NCT01732536|4460222|P2|Overall Study|Withdrawal by Subject|1
1352649|NCT01732536|4460223|P1|Overall Study|Withdrawal by Subject|1
1352650|NCT01732510|4460246|P7|Overall Study|Study Terminated By Sponsor|6
1352651|NCT01732510|4460247|P6|Overall Study|Study Terminated By Sponsor|12
1352652|NCT01732510|4460248|P5|Overall Study|Study Terminated By Sponsor|0
1352653|NCT01732510|4460249|P4|Overall Study|Study Terminated By Sponsor|1
1352654|NCT01732510|4460250|P3|Overall Study|Study Terminated By Sponsor|0
1352655|NCT01732510|4460251|P2|Overall Study|Study Terminated By Sponsor|0
1352656|NCT01732510|4460252|P1|Overall Study|Study Terminated By Sponsor|0
1352657|NCT01732510|4460246|P7|Overall Study|Pregnancy|0
1352658|NCT01732510|4460247|P6|Overall Study|Pregnancy|0
1352659|NCT01732510|4460248|P5|Overall Study|Pregnancy|0
1352660|NCT01732510|4460249|P4|Overall Study|Pregnancy|1
1352661|NCT01732510|4460250|P3|Overall Study|Pregnancy|0
1352662|NCT01732510|4460251|P2|Overall Study|Pregnancy|0
1352663|NCT01732510|4460252|P1|Overall Study|Pregnancy|0
1352664|NCT01732510|4460246|P7|Overall Study|Physician Decision|0
1352665|NCT01732510|4460247|P6|Overall Study|Physician Decision|0
1352666|NCT01732510|4460248|P5|Overall Study|Physician Decision|0
1352667|NCT01732510|4460249|P4|Overall Study|Physician Decision|0
1352668|NCT01732510|4460250|P3|Overall Study|Physician Decision|0
1352669|NCT01732510|4460251|P2|Overall Study|Physician Decision|1
1352670|NCT01732510|4460252|P1|Overall Study|Physician Decision|0
1352671|NCT01732510|4460246|P7|Overall Study|Lost to Follow-up|0
1352672|NCT01732510|4460247|P6|Overall Study|Lost to Follow-up|1
1352673|NCT01732510|4460248|P5|Overall Study|Lost to Follow-up|0
1352674|NCT01732510|4460249|P4|Overall Study|Lost to Follow-up|1
1352675|NCT01732510|4460250|P3|Overall Study|Lost to Follow-up|1
1352676|NCT01732510|4460251|P2|Overall Study|Lost to Follow-up|0
1352677|NCT01732510|4460252|P1|Overall Study|Lost to Follow-up|0
1352678|NCT01732510|4460246|P7|Overall Study|Withdrawal by Subject|1
1352679|NCT01732510|4460247|P6|Overall Study|Withdrawal by Subject|0
1352680|NCT01732510|4460248|P5|Overall Study|Withdrawal by Subject|5
1352681|NCT01732510|4460249|P4|Overall Study|Withdrawal by Subject|1
1352682|NCT01732510|4460250|P3|Overall Study|Withdrawal by Subject|2
1352683|NCT01732510|4460251|P2|Overall Study|Withdrawal by Subject|3
1352684|NCT01732510|4460252|P1|Overall Study|Withdrawal by Subject|1
1352685|NCT01732510|4460246|P7|Overall Study|Protocol Violation|0
1352686|NCT01732510|4460247|P6|Overall Study|Protocol Violation|0
1352687|NCT01732510|4460248|P5|Overall Study|Protocol Violation|0
1352688|NCT01732510|4460249|P4|Overall Study|Protocol Violation|1
1352689|NCT01732510|4460250|P3|Overall Study|Protocol Violation|0
1352690|NCT01732510|4460251|P2|Overall Study|Protocol Violation|0
1352691|NCT01732510|4460252|P1|Overall Study|Protocol Violation|0
1352692|NCT01732510|4460246|P7|Overall Study|Adverse Event|1
1352693|NCT01732510|4460247|P6|Overall Study|Adverse Event|0
1352694|NCT01732510|4460248|P5|Overall Study|Adverse Event|0
1352695|NCT01732510|4460249|P4|Overall Study|Adverse Event|0
1352696|NCT01732510|4460250|P3|Overall Study|Adverse Event|1
1352697|NCT01732510|4460251|P2|Overall Study|Adverse Event|1
1352698|NCT01732510|4460252|P1|Overall Study|Adverse Event|0
1352699|NCT01732484|4460331|P1|Overall Study|chronical illness|5
1352700|NCT01732484|4460331|P1|Overall Study|Lost to Follow-up|14
1352701|NCT01732484|4460331|P1|Overall Study|Death|7
1352702|NCT01732471|4460339|P1|Overall Study|Withdrawal by Subject|1
1352703|NCT01732458|4460350|P4|Overall Study|Screen Failure|0
1352704|NCT01732458|4460351|P3|Overall Study|Screen Failure|0
1352705|NCT01732458|4460352|P2|Overall Study|Screen Failure|1
1352706|NCT01732458|4460353|P1|Overall Study|Screen Failure|0
1352707|NCT01732458|4460350|P4|Overall Study|Protocol Violation|2
1352708|NCT01732458|4460351|P3|Overall Study|Protocol Violation|0
1352709|NCT01732458|4460352|P2|Overall Study|Protocol Violation|0
1352710|NCT01732458|4460353|P1|Overall Study|Protocol Violation|2
1352711|NCT01732458|4460350|P4|Overall Study|Physician Decision|0
1352712|NCT01732458|4460351|P3|Overall Study|Physician Decision|2
1352713|NCT01732458|4460352|P2|Overall Study|Physician Decision|2
1352714|NCT01732458|4460353|P1|Overall Study|Physician Decision|1
1352715|NCT01732458|4460350|P4|Overall Study|Non-Compliance With Study Drug|0
1352716|NCT01732458|4460351|P3|Overall Study|Non-Compliance With Study Drug|1
1352717|NCT01732458|4460352|P2|Overall Study|Non-Compliance With Study Drug|0
1352718|NCT01732458|4460353|P1|Overall Study|Non-Compliance With Study Drug|0
1352719|NCT01732458|4460350|P4|Overall Study|Lost to Follow-up|0
1352720|NCT01732458|4460351|P3|Overall Study|Lost to Follow-up|0
1352721|NCT01732458|4460352|P2|Overall Study|Lost to Follow-up|2
1352722|NCT01732458|4460353|P1|Overall Study|Lost to Follow-up|0
1352723|NCT01732107|4460465|P1|Overall Study|Withdrawal by Subject|2
1352724|NCT01732107|4460465|P1|Overall Study|Physician Decision|1
1352725|NCT01732107|4460465|P1|Overall Study|Disease Progression|8
1352726|NCT01732107|4460465|P1|Overall Study|Adverse Event|2
1352727|NCT01731990|4460482|P2|Overall Study|Death|0
1352728|NCT01731990|4460483|P1|Overall Study|Death|1
1352729|NCT01731990|4460482|P2|Overall Study|Protocol deviation|2
1352730|NCT01731990|4460483|P1|Overall Study|Protocol deviation|1
1352731|NCT01731990|4460482|P2|Overall Study|Withdrawal by Subject|1
1352732|NCT01731990|4460483|P1|Overall Study|Withdrawal by Subject|1
1352733|NCT01731990|4460482|P2|Overall Study|Adverse Event|5
1352734|NCT01731990|4460483|P1|Overall Study|Adverse Event|1
1352735|NCT01731938|4460499|P2|Primary Part II|Missed Week 6 visit|3
1352736|NCT01731938|4460500|P1|Primary Part II|Missed Week 6 visit|2
1352737|NCT01731938|4460499|P2|Primary Part II|Death|1
1352738|NCT01731938|4460500|P1|Primary Part II|Death|2
1352739|NCT01731938|4460499|P2|Primary Part II|Lost to Follow-up|5
1352740|NCT01731938|4460500|P1|Primary Part II|Lost to Follow-up|4
1352741|NCT01731938|4460499|P2|Primary Part II|Withdrawal by Subject|4
1352742|NCT01731938|4460500|P1|Primary Part II|Withdrawal by Subject|5
1352743|NCT01731938|4460499|P2|Preliminary Part I|Missed Week 6 visit|3
1352744|NCT01731938|4460500|P1|Preliminary Part I|Missed Week 6 visit|0
1352745|NCT01731938|4460499|P2|Preliminary Part I|Lost to Follow-up|3
1352746|NCT01731938|4460500|P1|Preliminary Part I|Lost to Follow-up|0
1352747|NCT01731938|4460499|P2|Preliminary Part I|Physician Decision|0
1352748|NCT01731938|4460500|P1|Preliminary Part I|Physician Decision|1
1352749|NCT01731938|4460499|P2|Preliminary Part I|Withdrawal by Subject|2
1352750|NCT01731938|4460500|P1|Preliminary Part I|Withdrawal by Subject|2
1352751|NCT01731470|4460512|P1|Overall Study|Did not meet study criteria|1
1352752|NCT01731470|4460512|P1|Overall Study|Withdrawal by Subject|1
1352753|NCT01731002|4460539|P3|Overall Study|Inappropriate use of study medications|1
1352754|NCT01731002|4460540|P2|Overall Study|Inappropriate use of study medications|0
1352755|NCT01731002|4460541|P1|Overall Study|Inappropriate use of study medications|0
1352756|NCT01731002|4460539|P3|Overall Study|Elevated IOP|0
1352757|NCT01731002|4460540|P2|Overall Study|Elevated IOP|0
1352758|NCT01731002|4460541|P1|Overall Study|Elevated IOP|1
1352759|NCT01731002|4460539|P3|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
1352760|NCT01731002|4460540|P2|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
1352761|NCT01731002|4460541|P1|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
1352762|NCT01731002|4460539|P3|Overall Study|Test Agent Discontinuation|0
1352763|NCT01731002|4460540|P2|Overall Study|Test Agent Discontinuation|1
1352764|NCT01731002|4460541|P1|Overall Study|Test Agent Discontinuation|0
1352765|NCT01731002|4460539|P3|Overall Study|Lost to Follow-up|0
1352766|NCT01731002|4460540|P2|Overall Study|Lost to Follow-up|0
1352767|NCT01731002|4460541|P1|Overall Study|Lost to Follow-up|1
1352768|NCT01731002|4460539|P3|Overall Study|Non-Compliant|0
1352769|NCT01731002|4460540|P2|Overall Study|Non-Compliant|1
1352770|NCT01731002|4460541|P1|Overall Study|Non-Compliant|0
1352771|NCT01731002|4460539|P3|Overall Study|Adverse Event|2
1352772|NCT01731002|4460540|P2|Overall Study|Adverse Event|2
1352773|NCT01731002|4460541|P1|Overall Study|Adverse Event|0
1352774|NCT01730378|4460570|P2|Overall Study|Lost to Follow-up|0
1352775|NCT01730378|4460571|P1|Overall Study|Lost to Follow-up|1
1352776|NCT01730339|4460602|P2|Overall Study|Un-specified|0
1352777|NCT01730339|4460603|P1|Overall Study|Un-specified|1
1352778|NCT01730339|4460602|P2|Overall Study|Lost to Follow-up|1
1352779|NCT01730339|4460603|P1|Overall Study|Lost to Follow-up|1
1352780|NCT01730339|4460602|P2|Overall Study|Withdrawal by Subject|2
1352781|NCT01730339|4460603|P1|Overall Study|Withdrawal by Subject|3
1352782|NCT01730053|4460643|P6|Overall Study|Other than specified|9
1352783|NCT01730053|4460644|P5|Overall Study|Other than specified|7
1352784|NCT01730053|4460645|P4|Overall Study|Other than specified|4
1352785|NCT01730053|4460646|P3|Overall Study|Other than specified|5
1352786|NCT01730053|4460647|P2|Overall Study|Other than specified|6
1352787|NCT01730053|4460648|P1|Overall Study|Other than specified|2
1352788|NCT01730053|4460643|P6|Overall Study|Poor compliance to protocol|2
1352789|NCT01730053|4460644|P5|Overall Study|Poor compliance to protocol|0
1352790|NCT01730053|4460645|P4|Overall Study|Poor compliance to protocol|0
1352791|NCT01730053|4460646|P3|Overall Study|Poor compliance to protocol|2
1352792|NCT01730053|4460647|P2|Overall Study|Poor compliance to protocol|2
1352793|NCT01730053|4460648|P1|Overall Study|Poor compliance to protocol|1
1352794|NCT01730053|4460643|P6|Overall Study|Adverse Event|2
1352795|NCT01730053|4460644|P5|Overall Study|Adverse Event|2
1352796|NCT01730053|4460645|P4|Overall Study|Adverse Event|3
1352797|NCT01730053|4460646|P3|Overall Study|Adverse Event|3
1352798|NCT01730053|4460647|P2|Overall Study|Adverse Event|6
1352799|NCT01730053|4460648|P1|Overall Study|Adverse Event|2
1352800|NCT01730053|4460643|P6|Overall Study|Physician Decision|0
1352801|NCT01730053|4460644|P5|Overall Study|Physician Decision|0
1352802|NCT01730053|4460645|P4|Overall Study|Physician Decision|1
1352803|NCT01730053|4460646|P3|Overall Study|Physician Decision|0
1352804|NCT01730053|4460647|P2|Overall Study|Physician Decision|0
1352805|NCT01730053|4460648|P1|Overall Study|Physician Decision|0
1352806|NCT01730053|4460643|P6|Overall Study|Participant moved|0
1352807|NCT01730053|4460644|P5|Overall Study|Participant moved|0
1352808|NCT01730053|4460645|P4|Overall Study|Participant moved|0
1352809|NCT01730053|4460646|P3|Overall Study|Participant moved|1
1352810|NCT01730053|4460647|P2|Overall Study|Participant moved|0
1352811|NCT01730053|4460648|P1|Overall Study|Participant moved|0
1352812|NCT01730040|4460807|P7|Overall Study|Poor compliance to protocol|1
1352813|NCT01730040|4460808|P6|Overall Study|Poor compliance to protocol|0
1352814|NCT01730040|4460809|P5|Overall Study|Poor compliance to protocol|0
1352815|NCT01730040|4460810|P4|Overall Study|Poor compliance to protocol|0
1352816|NCT01730040|4460811|P3|Overall Study|Poor compliance to protocol|0
1352817|NCT01730040|4460812|P2|Overall Study|Poor compliance to protocol|4
1352818|NCT01730040|4460813|P1|Overall Study|Poor compliance to protocol|2
1352819|NCT01730040|4460807|P7|Overall Study|Adverse Event|2
1352820|NCT01730040|4460808|P6|Overall Study|Adverse Event|1
1352821|NCT01730040|4460809|P5|Overall Study|Adverse Event|1
1352822|NCT01730040|4460810|P4|Overall Study|Adverse Event|3
1352823|NCT01730040|4460811|P3|Overall Study|Adverse Event|5
1352824|NCT01730040|4460812|P2|Overall Study|Adverse Event|3
1352825|NCT01730040|4460813|P1|Overall Study|Adverse Event|4
1352826|NCT01730040|4460807|P7|Overall Study|Other than specified|4
1352827|NCT01730040|4460808|P6|Overall Study|Other than specified|4
1352828|NCT01730040|4460809|P5|Overall Study|Other than specified|5
1352829|NCT01730040|4460810|P4|Overall Study|Other than specified|5
1352830|NCT01730040|4460811|P3|Overall Study|Other than specified|5
1352831|NCT01730040|4460812|P2|Overall Study|Other than specified|8
1352832|NCT01730040|4460813|P1|Overall Study|Other than specified|7
1352833|NCT01730040|4460807|P7|Overall Study|Physician Decision|1
1352834|NCT01730040|4460808|P6|Overall Study|Physician Decision|1
1352835|NCT01730040|4460809|P5|Overall Study|Physician Decision|0
1352836|NCT01730040|4460810|P4|Overall Study|Physician Decision|0
1352837|NCT01730040|4460811|P3|Overall Study|Physician Decision|0
1352838|NCT01730040|4460812|P2|Overall Study|Physician Decision|0
1352839|NCT01730040|4460813|P1|Overall Study|Physician Decision|0
1352840|NCT01730040|4460807|P7|Overall Study|Subject moved|1
1352841|NCT01730040|4460808|P6|Overall Study|Subject moved|0
1352842|NCT01730040|4460809|P5|Overall Study|Subject moved|0
1352843|NCT01730040|4460810|P4|Overall Study|Subject moved|0
1352844|NCT01730040|4460811|P3|Overall Study|Subject moved|1
1352845|NCT01730040|4460812|P2|Overall Study|Subject moved|0
1352846|NCT01730040|4460813|P1|Overall Study|Subject moved|0
1352847|NCT01730040|4460807|P7|Overall Study|Randomized but not treated|0
1352848|NCT01730040|4460808|P6|Overall Study|Randomized but not treated|1
1352849|NCT01730040|4460809|P5|Overall Study|Randomized but not treated|0
1352850|NCT01730040|4460810|P4|Overall Study|Randomized but not treated|0
1352851|NCT01730040|4460811|P3|Overall Study|Randomized but not treated|0
1352852|NCT01730040|4460812|P2|Overall Study|Randomized but not treated|0
1352853|NCT01730040|4460813|P1|Overall Study|Randomized but not treated|0
1352854|NCT01729871|4461002|P2|Overall Study|Other|9
1352855|NCT01729871|4461003|P1|Overall Study|Other|4
1352856|NCT01729871|4461002|P2|Overall Study|Withdrawal by Subject|3
1352857|NCT01729871|4461003|P1|Overall Study|Withdrawal by Subject|0
1352858|NCT01729871|4461002|P2|Overall Study|Protocol Violation|0
1352859|NCT01729871|4461003|P1|Overall Study|Protocol Violation|1
1352860|NCT01729871|4461002|P2|Overall Study|Physician Decision|2
1352861|NCT01729871|4461003|P1|Overall Study|Physician Decision|0
1352862|NCT01729871|4461002|P2|Overall Study|Lack of Efficacy|1
1352863|NCT01729871|4461003|P1|Overall Study|Lack of Efficacy|0
1352864|NCT01729871|4461002|P2|Overall Study|Death|1
1352865|NCT01729871|4461003|P1|Overall Study|Death|0
1352866|NCT01729871|4461002|P2|Overall Study|Adverse Event|7
1352867|NCT01729871|4461003|P1|Overall Study|Adverse Event|7
1352868|NCT01729819|4461037|P2|Overall Study|Withdrawal by Subject|2
1352869|NCT01729819|4461038|P1|Overall Study|Withdrawal by Subject|0
1352870|NCT01729819|4461037|P2|Overall Study|Protocol Violation|1
1352871|NCT01729819|4461038|P1|Overall Study|Protocol Violation|0
1352872|NCT01729819|4461037|P2|Overall Study|Other reason|0
1352873|NCT01729819|4461038|P1|Overall Study|Other reason|1
1352874|NCT01729819|4461037|P2|Overall Study|Lost to Follow-up|0
1352875|NCT01729819|4461038|P1|Overall Study|Lost to Follow-up|2
1352876|NCT01729819|4461037|P2|Overall Study|Lack of Efficacy|0
1352877|NCT01729819|4461038|P1|Overall Study|Lack of Efficacy|1
1352878|NCT01729819|4461037|P2|Overall Study|Adverse Event|4
1352879|NCT01729819|4461038|P1|Overall Study|Adverse Event|2
1352880|NCT01729754|4461057|P10|Part 3|Other Protocol Specified Criteria|0
1352881|NCT01729754|4461058|P9|Part 3|Other Protocol Specified Criteria|0
1352882|NCT01729754|4461059|P8|Part 3|Other Protocol Specified Criteria|1
1352883|NCT01729754|4461060|P7|Part 3|Other Protocol Specified Criteria|0
1352884|NCT01729754|4461061|P6|Part 3|Other Protocol Specified Criteria|2
1352885|NCT01729754|4461062|P5|Part 3|Other Protocol Specified Criteria|0
1352886|NCT01729754|4461063|P4|Part 3|Other Protocol Specified Criteria|0
1352887|NCT01729754|4461064|P3|Part 3|Other Protocol Specified Criteria|0
1352888|NCT01729754|4461065|P2|Part 3|Other Protocol Specified Criteria|0
1352889|NCT01729754|4461066|P1|Part 3|Other Protocol Specified Criteria|0
1352890|NCT01729754|4461057|P10|Part 3|Withdrawal by Subject|0
1352891|NCT01729754|4461058|P9|Part 3|Withdrawal by Subject|0
1352892|NCT01729754|4461059|P8|Part 3|Withdrawal by Subject|2
1352893|NCT01729754|4461060|P7|Part 3|Withdrawal by Subject|0
1352894|NCT01729754|4461061|P6|Part 3|Withdrawal by Subject|1
1352895|NCT01729754|4461062|P5|Part 3|Withdrawal by Subject|2
1352896|NCT01729754|4461063|P4|Part 3|Withdrawal by Subject|0
1352897|NCT01729754|4461064|P3|Part 3|Withdrawal by Subject|1
1352898|NCT01729754|4461065|P2|Part 3|Withdrawal by Subject|4
1352899|NCT01729754|4461066|P1|Part 3|Withdrawal by Subject|0
1352900|NCT01729754|4461057|P10|Part 3|Physician Decision|0
1352901|NCT01729754|4461058|P9|Part 3|Physician Decision|0
1352902|NCT01729754|4461059|P8|Part 3|Physician Decision|0
1352903|NCT01729754|4461060|P7|Part 3|Physician Decision|0
1352904|NCT01729754|4461061|P6|Part 3|Physician Decision|0
1352905|NCT01729754|4461062|P5|Part 3|Physician Decision|0
1352906|NCT01729754|4461063|P4|Part 3|Physician Decision|0
1352907|NCT01729754|4461064|P3|Part 3|Physician Decision|1
1352908|NCT01729754|4461065|P2|Part 3|Physician Decision|0
1352909|NCT01729754|4461066|P1|Part 3|Physician Decision|0
1352910|NCT01729754|4461057|P10|Part 3|Lost to Follow-up|0
1352911|NCT01729754|4461058|P9|Part 3|Lost to Follow-up|1
1352912|NCT01729754|4461059|P8|Part 3|Lost to Follow-up|0
1352913|NCT01729754|4461060|P7|Part 3|Lost to Follow-up|0
1352914|NCT01729754|4461061|P6|Part 3|Lost to Follow-up|3
1352915|NCT01729754|4461062|P5|Part 3|Lost to Follow-up|0
1352916|NCT01729754|4461063|P4|Part 3|Lost to Follow-up|0
1352917|NCT01729754|4461064|P3|Part 3|Lost to Follow-up|2
1352918|NCT01729754|4461065|P2|Part 3|Lost to Follow-up|1
1352919|NCT01729754|4461066|P1|Part 3|Lost to Follow-up|0
1352920|NCT01729754|4461057|P10|Part 3|Lack of Efficacy|4
1352921|NCT01729754|4461058|P9|Part 3|Lack of Efficacy|0
1352922|NCT01729754|4461059|P8|Part 3|Lack of Efficacy|0
1352923|NCT01729754|4461060|P7|Part 3|Lack of Efficacy|0
1352924|NCT01729754|4461061|P6|Part 3|Lack of Efficacy|0
1352925|NCT01729754|4461062|P5|Part 3|Lack of Efficacy|2
1352926|NCT01729754|4461063|P4|Part 3|Lack of Efficacy|0
1352927|NCT01729754|4461064|P3|Part 3|Lack of Efficacy|0
1352928|NCT01729754|4461065|P2|Part 3|Lack of Efficacy|0
1352929|NCT01729754|4461066|P1|Part 3|Lack of Efficacy|0
1352930|NCT01729754|4461057|P10|Part 3|Death|0
1352931|NCT01729754|4461058|P9|Part 3|Death|0
1352932|NCT01729754|4461059|P8|Part 3|Death|0
1352933|NCT01729754|4461060|P7|Part 3|Death|0
1352934|NCT01729754|4461061|P6|Part 3|Death|2
1352935|NCT01729754|4461062|P5|Part 3|Death|0
1352936|NCT01729754|4461063|P4|Part 3|Death|0
1352937|NCT01729754|4461064|P3|Part 3|Death|0
1352938|NCT01729754|4461065|P2|Part 3|Death|0
1352939|NCT01729754|4461066|P1|Part 3|Death|0
1352940|NCT01729754|4461057|P10|Part 3|Adverse Event|3
1352941|NCT01729754|4461058|P9|Part 3|Adverse Event|0
1352942|NCT01729754|4461059|P8|Part 3|Adverse Event|0
1352943|NCT01729754|4461060|P7|Part 3|Adverse Event|0
1352944|NCT01729754|4461061|P6|Part 3|Adverse Event|5
1352945|NCT01729754|4461062|P5|Part 3|Adverse Event|0
1352946|NCT01729754|4461063|P4|Part 3|Adverse Event|0
1352947|NCT01729754|4461064|P3|Part 3|Adverse Event|1
1352948|NCT01729754|4461065|P2|Part 3|Adverse Event|0
1352949|NCT01729754|4461066|P1|Part 3|Adverse Event|0
1352950|NCT01729754|4461057|P10|Part 2|Other Protocol Specified Criteria|0
1352951|NCT01729754|4461058|P9|Part 2|Other Protocol Specified Criteria|0
1352952|NCT01729754|4461059|P8|Part 2|Other Protocol Specified Criteria|1
1352953|NCT01729754|4461060|P7|Part 2|Other Protocol Specified Criteria|0
1352954|NCT01729754|4461061|P6|Part 2|Other Protocol Specified Criteria|0
1352955|NCT01729754|4461062|P5|Part 2|Other Protocol Specified Criteria|0
1352956|NCT01729754|4461063|P4|Part 2|Other Protocol Specified Criteria|0
1352957|NCT01729754|4461064|P3|Part 2|Other Protocol Specified Criteria|0
1352958|NCT01729754|4461065|P2|Part 2|Other Protocol Specified Criteria|0
1352959|NCT01729754|4461066|P1|Part 2|Other Protocol Specified Criteria|1
1352960|NCT01729754|4461057|P10|Part 2|Withdrawal by Subject|4
1352961|NCT01729754|4461058|P9|Part 2|Withdrawal by Subject|1
1352962|NCT01729754|4461059|P8|Part 2|Withdrawal by Subject|1
1352963|NCT01729754|4461060|P7|Part 2|Withdrawal by Subject|0
1352964|NCT01729754|4461061|P6|Part 2|Withdrawal by Subject|0
1352965|NCT01729754|4461062|P5|Part 2|Withdrawal by Subject|0
1352966|NCT01729754|4461063|P4|Part 2|Withdrawal by Subject|2
1352967|NCT01729754|4461064|P3|Part 2|Withdrawal by Subject|0
1352968|NCT01729754|4461065|P2|Part 2|Withdrawal by Subject|0
1352969|NCT01729754|4461066|P1|Part 2|Withdrawal by Subject|3
1352970|NCT01729754|4461057|P10|Part 2|Pregnancy|1
1352971|NCT01729754|4461058|P9|Part 2|Pregnancy|0
1352972|NCT01729754|4461059|P8|Part 2|Pregnancy|0
1352973|NCT01729754|4461060|P7|Part 2|Pregnancy|0
1352974|NCT01729754|4461061|P6|Part 2|Pregnancy|0
1352975|NCT01729754|4461062|P5|Part 2|Pregnancy|0
1352976|NCT01729754|4461063|P4|Part 2|Pregnancy|1
1352977|NCT01729754|4461064|P3|Part 2|Pregnancy|0
1352978|NCT01729754|4461065|P2|Part 2|Pregnancy|0
1352979|NCT01729754|4461066|P1|Part 2|Pregnancy|0
1352980|NCT01729754|4461057|P10|Part 2|Non-Compliance with Study Drug|1
1352981|NCT01729754|4461058|P9|Part 2|Non-Compliance with Study Drug|0
1352982|NCT01729754|4461059|P8|Part 2|Non-Compliance with Study Drug|0
1352983|NCT01729754|4461060|P7|Part 2|Non-Compliance with Study Drug|0
1352984|NCT01729754|4461061|P6|Part 2|Non-Compliance with Study Drug|0
1352985|NCT01729754|4461062|P5|Part 2|Non-Compliance with Study Drug|0
1352986|NCT01729754|4461063|P4|Part 2|Non-Compliance with Study Drug|0
1352987|NCT01729754|4461064|P3|Part 2|Non-Compliance with Study Drug|0
1352988|NCT01729754|4461065|P2|Part 2|Non-Compliance with Study Drug|0
1352989|NCT01729754|4461066|P1|Part 2|Non-Compliance with Study Drug|0
1352990|NCT01729754|4461057|P10|Part 2|Lost to Follow-up|2
1352991|NCT01729754|4461058|P9|Part 2|Lost to Follow-up|0
1352992|NCT01729754|4461059|P8|Part 2|Lost to Follow-up|1
1352993|NCT01729754|4461060|P7|Part 2|Lost to Follow-up|0
1352994|NCT01729754|4461061|P6|Part 2|Lost to Follow-up|0
1352995|NCT01729754|4461062|P5|Part 2|Lost to Follow-up|0
1352996|NCT01729754|4461063|P4|Part 2|Lost to Follow-up|2
1352997|NCT01729754|4461064|P3|Part 2|Lost to Follow-up|0
1352998|NCT01729754|4461065|P2|Part 2|Lost to Follow-up|0
1352999|NCT01729754|4461066|P1|Part 2|Lost to Follow-up|0
1353000|NCT01729754|4461057|P10|Part 2|Lack of Efficacy|2
1353001|NCT01729754|4461058|P9|Part 2|Lack of Efficacy|2
1353002|NCT01729754|4461059|P8|Part 2|Lack of Efficacy|0
1353003|NCT01729754|4461060|P7|Part 2|Lack of Efficacy|0
1353004|NCT01729754|4461061|P6|Part 2|Lack of Efficacy|0
1353005|NCT01729754|4461062|P5|Part 2|Lack of Efficacy|0
1353006|NCT01729754|4461063|P4|Part 2|Lack of Efficacy|0
1353007|NCT01729754|4461064|P3|Part 2|Lack of Efficacy|0
1353008|NCT01729754|4461065|P2|Part 2|Lack of Efficacy|0
1353009|NCT01729754|4461066|P1|Part 2|Lack of Efficacy|0
1353010|NCT01729754|4461057|P10|Part 2|Adverse Event|2
1353011|NCT01729754|4461058|P9|Part 2|Adverse Event|1
1353012|NCT01729754|4461059|P8|Part 2|Adverse Event|0
1353013|NCT01729754|4461060|P7|Part 2|Adverse Event|0
1353014|NCT01729754|4461061|P6|Part 2|Adverse Event|0
1353015|NCT01729754|4461062|P5|Part 2|Adverse Event|0
1353016|NCT01729754|4461063|P4|Part 2|Adverse Event|0
1353017|NCT01729754|4461064|P3|Part 2|Adverse Event|0
1353018|NCT01729754|4461065|P2|Part 2|Adverse Event|0
1353019|NCT01729754|4461066|P1|Part 2|Adverse Event|2
1353020|NCT01729754|4461057|P10|Part 1|Other Protocol Specified Criteria|4
1353021|NCT01729754|4461058|P9|Part 1|Other Protocol Specified Criteria|0
1353022|NCT01729754|4461059|P8|Part 1|Other Protocol Specified Criteria|0
1353023|NCT01729754|4461060|P7|Part 1|Other Protocol Specified Criteria|1
1353024|NCT01729754|4461061|P6|Part 1|Other Protocol Specified Criteria|0
1353025|NCT01729754|4461062|P5|Part 1|Other Protocol Specified Criteria|0
1353026|NCT01729754|4461063|P4|Part 1|Other Protocol Specified Criteria|0
1353027|NCT01729754|4461064|P3|Part 1|Other Protocol Specified Criteria|0
1353028|NCT01729754|4461065|P2|Part 1|Other Protocol Specified Criteria|0
1353029|NCT01729754|4461066|P1|Part 1|Other Protocol Specified Criteria|2
1353030|NCT01729754|4461057|P10|Part 1|Withdrawal by Subject|6
1353031|NCT01729754|4461058|P9|Part 1|Withdrawal by Subject|0
1353032|NCT01729754|4461059|P8|Part 1|Withdrawal by Subject|0
1353033|NCT01729754|4461060|P7|Part 1|Withdrawal by Subject|5
1353034|NCT01729754|4461061|P6|Part 1|Withdrawal by Subject|0
1353035|NCT01729754|4461062|P5|Part 1|Withdrawal by Subject|0
1353036|NCT01729754|4461063|P4|Part 1|Withdrawal by Subject|7
1353037|NCT01729754|4461064|P3|Part 1|Withdrawal by Subject|0
1353038|NCT01729754|4461065|P2|Part 1|Withdrawal by Subject|0
1353039|NCT01729754|4461066|P1|Part 1|Withdrawal by Subject|5
1353040|NCT01729754|4461057|P10|Part 1|Protocol Violation|0
1353041|NCT01729754|4461058|P9|Part 1|Protocol Violation|0
1353042|NCT01729754|4461059|P8|Part 1|Protocol Violation|0
1353043|NCT01729754|4461060|P7|Part 1|Protocol Violation|1
1353044|NCT01729754|4461061|P6|Part 1|Protocol Violation|0
1353045|NCT01729754|4461062|P5|Part 1|Protocol Violation|0
1353046|NCT01729754|4461063|P4|Part 1|Protocol Violation|1
1353047|NCT01729754|4461064|P3|Part 1|Protocol Violation|0
1353048|NCT01729754|4461065|P2|Part 1|Protocol Violation|0
1353049|NCT01729754|4461066|P1|Part 1|Protocol Violation|2
1353050|NCT01729754|4461057|P10|Part 1|Progressive Disease|1
1353051|NCT01729754|4461058|P9|Part 1|Progressive Disease|0
1353052|NCT01729754|4461059|P8|Part 1|Progressive Disease|0
1353053|NCT01729754|4461060|P7|Part 1|Progressive Disease|0
1353054|NCT01729754|4461061|P6|Part 1|Progressive Disease|0
1353055|NCT01729754|4461062|P5|Part 1|Progressive Disease|0
1353056|NCT01729754|4461063|P4|Part 1|Progressive Disease|0
1353057|NCT01729754|4461064|P3|Part 1|Progressive Disease|0
1353058|NCT01729754|4461065|P2|Part 1|Progressive Disease|0
1353059|NCT01729754|4461066|P1|Part 1|Progressive Disease|0
1353060|NCT01729754|4461057|P10|Part 1|Pregnancy|1
1353061|NCT01729754|4461058|P9|Part 1|Pregnancy|0
1353062|NCT01729754|4461059|P8|Part 1|Pregnancy|0
1353063|NCT01729754|4461060|P7|Part 1|Pregnancy|0
1353064|NCT01729754|4461061|P6|Part 1|Pregnancy|0
1353065|NCT01729754|4461062|P5|Part 1|Pregnancy|0
1353066|NCT01729754|4461063|P4|Part 1|Pregnancy|1
1353067|NCT01729754|4461064|P3|Part 1|Pregnancy|0
1353068|NCT01729754|4461065|P2|Part 1|Pregnancy|0
1353069|NCT01729754|4461066|P1|Part 1|Pregnancy|0
1353070|NCT01729754|4461057|P10|Part 1|Physician Decision|4
1353071|NCT01729754|4461058|P9|Part 1|Physician Decision|0
1353072|NCT01729754|4461059|P8|Part 1|Physician Decision|0
1353073|NCT01729754|4461060|P7|Part 1|Physician Decision|0
1353074|NCT01729754|4461061|P6|Part 1|Physician Decision|0
1353075|NCT01729754|4461062|P5|Part 1|Physician Decision|0
1353076|NCT01729754|4461063|P4|Part 1|Physician Decision|0
1353077|NCT01729754|4461064|P3|Part 1|Physician Decision|0
1353078|NCT01729754|4461065|P2|Part 1|Physician Decision|0
1353079|NCT01729754|4461066|P1|Part 1|Physician Decision|0
1353080|NCT01729754|4461057|P10|Part 1|Non-compliance with Study Drug|0
1353081|NCT01729754|4461058|P9|Part 1|Non-compliance with Study Drug|0
1353082|NCT01729754|4461059|P8|Part 1|Non-compliance with Study Drug|0
1353083|NCT01729754|4461060|P7|Part 1|Non-compliance with Study Drug|0
1353084|NCT01729754|4461061|P6|Part 1|Non-compliance with Study Drug|0
1353085|NCT01729754|4461062|P5|Part 1|Non-compliance with Study Drug|0
1353086|NCT01729754|4461063|P4|Part 1|Non-compliance with Study Drug|0
1353087|NCT01729754|4461064|P3|Part 1|Non-compliance with Study Drug|0
1353088|NCT01729754|4461065|P2|Part 1|Non-compliance with Study Drug|0
1353089|NCT01729754|4461066|P1|Part 1|Non-compliance with Study Drug|1
1353090|NCT01729754|4461057|P10|Part 1|Lost to Follow-up|3
1353091|NCT01729754|4461058|P9|Part 1|Lost to Follow-up|0
1353092|NCT01729754|4461059|P8|Part 1|Lost to Follow-up|0
1353093|NCT01729754|4461060|P7|Part 1|Lost to Follow-up|3
1353094|NCT01729754|4461061|P6|Part 1|Lost to Follow-up|0
1353095|NCT01729754|4461062|P5|Part 1|Lost to Follow-up|0
1353096|NCT01729754|4461063|P4|Part 1|Lost to Follow-up|2
1353097|NCT01729754|4461064|P3|Part 1|Lost to Follow-up|0
1353098|NCT01729754|4461065|P2|Part 1|Lost to Follow-up|0
1353099|NCT01729754|4461066|P1|Part 1|Lost to Follow-up|1
1353100|NCT01729754|4461057|P10|Part 1|Lack of Efficacy|0
1353101|NCT01729754|4461058|P9|Part 1|Lack of Efficacy|0
1353102|NCT01729754|4461059|P8|Part 1|Lack of Efficacy|0
1353103|NCT01729754|4461060|P7|Part 1|Lack of Efficacy|2
1353104|NCT01729754|4461061|P6|Part 1|Lack of Efficacy|0
1353105|NCT01729754|4461062|P5|Part 1|Lack of Efficacy|0
1353106|NCT01729754|4461063|P4|Part 1|Lack of Efficacy|0
1353107|NCT01729754|4461064|P3|Part 1|Lack of Efficacy|0
1353108|NCT01729754|4461065|P2|Part 1|Lack of Efficacy|0
1353109|NCT01729754|4461066|P1|Part 1|Lack of Efficacy|1
1353110|NCT01729754|4461057|P10|Part 1|Adverse Event|5
1353111|NCT01729754|4461058|P9|Part 1|Adverse Event|0
1353112|NCT01729754|4461059|P8|Part 1|Adverse Event|0
1353113|NCT01729754|4461060|P7|Part 1|Adverse Event|2
1353114|NCT01729754|4461061|P6|Part 1|Adverse Event|0
1353115|NCT01729754|4461062|P5|Part 1|Adverse Event|0
1353116|NCT01729754|4461063|P4|Part 1|Adverse Event|1
1353117|NCT01729754|4461064|P3|Part 1|Adverse Event|0
1353118|NCT01729754|4461065|P2|Part 1|Adverse Event|0
1353119|NCT01729754|4461066|P1|Part 1|Adverse Event|2
1353120|NCT01729728|4461273|P3|Overall Study|Protocol Violation|1
1353121|NCT01729728|4461274|P2|Overall Study|Protocol Violation|0
1353122|NCT01729728|4461275|P1|Overall Study|Protocol Violation|1
1353123|NCT01729728|4461273|P3|Overall Study|Adverse Event|0
1353124|NCT01729728|4461274|P2|Overall Study|Adverse Event|6
1353125|NCT01729728|4461275|P1|Overall Study|Adverse Event|0
1353126|NCT01729559|4461408|P2|Overall Study|Protocol Violation|28
1353127|NCT01729559|4461409|P1|Overall Study|Protocol Violation|31
1353128|NCT01729039|4461452|P2|Overall Study|Withdrawal by Subject|7
1353129|NCT01729039|4461453|P1|Overall Study|Withdrawal by Subject|8
1353130|NCT01729039|4461452|P2|Overall Study|disqualified|5
1353131|NCT01729039|4461453|P1|Overall Study|disqualified|2
1353132|NCT01729026|4461469|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
1353133|NCT01729026|4461470|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
1353134|NCT01729026|4461469|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
1353135|NCT01729026|4461470|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
1353136|NCT01728792|4461481|P5|Overall Study|Lost to Follow-up|0
1353137|NCT01728792|4461482|P4|Overall Study|Lost to Follow-up|2
1353138|NCT01728792|4461483|P3|Overall Study|Lost to Follow-up|4
1353139|NCT01728792|4461484|P2|Overall Study|Lost to Follow-up|1
1353140|NCT01728792|4461485|P1|Overall Study|Lost to Follow-up|2
1353141|NCT01728792|4461481|P5|Overall Study|Withdrawal of Consent|0
1353142|NCT01728792|4461482|P4|Overall Study|Withdrawal of Consent|1
1353143|NCT01728792|4461483|P3|Overall Study|Withdrawal of Consent|0
1353144|NCT01728792|4461484|P2|Overall Study|Withdrawal of Consent|1
1353145|NCT01728792|4461485|P1|Overall Study|Withdrawal of Consent|1
1353146|NCT01728584|4461536|P4|Overall Study|Other reason (not specified)|1
1353147|NCT01728584|4461537|P3|Overall Study|Other reason (not specified)|0
1353148|NCT01728584|4461538|P2|Overall Study|Other reason (not specified)|0
1353149|NCT01728584|4461539|P1|Overall Study|Other reason (not specified)|1
1353150|NCT01728584|4461536|P4|Overall Study|Screen failure|0
1353151|NCT01728584|4461537|P3|Overall Study|Screen failure|0
1353152|NCT01728584|4461538|P2|Overall Study|Screen failure|0
1353153|NCT01728584|4461539|P1|Overall Study|Screen failure|1
1353154|NCT01728584|4461536|P4|Overall Study|Withdrawal by Subject|0
1353155|NCT01728584|4461537|P3|Overall Study|Withdrawal by Subject|0
1353156|NCT01728584|4461538|P2|Overall Study|Withdrawal by Subject|0
1353157|NCT01728584|4461539|P1|Overall Study|Withdrawal by Subject|1
1353158|NCT01728584|4461536|P4|Overall Study|Physician Decision|0
1353159|NCT01728584|4461537|P3|Overall Study|Physician Decision|1
1353160|NCT01728584|4461538|P2|Overall Study|Physician Decision|0
1353161|NCT01728584|4461539|P1|Overall Study|Physician Decision|4
1353162|NCT01728584|4461536|P4|Overall Study|Adverse Event|0
1353163|NCT01728584|4461537|P3|Overall Study|Adverse Event|0
1353164|NCT01728584|4461538|P2|Overall Study|Adverse Event|0
1353165|NCT01728584|4461539|P1|Overall Study|Adverse Event|1
1353166|NCT01728376|4461597|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
1353167|NCT01728376|4461598|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
1353168|NCT01728376|4461599|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
1353169|NCT01728376|4461600|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
1353170|NCT01728376|4461601|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
1353171|NCT01728376|4461602|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
1353172|NCT01728376|4461597|P6|Overall Study|Did not receive treatment|0
1353173|NCT01728376|4461598|P5|Overall Study|Did not receive treatment|0
1353174|NCT01728376|4461599|P4|Overall Study|Did not receive treatment|0
1353175|NCT01728376|4461600|P3|Overall Study|Did not receive treatment|0
1353176|NCT01728376|4461601|P2|Overall Study|Did not receive treatment|1
1353177|NCT01728376|4461602|P1|Overall Study|Did not receive treatment|0
1353178|NCT01728376|4461597|P6|Overall Study|No relevant bacteria|1
1353179|NCT01728376|4461598|P5|Overall Study|No relevant bacteria|1
1353180|NCT01728376|4461599|P4|Overall Study|No relevant bacteria|0
1353181|NCT01728376|4461600|P3|Overall Study|No relevant bacteria|0
1353182|NCT01728376|4461601|P2|Overall Study|No relevant bacteria|0
1353183|NCT01728376|4461602|P1|Overall Study|No relevant bacteria|2
1353184|NCT01728376|4461597|P6|Overall Study|Persistent Positive Blood Cultures|0
1353185|NCT01728376|4461598|P5|Overall Study|Persistent Positive Blood Cultures|0
1353186|NCT01728376|4461599|P4|Overall Study|Persistent Positive Blood Cultures|0
1353187|NCT01728376|4461600|P3|Overall Study|Persistent Positive Blood Cultures|1
1353188|NCT01728376|4461601|P2|Overall Study|Persistent Positive Blood Cultures|0
1353189|NCT01728376|4461602|P1|Overall Study|Persistent Positive Blood Cultures|1
1353190|NCT01728376|4461597|P6|Overall Study|Adverse Event|0
1353191|NCT01728376|4461598|P5|Overall Study|Adverse Event|1
1353192|NCT01728376|4461599|P4|Overall Study|Adverse Event|1
1353193|NCT01728376|4461600|P3|Overall Study|Adverse Event|1
1353194|NCT01728376|4461601|P2|Overall Study|Adverse Event|1
1353195|NCT01728376|4461602|P1|Overall Study|Adverse Event|1
1353196|NCT01728324|4461675|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
1353197|NCT01728324|4461676|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
1353198|NCT01728324|4461677|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
1353199|NCT01728324|4461675|P3|Termination of RBV|Adverse Event (Placebo Period)|0
1353200|NCT01728324|4461676|P2|Termination of RBV|Adverse Event (Placebo Period)|1
1353201|NCT01728324|4461677|P1|Termination of RBV|Adverse Event (Placebo Period)|0
1353202|NCT01728324|4461675|P3|Termination of RBV|Other than stated|1
1353203|NCT01728324|4461676|P2|Termination of RBV|Other than stated|3
1353204|NCT01728324|4461677|P1|Termination of RBV|Other than stated|1
1353205|NCT01728324|4461675|P3|Termination of RBV|Withdrawal by Subject|2
1353206|NCT01728324|4461676|P2|Termination of RBV|Withdrawal by Subject|5
1353207|NCT01728324|4461677|P1|Termination of RBV|Withdrawal by Subject|9
1353208|NCT01728324|4461675|P3|Termination of RBV|Lack of Efficacy|7
1353209|NCT01728324|4461676|P2|Termination of RBV|Lack of Efficacy|11
1353210|NCT01728324|4461677|P1|Termination of RBV|Lack of Efficacy|14
1353211|NCT01728324|4461675|P3|Termination of RBV|Adverse Event|5
1353212|NCT01728324|4461676|P2|Termination of RBV|Adverse Event|16
1353213|NCT01728324|4461677|P1|Termination of RBV|Adverse Event|15
1353214|NCT01728324|4461675|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
1353215|NCT01728324|4461676|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
1353216|NCT01728324|4461677|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
1353217|NCT01728324|4461675|P3|Termination of FDV|Adverse Event (Placebo Period)|0
1353218|NCT01728324|4461676|P2|Termination of FDV|Adverse Event (Placebo Period)|1
1353219|NCT01728324|4461677|P1|Termination of FDV|Adverse Event (Placebo Period)|0
1353220|NCT01728324|4461675|P3|Termination of FDV|Other than stated|0
1353221|NCT01728324|4461676|P2|Termination of FDV|Other than stated|3
1353222|NCT01728324|4461677|P1|Termination of FDV|Other than stated|1
1353223|NCT01728324|4461675|P3|Termination of FDV|Withdrawal by Subject|2
1353224|NCT01728324|4461676|P2|Termination of FDV|Withdrawal by Subject|6
1353225|NCT01728324|4461677|P1|Termination of FDV|Withdrawal by Subject|9
1353226|NCT01728324|4461675|P3|Termination of FDV|Lack of Efficacy|8
1353227|NCT01728324|4461676|P2|Termination of FDV|Lack of Efficacy|12
1353228|NCT01728324|4461677|P1|Termination of FDV|Lack of Efficacy|14
1353229|NCT01728324|4461675|P3|Termination of FDV|Adverse Event|4
1353230|NCT01728324|4461676|P2|Termination of FDV|Adverse Event|13
1353231|NCT01728324|4461677|P1|Termination of FDV|Adverse Event|14
1353232|NCT01728324|4461675|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
1353233|NCT01728324|4461676|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
1353234|NCT01728324|4461677|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
1353235|NCT01728324|4461675|P3|Termination of DBV|Adverse Event (Placebo Period)|0
1353236|NCT01728324|4461676|P2|Termination of DBV|Adverse Event (Placebo Period)|1
1353237|NCT01728324|4461677|P1|Termination of DBV|Adverse Event (Placebo Period)|0
1353238|NCT01728324|4461675|P3|Termination of DBV|Other than stated|0
1353239|NCT01728324|4461676|P2|Termination of DBV|Other than stated|3
1353240|NCT01728324|4461677|P1|Termination of DBV|Other than stated|1
1353241|NCT01728324|4461675|P3|Termination of DBV|Withdrawal by Subject|2
1353242|NCT01728324|4461676|P2|Termination of DBV|Withdrawal by Subject|6
1353243|NCT01728324|4461677|P1|Termination of DBV|Withdrawal by Subject|9
1353244|NCT01728324|4461675|P3|Termination of DBV|Lack of Efficacy|8
1353245|NCT01728324|4461676|P2|Termination of DBV|Lack of Efficacy|12
1353246|NCT01728324|4461677|P1|Termination of DBV|Lack of Efficacy|14
1353247|NCT01728324|4461675|P3|Termination of DBV|Adverse Event|4
1353248|NCT01728324|4461676|P2|Termination of DBV|Adverse Event|13
1353249|NCT01728324|4461677|P1|Termination of DBV|Adverse Event|14
1353250|NCT01728246|4461698|P2|Overall Study|Adverse Event|5
1353251|NCT01728246|4461699|P1|Overall Study|Adverse Event|8
1353252|NCT01728246|4461698|P2|Overall Study|Lack of Efficacy|1
1353253|NCT01728246|4461699|P1|Overall Study|Lack of Efficacy|1
1353254|NCT01728246|4461698|P2|Overall Study|Lost to Follow-up|22
1353255|NCT01728246|4461699|P1|Overall Study|Lost to Follow-up|23
1353256|NCT01728246|4461698|P2|Overall Study|Withdrawal by Subject|3
1353257|NCT01728246|4461699|P1|Overall Study|Withdrawal by Subject|2
1353258|NCT01728246|4461698|P2|Overall Study|Protocol Violation|0
1353259|NCT01728246|4461699|P1|Overall Study|Protocol Violation|1
1353260|NCT01728246|4461698|P2|Overall Study|Participant needed rescue medication|5
1353261|NCT01728246|4461699|P1|Overall Study|Participant needed rescue medication|1
1353262|NCT01728116|4461717|P2|Overall Study|various not noted previously|0
1353263|NCT01728116|4461718|P1|Overall Study|various not noted previously|5
1353264|NCT01728116|4461717|P2|Overall Study|Incorrectly enrolled in Study|1
1353265|NCT01728116|4461718|P1|Overall Study|Incorrectly enrolled in Study|0
1353266|NCT01728116|4461717|P2|Overall Study|Inter-current finding at procedure|0
1353267|NCT01728116|4461718|P1|Overall Study|Inter-current finding at procedure|1
1353268|NCT01728116|4461717|P2|Overall Study|Subject Non-Compliance|0
1353269|NCT01728116|4461718|P1|Overall Study|Subject Non-Compliance|2
1353270|NCT01728116|4461717|P2|Overall Study|Physician Decision|0
1353271|NCT01728116|4461718|P1|Overall Study|Physician Decision|2
1353272|NCT01728116|4461717|P2|Overall Study|Lost to Follow-up|2
1353273|NCT01728116|4461718|P1|Overall Study|Lost to Follow-up|9
1353274|NCT01728116|4461717|P2|Overall Study|Procedure/device failure|0
1353275|NCT01728116|4461718|P1|Overall Study|Procedure/device failure|7
1353276|NCT01728116|4461717|P2|Overall Study|Adverse Event|0
1353277|NCT01728116|4461718|P1|Overall Study|Adverse Event|13
1353278|NCT01728116|4461717|P2|Overall Study|Withdrawal by Subject|9
1353279|NCT01728116|4461718|P1|Overall Study|Withdrawal by Subject|16
1353280|NCT01728116|4461717|P2|Overall Study|Sponsor Terminated Study|35
1353281|NCT01728116|4461718|P1|Overall Study|Sponsor Terminated Study|106
1353282|NCT01728077|4461743|P2|Overall Study|Non compliance|0
1353283|NCT01728077|4461744|P1|Overall Study|Non compliance|1
1353284|NCT01728077|4461743|P2|Overall Study|Patient moving|0
1353285|NCT01728077|4461744|P1|Overall Study|Patient moving|1
1353286|NCT01728077|4461743|P2|Overall Study|Death|1
1353287|NCT01728077|4461744|P1|Overall Study|Death|0
1353288|NCT01728077|4461743|P2|Overall Study|Subject choice|3
1353289|NCT01728077|4461744|P1|Overall Study|Subject choice|2
1353290|NCT01728077|4461743|P2|Overall Study|Lost to Follow-up|0
1353291|NCT01728077|4461744|P1|Overall Study|Lost to Follow-up|1
1353292|NCT01728077|4461743|P2|Overall Study|Lack of Efficacy|1
1353293|NCT01728077|4461744|P1|Overall Study|Lack of Efficacy|3
1353294|NCT01727713|4461833|P1|Overall Study|Protocol Deviation|2
1353295|NCT01727713|4461833|P1|Overall Study|Withdrawal by Subject|13
1353296|NCT01727713|4461833|P1|Overall Study|Participant Met Withdrawal Criteria|5
1353297|NCT01727713|4461833|P1|Overall Study|Adverse Event|10
1353298|NCT01727713|4461833|P1|Overall Study|Lost to Follow-up|5
1353299|NCT01727700|4461860|P3|Overall Study|Protocol Violation|0
1353300|NCT01727700|4461861|P2|Overall Study|Protocol Violation|0
1353301|NCT01727700|4461862|P1|Overall Study|Protocol Violation|2
1353302|NCT01727700|4461860|P3|Overall Study|Particpant withdrew consent|1
1353303|NCT01727700|4461861|P2|Overall Study|Particpant withdrew consent|3
1353304|NCT01727700|4461862|P1|Overall Study|Particpant withdrew consent|0
1353305|NCT01727700|4461860|P3|Overall Study|Adverse Event|1
1353306|NCT01727700|4461861|P2|Overall Study|Adverse Event|7
1353307|NCT01727700|4461862|P1|Overall Study|Adverse Event|0
1353308|NCT01727505|4461885|P2|Second 24 Hours|Missing data|1
1353309|NCT01727505|4461886|P1|Second 24 Hours|Missing data|0
1353310|NCT01727505|4461885|P2|First 24 Hours|Adverse Event|1
1353311|NCT01727505|4461886|P1|First 24 Hours|Adverse Event|0
1353312|NCT01727297|4461911|P2|Overall Study|Other (e.g. AF detection pre-implant)|8
1353313|NCT01727297|4461912|P1|Overall Study|Other (e.g. AF detection pre-implant)|29
1353314|NCT01727297|4461911|P2|Overall Study|Physician Decision|5
1353315|NCT01727297|4461912|P1|Overall Study|Physician Decision|19
1353316|NCT01727297|4461911|P2|Overall Study|Withdrawal by Subject|27
1353317|NCT01727297|4461912|P1|Overall Study|Withdrawal by Subject|26
1353318|NCT01727297|4461911|P2|Overall Study|Lost to Follow-up|0
1353319|NCT01727297|4461912|P1|Overall Study|Lost to Follow-up|11
1353320|NCT01727297|4461911|P2|Overall Study|Adverse Event|1
1353321|NCT01727297|4461912|P1|Overall Study|Adverse Event|3
1353322|NCT01727297|4461911|P2|Overall Study|Protocol Violation|10
1353323|NCT01727297|4461912|P1|Overall Study|Protocol Violation|1
1353324|NCT01727297|4461911|P2|Overall Study|Death|0
1353325|NCT01727297|4461912|P1|Overall Study|Death|13
1353326|NCT01727258|4461928|P3|Overall Study|Lost to Follow-up|0
1353327|NCT01727258|4461929|P2|Overall Study|Lost to Follow-up|0
1353328|NCT01727258|4461930|P1|Overall Study|Lost to Follow-up|1
1353329|NCT01727258|4461928|P3|Overall Study|Withdrawal by Subject|0
1353330|NCT01727258|4461929|P2|Overall Study|Withdrawal by Subject|1
1353331|NCT01727258|4461930|P1|Overall Study|Withdrawal by Subject|1
1353332|NCT01727258|4461928|P3|Overall Study|Noncompliance with Study Drug|1
1353333|NCT01727258|4461929|P2|Overall Study|Noncompliance with Study Drug|0
1353334|NCT01727258|4461930|P1|Overall Study|Noncompliance with Study Drug|0
1353335|NCT01727258|4461928|P3|Overall Study|Adverse Event|0
1353336|NCT01727258|4461929|P2|Overall Study|Adverse Event|2
1353337|NCT01727258|4461930|P1|Overall Study|Adverse Event|0
1353338|NCT01727141|4461972|P4|Overall Study|Withdrawal by Subject|11
1353339|NCT01727141|4461973|P3|Overall Study|Withdrawal by Subject|2
1353340|NCT01727141|4461974|P2|Overall Study|Withdrawal by Subject|4
1353341|NCT01727141|4461975|P1|Overall Study|Withdrawal by Subject|4
1353342|NCT01727141|4461972|P4|Overall Study|Protocol deviation|1
1353343|NCT01727141|4461973|P3|Overall Study|Protocol deviation|0
1353344|NCT01727141|4461974|P2|Overall Study|Protocol deviation|1
1353345|NCT01727141|4461975|P1|Overall Study|Protocol deviation|1
1353346|NCT01727141|4461972|P4|Overall Study|Death|1
1353347|NCT01727141|4461973|P3|Overall Study|Death|1
1353348|NCT01727141|4461974|P2|Overall Study|Death|1
1353349|NCT01727141|4461975|P1|Overall Study|Death|0
1353350|NCT01727141|4461972|P4|Overall Study|Lost to Follow-up|0
1353351|NCT01727141|4461973|P3|Overall Study|Lost to Follow-up|0
1353352|NCT01727141|4461974|P2|Overall Study|Lost to Follow-up|2
1353353|NCT01727141|4461975|P1|Overall Study|Lost to Follow-up|0
1353354|NCT01727141|4461972|P4|Overall Study|Physician Decision|2
1353355|NCT01727141|4461973|P3|Overall Study|Physician Decision|0
1353356|NCT01727141|4461974|P2|Overall Study|Physician Decision|1
1353357|NCT01727141|4461975|P1|Overall Study|Physician Decision|0
1353358|NCT01727024|4462040|P2|Period 1|Withdrawal by Subject|3
1353359|NCT01727024|4462041|P1|Period 1|Withdrawal by Subject|2
1353360|NCT01727024|4462040|P2|Period 1|Lost to Follow-up|1
1353361|NCT01727024|4462041|P1|Period 1|Lost to Follow-up|1
1353362|NCT01726517|4462076|P5|Overall Study|Withdrawal by Subject|0
1353363|NCT01726517|4462077|P4|Overall Study|Withdrawal by Subject|0
1353364|NCT01726517|4462078|P3|Overall Study|Withdrawal by Subject|1
1353365|NCT01726517|4462079|P2|Overall Study|Withdrawal by Subject|0
1353366|NCT01726517|4462080|P1|Overall Study|Withdrawal by Subject|0
1353367|NCT01726335|4462136|P1|Overall Study|Exacerbation of psychotic symptoms|1
1353368|NCT01726335|4462136|P1|Overall Study|Lost to Follow-up|2
1353369|NCT01726335|4462136|P1|Overall Study|Adverse Event|4
1353370|NCT01726335|4462136|P1|Overall Study|Withdrawal by Subject|15
1353371|NCT01726335|4462136|P1|Overall Study|Lost to Follow-up|2
1353372|NCT01726049|4462154|P2|Overall Study|refused second HC|2
1353373|NCT01726049|4462155|P1|Overall Study|refused second HC|0
1353374|NCT01726049|4462154|P2|Overall Study|Adverse Event|1
1353375|NCT01726049|4462155|P1|Overall Study|Adverse Event|4
1353376|NCT01726049|4462154|P2|Overall Study|Death|1
1353377|NCT01726049|4462155|P1|Overall Study|Death|1
1353378|NCT01726023|4462169|P2|Overall Study|Withdrawal by Subject|8
1353379|NCT01726023|4462170|P1|Overall Study|Withdrawal by Subject|16
1353380|NCT01726023|4462169|P2|Overall Study|Other Eligibility criteria|7
1353381|NCT01726023|4462170|P1|Overall Study|Other Eligibility criteria|7
1353382|NCT01726023|4462169|P2|Overall Study|Lost to Follow-up|10
1353383|NCT01726023|4462170|P1|Overall Study|Lost to Follow-up|5
1353384|NCT01726023|4462169|P2|Overall Study|Death|1
1353385|NCT01726023|4462170|P1|Overall Study|Death|1
1353386|NCT01725529|4462290|P3|Overall Study|Withdrawal by Subject|8
1353387|NCT01725529|4462291|P2|Overall Study|Withdrawal by Subject|14
1353388|NCT01725529|4462292|P1|Overall Study|Withdrawal by Subject|12
1353389|NCT01725529|4462290|P3|Overall Study|Protocol Violation|1
1353390|NCT01725529|4462291|P2|Overall Study|Protocol Violation|1
1353391|NCT01725529|4462292|P1|Overall Study|Protocol Violation|0
1353392|NCT01725529|4462290|P3|Overall Study|Lost to Follow-up|1
1353393|NCT01725529|4462291|P2|Overall Study|Lost to Follow-up|1
1353394|NCT01725529|4462292|P1|Overall Study|Lost to Follow-up|2
1353395|NCT01725529|4462290|P3|Overall Study|Adverse Event|0
1353396|NCT01725529|4462291|P2|Overall Study|Adverse Event|0
1353397|NCT01725529|4462292|P1|Overall Study|Adverse Event|1
1353398|NCT01725451|4462318|P4|Period 4|Adverse Event|0
1353399|NCT01725451|4462319|P3|Period 4|Adverse Event|1
1353400|NCT01725451|4462320|P2|Period 4|Adverse Event|0
1353401|NCT01725451|4462321|P1|Period 4|Adverse Event|0
1353402|NCT01725451|4462318|P4|Washout From Period 3|Adverse Event|0
1353403|NCT01725451|4462319|P3|Washout From Period 3|Adverse Event|0
1353404|NCT01725451|4462320|P2|Washout From Period 3|Adverse Event|1
1353405|NCT01725451|4462321|P1|Washout From Period 3|Adverse Event|0
1353406|NCT01725451|4462318|P4|Washout From Period 3|Protocol Violation|0
1353407|NCT01725451|4462319|P3|Washout From Period 3|Protocol Violation|1
1353408|NCT01725451|4462320|P2|Washout From Period 3|Protocol Violation|0
1353409|NCT01725451|4462321|P1|Washout From Period 3|Protocol Violation|0
1353410|NCT01725451|4462318|P4|Period 1|Withdrawal by Subject|0
1353411|NCT01725451|4462319|P3|Period 1|Withdrawal by Subject|0
1353412|NCT01725451|4462320|P2|Period 1|Withdrawal by Subject|0
1353413|NCT01725451|4462321|P1|Period 1|Withdrawal by Subject|1
1353414|NCT01725386|4462343|P2|Overall Study|Withdrawal by Subject|0
1353415|NCT01725386|4462344|P1|Overall Study|Withdrawal by Subject|10
1353416|NCT01725386|4462343|P2|Overall Study|Lost to Follow-up|6
1353417|NCT01725386|4462344|P1|Overall Study|Lost to Follow-up|81
1353418|NCT01725386|4462343|P2|Overall Study|Death|40
1353419|NCT01725386|4462344|P1|Overall Study|Death|84
1353420|NCT01725308|4462363|P3|Treatment Period II|Miscellaneous|7
1353421|NCT01725308|4462364|P2|Treatment Period II|Miscellaneous|3
1353422|NCT01725308|4462365|P1|Treatment Period II|Miscellaneous|5
1353423|NCT01725308|4462363|P3|Treatment Period II|Protocol Deviations|1
1353424|NCT01725308|4462364|P2|Treatment Period II|Protocol Deviations|0
1353425|NCT01725308|4462365|P1|Treatment Period II|Protocol Deviations|0
1353426|NCT01725308|4462363|P3|Treatment Period II|Lost to Follow-up|3
1353427|NCT01725308|4462364|P2|Treatment Period II|Lost to Follow-up|5
1353428|NCT01725308|4462365|P1|Treatment Period II|Lost to Follow-up|1
1353429|NCT01725308|4462363|P3|Treatment Period II|Withdrawal of Consent|16
1353430|NCT01725308|4462364|P2|Treatment Period II|Withdrawal of Consent|2
1353431|NCT01725308|4462365|P1|Treatment Period II|Withdrawal of Consent|28
1353432|NCT01725308|4462363|P3|Treatment Period II|Changes in the Episodes|5
1353433|NCT01725308|4462364|P2|Treatment Period II|Changes in the Episodes|0
1353434|NCT01725308|4462365|P1|Treatment Period II|Changes in the Episodes|1
1353435|NCT01725308|4462363|P3|Treatment Period II|Worsening of the Target Disease|2
1353436|NCT01725308|4462364|P2|Treatment Period II|Worsening of the Target Disease|4
1353437|NCT01725308|4462365|P1|Treatment Period II|Worsening of the Target Disease|1
1353438|NCT01725308|4462363|P3|Treatment Period II|Insufficient Response|6
1353439|NCT01725308|4462364|P2|Treatment Period II|Insufficient Response|4
1353440|NCT01725308|4462365|P1|Treatment Period II|Insufficient Response|2
1353441|NCT01725308|4462363|P3|Treatment Period II|Adverse Event|20
1353442|NCT01725308|4462364|P2|Treatment Period II|Adverse Event|8
1353443|NCT01725308|4462365|P1|Treatment Period II|Adverse Event|13
1353444|NCT01725308|4462363|P3|Treatment Period II|Did Not Receive Drug|0
1353445|NCT01725308|4462364|P2|Treatment Period II|Did Not Receive Drug|0
1353446|NCT01725308|4462365|P1|Treatment Period II|Did Not Receive Drug|4
1353447|NCT01725308|4462363|P3|Treatment Period II|Did Not Meet Transition Criteria|4
1353448|NCT01725308|4462364|P2|Treatment Period II|Did Not Meet Transition Criteria|3
1353449|NCT01725308|4462365|P1|Treatment Period II|Did Not Meet Transition Criteria|0
1353450|NCT01725308|4462363|P3|Treatment Period I|Miscellaneous|3
1353451|NCT01725308|4462364|P2|Treatment Period I|Miscellaneous|0
1353452|NCT01725308|4462365|P1|Treatment Period I|Miscellaneous|2
1353453|NCT01725308|4462363|P3|Treatment Period I|Protocol Deviations|1
1353454|NCT01725308|4462364|P2|Treatment Period I|Protocol Deviations|1
1353455|NCT01725308|4462365|P1|Treatment Period I|Protocol Deviations|3
1353456|NCT01725308|4462363|P3|Treatment Period I|Lost to Follow-up|2
1353457|NCT01725308|4462364|P2|Treatment Period I|Lost to Follow-up|2
1353458|NCT01725308|4462365|P1|Treatment Period I|Lost to Follow-up|3
1353459|NCT01725308|4462363|P3|Treatment Period I|Withdrawal of Consent|5
1353460|NCT01725308|4462364|P2|Treatment Period I|Withdrawal of Consent|7
1353461|NCT01725308|4462365|P1|Treatment Period I|Withdrawal of Consent|12
1353462|NCT01725308|4462363|P3|Treatment Period I|Changes in the Episodes|2
1353463|NCT01725308|4462364|P2|Treatment Period I|Changes in the Episodes|0
1353464|NCT01725308|4462365|P1|Treatment Period I|Changes in the Episodes|3
1353465|NCT01725308|4462363|P3|Treatment Period I|Worsening of the Target Disease|2
1353466|NCT01725308|4462364|P2|Treatment Period I|Worsening of the Target Disease|0
1353467|NCT01725308|4462365|P1|Treatment Period I|Worsening of the Target Disease|8
1353468|NCT01725308|4462363|P3|Treatment Period I|Insufficient Response|5
1353469|NCT01725308|4462364|P2|Treatment Period I|Insufficient Response|0
1353470|NCT01725308|4462365|P1|Treatment Period I|Insufficient Response|7
1353471|NCT01725308|4462363|P3|Treatment Period I|Adverse Event|21
1353472|NCT01725308|4462364|P2|Treatment Period I|Adverse Event|4
1353473|NCT01725308|4462365|P1|Treatment Period I|Adverse Event|5
1353474|NCT01725308|4462363|P3|Treatment Period I|Did Not Receive Drug|0
1353475|NCT01725308|4462364|P2|Treatment Period I|Did Not Receive Drug|0
1353476|NCT01725308|4462365|P1|Treatment Period I|Did Not Receive Drug|1
1353477|NCT01725282|4462512|P4|Overall Study|Lack of Efficacy|1
1353478|NCT01725282|4462513|P3|Overall Study|Lack of Efficacy|0
1353479|NCT01725282|4462514|P2|Overall Study|Lack of Efficacy|1
1353480|NCT01725282|4462515|P1|Overall Study|Lack of Efficacy|0
1353481|NCT01725282|4462512|P4|Overall Study|Withdrawal by Subject|1
1353482|NCT01725282|4462513|P3|Overall Study|Withdrawal by Subject|1
1353483|NCT01725282|4462514|P2|Overall Study|Withdrawal by Subject|0
1353484|NCT01725282|4462515|P1|Overall Study|Withdrawal by Subject|0
1353485|NCT01725282|4462512|P4|Overall Study|Study Site Withdrawal|0
1353486|NCT01725282|4462513|P3|Overall Study|Study Site Withdrawal|0
1353487|NCT01725282|4462514|P2|Overall Study|Study Site Withdrawal|1
1353488|NCT01725282|4462515|P1|Overall Study|Study Site Withdrawal|0
1353489|NCT01725282|4462512|P4|Overall Study|Met Exclusion Criteria|0
1353490|NCT01725282|4462513|P3|Overall Study|Met Exclusion Criteria|1
1353491|NCT01725282|4462514|P2|Overall Study|Met Exclusion Criteria|0
1353492|NCT01725282|4462515|P1|Overall Study|Met Exclusion Criteria|0
1353493|NCT01725282|4462512|P4|Overall Study|Exacerbation of Target Disease|1
1353494|NCT01725282|4462513|P3|Overall Study|Exacerbation of Target Disease|0
1353495|NCT01725282|4462514|P2|Overall Study|Exacerbation of Target Disease|0
1353496|NCT01725282|4462515|P1|Overall Study|Exacerbation of Target Disease|1
1353497|NCT01725282|4462512|P4|Overall Study|Adverse Event|4
1353498|NCT01725282|4462513|P3|Overall Study|Adverse Event|6
1353499|NCT01725282|4462514|P2|Overall Study|Adverse Event|3
1353500|NCT01725282|4462515|P1|Overall Study|Adverse Event|1
1353501|NCT01725217|4462548|P3|Overall Study|Withdrawal by Subject|0
1353502|NCT01725217|4462549|P2|Overall Study|Withdrawal by Subject|0
1353503|NCT01725217|4462550|P1|Overall Study|Withdrawal by Subject|1
1353504|NCT01725126|4462584|P6|Overall Study|Withdrawal by Subject|0
1353505|NCT01725126|4462585|P5|Overall Study|Withdrawal by Subject|0
1353506|NCT01725126|4462586|P4|Overall Study|Withdrawal by Subject|1
1353507|NCT01725126|4462587|P3|Overall Study|Withdrawal by Subject|0
1353508|NCT01725126|4462588|P2|Overall Study|Withdrawal by Subject|0
1353509|NCT01725126|4462589|P1|Overall Study|Withdrawal by Subject|0
1353510|NCT01725126|4462584|P6|Overall Study|Protocol Violation|0
1353511|NCT01725126|4462585|P5|Overall Study|Protocol Violation|0
1353512|NCT01725126|4462586|P4|Overall Study|Protocol Violation|0
1353513|NCT01725126|4462587|P3|Overall Study|Protocol Violation|0
1353514|NCT01725126|4462588|P2|Overall Study|Protocol Violation|1
1353515|NCT01725126|4462589|P1|Overall Study|Protocol Violation|0
1353516|NCT01724528|4462787|P2|Overall Study|Patient refused to attend last visit|0
1353517|NCT01724528|4462788|P1|Overall Study|Patient refused to attend last visit|1
1353518|NCT01724528|4462787|P2|Overall Study|Protocol Violation|1
1353519|NCT01724528|4462788|P1|Overall Study|Protocol Violation|0
1353520|NCT01724528|4462787|P2|Overall Study|Withdrawal by Subject|2
1353521|NCT01724528|4462788|P1|Overall Study|Withdrawal by Subject|0
1353522|NCT01724528|4462787|P2|Overall Study|Death|0
1353523|NCT01724528|4462788|P1|Overall Study|Death|3
1353524|NCT01724359|4462802|P1|Overall Study|Not specified|20
1353525|NCT01724359|4462802|P1|Overall Study|Death|1
1353526|NCT01724359|4462802|P1|Overall Study|Adverse Event|10
1353527|NCT01724216|4462815|P1|Overall Study|Scan was not completed|1
1353528|NCT01724177|4462819|P1|Overall Study|Serious Adverse Event Related|1
1353529|NCT01724177|4462819|P1|Overall Study|Nervous participant|1
1353530|NCT01724177|4462819|P1|Overall Study|Progressive disease or Relapsed Disease|16
1353531|NCT01724177|4462819|P1|Overall Study|Adverse Event|8
1353532|NCT01724021|4462832|P2|Overall Study|Missing|1
1353533|NCT01724021|4462833|P1|Overall Study|Missing|1
1353534|NCT01724021|4462832|P2|Overall Study|Reason Not Specified|39
1353535|NCT01724021|4462833|P1|Overall Study|Reason Not Specified|36
1353536|NCT01724021|4462832|P2|Overall Study|Lost to Follow-up|15
1353537|NCT01724021|4462833|P1|Overall Study|Lost to Follow-up|15
1353538|NCT01724021|4462832|P2|Overall Study|Participant request/ Withdrew consent|14
1353539|NCT01724021|4462833|P1|Overall Study|Participant request/ Withdrew consent|18
1353540|NCT01724021|4462832|P2|Overall Study|Death|58
1353541|NCT01724021|4462833|P1|Overall Study|Death|46
1353542|NCT01724021|4462832|P2|Overall Study|Adverse Event|6
1353543|NCT01724021|4462833|P1|Overall Study|Adverse Event|11
1353544|NCT01723904|4462865|P1|Overall Study|Unable to follow protocol/ judged by inv|3
1353545|NCT01723904|4462865|P1|Overall Study|Adverse Event|5
1353546|NCT01723904|4462865|P1|Overall Study|Noncompliant|3
1353547|NCT01723397|4462886|P2|Study Period 2|Protocol Violation|1
1353548|NCT01723397|4462887|P1|Study Period 2|Protocol Violation|0
1353549|NCT01723397|4462886|P2|Study Period 1|Protocol Violation|1
1353550|NCT01723397|4462887|P1|Study Period 1|Protocol Violation|0
1353551|NCT01723254|4462901|P8|Overall Study|Withdrawal by Subject|2
1353552|NCT01723254|4462902|P7|Overall Study|Withdrawal by Subject|1
1353553|NCT01723254|4462903|P6|Overall Study|Withdrawal by Subject|1
1353554|NCT01723254|4462904|P5|Overall Study|Withdrawal by Subject|1
1353555|NCT01723254|4462905|P4|Overall Study|Withdrawal by Subject|0
1353556|NCT01723254|4462906|P3|Overall Study|Withdrawal by Subject|1
1353557|NCT01723254|4462907|P2|Overall Study|Withdrawal by Subject|2
1353558|NCT01723254|4462908|P1|Overall Study|Withdrawal by Subject|1
1353559|NCT01723254|4462901|P8|Overall Study|Protocol Violation|0
1353560|NCT01723254|4462902|P7|Overall Study|Protocol Violation|0
1353561|NCT01723254|4462903|P6|Overall Study|Protocol Violation|0
1353562|NCT01723254|4462904|P5|Overall Study|Protocol Violation|0
1353563|NCT01723254|4462905|P4|Overall Study|Protocol Violation|0
1353564|NCT01723254|4462906|P3|Overall Study|Protocol Violation|0
1353565|NCT01723254|4462907|P2|Overall Study|Protocol Violation|1
1353566|NCT01723254|4462908|P1|Overall Study|Protocol Violation|0
1353567|NCT01723254|4462901|P8|Overall Study|Move/Left to another country/city|0
1353568|NCT01723254|4462902|P7|Overall Study|Move/Left to another country/city|0
1353569|NCT01723254|4462903|P6|Overall Study|Move/Left to another country/city|0
1353570|NCT01723254|4462904|P5|Overall Study|Move/Left to another country/city|1
1353571|NCT01723254|4462905|P4|Overall Study|Move/Left to another country/city|1
1353572|NCT01723254|4462906|P3|Overall Study|Move/Left to another country/city|2
1353573|NCT01723254|4462907|P2|Overall Study|Move/Left to another country/city|0
1353574|NCT01723254|4462908|P1|Overall Study|Move/Left to another country/city|0
1353575|NCT01723254|4462901|P8|Overall Study|No longer have time to participate|0
1353576|NCT01723254|4462902|P7|Overall Study|No longer have time to participate|0
1353577|NCT01723254|4462903|P6|Overall Study|No longer have time to participate|0
1353578|NCT01723254|4462904|P5|Overall Study|No longer have time to participate|0
1353579|NCT01723254|4462905|P4|Overall Study|No longer have time to participate|1
1353580|NCT01723254|4462906|P3|Overall Study|No longer have time to participate|0
1353581|NCT01723254|4462907|P2|Overall Study|No longer have time to participate|0
1353582|NCT01723254|4462908|P1|Overall Study|No longer have time to participate|0
1353583|NCT01723254|4462901|P8|Overall Study|Personal issues|0
1353584|NCT01723254|4462902|P7|Overall Study|Personal issues|0
1353585|NCT01723254|4462903|P6|Overall Study|Personal issues|1
1353586|NCT01723254|4462904|P5|Overall Study|Personal issues|0
1353587|NCT01723254|4462905|P4|Overall Study|Personal issues|0
1353588|NCT01723254|4462906|P3|Overall Study|Personal issues|0
1353589|NCT01723254|4462907|P2|Overall Study|Personal issues|0
1353590|NCT01723254|4462908|P1|Overall Study|Personal issues|0
1353591|NCT01723254|4462901|P8|Overall Study|Conflict with work schedule|1
1353592|NCT01723254|4462902|P7|Overall Study|Conflict with work schedule|0
1353593|NCT01723254|4462903|P6|Overall Study|Conflict with work schedule|0
1353594|NCT01723254|4462904|P5|Overall Study|Conflict with work schedule|0
1353595|NCT01723254|4462905|P4|Overall Study|Conflict with work schedule|0
1353596|NCT01723254|4462906|P3|Overall Study|Conflict with work schedule|0
1353597|NCT01723254|4462907|P2|Overall Study|Conflict with work schedule|0
1353598|NCT01723254|4462908|P1|Overall Study|Conflict with work schedule|0
1353599|NCT01723228|4462960|P2|Overall Study|Not Specified|1
1353600|NCT01723228|4462961|P1|Overall Study|Not Specified|2
1353601|NCT01723228|4462960|P2|Overall Study|Lost to Follow-up|1
1353602|NCT01723228|4462961|P1|Overall Study|Lost to Follow-up|2
1353603|NCT01723228|4462960|P2|Overall Study|Protocol Violation|2
1353604|NCT01723228|4462961|P1|Overall Study|Protocol Violation|0
1353605|NCT01723228|4462960|P2|Overall Study|Withdrawal by Subject|1
1353606|NCT01723228|4462961|P1|Overall Study|Withdrawal by Subject|2
1353607|NCT01723228|4462960|P2|Overall Study|Adverse Event|6
1353608|NCT01723228|4462961|P1|Overall Study|Adverse Event|2
1353609|NCT01722994|4462979|P2|Overall Study|Missing data|17
1353610|NCT01722994|4462980|P1|Overall Study|Missing data|25
1353611|NCT01722877|4462999|P1|Overall Study|Lost to Follow-up|1
1353612|NCT01722877|4462999|P1|Overall Study|Death|1
1353613|NCT01722331|4463070|P7|Part 3|Other Protocol Specified Criteria|0
1353614|NCT01722331|4463071|P6|Part 3|Other Protocol Specified Criteria|0
1353615|NCT01722331|4463072|P5|Part 3|Other Protocol Specified Criteria|0
1353616|NCT01722331|4463073|P4|Part 3|Other Protocol Specified Criteria|0
1353617|NCT01722331|4463074|P3|Part 3|Other Protocol Specified Criteria|0
1353618|NCT01722331|4463075|P2|Part 3|Other Protocol Specified Criteria|1
1353619|NCT01722331|4463076|P1|Part 3|Other Protocol Specified Criteria|1
1353620|NCT01722331|4463070|P7|Part 3|Withdrawal by Subject|1
1353621|NCT01722331|4463071|P6|Part 3|Withdrawal by Subject|2
1353622|NCT01722331|4463072|P5|Part 3|Withdrawal by Subject|0
1353623|NCT01722331|4463073|P4|Part 3|Withdrawal by Subject|0
1353624|NCT01722331|4463074|P3|Part 3|Withdrawal by Subject|0
1353625|NCT01722331|4463075|P2|Part 3|Withdrawal by Subject|7
1353626|NCT01722331|4463076|P1|Part 3|Withdrawal by Subject|4
1353627|NCT01722331|4463070|P7|Part 3|Protocol Violation|0
1353628|NCT01722331|4463071|P6|Part 3|Protocol Violation|0
1353629|NCT01722331|4463072|P5|Part 3|Protocol Violation|0
1353630|NCT01722331|4463073|P4|Part 3|Protocol Violation|0
1353631|NCT01722331|4463074|P3|Part 3|Protocol Violation|0
1353632|NCT01722331|4463075|P2|Part 3|Protocol Violation|1
1353633|NCT01722331|4463076|P1|Part 3|Protocol Violation|2
1353634|NCT01722331|4463070|P7|Part 3|Physician Decision|1
1353635|NCT01722331|4463071|P6|Part 3|Physician Decision|0
1353636|NCT01722331|4463072|P5|Part 3|Physician Decision|0
1353637|NCT01722331|4463073|P4|Part 3|Physician Decision|0
1353638|NCT01722331|4463074|P3|Part 3|Physician Decision|0
1353639|NCT01722331|4463075|P2|Part 3|Physician Decision|1
1353640|NCT01722331|4463076|P1|Part 3|Physician Decision|1
1353641|NCT01722331|4463070|P7|Part 3|Non-Compliance with Study Drug|0
1353642|NCT01722331|4463071|P6|Part 3|Non-Compliance with Study Drug|0
1353643|NCT01722331|4463072|P5|Part 3|Non-Compliance with Study Drug|0
1353644|NCT01722331|4463073|P4|Part 3|Non-Compliance with Study Drug|0
1353645|NCT01722331|4463074|P3|Part 3|Non-Compliance with Study Drug|0
1353646|NCT01722331|4463075|P2|Part 3|Non-Compliance with Study Drug|1
1353647|NCT01722331|4463076|P1|Part 3|Non-Compliance with Study Drug|0
1353648|NCT01722331|4463070|P7|Part 3|Lost to Follow-up|0
1353649|NCT01722331|4463071|P6|Part 3|Lost to Follow-up|1
1353650|NCT01722331|4463072|P5|Part 3|Lost to Follow-up|0
1353651|NCT01722331|4463073|P4|Part 3|Lost to Follow-up|0
1353652|NCT01722331|4463074|P3|Part 3|Lost to Follow-up|0
1353653|NCT01722331|4463075|P2|Part 3|Lost to Follow-up|4
1353654|NCT01722331|4463076|P1|Part 3|Lost to Follow-up|3
1353655|NCT01722331|4463070|P7|Part 3|Lack of Efficacy|0
1353656|NCT01722331|4463071|P6|Part 3|Lack of Efficacy|0
1353657|NCT01722331|4463072|P5|Part 3|Lack of Efficacy|0
1353658|NCT01722331|4463073|P4|Part 3|Lack of Efficacy|0
1353659|NCT01722331|4463074|P3|Part 3|Lack of Efficacy|0
1353660|NCT01722331|4463075|P2|Part 3|Lack of Efficacy|0
1353661|NCT01722331|4463076|P1|Part 3|Lack of Efficacy|1
1353662|NCT01722331|4463070|P7|Part 3|Death|0
1353663|NCT01722331|4463071|P6|Part 3|Death|0
1353664|NCT01722331|4463072|P5|Part 3|Death|0
1353665|NCT01722331|4463073|P4|Part 3|Death|0
1353666|NCT01722331|4463074|P3|Part 3|Death|0
1353667|NCT01722331|4463075|P2|Part 3|Death|0
1353668|NCT01722331|4463076|P1|Part 3|Death|1
1353669|NCT01722331|4463070|P7|Part 3|Adverse Event|0
1353670|NCT01722331|4463071|P6|Part 3|Adverse Event|0
1353671|NCT01722331|4463072|P5|Part 3|Adverse Event|0
1353672|NCT01722331|4463073|P4|Part 3|Adverse Event|1
1353673|NCT01722331|4463074|P3|Part 3|Adverse Event|0
1353674|NCT01722331|4463075|P2|Part 3|Adverse Event|2
1353675|NCT01722331|4463076|P1|Part 3|Adverse Event|2
1353676|NCT01722331|4463070|P7|Part 2|Other Protocol Specified Criteria|1
1353677|NCT01722331|4463071|P6|Part 2|Other Protocol Specified Criteria|2
1353678|NCT01722331|4463072|P5|Part 2|Other Protocol Specified Criteria|0
1353679|NCT01722331|4463073|P4|Part 2|Other Protocol Specified Criteria|0
1353680|NCT01722331|4463074|P3|Part 2|Other Protocol Specified Criteria|10
1353681|NCT01722331|4463075|P2|Part 2|Other Protocol Specified Criteria|0
1353682|NCT01722331|4463076|P1|Part 2|Other Protocol Specified Criteria|6
1353683|NCT01722331|4463070|P7|Part 2|Withdrawal by Subject|2
1353684|NCT01722331|4463071|P6|Part 2|Withdrawal by Subject|2
1353685|NCT01722331|4463072|P5|Part 2|Withdrawal by Subject|0
1353686|NCT01722331|4463073|P4|Part 2|Withdrawal by Subject|0
1353687|NCT01722331|4463074|P3|Part 2|Withdrawal by Subject|3
1353688|NCT01722331|4463075|P2|Part 2|Withdrawal by Subject|0
1353689|NCT01722331|4463076|P1|Part 2|Withdrawal by Subject|5
1353690|NCT01722331|4463070|P7|Part 2|Protocol Violation|0
1353691|NCT01722331|4463071|P6|Part 2|Protocol Violation|0
1353692|NCT01722331|4463072|P5|Part 2|Protocol Violation|0
1353693|NCT01722331|4463073|P4|Part 2|Protocol Violation|0
1353694|NCT01722331|4463074|P3|Part 2|Protocol Violation|0
1353695|NCT01722331|4463075|P2|Part 2|Protocol Violation|0
1353696|NCT01722331|4463076|P1|Part 2|Protocol Violation|1
1353697|NCT01722331|4463070|P7|Part 2|Progressive Disease|0
1353698|NCT01722331|4463071|P6|Part 2|Progressive Disease|0
1353699|NCT01722331|4463072|P5|Part 2|Progressive Disease|0
1353700|NCT01722331|4463073|P4|Part 2|Progressive Disease|0
1353701|NCT01722331|4463074|P3|Part 2|Progressive Disease|1
1353702|NCT01722331|4463075|P2|Part 2|Progressive Disease|0
1353703|NCT01722331|4463076|P1|Part 2|Progressive Disease|0
1353704|NCT01722331|4463070|P7|Part 2|Pregnancy|0
1353705|NCT01722331|4463071|P6|Part 2|Pregnancy|1
1353706|NCT01722331|4463072|P5|Part 2|Pregnancy|0
1353707|NCT01722331|4463073|P4|Part 2|Pregnancy|0
1353708|NCT01722331|4463074|P3|Part 2|Pregnancy|0
1353709|NCT01722331|4463075|P2|Part 2|Pregnancy|0
1353710|NCT01722331|4463076|P1|Part 2|Pregnancy|0
1353711|NCT01722331|4463070|P7|Part 2|Physician Decision|0
1353712|NCT01722331|4463071|P6|Part 2|Physician Decision|0
1353713|NCT01722331|4463072|P5|Part 2|Physician Decision|0
1353714|NCT01722331|4463073|P4|Part 2|Physician Decision|0
1353715|NCT01722331|4463074|P3|Part 2|Physician Decision|2
1353716|NCT01722331|4463075|P2|Part 2|Physician Decision|0
1353717|NCT01722331|4463076|P1|Part 2|Physician Decision|0
1353718|NCT01722331|4463070|P7|Part 2|Non-Compliance with Study Drug|0
1353719|NCT01722331|4463071|P6|Part 2|Non-Compliance with Study Drug|0
1353720|NCT01722331|4463072|P5|Part 2|Non-Compliance with Study Drug|0
1353721|NCT01722331|4463073|P4|Part 2|Non-Compliance with Study Drug|0
1353722|NCT01722331|4463074|P3|Part 2|Non-Compliance with Study Drug|1
1353723|NCT01722331|4463075|P2|Part 2|Non-Compliance with Study Drug|0
1353724|NCT01722331|4463076|P1|Part 2|Non-Compliance with Study Drug|1
1353725|NCT01722331|4463070|P7|Part 2|Lost to Follow-up|1
1353726|NCT01722331|4463071|P6|Part 2|Lost to Follow-up|1
1353727|NCT01722331|4463072|P5|Part 2|Lost to Follow-up|0
1353728|NCT01722331|4463073|P4|Part 2|Lost to Follow-up|0
1353729|NCT01722331|4463074|P3|Part 2|Lost to Follow-up|3
1353730|NCT01722331|4463075|P2|Part 2|Lost to Follow-up|0
1353731|NCT01722331|4463076|P1|Part 2|Lost to Follow-up|0
1353732|NCT01722331|4463070|P7|Part 2|Lack of Efficacy|3
1353733|NCT01722331|4463071|P6|Part 2|Lack of Efficacy|3
1353734|NCT01722331|4463072|P5|Part 2|Lack of Efficacy|0
1353735|NCT01722331|4463073|P4|Part 2|Lack of Efficacy|0
1353736|NCT01722331|4463074|P3|Part 2|Lack of Efficacy|11
1353737|NCT01722331|4463075|P2|Part 2|Lack of Efficacy|0
1353738|NCT01722331|4463076|P1|Part 2|Lack of Efficacy|3
1353739|NCT01722331|4463070|P7|Part 2|Adverse Event|0
1353740|NCT01722331|4463071|P6|Part 2|Adverse Event|1
1353741|NCT01722331|4463072|P5|Part 2|Adverse Event|0
1353742|NCT01722331|4463073|P4|Part 2|Adverse Event|0
1353743|NCT01722331|4463074|P3|Part 2|Adverse Event|0
1353744|NCT01722331|4463075|P2|Part 2|Adverse Event|0
1353745|NCT01722331|4463076|P1|Part 2|Adverse Event|3
1353746|NCT01722331|4463070|P7|Part 1|Withdrawal by Subject|0
1353747|NCT01722331|4463071|P6|Part 1|Withdrawal by Subject|0
1353748|NCT01722331|4463072|P5|Part 1|Withdrawal by Subject|3
1353749|NCT01722331|4463073|P4|Part 1|Withdrawal by Subject|0
1353750|NCT01722331|4463074|P3|Part 1|Withdrawal by Subject|3
1353751|NCT01722331|4463075|P2|Part 1|Withdrawal by Subject|0
1353752|NCT01722331|4463076|P1|Part 1|Withdrawal by Subject|2
1353753|NCT01722331|4463070|P7|Part 1|Protocol Violation|0
1353754|NCT01722331|4463071|P6|Part 1|Protocol Violation|0
1353755|NCT01722331|4463072|P5|Part 1|Protocol Violation|1
1353756|NCT01722331|4463073|P4|Part 1|Protocol Violation|0
1353757|NCT01722331|4463074|P3|Part 1|Protocol Violation|0
1353758|NCT01722331|4463075|P2|Part 1|Protocol Violation|0
1353759|NCT01722331|4463076|P1|Part 1|Protocol Violation|1
1353760|NCT01722331|4463070|P7|Part 1|Progressive Disease|0
1353761|NCT01722331|4463071|P6|Part 1|Progressive Disease|0
1353762|NCT01722331|4463072|P5|Part 1|Progressive Disease|1
1353763|NCT01722331|4463073|P4|Part 1|Progressive Disease|0
1353764|NCT01722331|4463074|P3|Part 1|Progressive Disease|0
1353765|NCT01722331|4463075|P2|Part 1|Progressive Disease|0
1353766|NCT01722331|4463076|P1|Part 1|Progressive Disease|0
1353767|NCT01722331|4463070|P7|Part 1|Pregnancy|0
1353768|NCT01722331|4463071|P6|Part 1|Pregnancy|0
1353769|NCT01722331|4463072|P5|Part 1|Pregnancy|0
1353770|NCT01722331|4463073|P4|Part 1|Pregnancy|0
1353771|NCT01722331|4463074|P3|Part 1|Pregnancy|0
1353772|NCT01722331|4463075|P2|Part 1|Pregnancy|0
1353773|NCT01722331|4463076|P1|Part 1|Pregnancy|1
1353774|NCT01722331|4463070|P7|Part 1|Physician Decision|0
1353775|NCT01722331|4463071|P6|Part 1|Physician Decision|0
1353776|NCT01722331|4463072|P5|Part 1|Physician Decision|1
1353777|NCT01722331|4463073|P4|Part 1|Physician Decision|0
1353778|NCT01722331|4463074|P3|Part 1|Physician Decision|3
1353779|NCT01722331|4463075|P2|Part 1|Physician Decision|0
1353780|NCT01722331|4463076|P1|Part 1|Physician Decision|0
1353781|NCT01722331|4463070|P7|Part 1|Lost to Follow-up|0
1353782|NCT01722331|4463071|P6|Part 1|Lost to Follow-up|0
1353783|NCT01722331|4463072|P5|Part 1|Lost to Follow-up|1
1353784|NCT01722331|4463073|P4|Part 1|Lost to Follow-up|0
1353785|NCT01722331|4463074|P3|Part 1|Lost to Follow-up|2
1353786|NCT01722331|4463075|P2|Part 1|Lost to Follow-up|0
1353787|NCT01722331|4463076|P1|Part 1|Lost to Follow-up|1
1353788|NCT01722331|4463070|P7|Part 1|Lack of Efficacy|0
1353789|NCT01722331|4463071|P6|Part 1|Lack of Efficacy|0
1353790|NCT01722331|4463072|P5|Part 1|Lack of Efficacy|2
1353791|NCT01722331|4463073|P4|Part 1|Lack of Efficacy|0
1353792|NCT01722331|4463074|P3|Part 1|Lack of Efficacy|1
1353793|NCT01722331|4463075|P2|Part 1|Lack of Efficacy|0
1353794|NCT01722331|4463076|P1|Part 1|Lack of Efficacy|0
1353795|NCT01722331|4463070|P7|Part 1|Adverse Event|0
1353796|NCT01722331|4463071|P6|Part 1|Adverse Event|0
1353797|NCT01722331|4463072|P5|Part 1|Adverse Event|0
1353798|NCT01722331|4463073|P4|Part 1|Adverse Event|0
1353799|NCT01722331|4463074|P3|Part 1|Adverse Event|0
1353800|NCT01722331|4463075|P2|Part 1|Adverse Event|0
1353801|NCT01722331|4463076|P1|Part 1|Adverse Event|5
1353802|NCT01722266|4463119|P4|Overall Study|Dropped out due to Nausea|0
1353803|NCT01722266|4463120|P3|Overall Study|Dropped out due to Nausea|2
1353804|NCT01722266|4463121|P2|Overall Study|Dropped out due to Nausea|0
1353805|NCT01722266|4463122|P1|Overall Study|Dropped out due to Nausea|0
1353806|NCT01722266|4463119|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
1353807|NCT01722266|4463120|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
1353808|NCT01722266|4463121|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
1353809|NCT01722266|4463122|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
1353810|NCT01722266|4463119|P4|Overall Study|Withdrawal by Subject|0
1353811|NCT01722266|4463120|P3|Overall Study|Withdrawal by Subject|0
1353812|NCT01722266|4463121|P2|Overall Study|Withdrawal by Subject|2
1353813|NCT01722266|4463122|P1|Overall Study|Withdrawal by Subject|1
1353814|NCT01722162|4463150|P2|Overall Study|Noncompliance|1
1353815|NCT01722162|4463151|P1|Overall Study|Noncompliance|0
1353816|NCT01722162|4463150|P2|Overall Study|Insurance denial post enrollment|1
1353817|NCT01722162|4463151|P1|Overall Study|Insurance denial post enrollment|0
1353818|NCT01722162|4463150|P2|Overall Study|Adverse Event|1
1353819|NCT01722162|4463151|P1|Overall Study|Adverse Event|1
1353820|NCT01722162|4463150|P2|Overall Study|Unrelated to study adverse event|2
1353821|NCT01722162|4463151|P1|Overall Study|Unrelated to study adverse event|2
1353822|NCT01722162|4463150|P2|Overall Study|Found ineligible|0
1353823|NCT01722162|4463151|P1|Overall Study|Found ineligible|1
1353824|NCT01722162|4463150|P2|Overall Study|Withdrawal by Subject|1
1353825|NCT01722162|4463151|P1|Overall Study|Withdrawal by Subject|1
1353826|NCT01722097|4463161|P2|Overall Study|Patient sheets not returned|5
1353827|NCT01722097|4463162|P1|Overall Study|Patient sheets not returned|6
1353828|NCT01722071|4463170|P2|Overall Study|Protocol Violation|0
1353829|NCT01722071|4463171|P1|Overall Study|Protocol Violation|1
1353830|NCT01722045|4463177|P1|Overall Study|Relocation (did not wish to transfer)|1
1353831|NCT01722045|4463177|P1|Overall Study|Physician Decision|3
1353832|NCT01722045|4463177|P1|Overall Study|Protocol Deviation|1
1353833|NCT01722045|4463177|P1|Overall Study|Lost to Follow-up|4
1353834|NCT01722045|4463177|P1|Overall Study|Withdrawal by Subject|8
1353835|NCT01722045|4463177|P1|Overall Study|Death|3
1353836|NCT01722045|4463177|P1|Overall Study|Adverse Event|8
1353837|NCT01721772|4463202|P2|Overall Study|Not specified|1
1353838|NCT01721772|4463203|P1|Overall Study|Not specified|0
1353839|NCT01721772|4463202|P2|Overall Study|Maximum clinical benefit|1
1353840|NCT01721772|4463203|P1|Overall Study|Maximum clinical benefit|1
1353841|NCT01721772|4463202|P2|Overall Study|Withdrawal by Subject|5
1353842|NCT01721772|4463203|P1|Overall Study|Withdrawal by Subject|7
1353843|NCT01721772|4463202|P2|Overall Study|Unrelated adverse event|3
1353844|NCT01721772|4463203|P1|Overall Study|Unrelated adverse event|2
1353845|NCT01721772|4463202|P2|Overall Study|Study drug toxicity|7
1353846|NCT01721772|4463203|P1|Overall Study|Study drug toxicity|5
1353847|NCT01721772|4463202|P2|Overall Study|Disease progression|175
1353848|NCT01721772|4463203|P1|Overall Study|Disease progression|96
1353849|NCT01721759|4463223|P1|Overall Study|Withdrawal by Subject|1
1353850|NCT01721759|4463223|P1|Overall Study|Adverse event unrelated to study drug|9
1353851|NCT01721759|4463223|P1|Overall Study|Study drug toxicity|14
1353852|NCT01721759|4463223|P1|Overall Study|Disease progression|78
1353853|NCT01721746|4463231|P3|Treatment Period|Other|1
1353854|NCT01721746|4463232|P2|Treatment Period|Other|1
1353855|NCT01721746|4463233|P1|Treatment Period|Other|2
1353856|NCT01721746|4463231|P3|Treatment Period|Subject No Longer Met Study Criteria|0
1353857|NCT01721746|4463232|P2|Treatment Period|Subject No Longer Met Study Criteria|0
1353858|NCT01721746|4463233|P1|Treatment Period|Subject No Longer Met Study Criteria|4
1353859|NCT01721746|4463231|P3|Treatment Period|Poor/Non-compliance|0
1353860|NCT01721746|4463232|P2|Treatment Period|Poor/Non-compliance|0
1353861|NCT01721746|4463233|P1|Treatment Period|Poor/Non-compliance|1
1353862|NCT01721746|4463231|P3|Treatment Period|Maximum Clinical Benefit|3
1353863|NCT01721746|4463232|P2|Treatment Period|Maximum Clinical Benefit|0
1353864|NCT01721746|4463233|P1|Treatment Period|Maximum Clinical Benefit|1
1353865|NCT01721746|4463231|P3|Treatment Period|Subject Withdrew Consent|2
1353866|NCT01721746|4463232|P2|Treatment Period|Subject Withdrew Consent|0
1353867|NCT01721746|4463233|P1|Treatment Period|Subject Withdrew Consent|3
1353868|NCT01721746|4463231|P3|Treatment Period|Subject Request to Discontinue Treatment|6
1353869|NCT01721746|4463232|P2|Treatment Period|Subject Request to Discontinue Treatment|1
1353870|NCT01721746|4463233|P1|Treatment Period|Subject Request to Discontinue Treatment|19
1353871|NCT01721746|4463231|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
1353872|NCT01721746|4463232|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
1353873|NCT01721746|4463233|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
1353874|NCT01721746|4463231|P3|Treatment Period|Study Drug Toxicity|9
1353875|NCT01721746|4463232|P2|Treatment Period|Study Drug Toxicity|2
1353876|NCT01721746|4463233|P1|Treatment Period|Study Drug Toxicity|15
1353877|NCT01721746|4463231|P3|Treatment Period|Disease Progression|34
1353878|NCT01721746|4463232|P2|Treatment Period|Disease Progression|40
1353879|NCT01721746|4463233|P1|Treatment Period|Disease Progression|182
1353880|NCT01721486|4463273|P2|Overall Study|Physician Decision|1
1353881|NCT01721486|4463274|P1|Overall Study|Physician Decision|0
1353882|NCT01721486|4463273|P2|Overall Study|Protocol Violation|0
1353883|NCT01721486|4463274|P1|Overall Study|Protocol Violation|1
1353884|NCT01721408|4463295|P2|Overall Study|Does not meet entrance criteria|0
1353885|NCT01721408|4463296|P1|Overall Study|Does not meet entrance criteria|1
1353886|NCT01721408|4463295|P2|Overall Study|Lost to Follow-up|2
1353887|NCT01721408|4463296|P1|Overall Study|Lost to Follow-up|1
1353888|NCT01721408|4463295|P2|Overall Study|Other|3
1353889|NCT01721408|4463296|P1|Overall Study|Other|3
1353890|NCT01721408|4463295|P2|Overall Study|Protocol Violation|2
1353891|NCT01721408|4463296|P1|Overall Study|Protocol Violation|0
1353892|NCT01721408|4463295|P2|Overall Study|No longer willing to participate study|10
1353893|NCT01721408|4463296|P1|Overall Study|No longer willing to participate study|9
1353894|NCT01721408|4463295|P2|Overall Study|Insufficient clinical response|6
1353895|NCT01721408|4463296|P1|Overall Study|Insufficient clinical response|15
1353896|NCT01721408|4463295|P2|Overall Study|Death|0
1353897|NCT01721408|4463296|P1|Overall Study|Death|1
1353898|NCT01721408|4463295|P2|Overall Study|Adverse Event|1
1353899|NCT01721408|4463296|P1|Overall Study|Adverse Event|6
1353900|NCT01721330|4463312|P2|Overall Study|Withdrawal by Subject|1
1353901|NCT01721330|4463313|P1|Overall Study|Withdrawal by Subject|0
1353902|NCT01721317|4463321|P2|Overall Study|Withdrawal by Subject|1
1353903|NCT01721317|4463322|P1|Overall Study|Withdrawal by Subject|0
1353904|NCT01721317|4463321|P2|Overall Study|Physician Decision|1
1353905|NCT01721317|4463322|P1|Overall Study|Physician Decision|0
1353906|NCT01721317|4463321|P2|Overall Study|Study Closed / Terminated|2
1353907|NCT01721317|4463322|P1|Overall Study|Study Closed / Terminated|2
1353908|NCT01721200|4463401|P2|Overall Study|Lost to Follow-up|5
1353909|NCT01721200|4463402|P1|Overall Study|Lost to Follow-up|3
1353910|NCT01721161|4463427|P2|Overall Study|Not Specified|1
1353911|NCT01721161|4463428|P1|Overall Study|Not Specified|0
1353912|NCT01721161|4463427|P2|Overall Study|Withdrawal by Subject|1
1353913|NCT01721161|4463428|P1|Overall Study|Withdrawal by Subject|1
1353914|NCT01721161|4463427|P2|Overall Study|Lost to Follow-up|2
1353915|NCT01721161|4463428|P1|Overall Study|Lost to Follow-up|1
1353916|NCT01721161|4463427|P2|Overall Study|Adverse Event|3
1353917|NCT01721161|4463428|P1|Overall Study|Adverse Event|2
1353918|NCT01721109|4463451|P1|Overall Study|Lost to Follow-up|2
1353919|NCT01721109|4463451|P1|Overall Study|Withdrew Consent|1
1353920|NCT01721109|4463451|P1|Overall Study|Non- Compliance with Study Drug|3
1353921|NCT01721109|4463451|P1|Overall Study|Lack of Efficacy|1
1353922|NCT01721096|4463466|P2|Overall Study|Site didn't entered reason;registrystudy|0
1353923|NCT01721096|4463467|P1|Overall Study|Site didn't entered reason;registrystudy|1
1353924|NCT01721096|4463466|P2|Overall Study|Lost to Follow-up|2
1353925|NCT01721096|4463467|P1|Overall Study|Lost to Follow-up|12
1353926|NCT01721096|4463466|P2|Overall Study|Physician Decision|0
1353927|NCT01721096|4463467|P1|Overall Study|Physician Decision|1
1353928|NCT01721096|4463466|P2|Overall Study|Withdrawal by Subject|0
1353929|NCT01721096|4463467|P1|Overall Study|Withdrawal by Subject|1
1353930|NCT01721096|4463466|P2|Overall Study|Death|8
1353931|NCT01721096|4463467|P1|Overall Study|Death|12
1353932|NCT01721070|4463616|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
1353933|NCT01721057|4463627|P7|Rescue Period|Lack of Efficacy|0
1353934|NCT01721057|4463628|P6|Rescue Period|Lack of Efficacy|0
1353935|NCT01721057|4463629|P5|Rescue Period|Lack of Efficacy|0
1353936|NCT01721057|4463630|P4|Rescue Period|Lack of Efficacy|2
1353937|NCT01721057|4463631|P3|Rescue Period|Lack of Efficacy|0
1353938|NCT01721057|4463632|P2|Rescue Period|Lack of Efficacy|0
1353939|NCT01721057|4463633|P1|Rescue Period|Lack of Efficacy|0
1353940|NCT01721057|4463627|P7|Rescue Period|Adverse Event|0
1353941|NCT01721057|4463628|P6|Rescue Period|Adverse Event|0
1353942|NCT01721057|4463629|P5|Rescue Period|Adverse Event|0
1353943|NCT01721057|4463630|P4|Rescue Period|Adverse Event|1
1353944|NCT01721057|4463631|P3|Rescue Period|Adverse Event|0
1353945|NCT01721057|4463632|P2|Rescue Period|Adverse Event|0
1353946|NCT01721057|4463633|P1|Rescue Period|Adverse Event|0
1353947|NCT01721057|4463627|P7|Treatment Period|Death|0
1353948|NCT01721057|4463628|P6|Treatment Period|Death|0
1353949|NCT01721057|4463629|P5|Treatment Period|Death|0
1353950|NCT01721057|4463630|P4|Treatment Period|Death|0
1353951|NCT01721057|4463631|P3|Treatment Period|Death|0
1353952|NCT01721057|4463632|P2|Treatment Period|Death|0
1353953|NCT01721057|4463633|P1|Treatment Period|Death|2
1353954|NCT01721057|4463627|P7|Treatment Period|Physician Decision|0
1353955|NCT01721057|4463628|P6|Treatment Period|Physician Decision|0
1353956|NCT01721057|4463629|P5|Treatment Period|Physician Decision|0
1353957|NCT01721057|4463630|P4|Treatment Period|Physician Decision|0
1353958|NCT01721057|4463631|P3|Treatment Period|Physician Decision|3
1353959|NCT01721057|4463632|P2|Treatment Period|Physician Decision|1
1353960|NCT01721057|4463633|P1|Treatment Period|Physician Decision|0
1353961|NCT01721057|4463627|P7|Treatment Period|Lost to Follow-up|0
1353962|NCT01721057|4463628|P6|Treatment Period|Lost to Follow-up|0
1353963|NCT01721057|4463629|P5|Treatment Period|Lost to Follow-up|0
1353964|NCT01721057|4463630|P4|Treatment Period|Lost to Follow-up|0
1353965|NCT01721057|4463631|P3|Treatment Period|Lost to Follow-up|0
1353966|NCT01721057|4463632|P2|Treatment Period|Lost to Follow-up|0
1353967|NCT01721057|4463633|P1|Treatment Period|Lost to Follow-up|1
1353968|NCT01721057|4463627|P7|Treatment Period|Lack of Efficacy|0
1353969|NCT01721057|4463628|P6|Treatment Period|Lack of Efficacy|0
1353970|NCT01721057|4463629|P5|Treatment Period|Lack of Efficacy|0
1353971|NCT01721057|4463630|P4|Treatment Period|Lack of Efficacy|0
1353972|NCT01721057|4463631|P3|Treatment Period|Lack of Efficacy|0
1353973|NCT01721057|4463632|P2|Treatment Period|Lack of Efficacy|3
1353974|NCT01721057|4463633|P1|Treatment Period|Lack of Efficacy|7
1353975|NCT01721057|4463627|P7|Treatment Period|Adverse Event|0
1353976|NCT01721057|4463628|P6|Treatment Period|Adverse Event|0
1353977|NCT01721057|4463629|P5|Treatment Period|Adverse Event|0
1353978|NCT01721057|4463630|P4|Treatment Period|Adverse Event|0
1353979|NCT01721057|4463631|P3|Treatment Period|Adverse Event|12
1353980|NCT01721057|4463632|P2|Treatment Period|Adverse Event|10
1353981|NCT01721057|4463633|P1|Treatment Period|Adverse Event|7
1353982|NCT01721057|4463627|P7|Treatment Period|Withdrawal by Subject|0
1353983|NCT01721057|4463628|P6|Treatment Period|Withdrawal by Subject|0
1353984|NCT01721057|4463629|P5|Treatment Period|Withdrawal by Subject|0
1353985|NCT01721057|4463630|P4|Treatment Period|Withdrawal by Subject|0
1353986|NCT01721057|4463631|P3|Treatment Period|Withdrawal by Subject|8
1353987|NCT01721057|4463632|P2|Treatment Period|Withdrawal by Subject|5
1353988|NCT01721057|4463633|P1|Treatment Period|Withdrawal by Subject|11
1353989|NCT01721044|4463706|P3|Treatment Period|Withdrawal by Subject|1
1353990|NCT01721044|4463707|P2|Treatment Period|Withdrawal by Subject|6
1353991|NCT01721044|4463708|P1|Treatment Period|Withdrawal by Subject|7
1353992|NCT01721044|4463706|P3|Treatment Period|Protocol Violation|0
1353993|NCT01721044|4463707|P2|Treatment Period|Protocol Violation|0
1353994|NCT01721044|4463708|P1|Treatment Period|Protocol Violation|1
1353995|NCT01721044|4463706|P3|Treatment Period|Physician Decision|2
1353996|NCT01721044|4463707|P2|Treatment Period|Physician Decision|0
1353997|NCT01721044|4463708|P1|Treatment Period|Physician Decision|1
1353998|NCT01721044|4463706|P3|Treatment Period|Lost to Follow-up|1
1353999|NCT01721044|4463707|P2|Treatment Period|Lost to Follow-up|0
1354000|NCT01721044|4463708|P1|Treatment Period|Lost to Follow-up|0
1354001|NCT01721044|4463706|P3|Treatment Period|Lack of Efficacy|4
1354002|NCT01721044|4463707|P2|Treatment Period|Lack of Efficacy|4
1354003|NCT01721044|4463708|P1|Treatment Period|Lack of Efficacy|16
1354004|NCT01721044|4463706|P3|Treatment Period|Death|1
1354005|NCT01721044|4463707|P2|Treatment Period|Death|0
1354006|NCT01721044|4463708|P1|Treatment Period|Death|0
1354007|NCT01721044|4463706|P3|Treatment Period|Adverse Event|10
1354008|NCT01721044|4463707|P2|Treatment Period|Adverse Event|7
1354009|NCT01721044|4463708|P1|Treatment Period|Adverse Event|7
1354010|NCT01720797|4463781|P2|Overall Study|Withdrawal by Subject|0
1354011|NCT01720797|4463782|P1|Overall Study|Withdrawal by Subject|3
1354012|NCT01720602|4463788|P1|Overall Study|Progressive disease on therapy|2
1354013|NCT01720602|4463788|P1|Overall Study|Adverse Event|3
1354014|NCT01720446|4463798|P4|Overall Study|Withdrawal by Subject|4
1354015|NCT01720446|4463799|P3|Overall Study|Withdrawal by Subject|4
1354016|NCT01720446|4463800|P2|Overall Study|Withdrawal by Subject|5
1354017|NCT01720446|4463801|P1|Overall Study|Withdrawal by Subject|2
1354018|NCT01720446|4463798|P4|Overall Study|Lost to Follow-up|16
1354019|NCT01720446|4463799|P3|Overall Study|Lost to Follow-up|16
1354020|NCT01720446|4463800|P2|Overall Study|Lost to Follow-up|6
1354021|NCT01720446|4463801|P1|Overall Study|Lost to Follow-up|12
1354022|NCT01720043|4463943|P1|Overall Study|Withdrawal by Subject|1
1354023|NCT01719861|4463947|P1|Cycle 2|Death|1
1354024|NCT01719861|4463947|P1|Cycle 1|Death|4
1354025|NCT01719757|4463955|P1|Overall Study|well controlled pain|27
1354026|NCT01719757|4463955|P1|Overall Study|Protocol Violation|1
1354027|NCT01719757|4463955|P1|Overall Study|Lost to Follow-up|20
1354028|NCT01719757|4463955|P1|Overall Study|Withdrawal by Subject|15
1354029|NCT01719757|4463955|P1|Overall Study|Adverse Event|38
1354030|NCT01719224|4464000|P2|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
1354031|NCT01719224|4464001|P1|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
1354032|NCT01719172|4464010|P1|Overall Study|Death|1
1354033|NCT01719172|4464010|P1|Overall Study|Lost to Follow-up|1
1354034|NCT01719003|4464024|P9|Overall Study|Lack of Efficacy|0
1354035|NCT01719003|4464025|P8|Overall Study|Lack of Efficacy|0
1354036|NCT01719003|4464026|P7|Overall Study|Lack of Efficacy|1
1354037|NCT01719003|4464027|P6|Overall Study|Lack of Efficacy|0
1354038|NCT01719003|4464028|P5|Overall Study|Lack of Efficacy|0
1354039|NCT01719003|4464029|P4|Overall Study|Lack of Efficacy|0
1354040|NCT01719003|4464030|P3|Overall Study|Lack of Efficacy|0
1354041|NCT01719003|4464031|P2|Overall Study|Lack of Efficacy|0
1354042|NCT01719003|4464032|P1|Overall Study|Lack of Efficacy|0
1354043|NCT01719003|4464024|P9|Overall Study|Reason other than those specified|1
1354044|NCT01719003|4464025|P8|Overall Study|Reason other than those specified|3
1354045|NCT01719003|4464026|P7|Overall Study|Reason other than those specified|0
1354046|NCT01719003|4464027|P6|Overall Study|Reason other than those specified|1
1354047|NCT01719003|4464028|P5|Overall Study|Reason other than those specified|4
1354048|NCT01719003|4464029|P4|Overall Study|Reason other than those specified|3
1354049|NCT01719003|4464030|P3|Overall Study|Reason other than those specified|2
1354050|NCT01719003|4464031|P2|Overall Study|Reason other than those specified|0
1354051|NCT01719003|4464032|P1|Overall Study|Reason other than those specified|0
1354052|NCT01719003|4464024|P9|Overall Study|Refusal to continue, not due to AE|1
1354053|NCT01719003|4464025|P8|Overall Study|Refusal to continue, not due to AE|7
1354054|NCT01719003|4464026|P7|Overall Study|Refusal to continue, not due to AE|8
1354055|NCT01719003|4464027|P6|Overall Study|Refusal to continue, not due to AE|3
1354056|NCT01719003|4464028|P5|Overall Study|Refusal to continue, not due to AE|4
1354057|NCT01719003|4464029|P4|Overall Study|Refusal to continue, not due to AE|4
1354058|NCT01719003|4464030|P3|Overall Study|Refusal to continue, not due to AE|4
1354059|NCT01719003|4464031|P2|Overall Study|Refusal to continue, not due to AE|5
1354060|NCT01719003|4464032|P1|Overall Study|Refusal to continue, not due to AE|2
1354061|NCT01719003|4464024|P9|Overall Study|Lost to Follow-up|2
1354062|NCT01719003|4464025|P8|Overall Study|Lost to Follow-up|2
1354063|NCT01719003|4464026|P7|Overall Study|Lost to Follow-up|3
1354064|NCT01719003|4464027|P6|Overall Study|Lost to Follow-up|4
1354065|NCT01719003|4464028|P5|Overall Study|Lost to Follow-up|3
1354066|NCT01719003|4464029|P4|Overall Study|Lost to Follow-up|2
1354067|NCT01719003|4464030|P3|Overall Study|Lost to Follow-up|7
1354068|NCT01719003|4464031|P2|Overall Study|Lost to Follow-up|6
1354069|NCT01719003|4464032|P1|Overall Study|Lost to Follow-up|0
1354070|NCT01719003|4464024|P9|Overall Study|Adverse Event|0
1354071|NCT01719003|4464025|P8|Overall Study|Adverse Event|5
1354072|NCT01719003|4464026|P7|Overall Study|Adverse Event|6
1354073|NCT01719003|4464027|P6|Overall Study|Adverse Event|3
1354074|NCT01719003|4464028|P5|Overall Study|Adverse Event|4
1354075|NCT01719003|4464029|P4|Overall Study|Adverse Event|3
1354076|NCT01719003|4464030|P3|Overall Study|Adverse Event|4
1354077|NCT01719003|4464031|P2|Overall Study|Adverse Event|5
1354078|NCT01719003|4464032|P1|Overall Study|Adverse Event|6
1354079|NCT01719003|4464024|P9|Overall Study|Non compliant with protocol|0
1354080|NCT01719003|4464025|P8|Overall Study|Non compliant with protocol|3
1354081|NCT01719003|4464026|P7|Overall Study|Non compliant with protocol|2
1354082|NCT01719003|4464027|P6|Overall Study|Non compliant with protocol|1
1354083|NCT01719003|4464028|P5|Overall Study|Non compliant with protocol|2
1354084|NCT01719003|4464029|P4|Overall Study|Non compliant with protocol|1
1354085|NCT01719003|4464030|P3|Overall Study|Non compliant with protocol|0
1354086|NCT01719003|4464031|P2|Overall Study|Non compliant with protocol|1
1354087|NCT01719003|4464032|P1|Overall Study|Non compliant with protocol|1
1354088|NCT01718535|4464113|P10|Overall Study|Bidirectional Sequencing not possible|0
1354089|NCT01718535|4464114|P9|Overall Study|Bidirectional Sequencing not possible|0
1354090|NCT01718535|4464115|P8|Overall Study|Bidirectional Sequencing not possible|0
1354091|NCT01718535|4464116|P7|Overall Study|Bidirectional Sequencing not possible|0
1354092|NCT01718535|4464117|P6|Overall Study|Bidirectional Sequencing not possible|0
1354093|NCT01718535|4464118|P5|Overall Study|Bidirectional Sequencing not possible|0
1354094|NCT01718535|4464119|P4|Overall Study|Bidirectional Sequencing not possible|1
1354095|NCT01718535|4464120|P3|Overall Study|Bidirectional Sequencing not possible|0
1354096|NCT01718535|4464121|P2|Overall Study|Bidirectional Sequencing not possible|0
1354097|NCT01718535|4464122|P1|Overall Study|Bidirectional Sequencing not possible|1
1354098|NCT01718509|4464146|P2|Overall Study|Lack of Efficacy|0
1354099|NCT01718509|4464147|P1|Overall Study|Lack of Efficacy|1
1354100|NCT01718509|4464146|P2|Overall Study|Protocol Violation|2
1354101|NCT01718509|4464147|P1|Overall Study|Protocol Violation|4
1354102|NCT01718509|4464146|P2|Overall Study|Not specified|11
1354103|NCT01718509|4464147|P1|Overall Study|Not specified|13
1354104|NCT01718509|4464146|P2|Overall Study|Adverse Event|7
1354105|NCT01718509|4464147|P1|Overall Study|Adverse Event|5
1354106|NCT01718509|4464146|P2|Overall Study|Withdrawal by Subject|13
1354107|NCT01718509|4464147|P1|Overall Study|Withdrawal by Subject|7
1354108|NCT01718509|4464146|P2|Overall Study|Lost to Follow-up|15
1354109|NCT01718509|4464147|P1|Overall Study|Lost to Follow-up|18
1354110|NCT01718483|4464193|P2|Overall Study|Lack of Efficacy|0
1354111|NCT01718483|4464194|P1|Overall Study|Lack of Efficacy|1
1354112|NCT01718483|4464193|P2|Overall Study|Pregnancy|1
1354113|NCT01718483|4464194|P1|Overall Study|Pregnancy|1
1354114|NCT01718483|4464193|P2|Overall Study|Not specified|4
1354115|NCT01718483|4464194|P1|Overall Study|Not specified|1
1354116|NCT01718483|4464193|P2|Overall Study|Protocol Violation|2
1354117|NCT01718483|4464194|P1|Overall Study|Protocol Violation|4
1354118|NCT01718483|4464193|P2|Overall Study|Lost to Follow-up|3
1354119|NCT01718483|4464194|P1|Overall Study|Lost to Follow-up|8
1354120|NCT01718483|4464193|P2|Overall Study|Adverse Event|12
1354121|NCT01718483|4464194|P1|Overall Study|Adverse Event|5
1354122|NCT01718483|4464193|P2|Overall Study|Withdrawal by Subject|12
1354123|NCT01718483|4464194|P1|Overall Study|Withdrawal by Subject|14
1354124|NCT01718353|4464240|P2|Overall Study|Randomized but not treated|0
1354125|NCT01718353|4464241|P1|Overall Study|Randomized but not treated|2
1354126|NCT01718353|4464240|P2|Overall Study|Principal Investigator's Decision|4
1354127|NCT01718353|4464241|P1|Overall Study|Principal Investigator's Decision|10
1354128|NCT01718353|4464240|P2|Overall Study|Lost to Follow-up|1
1354129|NCT01718353|4464241|P1|Overall Study|Lost to Follow-up|0
1354130|NCT01717989|4464272|P1|Overall Study|Other|40
1354131|NCT01717989|4464272|P1|Overall Study|Protocol-specified criteria|551
1354132|NCT01717989|4464272|P1|Overall Study|Death|439
1354133|NCT01717989|4464272|P1|Overall Study|Lost to Follow-up|11
1354134|NCT01717989|4464272|P1|Overall Study|Physician Decision|2
1354135|NCT01717989|4464272|P1|Overall Study|Withdrawal by Subject|11
1354136|NCT01717989|4464272|P1|Overall Study|Protocol deviation|6
1354137|NCT01717989|4464272|P1|Overall Study|Ineligibility determined|6
1354138|NCT01717976|4464340|P2|Overall Study|Protocol Violation|1
1354139|NCT01717976|4464341|P1|Overall Study|Protocol Violation|0
1354140|NCT01717768|4464406|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1354141|NCT01717768|4464407|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1354142|NCT01717768|4464408|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
1354143|NCT01717768|4464409|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1354144|NCT01717768|4464410|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1354145|NCT01717768|4464411|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1354146|NCT01717768|4464412|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1354147|NCT01717768|4464413|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1354148|NCT01717768|4464414|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1354149|NCT01717768|4464415|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1354150|NCT01717768|4464416|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1354151|NCT01717768|4464417|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1354152|NCT01717768|4464406|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1354153|NCT01717768|4464407|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1354154|NCT01717768|4464408|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1354155|NCT01717768|4464409|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1354156|NCT01717768|4464410|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
1354157|NCT01717768|4464411|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1354158|NCT01717768|4464412|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1354159|NCT01717768|4464413|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1354160|NCT01717768|4464414|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1354161|NCT01717768|4464415|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1354162|NCT01717768|4464416|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1354163|NCT01717768|4464417|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1354164|NCT01717768|4464406|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
1354165|NCT01717768|4464407|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1354166|NCT01717768|4464408|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1354167|NCT01717768|4464409|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1354168|NCT01717768|4464410|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1354169|NCT01717768|4464411|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1354170|NCT01717768|4464412|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1354171|NCT01717768|4464413|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1354172|NCT01717768|4464414|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1354173|NCT01717768|4464415|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1354174|NCT01717768|4464416|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1354175|NCT01717768|4464417|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1354176|NCT01717768|4464406|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1354177|NCT01717768|4464407|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1354178|NCT01717768|4464408|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1354179|NCT01717768|4464409|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1354180|NCT01717768|4464410|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1354181|NCT01717768|4464411|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1354182|NCT01717768|4464412|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1354183|NCT01717768|4464413|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1354184|NCT01717768|4464414|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1354185|NCT01717768|4464415|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1354186|NCT01717768|4464416|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
1354187|NCT01717768|4464417|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1354188|NCT01717638|4464468|P13|Overall Study|Withdrawal by Subject|18
1354189|NCT01717638|4464469|P12|Overall Study|Withdrawal by Subject|0
1354190|NCT01717638|4464470|P11|Overall Study|Withdrawal by Subject|0
1354191|NCT01717638|4464471|P10|Overall Study|Withdrawal by Subject|1
1354192|NCT01717638|4464472|P9|Overall Study|Withdrawal by Subject|2
1354193|NCT01717638|4464473|P8|Overall Study|Withdrawal by Subject|1
1354194|NCT01717638|4464474|P7|Overall Study|Withdrawal by Subject|2
1354195|NCT01717638|4464475|P6|Overall Study|Withdrawal by Subject|0
1354196|NCT01717638|4464476|P5|Overall Study|Withdrawal by Subject|1
1354197|NCT01717638|4464477|P4|Overall Study|Withdrawal by Subject|0
1354198|NCT01717638|4464478|P3|Overall Study|Withdrawal by Subject|1
1354199|NCT01717638|4464479|P2|Overall Study|Withdrawal by Subject|1
1354200|NCT01717638|4464480|P1|Overall Study|Withdrawal by Subject|0
1354201|NCT01717638|4464468|P13|Overall Study|Father in hospital|1
1354202|NCT01717638|4464469|P12|Overall Study|Father in hospital|0
1354203|NCT01717638|4464470|P11|Overall Study|Father in hospital|0
1354204|NCT01717638|4464471|P10|Overall Study|Father in hospital|0
1354205|NCT01717638|4464472|P9|Overall Study|Father in hospital|0
1354206|NCT01717638|4464473|P8|Overall Study|Father in hospital|0
1354207|NCT01717638|4464474|P7|Overall Study|Father in hospital|0
1354208|NCT01717638|4464475|P6|Overall Study|Father in hospital|0
1354209|NCT01717638|4464476|P5|Overall Study|Father in hospital|0
1354210|NCT01717638|4464477|P4|Overall Study|Father in hospital|0
1354211|NCT01717638|4464478|P3|Overall Study|Father in hospital|0
1354212|NCT01717638|4464479|P2|Overall Study|Father in hospital|0
1354213|NCT01717638|4464480|P1|Overall Study|Father in hospital|0
1354214|NCT01717638|4464468|P13|Overall Study|Lost to Follow-up|0
1354215|NCT01717638|4464469|P12|Overall Study|Lost to Follow-up|0
1354216|NCT01717638|4464470|P11|Overall Study|Lost to Follow-up|0
1354217|NCT01717638|4464471|P10|Overall Study|Lost to Follow-up|0
1354218|NCT01717638|4464472|P9|Overall Study|Lost to Follow-up|0
1354219|NCT01717638|4464473|P8|Overall Study|Lost to Follow-up|0
1354220|NCT01717638|4464474|P7|Overall Study|Lost to Follow-up|0
1354221|NCT01717638|4464475|P6|Overall Study|Lost to Follow-up|1
1354222|NCT01717638|4464476|P5|Overall Study|Lost to Follow-up|0
1354223|NCT01717638|4464477|P4|Overall Study|Lost to Follow-up|0
1354224|NCT01717638|4464478|P3|Overall Study|Lost to Follow-up|0
1354225|NCT01717638|4464479|P2|Overall Study|Lost to Follow-up|0
1354226|NCT01717638|4464480|P1|Overall Study|Lost to Follow-up|0
1354227|NCT01717456|4464624|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
1354228|NCT01717456|4464625|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
1354229|NCT01717456|4464624|P2|End of Treatment|Lost to Follow-up|1
1354230|NCT01717456|4464625|P1|End of Treatment|Lost to Follow-up|0
1354231|NCT01717456|4464624|P2|End of Treatment|Physician Decision|1
1354232|NCT01717456|4464625|P1|End of Treatment|Physician Decision|0
1354233|NCT01717391|4464693|P1|Overall Study|FLT technical failure|3
1354234|NCT01717391|4464693|P1|Overall Study|Physician Decision|1
1354235|NCT01717391|4464693|P1|Overall Study|Withdrawal by Subject|5
1354236|NCT01717326|4464722|P20|Overall Study|Withdrawal by Subject|3
1354237|NCT01717326|4464723|P19|Overall Study|Withdrawal by Subject|2
1354238|NCT01717326|4464724|P18|Overall Study|Withdrawal by Subject|0
1354239|NCT01717326|4464725|P17|Overall Study|Withdrawal by Subject|0
1354240|NCT01717326|4464726|P16|Overall Study|Withdrawal by Subject|1
1354241|NCT01717326|4464727|P15|Overall Study|Withdrawal by Subject|0
1354242|NCT01717326|4464728|P14|Overall Study|Withdrawal by Subject|0
1354243|NCT01717326|4464729|P13|Overall Study|Withdrawal by Subject|1
1354244|NCT01717326|4464730|P12|Overall Study|Withdrawal by Subject|0
1354245|NCT01717326|4464731|P11|Overall Study|Withdrawal by Subject|0
1354246|NCT01717326|4464732|P10|Overall Study|Withdrawal by Subject|1
1354247|NCT01717326|4464733|P9|Overall Study|Withdrawal by Subject|0
1354248|NCT01717326|4464734|P8|Overall Study|Withdrawal by Subject|0
1354249|NCT01717326|4464735|P7|Overall Study|Withdrawal by Subject|0
1354250|NCT01717326|4464736|P6|Overall Study|Withdrawal by Subject|0
1354251|NCT01717326|4464737|P5|Overall Study|Withdrawal by Subject|0
1354252|NCT01717326|4464738|P4|Overall Study|Withdrawal by Subject|0
1354253|NCT01717326|4464739|P3|Overall Study|Withdrawal by Subject|0
1354254|NCT01717326|4464740|P2|Overall Study|Withdrawal by Subject|1
1354255|NCT01717326|4464741|P1|Overall Study|Withdrawal by Subject|0
1354256|NCT01717326|4464722|P20|Overall Study|Protocol Violation|0
1354257|NCT01717326|4464723|P19|Overall Study|Protocol Violation|0
1354258|NCT01717326|4464724|P18|Overall Study|Protocol Violation|0
1354259|NCT01717326|4464725|P17|Overall Study|Protocol Violation|0
1354260|NCT01717326|4464726|P16|Overall Study|Protocol Violation|0
1354261|NCT01717326|4464727|P15|Overall Study|Protocol Violation|0
1354262|NCT01717326|4464728|P14|Overall Study|Protocol Violation|0
1354263|NCT01717326|4464729|P13|Overall Study|Protocol Violation|0
1354264|NCT01717326|4464730|P12|Overall Study|Protocol Violation|0
1354265|NCT01717326|4464731|P11|Overall Study|Protocol Violation|0
1354266|NCT01717326|4464732|P10|Overall Study|Protocol Violation|0
1354267|NCT01717326|4464733|P9|Overall Study|Protocol Violation|0
1354268|NCT01717326|4464734|P8|Overall Study|Protocol Violation|0
1354269|NCT01717326|4464735|P7|Overall Study|Protocol Violation|0
1354270|NCT01717326|4464736|P6|Overall Study|Protocol Violation|0
1354271|NCT01717326|4464737|P5|Overall Study|Protocol Violation|1
1354272|NCT01717326|4464738|P4|Overall Study|Protocol Violation|0
1354273|NCT01717326|4464739|P3|Overall Study|Protocol Violation|0
1354274|NCT01717326|4464740|P2|Overall Study|Protocol Violation|0
1354275|NCT01717326|4464741|P1|Overall Study|Protocol Violation|0
1354276|NCT01717326|4464722|P20|Overall Study|Physician Decision|0
1354277|NCT01717326|4464723|P19|Overall Study|Physician Decision|0
1354278|NCT01717326|4464724|P18|Overall Study|Physician Decision|0
1354279|NCT01717326|4464725|P17|Overall Study|Physician Decision|0
1354280|NCT01717326|4464726|P16|Overall Study|Physician Decision|0
1354281|NCT01717326|4464727|P15|Overall Study|Physician Decision|0
1354282|NCT01717326|4464728|P14|Overall Study|Physician Decision|0
1354283|NCT01717326|4464729|P13|Overall Study|Physician Decision|0
1354284|NCT01717326|4464730|P12|Overall Study|Physician Decision|0
1354285|NCT01717326|4464731|P11|Overall Study|Physician Decision|0
1354286|NCT01717326|4464732|P10|Overall Study|Physician Decision|1
1354287|NCT01717326|4464733|P9|Overall Study|Physician Decision|0
1354288|NCT01717326|4464734|P8|Overall Study|Physician Decision|0
1354289|NCT01717326|4464735|P7|Overall Study|Physician Decision|0
1354290|NCT01717326|4464736|P6|Overall Study|Physician Decision|0
1354291|NCT01717326|4464737|P5|Overall Study|Physician Decision|0
1354292|NCT01717326|4464738|P4|Overall Study|Physician Decision|0
1354293|NCT01717326|4464739|P3|Overall Study|Physician Decision|0
1354294|NCT01717326|4464740|P2|Overall Study|Physician Decision|0
1354295|NCT01717326|4464741|P1|Overall Study|Physician Decision|0
1354296|NCT01717326|4464722|P20|Overall Study|Lost to Follow-up|3
1354297|NCT01717326|4464723|P19|Overall Study|Lost to Follow-up|2
1354298|NCT01717326|4464724|P18|Overall Study|Lost to Follow-up|0
1354299|NCT01717326|4464725|P17|Overall Study|Lost to Follow-up|1
1354300|NCT01717326|4464726|P16|Overall Study|Lost to Follow-up|2
1354301|NCT01717326|4464727|P15|Overall Study|Lost to Follow-up|0
1354302|NCT01717326|4464728|P14|Overall Study|Lost to Follow-up|0
1354303|NCT01717326|4464729|P13|Overall Study|Lost to Follow-up|0
1354304|NCT01717326|4464730|P12|Overall Study|Lost to Follow-up|0
1354305|NCT01717326|4464731|P11|Overall Study|Lost to Follow-up|1
1354306|NCT01717326|4464732|P10|Overall Study|Lost to Follow-up|0
1354307|NCT01717326|4464733|P9|Overall Study|Lost to Follow-up|0
1354308|NCT01717326|4464734|P8|Overall Study|Lost to Follow-up|0
1354309|NCT01717326|4464735|P7|Overall Study|Lost to Follow-up|1
1354310|NCT01717326|4464736|P6|Overall Study|Lost to Follow-up|0
1354311|NCT01717326|4464737|P5|Overall Study|Lost to Follow-up|1
1354312|NCT01717326|4464738|P4|Overall Study|Lost to Follow-up|2
1354313|NCT01717326|4464739|P3|Overall Study|Lost to Follow-up|0
1354314|NCT01717326|4464740|P2|Overall Study|Lost to Follow-up|0
1354315|NCT01717326|4464741|P1|Overall Study|Lost to Follow-up|3
1354316|NCT01717326|4464722|P20|Overall Study|Death|0
1354317|NCT01717326|4464723|P19|Overall Study|Death|0
1354318|NCT01717326|4464724|P18|Overall Study|Death|0
1354319|NCT01717326|4464725|P17|Overall Study|Death|0
1354320|NCT01717326|4464726|P16|Overall Study|Death|0
1354321|NCT01717326|4464727|P15|Overall Study|Death|0
1354322|NCT01717326|4464728|P14|Overall Study|Death|0
1354323|NCT01717326|4464729|P13|Overall Study|Death|0
1354324|NCT01717326|4464730|P12|Overall Study|Death|0
1354325|NCT01717326|4464731|P11|Overall Study|Death|1
1354326|NCT01717326|4464732|P10|Overall Study|Death|0
1354327|NCT01717326|4464733|P9|Overall Study|Death|0
1354328|NCT01717326|4464734|P8|Overall Study|Death|0
1354329|NCT01717326|4464735|P7|Overall Study|Death|0
1354330|NCT01717326|4464736|P6|Overall Study|Death|0
1354331|NCT01717326|4464737|P5|Overall Study|Death|0
1354332|NCT01717326|4464738|P4|Overall Study|Death|0
1354333|NCT01717326|4464739|P3|Overall Study|Death|0
1354334|NCT01717326|4464740|P2|Overall Study|Death|0
1354335|NCT01717326|4464741|P1|Overall Study|Death|0
1354336|NCT01717313|4465005|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
1354337|NCT01717313|4465006|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
1354338|NCT01717313|4465005|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
1354339|NCT01717313|4465006|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
1354340|NCT01717313|4465005|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
1354341|NCT01717313|4465006|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
1354342|NCT01717313|4465005|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
1354343|NCT01717313|4465006|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
1354344|NCT01717313|4465005|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
1354345|NCT01717313|4465006|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
1354346|NCT01717313|4465005|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
1354347|NCT01717313|4465006|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
1354348|NCT01717313|4465005|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
1354349|NCT01717313|4465006|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
1354350|NCT01717313|4465005|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
1354351|NCT01717313|4465006|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
1354352|NCT01717313|4465005|P2|Phase A (Weeks 0 to 24)|Death|1
1354353|NCT01717313|4465006|P1|Phase A (Weeks 0 to 24)|Death|0
1354354|NCT01717287|4465044|P2|Overall Study|Protocol Violation|1
1354355|NCT01717287|4465045|P1|Overall Study|Protocol Violation|0
1354356|NCT01717287|4465044|P2|Overall Study|Lost to Follow-up|2
1354357|NCT01717287|4465045|P1|Overall Study|Lost to Follow-up|0
1354358|NCT01717040|4465078|P2|Overall Study|New Substance Use Disorder|0
1354359|NCT01717040|4465079|P1|Overall Study|New Substance Use Disorder|1
1354360|NCT01717040|4465078|P2|Overall Study|Required Medication Change|1
1354361|NCT01717040|4465079|P1|Overall Study|Required Medication Change|0
1354362|NCT01717040|4465078|P2|Overall Study|Adverse Event|0
1354363|NCT01717040|4465079|P1|Overall Study|Adverse Event|1
1354364|NCT01717040|4465078|P2|Overall Study|Lack of Efficacy|1
1354365|NCT01717040|4465079|P1|Overall Study|Lack of Efficacy|1
1354366|NCT01717040|4465078|P2|Overall Study|Lost to Follow-up|3
1354367|NCT01717040|4465079|P1|Overall Study|Lost to Follow-up|2
1354368|NCT01716754|4465097|P4|Overall Study|Withdrawal by Subject|3
1354369|NCT01716754|4465098|P3|Overall Study|Withdrawal by Subject|4
1354370|NCT01716754|4465099|P2|Overall Study|Withdrawal by Subject|0
1354371|NCT01716754|4465100|P1|Overall Study|Withdrawal by Subject|5
1354372|NCT01716754|4465097|P4|Overall Study|Adverse Event|1
1354373|NCT01716754|4465098|P3|Overall Study|Adverse Event|2
1354374|NCT01716754|4465099|P2|Overall Study|Adverse Event|2
1354375|NCT01716754|4465100|P1|Overall Study|Adverse Event|4
1354376|NCT01716754|4465097|P4|Overall Study|Lost to Follow-up|1
1354377|NCT01716754|4465098|P3|Overall Study|Lost to Follow-up|0
1354378|NCT01716754|4465099|P2|Overall Study|Lost to Follow-up|0
1354379|NCT01716754|4465100|P1|Overall Study|Lost to Follow-up|1
1354380|NCT01716754|4465097|P4|Overall Study|Physician Decision|0
1354381|NCT01716754|4465098|P3|Overall Study|Physician Decision|0
1354382|NCT01716754|4465099|P2|Overall Study|Physician Decision|0
1354383|NCT01716754|4465100|P1|Overall Study|Physician Decision|1
1354384|NCT01716754|4465097|P4|Overall Study|Non-compliance with study treatment|0
1354385|NCT01716754|4465098|P3|Overall Study|Non-compliance with study treatment|1
1354386|NCT01716754|4465099|P2|Overall Study|Non-compliance with study treatment|0
1354387|NCT01716754|4465100|P1|Overall Study|Non-compliance with study treatment|0
1354388|NCT01716754|4465097|P4|Overall Study|Protocol deviation|2
1354389|NCT01716754|4465098|P3|Overall Study|Protocol deviation|7
1354390|NCT01716754|4465099|P2|Overall Study|Protocol deviation|2
1354391|NCT01716754|4465100|P1|Overall Study|Protocol deviation|0
1354392|NCT01716754|4465097|P4|Overall Study|Death|1
1354393|NCT01716754|4465098|P3|Overall Study|Death|0
1354394|NCT01716754|4465099|P2|Overall Study|Death|0
1354395|NCT01716754|4465100|P1|Overall Study|Death|0
1354396|NCT01716663|4465121|P1|Overall Study|Treated with non-study catheter|2
1354397|NCT01716663|4465121|P1|Overall Study|Withdrawn prior to procedure|4
1354398|NCT01716585|4465131|P2|Open-label Treatment|Withdrawal by Subject|3
1354399|NCT01716585|4465132|P1|Open-label Treatment|Withdrawal by Subject|0
1354400|NCT01716585|4465131|P2|Open-label Treatment|Virologic Failure|2
1354401|NCT01716585|4465132|P1|Open-label Treatment|Virologic Failure|0
1354402|NCT01716585|4465131|P2|Open-label Treatment|Adverse Event|2
1354403|NCT01716585|4465132|P1|Open-label Treatment|Adverse Event|0
1354404|NCT01716585|4465131|P2|Double-blind Treatment|Not Specified|0
1354405|NCT01716585|4465132|P1|Double-blind Treatment|Not Specified|1
1354406|NCT01716585|4465131|P2|Double-blind Treatment|Subject Noncompliant|0
1354407|NCT01716585|4465132|P1|Double-blind Treatment|Subject Noncompliant|1
1354408|NCT01716585|4465131|P2|Double-blind Treatment|Lost to Follow-up|0
1354409|NCT01716585|4465132|P1|Double-blind Treatment|Lost to Follow-up|2
1354410|NCT01716585|4465131|P2|Double-blind Treatment|Withdrawal by Subject|0
1354411|NCT01716585|4465132|P1|Double-blind Treatment|Withdrawal by Subject|3
1354412|NCT01716585|4465131|P2|Double-blind Treatment|Adverse Event|1
1354413|NCT01716585|4465132|P1|Double-blind Treatment|Adverse Event|2
1354414|NCT01716585|4465131|P2|Double-blind Treatment|Did Not Receive Study Drug|1
1354415|NCT01716585|4465132|P1|Double-blind Treatment|Did Not Receive Study Drug|4
1354416|NCT01716559|4465144|P1|Overall Study|Other withdrawal reason|75
1354417|NCT01716559|4465144|P1|Overall Study|Withdrawal by Subject|4
1354418|NCT01716559|4465144|P1|Overall Study|Death|21
1354419|NCT01716559|4465144|P1|Overall Study|Adverse Event|11
1354420|NCT01716520|4465152|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1354421|NCT01716520|4465153|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1354422|NCT01716520|4465154|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1354423|NCT01716520|4465155|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
1354424|NCT01716520|4465156|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1354425|NCT01716520|4465157|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1354426|NCT01716520|4465152|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
1354427|NCT01716520|4465153|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1354428|NCT01716520|4465154|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1354429|NCT01716520|4465155|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1354430|NCT01716520|4465156|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1354431|NCT01716520|4465157|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1354432|NCT01716520|4465152|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1354433|NCT01716520|4465153|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1354434|NCT01716520|4465154|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1354435|NCT01716520|4465155|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1354436|NCT01716520|4465156|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
1354437|NCT01716520|4465157|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1354438|NCT01716520|4465152|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
1354439|NCT01716520|4465153|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1354440|NCT01716520|4465154|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1354441|NCT01716520|4465155|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1354442|NCT01716520|4465156|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1354443|NCT01716520|4465157|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1354444|NCT01716520|4465152|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1354445|NCT01716520|4465153|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1354446|NCT01716520|4465154|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1354447|NCT01716520|4465155|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1354448|NCT01716520|4465156|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1354449|NCT01716520|4465157|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
1354450|NCT01716520|4465152|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
1354451|NCT01716520|4465153|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
1354452|NCT01716520|4465154|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
1354453|NCT01716520|4465155|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
1354454|NCT01716520|4465156|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
1354455|NCT01716520|4465157|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
1354456|NCT01716520|4465152|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1354457|NCT01716520|4465153|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1354458|NCT01716520|4465154|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
1354459|NCT01716520|4465155|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1354460|NCT01716520|4465156|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1354461|NCT01716520|4465157|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1354462|NCT01716520|4465152|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
1354463|NCT01716520|4465153|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
1354464|NCT01716520|4465154|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
1354465|NCT01716520|4465155|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
1354466|NCT01716520|4465156|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
1354467|NCT01716520|4465157|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
1354468|NCT01716520|4465152|P6|Treatment Period 2 (14 Days)|Adverse Event|0
1354469|NCT01716520|4465153|P5|Treatment Period 2 (14 Days)|Adverse Event|1
1354470|NCT01716520|4465154|P4|Treatment Period 2 (14 Days)|Adverse Event|0
1354471|NCT01716520|4465155|P3|Treatment Period 2 (14 Days)|Adverse Event|0
1354472|NCT01716520|4465156|P2|Treatment Period 2 (14 Days)|Adverse Event|0
1354473|NCT01716520|4465157|P1|Treatment Period 2 (14 Days)|Adverse Event|0
1354474|NCT01716520|4465152|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
1354475|NCT01716520|4465153|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1354476|NCT01716520|4465154|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1354477|NCT01716520|4465155|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
1354478|NCT01716520|4465156|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1354479|NCT01716520|4465157|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1354480|NCT01716520|4465152|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
1354481|NCT01716520|4465153|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1354482|NCT01716520|4465154|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1354483|NCT01716520|4465155|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1354484|NCT01716520|4465156|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1354485|NCT01716520|4465157|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1354486|NCT01716520|4465152|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1354487|NCT01716520|4465153|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1354488|NCT01716520|4465154|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1354489|NCT01716520|4465155|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1354490|NCT01716520|4465156|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
1354491|NCT01716520|4465157|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1354492|NCT01716520|4465152|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1354493|NCT01716520|4465153|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1354494|NCT01716520|4465154|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1354495|NCT01716520|4465155|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1354496|NCT01716520|4465156|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1354497|NCT01716520|4465157|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1354498|NCT01716520|4465152|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
1354499|NCT01716520|4465153|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
1354500|NCT01716520|4465154|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
1354501|NCT01716520|4465155|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
1354502|NCT01716520|4465156|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
1354503|NCT01716520|4465157|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
1354504|NCT01716520|4465152|P6|Treatment Period 1 (14 Days)|Adverse Event|0
1354505|NCT01716520|4465153|P5|Treatment Period 1 (14 Days)|Adverse Event|0
1354506|NCT01716520|4465154|P4|Treatment Period 1 (14 Days)|Adverse Event|0
1354507|NCT01716520|4465155|P3|Treatment Period 1 (14 Days)|Adverse Event|0
1354508|NCT01716520|4465156|P2|Treatment Period 1 (14 Days)|Adverse Event|0
1354509|NCT01716520|4465157|P1|Treatment Period 1 (14 Days)|Adverse Event|1
1354510|NCT01716234|4465212|P7|Overall Study|Withdrawal by Subject|0
1354511|NCT01716234|4465213|P6|Overall Study|Withdrawal by Subject|3
1354512|NCT01716234|4465214|P5|Overall Study|Withdrawal by Subject|1
1354513|NCT01716234|4465215|P4|Overall Study|Withdrawal by Subject|2
1354514|NCT01716234|4465216|P3|Overall Study|Withdrawal by Subject|2
1354515|NCT01716234|4465217|P2|Overall Study|Withdrawal by Subject|0
1354516|NCT01716234|4465218|P1|Overall Study|Withdrawal by Subject|3
1354517|NCT01716234|4465212|P7|Overall Study|Adverse Event|0
1354518|NCT01716234|4465213|P6|Overall Study|Adverse Event|6
1354519|NCT01716234|4465214|P5|Overall Study|Adverse Event|3
1354520|NCT01716234|4465215|P4|Overall Study|Adverse Event|8
1354521|NCT01716234|4465216|P3|Overall Study|Adverse Event|2
1354522|NCT01716234|4465217|P2|Overall Study|Adverse Event|10
1354523|NCT01716234|4465218|P1|Overall Study|Adverse Event|7
1354524|NCT01716234|4465212|P7|Overall Study|Did not meet protocol eligibility|0
1354525|NCT01716234|4465213|P6|Overall Study|Did not meet protocol eligibility|4
1354526|NCT01716234|4465214|P5|Overall Study|Did not meet protocol eligibility|0
1354527|NCT01716234|4465215|P4|Overall Study|Did not meet protocol eligibility|0
1354528|NCT01716234|4465216|P3|Overall Study|Did not meet protocol eligibility|1
1354529|NCT01716234|4465217|P2|Overall Study|Did not meet protocol eligibility|0
1354530|NCT01716234|4465218|P1|Overall Study|Did not meet protocol eligibility|0
1354531|NCT01716234|4465212|P7|Overall Study|Lack of Efficacy|0
1354532|NCT01716234|4465213|P6|Overall Study|Lack of Efficacy|0
1354533|NCT01716234|4465214|P5|Overall Study|Lack of Efficacy|0
1354534|NCT01716234|4465215|P4|Overall Study|Lack of Efficacy|1
1354535|NCT01716234|4465216|P3|Overall Study|Lack of Efficacy|0
1354536|NCT01716234|4465217|P2|Overall Study|Lack of Efficacy|0
1354537|NCT01716234|4465218|P1|Overall Study|Lack of Efficacy|0
1354538|NCT01716234|4465212|P7|Overall Study|Protocol Violation|0
1354539|NCT01716234|4465213|P6|Overall Study|Protocol Violation|1
1354540|NCT01716234|4465214|P5|Overall Study|Protocol Violation|1
1354541|NCT01716234|4465215|P4|Overall Study|Protocol Violation|1
1354542|NCT01716234|4465216|P3|Overall Study|Protocol Violation|0
1354543|NCT01716234|4465217|P2|Overall Study|Protocol Violation|0
1354544|NCT01716234|4465218|P1|Overall Study|Protocol Violation|0
1354545|NCT01716169|4465281|P1|Overall Study|inconsistent dressing application|1
1354546|NCT01716169|4465281|P1|Overall Study|Withdrawal by Subject|1
1354547|NCT01716169|4465281|P1|Overall Study|Lost to Follow-up|1
1354548|NCT01716169|4465281|P1|Overall Study|Adverse Event|1
1354549|NCT01716156|4465290|P3|Overall Study|Lost to Follow-up|0
1354550|NCT01716156|4465291|P2|Overall Study|Lost to Follow-up|0
1354551|NCT01716156|4465292|P1|Overall Study|Lost to Follow-up|1
1354552|NCT01716156|4465290|P3|Overall Study|Withdrawal by Subject|2
1354553|NCT01716156|4465291|P2|Overall Study|Withdrawal by Subject|1
1354554|NCT01716156|4465292|P1|Overall Study|Withdrawal by Subject|0
1354555|NCT01716156|4465290|P3|Overall Study|Protocol Violation|0
1354556|NCT01716156|4465291|P2|Overall Study|Protocol Violation|0
1354557|NCT01716156|4465292|P1|Overall Study|Protocol Violation|1
1354558|NCT01716052|4465318|P2|Overall Study|Withdrawal of funding|1
1354559|NCT01716052|4465319|P1|Overall Study|Withdrawal of funding|1
1354560|NCT01715896|4465361|P2|Overall Study|Other|5
1354561|NCT01715896|4465362|P1|Overall Study|Other|2
1354562|NCT01715896|4465361|P2|Overall Study|Withdrawal by Subject|4
1354563|NCT01715896|4465362|P1|Overall Study|Withdrawal by Subject|1
1354564|NCT01715896|4465361|P2|Overall Study|Lost to Follow-up|2
1354565|NCT01715896|4465362|P1|Overall Study|Lost to Follow-up|0
1354566|NCT01715857|4465435|P1|Overall Study|Did Not Meet Eligibility Criteria|96
1354567|NCT01715831|4465445|P1|Overall Study|Adverse Event|1
1354568|NCT01715415|4465463|P2|Open-label Treatment|Subject Noncompliant|1
1354569|NCT01715415|4465464|P1|Open-label Treatment|Subject Noncompliant|0
1354570|NCT01715415|4465463|P2|Open-label Treatment|Adverse Event|1
1354571|NCT01715415|4465464|P1|Open-label Treatment|Adverse Event|0
1354572|NCT01715415|4465463|P2|Double-blind Treatment|Not Specified|0
1354573|NCT01715415|4465464|P1|Double-blind Treatment|Not Specified|1
1354574|NCT01715415|4465463|P2|Double-blind Treatment|Withdrawal by Subject|1
1354575|NCT01715415|4465464|P1|Double-blind Treatment|Withdrawal by Subject|1
1354576|NCT01715415|4465463|P2|Double-blind Treatment|Adverse Event|0
1354577|NCT01715415|4465464|P1|Double-blind Treatment|Adverse Event|3
1354578|NCT01715415|4465463|P2|Double-blind Treatment|Did Not Receive Study Drug|1
1354579|NCT01715415|4465464|P1|Double-blind Treatment|Did Not Receive Study Drug|0
1354580|NCT01715298|4465478|P2|Overall Study|Patient/guardian decision|9
1354581|NCT01715298|4465479|P1|Overall Study|Patient/guardian decision|7
1354582|NCT01715298|4465478|P2|Overall Study|Lost to Follow-up|2
1354583|NCT01715298|4465479|P1|Overall Study|Lost to Follow-up|0
1354584|NCT01715129|4465526|P1|Overall Study|Other|1
1354585|NCT01715129|4465526|P1|Overall Study|Lost to Follow-up|1
1354586|NCT01715129|4465526|P1|Overall Study|Consent Withdrawn|2
1354587|NCT01715129|4465526|P1|Overall Study|Protocol Violation|1
1354588|NCT01715129|4465526|P1|Overall Study|Lack of Efficacy|3
1354589|NCT01715129|4465526|P1|Overall Study|Adverse Event, fatal|1
1354590|NCT01714817|4465554|P2|Overall Study|Hypersensitivity to the medication|1
1354591|NCT01714817|4465555|P1|Overall Study|Hypersensitivity to the medication|0
1354592|NCT01714817|4465554|P2|Overall Study|Antiproteinuric changed/dose increased|1
1354593|NCT01714817|4465555|P1|Overall Study|Antiproteinuric changed/dose increased|0
1354594|NCT01714817|4465554|P2|Overall Study|Need of use of Prohibited Medications|0
1354595|NCT01714817|4465555|P1|Overall Study|Need of use of Prohibited Medications|1
1354596|NCT01714817|4465554|P2|Overall Study|Change in Concomitant Medication|1
1354597|NCT01714817|4465555|P1|Overall Study|Change in Concomitant Medication|0
1354598|NCT01714817|4465554|P2|Overall Study|Not treated- received ACE inhibition|0
1354599|NCT01714817|4465555|P1|Overall Study|Not treated- received ACE inhibition|1
1354600|NCT01714817|4465554|P2|Overall Study|Participant no longer meets criteria|2
1354601|NCT01714817|4465555|P1|Overall Study|Participant no longer meets criteria|6
1354602|NCT01714817|4465554|P2|Overall Study|Pregnancy|0
1354603|NCT01714817|4465555|P1|Overall Study|Pregnancy|2
1354604|NCT01714817|4465554|P2|Overall Study|Poor / non-compliance|1
1354605|NCT01714817|4465555|P1|Overall Study|Poor / non-compliance|0
1354606|NCT01714817|4465554|P2|Overall Study|Lost to Follow-up|2
1354607|NCT01714817|4465555|P1|Overall Study|Lost to Follow-up|0
1354608|NCT01714817|4465554|P2|Overall Study|Death|1
1354609|NCT01714817|4465555|P1|Overall Study|Death|1
1354610|NCT01714817|4465554|P2|Overall Study|Withdrawal by Subject|7
1354611|NCT01714817|4465555|P1|Overall Study|Withdrawal by Subject|6
1354612|NCT01714817|4465554|P2|Overall Study|Adverse Event|17
1354613|NCT01714817|4465555|P1|Overall Study|Adverse Event|20
1354614|NCT01714817|4465554|P2|Overall Study|Lack of Efficacy|9
1354615|NCT01714817|4465555|P1|Overall Study|Lack of Efficacy|11
1354616|NCT01714635|4465588|P3|Overall Study|Missed 6-month exam|0
1354617|NCT01714635|4465589|P2|Overall Study|Missed 6-month exam|0
1354618|NCT01714635|4465590|P1|Overall Study|Missed 6-month exam|1
1354619|NCT01714635|4465588|P3|Overall Study|Discontinued|2
1354620|NCT01714635|4465589|P2|Overall Study|Discontinued|0
1354621|NCT01714635|4465590|P1|Overall Study|Discontinued|1
1354622|NCT01714609|4465606|P2|Overall Study|Protocol Violation|0
1354623|NCT01714609|4465607|P1|Overall Study|Protocol Violation|1
1354624|NCT01714544|4465613|P1|Overall Study|Withdrawal by Subject|1
1354625|NCT01714544|4465613|P1|Overall Study|Physician Decision|1
1354626|NCT01714544|4465613|P1|Overall Study|Lost to Follow-up|1
1354627|NCT01714310|4465684|P3|Double Blind Adjunctive Treatment|Protocol Violation|0
1354628|NCT01714310|4465685|P2|Double Blind Adjunctive Treatment|Protocol Violation|2
1354629|NCT01714310|4465686|P1|Double Blind Adjunctive Treatment|Protocol Violation|1
1354630|NCT01714310|4465684|P3|Double Blind Adjunctive Treatment|Adverse Event|0
1354631|NCT01714310|4465685|P2|Double Blind Adjunctive Treatment|Adverse Event|1
1354632|NCT01714310|4465686|P1|Double Blind Adjunctive Treatment|Adverse Event|1
1354633|NCT01714310|4465684|P3|Open Lisdexamfetamine Titration|Adverse Event|3
1354634|NCT01714310|4465685|P2|Open Lisdexamfetamine Titration|Adverse Event|0
1354635|NCT01714310|4465686|P1|Open Lisdexamfetamine Titration|Adverse Event|0
1354636|NCT01714310|4465684|P3|Open Lisdexamfetamine Titration|Protocol Violation|1
1354637|NCT01714310|4465685|P2|Open Lisdexamfetamine Titration|Protocol Violation|0
1354638|NCT01714310|4465686|P1|Open Lisdexamfetamine Titration|Protocol Violation|0
1354639|NCT01713998|4465764|P3|Overall Study|Withdrawal by Subject|0
1354640|NCT01713998|4465765|P2|Overall Study|Withdrawal by Subject|0
1354641|NCT01713998|4465766|P1|Overall Study|Withdrawal by Subject|1
1354642|NCT01713998|4465764|P3|Overall Study|Lost to Follow-up|2
1354643|NCT01713998|4465765|P2|Overall Study|Lost to Follow-up|0
1354644|NCT01713998|4465766|P1|Overall Study|Lost to Follow-up|2
1354645|NCT01713933|4465784|P1|Overall Study|Excluded from analysis as a BMI outlier|1
1354646|NCT01713933|4465784|P1|Overall Study|Withdrawal by Subject|3
1354647|NCT01713933|4465784|P1|Overall Study|Lost to Follow-up|2
1354648|NCT01713686|4465796|P1|Overall Study|Withdrawal by Subject|6
1354649|NCT01713686|4465796|P1|Overall Study|Lost to Follow-up|9
1354650|NCT01713530|4465847|P2|Overall Study|Unclassified|2
1354651|NCT01713530|4465848|P1|Overall Study|Unclassified|4
1354652|NCT01713530|4465847|P2|Overall Study|Withdrawal criteria|12
1354653|NCT01713530|4465848|P1|Overall Study|Withdrawal criteria|21
1354654|NCT01713530|4465847|P2|Overall Study|Adverse Event|5
1354655|NCT01713530|4465848|P1|Overall Study|Adverse Event|0
1354656|NCT01713348|4465879|P4|Overall Study|Lost to Follow-up|0
1354657|NCT01713348|4465880|P3|Overall Study|Lost to Follow-up|0
1354658|NCT01713348|4465881|P2|Overall Study|Lost to Follow-up|0
1354659|NCT01713348|4465882|P1|Overall Study|Lost to Follow-up|1
1354660|NCT01713348|4465879|P4|Overall Study|Withdrawal by Subject|0
1354661|NCT01713348|4465880|P3|Overall Study|Withdrawal by Subject|2
1354662|NCT01713348|4465881|P2|Overall Study|Withdrawal by Subject|2
1354663|NCT01713348|4465882|P1|Overall Study|Withdrawal by Subject|3
1354664|NCT01713283|4465912|P2|Overall Study|Lost to Follow-up|1
1354665|NCT01713283|4465913|P1|Overall Study|Lost to Follow-up|1
1354666|NCT01713283|4465912|P2|Overall Study|Lack of Efficacy|2
1354667|NCT01713283|4465913|P1|Overall Study|Lack of Efficacy|10
1354668|NCT01713036|4465935|P1|Overall Study|Death|1
1354669|NCT01712984|4465975|P3|Overall Study|Withdrawal by Subject|7
1354670|NCT01712984|4465976|P2|Overall Study|Withdrawal by Subject|6
1354671|NCT01712984|4465977|P1|Overall Study|Withdrawal by Subject|6
1354672|NCT01712984|4465975|P3|Overall Study|Lost to Follow-up|1
1354673|NCT01712984|4465976|P2|Overall Study|Lost to Follow-up|10
1354674|NCT01712984|4465977|P1|Overall Study|Lost to Follow-up|8
1354675|NCT01712984|4465975|P3|Overall Study|Protocol Violation|1
1354676|NCT01712984|4465976|P2|Overall Study|Protocol Violation|0
1354677|NCT01712984|4465977|P1|Overall Study|Protocol Violation|2
1354678|NCT01712984|4465975|P3|Overall Study|Adverse Event|1
1354679|NCT01712984|4465976|P2|Overall Study|Adverse Event|0
1354680|NCT01712984|4465977|P1|Overall Study|Adverse Event|0
1354681|NCT01712854|4465997|P1|Overall Study|Physician Decision|1
1354682|NCT01712685|4466020|P1|Overall Study|pt declined to participate before trmt|1
1354683|NCT01712516|4466036|P4|Overall Study|Withdrawal by Subject|9
1354684|NCT01712516|4466037|P3|Overall Study|Withdrawal by Subject|3
1354685|NCT01712516|4466038|P2|Overall Study|Withdrawal by Subject|9
1354686|NCT01712516|4466039|P1|Overall Study|Withdrawal by Subject|3
1354687|NCT01712516|4466036|P4|Overall Study|Physician Decision|1
1354688|NCT01712516|4466037|P3|Overall Study|Physician Decision|0
1354689|NCT01712516|4466038|P2|Overall Study|Physician Decision|0
1354690|NCT01712516|4466039|P1|Overall Study|Physician Decision|2
1354691|NCT01712516|4466036|P4|Overall Study|Protocol deviation|0
1354692|NCT01712516|4466037|P3|Overall Study|Protocol deviation|1
1354693|NCT01712516|4466038|P2|Overall Study|Protocol deviation|0
1354694|NCT01712516|4466039|P1|Overall Study|Protocol deviation|1
1354695|NCT01712516|4466036|P4|Overall Study|Death|0
1354696|NCT01712516|4466037|P3|Overall Study|Death|0
1354697|NCT01712516|4466038|P2|Overall Study|Death|1
1354698|NCT01712516|4466039|P1|Overall Study|Death|0
1354699|NCT01712516|4466036|P4|Overall Study|Lost to Follow-up|1
1354700|NCT01712516|4466037|P3|Overall Study|Lost to Follow-up|2
1354701|NCT01712516|4466038|P2|Overall Study|Lost to Follow-up|0
1354702|NCT01712516|4466039|P1|Overall Study|Lost to Follow-up|0
1354703|NCT01712516|4466036|P4|Overall Study|Technical problems|2
1354704|NCT01712516|4466037|P3|Overall Study|Technical problems|0
1354705|NCT01712516|4466038|P2|Overall Study|Technical problems|0
1354706|NCT01712516|4466039|P1|Overall Study|Technical problems|0
1354707|NCT01712399|4466089|P1|Overall Study|Study closure|345
1354708|NCT01712399|4466089|P1|Overall Study|Adverse Event|11
1354709|NCT01712399|4466089|P1|Overall Study|Death|1
1354710|NCT01712399|4466089|P1|Overall Study|Withdrawal by Subject|39
1354711|NCT01712399|4466089|P1|Overall Study|Lost to Follow-up|1
1354712|NCT01712334|4466135|P2|Treatment Period 1|Randomized in Error|2
1354713|NCT01712334|4466136|P1|Treatment Period 1|Randomized in Error|0
1354714|NCT01712256|4466144|P1|Overall Study|Lost to Follow-up|1
1354715|NCT01712204|4466155|P2|Overall Study|Protocol Violation|1
1354716|NCT01712204|4466156|P1|Overall Study|Protocol Violation|1
1354717|NCT01712204|4466155|P2|Overall Study|Lost to Follow-up|0
1354718|NCT01712204|4466156|P1|Overall Study|Lost to Follow-up|1
1354719|NCT01712204|4466155|P2|Overall Study|Withdrawal by Subject|3
1354720|NCT01712204|4466156|P1|Overall Study|Withdrawal by Subject|3
1354721|NCT01712204|4466155|P2|Overall Study|Adverse Event|1
1354722|NCT01712204|4466156|P1|Overall Study|Adverse Event|3
1354723|NCT01712178|4466164|P2|Overall Study|Lost to Follow-up|1
1354724|NCT01712178|4466165|P1|Overall Study|Lost to Follow-up|0
1354725|NCT01712178|4466164|P2|Overall Study|Serious adverse event/withdrew consent|1
1354726|NCT01712178|4466165|P1|Overall Study|Serious adverse event/withdrew consent|0
1354727|NCT01712178|4466164|P2|Overall Study|Withdrew consent due to an adverse event|1
1354728|NCT01712178|4466165|P1|Overall Study|Withdrew consent due to an adverse event|1
1354729|NCT01712074|4466190|P3|Double Blind Period|No longer met eligibility criteria|0
1354730|NCT01712074|4466191|P2|Double Blind Period|No longer met eligibility criteria|3
1354731|NCT01712074|4466192|P1|Double Blind Period|No longer met eligibility criteria|0
1354732|NCT01712074|4466190|P3|Double Blind Period|Protocol Violation|1
1354733|NCT01712074|4466191|P2|Double Blind Period|Protocol Violation|0
1354734|NCT01712074|4466192|P1|Double Blind Period|Protocol Violation|0
1354735|NCT01712074|4466190|P3|Double Blind Period|Other|1
1354736|NCT01712074|4466191|P2|Double Blind Period|Other|4
1354737|NCT01712074|4466192|P1|Double Blind Period|Other|0
1354738|NCT01712074|4466190|P3|Double Blind Period|Lost to Follow-up|1
1354739|NCT01712074|4466191|P2|Double Blind Period|Lost to Follow-up|2
1354740|NCT01712074|4466192|P1|Double Blind Period|Lost to Follow-up|0
1354741|NCT01712074|4466190|P3|Double Blind Period|Death|0
1354742|NCT01712074|4466191|P2|Double Blind Period|Death|1
1354743|NCT01712074|4466192|P1|Double Blind Period|Death|0
1354744|NCT01712074|4466190|P3|Double Blind Period|No longer willing to participate|4
1354745|NCT01712074|4466191|P2|Double Blind Period|No longer willing to participate|2
1354746|NCT01712074|4466192|P1|Double Blind Period|No longer willing to participate|0
1354747|NCT01712074|4466190|P3|Double Blind Period|Adverse Event|1
1354748|NCT01712074|4466191|P2|Double Blind Period|Adverse Event|2
1354749|NCT01712074|4466192|P1|Double Blind Period|Adverse Event|0
1354750|NCT01712074|4466190|P3|Placebo Run-in Period|No longer willing to participate|0
1354751|NCT01712074|4466191|P2|Placebo Run-in Period|No longer willing to participate|0
1354752|NCT01712074|4466192|P1|Placebo Run-in Period|No longer willing to participate|1
1354753|NCT01712074|4466190|P3|Placebo Run-in Period|Other|0
1354754|NCT01712074|4466191|P2|Placebo Run-in Period|Other|0
1354755|NCT01712074|4466192|P1|Placebo Run-in Period|Other|1
1354756|NCT01712074|4466190|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
1354757|NCT01712074|4466191|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
1354758|NCT01712074|4466192|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
1354759|NCT01712074|4466190|P3|Placebo Run-in Period|Lost to Follow-up|0
1354760|NCT01712074|4466191|P2|Placebo Run-in Period|Lost to Follow-up|0
1354761|NCT01712074|4466192|P1|Placebo Run-in Period|Lost to Follow-up|1
1354762|NCT01712074|4466190|P3|Placebo Run-in Period|Adverse Event|0
1354763|NCT01712074|4466191|P2|Placebo Run-in Period|Adverse Event|0
1354764|NCT01712074|4466192|P1|Placebo Run-in Period|Adverse Event|2
1354765|NCT01712061|4466248|P3|Overall Study|Other|0
1354766|NCT01712061|4466249|P2|Overall Study|Other|3
1354767|NCT01712061|4466250|P1|Overall Study|Other|0
1354768|NCT01712061|4466248|P3|Overall Study|Withdrawal by Subject|1
1354769|NCT01712061|4466249|P2|Overall Study|Withdrawal by Subject|7
1354770|NCT01712061|4466250|P1|Overall Study|Withdrawal by Subject|1
1354771|NCT01712061|4466248|P3|Overall Study|Medication Error Without Associated AE|0
1354772|NCT01712061|4466249|P2|Overall Study|Medication Error Without Associated AE|1
1354773|NCT01712061|4466250|P1|Overall Study|Medication Error Without Associated AE|0
1354774|NCT01712061|4466248|P3|Overall Study|Did Not Meet Entrance Criteria|3
1354775|NCT01712061|4466249|P2|Overall Study|Did Not Meet Entrance Criteria|6
1354776|NCT01712061|4466250|P1|Overall Study|Did Not Meet Entrance Criteria|4
1354777|NCT01712061|4466248|P3|Overall Study|Lost to Follow-up|1
1354778|NCT01712061|4466249|P2|Overall Study|Lost to Follow-up|0
1354779|NCT01712061|4466250|P1|Overall Study|Lost to Follow-up|1
1354780|NCT01712061|4466248|P3|Overall Study|Death|1
1354781|NCT01712061|4466249|P2|Overall Study|Death|0
1354782|NCT01712061|4466250|P1|Overall Study|Death|0
1354783|NCT01712061|4466248|P3|Overall Study|Adverse Event|5
1354784|NCT01712061|4466249|P2|Overall Study|Adverse Event|9
1354785|NCT01712061|4466250|P1|Overall Study|Adverse Event|4
1354786|NCT01712009|4466290|P3|Overall Study|Decision by Sponsor|12
1354787|NCT01712009|4466291|P2|Overall Study|Decision by Sponsor|14
1354788|NCT01712009|4466292|P1|Overall Study|Decision by Sponsor|12
1354789|NCT01712009|4466290|P3|Overall Study|Lost to Follow-up|1
1354790|NCT01712009|4466291|P2|Overall Study|Lost to Follow-up|0
1354791|NCT01712009|4466292|P1|Overall Study|Lost to Follow-up|2
1354792|NCT01712009|4466290|P3|Overall Study|Withdrawal by Subject|8
1354793|NCT01712009|4466291|P2|Overall Study|Withdrawal by Subject|15
1354794|NCT01712009|4466292|P1|Overall Study|Withdrawal by Subject|24
1354795|NCT01711866|4466326|P1|Overall Study|Adverse Event|2
1354796|NCT01711866|4466326|P1|Overall Study|Withdrawal by Subject|3
1354797|NCT01711866|4466326|P1|Overall Study|Noncompliant|3
1354798|NCT01711853|4466331|P1|Overall Study|Not treated|3
1354799|NCT01711736|4466338|P2|Overall Study|Migrated/moved from study area|1
1354800|NCT01711736|4466339|P1|Overall Study|Migrated/moved from study area|2
1354801|NCT01711736|4466338|P2|Overall Study|Withdrawal by Subject|6
1354802|NCT01711736|4466339|P1|Overall Study|Withdrawal by Subject|6
1354803|NCT01711736|4466338|P2|Overall Study|Lost to Follow-up|1
1354804|NCT01711736|4466339|P1|Overall Study|Lost to Follow-up|4
1354805|NCT01711645|4466367|P1|Overall Study|Physician Decision|5
1354806|NCT01711645|4466367|P1|Overall Study|Lost to Follow-up|6
1354807|NCT01711645|4466367|P1|Overall Study|Withdrawal by Subject|8
1354808|NCT01711359|4466412|P3|Treatment Period|Randomized, Not Treated|0
1354809|NCT01711359|4466413|P2|Treatment Period|Randomized, Not Treated|1
1354810|NCT01711359|4466414|P1|Treatment Period|Randomized, Not Treated|3
1354811|NCT01711359|4466412|P3|Treatment Period|Lost to Follow-up|1
1354812|NCT01711359|4466413|P2|Treatment Period|Lost to Follow-up|1
1354813|NCT01711359|4466414|P1|Treatment Period|Lost to Follow-up|1
1354814|NCT01711359|4466412|P3|Treatment Period|Sponsor Decision|0
1354815|NCT01711359|4466413|P2|Treatment Period|Sponsor Decision|0
1354816|NCT01711359|4466414|P1|Treatment Period|Sponsor Decision|1
1354817|NCT01711359|4466412|P3|Treatment Period|Entry Criteria Not Met|0
1354818|NCT01711359|4466413|P2|Treatment Period|Entry Criteria Not Met|0
1354819|NCT01711359|4466414|P1|Treatment Period|Entry Criteria Not Met|1
1354820|NCT01711359|4466412|P3|Treatment Period|Death|0
1354821|NCT01711359|4466413|P2|Treatment Period|Death|0
1354822|NCT01711359|4466414|P1|Treatment Period|Death|3
1354823|NCT01711359|4466412|P3|Treatment Period|Physician Decision|2
1354824|NCT01711359|4466413|P2|Treatment Period|Physician Decision|3
1354825|NCT01711359|4466414|P1|Treatment Period|Physician Decision|4
1354826|NCT01711359|4466412|P3|Treatment Period|Adverse Event|24
1354827|NCT01711359|4466413|P2|Treatment Period|Adverse Event|10
1354828|NCT01711359|4466414|P1|Treatment Period|Adverse Event|8
1354829|NCT01711359|4466412|P3|Treatment Period|Lack of Efficacy|2
1354830|NCT01711359|4466413|P2|Treatment Period|Lack of Efficacy|2
1354831|NCT01711359|4466414|P1|Treatment Period|Lack of Efficacy|13
1354832|NCT01711359|4466412|P3|Treatment Period|Withdrawal by Subject|13
1354833|NCT01711359|4466413|P2|Treatment Period|Withdrawal by Subject|7
1354834|NCT01711359|4466414|P1|Treatment Period|Withdrawal by Subject|18
1354835|NCT01711216|4466485|P1|Overall Study|no reason specified|22
1354836|NCT01711216|4466485|P1|Overall Study|variety of other minor reasons|83
1354837|NCT01711216|4466485|P1|Overall Study|Lost to Follow-up|46
1354838|NCT01711216|4466485|P1|Overall Study|Withdrawal by Subject|6
1354839|NCT01711216|4466485|P1|Overall Study|Pregnancy|56
1354840|NCT01711216|4466485|P1|Overall Study|Adverse Event|4
1354841|NCT01710800|4466544|P1|Overall Study|Protocol Violation|1
1354842|NCT01710800|4466544|P1|Overall Study|Withdrawal by Subject|21
1354843|NCT01710709|4466608|P1|Overall Study|Lack of Efficacy|3
1354844|NCT01710709|4466608|P1|Overall Study|Protocol Violation|5
1354845|NCT01710709|4466608|P1|Overall Study|Withdrawal by Subject|53
1354846|NCT01710709|4466608|P1|Overall Study|Participant withdrawn by investigator|2
1354847|NCT01710709|4466608|P1|Overall Study|Participant met withdrawal criteria|33
1354848|NCT01710709|4466608|P1|Overall Study|Adverse Event|48
1354849|NCT01710709|4466608|P1|Overall Study|Lost to Follow-up|29
1354850|NCT01710657|4466623|P3|Overall Study|Lack of Efficacy|1
1354851|NCT01710657|4466624|P2|Overall Study|Lack of Efficacy|1
1354852|NCT01710657|4466625|P1|Overall Study|Lack of Efficacy|0
1354853|NCT01710657|4466623|P3|Overall Study|Withdrawal by Subject|2
1354854|NCT01710657|4466624|P2|Overall Study|Withdrawal by Subject|1
1354855|NCT01710657|4466625|P1|Overall Study|Withdrawal by Subject|0
1354856|NCT01710657|4466623|P3|Overall Study|Adverse Event|28
1354857|NCT01710657|4466624|P2|Overall Study|Adverse Event|8
1354858|NCT01710657|4466625|P1|Overall Study|Adverse Event|14
1354859|NCT01710657|4466623|P3|Overall Study|Protocol Violation|0
1354860|NCT01710657|4466624|P2|Overall Study|Protocol Violation|2
1354861|NCT01710657|4466625|P1|Overall Study|Protocol Violation|2
1354862|NCT01710657|4466623|P3|Overall Study|Lost to Follow-up|1
1354863|NCT01710657|4466624|P2|Overall Study|Lost to Follow-up|0
1354864|NCT01710657|4466625|P1|Overall Study|Lost to Follow-up|2
1354865|NCT01710527|4466642|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
1354866|NCT01710527|4466643|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
1354867|NCT01710514|4466669|P2|Overall Study|Withdrawal by Subject|0
1354868|NCT01710514|4466670|P1|Overall Study|Withdrawal by Subject|1
1354869|NCT01710514|4466669|P2|Overall Study|Adverse Event|7
1354870|NCT01710514|4466670|P1|Overall Study|Adverse Event|6
1354871|NCT01710501|4466691|P3|Overall Study|Lost to Follow-up|0
1354872|NCT01710501|4466692|P2|Overall Study|Lost to Follow-up|0
1354873|NCT01710501|4466693|P1|Overall Study|Lost to Follow-up|2
1354874|NCT01710358|4466725|P3|Rescue Period|Withdrawal by Subject|0
1354875|NCT01710358|4466726|P2|Rescue Period|Withdrawal by Subject|8
1354876|NCT01710358|4466727|P1|Rescue Period|Withdrawal by Subject|0
1354877|NCT01710358|4466725|P3|Rescue Period|Lack of Efficacy|0
1354878|NCT01710358|4466726|P2|Rescue Period|Lack of Efficacy|7
1354879|NCT01710358|4466727|P1|Rescue Period|Lack of Efficacy|0
1354880|NCT01710358|4466725|P3|Rescue Period|Death|0
1354881|NCT01710358|4466726|P2|Rescue Period|Death|1
1354882|NCT01710358|4466727|P1|Rescue Period|Death|0
1354883|NCT01710358|4466725|P3|Rescue Period|Adverse Event|0
1354884|NCT01710358|4466726|P2|Rescue Period|Adverse Event|15
1354885|NCT01710358|4466727|P1|Rescue Period|Adverse Event|0
1354886|NCT01710358|4466725|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
1354887|NCT01710358|4466726|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
1354888|NCT01710358|4466727|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
1354889|NCT01710358|4466725|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
1354890|NCT01710358|4466726|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
1354891|NCT01710358|4466727|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
1354892|NCT01710358|4466725|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
1354893|NCT01710358|4466726|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
1354894|NCT01710358|4466727|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
1354895|NCT01710358|4466725|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
1354896|NCT01710358|4466726|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
1354897|NCT01710358|4466727|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
1354898|NCT01710358|4466725|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
1354899|NCT01710358|4466726|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
1354900|NCT01710358|4466727|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
1354901|NCT01710358|4466725|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
1354902|NCT01710358|4466726|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
1354903|NCT01710358|4466727|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
1354904|NCT01710358|4466725|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
1354905|NCT01710358|4466726|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
1354906|NCT01710358|4466727|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
1354907|NCT01710358|4466725|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
1354908|NCT01710358|4466726|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
1354909|NCT01710358|4466727|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
1354910|NCT01710358|4466725|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
1354911|NCT01710358|4466726|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
1354912|NCT01710358|4466727|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
1354913|NCT01710358|4466725|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
1354914|NCT01710358|4466726|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
1354915|NCT01710358|4466727|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
1354916|NCT01710358|4466725|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
1354917|NCT01710358|4466726|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
1354918|NCT01710358|4466727|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
1354919|NCT01710358|4466725|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
1354920|NCT01710358|4466726|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
1354921|NCT01710358|4466727|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
1354922|NCT01710358|4466725|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
1354923|NCT01710358|4466726|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
1354924|NCT01710358|4466727|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
1354925|NCT01710358|4466725|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
1354926|NCT01710358|4466726|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
1354927|NCT01710358|4466727|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
1354928|NCT01710358|4466725|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
1354929|NCT01710358|4466726|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
1354930|NCT01710358|4466727|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
1354931|NCT01710358|4466725|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
1354932|NCT01710358|4466726|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
1354933|NCT01710358|4466727|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
1354934|NCT01710345|4466798|P3|Overall Study|Drug Dosing Error|0
1354935|NCT01710345|4466799|P2|Overall Study|Drug Dosing Error|0
1354936|NCT01710345|4466800|P1|Overall Study|Drug Dosing Error|1
1354937|NCT01710345|4466798|P3|Overall Study|Lack of Efficacy|1
1354938|NCT01710345|4466799|P2|Overall Study|Lack of Efficacy|3
1354939|NCT01710345|4466800|P1|Overall Study|Lack of Efficacy|2
1354940|NCT01710345|4466798|P3|Overall Study|Adverse Event|0
1354941|NCT01710345|4466799|P2|Overall Study|Adverse Event|2
1354942|NCT01710345|4466800|P1|Overall Study|Adverse Event|0
1354943|NCT01710046|4466827|P2|Overall Study|Lost to Follow-up|0
1354944|NCT01710046|4466828|P1|Overall Study|Lost to Follow-up|1
1354945|NCT01710033|4466868|P5|Stage 2|Adverse Event|1
1354946|NCT01710033|4466869|P4|Stage 2|Adverse Event|0
1354947|NCT01710033|4466870|P3|Stage 2|Adverse Event|0
1354948|NCT01710033|4466871|P2|Stage 2|Adverse Event|0
1354949|NCT01710033|4466872|P1|Stage 2|Adverse Event|0
1354950|NCT01710020|4466953|P1|Period 1|Protocol Violation|1
1354951|NCT01709903|4466972|P2|Overall Study|Adverse Event|18
1354952|NCT01709903|4466973|P1|Overall Study|Adverse Event|11
1354953|NCT01709903|4466972|P2|Overall Study|Withdrawal by Subject|6
1354954|NCT01709903|4466973|P1|Overall Study|Withdrawal by Subject|6
1354955|NCT01709903|4466972|P2|Overall Study|Lack of Efficacy|3
1354956|NCT01709903|4466973|P1|Overall Study|Lack of Efficacy|3
1354957|NCT01709903|4466972|P2|Overall Study|Protocol Violation|2
1354958|NCT01709903|4466973|P1|Overall Study|Protocol Violation|3
1354959|NCT01709903|4466972|P2|Overall Study|Death|0
1354960|NCT01709903|4466973|P1|Overall Study|Death|2
1354961|NCT01709903|4466972|P2|Overall Study|Lost to Follow-up|2
1354962|NCT01709903|4466973|P1|Overall Study|Lost to Follow-up|0
1354963|NCT01709903|4466972|P2|Overall Study|no longer needed study drug|1
1354964|NCT01709903|4466973|P1|Overall Study|no longer needed study drug|0
1354965|NCT01709903|4466972|P2|Overall Study|In ability to use device|1
1354966|NCT01709903|4466973|P1|Overall Study|In ability to use device|1
1354967|NCT01709903|4466972|P2|Overall Study|Abnormal test procedure results|0
1354968|NCT01709903|4466973|P1|Overall Study|Abnormal test procedure results|1
1354969|NCT01709903|4466972|P2|Overall Study|administrative problems|6
1354970|NCT01709903|4466973|P1|Overall Study|administrative problems|2
1354971|NCT01709864|4466997|P2|Overall Study|Death|1
1354972|NCT01709864|4466998|P1|Overall Study|Death|0
1354973|NCT01709864|4466997|P2|Overall Study|Adverse Event|2
1354974|NCT01709864|4466998|P1|Overall Study|Adverse Event|0
1354975|NCT01709864|4466997|P2|Overall Study|non-compliance with study treatment|1
1354976|NCT01709864|4466998|P1|Overall Study|non-compliance with study treatment|1
1354977|NCT01709864|4466997|P2|Overall Study|Lost to Follow-up|0
1354978|NCT01709864|4466998|P1|Overall Study|Lost to Follow-up|1
1354979|NCT01709864|4466997|P2|Overall Study|subject/guardian decision|6
1354980|NCT01709864|4466998|P1|Overall Study|subject/guardian decision|5
1354981|NCT01709864|4466997|P2|Overall Study|Physician Decision|1
1354982|NCT01709864|4466998|P1|Overall Study|Physician Decision|0
1354983|NCT01709708|4467069|P2|Overall Study|Protocol Violation|2
1354984|NCT01709708|4467070|P1|Overall Study|Protocol Violation|1
1354985|NCT01709695|4467094|P2|Overall Study|Withdrawal by Subject|1
1354986|NCT01709695|4467095|P1|Overall Study|Withdrawal by Subject|1
1354987|NCT01709578|4467120|P3|Overall Study|Other, not related to safety or efficacy|5
1354988|NCT01709578|4467121|P2|Overall Study|Other, not related to safety or efficacy|7
1354989|NCT01709578|4467122|P1|Overall Study|Other, not related to safety or efficacy|2
1354990|NCT01709578|4467120|P3|Overall Study|Poor compliance to protocol|1
1354991|NCT01709578|4467121|P2|Overall Study|Poor compliance to protocol|2
1354992|NCT01709578|4467122|P1|Overall Study|Poor compliance to protocol|1
1354993|NCT01709578|4467120|P3|Overall Study|Lack of Efficacy|2
1354994|NCT01709578|4467121|P2|Overall Study|Lack of Efficacy|4
1354995|NCT01709578|4467122|P1|Overall Study|Lack of Efficacy|5
1354996|NCT01709578|4467120|P3|Overall Study|Adverse Event|17
1354997|NCT01709578|4467121|P2|Overall Study|Adverse Event|18
1354998|NCT01709578|4467122|P1|Overall Study|Adverse Event|9
1354999|NCT01709578|4467120|P3|Overall Study|Rescued and entered in long term safety|26
1355000|NCT01709578|4467121|P2|Overall Study|Rescued and entered in long term safety|25
1355001|NCT01709578|4467122|P1|Overall Study|Rescued and entered in long term safety|63
1355002|NCT01709513|4467253|P3|Overall Study|Other|7
1355003|NCT01709513|4467254|P2|Overall Study|Other|11
1355004|NCT01709513|4467255|P1|Overall Study|Other|3
1355005|NCT01709513|4467253|P3|Overall Study|Poor compliance to protocol|0
1355006|NCT01709513|4467254|P2|Overall Study|Poor compliance to protocol|0
1355007|NCT01709513|4467255|P1|Overall Study|Poor compliance to protocol|2
1355008|NCT01709513|4467253|P3|Overall Study|Adverse Event|23
1355009|NCT01709513|4467254|P2|Overall Study|Adverse Event|31
1355010|NCT01709513|4467255|P1|Overall Study|Adverse Event|16
1355011|NCT01709513|4467253|P3|Overall Study|Randomized but not treated|0
1355012|NCT01709513|4467254|P2|Overall Study|Randomized but not treated|1
1355013|NCT01709513|4467255|P1|Overall Study|Randomized but not treated|0
1355014|NCT01709500|4467316|P2|Overall Study|Treatment ongoing|78
1355015|NCT01709500|4467317|P1|Overall Study|Treatment ongoing|156
1355016|NCT01709500|4467316|P2|Overall Study|Related to IMP administration|0
1355017|NCT01709500|4467317|P1|Overall Study|Related to IMP administration|1
1355018|NCT01709500|4467316|P2|Overall Study|Other|1
1355019|NCT01709500|4467317|P1|Overall Study|Other|3
1355020|NCT01709500|4467316|P2|Overall Study|Poor compliance to protocol|1
1355021|NCT01709500|4467317|P1|Overall Study|Poor compliance to protocol|2
1355022|NCT01709500|4467316|P2|Overall Study|Adverse Event|1
1355023|NCT01709500|4467317|P1|Overall Study|Adverse Event|5
1355024|NCT01709500|4467316|P2|Overall Study|Randomized but not treated|1
1355025|NCT01709500|4467317|P1|Overall Study|Randomized but not treated|0
1355026|NCT01709409|4467395|P2|Overall Study|Protocol Violation|0
1355027|NCT01709409|4467396|P1|Overall Study|Protocol Violation|1
1355028|NCT01709383|4467404|P2|Overall Study|Lost to Follow-up|0
1355029|NCT01709383|4467405|P1|Overall Study|Lost to Follow-up|1
1355030|NCT01709331|4467423|P1|Overall Study|Adverse Event|1
1355031|NCT01709305|4467429|P5|Phase 2|Withdrawal by Subject|12
1355032|NCT01709305|4467430|P4|Phase 2|Withdrawal by Subject|15
1355033|NCT01709305|4467431|P3|Phase 2|Withdrawal by Subject|6
1355034|NCT01709305|4467432|P2|Phase 2|Withdrawal by Subject|8
1355035|NCT01709305|4467433|P1|Phase 2|Withdrawal by Subject|0
1355036|NCT01709305|4467429|P5|Phase 2|Protocol Violation|9
1355037|NCT01709305|4467430|P4|Phase 2|Protocol Violation|13
1355038|NCT01709305|4467431|P3|Phase 2|Protocol Violation|19
1355039|NCT01709305|4467432|P2|Phase 2|Protocol Violation|19
1355040|NCT01709305|4467433|P1|Phase 2|Protocol Violation|0
1355041|NCT01709305|4467429|P5|Phase 2|Physician Decision|2
1355042|NCT01709305|4467430|P4|Phase 2|Physician Decision|1
1355043|NCT01709305|4467431|P3|Phase 2|Physician Decision|0
1355044|NCT01709305|4467432|P2|Phase 2|Physician Decision|2
1355045|NCT01709305|4467433|P1|Phase 2|Physician Decision|0
1355046|NCT01709305|4467429|P5|Phase 2|Travel, moving, etc.|5
1355047|NCT01709305|4467430|P4|Phase 2|Travel, moving, etc.|3
1355048|NCT01709305|4467431|P3|Phase 2|Travel, moving, etc.|3
1355049|NCT01709305|4467432|P2|Phase 2|Travel, moving, etc.|2
1355050|NCT01709305|4467433|P1|Phase 2|Travel, moving, etc.|0
1355051|NCT01709305|4467429|P5|Phase 2|Lost to Follow-up|5
1355052|NCT01709305|4467430|P4|Phase 2|Lost to Follow-up|9
1355053|NCT01709305|4467431|P3|Phase 2|Lost to Follow-up|6
1355054|NCT01709305|4467432|P2|Phase 2|Lost to Follow-up|10
1355055|NCT01709305|4467433|P1|Phase 2|Lost to Follow-up|0
1355056|NCT01709305|4467429|P5|Phase 2|Laboratory Adverse Event|1
1355057|NCT01709305|4467430|P4|Phase 2|Laboratory Adverse Event|1
1355058|NCT01709305|4467431|P3|Phase 2|Laboratory Adverse Event|0
1355059|NCT01709305|4467432|P2|Phase 2|Laboratory Adverse Event|1
1355060|NCT01709305|4467433|P1|Phase 2|Laboratory Adverse Event|0
1355061|NCT01709305|4467429|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
1355062|NCT01709305|4467430|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
1355063|NCT01709305|4467431|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
1355064|NCT01709305|4467432|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
1355065|NCT01709305|4467433|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
1355066|NCT01709305|4467429|P5|Phase 2|Death|0
1355067|NCT01709305|4467430|P4|Phase 2|Death|0
1355068|NCT01709305|4467431|P3|Phase 2|Death|1
1355069|NCT01709305|4467432|P2|Phase 2|Death|0
1355070|NCT01709305|4467433|P1|Phase 2|Death|0
1355071|NCT01709305|4467429|P5|Phase 2|Clinical Adverse Event|11
1355072|NCT01709305|4467430|P4|Phase 2|Clinical Adverse Event|6
1355073|NCT01709305|4467431|P3|Phase 2|Clinical Adverse Event|10
1355074|NCT01709305|4467432|P2|Phase 2|Clinical Adverse Event|10
1355075|NCT01709305|4467433|P1|Phase 2|Clinical Adverse Event|0
1355076|NCT01709305|4467429|P5|Phase 1|Withdrawal by Subject|0
1355077|NCT01709305|4467430|P4|Phase 1|Withdrawal by Subject|0
1355078|NCT01709305|4467431|P3|Phase 1|Withdrawal by Subject|0
1355079|NCT01709305|4467432|P2|Phase 1|Withdrawal by Subject|0
1355080|NCT01709305|4467433|P1|Phase 1|Withdrawal by Subject|218
1355081|NCT01709305|4467429|P5|Phase 1|Protocol Violation|0
1355082|NCT01709305|4467430|P4|Phase 1|Protocol Violation|0
1355083|NCT01709305|4467431|P3|Phase 1|Protocol Violation|0
1355084|NCT01709305|4467432|P2|Phase 1|Protocol Violation|0
1355085|NCT01709305|4467433|P1|Phase 1|Protocol Violation|118
1355086|NCT01709305|4467429|P5|Phase 1|Physician Decision|0
1355087|NCT01709305|4467430|P4|Phase 1|Physician Decision|0
1355088|NCT01709305|4467431|P3|Phase 1|Physician Decision|0
1355089|NCT01709305|4467432|P2|Phase 1|Physician Decision|0
1355090|NCT01709305|4467433|P1|Phase 1|Physician Decision|13
1355091|NCT01709305|4467429|P5|Phase 1|Travel, moving, etc.|0
1355092|NCT01709305|4467430|P4|Phase 1|Travel, moving, etc.|0
1355093|NCT01709305|4467431|P3|Phase 1|Travel, moving, etc.|0
1355094|NCT01709305|4467432|P2|Phase 1|Travel, moving, etc.|0
1355095|NCT01709305|4467433|P1|Phase 1|Travel, moving, etc.|30
1355096|NCT01709305|4467429|P5|Phase 1|Lost to Follow-up|0
1355097|NCT01709305|4467430|P4|Phase 1|Lost to Follow-up|0
1355098|NCT01709305|4467431|P3|Phase 1|Lost to Follow-up|0
1355099|NCT01709305|4467432|P2|Phase 1|Lost to Follow-up|0
1355100|NCT01709305|4467433|P1|Phase 1|Lost to Follow-up|147
1355101|NCT01709305|4467429|P5|Phase 1|Laboratory Adverse Event|0
1355102|NCT01709305|4467430|P4|Phase 1|Laboratory Adverse Event|0
1355103|NCT01709305|4467431|P3|Phase 1|Laboratory Adverse Event|0
1355104|NCT01709305|4467432|P2|Phase 1|Laboratory Adverse Event|0
1355105|NCT01709305|4467433|P1|Phase 1|Laboratory Adverse Event|16
1355106|NCT01709305|4467429|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
1355107|NCT01709305|4467430|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
1355108|NCT01709305|4467431|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
1355109|NCT01709305|4467432|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
1355110|NCT01709305|4467433|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
1355111|NCT01709305|4467429|P5|Phase 1|Death|0
1355112|NCT01709305|4467430|P4|Phase 1|Death|0
1355113|NCT01709305|4467431|P3|Phase 1|Death|0
1355114|NCT01709305|4467432|P2|Phase 1|Death|0
1355115|NCT01709305|4467433|P1|Phase 1|Death|2
1355116|NCT01709305|4467429|P5|Phase 1|Clinical Adverse Event|0
1355117|NCT01709305|4467430|P4|Phase 1|Clinical Adverse Event|0
1355118|NCT01709305|4467431|P3|Phase 1|Clinical Adverse Event|0
1355119|NCT01709305|4467432|P2|Phase 1|Clinical Adverse Event|0
1355120|NCT01709305|4467433|P1|Phase 1|Clinical Adverse Event|80
1355121|NCT01709227|4467470|P2|Overall Study|Pleural Peritoneal communication|9
1355122|NCT01709227|4467471|P1|Overall Study|Pleural Peritoneal communication|0
1355123|NCT01709227|4467470|P2|Overall Study|Physician Decision|0
1355124|NCT01709227|4467471|P1|Overall Study|Physician Decision|1
1355125|NCT01709162|4467497|P2|Overall Study|Withdrawal by Subject|1
1355126|NCT01709162|4467498|P1|Overall Study|Withdrawal by Subject|0
1355127|NCT01709162|4467497|P2|Overall Study|Not specified|0
1355128|NCT01709162|4467498|P1|Overall Study|Not specified|1
1355129|NCT01709162|4467497|P2|Overall Study|Administrative reason by sponsor|1
1355130|NCT01709162|4467498|P1|Overall Study|Administrative reason by sponsor|0
1355131|NCT01709162|4467497|P2|Overall Study|Study drug toxicity|0
1355132|NCT01709162|4467498|P1|Overall Study|Study drug toxicity|2
1355133|NCT01709162|4467497|P2|Overall Study|Disease progression|3
1355134|NCT01709162|4467498|P1|Overall Study|Disease progression|3
1355135|NCT01709110|4467519|P2|Overall Study|Caregiver Decision|1
1355136|NCT01709110|4467520|P1|Overall Study|Caregiver Decision|1
1355137|NCT01709110|4467519|P2|Overall Study|Lack of Efficacy|1
1355138|NCT01709110|4467520|P1|Overall Study|Lack of Efficacy|1
1355139|NCT01709110|4467519|P2|Overall Study|Sponsor Decision|2
1355140|NCT01709110|4467520|P1|Overall Study|Sponsor Decision|2
1355141|NCT01709110|4467519|P2|Overall Study|Physician Decision|10
1355142|NCT01709110|4467520|P1|Overall Study|Physician Decision|4
1355143|NCT01709110|4467519|P2|Overall Study|Withdrawal by Subject|89
1355144|NCT01709110|4467520|P1|Overall Study|Withdrawal by Subject|96
1355145|NCT01709110|4467519|P2|Overall Study|Protocol Violation|6
1355146|NCT01709110|4467520|P1|Overall Study|Protocol Violation|4
1355147|NCT01709110|4467519|P2|Overall Study|Lost to Follow-up|5
1355148|NCT01709110|4467520|P1|Overall Study|Lost to Follow-up|7
1355149|NCT01709110|4467519|P2|Overall Study|Death|6
1355150|NCT01709110|4467520|P1|Overall Study|Death|14
1355151|NCT01709110|4467519|P2|Overall Study|Adverse Event|48
1355152|NCT01709110|4467520|P1|Overall Study|Adverse Event|56
1355153|NCT01709084|4467550|P2|Overall Study|Not Treated|2
1355154|NCT01709084|4467551|P1|Overall Study|Not Treated|0
1355155|NCT01709084|4467550|P2|Overall Study|Participant Reached a Virologic Endpoint|1
1355156|NCT01709084|4467551|P1|Overall Study|Participant Reached a Virologic Endpoint|0
1355157|NCT01709084|4467550|P2|Overall Study|Other|3
1355158|NCT01709084|4467551|P1|Overall Study|Other|5
1355159|NCT01709084|4467550|P2|Overall Study|Adverse Event|0
1355160|NCT01709084|4467551|P1|Overall Study|Adverse Event|5
1355161|NCT01709084|4467550|P2|Overall Study|Withdrawal by Subject|2
1355162|NCT01709084|4467551|P1|Overall Study|Withdrawal by Subject|2
1355163|NCT01709084|4467550|P2|Overall Study|Lost to Follow-up|7
1355164|NCT01709084|4467551|P1|Overall Study|Lost to Follow-up|4
1355165|NCT01708954|4467579|P3|Step 2|Withdrawal by Subject|0
1355166|NCT01708954|4467580|P2|Step 2|Withdrawal by Subject|1
1355167|NCT01708954|4467581|P1|Step 2|Withdrawal by Subject|1
1355168|NCT01708954|4467579|P3|Step 2|Adverse Event|0
1355169|NCT01708954|4467580|P2|Step 2|Adverse Event|2
1355170|NCT01708954|4467581|P1|Step 2|Adverse Event|3
1355171|NCT01708954|4467579|P3|Step 2|Disease progression|0
1355172|NCT01708954|4467580|P2|Step 2|Disease progression|4
1355173|NCT01708954|4467581|P1|Step 2|Disease progression|9
1355174|NCT01708954|4467579|P3|Step 1|Ineligible or never received treatment|8
1355175|NCT01708954|4467580|P2|Step 1|Ineligible or never received treatment|2
1355176|NCT01708954|4467581|P1|Step 1|Ineligible or never received treatment|4
1355177|NCT01708954|4467579|P3|Step 1|Off-treatment reason not submitted|1
1355178|NCT01708954|4467580|P2|Step 1|Off-treatment reason not submitted|1
1355179|NCT01708954|4467581|P1|Step 1|Off-treatment reason not submitted|1
1355180|NCT01708954|4467579|P3|Step 1|Symptomatic deterioration|1
1355181|NCT01708954|4467580|P2|Step 1|Symptomatic deterioration|0
1355182|NCT01708954|4467581|P1|Step 1|Symptomatic deterioration|1
1355183|NCT01708954|4467579|P3|Step 1|Crossed over to Step 2|0
1355184|NCT01708954|4467580|P2|Step 1|Crossed over to Step 2|0
1355185|NCT01708954|4467581|P1|Step 1|Crossed over to Step 2|2
1355186|NCT01708954|4467579|P3|Step 1|Other complicating disease|0
1355187|NCT01708954|4467580|P2|Step 1|Other complicating disease|2
1355188|NCT01708954|4467581|P1|Step 1|Other complicating disease|0
1355189|NCT01708954|4467579|P3|Step 1|Withdrawal by Subject|3
1355190|NCT01708954|4467580|P2|Step 1|Withdrawal by Subject|5
1355191|NCT01708954|4467581|P1|Step 1|Withdrawal by Subject|2
1355192|NCT01708954|4467579|P3|Step 1|Death|3
1355193|NCT01708954|4467580|P2|Step 1|Death|2
1355194|NCT01708954|4467581|P1|Step 1|Death|3
1355195|NCT01708954|4467579|P3|Step 1|Adverse Event|13
1355196|NCT01708954|4467580|P2|Step 1|Adverse Event|11
1355197|NCT01708954|4467581|P1|Step 1|Adverse Event|3
1355198|NCT01708954|4467579|P3|Step 1|Disease progression|14
1355199|NCT01708954|4467580|P2|Step 1|Disease progression|17
1355200|NCT01708954|4467581|P1|Step 1|Disease progression|26
1355201|NCT01708915|4467606|P4|Overall Study|Other reasons than stated above|2
1355202|NCT01708915|4467607|P3|Overall Study|Other reasons than stated above|0
1355203|NCT01708915|4467608|P2|Overall Study|Other reasons than stated above|1
1355204|NCT01708915|4467609|P1|Overall Study|Other reasons than stated above|1
1355205|NCT01708915|4467606|P4|Overall Study|Withdrawal by Subject|2
1355206|NCT01708915|4467607|P3|Overall Study|Withdrawal by Subject|2
1355207|NCT01708915|4467608|P2|Overall Study|Withdrawal by Subject|1
1355208|NCT01708915|4467609|P1|Overall Study|Withdrawal by Subject|0
1355209|NCT01708915|4467606|P4|Overall Study|Protocol Violation|1
1355210|NCT01708915|4467607|P3|Overall Study|Protocol Violation|0
1355211|NCT01708915|4467608|P2|Overall Study|Protocol Violation|0
1355212|NCT01708915|4467609|P1|Overall Study|Protocol Violation|0
1355213|NCT01708915|4467606|P4|Overall Study|Lack of Efficacy|15
1355214|NCT01708915|4467607|P3|Overall Study|Lack of Efficacy|35
1355215|NCT01708915|4467608|P2|Overall Study|Lack of Efficacy|60
1355216|NCT01708915|4467609|P1|Overall Study|Lack of Efficacy|84
1355217|NCT01708915|4467606|P4|Overall Study|Adverse Event|13
1355218|NCT01708915|4467607|P3|Overall Study|Adverse Event|9
1355219|NCT01708915|4467608|P2|Overall Study|Adverse Event|0
1355220|NCT01708915|4467609|P1|Overall Study|Adverse Event|1
1355221|NCT01708902|4467638|P7|Overall Study|Other Reason|0
1355222|NCT01708902|4467639|P6|Overall Study|Other Reason|2
1355223|NCT01708902|4467640|P5|Overall Study|Other Reason|1
1355224|NCT01708902|4467641|P4|Overall Study|Other Reason|1
1355225|NCT01708902|4467642|P3|Overall Study|Other Reason|1
1355226|NCT01708902|4467643|P2|Overall Study|Other Reason|0
1355227|NCT01708902|4467644|P1|Overall Study|Other Reason|1
1355228|NCT01708902|4467638|P7|Overall Study|Refused to continue trial medication|1
1355229|NCT01708902|4467639|P6|Overall Study|Refused to continue trial medication|1
1355230|NCT01708902|4467640|P5|Overall Study|Refused to continue trial medication|8
1355231|NCT01708902|4467641|P4|Overall Study|Refused to continue trial medication|2
1355232|NCT01708902|4467642|P3|Overall Study|Refused to continue trial medication|4
1355233|NCT01708902|4467643|P2|Overall Study|Refused to continue trial medication|0
1355234|NCT01708902|4467644|P1|Overall Study|Refused to continue trial medication|8
1355235|NCT01708902|4467638|P7|Overall Study|Lost to Follow-up|1
1355236|NCT01708902|4467639|P6|Overall Study|Lost to Follow-up|0
1355237|NCT01708902|4467640|P5|Overall Study|Lost to Follow-up|0
1355238|NCT01708902|4467641|P4|Overall Study|Lost to Follow-up|2
1355239|NCT01708902|4467642|P3|Overall Study|Lost to Follow-up|2
1355240|NCT01708902|4467643|P2|Overall Study|Lost to Follow-up|1
1355241|NCT01708902|4467644|P1|Overall Study|Lost to Follow-up|2
1355242|NCT01708902|4467638|P7|Overall Study|Non compliance with protocol|0
1355243|NCT01708902|4467639|P6|Overall Study|Non compliance with protocol|0
1355244|NCT01708902|4467640|P5|Overall Study|Non compliance with protocol|0
1355245|NCT01708902|4467641|P4|Overall Study|Non compliance with protocol|3
1355246|NCT01708902|4467642|P3|Overall Study|Non compliance with protocol|1
1355247|NCT01708902|4467643|P2|Overall Study|Non compliance with protocol|2
1355248|NCT01708902|4467644|P1|Overall Study|Non compliance with protocol|0
1355249|NCT01708902|4467638|P7|Overall Study|Lack of Efficacy|0
1355250|NCT01708902|4467639|P6|Overall Study|Lack of Efficacy|1
1355251|NCT01708902|4467640|P5|Overall Study|Lack of Efficacy|0
1355252|NCT01708902|4467641|P4|Overall Study|Lack of Efficacy|0
1355253|NCT01708902|4467642|P3|Overall Study|Lack of Efficacy|0
1355254|NCT01708902|4467643|P2|Overall Study|Lack of Efficacy|1
1355255|NCT01708902|4467644|P1|Overall Study|Lack of Efficacy|3
1355256|NCT01708902|4467638|P7|Overall Study|Adverse Event|5
1355257|NCT01708902|4467639|P6|Overall Study|Adverse Event|3
1355258|NCT01708902|4467640|P5|Overall Study|Adverse Event|7
1355259|NCT01708902|4467641|P4|Overall Study|Adverse Event|2
1355260|NCT01708902|4467642|P3|Overall Study|Adverse Event|9
1355261|NCT01708902|4467643|P2|Overall Study|Adverse Event|4
1355262|NCT01708902|4467644|P1|Overall Study|Adverse Event|3
1355263|NCT01708291|4467717|P2|Overall Study|fighting|1
1355264|NCT01708291|4467718|P1|Overall Study|fighting|2
1355265|NCT01708187|4467757|P2|Overall Study|Lost to Follow-up|1
1355266|NCT01708187|4467758|P1|Overall Study|Lost to Follow-up|0
1355267|NCT01708174|4467767|P3|Treatment Period|Adverse Event|0
1355268|NCT01708174|4467768|P2|Treatment Period|Adverse Event|1
1355269|NCT01708174|4467769|P1|Treatment Period|Adverse Event|0
1355270|NCT01708174|4467767|P3|Treatment Period|Death|1
1355271|NCT01708174|4467768|P2|Treatment Period|Death|0
1355272|NCT01708174|4467769|P1|Treatment Period|Death|0
1355273|NCT01708174|4467767|P3|Treatment Period|Progressive disease|0
1355274|NCT01708174|4467768|P2|Treatment Period|Progressive disease|1
1355275|NCT01708174|4467769|P1|Treatment Period|Progressive disease|0
1355276|NCT01708174|4467767|P3|Treatment Period|Withdrawal by Subject|0
1355277|NCT01708174|4467768|P2|Treatment Period|Withdrawal by Subject|0
1355278|NCT01708174|4467769|P1|Treatment Period|Withdrawal by Subject|1
1355279|NCT01708161|4467801|P6|Overall Study|Disease progression|0
1355280|NCT01708161|4467802|P5|Overall Study|Disease progression|3
1355281|NCT01708161|4467803|P4|Overall Study|Disease progression|13
1355282|NCT01708161|4467804|P3|Overall Study|Disease progression|5
1355283|NCT01708161|4467805|P2|Overall Study|Disease progression|5
1355284|NCT01708161|4467806|P1|Overall Study|Disease progression|3
1355285|NCT01708161|4467801|P6|Overall Study|Administrative problems|0
1355286|NCT01708161|4467802|P5|Overall Study|Administrative problems|0
1355287|NCT01708161|4467803|P4|Overall Study|Administrative problems|0
1355288|NCT01708161|4467804|P3|Overall Study|Administrative problems|0
1355289|NCT01708161|4467805|P2|Overall Study|Administrative problems|1
1355290|NCT01708161|4467806|P1|Overall Study|Administrative problems|0
1355291|NCT01708161|4467801|P6|Overall Study|Withdrawal by Subject|0
1355292|NCT01708161|4467802|P5|Overall Study|Withdrawal by Subject|0
1355293|NCT01708161|4467803|P4|Overall Study|Withdrawal by Subject|0
1355294|NCT01708161|4467804|P3|Overall Study|Withdrawal by Subject|1
1355295|NCT01708161|4467805|P2|Overall Study|Withdrawal by Subject|1
1355296|NCT01708161|4467806|P1|Overall Study|Withdrawal by Subject|0
1355297|NCT01708161|4467801|P6|Overall Study|Death|1
1355298|NCT01708161|4467802|P5|Overall Study|Death|0
1355299|NCT01708161|4467803|P4|Overall Study|Death|1
1355300|NCT01708161|4467804|P3|Overall Study|Death|0
1355301|NCT01708161|4467805|P2|Overall Study|Death|0
1355302|NCT01708161|4467806|P1|Overall Study|Death|0
1355303|NCT01708161|4467801|P6|Overall Study|Adverse Event|0
1355304|NCT01708161|4467802|P5|Overall Study|Adverse Event|3
1355305|NCT01708161|4467803|P4|Overall Study|Adverse Event|2
1355306|NCT01708161|4467804|P3|Overall Study|Adverse Event|4
1355307|NCT01708161|4467805|P2|Overall Study|Adverse Event|3
1355308|NCT01708161|4467806|P1|Overall Study|Adverse Event|1
1355309|NCT01708057|4467857|P3|Overall Study|Withdrawal due to study termination.|1
1355310|NCT01708057|4467858|P2|Overall Study|Withdrawal due to study termination.|1
1355311|NCT01708057|4467859|P1|Overall Study|Withdrawal due to study termination.|1
1355312|NCT01707667|4467917|P2|Period 1|expulsion of colonic sensor catheter|0
1355313|NCT01707667|4467918|P1|Period 1|expulsion of colonic sensor catheter|1
1355314|NCT01707290|4467942|P2|Overall Study|Other unspecified|0
1355315|NCT01707290|4467943|P1|Overall Study|Other unspecified|17
1355316|NCT01707290|4467942|P2|Overall Study|Commercial drug available|1
1355317|NCT01707290|4467943|P1|Overall Study|Commercial drug available|60
1355318|NCT01707290|4467942|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
1355319|NCT01707290|4467943|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
1355320|NCT01707290|4467942|P2|Overall Study|Lost to Follow-up|0
1355321|NCT01707290|4467943|P1|Overall Study|Lost to Follow-up|3
1355322|NCT01707290|4467942|P2|Overall Study|Physician Decision|0
1355323|NCT01707290|4467943|P1|Overall Study|Physician Decision|1
1355324|NCT01707290|4467942|P2|Overall Study|Adverse event (AE)|0
1355325|NCT01707290|4467943|P1|Overall Study|Adverse event (AE)|1
1355326|NCT01706926|4468037|P4|Overall Study|Other|3
1355327|NCT01706926|4468038|P3|Overall Study|Other|4
1355328|NCT01706926|4468039|P2|Overall Study|Other|4
1355329|NCT01706926|4468040|P1|Overall Study|Other|4
1355330|NCT01706926|4468037|P4|Overall Study|Withdrawal by Subject|2
1355331|NCT01706926|4468038|P3|Overall Study|Withdrawal by Subject|1
1355332|NCT01706926|4468039|P2|Overall Study|Withdrawal by Subject|0
1355333|NCT01706926|4468040|P1|Overall Study|Withdrawal by Subject|2
1355334|NCT01706926|4468037|P4|Overall Study|Lost to Follow-up|0
1355335|NCT01706926|4468038|P3|Overall Study|Lost to Follow-up|1
1355336|NCT01706926|4468039|P2|Overall Study|Lost to Follow-up|0
1355337|NCT01706926|4468040|P1|Overall Study|Lost to Follow-up|0
1355338|NCT01706770|4468159|P2|Overall Study|Physician Decision|0
1355339|NCT01706770|4468160|P1|Overall Study|Physician Decision|1
1355340|NCT01706770|4468159|P2|Overall Study|Lost to Follow-up|0
1355341|NCT01706770|4468160|P1|Overall Study|Lost to Follow-up|1
1355342|NCT01706575|4468208|P1|Overall Study|Started but not Treated|6
1355343|NCT01706575|4468208|P1|Overall Study|Lost to Follow-up|2
1355344|NCT01706575|4468208|P1|Overall Study|Participant Withdrew Consent|4
1355345|NCT01706536|4468229|P5|Overall Study|non compliance|0
1355346|NCT01706536|4468230|P4|Overall Study|non compliance|0
1355347|NCT01706536|4468231|P3|Overall Study|non compliance|0
1355348|NCT01706536|4468232|P2|Overall Study|non compliance|1
1355349|NCT01706536|4468233|P1|Overall Study|non compliance|0
1355350|NCT01706536|4468229|P5|Overall Study|Lack of Efficacy|0
1355351|NCT01706536|4468230|P4|Overall Study|Lack of Efficacy|1
1355352|NCT01706536|4468231|P3|Overall Study|Lack of Efficacy|0
1355353|NCT01706536|4468232|P2|Overall Study|Lack of Efficacy|0
1355354|NCT01706536|4468233|P1|Overall Study|Lack of Efficacy|1
1355355|NCT01706536|4468229|P5|Overall Study|Adverse Event|2
1355356|NCT01706536|4468230|P4|Overall Study|Adverse Event|3
1355357|NCT01706536|4468231|P3|Overall Study|Adverse Event|4
1355358|NCT01706536|4468232|P2|Overall Study|Adverse Event|3
1355359|NCT01706536|4468233|P1|Overall Study|Adverse Event|2
1355360|NCT01706536|4468229|P5|Overall Study|Withdrawal by Subject|0
1355361|NCT01706536|4468230|P4|Overall Study|Withdrawal by Subject|0
1355362|NCT01706536|4468231|P3|Overall Study|Withdrawal by Subject|1
1355363|NCT01706536|4468232|P2|Overall Study|Withdrawal by Subject|0
1355364|NCT01706536|4468233|P1|Overall Study|Withdrawal by Subject|1
1355365|NCT01706458|4468292|P2|Overall Study|Physician Decision|4
1355366|NCT01706458|4468293|P1|Overall Study|Physician Decision|3
1355367|NCT01706328|4468317|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
1355368|NCT01706328|4468318|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
1355369|NCT01706328|4468319|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
1355370|NCT01706328|4468317|P3|12-week Double-blind Treatment Period|Physician Decision|2
1355371|NCT01706328|4468318|P2|12-week Double-blind Treatment Period|Physician Decision|2
1355372|NCT01706328|4468319|P1|12-week Double-blind Treatment Period|Physician Decision|0
1355373|NCT01706328|4468317|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
1355374|NCT01706328|4468318|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
1355375|NCT01706328|4468319|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
1355376|NCT01706328|4468317|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
1355377|NCT01706328|4468318|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
1355378|NCT01706328|4468319|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
1355379|NCT01706328|4468317|P3|12-week Double-blind Treatment Period|Protocol Violation|2
1355380|NCT01706328|4468318|P2|12-week Double-blind Treatment Period|Protocol Violation|4
1355381|NCT01706328|4468319|P1|12-week Double-blind Treatment Period|Protocol Violation|0
1355382|NCT01706328|4468317|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
1355383|NCT01706328|4468318|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
1355384|NCT01706328|4468319|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
1355385|NCT01706328|4468317|P3|12-week Double-blind Treatment Period|Adverse Event|16
1355386|NCT01706328|4468318|P2|12-week Double-blind Treatment Period|Adverse Event|14
1355387|NCT01706328|4468319|P1|12-week Double-blind Treatment Period|Adverse Event|0
1355388|NCT01706328|4468317|P3|2-week Run-in Period|Lost to Follow-up|0
1355389|NCT01706328|4468318|P2|2-week Run-in Period|Lost to Follow-up|0
1355390|NCT01706328|4468319|P1|2-week Run-in Period|Lost to Follow-up|2
1355391|NCT01706328|4468317|P3|2-week Run-in Period|Adverse Event|0
1355392|NCT01706328|4468318|P2|2-week Run-in Period|Adverse Event|0
1355393|NCT01706328|4468319|P1|2-week Run-in Period|Adverse Event|4
1355394|NCT01706328|4468317|P3|2-week Run-in Period|Physician Decision|0
1355395|NCT01706328|4468318|P2|2-week Run-in Period|Physician Decision|0
1355396|NCT01706328|4468319|P1|2-week Run-in Period|Physician Decision|4
1355397|NCT01706328|4468317|P3|2-week Run-in Period|Withdrawal by Subject|0
1355398|NCT01706328|4468318|P2|2-week Run-in Period|Withdrawal by Subject|0
1355399|NCT01706328|4468319|P1|2-week Run-in Period|Withdrawal by Subject|15
1355400|NCT01706328|4468317|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
1355401|NCT01706328|4468318|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
1355402|NCT01706328|4468319|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
1355403|NCT01706250|4468338|P1|Overall Study|Lost to Follow-up|2
1355404|NCT01706159|4468369|P2|Overall Study|Unclassified|1
1355405|NCT01706159|4468370|P1|Overall Study|Unclassified|6
1355406|NCT01706159|4468369|P2|Overall Study|Withdrawal Criteria|1
1355407|NCT01706159|4468370|P1|Overall Study|Withdrawal Criteria|2
1355408|NCT01706146|4468384|P1|Overall Study|Developed AF and need for antiplatelets|2
1355409|NCT01706146|4468384|P1|Overall Study|Adverse Event|3
1355410|NCT01706146|4468384|P1|Overall Study|Withdrawal by Subject|1
1355411|NCT01705717|4468391|P2|Overall Study|Not Specified|2
1355412|NCT01705717|4468392|P1|Overall Study|Not Specified|0
1355413|NCT01705717|4468391|P2|Overall Study|Lack of Efficacy|1
1355414|NCT01705717|4468392|P1|Overall Study|Lack of Efficacy|0
1355415|NCT01705717|4468391|P2|Overall Study|Adverse Event|2
1355416|NCT01705717|4468392|P1|Overall Study|Adverse Event|2
1355417|NCT01705652|4468409|P2|Overall Study|non-compliance|1
1355418|NCT01705652|4468410|P1|Overall Study|non-compliance|1
1355419|NCT01705652|4468409|P2|Overall Study|Withdrawal by Subject|2
1355420|NCT01705652|4468410|P1|Overall Study|Withdrawal by Subject|1
1355421|NCT01705652|4468409|P2|Overall Study|Adverse Event|0
1355422|NCT01705652|4468410|P1|Overall Study|Adverse Event|1
1355423|NCT01705587|4468418|P2|Overall Study|Withdrawal by Subject|1
1355424|NCT01705587|4468419|P1|Overall Study|Withdrawal by Subject|0
1355425|NCT01705574|4468437|P2|Overall Study|Still on Study|125
1355426|NCT01705574|4468438|P1|Overall Study|Still on Study|135
1355427|NCT01705574|4468437|P2|Overall Study|Lost to Follow-up|15
1355428|NCT01705574|4468438|P1|Overall Study|Lost to Follow-up|11
1355429|NCT01705574|4468437|P2|Overall Study|Withdrew Consent|5
1355430|NCT01705574|4468438|P1|Overall Study|Withdrew Consent|8
1355431|NCT01705574|4468437|P2|Overall Study|Protocol Violation|0
1355432|NCT01705574|4468438|P1|Overall Study|Protocol Violation|1
1355433|NCT01705574|4468437|P2|Overall Study|Non-Compliance with Study Drug|4
1355434|NCT01705574|4468438|P1|Overall Study|Non-Compliance with Study Drug|4
1355435|NCT01705574|4468437|P2|Overall Study|Pregnancy|1
1355436|NCT01705574|4468438|P1|Overall Study|Pregnancy|1
1355437|NCT01705574|4468437|P2|Overall Study|Adverse Event|9
1355438|NCT01705574|4468438|P1|Overall Study|Adverse Event|3
1355439|NCT01705574|4468437|P2|Overall Study|Randomized but Not Treated|4
1355440|NCT01705574|4468438|P1|Overall Study|Randomized but Not Treated|4
1355441|NCT01705145|4468456|P1|Part B|Adverse Event|1
1355442|NCT01704846|4468511|P2|Treatment Period 2|Withdrawal by Subject|1
1355443|NCT01704846|4468512|P1|Treatment Period 2|Withdrawal by Subject|0
1355444|NCT01704755|4468567|P2|Overall Study|Withdrew consent and personal issues|0
1355445|NCT01704755|4468568|P1|Overall Study|Withdrew consent and personal issues|1
1355446|NCT01704755|4468567|P2|Overall Study|Other (not specified)|1
1355447|NCT01704755|4468568|P1|Overall Study|Other (not specified)|3
1355448|NCT01704755|4468567|P2|Overall Study|Withdrew consent|1
1355449|NCT01704755|4468568|P1|Overall Study|Withdrew consent|1
1355450|NCT01704755|4468567|P2|Overall Study|Lost to Follow-up|4
1355451|NCT01704755|4468568|P1|Overall Study|Lost to Follow-up|3
1355452|NCT01704755|4468567|P2|Overall Study|Adverse Event|1
1355453|NCT01704755|4468568|P1|Overall Study|Adverse Event|4
1355454|NCT01704651|4468582|P2|Overall Study|Post-op did not have laparotomy|1
1355455|NCT01704651|4468583|P1|Overall Study|Post-op did not have laparotomy|2
1355456|NCT01704651|4468582|P2|Overall Study|Nasogastric tube placement in surgery|1
1355457|NCT01704651|4468583|P1|Overall Study|Nasogastric tube placement in surgery|1
1355458|NCT01704651|4468582|P2|Overall Study|Pre-op change in treatment plan|4
1355459|NCT01704651|4468583|P1|Overall Study|Pre-op change in treatment plan|1
1355460|NCT01704651|4468582|P2|Overall Study|Pre-op withdrawal by subject|1
1355461|NCT01704651|4468583|P1|Overall Study|Pre-op withdrawal by subject|1
1355462|NCT01704599|4468591|P1|Overall Study|Adverse Event|1
1355463|NCT01704495|4468631|P4|Optional Safety Extension|Withdrawal by Subject|2
1355464|NCT01704495|4468632|P3|Optional Safety Extension|Withdrawal by Subject|1
1355465|NCT01704495|4468633|P2|Optional Safety Extension|Withdrawal by Subject|0
1355466|NCT01704495|4468634|P1|Optional Safety Extension|Withdrawal by Subject|2
1355467|NCT01704495|4468631|P4|Optional Safety Extension|Other reason|28
1355468|NCT01704495|4468632|P3|Optional Safety Extension|Other reason|30
1355469|NCT01704495|4468633|P2|Optional Safety Extension|Other reason|29
1355470|NCT01704495|4468634|P1|Optional Safety Extension|Other reason|27
1355471|NCT01704495|4468631|P4|Optional Safety Extension|Adverse Event|1
1355472|NCT01704495|4468632|P3|Optional Safety Extension|Adverse Event|0
1355473|NCT01704495|4468633|P2|Optional Safety Extension|Adverse Event|4
1355474|NCT01704495|4468634|P1|Optional Safety Extension|Adverse Event|0
1355475|NCT01704495|4468631|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
1355476|NCT01704495|4468632|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
1355477|NCT01704495|4468633|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
1355478|NCT01704495|4468634|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
1355479|NCT01704495|4468631|P4|Subjects Randomized|Protocol Violation|0
1355480|NCT01704495|4468632|P3|Subjects Randomized|Protocol Violation|2
1355481|NCT01704495|4468633|P2|Subjects Randomized|Protocol Violation|1
1355482|NCT01704495|4468634|P1|Subjects Randomized|Protocol Violation|1
1355483|NCT01704495|4468631|P4|Subjects Randomized|Withdrawal by Subject|5
1355484|NCT01704495|4468632|P3|Subjects Randomized|Withdrawal by Subject|5
1355485|NCT01704495|4468633|P2|Subjects Randomized|Withdrawal by Subject|5
1355486|NCT01704495|4468634|P1|Subjects Randomized|Withdrawal by Subject|5
1355487|NCT01704495|4468631|P4|Subjects Randomized|Adverse Event|7
1355488|NCT01704495|4468632|P3|Subjects Randomized|Adverse Event|0
1355489|NCT01704495|4468633|P2|Subjects Randomized|Adverse Event|2
1355490|NCT01704495|4468634|P1|Subjects Randomized|Adverse Event|8
1355491|NCT01704495|4468631|P4|Subjects Randomized|Discontinuation criteria met|0
1355492|NCT01704495|4468632|P3|Subjects Randomized|Discontinuation criteria met|2
1355493|NCT01704495|4468633|P2|Subjects Randomized|Discontinuation criteria met|2
1355494|NCT01704495|4468634|P1|Subjects Randomized|Discontinuation criteria met|4
1355495|NCT01704495|4468631|P4|Subjects Randomized|Other Reason|2
1355496|NCT01704495|4468632|P3|Subjects Randomized|Other Reason|3
1355497|NCT01704495|4468633|P2|Subjects Randomized|Other Reason|2
1355498|NCT01704495|4468634|P1|Subjects Randomized|Other Reason|3
1355499|NCT01704287|4468850|P5|Switch to Pembrolizumab Treatment Period|Ongoing in Study|16
1355500|NCT01704287|4468851|P4|Switch to Pembrolizumab Treatment Period|Ongoing in Study|21
1355501|NCT01704287|4468852|P3|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
1355502|NCT01704287|4468853|P2|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
1355503|NCT01704287|4468854|P1|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
1355504|NCT01704287|4468850|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1355505|NCT01704287|4468851|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
1355506|NCT01704287|4468852|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1355507|NCT01704287|4468853|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1355508|NCT01704287|4468854|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1355509|NCT01704287|4468850|P5|Switch to Pembrolizumab Treatment Period|Death|28
1355510|NCT01704287|4468851|P4|Switch to Pembrolizumab Treatment Period|Death|29
1355511|NCT01704287|4468852|P3|Switch to Pembrolizumab Treatment Period|Death|0
1355512|NCT01704287|4468853|P2|Switch to Pembrolizumab Treatment Period|Death|0
1355513|NCT01704287|4468854|P1|Switch to Pembrolizumab Treatment Period|Death|0
1355514|NCT01704287|4468850|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
1355515|NCT01704287|4468851|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
1355516|NCT01704287|4468852|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
1355517|NCT01704287|4468853|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
1355518|NCT01704287|4468854|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
1355519|NCT01704287|4468850|P5|Initial Treatment Period|Switched to Pembrolizumab|0
1355520|NCT01704287|4468851|P4|Initial Treatment Period|Switched to Pembrolizumab|0
1355521|NCT01704287|4468852|P3|Initial Treatment Period|Switched to Pembrolizumab|98
1355522|NCT01704287|4468853|P2|Initial Treatment Period|Switched to Pembrolizumab|0
1355523|NCT01704287|4468854|P1|Initial Treatment Period|Switched to Pembrolizumab|0
1355524|NCT01704287|4468850|P5|Initial Treatment Period|Lost to Follow-up|0
1355525|NCT01704287|4468851|P4|Initial Treatment Period|Lost to Follow-up|0
1355526|NCT01704287|4468852|P3|Initial Treatment Period|Lost to Follow-up|3
1355527|NCT01704287|4468853|P2|Initial Treatment Period|Lost to Follow-up|1
1355528|NCT01704287|4468854|P1|Initial Treatment Period|Lost to Follow-up|3
1355529|NCT01704287|4468850|P5|Initial Treatment Period|Ongoing in Study|0
1355530|NCT01704287|4468851|P4|Initial Treatment Period|Ongoing in Study|0
1355531|NCT01704287|4468852|P3|Initial Treatment Period|Ongoing in Study|44
1355532|NCT01704287|4468853|P2|Initial Treatment Period|Ongoing in Study|62
1355533|NCT01704287|4468854|P1|Initial Treatment Period|Ongoing in Study|52
1355534|NCT01704287|4468850|P5|Initial Treatment Period|Other|0
1355535|NCT01704287|4468851|P4|Initial Treatment Period|Other|0
1355536|NCT01704287|4468852|P3|Initial Treatment Period|Other|0
1355537|NCT01704287|4468853|P2|Initial Treatment Period|Other|0
1355538|NCT01704287|4468854|P1|Initial Treatment Period|Other|1
1355539|NCT01704287|4468850|P5|Initial Treatment Period|Withdrawal by Subject|0
1355540|NCT01704287|4468851|P4|Initial Treatment Period|Withdrawal by Subject|0
1355541|NCT01704287|4468852|P3|Initial Treatment Period|Withdrawal by Subject|4
1355542|NCT01704287|4468853|P2|Initial Treatment Period|Withdrawal by Subject|1
1355543|NCT01704287|4468854|P1|Initial Treatment Period|Withdrawal by Subject|1
1355544|NCT01704287|4468850|P5|Initial Treatment Period|Death|0
1355545|NCT01704287|4468851|P4|Initial Treatment Period|Death|0
1355546|NCT01704287|4468852|P3|Initial Treatment Period|Death|30
1355547|NCT01704287|4468853|P2|Initial Treatment Period|Death|117
1355548|NCT01704287|4468854|P1|Initial Treatment Period|Death|123
1355549|NCT01704261|4468889|P2|Overall Study|Lost to Follow-up|0
1355550|NCT01704261|4468890|P1|Overall Study|Lost to Follow-up|1
1355551|NCT01704261|4468889|P2|Overall Study|Withdrawal by Subject|15
1355552|NCT01704261|4468890|P1|Overall Study|Withdrawal by Subject|12
1355553|NCT01704079|4468917|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
1355554|NCT01704079|4468918|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
1355555|NCT01704079|4468917|P2|Overall Study|Subject noncompliance|3
1355556|NCT01704079|4468918|P1|Overall Study|Subject noncompliance|2
1355557|NCT01704079|4468917|P2|Overall Study|Protocol Violation|0
1355558|NCT01704079|4468918|P1|Overall Study|Protocol Violation|1
1355559|NCT01704079|4468917|P2|Overall Study|Adverse Event|7
1355560|NCT01704079|4468918|P1|Overall Study|Adverse Event|4
1355561|NCT01704079|4468917|P2|Overall Study|Lost to Follow-up|5
1355562|NCT01704079|4468918|P1|Overall Study|Lost to Follow-up|2
1355563|NCT01704079|4468917|P2|Overall Study|Withdrawal by Subject|7
1355564|NCT01704079|4468918|P1|Overall Study|Withdrawal by Subject|5
1355565|NCT01703988|4468934|P4|Overall Study|Investigator Judgment|1
1355566|NCT01703988|4468935|P3|Overall Study|Investigator Judgment|0
1355567|NCT01703988|4468936|P2|Overall Study|Investigator Judgment|0
1355568|NCT01703988|4468937|P1|Overall Study|Investigator Judgment|0
1355569|NCT01703858|4468967|P3|Overall Study|Withdrawal by Subject|0
1355570|NCT01703858|4468968|P2|Overall Study|Withdrawal by Subject|1
1355571|NCT01703858|4468969|P1|Overall Study|Withdrawal by Subject|0
1355572|NCT01703845|4468994|P2|Overall Study|other than stated above|0
1355573|NCT01703845|4468995|P1|Overall Study|other than stated above|1
1355574|NCT01703845|4468994|P2|Overall Study|Protocol Violation|0
1355575|NCT01703845|4468995|P1|Overall Study|Protocol Violation|1
1355576|NCT01703845|4468994|P2|Overall Study|Adverse Event|0
1355577|NCT01703845|4468995|P1|Overall Study|Adverse Event|1
1355578|NCT01703832|4469032|P2|Overall Study|Withdrawal by Subject|0
1355579|NCT01703832|4469033|P1|Overall Study|Withdrawal by Subject|1
1355580|NCT01703819|4469065|P2|Overall Study|Withdrawal by Subject|1
1355581|NCT01703819|4469066|P1|Overall Study|Withdrawal by Subject|0
1355582|NCT01703819|4469065|P2|Overall Study|Adverse Event|1
1355583|NCT01703819|4469066|P1|Overall Study|Adverse Event|0
1355584|NCT01703741|4469096|P1|Overall Study|Subject started testosterone injections|1
1355585|NCT01703741|4469096|P1|Overall Study|Subject cannot comply with study visits|1
1355586|NCT01703741|4469096|P1|Overall Study|Subject did not want to continue|2
1355587|NCT01703741|4469096|P1|Overall Study|Lost to Follow-up|3
1355588|NCT01703741|4469096|P1|Overall Study|Protocol Violation|1
1355589|NCT01703741|4469096|P1|Overall Study|Physician Decision|2
1355590|NCT01703741|4469096|P1|Overall Study|Adverse Event|2
1355591|NCT01703741|4469096|P1|Overall Study|Withdrawal by Subject|6
1355592|NCT01703286|4469139|P6|Period 2 Including Washout|Adverse Event|0
1355593|NCT01703286|4469140|P5|Period 2 Including Washout|Adverse Event|0
1355594|NCT01703286|4469141|P4|Period 2 Including Washout|Adverse Event|1
1355595|NCT01703286|4469142|P3|Period 2 Including Washout|Adverse Event|0
1355596|NCT01703286|4469143|P2|Period 2 Including Washout|Adverse Event|0
1355597|NCT01703286|4469144|P1|Period 2 Including Washout|Adverse Event|0
1355598|NCT01703286|4469139|P6|Period 1 Including Washout|Withdrawal by Subject|1
1355599|NCT01703286|4469140|P5|Period 1 Including Washout|Withdrawal by Subject|0
1355600|NCT01703286|4469141|P4|Period 1 Including Washout|Withdrawal by Subject|1
1355601|NCT01703286|4469142|P3|Period 1 Including Washout|Withdrawal by Subject|0
1355602|NCT01703286|4469143|P2|Period 1 Including Washout|Withdrawal by Subject|0
1355603|NCT01703286|4469144|P1|Period 1 Including Washout|Withdrawal by Subject|0
1355604|NCT01703260|4469167|P3|Overall Study|Study Termination|0
1355605|NCT01703260|4469168|P2|Overall Study|Study Termination|2
1355606|NCT01703260|4469169|P1|Overall Study|Study Termination|1
1355607|NCT01703260|4469167|P3|Overall Study|Withdrawal by Subject|1
1355608|NCT01703260|4469168|P2|Overall Study|Withdrawal by Subject|0
1355609|NCT01703260|4469169|P1|Overall Study|Withdrawal by Subject|0
1355610|NCT01703260|4469167|P3|Overall Study|Lost to Follow-up|0
1355611|NCT01703260|4469168|P2|Overall Study|Lost to Follow-up|0
1355612|NCT01703260|4469169|P1|Overall Study|Lost to Follow-up|1
1355613|NCT01703260|4469167|P3|Overall Study|Adverse Event|2
1355614|NCT01703260|4469168|P2|Overall Study|Adverse Event|2
1355615|NCT01703260|4469169|P1|Overall Study|Adverse Event|1
1355616|NCT01703221|4469195|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
1355617|NCT01703221|4469196|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
1355618|NCT01703221|4469197|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
1355619|NCT01703221|4469195|P3|Phase B - (Week 25 to 52)|Adverse Event|2
1355620|NCT01703221|4469196|P2|Phase B - (Week 25 to 52)|Adverse Event|3
1355621|NCT01703221|4469197|P1|Phase B - (Week 25 to 52)|Adverse Event|2
1355622|NCT01703221|4469195|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
1355623|NCT01703221|4469196|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
1355624|NCT01703221|4469197|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
1355625|NCT01703221|4469195|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
1355626|NCT01703221|4469196|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
1355627|NCT01703221|4469197|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
1355628|NCT01703221|4469195|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1355629|NCT01703221|4469196|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1355630|NCT01703221|4469197|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
1355631|NCT01703221|4469195|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
1355632|NCT01703221|4469196|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
1355633|NCT01703221|4469197|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
1355634|NCT01703221|4469195|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
1355635|NCT01703221|4469196|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
1355636|NCT01703221|4469197|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
1355637|NCT01703221|4469195|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
1355638|NCT01703221|4469196|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
1355639|NCT01703221|4469197|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
1355640|NCT01703208|4469228|P2|Overall Study|Protocol Deviation|0
1355641|NCT01703208|4469229|P1|Overall Study|Protocol Deviation|2
1355642|NCT01703208|4469228|P2|Overall Study|Technical Problems|1
1355643|NCT01703208|4469229|P1|Overall Study|Technical Problems|0
1355644|NCT01703208|4469228|P2|Overall Study|Adverse Event|19
1355645|NCT01703208|4469229|P1|Overall Study|Adverse Event|14
1355646|NCT01703208|4469228|P2|Overall Study|Withdrawal by Subject|209
1355647|NCT01703208|4469229|P1|Overall Study|Withdrawal by Subject|205
1355648|NCT01703208|4469228|P2|Overall Study|Study Terminated by Sponsor|1716
1355649|NCT01703208|4469229|P1|Overall Study|Study Terminated by Sponsor|1710
1355650|NCT01703208|4469228|P2|Overall Study|Protocol Violation|1
1355651|NCT01703208|4469229|P1|Overall Study|Protocol Violation|1
1355652|NCT01703208|4469228|P2|Overall Study|Progressive disease|2
1355653|NCT01703208|4469229|P1|Overall Study|Progressive disease|2
1355654|NCT01703208|4469228|P2|Overall Study|Physician Decision|13
1355655|NCT01703208|4469229|P1|Overall Study|Physician Decision|11
1355656|NCT01703208|4469228|P2|Overall Study|Site Discontinued Study Participation|27
1355657|NCT01703208|4469229|P1|Overall Study|Site Discontinued Study Participation|23
1355658|NCT01703208|4469228|P2|Overall Study|Excluded Medication|2
1355659|NCT01703208|4469229|P1|Overall Study|Excluded Medication|1
1355660|NCT01703208|4469228|P2|Overall Study|Non-Compliance with Study Drug|0
1355661|NCT01703208|4469229|P1|Overall Study|Non-Compliance with Study Drug|1
1355662|NCT01703208|4469228|P2|Overall Study|Lost to Follow-up|62
1355663|NCT01703208|4469229|P1|Overall Study|Lost to Follow-up|68
1355664|NCT01703208|4469228|P2|Overall Study|Lack of Efficacy|2
1355665|NCT01703208|4469229|P1|Overall Study|Lack of Efficacy|1
1355666|NCT01703208|4469228|P2|Overall Study|Death|48
1355667|NCT01703208|4469229|P1|Overall Study|Death|61
1355668|NCT01703091|4469293|P2|Overall Study|Sponsor Decision|0
1355669|NCT01703091|4469294|P1|Overall Study|Sponsor Decision|1
1355670|NCT01703091|4469293|P2|Overall Study|Withdrawal by Subject|0
1355671|NCT01703091|4469294|P1|Overall Study|Withdrawal by Subject|1
1355672|NCT01703091|4469293|P2|Overall Study|Physician Decision|1
1355673|NCT01703091|4469294|P1|Overall Study|Physician Decision|2
1355674|NCT01703091|4469293|P2|Overall Study|Adverse Event|3
1355675|NCT01703091|4469294|P1|Overall Study|Adverse Event|5
1355676|NCT01703000|4469310|P1|Overall Study|Death|1
1355677|NCT01702987|4469343|P2|Overall Study|Withdrawal by Subject|0
1355678|NCT01702987|4469344|P1|Overall Study|Withdrawal by Subject|1
1355679|NCT01702961|4469350|P1|Overall Study|Ongoing|11
1355680|NCT01702961|4469350|P1|Overall Study|Lost to Follow-up|2
1355681|NCT01702961|4469350|P1|Overall Study|Death|6
1355682|NCT01702961|4469350|P1|Overall Study|Relapse|20
1355683|NCT01702961|4469350|P1|Overall Study|Progressive disease|5
1355684|NCT01702961|4469350|P1|Overall Study|Additional treatment|3
1355685|NCT01702532|4469370|P2|Overall Study|Adverse Event|1
1355686|NCT01702532|4469371|P1|Overall Study|Adverse Event|0
1355687|NCT01702519|4469381|P2|Washout Period|Withdrawal by Subject|2
1355688|NCT01702519|4469382|P1|Washout Period|Withdrawal by Subject|0
1355689|NCT01702519|4469381|P2|Washout Period|Lost to Follow-up|0
1355690|NCT01702519|4469382|P1|Washout Period|Lost to Follow-up|1
1355691|NCT01702454|4469400|P2|Overall Study|Lost to Follow-up|6
1355692|NCT01702454|4469401|P1|Overall Study|Lost to Follow-up|3
1355693|NCT01702454|4469400|P2|Overall Study|Migrated/moved from study area|1
1355694|NCT01702454|4469401|P1|Overall Study|Migrated/moved from study area|0
1355695|NCT01702454|4469400|P2|Overall Study|Consent withdrawal|1
1355696|NCT01702454|4469401|P1|Overall Study|Consent withdrawal|0
1355697|NCT01702428|4469483|P4|Overall Study|Withdrawal by Subject|10
1355698|NCT01702428|4469484|P3|Overall Study|Withdrawal by Subject|14
1355699|NCT01702428|4469485|P2|Overall Study|Withdrawal by Subject|23
1355700|NCT01702428|4469486|P1|Overall Study|Withdrawal by Subject|21
1355701|NCT01702428|4469483|P4|Overall Study|Protocol Violation|0
1355702|NCT01702428|4469484|P3|Overall Study|Protocol Violation|1
1355703|NCT01702428|4469485|P2|Overall Study|Protocol Violation|0
1355704|NCT01702428|4469486|P1|Overall Study|Protocol Violation|3
1355705|NCT01702428|4469483|P4|Overall Study|Parents too busy|0
1355706|NCT01702428|4469484|P3|Overall Study|Parents too busy|0
1355707|NCT01702428|4469485|P2|Overall Study|Parents too busy|0
1355708|NCT01702428|4469486|P1|Overall Study|Parents too busy|1
1355709|NCT01702428|4469483|P4|Overall Study|Mother transferred care|0
1355710|NCT01702428|4469484|P3|Overall Study|Mother transferred care|0
1355711|NCT01702428|4469485|P2|Overall Study|Mother transferred care|1
1355712|NCT01702428|4469486|P1|Overall Study|Mother transferred care|0
1355713|NCT01702428|4469483|P4|Overall Study|Lost Health Plan|2
1355714|NCT01702428|4469484|P3|Overall Study|Lost Health Plan|0
1355715|NCT01702428|4469485|P2|Overall Study|Lost Health Plan|5
1355716|NCT01702428|4469486|P1|Overall Study|Lost Health Plan|3
1355717|NCT01702428|4469483|P4|Overall Study|Lost Coverage|1
1355718|NCT01702428|4469484|P3|Overall Study|Lost Coverage|0
1355719|NCT01702428|4469485|P2|Overall Study|Lost Coverage|0
1355720|NCT01702428|4469486|P1|Overall Study|Lost Coverage|0
1355721|NCT01702428|4469483|P4|Overall Study|Parents cannot assist to site|0
1355722|NCT01702428|4469484|P3|Overall Study|Parents cannot assist to site|1
1355723|NCT01702428|4469485|P2|Overall Study|Parents cannot assist to site|0
1355724|NCT01702428|4469486|P1|Overall Study|Parents cannot assist to site|1
1355725|NCT01702428|4469483|P4|Overall Study|Lost to Follow-up|44
1355726|NCT01702428|4469484|P3|Overall Study|Lost to Follow-up|37
1355727|NCT01702428|4469485|P2|Overall Study|Lost to Follow-up|41
1355728|NCT01702428|4469486|P1|Overall Study|Lost to Follow-up|33
1355729|NCT01702428|4469483|P4|Overall Study|Adverse Event|0
1355730|NCT01702428|4469484|P3|Overall Study|Adverse Event|0
1355731|NCT01702428|4469485|P2|Overall Study|Adverse Event|0
1355732|NCT01702428|4469486|P1|Overall Study|Adverse Event|2
1355733|NCT01702363|4469573|P1|Overall Study|Withdrawal by Subject|2
1355734|NCT01702363|4469573|P1|Overall Study|Lack of Efficacy|4
1355735|NCT01702363|4469573|P1|Overall Study|Adverse Event|14
1355736|NCT01702311|4469590|P2|Overall Study|Physician Decision|4
1355737|NCT01702311|4469591|P1|Overall Study|Physician Decision|3
1355738|NCT01702311|4469590|P2|Overall Study|Discharge less than 24 hours|7
1355739|NCT01702311|4469591|P1|Overall Study|Discharge less than 24 hours|10
1355740|NCT01702311|4469590|P2|Overall Study|Withdrawal by Subject|2
1355741|NCT01702311|4469591|P1|Overall Study|Withdrawal by Subject|3
1355742|NCT01702298|4469621|P1|Overall Study|Withdrawal by Subject|1
1355743|NCT01702246|4469649|P1|Overall Study|Physician Decision|1
1355744|NCT01702246|4469649|P1|Overall Study|Withdrawal by Subject|2
1355745|NCT01702246|4469649|P1|Overall Study|Lost to Follow-up|2
1355746|NCT01702025|4469703|P4|Overall Study|Adverse Event|0
1355747|NCT01702025|4469704|P3|Overall Study|Adverse Event|1
1355748|NCT01702025|4469705|P2|Overall Study|Adverse Event|1
1355749|NCT01702025|4469706|P1|Overall Study|Adverse Event|1
1355750|NCT01702025|4469703|P4|Overall Study|Equipment failure|0
1355751|NCT01702025|4469704|P3|Overall Study|Equipment failure|0
1355752|NCT01702025|4469705|P2|Overall Study|Equipment failure|0
1355753|NCT01702025|4469706|P1|Overall Study|Equipment failure|1
1355754|NCT01701973|4469735|P8|Aim 1: First Intervention (1 Day)|Adverse Event|0
1355755|NCT01701973|4469736|P7|Aim 1: First Intervention (1 Day)|Adverse Event|0
1355756|NCT01701973|4469737|P6|Aim 1: First Intervention (1 Day)|Adverse Event|0
1355757|NCT01701973|4469738|P5|Aim 1: First Intervention (1 Day)|Adverse Event|0
1355758|NCT01701973|4469739|P4|Aim 1: First Intervention (1 Day)|Adverse Event|0
1355759|NCT01701973|4469740|P3|Aim 1: First Intervention (1 Day)|Adverse Event|0
1355760|NCT01701973|4469741|P2|Aim 1: First Intervention (1 Day)|Adverse Event|1
1355761|NCT01701973|4469742|P1|Aim 1: First Intervention (1 Day)|Adverse Event|0
1355762|NCT01701674|4469789|P1|Overall Study|Unable to safely complete treatment|1
1355763|NCT01701401|4469875|P4|Overall Study|Protocol Violation|0
1355764|NCT01701401|4469876|P3|Overall Study|Protocol Violation|1
1355765|NCT01701401|4469877|P2|Overall Study|Protocol Violation|0
1355766|NCT01701401|4469878|P1|Overall Study|Protocol Violation|0
1355767|NCT01701401|4469875|P4|Overall Study|Adverse Event|0
1355768|NCT01701401|4469876|P3|Overall Study|Adverse Event|0
1355769|NCT01701401|4469877|P2|Overall Study|Adverse Event|0
1355770|NCT01701401|4469878|P1|Overall Study|Adverse Event|1
1355771|NCT01701401|4469875|P4|Overall Study|Lack of Efficacy|0
1355772|NCT01701401|4469876|P3|Overall Study|Lack of Efficacy|2
1355773|NCT01701401|4469877|P2|Overall Study|Lack of Efficacy|0
1355774|NCT01701401|4469878|P1|Overall Study|Lack of Efficacy|1
1355775|NCT01701401|4469875|P4|Overall Study|Withdrew Consent|2
1355776|NCT01701401|4469876|P3|Overall Study|Withdrew Consent|1
1355777|NCT01701401|4469877|P2|Overall Study|Withdrew Consent|3
1355778|NCT01701401|4469878|P1|Overall Study|Withdrew Consent|0
1355779|NCT01701401|4469875|P4|Overall Study|Lost to Follow-up|3
1355780|NCT01701401|4469876|P3|Overall Study|Lost to Follow-up|1
1355781|NCT01701401|4469877|P2|Overall Study|Lost to Follow-up|5
1355782|NCT01701401|4469878|P1|Overall Study|Lost to Follow-up|5
1355783|NCT01701401|4469875|P4|Overall Study|Randomized But Not Treated|1
1355784|NCT01701401|4469876|P3|Overall Study|Randomized But Not Treated|0
1355785|NCT01701401|4469877|P2|Overall Study|Randomized But Not Treated|1
1355786|NCT01701401|4469878|P1|Overall Study|Randomized But Not Treated|3
1355787|NCT01701362|4469930|P2|Overall Study|Reasons other than those mentioned above|5
1355788|NCT01701362|4469931|P1|Overall Study|Reasons other than those mentioned above|3
1355789|NCT01701362|4469930|P2|Overall Study|Randomized but not treated|2
1355790|NCT01701362|4469931|P1|Overall Study|Randomized but not treated|1
1355791|NCT01701362|4469930|P2|Overall Study|Death|1
1355792|NCT01701362|4469931|P1|Overall Study|Death|0
1355793|NCT01701362|4469930|P2|Overall Study|Insufficient clinical response|6
1355794|NCT01701362|4469931|P1|Overall Study|Insufficient clinical response|6
1355795|NCT01701362|4469930|P2|Overall Study|Lost to Follow-up|9
1355796|NCT01701362|4469931|P1|Overall Study|Lost to Follow-up|6
1355797|NCT01701362|4469930|P2|Overall Study|No longer willing to participate|14
1355798|NCT01701362|4469931|P1|Overall Study|No longer willing to participate|8
1355799|NCT01701362|4469930|P2|Overall Study|Protocol Violation|3
1355800|NCT01701362|4469931|P1|Overall Study|Protocol Violation|5
1355801|NCT01701362|4469930|P2|Overall Study|Adverse events related to study drug|10
1355802|NCT01701362|4469931|P1|Overall Study|Adverse events related to study drug|12
1355803|NCT01701362|4469930|P2|Overall Study|Adverse events not related to study drug|6
1355804|NCT01701362|4469931|P1|Overall Study|Adverse events not related to study drug|1
1355805|NCT01701258|4469969|P13|Assessment and Scheduling|Investigator Terminated|0
1355806|NCT01701258|4469970|P12|Assessment and Scheduling|Investigator Terminated|0
1355807|NCT01701258|4469971|P11|Assessment and Scheduling|Investigator Terminated|0
1355808|NCT01701258|4469972|P10|Assessment and Scheduling|Investigator Terminated|0
1355809|NCT01701258|4469973|P9|Assessment and Scheduling|Investigator Terminated|0
1355810|NCT01701258|4469974|P8|Assessment and Scheduling|Investigator Terminated|0
1355811|NCT01701258|4469975|P7|Assessment and Scheduling|Investigator Terminated|0
1355812|NCT01701258|4469976|P6|Assessment and Scheduling|Investigator Terminated|0
1355813|NCT01701258|4469977|P5|Assessment and Scheduling|Investigator Terminated|0
1355814|NCT01701258|4469978|P4|Assessment and Scheduling|Investigator Terminated|0
1355815|NCT01701258|4469979|P3|Assessment and Scheduling|Investigator Terminated|0
1355816|NCT01701258|4469980|P2|Assessment and Scheduling|Investigator Terminated|0
1355817|NCT01701258|4469981|P1|Assessment and Scheduling|Investigator Terminated|2
1355818|NCT01701258|4469969|P13|Assessment and Scheduling|Withdrawal by Subject|0
1355819|NCT01701258|4469970|P12|Assessment and Scheduling|Withdrawal by Subject|0
1355820|NCT01701258|4469971|P11|Assessment and Scheduling|Withdrawal by Subject|0
1355821|NCT01701258|4469972|P10|Assessment and Scheduling|Withdrawal by Subject|0
1355822|NCT01701258|4469973|P9|Assessment and Scheduling|Withdrawal by Subject|0
1355823|NCT01701258|4469974|P8|Assessment and Scheduling|Withdrawal by Subject|0
1355824|NCT01701258|4469975|P7|Assessment and Scheduling|Withdrawal by Subject|0
1355825|NCT01701258|4469976|P6|Assessment and Scheduling|Withdrawal by Subject|0
1355826|NCT01701258|4469977|P5|Assessment and Scheduling|Withdrawal by Subject|0
1355827|NCT01701258|4469978|P4|Assessment and Scheduling|Withdrawal by Subject|0
1355828|NCT01701258|4469979|P3|Assessment and Scheduling|Withdrawal by Subject|0
1355829|NCT01701258|4469980|P2|Assessment and Scheduling|Withdrawal by Subject|0
1355830|NCT01701258|4469981|P1|Assessment and Scheduling|Withdrawal by Subject|14
1355831|NCT01701258|4469969|P13|Assessment and Scheduling|Lost to Follow-up|0
1355832|NCT01701258|4469970|P12|Assessment and Scheduling|Lost to Follow-up|0
1355833|NCT01701258|4469971|P11|Assessment and Scheduling|Lost to Follow-up|0
1355834|NCT01701258|4469972|P10|Assessment and Scheduling|Lost to Follow-up|0
1355835|NCT01701258|4469973|P9|Assessment and Scheduling|Lost to Follow-up|0
1355836|NCT01701258|4469974|P8|Assessment and Scheduling|Lost to Follow-up|0
1355837|NCT01701258|4469975|P7|Assessment and Scheduling|Lost to Follow-up|0
1355838|NCT01701258|4469976|P6|Assessment and Scheduling|Lost to Follow-up|0
1355839|NCT01701258|4469977|P5|Assessment and Scheduling|Lost to Follow-up|0
1355840|NCT01701258|4469978|P4|Assessment and Scheduling|Lost to Follow-up|0
1355841|NCT01701258|4469979|P3|Assessment and Scheduling|Lost to Follow-up|0
1355842|NCT01701258|4469980|P2|Assessment and Scheduling|Lost to Follow-up|0
1355843|NCT01701258|4469981|P1|Assessment and Scheduling|Lost to Follow-up|10
1355844|NCT01701258|4469969|P13|Assessment and Scheduling|Found to be Ineligible|0
1355845|NCT01701258|4469970|P12|Assessment and Scheduling|Found to be Ineligible|0
1355846|NCT01701258|4469971|P11|Assessment and Scheduling|Found to be Ineligible|0
1355847|NCT01701258|4469972|P10|Assessment and Scheduling|Found to be Ineligible|0
1355848|NCT01701258|4469973|P9|Assessment and Scheduling|Found to be Ineligible|0
1355849|NCT01701258|4469974|P8|Assessment and Scheduling|Found to be Ineligible|0
1355850|NCT01701258|4469975|P7|Assessment and Scheduling|Found to be Ineligible|0
1355851|NCT01701258|4469976|P6|Assessment and Scheduling|Found to be Ineligible|0
1355852|NCT01701258|4469977|P5|Assessment and Scheduling|Found to be Ineligible|0
1355853|NCT01701258|4469978|P4|Assessment and Scheduling|Found to be Ineligible|0
1355854|NCT01701258|4469979|P3|Assessment and Scheduling|Found to be Ineligible|0
1355855|NCT01701258|4469980|P2|Assessment and Scheduling|Found to be Ineligible|0
1355856|NCT01701258|4469981|P1|Assessment and Scheduling|Found to be Ineligible|57
1355857|NCT01701245|4470035|P2|Overall Study|Did not complete the open label period|12
1355858|NCT01701245|4470036|P1|Overall Study|Did not complete the open label period|11
1355859|NCT01701245|4470035|P2|Overall Study|Protocol Violation|3
1355860|NCT01701245|4470036|P1|Overall Study|Protocol Violation|1
1355861|NCT01701063|4470083|P3|Overall Study|Other|1
1355862|NCT01701063|4470084|P2|Overall Study|Other|0
1355863|NCT01701063|4470085|P1|Overall Study|Other|0
1355864|NCT01701063|4470083|P3|Overall Study|Withdrawal by Subject|1
1355865|NCT01701063|4470084|P2|Overall Study|Withdrawal by Subject|0
1355866|NCT01701063|4470085|P1|Overall Study|Withdrawal by Subject|0
1355867|NCT01701063|4470083|P3|Overall Study|Lost to Follow-up|0
1355868|NCT01701063|4470084|P2|Overall Study|Lost to Follow-up|1
1355869|NCT01701063|4470085|P1|Overall Study|Lost to Follow-up|0
1355870|NCT01700959|4470173|P6|Overall Study|Side effects|1
1355871|NCT01700959|4470174|P5|Overall Study|Side effects|4
1355872|NCT01700959|4470175|P4|Overall Study|Side effects|4
1355873|NCT01700959|4470176|P3|Overall Study|Side effects|8
1355874|NCT01700959|4470177|P2|Overall Study|Side effects|4
1355875|NCT01700959|4470178|P1|Overall Study|Side effects|1
1355876|NCT01700959|4470173|P6|Overall Study|Noncompliant|9
1355877|NCT01700959|4470174|P5|Overall Study|Noncompliant|15
1355878|NCT01700959|4470175|P4|Overall Study|Noncompliant|18
1355879|NCT01700959|4470176|P3|Overall Study|Noncompliant|17
1355880|NCT01700959|4470177|P2|Overall Study|Noncompliant|9
1355881|NCT01700959|4470178|P1|Overall Study|Noncompliant|9
1355882|NCT01700959|4470173|P6|Overall Study|Ineligible|1
1355883|NCT01700959|4470174|P5|Overall Study|Ineligible|0
1355884|NCT01700959|4470175|P4|Overall Study|Ineligible|0
1355885|NCT01700959|4470176|P3|Overall Study|Ineligible|2
1355886|NCT01700959|4470177|P2|Overall Study|Ineligible|1
1355887|NCT01700959|4470178|P1|Overall Study|Ineligible|2
1355888|NCT01700959|4470173|P6|Overall Study|Withdrawal by Subject|12
1355889|NCT01700959|4470174|P5|Overall Study|Withdrawal by Subject|8
1355890|NCT01700959|4470175|P4|Overall Study|Withdrawal by Subject|11
1355891|NCT01700959|4470176|P3|Overall Study|Withdrawal by Subject|12
1355892|NCT01700959|4470177|P2|Overall Study|Withdrawal by Subject|9
1355893|NCT01700959|4470178|P1|Overall Study|Withdrawal by Subject|15
1355894|NCT01700959|4470173|P6|Overall Study|Adverse Event|2
1355895|NCT01700959|4470174|P5|Overall Study|Adverse Event|0
1355896|NCT01700959|4470175|P4|Overall Study|Adverse Event|2
1355897|NCT01700959|4470176|P3|Overall Study|Adverse Event|1
1355898|NCT01700959|4470177|P2|Overall Study|Adverse Event|1
1355899|NCT01700959|4470178|P1|Overall Study|Adverse Event|0
1355900|NCT01700530|4470249|P3|Overall Study|Withdrawal by Subject|1
1355901|NCT01700530|4470250|P2|Overall Study|Withdrawal by Subject|3
1355902|NCT01700530|4470251|P1|Overall Study|Withdrawal by Subject|0
1355903|NCT01700387|4470300|P2|Overall Study|Lost to Follow-up|1
1355904|NCT01700387|4470301|P1|Overall Study|Lost to Follow-up|2
1355905|NCT01700387|4470300|P2|Overall Study|Adverse Event|1
1355906|NCT01700387|4470301|P1|Overall Study|Adverse Event|1
1355907|NCT01700387|4470300|P2|Overall Study|Withdrawal by Subject|2
1355908|NCT01700387|4470301|P1|Overall Study|Withdrawal by Subject|1
1355909|NCT01700348|4470311|P1|Overall Study|Lost to Follow-up|1
1355910|NCT01700348|4470311|P1|Overall Study|Withdrawal by Subject|22
1355911|NCT01700192|4470329|P2|Overall Study|Never received study drug|0
1355912|NCT01700192|4470330|P1|Overall Study|Never received study drug|1
1355913|NCT01700192|4470329|P2|Overall Study|Withdrawal by Subject|64
1355914|NCT01700192|4470330|P1|Overall Study|Withdrawal by Subject|56
1355915|NCT01700192|4470329|P2|Overall Study|Technical problems|1
1355916|NCT01700192|4470330|P1|Overall Study|Technical problems|0
1355917|NCT01700192|4470329|P2|Overall Study|Protocol Violation|4
1355918|NCT01700192|4470330|P1|Overall Study|Protocol Violation|3
1355919|NCT01700192|4470329|P2|Overall Study|Progressive disease|0
1355920|NCT01700192|4470330|P1|Overall Study|Progressive disease|1
1355921|NCT01700192|4470329|P2|Overall Study|Pregnancy|4
1355922|NCT01700192|4470330|P1|Overall Study|Pregnancy|1
1355923|NCT01700192|4470329|P2|Overall Study|Physician Decision|3
1355924|NCT01700192|4470330|P1|Overall Study|Physician Decision|2
1355925|NCT01700192|4470329|P2|Overall Study|Noncompliance with study drug|5
1355926|NCT01700192|4470330|P1|Overall Study|Noncompliance with study drug|0
1355927|NCT01700192|4470329|P2|Overall Study|Lost to Follow-up|29
1355928|NCT01700192|4470330|P1|Overall Study|Lost to Follow-up|42
1355929|NCT01700192|4470329|P2|Overall Study|Lack of Efficacy|0
1355930|NCT01700192|4470330|P1|Overall Study|Lack of Efficacy|1
1355931|NCT01700192|4470329|P2|Overall Study|Adverse Event|18
1355932|NCT01700192|4470330|P1|Overall Study|Adverse Event|73
1355933|NCT01700179|4470348|P1|Overall Study|Physician Decision|2
1355934|NCT01700140|4470355|P3|Overall Study|Inclusion/exclusion criteria deviation|0
1355935|NCT01700140|4470356|P2|Overall Study|Inclusion/exclusion criteria deviation|4
1355936|NCT01700140|4470357|P1|Overall Study|Inclusion/exclusion criteria deviation|1
1355937|NCT01700140|4470355|P3|Overall Study|Adverse Event|0
1355938|NCT01700140|4470356|P2|Overall Study|Adverse Event|1
1355939|NCT01700140|4470357|P1|Overall Study|Adverse Event|0
1355940|NCT01700140|4470355|P3|Overall Study|Aggravation of symptoms|0
1355941|NCT01700140|4470356|P2|Overall Study|Aggravation of symptoms|0
1355942|NCT01700140|4470357|P1|Overall Study|Aggravation of symptoms|1
1355943|NCT01700140|4470355|P3|Overall Study|Use of chemotherapy or surgical therapy|0
1355944|NCT01700140|4470356|P2|Overall Study|Use of chemotherapy or surgical therapy|1
1355945|NCT01700140|4470357|P1|Overall Study|Use of chemotherapy or surgical therapy|0
1355946|NCT01700140|4470355|P3|Overall Study|Discontinuation of radiotherapy|0
1355947|NCT01700140|4470356|P2|Overall Study|Discontinuation of radiotherapy|0
1355948|NCT01700140|4470357|P1|Overall Study|Discontinuation of radiotherapy|1
1355949|NCT01700140|4470355|P3|Overall Study|Use of rescue drugs|1
1355950|NCT01700140|4470356|P2|Overall Study|Use of rescue drugs|3
1355951|NCT01700140|4470357|P1|Overall Study|Use of rescue drugs|3
1355952|NCT01699867|4470398|P1|Overall Study|Screening Failure|3
1355953|NCT01699815|4470405|P2|Overall Study|Adverse Event|1
1355954|NCT01699815|4470406|P1|Overall Study|Adverse Event|0
1355955|NCT01699815|4470405|P2|Overall Study|record could not be located|0
1355956|NCT01699815|4470406|P1|Overall Study|record could not be located|1
1355957|NCT01699815|4470405|P2|Overall Study|Protocol Violation|7
1355958|NCT01699815|4470406|P1|Overall Study|Protocol Violation|4
1355959|NCT01699789|4470418|P2|Overall Study|Lost to Follow-up|101
1355960|NCT01699789|4470419|P1|Overall Study|Lost to Follow-up|83
1355961|NCT01699789|4470418|P2|Overall Study|Death|2
1355962|NCT01699789|4470419|P1|Overall Study|Death|1
1355963|NCT01699789|4470418|P2|Overall Study|Withdrawal by Subject|23
1355964|NCT01699789|4470419|P1|Overall Study|Withdrawal by Subject|18
1355965|NCT01699750|4470489|P2|Overall Study|Other|2
1355966|NCT01699750|4470490|P1|Overall Study|Other|0
1355967|NCT01699750|4470489|P2|Overall Study|Withdrew Consent|1
1355968|NCT01699750|4470490|P1|Overall Study|Withdrew Consent|0
1355969|NCT01699685|4470525|P2|Period 2|Lost to Follow-up|0
1355970|NCT01699685|4470526|P1|Period 2|Lost to Follow-up|1
1355971|NCT01699685|4470525|P2|Period 1|Patient request|1
1355972|NCT01699685|4470526|P1|Period 1|Patient request|0
1355973|NCT01699685|4470525|P2|Period 1|Other|1
1355974|NCT01699685|4470526|P1|Period 1|Other|0
1355975|NCT01699685|4470525|P2|Period 1|Medical or ethical, noncompliance|0
1355976|NCT01699685|4470526|P1|Period 1|Medical or ethical, noncompliance|2
1355977|NCT01699685|4470525|P2|Period 1|Adverse Event|1
1355978|NCT01699685|4470526|P1|Period 1|Adverse Event|1
1355979|NCT01699087|4470559|P1|Overall Study|Unable to make future visits|2
1355980|NCT01699087|4470559|P1|Overall Study|Screen failure (prior to treatment)|15
1355981|NCT01699087|4470559|P1|Overall Study|Lost to Follow-up|7
1355982|NCT01699022|4470573|P1|Overall Study|Early discontinuation from the study|3
1355983|NCT01698814|4470588|P2|Overall Study|Randomized in error|0
1355984|NCT01698814|4470589|P1|Overall Study|Randomized in error|1
1355985|NCT01698814|4470588|P2|Overall Study|Pregnancy|0
1355986|NCT01698814|4470589|P1|Overall Study|Pregnancy|1
1355987|NCT01698814|4470588|P2|Overall Study|Lost to Follow-up|1
1355988|NCT01698814|4470589|P1|Overall Study|Lost to Follow-up|0
1355989|NCT01698814|4470588|P2|Overall Study|Adverse Event|2
1355990|NCT01698814|4470589|P1|Overall Study|Adverse Event|0
1355991|NCT01698801|4470595|P1|Follow Up Phase|Death|4
1355992|NCT01698801|4470595|P1|Follow Up Phase|Withdrawal by Subject|1
1355993|NCT01698801|4470595|P1|Treatment Phase|Disease progression|1
1355994|NCT01698801|4470595|P1|Treatment Phase|Withdrawal by Subject|1
1355995|NCT01698801|4470595|P1|Treatment Phase|Not specified|4
1355996|NCT01698801|4470595|P1|Treatment Phase|Protocol Violation|1
1355997|NCT01698801|4470595|P1|Treatment Phase|Adverse Event|4
1355998|NCT01698775|4470606|P2|Phase B|Withdrawal by Subject|2
1355999|NCT01698775|4470607|P1|Phase B|Withdrawal by Subject|6
1356000|NCT01698775|4470606|P2|Phase B|Protocol Violation|1
1356001|NCT01698775|4470607|P1|Phase B|Protocol Violation|1
1356002|NCT01698775|4470606|P2|Phase B|Physician Decision|1
1356003|NCT01698775|4470607|P1|Phase B|Physician Decision|1
1356004|NCT01698775|4470606|P2|Phase B|Lost to Follow-up|1
1356005|NCT01698775|4470607|P1|Phase B|Lost to Follow-up|0
1356006|NCT01698775|4470606|P2|Phase B|Lack of Efficacy|1
1356007|NCT01698775|4470607|P1|Phase B|Lack of Efficacy|0
1356008|NCT01698775|4470606|P2|Phase B|Death|1
1356009|NCT01698775|4470607|P1|Phase B|Death|0
1356010|NCT01698775|4470606|P2|Phase B|Adverse Event|3
1356011|NCT01698775|4470607|P1|Phase B|Adverse Event|6
1356012|NCT01698775|4470606|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
1356013|NCT01698775|4470607|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
1356014|NCT01698775|4470606|P2|Phase A|Kidney [transplant]|1
1356015|NCT01698775|4470607|P1|Phase A|Kidney [transplant]|0
1356016|NCT01698775|4470606|P2|Phase A|Withdrawal by Subject|4
1356017|NCT01698775|4470607|P1|Phase A|Withdrawal by Subject|3
1356018|NCT01698775|4470606|P2|Phase A|Protocol Violation|0
1356019|NCT01698775|4470607|P1|Phase A|Protocol Violation|1
1356020|NCT01698775|4470606|P2|Phase A|Lost to Follow-up|2
1356021|NCT01698775|4470607|P1|Phase A|Lost to Follow-up|1
1356022|NCT01698775|4470606|P2|Phase A|Lack of Efficacy|0
1356023|NCT01698775|4470607|P1|Phase A|Lack of Efficacy|1
1356024|NCT01698775|4470606|P2|Phase A|Death|1
1356025|NCT01698775|4470607|P1|Phase A|Death|1
1356026|NCT01698775|4470606|P2|Phase A|Adverse Event|1
1356027|NCT01698775|4470607|P1|Phase A|Adverse Event|2
1356028|NCT01698554|4470656|P4|Overall Study|Other Miscellaneous Reasons|0
1356029|NCT01698554|4470657|P3|Overall Study|Other Miscellaneous Reasons|0
1356030|NCT01698554|4470658|P2|Overall Study|Other Miscellaneous Reasons|0
1356031|NCT01698554|4470659|P1|Overall Study|Other Miscellaneous Reasons|1
1356032|NCT01698554|4470656|P4|Overall Study|Protocol Violation|0
1356033|NCT01698554|4470657|P3|Overall Study|Protocol Violation|1
1356034|NCT01698554|4470658|P2|Overall Study|Protocol Violation|0
1356035|NCT01698554|4470659|P1|Overall Study|Protocol Violation|2
1356036|NCT01698554|4470656|P4|Overall Study|Personal Reasons|1
1356037|NCT01698554|4470657|P3|Overall Study|Personal Reasons|1
1356038|NCT01698554|4470658|P2|Overall Study|Personal Reasons|5
1356039|NCT01698554|4470659|P1|Overall Study|Personal Reasons|0
1356040|NCT01698554|4470656|P4|Overall Study|Lost to Follow-up|0
1356041|NCT01698554|4470657|P3|Overall Study|Lost to Follow-up|0
1356042|NCT01698554|4470658|P2|Overall Study|Lost to Follow-up|0
1356043|NCT01698554|4470659|P1|Overall Study|Lost to Follow-up|1
1356044|NCT01698554|4470656|P4|Overall Study|Adverse Event|1
1356045|NCT01698554|4470657|P3|Overall Study|Adverse Event|0
1356046|NCT01698554|4470658|P2|Overall Study|Adverse Event|5
1356047|NCT01698554|4470659|P1|Overall Study|Adverse Event|2
1356048|NCT01698320|4470715|P3|40-Week Open-Label Period|Lost to Follow-up|0
1356049|NCT01698320|4470716|P2|40-Week Open-Label Period|Lost to Follow-up|2
1356050|NCT01698320|4470717|P1|40-Week Open-Label Period|Lost to Follow-up|0
1356051|NCT01698320|4470715|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
1356052|NCT01698320|4470716|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
1356053|NCT01698320|4470717|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
1356054|NCT01698320|4470715|P3|40-Week Open-Label Period|Pregnancy|1
1356055|NCT01698320|4470716|P2|40-Week Open-Label Period|Pregnancy|2
1356056|NCT01698320|4470717|P1|40-Week Open-Label Period|Pregnancy|0
1356057|NCT01698320|4470715|P3|40-Week Open-Label Period|Withdrawal by Subject|7
1356058|NCT01698320|4470716|P2|40-Week Open-Label Period|Withdrawal by Subject|11
1356059|NCT01698320|4470717|P1|40-Week Open-Label Period|Withdrawal by Subject|0
1356060|NCT01698320|4470715|P3|40-Week Open-Label Period|Adverse Event|2
1356061|NCT01698320|4470716|P2|40-Week Open-Label Period|Adverse Event|3
1356062|NCT01698320|4470717|P1|40-Week Open-Label Period|Adverse Event|0
1356063|NCT01698320|4470715|P3|12-Week Double-Blind Period|Lost to Follow-up|4
1356064|NCT01698320|4470716|P2|12-Week Double-Blind Period|Lost to Follow-up|0
1356065|NCT01698320|4470717|P1|12-Week Double-Blind Period|Lost to Follow-up|0
1356066|NCT01698320|4470715|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
1356067|NCT01698320|4470716|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
1356068|NCT01698320|4470717|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
1356069|NCT01698320|4470715|P3|12-Week Double-Blind Period|Pregnancy|1
1356070|NCT01698320|4470716|P2|12-Week Double-Blind Period|Pregnancy|1
1356071|NCT01698320|4470717|P1|12-Week Double-Blind Period|Pregnancy|0
1356072|NCT01698320|4470715|P3|12-Week Double-Blind Period|Protocol Violation|2
1356073|NCT01698320|4470716|P2|12-Week Double-Blind Period|Protocol Violation|0
1356074|NCT01698320|4470717|P1|12-Week Double-Blind Period|Protocol Violation|0
1356075|NCT01698320|4470715|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
1356076|NCT01698320|4470716|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
1356077|NCT01698320|4470717|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
1356078|NCT01698320|4470715|P3|12-Week Double-Blind Period|Adverse Event|1
1356079|NCT01698320|4470716|P2|12-Week Double-Blind Period|Adverse Event|1
1356080|NCT01698320|4470717|P1|12-Week Double-Blind Period|Adverse Event|0
1356081|NCT01698320|4470715|P3|Run-In Period (Week -1 to Day 0)|Not specified|0
1356082|NCT01698320|4470716|P2|Run-In Period (Week -1 to Day 0)|Not specified|0
1356083|NCT01698320|4470717|P1|Run-In Period (Week -1 to Day 0)|Not specified|1
1356084|NCT01698320|4470715|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
1356085|NCT01698320|4470716|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
1356086|NCT01698320|4470717|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
1356087|NCT01698320|4470715|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
1356088|NCT01698320|4470716|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
1356089|NCT01698320|4470717|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
1356169|NCT01697592|4470824|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
1356090|NCT01698320|4470715|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
1356091|NCT01698320|4470716|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
1356092|NCT01698320|4470717|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
1356093|NCT01698268|4470737|P2|Overall Study|Physician Decision|1
1356094|NCT01698268|4470738|P1|Overall Study|Physician Decision|2
1356095|NCT01697969|4470744|P1|Overall Study|Did not meet inc/exc criteria|3
1356096|NCT01697956|4470751|P2|Overall Study|Protocol Violation|1
1356097|NCT01697956|4470752|P1|Overall Study|Protocol Violation|1
1356098|NCT01697696|4470782|P2|Overall Study|Subject/guardian decision|35
1356099|NCT01697696|4470783|P1|Overall Study|Subject/guardian decision|31
1356100|NCT01697696|4470782|P2|Overall Study|Lost to Follow-up|7
1356101|NCT01697696|4470783|P1|Overall Study|Lost to Follow-up|10
1356102|NCT01697696|4470782|P2|Overall Study|Death|2
1356103|NCT01697696|4470783|P1|Overall Study|Death|4
1356104|NCT01697696|4470782|P2|Overall Study|Physician Decision|0
1356105|NCT01697696|4470783|P1|Overall Study|Physician Decision|1
1356106|NCT01697696|4470782|P2|Overall Study|Protocol deviation|0
1356107|NCT01697696|4470783|P1|Overall Study|Protocol deviation|1
1356108|NCT01697696|4470782|P2|Overall Study|Study terminated by sponsor|3
1356109|NCT01697696|4470783|P1|Overall Study|Study terminated by sponsor|0
1356110|NCT01697592|4470815|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
1356111|NCT01697592|4470816|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
1356112|NCT01697592|4470817|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
1356113|NCT01697592|4470818|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
1356114|NCT01697592|4470819|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
1356115|NCT01697592|4470820|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
1356116|NCT01697592|4470821|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
1356117|NCT01697592|4470822|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
1356118|NCT01697592|4470823|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
1356119|NCT01697592|4470824|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
1356120|NCT01697592|4470815|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1356121|NCT01697592|4470816|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1356122|NCT01697592|4470817|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
1356123|NCT01697592|4470818|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1356124|NCT01697592|4470819|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
1356125|NCT01697592|4470820|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1356126|NCT01697592|4470821|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1356127|NCT01697592|4470822|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1356128|NCT01697592|4470823|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1356129|NCT01697592|4470824|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
1356130|NCT01697592|4470815|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
1356131|NCT01697592|4470816|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
1356132|NCT01697592|4470817|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
1356133|NCT01697592|4470818|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
1356134|NCT01697592|4470819|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
1356135|NCT01697592|4470820|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
1356136|NCT01697592|4470821|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
1356137|NCT01697592|4470822|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
1356138|NCT01697592|4470823|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
1356139|NCT01697592|4470824|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
1356140|NCT01697592|4470815|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
1356141|NCT01697592|4470816|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
1356142|NCT01697592|4470817|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
1356143|NCT01697592|4470818|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
1356144|NCT01697592|4470819|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
1356145|NCT01697592|4470820|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
1356146|NCT01697592|4470821|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
1356147|NCT01697592|4470822|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
1356148|NCT01697592|4470823|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
1356149|NCT01697592|4470824|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
1356150|NCT01697592|4470815|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1356151|NCT01697592|4470816|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1356152|NCT01697592|4470817|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1356153|NCT01697592|4470818|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1356154|NCT01697592|4470819|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1356155|NCT01697592|4470820|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1356156|NCT01697592|4470821|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1356157|NCT01697592|4470822|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1356158|NCT01697592|4470823|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1356159|NCT01697592|4470824|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1356160|NCT01697592|4470815|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
1356161|NCT01697592|4470816|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
1356162|NCT01697592|4470817|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
1356163|NCT01697592|4470818|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
1356164|NCT01697592|4470819|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
1356165|NCT01697592|4470820|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
1356166|NCT01697592|4470821|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
1356167|NCT01697592|4470822|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
1356168|NCT01697592|4470823|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
1356170|NCT01697592|4470815|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
1356171|NCT01697592|4470816|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
1356172|NCT01697592|4470817|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
1356173|NCT01697592|4470818|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
1356174|NCT01697592|4470819|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
1356175|NCT01697592|4470820|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
1356176|NCT01697592|4470821|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
1356177|NCT01697592|4470822|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
1356178|NCT01697592|4470823|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
1356179|NCT01697592|4470824|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
1356180|NCT01697592|4470815|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1356181|NCT01697592|4470816|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1356182|NCT01697592|4470817|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1356183|NCT01697592|4470818|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1356184|NCT01697592|4470819|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1356185|NCT01697592|4470820|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1356186|NCT01697592|4470821|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1356187|NCT01697592|4470822|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1356188|NCT01697592|4470823|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1356189|NCT01697592|4470824|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
1356190|NCT01697579|4470893|P7|Optional Extension-Cycles 2-6|Lost to Follow-up|1
1356191|NCT01697579|4470894|P6|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1356192|NCT01697579|4470895|P5|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1356193|NCT01697579|4470896|P4|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1356194|NCT01697579|4470897|P3|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1356195|NCT01697579|4470898|P2|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1356196|NCT01697579|4470899|P1|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1356197|NCT01697579|4470893|P7|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
1356198|NCT01697579|4470894|P6|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
1356199|NCT01697579|4470895|P5|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1356200|NCT01697579|4470896|P4|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1356201|NCT01697579|4470897|P3|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1356202|NCT01697579|4470898|P2|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1356203|NCT01697579|4470899|P1|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1356204|NCT01697579|4470893|P7|Optional Extension-Cycles 2-6|Participant Moved|2
1356205|NCT01697579|4470894|P6|Optional Extension-Cycles 2-6|Participant Moved|0
1356206|NCT01697579|4470895|P5|Optional Extension-Cycles 2-6|Participant Moved|0
1356207|NCT01697579|4470896|P4|Optional Extension-Cycles 2-6|Participant Moved|0
1356208|NCT01697579|4470897|P3|Optional Extension-Cycles 2-6|Participant Moved|0
1356209|NCT01697579|4470898|P2|Optional Extension-Cycles 2-6|Participant Moved|0
1356210|NCT01697579|4470899|P1|Optional Extension-Cycles 2-6|Participant Moved|0
1356211|NCT01697579|4470893|P7|Optional Extension-Cycles 2-6|Technical Problems|1
1356212|NCT01697579|4470894|P6|Optional Extension-Cycles 2-6|Technical Problems|0
1356213|NCT01697579|4470895|P5|Optional Extension-Cycles 2-6|Technical Problems|0
1356214|NCT01697579|4470896|P4|Optional Extension-Cycles 2-6|Technical Problems|0
1356215|NCT01697579|4470897|P3|Optional Extension-Cycles 2-6|Technical Problems|0
1356216|NCT01697579|4470898|P2|Optional Extension-Cycles 2-6|Technical Problems|0
1356217|NCT01697579|4470899|P1|Optional Extension-Cycles 2-6|Technical Problems|0
1356218|NCT01697579|4470893|P7|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
1356219|NCT01697579|4470894|P6|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1356220|NCT01697579|4470895|P5|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1356221|NCT01697579|4470896|P4|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1356222|NCT01697579|4470897|P3|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1356223|NCT01697579|4470898|P2|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1356224|NCT01697579|4470899|P1|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1356225|NCT01697579|4470893|P7|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
1356226|NCT01697579|4470894|P6|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
1356227|NCT01697579|4470895|P5|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1356228|NCT01697579|4470896|P4|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1356229|NCT01697579|4470897|P3|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1356230|NCT01697579|4470898|P2|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1356231|NCT01697579|4470899|P1|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1356232|NCT01697579|4470893|P7|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
1356233|NCT01697579|4470894|P6|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
1356234|NCT01697579|4470895|P5|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1356235|NCT01697579|4470896|P4|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1356236|NCT01697579|4470897|P3|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1356237|NCT01697579|4470898|P2|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1356238|NCT01697579|4470899|P1|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1356239|NCT01697579|4470893|P7|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1356240|NCT01697579|4470894|P6|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
1356241|NCT01697579|4470895|P5|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1356242|NCT01697579|4470896|P4|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1356243|NCT01697579|4470897|P3|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1356244|NCT01697579|4470898|P2|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1356245|NCT01697579|4470899|P1|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1356246|NCT01697579|4470893|P7|Optional Extension-Cycles 2-6|Excluded Medication|2
1356247|NCT01697579|4470894|P6|Optional Extension-Cycles 2-6|Excluded Medication|1
1356248|NCT01697579|4470895|P5|Optional Extension-Cycles 2-6|Excluded Medication|0
1356249|NCT01697579|4470896|P4|Optional Extension-Cycles 2-6|Excluded Medication|0
1356250|NCT01697579|4470897|P3|Optional Extension-Cycles 2-6|Excluded Medication|0
1356251|NCT01697579|4470898|P2|Optional Extension-Cycles 2-6|Excluded Medication|0
1356252|NCT01697579|4470899|P1|Optional Extension-Cycles 2-6|Excluded Medication|0
1356253|NCT01697579|4470893|P7|Optional Extension-Cycles 2-6|Protocol Violation|4
1356254|NCT01697579|4470894|P6|Optional Extension-Cycles 2-6|Protocol Violation|0
1356255|NCT01697579|4470895|P5|Optional Extension-Cycles 2-6|Protocol Violation|0
1356256|NCT01697579|4470896|P4|Optional Extension-Cycles 2-6|Protocol Violation|0
1356257|NCT01697579|4470897|P3|Optional Extension-Cycles 2-6|Protocol Violation|0
1356258|NCT01697579|4470898|P2|Optional Extension-Cycles 2-6|Protocol Violation|0
1356259|NCT01697579|4470899|P1|Optional Extension-Cycles 2-6|Protocol Violation|0
1356260|NCT01697579|4470893|P7|Optional Extension-Cycles 2-6|Physician Decision|11
1356261|NCT01697579|4470894|P6|Optional Extension-Cycles 2-6|Physician Decision|7
1356262|NCT01697579|4470895|P5|Optional Extension-Cycles 2-6|Physician Decision|0
1356263|NCT01697579|4470896|P4|Optional Extension-Cycles 2-6|Physician Decision|0
1356264|NCT01697579|4470897|P3|Optional Extension-Cycles 2-6|Physician Decision|0
1356265|NCT01697579|4470898|P2|Optional Extension-Cycles 2-6|Physician Decision|0
1356266|NCT01697579|4470899|P1|Optional Extension-Cycles 2-6|Physician Decision|0
1356267|NCT01697579|4470893|P7|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
1356268|NCT01697579|4470894|P6|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
1356269|NCT01697579|4470895|P5|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1356270|NCT01697579|4470896|P4|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1356271|NCT01697579|4470897|P3|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1356272|NCT01697579|4470898|P2|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1356273|NCT01697579|4470899|P1|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1356274|NCT01697579|4470893|P7|Optional Extension-Cycles 2-6|Death|2
1356275|NCT01697579|4470894|P6|Optional Extension-Cycles 2-6|Death|0
1356276|NCT01697579|4470895|P5|Optional Extension-Cycles 2-6|Death|0
1356277|NCT01697579|4470896|P4|Optional Extension-Cycles 2-6|Death|0
1356278|NCT01697579|4470897|P3|Optional Extension-Cycles 2-6|Death|0
1356279|NCT01697579|4470898|P2|Optional Extension-Cycles 2-6|Death|0
1356280|NCT01697579|4470899|P1|Optional Extension-Cycles 2-6|Death|0
1356281|NCT01697579|4470893|P7|Base Study-Cycle 1|Technical Problems|0
1356282|NCT01697579|4470894|P6|Base Study-Cycle 1|Technical Problems|0
1356283|NCT01697579|4470895|P5|Base Study-Cycle 1|Technical Problems|0
1356284|NCT01697579|4470896|P4|Base Study-Cycle 1|Technical Problems|1
1356285|NCT01697579|4470897|P3|Base Study-Cycle 1|Technical Problems|1
1356286|NCT01697579|4470898|P2|Base Study-Cycle 1|Technical Problems|0
1356287|NCT01697579|4470899|P1|Base Study-Cycle 1|Technical Problems|0
1356288|NCT01697579|4470893|P7|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1356289|NCT01697579|4470894|P6|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1356290|NCT01697579|4470895|P5|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1356291|NCT01697579|4470896|P4|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1356292|NCT01697579|4470897|P3|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1356293|NCT01697579|4470898|P2|Base Study-Cycle 1|Consent Withdrawn by Participant|1
1356294|NCT01697579|4470899|P1|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1356295|NCT01697579|4470893|P7|Base Study-Cycle 1|Protocol Violation|0
1356296|NCT01697579|4470894|P6|Base Study-Cycle 1|Protocol Violation|0
1356297|NCT01697579|4470895|P5|Base Study-Cycle 1|Protocol Violation|3
1356298|NCT01697579|4470896|P4|Base Study-Cycle 1|Protocol Violation|0
1356299|NCT01697579|4470897|P3|Base Study-Cycle 1|Protocol Violation|0
1356300|NCT01697579|4470898|P2|Base Study-Cycle 1|Protocol Violation|0
1356301|NCT01697579|4470899|P1|Base Study-Cycle 1|Protocol Violation|0
1356302|NCT01697579|4470893|P7|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1356303|NCT01697579|4470894|P6|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1356304|NCT01697579|4470895|P5|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1356305|NCT01697579|4470896|P4|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1356306|NCT01697579|4470897|P3|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1356307|NCT01697579|4470898|P2|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1356308|NCT01697579|4470899|P1|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
1356309|NCT01697579|4470893|P7|Base Study-Cycle 1|Adverse Event|0
1356310|NCT01697579|4470894|P6|Base Study-Cycle 1|Adverse Event|0
1356311|NCT01697579|4470895|P5|Base Study-Cycle 1|Adverse Event|0
1356312|NCT01697579|4470896|P4|Base Study-Cycle 1|Adverse Event|0
1356313|NCT01697579|4470897|P3|Base Study-Cycle 1|Adverse Event|0
1356314|NCT01697579|4470898|P2|Base Study-Cycle 1|Adverse Event|0
1356315|NCT01697579|4470899|P1|Base Study-Cycle 1|Adverse Event|1
1356316|NCT01697501|4471011|P1|Overall Study|Protocol Violation|2
1356317|NCT01697462|4471054|P1|Overall Study|Missing|5
1356318|NCT01697462|4471054|P1|Overall Study|Other|10
1356319|NCT01697462|4471054|P1|Overall Study|Death|1
1356320|NCT01697462|4471054|P1|Overall Study|Investigator Decision|21
1356321|NCT01697462|4471054|P1|Overall Study|Withdrawal by Subject|12
1356322|NCT01697462|4471054|P1|Overall Study|Lost to Follow-up|21
1356323|NCT01697462|4471054|P1|Overall Study|Adverse Event|6
1356324|NCT01697462|4471054|P1|Overall Study|Disease Progression|1
1356325|NCT01697449|4471061|P1|Overall Study|Missing|25
1356326|NCT01697449|4471061|P1|Overall Study|Other|1
1356327|NCT01697449|4471061|P1|Overall Study|Death|2
1356328|NCT01697449|4471061|P1|Overall Study|Physician Decision|1
1356329|NCT01697449|4471061|P1|Overall Study|Withdrawal by Subject|2
1356330|NCT01697449|4471061|P1|Overall Study|Lost to Follow-up|5
1356331|NCT01697449|4471061|P1|Overall Study|Adverse Event|7
1356332|NCT01697449|4471061|P1|Overall Study|Disease progression|47
1356333|NCT01697358|4471072|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
1356334|NCT01697358|4471073|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
1356335|NCT01697358|4471072|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
1356336|NCT01697358|4471073|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
1356337|NCT01697358|4471072|P2|Period II: 6-24M Long-term Follow-up|Death|1
1356338|NCT01697358|4471073|P1|Period II: 6-24M Long-term Follow-up|Death|1
1356339|NCT01697358|4471072|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
1356340|NCT01697358|4471073|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
1356341|NCT01697358|4471072|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
1356342|NCT01697358|4471073|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
1356343|NCT01697358|4471072|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
1356344|NCT01697358|4471073|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
1356345|NCT01697358|4471072|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
1356346|NCT01697358|4471073|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
1356347|NCT01697358|4471072|P2|Period I: Randomization to 6 Months|Adverse Event|1
1356348|NCT01697358|4471073|P1|Period I: Randomization to 6 Months|Adverse Event|1
1356349|NCT01697358|4471072|P2|Period I: Randomization to 6 Months|Physician Decision|0
1356350|NCT01697358|4471073|P1|Period I: Randomization to 6 Months|Physician Decision|4
1356351|NCT01697358|4471072|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
1356352|NCT01697358|4471073|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
1356353|NCT01697345|4471089|P1|Overall Study|Withdrawal by Subject|1
1356354|NCT01697319|4471114|P1|Extension Phase|Terminated by Sponsor|15
1356355|NCT01697319|4471114|P1|Primary Phase|Withdrawal by Subject|1
1356356|NCT01696994|4471123|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
1356357|NCT01696994|4471124|P1|Overall Study|Refused Screen (Ovarian Screening)|0
1356358|NCT01696994|4471123|P2|Overall Study|Refused ASU (Control)|0
1356359|NCT01696994|4471124|P1|Overall Study|Refused ASU (Control)|311
1356360|NCT01696994|4471123|P2|Overall Study|No Ovaries at Baseline|4851
1356361|NCT01696994|4471124|P1|Overall Study|No Ovaries at Baseline|4807
1356362|NCT01696994|4471123|P2|Overall Study|Died Before ASU (Control)|0
1356363|NCT01696994|4471124|P1|Overall Study|Died Before ASU (Control)|73
1356364|NCT01696994|4471123|P2|Overall Study|Died Before Randomization|2
1356365|NCT01696994|4471124|P1|Overall Study|Died Before Randomization|1
1356366|NCT01696994|4471123|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
1356367|NCT01696994|4471124|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
1356368|NCT01696981|4471152|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
1356369|NCT01696981|4471153|P1|Overall Study|Refused Screen (Colorectal Screening)|0
1356370|NCT01696981|4471152|P2|Overall Study|Refused ASU (Control)|0
1356371|NCT01696981|4471153|P1|Overall Study|Refused ASU (Control)|920
1356372|NCT01696981|4471152|P2|Overall Study|Died Before ASU (Control)|0
1356373|NCT01696981|4471153|P1|Overall Study|Died Before ASU (Control)|278
1356374|NCT01696981|4471152|P2|Overall Study|Died Before Randomization|8
1356375|NCT01696981|4471153|P1|Overall Study|Died Before Randomization|3
1356376|NCT01696981|4471152|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
1356377|NCT01696981|4471153|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
1356378|NCT01696968|4471173|P2|Overall Study|Refused Screen (Lung Screening)|6796
1356379|NCT01696968|4471174|P1|Overall Study|Refused Screen (Lung Screening)|0
1356380|NCT01696968|4471173|P2|Overall Study|Refused ASU (Control)|0
1356381|NCT01696968|4471174|P1|Overall Study|Refused ASU (Control)|920
1356382|NCT01696968|4471173|P2|Overall Study|Died Before ASU (Control)|0
1356383|NCT01696968|4471174|P1|Overall Study|Died Before ASU (Control)|278
1356384|NCT01696968|4471173|P2|Overall Study|Died Before Randomization|8
1356385|NCT01696968|4471174|P1|Overall Study|Died Before Randomization|3
1356386|NCT01696968|4471173|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
1356387|NCT01696968|4471174|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
1356388|NCT01696942|4471196|P2|Overall Study|screen failure|1
1356389|NCT01696942|4471197|P1|Overall Study|screen failure|0
1356390|NCT01696942|4471196|P2|Overall Study|Protocol Violation|2
1356391|NCT01696942|4471197|P1|Overall Study|Protocol Violation|1
1356392|NCT01696942|4471196|P2|Overall Study|Withdrawal by Subject|0
1356393|NCT01696942|4471197|P1|Overall Study|Withdrawal by Subject|1
1356394|NCT01696929|4471205|P1|Overall Study|Physician Decision|1
1356395|NCT01696773|4471212|P2|Days 15-27, Washout|Adverse Event|0
1356396|NCT01696773|4471213|P1|Days 15-27, Washout|Adverse Event|1
1356397|NCT01696695|4471240|P1|Overall Study|Major Protocol Violation|192
1356398|NCT01696695|4471240|P1|Overall Study|Other|74
1356399|NCT01696695|4471240|P1|Overall Study|Lost to Follow-up|48
1356400|NCT01696695|4471240|P1|Overall Study|Withdrawal by Subject|92
1356401|NCT01696695|4471240|P1|Overall Study|Adverse Event|74
1356402|NCT01696695|4471240|P1|Overall Study|Death|29
1356403|NCT01696695|4471240|P1|Overall Study|Disease progression|373
1356404|NCT01696643|4471252|P2|Overall Study|Participant Did Not Receive Study Drug|2
1356405|NCT01696643|4471253|P1|Overall Study|Participant Did Not Receive Study Drug|2
1356406|NCT01696643|4471252|P2|Overall Study|Medical Monitor Decision|2
1356407|NCT01696643|4471253|P1|Overall Study|Medical Monitor Decision|0
1356408|NCT01696643|4471252|P2|Overall Study|Participant Incarcerated|1
1356409|NCT01696643|4471253|P1|Overall Study|Participant Incarcerated|0
1356410|NCT01696643|4471252|P2|Overall Study|Site Error|1
1356411|NCT01696643|4471253|P1|Overall Study|Site Error|2
1356412|NCT01696643|4471252|P2|Overall Study|Participant on Restricted Bed Rest|0
1356413|NCT01696643|4471253|P1|Overall Study|Participant on Restricted Bed Rest|1
1356414|NCT01696643|4471252|P2|Overall Study|Withdrawal by Subject|149
1356415|NCT01696643|4471253|P1|Overall Study|Withdrawal by Subject|142
1356416|NCT01696643|4471252|P2|Overall Study|Study Terminated by Sponsor|294
1356417|NCT01696643|4471253|P1|Overall Study|Study Terminated by Sponsor|286
1356418|NCT01696643|4471252|P2|Overall Study|Protocol Violation|7
1356419|NCT01696643|4471253|P1|Overall Study|Protocol Violation|7
1356420|NCT01696643|4471252|P2|Overall Study|Pregnancy|1
1356421|NCT01696643|4471253|P1|Overall Study|Pregnancy|0
1356422|NCT01696643|4471252|P2|Overall Study|Physician Decision|2
1356423|NCT01696643|4471253|P1|Overall Study|Physician Decision|3
1356424|NCT01696643|4471252|P2|Overall Study|Lost to Follow-up|67
1356425|NCT01696643|4471253|P1|Overall Study|Lost to Follow-up|67
1356426|NCT01696643|4471252|P2|Overall Study|Lack of Efficacy|0
1356427|NCT01696643|4471253|P1|Overall Study|Lack of Efficacy|3
1356428|NCT01696643|4471252|P2|Overall Study|Death|2
1356429|NCT01696643|4471253|P1|Overall Study|Death|1
1356430|NCT01696643|4471252|P2|Overall Study|Adverse Event|7
1356431|NCT01696643|4471253|P1|Overall Study|Adverse Event|15
1356432|NCT01696214|4471281|P4|Overall Study|Lost to Follow-up|0
1356433|NCT01696214|4471282|P3|Overall Study|Lost to Follow-up|0
1356434|NCT01696214|4471283|P2|Overall Study|Lost to Follow-up|1
1356435|NCT01696214|4471284|P1|Overall Study|Lost to Follow-up|0
1356436|NCT01696188|4471296|P2|Overall Study|Protocol Violation|1
1356437|NCT01696188|4471297|P1|Overall Study|Protocol Violation|1
1356438|NCT01696071|4471328|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
1356439|NCT01696071|4471329|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
1356440|NCT01696058|4471357|P2|Overall Study|Other reason prematurely discontinued|3
1356441|NCT01696058|4471358|P1|Overall Study|Other reason prematurely discontinued|5
1356442|NCT01696058|4471357|P2|Overall Study|Withdrawal by Subject|6
1356443|NCT01696058|4471358|P1|Overall Study|Withdrawal by Subject|4
1356444|NCT01696058|4471357|P2|Overall Study|Lost to Follow-up|5
1356445|NCT01696058|4471358|P1|Overall Study|Lost to Follow-up|2
1356446|NCT01696058|4471357|P2|Overall Study|Protocol Violation|3
1356447|NCT01696058|4471358|P1|Overall Study|Protocol Violation|9
1356448|NCT01696058|4471357|P2|Overall Study|Lack of Efficacy|3
1356449|NCT01696058|4471358|P1|Overall Study|Lack of Efficacy|2
1356450|NCT01696058|4471357|P2|Overall Study|Adverse Event|11
1356451|NCT01696058|4471358|P1|Overall Study|Adverse Event|21
1356452|NCT01696045|4471386|P2|Overall Study|Disease progression|2
1356453|NCT01696045|4471387|P1|Overall Study|Disease progression|2
1356454|NCT01696045|4471386|P2|Overall Study|Study drug toxicity|5
1356455|NCT01696045|4471387|P1|Overall Study|Study drug toxicity|1
1356456|NCT01695993|4471406|P3|Overall Study|Changed Medical Facility|1
1356457|NCT01695993|4471407|P2|Overall Study|Changed Medical Facility|0
1356458|NCT01695993|4471408|P1|Overall Study|Changed Medical Facility|0
1356459|NCT01695993|4471406|P3|Overall Study|To ill to continue|0
1356460|NCT01695993|4471407|P2|Overall Study|To ill to continue|2
1356461|NCT01695993|4471408|P1|Overall Study|To ill to continue|1
1356462|NCT01695993|4471406|P3|Overall Study|Withdrawal by Subject|2
1356463|NCT01695993|4471407|P2|Overall Study|Withdrawal by Subject|2
1356464|NCT01695993|4471408|P1|Overall Study|Withdrawal by Subject|2
1356465|NCT01695993|4471406|P3|Overall Study|Lost to Follow-up|3
1356466|NCT01695993|4471407|P2|Overall Study|Lost to Follow-up|1
1356467|NCT01695993|4471408|P1|Overall Study|Lost to Follow-up|2
1356468|NCT01695772|4471416|P1|Overall Study|Unspecified Reason|1
1356469|NCT01695772|4471416|P1|Overall Study|Protocol Violation|2
1356470|NCT01695772|4471416|P1|Overall Study|Lost to Follow-up|4
1356471|NCT01695772|4471416|P1|Overall Study|Investigator Decision|5
1356472|NCT01695772|4471416|P1|Overall Study|Progressive Disease|8
1356473|NCT01695772|4471416|P1|Overall Study|Withdrawal by Subject|18
1356474|NCT01695746|4471428|P1|Overall Study|Participant not willing to participate|3
1356475|NCT01695746|4471428|P1|Overall Study|Protocol Violation|5
1356476|NCT01695746|4471428|P1|Overall Study|Non-compliance by the participant|3
1356477|NCT01695746|4471428|P1|Overall Study|Adverse Event|1
1356478|NCT01695239|4471477|P4|Overall Study|Protocol Violation|0
1356479|NCT01695239|4471478|P3|Overall Study|Protocol Violation|0
1356480|NCT01695239|4471479|P2|Overall Study|Protocol Violation|0
1356481|NCT01695239|4471480|P1|Overall Study|Protocol Violation|1
1356482|NCT01695239|4471477|P4|Overall Study|Lost to Follow-up|0
1356483|NCT01695239|4471478|P3|Overall Study|Lost to Follow-up|0
1356484|NCT01695239|4471479|P2|Overall Study|Lost to Follow-up|0
1356485|NCT01695239|4471480|P1|Overall Study|Lost to Follow-up|1
1356486|NCT01695239|4471477|P4|Overall Study|Sponsor Decision|0
1356487|NCT01695239|4471478|P3|Overall Study|Sponsor Decision|1
1356488|NCT01695239|4471479|P2|Overall Study|Sponsor Decision|0
1356489|NCT01695239|4471480|P1|Overall Study|Sponsor Decision|3
1356490|NCT01695239|4471477|P4|Overall Study|Withdrawal by Subject|0
1356491|NCT01695239|4471478|P3|Overall Study|Withdrawal by Subject|1
1356492|NCT01695239|4471479|P2|Overall Study|Withdrawal by Subject|1
1356493|NCT01695239|4471480|P1|Overall Study|Withdrawal by Subject|3
1356494|NCT01695239|4471477|P4|Overall Study|Lack of Efficacy|0
1356495|NCT01695239|4471478|P3|Overall Study|Lack of Efficacy|2
1356496|NCT01695239|4471479|P2|Overall Study|Lack of Efficacy|0
1356497|NCT01695239|4471480|P1|Overall Study|Lack of Efficacy|4
1356498|NCT01695239|4471477|P4|Overall Study|Adverse Event|3
1356499|NCT01695239|4471478|P3|Overall Study|Adverse Event|2
1356500|NCT01695239|4471479|P2|Overall Study|Adverse Event|2
1356501|NCT01695239|4471480|P1|Overall Study|Adverse Event|2
1356502|NCT01695239|4471477|P4|Overall Study|Entry Criteria Not Met|3
1356503|NCT01695239|4471478|P3|Overall Study|Entry Criteria Not Met|3
1356504|NCT01695239|4471479|P2|Overall Study|Entry Criteria Not Met|1
1356505|NCT01695239|4471480|P1|Overall Study|Entry Criteria Not Met|1
1356506|NCT01695239|4471477|P4|Overall Study|On Study Treatment|0
1356507|NCT01695239|4471478|P3|Overall Study|On Study Treatment|1
1356508|NCT01695239|4471479|P2|Overall Study|On Study Treatment|0
1356509|NCT01695239|4471480|P1|Overall Study|On Study Treatment|0
1356510|NCT01694771|4471596|P2|Overall Study|Other reasons|6
1356511|NCT01694771|4471597|P1|Overall Study|Other reasons|5
1356512|NCT01694771|4471596|P2|Overall Study|Consent withdrawn|9
1356513|NCT01694771|4471597|P1|Overall Study|Consent withdrawn|7
1356514|NCT01694771|4471596|P2|Overall Study|Lost to Follow-up|3
1356515|NCT01694771|4471597|P1|Overall Study|Lost to Follow-up|2
1356516|NCT01694771|4471596|P2|Overall Study|Non compliance protocol|6
1356517|NCT01694771|4471597|P1|Overall Study|Non compliance protocol|7
1356518|NCT01694771|4471596|P2|Overall Study|Lack of Efficacy|0
1356519|NCT01694771|4471597|P1|Overall Study|Lack of Efficacy|1
1356520|NCT01694771|4471596|P2|Overall Study|Adverse Event|16
1356521|NCT01694771|4471597|P1|Overall Study|Adverse Event|18
1356522|NCT01694706|4471621|P3|Overall Study|other reason not defined above|0
1356523|NCT01694706|4471622|P2|Overall Study|other reason not defined above|0
1356524|NCT01694706|4471623|P1|Overall Study|other reason not defined above|1
1356525|NCT01694706|4471621|P3|Overall Study|Adverse Event|0
1356526|NCT01694706|4471622|P2|Overall Study|Adverse Event|1
1356527|NCT01694706|4471623|P1|Overall Study|Adverse Event|0
1356528|NCT01694420|4471668|P1|Overall Study|Lost to Follow-up|3
1356529|NCT01693367|4471799|P2|Overall Study|Physician Decision|1
1356530|NCT01693367|4471800|P1|Overall Study|Physician Decision|0
1356531|NCT01693367|4471799|P2|Overall Study|Withdrawal by Subject|1
1356532|NCT01693367|4471800|P1|Overall Study|Withdrawal by Subject|1
1356533|NCT01693185|4471818|P2|Overall Study|diagnostic procedure after colonoscopy|6
1356534|NCT01693185|4471819|P1|Overall Study|diagnostic procedure after colonoscopy|0
1356535|NCT01693120|4471835|P1|Phased RF Study Procedure and Follow-up|Other reasons|7
1356536|NCT01693120|4471835|P1|Phased RF Study Procedure and Follow-up|Protocol Violation|1
1356537|NCT01693120|4471835|P1|Phased RF Study Procedure and Follow-up|Physician Decision|3
1356538|NCT01693120|4471835|P1|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
1356539|NCT01693120|4471835|P1|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
1356540|NCT01693120|4471835|P1|Enrollment|Not specified|1
1356541|NCT01693120|4471835|P1|Enrollment|Study closed|8
1356542|NCT01693120|4471835|P1|Enrollment|Adverse Event|1
1356543|NCT01693120|4471835|P1|Enrollment|Physician Decision|3
1356544|NCT01693120|4471835|P1|Enrollment|Protocol Violation|46
1356545|NCT01693120|4471835|P1|Enrollment|Withdrawal by Subject|10
1356546|NCT01693120|4471835|P1|Enrollment|Lost to Follow-up|1
1356547|NCT01693068|4471844|P3|Cross-over (Dacarbazine To Pimasertib)|On-study|1
1356548|NCT01693068|4471845|P2|Cross-over (Dacarbazine To Pimasertib)|On-study|0
1356549|NCT01693068|4471846|P1|Cross-over (Dacarbazine To Pimasertib)|On-study|0
1356550|NCT01693068|4471844|P3|Randomization Period|On-study|0
1356551|NCT01693068|4471845|P2|Randomization Period|On-study|5
1356552|NCT01693068|4471846|P1|Randomization Period|On-study|2
1356553|NCT01693029|4471878|P2|Overall Study|Non-compliance|1
1356554|NCT01693029|4471879|P1|Overall Study|Non-compliance|2
1356555|NCT01693029|4471878|P2|Overall Study|Death|8
1356556|NCT01693029|4471879|P1|Overall Study|Death|5
1356557|NCT01693029|4471878|P2|Overall Study|Adverse Event|6
1356558|NCT01693029|4471879|P1|Overall Study|Adverse Event|1
1356559|NCT01693029|4471878|P2|Overall Study|Lost to Follow-up|1
1356560|NCT01693029|4471879|P1|Overall Study|Lost to Follow-up|0
1356561|NCT01693029|4471878|P2|Overall Study|Physician Decision|2
1356562|NCT01693029|4471879|P1|Overall Study|Physician Decision|0
1356563|NCT01693029|4471878|P2|Overall Study|Change in dialysis modality|1
1356564|NCT01693029|4471879|P1|Overall Study|Change in dialysis modality|2
1356565|NCT01693029|4471878|P2|Overall Study|Protocol Violation|7
1356566|NCT01693029|4471879|P1|Overall Study|Protocol Violation|6
1356567|NCT01693029|4471878|P2|Overall Study|Bindinging anti-EPO antibodies|2
1356568|NCT01693029|4471879|P1|Overall Study|Bindinging anti-EPO antibodies|6
1356569|NCT01693029|4471878|P2|Overall Study|Kidney transplantation|7
1356570|NCT01693029|4471879|P1|Overall Study|Kidney transplantation|7
1356571|NCT01693029|4471878|P2|Overall Study|Withdrawal by Subject|22
1356572|NCT01693029|4471879|P1|Overall Study|Withdrawal by Subject|15
1356573|NCT01692938|4471910|P2|Overall Study|Study completed prior to site completion|3
1356574|NCT01692938|4471911|P1|Overall Study|Study completed prior to site completion|3
1356575|NCT01692938|4471910|P2|Overall Study|Protocol Deviation|1
1356576|NCT01692938|4471911|P1|Overall Study|Protocol Deviation|1
1356577|NCT01692782|4471922|P3|Overall Study|Withdrawal by Subject|3
1356578|NCT01692782|4471923|P2|Overall Study|Withdrawal by Subject|10
1356579|NCT01692782|4471924|P1|Overall Study|Withdrawal by Subject|3
1356580|NCT01692782|4471922|P3|Overall Study|SAE not related to study drug|0
1356581|NCT01692782|4471923|P2|Overall Study|SAE not related to study drug|1
1356582|NCT01692782|4471924|P1|Overall Study|SAE not related to study drug|0
1356583|NCT01692782|4471922|P3|Overall Study|Non-compliant with study visits|1
1356584|NCT01692782|4471923|P2|Overall Study|Non-compliant with study visits|0
1356585|NCT01692782|4471924|P1|Overall Study|Non-compliant with study visits|0
1356586|NCT01692782|4471922|P3|Overall Study|Non-complance with study drug|1
1356587|NCT01692782|4471923|P2|Overall Study|Non-complance with study drug|4
1356588|NCT01692782|4471924|P1|Overall Study|Non-complance with study drug|0
1356589|NCT01692782|4471922|P3|Overall Study|Protocol Violation|2
1356590|NCT01692782|4471923|P2|Overall Study|Protocol Violation|0
1356591|NCT01692782|4471924|P1|Overall Study|Protocol Violation|1
1356592|NCT01692782|4471922|P3|Overall Study|Pregnancy|0
1356593|NCT01692782|4471923|P2|Overall Study|Pregnancy|0
1356594|NCT01692782|4471924|P1|Overall Study|Pregnancy|1
1356595|NCT01692782|4471922|P3|Overall Study|Lost to Follow-up|1
1356596|NCT01692782|4471923|P2|Overall Study|Lost to Follow-up|7
1356597|NCT01692782|4471924|P1|Overall Study|Lost to Follow-up|2
1356598|NCT01692782|4471922|P3|Overall Study|Lack of Efficacy|0
1356599|NCT01692782|4471923|P2|Overall Study|Lack of Efficacy|2
1356600|NCT01692782|4471924|P1|Overall Study|Lack of Efficacy|1
1356601|NCT01692782|4471922|P3|Overall Study|Adverse Event|2
1356602|NCT01692782|4471923|P2|Overall Study|Adverse Event|32
1356603|NCT01692782|4471924|P1|Overall Study|Adverse Event|12
1356604|NCT01692730|4471949|P2|Overall Study|Lost to Follow-up|227
1356605|NCT01692730|4471950|P1|Overall Study|Lost to Follow-up|225
1356606|NCT01692626|4471964|P2|Overall Study|Withdrawal by Subject|0
1356607|NCT01692626|4471965|P1|Overall Study|Withdrawal by Subject|1
1356608|NCT01692626|4471964|P2|Overall Study|Protocol Violation|2
1356609|NCT01692626|4471965|P1|Overall Study|Protocol Violation|1
1356610|NCT01692626|4471964|P2|Overall Study|Adverse Event|3
1356611|NCT01692626|4471965|P1|Overall Study|Adverse Event|2
1356612|NCT01692626|4471964|P2|Overall Study|Death|1
1356613|NCT01692626|4471965|P1|Overall Study|Death|0
1356614|NCT01692301|4471992|P2|Overall Study|Lost to Follow-up|1
1356615|NCT01692301|4471993|P1|Overall Study|Lost to Follow-up|1
1356616|NCT01692301|4471992|P2|Overall Study|Physician Decision|2
1356617|NCT01692301|4471993|P1|Overall Study|Physician Decision|2
1356618|NCT01692301|4471992|P2|Overall Study|Technical problems|1
1356619|NCT01692301|4471993|P1|Overall Study|Technical problems|0
1356620|NCT01692301|4471992|P2|Overall Study|Patient/guardian decision|15
1356621|NCT01692301|4471993|P1|Overall Study|Patient/guardian decision|16
1356622|NCT01692301|4471992|P2|Overall Study|Protocol deviation|2
1356623|NCT01692301|4471993|P1|Overall Study|Protocol deviation|9
1356624|NCT01692301|4471992|P2|Overall Study|Non-compliance with study treatment|2
1356625|NCT01692301|4471993|P1|Overall Study|Non-compliance with study treatment|1
1356626|NCT01692301|4471992|P2|Overall Study|Lack of Efficacy|5
1356627|NCT01692301|4471993|P1|Overall Study|Lack of Efficacy|0
1356628|NCT01692301|4471992|P2|Overall Study|Death|2
1356629|NCT01692301|4471993|P1|Overall Study|Death|1
1356630|NCT01692301|4471992|P2|Overall Study|Adverse Event|12
1356631|NCT01692301|4471993|P1|Overall Study|Adverse Event|15
1356632|NCT01692197|4472019|P1|Overall Study|Failed Screening|3
1356633|NCT01691898|4472032|P6|Overall Study|Other|1
1356634|NCT01691898|4472033|P5|Overall Study|Other|0
1356635|NCT01691898|4472034|P4|Overall Study|Other|0
1356636|NCT01691898|4472035|P3|Overall Study|Other|1
1356637|NCT01691898|4472036|P2|Overall Study|Other|2
1356638|NCT01691898|4472037|P1|Overall Study|Other|0
1356639|NCT01691898|4472032|P6|Overall Study|Withdrawal by Subject|3
1356640|NCT01691898|4472033|P5|Overall Study|Withdrawal by Subject|2
1356641|NCT01691898|4472034|P4|Overall Study|Withdrawal by Subject|1
1356642|NCT01691898|4472035|P3|Overall Study|Withdrawal by Subject|1
1356643|NCT01691898|4472036|P2|Overall Study|Withdrawal by Subject|5
1356644|NCT01691898|4472037|P1|Overall Study|Withdrawal by Subject|8
1356645|NCT01691898|4472032|P6|Overall Study|Lost to Follow-up|0
1356646|NCT01691898|4472033|P5|Overall Study|Lost to Follow-up|0
1356647|NCT01691898|4472034|P4|Overall Study|Lost to Follow-up|0
1356648|NCT01691898|4472035|P3|Overall Study|Lost to Follow-up|0
1356649|NCT01691898|4472036|P2|Overall Study|Lost to Follow-up|0
1356650|NCT01691898|4472037|P1|Overall Study|Lost to Follow-up|1
1356651|NCT01691898|4472032|P6|Overall Study|Progression of Disease|2
1356652|NCT01691898|4472033|P5|Overall Study|Progression of Disease|1
1356653|NCT01691898|4472034|P4|Overall Study|Progression of Disease|0
1356654|NCT01691898|4472035|P3|Overall Study|Progression of Disease|1
1356655|NCT01691898|4472036|P2|Overall Study|Progression of Disease|3
1356656|NCT01691898|4472037|P1|Overall Study|Progression of Disease|2
1356657|NCT01691898|4472032|P6|Overall Study|Adverse Event|0
1356658|NCT01691898|4472033|P5|Overall Study|Adverse Event|0
1356659|NCT01691898|4472034|P4|Overall Study|Adverse Event|1
1356660|NCT01691898|4472035|P3|Overall Study|Adverse Event|0
1356661|NCT01691898|4472036|P2|Overall Study|Adverse Event|1
1356662|NCT01691898|4472037|P1|Overall Study|Adverse Event|0
1356663|NCT01691898|4472032|P6|Overall Study|Death|20
1356664|NCT01691898|4472033|P5|Overall Study|Death|5
1356665|NCT01691898|4472034|P4|Overall Study|Death|2
1356666|NCT01691898|4472035|P3|Overall Study|Death|4
1356667|NCT01691898|4472036|P2|Overall Study|Death|28
1356668|NCT01691898|4472037|P1|Overall Study|Death|31
1356669|NCT01691898|4472032|P6|Overall Study|Ongoing in Study|14
1356670|NCT01691898|4472033|P5|Overall Study|Ongoing in Study|31
1356671|NCT01691898|4472034|P4|Overall Study|Ongoing in Study|5
1356672|NCT01691898|4472035|P3|Overall Study|Ongoing in Study|11
1356673|NCT01691898|4472036|P2|Overall Study|Ongoing in Study|19
1356674|NCT01691898|4472037|P1|Overall Study|Ongoing in Study|18
1356675|NCT01691885|4472183|P2|Washout Period (7-9 Days)|Adverse Event|1
1356676|NCT01691885|4472184|P1|Washout Period (7-9 Days)|Adverse Event|0
1356677|NCT01691885|4472183|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
1356678|NCT01691885|4472184|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
1356679|NCT01691859|4472190|P1|Overall Study|Withdrawal by Subject|31
1356680|NCT01691859|4472190|P1|Overall Study|Physician Decision|6
1356681|NCT01691859|4472190|P1|Overall Study|Lost to Follow-up|5
1356682|NCT01691859|4472190|P1|Overall Study|Study closed/terminated|50
1356683|NCT01691859|4472190|P1|Overall Study|Product commercially available|221
1356684|NCT01691859|4472190|P1|Overall Study|Protocol Violation|4
1356685|NCT01691859|4472190|P1|Overall Study|Lack of Efficacy|11
1356686|NCT01691859|4472190|P1|Overall Study|Adverse Event|19
1356687|NCT01691794|4472212|P3|Overall Study|Did not complete first 24 weeks of study|3
1356688|NCT01691794|4472213|P2|Overall Study|Did not complete first 24 weeks of study|3
1356689|NCT01691794|4472214|P1|Overall Study|Did not complete first 24 weeks of study|0
1356690|NCT01691794|4472212|P3|Overall Study|Completed Only first 24 weeks of study|3
1356691|NCT01691794|4472213|P2|Overall Study|Completed Only first 24 weeks of study|2
1356692|NCT01691794|4472214|P1|Overall Study|Completed Only first 24 weeks of study|0
1356693|NCT01691794|4472212|P3|Overall Study|Adverse Event|1
1356694|NCT01691794|4472213|P2|Overall Study|Adverse Event|1
1356695|NCT01691794|4472214|P1|Overall Study|Adverse Event|0
1356696|NCT01691794|4472212|P3|Overall Study|Participant request to discontinue|0
1356697|NCT01691794|4472213|P2|Overall Study|Participant request to discontinue|1
1356698|NCT01691794|4472214|P1|Overall Study|Participant request to discontinue|0
1356699|NCT01691794|4472212|P3|Overall Study|Lack of Efficacy|1
1356700|NCT01691794|4472213|P2|Overall Study|Lack of Efficacy|7
1356701|NCT01691794|4472214|P1|Overall Study|Lack of Efficacy|0
1356702|NCT01691794|4472212|P3|Overall Study|Death|1
1356703|NCT01691794|4472213|P2|Overall Study|Death|0
1356704|NCT01691794|4472214|P1|Overall Study|Death|0
1356705|NCT01691794|4472212|P3|Overall Study|Poor/Non-Compliance|1
1356706|NCT01691794|4472213|P2|Overall Study|Poor/Non-Compliance|4
1356707|NCT01691794|4472214|P1|Overall Study|Poor/Non-Compliance|1
1356708|NCT01691781|4472230|P2|Overall Study|Adverse Event|1
1356709|NCT01691781|4472231|P1|Overall Study|Adverse Event|0
1356710|NCT01691781|4472230|P2|Overall Study|Protocol Violation|2
1356711|NCT01691781|4472231|P1|Overall Study|Protocol Violation|2
1356712|NCT01691781|4472230|P2|Overall Study|Physician Decision|1
1356713|NCT01691781|4472231|P1|Overall Study|Physician Decision|1
1356714|NCT01691781|4472230|P2|Overall Study|Withdrawal by Subject|3
1356715|NCT01691781|4472231|P1|Overall Study|Withdrawal by Subject|4
1356716|NCT01691612|4472254|P1|Overall Study|Adverse Event|1
1356717|NCT01691612|4472254|P1|Overall Study|deemed ineligible after 1st visit|6
1356718|NCT01691521|4472365|P3|Overall Study|Withdrawal by Subject|4
1356719|NCT01691521|4472366|P2|Overall Study|Withdrawal by Subject|9
1356720|NCT01691521|4472367|P1|Overall Study|Withdrawal by Subject|5
1356721|NCT01691521|4472365|P3|Overall Study|Physician Decision|0
1356722|NCT01691521|4472366|P2|Overall Study|Physician Decision|1
1356723|NCT01691521|4472367|P1|Overall Study|Physician Decision|2
1356724|NCT01691521|4472365|P3|Overall Study|Lost to Follow-up|2
1356725|NCT01691521|4472366|P2|Overall Study|Lost to Follow-up|2
1356726|NCT01691521|4472367|P1|Overall Study|Lost to Follow-up|0
1356727|NCT01691521|4472365|P3|Overall Study|Protocol Violation|0
1356728|NCT01691521|4472366|P2|Overall Study|Protocol Violation|3
1356729|NCT01691521|4472367|P1|Overall Study|Protocol Violation|0
1356730|NCT01691521|4472365|P3|Overall Study|Lack of Efficacy|2
1356731|NCT01691521|4472366|P2|Overall Study|Lack of Efficacy|1
1356732|NCT01691521|4472367|P1|Overall Study|Lack of Efficacy|1
1356733|NCT01691521|4472365|P3|Overall Study|Adverse Event|1
1356734|NCT01691521|4472366|P2|Overall Study|Adverse Event|0
1356735|NCT01691521|4472367|P1|Overall Study|Adverse Event|4
1356736|NCT01691508|4472389|P2|Overall Study|Withdrawal by Subject|0
1356737|NCT01691508|4472390|P1|Overall Study|Withdrawal by Subject|1
1356738|NCT01691508|4472389|P2|Overall Study|Adverse Event|3
1356739|NCT01691508|4472390|P1|Overall Study|Adverse Event|3
1356740|NCT01691482|4472404|P2|Treatment Period 2|Protocol Violation|1
1356741|NCT01691482|4472405|P1|Treatment Period 2|Protocol Violation|1
1356742|NCT01691482|4472404|P2|Treatment Period 2|Adverse Event|1
1356743|NCT01691482|4472405|P1|Treatment Period 2|Adverse Event|0
1356744|NCT01691430|4472423|P2|Overall Study|Lost to Follow-up|3
1356745|NCT01691430|4472424|P1|Overall Study|Lost to Follow-up|0
1356746|NCT01691430|4472423|P2|Overall Study|Withdrawal by Subject|1
1356747|NCT01691430|4472424|P1|Overall Study|Withdrawal by Subject|5
1356748|NCT01691430|4472423|P2|Overall Study|Death|16
1356749|NCT01691430|4472424|P1|Overall Study|Death|17
1356750|NCT01691248|4472521|P2|Overall Study|Not Treated|7
1356751|NCT01691248|4472522|P1|Overall Study|Not Treated|4
1356752|NCT01691248|4472521|P2|Overall Study|Reason not provided|4
1356753|NCT01691248|4472522|P1|Overall Study|Reason not provided|4
1356754|NCT01691248|4472521|P2|Overall Study|Lost to Follow-up|5
1356755|NCT01691248|4472522|P1|Overall Study|Lost to Follow-up|2
1356756|NCT01691248|4472521|P2|Overall Study|Confirmed CDAD|31
1356757|NCT01691248|4472522|P1|Overall Study|Confirmed CDAD|14
1356758|NCT01691248|4472521|P2|Overall Study|Withdrawal by Subject|18
1356759|NCT01691248|4472522|P1|Overall Study|Withdrawal by Subject|20
1356760|NCT01691248|4472521|P2|Overall Study|Adverse Event|22
1356761|NCT01691248|4472522|P1|Overall Study|Adverse Event|24
1356762|NCT01691248|4472521|P2|Overall Study|Protocol Violation|27
1356763|NCT01691248|4472522|P1|Overall Study|Protocol Violation|43
1356764|NCT01691092|4472532|P1|Overall Study|screen fail|19
1356765|NCT01691092|4472532|P1|Overall Study|used for different study|2
1356766|NCT01691092|4472532|P1|Overall Study|non-compliance|3
1356767|NCT01691092|4472532|P1|Overall Study|Withdrawal by Subject|3
1356768|NCT01691092|4472532|P1|Overall Study|Physician Decision|4
1356769|NCT01691092|4472532|P1|Overall Study|Lost to Follow-up|10
1356770|NCT01691014|4472545|P4|Overall Study|Lack of Efficacy|0
1356771|NCT01691014|4472546|P3|Overall Study|Lack of Efficacy|7
1356772|NCT01691014|4472547|P2|Overall Study|Lack of Efficacy|3
1356773|NCT01691014|4472548|P1|Overall Study|Lack of Efficacy|2
1356774|NCT01691014|4472545|P4|Overall Study|Adverse Event|1
1356775|NCT01691014|4472546|P3|Overall Study|Adverse Event|1
1356776|NCT01691014|4472547|P2|Overall Study|Adverse Event|5
1356777|NCT01691014|4472548|P1|Overall Study|Adverse Event|0
1356778|NCT01691014|4472545|P4|Overall Study|Withdrawal by Subject|1
1356779|NCT01691014|4472546|P3|Overall Study|Withdrawal by Subject|1
1356780|NCT01691014|4472547|P2|Overall Study|Withdrawal by Subject|1
1356781|NCT01691014|4472548|P1|Overall Study|Withdrawal by Subject|0
1356782|NCT01691014|4472545|P4|Overall Study|Other|0
1356783|NCT01691014|4472546|P3|Overall Study|Other|2
1356784|NCT01691014|4472547|P2|Overall Study|Other|0
1356785|NCT01691014|4472548|P1|Overall Study|Other|0
1356786|NCT01691014|4472545|P4|Overall Study|Premature Termination|3
1356787|NCT01691014|4472546|P3|Overall Study|Premature Termination|0
1356788|NCT01691014|4472547|P2|Overall Study|Premature Termination|6
1356789|NCT01691014|4472548|P1|Overall Study|Premature Termination|1
1356790|NCT01690988|4472593|P3|Overall Study|Sedated|2
1356791|NCT01690988|4472594|P2|Overall Study|Sedated|1
1356792|NCT01690988|4472595|P1|Overall Study|Sedated|1
1356793|NCT01690988|4472593|P3|Overall Study|Death|1
1356794|NCT01690988|4472594|P2|Overall Study|Death|1
1356795|NCT01690988|4472595|P1|Overall Study|Death|1
1356796|NCT01690988|4472593|P3|Overall Study|Determined ineligible|0
1356797|NCT01690988|4472594|P2|Overall Study|Determined ineligible|0
1356798|NCT01690988|4472595|P1|Overall Study|Determined ineligible|1
1356799|NCT01690988|4472593|P3|Overall Study|Operation Cancelled|0
1356800|NCT01690988|4472594|P2|Overall Study|Operation Cancelled|1
1356801|NCT01690988|4472595|P1|Overall Study|Operation Cancelled|1
1356802|NCT01690988|4472593|P3|Overall Study|Physician Decision|1
1356803|NCT01690988|4472594|P2|Overall Study|Physician Decision|0
1356804|NCT01690988|4472595|P1|Overall Study|Physician Decision|0
1356805|NCT01690988|4472593|P3|Overall Study|Withdrawal by Subject|3
1356806|NCT01690988|4472594|P2|Overall Study|Withdrawal by Subject|2
1356807|NCT01690988|4472595|P1|Overall Study|Withdrawal by Subject|2
1356808|NCT01690299|4472663|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
1356809|NCT01690299|4472664|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1356810|NCT01690299|4472665|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1356811|NCT01690299|4472666|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1356812|NCT01690299|4472667|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1356813|NCT01690299|4472668|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1356814|NCT01690299|4472663|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
1356815|NCT01690299|4472664|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
1356816|NCT01690299|4472665|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
1356817|NCT01690299|4472666|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
1356818|NCT01690299|4472667|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
1356819|NCT01690299|4472668|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
1356820|NCT01690299|4472663|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
1356821|NCT01690299|4472664|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
1356822|NCT01690299|4472665|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
1356823|NCT01690299|4472666|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
1356824|NCT01690299|4472667|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
1356825|NCT01690299|4472668|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
1356826|NCT01690299|4472663|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
1356827|NCT01690299|4472664|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
1356828|NCT01690299|4472665|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1356829|NCT01690299|4472666|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1356830|NCT01690299|4472667|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1356831|NCT01690299|4472668|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1356832|NCT01690299|4472663|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
1356833|NCT01690299|4472664|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
1356834|NCT01690299|4472665|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
1356835|NCT01690299|4472666|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
1356836|NCT01690299|4472667|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
1356837|NCT01690299|4472668|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
1356838|NCT01690299|4472663|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
1356839|NCT01690299|4472664|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
1356840|NCT01690299|4472665|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
1356841|NCT01690299|4472666|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
1356842|NCT01690299|4472667|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
1356843|NCT01690299|4472668|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
1356844|NCT01690299|4472663|P6|Placebo-controlled Phase (Weeks 0-16)|Other|0
1356845|NCT01690299|4472664|P5|Placebo-controlled Phase (Weeks 0-16)|Other|0
1356846|NCT01690299|4472665|P4|Placebo-controlled Phase (Weeks 0-16)|Other|0
1356847|NCT01690299|4472666|P3|Placebo-controlled Phase (Weeks 0-16)|Other|1
1356848|NCT01690299|4472667|P2|Placebo-controlled Phase (Weeks 0-16)|Other|1
1356849|NCT01690299|4472668|P1|Placebo-controlled Phase (Weeks 0-16)|Other|2
1356850|NCT01690299|4472663|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1356851|NCT01690299|4472664|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1356852|NCT01690299|4472665|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1356853|NCT01690299|4472666|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1356854|NCT01690299|4472667|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
1356855|NCT01690299|4472668|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
1356856|NCT01690299|4472663|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1356857|NCT01690299|4472664|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1356858|NCT01690299|4472665|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1356859|NCT01690299|4472666|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1356860|NCT01690299|4472667|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1356861|NCT01690299|4472668|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
1356862|NCT01690299|4472663|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
1356863|NCT01690299|4472664|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
1356864|NCT01690299|4472665|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
1356865|NCT01690299|4472666|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
1356866|NCT01690299|4472667|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
1356867|NCT01690299|4472668|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
1356868|NCT01690143|4472765|P1|Overall Study|Withdrawal by Subject|1
1356869|NCT01690052|4472812|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
1356870|NCT01690052|4472813|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
1356871|NCT01689974|4472830|P2|Overall Study|Termination of Study|5
1356872|NCT01689974|4472831|P1|Overall Study|Termination of Study|5
1356873|NCT01689857|4472860|P2|Overall Study|Lost to Follow-up|2
1356874|NCT01689857|4472861|P1|Overall Study|Lost to Follow-up|5
1356875|NCT01689649|4472886|P1|Overall Study|Lost to Follow-up|5
1356876|NCT01689649|4472886|P1|Overall Study|Protocol Violation|3
1356877|NCT01689649|4472886|P1|Overall Study|Non-compliance|11
1356878|NCT01689649|4472886|P1|Overall Study|Lack of Efficacy|3
1356879|NCT01689532|4472898|P2|Overall Study|Physician Decision|0
1356880|NCT01689532|4472899|P1|Overall Study|Physician Decision|2
1356881|NCT01689532|4472898|P2|Overall Study|Withdrawal by Subject|2
1356882|NCT01689532|4472899|P1|Overall Study|Withdrawal by Subject|1
1356883|NCT01689532|4472898|P2|Overall Study|Lack of Efficacy|2
1356884|NCT01689532|4472899|P1|Overall Study|Lack of Efficacy|2
1356885|NCT01689532|4472898|P2|Overall Study|Adverse Event|5
1356886|NCT01689532|4472899|P1|Overall Study|Adverse Event|9
1356887|NCT01689519|4472963|P2|Overall Study|Physician Decision|3
1356888|NCT01689519|4472964|P1|Overall Study|Physician Decision|0
1356889|NCT01689519|4472963|P2|Overall Study|Withdrawal by Subject|17
1356890|NCT01689519|4472964|P1|Overall Study|Withdrawal by Subject|17
1356891|NCT01689519|4472963|P2|Overall Study|Lost to Follow-up|2
1356892|NCT01689519|4472964|P1|Overall Study|Lost to Follow-up|6
1356893|NCT01689519|4472963|P2|Overall Study|Death|116
1356894|NCT01689519|4472964|P1|Overall Study|Death|143
1356895|NCT01689363|4472991|P8|Overall Study|Protocol Violation|0
1356896|NCT01689363|4472992|P7|Overall Study|Protocol Violation|0
1356897|NCT01689363|4472993|P6|Overall Study|Protocol Violation|0
1356898|NCT01689363|4472994|P5|Overall Study|Protocol Violation|0
1356899|NCT01689363|4472995|P4|Overall Study|Protocol Violation|0
1356900|NCT01689363|4472996|P3|Overall Study|Protocol Violation|0
1356901|NCT01689363|4472997|P2|Overall Study|Protocol Violation|1
1356902|NCT01689363|4472998|P1|Overall Study|Protocol Violation|0
1356903|NCT01689337|4473053|P1|Overall Study|Study Discontinuation|1
1356904|NCT01689207|4473092|P11|Overall Study|Adverse Event|0
1356905|NCT01689207|4473093|P10|Overall Study|Adverse Event|0
1356906|NCT01689207|4473094|P9|Overall Study|Adverse Event|1
1356907|NCT01689207|4473095|P8|Overall Study|Adverse Event|0
1356908|NCT01689207|4473096|P7|Overall Study|Adverse Event|0
1356909|NCT01689207|4473097|P6|Overall Study|Adverse Event|1
1356910|NCT01689207|4473098|P5|Overall Study|Adverse Event|2
1356911|NCT01689207|4473099|P4|Overall Study|Adverse Event|0
1356912|NCT01689207|4473100|P3|Overall Study|Adverse Event|0
1356913|NCT01689207|4473101|P2|Overall Study|Adverse Event|1
1356914|NCT01689207|4473102|P1|Overall Study|Adverse Event|0
1356915|NCT01688921|4473209|P2|Overall Study|informed consent|0
1356916|NCT01688921|4473210|P1|Overall Study|informed consent|3
1356917|NCT01688921|4473209|P2|Overall Study|Protocol Violation|1
1356918|NCT01688921|4473210|P1|Overall Study|Protocol Violation|0
1356919|NCT01688921|4473209|P2|Overall Study|Physician Decision|1
1356920|NCT01688921|4473210|P1|Overall Study|Physician Decision|6
1356921|NCT01688921|4473209|P2|Overall Study|Lost to Follow-up|13
1356922|NCT01688921|4473210|P1|Overall Study|Lost to Follow-up|7
1356923|NCT01688882|4473235|P2|Overall Study|Administrative problems|0
1356924|NCT01688882|4473236|P1|Overall Study|Administrative problems|1
1356925|NCT01688882|4473235|P2|Overall Study|Unsatisfactory therapeutic effect|1
1356926|NCT01688882|4473236|P1|Overall Study|Unsatisfactory therapeutic effect|1
1356927|NCT01688882|4473235|P2|Overall Study|Adverse Event|0
1356928|NCT01688882|4473236|P1|Overall Study|Adverse Event|1
1356929|NCT01688830|4473281|P21|Overall Study|Lost to Follow-up|0
1356930|NCT01688830|4473282|P20|Overall Study|Lost to Follow-up|0
1356931|NCT01688830|4473283|P19|Overall Study|Lost to Follow-up|0
1356932|NCT01688830|4473284|P18|Overall Study|Lost to Follow-up|0
1356933|NCT01688830|4473285|P17|Overall Study|Lost to Follow-up|0
1356934|NCT01688830|4473286|P16|Overall Study|Lost to Follow-up|0
1356935|NCT01688830|4473287|P15|Overall Study|Lost to Follow-up|0
1356936|NCT01688830|4473288|P14|Overall Study|Lost to Follow-up|0
1356937|NCT01688830|4473289|P13|Overall Study|Lost to Follow-up|0
1356938|NCT01688830|4473290|P12|Overall Study|Lost to Follow-up|0
1356939|NCT01688830|4473291|P11|Overall Study|Lost to Follow-up|1
1356940|NCT01688830|4473292|P10|Overall Study|Lost to Follow-up|0
1356941|NCT01688830|4473293|P9|Overall Study|Lost to Follow-up|0
1356942|NCT01688830|4473294|P8|Overall Study|Lost to Follow-up|0
1356943|NCT01688830|4473295|P7|Overall Study|Lost to Follow-up|0
1356944|NCT01688830|4473296|P6|Overall Study|Lost to Follow-up|0
1356945|NCT01688830|4473297|P5|Overall Study|Lost to Follow-up|0
1356946|NCT01688830|4473298|P4|Overall Study|Lost to Follow-up|0
1356947|NCT01688830|4473299|P3|Overall Study|Lost to Follow-up|0
1356948|NCT01688830|4473300|P2|Overall Study|Lost to Follow-up|0
1356949|NCT01688830|4473301|P1|Overall Study|Lost to Follow-up|0
1356950|NCT01688726|4473447|P2|Overall Study|Relocated abroad|1
1356951|NCT01688726|4473448|P1|Overall Study|Relocated abroad|0
1356952|NCT01688726|4473447|P2|Overall Study|Adverse Event|0
1356953|NCT01688726|4473448|P1|Overall Study|Adverse Event|1
1356954|NCT01688635|4473460|P2|Washout 3|Withdrawal by Subject|0
1356955|NCT01688635|4473461|P1|Washout 3|Withdrawal by Subject|1
1356956|NCT01688635|4473460|P2|Washout 2|Sponsor Decision|2
1356957|NCT01688635|4473461|P1|Washout 2|Sponsor Decision|1
1356958|NCT01688635|4473460|P2|Washout 2|Withdrawal by Subject|0
1356959|NCT01688635|4473461|P1|Washout 2|Withdrawal by Subject|1
1356960|NCT01688635|4473460|P2|Washout 2|Physician Decision|0
1356961|NCT01688635|4473461|P1|Washout 2|Physician Decision|1
1356962|NCT01688635|4473460|P2|Washout 1|Physician Decision|1
1356963|NCT01688635|4473461|P1|Washout 1|Physician Decision|0
1356964|NCT01688635|4473460|P2|Washout 1|Adverse Event|1
1356965|NCT01688635|4473461|P1|Washout 1|Adverse Event|0
1356966|NCT01688635|4473460|P2|Washout 1|Withdrawal by Subject|0
1356967|NCT01688635|4473461|P1|Washout 1|Withdrawal by Subject|1
1356968|NCT01688466|4473483|P2|Overall Study|Not evaluable|1
1356969|NCT01688466|4473484|P1|Overall Study|Not evaluable|0
1356970|NCT01688466|4473483|P2|Overall Study|Adverse Event|4
1356971|NCT01688466|4473484|P1|Overall Study|Adverse Event|0
1356972|NCT01688466|4473483|P2|Overall Study|Death|1
1356973|NCT01688466|4473484|P1|Overall Study|Death|0
1356974|NCT01688466|4473483|P2|Overall Study|Withdrawal by Subject|1
1356975|NCT01688466|4473484|P1|Overall Study|Withdrawal by Subject|2
1356976|NCT01688050|4473554|P1|Overall Study|Still be eligible for follow-up|37
1356977|NCT01688050|4473554|P1|Overall Study|Withdrawal by Subject|2
1356978|NCT01688050|4473554|P1|Overall Study|Lost to Follow-up|5
1356979|NCT01688050|4473554|P1|Overall Study|Conversion to open repair|1
1356980|NCT01688050|4473554|P1|Overall Study|Death|5
1356981|NCT01688037|4473563|P3|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
1356982|NCT01688037|4473564|P2|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
1356983|NCT01688037|4473565|P1|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
1356984|NCT01688037|4473563|P3|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
1356985|NCT01688037|4473564|P2|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
1356986|NCT01688037|4473565|P1|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
1356987|NCT01688037|4473563|P3|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
1356988|NCT01688037|4473564|P2|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
1356989|NCT01688037|4473565|P1|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
1356990|NCT01688037|4473563|P3|Open-Label Period (Week 6 to 12)|Non-compliance|2
1356991|NCT01688037|4473564|P2|Open-Label Period (Week 6 to 12)|Non-compliance|0
1356992|NCT01688037|4473565|P1|Open-Label Period (Week 6 to 12)|Non-compliance|0
1356993|NCT01688037|4473563|P3|Open-Label Period (Week 6 to 12)|Adverse Event|1
1356994|NCT01688037|4473564|P2|Open-Label Period (Week 6 to 12)|Adverse Event|1
1356995|NCT01688037|4473565|P1|Open-Label Period (Week 6 to 12)|Adverse Event|4
1356996|NCT01688037|4473563|P3|Double-Blind Period (Week 0 to 6)|Physician Decision|0
1356997|NCT01688037|4473564|P2|Double-Blind Period (Week 0 to 6)|Physician Decision|1
1356998|NCT01688037|4473565|P1|Double-Blind Period (Week 0 to 6)|Physician Decision|0
1356999|NCT01688037|4473563|P3|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
1357000|NCT01688037|4473564|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
1357001|NCT01688037|4473565|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
1357002|NCT01688037|4473563|P3|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
1357003|NCT01688037|4473564|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
1357004|NCT01688037|4473565|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
1357005|NCT01688037|4473563|P3|Double-Blind Period (Week 0 to 6)|Non-compliance|3
1357006|NCT01688037|4473564|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
1357007|NCT01688037|4473565|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|1
1357008|NCT01688037|4473563|P3|Double-Blind Period (Week 0 to 6)|Adverse Event|1
1357009|NCT01688037|4473564|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
1357010|NCT01688037|4473565|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|1
1357011|NCT01687998|4473581|P2|Overall Study|Lost to Follow-up|7
1357012|NCT01687998|4473582|P1|Overall Study|Lost to Follow-up|9
1357013|NCT01687998|4473581|P2|Overall Study|Known to be Alive at Study End|62
1357014|NCT01687998|4473582|P1|Overall Study|Known to be Alive at Study End|54
1357015|NCT01687998|4473581|P2|Overall Study|Withdrawal by Subject|51
1357016|NCT01687998|4473582|P1|Overall Study|Withdrawal by Subject|49
1357017|NCT01687712|4473618|P2|Cycle 3|Miscarriage/Spontaneous Abortion|0
1357018|NCT01687712|4473619|P1|Cycle 3|Miscarriage/Spontaneous Abortion|1
1357019|NCT01687712|4473618|P2|Cycle 3|Ectopic Pregnancy|0
1357020|NCT01687712|4473619|P1|Cycle 3|Ectopic Pregnancy|1
1357021|NCT01687712|4473618|P2|Cycle 3|Early Pregnancy Loss|2
1357022|NCT01687712|4473619|P1|Cycle 3|Early Pregnancy Loss|1
1357023|NCT01687712|4473618|P2|Cycle 3|Not Biochemically Pregnant|22
1357024|NCT01687712|4473619|P1|Cycle 3|Not Biochemically Pregnant|21
1357025|NCT01687712|4473618|P2|Cycle 2|Miscarriage/Spontaneous Abortion|1
1357026|NCT01687712|4473619|P1|Cycle 2|Miscarriage/Spontaneous Abortion|0
1357027|NCT01687712|4473618|P2|Cycle 2|Still Birth|0
1357028|NCT01687712|4473619|P1|Cycle 2|Still Birth|1
1357029|NCT01687712|4473618|P2|Cycle 2|Ectopic Pregnancy|1
1357030|NCT01687712|4473619|P1|Cycle 2|Ectopic Pregnancy|0
1357031|NCT01687712|4473618|P2|Cycle 2|Early Pregnancy Loss|16
1357032|NCT01687712|4473619|P1|Cycle 2|Early Pregnancy Loss|18
1357033|NCT01687712|4473618|P2|Cycle 2|Not Biochemically Pregnant|77
1357034|NCT01687712|4473619|P1|Cycle 2|Not Biochemically Pregnant|74
1357035|NCT01687712|4473618|P2|Cycle 1|Lost to Follow-up|1
1357036|NCT01687712|4473619|P1|Cycle 1|Lost to Follow-up|1
1357037|NCT01687712|4473618|P2|Cycle 1|Intrauterine Fetal Death|1
1357038|NCT01687712|4473619|P1|Cycle 1|Intrauterine Fetal Death|0
1357039|NCT01687712|4473618|P2|Cycle 1|Abortion|0
1357040|NCT01687712|4473619|P1|Cycle 1|Abortion|3
1357041|NCT01687712|4473618|P2|Cycle 1|Miscarriage/Spontaneous Abortion|14
1357042|NCT01687712|4473619|P1|Cycle 1|Miscarriage/Spontaneous Abortion|9
1357043|NCT01687712|4473618|P2|Cycle 1|Heterotropic Pregnancy|0
1357044|NCT01687712|4473619|P1|Cycle 1|Heterotropic Pregnancy|1
1357045|NCT01687712|4473618|P2|Cycle 1|Ectopic Pregnancy|5
1357046|NCT01687712|4473619|P1|Cycle 1|Ectopic Pregnancy|5
1357047|NCT01687712|4473618|P2|Cycle 1|Early Pregnancy Loss|60
1357048|NCT01687712|4473619|P1|Cycle 1|Early Pregnancy Loss|43
1357049|NCT01687712|4473618|P2|Cycle 1|Not Biochemically Pregnant|348
1357050|NCT01687712|4473619|P1|Cycle 1|Not Biochemically Pregnant|386
1357051|NCT01687478|4473659|P2|Overall Study|Entry Criteria Not Met|2
1357052|NCT01687478|4473660|P1|Overall Study|Entry Criteria Not Met|6
1357053|NCT01687478|4473659|P2|Overall Study|Physician Decision|3
1357054|NCT01687478|4473660|P1|Overall Study|Physician Decision|1
1357055|NCT01687478|4473659|P2|Overall Study|Withdrawal by Subject|19
1357056|NCT01687478|4473660|P1|Overall Study|Withdrawal by Subject|21
1357057|NCT01687478|4473659|P2|Overall Study|Protocol Violation|2
1357058|NCT01687478|4473660|P1|Overall Study|Protocol Violation|0
1357059|NCT01687478|4473659|P2|Overall Study|Lost to Follow-up|3
1357060|NCT01687478|4473660|P1|Overall Study|Lost to Follow-up|1
1357061|NCT01687478|4473659|P2|Overall Study|Adverse Event|10
1357062|NCT01687478|4473660|P1|Overall Study|Adverse Event|3
1357063|NCT01687296|4473684|P2|Overall Study|Withdrawal by Subject|3
1357064|NCT01687296|4473685|P1|Overall Study|Withdrawal by Subject|6
1357065|NCT01687296|4473684|P2|Overall Study|Protocol Violation|1
1357066|NCT01687296|4473685|P1|Overall Study|Protocol Violation|0
1357067|NCT01687296|4473684|P2|Overall Study|Lack of Efficacy|1
1357068|NCT01687296|4473685|P1|Overall Study|Lack of Efficacy|1
1357069|NCT01687283|4473707|P2|Overall Study|Withdrawal by Subject|8
1357070|NCT01687283|4473708|P1|Overall Study|Withdrawal by Subject|9
1357071|NCT01687283|4473707|P2|Overall Study|Investigator discretion|0
1357072|NCT01687283|4473708|P1|Overall Study|Investigator discretion|2
1357073|NCT01687283|4473707|P2|Overall Study|Lost to Follow-up|1
1357074|NCT01687283|4473708|P1|Overall Study|Lost to Follow-up|1
1357075|NCT01687283|4473707|P2|Overall Study|protocol defined stopping criteria|10
1357076|NCT01687283|4473708|P1|Overall Study|protocol defined stopping criteria|8
1357077|NCT01687283|4473707|P2|Overall Study|Protocol Violation|3
1357078|NCT01687283|4473708|P1|Overall Study|Protocol Violation|1
1357079|NCT01687283|4473707|P2|Overall Study|Lack of Efficacy|1
1357080|NCT01687283|4473708|P1|Overall Study|Lack of Efficacy|3
1357081|NCT01687283|4473707|P2|Overall Study|Adverse Event|4
1357082|NCT01687283|4473708|P1|Overall Study|Adverse Event|11
1357083|NCT01687270|4473731|P1|Overall Study|Lost to Follow-up|1
1357084|NCT01687270|4473731|P1|Overall Study|Lack of Efficacy|11
1357085|NCT01687257|4473742|P3|Overall Study|Investigator's Discretion|0
1357086|NCT01687257|4473743|P2|Overall Study|Investigator's Discretion|3
1357087|NCT01687257|4473744|P1|Overall Study|Investigator's Discretion|0
1357088|NCT01687257|4473742|P3|Overall Study|Adverse Event|0
1357089|NCT01687257|4473743|P2|Overall Study|Adverse Event|0
1357090|NCT01687257|4473744|P1|Overall Study|Adverse Event|1
1357091|NCT01687257|4473742|P3|Overall Study|Subject Withdrew Consent|1
1357092|NCT01687257|4473743|P2|Overall Study|Subject Withdrew Consent|1
1357093|NCT01687257|4473744|P1|Overall Study|Subject Withdrew Consent|1
1357094|NCT01687257|4473742|P3|Overall Study|Efficacy Failure|5
1357095|NCT01687257|4473743|P2|Overall Study|Efficacy Failure|0
1357096|NCT01687257|4473744|P1|Overall Study|Efficacy Failure|6
1357097|NCT01687218|4473809|P6|Overall Study|Relocated, no follow-up planned|0
1357098|NCT01687218|4473810|P5|Overall Study|Relocated, no follow-up planned|0
1357099|NCT01687218|4473811|P4|Overall Study|Relocated, no follow-up planned|1
1357100|NCT01687218|4473812|P3|Overall Study|Relocated, no follow-up planned|1
1357101|NCT01687218|4473813|P2|Overall Study|Relocated, no follow-up planned|0
1357102|NCT01687218|4473814|P1|Overall Study|Relocated, no follow-up planned|1
1357103|NCT01687218|4473809|P6|Overall Study|Withdrawal by Subject|0
1357104|NCT01687218|4473810|P5|Overall Study|Withdrawal by Subject|1
1357105|NCT01687218|4473811|P4|Overall Study|Withdrawal by Subject|1
1357106|NCT01687218|4473812|P3|Overall Study|Withdrawal by Subject|0
1357107|NCT01687218|4473813|P2|Overall Study|Withdrawal by Subject|3
1357108|NCT01687218|4473814|P1|Overall Study|Withdrawal by Subject|2
1357109|NCT01687166|4473838|P4|Overall Study|Insurance|1
1357110|NCT01687166|4473839|P3|Overall Study|Insurance|1
1357111|NCT01687166|4473840|P2|Overall Study|Insurance|0
1357112|NCT01687166|4473841|P1|Overall Study|Insurance|0
1357113|NCT01687166|4473838|P4|Overall Study|Physician choice to use different device|0
1357114|NCT01687166|4473839|P3|Overall Study|Physician choice to use different device|4
1357115|NCT01687166|4473840|P2|Overall Study|Physician choice to use different device|2
1357116|NCT01687166|4473841|P1|Overall Study|Physician choice to use different device|1
1357117|NCT01687166|4473838|P4|Overall Study|Patient unable to be compliant|0
1357118|NCT01687166|4473839|P3|Overall Study|Patient unable to be compliant|0
1357119|NCT01687166|4473840|P2|Overall Study|Patient unable to be compliant|0
1357120|NCT01687166|4473841|P1|Overall Study|Patient unable to be compliant|1
1357121|NCT01687166|4473838|P4|Overall Study|Subject moved out of state|0
1357122|NCT01687166|4473839|P3|Overall Study|Subject moved out of state|0
1357123|NCT01687166|4473840|P2|Overall Study|Subject moved out of state|1
1357124|NCT01687166|4473841|P1|Overall Study|Subject moved out of state|0
1357125|NCT01687166|4473838|P4|Overall Study|Protocol Violation|0
1357126|NCT01687166|4473839|P3|Overall Study|Protocol Violation|1
1357127|NCT01687166|4473840|P2|Overall Study|Protocol Violation|1
1357128|NCT01687166|4473841|P1|Overall Study|Protocol Violation|1
1357129|NCT01687166|4473838|P4|Overall Study|Death|0
1357130|NCT01687166|4473839|P3|Overall Study|Death|0
1357131|NCT01687166|4473840|P2|Overall Study|Death|1
1357132|NCT01687166|4473841|P1|Overall Study|Death|1
1357133|NCT01687166|4473838|P4|Overall Study|Equipment/Device Availability|0
1357134|NCT01687166|4473839|P3|Overall Study|Equipment/Device Availability|0
1357135|NCT01687166|4473840|P2|Overall Study|Equipment/Device Availability|1
1357136|NCT01687166|4473841|P1|Overall Study|Equipment/Device Availability|0
1357137|NCT01687166|4473838|P4|Overall Study|Lost to Follow-up|0
1357138|NCT01687166|4473839|P3|Overall Study|Lost to Follow-up|1
1357139|NCT01687166|4473840|P2|Overall Study|Lost to Follow-up|5
1357140|NCT01687166|4473841|P1|Overall Study|Lost to Follow-up|2
1357141|NCT01687166|4473838|P4|Overall Study|Withdrawal by Subject|0
1357142|NCT01687166|4473839|P3|Overall Study|Withdrawal by Subject|3
1357143|NCT01687166|4473840|P2|Overall Study|Withdrawal by Subject|4
1357144|NCT01687166|4473841|P1|Overall Study|Withdrawal by Subject|11
1357145|NCT01687166|4473838|P4|Overall Study|Physician Decision|0
1357146|NCT01687166|4473839|P3|Overall Study|Physician Decision|1
1357147|NCT01687166|4473840|P2|Overall Study|Physician Decision|2
1357148|NCT01687166|4473841|P1|Overall Study|Physician Decision|3
1357149|NCT01687166|4473838|P4|Overall Study|Adverse Event|0
1357150|NCT01687166|4473839|P3|Overall Study|Adverse Event|0
1357151|NCT01687166|4473840|P2|Overall Study|Adverse Event|1
1357152|NCT01687166|4473841|P1|Overall Study|Adverse Event|2
1357153|NCT01687166|4473838|P4|Overall Study|Did not meet eligibility criteria|1
1357154|NCT01687166|4473839|P3|Overall Study|Did not meet eligibility criteria|1
1357155|NCT01687166|4473840|P2|Overall Study|Did not meet eligibility criteria|6
1357156|NCT01687166|4473841|P1|Overall Study|Did not meet eligibility criteria|4
1357157|NCT01687166|4473838|P4|Overall Study|Attempt subject|0
1357158|NCT01687166|4473839|P3|Overall Study|Attempt subject|2
1357159|NCT01687166|4473840|P2|Overall Study|Attempt subject|3
1357160|NCT01687166|4473841|P1|Overall Study|Attempt subject|2
1357161|NCT01687101|4473857|P1|Overall Study|Lost to Follow-up|7
1357162|NCT01686932|4473884|P2|Period 1|Adverse Event|1
1357163|NCT01686932|4473885|P1|Period 1|Adverse Event|1
1357164|NCT01686828|4473915|P4|Overall Study|Weight Loss|0
1357165|NCT01686828|4473916|P3|Overall Study|Weight Loss|1
1357166|NCT01686828|4473917|P2|Overall Study|Weight Loss|0
1357167|NCT01686828|4473918|P1|Overall Study|Weight Loss|0
1357168|NCT01686828|4473915|P4|Overall Study|New Job|0
1357169|NCT01686828|4473916|P3|Overall Study|New Job|0
1357170|NCT01686828|4473917|P2|Overall Study|New Job|1
1357171|NCT01686828|4473918|P1|Overall Study|New Job|0
1357172|NCT01686828|4473915|P4|Overall Study|Physician Decision|0
1357173|NCT01686828|4473916|P3|Overall Study|Physician Decision|0
1357174|NCT01686828|4473917|P2|Overall Study|Physician Decision|0
1357175|NCT01686828|4473918|P1|Overall Study|Physician Decision|1
1357176|NCT01686633|4473992|P3|Overall Study|Lost to Follow-up|1
1357177|NCT01686633|4473993|P2|Overall Study|Lost to Follow-up|1
1357178|NCT01686633|4473994|P1|Overall Study|Lost to Follow-up|0
1357179|NCT01686633|4473992|P3|Overall Study|Protocol-defined Stopping Criteria|1
1357180|NCT01686633|4473993|P2|Overall Study|Protocol-defined Stopping Criteria|0
1357181|NCT01686633|4473994|P1|Overall Study|Protocol-defined Stopping Criteria|1
1357182|NCT01686633|4473992|P3|Overall Study|Protocol Violation|0
1357183|NCT01686633|4473993|P2|Overall Study|Protocol Violation|3
1357184|NCT01686633|4473994|P1|Overall Study|Protocol Violation|2
1357185|NCT01686633|4473992|P3|Overall Study|Adverse Event|3
1357186|NCT01686633|4473993|P2|Overall Study|Adverse Event|3
1357187|NCT01686633|4473994|P1|Overall Study|Adverse Event|4
1357188|NCT01686633|4473992|P3|Overall Study|Physician Decision|4
1357189|NCT01686633|4473993|P2|Overall Study|Physician Decision|4
1357190|NCT01686633|4473994|P1|Overall Study|Physician Decision|3
1357191|NCT01686633|4473992|P3|Overall Study|Withdrawal by Subject|5
1357192|NCT01686633|4473993|P2|Overall Study|Withdrawal by Subject|8
1357193|NCT01686633|4473994|P1|Overall Study|Withdrawal by Subject|8
1357194|NCT01686633|4473992|P3|Overall Study|Lack of Efficacy|11
1357195|NCT01686633|4473993|P2|Overall Study|Lack of Efficacy|13
1357196|NCT01686633|4473994|P1|Overall Study|Lack of Efficacy|33
1357197|NCT01686568|4474019|P2|Sub-Study|Not consented for sub-study|2
1357198|NCT01686568|4474020|P1|Sub-Study|Not consented for sub-study|2
1357199|NCT01686568|4474019|P2|Main Study|Liver enzymes above range of exclusion|0
1357200|NCT01686568|4474020|P1|Main Study|Liver enzymes above range of exclusion|1
1357201|NCT01686568|4474019|P2|Main Study|Noncompliance with protocol|1
1357202|NCT01686568|4474020|P1|Main Study|Noncompliance with protocol|0
1357203|NCT01686568|4474019|P2|Main Study|Withdrawal by Subject|3
1357204|NCT01686568|4474020|P1|Main Study|Withdrawal by Subject|1
1357205|NCT01685983|4474112|P1|Overall Study|Other|7
1357206|NCT01685983|4474112|P1|Overall Study|Noncompliance with Study Drug|1
1357207|NCT01685983|4474112|P1|Overall Study|Physician Decision|13
1357208|NCT01685983|4474112|P1|Overall Study|Progressive Disease|32
1357209|NCT01685983|4474112|P1|Overall Study|Protocol Violation|2
1357210|NCT01685983|4474112|P1|Overall Study|Withdrawal by Subject|19
1357211|NCT01685983|4474112|P1|Overall Study|Death|1
1357212|NCT01685983|4474112|P1|Overall Study|Adverse Event|7
1357213|NCT01685840|4474124|P2|Overall Study|Had VAD, Dialysis or Transplant|17
1357214|NCT01685840|4474125|P1|Overall Study|Had VAD, Dialysis or Transplant|11
1357215|NCT01685840|4474124|P2|Overall Study|Futility|200
1357216|NCT01685840|4474125|P1|Overall Study|Futility|197
1357217|NCT01685840|4474124|P2|Overall Study|Withdrawal by Subject|17
1357218|NCT01685840|4474125|P1|Overall Study|Withdrawal by Subject|14
1357219|NCT01685840|4474124|P2|Overall Study|Physician Decision|7
1357220|NCT01685840|4474125|P1|Overall Study|Physician Decision|3
1357221|NCT01685840|4474124|P2|Overall Study|Lost to Follow-up|25
1357222|NCT01685840|4474125|P1|Overall Study|Lost to Follow-up|27
1357223|NCT01685840|4474124|P2|Overall Study|Death|66
1357224|NCT01685840|4474125|P1|Overall Study|Death|77
1357225|NCT01685801|4474169|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
1357226|NCT01685801|4474170|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
1357227|NCT01685801|4474171|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
1357228|NCT01685801|4474172|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
1357229|NCT01685801|4474169|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
1357230|NCT01685801|4474170|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
1357231|NCT01685801|4474171|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
1357232|NCT01685801|4474172|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
1357233|NCT01685606|4474220|P1|Overall Study|Withdrawal by Subject|1
1357234|NCT01685437|4474233|P1|Overall Study|Unable to make visits due to work|1
1357235|NCT01685437|4474233|P1|Overall Study|Protocol Violation|4
1357236|NCT01685437|4474233|P1|Overall Study|Adverse Event|1
1357237|NCT01685437|4474233|P1|Overall Study|Lost to Follow-up|3
1357238|NCT01685437|4474233|P1|Overall Study|Withdrawal by Subject|22
1357239|NCT01685372|4474247|P2|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
1357240|NCT01685372|4474248|P1|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
1357241|NCT01685216|4474336|P1|Overall Study|Did not receive study drug|1
1357242|NCT01685203|4474353|P7|Overall Study|Patient's decision|0
1357243|NCT01685203|4474354|P6|Overall Study|Patient's decision|1
1357244|NCT01685203|4474355|P5|Overall Study|Patient's decision|0
1357245|NCT01685203|4474356|P4|Overall Study|Patient's decision|0
1357246|NCT01685203|4474357|P3|Overall Study|Patient's decision|0
1357247|NCT01685203|4474358|P2|Overall Study|Patient's decision|0
1357248|NCT01685203|4474359|P1|Overall Study|Patient's decision|0
1357249|NCT01685203|4474353|P7|Overall Study|Adverse event and withdrew consent|0
1357250|NCT01685203|4474354|P6|Overall Study|Adverse event and withdrew consent|0
1357251|NCT01685203|4474355|P5|Overall Study|Adverse event and withdrew consent|0
1357252|NCT01685203|4474356|P4|Overall Study|Adverse event and withdrew consent|0
1357253|NCT01685203|4474357|P3|Overall Study|Adverse event and withdrew consent|0
1357254|NCT01685203|4474358|P2|Overall Study|Adverse event and withdrew consent|0
1357255|NCT01685203|4474359|P1|Overall Study|Adverse event and withdrew consent|1
1357256|NCT01685203|4474353|P7|Overall Study|Adverse Event|0
1357257|NCT01685203|4474354|P6|Overall Study|Adverse Event|2
1357258|NCT01685203|4474355|P5|Overall Study|Adverse Event|0
1357259|NCT01685203|4474356|P4|Overall Study|Adverse Event|0
1357260|NCT01685203|4474357|P3|Overall Study|Adverse Event|0
1357261|NCT01685203|4474358|P2|Overall Study|Adverse Event|0
1357262|NCT01685203|4474359|P1|Overall Study|Adverse Event|0
1357263|NCT01685203|4474353|P7|Overall Study|Lost to Follow-up|0
1357264|NCT01685203|4474354|P6|Overall Study|Lost to Follow-up|0
1357265|NCT01685203|4474355|P5|Overall Study|Lost to Follow-up|0
1357266|NCT01685203|4474356|P4|Overall Study|Lost to Follow-up|1
1357267|NCT01685203|4474357|P3|Overall Study|Lost to Follow-up|0
1357268|NCT01685203|4474358|P2|Overall Study|Lost to Follow-up|3
1357269|NCT01685203|4474359|P1|Overall Study|Lost to Follow-up|3
1357270|NCT01685060|4474403|P1|Overall Study|Death|8
1357271|NCT01685060|4474403|P1|Overall Study|Lost to Follow-up|1
1357272|NCT01685060|4474403|P1|Overall Study|Subject/guardian decision|20
1357273|NCT01685060|4474403|P1|Overall Study|Physician Decision|14
1357274|NCT01685060|4474403|P1|Overall Study|Progressive disease|69
1357275|NCT01685060|4474403|P1|Overall Study|Adverse Event|12
1357276|NCT01685060|4474403|P1|Overall Study|Rollover patients|16
1357277|NCT01684930|4474429|P2|Overall Study|Withdrawal by Subject|1
1357278|NCT01684930|4474430|P1|Overall Study|Withdrawal by Subject|3
1357279|NCT01684878|4474450|P4|Part 2: Randomized Phase|Participant noncompliance|1
1357280|NCT01684878|4474451|P3|Part 2: Randomized Phase|Participant noncompliance|0
1357281|NCT01684878|4474452|P2|Part 2: Randomized Phase|Participant noncompliance|0
1357282|NCT01684878|4474453|P1|Part 2: Randomized Phase|Participant noncompliance|0
1357283|NCT01684878|4474450|P4|Part 2: Randomized Phase|Alive at data-cut|7
1357284|NCT01684878|4474451|P3|Part 2: Randomized Phase|Alive at data-cut|13
1357285|NCT01684878|4474452|P2|Part 2: Randomized Phase|Alive at data-cut|0
1357286|NCT01684878|4474453|P1|Part 2: Randomized Phase|Alive at data-cut|0
1357287|NCT01684878|4474450|P4|Part 2: Randomized Phase|Death|68
1357288|NCT01684878|4474451|P3|Part 2: Randomized Phase|Death|62
1357289|NCT01684878|4474452|P2|Part 2: Randomized Phase|Death|0
1357290|NCT01684878|4474453|P1|Part 2: Randomized Phase|Death|0
1357291|NCT01684878|4474450|P4|Part 2: Randomized Phase|Lost to Follow-up|0
1357292|NCT01684878|4474451|P3|Part 2: Randomized Phase|Lost to Follow-up|2
1357293|NCT01684878|4474452|P2|Part 2: Randomized Phase|Lost to Follow-up|0
1357294|NCT01684878|4474453|P1|Part 2: Randomized Phase|Lost to Follow-up|0
1357295|NCT01684878|4474450|P4|Part 2: Randomized Phase|Participant withdrew consent|2
1357296|NCT01684878|4474451|P3|Part 2: Randomized Phase|Participant withdrew consent|1
1357297|NCT01684878|4474452|P2|Part 2: Randomized Phase|Participant withdrew consent|0
1357298|NCT01684878|4474453|P1|Part 2: Randomized Phase|Participant withdrew consent|0
1357299|NCT01684878|4474450|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
1357300|NCT01684878|4474451|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
1357301|NCT01684878|4474452|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
1357302|NCT01684878|4474453|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
1357303|NCT01684878|4474450|P4|Part 1: Safety Run in Phase|Death|0
1357304|NCT01684878|4474451|P3|Part 1: Safety Run in Phase|Death|0
1357305|NCT01684878|4474452|P2|Part 1: Safety Run in Phase|Death|20
1357306|NCT01684878|4474453|P1|Part 1: Safety Run in Phase|Death|15
1357307|NCT01684878|4474450|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
1357308|NCT01684878|4474451|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
1357309|NCT01684878|4474452|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
1357310|NCT01684878|4474453|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
1357311|NCT01684423|4474557|P5|Overall Study|Withdrawal by Subject|0
1357312|NCT01684423|4474558|P4|Overall Study|Withdrawal by Subject|0
1357313|NCT01684423|4474559|P3|Overall Study|Withdrawal by Subject|1
1357314|NCT01684423|4474560|P2|Overall Study|Withdrawal by Subject|0
1357315|NCT01684423|4474561|P1|Overall Study|Withdrawal by Subject|0
1357316|NCT01684215|4474618|P4|Overall Study|Ongoing at date of cut-off|38
1357317|NCT01684215|4474619|P3|Overall Study|Ongoing at date of cut-off|4
1357318|NCT01684215|4474620|P2|Overall Study|Ongoing at date of cut-off|0
1357319|NCT01684215|4474621|P1|Overall Study|Ongoing at date of cut-off|0
1357320|NCT01684215|4474618|P4|Overall Study|Death|1
1357321|NCT01684215|4474619|P3|Overall Study|Death|0
1357322|NCT01684215|4474620|P2|Overall Study|Death|0
1357323|NCT01684215|4474621|P1|Overall Study|Death|0
1357324|NCT01684215|4474618|P4|Overall Study|Other|0
1357325|NCT01684215|4474619|P3|Overall Study|Other|1
1357326|NCT01684215|4474620|P2|Overall Study|Other|0
1357327|NCT01684215|4474621|P1|Overall Study|Other|0
1357328|NCT01684215|4474618|P4|Overall Study|Objective progression or relapse|0
1357329|NCT01684215|4474619|P3|Overall Study|Objective progression or relapse|0
1357330|NCT01684215|4474620|P2|Overall Study|Objective progression or relapse|6
1357331|NCT01684215|4474621|P1|Overall Study|Objective progression or relapse|5
1357332|NCT01684215|4474618|P4|Overall Study|Adverse Event|4
1357333|NCT01684215|4474619|P3|Overall Study|Adverse Event|1
1357334|NCT01684215|4474620|P2|Overall Study|Adverse Event|0
1357335|NCT01684215|4474621|P1|Overall Study|Adverse Event|1
1357336|NCT01684046|4474695|P2|Period 1, First 30 Days|Adverse Event|2
1357337|NCT01684046|4474696|P1|Period 1, First 30 Days|Adverse Event|0
1357338|NCT01684033|4474702|P2|Period 2, Second 30 Days|Adverse Event|0
1357339|NCT01684033|4474703|P1|Period 2, Second 30 Days|Adverse Event|1
1357340|NCT01684033|4474702|P2|Period 1, First 30 Days|Lost to Follow-up|0
1357341|NCT01684033|4474703|P1|Period 1, First 30 Days|Lost to Follow-up|1
1357342|NCT01684033|4474702|P2|Period 1, First 30 Days|Withdrawal by Subject|0
1357343|NCT01684033|4474703|P1|Period 1, First 30 Days|Withdrawal by Subject|1
1357344|NCT01684033|4474702|P2|Period 1, First 30 Days|Noncompliance|0
1357345|NCT01684033|4474703|P1|Period 1, First 30 Days|Noncompliance|1
1357346|NCT01684033|4474702|P2|Period 1, First 30 Days|Adverse Event|1
1357347|NCT01684033|4474703|P1|Period 1, First 30 Days|Adverse Event|1
1357348|NCT01683838|4474737|P2|Overall Study|not specified|3
1357349|NCT01683838|4474738|P1|Overall Study|not specified|4
1357350|NCT01683838|4474737|P2|Overall Study|Lost to Follow-up|1
1357351|NCT01683838|4474738|P1|Overall Study|Lost to Follow-up|1
1357352|NCT01683838|4474737|P2|Overall Study|Withdrawal by Subject|5
1357353|NCT01683838|4474738|P1|Overall Study|Withdrawal by Subject|6
1357354|NCT01683838|4474737|P2|Overall Study|Protocol Violation|1
1357355|NCT01683838|4474738|P1|Overall Study|Protocol Violation|3
1357356|NCT01683838|4474737|P2|Overall Study|Adverse Event|2
1357357|NCT01683838|4474738|P1|Overall Study|Adverse Event|12
1357358|NCT01683604|4474778|P1|Overall Study|Other|2
1357359|NCT01683604|4474778|P1|Overall Study|Lack of Efficacy|1
1357360|NCT01683604|4474778|P1|Overall Study|Adverse Event|2
1357361|NCT01683409|4474963|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1357362|NCT01683409|4474964|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1357363|NCT01683409|4474965|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
1357364|NCT01683409|4474966|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1357365|NCT01683409|4474967|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1357366|NCT01683409|4474963|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
1357367|NCT01683409|4474964|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1357368|NCT01683409|4474965|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1357369|NCT01683409|4474966|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1357370|NCT01683409|4474967|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1357371|NCT01683409|4474963|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
1357372|NCT01683409|4474964|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
1357373|NCT01683409|4474965|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
1357374|NCT01683409|4474966|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
1357375|NCT01683409|4474967|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
1357376|NCT01683409|4474963|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1357377|NCT01683409|4474964|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1357378|NCT01683409|4474965|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1357379|NCT01683409|4474966|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1357380|NCT01683409|4474967|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
1357381|NCT01683409|4474963|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
1357382|NCT01683409|4474964|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
1357383|NCT01683409|4474965|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
1357384|NCT01683409|4474966|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
1357385|NCT01683409|4474967|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
1357386|NCT01683409|4474963|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
1357387|NCT01683409|4474964|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
1357388|NCT01683409|4474965|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
1357389|NCT01683409|4474966|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
1357390|NCT01683409|4474967|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
1357391|NCT01683409|4474963|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1357392|NCT01683409|4474964|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1357393|NCT01683409|4474965|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
1357394|NCT01683409|4474966|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1357395|NCT01683409|4474967|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1357396|NCT01683409|4474963|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
1357397|NCT01683409|4474964|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
1357398|NCT01683409|4474965|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
1357399|NCT01683409|4474966|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
1357400|NCT01683409|4474967|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
1357401|NCT01683409|4474963|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1357402|NCT01683409|4474964|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1357403|NCT01683409|4474965|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1357404|NCT01683409|4474966|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
1357405|NCT01683409|4474967|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1357406|NCT01683409|4474963|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
1357407|NCT01683409|4474964|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
1357408|NCT01683409|4474965|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
1357409|NCT01683409|4474966|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
1357410|NCT01683409|4474967|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
1357411|NCT01683409|4474963|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1357412|NCT01683409|4474964|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1357413|NCT01683409|4474965|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
1357414|NCT01683409|4474966|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1357415|NCT01683409|4474967|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1357416|NCT01683383|4475010|P2|Overall Study|Infant was not transported|0
1357417|NCT01683383|4475011|P1|Overall Study|Infant was not transported|1
1357418|NCT01683266|4475027|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
1357419|NCT01683266|4475028|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
1357420|NCT01683266|4475027|P2|Overall Study|Possibly Hypoglycemia|0
1357421|NCT01683266|4475028|P1|Overall Study|Possibly Hypoglycemia|1
1357422|NCT01683266|4475027|P2|Overall Study|Perceived Lack of Efficacy|1
1357423|NCT01683266|4475028|P1|Overall Study|Perceived Lack of Efficacy|1
1357424|NCT01683266|4475027|P2|Overall Study|Nonserious Hypoglycemia|3
1357425|NCT01683266|4475028|P1|Overall Study|Nonserious Hypoglycemia|0
1357426|NCT01683266|4475027|P2|Overall Study|Site Closure / Site Withdrawal|3
1357427|NCT01683266|4475028|P1|Overall Study|Site Closure / Site Withdrawal|1
1357428|NCT01683266|4475027|P2|Overall Study|Lost to Follow-up|0
1357429|NCT01683266|4475028|P1|Overall Study|Lost to Follow-up|5
1357430|NCT01683266|4475027|P2|Overall Study|Selection Criterion / Protocol Violation|5
1357431|NCT01683266|4475028|P1|Overall Study|Selection Criterion / Protocol Violation|7
1357432|NCT01683266|4475027|P2|Overall Study|Personal Reason|25
1357433|NCT01683266|4475028|P1|Overall Study|Personal Reason|17
1357434|NCT01683266|4475027|P2|Overall Study|Protocol Violation|6
1357435|NCT01683266|4475028|P1|Overall Study|Protocol Violation|13
1357436|NCT01683266|4475027|P2|Overall Study|Lack of Efficacy|2
1357437|NCT01683266|4475028|P1|Overall Study|Lack of Efficacy|5
1357438|NCT01683266|4475027|P2|Overall Study|Adverse Event|4
1357439|NCT01683266|4475028|P1|Overall Study|Adverse Event|5
1357440|NCT01683058|4475056|P1|Overall Study|Lack of Efficacy|2
1357441|NCT01683058|4475056|P1|Overall Study|Withdrawal by Subject|7
1357442|NCT01683058|4475056|P1|Overall Study|Subject Met Withdrawal Criteria|5
1357443|NCT01683058|4475056|P1|Overall Study|Adverse Event|6
1357444|NCT01683058|4475056|P1|Overall Study|Lost to Follow-up|9
1357445|NCT01683019|4475087|P3|Overall Study|Withdrawal by Subject|4
1357446|NCT01683019|4475088|P2|Overall Study|Withdrawal by Subject|1
1357447|NCT01683019|4475089|P1|Overall Study|Withdrawal by Subject|2
1357448|NCT01682876|4475112|P4|Overall Study|Other|1
1357449|NCT01682876|4475113|P3|Overall Study|Other|1
1357450|NCT01682876|4475114|P2|Overall Study|Other|0
1357451|NCT01682876|4475115|P1|Overall Study|Other|1
1357452|NCT01682876|4475112|P4|Overall Study|Withdrawal by Subject|2
1357453|NCT01682876|4475113|P3|Overall Study|Withdrawal by Subject|0
1357454|NCT01682876|4475114|P2|Overall Study|Withdrawal by Subject|0
1357455|NCT01682876|4475115|P1|Overall Study|Withdrawal by Subject|4
1357456|NCT01682876|4475112|P4|Overall Study|Protocol Violation|1
1357457|NCT01682876|4475113|P3|Overall Study|Protocol Violation|1
1357458|NCT01682876|4475114|P2|Overall Study|Protocol Violation|1
1357459|NCT01682876|4475115|P1|Overall Study|Protocol Violation|1
1357460|NCT01682876|4475112|P4|Overall Study|Lost to Follow-up|11
1357461|NCT01682876|4475113|P3|Overall Study|Lost to Follow-up|9
1357462|NCT01682876|4475114|P2|Overall Study|Lost to Follow-up|15
1357463|NCT01682876|4475115|P1|Overall Study|Lost to Follow-up|11
1357464|NCT01682876|4475112|P4|Overall Study|Adverse Event|1
1357465|NCT01682876|4475113|P3|Overall Study|Adverse Event|0
1357466|NCT01682876|4475114|P2|Overall Study|Adverse Event|0
1357467|NCT01682876|4475115|P1|Overall Study|Adverse Event|0
1357468|NCT01682876|4475112|P4|Overall Study|Administrative reason|3
1357469|NCT01682876|4475113|P3|Overall Study|Administrative reason|0
1357470|NCT01682876|4475114|P2|Overall Study|Administrative reason|4
1357471|NCT01682876|4475115|P1|Overall Study|Administrative reason|4
1357472|NCT01682863|4475161|P3|Overall Study|Physician Decision|1
1357473|NCT01682863|4475162|P2|Overall Study|Physician Decision|0
1357474|NCT01682863|4475163|P1|Overall Study|Physician Decision|0
1357475|NCT01682863|4475161|P3|Overall Study|Adverse Event|2
1357476|NCT01682863|4475162|P2|Overall Study|Adverse Event|1
1357477|NCT01682863|4475163|P1|Overall Study|Adverse Event|0
1357478|NCT01682863|4475161|P3|Overall Study|Technical problems|0
1357479|NCT01682863|4475162|P2|Overall Study|Technical problems|0
1357480|NCT01682863|4475163|P1|Overall Study|Technical problems|1
1357481|NCT01682863|4475161|P3|Overall Study|Protocol deviation|1
1357482|NCT01682863|4475162|P2|Overall Study|Protocol deviation|0
1357483|NCT01682863|4475163|P1|Overall Study|Protocol deviation|1
1357484|NCT01682863|4475161|P3|Overall Study|Death|4
1357485|NCT01682863|4475162|P2|Overall Study|Death|3
1357486|NCT01682863|4475163|P1|Overall Study|Death|1
1357487|NCT01682863|4475161|P3|Overall Study|Lost to Follow-up|6
1357488|NCT01682863|4475162|P2|Overall Study|Lost to Follow-up|1
1357489|NCT01682863|4475163|P1|Overall Study|Lost to Follow-up|5
1357490|NCT01682863|4475161|P3|Overall Study|Subject/guardian decision|10
1357491|NCT01682863|4475162|P2|Overall Study|Subject/guardian decision|12
1357492|NCT01682863|4475163|P1|Overall Study|Subject/guardian decision|19
1357493|NCT01682837|4475192|P1|Baseline|Withdrawal by Subject|5
1357494|NCT01682759|4475236|P2|Overall Study|Withdrawal by Subject|55
1357495|NCT01682759|4475237|P1|Overall Study|Withdrawal by Subject|56
1357496|NCT01682759|4475236|P2|Overall Study|Physician Decision|1
1357497|NCT01682759|4475237|P1|Overall Study|Physician Decision|1
1357498|NCT01682759|4475236|P2|Overall Study|Lost to Follow-up|13
1357499|NCT01682759|4475237|P1|Overall Study|Lost to Follow-up|10
1357500|NCT01682759|4475236|P2|Overall Study|Death|1
1357501|NCT01682759|4475237|P1|Overall Study|Death|2
1357502|NCT01682720|4475261|P4|Overall Study|Adverse Event|1
1357503|NCT01682720|4475262|P3|Overall Study|Adverse Event|1
1357504|NCT01682720|4475263|P2|Overall Study|Adverse Event|0
1357505|NCT01682720|4475264|P1|Overall Study|Adverse Event|1
1357506|NCT01682720|4475261|P4|Overall Study|Subject Withdrew Consent|2
1357507|NCT01682720|4475262|P3|Overall Study|Subject Withdrew Consent|2
1357508|NCT01682720|4475263|P2|Overall Study|Subject Withdrew Consent|0
1357509|NCT01682720|4475264|P1|Overall Study|Subject Withdrew Consent|0
1357510|NCT01682720|4475261|P4|Overall Study|Lost to Follow-up|6
1357511|NCT01682720|4475262|P3|Overall Study|Lost to Follow-up|0
1357512|NCT01682720|4475263|P2|Overall Study|Lost to Follow-up|1
1357513|NCT01682720|4475264|P1|Overall Study|Lost to Follow-up|1
1357514|NCT01682720|4475261|P4|Overall Study|Efficacy Failure|30
1357515|NCT01682720|4475262|P3|Overall Study|Efficacy Failure|3
1357516|NCT01682720|4475263|P2|Overall Study|Efficacy Failure|3
1357517|NCT01682720|4475264|P1|Overall Study|Efficacy Failure|0
1357518|NCT01682720|4475261|P4|Overall Study|Terminated by Sponsor|0
1357519|NCT01682720|4475262|P3|Overall Study|Terminated by Sponsor|0
1357520|NCT01682720|4475263|P2|Overall Study|Terminated by Sponsor|0
1357521|NCT01682720|4475264|P1|Overall Study|Terminated by Sponsor|83
1357522|NCT01682720|4475261|P4|Overall Study|Randomized but Not Treated|0
1357523|NCT01682720|4475262|P3|Overall Study|Randomized but Not Treated|1
1357524|NCT01682720|4475263|P2|Overall Study|Randomized but Not Treated|1
1357525|NCT01682720|4475264|P1|Overall Study|Randomized but Not Treated|0
1357526|NCT01682681|4475281|P1|Overall Study|Low compliance|13
1357527|NCT01682681|4475281|P1|Overall Study|Other|21
1357528|NCT01682681|4475281|P1|Overall Study|tapering of topiramate|5
1357529|NCT01682681|4475281|P1|Overall Study|Adverse Event|46
1357530|NCT01682681|4475281|P1|Overall Study|Lost to Follow-up|174
1357531|NCT01682681|4475281|P1|Overall Study|Moved to other hospital|10
1357532|NCT01682681|4475281|P1|Overall Study|Withdrawal by Subject|1
1357533|NCT01682681|4475281|P1|Overall Study|Lack of Efficacy|62
1357534|NCT01682603|4475310|P1|Overall Study|Lost to Follow-up|3
1357535|NCT01682512|4475355|P3|Overall Study|Other than stated above|2
1357536|NCT01682512|4475356|P2|Overall Study|Other than stated above|4
1357537|NCT01682512|4475357|P1|Overall Study|Other than stated above|2
1357538|NCT01682512|4475355|P3|Overall Study|Secondary lack of efficacy|0
1357539|NCT01682512|4475356|P2|Overall Study|Secondary lack of efficacy|1
1357540|NCT01682512|4475357|P1|Overall Study|Secondary lack of efficacy|1
1357541|NCT01682512|4475355|P3|Overall Study|Primary lack of efficacy|7
1357542|NCT01682512|4475356|P2|Overall Study|Primary lack of efficacy|7
1357543|NCT01682512|4475357|P1|Overall Study|Primary lack of efficacy|10
1357544|NCT01682512|4475355|P3|Overall Study|Protocol Violation|2
1357545|NCT01682512|4475356|P2|Overall Study|Protocol Violation|3
1357546|NCT01682512|4475357|P1|Overall Study|Protocol Violation|2
1357547|NCT01682512|4475355|P3|Overall Study|Lost to Follow-up|2
1357548|NCT01682512|4475356|P2|Overall Study|Lost to Follow-up|0
1357549|NCT01682512|4475357|P1|Overall Study|Lost to Follow-up|3
1357550|NCT01682512|4475355|P3|Overall Study|Study terminated by sponsor|0
1357551|NCT01682512|4475356|P2|Overall Study|Study terminated by sponsor|43
1357552|NCT01682512|4475357|P1|Overall Study|Study terminated by sponsor|46
1357553|NCT01682512|4475355|P3|Overall Study|Physician Decision|0
1357554|NCT01682512|4475356|P2|Overall Study|Physician Decision|2
1357555|NCT01682512|4475357|P1|Overall Study|Physician Decision|0
1357556|NCT01682512|4475355|P3|Overall Study|Withdrawal by Subject|3
1357557|NCT01682512|4475356|P2|Overall Study|Withdrawal by Subject|6
1357558|NCT01682512|4475357|P1|Overall Study|Withdrawal by Subject|2
1357559|NCT01682512|4475355|P3|Overall Study|Adverse Event|2
1357560|NCT01682512|4475356|P2|Overall Study|Adverse Event|5
1357561|NCT01682512|4475357|P1|Overall Study|Adverse Event|6
1357562|NCT01682460|4475382|P1|Overall Study|Did not meet inclusion criteria|2
1357563|NCT01682460|4475382|P1|Overall Study|Withdrawal by Subject|2
1357564|NCT01682044|4475434|P1|Overall Study|Progression|3
1357565|NCT01682044|4475434|P1|Overall Study|Death|1
1357566|NCT01682031|4475446|P2|Overall Study|Patient stopped selenium on his own|1
1357567|NCT01682031|4475447|P1|Overall Study|Patient stopped selenium on his own|0
1357568|NCT01682031|4475446|P2|Overall Study|Patient could not swallow tablets|0
1357569|NCT01682031|4475447|P1|Overall Study|Patient could not swallow tablets|1
1357570|NCT01682031|4475446|P2|Overall Study|MRI results indicate increased nodul|1
1357571|NCT01682031|4475447|P1|Overall Study|MRI results indicate increased nodul|0
1357572|NCT01682031|4475446|P2|Overall Study|Adverse Event|2
1357573|NCT01682031|4475447|P1|Overall Study|Adverse Event|0
1357574|NCT01682031|4475446|P2|Overall Study|Withdrawal by Subject|1
1357575|NCT01682031|4475447|P1|Overall Study|Withdrawal by Subject|0
1357576|NCT01681992|4475470|P3|Overall Study|Withdrawal by Subject|25
1357577|NCT01681992|4475471|P2|Overall Study|Withdrawal by Subject|30
1357578|NCT01681992|4475472|P1|Overall Study|Withdrawal by Subject|27
1357579|NCT01681992|4475470|P3|Overall Study|Protocol Violation|1
1357580|NCT01681992|4475471|P2|Overall Study|Protocol Violation|0
1357581|NCT01681992|4475472|P1|Overall Study|Protocol Violation|0
1357582|NCT01681992|4475470|P3|Overall Study|As Per Sponsor Decision|1
1357583|NCT01681992|4475471|P2|Overall Study|As Per Sponsor Decision|0
1357584|NCT01681992|4475472|P1|Overall Study|As Per Sponsor Decision|0
1357585|NCT01681992|4475470|P3|Overall Study|Lost to Follow-up|53
1357586|NCT01681992|4475471|P2|Overall Study|Lost to Follow-up|38
1357587|NCT01681992|4475472|P1|Overall Study|Lost to Follow-up|36
1357588|NCT01681992|4475470|P3|Overall Study|Adverse Event|3
1357589|NCT01681992|4475471|P2|Overall Study|Adverse Event|2
1357590|NCT01681992|4475472|P1|Overall Study|Adverse Event|3
1357591|NCT01681849|4475561|P3|Overall Study|Lost to Follow-up|6
1357592|NCT01681849|4475562|P2|Overall Study|Lost to Follow-up|2
1357593|NCT01681849|4475563|P1|Overall Study|Lost to Follow-up|3
1357594|NCT01681849|4475561|P3|Overall Study|Withdrawal by Subject|33
1357595|NCT01681849|4475562|P2|Overall Study|Withdrawal by Subject|5
1357596|NCT01681849|4475563|P1|Overall Study|Withdrawal by Subject|3
1357597|NCT01681849|4475561|P3|Overall Study|Protocol Violation|0
1357598|NCT01681849|4475562|P2|Overall Study|Protocol Violation|0
1357599|NCT01681849|4475563|P1|Overall Study|Protocol Violation|2
1357600|NCT01681628|4475574|P2|19 Months Follow-up|Lost to Follow-up|43
1357601|NCT01681628|4475575|P1|19 Months Follow-up|Lost to Follow-up|61
1357602|NCT01681628|4475574|P2|19 Months Follow-up|Death|0
1357603|NCT01681628|4475575|P1|19 Months Follow-up|Death|1
1357604|NCT01681628|4475574|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
1357605|NCT01681628|4475575|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
1357606|NCT01681628|4475574|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
1357607|NCT01681628|4475575|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
1357608|NCT01681576|4475588|P2|Period 2|Non-compliance with study treatment|0
1357609|NCT01681576|4475589|P1|Period 2|Non-compliance with study treatment|1
1357610|NCT01681576|4475588|P2|Period 2|subject/guardian decision|1
1357611|NCT01681576|4475589|P1|Period 2|subject/guardian decision|3
1357612|NCT01681576|4475588|P2|Period 1|Protocol Deviation|0
1357613|NCT01681576|4475589|P1|Period 1|Protocol Deviation|1
1357614|NCT01681576|4475588|P2|Period 1|Adverse Event|0
1357615|NCT01681576|4475589|P1|Period 1|Adverse Event|1
1357616|NCT01681511|4475605|P2|Overall Study|No post-catheter sample collected|4
1357617|NCT01681511|4475606|P1|Overall Study|No post-catheter sample collected|11
1357618|NCT01681511|4475605|P2|Overall Study|No Daily Urine Sample Collected|1
1357619|NCT01681511|4475606|P1|Overall Study|No Daily Urine Sample Collected|0
1357620|NCT01681511|4475605|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
1357621|NCT01681511|4475606|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
1357622|NCT01681511|4475605|P2|Overall Study|Failed Inclusion/Exclusion|0
1357623|NCT01681511|4475606|P1|Overall Study|Failed Inclusion/Exclusion|3
1357624|NCT01681511|4475605|P2|Overall Study|No Treatment Received|3
1357625|NCT01681511|4475606|P1|Overall Study|No Treatment Received|1
1357626|NCT01681472|4475624|P4|Overall Study|Adverse Event|0
1357627|NCT01681472|4475625|P3|Overall Study|Adverse Event|0
1357628|NCT01681472|4475626|P2|Overall Study|Adverse Event|1
1357629|NCT01681472|4475627|P1|Overall Study|Adverse Event|0
1357630|NCT01681368|4475637|P1|Overall Study|Refused further follow up|1
1357631|NCT01681368|4475637|P1|Overall Study|Refused further treatment|1
1357632|NCT01681277|4475654|P5|Overall Study|Adverse Event|0
1357633|NCT01681277|4475655|P4|Overall Study|Adverse Event|0
1357634|NCT01681277|4475656|P3|Overall Study|Adverse Event|0
1357635|NCT01681277|4475657|P2|Overall Study|Adverse Event|0
1357636|NCT01681277|4475658|P1|Overall Study|Adverse Event|1
1357637|NCT01681212|4475699|P1|Overall Study|Administrative reason by sponsor|1
1357638|NCT01681212|4475699|P1|Overall Study|No longer met study criteria|5
1357639|NCT01681069|4475757|P2|Overall Study|Adverse Event|1
1357640|NCT01681069|4475758|P1|Overall Study|Adverse Event|0
1357641|NCT01681069|4475757|P2|Overall Study|Protocol Violation|1
1357642|NCT01681069|4475758|P1|Overall Study|Protocol Violation|1
1357643|NCT01681069|4475757|P2|Overall Study|Withdrawal by Subject|5
1357644|NCT01681069|4475758|P1|Overall Study|Withdrawal by Subject|4
1357645|NCT01681004|4475795|P2|Study Completion|Death|1
1357646|NCT01681004|4475796|P1|Study Completion|Death|1
1357647|NCT01681004|4475795|P2|Study Completion|Site Termination|1
1357648|NCT01681004|4475796|P1|Study Completion|Site Termination|2
1357649|NCT01681004|4475795|P2|Study Completion|Physician Decision|3
1357650|NCT01681004|4475796|P1|Study Completion|Physician Decision|1
1357651|NCT01681004|4475795|P2|Study Completion|Lost to Follow-up|3
1357652|NCT01681004|4475796|P1|Study Completion|Lost to Follow-up|8
1357653|NCT01681004|4475795|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
1357654|NCT01681004|4475796|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
1357655|NCT01680991|4475853|P3|Overall Study|PD confirmed in other hospital|0
1357656|NCT01680991|4475854|P2|Overall Study|PD confirmed in other hospital|0
1357657|NCT01680991|4475855|P1|Overall Study|PD confirmed in other hospital|1
1357658|NCT01680991|4475853|P3|Overall Study|Bad physical condition|1
1357659|NCT01680991|4475854|P2|Overall Study|Bad physical condition|0
1357660|NCT01680991|4475855|P1|Overall Study|Bad physical condition|0
1357661|NCT01680991|4475853|P3|Overall Study|Physician Decision|2
1357662|NCT01680991|4475854|P2|Overall Study|Physician Decision|7
1357663|NCT01680991|4475855|P1|Overall Study|Physician Decision|0
1357664|NCT01680991|4475853|P3|Overall Study|Progressive disease (PD)|0
1357665|NCT01680991|4475854|P2|Overall Study|Progressive disease (PD)|10
1357666|NCT01680991|4475855|P1|Overall Study|Progressive disease (PD)|0
1357667|NCT01680991|4475853|P3|Overall Study|Withdrawal by Subject|0
1357668|NCT01680991|4475854|P2|Overall Study|Withdrawal by Subject|1
1357669|NCT01680991|4475855|P1|Overall Study|Withdrawal by Subject|5
1357670|NCT01680991|4475853|P3|Overall Study|Protocol Violation|0
1357671|NCT01680991|4475854|P2|Overall Study|Protocol Violation|1
1357672|NCT01680991|4475855|P1|Overall Study|Protocol Violation|0
1357673|NCT01680991|4475853|P3|Overall Study|Death|1
1357674|NCT01680991|4475854|P2|Overall Study|Death|0
1357675|NCT01680991|4475855|P1|Overall Study|Death|1
1357676|NCT01680991|4475853|P3|Overall Study|Adverse Event|0
1357677|NCT01680991|4475854|P2|Overall Study|Adverse Event|0
1357678|NCT01680991|4475855|P1|Overall Study|Adverse Event|1
1357679|NCT01680861|4475935|P2|Early Post-transplant Period|Protocol Violation|1
1357680|NCT01680861|4475936|P1|Early Post-transplant Period|Protocol Violation|1
1357681|NCT01680497|4476009|P1|Overall Study|Lost to Follow-up|2
1357682|NCT01680458|4476019|P1|Overall Study|Protocol Violation|3
1357683|NCT01680341|4476030|P2|Overall Study|Unclassified|15
1357684|NCT01680341|4476031|P1|Overall Study|Unclassified|18
1357685|NCT01680341|4476030|P2|Overall Study|Adverse Event|2
1357686|NCT01680341|4476031|P1|Overall Study|Adverse Event|3
1357687|NCT01680159|4476102|P1|Increased Dose Period|Withdrawal by Subject|2
1357688|NCT01680159|4476102|P1|Increased Dose Period|Adverse Event|6
1357689|NCT01680159|4476102|P1|Screening Period|Not meet criteria for dose-up period|7
1357690|NCT01680016|4476129|P4|Overall Study|Withdrawal by Subject|1
1357691|NCT01680016|4476130|P3|Overall Study|Withdrawal by Subject|1
1357692|NCT01680016|4476131|P2|Overall Study|Withdrawal by Subject|7
1357693|NCT01680016|4476132|P1|Overall Study|Withdrawal by Subject|5
1357694|NCT01680016|4476129|P4|Overall Study|Protocol Violation|0
1357695|NCT01680016|4476130|P3|Overall Study|Protocol Violation|0
1357696|NCT01680016|4476131|P2|Overall Study|Protocol Violation|1
1357697|NCT01680016|4476132|P1|Overall Study|Protocol Violation|0
1357698|NCT01680016|4476129|P4|Overall Study|The Subject went out of The Trial|0
1357699|NCT01680016|4476130|P3|Overall Study|The Subject went out of The Trial|3
1357700|NCT01680016|4476131|P2|Overall Study|The Subject went out of The Trial|0
1357701|NCT01680016|4476132|P1|Overall Study|The Subject went out of The Trial|1
1357702|NCT01680016|4476129|P4|Overall Study|Adverse Event|4
1357703|NCT01680016|4476130|P3|Overall Study|Adverse Event|1
1357704|NCT01680016|4476131|P2|Overall Study|Adverse Event|0
1357705|NCT01680016|4476132|P1|Overall Study|Adverse Event|0
1357706|NCT01679613|4476194|P4|Overall Study|other than stated above|2
1357707|NCT01679613|4476195|P3|Overall Study|other than stated above|2
1357708|NCT01679613|4476196|P2|Overall Study|other than stated above|1
1357709|NCT01679613|4476197|P1|Overall Study|other than stated above|0
1357710|NCT01679236|4476240|P2|Overall Study|Lost to Follow-up|15
1357711|NCT01679236|4476241|P1|Overall Study|Lost to Follow-up|15
1357712|NCT01679002|4476288|P3|Overall Study|Adverse Event|0
1357713|NCT01679002|4476289|P2|Overall Study|Adverse Event|1
1357714|NCT01679002|4476290|P1|Overall Study|Adverse Event|1
1357715|NCT01678911|4476317|P2|Second Intervention|Lost to Follow-up|0
1357716|NCT01678911|4476318|P1|Second Intervention|Lost to Follow-up|2
1357717|NCT01678820|4476364|P3|Overall Study|Not treated with double-blind study drug|2
1357718|NCT01678820|4476365|P2|Overall Study|Not treated with double-blind study drug|2
1357719|NCT01678820|4476366|P1|Overall Study|Not treated with double-blind study drug|0
1357720|NCT01678820|4476364|P3|Overall Study|Protocol Violation|4
1357721|NCT01678820|4476365|P2|Overall Study|Protocol Violation|5
1357722|NCT01678820|4476366|P1|Overall Study|Protocol Violation|4
1357723|NCT01678820|4476364|P3|Overall Study|Physician Decision|1
1357724|NCT01678820|4476365|P2|Overall Study|Physician Decision|0
1357725|NCT01678820|4476366|P1|Overall Study|Physician Decision|0
1357726|NCT01678820|4476364|P3|Overall Study|Non-compliance with study drug|0
1357727|NCT01678820|4476365|P2|Overall Study|Non-compliance with study drug|1
1357728|NCT01678820|4476366|P1|Overall Study|Non-compliance with study drug|0
1357729|NCT01678820|4476364|P3|Overall Study|Lost to Follow-up|2
1357730|NCT01678820|4476365|P2|Overall Study|Lost to Follow-up|2
1357731|NCT01678820|4476366|P1|Overall Study|Lost to Follow-up|7
1357732|NCT01678820|4476364|P3|Overall Study|Adverse Event|2
1357733|NCT01678820|4476365|P2|Overall Study|Adverse Event|2
1357734|NCT01678820|4476366|P1|Overall Study|Adverse Event|2
1357735|NCT01678820|4476364|P3|Overall Study|Protocol Specified Criteria|1
1357736|NCT01678820|4476365|P2|Overall Study|Protocol Specified Criteria|3
1357737|NCT01678820|4476366|P1|Overall Study|Protocol Specified Criteria|2
1357738|NCT01678820|4476364|P3|Overall Study|Withdrawal by Subject|2
1357739|NCT01678820|4476365|P2|Overall Study|Withdrawal by Subject|5
1357740|NCT01678820|4476366|P1|Overall Study|Withdrawal by Subject|2
1357741|NCT01678820|4476364|P3|Overall Study|Study Terminated by Sponsor|43
1357742|NCT01678820|4476365|P2|Overall Study|Study Terminated by Sponsor|43
1357743|NCT01678820|4476366|P1|Overall Study|Study Terminated by Sponsor|45
1357744|NCT01678807|4476411|P3|Overall Study|Withdrawn by Parent/Guardian|0
1357745|NCT01678807|4476412|P2|Overall Study|Withdrawn by Parent/Guardian|1
1357746|NCT01678807|4476413|P1|Overall Study|Withdrawn by Parent/Guardian|0
1357747|NCT01678807|4476411|P3|Overall Study|Adverse Event|0
1357748|NCT01678807|4476412|P2|Overall Study|Adverse Event|4
1357749|NCT01678807|4476413|P1|Overall Study|Adverse Event|4
1357750|NCT01678313|4476431|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
1357751|NCT01678313|4476432|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
1357752|NCT01678313|4476431|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
1357753|NCT01678313|4476432|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
1357754|NCT01678313|4476431|P2|Completed the 3-month Therapy|Physician Decision|4
1357755|NCT01678313|4476432|P1|Completed the 3-month Therapy|Physician Decision|3
1357756|NCT01678313|4476431|P2|Completed the 3-month Therapy|Lost to Follow-up|8
1357757|NCT01678313|4476432|P1|Completed the 3-month Therapy|Lost to Follow-up|3
1357758|NCT01678131|4476466|P3|Overall Study|Withdrawal by Subject|2
1357759|NCT01678131|4476467|P2|Overall Study|Withdrawal by Subject|0
1357760|NCT01678131|4476468|P1|Overall Study|Withdrawal by Subject|0
1357761|NCT01678131|4476466|P3|Overall Study|Adverse Event|0
1357762|NCT01678131|4476467|P2|Overall Study|Adverse Event|1
1357763|NCT01678131|4476468|P1|Overall Study|Adverse Event|0
1357764|NCT01677988|4476476|P1|Overall Study|Lack of Efficacy|2
1357765|NCT01677936|4476489|P2|Overall Study|Protocol Violation|4
1357766|NCT01677936|4476490|P1|Overall Study|Protocol Violation|0
1357767|NCT01677936|4476489|P2|Overall Study|Lost to Follow-up|0
1357768|NCT01677936|4476490|P1|Overall Study|Lost to Follow-up|1
1357769|NCT01677936|4476489|P2|Overall Study|Adverse Event|0
1357770|NCT01677936|4476490|P1|Overall Study|Adverse Event|1
1357771|NCT01677936|4476489|P2|Overall Study|Protocol Violation|0
1357772|NCT01677936|4476490|P1|Overall Study|Protocol Violation|3
1357773|NCT01677936|4476489|P2|Overall Study|Lost to Follow-up|1
1357774|NCT01677936|4476490|P1|Overall Study|Lost to Follow-up|4
1357775|NCT01677910|4476501|P4|Open-Label Extension Period (OLE)|Lost to Follow-up|1
1357776|NCT01677910|4476502|P3|Open-Label Extension Period (OLE)|Lost to Follow-up|0
1357777|NCT01677910|4476503|P2|Open-Label Extension Period (OLE)|Lost to Follow-up|0
1357778|NCT01677910|4476504|P1|Open-Label Extension Period (OLE)|Lost to Follow-up|0
1357779|NCT01677910|4476501|P4|Open-Label Extension Period (OLE)|Adverse Event|15
1357780|NCT01677910|4476502|P3|Open-Label Extension Period (OLE)|Adverse Event|0
1357781|NCT01677910|4476503|P2|Open-Label Extension Period (OLE)|Adverse Event|0
1357782|NCT01677910|4476504|P1|Open-Label Extension Period (OLE)|Adverse Event|0
1357783|NCT01677910|4476501|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|5
1357784|NCT01677910|4476502|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1357785|NCT01677910|4476503|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1357786|NCT01677910|4476504|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1357787|NCT01677910|4476501|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
1357788|NCT01677910|4476502|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1357789|NCT01677910|4476503|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1357790|NCT01677910|4476504|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1357791|NCT01677910|4476501|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
1357792|NCT01677910|4476502|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
1357793|NCT01677910|4476503|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
1357794|NCT01677910|4476504|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
1357795|NCT01677910|4476501|P4|Open-Label Extension Period (OLE)|Physician Decision|4
1357796|NCT01677910|4476502|P3|Open-Label Extension Period (OLE)|Physician Decision|0
1357797|NCT01677910|4476503|P2|Open-Label Extension Period (OLE)|Physician Decision|0
1357798|NCT01677910|4476504|P1|Open-Label Extension Period (OLE)|Physician Decision|0
1357799|NCT01677910|4476501|P4|Double-Blind Treatment Period|Reason Not Specified|0
1357800|NCT01677910|4476502|P3|Double-Blind Treatment Period|Reason Not Specified|0
1357801|NCT01677910|4476503|P2|Double-Blind Treatment Period|Reason Not Specified|1
1357802|NCT01677910|4476504|P1|Double-Blind Treatment Period|Reason Not Specified|0
1357803|NCT01677910|4476501|P4|Double-Blind Treatment Period|Withdrawal of consent|0
1357804|NCT01677910|4476502|P3|Double-Blind Treatment Period|Withdrawal of consent|3
1357805|NCT01677910|4476503|P2|Double-Blind Treatment Period|Withdrawal of consent|0
1357806|NCT01677910|4476504|P1|Double-Blind Treatment Period|Withdrawal of consent|1
1357807|NCT01677910|4476501|P4|Double-Blind Treatment Period|Physician Decision|0
1357808|NCT01677910|4476502|P3|Double-Blind Treatment Period|Physician Decision|1
1357809|NCT01677910|4476503|P2|Double-Blind Treatment Period|Physician Decision|0
1357810|NCT01677910|4476504|P1|Double-Blind Treatment Period|Physician Decision|0
1357811|NCT01677910|4476501|P4|Double-Blind Treatment Period|Adverse Event|0
1357812|NCT01677910|4476502|P3|Double-Blind Treatment Period|Adverse Event|3
1357813|NCT01677910|4476503|P2|Double-Blind Treatment Period|Adverse Event|2
1357814|NCT01677910|4476504|P1|Double-Blind Treatment Period|Adverse Event|6
1357815|NCT01677858|4476531|P5|Overall Study|Lost to Follow-up|1
1357816|NCT01677858|4476532|P4|Overall Study|Lost to Follow-up|0
1357817|NCT01677858|4476533|P3|Overall Study|Lost to Follow-up|0
1357818|NCT01677858|4476534|P2|Overall Study|Lost to Follow-up|0
1357819|NCT01677858|4476535|P1|Overall Study|Lost to Follow-up|0
1357820|NCT01677858|4476531|P5|Overall Study|Withdrawal by Subject|15
1357821|NCT01677858|4476532|P4|Overall Study|Withdrawal by Subject|0
1357822|NCT01677858|4476533|P3|Overall Study|Withdrawal by Subject|1
1357823|NCT01677858|4476534|P2|Overall Study|Withdrawal by Subject|1
1357824|NCT01677858|4476535|P1|Overall Study|Withdrawal by Subject|0
1357825|NCT01677858|4476531|P5|Overall Study|Progressive Disease|43
1357826|NCT01677858|4476532|P4|Overall Study|Progressive Disease|3
1357827|NCT01677858|4476533|P3|Overall Study|Progressive Disease|9
1357828|NCT01677858|4476534|P2|Overall Study|Progressive Disease|1
1357829|NCT01677858|4476535|P1|Overall Study|Progressive Disease|2
1357830|NCT01677858|4476531|P5|Overall Study|Physician Decision|12
1357831|NCT01677858|4476532|P4|Overall Study|Physician Decision|0
1357832|NCT01677858|4476533|P3|Overall Study|Physician Decision|2
1357833|NCT01677858|4476534|P2|Overall Study|Physician Decision|0
1357834|NCT01677858|4476535|P1|Overall Study|Physician Decision|1
1357835|NCT01677858|4476531|P5|Overall Study|Death|1
1357836|NCT01677858|4476532|P4|Overall Study|Death|0
1357837|NCT01677858|4476533|P3|Overall Study|Death|0
1357838|NCT01677858|4476534|P2|Overall Study|Death|0
1357839|NCT01677858|4476535|P1|Overall Study|Death|0
1357840|NCT01677858|4476531|P5|Overall Study|Adverse Event|13
1357841|NCT01677858|4476532|P4|Overall Study|Adverse Event|3
1357842|NCT01677858|4476533|P3|Overall Study|Adverse Event|2
1357843|NCT01677858|4476534|P2|Overall Study|Adverse Event|0
1357844|NCT01677858|4476535|P1|Overall Study|Adverse Event|0
1357845|NCT01677767|4476608|P1|Overall Study|Non-compliance by the participants|3
1357846|NCT01677767|4476608|P1|Overall Study|Withdrawal by Subject|10
1357847|NCT01677767|4476608|P1|Overall Study|Protocol Violation|4
1357848|NCT01677767|4476608|P1|Overall Study|Death|4
1357849|NCT01677767|4476608|P1|Overall Study|Adverse Event|1
1357850|NCT01677624|4476622|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
1357851|NCT01677507|4476627|P2|Second Assigment|Adverse Event|3
1357852|NCT01677507|4476628|P1|Second Assigment|Adverse Event|1
1357853|NCT01677507|4476627|P2|Second Assigment|Withdrawal by Subject|2
1357854|NCT01677507|4476628|P1|Second Assigment|Withdrawal by Subject|2
1357855|NCT01677507|4476627|P2|Initial Assignment|Protocol Violation|1
1357856|NCT01677507|4476628|P1|Initial Assignment|Protocol Violation|0
1357857|NCT01677507|4476627|P2|Initial Assignment|Adverse Event|1
1357858|NCT01677507|4476628|P1|Initial Assignment|Adverse Event|0
1357859|NCT01677299|4476642|P4|Overall Study|Withdrawal by Subject|1
1357860|NCT01677299|4476643|P3|Overall Study|Withdrawal by Subject|0
1357861|NCT01677299|4476644|P2|Overall Study|Withdrawal by Subject|1
1357862|NCT01677299|4476645|P1|Overall Study|Withdrawal by Subject|0
1357863|NCT01677299|4476642|P4|Overall Study|Adverse Event|0
1357864|NCT01677299|4476643|P3|Overall Study|Adverse Event|1
1357865|NCT01677299|4476644|P2|Overall Study|Adverse Event|2
1357866|NCT01677299|4476645|P1|Overall Study|Adverse Event|0
1357867|NCT01677195|4476677|P3|Overall Study|Protocol Violation|4
1357868|NCT01677195|4476678|P2|Overall Study|Protocol Violation|3
1357869|NCT01677195|4476679|P1|Overall Study|Protocol Violation|7
1357870|NCT01677195|4476677|P3|Overall Study|Pregnancy|0
1357871|NCT01677195|4476678|P2|Overall Study|Pregnancy|1
1357872|NCT01677195|4476679|P1|Overall Study|Pregnancy|0
1357873|NCT01677195|4476677|P3|Overall Study|Physician Decision|2
1357874|NCT01677195|4476678|P2|Overall Study|Physician Decision|2
1357875|NCT01677195|4476679|P1|Overall Study|Physician Decision|1
1357876|NCT01677195|4476677|P3|Overall Study|Adverse Event|1
1357877|NCT01677195|4476678|P2|Overall Study|Adverse Event|4
1357878|NCT01677195|4476679|P1|Overall Study|Adverse Event|6
1357879|NCT01677195|4476677|P3|Overall Study|Withdrawal by Subject|1
1357880|NCT01677195|4476678|P2|Overall Study|Withdrawal by Subject|0
1357881|NCT01677195|4476679|P1|Overall Study|Withdrawal by Subject|1
1357882|NCT01677195|4476677|P3|Overall Study|Lost to Follow-up|22
1357883|NCT01677195|4476678|P2|Overall Study|Lost to Follow-up|22
1357884|NCT01677195|4476679|P1|Overall Study|Lost to Follow-up|14
1357885|NCT01677182|4476690|P3|Overall Study|Other reasons|2
1357886|NCT01677182|4476691|P2|Overall Study|Other reasons|5
1357887|NCT01677182|4476692|P1|Overall Study|Other reasons|1
1357888|NCT01677182|4476690|P3|Overall Study|Lack of Efficacy|1
1357889|NCT01677182|4476691|P2|Overall Study|Lack of Efficacy|0
1357890|NCT01677182|4476692|P1|Overall Study|Lack of Efficacy|3
1357891|NCT01677182|4476690|P3|Overall Study|Study termination|11
1357892|NCT01677182|4476691|P2|Overall Study|Study termination|9
1357893|NCT01677182|4476692|P1|Overall Study|Study termination|12
1357894|NCT01677182|4476690|P3|Overall Study|Withdrawal by Subject|10
1357895|NCT01677182|4476691|P2|Overall Study|Withdrawal by Subject|12
1357896|NCT01677182|4476692|P1|Overall Study|Withdrawal by Subject|7
1357897|NCT01677182|4476690|P3|Overall Study|Lost to Follow-up|3
1357898|NCT01677182|4476691|P2|Overall Study|Lost to Follow-up|0
1357899|NCT01677182|4476692|P1|Overall Study|Lost to Follow-up|4
1357900|NCT01677182|4476690|P3|Overall Study|Protocol Violation|4
1357901|NCT01677182|4476691|P2|Overall Study|Protocol Violation|1
1357902|NCT01677182|4476692|P1|Overall Study|Protocol Violation|5
1357903|NCT01677182|4476690|P3|Overall Study|Adverse Event|8
1357904|NCT01677182|4476691|P2|Overall Study|Adverse Event|1
1357905|NCT01677182|4476692|P1|Overall Study|Adverse Event|2
1357906|NCT01676961|4476724|P1|Overall Study|Withdrawal by Subject|1
1357907|NCT01676961|4476724|P1|Overall Study|Lost to Follow-up|1
1357908|NCT01676961|4476724|P1|Overall Study|Death|3
1357909|NCT01676896|4476732|P3|Overall Study|Withdrawal by Subject|19
1357910|NCT01676896|4476733|P2|Overall Study|Withdrawal by Subject|7
1357911|NCT01676896|4476734|P1|Overall Study|Withdrawal by Subject|12
1357912|NCT01676727|4476829|P1|Overall Study|Valve explanted|1
1357913|NCT01676727|4476829|P1|Overall Study|Not willing to attend 1-year visit|2
1357914|NCT01676727|4476829|P1|Overall Study|Screening failure|5
1357915|NCT01676727|4476829|P1|Overall Study|Withdrawal by Subject|6
1357916|NCT01676727|4476829|P1|Overall Study|Death|18
1357917|NCT01676701|4476843|P2|Overall Study|Sponsor Decision|4
1357918|NCT01676701|4476844|P1|Overall Study|Sponsor Decision|3
1357919|NCT01676701|4476843|P2|Overall Study|Protocol Violation|0
1357920|NCT01676701|4476844|P1|Overall Study|Protocol Violation|1
1357921|NCT01676220|4476929|P2|Overall Study|No More Need of Insulin|0
1357922|NCT01676220|4476930|P1|Overall Study|No More Need of Insulin|1
1357923|NCT01676220|4476929|P2|Overall Study|Non Serious Hypoglycemia|0
1357924|NCT01676220|4476930|P1|Overall Study|Non Serious Hypoglycemia|2
1357925|NCT01676220|4476929|P2|Overall Study|Perceived Lack of Efficacy|1
1357926|NCT01676220|4476930|P1|Overall Study|Perceived Lack of Efficacy|3
1357927|NCT01676220|4476929|P2|Overall Study|Site Closure/Site Withdrawal|4
1357928|NCT01676220|4476930|P1|Overall Study|Site Closure/Site Withdrawal|1
1357929|NCT01676220|4476929|P2|Overall Study|Selection Criterion/Protocol Violation|9
1357930|NCT01676220|4476930|P1|Overall Study|Selection Criterion/Protocol Violation|9
1357931|NCT01676220|4476929|P2|Overall Study|Lost to Follow-up|18
1357932|NCT01676220|4476930|P1|Overall Study|Lost to Follow-up|11
1357933|NCT01676220|4476929|P2|Overall Study|Personal Reason|45
1357934|NCT01676220|4476930|P1|Overall Study|Personal Reason|34
1357935|NCT01676220|4476929|P2|Overall Study|Received Rescue Therapy|22
1357936|NCT01676220|4476930|P1|Overall Study|Received Rescue Therapy|14
1357937|NCT01676220|4476929|P2|Overall Study|Protocol Violation|12
1357938|NCT01676220|4476930|P1|Overall Study|Protocol Violation|11
1357939|NCT01676220|4476929|P2|Overall Study|Lack of Efficacy|5
1357940|NCT01676220|4476930|P1|Overall Study|Lack of Efficacy|2
1357941|NCT01676220|4476929|P2|Overall Study|Adverse Event|8
1357942|NCT01676220|4476930|P1|Overall Study|Adverse Event|10
1357943|NCT01676220|4476929|P2|Overall Study|Randomized But Not Treated|1
1357944|NCT01676220|4476930|P1|Overall Study|Randomized But Not Treated|4
1357945|NCT01676116|4476962|P2|Overall Study|Protocol Violation|3
1357946|NCT01676116|4476963|P1|Overall Study|Protocol Violation|9
1357947|NCT01676116|4476962|P2|Overall Study|Unclassified|10
1357948|NCT01676116|4476963|P1|Overall Study|Unclassified|4
1357949|NCT01676116|4476962|P2|Overall Study|Adverse Event|2
1357950|NCT01676116|4476963|P1|Overall Study|Adverse Event|1
1357951|NCT01676116|4476962|P2|Overall Study|Withdrawal criteria|14
1357952|NCT01676116|4476963|P1|Overall Study|Withdrawal criteria|2
1357953|NCT01676012|4476985|P1|Overall Study|incomplete set of videos|1
1357954|NCT01676012|4476985|P1|Overall Study|Adverse Event|2
1357955|NCT01675661|4476996|P2|Overall Study|Other reason|2
1357956|NCT01675661|4476997|P1|Overall Study|Other reason|1
1357957|NCT01675661|4476996|P2|Overall Study|Death|1
1357958|NCT01675661|4476997|P1|Overall Study|Death|0
1357959|NCT01675661|4476996|P2|Overall Study|Physician Decision|2
1357960|NCT01675661|4476997|P1|Overall Study|Physician Decision|0
1357961|NCT01675661|4476996|P2|Overall Study|Withdrawal by Subject|7
1357962|NCT01675661|4476997|P1|Overall Study|Withdrawal by Subject|3
1357963|NCT01675661|4476996|P2|Overall Study|Moved away|6
1357964|NCT01675661|4476997|P1|Overall Study|Moved away|5
1357965|NCT01675661|4476996|P2|Overall Study|Practical problems|5
1357966|NCT01675661|4476997|P1|Overall Study|Practical problems|9
1357967|NCT01675661|4476996|P2|Overall Study|Lost to Follow-up|23
1357968|NCT01675661|4476997|P1|Overall Study|Lost to Follow-up|22
1357969|NCT01675622|4477026|P2|Overall Study|not specified|4
1357970|NCT01675622|4477027|P1|Overall Study|not specified|5
1357971|NCT01675622|4477026|P2|Overall Study|Lost to Follow-up|3
1357972|NCT01675622|4477027|P1|Overall Study|Lost to Follow-up|1
1357973|NCT01675622|4477026|P2|Overall Study|Lack of Efficacy|4
1357974|NCT01675622|4477027|P1|Overall Study|Lack of Efficacy|2
1357975|NCT01675622|4477026|P2|Overall Study|Protocol Violation|1
1357976|NCT01675622|4477027|P1|Overall Study|Protocol Violation|4
1357977|NCT01675622|4477026|P2|Overall Study|Adverse Event|10
1357978|NCT01675622|4477027|P1|Overall Study|Adverse Event|12
1357979|NCT01675622|4477026|P2|Overall Study|Withdrawal by Subject|2
1357980|NCT01675622|4477027|P1|Overall Study|Withdrawal by Subject|2
1357981|NCT01675544|4477051|P1|Overall Study|Withdrawal by Subject|2
1357982|NCT01675531|4477056|P1|Overall Study|Protocol Violation|8
1357983|NCT01675531|4477056|P1|Overall Study|Lack of Efficacy|1
1357984|NCT01675531|4477056|P1|Overall Study|Withdrawal by Subject|7
1357985|NCT01675531|4477056|P1|Overall Study|Adverse Event|9
1357986|NCT01675492|4477063|P1|Overall Study|study completed early - product approval|42
1357987|NCT01675479|4477068|P1|Overall Study|Lost to Follow-up|11
1357988|NCT01675427|4477082|P1|Overall Study|Not Specified|2
1357989|NCT01675427|4477082|P1|Overall Study|Lost to Follow-up|5
1357990|NCT01675427|4477082|P1|Overall Study|Sample not Collected by Mistake|2
1357991|NCT01675427|4477082|P1|Overall Study|Participant Refused Sample Collection|18
1357992|NCT01675427|4477082|P1|Overall Study|Withdrawal by Subject|7
1357993|NCT01675167|4477369|P3|Double-blind Treatment Phase|Not specified|5
1357994|NCT01675167|4477370|P2|Double-blind Treatment Phase|Not specified|7
1357995|NCT01675167|4477371|P1|Double-blind Treatment Phase|Not specified|0
1357996|NCT01675167|4477369|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
1357997|NCT01675167|4477370|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
1357998|NCT01675167|4477371|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
1357999|NCT01675167|4477369|P3|Double-blind Treatment Phase|Lost to Follow-up|5
1358000|NCT01675167|4477370|P2|Double-blind Treatment Phase|Lost to Follow-up|1
1358001|NCT01675167|4477371|P1|Double-blind Treatment Phase|Lost to Follow-up|0
1358002|NCT01675167|4477369|P3|Double-blind Treatment Phase|Protocol Violation|11
1358003|NCT01675167|4477370|P2|Double-blind Treatment Phase|Protocol Violation|4
1358004|NCT01675167|4477371|P1|Double-blind Treatment Phase|Protocol Violation|0
1358005|NCT01675167|4477369|P3|Double-blind Treatment Phase|Adverse Event|13
1358006|NCT01675167|4477370|P2|Double-blind Treatment Phase|Adverse Event|5
1358007|NCT01675167|4477371|P1|Double-blind Treatment Phase|Adverse Event|0
1358008|NCT01675167|4477369|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
1358009|NCT01675167|4477370|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
1358010|NCT01675167|4477371|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
1358011|NCT01675167|4477369|P3|Double-blind Treatment Phase|Lack of Efficacy|61
1358012|NCT01675167|4477370|P2|Double-blind Treatment Phase|Lack of Efficacy|19
1358013|NCT01675167|4477371|P1|Double-blind Treatment Phase|Lack of Efficacy|0
1358014|NCT01675167|4477369|P3|Open-label Titration Phase|Not specified|0
1358015|NCT01675167|4477370|P2|Open-label Titration Phase|Not specified|0
1358016|NCT01675167|4477371|P1|Open-label Titration Phase|Not specified|55
1358017|NCT01675167|4477369|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
1358018|NCT01675167|4477370|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
1358019|NCT01675167|4477371|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
1358020|NCT01675167|4477369|P3|Open-label Titration Phase|Lost to Follow-up|0
1358021|NCT01675167|4477370|P2|Open-label Titration Phase|Lost to Follow-up|0
1358022|NCT01675167|4477371|P1|Open-label Titration Phase|Lost to Follow-up|15
1358023|NCT01675167|4477369|P3|Open-label Titration Phase|Protocol Violation|0
1358024|NCT01675167|4477370|P2|Open-label Titration Phase|Protocol Violation|0
1358025|NCT01675167|4477371|P1|Open-label Titration Phase|Protocol Violation|43
1358026|NCT01675167|4477369|P3|Open-label Titration Phase|Withdrawal by Subject|0
1358027|NCT01675167|4477370|P2|Open-label Titration Phase|Withdrawal by Subject|0
1358028|NCT01675167|4477371|P1|Open-label Titration Phase|Withdrawal by Subject|46
1358029|NCT01675167|4477369|P3|Open-label Titration Phase|Lack of Efficacy|0
1358030|NCT01675167|4477370|P2|Open-label Titration Phase|Lack of Efficacy|0
1358031|NCT01675167|4477371|P1|Open-label Titration Phase|Lack of Efficacy|63
1358032|NCT01675167|4477369|P3|Open-label Titration Phase|Adverse Event|0
1358033|NCT01675167|4477370|P2|Open-label Titration Phase|Adverse Event|0
1358034|NCT01675167|4477371|P1|Open-label Titration Phase|Adverse Event|81
1358035|NCT01675141|4477393|P1|Overall Study|No treatment, per protocol|1
1358036|NCT01675141|4477393|P1|Overall Study|Physician Decision|4
1358037|NCT01675141|4477393|P1|Overall Study|Withdrawal by Subject|3
1358038|NCT01675141|4477393|P1|Overall Study|Lenalidomide outside NIH|3
1358039|NCT01675128|4477406|P3|Overall Study|Pulmonary complication; off study|0
1358040|NCT01675128|4477407|P2|Overall Study|Pulmonary complication; off study|1
1358041|NCT01675128|4477408|P1|Overall Study|Pulmonary complication; off study|0
1358042|NCT01675128|4477406|P3|Overall Study|Refused further treatment|0
1358043|NCT01675128|4477407|P2|Overall Study|Refused further treatment|0
1358044|NCT01675128|4477408|P1|Overall Study|Refused further treatment|1
1358045|NCT01675128|4477406|P3|Overall Study|Disease progression on study|1
1358046|NCT01675128|4477407|P2|Overall Study|Disease progression on study|1
1358047|NCT01675128|4477408|P1|Overall Study|Disease progression on study|1
1358048|NCT01675050|4477436|P2|Period One Treatment|Withdrawal by Subject|0
1358049|NCT01675050|4477437|P1|Period One Treatment|Withdrawal by Subject|1
1358050|NCT01675011|4477447|P2|Overall Study|Trial terminated by Sponsor|1
1358051|NCT01675011|4477448|P1|Overall Study|Trial terminated by Sponsor|3
1358052|NCT01674725|4477456|P2|Overall Study|Lost to Follow-up|1
1358053|NCT01674725|4477457|P1|Overall Study|Lost to Follow-up|0
1358054|NCT01674725|4477456|P2|Overall Study|Withdrawal by Subject|0
1358055|NCT01674725|4477457|P1|Overall Study|Withdrawal by Subject|1
1358056|NCT01674725|4477456|P2|Overall Study|Did not receive study drug|0
1358057|NCT01674725|4477457|P1|Overall Study|Did not receive study drug|1
1358058|NCT01674725|4477456|P2|Overall Study|Adverse Event|0
1358059|NCT01674725|4477457|P1|Overall Study|Adverse Event|1
1358060|NCT01674712|4477476|P5|Overall Study|Lack of Efficacy|1
1358061|NCT01674712|4477477|P4|Overall Study|Lack of Efficacy|0
1358062|NCT01674712|4477478|P3|Overall Study|Lack of Efficacy|1
1358063|NCT01674712|4477479|P2|Overall Study|Lack of Efficacy|0
1358064|NCT01674712|4477480|P1|Overall Study|Lack of Efficacy|0
1358065|NCT01674712|4477476|P5|Overall Study|Administrative|1
1358066|NCT01674712|4477477|P4|Overall Study|Administrative|0
1358067|NCT01674712|4477478|P3|Overall Study|Administrative|0
1358068|NCT01674712|4477479|P2|Overall Study|Administrative|1
1358069|NCT01674712|4477480|P1|Overall Study|Administrative|0
1358070|NCT01674712|4477476|P5|Overall Study|Withdrawal by Subject|3
1358071|NCT01674712|4477477|P4|Overall Study|Withdrawal by Subject|4
1358072|NCT01674712|4477478|P3|Overall Study|Withdrawal by Subject|5
1358073|NCT01674712|4477479|P2|Overall Study|Withdrawal by Subject|2
1358074|NCT01674712|4477480|P1|Overall Study|Withdrawal by Subject|2
1358075|NCT01674712|4477476|P5|Overall Study|Protocol Violation|0
1358076|NCT01674712|4477477|P4|Overall Study|Protocol Violation|0
1358077|NCT01674712|4477478|P3|Overall Study|Protocol Violation|0
1358078|NCT01674712|4477479|P2|Overall Study|Protocol Violation|0
1358079|NCT01674712|4477480|P1|Overall Study|Protocol Violation|2
1358080|NCT01674712|4477476|P5|Overall Study|Lost to Follow-up|0
1358081|NCT01674712|4477477|P4|Overall Study|Lost to Follow-up|0
1358082|NCT01674712|4477478|P3|Overall Study|Lost to Follow-up|0
1358083|NCT01674712|4477479|P2|Overall Study|Lost to Follow-up|0
1358084|NCT01674712|4477480|P1|Overall Study|Lost to Follow-up|1
1358085|NCT01674712|4477476|P5|Overall Study|Adverse Event|6
1358086|NCT01674712|4477477|P4|Overall Study|Adverse Event|4
1358087|NCT01674712|4477478|P3|Overall Study|Adverse Event|3
1358088|NCT01674712|4477479|P2|Overall Study|Adverse Event|6
1358089|NCT01674712|4477480|P1|Overall Study|Adverse Event|5
1358090|NCT01674647|4477504|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
1358091|NCT01674647|4477505|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
1358092|NCT01674647|4477504|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
1358093|NCT01674647|4477505|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
1358094|NCT01674647|4477504|P2|30-day Safety Follow-up Period|Logistical difficulties|3
1358095|NCT01674647|4477505|P1|30-day Safety Follow-up Period|Logistical difficulties|1
1358096|NCT01674647|4477504|P2|30-day Safety Follow-up Period|Protocol Violation|22
1358097|NCT01674647|4477505|P1|30-day Safety Follow-up Period|Protocol Violation|39
1358098|NCT01674647|4477504|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
1358099|NCT01674647|4477505|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
1358100|NCT01674647|4477504|P2|30-day Safety Follow-up Period|Death|2
1358101|NCT01674647|4477505|P1|30-day Safety Follow-up Period|Death|3
1358102|NCT01674647|4477504|P2|Treatment Period|Protocol Violation|36
1358103|NCT01674647|4477505|P1|Treatment Period|Protocol Violation|56
1358104|NCT01674647|4477504|P2|Treatment Period|Treatment failure|14
1358105|NCT01674647|4477505|P1|Treatment Period|Treatment failure|0
1358106|NCT01674647|4477504|P2|Treatment Period|Logistical difficulties|8
1358107|NCT01674647|4477505|P1|Treatment Period|Logistical difficulties|5
1358108|NCT01674647|4477504|P2|Treatment Period|Switching to other therapy|2
1358109|NCT01674647|4477505|P1|Treatment Period|Switching to other therapy|5
1358110|NCT01674647|4477504|P2|Treatment Period|Withdrawal by Subject|16
1358111|NCT01674647|4477505|P1|Treatment Period|Withdrawal by Subject|19
1358112|NCT01674647|4477504|P2|Treatment Period|Lost to Follow-up|1
1358113|NCT01674647|4477505|P1|Treatment Period|Lost to Follow-up|1
1358114|NCT01674647|4477504|P2|Treatment Period|Non-compliance with study drug|0
1358115|NCT01674647|4477505|P1|Treatment Period|Non-compliance with study drug|3
1358116|NCT01674647|4477504|P2|Treatment Period|Adverse Event|22
1358117|NCT01674647|4477505|P1|Treatment Period|Adverse Event|60
1358118|NCT01674647|4477504|P2|Treatment Period|Physician Decision|1
1358119|NCT01674647|4477505|P1|Treatment Period|Physician Decision|3
1358120|NCT01674647|4477504|P2|Treatment Period|Efficacy outcome reached|1
1358121|NCT01674647|4477505|P1|Treatment Period|Efficacy outcome reached|0
1358122|NCT01674647|4477504|P2|Treatment Period|Death|1
1358123|NCT01674647|4477505|P1|Treatment Period|Death|4
1358124|NCT01674634|4477531|P1|Overall Study|Lost to Follow-up|3
1358125|NCT01674634|4477531|P1|Overall Study|Withdrawal by Subject|3
1358126|NCT01674569|4477577|P6|Overall Study|Withdrawal by Subject|0
1358127|NCT01674569|4477578|P5|Overall Study|Withdrawal by Subject|0
1358128|NCT01674569|4477579|P4|Overall Study|Withdrawal by Subject|0
1358129|NCT01674569|4477580|P3|Overall Study|Withdrawal by Subject|1
1358130|NCT01674569|4477581|P2|Overall Study|Withdrawal by Subject|0
1358131|NCT01674569|4477582|P1|Overall Study|Withdrawal by Subject|0
1358132|NCT01674569|4477577|P6|Overall Study|Protocol Violation|0
1358133|NCT01674569|4477578|P5|Overall Study|Protocol Violation|0
1358134|NCT01674569|4477579|P4|Overall Study|Protocol Violation|0
1358135|NCT01674569|4477580|P3|Overall Study|Protocol Violation|1
1358136|NCT01674569|4477581|P2|Overall Study|Protocol Violation|1
1358137|NCT01674569|4477582|P1|Overall Study|Protocol Violation|0
1358138|NCT01674569|4477577|P6|Overall Study|Adverse Event|2
1358139|NCT01674569|4477578|P5|Overall Study|Adverse Event|2
1358140|NCT01674569|4477579|P4|Overall Study|Adverse Event|1
1358141|NCT01674569|4477580|P3|Overall Study|Adverse Event|0
1358142|NCT01674569|4477581|P2|Overall Study|Adverse Event|2
1358143|NCT01674569|4477582|P1|Overall Study|Adverse Event|0
1358144|NCT01674062|4477588|P2|Overall Study|Programming Error|0
1358145|NCT01674062|4477589|P1|Overall Study|Programming Error|1
1358146|NCT01674062|4477588|P2|Overall Study|Death|1
1358147|NCT01674062|4477589|P1|Overall Study|Death|0
1358148|NCT01674062|4477588|P2|Overall Study|Adverse Event|1
1358149|NCT01674062|4477589|P1|Overall Study|Adverse Event|1
1358150|NCT01674062|4477588|P2|Overall Study|Not Specified|1
1358151|NCT01674062|4477589|P1|Overall Study|Not Specified|8
1358152|NCT01674062|4477588|P2|Overall Study|Insufficient Therapeutic Response|26
1358153|NCT01674062|4477589|P1|Overall Study|Insufficient Therapeutic Response|56
1358154|NCT01674010|4477604|P3|Randomization Phase 2|Withdrawal by Subject|7
1358155|NCT01674010|4477605|P2|Randomization Phase 2|Withdrawal by Subject|8
1358156|NCT01674010|4477606|P1|Randomization Phase 2|Withdrawal by Subject|0
1358157|NCT01674010|4477604|P3|Randomization Phase 2|Sponsor Decision|45
1358158|NCT01674010|4477605|P2|Randomization Phase 2|Sponsor Decision|42
1358159|NCT01674010|4477606|P1|Randomization Phase 2|Sponsor Decision|0
1358160|NCT01674010|4477604|P3|Randomization Phase 2|Protocol Violation|1
1358161|NCT01674010|4477605|P2|Randomization Phase 2|Protocol Violation|1
1358162|NCT01674010|4477606|P1|Randomization Phase 2|Protocol Violation|0
1358163|NCT01674010|4477604|P3|Randomization Phase 2|Pregnancy|1
1358164|NCT01674010|4477605|P2|Randomization Phase 2|Pregnancy|1
1358165|NCT01674010|4477606|P1|Randomization Phase 2|Pregnancy|0
1358166|NCT01674010|4477604|P3|Randomization Phase 2|Physician Decision|2
1358167|NCT01674010|4477605|P2|Randomization Phase 2|Physician Decision|0
1358168|NCT01674010|4477606|P1|Randomization Phase 2|Physician Decision|0
1358169|NCT01674010|4477604|P3|Randomization Phase 2|Mood episode recurrence|2
1358170|NCT01674010|4477605|P2|Randomization Phase 2|Mood episode recurrence|8
1358171|NCT01674010|4477606|P1|Randomization Phase 2|Mood episode recurrence|0
1358172|NCT01674010|4477604|P3|Randomization Phase 2|Lost to Follow-up|2
1358173|NCT01674010|4477605|P2|Randomization Phase 2|Lost to Follow-up|1
1358174|NCT01674010|4477606|P1|Randomization Phase 2|Lost to Follow-up|0
1358175|NCT01674010|4477604|P3|Randomization Phase 2|Adverse Event|1
1358176|NCT01674010|4477605|P2|Randomization Phase 2|Adverse Event|1
1358177|NCT01674010|4477606|P1|Randomization Phase 2|Adverse Event|0
1358178|NCT01674010|4477604|P3|Open Treatment Phase 1|Withdrawal by Subject|0
1358179|NCT01674010|4477605|P2|Open Treatment Phase 1|Withdrawal by Subject|0
1358180|NCT01674010|4477606|P1|Open Treatment Phase 1|Withdrawal by Subject|25
1358181|NCT01674010|4477604|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
1358182|NCT01674010|4477605|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
1358183|NCT01674010|4477606|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
1358184|NCT01674010|4477604|P3|Open Treatment Phase 1|Sponsor Decision|0
1358185|NCT01674010|4477605|P2|Open Treatment Phase 1|Sponsor Decision|0
1358186|NCT01674010|4477606|P1|Open Treatment Phase 1|Sponsor Decision|79
1358187|NCT01674010|4477604|P3|Open Treatment Phase 1|Protocol Violation|0
1358188|NCT01674010|4477605|P2|Open Treatment Phase 1|Protocol Violation|0
1358189|NCT01674010|4477606|P1|Open Treatment Phase 1|Protocol Violation|7
1358190|NCT01674010|4477604|P3|Open Treatment Phase 1|Physician Decision|0
1358191|NCT01674010|4477605|P2|Open Treatment Phase 1|Physician Decision|0
1358192|NCT01674010|4477606|P1|Open Treatment Phase 1|Physician Decision|9
1358193|NCT01674010|4477604|P3|Open Treatment Phase 1|Lost to Follow-up|0
1358194|NCT01674010|4477605|P2|Open Treatment Phase 1|Lost to Follow-up|0
1358195|NCT01674010|4477606|P1|Open Treatment Phase 1|Lost to Follow-up|19
1358196|NCT01674010|4477604|P3|Open Treatment Phase 1|Death|0
1358197|NCT01674010|4477605|P2|Open Treatment Phase 1|Death|0
1358198|NCT01674010|4477606|P1|Open Treatment Phase 1|Death|1
1358199|NCT01674010|4477604|P3|Open Treatment Phase 1|Adverse Event|0
1358200|NCT01674010|4477605|P2|Open Treatment Phase 1|Adverse Event|0
1358201|NCT01674010|4477606|P1|Open Treatment Phase 1|Adverse Event|10
1358202|NCT01673984|4477625|P2|Overall Study|Study termination|6
1358203|NCT01673984|4477626|P1|Overall Study|Study termination|9
1358204|NCT01673984|4477625|P2|Overall Study|Adverse Event|0
1358205|NCT01673984|4477626|P1|Overall Study|Adverse Event|1
1358206|NCT01673867|4477668|P2|Treatment|Physician Decision|1
1358207|NCT01673867|4477669|P1|Treatment|Physician Decision|0
1358208|NCT01673867|4477668|P2|Treatment|Symptomatic deterioration|1
1358209|NCT01673867|4477669|P1|Treatment|Symptomatic deterioration|0
1358210|NCT01673867|4477668|P2|Treatment|Required prolonged hospitalization|1
1358211|NCT01673867|4477669|P1|Treatment|Required prolonged hospitalization|0
1358212|NCT01673867|4477668|P2|Treatment|Health status not improved|0
1358213|NCT01673867|4477669|P1|Treatment|Health status not improved|1
1358214|NCT01673867|4477668|P2|Treatment|Required steroid therapy|0
1358215|NCT01673867|4477669|P1|Treatment|Required steroid therapy|1
1358216|NCT01673867|4477668|P2|Treatment|No longer meets criteria|0
1358217|NCT01673867|4477669|P1|Treatment|No longer meets criteria|2
1358218|NCT01673867|4477668|P2|Treatment|Maximum clinical benefit|10
1358219|NCT01673867|4477669|P1|Treatment|Maximum clinical benefit|0
1358220|NCT01673867|4477668|P2|Treatment|Withdrawal by Subject|6
1358221|NCT01673867|4477669|P1|Treatment|Withdrawal by Subject|4
1358222|NCT01673867|4477668|P2|Treatment|Requested treatment discontinuation|16
1358223|NCT01673867|4477669|P1|Treatment|Requested treatment discontinuation|5
1358224|NCT01673867|4477668|P2|Treatment|AE unrelated to study drug|11
1358225|NCT01673867|4477669|P1|Treatment|AE unrelated to study drug|19
1358226|NCT01673867|4477668|P2|Treatment|Death|1
1358227|NCT01673867|4477669|P1|Treatment|Death|1
1358228|NCT01673867|4477668|P2|Treatment|Study Drug Toxicity|42
1358229|NCT01673867|4477669|P1|Treatment|Study Drug Toxicity|17
1358230|NCT01673867|4477668|P2|Treatment|Disease Progression|179
1358231|NCT01673867|4477669|P1|Treatment|Disease Progression|194
1358232|NCT01673867|4477668|P2|Randomization|No longer meets criteria|5
1358233|NCT01673867|4477669|P1|Randomization|No longer meets criteria|4
1358234|NCT01673867|4477668|P2|Randomization|Lost to Follow-up|1
1358235|NCT01673867|4477669|P1|Randomization|Lost to Follow-up|0
1358236|NCT01673867|4477668|P2|Randomization|Withdrawal by Subject|12
1358237|NCT01673867|4477669|P1|Randomization|Withdrawal by Subject|0
1358238|NCT01673867|4477668|P2|Randomization|Requested treatment discontinuation|4
1358239|NCT01673867|4477669|P1|Randomization|Requested treatment discontinuation|0
1358240|NCT01673867|4477668|P2|Randomization|AE unrelated to study drug|0
1358241|NCT01673867|4477669|P1|Randomization|AE unrelated to study drug|1
1358242|NCT01673854|4477695|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
1358243|NCT01673854|4477695|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
1358244|NCT01673854|4477695|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
1358245|NCT01673854|4477695|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
1358246|NCT01673854|4477695|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
1358247|NCT01673854|4477695|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
1358248|NCT01673854|4477695|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
1358249|NCT01673854|4477695|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
1358250|NCT01673854|4477695|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
1358251|NCT01673854|4477695|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
1358252|NCT01673854|4477695|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
1358253|NCT01673854|4477695|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
1358254|NCT01673698|4477718|P2|Overall Study|Lost to Follow-up|13
1358255|NCT01673698|4477719|P1|Overall Study|Lost to Follow-up|51
1358256|NCT01673620|4477729|P2|Overall Study|Adverse Event|0
1358257|NCT01673620|4477730|P1|Overall Study|Adverse Event|1
1358258|NCT01673594|4477740|P2|Overall Study|Withdrawal by Subject|1
1358259|NCT01673594|4477741|P1|Overall Study|Withdrawal by Subject|0
1358260|NCT01673594|4477740|P2|Overall Study|Physician Decision|4
1358261|NCT01673594|4477741|P1|Overall Study|Physician Decision|2
1358262|NCT01673594|4477740|P2|Overall Study|Lost to Follow-up|0
1358263|NCT01673594|4477741|P1|Overall Study|Lost to Follow-up|1
1358264|NCT01673594|4477740|P2|Overall Study|Adverse Event|1
1358265|NCT01673594|4477741|P1|Overall Study|Adverse Event|3
1358266|NCT01673490|4477760|P1|Overall Study|Withdrawal by Subject|3
1358267|NCT01673490|4477760|P1|Overall Study|Adverse Event|3
1358268|NCT01673490|4477760|P1|Overall Study|Lost to Follow-up|1
1358269|NCT01673347|4477777|P1|Overall Study|failure of allograft|7
1358270|NCT01673282|4477786|P2|Overall Study|Other|6
1358271|NCT01673282|4477787|P1|Overall Study|Other|1
1358272|NCT01673282|4477786|P2|Overall Study|Withdrawal by Subject|3
1358273|NCT01673282|4477787|P1|Overall Study|Withdrawal by Subject|3
1358274|NCT01673282|4477786|P2|Overall Study|Lost to Follow-up|10
1358275|NCT01673282|4477787|P1|Overall Study|Lost to Follow-up|11
1358276|NCT01673282|4477786|P2|Overall Study|Lack of Efficacy|2
1358277|NCT01673282|4477787|P1|Overall Study|Lack of Efficacy|9
1358278|NCT01673282|4477786|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
1358279|NCT01673282|4477787|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
1358280|NCT01673178|4477823|P5|Overall Study|Other|0
1358281|NCT01673178|4477824|P4|Overall Study|Other|1
1358282|NCT01673178|4477825|P3|Overall Study|Other|2
1358283|NCT01673178|4477826|P2|Overall Study|Other|0
1358284|NCT01673178|4477827|P1|Overall Study|Other|1
1358285|NCT01673178|4477823|P5|Overall Study|Adverse Event|0
1358286|NCT01673178|4477824|P4|Overall Study|Adverse Event|2
1358287|NCT01673178|4477825|P3|Overall Study|Adverse Event|0
1358288|NCT01673178|4477826|P2|Overall Study|Adverse Event|0
1358289|NCT01673178|4477827|P1|Overall Study|Adverse Event|1
1358290|NCT01673178|4477823|P5|Overall Study|Protocol Violation|0
1358291|NCT01673178|4477824|P4|Overall Study|Protocol Violation|1
1358292|NCT01673178|4477825|P3|Overall Study|Protocol Violation|0
1358293|NCT01673178|4477826|P2|Overall Study|Protocol Violation|1
1358294|NCT01673178|4477827|P1|Overall Study|Protocol Violation|1
1358295|NCT01673178|4477823|P5|Overall Study|Withdrawal by Subject|2
1358296|NCT01673178|4477824|P4|Overall Study|Withdrawal by Subject|4
1358297|NCT01673178|4477825|P3|Overall Study|Withdrawal by Subject|1
1358298|NCT01673178|4477826|P2|Overall Study|Withdrawal by Subject|0
1358299|NCT01673178|4477827|P1|Overall Study|Withdrawal by Subject|0
1358300|NCT01673178|4477823|P5|Overall Study|Lost to Follow-up|0
1358301|NCT01673178|4477824|P4|Overall Study|Lost to Follow-up|0
1358302|NCT01673178|4477825|P3|Overall Study|Lost to Follow-up|0
1358303|NCT01673178|4477826|P2|Overall Study|Lost to Follow-up|1
1358304|NCT01673178|4477827|P1|Overall Study|Lost to Follow-up|0
1358305|NCT01673126|4478066|P2|Overall Study|change of diagnosis|3
1358306|NCT01673126|4478067|P1|Overall Study|change of diagnosis|4
1358307|NCT01673009|4478087|P1|Overall Study|Withdrawal by Subject|8
1358308|NCT01673009|4478087|P1|Overall Study|Physician Decision|5
1358309|NCT01672970|4478172|P1|Overall Study|Enrolled but not treated|1
1358310|NCT01672970|4478172|P1|Overall Study|Other|9
1358311|NCT01672970|4478172|P1|Overall Study|Lost to Follow-up|5
1358312|NCT01672970|4478172|P1|Overall Study|Withdrawal by Subject|2
1358313|NCT01672970|4478172|P1|Overall Study|Adverse Event|18
1358314|NCT01672970|4478172|P1|Overall Study|Lack of Efficacy|12
1358315|NCT01672957|4478208|P1|Overall Study|ICF Signed After Transplantation|5
1358316|NCT01672957|4478208|P1|Overall Study|Death|2
1358317|NCT01672957|4478208|P1|Overall Study|Protocol Violation|48
1358318|NCT01672892|4478223|P2|Overall Study|Protocol Violation|3
1358319|NCT01672892|4478224|P1|Overall Study|Protocol Violation|8
1358320|NCT01672788|4478244|P4|Washout Period 2 (7 Days)|Adverse Event|1
1358321|NCT01672788|4478245|P3|Washout Period 2 (7 Days)|Adverse Event|0
1358322|NCT01672788|4478246|P2|Washout Period 2 (7 Days)|Adverse Event|0
1358323|NCT01672788|4478247|P1|Washout Period 2 (7 Days)|Adverse Event|0
1358324|NCT01672723|4478277|P2|First Intervention|Adverse Event|0
1358325|NCT01672723|4478278|P1|First Intervention|Adverse Event|3
1358326|NCT01672294|4478315|P4|Overall Study|Lost to Follow-up|9
1358327|NCT01672294|4478316|P3|Overall Study|Lost to Follow-up|7
1358328|NCT01672294|4478317|P2|Overall Study|Lost to Follow-up|16
1358329|NCT01672294|4478318|P1|Overall Study|Lost to Follow-up|1
1358330|NCT01672294|4478315|P4|Overall Study|Excluded by study|0
1358331|NCT01672294|4478316|P3|Overall Study|Excluded by study|0
1358332|NCT01672294|4478317|P2|Overall Study|Excluded by study|1
1358333|NCT01672294|4478318|P1|Overall Study|Excluded by study|1
1358334|NCT01672294|4478315|P4|Overall Study|Withdrawal by Subject|4
1358335|NCT01672294|4478316|P3|Overall Study|Withdrawal by Subject|4
1358336|NCT01672294|4478317|P2|Overall Study|Withdrawal by Subject|4
1358337|NCT01672294|4478318|P1|Overall Study|Withdrawal by Subject|4
1358338|NCT01671748|4478358|P2|4 Week run-in Phase|Not eligible|0
1358339|NCT01671748|4478359|P1|4 Week run-in Phase|Not eligible|9
1358340|NCT01671748|4478358|P2|4 Week run-in Phase|Adverse Event|0
1358341|NCT01671748|4478359|P1|4 Week run-in Phase|Adverse Event|1
1358342|NCT01671748|4478358|P2|4 Week run-in Phase|Withdrawal by Subject|0
1358343|NCT01671748|4478359|P1|4 Week run-in Phase|Withdrawal by Subject|1
1358344|NCT01671488|4478386|P1|Overall Study|Withdrawal by Subject|1
1358345|NCT01671319|4478392|P1|Overall Study|Withdrawal by Subject|1
1358346|NCT01671280|4478407|P1|Overall Study|Withdrawal by Subject|2
1358347|NCT01671111|4478418|P1|Overall Study|Other|24
1358348|NCT01671111|4478418|P1|Overall Study|Physician Decision|1
1358349|NCT01671111|4478418|P1|Overall Study|Withdrawal by Subject|2
1358350|NCT01671111|4478418|P1|Overall Study|Lack of Efficacy|1
1358351|NCT01671111|4478418|P1|Overall Study|Adverse Event|2
1358352|NCT01671059|4478428|P1|Overall Study|Lack of Efficacy|1
1358353|NCT01671059|4478428|P1|Overall Study|Adverse Event|4
1358354|NCT01670721|4478520|P1|Overall Study|Other than specified above|38
1358355|NCT01670721|4478520|P1|Overall Study|Participant's decision|15
1358356|NCT01670656|4478532|P5|Overall Study|Subject moved|0
1358357|NCT01670656|4478533|P4|Overall Study|Subject moved|1
1358358|NCT01670656|4478534|P3|Overall Study|Subject moved|0
1358359|NCT01670656|4478535|P2|Overall Study|Subject moved|0
1358360|NCT01670656|4478536|P1|Overall Study|Subject moved|0
1358361|NCT01670656|4478532|P5|Overall Study|Lost to Follow-up|3
1358362|NCT01670656|4478533|P4|Overall Study|Lost to Follow-up|0
1358363|NCT01670656|4478534|P3|Overall Study|Lost to Follow-up|0
1358364|NCT01670656|4478535|P2|Overall Study|Lost to Follow-up|0
1358365|NCT01670656|4478536|P1|Overall Study|Lost to Follow-up|0
1358366|NCT01670656|4478532|P5|Overall Study|Subject withdrew consent|1
1358367|NCT01670656|4478533|P4|Overall Study|Subject withdrew consent|1
1358368|NCT01670656|4478534|P3|Overall Study|Subject withdrew consent|2
1358369|NCT01670656|4478535|P2|Overall Study|Subject withdrew consent|1
1358370|NCT01670656|4478536|P1|Overall Study|Subject withdrew consent|0
1358371|NCT01670656|4478532|P5|Overall Study|Adverse Event|3
1358372|NCT01670656|4478533|P4|Overall Study|Adverse Event|3
1358373|NCT01670656|4478534|P3|Overall Study|Adverse Event|2
1358374|NCT01670656|4478535|P2|Overall Study|Adverse Event|2
1358375|NCT01670656|4478536|P1|Overall Study|Adverse Event|2
1358376|NCT01670656|4478532|P5|Overall Study|Non-compliance with protocol|2
1358377|NCT01670656|4478533|P4|Overall Study|Non-compliance with protocol|1
1358378|NCT01670656|4478534|P3|Overall Study|Non-compliance with protocol|1
1358379|NCT01670656|4478535|P2|Overall Study|Non-compliance with protocol|3
1358380|NCT01670656|4478536|P1|Overall Study|Non-compliance with protocol|0
1358381|NCT01670656|4478532|P5|Overall Study|Withdrawal by Subject|0
1358382|NCT01670656|4478533|P4|Overall Study|Withdrawal by Subject|0
1358383|NCT01670656|4478534|P3|Overall Study|Withdrawal by Subject|0
1358384|NCT01670656|4478535|P2|Overall Study|Withdrawal by Subject|1
1358385|NCT01670656|4478536|P1|Overall Study|Withdrawal by Subject|1
1358386|NCT01670656|4478532|P5|Overall Study|Pregnancy|1
1358387|NCT01670656|4478533|P4|Overall Study|Pregnancy|0
1358388|NCT01670656|4478534|P3|Overall Study|Pregnancy|0
1358389|NCT01670656|4478535|P2|Overall Study|Pregnancy|0
1358390|NCT01670656|4478536|P1|Overall Study|Pregnancy|0
1358391|NCT01670656|4478532|P5|Overall Study|Non-compliance with study drug|1
1358392|NCT01670656|4478533|P4|Overall Study|Non-compliance with study drug|0
1358393|NCT01670656|4478534|P3|Overall Study|Non-compliance with study drug|3
1358394|NCT01670656|4478535|P2|Overall Study|Non-compliance with study drug|0
1358395|NCT01670656|4478536|P1|Overall Study|Non-compliance with study drug|0
1358396|NCT01670526|4478565|P2|Overall Study|Lost to Follow-up|5
1358397|NCT01670526|4478566|P1|Overall Study|Lost to Follow-up|9
1358398|NCT01670526|4478565|P2|Overall Study|Withdrawal by Subject|1
1358399|NCT01670526|4478566|P1|Overall Study|Withdrawal by Subject|3
1358400|NCT01670292|4478587|P1|Overall Study|Lost to Follow-up|14
1358401|NCT01670279|4478628|P4|Overall Study|Participant met withdrawal criteria|1
1358402|NCT01670279|4478629|P3|Overall Study|Participant met withdrawal criteria|0
1358403|NCT01670279|4478630|P2|Overall Study|Participant met withdrawal criteria|0
1358404|NCT01670279|4478631|P1|Overall Study|Participant met withdrawal criteria|0
1358405|NCT01670279|4478628|P4|Overall Study|Physician Decision|0
1358406|NCT01670279|4478629|P3|Overall Study|Physician Decision|0
1358407|NCT01670279|4478630|P2|Overall Study|Physician Decision|1
1358408|NCT01670279|4478631|P1|Overall Study|Physician Decision|0
1358409|NCT01670279|4478628|P4|Overall Study|Adverse Event|0
1358410|NCT01670279|4478629|P3|Overall Study|Adverse Event|0
1358411|NCT01670279|4478630|P2|Overall Study|Adverse Event|1
1358412|NCT01670279|4478631|P1|Overall Study|Adverse Event|0
1358413|NCT01670188|4478673|P2|Overall Study|Death|1
1358414|NCT01670188|4478674|P1|Overall Study|Death|0
1358415|NCT01670045|4478680|P1|Overall Study|Lost to Follow-up|11
1358416|NCT01670045|4478680|P1|Overall Study|Death|1
1358417|NCT01670045|4478680|P1|Overall Study|Adverse Event|1
1358418|NCT01670045|4478680|P1|Overall Study|Withdrawal by Subject|3
1358419|NCT01670019|4478698|P2|Overall Study|Withdrawal by Subject|0
1358420|NCT01670019|4478699|P1|Overall Study|Withdrawal by Subject|6
1358421|NCT01670019|4478698|P2|Overall Study|Adverse Event|0
1358422|NCT01670019|4478699|P1|Overall Study|Adverse Event|3
1358423|NCT01669902|4478713|P1|Overall Study|Other|8
1358424|NCT01669902|4478713|P1|Overall Study|Lack of Efficacy|10
1358425|NCT01669902|4478713|P1|Overall Study|Adverse Event|11
1358426|NCT01669811|4478748|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
1358427|NCT01669811|4478749|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
1358428|NCT01669811|4478748|P2|Overall Study|Adverse Event|6
1358429|NCT01669811|4478749|P1|Overall Study|Adverse Event|2
1358430|NCT01669811|4478748|P2|Overall Study|Withdrawal by Subject|2
1358431|NCT01669811|4478749|P1|Overall Study|Withdrawal by Subject|1
1358432|NCT01669811|4478748|P2|Overall Study|Investigator decision|1
1358433|NCT01669811|4478749|P1|Overall Study|Investigator decision|0
1358434|NCT01669629|4478860|P2|Period 1|protocol deviation|2
1358435|NCT01669629|4478861|P1|Period 1|protocol deviation|1
1358436|NCT01669577|4478884|P1|Overall Study|Physician Decision|34
1358437|NCT01669577|4478884|P1|Overall Study|Lost to Follow-up|78
1358438|NCT01669577|4478884|P1|Overall Study|Death|22
1358439|NCT01669174|4478909|P2|Overall Study|Administrative problems|2
1358440|NCT01669174|4478910|P1|Overall Study|Administrative problems|1
1358441|NCT01669174|4478909|P2|Overall Study|Adverse Event|2
1358442|NCT01669174|4478910|P1|Overall Study|Adverse Event|2
1358443|NCT01669174|4478909|P2|Overall Study|Lost to Follow-up|0
1358444|NCT01669174|4478910|P1|Overall Study|Lost to Follow-up|1
1358445|NCT01669174|4478909|P2|Overall Study|Subject withdrew consent|2
1358446|NCT01669174|4478910|P1|Overall Study|Subject withdrew consent|2
1358447|NCT01669122|4478926|P1|Washout Period II|Protocol Violation|2
1358448|NCT01669122|4478926|P1|Period I|Lost to Follow-up|1
1358449|NCT01668797|4479019|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
1358450|NCT01668797|4479020|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
1358451|NCT01668797|4479021|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
1358452|NCT01668797|4479022|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
1358453|NCT01668797|4479019|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
1358454|NCT01668797|4479020|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
1358605|NCT01668589|4479204|P2|Overall Study|Other|10
1358455|NCT01668797|4479021|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
1358456|NCT01668797|4479022|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
1358457|NCT01668797|4479019|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
1358458|NCT01668797|4479020|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
1358459|NCT01668797|4479021|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
1358460|NCT01668797|4479022|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
1358461|NCT01668797|4479019|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
1358462|NCT01668797|4479020|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
1358463|NCT01668797|4479021|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
1358464|NCT01668797|4479022|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
1358465|NCT01668797|4479019|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
1358466|NCT01668797|4479020|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
1358467|NCT01668797|4479021|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
1358468|NCT01668797|4479022|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
1358469|NCT01668797|4479019|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
1358470|NCT01668797|4479020|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
1358471|NCT01668797|4479021|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
1358472|NCT01668797|4479022|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
1358473|NCT01668797|4479019|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
1358474|NCT01668797|4479020|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
1358475|NCT01668797|4479021|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
1358476|NCT01668797|4479022|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
1358477|NCT01668797|4479019|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
1358478|NCT01668797|4479020|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
1358479|NCT01668797|4479021|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
1358480|NCT01668797|4479022|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
1358481|NCT01668797|4479019|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
1358482|NCT01668797|4479020|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
1358483|NCT01668797|4479021|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
1358484|NCT01668797|4479022|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
1358485|NCT01668797|4479019|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
1358486|NCT01668797|4479020|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
1358487|NCT01668797|4479021|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
1358488|NCT01668797|4479022|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
1358489|NCT01668797|4479019|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
1358490|NCT01668797|4479020|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
1358491|NCT01668797|4479021|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
1358492|NCT01668797|4479022|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
1358493|NCT01668797|4479019|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
1358494|NCT01668797|4479020|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
1358495|NCT01668797|4479021|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
1358496|NCT01668797|4479022|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
1358497|NCT01668797|4479019|P4|Phase B (Stabilization Phase)|Protocol Violation|0
1358498|NCT01668797|4479020|P3|Phase B (Stabilization Phase)|Protocol Violation|0
1358499|NCT01668797|4479021|P2|Phase B (Stabilization Phase)|Protocol Violation|3
1358500|NCT01668797|4479022|P1|Phase B (Stabilization Phase)|Protocol Violation|0
1358501|NCT01668797|4479019|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
1358502|NCT01668797|4479020|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
1358503|NCT01668797|4479021|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
1358504|NCT01668797|4479022|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
1358505|NCT01668797|4479019|P4|Phase B (Stabilization Phase)|Physician Decision|0
1358506|NCT01668797|4479020|P3|Phase B (Stabilization Phase)|Physician Decision|0
1358507|NCT01668797|4479021|P2|Phase B (Stabilization Phase)|Physician Decision|11
1358508|NCT01668797|4479022|P1|Phase B (Stabilization Phase)|Physician Decision|0
1358509|NCT01668797|4479019|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
1358510|NCT01668797|4479020|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
1358511|NCT01668797|4479021|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
1358512|NCT01668797|4479022|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
1358513|NCT01668797|4479019|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
1358514|NCT01668797|4479020|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
1358515|NCT01668797|4479021|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
1358516|NCT01668797|4479022|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
1358517|NCT01668797|4479019|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
1358518|NCT01668797|4479020|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
1358519|NCT01668797|4479021|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
1358520|NCT01668797|4479022|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
1358521|NCT01668797|4479019|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
1358522|NCT01668797|4479020|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
1358523|NCT01668797|4479021|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
1358524|NCT01668797|4479022|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
1358525|NCT01668797|4479019|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
1358526|NCT01668797|4479020|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
1358527|NCT01668797|4479021|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
1358528|NCT01668797|4479022|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
1358529|NCT01668797|4479019|P4|Phase A (Conversion Phase)|Protocol Violation|0
1358530|NCT01668797|4479020|P3|Phase A (Conversion Phase)|Protocol Violation|0
1358531|NCT01668797|4479021|P2|Phase A (Conversion Phase)|Protocol Violation|0
1358532|NCT01668797|4479022|P1|Phase A (Conversion Phase)|Protocol Violation|2
1358533|NCT01668797|4479019|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
1358534|NCT01668797|4479020|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
1358535|NCT01668797|4479021|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
1358536|NCT01668797|4479022|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
1358537|NCT01668797|4479019|P4|Phase A (Conversion Phase)|Physician Decision|0
1358538|NCT01668797|4479020|P3|Phase A (Conversion Phase)|Physician Decision|0
1358539|NCT01668797|4479021|P2|Phase A (Conversion Phase)|Physician Decision|0
1358540|NCT01668797|4479022|P1|Phase A (Conversion Phase)|Physician Decision|2
1358541|NCT01668797|4479019|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
1358542|NCT01668797|4479020|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
1358543|NCT01668797|4479021|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
1358544|NCT01668797|4479022|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
1358545|NCT01668797|4479019|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
1358546|NCT01668797|4479020|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
1358547|NCT01668797|4479021|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
1358548|NCT01668797|4479022|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
1358549|NCT01668784|4479087|P2|Treated (Overall)|Not Specified|4
1358550|NCT01668784|4479088|P1|Treated (Overall)|Not Specified|0
1358551|NCT01668784|4479087|P2|Treated (Overall)|Maximal Clinical Benefit|3
1358552|NCT01668784|4479088|P1|Treated (Overall)|Maximal Clinical Benefit|2
1358553|NCT01668784|4479087|P2|Treated (Overall)|Withdrawal by Subject|3
1358554|NCT01668784|4479088|P1|Treated (Overall)|Withdrawal by Subject|2
1358555|NCT01668784|4479087|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
1358556|NCT01668784|4479088|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
1358557|NCT01668784|4479087|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
1358558|NCT01668784|4479088|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
1358559|NCT01668784|4479087|P2|Treated (Overall)|Death|1
1358560|NCT01668784|4479088|P1|Treated (Overall)|Death|1
1358561|NCT01668784|4479087|P2|Treated (Overall)|Study Drug Toxicity|53
1358562|NCT01668784|4479088|P1|Treated (Overall)|Study Drug Toxicity|35
1358563|NCT01668784|4479087|P2|Treated (Overall)|Disease Progression|273
1358564|NCT01668784|4479088|P1|Treated (Overall)|Disease Progression|285
1358565|NCT01668784|4479087|P2|Randomized (Pre-treatment)|Not Specified|1
1358566|NCT01668784|4479088|P1|Randomized (Pre-treatment)|Not Specified|0
1358567|NCT01668784|4479087|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
1358568|NCT01668784|4479088|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
1358569|NCT01668784|4479087|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
1358570|NCT01668784|4479088|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
1358571|NCT01668784|4479087|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
1358572|NCT01668784|4479088|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
1358573|NCT01668784|4479087|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
1358574|NCT01668784|4479088|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
1358575|NCT01668784|4479087|P2|Randomized (Pre-treatment)|Disease Progression|1
1358576|NCT01668784|4479088|P1|Randomized (Pre-treatment)|Disease Progression|0
1358577|NCT01668667|4479116|P4|Overall Study|Withdrawal by Subject|5
1358578|NCT01668667|4479117|P3|Overall Study|Withdrawal by Subject|5
1358579|NCT01668667|4479118|P2|Overall Study|Withdrawal by Subject|4
1358580|NCT01668667|4479119|P1|Overall Study|Withdrawal by Subject|7
1358581|NCT01668667|4479116|P4|Overall Study|Physician Decision|0
1358582|NCT01668667|4479117|P3|Overall Study|Physician Decision|1
1358583|NCT01668667|4479118|P2|Overall Study|Physician Decision|0
1358584|NCT01668667|4479119|P1|Overall Study|Physician Decision|3
1358585|NCT01668667|4479116|P4|Overall Study|Lost to Follow-up|6
1358586|NCT01668667|4479117|P3|Overall Study|Lost to Follow-up|7
1358587|NCT01668667|4479118|P2|Overall Study|Lost to Follow-up|4
1358588|NCT01668667|4479119|P1|Overall Study|Lost to Follow-up|9
1358589|NCT01668667|4479116|P4|Overall Study|Protocol Violation|5
1358590|NCT01668667|4479117|P3|Overall Study|Protocol Violation|12
1358591|NCT01668667|4479118|P2|Overall Study|Protocol Violation|10
1358592|NCT01668667|4479119|P1|Overall Study|Protocol Violation|6
1358593|NCT01668667|4479116|P4|Overall Study|Lack of Efficacy|3
1358594|NCT01668667|4479117|P3|Overall Study|Lack of Efficacy|2
1358595|NCT01668667|4479118|P2|Overall Study|Lack of Efficacy|2
1358596|NCT01668667|4479119|P1|Overall Study|Lack of Efficacy|3
1358597|NCT01668667|4479116|P4|Overall Study|Adverse Event|4
1358598|NCT01668667|4479117|P3|Overall Study|Adverse Event|4
1358599|NCT01668667|4479118|P2|Overall Study|Adverse Event|6
1358600|NCT01668667|4479119|P1|Overall Study|Adverse Event|3
1358601|NCT01668654|4479141|P1|Overall Study|Withdrawal by Subject|1
1358602|NCT01668654|4479141|P1|Overall Study|Study Closed/Terminated|3
1358603|NCT01668589|4479202|P4|Overall Study|Other|15
1358604|NCT01668589|4479203|P3|Overall Study|Other|7
1358606|NCT01668589|4479205|P1|Overall Study|Other|44
1358607|NCT01668589|4479202|P4|Overall Study|Death|11
1358608|NCT01668589|4479203|P3|Overall Study|Death|2
1358609|NCT01668589|4479204|P2|Overall Study|Death|3
1358610|NCT01668589|4479205|P1|Overall Study|Death|12
1358611|NCT01668589|4479202|P4|Overall Study|Full Consent/Agreement Withdrawn|4
1358612|NCT01668589|4479203|P3|Overall Study|Full Consent/Agreement Withdrawn|11
1358613|NCT01668589|4479204|P2|Overall Study|Full Consent/Agreement Withdrawn|8
1358614|NCT01668589|4479205|P1|Overall Study|Full Consent/Agreement Withdrawn|54
1358615|NCT01668589|4479202|P4|Overall Study|Lost to Follow-up|5
1358616|NCT01668589|4479203|P3|Overall Study|Lost to Follow-up|15
1358617|NCT01668589|4479204|P2|Overall Study|Lost to Follow-up|37
1358618|NCT01668589|4479205|P1|Overall Study|Lost to Follow-up|29
1358619|NCT01668173|4479243|P1|Overall Study|Trial suspension|4
1358620|NCT01668173|4479243|P1|Overall Study|Adverse Event|3
1358621|NCT01668004|4479369|P1|Overall Study|Non-compliance with treatment|2
1358622|NCT01668004|4479369|P1|Overall Study|Lack of Efficacy|9
1358623|NCT01668004|4479369|P1|Overall Study|Lost to Follow-up|5
1358624|NCT01668004|4479369|P1|Overall Study|Withdrawal by Subject|2
1358625|NCT01668004|4479369|P1|Overall Study|Adverse Event|7
1358626|NCT01667926|4479391|P3|Overall Study|Side effects|0
1358627|NCT01667926|4479392|P2|Overall Study|Side effects|0
1358628|NCT01667926|4479393|P1|Overall Study|Side effects|3
1358629|NCT01667926|4479391|P3|Overall Study|Lost to Follow-up|1
1358630|NCT01667926|4479392|P2|Overall Study|Lost to Follow-up|2
1358631|NCT01667926|4479393|P1|Overall Study|Lost to Follow-up|1
1358632|NCT01667926|4479391|P3|Overall Study|Inclusion/Exclusion Criteria|5
1358633|NCT01667926|4479392|P2|Overall Study|Inclusion/Exclusion Criteria|0
1358634|NCT01667926|4479393|P1|Overall Study|Inclusion/Exclusion Criteria|0
1358635|NCT01667926|4479391|P3|Overall Study|Time committment|2
1358636|NCT01667926|4479392|P2|Overall Study|Time committment|0
1358637|NCT01667926|4479393|P1|Overall Study|Time committment|0
1358638|NCT01667926|4479391|P3|Overall Study|Physician Decision|1
1358639|NCT01667926|4479392|P2|Overall Study|Physician Decision|0
1358640|NCT01667926|4479393|P1|Overall Study|Physician Decision|0
1358641|NCT01667926|4479391|P3|Overall Study|Withdrawal by Subject|2
1358642|NCT01667926|4479392|P2|Overall Study|Withdrawal by Subject|2
1358643|NCT01667926|4479393|P1|Overall Study|Withdrawal by Subject|1
1358644|NCT01667900|4479406|P20|Part B|Death|0
1358645|NCT01667900|4479407|P19|Part B|Death|0
1358646|NCT01667900|4479408|P18|Part B|Death|0
1358647|NCT01667900|4479409|P17|Part B|Death|1
1358648|NCT01667900|4479410|P16|Part B|Death|0
1358649|NCT01667900|4479411|P15|Part B|Death|0
1358650|NCT01667900|4479412|P14|Part B|Death|0
1358651|NCT01667900|4479413|P13|Part B|Death|0
1358652|NCT01667900|4479414|P12|Part B|Death|0
1358653|NCT01667900|4479415|P11|Part B|Death|0
1358654|NCT01667900|4479416|P10|Part B|Death|0
1358655|NCT01667900|4479417|P9|Part B|Death|0
1358656|NCT01667900|4479418|P8|Part B|Death|0
1358657|NCT01667900|4479419|P7|Part B|Death|0
1358658|NCT01667900|4479420|P6|Part B|Death|0
1358659|NCT01667900|4479421|P5|Part B|Death|0
1358660|NCT01667900|4479422|P4|Part B|Death|0
1358661|NCT01667900|4479423|P3|Part B|Death|0
1358662|NCT01667900|4479424|P2|Part B|Death|0
1358663|NCT01667900|4479425|P1|Part B|Death|0
1358664|NCT01667731|4479488|P5|Overall Study|Death|0
1358665|NCT01667731|4479489|P4|Overall Study|Death|0
1358666|NCT01667731|4479490|P3|Overall Study|Death|0
1358667|NCT01667731|4479491|P2|Overall Study|Death|1
1358668|NCT01667731|4479492|P1|Overall Study|Death|0
1358669|NCT01667731|4479488|P5|Overall Study|Subject Withdrew Consent|1
1358670|NCT01667731|4479489|P4|Overall Study|Subject Withdrew Consent|0
1358671|NCT01667731|4479490|P3|Overall Study|Subject Withdrew Consent|1
1358672|NCT01667731|4479491|P2|Overall Study|Subject Withdrew Consent|0
1358673|NCT01667731|4479492|P1|Overall Study|Subject Withdrew Consent|2
1358674|NCT01667731|4479488|P5|Overall Study|Lost to Follow-up|2
1358675|NCT01667731|4479489|P4|Overall Study|Lost to Follow-up|1
1358676|NCT01667731|4479490|P3|Overall Study|Lost to Follow-up|1
1358677|NCT01667731|4479491|P2|Overall Study|Lost to Follow-up|3
1358678|NCT01667731|4479492|P1|Overall Study|Lost to Follow-up|2
1358679|NCT01667731|4479488|P5|Overall Study|Efficacy Failure|24
1358680|NCT01667731|4479489|P4|Overall Study|Efficacy Failure|1
1358681|NCT01667731|4479490|P3|Overall Study|Efficacy Failure|0
1358682|NCT01667731|4479491|P2|Overall Study|Efficacy Failure|12
1358683|NCT01667731|4479492|P1|Overall Study|Efficacy Failure|1
1358684|NCT01667731|4479488|P5|Overall Study|Enrolled but not treated|1
1358685|NCT01667731|4479489|P4|Overall Study|Enrolled but not treated|0
1358686|NCT01667731|4479490|P3|Overall Study|Enrolled but not treated|0
1358687|NCT01667731|4479491|P2|Overall Study|Enrolled but not treated|0
1358688|NCT01667731|4479492|P1|Overall Study|Enrolled but not treated|0
1358689|NCT01667679|4479547|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
1358690|NCT01667679|4479548|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
1358691|NCT01667679|4479547|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
1358692|NCT01667679|4479548|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
1358693|NCT01667679|4479547|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
1358694|NCT01667679|4479548|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
1358695|NCT01667679|4479547|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
1358696|NCT01667679|4479548|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
1358697|NCT01667679|4479547|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
1358698|NCT01667679|4479548|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
1358699|NCT01667679|4479547|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
1358700|NCT01667679|4479548|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
1358701|NCT01667679|4479547|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
1358702|NCT01667679|4479548|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
1358703|NCT01667679|4479547|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
1358704|NCT01667679|4479548|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
1358705|NCT01667679|4479547|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
1358706|NCT01667679|4479548|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
1358707|NCT01667679|4479547|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
1358708|NCT01667679|4479548|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
1358709|NCT01667679|4479547|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
1358710|NCT01667679|4479548|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
1358711|NCT01667679|4479547|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
1358712|NCT01667679|4479548|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
1358713|NCT01667679|4479547|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
1358714|NCT01667679|4479548|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
1358715|NCT01667679|4479547|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
1358716|NCT01667679|4479548|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
1358717|NCT01667679|4479547|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
1358718|NCT01667679|4479548|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
1358719|NCT01667679|4479547|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
1358720|NCT01667679|4479548|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
1358721|NCT01667679|4479547|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
1358722|NCT01667679|4479548|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
1358723|NCT01667679|4479547|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
1358724|NCT01667679|4479548|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
1358725|NCT01667679|4479547|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
1358726|NCT01667679|4479548|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
1358727|NCT01667679|4479547|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
1358728|NCT01667679|4479548|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
1358729|NCT01667679|4479547|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
1358730|NCT01667679|4479548|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
1358731|NCT01667432|4479633|P1|Overall Study|Missing Information|4
1358732|NCT01667432|4479633|P1|Overall Study|Reason Not Specified|2
1358733|NCT01667432|4479633|P1|Overall Study|Principal Investigator Decision|1
1358734|NCT01667432|4479633|P1|Overall Study|Protocol Deviation|2
1358735|NCT01667432|4479633|P1|Overall Study|Adverse Event|1
1358736|NCT01667432|4479633|P1|Overall Study|Insufficient Therapeutic Response|4
1358737|NCT01667432|4479633|P1|Overall Study|Refused Treatment/Withdrew Consent|1
1358738|NCT01667432|4479633|P1|Overall Study|Lost to Follow-up|3
1358739|NCT01667432|4479633|P1|Overall Study|Moved to Another Center|3
1358740|NCT01667432|4479633|P1|Overall Study|Failure to Return|10
1358741|NCT01667432|4479633|P1|Overall Study|Premature Study Termination|26
1358742|NCT01667224|4479658|P2|Overall Study|Protocol Violation|1
1358743|NCT01667224|4479659|P1|Overall Study|Protocol Violation|1
1358744|NCT01667224|4479658|P2|Overall Study|Withdrawal by Subject|1
1358745|NCT01667224|4479659|P1|Overall Study|Withdrawal by Subject|3
1358746|NCT01667107|4479673|P2|Overall Study|Lack of Efficacy|1
1358747|NCT01667107|4479674|P1|Overall Study|Lack of Efficacy|0
1358748|NCT01667107|4479673|P2|Overall Study|Protocol Violation|1
1358749|NCT01667107|4479674|P1|Overall Study|Protocol Violation|0
1358750|NCT01667107|4479673|P2|Overall Study|Tolerability issues|2
1358751|NCT01667107|4479674|P1|Overall Study|Tolerability issues|0
1358752|NCT01667107|4479673|P2|Overall Study|Adverse Event|3
1358753|NCT01667107|4479674|P1|Overall Study|Adverse Event|4
1358754|NCT01666951|4479733|P2|Overall Study|Not dosed|1
1358755|NCT01666951|4479734|P1|Overall Study|Not dosed|1
1358756|NCT01666782|4479785|P2|Overall Study|Enrolled both years; year 1 data used|0
1358757|NCT01666782|4479786|P1|Overall Study|Enrolled both years; year 1 data used|4
1358758|NCT01666782|4479785|P2|Overall Study|Received 2 doses of vaccine|1
1358759|NCT01666782|4479786|P1|Overall Study|Received 2 doses of vaccine|0
1358760|NCT01666314|4479810|P4|Overall Study|Reason not Specified|5
1358761|NCT01666314|4479811|P3|Overall Study|Reason not Specified|5
1358762|NCT01666314|4479812|P2|Overall Study|Reason not Specified|7
1358763|NCT01666314|4479813|P1|Overall Study|Reason not Specified|10
1358764|NCT01666314|4479810|P4|Overall Study|Withdrawal by Subject|3
1358765|NCT01666314|4479811|P3|Overall Study|Withdrawal by Subject|2
1358766|NCT01666314|4479812|P2|Overall Study|Withdrawal by Subject|1
1358767|NCT01666314|4479813|P1|Overall Study|Withdrawal by Subject|1
1358768|NCT01666314|4479810|P4|Overall Study|Unsatisfactory Therapeutic Response|1
1358769|NCT01666314|4479811|P3|Overall Study|Unsatisfactory Therapeutic Response|1
1358770|NCT01666314|4479812|P2|Overall Study|Unsatisfactory Therapeutic Response|2
1358771|NCT01666314|4479813|P1|Overall Study|Unsatisfactory Therapeutic Response|7
1358772|NCT01666314|4479810|P4|Overall Study|Symptomatic Deterioration|0
1358773|NCT01666314|4479811|P3|Overall Study|Symptomatic Deterioration|2
1358774|NCT01666314|4479812|P2|Overall Study|Symptomatic Deterioration|0
1358775|NCT01666314|4479813|P1|Overall Study|Symptomatic Deterioration|1
1358776|NCT01666314|4479810|P4|Overall Study|Progressive Disease|20
1358777|NCT01666314|4479811|P3|Overall Study|Progressive Disease|19
1358778|NCT01666314|4479812|P2|Overall Study|Progressive Disease|9
1358779|NCT01666314|4479813|P1|Overall Study|Progressive Disease|11
1358780|NCT01666314|4479810|P4|Overall Study|Adverse Event|7
1358781|NCT01666314|4479811|P3|Overall Study|Adverse Event|7
1358782|NCT01666314|4479812|P2|Overall Study|Adverse Event|13
1358783|NCT01666314|4479813|P1|Overall Study|Adverse Event|3
1358784|NCT01666119|4479949|P1|Overall Study|Subject experiencing withdrawal symptoms|5
1358785|NCT01666119|4479949|P1|Overall Study|non compliance with study medication, pa|18
1358786|NCT01666119|4479949|P1|Overall Study|Lost to Follow-up|7
1358787|NCT01666119|4479949|P1|Overall Study|Withdrawal by Subject|16
1358788|NCT01666119|4479949|P1|Overall Study|Adverse Event|6
1358789|NCT01666002|4479956|P2|Overall Study|Lost to Follow-up|0
1358790|NCT01666002|4479957|P1|Overall Study|Lost to Follow-up|5
1358791|NCT01665911|4479978|P1|Overall Study|Adverse Event|1
1358792|NCT01665911|4479978|P1|Overall Study|Withdrawal by Subject|1
1358793|NCT01665911|4479978|P1|Overall Study|Protocol Violation|4
1358794|NCT01665807|4479987|P3|Overall Study|Withdrawal by Subject|1
1358795|NCT01665807|4479988|P2|Overall Study|Withdrawal by Subject|0
1358796|NCT01665807|4479989|P1|Overall Study|Withdrawal by Subject|2
1358797|NCT01665599|4480000|P1|Overall Study|Could Not Continue Due to Time Constrain|1
1358798|NCT01665599|4480000|P1|Overall Study|Participant Left for More Than 3 Months|1
1358799|NCT01665599|4480000|P1|Overall Study|Lost to Follow-up|2
1358800|NCT01665599|4480000|P1|Overall Study|Death|1
1358801|NCT01665599|4480000|P1|Overall Study|Investigator/Sponsor decision|1
1358802|NCT01665599|4480000|P1|Overall Study|Consent Withdrawn|1
1358803|NCT01665599|4480000|P1|Overall Study|Adverse Event|1
1358804|NCT01665430|4480036|P1|Overall Study|Other Unspecified|2
1358805|NCT01665430|4480036|P1|Overall Study|Withdrawal by Subject|6
1358806|NCT01665430|4480036|P1|Overall Study|Adverse Event|1
1358807|NCT01664949|4480184|P2|Overall Study|Other Miscellaneous Reasons|1
1358808|NCT01664949|4480185|P1|Overall Study|Other Miscellaneous Reasons|3
1358809|NCT01664949|4480184|P2|Overall Study|Protocol Violation|5
1358810|NCT01664949|4480185|P1|Overall Study|Protocol Violation|5
1358811|NCT01664949|4480184|P2|Overall Study|Personal Reasons|4
1358812|NCT01664949|4480185|P1|Overall Study|Personal Reasons|3
1358813|NCT01664949|4480184|P2|Overall Study|Lost to Follow-up|2
1358814|NCT01664949|4480185|P1|Overall Study|Lost to Follow-up|1
1358815|NCT01664949|4480184|P2|Overall Study|Lack of Efficacy|1
1358816|NCT01664949|4480185|P1|Overall Study|Lack of Efficacy|1
1358817|NCT01664949|4480184|P2|Overall Study|Adverse Event|12
1358818|NCT01664949|4480185|P1|Overall Study|Adverse Event|11
1358819|NCT01664923|4480201|P2|Overall Study|Miscellaneous|1
1358820|NCT01664923|4480202|P1|Overall Study|Miscellaneous|5
1358821|NCT01664923|4480201|P2|Overall Study|Adverse Event|12
1358822|NCT01664923|4480202|P1|Overall Study|Adverse Event|16
1358823|NCT01664923|4480201|P2|Overall Study|Disease Progression|139
1358824|NCT01664923|4480202|P1|Overall Study|Disease Progression|58
1358825|NCT01664923|4480201|P2|Overall Study|Withdrawal by Subject|5
1358826|NCT01664923|4480202|P1|Overall Study|Withdrawal by Subject|11
1358827|NCT01664923|4480201|P2|Overall Study|Protocol Violation|0
1358828|NCT01664923|4480202|P1|Overall Study|Protocol Violation|2
1358829|NCT01664923|4480201|P2|Overall Study|Lost to Follow-up|1
1358830|NCT01664923|4480202|P1|Overall Study|Lost to Follow-up|0
1358831|NCT01664923|4480201|P2|Overall Study|Death|0
1358832|NCT01664923|4480202|P1|Overall Study|Death|1
1358833|NCT01664624|4480246|P4|Overall Study|Adverse Event|0
1358834|NCT01664624|4480247|P3|Overall Study|Adverse Event|0
1358835|NCT01664624|4480248|P2|Overall Study|Adverse Event|1
1358836|NCT01664624|4480249|P1|Overall Study|Adverse Event|0
1358837|NCT01664533|4480296|P1|Overall Study|Protocol Violation|3
1358838|NCT01664533|4480296|P1|Overall Study|Study termination|9
1358839|NCT01664533|4480296|P1|Overall Study|Lost to Follow-up|3
1358840|NCT01664533|4480296|P1|Overall Study|Death|42
1358841|NCT01664494|4480304|P1|Overall Study|Lost to Follow-up|99
1358842|NCT01664494|4480304|P1|Overall Study|Not specified|49
1358843|NCT01664494|4480304|P1|Overall Study|Death|18
1358844|NCT01664494|4480304|P1|Overall Study|Withdrawal by Subject|27
1358845|NCT01664247|4480311|P2|Overall Study|Unclassified|29
1358846|NCT01664247|4480312|P1|Overall Study|Unclassified|5
1358847|NCT01664247|4480311|P2|Overall Study|Withdrawal Criteria|4
1358848|NCT01664247|4480312|P1|Overall Study|Withdrawal Criteria|1
1358849|NCT01664247|4480311|P2|Overall Study|Protocol Violation|5
1358850|NCT01664247|4480312|P1|Overall Study|Protocol Violation|3
1358851|NCT01664247|4480311|P2|Overall Study|Adverse Event|3
1358852|NCT01664247|4480312|P1|Overall Study|Adverse Event|5
1358853|NCT01664104|4480389|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
1358854|NCT01664104|4480389|P1|Overall Study|Other|1
1358855|NCT01664104|4480389|P1|Overall Study|Lost to Follow-up|4
1358856|NCT01664104|4480389|P1|Overall Study|Withdrawal by Subject|1
1358857|NCT01664104|4480389|P1|Overall Study|Lack of Efficacy|2
1358858|NCT01664104|4480389|P1|Overall Study|Adverse Event|6
1358859|NCT01664052|4480458|P2|Phase 2|No device placement|4
1358860|NCT01664052|4480459|P1|Phase 2|No device placement|0
1358861|NCT01664052|4480458|P2|Phase 1|No HSG 1 hr post placement|0
1358862|NCT01664052|4480459|P1|Phase 1|No HSG 1 hr post placement|1
1358863|NCT01664052|4480458|P2|Phase 1|No device placement|0
1358864|NCT01664052|4480459|P1|Phase 1|No device placement|6
1358865|NCT01664039|4480477|P2|Overall Study|Noncompliance|1
1358866|NCT01664039|4480478|P1|Overall Study|Noncompliance|1
1358867|NCT01664039|4480477|P2|Overall Study|Withdrawal by Subject|3
1358868|NCT01664039|4480478|P1|Overall Study|Withdrawal by Subject|1
1358869|NCT01664039|4480477|P2|Overall Study|Lost to Follow-up|1
1358870|NCT01664039|4480478|P1|Overall Study|Lost to Follow-up|1
1358871|NCT01664039|4480477|P2|Overall Study|Adverse Event|4
1358872|NCT01664039|4480478|P1|Overall Study|Adverse Event|3
1358873|NCT01663987|4480500|P2|Overall Study|Other reason not defined above|0
1358874|NCT01663987|4480501|P1|Overall Study|Other reason not defined above|3
1358875|NCT01663987|4480500|P2|Overall Study|Withdrawal by Subject|3
1358876|NCT01663987|4480501|P1|Overall Study|Withdrawal by Subject|2
1358877|NCT01663987|4480500|P2|Overall Study|Lost to Follow-up|1
1358878|NCT01663987|4480501|P1|Overall Study|Lost to Follow-up|1
1358879|NCT01663987|4480500|P2|Overall Study|Adverse Event|2
1358880|NCT01663987|4480501|P1|Overall Study|Adverse Event|7
1358881|NCT01663740|4480544|P2|Overall Study|No end of study status|0
1358882|NCT01663740|4480545|P1|Overall Study|No end of study status|3
1358883|NCT01663740|4480544|P2|Overall Study|Withdrawal by Subject|1
1358884|NCT01663740|4480545|P1|Overall Study|Withdrawal by Subject|2
1358885|NCT01663740|4480544|P2|Overall Study|Death|1
1358886|NCT01663740|4480545|P1|Overall Study|Death|0
1358887|NCT01663740|4480544|P2|Overall Study|Inclusion/Exclusion not met|0
1358888|NCT01663740|4480545|P1|Overall Study|Inclusion/Exclusion not met|1
1358889|NCT01663740|4480544|P2|Overall Study|Other|2
1358890|NCT01663740|4480545|P1|Overall Study|Other|9
1358891|NCT01663740|4480544|P2|Overall Study|Lost to Follow-up|4
1358892|NCT01663740|4480545|P1|Overall Study|Lost to Follow-up|1
1358893|NCT01663727|4480605|P2|Overall Study|Lost to Follow-up|3
1358894|NCT01663727|4480606|P1|Overall Study|Lost to Follow-up|8
1358895|NCT01663727|4480605|P2|Overall Study|Alive in Follow-Up|132
1358896|NCT01663727|4480606|P1|Overall Study|Alive in Follow-Up|143
1358897|NCT01663727|4480605|P2|Overall Study|Alive on Treatment|39
1358898|NCT01663727|4480606|P1|Overall Study|Alive on Treatment|31
1358899|NCT01663727|4480605|P2|Overall Study|Death|65
1358900|NCT01663727|4480606|P1|Overall Study|Death|60
1358901|NCT01663714|4480634|P1|Long-Term Follow-Up|Non-compliance|1
1358902|NCT01663714|4480634|P1|Long-Term Follow-Up|Death|4
1358903|NCT01663714|4480634|P1|Long-Term Follow-Up|Lost to Follow-up|1
1358904|NCT01663714|4480634|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
1358905|NCT01663714|4480634|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
1358906|NCT01663714|4480634|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
1358907|NCT01663623|4480663|P2|Overall Study|Withdrawal by Subject|1
1358908|NCT01663623|4480664|P1|Overall Study|Withdrawal by Subject|2
1358909|NCT01663623|4480663|P2|Overall Study|Physician Decision|4
1358910|NCT01663623|4480664|P1|Overall Study|Physician Decision|1
1358911|NCT01663623|4480663|P2|Overall Study|Other-Study closed/terminated|1
1358912|NCT01663623|4480664|P1|Overall Study|Other-Study closed/terminated|1
1358913|NCT01663623|4480663|P2|Overall Study|Protocol Violation|1
1358914|NCT01663623|4480664|P1|Overall Study|Protocol Violation|0
1358915|NCT01663623|4480663|P2|Overall Study|Lack of Efficacy|6
1358916|NCT01663623|4480664|P1|Overall Study|Lack of Efficacy|5
1358917|NCT01663623|4480663|P2|Overall Study|Adverse Event|7
1358918|NCT01663623|4480664|P1|Overall Study|Adverse Event|3
1358919|NCT01663532|4480674|P2|Overall Study|Lack of Efficacy|60
1358920|NCT01663532|4480675|P1|Overall Study|Lack of Efficacy|15
1358921|NCT01663532|4480674|P2|Overall Study|Withdrawal by Subject|17
1358922|NCT01663532|4480675|P1|Overall Study|Withdrawal by Subject|35
1358923|NCT01663532|4480674|P2|Overall Study|Physician Decision|1
1358924|NCT01663532|4480675|P1|Overall Study|Physician Decision|1
1358925|NCT01663532|4480674|P2|Overall Study|Met Withdrawal Criteria|6
1358926|NCT01663532|4480675|P1|Overall Study|Met Withdrawal Criteria|7
1358927|NCT01663532|4480674|P2|Overall Study|Adverse Event|13
1358928|NCT01663532|4480675|P1|Overall Study|Adverse Event|7
1358929|NCT01663532|4480674|P2|Overall Study|Lost to Follow-up|10
1358930|NCT01663532|4480675|P1|Overall Study|Lost to Follow-up|9
1358931|NCT01663506|4480693|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
1358932|NCT01663506|4480693|P1|Overall Study|Adverse Event|1
1358933|NCT01663506|4480693|P1|Overall Study|Lost to Follow-up|1
1358934|NCT01663506|4480693|P1|Overall Study|Consent Withdrawal by Subject|1
1358935|NCT01663506|4480693|P1|Overall Study|Lack of Efficacy|3
1358936|NCT01663233|4480735|P2|Overall Study|Lost to Follow-up|1
1358937|NCT01663233|4480736|P1|Overall Study|Lost to Follow-up|0
1358938|NCT01663233|4480735|P2|Overall Study|Protocol Deviation|4
1358939|NCT01663233|4480736|P1|Overall Study|Protocol Deviation|1
1358940|NCT01663233|4480735|P2|Overall Study|Withdrawal by Subject|2
1358941|NCT01663233|4480736|P1|Overall Study|Withdrawal by Subject|3
1358942|NCT01663103|4480760|P2|Overall Study|dog bite|0
1358943|NCT01663103|4480761|P1|Overall Study|dog bite|1
1358944|NCT01663103|4480760|P2|Overall Study|Adverse Event|0
1358945|NCT01663103|4480761|P1|Overall Study|Adverse Event|1
1358946|NCT01663103|4480760|P2|Overall Study|Withdrawal by Subject|2
1358947|NCT01663103|4480761|P1|Overall Study|Withdrawal by Subject|1
1358948|NCT01662999|4480789|P6|Period 3|Withdrawal by Subject|0
1358949|NCT01662999|4480790|P5|Period 3|Withdrawal by Subject|0
1358950|NCT01662999|4480791|P4|Period 3|Withdrawal by Subject|0
1358951|NCT01662999|4480792|P3|Period 3|Withdrawal by Subject|0
1358952|NCT01662999|4480793|P2|Period 3|Withdrawal by Subject|1
1358953|NCT01662999|4480794|P1|Period 3|Withdrawal by Subject|0
1358954|NCT01662986|4480865|P2|Overall Study|Other than stated above|0
1358955|NCT01662986|4480866|P1|Overall Study|Other than stated above|3
1358956|NCT01662986|4480865|P2|Overall Study|Not Treated|0
1358957|NCT01662986|4480866|P1|Overall Study|Not Treated|1
1358958|NCT01662986|4480865|P2|Overall Study|Withdrawal by Subject|2
1358959|NCT01662986|4480866|P1|Overall Study|Withdrawal by Subject|2
1358960|NCT01662986|4480865|P2|Overall Study|Lost to Follow-up|4
1358961|NCT01662986|4480866|P1|Overall Study|Lost to Follow-up|5
1358962|NCT01662986|4480865|P2|Overall Study|Protocol Violation|3
1358963|NCT01662986|4480866|P1|Overall Study|Protocol Violation|2
1358964|NCT01662986|4480865|P2|Overall Study|Adverse Event|4
1358965|NCT01662986|4480866|P1|Overall Study|Adverse Event|5
1358966|NCT01662648|4480986|P2|Overall Study|LOE and Participant non-compliant|1
1358967|NCT01662648|4480987|P1|Overall Study|LOE and Participant non-compliant|0
1358968|NCT01662648|4480986|P2|Overall Study|LOE and other reason unspecified|0
1358969|NCT01662648|4480987|P1|Overall Study|LOE and other reason unspecified|1
1358970|NCT01662648|4480986|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
1358971|NCT01662648|4480987|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
1358972|NCT01662648|4480986|P2|Overall Study|Other|11
1358973|NCT01662648|4480987|P1|Overall Study|Other|8
1358974|NCT01662648|4480986|P2|Overall Study|Participant non-compliant|20
1358975|NCT01662648|4480987|P1|Overall Study|Participant non-compliant|16
1358976|NCT01662648|4480986|P2|Overall Study|Withdrawal by Subject|53
1358977|NCT01662648|4480987|P1|Overall Study|Withdrawal by Subject|36
1358978|NCT01662648|4480986|P2|Overall Study|Lost to Follow-up|36
1358979|NCT01662648|4480987|P1|Overall Study|Lost to Follow-up|24
1358980|NCT01662648|4480986|P2|Overall Study|Participant ineligible to continue trial|1
1358981|NCT01662648|4480987|P1|Overall Study|Participant ineligible to continue trial|1
1358982|NCT01662648|4480986|P2|Overall Study|Lack of Efficacy|16
1358983|NCT01662648|4480987|P1|Overall Study|Lack of Efficacy|17
1358984|NCT01662648|4480986|P2|Overall Study|Adverse Event|37
1358985|NCT01662648|4480987|P1|Overall Study|Adverse Event|40
1358986|NCT01662648|4480986|P2|Overall Study|Death|3
1358987|NCT01662648|4480987|P1|Overall Study|Death|1
1358988|NCT01662635|4481009|P1|Overall Study|scarce samples for evaluation|30
1358989|NCT01662505|4481060|P3|Overall Study|Not specified above|2
1358990|NCT01662505|4481061|P2|Overall Study|Not specified above|3
1358991|NCT01662505|4481062|P1|Overall Study|Not specified above|1
1358992|NCT01662505|4481060|P3|Overall Study|Refused cont. medication|1
1358993|NCT01662505|4481061|P2|Overall Study|Refused cont. medication|0
1358994|NCT01662505|4481062|P1|Overall Study|Refused cont. medication|0
1358995|NCT01662505|4481060|P3|Overall Study|Progressive disease|5
1358996|NCT01662505|4481061|P2|Overall Study|Progressive disease|1
1358997|NCT01662505|4481062|P1|Overall Study|Progressive disease|6
1358998|NCT01662492|4481086|P3|Overall Study|Lack of Efficacy|2
1358999|NCT01662492|4481087|P2|Overall Study|Lack of Efficacy|1
1359000|NCT01662492|4481088|P1|Overall Study|Lack of Efficacy|1
1359001|NCT01662492|4481086|P3|Overall Study|Lost to Follow-up|2
1359002|NCT01662492|4481087|P2|Overall Study|Lost to Follow-up|0
1359003|NCT01662492|4481088|P1|Overall Study|Lost to Follow-up|0
1359004|NCT01662492|4481086|P3|Overall Study|Protocol Violation|0
1359005|NCT01662492|4481087|P2|Overall Study|Protocol Violation|0
1359006|NCT01662492|4481088|P1|Overall Study|Protocol Violation|1
1359007|NCT01662492|4481086|P3|Overall Study|Withdrawal by Subject|1
1359008|NCT01662492|4481087|P2|Overall Study|Withdrawal by Subject|0
1359009|NCT01662492|4481088|P1|Overall Study|Withdrawal by Subject|0
1359010|NCT01662492|4481086|P3|Overall Study|Other miscellaneous reasons.|1
1359011|NCT01662492|4481087|P2|Overall Study|Other miscellaneous reasons.|0
1359012|NCT01662492|4481088|P1|Overall Study|Other miscellaneous reasons.|1
1359013|NCT01662440|4481112|P4|Overall Study|Withdrawal by Subject|2
1359014|NCT01662440|4481113|P3|Overall Study|Withdrawal by Subject|2
1359015|NCT01662440|4481114|P2|Overall Study|Withdrawal by Subject|2
1359016|NCT01662440|4481115|P1|Overall Study|Withdrawal by Subject|5
1359017|NCT01662440|4481112|P4|Overall Study|Protocol Violation|0
1359018|NCT01662440|4481113|P3|Overall Study|Protocol Violation|0
1359019|NCT01662440|4481114|P2|Overall Study|Protocol Violation|0
1359020|NCT01662440|4481115|P1|Overall Study|Protocol Violation|1
1359021|NCT01662440|4481112|P4|Overall Study|Subject moved to another country.|0
1359022|NCT01662440|4481113|P3|Overall Study|Subject moved to another country.|0
1359023|NCT01662440|4481114|P2|Overall Study|Subject moved to another country.|1
1359024|NCT01662440|4481115|P1|Overall Study|Subject moved to another country.|0
1359025|NCT01662440|4481112|P4|Overall Study|Lost to Follow-up|1
1359026|NCT01662440|4481113|P3|Overall Study|Lost to Follow-up|4
1359027|NCT01662440|4481114|P2|Overall Study|Lost to Follow-up|2
1359028|NCT01662440|4481115|P1|Overall Study|Lost to Follow-up|2
1359029|NCT01662440|4481112|P4|Overall Study|Death|0
1359030|NCT01662440|4481113|P3|Overall Study|Death|0
1359031|NCT01662440|4481114|P2|Overall Study|Death|1
1359032|NCT01662440|4481115|P1|Overall Study|Death|0
1359033|NCT01662440|4481112|P4|Overall Study|Adverse Event|1
1359034|NCT01662440|4481113|P3|Overall Study|Adverse Event|0
1359035|NCT01662440|4481114|P2|Overall Study|Adverse Event|0
1359036|NCT01662440|4481115|P1|Overall Study|Adverse Event|1
1359037|NCT01662362|4481163|P1|Overall Study|Lost to Follow-up|38
1359038|NCT01662336|4481168|P1|Overall Study|Withdrawal by Subject|6
1359039|NCT01662336|4481168|P1|Overall Study|Other|29
1359040|NCT01662336|4481168|P1|Overall Study|No longer on LPV/r|30
1359041|NCT01662336|4481168|P1|Overall Study|Adverse Event|1
1359042|NCT01662310|4481194|P5|Open-Label Extension Phase|Withdrawal by Subject|7
1359043|NCT01662310|4481195|P4|Open-Label Extension Phase|Withdrawal by Subject|2
1359044|NCT01662310|4481196|P3|Open-Label Extension Phase|Withdrawal by Subject|0
1359045|NCT01662310|4481197|P2|Open-Label Extension Phase|Withdrawal by Subject|0
1359046|NCT01662310|4481198|P1|Open-Label Extension Phase|Withdrawal by Subject|0
1359047|NCT01662310|4481194|P5|Open-Label Extension Phase|Pregnancy|0
1359048|NCT01662310|4481195|P4|Open-Label Extension Phase|Pregnancy|1
1359049|NCT01662310|4481196|P3|Open-Label Extension Phase|Pregnancy|0
1359050|NCT01662310|4481197|P2|Open-Label Extension Phase|Pregnancy|0
1359051|NCT01662310|4481198|P1|Open-Label Extension Phase|Pregnancy|0
1359052|NCT01662310|4481194|P5|Open-Label Extension Phase|Lost to Follow-up|1
1359053|NCT01662310|4481195|P4|Open-Label Extension Phase|Lost to Follow-up|2
1359054|NCT01662310|4481196|P3|Open-Label Extension Phase|Lost to Follow-up|0
1359055|NCT01662310|4481197|P2|Open-Label Extension Phase|Lost to Follow-up|0
1359056|NCT01662310|4481198|P1|Open-Label Extension Phase|Lost to Follow-up|0
1359057|NCT01662310|4481194|P5|Open-Label Extension Phase|Lack of Efficacy|2
1359058|NCT01662310|4481195|P4|Open-Label Extension Phase|Lack of Efficacy|2
1359059|NCT01662310|4481196|P3|Open-Label Extension Phase|Lack of Efficacy|0
1359060|NCT01662310|4481197|P2|Open-Label Extension Phase|Lack of Efficacy|0
1359061|NCT01662310|4481198|P1|Open-Label Extension Phase|Lack of Efficacy|0
1359062|NCT01662310|4481194|P5|Open-Label Extension Phase|Death|0
1359063|NCT01662310|4481195|P4|Open-Label Extension Phase|Death|1
1359064|NCT01662310|4481196|P3|Open-Label Extension Phase|Death|0
1359065|NCT01662310|4481197|P2|Open-Label Extension Phase|Death|0
1359066|NCT01662310|4481198|P1|Open-Label Extension Phase|Death|0
1359067|NCT01662310|4481194|P5|Open-Label Extension Phase|Adverse Event|0
1359068|NCT01662310|4481195|P4|Open-Label Extension Phase|Adverse Event|3
1359069|NCT01662310|4481196|P3|Open-Label Extension Phase|Adverse Event|0
1359070|NCT01662310|4481197|P2|Open-Label Extension Phase|Adverse Event|0
1359071|NCT01662310|4481198|P1|Open-Label Extension Phase|Adverse Event|0
1359072|NCT01662310|4481194|P5|Double-Blind Phase|Randomized but not treated|0
1359073|NCT01662310|4481195|P4|Double-Blind Phase|Randomized but not treated|0
1359074|NCT01662310|4481196|P3|Double-Blind Phase|Randomized but not treated|0
1359075|NCT01662310|4481197|P2|Double-Blind Phase|Randomized but not treated|1
1359076|NCT01662310|4481198|P1|Double-Blind Phase|Randomized but not treated|0
1359077|NCT01662310|4481194|P5|Double-Blind Phase|Other|0
1359078|NCT01662310|4481195|P4|Double-Blind Phase|Other|0
1359079|NCT01662310|4481196|P3|Double-Blind Phase|Other|1
1359080|NCT01662310|4481197|P2|Double-Blind Phase|Other|0
1359081|NCT01662310|4481198|P1|Double-Blind Phase|Other|0
1359082|NCT01662310|4481194|P5|Double-Blind Phase|Withdrawal by Subject|0
1359083|NCT01662310|4481195|P4|Double-Blind Phase|Withdrawal by Subject|0
1359084|NCT01662310|4481196|P3|Double-Blind Phase|Withdrawal by Subject|3
1359085|NCT01662310|4481197|P2|Double-Blind Phase|Withdrawal by Subject|9
1359086|NCT01662310|4481198|P1|Double-Blind Phase|Withdrawal by Subject|0
1359087|NCT01662310|4481194|P5|Double-Blind Phase|Pregnancy|0
1359088|NCT01662310|4481195|P4|Double-Blind Phase|Pregnancy|0
1359089|NCT01662310|4481196|P3|Double-Blind Phase|Pregnancy|0
1359090|NCT01662310|4481197|P2|Double-Blind Phase|Pregnancy|2
1359091|NCT01662310|4481198|P1|Double-Blind Phase|Pregnancy|0
1359092|NCT01662310|4481194|P5|Double-Blind Phase|Lost to Follow-up|0
1359093|NCT01662310|4481195|P4|Double-Blind Phase|Lost to Follow-up|0
1359094|NCT01662310|4481196|P3|Double-Blind Phase|Lost to Follow-up|0
1359095|NCT01662310|4481197|P2|Double-Blind Phase|Lost to Follow-up|3
1359096|NCT01662310|4481198|P1|Double-Blind Phase|Lost to Follow-up|0
1359097|NCT01662310|4481194|P5|Double-Blind Phase|Adverse Event|0
1359098|NCT01662310|4481195|P4|Double-Blind Phase|Adverse Event|0
1359099|NCT01662310|4481196|P3|Double-Blind Phase|Adverse Event|1
1359100|NCT01662310|4481197|P2|Double-Blind Phase|Adverse Event|0
1359101|NCT01662310|4481198|P1|Double-Blind Phase|Adverse Event|0
1359102|NCT01662310|4481194|P5|Run-In or Stabilization Phase|Other|0
1359103|NCT01662310|4481195|P4|Run-In or Stabilization Phase|Other|0
1359104|NCT01662310|4481196|P3|Run-In or Stabilization Phase|Other|0
1359105|NCT01662310|4481197|P2|Run-In or Stabilization Phase|Other|0
1359106|NCT01662310|4481198|P1|Run-In or Stabilization Phase|Other|1
1359107|NCT01662310|4481194|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
1359108|NCT01662310|4481195|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
1359109|NCT01662310|4481196|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
1359110|NCT01662310|4481197|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
1359111|NCT01662310|4481198|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
1359112|NCT01662310|4481194|P5|Run-In or Stabilization Phase|Protocol Violation|0
1359113|NCT01662310|4481195|P4|Run-In or Stabilization Phase|Protocol Violation|0
1359114|NCT01662310|4481196|P3|Run-In or Stabilization Phase|Protocol Violation|0
1359115|NCT01662310|4481197|P2|Run-In or Stabilization Phase|Protocol Violation|0
1359116|NCT01662310|4481198|P1|Run-In or Stabilization Phase|Protocol Violation|15
1359117|NCT01662310|4481194|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
1359118|NCT01662310|4481195|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
1359119|NCT01662310|4481196|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
1359120|NCT01662310|4481197|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
1359121|NCT01662310|4481198|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
1359122|NCT01662310|4481194|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
1359123|NCT01662310|4481195|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
1359124|NCT01662310|4481196|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
1359125|NCT01662310|4481197|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
1359126|NCT01662310|4481198|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
1359127|NCT01662310|4481194|P5|Run-In or Stabilization Phase|Adverse Event|0
1359128|NCT01662310|4481195|P4|Run-In or Stabilization Phase|Adverse Event|0
1359129|NCT01662310|4481196|P3|Run-In or Stabilization Phase|Adverse Event|0
1359130|NCT01662310|4481197|P2|Run-In or Stabilization Phase|Adverse Event|0
1359131|NCT01662310|4481198|P1|Run-In or Stabilization Phase|Adverse Event|11
1359132|NCT01662102|4481254|P2|Overall Study|Sponsor's decision|0
1359133|NCT01662102|4481255|P1|Overall Study|Sponsor's decision|1
1359134|NCT01662063|4481263|P3|Overall Study|Not Specified|0
1359135|NCT01662063|4481264|P2|Overall Study|Not Specified|1
1359136|NCT01662063|4481265|P1|Overall Study|Not Specified|0
1359137|NCT01662063|4481263|P3|Overall Study|Physician Decision|0
1359138|NCT01662063|4481264|P2|Overall Study|Physician Decision|2
1359139|NCT01662063|4481265|P1|Overall Study|Physician Decision|0
1359140|NCT01662063|4481263|P3|Overall Study|Withdrawal by Subject|1
1359141|NCT01662063|4481264|P2|Overall Study|Withdrawal by Subject|4
1359142|NCT01662063|4481265|P1|Overall Study|Withdrawal by Subject|2
1359143|NCT01662063|4481263|P3|Overall Study|Protocol Violation|0
1359144|NCT01662063|4481264|P2|Overall Study|Protocol Violation|0
1359145|NCT01662063|4481265|P1|Overall Study|Protocol Violation|1
1359146|NCT01662063|4481263|P3|Overall Study|Lost to Follow-up|0
1359147|NCT01662063|4481264|P2|Overall Study|Lost to Follow-up|4
1359148|NCT01662063|4481265|P1|Overall Study|Lost to Follow-up|0
1359149|NCT01662063|4481263|P3|Overall Study|Lack of Efficacy|0
1359150|NCT01662063|4481264|P2|Overall Study|Lack of Efficacy|6
1359151|NCT01662063|4481265|P1|Overall Study|Lack of Efficacy|1
1359152|NCT01662063|4481263|P3|Overall Study|Adverse Event or Intercurrent Illness|0
1359153|NCT01662063|4481264|P2|Overall Study|Adverse Event or Intercurrent Illness|12
1359154|NCT01662063|4481265|P1|Overall Study|Adverse Event or Intercurrent Illness|1
1359155|NCT01662024|4481344|P1|Overall Study|Withdrawal by Subject|3
1359156|NCT01662024|4481344|P1|Overall Study|Pregnancy|2
1359157|NCT01661972|4481356|P2|Overall Study|Withdrawal by Subject|1
1359158|NCT01661972|4481357|P1|Overall Study|Withdrawal by Subject|0
1359159|NCT01661972|4481356|P2|Overall Study|Death during Treatment period|1
1359160|NCT01661972|4481357|P1|Overall Study|Death during Treatment period|1
1359161|NCT01661972|4481356|P2|Overall Study|Adverse Event|2
1359162|NCT01661972|4481357|P1|Overall Study|Adverse Event|1
1359163|NCT01661933|4481367|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
1359164|NCT01661933|4481367|P1|Low-dose Gluten Challenge|Physician Decision|2
1359165|NCT01661790|4481382|P2|Overall Study|Lost to Follow-up|2
1359166|NCT01661790|4481383|P1|Overall Study|Lost to Follow-up|0
1359167|NCT01661595|4481489|P4|Phase 2: Week 5-8.|Protocol Violation|0
1359168|NCT01661595|4481490|P3|Phase 2: Week 5-8.|Protocol Violation|1
1359169|NCT01661595|4481491|P2|Phase 2: Week 5-8.|Protocol Violation|0
1359170|NCT01661595|4481492|P1|Phase 2: Week 5-8.|Protocol Violation|0
1359171|NCT01661595|4481489|P4|Phase 1: Week 0-4|Adverse Event|0
1359172|NCT01661595|4481490|P3|Phase 1: Week 0-4|Adverse Event|0
1359173|NCT01661595|4481491|P2|Phase 1: Week 0-4|Adverse Event|0
1359174|NCT01661595|4481492|P1|Phase 1: Week 0-4|Adverse Event|1
1359175|NCT01661205|4481611|P1|Overall Study|Physician Decision|2
1359176|NCT01661179|4481622|P1|Overall Study|Other Eligibility criteria|4
1359177|NCT01661179|4481622|P1|Overall Study|Withdrawal by Subject|1
1359178|NCT01661179|4481622|P1|Overall Study|Death|1
1359179|NCT01661140|4481626|P3|Double-Blind Period|Administrative/Other|6
1359180|NCT01661140|4481627|P2|Double-Blind Period|Administrative/Other|7
1359181|NCT01661140|4481628|P1|Double-Blind Period|Administrative/Other|0
1359182|NCT01661140|4481626|P3|Double-Blind Period|Sponsor Termination|17
1359183|NCT01661140|4481627|P2|Double-Blind Period|Sponsor Termination|14
1359184|NCT01661140|4481628|P1|Double-Blind Period|Sponsor Termination|0
1359185|NCT01661140|4481626|P3|Double-Blind Period|Investigator's Decision|2
1359186|NCT01661140|4481627|P2|Double-Blind Period|Investigator's Decision|1
1359187|NCT01661140|4481628|P1|Double-Blind Period|Investigator's Decision|0
1359188|NCT01661140|4481626|P3|Double-Blind Period|Withdrawal by Subject|3
1359189|NCT01661140|4481627|P2|Double-Blind Period|Withdrawal by Subject|1
1359190|NCT01661140|4481628|P1|Double-Blind Period|Withdrawal by Subject|0
1359191|NCT01661140|4481626|P3|Double-Blind Period|Protocol Violation|3
1359192|NCT01661140|4481627|P2|Double-Blind Period|Protocol Violation|2
1359193|NCT01661140|4481628|P1|Double-Blind Period|Protocol Violation|0
1359194|NCT01661140|4481626|P3|Double-Blind Period|Adverse Event|18
1359195|NCT01661140|4481627|P2|Double-Blind Period|Adverse Event|16
1359196|NCT01661140|4481628|P1|Double-Blind Period|Adverse Event|0
1359197|NCT01661140|4481626|P3|Double-Blind Period|Refused Treatment|1
1359198|NCT01661140|4481627|P2|Double-Blind Period|Refused Treatment|0
1359199|NCT01661140|4481628|P1|Double-Blind Period|Refused Treatment|0
1359200|NCT01661140|4481626|P3|Open-Label Period|Lost to Follow-up|0
1359201|NCT01661140|4481627|P2|Open-Label Period|Lost to Follow-up|0
1359202|NCT01661140|4481628|P1|Open-Label Period|Lost to Follow-up|2
1359203|NCT01661140|4481626|P3|Open-Label Period|Did not meet EULAR criteria|0
1359204|NCT01661140|4481627|P2|Open-Label Period|Did not meet EULAR criteria|0
1359205|NCT01661140|4481628|P1|Open-Label Period|Did not meet EULAR criteria|1
1359206|NCT01661140|4481626|P3|Open-Label Period|Sponsor termination|0
1359207|NCT01661140|4481627|P2|Open-Label Period|Sponsor termination|0
1359208|NCT01661140|4481628|P1|Open-Label Period|Sponsor termination|16
1359209|NCT01661140|4481626|P3|Open-Label Period|Administrative/Other|0
1359210|NCT01661140|4481627|P2|Open-Label Period|Administrative/Other|0
1359211|NCT01661140|4481628|P1|Open-Label Period|Administrative/Other|1
1359212|NCT01661140|4481626|P3|Open-Label Period|Death|0
1359213|NCT01661140|4481627|P2|Open-Label Period|Death|0
1359214|NCT01661140|4481628|P1|Open-Label Period|Death|1
1359215|NCT01661140|4481626|P3|Open-Label Period|Investigator Decision|0
1359216|NCT01661140|4481627|P2|Open-Label Period|Investigator Decision|0
1359217|NCT01661140|4481628|P1|Open-Label Period|Investigator Decision|3
1359218|NCT01661140|4481626|P3|Open-Label Period|Withdrawal by Subject|0
1359219|NCT01661140|4481627|P2|Open-Label Period|Withdrawal by Subject|0
1359220|NCT01661140|4481628|P1|Open-Label Period|Withdrawal by Subject|5
1359221|NCT01661140|4481626|P3|Open-Label Period|Protocol Violation|0
1359222|NCT01661140|4481627|P2|Open-Label Period|Protocol Violation|0
1359223|NCT01661140|4481628|P1|Open-Label Period|Protocol Violation|3
1359224|NCT01661140|4481626|P3|Open-Label Period|Adverse Event|0
1359225|NCT01661140|4481627|P2|Open-Label Period|Adverse Event|0
1359226|NCT01661140|4481628|P1|Open-Label Period|Adverse Event|44
1359227|NCT01661062|4481680|P1|Overall Study|Withdrawal by Subject|2
1359228|NCT01661062|4481680|P1|Overall Study|Completed Treatment Off Study|3
1359229|NCT01660906|4481685|P1|Overall Study|Discontinued due to study drug toxicity|3
1359230|NCT01660763|4481768|P2|Overall Study|Patient ready for early discharge|4
1359231|NCT01660763|4481769|P1|Overall Study|Patient ready for early discharge|28
1359232|NCT01660763|4481768|P2|Overall Study|Withdrawal by Subject|0
1359233|NCT01660763|4481769|P1|Overall Study|Withdrawal by Subject|4
1359234|NCT01660763|4481768|P2|Overall Study|Protocol Violation|0
1359235|NCT01660763|4481769|P1|Overall Study|Protocol Violation|1
1359236|NCT01660763|4481768|P2|Overall Study|Adverse Event|7
1359237|NCT01660763|4481769|P1|Overall Study|Adverse Event|22
1359238|NCT01660763|4481768|P2|Overall Study|Lack of Efficacy|50
1359239|NCT01660763|4481769|P1|Overall Study|Lack of Efficacy|45
1359240|NCT01660451|4481817|P3|Overall Study|Ongoing with treatment|46
1359241|NCT01660451|4481818|P2|Overall Study|Ongoing with treatment|3
1359242|NCT01660451|4481819|P1|Overall Study|Ongoing with treatment|3
1359243|NCT01660451|4481817|P3|Overall Study|Withdrawal by Subject|16
1359244|NCT01660451|4481818|P2|Overall Study|Withdrawal by Subject|0
1359245|NCT01660451|4481819|P1|Overall Study|Withdrawal by Subject|1
1359246|NCT01660451|4481817|P3|Overall Study|Physician Decision|5
1359247|NCT01660451|4481818|P2|Overall Study|Physician Decision|2
1359248|NCT01660451|4481819|P1|Overall Study|Physician Decision|1
1359249|NCT01660451|4481817|P3|Overall Study|Protocol Deviation|1
1359250|NCT01660451|4481818|P2|Overall Study|Protocol Deviation|0
1359251|NCT01660451|4481819|P1|Overall Study|Protocol Deviation|0
1359252|NCT01660451|4481817|P3|Overall Study|Sponsor Decision|1
1359253|NCT01660451|4481818|P2|Overall Study|Sponsor Decision|0
1359254|NCT01660451|4481819|P1|Overall Study|Sponsor Decision|0
1359255|NCT01660451|4481817|P3|Overall Study|AE with Clinical PD|9
1359256|NCT01660451|4481818|P2|Overall Study|AE with Clinical PD|3
1359257|NCT01660451|4481819|P1|Overall Study|AE with Clinical PD|1
1359258|NCT01660451|4481817|P3|Overall Study|Adverse Event (AE) without Clinical PD|26
1359259|NCT01660451|4481818|P2|Overall Study|Adverse Event (AE) without Clinical PD|8
1359260|NCT01660451|4481819|P1|Overall Study|Adverse Event (AE) without Clinical PD|11
1359261|NCT01660451|4481817|P3|Overall Study|Protocol Violation|1
1359262|NCT01660451|4481818|P2|Overall Study|Protocol Violation|1
1359263|NCT01660451|4481819|P1|Overall Study|Protocol Violation|0
1359264|NCT01660412|4481847|P2|Overall Study|Protocol Violation|3
1359265|NCT01660412|4481848|P1|Overall Study|Protocol Violation|0
1359266|NCT01660334|4481854|P1|Overall Study|Lost to Follow-up|1
1359267|NCT01660022|4482097|P6|First Sequence (7 Days)|Protocol Violation|1
1359268|NCT01660022|4482098|P5|First Sequence (7 Days)|Protocol Violation|0
1359269|NCT01660022|4482099|P4|First Sequence (7 Days)|Protocol Violation|0
1359270|NCT01660022|4482100|P3|First Sequence (7 Days)|Protocol Violation|0
1359271|NCT01660022|4482101|P2|First Sequence (7 Days)|Protocol Violation|0
1359272|NCT01660022|4482102|P1|First Sequence (7 Days)|Protocol Violation|0
1359273|NCT01660022|4482097|P6|First Sequence (7 Days)|Adverse Event|3
1359274|NCT01660022|4482098|P5|First Sequence (7 Days)|Adverse Event|1
1359275|NCT01660022|4482099|P4|First Sequence (7 Days)|Adverse Event|0
1359276|NCT01660022|4482100|P3|First Sequence (7 Days)|Adverse Event|0
1359277|NCT01660022|4482101|P2|First Sequence (7 Days)|Adverse Event|0
1359278|NCT01660022|4482102|P1|First Sequence (7 Days)|Adverse Event|0
1359279|NCT01660022|4482097|P6|First Sequence (7 Days)|Withdrawal by Subject|0
1359280|NCT01660022|4482098|P5|First Sequence (7 Days)|Withdrawal by Subject|0
1359281|NCT01660022|4482099|P4|First Sequence (7 Days)|Withdrawal by Subject|1
1359282|NCT01660022|4482100|P3|First Sequence (7 Days)|Withdrawal by Subject|0
1359283|NCT01660022|4482101|P2|First Sequence (7 Days)|Withdrawal by Subject|1
1359284|NCT01660022|4482102|P1|First Sequence (7 Days)|Withdrawal by Subject|0
1359285|NCT01659996|4482161|P3|Overall Study|Withdrawal by Subject|5
1359286|NCT01659996|4482162|P2|Overall Study|Withdrawal by Subject|1
1359287|NCT01659996|4482163|P1|Overall Study|Withdrawal by Subject|4
1359288|NCT01659996|4482161|P3|Overall Study|Adverse Event|1
1359289|NCT01659996|4482162|P2|Overall Study|Adverse Event|0
1359290|NCT01659996|4482163|P1|Overall Study|Adverse Event|0
1359291|NCT01659996|4482161|P3|Overall Study|Lost to Follow-up|2
1359292|NCT01659996|4482162|P2|Overall Study|Lost to Follow-up|3
1359293|NCT01659996|4482163|P1|Overall Study|Lost to Follow-up|1
1359294|NCT01659996|4482161|P3|Overall Study|Protocol Violation|3
1359295|NCT01659996|4482162|P2|Overall Study|Protocol Violation|3
1359296|NCT01659996|4482163|P1|Overall Study|Protocol Violation|3
1359297|NCT01659853|4482195|P2|Washout , 3 to 7 Days|Protocol Violation|0
1359298|NCT01659853|4482196|P1|Washout , 3 to 7 Days|Protocol Violation|1
1359299|NCT01659853|4482195|P2|Washout , 3 to 7 Days|Adverse Event|0
1359300|NCT01659853|4482196|P1|Washout , 3 to 7 Days|Adverse Event|1
1359301|NCT01659736|4482206|P2|3-month Follow-up|Lost to Follow-up|1
1359302|NCT01659736|4482207|P1|3-month Follow-up|Lost to Follow-up|0
1359303|NCT01659736|4482206|P2|Treatment Period|Withdrawal by Subject|0
1359304|NCT01659736|4482207|P1|Treatment Period|Withdrawal by Subject|1
1359305|NCT01659736|4482206|P2|Treatment Period|Protocol Violation|1
1359306|NCT01659736|4482207|P1|Treatment Period|Protocol Violation|3
1359307|NCT01659736|4482206|P2|Treatment Period|Adverse Event|1
1359308|NCT01659736|4482207|P1|Treatment Period|Adverse Event|1
1359309|NCT01659567|4482221|P1|Overall Study|Other|13
1359310|NCT01659567|4482221|P1|Overall Study|Progression of the main disease|1
1359311|NCT01659567|4482221|P1|Overall Study|Withdrawal by Subject|64
1359312|NCT01659567|4482221|P1|Overall Study|Good result at early stage of treatment|5
1359313|NCT01659567|4482221|P1|Overall Study|Adverse Event|12
1359314|NCT01659567|4482221|P1|Overall Study|Switched to Pegferon|6
1359315|NCT01659567|4482221|P1|Overall Study|Lack of Efficacy|22
1359316|NCT01659554|4482238|P1|Overall Study|Study Termination|4
1359317|NCT01659320|4482245|P1|Overall Study|Physician Decision|1
1359318|NCT01659320|4482245|P1|Overall Study|Withdrawal by Subject|2
1359319|NCT01659125|4482264|P1|Overall Study|Failed to Start Treatment|2
1359320|NCT01659125|4482264|P1|Overall Study|Time Constraints|2
1359321|NCT01659125|4482264|P1|Overall Study|Technical Problem|1
1359322|NCT01659125|4482264|P1|Overall Study|Lost to Follow-up|7
1359323|NCT01659125|4482264|P1|Overall Study|Withdrawal by Subject|2
1359324|NCT01659021|4482271|P2|Overall Study|Still on Study|1
1359325|NCT01659021|4482272|P1|Overall Study|Still on Study|34
1359326|NCT01659021|4482271|P2|Overall Study|Withdrawal by Subject|16
1359327|NCT01659021|4482272|P1|Overall Study|Withdrawal by Subject|18
1359328|NCT01659021|4482271|P2|Overall Study|Physician Decision|16
1359329|NCT01659021|4482272|P1|Overall Study|Physician Decision|32
1359330|NCT01659021|4482271|P2|Overall Study|Other?|1
1359331|NCT01659021|4482272|P1|Overall Study|Other?|1
1359332|NCT01659021|4482271|P2|Overall Study|Lost to Follow-up|0
1359333|NCT01659021|4482272|P1|Overall Study|Lost to Follow-up|1
1359334|NCT01659021|4482271|P2|Overall Study|Adverse Event|3
1359335|NCT01659021|4482272|P1|Overall Study|Adverse Event|2
1359336|NCT01658943|4482290|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
1359337|NCT01658943|4482291|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
1359338|NCT01658943|4482290|P2|Overall Study|Not eligible|9
1359339|NCT01658943|4482291|P1|Overall Study|Not eligible|7
1359340|NCT01658943|4482290|P2|Overall Study|not protocol specified|1
1359341|NCT01658943|4482291|P1|Overall Study|not protocol specified|4
1359342|NCT01658943|4482290|P2|Overall Study|Death|2
1359343|NCT01658943|4482291|P1|Overall Study|Death|4
1359344|NCT01658943|4482290|P2|Overall Study|Progression/Relapse|40
1359345|NCT01658943|4482291|P1|Overall Study|Progression/Relapse|39
1359346|NCT01658943|4482290|P2|Overall Study|Withdrawal by Subject|2
1359347|NCT01658943|4482291|P1|Overall Study|Withdrawal by Subject|9
1359348|NCT01658943|4482290|P2|Overall Study|Adverse Event|13
1359349|NCT01658943|4482291|P1|Overall Study|Adverse Event|6
1359350|NCT01658904|4482306|P3|Overall Study|Principal Investigator discretion|0
1359351|NCT01658904|4482307|P2|Overall Study|Principal Investigator discretion|0
1359352|NCT01658904|4482308|P1|Overall Study|Principal Investigator discretion|2
1359353|NCT01658813|4482334|P1|Overall Study|Disease progression|3
1359354|NCT01658735|4482345|P3|Overall Study|Withdrawal by Subject|3
1359355|NCT01658735|4482346|P2|Overall Study|Withdrawal by Subject|5
1359356|NCT01658735|4482347|P1|Overall Study|Withdrawal by Subject|3
1359357|NCT01658735|4482345|P3|Overall Study|Protocol Violation|0
1359358|NCT01658735|4482346|P2|Overall Study|Protocol Violation|1
1359359|NCT01658735|4482347|P1|Overall Study|Protocol Violation|0
1359360|NCT01658735|4482345|P3|Overall Study|Lost to Follow-up|0
1359361|NCT01658735|4482346|P2|Overall Study|Lost to Follow-up|1
1359362|NCT01658735|4482347|P1|Overall Study|Lost to Follow-up|1
1359363|NCT01658735|4482345|P3|Overall Study|Lack of Efficacy|1
1359364|NCT01658735|4482346|P2|Overall Study|Lack of Efficacy|0
1359365|NCT01658735|4482347|P1|Overall Study|Lack of Efficacy|1
1359366|NCT01658579|4482389|P4|Treatment Period B|Other|1
1359367|NCT01658579|4482390|P3|Treatment Period B|Other|0
1359368|NCT01658579|4482391|P2|Treatment Period B|Other|0
1359369|NCT01658579|4482392|P1|Treatment Period B|Other|0
1359370|NCT01658579|4482389|P4|Treatment Period A|Adverse Event|0
1359371|NCT01658579|4482390|P3|Treatment Period A|Adverse Event|0
1359372|NCT01658579|4482391|P2|Treatment Period A|Adverse Event|0
1359373|NCT01658579|4482392|P1|Treatment Period A|Adverse Event|1
1359374|NCT01658579|4482389|P4|Treatment Period A|Other|1
1359375|NCT01658579|4482390|P3|Treatment Period A|Other|1
1359376|NCT01658579|4482391|P2|Treatment Period A|Other|0
1359377|NCT01658579|4482392|P1|Treatment Period A|Other|0
1359378|NCT01658514|4482420|P3|Overall Study|Protocol Violation|2
1359379|NCT01658514|4482421|P2|Overall Study|Protocol Violation|0
1359380|NCT01658514|4482422|P1|Overall Study|Protocol Violation|1
1359381|NCT01658436|4482433|P2|Overall Study|Death|0
1359382|NCT01658436|4482434|P1|Overall Study|Death|1
1359383|NCT01658436|4482433|P2|Overall Study|Subject/guardian decision|1
1359384|NCT01658436|4482434|P1|Overall Study|Subject/guardian decision|0
1359385|NCT01658436|4482433|P2|Overall Study|Study terminated by sponsor|1
1359386|NCT01658436|4482434|P1|Overall Study|Study terminated by sponsor|0
1359387|NCT01658436|4482433|P2|Overall Study|Progressive disease|4
1359388|NCT01658436|4482434|P1|Overall Study|Progressive disease|12
1359389|NCT01658436|4482433|P2|Overall Study|Physician Decision|0
1359390|NCT01658436|4482434|P1|Overall Study|Physician Decision|1
1359391|NCT01658436|4482433|P2|Overall Study|Adverse Event|5
1359392|NCT01658436|4482434|P1|Overall Study|Adverse Event|6
1359393|NCT01658072|4482456|P2|Overall Study|Protocol Violation|2
1359394|NCT01658072|4482457|P1|Overall Study|Protocol Violation|4
1359395|NCT01658020|4482465|P2|Overall Study|Protocol Violation|1
1359396|NCT01658020|4482466|P1|Overall Study|Protocol Violation|0
1359397|NCT01658020|4482465|P2|Overall Study|Withdrawal by Subject|5
1359398|NCT01658020|4482466|P1|Overall Study|Withdrawal by Subject|4
1359399|NCT01658020|4482465|P2|Overall Study|Lost to Follow-up|0
1359400|NCT01658020|4482466|P1|Overall Study|Lost to Follow-up|1
1359401|NCT01658020|4482465|P2|Overall Study|Adverse Event|3
1359402|NCT01658020|4482466|P1|Overall Study|Adverse Event|3
1359403|NCT01657903|4482482|P1|Overall Study|Withdrawal by Subject|1
1359404|NCT01657903|4482482|P1|Overall Study|Lost to Follow-up|1
1359405|NCT01657877|4482504|P1|Overall Study|Other Reason|2
1359406|NCT01657877|4482504|P1|Overall Study|Adverse Event|2
1359407|NCT01657877|4482504|P1|Overall Study|Protocol Violation|6
1359408|NCT01657877|4482504|P1|Overall Study|Withdrawal by Subject|4
1359409|NCT01657799|4482524|P3|Overall Study|Other|49
1359410|NCT01657799|4482525|P2|Overall Study|Other|62
1359411|NCT01657799|4482526|P1|Overall Study|Other|52
1359412|NCT01657799|4482524|P3|Overall Study|Radiographic & Clinical Progression|15
1359413|NCT01657799|4482525|P2|Overall Study|Radiographic & Clinical Progression|11
1359414|NCT01657799|4482526|P1|Overall Study|Radiographic & Clinical Progression|16
1359415|NCT01657799|4482524|P3|Overall Study|Progressive Disease Clinical|7
1359416|NCT01657799|4482525|P2|Overall Study|Progressive Disease Clinical|4
1359417|NCT01657799|4482526|P1|Overall Study|Progressive Disease Clinical|7
1359418|NCT01657799|4482524|P3|Overall Study|Disease Progression|4
1359419|NCT01657799|4482525|P2|Overall Study|Disease Progression|4
1359420|NCT01657799|4482526|P1|Overall Study|Disease Progression|2
1359421|NCT01657799|4482524|P3|Overall Study|Lost to Follow-up|1
1359422|NCT01657799|4482525|P2|Overall Study|Lost to Follow-up|0
1359423|NCT01657799|4482526|P1|Overall Study|Lost to Follow-up|1
1359424|NCT01657799|4482524|P3|Overall Study|Withdrawal by Subject|10
1359425|NCT01657799|4482525|P2|Overall Study|Withdrawal by Subject|10
1359426|NCT01657799|4482526|P1|Overall Study|Withdrawal by Subject|13
1359427|NCT01657799|4482524|P3|Overall Study|Adverse Event Not Related to Progression|4
1359428|NCT01657799|4482525|P2|Overall Study|Adverse Event Not Related to Progression|4
1359429|NCT01657799|4482526|P1|Overall Study|Adverse Event Not Related to Progression|5
1359430|NCT01657799|4482524|P3|Overall Study|Adverse Event Related to progression|12
1359431|NCT01657799|4482525|P2|Overall Study|Adverse Event Related to progression|8
1359432|NCT01657799|4482526|P1|Overall Study|Adverse Event Related to progression|6
1359433|NCT01657461|4482545|P2|Overall Study|Withdrawal by Subject|3
1359434|NCT01657461|4482546|P1|Overall Study|Withdrawal by Subject|1
1359435|NCT01657461|4482545|P2|Overall Study|Physician Decision|2
1359436|NCT01657461|4482546|P1|Overall Study|Physician Decision|0
1359437|NCT01657461|4482545|P2|Overall Study|Lost to Follow-up|3
1359438|NCT01657461|4482546|P1|Overall Study|Lost to Follow-up|0
1359439|NCT01657461|4482545|P2|Overall Study|Death|12
1359440|NCT01657461|4482546|P1|Overall Study|Death|9
1359441|NCT01657370|4482576|P6|Overall Study|Lost to Follow-up|1
1359442|NCT01657370|4482577|P5|Overall Study|Lost to Follow-up|0
1359443|NCT01657370|4482578|P4|Overall Study|Lost to Follow-up|0
1359444|NCT01657370|4482579|P3|Overall Study|Lost to Follow-up|1
1359445|NCT01657370|4482580|P2|Overall Study|Lost to Follow-up|0
1359446|NCT01657370|4482581|P1|Overall Study|Lost to Follow-up|2
1359447|NCT01657370|4482576|P6|Overall Study|Protocol Violation|0
1359448|NCT01657370|4482577|P5|Overall Study|Protocol Violation|0
1359449|NCT01657370|4482578|P4|Overall Study|Protocol Violation|1
1359450|NCT01657370|4482579|P3|Overall Study|Protocol Violation|1
1359451|NCT01657370|4482580|P2|Overall Study|Protocol Violation|1
1359452|NCT01657370|4482581|P1|Overall Study|Protocol Violation|1
1359453|NCT01657370|4482576|P6|Overall Study|Adverse Event|0
1359454|NCT01657370|4482577|P5|Overall Study|Adverse Event|1
1359455|NCT01657370|4482578|P4|Overall Study|Adverse Event|0
1359456|NCT01657370|4482579|P3|Overall Study|Adverse Event|0
1359457|NCT01657370|4482580|P2|Overall Study|Adverse Event|0
1359458|NCT01657370|4482581|P1|Overall Study|Adverse Event|0
1359459|NCT01657370|4482576|P6|Overall Study|Lack of Qualifying Event|2
1359460|NCT01657370|4482577|P5|Overall Study|Lack of Qualifying Event|1
1359461|NCT01657370|4482578|P4|Overall Study|Lack of Qualifying Event|2
1359462|NCT01657370|4482579|P3|Overall Study|Lack of Qualifying Event|3
1359463|NCT01657370|4482580|P2|Overall Study|Lack of Qualifying Event|0
1359464|NCT01657370|4482581|P1|Overall Study|Lack of Qualifying Event|1
1359465|NCT01657370|4482576|P6|Overall Study|Physician Decision|0
1359466|NCT01657370|4482577|P5|Overall Study|Physician Decision|5
1359467|NCT01657370|4482578|P4|Overall Study|Physician Decision|2
1359468|NCT01657370|4482579|P3|Overall Study|Physician Decision|1
1359469|NCT01657370|4482580|P2|Overall Study|Physician Decision|3
1359470|NCT01657370|4482581|P1|Overall Study|Physician Decision|2
1359471|NCT01657370|4482576|P6|Overall Study|Withdrawal by Subject|1
1359472|NCT01657370|4482577|P5|Overall Study|Withdrawal by Subject|0
1359473|NCT01657370|4482578|P4|Overall Study|Withdrawal by Subject|0
1359474|NCT01657370|4482579|P3|Overall Study|Withdrawal by Subject|1
1359475|NCT01657370|4482580|P2|Overall Study|Withdrawal by Subject|0
1359476|NCT01657370|4482581|P1|Overall Study|Withdrawal by Subject|0
1359477|NCT01657305|4482663|P1|Overall Study|Did not Adhere to Protocol/Procedures|4
1359478|NCT01657305|4482663|P1|Overall Study|Lost to Follow-up|1
1359479|NCT01657305|4482663|P1|Overall Study|Adverse Event|1
1359480|NCT01657305|4482663|P1|Overall Study|Withdrawal by Subject|4
1359481|NCT01657305|4482663|P1|Overall Study|Lack of Wound Closure at Day 28|15
1359482|NCT01657292|4482713|P1|Overall Study|Change of therapy|1
1359483|NCT01657292|4482713|P1|Overall Study|Violation of eligibility criteria|1
1359484|NCT01657292|4482713|P1|Overall Study|Withdrawal by Subject|2
1359485|NCT01657292|4482713|P1|Overall Study|Adverse Event|6
1359486|NCT01657253|4482722|P2|Overall Study|Adverse Event|1
1359487|NCT01657253|4482723|P1|Overall Study|Adverse Event|0
1359488|NCT01657253|4482722|P2|Overall Study|Withdrawal by Subject|12
1359489|NCT01657253|4482723|P1|Overall Study|Withdrawal by Subject|11
1359490|NCT01657253|4482722|P2|Overall Study|Lost to Follow-up|5
1359491|NCT01657253|4482723|P1|Overall Study|Lost to Follow-up|6
1359492|NCT01657032|4482735|P2|Overall Study|Lost to Follow-up|7
1359493|NCT01657032|4482736|P1|Overall Study|Lost to Follow-up|0
1359494|NCT01657019|4482762|P1|Overall Study|Not Specified|58
1359495|NCT01657019|4482762|P1|Overall Study|Lack of Efficacy|3
1359496|NCT01657019|4482762|P1|Overall Study|Protocol Violation|6
1359497|NCT01657019|4482762|P1|Overall Study|Lost to Follow-up|48
1359498|NCT01657019|4482762|P1|Overall Study|Adverse Event|55
1359499|NCT01657019|4482762|P1|Overall Study|Withdrawal by Subject|65
1359500|NCT01656967|4482776|P2|Overall Study|unsuccessful ETT insertion|2
1359501|NCT01656967|4482777|P1|Overall Study|unsuccessful ETT insertion|3
1359502|NCT01656967|4482776|P2|Overall Study|faulty monitor|0
1359503|NCT01656967|4482777|P1|Overall Study|faulty monitor|1
1359504|NCT01656889|4482799|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
1359505|NCT01656889|4482800|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
1359506|NCT01656889|4482799|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
1359507|NCT01656889|4482800|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
1359508|NCT01656889|4482799|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
1359509|NCT01656889|4482800|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
1359510|NCT01656889|4482799|P2|Post Treatment Follow-Up, 3 Months|Death|5
1359511|NCT01656889|4482800|P1|Post Treatment Follow-Up, 3 Months|Death|1
1359512|NCT01656889|4482799|P2|Treatment Period, 12 Weeks|Moved out of the area|2
1359513|NCT01656889|4482800|P1|Treatment Period, 12 Weeks|Moved out of the area|0
1359514|NCT01656889|4482799|P2|Treatment Period, 12 Weeks|Protocol Violation|1
1359515|NCT01656889|4482800|P1|Treatment Period, 12 Weeks|Protocol Violation|0
1359516|NCT01656889|4482799|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
1359517|NCT01656889|4482800|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
1359518|NCT01656889|4482799|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
1359519|NCT01656889|4482800|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
1359520|NCT01656889|4482799|P2|Treatment Period, 12 Weeks|Death|1
1359521|NCT01656889|4482800|P1|Treatment Period, 12 Weeks|Death|0
1359522|NCT01656889|4482799|P2|Treatment Period, 12 Weeks|Adverse Event|4
1359523|NCT01656889|4482800|P1|Treatment Period, 12 Weeks|Adverse Event|10
1359524|NCT01656850|4482820|P2|First Intervention (3 Months)|Withdrawal by Subject|4
1359525|NCT01656850|4482821|P1|First Intervention (3 Months)|Withdrawal by Subject|3
1359526|NCT01656759|4482912|P2|Overall Study|Protocol Violation|3
1359527|NCT01656759|4482913|P1|Overall Study|Protocol Violation|2
1359528|NCT01656434|4482944|P2|Overall Study|Withdrawal by Subject|7
1359529|NCT01656434|4482945|P1|Overall Study|Withdrawal by Subject|64
1359530|NCT01656434|4482944|P2|Overall Study|Participant withdrew consent|9
1359531|NCT01656434|4482945|P1|Overall Study|Participant withdrew consent|28
1359532|NCT01656434|4482944|P2|Overall Study|Participant moved|12
1359533|NCT01656434|4482945|P1|Overall Study|Participant moved|40
1359534|NCT01656434|4482944|P2|Overall Study|Non-compliance with protocol|15
1359535|NCT01656434|4482945|P1|Overall Study|Non-compliance with protocol|39
1359536|NCT01656434|4482944|P2|Overall Study|Part. discontinued; unrelated to drug|10
1359537|NCT01656434|4482945|P1|Overall Study|Part. discontinued; unrelated to drug|55
1359538|NCT01656434|4482944|P2|Overall Study|Participant discontinued; drug related|4
1359539|NCT01656434|4482945|P1|Overall Study|Participant discontinued; drug related|13
1359540|NCT01656434|4482944|P2|Overall Study|Study terminated by sponsor|348
1359541|NCT01656434|4482945|P1|Overall Study|Study terminated by sponsor|1501
1359542|NCT01656434|4482944|P2|Overall Study|Non-compliance with study drug|9
1359543|NCT01656434|4482945|P1|Overall Study|Non-compliance with study drug|48
1359544|NCT01656434|4482944|P2|Overall Study|Physician Decision|2
1359545|NCT01656434|4482945|P1|Overall Study|Physician Decision|7
1359546|NCT01656434|4482944|P2|Overall Study|Pregnancy|10
1359547|NCT01656434|4482945|P1|Overall Study|Pregnancy|45
1359548|NCT01656434|4482944|P2|Overall Study|Pregnancy wish|6
1359549|NCT01656434|4482945|P1|Overall Study|Pregnancy wish|18
1359550|NCT01656434|4482944|P2|Overall Study|Protocol Violation|0
1359551|NCT01656434|4482945|P1|Overall Study|Protocol Violation|7
1359552|NCT01656434|4482944|P2|Overall Study|Screen failure|0
1359553|NCT01656434|4482945|P1|Overall Study|Screen failure|2
1359554|NCT01656434|4482944|P2|Overall Study|Site discontinued study participation|9
1359555|NCT01656434|4482945|P1|Overall Study|Site discontinued study participation|24
1359556|NCT01656434|4482944|P2|Overall Study|Lost to Follow-up|76
1359557|NCT01656434|4482945|P1|Overall Study|Lost to Follow-up|309
1359558|NCT01656434|4482944|P2|Overall Study|Enrollment terminated at trial site|0
1359559|NCT01656434|4482945|P1|Overall Study|Enrollment terminated at trial site|2
1359560|NCT01656434|4482944|P2|Overall Study|Adverse Event|63
1359561|NCT01656434|4482945|P1|Overall Study|Adverse Event|199
1359562|NCT01656408|4482971|P10|Overall Study|Physician Decision|3
1359563|NCT01656408|4482972|P9|Overall Study|Physician Decision|1
1359564|NCT01656408|4482973|P8|Overall Study|Physician Decision|1
1359565|NCT01656408|4482974|P7|Overall Study|Physician Decision|0
1359566|NCT01656408|4482975|P6|Overall Study|Physician Decision|1
1359567|NCT01656408|4482976|P5|Overall Study|Physician Decision|1
1359568|NCT01656408|4482977|P4|Overall Study|Physician Decision|0
1359569|NCT01656408|4482978|P3|Overall Study|Physician Decision|1
1359570|NCT01656408|4482979|P2|Overall Study|Physician Decision|0
1359571|NCT01656408|4482980|P1|Overall Study|Physician Decision|1
1359572|NCT01656408|4482971|P10|Overall Study|Adverse Event|0
1359573|NCT01656408|4482972|P9|Overall Study|Adverse Event|1
1359574|NCT01656408|4482973|P8|Overall Study|Adverse Event|0
1359575|NCT01656408|4482974|P7|Overall Study|Adverse Event|1
1359576|NCT01656408|4482975|P6|Overall Study|Adverse Event|1
1359577|NCT01656408|4482976|P5|Overall Study|Adverse Event|0
1359578|NCT01656408|4482977|P4|Overall Study|Adverse Event|0
1359579|NCT01656408|4482978|P3|Overall Study|Adverse Event|1
1359580|NCT01656408|4482979|P2|Overall Study|Adverse Event|0
1359581|NCT01656408|4482980|P1|Overall Study|Adverse Event|0
1359582|NCT01656304|4483169|P1|Overall Study|Ineligible, uncontrolled hypertension|1
1359583|NCT01656161|4483210|P1|Overall Study|Withdrawal by Subject|1
1359584|NCT01656161|4483210|P1|Overall Study|Protocol Violation|1
1359585|NCT01656161|4483210|P1|Overall Study|Adverse Event|2
1359586|NCT01656161|4483210|P1|Overall Study|Death|3
1359587|NCT01655498|4483234|P1|Overall Study|Withdrawal by Subject|1
1359588|NCT01655498|4483234|P1|Overall Study|Protocol Violation|2
1359589|NCT01655498|4483234|P1|Overall Study|Unrelated health issue|2
1359590|NCT01655381|4483241|P1|Overall Study|Insufficient Treatment Response|1
1359591|NCT01655381|4483241|P1|Overall Study|Moved to Another City|1
1359592|NCT01655381|4483241|P1|Overall Study|Investigator Decision|1
1359593|NCT01655069|4483281|P4|Overall Study|Withdrawal by Subject|0
1359594|NCT01655069|4483282|P3|Overall Study|Withdrawal by Subject|0
1359595|NCT01655069|4483283|P2|Overall Study|Withdrawal by Subject|3
1359596|NCT01655069|4483284|P1|Overall Study|Withdrawal by Subject|2
1359597|NCT01655069|4483281|P4|Overall Study|No Treatment Needed|0
1359598|NCT01655069|4483282|P3|Overall Study|No Treatment Needed|0
1359599|NCT01655069|4483283|P2|Overall Study|No Treatment Needed|1
1359600|NCT01655069|4483284|P1|Overall Study|No Treatment Needed|0
1359601|NCT01655069|4483281|P4|Overall Study|Lack of Efficacy|0
1359602|NCT01655069|4483282|P3|Overall Study|Lack of Efficacy|0
1359603|NCT01655069|4483283|P2|Overall Study|Lack of Efficacy|1
1359604|NCT01655069|4483284|P1|Overall Study|Lack of Efficacy|0
1359605|NCT01655069|4483281|P4|Overall Study|Adverse Event|3
1359606|NCT01655069|4483282|P3|Overall Study|Adverse Event|2
1359607|NCT01655069|4483283|P2|Overall Study|Adverse Event|7
1359608|NCT01655069|4483284|P1|Overall Study|Adverse Event|6
1359609|NCT01655069|4483281|P4|Overall Study|Physician Decision|1
1359610|NCT01655069|4483282|P3|Overall Study|Physician Decision|0
1359611|NCT01655069|4483283|P2|Overall Study|Physician Decision|0
1359612|NCT01655069|4483284|P1|Overall Study|Physician Decision|0
1359613|NCT01654666|4483344|P3|Overall Study|Withdrawal by Subject|1
1359614|NCT01654666|4483345|P2|Overall Study|Withdrawal by Subject|4
1359615|NCT01654666|4483346|P1|Overall Study|Withdrawal by Subject|4
1359616|NCT01654666|4483344|P3|Overall Study|Lost to Follow-up|5
1359617|NCT01654666|4483345|P2|Overall Study|Lost to Follow-up|5
1359618|NCT01654666|4483346|P1|Overall Study|Lost to Follow-up|4
1359619|NCT01654666|4483344|P3|Overall Study|Protocol Violation|8
1359620|NCT01654666|4483345|P2|Overall Study|Protocol Violation|4
1359621|NCT01654666|4483346|P1|Overall Study|Protocol Violation|7
1359622|NCT01654601|4483371|P2|2nd Administration|Protocol Violation|1
1359623|NCT01654601|4483372|P1|2nd Administration|Protocol Violation|0
1359624|NCT01654601|4483371|P2|2nd Administration|Adverse Event|0
1359625|NCT01654601|4483372|P1|2nd Administration|Adverse Event|1
1359626|NCT01654601|4483371|P2|1st Administration|Protocol Violation|2
1359627|NCT01654601|4483372|P1|1st Administration|Protocol Violation|0
1359628|NCT01654601|4483371|P2|1st Administration|Withdrawal by Subject|0
1359629|NCT01654601|4483372|P1|1st Administration|Withdrawal by Subject|2
1359630|NCT01654549|4483386|P2|Overall Study|H.pylori eradication not successful|1
1359631|NCT01654549|4483387|P1|Overall Study|H.pylori eradication not successful|0
1359632|NCT01654536|4483399|P2|Overall Study|Withdrawal by Subject|25
1359633|NCT01654536|4483400|P1|Overall Study|Withdrawal by Subject|27
1359634|NCT01654536|4483399|P2|Overall Study|Physician Decision|8
1359635|NCT01654536|4483400|P1|Overall Study|Physician Decision|12
1359636|NCT01654536|4483399|P2|Overall Study|Lost to Follow-up|5
1359637|NCT01654536|4483400|P1|Overall Study|Lost to Follow-up|5
1359638|NCT01654523|4483436|P1|Overall Study|Withdrawal by Subject|1
1359639|NCT01654302|4483442|P2|Second Intervention (Day 7)|Lost to Follow-up|1
1359640|NCT01654302|4483443|P1|Second Intervention (Day 7)|Lost to Follow-up|1
1359641|NCT01654276|4483449|P1|Overall Study|Withdrawal by Subject|1
1359642|NCT01654276|4483449|P1|Overall Study|Lost to Follow-up|4
1359643|NCT01654276|4483449|P1|Overall Study|Lack of Efficacy|1
1359644|NCT01654250|4483503|P2|Overall Study|Lost to Follow-up|0
1359645|NCT01654250|4483504|P1|Overall Study|Lost to Follow-up|1
1359646|NCT01654224|4483521|P2|Overall Study|Insufficient blood sample|2
1359647|NCT01654224|4483522|P1|Overall Study|Insufficient blood sample|3
1359648|NCT01654224|4483521|P2|Overall Study|Did not receive allocation|8
1359649|NCT01654224|4483522|P1|Overall Study|Did not receive allocation|1
1359650|NCT01654224|4483521|P2|Overall Study|Lost to Follow-up|2
1359651|NCT01654224|4483522|P1|Overall Study|Lost to Follow-up|2
1359652|NCT01653912|4483547|P6|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
1359653|NCT01653912|4483548|P5|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1359654|NCT01653912|4483549|P4|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1359655|NCT01653912|4483550|P3|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1359656|NCT01653912|4483551|P2|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1359657|NCT01653912|4483552|P1|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1359658|NCT01653912|4483547|P6|Phase 2: GSK2110183 125 mg|Clinical Progression|6
1359659|NCT01653912|4483548|P5|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1359660|NCT01653912|4483549|P4|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1359661|NCT01653912|4483550|P3|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1359662|NCT01653912|4483551|P2|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1359663|NCT01653912|4483552|P1|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1359664|NCT01653912|4483547|P6|Phase 2: GSK2110183 125 mg|Adverse Event|1
1359665|NCT01653912|4483548|P5|Phase 2: GSK2110183 125 mg|Adverse Event|0
1359666|NCT01653912|4483549|P4|Phase 2: GSK2110183 125 mg|Adverse Event|0
1359667|NCT01653912|4483550|P3|Phase 2: GSK2110183 125 mg|Adverse Event|0
1359668|NCT01653912|4483551|P2|Phase 2: GSK2110183 125 mg|Adverse Event|0
1359669|NCT01653912|4483552|P1|Phase 2: GSK2110183 125 mg|Adverse Event|0
1359670|NCT01653912|4483547|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1359671|NCT01653912|4483548|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1359672|NCT01653912|4483549|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
1359673|NCT01653912|4483550|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1359674|NCT01653912|4483551|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1359675|NCT01653912|4483552|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1359676|NCT01653912|4483547|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1359677|NCT01653912|4483548|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1359678|NCT01653912|4483549|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
1359679|NCT01653912|4483550|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1359680|NCT01653912|4483551|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1359681|NCT01653912|4483552|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1359682|NCT01653912|4483547|P6|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1359683|NCT01653912|4483548|P5|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1359684|NCT01653912|4483549|P4|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1359685|NCT01653912|4483550|P3|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
1359686|NCT01653912|4483551|P2|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1359687|NCT01653912|4483552|P1|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1359688|NCT01653912|4483547|P6|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1359689|NCT01653912|4483548|P5|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1359690|NCT01653912|4483549|P4|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1359691|NCT01653912|4483550|P3|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1359692|NCT01653912|4483551|P2|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
1359693|NCT01653912|4483552|P1|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1359694|NCT01653782|4483570|P3|Overall Study|Lost to Follow-up|2
1359695|NCT01653782|4483571|P2|Overall Study|Lost to Follow-up|3
1359696|NCT01653782|4483572|P1|Overall Study|Lost to Follow-up|7
1359697|NCT01653782|4483570|P3|Overall Study|Withdrawal by Subject|4
1359698|NCT01653782|4483571|P2|Overall Study|Withdrawal by Subject|15
1359699|NCT01653782|4483572|P1|Overall Study|Withdrawal by Subject|9
1359700|NCT01653743|4483582|P2|Overall Study|Investigator discretion|0
1359701|NCT01653743|4483583|P1|Overall Study|Investigator discretion|3
1359702|NCT01653743|4483582|P2|Overall Study|Withdrawal by Subject|0
1359703|NCT01653743|4483583|P1|Overall Study|Withdrawal by Subject|1
1359704|NCT01653262|4483630|P1|Overall Study|AE, non-serious non-fatal|1
1359705|NCT01653262|4483630|P1|Overall Study|SAE, non-fatal|1
1359706|NCT01653262|4483630|P1|Overall Study|Lack of Efficacy|1
1359707|NCT01653158|4483643|P8|Overall Study|Withdrawal by Subject|0
1359708|NCT01653158|4483644|P7|Overall Study|Withdrawal by Subject|0
1359709|NCT01653158|4483645|P6|Overall Study|Withdrawal by Subject|0
1359710|NCT01653158|4483646|P5|Overall Study|Withdrawal by Subject|0
1359711|NCT01653158|4483647|P4|Overall Study|Withdrawal by Subject|0
1359712|NCT01653158|4483648|P3|Overall Study|Withdrawal by Subject|0
1359713|NCT01653158|4483649|P2|Overall Study|Withdrawal by Subject|0
1359714|NCT01653158|4483650|P1|Overall Study|Withdrawal by Subject|1
1359715|NCT01653158|4483643|P8|Overall Study|Progressive disease|9
1359716|NCT01653158|4483644|P7|Overall Study|Progressive disease|2
1359717|NCT01653158|4483645|P6|Overall Study|Progressive disease|1
1359718|NCT01653158|4483646|P5|Overall Study|Progressive disease|1
1359719|NCT01653158|4483647|P4|Overall Study|Progressive disease|0
1359720|NCT01653158|4483648|P3|Overall Study|Progressive disease|0
1359721|NCT01653158|4483649|P2|Overall Study|Progressive disease|0
1359722|NCT01653158|4483650|P1|Overall Study|Progressive disease|0
1359723|NCT01653158|4483643|P8|Overall Study|Other|1
1359724|NCT01653158|4483644|P7|Overall Study|Other|0
1359725|NCT01653158|4483645|P6|Overall Study|Other|0
1359726|NCT01653158|4483646|P5|Overall Study|Other|0
1359727|NCT01653158|4483647|P4|Overall Study|Other|0
1359728|NCT01653158|4483648|P3|Overall Study|Other|0
1359729|NCT01653158|4483649|P2|Overall Study|Other|0
1359730|NCT01653158|4483650|P1|Overall Study|Other|0
1359731|NCT01653158|4483643|P8|Overall Study|Adverse Event|3
1359732|NCT01653158|4483644|P7|Overall Study|Adverse Event|0
1359733|NCT01653158|4483645|P6|Overall Study|Adverse Event|0
1359734|NCT01653158|4483646|P5|Overall Study|Adverse Event|0
1359735|NCT01653158|4483647|P4|Overall Study|Adverse Event|1
1359736|NCT01653158|4483648|P3|Overall Study|Adverse Event|0
1359737|NCT01653158|4483649|P2|Overall Study|Adverse Event|0
1359738|NCT01653158|4483650|P1|Overall Study|Adverse Event|0
1359739|NCT01653158|4483643|P8|Overall Study|Death|2
1359740|NCT01653158|4483644|P7|Overall Study|Death|0
1359741|NCT01653158|4483645|P6|Overall Study|Death|0
1359742|NCT01653158|4483646|P5|Overall Study|Death|0
1359743|NCT01653158|4483647|P4|Overall Study|Death|1
1359744|NCT01653158|4483648|P3|Overall Study|Death|0
1359745|NCT01653158|4483649|P2|Overall Study|Death|0
1359746|NCT01653158|4483650|P1|Overall Study|Death|0
1359747|NCT01653132|4483922|P2|First Intervention|Protocol Violation|0
1359748|NCT01653132|4483923|P1|First Intervention|Protocol Violation|1
1359749|NCT01652885|4483973|P1|Overall Study|Adverse Event|1
1359750|NCT01652729|4484001|P3|Overall Study|Administrative|0
1359751|NCT01652729|4484002|P2|Overall Study|Administrative|0
1359752|NCT01652729|4484003|P1|Overall Study|Administrative|1
1359753|NCT01652729|4484001|P3|Overall Study|Lost to Follow-up|3
1359754|NCT01652729|4484002|P2|Overall Study|Lost to Follow-up|6
1359755|NCT01652729|4484003|P1|Overall Study|Lost to Follow-up|6
1359756|NCT01652729|4484001|P3|Overall Study|Protocol Violation|0
1359757|NCT01652729|4484002|P2|Overall Study|Protocol Violation|0
1359758|NCT01652729|4484003|P1|Overall Study|Protocol Violation|1
1359759|NCT01652729|4484001|P3|Overall Study|Physician Decision|1
1359760|NCT01652729|4484002|P2|Overall Study|Physician Decision|0
1359761|NCT01652729|4484003|P1|Overall Study|Physician Decision|1
1359762|NCT01652729|4484001|P3|Overall Study|Adverse Event|3
1359763|NCT01652729|4484002|P2|Overall Study|Adverse Event|0
1359764|NCT01652729|4484003|P1|Overall Study|Adverse Event|4
1359765|NCT01652729|4484001|P3|Overall Study|Withdrawal by Subject|7
1359766|NCT01652729|4484002|P2|Overall Study|Withdrawal by Subject|7
1359767|NCT01652729|4484003|P1|Overall Study|Withdrawal by Subject|14
1359768|NCT01652716|4484025|P2|Overall Study|Withdrawal by Subject|18
1359769|NCT01652716|4484026|P1|Overall Study|Withdrawal by Subject|33
1359770|NCT01652716|4484025|P2|Overall Study|Adverse Event|10
1359771|NCT01652716|4484026|P1|Overall Study|Adverse Event|7
1359772|NCT01652716|4484025|P2|Overall Study|Protocol Violation|1
1359773|NCT01652716|4484026|P1|Overall Study|Protocol Violation|2
1359774|NCT01652716|4484025|P2|Overall Study|Lost to Follow-up|11
1359775|NCT01652716|4484026|P1|Overall Study|Lost to Follow-up|12
1359776|NCT01652716|4484025|P2|Overall Study|Investigator decision|4
1359777|NCT01652716|4484026|P1|Overall Study|Investigator decision|1
1359778|NCT01652716|4484025|P2|Overall Study|Administrative|2
1359779|NCT01652716|4484026|P1|Overall Study|Administrative|0
1359780|NCT01652716|4484025|P2|Overall Study|Loss of glucose control|0
1359781|NCT01652716|4484026|P1|Overall Study|Loss of glucose control|1
1359782|NCT01652703|4484046|P6|Overall Study|Other|1
1359783|NCT01652703|4484047|P5|Overall Study|Other|1
1359784|NCT01652703|4484048|P4|Overall Study|Other|1
1359785|NCT01652703|4484049|P3|Overall Study|Other|0
1359786|NCT01652703|4484050|P2|Overall Study|Other|0
1359787|NCT01652703|4484051|P1|Overall Study|Other|0
1359788|NCT01652703|4484046|P6|Overall Study|Withdrawal by Subject|1
1359789|NCT01652703|4484047|P5|Overall Study|Withdrawal by Subject|0
1359790|NCT01652703|4484048|P4|Overall Study|Withdrawal by Subject|1
1359791|NCT01652703|4484049|P3|Overall Study|Withdrawal by Subject|3
1359792|NCT01652703|4484050|P2|Overall Study|Withdrawal by Subject|1
1359793|NCT01652703|4484051|P1|Overall Study|Withdrawal by Subject|0
1359794|NCT01652690|4484109|P2|Overall Study|Death|2
1359795|NCT01652690|4484110|P1|Overall Study|Death|5
1359796|NCT01652690|4484109|P2|Overall Study|Lost to Follow-up|6
1359797|NCT01652690|4484110|P1|Overall Study|Lost to Follow-up|6
1359798|NCT01652690|4484109|P2|Overall Study|Other|9
1359799|NCT01652690|4484110|P1|Overall Study|Other|8
1359800|NCT01652690|4484109|P2|Overall Study|Withdrawal by Subject|4
1359801|NCT01652690|4484110|P1|Overall Study|Withdrawal by Subject|16
1359802|NCT01652664|4484144|P2|Overall Study|Inadequate IOP control|0
1359803|NCT01652664|4484145|P1|Overall Study|Inadequate IOP control|1
1359804|NCT01652664|4484144|P2|Overall Study|Treatment Failure|1
1359805|NCT01652664|4484145|P1|Overall Study|Treatment Failure|5
1359806|NCT01652573|4484154|P2|Overall Study|Adverse Event|1
1359807|NCT01652573|4484155|P1|Overall Study|Adverse Event|0
1359808|NCT01652287|4484210|P2|Overall Study|Withdrawal by Subject|0
1359809|NCT01652287|4484211|P1|Overall Study|Withdrawal by Subject|2
1359810|NCT01651949|4484242|P3|Overall Study|Withdrawal by Subject|9
1359811|NCT01651949|4484243|P2|Overall Study|Withdrawal by Subject|18
1359812|NCT01651949|4484244|P1|Overall Study|Withdrawal by Subject|17
1359813|NCT01651949|4484242|P3|Overall Study|Screen failure|0
1359814|NCT01651949|4484243|P2|Overall Study|Screen failure|2
1359815|NCT01651949|4484244|P1|Overall Study|Screen failure|2
1359816|NCT01651949|4484242|P3|Overall Study|Adverse Event|1
1359817|NCT01651949|4484243|P2|Overall Study|Adverse Event|2
1359818|NCT01651949|4484244|P1|Overall Study|Adverse Event|0
1359819|NCT01651949|4484242|P3|Overall Study|Physician Decision|0
1359820|NCT01651949|4484243|P2|Overall Study|Physician Decision|2
1359821|NCT01651949|4484244|P1|Overall Study|Physician Decision|0
1359822|NCT01651949|4484242|P3|Overall Study|Protocol Violation|1
1359823|NCT01651949|4484243|P2|Overall Study|Protocol Violation|2
1359824|NCT01651949|4484244|P1|Overall Study|Protocol Violation|0
1359825|NCT01651949|4484242|P3|Overall Study|Lost to Follow-up|20
1359826|NCT01651949|4484243|P2|Overall Study|Lost to Follow-up|56
1359827|NCT01651949|4484244|P1|Overall Study|Lost to Follow-up|30
1359828|NCT01651949|4484242|P3|Overall Study|Unknown status|0
1359829|NCT01651949|4484243|P2|Overall Study|Unknown status|4
1359830|NCT01651949|4484244|P1|Overall Study|Unknown status|4
1359831|NCT01651936|4484264|P3|Extension Study|Study terminated by sponsor|13
1359832|NCT01651936|4484265|P2|Extension Study|Study terminated by sponsor|0
1359833|NCT01651936|4484266|P1|Extension Study|Study terminated by sponsor|0
1359834|NCT01651936|4484264|P3|Extension Study|Lack of Efficacy|1
1359835|NCT01651936|4484265|P2|Extension Study|Lack of Efficacy|0
1359836|NCT01651936|4484266|P1|Extension Study|Lack of Efficacy|0
1359837|NCT01651936|4484264|P3|Base Study|Study terminated by sponsor|0
1359838|NCT01651936|4484265|P2|Base Study|Study terminated by sponsor|16
1359839|NCT01651936|4484266|P1|Base Study|Study terminated by sponsor|21
1359840|NCT01651936|4484264|P3|Base Study|Early Escape|0
1359841|NCT01651936|4484265|P2|Base Study|Early Escape|8
1359842|NCT01651936|4484266|P1|Base Study|Early Escape|2
1359843|NCT01651936|4484264|P3|Base Study|Withdrawal by Subject|0
1359844|NCT01651936|4484265|P2|Base Study|Withdrawal by Subject|1
1359845|NCT01651936|4484266|P1|Base Study|Withdrawal by Subject|1
1359846|NCT01651936|4484264|P3|Base Study|Adverse Event|0
1359847|NCT01651936|4484265|P2|Base Study|Adverse Event|0
1359848|NCT01651936|4484266|P1|Base Study|Adverse Event|3
1359849|NCT01651780|4484336|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
1359850|NCT01651780|4484337|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
1359851|NCT01651780|4484336|P2|Overall Study|Lost to Follow-up|2
1359852|NCT01651780|4484337|P1|Overall Study|Lost to Follow-up|1
1359853|NCT01651780|4484336|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1359854|NCT01651780|4484337|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
1359855|NCT01651780|4484336|P2|Overall Study|Withdrawal by Subject|0
1359856|NCT01651780|4484337|P1|Overall Study|Withdrawal by Subject|2
1359857|NCT01651780|4484336|P2|Overall Study|Reason Not Specified: No 30-day visit|2
1359858|NCT01651780|4484337|P1|Overall Study|Reason Not Specified: No 30-day visit|2
1359859|NCT01651780|4484336|P2|Overall Study|Physician decision: No 30-day visit|1
1359860|NCT01651780|4484337|P1|Overall Study|Physician decision: No 30-day visit|2
1359861|NCT01651260|4484387|P1|Overall Study|unable to apply product|3
1359862|NCT01651208|4484394|P2|Overall Study|Lost to Follow-up|16
1359863|NCT01651208|4484395|P1|Overall Study|Lost to Follow-up|14
1359864|NCT01651039|4484410|P1|Overall Study|Progressive Disease|22
1359865|NCT01651039|4484410|P1|Overall Study|Withdrawal by Subject|1
1359866|NCT01651039|4484410|P1|Overall Study|Physician Decision|2
1359867|NCT01651039|4484410|P1|Overall Study|Non-evaluables|5
1359868|NCT01651000|4484423|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
1359869|NCT01651000|4484424|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
1359870|NCT01651000|4484423|P2|Overall Study|Administrative reason|0
1359871|NCT01651000|4484424|P1|Overall Study|Administrative reason|1
1359872|NCT01651000|4484423|P2|Overall Study|Physician Decision|0
1359873|NCT01651000|4484424|P1|Overall Study|Physician Decision|1
1359874|NCT01651000|4484423|P2|Overall Study|Lack of Efficacy|1
1359875|NCT01651000|4484424|P1|Overall Study|Lack of Efficacy|1
1359876|NCT01651000|4484423|P2|Overall Study|Subject noncompliance|3
1359877|NCT01651000|4484424|P1|Overall Study|Subject noncompliance|0
1359878|NCT01651000|4484423|P2|Overall Study|Withdrawal by Subject|10
1359879|NCT01651000|4484424|P1|Overall Study|Withdrawal by Subject|2
1359880|NCT01651000|4484423|P2|Overall Study|Protocol Violation|3
1359881|NCT01651000|4484424|P1|Overall Study|Protocol Violation|0
1359882|NCT01651000|4484423|P2|Overall Study|Lost to Follow-up|2
1359883|NCT01651000|4484424|P1|Overall Study|Lost to Follow-up|3
1359884|NCT01651000|4484423|P2|Overall Study|Adverse Event|8
1359885|NCT01651000|4484424|P1|Overall Study|Adverse Event|2
1359886|NCT01650831|4484445|P1|Overall Study|Screen failure|1
1359887|NCT01650805|4484455|P2|Overall Study|Withdrawal by Subject|0
1359888|NCT01650805|4484456|P1|Overall Study|Withdrawal by Subject|1
1359889|NCT01650779|4484466|P1|Overall Study|Withdrawal by Subject|1
1359890|NCT01650636|4484475|P2|Washout up to 9 Months|Lost to Follow-up|1
1359891|NCT01650636|4484476|P1|Washout up to 9 Months|Lost to Follow-up|2
1359892|NCT01650636|4484475|P2|Washout up to 9 Months|Withdrawal by Subject|2
1359893|NCT01650636|4484476|P1|Washout up to 9 Months|Withdrawal by Subject|4
1359894|NCT01650636|4484475|P2|Washout up to 5 Months|Lost to Follow-up|8
1359895|NCT01650636|4484476|P1|Washout up to 5 Months|Lost to Follow-up|2
1359896|NCT01650636|4484475|P2|Washout up to 5 Months|Death|0
1359897|NCT01650636|4484476|P1|Washout up to 5 Months|Death|1
1359898|NCT01650636|4484475|P2|Washout up to 5 Months|Physician Decision|2
1359899|NCT01650636|4484476|P1|Washout up to 5 Months|Physician Decision|2
1359900|NCT01650636|4484475|P2|Washout up to 5 Months|Withdrawal by Subject|8
1359901|NCT01650636|4484476|P1|Washout up to 5 Months|Withdrawal by Subject|4
1359902|NCT01650519|4484509|P2|Overall Study|Withdrawal by Subject|0
1359903|NCT01650519|4484510|P1|Overall Study|Withdrawal by Subject|1
1359904|NCT01650285|4484571|P1|Overall Study|Adverse Event|1
1359905|NCT01650246|4484576|P1|Overall Study|Lack of Efficacy|30
1359906|NCT01650246|4484576|P1|Overall Study|Death|1
1359907|NCT01650246|4484576|P1|Overall Study|Withdrawal by Subject|26
1359908|NCT01650246|4484576|P1|Overall Study|Lost to Follow-up|5
1359909|NCT01650246|4484576|P1|Overall Study|Sponsor terminated study|53
1359910|NCT01650246|4484576|P1|Overall Study|Protocol Violation|5
1359911|NCT01650246|4484576|P1|Overall Study|Adverse Event|23
1359912|NCT01649856|4484583|P2|Overall Study|Not Specified|5
1359913|NCT01649856|4484584|P1|Overall Study|Not Specified|20
1359914|NCT01649856|4484583|P2|Overall Study|Lack of Compliance|1
1359915|NCT01649856|4484584|P1|Overall Study|Lack of Compliance|6
1359916|NCT01649856|4484583|P2|Overall Study|Lost to Follow-up|16
1359917|NCT01649856|4484584|P1|Overall Study|Lost to Follow-up|20
1359918|NCT01649856|4484583|P2|Overall Study|Stable or Progressed Disease|3
1359919|NCT01649856|4484584|P1|Overall Study|Stable or Progressed Disease|5
1359920|NCT01649856|4484583|P2|Overall Study|Death|34
1359921|NCT01649856|4484584|P1|Overall Study|Death|69
1359922|NCT01649856|4484583|P2|Overall Study|Treatment Failure|1
1359923|NCT01649856|4484584|P1|Overall Study|Treatment Failure|1
1359924|NCT01649856|4484583|P2|Overall Study|Protocol Violation|4
1359925|NCT01649856|4484584|P1|Overall Study|Protocol Violation|4
1359926|NCT01649856|4484583|P2|Overall Study|Withdrawal by Subject|14
1359927|NCT01649856|4484584|P1|Overall Study|Withdrawal by Subject|14
1359928|NCT01649804|4484616|P1|Overall Study|Administrative/Other|8
1359929|NCT01649791|4484628|P1|Overall Study|Adverse Event|1
1359930|NCT01649791|4484628|P1|Overall Study|Disease Progression|2
1359931|NCT01649765|4484637|P2|Overall Study|Withdrawal by Subject|1
1359932|NCT01649765|4484638|P1|Overall Study|Withdrawal by Subject|2
1359933|NCT01649765|4484637|P2|Overall Study|Protocol Violation|0
1359934|NCT01649765|4484638|P1|Overall Study|Protocol Violation|1
1359935|NCT01649765|4484637|P2|Overall Study|Physician Decision|3
1359936|NCT01649765|4484638|P1|Overall Study|Physician Decision|0
1359937|NCT01649765|4484637|P2|Overall Study|Lack of Efficacy|1
1359938|NCT01649765|4484638|P1|Overall Study|Lack of Efficacy|1
1359939|NCT01649765|4484637|P2|Overall Study|Adverse Event|3
1359940|NCT01649765|4484638|P1|Overall Study|Adverse Event|5
1359941|NCT01649557|4484689|P3|Overall Study|Lack of Efficacy|0
1359942|NCT01649557|4484690|P2|Overall Study|Lack of Efficacy|0
1359943|NCT01649557|4484691|P1|Overall Study|Lack of Efficacy|5
1359944|NCT01649557|4484689|P3|Overall Study|Protocol deviation|0
1359945|NCT01649557|4484690|P2|Overall Study|Protocol deviation|2
1359946|NCT01649557|4484691|P1|Overall Study|Protocol deviation|0
1359947|NCT01649557|4484689|P3|Overall Study|Withdrawal by Subject|4
1359948|NCT01649557|4484690|P2|Overall Study|Withdrawal by Subject|5
1359949|NCT01649557|4484691|P1|Overall Study|Withdrawal by Subject|15
1359950|NCT01649557|4484689|P3|Overall Study|Physician Decision|1
1359951|NCT01649557|4484690|P2|Overall Study|Physician Decision|2
1359952|NCT01649557|4484691|P1|Overall Study|Physician Decision|8
1359953|NCT01649557|4484689|P3|Overall Study|Met withdrawal criteria|0
1359954|NCT01649557|4484690|P2|Overall Study|Met withdrawal criteria|0
1359955|NCT01649557|4484691|P1|Overall Study|Met withdrawal criteria|4
1359956|NCT01649557|4484689|P3|Overall Study|Adverse Event|1
1359957|NCT01649557|4484690|P2|Overall Study|Adverse Event|5
1359958|NCT01649557|4484691|P1|Overall Study|Adverse Event|7
1359959|NCT01649557|4484689|P3|Overall Study|Lost to Follow-up|3
1359960|NCT01649557|4484690|P2|Overall Study|Lost to Follow-up|0
1359961|NCT01649557|4484691|P1|Overall Study|Lost to Follow-up|5
1359962|NCT01649297|4484753|P5|Overall Study|For other reason|0
1359963|NCT01649297|4484754|P4|Overall Study|For other reason|0
1359964|NCT01649297|4484755|P3|Overall Study|For other reason|2
1359965|NCT01649297|4484756|P2|Overall Study|For other reason|1
1359966|NCT01649297|4484757|P1|Overall Study|For other reason|4
1359967|NCT01649297|4484753|P5|Overall Study|Patient withdrawal (not due to AE)|1
1359968|NCT01649297|4484754|P4|Overall Study|Patient withdrawal (not due to AE)|1
1359969|NCT01649297|4484755|P3|Overall Study|Patient withdrawal (not due to AE)|4
1359970|NCT01649297|4484756|P2|Overall Study|Patient withdrawal (not due to AE)|6
1359971|NCT01649297|4484757|P1|Overall Study|Patient withdrawal (not due to AE)|3
1359972|NCT01649297|4484753|P5|Overall Study|Lost to Follow-up|0
1359973|NCT01649297|4484754|P4|Overall Study|Lost to Follow-up|3
1359974|NCT01649297|4484755|P3|Overall Study|Lost to Follow-up|4
1359975|NCT01649297|4484756|P2|Overall Study|Lost to Follow-up|1
1359976|NCT01649297|4484757|P1|Overall Study|Lost to Follow-up|1
1359977|NCT01649297|4484753|P5|Overall Study|Non compliant with Protocol|1
1359978|NCT01649297|4484754|P4|Overall Study|Non compliant with Protocol|2
1359979|NCT01649297|4484755|P3|Overall Study|Non compliant with Protocol|3
1359980|NCT01649297|4484756|P2|Overall Study|Non compliant with Protocol|0
1359981|NCT01649297|4484757|P1|Overall Study|Non compliant with Protocol|1
1359982|NCT01649297|4484753|P5|Overall Study|Lack of Efficacy|1
1359983|NCT01649297|4484754|P4|Overall Study|Lack of Efficacy|0
1359984|NCT01649297|4484755|P3|Overall Study|Lack of Efficacy|0
1359985|NCT01649297|4484756|P2|Overall Study|Lack of Efficacy|0
1359986|NCT01649297|4484757|P1|Overall Study|Lack of Efficacy|0
1359987|NCT01649297|4484753|P5|Overall Study|Adverse Event|1
1359988|NCT01649297|4484754|P4|Overall Study|Adverse Event|13
1359989|NCT01649297|4484755|P3|Overall Study|Adverse Event|4
1359990|NCT01649297|4484756|P2|Overall Study|Adverse Event|5
1359991|NCT01649297|4484757|P1|Overall Study|Adverse Event|5
1359992|NCT01649271|4484776|P2|Overall Study|Other than stated above|0
1359993|NCT01649271|4484777|P1|Overall Study|Other than stated above|1
1359994|NCT01649271|4484776|P2|Overall Study|Withdrawal by Subject|0
1359995|NCT01649271|4484777|P1|Overall Study|Withdrawal by Subject|1
1359996|NCT01649271|4484776|P2|Overall Study|Other Adverse Event|2
1359997|NCT01649271|4484777|P1|Overall Study|Other Adverse Event|0
1359998|NCT01649271|4484776|P2|Overall Study|Progressive disease|5
1359999|NCT01649271|4484777|P1|Overall Study|Progressive disease|4
1360000|NCT01649232|4484792|P2|Overall Study|Physician Decision|0
1360001|NCT01649232|4484793|P1|Overall Study|Physician Decision|2
1360002|NCT01648790|4484845|P5|Treatment 3|Withdrawal by Subject|0
1360003|NCT01648790|4484846|P4|Treatment 3|Withdrawal by Subject|1
1360004|NCT01648790|4484847|P3|Treatment 3|Withdrawal by Subject|0
1360005|NCT01648790|4484848|P2|Treatment 3|Withdrawal by Subject|0
1360006|NCT01648790|4484849|P1|Treatment 3|Withdrawal by Subject|0
1360007|NCT01648699|4484870|P1|Overall Study|Unspecified/unable to complete 4 visits|2
1360008|NCT01648699|4484870|P1|Overall Study|Lost to Follow-up|2
1360009|NCT01648699|4484870|P1|Overall Study|Death|1
1360010|NCT01648582|4484899|P3|Overall Study|Sponsor Decision|1
1360011|NCT01648582|4484900|P2|Overall Study|Sponsor Decision|1
1360012|NCT01648582|4484901|P1|Overall Study|Sponsor Decision|0
1360013|NCT01648582|4484899|P3|Overall Study|Death|0
1360014|NCT01648582|4484900|P2|Overall Study|Death|0
1360015|NCT01648582|4484901|P1|Overall Study|Death|1
1360016|NCT01648582|4484899|P3|Overall Study|Physician Decision|3
1360017|NCT01648582|4484900|P2|Overall Study|Physician Decision|1
1360018|NCT01648582|4484901|P1|Overall Study|Physician Decision|0
1360019|NCT01648582|4484899|P3|Overall Study|Withdrawal by Subject|17
1360020|NCT01648582|4484900|P2|Overall Study|Withdrawal by Subject|17
1360021|NCT01648582|4484901|P1|Overall Study|Withdrawal by Subject|15
1360022|NCT01648582|4484899|P3|Overall Study|Protocol Violation|1
1360023|NCT01648582|4484900|P2|Overall Study|Protocol Violation|2
1360024|NCT01648582|4484901|P1|Overall Study|Protocol Violation|1
1360025|NCT01648582|4484899|P3|Overall Study|Lost to Follow-up|8
1360026|NCT01648582|4484900|P2|Overall Study|Lost to Follow-up|6
1360027|NCT01648582|4484901|P1|Overall Study|Lost to Follow-up|9
1360028|NCT01648582|4484899|P3|Overall Study|Adverse Event|2
1360029|NCT01648582|4484900|P2|Overall Study|Adverse Event|11
1360030|NCT01648582|4484901|P1|Overall Study|Adverse Event|6
1360031|NCT01648348|4485004|P6|Overall Study|Replaced for MTD analysis|0
1360032|NCT01648348|4485005|P5|Overall Study|Replaced for MTD analysis|0
1360033|NCT01648348|4485006|P4|Overall Study|Replaced for MTD analysis|0
1360034|NCT01648348|4485007|P3|Overall Study|Replaced for MTD analysis|1
1360035|NCT01648348|4485008|P2|Overall Study|Replaced for MTD analysis|0
1360036|NCT01648348|4485009|P1|Overall Study|Replaced for MTD analysis|1
1360037|NCT01648348|4485004|P6|Overall Study|Cancel|6
1360038|NCT01648348|4485005|P5|Overall Study|Cancel|3
1360039|NCT01648348|4485006|P4|Overall Study|Cancel|0
1360040|NCT01648348|4485007|P3|Overall Study|Cancel|0
1360041|NCT01648348|4485008|P2|Overall Study|Cancel|0
1360042|NCT01648348|4485009|P1|Overall Study|Cancel|1
1360043|NCT01648283|4485054|P1|Overall Study|Withdrawal by Subject|14
1360044|NCT01648140|4485064|P4|Overall Study|Lost to Follow-up|0
1360045|NCT01648140|4485065|P3|Overall Study|Lost to Follow-up|2
1360046|NCT01648140|4485066|P2|Overall Study|Lost to Follow-up|1
1360047|NCT01648140|4485067|P1|Overall Study|Lost to Follow-up|2
1360048|NCT01648140|4485064|P4|Overall Study|Withdrawal by Subject|2
1360049|NCT01648140|4485065|P3|Overall Study|Withdrawal by Subject|3
1360050|NCT01648140|4485066|P2|Overall Study|Withdrawal by Subject|3
1360051|NCT01648140|4485067|P1|Overall Study|Withdrawal by Subject|2
1360052|NCT01648140|4485064|P4|Overall Study|Adverse Event|0
1360053|NCT01648140|4485065|P3|Overall Study|Adverse Event|2
1360054|NCT01648140|4485066|P2|Overall Study|Adverse Event|1
1360055|NCT01648140|4485067|P1|Overall Study|Adverse Event|3
1360056|NCT01648140|4485064|P4|Overall Study|Lack of Efficacy|0
1360057|NCT01648140|4485065|P3|Overall Study|Lack of Efficacy|1
1360058|NCT01648140|4485066|P2|Overall Study|Lack of Efficacy|7
1360059|NCT01648140|4485067|P1|Overall Study|Lack of Efficacy|4
1360060|NCT01648140|4485064|P4|Overall Study|Physician Decision|0
1360061|NCT01648140|4485065|P3|Overall Study|Physician Decision|0
1360062|NCT01648140|4485066|P2|Overall Study|Physician Decision|0
1360063|NCT01648140|4485067|P1|Overall Study|Physician Decision|1
1360064|NCT01648101|4485232|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
1360065|NCT01648101|4485233|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
1360066|NCT01648101|4485234|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
1360067|NCT01648101|4485232|P3|Transition Phase (4 Weeks)|Study Terminated|0
1360068|NCT01648101|4485233|P2|Transition Phase (4 Weeks)|Study Terminated|0
1360069|NCT01648101|4485234|P1|Transition Phase (4 Weeks)|Study Terminated|1
1360070|NCT01648101|4485232|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
1360071|NCT01648101|4485233|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
1360072|NCT01648101|4485234|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
1360073|NCT01648101|4485232|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
1360074|NCT01648101|4485233|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
1360075|NCT01648101|4485234|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
1360076|NCT01648101|4485232|P3|Transition Phase (4 Weeks)|Adverse Event|2
1360077|NCT01648101|4485233|P2|Transition Phase (4 Weeks)|Adverse Event|3
1360078|NCT01648101|4485234|P1|Transition Phase (4 Weeks)|Adverse Event|4
1360079|NCT01648101|4485232|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
1360080|NCT01648101|4485233|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
1360081|NCT01648101|4485234|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
1360082|NCT01648101|4485232|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
1360083|NCT01648101|4485233|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
1360084|NCT01648101|4485234|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
1360085|NCT01648101|4485232|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
1360086|NCT01648101|4485233|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
1360087|NCT01648101|4485234|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
1360088|NCT01648101|4485232|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
1360089|NCT01648101|4485233|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
1360090|NCT01648101|4485234|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
1360091|NCT01648101|4485232|P3|Titration Phase (4 Weeks)|Adverse Event|3
1360092|NCT01648101|4485233|P2|Titration Phase (4 Weeks)|Adverse Event|2
1360093|NCT01648101|4485234|P1|Titration Phase (4 Weeks)|Adverse Event|0
1360094|NCT01648101|4485232|P3|Titration Phase (4 Weeks)|Protocol Violation|2
1360095|NCT01648101|4485233|P2|Titration Phase (4 Weeks)|Protocol Violation|1
1360096|NCT01648101|4485234|P1|Titration Phase (4 Weeks)|Protocol Violation|2
1360097|NCT01647711|4485321|P5|Overall Study|Other reason not defined|0
1360098|NCT01647711|4485322|P4|Overall Study|Other reason not defined|1
1360099|NCT01647711|4485323|P3|Overall Study|Other reason not defined|1
1360100|NCT01647711|4485324|P2|Overall Study|Other reason not defined|1
1360101|NCT01647711|4485325|P1|Overall Study|Other reason not defined|0
1360102|NCT01647711|4485321|P5|Overall Study|Refused to continue taking medication|1
1360103|NCT01647711|4485322|P4|Overall Study|Refused to continue taking medication|2
1360104|NCT01647711|4485323|P3|Overall Study|Refused to continue taking medication|0
1360105|NCT01647711|4485324|P2|Overall Study|Refused to continue taking medication|0
1360106|NCT01647711|4485325|P1|Overall Study|Refused to continue taking medication|0
1360107|NCT01647711|4485321|P5|Overall Study|Protocol Violation|1
1360108|NCT01647711|4485322|P4|Overall Study|Protocol Violation|0
1360109|NCT01647711|4485323|P3|Overall Study|Protocol Violation|0
1360110|NCT01647711|4485324|P2|Overall Study|Protocol Violation|0
1360111|NCT01647711|4485325|P1|Overall Study|Protocol Violation|0
1360112|NCT01647711|4485321|P5|Overall Study|Other adverse event|2
1360113|NCT01647711|4485322|P4|Overall Study|Other adverse event|0
1360114|NCT01647711|4485323|P3|Overall Study|Other adverse event|2
1360115|NCT01647711|4485324|P2|Overall Study|Other adverse event|0
1360116|NCT01647711|4485325|P1|Overall Study|Other adverse event|0
1360117|NCT01647711|4485321|P5|Overall Study|Progressive disease|2
1360118|NCT01647711|4485322|P4|Overall Study|Progressive disease|8
1360119|NCT01647711|4485323|P3|Overall Study|Progressive disease|6
1360120|NCT01647711|4485324|P2|Overall Study|Progressive disease|2
1360121|NCT01647711|4485325|P1|Overall Study|Progressive disease|6
1360122|NCT01647542|4485353|P3|Overall Study|Death|1
1360123|NCT01647542|4485354|P2|Overall Study|Death|0
1360124|NCT01647542|4485355|P1|Overall Study|Death|0
1360125|NCT01647542|4485353|P3|Overall Study|Lack of Efficacy|0
1360126|NCT01647542|4485354|P2|Overall Study|Lack of Efficacy|1
1360127|NCT01647542|4485355|P1|Overall Study|Lack of Efficacy|1
1360128|NCT01647542|4485353|P3|Overall Study|Study Termination|65
1360129|NCT01647542|4485354|P2|Overall Study|Study Termination|61
1360130|NCT01647542|4485355|P1|Overall Study|Study Termination|64
1360131|NCT01647542|4485353|P3|Overall Study|Withdrawal by Subject|0
1360132|NCT01647542|4485354|P2|Overall Study|Withdrawal by Subject|4
1360133|NCT01647542|4485355|P1|Overall Study|Withdrawal by Subject|6
1360134|NCT01647542|4485353|P3|Overall Study|Lost to Follow-up|2
1360135|NCT01647542|4485354|P2|Overall Study|Lost to Follow-up|2
1360136|NCT01647542|4485355|P1|Overall Study|Lost to Follow-up|0
1360137|NCT01647542|4485353|P3|Overall Study|Adverse Event|4
1360138|NCT01647542|4485354|P2|Overall Study|Adverse Event|5
1360139|NCT01647542|4485355|P1|Overall Study|Adverse Event|4
1360140|NCT01647542|4485353|P3|Overall Study|Major Protocol Deviation|0
1360141|NCT01647542|4485354|P2|Overall Study|Major Protocol Deviation|0
1360142|NCT01647542|4485355|P1|Overall Study|Major Protocol Deviation|1
1360143|NCT01647282|4485389|P2|Overall Study|Physician Decision|5
1360144|NCT01647282|4485390|P1|Overall Study|Physician Decision|7
1360145|NCT01646827|4485411|P2|Overall Study|Withdrawal by Subject|0
1360146|NCT01646827|4485412|P1|Overall Study|Withdrawal by Subject|1
1360147|NCT01646827|4485411|P2|Overall Study|Physician Decision|2
1360148|NCT01646827|4485412|P1|Overall Study|Physician Decision|1
1360149|NCT01646827|4485411|P2|Overall Study|Lost to Follow-up|3
1360150|NCT01646827|4485412|P1|Overall Study|Lost to Follow-up|0
1360151|NCT01646398|4485499|P2|Overall Study|Withdrawal by Subject|0
1360152|NCT01646398|4485500|P1|Overall Study|Withdrawal by Subject|1
1360153|NCT01646385|4485516|P2|Overall Study|Switched to alternate biologic|649
1360154|NCT01646385|4485517|P1|Overall Study|Switched to alternate biologic|636
1360155|NCT01646385|4485516|P2|Overall Study|Death|222
1360156|NCT01646385|4485517|P1|Overall Study|Death|202
1360157|NCT01646320|4485550|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
1360158|NCT01646320|4485551|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
1360159|NCT01646320|4485550|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
1360160|NCT01646320|4485551|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
1360161|NCT01646320|4485550|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
1360162|NCT01646320|4485551|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
1360163|NCT01646320|4485550|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
1360164|NCT01646320|4485551|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
1360165|NCT01646320|4485550|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
1360166|NCT01646320|4485551|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
1360167|NCT01646320|4485550|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
1360168|NCT01646320|4485551|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
1360169|NCT01646320|4485550|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
1360170|NCT01646320|4485551|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
1360171|NCT01646320|4485550|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
1360172|NCT01646320|4485551|P1|Short-term Period (Day 1 to Week 24)|Not specified|1
1360173|NCT01646320|4485550|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
1360174|NCT01646320|4485551|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
1360175|NCT01646320|4485550|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
1360176|NCT01646320|4485551|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
1360177|NCT01646320|4485550|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
1360178|NCT01646320|4485551|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
1360179|NCT01646268|4485567|P2|Overall Study|Other|0
1360180|NCT01646268|4485568|P1|Overall Study|Other|2
1360181|NCT01646268|4485567|P2|Overall Study|Withdrawal by Subject|5
1360182|NCT01646268|4485568|P1|Overall Study|Withdrawal by Subject|2
1360183|NCT01646268|4485567|P2|Overall Study|Protocol Violation|1
1360184|NCT01646268|4485568|P1|Overall Study|Protocol Violation|0
1360185|NCT01646268|4485567|P2|Overall Study|Lack of Efficacy|3
1360186|NCT01646268|4485568|P1|Overall Study|Lack of Efficacy|1
1360187|NCT01646268|4485567|P2|Overall Study|Adverse Event|7
1360188|NCT01646268|4485568|P1|Overall Study|Adverse Event|6
1360189|NCT01646255|4485582|P2|Overall Study|Inclusion Criteria Deviation|0
1360190|NCT01646255|4485583|P1|Overall Study|Inclusion Criteria Deviation|1
1360191|NCT01646255|4485582|P2|Overall Study|Compliance is not well|0
1360192|NCT01646255|4485583|P1|Overall Study|Compliance is not well|1
1360193|NCT01646255|4485582|P2|Overall Study|Withdrawal by Subject|6
1360194|NCT01646255|4485583|P1|Overall Study|Withdrawal by Subject|10
1360195|NCT01646255|4485582|P2|Overall Study|Lack of Efficacy|0
1360196|NCT01646255|4485583|P1|Overall Study|Lack of Efficacy|2
1360197|NCT01646255|4485582|P2|Overall Study|Adverse Event|8
1360198|NCT01646255|4485583|P1|Overall Study|Adverse Event|7
1360199|NCT01646216|4485615|P2|Overall Study|Investigator decision|1
1360200|NCT01646216|4485616|P1|Overall Study|Investigator decision|1
1360201|NCT01646216|4485615|P2|Overall Study|Did not complete training|2
1360202|NCT01646216|4485616|P1|Overall Study|Did not complete training|0
1360203|NCT01646216|4485615|P2|Overall Study|Baseline step length difference (<5cm)|10
1360204|NCT01646216|4485616|P1|Overall Study|Baseline step length difference (<5cm)|10
1360205|NCT01646177|4485639|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
1360206|NCT01646177|4485640|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
1360207|NCT01646177|4485641|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
1360208|NCT01646177|4485642|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
1360209|NCT01646177|4485639|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
1360210|NCT01646177|4485640|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
1360211|NCT01646177|4485641|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1360212|NCT01646177|4485642|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1360213|NCT01646177|4485639|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
1360214|NCT01646177|4485640|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
1360215|NCT01646177|4485641|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
1360216|NCT01646177|4485642|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
1360217|NCT01646177|4485639|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
1360218|NCT01646177|4485640|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
1360219|NCT01646177|4485641|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
1360220|NCT01646177|4485642|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
1360221|NCT01646177|4485639|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
1360222|NCT01646177|4485640|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
1360223|NCT01646177|4485641|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
1360224|NCT01646177|4485642|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
1360225|NCT01646177|4485639|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
1360226|NCT01646177|4485640|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
1360227|NCT01646177|4485641|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
1360228|NCT01646177|4485642|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
1360229|NCT01646138|4485736|P5|Overall Study|Lost to Follow-up|2
1360230|NCT01646138|4485737|P4|Overall Study|Lost to Follow-up|0
1360231|NCT01646138|4485738|P3|Overall Study|Lost to Follow-up|0
1360232|NCT01646138|4485739|P2|Overall Study|Lost to Follow-up|0
1360233|NCT01646138|4485740|P1|Overall Study|Lost to Follow-up|0
1360234|NCT01646125|4485754|P2|Overall Study|Subject/Guardian decision|1
1360235|NCT01646125|4485755|P1|Overall Study|Subject/Guardian decision|1
1360236|NCT01646125|4485754|P2|Overall Study|Study terminated by sponsor|1
1360237|NCT01646125|4485755|P1|Overall Study|Study terminated by sponsor|2
1360238|NCT01646125|4485754|P2|Overall Study|Progressive disease|16
1360239|NCT01646125|4485755|P1|Overall Study|Progressive disease|22
1360240|NCT01646125|4485754|P2|Overall Study|Physician Decision|3
1360241|NCT01646125|4485755|P1|Overall Study|Physician Decision|1
1360242|NCT01646125|4485754|P2|Overall Study|Death|1
1360243|NCT01646125|4485755|P1|Overall Study|Death|1
1360244|NCT01646125|4485754|P2|Overall Study|Adverse Event|1
1360245|NCT01646125|4485755|P1|Overall Study|Adverse Event|2
1360246|NCT01646125|4485754|P2|Overall Study|Untreated|5
1360247|NCT01646125|4485755|P1|Overall Study|Untreated|2
1360248|NCT01646073|4485780|P2|Period B (12 Weeks)|Lost to Follow-up|1
1360249|NCT01646073|4485781|P1|Period B (12 Weeks)|Lost to Follow-up|0
1360250|NCT01646073|4485780|P2|Period B (12 Weeks)|Withdrawal by Subject|5
1360251|NCT01646073|4485781|P1|Period B (12 Weeks)|Withdrawal by Subject|1
1360252|NCT01646073|4485780|P2|Period B (12 Weeks)|Adverse Event|7
1360253|NCT01646073|4485781|P1|Period B (12 Weeks)|Adverse Event|0
1360254|NCT01646073|4485780|P2|Period A (12 Weeks)|Not Specified|1
1360255|NCT01646073|4485781|P1|Period A (12 Weeks)|Not Specified|0
1360256|NCT01646073|4485780|P2|Period A (12 Weeks)|Protocol Violation|1
1360257|NCT01646073|4485781|P1|Period A (12 Weeks)|Protocol Violation|0
1360258|NCT01646073|4485780|P2|Period A (12 Weeks)|Lack of Efficacy|0
1360259|NCT01646073|4485781|P1|Period A (12 Weeks)|Lack of Efficacy|1
1360260|NCT01646073|4485780|P2|Period A (12 Weeks)|Withdrawal by Subject|1
1360261|NCT01646073|4485781|P1|Period A (12 Weeks)|Withdrawal by Subject|1
1360262|NCT01646073|4485780|P2|Period A (12 Weeks)|Adverse Event|2
1360263|NCT01646073|4485781|P1|Period A (12 Weeks)|Adverse Event|0
1360264|NCT01646021|4485822|P2|Overall Study|Withdrawal by Subject|15
1360265|NCT01646021|4485823|P1|Overall Study|Withdrawal by Subject|10
1360266|NCT01646021|4485822|P2|Overall Study|Lost to Follow-up|2
1360267|NCT01646021|4485823|P1|Overall Study|Lost to Follow-up|2
1360268|NCT01646021|4485822|P2|Overall Study|Study Terminated by Sponsor|41
1360269|NCT01646021|4485823|P1|Overall Study|Study Terminated by Sponsor|50
1360270|NCT01646021|4485822|P2|Overall Study|Death|83
1360271|NCT01646021|4485823|P1|Overall Study|Death|77
1360272|NCT01645735|4485862|P2|Overall Study|Adverse Event|1
1360273|NCT01645735|4485863|P1|Overall Study|Adverse Event|0
1360274|NCT01645735|4485862|P2|Overall Study|Protocol Violation|0
1360275|NCT01645735|4485863|P1|Overall Study|Protocol Violation|1
1360276|NCT01645735|4485862|P2|Overall Study|Withdrawal by Subject|0
1360277|NCT01645735|4485863|P1|Overall Study|Withdrawal by Subject|1
1360278|NCT01645735|4485862|P2|Overall Study|Physician Decision|0
1360279|NCT01645735|4485863|P1|Overall Study|Physician Decision|2
1360280|NCT01645280|4485905|P5|Overall Study|Treatment not completed/Completed f/u|2
1360281|NCT01645280|4485906|P4|Overall Study|Treatment not completed/Completed f/u|0
1360282|NCT01645280|4485907|P3|Overall Study|Treatment not completed/Completed f/u|2
1360283|NCT01645280|4485908|P2|Overall Study|Treatment not completed/Completed f/u|1
1360284|NCT01645280|4485909|P1|Overall Study|Treatment not completed/Completed f/u|1
1360285|NCT01645280|4485905|P5|Overall Study|Other|0
1360286|NCT01645280|4485906|P4|Overall Study|Other|0
1360287|NCT01645280|4485907|P3|Overall Study|Other|2
1360288|NCT01645280|4485908|P2|Overall Study|Other|1
1360289|NCT01645280|4485909|P1|Overall Study|Other|1
1360290|NCT01645280|4485905|P5|Overall Study|Lost to Follow-up|1
1360291|NCT01645280|4485906|P4|Overall Study|Lost to Follow-up|2
1360292|NCT01645280|4485907|P3|Overall Study|Lost to Follow-up|0
1360293|NCT01645280|4485908|P2|Overall Study|Lost to Follow-up|0
1360294|NCT01645280|4485909|P1|Overall Study|Lost to Follow-up|0
1360295|NCT01645280|4485905|P5|Overall Study|Withdrawal by Subject|5
1360296|NCT01645280|4485906|P4|Overall Study|Withdrawal by Subject|4
1360297|NCT01645280|4485907|P3|Overall Study|Withdrawal by Subject|2
1360298|NCT01645280|4485908|P2|Overall Study|Withdrawal by Subject|0
1360299|NCT01645280|4485909|P1|Overall Study|Withdrawal by Subject|4
1360300|NCT01645280|4485905|P5|Overall Study|Death|0
1360301|NCT01645280|4485906|P4|Overall Study|Death|0
1360302|NCT01645280|4485907|P3|Overall Study|Death|0
1360303|NCT01645280|4485908|P2|Overall Study|Death|1
1360304|NCT01645280|4485909|P1|Overall Study|Death|0
1360305|NCT01645176|4485937|P1|Overall Study|did not complete final MRI|1
1360306|NCT01645176|4485937|P1|Overall Study|Lack of Efficacy|4
1360307|NCT01645111|4485941|P1|Overall Study|Did not require Clevidipine|15
1360308|NCT01644734|4485980|P1|Overall Study|Missing documentation|238
1360309|NCT01644734|4485980|P1|Overall Study|Reasons other than stated above|7
1360310|NCT01644734|4485980|P1|Overall Study|Lost to Follow-up|17
1360311|NCT01644734|4485980|P1|Overall Study|Adverse Event|4
1360312|NCT01644643|4485994|P4|Overall Study|Other Eligibility criteria|2
1360313|NCT01644643|4485995|P3|Overall Study|Other Eligibility criteria|0
1360314|NCT01644643|4485996|P2|Overall Study|Other Eligibility criteria|0
1360315|NCT01644643|4485997|P1|Overall Study|Other Eligibility criteria|0
1360316|NCT01644643|4485994|P4|Overall Study|Withdrawal by Subject|1
1360317|NCT01644643|4485995|P3|Overall Study|Withdrawal by Subject|2
1360318|NCT01644643|4485996|P2|Overall Study|Withdrawal by Subject|0
1360319|NCT01644643|4485997|P1|Overall Study|Withdrawal by Subject|1
1360320|NCT01644643|4485994|P4|Overall Study|Lost to Follow-up|4
1360321|NCT01644643|4485995|P3|Overall Study|Lost to Follow-up|0
1360322|NCT01644643|4485996|P2|Overall Study|Lost to Follow-up|0
1360323|NCT01644643|4485997|P1|Overall Study|Lost to Follow-up|0
1360324|NCT01644643|4485994|P4|Overall Study|Death|3
1360325|NCT01644643|4485995|P3|Overall Study|Death|3
1360326|NCT01644643|4485996|P2|Overall Study|Death|0
1360327|NCT01644643|4485997|P1|Overall Study|Death|1
1360328|NCT01644617|4486162|P3|Overall Study|Adverse Event|6
1360329|NCT01644617|4486163|P2|Overall Study|Adverse Event|0
1360330|NCT01644617|4486164|P1|Overall Study|Adverse Event|3
1360331|NCT01644617|4486162|P3|Overall Study|Lost to Follow-up|0
1360332|NCT01644617|4486163|P2|Overall Study|Lost to Follow-up|1
1360333|NCT01644617|4486164|P1|Overall Study|Lost to Follow-up|0
1360334|NCT01644617|4486162|P3|Overall Study|Withdrawal by Subject|1
1360335|NCT01644617|4486163|P2|Overall Study|Withdrawal by Subject|4
1360336|NCT01644617|4486164|P1|Overall Study|Withdrawal by Subject|3
1360337|NCT01644500|4486217|P3|Overall Study|Physician Decision|1
1360338|NCT01644500|4486218|P2|Overall Study|Physician Decision|1
1360339|NCT01644500|4486219|P1|Overall Study|Physician Decision|1
1360340|NCT01644500|4486217|P3|Overall Study|Withdrawal by Subject|12
1360341|NCT01644500|4486218|P2|Overall Study|Withdrawal by Subject|12
1360342|NCT01644500|4486219|P1|Overall Study|Withdrawal by Subject|11
1360343|NCT01644500|4486217|P3|Overall Study|Protocol Violation|0
1360344|NCT01644500|4486218|P2|Overall Study|Protocol Violation|1
1360345|NCT01644500|4486219|P1|Overall Study|Protocol Violation|1
1360346|NCT01644500|4486217|P3|Overall Study|Lost to Follow-up|0
1360347|NCT01644500|4486218|P2|Overall Study|Lost to Follow-up|8
1360348|NCT01644500|4486219|P1|Overall Study|Lost to Follow-up|3
1360349|NCT01644500|4486217|P3|Overall Study|Death|0
1360350|NCT01644500|4486218|P2|Overall Study|Death|1
1360351|NCT01644500|4486219|P1|Overall Study|Death|0
1360352|NCT01644500|4486217|P3|Overall Study|Adverse Event|2
1360353|NCT01644500|4486218|P2|Overall Study|Adverse Event|1
1360354|NCT01644500|4486219|P1|Overall Study|Adverse Event|6
1360355|NCT01644474|4486289|P2|Overall Study|Protocol Violation|0
1360356|NCT01644474|4486290|P1|Overall Study|Protocol Violation|1
1360357|NCT01644474|4486289|P2|Overall Study|Site scheduling error|1
1360358|NCT01644474|4486290|P1|Overall Study|Site scheduling error|1
1360359|NCT01644474|4486289|P2|Overall Study|Adverse Event|5
1360360|NCT01644474|4486290|P1|Overall Study|Adverse Event|4
1360361|NCT01644474|4486289|P2|Overall Study|Participant moved|1
1360362|NCT01644474|4486290|P1|Overall Study|Participant moved|0
1360363|NCT01644474|4486289|P2|Overall Study|Consent withdrawn by participant|1
1360364|NCT01644474|4486290|P1|Overall Study|Consent withdrawn by participant|0
1360365|NCT01644474|4486289|P2|Overall Study|Poor compliance to protocol|0
1360366|NCT01644474|4486290|P1|Overall Study|Poor compliance to protocol|1
1360367|NCT01644188|4486474|P2|Overall Study|Other than specified above|7
1360368|NCT01644188|4486475|P1|Overall Study|Other than specified above|6
1360369|NCT01644188|4486474|P2|Overall Study|Site closure|1
1360370|NCT01644188|4486475|P1|Overall Study|Site closure|1
1360371|NCT01644188|4486474|P2|Overall Study|Last visit outside protocol visit window|16
1360372|NCT01644188|4486475|P1|Overall Study|Last visit outside protocol visit window|14
1360373|NCT01644188|4486474|P2|Overall Study|Death|3
1360374|NCT01644188|4486475|P1|Overall Study|Death|4
1360375|NCT01644188|4486474|P2|Overall Study|Lost to Follow-up|0
1360376|NCT01644188|4486475|P1|Overall Study|Lost to Follow-up|1
1360377|NCT01644188|4486474|P2|Overall Study|Selection criteria finally not met|0
1360378|NCT01644188|4486475|P1|Overall Study|Selection criteria finally not met|2
1360379|NCT01644188|4486474|P2|Overall Study|Consent withdrawn by participant|7
1360380|NCT01644188|4486475|P1|Overall Study|Consent withdrawn by participant|14
1360381|NCT01644188|4486474|P2|Overall Study|Related to auto-injector administration|2
1360382|NCT01644188|4486475|P1|Overall Study|Related to auto-injector administration|2
1360383|NCT01644188|4486474|P2|Overall Study|Participant moved|2
1360384|NCT01644188|4486475|P1|Overall Study|Participant moved|7
1360385|NCT01644188|4486474|P2|Overall Study|Physician Decision|3
1360386|NCT01644188|4486475|P1|Overall Study|Physician Decision|1
1360387|NCT01644188|4486474|P2|Overall Study|Poor compliance to protocol|14
1360388|NCT01644188|4486475|P1|Overall Study|Poor compliance to protocol|26
1360389|NCT01644188|4486474|P2|Overall Study|Adverse Event|20
1360390|NCT01644188|4486475|P1|Overall Study|Adverse Event|44
1360391|NCT01644175|4486533|P2|Overall Study|Other than specified above|3
1360392|NCT01644175|4486534|P1|Overall Study|Other than specified above|0
1360393|NCT01644175|4486533|P2|Overall Study|Lost to Follow-up|0
1360394|NCT01644175|4486534|P1|Overall Study|Lost to Follow-up|1
1360395|NCT01644175|4486533|P2|Overall Study|Site closure|2
1360396|NCT01644175|4486534|P1|Overall Study|Site closure|2
1360397|NCT01644175|4486533|P2|Overall Study|Selection criteria finally not met|1
1360398|NCT01644175|4486534|P1|Overall Study|Selection criteria finally not met|0
1360399|NCT01644175|4486533|P2|Overall Study|Last visit outside protocol visit window|11
1360400|NCT01644175|4486534|P1|Overall Study|Last visit outside protocol visit window|4
1360401|NCT01644175|4486533|P2|Overall Study|Related to Autoinjector Administration|1
1360402|NCT01644175|4486534|P1|Overall Study|Related to Autoinjector Administration|2
1360403|NCT01644175|4486533|P2|Overall Study|Consent withdrawn by participant|4
1360404|NCT01644175|4486534|P1|Overall Study|Consent withdrawn by participant|3
1360405|NCT01644175|4486533|P2|Overall Study|Participant Moved|2
1360406|NCT01644175|4486534|P1|Overall Study|Participant Moved|1
1360407|NCT01644175|4486533|P2|Overall Study|Physician Decision|2
1360408|NCT01644175|4486534|P1|Overall Study|Physician Decision|1
1360409|NCT01644175|4486533|P2|Overall Study|Poor compliance to protocol|10
1360410|NCT01644175|4486534|P1|Overall Study|Poor compliance to protocol|9
1360411|NCT01644175|4486533|P2|Overall Study|Death|2
1360412|NCT01644175|4486534|P1|Overall Study|Death|1
1360413|NCT01644175|4486533|P2|Overall Study|Adverse Event|13
1360414|NCT01644175|4486534|P1|Overall Study|Adverse Event|8
1360415|NCT01644175|4486533|P2|Overall Study|Randomized But Not Treated|2
1360416|NCT01644175|4486534|P1|Overall Study|Randomized But Not Treated|0
1360417|NCT01643928|4486594|P5|Overall Study|Adverse Event|2
1360418|NCT01643928|4486595|P4|Overall Study|Adverse Event|1
1360419|NCT01643928|4486596|P3|Overall Study|Adverse Event|0
1360420|NCT01643928|4486597|P2|Overall Study|Adverse Event|1
1360421|NCT01643928|4486598|P1|Overall Study|Adverse Event|2
1360422|NCT01643928|4486594|P5|Overall Study|Other|0
1360423|NCT01643928|4486595|P4|Overall Study|Other|0
1360424|NCT01643928|4486596|P3|Overall Study|Other|1
1360425|NCT01643928|4486597|P2|Overall Study|Other|1
1360426|NCT01643928|4486598|P1|Overall Study|Other|5
1360427|NCT01643928|4486594|P5|Overall Study|Pregnancy|0
1360428|NCT01643928|4486595|P4|Overall Study|Pregnancy|1
1360429|NCT01643928|4486596|P3|Overall Study|Pregnancy|0
1360430|NCT01643928|4486597|P2|Overall Study|Pregnancy|0
1360431|NCT01643928|4486598|P1|Overall Study|Pregnancy|0
1360432|NCT01643928|4486594|P5|Overall Study|Withdrawal by Subject|0
1360433|NCT01643928|4486595|P4|Overall Study|Withdrawal by Subject|1
1360434|NCT01643928|4486596|P3|Overall Study|Withdrawal by Subject|0
1360435|NCT01643928|4486597|P2|Overall Study|Withdrawal by Subject|0
1360436|NCT01643928|4486598|P1|Overall Study|Withdrawal by Subject|2
1360437|NCT01643928|4486594|P5|Overall Study|Lost to Follow-up|0
1360438|NCT01643928|4486595|P4|Overall Study|Lost to Follow-up|0
1360439|NCT01643928|4486596|P3|Overall Study|Lost to Follow-up|2
1360440|NCT01643928|4486597|P2|Overall Study|Lost to Follow-up|0
1360441|NCT01643928|4486598|P1|Overall Study|Lost to Follow-up|1
1360442|NCT01643798|4486893|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
1360443|NCT01643798|4486894|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
1360444|NCT01643668|4486905|P1|Overall Study|Death|1
1360445|NCT01643044|4486945|P2|Overall Study|Delivered outside of hospital|2
1360446|NCT01643044|4486946|P1|Overall Study|Delivered outside of hospital|1
1360447|NCT01643044|4486945|P2|Overall Study|Miscarried baby|2
1360448|NCT01643044|4486946|P1|Overall Study|Miscarried baby|2
1360449|NCT01643044|4486945|P2|Overall Study|Lost to Follow-up|1
1360450|NCT01643044|4486946|P1|Overall Study|Lost to Follow-up|1
1360451|NCT01642914|4486955|P3|Overall Study|Other Reason|0
1360452|NCT01642914|4486956|P2|Overall Study|Other Reason|0
1360453|NCT01642914|4486957|P1|Overall Study|Other Reason|1
1360454|NCT01642914|4486955|P3|Overall Study|Lost to Follow-up|7
1360455|NCT01642914|4486956|P2|Overall Study|Lost to Follow-up|3
1360456|NCT01642914|4486957|P1|Overall Study|Lost to Follow-up|5
1360457|NCT01642914|4486955|P3|Overall Study|Withdrawal by Subject|10
1360458|NCT01642914|4486956|P2|Overall Study|Withdrawal by Subject|5
1360459|NCT01642914|4486957|P1|Overall Study|Withdrawal by Subject|5
1360460|NCT01642914|4486955|P3|Overall Study|Protocol Violation|6
1360461|NCT01642914|4486956|P2|Overall Study|Protocol Violation|13
1360462|NCT01642914|4486957|P1|Overall Study|Protocol Violation|15
1360463|NCT01642914|4486955|P3|Overall Study|Lack of Efficacy|2
1360464|NCT01642914|4486956|P2|Overall Study|Lack of Efficacy|4
1360465|NCT01642914|4486957|P1|Overall Study|Lack of Efficacy|9
1360466|NCT01642914|4486955|P3|Overall Study|Adverse Event|15
1360467|NCT01642914|4486956|P2|Overall Study|Adverse Event|7
1360468|NCT01642914|4486957|P1|Overall Study|Adverse Event|11
1360469|NCT01642732|4487032|P1|Overall Study|Withdrawal by Subject|1
1360470|NCT01642615|4487037|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
1360471|NCT01642615|4487038|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
1360472|NCT01642615|4487039|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
1360473|NCT01642615|4487037|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
1360474|NCT01642615|4487038|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
1360475|NCT01642615|4487039|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
1360476|NCT01642615|4487037|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
1360477|NCT01642615|4487038|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
1360478|NCT01642615|4487039|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
1360479|NCT01642615|4487037|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
1360480|NCT01642615|4487038|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
1360481|NCT01642615|4487039|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
1360482|NCT01642615|4487037|P3|Open Label Maintenance Phase|Did not receive treatment|0
1360483|NCT01642615|4487038|P2|Open Label Maintenance Phase|Did not receive treatment|0
1360484|NCT01642615|4487039|P1|Open Label Maintenance Phase|Did not receive treatment|1
1360485|NCT01642615|4487037|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
1360486|NCT01642615|4487038|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
1360487|NCT01642615|4487039|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
1360488|NCT01642615|4487037|P3|Open Label Maintenance Phase|Lost to Follow-up|0
1360489|NCT01642615|4487038|P2|Open Label Maintenance Phase|Lost to Follow-up|0
1360490|NCT01642615|4487039|P1|Open Label Maintenance Phase|Lost to Follow-up|1
1360491|NCT01642615|4487037|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
1360492|NCT01642615|4487038|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
1360493|NCT01642615|4487039|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
1360494|NCT01642615|4487037|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
1360495|NCT01642615|4487038|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
1360496|NCT01642615|4487039|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
1360497|NCT01642602|4487053|P1|Overall Study|Adverse Event|2
1360498|NCT01642589|4487060|P2|Overall Study|Withdrawal by Subject|1
1360499|NCT01642589|4487061|P1|Overall Study|Withdrawal by Subject|1
1360500|NCT01642407|4487100|P1|Overall Study|Insufficient clinical response|2
1360501|NCT01642277|4487144|P2|Overall Study|Withdrawal by Subject|0
1360502|NCT01642277|4487145|P1|Overall Study|Withdrawal by Subject|11
1360503|NCT01642277|4487144|P2|Overall Study|Protocol Violation|0
1360504|NCT01642277|4487145|P1|Overall Study|Protocol Violation|1
1360505|NCT01642277|4487144|P2|Overall Study|Physician Decision|0
1360506|NCT01642277|4487145|P1|Overall Study|Physician Decision|2
1360507|NCT01642277|4487144|P2|Overall Study|Adverse Event|0
1360508|NCT01642277|4487145|P1|Overall Study|Adverse Event|10
1360509|NCT01642212|4487177|P5|Open-label Extension|Not Specified|1
1360510|NCT01642212|4487178|P4|Open-label Extension|Not Specified|0
1360511|NCT01642212|4487179|P3|Open-label Extension|Not Specified|0
1360512|NCT01642212|4487180|P2|Open-label Extension|Not Specified|0
1360513|NCT01642212|4487181|P1|Open-label Extension|Not Specified|0
1360514|NCT01642212|4487177|P5|Open-label Extension|Lost to Follow-up|1
1360515|NCT01642212|4487178|P4|Open-label Extension|Lost to Follow-up|0
1360516|NCT01642212|4487179|P3|Open-label Extension|Lost to Follow-up|0
1360517|NCT01642212|4487180|P2|Open-label Extension|Lost to Follow-up|0
1360518|NCT01642212|4487181|P1|Open-label Extension|Lost to Follow-up|0
1360519|NCT01642212|4487177|P5|Open-label Extension|Consent Withdrawn|2
1360520|NCT01642212|4487178|P4|Open-label Extension|Consent Withdrawn|0
1360521|NCT01642212|4487179|P3|Open-label Extension|Consent Withdrawn|0
1360522|NCT01642212|4487180|P2|Open-label Extension|Consent Withdrawn|0
1360523|NCT01642212|4487181|P1|Open-label Extension|Consent Withdrawn|0
1360524|NCT01642212|4487177|P5|Open-label Extension|Sponsor Decision|4
1360525|NCT01642212|4487178|P4|Open-label Extension|Sponsor Decision|7
1360526|NCT01642212|4487179|P3|Open-label Extension|Sponsor Decision|0
1360527|NCT01642212|4487180|P2|Open-label Extension|Sponsor Decision|0
1360528|NCT01642212|4487181|P1|Open-label Extension|Sponsor Decision|0
1360529|NCT01642212|4487177|P5|Open-label Extension|Adverse Event|0
1360530|NCT01642212|4487178|P4|Open-label Extension|Adverse Event|3
1360531|NCT01642212|4487179|P3|Open-label Extension|Adverse Event|0
1360532|NCT01642212|4487180|P2|Open-label Extension|Adverse Event|0
1360533|NCT01642212|4487181|P1|Open-label Extension|Adverse Event|0
1360534|NCT01642212|4487177|P5|Double-blind Treatment|Adverse Event|0
1360535|NCT01642212|4487178|P4|Double-blind Treatment|Adverse Event|0
1360536|NCT01642212|4487179|P3|Double-blind Treatment|Adverse Event|1
1360537|NCT01642212|4487180|P2|Double-blind Treatment|Adverse Event|0
1360538|NCT01642212|4487181|P1|Double-blind Treatment|Adverse Event|0
1360539|NCT01642212|4487177|P5|Double-blind Treatment|Non-compliance|0
1360540|NCT01642212|4487178|P4|Double-blind Treatment|Non-compliance|0
1360541|NCT01642212|4487179|P3|Double-blind Treatment|Non-compliance|0
1360542|NCT01642212|4487180|P2|Double-blind Treatment|Non-compliance|1
1360543|NCT01642212|4487181|P1|Double-blind Treatment|Non-compliance|0
1360544|NCT01642212|4487177|P5|Double-blind Treatment|Not Specified|0
1360545|NCT01642212|4487178|P4|Double-blind Treatment|Not Specified|0
1360546|NCT01642212|4487179|P3|Double-blind Treatment|Not Specified|1
1360547|NCT01642212|4487180|P2|Double-blind Treatment|Not Specified|2
1360548|NCT01642212|4487181|P1|Double-blind Treatment|Not Specified|0
1360549|NCT01642212|4487177|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1360550|NCT01642212|4487178|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1360551|NCT01642212|4487179|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1360552|NCT01642212|4487180|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1360553|NCT01642212|4487181|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
1360554|NCT01642004|4487276|P2|Treatment|Missing from data|1
1360555|NCT01642004|4487277|P1|Treatment|Missing from data|0
1360556|NCT01642004|4487276|P2|Treatment|Other|2
1360557|NCT01642004|4487277|P1|Treatment|Other|1
1360558|NCT01642004|4487276|P2|Treatment|No longer meets study criteria|2
1360559|NCT01642004|4487277|P1|Treatment|No longer meets study criteria|1
1360560|NCT01642004|4487276|P2|Treatment|Poor/non-compliance|0
1360561|NCT01642004|4487277|P1|Treatment|Poor/non-compliance|1
1360562|NCT01642004|4487276|P2|Treatment|Maximum clinical benefit|7
1360563|NCT01642004|4487277|P1|Treatment|Maximum clinical benefit|2
1360564|NCT01642004|4487276|P2|Treatment|Withdrawal by Subject|9
1360565|NCT01642004|4487277|P1|Treatment|Withdrawal by Subject|5
1360566|NCT01642004|4487276|P2|Treatment|Adverse event unrelated to study drug|13
1360567|NCT01642004|4487277|P1|Treatment|Adverse event unrelated to study drug|6
1360568|NCT01642004|4487276|P2|Treatment|Death|0
1360569|NCT01642004|4487277|P1|Treatment|Death|1
1360570|NCT01642004|4487276|P2|Treatment|Study drug toxicity|13
1360571|NCT01642004|4487277|P1|Treatment|Study drug toxicity|5
1360572|NCT01642004|4487276|P2|Treatment|Disease progression|80
1360573|NCT01642004|4487277|P1|Treatment|Disease progression|88
1360574|NCT01642004|4487276|P2|Randomization|No longer meets study criteria|2
1360575|NCT01642004|4487277|P1|Randomization|No longer meets study criteria|2
1360576|NCT01642004|4487276|P2|Randomization|Withdrawal by Subject|6
1360577|NCT01642004|4487277|P1|Randomization|Withdrawal by Subject|1
1360578|NCT01642004|4487276|P2|Randomization|Adverse Event unrelated to study drug|0
1360579|NCT01642004|4487277|P1|Randomization|Adverse Event unrelated to study drug|1
1360580|NCT01641991|4487311|P4|Overall Study|no longer eligible|4
1360581|NCT01641991|4487312|P3|Overall Study|no longer eligible|0
1360582|NCT01641991|4487313|P2|Overall Study|no longer eligible|1
1360583|NCT01641991|4487314|P1|Overall Study|no longer eligible|2
1360584|NCT01641991|4487311|P4|Overall Study|Pregnancy|0
1360585|NCT01641991|4487312|P3|Overall Study|Pregnancy|1
1360586|NCT01641991|4487313|P2|Overall Study|Pregnancy|0
1360587|NCT01641991|4487314|P1|Overall Study|Pregnancy|0
1360588|NCT01641991|4487311|P4|Overall Study|Protocol Violation|0
1360589|NCT01641991|4487312|P3|Overall Study|Protocol Violation|3
1360590|NCT01641991|4487313|P2|Overall Study|Protocol Violation|1
1360591|NCT01641991|4487314|P1|Overall Study|Protocol Violation|1
1360592|NCT01641991|4487311|P4|Overall Study|Lost to Follow-up|1
1360593|NCT01641991|4487312|P3|Overall Study|Lost to Follow-up|3
1360594|NCT01641991|4487313|P2|Overall Study|Lost to Follow-up|2
1360595|NCT01641991|4487314|P1|Overall Study|Lost to Follow-up|0
1360596|NCT01641991|4487311|P4|Overall Study|Adverse Event|1
1360597|NCT01641991|4487312|P3|Overall Study|Adverse Event|2
1360598|NCT01641991|4487313|P2|Overall Study|Adverse Event|1
1360599|NCT01641991|4487314|P1|Overall Study|Adverse Event|2
1360600|NCT01641991|4487311|P4|Overall Study|Withdrawal by Subject|5
1360601|NCT01641991|4487312|P3|Overall Study|Withdrawal by Subject|1
1360602|NCT01641991|4487313|P2|Overall Study|Withdrawal by Subject|2
1360603|NCT01641991|4487314|P1|Overall Study|Withdrawal by Subject|4
1360604|NCT01641991|4487311|P4|Overall Study|Physician Decision|5
1360605|NCT01641991|4487312|P3|Overall Study|Physician Decision|7
1360606|NCT01641991|4487313|P2|Overall Study|Physician Decision|1
1360607|NCT01641991|4487314|P1|Overall Study|Physician Decision|0
1360608|NCT01641952|4487398|P1|Overall Study|Adverse Event|6
1360609|NCT01641952|4487398|P1|Overall Study|Lost to Follow-up|28
1360610|NCT01641939|4487414|P3|Overall Study|Study Terminated by Sponsor|3
1360611|NCT01641939|4487415|P2|Overall Study|Study Terminated by Sponsor|28
1360612|NCT01641939|4487416|P1|Overall Study|Study Terminated by Sponsor|10
1360613|NCT01641939|4487414|P3|Overall Study|Withdrawal by Subject|5
1360614|NCT01641939|4487415|P2|Overall Study|Withdrawal by Subject|11
1360615|NCT01641939|4487416|P1|Overall Study|Withdrawal by Subject|14
1360616|NCT01641939|4487414|P3|Overall Study|Lost to Follow-up|1
1360617|NCT01641939|4487415|P2|Overall Study|Lost to Follow-up|2
1360618|NCT01641939|4487416|P1|Overall Study|Lost to Follow-up|3
1360619|NCT01641939|4487414|P3|Overall Study|Death|61
1360620|NCT01641939|4487415|P2|Overall Study|Death|187
1360621|NCT01641939|4487416|P1|Overall Study|Death|90
1360622|NCT01641926|4487459|P4|Overall Study|Not Treated|0
1360623|NCT01641926|4487460|P3|Overall Study|Not Treated|1
1360624|NCT01641926|4487461|P2|Overall Study|Not Treated|1
1360625|NCT01641926|4487462|P1|Overall Study|Not Treated|1
1360626|NCT01641926|4487459|P4|Overall Study|Withdrawal by Subject|1
1360627|NCT01641926|4487460|P3|Overall Study|Withdrawal by Subject|6
1360628|NCT01641926|4487461|P2|Overall Study|Withdrawal by Subject|5
1360629|NCT01641926|4487462|P1|Overall Study|Withdrawal by Subject|13
1360630|NCT01641926|4487459|P4|Overall Study|Protocol Violation|1
1360631|NCT01641926|4487460|P3|Overall Study|Protocol Violation|0
1360632|NCT01641926|4487461|P2|Overall Study|Protocol Violation|0
1360633|NCT01641926|4487462|P1|Overall Study|Protocol Violation|1
1360634|NCT01641926|4487459|P4|Overall Study|Physician Decision|1
1360635|NCT01641926|4487460|P3|Overall Study|Physician Decision|0
1360636|NCT01641926|4487461|P2|Overall Study|Physician Decision|5
1360637|NCT01641926|4487462|P1|Overall Study|Physician Decision|6
1360638|NCT01641926|4487459|P4|Overall Study|Lost to Follow-up|0
1360639|NCT01641926|4487460|P3|Overall Study|Lost to Follow-up|1
1360640|NCT01641926|4487461|P2|Overall Study|Lost to Follow-up|2
1360641|NCT01641926|4487462|P1|Overall Study|Lost to Follow-up|2
1360642|NCT01641926|4487459|P4|Overall Study|Adverse Event|1
1360643|NCT01641926|4487460|P3|Overall Study|Adverse Event|3
1360644|NCT01641926|4487461|P2|Overall Study|Adverse Event|2
1360645|NCT01641926|4487462|P1|Overall Study|Adverse Event|5
1360646|NCT01641900|4487490|P2|Overall Study|Withdrawal by Subject|2
1360647|NCT01641900|4487491|P1|Overall Study|Withdrawal by Subject|2
1360648|NCT01641861|4487503|P2|Overall Study|Died due to drowning|1
1360649|NCT01641861|4487504|P1|Overall Study|Died due to drowning|0
1360650|NCT01641861|4487503|P2|Overall Study|Lost the tooth due to normal exfoliation|8
1360651|NCT01641861|4487504|P1|Overall Study|Lost the tooth due to normal exfoliation|14
1360652|NCT01641861|4487503|P2|Overall Study|Lost to Follow-up|16
1360653|NCT01641861|4487504|P1|Overall Study|Lost to Follow-up|21
1360654|NCT01641822|4487525|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
1360655|NCT01641822|4487526|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
1360656|NCT01641822|4487527|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
1360657|NCT01641822|4487525|P3|Comparative Phase|Withdrew consent|7
1360658|NCT01641822|4487526|P2|Comparative Phase|Withdrew consent|3
1360659|NCT01641822|4487527|P1|Comparative Phase|Withdrew consent|0
1360660|NCT01641822|4487525|P3|Comparative Phase|Adverse event, serious fatal|0
1360661|NCT01641822|4487526|P2|Comparative Phase|Adverse event, serious fatal|1
1360662|NCT01641822|4487527|P1|Comparative Phase|Adverse event, serious fatal|0
1360663|NCT01641822|4487525|P3|Comparative Phase|Pregnancy|1
1360664|NCT01641822|4487526|P2|Comparative Phase|Pregnancy|0
1360665|NCT01641822|4487527|P1|Comparative Phase|Pregnancy|0
1360666|NCT01641822|4487525|P3|Comparative Phase|Investigator's discretion|1
1360667|NCT01641822|4487526|P2|Comparative Phase|Investigator's discretion|0
1360668|NCT01641822|4487527|P1|Comparative Phase|Investigator's discretion|0
1360669|NCT01641822|4487525|P3|Comparative Phase|Noncompliance with study drug|0
1360670|NCT01641822|4487526|P2|Comparative Phase|Noncompliance with study drug|1
1360671|NCT01641822|4487527|P1|Comparative Phase|Noncompliance with study drug|0
1360672|NCT01641822|4487525|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
1360673|NCT01641822|4487526|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
1360674|NCT01641822|4487527|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
1360675|NCT01641822|4487525|P3|Run-in Phase|Withdrew consent|0
1360676|NCT01641822|4487526|P2|Run-in Phase|Withdrew consent|0
1360677|NCT01641822|4487527|P1|Run-in Phase|Withdrew consent|1
1360678|NCT01641822|4487525|P3|Run-in Phase|Adverse Event|0
1360679|NCT01641822|4487526|P2|Run-in Phase|Adverse Event|0
1360680|NCT01641822|4487527|P1|Run-in Phase|Adverse Event|3
1360681|NCT01641822|4487525|P3|Run-in Phase|Noncompliance with study drug|0
1360682|NCT01641822|4487526|P2|Run-in Phase|Noncompliance with study drug|0
1360683|NCT01641822|4487527|P1|Run-in Phase|Noncompliance with study drug|1
1360684|NCT01641692|4487544|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
1360685|NCT01641692|4487545|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1360686|NCT01641692|4487546|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1360687|NCT01641692|4487547|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
1360688|NCT01641692|4487548|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1360689|NCT01641692|4487549|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1360690|NCT01641692|4487550|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
1360691|NCT01641692|4487551|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1360692|NCT01641692|4487544|P8|Washout Period 3 or Follow-up|Protocol Violation|0
1360693|NCT01641692|4487545|P7|Washout Period 3 or Follow-up|Protocol Violation|0
1360694|NCT01641692|4487546|P6|Washout Period 3 or Follow-up|Protocol Violation|1
1360695|NCT01641692|4487547|P5|Washout Period 3 or Follow-up|Protocol Violation|0
1360696|NCT01641692|4487548|P4|Washout Period 3 or Follow-up|Protocol Violation|0
1360697|NCT01641692|4487549|P3|Washout Period 3 or Follow-up|Protocol Violation|0
1360698|NCT01641692|4487550|P2|Washout Period 3 or Follow-up|Protocol Violation|0
1360699|NCT01641692|4487551|P1|Washout Period 3 or Follow-up|Protocol Violation|0
1360700|NCT01641692|4487544|P8|Treatment Period 3|Lost to Follow-up|0
1360701|NCT01641692|4487545|P7|Treatment Period 3|Lost to Follow-up|0
1360702|NCT01641692|4487546|P6|Treatment Period 3|Lost to Follow-up|0
1360703|NCT01641692|4487547|P5|Treatment Period 3|Lost to Follow-up|0
1360704|NCT01641692|4487548|P4|Treatment Period 3|Lost to Follow-up|0
1360705|NCT01641692|4487549|P3|Treatment Period 3|Lost to Follow-up|0
1360706|NCT01641692|4487550|P2|Treatment Period 3|Lost to Follow-up|1
1360707|NCT01641692|4487551|P1|Treatment Period 3|Lost to Follow-up|0
1360708|NCT01641692|4487544|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
1360709|NCT01641692|4487545|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
1360710|NCT01641692|4487546|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
1360711|NCT01641692|4487547|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
1360712|NCT01641692|4487548|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
1360713|NCT01641692|4487549|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
1360714|NCT01641692|4487550|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
1360715|NCT01641692|4487551|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
1360716|NCT01641692|4487544|P8|Treatment Period 3|Protocol Violation|0
1360717|NCT01641692|4487545|P7|Treatment Period 3|Protocol Violation|0
1360718|NCT01641692|4487546|P6|Treatment Period 3|Protocol Violation|0
1360719|NCT01641692|4487547|P5|Treatment Period 3|Protocol Violation|0
1360720|NCT01641692|4487548|P4|Treatment Period 3|Protocol Violation|0
1360721|NCT01641692|4487549|P3|Treatment Period 3|Protocol Violation|1
1360722|NCT01641692|4487550|P2|Treatment Period 3|Protocol Violation|0
1360723|NCT01641692|4487551|P1|Treatment Period 3|Protocol Violation|0
1360724|NCT01641692|4487544|P8|Treatment Period 3|Adverse Event|0
1360725|NCT01641692|4487545|P7|Treatment Period 3|Adverse Event|1
1360726|NCT01641692|4487546|P6|Treatment Period 3|Adverse Event|0
1360727|NCT01641692|4487547|P5|Treatment Period 3|Adverse Event|0
1360728|NCT01641692|4487548|P4|Treatment Period 3|Adverse Event|0
1360729|NCT01641692|4487549|P3|Treatment Period 3|Adverse Event|0
1360730|NCT01641692|4487550|P2|Treatment Period 3|Adverse Event|0
1360731|NCT01641692|4487551|P1|Treatment Period 3|Adverse Event|0
1360732|NCT01641692|4487544|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1360733|NCT01641692|4487545|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1360734|NCT01641692|4487546|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1360735|NCT01641692|4487547|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1360736|NCT01641692|4487548|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1360737|NCT01641692|4487549|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1360738|NCT01641692|4487550|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1360739|NCT01641692|4487551|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1360740|NCT01641692|4487544|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1360741|NCT01641692|4487545|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
1360742|NCT01641692|4487546|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1360743|NCT01641692|4487547|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
1360744|NCT01641692|4487548|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1360745|NCT01641692|4487549|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1360746|NCT01641692|4487550|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1360747|NCT01641692|4487551|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1360748|NCT01641692|4487544|P8|Treatment Period 2|Withdrawal by Subject|1
1360749|NCT01641692|4487545|P7|Treatment Period 2|Withdrawal by Subject|0
1360750|NCT01641692|4487546|P6|Treatment Period 2|Withdrawal by Subject|1
1360751|NCT01641692|4487547|P5|Treatment Period 2|Withdrawal by Subject|0
1360752|NCT01641692|4487548|P4|Treatment Period 2|Withdrawal by Subject|0
1360753|NCT01641692|4487549|P3|Treatment Period 2|Withdrawal by Subject|0
1360754|NCT01641692|4487550|P2|Treatment Period 2|Withdrawal by Subject|0
1360755|NCT01641692|4487551|P1|Treatment Period 2|Withdrawal by Subject|1
1360756|NCT01641692|4487544|P8|Treatment Period 2|Lost to Follow-up|0
1360757|NCT01641692|4487545|P7|Treatment Period 2|Lost to Follow-up|0
1360758|NCT01641692|4487546|P6|Treatment Period 2|Lost to Follow-up|1
1360759|NCT01641692|4487547|P5|Treatment Period 2|Lost to Follow-up|0
1360760|NCT01641692|4487548|P4|Treatment Period 2|Lost to Follow-up|0
1360761|NCT01641692|4487549|P3|Treatment Period 2|Lost to Follow-up|0
1360762|NCT01641692|4487550|P2|Treatment Period 2|Lost to Follow-up|0
1360763|NCT01641692|4487551|P1|Treatment Period 2|Lost to Follow-up|0
1360764|NCT01641692|4487544|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
1360765|NCT01641692|4487545|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
1360766|NCT01641692|4487546|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
1360767|NCT01641692|4487547|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
1360768|NCT01641692|4487548|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
1360769|NCT01641692|4487549|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
1360770|NCT01641692|4487550|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
1360771|NCT01641692|4487551|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
1360772|NCT01641692|4487544|P8|Treatment Period 2|Lack of Efficacy|0
1360773|NCT01641692|4487545|P7|Treatment Period 2|Lack of Efficacy|0
1360774|NCT01641692|4487546|P6|Treatment Period 2|Lack of Efficacy|0
1360775|NCT01641692|4487547|P5|Treatment Period 2|Lack of Efficacy|0
1360776|NCT01641692|4487548|P4|Treatment Period 2|Lack of Efficacy|0
1360777|NCT01641692|4487549|P3|Treatment Period 2|Lack of Efficacy|0
1360778|NCT01641692|4487550|P2|Treatment Period 2|Lack of Efficacy|0
1360779|NCT01641692|4487551|P1|Treatment Period 2|Lack of Efficacy|1
1360780|NCT01641692|4487544|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1360781|NCT01641692|4487545|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1360782|NCT01641692|4487546|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1360783|NCT01641692|4487547|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1360784|NCT01641692|4487548|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1360785|NCT01641692|4487549|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1360786|NCT01641692|4487550|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1360787|NCT01641692|4487551|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1360788|NCT01641692|4487544|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
1360789|NCT01641692|4487545|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
1360790|NCT01641692|4487546|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
1360791|NCT01641692|4487547|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
1360792|NCT01641692|4487548|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
1360793|NCT01641692|4487549|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
1360794|NCT01641692|4487550|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
1360795|NCT01641692|4487551|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
1360796|NCT01641692|4487544|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
1360797|NCT01641692|4487545|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
1360798|NCT01641692|4487546|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
1360799|NCT01641692|4487547|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
1360800|NCT01641692|4487548|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
1360801|NCT01641692|4487549|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
1360802|NCT01641692|4487550|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
1360803|NCT01641692|4487551|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
1360804|NCT01641692|4487544|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
1360805|NCT01641692|4487545|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
1360806|NCT01641692|4487546|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
1360807|NCT01641692|4487547|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
1360808|NCT01641692|4487548|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
1360809|NCT01641692|4487549|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
1360810|NCT01641692|4487550|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
1360811|NCT01641692|4487551|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
1360812|NCT01641692|4487544|P8|Treatment Period 1|Withdrawal by Subject|1
1360813|NCT01641692|4487545|P7|Treatment Period 1|Withdrawal by Subject|0
1360814|NCT01641692|4487546|P6|Treatment Period 1|Withdrawal by Subject|2
1360815|NCT01641692|4487547|P5|Treatment Period 1|Withdrawal by Subject|0
1360816|NCT01641692|4487548|P4|Treatment Period 1|Withdrawal by Subject|0
1360817|NCT01641692|4487549|P3|Treatment Period 1|Withdrawal by Subject|0
1360818|NCT01641692|4487550|P2|Treatment Period 1|Withdrawal by Subject|0
1360819|NCT01641692|4487551|P1|Treatment Period 1|Withdrawal by Subject|0
1360820|NCT01641692|4487544|P8|Treatment Period 1|Physician Decision|0
1360821|NCT01641692|4487545|P7|Treatment Period 1|Physician Decision|0
1360822|NCT01641692|4487546|P6|Treatment Period 1|Physician Decision|0
1360823|NCT01641692|4487547|P5|Treatment Period 1|Physician Decision|1
1360824|NCT01641692|4487548|P4|Treatment Period 1|Physician Decision|0
1360825|NCT01641692|4487549|P3|Treatment Period 1|Physician Decision|0
1360826|NCT01641692|4487550|P2|Treatment Period 1|Physician Decision|0
1360827|NCT01641692|4487551|P1|Treatment Period 1|Physician Decision|0
1360828|NCT01641692|4487544|P8|Treatment Period 1|Lost to Follow-up|0
1360829|NCT01641692|4487545|P7|Treatment Period 1|Lost to Follow-up|0
1360830|NCT01641692|4487546|P6|Treatment Period 1|Lost to Follow-up|0
1360831|NCT01641692|4487547|P5|Treatment Period 1|Lost to Follow-up|0
1360832|NCT01641692|4487548|P4|Treatment Period 1|Lost to Follow-up|0
1360833|NCT01641692|4487549|P3|Treatment Period 1|Lost to Follow-up|1
1360834|NCT01641692|4487550|P2|Treatment Period 1|Lost to Follow-up|0
1360835|NCT01641692|4487551|P1|Treatment Period 1|Lost to Follow-up|0
1360836|NCT01641692|4487544|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
1360837|NCT01641692|4487545|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
1360838|NCT01641692|4487546|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
1360839|NCT01641692|4487547|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
1360840|NCT01641692|4487548|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
1360841|NCT01641692|4487549|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
1360842|NCT01641692|4487550|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
1360843|NCT01641692|4487551|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
1360844|NCT01641692|4487544|P8|Treatment Period 1|Protocol Violation|0
1360845|NCT01641692|4487545|P7|Treatment Period 1|Protocol Violation|0
1360846|NCT01641692|4487546|P6|Treatment Period 1|Protocol Violation|0
1360847|NCT01641692|4487547|P5|Treatment Period 1|Protocol Violation|2
1360848|NCT01641692|4487548|P4|Treatment Period 1|Protocol Violation|0
1360849|NCT01641692|4487549|P3|Treatment Period 1|Protocol Violation|0
1360850|NCT01641692|4487550|P2|Treatment Period 1|Protocol Violation|0
1360851|NCT01641692|4487551|P1|Treatment Period 1|Protocol Violation|1
1360852|NCT01641692|4487544|P8|Treatment Period 1|Lack of Efficacy|1
1360853|NCT01641692|4487545|P7|Treatment Period 1|Lack of Efficacy|0
1360854|NCT01641692|4487546|P6|Treatment Period 1|Lack of Efficacy|0
1360855|NCT01641692|4487547|P5|Treatment Period 1|Lack of Efficacy|0
1360856|NCT01641692|4487548|P4|Treatment Period 1|Lack of Efficacy|0
1360857|NCT01641692|4487549|P3|Treatment Period 1|Lack of Efficacy|0
1360858|NCT01641692|4487550|P2|Treatment Period 1|Lack of Efficacy|0
1360859|NCT01641692|4487551|P1|Treatment Period 1|Lack of Efficacy|0
1360860|NCT01641692|4487544|P8|Treatment Period 1|Adverse Event|0
1360861|NCT01641692|4487545|P7|Treatment Period 1|Adverse Event|0
1360862|NCT01641692|4487546|P6|Treatment Period 1|Adverse Event|0
1360863|NCT01641692|4487547|P5|Treatment Period 1|Adverse Event|0
1360864|NCT01641692|4487548|P4|Treatment Period 1|Adverse Event|0
1360865|NCT01641692|4487549|P3|Treatment Period 1|Adverse Event|0
1360866|NCT01641692|4487550|P2|Treatment Period 1|Adverse Event|0
1360867|NCT01641692|4487551|P1|Treatment Period 1|Adverse Event|1
1360868|NCT01641640|4487751|P1|Overall Study|Adverse Event|1
1360869|NCT01641640|4487751|P1|Overall Study|Withdrawal by Subject|2
1360870|NCT01641640|4487751|P1|Overall Study|Lost to Follow-up|3
1360871|NCT01641640|4487751|P1|Overall Study|Efficacy failure|29
1360872|NCT01641640|4487751|P1|Overall Study|Enrolled but not treated|1
1360873|NCT01641471|4487762|P2|Overall Study|Protocol Violation|4
1360874|NCT01641471|4487763|P1|Overall Study|Protocol Violation|2
1360875|NCT01641471|4487762|P2|Overall Study|Lost to Follow-up|4
1360876|NCT01641471|4487763|P1|Overall Study|Lost to Follow-up|2
1360877|NCT01641471|4487762|P2|Overall Study|Withdrawal by Subject|19
1360878|NCT01641471|4487763|P1|Overall Study|Withdrawal by Subject|19
1360879|NCT01641367|4487781|P6|Overall Study|Lost to Follow-up|0
1360880|NCT01641367|4487782|P5|Overall Study|Lost to Follow-up|2
1360881|NCT01641367|4487783|P4|Overall Study|Lost to Follow-up|0
1360882|NCT01641367|4487784|P3|Overall Study|Lost to Follow-up|2
1360883|NCT01641367|4487785|P2|Overall Study|Lost to Follow-up|0
1360884|NCT01641367|4487786|P1|Overall Study|Lost to Follow-up|16
1360885|NCT01641367|4487781|P6|Overall Study|Death|1
1360886|NCT01641367|4487782|P5|Overall Study|Death|1
1360887|NCT01641367|4487783|P4|Overall Study|Death|0
1360888|NCT01641367|4487784|P3|Overall Study|Death|2
1360889|NCT01641367|4487785|P2|Overall Study|Death|1
1360890|NCT01641367|4487786|P1|Overall Study|Death|18
1360891|NCT01641237|4487801|P4|Period III|Lost to Follow-up|0
1360892|NCT01641237|4487802|P3|Period III|Lost to Follow-up|0
1360893|NCT01641237|4487803|P2|Period III|Lost to Follow-up|0
1360894|NCT01641237|4487804|P1|Period III|Lost to Follow-up|1
1360895|NCT01641237|4487801|P4|Period II|Withdrawal by Subject|0
1360896|NCT01641237|4487802|P3|Period II|Withdrawal by Subject|0
1360897|NCT01641237|4487803|P2|Period II|Withdrawal by Subject|0
1360898|NCT01641237|4487804|P1|Period II|Withdrawal by Subject|1
1360899|NCT01641159|4487828|P2|Overall Study|Withdrawal by Subject|1
1360900|NCT01641159|4487829|P1|Overall Study|Withdrawal by Subject|0
1360901|NCT01641159|4487828|P2|Overall Study|Lost to Follow-up|1
1360902|NCT01641159|4487829|P1|Overall Study|Lost to Follow-up|2
1360903|NCT01641133|4487840|P3|Overall Study|Lost to Follow-up|2
1360904|NCT01641133|4487841|P2|Overall Study|Lost to Follow-up|2
1360905|NCT01641133|4487842|P1|Overall Study|Lost to Follow-up|0
1360906|NCT01641133|4487840|P3|Overall Study|Withdrawal by Subject|3
1360907|NCT01641133|4487841|P2|Overall Study|Withdrawal by Subject|3
1360908|NCT01641133|4487842|P1|Overall Study|Withdrawal by Subject|5
1360909|NCT01641133|4487840|P3|Overall Study|Adverse Event|1
1360910|NCT01641133|4487841|P2|Overall Study|Adverse Event|0
1360911|NCT01641133|4487842|P1|Overall Study|Adverse Event|0
1360912|NCT01641133|4487840|P3|Overall Study|Migrated/moved from study area|1
1360913|NCT01641133|4487841|P2|Overall Study|Migrated/moved from study area|3
1360914|NCT01641133|4487842|P1|Overall Study|Migrated/moved from study area|5
1360915|NCT01641133|4487840|P3|Overall Study|Protocol Violation|1
1360916|NCT01641133|4487841|P2|Overall Study|Protocol Violation|1
1360917|NCT01641133|4487842|P1|Overall Study|Protocol Violation|0
1360918|NCT01641081|4487892|P10|Period 5|Adverse Event|0
1360919|NCT01641081|4487893|P9|Period 5|Adverse Event|0
1360920|NCT01641081|4487894|P8|Period 5|Adverse Event|0
1360921|NCT01641081|4487895|P7|Period 5|Adverse Event|0
1360922|NCT01641081|4487896|P6|Period 5|Adverse Event|0
1360923|NCT01641081|4487897|P5|Period 5|Adverse Event|0
1360924|NCT01641081|4487898|P4|Period 5|Adverse Event|0
1360925|NCT01641081|4487899|P3|Period 5|Adverse Event|2
1360926|NCT01641081|4487900|P2|Period 5|Adverse Event|0
1360927|NCT01641081|4487901|P1|Period 5|Adverse Event|0
1360928|NCT01641081|4487892|P10|Period 4|Adverse Event|0
1360929|NCT01641081|4487893|P9|Period 4|Adverse Event|0
1360930|NCT01641081|4487894|P8|Period 4|Adverse Event|0
1360931|NCT01641081|4487895|P7|Period 4|Adverse Event|0
1360932|NCT01641081|4487896|P6|Period 4|Adverse Event|0
1360933|NCT01641081|4487897|P5|Period 4|Adverse Event|0
1360934|NCT01641081|4487898|P4|Period 4|Adverse Event|1
1360935|NCT01641081|4487899|P3|Period 4|Adverse Event|0
1360936|NCT01641081|4487900|P2|Period 4|Adverse Event|1
1360937|NCT01641081|4487901|P1|Period 4|Adverse Event|0
1360938|NCT01641081|4487892|P10|Period 3|Withdrawal by Subject|0
1360939|NCT01641081|4487893|P9|Period 3|Withdrawal by Subject|1
1360940|NCT01641081|4487894|P8|Period 3|Withdrawal by Subject|0
1360941|NCT01641081|4487895|P7|Period 3|Withdrawal by Subject|0
1360942|NCT01641081|4487896|P6|Period 3|Withdrawal by Subject|0
1360943|NCT01641081|4487897|P5|Period 3|Withdrawal by Subject|0
1360944|NCT01641081|4487898|P4|Period 3|Withdrawal by Subject|0
1360945|NCT01641081|4487899|P3|Period 3|Withdrawal by Subject|0
1360946|NCT01641081|4487900|P2|Period 3|Withdrawal by Subject|0
1360947|NCT01641081|4487901|P1|Period 3|Withdrawal by Subject|0
1360948|NCT01641081|4487892|P10|Period 3|Adverse Event|0
1360949|NCT01641081|4487893|P9|Period 3|Adverse Event|0
1360950|NCT01641081|4487894|P8|Period 3|Adverse Event|0
1360951|NCT01641081|4487895|P7|Period 3|Adverse Event|0
1360952|NCT01641081|4487896|P6|Period 3|Adverse Event|0
1360953|NCT01641081|4487897|P5|Period 3|Adverse Event|0
1360954|NCT01641081|4487898|P4|Period 3|Adverse Event|0
1360955|NCT01641081|4487899|P3|Period 3|Adverse Event|1
1360956|NCT01641081|4487900|P2|Period 3|Adverse Event|0
1360957|NCT01641081|4487901|P1|Period 3|Adverse Event|0
1360958|NCT01641081|4487892|P10|Period 2|Protocol Violation|0
1360959|NCT01641081|4487893|P9|Period 2|Protocol Violation|0
1360960|NCT01641081|4487894|P8|Period 2|Protocol Violation|0
1360961|NCT01641081|4487895|P7|Period 2|Protocol Violation|0
1360962|NCT01641081|4487896|P6|Period 2|Protocol Violation|0
1360963|NCT01641081|4487897|P5|Period 2|Protocol Violation|0
1360964|NCT01641081|4487898|P4|Period 2|Protocol Violation|0
1360965|NCT01641081|4487899|P3|Period 2|Protocol Violation|0
1360966|NCT01641081|4487900|P2|Period 2|Protocol Violation|0
1360967|NCT01641081|4487901|P1|Period 2|Protocol Violation|1
1360968|NCT01641081|4487892|P10|Period 2|Withdrawal by Subject|0
1360969|NCT01641081|4487893|P9|Period 2|Withdrawal by Subject|0
1360970|NCT01641081|4487894|P8|Period 2|Withdrawal by Subject|0
1360971|NCT01641081|4487895|P7|Period 2|Withdrawal by Subject|2
1360972|NCT01641081|4487896|P6|Period 2|Withdrawal by Subject|0
1360973|NCT01641081|4487897|P5|Period 2|Withdrawal by Subject|0
1360974|NCT01641081|4487898|P4|Period 2|Withdrawal by Subject|1
1360975|NCT01641081|4487899|P3|Period 2|Withdrawal by Subject|0
1360976|NCT01641081|4487900|P2|Period 2|Withdrawal by Subject|0
1360977|NCT01641081|4487901|P1|Period 2|Withdrawal by Subject|0
1360978|NCT01641081|4487892|P10|Period 2|Adverse Event|0
1360979|NCT01641081|4487893|P9|Period 2|Adverse Event|0
1360980|NCT01641081|4487894|P8|Period 2|Adverse Event|0
1360981|NCT01641081|4487895|P7|Period 2|Adverse Event|0
1360982|NCT01641081|4487896|P6|Period 2|Adverse Event|1
1360983|NCT01641081|4487897|P5|Period 2|Adverse Event|0
1360984|NCT01641081|4487898|P4|Period 2|Adverse Event|0
1360985|NCT01641081|4487899|P3|Period 2|Adverse Event|0
1360986|NCT01641081|4487900|P2|Period 2|Adverse Event|0
1360987|NCT01641081|4487901|P1|Period 2|Adverse Event|0
1360988|NCT01641081|4487892|P10|Period 1|Adverse Event|0
1360989|NCT01641081|4487893|P9|Period 1|Adverse Event|0
1360990|NCT01641081|4487894|P8|Period 1|Adverse Event|2
1360991|NCT01641081|4487895|P7|Period 1|Adverse Event|0
1360992|NCT01641081|4487896|P6|Period 1|Adverse Event|0
1360993|NCT01641081|4487897|P5|Period 1|Adverse Event|0
1360994|NCT01641081|4487898|P4|Period 1|Adverse Event|0
1360995|NCT01641081|4487899|P3|Period 1|Adverse Event|0
1360996|NCT01641081|4487900|P2|Period 1|Adverse Event|0
1360997|NCT01641081|4487901|P1|Period 1|Adverse Event|1
1360998|NCT01641081|4487892|P10|Period 1|Protocol Violation|0
1360999|NCT01641081|4487893|P9|Period 1|Protocol Violation|0
1361000|NCT01641081|4487894|P8|Period 1|Protocol Violation|1
1361001|NCT01641081|4487895|P7|Period 1|Protocol Violation|0
1361002|NCT01641081|4487896|P6|Period 1|Protocol Violation|0
1361003|NCT01641081|4487897|P5|Period 1|Protocol Violation|1
1361004|NCT01641081|4487898|P4|Period 1|Protocol Violation|0
1361005|NCT01641081|4487899|P3|Period 1|Protocol Violation|0
1361006|NCT01641081|4487900|P2|Period 1|Protocol Violation|0
1361007|NCT01641081|4487901|P1|Period 1|Protocol Violation|0
1361008|NCT01641081|4487892|P10|Period 1|Sponsor request (potential unblinding)|0
1361009|NCT01641081|4487893|P9|Period 1|Sponsor request (potential unblinding)|0
1361010|NCT01641081|4487894|P8|Period 1|Sponsor request (potential unblinding)|0
1361011|NCT01641081|4487895|P7|Period 1|Sponsor request (potential unblinding)|1
1361012|NCT01641081|4487896|P6|Period 1|Sponsor request (potential unblinding)|0
1361013|NCT01641081|4487897|P5|Period 1|Sponsor request (potential unblinding)|0
1361014|NCT01641081|4487898|P4|Period 1|Sponsor request (potential unblinding)|0
1361015|NCT01641081|4487899|P3|Period 1|Sponsor request (potential unblinding)|0
1361016|NCT01641081|4487900|P2|Period 1|Sponsor request (potential unblinding)|0
1361017|NCT01641081|4487901|P1|Period 1|Sponsor request (potential unblinding)|0
1361018|NCT01640964|4487970|P3|Overall Study|Protocol Deviation|2
1361019|NCT01640964|4487971|P2|Overall Study|Protocol Deviation|1
1361020|NCT01640964|4487972|P1|Overall Study|Protocol Deviation|1
1361021|NCT01640964|4487970|P3|Overall Study|Lost to Follow-up|1
1361022|NCT01640964|4487971|P2|Overall Study|Lost to Follow-up|0
1361023|NCT01640964|4487972|P1|Overall Study|Lost to Follow-up|0
1361024|NCT01640951|4487995|P8|Overall Study|Death|2
1361025|NCT01640951|4487996|P7|Overall Study|Death|0
1361026|NCT01640951|4487997|P6|Overall Study|Death|0
1361027|NCT01640951|4487998|P5|Overall Study|Death|0
1361028|NCT01640951|4487999|P4|Overall Study|Death|0
1361029|NCT01640951|4488000|P3|Overall Study|Death|1
1361030|NCT01640951|4488001|P2|Overall Study|Death|1
1361031|NCT01640951|4488002|P1|Overall Study|Death|0
1361032|NCT01640951|4487995|P8|Overall Study|Subject/Guardian decision|4
1361033|NCT01640951|4487996|P7|Overall Study|Subject/Guardian decision|5
1361034|NCT01640951|4487997|P6|Overall Study|Subject/Guardian decision|19
1361035|NCT01640951|4487998|P5|Overall Study|Subject/Guardian decision|7
1361036|NCT01640951|4487999|P4|Overall Study|Subject/Guardian decision|15
1361037|NCT01640951|4488000|P3|Overall Study|Subject/Guardian decision|13
1361038|NCT01640951|4488001|P2|Overall Study|Subject/Guardian decision|4
1361039|NCT01640951|4488002|P1|Overall Study|Subject/Guardian decision|12
1361040|NCT01640951|4487995|P8|Overall Study|Protocol Deviation|0
1361041|NCT01640951|4487996|P7|Overall Study|Protocol Deviation|0
1361042|NCT01640951|4487997|P6|Overall Study|Protocol Deviation|1
1361043|NCT01640951|4487998|P5|Overall Study|Protocol Deviation|0
1361044|NCT01640951|4487999|P4|Overall Study|Protocol Deviation|1
1361045|NCT01640951|4488000|P3|Overall Study|Protocol Deviation|2
1361046|NCT01640951|4488001|P2|Overall Study|Protocol Deviation|1
1361047|NCT01640951|4488002|P1|Overall Study|Protocol Deviation|0
1361048|NCT01640951|4487995|P8|Overall Study|Pregnancy|0
1361049|NCT01640951|4487996|P7|Overall Study|Pregnancy|2
1361050|NCT01640951|4487997|P6|Overall Study|Pregnancy|0
1361051|NCT01640951|4487998|P5|Overall Study|Pregnancy|0
1361052|NCT01640951|4487999|P4|Overall Study|Pregnancy|4
1361053|NCT01640951|4488000|P3|Overall Study|Pregnancy|0
1361054|NCT01640951|4488001|P2|Overall Study|Pregnancy|0
1361055|NCT01640951|4488002|P1|Overall Study|Pregnancy|3
1361056|NCT01640951|4487995|P8|Overall Study|Physician Decision|0
1361057|NCT01640951|4487996|P7|Overall Study|Physician Decision|3
1361058|NCT01640951|4487997|P6|Overall Study|Physician Decision|3
1361059|NCT01640951|4487998|P5|Overall Study|Physician Decision|2
1361060|NCT01640951|4487999|P4|Overall Study|Physician Decision|2
1361061|NCT01640951|4488000|P3|Overall Study|Physician Decision|2
1361062|NCT01640951|4488001|P2|Overall Study|Physician Decision|5
1361063|NCT01640951|4488002|P1|Overall Study|Physician Decision|2
1361064|NCT01640951|4487995|P8|Overall Study|Non-compliance with study treatment|0
1361065|NCT01640951|4487996|P7|Overall Study|Non-compliance with study treatment|1
1361066|NCT01640951|4487997|P6|Overall Study|Non-compliance with study treatment|4
1361067|NCT01640951|4487998|P5|Overall Study|Non-compliance with study treatment|1
1361068|NCT01640951|4487999|P4|Overall Study|Non-compliance with study treatment|1
1361069|NCT01640951|4488000|P3|Overall Study|Non-compliance with study treatment|1
1361070|NCT01640951|4488001|P2|Overall Study|Non-compliance with study treatment|0
1361071|NCT01640951|4488002|P1|Overall Study|Non-compliance with study treatment|0
1361072|NCT01640951|4487995|P8|Overall Study|Lost to Follow-up|1
1361073|NCT01640951|4487996|P7|Overall Study|Lost to Follow-up|1
1361074|NCT01640951|4487997|P6|Overall Study|Lost to Follow-up|3
1361075|NCT01640951|4487998|P5|Overall Study|Lost to Follow-up|2
1361076|NCT01640951|4487999|P4|Overall Study|Lost to Follow-up|2
1361077|NCT01640951|4488000|P3|Overall Study|Lost to Follow-up|6
1361078|NCT01640951|4488001|P2|Overall Study|Lost to Follow-up|0
1361079|NCT01640951|4488002|P1|Overall Study|Lost to Follow-up|1
1361080|NCT01640951|4487995|P8|Overall Study|Lack of Efficacy|6
1361081|NCT01640951|4487996|P7|Overall Study|Lack of Efficacy|5
1361082|NCT01640951|4487997|P6|Overall Study|Lack of Efficacy|6
1361083|NCT01640951|4487998|P5|Overall Study|Lack of Efficacy|0
1361084|NCT01640951|4487999|P4|Overall Study|Lack of Efficacy|14
1361085|NCT01640951|4488000|P3|Overall Study|Lack of Efficacy|7
1361086|NCT01640951|4488001|P2|Overall Study|Lack of Efficacy|1
1361087|NCT01640951|4488002|P1|Overall Study|Lack of Efficacy|20
1361088|NCT01640951|4487995|P8|Overall Study|Adverse Event|3
1361089|NCT01640951|4487996|P7|Overall Study|Adverse Event|1
1361090|NCT01640951|4487997|P6|Overall Study|Adverse Event|11
1361091|NCT01640951|4487998|P5|Overall Study|Adverse Event|1
1361092|NCT01640951|4487999|P4|Overall Study|Adverse Event|6
1361093|NCT01640951|4488000|P3|Overall Study|Adverse Event|10
1361094|NCT01640951|4488001|P2|Overall Study|Adverse Event|3
1361095|NCT01640951|4488002|P1|Overall Study|Adverse Event|8
1361096|NCT01640925|4488104|P2|Overall Study|Previously enrolled in this trial|11
1361097|NCT01640925|4488105|P1|Overall Study|Previously enrolled in this trial|13
1361098|NCT01640925|4488104|P2|Overall Study|Withdrawal by Subject|0
1361099|NCT01640925|4488105|P1|Overall Study|Withdrawal by Subject|1
1361100|NCT01640353|4488142|P1|Overall Study|Physician Decision|1
1361101|NCT01640353|4488142|P1|Overall Study|Lost to Follow-up|12
1361102|NCT01640353|4488142|P1|Overall Study|Early site termination|3
1361103|NCT01640353|4488142|P1|Overall Study|Death|2
1361104|NCT01640353|4488142|P1|Overall Study|Withdrawal by Subject|5
1361105|NCT01640353|4488142|P1|Overall Study|Withdrawn from analysis at term site|12
1361106|NCT01640353|4488142|P1|Overall Study|Withdrew prior to treatment|10
1361107|NCT01640314|4488190|P2|Overall Study|Protocol Violation|1
1361108|NCT01640314|4488191|P1|Overall Study|Protocol Violation|0
1361109|NCT01640184|4488229|P3|Overall Study|Protocol Violation|1
1361110|NCT01640184|4488230|P2|Overall Study|Protocol Violation|0
1361111|NCT01640184|4488231|P1|Overall Study|Protocol Violation|0
1361112|NCT01640184|4488229|P3|Overall Study|Withdrawal by Subject|1
1361113|NCT01640184|4488230|P2|Overall Study|Withdrawal by Subject|1
1361114|NCT01640184|4488231|P1|Overall Study|Withdrawal by Subject|0
1361115|NCT01640184|4488229|P3|Overall Study|Physician Decision|0
1361116|NCT01640184|4488230|P2|Overall Study|Physician Decision|0
1361117|NCT01640184|4488231|P1|Overall Study|Physician Decision|3
1361118|NCT01640184|4488229|P3|Overall Study|Lost to Follow-up|0
1361119|NCT01640184|4488230|P2|Overall Study|Lost to Follow-up|1
1361120|NCT01640184|4488231|P1|Overall Study|Lost to Follow-up|4
1361121|NCT01640184|4488229|P3|Overall Study|Death|0
1361122|NCT01640184|4488230|P2|Overall Study|Death|0
1361123|NCT01640184|4488231|P1|Overall Study|Death|1
1361124|NCT01640054|4488260|P1|Overall Study|Adverse Event|2
1361125|NCT01640054|4488260|P1|Overall Study|Lack of Efficacy|3
1361126|NCT01640054|4488260|P1|Overall Study|Study-specific disc criteria|1
1361127|NCT01639833|4488270|P2|Overall Study|Withdrawal by Subject|2
1361128|NCT01639833|4488271|P1|Overall Study|Withdrawal by Subject|2
1361129|NCT01639833|4488270|P2|Overall Study|Death|2
1361130|NCT01639833|4488271|P1|Overall Study|Death|4
1361131|NCT01639755|4488279|P1|Overall Study|Patient had device explantation|4
1361132|NCT01639755|4488279|P1|Overall Study|Study Ongoing|15
1361133|NCT01639742|4488287|P1|Overall Study|Lost to Follow-up|1
1361134|NCT01639742|4488287|P1|Overall Study|Study Ongoing|17
1361135|NCT01639729|4488295|P6|Overall Study|Withdrawal by Subject|0
1361136|NCT01639729|4488296|P5|Overall Study|Withdrawal by Subject|0
1361137|NCT01639729|4488297|P4|Overall Study|Withdrawal by Subject|1
1361138|NCT01639729|4488298|P3|Overall Study|Withdrawal by Subject|1
1361139|NCT01639729|4488299|P2|Overall Study|Withdrawal by Subject|0
1361140|NCT01639729|4488300|P1|Overall Study|Withdrawal by Subject|1
1361141|NCT01639703|4488322|P1|Overall Study|Other reason|7
1361142|NCT01639703|4488322|P1|Overall Study|Withdrawal by Subject|5
1361143|NCT01639560|4488365|P2|Overall Study|Adverse Event|2
1361144|NCT01639560|4488366|P1|Overall Study|Adverse Event|0
1361145|NCT01639560|4488365|P2|Overall Study|Lost to Follow-up|11
1361146|NCT01639560|4488366|P1|Overall Study|Lost to Follow-up|9
1361147|NCT01639560|4488365|P2|Overall Study|Lack of Efficacy|2
1361148|NCT01639560|4488366|P1|Overall Study|Lack of Efficacy|1
1361149|NCT01639560|4488365|P2|Overall Study|Withdrawal by Subject|14
1361150|NCT01639560|4488366|P1|Overall Study|Withdrawal by Subject|9
1361151|NCT01639495|4488378|P1|Overall Study|No radiofrequency energy applied|2
1361152|NCT01639495|4488378|P1|Overall Study|Not meeting inclusion/exclusion criteria|4
1361153|NCT01639495|4488378|P1|Overall Study|Consented but didn’t have study catheter|4
1361154|NCT01639495|4488378|P1|Overall Study|Lost to Follow-up|6
1361155|NCT01639469|4488388|P2|Overall Study|Lost to Follow-up|1
1361156|NCT01639469|4488389|P1|Overall Study|Lost to Follow-up|1
1361157|NCT01639469|4488388|P2|Overall Study|Death|2
1361158|NCT01639469|4488389|P1|Overall Study|Death|4
1361159|NCT01639144|4488494|P2|Overall Study|Met postoperative exclusion criteria|3
1361160|NCT01639144|4488495|P1|Overall Study|Met postoperative exclusion criteria|4
1361161|NCT01639144|4488494|P2|Overall Study|Physician Decision|0
1361162|NCT01639144|4488495|P1|Overall Study|Physician Decision|2
1361163|NCT01639144|4488494|P2|Overall Study|Withdrawal by Subject|2
1361164|NCT01639144|4488495|P1|Overall Study|Withdrawal by Subject|4
1361165|NCT01639040|4488503|P2|Overall Study|Adverse Event|0
1361166|NCT01639040|4488504|P1|Overall Study|Adverse Event|1
1361167|NCT01639001|4488522|P2|Overall Study|Death|35
1361168|NCT01639001|4488523|P1|Overall Study|Death|35
1361169|NCT01639001|4488522|P2|Overall Study|Lost to Follow-up|0
1361170|NCT01639001|4488523|P1|Overall Study|Lost to Follow-up|1
1361171|NCT01639001|4488522|P2|Overall Study|Refused further follow-up|6
1361172|NCT01639001|4488523|P1|Overall Study|Refused further follow-up|3
1361173|NCT01639001|4488522|P2|Overall Study|Ongoing at date of cutoff|60
1361174|NCT01639001|4488523|P1|Overall Study|Ongoing at date of cutoff|65
1361175|NCT01639001|4488522|P2|Overall Study|Randomized but not treated|2
1361176|NCT01639001|4488523|P1|Overall Study|Randomized but not treated|0
1361177|NCT01638819|4488569|P2|Overall Study|Lost to Follow-up|0
1361178|NCT01638819|4488570|P1|Overall Study|Lost to Follow-up|1
1361179|NCT01638546|4488585|P2|Overall Study|Adverse Event|3
1361180|NCT01638546|4488586|P1|Overall Study|Adverse Event|1
1361181|NCT01638000|4488632|P2|Overall Study|Miscellaneous|2
1361182|NCT01638000|4488633|P1|Overall Study|Miscellaneous|2
1361183|NCT01638000|4488632|P2|Overall Study|Withdrawal by Subject|24
1361184|NCT01638000|4488633|P1|Overall Study|Withdrawal by Subject|21
1361185|NCT01638000|4488632|P2|Overall Study|Protocol Violation|13
1361186|NCT01638000|4488633|P1|Overall Study|Protocol Violation|11
1361187|NCT01638000|4488632|P2|Overall Study|Lack of Efficacy|6
1361188|NCT01638000|4488633|P1|Overall Study|Lack of Efficacy|5
1361189|NCT01638000|4488632|P2|Overall Study|Adverse Event|16
1361190|NCT01638000|4488633|P1|Overall Study|Adverse Event|14
1361191|NCT01638000|4488632|P2|Overall Study|Randomized but Never Received Drug|10
1361192|NCT01638000|4488633|P1|Overall Study|Randomized but Never Received Drug|7
1361193|NCT01637961|4488731|P1|Overall Study|Ineligible: inadequate pathology|1
1361194|NCT01637961|4488731|P1|Overall Study|Ineligible: wrong primary|1
1361195|NCT01637922|4488763|P2|Overall Study|Lost to Follow-up|0
1361196|NCT01637922|4488764|P1|Overall Study|Lost to Follow-up|2
1361197|NCT01637922|4488763|P2|Overall Study|Withdrawal by Subject|3
1361198|NCT01637922|4488764|P1|Overall Study|Withdrawal by Subject|0
1361199|NCT01637922|4488763|P2|Overall Study|Protocol Violation|1
1361200|NCT01637922|4488764|P1|Overall Study|Protocol Violation|0
1361201|NCT01637922|4488763|P2|Overall Study|Adverse Event|1
1361202|NCT01637922|4488764|P1|Overall Study|Adverse Event|0
1361203|NCT01637584|4488793|P2|Overall Study|Withdrawal by Subject|3
1361204|NCT01637584|4488794|P1|Overall Study|Withdrawal by Subject|1
1361205|NCT01637272|4488801|P1|Overall Study|Protocol Violation|2
1361206|NCT01637272|4488801|P1|Overall Study|Administrative problems|1
1361207|NCT01637272|4488801|P1|Overall Study|completed core, did not enter ext. phase|4
1361208|NCT01637272|4488801|P1|Overall Study|Lost to Follow-up|2
1361209|NCT01637272|4488801|P1|Overall Study|Withdrawal by Subject|3
1361210|NCT01637272|4488801|P1|Overall Study|Unsatisfactory therapeutic effect|2
1361211|NCT01637272|4488801|P1|Overall Study|Adverse Event|6
1361212|NCT01637077|4488881|P2|Overall Study|No cycle 1 questionnaire data|0
1361213|NCT01637077|4488882|P1|Overall Study|No cycle 1 questionnaire data|2
1361214|NCT01637077|4488881|P2|Overall Study|Withdrawal by Subject|0
1361215|NCT01637077|4488882|P1|Overall Study|Withdrawal by Subject|1
1361216|NCT01637077|4488881|P2|Overall Study|Cancel|1
1361217|NCT01637077|4488882|P1|Overall Study|Cancel|1
1361218|NCT01636986|4488910|P2|Overall Study|Corneal Staining|1
1361219|NCT01636986|4488911|P1|Overall Study|Corneal Staining|0
1361220|NCT01636986|4488910|P2|Overall Study|Withdrawal by Subject|1
1361221|NCT01636986|4488911|P1|Overall Study|Withdrawal by Subject|0
1361222|NCT01636960|4488917|P1|Maintenance Phase|Progressive disease|1
1361223|NCT01636960|4488917|P1|Maintenance Phase|Adverse Event|3
1361224|NCT01636960|4488917|P1|Maintenance Phase|Continued drug after regulatory approval|3
1361225|NCT01636960|4488917|P1|Induction Phase|Adverse Event|2
1361226|NCT01636947|4488925|P2|Overall Study|Did Not Meet Eligibility Criteria|4
1361227|NCT01636947|4488926|P1|Overall Study|Did Not Meet Eligibility Criteria|1
1361228|NCT01636947|4488925|P2|Overall Study|Adverse Event|1
1361229|NCT01636947|4488926|P1|Overall Study|Adverse Event|1
1361230|NCT01636947|4488925|P2|Overall Study|Withdrawal by Subject|3
1361231|NCT01636947|4488926|P1|Overall Study|Withdrawal by Subject|3
1361232|NCT01636947|4488925|P2|Overall Study|Protocol Violation|1
1361233|NCT01636947|4488926|P1|Overall Study|Protocol Violation|1
1361234|NCT01636947|4488925|P2|Overall Study|Lost to Follow-up|0
1361235|NCT01636947|4488926|P1|Overall Study|Lost to Follow-up|4
1361236|NCT01636947|4488925|P2|Overall Study|Not Treated|2
1361237|NCT01636947|4488926|P1|Overall Study|Not Treated|2
1361238|NCT01636778|4488950|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
1361239|NCT01636778|4488951|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
1361240|NCT01636778|4488952|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
1361241|NCT01636778|4488950|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
1361242|NCT01636778|4488951|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
1361243|NCT01636778|4488952|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
1361244|NCT01636778|4488950|P3|Follow-up Period After Part 2|Other|1
1361245|NCT01636778|4488951|P2|Follow-up Period After Part 2|Other|0
1361246|NCT01636778|4488952|P1|Follow-up Period After Part 2|Other|0
1361247|NCT01636778|4488950|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
1361248|NCT01636778|4488951|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
1361249|NCT01636778|4488952|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
1361250|NCT01636778|4488950|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
1361251|NCT01636778|4488951|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
1361252|NCT01636778|4488952|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
1361253|NCT01636778|4488950|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
1361254|NCT01636778|4488951|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
1361255|NCT01636778|4488952|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
1361256|NCT01636778|4488950|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
1361257|NCT01636778|4488951|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
1361258|NCT01636778|4488952|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
1361259|NCT01636778|4488950|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
1361260|NCT01636778|4488951|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
1361261|NCT01636778|4488952|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
1361262|NCT01636713|4489023|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
1361351|NCT01634165|4489472|P4|Period 2|Adverse Event|0
1361263|NCT01636713|4489024|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
1361264|NCT01636713|4489025|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
1361265|NCT01636713|4489023|P3|Overall Study|Withdrawal by Subject|8
1361266|NCT01636713|4489024|P2|Overall Study|Withdrawal by Subject|4
1361267|NCT01636713|4489025|P1|Overall Study|Withdrawal by Subject|5
1361268|NCT01636713|4489023|P3|Overall Study|Lost to Follow-up|1
1361269|NCT01636713|4489024|P2|Overall Study|Lost to Follow-up|0
1361270|NCT01636713|4489025|P1|Overall Study|Lost to Follow-up|0
1361271|NCT01636713|4489023|P3|Overall Study|Protocol Violation|1
1361272|NCT01636713|4489024|P2|Overall Study|Protocol Violation|0
1361273|NCT01636713|4489025|P1|Overall Study|Protocol Violation|3
1361274|NCT01636713|4489023|P3|Overall Study|Lack of Efficacy|2
1361275|NCT01636713|4489024|P2|Overall Study|Lack of Efficacy|6
1361276|NCT01636713|4489025|P1|Overall Study|Lack of Efficacy|6
1361277|NCT01636713|4489023|P3|Overall Study|Adverse Event|7
1361278|NCT01636713|4489024|P2|Overall Study|Adverse Event|16
1361279|NCT01636713|4489025|P1|Overall Study|Adverse Event|16
1361280|NCT01636362|4489093|P1|Overall Study|Withdrawal by Subject|1
1361281|NCT01636362|4489093|P1|Overall Study|Subject healed, not returning|1
1361282|NCT01636362|4489093|P1|Overall Study|Physician Decision|6
1361283|NCT01636258|4489101|P2|Overall Study|Lost to Follow-up|0
1361284|NCT01636258|4489102|P1|Overall Study|Lost to Follow-up|1
1361285|NCT01636076|4489142|P2|Overall Study|Withdrawal by Subject|10
1361286|NCT01636076|4489143|P1|Overall Study|Withdrawal by Subject|7
1361287|NCT01636076|4489142|P2|Overall Study|Adverse Event|11
1361288|NCT01636076|4489143|P1|Overall Study|Adverse Event|6
1361289|NCT01636076|4489142|P2|Overall Study|Non-compliance with study treatment|1
1361290|NCT01636076|4489143|P1|Overall Study|Non-compliance with study treatment|1
1361291|NCT01636076|4489142|P2|Overall Study|Physician Decision|1
1361292|NCT01636076|4489143|P1|Overall Study|Physician Decision|1
1361293|NCT01636076|4489142|P2|Overall Study|Lost to Follow-up|0
1361294|NCT01636076|4489143|P1|Overall Study|Lost to Follow-up|1
1361295|NCT01636076|4489142|P2|Overall Study|Lack of Efficacy|1
1361296|NCT01636076|4489143|P1|Overall Study|Lack of Efficacy|0
1361297|NCT01636076|4489142|P2|Overall Study|Terminated by sponsor|1
1361298|NCT01636076|4489143|P1|Overall Study|Terminated by sponsor|1
1361299|NCT01635933|4489214|P2|Overall Study|No longer had transportation|1
1361300|NCT01635933|4489215|P1|Overall Study|No longer had transportation|0
1361301|NCT01635933|4489214|P2|Overall Study|Noncompliance|1
1361302|NCT01635933|4489215|P1|Overall Study|Noncompliance|0
1361303|NCT01635933|4489214|P2|Overall Study|Subject decision|1
1361304|NCT01635933|4489215|P1|Overall Study|Subject decision|1
1361305|NCT01635933|4489214|P2|Overall Study|Lost to Follow-up|5
1361306|NCT01635933|4489215|P1|Overall Study|Lost to Follow-up|0
1361307|NCT01635933|4489214|P2|Overall Study|Adverse Event|0
1361308|NCT01635933|4489215|P1|Overall Study|Adverse Event|1
1361309|NCT01635920|4489227|P2|Overall Study|Subject decision|0
1361310|NCT01635920|4489228|P1|Overall Study|Subject decision|2
1361311|NCT01635920|4489227|P2|Overall Study|Lost to Follow-up|1
1361312|NCT01635920|4489228|P1|Overall Study|Lost to Follow-up|0
1361313|NCT01635920|4489227|P2|Overall Study|Adverse Event|0
1361314|NCT01635920|4489228|P1|Overall Study|Adverse Event|1
1361315|NCT01635855|4489241|P1|Overall Study|Withdrawal by Subject|4
1361316|NCT01635764|4489250|P1|Overall Study|Not Specified|28
1361317|NCT01635764|4489250|P1|Overall Study|Lost to Follow-up|53
1361318|NCT01635764|4489250|P1|Overall Study|Withdrew Consent|67
1361319|NCT01635764|4489250|P1|Overall Study|Protocol Deviation|1
1361320|NCT01635764|4489250|P1|Overall Study|Exceed Protocol-specified Interventions|2
1361321|NCT01635764|4489250|P1|Overall Study|Lack of Efficacy|76
1361322|NCT01635764|4489250|P1|Overall Study|Adverse Event|46
1361323|NCT01635218|4489316|P3|Overall Study|Lost to Follow-up|6
1361324|NCT01635218|4489317|P2|Overall Study|Lost to Follow-up|7
1361325|NCT01635218|4489318|P1|Overall Study|Lost to Follow-up|3
1361326|NCT01634854|4489353|P2|Overall Study|Cesarean delivery|7
1361327|NCT01634854|4489354|P1|Overall Study|Cesarean delivery|2
1361328|NCT01634659|4489374|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
1361329|NCT01634659|4489375|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
1361330|NCT01634659|4489374|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
1361331|NCT01634659|4489375|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
1361332|NCT01634555|4489405|P1|Overall Study|Ongoing receiving treatment|13
1361333|NCT01634555|4489405|P1|Overall Study|Physician Decision|1
1361334|NCT01634555|4489405|P1|Overall Study|Adverse Event|3
1361335|NCT01634360|4489415|P2|Overall Study|Study termination by sponsor|44
1361336|NCT01634360|4489416|P1|Overall Study|Study termination by sponsor|18
1361337|NCT01634360|4489415|P2|Overall Study|Not specified|20
1361338|NCT01634360|4489416|P1|Overall Study|Not specified|3
1361339|NCT01634360|4489415|P2|Overall Study|Lack of Efficacy|14
1361340|NCT01634360|4489416|P1|Overall Study|Lack of Efficacy|4
1361341|NCT01634360|4489415|P2|Overall Study|Protocol Violation|1
1361342|NCT01634360|4489416|P1|Overall Study|Protocol Violation|1
1361343|NCT01634360|4489415|P2|Overall Study|subject withdrew consent|23
1361344|NCT01634360|4489416|P1|Overall Study|subject withdrew consent|13
1361345|NCT01634360|4489415|P2|Overall Study|Adverse Event|34
1361346|NCT01634360|4489416|P1|Overall Study|Adverse Event|10
1361347|NCT01634243|4489445|P2|Overall Study|Lack of Efficacy|0
1361348|NCT01634243|4489446|P1|Overall Study|Lack of Efficacy|1
1361349|NCT01634243|4489445|P2|Overall Study|Adverse Event|5
1361350|NCT01634243|4489446|P1|Overall Study|Adverse Event|5
1361352|NCT01634165|4489473|P3|Period 2|Adverse Event|0
1361353|NCT01634165|4489474|P2|Period 2|Adverse Event|1
1361354|NCT01634165|4489475|P1|Period 2|Adverse Event|0
1361355|NCT01634152|4489508|P3|Overall Study|Other reason not defined above|1
1361356|NCT01634152|4489509|P2|Overall Study|Other reason not defined above|0
1361357|NCT01634152|4489510|P1|Overall Study|Other reason not defined above|1
1361358|NCT01634152|4489508|P3|Overall Study|Not treated|0
1361359|NCT01634152|4489509|P2|Overall Study|Not treated|1
1361360|NCT01634152|4489510|P1|Overall Study|Not treated|0
1361361|NCT01634152|4489508|P3|Overall Study|Consent withdrawn not due to AE|1
1361362|NCT01634152|4489509|P2|Overall Study|Consent withdrawn not due to AE|0
1361363|NCT01634152|4489510|P1|Overall Study|Consent withdrawn not due to AE|1
1361364|NCT01634152|4489508|P3|Overall Study|Adverse Event|2
1361365|NCT01634152|4489509|P2|Overall Study|Adverse Event|0
1361366|NCT01634152|4489510|P1|Overall Study|Adverse Event|2
1361367|NCT01634139|4489593|P3|Overall Study|Not treated|0
1361368|NCT01634139|4489594|P2|Overall Study|Not treated|1
1361369|NCT01634139|4489595|P1|Overall Study|Not treated|1
1361370|NCT01634139|4489593|P3|Overall Study|Lost to Follow-up|0
1361371|NCT01634139|4489594|P2|Overall Study|Lost to Follow-up|2
1361372|NCT01634139|4489595|P1|Overall Study|Lost to Follow-up|0
1361373|NCT01634139|4489593|P3|Overall Study|Other|3
1361374|NCT01634139|4489594|P2|Overall Study|Other|0
1361375|NCT01634139|4489595|P1|Overall Study|Other|4
1361376|NCT01634139|4489593|P3|Overall Study|Consent withdrawn not due to AE|2
1361377|NCT01634139|4489594|P2|Overall Study|Consent withdrawn not due to AE|3
1361378|NCT01634139|4489595|P1|Overall Study|Consent withdrawn not due to AE|4
1361379|NCT01634139|4489593|P3|Overall Study|Non compliant with protocol|0
1361380|NCT01634139|4489594|P2|Overall Study|Non compliant with protocol|0
1361381|NCT01634139|4489595|P1|Overall Study|Non compliant with protocol|1
1361382|NCT01634113|4489696|P3|Overall Study|Not treated|1
1361383|NCT01634113|4489697|P2|Overall Study|Not treated|0
1361384|NCT01634113|4489698|P1|Overall Study|Not treated|0
1361385|NCT01634100|4489742|P6|Overall Study|Withdrawal by Subject|0
1361386|NCT01634100|4489743|P5|Overall Study|Withdrawal by Subject|0
1361387|NCT01634100|4489744|P4|Overall Study|Withdrawal by Subject|0
1361388|NCT01634100|4489745|P3|Overall Study|Withdrawal by Subject|1
1361389|NCT01634100|4489746|P2|Overall Study|Withdrawal by Subject|0
1361390|NCT01634100|4489747|P1|Overall Study|Withdrawal by Subject|1
1361391|NCT01633944|4489763|P3|Double-blind Treatment Phase|Not specified|0
1361392|NCT01633944|4489764|P2|Double-blind Treatment Phase|Not specified|7
1361393|NCT01633944|4489765|P1|Double-blind Treatment Phase|Not specified|0
1361394|NCT01633944|4489763|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
1361395|NCT01633944|4489764|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
1361396|NCT01633944|4489765|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
1361397|NCT01633944|4489763|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
1361398|NCT01633944|4489764|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
1361399|NCT01633944|4489765|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
1361400|NCT01633944|4489763|P3|Double-blind Treatment Phase|Lost to Follow-up|9
1361401|NCT01633944|4489764|P2|Double-blind Treatment Phase|Lost to Follow-up|4
1361402|NCT01633944|4489765|P1|Double-blind Treatment Phase|Lost to Follow-up|0
1361403|NCT01633944|4489763|P3|Double-blind Treatment Phase|Protocol Violation|10
1361404|NCT01633944|4489764|P2|Double-blind Treatment Phase|Protocol Violation|7
1361405|NCT01633944|4489765|P1|Double-blind Treatment Phase|Protocol Violation|0
1361406|NCT01633944|4489763|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
1361407|NCT01633944|4489764|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
1361408|NCT01633944|4489765|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
1361409|NCT01633944|4489763|P3|Double-blind Treatment Phase|Lack of Efficacy|23
1361410|NCT01633944|4489764|P2|Double-blind Treatment Phase|Lack of Efficacy|8
1361411|NCT01633944|4489765|P1|Double-blind Treatment Phase|Lack of Efficacy|0
1361412|NCT01633944|4489763|P3|Double-blind Treatment Phase|Adverse Event|7
1361413|NCT01633944|4489764|P2|Double-blind Treatment Phase|Adverse Event|13
1361414|NCT01633944|4489765|P1|Double-blind Treatment Phase|Adverse Event|0
1361415|NCT01633944|4489763|P3|Open-label Titration Phase|Not specified|0
1361416|NCT01633944|4489764|P2|Open-label Titration Phase|Not specified|0
1361417|NCT01633944|4489765|P1|Open-label Titration Phase|Not specified|68
1361418|NCT01633944|4489763|P3|Open-label Titration Phase|Lost to Follow-up|0
1361419|NCT01633944|4489764|P2|Open-label Titration Phase|Lost to Follow-up|0
1361420|NCT01633944|4489765|P1|Open-label Titration Phase|Lost to Follow-up|22
1361421|NCT01633944|4489763|P3|Open-label Titration Phase|Protocol Violation|0
1361422|NCT01633944|4489764|P2|Open-label Titration Phase|Protocol Violation|0
1361423|NCT01633944|4489765|P1|Open-label Titration Phase|Protocol Violation|24
1361424|NCT01633944|4489763|P3|Open-label Titration Phase|Withdrawal by Subject|0
1361425|NCT01633944|4489764|P2|Open-label Titration Phase|Withdrawal by Subject|0
1361426|NCT01633944|4489765|P1|Open-label Titration Phase|Withdrawal by Subject|34
1361427|NCT01633944|4489763|P3|Open-label Titration Phase|Lack of Efficacy|0
1361428|NCT01633944|4489764|P2|Open-label Titration Phase|Lack of Efficacy|0
1361429|NCT01633944|4489765|P1|Open-label Titration Phase|Lack of Efficacy|33
1361430|NCT01633944|4489763|P3|Open-label Titration Phase|Adverse Event|0
1361431|NCT01633944|4489764|P2|Open-label Titration Phase|Adverse Event|0
1361432|NCT01633944|4489765|P1|Open-label Titration Phase|Adverse Event|109
1361433|NCT01633788|4489833|P4|Overall Study|Other Reasons|7
1361434|NCT01633788|4489834|P3|Overall Study|Other Reasons|3
1361435|NCT01633788|4489835|P2|Overall Study|Other Reasons|2
1361436|NCT01633788|4489836|P1|Overall Study|Other Reasons|0
1361437|NCT01633788|4489833|P4|Overall Study|Protocol Violation|0
1361438|NCT01633788|4489834|P3|Overall Study|Protocol Violation|1
1361439|NCT01633788|4489835|P2|Overall Study|Protocol Violation|0
1361440|NCT01633788|4489836|P1|Overall Study|Protocol Violation|1
1361441|NCT01633788|4489833|P4|Overall Study|Personal Reasons|3
1361442|NCT01633788|4489834|P3|Overall Study|Personal Reasons|1
1361443|NCT01633788|4489835|P2|Overall Study|Personal Reasons|1
1361444|NCT01633788|4489836|P1|Overall Study|Personal Reasons|3
1361445|NCT01633788|4489833|P4|Overall Study|Lost to Follow-up|0
1361446|NCT01633788|4489834|P3|Overall Study|Lost to Follow-up|2
1361447|NCT01633788|4489835|P2|Overall Study|Lost to Follow-up|2
1361448|NCT01633788|4489836|P1|Overall Study|Lost to Follow-up|2
1361449|NCT01633788|4489833|P4|Overall Study|Adverse Event|3
1361450|NCT01633788|4489834|P3|Overall Study|Adverse Event|3
1361451|NCT01633788|4489835|P2|Overall Study|Adverse Event|3
1361452|NCT01633788|4489836|P1|Overall Study|Adverse Event|1
1361453|NCT01632904|4489880|P2|Overall Study|Reason for discontinuation not available|1
1361454|NCT01632904|4489881|P1|Overall Study|Reason for discontinuation not available|0
1361455|NCT01632904|4489880|P2|Overall Study|Disease Progression|1
1361456|NCT01632904|4489881|P1|Overall Study|Disease Progression|0
1361457|NCT01632904|4489880|P2|Overall Study|Subject decision|2
1361458|NCT01632904|4489881|P1|Overall Study|Subject decision|3
1361459|NCT01632904|4489880|P2|Overall Study|Physician Decision|1
1361460|NCT01632904|4489881|P1|Overall Study|Physician Decision|0
1361461|NCT01632904|4489880|P2|Overall Study|Adverse Event|1
1361462|NCT01632904|4489881|P1|Overall Study|Adverse Event|4
1361463|NCT01632878|4489892|P1|Treatment|no information on study completion|43
1361464|NCT01632878|4489892|P1|Treatment|missing information|4
1361465|NCT01632878|4489892|P1|Treatment|Physician Decision|34
1361466|NCT01632878|4489892|P1|Treatment|Withdrawal by Subject|36
1361467|NCT01632878|4489892|P1|Treatment|Lost to Follow-up|41
1361468|NCT01632878|4489892|P1|Screening|Physician Decision|268
1361469|NCT01632800|4489896|P1|Overall Study|Subject did not fit in apparatus|1
1361470|NCT01632579|4489963|P9|Period 2 (Second Intervention)|Adverse Event|0
1361471|NCT01632579|4489964|P8|Period 2 (Second Intervention)|Adverse Event|0
1361472|NCT01632579|4489965|P7|Period 2 (Second Intervention)|Adverse Event|0
1361473|NCT01632579|4489966|P6|Period 2 (Second Intervention)|Adverse Event|0
1361474|NCT01632579|4489967|P5|Period 2 (Second Intervention)|Adverse Event|0
1361475|NCT01632579|4489968|P4|Period 2 (Second Intervention)|Adverse Event|0
1361476|NCT01632579|4489969|P3|Period 2 (Second Intervention)|Adverse Event|0
1361477|NCT01632579|4489970|P2|Period 2 (Second Intervention)|Adverse Event|0
1361478|NCT01632579|4489971|P1|Period 2 (Second Intervention)|Adverse Event|1
1361479|NCT01632579|4489963|P9|Washout Period|Adverse Event|0
1361480|NCT01632579|4489964|P8|Washout Period|Adverse Event|0
1361481|NCT01632579|4489965|P7|Washout Period|Adverse Event|0
1361482|NCT01632579|4489966|P6|Washout Period|Adverse Event|0
1361483|NCT01632579|4489967|P5|Washout Period|Adverse Event|0
1361484|NCT01632579|4489968|P4|Washout Period|Adverse Event|0
1361485|NCT01632579|4489969|P3|Washout Period|Adverse Event|0
1361486|NCT01632579|4489970|P2|Washout Period|Adverse Event|0
1361487|NCT01632579|4489971|P1|Washout Period|Adverse Event|1
1361488|NCT01632345|4490046|P7|Treatment: Part II|Withdrawal by Subject|2
1361489|NCT01632345|4490047|P6|Treatment: Part II|Withdrawal by Subject|2
1361490|NCT01632345|4490048|P5|Treatment: Part II|Withdrawal by Subject|0
1361491|NCT01632345|4490049|P4|Treatment: Part II|Withdrawal by Subject|0
1361492|NCT01632345|4490050|P3|Treatment: Part II|Withdrawal by Subject|0
1361493|NCT01632345|4490051|P2|Treatment: Part II|Withdrawal by Subject|0
1361494|NCT01632345|4490052|P1|Treatment: Part II|Withdrawal by Subject|0
1361495|NCT01632345|4490046|P7|Treatment: Part II|Non-Compliance with Study Drug|0
1361496|NCT01632345|4490047|P6|Treatment: Part II|Non-Compliance with Study Drug|3
1361497|NCT01632345|4490048|P5|Treatment: Part II|Non-Compliance with Study Drug|0
1361498|NCT01632345|4490049|P4|Treatment: Part II|Non-Compliance with Study Drug|0
1361499|NCT01632345|4490050|P3|Treatment: Part II|Non-Compliance with Study Drug|0
1361500|NCT01632345|4490051|P2|Treatment: Part II|Non-Compliance with Study Drug|0
1361501|NCT01632345|4490052|P1|Treatment: Part II|Non-Compliance with Study Drug|0
1361502|NCT01632345|4490046|P7|Treatment: Part II|Lost to Follow-up|1
1361503|NCT01632345|4490047|P6|Treatment: Part II|Lost to Follow-up|3
1361504|NCT01632345|4490048|P5|Treatment: Part II|Lost to Follow-up|0
1361505|NCT01632345|4490049|P4|Treatment: Part II|Lost to Follow-up|0
1361506|NCT01632345|4490050|P3|Treatment: Part II|Lost to Follow-up|0
1361507|NCT01632345|4490051|P2|Treatment: Part II|Lost to Follow-up|0
1361508|NCT01632345|4490052|P1|Treatment: Part II|Lost to Follow-up|0
1361509|NCT01632345|4490046|P7|Treatment: Part II|Adverse Event|8
1361510|NCT01632345|4490047|P6|Treatment: Part II|Adverse Event|3
1361511|NCT01632345|4490048|P5|Treatment: Part II|Adverse Event|0
1361512|NCT01632345|4490049|P4|Treatment: Part II|Adverse Event|0
1361513|NCT01632345|4490050|P3|Treatment: Part II|Adverse Event|0
1361514|NCT01632345|4490051|P2|Treatment: Part II|Adverse Event|0
1361515|NCT01632345|4490052|P1|Treatment: Part II|Adverse Event|0
1361516|NCT01632345|4490046|P7|Treatment: Part I|Withdrawal by Subject|0
1361517|NCT01632345|4490047|P6|Treatment: Part I|Withdrawal by Subject|0
1361518|NCT01632345|4490048|P5|Treatment: Part I|Withdrawal by Subject|4
1361519|NCT01632345|4490049|P4|Treatment: Part I|Withdrawal by Subject|1
1361520|NCT01632345|4490050|P3|Treatment: Part I|Withdrawal by Subject|4
1361521|NCT01632345|4490051|P2|Treatment: Part I|Withdrawal by Subject|4
1361522|NCT01632345|4490052|P1|Treatment: Part I|Withdrawal by Subject|3
1361523|NCT01632345|4490046|P7|Treatment: Part I|Protocol Deviation|0
1361524|NCT01632345|4490047|P6|Treatment: Part I|Protocol Deviation|0
1361525|NCT01632345|4490048|P5|Treatment: Part I|Protocol Deviation|0
1361526|NCT01632345|4490049|P4|Treatment: Part I|Protocol Deviation|1
1361527|NCT01632345|4490050|P3|Treatment: Part I|Protocol Deviation|1
1361528|NCT01632345|4490051|P2|Treatment: Part I|Protocol Deviation|0
1361529|NCT01632345|4490052|P1|Treatment: Part I|Protocol Deviation|0
1361530|NCT01632345|4490046|P7|Treatment: Part I|Pregnancy|0
1361531|NCT01632345|4490047|P6|Treatment: Part I|Pregnancy|0
1361532|NCT01632345|4490048|P5|Treatment: Part I|Pregnancy|0
1361533|NCT01632345|4490049|P4|Treatment: Part I|Pregnancy|0
1361534|NCT01632345|4490050|P3|Treatment: Part I|Pregnancy|0
1361535|NCT01632345|4490051|P2|Treatment: Part I|Pregnancy|1
1361536|NCT01632345|4490052|P1|Treatment: Part I|Pregnancy|0
1361537|NCT01632345|4490046|P7|Treatment: Part I|Physician Decision|0
1361538|NCT01632345|4490047|P6|Treatment: Part I|Physician Decision|0
1361539|NCT01632345|4490048|P5|Treatment: Part I|Physician Decision|1
1361540|NCT01632345|4490049|P4|Treatment: Part I|Physician Decision|0
1361541|NCT01632345|4490050|P3|Treatment: Part I|Physician Decision|0
1361542|NCT01632345|4490051|P2|Treatment: Part I|Physician Decision|1
1361543|NCT01632345|4490052|P1|Treatment: Part I|Physician Decision|2
1361544|NCT01632345|4490046|P7|Treatment: Part I|Non-Compliance with Study Drug|0
1361545|NCT01632345|4490047|P6|Treatment: Part I|Non-Compliance with Study Drug|0
1361546|NCT01632345|4490048|P5|Treatment: Part I|Non-Compliance with Study Drug|0
1361547|NCT01632345|4490049|P4|Treatment: Part I|Non-Compliance with Study Drug|1
1361548|NCT01632345|4490050|P3|Treatment: Part I|Non-Compliance with Study Drug|2
1361549|NCT01632345|4490051|P2|Treatment: Part I|Non-Compliance with Study Drug|2
1361550|NCT01632345|4490052|P1|Treatment: Part I|Non-Compliance with Study Drug|3
1361551|NCT01632345|4490046|P7|Treatment: Part I|Lost to Follow-up|0
1361552|NCT01632345|4490047|P6|Treatment: Part I|Lost to Follow-up|0
1361553|NCT01632345|4490048|P5|Treatment: Part I|Lost to Follow-up|4
1361554|NCT01632345|4490049|P4|Treatment: Part I|Lost to Follow-up|3
1361555|NCT01632345|4490050|P3|Treatment: Part I|Lost to Follow-up|1
1361556|NCT01632345|4490051|P2|Treatment: Part I|Lost to Follow-up|2
1361557|NCT01632345|4490052|P1|Treatment: Part I|Lost to Follow-up|3
1361558|NCT01632345|4490046|P7|Treatment: Part I|Lack of Efficacy|0
1361559|NCT01632345|4490047|P6|Treatment: Part I|Lack of Efficacy|0
1361560|NCT01632345|4490048|P5|Treatment: Part I|Lack of Efficacy|1
1361561|NCT01632345|4490049|P4|Treatment: Part I|Lack of Efficacy|1
1361562|NCT01632345|4490050|P3|Treatment: Part I|Lack of Efficacy|0
1361563|NCT01632345|4490051|P2|Treatment: Part I|Lack of Efficacy|1
1361564|NCT01632345|4490052|P1|Treatment: Part I|Lack of Efficacy|0
1361565|NCT01632345|4490046|P7|Treatment: Part I|Adverse Event|0
1361566|NCT01632345|4490047|P6|Treatment: Part I|Adverse Event|0
1361567|NCT01632345|4490048|P5|Treatment: Part I|Adverse Event|3
1361568|NCT01632345|4490049|P4|Treatment: Part I|Adverse Event|1
1361569|NCT01632345|4490050|P3|Treatment: Part I|Adverse Event|2
1361570|NCT01632345|4490051|P2|Treatment: Part I|Adverse Event|4
1361571|NCT01632345|4490052|P1|Treatment: Part I|Adverse Event|1
1361572|NCT01632280|4490114|P2|Overall Study|Withdrawal by Subject|0
1361573|NCT01632280|4490115|P1|Overall Study|Withdrawal by Subject|1
1361574|NCT01632150|4490138|P1|Overall Study|Moved to compassionate program|2
1361575|NCT01632150|4490138|P1|Overall Study|Patient underwent autologous transplant|1
1361576|NCT01632150|4490138|P1|Overall Study|Withdrawal by Subject|2
1361577|NCT01632150|4490138|P1|Overall Study|Unrelated adverse event|7
1361578|NCT01632150|4490138|P1|Overall Study|Study drug toxicity|1
1361579|NCT01632150|4490138|P1|Overall Study|Disease progression|27
1361580|NCT01632020|4490147|P2|Overall Study|Adverse Event|0
1361581|NCT01632020|4490148|P1|Overall Study|Adverse Event|1
1361582|NCT01632020|4490147|P2|Overall Study|Withdrawal by Subject|0
1361583|NCT01632020|4490148|P1|Overall Study|Withdrawal by Subject|1
1361584|NCT01631864|4490167|P2|Overall Study|Adverse Event|3
1361585|NCT01631864|4490168|P1|Overall Study|Adverse Event|2
1361586|NCT01631864|4490167|P2|Overall Study|Withdrawal by Subject|1
1361587|NCT01631864|4490168|P1|Overall Study|Withdrawal by Subject|0
1361588|NCT01631825|4490180|P1|Overall Study|Physician Decision|2
1361589|NCT01631825|4490180|P1|Overall Study|Discontinuation criteria|1
1361590|NCT01631825|4490180|P1|Overall Study|Protocol Violation|4
1361591|NCT01631825|4490180|P1|Overall Study|Withdrawal by Subject|9
1361592|NCT01631825|4490180|P1|Overall Study|Lack of Efficacy|7
1361593|NCT01631825|4490180|P1|Overall Study|Adverse Event|42
1361594|NCT01631812|4490200|P1|Overall Study|Physician Decision|3
1361595|NCT01631812|4490200|P1|Overall Study|Withdrawal by Subject|4
1361596|NCT01631812|4490200|P1|Overall Study|Lack of Efficacy|5
1361597|NCT01631812|4490200|P1|Overall Study|Adverse Event|25
1361598|NCT01631435|4490347|P1|Overall Study|incomplete study procedure|5
1361599|NCT01631435|4490347|P1|Overall Study|Withdrawal by Subject|2
1361600|NCT01631435|4490347|P1|Overall Study|Adverse Event|2
1361601|NCT01631227|4490361|P2|Overall Study|administrative|1
1361602|NCT01631227|4490362|P1|Overall Study|administrative|2
1361603|NCT01631227|4490361|P2|Overall Study|Adverse Event|0
1361604|NCT01631227|4490362|P1|Overall Study|Adverse Event|1
1361605|NCT01631227|4490361|P2|Overall Study|withdrawn consent|21
1361606|NCT01631227|4490362|P1|Overall Study|withdrawn consent|27
1361607|NCT01630811|4490415|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
1361608|NCT01630811|4490416|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
1361609|NCT01630616|4490443|P6|Overall Study|Withdrawal by Subject|0
1361610|NCT01630616|4490444|P5|Overall Study|Withdrawal by Subject|0
1361611|NCT01630616|4490445|P4|Overall Study|Withdrawal by Subject|2
1361612|NCT01630616|4490446|P3|Overall Study|Withdrawal by Subject|0
1361613|NCT01630616|4490447|P2|Overall Study|Withdrawal by Subject|0
1361614|NCT01630616|4490448|P1|Overall Study|Withdrawal by Subject|0
1361615|NCT01630616|4490443|P6|Overall Study|Adverse Event|0
1361616|NCT01630616|4490444|P5|Overall Study|Adverse Event|0
1361617|NCT01630616|4490445|P4|Overall Study|Adverse Event|1
1361618|NCT01630616|4490446|P3|Overall Study|Adverse Event|0
1361619|NCT01630616|4490447|P2|Overall Study|Adverse Event|0
1361620|NCT01630616|4490448|P1|Overall Study|Adverse Event|0
1361621|NCT01630135|4490523|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
1361622|NCT01630135|4490524|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
1361623|NCT01629953|4490587|P2|Overall Study|Lost to Follow-up|14
1361624|NCT01629953|4490588|P1|Overall Study|Lost to Follow-up|10
1361625|NCT01629953|4490587|P2|Overall Study|Death|1
1361626|NCT01629953|4490588|P1|Overall Study|Death|3
1361627|NCT01629823|4490608|P3|Washout Period|Protocol Violation|0
1361628|NCT01629823|4490609|P2|Washout Period|Protocol Violation|1
1361629|NCT01629823|4490610|P1|Washout Period|Protocol Violation|0
1361630|NCT01629823|4490608|P3|Washout Period|Pregnancy|0
1361631|NCT01629823|4490609|P2|Washout Period|Pregnancy|0
1361632|NCT01629823|4490610|P1|Washout Period|Pregnancy|1
1361633|NCT01629823|4490608|P3|Washout Period|Safety|0
1361634|NCT01629823|4490609|P2|Washout Period|Safety|5
1361635|NCT01629823|4490610|P1|Washout Period|Safety|2
1361636|NCT01629823|4490608|P3|Trial Period|Failed to hold medication|1
1361637|NCT01629823|4490609|P2|Trial Period|Failed to hold medication|0
1361638|NCT01629823|4490610|P1|Trial Period|Failed to hold medication|0
1361639|NCT01629823|4490608|P3|Trial Period|Out-of-window visit|0
1361640|NCT01629823|4490609|P2|Trial Period|Out-of-window visit|2
1361641|NCT01629823|4490610|P1|Trial Period|Out-of-window visit|0
1361642|NCT01629823|4490608|P3|Trial Period|Adverse Event|0
1361643|NCT01629823|4490609|P2|Trial Period|Adverse Event|1
1361644|NCT01629823|4490610|P1|Trial Period|Adverse Event|0
1361645|NCT01629823|4490608|P3|Trial Period|Pregnancy|0
1361646|NCT01629823|4490609|P2|Trial Period|Pregnancy|0
1361647|NCT01629823|4490610|P1|Trial Period|Pregnancy|1
1361648|NCT01629823|4490608|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
1361649|NCT01629823|4490609|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
1361650|NCT01629823|4490610|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
1361651|NCT01629823|4490608|P3|Trial Period|Missed visit|8
1361652|NCT01629823|4490609|P2|Trial Period|Missed visit|9
1361653|NCT01629823|4490610|P1|Trial Period|Missed visit|11
1361654|NCT01629706|4490645|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
1361655|NCT01629706|4490645|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
1361656|NCT01629706|4490645|P1|Phase 2 Habitual|Relocation prior to Dispense|1
1361657|NCT01629706|4490645|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
1361658|NCT01629706|4490645|P1|Phase 2 Habitual|Screen Failure|6
1361659|NCT01629706|4490645|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
1361660|NCT01629706|4490645|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
1361661|NCT01629706|4490645|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
1361662|NCT01629706|4490645|P1|Phase 1 PureVision|Screen Failure|4
1361663|NCT01629693|4490673|P2|Overall Study|Subject decision unrelated to AE|1
1361664|NCT01629693|4490674|P1|Overall Study|Subject decision unrelated to AE|0
1361665|NCT01629693|4490673|P2|Overall Study|Poor comfort of study lenses|2
1361666|NCT01629693|4490674|P1|Overall Study|Poor comfort of study lenses|0
1361667|NCT01629693|4490673|P2|Overall Study|Investigator decision|1
1361668|NCT01629693|4490674|P1|Overall Study|Investigator decision|0
1361669|NCT01629693|4490673|P2|Overall Study|Adverse Event|0
1361670|NCT01629693|4490674|P1|Overall Study|Adverse Event|1
1361671|NCT01629693|4490673|P2|Overall Study|Withdrawal by Subject|2
1361672|NCT01629693|4490674|P1|Overall Study|Withdrawal by Subject|2
1361673|NCT01629693|4490673|P2|Overall Study|Lost to Follow-up|4
1361674|NCT01629693|4490674|P1|Overall Study|Lost to Follow-up|2
1361675|NCT01629667|4490683|P3|Overall Study|Code break|0
1361676|NCT01629667|4490684|P2|Overall Study|Code break|0
1361677|NCT01629667|4490685|P1|Overall Study|Code break|1
1361678|NCT01629667|4490683|P3|Overall Study|Enrolled in another clinical study|0
1361679|NCT01629667|4490684|P2|Overall Study|Enrolled in another clinical study|1
1361680|NCT01629667|4490685|P1|Overall Study|Enrolled in another clinical study|0
1361681|NCT01629667|4490683|P3|Overall Study|Site error in safety follow-up|1
1361682|NCT01629667|4490684|P2|Overall Study|Site error in safety follow-up|0
1361683|NCT01629667|4490685|P1|Overall Study|Site error in safety follow-up|0
1361684|NCT01629667|4490683|P3|Overall Study|Started other medicine|1
1361685|NCT01629667|4490684|P2|Overall Study|Started other medicine|0
1361686|NCT01629667|4490685|P1|Overall Study|Started other medicine|1
1361687|NCT01629667|4490683|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
1361688|NCT01629667|4490684|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
1361689|NCT01629667|4490685|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
1361690|NCT01629667|4490683|P3|Overall Study|Requiring lung transplant|3
1361691|NCT01629667|4490684|P2|Overall Study|Requiring lung transplant|1
1361692|NCT01629667|4490685|P1|Overall Study|Requiring lung transplant|2
1361693|NCT01629667|4490683|P3|Overall Study|Ongoing AE worsening right heart failure|0
1361694|NCT01629667|4490684|P2|Overall Study|Ongoing AE worsening right heart failure|1
1361695|NCT01629667|4490685|P1|Overall Study|Ongoing AE worsening right heart failure|0
1361696|NCT01629667|4490683|P3|Overall Study|Randomized, not treated|0
1361697|NCT01629667|4490684|P2|Overall Study|Randomized, not treated|1
1361698|NCT01629667|4490685|P1|Overall Study|Randomized, not treated|2
1361699|NCT01629667|4490683|P3|Overall Study|Death|3
1361700|NCT01629667|4490684|P2|Overall Study|Death|5
1361701|NCT01629667|4490685|P1|Overall Study|Death|1
1361702|NCT01629667|4490683|P3|Overall Study|Withdrawal by Subject|28
1361703|NCT01629667|4490684|P2|Overall Study|Withdrawal by Subject|20
1361704|NCT01629667|4490685|P1|Overall Study|Withdrawal by Subject|31
1361705|NCT01629667|4490683|P3|Overall Study|Lost to Follow-up|1
1361706|NCT01629667|4490684|P2|Overall Study|Lost to Follow-up|1
1361707|NCT01629667|4490685|P1|Overall Study|Lost to Follow-up|0
1361708|NCT01629589|4490769|P2|Overall Study|Did not receive study vaccine|1
1361709|NCT01629589|4490770|P1|Overall Study|Did not receive study vaccine|0
1361710|NCT01629589|4490769|P2|Overall Study|Withdrawal by Subject|3
1361711|NCT01629589|4490770|P1|Overall Study|Withdrawal by Subject|2
1361712|NCT01629589|4490769|P2|Overall Study|Lost to Follow-up|1
1361713|NCT01629589|4490770|P1|Overall Study|Lost to Follow-up|2
1361714|NCT01629589|4490769|P2|Overall Study|Protocol Violation|2
1361715|NCT01629589|4490770|P1|Overall Study|Protocol Violation|4
1361716|NCT01628965|4490809|P1|Overall Study|Discontinuation criteria|8
1361717|NCT01628965|4490809|P1|Overall Study|Lost to Follow-up|1
1361718|NCT01628965|4490809|P1|Overall Study|Withdrawal by Subject|3
1361719|NCT01628965|4490809|P1|Overall Study|Lack of Efficacy|7
1361720|NCT01628965|4490809|P1|Overall Study|Adverse Event|30
1361721|NCT01628926|4490818|P3|Overall Study|Physician Decision|1
1361722|NCT01628926|4490819|P2|Overall Study|Physician Decision|2
1361723|NCT01628926|4490820|P1|Overall Study|Physician Decision|2
1361724|NCT01628926|4490818|P3|Overall Study|Discontinuation criteria|0
1361725|NCT01628926|4490819|P2|Overall Study|Discontinuation criteria|4
1361726|NCT01628926|4490820|P1|Overall Study|Discontinuation criteria|3
1361727|NCT01628926|4490818|P3|Overall Study|Protocol Violation|0
1361728|NCT01628926|4490819|P2|Overall Study|Protocol Violation|1
1361729|NCT01628926|4490820|P1|Overall Study|Protocol Violation|0
1361730|NCT01628926|4490818|P3|Overall Study|Withdrawal by Subject|2
1361731|NCT01628926|4490819|P2|Overall Study|Withdrawal by Subject|4
1361732|NCT01628926|4490820|P1|Overall Study|Withdrawal by Subject|6
1361733|NCT01628926|4490818|P3|Overall Study|Lack of Efficacy|5
1361734|NCT01628926|4490819|P2|Overall Study|Lack of Efficacy|1
1361735|NCT01628926|4490820|P1|Overall Study|Lack of Efficacy|2
1361736|NCT01628926|4490818|P3|Overall Study|Adverse Event|9
1361737|NCT01628926|4490819|P2|Overall Study|Adverse Event|11
1361738|NCT01628926|4490820|P1|Overall Study|Adverse Event|13
1361739|NCT01628913|4490869|P2|Overall Study|Physician Decision|3
1361740|NCT01628913|4490870|P1|Overall Study|Physician Decision|1
1361741|NCT01628913|4490869|P2|Overall Study|Withdrawal by Subject|0
1361742|NCT01628913|4490870|P1|Overall Study|Withdrawal by Subject|1
1361743|NCT01628913|4490869|P2|Overall Study|study terminated by Sponsor|9
1361744|NCT01628913|4490870|P1|Overall Study|study terminated by Sponsor|4
1361745|NCT01628913|4490869|P2|Overall Study|Death|0
1361746|NCT01628913|4490870|P1|Overall Study|Death|1
1361747|NCT01628913|4490869|P2|Overall Study|Protocol Violation|0
1361748|NCT01628913|4490870|P1|Overall Study|Protocol Violation|1
1361749|NCT01628913|4490869|P2|Overall Study|Disease Progression|14
1361750|NCT01628913|4490870|P1|Overall Study|Disease Progression|11
1361751|NCT01628913|4490869|P2|Overall Study|Adverse Event|5
1361752|NCT01628913|4490870|P1|Overall Study|Adverse Event|12
1361753|NCT01628848|4490884|P2|Overall Study|Physician Decision|1
1361754|NCT01628848|4490885|P1|Overall Study|Physician Decision|3
1361755|NCT01628848|4490884|P2|Overall Study|Withdrawal by Subject|2
1361756|NCT01628848|4490885|P1|Overall Study|Withdrawal by Subject|0
1361757|NCT01628848|4490884|P2|Overall Study|Lack of Efficacy|4
1361758|NCT01628848|4490885|P1|Overall Study|Lack of Efficacy|0
1361759|NCT01628848|4490884|P2|Overall Study|Adverse Event|7
1361760|NCT01628848|4490885|P1|Overall Study|Adverse Event|9
1361761|NCT01628692|4490919|P6|Overall Study|Completed 12 Week only|1
1361762|NCT01628692|4490920|P5|Overall Study|Completed 12 Week only|0
1361763|NCT01628692|4490921|P4|Overall Study|Completed 12 Week only|0
1361764|NCT01628692|4490922|P3|Overall Study|Completed 12 Week only|0
1361765|NCT01628692|4490923|P2|Overall Study|Completed 12 Week only|0
1361766|NCT01628692|4490924|P1|Overall Study|Completed 12 Week only|0
1361767|NCT01628692|4490919|P6|Overall Study|Administrative reason by sponsor|1
1361768|NCT01628692|4490920|P5|Overall Study|Administrative reason by sponsor|0
1361769|NCT01628692|4490921|P4|Overall Study|Administrative reason by sponsor|0
1361770|NCT01628692|4490922|P3|Overall Study|Administrative reason by sponsor|0
1361771|NCT01628692|4490923|P2|Overall Study|Administrative reason by sponsor|0
1361772|NCT01628692|4490924|P1|Overall Study|Administrative reason by sponsor|0
1361773|NCT01628692|4490919|P6|Overall Study|Poor compliance/noncompliance|0
1361774|NCT01628692|4490920|P5|Overall Study|Poor compliance/noncompliance|0
1361775|NCT01628692|4490921|P4|Overall Study|Poor compliance/noncompliance|0
1361776|NCT01628692|4490922|P3|Overall Study|Poor compliance/noncompliance|0
1361777|NCT01628692|4490923|P2|Overall Study|Poor compliance/noncompliance|0
1361778|NCT01628692|4490924|P1|Overall Study|Poor compliance/noncompliance|1
1361779|NCT01628692|4490919|P6|Overall Study|Death|0
1361780|NCT01628692|4490920|P5|Overall Study|Death|0
1361781|NCT01628692|4490921|P4|Overall Study|Death|0
1361782|NCT01628692|4490922|P3|Overall Study|Death|0
1361783|NCT01628692|4490923|P2|Overall Study|Death|1
1361784|NCT01628692|4490924|P1|Overall Study|Death|0
1361785|NCT01628692|4490919|P6|Overall Study|Withdrawal by Subject|0
1361786|NCT01628692|4490920|P5|Overall Study|Withdrawal by Subject|0
1361787|NCT01628692|4490921|P4|Overall Study|Withdrawal by Subject|0
1361788|NCT01628692|4490922|P3|Overall Study|Withdrawal by Subject|1
1361789|NCT01628692|4490923|P2|Overall Study|Withdrawal by Subject|1
1361790|NCT01628692|4490924|P1|Overall Study|Withdrawal by Subject|0
1361791|NCT01628692|4490919|P6|Overall Study|Adverse Event|0
1361792|NCT01628692|4490920|P5|Overall Study|Adverse Event|0
1361793|NCT01628692|4490921|P4|Overall Study|Adverse Event|0
1361794|NCT01628692|4490922|P3|Overall Study|Adverse Event|2
1361795|NCT01628692|4490923|P2|Overall Study|Adverse Event|0
1361796|NCT01628692|4490924|P1|Overall Study|Adverse Event|2
1361797|NCT01628692|4490919|P6|Overall Study|Lack of Efficacy|7
1361798|NCT01628692|4490920|P5|Overall Study|Lack of Efficacy|4
1361799|NCT01628692|4490921|P4|Overall Study|Lack of Efficacy|1
1361800|NCT01628692|4490922|P3|Overall Study|Lack of Efficacy|5
1361801|NCT01628692|4490923|P2|Overall Study|Lack of Efficacy|4
1361802|NCT01628692|4490924|P1|Overall Study|Lack of Efficacy|4
1361803|NCT01628510|4490992|P2|Overall Study|Death|1
1361804|NCT01628510|4490993|P1|Overall Study|Death|3
1361805|NCT01628510|4490992|P2|Overall Study|Withdrawal by Subject|4
1361806|NCT01628510|4490993|P1|Overall Study|Withdrawal by Subject|0
1361807|NCT01628367|4491003|P2|Overall Study|Adverse Event|0
1361808|NCT01628367|4491004|P1|Overall Study|Adverse Event|1
1361809|NCT01628198|4491023|P1|Overall Study|Screen failure|1
1361810|NCT01628198|4491023|P1|Overall Study|Withdrawal by Subject|10
1361811|NCT01628198|4491023|P1|Overall Study|Lost to Follow-up|7
1361812|NCT01628120|4491036|P1|Overall Study|Use of Standard of Care|1
1361813|NCT01628120|4491036|P1|Overall Study|Kidney Transplant|2
1361814|NCT01628120|4491036|P1|Overall Study|Moved or Relocated|5
1361815|NCT01628120|4491036|P1|Overall Study|Missed Study Drug More than 2 Weeks|3
1361816|NCT01628120|4491036|P1|Overall Study|Switched Dialysis Method|2
1361817|NCT01628120|4491036|P1|Overall Study|Sponsor Decision|5
1361818|NCT01628120|4491036|P1|Overall Study|Not Treated|3
1361819|NCT01628120|4491036|P1|Overall Study|Non-compliant with Study Procedures|1
1361820|NCT01628120|4491036|P1|Overall Study|Not met Inclusion/Exclusion Criteria|2
1361821|NCT01628120|4491036|P1|Overall Study|Lost to Follow-up|1
1361822|NCT01628120|4491036|P1|Overall Study|Adverse Event|12
1361823|NCT01628120|4491036|P1|Overall Study|Withdrawal by Subject|7
1361824|NCT01628107|4491061|P1|Overall Study|Use of Standard of Care|9
1361825|NCT01628107|4491061|P1|Overall Study|Kidney Transplant|9
1361826|NCT01628107|4491061|P1|Overall Study|Relocated|8
1361827|NCT01628107|4491061|P1|Overall Study|Missed Study Drug More than 2 Weeks|7
1361828|NCT01628107|4491061|P1|Overall Study|Sponsor Decision|11
1361829|NCT01628107|4491061|P1|Overall Study|Not Treated|8
1361830|NCT01628107|4491061|P1|Overall Study|Non-compliant with Study Procedures|10
1361831|NCT01628107|4491061|P1|Overall Study|Not met Inclusion/Exclusion Criteria|1
1361832|NCT01628107|4491061|P1|Overall Study|Physician Decision|2
1361833|NCT01628107|4491061|P1|Overall Study|Adverse Event|33
1361834|NCT01628107|4491061|P1|Overall Study|Lost to Follow-up|4
1361835|NCT01628107|4491061|P1|Overall Study|Withdrawal by Subject|17
1361836|NCT01627899|4491111|P1|Overall Study|Study terminated early by sponsor.|5
1361837|NCT01627860|4491121|P2|Overall Study|Protocol Violation|0
1361838|NCT01627860|4491122|P1|Overall Study|Protocol Violation|1
1361839|NCT01627860|4491121|P2|Overall Study|Seizure frequency doubled|1
1361840|NCT01627860|4491122|P1|Overall Study|Seizure frequency doubled|0
1361841|NCT01627860|4491121|P2|Overall Study|Withdrawal by Subject|1
1361842|NCT01627860|4491122|P1|Overall Study|Withdrawal by Subject|2
1361843|NCT01627860|4491121|P2|Overall Study|Adverse Event|4
1361844|NCT01627860|4491122|P1|Overall Study|Adverse Event|9
1361845|NCT01627782|4491136|P4|Overall Study|Randomized But Not Treated|0
1361846|NCT01627782|4491137|P3|Overall Study|Randomized But Not Treated|0
1361847|NCT01627782|4491138|P2|Overall Study|Randomized But Not Treated|0
1361848|NCT01627782|4491139|P1|Overall Study|Randomized But Not Treated|1
1361849|NCT01627782|4491136|P4|Overall Study|Other|3
1361850|NCT01627782|4491137|P3|Overall Study|Other|0
1361851|NCT01627782|4491138|P2|Overall Study|Other|2
1361852|NCT01627782|4491139|P1|Overall Study|Other|0
1361853|NCT01627782|4491136|P4|Overall Study|Withdrawal by Subject|0
1361854|NCT01627782|4491137|P3|Overall Study|Withdrawal by Subject|0
1361855|NCT01627782|4491138|P2|Overall Study|Withdrawal by Subject|1
1361856|NCT01627782|4491139|P1|Overall Study|Withdrawal by Subject|2
1361857|NCT01627782|4491136|P4|Overall Study|Protocol Violation|0
1361858|NCT01627782|4491137|P3|Overall Study|Protocol Violation|0
1361859|NCT01627782|4491138|P2|Overall Study|Protocol Violation|0
1361860|NCT01627782|4491139|P1|Overall Study|Protocol Violation|1
1361861|NCT01627782|4491136|P4|Overall Study|Lack of Efficacy|2
1361862|NCT01627782|4491137|P3|Overall Study|Lack of Efficacy|15
1361863|NCT01627782|4491138|P2|Overall Study|Lack of Efficacy|1
1361864|NCT01627782|4491139|P1|Overall Study|Lack of Efficacy|11
1361865|NCT01627782|4491136|P4|Overall Study|Adverse Event|1
1361866|NCT01627782|4491137|P3|Overall Study|Adverse Event|0
1361867|NCT01627782|4491138|P2|Overall Study|Adverse Event|2
1361868|NCT01627782|4491139|P1|Overall Study|Adverse Event|1
1361869|NCT01627561|4491197|P2|Overall Study|Withdrawal by Subject|2
1361870|NCT01627561|4491198|P1|Overall Study|Withdrawal by Subject|0
1361871|NCT01627561|4491197|P2|Overall Study|Migrated/moved from study area|1
1361872|NCT01627561|4491198|P1|Overall Study|Migrated/moved from study area|0
1361873|NCT01627340|4491246|P2|Overall Study|Withdrawal by Subject|0
1361874|NCT01627340|4491247|P1|Overall Study|Withdrawal by Subject|2
1361875|NCT01627340|4491246|P2|Overall Study|Pregnancy|0
1361876|NCT01627340|4491247|P1|Overall Study|Pregnancy|1
1361877|NCT01627340|4491246|P2|Overall Study|Lost to Follow-up|4
1361878|NCT01627340|4491247|P1|Overall Study|Lost to Follow-up|8
1361879|NCT01627340|4491246|P2|Overall Study|Adverse Event|0
1361880|NCT01627340|4491247|P1|Overall Study|Adverse Event|1
1361881|NCT01627327|4491265|P2|Overall Study|Withdrawal by Subject|3
1361882|NCT01627327|4491266|P1|Overall Study|Withdrawal by Subject|3
1361883|NCT01627327|4491265|P2|Overall Study|Physician Decision|0
1361884|NCT01627327|4491266|P1|Overall Study|Physician Decision|1
1361885|NCT01627327|4491265|P2|Overall Study|Lost to Follow-up|3
1361886|NCT01627327|4491266|P1|Overall Study|Lost to Follow-up|1
1361887|NCT01627327|4491265|P2|Overall Study|Protocol Violation|10
1361888|NCT01627327|4491266|P1|Overall Study|Protocol Violation|4
1361889|NCT01627327|4491265|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
1361890|NCT01627327|4491266|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
1361891|NCT01627327|4491265|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
1361892|NCT01627327|4491266|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
1361893|NCT01627327|4491265|P2|Overall Study|Adverse Event|12
1361894|NCT01627327|4491266|P1|Overall Study|Adverse Event|6
1361895|NCT01627249|4491279|P3|Overall Study|Missed Visit|0
1361896|NCT01627249|4491280|P2|Overall Study|Missed Visit|1
1361897|NCT01627249|4491281|P1|Overall Study|Missed Visit|1
1361898|NCT01627249|4491279|P3|Overall Study|Withdrawal by Subject|9
1361899|NCT01627249|4491280|P2|Overall Study|Withdrawal by Subject|6
1361900|NCT01627249|4491281|P1|Overall Study|Withdrawal by Subject|12
1361901|NCT01627249|4491279|P3|Overall Study|Death|3
1361902|NCT01627249|4491280|P2|Overall Study|Death|5
1361903|NCT01627249|4491281|P1|Overall Study|Death|3
1361904|NCT01626690|4491402|P2|Overall Study|Adverse Event|0
1361905|NCT01626690|4491403|P1|Overall Study|Adverse Event|1
1361906|NCT01626690|4491402|P2|Overall Study|Protocol Violation|0
1361907|NCT01626690|4491403|P1|Overall Study|Protocol Violation|1
1361908|NCT01626456|4491442|P2|Overall Study|Incarceration|2
1361909|NCT01626456|4491443|P1|Overall Study|Incarceration|0
1361910|NCT01626456|4491442|P2|Overall Study|Site Closure|3
1361911|NCT01626456|4491443|P1|Overall Study|Site Closure|2
1361912|NCT01626456|4491442|P2|Overall Study|Protocol Violation|1
1361913|NCT01626456|4491443|P1|Overall Study|Protocol Violation|1
1361914|NCT01626456|4491442|P2|Overall Study|Physician Decision|4
1361915|NCT01626456|4491443|P1|Overall Study|Physician Decision|1
1361916|NCT01626456|4491442|P2|Overall Study|Lack of Efficacy|7
1361917|NCT01626456|4491443|P1|Overall Study|Lack of Efficacy|6
1361918|NCT01626456|4491442|P2|Overall Study|Lost to Follow-up|27
1361919|NCT01626456|4491443|P1|Overall Study|Lost to Follow-up|2
1361920|NCT01626456|4491442|P2|Overall Study|Adverse Event|27
1361921|NCT01626456|4491443|P1|Overall Study|Adverse Event|2
1361922|NCT01626456|4491442|P2|Overall Study|Withdrawal by Subject|46
1361923|NCT01626456|4491443|P1|Overall Study|Withdrawal by Subject|21
1361924|NCT01626391|4491473|P2|Overall Study|Withdrawal by Subject|0
1361925|NCT01626391|4491474|P1|Overall Study|Withdrawal by Subject|1
1361926|NCT01626391|4491473|P2|Overall Study|Physician Decision|0
1361927|NCT01626391|4491474|P1|Overall Study|Physician Decision|1
1361928|NCT01626352|4491480|P1|Overall Study|Never Treated|1
1361929|NCT01626352|4491480|P1|Overall Study|Non-Compliance|1
1361930|NCT01626352|4491480|P1|Overall Study|Withdrawal by Subject|1
1361931|NCT01626352|4491480|P1|Overall Study|Death|2
1361932|NCT01626352|4491480|P1|Overall Study|Intercurrent Illness|2
1361933|NCT01626352|4491480|P1|Overall Study|Disease Progression|3
1361934|NCT01626118|4491494|P4|Overall Study|Investigator Decision|0
1361935|NCT01626118|4491495|P3|Overall Study|Investigator Decision|0
1361936|NCT01626118|4491496|P2|Overall Study|Investigator Decision|1
1361937|NCT01626118|4491497|P1|Overall Study|Investigator Decision|0
1361938|NCT01626118|4491494|P4|Overall Study|Adverse Event|0
1361939|NCT01626118|4491495|P3|Overall Study|Adverse Event|1
1361940|NCT01626118|4491496|P2|Overall Study|Adverse Event|1
1361941|NCT01626118|4491497|P1|Overall Study|Adverse Event|0
1361942|NCT01626118|4491494|P4|Overall Study|Lost to Follow-up|0
1361943|NCT01626118|4491495|P3|Overall Study|Lost to Follow-up|0
1361944|NCT01626118|4491496|P2|Overall Study|Lost to Follow-up|0
1361945|NCT01626118|4491497|P1|Overall Study|Lost to Follow-up|1
1361946|NCT01626118|4491494|P4|Overall Study|Lack of Efficacy|3
1361947|NCT01626118|4491495|P3|Overall Study|Lack of Efficacy|1
1361948|NCT01626118|4491496|P2|Overall Study|Lack of Efficacy|0
1361949|NCT01626118|4491497|P1|Overall Study|Lack of Efficacy|1
1361950|NCT01625910|4491543|P2|Overall Study|Lost to Follow-up|4
1361951|NCT01625910|4491544|P1|Overall Study|Lost to Follow-up|3
1361952|NCT01625845|4491554|P2|Overall Study|Withdrawal by Subject|0
1361953|NCT01625845|4491555|P1|Overall Study|Withdrawal by Subject|2
1361954|NCT01625845|4491554|P2|Overall Study|Lost to Follow-up|1
1361955|NCT01625845|4491555|P1|Overall Study|Lost to Follow-up|2
1361956|NCT01625845|4491554|P2|Overall Study|Adverse Event|2
1361957|NCT01625845|4491555|P1|Overall Study|Adverse Event|1
1361958|NCT01625689|4491575|P2|Overall Study|Migration|1
1361959|NCT01625689|4491576|P1|Overall Study|Migration|2
1361960|NCT01625377|4491631|P2|Overall Study|Abnormal laboratory values|0
1361961|NCT01625377|4491632|P1|Overall Study|Abnormal laboratory values|1
1361962|NCT01625377|4491631|P2|Overall Study|Unsatisfactory therapeutic effect|1
1361963|NCT01625377|4491632|P1|Overall Study|Unsatisfactory therapeutic effect|0
1361964|NCT01625377|4491631|P2|Overall Study|Graft loss|0
1361965|NCT01625377|4491632|P1|Overall Study|Graft loss|1
1361966|NCT01625377|4491631|P2|Overall Study|Adverse Event|16
1361967|NCT01625377|4491632|P1|Overall Study|Adverse Event|3
1361968|NCT01625377|4491631|P2|Overall Study|Protocol Violation|3
1361969|NCT01625377|4491632|P1|Overall Study|Protocol Violation|0
1361970|NCT01625377|4491631|P2|Overall Study|Administrative Problem|1
1361971|NCT01625377|4491632|P1|Overall Study|Administrative Problem|1
1361972|NCT01625377|4491631|P2|Overall Study|Death|1
1361973|NCT01625377|4491632|P1|Overall Study|Death|1
1361974|NCT01625338|4491665|P3|Overall Study|Study Discontinued by Sponsor|1
1361975|NCT01625338|4491666|P2|Overall Study|Study Discontinued by Sponsor|0
1361976|NCT01625338|4491667|P1|Overall Study|Study Discontinued by Sponsor|0
1361977|NCT01625338|4491665|P3|Overall Study|Adverse Event|1
1361978|NCT01625338|4491666|P2|Overall Study|Adverse Event|0
1361979|NCT01625338|4491667|P1|Overall Study|Adverse Event|1
1361980|NCT01625338|4491665|P3|Overall Study|Subject Withdrew Consent|2
1361981|NCT01625338|4491666|P2|Overall Study|Subject Withdrew Consent|0
1361982|NCT01625338|4491667|P1|Overall Study|Subject Withdrew Consent|1
1361983|NCT01625338|4491665|P3|Overall Study|Investigator Decision|1
1361984|NCT01625338|4491666|P2|Overall Study|Investigator Decision|2
1361985|NCT01625338|4491667|P1|Overall Study|Investigator Decision|0
1361986|NCT01625338|4491665|P3|Overall Study|Lost to Follow-up|2
1361987|NCT01625338|4491666|P2|Overall Study|Lost to Follow-up|3
1361988|NCT01625338|4491667|P1|Overall Study|Lost to Follow-up|3
1361989|NCT01625338|4491665|P3|Overall Study|Efficacy Failure|31
1361990|NCT01625338|4491666|P2|Overall Study|Efficacy Failure|39
1361991|NCT01625338|4491667|P1|Overall Study|Efficacy Failure|27
1361992|NCT01625338|4491665|P3|Overall Study|Enrolled but not Treated|1
1361993|NCT01625338|4491666|P2|Overall Study|Enrolled but not Treated|0
1361994|NCT01625338|4491667|P1|Overall Study|Enrolled but not Treated|0
1361995|NCT01625182|4491694|P2|Overall Study|Lack of Efficacy|8
1361996|NCT01625182|4491695|P1|Overall Study|Lack of Efficacy|12
1361997|NCT01625182|4491694|P2|Overall Study|Withdrawal by Subject|1
1361998|NCT01625182|4491695|P1|Overall Study|Withdrawal by Subject|5
1361999|NCT01625182|4491694|P2|Overall Study|Adverse Event|0
1362000|NCT01625182|4491695|P1|Overall Study|Adverse Event|2
1362001|NCT01625182|4491694|P2|Overall Study|Protocol deviation|2
1362002|NCT01625182|4491695|P1|Overall Study|Protocol deviation|0
1362003|NCT01625182|4491694|P2|Overall Study|Administrative problems|0
1362004|NCT01625182|4491695|P1|Overall Study|Administrative problems|1
1362005|NCT01625091|4491732|P2|Post-intervention|Study termination|1
1362006|NCT01625091|4491733|P1|Post-intervention|Study termination|2
1362007|NCT01625091|4491732|P2|Post-intervention|Lost to Follow-up|0
1362008|NCT01625091|4491733|P1|Post-intervention|Lost to Follow-up|2
1362009|NCT01625091|4491732|P2|Post-intervention|Death|1
1362010|NCT01625091|4491733|P1|Post-intervention|Death|0
1362011|NCT01625091|4491732|P2|Intervention|Study termination|3
1362012|NCT01625091|4491733|P1|Intervention|Study termination|2
1362013|NCT01625091|4491732|P2|Intervention|Lost to Follow-up|4
1362014|NCT01625091|4491733|P1|Intervention|Lost to Follow-up|4
1362015|NCT01625091|4491732|P2|Intervention|Adverse Event|2
1362016|NCT01625091|4491733|P1|Intervention|Adverse Event|0
1362017|NCT01625091|4491732|P2|Intervention|Withdrawal by Subject|1
1362018|NCT01625091|4491733|P1|Intervention|Withdrawal by Subject|4
1362019|NCT01625091|4491732|P2|Intervention|Death|1
1362020|NCT01625091|4491733|P1|Intervention|Death|1
1362021|NCT01624870|4491764|P1|Overall Study|Lost to follow up|1
1362022|NCT01624870|4491764|P1|Overall Study|CoreValve not implanted|6
1362023|NCT01624870|4491764|P1|Overall Study|Withdrawal by Subject|1
1362024|NCT01624870|4491764|P1|Overall Study|Death|19
1362025|NCT01624467|4491780|P1|Overall Study|Subject Withdrew from Treatment|1
1362026|NCT01624467|4491780|P1|Overall Study|Per Sponsor Requirement|1
1362027|NCT01624467|4491780|P1|Overall Study|Progressive Disease|19
1362028|NCT01624467|4491780|P1|Overall Study|Adverse Event|7
1362029|NCT01624467|4491780|P1|Overall Study|Lost to Follow-up|1
1362030|NCT01624467|4491780|P1|Overall Study|Withdrawal by Subject|2
1362031|NCT01624259|4491819|P2|Overall Study|Abnormal laboratory measure|0
1362032|NCT01624259|4491820|P1|Overall Study|Abnormal laboratory measure|3
1362033|NCT01624259|4491819|P2|Overall Study|Lost to Follow-up|3
1362034|NCT01624259|4491820|P1|Overall Study|Lost to Follow-up|2
1362035|NCT01624259|4491819|P2|Overall Study|Physician Decision|1
1362036|NCT01624259|4491820|P1|Overall Study|Physician Decision|1
1362037|NCT01624259|4491819|P2|Overall Study|Withdrawal by Subject|7
1362038|NCT01624259|4491820|P1|Overall Study|Withdrawal by Subject|5
1362039|NCT01624259|4491819|P2|Overall Study|Protocol Violation|2
1362040|NCT01624259|4491820|P1|Overall Study|Protocol Violation|1
1362041|NCT01624259|4491819|P2|Overall Study|Adverse Event|18
1362042|NCT01624259|4491820|P1|Overall Study|Adverse Event|18
1362043|NCT01624233|4491869|P1|Period 3 - Maintenance|Withdrawal by Subject|2
1362044|NCT01624233|4491869|P1|Period 3 - Maintenance|Physician Decision|2
1362045|NCT01624233|4491869|P1|Period 3 - Maintenance|Lack of Efficacy|1
1362046|NCT01624233|4491869|P1|Period 3 - Maintenance|Adverse Event|2
1362047|NCT01624233|4491869|P1|Period 2 - Induction|Adverse Event|1
1362048|NCT01624194|4491888|P2|Overall Study|Withdrawal by Subject|0
1362049|NCT01624194|4491889|P1|Overall Study|Withdrawal by Subject|1
1362050|NCT01624194|4491888|P2|Overall Study|Lost to Follow-up|0
1362051|NCT01624194|4491889|P1|Overall Study|Lost to Follow-up|1
1362052|NCT01623830|4491963|P2|Overall Study|Exclusion from Study|2
1362053|NCT01623830|4491964|P1|Overall Study|Exclusion from Study|1
1362054|NCT01623830|4491963|P2|Overall Study|Withdrawal by Subject|7
1362055|NCT01623830|4491964|P1|Overall Study|Withdrawal by Subject|6
1362056|NCT01623596|4491989|P2|Overall Study|Lack of Efficacy|3
1362057|NCT01623596|4491990|P1|Overall Study|Lack of Efficacy|5
1362058|NCT01623596|4491989|P2|Overall Study|Protocol Violation|6
1362059|NCT01623596|4491990|P1|Overall Study|Protocol Violation|0
1362060|NCT01623596|4491989|P2|Overall Study|Patient no longer requires study drug|0
1362061|NCT01623596|4491990|P1|Overall Study|Patient no longer requires study drug|1
1362062|NCT01623596|4491989|P2|Overall Study|Withdrawal by Subject|31
1362063|NCT01623596|4491990|P1|Overall Study|Withdrawal by Subject|13
1362064|NCT01623596|4491989|P2|Overall Study|Lost to Follow-up|16
1362065|NCT01623596|4491990|P1|Overall Study|Lost to Follow-up|12
1362066|NCT01623596|4491989|P2|Overall Study|Death|2
1362067|NCT01623596|4491990|P1|Overall Study|Death|0
1362068|NCT01623596|4491989|P2|Overall Study|Adverse Event|29
1362069|NCT01623596|4491990|P1|Overall Study|Adverse Event|20
1362070|NCT01623596|4491989|P2|Overall Study|Administrative problems|13
1362071|NCT01623596|4491990|P1|Overall Study|Administrative problems|9
1362072|NCT01623596|4491989|P2|Overall Study|Abnormal laboratory values|0
1362073|NCT01623596|4491990|P1|Overall Study|Abnormal laboratory values|2
1362074|NCT01623310|4492033|P1|Overall Study|Investigators Discretion-Noncompliant|1
1362075|NCT01623310|4492033|P1|Overall Study|Diagnoses of bilateral cateracts|1
1362076|NCT01623310|4492033|P1|Overall Study|Became potentially child-bearing|1
1362077|NCT01623310|4492033|P1|Overall Study|Withdrawal by Subject|25
1362078|NCT01623310|4492033|P1|Overall Study|Protocol Violation|6
1362079|NCT01623310|4492033|P1|Overall Study|Lack of Efficacy|6
1362080|NCT01623310|4492033|P1|Overall Study|Lost to Follow-up|18
1362081|NCT01623310|4492033|P1|Overall Study|Adverse Event|21
1362082|NCT01623271|4492042|P1|Overall Study|Withdrawal by Subject|2
1362083|NCT01623154|4492046|P1|Overall Study|Did not drink Pranactin Citric|4
1362084|NCT01623115|4492054|P2|Overall Study|Other than specified above|3
1362085|NCT01623115|4492055|P1|Overall Study|Other than specified above|0
1362086|NCT01623115|4492054|P2|Overall Study|Death|4
1362087|NCT01623115|4492055|P1|Overall Study|Death|0
1362088|NCT01623115|4492054|P2|Overall Study|Site closure|7
1362089|NCT01623115|4492055|P1|Overall Study|Site closure|1
1362090|NCT01623115|4492054|P2|Overall Study|Last visit outside protocol visit window|26
1362091|NCT01623115|4492055|P1|Overall Study|Last visit outside protocol visit window|14
1362092|NCT01623115|4492054|P2|Overall Study|Related to study drug administration|2
1362093|NCT01623115|4492055|P1|Overall Study|Related to study drug administration|0
1362094|NCT01623115|4492054|P2|Overall Study|Consent withdrawn by participant|6
1362095|NCT01623115|4492055|P1|Overall Study|Consent withdrawn by participant|2
1362096|NCT01623115|4492054|P2|Overall Study|Poor compliance to protocol|10
1362097|NCT01623115|4492055|P1|Overall Study|Poor compliance to protocol|4
1362098|NCT01623115|4492054|P2|Overall Study|Adverse Event|13
1362099|NCT01623115|4492055|P1|Overall Study|Adverse Event|10
1362100|NCT01623115|4492054|P2|Overall Study|Participants moved|5
1362101|NCT01623115|4492055|P1|Overall Study|Participants moved|1
1362102|NCT01623115|4492054|P2|Overall Study|Physician Decision|0
1362103|NCT01623115|4492055|P1|Overall Study|Physician Decision|1
1362104|NCT01623115|4492054|P2|Overall Study|Randomized but not treated|1
1362105|NCT01623115|4492055|P1|Overall Study|Randomized but not treated|0
1362106|NCT01623050|4492115|P1|Overall Study|Lost to Follow-up|9
1362107|NCT01622673|4492129|P6|Treatment Period 3|Protocol Violation|0
1362108|NCT01622673|4492130|P5|Treatment Period 3|Protocol Violation|0
1362109|NCT01622673|4492131|P4|Treatment Period 3|Protocol Violation|0
1362110|NCT01622673|4492132|P3|Treatment Period 3|Protocol Violation|0
1362111|NCT01622673|4492133|P2|Treatment Period 3|Protocol Violation|1
1362112|NCT01622673|4492134|P1|Treatment Period 3|Protocol Violation|0
1362113|NCT01622673|4492129|P6|Treatment Period 2|Withdrawal by Subject|0
1362114|NCT01622673|4492130|P5|Treatment Period 2|Withdrawal by Subject|0
1362115|NCT01622673|4492131|P4|Treatment Period 2|Withdrawal by Subject|1
1362116|NCT01622673|4492132|P3|Treatment Period 2|Withdrawal by Subject|0
1362117|NCT01622673|4492133|P2|Treatment Period 2|Withdrawal by Subject|0
1362118|NCT01622673|4492134|P1|Treatment Period 2|Withdrawal by Subject|0
1362119|NCT01622673|4492129|P6|Treatment Period 1|Protocol Violation|0
1362120|NCT01622673|4492130|P5|Treatment Period 1|Protocol Violation|0
1362121|NCT01622673|4492131|P4|Treatment Period 1|Protocol Violation|0
1362122|NCT01622673|4492132|P3|Treatment Period 1|Protocol Violation|0
1362123|NCT01622673|4492133|P2|Treatment Period 1|Protocol Violation|1
1362124|NCT01622673|4492134|P1|Treatment Period 1|Protocol Violation|0
1362125|NCT01622673|4492129|P6|Treatment Period 1|Withdrawal by Subject|0
1362126|NCT01622673|4492130|P5|Treatment Period 1|Withdrawal by Subject|0
1362127|NCT01622673|4492131|P4|Treatment Period 1|Withdrawal by Subject|1
1362128|NCT01622673|4492132|P3|Treatment Period 1|Withdrawal by Subject|0
1362129|NCT01622673|4492133|P2|Treatment Period 1|Withdrawal by Subject|0
1362130|NCT01622673|4492134|P1|Treatment Period 1|Withdrawal by Subject|0
1362131|NCT01622660|4492169|P1|Overall Study|Adverse Event|1
1362132|NCT01622348|4492176|P3|Overall Study|Withdrawal by Subject|1
1362133|NCT01622348|4492177|P2|Overall Study|Withdrawal by Subject|0
1362134|NCT01622348|4492178|P1|Overall Study|Withdrawal by Subject|1
1362135|NCT01622231|4492217|P1|Overall Study|Withdrawal by Subject|1
1362136|NCT01622231|4492217|P1|Overall Study|Physician Decision|1
1362137|NCT01621802|4492251|P6|Overall Study|Lost to Follow-up|11
1362138|NCT01621802|4492252|P5|Overall Study|Lost to Follow-up|31
1362139|NCT01621802|4492253|P4|Overall Study|Lost to Follow-up|7
1362140|NCT01621802|4492254|P3|Overall Study|Lost to Follow-up|24
1362141|NCT01621802|4492255|P2|Overall Study|Lost to Follow-up|16
1362142|NCT01621802|4492256|P1|Overall Study|Lost to Follow-up|36
1362143|NCT01621802|4492251|P6|Overall Study|Others|0
1362144|NCT01621802|4492252|P5|Overall Study|Others|1
1362145|NCT01621802|4492253|P4|Overall Study|Others|2
1362146|NCT01621802|4492254|P3|Overall Study|Others|3
1362147|NCT01621802|4492255|P2|Overall Study|Others|3
1362148|NCT01621802|4492256|P1|Overall Study|Others|3
1362149|NCT01621802|4492251|P6|Overall Study|Migrated/moved from study area|0
1362150|NCT01621802|4492252|P5|Overall Study|Migrated/moved from study area|1
1362151|NCT01621802|4492253|P4|Overall Study|Migrated/moved from study area|0
1362152|NCT01621802|4492254|P3|Overall Study|Migrated/moved from study area|2
1362153|NCT01621802|4492255|P2|Overall Study|Migrated/moved from study area|0
1362154|NCT01621802|4492256|P1|Overall Study|Migrated/moved from study area|0
1362155|NCT01621802|4492251|P6|Overall Study|Withdrawal by Subject|0
1362156|NCT01621802|4492252|P5|Overall Study|Withdrawal by Subject|2
1362157|NCT01621802|4492253|P4|Overall Study|Withdrawal by Subject|2
1362158|NCT01621802|4492254|P3|Overall Study|Withdrawal by Subject|4
1362159|NCT01621802|4492255|P2|Overall Study|Withdrawal by Subject|4
1362160|NCT01621802|4492256|P1|Overall Study|Withdrawal by Subject|8
1362161|NCT01621802|4492251|P6|Overall Study|Protocol Violation|1
1362162|NCT01621802|4492252|P5|Overall Study|Protocol Violation|0
1362163|NCT01621802|4492253|P4|Overall Study|Protocol Violation|0
1362164|NCT01621802|4492254|P3|Overall Study|Protocol Violation|0
1362165|NCT01621802|4492255|P2|Overall Study|Protocol Violation|0
1362166|NCT01621802|4492256|P1|Overall Study|Protocol Violation|0
1362167|NCT01621191|4492427|P1|Overall Study|Site Removed From Study|1
1362168|NCT01621191|4492427|P1|Overall Study|Lost to Follow-up|1
1362169|NCT01621191|4492427|P1|Overall Study|Lack of Efficacy|6
1362170|NCT01621191|4492427|P1|Overall Study|Withdrawal by Subject|8
1362171|NCT01621191|4492427|P1|Overall Study|Adverse Event|9
1362172|NCT01621178|4492441|P3|Overall Study|Physician Decision|7
1362173|NCT01621178|4492442|P2|Overall Study|Physician Decision|2
1362174|NCT01621178|4492443|P1|Overall Study|Physician Decision|5
1362175|NCT01621178|4492441|P3|Overall Study|Withdrawal by Subject|18
1362176|NCT01621178|4492442|P2|Overall Study|Withdrawal by Subject|17
1362177|NCT01621178|4492443|P1|Overall Study|Withdrawal by Subject|14
1362178|NCT01621178|4492441|P3|Overall Study|Lost to Follow-up|1
1362179|NCT01621178|4492442|P2|Overall Study|Lost to Follow-up|2
1362180|NCT01621178|4492443|P1|Overall Study|Lost to Follow-up|1
1362181|NCT01621178|4492441|P3|Overall Study|Death|2
1362182|NCT01621178|4492442|P2|Overall Study|Death|7
1362183|NCT01621178|4492443|P1|Overall Study|Death|6
1362184|NCT01621178|4492441|P3|Overall Study|Adverse Event|8
1362185|NCT01621178|4492442|P2|Overall Study|Adverse Event|2
1362186|NCT01621178|4492443|P1|Overall Study|Adverse Event|5
1362187|NCT01621126|4492535|P1|Overall Study|Physician Decision|6
1362188|NCT01620762|4492557|P3|Overall Study|Use of prohibted therapies|1
1362189|NCT01620762|4492558|P2|Overall Study|Use of prohibted therapies|1
1362190|NCT01620762|4492559|P1|Overall Study|Use of prohibted therapies|0
1362191|NCT01620762|4492557|P3|Overall Study|Non-specified|5
1362192|NCT01620762|4492558|P2|Overall Study|Non-specified|6
1362193|NCT01620762|4492559|P1|Overall Study|Non-specified|3
1362194|NCT01620762|4492557|P3|Overall Study|Subject deterioration|1
1362195|NCT01620762|4492558|P2|Overall Study|Subject deterioration|1
1362196|NCT01620762|4492559|P1|Overall Study|Subject deterioration|0
1362197|NCT01620762|4492557|P3|Overall Study|Protocol deviation|6
1362198|NCT01620762|4492558|P2|Overall Study|Protocol deviation|1
1362199|NCT01620762|4492559|P1|Overall Study|Protocol deviation|1
1362200|NCT01620762|4492557|P3|Overall Study|Lost to Follow-up|10
1362201|NCT01620762|4492558|P2|Overall Study|Lost to Follow-up|17
1362202|NCT01620762|4492559|P1|Overall Study|Lost to Follow-up|11
1362203|NCT01620762|4492557|P3|Overall Study|Withdrawal by Subject|27
1362204|NCT01620762|4492558|P2|Overall Study|Withdrawal by Subject|26
1362205|NCT01620762|4492559|P1|Overall Study|Withdrawal by Subject|23
1362206|NCT01620762|4492557|P3|Overall Study|Adverse Event|2
1362207|NCT01620762|4492558|P2|Overall Study|Adverse Event|5
1362208|NCT01620762|4492559|P1|Overall Study|Adverse Event|9
1362209|NCT01620762|4492557|P3|Overall Study|Protocol Violation|1
1362210|NCT01620762|4492558|P2|Overall Study|Protocol Violation|1
1362211|NCT01620762|4492559|P1|Overall Study|Protocol Violation|1
1362212|NCT01620489|4492604|P2|Overall Study|Unclassified|2
1362213|NCT01620489|4492605|P1|Overall Study|Unclassified|1
1362214|NCT01620489|4492604|P2|Overall Study|Withdrawal Criteria|25
1362215|NCT01620489|4492605|P1|Overall Study|Withdrawal Criteria|17
1362216|NCT01620489|4492604|P2|Overall Study|Protocol Violation|3
1362217|NCT01620489|4492605|P1|Overall Study|Protocol Violation|0
1362218|NCT01620489|4492604|P2|Overall Study|Adverse Event|4
1362219|NCT01620489|4492605|P1|Overall Study|Adverse Event|17
1362220|NCT01620255|4492626|P5|Overall Study|Withdrawn at discretion of investigator|1
1362221|NCT01620255|4492627|P4|Overall Study|Withdrawn at discretion of investigator|0
1362222|NCT01620255|4492628|P3|Overall Study|Withdrawn at discretion of investigator|0
1362223|NCT01620255|4492629|P2|Overall Study|Withdrawn at discretion of investigator|0
1362224|NCT01620255|4492630|P1|Overall Study|Withdrawn at discretion of investigator|0
1362225|NCT01620255|4492626|P5|Overall Study|Adverse Event|1
1362226|NCT01620255|4492627|P4|Overall Study|Adverse Event|1
1362227|NCT01620255|4492628|P3|Overall Study|Adverse Event|0
1362228|NCT01620255|4492629|P2|Overall Study|Adverse Event|4
1362229|NCT01620255|4492630|P1|Overall Study|Adverse Event|0
1362230|NCT01620255|4492626|P5|Overall Study|Non-compliance|0
1362231|NCT01620255|4492627|P4|Overall Study|Non-compliance|0
1362232|NCT01620255|4492628|P3|Overall Study|Non-compliance|0
1362233|NCT01620255|4492629|P2|Overall Study|Non-compliance|1
1362234|NCT01620255|4492630|P1|Overall Study|Non-compliance|0
1362235|NCT01620255|4492626|P5|Overall Study|Participant underwent fecal transplant|0
1362236|NCT01620255|4492627|P4|Overall Study|Participant underwent fecal transplant|0
1362237|NCT01620255|4492628|P3|Overall Study|Participant underwent fecal transplant|1
1362238|NCT01620255|4492629|P2|Overall Study|Participant underwent fecal transplant|0
1362239|NCT01620255|4492630|P1|Overall Study|Participant underwent fecal transplant|0
1362240|NCT01620255|4492626|P5|Overall Study|Withdrawal by Subject|4
1362241|NCT01620255|4492627|P4|Overall Study|Withdrawal by Subject|2
1362242|NCT01620255|4492628|P3|Overall Study|Withdrawal by Subject|1
1362243|NCT01620255|4492629|P2|Overall Study|Withdrawal by Subject|1
1362244|NCT01620255|4492630|P1|Overall Study|Withdrawal by Subject|4
1362245|NCT01620177|4492707|P1|Overall Study|Randomized, Not Active due to Scheduling|1
1362246|NCT01620177|4492707|P1|Overall Study|Physician Decision|2
1362247|NCT01620177|4492707|P1|Overall Study|Lost to Follow-up|7
1362248|NCT01620177|4492707|P1|Overall Study|Withdrawal by Subject|26
1362249|NCT01620177|4492707|P1|Overall Study|Failure at Screening Visit|43
1362250|NCT01620138|4492732|P2|Overall Study|Adverse Event|0
1362251|NCT01620138|4492733|P1|Overall Study|Adverse Event|2
1362252|NCT01620138|4492732|P2|Overall Study|Lack of Efficacy|0
1362253|NCT01620138|4492733|P1|Overall Study|Lack of Efficacy|1
1362254|NCT01620138|4492732|P2|Overall Study|Withdrawal by Subject|0
1362255|NCT01620138|4492733|P1|Overall Study|Withdrawal by Subject|3
1362256|NCT01620086|4492741|P3|Overall Study|Physician Decision|0
1362257|NCT01620086|4492742|P2|Overall Study|Physician Decision|0
1362258|NCT01620086|4492743|P1|Overall Study|Physician Decision|1
1362259|NCT01620086|4492741|P3|Overall Study|failed study criteria|0
1362260|NCT01620086|4492742|P2|Overall Study|failed study criteria|4
1362261|NCT01620086|4492743|P1|Overall Study|failed study criteria|1
1362262|NCT01620086|4492741|P3|Overall Study|Withdrawal by Subject|0
1362263|NCT01620086|4492742|P2|Overall Study|Withdrawal by Subject|3
1362264|NCT01620086|4492743|P1|Overall Study|Withdrawal by Subject|3
1362265|NCT01620060|4492762|P1|Overall Study|Per Sponsor Decision|2
1362266|NCT01620060|4492762|P1|Overall Study|Family emergency|1
1362267|NCT01620060|4492762|P1|Overall Study|Did not comply with Study Produre|1
1362268|NCT01620060|4492762|P1|Overall Study|Withdrawal by Subject|1
1362269|NCT01620060|4492762|P1|Overall Study|Protocol Violation|1
1362270|NCT01620060|4492762|P1|Overall Study|Adverse Event|9
1362271|NCT01619878|4492800|P1|Follow-up at 12 Months of Age|Death|2
1362272|NCT01619878|4492800|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
1362273|NCT01619878|4492800|P1|6 Week Follow-up Phase|Adverse Event|1
1362274|NCT01619800|4492814|P2|Overall Study|study terminated|0
1362275|NCT01619800|4492815|P1|Overall Study|study terminated|2
1362276|NCT01619787|4492823|P1|Overall Study|Lost to Follow-up|5
1362277|NCT01619579|4492840|P2|Overall Study|Withdrawal by Subject|3
1362278|NCT01619579|4492841|P1|Overall Study|Withdrawal by Subject|0
1362279|NCT01619423|4492855|P4|Part 1 (Dose Escalation)|High basal Mn|0
1362280|NCT01619423|4492856|P3|Part 1 (Dose Escalation)|High basal Mn|0
1362281|NCT01619423|4492857|P2|Part 1 (Dose Escalation)|High basal Mn|2
1362282|NCT01619423|4492858|P1|Part 1 (Dose Escalation)|High basal Mn|0
1362283|NCT01619085|4492869|P1|Overall Study|Ongoing on trial|27
1362284|NCT01619085|4492869|P1|Overall Study|Not treated|1
1362285|NCT01619085|4492869|P1|Overall Study|Other than specified|94
1362286|NCT01619085|4492869|P1|Overall Study|Withdrawal by Subject|15
1362287|NCT01619085|4492869|P1|Overall Study|Lost to Follow-up|10
1362288|NCT01619085|4492869|P1|Overall Study|Protocol Violation|10
1362289|NCT01619085|4492869|P1|Overall Study|Adverse Event|212
1362290|NCT01619059|4492875|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
1362291|NCT01619059|4492876|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
1362292|NCT01619059|4492875|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
1362293|NCT01619059|4492876|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
1362294|NCT01619059|4492875|P2|Long-Term (LT) Treatment Period|Death|0
1362295|NCT01619059|4492876|P1|Long-Term (LT) Treatment Period|Death|1
1362296|NCT01619059|4492875|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
1362297|NCT01619059|4492876|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
1362298|NCT01619059|4492875|P2|Long-Term (LT) Treatment Period|Adverse Event|3
1362299|NCT01619059|4492876|P1|Long-Term (LT) Treatment Period|Adverse Event|2
1362300|NCT01619059|4492875|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
1362301|NCT01619059|4492876|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
1362302|NCT01619059|4492875|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
1362303|NCT01619059|4492876|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
1362304|NCT01619059|4492875|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
1362305|NCT01619059|4492876|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
1362393|NCT01617668|4493178|P3|Overall Study|Subject/guardian decision|2
1362306|NCT01619059|4492875|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
1362307|NCT01619059|4492876|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
1362308|NCT01619059|4492875|P2|Short-Term (ST) Treatment Period|Adverse Event|0
1362309|NCT01619059|4492876|P1|Short-Term (ST) Treatment Period|Adverse Event|1
1362310|NCT01618968|4492892|P4|Overall Study|Death|1
1362311|NCT01618968|4492893|P3|Overall Study|Death|0
1362312|NCT01618968|4492894|P2|Overall Study|Death|0
1362313|NCT01618968|4492895|P1|Overall Study|Death|0
1362314|NCT01618968|4492892|P4|Overall Study|Adverse Event|0
1362315|NCT01618968|4492893|P3|Overall Study|Adverse Event|0
1362316|NCT01618968|4492894|P2|Overall Study|Adverse Event|0
1362317|NCT01618968|4492895|P1|Overall Study|Adverse Event|1
1362318|NCT01618864|4492962|P1|Overall Study|Lost to Follow-up|2
1362319|NCT01618864|4492962|P1|Overall Study|Withdrawal by Subject|2
1362320|NCT01618838|4492971|P1|Overall Study|slow accrual, trial closed prematurely.|4
1362321|NCT01618708|4492979|P2|Overall Study|Randomized but not treated|2
1362322|NCT01618708|4492980|P1|Overall Study|Randomized but not treated|3
1362323|NCT01618708|4492979|P2|Overall Study|Other than specified above|1
1362324|NCT01618708|4492980|P1|Overall Study|Other than specified above|1
1362325|NCT01618708|4492979|P2|Overall Study|Technical problems|0
1362326|NCT01618708|4492980|P1|Overall Study|Technical problems|2
1362327|NCT01618708|4492979|P2|Overall Study|Lack of Efficacy|8
1362328|NCT01618708|4492980|P1|Overall Study|Lack of Efficacy|8
1362329|NCT01618708|4492979|P2|Overall Study|Withdrawal by Subject|22
1362330|NCT01618708|4492980|P1|Overall Study|Withdrawal by Subject|17
1362331|NCT01618708|4492979|P2|Overall Study|Lost to Follow-up|3
1362332|NCT01618708|4492980|P1|Overall Study|Lost to Follow-up|3
1362333|NCT01618708|4492979|P2|Overall Study|Adverse Event|10
1362334|NCT01618708|4492980|P1|Overall Study|Adverse Event|10
1362335|NCT01618669|4492994|P2|Overall Study|Miscellaneous Reason|1
1362336|NCT01618669|4492995|P1|Overall Study|Miscellaneous Reason|0
1362337|NCT01618669|4492994|P2|Overall Study|Withdrawal by Subject|9
1362338|NCT01618669|4492995|P1|Overall Study|Withdrawal by Subject|9
1362339|NCT01618669|4492994|P2|Overall Study|Protocol Violation|3
1362340|NCT01618669|4492995|P1|Overall Study|Protocol Violation|5
1362341|NCT01618669|4492994|P2|Overall Study|Adverse Event|7
1362342|NCT01618669|4492995|P1|Overall Study|Adverse Event|16
1362343|NCT01618669|4492994|P2|Overall Study|Randomized but Never Received Study Drug|2
1362344|NCT01618669|4492995|P1|Overall Study|Randomized but Never Received Study Drug|3
1362345|NCT01618669|4492994|P2|Overall Study|Lost to Follow-up|1
1362346|NCT01618669|4492995|P1|Overall Study|Lost to Follow-up|1
1362347|NCT01618266|4493052|P1|Overall Study|Protocol Violation|43
1362348|NCT01618266|4493052|P1|Overall Study|Lack of Efficacy|23
1362349|NCT01618266|4493052|P1|Overall Study|Other reasons|11
1362350|NCT01618266|4493052|P1|Overall Study|Treatment satisfaction|10
1362351|NCT01618266|4493052|P1|Overall Study|Lost to Follow-up|9
1362352|NCT01618214|4493089|P2|Overall Study|Unclassified|5
1362353|NCT01618214|4493090|P1|Overall Study|Unclassified|4
1362354|NCT01618214|4493089|P2|Overall Study|Withdrawal Criteria|2
1362355|NCT01618214|4493090|P1|Overall Study|Withdrawal Criteria|1
1362356|NCT01618214|4493089|P2|Overall Study|Protocol Violation|4
1362357|NCT01618214|4493090|P1|Overall Study|Protocol Violation|1
1362358|NCT01618214|4493089|P2|Overall Study|Lack of Efficacy|1
1362359|NCT01618214|4493090|P1|Overall Study|Lack of Efficacy|1
1362360|NCT01618214|4493089|P2|Overall Study|Adverse Event|1
1362361|NCT01618214|4493090|P1|Overall Study|Adverse Event|3
1362362|NCT01618162|4493106|P2|Overall Study|Unclassified|13
1362363|NCT01618162|4493107|P1|Overall Study|Unclassified|14
1362364|NCT01618162|4493106|P2|Overall Study|Withdrawal Criteria|10
1362365|NCT01618162|4493107|P1|Overall Study|Withdrawal Criteria|2
1362366|NCT01618162|4493106|P2|Overall Study|Adverse Event|2
1362367|NCT01618162|4493107|P1|Overall Study|Adverse Event|9
1362368|NCT01618162|4493106|P2|Overall Study|Protocol Violation|10
1362369|NCT01618162|4493107|P1|Overall Study|Protocol Violation|13
1362370|NCT01618019|4493127|P2|Overall Study|Withdrawal by Subject|14
1362371|NCT01618019|4493128|P1|Overall Study|Withdrawal by Subject|14
1362372|NCT01617681|4493152|P5|Period 2 Open Label|Withdrawal by Subject|3
1362373|NCT01617681|4493153|P4|Period 2 Open Label|Withdrawal by Subject|0
1362374|NCT01617681|4493154|P3|Period 2 Open Label|Withdrawal by Subject|0
1362375|NCT01617681|4493155|P2|Period 2 Open Label|Withdrawal by Subject|0
1362376|NCT01617681|4493156|P1|Period 2 Open Label|Withdrawal by Subject|0
1362377|NCT01617681|4493152|P5|Period 2 Open Label|Adverse Event|3
1362378|NCT01617681|4493153|P4|Period 2 Open Label|Adverse Event|0
1362379|NCT01617681|4493154|P3|Period 2 Open Label|Adverse Event|0
1362380|NCT01617681|4493155|P2|Period 2 Open Label|Adverse Event|0
1362381|NCT01617681|4493156|P1|Period 2 Open Label|Adverse Event|0
1362382|NCT01617681|4493152|P5|Period 1 Double Blind|Withdrawal by Subject|0
1362383|NCT01617681|4493153|P4|Period 1 Double Blind|Withdrawal by Subject|0
1362384|NCT01617681|4493154|P3|Period 1 Double Blind|Withdrawal by Subject|1
1362385|NCT01617681|4493155|P2|Period 1 Double Blind|Withdrawal by Subject|1
1362386|NCT01617681|4493156|P1|Period 1 Double Blind|Withdrawal by Subject|1
1362387|NCT01617681|4493152|P5|Period 1 Double Blind|Adverse Event|0
1362388|NCT01617681|4493153|P4|Period 1 Double Blind|Adverse Event|2
1362389|NCT01617681|4493154|P3|Period 1 Double Blind|Adverse Event|0
1362390|NCT01617681|4493155|P2|Period 1 Double Blind|Adverse Event|0
1362391|NCT01617681|4493156|P1|Period 1 Double Blind|Adverse Event|2
1362392|NCT01617668|4493177|P4|Overall Study|Subject/guardian decision|1
1362394|NCT01617668|4493179|P2|Overall Study|Subject/guardian decision|3
1362395|NCT01617668|4493180|P1|Overall Study|Subject/guardian decision|1
1362396|NCT01617668|4493177|P4|Overall Study|Progressive Disease|9
1362397|NCT01617668|4493178|P3|Overall Study|Progressive Disease|6
1362398|NCT01617668|4493179|P2|Overall Study|Progressive Disease|4
1362399|NCT01617668|4493180|P1|Overall Study|Progressive Disease|4
1362400|NCT01617668|4493177|P4|Overall Study|Physician Decision|0
1362401|NCT01617668|4493178|P3|Overall Study|Physician Decision|3
1362402|NCT01617668|4493179|P2|Overall Study|Physician Decision|2
1362403|NCT01617668|4493180|P1|Overall Study|Physician Decision|1
1362404|NCT01617668|4493177|P4|Overall Study|Adverse Event|5
1362405|NCT01617668|4493178|P3|Overall Study|Adverse Event|12
1362406|NCT01617668|4493179|P2|Overall Study|Adverse Event|0
1362407|NCT01617668|4493180|P1|Overall Study|Adverse Event|7
1362408|NCT01617655|4493221|P2|Overall Study|Other than specified above|2
1362409|NCT01617655|4493222|P1|Overall Study|Other than specified above|1
1362410|NCT01617655|4493221|P2|Overall Study|Site closure|5
1362411|NCT01617655|4493222|P1|Overall Study|Site closure|3
1362412|NCT01617655|4493221|P2|Overall Study|Last visit outside protocol visit window|10
1362413|NCT01617655|4493222|P1|Overall Study|Last visit outside protocol visit window|1
1362414|NCT01617655|4493221|P2|Overall Study|Consent withdrawn by participant|1
1362415|NCT01617655|4493222|P1|Overall Study|Consent withdrawn by participant|1
1362416|NCT01617655|4493221|P2|Overall Study|Participants moved|4
1362417|NCT01617655|4493222|P1|Overall Study|Participants moved|0
1362418|NCT01617655|4493221|P2|Overall Study|Poor compliance to protocol|4
1362419|NCT01617655|4493222|P1|Overall Study|Poor compliance to protocol|1
1362420|NCT01617655|4493221|P2|Overall Study|Adverse Event|3
1362421|NCT01617655|4493222|P1|Overall Study|Adverse Event|2
1362422|NCT01617629|4493282|P1|Overall Study|Participant Withdrew Consent|2
1362423|NCT01617629|4493282|P1|Overall Study|Reason Not Specified|1
1362424|NCT01617629|4493282|P1|Overall Study|Investigator's Clinical Judgement|1
1362425|NCT01617629|4493282|P1|Overall Study|Death|2
1362426|NCT01617460|4493310|P1|Overall Study|Withdrawal by Subject|9
1362427|NCT01617460|4493310|P1|Overall Study|Protocol Violation|5
1362428|NCT01617460|4493310|P1|Overall Study|Physician Decision|16
1362429|NCT01617460|4493310|P1|Overall Study|Adverse Event|10
1362430|NCT01617447|4493316|P2|Overall Study|Physician Decision|2
1362431|NCT01617447|4493317|P1|Overall Study|Physician Decision|0
1362432|NCT01617447|4493316|P2|Overall Study|Adverse Event|1
1362433|NCT01617447|4493317|P1|Overall Study|Adverse Event|0
1362434|NCT01617434|4493325|P2|Overall Study|Unclassified|4
1362435|NCT01617434|4493326|P1|Overall Study|Unclassified|3
1362436|NCT01617434|4493325|P2|Overall Study|Withdrawal Criteria|37
1362437|NCT01617434|4493326|P1|Overall Study|Withdrawal Criteria|12
1362438|NCT01617434|4493325|P2|Overall Study|Protocol Violation|7
1362439|NCT01617434|4493326|P1|Overall Study|Protocol Violation|8
1362440|NCT01617434|4493325|P2|Overall Study|Adverse Event|3
1362441|NCT01617434|4493326|P1|Overall Study|Adverse Event|12
1362442|NCT01617187|4493358|P4|Treatment Through Study Completion|Protocol Violation|1
1362443|NCT01617187|4493359|P3|Treatment Through Study Completion|Protocol Violation|0
1362444|NCT01617187|4493360|P2|Treatment Through Study Completion|Protocol Violation|0
1362445|NCT01617187|4493361|P1|Treatment Through Study Completion|Protocol Violation|1
1362446|NCT01617187|4493358|P4|Treatment Through Study Completion|Withdrawal by Subject|6
1362447|NCT01617187|4493359|P3|Treatment Through Study Completion|Withdrawal by Subject|3
1362448|NCT01617187|4493360|P2|Treatment Through Study Completion|Withdrawal by Subject|8
1362449|NCT01617187|4493361|P1|Treatment Through Study Completion|Withdrawal by Subject|5
1362450|NCT01617187|4493358|P4|Treatment Through Study Completion|Lost to Follow-up|2
1362451|NCT01617187|4493359|P3|Treatment Through Study Completion|Lost to Follow-up|2
1362452|NCT01617187|4493360|P2|Treatment Through Study Completion|Lost to Follow-up|2
1362453|NCT01617187|4493361|P1|Treatment Through Study Completion|Lost to Follow-up|4
1362454|NCT01617187|4493358|P4|Treatment Through Study Completion|Adverse Event|1
1362455|NCT01617187|4493359|P3|Treatment Through Study Completion|Adverse Event|0
1362456|NCT01617187|4493360|P2|Treatment Through Study Completion|Adverse Event|1
1362457|NCT01617187|4493361|P1|Treatment Through Study Completion|Adverse Event|1
1362458|NCT01617187|4493358|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
1362459|NCT01617187|4493359|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
1362460|NCT01617187|4493360|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
1362461|NCT01617187|4493361|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
1362462|NCT01617187|4493358|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
1362463|NCT01617187|4493359|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
1362464|NCT01617187|4493360|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
1362465|NCT01617187|4493361|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
1362466|NCT01617187|4493358|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
1362467|NCT01617187|4493359|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
1362468|NCT01617187|4493360|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
1362469|NCT01617187|4493361|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
1362470|NCT01617070|4493458|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
1362471|NCT01617005|4493476|P1|Overall Study|Lack of motivation for treatment|1
1362472|NCT01617005|4493476|P1|Overall Study|Pregnancy|1
1362473|NCT01616953|4493485|P2|Overall Study|lack of bone and soft tissue|0
1362474|NCT01616953|4493486|P1|Overall Study|lack of bone and soft tissue|1
1362475|NCT01616953|4493485|P2|Overall Study|Lost to Follow-up|0
1362476|NCT01616953|4493486|P1|Overall Study|Lost to Follow-up|1
1362477|NCT01616771|4493494|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
1362478|NCT01616459|4493519|P4|Overall Study|Other reason|0
1362479|NCT01616459|4493520|P3|Overall Study|Other reason|1
1362480|NCT01616459|4493521|P2|Overall Study|Other reason|1
1362481|NCT01616459|4493522|P1|Overall Study|Other reason|0
1362482|NCT01616459|4493519|P4|Overall Study|Withdrawal by Subject|4
1362483|NCT01616459|4493520|P3|Overall Study|Withdrawal by Subject|4
1362484|NCT01616459|4493521|P2|Overall Study|Withdrawal by Subject|4
1362485|NCT01616459|4493522|P1|Overall Study|Withdrawal by Subject|2
1362486|NCT01616459|4493519|P4|Overall Study|Protocol Violation|2
1362487|NCT01616459|4493520|P3|Overall Study|Protocol Violation|0
1362488|NCT01616459|4493521|P2|Overall Study|Protocol Violation|0
1362489|NCT01616459|4493522|P1|Overall Study|Protocol Violation|0
1362490|NCT01616459|4493519|P4|Overall Study|Lost to Follow-up|2
1362491|NCT01616459|4493520|P3|Overall Study|Lost to Follow-up|3
1362492|NCT01616459|4493521|P2|Overall Study|Lost to Follow-up|11
1362493|NCT01616459|4493522|P1|Overall Study|Lost to Follow-up|1
1362494|NCT01616459|4493519|P4|Overall Study|Adverse Event|0
1362495|NCT01616459|4493520|P3|Overall Study|Adverse Event|2
1362496|NCT01616459|4493521|P2|Overall Study|Adverse Event|1
1362497|NCT01616459|4493522|P1|Overall Study|Adverse Event|1
1362498|NCT01616173|4493611|P3|Overall Study|Lost to Follow-up|0
1362499|NCT01616173|4493612|P2|Overall Study|Lost to Follow-up|2
1362500|NCT01616173|4493613|P1|Overall Study|Lost to Follow-up|0
1362501|NCT01615939|4493646|P2|Overall Study|Lost to Follow-up|0
1362502|NCT01615939|4493647|P1|Overall Study|Lost to Follow-up|5
1362503|NCT01615822|4493660|P3|Period 2|Lost to Follow-up|2
1362504|NCT01615822|4493661|P2|Period 2|Lost to Follow-up|1
1362505|NCT01615822|4493662|P1|Period 2|Lost to Follow-up|0
1362506|NCT01615822|4493660|P3|Period 1|Adverse Event|0
1362507|NCT01615822|4493661|P2|Period 1|Adverse Event|1
1362508|NCT01615822|4493662|P1|Period 1|Adverse Event|1
1362509|NCT01615822|4493660|P3|Period 1|Withdrawal by Subject|0
1362510|NCT01615822|4493661|P2|Period 1|Withdrawal by Subject|1
1362511|NCT01615822|4493662|P1|Period 1|Withdrawal by Subject|0
1362512|NCT01615328|4493750|P2|Overall Study|Lost to Follow-up|5
1362513|NCT01615328|4493751|P1|Overall Study|Lost to Follow-up|3
1362514|NCT01615263|4493763|P2|Overall Study|Post-randomization exclusion|2
1362515|NCT01615263|4493764|P1|Overall Study|Post-randomization exclusion|0
1362516|NCT01615198|4493778|P2|Overall Study|Adverse Event|5
1362517|NCT01615198|4493779|P1|Overall Study|Adverse Event|11
1362518|NCT01615198|4493778|P2|Overall Study|Lack of Efficacy|6
1362519|NCT01615198|4493779|P1|Overall Study|Lack of Efficacy|1
1362520|NCT01615198|4493778|P2|Overall Study|Lost to Follow-up|1
1362521|NCT01615198|4493779|P1|Overall Study|Lost to Follow-up|1
1362522|NCT01615198|4493778|P2|Overall Study|Physician Decision|1
1362523|NCT01615198|4493779|P1|Overall Study|Physician Decision|5
1362524|NCT01615198|4493778|P2|Overall Study|Protocol deviation|1
1362525|NCT01615198|4493779|P1|Overall Study|Protocol deviation|1
1362526|NCT01615198|4493778|P2|Overall Study|Withdrawal by Subject|5
1362527|NCT01615198|4493779|P1|Overall Study|Withdrawal by Subject|5
1362528|NCT01615029|4493812|P5|Overall Study|Ongoing|23
1362529|NCT01615029|4493813|P4|Overall Study|Ongoing|2
1362530|NCT01615029|4493814|P3|Overall Study|Ongoing|3
1362531|NCT01615029|4493815|P2|Overall Study|Ongoing|2
1362532|NCT01615029|4493816|P1|Overall Study|Ongoing|1
1362533|NCT01615029|4493812|P5|Overall Study|Physician Decision|1
1362534|NCT01615029|4493813|P4|Overall Study|Physician Decision|0
1362535|NCT01615029|4493814|P3|Overall Study|Physician Decision|0
1362536|NCT01615029|4493815|P2|Overall Study|Physician Decision|0
1362537|NCT01615029|4493816|P1|Overall Study|Physician Decision|0
1362538|NCT01615029|4493812|P5|Overall Study|Progressive disease|5
1362539|NCT01615029|4493813|P4|Overall Study|Progressive disease|1
1362540|NCT01615029|4493814|P3|Overall Study|Progressive disease|1
1362541|NCT01615029|4493815|P2|Overall Study|Progressive disease|1
1362542|NCT01615029|4493816|P1|Overall Study|Progressive disease|2
1362543|NCT01615029|4493812|P5|Overall Study|Lost to Follow-up|1
1362544|NCT01615029|4493813|P4|Overall Study|Lost to Follow-up|0
1362545|NCT01615029|4493814|P3|Overall Study|Lost to Follow-up|0
1362546|NCT01615029|4493815|P2|Overall Study|Lost to Follow-up|0
1362547|NCT01615029|4493816|P1|Overall Study|Lost to Follow-up|0
1362548|NCT01615029|4493812|P5|Overall Study|Death|1
1362549|NCT01615029|4493813|P4|Overall Study|Death|0
1362550|NCT01615029|4493814|P3|Overall Study|Death|0
1362551|NCT01615029|4493815|P2|Overall Study|Death|0
1362552|NCT01615029|4493816|P1|Overall Study|Death|0
1362553|NCT01615029|4493812|P5|Overall Study|Adverse Event|1
1362554|NCT01615029|4493813|P4|Overall Study|Adverse Event|0
1362555|NCT01615029|4493814|P3|Overall Study|Adverse Event|0
1362556|NCT01615029|4493815|P2|Overall Study|Adverse Event|0
1362557|NCT01615029|4493816|P1|Overall Study|Adverse Event|0
1362558|NCT01614886|4493839|P2|Overall Study|Protocol deviation|2
1362559|NCT01614886|4493840|P1|Overall Study|Protocol deviation|0
1362560|NCT01614886|4493839|P2|Overall Study|Death|0
1362561|NCT01614886|4493840|P1|Overall Study|Death|1
1362562|NCT01614886|4493839|P2|Overall Study|Withdrawal by Subject|4
1362563|NCT01614886|4493840|P1|Overall Study|Withdrawal by Subject|4
1362564|NCT01614886|4493839|P2|Overall Study|Adverse Event|20
1362565|NCT01614886|4493840|P1|Overall Study|Adverse Event|15
1362566|NCT01614795|4493858|P4|Overall Study|Ineligible|0
1362567|NCT01614795|4493859|P3|Overall Study|Ineligible|0
1362568|NCT01614795|4493860|P2|Overall Study|Ineligible|1
1362569|NCT01614795|4493861|P1|Overall Study|Ineligible|0
1362570|NCT01614795|4493858|P4|Overall Study|Withdrawal by Subject|2
1362571|NCT01614795|4493859|P3|Overall Study|Withdrawal by Subject|0
1362572|NCT01614795|4493860|P2|Overall Study|Withdrawal by Subject|1
1362573|NCT01614795|4493861|P1|Overall Study|Withdrawal by Subject|0
1362574|NCT01614795|4493858|P4|Overall Study|Physician Decision|1
1362575|NCT01614795|4493859|P3|Overall Study|Physician Decision|1
1362576|NCT01614795|4493860|P2|Overall Study|Physician Decision|0
1362577|NCT01614795|4493861|P1|Overall Study|Physician Decision|1
1362578|NCT01614795|4493858|P4|Overall Study|Lack of Efficacy|8
1362579|NCT01614795|4493859|P3|Overall Study|Lack of Efficacy|9
1362580|NCT01614795|4493860|P2|Overall Study|Lack of Efficacy|10
1362581|NCT01614795|4493861|P1|Overall Study|Lack of Efficacy|10
1362582|NCT01614795|4493858|P4|Overall Study|Adverse Event|1
1362583|NCT01614795|4493859|P3|Overall Study|Adverse Event|1
1362584|NCT01614795|4493860|P2|Overall Study|Adverse Event|0
1362585|NCT01614795|4493861|P1|Overall Study|Adverse Event|0
1362586|NCT01614769|4493881|P6|Period 3|Withdrawal by Subject|0
1362587|NCT01614769|4493882|P5|Period 3|Withdrawal by Subject|0
1362588|NCT01614769|4493883|P4|Period 3|Withdrawal by Subject|0
1362589|NCT01614769|4493884|P3|Period 3|Withdrawal by Subject|1
1362590|NCT01614769|4493885|P2|Period 3|Withdrawal by Subject|0
1362591|NCT01614769|4493886|P1|Period 3|Withdrawal by Subject|0
1362592|NCT01614769|4493881|P6|Period 1|Withdrawal by Subject|0
1362593|NCT01614769|4493882|P5|Period 1|Withdrawal by Subject|0
1362594|NCT01614769|4493883|P4|Period 1|Withdrawal by Subject|0
1362595|NCT01614769|4493884|P3|Period 1|Withdrawal by Subject|0
1362596|NCT01614769|4493885|P2|Period 1|Withdrawal by Subject|0
1362597|NCT01614769|4493886|P1|Period 1|Withdrawal by Subject|1
1362598|NCT01614769|4493881|P6|Period 1|Protocol Violation|0
1362599|NCT01614769|4493882|P5|Period 1|Protocol Violation|0
1362600|NCT01614769|4493883|P4|Period 1|Protocol Violation|1
1362601|NCT01614769|4493884|P3|Period 1|Protocol Violation|0
1362602|NCT01614769|4493885|P2|Period 1|Protocol Violation|0
1362603|NCT01614769|4493886|P1|Period 1|Protocol Violation|0
1362604|NCT01614769|4493881|P6|Period 1|Discontinued due to Hypoglycemia|1
1362605|NCT01614769|4493882|P5|Period 1|Discontinued due to Hypoglycemia|0
1362606|NCT01614769|4493883|P4|Period 1|Discontinued due to Hypoglycemia|1
1362607|NCT01614769|4493884|P3|Period 1|Discontinued due to Hypoglycemia|0
1362608|NCT01614769|4493885|P2|Period 1|Discontinued due to Hypoglycemia|0
1362609|NCT01614769|4493886|P1|Period 1|Discontinued due to Hypoglycemia|0
1362610|NCT01614600|4493908|P1|Overall Study|Protocol deviation|1
1362611|NCT01614600|4493908|P1|Overall Study|Unable to remove lens at the end of day|1
1362612|NCT01614600|4493908|P1|Overall Study|Discomfort|1
1362613|NCT01614600|4493908|P1|Overall Study|Unacceptable fit|1
1362614|NCT01614470|4493939|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
1362615|NCT01614470|4493940|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
1362616|NCT01614470|4493941|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
1362617|NCT01614470|4493939|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1362618|NCT01614470|4493940|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1362619|NCT01614470|4493941|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
1362620|NCT01614457|4493963|P2|Overall Study|Pregnancy (Self or Partner)|0
1362621|NCT01614457|4493964|P1|Overall Study|Pregnancy (Self or Partner)|1
1362622|NCT01614457|4493963|P2|Overall Study|Non-Compliance|0
1362623|NCT01614457|4493964|P1|Overall Study|Non-Compliance|1
1362624|NCT01614249|4493982|P2|Overall Study|Lost to Follow-up|23
1362625|NCT01614249|4493983|P1|Overall Study|Lost to Follow-up|11
1362626|NCT01614093|4493997|P1|Overall Study|Withdrawal by Subject|1
1362627|NCT01613716|4494010|P1|Overall Study|Lost to Follow-up|4
1362628|NCT01613716|4494010|P1|Overall Study|screen failures|3
1362629|NCT01613599|4494015|P1|Overall Study|Reason not specified|3
1362630|NCT01613599|4494015|P1|Overall Study|Withdrawal by Subject|8
1362631|NCT01613599|4494015|P1|Overall Study|Lost to Follow-up|5
1362632|NCT01613599|4494015|P1|Overall Study|Death|9
1362633|NCT01613417|4494030|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
1362634|NCT01613417|4494031|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
1362635|NCT01613378|4494068|P1|Overall Study|Other Reason|4
1362636|NCT01613378|4494068|P1|Overall Study|Lost to Follow-up|1
1362637|NCT01613378|4494068|P1|Overall Study|Death|2
1362638|NCT01613378|4494068|P1|Overall Study|Withdrawal by Subject|8
1362639|NCT01613378|4494068|P1|Overall Study|Adverse Event|11
1362640|NCT01613378|4494068|P1|Overall Study|Lack of Efficacy|13
1362641|NCT01613326|4494098|P2|Overall Study|Protocol Violation|1
1362642|NCT01613326|4494099|P1|Overall Study|Protocol Violation|0
1362643|NCT01613326|4494098|P2|Overall Study|Administrative|2
1362644|NCT01613326|4494099|P1|Overall Study|Administrative|0
1362645|NCT01613326|4494098|P2|Overall Study|Lost to Follow-up|1
1362646|NCT01613326|4494099|P1|Overall Study|Lost to Follow-up|0
1362647|NCT01613326|4494098|P2|Overall Study|Lack of Efficacy|1
1362648|NCT01613326|4494099|P1|Overall Study|Lack of Efficacy|0
1362649|NCT01613326|4494098|P2|Overall Study|inability to use device|0
1362650|NCT01613326|4494099|P1|Overall Study|inability to use device|1
1362651|NCT01613326|4494098|P2|Overall Study|Abnormal test procedure result(s)|0
1362652|NCT01613326|4494099|P1|Overall Study|Abnormal test procedure result(s)|2
1362653|NCT01613326|4494098|P2|Overall Study|Withdrawal by Subject|4
1362654|NCT01613326|4494099|P1|Overall Study|Withdrawal by Subject|3
1362655|NCT01613326|4494098|P2|Overall Study|Adverse Event|5
1362656|NCT01613326|4494099|P1|Overall Study|Adverse Event|7
1362657|NCT01613248|4494156|P6|Overall Study|Pregnancy|0
1362658|NCT01613248|4494157|P5|Overall Study|Pregnancy|0
1362659|NCT01613248|4494158|P4|Overall Study|Pregnancy|1
1362660|NCT01613248|4494159|P3|Overall Study|Pregnancy|0
1362661|NCT01613248|4494160|P2|Overall Study|Pregnancy|0
1362662|NCT01613248|4494161|P1|Overall Study|Pregnancy|0
1362663|NCT01613248|4494156|P6|Overall Study|Lack of Qualifying Event|18
1362664|NCT01613248|4494157|P5|Overall Study|Lack of Qualifying Event|15
1362665|NCT01613248|4494158|P4|Overall Study|Lack of Qualifying Event|11
1362666|NCT01613248|4494159|P3|Overall Study|Lack of Qualifying Event|10
1362667|NCT01613248|4494160|P2|Overall Study|Lack of Qualifying Event|11
1362668|NCT01613248|4494161|P1|Overall Study|Lack of Qualifying Event|9
1362669|NCT01613248|4494156|P6|Overall Study|Physician Decision|6
1362670|NCT01613248|4494157|P5|Overall Study|Physician Decision|7
1362671|NCT01613248|4494158|P4|Overall Study|Physician Decision|4
1362672|NCT01613248|4494159|P3|Overall Study|Physician Decision|9
1362673|NCT01613248|4494160|P2|Overall Study|Physician Decision|8
1362674|NCT01613248|4494161|P1|Overall Study|Physician Decision|8
1362675|NCT01613248|4494156|P6|Overall Study|Study Terminated by Sponsor|11
1362676|NCT01613248|4494157|P5|Overall Study|Study Terminated by Sponsor|9
1362677|NCT01613248|4494158|P4|Overall Study|Study Terminated by Sponsor|8
1362678|NCT01613248|4494159|P3|Overall Study|Study Terminated by Sponsor|8
1362679|NCT01613248|4494160|P2|Overall Study|Study Terminated by Sponsor|6
1362680|NCT01613248|4494161|P1|Overall Study|Study Terminated by Sponsor|4
1362681|NCT01613248|4494156|P6|Overall Study|Lost to Follow-up|2
1362682|NCT01613248|4494157|P5|Overall Study|Lost to Follow-up|4
1362683|NCT01613248|4494158|P4|Overall Study|Lost to Follow-up|8
1362684|NCT01613248|4494159|P3|Overall Study|Lost to Follow-up|4
1362685|NCT01613248|4494160|P2|Overall Study|Lost to Follow-up|7
1362686|NCT01613248|4494161|P1|Overall Study|Lost to Follow-up|5
1362687|NCT01613248|4494156|P6|Overall Study|Withdrawal by Subject|1
1362688|NCT01613248|4494157|P5|Overall Study|Withdrawal by Subject|0
1362689|NCT01613248|4494158|P4|Overall Study|Withdrawal by Subject|5
1362690|NCT01613248|4494159|P3|Overall Study|Withdrawal by Subject|2
1362691|NCT01613248|4494160|P2|Overall Study|Withdrawal by Subject|2
1362692|NCT01613248|4494161|P1|Overall Study|Withdrawal by Subject|3
1362693|NCT01613248|4494156|P6|Overall Study|Adverse Event|0
1362694|NCT01613248|4494157|P5|Overall Study|Adverse Event|0
1362695|NCT01613248|4494158|P4|Overall Study|Adverse Event|1
1362696|NCT01613248|4494159|P3|Overall Study|Adverse Event|0
1362697|NCT01613248|4494160|P2|Overall Study|Adverse Event|0
1362698|NCT01613248|4494161|P1|Overall Study|Adverse Event|0
1362699|NCT01613131|4494261|P2|Overall Study|Withdrawal by Subject|5
1362700|NCT01613131|4494262|P1|Overall Study|Withdrawal by Subject|3
1362701|NCT01613027|4494290|P1|Overall Study|Patient’s Decision Due to Adverse Event|1
1362702|NCT01613027|4494290|P1|Overall Study|Lack of Efficacy|1
1362703|NCT01613027|4494290|P1|Overall Study|Switched Physician|1
1362704|NCT01613027|4494290|P1|Overall Study|Lost to Follow-up|5
1362705|NCT01612858|4494333|P2|Overall Study|Withdrawal by Subject|1
1362706|NCT01612858|4494334|P1|Overall Study|Withdrawal by Subject|5
1362707|NCT01612702|4494371|P2|Overall Study|Protocol Violation|11
1362708|NCT01612702|4494372|P1|Overall Study|Protocol Violation|11
1362709|NCT01612676|4494386|P4|Overall Study|Protocol Violation|0
1362710|NCT01612676|4494387|P3|Overall Study|Protocol Violation|0
1362711|NCT01612676|4494388|P2|Overall Study|Protocol Violation|1
1362712|NCT01612676|4494389|P1|Overall Study|Protocol Violation|0
1362713|NCT01612676|4494386|P4|Overall Study|Adverse Event|3
1362714|NCT01612676|4494387|P3|Overall Study|Adverse Event|1
1362715|NCT01612676|4494388|P2|Overall Study|Adverse Event|3
1362716|NCT01612676|4494389|P1|Overall Study|Adverse Event|2
1362717|NCT01612156|4494487|P2|Overall Study|Protocol Violation|0
1362718|NCT01612156|4494488|P1|Overall Study|Protocol Violation|2
1362719|NCT01612000|4494500|P4|Overall Study|Withdrawal by Subject|2
1362720|NCT01612000|4494501|P3|Overall Study|Withdrawal by Subject|2
1362721|NCT01612000|4494502|P2|Overall Study|Withdrawal by Subject|1
1362722|NCT01612000|4494503|P1|Overall Study|Withdrawal by Subject|3
1362723|NCT01612000|4494500|P4|Overall Study|Physician Decision|0
1362724|NCT01612000|4494501|P3|Overall Study|Physician Decision|1
1362725|NCT01612000|4494502|P2|Overall Study|Physician Decision|0
1362726|NCT01612000|4494503|P1|Overall Study|Physician Decision|0
1362727|NCT01612000|4494500|P4|Overall Study|Lost to Follow-up|8
1362728|NCT01612000|4494501|P3|Overall Study|Lost to Follow-up|4
1362729|NCT01612000|4494502|P2|Overall Study|Lost to Follow-up|4
1362730|NCT01612000|4494503|P1|Overall Study|Lost to Follow-up|6
1362731|NCT01611974|4494528|P3|Overall Study|Withdrawal by Subject|4
1362732|NCT01611974|4494529|P2|Overall Study|Withdrawal by Subject|1
1362733|NCT01611974|4494530|P1|Overall Study|Withdrawal by Subject|0
1362734|NCT01611974|4494528|P3|Overall Study|Physician Decision|2
1362735|NCT01611974|4494529|P2|Overall Study|Physician Decision|1
1362736|NCT01611974|4494530|P1|Overall Study|Physician Decision|5
1362737|NCT01611974|4494528|P3|Overall Study|Lost to Follow-up|0
1362738|NCT01611974|4494529|P2|Overall Study|Lost to Follow-up|1
1362739|NCT01611974|4494530|P1|Overall Study|Lost to Follow-up|0
1362740|NCT01611974|4494528|P3|Overall Study|Death|10
1362741|NCT01611974|4494529|P2|Overall Study|Death|12
1362742|NCT01611974|4494530|P1|Overall Study|Death|10
1362743|NCT01611883|4494576|P2|Overall Study|Adverse Event|1
1362744|NCT01611883|4494577|P1|Overall Study|Adverse Event|1
1362745|NCT01611857|4494603|P2|Overall Study|Withdrawal by Subject|2
1362746|NCT01611857|4494604|P1|Overall Study|Withdrawal by Subject|0
1362747|NCT01611792|4494616|P2|Followup: at 6 Months|Lost to Follow-up|13
1362748|NCT01611792|4494617|P1|Followup: at 6 Months|Lost to Follow-up|6
1362749|NCT01611792|4494616|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
1362750|NCT01611792|4494617|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
1362751|NCT01611558|4494671|P1|Maintenance Phase|Study drug toxicity|1
1362752|NCT01611558|4494671|P1|Maintenance Phase|Withdrawal by Subject|1
1362753|NCT01611558|4494671|P1|Induction Phase|Death|1
1362754|NCT01611558|4494671|P1|Induction Phase|Adverse event unrelated to study drug|1
1362755|NCT01611558|4494671|P1|Induction Phase|Not reported|5
1362756|NCT01611558|4494671|P1|Induction Phase|Disease progression|14
1362757|NCT01611558|4494671|P1|Induction Phase|Study drug toxicity|17
1362758|NCT01611259|4494677|P1|Overall Study|Withdrawal by Subject|7
1362759|NCT01611259|4494677|P1|Overall Study|Adverse Event|4
1362760|NCT01611259|4494677|P1|Overall Study|Lack of Efficacy|2
1362761|NCT01611259|4494677|P1|Overall Study|Physician Decision|1
1362762|NCT01610791|4494681|P1|Overall Study|Not determined|5
1362763|NCT01610791|4494681|P1|Overall Study|Death|1
1362764|NCT01610791|4494681|P1|Overall Study|Adverse event and Investigator decision|1
1362765|NCT01610791|4494681|P1|Overall Study|Physician Decision|1
1362766|NCT01610791|4494681|P1|Overall Study|Adverse Event|6
1362767|NCT01610791|4494681|P1|Overall Study|Lost to Follow-up|7
1362768|NCT01610713|4494704|P2|Overall Study|Lost to Follow-up|1
1362769|NCT01610713|4494705|P1|Overall Study|Lost to Follow-up|0
1362770|NCT01610713|4494704|P2|Overall Study|adv. to use original dose/amitriptyline|0
1362771|NCT01610713|4494705|P1|Overall Study|adv. to use original dose/amitriptyline|1
1362772|NCT01610713|4494704|P2|Overall Study|low mood and poor motivation|0
1362773|NCT01610713|4494705|P1|Overall Study|low mood and poor motivation|1
1362774|NCT01610713|4494704|P2|Overall Study|Lack of Efficacy|0
1362775|NCT01610713|4494705|P1|Overall Study|Lack of Efficacy|1
1362776|NCT01610713|4494704|P2|Overall Study|Adverse Event|0
1362777|NCT01610713|4494705|P1|Overall Study|Adverse Event|3
1362778|NCT01610700|4494763|P2|Overall Study|subject took one dose of street cannabis|1
1362779|NCT01610700|4494764|P1|Overall Study|subject took one dose of street cannabis|0
1362780|NCT01610700|4494763|P2|Overall Study|Withdrawal by Subject|1
1362781|NCT01610700|4494764|P1|Overall Study|Withdrawal by Subject|0
1362782|NCT01610700|4494763|P2|Overall Study|Adverse Event|1
1362783|NCT01610700|4494764|P1|Overall Study|Adverse Event|3
1362784|NCT01610687|4494818|P1|Overall Study|Felt more alter without study medication|1
1362785|NCT01610687|4494818|P1|Overall Study|Cannabis affecting job|1
1362786|NCT01610687|4494818|P1|Overall Study|Death|1
1362787|NCT01610687|4494818|P1|Overall Study|Unable to make journey|1
1362788|NCT01610687|4494818|P1|Overall Study|Symptom control without study medication|2
1362789|NCT01610687|4494818|P1|Overall Study|Lost to Follow-up|4
1362790|NCT01610687|4494818|P1|Overall Study|Withdrawal by Subject|7
1362791|NCT01610687|4494818|P1|Overall Study|Moved out of area|6
1362792|NCT01610687|4494818|P1|Overall Study|Adverse Event|18
1362793|NCT01610687|4494818|P1|Overall Study|Lack of Efficacy|26
1362794|NCT01610596|4494831|P2|Overall Study|Lost to Follow-up|1
1362795|NCT01610596|4494832|P1|Overall Study|Lost to Follow-up|0
1362796|NCT01610557|4494890|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
1362797|NCT01610557|4494891|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
1362798|NCT01610557|4494892|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
1362799|NCT01610557|4494893|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
1362800|NCT01610557|4494894|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
1362801|NCT01610557|4494890|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1362802|NCT01610557|4494891|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1362803|NCT01610557|4494892|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1362804|NCT01610557|4494893|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
1362805|NCT01610557|4494894|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1362806|NCT01610492|4494907|P1|Overall Study|Other:Treatment stopped due to remission|1
1362807|NCT01610492|4494907|P1|Overall Study|Other: Reached stopping criteria|1
1362808|NCT01610492|4494907|P1|Overall Study|Lack of Efficacy|3
1362809|NCT01610492|4494907|P1|Overall Study|Adverse Event|1
1362810|NCT01610414|4494958|P2|After Month 25|Study end not reached|53
1362811|NCT01610414|4494959|P1|After Month 25|Study end not reached|48
1362812|NCT01610414|4494958|P2|Month 13 - Month 25|Other reasons for withdrawal|7
1362813|NCT01610414|4494959|P1|Month 13 - Month 25|Other reasons for withdrawal|6
1362814|NCT01610414|4494958|P2|Month 13 - Month 25|Lost to Follow-up|9
1362815|NCT01610414|4494959|P1|Month 13 - Month 25|Lost to Follow-up|5
1362816|NCT01610414|4494958|P2|Month 13 - Month 25|Protocol Violation|2
1362817|NCT01610414|4494959|P1|Month 13 - Month 25|Protocol Violation|0
1362818|NCT01610414|4494958|P2|Month 13 - Month 25|Migrated/moved from study area|2
1362819|NCT01610414|4494959|P1|Month 13 - Month 25|Migrated/moved from study area|4
1362820|NCT01610414|4494958|P2|Month 13 - Month 25|Withdrawal by Subject|8
1362821|NCT01610414|4494959|P1|Month 13 - Month 25|Withdrawal by Subject|7
1362822|NCT01610414|4494958|P2|Month 13 - Month 25|Adverse Event|4
1362823|NCT01610414|4494959|P1|Month 13 - Month 25|Adverse Event|8
1362824|NCT01610414|4494958|P2|Month 13 - Month 25|Serious Adverse Event|38
1362825|NCT01610414|4494959|P1|Month 13 - Month 25|Serious Adverse Event|35
1362826|NCT01610414|4494958|P2|Study Start - Month 13|Other reasons for withdrawal|4
1362827|NCT01610414|4494959|P1|Study Start - Month 13|Other reasons for withdrawal|3
1362828|NCT01610414|4494958|P2|Study Start - Month 13|Suspected HZ episode|3
1362829|NCT01610414|4494959|P1|Study Start - Month 13|Suspected HZ episode|1
1362830|NCT01610414|4494958|P2|Study Start - Month 13|Lost to Follow-up|6
1362831|NCT01610414|4494959|P1|Study Start - Month 13|Lost to Follow-up|4
1362832|NCT01610414|4494958|P2|Study Start - Month 13|Migrated/moved from study area|4
1362833|NCT01610414|4494959|P1|Study Start - Month 13|Migrated/moved from study area|2
1362834|NCT01610414|4494958|P2|Study Start - Month 13|Withdrawal by Subject|30
1362835|NCT01610414|4494959|P1|Study Start - Month 13|Withdrawal by Subject|23
1362836|NCT01610414|4494958|P2|Study Start - Month 13|Protocol Violation|1
1362837|NCT01610414|4494959|P1|Study Start - Month 13|Protocol Violation|3
1362838|NCT01610414|4494958|P2|Study Start - Month 13|Adverse Event|14
1362839|NCT01610414|4494959|P1|Study Start - Month 13|Adverse Event|14
1362840|NCT01610414|4494958|P2|Study Start - Month 13|Serious Adverse Event|67
1362841|NCT01610414|4494959|P1|Study Start - Month 13|Serious Adverse Event|65
1362842|NCT01610297|4494988|P1|Overall Study|Lost to Follow-up|1
1362843|NCT01610167|4494999|P3|Overall Study|Scheduling conflict.|2
1362844|NCT01610167|4495000|P2|Overall Study|Scheduling conflict.|0
1362845|NCT01610167|4495001|P1|Overall Study|Scheduling conflict.|0
1362846|NCT01610076|4495038|P2|Overall Study|Lost to Follow-up|4
1362847|NCT01610076|4495039|P1|Overall Study|Lost to Follow-up|3
1362848|NCT01610076|4495038|P2|Overall Study|Technical issue with video|1
1362849|NCT01610076|4495039|P1|Overall Study|Technical issue with video|0
1362850|NCT01610063|4495050|P2|Overall Study|Lost to Follow-up|20
1362851|NCT01610063|4495051|P1|Overall Study|Lost to Follow-up|42
1362852|NCT01610037|4495074|P3|Treatment and Follow up Period|Lost to Follow-up|4
1362853|NCT01610037|4495075|P2|Treatment and Follow up Period|Lost to Follow-up|6
1362854|NCT01610037|4495076|P1|Treatment and Follow up Period|Lost to Follow-up|1
1362855|NCT01610037|4495074|P3|Treatment and Follow up Period|Administrative problems|2
1362856|NCT01610037|4495075|P2|Treatment and Follow up Period|Administrative problems|3
1362857|NCT01610037|4495076|P1|Treatment and Follow up Period|Administrative problems|1
1362858|NCT01610037|4495074|P3|Treatment and Follow up Period|Death|4
1362859|NCT01610037|4495075|P2|Treatment and Follow up Period|Death|5
1362860|NCT01610037|4495076|P1|Treatment and Follow up Period|Death|10
1362861|NCT01610037|4495074|P3|Treatment and Follow up Period|Subject withdrew consent|16
1362862|NCT01610037|4495075|P2|Treatment and Follow up Period|Subject withdrew consent|14
1362863|NCT01610037|4495076|P1|Treatment and Follow up Period|Subject withdrew consent|13
1362864|NCT01610037|4495074|P3|All Patients|Abnormal test procedure result(s)|3
1362865|NCT01610037|4495075|P2|All Patients|Abnormal test procedure result(s)|1
1362866|NCT01610037|4495076|P1|All Patients|Abnormal test procedure result(s)|0
1362867|NCT01610037|4495074|P3|All Patients|Lost to Follow-up|0
1362868|NCT01610037|4495075|P2|All Patients|Lost to Follow-up|0
1362869|NCT01610037|4495076|P1|All Patients|Lost to Follow-up|1
1362870|NCT01610037|4495074|P3|All Patients|Administrative problems|4
1362871|NCT01610037|4495075|P2|All Patients|Administrative problems|4
1362872|NCT01610037|4495076|P1|All Patients|Administrative problems|1
1362873|NCT01610037|4495074|P3|All Patients|Abnormal laboratory value|0
1362874|NCT01610037|4495075|P2|All Patients|Abnormal laboratory value|1
1362875|NCT01610037|4495076|P1|All Patients|Abnormal laboratory value|1
1362876|NCT01610037|4495074|P3|All Patients|Protocol deviation|3
1362877|NCT01610037|4495075|P2|All Patients|Protocol deviation|3
1362878|NCT01610037|4495076|P1|All Patients|Protocol deviation|4
1362879|NCT01610037|4495074|P3|All Patients|Death|1
1362880|NCT01610037|4495075|P2|All Patients|Death|2
1362881|NCT01610037|4495076|P1|All Patients|Death|4
1362882|NCT01610037|4495074|P3|All Patients|Unsatisfactory therapeutic effect|27
1362883|NCT01610037|4495075|P2|All Patients|Unsatisfactory therapeutic effect|8
1362884|NCT01610037|4495076|P1|All Patients|Unsatisfactory therapeutic effect|9
1362885|NCT01610037|4495074|P3|All Patients|Withdrawal by Subject|20
1362886|NCT01610037|4495075|P2|All Patients|Withdrawal by Subject|10
1362887|NCT01610037|4495076|P1|All Patients|Withdrawal by Subject|12
1362888|NCT01610037|4495074|P3|All Patients|Adverse Event|26
1362889|NCT01610037|4495075|P2|All Patients|Adverse Event|22
1362890|NCT01610037|4495076|P1|All Patients|Adverse Event|27
1362891|NCT01609933|4495126|P1|Overall Study|Withdrawal by Subject|3
1362892|NCT01609933|4495126|P1|Overall Study|Adverse Event|1
1362893|NCT01609790|4495136|P3|Overall Study|Protocol Violation|8
1362894|NCT01609790|4495137|P2|Overall Study|Protocol Violation|7
1362895|NCT01609790|4495138|P1|Overall Study|Protocol Violation|1
1362896|NCT01609582|4495157|P2|Overall Study|Randomized, but not treated|3
1362897|NCT01609582|4495158|P1|Overall Study|Randomized, but not treated|0
1362898|NCT01609582|4495157|P2|Overall Study|Other|10
1362899|NCT01609582|4495158|P1|Overall Study|Other|9
1362900|NCT01609582|4495157|P2|Overall Study|Study Terminated by Sponsor|1548
1362901|NCT01609582|4495158|P1|Overall Study|Study Terminated by Sponsor|1543
1362902|NCT01609582|4495157|P2|Overall Study|Withdrawal by Subject|15
1362903|NCT01609582|4495158|P1|Overall Study|Withdrawal by Subject|21
1362904|NCT01609582|4495157|P2|Overall Study|Lost to Follow-up|10
1362905|NCT01609582|4495158|P1|Overall Study|Lost to Follow-up|10
1362906|NCT01609582|4495157|P2|Overall Study|Adverse Event|18
1362907|NCT01609582|4495158|P1|Overall Study|Adverse Event|20
1362908|NCT01609543|4495166|P1|Overall Study|Death|7
1362909|NCT01609543|4495166|P1|Overall Study|Protocol Violation|1
1362910|NCT01609543|4495166|P1|Overall Study|Withdrawal by Subject|1
1362911|NCT01609543|4495166|P1|Overall Study|Adverse Event|5
1362912|NCT01609543|4495166|P1|Overall Study|Disease Progression|28
1362913|NCT01609478|4495175|P3|Overall Study|Withdrawal by Subject|2
1362914|NCT01609478|4495176|P2|Overall Study|Withdrawal by Subject|0
1362915|NCT01609478|4495177|P1|Overall Study|Withdrawal by Subject|2
1362916|NCT01609478|4495175|P3|Overall Study|Physician Decision|1
1362917|NCT01609478|4495176|P2|Overall Study|Physician Decision|0
1362918|NCT01609478|4495177|P1|Overall Study|Physician Decision|1
1362919|NCT01609478|4495175|P3|Overall Study|Non-Compliance with study treatment|0
1362920|NCT01609478|4495176|P2|Overall Study|Non-Compliance with study treatment|0
1362921|NCT01609478|4495177|P1|Overall Study|Non-Compliance with study treatment|1
1362922|NCT01609478|4495175|P3|Overall Study|Protocol Deviation|1
1362923|NCT01609478|4495176|P2|Overall Study|Protocol Deviation|1
1362924|NCT01609478|4495177|P1|Overall Study|Protocol Deviation|0
1362925|NCT01609478|4495175|P3|Overall Study|Adverse Event|5
1362926|NCT01609478|4495176|P2|Overall Study|Adverse Event|1
1362927|NCT01609478|4495177|P1|Overall Study|Adverse Event|3
1362928|NCT01609257|4495252|P2|Overall Study|Non-compliance/Protocol deviation|6
1362929|NCT01609257|4495253|P1|Overall Study|Non-compliance/Protocol deviation|4
1362930|NCT01609257|4495252|P2|Overall Study|Voluntary Withdrawal by Subject|1
1362931|NCT01609257|4495253|P1|Overall Study|Voluntary Withdrawal by Subject|0
1362932|NCT01609257|4495252|P2|Overall Study|Lost to Follow-up|1
1362933|NCT01609257|4495253|P1|Overall Study|Lost to Follow-up|2
1362934|NCT01609062|4495325|P2|Extension Phase|Anticipated surgery & transition to EAP|1
1362935|NCT01609062|4495326|P1|Extension Phase|Anticipated surgery & transition to EAP|0
1362936|NCT01609062|4495325|P2|Extension Phase|Discontinued drug and then was pregnant|0
1362937|NCT01609062|4495326|P1|Extension Phase|Discontinued drug and then was pregnant|1
1362938|NCT01609062|4495325|P2|Extension Phase|Terminated by Sponsor|9
1362939|NCT01609062|4495326|P1|Extension Phase|Terminated by Sponsor|14
1362940|NCT01609023|4495369|P1|Overall Study|Personal reasons|1
1362941|NCT01609023|4495369|P1|Overall Study|Death|2
1362942|NCT01609023|4495369|P1|Overall Study|Physician Decision|2
1362943|NCT01609023|4495369|P1|Overall Study|Disease progression|10
1362944|NCT01609023|4495369|P1|Overall Study|Toxicity|3
1362945|NCT01609023|4495369|P1|Overall Study|Lost to Follow-up|8
1362946|NCT01609023|4495369|P1|Overall Study|Withdrawal by Subject|4
1362947|NCT01609023|4495369|P1|Overall Study|Lack of Efficacy|3
1362948|NCT01609010|4495381|P2|Overall Study|Lost to Follow-up|1
1362949|NCT01609010|4495382|P1|Overall Study|Lost to Follow-up|1
1362950|NCT01609010|4495381|P2|Overall Study|New cancer|0
1362951|NCT01609010|4495382|P1|Overall Study|New cancer|1
1362952|NCT01609010|4495381|P2|Overall Study|Protocol Violation|1
1362953|NCT01609010|4495382|P1|Overall Study|Protocol Violation|1
1362954|NCT01609010|4495381|P2|Overall Study|Pathology review|1
1362955|NCT01609010|4495382|P1|Overall Study|Pathology review|2
1362956|NCT01609010|4495381|P2|Overall Study|Other malignancy|0
1362957|NCT01609010|4495382|P1|Overall Study|Other malignancy|1
1362958|NCT01609010|4495381|P2|Overall Study|Not specified|0
1362959|NCT01609010|4495382|P1|Overall Study|Not specified|2
1362960|NCT01609010|4495381|P2|Overall Study|Withdrawal by Subject|2
1362961|NCT01609010|4495382|P1|Overall Study|Withdrawal by Subject|2
1362962|NCT01609010|4495381|P2|Overall Study|Adverse Event|6
1362963|NCT01609010|4495382|P1|Overall Study|Adverse Event|3
1362964|NCT01609010|4495381|P2|Overall Study|Progressive disease (PD)|10
1362965|NCT01609010|4495382|P1|Overall Study|Progressive disease (PD)|8
1362966|NCT01609010|4495381|P2|Overall Study|Stable disease (SD)|16
1362967|NCT01609010|4495382|P1|Overall Study|Stable disease (SD)|22
1362968|NCT01608724|4495443|P1|Overall Study|Safety reasons|1
1362969|NCT01608724|4495443|P1|Overall Study|bood sugar too high, etc.|3
1362970|NCT01608724|4495443|P1|Overall Study|Protocol Violation|6
1362971|NCT01608724|4495443|P1|Overall Study|Adverse Event|29
1362972|NCT01608724|4495443|P1|Overall Study|Study-specific discontinuation criteria|32
1362973|NCT01608724|4495443|P1|Overall Study|Lost to Follow-up|41
1362974|NCT01608724|4495443|P1|Overall Study|Withdrawal by Subject|131
1362975|NCT01608321|4495475|P2|Overall Study|Withdrawal by Subject|0
1362976|NCT01608321|4495476|P1|Overall Study|Withdrawal by Subject|1
1362977|NCT01608308|4495484|P2|Overall Study|pretreatment medical and billing reasons|2
1362978|NCT01608308|4495485|P1|Overall Study|pretreatment medical and billing reasons|0
1362979|NCT01607593|4495714|P1|Overall Study|Other|4
1362980|NCT01607593|4495714|P1|Overall Study|Continuation|33
1362981|NCT01607593|4495714|P1|Overall Study|Lost to Follow-up|25
1362982|NCT01607593|4495714|P1|Overall Study|Lack of Efficacy|16
1362983|NCT01607593|4495714|P1|Overall Study|Adverse Event|15
1362984|NCT01607554|4495720|P1|Overall Study|Disease progression|2
1362985|NCT01607476|4495733|P3|Overall Study|Lost to Follow-up|2
1362986|NCT01607476|4495734|P2|Overall Study|Lost to Follow-up|0
1362987|NCT01607476|4495735|P1|Overall Study|Lost to Follow-up|0
1362988|NCT01607476|4495733|P3|Overall Study|Withdrawal by Subject|1
1362989|NCT01607476|4495734|P2|Overall Study|Withdrawal by Subject|0
1362990|NCT01607476|4495735|P1|Overall Study|Withdrawal by Subject|1
1362991|NCT01607398|4495829|P2|Overall Study|Severe COPD|0
1362992|NCT01607398|4495830|P1|Overall Study|Severe COPD|2
1362993|NCT01607398|4495829|P2|Overall Study|Adverse Event|2
1362994|NCT01607398|4495830|P1|Overall Study|Adverse Event|0
1362995|NCT01607346|4495874|P1|Overall Study|Adverse Event|3
1362996|NCT01606800|4495958|P2|Overall Study|Missing completion status|0
1362997|NCT01606800|4495959|P1|Overall Study|Missing completion status|2
1362998|NCT01606800|4495958|P2|Overall Study|Participant withdrew consent|1
1362999|NCT01606800|4495959|P1|Overall Study|Participant withdrew consent|0
1363000|NCT01606800|4495958|P2|Overall Study|Adverse Event|1
1363001|NCT01606800|4495959|P1|Overall Study|Adverse Event|3
1363002|NCT01606787|4495967|P2|Overall Study|Surgery canceled|2
1363003|NCT01606787|4495968|P1|Overall Study|Surgery canceled|0
1363004|NCT01606787|4495967|P2|Overall Study|Withdrawal by Subject|5
1363005|NCT01606787|4495968|P1|Overall Study|Withdrawal by Subject|4
1363006|NCT01606761|4495979|P5|Safety Follow-up Period (Week 52-68)|Other|3
1363007|NCT01606761|4495980|P4|Safety Follow-up Period (Week 52-68)|Other|1
1363008|NCT01606761|4495981|P3|Safety Follow-up Period (Week 52-68)|Other|9
1363009|NCT01606761|4495982|P2|Safety Follow-up Period (Week 52-68)|Other|3
1363010|NCT01606761|4495983|P1|Safety Follow-up Period (Week 52-68)|Other|0
1363011|NCT01606761|4495979|P5|Safety Follow-up Period (Week 52-68)|Death|1
1363012|NCT01606761|4495980|P4|Safety Follow-up Period (Week 52-68)|Death|0
1363013|NCT01606761|4495981|P3|Safety Follow-up Period (Week 52-68)|Death|0
1363014|NCT01606761|4495982|P2|Safety Follow-up Period (Week 52-68)|Death|0
1363015|NCT01606761|4495983|P1|Safety Follow-up Period (Week 52-68)|Death|0
1363016|NCT01606761|4495979|P5|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
1363017|NCT01606761|4495980|P4|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
1363018|NCT01606761|4495981|P3|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
1363019|NCT01606761|4495982|P2|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
1363020|NCT01606761|4495983|P1|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
1363021|NCT01606761|4495979|P5|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
1363022|NCT01606761|4495980|P4|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
1363023|NCT01606761|4495981|P3|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
1363024|NCT01606761|4495982|P2|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
1363025|NCT01606761|4495983|P1|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
1363026|NCT01606761|4495979|P5|Week 24 to Week 52|Other|2
1363027|NCT01606761|4495980|P4|Week 24 to Week 52|Other|2
1363028|NCT01606761|4495981|P3|Week 24 to Week 52|Other|5
1363029|NCT01606761|4495982|P2|Week 24 to Week 52|Other|1
1363030|NCT01606761|4495983|P1|Week 24 to Week 52|Other|0
1363031|NCT01606761|4495979|P5|Week 24 to Week 52|Physician Decision|0
1363032|NCT01606761|4495980|P4|Week 24 to Week 52|Physician Decision|0
1363033|NCT01606761|4495981|P3|Week 24 to Week 52|Physician Decision|1
1363034|NCT01606761|4495982|P2|Week 24 to Week 52|Physician Decision|1
1363035|NCT01606761|4495983|P1|Week 24 to Week 52|Physician Decision|0
1363036|NCT01606761|4495979|P5|Week 24 to Week 52|Lack of Efficacy|3
1363037|NCT01606761|4495980|P4|Week 24 to Week 52|Lack of Efficacy|10
1363038|NCT01606761|4495981|P3|Week 24 to Week 52|Lack of Efficacy|7
1363039|NCT01606761|4495982|P2|Week 24 to Week 52|Lack of Efficacy|13
1363040|NCT01606761|4495983|P1|Week 24 to Week 52|Lack of Efficacy|0
1363041|NCT01606761|4495979|P5|Week 24 to Week 52|Death|0
1363042|NCT01606761|4495980|P4|Week 24 to Week 52|Death|1
1363043|NCT01606761|4495981|P3|Week 24 to Week 52|Death|2
1363044|NCT01606761|4495982|P2|Week 24 to Week 52|Death|0
1363045|NCT01606761|4495983|P1|Week 24 to Week 52|Death|0
1363046|NCT01606761|4495979|P5|Week 24 to Week 52|Adverse Event|15
1363047|NCT01606761|4495980|P4|Week 24 to Week 52|Adverse Event|3
1363048|NCT01606761|4495981|P3|Week 24 to Week 52|Adverse Event|14
1363049|NCT01606761|4495982|P2|Week 24 to Week 52|Adverse Event|11
1363050|NCT01606761|4495983|P1|Week 24 to Week 52|Adverse Event|0
1363051|NCT01606761|4495979|P5|Week 24 to Week 52|Withdrawal by Subject|0
1363052|NCT01606761|4495980|P4|Week 24 to Week 52|Withdrawal by Subject|0
1363053|NCT01606761|4495981|P3|Week 24 to Week 52|Withdrawal by Subject|3
1363054|NCT01606761|4495982|P2|Week 24 to Week 52|Withdrawal by Subject|6
1363055|NCT01606761|4495983|P1|Week 24 to Week 52|Withdrawal by Subject|0
1363056|NCT01606761|4495979|P5|Week 24 to Week 52|Lost to Follow-up|0
1363057|NCT01606761|4495980|P4|Week 24 to Week 52|Lost to Follow-up|1
1363058|NCT01606761|4495981|P3|Week 24 to Week 52|Lost to Follow-up|1
1363059|NCT01606761|4495982|P2|Week 24 to Week 52|Lost to Follow-up|1
1363060|NCT01606761|4495983|P1|Week 24 to Week 52|Lost to Follow-up|0
1363061|NCT01606761|4495979|P5|Prior to Week 24|Other|0
1363062|NCT01606761|4495980|P4|Prior to Week 24|Other|0
1363063|NCT01606761|4495981|P3|Prior to Week 24|Other|5
1363064|NCT01606761|4495982|P2|Prior to Week 24|Other|7
1363065|NCT01606761|4495983|P1|Prior to Week 24|Other|4
1363066|NCT01606761|4495979|P5|Prior to Week 24|Physician Decision|0
1363067|NCT01606761|4495980|P4|Prior to Week 24|Physician Decision|0
1363068|NCT01606761|4495981|P3|Prior to Week 24|Physician Decision|1
1363069|NCT01606761|4495982|P2|Prior to Week 24|Physician Decision|3
1363070|NCT01606761|4495983|P1|Prior to Week 24|Physician Decision|0
1363071|NCT01606761|4495979|P5|Prior to Week 24|Lack of Efficacy|0
1363072|NCT01606761|4495980|P4|Prior to Week 24|Lack of Efficacy|0
1363073|NCT01606761|4495981|P3|Prior to Week 24|Lack of Efficacy|8
1363074|NCT01606761|4495982|P2|Prior to Week 24|Lack of Efficacy|14
1363075|NCT01606761|4495983|P1|Prior to Week 24|Lack of Efficacy|15
1363076|NCT01606761|4495979|P5|Prior to Week 24|Adverse Event|0
1363077|NCT01606761|4495980|P4|Prior to Week 24|Adverse Event|0
1363078|NCT01606761|4495981|P3|Prior to Week 24|Adverse Event|22
1363079|NCT01606761|4495982|P2|Prior to Week 24|Adverse Event|18
1363080|NCT01606761|4495983|P1|Prior to Week 24|Adverse Event|11
1363081|NCT01606761|4495979|P5|Prior to Week 24|Withdrawal by Subject|0
1363082|NCT01606761|4495980|P4|Prior to Week 24|Withdrawal by Subject|0
1363083|NCT01606761|4495981|P3|Prior to Week 24|Withdrawal by Subject|9
1363084|NCT01606761|4495982|P2|Prior to Week 24|Withdrawal by Subject|10
1363085|NCT01606761|4495983|P1|Prior to Week 24|Withdrawal by Subject|12
1363086|NCT01606761|4495979|P5|Prior to Week 24|Lost to Follow-up|0
1363087|NCT01606761|4495980|P4|Prior to Week 24|Lost to Follow-up|0
1363088|NCT01606761|4495981|P3|Prior to Week 24|Lost to Follow-up|2
1363089|NCT01606761|4495982|P2|Prior to Week 24|Lost to Follow-up|3
1363090|NCT01606761|4495983|P1|Prior to Week 24|Lost to Follow-up|0
1363091|NCT01606748|4496009|P2|Overall Study|Withdrawal by Subject|0
1363092|NCT01606748|4496010|P1|Overall Study|Withdrawal by Subject|1
1363093|NCT01606748|4496009|P2|Overall Study|Progressive Disease|0
1363094|NCT01606748|4496010|P1|Overall Study|Progressive Disease|1
1363095|NCT01606748|4496009|P2|Overall Study|Adverse Event|0
1363096|NCT01606748|4496010|P1|Overall Study|Adverse Event|1
1363097|NCT01606670|4496051|P1|Overall Study|Other Reason|2
1363098|NCT01606670|4496051|P1|Overall Study|Withdrawal by Subject|3
1363099|NCT01606670|4496051|P1|Overall Study|Lost to Follow-up|3
1363100|NCT01606670|4496051|P1|Overall Study|Lack of Efficacy|2
1363101|NCT01606670|4496051|P1|Overall Study|Adverse Event|6
1363102|NCT01606319|4496061|P2|Overall Study|Adverse Event|4
1363103|NCT01606319|4496062|P1|Overall Study|Adverse Event|1
1363104|NCT01606319|4496061|P2|Overall Study|Lack of Efficacy|8
1363105|NCT01606319|4496062|P1|Overall Study|Lack of Efficacy|6
1363106|NCT01606319|4496061|P2|Overall Study|Physician Decision|2
1363107|NCT01606319|4496062|P1|Overall Study|Physician Decision|1
1363108|NCT01606319|4496061|P2|Overall Study|Withdrawal by Subject|12
1363109|NCT01606319|4496062|P1|Overall Study|Withdrawal by Subject|9
1363110|NCT01606319|4496061|P2|Overall Study|Lost to Follow-up|14
1363111|NCT01606319|4496062|P1|Overall Study|Lost to Follow-up|17
1363112|NCT01606306|4496080|P6|Overall Study|Physician Decision|0
1363113|NCT01606306|4496081|P5|Overall Study|Physician Decision|0
1363114|NCT01606306|4496082|P4|Overall Study|Physician Decision|0
1363115|NCT01606306|4496083|P3|Overall Study|Physician Decision|0
1363116|NCT01606306|4496084|P2|Overall Study|Physician Decision|2
1363117|NCT01606306|4496085|P1|Overall Study|Physician Decision|1
1363118|NCT01606306|4496080|P6|Overall Study|Withdrawal by Subject|4
1363119|NCT01606306|4496081|P5|Overall Study|Withdrawal by Subject|5
1363120|NCT01606306|4496082|P4|Overall Study|Withdrawal by Subject|4
1363121|NCT01606306|4496083|P3|Overall Study|Withdrawal by Subject|4
1363122|NCT01606306|4496084|P2|Overall Study|Withdrawal by Subject|3
1363123|NCT01606306|4496085|P1|Overall Study|Withdrawal by Subject|4
1363124|NCT01606306|4496080|P6|Overall Study|Lost to Follow-up|5
1363125|NCT01606306|4496081|P5|Overall Study|Lost to Follow-up|3
1363126|NCT01606306|4496082|P4|Overall Study|Lost to Follow-up|4
1363127|NCT01606306|4496083|P3|Overall Study|Lost to Follow-up|5
1363128|NCT01606306|4496084|P2|Overall Study|Lost to Follow-up|4
1363129|NCT01606306|4496085|P1|Overall Study|Lost to Follow-up|7
1363130|NCT01606306|4496080|P6|Overall Study|Adverse Event|0
1363131|NCT01606306|4496081|P5|Overall Study|Adverse Event|2
1363132|NCT01606306|4496082|P4|Overall Study|Adverse Event|1
1363133|NCT01606306|4496083|P3|Overall Study|Adverse Event|1
1363134|NCT01606306|4496084|P2|Overall Study|Adverse Event|0
1363135|NCT01606306|4496085|P1|Overall Study|Adverse Event|1
1363136|NCT01606306|4496080|P6|Overall Study|Lack of Efficacy|2
1363137|NCT01606306|4496081|P5|Overall Study|Lack of Efficacy|1
1363138|NCT01606306|4496082|P4|Overall Study|Lack of Efficacy|4
1363139|NCT01606306|4496083|P3|Overall Study|Lack of Efficacy|4
1363140|NCT01606306|4496084|P2|Overall Study|Lack of Efficacy|1
1363141|NCT01606306|4496085|P1|Overall Study|Lack of Efficacy|2
1363142|NCT01606254|4496095|P4|Overall Study|Adverse Event|1
1363143|NCT01606254|4496096|P3|Overall Study|Adverse Event|0
1363144|NCT01606254|4496097|P2|Overall Study|Adverse Event|1
1363145|NCT01606254|4496098|P1|Overall Study|Adverse Event|1
1363146|NCT01606254|4496095|P4|Overall Study|Withdrawal by Subject|2
1363147|NCT01606254|4496096|P3|Overall Study|Withdrawal by Subject|0
1363148|NCT01606254|4496097|P2|Overall Study|Withdrawal by Subject|3
1363149|NCT01606254|4496098|P1|Overall Study|Withdrawal by Subject|1
1363150|NCT01606228|4496180|P1|Overall Study|Adverse Event|1
1363151|NCT01606228|4496180|P1|Overall Study|Lack of Efficacy|2
1363152|NCT01606228|4496180|P1|Overall Study|Non-compliant|3
1363153|NCT01606228|4496180|P1|Overall Study|Withdrawal by Subject|3
1363154|NCT01606228|4496180|P1|Overall Study|Lost to Follow-up|20
1363155|NCT01606202|4496197|P2|Overall Study|Problems with administration|1
1363156|NCT01606202|4496198|P1|Overall Study|Problems with administration|0
1363157|NCT01606202|4496197|P2|Overall Study|Personal problems|1
1363158|NCT01606202|4496198|P1|Overall Study|Personal problems|0
1363159|NCT01606202|4496197|P2|Overall Study|Withdrawal by Subject|1
1363160|NCT01606202|4496198|P1|Overall Study|Withdrawal by Subject|2
1363161|NCT01606202|4496197|P2|Overall Study|Adverse Event|0
1363162|NCT01606202|4496198|P1|Overall Study|Adverse Event|5
1363163|NCT01606189|4496230|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
1363164|NCT01606189|4496231|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1363165|NCT01606189|4496232|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1363252|NCT01605461|4496636|P1|Overall Study|Lost to Follow-up|3
1363166|NCT01606189|4496233|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1363167|NCT01606189|4496234|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1363168|NCT01606189|4496235|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1363169|NCT01606189|4496230|P6|Second Intenvention (14-20 Days)|Adverse Event|1
1363170|NCT01606189|4496231|P5|Second Intenvention (14-20 Days)|Adverse Event|0
1363171|NCT01606189|4496232|P4|Second Intenvention (14-20 Days)|Adverse Event|0
1363172|NCT01606189|4496233|P3|Second Intenvention (14-20 Days)|Adverse Event|0
1363173|NCT01606189|4496234|P2|Second Intenvention (14-20 Days)|Adverse Event|0
1363174|NCT01606189|4496235|P1|Second Intenvention (14-20 Days)|Adverse Event|0
1363175|NCT01606176|4496269|P2|Overall Study|Withdrawal by Subject|0
1363176|NCT01606176|4496270|P1|Overall Study|Withdrawal by Subject|1
1363177|NCT01606176|4496269|P2|Overall Study|Disease progression|0
1363178|NCT01606176|4496270|P1|Overall Study|Disease progression|1
1363179|NCT01606176|4496269|P2|Overall Study|Adverse Event|3
1363180|NCT01606176|4496270|P1|Overall Study|Adverse Event|2
1363181|NCT01606137|4496315|P1|Overall Study|Unable to collect consistent data|1
1363182|NCT01606137|4496315|P1|Overall Study|Patient moving|1
1363183|NCT01606137|4496315|P1|Overall Study|Unable to tolerate study med. taste|1
1363184|NCT01606137|4496315|P1|Overall Study|Personal reasons|1
1363185|NCT01606137|4496315|P1|Overall Study|Patient leaving country|1
1363186|NCT01606137|4496315|P1|Overall Study|Wanted to try another treatment|1
1363187|NCT01606137|4496315|P1|Overall Study|Not enough improvement|4
1363188|NCT01606137|4496315|P1|Overall Study|Spray causes nausea|1
1363189|NCT01606137|4496315|P1|Overall Study|Increased bilirubin|1
1363190|NCT01606137|4496315|P1|Overall Study|multiple sclerosis less stable|1
1363191|NCT01606137|4496315|P1|Overall Study|Issues with driving|4
1363192|NCT01606137|4496315|P1|Overall Study|Decreased/no pain|4
1363193|NCT01606137|4496315|P1|Overall Study|Death|1
1363194|NCT01606137|4496315|P1|Overall Study|Patient non-compliance|9
1363195|NCT01606137|4496315|P1|Overall Study|Protocol Violation|1
1363196|NCT01606137|4496315|P1|Overall Study|Lost to Follow-up|15
1363197|NCT01606137|4496315|P1|Overall Study|Lack of Efficacy|56
1363198|NCT01606137|4496315|P1|Overall Study|Withdrawal by Subject|74
1363199|NCT01606137|4496315|P1|Overall Study|Adverse Event|85
1363200|NCT01606007|4496349|P3|Overall Study|Poor/Non-compliance|0
1363201|NCT01606007|4496350|P2|Overall Study|Poor/Non-compliance|0
1363202|NCT01606007|4496351|P1|Overall Study|Poor/Non-compliance|1
1363203|NCT01606007|4496349|P3|Overall Study|Lost to Follow-up|5
1363204|NCT01606007|4496350|P2|Overall Study|Lost to Follow-up|8
1363205|NCT01606007|4496351|P1|Overall Study|Lost to Follow-up|6
1363206|NCT01606007|4496349|P3|Overall Study|discontinue study treatment|1
1363207|NCT01606007|4496350|P2|Overall Study|discontinue study treatment|2
1363208|NCT01606007|4496351|P1|Overall Study|discontinue study treatment|0
1363209|NCT01606007|4496349|P3|Overall Study|Adverse Event|1
1363210|NCT01606007|4496350|P2|Overall Study|Adverse Event|1
1363211|NCT01606007|4496351|P1|Overall Study|Adverse Event|0
1363212|NCT01606007|4496349|P3|Overall Study|Withdrawal by Subject|1
1363213|NCT01606007|4496350|P2|Overall Study|Withdrawal by Subject|6
1363214|NCT01606007|4496351|P1|Overall Study|Withdrawal by Subject|8
1363215|NCT01606007|4496349|P3|Overall Study|Pregnancy|1
1363216|NCT01606007|4496350|P2|Overall Study|Pregnancy|1
1363217|NCT01606007|4496351|P1|Overall Study|Pregnancy|0
1363218|NCT01606007|4496349|P3|Overall Study|Reason 'Other' in the protocol|1
1363219|NCT01606007|4496350|P2|Overall Study|Reason 'Other' in the protocol|1
1363220|NCT01606007|4496351|P1|Overall Study|Reason 'Other' in the protocol|0
1363221|NCT01605916|4496386|P5|Overall Study|Withdrawal by Subject|2
1363222|NCT01605916|4496387|P4|Overall Study|Withdrawal by Subject|0
1363223|NCT01605916|4496388|P3|Overall Study|Withdrawal by Subject|0
1363224|NCT01605916|4496389|P2|Overall Study|Withdrawal by Subject|1
1363225|NCT01605916|4496390|P1|Overall Study|Withdrawal by Subject|1
1363226|NCT01605916|4496386|P5|Overall Study|Lack of Efficacy|4
1363227|NCT01605916|4496387|P4|Overall Study|Lack of Efficacy|5
1363228|NCT01605916|4496388|P3|Overall Study|Lack of Efficacy|3
1363229|NCT01605916|4496389|P2|Overall Study|Lack of Efficacy|3
1363230|NCT01605916|4496390|P1|Overall Study|Lack of Efficacy|2
1363231|NCT01605916|4496386|P5|Overall Study|Adverse Event|0
1363232|NCT01605916|4496387|P4|Overall Study|Adverse Event|1
1363233|NCT01605916|4496388|P3|Overall Study|Adverse Event|0
1363234|NCT01605916|4496389|P2|Overall Study|Adverse Event|0
1363235|NCT01605916|4496390|P1|Overall Study|Adverse Event|1
1363236|NCT01605877|4496487|P1|Overall Study|Withdrawal by Subject|1
1363237|NCT01605825|4496551|P2|Overall Study|Non-Compliance with Protocol|0
1363238|NCT01605825|4496552|P1|Overall Study|Non-Compliance with Protocol|3
1363239|NCT01605825|4496551|P2|Overall Study|Non-Compliance -Investigational Drug|0
1363240|NCT01605825|4496552|P1|Overall Study|Non-Compliance -Investigational Drug|3
1363241|NCT01605825|4496551|P2|Overall Study|Withdrawal by Subject|1
1363242|NCT01605825|4496552|P1|Overall Study|Withdrawal by Subject|0
1363243|NCT01605825|4496551|P2|Overall Study|Adverse Event|2
1363244|NCT01605825|4496552|P1|Overall Study|Adverse Event|4
1363245|NCT01605799|4496560|P2|Overall Study|Withdrawal by Subject|1
1363246|NCT01605799|4496561|P1|Overall Study|Withdrawal by Subject|2
1363247|NCT01605617|4496576|P2|Washout Period of 4 Weeks|Study Terminated|1
1363248|NCT01605617|4496577|P1|Washout Period of 4 Weeks|Study Terminated|2
1363249|NCT01605617|4496576|P2|First Intervention|Adverse Event|1
1363250|NCT01605617|4496577|P1|First Intervention|Adverse Event|0
1363251|NCT01605461|4496636|P1|Overall Study|Withdrawal by Subject|1
1363253|NCT01605370|4496647|P2|Overall Study|Adverse Event|0
1363254|NCT01605370|4496648|P1|Overall Study|Adverse Event|1
1363255|NCT01605227|4496683|P2|Overall Study|Dose Held >6 weeks|1
1363256|NCT01605227|4496684|P1|Overall Study|Dose Held >6 weeks|0
1363257|NCT01605227|4496683|P2|Overall Study|Subject Decision|1
1363258|NCT01605227|4496684|P1|Overall Study|Subject Decision|0
1363259|NCT01605227|4496683|P2|Overall Study|Started New Therapy|0
1363260|NCT01605227|4496684|P1|Overall Study|Started New Therapy|1
1363261|NCT01605227|4496683|P2|Overall Study|Sponsor Decision|0
1363262|NCT01605227|4496684|P1|Overall Study|Sponsor Decision|2
1363263|NCT01605227|4496683|P2|Overall Study|Withdrawal by Subject|14
1363264|NCT01605227|4496684|P1|Overall Study|Withdrawal by Subject|18
1363265|NCT01605227|4496683|P2|Overall Study|Physician Decision|7
1363266|NCT01605227|4496684|P1|Overall Study|Physician Decision|9
1363267|NCT01605227|4496683|P2|Overall Study|Protocol Violation|0
1363268|NCT01605227|4496684|P1|Overall Study|Protocol Violation|1
1363269|NCT01605227|4496683|P2|Overall Study|Lost to Follow-up|0
1363270|NCT01605227|4496684|P1|Overall Study|Lost to Follow-up|1
1363271|NCT01605227|4496683|P2|Overall Study|Clinical Deterioration|133
1363272|NCT01605227|4496684|P1|Overall Study|Clinical Deterioration|227
1363273|NCT01605227|4496683|P2|Overall Study|Progressive Disease|128
1363274|NCT01605227|4496684|P1|Overall Study|Progressive Disease|132
1363275|NCT01605227|4496683|P2|Overall Study|Adverse Event|42
1363276|NCT01605227|4496684|P1|Overall Study|Adverse Event|228
1363277|NCT01605227|4496683|P2|Overall Study|Did not receive study treatment|3
1363278|NCT01605227|4496684|P1|Overall Study|Did not receive study treatment|2
1363279|NCT01605019|4496696|P2|Overall Study|pt did not meet transplant endpoint|0
1363280|NCT01605019|4496697|P1|Overall Study|pt did not meet transplant endpoint|3
1363281|NCT01604941|4496707|P6|Overall Study|Early Study Termination|0
1363282|NCT01604941|4496708|P5|Overall Study|Early Study Termination|0
1363283|NCT01604941|4496709|P4|Overall Study|Early Study Termination|3
1363284|NCT01604941|4496710|P3|Overall Study|Early Study Termination|3
1363285|NCT01604941|4496711|P2|Overall Study|Early Study Termination|2
1363286|NCT01604941|4496712|P1|Overall Study|Early Study Termination|9
1363287|NCT01604941|4496707|P6|Overall Study|Participant Decision|2
1363288|NCT01604941|4496708|P5|Overall Study|Participant Decision|0
1363289|NCT01604941|4496709|P4|Overall Study|Participant Decision|0
1363290|NCT01604941|4496710|P3|Overall Study|Participant Decision|0
1363291|NCT01604941|4496711|P2|Overall Study|Participant Decision|0
1363292|NCT01604941|4496712|P1|Overall Study|Participant Decision|0
1363293|NCT01604941|4496707|P6|Overall Study|Non-compliance|0
1363294|NCT01604941|4496708|P5|Overall Study|Non-compliance|0
1363295|NCT01604941|4496709|P4|Overall Study|Non-compliance|0
1363296|NCT01604941|4496710|P3|Overall Study|Non-compliance|0
1363297|NCT01604941|4496711|P2|Overall Study|Non-compliance|0
1363298|NCT01604941|4496712|P1|Overall Study|Non-compliance|1
1363299|NCT01604941|4496707|P6|Overall Study|Adverse Event|5
1363300|NCT01604941|4496708|P5|Overall Study|Adverse Event|1
1363301|NCT01604941|4496709|P4|Overall Study|Adverse Event|0
1363302|NCT01604941|4496710|P3|Overall Study|Adverse Event|0
1363303|NCT01604941|4496711|P2|Overall Study|Adverse Event|2
1363304|NCT01604941|4496712|P1|Overall Study|Adverse Event|1
1363305|NCT01604850|4496740|P2|Overall Study|Subject withdrew consent|0
1363306|NCT01604850|4496741|P1|Overall Study|Subject withdrew consent|1
1363307|NCT01604850|4496740|P2|Overall Study|Lost to Follow-up|0
1363308|NCT01604850|4496741|P1|Overall Study|Lost to Follow-up|1
1363309|NCT01604850|4496740|P2|Overall Study|Efficacy Failure|29
1363310|NCT01604850|4496741|P1|Overall Study|Efficacy Failure|50
1363311|NCT01604850|4496740|P2|Overall Study|Enrolled but never treated|1
1363312|NCT01604850|4496741|P1|Overall Study|Enrolled but never treated|0
1363313|NCT01604408|4496765|P2|Observation Period|Withdrawal by Subject|2
1363314|NCT01604408|4496766|P1|Observation Period|Withdrawal by Subject|0
1363315|NCT01604408|4496765|P2|Observation Period|Adverse Event|1
1363316|NCT01604408|4496766|P1|Observation Period|Adverse Event|1
1363317|NCT01604408|4496765|P2|Treatment Period 6|Sponsor decision|1
1363318|NCT01604408|4496766|P1|Treatment Period 6|Sponsor decision|0
1363319|NCT01604408|4496765|P2|Treatment Period 6|Adverse Event|0
1363320|NCT01604408|4496766|P1|Treatment Period 6|Adverse Event|2
1363321|NCT01604408|4496765|P2|Treatment Period 6|Lost to Follow-up|1
1363322|NCT01604408|4496766|P1|Treatment Period 6|Lost to Follow-up|0
1363323|NCT01604408|4496765|P2|Treatment Period 5|Adverse Event|0
1363324|NCT01604408|4496766|P1|Treatment Period 5|Adverse Event|4
1363325|NCT01604408|4496765|P2|Treatment Period 4|Adverse Event|1
1363326|NCT01604408|4496766|P1|Treatment Period 4|Adverse Event|0
1363327|NCT01604408|4496765|P2|Treatment Period 4|Withdrawal by Subject|1
1363328|NCT01604408|4496766|P1|Treatment Period 4|Withdrawal by Subject|2
1363329|NCT01604408|4496765|P2|Treatment Period 4|Death|0
1363330|NCT01604408|4496766|P1|Treatment Period 4|Death|1
1363331|NCT01604408|4496765|P2|Treatment Period 3|Sponsor Decision|0
1363332|NCT01604408|4496766|P1|Treatment Period 3|Sponsor Decision|1
1363333|NCT01604408|4496765|P2|Treatment Period 3|Withdrawal by Subject|1
1363334|NCT01604408|4496766|P1|Treatment Period 3|Withdrawal by Subject|3
1363335|NCT01604408|4496765|P2|Treatment Period 3|Adverse Event|3
1363336|NCT01604408|4496766|P1|Treatment Period 3|Adverse Event|0
1363337|NCT01604408|4496765|P2|Treatment Period 3|Protocol Violation|1
1363338|NCT01604408|4496766|P1|Treatment Period 3|Protocol Violation|1
1363339|NCT01604408|4496765|P2|Treatment Period 2|Adverse Event|1
1363340|NCT01604408|4496766|P1|Treatment Period 2|Adverse Event|0
1363341|NCT01604408|4496765|P2|Treatment Period 2|Protocol Violation|0
1363342|NCT01604408|4496766|P1|Treatment Period 2|Protocol Violation|1
1363343|NCT01604408|4496765|P2|Treatment Period 2|Withdrawal by Subject|1
1363344|NCT01604408|4496766|P1|Treatment Period 2|Withdrawal by Subject|1
1363345|NCT01604408|4496765|P2|Treatment Period 1|Protocol Violation|1
1363346|NCT01604408|4496766|P1|Treatment Period 1|Protocol Violation|0
1363347|NCT01604343|4496781|P5|Safety Follow-up Period (Week 104-120)|Other|14
1363348|NCT01604343|4496782|P4|Safety Follow-up Period (Week 104-120)|Other|6
1363349|NCT01604343|4496783|P3|Safety Follow-up Period (Week 104-120)|Other|20
1363350|NCT01604343|4496784|P2|Safety Follow-up Period (Week 104-120)|Other|2
1363351|NCT01604343|4496785|P1|Safety Follow-up Period (Week 104-120)|Other|15
1363352|NCT01604343|4496781|P5|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
1363353|NCT01604343|4496782|P4|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
1363354|NCT01604343|4496783|P3|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
1363355|NCT01604343|4496784|P2|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
1363356|NCT01604343|4496785|P1|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
1363357|NCT01604343|4496781|P5|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
1363358|NCT01604343|4496782|P4|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
1363359|NCT01604343|4496783|P3|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
1363360|NCT01604343|4496784|P2|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
1363361|NCT01604343|4496785|P1|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
1363362|NCT01604343|4496781|P5|Week 52 to Week 104|Other|3
1363363|NCT01604343|4496782|P4|Week 52 to Week 104|Other|6
1363364|NCT01604343|4496783|P3|Week 52 to Week 104|Other|11
1363365|NCT01604343|4496784|P2|Week 52 to Week 104|Other|11
1363366|NCT01604343|4496785|P1|Week 52 to Week 104|Other|0
1363367|NCT01604343|4496781|P5|Week 52 to Week 104|Pregnancy|1
1363368|NCT01604343|4496782|P4|Week 52 to Week 104|Pregnancy|2
1363369|NCT01604343|4496783|P3|Week 52 to Week 104|Pregnancy|1
1363370|NCT01604343|4496784|P2|Week 52 to Week 104|Pregnancy|0
1363371|NCT01604343|4496785|P1|Week 52 to Week 104|Pregnancy|0
1363372|NCT01604343|4496781|P5|Week 52 to Week 104|Physician Decision|2
1363373|NCT01604343|4496782|P4|Week 52 to Week 104|Physician Decision|0
1363374|NCT01604343|4496783|P3|Week 52 to Week 104|Physician Decision|0
1363375|NCT01604343|4496784|P2|Week 52 to Week 104|Physician Decision|1
1363376|NCT01604343|4496785|P1|Week 52 to Week 104|Physician Decision|0
1363377|NCT01604343|4496781|P5|Week 52 to Week 104|Lack of Efficacy|3
1363378|NCT01604343|4496782|P4|Week 52 to Week 104|Lack of Efficacy|2
1363379|NCT01604343|4496783|P3|Week 52 to Week 104|Lack of Efficacy|11
1363380|NCT01604343|4496784|P2|Week 52 to Week 104|Lack of Efficacy|6
1363381|NCT01604343|4496785|P1|Week 52 to Week 104|Lack of Efficacy|0
1363382|NCT01604343|4496781|P5|Week 52 to Week 104|Death|0
1363383|NCT01604343|4496782|P4|Week 52 to Week 104|Death|5
1363384|NCT01604343|4496783|P3|Week 52 to Week 104|Death|2
1363385|NCT01604343|4496784|P2|Week 52 to Week 104|Death|4
1363386|NCT01604343|4496785|P1|Week 52 to Week 104|Death|0
1363387|NCT01604343|4496781|P5|Week 52 to Week 104|Adverse Event|27
1363388|NCT01604343|4496782|P4|Week 52 to Week 104|Adverse Event|21
1363389|NCT01604343|4496783|P3|Week 52 to Week 104|Adverse Event|26
1363390|NCT01604343|4496784|P2|Week 52 to Week 104|Adverse Event|12
1363391|NCT01604343|4496785|P1|Week 52 to Week 104|Adverse Event|0
1363392|NCT01604343|4496781|P5|Week 52 to Week 104|Withdrawal by Subject|4
1363393|NCT01604343|4496782|P4|Week 52 to Week 104|Withdrawal by Subject|8
1363394|NCT01604343|4496783|P3|Week 52 to Week 104|Withdrawal by Subject|12
1363395|NCT01604343|4496784|P2|Week 52 to Week 104|Withdrawal by Subject|7
1363396|NCT01604343|4496785|P1|Week 52 to Week 104|Withdrawal by Subject|0
1363397|NCT01604343|4496781|P5|Week 52 to Week 104|Lost to Follow-up|1
1363398|NCT01604343|4496782|P4|Week 52 to Week 104|Lost to Follow-up|2
1363399|NCT01604343|4496783|P3|Week 52 to Week 104|Lost to Follow-up|4
1363400|NCT01604343|4496784|P2|Week 52 to Week 104|Lost to Follow-up|2
1363401|NCT01604343|4496785|P1|Week 52 to Week 104|Lost to Follow-up|0
1363402|NCT01604343|4496781|P5|Prior to W52 Administration(Through W52)|Other|6
1363403|NCT01604343|4496782|P4|Prior to W52 Administration(Through W52)|Other|0
1363404|NCT01604343|4496783|P3|Prior to W52 Administration(Through W52)|Other|10
1363405|NCT01604343|4496784|P2|Prior to W52 Administration(Through W52)|Other|0
1363406|NCT01604343|4496785|P1|Prior to W52 Administration(Through W52)|Other|15
1363407|NCT01604343|4496781|P5|Prior to W52 Administration(Through W52)|Pregnancy|0
1363408|NCT01604343|4496782|P4|Prior to W52 Administration(Through W52)|Pregnancy|0
1363409|NCT01604343|4496783|P3|Prior to W52 Administration(Through W52)|Pregnancy|1
1363410|NCT01604343|4496784|P2|Prior to W52 Administration(Through W52)|Pregnancy|0
1363411|NCT01604343|4496785|P1|Prior to W52 Administration(Through W52)|Pregnancy|1
1363412|NCT01604343|4496781|P5|Prior to W52 Administration(Through W52)|Physician Decision|2
1363413|NCT01604343|4496782|P4|Prior to W52 Administration(Through W52)|Physician Decision|0
1363414|NCT01604343|4496783|P3|Prior to W52 Administration(Through W52)|Physician Decision|1
1363415|NCT01604343|4496784|P2|Prior to W52 Administration(Through W52)|Physician Decision|0
1363416|NCT01604343|4496785|P1|Prior to W52 Administration(Through W52)|Physician Decision|4
1363417|NCT01604343|4496781|P5|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
1363418|NCT01604343|4496782|P4|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
1363419|NCT01604343|4496783|P3|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
1363420|NCT01604343|4496784|P2|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
1363421|NCT01604343|4496785|P1|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
1363422|NCT01604343|4496781|P5|Prior to W52 Administration(Through W52)|Death|4
1363423|NCT01604343|4496782|P4|Prior to W52 Administration(Through W52)|Death|0
1363424|NCT01604343|4496783|P3|Prior to W52 Administration(Through W52)|Death|2
1363425|NCT01604343|4496784|P2|Prior to W52 Administration(Through W52)|Death|0
1363426|NCT01604343|4496785|P1|Prior to W52 Administration(Through W52)|Death|5
1363427|NCT01604343|4496781|P5|Prior to W52 Administration(Through W52)|Adverse Event|42
1363428|NCT01604343|4496782|P4|Prior to W52 Administration(Through W52)|Adverse Event|0
1363429|NCT01604343|4496783|P3|Prior to W52 Administration(Through W52)|Adverse Event|41
1363430|NCT01604343|4496784|P2|Prior to W52 Administration(Through W52)|Adverse Event|0
1363431|NCT01604343|4496785|P1|Prior to W52 Administration(Through W52)|Adverse Event|25
1363432|NCT01604343|4496781|P5|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
1363433|NCT01604343|4496782|P4|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
1363434|NCT01604343|4496783|P3|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
1363435|NCT01604343|4496784|P2|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
1363436|NCT01604343|4496785|P1|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
1363437|NCT01604343|4496781|P5|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
1363438|NCT01604343|4496782|P4|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
1363439|NCT01604343|4496783|P3|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
1363440|NCT01604343|4496784|P2|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
1363441|NCT01604343|4496785|P1|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
1363442|NCT01604278|4496896|P2|Overall Study|Protocol Deviation|3
1363443|NCT01604278|4496897|P1|Overall Study|Protocol Deviation|5
1363444|NCT01604278|4496896|P2|Overall Study|Adverse Event|5
1363445|NCT01604278|4496897|P1|Overall Study|Adverse Event|3
1363446|NCT01604278|4496896|P2|Overall Study|Withdrawal by Subject|3
1363447|NCT01604278|4496897|P1|Overall Study|Withdrawal by Subject|3
1363448|NCT01604278|4496896|P2|Overall Study|Administrative problems|1
1363449|NCT01604278|4496897|P1|Overall Study|Administrative problems|2
1363450|NCT01604278|4496896|P2|Overall Study|Lost to Follow-up|0
1363451|NCT01604278|4496897|P1|Overall Study|Lost to Follow-up|1
1363452|NCT01604278|4496896|P2|Overall Study|Lack of Efficacy|1
1363453|NCT01604278|4496897|P1|Overall Study|Lack of Efficacy|0
1363454|NCT01604265|4496923|P2|Overall Study|Withdrawal by Subject|0
1363455|NCT01604265|4496924|P1|Overall Study|Withdrawal by Subject|1
1363456|NCT01604265|4496923|P2|Overall Study|Adverse Event|0
1363457|NCT01604265|4496924|P1|Overall Study|Adverse Event|1
1363458|NCT01603875|4497035|P3|Overall Study|Protocol Violation|0
1363459|NCT01603875|4497036|P2|Overall Study|Protocol Violation|1
1363460|NCT01603875|4497037|P1|Overall Study|Protocol Violation|0
1363461|NCT01603875|4497035|P3|Overall Study|Lost to Follow-up|6
1363462|NCT01603875|4497036|P2|Overall Study|Lost to Follow-up|3
1363463|NCT01603875|4497037|P1|Overall Study|Lost to Follow-up|4
1363464|NCT01603875|4497035|P3|Overall Study|Preexisting rabies antibody|3
1363465|NCT01603875|4497036|P2|Overall Study|Preexisting rabies antibody|4
1363466|NCT01603875|4497037|P1|Overall Study|Preexisting rabies antibody|3
1363467|NCT01603628|4497060|P3|Overall Study|Other Miscellaneous Reason|0
1363468|NCT01603628|4497061|P2|Overall Study|Other Miscellaneous Reason|0
1363469|NCT01603628|4497062|P1|Overall Study|Other Miscellaneous Reason|1
1363470|NCT01603628|4497060|P3|Overall Study|Lost to Follow-up|0
1363471|NCT01603628|4497061|P2|Overall Study|Lost to Follow-up|1
1363472|NCT01603628|4497062|P1|Overall Study|Lost to Follow-up|0
1363473|NCT01603628|4497060|P3|Overall Study|Protocol Violation|0
1363474|NCT01603628|4497061|P2|Overall Study|Protocol Violation|1
1363475|NCT01603628|4497062|P1|Overall Study|Protocol Violation|1
1363476|NCT01603628|4497060|P3|Overall Study|Personal Reasons|2
1363477|NCT01603628|4497061|P2|Overall Study|Personal Reasons|1
1363478|NCT01603628|4497062|P1|Overall Study|Personal Reasons|1
1363479|NCT01603602|4497082|P3|Overall Study|Personal Reasons|1
1363480|NCT01603602|4497083|P2|Overall Study|Personal Reasons|0
1363481|NCT01603602|4497084|P1|Overall Study|Personal Reasons|1
1363482|NCT01603602|4497082|P3|Overall Study|Adverse Event|0
1363483|NCT01603602|4497083|P2|Overall Study|Adverse Event|0
1363484|NCT01603602|4497084|P1|Overall Study|Adverse Event|1
1363485|NCT01603459|4497104|P1|Overall Study|Administrative reason|1
1363486|NCT01603459|4497104|P1|Overall Study|Non-compliance|1
1363487|NCT01603459|4497104|P1|Overall Study|Predefined discontinuation criteria|3
1363488|NCT01603459|4497104|P1|Overall Study|Lost to Follow-up|3
1363489|NCT01603459|4497104|P1|Overall Study|Withdrawal by Subject|5
1363490|NCT01603459|4497104|P1|Overall Study|Adverse Event|5
1363491|NCT01603394|4497255|P1|Overall Study|Adverse Event|1
1363492|NCT01603277|4497272|P2|Overall Study|Non-Compliance|1
1363493|NCT01603277|4497273|P1|Overall Study|Non-Compliance|2
1363494|NCT01603277|4497272|P2|Overall Study|Withdrawal by Subject|4
1363495|NCT01603277|4497273|P1|Overall Study|Withdrawal by Subject|5
1363496|NCT01603277|4497272|P2|Overall Study|Protocol Violation|10
1363497|NCT01603277|4497273|P1|Overall Study|Protocol Violation|6
1363498|NCT01603277|4497272|P2|Overall Study|Physician Decision|1
1363499|NCT01603277|4497273|P1|Overall Study|Physician Decision|0
1363500|NCT01603277|4497272|P2|Overall Study|Adverse Event|2
1363501|NCT01603277|4497273|P1|Overall Study|Adverse Event|1
1363502|NCT01603121|4497279|P2|Second Intervention, 10 Hours|Adverse Event|0
1363503|NCT01603121|4497280|P1|Second Intervention, 10 Hours|Adverse Event|1
1363504|NCT01603082|4497292|P2|Overall Study|Failed inclusion criterion after dosed|0
1363505|NCT01603082|4497293|P1|Overall Study|Failed inclusion criterion after dosed|1
1363506|NCT01603082|4497292|P2|Overall Study|Withdrawal by Subject|0
1363507|NCT01603082|4497293|P1|Overall Study|Withdrawal by Subject|1
1363508|NCT01603082|4497292|P2|Overall Study|Adverse Event|1
1363509|NCT01603082|4497293|P1|Overall Study|Adverse Event|0
1363510|NCT01603043|4497334|P2|Overall Study|Study Futility|3
1363511|NCT01603043|4497335|P1|Overall Study|Study Futility|7
1363512|NCT01602965|4497347|P2|Overall Study|Lost to Follow-up|2
1363513|NCT01602965|4497348|P1|Overall Study|Lost to Follow-up|4
1363514|NCT01602744|4497356|P2|Overall Study|Lost to Follow-up|8
1363515|NCT01602744|4497357|P1|Overall Study|Lost to Follow-up|13
1363516|NCT01602744|4497356|P2|Overall Study|Death|15
1363517|NCT01602744|4497357|P1|Overall Study|Death|17
1363518|NCT01602562|4497381|P2|Overall Study|Withdrawal by Subject|1
1363519|NCT01602562|4497382|P1|Overall Study|Withdrawal by Subject|1
1363520|NCT01602562|4497381|P2|Overall Study|Physician Decision|1
1363521|NCT01602562|4497382|P1|Overall Study|Physician Decision|1
1363522|NCT01602562|4497381|P2|Overall Study|Adverse Event|1
1363523|NCT01602562|4497382|P1|Overall Study|Adverse Event|3
1363524|NCT01602549|4497418|P2|Overall Study|Withdrawal by Subject|0
1363525|NCT01602549|4497419|P1|Overall Study|Withdrawal by Subject|1
1363526|NCT01602549|4497418|P2|Overall Study|Protocol Violation|1
1363527|NCT01602549|4497419|P1|Overall Study|Protocol Violation|0
1363528|NCT01602510|4497498|P3|Randomized Phase|Withdrawal by Subject|7
1363529|NCT01602510|4497499|P2|Randomized Phase|Withdrawal by Subject|6
1363530|NCT01602510|4497500|P1|Randomized Phase|Withdrawal by Subject|0
1363531|NCT01602510|4497498|P3|Randomized Phase|Physician Decision|2
1363532|NCT01602510|4497499|P2|Randomized Phase|Physician Decision|0
1363533|NCT01602510|4497500|P1|Randomized Phase|Physician Decision|0
1363534|NCT01602510|4497498|P3|Randomized Phase|Lost to Follow-up|3
1363535|NCT01602510|4497499|P2|Randomized Phase|Lost to Follow-up|1
1363536|NCT01602510|4497500|P1|Randomized Phase|Lost to Follow-up|0
1363537|NCT01602510|4497498|P3|Randomized Phase|Met protocol-defined stopping criteria|48
1363538|NCT01602510|4497499|P2|Randomized Phase|Met protocol-defined stopping criteria|58
1363539|NCT01602510|4497500|P1|Randomized Phase|Met protocol-defined stopping criteria|0
1363540|NCT01602510|4497498|P3|Randomized Phase|Protocol Violation|3
1363541|NCT01602510|4497499|P2|Randomized Phase|Protocol Violation|3
1363542|NCT01602510|4497500|P1|Randomized Phase|Protocol Violation|0
1363543|NCT01602510|4497498|P3|Randomized Phase|Lack of Efficacy|4
1363544|NCT01602510|4497499|P2|Randomized Phase|Lack of Efficacy|4
1363545|NCT01602510|4497500|P1|Randomized Phase|Lack of Efficacy|0
1363546|NCT01602510|4497498|P3|Randomized Phase|Adverse Event|6
1363547|NCT01602510|4497499|P2|Randomized Phase|Adverse Event|2
1363548|NCT01602510|4497500|P1|Randomized Phase|Adverse Event|0
1363549|NCT01602510|4497498|P3|Open Label Phase|Withdrawal by Subject|0
1363550|NCT01602510|4497499|P2|Open Label Phase|Withdrawal by Subject|0
1363551|NCT01602510|4497500|P1|Open Label Phase|Withdrawal by Subject|57
1363552|NCT01602510|4497498|P3|Open Label Phase|Physician Decision|0
1363553|NCT01602510|4497499|P2|Open Label Phase|Physician Decision|0
1363554|NCT01602510|4497500|P1|Open Label Phase|Physician Decision|19
1363555|NCT01602510|4497498|P3|Open Label Phase|Lost to Follow-up|0
1363556|NCT01602510|4497499|P2|Open Label Phase|Lost to Follow-up|0
1363557|NCT01602510|4497500|P1|Open Label Phase|Lost to Follow-up|22
1363558|NCT01602510|4497498|P3|Open Label Phase|Met protocol-defined stopping criteria|0
1363559|NCT01602510|4497499|P2|Open Label Phase|Met protocol-defined stopping criteria|0
1363560|NCT01602510|4497500|P1|Open Label Phase|Met protocol-defined stopping criteria|122
1363561|NCT01602510|4497498|P3|Open Label Phase|Protocol Violation|0
1363562|NCT01602510|4497499|P2|Open Label Phase|Protocol Violation|0
1363563|NCT01602510|4497500|P1|Open Label Phase|Protocol Violation|15
1363564|NCT01602510|4497498|P3|Open Label Phase|Lack of Efficacy|0
1363565|NCT01602510|4497499|P2|Open Label Phase|Lack of Efficacy|0
1363566|NCT01602510|4497500|P1|Open Label Phase|Lack of Efficacy|22
1363567|NCT01602510|4497498|P3|Open Label Phase|Adverse Event|0
1363568|NCT01602510|4497499|P2|Open Label Phase|Adverse Event|0
1363569|NCT01602510|4497500|P1|Open Label Phase|Adverse Event|46
1363570|NCT01602484|4497526|P2|Overall Study|Airway issues unrelated to study|1
1363571|NCT01602484|4497527|P1|Overall Study|Airway issues unrelated to study|0
1363572|NCT01602380|4497545|P2|Overall Study|Eligibility criteria not fulfilled|3
1363573|NCT01602380|4497546|P1|Overall Study|Eligibility criteria not fulfilled|2
1363574|NCT01602380|4497545|P2|Overall Study|Lost to Follow-up|1
1363575|NCT01602380|4497546|P1|Overall Study|Lost to Follow-up|6
1363576|NCT01602380|4497545|P2|Overall Study|Withdrawal by Subject|29
1363577|NCT01602380|4497546|P1|Overall Study|Withdrawal by Subject|22
1363578|NCT01602380|4497545|P2|Overall Study|Death|68
1363579|NCT01602380|4497546|P1|Overall Study|Death|63
1363580|NCT01602341|4497570|P2|Overall Study|Adverse Event|1
1363581|NCT01602341|4497571|P1|Overall Study|Adverse Event|0
1363582|NCT01602315|4497612|P7|Overall Study|Cross-over patients to combo treatment|0
1363583|NCT01602315|4497613|P6|Overall Study|Cross-over patients to combo treatment|16
1363584|NCT01602315|4497614|P5|Overall Study|Cross-over patients to combo treatment|0
1363585|NCT01602315|4497615|P4|Overall Study|Cross-over patients to combo treatment|0
1363586|NCT01602315|4497616|P3|Overall Study|Cross-over patients to combo treatment|0
1363587|NCT01602315|4497617|P2|Overall Study|Cross-over patients to combo treatment|0
1363588|NCT01602315|4497618|P1|Overall Study|Cross-over patients to combo treatment|0
1363589|NCT01602315|4497612|P7|Overall Study|Subject/guardian decision|1
1363590|NCT01602315|4497613|P6|Overall Study|Subject/guardian decision|0
1363591|NCT01602315|4497614|P5|Overall Study|Subject/guardian decision|0
1363592|NCT01602315|4497615|P4|Overall Study|Subject/guardian decision|0
1363593|NCT01602315|4497616|P3|Overall Study|Subject/guardian decision|0
1363594|NCT01602315|4497617|P2|Overall Study|Subject/guardian decision|0
1363595|NCT01602315|4497618|P1|Overall Study|Subject/guardian decision|0
1363596|NCT01602315|4497612|P7|Overall Study|Adverse Event|9
1363597|NCT01602315|4497613|P6|Overall Study|Adverse Event|3
1363598|NCT01602315|4497614|P5|Overall Study|Adverse Event|15
1363599|NCT01602315|4497615|P4|Overall Study|Adverse Event|4
1363600|NCT01602315|4497616|P3|Overall Study|Adverse Event|5
1363601|NCT01602315|4497617|P2|Overall Study|Adverse Event|1
1363602|NCT01602315|4497618|P1|Overall Study|Adverse Event|5
1363603|NCT01602315|4497612|P7|Overall Study|Withdrawal by Subject|1
1363604|NCT01602315|4497613|P6|Overall Study|Withdrawal by Subject|0
1363605|NCT01602315|4497614|P5|Overall Study|Withdrawal by Subject|6
1363606|NCT01602315|4497615|P4|Overall Study|Withdrawal by Subject|0
1363607|NCT01602315|4497616|P3|Overall Study|Withdrawal by Subject|2
1363608|NCT01602315|4497617|P2|Overall Study|Withdrawal by Subject|0
1363609|NCT01602315|4497618|P1|Overall Study|Withdrawal by Subject|2
1363610|NCT01602315|4497612|P7|Overall Study|Death|2
1363611|NCT01602315|4497613|P6|Overall Study|Death|2
1363612|NCT01602315|4497614|P5|Overall Study|Death|7
1363613|NCT01602315|4497615|P4|Overall Study|Death|1
1363614|NCT01602315|4497616|P3|Overall Study|Death|1
1363615|NCT01602315|4497617|P2|Overall Study|Death|1
1363616|NCT01602315|4497618|P1|Overall Study|Death|1
1363617|NCT01602315|4497612|P7|Overall Study|Disease progression|15
1363618|NCT01602315|4497613|P6|Overall Study|Disease progression|12
1363619|NCT01602315|4497614|P5|Overall Study|Disease progression|41
1363620|NCT01602315|4497615|P4|Overall Study|Disease progression|1
1363621|NCT01602315|4497616|P3|Overall Study|Disease progression|10
1363622|NCT01602315|4497617|P2|Overall Study|Disease progression|3
1363623|NCT01602315|4497618|P1|Overall Study|Disease progression|6
1363624|NCT01602315|4497612|P7|Overall Study|Physician Decision|1
1363625|NCT01602315|4497613|P6|Overall Study|Physician Decision|1
1363626|NCT01602315|4497614|P5|Overall Study|Physician Decision|2
1363627|NCT01602315|4497615|P4|Overall Study|Physician Decision|0
1363628|NCT01602315|4497616|P3|Overall Study|Physician Decision|0
1363629|NCT01602315|4497617|P2|Overall Study|Physician Decision|0
1363630|NCT01602315|4497618|P1|Overall Study|Physician Decision|2
1363631|NCT01602315|4497612|P7|Overall Study|Protocol Violation|0
1363632|NCT01602315|4497613|P6|Overall Study|Protocol Violation|1
1363633|NCT01602315|4497614|P5|Overall Study|Protocol Violation|0
1363634|NCT01602315|4497615|P4|Overall Study|Protocol Violation|0
1363635|NCT01602315|4497616|P3|Overall Study|Protocol Violation|0
1363636|NCT01602315|4497617|P2|Overall Study|Protocol Violation|0
1363637|NCT01602315|4497618|P1|Overall Study|Protocol Violation|0
1363638|NCT01602224|4497707|P3|Overall Study|Withdrawal by Subject|3
1363639|NCT01602224|4497708|P2|Overall Study|Withdrawal by Subject|3
1363640|NCT01602224|4497709|P1|Overall Study|Withdrawal by Subject|5
1363641|NCT01602224|4497707|P3|Overall Study|Sponsor Decision|2
1363642|NCT01602224|4497708|P2|Overall Study|Sponsor Decision|3
1363643|NCT01602224|4497709|P1|Overall Study|Sponsor Decision|2
1363644|NCT01602224|4497707|P3|Overall Study|Protocol Violation|0
1363645|NCT01602224|4497708|P2|Overall Study|Protocol Violation|1
1363646|NCT01602224|4497709|P1|Overall Study|Protocol Violation|0
1363647|NCT01602224|4497707|P3|Overall Study|Lost to Follow-up|1
1363648|NCT01602224|4497708|P2|Overall Study|Lost to Follow-up|0
1363649|NCT01602224|4497709|P1|Overall Study|Lost to Follow-up|0
1363650|NCT01602224|4497707|P3|Overall Study|Investigator Decison|0
1363651|NCT01602224|4497708|P2|Overall Study|Investigator Decison|0
1363652|NCT01602224|4497709|P1|Overall Study|Investigator Decison|1
1363653|NCT01602224|4497707|P3|Overall Study|Adverse Event|0
1363654|NCT01602224|4497708|P2|Overall Study|Adverse Event|1
1363655|NCT01602224|4497709|P1|Overall Study|Adverse Event|0
1363656|NCT01601847|4497798|P2|Overall Study|Lost to Follow-up|3
1363657|NCT01601847|4497799|P1|Overall Study|Lost to Follow-up|1
1363658|NCT01601847|4497798|P2|Overall Study|Withdrawal by Subject|7
1363659|NCT01601847|4497799|P1|Overall Study|Withdrawal by Subject|11
1363660|NCT01601847|4497798|P2|Overall Study|Death|0
1363661|NCT01601847|4497799|P1|Overall Study|Death|1
1363662|NCT01601821|4497811|P2|Overall Study|Other|1
1363663|NCT01601821|4497812|P1|Overall Study|Other|5
1363664|NCT01601821|4497811|P2|Overall Study|Study Events|1
1363665|NCT01601821|4497812|P1|Overall Study|Study Events|7
1363666|NCT01601821|4497811|P2|Overall Study|Graft Loss|6
1363667|NCT01601821|4497812|P1|Overall Study|Graft Loss|6
1363668|NCT01601821|4497811|P2|Overall Study|Withdrawal by Subject|0
1363669|NCT01601821|4497812|P1|Overall Study|Withdrawal by Subject|1
1363670|NCT01601821|4497811|P2|Overall Study|Lost to Follow-up|14
1363671|NCT01601821|4497812|P1|Overall Study|Lost to Follow-up|6
1363672|NCT01601821|4497811|P2|Overall Study|Protocol Violation|2
1363673|NCT01601821|4497812|P1|Overall Study|Protocol Violation|2
1363674|NCT01601821|4497811|P2|Overall Study|Death|5
1363675|NCT01601821|4497812|P1|Overall Study|Death|2
1363676|NCT01601704|4497848|P2|Overall Study|Randomized but not dispensed study med|4
1363677|NCT01601704|4497849|P1|Overall Study|Randomized but not dispensed study med|1
1363678|NCT01601626|4497870|P3|Overall Study|Not Willing to Adhere to Requirements|0
1363845|NCT01599104|4498611|P1|Overall Study|Withdrawal by Subject|1
1363679|NCT01601626|4497871|P2|Overall Study|Not Willing to Adhere to Requirements|0
1363680|NCT01601626|4497872|P1|Overall Study|Not Willing to Adhere to Requirements|1
1363681|NCT01601626|4497870|P3|Overall Study|Withdrawal by Subject|1
1363682|NCT01601626|4497871|P2|Overall Study|Withdrawal by Subject|1
1363683|NCT01601626|4497872|P1|Overall Study|Withdrawal by Subject|0
1363684|NCT01601626|4497870|P3|Overall Study|Unable to Get to Clinic|0
1363685|NCT01601626|4497871|P2|Overall Study|Unable to Get to Clinic|1
1363686|NCT01601626|4497872|P1|Overall Study|Unable to Get to Clinic|0
1363687|NCT01601626|4497870|P3|Overall Study|Lost to Follow-up|0
1363688|NCT01601626|4497871|P2|Overall Study|Lost to Follow-up|2
1363689|NCT01601626|4497872|P1|Overall Study|Lost to Follow-up|1
1363690|NCT01601626|4497870|P3|Overall Study|Death|1
1363691|NCT01601626|4497871|P2|Overall Study|Death|1
1363692|NCT01601626|4497872|P1|Overall Study|Death|1
1363693|NCT01601470|4497955|P1|Period 2 - LCZ696|Physician Decision|1
1363694|NCT01601132|4498026|P1|Overall Study|Protocol deviation|1
1363695|NCT01601132|4498026|P1|Overall Study|Patient withdrew consent|1
1363696|NCT01600885|4498060|P2|First Period|moved out of area|0
1363697|NCT01600885|4498061|P1|First Period|moved out of area|1
1363698|NCT01600885|4498060|P2|First Period|Adverse Event|1
1363699|NCT01600885|4498061|P1|First Period|Adverse Event|1
1363700|NCT01600716|4498078|P2|Overall Study|Adverse Event|1
1363701|NCT01600716|4498079|P1|Overall Study|Adverse Event|1
1363702|NCT01600716|4498078|P2|Overall Study|Lack of Efficacy|1
1363703|NCT01600716|4498079|P1|Overall Study|Lack of Efficacy|2
1363704|NCT01600716|4498078|P2|Overall Study|Pregnancy|0
1363705|NCT01600716|4498079|P1|Overall Study|Pregnancy|1
1363706|NCT01600716|4498078|P2|Overall Study|Lost to Follow-up|2
1363707|NCT01600716|4498079|P1|Overall Study|Lost to Follow-up|0
1363708|NCT01600716|4498078|P2|Overall Study|Personal Reasons|2
1363709|NCT01600716|4498079|P1|Overall Study|Personal Reasons|0
1363710|NCT01600716|4498078|P2|Overall Study|Other Reasons|1
1363711|NCT01600716|4498079|P1|Overall Study|Other Reasons|3
1363712|NCT01600586|4498119|P2|Overall Study|Physician Decision|3
1363713|NCT01600586|4498120|P1|Overall Study|Physician Decision|3
1363714|NCT01600326|4498172|P2|Overall Study|Lost to Follow-up|1
1363715|NCT01600326|4498173|P1|Overall Study|Lost to Follow-up|1
1363716|NCT01600092|4498249|P2|Overall Study|Randomized but not vaccinated|3
1363717|NCT01600092|4498250|P1|Overall Study|Randomized but not vaccinated|3
1363718|NCT01600092|4498249|P2|Overall Study|Physician Decision|1
1363719|NCT01600092|4498250|P1|Overall Study|Physician Decision|1
1363720|NCT01600092|4498249|P2|Overall Study|Withdrawal by parent/guardian|6
1363721|NCT01600092|4498250|P1|Overall Study|Withdrawal by parent/guardian|8
1363722|NCT01600092|4498249|P2|Overall Study|Lost to Follow-up|6
1363723|NCT01600092|4498250|P1|Overall Study|Lost to Follow-up|4
1363724|NCT01600092|4498249|P2|Overall Study|Adverse Event|0
1363725|NCT01600092|4498250|P1|Overall Study|Adverse Event|2
1363726|NCT01600053|4498264|P1|Overall Study|trial will not meet the interim endpoint|9
1363727|NCT01600053|4498264|P1|Overall Study|Adverse Event|2
1363728|NCT01600014|4498269|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
1363729|NCT01600014|4498270|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
1363730|NCT01600014|4498269|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
1363731|NCT01600014|4498270|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
1363732|NCT01600014|4498269|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
1363733|NCT01600014|4498270|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
1363734|NCT01600014|4498269|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
1363735|NCT01600014|4498270|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
1363736|NCT01600014|4498269|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
1363737|NCT01600014|4498270|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
1363738|NCT01600014|4498269|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
1363739|NCT01600014|4498270|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
1363740|NCT01600014|4498269|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
1363741|NCT01600014|4498270|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
1363742|NCT01600014|4498269|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
1363743|NCT01600014|4498270|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
1363744|NCT01600014|4498269|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
1363745|NCT01600014|4498270|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
1363746|NCT01600014|4498269|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
1363747|NCT01600014|4498270|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
1363748|NCT01600014|4498269|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
1363749|NCT01600014|4498270|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
1363750|NCT01600014|4498269|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
1363751|NCT01600014|4498270|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
1363752|NCT01600014|4498269|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
1363753|NCT01600014|4498270|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
1363754|NCT01600014|4498269|P2|1. Cycle & Observation Period D1 to W52|Other|0
1363755|NCT01600014|4498270|P1|1. Cycle & Observation Period D1 to W52|Other|27
1363756|NCT01600014|4498269|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
1363757|NCT01600014|4498270|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
1363846|NCT01598987|4498649|P1|Baseline to 24 Month|Lost to Follow-up|1
1363758|NCT01600014|4498269|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
1363759|NCT01600014|4498270|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
1363760|NCT01600014|4498269|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
1363761|NCT01600014|4498270|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
1363762|NCT01599806|4498298|P2|Overall Study|Other Eligibility criteria|9
1363763|NCT01599806|4498299|P1|Overall Study|Other Eligibility criteria|11
1363764|NCT01599806|4498298|P2|Overall Study|Withdrawal by Subject|12
1363765|NCT01599806|4498299|P1|Overall Study|Withdrawal by Subject|12
1363766|NCT01599806|4498298|P2|Overall Study|Lost to Follow-up|20
1363767|NCT01599806|4498299|P1|Overall Study|Lost to Follow-up|20
1363768|NCT01599650|4498432|P3|Overall Study|Adverse Event|4
1363769|NCT01599650|4498433|P2|Overall Study|Adverse Event|8
1363770|NCT01599650|4498434|P1|Overall Study|Adverse Event|3
1363771|NCT01599650|4498432|P3|Overall Study|Withdrawal by Subject|10
1363772|NCT01599650|4498433|P2|Overall Study|Withdrawal by Subject|11
1363773|NCT01599650|4498434|P1|Overall Study|Withdrawal by Subject|11
1363774|NCT01599650|4498432|P3|Overall Study|Lost to Follow-up|3
1363775|NCT01599650|4498433|P2|Overall Study|Lost to Follow-up|3
1363776|NCT01599650|4498434|P1|Overall Study|Lost to Follow-up|3
1363777|NCT01599650|4498432|P3|Overall Study|Death|2
1363778|NCT01599650|4498433|P2|Overall Study|Death|1
1363779|NCT01599650|4498434|P1|Overall Study|Death|2
1363780|NCT01599650|4498432|P3|Overall Study|Protocol Violation|0
1363781|NCT01599650|4498433|P2|Overall Study|Protocol Violation|3
1363782|NCT01599650|4498434|P1|Overall Study|Protocol Violation|0
1363783|NCT01599650|4498432|P3|Overall Study|Physician Decision|7
1363784|NCT01599650|4498433|P2|Overall Study|Physician Decision|0
1363785|NCT01599650|4498434|P1|Overall Study|Physician Decision|2
1363786|NCT01599650|4498432|P3|Overall Study|Administrative issue|1
1363787|NCT01599650|4498433|P2|Overall Study|Administrative issue|0
1363788|NCT01599650|4498434|P1|Overall Study|Administrative issue|1
1363789|NCT01599637|4498473|P3|Overall Study|Adverse Event|0
1363790|NCT01599637|4498474|P2|Overall Study|Adverse Event|0
1363791|NCT01599637|4498475|P1|Overall Study|Adverse Event|1
1363792|NCT01599637|4498473|P3|Overall Study|administrative problems|0
1363793|NCT01599637|4498474|P2|Overall Study|administrative problems|2
1363794|NCT01599637|4498475|P1|Overall Study|administrative problems|0
1363795|NCT01599585|4498522|P2|Overall Study|randomized did not start treatment|3
1363796|NCT01599585|4498523|P1|Overall Study|randomized did not start treatment|3
1363797|NCT01599585|4498522|P2|Overall Study|Lost to Follow-up|5
1363798|NCT01599585|4498523|P1|Overall Study|Lost to Follow-up|3
1363799|NCT01599585|4498522|P2|Overall Study|Withdrawal by Subject|9
1363800|NCT01599585|4498523|P1|Overall Study|Withdrawal by Subject|16
1363801|NCT01599325|4498561|P1|Overall Study|Other|2
1363802|NCT01599325|4498561|P1|Overall Study|Lack of Therapeutic Effect|9
1363803|NCT01599325|4498561|P1|Overall Study|Protocol Violation|1
1363804|NCT01599325|4498561|P1|Overall Study|Death|13
1363805|NCT01599325|4498561|P1|Overall Study|Withdrawal by Subject|20
1363806|NCT01599325|4498561|P1|Overall Study|Disease Progression|7
1363807|NCT01599325|4498561|P1|Overall Study|Adverse Event|5
1363808|NCT01599234|4498583|P2|Overall Study|Pregnancy|1
1363809|NCT01599234|4498584|P1|Overall Study|Pregnancy|0
1363810|NCT01599234|4498583|P2|Overall Study|Contra-indication discovered|1
1363811|NCT01599234|4498584|P1|Overall Study|Contra-indication discovered|0
1363812|NCT01599234|4498583|P2|Overall Study|Patient would not stop driving|0
1363813|NCT01599234|4498584|P1|Overall Study|Patient would not stop driving|1
1363814|NCT01599234|4498583|P2|Overall Study|Death|0
1363815|NCT01599234|4498584|P1|Overall Study|Death|1
1363816|NCT01599234|4498583|P2|Overall Study|Sponsor request as creatinine levels <50|1
1363817|NCT01599234|4498584|P1|Overall Study|Sponsor request as creatinine levels <50|0
1363818|NCT01599234|4498583|P2|Overall Study|Unable to operate spray|0
1363819|NCT01599234|4498584|P1|Overall Study|Unable to operate spray|1
1363820|NCT01599234|4498583|P2|Overall Study|Lack of Efficacy|4
1363821|NCT01599234|4498584|P1|Overall Study|Lack of Efficacy|2
1363822|NCT01599234|4498583|P2|Overall Study|Lost to Follow-up|2
1363823|NCT01599234|4498584|P1|Overall Study|Lost to Follow-up|1
1363824|NCT01599234|4498583|P2|Overall Study|Withdrawal by Subject|1
1363825|NCT01599234|4498584|P1|Overall Study|Withdrawal by Subject|2
1363826|NCT01599234|4498583|P2|Overall Study|Adverse Event|5
1363827|NCT01599234|4498584|P1|Overall Study|Adverse Event|9
1363828|NCT01599104|4498609|P3|Overall Study|Adverse Event|12
1363829|NCT01599104|4498610|P2|Overall Study|Adverse Event|6
1363830|NCT01599104|4498611|P1|Overall Study|Adverse Event|7
1363831|NCT01599104|4498609|P3|Overall Study|Lack of Efficacy|10
1363832|NCT01599104|4498610|P2|Overall Study|Lack of Efficacy|4
1363833|NCT01599104|4498611|P1|Overall Study|Lack of Efficacy|4
1363834|NCT01599104|4498609|P3|Overall Study|Non-compliance with study treatment|0
1363835|NCT01599104|4498610|P2|Overall Study|Non-compliance with study treatment|1
1363836|NCT01599104|4498611|P1|Overall Study|Non-compliance with study treatment|0
1363837|NCT01599104|4498609|P3|Overall Study|Physician Decision|2
1363838|NCT01599104|4498610|P2|Overall Study|Physician Decision|2
1363839|NCT01599104|4498611|P1|Overall Study|Physician Decision|3
1363840|NCT01599104|4498609|P3|Overall Study|Technical Problems|0
1363841|NCT01599104|4498610|P2|Overall Study|Technical Problems|0
1363842|NCT01599104|4498611|P1|Overall Study|Technical Problems|1
1363843|NCT01599104|4498609|P3|Overall Study|Withdrawal by Subject|2
1363844|NCT01599104|4498610|P2|Overall Study|Withdrawal by Subject|1
1363847|NCT01598987|4498649|P1|Baseline to 24 Month|Administrative problems|2
1363848|NCT01598987|4498649|P1|Baseline to 24 Month|Withdrawal by Subject|5
1363849|NCT01598987|4498649|P1|Baseline to Month 12|Withdrawal by Subject|4
1363850|NCT01598987|4498649|P1|Baseline to Month 12|Administrative problems|2
1363851|NCT01598896|4498685|P2|Overall Study|Lack of Efficacy|1
1363852|NCT01598896|4498686|P1|Overall Study|Lack of Efficacy|0
1363853|NCT01598896|4498685|P2|Overall Study|Withdrawal by Subject|1
1363854|NCT01598896|4498686|P1|Overall Study|Withdrawal by Subject|0
1363855|NCT01598662|4498732|P2|Overall Study|IUD expelled before month 6|2
1363856|NCT01598662|4498733|P1|Overall Study|IUD expelled before month 6|0
1363857|NCT01598662|4498732|P2|Overall Study|Physician Decision|2
1363858|NCT01598662|4498733|P1|Overall Study|Physician Decision|1
1363859|NCT01598662|4498732|P2|Overall Study|Lost to Follow-up|17
1363860|NCT01598662|4498733|P1|Overall Study|Lost to Follow-up|10
1363861|NCT01598610|4498739|P1|Overall Study|Adverse Event|1
1363862|NCT01598532|4498756|P1|Overall Study|Did not meet inclusion criteria|8
1363863|NCT01598532|4498756|P1|Overall Study|Lost to Follow-up|3
1363864|NCT01598506|4498765|P1|Overall Study|Withdrawal by Subject|2
1363865|NCT01598311|4498785|P2|Overall Study|Assigned to CB but received vancomycin|0
1363866|NCT01598311|4498786|P1|Overall Study|Assigned to CB but received vancomycin|1
1363867|NCT01598311|4498785|P2|Overall Study|Treated but no confirmed CDAD|8
1363868|NCT01598311|4498786|P1|Overall Study|Treated but no confirmed CDAD|9
1363869|NCT01598311|4498785|P2|Overall Study|Randomized but never treated|5
1363870|NCT01598311|4498786|P1|Overall Study|Randomized but never treated|8
1363871|NCT01598311|4498785|P2|Overall Study|No reason provided.|5
1363872|NCT01598311|4498786|P1|Overall Study|No reason provided.|0
1363873|NCT01598311|4498785|P2|Overall Study|Withdrawal by Subject|13
1363874|NCT01598311|4498786|P1|Overall Study|Withdrawal by Subject|9
1363875|NCT01598311|4498785|P2|Overall Study|Lost to Follow-up|12
1363876|NCT01598311|4498786|P1|Overall Study|Lost to Follow-up|7
1363877|NCT01598311|4498785|P2|Overall Study|Adverse Event|13
1363878|NCT01598311|4498786|P1|Overall Study|Adverse Event|9
1363879|NCT01598311|4498785|P2|Overall Study|Physician Decision|5
1363880|NCT01598311|4498786|P1|Overall Study|Physician Decision|4
1363881|NCT01598298|4498802|P2|Overall Study|Other reason (not protocol specified)|0
1363882|NCT01598298|4498803|P1|Overall Study|Other reason (not protocol specified)|4
1363883|NCT01598298|4498802|P2|Overall Study|Withdrawal by Subject|15
1363884|NCT01598298|4498803|P1|Overall Study|Withdrawal by Subject|10
1363885|NCT01598298|4498802|P2|Overall Study|Progression/relapse|2
1363886|NCT01598298|4498803|P1|Overall Study|Progression/relapse|0
1363887|NCT01598298|4498802|P2|Overall Study|Adverse Event|19
1363888|NCT01598298|4498803|P1|Overall Study|Adverse Event|21
1363889|NCT01598298|4498802|P2|Overall Study|Not eligible|5
1363890|NCT01598298|4498803|P1|Overall Study|Not eligible|5
1363891|NCT01598129|4498834|P1|Overall Study|Withdrawal by Subject|1
1363892|NCT01598129|4498834|P1|Overall Study|Deterioration of WHO status to WHO 4|2
1363893|NCT01598129|4498834|P1|Overall Study|Disease progression|6
1363894|NCT01597908|4498866|P2|Overall Study|Ongoing|202
1363895|NCT01597908|4498867|P1|Overall Study|Ongoing|236
1363896|NCT01597908|4498866|P2|Overall Study|Withdrawal by Subject|18
1363897|NCT01597908|4498867|P1|Overall Study|Withdrawal by Subject|10
1363898|NCT01597908|4498866|P2|Overall Study|Physician Decision|1
1363899|NCT01597908|4498867|P1|Overall Study|Physician Decision|2
1363900|NCT01597908|4498866|P2|Overall Study|Lost to Follow-up|9
1363901|NCT01597908|4498867|P1|Overall Study|Lost to Follow-up|4
1363902|NCT01597908|4498866|P2|Overall Study|Death|122
1363903|NCT01597908|4498867|P1|Overall Study|Death|100
1363904|NCT01597791|4498894|P2|Overall Study|Protocol Violation|1
1363905|NCT01597791|4498895|P1|Overall Study|Protocol Violation|0
1363906|NCT01597791|4498894|P2|Overall Study|Subject withdrawal|1
1363907|NCT01597791|4498895|P1|Overall Study|Subject withdrawal|0
1363908|NCT01597791|4498894|P2|Overall Study|Cesarean Section|7
1363909|NCT01597791|4498895|P1|Overall Study|Cesarean Section|6
1363910|NCT01597791|4498894|P2|Overall Study|Physician Decision|1
1363911|NCT01597791|4498895|P1|Overall Study|Physician Decision|2
1363912|NCT01597635|4498904|P3|Part B|Withdrawal by Subject|0
1363913|NCT01597635|4498905|P2|Part B|Withdrawal by Subject|1
1363914|NCT01597635|4498906|P1|Part B|Withdrawal by Subject|0
1363915|NCT01597635|4498904|P3|Part B|Protocol-defined stopping criteria|3
1363916|NCT01597635|4498905|P2|Part B|Protocol-defined stopping criteria|4
1363917|NCT01597635|4498906|P1|Part B|Protocol-defined stopping criteria|0
1363918|NCT01597635|4498904|P3|Part B|Protocol Violation|0
1363919|NCT01597635|4498905|P2|Part B|Protocol Violation|1
1363920|NCT01597635|4498906|P1|Part B|Protocol Violation|0
1363921|NCT01597635|4498904|P3|Part B|Adverse Event|1
1363922|NCT01597635|4498905|P2|Part B|Adverse Event|0
1363923|NCT01597635|4498906|P1|Part B|Adverse Event|0
1363924|NCT01597635|4498904|P3|Part A|Adverse Event|0
1363925|NCT01597635|4498905|P2|Part A|Adverse Event|0
1363926|NCT01597635|4498906|P1|Part A|Adverse Event|3
1363927|NCT01597596|4498971|P2|Overall Study|Physician Decision|1
1363928|NCT01597596|4498972|P1|Overall Study|Physician Decision|0
1363929|NCT01597596|4498971|P2|Overall Study|Study terminated by sponsor|0
1363930|NCT01597596|4498972|P1|Overall Study|Study terminated by sponsor|1
1363931|NCT01597505|4498986|P2|Overall Study|Missing|0
1363932|NCT01597505|4498987|P1|Overall Study|Missing|1
1363933|NCT01597505|4498986|P2|Overall Study|Other|6
1363934|NCT01597505|4498987|P1|Overall Study|Other|5
1363935|NCT01597505|4498986|P2|Overall Study|Withdrawal by Subject|18
1363936|NCT01597505|4498987|P1|Overall Study|Withdrawal by Subject|10
1363937|NCT01597505|4498986|P2|Overall Study|Lost to Follow-up|2
1363938|NCT01597505|4498987|P1|Overall Study|Lost to Follow-up|4
1363939|NCT01597505|4498986|P2|Overall Study|Adverse Event|7
1363940|NCT01597505|4498987|P1|Overall Study|Adverse Event|19
1363941|NCT01597505|4498986|P2|Overall Study|Physician Decision|0
1363942|NCT01597505|4498987|P1|Overall Study|Physician Decision|5
1363943|NCT01597492|4499021|P2|Overall Study|Other Reason|0
1363944|NCT01597492|4499022|P1|Overall Study|Other Reason|2
1363945|NCT01597492|4499021|P2|Overall Study|Lost to Follow-up|2
1363946|NCT01597492|4499022|P1|Overall Study|Lost to Follow-up|0
1363947|NCT01597492|4499021|P2|Overall Study|Adverse Event|0
1363948|NCT01597492|4499022|P1|Overall Study|Adverse Event|3
1363949|NCT01597492|4499021|P2|Overall Study|Withdrawal by Subject|2
1363950|NCT01597492|4499022|P1|Overall Study|Withdrawal by Subject|1
1363951|NCT01597479|4499030|P2|Overall Study|Lost to Follow-up|0
1363952|NCT01597479|4499031|P1|Overall Study|Lost to Follow-up|1
1363953|NCT01597479|4499030|P2|Overall Study|Protocol Violation|0
1363954|NCT01597479|4499031|P1|Overall Study|Protocol Violation|1
1363955|NCT01597375|4499049|P2|Second Intervention|Failed to react at both Aspirin|1
1363956|NCT01597375|4499050|P1|Second Intervention|Failed to react at both Aspirin|1
1363957|NCT01597375|4499049|P2|Washout (2 Weeks)|Adverse Event|0
1363958|NCT01597375|4499050|P1|Washout (2 Weeks)|Adverse Event|1
1363959|NCT01597375|4499049|P2|First Intervention (4 Weeks)|Lost to Follow-up|1
1363960|NCT01597375|4499050|P1|First Intervention (4 Weeks)|Lost to Follow-up|0
1363961|NCT01597375|4499049|P2|First Intervention (4 Weeks)|Needed surgery|0
1363962|NCT01597375|4499050|P1|First Intervention (4 Weeks)|Needed surgery|1
1363963|NCT01597375|4499049|P2|First Intervention (4 Weeks)|Uncontrolled Asthma|0
1363964|NCT01597375|4499050|P1|First Intervention (4 Weeks)|Uncontrolled Asthma|1
1363965|NCT01597245|4499071|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1363966|NCT01597245|4499072|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1363967|NCT01597245|4499073|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
1363968|NCT01597245|4499074|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1363969|NCT01597245|4499075|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1363970|NCT01597245|4499076|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1363971|NCT01597245|4499077|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1363972|NCT01597245|4499078|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1363973|NCT01597245|4499079|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1363974|NCT01597245|4499080|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1363975|NCT01597245|4499081|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1363976|NCT01597245|4499082|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1363977|NCT01597245|4499083|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1363978|NCT01597245|4499071|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1363979|NCT01597245|4499072|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1363980|NCT01597245|4499073|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1363981|NCT01597245|4499074|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1363982|NCT01597245|4499075|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1363983|NCT01597245|4499076|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1363984|NCT01597245|4499077|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1363985|NCT01597245|4499078|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1363986|NCT01597245|4499079|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1363987|NCT01597245|4499080|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1363988|NCT01597245|4499081|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1363989|NCT01597245|4499082|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1363990|NCT01597245|4499083|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1363991|NCT01597245|4499071|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
1363992|NCT01597245|4499072|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
1363993|NCT01597245|4499073|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
1363994|NCT01597245|4499074|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
1363995|NCT01597245|4499075|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
1363996|NCT01597245|4499076|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1363997|NCT01597245|4499077|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
1363998|NCT01597245|4499078|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
1363999|NCT01597245|4499079|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
1364000|NCT01597245|4499080|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1364001|NCT01597245|4499081|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1364002|NCT01597245|4499082|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1364003|NCT01597245|4499083|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1364004|NCT01597245|4499071|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
1364005|NCT01597245|4499072|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1364006|NCT01597245|4499073|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
1364007|NCT01597245|4499074|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
1364008|NCT01597245|4499075|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
1364009|NCT01597245|4499076|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1364010|NCT01597245|4499077|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1364239|NCT01594125|4499854|P1|Overall Study|Progressive Disease|3
1364011|NCT01597245|4499078|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1364012|NCT01597245|4499079|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
1364013|NCT01597245|4499080|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1364014|NCT01597245|4499081|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1364015|NCT01597245|4499082|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1364016|NCT01597245|4499083|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1364017|NCT01597245|4499071|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
1364018|NCT01597245|4499072|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
1364019|NCT01597245|4499073|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
1364020|NCT01597245|4499074|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
1364021|NCT01597245|4499075|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
1364022|NCT01597245|4499076|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1364023|NCT01597245|4499077|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
1364024|NCT01597245|4499078|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
1364025|NCT01597245|4499079|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
1364026|NCT01597245|4499080|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1364027|NCT01597245|4499081|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1364028|NCT01597245|4499082|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1364029|NCT01597245|4499083|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1364030|NCT01597245|4499071|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
1364031|NCT01597245|4499072|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
1364032|NCT01597245|4499073|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
1364033|NCT01597245|4499074|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
1364034|NCT01597245|4499075|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
1364035|NCT01597245|4499076|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
1364036|NCT01597245|4499077|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
1364037|NCT01597245|4499078|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
1364038|NCT01597245|4499079|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
1364039|NCT01597245|4499080|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1364040|NCT01597245|4499081|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1364041|NCT01597245|4499082|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1364042|NCT01597245|4499083|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1364043|NCT01597245|4499071|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
1364044|NCT01597245|4499072|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
1364045|NCT01597245|4499073|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
1364046|NCT01597245|4499074|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1364047|NCT01597245|4499075|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
1364048|NCT01597245|4499076|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1364049|NCT01597245|4499077|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
1364050|NCT01597245|4499078|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1364051|NCT01597245|4499079|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1364052|NCT01597245|4499080|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1364053|NCT01597245|4499081|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1364054|NCT01597245|4499082|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1364055|NCT01597245|4499083|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1364056|NCT01597245|4499071|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1364057|NCT01597245|4499072|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1364058|NCT01597245|4499073|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1364059|NCT01597245|4499074|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|111
1364060|NCT01597245|4499075|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1364061|NCT01597245|4499076|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
1364062|NCT01597245|4499077|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|21
1364063|NCT01597245|4499078|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|80
1364064|NCT01597245|4499079|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|148
1364065|NCT01597245|4499080|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1364066|NCT01597245|4499081|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1364067|NCT01597245|4499082|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1364068|NCT01597245|4499083|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1364069|NCT01597245|4499071|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1364070|NCT01597245|4499072|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1364071|NCT01597245|4499073|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1364072|NCT01597245|4499074|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1364073|NCT01597245|4499075|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1364074|NCT01597245|4499076|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1364075|NCT01597245|4499077|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
1364076|NCT01597245|4499078|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
1364077|NCT01597245|4499079|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1364078|NCT01597245|4499080|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1364079|NCT01597245|4499081|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1364080|NCT01597245|4499082|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1364081|NCT01597245|4499083|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1364082|NCT01597245|4499071|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1364083|NCT01597245|4499072|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1364084|NCT01597245|4499073|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1364085|NCT01597245|4499074|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1364086|NCT01597245|4499075|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1364087|NCT01597245|4499076|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1364088|NCT01597245|4499077|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1364089|NCT01597245|4499078|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1364090|NCT01597245|4499079|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1364091|NCT01597245|4499080|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1364092|NCT01597245|4499081|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
1364093|NCT01597245|4499082|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
1364094|NCT01597245|4499083|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
1364095|NCT01597245|4499071|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
1364096|NCT01597245|4499072|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
1364097|NCT01597245|4499073|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
1364098|NCT01597245|4499074|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
1364099|NCT01597245|4499075|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
1364100|NCT01597245|4499076|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
1364101|NCT01597245|4499077|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
1364102|NCT01597245|4499078|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
1364103|NCT01597245|4499079|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
1364104|NCT01597245|4499080|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
1364105|NCT01597245|4499081|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
1364106|NCT01597245|4499082|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
1364107|NCT01597245|4499083|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
1364108|NCT01597245|4499071|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1364109|NCT01597245|4499072|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1364110|NCT01597245|4499073|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1364111|NCT01597245|4499074|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1364112|NCT01597245|4499075|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1364113|NCT01597245|4499076|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1364114|NCT01597245|4499077|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1364115|NCT01597245|4499078|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1364116|NCT01597245|4499079|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1364117|NCT01597245|4499080|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1364118|NCT01597245|4499081|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
1364119|NCT01597245|4499082|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
1364120|NCT01597245|4499083|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
1364121|NCT01597245|4499071|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1364122|NCT01597245|4499072|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1364123|NCT01597245|4499073|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1364124|NCT01597245|4499074|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1364125|NCT01597245|4499075|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1364126|NCT01597245|4499076|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1364127|NCT01597245|4499077|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1364128|NCT01597245|4499078|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1364129|NCT01597245|4499079|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1364130|NCT01597245|4499080|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
1364131|NCT01597245|4499081|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
1364132|NCT01597245|4499082|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
1364133|NCT01597245|4499083|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
1364134|NCT01597245|4499071|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1364135|NCT01597245|4499072|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1364136|NCT01597245|4499073|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1364137|NCT01597245|4499074|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1364138|NCT01597245|4499075|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1364139|NCT01597245|4499076|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1364140|NCT01597245|4499077|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1364141|NCT01597245|4499078|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1364142|NCT01597245|4499079|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1364143|NCT01597245|4499080|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
1364144|NCT01597245|4499081|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
1364145|NCT01597245|4499082|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
1364146|NCT01597245|4499083|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
1364147|NCT01597245|4499071|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
1364148|NCT01597245|4499072|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
1364149|NCT01597245|4499073|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
1364150|NCT01597245|4499074|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
1364151|NCT01597245|4499075|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
1364152|NCT01597245|4499076|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
1364153|NCT01597245|4499077|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
1364154|NCT01597245|4499078|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
1364155|NCT01597245|4499079|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
1364156|NCT01597245|4499080|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
1364157|NCT01597245|4499081|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
1364158|NCT01597245|4499082|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
1364159|NCT01597245|4499083|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
1364160|NCT01597050|4499206|P2|Overall Study|Withdrawal by Subject|0
1364161|NCT01597050|4499207|P1|Overall Study|Withdrawal by Subject|1
1364162|NCT01596972|4499215|P2|Overall Study|Withdrawal by Subject|1
1364163|NCT01596972|4499216|P1|Overall Study|Withdrawal by Subject|0
1364164|NCT01596972|4499215|P2|Overall Study|Lost to Follow-up|4
1364165|NCT01596972|4499216|P1|Overall Study|Lost to Follow-up|0
1364166|NCT01596972|4499215|P2|Overall Study|Physician Decision|9
1364167|NCT01596972|4499216|P1|Overall Study|Physician Decision|1
1364168|NCT01596582|4499239|P2|Overall Study|Missing all outcome data|1
1364169|NCT01596582|4499240|P1|Overall Study|Missing all outcome data|1
1364170|NCT01596582|4499239|P2|Overall Study|Deemed ineligible after study visit|6
1364171|NCT01596582|4499240|P1|Overall Study|Deemed ineligible after study visit|3
1364172|NCT01596504|4499267|P3|Overall Study|Withdrawal by Subject|0
1364173|NCT01596504|4499268|P2|Overall Study|Withdrawal by Subject|0
1364174|NCT01596504|4499269|P1|Overall Study|Withdrawal by Subject|1
1364175|NCT01596504|4499267|P3|Overall Study|Adverse Event|1
1364176|NCT01596504|4499268|P2|Overall Study|Adverse Event|2
1364177|NCT01596504|4499269|P1|Overall Study|Adverse Event|1
1364178|NCT01596504|4499267|P3|Overall Study|Participant's Private Reason|0
1364179|NCT01596504|4499268|P2|Overall Study|Participant's Private Reason|1
1364180|NCT01596504|4499269|P1|Overall Study|Participant's Private Reason|0
1364181|NCT01596127|4499351|P1|Overall Study|Patient Ineligible|1
1364182|NCT01596062|4499363|P3|Overall Study|Lack of Efficacy|1
1364183|NCT01596062|4499364|P2|Overall Study|Lack of Efficacy|0
1364184|NCT01596062|4499365|P1|Overall Study|Lack of Efficacy|0
1364185|NCT01596062|4499363|P3|Overall Study|Adverse Event|2
1364186|NCT01596062|4499364|P2|Overall Study|Adverse Event|0
1364187|NCT01596062|4499365|P1|Overall Study|Adverse Event|1
1364188|NCT01595646|4499429|P3|Overall Study|Withdrawal by Subject|0
1364189|NCT01595646|4499430|P2|Overall Study|Withdrawal by Subject|0
1364190|NCT01595646|4499431|P1|Overall Study|Withdrawal by Subject|1
1364191|NCT01595438|4499453|P2|Overall Study|Other Eligibility criteria|9
1364192|NCT01595438|4499454|P1|Overall Study|Other Eligibility criteria|11
1364193|NCT01595438|4499453|P2|Overall Study|Withdrawal by Subject|12
1364194|NCT01595438|4499454|P1|Overall Study|Withdrawal by Subject|12
1364195|NCT01595438|4499453|P2|Overall Study|Lost to Follow-up|20
1364196|NCT01595438|4499454|P1|Overall Study|Lost to Follow-up|20
1364197|NCT01594970|4499623|P3|Overall Study|Lost to Follow-up|37
1364198|NCT01594970|4499624|P2|Overall Study|Lost to Follow-up|54
1364199|NCT01594970|4499625|P1|Overall Study|Lost to Follow-up|54
1364200|NCT01594970|4499623|P3|Overall Study|Adverse Event|23
1364201|NCT01594970|4499624|P2|Overall Study|Adverse Event|23
1364202|NCT01594970|4499625|P1|Overall Study|Adverse Event|17
1364203|NCT01594970|4499623|P3|Overall Study|Non-Adverse Event Related|6
1364204|NCT01594970|4499624|P2|Overall Study|Non-Adverse Event Related|5
1364205|NCT01594970|4499625|P1|Overall Study|Non-Adverse Event Related|4
1364206|NCT01594853|4499644|P2|Overall Study|noncompliance with exercise|1
1364207|NCT01594853|4499645|P1|Overall Study|noncompliance with exercise|0
1364208|NCT01594853|4499644|P2|Overall Study|Lost to Follow-up|1
1364209|NCT01594853|4499645|P1|Overall Study|Lost to Follow-up|1
1364210|NCT01594853|4499644|P2|Overall Study|Withdrawal by Subject|1
1364211|NCT01594853|4499645|P1|Overall Study|Withdrawal by Subject|1
1364212|NCT01594762|4499653|P2|Overall Study|Lost to Follow-up|10
1364213|NCT01594762|4499654|P1|Overall Study|Lost to Follow-up|10
1364214|NCT01594762|4499653|P2|Overall Study|Withdrawal by Subject|0
1364215|NCT01594762|4499654|P1|Overall Study|Withdrawal by Subject|1
1364216|NCT01594749|4499666|P2|Overall Study|Lost Source Documentation|0
1364217|NCT01594749|4499667|P1|Overall Study|Lost Source Documentation|1
1364218|NCT01594749|4499666|P2|Overall Study|Not Treated|10
1364219|NCT01594749|4499667|P1|Overall Study|Not Treated|4
1364220|NCT01594749|4499666|P2|Overall Study|Death|3
1364221|NCT01594749|4499667|P1|Overall Study|Death|9
1364222|NCT01594749|4499666|P2|Overall Study|Lost to Follow-up|0
1364223|NCT01594749|4499667|P1|Overall Study|Lost to Follow-up|1
1364224|NCT01594749|4499666|P2|Overall Study|Non-compliance with Protocol|1
1364225|NCT01594749|4499667|P1|Overall Study|Non-compliance with Protocol|0
1364226|NCT01594749|4499666|P2|Overall Study|Physician Decision|1
1364227|NCT01594749|4499667|P1|Overall Study|Physician Decision|1
1364228|NCT01594749|4499666|P2|Overall Study|Protocol Violation|0
1364229|NCT01594749|4499667|P1|Overall Study|Protocol Violation|2
1364230|NCT01594749|4499666|P2|Overall Study|Withdrawal by Subject|2
1364231|NCT01594749|4499667|P1|Overall Study|Withdrawal by Subject|2
1364232|NCT01594749|4499666|P2|Overall Study|Adverse Event|1
1364233|NCT01594749|4499667|P1|Overall Study|Adverse Event|2
1364234|NCT01594411|4499796|P1|Overall Study|Lost to Follow-up|2
1364235|NCT01594125|4499850|P5|Overall Study|Progressive Disease|7
1364236|NCT01594125|4499851|P4|Overall Study|Progressive Disease|3
1364237|NCT01594125|4499852|P3|Overall Study|Progressive Disease|3
1364238|NCT01594125|4499853|P2|Overall Study|Progressive Disease|12
1364240|NCT01594125|4499850|P5|Overall Study|Withdrawal by Subject|0
1364241|NCT01594125|4499851|P4|Overall Study|Withdrawal by Subject|1
1364242|NCT01594125|4499852|P3|Overall Study|Withdrawal by Subject|0
1364243|NCT01594125|4499853|P2|Overall Study|Withdrawal by Subject|0
1364244|NCT01594125|4499854|P1|Overall Study|Withdrawal by Subject|1
1364245|NCT01593787|4499914|P3|Overall Study|Adverse Event|0
1364246|NCT01593787|4499915|P2|Overall Study|Adverse Event|0
1364247|NCT01593787|4499916|P1|Overall Study|Adverse Event|1
1364248|NCT01592864|4500003|P2|Overall Study|Withdrawal by Subject|1
1364249|NCT01592864|4500004|P1|Overall Study|Withdrawal by Subject|0
1364250|NCT01592786|4500065|P1|Overall Study|Other|3
1364251|NCT01592786|4500065|P1|Overall Study|Lost to Follow-up|19
1364252|NCT01592786|4500065|P1|Overall Study|Withdrawal by Subject|23
1364253|NCT01592786|4500065|P1|Overall Study|Protocol Violation|14
1364254|NCT01592786|4500065|P1|Overall Study|Lack of Efficacy|19
1364255|NCT01592786|4500065|P1|Overall Study|Adverse Event|60
1364256|NCT01592773|4500069|P1|Overall Study|Other Reason|1
1364257|NCT01592773|4500069|P1|Overall Study|Inclusion/exclusion not meet|1
1364258|NCT01592773|4500069|P1|Overall Study|Protocol Violation|2
1364259|NCT01592773|4500069|P1|Overall Study|Lack of Efficacy|9
1364260|NCT01592773|4500069|P1|Overall Study|Adverse Event|17
1364261|NCT01592773|4500069|P1|Overall Study|Lost to Follow-up|19
1364262|NCT01592773|4500069|P1|Overall Study|Withdrawal by Subject|35
1364263|NCT01592773|4500069|P1|Overall Study|Study Terminated by Sponsor|582
1364264|NCT01592760|4500076|P3|24-hour Follow-Up|Lost to Follow-up|2
1364265|NCT01592760|4500077|P2|24-hour Follow-Up|Lost to Follow-up|3
1364266|NCT01592760|4500078|P1|24-hour Follow-Up|Lost to Follow-up|4
1364267|NCT01592708|4500121|P2|Overall Study|Protocol Violation|0
1364268|NCT01592708|4500122|P1|Overall Study|Protocol Violation|3
1364269|NCT01592695|4500138|P2|Overall Study|Lost to Follow-up|4
1364270|NCT01592695|4500139|P1|Overall Study|Lost to Follow-up|8
1364271|NCT01592344|4500183|P2|Overall Study|not available at primary outcome visit|4
1364272|NCT01592344|4500184|P1|Overall Study|not available at primary outcome visit|2
1364273|NCT01592344|4500183|P2|Overall Study|Lack of Efficacy|0
1364274|NCT01592344|4500184|P1|Overall Study|Lack of Efficacy|1
1364275|NCT01592344|4500183|P2|Overall Study|Adverse Event|1
1364276|NCT01592344|4500184|P1|Overall Study|Adverse Event|1
1364277|NCT01592292|4500198|P4|Overall Study|Not specified|1
1364278|NCT01592292|4500199|P3|Overall Study|Not specified|2
1364279|NCT01592292|4500200|P2|Overall Study|Not specified|1
1364280|NCT01592292|4500201|P1|Overall Study|Not specified|1
1364281|NCT01592292|4500198|P4|Overall Study|Withdrew consent|0
1364282|NCT01592292|4500199|P3|Overall Study|Withdrew consent|0
1364283|NCT01592292|4500200|P2|Overall Study|Withdrew consent|1
1364284|NCT01592292|4500201|P1|Overall Study|Withdrew consent|2
1364285|NCT01592292|4500198|P4|Overall Study|Follow-up loss|0
1364286|NCT01592292|4500199|P3|Overall Study|Follow-up loss|1
1364287|NCT01592292|4500200|P2|Overall Study|Follow-up loss|3
1364288|NCT01592292|4500201|P1|Overall Study|Follow-up loss|3
1364289|NCT01592240|4500240|P7|Overall Study|Did Not Meet Entrance Criteria|0
1364290|NCT01592240|4500241|P6|Overall Study|Did Not Meet Entrance Criteria|0
1364291|NCT01592240|4500242|P5|Overall Study|Did Not Meet Entrance Criteria|0
1364292|NCT01592240|4500243|P4|Overall Study|Did Not Meet Entrance Criteria|0
1364293|NCT01592240|4500244|P3|Overall Study|Did Not Meet Entrance Criteria|1
1364294|NCT01592240|4500245|P2|Overall Study|Did Not Meet Entrance Criteria|0
1364295|NCT01592240|4500246|P1|Overall Study|Did Not Meet Entrance Criteria|1
1364296|NCT01592240|4500240|P7|Overall Study|Other|1
1364297|NCT01592240|4500241|P6|Overall Study|Other|0
1364298|NCT01592240|4500242|P5|Overall Study|Other|0
1364299|NCT01592240|4500243|P4|Overall Study|Other|1
1364300|NCT01592240|4500244|P3|Overall Study|Other|1
1364301|NCT01592240|4500245|P2|Overall Study|Other|3
1364302|NCT01592240|4500246|P1|Overall Study|Other|0
1364303|NCT01592240|4500240|P7|Overall Study|Withdrawal by Subject|2
1364304|NCT01592240|4500241|P6|Overall Study|Withdrawal by Subject|0
1364305|NCT01592240|4500242|P5|Overall Study|Withdrawal by Subject|3
1364306|NCT01592240|4500243|P4|Overall Study|Withdrawal by Subject|1
1364307|NCT01592240|4500244|P3|Overall Study|Withdrawal by Subject|4
1364308|NCT01592240|4500245|P2|Overall Study|Withdrawal by Subject|4
1364309|NCT01592240|4500246|P1|Overall Study|Withdrawal by Subject|0
1364310|NCT01592240|4500240|P7|Overall Study|Protocol Violation|0
1364311|NCT01592240|4500241|P6|Overall Study|Protocol Violation|1
1364312|NCT01592240|4500242|P5|Overall Study|Protocol Violation|0
1364313|NCT01592240|4500243|P4|Overall Study|Protocol Violation|0
1364314|NCT01592240|4500244|P3|Overall Study|Protocol Violation|0
1364315|NCT01592240|4500245|P2|Overall Study|Protocol Violation|0
1364316|NCT01592240|4500246|P1|Overall Study|Protocol Violation|0
1364317|NCT01592240|4500240|P7|Overall Study|Lost to Follow-up|0
1364318|NCT01592240|4500241|P6|Overall Study|Lost to Follow-up|2
1364319|NCT01592240|4500242|P5|Overall Study|Lost to Follow-up|3
1364320|NCT01592240|4500243|P4|Overall Study|Lost to Follow-up|0
1364321|NCT01592240|4500244|P3|Overall Study|Lost to Follow-up|1
1364322|NCT01592240|4500245|P2|Overall Study|Lost to Follow-up|3
1364323|NCT01592240|4500246|P1|Overall Study|Lost to Follow-up|1
1364324|NCT01592240|4500240|P7|Overall Study|Death|0
1364325|NCT01592240|4500241|P6|Overall Study|Death|0
1364326|NCT01592240|4500242|P5|Overall Study|Death|0
1364327|NCT01592240|4500243|P4|Overall Study|Death|0
1364328|NCT01592240|4500244|P3|Overall Study|Death|0
1364329|NCT01592240|4500245|P2|Overall Study|Death|1
1364330|NCT01592240|4500246|P1|Overall Study|Death|0
1364331|NCT01592240|4500240|P7|Overall Study|Adverse Event|0
1364332|NCT01592240|4500241|P6|Overall Study|Adverse Event|0
1364333|NCT01592240|4500242|P5|Overall Study|Adverse Event|1
1364334|NCT01592240|4500243|P4|Overall Study|Adverse Event|1
1364335|NCT01592240|4500244|P3|Overall Study|Adverse Event|0
1364336|NCT01592240|4500245|P2|Overall Study|Adverse Event|0
1364337|NCT01592240|4500246|P1|Overall Study|Adverse Event|1
1364338|NCT01592045|4500439|P2|Overall Study|Moved out of country|0
1364339|NCT01592045|4500440|P1|Overall Study|Moved out of country|2
1364340|NCT01592045|4500439|P2|Overall Study|Withdrawal by Subject|0
1364341|NCT01592045|4500440|P1|Overall Study|Withdrawal by Subject|1
1364342|NCT01592045|4500439|P2|Overall Study|Adverse Event|1
1364343|NCT01592045|4500440|P1|Overall Study|Adverse Event|1
1364344|NCT01592045|4500439|P2|Overall Study|Disease Progression|1
1364345|NCT01592045|4500440|P1|Overall Study|Disease Progression|1
1364346|NCT01591863|4500458|P1|Overall Study|Lack of Efficacy|1
1364347|NCT01591863|4500458|P1|Overall Study|recurrence|9
1364348|NCT01591863|4500458|P1|Overall Study|Withdrawal by Subject|1
1364349|NCT01591863|4500458|P1|Overall Study|Adverse Event|3
1364350|NCT01591681|4500496|P1|Overall Study|Failed to use system during run-in|1
1364351|NCT01591681|4500496|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
1364352|NCT01591616|4500522|P1|Overall Study|Withdrawal by Subject|1
1364353|NCT01591499|4500663|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
1364354|NCT01591499|4500664|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
1364355|NCT01591499|4500665|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
1364356|NCT01591499|4500666|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
1364357|NCT01591499|4500663|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
1364358|NCT01591499|4500664|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
1364359|NCT01591499|4500665|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
1364360|NCT01591499|4500666|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
1364361|NCT01591499|4500663|P4|Baseline Visit|Withdrawal by Subject|2
1364362|NCT01591499|4500664|P3|Baseline Visit|Withdrawal by Subject|0
1364363|NCT01591499|4500665|P2|Baseline Visit|Withdrawal by Subject|2
1364364|NCT01591499|4500666|P1|Baseline Visit|Withdrawal by Subject|0
1364365|NCT01591460|4500732|P1|Overall Study|Protocol Violation|1
1364366|NCT01591460|4500732|P1|Overall Study|Withdrawal by Subject|1
1364367|NCT01591460|4500732|P1|Overall Study|Participant Refusal|3
1364368|NCT01591460|4500732|P1|Overall Study|Noncompliance|1
1364369|NCT01591460|4500732|P1|Overall Study|Lost to Follow-up|1
1364370|NCT01591460|4500732|P1|Overall Study|Treatment Discontinued by Error|1
1364371|NCT01591460|4500732|P1|Overall Study|Rebound or Breakthrough|3
1364372|NCT01591460|4500732|P1|Overall Study|Futility Rule (Week 24)|3
1364373|NCT01591460|4500732|P1|Overall Study|Futility Rule (Week 12)|7
1364374|NCT01591460|4500732|P1|Overall Study|Adverse Event or Intercurrent Illness|5
1364375|NCT01591382|4500823|P2|Overall Study|Participant Opted for Morphine PCA|1
1364376|NCT01591382|4500824|P1|Overall Study|Participant Opted for Morphine PCA|1
1364377|NCT01591382|4500823|P2|Overall Study|Discharged Prior to Study Completion|1
1364378|NCT01591382|4500824|P1|Overall Study|Discharged Prior to Study Completion|2
1364379|NCT01591096|4500869|P1|Overall Study|Adverse Event|1
1364380|NCT01590888|4500954|P3|Overall Study|Lost to Follow-up|0
1364381|NCT01590888|4500955|P2|Overall Study|Lost to Follow-up|0
1364382|NCT01590888|4500956|P1|Overall Study|Lost to Follow-up|1
1364383|NCT01590888|4500954|P3|Overall Study|Adverse Event|1
1364384|NCT01590888|4500955|P2|Overall Study|Adverse Event|0
1364385|NCT01590888|4500956|P1|Overall Study|Adverse Event|3
1364386|NCT01590810|4501016|P5|Overall Study|Physician Decision|0
1364387|NCT01590810|4501017|P4|Overall Study|Physician Decision|0
1364388|NCT01590810|4501018|P3|Overall Study|Physician Decision|1
1364389|NCT01590810|4501019|P2|Overall Study|Physician Decision|1
1364390|NCT01590810|4501020|P1|Overall Study|Physician Decision|0
1364391|NCT01590797|4501165|P2|Overall Study|Other Protocol Specified Criteria|4
1364392|NCT01590797|4501166|P1|Overall Study|Other Protocol Specified Criteria|2
1364393|NCT01590797|4501165|P2|Overall Study|Withdrawal by Subject|5
1364394|NCT01590797|4501166|P1|Overall Study|Withdrawal by Subject|7
1364395|NCT01590797|4501165|P2|Overall Study|Protocol Violation|1
1364396|NCT01590797|4501166|P1|Overall Study|Protocol Violation|4
1364397|NCT01590797|4501165|P2|Overall Study|Lost to Follow-up|1
1364398|NCT01590797|4501166|P1|Overall Study|Lost to Follow-up|0
1364399|NCT01590797|4501165|P2|Overall Study|Lack of Efficacy|2
1364400|NCT01590797|4501166|P1|Overall Study|Lack of Efficacy|0
1364401|NCT01590797|4501165|P2|Overall Study|Adverse Event|3
1364402|NCT01590797|4501166|P1|Overall Study|Adverse Event|4
1364403|NCT01590771|4501182|P2|Overall Study|Adverse Event|7
1364404|NCT01590771|4501183|P1|Overall Study|Adverse Event|3
1364405|NCT01590771|4501182|P2|Overall Study|Lack of Efficacy|0
1364406|NCT01590771|4501183|P1|Overall Study|Lack of Efficacy|1
1364407|NCT01590771|4501182|P2|Overall Study|Lost to Follow-up|1
1364408|NCT01590771|4501183|P1|Overall Study|Lost to Follow-up|1
1364409|NCT01590771|4501182|P2|Overall Study|Protocol Violation|2
1364410|NCT01590771|4501183|P1|Overall Study|Protocol Violation|1
1364411|NCT01590771|4501182|P2|Overall Study|Withdrawal by Subject|15
1364412|NCT01590771|4501183|P1|Overall Study|Withdrawal by Subject|8
1364413|NCT01590771|4501182|P2|Overall Study|Other Protocol Specified Criteria|14
1364414|NCT01590771|4501183|P1|Overall Study|Other Protocol Specified Criteria|5
1364415|NCT01590758|4501211|P2|Overall Study|Lost to Follow-up|2
1364416|NCT01590758|4501212|P1|Overall Study|Lost to Follow-up|4
1364417|NCT01590758|4501211|P2|Overall Study|Physician Decision|2
1364418|NCT01590758|4501212|P1|Overall Study|Physician Decision|1
1364419|NCT01590758|4501211|P2|Overall Study|Withdrawal by Subject|3
1364420|NCT01590758|4501212|P1|Overall Study|Withdrawal by Subject|0
1364421|NCT01590563|4501222|P1|Overall Study|simple uterine hyperplasia - not related|1
1364422|NCT01590212|4501250|P3|Overall Study|Lost to Follow-up|3
1364423|NCT01590212|4501251|P2|Overall Study|Lost to Follow-up|2
1364424|NCT01590212|4501252|P1|Overall Study|Lost to Follow-up|1
1364425|NCT01590212|4501250|P3|Overall Study|Withdrawal by Subject|2
1364426|NCT01590212|4501251|P2|Overall Study|Withdrawal by Subject|2
1364427|NCT01590212|4501252|P1|Overall Study|Withdrawal by Subject|2
1364428|NCT01589822|4501296|P3|Overall Study|Missed 90 day visit|1
1364429|NCT01589822|4501297|P2|Overall Study|Missed 90 day visit|1
1364430|NCT01589822|4501298|P1|Overall Study|Missed 90 day visit|2
1364431|NCT01589822|4501296|P3|Overall Study|Death|0
1364432|NCT01589822|4501297|P2|Overall Study|Death|0
1364433|NCT01589822|4501298|P1|Overall Study|Death|1
1364434|NCT01589822|4501296|P3|Overall Study|Withdrawal by Subject|0
1364435|NCT01589822|4501297|P2|Overall Study|Withdrawal by Subject|2
1364436|NCT01589822|4501298|P1|Overall Study|Withdrawal by Subject|1
1364437|NCT01589653|4501317|P2|Overall Study|Unclassified|3
1364438|NCT01589653|4501318|P1|Overall Study|Unclassified|0
1364439|NCT01589653|4501317|P2|Overall Study|Withdrawal criteria|7
1364440|NCT01589653|4501318|P1|Overall Study|Withdrawal criteria|4
1364441|NCT01589653|4501317|P2|Overall Study|Protocol Violation|1
1364442|NCT01589653|4501318|P1|Overall Study|Protocol Violation|3
1364443|NCT01589497|4501366|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
1364444|NCT01589497|4501367|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
1364445|NCT01589497|4501368|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
1364446|NCT01589497|4501369|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
1364447|NCT01589497|4501366|P4|Overall Study|Death|0
1364448|NCT01589497|4501367|P3|Overall Study|Death|0
1364449|NCT01589497|4501368|P2|Overall Study|Death|0
1364450|NCT01589497|4501369|P1|Overall Study|Death|1
1364451|NCT01589497|4501366|P4|Overall Study|Withdrawal by Subject|1
1364452|NCT01589497|4501367|P3|Overall Study|Withdrawal by Subject|0
1364453|NCT01589497|4501368|P2|Overall Study|Withdrawal by Subject|1
1364454|NCT01589497|4501369|P1|Overall Study|Withdrawal by Subject|0
1364455|NCT01589445|4501475|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
1364456|NCT01589445|4501475|P1|002 (Metformin)-3 Months|Adverse Event|2
1364457|NCT01589445|4501475|P1|002 (Metformin)-3 Months|Protocol Violation|2
1364458|NCT01589445|4501475|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
1364459|NCT01589445|4501475|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
1364460|NCT01589445|4501475|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
1364461|NCT01589445|4501475|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
1364462|NCT01589445|4501475|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
1364463|NCT01589445|4501475|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
1364464|NCT01589445|4501475|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
1364465|NCT01589237|4501495|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
1364466|NCT01589237|4501496|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
1364467|NCT01589237|4501497|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
1364468|NCT01589237|4501498|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
1364469|NCT01589237|4501495|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
1364470|NCT01589237|4501496|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
1364471|NCT01589237|4501497|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
1364472|NCT01589237|4501498|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
1364473|NCT01589237|4501495|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
1364474|NCT01589237|4501496|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
1364475|NCT01589237|4501497|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
1364476|NCT01589237|4501498|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
1364477|NCT01589237|4501495|P4|Part A (52 Weeks)|Subject/guardian decision|0
1364478|NCT01589237|4501496|P3|Part A (52 Weeks)|Subject/guardian decision|2
1364479|NCT01589237|4501497|P2|Part A (52 Weeks)|Subject/guardian decision|3
1364480|NCT01589237|4501498|P1|Part A (52 Weeks)|Subject/guardian decision|2
1364481|NCT01588951|4501547|P3|Overall Study|Ineligible in retrospect|1
1364482|NCT01588951|4501548|P2|Overall Study|Ineligible in retrospect|0
1364483|NCT01588951|4501549|P1|Overall Study|Ineligible in retrospect|0
1364484|NCT01588548|4501580|P6|Overall Study|Condition Under Investigation Worsened|3
1364485|NCT01588548|4501581|P5|Overall Study|Condition Under Investigation Worsened|3
1364486|NCT01588548|4501582|P4|Overall Study|Condition Under Investigation Worsened|4
1364487|NCT01588548|4501583|P3|Overall Study|Condition Under Investigation Worsened|4
1364488|NCT01588548|4501584|P2|Overall Study|Condition Under Investigation Worsened|6
1364489|NCT01588548|4501585|P1|Overall Study|Condition Under Investigation Worsened|3
1364490|NCT01588548|4501580|P6|Overall Study|Adverse Event|0
1364491|NCT01588548|4501581|P5|Overall Study|Adverse Event|1
1364492|NCT01588548|4501582|P4|Overall Study|Adverse Event|2
1364493|NCT01588548|4501583|P3|Overall Study|Adverse Event|1
1364494|NCT01588548|4501584|P2|Overall Study|Adverse Event|0
1364495|NCT01588548|4501585|P1|Overall Study|Adverse Event|0
1364496|NCT01588548|4501580|P6|Overall Study|Withdrawal by Subject|3
1364497|NCT01588548|4501581|P5|Overall Study|Withdrawal by Subject|2
1364498|NCT01588548|4501582|P4|Overall Study|Withdrawal by Subject|1
1364499|NCT01588548|4501583|P3|Overall Study|Withdrawal by Subject|1
1364500|NCT01588548|4501584|P2|Overall Study|Withdrawal by Subject|1
1364501|NCT01588548|4501585|P1|Overall Study|Withdrawal by Subject|0
1364502|NCT01588496|4501602|P3|Overall Study|Withdrawal by Subject|0
1364503|NCT01588496|4501603|P2|Overall Study|Withdrawal by Subject|1
1364504|NCT01588496|4501604|P1|Overall Study|Withdrawal by Subject|0
1364505|NCT01588405|4501654|P1|Overall Study|Clinical Worsening|1
1364506|NCT01588405|4501654|P1|Overall Study|Adverse Event|1
1364507|NCT01588353|4501681|P3|Step3|Adverse Event|2
1364508|NCT01588353|4501682|P2|Step3|Adverse Event|0
1364509|NCT01588353|4501683|P1|Step3|Adverse Event|0
1364510|NCT01588353|4501681|P3|Step2|Withdrawal by Subject|0
1364511|NCT01588353|4501682|P2|Step2|Withdrawal by Subject|1
1364512|NCT01588353|4501683|P1|Step2|Withdrawal by Subject|0
1364513|NCT01588106|4501726|P2|Overall Study|Withdrawal by Subject|4
1364514|NCT01588106|4501727|P1|Overall Study|Withdrawal by Subject|5
1364515|NCT01587989|4501735|P3|Randomized Study Treatment|Physician Decision|1
1364516|NCT01587989|4501736|P2|Randomized Study Treatment|Physician Decision|0
1364517|NCT01587989|4501737|P1|Randomized Study Treatment|Physician Decision|0
1364518|NCT01587989|4501735|P3|Randomized Study Treatment|Screening failure|0
1364519|NCT01587989|4501736|P2|Randomized Study Treatment|Screening failure|1
1364520|NCT01587989|4501737|P1|Randomized Study Treatment|Screening failure|0
1364521|NCT01587989|4501735|P3|Randomized Study Treatment|Withdrawal by Subject|0
1364522|NCT01587989|4501736|P2|Randomized Study Treatment|Withdrawal by Subject|1
1364523|NCT01587989|4501737|P1|Randomized Study Treatment|Withdrawal by Subject|0
1364524|NCT01587989|4501735|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
1364525|NCT01587989|4501736|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
1364526|NCT01587989|4501737|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
1364527|NCT01587989|4501735|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
1364528|NCT01587989|4501736|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
1364529|NCT01587989|4501737|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
1364530|NCT01587989|4501735|P3|12-Week Open-Label Run-In Period|Physician Decision|0
1364531|NCT01587989|4501736|P2|12-Week Open-Label Run-In Period|Physician Decision|0
1364532|NCT01587989|4501737|P1|12-Week Open-Label Run-In Period|Physician Decision|7
1364533|NCT01587924|4501802|P4|Overall Study|Withdrawal by Subject|0
1364534|NCT01587924|4501803|P3|Overall Study|Withdrawal by Subject|1
1364535|NCT01587924|4501804|P2|Overall Study|Withdrawal by Subject|1
1364536|NCT01587924|4501805|P1|Overall Study|Withdrawal by Subject|0
1364537|NCT01587924|4501802|P4|Overall Study|Met Hemoglobin stopping criteria|0
1364538|NCT01587924|4501803|P3|Overall Study|Met Hemoglobin stopping criteria|1
1364539|NCT01587924|4501804|P2|Overall Study|Met Hemoglobin stopping criteria|0
1364540|NCT01587924|4501805|P1|Overall Study|Met Hemoglobin stopping criteria|2
1364541|NCT01587924|4501802|P4|Overall Study|Protocol Violation|1
1364542|NCT01587924|4501803|P3|Overall Study|Protocol Violation|2
1364543|NCT01587924|4501804|P2|Overall Study|Protocol Violation|1
1364544|NCT01587924|4501805|P1|Overall Study|Protocol Violation|2
1364545|NCT01587924|4501802|P4|Overall Study|Adverse Event|0
1364546|NCT01587924|4501803|P3|Overall Study|Adverse Event|0
1364547|NCT01587924|4501804|P2|Overall Study|Adverse Event|2
1364548|NCT01587924|4501805|P1|Overall Study|Adverse Event|0
1364549|NCT01587898|4501906|P4|Overall Study|Met haemoglobin stopping criteria|0
1364550|NCT01587898|4501907|P3|Overall Study|Met haemoglobin stopping criteria|1
1364551|NCT01587898|4501908|P2|Overall Study|Met haemoglobin stopping criteria|1
1364552|NCT01587898|4501909|P1|Overall Study|Met haemoglobin stopping criteria|1
1364553|NCT01587898|4501906|P4|Overall Study|Withdrawal by Subject|0
1364554|NCT01587898|4501907|P3|Overall Study|Withdrawal by Subject|0
1364555|NCT01587898|4501908|P2|Overall Study|Withdrawal by Subject|1
1364556|NCT01587898|4501909|P1|Overall Study|Withdrawal by Subject|2
1364557|NCT01587898|4501906|P4|Overall Study|Lost to Follow-up|1
1364558|NCT01587898|4501907|P3|Overall Study|Lost to Follow-up|0
1364559|NCT01587898|4501908|P2|Overall Study|Lost to Follow-up|0
1364560|NCT01587898|4501909|P1|Overall Study|Lost to Follow-up|0
1364561|NCT01587898|4501906|P4|Overall Study|Protocol Violation|1
1364562|NCT01587898|4501907|P3|Overall Study|Protocol Violation|1
1364563|NCT01587898|4501908|P2|Overall Study|Protocol Violation|2
1364564|NCT01587898|4501909|P1|Overall Study|Protocol Violation|0
1364565|NCT01587898|4501906|P4|Overall Study|Adverse Event|0
1364566|NCT01587898|4501907|P3|Overall Study|Adverse Event|0
1364567|NCT01587898|4501908|P2|Overall Study|Adverse Event|1
1364568|NCT01587898|4501909|P1|Overall Study|Adverse Event|1
1364569|NCT01587885|4502085|P2|Treatment Period 1|Protocol Violation|2
1364570|NCT01587885|4502086|P1|Treatment Period 1|Protocol Violation|0
1364571|NCT01587885|4502085|P2|Treatment Period 1|Failure to Return|1
1364572|NCT01587885|4502086|P1|Treatment Period 1|Failure to Return|0
1364573|NCT01587651|4502102|P3|Overall Study|Withdrawal by Subject|0
1364574|NCT01587651|4502103|P2|Overall Study|Withdrawal by Subject|1
1364575|NCT01587651|4502104|P1|Overall Study|Withdrawal by Subject|0
1364576|NCT01587651|4502102|P3|Overall Study|Protocol Violation|1
1364577|NCT01587651|4502103|P2|Overall Study|Protocol Violation|1
1364578|NCT01587651|4502104|P1|Overall Study|Protocol Violation|0
1364579|NCT01587651|4502102|P3|Overall Study|Adverse Event|0
1364580|NCT01587651|4502103|P2|Overall Study|Adverse Event|1
1364581|NCT01587651|4502104|P1|Overall Study|Adverse Event|0
1364582|NCT01587274|4502134|P3|Overall Study|Lost to Follow-up|3
1364583|NCT01587274|4502135|P2|Overall Study|Lost to Follow-up|5
1364584|NCT01587274|4502136|P1|Overall Study|Lost to Follow-up|4
1364585|NCT01587118|4502144|P1|Overall Study|nonresponse|1
1364586|NCT01587118|4502144|P1|Overall Study|Relocation|1
1364587|NCT01587118|4502144|P1|Overall Study|Lost to Follow-up|2
1364588|NCT01587118|4502144|P1|Overall Study|Adverse Event|3
1364589|NCT01587079|4502168|P1|Overall Study|Adverse Event|14
1364590|NCT01587079|4502168|P1|Overall Study|Withdrawal by Subject|7
1364591|NCT01587079|4502168|P1|Overall Study|Physician Decision|2
1364592|NCT01587079|4502168|P1|Overall Study|Lost to Follow-up|2
1364593|NCT01587079|4502168|P1|Overall Study|Protocol Violation|5
1364594|NCT01587079|4502168|P1|Overall Study|Protocol-specified criteria|9
1364595|NCT01587014|4502299|P1|Overall Study|Death|2
1364596|NCT01587001|4502306|P2|Overall Study|Insufficient samples to complete testing|1
1364597|NCT01587001|4502307|P1|Overall Study|Insufficient samples to complete testing|4
1364598|NCT01587001|4502306|P2|Overall Study|Lost to Follow-up|0
1364599|NCT01587001|4502307|P1|Overall Study|Lost to Follow-up|2
1364600|NCT01586819|4502355|P2|Overall Study|Withdrawal by Subject|0
1364601|NCT01586819|4502356|P1|Overall Study|Withdrawal by Subject|1
1364602|NCT01586806|4502367|P3|Overall Study|Lost to Follow-up|2
1364603|NCT01586806|4502368|P2|Overall Study|Lost to Follow-up|3
1364604|NCT01586806|4502369|P1|Overall Study|Lost to Follow-up|2
1364605|NCT01586806|4502367|P3|Overall Study|Withdrawal by Subject|0
1364606|NCT01586806|4502368|P2|Overall Study|Withdrawal by Subject|0
1364607|NCT01586806|4502369|P1|Overall Study|Withdrawal by Subject|1
1364608|NCT01586806|4502367|P3|Overall Study|Protocol Violation|0
1364609|NCT01586806|4502368|P2|Overall Study|Protocol Violation|1
1364610|NCT01586806|4502369|P1|Overall Study|Protocol Violation|0
1364611|NCT01586364|4502389|P1|Overall Study|Other-Not specified|1
1364612|NCT01586364|4502389|P1|Overall Study|Other-PI discretion, site closing|2
1364613|NCT01586364|4502389|P1|Overall Study|Other-Site closure due to PI illness|1
1364614|NCT01586364|4502389|P1|Overall Study|Other-Subject wasn't getting much relief|1
1364615|NCT01586364|4502389|P1|Overall Study|Other-Did not feel better post-treatment|1
1364616|NCT01586364|4502389|P1|Overall Study|Lack of Efficacy|1
1364617|NCT01586364|4502389|P1|Overall Study|Protocol Violation|16
1364618|NCT01586364|4502389|P1|Overall Study|Lost to Follow-up|17
1364619|NCT01586364|4502389|P1|Overall Study|Adverse Event|37
1364620|NCT01586364|4502389|P1|Overall Study|Withdrawal by Subject|40
1364621|NCT01586338|4502442|P1|Overall Study|Other|1
1364622|NCT01586338|4502442|P1|Overall Study|Withdrawal by participant|3
1364623|NCT01586338|4502442|P1|Overall Study|Lost to Follow-up|1
1364624|NCT01586338|4502442|P1|Overall Study|Adverse Event|3
1364625|NCT01586195|4502465|P1|Overall Study|Reason not specified|9
1364626|NCT01586195|4502465|P1|Overall Study|Started new anti-melanoma therapy|1
1364627|NCT01586195|4502465|P1|Overall Study|Withdrawal of Consent|5
1364628|NCT01586195|4502465|P1|Overall Study|Death|11
1364629|NCT01586156|4502479|P3|Overall Study|Pregnancy|0
1364630|NCT01586156|4502480|P2|Overall Study|Pregnancy|1
1364631|NCT01586156|4502481|P1|Overall Study|Pregnancy|0
1364632|NCT01585987|4502519|P2|Treated|Poor/Non-Compliance|1
1364633|NCT01585987|4502520|P1|Treated|Poor/Non-Compliance|0
1364634|NCT01585987|4502519|P2|Treated|Subject Request|1
1364635|NCT01585987|4502520|P1|Treated|Subject Request|0
1364636|NCT01585987|4502519|P2|Treated|Non-Specified|2
1364637|NCT01585987|4502520|P1|Treated|Non-Specified|1
1364638|NCT01585987|4502519|P2|Treated|Maximum Clinical Benefit|1
1364639|NCT01585987|4502520|P1|Treated|Maximum Clinical Benefit|0
1364640|NCT01585987|4502519|P2|Treated|Lost to Follow-up|1
1364641|NCT01585987|4502520|P1|Treated|Lost to Follow-up|0
1364642|NCT01585987|4502519|P2|Treated|Death|0
1364643|NCT01585987|4502520|P1|Treated|Death|1
1364644|NCT01585987|4502519|P2|Treated|Withdrawal by Subject|2
1364645|NCT01585987|4502520|P1|Treated|Withdrawal by Subject|1
1364646|NCT01585987|4502519|P2|Treated|Adverse Event|0
1364647|NCT01585987|4502520|P1|Treated|Adverse Event|3
1364648|NCT01585987|4502519|P2|Treated|Study Drug Toxicity|5
1364649|NCT01585987|4502520|P1|Treated|Study Drug Toxicity|9
1364650|NCT01585987|4502519|P2|Treated|Disease Progression|36
1364651|NCT01585987|4502520|P1|Treated|Disease Progression|39
1364652|NCT01585987|4502519|P2|Randomized|No longer met criteria|2
1364653|NCT01585987|4502520|P1|Randomized|No longer met criteria|0
1364654|NCT01585987|4502519|P2|Randomized|Withdrawal by Subject|4
1364655|NCT01585987|4502520|P1|Randomized|Withdrawal by Subject|0
1364656|NCT01585961|4502535|P1|Overall Study|Ablation cancelled for slow-heal wound|1
1364657|NCT01585961|4502535|P1|Overall Study|Lost to Follow-up|23
1364658|NCT01585961|4502535|P1|Overall Study|Withdrawal by Subject|1
1364659|NCT01585961|4502535|P1|Overall Study|Decision to use non-study catheter|1
1364660|NCT01585961|4502535|P1|Overall Study|Physician Decision|1
1364661|NCT01585961|4502535|P1|Overall Study|Death|6
1364662|NCT01585584|4502612|P1|Overall Study|Physician Decision|2
1364663|NCT01585584|4502612|P1|Overall Study|Withdrawal by Subject|1
1364664|NCT01585584|4502612|P1|Overall Study|Lack of Efficacy|1
1364665|NCT01585558|4502619|P3|Overall Study|Lack of Efficacy|1
1364666|NCT01585558|4502620|P2|Overall Study|Lack of Efficacy|0
1364667|NCT01585558|4502621|P1|Overall Study|Lack of Efficacy|0
1364668|NCT01585558|4502619|P3|Overall Study|Protocol Violation|2
1364669|NCT01585558|4502620|P2|Overall Study|Protocol Violation|3
1364670|NCT01585558|4502621|P1|Overall Study|Protocol Violation|4
1364671|NCT01585558|4502619|P3|Overall Study|Adverse Event|1
1364672|NCT01585558|4502620|P2|Overall Study|Adverse Event|4
1364673|NCT01585558|4502621|P1|Overall Study|Adverse Event|3
1364674|NCT01585558|4502619|P3|Overall Study|Lost to Follow-up|3
1364675|NCT01585558|4502620|P2|Overall Study|Lost to Follow-up|0
1364676|NCT01585558|4502621|P1|Overall Study|Lost to Follow-up|2
1364677|NCT01585558|4502619|P3|Overall Study|Withdrawal by Subject|8
1364678|NCT01585558|4502620|P2|Overall Study|Withdrawal by Subject|5
1364679|NCT01585558|4502621|P1|Overall Study|Withdrawal by Subject|4
1364680|NCT01585428|4502855|P2|Overall Study|Death during treatment|0
1364681|NCT01585428|4502856|P1|Overall Study|Death during treatment|1
1364682|NCT01585272|4502880|P1|Overall Study|Withdrawal by Subject|10
1364683|NCT01585272|4502880|P1|Overall Study|Protocol Violation|7
1364684|NCT01585272|4502880|P1|Overall Study|Adverse Event|22
1364685|NCT01585246|4502893|P5|Overall Study|Other|0
1364686|NCT01585246|4502894|P4|Overall Study|Other|1
1364687|NCT01585246|4502895|P3|Overall Study|Other|1
1364688|NCT01585246|4502896|P2|Overall Study|Other|1
1364689|NCT01585246|4502897|P1|Overall Study|Other|0
1364690|NCT01585246|4502893|P5|Overall Study|Withdrawal by Subject|1
1364691|NCT01585246|4502894|P4|Overall Study|Withdrawal by Subject|2
1364692|NCT01585246|4502895|P3|Overall Study|Withdrawal by Subject|1
1364693|NCT01585246|4502896|P2|Overall Study|Withdrawal by Subject|0
1364694|NCT01585246|4502897|P1|Overall Study|Withdrawal by Subject|0
1364695|NCT01585246|4502893|P5|Overall Study|Protocol Violation|1
1364696|NCT01585246|4502894|P4|Overall Study|Protocol Violation|0
1364697|NCT01585246|4502895|P3|Overall Study|Protocol Violation|0
1364698|NCT01585246|4502896|P2|Overall Study|Protocol Violation|0
1364699|NCT01585246|4502897|P1|Overall Study|Protocol Violation|0
1364700|NCT01585246|4502893|P5|Overall Study|Lost to Follow-up|0
1364701|NCT01585246|4502894|P4|Overall Study|Lost to Follow-up|1
1364702|NCT01585246|4502895|P3|Overall Study|Lost to Follow-up|2
1364703|NCT01585246|4502896|P2|Overall Study|Lost to Follow-up|0
1364704|NCT01585246|4502897|P1|Overall Study|Lost to Follow-up|0
1364705|NCT01585168|4502918|P4|Overall Study|Lost to Follow-up|1
1364706|NCT01585168|4502919|P3|Overall Study|Lost to Follow-up|1
1364707|NCT01585168|4502920|P2|Overall Study|Lost to Follow-up|1
1364708|NCT01585168|4502921|P1|Overall Study|Lost to Follow-up|3
1364709|NCT01585038|4502956|P2|Overall Study|Adverse Event|2
1364710|NCT01585038|4502957|P1|Overall Study|Adverse Event|2
1364711|NCT01584843|4502973|P6|Second Treatment Period|Withdrawal by Subject|1
1364712|NCT01584843|4502974|P5|Second Treatment Period|Withdrawal by Subject|0
1364713|NCT01584843|4502975|P4|Second Treatment Period|Withdrawal by Subject|0
1364714|NCT01584843|4502976|P3|Second Treatment Period|Withdrawal by Subject|0
1364715|NCT01584843|4502977|P2|Second Treatment Period|Withdrawal by Subject|0
1364716|NCT01584843|4502978|P1|Second Treatment Period|Withdrawal by Subject|0
1364717|NCT01584843|4502973|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
1364718|NCT01584843|4502974|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1364719|NCT01584843|4502975|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1364720|NCT01584843|4502976|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1364721|NCT01584843|4502977|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1364722|NCT01584843|4502978|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1364723|NCT01584843|4502973|P6|First Treatment Period|Protocol Violation|1
1364724|NCT01584843|4502974|P5|First Treatment Period|Protocol Violation|0
1364725|NCT01584843|4502975|P4|First Treatment Period|Protocol Violation|0
1364726|NCT01584843|4502976|P3|First Treatment Period|Protocol Violation|0
1364727|NCT01584843|4502977|P2|First Treatment Period|Protocol Violation|0
1364728|NCT01584843|4502978|P1|First Treatment Period|Protocol Violation|0
1364729|NCT01584843|4502973|P6|First Treatment Period|Adverse Event|0
1364730|NCT01584843|4502974|P5|First Treatment Period|Adverse Event|0
1364731|NCT01584843|4502975|P4|First Treatment Period|Adverse Event|0
1364732|NCT01584843|4502976|P3|First Treatment Period|Adverse Event|1
1364733|NCT01584843|4502977|P2|First Treatment Period|Adverse Event|0
1364734|NCT01584843|4502978|P1|First Treatment Period|Adverse Event|0
1364735|NCT01584648|4503089|P2|Overall Study|Ongoing|147
1364736|NCT01584648|4503090|P1|Overall Study|Ongoing|154
1364737|NCT01584648|4503089|P2|Overall Study|Death|55
1364738|NCT01584648|4503090|P1|Overall Study|Death|40
1364739|NCT01584648|4503089|P2|Overall Study|Withdrawal by Subject|5
1364740|NCT01584648|4503090|P1|Overall Study|Withdrawal by Subject|11
1364741|NCT01584648|4503089|P2|Overall Study|Physician Decision|2
1364742|NCT01584648|4503090|P1|Overall Study|Physician Decision|2
1364743|NCT01584648|4503089|P2|Overall Study|Lost to Follow-up|3
1364744|NCT01584648|4503090|P1|Overall Study|Lost to Follow-up|4
1364745|NCT01584232|4503195|P2|Overall Study|Lost to Follow-up|0
1364746|NCT01584232|4503196|P1|Overall Study|Lost to Follow-up|1
1364747|NCT01584232|4503195|P2|Overall Study|Physician Decision|1
1364748|NCT01584232|4503196|P1|Overall Study|Physician Decision|2
1364749|NCT01584232|4503195|P2|Overall Study|Withdrawal by Subject|1
1364750|NCT01584232|4503196|P1|Overall Study|Withdrawal by Subject|2
1364751|NCT01584232|4503195|P2|Overall Study|Adverse Event|1
1364752|NCT01584232|4503196|P1|Overall Study|Adverse Event|3
1364753|NCT01583530|4503242|P6|Overall Study|Lack of compliance|0
1364754|NCT01583530|4503243|P5|Overall Study|Lack of compliance|1
1364755|NCT01583530|4503244|P4|Overall Study|Lack of compliance|0
1364756|NCT01583530|4503245|P3|Overall Study|Lack of compliance|0
1364757|NCT01583530|4503246|P2|Overall Study|Lack of compliance|0
1364758|NCT01583530|4503247|P1|Overall Study|Lack of compliance|0
1364759|NCT01583530|4503242|P6|Overall Study|Lost to Follow-up|0
1364760|NCT01583530|4503243|P5|Overall Study|Lost to Follow-up|3
1364761|NCT01583530|4503244|P4|Overall Study|Lost to Follow-up|0
1364762|NCT01583530|4503245|P3|Overall Study|Lost to Follow-up|0
1364763|NCT01583530|4503246|P2|Overall Study|Lost to Follow-up|0
1364764|NCT01583530|4503247|P1|Overall Study|Lost to Follow-up|0
1364765|NCT01583530|4503242|P6|Overall Study|Withdrawal by Subject|2
1364766|NCT01583530|4503243|P5|Overall Study|Withdrawal by Subject|1
1364767|NCT01583530|4503244|P4|Overall Study|Withdrawal by Subject|1
1364768|NCT01583530|4503245|P3|Overall Study|Withdrawal by Subject|0
1364769|NCT01583530|4503246|P2|Overall Study|Withdrawal by Subject|3
1364770|NCT01583530|4503247|P1|Overall Study|Withdrawal by Subject|0
1364771|NCT01583530|4503242|P6|Overall Study|Adverse Event|1
1364772|NCT01583530|4503243|P5|Overall Study|Adverse Event|0
1364773|NCT01583530|4503244|P4|Overall Study|Adverse Event|0
1364774|NCT01583530|4503245|P3|Overall Study|Adverse Event|0
1364775|NCT01583530|4503246|P2|Overall Study|Adverse Event|0
1364776|NCT01583530|4503247|P1|Overall Study|Adverse Event|0
1364777|NCT01583374|4503309|P3|Overall Study|Other|0
1364778|NCT01583374|4503310|P2|Overall Study|Other|1
1364779|NCT01583374|4503311|P1|Overall Study|Other|0
1364780|NCT01583374|4503309|P3|Overall Study|Protocol Violation|3
1364781|NCT01583374|4503310|P2|Overall Study|Protocol Violation|0
1364782|NCT01583374|4503311|P1|Overall Study|Protocol Violation|0
1364783|NCT01583374|4503309|P3|Overall Study|Lost to Follow-up|0
1364784|NCT01583374|4503310|P2|Overall Study|Lost to Follow-up|2
1364785|NCT01583374|4503311|P1|Overall Study|Lost to Follow-up|1
1364786|NCT01583374|4503309|P3|Overall Study|Withdrawal by Subject|5
1364787|NCT01583374|4503310|P2|Overall Study|Withdrawal by Subject|3
1364788|NCT01583374|4503311|P1|Overall Study|Withdrawal by Subject|8
1364789|NCT01583374|4503309|P3|Overall Study|Non-compliance with study drug|0
1364790|NCT01583374|4503310|P2|Overall Study|Non-compliance with study drug|1
1364791|NCT01583374|4503311|P1|Overall Study|Non-compliance with study drug|1
1364792|NCT01583374|4503309|P3|Overall Study|Lack of Efficacy|5
1364793|NCT01583374|4503310|P2|Overall Study|Lack of Efficacy|2
1364794|NCT01583374|4503311|P1|Overall Study|Lack of Efficacy|3
1364795|NCT01583374|4503309|P3|Overall Study|Adverse Event|12
1364796|NCT01583374|4503310|P2|Overall Study|Adverse Event|7
1364797|NCT01583374|4503311|P1|Overall Study|Adverse Event|6
1364798|NCT01583218|4503323|P2|Overall Study|Withdraw of consent on day of random|0
1364799|NCT01583218|4503324|P1|Overall Study|Withdraw of consent on day of random|1
1364800|NCT01583218|4503323|P2|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
1364801|NCT01583218|4503324|P1|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
1364802|NCT01583218|4503323|P2|Overall Study|Patient was randomized due to mistake|0
1364803|NCT01583218|4503324|P1|Overall Study|Patient was randomized due to mistake|1
1364804|NCT01583218|4503323|P2|Overall Study|Patient was early terminated from study|1
1364805|NCT01583218|4503324|P1|Overall Study|Patient was early terminated from study|0
1364806|NCT01583218|4503323|P2|Overall Study|Patient deemed ineligible after random|0
1364807|NCT01583218|4503324|P1|Overall Study|Patient deemed ineligible after random|2
1364808|NCT01583218|4503323|P2|Overall Study|Patient was assessed via phone in person|0
1364809|NCT01583218|4503324|P1|Overall Study|Patient was assessed via phone in person|1
1364810|NCT01583218|4503323|P2|Overall Study|Patient randomized but not dosed|16
1364811|NCT01583218|4503324|P1|Overall Study|Patient randomized but not dosed|17
1364812|NCT01583218|4503323|P2|Overall Study|Patient did not wish to attend visits|1
1364813|NCT01583218|4503324|P1|Overall Study|Patient did not wish to attend visits|0
1364814|NCT01583218|4503323|P2|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
1364815|NCT01583218|4503324|P1|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
1364816|NCT01583218|4503323|P2|Overall Study|Cannot contact patient directly|2
1364817|NCT01583218|4503324|P1|Overall Study|Cannot contact patient directly|1
1364818|NCT01583218|4503323|P2|Overall Study|Patient /Family decision|0
1364819|NCT01583218|4503324|P1|Overall Study|Patient /Family decision|3
1364820|NCT01583218|4503323|P2|Overall Study|Adverse event or serious adverse event|3
1364821|NCT01583218|4503324|P1|Overall Study|Adverse event or serious adverse event|3
1364822|NCT01583218|4503323|P2|Overall Study|Lost to Follow-up|17
1364823|NCT01583218|4503324|P1|Overall Study|Lost to Follow-up|11
1364824|NCT01583218|4503323|P2|Overall Study|Death|211
1364825|NCT01583218|4503324|P1|Overall Study|Death|206
1364826|NCT01583218|4503323|P2|Overall Study|Withdrawal by Subject|29
1364827|NCT01583218|4503324|P1|Overall Study|Withdrawal by Subject|43
1364828|NCT01582971|4503353|P2|Overall Study|Other|13
1364829|NCT01582971|4503354|P1|Overall Study|Other|15
1364830|NCT01582971|4503353|P2|Overall Study|Withdrawal by Subject|2
1364831|NCT01582971|4503354|P1|Overall Study|Withdrawal by Subject|4
1364832|NCT01582971|4503353|P2|Overall Study|Lost to Follow-up|21
1364833|NCT01582971|4503354|P1|Overall Study|Lost to Follow-up|18
1364834|NCT01582971|4503353|P2|Overall Study|Death|1
1364835|NCT01582971|4503354|P1|Overall Study|Death|2
1364836|NCT01582945|4503372|P1|Overall Study|Scheduling conflicts|1
1364837|NCT01582945|4503372|P1|Overall Study|Intolerable side-effects|1
1364838|NCT01582854|4503386|P2|Overall Study|Other Miscellaneous Reason|0
1364839|NCT01582854|4503387|P1|Overall Study|Other Miscellaneous Reason|1
1364840|NCT01582854|4503386|P2|Overall Study|General Anaesthesia|1
1364841|NCT01582854|4503387|P1|Overall Study|General Anaesthesia|0
1364842|NCT01582854|4503386|P2|Overall Study|Carotid or Neurosurgery|1
1364843|NCT01582854|4503387|P1|Overall Study|Carotid or Neurosurgery|0
1364844|NCT01582854|4503386|P2|Overall Study|Disallowed Concomitant Medication|2
1364845|NCT01582854|4503387|P1|Overall Study|Disallowed Concomitant Medication|3
1364846|NCT01582854|4503386|P2|Overall Study|Recurrent Stroke|8
1364847|NCT01582854|4503387|P1|Overall Study|Recurrent Stroke|13
1364848|NCT01582854|4503386|P2|Overall Study|Physician Decision|1
1364849|NCT01582854|4503387|P1|Overall Study|Physician Decision|0
1364850|NCT01582854|4503386|P2|Overall Study|Lost to Follow-up|2
1364851|NCT01582854|4503387|P1|Overall Study|Lost to Follow-up|1
1364852|NCT01582854|4503386|P2|Overall Study|Withdrawal by Participant|11
1364853|NCT01582854|4503387|P1|Overall Study|Withdrawal by Participant|8
1364854|NCT01582854|4503386|P2|Overall Study|Adverse Event|3
1364855|NCT01582854|4503387|P1|Overall Study|Adverse Event|2
1364856|NCT01582854|4503386|P2|Overall Study|Death|5
1364857|NCT01582854|4503387|P1|Overall Study|Death|8
1364858|NCT01582789|4503415|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
1364859|NCT01582789|4503416|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
1364860|NCT01582451|4503476|P2|Overall Study|Sponsor Decision|0
1364861|NCT01582451|4503477|P1|Overall Study|Sponsor Decision|1
1364862|NCT01582451|4503476|P2|Overall Study|Physician Decision|0
1364863|NCT01582451|4503477|P1|Overall Study|Physician Decision|3
1364864|NCT01582451|4503476|P2|Overall Study|Withdrawal by Subject|9
1364865|NCT01582451|4503477|P1|Overall Study|Withdrawal by Subject|13
1364866|NCT01582451|4503476|P2|Overall Study|Protocol Violation|3
1364867|NCT01582451|4503477|P1|Overall Study|Protocol Violation|11
1364868|NCT01582451|4503476|P2|Overall Study|Lost to Follow-up|2
1364869|NCT01582451|4503477|P1|Overall Study|Lost to Follow-up|0
1364870|NCT01582451|4503476|P2|Overall Study|Death|3
1364871|NCT01582451|4503477|P1|Overall Study|Death|3
1364872|NCT01582451|4503476|P2|Overall Study|Adverse Event|3
1364873|NCT01582451|4503477|P1|Overall Study|Adverse Event|1
1364874|NCT01582308|4503519|P10|Period 4|Physician Decision|1
1364875|NCT01582308|4503520|P9|Period 4|Physician Decision|0
1364876|NCT01582308|4503521|P8|Period 4|Physician Decision|0
1364877|NCT01582308|4503522|P7|Period 4|Physician Decision|0
1364878|NCT01582308|4503523|P6|Period 4|Physician Decision|1
1364879|NCT01582308|4503524|P5|Period 4|Physician Decision|0
1364880|NCT01582308|4503525|P4|Period 4|Physician Decision|0
1364881|NCT01582308|4503526|P3|Period 4|Physician Decision|0
1364882|NCT01582308|4503527|P2|Period 4|Physician Decision|0
1364883|NCT01582308|4503528|P1|Period 4|Physician Decision|1
1364884|NCT01582308|4503519|P10|10-day Washout Following Period 1|Physician Decision|0
1364885|NCT01582308|4503520|P9|10-day Washout Following Period 1|Physician Decision|0
1364886|NCT01582308|4503521|P8|10-day Washout Following Period 1|Physician Decision|0
1364887|NCT01582308|4503522|P7|10-day Washout Following Period 1|Physician Decision|0
1364888|NCT01582308|4503523|P6|10-day Washout Following Period 1|Physician Decision|0
1364889|NCT01582308|4503524|P5|10-day Washout Following Period 1|Physician Decision|1
1364890|NCT01582308|4503525|P4|10-day Washout Following Period 1|Physician Decision|0
1364891|NCT01582308|4503526|P3|10-day Washout Following Period 1|Physician Decision|0
1364892|NCT01582308|4503527|P2|10-day Washout Following Period 1|Physician Decision|0
1364893|NCT01582308|4503528|P1|10-day Washout Following Period 1|Physician Decision|0
1364894|NCT01582308|4503519|P10|Period 1|Withdrawal by Subject|0
1364895|NCT01582308|4503520|P9|Period 1|Withdrawal by Subject|0
1364896|NCT01582308|4503521|P8|Period 1|Withdrawal by Subject|0
1364897|NCT01582308|4503522|P7|Period 1|Withdrawal by Subject|1
1364898|NCT01582308|4503523|P6|Period 1|Withdrawal by Subject|0
1364899|NCT01582308|4503524|P5|Period 1|Withdrawal by Subject|0
1364900|NCT01582308|4503525|P4|Period 1|Withdrawal by Subject|0
1364901|NCT01582308|4503526|P3|Period 1|Withdrawal by Subject|0
1364902|NCT01582308|4503527|P2|Period 1|Withdrawal by Subject|0
1364903|NCT01582308|4503528|P1|Period 1|Withdrawal by Subject|0
1364904|NCT01582282|4503556|P3|Overall Study|fasting blood glucose outside Protocol|0
1364905|NCT01582282|4503557|P2|Overall Study|fasting blood glucose outside Protocol|1
1364906|NCT01582282|4503558|P1|Overall Study|fasting blood glucose outside Protocol|0
1364907|NCT01582282|4503556|P3|Overall Study|Lost to Follow-up|0
1364908|NCT01582282|4503557|P2|Overall Study|Lost to Follow-up|0
1364909|NCT01582282|4503558|P1|Overall Study|Lost to Follow-up|1
1364910|NCT01582282|4503556|P3|Overall Study|Adverse Event|0
1364911|NCT01582282|4503557|P2|Overall Study|Adverse Event|1
1364912|NCT01582282|4503558|P1|Overall Study|Adverse Event|1
1364913|NCT01582243|4503581|P1|Overall Study|Lost to Follow-up|1
1364914|NCT01582243|4503581|P1|Overall Study|Adverse Event|1
1364915|NCT01582243|4503581|P1|Overall Study|Withdrawal by Subject|1
1364916|NCT01582178|4503592|P2|Overall Study|Physician Decision|5
1364917|NCT01582178|4503593|P1|Overall Study|Physician Decision|6
1364918|NCT01582100|4503614|P1|Overall Study|Withdrawal by Subject|1
1364919|NCT01582100|4503614|P1|Overall Study|Adverse Event|1
1364920|NCT01582061|4503620|P2|Overall Study|Lost to Follow-up|0
1364921|NCT01582061|4503621|P1|Overall Study|Lost to Follow-up|1
1364922|NCT01582061|4503620|P2|Overall Study|condition no longer requires study drug|0
1364923|NCT01582061|4503621|P1|Overall Study|condition no longer requires study drug|1
1364924|NCT01582061|4503620|P2|Overall Study|Death|1
1364925|NCT01582061|4503621|P1|Overall Study|Death|0
1364926|NCT01582061|4503620|P2|Overall Study|Abnormal laboratory value(s)|0
1364927|NCT01582061|4503621|P1|Overall Study|Abnormal laboratory value(s)|1
1364928|NCT01582061|4503620|P2|Overall Study|Withdrawal by Subject|4
1364929|NCT01582061|4503621|P1|Overall Study|Withdrawal by Subject|10
1364930|NCT01582061|4503620|P2|Overall Study|Adverse Event|8
1364931|NCT01582061|4503621|P1|Overall Study|Adverse Event|12
1364932|NCT01582061|4503620|P2|Overall Study|Lack of Efficacy|23
1364933|NCT01582061|4503621|P1|Overall Study|Lack of Efficacy|3
1364934|NCT01582009|4503671|P1|Overall Study|Physician Decision|1
1364935|NCT01582009|4503671|P1|Overall Study|Withdrawal by Subject|1
1364936|NCT01581931|4503679|P2|Washout|Adverse Event|1
1364937|NCT01581931|4503680|P1|Washout|Adverse Event|0
1364938|NCT01581684|4503733|P10|Overall Study|Other reason not defined|0
1364939|NCT01581684|4503734|P9|Overall Study|Other reason not defined|1
1364940|NCT01581684|4503735|P8|Overall Study|Other reason not defined|0
1364941|NCT01581684|4503736|P7|Overall Study|Other reason not defined|0
1364942|NCT01581684|4503737|P6|Overall Study|Other reason not defined|0
1364943|NCT01581684|4503738|P5|Overall Study|Other reason not defined|0
1364944|NCT01581684|4503739|P4|Overall Study|Other reason not defined|0
1364945|NCT01581684|4503740|P3|Overall Study|Other reason not defined|0
1364946|NCT01581684|4503741|P2|Overall Study|Other reason not defined|0
1364947|NCT01581684|4503742|P1|Overall Study|Other reason not defined|0
1364948|NCT01581619|4503838|P1|Overall Study|Lost to Follow-up|1
1364949|NCT01581619|4503838|P1|Overall Study|Withdrawal by Subject|1
1364950|NCT01581307|4503991|P1|Overall Study|Withdrawal by Subject|1
1364951|NCT01581281|4504000|P3|Overall Study|Early Study Closure|12
1364952|NCT01581281|4504001|P2|Overall Study|Early Study Closure|6
1364953|NCT01581281|4504002|P1|Overall Study|Early Study Closure|15
1364954|NCT01581021|4504024|P2|Overall Study|Lack of Efficacy|1
1364955|NCT01581021|4504025|P1|Overall Study|Lack of Efficacy|0
1364956|NCT01581021|4504024|P2|Overall Study|Lenke 6 Classification|1
1364957|NCT01581021|4504025|P1|Overall Study|Lenke 6 Classification|0
1364958|NCT01581021|4504024|P2|Overall Study|Not Randomized|2
1364959|NCT01581021|4504025|P1|Overall Study|Not Randomized|1
1364960|NCT01581021|4504024|P2|Overall Study|Neuromuscular|1
1364961|NCT01581021|4504025|P1|Overall Study|Neuromuscular|2
1364962|NCT01581021|4504024|P2|Overall Study|More than 2 hooks in thoracic|0
1364963|NCT01581021|4504025|P1|Overall Study|More than 2 hooks in thoracic|3
1364964|NCT01581021|4504024|P2|Overall Study|Lost to Follow-up|6
1364965|NCT01581021|4504025|P1|Overall Study|Lost to Follow-up|4
1364966|NCT01580995|4504052|P2|Overall Study|Lost to Follow-up|2
1364967|NCT01580995|4504053|P1|Overall Study|Lost to Follow-up|2
1364968|NCT01580488|4504106|P1|Overall Study|Withdrawal by Subject|1
1364969|NCT01580020|4504262|P4|Overall Study|Lost to Follow-up|0
1364970|NCT01580020|4504263|P3|Overall Study|Lost to Follow-up|1
1364971|NCT01580020|4504264|P2|Overall Study|Lost to Follow-up|0
1364972|NCT01580020|4504265|P1|Overall Study|Lost to Follow-up|0
1364973|NCT01580020|4504262|P4|Overall Study|Administrative Problems|0
1364974|NCT01580020|4504263|P3|Overall Study|Administrative Problems|1
1364975|NCT01580020|4504264|P2|Overall Study|Administrative Problems|0
1364976|NCT01580020|4504265|P1|Overall Study|Administrative Problems|0
1364977|NCT01580020|4504262|P4|Overall Study|Adverse Event|1
1364978|NCT01580020|4504263|P3|Overall Study|Adverse Event|1
1364979|NCT01580020|4504264|P2|Overall Study|Adverse Event|1
1364980|NCT01580020|4504265|P1|Overall Study|Adverse Event|1
1364981|NCT01580020|4504262|P4|Overall Study|Withdrawal by Subject|0
1364982|NCT01580020|4504263|P3|Overall Study|Withdrawal by Subject|1
1364983|NCT01580020|4504264|P2|Overall Study|Withdrawal by Subject|1
1364984|NCT01580020|4504265|P1|Overall Study|Withdrawal by Subject|0
1364985|NCT01580020|4504262|P4|Overall Study|Lack of Efficacy|1
1364986|NCT01580020|4504263|P3|Overall Study|Lack of Efficacy|0
1364987|NCT01580020|4504264|P2|Overall Study|Lack of Efficacy|5
1364988|NCT01580020|4504265|P1|Overall Study|Lack of Efficacy|0
1364989|NCT01579916|4504309|P2|Overall Study|Death|0
1364990|NCT01579916|4504310|P1|Overall Study|Death|1
1364991|NCT01579916|4504309|P2|Overall Study|Withdrawal by Subject|1
1364992|NCT01579916|4504310|P1|Overall Study|Withdrawal by Subject|1
1364993|NCT01579916|4504309|P2|Overall Study|Lost to Follow-up|1
1364994|NCT01579916|4504310|P1|Overall Study|Lost to Follow-up|6
1364995|NCT01579812|4504336|P1|Overall Study|Withdrawal by Subject|6
1364996|NCT01579812|4504336|P1|Overall Study|Noncompliance|3
1364997|NCT01579812|4504336|P1|Overall Study|Patient choice|3
1364998|NCT01579812|4504336|P1|Overall Study|Ineligible after treatment start|40
1364999|NCT01579578|4504370|P2|Overall Study|Ongoing|0
1365000|NCT01579578|4504371|P1|Overall Study|Ongoing|3
1365001|NCT01579578|4504370|P2|Overall Study|Eligibility criteria|9
1365002|NCT01579578|4504371|P1|Overall Study|Eligibility criteria|3
1365003|NCT01579578|4504370|P2|Overall Study|Withdrawal by Subject|1
1365004|NCT01579578|4504371|P1|Overall Study|Withdrawal by Subject|2
1365005|NCT01579578|4504370|P2|Overall Study|Lost to Follow-up|1
1365006|NCT01579578|4504371|P1|Overall Study|Lost to Follow-up|1
1365007|NCT01579578|4504370|P2|Overall Study|Death|1
1365008|NCT01579578|4504371|P1|Overall Study|Death|4
1365009|NCT01579565|4504383|P2|Treated|declined to return for final visit|1
1365010|NCT01579565|4504384|P1|Treated|declined to return for final visit|0
1365011|NCT01579565|4504383|P2|Treated|Lost to Follow-up|1
1365012|NCT01579565|4504384|P1|Treated|Lost to Follow-up|2
1365013|NCT01579565|4504383|P2|Treated|Physician Decision|1
1365014|NCT01579565|4504384|P1|Treated|Physician Decision|0
1365015|NCT01579565|4504383|P2|Randomized|prohibited preoperative medication|1
1365016|NCT01579565|4504384|P1|Randomized|prohibited preoperative medication|0
1365017|NCT01579565|4504383|P2|Randomized|prohibited preoperative eating|0
1365018|NCT01579565|4504384|P1|Randomized|prohibited preoperative eating|1
1365019|NCT01579565|4504383|P2|Randomized|inadequate preoperative pupil dilation|1
1365020|NCT01579565|4504384|P1|Randomized|inadequate preoperative pupil dilation|0
1365021|NCT01579565|4504383|P2|Randomized|Withdrawal by Subject|0
1365022|NCT01579565|4504384|P1|Randomized|Withdrawal by Subject|3
1365023|NCT01579565|4504383|P2|Randomized|Adverse Event|3
1365024|NCT01579565|4504384|P1|Randomized|Adverse Event|1
1365025|NCT01579474|4504418|P6|Overall Study|Withdrawal by Subject|0
1365026|NCT01579474|4504419|P5|Overall Study|Withdrawal by Subject|0
1365027|NCT01579474|4504420|P4|Overall Study|Withdrawal by Subject|0
1365028|NCT01579474|4504421|P3|Overall Study|Withdrawal by Subject|0
1365029|NCT01579474|4504422|P2|Overall Study|Withdrawal by Subject|0
1365030|NCT01579474|4504423|P1|Overall Study|Withdrawal by Subject|1
1365031|NCT01579474|4504418|P6|Overall Study|Lack of Efficacy|0
1365032|NCT01579474|4504419|P5|Overall Study|Lack of Efficacy|1
1365033|NCT01579474|4504420|P4|Overall Study|Lack of Efficacy|0
1365034|NCT01579474|4504421|P3|Overall Study|Lack of Efficacy|0
1365035|NCT01579474|4504422|P2|Overall Study|Lack of Efficacy|0
1365036|NCT01579474|4504423|P1|Overall Study|Lack of Efficacy|1
1365037|NCT01579474|4504418|P6|Overall Study|Adverse Event|1
1365038|NCT01579474|4504419|P5|Overall Study|Adverse Event|0
1365039|NCT01579474|4504420|P4|Overall Study|Adverse Event|0
1365040|NCT01579474|4504421|P3|Overall Study|Adverse Event|2
1365041|NCT01579474|4504422|P2|Overall Study|Adverse Event|13
1365042|NCT01579474|4504423|P1|Overall Study|Adverse Event|1
1365043|NCT01579318|4504497|P1|Overall Study|Disease Progression|1
1365044|NCT01579006|4504592|P1|Overall Study|Scheduled surgery|1
1365045|NCT01579006|4504592|P1|Overall Study|Due to participant's health fund|1
1365046|NCT01579006|4504592|P1|Overall Study|Non-compliance|3
1365047|NCT01579006|4504592|P1|Overall Study|Withdrawal by Subject|5
1365048|NCT01579006|4504592|P1|Overall Study|Adverse Event|13
1365049|NCT01579006|4504592|P1|Overall Study|Lack of Efficacy|10
1365050|NCT01578850|4504651|P3|Period 2|Unspecified Reasons|0
1365051|NCT01578850|4504652|P2|Period 2|Unspecified Reasons|1
1365052|NCT01578850|4504653|P1|Period 2|Unspecified Reasons|0
1365053|NCT01578850|4504651|P3|Period 2|Study Terminated by Sponsor|4
1365054|NCT01578850|4504652|P2|Period 2|Study Terminated by Sponsor|5
1365055|NCT01578850|4504653|P1|Period 2|Study Terminated by Sponsor|0
1365056|NCT01578850|4504651|P3|Period 2|Withdrawal by Subject|2
1365057|NCT01578850|4504652|P2|Period 2|Withdrawal by Subject|2
1365058|NCT01578850|4504653|P1|Period 2|Withdrawal by Subject|0
1365059|NCT01578850|4504651|P3|Period 2|Lost to Follow-up|2
1365060|NCT01578850|4504652|P2|Period 2|Lost to Follow-up|1
1365061|NCT01578850|4504653|P1|Period 2|Lost to Follow-up|0
1365062|NCT01578850|4504651|P3|Period 2|Adverse Event|6
1365063|NCT01578850|4504652|P2|Period 2|Adverse Event|3
1365064|NCT01578850|4504653|P1|Period 2|Adverse Event|0
1365065|NCT01578850|4504651|P3|Period 2|Insufficient Clinical Response|0
1365066|NCT01578850|4504652|P2|Period 2|Insufficient Clinical Response|1
1365067|NCT01578850|4504653|P1|Period 2|Insufficient Clinical Response|0
1365068|NCT01578850|4504651|P3|Period 1|Study Terminated by Sponsor|0
1365069|NCT01578850|4504652|P2|Period 1|Study Terminated by Sponsor|0
1365070|NCT01578850|4504653|P1|Period 1|Study Terminated by Sponsor|3
1365071|NCT01578850|4504651|P3|Period 1|Withdrawal by Subject|0
1365072|NCT01578850|4504652|P2|Period 1|Withdrawal by Subject|0
1365073|NCT01578850|4504653|P1|Period 1|Withdrawal by Subject|9
1365074|NCT01578850|4504651|P3|Period 1|Does Not Meet Entrance Criteria|0
1365075|NCT01578850|4504652|P2|Period 1|Does Not Meet Entrance Criteria|0
1365076|NCT01578850|4504653|P1|Period 1|Does Not Meet Entrance Criteria|12
1365077|NCT01578850|4504651|P3|Period 1|Death|0
1365078|NCT01578850|4504652|P2|Period 1|Death|0
1365079|NCT01578850|4504653|P1|Period 1|Death|1
1365080|NCT01578850|4504651|P3|Period 1|Adverse Event|0
1365081|NCT01578850|4504652|P2|Period 1|Adverse Event|0
1365082|NCT01578850|4504653|P1|Period 1|Adverse Event|11
1365083|NCT01578850|4504651|P3|Period 1|Insufficient Clinical Response|0
1365084|NCT01578850|4504652|P2|Period 1|Insufficient Clinical Response|0
1365085|NCT01578850|4504653|P1|Period 1|Insufficient Clinical Response|1
1365086|NCT01578785|4504705|P2|Overall Study|Study terminated by sponsor|118
1365087|NCT01578785|4504706|P1|Overall Study|Study terminated by sponsor|59
1365088|NCT01578785|4504705|P2|Overall Study|Withdrawal by Subject|1
1365089|NCT01578785|4504706|P1|Overall Study|Withdrawal by Subject|0
1365090|NCT01578499|4504738|P2|Overall Study|Participants on Study Treatment|0
1365091|NCT01578499|4504739|P1|Overall Study|Participants on Study Treatment|3
1365092|NCT01578499|4504738|P2|Overall Study|Participants in Follow-up|39
1365093|NCT01578499|4504739|P1|Overall Study|Participants in Follow-up|42
1365094|NCT01578499|4504738|P2|Overall Study|Reason not Specified|1
1365095|NCT01578499|4504739|P1|Overall Study|Reason not Specified|0
1365096|NCT01578499|4504738|P2|Overall Study|Lost to Follow-up|1
1365097|NCT01578499|4504739|P1|Overall Study|Lost to Follow-up|2
1365098|NCT01578499|4504738|P2|Overall Study|Withdrawal by Participant|10
1365099|NCT01578499|4504739|P1|Overall Study|Withdrawal by Participant|8
1365100|NCT01578499|4504738|P2|Overall Study|Death|14
1365101|NCT01578499|4504739|P1|Overall Study|Death|11
1365102|NCT01578486|4504773|P1|Overall Study|Withdrawal by Subject|2
1365103|NCT01578486|4504773|P1|Overall Study|Physician Decision|3
1365104|NCT01578330|4504784|P1|Overall Study|Protocol Violation|5
1365105|NCT01578330|4504784|P1|Overall Study|Adverse Event|2
1365106|NCT01578187|4504800|P1|Usability Phase|Withdrawal by Subject|1
1365107|NCT01577758|4504834|P8|mCRC Expansion Phase|Progression Disease|19
1365108|NCT01577758|4504835|P7|mCRC Expansion Phase|Progression Disease|0
1365109|NCT01577758|4504836|P6|mCRC Expansion Phase|Progression Disease|0
1365110|NCT01577758|4504837|P5|mCRC Expansion Phase|Progression Disease|0
1365111|NCT01577758|4504838|P4|mCRC Expansion Phase|Progression Disease|0
1365112|NCT01577758|4504839|P3|mCRC Expansion Phase|Progression Disease|0
1365113|NCT01577758|4504840|P2|mCRC Expansion Phase|Progression Disease|0
1365114|NCT01577758|4504841|P1|mCRC Expansion Phase|Progression Disease|0
1365115|NCT01577758|4504834|P8|mCRC Expansion Phase|Withdrawal by Subject|2
1365116|NCT01577758|4504835|P7|mCRC Expansion Phase|Withdrawal by Subject|0
1365117|NCT01577758|4504836|P6|mCRC Expansion Phase|Withdrawal by Subject|0
1365118|NCT01577758|4504837|P5|mCRC Expansion Phase|Withdrawal by Subject|0
1365119|NCT01577758|4504838|P4|mCRC Expansion Phase|Withdrawal by Subject|0
1365120|NCT01577758|4504839|P3|mCRC Expansion Phase|Withdrawal by Subject|0
1365121|NCT01577758|4504840|P2|mCRC Expansion Phase|Withdrawal by Subject|0
1365122|NCT01577758|4504841|P1|mCRC Expansion Phase|Withdrawal by Subject|0
1365123|NCT01577758|4504834|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
1365124|NCT01577758|4504835|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
1365125|NCT01577758|4504836|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
1365126|NCT01577758|4504837|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
1365127|NCT01577758|4504838|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
1365128|NCT01577758|4504839|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
1365129|NCT01577758|4504840|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
1365130|NCT01577758|4504841|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
1365131|NCT01577758|4504834|P8|Dose Escalation Phase|Progression Disease|0
1365132|NCT01577758|4504835|P7|Dose Escalation Phase|Progression Disease|0
1365133|NCT01577758|4504836|P6|Dose Escalation Phase|Progression Disease|0
1365134|NCT01577758|4504837|P5|Dose Escalation Phase|Progression Disease|5
1365135|NCT01577758|4504838|P4|Dose Escalation Phase|Progression Disease|2
1365136|NCT01577758|4504839|P3|Dose Escalation Phase|Progression Disease|1
1365137|NCT01577758|4504840|P2|Dose Escalation Phase|Progression Disease|2
1365138|NCT01577758|4504841|P1|Dose Escalation Phase|Progression Disease|2
1365139|NCT01577758|4504834|P8|Dose Escalation Phase|Withdrawal by Subject|0
1365140|NCT01577758|4504835|P7|Dose Escalation Phase|Withdrawal by Subject|0
1365141|NCT01577758|4504836|P6|Dose Escalation Phase|Withdrawal by Subject|1
1365142|NCT01577758|4504837|P5|Dose Escalation Phase|Withdrawal by Subject|0
1365143|NCT01577758|4504838|P4|Dose Escalation Phase|Withdrawal by Subject|0
1365144|NCT01577758|4504839|P3|Dose Escalation Phase|Withdrawal by Subject|0
1365145|NCT01577758|4504840|P2|Dose Escalation Phase|Withdrawal by Subject|0
1365146|NCT01577758|4504841|P1|Dose Escalation Phase|Withdrawal by Subject|0
1365147|NCT01577758|4504834|P8|Dose Escalation Phase|Symptomatic Deterioration|0
1365148|NCT01577758|4504835|P7|Dose Escalation Phase|Symptomatic Deterioration|0
1365149|NCT01577758|4504836|P6|Dose Escalation Phase|Symptomatic Deterioration|1
1365150|NCT01577758|4504837|P5|Dose Escalation Phase|Symptomatic Deterioration|1
1365151|NCT01577758|4504838|P4|Dose Escalation Phase|Symptomatic Deterioration|0
1365152|NCT01577758|4504839|P3|Dose Escalation Phase|Symptomatic Deterioration|1
1365153|NCT01577758|4504840|P2|Dose Escalation Phase|Symptomatic Deterioration|0
1365154|NCT01577758|4504841|P1|Dose Escalation Phase|Symptomatic Deterioration|0
1365155|NCT01577758|4504834|P8|Dose Escalation Phase|Adverse Event|0
1365156|NCT01577758|4504835|P7|Dose Escalation Phase|Adverse Event|1
1365157|NCT01577758|4504836|P6|Dose Escalation Phase|Adverse Event|2
1365158|NCT01577758|4504837|P5|Dose Escalation Phase|Adverse Event|0
1365159|NCT01577758|4504838|P4|Dose Escalation Phase|Adverse Event|0
1365160|NCT01577758|4504839|P3|Dose Escalation Phase|Adverse Event|0
1365161|NCT01577758|4504840|P2|Dose Escalation Phase|Adverse Event|0
1365162|NCT01577758|4504841|P1|Dose Escalation Phase|Adverse Event|0
1365163|NCT01577745|4504880|P6|Overall Study|Alternative Therapy|0
1365164|NCT01577745|4504881|P5|Overall Study|Alternative Therapy|1
1365165|NCT01577745|4504882|P4|Overall Study|Alternative Therapy|1
1365166|NCT01577745|4504883|P3|Overall Study|Alternative Therapy|0
1365167|NCT01577745|4504884|P2|Overall Study|Alternative Therapy|0
1365168|NCT01577745|4504885|P1|Overall Study|Alternative Therapy|0
1365169|NCT01577745|4504880|P6|Overall Study|Lost to Follow-up|1
1365170|NCT01577745|4504881|P5|Overall Study|Lost to Follow-up|0
1365171|NCT01577745|4504882|P4|Overall Study|Lost to Follow-up|0
1365172|NCT01577745|4504883|P3|Overall Study|Lost to Follow-up|0
1365173|NCT01577745|4504884|P2|Overall Study|Lost to Follow-up|0
1365174|NCT01577745|4504885|P1|Overall Study|Lost to Follow-up|0
1365175|NCT01577745|4504880|P6|Overall Study|Physician Decision|0
1365176|NCT01577745|4504881|P5|Overall Study|Physician Decision|1
1365177|NCT01577745|4504882|P4|Overall Study|Physician Decision|1
1365178|NCT01577745|4504883|P3|Overall Study|Physician Decision|0
1365179|NCT01577745|4504884|P2|Overall Study|Physician Decision|0
1365180|NCT01577745|4504885|P1|Overall Study|Physician Decision|0
1365181|NCT01577745|4504880|P6|Overall Study|Death|3
1365182|NCT01577745|4504881|P5|Overall Study|Death|1
1365183|NCT01577745|4504882|P4|Overall Study|Death|1
1365184|NCT01577745|4504883|P3|Overall Study|Death|2
1365185|NCT01577745|4504884|P2|Overall Study|Death|2
1365186|NCT01577745|4504885|P1|Overall Study|Death|3
1365187|NCT01577745|4504880|P6|Overall Study|Withdrawal by Subject|0
1365188|NCT01577745|4504881|P5|Overall Study|Withdrawal by Subject|2
1365189|NCT01577745|4504882|P4|Overall Study|Withdrawal by Subject|3
1365190|NCT01577745|4504883|P3|Overall Study|Withdrawal by Subject|0
1365191|NCT01577745|4504884|P2|Overall Study|Withdrawal by Subject|1
1365192|NCT01577745|4504885|P1|Overall Study|Withdrawal by Subject|0
1365193|NCT01577381|4505069|P4|Overall Study|Ongoing at Date of Cut-Off|0
1365194|NCT01577381|4505070|P3|Overall Study|Ongoing at Date of Cut-Off|1
1365195|NCT01577381|4505071|P2|Overall Study|Ongoing at Date of Cut-Off|2
1365196|NCT01577381|4505072|P1|Overall Study|Ongoing at Date of Cut-Off|0
1365197|NCT01577381|4505069|P4|Overall Study|Discontinued|2
1365198|NCT01577381|4505070|P3|Overall Study|Discontinued|2
1365199|NCT01577381|4505071|P2|Overall Study|Discontinued|1
1365200|NCT01577381|4505072|P1|Overall Study|Discontinued|2
1365201|NCT01577186|4505210|P1|Overall Study|Other|2
1365202|NCT01577186|4505210|P1|Overall Study|Non-Compliant|8
1365203|NCT01577186|4505210|P1|Overall Study|Ineligible to Continue|15
1365204|NCT01577186|4505210|P1|Overall Study|Insufficient Response|18
1365205|NCT01577186|4505210|P1|Overall Study|Withdrawal by Subject|35
1365206|NCT01577186|4505210|P1|Overall Study|Lost to Follow-up|28
1365207|NCT01577186|4505210|P1|Overall Study|Death|1
1365208|NCT01577186|4505210|P1|Overall Study|Adverse Event|23
1365209|NCT01577160|4505218|P1|Overall Study|Other|9
1365210|NCT01577160|4505218|P1|Overall Study|Subject Uncooperative|7
1365211|NCT01577160|4505218|P1|Overall Study|Withdrawal by Subject|18
1365212|NCT01577160|4505218|P1|Overall Study|Lost to Follow-up|40
1365213|NCT01577160|4505218|P1|Overall Study|Lack of Efficacy|15
1365214|NCT01577160|4505218|P1|Overall Study|Adverse Event|9
1365215|NCT01576718|4505264|P7|Treatment Period|Noncompliance to study medication|1
1365216|NCT01576718|4505265|P6|Treatment Period|Noncompliance to study medication|1
1365217|NCT01576718|4505266|P5|Treatment Period|Noncompliance to study medication|0
1365218|NCT01576718|4505267|P4|Treatment Period|Noncompliance to study medication|0
1365219|NCT01576718|4505268|P3|Treatment Period|Noncompliance to study medication|0
1365220|NCT01576718|4505269|P2|Treatment Period|Noncompliance to study medication|0
1365221|NCT01576718|4505270|P1|Treatment Period|Noncompliance to study medication|0
1365222|NCT01576718|4505264|P7|Treatment Period|Lost to Follow-up|0
1365223|NCT01576718|4505265|P6|Treatment Period|Lost to Follow-up|0
1365224|NCT01576718|4505266|P5|Treatment Period|Lost to Follow-up|1
1365225|NCT01576718|4505267|P4|Treatment Period|Lost to Follow-up|0
1365226|NCT01576718|4505268|P3|Treatment Period|Lost to Follow-up|0
1365227|NCT01576718|4505269|P2|Treatment Period|Lost to Follow-up|0
1365228|NCT01576718|4505270|P1|Treatment Period|Lost to Follow-up|0
1365229|NCT01576718|4505264|P7|Treatment Period|Met stopping criteria|15
1365230|NCT01576718|4505265|P6|Treatment Period|Met stopping criteria|33
1365231|NCT01576718|4505266|P5|Treatment Period|Met stopping criteria|16
1365232|NCT01576718|4505267|P4|Treatment Period|Met stopping criteria|19
1365233|NCT01576718|4505268|P3|Treatment Period|Met stopping criteria|13
1365234|NCT01576718|4505269|P2|Treatment Period|Met stopping criteria|16
1365235|NCT01576718|4505270|P1|Treatment Period|Met stopping criteria|0
1365236|NCT01576718|4505264|P7|Treatment Period|Sponsor request|0
1365237|NCT01576718|4505265|P6|Treatment Period|Sponsor request|1
1365238|NCT01576718|4505266|P5|Treatment Period|Sponsor request|0
1365239|NCT01576718|4505267|P4|Treatment Period|Sponsor request|0
1365240|NCT01576718|4505268|P3|Treatment Period|Sponsor request|0
1365241|NCT01576718|4505269|P2|Treatment Period|Sponsor request|1
1365242|NCT01576718|4505270|P1|Treatment Period|Sponsor request|0
1365243|NCT01576718|4505264|P7|Treatment Period|Protocol Violation|12
1365244|NCT01576718|4505265|P6|Treatment Period|Protocol Violation|8
1365245|NCT01576718|4505266|P5|Treatment Period|Protocol Violation|6
1365246|NCT01576718|4505267|P4|Treatment Period|Protocol Violation|10
1365247|NCT01576718|4505268|P3|Treatment Period|Protocol Violation|4
1365248|NCT01576718|4505269|P2|Treatment Period|Protocol Violation|5
1365249|NCT01576718|4505270|P1|Treatment Period|Protocol Violation|0
1365250|NCT01576718|4505264|P7|Treatment Period|Physician Decision|0
1365251|NCT01576718|4505265|P6|Treatment Period|Physician Decision|0
1365252|NCT01576718|4505266|P5|Treatment Period|Physician Decision|1
1365253|NCT01576718|4505267|P4|Treatment Period|Physician Decision|1
1365254|NCT01576718|4505268|P3|Treatment Period|Physician Decision|1
1365255|NCT01576718|4505269|P2|Treatment Period|Physician Decision|1
1365256|NCT01576718|4505270|P1|Treatment Period|Physician Decision|0
1365257|NCT01576718|4505264|P7|Treatment Period|Withdrawal by Subject|2
1365258|NCT01576718|4505265|P6|Treatment Period|Withdrawal by Subject|4
1365259|NCT01576718|4505266|P5|Treatment Period|Withdrawal by Subject|2
1365260|NCT01576718|4505267|P4|Treatment Period|Withdrawal by Subject|0
1365261|NCT01576718|4505268|P3|Treatment Period|Withdrawal by Subject|1
1365262|NCT01576718|4505269|P2|Treatment Period|Withdrawal by Subject|1
1365263|NCT01576718|4505270|P1|Treatment Period|Withdrawal by Subject|0
1365264|NCT01576718|4505264|P7|Treatment Period|Adverse Event|0
1365265|NCT01576718|4505265|P6|Treatment Period|Adverse Event|1
1365266|NCT01576718|4505266|P5|Treatment Period|Adverse Event|1
1365267|NCT01576718|4505267|P4|Treatment Period|Adverse Event|1
1365268|NCT01576718|4505268|P3|Treatment Period|Adverse Event|1
1365269|NCT01576718|4505269|P2|Treatment Period|Adverse Event|1
1365270|NCT01576718|4505270|P1|Treatment Period|Adverse Event|0
1365271|NCT01576718|4505264|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1365272|NCT01576718|4505265|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1365273|NCT01576718|4505266|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1365274|NCT01576718|4505267|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1365275|NCT01576718|4505268|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1365276|NCT01576718|4505269|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1365277|NCT01576718|4505270|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
1365278|NCT01576718|4505264|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1365279|NCT01576718|4505265|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1365280|NCT01576718|4505266|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1365281|NCT01576718|4505267|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1365282|NCT01576718|4505268|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1365283|NCT01576718|4505269|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1365284|NCT01576718|4505270|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
1365285|NCT01576718|4505264|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1365286|NCT01576718|4505265|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1365287|NCT01576718|4505266|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1365288|NCT01576718|4505267|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1365289|NCT01576718|4505268|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1365290|NCT01576718|4505269|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1365291|NCT01576718|4505270|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
1365292|NCT01576718|4505264|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1365293|NCT01576718|4505265|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1365294|NCT01576718|4505266|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1365295|NCT01576718|4505267|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1365296|NCT01576718|4505268|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1365297|NCT01576718|4505269|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1365298|NCT01576718|4505270|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
1365299|NCT01576718|4505264|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1365300|NCT01576718|4505265|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1365301|NCT01576718|4505266|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1365302|NCT01576718|4505267|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1365303|NCT01576718|4505268|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1365304|NCT01576718|4505269|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1365305|NCT01576718|4505270|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
1365306|NCT01576549|4505362|P1|Overall Study|Sponsor Decision|2
1365307|NCT01576367|4505379|P1|Overall Study|Moved to commercial use after 6 months|1
1365308|NCT01576367|4505379|P1|Overall Study|Unsatisfactory therapeutic effect|2
1365309|NCT01576341|4505387|P1|Overall Study|Other|12
1365310|NCT01576341|4505387|P1|Overall Study|Protocol Violation|12
1365311|NCT01576341|4505387|P1|Overall Study|Kidney transplantation|10
1365312|NCT01576341|4505387|P1|Overall Study|Lost to Follow-up|2
1365313|NCT01576341|4505387|P1|Overall Study|Physician Decision|2
1365314|NCT01576341|4505387|P1|Overall Study|Death|21
1365315|NCT01576341|4505387|P1|Overall Study|Adverse Event|10
1365316|NCT01576341|4505387|P1|Overall Study|Withdrawal by Subject|24
1365317|NCT01576159|4505408|P4|Overall Study|Protocol Violation|0
1365318|NCT01576159|4505409|P3|Overall Study|Protocol Violation|0
1365319|NCT01576159|4505410|P2|Overall Study|Protocol Violation|0
1365320|NCT01576159|4505411|P1|Overall Study|Protocol Violation|1
1365321|NCT01576159|4505408|P4|Overall Study|Lost to Follow-up|1
1365322|NCT01576159|4505409|P3|Overall Study|Lost to Follow-up|0
1365323|NCT01576159|4505410|P2|Overall Study|Lost to Follow-up|0
1365324|NCT01576159|4505411|P1|Overall Study|Lost to Follow-up|0
1365325|NCT01576159|4505408|P4|Overall Study|Physician Decision|0
1365326|NCT01576159|4505409|P3|Overall Study|Physician Decision|1
1365327|NCT01576159|4505410|P2|Overall Study|Physician Decision|0
1365328|NCT01576159|4505411|P1|Overall Study|Physician Decision|0
1365329|NCT01576159|4505408|P4|Overall Study|Withdrawal by Subject|0
1365330|NCT01576159|4505409|P3|Overall Study|Withdrawal by Subject|0
1365331|NCT01576159|4505410|P2|Overall Study|Withdrawal by Subject|1
1365332|NCT01576159|4505411|P1|Overall Study|Withdrawal by Subject|0
1365333|NCT01576146|4505429|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
1365334|NCT01576146|4505429|P1|Extension Period 2|Renal Transplant|1
1365335|NCT01576146|4505429|P1|Extension Period 2|Adverse Event|1
1365336|NCT01576146|4505429|P1|Extension Period 2|Death|1
1365337|NCT01576146|4505429|P1|Extension Period 2|Sponsor Decision|13
1365338|NCT01576146|4505429|P1|Extension Period 1|Renal Transplant|1
1365339|NCT01576146|4505429|P1|Extension Period 1|Parathyroidectomy|1
1365340|NCT01576146|4505429|P1|Extension Period 1|Lost to Follow-up|1
1365341|NCT01576146|4505429|P1|Extension Period 1|Withdrawal by Subject|1
1365342|NCT01576146|4505429|P1|Extension Period 1|Physician Decision|2
1365343|NCT01576146|4505429|P1|Extension Period 1|Death|2
1365344|NCT01576146|4505429|P1|Extension Period 1|Adverse Event|2
1365345|NCT01576042|4505462|P2|Overall Study|Physician Decision|0
1365346|NCT01576042|4505463|P1|Overall Study|Physician Decision|2
1365347|NCT01575899|4505499|P3|Overall Study|Protocol Violation|0
1365348|NCT01575899|4505500|P2|Overall Study|Protocol Violation|1
1365349|NCT01575899|4505501|P1|Overall Study|Protocol Violation|2
1365350|NCT01575899|4505499|P3|Overall Study|Lost to Follow-up|2
1365351|NCT01575899|4505500|P2|Overall Study|Lost to Follow-up|4
1365352|NCT01575899|4505501|P1|Overall Study|Lost to Follow-up|3
1365353|NCT01575873|4505515|P4|Overall Study|Other|2
1365354|NCT01575873|4505516|P3|Overall Study|Other|4
1365355|NCT01575873|4505517|P2|Overall Study|Other|0
1365356|NCT01575873|4505518|P1|Overall Study|Other|0
1365357|NCT01575873|4505515|P4|Overall Study|Requirement for Alternative Therapy|1
1365358|NCT01575873|4505516|P3|Overall Study|Requirement for Alternative Therapy|1
1365359|NCT01575873|4505517|P2|Overall Study|Requirement for Alternative Therapy|0
1365360|NCT01575873|4505518|P1|Overall Study|Requirement for Alternative Therapy|0
1365361|NCT01575873|4505515|P4|Overall Study|Protocol deviation|1
1365362|NCT01575873|4505516|P3|Overall Study|Protocol deviation|0
1365363|NCT01575873|4505517|P2|Overall Study|Protocol deviation|1
1365364|NCT01575873|4505518|P1|Overall Study|Protocol deviation|0
1365365|NCT01575873|4505515|P4|Overall Study|Administrative decision|0
1365366|NCT01575873|4505516|P3|Overall Study|Administrative decision|1
1365367|NCT01575873|4505517|P2|Overall Study|Administrative decision|1
1365368|NCT01575873|4505518|P1|Overall Study|Administrative decision|1
1365369|NCT01575873|4505515|P4|Overall Study|Noncompliance|3
1365370|NCT01575873|4505516|P3|Overall Study|Noncompliance|4
1365371|NCT01575873|4505517|P2|Overall Study|Noncompliance|2
1365372|NCT01575873|4505518|P1|Overall Study|Noncompliance|1
1365373|NCT01575873|4505515|P4|Overall Study|Death|9
1365374|NCT01575873|4505516|P3|Overall Study|Death|8
1365375|NCT01575873|4505517|P2|Overall Study|Death|2
1365376|NCT01575873|4505518|P1|Overall Study|Death|3
1365377|NCT01575873|4505515|P4|Overall Study|Lost to Follow-up|5
1365378|NCT01575873|4505516|P3|Overall Study|Lost to Follow-up|13
1365379|NCT01575873|4505517|P2|Overall Study|Lost to Follow-up|3
1365380|NCT01575873|4505518|P1|Overall Study|Lost to Follow-up|1
1365381|NCT01575873|4505515|P4|Overall Study|Adverse Event|12
1365382|NCT01575873|4505516|P3|Overall Study|Adverse Event|9
1365383|NCT01575873|4505517|P2|Overall Study|Adverse Event|7
1365384|NCT01575873|4505518|P1|Overall Study|Adverse Event|7
1365385|NCT01575873|4505515|P4|Overall Study|Withdrawal by Subject|34
1365386|NCT01575873|4505516|P3|Overall Study|Withdrawal by Subject|34
1365387|NCT01575873|4505517|P2|Overall Study|Withdrawal by Subject|20
1365388|NCT01575873|4505518|P1|Overall Study|Withdrawal by Subject|15
1365389|NCT01575808|4505544|P2|Overall Study|Withdrawal by Subject|0
1365390|NCT01575808|4505545|P1|Overall Study|Withdrawal by Subject|1
1365391|NCT01575808|4505544|P2|Overall Study|Death|0
1365392|NCT01575808|4505545|P1|Overall Study|Death|2
1365393|NCT01575769|4505592|P1|Overall Study|Study terminated by sponsor|40
1365394|NCT01575769|4505592|P1|Overall Study|Adverse Event|1
1365395|NCT01575561|4505650|P1|Overall Study|administration|1
1365396|NCT01575561|4505650|P1|Overall Study|Withdrawal by Subject|11
1365397|NCT01575561|4505650|P1|Overall Study|Protocol Violation|4
1365398|NCT01575561|4505650|P1|Overall Study|Lost to Follow-up|6
1365399|NCT01575561|4505650|P1|Overall Study|Lack of Efficacy|8
1365400|NCT01575561|4505650|P1|Overall Study|Adverse Event|9
1365401|NCT01575197|4505680|P3|Overall Study|Protocol Violation|1
1365402|NCT01575197|4505681|P2|Overall Study|Protocol Violation|1
1365403|NCT01575197|4505682|P1|Overall Study|Protocol Violation|2
1365404|NCT01575197|4505680|P3|Overall Study|Withdrawal by Subject|1
1365405|NCT01575197|4505681|P2|Overall Study|Withdrawal by Subject|1
1365406|NCT01575197|4505682|P1|Overall Study|Withdrawal by Subject|0
1365407|NCT01575197|4505680|P3|Overall Study|Lost to Follow-up|0
1365408|NCT01575197|4505681|P2|Overall Study|Lost to Follow-up|1
1365409|NCT01575197|4505682|P1|Overall Study|Lost to Follow-up|0
1365410|NCT01575197|4505680|P3|Overall Study|SAE|0
1365411|NCT01575197|4505681|P2|Overall Study|SAE|1
1365412|NCT01575197|4505682|P1|Overall Study|SAE|0
1365413|NCT01575197|4505680|P3|Overall Study|Migration out of study area|4
1365414|NCT01575197|4505681|P2|Overall Study|Migration out of study area|5
1365415|NCT01575197|4505682|P1|Overall Study|Migration out of study area|1
1365416|NCT01575054|4505710|P2|Overall Study|Adverse Event|8
1365417|NCT01575054|4505711|P1|Overall Study|Adverse Event|9
1365418|NCT01575054|4505710|P2|Overall Study|Lost to Follow-up|3
1365419|NCT01575054|4505711|P1|Overall Study|Lost to Follow-up|3
1365420|NCT01575054|4505710|P2|Overall Study|Personal Reasons|11
1365421|NCT01575054|4505711|P1|Overall Study|Personal Reasons|10
1365422|NCT01575054|4505710|P2|Overall Study|Protocol Violation|1
1365423|NCT01575054|4505711|P1|Overall Study|Protocol Violation|2
1365424|NCT01575054|4505710|P2|Overall Study|Other Reasons|3
1365425|NCT01575054|4505711|P1|Overall Study|Other Reasons|5
1365426|NCT01575028|4505727|P2|Overall Study|Physician Decision|1
1365427|NCT01575028|4505728|P1|Overall Study|Physician Decision|0
1365428|NCT01574703|4505738|P4|Overall Study|Death|0
1365429|NCT01574703|4505739|P3|Overall Study|Death|1
1365430|NCT01574703|4505740|P2|Overall Study|Death|1
1365431|NCT01574703|4505741|P1|Overall Study|Death|2
1365432|NCT01574703|4505738|P4|Overall Study|Lost to Follow-up|35
1365433|NCT01574703|4505739|P3|Overall Study|Lost to Follow-up|46
1365434|NCT01574703|4505740|P2|Overall Study|Lost to Follow-up|41
1365435|NCT01574703|4505741|P1|Overall Study|Lost to Follow-up|43
1365436|NCT01574703|4505738|P4|Overall Study|Met Withdrawal Criteria|0
1365437|NCT01574703|4505739|P3|Overall Study|Met Withdrawal Criteria|1
1365438|NCT01574703|4505740|P2|Overall Study|Met Withdrawal Criteria|1
1365439|NCT01574703|4505741|P1|Overall Study|Met Withdrawal Criteria|0
1365440|NCT01574703|4505738|P4|Overall Study|Withdrawal by Subject|61
1365441|NCT01574703|4505739|P3|Overall Study|Withdrawal by Subject|36
1365442|NCT01574703|4505740|P2|Overall Study|Withdrawal by Subject|52
1365443|NCT01574703|4505741|P1|Overall Study|Withdrawal by Subject|53
1365444|NCT01574703|4505738|P4|Overall Study|Unspecified Reason|16
1365445|NCT01574703|4505739|P3|Overall Study|Unspecified Reason|20
1365446|NCT01574703|4505740|P2|Overall Study|Unspecified Reason|15
1365447|NCT01574703|4505741|P1|Overall Study|Unspecified Reason|27
1365448|NCT01574703|4505738|P4|Overall Study|Protocol Violation|1
1365449|NCT01574703|4505739|P3|Overall Study|Protocol Violation|0
1365450|NCT01574703|4505740|P2|Overall Study|Protocol Violation|0
1365451|NCT01574703|4505741|P1|Overall Study|Protocol Violation|0
1365452|NCT01574703|4505738|P4|Overall Study|Adverse Event|1
1365453|NCT01574703|4505739|P3|Overall Study|Adverse Event|1
1365454|NCT01574703|4505740|P2|Overall Study|Adverse Event|2
1365455|NCT01574703|4505741|P1|Overall Study|Adverse Event|0
1365456|NCT01574651|4505785|P2|Overall Study|Withdrawal by Subject|10
1365457|NCT01574651|4505786|P1|Overall Study|Withdrawal by Subject|9
1365458|NCT01574651|4505785|P2|Overall Study|Protocol Violation|5
1365459|NCT01574651|4505786|P1|Overall Study|Protocol Violation|3
1365460|NCT01574651|4505785|P2|Overall Study|Unsatisfactory therapeutic effect|0
1365461|NCT01574651|4505786|P1|Overall Study|Unsatisfactory therapeutic effect|6
1365462|NCT01574651|4505785|P2|Overall Study|Abnormal test procedure result(s)|1
1365463|NCT01574651|4505786|P1|Overall Study|Abnormal test procedure result(s)|1
1365464|NCT01574651|4505785|P2|Overall Study|Abnormal laboratory value(s)|0
1365465|NCT01574651|4505786|P1|Overall Study|Abnormal laboratory value(s)|1
1365466|NCT01574651|4505785|P2|Overall Study|Adverse Event|27
1365467|NCT01574651|4505786|P1|Overall Study|Adverse Event|36
1365468|NCT01574651|4505785|P2|Overall Study|Patient's inability to use the device|1
1365469|NCT01574651|4505786|P1|Overall Study|Patient's inability to use the device|0
1365470|NCT01574651|4505785|P2|Overall Study|Death|3
1365471|NCT01574651|4505786|P1|Overall Study|Death|3
1365472|NCT01574651|4505785|P2|Overall Study|Administrative problems|1
1365473|NCT01574651|4505786|P1|Overall Study|Administrative problems|0
1365474|NCT01574651|4505785|P2|Overall Study|Lost to Follow-up|4
1365475|NCT01574651|4505786|P1|Overall Study|Lost to Follow-up|2
1365476|NCT01574612|4505808|P1|Overall Study|Lost to Follow-up|2
1365477|NCT01574612|4505808|P1|Overall Study|Withdrawal by Subject|1
1365478|NCT01574612|4505808|P1|Overall Study|non compliant with drug|2
1365479|NCT01574612|4505808|P1|Overall Study|Adverse Event|3
1365480|NCT01574326|4505814|P2|Overall Study|Other: Mainly kidney transplant|8
1365481|NCT01574326|4505815|P1|Overall Study|Other: Mainly kidney transplant|8
1365482|NCT01574326|4505814|P2|Overall Study|Adverse Event|3
1365483|NCT01574326|4505815|P1|Overall Study|Adverse Event|1
1365484|NCT01574326|4505814|P2|Overall Study|Physician Decision|3
1365485|NCT01574326|4505815|P1|Overall Study|Physician Decision|5
1365486|NCT01574326|4505814|P2|Overall Study|Withdrawal by Participant|4
1365487|NCT01574326|4505815|P1|Overall Study|Withdrawal by Participant|2
1365488|NCT01574326|4505814|P2|Overall Study|Randomized but not treated|1
1365489|NCT01574326|4505815|P1|Overall Study|Randomized but not treated|0
1365490|NCT01574248|4505828|P2|Overall Study|Missing primary endpoint data|0
1365491|NCT01574248|4505829|P1|Overall Study|Missing primary endpoint data|1
1365492|NCT01574248|4505828|P2|Overall Study|Withdrawal by Subject|0
1365493|NCT01574248|4505829|P1|Overall Study|Withdrawal by Subject|2
1365494|NCT01574079|4505873|P2|Overall Study|Lost to Follow-up|0
1365495|NCT01574079|4505874|P1|Overall Study|Lost to Follow-up|1
1365496|NCT01574079|4505873|P2|Overall Study|Physician Decision|2
1365497|NCT01574079|4505874|P1|Overall Study|Physician Decision|0
1365498|NCT01573910|4505886|P2|Overall Study|Patient decision unrelated to Advs Event|11
1365499|NCT01573910|4505887|P1|Overall Study|Patient decision unrelated to Advs Event|11
1365500|NCT01573910|4505886|P2|Overall Study|Protocol Violation|0
1365501|NCT01573910|4505887|P1|Overall Study|Protocol Violation|3
1365502|NCT01573910|4505886|P2|Overall Study|Withdrawal by Subject|1
1365503|NCT01573910|4505887|P1|Overall Study|Withdrawal by Subject|0
1365504|NCT01573910|4505886|P2|Overall Study|Lost to Follow-up|1
1365505|NCT01573910|4505887|P1|Overall Study|Lost to Follow-up|2
1365506|NCT01573910|4505886|P2|Overall Study|Adverse Event|4
1365507|NCT01573910|4505887|P1|Overall Study|Adverse Event|4
1365508|NCT01573767|4505899|P4|Overall Study|Withdrawal by Subject|0
1365509|NCT01573767|4505900|P3|Overall Study|Withdrawal by Subject|0
1365510|NCT01573767|4505901|P2|Overall Study|Withdrawal by Subject|1
1365511|NCT01573767|4505902|P1|Overall Study|Withdrawal by Subject|0
1365512|NCT01573767|4505899|P4|Overall Study|Physician Decision|2
1365513|NCT01573767|4505900|P3|Overall Study|Physician Decision|0
1365514|NCT01573767|4505901|P2|Overall Study|Physician Decision|2
1365515|NCT01573767|4505902|P1|Overall Study|Physician Decision|1
1365516|NCT01573767|4505899|P4|Overall Study|Lost to Follow-up|1
1365517|NCT01573767|4505900|P3|Overall Study|Lost to Follow-up|1
1365518|NCT01573767|4505901|P2|Overall Study|Lost to Follow-up|1
1365519|NCT01573767|4505902|P1|Overall Study|Lost to Follow-up|0
1365520|NCT01573767|4505899|P4|Overall Study|Protocol Violation|3
1365521|NCT01573767|4505900|P3|Overall Study|Protocol Violation|1
1365522|NCT01573767|4505901|P2|Overall Study|Protocol Violation|1
1365523|NCT01573767|4505902|P1|Overall Study|Protocol Violation|3
1365524|NCT01573767|4505899|P4|Overall Study|Lack of Efficacy|17
1365525|NCT01573767|4505900|P3|Overall Study|Lack of Efficacy|12
1365526|NCT01573767|4505901|P2|Overall Study|Lack of Efficacy|15
1365527|NCT01573767|4505902|P1|Overall Study|Lack of Efficacy|18
1365528|NCT01573767|4505899|P4|Overall Study|Adverse Event|1
1365529|NCT01573767|4505900|P3|Overall Study|Adverse Event|0
1365530|NCT01573767|4505901|P2|Overall Study|Adverse Event|1
1365531|NCT01573767|4505902|P1|Overall Study|Adverse Event|0
1365532|NCT01573624|4505936|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1365533|NCT01573624|4505937|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1365534|NCT01573624|4505938|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1365535|NCT01573624|4505939|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1365536|NCT01573624|4505940|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1365537|NCT01573624|4505941|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1365538|NCT01573624|4505942|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
1365539|NCT01573624|4505936|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1365540|NCT01573624|4505937|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
1365541|NCT01573624|4505938|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
1365542|NCT01573624|4505939|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1365543|NCT01573624|4505940|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1365544|NCT01573624|4505941|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1365545|NCT01573624|4505942|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1365546|NCT01573624|4505936|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1365547|NCT01573624|4505937|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1365548|NCT01573624|4505938|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1365549|NCT01573624|4505939|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1365550|NCT01573624|4505940|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1365551|NCT01573624|4505941|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1365552|NCT01573624|4505942|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
1365553|NCT01573624|4505936|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1365554|NCT01573624|4505937|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
1365555|NCT01573624|4505938|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1365556|NCT01573624|4505939|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1365557|NCT01573624|4505940|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1365558|NCT01573624|4505941|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
1365559|NCT01573624|4505942|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1365560|NCT01573624|4505936|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
1365561|NCT01573624|4505937|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
1365562|NCT01573624|4505938|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
1365563|NCT01573624|4505939|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
1365564|NCT01573624|4505940|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
1365565|NCT01573624|4505941|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
1365566|NCT01573624|4505942|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
1365567|NCT01573624|4505936|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
1365568|NCT01573624|4505937|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1365569|NCT01573624|4505938|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
1365570|NCT01573624|4505939|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1365571|NCT01573624|4505940|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1365572|NCT01573624|4505941|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1365573|NCT01573624|4505942|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
1365574|NCT01573624|4505936|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1365575|NCT01573624|4505937|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1365576|NCT01573624|4505938|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1365577|NCT01573624|4505939|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1365578|NCT01573624|4505940|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1365579|NCT01573624|4505941|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1365580|NCT01573624|4505942|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1365581|NCT01573624|4505936|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1365582|NCT01573624|4505937|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1365583|NCT01573624|4505938|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1365584|NCT01573624|4505939|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1365585|NCT01573624|4505940|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1365586|NCT01573624|4505941|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
1365587|NCT01573624|4505942|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1365588|NCT01573624|4505936|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1365589|NCT01573624|4505937|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1365590|NCT01573624|4505938|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1365591|NCT01573624|4505939|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1365592|NCT01573624|4505940|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1365593|NCT01573624|4505941|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
1365594|NCT01573624|4505942|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1365595|NCT01573624|4505936|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1365596|NCT01573624|4505937|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
1365597|NCT01573624|4505938|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1365598|NCT01573624|4505939|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1365599|NCT01573624|4505940|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1365600|NCT01573624|4505941|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1365601|NCT01573624|4505942|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
1365602|NCT01573624|4505936|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
1365603|NCT01573624|4505937|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1365604|NCT01573624|4505938|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1365605|NCT01573624|4505939|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1365606|NCT01573624|4505940|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1365607|NCT01573624|4505941|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1365608|NCT01573624|4505942|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
1365609|NCT01573624|4505936|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1365610|NCT01573624|4505937|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1365611|NCT01573624|4505938|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1365612|NCT01573624|4505939|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1365613|NCT01573624|4505940|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1365614|NCT01573624|4505941|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1365615|NCT01573624|4505942|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
1365616|NCT01573624|4505936|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1365617|NCT01573624|4505937|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
1365618|NCT01573624|4505938|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1365619|NCT01573624|4505939|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1365620|NCT01573624|4505940|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
1365621|NCT01573624|4505941|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
1365622|NCT01573624|4505942|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1365623|NCT01573624|4505936|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1365624|NCT01573624|4505937|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1365625|NCT01573624|4505938|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1365626|NCT01573624|4505939|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1365627|NCT01573624|4505940|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1365628|NCT01573624|4505941|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1365629|NCT01573624|4505942|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
1365630|NCT01573624|4505936|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1365631|NCT01573624|4505937|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
1365632|NCT01573624|4505938|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1365633|NCT01573624|4505939|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1365634|NCT01573624|4505940|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1365635|NCT01573624|4505941|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
1365636|NCT01573624|4505942|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1365637|NCT01573624|4505936|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
1365638|NCT01573624|4505937|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
1365639|NCT01573624|4505938|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
1365640|NCT01573624|4505939|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
1365641|NCT01573624|4505940|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
1365642|NCT01573624|4505941|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
1365643|NCT01573624|4505942|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
1365644|NCT01573624|4505936|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1365645|NCT01573624|4505937|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
1365646|NCT01573624|4505938|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1365647|NCT01573624|4505939|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
1365648|NCT01573624|4505940|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
1365649|NCT01573624|4505941|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1365650|NCT01573624|4505942|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1365651|NCT01573624|4505936|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1365652|NCT01573624|4505937|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1365653|NCT01573624|4505938|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1365654|NCT01573624|4505939|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
1365655|NCT01573624|4505940|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1365656|NCT01573624|4505941|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1365657|NCT01573624|4505942|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1365658|NCT01573624|4505936|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1365659|NCT01573624|4505937|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
1365660|NCT01573624|4505938|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1365661|NCT01573624|4505939|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1365662|NCT01573624|4505940|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1365663|NCT01573624|4505941|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1365664|NCT01573624|4505942|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1365665|NCT01573624|4505936|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1365666|NCT01573624|4505937|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1365667|NCT01573624|4505938|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1365668|NCT01573624|4505939|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
1365669|NCT01573624|4505940|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
1365670|NCT01573624|4505941|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1365671|NCT01573624|4505942|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
1365672|NCT01573624|4505936|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
1365673|NCT01573624|4505937|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
1365674|NCT01573624|4505938|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
1365675|NCT01573624|4505939|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
1365676|NCT01573624|4505940|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
1365677|NCT01573624|4505941|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
1365678|NCT01573624|4505942|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
1365679|NCT01573624|4505936|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1365680|NCT01573624|4505937|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
1365681|NCT01573624|4505938|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1365682|NCT01573624|4505939|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1365683|NCT01573624|4505940|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1365684|NCT01573624|4505941|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1365685|NCT01573624|4505942|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1365686|NCT01573624|4505936|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1365687|NCT01573624|4505937|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1365688|NCT01573624|4505938|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
1365689|NCT01573624|4505939|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1365690|NCT01573624|4505940|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1365691|NCT01573624|4505941|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
1365692|NCT01573624|4505942|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
1365693|NCT01573624|4505936|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1365694|NCT01573624|4505937|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
1365695|NCT01573624|4505938|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1365696|NCT01573624|4505939|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1365697|NCT01573624|4505940|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1365698|NCT01573624|4505941|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1365699|NCT01573624|4505942|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1365700|NCT01573624|4505936|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1365701|NCT01573624|4505937|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1365702|NCT01573624|4505938|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1365703|NCT01573624|4505939|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1365704|NCT01573624|4505940|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1365705|NCT01573624|4505941|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1365706|NCT01573624|4505942|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
1365707|NCT01573624|4505936|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
1365708|NCT01573624|4505937|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
1365709|NCT01573624|4505938|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
1365710|NCT01573624|4505939|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
1365711|NCT01573624|4505940|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
1365712|NCT01573624|4505941|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
1365713|NCT01573624|4505942|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
1365714|NCT01573624|4505936|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1365715|NCT01573624|4505937|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
1365716|NCT01573624|4505938|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1365717|NCT01573624|4505939|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1365718|NCT01573624|4505940|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
1365719|NCT01573624|4505941|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1365720|NCT01573624|4505942|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1365721|NCT01573000|4506031|P2|Long-Term Follow-Up|Lost to Follow-up|1
1365722|NCT01573000|4506032|P1|Long-Term Follow-Up|Lost to Follow-up|0
1365723|NCT01573000|4506031|P2|Long-Term Follow-Up|Death|0
1365724|NCT01573000|4506032|P1|Long-Term Follow-Up|Death|3
1365725|NCT01573000|4506031|P2|Crossover Phase|Death|3
1365726|NCT01573000|4506032|P1|Crossover Phase|Death|0
1365727|NCT01573000|4506031|P2|Crossover Phase|Lost to Follow-up|2
1365728|NCT01573000|4506032|P1|Crossover Phase|Lost to Follow-up|0
1365729|NCT01573000|4506031|P2|Crossover Phase|Lack of Efficacy|13
1365730|NCT01573000|4506032|P1|Crossover Phase|Lack of Efficacy|0
1365731|NCT01573000|4506031|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
1365732|NCT01573000|4506032|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
1365733|NCT01573000|4506031|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
1365734|NCT01573000|4506032|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
1365735|NCT01573000|4506031|P2|Dosimetric and Therapeutic Treatment|Death|1
1365736|NCT01573000|4506032|P1|Dosimetric and Therapeutic Treatment|Death|0
1365737|NCT01573000|4506031|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
1365738|NCT01573000|4506032|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
1365739|NCT01573000|4506031|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
1365740|NCT01573000|4506032|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
1365741|NCT01572948|4506128|P2|Overall Study|unable to contact|1
1365742|NCT01572948|4506129|P1|Overall Study|unable to contact|0
1365743|NCT01572948|4506128|P2|Overall Study|Lost to Follow-up|0
1365744|NCT01572948|4506129|P1|Overall Study|Lost to Follow-up|1
1365745|NCT01572844|4506145|P2|Overall Study|Physician Decision|1
1365746|NCT01572844|4506146|P1|Overall Study|Physician Decision|1
1365747|NCT01572792|4506164|P5|Extension Study|Site termination/COPD exacerbation/other|6
1365748|NCT01572792|4506165|P4|Extension Study|Site termination/COPD exacerbation/other|6
1365749|NCT01572792|4506166|P3|Extension Study|Site termination/COPD exacerbation/other|4
1365750|NCT01572792|4506167|P2|Extension Study|Site termination/COPD exacerbation/other|8
1365751|NCT01572792|4506168|P1|Extension Study|Site termination/COPD exacerbation/other|3
1365752|NCT01572792|4506164|P5|Extension Study|Adverse Event|4
1365753|NCT01572792|4506165|P4|Extension Study|Adverse Event|6
1365754|NCT01572792|4506166|P3|Extension Study|Adverse Event|5
1365755|NCT01572792|4506167|P2|Extension Study|Adverse Event|6
1365756|NCT01572792|4506168|P1|Extension Study|Adverse Event|7
1365757|NCT01572792|4506164|P5|Extension Study|Lack of Efficacy|2
1365758|NCT01572792|4506165|P4|Extension Study|Lack of Efficacy|2
1365759|NCT01572792|4506166|P3|Extension Study|Lack of Efficacy|3
1365760|NCT01572792|4506167|P2|Extension Study|Lack of Efficacy|3
1365761|NCT01572792|4506168|P1|Extension Study|Lack of Efficacy|2
1365762|NCT01572792|4506164|P5|Extension Study|Protocol Violation|3
1365763|NCT01572792|4506165|P4|Extension Study|Protocol Violation|4
1365764|NCT01572792|4506166|P3|Extension Study|Protocol Violation|3
1365765|NCT01572792|4506167|P2|Extension Study|Protocol Violation|4
1365766|NCT01572792|4506168|P1|Extension Study|Protocol Violation|0
1365767|NCT01572792|4506164|P5|Extension Study|Withdrawal by Subject|14
1365768|NCT01572792|4506165|P4|Extension Study|Withdrawal by Subject|8
1365769|NCT01572792|4506166|P3|Extension Study|Withdrawal by Subject|11
1365770|NCT01572792|4506167|P2|Extension Study|Withdrawal by Subject|6
1365771|NCT01572792|4506168|P1|Extension Study|Withdrawal by Subject|7
1365772|NCT01572792|4506164|P5|Extension Study|Lost to Follow-up|3
1365773|NCT01572792|4506165|P4|Extension Study|Lost to Follow-up|3
1365774|NCT01572792|4506166|P3|Extension Study|Lost to Follow-up|0
1365775|NCT01572792|4506167|P2|Extension Study|Lost to Follow-up|2
1365776|NCT01572792|4506168|P1|Extension Study|Lost to Follow-up|6
1365777|NCT01572792|4506164|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
1365778|NCT01572792|4506165|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
1365779|NCT01572792|4506166|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
1365780|NCT01572792|4506167|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
1365781|NCT01572792|4506168|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
1365782|NCT01572792|4506164|P5|Lead-in Study|Adverse Event|14
1365783|NCT01572792|4506165|P4|Lead-in Study|Adverse Event|16
1365784|NCT01572792|4506166|P3|Lead-in Study|Adverse Event|22
1365785|NCT01572792|4506167|P2|Lead-in Study|Adverse Event|21
1365786|NCT01572792|4506168|P1|Lead-in Study|Adverse Event|21
1365787|NCT01572792|4506164|P5|Lead-in Study|Lack of Efficacy|10
1365788|NCT01572792|4506165|P4|Lead-in Study|Lack of Efficacy|8
1365789|NCT01572792|4506166|P3|Lead-in Study|Lack of Efficacy|4
1365790|NCT01572792|4506167|P2|Lead-in Study|Lack of Efficacy|5
1365791|NCT01572792|4506168|P1|Lead-in Study|Lack of Efficacy|20
1365792|NCT01572792|4506164|P5|Lead-in Study|Protocol Violation|21
1365793|NCT01572792|4506165|P4|Lead-in Study|Protocol Violation|13
1365794|NCT01572792|4506166|P3|Lead-in Study|Protocol Violation|12
1365795|NCT01572792|4506167|P2|Lead-in Study|Protocol Violation|10
1365796|NCT01572792|4506168|P1|Lead-in Study|Protocol Violation|19
1365797|NCT01572792|4506164|P5|Lead-in Study|Withdrawal by Subject|11
1365798|NCT01572792|4506165|P4|Lead-in Study|Withdrawal by Subject|24
1365799|NCT01572792|4506166|P3|Lead-in Study|Withdrawal by Subject|12
1365800|NCT01572792|4506167|P2|Lead-in Study|Withdrawal by Subject|11
1365801|NCT01572792|4506168|P1|Lead-in Study|Withdrawal by Subject|22
1365802|NCT01572792|4506164|P5|Lead-in Study|Lost to Follow-up|4
1365803|NCT01572792|4506165|P4|Lead-in Study|Lost to Follow-up|2
1365804|NCT01572792|4506166|P3|Lead-in Study|Lost to Follow-up|4
1365805|NCT01572792|4506167|P2|Lead-in Study|Lost to Follow-up|9
1365806|NCT01572792|4506168|P1|Lead-in Study|Lost to Follow-up|5
1365807|NCT01572740|4506217|P2|Overall Study|unclassified|3
1365808|NCT01572740|4506218|P1|Overall Study|unclassified|4
1365809|NCT01572740|4506217|P2|Overall Study|Withdrawal by Subject|1
1365810|NCT01572740|4506218|P1|Overall Study|Withdrawal by Subject|1
1365811|NCT01572740|4506217|P2|Overall Study|Adverse Event|1
1365812|NCT01572740|4506218|P1|Overall Study|Adverse Event|1
1365813|NCT01572727|4506248|P2|Overall Study|Untreated|7
1365814|NCT01572727|4506249|P1|Overall Study|Untreated|4
1365815|NCT01572727|4506248|P2|Overall Study|Death|2
1365816|NCT01572727|4506249|P1|Overall Study|Death|2
1365817|NCT01572727|4506248|P2|Overall Study|Parent/guardian decision|9
1365818|NCT01572727|4506249|P1|Overall Study|Parent/guardian decision|14
1365819|NCT01572727|4506248|P2|Overall Study|Study terminated by sponsor|83
1365820|NCT01572727|4506249|P1|Overall Study|Study terminated by sponsor|61
1365821|NCT01572727|4506248|P2|Overall Study|Protocol Violation|1
1365822|NCT01572727|4506249|P1|Overall Study|Protocol Violation|0
1365823|NCT01572727|4506248|P2|Overall Study|Progressive disease|82
1365824|NCT01572727|4506249|P1|Overall Study|Progressive disease|59
1365825|NCT01572727|4506248|P2|Overall Study|Physician Decision|9
1365826|NCT01572727|4506249|P1|Overall Study|Physician Decision|23
1365827|NCT01572727|4506248|P2|Overall Study|Lost to Follow-up|1
1365828|NCT01572727|4506249|P1|Overall Study|Lost to Follow-up|1
1365829|NCT01572727|4506248|P2|Overall Study|Adverse Event|15
1365830|NCT01572727|4506249|P1|Overall Study|Adverse Event|43
1365831|NCT01572675|4506271|P2|Overall Study|Lost to Follow-up|27
1365832|NCT01572675|4506272|P1|Overall Study|Lost to Follow-up|22
1365833|NCT01572675|4506271|P2|Overall Study|Missing data|4
1365834|NCT01572675|4506272|P1|Overall Study|Missing data|1
1365835|NCT01572675|4506271|P2|Overall Study|Rheumatologist new evaluation|1
1365836|NCT01572675|4506272|P1|Overall Study|Rheumatologist new evaluation|0
1365837|NCT01572675|4506271|P2|Overall Study|Unknown reason|1
1365838|NCT01572675|4506272|P1|Overall Study|Unknown reason|1
1365839|NCT01572675|4506271|P2|Overall Study|Other disease detected|1
1365840|NCT01572675|4506272|P1|Overall Study|Other disease detected|1
1365841|NCT01572675|4506271|P2|Overall Study|Death unrelated to coxibs|1
1365842|NCT01572675|4506272|P1|Overall Study|Death unrelated to coxibs|1
1365843|NCT01572675|4506271|P2|Overall Study|Physician Decision|2
1365844|NCT01572675|4506272|P1|Overall Study|Physician Decision|2
1365845|NCT01572675|4506271|P2|Overall Study|Withdrawal by Subject|1
1365846|NCT01572675|4506272|P1|Overall Study|Withdrawal by Subject|5
1365847|NCT01572675|4506271|P2|Overall Study|Surgical intervention|6
1365848|NCT01572675|4506272|P1|Overall Study|Surgical intervention|3
1365849|NCT01572675|4506271|P2|Overall Study|Improved symptoms|2
1365850|NCT01572675|4506272|P1|Overall Study|Improved symptoms|8
1365851|NCT01572675|4506271|P2|Overall Study|Intolerance|5
1365852|NCT01572675|4506272|P1|Overall Study|Intolerance|6
1365853|NCT01572675|4506271|P2|Overall Study|Lack of Efficacy|31
1365854|NCT01572675|4506272|P1|Overall Study|Lack of Efficacy|31
1365855|NCT01572675|4506271|P2|Overall Study|Recovery|23
1365856|NCT01572675|4506272|P1|Overall Study|Recovery|16
1365857|NCT01572675|4506271|P2|Overall Study|End of prescribed treatment|118
1365858|NCT01572675|4506272|P1|Overall Study|End of prescribed treatment|140
1365859|NCT01572389|4506371|P2|Overall Study|Only A1C or Assessment was Collected|2
1365860|NCT01572389|4506372|P1|Overall Study|Only A1C or Assessment was Collected|6
1365861|NCT01572389|4506371|P2|Overall Study|Lost to Follow-up|14
1365862|NCT01572389|4506372|P1|Overall Study|Lost to Follow-up|25
1365863|NCT01572389|4506371|P2|Overall Study|Withdrawal by Subject|2
1365864|NCT01572389|4506372|P1|Overall Study|Withdrawal by Subject|14
1365865|NCT01572389|4506371|P2|Overall Study|Death|3
1365866|NCT01572389|4506372|P1|Overall Study|Death|1
1365867|NCT01571453|4506413|P2|Overall Study|Administrative or other reason(s)|3
1365868|NCT01571453|4506414|P1|Overall Study|Administrative or other reason(s)|4
1365869|NCT01571453|4506413|P2|Overall Study|Lost to Follow-up|2
1365870|NCT01571453|4506414|P1|Overall Study|Lost to Follow-up|4
1365871|NCT01571453|4506413|P2|Overall Study|Withdrawal of consent|13
1365872|NCT01571453|4506414|P1|Overall Study|Withdrawal of consent|5
1365873|NCT01571453|4506413|P2|Overall Study|Protocol Violation|5
1365874|NCT01571453|4506414|P1|Overall Study|Protocol Violation|1
1365875|NCT01571453|4506413|P2|Overall Study|Non-compliance|4
1365876|NCT01571453|4506414|P1|Overall Study|Non-compliance|2
1365877|NCT01571453|4506413|P2|Overall Study|Lack of Efficacy|3
1365878|NCT01571453|4506414|P1|Overall Study|Lack of Efficacy|8
1365879|NCT01571453|4506413|P2|Overall Study|Adverse Event|32
1365880|NCT01571453|4506414|P1|Overall Study|Adverse Event|14
1365881|NCT01571362|4506430|P3|Double-Blind Treatment Period|Other - unspecified|1
1365882|NCT01571362|4506431|P2|Double-Blind Treatment Period|Other - unspecified|6
1365883|NCT01571362|4506432|P1|Double-Blind Treatment Period|Other - unspecified|0
1365884|NCT01571362|4506430|P3|Double-Blind Treatment Period|Insufficient clinical response|4
1365885|NCT01571362|4506431|P2|Double-Blind Treatment Period|Insufficient clinical response|16
1365886|NCT01571362|4506432|P1|Double-Blind Treatment Period|Insufficient clinical response|0
1365887|NCT01571362|4506430|P3|Double-Blind Treatment Period|Lost to Follow-up|6
1365888|NCT01571362|4506431|P2|Double-Blind Treatment Period|Lost to Follow-up|3
1365889|NCT01571362|4506432|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1365890|NCT01571362|4506430|P3|Double-Blind Treatment Period|Adverse Event|14
1365891|NCT01571362|4506431|P2|Double-Blind Treatment Period|Adverse Event|9
1365892|NCT01571362|4506432|P1|Double-Blind Treatment Period|Adverse Event|0
1365893|NCT01571362|4506430|P3|Double-Blind Treatment Period|Protocol Violation|9
1365894|NCT01571362|4506431|P2|Double-Blind Treatment Period|Protocol Violation|8
1365895|NCT01571362|4506432|P1|Double-Blind Treatment Period|Protocol Violation|0
1365896|NCT01571362|4506430|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
1365897|NCT01571362|4506431|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
1365898|NCT01571362|4506432|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
1365899|NCT01571362|4506430|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
1365900|NCT01571362|4506431|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
1365901|NCT01571362|4506432|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
1365902|NCT01571362|4506430|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
1365903|NCT01571362|4506431|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
1365904|NCT01571362|4506432|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
1365905|NCT01571362|4506430|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
1365906|NCT01571362|4506431|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
1365907|NCT01571362|4506432|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
1365908|NCT01571362|4506430|P3|Open-Label Conversion + Titration Period|Adverse Event|0
1365909|NCT01571362|4506431|P2|Open-Label Conversion + Titration Period|Adverse Event|0
1365910|NCT01571362|4506432|P1|Open-Label Conversion + Titration Period|Adverse Event|57
1365911|NCT01571362|4506430|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
1365912|NCT01571362|4506431|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
1365913|NCT01571362|4506432|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
1365914|NCT01571362|4506430|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
1365915|NCT01571362|4506431|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
1365916|NCT01571362|4506432|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
1365917|NCT01571284|4506602|P1|Overall Study|Other than specified above|80
1365918|NCT01571284|4506602|P1|Overall Study|Enrolled but not treated|2
1365919|NCT01571284|4506602|P1|Overall Study|Lost to Follow-up|3
1365920|NCT01571284|4506602|P1|Overall Study|Participant's decision|84
1365921|NCT01571232|4506625|P2|Overall Study|Withdrawal by Subject|0
1365922|NCT01571232|4506626|P1|Overall Study|Withdrawal by Subject|1
1365923|NCT01571232|4506625|P2|Overall Study|Lost to Follow-up|1
1365924|NCT01571232|4506626|P1|Overall Study|Lost to Follow-up|0
1365925|NCT01570751|4506638|P2|Period B (16 Weeks)|Protocol Violation|1
1365926|NCT01570751|4506639|P1|Period B (16 Weeks)|Protocol Violation|0
1365927|NCT01570751|4506638|P2|Period B (16 Weeks)|Adverse Event|0
1365928|NCT01570751|4506639|P1|Period B (16 Weeks)|Adverse Event|1
1365929|NCT01570751|4506638|P2|Period A (16 Weeks)|Unclassified|3
1365930|NCT01570751|4506639|P1|Period A (16 Weeks)|Unclassified|2
1365931|NCT01570751|4506638|P2|Period A (16 Weeks)|Withdrawal criteria|1
1365932|NCT01570751|4506639|P1|Period A (16 Weeks)|Withdrawal criteria|0
1365933|NCT01570751|4506638|P2|Period A (16 Weeks)|Protocol Violation|1
1365934|NCT01570751|4506639|P1|Period A (16 Weeks)|Protocol Violation|1
1365935|NCT01570686|4506657|P2|Overall Study|Unsatisfactory therapeutic effect|1
1365936|NCT01570686|4506658|P1|Overall Study|Unsatisfactory therapeutic effect|2
1365937|NCT01570686|4506657|P2|Overall Study|Withdrawal by Subject|4
1365938|NCT01570686|4506658|P1|Overall Study|Withdrawal by Subject|4
1365939|NCT01570686|4506657|P2|Overall Study|Protocol Deviation|0
1365940|NCT01570686|4506658|P1|Overall Study|Protocol Deviation|3
1365941|NCT01570686|4506657|P2|Overall Study|Lost to Follow-up|3
1365942|NCT01570686|4506658|P1|Overall Study|Lost to Follow-up|4
1365943|NCT01570686|4506657|P2|Overall Study|Adverse Event|6
1365944|NCT01570686|4506658|P1|Overall Study|Adverse Event|8
1365945|NCT01570686|4506657|P2|Overall Study|Administrative problems|1
1365946|NCT01570686|4506658|P1|Overall Study|Administrative problems|0
1365947|NCT01570686|4506657|P2|Overall Study|Abnormal test procedure result(s)|1
1365948|NCT01570686|4506658|P1|Overall Study|Abnormal test procedure result(s)|1
1365949|NCT01570309|4506694|P2|Overall Study|Withdrawal by Subject|3
1365950|NCT01570309|4506695|P1|Overall Study|Withdrawal by Subject|3
1365951|NCT01570244|4506709|P1|Microgynon+Faldaprevir|Adverse Event|1
1365952|NCT01570192|4506731|P2|Overall Study|Physician Decision|1
1365953|NCT01570192|4506732|P1|Overall Study|Physician Decision|0
1365954|NCT01570192|4506731|P2|Overall Study|changed to palliative care|0
1365955|NCT01570192|4506732|P1|Overall Study|changed to palliative care|1
1365956|NCT01570192|4506731|P2|Overall Study|no qualifying organism|12
1365957|NCT01570192|4506732|P1|Overall Study|no qualifying organism|6
1365958|NCT01569841|4506770|P2|Period A (6 Weeks)|Withdrawal by Subject|1
1365959|NCT01569841|4506771|P1|Period A (6 Weeks)|Withdrawal by Subject|0
1365960|NCT01569763|4506860|P2|Overall Study|Adverse Event|0
1365961|NCT01569763|4506861|P1|Overall Study|Adverse Event|1
1365962|NCT01569763|4506860|P2|Overall Study|Lack of Efficacy|7
1365963|NCT01569763|4506861|P1|Overall Study|Lack of Efficacy|2
1365964|NCT01569568|4506898|P2|Overall Study|Physician Decision|2
1365965|NCT01569568|4506899|P1|Overall Study|Physician Decision|0
1365966|NCT01569464|4506922|P2|Overall Study|Other|1
1365967|NCT01569464|4506923|P1|Overall Study|Other|1
1365968|NCT01569464|4506922|P2|Overall Study|Withdrawal by Subject|1
1365969|NCT01569464|4506923|P1|Overall Study|Withdrawal by Subject|1
1365970|NCT01569464|4506922|P2|Overall Study|Lost to Follow-up|3
1365971|NCT01569464|4506923|P1|Overall Study|Lost to Follow-up|2
1365972|NCT01569464|4506922|P2|Overall Study|Protocol Violation|0
1365973|NCT01569464|4506923|P1|Overall Study|Protocol Violation|1
1365974|NCT01569464|4506922|P2|Overall Study|Lack of Efficacy|0
1365975|NCT01569464|4506923|P1|Overall Study|Lack of Efficacy|1
1365976|NCT01569464|4506922|P2|Overall Study|Adverse Event|0
1365977|NCT01569464|4506923|P1|Overall Study|Adverse Event|4
1365978|NCT01569438|4506990|P2|Overall Study|Protocol Violation|0
1365979|NCT01569438|4506991|P1|Overall Study|Protocol Violation|1
1365980|NCT01569438|4506990|P2|Overall Study|Withdrawal by Subject|1
1365981|NCT01569438|4506991|P1|Overall Study|Withdrawal by Subject|0
1365982|NCT01569438|4506990|P2|Overall Study|Lack of Efficacy|1
1365983|NCT01569438|4506991|P1|Overall Study|Lack of Efficacy|1
1365984|NCT01569438|4506990|P2|Overall Study|Adverse Event|7
1365985|NCT01569438|4506991|P1|Overall Study|Adverse Event|0
1365986|NCT01569295|4507005|P2|Overall Study|Lost to Follow-up|0
1365987|NCT01569295|4507006|P1|Overall Study|Lost to Follow-up|1
1365988|NCT01569295|4507005|P2|Overall Study|Other Anticancer/Experimental Therapy|1
1365989|NCT01569295|4507006|P1|Overall Study|Other Anticancer/Experimental Therapy|2
1365990|NCT01569295|4507005|P2|Overall Study|Noncompliance with Study Drug|0
1365991|NCT01569295|4507006|P1|Overall Study|Noncompliance with Study Drug|3
1365992|NCT01569295|4507005|P2|Overall Study|Other|3
1365993|NCT01569295|4507006|P1|Overall Study|Other|4
1365994|NCT01569295|4507005|P2|Overall Study|Physician Decision|19
1365995|NCT01569295|4507006|P1|Overall Study|Physician Decision|7
1365996|NCT01569295|4507005|P2|Overall Study|Withdrawal by Subject|8
1365997|NCT01569295|4507006|P1|Overall Study|Withdrawal by Subject|20
1365998|NCT01569295|4507005|P2|Overall Study|Adverse Event|13
1365999|NCT01569295|4507006|P1|Overall Study|Adverse Event|27
1366000|NCT01569295|4507005|P2|Overall Study|Ongoing in Study|23
1366001|NCT01569295|4507006|P1|Overall Study|Ongoing in Study|70
1366002|NCT01569152|4507043|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
1366003|NCT01569152|4507044|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
1366004|NCT01569152|4507045|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
1366005|NCT01569152|4507043|P3|Safety Extension, Period 3|Physician Decision|2
1366006|NCT01569152|4507044|P2|Safety Extension, Period 3|Physician Decision|0
1366007|NCT01569152|4507045|P1|Safety Extension, Period 3|Physician Decision|0
1366008|NCT01569152|4507043|P3|Safety Extension, Period 3|Withdrawal by Subject|2
1366009|NCT01569152|4507044|P2|Safety Extension, Period 3|Withdrawal by Subject|0
1366010|NCT01569152|4507045|P1|Safety Extension, Period 3|Withdrawal by Subject|0
1366011|NCT01569152|4507043|P3|Safety Extension, Period 3|Adverse Event|4
1366012|NCT01569152|4507044|P2|Safety Extension, Period 3|Adverse Event|0
1366013|NCT01569152|4507045|P1|Safety Extension, Period 3|Adverse Event|0
1366014|NCT01569152|4507043|P3|Phase IIa, Period 1|Withdrawal by Subject|0
1366015|NCT01569152|4507044|P2|Phase IIa, Period 1|Withdrawal by Subject|1
1366016|NCT01569152|4507045|P1|Phase IIa, Period 1|Withdrawal by Subject|2
1366017|NCT01569152|4507043|P3|Phase IIa, Period 1|Protocol Violation|0
1366018|NCT01569152|4507044|P2|Phase IIa, Period 1|Protocol Violation|1
1366019|NCT01569152|4507045|P1|Phase IIa, Period 1|Protocol Violation|0
1366020|NCT01569152|4507043|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
1366021|NCT01569152|4507044|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
1366022|NCT01569152|4507045|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
1366023|NCT01569152|4507043|P3|Phase IIa, Period 1|Lost to Follow-up|0
1366024|NCT01569152|4507044|P2|Phase IIa, Period 1|Lost to Follow-up|0
1366025|NCT01569152|4507045|P1|Phase IIa, Period 1|Lost to Follow-up|1
1366026|NCT01569152|4507043|P3|Phase IIa, Period 1|Adverse Event|0
1366027|NCT01569152|4507044|P2|Phase IIa, Period 1|Adverse Event|0
1366028|NCT01569152|4507045|P1|Phase IIa, Period 1|Adverse Event|4
1366029|NCT01569152|4507043|P3|Phase IIa, Period 1|Early Escape|0
1366030|NCT01569152|4507044|P2|Phase IIa, Period 1|Early Escape|22
1366031|NCT01569152|4507045|P1|Phase IIa, Period 1|Early Escape|5
1366032|NCT01569074|4507181|P5|Overall Study|Adverse Event|0
1366033|NCT01569074|4507182|P4|Overall Study|Adverse Event|0
1366034|NCT01569074|4507183|P3|Overall Study|Adverse Event|3
1366035|NCT01569074|4507184|P2|Overall Study|Adverse Event|0
1366036|NCT01569074|4507185|P1|Overall Study|Adverse Event|1
1366037|NCT01569074|4507181|P5|Overall Study|eg change in circumstances|1
1366038|NCT01569074|4507182|P4|Overall Study|eg change in circumstances|1
1366039|NCT01569074|4507183|P3|Overall Study|eg change in circumstances|0
1366040|NCT01569074|4507184|P2|Overall Study|eg change in circumstances|2
1366041|NCT01569074|4507185|P1|Overall Study|eg change in circumstances|0
1366042|NCT01569074|4507181|P5|Overall Study|Severe non-compliance to protocol|0
1366043|NCT01569074|4507182|P4|Overall Study|Severe non-compliance to protocol|0
1366044|NCT01569074|4507183|P3|Overall Study|Severe non-compliance to protocol|1
1366045|NCT01569074|4507184|P2|Overall Study|Severe non-compliance to protocol|0
1366046|NCT01569074|4507185|P1|Overall Study|Severe non-compliance to protocol|0
1366047|NCT01569074|4507181|P5|Overall Study|Study-specific discontinuation criteria|0
1366048|NCT01569074|4507182|P4|Overall Study|Study-specific discontinuation criteria|0
1366049|NCT01569074|4507183|P3|Overall Study|Study-specific discontinuation criteria|0
1366050|NCT01569074|4507184|P2|Overall Study|Study-specific discontinuation criteria|1
1366051|NCT01569074|4507185|P1|Overall Study|Study-specific discontinuation criteria|0
1366052|NCT01569074|4507181|P5|Overall Study|Study stopped|7
1366053|NCT01569074|4507182|P4|Overall Study|Study stopped|7
1366054|NCT01569074|4507183|P3|Overall Study|Study stopped|8
1366055|NCT01569074|4507184|P2|Overall Study|Study stopped|6
1366056|NCT01569074|4507185|P1|Overall Study|Study stopped|6
1366057|NCT01569022|4507241|P2|Second Intervention|Lost to Follow-up|2
1366058|NCT01569022|4507242|P1|Second Intervention|Lost to Follow-up|2
1366059|NCT01569022|4507241|P2|First Intervention|Lost to Follow-up|1
1366060|NCT01569022|4507242|P1|First Intervention|Lost to Follow-up|2
1366061|NCT01568892|4507278|P2|Open-label Phase|Lost to Follow-up|1
1366062|NCT01568892|4507279|P1|Open-label Phase|Lost to Follow-up|0
1366063|NCT01568892|4507278|P2|Open-label Phase|Lack of Efficacy|2
1366064|NCT01568892|4507279|P1|Open-label Phase|Lack of Efficacy|4
1366065|NCT01568892|4507278|P2|Open-label Phase|Adverse Event|0
1366066|NCT01568892|4507279|P1|Open-label Phase|Adverse Event|2
1366067|NCT01568866|4507349|P2|Overall Study|Randomized but Not Dosed|1
1366068|NCT01568866|4507350|P1|Overall Study|Randomized but Not Dosed|9
1366069|NCT01568866|4507349|P2|Overall Study|Lost to Follow-up|0
1366070|NCT01568866|4507350|P1|Overall Study|Lost to Follow-up|1
1366071|NCT01568866|4507349|P2|Overall Study|Protocol Non-compliance|4
1366072|NCT01568866|4507350|P1|Overall Study|Protocol Non-compliance|2
1366073|NCT01568866|4507349|P2|Overall Study|Death|18
1366074|NCT01568866|4507350|P1|Overall Study|Death|10
1366075|NCT01568866|4507349|P2|Overall Study|Withdrawal by Subject|11
1366076|NCT01568866|4507350|P1|Overall Study|Withdrawal by Subject|19
1366077|NCT01568866|4507349|P2|Overall Study|Physician Decision|32
1366078|NCT01568866|4507350|P1|Overall Study|Physician Decision|40
1366079|NCT01568866|4507349|P2|Overall Study|Patient Request|71
1366080|NCT01568866|4507350|P1|Overall Study|Patient Request|55
1366081|NCT01568866|4507349|P2|Overall Study|Adverse Event|96
1366082|NCT01568866|4507350|P1|Overall Study|Adverse Event|94
1366083|NCT01568866|4507349|P2|Overall Study|Disease Progression|183
1366084|NCT01568866|4507350|P1|Overall Study|Disease Progression|208
1366085|NCT01568593|4507381|P2|Overall Study|Adverse Event|2
1366086|NCT01568593|4507382|P1|Overall Study|Adverse Event|3
1366087|NCT01568593|4507381|P2|Overall Study|Lack of Efficacy|1
1366088|NCT01568593|4507382|P1|Overall Study|Lack of Efficacy|4
1366089|NCT01568112|4507402|P4|Overall Study|Withdrawal by Physician|1
1366090|NCT01568112|4507403|P3|Overall Study|Withdrawal by Physician|1
1366091|NCT01568112|4507404|P2|Overall Study|Withdrawal by Physician|0
1366092|NCT01568112|4507405|P1|Overall Study|Withdrawal by Physician|1
1366093|NCT01568112|4507402|P4|Overall Study|Withdrawal by Subject|7
1366094|NCT01568112|4507403|P3|Overall Study|Withdrawal by Subject|0
1366095|NCT01568112|4507404|P2|Overall Study|Withdrawal by Subject|3
1366096|NCT01568112|4507405|P1|Overall Study|Withdrawal by Subject|2
1366097|NCT01568112|4507402|P4|Overall Study|Lost to Follow-up|1
1366098|NCT01568112|4507403|P3|Overall Study|Lost to Follow-up|0
1366099|NCT01568112|4507404|P2|Overall Study|Lost to Follow-up|0
1366100|NCT01568112|4507405|P1|Overall Study|Lost to Follow-up|0
1366101|NCT01568112|4507402|P4|Overall Study|Withdrew due to Adverse Event|3
1366102|NCT01568112|4507403|P3|Overall Study|Withdrew due to Adverse Event|6
1366103|NCT01568112|4507404|P2|Overall Study|Withdrew due to Adverse Event|4
1366104|NCT01568112|4507405|P1|Overall Study|Withdrew due to Adverse Event|2
1366105|NCT01568112|4507402|P4|Overall Study|Randomized But Not Treated|0
1366106|NCT01568112|4507403|P3|Overall Study|Randomized But Not Treated|0
1366107|NCT01568112|4507404|P2|Overall Study|Randomized But Not Treated|1
1366108|NCT01568112|4507405|P1|Overall Study|Randomized But Not Treated|0
1366109|NCT01568047|4507563|P4|Overall Study|Adverse Event|1
1366110|NCT01568047|4507564|P3|Overall Study|Adverse Event|1
1366111|NCT01568047|4507565|P2|Overall Study|Adverse Event|0
1366112|NCT01568047|4507566|P1|Overall Study|Adverse Event|0
1366113|NCT01568047|4507563|P4|Overall Study|Withdrawal by Subject|0
1366114|NCT01568047|4507564|P3|Overall Study|Withdrawal by Subject|0
1366115|NCT01568047|4507565|P2|Overall Study|Withdrawal by Subject|1
1366116|NCT01568047|4507566|P1|Overall Study|Withdrawal by Subject|0
1366117|NCT01568047|4507563|P4|Overall Study|Ineligibility|0
1366118|NCT01568047|4507564|P3|Overall Study|Ineligibility|0
1366119|NCT01568047|4507565|P2|Overall Study|Ineligibility|0
1366120|NCT01568047|4507566|P1|Overall Study|Ineligibility|1
1366121|NCT01568034|4507584|P4|Overall Study|Withdrawal by Subject|0
1366122|NCT01568034|4507585|P3|Overall Study|Withdrawal by Subject|0
1366123|NCT01568034|4507586|P2|Overall Study|Withdrawal by Subject|0
1366124|NCT01568034|4507587|P1|Overall Study|Withdrawal by Subject|1
1366125|NCT01567852|4507634|P2|Overall Study|ECT discontinued|1
1366126|NCT01567852|4507635|P1|Overall Study|ECT discontinued|1
1366127|NCT01567852|4507634|P2|Overall Study|Withdrawal by Subject|6
1366128|NCT01567852|4507635|P1|Overall Study|Withdrawal by Subject|3
1366129|NCT01567826|4507653|P2|Overall Study|Lost to Follow-up|2
1366130|NCT01567826|4507654|P1|Overall Study|Lost to Follow-up|3
1366131|NCT01567527|4507680|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
1366132|NCT01567527|4507681|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
1366133|NCT01567527|4507682|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1366134|NCT01567527|4507683|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1366135|NCT01567527|4507684|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1366136|NCT01567527|4507680|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
1366137|NCT01567527|4507681|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
1366138|NCT01567527|4507682|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
1366139|NCT01567527|4507683|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
1366140|NCT01567527|4507684|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
1366141|NCT01567527|4507680|P5|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
1366142|NCT01567527|4507681|P4|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
1366143|NCT01567527|4507682|P3|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
1366144|NCT01567527|4507683|P2|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
1366145|NCT01567527|4507684|P1|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
1366146|NCT01567527|4507680|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
1366147|NCT01567527|4507681|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
1366148|NCT01567527|4507682|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1366149|NCT01567527|4507683|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1366150|NCT01567527|4507684|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1366151|NCT01567527|4507680|P5|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
1366152|NCT01567527|4507681|P4|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
1366153|NCT01567527|4507682|P3|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
1366154|NCT01567527|4507683|P2|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
1366155|NCT01567527|4507684|P1|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
1366156|NCT01567527|4507680|P5|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
1366157|NCT01567527|4507681|P4|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
1366158|NCT01567527|4507682|P3|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
1366159|NCT01567527|4507683|P2|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
1366160|NCT01567527|4507684|P1|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
1366161|NCT01567527|4507680|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
1366162|NCT01567527|4507681|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
1366163|NCT01567527|4507682|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
1366164|NCT01567527|4507683|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
1366165|NCT01567527|4507684|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
1366166|NCT01567527|4507680|P5|Double-blind, Placebo-controlled Phase|Protocol deviation|1
1366167|NCT01567527|4507681|P4|Double-blind, Placebo-controlled Phase|Protocol deviation|1
1366168|NCT01567527|4507682|P3|Double-blind, Placebo-controlled Phase|Protocol deviation|0
1366169|NCT01567527|4507683|P2|Double-blind, Placebo-controlled Phase|Protocol deviation|0
1366170|NCT01567527|4507684|P1|Double-blind, Placebo-controlled Phase|Protocol deviation|0
1366171|NCT01567527|4507680|P5|IM Depot Stabilization.|Withdrawn by the investigator|0
1366172|NCT01567527|4507681|P4|IM Depot Stabilization.|Withdrawn by the investigator|0
1366173|NCT01567527|4507682|P3|IM Depot Stabilization.|Withdrawn by the investigator|6
1366174|NCT01567527|4507683|P2|IM Depot Stabilization.|Withdrawn by the investigator|0
1366175|NCT01567527|4507684|P1|IM Depot Stabilization.|Withdrawn by the investigator|0
1366176|NCT01567527|4507680|P5|IM Depot Stabilization.|Adverse Event|0
1366177|NCT01567527|4507681|P4|IM Depot Stabilization.|Adverse Event|0
1366178|NCT01567527|4507682|P3|IM Depot Stabilization.|Adverse Event|37
1366179|NCT01567527|4507683|P2|IM Depot Stabilization.|Adverse Event|0
1366180|NCT01567527|4507684|P1|IM Depot Stabilization.|Adverse Event|0
1366181|NCT01567527|4507680|P5|IM Depot Stabilization.|Lack of Efficacy|0
1366182|NCT01567527|4507681|P4|IM Depot Stabilization.|Lack of Efficacy|0
1366183|NCT01567527|4507682|P3|IM Depot Stabilization.|Lack of Efficacy|7
1366184|NCT01567527|4507683|P2|IM Depot Stabilization.|Lack of Efficacy|0
1366185|NCT01567527|4507684|P1|IM Depot Stabilization.|Lack of Efficacy|0
1366186|NCT01567527|4507680|P5|IM Depot Stabilization.|Lost to Follow-up|0
1366187|NCT01567527|4507681|P4|IM Depot Stabilization.|Lost to Follow-up|0
1366188|NCT01567527|4507682|P3|IM Depot Stabilization.|Lost to Follow-up|21
1366189|NCT01567527|4507683|P2|IM Depot Stabilization.|Lost to Follow-up|0
1366190|NCT01567527|4507684|P1|IM Depot Stabilization.|Lost to Follow-up|0
1366191|NCT01567527|4507680|P5|IM Depot Stabilization.|Sponsor discontinued study|0
1366192|NCT01567527|4507681|P4|IM Depot Stabilization.|Sponsor discontinued study|0
1366193|NCT01567527|4507682|P3|IM Depot Stabilization.|Sponsor discontinued study|1
1366194|NCT01567527|4507683|P2|IM Depot Stabilization.|Sponsor discontinued study|0
1366195|NCT01567527|4507684|P1|IM Depot Stabilization.|Sponsor discontinued study|0
1366196|NCT01567527|4507680|P5|IM Depot Stabilization.|Withdrawal by Subject|0
1366197|NCT01567527|4507681|P4|IM Depot Stabilization.|Withdrawal by Subject|0
1366198|NCT01567527|4507682|P3|IM Depot Stabilization.|Withdrawal by Subject|56
1366199|NCT01567527|4507683|P2|IM Depot Stabilization.|Withdrawal by Subject|0
1366200|NCT01567527|4507684|P1|IM Depot Stabilization.|Withdrawal by Subject|0
1366201|NCT01567527|4507680|P5|IM Depot Stabilization.|Met withdrawal criteria|0
1366202|NCT01567527|4507681|P4|IM Depot Stabilization.|Met withdrawal criteria|0
1366203|NCT01567527|4507682|P3|IM Depot Stabilization.|Met withdrawal criteria|26
1366204|NCT01567527|4507683|P2|IM Depot Stabilization.|Met withdrawal criteria|0
1366205|NCT01567527|4507684|P1|IM Depot Stabilization.|Met withdrawal criteria|0
1366206|NCT01567527|4507680|P5|IM Depot Stabilization.|Protocol deviation|0
1366207|NCT01567527|4507681|P4|IM Depot Stabilization.|Protocol deviation|0
1366208|NCT01567527|4507682|P3|IM Depot Stabilization.|Protocol deviation|5
1366209|NCT01567527|4507683|P2|IM Depot Stabilization.|Protocol deviation|0
1366210|NCT01567527|4507684|P1|IM Depot Stabilization.|Protocol deviation|0
1366211|NCT01567527|4507680|P5|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1366212|NCT01567527|4507681|P4|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1366213|NCT01567527|4507682|P3|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1366214|NCT01567527|4507683|P2|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
1366215|NCT01567527|4507684|P1|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1366216|NCT01567527|4507680|P5|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1366217|NCT01567527|4507681|P4|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1366218|NCT01567527|4507682|P3|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1366219|NCT01567527|4507683|P2|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
1366220|NCT01567527|4507684|P1|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1366221|NCT01567527|4507680|P5|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1366222|NCT01567527|4507681|P4|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1366223|NCT01567527|4507682|P3|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1366224|NCT01567527|4507683|P2|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
1366225|NCT01567527|4507684|P1|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1366226|NCT01567527|4507680|P5|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1366227|NCT01567527|4507681|P4|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1366228|NCT01567527|4507682|P3|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1366229|NCT01567527|4507683|P2|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
1366230|NCT01567527|4507684|P1|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1366231|NCT01567527|4507680|P5|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1366232|NCT01567527|4507681|P4|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1366233|NCT01567527|4507682|P3|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1366234|NCT01567527|4507683|P2|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
1366235|NCT01567527|4507684|P1|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1366236|NCT01567527|4507680|P5|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1366237|NCT01567527|4507681|P4|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1366238|NCT01567527|4507682|P3|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1366239|NCT01567527|4507683|P2|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
1366240|NCT01567527|4507684|P1|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1366241|NCT01567527|4507680|P5|Conversion Phase.|Withdrawn by the investigator|0
1366242|NCT01567527|4507681|P4|Conversion Phase.|Withdrawn by the investigator|0
1366243|NCT01567527|4507682|P3|Conversion Phase.|Withdrawn by the investigator|0
1366244|NCT01567527|4507683|P2|Conversion Phase.|Withdrawn by the investigator|0
1366245|NCT01567527|4507684|P1|Conversion Phase.|Withdrawn by the investigator|3
1366246|NCT01567527|4507680|P5|Conversion Phase.|Adverse Event|0
1366247|NCT01567527|4507681|P4|Conversion Phase.|Adverse Event|0
1366248|NCT01567527|4507682|P3|Conversion Phase.|Adverse Event|0
1366249|NCT01567527|4507683|P2|Conversion Phase.|Adverse Event|0
1366250|NCT01567527|4507684|P1|Conversion Phase.|Adverse Event|33
1366251|NCT01567527|4507680|P5|Conversion Phase.|Lack of Efficacy|0
1366252|NCT01567527|4507681|P4|Conversion Phase.|Lack of Efficacy|0
1366253|NCT01567527|4507682|P3|Conversion Phase.|Lack of Efficacy|0
1366254|NCT01567527|4507683|P2|Conversion Phase.|Lack of Efficacy|0
1366255|NCT01567527|4507684|P1|Conversion Phase.|Lack of Efficacy|2
1366256|NCT01567527|4507680|P5|Conversion Phase.|Lost to Follow-up|0
1366257|NCT01567527|4507681|P4|Conversion Phase.|Lost to Follow-up|0
1366258|NCT01567527|4507682|P3|Conversion Phase.|Lost to Follow-up|0
1366259|NCT01567527|4507683|P2|Conversion Phase.|Lost to Follow-up|0
1366260|NCT01567527|4507684|P1|Conversion Phase.|Lost to Follow-up|16
1366261|NCT01567527|4507680|P5|Conversion Phase.|Withdrawal by Subject|0
1366262|NCT01567527|4507681|P4|Conversion Phase.|Withdrawal by Subject|0
1366263|NCT01567527|4507682|P3|Conversion Phase.|Withdrawal by Subject|0
1366264|NCT01567527|4507683|P2|Conversion Phase.|Withdrawal by Subject|0
1366265|NCT01567527|4507684|P1|Conversion Phase.|Withdrawal by Subject|32
1366266|NCT01567527|4507680|P5|Conversion Phase.|Met withdrawal criteria|0
1366267|NCT01567527|4507681|P4|Conversion Phase.|Met withdrawal criteria|0
1366268|NCT01567527|4507682|P3|Conversion Phase.|Met withdrawal criteria|0
1366269|NCT01567527|4507683|P2|Conversion Phase.|Met withdrawal criteria|0
1366270|NCT01567527|4507684|P1|Conversion Phase.|Met withdrawal criteria|10
1366271|NCT01567527|4507680|P5|Conversion Phase.|Protocol deviation|0
1366272|NCT01567527|4507681|P4|Conversion Phase.|Protocol deviation|0
1366273|NCT01567527|4507682|P3|Conversion Phase.|Protocol deviation|0
1366274|NCT01567527|4507683|P2|Conversion Phase.|Protocol deviation|0
1366275|NCT01567527|4507684|P1|Conversion Phase.|Protocol deviation|3
1366276|NCT01567462|4507701|P2|Overall Study|Withdrawal by Subject|7
1366277|NCT01567462|4507702|P1|Overall Study|Withdrawal by Subject|4
1366278|NCT01567163|4507719|P1|Overall Study|Lost to Follow-up|2
1366279|NCT01567163|4507719|P1|Overall Study|Progressive Disease|2
1366280|NCT01566981|4507759|P2|Overall Study|Lost to Follow-up|8
1366281|NCT01566981|4507760|P1|Overall Study|Lost to Follow-up|5
1366282|NCT01566773|4507789|P1|Overall Study|Physician Decision|2
1366283|NCT01566773|4507789|P1|Overall Study|Adverse Event|10
1366284|NCT01566773|4507789|P1|Overall Study|Administrative reason|1
1366285|NCT01566773|4507789|P1|Overall Study|Withdrawal by Subject|9
1366286|NCT01566773|4507789|P1|Overall Study|Protocol Violation|4
1366287|NCT01566773|4507789|P1|Overall Study|Protocol specified criteria|4
1366288|NCT01566721|4507998|P2|Overall Study|Withdrew Prior to Treatment|1
1366289|NCT01566721|4507999|P1|Overall Study|Withdrew Prior to Treatment|3
1366290|NCT01566721|4507998|P2|Overall Study|Not Specified|4
1366291|NCT01566721|4507999|P1|Overall Study|Not Specified|10
1366292|NCT01566721|4507998|P2|Overall Study|Death|3
1366293|NCT01566721|4507999|P1|Overall Study|Death|6
1366294|NCT01566721|4507998|P2|Overall Study|Lost to Follow-up|0
1366295|NCT01566721|4507999|P1|Overall Study|Lost to Follow-up|18
1366296|NCT01566721|4507998|P2|Overall Study|Disease Progression/Recurrence|28
1366297|NCT01566721|4507999|P1|Overall Study|Disease Progression/Recurrence|123
1366298|NCT01566721|4507998|P2|Overall Study|Withdrawal by Subject|15
1366299|NCT01566721|4507999|P1|Overall Study|Withdrawal by Subject|58
1366300|NCT01566721|4507998|P2|Overall Study|Ongoing Study|659
1366301|NCT01566721|4507999|P1|Overall Study|Ongoing Study|1649
1366302|NCT01566604|4508081|P2|Overall Study|Withdrawal by Subject|6
1366303|NCT01566604|4508082|P1|Overall Study|Withdrawal by Subject|9
1366304|NCT01566604|4508081|P2|Overall Study|Adverse Event|2
1366305|NCT01566604|4508082|P1|Overall Study|Adverse Event|4
1366306|NCT01566604|4508081|P2|Overall Study|Death|1
1366307|NCT01566604|4508082|P1|Overall Study|Death|4
1366308|NCT01566604|4508081|P2|Overall Study|Abnormal laboratory value|0
1366309|NCT01566604|4508082|P1|Overall Study|Abnormal laboratory value|2
1366310|NCT01566604|4508081|P2|Overall Study|Protocol deviation|0
1366311|NCT01566604|4508082|P1|Overall Study|Protocol deviation|2
1366312|NCT01566604|4508081|P2|Overall Study|Lack of Efficacy|2
1366313|NCT01566604|4508082|P1|Overall Study|Lack of Efficacy|1
1366314|NCT01566604|4508081|P2|Overall Study|Administrative problems|0
1366315|NCT01566604|4508082|P1|Overall Study|Administrative problems|1
1366316|NCT01566604|4508081|P2|Overall Study|Patient's inability to use the device|0
1366317|NCT01566604|4508082|P1|Overall Study|Patient's inability to use the device|1
1366318|NCT01566435|4508238|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
1366319|NCT01566149|4508311|P2|Overall Study|Withdrawal by Subject|0
1366320|NCT01566149|4508312|P1|Overall Study|Withdrawal by Subject|1
1366321|NCT01566149|4508311|P2|Overall Study|Protocol Violation|1
1366322|NCT01566149|4508312|P1|Overall Study|Protocol Violation|0
1366323|NCT01566149|4508311|P2|Overall Study|Non-compliance with study medication|0
1366324|NCT01566149|4508312|P1|Overall Study|Non-compliance with study medication|2
1366325|NCT01566149|4508311|P2|Overall Study|Adverse Event|1
1366326|NCT01566149|4508312|P1|Overall Study|Adverse Event|0
1366327|NCT01565993|4508345|P2|Overall Study|Physician Decision|3
1366328|NCT01565993|4508346|P1|Overall Study|Physician Decision|0
1366329|NCT01565980|4508354|P2|Overall Study|Withdrawal by Subject|3
1366330|NCT01565980|4508355|P1|Overall Study|Withdrawal by Subject|0
1366331|NCT01565980|4508354|P2|Overall Study|stopped medical treatment|0
1366332|NCT01565980|4508355|P1|Overall Study|stopped medical treatment|1
1366333|NCT01565980|4508354|P2|Overall Study|health complications|1
1366334|NCT01565980|4508355|P1|Overall Study|health complications|1
1366335|NCT01565980|4508354|P2|Overall Study|Lost to Follow-up|0
1366336|NCT01565980|4508355|P1|Overall Study|Lost to Follow-up|1
1366337|NCT01565980|4508354|P2|Overall Study|Death|0
1366338|NCT01565980|4508355|P1|Overall Study|Death|1
1366339|NCT01565941|4508375|P2|Overall Study|Randomized; did not receive intevention|2
1366340|NCT01565941|4508376|P1|Overall Study|Randomized; did not receive intevention|8
1366341|NCT01565941|4508375|P2|Overall Study|Withdrawn by parent/guardian|2
1366342|NCT01565941|4508376|P1|Overall Study|Withdrawn by parent/guardian|3
1366343|NCT01565889|4508455|P6|Part B|Lost to Follow-up|1
1366344|NCT01565889|4508456|P5|Part B|Lost to Follow-up|0
1366345|NCT01565889|4508457|P4|Part B|Lost to Follow-up|0
1366346|NCT01565889|4508458|P3|Part B|Lost to Follow-up|0
1366347|NCT01565889|4508459|P2|Part B|Lost to Follow-up|0
1366348|NCT01565889|4508460|P1|Part B|Lost to Follow-up|0
1366349|NCT01565889|4508455|P6|Part B|Lack of Efficacy|2
1366350|NCT01565889|4508456|P5|Part B|Lack of Efficacy|0
1366351|NCT01565889|4508457|P4|Part B|Lack of Efficacy|0
1366352|NCT01565889|4508458|P3|Part B|Lack of Efficacy|0
1366353|NCT01565889|4508459|P2|Part B|Lack of Efficacy|0
1366354|NCT01565889|4508460|P1|Part B|Lack of Efficacy|0
1366355|NCT01565889|4508455|P6|Part B|Withdrawal by Subject|1
1366356|NCT01565889|4508456|P5|Part B|Withdrawal by Subject|0
1366357|NCT01565889|4508457|P4|Part B|Withdrawal by Subject|0
1366358|NCT01565889|4508458|P3|Part B|Withdrawal by Subject|0
1366359|NCT01565889|4508459|P2|Part B|Withdrawal by Subject|0
1366360|NCT01565889|4508460|P1|Part B|Withdrawal by Subject|0
1366361|NCT01565889|4508455|P6|Part A|Withdrawal by Subject|0
1366362|NCT01565889|4508456|P5|Part A|Withdrawal by Subject|0
1366363|NCT01565889|4508457|P4|Part A|Withdrawal by Subject|0
1366364|NCT01565889|4508458|P3|Part A|Withdrawal by Subject|0
1366365|NCT01565889|4508459|P2|Part A|Withdrawal by Subject|0
1366366|NCT01565889|4508460|P1|Part A|Withdrawal by Subject|1
1366367|NCT01565850|4508491|P2|Overall Study|Withdrew Consent|2
1366368|NCT01565850|4508492|P1|Overall Study|Withdrew Consent|4
1366369|NCT01565850|4508491|P2|Overall Study|Participant noncompliance|0
1366370|NCT01565850|4508492|P1|Overall Study|Participant noncompliance|2
1366371|NCT01565850|4508491|P2|Overall Study|Investigator’s Discretion|1
1366372|NCT01565850|4508492|P1|Overall Study|Investigator’s Discretion|2
1366373|NCT01565850|4508491|P2|Overall Study|Lost to Follow-up|4
1366374|NCT01565850|4508492|P1|Overall Study|Lost to Follow-up|12
1366375|NCT01565850|4508491|P2|Overall Study|Adverse Event|1
1366376|NCT01565850|4508492|P1|Overall Study|Adverse Event|0
1366377|NCT01565707|4508512|P4|Overall Study|Miscellaneous|2
1366378|NCT01565707|4508513|P3|Overall Study|Miscellaneous|0
1366379|NCT01565707|4508514|P2|Overall Study|Miscellaneous|1
1366380|NCT01565707|4508515|P1|Overall Study|Miscellaneous|1
1366381|NCT01565707|4508512|P4|Overall Study|Randomized but not evaluable|0
1366382|NCT01565707|4508513|P3|Overall Study|Randomized but not evaluable|0
1366383|NCT01565707|4508514|P2|Overall Study|Randomized but not evaluable|0
1366384|NCT01565707|4508515|P1|Overall Study|Randomized but not evaluable|2
1366385|NCT01565707|4508512|P4|Overall Study|Withdrawal by Subject|1
1366386|NCT01565707|4508513|P3|Overall Study|Withdrawal by Subject|1
1366387|NCT01565707|4508514|P2|Overall Study|Withdrawal by Subject|1
1366388|NCT01565707|4508515|P1|Overall Study|Withdrawal by Subject|3
1366389|NCT01565707|4508512|P4|Overall Study|Protocol Violation|1
1366390|NCT01565707|4508513|P3|Overall Study|Protocol Violation|0
1366391|NCT01565707|4508514|P2|Overall Study|Protocol Violation|0
1366392|NCT01565707|4508515|P1|Overall Study|Protocol Violation|1
1366393|NCT01565707|4508512|P4|Overall Study|Lost to Follow-up|0
1366394|NCT01565707|4508513|P3|Overall Study|Lost to Follow-up|0
1366395|NCT01565707|4508514|P2|Overall Study|Lost to Follow-up|0
1366396|NCT01565707|4508515|P1|Overall Study|Lost to Follow-up|1
1366397|NCT01565707|4508512|P4|Overall Study|Adverse Event|1
1366398|NCT01565707|4508513|P3|Overall Study|Adverse Event|2
1366399|NCT01565707|4508514|P2|Overall Study|Adverse Event|6
1366400|NCT01565707|4508515|P1|Overall Study|Adverse Event|1
1366401|NCT01565642|4508608|P2|Overall Study|Withdrawal by Subject|1
1366402|NCT01565642|4508609|P1|Overall Study|Withdrawal by Subject|2
1366403|NCT01565564|4508644|P2|Overall Study|Lost to Follow-up|1
1366404|NCT01565564|4508645|P1|Overall Study|Lost to Follow-up|5
1366405|NCT01565343|4508695|P3|Overall Study|Administrative decision/technical issues|0
1366406|NCT01565343|4508696|P2|Overall Study|Administrative decision/technical issues|0
1366407|NCT01565343|4508697|P1|Overall Study|Administrative decision/technical issues|1
1366408|NCT01565291|4508727|P2|Overall Study|Withdrawal by Subject|0
1366409|NCT01565291|4508728|P1|Overall Study|Withdrawal by Subject|1
1366410|NCT01565148|4508740|P4|Overall Study|Physician Decision|0
1366411|NCT01565148|4508741|P3|Overall Study|Physician Decision|0
1366412|NCT01565148|4508742|P2|Overall Study|Physician Decision|5
1366413|NCT01565148|4508743|P1|Overall Study|Physician Decision|2
1366414|NCT01565148|4508740|P4|Overall Study|Death|0
1366415|NCT01565148|4508741|P3|Overall Study|Death|1
1366416|NCT01565148|4508742|P2|Overall Study|Death|0
1366417|NCT01565148|4508743|P1|Overall Study|Death|0
1366418|NCT01565148|4508740|P4|Overall Study|Rescue Therapy|8
1366419|NCT01565148|4508741|P3|Overall Study|Rescue Therapy|5
1366420|NCT01565148|4508742|P2|Overall Study|Rescue Therapy|5
1366421|NCT01565148|4508743|P1|Overall Study|Rescue Therapy|8
1366422|NCT01565148|4508740|P4|Overall Study|Lost to Follow-up|3
1366423|NCT01565148|4508741|P3|Overall Study|Lost to Follow-up|0
1366424|NCT01565148|4508742|P2|Overall Study|Lost to Follow-up|4
1366425|NCT01565148|4508743|P1|Overall Study|Lost to Follow-up|4
1366426|NCT01565148|4508740|P4|Overall Study|Withdrawal by Subject|2
1366427|NCT01565148|4508741|P3|Overall Study|Withdrawal by Subject|1
1366428|NCT01565148|4508742|P2|Overall Study|Withdrawal by Subject|1
1366429|NCT01565148|4508743|P1|Overall Study|Withdrawal by Subject|1
1366430|NCT01565083|4508779|P2|Overall Study|Other|5
1366431|NCT01565083|4508780|P1|Overall Study|Other|3
1366432|NCT01565083|4508779|P2|Overall Study|Death|23
1366433|NCT01565083|4508780|P1|Overall Study|Death|22
1366434|NCT01565083|4508779|P2|Overall Study|Lost to Follow-up|7
1366435|NCT01565083|4508780|P1|Overall Study|Lost to Follow-up|2
1366436|NCT01565083|4508779|P2|Overall Study|Withdrawal by Subject|4
1366437|NCT01565083|4508780|P1|Overall Study|Withdrawal by Subject|6
1366438|NCT01564862|4508817|P3|Overall Study|Other reason(s)|0
1366439|NCT01564862|4508818|P2|Overall Study|Other reason(s)|0
1366440|NCT01564862|4508819|P1|Overall Study|Other reason(s)|1
1366441|NCT01564862|4508817|P3|Overall Study|Lack of Efficacy|6
1366442|NCT01564862|4508818|P2|Overall Study|Lack of Efficacy|5
1366443|NCT01564862|4508819|P1|Overall Study|Lack of Efficacy|1
1366444|NCT01564862|4508817|P3|Overall Study|Voluntary Withdrawal|8
1366445|NCT01564862|4508818|P2|Overall Study|Voluntary Withdrawal|6
1366446|NCT01564862|4508819|P1|Overall Study|Voluntary Withdrawal|9
1366447|NCT01564862|4508817|P3|Overall Study|Lost to Follow-up|6
1366448|NCT01564862|4508818|P2|Overall Study|Lost to Follow-up|8
1366449|NCT01564862|4508819|P1|Overall Study|Lost to Follow-up|10
1366450|NCT01564862|4508817|P3|Overall Study|Major Protocol Deviation|4
1366451|NCT01564862|4508818|P2|Overall Study|Major Protocol Deviation|3
1366452|NCT01564862|4508819|P1|Overall Study|Major Protocol Deviation|3
1366453|NCT01564862|4508817|P3|Overall Study|Pretreatment Event or Adverse Event|6
1366454|NCT01564862|4508818|P2|Overall Study|Pretreatment Event or Adverse Event|12
1366455|NCT01564862|4508819|P1|Overall Study|Pretreatment Event or Adverse Event|6
1366456|NCT01564784|4508870|P2|Overall Study|Death|126
1366457|NCT01564784|4508871|P1|Overall Study|Death|131
1366458|NCT01564784|4508870|P2|Overall Study|Lost to Follow-up|1
1366459|NCT01564784|4508871|P1|Overall Study|Lost to Follow-up|1
1366460|NCT01564784|4508870|P2|Overall Study|Subject refused further follow-up|6
1366461|NCT01564784|4508871|P1|Overall Study|Subject refused further follow-up|1
1366462|NCT01564784|4508870|P2|Overall Study|Other|0
1366463|NCT01564784|4508871|P1|Overall Study|Other|1
1366464|NCT01564758|4508898|P1|Overall Study|Other|3
1366465|NCT01564758|4508898|P1|Overall Study|Adverse Event|3
1366466|NCT01564758|4508898|P1|Overall Study|Death|8
1366467|NCT01564732|4508905|P2|Overall Study|Early termination by the study sponsor|5
1366468|NCT01564732|4508906|P1|Overall Study|Early termination by the study sponsor|6
1366469|NCT01564537|4508941|P2|Overall Study|Other Miscellaneous Reasons|2
1366470|NCT01564537|4508942|P1|Overall Study|Other Miscellaneous Reasons|1
1366471|NCT01564537|4508941|P2|Overall Study|Lost to Follow-up|0
1366472|NCT01564537|4508942|P1|Overall Study|Lost to Follow-up|1
1366473|NCT01564537|4508941|P2|Overall Study|Withdrawal by Participant|4
1366474|NCT01564537|4508942|P1|Overall Study|Withdrawal by Participant|4
1366475|NCT01564459|4508965|P3|Double-blind Treatment|Adverse Event|1
1366476|NCT01564459|4508966|P2|Double-blind Treatment|Adverse Event|0
1366477|NCT01564459|4508967|P1|Double-blind Treatment|Adverse Event|0
1366478|NCT01564459|4508965|P3|Run-In|Withdrawal by Subject|0
1366479|NCT01564459|4508966|P2|Run-In|Withdrawal by Subject|0
1366480|NCT01564459|4508967|P1|Run-In|Withdrawal by Subject|1
1366481|NCT01564459|4508965|P3|Run-In|Protocol Violation|0
1366482|NCT01564459|4508966|P2|Run-In|Protocol Violation|0
1366483|NCT01564459|4508967|P1|Run-In|Protocol Violation|1
1366484|NCT01564459|4508965|P3|Run-In|Non-compliance with study drug|0
1366485|NCT01564459|4508966|P2|Run-In|Non-compliance with study drug|0
1366486|NCT01564459|4508967|P1|Run-In|Non-compliance with study drug|2
1366487|NCT01564459|4508965|P3|Run-In|Lost to Follow-up|0
1366488|NCT01564459|4508966|P2|Run-In|Lost to Follow-up|0
1366489|NCT01564459|4508967|P1|Run-In|Lost to Follow-up|1
1366490|NCT01564459|4508965|P3|Run-In|Adverse Event|0
1366491|NCT01564459|4508966|P2|Run-In|Adverse Event|0
1366492|NCT01564459|4508967|P1|Run-In|Adverse Event|7
1366493|NCT01564407|4508991|P5|Overall Study|funding lost, study ended|0
1366494|NCT01564407|4508992|P4|Overall Study|funding lost, study ended|1
1366495|NCT01564407|4508993|P3|Overall Study|funding lost, study ended|0
1366496|NCT01564407|4508994|P2|Overall Study|funding lost, study ended|0
1366497|NCT01564407|4508995|P1|Overall Study|funding lost, study ended|0
1366498|NCT01564407|4508991|P5|Overall Study|Withdrawal by Subject|0
1366499|NCT01564407|4508992|P4|Overall Study|Withdrawal by Subject|0
1366500|NCT01564407|4508993|P3|Overall Study|Withdrawal by Subject|0
1366501|NCT01564407|4508994|P2|Overall Study|Withdrawal by Subject|1
1366502|NCT01564407|4508995|P1|Overall Study|Withdrawal by Subject|0
1366503|NCT01564407|4508991|P5|Overall Study|Lost to Follow-up|0
1366504|NCT01564407|4508992|P4|Overall Study|Lost to Follow-up|0
1366505|NCT01564407|4508993|P3|Overall Study|Lost to Follow-up|0
1366506|NCT01564407|4508994|P2|Overall Study|Lost to Follow-up|1
1366507|NCT01564407|4508995|P1|Overall Study|Lost to Follow-up|0
1366508|NCT01564394|4509036|P2|Overall Study|Withdrawal by Subject|10
1366509|NCT01564394|4509037|P1|Overall Study|Withdrawal by Subject|6
1366510|NCT01564277|4509051|P2|Overall Study|Physician Decision|0
1366511|NCT01564277|4509052|P1|Overall Study|Physician Decision|1
1366512|NCT01564277|4509051|P2|Overall Study|Protocol Violation|1
1366513|NCT01564277|4509052|P1|Overall Study|Protocol Violation|0
1366514|NCT01563978|4509070|P2|Overall Study|Adverse Event|2
1366515|NCT01563978|4509071|P1|Overall Study|Adverse Event|1
1366516|NCT01563978|4509070|P2|Overall Study|Dev. of study specific discont. criteria|0
1366517|NCT01563978|4509071|P1|Overall Study|Dev. of study specific discont. criteria|1
1366518|NCT01563978|4509070|P2|Overall Study|Lost to Follow-up|0
1366519|NCT01563978|4509071|P1|Overall Study|Lost to Follow-up|1
1366520|NCT01563978|4509070|P2|Overall Study|Physician Decision|0
1366521|NCT01563978|4509071|P1|Overall Study|Physician Decision|1
1366522|NCT01563913|4509097|P2|Overall Study|Spouse Passed Away|0
1366523|NCT01563913|4509098|P1|Overall Study|Spouse Passed Away|1
1366524|NCT01563913|4509097|P2|Overall Study|Physician Decision|0
1366525|NCT01563913|4509098|P1|Overall Study|Physician Decision|1
1366526|NCT01563536|4509110|P2|Overall Study|Lost to Follow-up|0
1366527|NCT01563536|4509111|P1|Overall Study|Lost to Follow-up|1
1366528|NCT01563536|4509110|P2|Overall Study|Withdrawal by Subject|2
1366529|NCT01563536|4509111|P1|Overall Study|Withdrawal by Subject|0
1366530|NCT01563185|4509170|P1|Overall Study|Non-Compliance with study drug|1
1366531|NCT01563185|4509170|P1|Overall Study|Withdrawal by Subject|1
1366532|NCT01563172|4509184|P1|Overall Study|Other (Not specified)|1
1366533|NCT01563172|4509184|P1|Overall Study|Other (Protocol deviation)|5
1366534|NCT01563172|4509184|P1|Overall Study|Lost to Follow-up|2
1366535|NCT01563172|4509184|P1|Overall Study|Adverse Event|5
1366536|NCT01563029|4509290|P5|Overall Study|Withdrawal by Subject|3
1366537|NCT01563029|4509291|P4|Overall Study|Withdrawal by Subject|4
1366538|NCT01563029|4509292|P3|Overall Study|Withdrawal by Subject|3
1366539|NCT01563029|4509293|P2|Overall Study|Withdrawal by Subject|1
1366540|NCT01563029|4509294|P1|Overall Study|Withdrawal by Subject|4
1366541|NCT01563029|4509290|P5|Overall Study|Physician Decision|2
1366542|NCT01563029|4509291|P4|Overall Study|Physician Decision|4
1366543|NCT01563029|4509292|P3|Overall Study|Physician Decision|2
1366544|NCT01563029|4509293|P2|Overall Study|Physician Decision|5
1366545|NCT01563029|4509294|P1|Overall Study|Physician Decision|3
1366546|NCT01563029|4509290|P5|Overall Study|Lost to Follow-up|1
1366547|NCT01563029|4509291|P4|Overall Study|Lost to Follow-up|1
1366548|NCT01563029|4509292|P3|Overall Study|Lost to Follow-up|1
1366549|NCT01563029|4509293|P2|Overall Study|Lost to Follow-up|0
1366550|NCT01563029|4509294|P1|Overall Study|Lost to Follow-up|1
1366551|NCT01563029|4509290|P5|Overall Study|Protocol defined stopping criteria|0
1366552|NCT01563029|4509291|P4|Overall Study|Protocol defined stopping criteria|0
1366553|NCT01563029|4509292|P3|Overall Study|Protocol defined stopping criteria|0
1366554|NCT01563029|4509293|P2|Overall Study|Protocol defined stopping criteria|0
1366555|NCT01563029|4509294|P1|Overall Study|Protocol defined stopping criteria|1
1366556|NCT01563029|4509290|P5|Overall Study|Protocol Violation|3
1366557|NCT01563029|4509291|P4|Overall Study|Protocol Violation|1
1366558|NCT01563029|4509292|P3|Overall Study|Protocol Violation|3
1366559|NCT01563029|4509293|P2|Overall Study|Protocol Violation|2
1366560|NCT01563029|4509294|P1|Overall Study|Protocol Violation|1
1366561|NCT01563029|4509290|P5|Overall Study|Lack of Efficacy|19
1366562|NCT01563029|4509291|P4|Overall Study|Lack of Efficacy|21
1366563|NCT01563029|4509292|P3|Overall Study|Lack of Efficacy|23
1366564|NCT01563029|4509293|P2|Overall Study|Lack of Efficacy|16
1366565|NCT01563029|4509294|P1|Overall Study|Lack of Efficacy|42
1366566|NCT01563029|4509290|P5|Overall Study|Adverse Event|1
1366567|NCT01563029|4509291|P4|Overall Study|Adverse Event|2
1366568|NCT01563029|4509292|P3|Overall Study|Adverse Event|1
1366569|NCT01563029|4509293|P2|Overall Study|Adverse Event|0
1366570|NCT01563029|4509294|P1|Overall Study|Adverse Event|1
1366571|NCT01562873|4509360|P2|Overall Study|Clinical PD and adverse event|0
1366572|NCT01562873|4509361|P1|Overall Study|Clinical PD and adverse event|1
1366573|NCT01562873|4509360|P2|Overall Study|Clinical Disease Progression|0
1366574|NCT01562873|4509361|P1|Overall Study|Clinical Disease Progression|9
1366575|NCT01562873|4509360|P2|Overall Study|Adverse Event|0
1366576|NCT01562873|4509361|P1|Overall Study|Adverse Event|1
1366577|NCT01562873|4509360|P2|Overall Study|Disease Progression per RECIST|0
1366578|NCT01562873|4509361|P1|Overall Study|Disease Progression per RECIST|10
1366579|NCT01562743|4509373|P1|Overall Study|Physician Decision|2
1366580|NCT01562743|4509373|P1|Overall Study|Lost to Follow-up|2
1366581|NCT01562743|4509373|P1|Overall Study|Discontinuation criteria|2
1366582|NCT01562743|4509373|P1|Overall Study|Protocol Violation|1
1366583|NCT01562743|4509373|P1|Overall Study|Withdrawal by Subject|13
1366584|NCT01562743|4509373|P1|Overall Study|Lack of Efficacy|3
1366585|NCT01562743|4509373|P1|Overall Study|Adverse Event|29
1366586|NCT01562613|4509392|P1|Overall Study|Withdrawal by Subject|2
1366587|NCT01562613|4509392|P1|Overall Study|Lost to Follow-up|2
1366588|NCT01562548|4509402|P4|Overall Study|Lost to Follow-up|0
1366589|NCT01562548|4509403|P3|Overall Study|Lost to Follow-up|1
1366590|NCT01562548|4509404|P2|Overall Study|Lost to Follow-up|0
1366591|NCT01562548|4509405|P1|Overall Study|Lost to Follow-up|0
1366592|NCT01562444|4509458|P3|Overall Study|Protocol forbidden medication|0
1366593|NCT01562444|4509459|P2|Overall Study|Protocol forbidden medication|0
1366594|NCT01562444|4509460|P1|Overall Study|Protocol forbidden medication|1
1366595|NCT01562444|4509458|P3|Overall Study|Protocol forbidden concomitant vaccine|1
1366596|NCT01562444|4509459|P2|Overall Study|Protocol forbidden concomitant vaccine|0
1366597|NCT01562444|4509460|P1|Overall Study|Protocol forbidden concomitant vaccine|1
1366598|NCT01562444|4509458|P3|Overall Study|Unavailable serological results|2
1366599|NCT01562444|4509459|P2|Overall Study|Unavailable serological results|2
1366600|NCT01562444|4509460|P1|Overall Study|Unavailable serological results|0
1366601|NCT01562444|4509458|P3|Overall Study|Did not comply with blood draw schedule|1
1366602|NCT01562444|4509459|P2|Overall Study|Did not comply with blood draw schedule|0
1366603|NCT01562444|4509460|P1|Overall Study|Did not comply with blood draw schedule|1
1366604|NCT01562444|4509458|P3|Overall Study|Did not meet entry criteria|3
1366605|NCT01562444|4509459|P2|Overall Study|Did not meet entry criteria|0
1366606|NCT01562444|4509460|P1|Overall Study|Did not meet entry criteria|2
1366607|NCT01562327|4509726|P1|Overall Study|Infusion not received at 6 month window|4
1366608|NCT01562327|4509726|P1|Overall Study|Participant drop-out|1
1366609|NCT01562327|4509726|P1|Overall Study|Lack of Efficacy|1
1366610|NCT01562327|4509726|P1|Overall Study|Adverse Event|2
1366611|NCT01562314|4509756|P2|Overall Study|Withdrawal by Subject|1
1366612|NCT01562314|4509757|P1|Overall Study|Withdrawal by Subject|0
1366613|NCT01562314|4509756|P2|Overall Study|Met Withdrawal Criteria|2
1366614|NCT01562314|4509757|P1|Overall Study|Met Withdrawal Criteria|3
1366615|NCT01562314|4509756|P2|Overall Study|Adverse Event|5
1366616|NCT01562314|4509757|P1|Overall Study|Adverse Event|10
1366617|NCT01562275|4509814|P13|Stage 2|Progression of Disease|4
1366618|NCT01562275|4509815|P12|Stage 2|Progression of Disease|12
1366619|NCT01562275|4509816|P11|Stage 2|Progression of Disease|0
1366620|NCT01562275|4509817|P10|Stage 2|Progression of Disease|0
1366621|NCT01562275|4509818|P9|Stage 2|Progression of Disease|0
1366622|NCT01562275|4509819|P8|Stage 2|Progression of Disease|0
1366623|NCT01562275|4509820|P7|Stage 2|Progression of Disease|0
1366624|NCT01562275|4509821|P6|Stage 2|Progression of Disease|0
1366625|NCT01562275|4509822|P5|Stage 2|Progression of Disease|0
1366626|NCT01562275|4509823|P4|Stage 2|Progression of Disease|0
1366627|NCT01562275|4509824|P3|Stage 2|Progression of Disease|0
1366628|NCT01562275|4509825|P2|Stage 2|Progression of Disease|0
1366629|NCT01562275|4509826|P1|Stage 2|Progression of Disease|0
1366630|NCT01562275|4509814|P13|Stage 2|Death|1
1366631|NCT01562275|4509815|P12|Stage 2|Death|2
1366632|NCT01562275|4509816|P11|Stage 2|Death|0
1366633|NCT01562275|4509817|P10|Stage 2|Death|0
1366634|NCT01562275|4509818|P9|Stage 2|Death|0
1366635|NCT01562275|4509819|P8|Stage 2|Death|0
1366636|NCT01562275|4509820|P7|Stage 2|Death|0
1366637|NCT01562275|4509821|P6|Stage 2|Death|0
1366638|NCT01562275|4509822|P5|Stage 2|Death|0
1366639|NCT01562275|4509823|P4|Stage 2|Death|0
1366640|NCT01562275|4509824|P3|Stage 2|Death|0
1366641|NCT01562275|4509825|P2|Stage 2|Death|0
1366642|NCT01562275|4509826|P1|Stage 2|Death|0
1366643|NCT01562275|4509814|P13|Stage 1|Withdrawal by Subject|0
1366644|NCT01562275|4509815|P12|Stage 1|Withdrawal by Subject|0
1366645|NCT01562275|4509816|P11|Stage 1|Withdrawal by Subject|0
1366646|NCT01562275|4509817|P10|Stage 1|Withdrawal by Subject|1
1366647|NCT01562275|4509818|P9|Stage 1|Withdrawal by Subject|0
1366648|NCT01562275|4509819|P8|Stage 1|Withdrawal by Subject|0
1366649|NCT01562275|4509820|P7|Stage 1|Withdrawal by Subject|1
1366650|NCT01562275|4509821|P6|Stage 1|Withdrawal by Subject|0
1366651|NCT01562275|4509822|P5|Stage 1|Withdrawal by Subject|0
1366652|NCT01562275|4509823|P4|Stage 1|Withdrawal by Subject|2
1366653|NCT01562275|4509824|P3|Stage 1|Withdrawal by Subject|0
1366654|NCT01562275|4509825|P2|Stage 1|Withdrawal by Subject|1
1366655|NCT01562275|4509826|P1|Stage 1|Withdrawal by Subject|0
1366656|NCT01562275|4509814|P13|Stage 1|Progression of Disease|0
1366657|NCT01562275|4509815|P12|Stage 1|Progression of Disease|0
1366658|NCT01562275|4509816|P11|Stage 1|Progression of Disease|3
1366659|NCT01562275|4509817|P10|Stage 1|Progression of Disease|5
1366660|NCT01562275|4509818|P9|Stage 1|Progression of Disease|2
1366661|NCT01562275|4509819|P8|Stage 1|Progression of Disease|7
1366662|NCT01562275|4509820|P7|Stage 1|Progression of Disease|1
1366663|NCT01562275|4509821|P6|Stage 1|Progression of Disease|4
1366664|NCT01562275|4509822|P5|Stage 1|Progression of Disease|2
1366665|NCT01562275|4509823|P4|Stage 1|Progression of Disease|1
1366666|NCT01562275|4509824|P3|Stage 1|Progression of Disease|2
1366667|NCT01562275|4509825|P2|Stage 1|Progression of Disease|6
1366668|NCT01562275|4509826|P1|Stage 1|Progression of Disease|2
1366669|NCT01562275|4509814|P13|Stage 1|Physician Decision|0
1366670|NCT01562275|4509815|P12|Stage 1|Physician Decision|0
1366671|NCT01562275|4509816|P11|Stage 1|Physician Decision|0
1366672|NCT01562275|4509817|P10|Stage 1|Physician Decision|0
1366673|NCT01562275|4509818|P9|Stage 1|Physician Decision|1
1366674|NCT01562275|4509819|P8|Stage 1|Physician Decision|0
1366675|NCT01562275|4509820|P7|Stage 1|Physician Decision|1
1366676|NCT01562275|4509821|P6|Stage 1|Physician Decision|0
1366677|NCT01562275|4509822|P5|Stage 1|Physician Decision|1
1366678|NCT01562275|4509823|P4|Stage 1|Physician Decision|0
1366679|NCT01562275|4509824|P3|Stage 1|Physician Decision|0
1366680|NCT01562275|4509825|P2|Stage 1|Physician Decision|0
1366681|NCT01562275|4509826|P1|Stage 1|Physician Decision|0
1366682|NCT01562275|4509814|P13|Stage 1|Non Compliance|0
1366683|NCT01562275|4509815|P12|Stage 1|Non Compliance|0
1366684|NCT01562275|4509816|P11|Stage 1|Non Compliance|0
1366685|NCT01562275|4509817|P10|Stage 1|Non Compliance|0
1366686|NCT01562275|4509818|P9|Stage 1|Non Compliance|0
1366687|NCT01562275|4509819|P8|Stage 1|Non Compliance|0
1366688|NCT01562275|4509820|P7|Stage 1|Non Compliance|0
1366689|NCT01562275|4509821|P6|Stage 1|Non Compliance|0
1366690|NCT01562275|4509822|P5|Stage 1|Non Compliance|0
1366691|NCT01562275|4509823|P4|Stage 1|Non Compliance|0
1366692|NCT01562275|4509824|P3|Stage 1|Non Compliance|1
1366693|NCT01562275|4509825|P2|Stage 1|Non Compliance|0
1366694|NCT01562275|4509826|P1|Stage 1|Non Compliance|0
1366695|NCT01562275|4509814|P13|Stage 1|Death|0
1366696|NCT01562275|4509815|P12|Stage 1|Death|0
1366697|NCT01562275|4509816|P11|Stage 1|Death|0
1366698|NCT01562275|4509817|P10|Stage 1|Death|0
1366699|NCT01562275|4509818|P9|Stage 1|Death|0
1366700|NCT01562275|4509819|P8|Stage 1|Death|0
1366701|NCT01562275|4509820|P7|Stage 1|Death|0
1366702|NCT01562275|4509821|P6|Stage 1|Death|0
1366703|NCT01562275|4509822|P5|Stage 1|Death|0
1366704|NCT01562275|4509823|P4|Stage 1|Death|0
1366705|NCT01562275|4509824|P3|Stage 1|Death|0
1366706|NCT01562275|4509825|P2|Stage 1|Death|0
1366707|NCT01562275|4509826|P1|Stage 1|Death|1
1366708|NCT01562275|4509814|P13|Stage 1|Adverse Event|0
1366709|NCT01562275|4509815|P12|Stage 1|Adverse Event|0
1366710|NCT01562275|4509816|P11|Stage 1|Adverse Event|0
1366711|NCT01562275|4509817|P10|Stage 1|Adverse Event|1
1366712|NCT01562275|4509818|P9|Stage 1|Adverse Event|0
1366713|NCT01562275|4509819|P8|Stage 1|Adverse Event|0
1366714|NCT01562275|4509820|P7|Stage 1|Adverse Event|0
1366715|NCT01562275|4509821|P6|Stage 1|Adverse Event|0
1366716|NCT01562275|4509822|P5|Stage 1|Adverse Event|1
1366717|NCT01562275|4509823|P4|Stage 1|Adverse Event|1
1366718|NCT01562275|4509824|P3|Stage 1|Adverse Event|0
1366719|NCT01562275|4509825|P2|Stage 1|Adverse Event|0
1366720|NCT01562275|4509826|P1|Stage 1|Adverse Event|0
1366721|NCT01561976|4509971|P6|Washout Period 2 (7 Days)|Non-compliance|0
1366722|NCT01561976|4509972|P5|Washout Period 2 (7 Days)|Non-compliance|0
1366723|NCT01561976|4509973|P4|Washout Period 2 (7 Days)|Non-compliance|0
1366724|NCT01561976|4509974|P3|Washout Period 2 (7 Days)|Non-compliance|1
1366725|NCT01561976|4509975|P2|Washout Period 2 (7 Days)|Non-compliance|0
1366726|NCT01561976|4509976|P1|Washout Period 2 (7 Days)|Non-compliance|1
1366727|NCT01561976|4509971|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1366728|NCT01561976|4509972|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1366729|NCT01561976|4509973|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1366730|NCT01561976|4509974|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1366731|NCT01561976|4509975|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1366732|NCT01561976|4509976|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1366733|NCT01561976|4509971|P6|Washout Period 1 (7 Days)|Adverse Event|0
1366734|NCT01561976|4509972|P5|Washout Period 1 (7 Days)|Adverse Event|0
1366735|NCT01561976|4509973|P4|Washout Period 1 (7 Days)|Adverse Event|1
1366736|NCT01561976|4509974|P3|Washout Period 1 (7 Days)|Adverse Event|0
1366737|NCT01561976|4509975|P2|Washout Period 1 (7 Days)|Adverse Event|0
1366738|NCT01561976|4509976|P1|Washout Period 1 (7 Days)|Adverse Event|0
1366739|NCT01561976|4509971|P6|Period 1|Adverse Event|0
1366740|NCT01561976|4509972|P5|Period 1|Adverse Event|0
1366741|NCT01561976|4509973|P4|Period 1|Adverse Event|0
1366742|NCT01561976|4509974|P3|Period 1|Adverse Event|1
1366743|NCT01561976|4509975|P2|Period 1|Adverse Event|0
1366744|NCT01561976|4509976|P1|Period 1|Adverse Event|0
1366745|NCT01561898|4510009|P4|Overall Study|Physician Decision|1
1366746|NCT01561898|4510010|P3|Overall Study|Physician Decision|7
1366747|NCT01561898|4510011|P2|Overall Study|Physician Decision|5
1366748|NCT01561898|4510012|P1|Overall Study|Physician Decision|1
1366749|NCT01561898|4510009|P4|Overall Study|Adverse Event|9
1366750|NCT01561898|4510010|P3|Overall Study|Adverse Event|14
1366751|NCT01561898|4510011|P2|Overall Study|Adverse Event|19
1366752|NCT01561898|4510012|P1|Overall Study|Adverse Event|1
1366753|NCT01561898|4510009|P4|Overall Study|Lost to Follow-up|0
1366754|NCT01561898|4510010|P3|Overall Study|Lost to Follow-up|1
1366755|NCT01561898|4510011|P2|Overall Study|Lost to Follow-up|0
1366756|NCT01561898|4510012|P1|Overall Study|Lost to Follow-up|0
1366757|NCT01561898|4510009|P4|Overall Study|Worsening of complications|0
1366758|NCT01561898|4510010|P3|Overall Study|Worsening of complications|0
1366759|NCT01561898|4510011|P2|Overall Study|Worsening of complications|1
1366760|NCT01561898|4510012|P1|Overall Study|Worsening of complications|0
1366761|NCT01561898|4510009|P4|Overall Study|Lack of Efficacy|5
1366762|NCT01561898|4510010|P3|Overall Study|Lack of Efficacy|10
1366763|NCT01561898|4510011|P2|Overall Study|Lack of Efficacy|8
1366764|NCT01561898|4510012|P1|Overall Study|Lack of Efficacy|0
1366765|NCT01561898|4510009|P4|Overall Study|Withdrawal by Subject|5
1366766|NCT01561898|4510010|P3|Overall Study|Withdrawal by Subject|12
1366767|NCT01561898|4510011|P2|Overall Study|Withdrawal by Subject|8
1366768|NCT01561898|4510012|P1|Overall Study|Withdrawal by Subject|0
1366769|NCT01561755|4510026|P2|Overall Study|Lost to Follow-up|1
1366770|NCT01561755|4510027|P1|Overall Study|Lost to Follow-up|0
1366771|NCT01561560|4510079|P2|Second Two Weeks of Wear|Adverse Event|1
1366772|NCT01561560|4510080|P1|Second Two Weeks of Wear|Adverse Event|0
1366773|NCT01561560|4510079|P2|First Two Weeks of Wear|Adverse Event|1
1366774|NCT01561560|4510080|P1|First Two Weeks of Wear|Adverse Event|0
1366775|NCT01561560|4510079|P2|First Two Weeks of Wear|Time/job conflict|1
1366776|NCT01561560|4510080|P1|First Two Weeks of Wear|Time/job conflict|0
1366777|NCT01561430|4510111|P4|Overall Study|Sponsor Decision|12
1366778|NCT01561430|4510112|P3|Overall Study|Sponsor Decision|13
1366779|NCT01561430|4510113|P2|Overall Study|Sponsor Decision|14
1366780|NCT01561430|4510114|P1|Overall Study|Sponsor Decision|1
1366781|NCT01561430|4510111|P4|Overall Study|Physician Decision|0
1366782|NCT01561430|4510112|P3|Overall Study|Physician Decision|0
1366783|NCT01561430|4510113|P2|Overall Study|Physician Decision|1
1366784|NCT01561430|4510114|P1|Overall Study|Physician Decision|0
1366785|NCT01561430|4510111|P4|Overall Study|Withdrawal by Subject|0
1366786|NCT01561430|4510112|P3|Overall Study|Withdrawal by Subject|1
1366787|NCT01561430|4510113|P2|Overall Study|Withdrawal by Subject|0
1366788|NCT01561430|4510114|P1|Overall Study|Withdrawal by Subject|0
1366789|NCT01561430|4510111|P4|Overall Study|Adverse Event|1
1366790|NCT01561430|4510112|P3|Overall Study|Adverse Event|3
1366791|NCT01561430|4510113|P2|Overall Study|Adverse Event|0
1366792|NCT01561430|4510114|P1|Overall Study|Adverse Event|0
1366793|NCT01561313|4510154|P2|Overall Study|Adverse event and withdrawal by subject|0
1366794|NCT01561313|4510155|P1|Overall Study|Adverse event and withdrawal by subject|1
1366795|NCT01561313|4510154|P2|Overall Study|Withdrawal by Subject|0
1366796|NCT01561313|4510155|P1|Overall Study|Withdrawal by Subject|1
1366797|NCT01561300|4510173|P2|Run in on Placebo|Adverse Event|0
1366798|NCT01561300|4510174|P1|Run in on Placebo|Adverse Event|1
1366799|NCT01561079|4510185|P1|Overall Study|Protocol Violation|2
1366800|NCT01561079|4510185|P1|Overall Study|Withdrawal by Subject|59
1366801|NCT01561079|4510185|P1|Overall Study|Physician Decision|17
1366802|NCT01560988|4510228|P2|Washout (Six Weeks)|Lost to Follow-up|2
1366803|NCT01560988|4510229|P1|Washout (Six Weeks)|Lost to Follow-up|2
1366804|NCT01560988|4510228|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
1366805|NCT01560988|4510229|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
1366806|NCT01560988|4510228|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
1366807|NCT01560988|4510229|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
1366808|NCT01560819|4510267|P2|Overall Study|Physician Decision|0
1366809|NCT01560819|4510268|P1|Overall Study|Physician Decision|1
1366810|NCT01560507|4510275|P3|Overall Study|Withdrawal by Subject|0
1366811|NCT01560507|4510276|P2|Overall Study|Withdrawal by Subject|1
1366812|NCT01560507|4510277|P1|Overall Study|Withdrawal by Subject|1
1366813|NCT01560507|4510275|P3|Overall Study|Lost to Follow-up|2
1366814|NCT01560507|4510276|P2|Overall Study|Lost to Follow-up|1
1366815|NCT01560507|4510277|P1|Overall Study|Lost to Follow-up|3
1366816|NCT01560429|4510290|P2|Overall Study|Protocol Violation|6
1366817|NCT01560429|4510291|P1|Overall Study|Protocol Violation|3
1366818|NCT01560403|4510301|P2|Overall Study|Lost to Follow-up|1
1366819|NCT01560403|4510302|P1|Overall Study|Lost to Follow-up|0
1366820|NCT01560234|4510320|P8|Overall Study|Lost to Follow-up|2
1366821|NCT01560234|4510321|P7|Overall Study|Lost to Follow-up|0
1366822|NCT01560234|4510322|P6|Overall Study|Lost to Follow-up|2
1366823|NCT01560234|4510323|P5|Overall Study|Lost to Follow-up|0
1366824|NCT01560234|4510324|P4|Overall Study|Lost to Follow-up|0
1366825|NCT01560234|4510325|P3|Overall Study|Lost to Follow-up|1
1366826|NCT01560234|4510326|P2|Overall Study|Lost to Follow-up|0
1366827|NCT01560234|4510327|P1|Overall Study|Lost to Follow-up|3
1366828|NCT01559935|4510405|P1|Maintenance Phase|Non-compliance|2
1366829|NCT01559935|4510405|P1|Maintenance Phase|Withdrawal by Subject|5
1366830|NCT01559935|4510405|P1|Maintenance Phase|Lack of Efficacy|18
1366831|NCT01559935|4510405|P1|Maintenance Phase|Toxicity|1
1366832|NCT01559935|4510405|P1|Maintenance Phase|Remains on study|28
1366833|NCT01559935|4510405|P1|BiRD Phase|Withdrawal by Subject|2
1366834|NCT01559935|4510405|P1|BiRD Phase|Lack of Efficacy|1
1366835|NCT01559935|4510405|P1|BiRD Phase|Toxicity|1
1366836|NCT01559935|4510405|P1|Car Phase|non-compliance|1
1366837|NCT01559935|4510405|P1|Car Phase|Insurance|1
1366838|NCT01559935|4510405|P1|Car Phase|Per protocol|1
1366839|NCT01559935|4510405|P1|Car Phase|Withdrawal by Subject|2
1366840|NCT01559935|4510405|P1|Car Phase|Physician Decision|1
1366841|NCT01559935|4510405|P1|Car Phase|Lost to Follow-up|1
1366842|NCT01559935|4510405|P1|Car Phase|Lack of Efficacy|2
1366843|NCT01559935|4510405|P1|Car Phase|Death|1
1366844|NCT01559935|4510405|P1|Car Phase|Toxicity|4
1366845|NCT01559844|4510441|P1|Overall Study|No Longer A Transplant Candidate|3
1366846|NCT01559844|4510441|P1|Overall Study|Efficacy Failure|10
1366847|NCT01559844|4510441|P1|Overall Study|Death|5
1366848|NCT01559844|4510441|P1|Overall Study|Consent Withdrawn|7
1366849|NCT01559675|4510454|P2|Overall Study|2nd operation on same patient excluded|12
1366850|NCT01559675|4510455|P1|Overall Study|2nd operation on same patient excluded|14
1366851|NCT01559675|4510454|P2|Overall Study|Protocol Violation|2
1366852|NCT01559675|4510455|P1|Overall Study|Protocol Violation|1
1366853|NCT01559454|4510486|P2|Overall Study|Lack of Efficacy|1
1366854|NCT01559454|4510487|P1|Overall Study|Lack of Efficacy|0
1366855|NCT01559454|4510486|P2|Overall Study|Protocol Violation|1
1366856|NCT01559454|4510487|P1|Overall Study|Protocol Violation|0
1366857|NCT01559454|4510486|P2|Overall Study|Physician Decision|1
1366858|NCT01559454|4510487|P1|Overall Study|Physician Decision|0
1366859|NCT01559454|4510486|P2|Overall Study|Withdrawal by Subject|1
1366860|NCT01559454|4510487|P1|Overall Study|Withdrawal by Subject|0
1366861|NCT01559454|4510486|P2|Overall Study|Lost to Follow-up|2
1366862|NCT01559454|4510487|P1|Overall Study|Lost to Follow-up|3
1366863|NCT01559311|4510506|P3|Overall Study|Adverse Event|1
1366864|NCT01559311|4510507|P2|Overall Study|Adverse Event|0
1366865|NCT01559311|4510508|P1|Overall Study|Adverse Event|0
1366866|NCT01559311|4510506|P3|Overall Study|Lost to Follow-up|2
1366867|NCT01559311|4510507|P2|Overall Study|Lost to Follow-up|3
1366868|NCT01559311|4510508|P1|Overall Study|Lost to Follow-up|0
1366869|NCT01559311|4510506|P3|Overall Study|Death|3
1366870|NCT01559311|4510507|P2|Overall Study|Death|2
1366871|NCT01559311|4510508|P1|Overall Study|Death|0
1366872|NCT01559311|4510506|P3|Overall Study|Withdrawal by Subject|0
1366873|NCT01559311|4510507|P2|Overall Study|Withdrawal by Subject|1
1366874|NCT01559311|4510508|P1|Overall Study|Withdrawal by Subject|2
1366875|NCT01559311|4510506|P3|Overall Study|Difficulty in cannulating the lateral ve|0
1366876|NCT01559311|4510507|P2|Overall Study|Difficulty in cannulating the lateral ve|0
1366877|NCT01559311|4510508|P1|Overall Study|Difficulty in cannulating the lateral ve|1
1366878|NCT01559311|4510506|P3|Overall Study|Protocol Violation|2
1366879|NCT01559311|4510507|P2|Overall Study|Protocol Violation|0
1366880|NCT01559311|4510508|P1|Overall Study|Protocol Violation|0
1366881|NCT01559116|4510519|P1|Overall Study|other than stated above|9
1366882|NCT01559116|4510519|P1|Overall Study|Withdrawal by Subject|4
1366883|NCT01559116|4510519|P1|Overall Study|Protocol Violation|1
1366884|NCT01559116|4510519|P1|Overall Study|Lost to Follow-up|1
1366885|NCT01559116|4510519|P1|Overall Study|Lack of Efficacy|1
1366886|NCT01559116|4510519|P1|Overall Study|Adverse Event|10
1366887|NCT01559012|4510602|P2|Overall Study|Withdrawal by Subject|1
1366888|NCT01559012|4510603|P1|Overall Study|Withdrawal by Subject|0
1366889|NCT01558739|4510639|P1|Overall Study|Protocol Violation|1
1366890|NCT01558739|4510639|P1|Overall Study|Disease Progression|4
1366891|NCT01558739|4510639|P1|Overall Study|Death|3
1366892|NCT01558739|4510639|P1|Overall Study|Withdrawal by Subject|2
1366893|NCT01558739|4510639|P1|Overall Study|Adverse Event|7
1366894|NCT01558674|4510664|P2|Part 1|Withdrawal by Subject|0
1366895|NCT01558674|4510665|P1|Part 1|Withdrawal by Subject|1
1366896|NCT01558674|4510664|P2|Part 1|Study Terminated by Sponsor|0
1366897|NCT01558674|4510665|P1|Part 1|Study Terminated by Sponsor|10
1366898|NCT01558596|4510718|P2|Overall Study|Protocol Violation|0
1366899|NCT01558596|4510719|P1|Overall Study|Protocol Violation|1
1366900|NCT01558596|4510718|P2|Overall Study|surgery elsewhere or cancelled|1
1366901|NCT01558596|4510719|P1|Overall Study|surgery elsewhere or cancelled|1
1366902|NCT01558596|4510718|P2|Overall Study|Withdrawal by Subject|0
1366903|NCT01558596|4510719|P1|Overall Study|Withdrawal by Subject|1
1366904|NCT01558297|4510734|P3|Overall Study|Withdrawal by Subject|1
1366905|NCT01558297|4510735|P2|Overall Study|Withdrawal by Subject|2
1366906|NCT01558297|4510736|P1|Overall Study|Withdrawal by Subject|2
1366907|NCT01558271|4510753|P3|Overall Study|Physician Decision|1
1366908|NCT01558271|4510754|P2|Overall Study|Physician Decision|2
1366909|NCT01558271|4510755|P1|Overall Study|Physician Decision|0
1366910|NCT01558271|4510753|P3|Overall Study|Withdrawal by Subject|12
1366911|NCT01558271|4510754|P2|Overall Study|Withdrawal by Subject|6
1366912|NCT01558271|4510755|P1|Overall Study|Withdrawal by Subject|10
1366913|NCT01558271|4510753|P3|Overall Study|Protocol Violation|0
1366914|NCT01558271|4510754|P2|Overall Study|Protocol Violation|0
1366915|NCT01558271|4510755|P1|Overall Study|Protocol Violation|1
1366916|NCT01558271|4510753|P3|Overall Study|Lost to Follow-up|0
1366917|NCT01558271|4510754|P2|Overall Study|Lost to Follow-up|0
1366918|NCT01558271|4510755|P1|Overall Study|Lost to Follow-up|1
1366919|NCT01558271|4510753|P3|Overall Study|Adverse Event|4
1366920|NCT01558271|4510754|P2|Overall Study|Adverse Event|3
1366921|NCT01558271|4510755|P1|Overall Study|Adverse Event|6
1366922|NCT01558089|4510821|P1|Overall Study|Withdrawal by Subject|6
1366923|NCT01558089|4510821|P1|Overall Study|Lost to Follow-up|5
1366924|NCT01558089|4510821|P1|Overall Study|Lack of Efficacy|1
1366925|NCT01558089|4510821|P1|Overall Study|Adverse Event|1
1366926|NCT01557946|4510842|P2|Overall Study|Adverse Event|0
1366927|NCT01557946|4510843|P1|Overall Study|Adverse Event|3
1366928|NCT01557920|4510849|P2|Overall Study|Lack of Efficacy|0
1366929|NCT01557920|4510850|P1|Overall Study|Lack of Efficacy|1
1366930|NCT01557920|4510849|P2|Overall Study|Withdrawal by Subject|3
1366931|NCT01557920|4510850|P1|Overall Study|Withdrawal by Subject|2
1366932|NCT01557842|4510913|P2|Overall Study|Not Ablated|0
1366933|NCT01557842|4510914|P1|Overall Study|Not Ablated|2
1366934|NCT01557842|4510913|P2|Overall Study|Study Terminated by Sponsor|4
1366935|NCT01557842|4510914|P1|Overall Study|Study Terminated by Sponsor|3
1366936|NCT01557842|4510913|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
1366937|NCT01557842|4510914|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
1366938|NCT01557842|4510913|P2|Overall Study|Lack of Efficacy|1
1366939|NCT01557842|4510914|P1|Overall Study|Lack of Efficacy|0
1366940|NCT01557842|4510913|P2|Overall Study|Death|0
1366941|NCT01557842|4510914|P1|Overall Study|Death|1
1366942|NCT01557842|4510913|P2|Overall Study|Lost to Follow-up|1
1366943|NCT01557842|4510914|P1|Overall Study|Lost to Follow-up|0
1366944|NCT01557751|4510922|P1|Overall Study|Physician Decision|3
1366945|NCT01557582|4510967|P1|Overall Study|Operator error|2
1366946|NCT01557582|4510967|P1|Overall Study|Protocol Violation|4
1366947|NCT01557569|4510975|P2|Overall Study|noncompliance with rules of residential|1
1366948|NCT01557569|4510976|P1|Overall Study|noncompliance with rules of residential|0
1366949|NCT01557569|4510975|P2|Overall Study|Withdrawal by Subject|5
1366950|NCT01557569|4510976|P1|Overall Study|Withdrawal by Subject|3
1366951|NCT01557569|4510975|P2|Overall Study|high blood pressure|1
1366952|NCT01557569|4510976|P1|Overall Study|high blood pressure|0
1366953|NCT01557569|4510975|P2|Overall Study|Adverse Event|0
1366954|NCT01557569|4510976|P1|Overall Study|Adverse Event|2
1366955|NCT01557504|4510984|P2|Overall Study|Physician Decision|0
1366956|NCT01557504|4510985|P1|Overall Study|Physician Decision|1
1366957|NCT01557348|4511010|P2|Overall Study|Administrative|11
1366958|NCT01557348|4511011|P1|Overall Study|Administrative|18
1366959|NCT01557348|4511010|P2|Overall Study|Lost to Follow-up|22
1366960|NCT01557348|4511011|P1|Overall Study|Lost to Follow-up|26
1366961|NCT01557348|4511010|P2|Overall Study|Withdrawal by Subject|4
1366962|NCT01557348|4511011|P1|Overall Study|Withdrawal by Subject|5
1366963|NCT01557348|4511010|P2|Overall Study|Insufficient Therapeutic Response|28
1366964|NCT01557348|4511011|P1|Overall Study|Insufficient Therapeutic Response|13
1366965|NCT01557348|4511010|P2|Overall Study|Death|4
1366966|NCT01557348|4511011|P1|Overall Study|Death|7
1366967|NCT01557348|4511010|P2|Overall Study|Infusion reaction event|5
1366968|NCT01557348|4511011|P1|Overall Study|Infusion reaction event|5
1366969|NCT01557348|4511010|P2|Overall Study|Adverse Event|16
1366970|NCT01557348|4511011|P1|Overall Study|Adverse Event|6
1366971|NCT01557283|4511128|P1|Overall Study|Other|6
1366972|NCT01557283|4511128|P1|Overall Study|Worsening of psoriasis|1
1366973|NCT01557283|4511128|P1|Overall Study|Participant’s weight too high for dose|1
1366974|NCT01557283|4511128|P1|Overall Study|Withdrawal by Subject|1
1366975|NCT01557283|4511128|P1|Overall Study|Non-compliance|1
1366976|NCT01557283|4511128|P1|Overall Study|Lack of Efficacy|1
1366977|NCT01557283|4511128|P1|Overall Study|Adverse Event|7
1366978|NCT01557283|4511128|P1|Overall Study|Non-responder|19
1366979|NCT01557283|4511128|P1|Overall Study|Lost to Follow-up|7
1366980|NCT01557166|4511140|P2|Overall Study|Unclassified|5
1366981|NCT01557166|4511141|P1|Overall Study|Unclassified|2
1366982|NCT01557166|4511140|P2|Overall Study|Psychiatric disorder|0
1366983|NCT01557166|4511141|P1|Overall Study|Psychiatric disorder|1
1366984|NCT01557166|4511140|P2|Overall Study|Target dose not tolerated|0
1366985|NCT01557166|4511141|P1|Overall Study|Target dose not tolerated|1
1366986|NCT01557166|4511140|P2|Overall Study|Withdrawn consent|20
1366987|NCT01557166|4511141|P1|Overall Study|Withdrawn consent|12
1366988|NCT01557166|4511140|P2|Overall Study|Protocol Violation|5
1366989|NCT01557166|4511141|P1|Overall Study|Protocol Violation|8
1366990|NCT01557166|4511140|P2|Overall Study|Lack of Efficacy|1
1366991|NCT01557166|4511141|P1|Overall Study|Lack of Efficacy|2
1366992|NCT01557166|4511140|P2|Overall Study|Adverse Event|6
1366993|NCT01557166|4511141|P1|Overall Study|Adverse Event|20
1366994|NCT01556997|4511156|P3|Overall Study|Not specified|7
1366995|NCT01556997|4511157|P2|Overall Study|Not specified|3
1366996|NCT01556997|4511158|P1|Overall Study|Not specified|2
1366997|NCT01556997|4511156|P3|Overall Study|Withdrawal by Subject|8
1366998|NCT01556997|4511157|P2|Overall Study|Withdrawal by Subject|6
1366999|NCT01556997|4511158|P1|Overall Study|Withdrawal by Subject|7
1367000|NCT01556997|4511156|P3|Overall Study|Physician Decision|1
1367001|NCT01556997|4511157|P2|Overall Study|Physician Decision|1
1367002|NCT01556997|4511158|P1|Overall Study|Physician Decision|1
1367003|NCT01556997|4511156|P3|Overall Study|Lost to Follow-up|4
1367004|NCT01556997|4511157|P2|Overall Study|Lost to Follow-up|6
1367005|NCT01556997|4511158|P1|Overall Study|Lost to Follow-up|6
1367006|NCT01556997|4511156|P3|Overall Study|Adverse Event|12
1367007|NCT01556997|4511157|P2|Overall Study|Adverse Event|12
1367008|NCT01556997|4511158|P1|Overall Study|Adverse Event|10
1367009|NCT01556932|4511169|P2|Time Point 60 Minutes|Withdrawal by Subject|1
1367010|NCT01556932|4511170|P1|Time Point 60 Minutes|Withdrawal by Subject|1
1367011|NCT01556763|4511196|P3|Overall Study|Withdrawal by Subject|0
1367012|NCT01556763|4511197|P2|Overall Study|Withdrawal by Subject|1
1367013|NCT01556763|4511198|P1|Overall Study|Withdrawal by Subject|0
1367014|NCT01556165|4511384|P2|Overall Study|Withdrawal of Consent|1
1367015|NCT01556165|4511385|P1|Overall Study|Withdrawal of Consent|7
1367016|NCT01556165|4511384|P2|Overall Study|Protocol Violation|3
1367017|NCT01556165|4511385|P1|Overall Study|Protocol Violation|0
1367018|NCT01556165|4511384|P2|Overall Study|Adverse Event|3
1367019|NCT01556165|4511385|P1|Overall Study|Adverse Event|5
1367020|NCT01555983|4511415|P6|Overall Study|Withdrawal by Subject|1
1367021|NCT01555983|4511416|P5|Overall Study|Withdrawal by Subject|1
1367022|NCT01555983|4511417|P4|Overall Study|Withdrawal by Subject|0
1367023|NCT01555983|4511418|P3|Overall Study|Withdrawal by Subject|0
1367024|NCT01555983|4511419|P2|Overall Study|Withdrawal by Subject|0
1367025|NCT01555983|4511420|P1|Overall Study|Withdrawal by Subject|1
1367026|NCT01555931|4511430|P2|Overall Study|Lost to Follow-up|5
1367027|NCT01555931|4511431|P1|Overall Study|Lost to Follow-up|2
1367028|NCT01555463|4511467|P2|Follow up|Other reason|3
1367029|NCT01555463|4511468|P1|Follow up|Other reason|3
1367030|NCT01555463|4511467|P2|Follow up|Protocol Violation|4
1367031|NCT01555463|4511468|P1|Follow up|Protocol Violation|2
1367032|NCT01555463|4511467|P2|Follow up|Lost to Follow-up|10
1367033|NCT01555463|4511468|P1|Follow up|Lost to Follow-up|9
1367034|NCT01555463|4511467|P2|Follow up|Withdrawal by Subject|22
1367035|NCT01555463|4511468|P1|Follow up|Withdrawal by Subject|22
1367036|NCT01555463|4511467|P2|Follow up|Death|1
1367037|NCT01555463|4511468|P1|Follow up|Death|0
1367038|NCT01555463|4511467|P2|Follow up|Adverse Event|5
1367039|NCT01555463|4511468|P1|Follow up|Adverse Event|2
1367040|NCT01555463|4511467|P2|Treatment|Other reason|3
1367041|NCT01555463|4511468|P1|Treatment|Other reason|2
1367042|NCT01555463|4511467|P2|Treatment|Protocol Violation|5
1367043|NCT01555463|4511468|P1|Treatment|Protocol Violation|4
1367044|NCT01555463|4511467|P2|Treatment|Lost to Follow-up|23
1367045|NCT01555463|4511468|P1|Treatment|Lost to Follow-up|28
1367046|NCT01555463|4511467|P2|Treatment|Withdrawal by Subject|36
1367047|NCT01555463|4511468|P1|Treatment|Withdrawal by Subject|24
1367048|NCT01555463|4511467|P2|Treatment|Adverse Event|12
1367049|NCT01555463|4511468|P1|Treatment|Adverse Event|6
1367050|NCT01555164|4511510|P2|Overall Study|Subject Withdrew Consent|11
1367051|NCT01555164|4511511|P1|Overall Study|Subject Withdrew Consent|6
1367052|NCT01555164|4511510|P2|Overall Study|Subject Non-compliance|6
1367053|NCT01555164|4511511|P1|Overall Study|Subject Non-compliance|14
1367054|NCT01555164|4511510|P2|Overall Study|Protocol Violation|5
1367055|NCT01555164|4511511|P1|Overall Study|Protocol Violation|9
1367056|NCT01555164|4511510|P2|Overall Study|Lost to Follow-up|3
1367057|NCT01555164|4511511|P1|Overall Study|Lost to Follow-up|4
1367058|NCT01555164|4511510|P2|Overall Study|Investigator's Discretion|2
1367059|NCT01555164|4511511|P1|Overall Study|Investigator's Discretion|2
1367060|NCT01555164|4511510|P2|Overall Study|Hyperglycemia|1
1367061|NCT01555164|4511511|P1|Overall Study|Hyperglycemia|0
1367062|NCT01555164|4511510|P2|Overall Study|Adverse Event|7
1367063|NCT01555164|4511511|P1|Overall Study|Adverse Event|5
1367064|NCT01555151|4511525|P4|Overall Study|Lost to Follow-up|1
1367065|NCT01555151|4511526|P3|Overall Study|Lost to Follow-up|0
1367066|NCT01555151|4511527|P2|Overall Study|Lost to Follow-up|0
1367067|NCT01555151|4511528|P1|Overall Study|Lost to Follow-up|0
1367068|NCT01555151|4511525|P4|Overall Study|Adverse Event|2
1367069|NCT01555151|4511526|P3|Overall Study|Adverse Event|1
1367070|NCT01555151|4511527|P2|Overall Study|Adverse Event|2
1367071|NCT01555151|4511528|P1|Overall Study|Adverse Event|1
1367072|NCT01555151|4511525|P4|Overall Study|Protocol Violation|5
1367073|NCT01555151|4511526|P3|Overall Study|Protocol Violation|3
1367074|NCT01555151|4511527|P2|Overall Study|Protocol Violation|3
1367075|NCT01555151|4511528|P1|Overall Study|Protocol Violation|3
1367076|NCT01555151|4511525|P4|Overall Study|Administrative|0
1367077|NCT01555151|4511526|P3|Overall Study|Administrative|2
1367078|NCT01555151|4511527|P2|Overall Study|Administrative|1
1367079|NCT01555151|4511528|P1|Overall Study|Administrative|3
1367080|NCT01555151|4511525|P4|Overall Study|Withdrawal by Subject|2
1367081|NCT01555151|4511526|P3|Overall Study|Withdrawal by Subject|0
1367082|NCT01555151|4511527|P2|Overall Study|Withdrawal by Subject|2
1367083|NCT01555151|4511528|P1|Overall Study|Withdrawal by Subject|6
1367084|NCT01555138|4511581|P2|Overall Study|Adverse Event|14
1367085|NCT01555138|4511582|P1|Overall Study|Adverse Event|14
1367086|NCT01555138|4511581|P2|Overall Study|Withdrawal by Subject|15
1367087|NCT01555138|4511582|P1|Overall Study|Withdrawal by Subject|16
1367088|NCT01555138|4511581|P2|Overall Study|Administrative problems|0
1367089|NCT01555138|4511582|P1|Overall Study|Administrative problems|8
1367090|NCT01555138|4511581|P2|Overall Study|Protocol Violation|3
1367091|NCT01555138|4511582|P1|Overall Study|Protocol Violation|5
1367092|NCT01555138|4511581|P2|Overall Study|Lack of Efficacy|2
1367093|NCT01555138|4511582|P1|Overall Study|Lack of Efficacy|2
1367094|NCT01555138|4511581|P2|Overall Study|Abnormal Lab reults|3
1367095|NCT01555138|4511582|P1|Overall Study|Abnormal Lab reults|1
1367096|NCT01555138|4511581|P2|Overall Study|Lost to Follow-up|0
1367097|NCT01555138|4511582|P1|Overall Study|Lost to Follow-up|1
1367098|NCT01555138|4511581|P2|Overall Study|Death|1
1367099|NCT01555138|4511582|P1|Overall Study|Death|0
1367100|NCT01555125|4511611|P5|Follow-Up Period|Subject / guardian decision|0
1367101|NCT01555125|4511612|P4|Follow-Up Period|Subject / guardian decision|1
1367102|NCT01555125|4511613|P3|Follow-Up Period|Subject / guardian decision|1
1367103|NCT01555125|4511614|P2|Follow-Up Period|Subject / guardian decision|1
1367104|NCT01555125|4511615|P1|Follow-Up Period|Subject / guardian decision|3
1367105|NCT01555125|4511611|P5|Follow-Up Period|Lost to Follow-up|0
1367106|NCT01555125|4511612|P4|Follow-Up Period|Lost to Follow-up|0
1367107|NCT01555125|4511613|P3|Follow-Up Period|Lost to Follow-up|0
1367108|NCT01555125|4511614|P2|Follow-Up Period|Lost to Follow-up|0
1367109|NCT01555125|4511615|P1|Follow-Up Period|Lost to Follow-up|1
1367110|NCT01555125|4511611|P5|Extension|Technical Problems|0
1367111|NCT01555125|4511612|P4|Extension|Technical Problems|1
1367112|NCT01555125|4511613|P3|Extension|Technical Problems|0
1367113|NCT01555125|4511614|P2|Extension|Technical Problems|0
1367114|NCT01555125|4511615|P1|Extension|Technical Problems|1
1367115|NCT01555125|4511611|P5|Extension|Subject/guardian decision|0
1367116|NCT01555125|4511612|P4|Extension|Subject/guardian decision|0
1367117|NCT01555125|4511613|P3|Extension|Subject/guardian decision|1
1367118|NCT01555125|4511614|P2|Extension|Subject/guardian decision|9
1367119|NCT01555125|4511615|P1|Extension|Subject/guardian decision|1
1367120|NCT01555125|4511611|P5|Extension|Study terminated by sponsor|0
1367121|NCT01555125|4511612|P4|Extension|Study terminated by sponsor|20
1367122|NCT01555125|4511613|P3|Extension|Study terminated by sponsor|16
1367123|NCT01555125|4511614|P2|Extension|Study terminated by sponsor|33
1367124|NCT01555125|4511615|P1|Extension|Study terminated by sponsor|32
1367125|NCT01555125|4511611|P5|Extension|Lost to Follow-up|0
1367126|NCT01555125|4511612|P4|Extension|Lost to Follow-up|0
1367127|NCT01555125|4511613|P3|Extension|Lost to Follow-up|2
1367128|NCT01555125|4511614|P2|Extension|Lost to Follow-up|1
1367129|NCT01555125|4511615|P1|Extension|Lost to Follow-up|2
1367130|NCT01555125|4511611|P5|Extension|Lack of Efficacy|0
1367131|NCT01555125|4511612|P4|Extension|Lack of Efficacy|0
1367132|NCT01555125|4511613|P3|Extension|Lack of Efficacy|3
1367133|NCT01555125|4511614|P2|Extension|Lack of Efficacy|6
1367134|NCT01555125|4511615|P1|Extension|Lack of Efficacy|7
1367135|NCT01555125|4511611|P5|Extension|Protocol deviation|0
1367136|NCT01555125|4511612|P4|Extension|Protocol deviation|0
1367137|NCT01555125|4511613|P3|Extension|Protocol deviation|0
1367138|NCT01555125|4511614|P2|Extension|Protocol deviation|0
1367139|NCT01555125|4511615|P1|Extension|Protocol deviation|1
1367140|NCT01555125|4511611|P5|Extension|Adverse Event|0
1367141|NCT01555125|4511612|P4|Extension|Adverse Event|1
1367142|NCT01555125|4511613|P3|Extension|Adverse Event|1
1367143|NCT01555125|4511614|P2|Extension|Adverse Event|2
1367144|NCT01555125|4511615|P1|Extension|Adverse Event|1
1367145|NCT01555125|4511611|P5|Maintenance Period|Death|0
1367146|NCT01555125|4511612|P4|Maintenance Period|Death|1
1367147|NCT01555125|4511613|P3|Maintenance Period|Death|0
1367148|NCT01555125|4511614|P2|Maintenance Period|Death|0
1367149|NCT01555125|4511615|P1|Maintenance Period|Death|0
1367150|NCT01555125|4511611|P5|Maintenance Period|Physician Decision|0
1367151|NCT01555125|4511612|P4|Maintenance Period|Physician Decision|0
1367152|NCT01555125|4511613|P3|Maintenance Period|Physician Decision|1
1367153|NCT01555125|4511614|P2|Maintenance Period|Physician Decision|0
1367154|NCT01555125|4511615|P1|Maintenance Period|Physician Decision|0
1367155|NCT01555125|4511611|P5|Maintenance Period|Lack of Efficacy|0
1367156|NCT01555125|4511612|P4|Maintenance Period|Lack of Efficacy|0
1367157|NCT01555125|4511613|P3|Maintenance Period|Lack of Efficacy|3
1367158|NCT01555125|4511614|P2|Maintenance Period|Lack of Efficacy|1
1367159|NCT01555125|4511615|P1|Maintenance Period|Lack of Efficacy|6
1367160|NCT01555125|4511611|P5|Maintenance Period|Lost to Follow-up|0
1367161|NCT01555125|4511612|P4|Maintenance Period|Lost to Follow-up|1
1367162|NCT01555125|4511613|P3|Maintenance Period|Lost to Follow-up|0
1367163|NCT01555125|4511614|P2|Maintenance Period|Lost to Follow-up|0
1367164|NCT01555125|4511615|P1|Maintenance Period|Lost to Follow-up|2
1367165|NCT01555125|4511611|P5|Maintenance Period|Subject / guardian decision|0
1367166|NCT01555125|4511612|P4|Maintenance Period|Subject / guardian decision|0
1367167|NCT01555125|4511613|P3|Maintenance Period|Subject / guardian decision|0
1367168|NCT01555125|4511614|P2|Maintenance Period|Subject / guardian decision|2
1367169|NCT01555125|4511615|P1|Maintenance Period|Subject / guardian decision|1
1367170|NCT01555125|4511611|P5|Maintenance Period|Adverse Event|0
1367171|NCT01555125|4511612|P4|Maintenance Period|Adverse Event|0
1367172|NCT01555125|4511613|P3|Maintenance Period|Adverse Event|0
1367173|NCT01555125|4511614|P2|Maintenance Period|Adverse Event|1
1367174|NCT01555125|4511615|P1|Maintenance Period|Adverse Event|1
1367175|NCT01555125|4511611|P5|Induction Period|Death|0
1367176|NCT01555125|4511612|P4|Induction Period|Death|0
1367177|NCT01555125|4511613|P3|Induction Period|Death|0
1367178|NCT01555125|4511614|P2|Induction Period|Death|0
1367179|NCT01555125|4511615|P1|Induction Period|Death|1
1367180|NCT01555125|4511611|P5|Induction Period|Subject / guardian decision|2
1367181|NCT01555125|4511612|P4|Induction Period|Subject / guardian decision|0
1367182|NCT01555125|4511613|P3|Induction Period|Subject / guardian decision|0
1367183|NCT01555125|4511614|P2|Induction Period|Subject / guardian decision|0
1367184|NCT01555125|4511615|P1|Induction Period|Subject / guardian decision|0
1367185|NCT01555125|4511611|P5|Induction Period|Adverse Event|1
1367186|NCT01555125|4511612|P4|Induction Period|Adverse Event|0
1367187|NCT01555125|4511613|P3|Induction Period|Adverse Event|0
1367188|NCT01555125|4511614|P2|Induction Period|Adverse Event|1
1367189|NCT01555125|4511615|P1|Induction Period|Adverse Event|0
1367190|NCT01555125|4511611|P5|Induction Period|Lost to Follow-up|0
1367191|NCT01555125|4511612|P4|Induction Period|Lost to Follow-up|0
1367192|NCT01555125|4511613|P3|Induction Period|Lost to Follow-up|0
1367193|NCT01555125|4511614|P2|Induction Period|Lost to Follow-up|2
1367194|NCT01555125|4511615|P1|Induction Period|Lost to Follow-up|0
1367195|NCT01555073|4511708|P4|Overall Study|Lost to Follow-up|5
1367196|NCT01555073|4511709|P3|Overall Study|Lost to Follow-up|0
1367197|NCT01555073|4511710|P2|Overall Study|Lost to Follow-up|2
1367198|NCT01555073|4511711|P1|Overall Study|Lost to Follow-up|1
1367199|NCT01554904|4511738|P1|Overall Study|Had sleep apnea on Home Study 1|1
1367200|NCT01554904|4511738|P1|Overall Study|Withdrawal by Subject|3
1367201|NCT01554579|4511758|P2|Overall Study|Withdrawal by Subject|1
1367202|NCT01554579|4511759|P1|Overall Study|Withdrawal by Subject|2
1367203|NCT01554579|4511758|P2|Overall Study|Lack of Efficacy|1
1367204|NCT01554579|4511759|P1|Overall Study|Lack of Efficacy|2
1367205|NCT01554579|4511758|P2|Overall Study|Adverse Event|25
1367206|NCT01554579|4511759|P1|Overall Study|Adverse Event|6
1367207|NCT01554241|4511773|P4|Overall Study|Withdrawal by Subject|0
1367208|NCT01554241|4511774|P3|Overall Study|Withdrawal by Subject|2
1367209|NCT01554241|4511775|P2|Overall Study|Withdrawal by Subject|0
1367210|NCT01554241|4511776|P1|Overall Study|Withdrawal by Subject|0
1367211|NCT01554241|4511773|P4|Overall Study|protocol specified change in eGFR|0
1367212|NCT01554241|4511774|P3|Overall Study|protocol specified change in eGFR|1
1367213|NCT01554241|4511775|P2|Overall Study|protocol specified change in eGFR|0
1367214|NCT01554241|4511776|P1|Overall Study|protocol specified change in eGFR|0
1367215|NCT01554241|4511773|P4|Overall Study|protocol specified renal stone|1
1367216|NCT01554241|4511774|P3|Overall Study|protocol specified renal stone|0
1367217|NCT01554241|4511775|P2|Overall Study|protocol specified renal stone|0
1367218|NCT01554241|4511776|P1|Overall Study|protocol specified renal stone|0
1367219|NCT01554241|4511773|P4|Overall Study|Death|0
1367220|NCT01554241|4511774|P3|Overall Study|Death|1
1367221|NCT01554241|4511775|P2|Overall Study|Death|1
1367222|NCT01554241|4511776|P1|Overall Study|Death|3
1367223|NCT01554176|4511792|P5|Run-out Phase|Protocol Violation|0
1367224|NCT01554176|4511793|P4|Run-out Phase|Protocol Violation|1
1367225|NCT01554176|4511794|P3|Run-out Phase|Protocol Violation|0
1367226|NCT01554176|4511795|P2|Run-out Phase|Protocol Violation|0
1367227|NCT01554176|4511796|P1|Run-out Phase|Protocol Violation|0
1367228|NCT01554176|4511792|P5|Treatment Phase|Lost to Follow-up|0
1367229|NCT01554176|4511793|P4|Treatment Phase|Lost to Follow-up|0
1367230|NCT01554176|4511794|P3|Treatment Phase|Lost to Follow-up|0
1367231|NCT01554176|4511795|P2|Treatment Phase|Lost to Follow-up|0
1367232|NCT01554176|4511796|P1|Treatment Phase|Lost to Follow-up|3
1367233|NCT01554176|4511792|P5|Treatment Phase|Withdrawal by Subject|0
1367234|NCT01554176|4511793|P4|Treatment Phase|Withdrawal by Subject|0
1367235|NCT01554176|4511794|P3|Treatment Phase|Withdrawal by Subject|0
1367236|NCT01554176|4511795|P2|Treatment Phase|Withdrawal by Subject|0
1367237|NCT01554176|4511796|P1|Treatment Phase|Withdrawal by Subject|1
1367238|NCT01554176|4511792|P5|Treatment Phase|Non-compliance with study drug|0
1367239|NCT01554176|4511793|P4|Treatment Phase|Non-compliance with study drug|0
1367240|NCT01554176|4511794|P3|Treatment Phase|Non-compliance with study drug|0
1367241|NCT01554176|4511795|P2|Treatment Phase|Non-compliance with study drug|0
1367242|NCT01554176|4511796|P1|Treatment Phase|Non-compliance with study drug|1
1367243|NCT01554176|4511792|P5|Treatment Phase|Adverse event, non-fatal|0
1367244|NCT01554176|4511793|P4|Treatment Phase|Adverse event, non-fatal|0
1367245|NCT01554176|4511794|P3|Treatment Phase|Adverse event, non-fatal|0
1367246|NCT01554176|4511795|P2|Treatment Phase|Adverse event, non-fatal|1
1367247|NCT01554176|4511796|P1|Treatment Phase|Adverse event, non-fatal|1
1367248|NCT01554176|4511792|P5|Treatment Phase|Lack of Efficacy|0
1367249|NCT01554176|4511793|P4|Treatment Phase|Lack of Efficacy|0
1367250|NCT01554176|4511794|P3|Treatment Phase|Lack of Efficacy|0
1367251|NCT01554176|4511795|P2|Treatment Phase|Lack of Efficacy|1
1367252|NCT01554176|4511796|P1|Treatment Phase|Lack of Efficacy|0
1367253|NCT01554176|4511792|P5|Treatment Phase|Physician Decision|0
1367254|NCT01554176|4511793|P4|Treatment Phase|Physician Decision|0
1367255|NCT01554176|4511794|P3|Treatment Phase|Physician Decision|0
1367256|NCT01554176|4511795|P2|Treatment Phase|Physician Decision|1
1367257|NCT01554176|4511796|P1|Treatment Phase|Physician Decision|1
1367258|NCT01554176|4511792|P5|Treatment Phase|Protocol Violation|0
1367259|NCT01554176|4511793|P4|Treatment Phase|Protocol Violation|0
1367260|NCT01554176|4511794|P3|Treatment Phase|Protocol Violation|0
1367261|NCT01554176|4511795|P2|Treatment Phase|Protocol Violation|2
1367262|NCT01554176|4511796|P1|Treatment Phase|Protocol Violation|1
1367263|NCT01554163|4511823|P2|Overall Study|Not Treated|0
1367264|NCT01554163|4511824|P1|Overall Study|Not Treated|1
1367265|NCT01554163|4511823|P2|Overall Study|Withdrawal by Subject|5
1367266|NCT01554163|4511824|P1|Overall Study|Withdrawal by Subject|1
1367267|NCT01554163|4511823|P2|Overall Study|Protocol Violation|4
1367268|NCT01554163|4511824|P1|Overall Study|Protocol Violation|0
1367269|NCT01554163|4511823|P2|Overall Study|Non-Compliance With Study Drug|1
1367270|NCT01554163|4511824|P1|Overall Study|Non-Compliance With Study Drug|1
1367271|NCT01554163|4511823|P2|Overall Study|Lost to Follow-up|0
1367272|NCT01554163|4511824|P1|Overall Study|Lost to Follow-up|1
1367273|NCT01554163|4511823|P2|Overall Study|Lack of Efficacy|0
1367274|NCT01554163|4511824|P1|Overall Study|Lack of Efficacy|1
1367275|NCT01554163|4511823|P2|Overall Study|Adverse Event|0
1367276|NCT01554163|4511824|P1|Overall Study|Adverse Event|3
1367277|NCT01553916|4511842|P1|Overall Study|Pre-treatment MRI metastatic disease|1
1367278|NCT01553916|4511842|P1|Overall Study|Withdrawal by Subject|2
1367279|NCT01553851|4511859|P1|Overall Study|constipation|1
1367280|NCT01553851|4511859|P1|Overall Study|Adverse Event|2
1367281|NCT01553747|4511874|P3|Overall Study|Physician decision: lack of efficacy|3
1367282|NCT01553747|4511875|P2|Overall Study|Physician decision: lack of efficacy|5
1367283|NCT01553747|4511876|P1|Overall Study|Physician decision: lack of efficacy|1
1367284|NCT01553747|4511874|P3|Overall Study|Sponsor decision, specify|0
1367285|NCT01553747|4511875|P2|Overall Study|Sponsor decision, specify|5
1367286|NCT01553747|4511876|P1|Overall Study|Sponsor decision, specify|7
1367287|NCT01553747|4511874|P3|Overall Study|Lost to Follow-up|6
1367288|NCT01553747|4511875|P2|Overall Study|Lost to Follow-up|5
1367289|NCT01553747|4511876|P1|Overall Study|Lost to Follow-up|11
1367290|NCT01553747|4511874|P3|Overall Study|Physician decision: other|7
1367291|NCT01553747|4511875|P2|Overall Study|Physician decision: other|8
1367292|NCT01553747|4511876|P1|Overall Study|Physician decision: other|10
1367293|NCT01553747|4511874|P3|Overall Study|Adverse event or SAE|19
1367294|NCT01553747|4511875|P2|Overall Study|Adverse event or SAE|28
1367295|NCT01553747|4511876|P1|Overall Study|Adverse event or SAE|32
1367296|NCT01553747|4511874|P3|Overall Study|Voluntarily withdrew|74
1367297|NCT01553747|4511875|P2|Overall Study|Voluntarily withdrew|66
1367298|NCT01553747|4511876|P1|Overall Study|Voluntarily withdrew|70
1367299|NCT01553747|4511874|P3|Overall Study|Protocol Violation|0
1367300|NCT01553747|4511875|P2|Overall Study|Protocol Violation|2
1367301|NCT01553747|4511876|P1|Overall Study|Protocol Violation|0
1367302|NCT01553318|4511945|P2|Overall Study|Protocol Violation|2
1367303|NCT01553318|4511946|P1|Overall Study|Protocol Violation|3
1367304|NCT01553136|4511981|P2|Overall Study|Scheduling Difficulties|4
1367305|NCT01553136|4511982|P1|Overall Study|Scheduling Difficulties|5
1367306|NCT01553136|4511981|P2|Overall Study|Physician Decision|3
1367307|NCT01553136|4511982|P1|Overall Study|Physician Decision|2
1367308|NCT01553136|4511981|P2|Overall Study|Lost to Follow-up|10
1367309|NCT01553136|4511982|P1|Overall Study|Lost to Follow-up|4
1367310|NCT01553136|4511981|P2|Overall Study|Withdrawal by Subject|3
1367311|NCT01553136|4511982|P1|Overall Study|Withdrawal by Subject|2
1367312|NCT01553136|4511981|P2|Overall Study|Adverse Event|2
1367313|NCT01553136|4511982|P1|Overall Study|Adverse Event|3
1367314|NCT01552954|4512062|P2|Overall Study|diagnosed DM|0
1367315|NCT01552954|4512063|P1|Overall Study|diagnosed DM|1
1367316|NCT01552954|4512062|P2|Overall Study|Protocol Violation|2
1367317|NCT01552954|4512063|P1|Overall Study|Protocol Violation|1
1367318|NCT01552954|4512062|P2|Overall Study|Withdrawal by Subject|1
1367319|NCT01552954|4512063|P1|Overall Study|Withdrawal by Subject|1
1367320|NCT01552954|4512062|P2|Overall Study|Lost to Follow-up|1
1367321|NCT01552954|4512063|P1|Overall Study|Lost to Follow-up|1
1367322|NCT01552954|4512062|P2|Overall Study|Adverse Event|2
1367323|NCT01552954|4512063|P1|Overall Study|Adverse Event|1
1367324|NCT01552928|4512079|P4|Period 3|Adverse Event|0
1367325|NCT01552928|4512080|P3|Period 3|Adverse Event|1
1367326|NCT01552928|4512081|P2|Period 3|Adverse Event|0
1367327|NCT01552928|4512082|P1|Period 3|Adverse Event|0
1367328|NCT01552915|4512129|P3|Overall Study|Not specified|6
1367329|NCT01552915|4512130|P2|Overall Study|Not specified|0
1367330|NCT01552915|4512131|P1|Overall Study|Not specified|2
1367331|NCT01552915|4512129|P3|Overall Study|Lack of Efficacy|4
1367332|NCT01552915|4512130|P2|Overall Study|Lack of Efficacy|1
1367333|NCT01552915|4512131|P1|Overall Study|Lack of Efficacy|8
1367334|NCT01552915|4512129|P3|Overall Study|Protocol Violation|4
1367335|NCT01552915|4512130|P2|Overall Study|Protocol Violation|4
1367336|NCT01552915|4512131|P1|Overall Study|Protocol Violation|0
1367337|NCT01552915|4512129|P3|Overall Study|Withdrawal by Subject|5
1367338|NCT01552915|4512130|P2|Overall Study|Withdrawal by Subject|4
1367339|NCT01552915|4512131|P1|Overall Study|Withdrawal by Subject|6
1367340|NCT01552915|4512129|P3|Overall Study|Lost to Follow-up|5
1367341|NCT01552915|4512130|P2|Overall Study|Lost to Follow-up|6
1367342|NCT01552915|4512131|P1|Overall Study|Lost to Follow-up|4
1367343|NCT01552915|4512129|P3|Overall Study|Adverse Event|3
1367344|NCT01552915|4512130|P2|Overall Study|Adverse Event|14
1367345|NCT01552915|4512131|P1|Overall Study|Adverse Event|3
1367346|NCT01552902|4512154|P3|Overall Study|Other|3
1367347|NCT01552902|4512155|P2|Overall Study|Other|4
1367348|NCT01552902|4512156|P1|Overall Study|Other|3
1367349|NCT01552902|4512154|P3|Overall Study|Lost to Follow-up|6
1367350|NCT01552902|4512155|P2|Overall Study|Lost to Follow-up|3
1367351|NCT01552902|4512156|P1|Overall Study|Lost to Follow-up|1
1367352|NCT01552902|4512154|P3|Overall Study|Withdrawal by Subject|6
1367353|NCT01552902|4512155|P2|Overall Study|Withdrawal by Subject|9
1367354|NCT01552902|4512156|P1|Overall Study|Withdrawal by Subject|1
1367355|NCT01552902|4512154|P3|Overall Study|Lack of Efficacy|1
1367356|NCT01552902|4512155|P2|Overall Study|Lack of Efficacy|3
1367357|NCT01552902|4512156|P1|Overall Study|Lack of Efficacy|4
1367358|NCT01552902|4512154|P3|Overall Study|Protocol Violation|3
1367359|NCT01552902|4512155|P2|Overall Study|Protocol Violation|3
1367360|NCT01552902|4512156|P1|Overall Study|Protocol Violation|3
1367361|NCT01552902|4512154|P3|Overall Study|Adverse Event|14
1367362|NCT01552902|4512155|P2|Overall Study|Adverse Event|15
1367363|NCT01552902|4512156|P1|Overall Study|Adverse Event|1
1367364|NCT01552772|4512206|P1|Overall Study|Protocol Deviation|1
1367365|NCT01552772|4512206|P1|Overall Study|Adverse Event|1
1367366|NCT01552772|4512206|P1|Overall Study|Lost to Follow-up|2
1367367|NCT01552694|4512222|P2|Overall Study|Protocol Violation|1
1367368|NCT01552694|4512223|P1|Overall Study|Protocol Violation|0
1367369|NCT01552694|4512222|P2|Overall Study|Lost to Follow-up|1
1367370|NCT01552694|4512223|P1|Overall Study|Lost to Follow-up|0
1367371|NCT01552681|4512239|P2|Overall Study|Subject moved away|1
1367372|NCT01552681|4512240|P1|Overall Study|Subject moved away|0
1367373|NCT01552681|4512239|P2|Overall Study|Physician Decision|0
1367374|NCT01552681|4512240|P1|Overall Study|Physician Decision|1
1367375|NCT01552681|4512239|P2|Overall Study|Withdrawal by Subject|0
1367376|NCT01552681|4512240|P1|Overall Study|Withdrawal by Subject|4
1367377|NCT01552603|4512288|P1|Overall Study|Physician Decision|1
1367378|NCT01552057|4512319|P2|Overall Study|Physician Decision|0
1367379|NCT01552057|4512320|P1|Overall Study|Physician Decision|1
1367380|NCT01552057|4512319|P2|Overall Study|Entry Criteria Not Met|2
1367381|NCT01552057|4512320|P1|Overall Study|Entry Criteria Not Met|2
1367382|NCT01552057|4512319|P2|Overall Study|Withdrawal by Subject|8
1367383|NCT01552057|4512320|P1|Overall Study|Withdrawal by Subject|5
1367384|NCT01552057|4512319|P2|Overall Study|Lack of Efficacy|23
1367385|NCT01552057|4512320|P1|Overall Study|Lack of Efficacy|8
1367386|NCT01552057|4512319|P2|Overall Study|Adverse Event|15
1367387|NCT01552057|4512320|P1|Overall Study|Adverse Event|14
1367388|NCT01551758|4512386|P2|Overall Study|Withdrawal by Subject|17
1367389|NCT01551758|4512387|P1|Overall Study|Withdrawal by Subject|14
1367390|NCT01551758|4512386|P2|Overall Study|Physician Decision|3
1367391|NCT01551758|4512387|P1|Overall Study|Physician Decision|9
1367392|NCT01551758|4512386|P2|Overall Study|Lost to Follow-up|25
1367393|NCT01551758|4512387|P1|Overall Study|Lost to Follow-up|29
1367394|NCT01551758|4512386|P2|Overall Study|Met Protocol-defined stopping criteria|10
1367395|NCT01551758|4512387|P1|Overall Study|Met Protocol-defined stopping criteria|8
1367396|NCT01551758|4512386|P2|Overall Study|Protocol Violation|6
1367397|NCT01551758|4512387|P1|Overall Study|Protocol Violation|5
1367398|NCT01551758|4512386|P2|Overall Study|Lack of Efficacy|1
1367399|NCT01551758|4512387|P1|Overall Study|Lack of Efficacy|0
1367400|NCT01551758|4512386|P2|Overall Study|Adverse Event|43
1367401|NCT01551758|4512387|P1|Overall Study|Adverse Event|29
1367402|NCT01551745|4512425|P1|Overall Study|Disease Progression|2
1367403|NCT01551745|4512425|P1|Overall Study|Withdrawal by Subject|1
1367404|NCT01551693|4512434|P2|Overall Study|Withdrawal by Subject|1
1367405|NCT01551693|4512435|P1|Overall Study|Withdrawal by Subject|0
1367406|NCT01551693|4512434|P2|Overall Study|Adverse Event|1
1367407|NCT01551693|4512435|P1|Overall Study|Adverse Event|0
1367408|NCT01551693|4512434|P2|Overall Study|Disease Progression|0
1367409|NCT01551693|4512435|P1|Overall Study|Disease Progression|1
1367410|NCT01551355|4512451|P6|Overall Study|Lost to Follow-up|6
1367411|NCT01551355|4512452|P5|Overall Study|Lost to Follow-up|9
1367412|NCT01551355|4512453|P4|Overall Study|Lost to Follow-up|24
1367413|NCT01551355|4512454|P3|Overall Study|Lost to Follow-up|34
1367414|NCT01551355|4512455|P2|Overall Study|Lost to Follow-up|49
1367415|NCT01551355|4512456|P1|Overall Study|Lost to Follow-up|51
1367416|NCT01551303|4512470|P2|Overall Study|failed awareness check on vision test|7
1367417|NCT01551303|4512471|P1|Overall Study|failed awareness check on vision test|4
1367418|NCT01551173|4512485|P2|Overall Study|Not specified|3
1367419|NCT01551173|4512486|P1|Overall Study|Not specified|5
1367420|NCT01551173|4512485|P2|Overall Study|Lost to Follow-up|7
1367421|NCT01551173|4512486|P1|Overall Study|Lost to Follow-up|5
1367422|NCT01551173|4512485|P2|Overall Study|Adverse Event|6
1367423|NCT01551173|4512486|P1|Overall Study|Adverse Event|7
1367424|NCT01551173|4512485|P2|Overall Study|Withdrawal by Subject|16
1367425|NCT01551173|4512486|P1|Overall Study|Withdrawal by Subject|11
1367426|NCT01550965|4512563|P1|Overall Study|Not Specified|13
1367427|NCT01550965|4512563|P1|Overall Study|Lack of Efficacy|59
1367428|NCT01550965|4512563|P1|Overall Study|Lost to Follow-up|2
1367429|NCT01550965|4512563|P1|Overall Study|Withdrawal by Subject|10
1367430|NCT01550965|4512563|P1|Overall Study|Adverse Event|26
1367431|NCT01550757|4512607|P4|Overall Study|Withdrawal by Subject|1
1367432|NCT01550757|4512608|P3|Overall Study|Withdrawal by Subject|3
1367433|NCT01550757|4512609|P2|Overall Study|Withdrawal by Subject|0
1367434|NCT01550757|4512610|P1|Overall Study|Withdrawal by Subject|2
1367435|NCT01550757|4512607|P4|Overall Study|Lost to Follow-up|53
1367436|NCT01550757|4512608|P3|Overall Study|Lost to Follow-up|42
1367437|NCT01550757|4512609|P2|Overall Study|Lost to Follow-up|14
1367438|NCT01550757|4512610|P1|Overall Study|Lost to Follow-up|21
1367439|NCT01550744|4512620|P3|Double-Blind|Other|10
1367440|NCT01550744|4512621|P2|Double-Blind|Other|2
1367441|NCT01550744|4512622|P1|Double-Blind|Other|0
1367442|NCT01550744|4512620|P3|Double-Blind|Pregnancy|3
1367443|NCT01550744|4512621|P2|Double-Blind|Pregnancy|0
1367444|NCT01550744|4512622|P1|Double-Blind|Pregnancy|0
1367445|NCT01550744|4512620|P3|Double-Blind|Protocol Violation|4
1367446|NCT01550744|4512621|P2|Double-Blind|Protocol Violation|0
1367447|NCT01550744|4512622|P1|Double-Blind|Protocol Violation|0
1367448|NCT01550744|4512620|P3|Double-Blind|Lack of Efficacy|8
1367449|NCT01550744|4512621|P2|Double-Blind|Lack of Efficacy|2
1367450|NCT01550744|4512622|P1|Double-Blind|Lack of Efficacy|0
1367451|NCT01550744|4512620|P3|Double-Blind|Death|0
1367452|NCT01550744|4512621|P2|Double-Blind|Death|1
1367453|NCT01550744|4512622|P1|Double-Blind|Death|0
1367454|NCT01550744|4512620|P3|Double-Blind|Adverse Event|15
1367455|NCT01550744|4512621|P2|Double-Blind|Adverse Event|4
1367456|NCT01550744|4512622|P1|Double-Blind|Adverse Event|0
1367457|NCT01550744|4512620|P3|Double-Blind|Withdrawal by Subject|15
1367458|NCT01550744|4512621|P2|Double-Blind|Withdrawal by Subject|2
1367459|NCT01550744|4512622|P1|Double-Blind|Withdrawal by Subject|0
1367460|NCT01550744|4512620|P3|Double-Blind|Lost to Follow-up|12
1367461|NCT01550744|4512621|P2|Double-Blind|Lost to Follow-up|6
1367462|NCT01550744|4512622|P1|Double-Blind|Lost to Follow-up|0
1367463|NCT01550744|4512620|P3|Open-Label|Other|0
1367464|NCT01550744|4512621|P2|Open-Label|Other|0
1367465|NCT01550744|4512622|P1|Open-Label|Other|1
1367466|NCT01550744|4512620|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
1367467|NCT01550744|4512621|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
1367468|NCT01550744|4512622|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
1367469|NCT01550744|4512620|P3|Open-Label|Not all 3 study drug injections received|0
1367470|NCT01550744|4512621|P2|Open-Label|Not all 3 study drug injections received|0
1367471|NCT01550744|4512622|P1|Open-Label|Not all 3 study drug injections received|2
1367472|NCT01550744|4512620|P3|Open-Label|Protocol Violation|0
1367473|NCT01550744|4512621|P2|Open-Label|Protocol Violation|0
1367474|NCT01550744|4512622|P1|Open-Label|Protocol Violation|4
1367475|NCT01550744|4512620|P3|Open-Label|Lack of Efficacy|0
1367476|NCT01550744|4512621|P2|Open-Label|Lack of Efficacy|0
1367477|NCT01550744|4512622|P1|Open-Label|Lack of Efficacy|4
1367478|NCT01550744|4512620|P3|Open-Label|Adverse Event|0
1367479|NCT01550744|4512621|P2|Open-Label|Adverse Event|0
1367480|NCT01550744|4512622|P1|Open-Label|Adverse Event|11
1367481|NCT01550744|4512620|P3|Open-Label|Withdrawal by Subject|0
1367482|NCT01550744|4512621|P2|Open-Label|Withdrawal by Subject|0
1367483|NCT01550744|4512622|P1|Open-Label|Withdrawal by Subject|13
1367484|NCT01550744|4512620|P3|Open-Label|Lost to Follow-up|0
1367485|NCT01550744|4512621|P2|Open-Label|Lost to Follow-up|0
1367486|NCT01550744|4512622|P1|Open-Label|Lost to Follow-up|7
1367487|NCT01550289|4512680|P2|Overall Study|Withdrawal by Subject|3
1367488|NCT01550289|4512681|P1|Overall Study|Withdrawal by Subject|11
1367489|NCT01550289|4512680|P2|Overall Study|Lost to Follow-up|1
1367490|NCT01550289|4512681|P1|Overall Study|Lost to Follow-up|1
1367491|NCT01550289|4512680|P2|Overall Study|Protocol Violation|0
1367492|NCT01550289|4512681|P1|Overall Study|Protocol Violation|1
1367493|NCT01549964|4512757|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
1367494|NCT01549964|4512758|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
1367495|NCT01549964|4512759|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
1367496|NCT01549964|4512760|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
1367497|NCT01549964|4512757|P4|80-Week Extension Period|Lost to Follow-up|1
1367498|NCT01549964|4512758|P3|80-Week Extension Period|Lost to Follow-up|2
1367499|NCT01549964|4512759|P2|80-Week Extension Period|Lost to Follow-up|0
1367500|NCT01549964|4512760|P1|80-Week Extension Period|Lost to Follow-up|1
1367501|NCT01549964|4512757|P4|80-Week Extension Period|Voluntary Withdrawal|2
1367502|NCT01549964|4512758|P3|80-Week Extension Period|Voluntary Withdrawal|4
1367503|NCT01549964|4512759|P2|80-Week Extension Period|Voluntary Withdrawal|1
1367504|NCT01549964|4512760|P1|80-Week Extension Period|Voluntary Withdrawal|0
1367505|NCT01549964|4512757|P4|80-Week Extension Period|Study Terminated by Sponsor|132
1367506|NCT01549964|4512758|P3|80-Week Extension Period|Study Terminated by Sponsor|132
1367507|NCT01549964|4512759|P2|80-Week Extension Period|Study Terminated by Sponsor|137
1367508|NCT01549964|4512760|P1|80-Week Extension Period|Study Terminated by Sponsor|65
1367509|NCT01549964|4512757|P4|80-Week Extension Period|Pregnancy|0
1367510|NCT01549964|4512758|P3|80-Week Extension Period|Pregnancy|1
1367511|NCT01549964|4512759|P2|80-Week Extension Period|Pregnancy|0
1367512|NCT01549964|4512760|P1|80-Week Extension Period|Pregnancy|0
1367513|NCT01549964|4512757|P4|24-Week Treatment Period|Completion Status Unknown|0
1367514|NCT01549964|4512758|P3|24-Week Treatment Period|Completion Status Unknown|1
1367515|NCT01549964|4512759|P2|24-Week Treatment Period|Completion Status Unknown|0
1367516|NCT01549964|4512760|P1|24-Week Treatment Period|Completion Status Unknown|1
1367517|NCT01549964|4512757|P4|24-Week Treatment Period|Randomized but Not Treated|1
1367518|NCT01549964|4512758|P3|24-Week Treatment Period|Randomized but Not Treated|0
1367519|NCT01549964|4512759|P2|24-Week Treatment Period|Randomized but Not Treated|0
1367520|NCT01549964|4512760|P1|24-Week Treatment Period|Randomized but Not Treated|0
1367521|NCT01549964|4512757|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
1367522|NCT01549964|4512758|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
1367523|NCT01549964|4512759|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
1367524|NCT01549964|4512760|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
1367525|NCT01549964|4512757|P4|24-Week Treatment Period|Other|0
1367526|NCT01549964|4512758|P3|24-Week Treatment Period|Other|1
1367527|NCT01549964|4512759|P2|24-Week Treatment Period|Other|0
1367528|NCT01549964|4512760|P1|24-Week Treatment Period|Other|1
1367529|NCT01549964|4512757|P4|24-Week Treatment Period|Lack of Efficacy|1
1367530|NCT01549964|4512758|P3|24-Week Treatment Period|Lack of Efficacy|1
1367531|NCT01549964|4512759|P2|24-Week Treatment Period|Lack of Efficacy|0
1367532|NCT01549964|4512760|P1|24-Week Treatment Period|Lack of Efficacy|1
1367533|NCT01549964|4512757|P4|24-Week Treatment Period|Lost to Follow-up|2
1367534|NCT01549964|4512758|P3|24-Week Treatment Period|Lost to Follow-up|1
1367535|NCT01549964|4512759|P2|24-Week Treatment Period|Lost to Follow-up|0
1367536|NCT01549964|4512760|P1|24-Week Treatment Period|Lost to Follow-up|1
1367537|NCT01549964|4512757|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
1367538|NCT01549964|4512758|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
1367539|NCT01549964|4512759|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
1367540|NCT01549964|4512760|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
1367541|NCT01549964|4512757|P4|24-Week Treatment Period|Voluntary Withdrawal|8
1367542|NCT01549964|4512758|P3|24-Week Treatment Period|Voluntary Withdrawal|3
1367543|NCT01549964|4512759|P2|24-Week Treatment Period|Voluntary Withdrawal|3
1367544|NCT01549964|4512760|P1|24-Week Treatment Period|Voluntary Withdrawal|6
1367545|NCT01549964|4512757|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
1367546|NCT01549964|4512758|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
1367547|NCT01549964|4512759|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
1367548|NCT01549964|4512760|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
1367549|NCT01549951|4512778|P1|Overall Study|Other|2
1367550|NCT01549951|4512778|P1|Overall Study|Symptomatic deterioration|1
1367551|NCT01549951|4512778|P1|Overall Study|Progressive disease|29
1367552|NCT01549951|4512778|P1|Overall Study|Unsatisfactory therapeutic response|1
1367553|NCT01549951|4512778|P1|Overall Study|Withdrawal by Subject|2
1367554|NCT01549951|4512778|P1|Overall Study|Adverse Event|15
1367555|NCT01549873|4512805|P2|Overall Study|Physician Decision|1
1367556|NCT01549873|4512806|P1|Overall Study|Physician Decision|0
1367557|NCT01549860|4512818|P2|Overall Study|Physician Decision|1
1367558|NCT01549860|4512819|P1|Overall Study|Physician Decision|1
1367559|NCT01549860|4512818|P2|Overall Study|Withdrawal by Subject|0
1367560|NCT01549860|4512819|P1|Overall Study|Withdrawal by Subject|1
1367561|NCT01549613|4512831|P2|Overall Study|Lost to Follow-up|11
1367562|NCT01549613|4512832|P1|Overall Study|Lost to Follow-up|11
1367563|NCT01549392|4512851|P2|Overall Study|Withdrawal by Subject|0
1367564|NCT01549392|4512852|P1|Overall Study|Withdrawal by Subject|1
1367565|NCT01549275|4512871|P2|Overall Study|Lost to Follow-up|0
1367566|NCT01549275|4512872|P1|Overall Study|Lost to Follow-up|1
1367567|NCT01549041|4512895|P2|Overall Study|Adverse Event|4
1367568|NCT01549041|4512896|P1|Overall Study|Adverse Event|0
1367569|NCT01549041|4512895|P2|Overall Study|Lack of Efficacy|4
1367570|NCT01549041|4512896|P1|Overall Study|Lack of Efficacy|2
1367571|NCT01549002|4512906|P2|Overall Study|Moderate sedation required|2
1367572|NCT01549002|4512907|P1|Overall Study|Moderate sedation required|0
1367573|NCT01549002|4512906|P2|Overall Study|Excessive pain|2
1367574|NCT01549002|4512907|P1|Overall Study|Excessive pain|0
1367575|NCT01548638|4512947|P1|Overall Study|Withdrawal by Subject|1
1367576|NCT01548638|4512947|P1|Overall Study|Protocol Violation|3
1367577|NCT01548573|4512957|P1|Overall Study|Withdrawal by Subject|2
1367578|NCT01548573|4512957|P1|Overall Study|Death|3
1367579|NCT01548417|4512966|P2|Overall Study|Withdrawal by Subject|2
1367580|NCT01548417|4512967|P1|Overall Study|Withdrawal by Subject|0
1367581|NCT01548404|4512977|P2|Overall Study|Other than specified above|2
1367582|NCT01548404|4512978|P1|Overall Study|Other than specified above|0
1367583|NCT01548404|4512977|P2|Overall Study|Withdrawal by Subject|3
1367584|NCT01548404|4512978|P1|Overall Study|Withdrawal by Subject|0
1367585|NCT01548404|4512977|P2|Overall Study|Lost to Follow-up|0
1367586|NCT01548404|4512978|P1|Overall Study|Lost to Follow-up|2
1367587|NCT01548404|4512977|P2|Overall Study|Inadequate response to study treatment|7
1367588|NCT01548404|4512978|P1|Overall Study|Inadequate response to study treatment|23
1367589|NCT01548404|4512977|P2|Overall Study|Physician Decision|1
1367590|NCT01548404|4512978|P1|Overall Study|Physician Decision|2
1367591|NCT01548404|4512977|P2|Overall Study|Adverse Event|1
1367592|NCT01548404|4512978|P1|Overall Study|Adverse Event|3
1367593|NCT01548287|4513004|P5|Randomized Period|Adverse Event|0
1367594|NCT01548287|4513005|P4|Randomized Period|Adverse Event|0
1367595|NCT01548287|4513006|P3|Randomized Period|Adverse Event|5
1367596|NCT01548287|4513007|P2|Randomized Period|Adverse Event|2
1367597|NCT01548287|4513008|P1|Randomized Period|Adverse Event|0
1367598|NCT01548287|4513004|P5|Randomized Period|Did not meet inclusion criteria|0
1367599|NCT01548287|4513005|P4|Randomized Period|Did not meet inclusion criteria|0
1367600|NCT01548287|4513006|P3|Randomized Period|Did not meet inclusion criteria|2
1367601|NCT01548287|4513007|P2|Randomized Period|Did not meet inclusion criteria|0
1367602|NCT01548287|4513008|P1|Randomized Period|Did not meet inclusion criteria|0
1367603|NCT01548287|4513004|P5|Screening|Did not meet eligibility criteria|74
1367604|NCT01548287|4513005|P4|Screening|Did not meet eligibility criteria|0
1367605|NCT01548287|4513006|P3|Screening|Did not meet eligibility criteria|0
1367606|NCT01548287|4513007|P2|Screening|Did not meet eligibility criteria|0
1367607|NCT01548287|4513008|P1|Screening|Did not meet eligibility criteria|0
1367608|NCT01548287|4513004|P5|Screening|No reason provided|9
1367609|NCT01548287|4513005|P4|Screening|No reason provided|0
1367610|NCT01548287|4513006|P3|Screening|No reason provided|0
1367611|NCT01548287|4513007|P2|Screening|No reason provided|0
1367612|NCT01548287|4513008|P1|Screening|No reason provided|0
1367613|NCT01547728|4513065|P1|Overall Study|Screen failure|39
1367614|NCT01547728|4513065|P1|Overall Study|Drug not ready for subject|1
1367615|NCT01547728|4513065|P1|Overall Study|Change in procedure and equipment|1
1367616|NCT01547598|4513174|P2|Overall Study|Other Miscellaneous Reasons|1
1367617|NCT01547598|4513175|P1|Overall Study|Other Miscellaneous Reasons|2
1367618|NCT01547598|4513174|P2|Overall Study|Protocol Violation|1
1367619|NCT01547598|4513175|P1|Overall Study|Protocol Violation|1
1367620|NCT01547598|4513174|P2|Overall Study|Adverse Event|1
1367621|NCT01547598|4513175|P1|Overall Study|Adverse Event|1
1367622|NCT01547598|4513174|P2|Overall Study|Lost to Follow-up|1
1367623|NCT01547598|4513175|P1|Overall Study|Lost to Follow-up|1
1367624|NCT01547598|4513174|P2|Overall Study|Withdrew consent|1
1367625|NCT01547598|4513175|P1|Overall Study|Withdrew consent|1
1367626|NCT01547390|4513192|P2|Overall Study|Adverse Event|0
1367627|NCT01547390|4513193|P1|Overall Study|Adverse Event|3
1367628|NCT01547390|4513192|P2|Overall Study|Lost to Follow-up|2
1367629|NCT01547390|4513193|P1|Overall Study|Lost to Follow-up|0
1367630|NCT01547390|4513192|P2|Overall Study|termination of pregnancy|1
1367631|NCT01547390|4513193|P1|Overall Study|termination of pregnancy|0
1367632|NCT01547390|4513192|P2|Overall Study|Withdrawal by Subject|7
1367633|NCT01547390|4513193|P1|Overall Study|Withdrawal by Subject|10
1367634|NCT01547299|4513203|P2|Overall Study|Withdrawal by Subject|2
1367635|NCT01547299|4513204|P1|Overall Study|Withdrawal by Subject|2
1367636|NCT01547286|4513270|P1|Overall Study|Physician Decision|1
1367637|NCT01547286|4513270|P1|Overall Study|Did not meet all eligibility criteria|1
1367638|NCT01547130|4513290|P2|Overall Study|Lost to Follow-up|5
1367639|NCT01547130|4513291|P1|Overall Study|Lost to Follow-up|9
1367640|NCT01546922|4513314|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
1367641|NCT01546922|4513315|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
1367642|NCT01546922|4513314|P2|Second Period of 10 Weeks|Protocol Violation|1
1367643|NCT01546922|4513315|P1|Second Period of 10 Weeks|Protocol Violation|3
1367644|NCT01546922|4513314|P2|First Period of 10 Weeks|Investigator's judgment|0
1367645|NCT01546922|4513315|P1|First Period of 10 Weeks|Investigator's judgment|1
1367646|NCT01546922|4513314|P2|First Period of 10 Weeks|Withdrawal by Subject|1
1367647|NCT01546922|4513315|P1|First Period of 10 Weeks|Withdrawal by Subject|1
1367648|NCT01546922|4513314|P2|First Period of 10 Weeks|Protocol Violation|1
1367649|NCT01546922|4513315|P1|First Period of 10 Weeks|Protocol Violation|3
1367650|NCT01546883|4513321|P1|Overall Study|other unrelated illness|1
1367651|NCT01546883|4513321|P1|Overall Study|early closure of study|2
1367652|NCT01546883|4513321|P1|Overall Study|Lost to Follow-up|2
1367653|NCT01546883|4513321|P1|Overall Study|Adverse Event|4
1367654|NCT01546883|4513321|P1|Overall Study|Withdrawal by Subject|3
1367655|NCT01546688|4513327|P2|Overall Study|Lack of Efficacy|0
1367656|NCT01546688|4513328|P1|Overall Study|Lack of Efficacy|1
1367657|NCT01546688|4513327|P2|Overall Study|Withdrawal by Subject|1
1367658|NCT01546688|4513328|P1|Overall Study|Withdrawal by Subject|2
1367659|NCT01546688|4513327|P2|Overall Study|Adverse Event|4
1367660|NCT01546688|4513328|P1|Overall Study|Adverse Event|0
1367661|NCT01546649|4513360|P2|Overall Study|Withdrawal by Subject|2
1367662|NCT01546649|4513361|P1|Overall Study|Withdrawal by Subject|1
1367663|NCT01546649|4513360|P2|Overall Study|Discovery of secondary cancer|1
1367664|NCT01546649|4513361|P1|Overall Study|Discovery of secondary cancer|0
1367665|NCT01546649|4513360|P2|Overall Study|Recurrence|1
1367666|NCT01546649|4513361|P1|Overall Study|Recurrence|1
1367667|NCT01546649|4513360|P2|Overall Study|Lack of Efficacy|0
1367668|NCT01546649|4513361|P1|Overall Study|Lack of Efficacy|1
1367669|NCT01546649|4513360|P2|Overall Study|Protocol Violation|0
1367670|NCT01546649|4513361|P1|Overall Study|Protocol Violation|1
1367671|NCT01546649|4513360|P2|Overall Study|Adverse Event|5
1367672|NCT01546649|4513361|P1|Overall Study|Adverse Event|4
1367673|NCT01546623|4513396|P2|Overall Study|Did Not Receive Study Drug|1
1367674|NCT01546623|4513397|P1|Overall Study|Did Not Receive Study Drug|1
1367675|NCT01546623|4513396|P2|Overall Study|High Prostate specific antigen|1
1367676|NCT01546623|4513397|P1|Overall Study|High Prostate specific antigen|2
1367677|NCT01546623|4513396|P2|Overall Study|Major Protocol Deviation|1
1367678|NCT01546623|4513397|P1|Overall Study|Major Protocol Deviation|1
1367679|NCT01546623|4513396|P2|Overall Study|Adverse Event|3
1367680|NCT01546623|4513397|P1|Overall Study|Adverse Event|2
1367681|NCT01546519|4513427|P4|Overall Study|Withdrawal by Subject|0
1367682|NCT01546519|4513428|P3|Overall Study|Withdrawal by Subject|0
1367683|NCT01546519|4513429|P2|Overall Study|Withdrawal by Subject|0
1367684|NCT01546519|4513430|P1|Overall Study|Withdrawal by Subject|1
1367685|NCT01546519|4513427|P4|Overall Study|Physician Decision|3
1367686|NCT01546519|4513428|P3|Overall Study|Physician Decision|2
1367687|NCT01546519|4513429|P2|Overall Study|Physician Decision|5
1367688|NCT01546519|4513430|P1|Overall Study|Physician Decision|6
1367689|NCT01546519|4513427|P4|Overall Study|related to disease progression|1
1367690|NCT01546519|4513428|P3|Overall Study|related to disease progression|2
1367691|NCT01546519|4513429|P2|Overall Study|related to disease progression|2
1367692|NCT01546519|4513430|P1|Overall Study|related to disease progression|2
1367693|NCT01546519|4513427|P4|Overall Study|Death|1
1367694|NCT01546519|4513428|P3|Overall Study|Death|3
1367695|NCT01546519|4513429|P2|Overall Study|Death|1
1367696|NCT01546519|4513430|P1|Overall Study|Death|0
1367697|NCT01546519|4513427|P4|Overall Study|Adverse Event|1
1367698|NCT01546519|4513428|P3|Overall Study|Adverse Event|1
1367699|NCT01546519|4513429|P2|Overall Study|Adverse Event|0
1367700|NCT01546519|4513430|P1|Overall Study|Adverse Event|0
1367701|NCT01546207|4513495|P1|Overall Study|Death|1
1367702|NCT01546168|4513510|P2|Overall Study|ineligible after signing consent|0
1367703|NCT01546168|4513511|P1|Overall Study|ineligible after signing consent|2
1367704|NCT01546168|4513510|P2|Overall Study|Withdrawal by Subject|0
1367705|NCT01546168|4513511|P1|Overall Study|Withdrawal by Subject|1
1367706|NCT01546168|4513510|P2|Overall Study|Lost to Follow-up|0
1367707|NCT01546168|4513511|P1|Overall Study|Lost to Follow-up|1
1367708|NCT01546155|4513523|P1|Overall Study|could not tolerate long scan duration|3
1367709|NCT01546142|4513529|P2|Overall Study|Subject Randomized but Not Treated|0
1367710|NCT01546142|4513530|P1|Overall Study|Subject Randomized but Not Treated|1
1367711|NCT01546142|4513529|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
1367712|NCT01546142|4513530|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
1367713|NCT01546142|4513529|P2|Overall Study|Lost to Follow-up|15
1367714|NCT01546142|4513530|P1|Overall Study|Lost to Follow-up|20
1367715|NCT01546142|4513529|P2|Overall Study|Adverse Event|3
1367716|NCT01546142|4513530|P1|Overall Study|Adverse Event|6
1367717|NCT01546142|4513529|P2|Overall Study|Subject Noncompliance|1
1367718|NCT01546142|4513530|P1|Overall Study|Subject Noncompliance|1
1367719|NCT01546142|4513529|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
1367720|NCT01546142|4513530|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
1367721|NCT01546038|4513548|P9|Overall Study|: Randomized, not treated|3
1367722|NCT01546038|4513549|P8|Overall Study|: Randomized, not treated|4
1367723|NCT01546038|4513550|P7|Overall Study|: Randomized, not treated|2
1367724|NCT01546038|4513551|P6|Overall Study|: Randomized, not treated|0
1367725|NCT01546038|4513552|P5|Overall Study|: Randomized, not treated|0
1367726|NCT01546038|4513553|P4|Overall Study|: Randomized, not treated|0
1367727|NCT01546038|4513554|P3|Overall Study|: Randomized, not treated|0
1367728|NCT01546038|4513555|P2|Overall Study|: Randomized, not treated|0
1367729|NCT01546038|4513556|P1|Overall Study|: Randomized, not treated|0
1367730|NCT01546038|4513548|P9|Overall Study|: Study ongoing at cutoff date|1
1367731|NCT01546038|4513549|P8|Overall Study|: Study ongoing at cutoff date|16
1367732|NCT01546038|4513550|P7|Overall Study|: Study ongoing at cutoff date|24
1367733|NCT01546038|4513551|P6|Overall Study|: Study ongoing at cutoff date|2
1367734|NCT01546038|4513552|P5|Overall Study|: Study ongoing at cutoff date|8
1367735|NCT01546038|4513553|P4|Overall Study|: Study ongoing at cutoff date|0
1367736|NCT01546038|4513554|P3|Overall Study|: Study ongoing at cutoff date|0
1367737|NCT01546038|4513555|P2|Overall Study|: Study ongoing at cutoff date|0
1367738|NCT01546038|4513556|P1|Overall Study|: Study ongoing at cutoff date|1
1367739|NCT01546038|4513548|P9|Overall Study|Withdrawal by Subject|0
1367740|NCT01546038|4513549|P8|Overall Study|Withdrawal by Subject|3
1367741|NCT01546038|4513550|P7|Overall Study|Withdrawal by Subject|3
1367742|NCT01546038|4513551|P6|Overall Study|Withdrawal by Subject|1
1367743|NCT01546038|4513552|P5|Overall Study|Withdrawal by Subject|0
1367744|NCT01546038|4513553|P4|Overall Study|Withdrawal by Subject|1
1367745|NCT01546038|4513554|P3|Overall Study|Withdrawal by Subject|0
1367746|NCT01546038|4513555|P2|Overall Study|Withdrawal by Subject|0
1367747|NCT01546038|4513556|P1|Overall Study|Withdrawal by Subject|1
1367748|NCT01546038|4513548|P9|Overall Study|Lost to Follow-up|0
1367749|NCT01546038|4513549|P8|Overall Study|Lost to Follow-up|1
1367750|NCT01546038|4513550|P7|Overall Study|Lost to Follow-up|1
1367751|NCT01546038|4513551|P6|Overall Study|Lost to Follow-up|0
1367752|NCT01546038|4513552|P5|Overall Study|Lost to Follow-up|1
1367753|NCT01546038|4513553|P4|Overall Study|Lost to Follow-up|0
1367754|NCT01546038|4513554|P3|Overall Study|Lost to Follow-up|0
1367755|NCT01546038|4513555|P2|Overall Study|Lost to Follow-up|0
1367756|NCT01546038|4513556|P1|Overall Study|Lost to Follow-up|0
1367757|NCT01546038|4513548|P9|Overall Study|Death|40
1367758|NCT01546038|4513549|P8|Overall Study|Death|64
1367759|NCT01546038|4513550|P7|Overall Study|Death|41
1367760|NCT01546038|4513551|P6|Overall Study|Death|3
1367761|NCT01546038|4513552|P5|Overall Study|Death|7
1367762|NCT01546038|4513553|P4|Overall Study|Death|2
1367763|NCT01546038|4513554|P3|Overall Study|Death|4
1367764|NCT01546038|4513555|P2|Overall Study|Death|6
1367765|NCT01546038|4513556|P1|Overall Study|Death|15
1367766|NCT01545388|4513882|P3|Overall Study|Not specified|0
1367767|NCT01545388|4513883|P2|Overall Study|Not specified|1
1367768|NCT01545388|4513884|P1|Overall Study|Not specified|1
1367769|NCT01545388|4513882|P3|Overall Study|Withdrawal by Subject|2
1367770|NCT01545388|4513883|P2|Overall Study|Withdrawal by Subject|4
1367771|NCT01545388|4513884|P1|Overall Study|Withdrawal by Subject|1
1367772|NCT01545388|4513882|P3|Overall Study|Participant moved or relocated|0
1367773|NCT01545388|4513883|P2|Overall Study|Participant moved or relocated|0
1367774|NCT01545388|4513884|P1|Overall Study|Participant moved or relocated|1
1367775|NCT01545388|4513882|P3|Overall Study|Lack of Efficacy|5
1367776|NCT01545388|4513883|P2|Overall Study|Lack of Efficacy|2
1367777|NCT01545388|4513884|P1|Overall Study|Lack of Efficacy|3
1367778|NCT01545388|4513882|P3|Overall Study|Adverse Event|1
1367779|NCT01545388|4513883|P2|Overall Study|Adverse Event|4
1367780|NCT01545388|4513884|P1|Overall Study|Adverse Event|2
1367781|NCT01545375|4513903|P2|Overall Study|Withdrawal by Subject|55
1367782|NCT01545375|4513904|P1|Overall Study|Withdrawal by Subject|58
1367783|NCT01545375|4513903|P2|Overall Study|Protocol Violation|3
1367784|NCT01545375|4513904|P1|Overall Study|Protocol Violation|3
1367785|NCT01545375|4513903|P2|Overall Study|Lost to Follow-up|31
1367786|NCT01545375|4513904|P1|Overall Study|Lost to Follow-up|34
1367787|NCT01545375|4513903|P2|Overall Study|Adverse Event|1
1367788|NCT01545375|4513904|P1|Overall Study|Adverse Event|2
1367789|NCT01545076|4514011|P5|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
1367790|NCT01545076|4514012|P4|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
1367791|NCT01545076|4514013|P3|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
1367792|NCT01545076|4514014|P2|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
1367793|NCT01545076|4514015|P1|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
1367794|NCT01545076|4514011|P5|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
1367795|NCT01545076|4514012|P4|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
1367796|NCT01545076|4514013|P3|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
1367797|NCT01545076|4514014|P2|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
1367798|NCT01545076|4514015|P1|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
1367799|NCT01545076|4514011|P5|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
1367800|NCT01545076|4514012|P4|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
1367801|NCT01545076|4514013|P3|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
1367802|NCT01545076|4514014|P2|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
1367803|NCT01545076|4514015|P1|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
1367804|NCT01545076|4514011|P5|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1367805|NCT01545076|4514012|P4|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
1367806|NCT01545076|4514013|P3|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1367807|NCT01545076|4514014|P2|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1367808|NCT01545076|4514015|P1|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1367809|NCT01545076|4514011|P5|IgPro10 Restabilization Period|Withdrawal by Subject|0
1367810|NCT01545076|4514012|P4|IgPro10 Restabilization Period|Withdrawal by Subject|0
1367811|NCT01545076|4514013|P3|IgPro10 Restabilization Period|Withdrawal by Subject|0
1367812|NCT01545076|4514014|P2|IgPro10 Restabilization Period|Withdrawal by Subject|0
1367813|NCT01545076|4514015|P1|IgPro10 Restabilization Period|Withdrawal by Subject|7
1367814|NCT01545076|4514011|P5|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1367815|NCT01545076|4514012|P4|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1367816|NCT01545076|4514013|P3|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1367817|NCT01545076|4514014|P2|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1367818|NCT01545076|4514015|P1|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
1367819|NCT01545076|4514011|P5|IgPro10 Restabilization Period|Protocol Violation|0
1367820|NCT01545076|4514012|P4|IgPro10 Restabilization Period|Protocol Violation|0
1367821|NCT01545076|4514013|P3|IgPro10 Restabilization Period|Protocol Violation|0
1367822|NCT01545076|4514014|P2|IgPro10 Restabilization Period|Protocol Violation|0
1367823|NCT01545076|4514015|P1|IgPro10 Restabilization Period|Protocol Violation|1
1367824|NCT01545076|4514011|P5|IgPro10 Restabilization Period|Physician Decision|0
1367825|NCT01545076|4514012|P4|IgPro10 Restabilization Period|Physician Decision|0
1367826|NCT01545076|4514013|P3|IgPro10 Restabilization Period|Physician Decision|0
1367827|NCT01545076|4514014|P2|IgPro10 Restabilization Period|Physician Decision|0
1367828|NCT01545076|4514015|P1|IgPro10 Restabilization Period|Physician Decision|2
1367829|NCT01545076|4514011|P5|IgPro10 Restabilization Period|Adverse Event|0
1367830|NCT01545076|4514012|P4|IgPro10 Restabilization Period|Adverse Event|0
1367831|NCT01545076|4514013|P3|IgPro10 Restabilization Period|Adverse Event|0
1367832|NCT01545076|4514014|P2|IgPro10 Restabilization Period|Adverse Event|0
1367833|NCT01545076|4514015|P1|IgPro10 Restabilization Period|Adverse Event|4
1367834|NCT01544920|4514086|P2|Overall Study|Withdrawal by Subject|4
1367835|NCT01544920|4514087|P1|Overall Study|Withdrawal by Subject|4
1367836|NCT01544920|4514086|P2|Overall Study|Physician Decision|1
1367837|NCT01544920|4514087|P1|Overall Study|Physician Decision|4
1367838|NCT01544920|4514086|P2|Overall Study|Protocol Violation|2
1367839|NCT01544920|4514087|P1|Overall Study|Protocol Violation|0
1367840|NCT01544920|4514086|P2|Overall Study|Lost to Follow-up|12
1367841|NCT01544920|4514087|P1|Overall Study|Lost to Follow-up|11
1367842|NCT01544920|4514086|P2|Overall Study|Death|1
1367843|NCT01544920|4514087|P1|Overall Study|Death|0
1367844|NCT01544920|4514086|P2|Overall Study|Adverse Event|3
1367845|NCT01544920|4514087|P1|Overall Study|Adverse Event|0
1367846|NCT01544582|4514098|P4|Analysis Population|Participant in Jail|0
1367847|NCT01544582|4514099|P3|Analysis Population|Participant in Jail|1
1367848|NCT01544582|4514100|P2|Analysis Population|Participant in Jail|0
1367849|NCT01544582|4514101|P1|Analysis Population|Participant in Jail|0
1367850|NCT01544582|4514098|P4|Analysis Population|Programmed Surgery|0
1367851|NCT01544582|4514099|P3|Analysis Population|Programmed Surgery|0
1367852|NCT01544582|4514100|P2|Analysis Population|Programmed Surgery|1
1367853|NCT01544582|4514101|P1|Analysis Population|Programmed Surgery|0
1367854|NCT01544582|4514098|P4|Analysis Population|Poor Participant Compliance|0
1367855|NCT01544582|4514099|P3|Analysis Population|Poor Participant Compliance|0
1367856|NCT01544582|4514100|P2|Analysis Population|Poor Participant Compliance|1
1367857|NCT01544582|4514101|P1|Analysis Population|Poor Participant Compliance|0
1367858|NCT01544582|4514098|P4|Analysis Population|Poor Adherence|0
1367859|NCT01544582|4514099|P3|Analysis Population|Poor Adherence|1
1367860|NCT01544582|4514100|P2|Analysis Population|Poor Adherence|0
1367861|NCT01544582|4514101|P1|Analysis Population|Poor Adherence|0
1367862|NCT01544582|4514098|P4|Analysis Population|No Social Insurance|0
1367863|NCT01544582|4514099|P3|Analysis Population|No Social Insurance|1
1367864|NCT01544582|4514100|P2|Analysis Population|No Social Insurance|0
1367865|NCT01544582|4514101|P1|Analysis Population|No Social Insurance|0
1367866|NCT01544582|4514098|P4|Analysis Population|Liver Transplantation|0
1367867|NCT01544582|4514099|P3|Analysis Population|Liver Transplantation|1
1367868|NCT01544582|4514100|P2|Analysis Population|Liver Transplantation|0
1367869|NCT01544582|4514101|P1|Analysis Population|Liver Transplantation|0
1367870|NCT01544582|4514098|P4|Analysis Population|Intolerance|0
1367871|NCT01544582|4514099|P3|Analysis Population|Intolerance|0
1367872|NCT01544582|4514100|P2|Analysis Population|Intolerance|1
1367873|NCT01544582|4514101|P1|Analysis Population|Intolerance|0
1367874|NCT01544582|4514098|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
1367875|NCT01544582|4514099|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
1367876|NCT01544582|4514100|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
1367877|NCT01544582|4514101|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
1367878|NCT01544582|4514098|P4|Analysis Population|Bad Tolerance to Treatment|0
1367879|NCT01544582|4514099|P3|Analysis Population|Bad Tolerance to Treatment|2
1367880|NCT01544582|4514100|P2|Analysis Population|Bad Tolerance to Treatment|0
1367881|NCT01544582|4514101|P1|Analysis Population|Bad Tolerance to Treatment|0
1367882|NCT01544582|4514098|P4|Analysis Population|Lost to Follow-up|5
1367883|NCT01544582|4514099|P3|Analysis Population|Lost to Follow-up|6
1367884|NCT01544582|4514100|P2|Analysis Population|Lost to Follow-up|6
1367885|NCT01544582|4514101|P1|Analysis Population|Lost to Follow-up|0
1367886|NCT01544582|4514098|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
1367887|NCT01544582|4514099|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
1367888|NCT01544582|4514100|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
1367889|NCT01544582|4514101|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
1367890|NCT01544582|4514098|P4|Analysis Population|Effectiveness Reason|12
1367891|NCT01544582|4514099|P3|Analysis Population|Effectiveness Reason|29
1367892|NCT01544582|4514100|P2|Analysis Population|Effectiveness Reason|48
1367893|NCT01544582|4514101|P1|Analysis Population|Effectiveness Reason|0
1367894|NCT01544582|4514098|P4|Analysis Population|Safety Reason|8
1367895|NCT01544582|4514099|P3|Analysis Population|Safety Reason|31
1367896|NCT01544582|4514100|P2|Analysis Population|Safety Reason|33
1367897|NCT01544582|4514101|P1|Analysis Population|Safety Reason|0
1367898|NCT01544582|4514098|P4|Analysis Population|Physician Decision|9
1367899|NCT01544582|4514099|P3|Analysis Population|Physician Decision|10
1367900|NCT01544582|4514100|P2|Analysis Population|Physician Decision|13
1367901|NCT01544582|4514101|P1|Analysis Population|Physician Decision|0
1367902|NCT01544582|4514098|P4|Analysis Population|Participant Refuses to Continue Study|4
1367903|NCT01544582|4514099|P3|Analysis Population|Participant Refuses to Continue Study|17
1367904|NCT01544582|4514100|P2|Analysis Population|Participant Refuses to Continue Study|15
1367905|NCT01544582|4514101|P1|Analysis Population|Participant Refuses to Continue Study|0
1367906|NCT01544582|4514098|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
1367907|NCT01544582|4514099|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
1367908|NCT01544582|4514100|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
1367909|NCT01544582|4514101|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
1367910|NCT01544582|4514098|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
1367911|NCT01544582|4514099|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
1367912|NCT01544582|4514100|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
1367913|NCT01544582|4514101|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
1367914|NCT01544478|4514159|P1|Overall Study|Withdrawal by Subject|52
1367915|NCT01544478|4514159|P1|Overall Study|Pregnancy|1
1367916|NCT01544478|4514159|P1|Overall Study|Physician Decision|15
1367917|NCT01544478|4514159|P1|Overall Study|Lost to Follow-up|48
1367918|NCT01544478|4514159|P1|Overall Study|Death|1
1367919|NCT01544478|4514159|P1|Overall Study|Adverse Event|1
1367920|NCT01544348|4514202|P8|Overall Study|Physician Decision|0
1367921|NCT01544348|4514203|P7|Overall Study|Physician Decision|0
1367922|NCT01544348|4514204|P6|Overall Study|Physician Decision|1
1367923|NCT01544348|4514205|P5|Overall Study|Physician Decision|0
1367924|NCT01544348|4514206|P4|Overall Study|Physician Decision|0
1367925|NCT01544348|4514207|P3|Overall Study|Physician Decision|0
1367926|NCT01544348|4514208|P2|Overall Study|Physician Decision|0
1367927|NCT01544348|4514209|P1|Overall Study|Physician Decision|0
1367928|NCT01544348|4514202|P8|Overall Study|Withdrawal by Subject|0
1367929|NCT01544348|4514203|P7|Overall Study|Withdrawal by Subject|1
1367930|NCT01544348|4514204|P6|Overall Study|Withdrawal by Subject|2
1367931|NCT01544348|4514205|P5|Overall Study|Withdrawal by Subject|1
1367932|NCT01544348|4514206|P4|Overall Study|Withdrawal by Subject|0
1367933|NCT01544348|4514207|P3|Overall Study|Withdrawal by Subject|0
1367934|NCT01544348|4514208|P2|Overall Study|Withdrawal by Subject|0
1367935|NCT01544348|4514209|P1|Overall Study|Withdrawal by Subject|1
1367936|NCT01544348|4514202|P8|Overall Study|Lost to Follow-up|0
1367937|NCT01544348|4514203|P7|Overall Study|Lost to Follow-up|1
1367938|NCT01544348|4514204|P6|Overall Study|Lost to Follow-up|0
1367939|NCT01544348|4514205|P5|Overall Study|Lost to Follow-up|0
1367940|NCT01544348|4514206|P4|Overall Study|Lost to Follow-up|0
1367941|NCT01544348|4514207|P3|Overall Study|Lost to Follow-up|0
1367942|NCT01544348|4514208|P2|Overall Study|Lost to Follow-up|0
1367943|NCT01544348|4514209|P1|Overall Study|Lost to Follow-up|1
1367944|NCT01544309|4514251|P2|Overall Study|Administered prohibit prior medication|0
1367945|NCT01544309|4514252|P1|Overall Study|Administered prohibit prior medication|1
1367946|NCT01544309|4514251|P2|Overall Study|Not performed pre-dose examination|2
1367947|NCT01544309|4514252|P1|Overall Study|Not performed pre-dose examination|1
1367948|NCT01544309|4514251|P2|Overall Study|Physician Decision|1
1367949|NCT01544309|4514252|P1|Overall Study|Physician Decision|4
1367950|NCT01544309|4514251|P2|Overall Study|Protocol Violation|1
1367951|NCT01544309|4514252|P1|Overall Study|Protocol Violation|2
1367952|NCT01544309|4514251|P2|Overall Study|Withdrawal by Subject|7
1367953|NCT01544309|4514252|P1|Overall Study|Withdrawal by Subject|12
1367954|NCT01544179|4514290|P2|Overall Study|Eligibility criteria not fulfilled|0
1367955|NCT01544179|4514291|P1|Overall Study|Eligibility criteria not fulfilled|1
1367956|NCT01544179|4514290|P2|Overall Study|Withdrawal by Subject|7
1367957|NCT01544179|4514291|P1|Overall Study|Withdrawal by Subject|12
1367958|NCT01544179|4514290|P2|Overall Study|Adverse Event|1
1367959|NCT01544179|4514291|P1|Overall Study|Adverse Event|0
1367960|NCT01544179|4514290|P2|Overall Study|Lost to Follow-up|1
1367961|NCT01544179|4514291|P1|Overall Study|Lost to Follow-up|0
1367962|NCT01544179|4514290|P2|Overall Study|Death|37
1367963|NCT01544179|4514291|P1|Overall Study|Death|50
1367964|NCT01544153|4514384|P4|Overall Study|Non-smoker|0
1367965|NCT01544153|4514385|P3|Overall Study|Non-smoker|1
1367966|NCT01544153|4514386|P2|Overall Study|Non-smoker|0
1367967|NCT01544153|4514387|P1|Overall Study|Non-smoker|0
1367968|NCT01544153|4514384|P4|Overall Study|Under 18|0
1367969|NCT01544153|4514385|P3|Overall Study|Under 18|0
1367970|NCT01544153|4514386|P2|Overall Study|Under 18|1
1367971|NCT01544153|4514387|P1|Overall Study|Under 18|0
1367972|NCT01544114|4514404|P3|Overall Study|Protocol Violation|0
1367973|NCT01544114|4514405|P2|Overall Study|Protocol Violation|1
1367974|NCT01544114|4514406|P1|Overall Study|Protocol Violation|0
1367975|NCT01544114|4514404|P3|Overall Study|Adverse Event|2
1367976|NCT01544114|4514405|P2|Overall Study|Adverse Event|1
1367977|NCT01544114|4514406|P1|Overall Study|Adverse Event|1
1367978|NCT01544114|4514404|P3|Overall Study|Lost to Follow-up|0
1367979|NCT01544114|4514405|P2|Overall Study|Lost to Follow-up|2
1367980|NCT01544114|4514406|P1|Overall Study|Lost to Follow-up|0
1367981|NCT01544114|4514404|P3|Overall Study|Withdrawal by Subject|3
1367982|NCT01544114|4514405|P2|Overall Study|Withdrawal by Subject|0
1367983|NCT01544114|4514406|P1|Overall Study|Withdrawal by Subject|0
1367984|NCT01543958|4514489|P1|Overall Study|ART initiation|1
1367985|NCT01543958|4514489|P1|Overall Study|Loss to follow-up|3
1367986|NCT01543828|4514544|P2|Treatment 2|Lost to Follow-up|0
1367987|NCT01543828|4514545|P1|Treatment 2|Lost to Follow-up|1
1367988|NCT01543685|4514558|P5|Overall Study|Adverse Event|2
1367989|NCT01543685|4514559|P4|Overall Study|Adverse Event|0
1367990|NCT01543685|4514560|P3|Overall Study|Adverse Event|0
1367991|NCT01543685|4514561|P2|Overall Study|Adverse Event|1
1367992|NCT01543685|4514562|P1|Overall Study|Adverse Event|2
1367993|NCT01543685|4514558|P5|Overall Study|Lack of Efficacy|2
1367994|NCT01543685|4514559|P4|Overall Study|Lack of Efficacy|0
1367995|NCT01543685|4514560|P3|Overall Study|Lack of Efficacy|2
1367996|NCT01543685|4514561|P2|Overall Study|Lack of Efficacy|2
1367997|NCT01543685|4514562|P1|Overall Study|Lack of Efficacy|1
1367998|NCT01543503|4514634|P2|Overall Study|Screen failure|0
1367999|NCT01543503|4514635|P1|Overall Study|Screen failure|1
1368000|NCT01543503|4514634|P2|Overall Study|Participant went to United States|0
1368001|NCT01543503|4514635|P1|Overall Study|Participant went to United States|1
1368002|NCT01543503|4514634|P2|Overall Study|Participant consented to another study|2
1368003|NCT01543503|4514635|P1|Overall Study|Participant consented to another study|0
1368004|NCT01543503|4514634|P2|Overall Study|Moved to other rheumatologic site|1
1368005|NCT01543503|4514635|P1|Overall Study|Moved to other rheumatologic site|0
1368006|NCT01543503|4514634|P2|Overall Study|Participant did not attend a visit|0
1368007|NCT01543503|4514635|P1|Overall Study|Participant did not attend a visit|1
1368008|NCT01543503|4514634|P2|Overall Study|Site stopped participation|1
1368009|NCT01543503|4514635|P1|Overall Study|Site stopped participation|5
1368010|NCT01543503|4514634|P2|Overall Study|Participant recruited after closing date|1
1368011|NCT01543503|4514635|P1|Overall Study|Participant recruited after closing date|0
1368012|NCT01543503|4514634|P2|Overall Study|Investigator did not wish to participate|1
1368013|NCT01543503|4514635|P1|Overall Study|Investigator did not wish to participate|1
1368014|NCT01543503|4514634|P2|Overall Study|Participant decision to stop treatment|0
1368015|NCT01543503|4514635|P1|Overall Study|Participant decision to stop treatment|1
1368016|NCT01543503|4514634|P2|Overall Study|Participant moved to Scotland|0
1368017|NCT01543503|4514635|P1|Overall Study|Participant moved to Scotland|1
1368018|NCT01543503|4514634|P2|Overall Study|Participant transferred to another city|0
1368019|NCT01543503|4514635|P1|Overall Study|Participant transferred to another city|1
1368020|NCT01543503|4514634|P2|Overall Study|Participant will not return for visits|2
1368021|NCT01543503|4514635|P1|Overall Study|Participant will not return for visits|0
1368022|NCT01543503|4514634|P2|Overall Study|Participant moved to another city|0
1368023|NCT01543503|4514635|P1|Overall Study|Participant moved to another city|2
1368024|NCT01543503|4514634|P2|Overall Study|Incorrect medication received|0
1368025|NCT01543503|4514635|P1|Overall Study|Incorrect medication received|1
1368026|NCT01543503|4514634|P2|Overall Study|Refused to continue treatment|0
1368027|NCT01543503|4514635|P1|Overall Study|Refused to continue treatment|7
1368028|NCT01543503|4514634|P2|Overall Study|Participant did not complete last visit|2
1368029|NCT01543503|4514635|P1|Overall Study|Participant did not complete last visit|0
1368030|NCT01543503|4514634|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
1368031|NCT01543503|4514635|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
1368032|NCT01543503|4514634|P2|Overall Study|Intolerance to the biologic treatment|1
1368033|NCT01543503|4514635|P1|Overall Study|Intolerance to the biologic treatment|0
1368034|NCT01543503|4514634|P2|Overall Study|Change of jobs|1
1368035|NCT01543503|4514635|P1|Overall Study|Change of jobs|0
1368036|NCT01543503|4514634|P2|Overall Study|Participant withdrew informed consent|10
1368037|NCT01543503|4514635|P1|Overall Study|Participant withdrew informed consent|8
1368038|NCT01543503|4514634|P2|Overall Study|Lack of Efficacy|16
1368039|NCT01543503|4514635|P1|Overall Study|Lack of Efficacy|4
1368040|NCT01543503|4514634|P2|Overall Study|Adverse Event|13
1368041|NCT01543503|4514635|P1|Overall Study|Adverse Event|9
1368042|NCT01543503|4514634|P2|Overall Study|Lost to Follow-up|36
1368043|NCT01543503|4514635|P1|Overall Study|Lost to Follow-up|32
1368044|NCT01543204|4514679|P1|Overall Study|Lost to Follow-up|1
1368045|NCT01543204|4514679|P1|Overall Study|Requirement for Alternative Therapy|1
1368046|NCT01543204|4514679|P1|Overall Study|Withdrawal by Subject|4
1368047|NCT01543204|4514679|P1|Overall Study|Adverse Event|1
1368048|NCT01543204|4514679|P1|Overall Study|Non-compliance|1
1368049|NCT01542788|4514771|P2|Overall Study|Withdrawal by Subject|0
1368050|NCT01542788|4514772|P1|Overall Study|Withdrawal by Subject|1
1368051|NCT01542788|4514771|P2|Overall Study|Physician Decision|0
1368052|NCT01542788|4514772|P1|Overall Study|Physician Decision|1
1368053|NCT01542788|4514771|P2|Overall Study|Protocol Violation|0
1368054|NCT01542788|4514772|P1|Overall Study|Protocol Violation|2
1368055|NCT01542788|4514771|P2|Overall Study|Death|0
1368056|NCT01542788|4514772|P1|Overall Study|Death|3
1368057|NCT01542788|4514771|P2|Overall Study|Lost to Follow-up|0
1368058|NCT01542788|4514772|P1|Overall Study|Lost to Follow-up|5
1368059|NCT01542788|4514771|P2|Overall Study|Lack of Efficacy|71
1368060|NCT01542788|4514772|P1|Overall Study|Lack of Efficacy|41
1368061|NCT01542788|4514771|P2|Overall Study|Randomized but Not Treated|0
1368062|NCT01542788|4514772|P1|Overall Study|Randomized but Not Treated|2
1368063|NCT01542632|4514811|P6|Overall Study|Sponsor/Investigator Decision|0
1368064|NCT01542632|4514812|P5|Overall Study|Sponsor/Investigator Decision|1
1368065|NCT01542632|4514813|P4|Overall Study|Sponsor/Investigator Decision|0
1368066|NCT01542632|4514814|P3|Overall Study|Sponsor/Investigator Decision|0
1368067|NCT01542632|4514815|P2|Overall Study|Sponsor/Investigator Decision|0
1368068|NCT01542632|4514816|P1|Overall Study|Sponsor/Investigator Decision|0
1368069|NCT01542632|4514811|P6|Overall Study|Lost to Follow-up|0
1368070|NCT01542632|4514812|P5|Overall Study|Lost to Follow-up|0
1368071|NCT01542632|4514813|P4|Overall Study|Lost to Follow-up|0
1368072|NCT01542632|4514814|P3|Overall Study|Lost to Follow-up|0
1368073|NCT01542632|4514815|P2|Overall Study|Lost to Follow-up|1
1368074|NCT01542632|4514816|P1|Overall Study|Lost to Follow-up|0
1368075|NCT01542632|4514811|P6|Overall Study|Adverse Event|0
1368076|NCT01542632|4514812|P5|Overall Study|Adverse Event|0
1368077|NCT01542632|4514813|P4|Overall Study|Adverse Event|0
1368078|NCT01542632|4514814|P3|Overall Study|Adverse Event|1
1368079|NCT01542632|4514815|P2|Overall Study|Adverse Event|0
1368080|NCT01542632|4514816|P1|Overall Study|Adverse Event|0
1368081|NCT01542632|4514811|P6|Overall Study|Withdrawal of Consent|0
1368082|NCT01542632|4514812|P5|Overall Study|Withdrawal of Consent|3
1368083|NCT01542632|4514813|P4|Overall Study|Withdrawal of Consent|2
1368084|NCT01542632|4514814|P3|Overall Study|Withdrawal of Consent|0
1368085|NCT01542632|4514815|P2|Overall Study|Withdrawal of Consent|0
1368086|NCT01542632|4514816|P1|Overall Study|Withdrawal of Consent|0
1368087|NCT01542528|4514873|P2|Overall Study|Withdrawal by Subject|6
1368088|NCT01542528|4514874|P1|Overall Study|Withdrawal by Subject|9
1368089|NCT01542528|4514873|P2|Overall Study|Physician Decision|0
1368090|NCT01542528|4514874|P1|Overall Study|Physician Decision|1
1368091|NCT01542528|4514873|P2|Overall Study|Lost to Follow-up|1
1368092|NCT01542528|4514874|P1|Overall Study|Lost to Follow-up|2
1368093|NCT01542034|4514943|P2|Overall Study|Lost to Follow-up|6
1368094|NCT01542034|4514944|P1|Overall Study|Lost to Follow-up|7
1368095|NCT01542034|4514943|P2|Overall Study|Adverse Event|2
1368096|NCT01542034|4514944|P1|Overall Study|Adverse Event|2
1368097|NCT01542034|4514943|P2|Overall Study|Subject Noncompliance|0
1368098|NCT01542034|4514944|P1|Overall Study|Subject Noncompliance|1
1368099|NCT01542034|4514943|P2|Overall Study|Administrative decision|3
1368100|NCT01542034|4514944|P1|Overall Study|Administrative decision|0
1368101|NCT01542034|4514943|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
1368102|NCT01542034|4514944|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
1368103|NCT01541969|4514958|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
1368104|NCT01541969|4514959|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
1368105|NCT01541969|4514958|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
1368106|NCT01541969|4514959|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
1368107|NCT01541969|4514958|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
1368108|NCT01541969|4514959|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
1368109|NCT01541969|4514958|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
1368110|NCT01541969|4514959|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
1368111|NCT01541969|4514958|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
1368112|NCT01541969|4514959|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
1368113|NCT01541969|4514958|P2|Double-blind (0-12 Weeks)|Adverse Event|0
1368114|NCT01541969|4514959|P1|Double-blind (0-12 Weeks)|Adverse Event|2
1368115|NCT01541969|4514958|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
1368116|NCT01541969|4514959|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
1368117|NCT01541969|4514958|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
1368118|NCT01541969|4514959|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
1368119|NCT01541969|4514958|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
1368120|NCT01541969|4514959|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
1368121|NCT01541969|4514958|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
1368122|NCT01541969|4514959|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
1368123|NCT01541930|4514975|P1|Overall Study|Withdrawal by Subject|1
1368124|NCT01541917|4514997|P2|Overall Study|Withdrawal by Subject|7
1368125|NCT01541917|4514998|P1|Overall Study|Withdrawal by Subject|13
1368126|NCT01541917|4514997|P2|Overall Study|Lost to Follow-up|2
1368127|NCT01541917|4514998|P1|Overall Study|Lost to Follow-up|2
1368128|NCT01541865|4515014|P1|Overall Study|Protocol Violation|1
1368129|NCT01541865|4515014|P1|Overall Study|Adverse Event|1
1368130|NCT01541865|4515014|P1|Overall Study|Withdrawal by Subject|9
1368131|NCT01541865|4515014|P1|Overall Study|Lost to Follow-up|11
1368132|NCT01541826|4515032|P3|Overall Study|Withdrawal by Subject|0
1368133|NCT01541826|4515033|P2|Overall Study|Withdrawal by Subject|0
1368134|NCT01541826|4515034|P1|Overall Study|Withdrawal by Subject|2
1368135|NCT01541826|4515032|P3|Overall Study|Lost to Follow-up|0
1368136|NCT01541826|4515033|P2|Overall Study|Lost to Follow-up|3
1368137|NCT01541826|4515034|P1|Overall Study|Lost to Follow-up|2
1368138|NCT01541644|4515116|P1|Overall Study|Withdrawal by Subject|3
1368139|NCT01541397|4515135|P2|Overall Study|Study ended prior to data collection|2
1368140|NCT01541397|4515136|P1|Overall Study|Study ended prior to data collection|4
1368141|NCT01541371|4515161|P1|Overall Study|Other|6
1368142|NCT01541371|4515161|P1|Overall Study|Study medication non-compliance|3
1368143|NCT01541371|4515161|P1|Overall Study|Protocol Violation|6
1368144|NCT01541371|4515161|P1|Overall Study|Lack of Efficacy|12
1368145|NCT01541371|4515161|P1|Overall Study|Adverse Event|15
1368146|NCT01541371|4515161|P1|Overall Study|Lost to Follow-up|21
1368147|NCT01541371|4515161|P1|Overall Study|Withdrawal by Subject|14
1368148|NCT01541254|4515190|P1|Overall Study|alternate stent used|1
1368149|NCT01541254|4515190|P1|Overall Study|stent not required|1
1368150|NCT01541254|4515190|P1|Overall Study|GI bleed prior to procedure|1
1368151|NCT01541254|4515190|P1|Overall Study|enrolled after study closed|1
1368152|NCT01541254|4515190|P1|Overall Study|excluded - metal allergy|1
1368153|NCT01541254|4515190|P1|Overall Study|Withdrawal by Subject|1
1368154|NCT01540981|4515197|P2|Overall Study|Withdrawal by Subject|0
1368155|NCT01540981|4515198|P1|Overall Study|Withdrawal by Subject|1
1368156|NCT01540851|4515208|P2|Overall Study|Withdrawal by Subject|3
1368157|NCT01540851|4515209|P1|Overall Study|Withdrawal by Subject|7
1368158|NCT01540851|4515208|P2|Overall Study|Lost to Follow-up|15
1368159|NCT01540851|4515209|P1|Overall Study|Lost to Follow-up|14
1368160|NCT01540487|4515354|P2|Overall Study|Protocol Violation|0
1368161|NCT01540487|4515355|P1|Overall Study|Protocol Violation|1
1368162|NCT01539759|4515490|P2|Overall Study|Lost to Follow-up|8
1368163|NCT01539759|4515491|P1|Overall Study|Lost to Follow-up|6
1368164|NCT01539642|4515503|P2|Overall Study|Withdrawal by Subject|2
1368165|NCT01539642|4515504|P1|Overall Study|Withdrawal by Subject|2
1368166|NCT01539642|4515503|P2|Overall Study|Adverse Event|4
1368167|NCT01539642|4515504|P1|Overall Study|Adverse Event|6
1368168|NCT01539642|4515503|P2|Overall Study|Patient ready for early discharge|7
1368169|NCT01539642|4515504|P1|Overall Study|Patient ready for early discharge|8
1368170|NCT01539642|4515503|P2|Overall Study|Lack of Efficacy|18
1368171|NCT01539642|4515504|P1|Overall Study|Lack of Efficacy|20
1368172|NCT01539538|4515521|P2|Overall Study|PCA no longer required or PCA problem|7
1368173|NCT01539538|4515522|P1|Overall Study|PCA no longer required or PCA problem|3
1368174|NCT01539538|4515521|P2|Overall Study|Withdrawal by Subject|3
1368175|NCT01539538|4515522|P1|Overall Study|Withdrawal by Subject|2
1368176|NCT01539538|4515521|P2|Overall Study|Lack of Efficacy|16
1368177|NCT01539538|4515522|P1|Overall Study|Lack of Efficacy|13
1368178|NCT01539538|4515521|P2|Overall Study|Adverse Event|18
1368179|NCT01539538|4515522|P1|Overall Study|Adverse Event|13
1368180|NCT01539525|4515531|P3|Overall Study|Protocol Violation|4
1368181|NCT01539525|4515532|P2|Overall Study|Protocol Violation|1
1368182|NCT01539525|4515533|P1|Overall Study|Protocol Violation|1
1368183|NCT01539525|4515531|P3|Overall Study|Withdrawal by Subject|2
1368184|NCT01539525|4515532|P2|Overall Study|Withdrawal by Subject|3
1368185|NCT01539525|4515533|P1|Overall Study|Withdrawal by Subject|0
1368186|NCT01539525|4515531|P3|Overall Study|Lost to Follow-up|11
1368187|NCT01539525|4515532|P2|Overall Study|Lost to Follow-up|12
1368188|NCT01539525|4515533|P1|Overall Study|Lost to Follow-up|19
1368189|NCT01539512|4515552|P2|Overall Study|Richter's Transformation|0
1368190|NCT01539512|4515553|P1|Overall Study|Richter's Transformation|1
1368191|NCT01539512|4515552|P2|Overall Study|Withdrawal by Subject|5
1368192|NCT01539512|4515553|P1|Overall Study|Withdrawal by Subject|12
1368193|NCT01539512|4515552|P2|Overall Study|Physician Decision|1
1368194|NCT01539512|4515553|P1|Overall Study|Physician Decision|1
1368195|NCT01539512|4515552|P2|Overall Study|Adverse Event|7
1368196|NCT01539512|4515553|P1|Overall Study|Adverse Event|9
1368197|NCT01539317|4515569|P2|Overall Study|Screening Error. Deleted from analysis.|0
1368198|NCT01539317|4515570|P1|Overall Study|Screening Error. Deleted from analysis.|1
1368199|NCT01539083|4515600|P3|After Randomization (TP and VTP)|Progressive Disease|2
1368200|NCT01539083|4515601|P2|After Randomization (TP and VTP)|Progressive Disease|3
1368201|NCT01539083|4515602|P1|After Randomization (TP and VTP)|Progressive Disease|0
1368202|NCT01539083|4515600|P3|After Randomization (TP and VTP)|Death|6
1368203|NCT01539083|4515601|P2|After Randomization (TP and VTP)|Death|4
1368204|NCT01539083|4515602|P1|After Randomization (TP and VTP)|Death|0
1368205|NCT01539083|4515600|P3|After Randomization (TP and VTP)|Adverse Event|0
1368206|NCT01539083|4515601|P2|After Randomization (TP and VTP)|Adverse Event|1
1368207|NCT01539083|4515602|P1|After Randomization (TP and VTP)|Adverse Event|0
1368208|NCT01539083|4515600|P3|After Randomization (TP and VTP)|Withdrawal by Subject|1
1368209|NCT01539083|4515601|P2|After Randomization (TP and VTP)|Withdrawal by Subject|3
1368210|NCT01539083|4515602|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
1368211|NCT01539083|4515600|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
1368212|NCT01539083|4515601|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
1368213|NCT01539083|4515602|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
1368214|NCT01539083|4515600|P3|Before Randomization (VCD Induction)|Other|0
1368215|NCT01539083|4515601|P2|Before Randomization (VCD Induction)|Other|0
1368216|NCT01539083|4515602|P1|Before Randomization (VCD Induction)|Other|5
1368217|NCT01539083|4515600|P3|Before Randomization (VCD Induction)|Progressive Disease|0
1368218|NCT01539083|4515601|P2|Before Randomization (VCD Induction)|Progressive Disease|0
1368219|NCT01539083|4515602|P1|Before Randomization (VCD Induction)|Progressive Disease|8
1368220|NCT01539083|4515600|P3|Before Randomization (VCD Induction)|Physician Decision|0
1368221|NCT01539083|4515601|P2|Before Randomization (VCD Induction)|Physician Decision|0
1368222|NCT01539083|4515602|P1|Before Randomization (VCD Induction)|Physician Decision|14
1368223|NCT01539083|4515600|P3|Before Randomization (VCD Induction)|Protocol Violation|0
1368224|NCT01539083|4515601|P2|Before Randomization (VCD Induction)|Protocol Violation|0
1368225|NCT01539083|4515602|P1|Before Randomization (VCD Induction)|Protocol Violation|2
1368226|NCT01539083|4515600|P3|Before Randomization (VCD Induction)|Death|0
1368227|NCT01539083|4515601|P2|Before Randomization (VCD Induction)|Death|0
1368228|NCT01539083|4515602|P1|Before Randomization (VCD Induction)|Death|6
1368229|NCT01539083|4515600|P3|Before Randomization (VCD Induction)|Adverse Event|0
1368230|NCT01539083|4515601|P2|Before Randomization (VCD Induction)|Adverse Event|0
1368231|NCT01539083|4515602|P1|Before Randomization (VCD Induction)|Adverse Event|14
1368232|NCT01539083|4515600|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
1368233|NCT01539083|4515601|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
1368234|NCT01539083|4515602|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
1368235|NCT01538719|4515646|P2|Overall Study|Lost to Follow-up|0
1368236|NCT01538719|4515647|P1|Overall Study|Lost to Follow-up|2
1368237|NCT01538472|4515670|P1|Overall Study|Death|1
1368238|NCT01538472|4515670|P1|Overall Study|Disease Progression|3
1368239|NCT01538199|4515681|P4|Overall Study|Lack of Efficacy|0
1368240|NCT01538199|4515682|P3|Overall Study|Lack of Efficacy|0
1368241|NCT01538199|4515683|P2|Overall Study|Lack of Efficacy|1
1368242|NCT01538199|4515684|P1|Overall Study|Lack of Efficacy|0
1368243|NCT01538199|4515681|P4|Overall Study|participant did not have time|2
1368244|NCT01538199|4515682|P3|Overall Study|participant did not have time|0
1368245|NCT01538199|4515683|P2|Overall Study|participant did not have time|0
1368246|NCT01538199|4515684|P1|Overall Study|participant did not have time|1
1368247|NCT01538199|4515681|P4|Overall Study|Lost to Follow-up|0
1368248|NCT01538199|4515682|P3|Overall Study|Lost to Follow-up|1
1368249|NCT01538199|4515683|P2|Overall Study|Lost to Follow-up|2
1368250|NCT01538199|4515684|P1|Overall Study|Lost to Follow-up|1
1368251|NCT01537783|4515736|P2|Overall Study|Lost to Follow-up|2
1368252|NCT01537783|4515737|P1|Overall Study|Lost to Follow-up|11
1368253|NCT01537549|4515788|P1|Overall Study|Withdrawal by Subject|2
1368254|NCT01537549|4515788|P1|Overall Study|Lost to Follow-up|1
1368255|NCT01537432|4515796|P2|Overall Study|Unsatisfactory therapeutic effect|0
1368256|NCT01537432|4515797|P1|Overall Study|Unsatisfactory therapeutic effect|1
1368257|NCT01537432|4515796|P2|Overall Study|Adverse Event|0
1368258|NCT01537432|4515797|P1|Overall Study|Adverse Event|1
1368259|NCT01537432|4515796|P2|Overall Study|Administrative problems|0
1368260|NCT01537432|4515797|P1|Overall Study|Administrative problems|1
1368261|NCT01537432|4515796|P2|Overall Study|Withdrawal by Subject|1
1368262|NCT01537432|4515797|P1|Overall Study|Withdrawal by Subject|0
1368263|NCT01537432|4515796|P2|Overall Study|Lost to Follow-up|1
1368264|NCT01537432|4515797|P1|Overall Study|Lost to Follow-up|3
1368265|NCT01537393|4515820|P2|Overall Study|Censored (severe event unrelated to PT)|1
1368266|NCT01537393|4515821|P1|Overall Study|Censored (severe event unrelated to PT)|1
1368267|NCT01537393|4515820|P2|Overall Study|Failure - Not regrafted|6
1368268|NCT01537393|4515821|P1|Overall Study|Failure - Not regrafted|2
1368269|NCT01537393|4515820|P2|Overall Study|Failure - Regrafted|43
1368270|NCT01537393|4515821|P1|Overall Study|Failure - Regrafted|28
1368271|NCT01537393|4515820|P2|Overall Study|Lost to Follow-up|48
1368272|NCT01537393|4515821|P1|Overall Study|Lost to Follow-up|53
1368273|NCT01537393|4515820|P2|Overall Study|Withdrawal by Subject|17
1368274|NCT01537393|4515821|P1|Overall Study|Withdrawal by Subject|18
1368275|NCT01537393|4515820|P2|Overall Study|Death|32
1368276|NCT01537393|4515821|P1|Overall Study|Death|20
1368277|NCT01537393|4515820|P2|Overall Study|Exclude prior to study|44
1368278|NCT01537393|4515821|P1|Overall Study|Exclude prior to study|32
1368279|NCT01537302|4515857|P1|Overall Study|Withdrawal by Subject|1
1368280|NCT01537302|4515857|P1|Overall Study|Lost to Follow-up|1
1368281|NCT01537198|4515864|P1|Overall Study|Not Specified|111
1368282|NCT01537198|4515864|P1|Overall Study|No Further Visits to the Clinic|37
1368283|NCT01537198|4515864|P1|Overall Study|Adverse Event|4
1368284|NCT01537198|4515864|P1|Overall Study|RSV infection|2
1368285|NCT01537133|4515893|P4|Overall Study|Lost to Follow-up|0
1368286|NCT01537133|4515894|P3|Overall Study|Lost to Follow-up|0
1368287|NCT01537133|4515895|P2|Overall Study|Lost to Follow-up|0
1368288|NCT01537133|4515896|P1|Overall Study|Lost to Follow-up|1
1368289|NCT01537133|4515893|P4|Overall Study|Withdrawal by Subject|0
1368290|NCT01537133|4515894|P3|Overall Study|Withdrawal by Subject|0
1368291|NCT01537133|4515895|P2|Overall Study|Withdrawal by Subject|0
1368292|NCT01537133|4515896|P1|Overall Study|Withdrawal by Subject|2
1368293|NCT01537120|4515912|P1|3 Weeks Placebo|Withdrawal by Subject|1
1368294|NCT01537120|4515912|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
1368295|NCT01537081|4515925|P3|Overall Study|Assigned but never dosed|0
1368296|NCT01537081|4515926|P2|Overall Study|Assigned but never dosed|0
1368297|NCT01537081|4515927|P1|Overall Study|Assigned but never dosed|1
1368298|NCT01537081|4515925|P3|Overall Study|Sponsor decision|0
1368299|NCT01537081|4515926|P2|Overall Study|Sponsor decision|1
1368300|NCT01537081|4515927|P1|Overall Study|Sponsor decision|0
1368301|NCT01537081|4515925|P3|Overall Study|Physician Decision|0
1368302|NCT01537081|4515926|P2|Overall Study|Physician Decision|6
1368303|NCT01537081|4515927|P1|Overall Study|Physician Decision|5
1368304|NCT01537081|4515925|P3|Overall Study|Withdrawal by Subject|3
1368305|NCT01537081|4515926|P2|Overall Study|Withdrawal by Subject|11
1368306|NCT01537081|4515927|P1|Overall Study|Withdrawal by Subject|6
1368307|NCT01537081|4515925|P3|Overall Study|Protocol Violation|2
1368308|NCT01537081|4515926|P2|Overall Study|Protocol Violation|2
1368309|NCT01537081|4515927|P1|Overall Study|Protocol Violation|3
1368310|NCT01537081|4515925|P3|Overall Study|Lost to Follow-up|9
1368311|NCT01537081|4515926|P2|Overall Study|Lost to Follow-up|15
1368312|NCT01537081|4515927|P1|Overall Study|Lost to Follow-up|17
1368313|NCT01537081|4515925|P3|Overall Study|Lack of Efficacy|0
1368314|NCT01537081|4515926|P2|Overall Study|Lack of Efficacy|1
1368315|NCT01537081|4515927|P1|Overall Study|Lack of Efficacy|2
1368316|NCT01537081|4515925|P3|Overall Study|Adverse Event|2
1368317|NCT01537081|4515926|P2|Overall Study|Adverse Event|2
1368318|NCT01537081|4515927|P1|Overall Study|Adverse Event|5
1368319|NCT01537068|4515940|P2|Overall Study|Lack of Efficacy|0
1368320|NCT01537068|4515941|P1|Overall Study|Lack of Efficacy|1
1368321|NCT01537068|4515940|P2|Overall Study|Withdrawal by Subject|1
1368322|NCT01537068|4515941|P1|Overall Study|Withdrawal by Subject|1
1368323|NCT01537068|4515940|P2|Overall Study|Adverse Event|1
1368324|NCT01537068|4515941|P1|Overall Study|Adverse Event|0
1368325|NCT01537068|4515940|P2|Overall Study|Lost to Follow-up|1
1368326|NCT01537068|4515941|P1|Overall Study|Lost to Follow-up|2
1368327|NCT01537042|4515953|P2|Overall Study|Other|1
1368328|NCT01537042|4515954|P1|Overall Study|Other|0
1368329|NCT01537042|4515953|P2|Overall Study|Protocol Violation|1
1368330|NCT01537042|4515954|P1|Overall Study|Protocol Violation|0
1368331|NCT01537042|4515953|P2|Overall Study|Lack of Efficacy|1
1368332|NCT01537042|4515954|P1|Overall Study|Lack of Efficacy|0
1368333|NCT01537042|4515953|P2|Overall Study|Adverse Event|2
1368334|NCT01537042|4515954|P1|Overall Study|Adverse Event|0
1368335|NCT01536951|4515996|P9|Second Intervention and Washout Period 2|Adverse Event|0
1368336|NCT01536951|4515997|P8|Second Intervention and Washout Period 2|Adverse Event|1
1368337|NCT01536951|4515998|P7|Second Intervention and Washout Period 2|Adverse Event|0
1368338|NCT01536951|4515999|P6|Second Intervention and Washout Period 2|Adverse Event|0
1368339|NCT01536951|4516000|P5|Second Intervention and Washout Period 2|Adverse Event|0
1368340|NCT01536951|4516001|P4|Second Intervention and Washout Period 2|Adverse Event|0
1368341|NCT01536951|4516002|P3|Second Intervention and Washout Period 2|Adverse Event|0
1368342|NCT01536951|4516003|P2|Second Intervention and Washout Period 2|Adverse Event|0
1368343|NCT01536951|4516004|P1|Second Intervention and Washout Period 2|Adverse Event|0
1368344|NCT01536951|4515996|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
1368345|NCT01536951|4515997|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
1368346|NCT01536951|4515998|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
1368347|NCT01536951|4515999|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
1368348|NCT01536951|4516000|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
1368349|NCT01536951|4516001|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
1368350|NCT01536951|4516002|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
1368351|NCT01536951|4516003|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
1368352|NCT01536951|4516004|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
1368353|NCT01536860|4516061|P3|Washout Period (3 Days)|Lost to Follow-up|0
1368354|NCT01536860|4516062|P2|Washout Period (3 Days)|Lost to Follow-up|0
1368355|NCT01536860|4516063|P1|Washout Period (3 Days)|Lost to Follow-up|1
1368356|NCT01536704|4516071|P4|Washout Period 3|Adverse Event|0
1368357|NCT01536704|4516072|P3|Washout Period 3|Adverse Event|1
1368358|NCT01536704|4516073|P2|Washout Period 3|Adverse Event|0
1368359|NCT01536704|4516074|P1|Washout Period 3|Adverse Event|0
1368360|NCT01536704|4516071|P4|Period 3|Adverse Event|1
1368361|NCT01536704|4516072|P3|Period 3|Adverse Event|0
1368362|NCT01536704|4516073|P2|Period 3|Adverse Event|0
1368363|NCT01536704|4516074|P1|Period 3|Adverse Event|0
1368364|NCT01536704|4516071|P4|Washout Period 2|Withdrawal by Subject|1
1368365|NCT01536704|4516072|P3|Washout Period 2|Withdrawal by Subject|0
1368366|NCT01536704|4516073|P2|Washout Period 2|Withdrawal by Subject|0
1368367|NCT01536704|4516074|P1|Washout Period 2|Withdrawal by Subject|0
1368368|NCT01536704|4516071|P4|Washout Period 2|Adverse Event|0
1368369|NCT01536704|4516072|P3|Washout Period 2|Adverse Event|0
1368370|NCT01536704|4516073|P2|Washout Period 2|Adverse Event|0
1368371|NCT01536704|4516074|P1|Washout Period 2|Adverse Event|1
1368372|NCT01536704|4516071|P4|Washout Period 1|Withdrawal by Subject|0
1368373|NCT01536704|4516072|P3|Washout Period 1|Withdrawal by Subject|0
1368374|NCT01536704|4516073|P2|Washout Period 1|Withdrawal by Subject|2
1368375|NCT01536704|4516074|P1|Washout Period 1|Withdrawal by Subject|1
1368376|NCT01536587|4516104|P1|Overall Study|Adverse Event|2
1368377|NCT01536574|4516143|P2|Overall Study|Lack of Efficacy|0
1368378|NCT01536574|4516144|P1|Overall Study|Lack of Efficacy|1
1368379|NCT01536574|4516143|P2|Overall Study|Withdrawal by Subject|2
1368380|NCT01536574|4516144|P1|Overall Study|Withdrawal by Subject|1
1368381|NCT01536574|4516143|P2|Overall Study|Adverse Event|5
1368382|NCT01536574|4516144|P1|Overall Study|Adverse Event|4
1368383|NCT01536561|4516162|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
1368384|NCT01536561|4516162|P1|Dosimetric and Therapeutic Treatment|Death|2
1368385|NCT01536561|4516162|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
1368386|NCT01536561|4516162|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
1368387|NCT01536561|4516162|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
1368388|NCT01536561|4516162|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
1368389|NCT01536418|4516239|P2|Overall Study|Withdrawal by Subject|3
1368390|NCT01536418|4516240|P1|Overall Study|Withdrawal by Subject|5
1368391|NCT01536418|4516239|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
1368392|NCT01536418|4516240|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
1368393|NCT01536418|4516239|P2|Overall Study|Adverse Event|4
1368394|NCT01536418|4516240|P1|Overall Study|Adverse Event|9
1368395|NCT01536418|4516239|P2|Overall Study|Lack of Efficacy|16
1368396|NCT01536418|4516240|P1|Overall Study|Lack of Efficacy|10
1368397|NCT01536418|4516239|P2|Overall Study|Study closed/terminated|37
1368398|NCT01536418|4516240|P1|Overall Study|Study closed/terminated|41
1368399|NCT01536418|4516239|P2|Overall Study|Physician Decision|3
1368400|NCT01536418|4516240|P1|Overall Study|Physician Decision|1
1368401|NCT01536418|4516239|P2|Overall Study|Protocol Violation|3
1368402|NCT01536418|4516240|P1|Overall Study|Protocol Violation|2
1368403|NCT01536405|4516260|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
1368404|NCT01536405|4516261|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
1368405|NCT01536405|4516260|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
1368406|NCT01536405|4516261|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
1368407|NCT01536405|4516260|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
1368408|NCT01536405|4516261|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
1368409|NCT01536405|4516260|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
1368410|NCT01536405|4516261|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
1368411|NCT01536405|4516260|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
1368412|NCT01536405|4516261|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
1368413|NCT01536405|4516260|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
1368414|NCT01536405|4516261|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
1368415|NCT01536405|4516260|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
1368416|NCT01536405|4516261|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
1368417|NCT01536405|4516260|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
1368418|NCT01536405|4516261|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
1368419|NCT01536405|4516260|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
1368420|NCT01536405|4516261|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
1368421|NCT01536405|4516260|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
1368422|NCT01536405|4516261|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
1368423|NCT01536405|4516260|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
1368424|NCT01536405|4516261|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
1368425|NCT01536405|4516260|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
1368426|NCT01536405|4516261|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
1368427|NCT01536405|4516260|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
1368428|NCT01536405|4516261|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
1368429|NCT01536379|4516299|P2|Overall Study|Withdrawal by Subject|1
1368430|NCT01536379|4516300|P1|Overall Study|Withdrawal by Subject|1
1368431|NCT01536379|4516299|P2|Overall Study|Adverse Event|2
1368432|NCT01536379|4516300|P1|Overall Study|Adverse Event|1
1368433|NCT01536262|4516392|P3|Overall Study|Other than stated above|0
1368434|NCT01536262|4516393|P2|Overall Study|Other than stated above|0
1368435|NCT01536262|4516394|P1|Overall Study|Other than stated above|1
1368436|NCT01536262|4516392|P3|Overall Study|Withdrawal by Subject|0
1368437|NCT01536262|4516393|P2|Overall Study|Withdrawal by Subject|1
1368438|NCT01536262|4516394|P1|Overall Study|Withdrawal by Subject|1
1368439|NCT01536262|4516392|P3|Overall Study|Adverse Event|2
1368440|NCT01536262|4516393|P2|Overall Study|Adverse Event|1
1368441|NCT01536262|4516394|P1|Overall Study|Adverse Event|6
1368442|NCT01536171|4516436|P1|Overall Study|Withdrawal by Subject|1
1368443|NCT01536145|4516441|P11|Overall Study|Adverse Event|3
1368444|NCT01536145|4516442|P10|Overall Study|Adverse Event|0
1368445|NCT01536145|4516443|P9|Overall Study|Adverse Event|0
1368446|NCT01536145|4516444|P8|Overall Study|Adverse Event|2
1368447|NCT01536145|4516445|P7|Overall Study|Adverse Event|0
1368448|NCT01536145|4516446|P6|Overall Study|Adverse Event|0
1368449|NCT01536145|4516447|P5|Overall Study|Adverse Event|0
1368450|NCT01536145|4516448|P4|Overall Study|Adverse Event|0
1368451|NCT01536145|4516449|P3|Overall Study|Adverse Event|0
1368452|NCT01536145|4516450|P2|Overall Study|Adverse Event|0
1368453|NCT01536145|4516451|P1|Overall Study|Adverse Event|0
1368454|NCT01536145|4516441|P11|Overall Study|Death|0
1368455|NCT01536145|4516442|P10|Overall Study|Death|0
1368456|NCT01536145|4516443|P9|Overall Study|Death|0
1368457|NCT01536145|4516444|P8|Overall Study|Death|0
1368458|NCT01536145|4516445|P7|Overall Study|Death|1
1368459|NCT01536145|4516446|P6|Overall Study|Death|0
1368460|NCT01536145|4516447|P5|Overall Study|Death|0
1368461|NCT01536145|4516448|P4|Overall Study|Death|0
1368462|NCT01536145|4516449|P3|Overall Study|Death|0
1368463|NCT01536145|4516450|P2|Overall Study|Death|0
1368464|NCT01536145|4516451|P1|Overall Study|Death|0
1368465|NCT01536145|4516441|P11|Overall Study|Other|2
1368466|NCT01536145|4516442|P10|Overall Study|Other|3
1368467|NCT01536145|4516443|P9|Overall Study|Other|0
1368468|NCT01536145|4516444|P8|Overall Study|Other|0
1368469|NCT01536145|4516445|P7|Overall Study|Other|0
1368470|NCT01536145|4516446|P6|Overall Study|Other|0
1368471|NCT01536145|4516447|P5|Overall Study|Other|1
1368472|NCT01536145|4516448|P4|Overall Study|Other|0
1368473|NCT01536145|4516449|P3|Overall Study|Other|0
1368474|NCT01536145|4516450|P2|Overall Study|Other|0
1368475|NCT01536145|4516451|P1|Overall Study|Other|0
1368476|NCT01536145|4516441|P11|Overall Study|Withdrawal by Subject|2
1368477|NCT01536145|4516442|P10|Overall Study|Withdrawal by Subject|0
1368478|NCT01536145|4516443|P9|Overall Study|Withdrawal by Subject|2
1368479|NCT01536145|4516444|P8|Overall Study|Withdrawal by Subject|0
1368480|NCT01536145|4516445|P7|Overall Study|Withdrawal by Subject|0
1368481|NCT01536145|4516446|P6|Overall Study|Withdrawal by Subject|1
1368482|NCT01536145|4516447|P5|Overall Study|Withdrawal by Subject|0
1368483|NCT01536145|4516448|P4|Overall Study|Withdrawal by Subject|0
1368484|NCT01536145|4516449|P3|Overall Study|Withdrawal by Subject|1
1368485|NCT01536145|4516450|P2|Overall Study|Withdrawal by Subject|0
1368486|NCT01536145|4516451|P1|Overall Study|Withdrawal by Subject|0
1368487|NCT01536145|4516441|P11|Overall Study|Progressive disease|3
1368488|NCT01536145|4516442|P10|Overall Study|Progressive disease|3
1368489|NCT01536145|4516443|P9|Overall Study|Progressive disease|1
1368490|NCT01536145|4516444|P8|Overall Study|Progressive disease|2
1368491|NCT01536145|4516445|P7|Overall Study|Progressive disease|1
1368492|NCT01536145|4516446|P6|Overall Study|Progressive disease|2
1368493|NCT01536145|4516447|P5|Overall Study|Progressive disease|1
1368494|NCT01536145|4516448|P4|Overall Study|Progressive disease|2
1368495|NCT01536145|4516449|P3|Overall Study|Progressive disease|1
1368496|NCT01536145|4516450|P2|Overall Study|Progressive disease|4
1368497|NCT01536145|4516451|P1|Overall Study|Progressive disease|3
1368498|NCT01536119|4516558|P2|Overall Study|Lost to Follow-up|14
1368499|NCT01536119|4516559|P1|Overall Study|Lost to Follow-up|17
1368500|NCT01536093|4516585|P2|Overall Study|Withdrawal by Subject|1
1368501|NCT01536093|4516586|P1|Overall Study|Withdrawal by Subject|0
1368502|NCT01536093|4516585|P2|Overall Study|absence of maternal colostrum|0
1368503|NCT01536093|4516586|P1|Overall Study|absence of maternal colostrum|2
1368504|NCT01536093|4516585|P2|Overall Study|Death|2
1368505|NCT01536093|4516586|P1|Overall Study|Death|1
1368506|NCT01536067|4516602|P1|Overall Study|Disease Progression|1
1368507|NCT01536015|4516615|P2|Overall Study|Study closure|5
1368508|NCT01536015|4516616|P1|Overall Study|Study closure|5
1368509|NCT01536015|4516615|P2|Overall Study|Inclusion Criterion not met|0
1368510|NCT01536015|4516616|P1|Overall Study|Inclusion Criterion not met|2
1368511|NCT01536015|4516615|P2|Overall Study|Lost to Follow-up|1
1368512|NCT01536015|4516616|P1|Overall Study|Lost to Follow-up|0
1368513|NCT01536015|4516615|P2|Overall Study|Adverse Event|4
1368514|NCT01536015|4516616|P1|Overall Study|Adverse Event|1
1368515|NCT01535807|4516643|P2|Overall Study|Data collection error|1
1368516|NCT01535807|4516644|P1|Overall Study|Data collection error|1
1368517|NCT01535807|4516643|P2|Overall Study|Withdrawal by Subject|1
1368518|NCT01535807|4516644|P1|Overall Study|Withdrawal by Subject|1
1368519|NCT01535729|4516650|P1|Overall Study|No participant record available|5
1368520|NCT01535729|4516650|P1|Overall Study|Not treated|9
1368521|NCT01535729|4516650|P1|Overall Study|Screening failure|1
1368522|NCT01535729|4516650|P1|Overall Study|Protocol Violation|11
1368523|NCT01535729|4516650|P1|Overall Study|NSCLC grade IV histology not confirmed|20
1368524|NCT01535729|4516650|P1|Overall Study|No previous chemotherapy|33
1368525|NCT01535729|4516650|P1|Overall Study|Did not sign informed consent|1
1368526|NCT01535729|4516650|P1|Overall Study|Other|19
1368527|NCT01535729|4516650|P1|Overall Study|Death|52
1368528|NCT01535729|4516650|P1|Overall Study|Lost to Follow-up|8
1368529|NCT01535729|4516650|P1|Overall Study|Discontinued treatment|25
1368530|NCT01535729|4516650|P1|Overall Study|Disease progression|230
1368531|NCT01535729|4516650|P1|Overall Study|Withdrawal by Subject|2
1368532|NCT01535638|4516691|P6|Treatment 3 (Single Dose)|Protocol Violation|0
1368533|NCT01535638|4516692|P5|Treatment 3 (Single Dose)|Protocol Violation|0
1368534|NCT01535638|4516693|P4|Treatment 3 (Single Dose)|Protocol Violation|1
1368535|NCT01535638|4516694|P3|Treatment 3 (Single Dose)|Protocol Violation|0
1368536|NCT01535638|4516695|P2|Treatment 3 (Single Dose)|Protocol Violation|0
1368537|NCT01535638|4516696|P1|Treatment 3 (Single Dose)|Protocol Violation|0
1368538|NCT01535638|4516691|P6|Treatment 1 (Single Dose)|Protocol Violation|1
1368539|NCT01535638|4516692|P5|Treatment 1 (Single Dose)|Protocol Violation|0
1368540|NCT01535638|4516693|P4|Treatment 1 (Single Dose)|Protocol Violation|0
1368541|NCT01535638|4516694|P3|Treatment 1 (Single Dose)|Protocol Violation|0
1368542|NCT01535638|4516695|P2|Treatment 1 (Single Dose)|Protocol Violation|0
1368543|NCT01535638|4516696|P1|Treatment 1 (Single Dose)|Protocol Violation|0
1368544|NCT01535599|4516710|P2|Overall Study|Noncompliance|1
1368545|NCT01535599|4516711|P1|Overall Study|Noncompliance|0
1368546|NCT01535599|4516710|P2|Overall Study|Stopped medication|1
1368547|NCT01535599|4516711|P1|Overall Study|Stopped medication|0
1368548|NCT01535599|4516710|P2|Overall Study|Other|0
1368549|NCT01535599|4516711|P1|Overall Study|Other|1
1368550|NCT01535599|4516710|P2|Overall Study|Did not use product|0
1368551|NCT01535599|4516711|P1|Overall Study|Did not use product|1
1368552|NCT01535599|4516710|P2|Overall Study|Randomized in Error|4
1368553|NCT01535599|4516711|P1|Overall Study|Randomized in Error|2
1368554|NCT01535599|4516710|P2|Overall Study|BL Culture + for Yeast//Fungi|1
1368555|NCT01535599|4516711|P1|Overall Study|BL Culture + for Yeast//Fungi|0
1368556|NCT01535599|4516710|P2|Overall Study|BL Culture + for Group A Strep|1
1368557|NCT01535599|4516711|P1|Overall Study|BL Culture + for Group A Strep|0
1368558|NCT01535599|4516710|P2|Overall Study|Treatment Failure|66
1368559|NCT01535599|4516711|P1|Overall Study|Treatment Failure|33
1368560|NCT01535599|4516710|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
1368561|NCT01535599|4516711|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
1368562|NCT01535599|4516710|P2|Overall Study|Lost to Follow-up|4
1368563|NCT01535599|4516711|P1|Overall Study|Lost to Follow-up|3
1368564|NCT01535599|4516710|P2|Overall Study|Adverse Event|15
1368565|NCT01535599|4516711|P1|Overall Study|Adverse Event|6
1368566|NCT01535560|4516723|P2|Overall Study|Randomized in Error|1
1368567|NCT01535560|4516724|P1|Overall Study|Randomized in Error|0
1368568|NCT01535560|4516723|P2|Overall Study|Other|1
1368569|NCT01535560|4516724|P1|Overall Study|Other|0
1368570|NCT01535560|4516723|P2|Overall Study|Treatment Failure|83
1368571|NCT01535560|4516724|P1|Overall Study|Treatment Failure|21
1368572|NCT01535560|4516723|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
1368573|NCT01535560|4516724|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
1368574|NCT01535560|4516723|P2|Overall Study|Lost to Follow-up|3
1368575|NCT01535560|4516724|P1|Overall Study|Lost to Follow-up|1
1368576|NCT01535560|4516723|P2|Overall Study|Adverse Event|7
1368577|NCT01535560|4516724|P1|Overall Study|Adverse Event|12
1368578|NCT01535287|4516769|P2|Overall Study|drug not prepared in time|6
1368579|NCT01535287|4516770|P1|Overall Study|drug not prepared in time|5
1368580|NCT01535261|4516786|P1|Overall Study|Adverse Event|12
1368581|NCT01535261|4516786|P1|Overall Study|Withdrawal by Subject|14
1368582|NCT01535261|4516786|P1|Overall Study|Lost to Follow-up|8
1368583|NCT01535261|4516786|P1|Overall Study|Death|5
1368584|NCT01535261|4516786|P1|Overall Study|Protocol Violation|3
1368585|NCT01535261|4516786|P1|Overall Study|Physician Decision|8
1368586|NCT01535235|4516799|P2|Overall Study|Adverse Event|0
1368587|NCT01535235|4516800|P1|Overall Study|Adverse Event|1
1368588|NCT01535222|4516814|P6|Overall Study|Inclusion/exclusion|0
1368589|NCT01535222|4516815|P5|Overall Study|Inclusion/exclusion|0
1368590|NCT01535222|4516816|P4|Overall Study|Inclusion/exclusion|0
1368591|NCT01535222|4516817|P3|Overall Study|Inclusion/exclusion|1
1368592|NCT01535222|4516818|P2|Overall Study|Inclusion/exclusion|0
1368593|NCT01535222|4516819|P1|Overall Study|Inclusion/exclusion|0
1368594|NCT01535040|4516850|P2|Overall Study|Multiple Reasons|1
1368595|NCT01535040|4516851|P1|Overall Study|Multiple Reasons|1
1368596|NCT01535040|4516850|P2|Overall Study|Toxicity|5
1368597|NCT01535040|4516851|P1|Overall Study|Toxicity|7
1368598|NCT01535040|4516850|P2|Overall Study|Never Started|4
1368599|NCT01535040|4516851|P1|Overall Study|Never Started|9
1368600|NCT01535040|4516850|P2|Overall Study|Withdrawal by Subject|10
1368601|NCT01535040|4516851|P1|Overall Study|Withdrawal by Subject|13
1368602|NCT01535040|4516850|P2|Overall Study|Physician Decision|1
1368603|NCT01535040|4516851|P1|Overall Study|Physician Decision|0
1368604|NCT01534962|4516909|P4|Overall Study|Discontinued at AF recurrence|31
1368605|NCT01534962|4516910|P3|Overall Study|Discontinued at AF recurrence|24
1368606|NCT01534962|4516911|P2|Overall Study|Discontinued at AF recurrence|26
1368607|NCT01534962|4516912|P1|Overall Study|Discontinued at AF recurrence|35
1368608|NCT01534962|4516909|P4|Overall Study|Randomized but did not start treatment|1
1368609|NCT01534962|4516910|P3|Overall Study|Randomized but did not start treatment|0
1368610|NCT01534962|4516911|P2|Overall Study|Randomized but did not start treatment|0
1368611|NCT01534962|4516912|P1|Overall Study|Randomized but did not start treatment|2
1368612|NCT01534676|4516969|P2|Overall Study|Study closed due to poor enrollment|1
1368613|NCT01534676|4516970|P1|Overall Study|Study closed due to poor enrollment|2
1368614|NCT01534637|4516976|P1|Overall Study|Liver Mets before treatment|1
1368615|NCT01534637|4516976|P1|Overall Study|Adverse Event|1
1368616|NCT01534637|4516976|P1|Overall Study|Withdrawal by Subject|1
1368617|NCT01534637|4516976|P1|Overall Study|Lack of Efficacy|3
1368618|NCT01534637|4516976|P1|Overall Study|Physician Decision|3
1368619|NCT01534533|4516986|P4|Overall Study|Withdrawal by Subject|1
1368620|NCT01534533|4516987|P3|Overall Study|Withdrawal by Subject|4
1368621|NCT01534533|4516988|P2|Overall Study|Withdrawal by Subject|3
1368622|NCT01534533|4516989|P1|Overall Study|Withdrawal by Subject|5
1368623|NCT01534533|4516986|P4|Overall Study|Lost to Follow-up|3
1368624|NCT01534533|4516987|P3|Overall Study|Lost to Follow-up|4
1368625|NCT01534533|4516988|P2|Overall Study|Lost to Follow-up|0
1368626|NCT01534533|4516989|P1|Overall Study|Lost to Follow-up|3
1368627|NCT01534520|4517017|P2|Overall Study|Adverse Event|1
1368628|NCT01534520|4517018|P1|Overall Study|Adverse Event|0
1368629|NCT01534351|4517052|P3|Overall Study|Study Terminated Early|0
1368630|NCT01534351|4517053|P2|Overall Study|Study Terminated Early|0
1368631|NCT01534351|4517054|P1|Overall Study|Study Terminated Early|1
1368632|NCT01534260|4517073|P2|Overall Study|No treatment, per protocol|1
1368633|NCT01534260|4517074|P1|Overall Study|No treatment, per protocol|0
1368634|NCT01534260|4517073|P2|Overall Study|Physician Decision|1
1368635|NCT01534260|4517074|P1|Overall Study|Physician Decision|3
1368636|NCT01534260|4517073|P2|Overall Study|Disease Progression|6
1368637|NCT01534260|4517074|P1|Overall Study|Disease Progression|8
1368638|NCT01534260|4517073|P2|Overall Study|Withdrawal by Subject|3
1368639|NCT01534260|4517074|P1|Overall Study|Withdrawal by Subject|1
1368640|NCT01534260|4517073|P2|Overall Study|Lack of Efficacy|1
1368641|NCT01534260|4517074|P1|Overall Study|Lack of Efficacy|1
1368642|NCT01534260|4517073|P2|Overall Study|Death|0
1368643|NCT01534260|4517074|P1|Overall Study|Death|2
1368644|NCT01534260|4517073|P2|Overall Study|Adverse Event|8
1368645|NCT01534260|4517074|P1|Overall Study|Adverse Event|1
1368646|NCT01534208|4517084|P2|Overall Study|Needed prohibited meds|0
1368647|NCT01534208|4517085|P1|Overall Study|Needed prohibited meds|1
1368648|NCT01534208|4517084|P2|Overall Study|PCP decision|0
1368649|NCT01534208|4517085|P1|Overall Study|PCP decision|1
1368650|NCT01534208|4517084|P2|Overall Study|Eligibility error|0
1368651|NCT01534208|4517085|P1|Overall Study|Eligibility error|3
1368652|NCT01534208|4517084|P2|Overall Study|Lab assessment|1
1368653|NCT01534208|4517085|P1|Overall Study|Lab assessment|2
1368654|NCT01534208|4517084|P2|Overall Study|Subject relocation|0
1368655|NCT01534208|4517085|P1|Overall Study|Subject relocation|2
1368656|NCT01534208|4517084|P2|Overall Study|Sponsor decision|1
1368657|NCT01534208|4517085|P1|Overall Study|Sponsor decision|4
1368658|NCT01534208|4517084|P2|Overall Study|Protocol Violation|2
1368659|NCT01534208|4517085|P1|Overall Study|Protocol Violation|2
1368660|NCT01534208|4517084|P2|Overall Study|Lack of Efficacy|3
1368661|NCT01534208|4517085|P1|Overall Study|Lack of Efficacy|0
1368662|NCT01534208|4517084|P2|Overall Study|Physician Decision|0
1368663|NCT01534208|4517085|P1|Overall Study|Physician Decision|2
1368664|NCT01534208|4517084|P2|Overall Study|Adverse Event|8
1368665|NCT01534208|4517085|P1|Overall Study|Adverse Event|15
1368666|NCT01534208|4517084|P2|Overall Study|Withdrawal by Subject|20
1368667|NCT01534208|4517085|P1|Overall Study|Withdrawal by Subject|6
1368668|NCT01534208|4517084|P2|Overall Study|Lost to Follow-up|14
1368669|NCT01534208|4517085|P1|Overall Study|Lost to Follow-up|19
1368670|NCT01534182|4517103|P2|Overall Study|Adverse Event|3
1368671|NCT01534182|4517104|P1|Overall Study|Adverse Event|7
1368672|NCT01534182|4517103|P2|Overall Study|Withdrawal by Subject|7
1368673|NCT01534182|4517104|P1|Overall Study|Withdrawal by Subject|4
1368674|NCT01534182|4517103|P2|Overall Study|Administrative problems|0
1368675|NCT01534182|4517104|P1|Overall Study|Administrative problems|1
1368676|NCT01534078|4517135|P1|Overall Study|Withdrawal by Subject|1
1368677|NCT01534078|4517135|P1|Overall Study|Death|1
1368678|NCT01533935|4517163|P5|Overall Study|Other reason not defined above|1
1368679|NCT01533935|4517164|P4|Overall Study|Other reason not defined above|0
1368680|NCT01533935|4517165|P3|Overall Study|Other reason not defined above|1
1368681|NCT01533935|4517166|P2|Overall Study|Other reason not defined above|0
1368682|NCT01533935|4517167|P1|Overall Study|Other reason not defined above|1
1368683|NCT01533935|4517163|P5|Overall Study|Withdrawal by Subject|4
1368684|NCT01533935|4517164|P4|Overall Study|Withdrawal by Subject|2
1368685|NCT01533935|4517165|P3|Overall Study|Withdrawal by Subject|5
1368686|NCT01533935|4517166|P2|Overall Study|Withdrawal by Subject|4
1368687|NCT01533935|4517167|P1|Overall Study|Withdrawal by Subject|0
1368688|NCT01533935|4517163|P5|Overall Study|Lost to Follow-up|0
1368689|NCT01533935|4517164|P4|Overall Study|Lost to Follow-up|0
1368690|NCT01533935|4517165|P3|Overall Study|Lost to Follow-up|1
1368691|NCT01533935|4517166|P2|Overall Study|Lost to Follow-up|0
1368692|NCT01533935|4517167|P1|Overall Study|Lost to Follow-up|0
1368693|NCT01533935|4517163|P5|Overall Study|Protocol Violation|0
1368694|NCT01533935|4517164|P4|Overall Study|Protocol Violation|0
1368695|NCT01533935|4517165|P3|Overall Study|Protocol Violation|0
1368696|NCT01533935|4517166|P2|Overall Study|Protocol Violation|2
1368697|NCT01533935|4517167|P1|Overall Study|Protocol Violation|0
1368698|NCT01533935|4517163|P5|Overall Study|Adverse Event|3
1368699|NCT01533935|4517164|P4|Overall Study|Adverse Event|5
1368700|NCT01533935|4517165|P3|Overall Study|Adverse Event|1
1368701|NCT01533935|4517166|P2|Overall Study|Adverse Event|7
1368702|NCT01533935|4517167|P1|Overall Study|Adverse Event|5
1368703|NCT01533922|4517194|P5|Overall Study|Other reason not defined above|0
1368704|NCT01533922|4517195|P4|Overall Study|Other reason not defined above|0
1368705|NCT01533922|4517196|P3|Overall Study|Other reason not defined above|1
1368706|NCT01533922|4517197|P2|Overall Study|Other reason not defined above|0
1368707|NCT01533922|4517198|P1|Overall Study|Other reason not defined above|2
1368708|NCT01533922|4517194|P5|Overall Study|Withdrawal by Subject|1
1368709|NCT01533922|4517195|P4|Overall Study|Withdrawal by Subject|2
1368710|NCT01533922|4517196|P3|Overall Study|Withdrawal by Subject|2
1368711|NCT01533922|4517197|P2|Overall Study|Withdrawal by Subject|1
1368712|NCT01533922|4517198|P1|Overall Study|Withdrawal by Subject|3
1368713|NCT01533922|4517194|P5|Overall Study|Protocol Violation|1
1368714|NCT01533922|4517195|P4|Overall Study|Protocol Violation|0
1368715|NCT01533922|4517196|P3|Overall Study|Protocol Violation|0
1368716|NCT01533922|4517197|P2|Overall Study|Protocol Violation|3
1368717|NCT01533922|4517198|P1|Overall Study|Protocol Violation|0
1368718|NCT01533922|4517194|P5|Overall Study|Lack of Efficacy|0
1368719|NCT01533922|4517195|P4|Overall Study|Lack of Efficacy|0
1368720|NCT01533922|4517196|P3|Overall Study|Lack of Efficacy|1
1368721|NCT01533922|4517197|P2|Overall Study|Lack of Efficacy|0
1368722|NCT01533922|4517198|P1|Overall Study|Lack of Efficacy|0
1368723|NCT01533922|4517194|P5|Overall Study|Adverse Event|4
1368724|NCT01533922|4517195|P4|Overall Study|Adverse Event|3
1368725|NCT01533922|4517196|P3|Overall Study|Adverse Event|6
1368726|NCT01533922|4517197|P2|Overall Study|Adverse Event|8
1368727|NCT01533922|4517198|P1|Overall Study|Adverse Event|5
1368728|NCT01533688|4517243|P3|Overall Study|Had colonoscopy at outside hospital|2
1368729|NCT01533688|4517244|P2|Overall Study|Had colonoscopy at outside hospital|3
1368730|NCT01533688|4517245|P1|Overall Study|Had colonoscopy at outside hospital|2
1368731|NCT01533688|4517243|P3|Overall Study|Medically unstable|3
1368732|NCT01533688|4517244|P2|Overall Study|Medically unstable|3
1368733|NCT01533688|4517245|P1|Overall Study|Medically unstable|1
1368734|NCT01533688|4517243|P3|Overall Study|Withdrawal by Subject|3
1368735|NCT01533688|4517244|P2|Overall Study|Withdrawal by Subject|4
1368736|NCT01533688|4517245|P1|Overall Study|Withdrawal by Subject|5
1368737|NCT01533493|4517277|P2|Overall Study|Lost to Follow-up|0
1368738|NCT01533493|4517278|P1|Overall Study|Lost to Follow-up|2
1368739|NCT01533493|4517277|P2|Overall Study|Withdrawal by Subject|2
1368740|NCT01533493|4517278|P1|Overall Study|Withdrawal by Subject|1
1368741|NCT01533493|4517277|P2|Overall Study|Adverse Event|1
1368742|NCT01533493|4517278|P1|Overall Study|Adverse Event|2
1368743|NCT01533428|4517286|P2|Overall Study|Withdrawal by Subject|6
1368744|NCT01533428|4517287|P1|Overall Study|Withdrawal by Subject|7
1368745|NCT01533428|4517286|P2|Overall Study|Lost to Follow-up|1
1368746|NCT01533428|4517287|P1|Overall Study|Lost to Follow-up|2
1368747|NCT01533428|4517286|P2|Overall Study|Adverse Event|1
1368748|NCT01533428|4517287|P1|Overall Study|Adverse Event|0
1368749|NCT01533246|4517333|P1|Overall Study|Withdrawal by Subject|1
1368750|NCT01533246|4517333|P1|Overall Study|Adverse Event|1
1368751|NCT01533181|4517344|P2|Overall Study|Patient withdrawal pre-active treatment|0
1368752|NCT01533181|4517345|P1|Overall Study|Patient withdrawal pre-active treatment|1
1368753|NCT01533181|4517344|P2|Overall Study|Disease progression pre-active treatment|1
1368754|NCT01533181|4517345|P1|Overall Study|Disease progression pre-active treatment|0
1368755|NCT01532999|4517462|P2|Overall Study|New job|2
1368756|NCT01532999|4517463|P1|Overall Study|New job|0
1368757|NCT01532999|4517462|P2|Overall Study|incarcerated|1
1368758|NCT01532999|4517463|P1|Overall Study|incarcerated|0
1368759|NCT01532999|4517462|P2|Overall Study|Adverse Event|1
1368760|NCT01532999|4517463|P1|Overall Study|Adverse Event|0
1368761|NCT01532999|4517462|P2|Overall Study|no show for week 9 assessments|4
1368762|NCT01532999|4517463|P1|Overall Study|no show for week 9 assessments|6
1368763|NCT01532999|4517462|P2|Overall Study|substantial noncompliance|0
1368764|NCT01532999|4517463|P1|Overall Study|substantial noncompliance|2
1368765|NCT01532999|4517462|P2|Overall Study|should not have been randomized|0
1368766|NCT01532999|4517463|P1|Overall Study|should not have been randomized|1
1368767|NCT01532999|4517462|P2|Overall Study|Relocated|0
1368768|NCT01532999|4517463|P1|Overall Study|Relocated|2
1368769|NCT01532999|4517462|P2|Overall Study|Withdrawal by Subject|0
1368770|NCT01532999|4517463|P1|Overall Study|Withdrawal by Subject|5
1368771|NCT01532999|4517462|P2|Overall Study|Physician Decision|2
1368772|NCT01532999|4517463|P1|Overall Study|Physician Decision|1
1368773|NCT01532999|4517462|P2|Overall Study|Lost to Follow-up|8
1368774|NCT01532999|4517463|P1|Overall Study|Lost to Follow-up|14
1368775|NCT01532934|4517545|P2|Overall Study|In controlled environment|2
1368776|NCT01532934|4517546|P1|Overall Study|In controlled environment|3
1368777|NCT01532934|4517545|P2|Overall Study|Lost to Follow-up|11
1368778|NCT01532934|4517546|P1|Overall Study|Lost to Follow-up|11
1368779|NCT01532921|4517556|P1|Overall Study|Device was explanted during procedure|1
1368780|NCT01532921|4517556|P1|Overall Study|Physician Decision|7
1368781|NCT01532921|4517556|P1|Overall Study|Lost to Follow-up|3
1368782|NCT01532921|4517556|P1|Overall Study|Withdrawal by Subject|2
1368783|NCT01532921|4517556|P1|Overall Study|Death|3
1368784|NCT01532869|4517578|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
1368785|NCT01532869|4517579|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
1368786|NCT01532869|4517578|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
1368787|NCT01532869|4517579|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
1368788|NCT01532869|4517578|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
1368789|NCT01532869|4517579|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
1368790|NCT01532869|4517578|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
1368791|NCT01532869|4517579|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
1368792|NCT01532869|4517578|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
1368793|NCT01532869|4517579|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
1368794|NCT01532869|4517578|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
1368795|NCT01532869|4517579|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
1368796|NCT01532869|4517578|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
1368797|NCT01532869|4517579|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
1368798|NCT01532869|4517578|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
1368799|NCT01532869|4517579|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
1368800|NCT01532869|4517578|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
1368801|NCT01532869|4517579|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
1368802|NCT01532869|4517578|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
1368803|NCT01532869|4517579|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
1368804|NCT01532869|4517578|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
1368805|NCT01532869|4517579|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
1368806|NCT01532869|4517578|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
1368807|NCT01532869|4517579|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
1368808|NCT01532869|4517578|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
1368809|NCT01532869|4517579|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
1368810|NCT01532869|4517578|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
1368811|NCT01532869|4517579|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
1368812|NCT01532869|4517578|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
1368813|NCT01532869|4517579|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
1368814|NCT01532869|4517578|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
1368815|NCT01532869|4517579|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
1368816|NCT01532869|4517578|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
1368817|NCT01532869|4517579|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
1368818|NCT01532570|4517645|P4|Overall Study|Withdrawal by Subject|0
1368819|NCT01532570|4517646|P3|Overall Study|Withdrawal by Subject|0
1368820|NCT01532570|4517647|P2|Overall Study|Withdrawal by Subject|1
1368821|NCT01532570|4517648|P1|Overall Study|Withdrawal by Subject|0
1368822|NCT01532570|4517645|P4|Overall Study|Lack of Efficacy|0
1368823|NCT01532570|4517646|P3|Overall Study|Lack of Efficacy|0
1368824|NCT01532570|4517647|P2|Overall Study|Lack of Efficacy|0
1368825|NCT01532570|4517648|P1|Overall Study|Lack of Efficacy|1
1368826|NCT01532414|4517693|P3|Overall Study|Withdrawn by sponsor|0
1368827|NCT01532414|4517694|P2|Overall Study|Withdrawn by sponsor|0
1368828|NCT01532414|4517695|P1|Overall Study|Withdrawn by sponsor|1
1368829|NCT01532414|4517693|P3|Overall Study|Unable to complete 24 hour PK|1
1368830|NCT01532414|4517694|P2|Overall Study|Unable to complete 24 hour PK|0
1368831|NCT01532414|4517695|P1|Overall Study|Unable to complete 24 hour PK|0
1368832|NCT01532414|4517693|P3|Overall Study|Adverse Event|1
1368833|NCT01532414|4517694|P2|Overall Study|Adverse Event|1
1368834|NCT01532414|4517695|P1|Overall Study|Adverse Event|0
1368835|NCT01532414|4517693|P3|Overall Study|No V6 semen sample|0
1368836|NCT01532414|4517694|P2|Overall Study|No V6 semen sample|1
1368837|NCT01532414|4517695|P1|Overall Study|No V6 semen sample|0
1368838|NCT01532414|4517693|P3|Overall Study|Withdrawal by Subject|0
1368839|NCT01532414|4517694|P2|Overall Study|Withdrawal by Subject|0
1368840|NCT01532414|4517695|P1|Overall Study|Withdrawal by Subject|3
1368841|NCT01532414|4517693|P3|Overall Study|Lost to Follow-up|1
1368842|NCT01532414|4517694|P2|Overall Study|Lost to Follow-up|0
1368843|NCT01532414|4517695|P1|Overall Study|Lost to Follow-up|3
1368844|NCT01531998|4517761|P1|Overall Study|Withdrawal by Subject|3
1368845|NCT01531725|4517766|P1|Overall Study|Protocol Violation|5
1368846|NCT01531673|4517784|P13|Overall Study|Other|0
1368847|NCT01531673|4517785|P12|Overall Study|Other|0
1368848|NCT01531673|4517786|P11|Overall Study|Other|0
1368849|NCT01531673|4517787|P10|Overall Study|Other|1
1368850|NCT01531673|4517788|P9|Overall Study|Other|0
1368851|NCT01531673|4517789|P8|Overall Study|Other|0
1368852|NCT01531673|4517790|P7|Overall Study|Other|0
1368853|NCT01531673|4517791|P6|Overall Study|Other|0
1368854|NCT01531673|4517792|P5|Overall Study|Other|0
1368855|NCT01531673|4517793|P4|Overall Study|Other|1
1368856|NCT01531673|4517794|P3|Overall Study|Other|0
1368857|NCT01531673|4517795|P2|Overall Study|Other|0
1368858|NCT01531673|4517796|P1|Overall Study|Other|0
1368859|NCT01531673|4517784|P13|Overall Study|Lost to Follow-up|0
1368860|NCT01531673|4517785|P12|Overall Study|Lost to Follow-up|0
1368861|NCT01531673|4517786|P11|Overall Study|Lost to Follow-up|0
1368862|NCT01531673|4517787|P10|Overall Study|Lost to Follow-up|0
1368863|NCT01531673|4517788|P9|Overall Study|Lost to Follow-up|0
1368864|NCT01531673|4517789|P8|Overall Study|Lost to Follow-up|0
1368865|NCT01531673|4517790|P7|Overall Study|Lost to Follow-up|0
1368866|NCT01531673|4517791|P6|Overall Study|Lost to Follow-up|0
1368867|NCT01531673|4517792|P5|Overall Study|Lost to Follow-up|1
1368868|NCT01531673|4517793|P4|Overall Study|Lost to Follow-up|0
1368869|NCT01531673|4517794|P3|Overall Study|Lost to Follow-up|0
1368870|NCT01531673|4517795|P2|Overall Study|Lost to Follow-up|0
1368871|NCT01531673|4517796|P1|Overall Study|Lost to Follow-up|0
1368872|NCT01531673|4517784|P13|Overall Study|Adverse Event|0
1368873|NCT01531673|4517785|P12|Overall Study|Adverse Event|0
1368874|NCT01531673|4517786|P11|Overall Study|Adverse Event|0
1368875|NCT01531673|4517787|P10|Overall Study|Adverse Event|0
1368876|NCT01531673|4517788|P9|Overall Study|Adverse Event|0
1368877|NCT01531673|4517789|P8|Overall Study|Adverse Event|0
1368878|NCT01531673|4517790|P7|Overall Study|Adverse Event|0
1368879|NCT01531673|4517791|P6|Overall Study|Adverse Event|0
1368880|NCT01531673|4517792|P5|Overall Study|Adverse Event|0
1368881|NCT01531673|4517793|P4|Overall Study|Adverse Event|0
1368882|NCT01531673|4517794|P3|Overall Study|Adverse Event|0
1368883|NCT01531673|4517795|P2|Overall Study|Adverse Event|1
1368884|NCT01531673|4517796|P1|Overall Study|Adverse Event|0
1368885|NCT01531673|4517784|P13|Overall Study|Non-Compliance|0
1368886|NCT01531673|4517785|P12|Overall Study|Non-Compliance|0
1368887|NCT01531673|4517786|P11|Overall Study|Non-Compliance|0
1368888|NCT01531673|4517787|P10|Overall Study|Non-Compliance|0
1368889|NCT01531673|4517788|P9|Overall Study|Non-Compliance|0
1368890|NCT01531673|4517789|P8|Overall Study|Non-Compliance|0
1368891|NCT01531673|4517790|P7|Overall Study|Non-Compliance|0
1368892|NCT01531673|4517791|P6|Overall Study|Non-Compliance|1
1368893|NCT01531673|4517792|P5|Overall Study|Non-Compliance|0
1368894|NCT01531673|4517793|P4|Overall Study|Non-Compliance|0
1368895|NCT01531673|4517794|P3|Overall Study|Non-Compliance|0
1368896|NCT01531673|4517795|P2|Overall Study|Non-Compliance|0
1368897|NCT01531673|4517796|P1|Overall Study|Non-Compliance|0
1368898|NCT01531387|4517907|P2|Overall Study|Early termination of study|11
1368899|NCT01531387|4517908|P1|Overall Study|Early termination of study|11
1368900|NCT01531205|4518000|P1|Overall Study|Did not proceed to surgery|1
1368901|NCT01530997|4518009|P1|Overall Study|Withdrawal by Subject|1
1368902|NCT01530997|4518009|P1|Overall Study|Physician Decision|1
1368903|NCT01530464|4518053|P2|Washout (24h)|Withdrawal by Subject|1
1368904|NCT01530464|4518054|P1|Washout (24h)|Withdrawal by Subject|0
1368905|NCT01530464|4518053|P2|Washout (24h)|Withdrawal by Subject|0
1368906|NCT01530464|4518054|P1|Washout (24h)|Withdrawal by Subject|1
1368907|NCT01530334|4518106|P1|Overall Study|Progressive disease|47
1368908|NCT01530334|4518106|P1|Overall Study|unknown reason|1
1368909|NCT01530334|4518106|P1|Overall Study|Adverse Event|3
1368910|NCT01530087|4518153|P1|Overall Study|Physician Decision|2
1368911|NCT01529645|4518175|P10|Overall Study|Withdrawal by Subject|0
1368912|NCT01529645|4518176|P9|Overall Study|Withdrawal by Subject|0
1368913|NCT01529645|4518177|P8|Overall Study|Withdrawal by Subject|0
1368914|NCT01529645|4518178|P7|Overall Study|Withdrawal by Subject|0
1368915|NCT01529645|4518179|P6|Overall Study|Withdrawal by Subject|1
1368916|NCT01529645|4518180|P5|Overall Study|Withdrawal by Subject|1
1368917|NCT01529645|4518181|P4|Overall Study|Withdrawal by Subject|1
1368918|NCT01529645|4518182|P3|Overall Study|Withdrawal by Subject|0
1368919|NCT01529645|4518183|P2|Overall Study|Withdrawal by Subject|0
1368920|NCT01529645|4518184|P1|Overall Study|Withdrawal by Subject|2
1368921|NCT01529645|4518175|P10|Overall Study|SAE - Premature contractions|0
1368922|NCT01529645|4518176|P9|Overall Study|SAE - Premature contractions|0
1368923|NCT01529645|4518177|P8|Overall Study|SAE - Premature contractions|0
1368924|NCT01529645|4518178|P7|Overall Study|SAE - Premature contractions|0
1368925|NCT01529645|4518179|P6|Overall Study|SAE - Premature contractions|0
1368926|NCT01529645|4518180|P5|Overall Study|SAE - Premature contractions|0
1368927|NCT01529645|4518181|P4|Overall Study|SAE - Premature contractions|0
1368928|NCT01529645|4518182|P3|Overall Study|SAE - Premature contractions|1
1368929|NCT01529645|4518183|P2|Overall Study|SAE - Premature contractions|0
1368930|NCT01529645|4518184|P1|Overall Study|SAE - Premature contractions|0
1368931|NCT01529645|4518175|P10|Overall Study|Lost to Follow-up|0
1368932|NCT01529645|4518176|P9|Overall Study|Lost to Follow-up|1
1368933|NCT01529645|4518177|P8|Overall Study|Lost to Follow-up|0
1368934|NCT01529645|4518178|P7|Overall Study|Lost to Follow-up|2
1368935|NCT01529645|4518179|P6|Overall Study|Lost to Follow-up|0
1368936|NCT01529645|4518180|P5|Overall Study|Lost to Follow-up|1
1368937|NCT01529645|4518181|P4|Overall Study|Lost to Follow-up|1
1368938|NCT01529645|4518182|P3|Overall Study|Lost to Follow-up|1
1368939|NCT01529645|4518183|P2|Overall Study|Lost to Follow-up|1
1368940|NCT01529645|4518184|P1|Overall Study|Lost to Follow-up|0
1368941|NCT01529632|4518282|P2|Overall Study|Adverse Event|1
1368942|NCT01529632|4518283|P1|Overall Study|Adverse Event|1
1368943|NCT01529632|4518282|P2|Overall Study|Protocol Violation|1
1368944|NCT01529632|4518283|P1|Overall Study|Protocol Violation|0
1368945|NCT01529632|4518282|P2|Overall Study|Administrative problem|1
1368946|NCT01529632|4518283|P1|Overall Study|Administrative problem|2
1368947|NCT01529515|4518303|P4|DOUBLE BLIND PHASE|Other|2
1368948|NCT01529515|4518304|P3|DOUBLE BLIND PHASE|Other|9
1368949|NCT01529515|4518305|P2|DOUBLE BLIND PHASE|Other|0
1368950|NCT01529515|4518306|P1|DOUBLE BLIND PHASE|Other|0
1368951|NCT01529515|4518303|P4|DOUBLE BLIND PHASE|Protocol Violation|0
1368952|NCT01529515|4518304|P3|DOUBLE BLIND PHASE|Protocol Violation|1
1368953|NCT01529515|4518305|P2|DOUBLE BLIND PHASE|Protocol Violation|0
1368954|NCT01529515|4518306|P1|DOUBLE BLIND PHASE|Protocol Violation|0
1368955|NCT01529515|4518303|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
1368956|NCT01529515|4518304|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
1368957|NCT01529515|4518305|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
1368958|NCT01529515|4518306|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
1368959|NCT01529515|4518303|P4|DOUBLE BLIND PHASE|Pregnancy|0
1368960|NCT01529515|4518304|P3|DOUBLE BLIND PHASE|Pregnancy|1
1368961|NCT01529515|4518305|P2|DOUBLE BLIND PHASE|Pregnancy|0
1368962|NCT01529515|4518306|P1|DOUBLE BLIND PHASE|Pregnancy|0
1368963|NCT01529515|4518303|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
1368964|NCT01529515|4518304|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
1368965|NCT01529515|4518305|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
1368966|NCT01529515|4518306|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
1368967|NCT01529515|4518303|P4|DOUBLE BLIND PHASE|Adverse Event|0
1368968|NCT01529515|4518304|P3|DOUBLE BLIND PHASE|Adverse Event|1
1368969|NCT01529515|4518305|P2|DOUBLE BLIND PHASE|Adverse Event|0
1368970|NCT01529515|4518306|P1|DOUBLE BLIND PHASE|Adverse Event|0
1368971|NCT01529515|4518303|P4|MAINTENANCE PHASE|Other|0
1368972|NCT01529515|4518304|P3|MAINTENANCE PHASE|Other|0
1368973|NCT01529515|4518305|P2|MAINTENANCE PHASE|Other|10
1368974|NCT01529515|4518306|P1|MAINTENANCE PHASE|Other|0
1368975|NCT01529515|4518303|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
1368976|NCT01529515|4518304|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
1368977|NCT01529515|4518305|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
1368978|NCT01529515|4518306|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
1368979|NCT01529515|4518303|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
1368980|NCT01529515|4518304|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
1368981|NCT01529515|4518305|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
1368982|NCT01529515|4518306|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
1368983|NCT01529515|4518303|P4|MAINTENANCE PHASE|Protocol Violation|0
1368984|NCT01529515|4518304|P3|MAINTENANCE PHASE|Protocol Violation|0
1368985|NCT01529515|4518305|P2|MAINTENANCE PHASE|Protocol Violation|12
1368986|NCT01529515|4518306|P1|MAINTENANCE PHASE|Protocol Violation|0
1368987|NCT01529515|4518303|P4|MAINTENANCE PHASE|Lost to Follow-up|0
1368988|NCT01529515|4518304|P3|MAINTENANCE PHASE|Lost to Follow-up|0
1368989|NCT01529515|4518305|P2|MAINTENANCE PHASE|Lost to Follow-up|5
1368990|NCT01529515|4518306|P1|MAINTENANCE PHASE|Lost to Follow-up|0
1368991|NCT01529515|4518303|P4|MAINTENANCE PHASE|Lack of Efficacy|0
1368992|NCT01529515|4518304|P3|MAINTENANCE PHASE|Lack of Efficacy|0
1368993|NCT01529515|4518305|P2|MAINTENANCE PHASE|Lack of Efficacy|9
1368994|NCT01529515|4518306|P1|MAINTENANCE PHASE|Lack of Efficacy|0
1368995|NCT01529515|4518303|P4|MAINTENANCE PHASE|Adverse Event|0
1368996|NCT01529515|4518304|P3|MAINTENANCE PHASE|Adverse Event|0
1368997|NCT01529515|4518305|P2|MAINTENANCE PHASE|Adverse Event|10
1368998|NCT01529515|4518306|P1|MAINTENANCE PHASE|Adverse Event|0
1368999|NCT01529515|4518303|P4|TRANSITION PHASE|Other|0
1369000|NCT01529515|4518304|P3|TRANSITION PHASE|Other|0
1369001|NCT01529515|4518305|P2|TRANSITION PHASE|Other|0
1369002|NCT01529515|4518306|P1|TRANSITION PHASE|Other|9
1369003|NCT01529515|4518303|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
1369004|NCT01529515|4518304|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
1369005|NCT01529515|4518305|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
1369006|NCT01529515|4518306|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
1369007|NCT01529515|4518303|P4|TRANSITION PHASE|Withdrawal by Subject|0
1369008|NCT01529515|4518304|P3|TRANSITION PHASE|Withdrawal by Subject|0
1369009|NCT01529515|4518305|P2|TRANSITION PHASE|Withdrawal by Subject|0
1369010|NCT01529515|4518306|P1|TRANSITION PHASE|Withdrawal by Subject|51
1369011|NCT01529515|4518303|P4|TRANSITION PHASE|Protocol Violation|0
1369012|NCT01529515|4518304|P3|TRANSITION PHASE|Protocol Violation|0
1369013|NCT01529515|4518305|P2|TRANSITION PHASE|Protocol Violation|0
1369014|NCT01529515|4518306|P1|TRANSITION PHASE|Protocol Violation|4
1369015|NCT01529515|4518303|P4|TRANSITION PHASE|Lost to Follow-up|0
1369016|NCT01529515|4518304|P3|TRANSITION PHASE|Lost to Follow-up|0
1369017|NCT01529515|4518305|P2|TRANSITION PHASE|Lost to Follow-up|0
1369018|NCT01529515|4518306|P1|TRANSITION PHASE|Lost to Follow-up|19
1369019|NCT01529515|4518303|P4|TRANSITION PHASE|Lack of Efficacy|0
1369020|NCT01529515|4518304|P3|TRANSITION PHASE|Lack of Efficacy|0
1369021|NCT01529515|4518305|P2|TRANSITION PHASE|Lack of Efficacy|0
1369022|NCT01529515|4518306|P1|TRANSITION PHASE|Lack of Efficacy|19
1369023|NCT01529515|4518303|P4|TRANSITION PHASE|Death|0
1369024|NCT01529515|4518304|P3|TRANSITION PHASE|Death|0
1369025|NCT01529515|4518305|P2|TRANSITION PHASE|Death|0
1369026|NCT01529515|4518306|P1|TRANSITION PHASE|Death|1
1369027|NCT01529515|4518303|P4|TRANSITION PHASE|Adverse Event|0
1369028|NCT01529515|4518304|P3|TRANSITION PHASE|Adverse Event|0
1369029|NCT01529515|4518305|P2|TRANSITION PHASE|Adverse Event|0
1369030|NCT01529515|4518306|P1|TRANSITION PHASE|Adverse Event|16
1369031|NCT01529385|4518353|P2|Overall Study|Lost to Follow-up|1
1369032|NCT01529385|4518354|P1|Overall Study|Lost to Follow-up|2
1369033|NCT01529346|4518383|P5|Overall Study|Other|0
1369034|NCT01529346|4518384|P4|Overall Study|Other|0
1369035|NCT01529346|4518385|P3|Overall Study|Other|1
1369036|NCT01529346|4518386|P2|Overall Study|Other|1
1369037|NCT01529346|4518387|P1|Overall Study|Other|0
1369038|NCT01529346|4518383|P5|Overall Study|Lost to Follow-up|0
1369039|NCT01529346|4518384|P4|Overall Study|Lost to Follow-up|0
1369040|NCT01529346|4518385|P3|Overall Study|Lost to Follow-up|1
1369041|NCT01529346|4518386|P2|Overall Study|Lost to Follow-up|0
1369042|NCT01529346|4518387|P1|Overall Study|Lost to Follow-up|2
1369043|NCT01529268|4518475|P2|Overall Study|Moved|0
1369044|NCT01529268|4518476|P1|Overall Study|Moved|3
1369045|NCT01529268|4518475|P2|Overall Study|Lost to Follow-up|3
1369046|NCT01529268|4518476|P1|Overall Study|Lost to Follow-up|9
1369047|NCT01529112|4518538|P2|Overall Study|Withdrawal by Subject|3
1369048|NCT01529112|4518539|P1|Overall Study|Withdrawal by Subject|7
1369049|NCT01529112|4518538|P2|Overall Study|Protocol Violation|0
1369050|NCT01529112|4518539|P1|Overall Study|Protocol Violation|1
1369051|NCT01529112|4518538|P2|Overall Study|Death|38
1369052|NCT01529112|4518539|P1|Overall Study|Death|59
1369053|NCT01529112|4518538|P2|Overall Study|Adverse Event|0
1369054|NCT01529112|4518539|P1|Overall Study|Adverse Event|2
1369055|NCT01528969|4518566|P2|Overall Study|absent from the school at baseline|0
1369056|NCT01528969|4518567|P1|Overall Study|absent from the school at baseline|2
1369057|NCT01528787|4518600|P4|Overall Study|Family Emergency|0
1369058|NCT01528787|4518601|P3|Overall Study|Family Emergency|1
1369059|NCT01528787|4518602|P2|Overall Study|Family Emergency|0
1369060|NCT01528787|4518603|P1|Overall Study|Family Emergency|0
1369061|NCT01528787|4518600|P4|Overall Study|Withdrawal by Subject|1
1369062|NCT01528787|4518601|P3|Overall Study|Withdrawal by Subject|0
1369063|NCT01528787|4518602|P2|Overall Study|Withdrawal by Subject|0
1369064|NCT01528787|4518603|P1|Overall Study|Withdrawal by Subject|0
1369065|NCT01528735|4518615|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
1369066|NCT01528735|4518616|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
1369067|NCT01528735|4518615|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
1369068|NCT01528735|4518616|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
1369069|NCT01528709|4518718|P2|Overall Study|allergy|0
1369070|NCT01528709|4518719|P1|Overall Study|allergy|1
1369071|NCT01528709|4518718|P2|Overall Study|Withdrawal by Subject|15
1369072|NCT01528709|4518719|P1|Overall Study|Withdrawal by Subject|10
1369073|NCT01528709|4518718|P2|Overall Study|Death|0
1369074|NCT01528709|4518719|P1|Overall Study|Death|2
1369075|NCT01528696|4518729|P2|Overall Study|See detailed description|19
1369076|NCT01528696|4518730|P1|Overall Study|See detailed description|18
1369077|NCT01528605|4518746|P6|Overall Study|Death|0
1369078|NCT01528605|4518747|P5|Overall Study|Death|0
1369079|NCT01528605|4518748|P4|Overall Study|Death|0
1369080|NCT01528605|4518749|P3|Overall Study|Death|0
1369081|NCT01528605|4518750|P2|Overall Study|Death|0
1369082|NCT01528605|4518751|P1|Overall Study|Death|1
1369083|NCT01528605|4518746|P6|Overall Study|Lost to Follow-up|0
1369084|NCT01528605|4518747|P5|Overall Study|Lost to Follow-up|0
1369085|NCT01528605|4518748|P4|Overall Study|Lost to Follow-up|1
1369086|NCT01528605|4518749|P3|Overall Study|Lost to Follow-up|1
1369087|NCT01528605|4518750|P2|Overall Study|Lost to Follow-up|0
1369088|NCT01528605|4518751|P1|Overall Study|Lost to Follow-up|1
1369089|NCT01528345|4518781|P2|Overall Study|Subject/Guardian Decision|0
1369090|NCT01528345|4518782|P1|Overall Study|Subject/Guardian Decision|5
1369091|NCT01528345|4518781|P2|Overall Study|Study Terminated by Sponsor|8
1369092|NCT01528345|4518782|P1|Overall Study|Study Terminated by Sponsor|4
1369093|NCT01528345|4518781|P2|Overall Study|Progressive Disease|40
1369094|NCT01528345|4518782|P1|Overall Study|Progressive Disease|26
1369095|NCT01528345|4518781|P2|Overall Study|Non-compliance with study treatment|0
1369096|NCT01528345|4518782|P1|Overall Study|Non-compliance with study treatment|1
1369097|NCT01528345|4518781|P2|Overall Study|Death|1
1369098|NCT01528345|4518782|P1|Overall Study|Death|1
1369099|NCT01528345|4518781|P2|Overall Study|Adverse Event|1
1369100|NCT01528345|4518782|P1|Overall Study|Adverse Event|10
1369101|NCT01527500|4518921|P2|Part B|Adverse Event|0
1369102|NCT01527500|4518922|P1|Part B|Adverse Event|1
1369103|NCT01527500|4518921|P2|Part A|Withdrawal by Subject|0
1369104|NCT01527500|4518922|P1|Part A|Withdrawal by Subject|2
1369105|NCT01527500|4518921|P2|Part A|Protocol Deviation|2
1369106|NCT01527500|4518922|P1|Part A|Protocol Deviation|9
1369107|NCT01527500|4518921|P2|Part A|Lost to Follow-up|1
1369108|NCT01527500|4518922|P1|Part A|Lost to Follow-up|0
1369109|NCT01527500|4518921|P2|Part A|Death|1
1369110|NCT01527500|4518922|P1|Part A|Death|4
1369111|NCT01527500|4518921|P2|Part A|Adverse Event|2
1369112|NCT01527500|4518922|P1|Part A|Adverse Event|4
1369113|NCT01527500|4518921|P2|Part A|Administrative|7
1369114|NCT01527500|4518922|P1|Part A|Administrative|11
1369115|NCT01527487|4518952|P2|Overall Study|Death|1
1369116|NCT01527487|4518953|P1|Overall Study|Death|0
1369117|NCT01527487|4518952|P2|Overall Study|Adverse Event|1
1369118|NCT01527487|4518953|P1|Overall Study|Adverse Event|1
1369119|NCT01527487|4518952|P2|Overall Study|Disease Progression|1
1369120|NCT01527487|4518953|P1|Overall Study|Disease Progression|4
1369121|NCT01527487|4518952|P2|Overall Study|MD Discretion/Lack of Efficacy|4
1369122|NCT01527487|4518953|P1|Overall Study|MD Discretion/Lack of Efficacy|3
1369123|NCT01527370|4518965|P1|Overall Study|Death|1
1369124|NCT01527370|4518965|P1|Overall Study|Physician Decision|1
1369125|NCT01527370|4518965|P1|Overall Study|Withdrawal by Subject|4
1369126|NCT01527110|4518982|P1|Overall Study|Adverse Event|1
1369127|NCT01527006|4519029|P2|Extension Phase|Not Specified|3
1369128|NCT01527006|4519030|P1|Extension Phase|Not Specified|0
1369129|NCT01527006|4519029|P2|Extension Phase|Inadequate therapeutic effect|1
1369130|NCT01527006|4519030|P1|Extension Phase|Inadequate therapeutic effect|1
1369131|NCT01527006|4519029|P2|Extension Phase|Subject Choice|1
1369132|NCT01527006|4519030|P1|Extension Phase|Subject Choice|1
1369133|NCT01527006|4519029|P2|Extension Phase|Lost to Follow-up|1
1369134|NCT01527006|4519030|P1|Extension Phase|Lost to Follow-up|0
1369135|NCT01527006|4519029|P2|Extension Phase|Adverse Event|2
1369136|NCT01527006|4519030|P1|Extension Phase|Adverse Event|4
1369137|NCT01527006|4519029|P2|Core Study|Not Specified|2
1369138|NCT01527006|4519030|P1|Core Study|Not Specified|0
1369139|NCT01527006|4519029|P2|Core Study|Withdrawal by Subject|1
1369140|NCT01527006|4519030|P1|Core Study|Withdrawal by Subject|0
1369141|NCT01527006|4519029|P2|Core Study|Inadequate Therapeutic Effect|0
1369142|NCT01527006|4519030|P1|Core Study|Inadequate Therapeutic Effect|1
1369143|NCT01527006|4519029|P2|Core Study|Subject Choice|0
1369144|NCT01527006|4519030|P1|Core Study|Subject Choice|1
1369145|NCT01527006|4519029|P2|Core Study|Lost to Follow-up|1
1369146|NCT01527006|4519030|P1|Core Study|Lost to Follow-up|0
1369147|NCT01527006|4519029|P2|Core Study|Adverse Event|2
1369148|NCT01527006|4519030|P1|Core Study|Adverse Event|0
1369149|NCT01526785|4519097|P1|Overall Study|Withdrawal by Subject|2
1369150|NCT01526785|4519097|P1|Overall Study|Physician Decision|1
1369151|NCT01526785|4519097|P1|Overall Study|Death|2
1369152|NCT01526785|4519097|P1|Overall Study|Study Terminated by Sponsor|8
1369153|NCT01526733|4519107|P2|Phase 1|Withdrawal by Subject|1
1369154|NCT01526733|4519108|P1|Phase 1|Withdrawal by Subject|1
1369155|NCT01526733|4519107|P2|Phase 1|Protocol Violation|0
1369156|NCT01526733|4519108|P1|Phase 1|Protocol Violation|1
1369157|NCT01526551|4519147|P1|Overall Study|Lack of returned parental consent form|424
1369158|NCT01526148|4519194|P2|Overall Study|Incarcerated|2
1369159|NCT01526148|4519195|P1|Overall Study|Incarcerated|0
1369160|NCT01526148|4519194|P2|Overall Study|Moved out of state|0
1369161|NCT01526148|4519195|P1|Overall Study|Moved out of state|1
1369162|NCT01526148|4519194|P2|Overall Study|Unable to discontinue concomitant med|0
1369163|NCT01526148|4519195|P1|Overall Study|Unable to discontinue concomitant med|1
1369164|NCT01526148|4519194|P2|Overall Study|Unstable Medical Condition|0
1369165|NCT01526148|4519195|P1|Overall Study|Unstable Medical Condition|1
1369166|NCT01526148|4519194|P2|Overall Study|Withdrawal by Subject|0
1369167|NCT01526148|4519195|P1|Overall Study|Withdrawal by Subject|2
1369168|NCT01526148|4519194|P2|Overall Study|Lost to Follow-up|6
1369169|NCT01526148|4519195|P1|Overall Study|Lost to Follow-up|3
1369170|NCT01526148|4519194|P2|Overall Study|Adverse Event|5
1369171|NCT01526148|4519195|P1|Overall Study|Adverse Event|6
1369172|NCT01525849|4519219|P2|Overall Study|Anatomic exclusion criteria identified|3
1369173|NCT01525849|4519220|P1|Overall Study|Anatomic exclusion criteria identified|0
1369174|NCT01525849|4519219|P2|Overall Study|Unrelated medical issue (not treated)|2
1369175|NCT01525849|4519220|P1|Overall Study|Unrelated medical issue (not treated)|1
1369176|NCT01525849|4519219|P2|Overall Study|Withdrawal by Subject|9
1369177|NCT01525849|4519220|P1|Overall Study|Withdrawal by Subject|1
1369178|NCT01525849|4519219|P2|Overall Study|Lost to Follow-up|2
1369179|NCT01525849|4519220|P1|Overall Study|Lost to Follow-up|3
1369180|NCT01525641|4519276|P1|Overall Study|Other than stated above|7
1369181|NCT01525641|4519276|P1|Overall Study|Lost to follow-up (Changing hospital)|19
1369182|NCT01525641|4519276|P1|Overall Study|Lost to follow-up (Unknown reason)|10
1369183|NCT01525641|4519276|P1|Overall Study|Lost to follow-up (relocation)|1
1369184|NCT01525641|4519276|P1|Overall Study|Improvement|5
1369185|NCT01525641|4519276|P1|Overall Study|Lack of Efficacy|24
1369186|NCT01525641|4519276|P1|Overall Study|Adverse Event|73
1369187|NCT01525641|4519276|P1|Overall Study|No visit since the first visit|16
1369188|NCT01525641|4519276|P1|Overall Study|Case report form not collected|25
1369189|NCT01525628|4519290|P5|Overall Study|Other reason not defined above|0
1369190|NCT01525628|4519291|P4|Overall Study|Other reason not defined above|3
1369191|NCT01525628|4519292|P3|Overall Study|Other reason not defined above|0
1369192|NCT01525628|4519293|P2|Overall Study|Other reason not defined above|0
1369193|NCT01525628|4519294|P1|Overall Study|Other reason not defined above|0
1369194|NCT01525628|4519290|P5|Overall Study|Withdrawal by Subject|0
1369195|NCT01525628|4519291|P4|Overall Study|Withdrawal by Subject|0
1369196|NCT01525628|4519292|P3|Overall Study|Withdrawal by Subject|0
1369197|NCT01525628|4519293|P2|Overall Study|Withdrawal by Subject|1
1369198|NCT01525628|4519294|P1|Overall Study|Withdrawal by Subject|0
1369199|NCT01525628|4519290|P5|Overall Study|Lost to Follow-up|0
1369200|NCT01525628|4519291|P4|Overall Study|Lost to Follow-up|0
1369201|NCT01525628|4519292|P3|Overall Study|Lost to Follow-up|0
1369202|NCT01525628|4519293|P2|Overall Study|Lost to Follow-up|1
1369203|NCT01525628|4519294|P1|Overall Study|Lost to Follow-up|1
1369204|NCT01525628|4519290|P5|Overall Study|Protocol Violation|0
1369205|NCT01525628|4519291|P4|Overall Study|Protocol Violation|0
1369206|NCT01525628|4519292|P3|Overall Study|Protocol Violation|1
1369207|NCT01525628|4519293|P2|Overall Study|Protocol Violation|0
1369208|NCT01525628|4519294|P1|Overall Study|Protocol Violation|0
1369209|NCT01525628|4519290|P5|Overall Study|Lack of Efficacy|2
1369210|NCT01525628|4519291|P4|Overall Study|Lack of Efficacy|1
1369211|NCT01525628|4519292|P3|Overall Study|Lack of Efficacy|2
1369212|NCT01525628|4519293|P2|Overall Study|Lack of Efficacy|2
1369213|NCT01525628|4519294|P1|Overall Study|Lack of Efficacy|0
1369214|NCT01525628|4519290|P5|Overall Study|Adverse Event|1
1369215|NCT01525628|4519291|P4|Overall Study|Adverse Event|0
1369216|NCT01525628|4519292|P3|Overall Study|Adverse Event|2
1369217|NCT01525628|4519293|P2|Overall Study|Adverse Event|1
1369218|NCT01525628|4519294|P1|Overall Study|Adverse Event|1
1369219|NCT01525615|4519361|P3|Overall Study|Other reason not described above|1
1369220|NCT01525615|4519362|P2|Overall Study|Other reason not described above|0
1369221|NCT01525615|4519363|P1|Overall Study|Other reason not described above|1
1369222|NCT01525615|4519361|P3|Overall Study|Withdrawal by Subject|0
1369223|NCT01525615|4519362|P2|Overall Study|Withdrawal by Subject|0
1369224|NCT01525615|4519363|P1|Overall Study|Withdrawal by Subject|1
1369225|NCT01525615|4519361|P3|Overall Study|Lost to Follow-up|0
1369226|NCT01525615|4519362|P2|Overall Study|Lost to Follow-up|0
1369227|NCT01525615|4519363|P1|Overall Study|Lost to Follow-up|1
1369228|NCT01525615|4519361|P3|Overall Study|Adverse Event|5
1369229|NCT01525615|4519362|P2|Overall Study|Adverse Event|7
1369230|NCT01525615|4519363|P1|Overall Study|Adverse Event|11
1369231|NCT01525550|4519419|P2|Overall Study|Ongoing|23
1369232|NCT01525550|4519420|P1|Overall Study|Ongoing|45
1369233|NCT01525550|4519419|P2|Overall Study|Other Unspecified|2
1369234|NCT01525550|4519420|P1|Overall Study|Other Unspecified|0
1369235|NCT01525550|4519419|P2|Overall Study|Death|19
1369236|NCT01525550|4519420|P1|Overall Study|Death|10
1369237|NCT01525550|4519419|P2|Overall Study|Lost to Follow-up|1
1369238|NCT01525550|4519420|P1|Overall Study|Lost to Follow-up|4
1369239|NCT01525550|4519419|P2|Overall Study|Withdrawal by Subject|0
1369240|NCT01525550|4519420|P1|Overall Study|Withdrawal by Subject|2
1369241|NCT01525407|4519491|P2|Overall Study|Delay in Transplant|0
1369242|NCT01525407|4519492|P1|Overall Study|Delay in Transplant|1
1369243|NCT01525407|4519491|P2|Overall Study|Transplant was delayed|1
1369244|NCT01525407|4519492|P1|Overall Study|Transplant was delayed|0
1369245|NCT01525407|4519491|P2|Overall Study|Withdrawal by Subject|1
1369246|NCT01525407|4519492|P1|Overall Study|Withdrawal by Subject|0
1369247|NCT01525407|4519491|P2|Overall Study|Change in recipient treatment plan|2
1369248|NCT01525407|4519492|P1|Overall Study|Change in recipient treatment plan|2
1369249|NCT01525238|4519524|P3|Overall Study|Withdrawal by Subject|0
1369250|NCT01525238|4519525|P2|Overall Study|Withdrawal by Subject|0
1369251|NCT01525238|4519526|P1|Overall Study|Withdrawal by Subject|1
1369252|NCT01525225|4519591|P1|Enrollment|Not Specified|1
1369253|NCT01525225|4519591|P1|Enrollment|No longer met study criteria|1
1369254|NCT01524978|4519616|P11|Overall Study|Death|17
1369255|NCT01524978|4519617|P10|Overall Study|Death|6
1369256|NCT01524978|4519618|P9|Overall Study|Death|5
1369257|NCT01524978|4519619|P8|Overall Study|Death|9
1369258|NCT01524978|4519620|P7|Overall Study|Death|1
1369259|NCT01524978|4519621|P6|Overall Study|Death|4
1369260|NCT01524978|4519622|P5|Overall Study|Death|4
1369261|NCT01524978|4519623|P4|Overall Study|Death|24
1369262|NCT01524978|4519624|P3|Overall Study|Death|5
1369263|NCT01524978|4519625|P2|Overall Study|Death|2
1369264|NCT01524978|4519626|P1|Overall Study|Death|34
1369265|NCT01524978|4519616|P11|Overall Study|Lost to Follow-up|1
1369266|NCT01524978|4519617|P10|Overall Study|Lost to Follow-up|1
1369267|NCT01524978|4519618|P9|Overall Study|Lost to Follow-up|1
1369268|NCT01524978|4519619|P8|Overall Study|Lost to Follow-up|0
1369269|NCT01524978|4519620|P7|Overall Study|Lost to Follow-up|2
1369270|NCT01524978|4519621|P6|Overall Study|Lost to Follow-up|1
1369271|NCT01524978|4519622|P5|Overall Study|Lost to Follow-up|1
1369272|NCT01524978|4519623|P4|Overall Study|Lost to Follow-up|0
1369273|NCT01524978|4519624|P3|Overall Study|Lost to Follow-up|3
1369274|NCT01524978|4519625|P2|Overall Study|Lost to Follow-up|0
1369275|NCT01524978|4519626|P1|Overall Study|Lost to Follow-up|0
1369276|NCT01524978|4519616|P11|Overall Study|Withdrawal by Subject|5
1369277|NCT01524978|4519617|P10|Overall Study|Withdrawal by Subject|0
1369278|NCT01524978|4519618|P9|Overall Study|Withdrawal by Subject|4
1369279|NCT01524978|4519619|P8|Overall Study|Withdrawal by Subject|2
1369280|NCT01524978|4519620|P7|Overall Study|Withdrawal by Subject|6
1369281|NCT01524978|4519621|P6|Overall Study|Withdrawal by Subject|1
1369282|NCT01524978|4519622|P5|Overall Study|Withdrawal by Subject|3
1369283|NCT01524978|4519623|P4|Overall Study|Withdrawal by Subject|1
1369284|NCT01524978|4519624|P3|Overall Study|Withdrawal by Subject|1
1369285|NCT01524978|4519625|P2|Overall Study|Withdrawal by Subject|0
1369286|NCT01524978|4519626|P1|Overall Study|Withdrawal by Subject|12
1369287|NCT01524978|4519616|P11|Overall Study|Other|5
1369288|NCT01524978|4519617|P10|Overall Study|Other|2
1369289|NCT01524978|4519618|P9|Overall Study|Other|2
1369290|NCT01524978|4519619|P8|Overall Study|Other|1
1369291|NCT01524978|4519620|P7|Overall Study|Other|17
1369292|NCT01524978|4519621|P6|Overall Study|Other|3
1369293|NCT01524978|4519622|P5|Overall Study|Other|1
1369294|NCT01524978|4519623|P4|Overall Study|Other|2
1369295|NCT01524978|4519624|P3|Overall Study|Other|1
1369296|NCT01524978|4519625|P2|Overall Study|Other|2
1369297|NCT01524978|4519626|P1|Overall Study|Other|16
1369298|NCT01524913|4519754|P3|Overall Study|Lost to Follow-up|0
1369299|NCT01524913|4519755|P2|Overall Study|Lost to Follow-up|0
1369300|NCT01524913|4519756|P1|Overall Study|Lost to Follow-up|4
1369301|NCT01524900|4519778|P5|Overall Study|No reason documented|0
1369302|NCT01524900|4519779|P4|Overall Study|No reason documented|1
1369303|NCT01524900|4519780|P3|Overall Study|No reason documented|0
1369304|NCT01524900|4519781|P2|Overall Study|No reason documented|1
1369305|NCT01524900|4519782|P1|Overall Study|No reason documented|2
1369306|NCT01524900|4519778|P5|Overall Study|Other reason than stated above|0
1369307|NCT01524900|4519779|P4|Overall Study|Other reason than stated above|0
1369308|NCT01524900|4519780|P3|Overall Study|Other reason than stated above|0
1369309|NCT01524900|4519781|P2|Overall Study|Other reason than stated above|1
1369310|NCT01524900|4519782|P1|Overall Study|Other reason than stated above|1
1369311|NCT01524900|4519778|P5|Overall Study|Lost to Follow-up|0
1369312|NCT01524900|4519779|P4|Overall Study|Lost to Follow-up|0
1369313|NCT01524900|4519780|P3|Overall Study|Lost to Follow-up|1
1369314|NCT01524900|4519781|P2|Overall Study|Lost to Follow-up|12
1369315|NCT01524900|4519782|P1|Overall Study|Lost to Follow-up|3
1369316|NCT01524887|4519827|P3|Overall Study|Use of prohibited medication|0
1369317|NCT01524887|4519828|P2|Overall Study|Use of prohibited medication|0
1369318|NCT01524887|4519829|P1|Overall Study|Use of prohibited medication|1
1369319|NCT01524887|4519827|P3|Overall Study|Withdrawal by Caregiver|2
1369320|NCT01524887|4519828|P2|Overall Study|Withdrawal by Caregiver|0
1369321|NCT01524887|4519829|P1|Overall Study|Withdrawal by Caregiver|0
1369322|NCT01524887|4519827|P3|Overall Study|Study termination|79
1369323|NCT01524887|4519828|P2|Overall Study|Study termination|87
1369324|NCT01524887|4519829|P1|Overall Study|Study termination|73
1369325|NCT01524887|4519827|P3|Overall Study|Protocol Violation|1
1369326|NCT01524887|4519828|P2|Overall Study|Protocol Violation|0
1369327|NCT01524887|4519829|P1|Overall Study|Protocol Violation|0
1369328|NCT01524887|4519827|P3|Overall Study|Adverse Event|1
1369329|NCT01524887|4519828|P2|Overall Study|Adverse Event|1
1369330|NCT01524887|4519829|P1|Overall Study|Adverse Event|5
1369331|NCT01524887|4519827|P3|Overall Study|Withdrawal by Subject|3
1369332|NCT01524887|4519828|P2|Overall Study|Withdrawal by Subject|2
1369333|NCT01524887|4519829|P1|Overall Study|Withdrawal by Subject|6
1369334|NCT01524796|4519873|P1|Overall Study|Adverse Event and Lack of Efficacy|1
1369335|NCT01524796|4519873|P1|Overall Study|Switch to carbamazapine|1
1369336|NCT01524796|4519873|P1|Overall Study|Nervous about confidentiality|1
1369337|NCT01524796|4519873|P1|Overall Study|Gall stone surgery|1
1369338|NCT01524796|4519873|P1|Overall Study|Deterioration of pains|1
1369339|NCT01524796|4519873|P1|Overall Study|Move|1
1369340|NCT01524796|4519873|P1|Overall Study|Withdrawal by Subject|4
1369341|NCT01524796|4519873|P1|Overall Study|The price|1
1369342|NCT01524796|4519873|P1|Overall Study|Lost to Follow-up|1
1369343|NCT01524796|4519873|P1|Overall Study|Lack of Efficacy|3
1369344|NCT01524796|4519873|P1|Overall Study|Adverse Event|13
1369345|NCT01524783|4519888|P2|Randomized and Treated|Death|1
1369346|NCT01524783|4519889|P1|Randomized and Treated|Death|4
1369347|NCT01524783|4519888|P2|Randomized and Treated|Protocol Violation|1
1369348|NCT01524783|4519889|P1|Randomized and Treated|Protocol Violation|1
1369349|NCT01524783|4519888|P2|Randomized and Treated|Withdrawal by Subject|5
1369350|NCT01524783|4519889|P1|Randomized and Treated|Withdrawal by Subject|15
1369351|NCT01524783|4519888|P2|Randomized and Treated|Disease Progression|70
1369352|NCT01524783|4519889|P1|Randomized and Treated|Disease Progression|76
1369353|NCT01524783|4519888|P2|Randomized and Treated|Adverse Event|7
1369354|NCT01524783|4519889|P1|Randomized and Treated|Adverse Event|59
1369355|NCT01524783|4519888|P2|Randomized But Not Treated|Randomized, did not receive drug|0
1369356|NCT01524783|4519889|P1|Randomized But Not Treated|Randomized, did not receive drug|2
1369357|NCT01524770|4519911|P2|First Intervention|Protocol Violation|0
1369358|NCT01524770|4519912|P1|First Intervention|Protocol Violation|1
1369359|NCT01524770|4519911|P2|First Intervention|Adverse Event|1
1369360|NCT01524770|4519912|P1|First Intervention|Adverse Event|1
1369361|NCT01524770|4519911|P2|First Intervention|Withdrawal by Subject|0
1369362|NCT01524770|4519912|P1|First Intervention|Withdrawal by Subject|1
1369363|NCT01524692|4519922|P1|Overall Study|Withdrawal by Subject|3
1369364|NCT01524627|4519932|P2|Overall Study|Lost to Follow-up|1
1369365|NCT01524627|4519933|P1|Overall Study|Lost to Follow-up|1
1369366|NCT01524627|4519932|P2|Overall Study|Physician Decision|1
1369367|NCT01524627|4519933|P1|Overall Study|Physician Decision|0
1369368|NCT01524198|4519960|P2|Overall Study|Withdrawal by Subject|10
1369369|NCT01524198|4519961|P1|Overall Study|Withdrawal by Subject|15
1369370|NCT01524198|4519960|P2|Overall Study|Protocol Violation|6
1369371|NCT01524198|4519961|P1|Overall Study|Protocol Violation|8
1369372|NCT01524133|4519972|P3|Overall Study 52 Weeks|Lost to Follow-up|15
1369373|NCT01524133|4519973|P2|Overall Study 52 Weeks|Lost to Follow-up|15
1369374|NCT01524133|4519974|P1|Overall Study 52 Weeks|Lost to Follow-up|16
1369375|NCT01524133|4519972|P3|Overall Study 52 Weeks|Physician Decision|2
1369376|NCT01524133|4519973|P2|Overall Study 52 Weeks|Physician Decision|0
1369377|NCT01524133|4519974|P1|Overall Study 52 Weeks|Physician Decision|1
1369378|NCT01524133|4519972|P3|Overall Study 52 Weeks|Withdrawal by Subject|10
1369379|NCT01524133|4519973|P2|Overall Study 52 Weeks|Withdrawal by Subject|5
1369380|NCT01524133|4519974|P1|Overall Study 52 Weeks|Withdrawal by Subject|4
1369381|NCT01524133|4519972|P3|Treatment Phase|Lost to Follow-up|2
1369382|NCT01524133|4519973|P2|Treatment Phase|Lost to Follow-up|1
1369383|NCT01524133|4519974|P1|Treatment Phase|Lost to Follow-up|0
1369384|NCT01524133|4519972|P3|Treatment Phase|Physician Decision|3
1369385|NCT01524133|4519973|P2|Treatment Phase|Physician Decision|3
1369386|NCT01524133|4519974|P1|Treatment Phase|Physician Decision|6
1369387|NCT01524133|4519972|P3|Treatment Phase|Withdrawal by Subject|31
1369388|NCT01524133|4519973|P2|Treatment Phase|Withdrawal by Subject|28
1369389|NCT01524133|4519974|P1|Treatment Phase|Withdrawal by Subject|13
1369390|NCT01523886|4520017|P2|Overall Study|surgery cancelled|1
1369391|NCT01523886|4520018|P1|Overall Study|surgery cancelled|0
1369392|NCT01523873|4520024|P1|Overall Study|Protocol Violation|422
1369393|NCT01523756|4520083|P2|Test Period 2|Withdrawal by Subject|1
1369394|NCT01523756|4520084|P1|Test Period 2|Withdrawal by Subject|0
1369395|NCT01523756|4520083|P2|Test Period 1|Adverse Event|0
1369396|NCT01523756|4520084|P1|Test Period 1|Adverse Event|1
1369397|NCT01523756|4520083|P2|Baseline Period|Adverse Event|1
1369398|NCT01523756|4520084|P1|Baseline Period|Adverse Event|0
1369399|NCT01523743|4520092|P2|Period 2|Adverse Event|0
1369400|NCT01523743|4520093|P1|Period 2|Adverse Event|1
1369401|NCT01523743|4520092|P2|Period 2|Withdrawal by Subject|2
1369402|NCT01523743|4520093|P1|Period 2|Withdrawal by Subject|0
1369403|NCT01523743|4520092|P2|Period 1|Felt unable to empty bladder|0
1369404|NCT01523743|4520093|P1|Period 1|Felt unable to empty bladder|1
1369405|NCT01523743|4520092|P2|Period 1|Lack of Efficacy|0
1369406|NCT01523743|4520093|P1|Period 1|Lack of Efficacy|1
1369407|NCT01523743|4520092|P2|Period 1|Lost to Follow-up|0
1369408|NCT01523743|4520093|P1|Period 1|Lost to Follow-up|1
1369409|NCT01523743|4520092|P2|Period 1|Withdrawal by Subject|2
1369410|NCT01523743|4520093|P1|Period 1|Withdrawal by Subject|6
1369411|NCT01523743|4520092|P2|Period 1|Adverse Event|0
1369412|NCT01523743|4520093|P1|Period 1|Adverse Event|1
1369413|NCT01523587|4520116|P2|Overall Study|Randomised but not treated|2
1369414|NCT01523587|4520117|P1|Overall Study|Randomised but not treated|6
1369415|NCT01523587|4520116|P2|Overall Study|no reason given|3
1369416|NCT01523587|4520117|P1|Overall Study|no reason given|2
1369417|NCT01523587|4520116|P2|Overall Study|Withdrawal by Subject|12
1369418|NCT01523587|4520117|P1|Overall Study|Withdrawal by Subject|23
1369419|NCT01523587|4520116|P2|Overall Study|Lost to Follow-up|2
1369420|NCT01523587|4520117|P1|Overall Study|Lost to Follow-up|2
1369421|NCT01523587|4520116|P2|Overall Study|Non Compliance with protocol|1
1369422|NCT01523587|4520117|P1|Overall Study|Non Compliance with protocol|2
1369423|NCT01523587|4520116|P2|Overall Study|Adverse Event|34
1369424|NCT01523587|4520117|P1|Overall Study|Adverse Event|52
1369425|NCT01523457|4520158|P2|Overall Study|Withdrawal by Subject|2
1369426|NCT01523457|4520159|P1|Overall Study|Withdrawal by Subject|7
1369427|NCT01523392|4520177|P2|Washout Period - 10 to 14 Days|Adverse Event|0
1369428|NCT01523392|4520178|P1|Washout Period - 10 to 14 Days|Adverse Event|1
1369429|NCT01523392|4520177|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
1369430|NCT01523392|4520178|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
1369431|NCT01523392|4520177|P2|Treatment Period 1|Withdrawal by Subject|0
1369432|NCT01523392|4520178|P1|Treatment Period 1|Withdrawal by Subject|2
1369433|NCT01523366|4520194|P2|Treatment Period 2|Not completed at least 7 days treatment|0
1369434|NCT01523366|4520195|P1|Treatment Period 2|Not completed at least 7 days treatment|1
1369435|NCT01523366|4520194|P2|Treatment Period 1|Withdrawal by Subject|0
1369436|NCT01523366|4520195|P1|Treatment Period 1|Withdrawal by Subject|1
1369437|NCT01523301|4520211|P2|Overall Study|Other Reason|2
1369438|NCT01523301|4520212|P1|Overall Study|Other Reason|0
1369439|NCT01523301|4520211|P2|Overall Study|Withdrawal by Subject|8
1369440|NCT01523301|4520212|P1|Overall Study|Withdrawal by Subject|6
1369441|NCT01523301|4520211|P2|Overall Study|Lost to Follow-up|0
1369442|NCT01523301|4520212|P1|Overall Study|Lost to Follow-up|1
1369443|NCT01523301|4520211|P2|Overall Study|Protocol Violation|4
1369444|NCT01523301|4520212|P1|Overall Study|Protocol Violation|3
1369445|NCT01523301|4520211|P2|Overall Study|Lack of Efficacy|2
1369446|NCT01523301|4520212|P1|Overall Study|Lack of Efficacy|0
1369447|NCT01523301|4520211|P2|Overall Study|Adverse Event|16
1369448|NCT01523301|4520212|P1|Overall Study|Adverse Event|25
1369449|NCT01522976|4520233|P3|Overall Study|Not protocol specified|27
1369450|NCT01522976|4520234|P2|Overall Study|Not protocol specified|27
1369451|NCT01522976|4520235|P1|Overall Study|Not protocol specified|22
1369452|NCT01522976|4520233|P3|Overall Study|Refusal unrelated to adverse event|14
1369453|NCT01522976|4520234|P2|Overall Study|Refusal unrelated to adverse event|13
1369454|NCT01522976|4520235|P1|Overall Study|Refusal unrelated to adverse event|10
1369455|NCT01522976|4520233|P3|Overall Study|Adverse Event|18
1369456|NCT01522976|4520234|P2|Overall Study|Adverse Event|7
1369457|NCT01522976|4520235|P1|Overall Study|Adverse Event|17
1369458|NCT01522976|4520233|P3|Overall Study|Disease progression|25
1369459|NCT01522976|4520234|P2|Overall Study|Disease progression|30
1369460|NCT01522976|4520235|P1|Overall Study|Disease progression|28
1369461|NCT01522976|4520233|P3|Overall Study|Still on treatment|6
1369462|NCT01522976|4520234|P2|Overall Study|Still on treatment|9
1369463|NCT01522976|4520235|P1|Overall Study|Still on treatment|9
1369464|NCT01522976|4520233|P3|Overall Study|Death|2
1369465|NCT01522976|4520234|P2|Overall Study|Death|6
1369466|NCT01522976|4520235|P1|Overall Study|Death|7
1369467|NCT01522976|4520233|P3|Overall Study|Ineligible|1
1369468|NCT01522976|4520234|P2|Overall Study|Ineligible|0
1369469|NCT01522976|4520235|P1|Overall Study|Ineligible|4
1369470|NCT01522456|4520315|P1|Overall Study|Tolerability Assessment|1
1369471|NCT01522456|4520315|P1|Overall Study|Pregnancy|1
1369472|NCT01522456|4520315|P1|Overall Study|Withdrawal by Subject|2
1369473|NCT01522456|4520315|P1|Overall Study|Lost to Follow-up|2
1369474|NCT01522456|4520315|P1|Overall Study|Adverse Event|2
1369475|NCT01522443|4520378|P2|Overall Study|Other|3
1369476|NCT01522443|4520379|P1|Overall Study|Other|1
1369477|NCT01522443|4520378|P2|Overall Study|No study treatment given|1
1369478|NCT01522443|4520379|P1|Overall Study|No study treatment given|1
1369479|NCT01522443|4520378|P2|Overall Study|Withdrawal by Subject|8
1369480|NCT01522443|4520379|P1|Overall Study|Withdrawal by Subject|5
1369481|NCT01522443|4520378|P2|Overall Study|Adverse Event|15
1369482|NCT01522443|4520379|P1|Overall Study|Adverse Event|10
1369483|NCT01522443|4520378|P2|Overall Study|No longer receiving clinical benefit|28
1369484|NCT01522443|4520379|P1|Overall Study|No longer receiving clinical benefit|36
1369485|NCT01522235|4520396|P2|Overall Study|Physician Decision|1
1369486|NCT01522235|4520397|P1|Overall Study|Physician Decision|1
1369487|NCT01521923|4520433|P4|Overall Study|AE, captured in Period 1|1
1369488|NCT01521923|4520434|P3|Overall Study|AE, captured in Period 1|0
1369489|NCT01521923|4520435|P2|Overall Study|AE, captured in Period 1|1
1369490|NCT01521923|4520436|P1|Overall Study|AE, captured in Period 1|0
1369491|NCT01521923|4520433|P4|Overall Study|Other|6
1369492|NCT01521923|4520434|P3|Overall Study|Other|3
1369493|NCT01521923|4520435|P2|Overall Study|Other|1
1369494|NCT01521923|4520436|P1|Overall Study|Other|2
1369495|NCT01521923|4520433|P4|Overall Study|Withdrawal by Subject|2
1369496|NCT01521923|4520434|P3|Overall Study|Withdrawal by Subject|1
1369497|NCT01521923|4520435|P2|Overall Study|Withdrawal by Subject|1
1369498|NCT01521923|4520436|P1|Overall Study|Withdrawal by Subject|1
1369499|NCT01521923|4520433|P4|Overall Study|Lost to Follow-up|1
1369500|NCT01521923|4520434|P3|Overall Study|Lost to Follow-up|2
1369501|NCT01521923|4520435|P2|Overall Study|Lost to Follow-up|0
1369502|NCT01521923|4520436|P1|Overall Study|Lost to Follow-up|1
1369503|NCT01521923|4520433|P4|Overall Study|Protocol Violation|0
1369504|NCT01521923|4520434|P3|Overall Study|Protocol Violation|1
1369505|NCT01521923|4520435|P2|Overall Study|Protocol Violation|0
1369506|NCT01521923|4520436|P1|Overall Study|Protocol Violation|0
1369507|NCT01521923|4520433|P4|Overall Study|Lack of Efficacy|0
1369508|NCT01521923|4520434|P3|Overall Study|Lack of Efficacy|0
1369509|NCT01521923|4520435|P2|Overall Study|Lack of Efficacy|1
1369510|NCT01521923|4520436|P1|Overall Study|Lack of Efficacy|1
1369511|NCT01521923|4520433|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
1369512|NCT01521923|4520434|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
1369513|NCT01521923|4520435|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
1369514|NCT01521923|4520436|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
1369515|NCT01521923|4520433|P4|Overall Study|AE, non-serious, non-fatal|2
1369516|NCT01521923|4520434|P3|Overall Study|AE, non-serious, non-fatal|6
1369517|NCT01521923|4520435|P2|Overall Study|AE, non-serious, non-fatal|3
1369518|NCT01521923|4520436|P1|Overall Study|AE, non-serious, non-fatal|1
1369519|NCT01521923|4520433|P4|Overall Study|SAE, non-fatal|0
1369520|NCT01521923|4520434|P3|Overall Study|SAE, non-fatal|2
1369521|NCT01521923|4520435|P2|Overall Study|SAE, non-fatal|2
1369522|NCT01521923|4520436|P1|Overall Study|SAE, non-fatal|0
1369523|NCT01521923|4520433|P4|Overall Study|AE, serious fatal|0
1369524|NCT01521923|4520434|P3|Overall Study|AE, serious fatal|0
1369525|NCT01521923|4520435|P2|Overall Study|AE, serious fatal|0
1369526|NCT01521923|4520436|P1|Overall Study|AE, serious fatal|1
1369527|NCT01521897|4520556|P1|Overall Study|Lost to Follow-up|5
1369528|NCT01521897|4520556|P1|Overall Study|Protocol Violation|18
1369529|NCT01521884|4520568|P1|Overall Study|Lost to Follow-up|4
1369530|NCT01521884|4520568|P1|Overall Study|Participant non-eligible|1
1369531|NCT01521884|4520568|P1|Overall Study|Protocol Violation|3
1369532|NCT01521884|4520568|P1|Overall Study|Physician Decision|2
1369533|NCT01521884|4520568|P1|Overall Study|Withdrawal by Subject|1
1369534|NCT01521884|4520568|P1|Overall Study|Pregnancy|1
1369535|NCT01521884|4520568|P1|Overall Study|Adverse Event|5
1369536|NCT01521884|4520568|P1|Overall Study|Non Responders|10
1369537|NCT01521559|4520665|P2|Overall Study|Other|2
1369538|NCT01521559|4520666|P1|Overall Study|Other|1
1369539|NCT01521559|4520665|P2|Overall Study|Protocol Violation|0
1369540|NCT01521559|4520666|P1|Overall Study|Protocol Violation|1
1369541|NCT01521559|4520665|P2|Overall Study|Lost to Follow-up|1
1369542|NCT01521559|4520666|P1|Overall Study|Lost to Follow-up|3
1369543|NCT01521559|4520665|P2|Overall Study|Withdrawal by Subject|11
1369544|NCT01521559|4520666|P1|Overall Study|Withdrawal by Subject|9
1369545|NCT01521559|4520665|P2|Overall Study|Death|0
1369546|NCT01521559|4520666|P1|Overall Study|Death|1
1369547|NCT01521559|4520665|P2|Overall Study|Adverse Event|4
1369548|NCT01521559|4520666|P1|Overall Study|Adverse Event|0
1369549|NCT01521507|4520689|P2|Stage 2: Observational Design|Physician Decision|0
1369550|NCT01521507|4520690|P1|Stage 2: Observational Design|Physician Decision|1
1369551|NCT01521507|4520689|P2|Stage 2: Observational Design|Withdrawal by Subject|1
1369552|NCT01521507|4520690|P1|Stage 2: Observational Design|Withdrawal by Subject|3
1369553|NCT01521507|4520689|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
1369554|NCT01521507|4520690|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
1369555|NCT01521507|4520689|P2|Stage 1: Randomized Design|Lost to Follow-up|2
1369556|NCT01521507|4520690|P1|Stage 1: Randomized Design|Lost to Follow-up|0
1369557|NCT01521507|4520689|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
1369558|NCT01521507|4520690|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
1369559|NCT01521507|4520689|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
1369560|NCT01521507|4520690|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
1369561|NCT01521494|4520712|P5|Overall Study|Physician Decision|2
1369562|NCT01521494|4520713|P4|Overall Study|Physician Decision|0
1369563|NCT01521494|4520714|P3|Overall Study|Physician Decision|0
1369564|NCT01521494|4520715|P2|Overall Study|Physician Decision|0
1369565|NCT01521494|4520716|P1|Overall Study|Physician Decision|0
1369566|NCT01521494|4520712|P5|Overall Study|Decrease in serum calcium|1
1369567|NCT01521494|4520713|P4|Overall Study|Decrease in serum calcium|1
1369568|NCT01521494|4520714|P3|Overall Study|Decrease in serum calcium|0
1369569|NCT01521494|4520715|P2|Overall Study|Decrease in serum calcium|0
1369570|NCT01521494|4520716|P1|Overall Study|Decrease in serum calcium|0
1369571|NCT01521494|4520712|P5|Overall Study|Decrease in serum phosphate|0
1369572|NCT01521494|4520713|P4|Overall Study|Decrease in serum phosphate|12
1369573|NCT01521494|4520714|P3|Overall Study|Decrease in serum phosphate|3
1369574|NCT01521494|4520715|P2|Overall Study|Decrease in serum phosphate|2
1369575|NCT01521494|4520716|P1|Overall Study|Decrease in serum phosphate|0
1369576|NCT01521494|4520712|P5|Overall Study|Withdrawal by Subject|0
1369577|NCT01521494|4520713|P4|Overall Study|Withdrawal by Subject|2
1369578|NCT01521494|4520714|P3|Overall Study|Withdrawal by Subject|0
1369579|NCT01521494|4520715|P2|Overall Study|Withdrawal by Subject|1
1369580|NCT01521494|4520716|P1|Overall Study|Withdrawal by Subject|1
1369581|NCT01521494|4520712|P5|Overall Study|Lack of Efficacy|2
1369582|NCT01521494|4520713|P4|Overall Study|Lack of Efficacy|0
1369583|NCT01521494|4520714|P3|Overall Study|Lack of Efficacy|0
1369584|NCT01521494|4520715|P2|Overall Study|Lack of Efficacy|0
1369585|NCT01521494|4520716|P1|Overall Study|Lack of Efficacy|0
1369586|NCT01521494|4520712|P5|Overall Study|Adverse Event|2
1369587|NCT01521494|4520713|P4|Overall Study|Adverse Event|6
1369588|NCT01521494|4520714|P3|Overall Study|Adverse Event|9
1369589|NCT01521494|4520715|P2|Overall Study|Adverse Event|2
1369590|NCT01521494|4520716|P1|Overall Study|Adverse Event|1
1369591|NCT01521364|4520738|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
1369592|NCT01521364|4520738|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
1369593|NCT01520987|4520814|P8|Overall Study|Withdrawal by Subject|0
1369594|NCT01520987|4520815|P7|Overall Study|Withdrawal by Subject|0
1369595|NCT01520987|4520816|P6|Overall Study|Withdrawal by Subject|1
1369596|NCT01520987|4520817|P5|Overall Study|Withdrawal by Subject|0
1369597|NCT01520987|4520818|P4|Overall Study|Withdrawal by Subject|0
1369598|NCT01520987|4520819|P3|Overall Study|Withdrawal by Subject|0
1369599|NCT01520987|4520820|P2|Overall Study|Withdrawal by Subject|0
1369600|NCT01520987|4520821|P1|Overall Study|Withdrawal by Subject|1
1369601|NCT01520922|4520881|P2|Survival Follow-up|Withdrawal by Subject|0
1369602|NCT01520922|4520882|P1|Survival Follow-up|Withdrawal by Subject|1
1369603|NCT01520922|4520881|P2|Follow up|Lost to Follow-up|1
1369604|NCT01520922|4520882|P1|Follow up|Lost to Follow-up|0
1369605|NCT01520922|4520881|P2|Treatment Phase|Adverse Event|5
1369606|NCT01520922|4520882|P1|Treatment Phase|Adverse Event|3
1369607|NCT01520922|4520881|P2|Treatment Phase|Progression|2
1369608|NCT01520922|4520882|P1|Treatment Phase|Progression|0
1369609|NCT01520922|4520881|P2|Treatment Phase|Physician Decision|1
1369610|NCT01520922|4520882|P1|Treatment Phase|Physician Decision|2
1369611|NCT01520909|4520944|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
1369697|NCT01519765|4521448|P2|Overall Study|Protocol Violation|0
1369612|NCT01520909|4520945|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
1369613|NCT01520909|4520946|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
1369614|NCT01520909|4520944|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
1369615|NCT01520909|4520945|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
1369616|NCT01520909|4520946|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
1369617|NCT01520909|4520944|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
1369618|NCT01520909|4520945|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
1369619|NCT01520909|4520946|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
1369620|NCT01520909|4520944|P3|Part 1 (Randomized Period)|Adverse Event|0
1369621|NCT01520909|4520945|P2|Part 1 (Randomized Period)|Adverse Event|2
1369622|NCT01520909|4520946|P1|Part 1 (Randomized Period)|Adverse Event|1
1369623|NCT01520714|4521063|P2|Overall Study|Lack of Efficacy|1
1369624|NCT01520714|4521064|P1|Overall Study|Lack of Efficacy|0
1369625|NCT01520714|4521063|P2|Overall Study|Adverse Event|2
1369626|NCT01520714|4521064|P1|Overall Study|Adverse Event|0
1369627|NCT01520714|4521063|P2|Overall Study|Protocol Violation|3
1369628|NCT01520714|4521064|P1|Overall Study|Protocol Violation|0
1369629|NCT01520506|4521089|P1|Overall Study|Withdrawal by Subject|1
1369630|NCT01520506|4521089|P1|Overall Study|Lost to Follow-up|1
1369631|NCT01520506|4521089|P1|Overall Study|Missed Visit|4
1369632|NCT01520402|4521144|P1|Overall Study|Physician Decision|3
1369633|NCT01520402|4521144|P1|Overall Study|Withdrawal by Subject|2
1369634|NCT01519960|4521167|P3|Overall Study|Lost to Follow-up|0
1369635|NCT01519960|4521168|P2|Overall Study|Lost to Follow-up|1
1369636|NCT01519960|4521169|P1|Overall Study|Lost to Follow-up|0
1369637|NCT01519960|4521167|P3|Overall Study|Withdrawal by Subject|0
1369638|NCT01519960|4521168|P2|Overall Study|Withdrawal by Subject|4
1369639|NCT01519960|4521169|P1|Overall Study|Withdrawal by Subject|0
1369640|NCT01519960|4521167|P3|Overall Study|Adverse Event|0
1369641|NCT01519960|4521168|P2|Overall Study|Adverse Event|1
1369642|NCT01519960|4521169|P1|Overall Study|Adverse Event|0
1369643|NCT01519960|4521167|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
1369644|NCT01519960|4521168|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
1369645|NCT01519960|4521169|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
1369646|NCT01519960|4521167|P3|Overall Study|Ongoing in Follow-Up|10
1369647|NCT01519960|4521168|P2|Overall Study|Ongoing in Follow-Up|11
1369648|NCT01519960|4521169|P1|Overall Study|Ongoing in Follow-Up|101
1369649|NCT01519934|4521275|P1|Overall Study|Lost to Follow-up|3
1369650|NCT01519921|4521284|P2|Overall Study|High alanine aminotransferase (ALT)|1
1369651|NCT01519921|4521285|P1|Overall Study|High alanine aminotransferase (ALT)|0
1369652|NCT01519921|4521284|P2|Overall Study|Treatment refusal|1
1369653|NCT01519921|4521285|P1|Overall Study|Treatment refusal|2
1369654|NCT01519921|4521284|P2|Overall Study|Lost to Follow-up|1
1369655|NCT01519921|4521285|P1|Overall Study|Lost to Follow-up|2
1369656|NCT01519921|4521284|P2|Overall Study|Withdrawal by Subject|0
1369657|NCT01519921|4521285|P1|Overall Study|Withdrawal by Subject|3
1369658|NCT01519921|4521284|P2|Overall Study|Lack of Efficacy|3
1369659|NCT01519921|4521285|P1|Overall Study|Lack of Efficacy|4
1369660|NCT01519921|4521284|P2|Overall Study|Adverse Event|9
1369661|NCT01519921|4521285|P1|Overall Study|Adverse Event|10
1369662|NCT01519817|4521334|P4|Overall Study|Off study due to infection|1
1369663|NCT01519817|4521335|P3|Overall Study|Off study due to infection|0
1369664|NCT01519817|4521336|P2|Overall Study|Off study due to infection|0
1369665|NCT01519817|4521337|P1|Overall Study|Off study due to infection|0
1369666|NCT01519817|4521334|P4|Overall Study|Withdrawal by Subject|0
1369667|NCT01519817|4521335|P3|Overall Study|Withdrawal by Subject|0
1369668|NCT01519817|4521336|P2|Overall Study|Withdrawal by Subject|0
1369669|NCT01519817|4521337|P1|Overall Study|Withdrawal by Subject|1
1369670|NCT01519791|4521377|P2|Overall Study|Lost to Follow-up|14
1369671|NCT01519791|4521378|P1|Overall Study|Lost to Follow-up|6
1369672|NCT01519791|4521377|P2|Overall Study|Withdrawal by Subject|37
1369673|NCT01519791|4521378|P1|Overall Study|Withdrawal by Subject|15
1369674|NCT01519791|4521377|P2|Overall Study|AE, non-serious non-fatal|31
1369675|NCT01519791|4521378|P1|Overall Study|AE, non-serious non-fatal|12
1369676|NCT01519791|4521377|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
1369677|NCT01519791|4521378|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
1369678|NCT01519791|4521377|P2|Overall Study|AE, serious fatal|1
1369679|NCT01519791|4521378|P1|Overall Study|AE, serious fatal|0
1369680|NCT01519791|4521377|P2|Overall Study|SAE, non-fatal|22
1369681|NCT01519791|4521378|P1|Overall Study|SAE, non-fatal|6
1369682|NCT01519791|4521377|P2|Overall Study|Lack of Efficacy|20
1369683|NCT01519791|4521378|P1|Overall Study|Lack of Efficacy|16
1369684|NCT01519791|4521377|P2|Overall Study|subjects randomized in error|0
1369685|NCT01519791|4521378|P1|Overall Study|subjects randomized in error|2
1369686|NCT01519791|4521377|P2|Overall Study|Other Reason|222
1369687|NCT01519791|4521378|P1|Overall Study|Other Reason|87
1369688|NCT01519791|4521377|P2|Overall Study|Protocol Violation|19
1369689|NCT01519791|4521378|P1|Overall Study|Protocol Violation|6
1369690|NCT01519791|4521377|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
1369691|NCT01519791|4521378|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
1369692|NCT01519778|4521442|P1|Overall Study|Physician Decision|1
1369693|NCT01519778|4521442|P1|Overall Study|Lost to Follow-up|10
1369694|NCT01519778|4521442|P1|Overall Study|Withdrawal by Subject|3
1369695|NCT01519765|4521448|P2|Overall Study|Withdrawal by Subject|1
1369696|NCT01519765|4521449|P1|Overall Study|Withdrawal by Subject|0
1369698|NCT01519765|4521449|P1|Overall Study|Protocol Violation|1
1369699|NCT01519765|4521448|P2|Overall Study|Lack of Efficacy|0
1369700|NCT01519765|4521449|P1|Overall Study|Lack of Efficacy|2
1369701|NCT01519765|4521448|P2|Overall Study|Adverse Event|1
1369702|NCT01519765|4521449|P1|Overall Study|Adverse Event|0
1369703|NCT01519700|4521527|P4|Overall Study|Other Reason|4
1369704|NCT01519700|4521528|P3|Overall Study|Other Reason|0
1369705|NCT01519700|4521529|P2|Overall Study|Other Reason|2
1369706|NCT01519700|4521530|P1|Overall Study|Other Reason|2
1369707|NCT01519700|4521527|P4|Overall Study|Withdrawal by Subject|2
1369708|NCT01519700|4521528|P3|Overall Study|Withdrawal by Subject|3
1369709|NCT01519700|4521529|P2|Overall Study|Withdrawal by Subject|3
1369710|NCT01519700|4521530|P1|Overall Study|Withdrawal by Subject|5
1369711|NCT01519700|4521527|P4|Overall Study|Physician Decision|0
1369712|NCT01519700|4521528|P3|Overall Study|Physician Decision|3
1369713|NCT01519700|4521529|P2|Overall Study|Physician Decision|1
1369714|NCT01519700|4521530|P1|Overall Study|Physician Decision|1
1369715|NCT01519700|4521527|P4|Overall Study|Lost to Follow-up|1
1369716|NCT01519700|4521528|P3|Overall Study|Lost to Follow-up|1
1369717|NCT01519700|4521529|P2|Overall Study|Lost to Follow-up|0
1369718|NCT01519700|4521530|P1|Overall Study|Lost to Follow-up|0
1369719|NCT01519700|4521527|P4|Overall Study|Death|0
1369720|NCT01519700|4521528|P3|Overall Study|Death|0
1369721|NCT01519700|4521529|P2|Overall Study|Death|0
1369722|NCT01519700|4521530|P1|Overall Study|Death|1
1369723|NCT01519674|4521565|P3|Overall Study|Unsclassified|3
1369724|NCT01519674|4521566|P2|Overall Study|Unsclassified|4
1369725|NCT01519674|4521567|P1|Overall Study|Unsclassified|10
1369726|NCT01519674|4521565|P3|Overall Study|Withdrawal Criteria|7
1369727|NCT01519674|4521566|P2|Overall Study|Withdrawal Criteria|2
1369728|NCT01519674|4521567|P1|Overall Study|Withdrawal Criteria|7
1369729|NCT01519674|4521565|P3|Overall Study|Protocol Violation|1
1369730|NCT01519674|4521566|P2|Overall Study|Protocol Violation|3
1369731|NCT01519674|4521567|P1|Overall Study|Protocol Violation|0
1369732|NCT01519674|4521565|P3|Overall Study|Lack of Efficacy|1
1369733|NCT01519674|4521566|P2|Overall Study|Lack of Efficacy|1
1369734|NCT01519674|4521567|P1|Overall Study|Lack of Efficacy|1
1369735|NCT01519674|4521565|P3|Overall Study|Adverse Event|0
1369736|NCT01519674|4521566|P2|Overall Study|Adverse Event|3
1369737|NCT01519674|4521567|P1|Overall Study|Adverse Event|3
1369738|NCT01519661|4521605|P1|Overall Study|Adverse Event|29
1369739|NCT01519661|4521605|P1|Overall Study|Lack of Efficacy|6
1369740|NCT01519661|4521605|P1|Overall Study|Withdrawal by Subject|17
1369741|NCT01519661|4521605|P1|Overall Study|Lost to Follow-up|3
1369742|NCT01519661|4521605|P1|Overall Study|Protocol deviation|6
1369743|NCT01519518|4521631|P2|Overall Study|Consent not available|10
1369744|NCT01519518|4521632|P1|Overall Study|Consent not available|7
1369745|NCT01519427|4521657|P1|Overall Study|disease progression|2
1369746|NCT01519323|4521664|P2|Overall Study|Study terminated by sponsor|1
1369747|NCT01519323|4521665|P1|Overall Study|Study terminated by sponsor|0
1369748|NCT01519323|4521664|P2|Overall Study|Death|2
1369749|NCT01519323|4521665|P1|Overall Study|Death|3
1369750|NCT01519245|4521725|P2|Overall Study|Met exclusion criteria, not analysed|2
1369751|NCT01519245|4521726|P1|Overall Study|Met exclusion criteria, not analysed|1
1369752|NCT01519206|4521738|P1|Overall Study|Missed Visit|2
1369753|NCT01519206|4521738|P1|Overall Study|Lost to Follow-up|3
1369754|NCT01519167|4521752|P2|Overall Study|Physician Decision|1
1369755|NCT01519167|4521753|P1|Overall Study|Physician Decision|0
1369756|NCT01519167|4521752|P2|Overall Study|Medical condition changes&deep sedation|2
1369757|NCT01519167|4521753|P1|Overall Study|Medical condition changes&deep sedation|0
1369758|NCT01519167|4521752|P2|Overall Study|Lack of Efficacy|1
1369759|NCT01519167|4521753|P1|Overall Study|Lack of Efficacy|0
1369760|NCT01519167|4521752|P2|Overall Study|Adverse Event|1
1369761|NCT01519167|4521753|P1|Overall Study|Adverse Event|0
1369762|NCT01519167|4521752|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
1369763|NCT01519167|4521753|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
1369764|NCT01519089|4521779|P2|Overall Study|Not received study drug|1
1369765|NCT01519089|4521780|P1|Overall Study|Not received study drug|0
1369766|NCT01519089|4521779|P2|Overall Study|Other|6
1369767|NCT01519089|4521780|P1|Overall Study|Other|2
1369768|NCT01519089|4521779|P2|Overall Study|Withdrawal by Subject|2
1369769|NCT01519089|4521780|P1|Overall Study|Withdrawal by Subject|0
1369770|NCT01519089|4521779|P2|Overall Study|Lost to Follow-up|0
1369771|NCT01519089|4521780|P1|Overall Study|Lost to Follow-up|1
1369772|NCT01519089|4521779|P2|Overall Study|Lack of Efficacy|2
1369773|NCT01519089|4521780|P1|Overall Study|Lack of Efficacy|0
1369774|NCT01519089|4521779|P2|Overall Study|Adverse Event|4
1369775|NCT01519089|4521780|P1|Overall Study|Adverse Event|4
1369776|NCT01518946|4521901|P3|Randomized Phase (First Intervention)|Not specified|0
1369777|NCT01518946|4521902|P2|Randomized Phase (First Intervention)|Not specified|1
1369778|NCT01518946|4521903|P1|Randomized Phase (First Intervention)|Not specified|0
1369779|NCT01518946|4521901|P3|Open-label Phase|Not specified|0
1369780|NCT01518946|4521902|P2|Open-label Phase|Not specified|0
1369781|NCT01518946|4521903|P1|Open-label Phase|Not specified|4
1369782|NCT01518374|4521914|P1|Overall Study|Lost to Follow-up|2
1369783|NCT01518374|4521914|P1|Overall Study|Protocol Violation|3
1369784|NCT01518374|4521914|P1|Overall Study|Withdrawal by Subject|2
1369785|NCT01518322|4521918|P1|Overall Study|FeNO measurement was missing|13
1369786|NCT01518257|4521939|P2|Overall Study|Other Miscellaneous Reason|0
1369787|NCT01518257|4521940|P1|Overall Study|Other Miscellaneous Reason|1
1369788|NCT01518257|4521939|P2|Overall Study|Lost to Follow-up|0
1369789|NCT01518257|4521940|P1|Overall Study|Lost to Follow-up|1
1369790|NCT01518244|4521962|P1|Overall Study|Adverse Event|3
1369791|NCT01518192|4521970|P3|Overall Study|Lost to Follow-up|35
1369792|NCT01518192|4521971|P2|Overall Study|Lost to Follow-up|26
1369793|NCT01518192|4521972|P1|Overall Study|Lost to Follow-up|29
1369794|NCT01518153|4521993|P3|Donor Lymphocyte Infusion|Death|1
1369795|NCT01518153|4521994|P2|Donor Lymphocyte Infusion|Death|2
1369796|NCT01518153|4521995|P1|Donor Lymphocyte Infusion|Death|0
1369797|NCT01518153|4521993|P3|Stem Cell Transplant|Adverse Event|0
1369798|NCT01518153|4521994|P2|Stem Cell Transplant|Adverse Event|0
1369799|NCT01518153|4521995|P1|Stem Cell Transplant|Adverse Event|1
1369800|NCT01518153|4521993|P3|Stem Cell Transplant|Secondary graft failure|0
1369801|NCT01518153|4521994|P2|Stem Cell Transplant|Secondary graft failure|0
1369802|NCT01518153|4521995|P1|Stem Cell Transplant|Secondary graft failure|1
1369803|NCT01518153|4521993|P3|Stem Cell Transplant|Death|0
1369804|NCT01518153|4521994|P2|Stem Cell Transplant|Death|0
1369805|NCT01518153|4521995|P1|Stem Cell Transplant|Death|2
1369806|NCT01518153|4521993|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
1369807|NCT01518153|4521994|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
1369808|NCT01518153|4521995|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
1369809|NCT01517984|4522006|P4|Overall Study|Ineligible for randomization|0
1369810|NCT01517984|4522007|P3|Overall Study|Ineligible for randomization|0
1369811|NCT01517984|4522008|P2|Overall Study|Ineligible for randomization|14
1369812|NCT01517984|4522009|P1|Overall Study|Ineligible for randomization|0
1369813|NCT01517984|4522006|P4|Overall Study|Screen Failure|0
1369814|NCT01517984|4522007|P3|Overall Study|Screen Failure|0
1369815|NCT01517984|4522008|P2|Overall Study|Screen Failure|0
1369816|NCT01517984|4522009|P1|Overall Study|Screen Failure|4
1369817|NCT01517984|4522006|P4|Overall Study|Withdrawal by Subject|1
1369818|NCT01517984|4522007|P3|Overall Study|Withdrawal by Subject|4
1369819|NCT01517984|4522008|P2|Overall Study|Withdrawal by Subject|8
1369820|NCT01517984|4522009|P1|Overall Study|Withdrawal by Subject|1
1369821|NCT01517984|4522006|P4|Overall Study|Lost to Follow-up|0
1369822|NCT01517984|4522007|P3|Overall Study|Lost to Follow-up|0
1369823|NCT01517984|4522008|P2|Overall Study|Lost to Follow-up|1
1369824|NCT01517984|4522009|P1|Overall Study|Lost to Follow-up|0
1369825|NCT01517867|4522044|P2|Overall Study|Still in treatment at study end|3
1369826|NCT01517867|4522045|P1|Overall Study|Still in treatment at study end|0
1369827|NCT01517867|4522044|P2|Overall Study|Withdrawal by Subject|30
1369828|NCT01517867|4522045|P1|Overall Study|Withdrawal by Subject|34
1369829|NCT01517867|4522044|P2|Overall Study|never started treatment|32
1369830|NCT01517867|4522045|P1|Overall Study|never started treatment|29
1369831|NCT01517750|4522057|P4|Overall Study|Lost to Follow-up|1
1369832|NCT01517750|4522058|P3|Overall Study|Lost to Follow-up|4
1369833|NCT01517750|4522059|P2|Overall Study|Lost to Follow-up|2
1369834|NCT01517750|4522060|P1|Overall Study|Lost to Follow-up|1
1369835|NCT01517412|4522097|P2|Overall Study|Other than specified above|5
1369836|NCT01517412|4522098|P1|Overall Study|Other than specified above|8
1369837|NCT01517412|4522097|P2|Overall Study|Poor compliance to protocol|3
1369838|NCT01517412|4522098|P1|Overall Study|Poor compliance to protocol|8
1369839|NCT01517412|4522097|P2|Overall Study|Lack of Efficacy|5
1369840|NCT01517412|4522098|P1|Overall Study|Lack of Efficacy|10
1369841|NCT01517412|4522097|P2|Overall Study|Adverse Event|11
1369842|NCT01517412|4522098|P1|Overall Study|Adverse Event|10
1369843|NCT01517373|4522127|P6|Treatment Period|Medication error without AEs|2
1369844|NCT01517373|4522128|P5|Treatment Period|Medication error without AEs|0
1369845|NCT01517373|4522129|P4|Treatment Period|Medication error without AEs|1
1369846|NCT01517373|4522130|P3|Treatment Period|Medication error without AEs|2
1369847|NCT01517373|4522131|P2|Treatment Period|Medication error without AEs|0
1369848|NCT01517373|4522132|P1|Treatment Period|Medication error without AEs|0
1369849|NCT01517373|4522127|P6|Treatment Period|Lack of Efficacy|0
1369850|NCT01517373|4522128|P5|Treatment Period|Lack of Efficacy|2
1369851|NCT01517373|4522129|P4|Treatment Period|Lack of Efficacy|3
1369852|NCT01517373|4522130|P3|Treatment Period|Lack of Efficacy|1
1369853|NCT01517373|4522131|P2|Treatment Period|Lack of Efficacy|1
1369854|NCT01517373|4522132|P1|Treatment Period|Lack of Efficacy|0
1369855|NCT01517373|4522127|P6|Treatment Period|Protocol Violation|0
1369856|NCT01517373|4522128|P5|Treatment Period|Protocol Violation|1
1369857|NCT01517373|4522129|P4|Treatment Period|Protocol Violation|0
1369858|NCT01517373|4522130|P3|Treatment Period|Protocol Violation|0
1369859|NCT01517373|4522131|P2|Treatment Period|Protocol Violation|0
1369860|NCT01517373|4522132|P1|Treatment Period|Protocol Violation|0
1369861|NCT01517373|4522127|P6|Treatment Period|Other|0
1369862|NCT01517373|4522128|P5|Treatment Period|Other|1
1369863|NCT01517373|4522129|P4|Treatment Period|Other|0
1369864|NCT01517373|4522130|P3|Treatment Period|Other|0
1369865|NCT01517373|4522131|P2|Treatment Period|Other|0
1369866|NCT01517373|4522132|P1|Treatment Period|Other|0
1369867|NCT01517373|4522127|P6|Treatment Period|Withdrawal by Subject|3
1369868|NCT01517373|4522128|P5|Treatment Period|Withdrawal by Subject|2
1369869|NCT01517373|4522129|P4|Treatment Period|Withdrawal by Subject|2
1369870|NCT01517373|4522130|P3|Treatment Period|Withdrawal by Subject|2
1369871|NCT01517373|4522131|P2|Treatment Period|Withdrawal by Subject|3
1369872|NCT01517373|4522132|P1|Treatment Period|Withdrawal by Subject|0
1369873|NCT01517373|4522127|P6|Treatment Period|Lost to Follow-up|0
1369874|NCT01517373|4522128|P5|Treatment Period|Lost to Follow-up|0
1369875|NCT01517373|4522129|P4|Treatment Period|Lost to Follow-up|1
1369876|NCT01517373|4522130|P3|Treatment Period|Lost to Follow-up|1
1369877|NCT01517373|4522131|P2|Treatment Period|Lost to Follow-up|0
1369878|NCT01517373|4522132|P1|Treatment Period|Lost to Follow-up|0
1369879|NCT01517373|4522127|P6|Treatment Period|Adverse Event|2
1369880|NCT01517373|4522128|P5|Treatment Period|Adverse Event|0
1369881|NCT01517373|4522129|P4|Treatment Period|Adverse Event|0
1369882|NCT01517373|4522130|P3|Treatment Period|Adverse Event|0
1369883|NCT01517373|4522131|P2|Treatment Period|Adverse Event|0
1369884|NCT01517373|4522132|P1|Treatment Period|Adverse Event|0
1369885|NCT01517373|4522127|P6|Run-in Period|Other|0
1369886|NCT01517373|4522128|P5|Run-in Period|Other|0
1369887|NCT01517373|4522129|P4|Run-in Period|Other|0
1369888|NCT01517373|4522130|P3|Run-in Period|Other|0
1369889|NCT01517373|4522131|P2|Run-in Period|Other|0
1369890|NCT01517373|4522132|P1|Run-in Period|Other|1
1369891|NCT01517373|4522127|P6|Run-in Period|Sponsor Decision|0
1369892|NCT01517373|4522128|P5|Run-in Period|Sponsor Decision|0
1369893|NCT01517373|4522129|P4|Run-in Period|Sponsor Decision|0
1369894|NCT01517373|4522130|P3|Run-in Period|Sponsor Decision|0
1369895|NCT01517373|4522131|P2|Run-in Period|Sponsor Decision|0
1369896|NCT01517373|4522132|P1|Run-in Period|Sponsor Decision|3
1369897|NCT01517373|4522127|P6|Run-in Period|Withdrawal by Subject|0
1369898|NCT01517373|4522128|P5|Run-in Period|Withdrawal by Subject|0
1369899|NCT01517373|4522129|P4|Run-in Period|Withdrawal by Subject|0
1369900|NCT01517373|4522130|P3|Run-in Period|Withdrawal by Subject|0
1369901|NCT01517373|4522131|P2|Run-in Period|Withdrawal by Subject|0
1369902|NCT01517373|4522132|P1|Run-in Period|Withdrawal by Subject|12
1369903|NCT01517373|4522127|P6|Run-in Period|Lost to Follow-up|0
1369904|NCT01517373|4522128|P5|Run-in Period|Lost to Follow-up|0
1369905|NCT01517373|4522129|P4|Run-in Period|Lost to Follow-up|0
1369906|NCT01517373|4522130|P3|Run-in Period|Lost to Follow-up|0
1369907|NCT01517373|4522131|P2|Run-in Period|Lost to Follow-up|0
1369908|NCT01517373|4522132|P1|Run-in Period|Lost to Follow-up|1
1369909|NCT01517373|4522127|P6|Run-in Period|Did not meet eligibility criteria|0
1369910|NCT01517373|4522128|P5|Run-in Period|Did not meet eligibility criteria|0
1369911|NCT01517373|4522129|P4|Run-in Period|Did not meet eligibility criteria|0
1369912|NCT01517373|4522130|P3|Run-in Period|Did not meet eligibility criteria|0
1369913|NCT01517373|4522131|P2|Run-in Period|Did not meet eligibility criteria|0
1369914|NCT01517373|4522132|P1|Run-in Period|Did not meet eligibility criteria|34
1369915|NCT01517373|4522127|P6|Run-in Period|Adverse Event|0
1369916|NCT01517373|4522128|P5|Run-in Period|Adverse Event|0
1369917|NCT01517373|4522129|P4|Run-in Period|Adverse Event|0
1369918|NCT01517373|4522130|P3|Run-in Period|Adverse Event|0
1369919|NCT01517373|4522131|P2|Run-in Period|Adverse Event|0
1369920|NCT01517373|4522132|P1|Run-in Period|Adverse Event|5
1369921|NCT01517373|4522127|P6|Run-in Period|Death|0
1369922|NCT01517373|4522128|P5|Run-in Period|Death|0
1369923|NCT01517373|4522129|P4|Run-in Period|Death|0
1369924|NCT01517373|4522130|P3|Run-in Period|Death|0
1369925|NCT01517373|4522131|P2|Run-in Period|Death|0
1369926|NCT01517373|4522132|P1|Run-in Period|Death|1
1369927|NCT01517295|4522202|P2|Overall Study|Physician Decision|0
1369928|NCT01517295|4522203|P1|Overall Study|Physician Decision|1
1369929|NCT01517282|4522217|P4|Overall Study|Physician Decision|0
1369930|NCT01517282|4522218|P3|Overall Study|Physician Decision|0
1369931|NCT01517282|4522219|P2|Overall Study|Physician Decision|0
1369932|NCT01517282|4522220|P1|Overall Study|Physician Decision|1
1369933|NCT01517282|4522217|P4|Overall Study|Consent withdrawn|1
1369934|NCT01517282|4522218|P3|Overall Study|Consent withdrawn|1
1369935|NCT01517282|4522219|P2|Overall Study|Consent withdrawn|1
1369936|NCT01517282|4522220|P1|Overall Study|Consent withdrawn|0
1369937|NCT01517178|4522254|P2|Period 2|E.g. study termination|2
1369938|NCT01517178|4522255|P1|Period 2|E.g. study termination|2
1369939|NCT01517178|4522254|P2|Period 2|Withdrawal by Subject|0
1369940|NCT01517178|4522255|P1|Period 2|Withdrawal by Subject|3
1369941|NCT01517178|4522254|P2|Period 2|Adverse Event|0
1369942|NCT01517178|4522255|P1|Period 2|Adverse Event|1
1369943|NCT01517178|4522254|P2|Period 1|Withdrawal by Subject|1
1369944|NCT01517178|4522255|P1|Period 1|Withdrawal by Subject|0
1369945|NCT01517178|4522254|P2|Period 1|E.g. study termination|1
1369946|NCT01517178|4522255|P1|Period 1|E.g. study termination|3
1369947|NCT01517178|4522254|P2|Period 1|Lack of Efficacy|1
1369948|NCT01517178|4522255|P1|Period 1|Lack of Efficacy|0
1369949|NCT01517178|4522254|P2|Period 1|Adverse Event|2
1369950|NCT01517178|4522255|P1|Period 1|Adverse Event|1
1369951|NCT01516970|4522274|P2|Overall Study|Other|7
1369952|NCT01516970|4522275|P1|Overall Study|Other|9
1369953|NCT01516970|4522274|P2|Overall Study|Withdrawal by Subject|1
1369954|NCT01516970|4522275|P1|Overall Study|Withdrawal by Subject|1
1369955|NCT01516970|4522274|P2|Overall Study|Adverse Event|5
1369956|NCT01516970|4522275|P1|Overall Study|Adverse Event|1
1369957|NCT01516970|4522274|P2|Overall Study|Lost to Follow-up|8
1369958|NCT01516970|4522275|P1|Overall Study|Lost to Follow-up|7
1369959|NCT01516892|4522287|P1|Overall Study|Missing|1
1369960|NCT01516892|4522287|P1|Overall Study|Other Miscellaneous Reasons|43
1369961|NCT01516892|4522287|P1|Overall Study|Protocol Violation|60
1369962|NCT01516892|4522287|P1|Overall Study|Subject Withdrew Consent|92
1369963|NCT01516892|4522287|P1|Overall Study|Lost to Follow-up|82
1369964|NCT01516892|4522287|P1|Overall Study|Pregnancy|5
1369965|NCT01516892|4522287|P1|Overall Study|Lack of Efficacy|35
1369966|NCT01516892|4522287|P1|Overall Study|Adverse Event|25
1369967|NCT01516879|4522295|P2|Overall Study|Other|10
1369968|NCT01516879|4522296|P1|Overall Study|Other|5
1369969|NCT01516879|4522295|P2|Overall Study|Lost to Follow-up|11
1369970|NCT01516879|4522296|P1|Overall Study|Lost to Follow-up|2
1369971|NCT01516879|4522295|P2|Overall Study|Death|2
1369972|NCT01516879|4522296|P1|Overall Study|Death|0
1369973|NCT01516879|4522295|P2|Overall Study|Withdrawal by Subject|11
1369974|NCT01516879|4522296|P1|Overall Study|Withdrawal by Subject|9
1369975|NCT01516749|4522330|P1|Follow-up Off Therapy|Lost to Follow-up|1
1369976|NCT01516749|4522330|P1|Active Therapy|Lost to Follow-up|1
1369977|NCT01516736|4522339|P2|Overall Study|Other (not specified)|1
1369978|NCT01516736|4522340|P1|Overall Study|Other (not specified)|0
1369979|NCT01516736|4522339|P2|Overall Study|Protocol Violation|1
1369980|NCT01516736|4522340|P1|Overall Study|Protocol Violation|0
1369981|NCT01516736|4522339|P2|Overall Study|Lack of Efficacy|0
1369982|NCT01516736|4522340|P1|Overall Study|Lack of Efficacy|1
1369983|NCT01516736|4522339|P2|Overall Study|Physician Decision|1
1369984|NCT01516736|4522340|P1|Overall Study|Physician Decision|2
1369985|NCT01516736|4522339|P2|Overall Study|Death|1
1369986|NCT01516736|4522340|P1|Overall Study|Death|3
1369987|NCT01516736|4522339|P2|Overall Study|Adverse Event|5
1369988|NCT01516736|4522340|P1|Overall Study|Adverse Event|4
1369989|NCT01516736|4522339|P2|Overall Study|Withdrawal by Subject|4
1369990|NCT01516736|4522340|P1|Overall Study|Withdrawal by Subject|10
1369991|NCT01516437|4522377|P4|Overall Study|Reason not specified|1
1369992|NCT01516437|4522378|P3|Overall Study|Reason not specified|1
1369993|NCT01516437|4522379|P2|Overall Study|Reason not specified|0
1369994|NCT01516437|4522380|P1|Overall Study|Reason not specified|0
1369995|NCT01516034|4522443|P1|Overall Study|Lack of Efficacy|7
1369996|NCT01516034|4522443|P1|Overall Study|Physician Decision|1
1369997|NCT01516008|4522450|P3|Overall Study|Reason not specified|1
1369998|NCT01516008|4522451|P2|Overall Study|Reason not specified|0
1369999|NCT01516008|4522452|P1|Overall Study|Reason not specified|0
1370000|NCT01516008|4522450|P3|Overall Study|Protocol Violation|0
1370001|NCT01516008|4522451|P2|Overall Study|Protocol Violation|0
1370002|NCT01516008|4522452|P1|Overall Study|Protocol Violation|1
1370003|NCT01516008|4522450|P3|Overall Study|Lack of Efficacy|10
1370004|NCT01516008|4522451|P2|Overall Study|Lack of Efficacy|14
1370005|NCT01516008|4522452|P1|Overall Study|Lack of Efficacy|44
1370006|NCT01516008|4522450|P3|Overall Study|Adverse Event|7
1370007|NCT01516008|4522451|P2|Overall Study|Adverse Event|2
1370008|NCT01516008|4522452|P1|Overall Study|Adverse Event|0
1370009|NCT01515865|4522548|P3|Part B (Open-label)|Not Specified|0
1370010|NCT01515865|4522549|P2|Part B (Open-label)|Not Specified|0
1370011|NCT01515865|4522550|P1|Part B (Open-label)|Not Specified|1
1370012|NCT01515865|4522548|P3|Part B (Open-label)|Withdrawal by Subject|0
1370013|NCT01515865|4522549|P2|Part B (Open-label)|Withdrawal by Subject|0
1370014|NCT01515865|4522550|P1|Part B (Open-label)|Withdrawal by Subject|1
1370015|NCT01515865|4522548|P3|Part A (Open-label)|Not Specified|0
1370016|NCT01515865|4522549|P2|Part A (Open-label)|Not Specified|0
1370017|NCT01515865|4522550|P1|Part A (Open-label)|Not Specified|3
1370018|NCT01515423|4522618|P3|DOUBLE BLIND|Blind broken by investigator|0
1370019|NCT01515423|4522619|P2|DOUBLE BLIND|Blind broken by investigator|1
1370020|NCT01515423|4522620|P1|DOUBLE BLIND|Blind broken by investigator|0
1370021|NCT01515423|4522618|P3|DOUBLE BLIND|Other|12
1370022|NCT01515423|4522619|P2|DOUBLE BLIND|Other|6
1370023|NCT01515423|4522620|P1|DOUBLE BLIND|Other|0
1370024|NCT01515423|4522618|P3|DOUBLE BLIND|Withdrawal by Subject|53
1370025|NCT01515423|4522619|P2|DOUBLE BLIND|Withdrawal by Subject|50
1370026|NCT01515423|4522620|P1|DOUBLE BLIND|Withdrawal by Subject|0
1370027|NCT01515423|4522618|P3|DOUBLE BLIND|Pregnancy|0
1370028|NCT01515423|4522619|P2|DOUBLE BLIND|Pregnancy|2
1370029|NCT01515423|4522620|P1|DOUBLE BLIND|Pregnancy|0
1370030|NCT01515423|4522618|P3|DOUBLE BLIND|Lost to Follow-up|12
1370031|NCT01515423|4522619|P2|DOUBLE BLIND|Lost to Follow-up|7
1370032|NCT01515423|4522620|P1|DOUBLE BLIND|Lost to Follow-up|0
1370033|NCT01515423|4522618|P3|DOUBLE BLIND|Death|2
1370034|NCT01515423|4522619|P2|DOUBLE BLIND|Death|1
1370035|NCT01515423|4522620|P1|DOUBLE BLIND|Death|0
1370036|NCT01515423|4522618|P3|DOUBLE BLIND|Adverse Event|13
1370037|NCT01515423|4522619|P2|DOUBLE BLIND|Adverse Event|15
1370038|NCT01515423|4522620|P1|DOUBLE BLIND|Adverse Event|0
1370039|NCT01515423|4522618|P3|Open Label Phase|Other|0
1370040|NCT01515423|4522619|P2|Open Label Phase|Other|0
1370041|NCT01515423|4522620|P1|Open Label Phase|Other|28
1370042|NCT01515423|4522618|P3|Open Label Phase|excluded from DB Phase|0
1370043|NCT01515423|4522619|P2|Open Label Phase|excluded from DB Phase|0
1370044|NCT01515423|4522620|P1|Open Label Phase|excluded from DB Phase|70
1370045|NCT01515423|4522618|P3|Open Label Phase|Withdrawal by Subject|0
1370046|NCT01515423|4522619|P2|Open Label Phase|Withdrawal by Subject|0
1370047|NCT01515423|4522620|P1|Open Label Phase|Withdrawal by Subject|118
1370048|NCT01515423|4522618|P3|Open Label Phase|Lost to Follow-up|0
1370049|NCT01515423|4522619|P2|Open Label Phase|Lost to Follow-up|0
1370050|NCT01515423|4522620|P1|Open Label Phase|Lost to Follow-up|21
1370051|NCT01515423|4522618|P3|Open Label Phase|Lack of Efficacy|0
1370052|NCT01515423|4522619|P2|Open Label Phase|Lack of Efficacy|0
1370053|NCT01515423|4522620|P1|Open Label Phase|Lack of Efficacy|117
1370054|NCT01515423|4522618|P3|Open Label Phase|Death|0
1370055|NCT01515423|4522619|P2|Open Label Phase|Death|0
1370056|NCT01515423|4522620|P1|Open Label Phase|Death|2
1370057|NCT01515423|4522618|P3|Open Label Phase|Adverse Event|0
1370058|NCT01515423|4522619|P2|Open Label Phase|Adverse Event|0
1370059|NCT01515423|4522620|P1|Open Label Phase|Adverse Event|57
1370060|NCT01515306|4522661|P2|Overall Study|Ongoing receiving treatment|14
1370061|NCT01515306|4522662|P1|Overall Study|Ongoing receiving treatment|9
1370062|NCT01515306|4522661|P2|Overall Study|Progressive Disease|0
1370063|NCT01515306|4522662|P1|Overall Study|Progressive Disease|1
1370064|NCT01515306|4522661|P2|Overall Study|Adverse Event|0
1370065|NCT01515306|4522662|P1|Overall Study|Adverse Event|2
1370066|NCT01515189|4522675|P2|First Re-Induction Phase|Other|0
1370067|NCT01515189|4522676|P1|First Re-Induction Phase|Other|1
1370068|NCT01515189|4522675|P2|First Re-Induction Phase|No longer meets study criteria|0
1370069|NCT01515189|4522676|P1|First Re-Induction Phase|No longer meets study criteria|1
1370070|NCT01515189|4522675|P2|First Re-Induction Phase|Withdrawal by Subject|1
1370071|NCT01515189|4522676|P1|First Re-Induction Phase|Withdrawal by Subject|1
1370072|NCT01515189|4522675|P2|First Re-Induction Phase|Study drug toxicity|0
1370073|NCT01515189|4522676|P1|First Re-Induction Phase|Study drug toxicity|5
1370074|NCT01515189|4522675|P2|First Re-Induction Phase|Disease progression|14
1370075|NCT01515189|4522676|P1|First Re-Induction Phase|Disease progression|6
1370076|NCT01515189|4522675|P2|Induction|Other|4
1370077|NCT01515189|4522676|P1|Induction|Other|0
1370078|NCT01515189|4522675|P2|Induction|Lost to Follow-up|0
1370079|NCT01515189|4522676|P1|Induction|Lost to Follow-up|1
1370080|NCT01515189|4522675|P2|Induction|No longer meets study criteria|2
1370081|NCT01515189|4522676|P1|Induction|No longer meets study criteria|0
1370082|NCT01515189|4522675|P2|Induction|Withdrawal by Subject|9
1370083|NCT01515189|4522676|P1|Induction|Withdrawal by Subject|3
1370084|NCT01515189|4522675|P2|Induction|Adverse Event|9
1370085|NCT01515189|4522676|P1|Induction|Adverse Event|14
1370086|NCT01515189|4522675|P2|Induction|Death|17
1370087|NCT01515189|4522676|P1|Induction|Death|24
1370088|NCT01515189|4522675|P2|Induction|Study drug toxicity|36
1370089|NCT01515189|4522676|P1|Induction|Study drug toxicity|86
1370090|NCT01515189|4522675|P2|Induction|Disease Progression|155
1370091|NCT01515189|4522676|P1|Induction|Disease Progression|109
1370092|NCT01514864|4522764|P2|Overall Study|Study drug toxicity|0
1370093|NCT01514864|4522765|P1|Overall Study|Study drug toxicity|2
1370094|NCT01514864|4522764|P2|Overall Study|Disease progression|5
1370095|NCT01514864|4522765|P1|Overall Study|Disease progression|7
1370096|NCT01514760|4522790|P1|Overall Study|Lost to Follow-up|2
1370097|NCT01514682|4522803|P2|Overall Study|Physician Decision|3
1370098|NCT01514682|4522804|P1|Overall Study|Physician Decision|4
1370099|NCT01514682|4522803|P2|Overall Study|Withdrawal by Subject|3
1370100|NCT01514682|4522804|P1|Overall Study|Withdrawal by Subject|2
1370101|NCT01514461|4522838|P3|Overall Study|Death|0
1370102|NCT01514461|4522839|P2|Overall Study|Death|0
1370103|NCT01514461|4522840|P1|Overall Study|Death|1
1370104|NCT01514461|4522838|P3|Overall Study|Patient/guardian decision|1
1370105|NCT01514461|4522839|P2|Overall Study|Patient/guardian decision|1
1370106|NCT01514461|4522840|P1|Overall Study|Patient/guardian decision|1
1370107|NCT01514461|4522838|P3|Overall Study|Physician Decision|0
1370108|NCT01514461|4522839|P2|Overall Study|Physician Decision|1
1370109|NCT01514461|4522840|P1|Overall Study|Physician Decision|1
1370110|NCT01514461|4522838|P3|Overall Study|Adverse Event|3
1370111|NCT01514461|4522839|P2|Overall Study|Adverse Event|1
1370112|NCT01514461|4522840|P1|Overall Study|Adverse Event|2
1370113|NCT01514448|4522879|P2|Overall Study|New Cancer Therapy|0
1370114|NCT01514448|4522880|P1|Overall Study|New Cancer Therapy|1
1370115|NCT01514448|4522879|P2|Overall Study|Lost to Follow-up|0
1370116|NCT01514448|4522880|P1|Overall Study|Lost to Follow-up|2
1370117|NCT01514448|4522879|P2|Overall Study|Withdrawal by Subject|0
1370118|NCT01514448|4522880|P1|Overall Study|Withdrawal by Subject|2
1370119|NCT01514448|4522879|P2|Overall Study|Death|8
1370120|NCT01514448|4522880|P1|Overall Study|Death|7
1370121|NCT01514422|4522895|P1|Overall Study|Lost to Follow-up|1
1370122|NCT01514357|4522903|P2|Overall Study|Withdrawal by Subject|0
1370123|NCT01514357|4522904|P1|Overall Study|Withdrawal by Subject|2
1370124|NCT01514357|4522903|P2|Overall Study|Screen failure|0
1370125|NCT01514357|4522904|P1|Overall Study|Screen failure|2
1370126|NCT01514240|4522922|P2|Overall Study|Subject Decision|7
1370127|NCT01514240|4522923|P1|Overall Study|Subject Decision|2
1370128|NCT01514240|4522922|P2|Overall Study|Adverse Event|4
1370129|NCT01514240|4522923|P1|Overall Study|Adverse Event|4
1370130|NCT01514136|4523036|P8|Test Period 2; Test C*|Protocol Violation|0
1370131|NCT01514136|4523037|P7|Test Period 2; Test C*|Protocol Violation|1
1370132|NCT01514136|4523038|P6|Test Period 2; Test C*|Protocol Violation|0
1370133|NCT01514136|4523039|P5|Test Period 2; Test C*|Protocol Violation|0
1370134|NCT01514136|4523040|P4|Test Period 2; Test C*|Protocol Violation|0
1370135|NCT01514136|4523041|P3|Test Period 2; Test C*|Protocol Violation|0
1370136|NCT01514136|4523042|P2|Test Period 2; Test C*|Protocol Violation|0
1370137|NCT01514136|4523043|P1|Test Period 2; Test C*|Protocol Violation|0
1370138|NCT01514136|4523036|P8|Test Period 2; Test C*|holiday|0
1370139|NCT01514136|4523037|P7|Test Period 2; Test C*|holiday|1
1370140|NCT01514136|4523038|P6|Test Period 2; Test C*|holiday|0
1370141|NCT01514136|4523039|P5|Test Period 2; Test C*|holiday|0
1370142|NCT01514136|4523040|P4|Test Period 2; Test C*|holiday|0
1370143|NCT01514136|4523041|P3|Test Period 2; Test C*|holiday|0
1370144|NCT01514136|4523042|P2|Test Period 2; Test C*|holiday|0
1370145|NCT01514136|4523043|P1|Test Period 2; Test C*|holiday|0
1370146|NCT01514136|4523036|P8|Test Period 2; Test C*|Withdrawal by Subject|0
1370147|NCT01514136|4523037|P7|Test Period 2; Test C*|Withdrawal by Subject|1
1370148|NCT01514136|4523038|P6|Test Period 2; Test C*|Withdrawal by Subject|0
1370149|NCT01514136|4523039|P5|Test Period 2; Test C*|Withdrawal by Subject|0
1370150|NCT01514136|4523040|P4|Test Period 2; Test C*|Withdrawal by Subject|0
1370151|NCT01514136|4523041|P3|Test Period 2; Test C*|Withdrawal by Subject|0
1370152|NCT01514136|4523042|P2|Test Period 2; Test C*|Withdrawal by Subject|0
1370153|NCT01514136|4523043|P1|Test Period 2; Test C*|Withdrawal by Subject|0
1370154|NCT01514136|4523036|P8|Test Period 2; Test B*|Withdrawal by Subject|0
1370155|NCT01514136|4523037|P7|Test Period 2; Test B*|Withdrawal by Subject|0
1370156|NCT01514136|4523038|P6|Test Period 2; Test B*|Withdrawal by Subject|2
1370157|NCT01514136|4523039|P5|Test Period 2; Test B*|Withdrawal by Subject|0
1370158|NCT01514136|4523040|P4|Test Period 2; Test B*|Withdrawal by Subject|0
1370159|NCT01514136|4523041|P3|Test Period 2; Test B*|Withdrawal by Subject|0
1370160|NCT01514136|4523042|P2|Test Period 2; Test B*|Withdrawal by Subject|0
1370161|NCT01514136|4523043|P1|Test Period 2; Test B*|Withdrawal by Subject|0
1370162|NCT01514136|4523036|P8|Test Period 2; Test A*|Holiday|0
1370163|NCT01514136|4523037|P7|Test Period 2; Test A*|Holiday|0
1370164|NCT01514136|4523038|P6|Test Period 2; Test A*|Holiday|0
1370165|NCT01514136|4523039|P5|Test Period 2; Test A*|Holiday|1
1370166|NCT01514136|4523040|P4|Test Period 2; Test A*|Holiday|0
1370167|NCT01514136|4523041|P3|Test Period 2; Test A*|Holiday|0
1370168|NCT01514136|4523042|P2|Test Period 2; Test A*|Holiday|0
1370169|NCT01514136|4523043|P1|Test Period 2; Test A*|Holiday|0
1370170|NCT01514136|4523036|P8|Test Period 2; Test A*|Adverse Event|0
1370171|NCT01514136|4523037|P7|Test Period 2; Test A*|Adverse Event|0
1370172|NCT01514136|4523038|P6|Test Period 2; Test A*|Adverse Event|0
1370173|NCT01514136|4523039|P5|Test Period 2; Test A*|Adverse Event|1
1370174|NCT01514136|4523040|P4|Test Period 2; Test A*|Adverse Event|0
1370175|NCT01514136|4523041|P3|Test Period 2; Test A*|Adverse Event|0
1370176|NCT01514136|4523042|P2|Test Period 2; Test A*|Adverse Event|0
1370177|NCT01514136|4523043|P1|Test Period 2; Test A*|Adverse Event|0
1370178|NCT01514136|4523036|P8|Test Period 1; Test D|Subject took a break due to holiday|0
1370179|NCT01514136|4523037|P7|Test Period 1; Test D|Subject took a break due to holiday|0
1370180|NCT01514136|4523038|P6|Test Period 1; Test D|Subject took a break due to holiday|0
1370181|NCT01514136|4523039|P5|Test Period 1; Test D|Subject took a break due to holiday|0
1370182|NCT01514136|4523040|P4|Test Period 1; Test D|Subject took a break due to holiday|2
1370183|NCT01514136|4523041|P3|Test Period 1; Test D|Subject took a break due to holiday|0
1370184|NCT01514136|4523042|P2|Test Period 1; Test D|Subject took a break due to holiday|0
1370185|NCT01514136|4523043|P1|Test Period 1; Test D|Subject took a break due to holiday|0
1370186|NCT01514136|4523036|P8|Test Period 1; Test B|Withdrawal by Subject|0
1370187|NCT01514136|4523037|P7|Test Period 1; Test B|Withdrawal by Subject|0
1370188|NCT01514136|4523038|P6|Test Period 1; Test B|Withdrawal by Subject|0
1370189|NCT01514136|4523039|P5|Test Period 1; Test B|Withdrawal by Subject|0
1370190|NCT01514136|4523040|P4|Test Period 1; Test B|Withdrawal by Subject|0
1370191|NCT01514136|4523041|P3|Test Period 1; Test B|Withdrawal by Subject|0
1370192|NCT01514136|4523042|P2|Test Period 1; Test B|Withdrawal by Subject|1
1370193|NCT01514136|4523043|P1|Test Period 1; Test B|Withdrawal by Subject|0
1370194|NCT01514136|4523036|P8|Test Period 1; Test A|Break from study holiday|0
1370195|NCT01514136|4523037|P7|Test Period 1; Test A|Break from study holiday|0
1370196|NCT01514136|4523038|P6|Test Period 1; Test A|Break from study holiday|0
1370197|NCT01514136|4523039|P5|Test Period 1; Test A|Break from study holiday|0
1370198|NCT01514136|4523040|P4|Test Period 1; Test A|Break from study holiday|0
1370199|NCT01514136|4523041|P3|Test Period 1; Test A|Break from study holiday|0
1370200|NCT01514136|4523042|P2|Test Period 1; Test A|Break from study holiday|0
1370201|NCT01514136|4523043|P1|Test Period 1; Test A|Break from study holiday|2
1370202|NCT01514136|4523036|P8|Test Period 1; Test A|Protocol Violation|0
1370203|NCT01514136|4523037|P7|Test Period 1; Test A|Protocol Violation|0
1370204|NCT01514136|4523038|P6|Test Period 1; Test A|Protocol Violation|0
1370205|NCT01514136|4523039|P5|Test Period 1; Test A|Protocol Violation|0
1370206|NCT01514136|4523040|P4|Test Period 1; Test A|Protocol Violation|0
1370207|NCT01514136|4523041|P3|Test Period 1; Test A|Protocol Violation|0
1370208|NCT01514136|4523042|P2|Test Period 1; Test A|Protocol Violation|0
1370209|NCT01514136|4523043|P1|Test Period 1; Test A|Protocol Violation|1
1370210|NCT01513590|4523111|P2|Overall Study|Unclassified|10
1370211|NCT01513590|4523112|P1|Overall Study|Unclassified|5
1370212|NCT01513590|4523111|P2|Overall Study|Withdrawal Criteria|0
1370213|NCT01513590|4523112|P1|Overall Study|Withdrawal Criteria|3
1370214|NCT01513590|4523111|P2|Overall Study|Adverse Event|3
1370215|NCT01513590|4523112|P1|Overall Study|Adverse Event|2
1370216|NCT01513473|4523136|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
1370217|NCT01513473|4523137|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
1370218|NCT01513473|4523136|P2|Extension Trial (26 Weeks)|Adverse Event|1
1370219|NCT01513473|4523137|P1|Extension Trial (26 Weeks)|Adverse Event|0
1370220|NCT01513473|4523136|P2|Main Trial (26 Weeks)|Unclassified|2
1370221|NCT01513473|4523137|P1|Main Trial (26 Weeks)|Unclassified|0
1370222|NCT01513473|4523136|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
1370223|NCT01513473|4523137|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
1370224|NCT01513473|4523136|P2|Main Trial (26 Weeks)|Adverse Event|2
1370225|NCT01513473|4523137|P1|Main Trial (26 Weeks)|Adverse Event|0
1370226|NCT01513460|4523164|P3|Overall Study|Abnormal test procedure|0
1370227|NCT01513460|4523165|P2|Overall Study|Abnormal test procedure|0
1370228|NCT01513460|4523166|P1|Overall Study|Abnormal test procedure|1
1370229|NCT01513460|4523164|P3|Overall Study|Adverse Event|23
1370230|NCT01513460|4523165|P2|Overall Study|Adverse Event|18
1370231|NCT01513460|4523166|P1|Overall Study|Adverse Event|16
1370232|NCT01513460|4523164|P3|Overall Study|Withdrawal by Subject|21
1370233|NCT01513460|4523165|P2|Overall Study|Withdrawal by Subject|8
1370234|NCT01513460|4523166|P1|Overall Study|Withdrawal by Subject|7
1370235|NCT01513460|4523164|P3|Overall Study|Protocol deviations|3
1370236|NCT01513460|4523165|P2|Overall Study|Protocol deviations|4
1370237|NCT01513460|4523166|P1|Overall Study|Protocol deviations|3
1370238|NCT01513460|4523164|P3|Overall Study|Lack of Efficacy|5
1370239|NCT01513460|4523165|P2|Overall Study|Lack of Efficacy|2
1370240|NCT01513460|4523166|P1|Overall Study|Lack of Efficacy|1
1370241|NCT01513460|4523164|P3|Overall Study|Abnormal laboratory value|1
1370242|NCT01513460|4523165|P2|Overall Study|Abnormal laboratory value|0
1370243|NCT01513460|4523166|P1|Overall Study|Abnormal laboratory value|1
1370244|NCT01513460|4523164|P3|Overall Study|Lost to Follow-up|2
1370245|NCT01513460|4523165|P2|Overall Study|Lost to Follow-up|0
1370246|NCT01513460|4523166|P1|Overall Study|Lost to Follow-up|0
1370247|NCT01513460|4523164|P3|Overall Study|Death|1
1370248|NCT01513460|4523165|P2|Overall Study|Death|0
1370249|NCT01513460|4523166|P1|Overall Study|Death|0
1370250|NCT01513330|4523201|P2|Standard Care First,|Other|0
1370251|NCT01513330|4523202|P1|Standard Care First,|Other|1
1370252|NCT01513330|4523201|P2|Standard Care First,|Withdrawal by Subject|2
1370253|NCT01513330|4523202|P1|Standard Care First,|Withdrawal by Subject|1
1370254|NCT01513330|4523201|P2|Standard Care First,|Lack of Efficacy|2
1370255|NCT01513330|4523202|P1|Standard Care First,|Lack of Efficacy|2
1370256|NCT01513330|4523201|P2|SenSura Mio First,|Other|0
1370257|NCT01513330|4523202|P1|SenSura Mio First,|Other|1
1370258|NCT01513330|4523201|P2|SenSura Mio First,|Withdrawal by Subject|1
1370259|NCT01513330|4523202|P1|SenSura Mio First,|Withdrawal by Subject|1
1370260|NCT01513330|4523201|P2|SenSura Mio First,|Lack of Efficacy|1
1370261|NCT01513330|4523202|P1|SenSura Mio First,|Lack of Efficacy|0
1370262|NCT01513330|4523201|P2|SenSura Mio First,|Adverse Event|0
1370263|NCT01513330|4523202|P1|SenSura Mio First,|Adverse Event|2
1370264|NCT01513317|4523210|P2|Overall Study|Not specified|1
1370265|NCT01513317|4523211|P1|Overall Study|Not specified|0
1370266|NCT01513317|4523210|P2|Overall Study|Study terminated by sponsor|18
1370267|NCT01513317|4523211|P1|Overall Study|Study terminated by sponsor|18
1370268|NCT01513317|4523210|P2|Overall Study|Death|1
1370269|NCT01513317|4523211|P1|Overall Study|Death|1
1370270|NCT01513317|4523210|P2|Overall Study|Withdrawal by Subject|4
1370271|NCT01513317|4523211|P1|Overall Study|Withdrawal by Subject|15
1370272|NCT01513291|4523229|P5|Run-out Period|Withdrawal by Subject|0
1370273|NCT01513291|4523230|P4|Run-out Period|Withdrawal by Subject|1
1370274|NCT01513291|4523231|P3|Run-out Period|Withdrawal by Subject|0
1370275|NCT01513291|4523232|P2|Run-out Period|Withdrawal by Subject|0
1370276|NCT01513291|4523233|P1|Run-out Period|Withdrawal by Subject|0
1370277|NCT01513291|4523229|P5|Run-out Period|Lost to Follow-up|0
1370278|NCT01513291|4523230|P4|Run-out Period|Lost to Follow-up|1
1370279|NCT01513291|4523231|P3|Run-out Period|Lost to Follow-up|0
1370280|NCT01513291|4523232|P2|Run-out Period|Lost to Follow-up|0
1370281|NCT01513291|4523233|P1|Run-out Period|Lost to Follow-up|0
1370282|NCT01513291|4523229|P5|Treatment Period|Randomized not treated|0
1370283|NCT01513291|4523230|P4|Treatment Period|Randomized not treated|0
1370284|NCT01513291|4523231|P3|Treatment Period|Randomized not treated|0
1370285|NCT01513291|4523232|P2|Treatment Period|Randomized not treated|2
1370286|NCT01513291|4523233|P1|Treatment Period|Randomized not treated|0
1370287|NCT01513291|4523229|P5|Treatment Period|Withdrawal by Subject|0
1370288|NCT01513291|4523230|P4|Treatment Period|Withdrawal by Subject|0
1370289|NCT01513291|4523231|P3|Treatment Period|Withdrawal by Subject|0
1370290|NCT01513291|4523232|P2|Treatment Period|Withdrawal by Subject|5
1370291|NCT01513291|4523233|P1|Treatment Period|Withdrawal by Subject|8
1370292|NCT01513291|4523229|P5|Treatment Period|Protocol Violation|0
1370293|NCT01513291|4523230|P4|Treatment Period|Protocol Violation|0
1370294|NCT01513291|4523231|P3|Treatment Period|Protocol Violation|0
1370295|NCT01513291|4523232|P2|Treatment Period|Protocol Violation|2
1370296|NCT01513291|4523233|P1|Treatment Period|Protocol Violation|1
1370297|NCT01513291|4523229|P5|Treatment Period|Physician Decision|0
1370298|NCT01513291|4523230|P4|Treatment Period|Physician Decision|0
1370299|NCT01513291|4523231|P3|Treatment Period|Physician Decision|0
1370300|NCT01513291|4523232|P2|Treatment Period|Physician Decision|0
1370301|NCT01513291|4523233|P1|Treatment Period|Physician Decision|1
1370302|NCT01513291|4523229|P5|Treatment Period|Lost to Follow-up|0
1370303|NCT01513291|4523230|P4|Treatment Period|Lost to Follow-up|0
1370304|NCT01513291|4523231|P3|Treatment Period|Lost to Follow-up|0
1370305|NCT01513291|4523232|P2|Treatment Period|Lost to Follow-up|3
1370306|NCT01513291|4523233|P1|Treatment Period|Lost to Follow-up|2
1370307|NCT01513291|4523229|P5|Treatment Period|Lack of Efficacy|0
1370308|NCT01513291|4523230|P4|Treatment Period|Lack of Efficacy|0
1370309|NCT01513291|4523231|P3|Treatment Period|Lack of Efficacy|0
1370310|NCT01513291|4523232|P2|Treatment Period|Lack of Efficacy|0
1370311|NCT01513291|4523233|P1|Treatment Period|Lack of Efficacy|3
1370312|NCT01513291|4523229|P5|Treatment Period|Adverse Event|0
1370313|NCT01513291|4523230|P4|Treatment Period|Adverse Event|0
1370314|NCT01513291|4523231|P3|Treatment Period|Adverse Event|0
1370315|NCT01513291|4523232|P2|Treatment Period|Adverse Event|4
1370316|NCT01513291|4523233|P1|Treatment Period|Adverse Event|8
1370317|NCT01513239|4523261|P6|Period 2: 9 Month Extension Phase|Technical Problems|1
1370318|NCT01513239|4523262|P5|Period 2: 9 Month Extension Phase|Technical Problems|1
1370319|NCT01513239|4523263|P4|Period 2: 9 Month Extension Phase|Technical Problems|0
1370320|NCT01513239|4523264|P3|Period 2: 9 Month Extension Phase|Technical Problems|0
1370321|NCT01513239|4523265|P2|Period 2: 9 Month Extension Phase|Technical Problems|0
1370322|NCT01513239|4523266|P1|Period 2: 9 Month Extension Phase|Technical Problems|0
1370323|NCT01513239|4523261|P6|Period 2: 9 Month Extension Phase|Physician Decision|0
1370324|NCT01513239|4523262|P5|Period 2: 9 Month Extension Phase|Physician Decision|0
1370325|NCT01513239|4523263|P4|Period 2: 9 Month Extension Phase|Physician Decision|1
1370326|NCT01513239|4523264|P3|Period 2: 9 Month Extension Phase|Physician Decision|0
1370327|NCT01513239|4523265|P2|Period 2: 9 Month Extension Phase|Physician Decision|0
1370328|NCT01513239|4523266|P1|Period 2: 9 Month Extension Phase|Physician Decision|0
1370329|NCT01513239|4523261|P6|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
1370330|NCT01513239|4523262|P5|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
1370331|NCT01513239|4523263|P4|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
1370332|NCT01513239|4523264|P3|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
1370333|NCT01513239|4523265|P2|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
1370334|NCT01513239|4523266|P1|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
1370335|NCT01513239|4523261|P6|Period 2: 9 Month Extension Phase|Death|2
1370336|NCT01513239|4523262|P5|Period 2: 9 Month Extension Phase|Death|5
1370337|NCT01513239|4523263|P4|Period 2: 9 Month Extension Phase|Death|2
1370338|NCT01513239|4523264|P3|Period 2: 9 Month Extension Phase|Death|0
1370339|NCT01513239|4523265|P2|Period 2: 9 Month Extension Phase|Death|0
1370340|NCT01513239|4523266|P1|Period 2: 9 Month Extension Phase|Death|0
1370341|NCT01513239|4523261|P6|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
1370342|NCT01513239|4523262|P5|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
1370343|NCT01513239|4523263|P4|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
1370344|NCT01513239|4523264|P3|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
1370345|NCT01513239|4523265|P2|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
1370346|NCT01513239|4523266|P1|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
1370347|NCT01513239|4523261|P6|Period 1: Main Phase|Withdrawal by Subject|0
1370348|NCT01513239|4523262|P5|Period 1: Main Phase|Withdrawal by Subject|0
1370349|NCT01513239|4523263|P4|Period 1: Main Phase|Withdrawal by Subject|0
1370350|NCT01513239|4523264|P3|Period 1: Main Phase|Withdrawal by Subject|42
1370351|NCT01513239|4523265|P2|Period 1: Main Phase|Withdrawal by Subject|29
1370352|NCT01513239|4523266|P1|Period 1: Main Phase|Withdrawal by Subject|27
1370353|NCT01513239|4523261|P6|Period 1: Main Phase|Technical Problems|0
1370354|NCT01513239|4523262|P5|Period 1: Main Phase|Technical Problems|0
1370355|NCT01513239|4523263|P4|Period 1: Main Phase|Technical Problems|0
1370356|NCT01513239|4523264|P3|Period 1: Main Phase|Technical Problems|0
1370357|NCT01513239|4523265|P2|Period 1: Main Phase|Technical Problems|2
1370358|NCT01513239|4523266|P1|Period 1: Main Phase|Technical Problems|1
1370359|NCT01513239|4523261|P6|Period 1: Main Phase|Protocol Violation|0
1370360|NCT01513239|4523262|P5|Period 1: Main Phase|Protocol Violation|0
1370361|NCT01513239|4523263|P4|Period 1: Main Phase|Protocol Violation|0
1370362|NCT01513239|4523264|P3|Period 1: Main Phase|Protocol Violation|2
1370363|NCT01513239|4523265|P2|Period 1: Main Phase|Protocol Violation|2
1370364|NCT01513239|4523266|P1|Period 1: Main Phase|Protocol Violation|2
1370365|NCT01513239|4523261|P6|Period 1: Main Phase|Physician Decision|0
1370366|NCT01513239|4523262|P5|Period 1: Main Phase|Physician Decision|0
1370367|NCT01513239|4523263|P4|Period 1: Main Phase|Physician Decision|0
1370368|NCT01513239|4523264|P3|Period 1: Main Phase|Physician Decision|4
1370369|NCT01513239|4523265|P2|Period 1: Main Phase|Physician Decision|4
1370370|NCT01513239|4523266|P1|Period 1: Main Phase|Physician Decision|4
1370371|NCT01513239|4523261|P6|Period 1: Main Phase|Lost to Follow-up|0
1370372|NCT01513239|4523262|P5|Period 1: Main Phase|Lost to Follow-up|0
1370373|NCT01513239|4523263|P4|Period 1: Main Phase|Lost to Follow-up|0
1370374|NCT01513239|4523264|P3|Period 1: Main Phase|Lost to Follow-up|6
1370375|NCT01513239|4523265|P2|Period 1: Main Phase|Lost to Follow-up|10
1370376|NCT01513239|4523266|P1|Period 1: Main Phase|Lost to Follow-up|11
1370377|NCT01513239|4523261|P6|Period 1: Main Phase|Death|0
1370378|NCT01513239|4523262|P5|Period 1: Main Phase|Death|0
1370379|NCT01513239|4523263|P4|Period 1: Main Phase|Death|0
1370380|NCT01513239|4523264|P3|Period 1: Main Phase|Death|32
1370381|NCT01513239|4523265|P2|Period 1: Main Phase|Death|22
1370382|NCT01513239|4523266|P1|Period 1: Main Phase|Death|29
1370383|NCT01513239|4523261|P6|Period 1: Main Phase|Adverse Event|0
1370384|NCT01513239|4523262|P5|Period 1: Main Phase|Adverse Event|0
1370385|NCT01513239|4523263|P4|Period 1: Main Phase|Adverse Event|0
1370386|NCT01513239|4523264|P3|Period 1: Main Phase|Adverse Event|2
1370387|NCT01513239|4523265|P2|Period 1: Main Phase|Adverse Event|1
1370388|NCT01513239|4523266|P1|Period 1: Main Phase|Adverse Event|1
1370389|NCT01513148|4523319|P2|Overall Study|Protocol Violation|2
1370390|NCT01513148|4523320|P1|Overall Study|Protocol Violation|2
1370391|NCT01512979|4523387|P2|Overall Study|Reason other than stated above|9
1370392|NCT01512979|4523388|P1|Overall Study|Reason other than stated above|13
1370393|NCT01512979|4523387|P2|Overall Study|Withdrawal by Subject|2
1370394|NCT01512979|4523388|P1|Overall Study|Withdrawal by Subject|1
1370395|NCT01512979|4523387|P2|Overall Study|Lost to Follow-up|5
1370396|NCT01512979|4523388|P1|Overall Study|Lost to Follow-up|2
1370397|NCT01512979|4523387|P2|Overall Study|Protocol Violation|4
1370398|NCT01512979|4523388|P1|Overall Study|Protocol Violation|1
1370399|NCT01512979|4523387|P2|Overall Study|Adverse Event|2
1370400|NCT01512979|4523388|P1|Overall Study|Adverse Event|2
1370401|NCT01512745|4523452|P2|Overall Study|Protocol Violation|0
1370402|NCT01512745|4523453|P1|Overall Study|Protocol Violation|1
1370403|NCT01512745|4523452|P2|Overall Study|Lack of Efficacy|2
1370404|NCT01512745|4523453|P1|Overall Study|Lack of Efficacy|2
1370405|NCT01512745|4523452|P2|Overall Study|Lost to Follow-up|0
1370406|NCT01512745|4523453|P1|Overall Study|Lost to Follow-up|4
1370407|NCT01512745|4523452|P2|Overall Study|Withdrawal by Subject|2
1370408|NCT01512745|4523453|P1|Overall Study|Withdrawal by Subject|2
1370409|NCT01512745|4523452|P2|Overall Study|Death|13
1370410|NCT01512745|4523453|P1|Overall Study|Death|9
1370411|NCT01512745|4523452|P2|Overall Study|Adverse Event|3
1370412|NCT01512745|4523453|P1|Overall Study|Adverse Event|22
1370413|NCT01512693|4523469|P2|Overall Study|Withdrawal by Subject|1
1370414|NCT01512693|4523470|P1|Overall Study|Withdrawal by Subject|0
1370415|NCT01512368|4523497|P1|Overall Study|Protocol Violation|3
1370416|NCT01512160|4523555|P4|Overall Study|Withdrawal by Subject|1
1370417|NCT01512160|4523556|P3|Overall Study|Withdrawal by Subject|0
1370418|NCT01512160|4523557|P2|Overall Study|Withdrawal by Subject|0
1370419|NCT01512160|4523558|P1|Overall Study|Withdrawal by Subject|1
1370420|NCT01512160|4523555|P4|Overall Study|Lost to Follow-up|0
1370421|NCT01512160|4523556|P3|Overall Study|Lost to Follow-up|0
1370422|NCT01512160|4523557|P2|Overall Study|Lost to Follow-up|0
1370423|NCT01512160|4523558|P1|Overall Study|Lost to Follow-up|1
1370424|NCT01512108|4523650|P2|Overall Study|Unclassified|3
1370425|NCT01512108|4523651|P1|Overall Study|Unclassified|11
1370426|NCT01512108|4523650|P2|Overall Study|Withdrawal Criteria|0
1370427|NCT01512108|4523651|P1|Overall Study|Withdrawal Criteria|1
1370428|NCT01512108|4523650|P2|Overall Study|Protocol Violation|2
1370429|NCT01512108|4523651|P1|Overall Study|Protocol Violation|1
1370430|NCT01512108|4523650|P2|Overall Study|Adverse Event|4
1370431|NCT01512108|4523651|P1|Overall Study|Adverse Event|9
1370432|NCT01511939|4523677|P3|Overall Study|Withdrawal by Subject|0
1370433|NCT01511939|4523678|P2|Overall Study|Withdrawal by Subject|1
1370434|NCT01511939|4523679|P1|Overall Study|Withdrawal by Subject|2
1370435|NCT01511536|4523708|P3|Phase 2|Other|9
1370436|NCT01511536|4523709|P2|Phase 2|Other|0
1370437|NCT01511536|4523710|P1|Phase 2|Other|0
1370438|NCT01511536|4523708|P3|Phase 1|Other|0
1370439|NCT01511536|4523709|P2|Phase 1|Other|1
1370440|NCT01511536|4523710|P1|Phase 1|Other|0
1370441|NCT01511445|4523732|P2|Overall Study|Protocol Violation|0
1370442|NCT01511445|4523733|P1|Overall Study|Protocol Violation|1
1370443|NCT01511445|4523732|P2|Overall Study|Protocol Violation|3
1370444|NCT01511445|4523733|P1|Overall Study|Protocol Violation|1
1370445|NCT01511445|4523732|P2|Overall Study|Lost to Follow-up|1
1370446|NCT01511445|4523733|P1|Overall Study|Lost to Follow-up|3
1370447|NCT01511250|4523761|P10|Overall Study|Protocol Violation|0
1370448|NCT01511250|4523762|P9|Overall Study|Protocol Violation|0
1370449|NCT01511250|4523763|P8|Overall Study|Protocol Violation|0
1370450|NCT01511250|4523764|P7|Overall Study|Protocol Violation|0
1370451|NCT01511250|4523765|P6|Overall Study|Protocol Violation|0
1370452|NCT01511250|4523766|P5|Overall Study|Protocol Violation|0
1370453|NCT01511250|4523767|P4|Overall Study|Protocol Violation|0
1370454|NCT01511250|4523768|P3|Overall Study|Protocol Violation|1
1370455|NCT01511250|4523769|P2|Overall Study|Protocol Violation|2
1370456|NCT01511250|4523770|P1|Overall Study|Protocol Violation|0
1370457|NCT01511250|4523761|P10|Overall Study|Lost to Follow-up|5
1370458|NCT01511250|4523762|P9|Overall Study|Lost to Follow-up|13
1370459|NCT01511250|4523763|P8|Overall Study|Lost to Follow-up|3
1370460|NCT01511250|4523764|P7|Overall Study|Lost to Follow-up|2
1370461|NCT01511250|4523765|P6|Overall Study|Lost to Follow-up|0
1370462|NCT01511250|4523766|P5|Overall Study|Lost to Follow-up|0
1370463|NCT01511250|4523767|P4|Overall Study|Lost to Follow-up|3
1370464|NCT01511250|4523768|P3|Overall Study|Lost to Follow-up|3
1370465|NCT01511250|4523769|P2|Overall Study|Lost to Follow-up|3
1370466|NCT01511250|4523770|P1|Overall Study|Lost to Follow-up|7
1370467|NCT01511250|4523761|P10|Overall Study|Sponsor/Investigator Decision|0
1370468|NCT01511250|4523762|P9|Overall Study|Sponsor/Investigator Decision|0
1370469|NCT01511250|4523763|P8|Overall Study|Sponsor/Investigator Decision|0
1370470|NCT01511250|4523764|P7|Overall Study|Sponsor/Investigator Decision|0
1370471|NCT01511250|4523765|P6|Overall Study|Sponsor/Investigator Decision|0
1370472|NCT01511250|4523766|P5|Overall Study|Sponsor/Investigator Decision|0
1370473|NCT01511250|4523767|P4|Overall Study|Sponsor/Investigator Decision|0
1370474|NCT01511250|4523768|P3|Overall Study|Sponsor/Investigator Decision|0
1370475|NCT01511250|4523769|P2|Overall Study|Sponsor/Investigator Decision|0
1370476|NCT01511250|4523770|P1|Overall Study|Sponsor/Investigator Decision|1
1370477|NCT01511250|4523761|P10|Overall Study|Withdrawal of Consent|0
1370478|NCT01511250|4523762|P9|Overall Study|Withdrawal of Consent|1
1370479|NCT01511250|4523763|P8|Overall Study|Withdrawal of Consent|1
1370480|NCT01511250|4523764|P7|Overall Study|Withdrawal of Consent|0
1370481|NCT01511250|4523765|P6|Overall Study|Withdrawal of Consent|0
1370482|NCT01511250|4523766|P5|Overall Study|Withdrawal of Consent|0
1370483|NCT01511250|4523767|P4|Overall Study|Withdrawal of Consent|0
1370484|NCT01511250|4523768|P3|Overall Study|Withdrawal of Consent|0
1370485|NCT01511250|4523769|P2|Overall Study|Withdrawal of Consent|0
1370486|NCT01511250|4523770|P1|Overall Study|Withdrawal of Consent|1
1370487|NCT01511107|4523918|P2|Overall Study|Withdrawal by Subject|20
1370488|NCT01511107|4523919|P1|Overall Study|Withdrawal by Subject|9
1370489|NCT01511107|4523918|P2|Overall Study|Lost to Follow-up|19
1370490|NCT01511107|4523919|P1|Overall Study|Lost to Follow-up|10
1370491|NCT01511107|4523918|P2|Overall Study|Ineligible|2
1370492|NCT01511107|4523919|P1|Overall Study|Ineligible|3
1370493|NCT01510912|4523997|P1|Overall Study|Other, including joint replacement|5
1370494|NCT01510912|4523997|P1|Overall Study|Lost to Follow-up|26
1370495|NCT01510912|4523997|P1|Overall Study|Protocol Violation|27
1370496|NCT01510912|4523997|P1|Overall Study|Physician Decision|1
1370497|NCT01510912|4523997|P1|Overall Study|Withdrawal by Subject|49
1370498|NCT01510912|4523997|P1|Overall Study|Non-compliance with trial drug|23
1370499|NCT01510912|4523997|P1|Overall Study|Lack of Efficacy|12
1370500|NCT01510912|4523997|P1|Overall Study|Adverse Event|99
1370501|NCT01510769|4524013|P3|Overall Study|Death|0
1370502|NCT01510769|4524014|P2|Overall Study|Death|1
1370503|NCT01510769|4524015|P1|Overall Study|Death|1
1370504|NCT01510769|4524013|P3|Overall Study|Withdrawal by Subject|3
1370505|NCT01510769|4524014|P2|Overall Study|Withdrawal by Subject|4
1370506|NCT01510769|4524015|P1|Overall Study|Withdrawal by Subject|3
1370507|NCT01510769|4524013|P3|Overall Study|Lost to Follow-up|5
1370508|NCT01510769|4524014|P2|Overall Study|Lost to Follow-up|1
1370509|NCT01510769|4524015|P1|Overall Study|Lost to Follow-up|5
1370510|NCT01510769|4524013|P3|Overall Study|Protocol Violation|9
1370511|NCT01510769|4524014|P2|Overall Study|Protocol Violation|10
1370512|NCT01510769|4524015|P1|Overall Study|Protocol Violation|11
1370513|NCT01510769|4524013|P3|Overall Study|Gout Flare|1
1370514|NCT01510769|4524014|P2|Overall Study|Gout Flare|3
1370515|NCT01510769|4524015|P1|Overall Study|Gout Flare|0
1370516|NCT01510769|4524013|P3|Overall Study|Adverse Event|4
1370517|NCT01510769|4524014|P2|Overall Study|Adverse Event|6
1370518|NCT01510769|4524015|P1|Overall Study|Adverse Event|7
1370519|NCT01510756|4524032|P1|Overall Study|Physician Decision|1
1370520|NCT01510756|4524032|P1|Overall Study|Lack of Efficacy|2
1370521|NCT01510756|4524032|P1|Overall Study|Death|1
1370522|NCT01510717|4524040|P2|Overall Study|Withdrawal by Subject|2
1370523|NCT01510717|4524041|P1|Overall Study|Withdrawal by Subject|0
1370524|NCT01510717|4524040|P2|Overall Study|Lost to Follow-up|1
1370525|NCT01510717|4524041|P1|Overall Study|Lost to Follow-up|0
1370526|NCT01510717|4524040|P2|Overall Study|Death|0
1370527|NCT01510717|4524041|P1|Overall Study|Death|1
1370528|NCT01510717|4524040|P2|Overall Study|Adverse Event|2
1370529|NCT01510717|4524041|P1|Overall Study|Adverse Event|1
1370530|NCT01510158|4524161|P3|Overall Study|Death|0
1370531|NCT01510158|4524162|P2|Overall Study|Death|0
1370532|NCT01510158|4524163|P1|Overall Study|Death|1
1370533|NCT01510158|4524161|P3|Overall Study|Withdrawal by Subject|10
1370534|NCT01510158|4524162|P2|Overall Study|Withdrawal by Subject|13
1370535|NCT01510158|4524163|P1|Overall Study|Withdrawal by Subject|10
1370536|NCT01510158|4524161|P3|Overall Study|Lost to Follow-up|9
1370537|NCT01510158|4524162|P2|Overall Study|Lost to Follow-up|16
1370538|NCT01510158|4524163|P1|Overall Study|Lost to Follow-up|13
1370539|NCT01510158|4524161|P3|Overall Study|Sponsor terminated study.|2
1370540|NCT01510158|4524162|P2|Overall Study|Sponsor terminated study.|0
1370541|NCT01510158|4524163|P1|Overall Study|Sponsor terminated study.|2
1370542|NCT01510158|4524161|P3|Overall Study|Protocol Violation|24
1370543|NCT01510158|4524162|P2|Overall Study|Protocol Violation|16
1370544|NCT01510158|4524163|P1|Overall Study|Protocol Violation|17
1370545|NCT01510158|4524161|P3|Overall Study|Gout flare|0
1370546|NCT01510158|4524162|P2|Overall Study|Gout flare|0
1370547|NCT01510158|4524163|P1|Overall Study|Gout flare|1
1370548|NCT01510158|4524161|P3|Overall Study|Adverse Event|5
1370549|NCT01510158|4524162|P2|Overall Study|Adverse Event|8
1370550|NCT01510158|4524163|P1|Overall Study|Adverse Event|7
1370551|NCT01510145|4524177|P1|Overall Study|Relative reported subject withdrew|1
1370552|NCT01510145|4524177|P1|Overall Study|Withdrawal by Subject|6
1370553|NCT01510145|4524177|P1|Overall Study|Lost to Follow-up|5
1370554|NCT01510145|4524177|P1|Overall Study|Adverse Event|6
1370555|NCT01509664|4524211|P2|Overall Study|Lost to Follow-up|21
1370556|NCT01509664|4524212|P1|Overall Study|Lost to Follow-up|15
1370557|NCT01509079|4524298|P2|Overall Study|started an excluded medication|1
1370558|NCT01509079|4524299|P1|Overall Study|started an excluded medication|0
1370559|NCT01509079|4524298|P2|Overall Study|Lack of Efficacy|2
1370560|NCT01509079|4524299|P1|Overall Study|Lack of Efficacy|0
1370561|NCT01509053|4524315|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
1370562|NCT01509053|4524315|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
1370563|NCT01509053|4524315|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
1370564|NCT01509053|4524315|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
1370565|NCT01509053|4524315|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
1370566|NCT01509053|4524315|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
1370567|NCT01508936|4524377|P2|Overall Study|Data from 2 sites deemed invalid|11
1370568|NCT01508936|4524378|P1|Overall Study|Data from 2 sites deemed invalid|4
1370569|NCT01508936|4524377|P2|Overall Study|Not specified|5
1370570|NCT01508936|4524378|P1|Overall Study|Not specified|0
1370571|NCT01508936|4524377|P2|Overall Study|Lost to Follow-up|9
1370572|NCT01508936|4524378|P1|Overall Study|Lost to Follow-up|2
1370573|NCT01508936|4524377|P2|Overall Study|Protocol Violation|3
1370574|NCT01508936|4524378|P1|Overall Study|Protocol Violation|2
1370575|NCT01508936|4524377|P2|Overall Study|Withdrawal by Subject|18
1370576|NCT01508936|4524378|P1|Overall Study|Withdrawal by Subject|4
1370577|NCT01508936|4524377|P2|Overall Study|Lack of Efficacy|1
1370578|NCT01508936|4524378|P1|Overall Study|Lack of Efficacy|0
1370579|NCT01508936|4524377|P2|Overall Study|Adverse Event|32
1370580|NCT01508936|4524378|P1|Overall Study|Adverse Event|11
1370581|NCT01508910|4524417|P4|Treatment|Sponsor Decision|1
1370582|NCT01508910|4524418|P3|Treatment|Sponsor Decision|0
1370583|NCT01508910|4524419|P2|Treatment|Sponsor Decision|0
1370584|NCT01508910|4524420|P1|Treatment|Sponsor Decision|0
1370585|NCT01508910|4524417|P4|Treatment|Withdrawal by Subject|1
1370586|NCT01508910|4524418|P3|Treatment|Withdrawal by Subject|6
1370587|NCT01508910|4524419|P2|Treatment|Withdrawal by Subject|1
1370588|NCT01508910|4524420|P1|Treatment|Withdrawal by Subject|0
1370589|NCT01508910|4524417|P4|Treatment|Lost to Follow-up|1
1370590|NCT01508910|4524418|P3|Treatment|Lost to Follow-up|2
1370591|NCT01508910|4524419|P2|Treatment|Lost to Follow-up|0
1370592|NCT01508910|4524420|P1|Treatment|Lost to Follow-up|0
1370593|NCT01508910|4524417|P4|Treatment|Death|0
1370594|NCT01508910|4524418|P3|Treatment|Death|2
1370595|NCT01508910|4524419|P2|Treatment|Death|3
1370596|NCT01508910|4524420|P1|Treatment|Death|2
1370597|NCT01508702|4524453|P2|Overall Study|Withdrawal by Subject|7
1370598|NCT01508702|4524454|P1|Overall Study|Withdrawal by Subject|11
1370599|NCT01508702|4524453|P2|Overall Study|Lost to Follow-up|2
1370600|NCT01508702|4524454|P1|Overall Study|Lost to Follow-up|1
1370601|NCT01508702|4524453|P2|Overall Study|Protocol Violation|1
1370602|NCT01508702|4524454|P1|Overall Study|Protocol Violation|2
1370603|NCT01508702|4524453|P2|Overall Study|Gout flare|0
1370604|NCT01508702|4524454|P1|Overall Study|Gout flare|2
1370605|NCT01508702|4524453|P2|Overall Study|Adverse Event|3
1370606|NCT01508702|4524454|P1|Overall Study|Adverse Event|7
1370607|NCT01508676|4524462|P2|Phase II (2 Weeks)|Medication Exclusion|0
1370608|NCT01508676|4524463|P1|Phase II (2 Weeks)|Medication Exclusion|1
1370609|NCT01508676|4524462|P2|Phase II (2 Weeks)|Skin Sensitivity|1
1370610|NCT01508676|4524463|P1|Phase II (2 Weeks)|Skin Sensitivity|0
1370611|NCT01508676|4524462|P2|Phase I (2 Weeks)|Positive Drug Screen|2
1370612|NCT01508676|4524463|P1|Phase I (2 Weeks)|Positive Drug Screen|0
1370613|NCT01508676|4524462|P2|Phase I (2 Weeks)|Wrong Pain Type|0
1370614|NCT01508676|4524463|P1|Phase I (2 Weeks)|Wrong Pain Type|1
1370615|NCT01508676|4524462|P2|Phase I (2 Weeks)|Medication Exclusion|1
1370616|NCT01508676|4524463|P1|Phase I (2 Weeks)|Medication Exclusion|1
1370617|NCT01508325|4524484|P2|Overall Study|Other|2
1370618|NCT01508325|4524485|P1|Overall Study|Other|2
1370619|NCT01508325|4524484|P2|Overall Study|Lost to Follow-up|6
1370620|NCT01508325|4524485|P1|Overall Study|Lost to Follow-up|5
1370621|NCT01508325|4524484|P2|Overall Study|Adverse Event|0
1370622|NCT01508325|4524485|P1|Overall Study|Adverse Event|1
1370623|NCT01508325|4524484|P2|Overall Study|Physician Decision|1
1370624|NCT01508325|4524485|P1|Overall Study|Physician Decision|2
1370625|NCT01508325|4524484|P2|Overall Study|Protocol Violation|3
1370626|NCT01508325|4524485|P1|Overall Study|Protocol Violation|0
1370627|NCT01508325|4524484|P2|Overall Study|Withdrawal by Subject|9
1370628|NCT01508325|4524485|P1|Overall Study|Withdrawal by Subject|8
1370629|NCT01508169|4524515|P2|Overall Study|Lost to Follow-up|2
1370630|NCT01508169|4524516|P1|Overall Study|Lost to Follow-up|1
1370631|NCT01508169|4524515|P2|Overall Study|Withdrawal by Subject|0
1370632|NCT01508169|4524516|P1|Overall Study|Withdrawal by Subject|1
1370633|NCT01508169|4524515|P2|Overall Study|Adverse Event|0
1370634|NCT01508169|4524516|P1|Overall Study|Adverse Event|1
1370635|NCT01508130|4524530|P2|Overall Study|Administrative|3
1370636|NCT01508130|4524531|P1|Overall Study|Administrative|14
1370637|NCT01508130|4524530|P2|Overall Study|Insufficient therapeutic response|23
1370638|NCT01508130|4524531|P1|Overall Study|Insufficient therapeutic response|74
1370639|NCT01508130|4524530|P2|Overall Study|Subject’s substantial non-compliance|9
1370640|NCT01508130|4524531|P1|Overall Study|Subject’s substantial non-compliance|25
1370641|NCT01508130|4524530|P2|Overall Study|Withdrawal by Subject|3
1370642|NCT01508130|4524531|P1|Overall Study|Withdrawal by Subject|3
1370643|NCT01508130|4524530|P2|Overall Study|Lost to Follow-up|2
1370644|NCT01508130|4524531|P1|Overall Study|Lost to Follow-up|25
1370645|NCT01508130|4524530|P2|Overall Study|Protocol Violation|0
1370646|NCT01508130|4524531|P1|Overall Study|Protocol Violation|2
1370647|NCT01508130|4524530|P2|Overall Study|Death|1
1370648|NCT01508130|4524531|P1|Overall Study|Death|3
1370649|NCT01508130|4524530|P2|Overall Study|Adverse Event|28
1370650|NCT01508130|4524531|P1|Overall Study|Adverse Event|81
1370651|NCT01507896|4524599|P1|Overall Study|The surgery was denied by the sponsor.|1
1370652|NCT01507896|4524599|P1|Overall Study|Withdrawal by Subject|1
1370653|NCT01507831|4524642|P2|Overall Study|Other|6
1370654|NCT01507831|4524643|P1|Overall Study|Other|3
1370655|NCT01507831|4524642|P2|Overall Study|Potential lost to follow-up|0
1370656|NCT01507831|4524643|P1|Overall Study|Potential lost to follow-up|3
1370657|NCT01507831|4524642|P2|Overall Study|Site closure|3
1370658|NCT01507831|4524643|P1|Overall Study|Site closure|0
1370659|NCT01507831|4524642|P2|Overall Study|Selection criteria finally not met|1
1370660|NCT01507831|4524643|P1|Overall Study|Selection criteria finally not met|0
1370661|NCT01507831|4524642|P2|Overall Study|Last visit outside protocol visit window|143
1370662|NCT01507831|4524643|P1|Overall Study|Last visit outside protocol visit window|51
1370663|NCT01507831|4524642|P2|Overall Study|Related to study drug administration|14
1370664|NCT01507831|4524643|P1|Overall Study|Related to study drug administration|5
1370665|NCT01507831|4524642|P2|Overall Study|Consent withdrawn by participant|72
1370666|NCT01507831|4524643|P1|Overall Study|Consent withdrawn by participant|34
1370667|NCT01507831|4524642|P2|Overall Study|Participant moved|19
1370668|NCT01507831|4524643|P1|Overall Study|Participant moved|5
1370669|NCT01507831|4524642|P2|Overall Study|Physician Decision|4
1370670|NCT01507831|4524643|P1|Overall Study|Physician Decision|0
1370671|NCT01507831|4524642|P2|Overall Study|Poor compliance to protocol|60
1370672|NCT01507831|4524643|P1|Overall Study|Poor compliance to protocol|38
1370673|NCT01507831|4524642|P2|Overall Study|Death|2
1370674|NCT01507831|4524643|P1|Overall Study|Death|6
1370675|NCT01507831|4524642|P2|Overall Study|Adverse Event|113
1370676|NCT01507831|4524643|P1|Overall Study|Adverse Event|48
1370677|NCT01507831|4524642|P2|Overall Study|Randomized but not treated|3
1370678|NCT01507831|4524643|P1|Overall Study|Randomized but not treated|0
1370679|NCT01507662|4524713|P2|Overall Study|Proxy interview done|3
1370680|NCT01507662|4524714|P1|Overall Study|Proxy interview done|2
1370681|NCT01507662|4524713|P2|Overall Study|Lost to Follow-up|523
1370682|NCT01507662|4524714|P1|Overall Study|Lost to Follow-up|498
1370683|NCT01507662|4524713|P2|Overall Study|Withdrawal by Subject|287
1370684|NCT01507662|4524714|P1|Overall Study|Withdrawal by Subject|290
1370685|NCT01507662|4524713|P2|Overall Study|Death|18
1370686|NCT01507662|4524714|P1|Overall Study|Death|26
1370687|NCT01507246|4524739|P2|Overall Study|Required different surgical procedures|1
1370688|NCT01507246|4524740|P1|Overall Study|Required different surgical procedures|2
1370689|NCT01507090|4524838|P1|Overall Study|incomplete dataset|18
1370690|NCT01507051|4524877|P4|Overall Study|Adverse Event|0
1370691|NCT01507051|4524878|P3|Overall Study|Adverse Event|0
1370692|NCT01507051|4524879|P2|Overall Study|Adverse Event|0
1370693|NCT01507051|4524880|P1|Overall Study|Adverse Event|1
1370694|NCT01507051|4524877|P4|Overall Study|Physician Decision|1
1370695|NCT01507051|4524878|P3|Overall Study|Physician Decision|0
1370696|NCT01507051|4524879|P2|Overall Study|Physician Decision|0
1370697|NCT01507051|4524880|P1|Overall Study|Physician Decision|0
1370698|NCT01507051|4524877|P4|Overall Study|Withdrawal by Subject|6
1370699|NCT01507051|4524878|P3|Overall Study|Withdrawal by Subject|1
1370700|NCT01507051|4524879|P2|Overall Study|Withdrawal by Subject|3
1370701|NCT01507051|4524880|P1|Overall Study|Withdrawal by Subject|1
1370702|NCT01506960|4524998|P1|Overall Study|Did not meet angiographic criteria|47
1370703|NCT01506947|4525004|P1|Overall Study|Did Not Meet Eligibility Criteria|3
1370704|NCT01506947|4525004|P1|Overall Study|Death|1
1370705|NCT01506947|4525004|P1|Overall Study|Adverse Event|5
1370706|NCT01506947|4525004|P1|Overall Study|Lost to Follow-up|7
1370707|NCT01506908|4525022|P2|Overall Study|Adverse Event|0
1370708|NCT01506908|4525023|P1|Overall Study|Adverse Event|1
1370709|NCT01506882|4525041|P2|Overall Study|Other Reason|0
1370710|NCT01506882|4525042|P1|Overall Study|Other Reason|2
1370711|NCT01506882|4525041|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1370712|NCT01506882|4525042|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
1370713|NCT01506882|4525041|P2|Overall Study|AE, non-serious non-fatal|1
1370714|NCT01506882|4525042|P1|Overall Study|AE, non-serious non-fatal|3
1370715|NCT01506882|4525041|P2|Overall Study|SAE, non-fatal|0
1370716|NCT01506882|4525042|P1|Overall Study|SAE, non-fatal|2
1370717|NCT01506882|4525041|P2|Overall Study|Withdrawal by Subject|3
1370718|NCT01506882|4525042|P1|Overall Study|Withdrawal by Subject|9
1370719|NCT01506882|4525041|P2|Overall Study|Lost to Follow-up|0
1370720|NCT01506882|4525042|P1|Overall Study|Lost to Follow-up|1
1370721|NCT01506882|4525041|P2|Overall Study|Lack of Efficacy|3
1370722|NCT01506882|4525042|P1|Overall Study|Lack of Efficacy|4
1370723|NCT01506726|4525056|P2|Overall Study|Adverse Event|2
1370724|NCT01506726|4525057|P1|Overall Study|Adverse Event|1
1370725|NCT01506596|4525097|P1|Overall Study|ineligible pathology|1
1370726|NCT01506479|4525108|P3|Overall Study|Adverse Event|0
1370727|NCT01506479|4525109|P2|Overall Study|Adverse Event|1
1370728|NCT01506479|4525110|P1|Overall Study|Adverse Event|0
1370729|NCT01506479|4525108|P3|Overall Study|Missing assessment|0
1370730|NCT01506479|4525109|P2|Overall Study|Missing assessment|0
1370731|NCT01506479|4525110|P1|Overall Study|Missing assessment|1
1370732|NCT01506479|4525108|P3|Overall Study|Withdrawal by Subject|1
1370733|NCT01506479|4525109|P2|Overall Study|Withdrawal by Subject|2
1370734|NCT01506479|4525110|P1|Overall Study|Withdrawal by Subject|1
1370735|NCT01506479|4525108|P3|Overall Study|Lost to Follow-up|2
1370736|NCT01506479|4525109|P2|Overall Study|Lost to Follow-up|2
1370737|NCT01506479|4525110|P1|Overall Study|Lost to Follow-up|1
1370738|NCT01506323|4525128|P2|Overall Study|Started another treatment|0
1370739|NCT01506323|4525129|P1|Overall Study|Started another treatment|1
1370740|NCT01506323|4525128|P2|Overall Study|Schedule or Transportation conflict|0
1370741|NCT01506323|4525129|P1|Overall Study|Schedule or Transportation conflict|8
1370742|NCT01506323|4525128|P2|Overall Study|Moved out of area|2
1370743|NCT01506323|4525129|P1|Overall Study|Moved out of area|5
1370744|NCT01506323|4525128|P2|Overall Study|Lack of Efficacy|3
1370745|NCT01506323|4525129|P1|Overall Study|Lack of Efficacy|1
1370746|NCT01506323|4525128|P2|Overall Study|Withdrawal by Subject|4
1370747|NCT01506323|4525129|P1|Overall Study|Withdrawal by Subject|4
1370748|NCT01506323|4525128|P2|Overall Study|Lost to Follow-up|4
1370749|NCT01506323|4525129|P1|Overall Study|Lost to Follow-up|5
1370750|NCT01506193|4525158|P3|Overall Study|Lost to Follow-up|3
1370751|NCT01506193|4525159|P2|Overall Study|Lost to Follow-up|3
1370752|NCT01506193|4525160|P1|Overall Study|Lost to Follow-up|8
1370753|NCT01506193|4525158|P3|Overall Study|Withdrawal by Subject|8
1370754|NCT01506193|4525159|P2|Overall Study|Withdrawal by Subject|1
1370755|NCT01506193|4525160|P1|Overall Study|Withdrawal by Subject|5
1370756|NCT01506193|4525158|P3|Overall Study|Adverse event, non-fatal|1
1370757|NCT01506193|4525159|P2|Overall Study|Adverse event, non-fatal|0
1370758|NCT01506193|4525160|P1|Overall Study|Adverse event, non-fatal|0
1370759|NCT01506193|4525158|P3|Overall Study|Migrated/moved from study area|1
1370760|NCT01506193|4525159|P2|Overall Study|Migrated/moved from study area|0
1370761|NCT01506193|4525160|P1|Overall Study|Migrated/moved from study area|0
1370762|NCT01506193|4525158|P3|Overall Study|Protocol Violation|1
1370763|NCT01506193|4525159|P2|Overall Study|Protocol Violation|0
1370764|NCT01506193|4525160|P1|Overall Study|Protocol Violation|1
1370765|NCT01505881|4525193|P2|Overall Study|Withdrawal by Subject|0
1370766|NCT01505881|4525194|P1|Overall Study|Withdrawal by Subject|2
1370767|NCT01505881|4525193|P2|Overall Study|Lost to Follow-up|0
1370768|NCT01505881|4525194|P1|Overall Study|Lost to Follow-up|2
1370769|NCT01505881|4525193|P2|Overall Study|Adverse Event|1
1370770|NCT01505881|4525194|P1|Overall Study|Adverse Event|0
1370771|NCT01505647|4525300|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
1370772|NCT01505647|4525301|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
1370773|NCT01505647|4525300|P2|Day 43 Through Day 182 Follow-up|Death|1
1370774|NCT01505647|4525301|P1|Day 43 Through Day 182 Follow-up|Death|0
1370775|NCT01505647|4525300|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
1370776|NCT01505647|4525301|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
1370777|NCT01505647|4525300|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
1370778|NCT01505647|4525301|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
1370779|NCT01505647|4525300|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
1370780|NCT01505647|4525301|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
1370781|NCT01505608|4525317|P2|Phase II|Protocol Violation|1
1370782|NCT01505608|4525318|P1|Phase II|Protocol Violation|0
1370783|NCT01505608|4525317|P2|Phase II|Lack of Efficacy|1
1370784|NCT01505608|4525318|P1|Phase II|Lack of Efficacy|2
1370785|NCT01505608|4525317|P2|Phase I|Withdrawal by Subject|1
1370786|NCT01505608|4525318|P1|Phase I|Withdrawal by Subject|0
1370787|NCT01505608|4525317|P2|Phase I|Adverse Event|1
1370788|NCT01505608|4525318|P1|Phase I|Adverse Event|0
1370789|NCT01505608|4525317|P2|Phase I|Lack of Efficacy|4
1370790|NCT01505608|4525318|P1|Phase I|Lack of Efficacy|0
1370791|NCT01505530|4525337|P3|Overall Study|entry criteria not met|0
1370792|NCT01505530|4525338|P2|Overall Study|entry criteria not met|1
1370793|NCT01505530|4525339|P1|Overall Study|entry criteria not met|0
1370794|NCT01505530|4525337|P3|Overall Study|Death|5
1370795|NCT01505530|4525338|P2|Overall Study|Death|6
1370796|NCT01505530|4525339|P1|Overall Study|Death|7
1370797|NCT01505530|4525337|P3|Overall Study|Sponsor Decision|7
1370798|NCT01505530|4525338|P2|Overall Study|Sponsor Decision|8
1370799|NCT01505530|4525339|P1|Overall Study|Sponsor Decision|1
1370800|NCT01505530|4525337|P3|Overall Study|Physician Decision|5
1370801|NCT01505530|4525338|P2|Overall Study|Physician Decision|2
1370802|NCT01505530|4525339|P1|Overall Study|Physician Decision|6
1370803|NCT01505530|4525337|P3|Overall Study|Withdrawal by Subject|6
1370804|NCT01505530|4525338|P2|Overall Study|Withdrawal by Subject|8
1370805|NCT01505530|4525339|P1|Overall Study|Withdrawal by Subject|7
1370806|NCT01505530|4525337|P3|Overall Study|Adverse Event|0
1370807|NCT01505530|4525338|P2|Overall Study|Adverse Event|1
1370808|NCT01505530|4525339|P1|Overall Study|Adverse Event|1
1370809|NCT01505530|4525337|P3|Overall Study|Progressive Disease|18
1370810|NCT01505530|4525338|P2|Overall Study|Progressive Disease|17
1370811|NCT01505530|4525339|P1|Overall Study|Progressive Disease|19
1370812|NCT01505387|4525399|P2|Overall Study|Withdrawal by Subject|1
1370813|NCT01505387|4525400|P1|Overall Study|Withdrawal by Subject|1
1370814|NCT01505387|4525399|P2|Overall Study|Protocol Violation|0
1370815|NCT01505387|4525400|P1|Overall Study|Protocol Violation|1
1370816|NCT01505374|4525406|P2|Overall Study|Lost to Follow-up|0
1370817|NCT01505374|4525407|P1|Overall Study|Lost to Follow-up|1
1370818|NCT01505114|4525442|P4|Overall Study|investigator decision|0
1370819|NCT01505114|4525443|P3|Overall Study|investigator decision|1
1370820|NCT01505114|4525444|P2|Overall Study|investigator decision|0
1370821|NCT01505114|4525445|P1|Overall Study|investigator decision|1
1370822|NCT01505114|4525442|P4|Overall Study|staff safety concerns|1
1370823|NCT01505114|4525443|P3|Overall Study|staff safety concerns|0
1370824|NCT01505114|4525444|P2|Overall Study|staff safety concerns|0
1370825|NCT01505114|4525445|P1|Overall Study|staff safety concerns|0
1370826|NCT01505114|4525442|P4|Overall Study|inadvertent enrollment due to peanut all|1
1370827|NCT01505114|4525443|P3|Overall Study|inadvertent enrollment due to peanut all|0
1370828|NCT01505114|4525444|P2|Overall Study|inadvertent enrollment due to peanut all|0
1370829|NCT01505114|4525445|P1|Overall Study|inadvertent enrollment due to peanut all|0
1370830|NCT01505114|4525442|P4|Overall Study|relocated|3
1370831|NCT01505114|4525443|P3|Overall Study|relocated|2
1370832|NCT01505114|4525444|P2|Overall Study|relocated|2
1370833|NCT01505114|4525445|P1|Overall Study|relocated|4
1370834|NCT01505114|4525442|P4|Overall Study|Lost to Follow-up|7
1370835|NCT01505114|4525443|P3|Overall Study|Lost to Follow-up|8
1370836|NCT01505114|4525444|P2|Overall Study|Lost to Follow-up|5
1370837|NCT01505114|4525445|P1|Overall Study|Lost to Follow-up|11
1370838|NCT01505114|4525442|P4|Overall Study|unable to adhere to visit schedule|3
1370839|NCT01505114|4525443|P3|Overall Study|unable to adhere to visit schedule|3
1370840|NCT01505114|4525444|P2|Overall Study|unable to adhere to visit schedule|2
1370841|NCT01505114|4525445|P1|Overall Study|unable to adhere to visit schedule|3
1370842|NCT01505114|4525442|P4|Overall Study|Death|1
1370843|NCT01505114|4525443|P3|Overall Study|Death|0
1370844|NCT01505114|4525444|P2|Overall Study|Death|0
1370845|NCT01505114|4525445|P1|Overall Study|Death|1
1370846|NCT01505114|4525442|P4|Overall Study|Withdrawal by Subject|7
1370847|NCT01505114|4525443|P3|Overall Study|Withdrawal by Subject|4
1370848|NCT01505114|4525444|P2|Overall Study|Withdrawal by Subject|4
1370849|NCT01505114|4525445|P1|Overall Study|Withdrawal by Subject|5
1370850|NCT01504971|4525459|P1|Overall Study|Physician Decision|13
1370851|NCT01504867|4525488|P2|Overall Study|Consent revoked|1
1370852|NCT01504867|4525489|P1|Overall Study|Consent revoked|5
1370853|NCT01504867|4525488|P2|Overall Study|Inclusion criteria not met|2
1370854|NCT01504867|4525489|P1|Overall Study|Inclusion criteria not met|2
1370855|NCT01504204|4525526|P2|Overall Study|Lost to Follow-up|1
1370856|NCT01504204|4525527|P1|Overall Study|Lost to Follow-up|1
1370857|NCT01503164|4525555|P2|Overall Study|Withdrawal by Subject|1
1370858|NCT01503164|4525556|P1|Overall Study|Withdrawal by Subject|2
1370859|NCT01503021|4525586|P2|Overall Study|Moved, received transplant, etc.|7
1370860|NCT01503021|4525587|P1|Overall Study|Moved, received transplant, etc.|5
1370861|NCT01503021|4525586|P2|Overall Study|Withdrawal by Subject|8
1370862|NCT01503021|4525587|P1|Overall Study|Withdrawal by Subject|9
1370863|NCT01503021|4525586|P2|Overall Study|Protocol Violation|3
1370864|NCT01503021|4525587|P1|Overall Study|Protocol Violation|1
1370865|NCT01503021|4525586|P2|Overall Study|Physician Decision|0
1370866|NCT01503021|4525587|P1|Overall Study|Physician Decision|3
1370867|NCT01503021|4525586|P2|Overall Study|Lost to Follow-up|0
1370868|NCT01503021|4525587|P1|Overall Study|Lost to Follow-up|2
1370869|NCT01503021|4525586|P2|Overall Study|Death|2
1370870|NCT01503021|4525587|P1|Overall Study|Death|0
1370871|NCT01503021|4525586|P2|Overall Study|Adverse Event|6
1370872|NCT01503021|4525587|P1|Overall Study|Adverse Event|7
1370873|NCT01502956|4525636|P2|Overall Study|Withdrawal by Subject|10
1370874|NCT01502956|4525637|P1|Overall Study|Withdrawal by Subject|8
1370875|NCT01502956|4525636|P2|Overall Study|Physician Decision|3
1370876|NCT01502956|4525637|P1|Overall Study|Physician Decision|2
1370877|NCT01502956|4525636|P2|Overall Study|Lost to Follow-up|11
1370878|NCT01502956|4525637|P1|Overall Study|Lost to Follow-up|14
1370879|NCT01502956|4525636|P2|Overall Study|Death|2
1370880|NCT01502956|4525637|P1|Overall Study|Death|0
1370881|NCT01502709|4525695|P2|Overall Study|Lost to Follow-up|0
1370882|NCT01502709|4525696|P1|Overall Study|Lost to Follow-up|4
1370883|NCT01502644|4525709|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
1370884|NCT01502644|4525710|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
1370885|NCT01502644|4525711|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
1370886|NCT01502644|4525712|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
1370887|NCT01502644|4525709|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
1370888|NCT01502644|4525710|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
1370889|NCT01502644|4525711|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
1370890|NCT01502644|4525712|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
1370891|NCT01502644|4525709|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
1370892|NCT01502644|4525710|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
1370893|NCT01502644|4525711|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
1370894|NCT01502644|4525712|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
1370895|NCT01502644|4525709|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
1370896|NCT01502644|4525710|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
1370897|NCT01502644|4525711|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
1370898|NCT01502644|4525712|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
1370899|NCT01502644|4525709|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
1370900|NCT01502644|4525710|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
1370901|NCT01502644|4525711|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
1370902|NCT01502644|4525712|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
1370903|NCT01502423|4525722|P2|Overall Study|Withdrawal by Subject|1
1370904|NCT01502423|4525723|P1|Overall Study|Withdrawal by Subject|0
1370905|NCT01502410|4525745|P4|Overall Study|Withdrawal by Subject|0
1370906|NCT01502410|4525746|P3|Overall Study|Withdrawal by Subject|0
1370907|NCT01502410|4525747|P2|Overall Study|Withdrawal by Subject|0
1370908|NCT01502410|4525748|P1|Overall Study|Withdrawal by Subject|2
1370909|NCT01502410|4525745|P4|Overall Study|Physician Decision|0
1370910|NCT01502410|4525746|P3|Overall Study|Physician Decision|0
1370911|NCT01502410|4525747|P2|Overall Study|Physician Decision|1
1370912|NCT01502410|4525748|P1|Overall Study|Physician Decision|0
1370913|NCT01502410|4525745|P4|Overall Study|Lack of Efficacy|0
1370914|NCT01502410|4525746|P3|Overall Study|Lack of Efficacy|0
1370915|NCT01502410|4525747|P2|Overall Study|Lack of Efficacy|7
1370916|NCT01502410|4525748|P1|Overall Study|Lack of Efficacy|7
1370917|NCT01502410|4525745|P4|Overall Study|Adverse Event|0
1370918|NCT01502410|4525746|P3|Overall Study|Adverse Event|0
1370919|NCT01502410|4525747|P2|Overall Study|Adverse Event|2
1370920|NCT01502410|4525748|P1|Overall Study|Adverse Event|1
1370921|NCT01502371|4525766|P5|Overall Study|Excluded Medication|1
1370922|NCT01502371|4525767|P4|Overall Study|Excluded Medication|0
1370923|NCT01502371|4525768|P3|Overall Study|Excluded Medication|1
1370924|NCT01502371|4525769|P2|Overall Study|Excluded Medication|1
1370925|NCT01502371|4525770|P1|Overall Study|Excluded Medication|0
1370926|NCT01502371|4525766|P5|Overall Study|Protocol Violation|10
1370927|NCT01502371|4525767|P4|Overall Study|Protocol Violation|5
1370928|NCT01502371|4525768|P3|Overall Study|Protocol Violation|6
1370929|NCT01502371|4525769|P2|Overall Study|Protocol Violation|5
1370930|NCT01502371|4525770|P1|Overall Study|Protocol Violation|9
1370931|NCT01502371|4525766|P5|Overall Study|Technical Problems|1
1370932|NCT01502371|4525767|P4|Overall Study|Technical Problems|4
1370933|NCT01502371|4525768|P3|Overall Study|Technical Problems|2
1370934|NCT01502371|4525769|P2|Overall Study|Technical Problems|0
1370935|NCT01502371|4525770|P1|Overall Study|Technical Problems|1
1370936|NCT01502371|4525766|P5|Overall Study|Noncompliance with Study Drug|1
1370937|NCT01502371|4525767|P4|Overall Study|Noncompliance with Study Drug|2
1370938|NCT01502371|4525768|P3|Overall Study|Noncompliance with Study Drug|1
1370939|NCT01502371|4525769|P2|Overall Study|Noncompliance with Study Drug|0
1370940|NCT01502371|4525770|P1|Overall Study|Noncompliance with Study Drug|0
1370941|NCT01502371|4525766|P5|Overall Study|Physician Decision|1
1370942|NCT01502371|4525767|P4|Overall Study|Physician Decision|0
1370943|NCT01502371|4525768|P3|Overall Study|Physician Decision|0
1370944|NCT01502371|4525769|P2|Overall Study|Physician Decision|0
1370945|NCT01502371|4525770|P1|Overall Study|Physician Decision|3
1370946|NCT01502371|4525766|P5|Overall Study|Lack of Efficacy|4
1370947|NCT01502371|4525767|P4|Overall Study|Lack of Efficacy|2
1370948|NCT01502371|4525768|P3|Overall Study|Lack of Efficacy|2
1370949|NCT01502371|4525769|P2|Overall Study|Lack of Efficacy|3
1370950|NCT01502371|4525770|P1|Overall Study|Lack of Efficacy|3
1370951|NCT01502371|4525766|P5|Overall Study|Treatment Failure|30
1370952|NCT01502371|4525767|P4|Overall Study|Treatment Failure|19
1370953|NCT01502371|4525768|P3|Overall Study|Treatment Failure|12
1370954|NCT01502371|4525769|P2|Overall Study|Treatment Failure|20
1370955|NCT01502371|4525770|P1|Overall Study|Treatment Failure|22
1370956|NCT01502371|4525766|P5|Overall Study|Adverse Event|3
1370957|NCT01502371|4525767|P4|Overall Study|Adverse Event|4
1370958|NCT01502371|4525768|P3|Overall Study|Adverse Event|0
1370959|NCT01502371|4525769|P2|Overall Study|Adverse Event|1
1370960|NCT01502371|4525770|P1|Overall Study|Adverse Event|2
1370961|NCT01502371|4525766|P5|Overall Study|Withdrawal by Subject|1
1370962|NCT01502371|4525767|P4|Overall Study|Withdrawal by Subject|1
1370963|NCT01502371|4525768|P3|Overall Study|Withdrawal by Subject|1
1370964|NCT01502371|4525769|P2|Overall Study|Withdrawal by Subject|2
1370965|NCT01502371|4525770|P1|Overall Study|Withdrawal by Subject|1
1370966|NCT01502228|4525810|P1|Overall Study|Death|1
1370967|NCT01502033|4525815|P1|Overall Study|1 participant went back to school|1
1370968|NCT01502033|4525815|P1|Overall Study|1 participant had worsening depression|1
1370969|NCT01502033|4525815|P1|Overall Study|1 participant had scalp discomfort|1
1370970|NCT01501955|4525823|P2|Overall Study|Adverse Event|3
1370971|NCT01501955|4525824|P1|Overall Study|Adverse Event|1
1370972|NCT01501955|4525823|P2|Overall Study|Withdrawal by Subject|0
1370973|NCT01501955|4525824|P1|Overall Study|Withdrawal by Subject|1
1370974|NCT01501110|4525879|P2|Overall Study|Death|1
1370975|NCT01501110|4525880|P1|Overall Study|Death|0
1370976|NCT01500720|4525913|P2|Overall Study|Other|8
1370977|NCT01500720|4525914|P1|Overall Study|Other|4
1370978|NCT01500720|4525913|P2|Overall Study|Randomized But Not Treated|1
1370979|NCT01500720|4525914|P1|Overall Study|Randomized But Not Treated|1
1370980|NCT01500694|4525928|P2|Overall Study|Other|3
1370981|NCT01500694|4525929|P1|Overall Study|Other|9
1370982|NCT01500694|4525928|P2|Overall Study|Lack of Efficacy|5
1370983|NCT01500694|4525929|P1|Overall Study|Lack of Efficacy|14
1370984|NCT01500694|4525928|P2|Overall Study|Lost to Follow-up|3
1370985|NCT01500694|4525929|P1|Overall Study|Lost to Follow-up|2
1370986|NCT01500694|4525928|P2|Overall Study|Withdrawal by Subject|14
1370987|NCT01500694|4525929|P1|Overall Study|Withdrawal by Subject|23
1370988|NCT01500694|4525928|P2|Overall Study|Protocol Violation|1
1370989|NCT01500694|4525929|P1|Overall Study|Protocol Violation|0
1370990|NCT01500694|4525928|P2|Overall Study|Adverse Event|3
1370991|NCT01500694|4525929|P1|Overall Study|Adverse Event|4
1370992|NCT01500629|4525955|P2|Washout Period of 14 to 30 Days|Pregnancy|0
1370993|NCT01500629|4525956|P1|Washout Period of 14 to 30 Days|Pregnancy|1
1370994|NCT01500434|4526040|P1|Overall Study|Missed 12-month follow-up|5
1370995|NCT01500434|4526040|P1|Overall Study|Withdrawal by Subject|1
1370996|NCT01500434|4526040|P1|Overall Study|Death|1
1370997|NCT01500382|4526073|P4|Washout Period|Study site went out of business|0
1370998|NCT01500382|4526074|P3|Washout Period|Study site went out of business|1
1370999|NCT01500382|4526075|P2|Washout Period|Study site went out of business|0
1371000|NCT01500382|4526076|P1|Washout Period|Study site went out of business|0
1371001|NCT01500317|4526101|P3|Overall Study|Withdrawal by Subject|0
1371002|NCT01500317|4526102|P2|Overall Study|Withdrawal by Subject|2
1371003|NCT01500317|4526103|P1|Overall Study|Withdrawal by Subject|3
1371004|NCT01500278|4526125|P2|Week 13 - Week 104|Adverse Event|54
1371005|NCT01500278|4526126|P1|Week 13 - Week 104|Adverse Event|54
1371006|NCT01500278|4526125|P2|Week 13 - Week 104|Death|4
1371007|NCT01500278|4526126|P1|Week 13 - Week 104|Death|2
1371008|NCT01500278|4526125|P2|Week 13 - Week 104|Not completed|1
1371009|NCT01500278|4526126|P1|Week 13 - Week 104|Not completed|0
1371010|NCT01500278|4526125|P2|Week 13 - Week 104|Personal reason|1
1371011|NCT01500278|4526126|P1|Week 13 - Week 104|Personal reason|0
1371012|NCT01500278|4526125|P2|Week 13 - Week 104|Medical monitor decision|2
1371013|NCT01500278|4526126|P1|Week 13 - Week 104|Medical monitor decision|0
1371014|NCT01500278|4526125|P2|Week 13 - Week 104|Sponsor decision|2
1371015|NCT01500278|4526126|P1|Week 13 - Week 104|Sponsor decision|0
1371016|NCT01500278|4526125|P2|Week 13 - Week 104|Relocation|1
1371017|NCT01500278|4526126|P1|Week 13 - Week 104|Relocation|0
1371018|NCT01500278|4526125|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
1371019|NCT01500278|4526126|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
1371020|NCT01500278|4526125|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
1371021|NCT01500278|4526126|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
1371022|NCT01500278|4526125|P2|Week 13 - Week 104|Principal investigator retiring|0
1371023|NCT01500278|4526126|P1|Week 13 - Week 104|Principal investigator retiring|1
1371024|NCT01500278|4526125|P2|Week 13 - Week 104|Protocol deviation|0
1371025|NCT01500278|4526126|P1|Week 13 - Week 104|Protocol deviation|1
1371026|NCT01500278|4526125|P2|Week 13 - Week 104|Exclusion criteria not met|0
1371027|NCT01500278|4526126|P1|Week 13 - Week 104|Exclusion criteria not met|1
1371028|NCT01500278|4526125|P2|Week 13 - Week 104|Withdrawn in error|0
1371029|NCT01500278|4526126|P1|Week 13 - Week 104|Withdrawn in error|1
1371030|NCT01500278|4526125|P2|Week 13 - Week 104|Sponsor request|0
1371031|NCT01500278|4526126|P1|Week 13 - Week 104|Sponsor request|4
1371032|NCT01500278|4526125|P2|Week 13 - Week 104|False positive test|2
1371033|NCT01500278|4526126|P1|Week 13 - Week 104|False positive test|1
1371034|NCT01500278|4526125|P2|Week 13 - Week 104|Recurrent infections|0
1371035|NCT01500278|4526126|P1|Week 13 - Week 104|Recurrent infections|1
1371036|NCT01500278|4526125|P2|Week 13 - Week 104|Non/bad compliance|5
1371037|NCT01500278|4526126|P1|Week 13 - Week 104|Non/bad compliance|7
1371038|NCT01500278|4526125|P2|Week 13 - Week 104|Week 24 Non-Responder|16
1371039|NCT01500278|4526126|P1|Week 13 - Week 104|Week 24 Non-Responder|20
1371040|NCT01500278|4526125|P2|Week 13 - Week 104|Withdrawal by Subject|13
1371041|NCT01500278|4526126|P1|Week 13 - Week 104|Withdrawal by Subject|22
1371042|NCT01500278|4526125|P2|Week 13 - Week 104|Lost to Follow-up|5
1371043|NCT01500278|4526126|P1|Week 13 - Week 104|Lost to Follow-up|6
1371044|NCT01500278|4526125|P2|Week 13 - Week 104|Protocol Violation|6
1371045|NCT01500278|4526126|P1|Week 13 - Week 104|Protocol Violation|6
1371046|NCT01500278|4526125|P2|Week 13 - Week 104|Lack of Efficacy|12
1371047|NCT01500278|4526126|P1|Week 13 - Week 104|Lack of Efficacy|11
1371048|NCT01500278|4526125|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
1371049|NCT01500278|4526126|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
1371050|NCT01500278|4526125|P2|Week 0 - Week 12|Other serious disease|1
1371051|NCT01500278|4526126|P1|Week 0 - Week 12|Other serious disease|0
1371052|NCT01500278|4526125|P2|Week 0 - Week 12|Personal reason|1
1371053|NCT01500278|4526126|P1|Week 0 - Week 12|Personal reason|0
1371054|NCT01500278|4526125|P2|Week 0 - Week 12|Sponsor decision|0
1371055|NCT01500278|4526126|P1|Week 0 - Week 12|Sponsor decision|1
1371056|NCT01500278|4526125|P2|Week 0 - Week 12|Prior history of serious disease|0
1371057|NCT01500278|4526126|P1|Week 0 - Week 12|Prior history of serious disease|1
1371058|NCT01500278|4526125|P2|Week 0 - Week 12|Investigator decision|0
1371059|NCT01500278|4526126|P1|Week 0 - Week 12|Investigator decision|1
1371060|NCT01500278|4526125|P2|Week 0 - Week 12|Exclusion criteria not met|0
1371061|NCT01500278|4526126|P1|Week 0 - Week 12|Exclusion criteria not met|1
1371062|NCT01500278|4526125|P2|Week 0 - Week 12|Patient decision|0
1371063|NCT01500278|4526126|P1|Week 0 - Week 12|Patient decision|1
1371064|NCT01500278|4526125|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
1371065|NCT01500278|4526126|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
1371066|NCT01500278|4526125|P2|Week 0 - Week 12|Withdrawal by Subject|2
1371067|NCT01500278|4526126|P1|Week 0 - Week 12|Withdrawal by Subject|7
1371068|NCT01500278|4526125|P2|Week 0 - Week 12|Lost to Follow-up|1
1371069|NCT01500278|4526126|P1|Week 0 - Week 12|Lost to Follow-up|1
1371070|NCT01500278|4526125|P2|Week 0 - Week 12|Protocol Violation|16
1371071|NCT01500278|4526126|P1|Week 0 - Week 12|Protocol Violation|10
1371072|NCT01500278|4526125|P2|Week 0 - Week 12|Lack of Efficacy|1
1371073|NCT01500278|4526126|P1|Week 0 - Week 12|Lack of Efficacy|0
1371074|NCT01500252|4526150|P2|Overall Study|Lost to Follow-up|4
1371075|NCT01500252|4526151|P1|Overall Study|Lost to Follow-up|5
1371076|NCT01500252|4526150|P2|Overall Study|Death|2
1371077|NCT01500252|4526151|P1|Overall Study|Death|4
1371078|NCT01500226|4526177|P2|Overall Study|Other Reasons|16
1371079|NCT01500226|4526178|P1|Overall Study|Other Reasons|19
1371080|NCT01500226|4526177|P2|Overall Study|Lost to Follow-up|5
1371081|NCT01500226|4526178|P1|Overall Study|Lost to Follow-up|9
1371082|NCT01500226|4526177|P2|Overall Study|Lack of Efficacy|30
1371083|NCT01500226|4526178|P1|Overall Study|Lack of Efficacy|14
1371084|NCT01500226|4526177|P2|Overall Study|Physician Decision|15
1371085|NCT01500226|4526178|P1|Overall Study|Physician Decision|17
1371086|NCT01500226|4526177|P2|Overall Study|Protocol Violation|39
1371087|NCT01500226|4526178|P1|Overall Study|Protocol Violation|53
1371088|NCT01500226|4526177|P2|Overall Study|Disease Progression|14
1371089|NCT01500226|4526178|P1|Overall Study|Disease Progression|16
1371090|NCT01500226|4526177|P2|Overall Study|Death|4
1371091|NCT01500226|4526178|P1|Overall Study|Death|12
1371092|NCT01500226|4526177|P2|Overall Study|Withdrawal by Subject|96
1371093|NCT01500226|4526178|P1|Overall Study|Withdrawal by Subject|93
1371094|NCT01500226|4526177|P2|Overall Study|Chemo Completed or Change in Therapy|237
1371095|NCT01500226|4526178|P1|Overall Study|Chemo Completed or Change in Therapy|235
1371096|NCT01500226|4526177|P2|Overall Study|Adverse Event|38
1371097|NCT01500226|4526178|P1|Overall Study|Adverse Event|31
1371098|NCT01500213|4526190|P2|Overall Study|Other Reasons|5
1371099|NCT01500213|4526191|P1|Overall Study|Other Reasons|7
1371100|NCT01500213|4526190|P2|Overall Study|Lost to Follow-up|6
1371101|NCT01500213|4526191|P1|Overall Study|Lost to Follow-up|3
1371102|NCT01500213|4526190|P2|Overall Study|Lack of Efficacy|7
1371103|NCT01500213|4526191|P1|Overall Study|Lack of Efficacy|9
1371104|NCT01500213|4526190|P2|Overall Study|Physician Decision|10
1371105|NCT01500213|4526191|P1|Overall Study|Physician Decision|12
1371106|NCT01500213|4526190|P2|Overall Study|Protocol Violation|19
1371107|NCT01500213|4526191|P1|Overall Study|Protocol Violation|19
1371108|NCT01500213|4526190|P2|Overall Study|Disease Progression|21
1371109|NCT01500213|4526191|P1|Overall Study|Disease Progression|13
1371110|NCT01500213|4526190|P2|Overall Study|Death|3
1371111|NCT01500213|4526191|P1|Overall Study|Death|7
1371112|NCT01500213|4526190|P2|Overall Study|Withdrawal by Subject|37
1371113|NCT01500213|4526191|P1|Overall Study|Withdrawal by Subject|28
1371114|NCT01500213|4526190|P2|Overall Study|Chemo Completed or Change in Therapy|81
1371115|NCT01500213|4526191|P1|Overall Study|Chemo Completed or Change in Therapy|84
1371116|NCT01500213|4526190|P2|Overall Study|Adverse Event|35
1371117|NCT01500213|4526191|P1|Overall Study|Adverse Event|35
1371118|NCT01500135|4526203|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
1371119|NCT01500135|4526204|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
1371120|NCT01500135|4526203|P2|Overall Study|Participant was a Safety Concern|0
1371121|NCT01500135|4526204|P1|Overall Study|Participant was a Safety Concern|1
1371122|NCT01500135|4526203|P2|Overall Study|Patient Missed Scheduled Appointments|1
1371123|NCT01500135|4526204|P1|Overall Study|Patient Missed Scheduled Appointments|0
1371124|NCT01500135|4526203|P2|Overall Study|Principal Investigator (PI) Discretion|0
1371125|NCT01500135|4526204|P1|Overall Study|Principal Investigator (PI) Discretion|1
1371126|NCT01500135|4526203|P2|Overall Study|Fatal Adverse Event (AE)|5
1371127|NCT01500135|4526204|P1|Overall Study|Fatal Adverse Event (AE)|5
1371128|NCT01500135|4526203|P2|Overall Study|Lost to Follow-up|4
1371129|NCT01500135|4526204|P1|Overall Study|Lost to Follow-up|6
1371130|NCT01500135|4526203|P2|Overall Study|Withdrawal of Consent|0
1371131|NCT01500135|4526204|P1|Overall Study|Withdrawal of Consent|4
1371132|NCT01500096|4526231|P4|Overall Study|Lost to Follow-up|2
1371133|NCT01500096|4526232|P3|Overall Study|Lost to Follow-up|0
1371134|NCT01500096|4526233|P2|Overall Study|Lost to Follow-up|0
1371135|NCT01500096|4526234|P1|Overall Study|Lost to Follow-up|1
1371136|NCT01500083|4526290|P2|Overall Study|Other Reasons|5
1371137|NCT01500083|4526291|P1|Overall Study|Other Reasons|2
1371138|NCT01500083|4526290|P2|Overall Study|Investigator Discretion|8
1371139|NCT01500083|4526291|P1|Overall Study|Investigator Discretion|3
1371140|NCT01500083|4526290|P2|Overall Study|Disease Progression|10
1371141|NCT01500083|4526291|P1|Overall Study|Disease Progression|2
1371142|NCT01500083|4526290|P2|Overall Study|Withdrawal of Consent|1
1371143|NCT01500083|4526291|P1|Overall Study|Withdrawal of Consent|0
1371144|NCT01500083|4526290|P2|Overall Study|Lost to Follow-up|0
1371145|NCT01500083|4526291|P1|Overall Study|Lost to Follow-up|1
1371146|NCT01500083|4526290|P2|Overall Study|Death|2
1371147|NCT01500083|4526291|P1|Overall Study|Death|0
1371148|NCT01500083|4526290|P2|Overall Study|Adverse Event|17
1371149|NCT01500083|4526291|P1|Overall Study|Adverse Event|4
1371150|NCT01500057|4526299|P2|Overall Study|Lost to Follow-up|4
1371151|NCT01500057|4526300|P1|Overall Study|Lost to Follow-up|6
1371152|NCT01500031|4526310|P1|Overall Study|Withdrawal by Subject|4
1371153|NCT01500031|4526310|P1|Overall Study|Death|1
1371154|NCT01499849|4526345|P2|Overall Study|Other Reasons|30
1371155|NCT01499849|4526346|P1|Overall Study|Other Reasons|27
1371156|NCT01499849|4526345|P2|Overall Study|Lost to Follow-up|3
1371157|NCT01499849|4526346|P1|Overall Study|Lost to Follow-up|6
1371158|NCT01499849|4526345|P2|Overall Study|Lack of Efficacy|4
1371159|NCT01499849|4526346|P1|Overall Study|Lack of Efficacy|3
1371160|NCT01499849|4526345|P2|Overall Study|Physician Decision|19
1371161|NCT01499849|4526346|P1|Overall Study|Physician Decision|20
1371162|NCT01499849|4526345|P2|Overall Study|Protocol Violation|11
1371163|NCT01499849|4526346|P1|Overall Study|Protocol Violation|11
1371164|NCT01499849|4526345|P2|Overall Study|Disease Progression|10
1371165|NCT01499849|4526346|P1|Overall Study|Disease Progression|11
1371166|NCT01499849|4526345|P2|Overall Study|Death|7
1371167|NCT01499849|4526346|P1|Overall Study|Death|5
1371168|NCT01499849|4526345|P2|Overall Study|Withdrawal by Subject|43
1371169|NCT01499849|4526346|P1|Overall Study|Withdrawal by Subject|43
1371170|NCT01499849|4526345|P2|Overall Study|Chemo completed or Change in Therapy|67
1371171|NCT01499849|4526346|P1|Overall Study|Chemo completed or Change in Therapy|70
1371172|NCT01499849|4526345|P2|Overall Study|Adverse Event|32
1371173|NCT01499849|4526346|P1|Overall Study|Adverse Event|28
1371174|NCT01499810|4526356|P1|Overall Study|Withdrawal by Subject|1
1371175|NCT01499810|4526356|P1|Overall Study|Protocol Violation|1
1371176|NCT01499810|4526356|P1|Overall Study|Lost to Follow-up|10
1371177|NCT01499667|4526406|P3|Overall Study|Lack of Efficacy|0
1371178|NCT01499667|4526407|P2|Overall Study|Lack of Efficacy|0
1371179|NCT01499667|4526408|P1|Overall Study|Lack of Efficacy|2
1371180|NCT01499667|4526406|P3|Overall Study|Withdrawal by Subject|1
1371181|NCT01499667|4526407|P2|Overall Study|Withdrawal by Subject|1
1371182|NCT01499667|4526408|P1|Overall Study|Withdrawal by Subject|2
1371183|NCT01499667|4526406|P3|Overall Study|Adverse Event|2
1371184|NCT01499667|4526407|P2|Overall Study|Adverse Event|2
1371185|NCT01499667|4526408|P1|Overall Study|Adverse Event|0
1371186|NCT01499667|4526406|P3|Overall Study|Protocol Violation|2
1371187|NCT01499667|4526407|P2|Overall Study|Protocol Violation|3
1371188|NCT01499667|4526408|P1|Overall Study|Protocol Violation|1
1371189|NCT01499667|4526406|P3|Overall Study|administrative problems|5
1371190|NCT01499667|4526407|P2|Overall Study|administrative problems|5
1371191|NCT01499667|4526408|P1|Overall Study|administrative problems|4
1371192|NCT01499576|4526456|P1|Overall Study|Withdrawal by Subject|9
1371193|NCT01499576|4526456|P1|Overall Study|Physician Decision|12
1371194|NCT01499355|4526470|P4|Double-Blind Period|Lost to Follow-up|0
1371195|NCT01499355|4526471|P3|Double-Blind Period|Lost to Follow-up|0
1371196|NCT01499355|4526472|P2|Double-Blind Period|Lost to Follow-up|1
1371197|NCT01499355|4526473|P1|Double-Blind Period|Lost to Follow-up|0
1371198|NCT01499355|4526470|P4|Double-Blind Period|Consent Withdrawn|2
1371199|NCT01499355|4526471|P3|Double-Blind Period|Consent Withdrawn|1
1371200|NCT01499355|4526472|P2|Double-Blind Period|Consent Withdrawn|0
1371201|NCT01499355|4526473|P1|Double-Blind Period|Consent Withdrawn|0
1371202|NCT01499355|4526470|P4|Double-Blind Period|Investigator Decision|3
1371203|NCT01499355|4526471|P3|Double-Blind Period|Investigator Decision|3
1371204|NCT01499355|4526472|P2|Double-Blind Period|Investigator Decision|0
1371205|NCT01499355|4526473|P1|Double-Blind Period|Investigator Decision|0
1371206|NCT01499355|4526470|P4|Double-Blind Period|Death|0
1371207|NCT01499355|4526471|P3|Double-Blind Period|Death|0
1371208|NCT01499355|4526472|P2|Double-Blind Period|Death|1
1371209|NCT01499355|4526473|P1|Double-Blind Period|Death|0
1371210|NCT01499355|4526470|P4|Double-Blind Period|Not Specified|2
1371211|NCT01499355|4526471|P3|Double-Blind Period|Not Specified|2
1371212|NCT01499355|4526472|P2|Double-Blind Period|Not Specified|1
1371213|NCT01499355|4526473|P1|Double-Blind Period|Not Specified|0
1371214|NCT01499355|4526470|P4|Double-Blind Period|Study Termination|14
1371215|NCT01499355|4526471|P3|Double-Blind Period|Study Termination|16
1371216|NCT01499355|4526472|P2|Double-Blind Period|Study Termination|18
1371217|NCT01499355|4526473|P1|Double-Blind Period|Study Termination|0
1371218|NCT01499355|4526470|P4|Double-Blind Period|Adverse Event|2
1371219|NCT01499355|4526471|P3|Double-Blind Period|Adverse Event|3
1371220|NCT01499355|4526472|P2|Double-Blind Period|Adverse Event|2
1371221|NCT01499355|4526473|P1|Double-Blind Period|Adverse Event|0
1371222|NCT01499355|4526470|P4|Run-In Period|Adverse Event|0
1371223|NCT01499355|4526471|P3|Run-In Period|Adverse Event|0
1371224|NCT01499355|4526472|P2|Run-In Period|Adverse Event|0
1371225|NCT01499355|4526473|P1|Run-In Period|Adverse Event|8
1371226|NCT01499355|4526470|P4|Run-In Period|Consent Withdrawn|0
1371227|NCT01499355|4526471|P3|Run-In Period|Consent Withdrawn|0
1371228|NCT01499355|4526472|P2|Run-In Period|Consent Withdrawn|0
1371229|NCT01499355|4526473|P1|Run-In Period|Consent Withdrawn|1
1371230|NCT01499355|4526470|P4|Run-In Period|Investigator Decision|0
1371231|NCT01499355|4526471|P3|Run-In Period|Investigator Decision|0
1371232|NCT01499355|4526472|P2|Run-In Period|Investigator Decision|0
1371233|NCT01499355|4526473|P1|Run-In Period|Investigator Decision|2
1371234|NCT01499355|4526470|P4|Run-In Period|Death|0
1371235|NCT01499355|4526471|P3|Run-In Period|Death|0
1371236|NCT01499355|4526472|P2|Run-In Period|Death|0
1371237|NCT01499355|4526473|P1|Run-In Period|Death|2
1371238|NCT01499355|4526470|P4|Run-In Period|Not Specified|0
1371239|NCT01499355|4526471|P3|Run-In Period|Not Specified|0
1371240|NCT01499355|4526472|P2|Run-In Period|Not Specified|0
1371241|NCT01499355|4526473|P1|Run-In Period|Not Specified|3
1371242|NCT01499355|4526470|P4|Run-In Period|Study Termination|0
1371243|NCT01499355|4526471|P3|Run-In Period|Study Termination|0
1371244|NCT01499355|4526472|P2|Run-In Period|Study Termination|0
1371245|NCT01499355|4526473|P1|Run-In Period|Study Termination|15
1371246|NCT01499303|4526506|P2|Overall Study|Other|1
1371247|NCT01499303|4526507|P1|Overall Study|Other|0
1371248|NCT01499303|4526506|P2|Overall Study|Adverse Event|4
1371249|NCT01499303|4526507|P1|Overall Study|Adverse Event|1
1371250|NCT01499303|4526506|P2|Overall Study|Withdrawal by Subject|1
1371251|NCT01499303|4526507|P1|Overall Study|Withdrawal by Subject|0
1371252|NCT01499303|4526506|P2|Overall Study|Ongoing|1
1371253|NCT01499303|4526507|P1|Overall Study|Ongoing|2
1371254|NCT01499290|4526515|P2|Overall Study|Adverse Event|7
1371255|NCT01499290|4526516|P1|Overall Study|Adverse Event|14
1371256|NCT01499290|4526515|P2|Overall Study|Lack of Efficacy|8
1371257|NCT01499290|4526516|P1|Overall Study|Lack of Efficacy|7
1371258|NCT01499290|4526515|P2|Overall Study|Condition improved/subject recovered|0
1371259|NCT01499290|4526516|P1|Overall Study|Condition improved/subject recovered|1
1371260|NCT01499290|4526515|P2|Overall Study|Not specified in study report|5
1371261|NCT01499290|4526516|P1|Overall Study|Not specified in study report|11
1371262|NCT01499290|4526515|P2|Overall Study|Withdrawal by Subject|15
1371263|NCT01499290|4526516|P1|Overall Study|Withdrawal by Subject|22
1371264|NCT01499277|4526566|P2|Overall Study|Lack of therapeutic response and other|7
1371265|NCT01499277|4526567|P1|Overall Study|Lack of therapeutic response and other|8
1371266|NCT01499277|4526566|P2|Overall Study|Withdrawal by Subject|6
1371267|NCT01499277|4526567|P1|Overall Study|Withdrawal by Subject|16
1371268|NCT01499277|4526566|P2|Overall Study|Protocol Violation|3
1371269|NCT01499277|4526567|P1|Overall Study|Protocol Violation|2
1371270|NCT01499277|4526566|P2|Overall Study|Lost to Follow-up|8
1371271|NCT01499277|4526567|P1|Overall Study|Lost to Follow-up|15
1371272|NCT01499277|4526566|P2|Overall Study|Death|2
1371273|NCT01499277|4526567|P1|Overall Study|Death|3
1371274|NCT01499277|4526566|P2|Overall Study|Adverse Event|6
1371275|NCT01499277|4526567|P1|Overall Study|Adverse Event|3
1371276|NCT01499199|4526589|P1|Overall Study|Lack of Efficacy|1
1371277|NCT01499199|4526589|P1|Overall Study|Adverse Event|1
1371278|NCT01499160|4526618|P1|Overall Study|Withdrawal by Subject|1
1371279|NCT01499160|4526618|P1|Overall Study|Adverse Event|1
1371280|NCT01499134|4526641|P2|Overall Study|Withdrawal by Subject|1
1371281|NCT01499134|4526642|P1|Overall Study|Withdrawal by Subject|0
1371282|NCT01499095|4526664|P2|Overall Study|Perceived Lack of Efficacy|1
1371283|NCT01499095|4526665|P1|Overall Study|Perceived Lack of Efficacy|1
1371284|NCT01499095|4526664|P2|Overall Study|Change in Injection Schedule|0
1371285|NCT01499095|4526665|P1|Overall Study|Change in Injection Schedule|2
1371286|NCT01499095|4526664|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
1371287|NCT01499095|4526665|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
1371288|NCT01499095|4526664|P2|Overall Study|Hypoglycemia|1
1371289|NCT01499095|4526665|P1|Overall Study|Hypoglycemia|3
1371290|NCT01499095|4526664|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
1371291|NCT01499095|4526665|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
1371292|NCT01499095|4526664|P2|Overall Study|Lost to Follow-up|4
1371293|NCT01499095|4526665|P1|Overall Study|Lost to Follow-up|6
1371294|NCT01499095|4526664|P2|Overall Study|Diverse Reasons|25
1371295|NCT01499095|4526665|P1|Overall Study|Diverse Reasons|22
1371296|NCT01499095|4526664|P2|Overall Study|Received Rescue Therapy|40
1371297|NCT01499095|4526665|P1|Overall Study|Received Rescue Therapy|32
1371298|NCT01499095|4526664|P2|Overall Study|Protocol Violation|7
1371299|NCT01499095|4526665|P1|Overall Study|Protocol Violation|6
1371300|NCT01499095|4526664|P2|Overall Study|Lack of Efficacy|1
1371301|NCT01499095|4526665|P1|Overall Study|Lack of Efficacy|2
1371302|NCT01499095|4526664|P2|Overall Study|Adverse Event|7
1371303|NCT01499095|4526665|P1|Overall Study|Adverse Event|12
1371304|NCT01499095|4526664|P2|Overall Study|Randomized But Not Treated|1
1371305|NCT01499095|4526665|P1|Overall Study|Randomized But Not Treated|1
1371306|NCT01499082|4526695|P2|Overall Study|Lost to Follow-up|3
1371307|NCT01499082|4526696|P1|Overall Study|Lost to Follow-up|1
1371308|NCT01499082|4526695|P2|Overall Study|Hypoglycemia|3
1371309|NCT01499082|4526696|P1|Overall Study|Hypoglycemia|2
1371310|NCT01499082|4526695|P2|Overall Study|Site Closure for Noncompliance|2
1371311|NCT01499082|4526696|P1|Overall Study|Site Closure for Noncompliance|5
1371312|NCT01499082|4526695|P2|Overall Study|Diverse Reasons|14
1371313|NCT01499082|4526696|P1|Overall Study|Diverse Reasons|18
1371314|NCT01499082|4526695|P2|Overall Study|Protocol Violation|8
1371315|NCT01499082|4526696|P1|Overall Study|Protocol Violation|6
1371316|NCT01499082|4526695|P2|Overall Study|Lack of Efficacy|1
1371317|NCT01499082|4526696|P1|Overall Study|Lack of Efficacy|1
1371318|NCT01499082|4526695|P2|Overall Study|Adverse Event|16
1371319|NCT01499082|4526696|P1|Overall Study|Adverse Event|12
1371320|NCT01499082|4526695|P2|Overall Study|Randomized but not Treated|1
1371321|NCT01499082|4526696|P1|Overall Study|Randomized but not Treated|0
1371322|NCT01498822|4526746|P2|Overall Study|Lost to Follow-up|3
1371323|NCT01498822|4526747|P1|Overall Study|Lost to Follow-up|8
1371324|NCT01498822|4526746|P2|Overall Study|Withdrawal by Subject|25
1371325|NCT01498822|4526747|P1|Overall Study|Withdrawal by Subject|15
1371326|NCT01498822|4526746|P2|Overall Study|Adverse Event, serious fatal|1
1371327|NCT01498822|4526747|P1|Overall Study|Adverse Event, serious fatal|1
1371328|NCT01498822|4526746|P2|Overall Study|SAE, non-fatal|2
1371329|NCT01498822|4526747|P1|Overall Study|SAE, non-fatal|2
1371330|NCT01498822|4526746|P2|Overall Study|AE, non-serious non-fatal|17
1371331|NCT01498822|4526747|P1|Overall Study|AE, non-serious non-fatal|8
1371332|NCT01498822|4526746|P2|Overall Study|Lack of Efficacy|2
1371333|NCT01498822|4526747|P1|Overall Study|Lack of Efficacy|7
1371334|NCT01498822|4526746|P2|Overall Study|Other Reason|2
1371335|NCT01498822|4526747|P1|Overall Study|Other Reason|5
1371336|NCT01498822|4526746|P2|Overall Study|Protocol Violation|4
1371337|NCT01498822|4526747|P1|Overall Study|Protocol Violation|8
1371338|NCT01498692|4526774|P1|Overall Study|Missed 12-month visit|3
1371339|NCT01498692|4526774|P1|Overall Study|Withdrawal by Subject|1
1371340|NCT01498692|4526774|P1|Overall Study|Death|4
1371341|NCT01498679|4526805|P2|Overall Study|Withdrawal by Subject|4
1371342|NCT01498679|4526806|P1|Overall Study|Withdrawal by Subject|12
1371343|NCT01498679|4526805|P2|Overall Study|Physician Decision|2
1371344|NCT01498679|4526806|P1|Overall Study|Physician Decision|0
1371345|NCT01498679|4526805|P2|Overall Study|Protocol Violation|0
1371346|NCT01498679|4526806|P1|Overall Study|Protocol Violation|4
1371347|NCT01498679|4526805|P2|Overall Study|Lack of Efficacy|12
1371348|NCT01498679|4526806|P1|Overall Study|Lack of Efficacy|72
1371349|NCT01498679|4526805|P2|Overall Study|Adverse Event|4
1371350|NCT01498679|4526806|P1|Overall Study|Adverse Event|1
1371351|NCT01498653|4526822|P2|Overall Study|Withdrawal by Subject|3
1371352|NCT01498653|4526823|P1|Overall Study|Withdrawal by Subject|2
1371353|NCT01498653|4526822|P2|Overall Study|Physician Decision|0
1371354|NCT01498653|4526823|P1|Overall Study|Physician Decision|2
1371355|NCT01498653|4526822|P2|Overall Study|Lost to Follow-up|0
1371356|NCT01498653|4526823|P1|Overall Study|Lost to Follow-up|1
1371357|NCT01498653|4526822|P2|Overall Study|Protocol Violation|4
1371358|NCT01498653|4526823|P1|Overall Study|Protocol Violation|0
1371359|NCT01498653|4526822|P2|Overall Study|Lack of Efficacy|26
1371360|NCT01498653|4526823|P1|Overall Study|Lack of Efficacy|12
1371361|NCT01498653|4526822|P2|Overall Study|Adverse Event|2
1371362|NCT01498653|4526823|P1|Overall Study|Adverse Event|2
1371363|NCT01498640|4526837|P1|Overall Study|not specified|3
1371364|NCT01498640|4526837|P1|Overall Study|Death|1
1371365|NCT01498640|4526837|P1|Overall Study|Lost to Follow-up|1
1371366|NCT01498575|4526867|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
1371367|NCT01498575|4526868|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
1371368|NCT01498575|4526867|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
1371369|NCT01498575|4526868|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
1371370|NCT01498575|4526867|P2|Overall Sample|Withdrawal by Subject|14
1371371|NCT01498575|4526868|P1|Overall Sample|Withdrawal by Subject|60
1371372|NCT01498458|4526885|P1|Overall Study|Physician Decision|3
1371373|NCT01498458|4526885|P1|Overall Study|Adverse Event|4
1371374|NCT01498185|4526940|P5|Overall Study|No longer met criteria, etc|2
1371375|NCT01498185|4526941|P4|Overall Study|No longer met criteria, etc|0
1371376|NCT01498185|4526942|P3|Overall Study|No longer met criteria, etc|0
1371377|NCT01498185|4526943|P2|Overall Study|No longer met criteria, etc|0
1371378|NCT01498185|4526944|P1|Overall Study|No longer met criteria, etc|0
1371379|NCT01498185|4526940|P5|Overall Study|Withdrawal by Subject|1
1371380|NCT01498185|4526941|P4|Overall Study|Withdrawal by Subject|2
1371381|NCT01498185|4526942|P3|Overall Study|Withdrawal by Subject|0
1371382|NCT01498185|4526943|P2|Overall Study|Withdrawal by Subject|1
1371383|NCT01498185|4526944|P1|Overall Study|Withdrawal by Subject|1
1371384|NCT01498185|4526940|P5|Overall Study|Adverse Event|0
1371385|NCT01498185|4526941|P4|Overall Study|Adverse Event|1
1371386|NCT01498185|4526942|P3|Overall Study|Adverse Event|0
1371387|NCT01498185|4526943|P2|Overall Study|Adverse Event|0
1371388|NCT01498185|4526944|P1|Overall Study|Adverse Event|0
1371389|NCT01498120|4526984|P1|Overall Study|Other|4
1371390|NCT01498120|4526984|P1|Overall Study|AE, non-serious non-fatal|3
1371391|NCT01498120|4526984|P1|Overall Study|Withdrawal by Subject|5
1371392|NCT01498120|4526984|P1|Overall Study|Lost to Follow-up|1
1371393|NCT01498068|4526991|P2|Overall Study|Withdrawal by Subject|1
1371394|NCT01498068|4526992|P1|Overall Study|Withdrawal by Subject|1
1371395|NCT01497938|4527010|P2|Overall Study|Device Violation|0
1371396|NCT01497938|4527011|P1|Overall Study|Device Violation|1
1371397|NCT01497938|4527010|P2|Overall Study|Withdrawal by Subject|0
1371398|NCT01497938|4527011|P1|Overall Study|Withdrawal by Subject|4
1371399|NCT01497938|4527010|P2|Overall Study|Physician Decision|1
1371400|NCT01497938|4527011|P1|Overall Study|Physician Decision|0
1371401|NCT01497938|4527010|P2|Overall Study|Adverse Event|1
1371402|NCT01497938|4527011|P1|Overall Study|Adverse Event|0
1371403|NCT01497899|4527023|P4|Open-Label Extension Phase|Lost to Follow-up|5
1371404|NCT01497899|4527024|P3|Open-Label Extension Phase|Lost to Follow-up|5
1371405|NCT01497899|4527025|P2|Open-Label Extension Phase|Lost to Follow-up|3
1371406|NCT01497899|4527026|P1|Open-Label Extension Phase|Lost to Follow-up|9
1371407|NCT01497899|4527023|P4|Open-Label Extension Phase|Protocol Violation|0
1371408|NCT01497899|4527024|P3|Open-Label Extension Phase|Protocol Violation|1
1371409|NCT01497899|4527025|P2|Open-Label Extension Phase|Protocol Violation|0
1371410|NCT01497899|4527026|P1|Open-Label Extension Phase|Protocol Violation|0
1371411|NCT01497899|4527023|P4|Open-Label Extension Phase|Pregnancy|0
1371412|NCT01497899|4527024|P3|Open-Label Extension Phase|Pregnancy|1
1371413|NCT01497899|4527025|P2|Open-Label Extension Phase|Pregnancy|1
1371414|NCT01497899|4527026|P1|Open-Label Extension Phase|Pregnancy|0
1371415|NCT01497899|4527023|P4|Open-Label Extension Phase|Withdrew Consent|0
1371416|NCT01497899|4527024|P3|Open-Label Extension Phase|Withdrew Consent|2
1371417|NCT01497899|4527025|P2|Open-Label Extension Phase|Withdrew Consent|3
1371418|NCT01497899|4527026|P1|Open-Label Extension Phase|Withdrew Consent|8
1371419|NCT01497899|4527023|P4|Open-Label Extension Phase|Death|0
1371420|NCT01497899|4527024|P3|Open-Label Extension Phase|Death|0
1371421|NCT01497899|4527025|P2|Open-Label Extension Phase|Death|0
1371422|NCT01497899|4527026|P1|Open-Label Extension Phase|Death|1
1371423|NCT01497899|4527023|P4|Open-Label Extension Phase|Adverse Event|0
1371424|NCT01497899|4527024|P3|Open-Label Extension Phase|Adverse Event|0
1371425|NCT01497899|4527025|P2|Open-Label Extension Phase|Adverse Event|0
1371426|NCT01497899|4527026|P1|Open-Label Extension Phase|Adverse Event|1
1371427|NCT01497899|4527023|P4|Double-Blind Phase|Subject Non-Compliance|0
1371428|NCT01497899|4527024|P3|Double-Blind Phase|Subject Non-Compliance|0
1371429|NCT01497899|4527025|P2|Double-Blind Phase|Subject Non-Compliance|1
1371430|NCT01497899|4527026|P1|Double-Blind Phase|Subject Non-Compliance|0
1371431|NCT01497899|4527023|P4|Double-Blind Phase|Lost to Follow-up|0
1371432|NCT01497899|4527024|P3|Double-Blind Phase|Lost to Follow-up|0
1371433|NCT01497899|4527025|P2|Double-Blind Phase|Lost to Follow-up|2
1371434|NCT01497899|4527026|P1|Double-Blind Phase|Lost to Follow-up|3
1371435|NCT01497899|4527023|P4|Double-Blind Phase|Withdrew Consent|0
1371436|NCT01497899|4527024|P3|Double-Blind Phase|Withdrew Consent|0
1371437|NCT01497899|4527025|P2|Double-Blind Phase|Withdrew Consent|1
1371438|NCT01497899|4527026|P1|Double-Blind Phase|Withdrew Consent|0
1371439|NCT01497899|4527023|P4|Double-Blind Phase|Investigator's Discretion|0
1371440|NCT01497899|4527024|P3|Double-Blind Phase|Investigator's Discretion|0
1371441|NCT01497899|4527025|P2|Double-Blind Phase|Investigator's Discretion|0
1371442|NCT01497899|4527026|P1|Double-Blind Phase|Investigator's Discretion|1
1371443|NCT01497899|4527023|P4|Double-Blind Phase|Lack of Efficacy|0
1371444|NCT01497899|4527024|P3|Double-Blind Phase|Lack of Efficacy|0
1371445|NCT01497899|4527025|P2|Double-Blind Phase|Lack of Efficacy|1
1371446|NCT01497899|4527026|P1|Double-Blind Phase|Lack of Efficacy|0
1371447|NCT01497899|4527023|P4|Double-Blind Phase|Adverse Event|0
1371448|NCT01497899|4527024|P3|Double-Blind Phase|Adverse Event|0
1371449|NCT01497899|4527025|P2|Double-Blind Phase|Adverse Event|0
1371450|NCT01497899|4527026|P1|Double-Blind Phase|Adverse Event|1
1371451|NCT01497899|4527023|P4|Double-Blind Phase|Randomized but not Treated|0
1371452|NCT01497899|4527024|P3|Double-Blind Phase|Randomized but not Treated|0
1371453|NCT01497899|4527025|P2|Double-Blind Phase|Randomized but not Treated|0
1371454|NCT01497899|4527026|P1|Double-Blind Phase|Randomized but not Treated|1
1371455|NCT01497366|4527093|P2|Overall Study|Randomized but not treated|21
1371456|NCT01497366|4527094|P1|Overall Study|Randomized but not treated|7
1371457|NCT01497366|4527093|P2|Overall Study|Death|1
1371458|NCT01497366|4527094|P1|Overall Study|Death|1
1371459|NCT01497366|4527093|P2|Overall Study|Other|0
1371460|NCT01497366|4527094|P1|Overall Study|Other|5
1371461|NCT01497366|4527093|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
1371462|NCT01497366|4527094|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
1371463|NCT01497366|4527093|P2|Overall Study|Withdrawal by Subject|6
1371464|NCT01497366|4527094|P1|Overall Study|Withdrawal by Subject|6
1371465|NCT01497366|4527093|P2|Overall Study|Lost to Follow-up|10
1371466|NCT01497366|4527094|P1|Overall Study|Lost to Follow-up|11
1371467|NCT01497366|4527093|P2|Overall Study|Virologic failure|50
1371468|NCT01497366|4527094|P1|Overall Study|Virologic failure|2
1371469|NCT01497275|4527112|P1|Overall Study|Adverse Event|1
1371470|NCT01497275|4527112|P1|Overall Study|Death|1
1371471|NCT01497262|4527119|P1|Overall Study|Protocol Violation|1
1371472|NCT01497262|4527119|P1|Overall Study|Adverse Event|2
1371473|NCT01497262|4527119|P1|Overall Study|Withdrawal by Subject|2
1371474|NCT01497262|4527119|P1|Overall Study|Physician Decision|1
1371475|NCT01497262|4527119|P1|Overall Study|Abnormal Test Procedure Result|1
1371476|NCT01497262|4527119|P1|Overall Study|Abnormal Lab Values|4
1371477|NCT01497197|4527126|P2|Overall Study|Other|1
1371478|NCT01497197|4527127|P1|Overall Study|Other|3
1371479|NCT01497197|4527126|P2|Overall Study|All embryos discarded|3
1371480|NCT01497197|4527127|P1|Overall Study|All embryos discarded|0
1371481|NCT01497197|4527126|P2|Overall Study|Intention to freeze all embryos|1
1371482|NCT01497197|4527127|P1|Overall Study|Intention to freeze all embryos|0
1371483|NCT01497197|4527126|P2|Overall Study|No fertilisation|5
1371484|NCT01497197|4527127|P1|Overall Study|No fertilisation|6
1371485|NCT01497197|4527126|P2|Overall Study|No oocytes retrieved|2
1371486|NCT01497197|4527127|P1|Overall Study|No oocytes retrieved|3
1371487|NCT01497197|4527126|P2|Overall Study|Risk of OHSS|0
1371488|NCT01497197|4527127|P1|Overall Study|Risk of OHSS|1
1371489|NCT01497197|4527126|P2|Overall Study|Excessive/lack of response to treatment|0
1371490|NCT01497197|4527127|P1|Overall Study|Excessive/lack of response to treatment|1
1371491|NCT01497197|4527126|P2|Overall Study|Withdrawal by Subject|1
1371492|NCT01497197|4527127|P1|Overall Study|Withdrawal by Subject|2
1371493|NCT01497197|4527126|P2|Overall Study|Protocol Violation|2
1371494|NCT01497197|4527127|P1|Overall Study|Protocol Violation|0
1371495|NCT01497197|4527126|P2|Overall Study|Lost to Follow-up|0
1371496|NCT01497197|4527127|P1|Overall Study|Lost to Follow-up|1
1371497|NCT01496846|4527168|P6|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1371498|NCT01496846|4527169|P5|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1371499|NCT01496846|4527170|P4|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1371500|NCT01496846|4527171|P3|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1371501|NCT01496846|4527172|P2|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
1371502|NCT01496846|4527173|P1|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
1371503|NCT01496807|4527184|P1|Overall Study|Change in diagnosis|1
1371504|NCT01496807|4527184|P1|Overall Study|Participant preference/toxicity|8
1371505|NCT01496807|4527184|P1|Overall Study|Progressive Disease|21
1371506|NCT01496469|4527196|P2|Overall Study|Other|1
1371507|NCT01496469|4527197|P1|Overall Study|Other|1
1371508|NCT01496469|4527196|P2|Overall Study|BP exceeds protocol limits|2
1371509|NCT01496469|4527197|P1|Overall Study|BP exceeds protocol limits|1
1371510|NCT01496469|4527196|P2|Overall Study|Withdrawal by Subject|4
1371511|NCT01496469|4527197|P1|Overall Study|Withdrawal by Subject|4
1371512|NCT01496469|4527196|P2|Overall Study|Lost to Follow-up|1
1371513|NCT01496469|4527197|P1|Overall Study|Lost to Follow-up|1
1371514|NCT01496469|4527196|P2|Overall Study|Protocol Violation|0
1371515|NCT01496469|4527197|P1|Overall Study|Protocol Violation|2
1371516|NCT01496469|4527196|P2|Overall Study|Adverse Event|0
1371517|NCT01496469|4527197|P1|Overall Study|Adverse Event|1
1371518|NCT01496456|4527207|P1|Overall Study|Lost to Follow-up|7
1371519|NCT01496456|4527207|P1|Overall Study|Protocol Violation|1
1371520|NCT01496430|4527220|P3|Overall Study|Other|0
1371521|NCT01496430|4527221|P2|Overall Study|Other|0
1371522|NCT01496430|4527222|P1|Overall Study|Other|2
1371523|NCT01496430|4527220|P3|Overall Study|Principal Investigator Discretion|1
1371524|NCT01496430|4527221|P2|Overall Study|Principal Investigator Discretion|1
1371525|NCT01496430|4527222|P1|Overall Study|Principal Investigator Discretion|0
1371526|NCT01496430|4527220|P3|Overall Study|Voluntary Withdrawal|6
1371527|NCT01496430|4527221|P2|Overall Study|Voluntary Withdrawal|1
1371528|NCT01496430|4527222|P1|Overall Study|Voluntary Withdrawal|2
1371529|NCT01496430|4527220|P3|Overall Study|Lost to Follow-up|1
1371530|NCT01496430|4527221|P2|Overall Study|Lost to Follow-up|3
1371531|NCT01496430|4527222|P1|Overall Study|Lost to Follow-up|2
1371532|NCT01496430|4527220|P3|Overall Study|Major Protocol Deviation|1
1371533|NCT01496430|4527221|P2|Overall Study|Major Protocol Deviation|0
1371534|NCT01496430|4527222|P1|Overall Study|Major Protocol Deviation|0
1371535|NCT01496430|4527220|P3|Overall Study|Adverse Event|1
1371536|NCT01496430|4527221|P2|Overall Study|Adverse Event|0
1371537|NCT01496430|4527222|P1|Overall Study|Adverse Event|0
1371538|NCT01496287|4527334|P1|Overall Study|Incomplete anesthesia|5
1371539|NCT01496287|4527334|P1|Overall Study|Lost to Follow-up|1
1371540|NCT01496274|4527344|P2|Overall Study|Lost to Follow-up|3
1371541|NCT01496274|4527345|P1|Overall Study|Lost to Follow-up|0
1371542|NCT01496274|4527344|P2|Overall Study|Withdrawal by Subject|0
1371543|NCT01496274|4527345|P1|Overall Study|Withdrawal by Subject|2
1371544|NCT01496274|4527344|P2|Overall Study|Adverse Event|1
1371545|NCT01496274|4527345|P1|Overall Study|Adverse Event|1
1371546|NCT01496274|4527344|P2|Overall Study|Protocol Violation|1
1371547|NCT01496274|4527345|P1|Overall Study|Protocol Violation|0
1371548|NCT01496183|4527390|P2|Overall Study|Withdrawal by Subject|1
1371549|NCT01496183|4527391|P1|Overall Study|Withdrawal by Subject|0
1371550|NCT01496183|4527390|P2|Overall Study|Physician Decision|1
1371551|NCT01496183|4527391|P1|Overall Study|Physician Decision|3
1371552|NCT01496066|4527443|P2|Overall Study|Death|4
1371553|NCT01496066|4527444|P1|Overall Study|Death|1
1371554|NCT01496066|4527443|P2|Overall Study|Explant|0
1371555|NCT01496066|4527444|P1|Overall Study|Explant|3
1371556|NCT01496066|4527443|P2|Overall Study|Lost to Follow-up|5
1371557|NCT01496066|4527444|P1|Overall Study|Lost to Follow-up|8
1371558|NCT01495975|4527506|P2|Overall Study|Lost to Follow-up|0
1371559|NCT01495975|4527507|P1|Overall Study|Lost to Follow-up|1
1371560|NCT01495793|4527631|P1|Overall Study|Violation of inclusion criteria|1
1371561|NCT01495793|4527631|P1|Overall Study|Lost to Follow-up|1
1371562|NCT01495702|4527644|P2|Randomized Phase|Protocol Violation|1
1371563|NCT01495702|4527645|P1|Randomized Phase|Protocol Violation|3
1371564|NCT01495702|4527644|P2|Randomized Phase|Participant Noncompliance|0
1371565|NCT01495702|4527645|P1|Randomized Phase|Participant Noncompliance|1
1371566|NCT01495702|4527644|P2|Randomized Phase|Lost to Follow-up|3
1371567|NCT01495702|4527645|P1|Randomized Phase|Lost to Follow-up|4
1371568|NCT01495702|4527644|P2|Randomized Phase|Withdrew Consent|18
1371569|NCT01495702|4527645|P1|Randomized Phase|Withdrew Consent|10
1371570|NCT01495702|4527644|P2|Randomized Phase|Investigators Discretion|0
1371571|NCT01495702|4527645|P1|Randomized Phase|Investigators Discretion|2
1371572|NCT01495702|4527644|P2|Randomized Phase|Lack of Efficacy|0
1371573|NCT01495702|4527645|P1|Randomized Phase|Lack of Efficacy|2
1371574|NCT01495702|4527644|P2|Randomized Phase|Death|0
1371575|NCT01495702|4527645|P1|Randomized Phase|Death|1
1371576|NCT01495702|4527644|P2|Randomized Phase|Adverse Event|2
1371577|NCT01495702|4527645|P1|Randomized Phase|Adverse Event|2
1371578|NCT01495702|4527644|P2|Randomized Phase|Randomized But Not Treated|4
1371579|NCT01495702|4527645|P1|Randomized Phase|Randomized But Not Treated|1
1371580|NCT01495000|4527716|P2|Overall Study|Withdrawal by Subject|10
1371581|NCT01495000|4527717|P1|Overall Study|Withdrawal by Subject|10
1371582|NCT01495000|4527716|P2|Overall Study|Protocol Violation|0
1371583|NCT01495000|4527717|P1|Overall Study|Protocol Violation|1
1371584|NCT01495000|4527716|P2|Overall Study|Lost to Follow-up|2
1371585|NCT01495000|4527717|P1|Overall Study|Lost to Follow-up|2
1371586|NCT01494987|4527759|P2|Overall Study|Subject Withdrew Consent|3
1371587|NCT01494987|4527760|P1|Overall Study|Subject Withdrew Consent|2
1371588|NCT01494987|4527759|P2|Overall Study|Subject Non-Compliance|10
1371589|NCT01494987|4527760|P1|Overall Study|Subject Non-Compliance|9
1371590|NCT01494987|4527759|P2|Overall Study|Protocol Violation|3
1371591|NCT01494987|4527760|P1|Overall Study|Protocol Violation|3
1371592|NCT01494987|4527759|P2|Overall Study|Lost to Follow-up|1
1371593|NCT01494987|4527760|P1|Overall Study|Lost to Follow-up|1
1371594|NCT01494987|4527759|P2|Overall Study|Investigator's Discretion|2
1371595|NCT01494987|4527760|P1|Overall Study|Investigator's Discretion|1
1371596|NCT01494987|4527759|P2|Overall Study|Hyperglycemia|4
1371597|NCT01494987|4527760|P1|Overall Study|Hyperglycemia|6
1371598|NCT01494987|4527759|P2|Overall Study|Adverse Event|5
1371599|NCT01494987|4527760|P1|Overall Study|Adverse Event|6
1371600|NCT01494818|4527774|P2|Overall Study|Lost to Follow-up|0
1371601|NCT01494818|4527775|P1|Overall Study|Lost to Follow-up|1
1371602|NCT01494818|4527774|P2|Overall Study|Relocation|2
1371603|NCT01494818|4527775|P1|Overall Study|Relocation|1
1371604|NCT01494649|4527806|P2|Overall Study|Lost to Follow-up|1
1371605|NCT01494649|4527807|P1|Overall Study|Lost to Follow-up|0
1371606|NCT01494610|4527823|P2|Period 4|Protocol Violation|0
1371607|NCT01494610|4527824|P1|Period 4|Protocol Violation|1
1371608|NCT01494610|4527823|P2|Period 3|Withdrawal by Subject|0
1371609|NCT01494610|4527824|P1|Period 3|Withdrawal by Subject|1
1371610|NCT01494610|4527823|P2|Period 3|Adverse Event|0
1371611|NCT01494610|4527824|P1|Period 3|Adverse Event|1
1371612|NCT01494610|4527823|P2|Period 1|Withdrawal by Subject|1
1371613|NCT01494610|4527824|P1|Period 1|Withdrawal by Subject|1
1371614|NCT01494584|4527892|P1|Overall Study|Study Closed/Terminated|1
1371615|NCT01494532|4528024|P6|Overall Study|Withdrawal by Subject|0
1371616|NCT01494532|4528025|P5|Overall Study|Withdrawal by Subject|2
1371617|NCT01494532|4528026|P4|Overall Study|Withdrawal by Subject|3
1371618|NCT01494532|4528027|P3|Overall Study|Withdrawal by Subject|4
1371619|NCT01494532|4528028|P2|Overall Study|Withdrawal by Subject|1
1371620|NCT01494532|4528029|P1|Overall Study|Withdrawal by Subject|3
1371621|NCT01494532|4528024|P6|Overall Study|Physician Decision|0
1371622|NCT01494532|4528025|P5|Overall Study|Physician Decision|0
1371623|NCT01494532|4528026|P4|Overall Study|Physician Decision|2
1371624|NCT01494532|4528027|P3|Overall Study|Physician Decision|1
1371625|NCT01494532|4528028|P2|Overall Study|Physician Decision|1
1371626|NCT01494532|4528029|P1|Overall Study|Physician Decision|0
1371627|NCT01494532|4528024|P6|Overall Study|Lost to Follow-up|0
1371628|NCT01494532|4528025|P5|Overall Study|Lost to Follow-up|0
1371629|NCT01494532|4528026|P4|Overall Study|Lost to Follow-up|2
1371630|NCT01494532|4528027|P3|Overall Study|Lost to Follow-up|0
1371631|NCT01494532|4528028|P2|Overall Study|Lost to Follow-up|0
1371632|NCT01494532|4528029|P1|Overall Study|Lost to Follow-up|1
1371633|NCT01494532|4528024|P6|Overall Study|Protocol-defined stopping criteria|0
1371634|NCT01494532|4528025|P5|Overall Study|Protocol-defined stopping criteria|0
1371635|NCT01494532|4528026|P4|Overall Study|Protocol-defined stopping criteria|0
1371636|NCT01494532|4528027|P3|Overall Study|Protocol-defined stopping criteria|1
1371637|NCT01494532|4528028|P2|Overall Study|Protocol-defined stopping criteria|0
1371638|NCT01494532|4528029|P1|Overall Study|Protocol-defined stopping criteria|0
1371639|NCT01494532|4528024|P6|Overall Study|Protocol deviation|0
1371640|NCT01494532|4528025|P5|Overall Study|Protocol deviation|3
1371641|NCT01494532|4528026|P4|Overall Study|Protocol deviation|2
1371642|NCT01494532|4528027|P3|Overall Study|Protocol deviation|3
1371643|NCT01494532|4528028|P2|Overall Study|Protocol deviation|1
1371644|NCT01494532|4528029|P1|Overall Study|Protocol deviation|2
1371645|NCT01494532|4528024|P6|Overall Study|Lack of Efficacy|0
1371646|NCT01494532|4528025|P5|Overall Study|Lack of Efficacy|2
1371647|NCT01494532|4528026|P4|Overall Study|Lack of Efficacy|0
1371648|NCT01494532|4528027|P3|Overall Study|Lack of Efficacy|0
1371649|NCT01494532|4528028|P2|Overall Study|Lack of Efficacy|0
1371650|NCT01494532|4528029|P1|Overall Study|Lack of Efficacy|0
1371651|NCT01494532|4528024|P6|Overall Study|Adverse Event|0
1371652|NCT01494532|4528025|P5|Overall Study|Adverse Event|5
1371653|NCT01494532|4528026|P4|Overall Study|Adverse Event|6
1371654|NCT01494532|4528027|P3|Overall Study|Adverse Event|8
1371655|NCT01494532|4528028|P2|Overall Study|Adverse Event|1
1371656|NCT01494532|4528029|P1|Overall Study|Adverse Event|4
1371657|NCT01494506|4528184|P3|Overall Study|Other|1
1371658|NCT01494506|4528185|P2|Overall Study|Other|3
1371659|NCT01494506|4528186|P1|Overall Study|Other|0
1371660|NCT01494506|4528184|P3|Overall Study|Sponsor Decision|1
1371661|NCT01494506|4528185|P2|Overall Study|Sponsor Decision|0
1371662|NCT01494506|4528186|P1|Overall Study|Sponsor Decision|0
1371663|NCT01494506|4528184|P3|Overall Study|Clinical Deterioration|13
1371664|NCT01494506|4528185|P2|Overall Study|Clinical Deterioration|17
1371665|NCT01494506|4528186|P1|Overall Study|Clinical Deterioration|21
1371666|NCT01494506|4528184|P3|Overall Study|Withdrawal by Subject|14
1371667|NCT01494506|4528185|P2|Overall Study|Withdrawal by Subject|20
1371668|NCT01494506|4528186|P1|Overall Study|Withdrawal by Subject|17
1371669|NCT01494506|4528184|P3|Overall Study|Physician Decision|4
1371670|NCT01494506|4528185|P2|Overall Study|Physician Decision|5
1371671|NCT01494506|4528186|P1|Overall Study|Physician Decision|7
1371672|NCT01494506|4528184|P3|Overall Study|Death|2
1371673|NCT01494506|4528185|P2|Overall Study|Death|5
1371674|NCT01494506|4528186|P1|Overall Study|Death|9
1371675|NCT01494506|4528184|P3|Overall Study|Adverse Event|11
1371676|NCT01494506|4528185|P2|Overall Study|Adverse Event|10
1371677|NCT01494506|4528186|P1|Overall Study|Adverse Event|17
1371678|NCT01494506|4528184|P3|Overall Study|Lack of Efficacy|57
1371679|NCT01494506|4528185|P2|Overall Study|Lack of Efficacy|83
1371680|NCT01494506|4528186|P1|Overall Study|Lack of Efficacy|77
1371681|NCT01494467|4528223|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
1371682|NCT01494467|4528224|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
1371683|NCT01494467|4528223|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
1371684|NCT01494467|4528224|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
1371685|NCT01494467|4528223|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
1371686|NCT01494467|4528224|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
1371687|NCT01494467|4528223|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
1371688|NCT01494467|4528224|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
1371689|NCT01494467|4528223|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
1371690|NCT01494467|4528224|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
1371691|NCT01494467|4528223|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
1371692|NCT01494467|4528224|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
1371693|NCT01494467|4528223|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
1371694|NCT01494467|4528224|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
1371695|NCT01494467|4528223|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
1371696|NCT01494467|4528224|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
1371697|NCT01494467|4528223|P2|Part A Vehicle Control (12 Weeks)|Other|1
1371698|NCT01494467|4528224|P1|Part A Vehicle Control (12 Weeks)|Other|1
1371699|NCT01494467|4528223|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
1371700|NCT01494467|4528224|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
1371701|NCT01494467|4528223|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
1371702|NCT01494467|4528224|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
1371703|NCT01494467|4528223|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
1371704|NCT01494467|4528224|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
1371705|NCT01494467|4528223|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
1371706|NCT01494467|4528224|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
1371707|NCT01494467|4528223|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
1371708|NCT01494467|4528224|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
1371709|NCT01494350|4528240|P1|Overall Study|Worsening of lesion|1
1371710|NCT01494298|4528250|P2|Overall Study|Protocol Violation|8
1371711|NCT01494298|4528251|P1|Overall Study|Protocol Violation|2
1371712|NCT01493960|4528263|P2|Overall Study|Non-specified|4
1371713|NCT01493960|4528264|P1|Overall Study|Non-specified|4
1371714|NCT01493960|4528263|P2|Overall Study|Withdrawal by Subject|4
1371715|NCT01493960|4528264|P1|Overall Study|Withdrawal by Subject|10
1371716|NCT01493960|4528263|P2|Overall Study|Protocol Violation|0
1371717|NCT01493960|4528264|P1|Overall Study|Protocol Violation|3
1371718|NCT01493960|4528263|P2|Overall Study|Lack of Efficacy|9
1371719|NCT01493960|4528264|P1|Overall Study|Lack of Efficacy|15
1371720|NCT01493960|4528263|P2|Overall Study|Adverse Event|1
1371721|NCT01493960|4528264|P1|Overall Study|Adverse Event|0
1371722|NCT01493687|4528297|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
1371723|NCT01493687|4528298|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
1371724|NCT01493687|4528297|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
1371725|NCT01493687|4528298|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
1371726|NCT01493687|4528297|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
1371727|NCT01493687|4528298|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
1371728|NCT01493687|4528297|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
1371729|NCT01493687|4528298|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
1371730|NCT01493687|4528297|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
1371731|NCT01493687|4528298|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
1371732|NCT01493687|4528297|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
1371733|NCT01493687|4528298|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
1371734|NCT01493687|4528297|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
1371735|NCT01493687|4528298|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
1371736|NCT01493687|4528297|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
1371737|NCT01493687|4528298|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
1371738|NCT01493687|4528297|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
1371739|NCT01493687|4528298|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
1371740|NCT01493687|4528297|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
1371741|NCT01493687|4528298|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
1371742|NCT01493687|4528297|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
1371743|NCT01493687|4528298|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
1371744|NCT01493687|4528297|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
1371745|NCT01493687|4528298|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
1371746|NCT01493687|4528297|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
1371747|NCT01493687|4528298|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
1371748|NCT01493687|4528297|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
1371749|NCT01493687|4528298|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
1371750|NCT01493687|4528297|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
1371751|NCT01493687|4528298|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
1371752|NCT01493557|4528317|P3|Adding the Second Strategy|Withdrawal by Subject|0
1371753|NCT01493557|4528318|P2|Adding the Second Strategy|Withdrawal by Subject|1
1371754|NCT01493557|4528319|P1|Adding the Second Strategy|Withdrawal by Subject|0
1371755|NCT01493557|4528317|P3|Adding the Second Strategy|Other adverse event|0
1371756|NCT01493557|4528318|P2|Adding the Second Strategy|Other adverse event|2
1371757|NCT01493557|4528319|P1|Adding the Second Strategy|Other adverse event|1
1371758|NCT01493557|4528317|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
1371759|NCT01493557|4528318|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
1371760|NCT01493557|4528319|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
1371761|NCT01493557|4528317|P3|Randomized to Management Strategies|Other than stated above|0
1371762|NCT01493557|4528318|P2|Randomized to Management Strategies|Other than stated above|3
1371763|NCT01493557|4528319|P1|Randomized to Management Strategies|Other than stated above|1
1371764|NCT01493557|4528317|P3|Randomized to Management Strategies|Withdrawal by Subject|0
1371765|NCT01493557|4528318|P2|Randomized to Management Strategies|Withdrawal by Subject|1
1371766|NCT01493557|4528319|P1|Randomized to Management Strategies|Withdrawal by Subject|0
1371767|NCT01493557|4528317|P3|Randomized to Management Strategies|Protocol Violation|0
1371768|NCT01493557|4528318|P2|Randomized to Management Strategies|Protocol Violation|0
1371769|NCT01493557|4528319|P1|Randomized to Management Strategies|Protocol Violation|3
1371770|NCT01493557|4528317|P3|Randomized to Management Strategies|Other adverse event|0
1371771|NCT01493557|4528318|P2|Randomized to Management Strategies|Other adverse event|5
1371772|NCT01493557|4528319|P1|Randomized to Management Strategies|Other adverse event|8
1371773|NCT01493557|4528317|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
1371774|NCT01493557|4528318|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
1371775|NCT01493557|4528319|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
1371776|NCT01493557|4528317|P3|Not Randomized to Management Strategies|Other than stated above|21
1371777|NCT01493557|4528318|P2|Not Randomized to Management Strategies|Other than stated above|0
1371778|NCT01493557|4528319|P1|Not Randomized to Management Strategies|Other than stated above|0
1371779|NCT01493557|4528317|P3|Not Randomized to Management Strategies|Early termination|34
1371780|NCT01493557|4528318|P2|Not Randomized to Management Strategies|Early termination|0
1371781|NCT01493557|4528319|P1|Not Randomized to Management Strategies|Early termination|0
1371782|NCT01493557|4528317|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
1371783|NCT01493557|4528318|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
1371784|NCT01493557|4528319|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
1371785|NCT01493557|4528317|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
1371786|NCT01493557|4528318|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
1371787|NCT01493557|4528319|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
1371788|NCT01493557|4528317|P3|Not Randomized to Management Strategies|Protocol Violation|1
1371789|NCT01493557|4528318|P2|Not Randomized to Management Strategies|Protocol Violation|0
1371790|NCT01493557|4528319|P1|Not Randomized to Management Strategies|Protocol Violation|0
1371791|NCT01493557|4528317|P3|Not Randomized to Management Strategies|Other adverse event|54
1371792|NCT01493557|4528318|P2|Not Randomized to Management Strategies|Other adverse event|0
1371793|NCT01493557|4528319|P1|Not Randomized to Management Strategies|Other adverse event|0
1371794|NCT01493557|4528317|P3|Not Randomized to Management Strategies|Worsening of other pre−existing disease|9
1371795|NCT01493557|4528318|P2|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
1371796|NCT01493557|4528319|P1|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
1371797|NCT01493557|4528317|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
1371798|NCT01493557|4528318|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
1371799|NCT01493557|4528319|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
1371800|NCT01493531|4528347|P3|Overall Study|Death|0
1371801|NCT01493531|4528348|P2|Overall Study|Death|1
1371802|NCT01493531|4528349|P1|Overall Study|Death|0
1371803|NCT01493531|4528347|P3|Overall Study|Withdrawal by Subject|11
1371804|NCT01493531|4528348|P2|Overall Study|Withdrawal by Subject|13
1371805|NCT01493531|4528349|P1|Overall Study|Withdrawal by Subject|16
1371806|NCT01493531|4528347|P3|Overall Study|Lost to Follow-up|11
1371807|NCT01493531|4528348|P2|Overall Study|Lost to Follow-up|7
1371808|NCT01493531|4528349|P1|Overall Study|Lost to Follow-up|5
1371809|NCT01493531|4528347|P3|Overall Study|Sponsor terminated study|3
1371810|NCT01493531|4528348|P2|Overall Study|Sponsor terminated study|2
1371811|NCT01493531|4528349|P1|Overall Study|Sponsor terminated study|5
1371812|NCT01493531|4528347|P3|Overall Study|Protocol Violation|12
1371813|NCT01493531|4528348|P2|Overall Study|Protocol Violation|15
1371814|NCT01493531|4528349|P1|Overall Study|Protocol Violation|8
1371815|NCT01493531|4528347|P3|Overall Study|Gout flare|2
1371816|NCT01493531|4528348|P2|Overall Study|Gout flare|0
1371817|NCT01493531|4528349|P1|Overall Study|Gout flare|3
1371818|NCT01493531|4528347|P3|Overall Study|Adverse Event|9
1371819|NCT01493531|4528348|P2|Overall Study|Adverse Event|12
1371820|NCT01493531|4528349|P1|Overall Study|Adverse Event|4
1371821|NCT01493427|4528363|P1|Overall Study|Other|2
1371822|NCT01493427|4528363|P1|Overall Study|Inability to Follow Instructions|2
1371823|NCT01493427|4528363|P1|Overall Study|Lost to Follow-up|2
1371824|NCT01493427|4528363|P1|Overall Study|Personal Reasons|4
1371825|NCT01493427|4528363|P1|Overall Study|Adverse Event|10
1371826|NCT01493284|4528368|P1|Overall Study|Withdrawal by Subject|32
1371827|NCT01493284|4528368|P1|Overall Study|Death|29
1371828|NCT01493089|4528390|P2|Overall Study|Physician Decision|1
1371829|NCT01493089|4528391|P1|Overall Study|Physician Decision|0
1371830|NCT01493089|4528390|P2|Overall Study|Withdrawal by Subject|0
1371831|NCT01493089|4528391|P1|Overall Study|Withdrawal by Subject|1
1371832|NCT01493089|4528390|P2|Overall Study|Protocol Violation|2
1371833|NCT01493089|4528391|P1|Overall Study|Protocol Violation|2
1371834|NCT01492439|4528490|P2|Overall Study|Withdrew from RTE|9
1371835|NCT01492439|4528491|P1|Overall Study|Withdrew from RTE|4
1371836|NCT01492426|4528539|P2|Follow-Up|Lost to Follow-up|6
1371837|NCT01492426|4528540|P1|Follow-Up|Lost to Follow-up|12
1371838|NCT01492426|4528539|P2|Follow-Up|Participant Withdrew Consent|1
1371839|NCT01492426|4528540|P1|Follow-Up|Participant Withdrew Consent|6
1371840|NCT01492426|4528539|P2|Follow-Up|Other|2
1371841|NCT01492426|4528540|P1|Follow-Up|Other|4
1371842|NCT01492426|4528539|P2|Follow-Up|Death|0
1371843|NCT01492426|4528540|P1|Follow-Up|Death|1
1371844|NCT01492426|4528539|P2|Follow-Up|Protocol Requires no Follow-Up|1
1371845|NCT01492426|4528540|P1|Follow-Up|Protocol Requires no Follow-Up|2
1371846|NCT01492426|4528539|P2|Treatment|Participant does not meet study criteria|0
1371847|NCT01492426|4528540|P1|Treatment|Participant does not meet study criteria|1
1371848|NCT01492426|4528539|P2|Treatment|Lost to Follow-up|4
1371849|NCT01492426|4528540|P1|Treatment|Lost to Follow-up|9
1371850|NCT01492426|4528539|P2|Treatment|Subject requested discontinue study drug|3
1371851|NCT01492426|4528540|P1|Treatment|Subject requested discontinue study drug|7
1371852|NCT01492426|4528539|P2|Treatment|Poor compliance/noncompliance|0
1371853|NCT01492426|4528540|P1|Treatment|Poor compliance/noncompliance|1
1371854|NCT01492426|4528539|P2|Treatment|Participant withdrew consent|2
1371855|NCT01492426|4528540|P1|Treatment|Participant withdrew consent|1
1371856|NCT01492426|4528539|P2|Treatment|Lack of Efficacy|5
1371857|NCT01492426|4528540|P1|Treatment|Lack of Efficacy|38
1371858|NCT01492426|4528539|P2|Treatment|Adverse Event|25
1371859|NCT01492426|4528540|P1|Treatment|Adverse Event|25
1371860|NCT01492426|4528539|P2|Treatment|Other|0
1371861|NCT01492426|4528540|P1|Treatment|Other|1
1371862|NCT01492426|4528539|P2|Treatment|Death|1
1371863|NCT01492426|4528540|P1|Treatment|Death|0
1371864|NCT01492400|4528558|P2|Overall Study|Adverse Event|5
1371865|NCT01492400|4528559|P1|Overall Study|Adverse Event|10
1371866|NCT01492400|4528558|P2|Overall Study|Lack of Efficacy|1
1371867|NCT01492400|4528559|P1|Overall Study|Lack of Efficacy|1
1371868|NCT01492400|4528558|P2|Overall Study|Pregnancy|1
1371869|NCT01492400|4528559|P1|Overall Study|Pregnancy|0
1371870|NCT01492400|4528558|P2|Overall Study|Lost to Follow-up|1
1371871|NCT01492400|4528559|P1|Overall Study|Lost to Follow-up|3
1371872|NCT01492400|4528558|P2|Overall Study|Personal Reasons|5
1371873|NCT01492400|4528559|P1|Overall Study|Personal Reasons|0
1371874|NCT01492400|4528558|P2|Overall Study|Miscellaneous Reasons|3
1371875|NCT01492400|4528559|P1|Overall Study|Miscellaneous Reasons|2
1371876|NCT01492088|4528583|P3|Overall Study|Reason Not Specified|12
1371877|NCT01492088|4528584|P2|Overall Study|Reason Not Specified|6
1371878|NCT01492088|4528585|P1|Overall Study|Reason Not Specified|2
1371879|NCT01492088|4528583|P3|Overall Study|Death|1
1371880|NCT01492088|4528584|P2|Overall Study|Death|6
1371881|NCT01492088|4528585|P1|Overall Study|Death|1
1371882|NCT01492088|4528583|P3|Overall Study|Withdrawal by Patient|0
1371883|NCT01492088|4528584|P2|Overall Study|Withdrawal by Patient|2
1371884|NCT01492088|4528585|P1|Overall Study|Withdrawal by Patient|0
1371885|NCT01491919|4528666|P3|Overall Study|Insufficient PK sampling|1
1371886|NCT01491919|4528667|P2|Overall Study|Insufficient PK sampling|2
1371887|NCT01491919|4528668|P1|Overall Study|Insufficient PK sampling|1
1371888|NCT01491802|4528714|P2|Overall Study|Withdrawal by Subject|1
1371889|NCT01491802|4528715|P1|Overall Study|Withdrawal by Subject|0
1371890|NCT01491802|4528714|P2|Overall Study|Adverse Event|1
1371891|NCT01491802|4528715|P1|Overall Study|Adverse Event|1
1371892|NCT01491737|4528742|P2|Overall Study|Reason not specified|3
1371893|NCT01491737|4528743|P1|Overall Study|Reason not specified|2
1371894|NCT01491737|4528742|P2|Overall Study|Death|28
1371895|NCT01491737|4528743|P1|Overall Study|Death|33
1371896|NCT01491737|4528742|P2|Overall Study|Lost to Follow-up|6
1371897|NCT01491737|4528743|P1|Overall Study|Lost to Follow-up|1
1371898|NCT01491737|4528742|P2|Overall Study|Withdrawal of consent|13
1371899|NCT01491737|4528743|P1|Overall Study|Withdrawal of consent|13
1371900|NCT01491672|4528766|P3|Overall Study|Death|0
1371901|NCT01491672|4528767|P2|Overall Study|Death|4
1371902|NCT01491672|4528768|P1|Overall Study|Death|0
1371903|NCT01491672|4528766|P3|Overall Study|Protocol deviation|0
1371904|NCT01491672|4528767|P2|Overall Study|Protocol deviation|1
1371905|NCT01491672|4528768|P1|Overall Study|Protocol deviation|0
1371906|NCT01491672|4528766|P3|Overall Study|Disease progression|6
1371907|NCT01491672|4528767|P2|Overall Study|Disease progression|34
1371908|NCT01491672|4528768|P1|Overall Study|Disease progression|42
1371909|NCT01491672|4528766|P3|Overall Study|Adverse Event|4
1371910|NCT01491672|4528767|P2|Overall Study|Adverse Event|10
1371911|NCT01491672|4528768|P1|Overall Study|Adverse Event|8
1371912|NCT01491672|4528766|P3|Overall Study|Withdrawal by Subject|0
1371913|NCT01491672|4528767|P2|Overall Study|Withdrawal by Subject|7
1371914|NCT01491672|4528768|P1|Overall Study|Withdrawal by Subject|6
1371915|NCT01491672|4528766|P3|Overall Study|Lost to Follow-up|1
1371916|NCT01491672|4528767|P2|Overall Study|Lost to Follow-up|4
1371917|NCT01491672|4528768|P1|Overall Study|Lost to Follow-up|0
1371918|NCT01491607|4528805|P1|Overall Study|Withdrawal by Subject|3
1371919|NCT01491607|4528805|P1|Overall Study|Lost to Follow-up|7
1371920|NCT01491178|4528910|P1|Overall Study|Other than specified above|657
1371921|NCT01491178|4528910|P1|Overall Study|To take a contraindication|20
1371922|NCT01491178|4528910|P1|Overall Study|Lost to follow−up (changing hospital)|545
1371923|NCT01491178|4528910|P1|Overall Study|Lost to follow−up (unknown reason)|287
1371924|NCT01491178|4528910|P1|Overall Study|To conduct invasive treatment|59
1371925|NCT01491178|4528910|P1|Overall Study|Improvement of NVAF|210
1371926|NCT01491178|4528910|P1|Overall Study|Adverse Event|1016
1371927|NCT01491035|4529019|P8|Overall Study|Lost to Follow-up|0
1371928|NCT01491035|4529020|P7|Overall Study|Lost to Follow-up|0
1371929|NCT01491035|4529021|P6|Overall Study|Lost to Follow-up|0
1371930|NCT01491035|4529022|P5|Overall Study|Lost to Follow-up|1
1371931|NCT01491035|4529023|P4|Overall Study|Lost to Follow-up|0
1371932|NCT01491035|4529024|P3|Overall Study|Lost to Follow-up|0
1371933|NCT01491035|4529025|P2|Overall Study|Lost to Follow-up|0
1371934|NCT01491035|4529026|P1|Overall Study|Lost to Follow-up|0
1371935|NCT01490866|4529127|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
1371936|NCT01490866|4529127|P1|Axitinib Maintenance Therapy|Protocol Violation|2
1371937|NCT01490866|4529127|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
1371938|NCT01490866|4529127|P1|Axitinib Maintenance Therapy|Adverse Event|12
1371939|NCT01490866|4529127|P1|Axitinib Maintenance Therapy|Disease Progression|30
1371940|NCT01490866|4529127|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
1371941|NCT01490866|4529127|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
1371942|NCT01490866|4529127|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
1371943|NCT01490866|4529127|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
1371944|NCT01490866|4529127|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
1371945|NCT01490866|4529127|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
1371946|NCT01490840|4529138|P2|Phase 2|Adverse Event|1
1371947|NCT01490840|4529139|P1|Phase 2|Adverse Event|1
1371948|NCT01490840|4529138|P2|Phase 2|Lost to Follow-up|1
1371949|NCT01490840|4529139|P1|Phase 2|Lost to Follow-up|1
1371950|NCT01490840|4529138|P2|Phase 2|Permanent interruption of fingolimod|1
1371951|NCT01490840|4529139|P1|Phase 2|Permanent interruption of fingolimod|0
1371952|NCT01490840|4529138|P2|Phase 2|Withdrawal by Subject|3
1371953|NCT01490840|4529139|P1|Phase 2|Withdrawal by Subject|4
1371954|NCT01490840|4529138|P2|Phase 1|Visit 6a omitted|0
1371955|NCT01490840|4529139|P1|Phase 1|Visit 6a omitted|1
1371956|NCT01490840|4529138|P2|Phase 1|Withdrawal by Subject|5
1371957|NCT01490840|4529139|P1|Phase 1|Withdrawal by Subject|6
1371958|NCT01490840|4529138|P2|Phase 1|Adverse Event|1
1371959|NCT01490840|4529139|P1|Phase 1|Adverse Event|2
1371960|NCT01490840|4529138|P2|Phase 1|Lost to Follow-up|0
1371961|NCT01490840|4529139|P1|Phase 1|Lost to Follow-up|1
1371962|NCT01490697|4529163|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
1371963|NCT01490697|4529164|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
1371964|NCT01490632|4529184|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
1371965|NCT01490632|4529185|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
1371966|NCT01490632|4529186|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
1371967|NCT01490632|4529187|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371968|NCT01490632|4529188|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371969|NCT01490632|4529189|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371970|NCT01490632|4529190|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371971|NCT01490632|4529191|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371972|NCT01490632|4529192|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371973|NCT01490632|4529193|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371974|NCT01490632|4529194|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371975|NCT01490632|4529195|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371976|NCT01490632|4529196|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371977|NCT01490632|4529197|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371978|NCT01490632|4529198|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371979|NCT01490632|4529199|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371980|NCT01490632|4529200|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371981|NCT01490632|4529201|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371982|NCT01490632|4529202|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371983|NCT01490632|4529203|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
1371984|NCT01490632|4529184|P20|Part D: Re-Treatment Period|Protocol Violation|0
1371985|NCT01490632|4529185|P19|Part D: Re-Treatment Period|Protocol Violation|1
1371986|NCT01490632|4529186|P18|Part D: Re-Treatment Period|Protocol Violation|0
1371987|NCT01490632|4529187|P17|Part D: Re-Treatment Period|Protocol Violation|0
1371988|NCT01490632|4529188|P16|Part D: Re-Treatment Period|Protocol Violation|0
1371989|NCT01490632|4529189|P15|Part D: Re-Treatment Period|Protocol Violation|0
1371990|NCT01490632|4529190|P14|Part D: Re-Treatment Period|Protocol Violation|0
1371991|NCT01490632|4529191|P13|Part D: Re-Treatment Period|Protocol Violation|0
1371992|NCT01490632|4529192|P12|Part D: Re-Treatment Period|Protocol Violation|0
1371993|NCT01490632|4529193|P11|Part D: Re-Treatment Period|Protocol Violation|0
1371994|NCT01490632|4529194|P10|Part D: Re-Treatment Period|Protocol Violation|0
1371995|NCT01490632|4529195|P9|Part D: Re-Treatment Period|Protocol Violation|0
1371996|NCT01490632|4529196|P8|Part D: Re-Treatment Period|Protocol Violation|0
1371997|NCT01490632|4529197|P7|Part D: Re-Treatment Period|Protocol Violation|0
1371998|NCT01490632|4529198|P6|Part D: Re-Treatment Period|Protocol Violation|0
1371999|NCT01490632|4529199|P5|Part D: Re-Treatment Period|Protocol Violation|0
1372000|NCT01490632|4529200|P4|Part D: Re-Treatment Period|Protocol Violation|0
1372001|NCT01490632|4529201|P3|Part D: Re-Treatment Period|Protocol Violation|0
1372002|NCT01490632|4529202|P2|Part D: Re-Treatment Period|Protocol Violation|0
1372003|NCT01490632|4529203|P1|Part D: Re-Treatment Period|Protocol Violation|0
1372004|NCT01490632|4529184|P20|Part D: Re-Treatment Period|Physician Decision|1
1372005|NCT01490632|4529185|P19|Part D: Re-Treatment Period|Physician Decision|1
1372006|NCT01490632|4529186|P18|Part D: Re-Treatment Period|Physician Decision|0
1372007|NCT01490632|4529187|P17|Part D: Re-Treatment Period|Physician Decision|0
1372008|NCT01490632|4529188|P16|Part D: Re-Treatment Period|Physician Decision|0
1372009|NCT01490632|4529189|P15|Part D: Re-Treatment Period|Physician Decision|0
1372010|NCT01490632|4529190|P14|Part D: Re-Treatment Period|Physician Decision|0
1372011|NCT01490632|4529191|P13|Part D: Re-Treatment Period|Physician Decision|0
1372012|NCT01490632|4529192|P12|Part D: Re-Treatment Period|Physician Decision|0
1372013|NCT01490632|4529193|P11|Part D: Re-Treatment Period|Physician Decision|0
1372014|NCT01490632|4529194|P10|Part D: Re-Treatment Period|Physician Decision|0
1372015|NCT01490632|4529195|P9|Part D: Re-Treatment Period|Physician Decision|0
1372016|NCT01490632|4529196|P8|Part D: Re-Treatment Period|Physician Decision|0
1372017|NCT01490632|4529197|P7|Part D: Re-Treatment Period|Physician Decision|0
1372018|NCT01490632|4529198|P6|Part D: Re-Treatment Period|Physician Decision|0
1372019|NCT01490632|4529199|P5|Part D: Re-Treatment Period|Physician Decision|0
1372020|NCT01490632|4529200|P4|Part D: Re-Treatment Period|Physician Decision|0
1372021|NCT01490632|4529201|P3|Part D: Re-Treatment Period|Physician Decision|0
1372022|NCT01490632|4529202|P2|Part D: Re-Treatment Period|Physician Decision|0
1372023|NCT01490632|4529203|P1|Part D: Re-Treatment Period|Physician Decision|0
1372024|NCT01490632|4529184|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
1372025|NCT01490632|4529185|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
1372026|NCT01490632|4529186|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
1372027|NCT01490632|4529187|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
1372028|NCT01490632|4529188|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
1372029|NCT01490632|4529189|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
1372030|NCT01490632|4529190|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
1372031|NCT01490632|4529191|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
1372032|NCT01490632|4529192|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
1372033|NCT01490632|4529193|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
1372034|NCT01490632|4529194|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
1372035|NCT01490632|4529195|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
1372036|NCT01490632|4529196|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
1372037|NCT01490632|4529197|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
1372038|NCT01490632|4529198|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
1372039|NCT01490632|4529199|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
1372040|NCT01490632|4529200|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
1372041|NCT01490632|4529201|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
1372042|NCT01490632|4529202|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
1372043|NCT01490632|4529203|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
1372044|NCT01490632|4529184|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
1372045|NCT01490632|4529185|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
1372046|NCT01490632|4529186|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
1372047|NCT01490632|4529187|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
1372048|NCT01490632|4529188|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
1372049|NCT01490632|4529189|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
1372050|NCT01490632|4529190|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
1372051|NCT01490632|4529191|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
1372052|NCT01490632|4529192|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
1372053|NCT01490632|4529193|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
1372054|NCT01490632|4529194|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
1372055|NCT01490632|4529195|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
1372056|NCT01490632|4529196|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
1372057|NCT01490632|4529197|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
1372058|NCT01490632|4529198|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
1372059|NCT01490632|4529199|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
1372060|NCT01490632|4529200|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
1372061|NCT01490632|4529201|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
1372062|NCT01490632|4529202|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
1372063|NCT01490632|4529203|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
1372064|NCT01490632|4529184|P20|Part D: Re-Treatment Period|Death|0
1372065|NCT01490632|4529185|P19|Part D: Re-Treatment Period|Death|1
1372066|NCT01490632|4529186|P18|Part D: Re-Treatment Period|Death|0
1372067|NCT01490632|4529187|P17|Part D: Re-Treatment Period|Death|0
1372068|NCT01490632|4529188|P16|Part D: Re-Treatment Period|Death|0
1372069|NCT01490632|4529189|P15|Part D: Re-Treatment Period|Death|0
1372070|NCT01490632|4529190|P14|Part D: Re-Treatment Period|Death|0
1372071|NCT01490632|4529191|P13|Part D: Re-Treatment Period|Death|0
1372072|NCT01490632|4529192|P12|Part D: Re-Treatment Period|Death|0
1372073|NCT01490632|4529193|P11|Part D: Re-Treatment Period|Death|0
1372074|NCT01490632|4529194|P10|Part D: Re-Treatment Period|Death|0
1372075|NCT01490632|4529195|P9|Part D: Re-Treatment Period|Death|0
1372076|NCT01490632|4529196|P8|Part D: Re-Treatment Period|Death|0
1372077|NCT01490632|4529197|P7|Part D: Re-Treatment Period|Death|0
1372078|NCT01490632|4529198|P6|Part D: Re-Treatment Period|Death|0
1372079|NCT01490632|4529199|P5|Part D: Re-Treatment Period|Death|0
1372080|NCT01490632|4529200|P4|Part D: Re-Treatment Period|Death|0
1372081|NCT01490632|4529201|P3|Part D: Re-Treatment Period|Death|0
1372082|NCT01490632|4529202|P2|Part D: Re-Treatment Period|Death|0
1372083|NCT01490632|4529203|P1|Part D: Re-Treatment Period|Death|0
1372084|NCT01490632|4529184|P20|Part D: Re-Treatment Period|Adverse Event|3
1372085|NCT01490632|4529185|P19|Part D: Re-Treatment Period|Adverse Event|1
1372086|NCT01490632|4529186|P18|Part D: Re-Treatment Period|Adverse Event|1
1372087|NCT01490632|4529187|P17|Part D: Re-Treatment Period|Adverse Event|0
1372088|NCT01490632|4529188|P16|Part D: Re-Treatment Period|Adverse Event|0
1372089|NCT01490632|4529189|P15|Part D: Re-Treatment Period|Adverse Event|0
1372090|NCT01490632|4529190|P14|Part D: Re-Treatment Period|Adverse Event|0
1372091|NCT01490632|4529191|P13|Part D: Re-Treatment Period|Adverse Event|0
1372092|NCT01490632|4529192|P12|Part D: Re-Treatment Period|Adverse Event|0
1372093|NCT01490632|4529193|P11|Part D: Re-Treatment Period|Adverse Event|0
1372094|NCT01490632|4529194|P10|Part D: Re-Treatment Period|Adverse Event|0
1372095|NCT01490632|4529195|P9|Part D: Re-Treatment Period|Adverse Event|0
1372096|NCT01490632|4529196|P8|Part D: Re-Treatment Period|Adverse Event|0
1372097|NCT01490632|4529197|P7|Part D: Re-Treatment Period|Adverse Event|0
1372098|NCT01490632|4529198|P6|Part D: Re-Treatment Period|Adverse Event|0
1372099|NCT01490632|4529199|P5|Part D: Re-Treatment Period|Adverse Event|0
1372100|NCT01490632|4529200|P4|Part D: Re-Treatment Period|Adverse Event|0
1372101|NCT01490632|4529201|P3|Part D: Re-Treatment Period|Adverse Event|0
1372102|NCT01490632|4529202|P2|Part D: Re-Treatment Period|Adverse Event|0
1372103|NCT01490632|4529203|P1|Part D: Re-Treatment Period|Adverse Event|0
1372104|NCT01490632|4529184|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372105|NCT01490632|4529185|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372106|NCT01490632|4529186|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372107|NCT01490632|4529187|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372108|NCT01490632|4529188|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
1372109|NCT01490632|4529189|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
1372110|NCT01490632|4529190|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
1372111|NCT01490632|4529191|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
1372112|NCT01490632|4529192|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372113|NCT01490632|4529193|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372114|NCT01490632|4529194|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372115|NCT01490632|4529195|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372116|NCT01490632|4529196|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372117|NCT01490632|4529197|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372118|NCT01490632|4529198|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372119|NCT01490632|4529199|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372120|NCT01490632|4529200|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372121|NCT01490632|4529201|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372122|NCT01490632|4529202|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372123|NCT01490632|4529203|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1372124|NCT01490632|4529184|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372125|NCT01490632|4529185|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372126|NCT01490632|4529186|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372127|NCT01490632|4529187|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372128|NCT01490632|4529188|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
1372129|NCT01490632|4529189|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
1372130|NCT01490632|4529190|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372131|NCT01490632|4529191|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372132|NCT01490632|4529192|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372133|NCT01490632|4529193|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372134|NCT01490632|4529194|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372135|NCT01490632|4529195|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372136|NCT01490632|4529196|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372137|NCT01490632|4529197|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372138|NCT01490632|4529198|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372139|NCT01490632|4529199|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372140|NCT01490632|4529200|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372141|NCT01490632|4529201|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372142|NCT01490632|4529202|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372143|NCT01490632|4529203|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1372144|NCT01490632|4529184|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372145|NCT01490632|4529185|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372146|NCT01490632|4529186|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372147|NCT01490632|4529187|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372148|NCT01490632|4529188|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372149|NCT01490632|4529189|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372150|NCT01490632|4529190|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
1372151|NCT01490632|4529191|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372152|NCT01490632|4529192|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372153|NCT01490632|4529193|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372154|NCT01490632|4529194|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372155|NCT01490632|4529195|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372156|NCT01490632|4529196|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372157|NCT01490632|4529197|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372158|NCT01490632|4529198|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372159|NCT01490632|4529199|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372160|NCT01490632|4529200|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372161|NCT01490632|4529201|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372162|NCT01490632|4529202|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372163|NCT01490632|4529203|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1372164|NCT01490632|4529184|P20|Part C: Washout or Step-Down Period|Adverse Event|0
1372165|NCT01490632|4529185|P19|Part C: Washout or Step-Down Period|Adverse Event|0
1372166|NCT01490632|4529186|P18|Part C: Washout or Step-Down Period|Adverse Event|0
1372167|NCT01490632|4529187|P17|Part C: Washout or Step-Down Period|Adverse Event|0
1372168|NCT01490632|4529188|P16|Part C: Washout or Step-Down Period|Adverse Event|2
1372169|NCT01490632|4529189|P15|Part C: Washout or Step-Down Period|Adverse Event|2
1372170|NCT01490632|4529190|P14|Part C: Washout or Step-Down Period|Adverse Event|0
1372171|NCT01490632|4529191|P13|Part C: Washout or Step-Down Period|Adverse Event|0
1372172|NCT01490632|4529192|P12|Part C: Washout or Step-Down Period|Adverse Event|0
1372173|NCT01490632|4529193|P11|Part C: Washout or Step-Down Period|Adverse Event|0
1372174|NCT01490632|4529194|P10|Part C: Washout or Step-Down Period|Adverse Event|0
1372175|NCT01490632|4529195|P9|Part C: Washout or Step-Down Period|Adverse Event|0
1372176|NCT01490632|4529196|P8|Part C: Washout or Step-Down Period|Adverse Event|0
1372177|NCT01490632|4529197|P7|Part C: Washout or Step-Down Period|Adverse Event|0
1372178|NCT01490632|4529198|P6|Part C: Washout or Step-Down Period|Adverse Event|0
1372179|NCT01490632|4529199|P5|Part C: Washout or Step-Down Period|Adverse Event|0
1372180|NCT01490632|4529200|P4|Part C: Washout or Step-Down Period|Adverse Event|0
1372181|NCT01490632|4529201|P3|Part C: Washout or Step-Down Period|Adverse Event|0
1372182|NCT01490632|4529202|P2|Part C: Washout or Step-Down Period|Adverse Event|0
1372183|NCT01490632|4529203|P1|Part C: Washout or Step-Down Period|Adverse Event|0
1372184|NCT01490632|4529184|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1372185|NCT01490632|4529185|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1372186|NCT01490632|4529186|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1372187|NCT01490632|4529187|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1372188|NCT01490632|4529188|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1372189|NCT01490632|4529189|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1372190|NCT01490632|4529190|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1372191|NCT01490632|4529191|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1372192|NCT01490632|4529192|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
1372193|NCT01490632|4529193|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
1372194|NCT01490632|4529194|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
1372195|NCT01490632|4529195|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
1372196|NCT01490632|4529196|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
1372197|NCT01490632|4529197|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
1372198|NCT01490632|4529198|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
1372199|NCT01490632|4529199|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1372200|NCT01490632|4529200|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1372201|NCT01490632|4529201|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1372202|NCT01490632|4529202|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1372203|NCT01490632|4529203|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1372204|NCT01490632|4529184|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372205|NCT01490632|4529185|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372206|NCT01490632|4529186|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372207|NCT01490632|4529187|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372208|NCT01490632|4529188|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372209|NCT01490632|4529189|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372210|NCT01490632|4529190|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372211|NCT01490632|4529191|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372212|NCT01490632|4529192|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
1372213|NCT01490632|4529193|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
1372214|NCT01490632|4529194|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372215|NCT01490632|4529195|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
1372216|NCT01490632|4529196|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372217|NCT01490632|4529197|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
1372218|NCT01490632|4529198|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372219|NCT01490632|4529199|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372220|NCT01490632|4529200|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372221|NCT01490632|4529201|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372222|NCT01490632|4529202|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372223|NCT01490632|4529203|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1372224|NCT01490632|4529184|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372225|NCT01490632|4529185|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372226|NCT01490632|4529186|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372227|NCT01490632|4529187|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372228|NCT01490632|4529188|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372229|NCT01490632|4529189|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372230|NCT01490632|4529190|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372231|NCT01490632|4529191|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372232|NCT01490632|4529192|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372233|NCT01490632|4529193|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372234|NCT01490632|4529194|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372235|NCT01490632|4529195|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372236|NCT01490632|4529196|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372237|NCT01490632|4529197|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372238|NCT01490632|4529198|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
1372239|NCT01490632|4529199|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372240|NCT01490632|4529200|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372241|NCT01490632|4529201|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372242|NCT01490632|4529202|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372243|NCT01490632|4529203|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
1372244|NCT01490632|4529184|P20|Part B: Extension or Step-Up Period|Physician Decision|0
1372245|NCT01490632|4529185|P19|Part B: Extension or Step-Up Period|Physician Decision|0
1372246|NCT01490632|4529186|P18|Part B: Extension or Step-Up Period|Physician Decision|0
1372247|NCT01490632|4529187|P17|Part B: Extension or Step-Up Period|Physician Decision|0
1372248|NCT01490632|4529188|P16|Part B: Extension or Step-Up Period|Physician Decision|0
1372249|NCT01490632|4529189|P15|Part B: Extension or Step-Up Period|Physician Decision|0
1372250|NCT01490632|4529190|P14|Part B: Extension or Step-Up Period|Physician Decision|0
1372251|NCT01490632|4529191|P13|Part B: Extension or Step-Up Period|Physician Decision|0
1372252|NCT01490632|4529192|P12|Part B: Extension or Step-Up Period|Physician Decision|0
1372253|NCT01490632|4529193|P11|Part B: Extension or Step-Up Period|Physician Decision|0
1372254|NCT01490632|4529194|P10|Part B: Extension or Step-Up Period|Physician Decision|0
1372255|NCT01490632|4529195|P9|Part B: Extension or Step-Up Period|Physician Decision|0
1372256|NCT01490632|4529196|P8|Part B: Extension or Step-Up Period|Physician Decision|0
1372257|NCT01490632|4529197|P7|Part B: Extension or Step-Up Period|Physician Decision|1
1372258|NCT01490632|4529198|P6|Part B: Extension or Step-Up Period|Physician Decision|0
1372259|NCT01490632|4529199|P5|Part B: Extension or Step-Up Period|Physician Decision|0
1372260|NCT01490632|4529200|P4|Part B: Extension or Step-Up Period|Physician Decision|0
1372261|NCT01490632|4529201|P3|Part B: Extension or Step-Up Period|Physician Decision|0
1372262|NCT01490632|4529202|P2|Part B: Extension or Step-Up Period|Physician Decision|0
1372263|NCT01490632|4529203|P1|Part B: Extension or Step-Up Period|Physician Decision|0
1372264|NCT01490632|4529184|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372265|NCT01490632|4529185|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372266|NCT01490632|4529186|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372267|NCT01490632|4529187|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372268|NCT01490632|4529188|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372269|NCT01490632|4529189|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372270|NCT01490632|4529190|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372271|NCT01490632|4529191|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372272|NCT01490632|4529192|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372273|NCT01490632|4529193|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372274|NCT01490632|4529194|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
1372275|NCT01490632|4529195|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372276|NCT01490632|4529196|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372277|NCT01490632|4529197|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
1372278|NCT01490632|4529198|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372279|NCT01490632|4529199|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372280|NCT01490632|4529200|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372281|NCT01490632|4529201|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372282|NCT01490632|4529202|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372283|NCT01490632|4529203|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1372284|NCT01490632|4529184|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372285|NCT01490632|4529185|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372286|NCT01490632|4529186|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372287|NCT01490632|4529187|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372288|NCT01490632|4529188|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372289|NCT01490632|4529189|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372290|NCT01490632|4529190|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372291|NCT01490632|4529191|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372292|NCT01490632|4529192|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372293|NCT01490632|4529193|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
1372294|NCT01490632|4529194|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
1372295|NCT01490632|4529195|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
1372296|NCT01490632|4529196|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372297|NCT01490632|4529197|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
1372298|NCT01490632|4529198|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372299|NCT01490632|4529199|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372300|NCT01490632|4529200|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372301|NCT01490632|4529201|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372302|NCT01490632|4529202|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372303|NCT01490632|4529203|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1372304|NCT01490632|4529184|P20|Part B: Extension or Step-Up Period|Adverse Event|0
1372305|NCT01490632|4529185|P19|Part B: Extension or Step-Up Period|Adverse Event|0
1372306|NCT01490632|4529186|P18|Part B: Extension or Step-Up Period|Adverse Event|0
1372307|NCT01490632|4529187|P17|Part B: Extension or Step-Up Period|Adverse Event|0
1372308|NCT01490632|4529188|P16|Part B: Extension or Step-Up Period|Adverse Event|0
1372309|NCT01490632|4529189|P15|Part B: Extension or Step-Up Period|Adverse Event|0
1372310|NCT01490632|4529190|P14|Part B: Extension or Step-Up Period|Adverse Event|0
1372311|NCT01490632|4529191|P13|Part B: Extension or Step-Up Period|Adverse Event|0
1372312|NCT01490632|4529192|P12|Part B: Extension or Step-Up Period|Adverse Event|1
1372313|NCT01490632|4529193|P11|Part B: Extension or Step-Up Period|Adverse Event|3
1372314|NCT01490632|4529194|P10|Part B: Extension or Step-Up Period|Adverse Event|2
1372315|NCT01490632|4529195|P9|Part B: Extension or Step-Up Period|Adverse Event|0
1372316|NCT01490632|4529196|P8|Part B: Extension or Step-Up Period|Adverse Event|0
1372317|NCT01490632|4529197|P7|Part B: Extension or Step-Up Period|Adverse Event|2
1372318|NCT01490632|4529198|P6|Part B: Extension or Step-Up Period|Adverse Event|2
1372319|NCT01490632|4529199|P5|Part B: Extension or Step-Up Period|Adverse Event|0
1372320|NCT01490632|4529200|P4|Part B: Extension or Step-Up Period|Adverse Event|0
1372321|NCT01490632|4529201|P3|Part B: Extension or Step-Up Period|Adverse Event|0
1372322|NCT01490632|4529202|P2|Part B: Extension or Step-Up Period|Adverse Event|0
1372323|NCT01490632|4529203|P1|Part B: Extension or Step-Up Period|Adverse Event|0
1372324|NCT01490632|4529184|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372325|NCT01490632|4529185|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372326|NCT01490632|4529186|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372327|NCT01490632|4529187|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372328|NCT01490632|4529188|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372329|NCT01490632|4529189|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372330|NCT01490632|4529190|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372331|NCT01490632|4529191|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372332|NCT01490632|4529192|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372333|NCT01490632|4529193|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372334|NCT01490632|4529194|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372335|NCT01490632|4529195|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372336|NCT01490632|4529196|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372337|NCT01490632|4529197|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372338|NCT01490632|4529198|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372339|NCT01490632|4529199|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
1372340|NCT01490632|4529200|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372341|NCT01490632|4529201|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372342|NCT01490632|4529202|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372343|NCT01490632|4529203|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1372344|NCT01490632|4529184|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372345|NCT01490632|4529185|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372346|NCT01490632|4529186|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372347|NCT01490632|4529187|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372348|NCT01490632|4529188|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372349|NCT01490632|4529189|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372350|NCT01490632|4529190|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372351|NCT01490632|4529191|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372352|NCT01490632|4529192|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372353|NCT01490632|4529193|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372354|NCT01490632|4529194|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372355|NCT01490632|4529195|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372356|NCT01490632|4529196|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372357|NCT01490632|4529197|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372358|NCT01490632|4529198|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372359|NCT01490632|4529199|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
1372360|NCT01490632|4529200|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
1372361|NCT01490632|4529201|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
1372362|NCT01490632|4529202|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
1372363|NCT01490632|4529203|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
1372364|NCT01490632|4529184|P20|Part A: Initial Treatment Period|Sponsor Decision|0
1372365|NCT01490632|4529185|P19|Part A: Initial Treatment Period|Sponsor Decision|0
1372366|NCT01490632|4529186|P18|Part A: Initial Treatment Period|Sponsor Decision|0
1372367|NCT01490632|4529187|P17|Part A: Initial Treatment Period|Sponsor Decision|0
1372368|NCT01490632|4529188|P16|Part A: Initial Treatment Period|Sponsor Decision|0
1372369|NCT01490632|4529189|P15|Part A: Initial Treatment Period|Sponsor Decision|0
1372370|NCT01490632|4529190|P14|Part A: Initial Treatment Period|Sponsor Decision|0
1372371|NCT01490632|4529191|P13|Part A: Initial Treatment Period|Sponsor Decision|0
1372372|NCT01490632|4529192|P12|Part A: Initial Treatment Period|Sponsor Decision|0
1372373|NCT01490632|4529193|P11|Part A: Initial Treatment Period|Sponsor Decision|0
1372374|NCT01490632|4529194|P10|Part A: Initial Treatment Period|Sponsor Decision|0
1372375|NCT01490632|4529195|P9|Part A: Initial Treatment Period|Sponsor Decision|0
1372376|NCT01490632|4529196|P8|Part A: Initial Treatment Period|Sponsor Decision|0
1372377|NCT01490632|4529197|P7|Part A: Initial Treatment Period|Sponsor Decision|0
1372378|NCT01490632|4529198|P6|Part A: Initial Treatment Period|Sponsor Decision|0
1372379|NCT01490632|4529199|P5|Part A: Initial Treatment Period|Sponsor Decision|0
1372380|NCT01490632|4529200|P4|Part A: Initial Treatment Period|Sponsor Decision|0
1372381|NCT01490632|4529201|P3|Part A: Initial Treatment Period|Sponsor Decision|0
1372382|NCT01490632|4529202|P2|Part A: Initial Treatment Period|Sponsor Decision|0
1372383|NCT01490632|4529203|P1|Part A: Initial Treatment Period|Sponsor Decision|2
1372384|NCT01490632|4529184|P20|Part A: Initial Treatment Period|Physician Decision|0
1372385|NCT01490632|4529185|P19|Part A: Initial Treatment Period|Physician Decision|0
1372386|NCT01490632|4529186|P18|Part A: Initial Treatment Period|Physician Decision|0
1372387|NCT01490632|4529187|P17|Part A: Initial Treatment Period|Physician Decision|0
1372388|NCT01490632|4529188|P16|Part A: Initial Treatment Period|Physician Decision|0
1372389|NCT01490632|4529189|P15|Part A: Initial Treatment Period|Physician Decision|0
1372390|NCT01490632|4529190|P14|Part A: Initial Treatment Period|Physician Decision|0
1372391|NCT01490632|4529191|P13|Part A: Initial Treatment Period|Physician Decision|0
1372392|NCT01490632|4529192|P12|Part A: Initial Treatment Period|Physician Decision|0
1372393|NCT01490632|4529193|P11|Part A: Initial Treatment Period|Physician Decision|0
1372394|NCT01490632|4529194|P10|Part A: Initial Treatment Period|Physician Decision|0
1372395|NCT01490632|4529195|P9|Part A: Initial Treatment Period|Physician Decision|0
1372396|NCT01490632|4529196|P8|Part A: Initial Treatment Period|Physician Decision|0
1372397|NCT01490632|4529197|P7|Part A: Initial Treatment Period|Physician Decision|0
1372398|NCT01490632|4529198|P6|Part A: Initial Treatment Period|Physician Decision|0
1372399|NCT01490632|4529199|P5|Part A: Initial Treatment Period|Physician Decision|0
1372400|NCT01490632|4529200|P4|Part A: Initial Treatment Period|Physician Decision|1
1372401|NCT01490632|4529201|P3|Part A: Initial Treatment Period|Physician Decision|0
1372402|NCT01490632|4529202|P2|Part A: Initial Treatment Period|Physician Decision|1
1372403|NCT01490632|4529203|P1|Part A: Initial Treatment Period|Physician Decision|0
1372404|NCT01490632|4529184|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
1372405|NCT01490632|4529185|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
1372406|NCT01490632|4529186|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
1372407|NCT01490632|4529187|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
1372408|NCT01490632|4529188|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
1372409|NCT01490632|4529189|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
1372410|NCT01490632|4529190|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
1372411|NCT01490632|4529191|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
1372412|NCT01490632|4529192|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
1372413|NCT01490632|4529193|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
1372414|NCT01490632|4529194|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
1372415|NCT01490632|4529195|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
1372416|NCT01490632|4529196|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
1372417|NCT01490632|4529197|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
1372418|NCT01490632|4529198|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
1372419|NCT01490632|4529199|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
1372420|NCT01490632|4529200|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
1372421|NCT01490632|4529201|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
1372422|NCT01490632|4529202|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
1372423|NCT01490632|4529203|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
1372424|NCT01490632|4529184|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
1372425|NCT01490632|4529185|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
1372426|NCT01490632|4529186|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
1372427|NCT01490632|4529187|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
1372428|NCT01490632|4529188|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
1372429|NCT01490632|4529189|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
1372430|NCT01490632|4529190|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
1372431|NCT01490632|4529191|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
1372432|NCT01490632|4529192|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
1372433|NCT01490632|4529193|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
1372434|NCT01490632|4529194|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
1372435|NCT01490632|4529195|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
1372436|NCT01490632|4529196|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
1372437|NCT01490632|4529197|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
1372438|NCT01490632|4529198|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
1372439|NCT01490632|4529199|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
1372440|NCT01490632|4529200|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
1372441|NCT01490632|4529201|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
1372442|NCT01490632|4529202|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
1372443|NCT01490632|4529203|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
1372444|NCT01490632|4529184|P20|Part A: Initial Treatment Period|Adverse Event|0
1372445|NCT01490632|4529185|P19|Part A: Initial Treatment Period|Adverse Event|0
1372446|NCT01490632|4529186|P18|Part A: Initial Treatment Period|Adverse Event|0
1372447|NCT01490632|4529187|P17|Part A: Initial Treatment Period|Adverse Event|0
1372448|NCT01490632|4529188|P16|Part A: Initial Treatment Period|Adverse Event|0
1372449|NCT01490632|4529189|P15|Part A: Initial Treatment Period|Adverse Event|0
1372450|NCT01490632|4529190|P14|Part A: Initial Treatment Period|Adverse Event|0
1372451|NCT01490632|4529191|P13|Part A: Initial Treatment Period|Adverse Event|0
1372452|NCT01490632|4529192|P12|Part A: Initial Treatment Period|Adverse Event|0
1372453|NCT01490632|4529193|P11|Part A: Initial Treatment Period|Adverse Event|0
1372454|NCT01490632|4529194|P10|Part A: Initial Treatment Period|Adverse Event|0
1372455|NCT01490632|4529195|P9|Part A: Initial Treatment Period|Adverse Event|0
1372456|NCT01490632|4529196|P8|Part A: Initial Treatment Period|Adverse Event|0
1372457|NCT01490632|4529197|P7|Part A: Initial Treatment Period|Adverse Event|0
1372458|NCT01490632|4529198|P6|Part A: Initial Treatment Period|Adverse Event|0
1372459|NCT01490632|4529199|P5|Part A: Initial Treatment Period|Adverse Event|4
1372460|NCT01490632|4529200|P4|Part A: Initial Treatment Period|Adverse Event|4
1372461|NCT01490632|4529201|P3|Part A: Initial Treatment Period|Adverse Event|2
1372462|NCT01490632|4529202|P2|Part A: Initial Treatment Period|Adverse Event|0
1372463|NCT01490632|4529203|P1|Part A: Initial Treatment Period|Adverse Event|0
1372464|NCT01490294|4529358|P4|Overall Study|Adverse Event|0
1372465|NCT01490294|4529359|P3|Overall Study|Adverse Event|0
1372466|NCT01490294|4529360|P2|Overall Study|Adverse Event|0
1372467|NCT01490294|4529361|P1|Overall Study|Adverse Event|1
1372468|NCT01490294|4529358|P4|Overall Study|Prematurely discontinuation|1
1372469|NCT01490294|4529359|P3|Overall Study|Prematurely discontinuation|1
1372470|NCT01490294|4529360|P2|Overall Study|Prematurely discontinuation|0
1372471|NCT01490294|4529361|P1|Overall Study|Prematurely discontinuation|4
1372472|NCT01490190|4529595|P1|Overall Study|Ring expulsion|2
1372473|NCT01490190|4529595|P1|Overall Study|Inconvenience|1
1372474|NCT01490190|4529595|P1|Overall Study|Relocation|1
1372475|NCT01490190|4529595|P1|Overall Study|Lost to Follow-up|13
1372476|NCT01490190|4529595|P1|Overall Study|Protocol Violation|5
1372477|NCT01490190|4529595|P1|Overall Study|Adverse Event|17
1372478|NCT01490190|4529595|P1|Overall Study|Withdrawal by Subject|9
1372479|NCT01490125|4529622|P6|Period III|Lack of Efficacy|0
1372480|NCT01490125|4529623|P5|Period III|Lack of Efficacy|1
1372481|NCT01490125|4529624|P4|Period III|Lack of Efficacy|0
1372482|NCT01490125|4529625|P3|Period III|Lack of Efficacy|0
1372483|NCT01490125|4529626|P2|Period III|Lack of Efficacy|0
1372484|NCT01490125|4529627|P1|Period III|Lack of Efficacy|0
1372485|NCT01490125|4529622|P6|Period III|Death|0
1372486|NCT01490125|4529623|P5|Period III|Death|0
1372487|NCT01490125|4529624|P4|Period III|Death|1
1372488|NCT01490125|4529625|P3|Period III|Death|0
1372489|NCT01490125|4529626|P2|Period III|Death|0
1372490|NCT01490125|4529627|P1|Period III|Death|0
1372491|NCT01490125|4529622|P6|Period III|Adverse Event|0
1372492|NCT01490125|4529623|P5|Period III|Adverse Event|0
1372493|NCT01490125|4529624|P4|Period III|Adverse Event|1
1372494|NCT01490125|4529625|P3|Period III|Adverse Event|0
1372495|NCT01490125|4529626|P2|Period III|Adverse Event|1
1372496|NCT01490125|4529627|P1|Period III|Adverse Event|3
1372497|NCT01490125|4529622|P6|Period II|Withdrawal by Subject|0
1372498|NCT01490125|4529623|P5|Period II|Withdrawal by Subject|0
1372499|NCT01490125|4529624|P4|Period II|Withdrawal by Subject|0
1372500|NCT01490125|4529625|P3|Period II|Withdrawal by Subject|0
1372501|NCT01490125|4529626|P2|Period II|Withdrawal by Subject|0
1372502|NCT01490125|4529627|P1|Period II|Withdrawal by Subject|1
1372503|NCT01490125|4529622|P6|Period II|Lost to Follow-up|0
1372504|NCT01490125|4529623|P5|Period II|Lost to Follow-up|0
1372505|NCT01490125|4529624|P4|Period II|Lost to Follow-up|0
1372506|NCT01490125|4529625|P3|Period II|Lost to Follow-up|0
1372507|NCT01490125|4529626|P2|Period II|Lost to Follow-up|1
1372508|NCT01490125|4529627|P1|Period II|Lost to Follow-up|0
1372509|NCT01490125|4529622|P6|Period II|Protocol Violation|0
1372510|NCT01490125|4529623|P5|Period II|Protocol Violation|0
1372511|NCT01490125|4529624|P4|Period II|Protocol Violation|1
1372512|NCT01490125|4529625|P3|Period II|Protocol Violation|1
1372513|NCT01490125|4529626|P2|Period II|Protocol Violation|0
1372514|NCT01490125|4529627|P1|Period II|Protocol Violation|0
1372515|NCT01490125|4529622|P6|Period II|Adverse Event|2
1372516|NCT01490125|4529623|P5|Period II|Adverse Event|4
1372517|NCT01490125|4529624|P4|Period II|Adverse Event|2
1372518|NCT01490125|4529625|P3|Period II|Adverse Event|2
1372519|NCT01490125|4529626|P2|Period II|Adverse Event|3
1372520|NCT01490125|4529627|P1|Period II|Adverse Event|2
1372521|NCT01490125|4529622|P6|Period I|Withdrawal by Subject|1
1372522|NCT01490125|4529623|P5|Period I|Withdrawal by Subject|2
1372523|NCT01490125|4529624|P4|Period I|Withdrawal by Subject|1
1372524|NCT01490125|4529625|P3|Period I|Withdrawal by Subject|2
1372525|NCT01490125|4529626|P2|Period I|Withdrawal by Subject|3
1372526|NCT01490125|4529627|P1|Period I|Withdrawal by Subject|1
1372527|NCT01490125|4529622|P6|Period I|Protocol Violation|0
1372528|NCT01490125|4529623|P5|Period I|Protocol Violation|0
1372529|NCT01490125|4529624|P4|Period I|Protocol Violation|1
1372530|NCT01490125|4529625|P3|Period I|Protocol Violation|1
1372531|NCT01490125|4529626|P2|Period I|Protocol Violation|1
1372532|NCT01490125|4529627|P1|Period I|Protocol Violation|1
1372533|NCT01490125|4529622|P6|Period I|Adverse Event|4
1372534|NCT01490125|4529623|P5|Period I|Adverse Event|2
1372535|NCT01490125|4529624|P4|Period I|Adverse Event|3
1372536|NCT01490125|4529625|P3|Period I|Adverse Event|1
1372537|NCT01490125|4529626|P2|Period I|Adverse Event|1
1372538|NCT01490125|4529627|P1|Period I|Adverse Event|4
1372539|NCT01490086|4529655|P5|Overall Study|Subject left hospital|0
1372540|NCT01490086|4529656|P4|Overall Study|Subject left hospital|1
1372541|NCT01490086|4529657|P3|Overall Study|Subject left hospital|0
1372542|NCT01490086|4529658|P2|Overall Study|Subject left hospital|1
1372543|NCT01490086|4529659|P1|Overall Study|Subject left hospital|0
1372544|NCT01490086|4529655|P5|Overall Study|Subject uncontrollable and abusive|0
1372545|NCT01490086|4529656|P4|Overall Study|Subject uncontrollable and abusive|0
1372546|NCT01490086|4529657|P3|Overall Study|Subject uncontrollable and abusive|0
1372547|NCT01490086|4529658|P2|Overall Study|Subject uncontrollable and abusive|1
1372548|NCT01490086|4529659|P1|Overall Study|Subject uncontrollable and abusive|0
1372549|NCT01490086|4529655|P5|Overall Study|Worsening of symptoms|0
1372550|NCT01490086|4529656|P4|Overall Study|Worsening of symptoms|1
1372551|NCT01490086|4529657|P3|Overall Study|Worsening of symptoms|0
1372552|NCT01490086|4529658|P2|Overall Study|Worsening of symptoms|1
1372553|NCT01490086|4529659|P1|Overall Study|Worsening of symptoms|0
1372554|NCT01490086|4529655|P5|Overall Study|Lack of Efficacy|8
1372555|NCT01490086|4529656|P4|Overall Study|Lack of Efficacy|0
1372556|NCT01490086|4529657|P3|Overall Study|Lack of Efficacy|1
1372557|NCT01490086|4529658|P2|Overall Study|Lack of Efficacy|3
1372558|NCT01490086|4529659|P1|Overall Study|Lack of Efficacy|0
1372559|NCT01490086|4529655|P5|Overall Study|Adverse Event|0
1372560|NCT01490086|4529656|P4|Overall Study|Adverse Event|2
1372561|NCT01490086|4529657|P3|Overall Study|Adverse Event|1
1372562|NCT01490086|4529658|P2|Overall Study|Adverse Event|0
1372563|NCT01490086|4529659|P1|Overall Study|Adverse Event|0
1372564|NCT01490086|4529655|P5|Overall Study|Physician Decision|1
1372565|NCT01490086|4529656|P4|Overall Study|Physician Decision|3
1372566|NCT01490086|4529657|P3|Overall Study|Physician Decision|2
1372567|NCT01490086|4529658|P2|Overall Study|Physician Decision|4
1372568|NCT01490086|4529659|P1|Overall Study|Physician Decision|3
1372569|NCT01490086|4529655|P5|Overall Study|Lost to Follow-up|1
1372570|NCT01490086|4529656|P4|Overall Study|Lost to Follow-up|0
1372571|NCT01490086|4529657|P3|Overall Study|Lost to Follow-up|0
1372572|NCT01490086|4529658|P2|Overall Study|Lost to Follow-up|0
1372573|NCT01490086|4529659|P1|Overall Study|Lost to Follow-up|0
1372574|NCT01490086|4529655|P5|Overall Study|Abnormal laboratory findings|0
1372575|NCT01490086|4529656|P4|Overall Study|Abnormal laboratory findings|0
1372576|NCT01490086|4529657|P3|Overall Study|Abnormal laboratory findings|0
1372577|NCT01490086|4529658|P2|Overall Study|Abnormal laboratory findings|0
1372578|NCT01490086|4529659|P1|Overall Study|Abnormal laboratory findings|1
1372579|NCT01490086|4529655|P5|Overall Study|Non-compliance|0
1372580|NCT01490086|4529656|P4|Overall Study|Non-compliance|0
1372581|NCT01490086|4529657|P3|Overall Study|Non-compliance|0
1372582|NCT01490086|4529658|P2|Overall Study|Non-compliance|1
1372583|NCT01490086|4529659|P1|Overall Study|Non-compliance|0
1372584|NCT01490086|4529655|P5|Overall Study|Consent withdrawn|1
1372585|NCT01490086|4529656|P4|Overall Study|Consent withdrawn|0
1372586|NCT01490086|4529657|P3|Overall Study|Consent withdrawn|3
1372587|NCT01490086|4529658|P2|Overall Study|Consent withdrawn|4
1372588|NCT01490086|4529659|P1|Overall Study|Consent withdrawn|4
1372589|NCT01490060|4529693|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
1372590|NCT01490060|4529694|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
1372591|NCT01490060|4529695|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
1372592|NCT01490060|4529696|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
1372593|NCT01490060|4529693|P4|Cycle 2|Non-Compliance|0
1372594|NCT01490060|4529694|P3|Cycle 2|Non-Compliance|1
1372595|NCT01490060|4529695|P2|Cycle 2|Non-Compliance|0
1372596|NCT01490060|4529696|P1|Cycle 2|Non-Compliance|0
1372597|NCT01490060|4529693|P4|Cycle 2|Change of Treatment|0
1372598|NCT01490060|4529694|P3|Cycle 2|Change of Treatment|0
1372599|NCT01490060|4529695|P2|Cycle 2|Change of Treatment|1
1372600|NCT01490060|4529696|P1|Cycle 2|Change of Treatment|1
1372601|NCT01490060|4529693|P4|Cycle 1|Treatment at Another Facility|1
1372602|NCT01490060|4529694|P3|Cycle 1|Treatment at Another Facility|0
1372603|NCT01490060|4529695|P2|Cycle 1|Treatment at Another Facility|0
1372604|NCT01490060|4529696|P1|Cycle 1|Treatment at Another Facility|0
1372605|NCT01490060|4529693|P4|Cycle 1|Withdrawal by Subject|1
1372606|NCT01490060|4529694|P3|Cycle 1|Withdrawal by Subject|0
1372607|NCT01490060|4529695|P2|Cycle 1|Withdrawal by Subject|0
1372608|NCT01490060|4529696|P1|Cycle 1|Withdrawal by Subject|0
1372609|NCT01490060|4529693|P4|Cycle 1|Insurance Denied|0
1372610|NCT01490060|4529694|P3|Cycle 1|Insurance Denied|2
1372611|NCT01490060|4529695|P2|Cycle 1|Insurance Denied|0
1372612|NCT01490060|4529696|P1|Cycle 1|Insurance Denied|0
1372613|NCT01490060|4529693|P4|Cycle 1|Change of Treatment|1
1372614|NCT01490060|4529694|P3|Cycle 1|Change of Treatment|1
1372615|NCT01490060|4529695|P2|Cycle 1|Change of Treatment|1
1372616|NCT01490060|4529696|P1|Cycle 1|Change of Treatment|0
1372617|NCT01489956|4529725|P3|Overall Study|Withdrawal by Subject|1
1372618|NCT01489956|4529726|P2|Overall Study|Withdrawal by Subject|0
1372619|NCT01489956|4529727|P1|Overall Study|Withdrawal by Subject|0
1372620|NCT01489956|4529725|P3|Overall Study|Lost to Follow-up|0
1372621|NCT01489956|4529726|P2|Overall Study|Lost to Follow-up|0
1372622|NCT01489956|4529727|P1|Overall Study|Lost to Follow-up|1
1372623|NCT01489891|4529764|P2|Overall Study|Endoscopy failure|0
1372624|NCT01489891|4529765|P1|Overall Study|Endoscopy failure|1
1372625|NCT01489527|4529903|P2|Overall Study|Not compliant|0
1372626|NCT01489527|4529904|P1|Overall Study|Not compliant|1
1372627|NCT01489527|4529903|P2|Overall Study|Procedures|0
1372628|NCT01489527|4529904|P1|Overall Study|Procedures|1
1372629|NCT01489527|4529903|P2|Overall Study|Lost to Follow-up|1
1372630|NCT01489527|4529904|P1|Overall Study|Lost to Follow-up|5
1372631|NCT01489527|4529903|P2|Overall Study|Withdrawal by Subject|4
1372632|NCT01489527|4529904|P1|Overall Study|Withdrawal by Subject|0
1372633|NCT01489527|4529903|P2|Overall Study|Participant moved|7
1372634|NCT01489527|4529904|P1|Overall Study|Participant moved|6
1372635|NCT01489527|4529903|P2|Overall Study|Pregnancy|14
1372636|NCT01489527|4529904|P1|Overall Study|Pregnancy|9
1372637|NCT01489358|4529921|P3|Overall Study|Lost to Follow-up|2
1372638|NCT01489358|4529922|P2|Overall Study|Lost to Follow-up|0
1372639|NCT01489358|4529923|P1|Overall Study|Lost to Follow-up|0
1372640|NCT01489254|4529973|P4|Open-label Extension Part|Other reasons for not completing study|5
1372641|NCT01489254|4529974|P3|Open-label Extension Part|Other reasons for not completing study|0
1372642|NCT01489254|4529975|P2|Open-label Extension Part|Other reasons for not completing study|0
1372643|NCT01489254|4529976|P1|Open-label Extension Part|Other reasons for not completing study|0
1372644|NCT01489254|4529973|P4|Open-label Extension Part|Lost to Follow-up|9
1372645|NCT01489254|4529974|P3|Open-label Extension Part|Lost to Follow-up|0
1372646|NCT01489254|4529975|P2|Open-label Extension Part|Lost to Follow-up|0
1372647|NCT01489254|4529976|P1|Open-label Extension Part|Lost to Follow-up|0
1372648|NCT01489254|4529973|P4|Open-label Extension Part|Protocol Violation|1
1372649|NCT01489254|4529974|P3|Open-label Extension Part|Protocol Violation|0
1372650|NCT01489254|4529975|P2|Open-label Extension Part|Protocol Violation|0
1372651|NCT01489254|4529976|P1|Open-label Extension Part|Protocol Violation|0
1372652|NCT01489254|4529973|P4|Open-label Extension Part|Withdrawal by Subject|30
1372653|NCT01489254|4529974|P3|Open-label Extension Part|Withdrawal by Subject|0
1372654|NCT01489254|4529975|P2|Open-label Extension Part|Withdrawal by Subject|0
1372655|NCT01489254|4529976|P1|Open-label Extension Part|Withdrawal by Subject|0
1372656|NCT01489254|4529973|P4|Open-label Extension Part|Pregnancy|3
1372657|NCT01489254|4529974|P3|Open-label Extension Part|Pregnancy|0
1372658|NCT01489254|4529975|P2|Open-label Extension Part|Pregnancy|0
1372659|NCT01489254|4529976|P1|Open-label Extension Part|Pregnancy|0
1372660|NCT01489254|4529973|P4|Open-label Extension Part|Adverse Event|10
1372661|NCT01489254|4529974|P3|Open-label Extension Part|Adverse Event|0
1372662|NCT01489254|4529975|P2|Open-label Extension Part|Adverse Event|0
1372663|NCT01489254|4529976|P1|Open-label Extension Part|Adverse Event|0
1372664|NCT01489254|4529973|P4|Double-blind Part|Other reasons for not completing study|0
1372665|NCT01489254|4529974|P3|Double-blind Part|Other reasons for not completing study|0
1372666|NCT01489254|4529975|P2|Double-blind Part|Other reasons for not completing study|6
1372667|NCT01489254|4529976|P1|Double-blind Part|Other reasons for not completing study|4
1372668|NCT01489254|4529973|P4|Double-blind Part|Lost to Follow-up|0
1372669|NCT01489254|4529974|P3|Double-blind Part|Lost to Follow-up|0
1372670|NCT01489254|4529975|P2|Double-blind Part|Lost to Follow-up|2
1372671|NCT01489254|4529976|P1|Double-blind Part|Lost to Follow-up|1
1372672|NCT01489254|4529973|P4|Double-blind Part|Withdrawal by Subject|0
1372673|NCT01489254|4529974|P3|Double-blind Part|Withdrawal by Subject|1
1372674|NCT01489254|4529975|P2|Double-blind Part|Withdrawal by Subject|20
1372675|NCT01489254|4529976|P1|Double-blind Part|Withdrawal by Subject|12
1372676|NCT01489254|4529973|P4|Double-blind Part|Pregnancy|0
1372677|NCT01489254|4529974|P3|Double-blind Part|Pregnancy|0
1372678|NCT01489254|4529975|P2|Double-blind Part|Pregnancy|3
1372679|NCT01489254|4529976|P1|Double-blind Part|Pregnancy|1
1372680|NCT01489254|4529973|P4|Double-blind Part|Adverse Event|0
1372681|NCT01489254|4529974|P3|Double-blind Part|Adverse Event|2
1372682|NCT01489254|4529975|P2|Double-blind Part|Adverse Event|2
1372683|NCT01489254|4529976|P1|Double-blind Part|Adverse Event|7
1372684|NCT01489189|4529987|P2|Overall Study|Missed Visit|4
1372685|NCT01489189|4529988|P1|Overall Study|Missed Visit|1
1372686|NCT01489189|4529987|P2|Overall Study|Death|8
1372687|NCT01489189|4529988|P1|Overall Study|Death|10
1372688|NCT01489189|4529987|P2|Overall Study|Withdrawal by Subject|23
1372689|NCT01489189|4529988|P1|Overall Study|Withdrawal by Subject|20
1372690|NCT01488994|4530015|P2|Overall Study|Withdrawal by Subject|1
1372691|NCT01488994|4530016|P1|Overall Study|Withdrawal by Subject|0
1372692|NCT01488578|4530143|P1|Overall Study|Protocol Violation|1836
1372693|NCT01488487|4530177|P1|Overall Study|Withdrawal by Subject|2
1372694|NCT01488487|4530177|P1|Overall Study|Death|1
1372695|NCT01488487|4530177|P1|Overall Study|Adverse Event|6
1372696|NCT01488448|4530186|P2|Overall Study|Protocol Violation|3
1372697|NCT01488448|4530187|P1|Overall Study|Protocol Violation|4
1372698|NCT01488448|4530186|P2|Overall Study|Physician Decision|9
1372699|NCT01488448|4530187|P1|Overall Study|Physician Decision|4
1372700|NCT01488448|4530186|P2|Overall Study|Adverse Event|4
1372701|NCT01488448|4530187|P1|Overall Study|Adverse Event|9
1372702|NCT01488448|4530186|P2|Overall Study|Withdrawal by Subject|1
1372703|NCT01488448|4530187|P1|Overall Study|Withdrawal by Subject|3
1372704|NCT01488370|4530229|P3|Overall Study|Protocol Violation|1
1372705|NCT01488370|4530230|P2|Overall Study|Protocol Violation|1
1372706|NCT01488370|4530231|P1|Overall Study|Protocol Violation|0
1372707|NCT01488097|4530290|P1|Overall Study|Lost to Follow-up|1
1372708|NCT01488071|4530303|P2|Overall Study|Administrative or Other Reason(s)|4
1372709|NCT01488071|4530304|P1|Overall Study|Administrative or Other Reason(s)|5
1372710|NCT01488071|4530303|P2|Overall Study|Lost to Follow-up|0
1372711|NCT01488071|4530304|P1|Overall Study|Lost to Follow-up|1
1372712|NCT01488071|4530303|P2|Overall Study|Withdrawal of Consent|12
1372713|NCT01488071|4530304|P1|Overall Study|Withdrawal of Consent|14
1372714|NCT01488071|4530303|P2|Overall Study|Protocol Violation|7
1372715|NCT01488071|4530304|P1|Overall Study|Protocol Violation|5
1372716|NCT01488071|4530303|P2|Overall Study|Non-compliance with study drug|0
1372717|NCT01488071|4530304|P1|Overall Study|Non-compliance with study drug|2
1372718|NCT01488071|4530303|P2|Overall Study|Lack of Efficacy|17
1372719|NCT01488071|4530304|P1|Overall Study|Lack of Efficacy|11
1372720|NCT01488071|4530303|P2|Overall Study|Adverse Event|23
1372721|NCT01488071|4530304|P1|Overall Study|Adverse Event|15
1372722|NCT01487863|4530384|P2|Overall Study|Death|19
1372723|NCT01487863|4530385|P1|Overall Study|Death|19
1372724|NCT01487577|4530402|P1|Overall Study|Became ineligible after signing consent|1
1372725|NCT01487525|4530416|P2|Overall Study|Withdrawal by Subject|1
1372726|NCT01487525|4530417|P1|Overall Study|Withdrawal by Subject|0
1372727|NCT01487265|4530433|P1|Overall Study|Still on Treatment|1
1372728|NCT01487265|4530433|P1|Overall Study|Death|2
1372729|NCT01487265|4530433|P1|Overall Study|Disease Progression|21
1372730|NCT01487265|4530433|P1|Overall Study|Withdrawal by Subject|5
1372731|NCT01487265|4530433|P1|Overall Study|Adverse Event|8
1372732|NCT01487161|4530445|P4|Overall Study|missing data|0
1372733|NCT01487161|4530446|P3|Overall Study|missing data|0
1372734|NCT01487161|4530447|P2|Overall Study|missing data|1
1372735|NCT01487161|4530448|P1|Overall Study|missing data|0
1372736|NCT01487161|4530445|P4|Overall Study|Withdrawal by Subject|2
1372737|NCT01487161|4530446|P3|Overall Study|Withdrawal by Subject|1
1372738|NCT01487161|4530447|P2|Overall Study|Withdrawal by Subject|1
1372739|NCT01487161|4530448|P1|Overall Study|Withdrawal by Subject|1
1372740|NCT01487161|4530445|P4|Overall Study|Adverse Event|0
1372741|NCT01487161|4530446|P3|Overall Study|Adverse Event|0
1372742|NCT01487161|4530447|P2|Overall Study|Adverse Event|0
1372743|NCT01487161|4530448|P1|Overall Study|Adverse Event|1
1372744|NCT01486966|4530513|P2|Overall Study|Withdrawal by Subject|1
1372745|NCT01486966|4530514|P1|Overall Study|Withdrawal by Subject|0
1372746|NCT01486966|4530513|P2|Overall Study|Adverse Event|1
1372747|NCT01486966|4530514|P1|Overall Study|Adverse Event|0
1372748|NCT01486927|4530538|P1|Overall Study|Subject did not reach 6 mo of treatment|1
1372749|NCT01486927|4530538|P1|Overall Study|Withdrawal by Subject|8
1372750|NCT01486927|4530538|P1|Overall Study|50 Exposure days not reached|2
1372751|NCT01486927|4530538|P1|Overall Study|Physician Decision|1
1372752|NCT01486927|4530538|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
1372753|NCT01486758|4530576|P2|Overall Study|Lost to Follow-up|1
1372754|NCT01486758|4530577|P1|Overall Study|Lost to Follow-up|0
1372755|NCT01486446|4530644|P2|Overall Study|Adverse Event|0
1372756|NCT01486446|4530645|P1|Overall Study|Adverse Event|1
1372757|NCT01486316|4530668|P4|Overall Study|Death|0
1372758|NCT01486316|4530669|P3|Overall Study|Death|0
1372759|NCT01486316|4530670|P2|Overall Study|Death|1
1372760|NCT01486316|4530671|P1|Overall Study|Death|0
1372761|NCT01486316|4530668|P4|Overall Study|Physician Decision|0
1372762|NCT01486316|4530669|P3|Overall Study|Physician Decision|1
1372763|NCT01486316|4530670|P2|Overall Study|Physician Decision|0
1372764|NCT01486316|4530671|P1|Overall Study|Physician Decision|0
1372765|NCT01486316|4530668|P4|Overall Study|Withdrawal by Subject|0
1372766|NCT01486316|4530669|P3|Overall Study|Withdrawal by Subject|3
1372767|NCT01486316|4530670|P2|Overall Study|Withdrawal by Subject|0
1372768|NCT01486316|4530671|P1|Overall Study|Withdrawal by Subject|1
1372769|NCT01486316|4530668|P4|Overall Study|Not meeting eligibility criteria|0
1372770|NCT01486316|4530669|P3|Overall Study|Not meeting eligibility criteria|1
1372771|NCT01486316|4530670|P2|Overall Study|Not meeting eligibility criteria|0
1372772|NCT01486316|4530671|P1|Overall Study|Not meeting eligibility criteria|0
1372773|NCT01486316|4530668|P4|Overall Study|Device explanted with/without re-implant|2
1372774|NCT01486316|4530669|P3|Overall Study|Device explanted with/without re-implant|0
1372775|NCT01486316|4530670|P2|Overall Study|Device explanted with/without re-implant|2
1372776|NCT01486316|4530671|P1|Overall Study|Device explanted with/without re-implant|3
1372777|NCT01486238|4530683|P2|Overall Study|Lost to Follow-up|3
1372778|NCT01486238|4530684|P1|Overall Study|Lost to Follow-up|0
1372779|NCT01486238|4530683|P2|Overall Study|Withdrawal by Subject|1
1372780|NCT01486238|4530684|P1|Overall Study|Withdrawal by Subject|2
1372781|NCT01486238|4530683|P2|Overall Study|Death|2
1372782|NCT01486238|4530684|P1|Overall Study|Death|0
1372783|NCT01486199|4530692|P2|Two Year Period Between Study Days|Physician Decision|0
1372784|NCT01486199|4530693|P1|Two Year Period Between Study Days|Physician Decision|1
1372785|NCT01485991|4530713|P2|Overall Study|randomized but not treated|2
1372786|NCT01485991|4530714|P1|Overall Study|randomized but not treated|6
1372787|NCT01485991|4530713|P2|Overall Study|Withdrawal by Subject|20
1372788|NCT01485991|4530714|P1|Overall Study|Withdrawal by Subject|13
1372789|NCT01485991|4530713|P2|Overall Study|Lost to Follow-up|10
1372790|NCT01485991|4530714|P1|Overall Study|Lost to Follow-up|13
1372791|NCT01485991|4530713|P2|Overall Study|Adverse Event|4
1372792|NCT01485991|4530714|P1|Overall Study|Adverse Event|0
1372793|NCT01485887|4530724|P1|Overall Study|Primary disease markedly improved|1
1372794|NCT01485887|4530724|P1|Overall Study|Deterioration of primary disease|1
1372795|NCT01485887|4530724|P1|Overall Study|Adverse Event|8
1372796|NCT01485887|4530724|P1|Overall Study|Withdrawal by Subject|2
1372797|NCT01485796|4530736|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
1372798|NCT01485796|4530736|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
1372799|NCT01485796|4530736|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
1372800|NCT01485796|4530736|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
1372801|NCT01485796|4530736|P1|Period 2: Epoch 2|Switch to safety follow-up|26
1372802|NCT01485796|4530736|P1|Period 2: Epoch 2|Adverse Event|3
1372803|NCT01485796|4530736|P1|Period 2: Epoch 2|Withdrawal by Subject|6
1372804|NCT01485796|4530736|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
1372805|NCT01485640|4530758|P1|Overall Study|Terminated by Sponsor|95
1372806|NCT01485640|4530758|P1|Overall Study|Withdrawal by Subject|14
1372807|NCT01485640|4530758|P1|Overall Study|Protocol Violation|1
1372808|NCT01485640|4530758|P1|Overall Study|Lack of Efficacy|2
1372809|NCT01485640|4530758|P1|Overall Study|Adverse Event|10
1372810|NCT01485536|4530763|P1|Overall Study|Adverse Event|1
1372811|NCT01485536|4530763|P1|Overall Study|Withdrawal by Subject|3
1372812|NCT01485354|4530772|P1|Overall Study|Withdrawal by Subject|5
1372813|NCT01485172|4530786|P6|Overall Study|Withdrawal by Subject|1
1372814|NCT01485172|4530787|P5|Overall Study|Withdrawal by Subject|1
1372815|NCT01485172|4530788|P4|Overall Study|Withdrawal by Subject|1
1372816|NCT01485172|4530789|P3|Overall Study|Withdrawal by Subject|0
1372817|NCT01485172|4530790|P2|Overall Study|Withdrawal by Subject|0
1372818|NCT01485172|4530791|P1|Overall Study|Withdrawal by Subject|2
1372819|NCT01485172|4530786|P6|Overall Study|Physician Decision|0
1372820|NCT01485172|4530787|P5|Overall Study|Physician Decision|1
1372821|NCT01485172|4530788|P4|Overall Study|Physician Decision|0
1372822|NCT01485172|4530789|P3|Overall Study|Physician Decision|0
1372823|NCT01485172|4530790|P2|Overall Study|Physician Decision|0
1372824|NCT01485172|4530791|P1|Overall Study|Physician Decision|0
1372825|NCT01485172|4530786|P6|Overall Study|Lost to Follow-up|1
1372826|NCT01485172|4530787|P5|Overall Study|Lost to Follow-up|0
1372827|NCT01485172|4530788|P4|Overall Study|Lost to Follow-up|0
1372828|NCT01485172|4530789|P3|Overall Study|Lost to Follow-up|1
1372829|NCT01485172|4530790|P2|Overall Study|Lost to Follow-up|0
1372830|NCT01485172|4530791|P1|Overall Study|Lost to Follow-up|0
1372831|NCT01485172|4530786|P6|Overall Study|Protocol defined stopping criteria|0
1372832|NCT01485172|4530787|P5|Overall Study|Protocol defined stopping criteria|1
1372833|NCT01485172|4530788|P4|Overall Study|Protocol defined stopping criteria|0
1372834|NCT01485172|4530789|P3|Overall Study|Protocol defined stopping criteria|0
1372835|NCT01485172|4530790|P2|Overall Study|Protocol defined stopping criteria|0
1372836|NCT01485172|4530791|P1|Overall Study|Protocol defined stopping criteria|1
1372837|NCT01485172|4530786|P6|Overall Study|Protocol Violation|0
1372838|NCT01485172|4530787|P5|Overall Study|Protocol Violation|1
1372839|NCT01485172|4530788|P4|Overall Study|Protocol Violation|5
1372840|NCT01485172|4530789|P3|Overall Study|Protocol Violation|4
1372841|NCT01485172|4530790|P2|Overall Study|Protocol Violation|0
1372842|NCT01485172|4530791|P1|Overall Study|Protocol Violation|0
1372843|NCT01485172|4530786|P6|Overall Study|Lack of Efficacy|0
1372844|NCT01485172|4530787|P5|Overall Study|Lack of Efficacy|0
1372845|NCT01485172|4530788|P4|Overall Study|Lack of Efficacy|0
1372846|NCT01485172|4530789|P3|Overall Study|Lack of Efficacy|0
1372847|NCT01485172|4530790|P2|Overall Study|Lack of Efficacy|0
1372848|NCT01485172|4530791|P1|Overall Study|Lack of Efficacy|2
1372849|NCT01485172|4530786|P6|Overall Study|Adverse Event|2
1372850|NCT01485172|4530787|P5|Overall Study|Adverse Event|1
1372851|NCT01485172|4530788|P4|Overall Study|Adverse Event|2
1372852|NCT01485172|4530789|P3|Overall Study|Adverse Event|2
1372853|NCT01485172|4530790|P2|Overall Study|Adverse Event|1
1372854|NCT01485172|4530791|P1|Overall Study|Adverse Event|2
1372855|NCT01485094|4530868|P3|Overall Study|Withdrawal by Subject|0
1372856|NCT01485094|4530869|P2|Overall Study|Withdrawal by Subject|1
1372857|NCT01485094|4530870|P1|Overall Study|Withdrawal by Subject|1
1372858|NCT01485094|4530868|P3|Overall Study|Lost to Follow-up|0
1372859|NCT01485094|4530869|P2|Overall Study|Lost to Follow-up|0
1372860|NCT01485094|4530870|P1|Overall Study|Lost to Follow-up|1
1372861|NCT01485094|4530868|P3|Overall Study|Adverse Event|1
1372862|NCT01485094|4530869|P2|Overall Study|Adverse Event|1
1372863|NCT01485094|4530870|P1|Overall Study|Adverse Event|1
1372864|NCT01484977|4530911|P1|Overall Study|Lack of Compliance|1
1372865|NCT01484977|4530911|P1|Overall Study|Low White Blood Cell Count|1
1372866|NCT01484977|4530911|P1|Overall Study|Moving Overseas|1
1372867|NCT01484977|4530911|P1|Overall Study|Subject Protocol Non-compliant|1
1372868|NCT01484977|4530911|P1|Overall Study|Withdrawal by Subject|4
1372869|NCT01484977|4530911|P1|Overall Study|Lost to Follow-up|1
1372870|NCT01484977|4530911|P1|Overall Study|Protocol Violation|6
1372871|NCT01484977|4530911|P1|Overall Study|Lack of Efficacy|4
1372872|NCT01484977|4530911|P1|Overall Study|Adverse Event|8
1372873|NCT01484951|4530915|P1|Overall Study|Non-Compliance|1
1372874|NCT01484951|4530915|P1|Overall Study|Personal Reasons|1
1372875|NCT01484951|4530915|P1|Overall Study|Adverse Event|3
1372876|NCT01484938|4530920|P1|Overall Study|Noncompliance|1
1372877|NCT01484938|4530920|P1|Overall Study|Lost to Follow-up|1
1372878|NCT01484938|4530920|P1|Overall Study|Adverse Event|2
1372879|NCT01484912|4530927|P2|Overall Study|Physician Decision|1
1372880|NCT01484912|4530928|P1|Overall Study|Physician Decision|0
1372881|NCT01484912|4530927|P2|Overall Study|Withdrawal by Subject|0
1372882|NCT01484912|4530928|P1|Overall Study|Withdrawal by Subject|1
1372883|NCT01484873|4530938|P1|Overall Study|Withdrawal by Subject|2
1372884|NCT01484834|4530950|P4|Overall Study|Lost to Follow-up|4
1372885|NCT01484834|4530951|P3|Overall Study|Lost to Follow-up|1
1372886|NCT01484834|4530952|P2|Overall Study|Lost to Follow-up|8
1372887|NCT01484834|4530953|P1|Overall Study|Lost to Follow-up|5
1372888|NCT01484561|4530994|P2|Overall Study|Adverse Event|4
1372889|NCT01484561|4530995|P1|Overall Study|Adverse Event|1
1372890|NCT01484561|4530994|P2|Overall Study|Not specified|1
1372891|NCT01484561|4530995|P1|Overall Study|Not specified|1
1372892|NCT01484561|4530994|P2|Overall Study|Withdrawal by Subject|0
1372893|NCT01484561|4530995|P1|Overall Study|Withdrawal by Subject|3
1372894|NCT01484561|4530994|P2|Overall Study|Lost to Follow-up|0
1372895|NCT01484561|4530995|P1|Overall Study|Lost to Follow-up|1
1372896|NCT01484561|4530994|P2|Overall Study|Lack of Efficacy|1
1372897|NCT01484561|4530995|P1|Overall Study|Lack of Efficacy|3
1372898|NCT01484496|4531085|P4|Period 2|Other|6
1372899|NCT01484496|4531086|P3|Period 2|Other|9
1372900|NCT01484496|4531087|P2|Period 2|Other|0
1372901|NCT01484496|4531088|P1|Period 2|Other|0
1372902|NCT01484496|4531085|P4|Period 2|Adverse Event|13
1372903|NCT01484496|4531086|P3|Period 2|Adverse Event|5
1372904|NCT01484496|4531087|P2|Period 2|Adverse Event|0
1372905|NCT01484496|4531088|P1|Period 2|Adverse Event|0
1372906|NCT01484496|4531085|P4|Period 2|Lack of Efficacy|3
1372907|NCT01484496|4531086|P3|Period 2|Lack of Efficacy|1
1372908|NCT01484496|4531087|P2|Period 2|Lack of Efficacy|0
1372909|NCT01484496|4531088|P1|Period 2|Lack of Efficacy|0
1372910|NCT01484496|4531085|P4|Period 1|Unable to Visit Site|0
1372911|NCT01484496|4531086|P3|Period 1|Unable to Visit Site|0
1372912|NCT01484496|4531087|P2|Period 1|Unable to Visit Site|2
1372913|NCT01484496|4531088|P1|Period 1|Unable to Visit Site|0
1372914|NCT01484496|4531085|P4|Period 1|Lack of Compliance|0
1372915|NCT01484496|4531086|P3|Period 1|Lack of Compliance|0
1372916|NCT01484496|4531087|P2|Period 1|Lack of Compliance|1
1372917|NCT01484496|4531088|P1|Period 1|Lack of Compliance|2
1372918|NCT01484496|4531085|P4|Period 1|Treatment Failure|0
1372919|NCT01484496|4531086|P3|Period 1|Treatment Failure|0
1372920|NCT01484496|4531087|P2|Period 1|Treatment Failure|6
1372921|NCT01484496|4531088|P1|Period 1|Treatment Failure|3
1372922|NCT01484496|4531085|P4|Period 1|Positive Pregnancy|0
1372923|NCT01484496|4531086|P3|Period 1|Positive Pregnancy|0
1372924|NCT01484496|4531087|P2|Period 1|Positive Pregnancy|6
1372925|NCT01484496|4531088|P1|Period 1|Positive Pregnancy|1
1372926|NCT01484496|4531085|P4|Period 1|Lost to Follow-up|0
1372927|NCT01484496|4531086|P3|Period 1|Lost to Follow-up|0
1372928|NCT01484496|4531087|P2|Period 1|Lost to Follow-up|6
1372929|NCT01484496|4531088|P1|Period 1|Lost to Follow-up|2
1372930|NCT01484496|4531085|P4|Period 1|Withdrawal by Subject|0
1372931|NCT01484496|4531086|P3|Period 1|Withdrawal by Subject|0
1372932|NCT01484496|4531087|P2|Period 1|Withdrawal by Subject|12
1372933|NCT01484496|4531088|P1|Period 1|Withdrawal by Subject|15
1372934|NCT01484496|4531085|P4|Period 1|Adverse Event|0
1372935|NCT01484496|4531086|P3|Period 1|Adverse Event|0
1372936|NCT01484496|4531087|P2|Period 1|Adverse Event|40
1372937|NCT01484496|4531088|P1|Period 1|Adverse Event|25
1372938|NCT01484496|4531085|P4|Period 1|Lack of Efficacy|0
1372939|NCT01484496|4531086|P3|Period 1|Lack of Efficacy|0
1372940|NCT01484496|4531087|P2|Period 1|Lack of Efficacy|15
1372941|NCT01484496|4531088|P1|Period 1|Lack of Efficacy|10
1372942|NCT01484496|4531085|P4|Period 1|Physician Decision|0
1372943|NCT01484496|4531086|P3|Period 1|Physician Decision|0
1372944|NCT01484496|4531087|P2|Period 1|Physician Decision|1
1372945|NCT01484496|4531088|P1|Period 1|Physician Decision|5
1372946|NCT01484496|4531085|P4|Period 1|Protocol Violation|0
1372947|NCT01484496|4531086|P3|Period 1|Protocol Violation|0
1372948|NCT01484496|4531087|P2|Period 1|Protocol Violation|4
1372949|NCT01484496|4531088|P1|Period 1|Protocol Violation|3
1372950|NCT01484197|4531106|P4|Treatment Period 2|Subject withdrew consent|1
1372951|NCT01484197|4531107|P3|Treatment Period 2|Subject withdrew consent|0
1372952|NCT01484197|4531108|P2|Treatment Period 2|Subject withdrew consent|0
1372953|NCT01484197|4531109|P1|Treatment Period 2|Subject withdrew consent|0
1372954|NCT01484197|4531106|P4|Treatment Period 1|Adverse Event|0
1372955|NCT01484197|4531107|P3|Treatment Period 1|Adverse Event|0
1372956|NCT01484197|4531108|P2|Treatment Period 1|Adverse Event|0
1372957|NCT01484197|4531109|P1|Treatment Period 1|Adverse Event|1
1372958|NCT01484132|4531192|P1|Overall Study|No post-treatment urine sample collected|10
1372959|NCT01484132|4531192|P1|Overall Study|No pre-treatment urine sample collected|1
1372960|NCT01484132|4531192|P1|Overall Study|Ineligible|1
1372961|NCT01484132|4531192|P1|Overall Study|Difficulty with time commitment|2
1372962|NCT01484132|4531192|P1|Overall Study|Lost to Follow-up|8
1372963|NCT01484054|4531200|P2|Period 1|Withdrawal by Subject|1
1372964|NCT01484054|4531201|P1|Period 1|Withdrawal by Subject|0
1372965|NCT01484028|4531219|P4|Period 1|Lens Discomfort|0
1372966|NCT01484028|4531220|P3|Period 1|Lens Discomfort|0
1372967|NCT01484028|4531221|P2|Period 1|Lens Discomfort|1
1372968|NCT01484028|4531222|P1|Period 1|Lens Discomfort|0
1372969|NCT01484028|4531219|P4|Period 1|Non-Compliance to Protocol|1
1372970|NCT01484028|4531220|P3|Period 1|Non-Compliance to Protocol|0
1372971|NCT01484028|4531221|P2|Period 1|Non-Compliance to Protocol|1
1372972|NCT01484028|4531222|P1|Period 1|Non-Compliance to Protocol|0
1372973|NCT01484028|4531219|P4|Period 1|Lost to Follow-up|0
1372974|NCT01484028|4531220|P3|Period 1|Lost to Follow-up|0
1372975|NCT01484028|4531221|P2|Period 1|Lost to Follow-up|1
1372976|NCT01484028|4531222|P1|Period 1|Lost to Follow-up|0
1372977|NCT01483937|4531315|P2|Overall Study|Withdrawal by Subject|3
1372978|NCT01483937|4531316|P1|Overall Study|Withdrawal by Subject|4
1372979|NCT01483924|4531343|P5|Overall Study|Sponsor concern over ECG result|0
1372980|NCT01483924|4531344|P4|Overall Study|Sponsor concern over ECG result|1
1372981|NCT01483924|4531345|P3|Overall Study|Sponsor concern over ECG result|0
1372982|NCT01483924|4531346|P2|Overall Study|Sponsor concern over ECG result|0
1372983|NCT01483924|4531347|P1|Overall Study|Sponsor concern over ECG result|0
1372984|NCT01483924|4531343|P5|Overall Study|Non-compliance|1
1372985|NCT01483924|4531344|P4|Overall Study|Non-compliance|1
1372986|NCT01483924|4531345|P3|Overall Study|Non-compliance|0
1372987|NCT01483924|4531346|P2|Overall Study|Non-compliance|0
1372988|NCT01483924|4531347|P1|Overall Study|Non-compliance|0
1372989|NCT01483924|4531343|P5|Overall Study|Adverse Event|0
1372990|NCT01483924|4531344|P4|Overall Study|Adverse Event|1
1372991|NCT01483924|4531345|P3|Overall Study|Adverse Event|1
1372992|NCT01483924|4531346|P2|Overall Study|Adverse Event|0
1372993|NCT01483924|4531347|P1|Overall Study|Adverse Event|0
1372994|NCT01483924|4531343|P5|Overall Study|Withdrawal by Subject|1
1372995|NCT01483924|4531344|P4|Overall Study|Withdrawal by Subject|1
1372996|NCT01483924|4531345|P3|Overall Study|Withdrawal by Subject|0
1372997|NCT01483924|4531346|P2|Overall Study|Withdrawal by Subject|0
1372998|NCT01483924|4531347|P1|Overall Study|Withdrawal by Subject|2
1372999|NCT01483820|4531395|P1|Overall Study|Death|1
1373000|NCT01483820|4531395|P1|Overall Study|Adverse Event|1
1373001|NCT01483820|4531395|P1|Overall Study|Lack of Efficacy|6
1373002|NCT01483651|4531404|P6|Overall Study|Withdrawal by Subject|1
1373003|NCT01483651|4531405|P5|Overall Study|Withdrawal by Subject|0
1373004|NCT01483651|4531406|P4|Overall Study|Withdrawal by Subject|0
1373005|NCT01483651|4531407|P3|Overall Study|Withdrawal by Subject|1
1373006|NCT01483651|4531408|P2|Overall Study|Withdrawal by Subject|1
1373007|NCT01483651|4531409|P1|Overall Study|Withdrawal by Subject|0
1373008|NCT01483625|4531419|P2|Overall Study|Due to other reason|0
1373009|NCT01483625|4531420|P1|Overall Study|Due to other reason|1
1373010|NCT01483625|4531419|P2|Overall Study|Refused to continue medication|1
1373011|NCT01483625|4531420|P1|Overall Study|Refused to continue medication|2
1373012|NCT01483625|4531419|P2|Overall Study|Adverse Event|1
1373013|NCT01483625|4531420|P1|Overall Study|Adverse Event|1
1373014|NCT01483599|4531443|P14|After Controlled Period(Week 16-Week 40)|Other|0
1373015|NCT01483599|4531444|P13|After Controlled Period(Week 16-Week 40)|Other|1
1373016|NCT01483599|4531445|P12|After Controlled Period(Week 16-Week 40)|Other|0
1373017|NCT01483599|4531446|P11|After Controlled Period(Week 16-Week 40)|Other|0
1373018|NCT01483599|4531447|P10|After Controlled Period(Week 16-Week 40)|Other|4
1373019|NCT01483599|4531448|P9|After Controlled Period(Week 16-Week 40)|Other|0
1373020|NCT01483599|4531449|P8|After Controlled Period(Week 16-Week 40)|Other|1
1373021|NCT01483599|4531450|P7|After Controlled Period(Week 16-Week 40)|Other|0
1373022|NCT01483599|4531451|P6|After Controlled Period(Week 16-Week 40)|Other|0
1373023|NCT01483599|4531452|P5|After Controlled Period(Week 16-Week 40)|Other|0
1373024|NCT01483599|4531453|P4|After Controlled Period(Week 16-Week 40)|Other|0
1373025|NCT01483599|4531454|P3|After Controlled Period(Week 16-Week 40)|Other|0
1373026|NCT01483599|4531455|P2|After Controlled Period(Week 16-Week 40)|Other|0
1373027|NCT01483599|4531456|P1|After Controlled Period(Week 16-Week 40)|Other|0
1373028|NCT01483599|4531443|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
1373029|NCT01483599|4531444|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
1373030|NCT01483599|4531445|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1373031|NCT01483599|4531446|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1373032|NCT01483599|4531447|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1373033|NCT01483599|4531448|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
1373034|NCT01483599|4531449|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1373035|NCT01483599|4531450|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1373036|NCT01483599|4531451|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1373037|NCT01483599|4531452|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1373038|NCT01483599|4531453|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1373039|NCT01483599|4531454|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1373040|NCT01483599|4531455|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1373041|NCT01483599|4531456|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1373042|NCT01483599|4531443|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
1373043|NCT01483599|4531444|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1373044|NCT01483599|4531445|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1373045|NCT01483599|4531446|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
1373046|NCT01483599|4531447|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1373047|NCT01483599|4531448|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
1373048|NCT01483599|4531449|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1373049|NCT01483599|4531450|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1373050|NCT01483599|4531451|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1373051|NCT01483599|4531452|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1373052|NCT01483599|4531453|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1373053|NCT01483599|4531454|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1373054|NCT01483599|4531455|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1373055|NCT01483599|4531456|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1373056|NCT01483599|4531443|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
1373057|NCT01483599|4531444|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1373058|NCT01483599|4531445|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
1373059|NCT01483599|4531446|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1373060|NCT01483599|4531447|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1373061|NCT01483599|4531448|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
1373062|NCT01483599|4531449|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1373063|NCT01483599|4531450|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1373064|NCT01483599|4531451|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1373065|NCT01483599|4531452|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1373066|NCT01483599|4531453|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1373067|NCT01483599|4531454|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1373068|NCT01483599|4531455|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1373069|NCT01483599|4531456|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1373070|NCT01483599|4531443|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1373071|NCT01483599|4531444|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1373072|NCT01483599|4531445|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1373073|NCT01483599|4531446|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1373074|NCT01483599|4531447|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1373075|NCT01483599|4531448|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1373076|NCT01483599|4531449|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1373077|NCT01483599|4531450|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1373078|NCT01483599|4531451|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1373079|NCT01483599|4531452|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1373080|NCT01483599|4531453|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1373081|NCT01483599|4531454|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1373082|NCT01483599|4531455|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1373083|NCT01483599|4531456|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1373084|NCT01483599|4531443|P14|After Controlled Period(Week 16-Week 40)|Death|0
1373085|NCT01483599|4531444|P13|After Controlled Period(Week 16-Week 40)|Death|0
1373086|NCT01483599|4531445|P12|After Controlled Period(Week 16-Week 40)|Death|0
1373087|NCT01483599|4531446|P11|After Controlled Period(Week 16-Week 40)|Death|0
1373088|NCT01483599|4531447|P10|After Controlled Period(Week 16-Week 40)|Death|0
1373089|NCT01483599|4531448|P9|After Controlled Period(Week 16-Week 40)|Death|1
1373090|NCT01483599|4531449|P8|After Controlled Period(Week 16-Week 40)|Death|0
1373091|NCT01483599|4531450|P7|After Controlled Period(Week 16-Week 40)|Death|0
1373092|NCT01483599|4531451|P6|After Controlled Period(Week 16-Week 40)|Death|0
1373093|NCT01483599|4531452|P5|After Controlled Period(Week 16-Week 40)|Death|0
1373094|NCT01483599|4531453|P4|After Controlled Period(Week 16-Week 40)|Death|0
1373095|NCT01483599|4531454|P3|After Controlled Period(Week 16-Week 40)|Death|0
1373096|NCT01483599|4531455|P2|After Controlled Period(Week 16-Week 40)|Death|0
1373097|NCT01483599|4531456|P1|After Controlled Period(Week 16-Week 40)|Death|0
1373098|NCT01483599|4531443|P14|Controlled Period (CP) (up to Week 16)|Other|0
1373099|NCT01483599|4531444|P13|Controlled Period (CP) (up to Week 16)|Other|0
1373100|NCT01483599|4531445|P12|Controlled Period (CP) (up to Week 16)|Other|0
1373101|NCT01483599|4531446|P11|Controlled Period (CP) (up to Week 16)|Other|0
1373102|NCT01483599|4531447|P10|Controlled Period (CP) (up to Week 16)|Other|0
1373103|NCT01483599|4531448|P9|Controlled Period (CP) (up to Week 16)|Other|0
1373104|NCT01483599|4531449|P8|Controlled Period (CP) (up to Week 16)|Other|0
1373105|NCT01483599|4531450|P7|Controlled Period (CP) (up to Week 16)|Other|0
1373106|NCT01483599|4531451|P6|Controlled Period (CP) (up to Week 16)|Other|0
1373107|NCT01483599|4531452|P5|Controlled Period (CP) (up to Week 16)|Other|1
1373108|NCT01483599|4531453|P4|Controlled Period (CP) (up to Week 16)|Other|1
1373109|NCT01483599|4531454|P3|Controlled Period (CP) (up to Week 16)|Other|0
1373110|NCT01483599|4531455|P2|Controlled Period (CP) (up to Week 16)|Other|2
1373111|NCT01483599|4531456|P1|Controlled Period (CP) (up to Week 16)|Other|0
1373112|NCT01483599|4531443|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1373113|NCT01483599|4531444|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1373114|NCT01483599|4531445|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1373115|NCT01483599|4531446|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1373116|NCT01483599|4531447|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1373117|NCT01483599|4531448|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1373118|NCT01483599|4531449|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1373119|NCT01483599|4531450|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1373120|NCT01483599|4531451|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1373121|NCT01483599|4531452|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1373122|NCT01483599|4531453|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1373123|NCT01483599|4531454|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1373124|NCT01483599|4531455|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1373125|NCT01483599|4531456|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
1373126|NCT01483599|4531443|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1373127|NCT01483599|4531444|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1373128|NCT01483599|4531445|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1373129|NCT01483599|4531446|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1373130|NCT01483599|4531447|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1373131|NCT01483599|4531448|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1373132|NCT01483599|4531449|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1373133|NCT01483599|4531450|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
1373134|NCT01483599|4531451|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1373219|NCT01482767|4531732|P2|Overall Study|Alternate HCV treatment|8
1373135|NCT01483599|4531452|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1373136|NCT01483599|4531453|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
1373137|NCT01483599|4531454|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1373138|NCT01483599|4531455|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
1373139|NCT01483599|4531456|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1373140|NCT01483599|4531443|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1373141|NCT01483599|4531444|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1373142|NCT01483599|4531445|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1373143|NCT01483599|4531446|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1373144|NCT01483599|4531447|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1373145|NCT01483599|4531448|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1373146|NCT01483599|4531449|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1373147|NCT01483599|4531450|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
1373148|NCT01483599|4531451|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
1373149|NCT01483599|4531452|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
1373150|NCT01483599|4531453|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
1373151|NCT01483599|4531454|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1373152|NCT01483599|4531455|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1373153|NCT01483599|4531456|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
1373154|NCT01483183|4531546|P10|Overall Study|Withdrawal by Subject|1
1373155|NCT01483183|4531547|P9|Overall Study|Withdrawal by Subject|0
1373156|NCT01483183|4531548|P8|Overall Study|Withdrawal by Subject|0
1373157|NCT01483183|4531549|P7|Overall Study|Withdrawal by Subject|0
1373158|NCT01483183|4531550|P6|Overall Study|Withdrawal by Subject|0
1373159|NCT01483183|4531551|P5|Overall Study|Withdrawal by Subject|0
1373160|NCT01483183|4531552|P4|Overall Study|Withdrawal by Subject|0
1373161|NCT01483183|4531553|P3|Overall Study|Withdrawal by Subject|0
1373162|NCT01483183|4531554|P2|Overall Study|Withdrawal by Subject|0
1373163|NCT01483183|4531555|P1|Overall Study|Withdrawal by Subject|0
1373164|NCT01483183|4531546|P10|Overall Study|Physician Decision|0
1373165|NCT01483183|4531547|P9|Overall Study|Physician Decision|0
1373166|NCT01483183|4531548|P8|Overall Study|Physician Decision|0
1373167|NCT01483183|4531549|P7|Overall Study|Physician Decision|2
1373168|NCT01483183|4531550|P6|Overall Study|Physician Decision|0
1373169|NCT01483183|4531551|P5|Overall Study|Physician Decision|0
1373170|NCT01483183|4531552|P4|Overall Study|Physician Decision|0
1373171|NCT01483183|4531553|P3|Overall Study|Physician Decision|0
1373172|NCT01483183|4531554|P2|Overall Study|Physician Decision|0
1373173|NCT01483183|4531555|P1|Overall Study|Physician Decision|0
1373174|NCT01483118|4531625|P2|Overall Study|Lost to Follow-up|16
1373175|NCT01483118|4531626|P1|Overall Study|Lost to Follow-up|12
1373176|NCT01482962|4531638|P2|Overall Study|Did not Receive Study Drug|6
1373177|NCT01482962|4531639|P1|Overall Study|Did not Receive Study Drug|1
1373178|NCT01482962|4531638|P2|Overall Study|Study Terminated by Sponsor|2
1373179|NCT01482962|4531639|P1|Overall Study|Study Terminated by Sponsor|5
1373180|NCT01482962|4531638|P2|Overall Study|Other Reason|5
1373181|NCT01482962|4531639|P1|Overall Study|Other Reason|1
1373182|NCT01482962|4531638|P2|Overall Study|Hematopoietic Stem Cell Transplant|9
1373183|NCT01482962|4531639|P1|Overall Study|Hematopoietic Stem Cell Transplant|3
1373184|NCT01482962|4531638|P2|Overall Study|Withdrawal by Participant|13
1373185|NCT01482962|4531639|P1|Overall Study|Withdrawal by Participant|8
1373186|NCT01482962|4531638|P2|Overall Study|Adverse Event|22
1373187|NCT01482962|4531639|P1|Overall Study|Adverse Event|18
1373188|NCT01482962|4531638|P2|Overall Study|Unsatisfactory Therapeutic Response|23
1373189|NCT01482962|4531639|P1|Overall Study|Unsatisfactory Therapeutic Response|37
1373190|NCT01482962|4531638|P2|Overall Study|Progressive Disease|53
1373191|NCT01482962|4531639|P1|Overall Study|Progressive Disease|65
1373192|NCT01482910|4531672|P2|Overall Study|Death|0
1373193|NCT01482910|4531673|P1|Overall Study|Death|1
1373194|NCT01482910|4531672|P2|Overall Study|Withdrawal by Subject|2
1373195|NCT01482910|4531673|P1|Overall Study|Withdrawal by Subject|7
1373196|NCT01482910|4531672|P2|Overall Study|Protocol Violation|1
1373197|NCT01482910|4531673|P1|Overall Study|Protocol Violation|1
1373198|NCT01482910|4531672|P2|Overall Study|Lost to Follow-up|1
1373199|NCT01482910|4531673|P1|Overall Study|Lost to Follow-up|0
1373200|NCT01482910|4531672|P2|Overall Study|Adverse Event|5
1373201|NCT01482910|4531673|P1|Overall Study|Adverse Event|6
1373202|NCT01482884|4531685|P2|Overall Study|Withdrawal by Subject|13
1373203|NCT01482884|4531686|P1|Overall Study|Withdrawal by Subject|8
1373204|NCT01482884|4531685|P2|Overall Study|Adverse Event|1
1373205|NCT01482884|4531686|P1|Overall Study|Adverse Event|2
1373206|NCT01482884|4531685|P2|Overall Study|Lack of Efficacy|1
1373207|NCT01482884|4531686|P1|Overall Study|Lack of Efficacy|0
1373208|NCT01482884|4531685|P2|Overall Study|Lost to Follow-up|2
1373209|NCT01482884|4531686|P1|Overall Study|Lost to Follow-up|2
1373210|NCT01482884|4531685|P2|Overall Study|Protocol Violation|0
1373211|NCT01482884|4531686|P1|Overall Study|Protocol Violation|1
1373212|NCT01482884|4531685|P2|Overall Study|Medical decision due to lack of efficacy|1
1373213|NCT01482884|4531686|P1|Overall Study|Medical decision due to lack of efficacy|0
1373214|NCT01482819|4531712|P1|Overall Study|Lost to Follow-up|2
1373215|NCT01482767|4531732|P2|Overall Study|Nurse error|0
1373216|NCT01482767|4531733|P1|Overall Study|Nurse error|1
1373217|NCT01482767|4531732|P2|Overall Study|Ineligible|5
1373218|NCT01482767|4531733|P1|Overall Study|Ineligible|0
1373220|NCT01482767|4531733|P1|Overall Study|Alternate HCV treatment|7
1373221|NCT01482767|4531732|P2|Overall Study|Non-adherence to study requirements|7
1373222|NCT01482767|4531733|P1|Overall Study|Non-adherence to study requirements|4
1373223|NCT01482767|4531732|P2|Overall Study|Site closure|14
1373224|NCT01482767|4531733|P1|Overall Study|Site closure|22
1373225|NCT01482767|4531732|P2|Overall Study|Adverse Event|3
1373226|NCT01482767|4531733|P1|Overall Study|Adverse Event|0
1373227|NCT01482767|4531732|P2|Overall Study|Lost to Follow-up|6
1373228|NCT01482767|4531733|P1|Overall Study|Lost to Follow-up|12
1373229|NCT01482767|4531732|P2|Overall Study|Withdrawal by Subject|5
1373230|NCT01482767|4531733|P1|Overall Study|Withdrawal by Subject|7
1373231|NCT01482767|4531732|P2|Overall Study|Death|1
1373232|NCT01482767|4531733|P1|Overall Study|Death|1
1373233|NCT01482429|4531755|P2|Protocol|Protocol Violation|0
1373234|NCT01482429|4531756|P1|Protocol|Protocol Violation|275
1373235|NCT01482429|4531755|P2|Care Usual|Lost to Follow-up|1
1373236|NCT01482429|4531756|P1|Care Usual|Lost to Follow-up|0
1373237|NCT01482429|4531755|P2|Care Usual|Protocol Violation|172
1373238|NCT01482429|4531756|P1|Care Usual|Protocol Violation|0
1373239|NCT01482312|4531768|P3|Period 2, 90 Minutes of Wear|Other|0
1373240|NCT01482312|4531769|P2|Period 2, 90 Minutes of Wear|Other|0
1373241|NCT01482312|4531770|P1|Period 2, 90 Minutes of Wear|Other|1
1373242|NCT01482312|4531768|P3|Period 1, 90 Minutes of Wear|Other|0
1373243|NCT01482312|4531769|P2|Period 1, 90 Minutes of Wear|Other|0
1373244|NCT01482312|4531770|P1|Period 1, 90 Minutes of Wear|Other|1
1373245|NCT01482221|4531784|P3|Overall Study|Physician Decision|0
1373246|NCT01482221|4531785|P2|Overall Study|Physician Decision|1
1373247|NCT01482221|4531786|P1|Overall Study|Physician Decision|0
1373248|NCT01482221|4531784|P3|Overall Study|Incorrect randomization|0
1373249|NCT01482221|4531785|P2|Overall Study|Incorrect randomization|1
1373250|NCT01482221|4531786|P1|Overall Study|Incorrect randomization|0
1373251|NCT01482221|4531784|P3|Overall Study|Withdrawal by Subject|12
1373252|NCT01482221|4531785|P2|Overall Study|Withdrawal by Subject|7
1373253|NCT01482221|4531786|P1|Overall Study|Withdrawal by Subject|10
1373254|NCT01482221|4531784|P3|Overall Study|Adverse Event|3
1373255|NCT01482221|4531785|P2|Overall Study|Adverse Event|7
1373256|NCT01482221|4531786|P1|Overall Study|Adverse Event|1
1373257|NCT01482221|4531784|P3|Overall Study|Severe Non-Compliance to Protocol|1
1373258|NCT01482221|4531785|P2|Overall Study|Severe Non-Compliance to Protocol|0
1373259|NCT01482221|4531786|P1|Overall Study|Severe Non-Compliance to Protocol|1
1373260|NCT01482221|4531784|P3|Overall Study|Condition under Investigation Worsened|4
1373261|NCT01482221|4531785|P2|Overall Study|Condition under Investigation Worsened|2
1373262|NCT01482221|4531786|P1|Overall Study|Condition under Investigation Worsened|3
1373263|NCT01482221|4531784|P3|Overall Study|Study-Specific Withdrawal Criteria|1
1373264|NCT01482221|4531785|P2|Overall Study|Study-Specific Withdrawal Criteria|0
1373265|NCT01482221|4531786|P1|Overall Study|Study-Specific Withdrawal Criteria|2
1373266|NCT01482221|4531784|P3|Overall Study|Lost to Follow-up|1
1373267|NCT01482221|4531785|P2|Overall Study|Lost to Follow-up|2
1373268|NCT01482221|4531786|P1|Overall Study|Lost to Follow-up|3
1373269|NCT01482221|4531784|P3|Overall Study|Lack of Efficacy|1
1373270|NCT01482221|4531785|P2|Overall Study|Lack of Efficacy|0
1373271|NCT01482221|4531786|P1|Overall Study|Lack of Efficacy|1
1373272|NCT01482169|4531827|P1|Overall Study|Physician Decision|2
1373273|NCT01482065|4531869|P2|Overall Study|Withdrawal by Subject|1
1373274|NCT01482065|4531870|P1|Overall Study|Withdrawal by Subject|0
1373275|NCT01481896|4531891|P1|Overall Study|Lost to Follow-up|12
1373276|NCT01481779|4531907|P2|Overall Study|Sponsor Decision|1
1373277|NCT01481779|4531908|P1|Overall Study|Sponsor Decision|3
1373278|NCT01481779|4531907|P2|Overall Study|Physician Decision|4
1373279|NCT01481779|4531908|P1|Overall Study|Physician Decision|13
1373280|NCT01481779|4531907|P2|Overall Study|Withdrawal by Subject|13
1373281|NCT01481779|4531908|P1|Overall Study|Withdrawal by Subject|26
1373282|NCT01481779|4531907|P2|Overall Study|Protocol Violation|3
1373283|NCT01481779|4531908|P1|Overall Study|Protocol Violation|2
1373284|NCT01481779|4531907|P2|Overall Study|Lost to Follow-up|2
1373285|NCT01481779|4531908|P1|Overall Study|Lost to Follow-up|3
1373286|NCT01481779|4531907|P2|Overall Study|Adverse Event|5
1373287|NCT01481779|4531908|P1|Overall Study|Adverse Event|23
1373288|NCT01481324|4531993|P3|Overall Study|Missing Data|2
1373289|NCT01481324|4531994|P2|Overall Study|Missing Data|2
1373290|NCT01481324|4531995|P1|Overall Study|Missing Data|0
1373291|NCT01481116|4532014|P3|Overall Study|Hypoglycemic Event|0
1373292|NCT01481116|4532015|P2|Overall Study|Hypoglycemic Event|0
1373293|NCT01481116|4532016|P1|Overall Study|Hypoglycemic Event|4
1373294|NCT01481116|4532014|P3|Overall Study|Death|0
1373295|NCT01481116|4532015|P2|Overall Study|Death|1
1373296|NCT01481116|4532016|P1|Overall Study|Death|2
1373297|NCT01481116|4532014|P3|Overall Study|Investigator's Discretion|0
1373298|NCT01481116|4532015|P2|Overall Study|Investigator's Discretion|0
1373299|NCT01481116|4532016|P1|Overall Study|Investigator's Discretion|2
1373300|NCT01481116|4532014|P3|Overall Study|Non-Compliant With Study Drug|1
1373301|NCT01481116|4532015|P2|Overall Study|Non-Compliant With Study Drug|1
1373302|NCT01481116|4532016|P1|Overall Study|Non-Compliant With Study Drug|0
1373303|NCT01481116|4532014|P3|Overall Study|Sponsor Decision|3
1373304|NCT01481116|4532015|P2|Overall Study|Sponsor Decision|1
1373305|NCT01481116|4532016|P1|Overall Study|Sponsor Decision|0
1373306|NCT01481116|4532014|P3|Overall Study|Investigator Decision|1
1373307|NCT01481116|4532015|P2|Overall Study|Investigator Decision|2
1373308|NCT01481116|4532016|P1|Overall Study|Investigator Decision|3
1373309|NCT01481116|4532014|P3|Overall Study|Participant Moved Out of Country|1
1373310|NCT01481116|4532015|P2|Overall Study|Participant Moved Out of Country|0
1373311|NCT01481116|4532016|P1|Overall Study|Participant Moved Out of Country|1
1373312|NCT01481116|4532014|P3|Overall Study|Participant Moved Out of Area|1
1373313|NCT01481116|4532015|P2|Overall Study|Participant Moved Out of Area|0
1373314|NCT01481116|4532016|P1|Overall Study|Participant Moved Out of Area|2
1373315|NCT01481116|4532014|P3|Overall Study|Participant Started Taking Glipizide|0
1373316|NCT01481116|4532015|P2|Overall Study|Participant Started Taking Glipizide|0
1373317|NCT01481116|4532016|P1|Overall Study|Participant Started Taking Glipizide|1
1373318|NCT01481116|4532014|P3|Overall Study|Other|0
1373319|NCT01481116|4532015|P2|Overall Study|Other|1
1373320|NCT01481116|4532016|P1|Overall Study|Other|1
1373321|NCT01481116|4532014|P3|Overall Study|Contraindications|0
1373322|NCT01481116|4532015|P2|Overall Study|Contraindications|1
1373323|NCT01481116|4532016|P1|Overall Study|Contraindications|1
1373324|NCT01481116|4532014|P3|Overall Study|Lack of Efficacy|1
1373325|NCT01481116|4532015|P2|Overall Study|Lack of Efficacy|3
1373326|NCT01481116|4532016|P1|Overall Study|Lack of Efficacy|3
1373327|NCT01481116|4532014|P3|Overall Study|Pregnancy|1
1373328|NCT01481116|4532015|P2|Overall Study|Pregnancy|0
1373329|NCT01481116|4532016|P1|Overall Study|Pregnancy|0
1373330|NCT01481116|4532014|P3|Overall Study|Study Termination|713
1373331|NCT01481116|4532015|P2|Overall Study|Study Termination|729
1373332|NCT01481116|4532016|P1|Overall Study|Study Termination|730
1373333|NCT01481116|4532014|P3|Overall Study|Withdrawal by Subject|37
1373334|NCT01481116|4532015|P2|Overall Study|Withdrawal by Subject|33
1373335|NCT01481116|4532016|P1|Overall Study|Withdrawal by Subject|37
1373336|NCT01481116|4532014|P3|Overall Study|Lost to Follow-up|11
1373337|NCT01481116|4532015|P2|Overall Study|Lost to Follow-up|12
1373338|NCT01481116|4532016|P1|Overall Study|Lost to Follow-up|8
1373339|NCT01481116|4532014|P3|Overall Study|Major Protocol Deviation|1
1373340|NCT01481116|4532015|P2|Overall Study|Major Protocol Deviation|7
1373341|NCT01481116|4532016|P1|Overall Study|Major Protocol Deviation|3
1373342|NCT01481116|4532014|P3|Overall Study|Adverse Event|42
1373343|NCT01481116|4532015|P2|Overall Study|Adverse Event|26
1373344|NCT01481116|4532016|P1|Overall Study|Adverse Event|26
1373345|NCT01480674|4532047|P1|Overall Study|visit not done|10
1373346|NCT01480674|4532047|P1|Overall Study|Lost to Follow-up|2
1373347|NCT01480674|4532047|P1|Overall Study|Death|23
1373348|NCT01480596|4532061|P2|Overall Study|MG exacerbation or change in medication|2
1373349|NCT01480596|4532062|P1|Overall Study|MG exacerbation or change in medication|2
1373350|NCT01480596|4532061|P2|Overall Study|Adverse Event|0
1373351|NCT01480596|4532062|P1|Overall Study|Adverse Event|3
1373352|NCT01480284|4532110|P2|Overall Study|Physician Decision|0
1373353|NCT01480284|4532111|P1|Overall Study|Physician Decision|1
1373354|NCT01480284|4532110|P2|Overall Study|Lost to Follow-up|0
1373355|NCT01480284|4532111|P1|Overall Study|Lost to Follow-up|1
1373356|NCT01480284|4532110|P2|Overall Study|Study closed/terminated|0
1373357|NCT01480284|4532111|P1|Overall Study|Study closed/terminated|3
1373358|NCT01480284|4532110|P2|Overall Study|Adverse Event|0
1373359|NCT01480284|4532111|P1|Overall Study|Adverse Event|1
1373360|NCT01480284|4532110|P2|Overall Study|Withdrawal by Subject|0
1373361|NCT01480284|4532111|P1|Overall Study|Withdrawal by Subject|2
1373362|NCT01480076|4532194|P1|Overall Study|Not Specified|52
1373363|NCT01480076|4532194|P1|Overall Study|Investigator Decision|13
1373364|NCT01480076|4532194|P1|Overall Study|Lost to Follow-up|7
1373365|NCT01480076|4532194|P1|Overall Study|Withdrawal by Subject|105
1373366|NCT01480076|4532194|P1|Overall Study|Non-compliance With Study Protocol|15
1373367|NCT01480076|4532194|P1|Overall Study|Disease Progression|5
1373368|NCT01480076|4532194|P1|Overall Study|Death|2
1373369|NCT01480076|4532194|P1|Overall Study|Adverse Event|39
1373370|NCT01480076|4532194|P1|Overall Study|Run-in Failure|52
1373371|NCT01479868|4532313|P1|Overall Study|Initiation of new HCV Therapy|1
1373372|NCT01479868|4532313|P1|Overall Study|Sponsor's Decision|1
1373373|NCT01479868|4532313|P1|Overall Study|Withdrawal by Subject|1
1373374|NCT01479868|4532313|P1|Overall Study|Protocol Violation|1
1373375|NCT01479868|4532313|P1|Overall Study|Lost to Follow-up|4
1373376|NCT01479868|4532313|P1|Overall Study|Adverse Event|1
1373377|NCT01479777|4532328|P1|Overall Study|Physician Decision|2
1373378|NCT01479764|4532340|P2|Treated|Lost to Follow-up|2
1373379|NCT01479764|4532341|P1|Treated|Lost to Follow-up|0
1373380|NCT01479764|4532340|P2|Randomized|Withdrawal by Subject|0
1373381|NCT01479764|4532341|P1|Randomized|Withdrawal by Subject|1
1373382|NCT01479764|4532340|P2|Randomized|Adverse Event|1
1373383|NCT01479764|4532341|P1|Randomized|Adverse Event|1
1373384|NCT01479621|4532364|P7|Treatment Period|Met stopping criteria|6
1373385|NCT01479621|4532365|P6|Treatment Period|Met stopping criteria|20
1373386|NCT01479621|4532366|P5|Treatment Period|Met stopping criteria|9
1373387|NCT01479621|4532367|P4|Treatment Period|Met stopping criteria|4
1373388|NCT01479621|4532368|P3|Treatment Period|Met stopping criteria|7
1373389|NCT01479621|4532369|P2|Treatment Period|Met stopping criteria|8
1373390|NCT01479621|4532370|P1|Treatment Period|Met stopping criteria|0
1373391|NCT01479621|4532364|P7|Treatment Period|Lost to Follow-up|1
1373392|NCT01479621|4532365|P6|Treatment Period|Lost to Follow-up|2
1373393|NCT01479621|4532366|P5|Treatment Period|Lost to Follow-up|2
1373394|NCT01479621|4532367|P4|Treatment Period|Lost to Follow-up|0
1373395|NCT01479621|4532368|P3|Treatment Period|Lost to Follow-up|1
1373396|NCT01479621|4532369|P2|Treatment Period|Lost to Follow-up|0
1373397|NCT01479621|4532370|P1|Treatment Period|Lost to Follow-up|0
1373398|NCT01479621|4532364|P7|Treatment Period|Sponsor request subject to be withdrawn|3
1373399|NCT01479621|4532365|P6|Treatment Period|Sponsor request subject to be withdrawn|1
1373400|NCT01479621|4532366|P5|Treatment Period|Sponsor request subject to be withdrawn|1
1373401|NCT01479621|4532367|P4|Treatment Period|Sponsor request subject to be withdrawn|1
1373402|NCT01479621|4532368|P3|Treatment Period|Sponsor request subject to be withdrawn|3
1373403|NCT01479621|4532369|P2|Treatment Period|Sponsor request subject to be withdrawn|2
1373404|NCT01479621|4532370|P1|Treatment Period|Sponsor request subject to be withdrawn|0
1373405|NCT01479621|4532364|P7|Treatment Period|Pregnancy|0
1373406|NCT01479621|4532365|P6|Treatment Period|Pregnancy|0
1373407|NCT01479621|4532366|P5|Treatment Period|Pregnancy|0
1373408|NCT01479621|4532367|P4|Treatment Period|Pregnancy|0
1373409|NCT01479621|4532368|P3|Treatment Period|Pregnancy|2
1373410|NCT01479621|4532369|P2|Treatment Period|Pregnancy|0
1373411|NCT01479621|4532370|P1|Treatment Period|Pregnancy|0
1373412|NCT01479621|4532364|P7|Treatment Period|Protocol Violation|6
1373413|NCT01479621|4532365|P6|Treatment Period|Protocol Violation|10
1373414|NCT01479621|4532366|P5|Treatment Period|Protocol Violation|2
1373415|NCT01479621|4532367|P4|Treatment Period|Protocol Violation|5
1373416|NCT01479621|4532368|P3|Treatment Period|Protocol Violation|6
1373417|NCT01479621|4532369|P2|Treatment Period|Protocol Violation|9
1373418|NCT01479621|4532370|P1|Treatment Period|Protocol Violation|0
1373419|NCT01479621|4532364|P7|Treatment Period|Non-compliance to study drug|1
1373420|NCT01479621|4532365|P6|Treatment Period|Non-compliance to study drug|0
1373421|NCT01479621|4532366|P5|Treatment Period|Non-compliance to study drug|0
1373422|NCT01479621|4532367|P4|Treatment Period|Non-compliance to study drug|0
1373423|NCT01479621|4532368|P3|Treatment Period|Non-compliance to study drug|0
1373424|NCT01479621|4532369|P2|Treatment Period|Non-compliance to study drug|1
1373425|NCT01479621|4532370|P1|Treatment Period|Non-compliance to study drug|0
1373426|NCT01479621|4532364|P7|Treatment Period|Physician Decision|0
1373427|NCT01479621|4532365|P6|Treatment Period|Physician Decision|1
1373428|NCT01479621|4532366|P5|Treatment Period|Physician Decision|1
1373429|NCT01479621|4532367|P4|Treatment Period|Physician Decision|0
1373430|NCT01479621|4532368|P3|Treatment Period|Physician Decision|0
1373431|NCT01479621|4532369|P2|Treatment Period|Physician Decision|0
1373432|NCT01479621|4532370|P1|Treatment Period|Physician Decision|0
1373433|NCT01479621|4532364|P7|Treatment Period|Withdrawal by Subject|1
1373434|NCT01479621|4532365|P6|Treatment Period|Withdrawal by Subject|5
1373435|NCT01479621|4532366|P5|Treatment Period|Withdrawal by Subject|5
1373436|NCT01479621|4532367|P4|Treatment Period|Withdrawal by Subject|2
1373437|NCT01479621|4532368|P3|Treatment Period|Withdrawal by Subject|2
1373438|NCT01479621|4532369|P2|Treatment Period|Withdrawal by Subject|4
1373439|NCT01479621|4532370|P1|Treatment Period|Withdrawal by Subject|0
1373440|NCT01479621|4532364|P7|Treatment Period|Adverse Event|2
1373441|NCT01479621|4532365|P6|Treatment Period|Adverse Event|2
1373442|NCT01479621|4532366|P5|Treatment Period|Adverse Event|1
1373443|NCT01479621|4532367|P4|Treatment Period|Adverse Event|0
1373444|NCT01479621|4532368|P3|Treatment Period|Adverse Event|0
1373445|NCT01479621|4532369|P2|Treatment Period|Adverse Event|0
1373446|NCT01479621|4532370|P1|Treatment Period|Adverse Event|0
1373447|NCT01479621|4532364|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1373448|NCT01479621|4532365|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1373449|NCT01479621|4532366|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1373450|NCT01479621|4532367|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1373451|NCT01479621|4532368|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1373452|NCT01479621|4532369|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
1373453|NCT01479621|4532370|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
1373454|NCT01479621|4532364|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1373455|NCT01479621|4532365|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1373456|NCT01479621|4532366|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1373457|NCT01479621|4532367|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1373458|NCT01479621|4532368|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1373459|NCT01479621|4532369|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1373460|NCT01479621|4532370|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
1373461|NCT01479621|4532364|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1373462|NCT01479621|4532365|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1373463|NCT01479621|4532366|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1373464|NCT01479621|4532367|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1373465|NCT01479621|4532368|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1373466|NCT01479621|4532369|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1373467|NCT01479621|4532370|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
1373468|NCT01479621|4532364|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1373469|NCT01479621|4532365|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1373470|NCT01479621|4532366|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1373471|NCT01479621|4532367|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1373472|NCT01479621|4532368|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1373473|NCT01479621|4532369|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1373474|NCT01479621|4532370|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
1373475|NCT01479621|4532364|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1373476|NCT01479621|4532365|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1373477|NCT01479621|4532366|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1373478|NCT01479621|4532367|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1373479|NCT01479621|4532368|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1373480|NCT01479621|4532369|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1373481|NCT01479621|4532370|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
1373482|NCT01479595|4532458|P2|Overall Study|Adverse Event|1
1373483|NCT01479595|4532459|P1|Overall Study|Adverse Event|2
1373484|NCT01479595|4532458|P2|Overall Study|Protocol deviation|1
1373485|NCT01479595|4532459|P1|Overall Study|Protocol deviation|0
1373486|NCT01479530|4532504|P2|Overall Study|Withdrawal of Consent|2
1373487|NCT01479530|4532505|P1|Overall Study|Withdrawal of Consent|3
1373488|NCT01479530|4532504|P2|Overall Study|Protocol Violation|3
1373489|NCT01479530|4532505|P1|Overall Study|Protocol Violation|2
1373490|NCT01479530|4532504|P2|Overall Study|Lack of Efficacy|1
1373491|NCT01479530|4532505|P1|Overall Study|Lack of Efficacy|0
1373492|NCT01479530|4532504|P2|Overall Study|Adverse Event|6
1373493|NCT01479530|4532505|P1|Overall Study|Adverse Event|5
1373494|NCT01479374|4532585|P3|Overall Study|Other|5
1373495|NCT01479374|4532586|P2|Overall Study|Other|4
1373496|NCT01479374|4532587|P1|Overall Study|Other|0
1373497|NCT01479374|4532585|P3|Overall Study|Decision Unrelated to Adverse Event|0
1373498|NCT01479374|4532586|P2|Overall Study|Decision Unrelated to Adverse Event|1
1373499|NCT01479374|4532587|P1|Overall Study|Decision Unrelated to Adverse Event|0
1373500|NCT01479374|4532585|P3|Overall Study|Lost to Follow-up|0
1373501|NCT01479374|4532586|P2|Overall Study|Lost to Follow-up|2
1373502|NCT01479374|4532587|P1|Overall Study|Lost to Follow-up|1
1373503|NCT01479374|4532585|P3|Overall Study|Adverse Event|0
1373504|NCT01479374|4532586|P2|Overall Study|Adverse Event|1
1373505|NCT01479374|4532587|P1|Overall Study|Adverse Event|2
1373506|NCT01478971|4532658|P1|Peginesatide Treatment Period|Other|4
1373507|NCT01478971|4532658|P1|Peginesatide Treatment Period|Lost to Follow-up|4
1373508|NCT01478971|4532658|P1|Peginesatide Treatment Period|Death|4
1373509|NCT01478971|4532658|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
1373510|NCT01478971|4532658|P1|Peginesatide Treatment Period|Adverse Event|1
1373511|NCT01478971|4532658|P1|Standard of Care Period|Other|4
1373512|NCT01478971|4532658|P1|Standard of Care Period|Lost to Follow-up|9
1373513|NCT01478971|4532658|P1|Standard of Care Period|Death|8
1373514|NCT01478971|4532658|P1|Standard of Care Period|Withdrawal by Subject|3
1373515|NCT01478971|4532658|P1|Standard of Care Period|Adverse Event|1
1373516|NCT01478958|4532675|P3|Overall Study|Unable to comply|2
1373517|NCT01478958|4532676|P2|Overall Study|Unable to comply|0
1373518|NCT01478958|4532677|P1|Overall Study|Unable to comply|0
1373519|NCT01478958|4532675|P3|Overall Study|Re-located|0
1373520|NCT01478958|4532676|P2|Overall Study|Re-located|1
1373521|NCT01478958|4532677|P1|Overall Study|Re-located|0
1373522|NCT01478958|4532675|P3|Overall Study|Weight loss|0
1373523|NCT01478958|4532676|P2|Overall Study|Weight loss|0
1373524|NCT01478958|4532677|P1|Overall Study|Weight loss|1
1373525|NCT01478958|4532675|P3|Overall Study|Withdrawal by Subject|1
1373526|NCT01478958|4532676|P2|Overall Study|Withdrawal by Subject|1
1373527|NCT01478958|4532677|P1|Overall Study|Withdrawal by Subject|1
1373528|NCT01478828|4532685|P1|Overall Study|Adverse Event|1
1373529|NCT01478620|4532690|P1|Overall Study|Lost to Follow-up|6
1373530|NCT01478594|4532696|P2|Overall Study|Study Closed by Sponsor|5
1373531|NCT01478594|4532697|P1|Overall Study|Study Closed by Sponsor|8
1373532|NCT01478594|4532696|P2|Overall Study|Withdrawal by Subject|3
1373533|NCT01478594|4532697|P1|Overall Study|Withdrawal by Subject|9
1373534|NCT01478594|4532696|P2|Overall Study|Lost to Follow-up|1
1373535|NCT01478594|4532697|P1|Overall Study|Lost to Follow-up|3
1373536|NCT01478594|4532696|P2|Overall Study|Death|18
1373537|NCT01478594|4532697|P1|Overall Study|Death|45
1373538|NCT01478594|4532696|P2|Overall Study|Randomized but Never Received Study Drug|1
1373539|NCT01478594|4532697|P1|Overall Study|Randomized but Never Received Study Drug|0
1373540|NCT01478373|4532822|P1|Survival Phase|Progressive Disease|27
1373541|NCT01478373|4532822|P1|Survival Phase|crossover to another study|2
1373542|NCT01478373|4532822|P1|Survival Phase|Protocol Violation|1
1373543|NCT01478373|4532822|P1|Survival Phase|Adverse Event|8
1373544|NCT01478373|4532822|P1|Treatment Phase|Protocol Violation|1
1373545|NCT01478360|4532835|P2|Overall Study|Administrative problems|2
1373546|NCT01478360|4532836|P1|Overall Study|Administrative problems|1
1373547|NCT01478360|4532835|P2|Overall Study|Adverse Event|1
1373548|NCT01478360|4532836|P1|Overall Study|Adverse Event|0
1373549|NCT01478360|4532835|P2|Overall Study|Lost to Follow-up|0
1373550|NCT01478360|4532836|P1|Overall Study|Lost to Follow-up|1
1373551|NCT01478347|4532842|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
1373552|NCT01478347|4532842|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
1373553|NCT01478347|4532842|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
1373554|NCT01478113|4532860|P2|Overall Study|Physician Decision|0
1373555|NCT01478113|4532861|P1|Overall Study|Physician Decision|1
1373556|NCT01478113|4532860|P2|Overall Study|Withdrawal by Subject|1
1373557|NCT01478113|4532861|P1|Overall Study|Withdrawal by Subject|0
1373558|NCT01478087|4532879|P1|Overall Study|due to sponsor closing study|1
1373559|NCT01478048|4532886|P2|Overall Study|no longer meets study criteria|0
1373560|NCT01478048|4532887|P1|Overall Study|no longer meets study criteria|1
1373561|NCT01478048|4532886|P2|Overall Study|poor/non-compliance|1
1373562|NCT01478048|4532887|P1|Overall Study|poor/non-compliance|0
1373563|NCT01478048|4532886|P2|Overall Study|non-specified|4
1373564|NCT01478048|4532887|P1|Overall Study|non-specified|6
1373565|NCT01478048|4532886|P2|Overall Study|Withdrawal by Subject|5
1373566|NCT01478048|4532887|P1|Overall Study|Withdrawal by Subject|2
1373567|NCT01478048|4532886|P2|Overall Study|subject request to discontinue treatment|5
1373568|NCT01478048|4532887|P1|Overall Study|subject request to discontinue treatment|3
1373569|NCT01478048|4532886|P2|Overall Study|Adverse Event|11
1373570|NCT01478048|4532887|P1|Overall Study|Adverse Event|2
1373571|NCT01478048|4532886|P2|Overall Study|study drug toxicity|14
1373572|NCT01478048|4532887|P1|Overall Study|study drug toxicity|11
1373573|NCT01478048|4532886|P2|Overall Study|Disease Progression|35
1373574|NCT01478048|4532887|P1|Overall Study|Disease Progression|52
1373575|NCT01477892|4532916|P2|Overall Study|Withdrawal by Subject|2
1373576|NCT01477892|4532917|P1|Overall Study|Withdrawal by Subject|0
1373577|NCT01477853|4532928|P3|Phase B|Study terminated by sponsor|11
1373578|NCT01477853|4532929|P2|Phase B|Study terminated by sponsor|10
1373579|NCT01477853|4532930|P1|Phase B|Study terminated by sponsor|12
1373580|NCT01477853|4532928|P3|Phase B|Lost to Follow-up|0
1373581|NCT01477853|4532929|P2|Phase B|Lost to Follow-up|1
1373582|NCT01477853|4532930|P1|Phase B|Lost to Follow-up|0
1373583|NCT01477853|4532928|P3|Phase A|Study terminated by sponsor|39
1373584|NCT01477853|4532929|P2|Phase A|Study terminated by sponsor|40
1373585|NCT01477853|4532930|P1|Phase A|Study terminated by sponsor|37
1373586|NCT01477853|4532928|P3|Phase A|Physician Decision|1
1373587|NCT01477853|4532929|P2|Phase A|Physician Decision|0
1373588|NCT01477853|4532930|P1|Phase A|Physician Decision|1
1373589|NCT01477853|4532928|P3|Phase A|Lost to Follow-up|2
1373590|NCT01477853|4532929|P2|Phase A|Lost to Follow-up|3
1373591|NCT01477853|4532930|P1|Phase A|Lost to Follow-up|4
1373592|NCT01477853|4532928|P3|Phase A|Adverse Event|2
1373593|NCT01477853|4532929|P2|Phase A|Adverse Event|2
1373594|NCT01477853|4532930|P1|Phase A|Adverse Event|1
1373595|NCT01477749|4532997|P1|Overall Study|Physician Decision|4
1373596|NCT01477333|4533105|P1|Overall Study|Clinical Deterioration|1
1373597|NCT01477333|4533105|P1|Overall Study|Withdrawal by Subject|1
1373598|NCT01477333|4533105|P1|Overall Study|Adverse Event|1
1373599|NCT01476722|4533148|P1|Overall Study|Adverse Event|1
1373600|NCT01476696|4533155|P3|Overall Study|Withdrawal by Subject|0
1373601|NCT01476696|4533156|P2|Overall Study|Withdrawal by Subject|0
1373602|NCT01476696|4533157|P1|Overall Study|Withdrawal by Subject|1
1373603|NCT01476696|4533155|P3|Overall Study|Sponsor decision|0
1373604|NCT01476696|4533156|P2|Overall Study|Sponsor decision|1
1373605|NCT01476696|4533157|P1|Overall Study|Sponsor decision|2
1373606|NCT01476475|4533173|P2|Overall Study|Other reasons|2
1373607|NCT01476475|4533174|P1|Overall Study|Other reasons|4
1373608|NCT01476475|4533173|P2|Overall Study|Poor compliance to protocol|1
1373609|NCT01476475|4533174|P1|Overall Study|Poor compliance to protocol|1
1373610|NCT01476475|4533173|P2|Overall Study|Adverse Event|0
1373611|NCT01476475|4533174|P1|Overall Study|Adverse Event|6
1373612|NCT01475851|4533603|P2|Overall Study|Protocol defined stopping criteria|0
1373613|NCT01475851|4533604|P1|Overall Study|Protocol defined stopping criteria|1
1373614|NCT01475838|4533632|P2|Extension Phase|Participant Noncompliance|0
1373615|NCT01475838|4533633|P1|Extension Phase|Participant Noncompliance|1
1373616|NCT01475838|4533632|P2|Randomized Phase|Protocol Violation|4
1373617|NCT01475838|4533633|P1|Randomized Phase|Protocol Violation|9
1373618|NCT01475838|4533632|P2|Randomized Phase|Participant Noncompliance|5
1373619|NCT01475838|4533633|P1|Randomized Phase|Participant Noncompliance|1
1373620|NCT01475838|4533632|P2|Randomized Phase|Lost to Follow-up|4
1373621|NCT01475838|4533633|P1|Randomized Phase|Lost to Follow-up|3
1373622|NCT01475838|4533632|P2|Randomized Phase|Withdrew Consent|14
1373623|NCT01475838|4533633|P1|Randomized Phase|Withdrew Consent|10
1373624|NCT01475838|4533632|P2|Randomized Phase|Investigators Discretion|2
1373625|NCT01475838|4533633|P1|Randomized Phase|Investigators Discretion|1
1373626|NCT01475838|4533632|P2|Randomized Phase|Pregnancy|1
1373627|NCT01475838|4533633|P1|Randomized Phase|Pregnancy|0
1373628|NCT01475838|4533632|P2|Randomized Phase|Adverse Event|1
1373629|NCT01475838|4533633|P1|Randomized Phase|Adverse Event|6
1373630|NCT01475838|4533632|P2|Randomized Phase|Randomized but Not Treated|5
1373631|NCT01475838|4533633|P1|Randomized Phase|Randomized but Not Treated|0
1373632|NCT01475734|4533648|P2|Overall Study|Physician Decision|1
1373633|NCT01475734|4533649|P1|Overall Study|Physician Decision|0
1373634|NCT01475734|4533648|P2|Overall Study|Protocol Violation|0
1373635|NCT01475734|4533649|P1|Overall Study|Protocol Violation|1
1373636|NCT01475734|4533648|P2|Overall Study|Withdrawal by Subject|0
1373637|NCT01475734|4533649|P1|Overall Study|Withdrawal by Subject|1
1373638|NCT01475721|4533677|P2|Overall Study|Withdrawal by Subject|8
1373639|NCT01475721|4533678|P1|Overall Study|Withdrawal by Subject|8
1373640|NCT01475721|4533677|P2|Overall Study|Death|6
1373641|NCT01475721|4533678|P1|Overall Study|Death|3
1373642|NCT01475487|4533733|P2|Overall Study|had to leave early for personal reasons|1
1373643|NCT01475487|4533734|P1|Overall Study|had to leave early for personal reasons|2
1373644|NCT01475474|4533746|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
1373645|NCT01475474|4533746|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
1373646|NCT01475461|4533757|P7|Treatment Period|Adverse Event|0
1373647|NCT01475461|4533758|P6|Treatment Period|Adverse Event|0
1373648|NCT01475461|4533759|P5|Treatment Period|Adverse Event|0
1373649|NCT01475461|4533760|P4|Treatment Period|Adverse Event|1
1373650|NCT01475461|4533761|P3|Treatment Period|Adverse Event|0
1373651|NCT01475461|4533762|P2|Treatment Period|Adverse Event|0
1373652|NCT01475461|4533763|P1|Treatment Period|Adverse Event|0
1373653|NCT01475461|4533757|P7|Treatment Period|Medication Error|0
1373654|NCT01475461|4533758|P6|Treatment Period|Medication Error|0
1373655|NCT01475461|4533759|P5|Treatment Period|Medication Error|0
1373656|NCT01475461|4533760|P4|Treatment Period|Medication Error|1
1373657|NCT01475461|4533761|P3|Treatment Period|Medication Error|0
1373658|NCT01475461|4533762|P2|Treatment Period|Medication Error|0
1373659|NCT01475461|4533763|P1|Treatment Period|Medication Error|0
1373660|NCT01475461|4533757|P7|Treatment Period|Lack of Efficacy|0
1373661|NCT01475461|4533758|P6|Treatment Period|Lack of Efficacy|1
1373662|NCT01475461|4533759|P5|Treatment Period|Lack of Efficacy|1
1373663|NCT01475461|4533760|P4|Treatment Period|Lack of Efficacy|2
1373664|NCT01475461|4533761|P3|Treatment Period|Lack of Efficacy|0
1373665|NCT01475461|4533762|P2|Treatment Period|Lack of Efficacy|2
1373666|NCT01475461|4533763|P1|Treatment Period|Lack of Efficacy|0
1373667|NCT01475461|4533757|P7|Treatment Period|Protocol Violation|1
1373668|NCT01475461|4533758|P6|Treatment Period|Protocol Violation|0
1373669|NCT01475461|4533759|P5|Treatment Period|Protocol Violation|0
1373670|NCT01475461|4533760|P4|Treatment Period|Protocol Violation|0
1373671|NCT01475461|4533761|P3|Treatment Period|Protocol Violation|0
1373672|NCT01475461|4533762|P2|Treatment Period|Protocol Violation|1
1373673|NCT01475461|4533763|P1|Treatment Period|Protocol Violation|0
1373674|NCT01475461|4533757|P7|Treatment Period|Other|0
1373675|NCT01475461|4533758|P6|Treatment Period|Other|0
1373676|NCT01475461|4533759|P5|Treatment Period|Other|0
1373677|NCT01475461|4533760|P4|Treatment Period|Other|0
1373678|NCT01475461|4533761|P3|Treatment Period|Other|0
1373679|NCT01475461|4533762|P2|Treatment Period|Other|1
1373680|NCT01475461|4533763|P1|Treatment Period|Other|0
1373681|NCT01475461|4533757|P7|Treatment Period|Withdrawal by Subject|0
1373682|NCT01475461|4533758|P6|Treatment Period|Withdrawal by Subject|2
1373683|NCT01475461|4533759|P5|Treatment Period|Withdrawal by Subject|2
1373684|NCT01475461|4533760|P4|Treatment Period|Withdrawal by Subject|0
1373685|NCT01475461|4533761|P3|Treatment Period|Withdrawal by Subject|2
1373686|NCT01475461|4533762|P2|Treatment Period|Withdrawal by Subject|2
1373687|NCT01475461|4533763|P1|Treatment Period|Withdrawal by Subject|0
1373688|NCT01475461|4533757|P7|Treatment Period|Lost to Follow-up|1
1373689|NCT01475461|4533758|P6|Treatment Period|Lost to Follow-up|2
1373690|NCT01475461|4533759|P5|Treatment Period|Lost to Follow-up|1
1373691|NCT01475461|4533760|P4|Treatment Period|Lost to Follow-up|3
1373692|NCT01475461|4533761|P3|Treatment Period|Lost to Follow-up|2
1373693|NCT01475461|4533762|P2|Treatment Period|Lost to Follow-up|3
1373694|NCT01475461|4533763|P1|Treatment Period|Lost to Follow-up|0
1373695|NCT01475461|4533757|P7|Treatment Period|Death|0
1373696|NCT01475461|4533758|P6|Treatment Period|Death|0
1373697|NCT01475461|4533759|P5|Treatment Period|Death|0
1373698|NCT01475461|4533760|P4|Treatment Period|Death|1
1373699|NCT01475461|4533761|P3|Treatment Period|Death|0
1373700|NCT01475461|4533762|P2|Treatment Period|Death|0
1373701|NCT01475461|4533763|P1|Treatment Period|Death|0
1373702|NCT01475461|4533757|P7|Run-in Period|Protocol Violation|0
1373703|NCT01475461|4533758|P6|Run-in Period|Protocol Violation|0
1373704|NCT01475461|4533759|P5|Run-in Period|Protocol Violation|0
1373705|NCT01475461|4533760|P4|Run-in Period|Protocol Violation|0
1373706|NCT01475461|4533761|P3|Run-in Period|Protocol Violation|0
1373707|NCT01475461|4533762|P2|Run-in Period|Protocol Violation|0
1373708|NCT01475461|4533763|P1|Run-in Period|Protocol Violation|4
1373709|NCT01475461|4533757|P7|Run-in Period|Other|0
1373710|NCT01475461|4533758|P6|Run-in Period|Other|0
1373711|NCT01475461|4533759|P5|Run-in Period|Other|0
1373712|NCT01475461|4533760|P4|Run-in Period|Other|0
1373713|NCT01475461|4533761|P3|Run-in Period|Other|0
1373714|NCT01475461|4533762|P2|Run-in Period|Other|0
1373715|NCT01475461|4533763|P1|Run-in Period|Other|3
1373716|NCT01475461|4533757|P7|Run-in Period|Withdrawal by Subject|0
1373717|NCT01475461|4533758|P6|Run-in Period|Withdrawal by Subject|0
1373718|NCT01475461|4533759|P5|Run-in Period|Withdrawal by Subject|0
1373719|NCT01475461|4533760|P4|Run-in Period|Withdrawal by Subject|0
1373720|NCT01475461|4533761|P3|Run-in Period|Withdrawal by Subject|0
1373721|NCT01475461|4533762|P2|Run-in Period|Withdrawal by Subject|0
1373722|NCT01475461|4533763|P1|Run-in Period|Withdrawal by Subject|11
1373723|NCT01475461|4533757|P7|Run-in Period|Lost to Follow-up|0
1373724|NCT01475461|4533758|P6|Run-in Period|Lost to Follow-up|0
1373725|NCT01475461|4533759|P5|Run-in Period|Lost to Follow-up|0
1373726|NCT01475461|4533760|P4|Run-in Period|Lost to Follow-up|0
1373727|NCT01475461|4533761|P3|Run-in Period|Lost to Follow-up|0
1373728|NCT01475461|4533762|P2|Run-in Period|Lost to Follow-up|0
1373729|NCT01475461|4533763|P1|Run-in Period|Lost to Follow-up|7
1373730|NCT01475461|4533757|P7|Run-in Period|Not meet eligibility criteria|0
1373731|NCT01475461|4533758|P6|Run-in Period|Not meet eligibility criteria|0
1373732|NCT01475461|4533759|P5|Run-in Period|Not meet eligibility criteria|0
1373733|NCT01475461|4533760|P4|Run-in Period|Not meet eligibility criteria|0
1373734|NCT01475461|4533761|P3|Run-in Period|Not meet eligibility criteria|0
1373735|NCT01475461|4533762|P2|Run-in Period|Not meet eligibility criteria|0
1373736|NCT01475461|4533763|P1|Run-in Period|Not meet eligibility criteria|16
1373737|NCT01475331|4533843|P2|Overall Study|cyst found to be prohibitively small|1
1373738|NCT01475331|4533844|P1|Overall Study|cyst found to be prohibitively small|0
1373739|NCT01475331|4533843|P2|Overall Study|Sign of malignancy during the procedure|0
1373740|NCT01475331|4533844|P1|Overall Study|Sign of malignancy during the procedure|2
1373741|NCT01475331|4533843|P2|Overall Study|Loss of needle positioning due pt. cough|0
1373742|NCT01475331|4533844|P1|Overall Study|Loss of needle positioning due pt. cough|1
1373743|NCT01475331|4533843|P2|Overall Study|excessive main duct communication|1
1373744|NCT01475331|4533844|P1|Overall Study|excessive main duct communication|1
1373745|NCT01475331|4533843|P2|Overall Study|Osteophyte obstruction of the proximal|0
1373746|NCT01475331|4533844|P1|Overall Study|Osteophyte obstruction of the proximal|1
1373747|NCT01475253|4533896|P4|Randomized, Blinded Study|Lost to Follow-up|0
1373748|NCT01475253|4533897|P3|Randomized, Blinded Study|Lost to Follow-up|0
1373749|NCT01475253|4533898|P2|Randomized, Blinded Study|Lost to Follow-up|0
1373750|NCT01475253|4533899|P1|Randomized, Blinded Study|Lost to Follow-up|1
1373751|NCT01475253|4533896|P4|Randomized, Blinded Study|Withdrawal by Subject|0
1373752|NCT01475253|4533897|P3|Randomized, Blinded Study|Withdrawal by Subject|0
1373753|NCT01475253|4533898|P2|Randomized, Blinded Study|Withdrawal by Subject|1
1373754|NCT01475253|4533899|P1|Randomized, Blinded Study|Withdrawal by Subject|1
1373755|NCT01475214|4533928|P3|Overall Study|Withdrawal by Subject|1
1373756|NCT01475214|4533929|P2|Overall Study|Withdrawal by Subject|4
1373757|NCT01475214|4533930|P1|Overall Study|Withdrawal by Subject|2
1373758|NCT01475214|4533928|P3|Overall Study|Physician Decision|0
1373759|NCT01475214|4533929|P2|Overall Study|Physician Decision|0
1373760|NCT01475214|4533930|P1|Overall Study|Physician Decision|2
1373761|NCT01475214|4533928|P3|Overall Study|Lost to Follow-up|1
1373762|NCT01475214|4533929|P2|Overall Study|Lost to Follow-up|0
1373763|NCT01475214|4533930|P1|Overall Study|Lost to Follow-up|1
1373764|NCT01475097|4533955|P2|Overall Study|Protocol Violation|1
1373765|NCT01475097|4533956|P1|Overall Study|Protocol Violation|1
1373766|NCT01475071|4533964|P1|Overall Study|Lost to Follow-up|1
1373767|NCT01475071|4533964|P1|Overall Study|Withdrawal by Subject|6
1373768|NCT01475071|4533964|P1|Overall Study|Physician Decision|1
1373769|NCT01474993|4533974|P2|Overall Study|Adverse Event|1
1373770|NCT01474993|4533975|P1|Overall Study|Adverse Event|0
1373771|NCT01474993|4533974|P2|Overall Study|Lost to Follow-up|2
1373772|NCT01474993|4533975|P1|Overall Study|Lost to Follow-up|1
1373773|NCT01474876|4534013|P3|Overall Study|Investigator's decision and pt request|0
1373774|NCT01474876|4534014|P2|Overall Study|Investigator's decision and pt request|0
1373775|NCT01474876|4534015|P1|Overall Study|Investigator's decision and pt request|1
1373776|NCT01474876|4534013|P3|Overall Study|Patient's request|0
1373777|NCT01474876|4534014|P2|Overall Study|Patient's request|5
1373778|NCT01474876|4534015|P1|Overall Study|Patient's request|19
1373779|NCT01474876|4534013|P3|Overall Study|Investigator's decision|0
1373780|NCT01474876|4534014|P2|Overall Study|Investigator's decision|6
1373781|NCT01474876|4534015|P1|Overall Study|Investigator's decision|28
1373782|NCT01474876|4534013|P3|Overall Study|Lost to Follow-up|0
1373783|NCT01474876|4534014|P2|Overall Study|Lost to Follow-up|4
1373784|NCT01474876|4534015|P1|Overall Study|Lost to Follow-up|5
1373785|NCT01474876|4534013|P3|Overall Study|Serious Adverse Event|0
1373786|NCT01474876|4534014|P2|Overall Study|Serious Adverse Event|3
1373787|NCT01474876|4534015|P1|Overall Study|Serious Adverse Event|2
1373788|NCT01474876|4534013|P3|Overall Study|Adverse Event|0
1373789|NCT01474876|4534014|P2|Overall Study|Adverse Event|5
1373790|NCT01474876|4534015|P1|Overall Study|Adverse Event|11
1373791|NCT01474772|4534061|P2|Follow-up|AE not Related to Study Drug|1
1373792|NCT01474772|4534062|P1|Follow-up|AE not Related to Study Drug|0
1373793|NCT01474772|4534061|P2|Period 2|Reason not Specified|2
1373794|NCT01474772|4534062|P1|Period 2|Reason not Specified|0
1373795|NCT01474772|4534061|P2|Period 2|Lost to Follow-up|1
1373796|NCT01474772|4534062|P1|Period 2|Lost to Follow-up|1
1373797|NCT01474772|4534061|P2|Period 2|Withdrawal by Subject|4
1373798|NCT01474772|4534062|P1|Period 2|Withdrawal by Subject|3
1373799|NCT01474772|4534061|P2|Period 2|Lack of Efficacy|0
1373800|NCT01474772|4534062|P1|Period 2|Lack of Efficacy|1
1373801|NCT01474772|4534061|P2|Period 2|AE not Related to Study Drug|1
1373802|NCT01474772|4534062|P1|Period 2|AE not Related to Study Drug|4
1373803|NCT01474772|4534061|P2|Period 2|AE Related to Study Drug|1
1373804|NCT01474772|4534062|P1|Period 2|AE Related to Study Drug|0
1373805|NCT01474772|4534061|P2|Period 2|Death|1
1373806|NCT01474772|4534062|P1|Period 2|Death|0
1373807|NCT01474772|4534061|P2|Washout|Reason not Specified|1
1373808|NCT01474772|4534062|P1|Washout|Reason not Specified|0
1373809|NCT01474772|4534061|P2|Washout|Lost to Follow-up|1
1373810|NCT01474772|4534062|P1|Washout|Lost to Follow-up|0
1373811|NCT01474772|4534061|P2|Washout|Withdrawal by Subject|0
1373812|NCT01474772|4534062|P1|Washout|Withdrawal by Subject|1
1373813|NCT01474772|4534061|P2|Washout|AE not Related to Study Drug|0
1373814|NCT01474772|4534062|P1|Washout|AE not Related to Study Drug|2
1373815|NCT01474772|4534061|P2|Period 1|Reason not Specified|1
1373816|NCT01474772|4534062|P1|Period 1|Reason not Specified|1
1373817|NCT01474772|4534061|P2|Period 1|Lost to Follow-up|0
1373818|NCT01474772|4534062|P1|Period 1|Lost to Follow-up|1
1373819|NCT01474772|4534061|P2|Period 1|Withdrawal by Subject|1
1373820|NCT01474772|4534062|P1|Period 1|Withdrawal by Subject|3
1373821|NCT01474772|4534061|P2|Period 1|AE not Related to Study Drug|0
1373822|NCT01474772|4534062|P1|Period 1|AE not Related to Study Drug|1
1373823|NCT01474772|4534061|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
1373824|NCT01474772|4534062|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
1373825|NCT01474746|4534112|P2|Overall Study|Withdrawal by Subject|1
1373826|NCT01474746|4534113|P1|Overall Study|Withdrawal by Subject|2
1373827|NCT01474746|4534112|P2|Overall Study|Lost to Follow-up|1
1373828|NCT01474746|4534113|P1|Overall Study|Lost to Follow-up|1
1373829|NCT01474681|4534177|P4|Overall Study|Death|6
1373830|NCT01474681|4534178|P3|Overall Study|Death|2
1373831|NCT01474681|4534179|P2|Overall Study|Death|3
1373832|NCT01474681|4534180|P1|Overall Study|Death|0
1373833|NCT01474551|4534231|P1|Overall Study|Death|1
1373834|NCT01474538|4534237|P2|Treatment Period 2|Protocol Violation|0
1373835|NCT01474538|4534238|P1|Treatment Period 2|Protocol Violation|1
1373836|NCT01474538|4534237|P2|Treatment Period 2|Physician Decision|1
1373837|NCT01474538|4534238|P1|Treatment Period 2|Physician Decision|0
1373838|NCT01474538|4534237|P2|Treatment Period 2|Sponsor decision|0
1373839|NCT01474538|4534238|P1|Treatment Period 2|Sponsor decision|1
1373840|NCT01474538|4534237|P2|Treatment Period 2|Withdrawal by Subject|0
1373841|NCT01474538|4534238|P1|Treatment Period 2|Withdrawal by Subject|2
1373842|NCT01474538|4534237|P2|Treatment Period 2|Adverse Event|1
1373843|NCT01474538|4534238|P1|Treatment Period 2|Adverse Event|1
1373844|NCT01474538|4534237|P2|Treatment Period 2|Death|0
1373845|NCT01474538|4534238|P1|Treatment Period 2|Death|1
1373846|NCT01474538|4534237|P2|Treatment Period 1|Protocol Violation|1
1373847|NCT01474538|4534238|P1|Treatment Period 1|Protocol Violation|0
1373848|NCT01474538|4534237|P2|Treatment Period 1|Withdrawal by Subject|3
1373849|NCT01474538|4534238|P1|Treatment Period 1|Withdrawal by Subject|1
1373850|NCT01474538|4534237|P2|Treatment Period 1|Physician Decision|0
1373851|NCT01474538|4534238|P1|Treatment Period 1|Physician Decision|1
1373852|NCT01474538|4534237|P2|Treatment Period 1|Death|0
1373853|NCT01474538|4534238|P1|Treatment Period 1|Death|1
1373854|NCT01474512|4534255|P10|Maintenance Period|Treated but Discontinued in Induction|0
1373855|NCT01474512|4534256|P9|Maintenance Period|Treated but Discontinued in Induction|0
1373856|NCT01474512|4534257|P8|Maintenance Period|Treated but Discontinued in Induction|0
1373857|NCT01474512|4534258|P7|Maintenance Period|Treated but Discontinued in Induction|0
1373858|NCT01474512|4534259|P6|Maintenance Period|Treated but Discontinued in Induction|0
1373859|NCT01474512|4534260|P5|Maintenance Period|Treated but Discontinued in Induction|1
1373860|NCT01474512|4534261|P4|Maintenance Period|Treated but Discontinued in Induction|0
1373861|NCT01474512|4534262|P3|Maintenance Period|Treated but Discontinued in Induction|0
1373862|NCT01474512|4534263|P2|Maintenance Period|Treated but Discontinued in Induction|0
1373863|NCT01474512|4534264|P1|Maintenance Period|Treated but Discontinued in Induction|0
1373864|NCT01474512|4534255|P10|Maintenance Period|Protocol Violation|1
1373865|NCT01474512|4534256|P9|Maintenance Period|Protocol Violation|0
1373866|NCT01474512|4534257|P8|Maintenance Period|Protocol Violation|1
1373867|NCT01474512|4534258|P7|Maintenance Period|Protocol Violation|0
1373868|NCT01474512|4534259|P6|Maintenance Period|Protocol Violation|0
1373869|NCT01474512|4534260|P5|Maintenance Period|Protocol Violation|0
1373870|NCT01474512|4534261|P4|Maintenance Period|Protocol Violation|1
1373871|NCT01474512|4534262|P3|Maintenance Period|Protocol Violation|0
1373872|NCT01474512|4534263|P2|Maintenance Period|Protocol Violation|0
1373873|NCT01474512|4534264|P1|Maintenance Period|Protocol Violation|0
1373874|NCT01474512|4534255|P10|Maintenance Period|Lack of Efficacy|12
1373875|NCT01474512|4534256|P9|Maintenance Period|Lack of Efficacy|11
1373876|NCT01474512|4534257|P8|Maintenance Period|Lack of Efficacy|11
1373877|NCT01474512|4534258|P7|Maintenance Period|Lack of Efficacy|0
1373878|NCT01474512|4534259|P6|Maintenance Period|Lack of Efficacy|0
1373879|NCT01474512|4534260|P5|Maintenance Period|Lack of Efficacy|0
1373880|NCT01474512|4534261|P4|Maintenance Period|Lack of Efficacy|1
1373881|NCT01474512|4534262|P3|Maintenance Period|Lack of Efficacy|0
1373882|NCT01474512|4534263|P2|Maintenance Period|Lack of Efficacy|0
1373883|NCT01474512|4534264|P1|Maintenance Period|Lack of Efficacy|0
1373884|NCT01474512|4534255|P10|Maintenance Period|Clinical Relapse|0
1373885|NCT01474512|4534256|P9|Maintenance Period|Clinical Relapse|0
1373886|NCT01474512|4534257|P8|Maintenance Period|Clinical Relapse|0
1373887|NCT01474512|4534258|P7|Maintenance Period|Clinical Relapse|0
1373888|NCT01474512|4534259|P6|Maintenance Period|Clinical Relapse|0
1373889|NCT01474512|4534260|P5|Maintenance Period|Clinical Relapse|0
1373890|NCT01474512|4534261|P4|Maintenance Period|Clinical Relapse|1
1373891|NCT01474512|4534262|P3|Maintenance Period|Clinical Relapse|0
1373892|NCT01474512|4534263|P2|Maintenance Period|Clinical Relapse|0
1373893|NCT01474512|4534264|P1|Maintenance Period|Clinical Relapse|0
1373894|NCT01474512|4534255|P10|Maintenance Period|Investigator Decision|0
1373895|NCT01474512|4534256|P9|Maintenance Period|Investigator Decision|0
1373896|NCT01474512|4534257|P8|Maintenance Period|Investigator Decision|2
1373897|NCT01474512|4534258|P7|Maintenance Period|Investigator Decision|0
1373898|NCT01474512|4534259|P6|Maintenance Period|Investigator Decision|1
1373899|NCT01474512|4534260|P5|Maintenance Period|Investigator Decision|0
1373900|NCT01474512|4534261|P4|Maintenance Period|Investigator Decision|0
1373901|NCT01474512|4534262|P3|Maintenance Period|Investigator Decision|0
1373902|NCT01474512|4534263|P2|Maintenance Period|Investigator Decision|0
1373903|NCT01474512|4534264|P1|Maintenance Period|Investigator Decision|0
1373904|NCT01474512|4534255|P10|Maintenance Period|Death|0
1373905|NCT01474512|4534256|P9|Maintenance Period|Death|0
1373906|NCT01474512|4534257|P8|Maintenance Period|Death|0
1373907|NCT01474512|4534258|P7|Maintenance Period|Death|0
1373908|NCT01474512|4534259|P6|Maintenance Period|Death|2
1373909|NCT01474512|4534260|P5|Maintenance Period|Death|0
1373910|NCT01474512|4534261|P4|Maintenance Period|Death|0
1373911|NCT01474512|4534262|P3|Maintenance Period|Death|0
1373912|NCT01474512|4534263|P2|Maintenance Period|Death|0
1373913|NCT01474512|4534264|P1|Maintenance Period|Death|0
1373914|NCT01474512|4534255|P10|Maintenance Period|Lost to Follow-up|1
1373915|NCT01474512|4534256|P9|Maintenance Period|Lost to Follow-up|1
1373916|NCT01474512|4534257|P8|Maintenance Period|Lost to Follow-up|2
1373917|NCT01474512|4534258|P7|Maintenance Period|Lost to Follow-up|0
1373918|NCT01474512|4534259|P6|Maintenance Period|Lost to Follow-up|0
1373919|NCT01474512|4534260|P5|Maintenance Period|Lost to Follow-up|3
1373920|NCT01474512|4534261|P4|Maintenance Period|Lost to Follow-up|3
1373921|NCT01474512|4534262|P3|Maintenance Period|Lost to Follow-up|0
1373922|NCT01474512|4534263|P2|Maintenance Period|Lost to Follow-up|0
1373923|NCT01474512|4534264|P1|Maintenance Period|Lost to Follow-up|0
1373924|NCT01474512|4534255|P10|Maintenance Period|Withdrawal by Subject|1
1373925|NCT01474512|4534256|P9|Maintenance Period|Withdrawal by Subject|3
1373926|NCT01474512|4534257|P8|Maintenance Period|Withdrawal by Subject|6
1373927|NCT01474512|4534258|P7|Maintenance Period|Withdrawal by Subject|1
1373928|NCT01474512|4534259|P6|Maintenance Period|Withdrawal by Subject|3
1373929|NCT01474512|4534260|P5|Maintenance Period|Withdrawal by Subject|2
1373930|NCT01474512|4534261|P4|Maintenance Period|Withdrawal by Subject|6
1373931|NCT01474512|4534262|P3|Maintenance Period|Withdrawal by Subject|0
1373932|NCT01474512|4534263|P2|Maintenance Period|Withdrawal by Subject|0
1373933|NCT01474512|4534264|P1|Maintenance Period|Withdrawal by Subject|0
1373934|NCT01474512|4534255|P10|Maintenance Period|Adverse Event|3
1373935|NCT01474512|4534256|P9|Maintenance Period|Adverse Event|1
1373936|NCT01474512|4534257|P8|Maintenance Period|Adverse Event|19
1373937|NCT01474512|4534258|P7|Maintenance Period|Adverse Event|0
1373938|NCT01474512|4534259|P6|Maintenance Period|Adverse Event|7
1373939|NCT01474512|4534260|P5|Maintenance Period|Adverse Event|2
1373940|NCT01474512|4534261|P4|Maintenance Period|Adverse Event|4
1373941|NCT01474512|4534262|P3|Maintenance Period|Adverse Event|0
1373942|NCT01474512|4534263|P2|Maintenance Period|Adverse Event|0
1373943|NCT01474512|4534264|P1|Maintenance Period|Adverse Event|0
1373944|NCT01474512|4534255|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
1373945|NCT01474512|4534256|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
1373946|NCT01474512|4534257|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
1373947|NCT01474512|4534258|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
1373948|NCT01474512|4534259|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
1373949|NCT01474512|4534260|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
1373950|NCT01474512|4534261|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
1373951|NCT01474512|4534262|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
1373952|NCT01474512|4534263|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
1373953|NCT01474512|4534264|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
1373954|NCT01474512|4534255|P10|Induction Period|Lost to Follow-up|0
1373955|NCT01474512|4534256|P9|Induction Period|Lost to Follow-up|0
1373956|NCT01474512|4534257|P8|Induction Period|Lost to Follow-up|0
1373957|NCT01474512|4534258|P7|Induction Period|Lost to Follow-up|0
1373958|NCT01474512|4534259|P6|Induction Period|Lost to Follow-up|0
1373959|NCT01474512|4534260|P5|Induction Period|Lost to Follow-up|0
1373960|NCT01474512|4534261|P4|Induction Period|Lost to Follow-up|0
1373961|NCT01474512|4534262|P3|Induction Period|Lost to Follow-up|2
1373962|NCT01474512|4534263|P2|Induction Period|Lost to Follow-up|0
1373963|NCT01474512|4534264|P1|Induction Period|Lost to Follow-up|1
1373964|NCT01474512|4534255|P10|Induction Period|Sponsor Decision|0
1373965|NCT01474512|4534256|P9|Induction Period|Sponsor Decision|0
1373966|NCT01474512|4534257|P8|Induction Period|Sponsor Decision|0
1373967|NCT01474512|4534258|P7|Induction Period|Sponsor Decision|0
1373968|NCT01474512|4534259|P6|Induction Period|Sponsor Decision|0
1373969|NCT01474512|4534260|P5|Induction Period|Sponsor Decision|0
1373970|NCT01474512|4534261|P4|Induction Period|Sponsor Decision|0
1373971|NCT01474512|4534262|P3|Induction Period|Sponsor Decision|1
1373972|NCT01474512|4534263|P2|Induction Period|Sponsor Decision|1
1373973|NCT01474512|4534264|P1|Induction Period|Sponsor Decision|1
1373974|NCT01474512|4534255|P10|Induction Period|Protocol Violation|0
1373975|NCT01474512|4534256|P9|Induction Period|Protocol Violation|0
1373976|NCT01474512|4534257|P8|Induction Period|Protocol Violation|0
1373977|NCT01474512|4534258|P7|Induction Period|Protocol Violation|0
1373978|NCT01474512|4534259|P6|Induction Period|Protocol Violation|0
1373979|NCT01474512|4534260|P5|Induction Period|Protocol Violation|0
1373980|NCT01474512|4534261|P4|Induction Period|Protocol Violation|0
1373981|NCT01474512|4534262|P3|Induction Period|Protocol Violation|0
1373982|NCT01474512|4534263|P2|Induction Period|Protocol Violation|6
1373983|NCT01474512|4534264|P1|Induction Period|Protocol Violation|3
1373984|NCT01474512|4534255|P10|Induction Period|Withdrawal by Subject|0
1373985|NCT01474512|4534256|P9|Induction Period|Withdrawal by Subject|0
1373986|NCT01474512|4534257|P8|Induction Period|Withdrawal by Subject|0
1373987|NCT01474512|4534258|P7|Induction Period|Withdrawal by Subject|0
1373988|NCT01474512|4534259|P6|Induction Period|Withdrawal by Subject|0
1373989|NCT01474512|4534260|P5|Induction Period|Withdrawal by Subject|0
1373990|NCT01474512|4534261|P4|Induction Period|Withdrawal by Subject|0
1373991|NCT01474512|4534262|P3|Induction Period|Withdrawal by Subject|5
1373992|NCT01474512|4534263|P2|Induction Period|Withdrawal by Subject|6
1373993|NCT01474512|4534264|P1|Induction Period|Withdrawal by Subject|6
1373994|NCT01474512|4534255|P10|Induction Period|Lack of Efficacy|0
1373995|NCT01474512|4534256|P9|Induction Period|Lack of Efficacy|0
1373996|NCT01474512|4534257|P8|Induction Period|Lack of Efficacy|0
1373997|NCT01474512|4534258|P7|Induction Period|Lack of Efficacy|0
1373998|NCT01474512|4534259|P6|Induction Period|Lack of Efficacy|0
1373999|NCT01474512|4534260|P5|Induction Period|Lack of Efficacy|0
1374000|NCT01474512|4534261|P4|Induction Period|Lack of Efficacy|0
1374001|NCT01474512|4534262|P3|Induction Period|Lack of Efficacy|0
1374002|NCT01474512|4534263|P2|Induction Period|Lack of Efficacy|1
1374003|NCT01474512|4534264|P1|Induction Period|Lack of Efficacy|7
1374004|NCT01474512|4534255|P10|Induction Period|Adverse Event|0
1374005|NCT01474512|4534256|P9|Induction Period|Adverse Event|0
1374006|NCT01474512|4534257|P8|Induction Period|Adverse Event|0
1374007|NCT01474512|4534258|P7|Induction Period|Adverse Event|0
1374008|NCT01474512|4534259|P6|Induction Period|Adverse Event|0
1374009|NCT01474512|4534260|P5|Induction Period|Adverse Event|0
1374010|NCT01474512|4534261|P4|Induction Period|Adverse Event|0
1374011|NCT01474512|4534262|P3|Induction Period|Adverse Event|10
1374012|NCT01474512|4534263|P2|Induction Period|Adverse Event|10
1374013|NCT01474512|4534264|P1|Induction Period|Adverse Event|6
1374014|NCT01474434|4534333|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
1374015|NCT01474434|4534334|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
1374016|NCT01474434|4534335|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
1374017|NCT01474434|4534336|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
1374018|NCT01474434|4534333|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
1374019|NCT01474434|4534334|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
1374020|NCT01474434|4534335|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
1374021|NCT01474434|4534336|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
1374022|NCT01474434|4534333|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
1374023|NCT01474434|4534334|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
1374024|NCT01474434|4534335|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
1374025|NCT01474434|4534336|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
1374026|NCT01474317|4534378|P1|Overall Study|Subject ineligible for study|1
1374027|NCT01474317|4534378|P1|Overall Study|Adverse Event|1
1374028|NCT01474291|4534387|P1|Overall Study|Death|2
1374029|NCT01474291|4534387|P1|Overall Study|No Reason Reported|10
1374030|NCT01474291|4534387|P1|Overall Study|Patient No Longer Wanted to Participate|12
1374031|NCT01474291|4534387|P1|Overall Study|Lost to Follow-up|29
1374032|NCT01474291|4534387|P1|Overall Study|Adverse Event|53
1374033|NCT01474291|4534387|P1|Overall Study|Lack of Treatment Efficacy|88
1374034|NCT01474291|4534387|P1|Overall Study|Not Evaluable for Efficacy|26
1374035|NCT01474239|4534431|P2|Overall Study|Withdrawal for Economic Reason|0
1374036|NCT01474239|4534432|P1|Overall Study|Withdrawal for Economic Reason|1
1374037|NCT01474239|4534431|P2|Overall Study|Clinical Disease Progression|1
1374038|NCT01474239|4534432|P1|Overall Study|Clinical Disease Progression|7
1374039|NCT01474239|4534431|P2|Overall Study|Death|1
1374040|NCT01474239|4534432|P1|Overall Study|Death|1
1374041|NCT01474239|4534431|P2|Overall Study|Withdrawal by Subject|2
1374042|NCT01474239|4534432|P1|Overall Study|Withdrawal by Subject|1
1374043|NCT01474239|4534431|P2|Overall Study|Adverse Event|3
1374044|NCT01474239|4534432|P1|Overall Study|Adverse Event|12
1374045|NCT01474239|4534431|P2|Overall Study|Disease Progression|25
1374046|NCT01474239|4534432|P1|Overall Study|Disease Progression|37
1374047|NCT01473953|4534626|P5|Overall Study|Other|0
1374048|NCT01473953|4534627|P4|Overall Study|Other|0
1374049|NCT01473953|4534628|P3|Overall Study|Other|0
1374050|NCT01473953|4534629|P2|Overall Study|Other|0
1374051|NCT01473953|4534630|P1|Overall Study|Other|1
1374052|NCT01473836|4534672|P1|Overall Study|Does not meet entrance criteria|1
1374053|NCT01473836|4534672|P1|Overall Study|Lack of Efficacy|1
1374054|NCT01473836|4534672|P1|Overall Study|Adverse Event|4
1374055|NCT01473758|4534683|P4|Cycle 2|Adverse Event|0
1374056|NCT01473758|4534684|P3|Cycle 2|Adverse Event|5
1374057|NCT01473758|4534685|P2|Cycle 2|Adverse Event|0
1374058|NCT01473758|4534686|P1|Cycle 2|Adverse Event|0
1374059|NCT01473758|4534683|P4|Cycle 1|Withdrawal by Subject|0
1374060|NCT01473758|4534684|P3|Cycle 1|Withdrawal by Subject|0
1374061|NCT01473758|4534685|P2|Cycle 1|Withdrawal by Subject|1
1374062|NCT01473758|4534686|P1|Cycle 1|Withdrawal by Subject|1
1374063|NCT01473758|4534683|P4|Cycle 1|Adverse Event|0
1374064|NCT01473758|4534684|P3|Cycle 1|Adverse Event|0
1374065|NCT01473758|4534685|P2|Cycle 1|Adverse Event|2
1374066|NCT01473758|4534686|P1|Cycle 1|Adverse Event|10
1374067|NCT01473602|4534823|P2|Overall Study|Physician Decision|0
1374068|NCT01473602|4534824|P1|Overall Study|Physician Decision|1
1374069|NCT01473602|4534823|P2|Overall Study|Withdrawal by Subject|4
1374070|NCT01473602|4534824|P1|Overall Study|Withdrawal by Subject|5
1374071|NCT01473602|4534823|P2|Overall Study|Lost to Follow-up|1
1374072|NCT01473602|4534824|P1|Overall Study|Lost to Follow-up|1
1374073|NCT01473602|4534823|P2|Overall Study|Death|1
1374074|NCT01473602|4534824|P1|Overall Study|Death|0
1374075|NCT01473602|4534823|P2|Overall Study|Adverse Event|2
1374076|NCT01473602|4534824|P1|Overall Study|Adverse Event|1
1374077|NCT01473589|4534860|P2|Overall Study|Entry criteria not met|1
1374078|NCT01473589|4534861|P1|Overall Study|Entry criteria not met|0
1374079|NCT01473589|4534860|P2|Overall Study|Physician Decision|1
1374080|NCT01473589|4534861|P1|Overall Study|Physician Decision|0
1374081|NCT01473589|4534860|P2|Overall Study|Withdrawal by Subject|11
1374082|NCT01473589|4534861|P1|Overall Study|Withdrawal by Subject|5
1374083|NCT01473589|4534860|P2|Overall Study|Protocol Violation|0
1374084|NCT01473589|4534861|P1|Overall Study|Protocol Violation|1
1374085|NCT01473589|4534860|P2|Overall Study|Lost to Follow-up|2
1374086|NCT01473589|4534861|P1|Overall Study|Lost to Follow-up|2
1374087|NCT01473589|4534860|P2|Overall Study|Death|0
1374088|NCT01473589|4534861|P1|Overall Study|Death|2
1374089|NCT01473589|4534860|P2|Overall Study|Adverse Event|1
1374090|NCT01473589|4534861|P1|Overall Study|Adverse Event|1
1374091|NCT01473563|4534895|P1|Overall Study|Lost to FU post tx discontinuation|1
1374092|NCT01473524|4534917|P3|Overall Study|Withdrawal by Subject|1
1374093|NCT01473524|4534918|P2|Overall Study|Withdrawal by Subject|1
1374094|NCT01473524|4534919|P1|Overall Study|Withdrawal by Subject|2
1374095|NCT01473524|4534917|P3|Overall Study|Death|0
1374096|NCT01473524|4534918|P2|Overall Study|Death|0
1374097|NCT01473524|4534919|P1|Overall Study|Death|1
1374098|NCT01473524|4534917|P3|Overall Study|Adverse Event|2
1374099|NCT01473524|4534918|P2|Overall Study|Adverse Event|8
1374100|NCT01473524|4534919|P1|Overall Study|Adverse Event|4
1374101|NCT01473420|4534952|P2|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
1374102|NCT01473420|4534953|P1|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
1374103|NCT01473420|4534952|P2|Maintenance Period (16 Weeks)|Sponsor's Decision|0
1374104|NCT01473420|4534953|P1|Maintenance Period (16 Weeks)|Sponsor's Decision|1
1374105|NCT01473420|4534952|P2|Maintenance Period (16 Weeks)|Long term hospitalization|1
1374106|NCT01473420|4534953|P1|Maintenance Period (16 Weeks)|Long term hospitalization|0
1374107|NCT01473420|4534952|P2|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
1374108|NCT01473420|4534953|P1|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
1374109|NCT01473420|4534952|P2|Maintenance Period (16 Weeks)|Site closure|1
1374110|NCT01473420|4534953|P1|Maintenance Period (16 Weeks)|Site closure|3
1374111|NCT01473420|4534952|P2|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
1374112|NCT01473420|4534953|P1|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
1374113|NCT01473420|4534952|P2|Maintenance Period (16 Weeks)|Lost to Follow-up|2
1374114|NCT01473420|4534953|P1|Maintenance Period (16 Weeks)|Lost to Follow-up|1
1374115|NCT01473420|4534952|P2|Maintenance Period (16 Weeks)|Kidney transplant|1
1374116|NCT01473420|4534953|P1|Maintenance Period (16 Weeks)|Kidney transplant|3
1374117|NCT01473420|4534952|P2|Maintenance Period (16 Weeks)|Did not meet criteria|2
1374118|NCT01473420|4534953|P1|Maintenance Period (16 Weeks)|Did not meet criteria|0
1374119|NCT01473420|4534952|P2|Maintenance Period (16 Weeks)|Physician Decision|2
1374120|NCT01473420|4534953|P1|Maintenance Period (16 Weeks)|Physician Decision|1
1374121|NCT01473420|4534952|P2|Maintenance Period (16 Weeks)|Adverse Event|2
1374122|NCT01473420|4534953|P1|Maintenance Period (16 Weeks)|Adverse Event|3
1374123|NCT01473420|4534952|P2|Titration Period (18 Weeks)|Did not meet criteria|32
1374124|NCT01473420|4534953|P1|Titration Period (18 Weeks)|Did not meet criteria|32
1374125|NCT01473420|4534952|P2|Titration Period (18 Weeks)|Adverse Event|6
1374126|NCT01473420|4534953|P1|Titration Period (18 Weeks)|Adverse Event|4
1374127|NCT01473407|4535037|P2|Overall Study|Site Closure|0
1374128|NCT01473407|4535038|P1|Overall Study|Site Closure|1
1374129|NCT01473407|4535037|P2|Overall Study|Sponsor's Decision|10
1374130|NCT01473407|4535038|P1|Overall Study|Sponsor's Decision|10
1374131|NCT01473407|4535037|P2|Overall Study|Transfer to Another Facility/Unit|3
1374132|NCT01473407|4535038|P1|Overall Study|Transfer to Another Facility/Unit|4
1374133|NCT01473407|4535037|P2|Overall Study|Temperature Excursion|3
1374134|NCT01473407|4535038|P1|Overall Study|Temperature Excursion|2
1374135|NCT01473407|4535037|P2|Overall Study|Patient Lost Green Card Status|0
1374136|NCT01473407|4535038|P1|Overall Study|Patient Lost Green Card Status|1
1374137|NCT01473407|4535037|P2|Overall Study|Patient Received Aranesp|0
1374138|NCT01473407|4535038|P1|Overall Study|Patient Received Aranesp|1
1374139|NCT01473407|4535037|P2|Overall Study|Elevated Hemoglobin|0
1374140|NCT01473407|4535038|P1|Overall Study|Elevated Hemoglobin|1
1374141|NCT01473407|4535037|P2|Overall Study|Vacation/Travel|1
1374142|NCT01473407|4535038|P1|Overall Study|Vacation/Travel|1
1374143|NCT01473407|4535037|P2|Overall Study|Kidney Transplant|6
1374144|NCT01473407|4535038|P1|Overall Study|Kidney Transplant|7
1374145|NCT01473407|4535037|P2|Overall Study|Withdrawal by Subject|7
1374146|NCT01473407|4535038|P1|Overall Study|Withdrawal by Subject|4
1374147|NCT01473407|4535037|P2|Overall Study|Randomization Error|1
1374148|NCT01473407|4535038|P1|Overall Study|Randomization Error|3
1374149|NCT01473407|4535037|P2|Overall Study|Adverse Event|8
1374150|NCT01473407|4535038|P1|Overall Study|Adverse Event|8
1374151|NCT01473407|4535037|P2|Overall Study|Lost to Follow-up|4
1374152|NCT01473407|4535038|P1|Overall Study|Lost to Follow-up|10
1374153|NCT01473407|4535037|P2|Overall Study|Physician Decision|4
1374154|NCT01473407|4535038|P1|Overall Study|Physician Decision|1
1374155|NCT01473394|4535092|P2|Overall Study|Lost to Follow-up|11
1374156|NCT01473394|4535093|P1|Overall Study|Lost to Follow-up|9
1374157|NCT01473394|4535092|P2|Overall Study|Withdrew Consent|10
1374158|NCT01473394|4535093|P1|Overall Study|Withdrew Consent|12
1374159|NCT01473394|4535092|P2|Overall Study|Protocol Violation|5
1374160|NCT01473394|4535093|P1|Overall Study|Protocol Violation|7
1374161|NCT01473394|4535092|P2|Overall Study|Insufficient Therapeutic Response|1
1374162|NCT01473394|4535093|P1|Overall Study|Insufficient Therapeutic Response|4
1374163|NCT01473394|4535092|P2|Overall Study|Adverse Event|16
1374164|NCT01473394|4535093|P1|Overall Study|Adverse Event|13
1374165|NCT01473381|4535107|P4|Overall Study|Other Reasons|3
1374166|NCT01473381|4535108|P3|Overall Study|Other Reasons|1
1374167|NCT01473381|4535109|P2|Overall Study|Other Reasons|0
1374168|NCT01473381|4535110|P1|Overall Study|Other Reasons|0
1374169|NCT01473381|4535107|P4|Overall Study|Lost to Follow-up|23
1374170|NCT01473381|4535108|P3|Overall Study|Lost to Follow-up|35
1374171|NCT01473381|4535109|P2|Overall Study|Lost to Follow-up|28
1374172|NCT01473381|4535110|P1|Overall Study|Lost to Follow-up|25
1374173|NCT01473381|4535107|P4|Overall Study|Withdrawal of Consent|26
1374174|NCT01473381|4535108|P3|Overall Study|Withdrawal of Consent|20
1374175|NCT01473381|4535109|P2|Overall Study|Withdrawal of Consent|21
1374176|NCT01473381|4535110|P1|Overall Study|Withdrawal of Consent|20
1374177|NCT01473381|4535107|P4|Overall Study|Protocol Violation|17
1374178|NCT01473381|4535108|P3|Overall Study|Protocol Violation|19
1374179|NCT01473381|4535109|P2|Overall Study|Protocol Violation|23
1374180|NCT01473381|4535110|P1|Overall Study|Protocol Violation|17
1374181|NCT01473381|4535107|P4|Overall Study|Insufficient Therapeutic Response|3
1374182|NCT01473381|4535108|P3|Overall Study|Insufficient Therapeutic Response|2
1374183|NCT01473381|4535109|P2|Overall Study|Insufficient Therapeutic Response|1
1374184|NCT01473381|4535110|P1|Overall Study|Insufficient Therapeutic Response|10
1374185|NCT01473381|4535107|P4|Overall Study|Adverse Event|17
1374186|NCT01473381|4535108|P3|Overall Study|Adverse Event|25
1374187|NCT01473381|4535109|P2|Overall Study|Adverse Event|20
1374188|NCT01473381|4535110|P1|Overall Study|Adverse Event|8
1374189|NCT01472965|4535192|P2|Overall Study|Withdrawal by Subject|0
1374190|NCT01472965|4535193|P1|Overall Study|Withdrawal by Subject|1
1374191|NCT01472939|4535213|P4|Overall Study|Withdrawal by Subject|4
1374192|NCT01472939|4535214|P3|Overall Study|Withdrawal by Subject|1
1374193|NCT01472939|4535215|P2|Overall Study|Withdrawal by Subject|3
1374194|NCT01472939|4535216|P1|Overall Study|Withdrawal by Subject|9
1374195|NCT01472939|4535213|P4|Overall Study|Protocol Violation|1
1374196|NCT01472939|4535214|P3|Overall Study|Protocol Violation|0
1374197|NCT01472939|4535215|P2|Overall Study|Protocol Violation|3
1374198|NCT01472939|4535216|P1|Overall Study|Protocol Violation|3
1374199|NCT01472939|4535213|P4|Overall Study|Withdrawal By PI|0
1374200|NCT01472939|4535214|P3|Overall Study|Withdrawal By PI|0
1374201|NCT01472939|4535215|P2|Overall Study|Withdrawal By PI|0
1374202|NCT01472939|4535216|P1|Overall Study|Withdrawal By PI|1
1374203|NCT01472939|4535213|P4|Overall Study|Prohibited Medication|0
1374204|NCT01472939|4535214|P3|Overall Study|Prohibited Medication|0
1374205|NCT01472939|4535215|P2|Overall Study|Prohibited Medication|1
1374206|NCT01472939|4535216|P1|Overall Study|Prohibited Medication|0
1374207|NCT01472939|4535213|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
1374208|NCT01472939|4535214|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
1374209|NCT01472939|4535215|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
1374210|NCT01472939|4535216|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
1374211|NCT01472939|4535213|P4|Overall Study|Lost to Follow-up|0
1374212|NCT01472939|4535214|P3|Overall Study|Lost to Follow-up|2
1374213|NCT01472939|4535215|P2|Overall Study|Lost to Follow-up|0
1374214|NCT01472939|4535216|P1|Overall Study|Lost to Follow-up|3
1374215|NCT01472939|4535213|P4|Overall Study|Lack of Efficacy|1
1374216|NCT01472939|4535214|P3|Overall Study|Lack of Efficacy|0
1374217|NCT01472939|4535215|P2|Overall Study|Lack of Efficacy|0
1374218|NCT01472939|4535216|P1|Overall Study|Lack of Efficacy|1
1374219|NCT01472939|4535213|P4|Overall Study|Adverse Event|14
1374220|NCT01472939|4535214|P3|Overall Study|Adverse Event|7
1374221|NCT01472939|4535215|P2|Overall Study|Adverse Event|7
1374222|NCT01472939|4535216|P1|Overall Study|Adverse Event|3
1374223|NCT01472835|4535260|P2|Overall Study|Lost to Follow-up|0
1374224|NCT01472835|4535261|P1|Overall Study|Lost to Follow-up|2
1374225|NCT01472380|4535339|P1|1 Day Period Between Dosing|Protocol Violation|1
1374226|NCT01472380|4535339|P1|Efavirenz Alone|Withdrawal by Subject|1
1374227|NCT01472341|4535350|P1|Overall Study|Death|9
1374228|NCT01472341|4535350|P1|Overall Study|Laboratory parameters unavailable|25
1374229|NCT01472341|4535350|P1|Overall Study|Lost to Follow-up|52
1374230|NCT01472341|4535350|P1|Overall Study|Withdrawal by Subject|39
1374231|NCT01472341|4535350|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
1374232|NCT01472341|4535350|P1|Overall Study|Started insulin therapy|55
1374233|NCT01472289|4535356|P1|Overall Study|Death|2
1374234|NCT01472185|4535368|P2|Overall Study|Subject Withdrew Consent|3
1374235|NCT01472185|4535369|P1|Overall Study|Subject Withdrew Consent|6
1374236|NCT01472185|4535368|P2|Overall Study|Subject Noncompliance|15
1374237|NCT01472185|4535369|P1|Overall Study|Subject Noncompliance|8
1374238|NCT01472185|4535368|P2|Overall Study|Protocol Violation|1
1374239|NCT01472185|4535369|P1|Overall Study|Protocol Violation|5
1374240|NCT01472185|4535368|P2|Overall Study|Lost to Follow-up|1
1374241|NCT01472185|4535369|P1|Overall Study|Lost to Follow-up|4
1374242|NCT01472185|4535368|P2|Overall Study|Investigator’s Discretion|1
1374243|NCT01472185|4535369|P1|Overall Study|Investigator’s Discretion|3
1374244|NCT01472185|4535368|P2|Overall Study|Hyperglycemia|2
1374245|NCT01472185|4535369|P1|Overall Study|Hyperglycemia|5
1374246|NCT01472185|4535368|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
1374247|NCT01472185|4535369|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
1374248|NCT01472185|4535368|P2|Overall Study|Randomized but Not Treated|1
1374249|NCT01472185|4535369|P1|Overall Study|Randomized but Not Treated|0
1374250|NCT01471782|4535389|P6|Overall Study|Death|1
1374251|NCT01471782|4535390|P5|Overall Study|Death|0
1374252|NCT01471782|4535391|P4|Overall Study|Death|0
1374253|NCT01471782|4535392|P3|Overall Study|Death|0
1374254|NCT01471782|4535393|P2|Overall Study|Death|0
1374255|NCT01471782|4535394|P1|Overall Study|Death|0
1374256|NCT01471782|4535389|P6|Overall Study|Withdrawal by Parent/Guardian|0
1374257|NCT01471782|4535390|P5|Overall Study|Withdrawal by Parent/Guardian|1
1374258|NCT01471782|4535391|P4|Overall Study|Withdrawal by Parent/Guardian|0
1374259|NCT01471782|4535392|P3|Overall Study|Withdrawal by Parent/Guardian|0
1374260|NCT01471782|4535393|P2|Overall Study|Withdrawal by Parent/Guardian|0
1374261|NCT01471782|4535394|P1|Overall Study|Withdrawal by Parent/Guardian|0
1374262|NCT01471782|4535389|P6|Overall Study|Physician Decision|8
1374263|NCT01471782|4535390|P5|Overall Study|Physician Decision|3
1374264|NCT01471782|4535391|P4|Overall Study|Physician Decision|0
1374265|NCT01471782|4535392|P3|Overall Study|Physician Decision|0
1374266|NCT01471782|4535393|P2|Overall Study|Physician Decision|0
1374267|NCT01471782|4535394|P1|Overall Study|Physician Decision|0
1374268|NCT01471782|4535389|P6|Overall Study|Disease Relapse|1
1374269|NCT01471782|4535390|P5|Overall Study|Disease Relapse|2
1374270|NCT01471782|4535391|P4|Overall Study|Disease Relapse|1
1374271|NCT01471782|4535392|P3|Overall Study|Disease Relapse|0
1374272|NCT01471782|4535393|P2|Overall Study|Disease Relapse|0
1374273|NCT01471782|4535394|P1|Overall Study|Disease Relapse|0
1374274|NCT01471782|4535389|P6|Overall Study|Change of Chemotherapy|4
1374275|NCT01471782|4535390|P5|Overall Study|Change of Chemotherapy|1
1374276|NCT01471782|4535391|P4|Overall Study|Change of Chemotherapy|0
1374277|NCT01471782|4535392|P3|Overall Study|Change of Chemotherapy|0
1374278|NCT01471782|4535393|P2|Overall Study|Change of Chemotherapy|1
1374279|NCT01471782|4535394|P1|Overall Study|Change of Chemotherapy|1
1374280|NCT01471782|4535389|P6|Overall Study|Other|5
1374281|NCT01471782|4535390|P5|Overall Study|Other|6
1374282|NCT01471782|4535391|P4|Overall Study|Other|1
1374283|NCT01471782|4535392|P3|Overall Study|Other|1
1374284|NCT01471782|4535393|P2|Overall Study|Other|0
1374285|NCT01471782|4535394|P1|Overall Study|Other|0
1374286|NCT01471782|4535389|P6|Overall Study|Adverse Event|1
1374287|NCT01471782|4535390|P5|Overall Study|Adverse Event|3
1374288|NCT01471782|4535391|P4|Overall Study|Adverse Event|2
1374289|NCT01471782|4535392|P3|Overall Study|Adverse Event|2
1374290|NCT01471782|4535393|P2|Overall Study|Adverse Event|1
1374291|NCT01471782|4535394|P1|Overall Study|Adverse Event|1
1374292|NCT01471782|4535389|P6|Overall Study|Lack of Efficacy|18
1374293|NCT01471782|4535390|P5|Overall Study|Lack of Efficacy|5
1374294|NCT01471782|4535391|P4|Overall Study|Lack of Efficacy|1
1374295|NCT01471782|4535392|P3|Overall Study|Lack of Efficacy|1
1374296|NCT01471782|4535393|P2|Overall Study|Lack of Efficacy|2
1374297|NCT01471782|4535394|P1|Overall Study|Lack of Efficacy|1
1374298|NCT01471782|4535389|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
1374299|NCT01471782|4535390|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
1374300|NCT01471782|4535391|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
1374301|NCT01471782|4535392|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
1374302|NCT01471782|4535393|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
1374303|NCT01471782|4535394|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
1374304|NCT01471691|4535448|P2|Overall Study|Lack of Efficacy|1
1374305|NCT01471691|4535449|P1|Overall Study|Lack of Efficacy|0
1374306|NCT01471379|4535458|P3|Overall Study|Study terminated|0
1374307|NCT01471379|4535459|P2|Overall Study|Study terminated|1
1374308|NCT01471379|4535460|P1|Overall Study|Study terminated|0
1374309|NCT01471379|4535458|P3|Overall Study|Adverse Event|0
1374310|NCT01471379|4535459|P2|Overall Study|Adverse Event|0
1374311|NCT01471379|4535460|P1|Overall Study|Adverse Event|1
1374312|NCT01471353|4535480|P1|Overall Study|remain on study|3
1374313|NCT01471340|4535488|P2|Overall Study|Invalid informed consent|0
1374314|NCT01471340|4535489|P1|Overall Study|Invalid informed consent|1
1374315|NCT01471340|4535488|P2|Overall Study|Investigational site closure|1
1374316|NCT01471340|4535489|P1|Overall Study|Investigational site closure|0
1374317|NCT01471340|4535488|P2|Overall Study|Lost to Follow-up|1
1374318|NCT01471340|4535489|P1|Overall Study|Lost to Follow-up|0
1374319|NCT01471340|4535488|P2|Overall Study|Death|4
1374320|NCT01471340|4535489|P1|Overall Study|Death|5
1374321|NCT01471574|4535512|P4|Follow-up Period|Follow-up no longer required|0
1374322|NCT01471574|4535513|P3|Follow-up Period|Follow-up no longer required|0
1374323|NCT01471574|4535514|P2|Follow-up Period|Follow-up no longer required|1
1374324|NCT01471574|4535515|P1|Follow-up Period|Follow-up no longer required|0
1374325|NCT01471574|4535512|P4|Follow-up Period|Death|0
1374326|NCT01471574|4535513|P3|Follow-up Period|Death|1
1374327|NCT01471574|4535514|P2|Follow-up Period|Death|0
1374328|NCT01471574|4535515|P1|Follow-up Period|Death|0
1374329|NCT01471574|4535512|P4|Follow-up Period|Lost to Follow-up|2
1374330|NCT01471574|4535513|P3|Follow-up Period|Lost to Follow-up|3
1374331|NCT01471574|4535514|P2|Follow-up Period|Lost to Follow-up|1
1374332|NCT01471574|4535515|P1|Follow-up Period|Lost to Follow-up|4
1374333|NCT01471574|4535512|P4|Follow-up Period|Withdrawal by Subject|1
1374334|NCT01471574|4535513|P3|Follow-up Period|Withdrawal by Subject|3
1374335|NCT01471574|4535514|P2|Follow-up Period|Withdrawal by Subject|0
1374336|NCT01471574|4535515|P1|Follow-up Period|Withdrawal by Subject|3
1374337|NCT01471574|4535512|P4|Treatment Period|Not specified|0
1374338|NCT01471574|4535513|P3|Treatment Period|Not specified|0
1374339|NCT01471574|4535514|P2|Treatment Period|Not specified|0
1374340|NCT01471574|4535515|P1|Treatment Period|Not specified|1
1374341|NCT01471574|4535512|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
1374342|NCT01471574|4535513|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
1374343|NCT01471574|4535514|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
1374344|NCT01471574|4535515|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
1374345|NCT01471574|4535512|P4|Treatment Period|Lost to Follow-up|0
1374346|NCT01471574|4535513|P3|Treatment Period|Lost to Follow-up|2
1374347|NCT01471574|4535514|P2|Treatment Period|Lost to Follow-up|2
1374348|NCT01471574|4535515|P1|Treatment Period|Lost to Follow-up|1
1374349|NCT01471574|4535512|P4|Treatment Period|Patient Requested Discontinue Study drug|1
1374350|NCT01471574|4535513|P3|Treatment Period|Patient Requested Discontinue Study drug|1
1374351|NCT01471574|4535514|P2|Treatment Period|Patient Requested Discontinue Study drug|0
1374352|NCT01471574|4535515|P1|Treatment Period|Patient Requested Discontinue Study drug|4
1374353|NCT01471574|4535512|P4|Treatment Period|Withdrawal by Subject|0
1374354|NCT01471574|4535513|P3|Treatment Period|Withdrawal by Subject|1
1374355|NCT01471574|4535514|P2|Treatment Period|Withdrawal by Subject|1
1374356|NCT01471574|4535515|P1|Treatment Period|Withdrawal by Subject|5
1374357|NCT01471574|4535512|P4|Treatment Period|Adverse Event|1
1374358|NCT01471574|4535513|P3|Treatment Period|Adverse Event|6
1374359|NCT01471574|4535514|P2|Treatment Period|Adverse Event|3
1374360|NCT01471574|4535515|P1|Treatment Period|Adverse Event|7
1374361|NCT01471574|4535512|P4|Treatment Period|Lack of Efficacy|1
1374362|NCT01471574|4535513|P3|Treatment Period|Lack of Efficacy|14
1374363|NCT01471574|4535514|P2|Treatment Period|Lack of Efficacy|4
1374364|NCT01471574|4535515|P1|Treatment Period|Lack of Efficacy|12
1374365|NCT01471197|4535546|P2|Overall Study|Study Drug Toxicity|0
1374366|NCT01471197|4535547|P1|Overall Study|Study Drug Toxicity|1
1374367|NCT01471197|4535546|P2|Overall Study|Death|0
1374368|NCT01471197|4535547|P1|Overall Study|Death|1
1374369|NCT01471197|4535546|P2|Overall Study|Disease Progression|2
1374370|NCT01471197|4535547|P1|Overall Study|Disease Progression|4
1374371|NCT01471171|4535557|P2|Treatment Period 2|Adverse Event|0
1374372|NCT01471171|4535558|P1|Treatment Period 2|Adverse Event|1
1374373|NCT01471171|4535557|P2|Treatment Period 1|Adverse Event|1
1374374|NCT01471171|4535558|P1|Treatment Period 1|Adverse Event|4
1374375|NCT01471015|4535576|P3|Overall Study|Death|1
1374376|NCT01471015|4535577|P2|Overall Study|Death|1
1374377|NCT01471015|4535578|P1|Overall Study|Death|0
1374378|NCT01470599|4535620|P2|Overall Study|Adverse event not related to study drug|5
1374379|NCT01470599|4535621|P1|Overall Study|Adverse event not related to study drug|1
1374380|NCT01470599|4535620|P2|Overall Study|Insufficient clinical response|27
1374381|NCT01470599|4535621|P1|Overall Study|Insufficient clinical response|6
1374382|NCT01470599|4535620|P2|Overall Study|Adverse event related to study drug|5
1374383|NCT01470599|4535621|P1|Overall Study|Adverse event related to study drug|2
1374384|NCT01470599|4535620|P2|Overall Study|Protocol Violation|1
1374385|NCT01470599|4535621|P1|Overall Study|Protocol Violation|3
1374386|NCT01470599|4535620|P2|Overall Study|Other|0
1374387|NCT01470599|4535621|P1|Overall Study|Other|1
1374388|NCT01470599|4535620|P2|Overall Study|Withdrawal by Subject|4
1374389|NCT01470599|4535621|P1|Overall Study|Withdrawal by Subject|3
1374390|NCT01470599|4535620|P2|Overall Study|Lost to Follow-up|1
1374391|NCT01470599|4535621|P1|Overall Study|Lost to Follow-up|2
1374392|NCT01470599|4535620|P2|Overall Study|Did not meet entrance criteria|0
1374393|NCT01470599|4535621|P1|Overall Study|Did not meet entrance criteria|1
1374394|NCT01470469|4535685|P2|Overall Study|Not specified|1
1374395|NCT01470469|4535686|P1|Overall Study|Not specified|2
1374396|NCT01470469|4535685|P2|Overall Study|Protocol Violation|1
1374397|NCT01470469|4535686|P1|Overall Study|Protocol Violation|1
1374398|NCT01470469|4535685|P2|Overall Study|Lost to Follow-up|2
1374399|NCT01470469|4535686|P1|Overall Study|Lost to Follow-up|2
1374400|NCT01470469|4535685|P2|Overall Study|Adverse Event|7
1374401|NCT01470469|4535686|P1|Overall Study|Adverse Event|0
1374402|NCT01470469|4535685|P2|Overall Study|Lack of Efficacy|7
1374403|NCT01470469|4535686|P1|Overall Study|Lack of Efficacy|1
1374404|NCT01470469|4535685|P2|Overall Study|Withdrawal by Subject|6
1374405|NCT01470469|4535686|P1|Overall Study|Withdrawal by Subject|4
1374406|NCT01470417|4535706|P2|Overall Study|Disease progression|2
1374407|NCT01470417|4535707|P1|Overall Study|Disease progression|0
1374408|NCT01470248|4535719|P1|Overall Study|Withdrawal by Subject|1
1374409|NCT01470144|4535775|P1|Overall Study|Patient’s and investigator’s decision|1
1374410|NCT01470144|4535775|P1|Overall Study|Lung transplant|6
1374411|NCT01470144|4535775|P1|Overall Study|Death|1
1374412|NCT01470144|4535775|P1|Overall Study|Adverse Event|2
1374413|NCT01470001|4535880|P2|Overall Study|Withdrawal by Subject|1
1374414|NCT01470001|4535881|P1|Overall Study|Withdrawal by Subject|2
1374415|NCT01470001|4535880|P2|Overall Study|Physician Decision|0
1374416|NCT01470001|4535881|P1|Overall Study|Physician Decision|2
1374417|NCT01470001|4535880|P2|Overall Study|Lost to Follow-up|1
1374418|NCT01470001|4535881|P1|Overall Study|Lost to Follow-up|1
1374419|NCT01469819|4535891|P1|Overall Study|Technical malfunction of SmartPill data|3
1374420|NCT01469819|4535891|P1|Overall Study|Could not swallow SmartPill|2
1374421|NCT01469819|4535891|P1|Overall Study|Did not meet inclusionary criteria|2
1374422|NCT01469819|4535891|P1|Overall Study|Withdrawal by Subject|1
1374423|NCT01469637|4535915|P2|Second Intervention|Incarcerated|0
1374424|NCT01469637|4535916|P1|Second Intervention|Incarcerated|1
1374425|NCT01469637|4535915|P2|First Intervention|Unacceptable behavior|1
1374426|NCT01469637|4535916|P1|First Intervention|Unacceptable behavior|0
1374427|NCT01469546|4535924|P1|Received 5 mg Dose|Physician Decision|3
1374428|NCT01469546|4535924|P1|Received 5 mg Dose|Progressive Disease|3
1374429|NCT01469546|4535924|P1|Received 5 mg Dose|Protocol Violation|2
1374430|NCT01469546|4535924|P1|Received 5 mg Dose|Death|2
1374431|NCT01469546|4535924|P1|Received 5 mg Dose|Adverse Event|13
1374432|NCT01469377|4535934|P3|Overall Study|Other Miscellaneous Reasons|0
1374433|NCT01469377|4535935|P2|Overall Study|Other Miscellaneous Reasons|0
1374434|NCT01469377|4535936|P1|Overall Study|Other Miscellaneous Reasons|2
1374435|NCT01469377|4535934|P3|Overall Study|Insufficient Therapeutic Response|0
1374436|NCT01469377|4535935|P2|Overall Study|Insufficient Therapeutic Response|4
1374437|NCT01469377|4535936|P1|Overall Study|Insufficient Therapeutic Response|3
1374438|NCT01469377|4535934|P3|Overall Study|Adverse Event|36
1374439|NCT01469377|4535935|P2|Overall Study|Adverse Event|18
1374440|NCT01469377|4535936|P1|Overall Study|Adverse Event|8
1374441|NCT01469377|4535934|P3|Overall Study|Withdrawal of Consent|15
1374442|NCT01469377|4535935|P2|Overall Study|Withdrawal of Consent|14
1374443|NCT01469377|4535936|P1|Overall Study|Withdrawal of Consent|12
1374444|NCT01469377|4535934|P3|Overall Study|Lost to Follow-up|5
1374445|NCT01469377|4535935|P2|Overall Study|Lost to Follow-up|2
1374446|NCT01469377|4535936|P1|Overall Study|Lost to Follow-up|3
1374447|NCT01469377|4535934|P3|Overall Study|Protocol Deviation|10
1374448|NCT01469377|4535935|P2|Overall Study|Protocol Deviation|10
1374449|NCT01469377|4535936|P1|Overall Study|Protocol Deviation|7
1374450|NCT01469364|4535947|P1|Overall Study|Withdrawal by Subject|1
1374451|NCT01469364|4535947|P1|Overall Study|Adverse Event|1
1374452|NCT01469221|4535998|P3|Double Blind Phase|Sponsor Terminate Study|0
1374453|NCT01469221|4535999|P2|Double Blind Phase|Sponsor Terminate Study|16
1374454|NCT01469221|4536000|P1|Double Blind Phase|Sponsor Terminate Study|12
1374455|NCT01469221|4535998|P3|Double Blind Phase|Physician Decision|0
1374456|NCT01469221|4535999|P2|Double Blind Phase|Physician Decision|1
1374457|NCT01469221|4536000|P1|Double Blind Phase|Physician Decision|1
1374458|NCT01469221|4535998|P3|Double Blind Phase|Protocol Violation|0
1374459|NCT01469221|4535999|P2|Double Blind Phase|Protocol Violation|0
1374460|NCT01469221|4536000|P1|Double Blind Phase|Protocol Violation|1
1374461|NCT01469182|4536011|P2|Overall Study|Did not meet Protocol Eligibility|0
1374462|NCT01469182|4536012|P1|Overall Study|Did not meet Protocol Eligibility|3
1374463|NCT01469182|4536011|P2|Overall Study|Protocol Violation|2
1374464|NCT01469182|4536012|P1|Overall Study|Protocol Violation|4
1374465|NCT01469182|4536011|P2|Overall Study|Withdrawal by Subject|1
1374466|NCT01469182|4536012|P1|Overall Study|Withdrawal by Subject|4
1374467|NCT01469182|4536011|P2|Overall Study|Lost to Follow-up|0
1374468|NCT01469182|4536012|P1|Overall Study|Lost to Follow-up|3
1374469|NCT01469182|4536011|P2|Overall Study|Adverse Event|3
1374470|NCT01469182|4536012|P1|Overall Study|Adverse Event|21
1374471|NCT01469065|4536039|P5|Overall Study|Not specified|0
1374472|NCT01469065|4536040|P4|Overall Study|Not specified|0
1374473|NCT01469065|4536041|P3|Overall Study|Not specified|0
1374474|NCT01469065|4536042|P2|Overall Study|Not specified|1
1374475|NCT01469065|4536043|P1|Overall Study|Not specified|0
1374476|NCT01469065|4536039|P5|Overall Study|Lack of Efficacy|1
1374477|NCT01469065|4536040|P4|Overall Study|Lack of Efficacy|0
1374478|NCT01469065|4536041|P3|Overall Study|Lack of Efficacy|0
1374479|NCT01469065|4536042|P2|Overall Study|Lack of Efficacy|0
1374480|NCT01469065|4536043|P1|Overall Study|Lack of Efficacy|0
1374481|NCT01469052|4536139|P6|Overall Study|Other|0
1374482|NCT01469052|4536140|P5|Overall Study|Other|1
1374483|NCT01469052|4536141|P4|Overall Study|Other|0
1374484|NCT01469052|4536142|P3|Overall Study|Other|0
1374485|NCT01469052|4536143|P2|Overall Study|Other|1
1374486|NCT01469052|4536144|P1|Overall Study|Other|0
1374487|NCT01469052|4536139|P6|Overall Study|Moved to rollover protocol|1
1374488|NCT01469052|4536140|P5|Overall Study|Moved to rollover protocol|0
1374489|NCT01469052|4536141|P4|Overall Study|Moved to rollover protocol|0
1374490|NCT01469052|4536142|P3|Overall Study|Moved to rollover protocol|1
1374491|NCT01469052|4536143|P2|Overall Study|Moved to rollover protocol|0
1374492|NCT01469052|4536144|P1|Overall Study|Moved to rollover protocol|1
1374493|NCT01469052|4536139|P6|Overall Study|Lack of Efficacy|2
1374494|NCT01469052|4536140|P5|Overall Study|Lack of Efficacy|0
1374495|NCT01469052|4536141|P4|Overall Study|Lack of Efficacy|0
1374496|NCT01469052|4536142|P3|Overall Study|Lack of Efficacy|0
1374497|NCT01469052|4536143|P2|Overall Study|Lack of Efficacy|0
1374498|NCT01469052|4536144|P1|Overall Study|Lack of Efficacy|0
1374499|NCT01469052|4536139|P6|Overall Study|Progressive disease|2
1374500|NCT01469052|4536140|P5|Overall Study|Progressive disease|7
1374501|NCT01469052|4536141|P4|Overall Study|Progressive disease|3
1374502|NCT01469052|4536142|P3|Overall Study|Progressive disease|5
1374503|NCT01469052|4536143|P2|Overall Study|Progressive disease|0
1374504|NCT01469052|4536144|P1|Overall Study|Progressive disease|3
1374505|NCT01469052|4536139|P6|Overall Study|Adverse Event|1
1374506|NCT01469052|4536140|P5|Overall Study|Adverse Event|0
1374507|NCT01469052|4536141|P4|Overall Study|Adverse Event|2
1374508|NCT01469052|4536142|P3|Overall Study|Adverse Event|0
1374509|NCT01469052|4536143|P2|Overall Study|Adverse Event|3
1374510|NCT01469052|4536144|P1|Overall Study|Adverse Event|2
1374511|NCT01469000|4536206|P2|Overall Study|On treatment, not yet died or PD|7
1374512|NCT01469000|4536207|P1|Overall Study|On treatment, not yet died or PD|23
1374513|NCT01469000|4536206|P2|Overall Study|Entry Criteria Not Met|0
1374514|NCT01469000|4536207|P1|Overall Study|Entry Criteria Not Met|1
1374515|NCT01469000|4536206|P2|Overall Study|Physician Decision|1
1374516|NCT01469000|4536207|P1|Overall Study|Physician Decision|0
1374517|NCT01469000|4536206|P2|Overall Study|Withdrawal by Subject|1
1374518|NCT01469000|4536207|P1|Overall Study|Withdrawal by Subject|9
1374519|NCT01468987|4536223|P2|Overall Study|Sponsor Decision|0
1374520|NCT01468987|4536224|P1|Overall Study|Sponsor Decision|1
1374521|NCT01468987|4536223|P2|Overall Study|Physician Decision|15
1374522|NCT01468987|4536224|P1|Overall Study|Physician Decision|8
1374523|NCT01468987|4536223|P2|Overall Study|Withdrawal by Subject|28
1374524|NCT01468987|4536224|P1|Overall Study|Withdrawal by Subject|28
1374525|NCT01468987|4536223|P2|Overall Study|Protocol Violation|2
1374526|NCT01468987|4536224|P1|Overall Study|Protocol Violation|8
1374527|NCT01468987|4536223|P2|Overall Study|Lost to Follow-up|5
1374528|NCT01468987|4536224|P1|Overall Study|Lost to Follow-up|10
1374529|NCT01468987|4536223|P2|Overall Study|Death|1
1374530|NCT01468987|4536224|P1|Overall Study|Death|4
1374531|NCT01468987|4536223|P2|Overall Study|Adverse Event|9
1374532|NCT01468987|4536224|P1|Overall Study|Adverse Event|12
1374533|NCT01468818|4536287|P1|Overall Study|Death during treatment|2
1374534|NCT01468311|4536345|P1|Overall Study|Withdrawal by Subject|1
1374535|NCT01468311|4536345|P1|Overall Study|mobilization failure|1
1374536|NCT01468233|4536357|P6|Treatment Period 2|Not specified|0
1374537|NCT01468233|4536358|P5|Treatment Period 2|Not specified|1
1374538|NCT01468233|4536359|P4|Treatment Period 2|Not specified|0
1374539|NCT01468233|4536360|P3|Treatment Period 2|Not specified|3
1374540|NCT01468233|4536361|P2|Treatment Period 2|Not specified|0
1374541|NCT01468233|4536362|P1|Treatment Period 2|Not specified|0
1374542|NCT01468233|4536357|P6|Treatment Period 2|Lost to Follow-up|0
1374543|NCT01468233|4536358|P5|Treatment Period 2|Lost to Follow-up|2
1374544|NCT01468233|4536359|P4|Treatment Period 2|Lost to Follow-up|0
1374545|NCT01468233|4536360|P3|Treatment Period 2|Lost to Follow-up|3
1374546|NCT01468233|4536361|P2|Treatment Period 2|Lost to Follow-up|0
1374547|NCT01468233|4536362|P1|Treatment Period 2|Lost to Follow-up|0
1374548|NCT01468233|4536357|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
1374549|NCT01468233|4536358|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
1374550|NCT01468233|4536359|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
1374551|NCT01468233|4536360|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
1374552|NCT01468233|4536361|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
1374553|NCT01468233|4536362|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
1374554|NCT01468233|4536357|P6|Treatment Period 2|Withdrawal by Subject|1
1374555|NCT01468233|4536358|P5|Treatment Period 2|Withdrawal by Subject|1
1374556|NCT01468233|4536359|P4|Treatment Period 2|Withdrawal by Subject|1
1374557|NCT01468233|4536360|P3|Treatment Period 2|Withdrawal by Subject|9
1374558|NCT01468233|4536361|P2|Treatment Period 2|Withdrawal by Subject|0
1374559|NCT01468233|4536362|P1|Treatment Period 2|Withdrawal by Subject|0
1374560|NCT01468233|4536357|P6|Treatment Period 2|Lack of Efficacy|1
1374561|NCT01468233|4536358|P5|Treatment Period 2|Lack of Efficacy|0
1374562|NCT01468233|4536359|P4|Treatment Period 2|Lack of Efficacy|2
1374563|NCT01468233|4536360|P3|Treatment Period 2|Lack of Efficacy|9
1374564|NCT01468233|4536361|P2|Treatment Period 2|Lack of Efficacy|0
1374565|NCT01468233|4536362|P1|Treatment Period 2|Lack of Efficacy|0
1374566|NCT01468233|4536357|P6|Treatment Period 2|Adverse Event|1
1374567|NCT01468233|4536358|P5|Treatment Period 2|Adverse Event|2
1374568|NCT01468233|4536359|P4|Treatment Period 2|Adverse Event|0
1374569|NCT01468233|4536360|P3|Treatment Period 2|Adverse Event|3
1374570|NCT01468233|4536361|P2|Treatment Period 2|Adverse Event|0
1374571|NCT01468233|4536362|P1|Treatment Period 2|Adverse Event|0
1374572|NCT01468233|4536357|P6|Treatment Period 1|Not specified|0
1374573|NCT01468233|4536358|P5|Treatment Period 1|Not specified|0
1374574|NCT01468233|4536359|P4|Treatment Period 1|Not specified|0
1374575|NCT01468233|4536360|P3|Treatment Period 1|Not specified|0
1374576|NCT01468233|4536361|P2|Treatment Period 1|Not specified|1
1374577|NCT01468233|4536362|P1|Treatment Period 1|Not specified|1
1374578|NCT01468233|4536357|P6|Treatment Period 1|Lost to Follow-up|0
1374579|NCT01468233|4536358|P5|Treatment Period 1|Lost to Follow-up|0
1374580|NCT01468233|4536359|P4|Treatment Period 1|Lost to Follow-up|0
1374581|NCT01468233|4536360|P3|Treatment Period 1|Lost to Follow-up|0
1374582|NCT01468233|4536361|P2|Treatment Period 1|Lost to Follow-up|0
1374583|NCT01468233|4536362|P1|Treatment Period 1|Lost to Follow-up|3
1374584|NCT01468233|4536357|P6|Treatment Period 1|Withdrawal by Subject|0
1374585|NCT01468233|4536358|P5|Treatment Period 1|Withdrawal by Subject|0
1374586|NCT01468233|4536359|P4|Treatment Period 1|Withdrawal by Subject|0
1374587|NCT01468233|4536360|P3|Treatment Period 1|Withdrawal by Subject|0
1374588|NCT01468233|4536361|P2|Treatment Period 1|Withdrawal by Subject|4
1374589|NCT01468233|4536362|P1|Treatment Period 1|Withdrawal by Subject|3
1374590|NCT01468233|4536357|P6|Treatment Period 1|Adverse Event|0
1374591|NCT01468233|4536358|P5|Treatment Period 1|Adverse Event|0
1374592|NCT01468233|4536359|P4|Treatment Period 1|Adverse Event|0
1374593|NCT01468233|4536360|P3|Treatment Period 1|Adverse Event|0
1374594|NCT01468233|4536361|P2|Treatment Period 1|Adverse Event|3
1374595|NCT01468233|4536362|P1|Treatment Period 1|Adverse Event|5
1374596|NCT01468207|4536384|P6|Treatment Period 2|Not specified|2
1374597|NCT01468207|4536385|P5|Treatment Period 2|Not specified|1
1374598|NCT01468207|4536386|P4|Treatment Period 2|Not specified|1
1374599|NCT01468207|4536387|P3|Treatment Period 2|Not specified|5
1374600|NCT01468207|4536388|P2|Treatment Period 2|Not specified|0
1374601|NCT01468207|4536389|P1|Treatment Period 2|Not specified|0
1374602|NCT01468207|4536384|P6|Treatment Period 2|Lost to Follow-up|0
1374603|NCT01468207|4536385|P5|Treatment Period 2|Lost to Follow-up|0
1374604|NCT01468207|4536386|P4|Treatment Period 2|Lost to Follow-up|1
1374605|NCT01468207|4536387|P3|Treatment Period 2|Lost to Follow-up|5
1374606|NCT01468207|4536388|P2|Treatment Period 2|Lost to Follow-up|0
1374607|NCT01468207|4536389|P1|Treatment Period 2|Lost to Follow-up|0
1374608|NCT01468207|4536384|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
1374609|NCT01468207|4536385|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
1374610|NCT01468207|4536386|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
1374611|NCT01468207|4536387|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
1374612|NCT01468207|4536388|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
1374613|NCT01468207|4536389|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
1374614|NCT01468207|4536384|P6|Treatment Period 2|Withdrawal by Subject|2
1374615|NCT01468207|4536385|P5|Treatment Period 2|Withdrawal by Subject|0
1374616|NCT01468207|4536386|P4|Treatment Period 2|Withdrawal by Subject|0
1374617|NCT01468207|4536387|P3|Treatment Period 2|Withdrawal by Subject|5
1374618|NCT01468207|4536388|P2|Treatment Period 2|Withdrawal by Subject|0
1374619|NCT01468207|4536389|P1|Treatment Period 2|Withdrawal by Subject|0
1374620|NCT01468207|4536384|P6|Treatment Period 2|Lack of Efficacy|2
1374621|NCT01468207|4536385|P5|Treatment Period 2|Lack of Efficacy|0
1374622|NCT01468207|4536386|P4|Treatment Period 2|Lack of Efficacy|1
1374623|NCT01468207|4536387|P3|Treatment Period 2|Lack of Efficacy|1
1374624|NCT01468207|4536388|P2|Treatment Period 2|Lack of Efficacy|0
1374625|NCT01468207|4536389|P1|Treatment Period 2|Lack of Efficacy|0
1374626|NCT01468207|4536384|P6|Treatment Period 2|Adverse Event|1
1374627|NCT01468207|4536385|P5|Treatment Period 2|Adverse Event|2
1374628|NCT01468207|4536386|P4|Treatment Period 2|Adverse Event|1
1374629|NCT01468207|4536387|P3|Treatment Period 2|Adverse Event|6
1374630|NCT01468207|4536388|P2|Treatment Period 2|Adverse Event|0
1374631|NCT01468207|4536389|P1|Treatment Period 2|Adverse Event|0
1374632|NCT01468207|4536384|P6|Treatment Period 1|Not specified|0
1374633|NCT01468207|4536385|P5|Treatment Period 1|Not specified|0
1374634|NCT01468207|4536386|P4|Treatment Period 1|Not specified|0
1374635|NCT01468207|4536387|P3|Treatment Period 1|Not specified|0
1374636|NCT01468207|4536388|P2|Treatment Period 1|Not specified|2
1374637|NCT01468207|4536389|P1|Treatment Period 1|Not specified|0
1374638|NCT01468207|4536384|P6|Treatment Period 1|Lost to Follow-up|0
1374639|NCT01468207|4536385|P5|Treatment Period 1|Lost to Follow-up|0
1374640|NCT01468207|4536386|P4|Treatment Period 1|Lost to Follow-up|0
1374641|NCT01468207|4536387|P3|Treatment Period 1|Lost to Follow-up|0
1374642|NCT01468207|4536388|P2|Treatment Period 1|Lost to Follow-up|1
1374643|NCT01468207|4536389|P1|Treatment Period 1|Lost to Follow-up|2
1374644|NCT01468207|4536384|P6|Treatment Period 1|Withdrawal by Subject|0
1374645|NCT01468207|4536385|P5|Treatment Period 1|Withdrawal by Subject|0
1374646|NCT01468207|4536386|P4|Treatment Period 1|Withdrawal by Subject|0
1374647|NCT01468207|4536387|P3|Treatment Period 1|Withdrawal by Subject|0
1374648|NCT01468207|4536388|P2|Treatment Period 1|Withdrawal by Subject|4
1374649|NCT01468207|4536389|P1|Treatment Period 1|Withdrawal by Subject|5
1374650|NCT01468207|4536384|P6|Treatment Period 1|Protocol Violation|0
1374651|NCT01468207|4536385|P5|Treatment Period 1|Protocol Violation|0
1374652|NCT01468207|4536386|P4|Treatment Period 1|Protocol Violation|0
1374653|NCT01468207|4536387|P3|Treatment Period 1|Protocol Violation|0
1374654|NCT01468207|4536388|P2|Treatment Period 1|Protocol Violation|1
1374655|NCT01468207|4536389|P1|Treatment Period 1|Protocol Violation|1
1374656|NCT01468207|4536384|P6|Treatment Period 1|Adverse Event|0
1374657|NCT01468207|4536385|P5|Treatment Period 1|Adverse Event|0
1374658|NCT01468207|4536386|P4|Treatment Period 1|Adverse Event|0
1374659|NCT01468207|4536387|P3|Treatment Period 1|Adverse Event|0
1374660|NCT01468207|4536388|P2|Treatment Period 1|Adverse Event|0
1374661|NCT01468207|4536389|P1|Treatment Period 1|Adverse Event|1
1374662|NCT01468181|4536414|P5|Overall Study|Withdrawal by Subject|0
1374663|NCT01468181|4536415|P4|Overall Study|Withdrawal by Subject|0
1374664|NCT01468181|4536416|P3|Overall Study|Withdrawal by Subject|0
1374665|NCT01468181|4536417|P2|Overall Study|Withdrawal by Subject|1
1374666|NCT01468181|4536418|P1|Overall Study|Withdrawal by Subject|0
1374667|NCT01468181|4536414|P5|Overall Study|Lost to Follow-up|1
1374668|NCT01468181|4536415|P4|Overall Study|Lost to Follow-up|0
1374669|NCT01468181|4536416|P3|Overall Study|Lost to Follow-up|1
1374670|NCT01468181|4536417|P2|Overall Study|Lost to Follow-up|0
1374671|NCT01468181|4536418|P1|Overall Study|Lost to Follow-up|0
1374672|NCT01468181|4536414|P5|Overall Study|Physician Decision|1
1374673|NCT01468181|4536415|P4|Overall Study|Physician Decision|1
1374674|NCT01468181|4536416|P3|Overall Study|Physician Decision|0
1374675|NCT01468181|4536417|P2|Overall Study|Physician Decision|0
1374676|NCT01468181|4536418|P1|Overall Study|Physician Decision|0
1374677|NCT01468181|4536414|P5|Overall Study|Protocol Violation|1
1374678|NCT01468181|4536415|P4|Overall Study|Protocol Violation|0
1374679|NCT01468181|4536416|P3|Overall Study|Protocol Violation|1
1374680|NCT01468181|4536417|P2|Overall Study|Protocol Violation|0
1374681|NCT01468181|4536418|P1|Overall Study|Protocol Violation|2
1374682|NCT01468181|4536414|P5|Overall Study|Adverse Event|2
1374683|NCT01468181|4536415|P4|Overall Study|Adverse Event|2
1374684|NCT01468181|4536416|P3|Overall Study|Adverse Event|6
1374685|NCT01468181|4536417|P2|Overall Study|Adverse Event|1
1374686|NCT01468181|4536418|P1|Overall Study|Adverse Event|8
1374687|NCT01468077|4536467|P2|Overall Study|Physician Decision|0
1374688|NCT01468077|4536468|P1|Overall Study|Physician Decision|1
1374689|NCT01468077|4536467|P2|Overall Study|Lack of Efficacy|1
1374690|NCT01468077|4536468|P1|Overall Study|Lack of Efficacy|1
1374691|NCT01468077|4536467|P2|Overall Study|Adverse Event|2
1374692|NCT01468077|4536468|P1|Overall Study|Adverse Event|2
1374693|NCT01467960|4536526|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
1374694|NCT01467960|4536527|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
1374695|NCT01467960|4536528|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
1374696|NCT01467960|4536529|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
1374697|NCT01467960|4536530|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
1374698|NCT01467960|4536531|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
1374699|NCT01467713|4536590|P4|Overall Study|Reason not Specified|7
1374700|NCT01467713|4536591|P3|Overall Study|Reason not Specified|8
1374701|NCT01467713|4536592|P2|Overall Study|Reason not Specified|11
1374702|NCT01467713|4536593|P1|Overall Study|Reason not Specified|6
1374703|NCT01467713|4536590|P4|Overall Study|Relapse|35
1374704|NCT01467713|4536591|P3|Overall Study|Relapse|28
1374705|NCT01467713|4536592|P2|Overall Study|Relapse|25
1374706|NCT01467713|4536593|P1|Overall Study|Relapse|35
1374707|NCT01467713|4536590|P4|Overall Study|Pregnancy|3
1374708|NCT01467713|4536591|P3|Overall Study|Pregnancy|1
1374709|NCT01467713|4536592|P2|Overall Study|Pregnancy|1
1374710|NCT01467713|4536593|P1|Overall Study|Pregnancy|0
1374711|NCT01467713|4536590|P4|Overall Study|Study Termination|29
1374712|NCT01467713|4536591|P3|Overall Study|Study Termination|28
1374713|NCT01467713|4536592|P2|Overall Study|Study Termination|33
1374714|NCT01467713|4536593|P1|Overall Study|Study Termination|23
1374715|NCT01467713|4536590|P4|Overall Study|Voluntary Withdrawal|20
1374716|NCT01467713|4536591|P3|Overall Study|Voluntary Withdrawal|21
1374717|NCT01467713|4536592|P2|Overall Study|Voluntary Withdrawal|14
1374718|NCT01467713|4536593|P1|Overall Study|Voluntary Withdrawal|18
1374719|NCT01467713|4536590|P4|Overall Study|Lost to Follow-up|9
1374720|NCT01467713|4536591|P3|Overall Study|Lost to Follow-up|6
1374721|NCT01467713|4536592|P2|Overall Study|Lost to Follow-up|12
1374722|NCT01467713|4536593|P1|Overall Study|Lost to Follow-up|9
1374723|NCT01467713|4536590|P4|Overall Study|Major Protocol Deviation|1
1374724|NCT01467713|4536591|P3|Overall Study|Major Protocol Deviation|4
1374725|NCT01467713|4536592|P2|Overall Study|Major Protocol Deviation|4
1374726|NCT01467713|4536593|P1|Overall Study|Major Protocol Deviation|2
1374727|NCT01467713|4536590|P4|Overall Study|Pretreatment Event or Adverse Event|5
1374728|NCT01467713|4536591|P3|Overall Study|Pretreatment Event or Adverse Event|6
1374729|NCT01467713|4536592|P2|Overall Study|Pretreatment Event or Adverse Event|4
1374730|NCT01467713|4536593|P1|Overall Study|Pretreatment Event or Adverse Event|9
1374731|NCT01467700|4536647|P4|Overall Study|Reason not Specified|8
1374732|NCT01467700|4536648|P3|Overall Study|Reason not Specified|2
1374733|NCT01467700|4536649|P2|Overall Study|Reason not Specified|3
1374734|NCT01467700|4536650|P1|Overall Study|Reason not Specified|1
1374735|NCT01467700|4536647|P4|Overall Study|Lack of Efficacy|1
1374736|NCT01467700|4536648|P3|Overall Study|Lack of Efficacy|2
1374737|NCT01467700|4536649|P2|Overall Study|Lack of Efficacy|0
1374738|NCT01467700|4536650|P1|Overall Study|Lack of Efficacy|2
1374739|NCT01467700|4536647|P4|Overall Study|Pregnancy|0
1374740|NCT01467700|4536648|P3|Overall Study|Pregnancy|1
1374741|NCT01467700|4536649|P2|Overall Study|Pregnancy|1
1374742|NCT01467700|4536650|P1|Overall Study|Pregnancy|0
1374743|NCT01467700|4536647|P4|Overall Study|Study Termination|7
1374744|NCT01467700|4536648|P3|Overall Study|Study Termination|10
1374745|NCT01467700|4536649|P2|Overall Study|Study Termination|5
1374746|NCT01467700|4536650|P1|Overall Study|Study Termination|6
1374747|NCT01467700|4536647|P4|Overall Study|Voluntary Withdrawal|2
1374748|NCT01467700|4536648|P3|Overall Study|Voluntary Withdrawal|6
1374749|NCT01467700|4536649|P2|Overall Study|Voluntary Withdrawal|7
1374750|NCT01467700|4536650|P1|Overall Study|Voluntary Withdrawal|5
1374751|NCT01467700|4536647|P4|Overall Study|Lost to Follow-up|3
1374752|NCT01467700|4536648|P3|Overall Study|Lost to Follow-up|2
1374753|NCT01467700|4536649|P2|Overall Study|Lost to Follow-up|5
1374754|NCT01467700|4536650|P1|Overall Study|Lost to Follow-up|6
1374755|NCT01467700|4536647|P4|Overall Study|Major Protocol Deviation|3
1374756|NCT01467700|4536648|P3|Overall Study|Major Protocol Deviation|2
1374757|NCT01467700|4536649|P2|Overall Study|Major Protocol Deviation|3
1374758|NCT01467700|4536650|P1|Overall Study|Major Protocol Deviation|3
1374759|NCT01467700|4536647|P4|Overall Study|Pretreatment Event or Adverse Event|3
1374760|NCT01467700|4536648|P3|Overall Study|Pretreatment Event or Adverse Event|2
1374761|NCT01467700|4536649|P2|Overall Study|Pretreatment Event or Adverse Event|4
1374762|NCT01467700|4536650|P1|Overall Study|Pretreatment Event or Adverse Event|6
1374763|NCT01467661|4536692|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
1374764|NCT01467661|4536692|P1|Overall Study|Lack of Efficacy|3
1374765|NCT01467661|4536692|P1|Overall Study|Withdrawal by Subject|1
1374766|NCT01467661|4536692|P1|Overall Study|Adverse Event|16
1374767|NCT01467583|4536712|P3|Overall Study|Protocol Violation|2
1374768|NCT01467583|4536713|P2|Overall Study|Protocol Violation|0
1374769|NCT01467583|4536714|P1|Overall Study|Protocol Violation|0
1374770|NCT01467583|4536712|P3|Overall Study|Withdrawal by Subject|0
1374771|NCT01467583|4536713|P2|Overall Study|Withdrawal by Subject|0
1374772|NCT01467583|4536714|P1|Overall Study|Withdrawal by Subject|1
1374773|NCT01467583|4536712|P3|Overall Study|Death|0
1374774|NCT01467583|4536713|P2|Overall Study|Death|1
1374775|NCT01467583|4536714|P1|Overall Study|Death|1
1374776|NCT01467570|4536727|P2|Overall Study|Lost to Follow-up|9
1374777|NCT01467570|4536728|P1|Overall Study|Lost to Follow-up|8
1374778|NCT01467505|4536765|P2|Overall Study|Study Terminated by Sponsor|3
1374779|NCT01467505|4536766|P1|Overall Study|Study Terminated by Sponsor|28
1374780|NCT01467505|4536765|P2|Overall Study|Withdrawal by Subject|0
1374781|NCT01467505|4536766|P1|Overall Study|Withdrawal by Subject|4
1374782|NCT01467505|4536765|P2|Overall Study|Adverse Event|0
1374783|NCT01467505|4536766|P1|Overall Study|Adverse Event|1
1374784|NCT01467492|4536798|P2|Overall Study|Enrolled But Not Treated|0
1374785|NCT01467492|4536799|P1|Overall Study|Enrolled But Not Treated|1
1374786|NCT01467492|4536798|P2|Overall Study|Undefined|0
1374787|NCT01467492|4536799|P1|Overall Study|Undefined|2
1374788|NCT01467492|4536798|P2|Overall Study|Lost to Follow-up|2
1374789|NCT01467492|4536799|P1|Overall Study|Lost to Follow-up|3
1374790|NCT01467492|4536798|P2|Overall Study|Adverse Event|3
1374791|NCT01467492|4536799|P1|Overall Study|Adverse Event|4
1374792|NCT01467492|4536798|P2|Overall Study|Study Terminated by Sponsor|4
1374793|NCT01467492|4536799|P1|Overall Study|Study Terminated by Sponsor|6
1374794|NCT01467492|4536798|P2|Overall Study|Withdrawal by Subject|4
1374795|NCT01467492|4536799|P1|Overall Study|Withdrawal by Subject|6
1374796|NCT01467479|4536823|P3|Overall Study|Other|0
1374797|NCT01467479|4536824|P2|Overall Study|Other|0
1374798|NCT01467479|4536825|P1|Overall Study|Other|1
1374799|NCT01467479|4536823|P3|Overall Study|Study Terminated by Sponsor|3
1374800|NCT01467479|4536824|P2|Overall Study|Study Terminated by Sponsor|3
1374801|NCT01467479|4536825|P1|Overall Study|Study Terminated by Sponsor|1
1374802|NCT01467479|4536823|P3|Overall Study|Withdrawal of Consent|7
1374803|NCT01467479|4536824|P2|Overall Study|Withdrawal of Consent|7
1374804|NCT01467479|4536825|P1|Overall Study|Withdrawal of Consent|3
1374805|NCT01467479|4536823|P3|Overall Study|Lost to Follow-up|3
1374806|NCT01467479|4536824|P2|Overall Study|Lost to Follow-up|5
1374807|NCT01467479|4536825|P1|Overall Study|Lost to Follow-up|2
1374808|NCT01467479|4536823|P3|Overall Study|Death|1
1374809|NCT01467479|4536824|P2|Overall Study|Death|0
1374810|NCT01467479|4536825|P1|Overall Study|Death|0
1374811|NCT01467479|4536823|P3|Overall Study|Adverse Event|0
1374812|NCT01467479|4536824|P2|Overall Study|Adverse Event|2
1374813|NCT01467479|4536825|P1|Overall Study|Adverse Event|1
1374814|NCT01467479|4536823|P3|Overall Study|No Study Medication|2
1374815|NCT01467479|4536824|P2|Overall Study|No Study Medication|0
1374816|NCT01467479|4536825|P1|Overall Study|No Study Medication|1
1374817|NCT01467427|4536854|P2|Overall Study|Not continuing in extension phase|2
1374818|NCT01467427|4536855|P1|Overall Study|Not continuing in extension phase|0
1374819|NCT01467427|4536854|P2|Overall Study|Entered extension phase|11
1374820|NCT01467427|4536855|P1|Overall Study|Entered extension phase|11
1374821|NCT01467427|4536854|P2|Overall Study|Withdrawal by Subject|0
1374822|NCT01467427|4536855|P1|Overall Study|Withdrawal by Subject|1
1374823|NCT01467076|4536876|P3|Overall Study|Lost to Follow-up|0
1374824|NCT01467076|4536877|P2|Overall Study|Lost to Follow-up|0
1374825|NCT01467076|4536878|P1|Overall Study|Lost to Follow-up|1
1374826|NCT01466881|4536895|P1|Overall Study|Other reason not protocol specified|5
1374827|NCT01466881|4536895|P1|Overall Study|Death|4
1374828|NCT01466881|4536895|P1|Overall Study|Progression/relapse|20
1374829|NCT01466881|4536895|P1|Overall Study|Adverse Event|6
1374830|NCT01466881|4536895|P1|Overall Study|Ineligible|5
1374831|NCT01466790|4536912|P8|Overall Study|Withdrawal by Subject|1
1374832|NCT01466790|4536913|P7|Overall Study|Withdrawal by Subject|1
1374833|NCT01466790|4536914|P6|Overall Study|Withdrawal by Subject|0
1374834|NCT01466790|4536915|P5|Overall Study|Withdrawal by Subject|1
1374835|NCT01466790|4536916|P4|Overall Study|Withdrawal by Subject|0
1374836|NCT01466790|4536917|P3|Overall Study|Withdrawal by Subject|0
1374837|NCT01466790|4536918|P2|Overall Study|Withdrawal by Subject|1
1374838|NCT01466790|4536919|P1|Overall Study|Withdrawal by Subject|1
1374839|NCT01466790|4536912|P8|Overall Study|Lost to Follow-up|0
1374840|NCT01466790|4536913|P7|Overall Study|Lost to Follow-up|0
1374841|NCT01466790|4536914|P6|Overall Study|Lost to Follow-up|0
1374842|NCT01466790|4536915|P5|Overall Study|Lost to Follow-up|0
1374843|NCT01466790|4536916|P4|Overall Study|Lost to Follow-up|0
1374844|NCT01466790|4536917|P3|Overall Study|Lost to Follow-up|0
1374845|NCT01466790|4536918|P2|Overall Study|Lost to Follow-up|0
1374846|NCT01466790|4536919|P1|Overall Study|Lost to Follow-up|2
1374847|NCT01466790|4536912|P8|Overall Study|Adverse Event|0
1374848|NCT01466790|4536913|P7|Overall Study|Adverse Event|0
1374849|NCT01466790|4536914|P6|Overall Study|Adverse Event|0
1374850|NCT01466790|4536915|P5|Overall Study|Adverse Event|2
1374851|NCT01466790|4536916|P4|Overall Study|Adverse Event|0
1374852|NCT01466790|4536917|P3|Overall Study|Adverse Event|0
1374853|NCT01466790|4536918|P2|Overall Study|Adverse Event|0
1374854|NCT01466790|4536919|P1|Overall Study|Adverse Event|1
1374855|NCT01466673|4537004|P2|Overall Study|Adverse Event|1
1374856|NCT01466673|4537005|P1|Overall Study|Adverse Event|2
1374857|NCT01466673|4537004|P2|Overall Study|Lost to Follow-up|5
1374858|NCT01466673|4537005|P1|Overall Study|Lost to Follow-up|3
1374859|NCT01466673|4537004|P2|Overall Study|Non-compliance with study treatment|0
1374860|NCT01466673|4537005|P1|Overall Study|Non-compliance with study treatment|2
1374861|NCT01466660|4537031|P2|Overall Study|Other reason not defined above|6
1374862|NCT01466660|4537032|P1|Overall Study|Other reason not defined above|3
1374863|NCT01466660|4537031|P2|Overall Study|Refused continuation of trial medication|3
1374864|NCT01466660|4537032|P1|Overall Study|Refused continuation of trial medication|4
1374865|NCT01466660|4537031|P2|Overall Study|Protocol Violation|1
1374866|NCT01466660|4537032|P1|Overall Study|Protocol Violation|1
1374867|NCT01466660|4537031|P2|Overall Study|Other adverse event|17
1374868|NCT01466660|4537032|P1|Overall Study|Other adverse event|18
1374869|NCT01466660|4537031|P2|Overall Study|Worsening of underlying cancer disease|2
1374870|NCT01466660|4537032|P1|Overall Study|Worsening of underlying cancer disease|5
1374871|NCT01466660|4537031|P2|Overall Study|Progressive Disease (RECIST 1.1)|122
1374872|NCT01466660|4537032|P1|Overall Study|Progressive Disease (RECIST 1.1)|115
1374873|NCT01466595|4537058|P2|Overall Study|Withdrawal by Subject|1
1374874|NCT01466595|4537059|P1|Overall Study|Withdrawal by Subject|0
1374875|NCT01466491|4537153|P4|Overall Study|Missing Data|0
1374876|NCT01466491|4537154|P3|Overall Study|Missing Data|1
1374877|NCT01466491|4537155|P2|Overall Study|Missing Data|0
1374878|NCT01466491|4537156|P1|Overall Study|Missing Data|0
1374879|NCT01466491|4537153|P4|Overall Study|Protocol Violation|0
1374880|NCT01466491|4537154|P3|Overall Study|Protocol Violation|2
1374881|NCT01466491|4537155|P2|Overall Study|Protocol Violation|3
1374882|NCT01466491|4537156|P1|Overall Study|Protocol Violation|0
1374883|NCT01466387|4537176|P6|Overall Study|Protocol Violation|0
1374884|NCT01466387|4537177|P5|Overall Study|Protocol Violation|0
1374885|NCT01466387|4537178|P4|Overall Study|Protocol Violation|1
1374886|NCT01466387|4537179|P3|Overall Study|Protocol Violation|0
1374887|NCT01466387|4537180|P2|Overall Study|Protocol Violation|0
1374888|NCT01466387|4537181|P1|Overall Study|Protocol Violation|1
1374889|NCT01466387|4537176|P6|Overall Study|Lost to Follow-up|1
1374890|NCT01466387|4537177|P5|Overall Study|Lost to Follow-up|0
1374891|NCT01466387|4537178|P4|Overall Study|Lost to Follow-up|0
1374892|NCT01466387|4537179|P3|Overall Study|Lost to Follow-up|0
1374893|NCT01466387|4537180|P2|Overall Study|Lost to Follow-up|0
1374894|NCT01466387|4537181|P1|Overall Study|Lost to Follow-up|0
1374895|NCT01466387|4537176|P6|Overall Study|Adverse Event|0
1374896|NCT01466387|4537177|P5|Overall Study|Adverse Event|0
1374897|NCT01466387|4537178|P4|Overall Study|Adverse Event|1
1374898|NCT01466387|4537179|P3|Overall Study|Adverse Event|1
1374899|NCT01466387|4537180|P2|Overall Study|Adverse Event|0
1374900|NCT01466387|4537181|P1|Overall Study|Adverse Event|0
1374901|NCT01466348|4537242|P2|Period I - First Intervention|Withdrawal by Subject|1
1374902|NCT01466348|4537243|P1|Period I - First Intervention|Withdrawal by Subject|0
1374903|NCT01466270|4537271|P2|Overall Study|Multiple|1
1374904|NCT01466270|4537272|P1|Overall Study|Multiple|1
1374905|NCT01466270|4537271|P2|Overall Study|Toxicity|1
1374906|NCT01466270|4537272|P1|Overall Study|Toxicity|4
1374907|NCT01466270|4537271|P2|Overall Study|Progression|0
1374908|NCT01466270|4537272|P1|Overall Study|Progression|1
1374909|NCT01466270|4537271|P2|Overall Study|Lost to Follow-up|3
1374910|NCT01466270|4537272|P1|Overall Study|Lost to Follow-up|1
1374911|NCT01466270|4537271|P2|Overall Study|Physician Decision|0
1374912|NCT01466270|4537272|P1|Overall Study|Physician Decision|1
1374913|NCT01466270|4537271|P2|Overall Study|Withdrawal by Subject|1
1374914|NCT01466270|4537272|P1|Overall Study|Withdrawal by Subject|4
1374915|NCT01466192|4537284|P1|Overall Study|Withdrawal by Subject|3
1374916|NCT01466192|4537284|P1|Overall Study|Physician Decision|1
1374917|NCT01466179|4537288|P1|Overall Study|Other|3
1374918|NCT01466179|4537288|P1|Overall Study|Protocol Violation|2
1374919|NCT01466179|4537288|P1|Overall Study|Withdrawal by Subject|7
1374920|NCT01466179|4537288|P1|Overall Study|Death|7
1374921|NCT01466179|4537288|P1|Overall Study|Lack of Efficacy|14
1374922|NCT01466179|4537288|P1|Overall Study|Disease relapse|23
1374923|NCT01466179|4537288|P1|Overall Study|Adverse Event|32
1374924|NCT01466179|4537288|P1|Overall Study|Progressive disease|43
1374925|NCT01466179|4537288|P1|Overall Study|Physician Decision|46
1374926|NCT01466179|4537288|P1|Overall Study|Ongoing in core study|2
1374927|NCT01466153|4537311|P3|Overall Study|Other-Unspecified|2
1374928|NCT01466153|4537312|P2|Overall Study|Other-Unspecified|4
1374929|NCT01466153|4537313|P1|Overall Study|Other-Unspecified|6
1374930|NCT01466153|4537311|P3|Overall Study|Randomized-Not Treated|4
1374931|NCT01466153|4537312|P2|Overall Study|Randomized-Not Treated|3
1374932|NCT01466153|4537313|P1|Overall Study|Randomized-Not Treated|2
1374933|NCT01466153|4537311|P3|Overall Study|Investigator Discretion|2
1374934|NCT01466153|4537312|P2|Overall Study|Investigator Discretion|2
1374935|NCT01466153|4537313|P1|Overall Study|Investigator Discretion|3
1374936|NCT01466153|4537311|P3|Overall Study|Withdrawal of Consent|0
1374937|NCT01466153|4537312|P2|Overall Study|Withdrawal of Consent|0
1374938|NCT01466153|4537313|P1|Overall Study|Withdrawal of Consent|2
1374939|NCT01466153|4537311|P3|Overall Study|Adverse Event|17
1374940|NCT01466153|4537312|P2|Overall Study|Adverse Event|13
1374941|NCT01466153|4537313|P1|Overall Study|Adverse Event|14
1374942|NCT01466153|4537311|P3|Overall Study|Disease Progression|0
1374943|NCT01466153|4537312|P2|Overall Study|Disease Progression|2
1374944|NCT01466153|4537313|P1|Overall Study|Disease Progression|2
1374945|NCT01466062|4537368|P1|Overall Study|Withdrawal by Subject|1
1374946|NCT01466062|4537368|P1|Overall Study|Adverse Event|1
1374947|NCT01465997|4537391|P2|Overall Study|subject left participation SP0993|1
1374948|NCT01465997|4537392|P1|Overall Study|subject left participation SP0993|0
1374949|NCT01465997|4537391|P2|Overall Study|decision by site staff|1
1374950|NCT01465997|4537392|P1|Overall Study|decision by site staff|0
1374951|NCT01465997|4537391|P2|Overall Study|withdrew before follow-up|13
1374952|NCT01465997|4537392|P1|Overall Study|withdrew before follow-up|0
1374953|NCT01465997|4537391|P2|Overall Study|local lab unblinded site|0
1374954|NCT01465997|4537392|P1|Overall Study|local lab unblinded site|1
1374955|NCT01465997|4537391|P2|Overall Study|subject withdrew consent|0
1374956|NCT01465997|4537392|P1|Overall Study|subject withdrew consent|1
1374957|NCT01465997|4537391|P2|Overall Study|sponsor's decision|1
1374958|NCT01465997|4537392|P1|Overall Study|sponsor's decision|1
1374959|NCT01465997|4537391|P2|Overall Study|Death|1
1374960|NCT01465997|4537392|P1|Overall Study|Death|0
1374961|NCT01465997|4537391|P2|Overall Study|investigator's decision|1
1374962|NCT01465997|4537392|P1|Overall Study|investigator's decision|1
1374963|NCT01465997|4537391|P2|Overall Study|Withdrawal by Subject|35
1374964|NCT01465997|4537392|P1|Overall Study|Withdrawal by Subject|32
1374965|NCT01465997|4537391|P2|Overall Study|Lost to Follow-up|9
1374966|NCT01465997|4537392|P1|Overall Study|Lost to Follow-up|6
1374967|NCT01465997|4537391|P2|Overall Study|Protocol Violation|4
1374968|NCT01465997|4537392|P1|Overall Study|Protocol Violation|1
1374969|NCT01465997|4537391|P2|Overall Study|Lack of Efficacy|1
1374970|NCT01465997|4537392|P1|Overall Study|Lack of Efficacy|13
1374971|NCT01465997|4537391|P2|Overall Study|Adverse Event|22
1374972|NCT01465997|4537392|P1|Overall Study|Adverse Event|12
1374973|NCT01465958|4537402|P2|Subcutaneous (SC) Phase|Adverse Event|1
1374974|NCT01465958|4537403|P1|Subcutaneous (SC) Phase|Adverse Event|0
1374975|NCT01465958|4537402|P2|Run-in Phase|Protocol Violation|0
1374976|NCT01465958|4537403|P1|Run-in Phase|Protocol Violation|1
1374977|NCT01465802|4537416|P5|Overall Study|Death|2
1374978|NCT01465802|4537417|P4|Overall Study|Death|10
1374979|NCT01465802|4537418|P3|Overall Study|Death|0
1374980|NCT01465802|4537419|P2|Overall Study|Death|12
1374981|NCT01465802|4537420|P1|Overall Study|Death|15
1374982|NCT01465802|4537416|P5|Overall Study|Reason not specified|2
1374983|NCT01465802|4537417|P4|Overall Study|Reason not specified|10
1374984|NCT01465802|4537418|P3|Overall Study|Reason not specified|0
1374985|NCT01465802|4537419|P2|Overall Study|Reason not specified|4
1374986|NCT01465802|4537420|P1|Overall Study|Reason not specified|9
1374987|NCT01465802|4537416|P5|Overall Study|Lost to Follow-up|0
1374988|NCT01465802|4537417|P4|Overall Study|Lost to Follow-up|0
1374989|NCT01465802|4537418|P3|Overall Study|Lost to Follow-up|0
1374990|NCT01465802|4537419|P2|Overall Study|Lost to Follow-up|1
1374991|NCT01465802|4537420|P1|Overall Study|Lost to Follow-up|1
1374992|NCT01465802|4537416|P5|Overall Study|Withdrawal by Subject|1
1374993|NCT01465802|4537417|P4|Overall Study|Withdrawal by Subject|8
1374994|NCT01465802|4537418|P3|Overall Study|Withdrawal by Subject|0
1374995|NCT01465802|4537419|P2|Overall Study|Withdrawal by Subject|7
1374996|NCT01465802|4537420|P1|Overall Study|Withdrawal by Subject|7
1374997|NCT01465802|4537416|P5|Overall Study|Study terminated by sponsor|7
1374998|NCT01465802|4537417|P4|Overall Study|Study terminated by sponsor|1
1374999|NCT01465802|4537418|P3|Overall Study|Study terminated by sponsor|0
1375000|NCT01465802|4537419|P2|Overall Study|Study terminated by sponsor|0
1375001|NCT01465802|4537420|P1|Overall Study|Study terminated by sponsor|1
1375002|NCT01465763|4537472|P3|Overall Study|Death|0
1375003|NCT01465763|4537473|P2|Overall Study|Death|0
1375004|NCT01465763|4537474|P1|Overall Study|Death|1
1375005|NCT01465763|4537472|P3|Overall Study|Protocol Violation|1
1375006|NCT01465763|4537473|P2|Overall Study|Protocol Violation|1
1375007|NCT01465763|4537474|P1|Overall Study|Protocol Violation|4
1375008|NCT01465763|4537472|P3|Overall Study|Other|0
1375009|NCT01465763|4537473|P2|Overall Study|Other|0
1375010|NCT01465763|4537474|P1|Overall Study|Other|2
1375011|NCT01465763|4537472|P3|Overall Study|Adverse Event|1
1375012|NCT01465763|4537473|P2|Overall Study|Adverse Event|0
1375013|NCT01465763|4537474|P1|Overall Study|Adverse Event|9
1375014|NCT01465763|4537472|P3|Overall Study|Insufficient Clinical Response|1
1375015|NCT01465763|4537473|P2|Overall Study|Insufficient Clinical Response|0
1375016|NCT01465763|4537474|P1|Overall Study|Insufficient Clinical Response|11
1375017|NCT01465763|4537472|P3|Overall Study|Withdrawal by Subject|1
1375018|NCT01465763|4537473|P2|Overall Study|Withdrawal by Subject|0
1375019|NCT01465763|4537474|P1|Overall Study|Withdrawal by Subject|4
1375020|NCT01465386|4537544|P1|Overall Study|Adverse Event|1
1375021|NCT01465386|4537544|P1|Overall Study|Lack of Efficacy|3
1375022|NCT01465347|4537548|P2|Overall Study|Admitted to hospice|1
1375023|NCT01465347|4537549|P1|Overall Study|Admitted to hospice|0
1375024|NCT01465347|4537548|P2|Overall Study|Physician Decision|1
1375025|NCT01465347|4537549|P1|Overall Study|Physician Decision|0
1375026|NCT01465347|4537548|P2|Overall Study|Withdrawal by Subject|1
1375027|NCT01465347|4537549|P1|Overall Study|Withdrawal by Subject|1
1375028|NCT01465230|4537559|P1|Overall Study|Withdrawal by Subject|2
1375029|NCT01465178|4537565|P2|Overall Study|Withdrawal by Subject|0
1375030|NCT01465178|4537566|P1|Overall Study|Withdrawal by Subject|1
1375031|NCT01465022|4537590|P3|Overall Study|Not Randomized|70
1375032|NCT01465022|4537591|P2|Overall Study|Not Randomized|0
1375033|NCT01465022|4537592|P1|Overall Study|Not Randomized|0
1375034|NCT01465022|4537590|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
1375035|NCT01465022|4537591|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
1375036|NCT01465022|4537592|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
1375037|NCT01465022|4537590|P3|Overall Study|Lost to Follow-up|0
1375038|NCT01465022|4537591|P2|Overall Study|Lost to Follow-up|14
1375039|NCT01465022|4537592|P1|Overall Study|Lost to Follow-up|15
1375040|NCT01464931|4537626|P2|Overall Study|Withdrawal by Subject|0
1375041|NCT01464931|4537627|P1|Overall Study|Withdrawal by Subject|1
1375042|NCT01464879|4537664|P1|Overall Study|Non-compliance|1
1375043|NCT01464879|4537664|P1|Overall Study|Physician Decision|1
1375044|NCT01464827|4537725|P14|Overall Study|Not Treated|2
1375045|NCT01464827|4537726|P13|Overall Study|Not Treated|0
1375046|NCT01464827|4537727|P12|Overall Study|Not Treated|1
1375047|NCT01464827|4537728|P11|Overall Study|Not Treated|0
1375048|NCT01464827|4537729|P10|Overall Study|Not Treated|2
1375049|NCT01464827|4537730|P9|Overall Study|Not Treated|0
1375050|NCT01464827|4537731|P8|Overall Study|Not Treated|0
1375051|NCT01464827|4537732|P7|Overall Study|Not Treated|1
1375052|NCT01464827|4537733|P6|Overall Study|Not Treated|0
1375053|NCT01464827|4537734|P5|Overall Study|Not Treated|1
1375054|NCT01464827|4537735|P4|Overall Study|Not Treated|0
1375055|NCT01464827|4537736|P3|Overall Study|Not Treated|0
1375056|NCT01464827|4537737|P2|Overall Study|Not Treated|2
1375057|NCT01464827|4537738|P1|Overall Study|Not Treated|0
1375058|NCT01464827|4537725|P14|Overall Study|Other|0
1375059|NCT01464827|4537726|P13|Overall Study|Other|1
1375060|NCT01464827|4537727|P12|Overall Study|Other|0
1375061|NCT01464827|4537728|P11|Overall Study|Other|2
1375062|NCT01464827|4537729|P10|Overall Study|Other|1
1375063|NCT01464827|4537730|P9|Overall Study|Other|3
1375064|NCT01464827|4537731|P8|Overall Study|Other|0
1375065|NCT01464827|4537732|P7|Overall Study|Other|1
1375066|NCT01464827|4537733|P6|Overall Study|Other|0
1375067|NCT01464827|4537734|P5|Overall Study|Other|3
1375068|NCT01464827|4537735|P4|Overall Study|Other|2
1375069|NCT01464827|4537736|P3|Overall Study|Other|0
1375070|NCT01464827|4537737|P2|Overall Study|Other|3
1375071|NCT01464827|4537738|P1|Overall Study|Other|2
1375072|NCT01464827|4537725|P14|Overall Study|Lost to Follow-up|1
1375073|NCT01464827|4537726|P13|Overall Study|Lost to Follow-up|0
1375074|NCT01464827|4537727|P12|Overall Study|Lost to Follow-up|1
1375075|NCT01464827|4537728|P11|Overall Study|Lost to Follow-up|0
1375076|NCT01464827|4537729|P10|Overall Study|Lost to Follow-up|0
1375077|NCT01464827|4537730|P9|Overall Study|Lost to Follow-up|0
1375078|NCT01464827|4537731|P8|Overall Study|Lost to Follow-up|2
1375079|NCT01464827|4537732|P7|Overall Study|Lost to Follow-up|2
1375080|NCT01464827|4537733|P6|Overall Study|Lost to Follow-up|1
1375081|NCT01464827|4537734|P5|Overall Study|Lost to Follow-up|3
1375082|NCT01464827|4537735|P4|Overall Study|Lost to Follow-up|2
1375083|NCT01464827|4537736|P3|Overall Study|Lost to Follow-up|0
1375084|NCT01464827|4537737|P2|Overall Study|Lost to Follow-up|2
1375085|NCT01464827|4537738|P1|Overall Study|Lost to Follow-up|0
1375086|NCT01464827|4537725|P14|Overall Study|Withdrawal by Subject|0
1375087|NCT01464827|4537726|P13|Overall Study|Withdrawal by Subject|0
1375088|NCT01464827|4537727|P12|Overall Study|Withdrawal by Subject|0
1375089|NCT01464827|4537728|P11|Overall Study|Withdrawal by Subject|0
1375090|NCT01464827|4537729|P10|Overall Study|Withdrawal by Subject|0
1375091|NCT01464827|4537730|P9|Overall Study|Withdrawal by Subject|0
1375092|NCT01464827|4537731|P8|Overall Study|Withdrawal by Subject|1
1375093|NCT01464827|4537732|P7|Overall Study|Withdrawal by Subject|0
1375094|NCT01464827|4537733|P6|Overall Study|Withdrawal by Subject|0
1375095|NCT01464827|4537734|P5|Overall Study|Withdrawal by Subject|1
1375096|NCT01464827|4537735|P4|Overall Study|Withdrawal by Subject|0
1375097|NCT01464827|4537736|P3|Overall Study|Withdrawal by Subject|0
1375098|NCT01464827|4537737|P2|Overall Study|Withdrawal by Subject|0
1375099|NCT01464827|4537738|P1|Overall Study|Withdrawal by Subject|1
1375100|NCT01464827|4537725|P14|Overall Study|Adverse Event|0
1375101|NCT01464827|4537726|P13|Overall Study|Adverse Event|1
1375102|NCT01464827|4537727|P12|Overall Study|Adverse Event|0
1375103|NCT01464827|4537728|P11|Overall Study|Adverse Event|0
1375104|NCT01464827|4537729|P10|Overall Study|Adverse Event|0
1375105|NCT01464827|4537730|P9|Overall Study|Adverse Event|0
1375106|NCT01464827|4537731|P8|Overall Study|Adverse Event|0
1375107|NCT01464827|4537732|P7|Overall Study|Adverse Event|0
1375108|NCT01464827|4537733|P6|Overall Study|Adverse Event|0
1375109|NCT01464827|4537734|P5|Overall Study|Adverse Event|0
1375110|NCT01464827|4537735|P4|Overall Study|Adverse Event|0
1375111|NCT01464827|4537736|P3|Overall Study|Adverse Event|0
1375112|NCT01464827|4537737|P2|Overall Study|Adverse Event|0
1375113|NCT01464827|4537738|P1|Overall Study|Adverse Event|0
1375114|NCT01464788|4537785|P3|Overall Study|Patient had hemorrhage after tPA started|0
1375115|NCT01464788|4537786|P2|Overall Study|Patient had hemorrhage after tPA started|1
1375116|NCT01464788|4537787|P1|Overall Study|Patient had hemorrhage after tPA started|0
1375117|NCT01464788|4537785|P3|Overall Study|Lost to Follow-up|0
1375118|NCT01464788|4537786|P2|Overall Study|Lost to Follow-up|1
1375119|NCT01464788|4537787|P1|Overall Study|Lost to Follow-up|0
1375120|NCT01464619|4537800|P2|Overall Study|Lost to Follow-up|4
1375121|NCT01464619|4537801|P1|Overall Study|Lost to Follow-up|3
1375122|NCT01464424|4537821|P2|Period 1, First 6 Weeks|Adverse Event|1
1375123|NCT01464424|4537822|P1|Period 1, First 6 Weeks|Adverse Event|0
1375124|NCT01464346|4537842|P3|Overall Study|Withdrawal by Subject|1
1375125|NCT01464346|4537843|P2|Overall Study|Withdrawal by Subject|0
1375126|NCT01464346|4537844|P1|Overall Study|Withdrawal by Subject|0
1375127|NCT01464307|4537855|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
1375128|NCT01464307|4537856|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
1375129|NCT01464307|4537855|P2|Open-Label Extension Period|Non-compliance|0
1375130|NCT01464307|4537856|P1|Open-Label Extension Period|Non-compliance|9
1375131|NCT01464307|4537855|P2|Open-Label Extension Period|Lost to Follow-up|0
1375132|NCT01464307|4537856|P1|Open-Label Extension Period|Lost to Follow-up|1
1375133|NCT01464307|4537855|P2|Open-Label Extension Period|Death|0
1375134|NCT01464307|4537856|P1|Open-Label Extension Period|Death|1
1375135|NCT01464307|4537855|P2|Open-Label Extension Period|Lack of Efficacy|0
1375136|NCT01464307|4537856|P1|Open-Label Extension Period|Lack of Efficacy|5
1375137|NCT01464307|4537855|P2|Open-Label Extension Period|Withdrawal by Subject|0
1375138|NCT01464307|4537856|P1|Open-Label Extension Period|Withdrawal by Subject|14
1375139|NCT01464307|4537855|P2|Open-Label Extension Period|Adverse Event|0
1375140|NCT01464307|4537856|P1|Open-Label Extension Period|Adverse Event|15
1375141|NCT01464307|4537855|P2|Main Period|Predefined discontinuation criteria|1
1375142|NCT01464307|4537856|P1|Main Period|Predefined discontinuation criteria|2
1375143|NCT01464307|4537855|P2|Main Period|Withdrawal by Subject|2
1375144|NCT01464307|4537856|P1|Main Period|Withdrawal by Subject|5
1375145|NCT01464307|4537855|P2|Main Period|Lack of Efficacy|0
1375146|NCT01464307|4537856|P1|Main Period|Lack of Efficacy|2
1375147|NCT01464307|4537855|P2|Main Period|Adverse Event|1
1375148|NCT01464307|4537856|P1|Main Period|Adverse Event|6
1375149|NCT01464307|4537855|P2|Main Period|Death|1
1375150|NCT01464307|4537856|P1|Main Period|Death|0
1375151|NCT01464255|4537871|P2|Overall Study|unresolve corneal staining|1
1375152|NCT01464255|4537872|P1|Overall Study|unresolve corneal staining|0
1375153|NCT01464021|4537917|P1|Overall Study|various|11
1375154|NCT01464021|4537917|P1|Overall Study|Lack of Efficacy|1
1375155|NCT01464021|4537917|P1|Overall Study|Lost to Follow-up|1
1375156|NCT01464021|4537917|P1|Overall Study|Withdrawal by Subject|13
1375157|NCT01463982|4537933|P4|Overall Study|Treatment delay over 5 week|0
1375158|NCT01463982|4537934|P3|Overall Study|Treatment delay over 5 week|1
1375159|NCT01463982|4537935|P2|Overall Study|Treatment delay over 5 week|0
1375160|NCT01463982|4537936|P1|Overall Study|Treatment delay over 5 week|0
1375161|NCT01463982|4537933|P4|Overall Study|Withdrawal by Subject|0
1375162|NCT01463982|4537934|P3|Overall Study|Withdrawal by Subject|1
1375163|NCT01463982|4537935|P2|Overall Study|Withdrawal by Subject|1
1375164|NCT01463982|4537936|P1|Overall Study|Withdrawal by Subject|0
1375165|NCT01463878|4537952|P2|Overall Study|no longer met criteria for tube feed|2
1375166|NCT01463878|4537953|P1|Overall Study|no longer met criteria for tube feed|2
1375167|NCT01463696|4537967|P8|Overall Study|Not Treated|0
1375168|NCT01463696|4537968|P7|Overall Study|Not Treated|1
1375169|NCT01463696|4537969|P6|Overall Study|Not Treated|0
1375170|NCT01463696|4537970|P5|Overall Study|Not Treated|0
1375171|NCT01463696|4537971|P4|Overall Study|Not Treated|0
1375172|NCT01463696|4537972|P3|Overall Study|Not Treated|0
1375173|NCT01463696|4537973|P2|Overall Study|Not Treated|0
1375174|NCT01463696|4537974|P1|Overall Study|Not Treated|0
1375175|NCT01463696|4537967|P8|Overall Study|Withdrawal by Subject|0
1375176|NCT01463696|4537968|P7|Overall Study|Withdrawal by Subject|2
1375177|NCT01463696|4537969|P6|Overall Study|Withdrawal by Subject|1
1375178|NCT01463696|4537970|P5|Overall Study|Withdrawal by Subject|1
1375179|NCT01463696|4537971|P4|Overall Study|Withdrawal by Subject|1
1375180|NCT01463696|4537972|P3|Overall Study|Withdrawal by Subject|0
1375181|NCT01463696|4537973|P2|Overall Study|Withdrawal by Subject|0
1375182|NCT01463696|4537974|P1|Overall Study|Withdrawal by Subject|0
1375183|NCT01463696|4537967|P8|Overall Study|Progressive Disease|2
1375184|NCT01463696|4537968|P7|Overall Study|Progressive Disease|4
1375185|NCT01463696|4537969|P6|Overall Study|Progressive Disease|1
1375186|NCT01463696|4537970|P5|Overall Study|Progressive Disease|0
1375187|NCT01463696|4537971|P4|Overall Study|Progressive Disease|1
1375188|NCT01463696|4537972|P3|Overall Study|Progressive Disease|0
1375189|NCT01463696|4537973|P2|Overall Study|Progressive Disease|1
1375190|NCT01463696|4537974|P1|Overall Study|Progressive Disease|0
1375191|NCT01463696|4537967|P8|Overall Study|Lost to Follow-up|0
1375192|NCT01463696|4537968|P7|Overall Study|Lost to Follow-up|0
1375193|NCT01463696|4537969|P6|Overall Study|Lost to Follow-up|0
1375194|NCT01463696|4537970|P5|Overall Study|Lost to Follow-up|0
1375195|NCT01463696|4537971|P4|Overall Study|Lost to Follow-up|0
1375196|NCT01463696|4537972|P3|Overall Study|Lost to Follow-up|1
1375197|NCT01463696|4537973|P2|Overall Study|Lost to Follow-up|0
1375198|NCT01463696|4537974|P1|Overall Study|Lost to Follow-up|0
1375199|NCT01463696|4537967|P8|Overall Study|Adverse Event|2
1375200|NCT01463696|4537968|P7|Overall Study|Adverse Event|3
1375201|NCT01463696|4537969|P6|Overall Study|Adverse Event|1
1375202|NCT01463696|4537970|P5|Overall Study|Adverse Event|0
1375203|NCT01463696|4537971|P4|Overall Study|Adverse Event|2
1375204|NCT01463696|4537972|P3|Overall Study|Adverse Event|0
1375205|NCT01463696|4537973|P2|Overall Study|Adverse Event|1
1375206|NCT01463696|4537974|P1|Overall Study|Adverse Event|0
1375207|NCT01463683|4538027|P3|Overall Study|Withdrawal by Subject|2
1375208|NCT01463683|4538028|P2|Overall Study|Withdrawal by Subject|17
1375209|NCT01463683|4538029|P1|Overall Study|Withdrawal by Subject|5
1375210|NCT01463683|4538027|P3|Overall Study|Pregnancy|1
1375211|NCT01463683|4538028|P2|Overall Study|Pregnancy|2
1375212|NCT01463683|4538029|P1|Overall Study|Pregnancy|2
1375213|NCT01463683|4538027|P3|Overall Study|Physician Decision|1
1375214|NCT01463683|4538028|P2|Overall Study|Physician Decision|3
1375215|NCT01463683|4538029|P1|Overall Study|Physician Decision|0
1375216|NCT01463683|4538027|P3|Overall Study|Lost to Follow-up|7
1375217|NCT01463683|4538028|P2|Overall Study|Lost to Follow-up|9
1375218|NCT01463683|4538029|P1|Overall Study|Lost to Follow-up|10
1375219|NCT01463683|4538027|P3|Overall Study|Adverse Event|0
1375220|NCT01463683|4538028|P2|Overall Study|Adverse Event|0
1375221|NCT01463683|4538029|P1|Overall Study|Adverse Event|2
1375222|NCT01463631|4538046|P4|Overall Study|Progressive Disease|5
1375223|NCT01463631|4538047|P3|Overall Study|Progressive Disease|0
1375224|NCT01463631|4538048|P2|Overall Study|Progressive Disease|0
1375225|NCT01463631|4538049|P1|Overall Study|Progressive Disease|0
1375226|NCT01463631|4538046|P4|Overall Study|Death|0
1375227|NCT01463631|4538047|P3|Overall Study|Death|1
1375228|NCT01463631|4538048|P2|Overall Study|Death|0
1375229|NCT01463631|4538049|P1|Overall Study|Death|0
1375230|NCT01463631|4538046|P4|Overall Study|Withdrawal by Subject|1
1375231|NCT01463631|4538047|P3|Overall Study|Withdrawal by Subject|0
1375232|NCT01463631|4538048|P2|Overall Study|Withdrawal by Subject|0
1375233|NCT01463631|4538049|P1|Overall Study|Withdrawal by Subject|0
1375234|NCT01463527|4538071|P2|Overall Study|Crying >20% of sedation|6
1375235|NCT01463527|4538072|P1|Overall Study|Crying >20% of sedation|5
1375236|NCT01463527|4538071|P2|Overall Study|Protocol Violation|1
1375237|NCT01463527|4538072|P1|Overall Study|Protocol Violation|1
1375238|NCT01463293|4538095|P3|Overall Study|Other|2
1375239|NCT01463293|4538096|P2|Overall Study|Other|0
1375240|NCT01463293|4538097|P1|Overall Study|Other|0
1375241|NCT01463293|4538095|P3|Overall Study|Withdrawal by Subject|5
1375242|NCT01463293|4538096|P2|Overall Study|Withdrawal by Subject|10
1375243|NCT01463293|4538097|P1|Overall Study|Withdrawal by Subject|4
1375244|NCT01463293|4538095|P3|Overall Study|Adverse Event|0
1375245|NCT01463293|4538096|P2|Overall Study|Adverse Event|2
1375246|NCT01463293|4538097|P1|Overall Study|Adverse Event|1
1375247|NCT01463293|4538095|P3|Overall Study|Lost to Follow-up|5
1375248|NCT01463293|4538096|P2|Overall Study|Lost to Follow-up|4
1375249|NCT01463293|4538097|P1|Overall Study|Lost to Follow-up|1
1375250|NCT01463111|4538120|P1|Overall Study|Physician Decision|2
1375251|NCT01463111|4538120|P1|Overall Study|Lost to Follow-up|5
1375252|NCT01463111|4538120|P1|Overall Study|Withdrawal by Subject|2
1375253|NCT01463033|4538130|P2|Overall Study|Death|2
1375254|NCT01463033|4538131|P1|Overall Study|Death|3
1375255|NCT01463033|4538130|P2|Overall Study|Lost to Follow-up|4
1375256|NCT01463033|4538131|P1|Overall Study|Lost to Follow-up|4
1375257|NCT01463007|4538138|P1|Overall Study|Physician Decision|1
1375258|NCT01462942|4538149|P5|Overall Study|Protocol Violation|6
1375259|NCT01462942|4538150|P4|Overall Study|Protocol Violation|9
1375260|NCT01462942|4538151|P3|Overall Study|Protocol Violation|9
1375261|NCT01462942|4538152|P2|Overall Study|Protocol Violation|6
1375262|NCT01462942|4538153|P1|Overall Study|Protocol Violation|4
1375263|NCT01462942|4538149|P5|Overall Study|Lost to Follow-up|1
1375264|NCT01462942|4538150|P4|Overall Study|Lost to Follow-up|1
1375265|NCT01462942|4538151|P3|Overall Study|Lost to Follow-up|1
1375266|NCT01462942|4538152|P2|Overall Study|Lost to Follow-up|1
1375267|NCT01462942|4538153|P1|Overall Study|Lost to Follow-up|0
1375268|NCT01462942|4538149|P5|Overall Study|Lack of Efficacy|3
1375269|NCT01462942|4538150|P4|Overall Study|Lack of Efficacy|5
1375270|NCT01462942|4538151|P3|Overall Study|Lack of Efficacy|4
1375271|NCT01462942|4538152|P2|Overall Study|Lack of Efficacy|0
1375272|NCT01462942|4538153|P1|Overall Study|Lack of Efficacy|6
1375273|NCT01462942|4538149|P5|Overall Study|Withdrawal by Subject|19
1375274|NCT01462942|4538150|P4|Overall Study|Withdrawal by Subject|16
1375275|NCT01462942|4538151|P3|Overall Study|Withdrawal by Subject|14
1375276|NCT01462942|4538152|P2|Overall Study|Withdrawal by Subject|10
1375277|NCT01462942|4538153|P1|Overall Study|Withdrawal by Subject|14
1375278|NCT01462942|4538149|P5|Overall Study|Other, including COPD exacerbation|5
1375279|NCT01462942|4538150|P4|Overall Study|Other, including COPD exacerbation|8
1375280|NCT01462942|4538151|P3|Overall Study|Other, including COPD exacerbation|2
1375281|NCT01462942|4538152|P2|Overall Study|Other, including COPD exacerbation|5
1375282|NCT01462942|4538153|P1|Overall Study|Other, including COPD exacerbation|3
1375283|NCT01462942|4538149|P5|Overall Study|Adverse Event|11
1375284|NCT01462942|4538150|P4|Overall Study|Adverse Event|11
1375285|NCT01462942|4538151|P3|Overall Study|Adverse Event|10
1375286|NCT01462942|4538152|P2|Overall Study|Adverse Event|12
1375287|NCT01462942|4538153|P1|Overall Study|Adverse Event|7
1375288|NCT01462929|4538183|P3|Overall Study|Lack of Efficacy|1
1375289|NCT01462929|4538184|P2|Overall Study|Lack of Efficacy|0
1375290|NCT01462929|4538185|P1|Overall Study|Lack of Efficacy|0
1375291|NCT01462929|4538183|P3|Overall Study|Withdrawal by Subject|0
1375292|NCT01462929|4538184|P2|Overall Study|Withdrawal by Subject|1
1375293|NCT01462929|4538185|P1|Overall Study|Withdrawal by Subject|2
1375294|NCT01462929|4538183|P3|Overall Study|Adverse Event|4
1375295|NCT01462929|4538184|P2|Overall Study|Adverse Event|3
1375296|NCT01462929|4538185|P1|Overall Study|Adverse Event|3
1375297|NCT01462695|4538226|P2|Overall Study|Inevaluable (did not receive study drug)|0
1375298|NCT01462695|4538227|P1|Overall Study|Inevaluable (did not receive study drug)|1
1375299|NCT01462695|4538226|P2|Overall Study|Withdrawal by Subject|0
1375300|NCT01462695|4538227|P1|Overall Study|Withdrawal by Subject|2
1375301|NCT01462695|4538226|P2|Overall Study|Physician Decision|0
1375302|NCT01462695|4538227|P1|Overall Study|Physician Decision|5
1375303|NCT01462695|4538226|P2|Overall Study|Lack of Efficacy|12
1375304|NCT01462695|4538227|P1|Overall Study|Lack of Efficacy|6
1375305|NCT01462695|4538226|P2|Overall Study|Death|0
1375306|NCT01462695|4538227|P1|Overall Study|Death|2
1375307|NCT01462695|4538226|P2|Overall Study|Adverse Event|1
1375308|NCT01462695|4538227|P1|Overall Study|Adverse Event|1
1375309|NCT01462435|4538255|P4|Overall Study|Lost to Follow-up|1
1375310|NCT01462435|4538256|P3|Overall Study|Lost to Follow-up|0
1375311|NCT01462435|4538257|P2|Overall Study|Lost to Follow-up|0
1375312|NCT01462435|4538258|P1|Overall Study|Lost to Follow-up|0
1375313|NCT01462435|4538255|P4|Overall Study|Withdrawal by Subject|1
1375314|NCT01462435|4538256|P3|Overall Study|Withdrawal by Subject|0
1375315|NCT01462435|4538257|P2|Overall Study|Withdrawal by Subject|0
1375316|NCT01462435|4538258|P1|Overall Study|Withdrawal by Subject|0
1375317|NCT01462435|4538255|P4|Overall Study|Physician Decision|0
1375318|NCT01462435|4538256|P3|Overall Study|Physician Decision|1
1375319|NCT01462435|4538257|P2|Overall Study|Physician Decision|0
1375320|NCT01462435|4538258|P1|Overall Study|Physician Decision|0
1375321|NCT01462435|4538255|P4|Overall Study|Lack of Efficacy|3
1375322|NCT01462435|4538256|P3|Overall Study|Lack of Efficacy|0
1375323|NCT01462435|4538257|P2|Overall Study|Lack of Efficacy|0
1375324|NCT01462435|4538258|P1|Overall Study|Lack of Efficacy|1
1375325|NCT01462370|4538296|P2|Overall Study|Withdrawal by Subject|3
1375326|NCT01462370|4538297|P1|Overall Study|Withdrawal by Subject|0
1375327|NCT01462370|4538296|P2|Overall Study|Physician Decision|1
1375328|NCT01462370|4538297|P1|Overall Study|Physician Decision|0
1375329|NCT01462370|4538296|P2|Overall Study|Lack of Qualifying Event|1
1375330|NCT01462370|4538297|P1|Overall Study|Lack of Qualifying Event|1
1375331|NCT01462357|4538332|P3|Month 24|Migrated/moved from study area|0
1375332|NCT01462357|4538333|P2|Month 24|Migrated/moved from study area|2
1375333|NCT01462357|4538334|P1|Month 24|Migrated/moved from study area|0
1375334|NCT01462357|4538332|P3|Month 24|Lost to Follow-up|6
1375335|NCT01462357|4538333|P2|Month 24|Lost to Follow-up|4
1375336|NCT01462357|4538334|P1|Month 24|Lost to Follow-up|2
1375337|NCT01462357|4538332|P3|Month 24|Withdrawal by Subject|3
1375338|NCT01462357|4538333|P2|Month 24|Withdrawal by Subject|8
1375339|NCT01462357|4538334|P1|Month 24|Withdrawal by Subject|2
1375340|NCT01462357|4538332|P3|Month 18|Other|1
1375341|NCT01462357|4538333|P2|Month 18|Other|1
1375342|NCT01462357|4538334|P1|Month 18|Other|0
1375343|NCT01462357|4538332|P3|Month 18|Lost to Follow-up|5
1375344|NCT01462357|4538333|P2|Month 18|Lost to Follow-up|4
1375345|NCT01462357|4538334|P1|Month 18|Lost to Follow-up|1
1375346|NCT01462357|4538332|P3|Month 18|Withdrawal by Subject|3
1375347|NCT01462357|4538333|P2|Month 18|Withdrawal by Subject|6
1375348|NCT01462357|4538334|P1|Month 18|Withdrawal by Subject|2
1375349|NCT01462357|4538332|P3|Month 12|Lost to Follow-up|5
1375350|NCT01462357|4538333|P2|Month 12|Lost to Follow-up|4
1375351|NCT01462357|4538334|P1|Month 12|Lost to Follow-up|1
1375352|NCT01462357|4538332|P3|Month 12|Withdrawal by Subject|3
1375353|NCT01462357|4538333|P2|Month 12|Withdrawal by Subject|6
1375354|NCT01462357|4538334|P1|Month 12|Withdrawal by Subject|2
1375355|NCT01462357|4538332|P3|Month 7|Withdrawal by Subject|6
1375356|NCT01462357|4538333|P2|Month 7|Withdrawal by Subject|5
1375357|NCT01462357|4538334|P1|Month 7|Withdrawal by Subject|1
1375358|NCT01462344|4538407|P2|Overall Study|Lost to Follow-up|7
1375359|NCT01462344|4538408|P1|Overall Study|Lost to Follow-up|7
1375360|NCT01462344|4538407|P2|Overall Study|Protocol Violation|53
1375361|NCT01462344|4538408|P1|Overall Study|Protocol Violation|68
1375362|NCT01462344|4538407|P2|Overall Study|Lack of Efficacy|6
1375363|NCT01462344|4538408|P1|Overall Study|Lack of Efficacy|5
1375364|NCT01462344|4538407|P2|Overall Study|Asthma Exacerbation|35
1375365|NCT01462344|4538408|P1|Overall Study|Asthma Exacerbation|34
1375366|NCT01462344|4538407|P2|Overall Study|Adverse Event|23
1375367|NCT01462344|4538408|P1|Overall Study|Adverse Event|24
1375368|NCT01462344|4538407|P2|Overall Study|Withdrawal by Subject|226
1375369|NCT01462344|4538408|P1|Overall Study|Withdrawal by Subject|245
1375370|NCT01462318|4538430|P3|Extension Phase|Adverse Event|22
1375371|NCT01462318|4538431|P2|Extension Phase|Adverse Event|0
1375372|NCT01462318|4538432|P1|Extension Phase|Adverse Event|0
1375373|NCT01462318|4538430|P3|Extension Phase|Investigator Decision|5
1375374|NCT01462318|4538431|P2|Extension Phase|Investigator Decision|0
1375375|NCT01462318|4538432|P1|Extension Phase|Investigator Decision|0
1375376|NCT01462318|4538430|P3|Extension Phase|Withdrawal by Subject|15
1375377|NCT01462318|4538431|P2|Extension Phase|Withdrawal by Subject|0
1375378|NCT01462318|4538432|P1|Extension Phase|Withdrawal by Subject|0
1375379|NCT01462318|4538430|P3|Extension Phase|Disease Progression|1
1375380|NCT01462318|4538431|P2|Extension Phase|Disease Progression|0
1375381|NCT01462318|4538432|P1|Extension Phase|Disease Progression|0
1375382|NCT01462318|4538430|P3|Extension Phase|Not Specified|1
1375383|NCT01462318|4538431|P2|Extension Phase|Not Specified|0
1375384|NCT01462318|4538432|P1|Extension Phase|Not Specified|0
1375385|NCT01462318|4538430|P3|Extension Phase|Lost to Follow-up|1
1375386|NCT01462318|4538431|P2|Extension Phase|Lost to Follow-up|0
1375387|NCT01462318|4538432|P1|Extension Phase|Lost to Follow-up|0
1375388|NCT01462318|4538430|P3|Main Study / TP-DI Study|Adverse Event|0
1375389|NCT01462318|4538431|P2|Main Study / TP-DI Study|Adverse Event|0
1375390|NCT01462318|4538432|P1|Main Study / TP-DI Study|Adverse Event|4
1375391|NCT01462318|4538430|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
1375392|NCT01462318|4538431|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
1375393|NCT01462318|4538432|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
1375394|NCT01462318|4538430|P3|Main Study / TP-DI Study|Not Specified|0
1375395|NCT01462318|4538431|P2|Main Study / TP-DI Study|Not Specified|0
1375396|NCT01462318|4538432|P1|Main Study / TP-DI Study|Not Specified|2
1375397|NCT01462266|4538520|P2|Overall Study|Screen failure|1
1375398|NCT01462266|4538521|P1|Overall Study|Screen failure|1
1375399|NCT01462266|4538520|P2|Overall Study|Withdrawal by Subject|2
1375400|NCT01462266|4538521|P1|Overall Study|Withdrawal by Subject|7
1375401|NCT01462266|4538520|P2|Overall Study|Protocol Violation|3
1375402|NCT01462266|4538521|P1|Overall Study|Protocol Violation|1
1375403|NCT01462266|4538520|P2|Overall Study|Physician Decision|5
1375404|NCT01462266|4538521|P1|Overall Study|Physician Decision|2
1375405|NCT01462266|4538520|P2|Overall Study|Creatinine and eGFR, excluded medication|4
1375406|NCT01462266|4538521|P1|Overall Study|Creatinine and eGFR, excluded medication|8
1375407|NCT01462266|4538520|P2|Overall Study|Non-compliance with study drug|0
1375408|NCT01462266|4538521|P1|Overall Study|Non-compliance with study drug|3
1375409|NCT01462266|4538520|P2|Overall Study|Lost to Follow-up|3
1375410|NCT01462266|4538521|P1|Overall Study|Lost to Follow-up|4
1375411|NCT01462266|4538520|P2|Overall Study|Lack of Efficacy|2
1375412|NCT01462266|4538521|P1|Overall Study|Lack of Efficacy|0
1375413|NCT01462266|4538520|P2|Overall Study|Death|1
1375414|NCT01462266|4538521|P1|Overall Study|Death|2
1375415|NCT01462266|4538520|P2|Overall Study|Adverse Event|6
1375416|NCT01462266|4538521|P1|Overall Study|Adverse Event|7
1375417|NCT01462227|4538537|P4|Second Assignment|Protocol Violation|0
1375418|NCT01462227|4538538|P3|Second Assignment|Protocol Violation|1
1375419|NCT01462227|4538539|P2|Second Assignment|Protocol Violation|1
1375420|NCT01462227|4538540|P1|Second Assignment|Protocol Violation|0
1375421|NCT01462227|4538537|P4|Second Assignment|Lost to Follow-up|0
1375422|NCT01462227|4538538|P3|Second Assignment|Lost to Follow-up|0
1375423|NCT01462227|4538539|P2|Second Assignment|Lost to Follow-up|0
1375424|NCT01462227|4538540|P1|Second Assignment|Lost to Follow-up|1
1375425|NCT01462162|4538558|P1|Overall Study|Other|2
1375426|NCT01462162|4538558|P1|Overall Study|Abnormal laboratory parameters|1
1375427|NCT01462162|4538558|P1|Overall Study|Lack of Efficacy|4
1375428|NCT01462162|4538558|P1|Overall Study|Adverse Event|5
1375429|NCT01462084|4538583|P2|Overall Study|Protocol Violation|1
1375430|NCT01462084|4538584|P1|Overall Study|Protocol Violation|1
1375431|NCT01462084|4538583|P2|Overall Study|Withdrawal by Subject|0
1375432|NCT01462084|4538584|P1|Overall Study|Withdrawal by Subject|1
1375433|NCT01462045|4538595|P3|Overall Study|Family matter|0
1375434|NCT01462045|4538596|P2|Overall Study|Family matter|1
1375435|NCT01462045|4538597|P1|Overall Study|Family matter|0
1375436|NCT01461993|4538611|P3|Overall Study|Other|6
1375437|NCT01461993|4538612|P2|Overall Study|Other|15
1375438|NCT01461993|4538613|P1|Overall Study|Other|13
1375439|NCT01461993|4538611|P3|Overall Study|Did not meet entrance criteria|0
1375440|NCT01461993|4538612|P2|Overall Study|Did not meet entrance criteria|3
1375441|NCT01461993|4538613|P1|Overall Study|Did not meet entrance criteria|2
1375442|NCT01461993|4538611|P3|Overall Study|No longer met eligibility criteria|10
1375443|NCT01461993|4538612|P2|Overall Study|No longer met eligibility criteria|18
1375444|NCT01461993|4538613|P1|Overall Study|No longer met eligibility criteria|13
1375445|NCT01461993|4538611|P3|Overall Study|Adverse Event|3
1375446|NCT01461993|4538612|P2|Overall Study|Adverse Event|11
1375447|NCT01461993|4538613|P1|Overall Study|Adverse Event|9
1375448|NCT01461993|4538611|P3|Overall Study|Protocol Violation|7
1375449|NCT01461993|4538612|P2|Overall Study|Protocol Violation|9
1375450|NCT01461993|4538613|P1|Overall Study|Protocol Violation|10
1375451|NCT01461993|4538611|P3|Overall Study|Lost to Follow-up|22
1375452|NCT01461993|4538612|P2|Overall Study|Lost to Follow-up|48
1375453|NCT01461993|4538613|P1|Overall Study|Lost to Follow-up|44
1375454|NCT01461993|4538611|P3|Overall Study|Withdrawal by Subject|16
1375455|NCT01461993|4538612|P2|Overall Study|Withdrawal by Subject|53
1375456|NCT01461993|4538613|P1|Overall Study|Withdrawal by Subject|60
1375457|NCT01461980|4538638|P3|Overall Study|Randomized but not vaccinated|7
1375458|NCT01461980|4538639|P2|Overall Study|Randomized but not vaccinated|8
1375459|NCT01461980|4538640|P1|Overall Study|Randomized but not vaccinated|4
1375460|NCT01461980|4538638|P3|Overall Study|No longer willing to participate|54
1375461|NCT01461980|4538639|P2|Overall Study|No longer willing to participate|38
1375462|NCT01461980|4538640|P1|Overall Study|No longer willing to participate|52
1375463|NCT01461980|4538638|P3|Overall Study|Lost to Follow-up|51
1375464|NCT01461980|4538639|P2|Overall Study|Lost to Follow-up|53
1375465|NCT01461980|4538640|P1|Overall Study|Lost to Follow-up|52
1375466|NCT01461980|4538638|P3|Overall Study|No longer meets eligibility criteria|19
1375467|NCT01461980|4538639|P2|Overall Study|No longer meets eligibility criteria|9
1375468|NCT01461980|4538640|P1|Overall Study|No longer meets eligibility criteria|18
1375469|NCT01461980|4538638|P3|Overall Study|Protocol Violation|16
1375470|NCT01461980|4538639|P2|Overall Study|Protocol Violation|19
1375471|NCT01461980|4538640|P1|Overall Study|Protocol Violation|12
1375472|NCT01461980|4538638|P3|Overall Study|Adverse Event|6
1375473|NCT01461980|4538639|P2|Overall Study|Adverse Event|5
1375474|NCT01461980|4538640|P1|Overall Study|Adverse Event|12
1375475|NCT01461980|4538638|P3|Overall Study|Medication error|6
1375476|NCT01461980|4538639|P2|Overall Study|Medication error|5
1375477|NCT01461980|4538640|P1|Overall Study|Medication error|7
1375478|NCT01461980|4538638|P3|Overall Study|Other|6
1375479|NCT01461980|4538639|P2|Overall Study|Other|8
1375480|NCT01461980|4538640|P1|Overall Study|Other|9
1375481|NCT01461811|4538702|P2|Overall Study|Noncompliance|1
1375482|NCT01461811|4538703|P1|Overall Study|Noncompliance|1
1375483|NCT01461811|4538702|P2|Overall Study|Subject decision unrelated to an AE|1
1375484|NCT01461811|4538703|P1|Overall Study|Subject decision unrelated to an AE|1
1375485|NCT01461811|4538702|P2|Overall Study|Adverse Event|1
1375486|NCT01461811|4538703|P1|Overall Study|Adverse Event|2
1375487|NCT01461707|4538742|P2|Overall Study|Withdrawal by Subject|0
1375488|NCT01461707|4538743|P1|Overall Study|Withdrawal by Subject|1
1375489|NCT01461551|4538780|P3|Overall Study|Physician Decision|2
1375490|NCT01461551|4538781|P2|Overall Study|Physician Decision|1
1375491|NCT01461551|4538782|P1|Overall Study|Physician Decision|2
1375492|NCT01461538|4538793|P3|Overall Study|Withdrawal by Subject|0
1375493|NCT01461538|4538794|P2|Overall Study|Withdrawal by Subject|1
1375494|NCT01461538|4538795|P1|Overall Study|Withdrawal by Subject|1
1375495|NCT01461538|4538793|P3|Overall Study|Study Stopped by Sponsor|0
1375496|NCT01461538|4538794|P2|Overall Study|Study Stopped by Sponsor|1
1375497|NCT01461538|4538795|P1|Overall Study|Study Stopped by Sponsor|2
1375498|NCT01461538|4538793|P3|Overall Study|Death|2
1375499|NCT01461538|4538794|P2|Overall Study|Death|6
1375500|NCT01461538|4538795|P1|Overall Study|Death|15
1375501|NCT01461369|4538864|P3|Overall Study|Withdrawal by Subject|2
1375502|NCT01461369|4538865|P2|Overall Study|Withdrawal by Subject|3
1375503|NCT01461369|4538866|P1|Overall Study|Withdrawal by Subject|1
1375504|NCT01461369|4538864|P3|Overall Study|Protocol Violation|2
1375505|NCT01461369|4538865|P2|Overall Study|Protocol Violation|2
1375506|NCT01461369|4538866|P1|Overall Study|Protocol Violation|1
1375507|NCT01461369|4538864|P3|Overall Study|Adverse Event|4
1375508|NCT01461369|4538865|P2|Overall Study|Adverse Event|12
1375509|NCT01461369|4538866|P1|Overall Study|Adverse Event|9
1375510|NCT01461369|4538864|P3|Overall Study|Lost to Follow-up|3
1375511|NCT01461369|4538865|P2|Overall Study|Lost to Follow-up|0
1375512|NCT01461369|4538866|P1|Overall Study|Lost to Follow-up|0
1375513|NCT01461369|4538864|P3|Overall Study|Lack of Efficacy|6
1375514|NCT01461369|4538865|P2|Overall Study|Lack of Efficacy|0
1375515|NCT01461369|4538866|P1|Overall Study|Lack of Efficacy|2
1375516|NCT01461096|4538891|P2|Overall Study|Lost to Follow-up|4
1375517|NCT01461096|4538892|P1|Overall Study|Lost to Follow-up|8
1375518|NCT01461096|4538891|P2|Overall Study|Subj not willing to adhere to reqs|4
1375519|NCT01461096|4538892|P1|Overall Study|Subj not willing to adhere to reqs|3
1375520|NCT01461096|4538891|P2|Overall Study|Withdrawal by Subject|3
1375521|NCT01461096|4538892|P1|Overall Study|Withdrawal by Subject|5
1375522|NCT01461096|4538891|P2|Overall Study|Site is closing|30
1375523|NCT01461096|4538892|P1|Overall Study|Site is closing|27
1375524|NCT01461096|4538891|P2|Overall Study|Subj not able to get to clinic|13
1375525|NCT01461096|4538892|P1|Overall Study|Subj not able to get to clinic|15
1375526|NCT01461096|4538891|P2|Overall Study|Severe debilitation, unable to continue|1
1375527|NCT01461096|4538892|P1|Overall Study|Severe debilitation, unable to continue|1
1375528|NCT01461096|4538891|P2|Overall Study|Death|6
1375529|NCT01461096|4538892|P1|Overall Study|Death|3
1375530|NCT01461057|4538908|P2|Overall Study|Study Terminated by Sponsor|0
1375531|NCT01461057|4538909|P1|Overall Study|Study Terminated by Sponsor|2
1375532|NCT01461057|4538908|P2|Overall Study|Progression of Disease|0
1375533|NCT01461057|4538909|P1|Overall Study|Progression of Disease|1
1375534|NCT01461057|4538908|P2|Overall Study|Adverse Event|1
1375535|NCT01461057|4538909|P1|Overall Study|Adverse Event|0
1375536|NCT01461057|4538908|P2|Overall Study|Physician Decision|2
1375537|NCT01461057|4538909|P1|Overall Study|Physician Decision|0
1375538|NCT01461057|4538908|P2|Overall Study|Withdrawal by Subject|3
1375539|NCT01461057|4538909|P1|Overall Study|Withdrawal by Subject|2
1375540|NCT01461057|4538908|P2|Overall Study|Death|9
1375541|NCT01461057|4538909|P1|Overall Study|Death|10
1375542|NCT01461044|4538919|P2|Overall Study|Lost to Follow-up|5
1375543|NCT01461044|4538920|P1|Overall Study|Lost to Follow-up|12
1375544|NCT01461044|4538919|P2|Overall Study|Death|35
1375545|NCT01461044|4538920|P1|Overall Study|Death|58
1375546|NCT01460628|4539020|P1|Overall Study|Withdrawal by Subject|2
1375547|NCT01460628|4539020|P1|Overall Study|Adverse Event|3
1375548|NCT01460446|4539032|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
1375549|NCT01460446|4539033|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
1375550|NCT01460446|4539032|P2|Overall Study|Pregnancy|0
1375551|NCT01460446|4539033|P1|Overall Study|Pregnancy|1
1375552|NCT01460446|4539032|P2|Overall Study|Surgery/Illness|1
1375553|NCT01460446|4539033|P1|Overall Study|Surgery/Illness|1
1375554|NCT01460446|4539032|P2|Overall Study|Non-compliance & Consent Withdrawn|3
1375555|NCT01460446|4539033|P1|Overall Study|Non-compliance & Consent Withdrawn|1
1375556|NCT01460446|4539032|P2|Overall Study|Consent Withdrawn|4
1375557|NCT01460446|4539033|P1|Overall Study|Consent Withdrawn|0
1375558|NCT01460446|4539032|P2|Overall Study|Non-compliance|9
1375559|NCT01460446|4539033|P1|Overall Study|Non-compliance|2
1375560|NCT01460342|4539062|P2|Overall Study|Lack of Efficacy|0
1375561|NCT01460342|4539063|P1|Overall Study|Lack of Efficacy|1
1375562|NCT01460342|4539062|P2|Overall Study|Physician Decision|3
1375563|NCT01460342|4539063|P1|Overall Study|Physician Decision|1
1375564|NCT01460342|4539062|P2|Overall Study|Withdrawal by Subject|4
1375565|NCT01460342|4539063|P1|Overall Study|Withdrawal by Subject|3
1375566|NCT01460342|4539062|P2|Overall Study|Protocol Violation|1
1375567|NCT01460342|4539063|P1|Overall Study|Protocol Violation|0
1375568|NCT01460342|4539062|P2|Overall Study|Lost to Follow-up|2
1375569|NCT01460342|4539063|P1|Overall Study|Lost to Follow-up|1
1375570|NCT01460342|4539062|P2|Overall Study|Adverse Event|4
1375571|NCT01460342|4539063|P1|Overall Study|Adverse Event|5
1375572|NCT01460290|4539094|P1|Overall Study|Elevated liver function|1
1375573|NCT01460290|4539094|P1|Overall Study|Adverse Event|3
1375574|NCT01460160|4539121|P2|Follow-up|Lost to Follow-up|0
1375575|NCT01460160|4539122|P1|Follow-up|Lost to Follow-up|1
1375576|NCT01460160|4539121|P2|Follow-up|Death|2
1375577|NCT01460160|4539122|P1|Follow-up|Death|7
1375578|NCT01460160|4539121|P2|Follow-up|Withdrawal by Subject|0
1375579|NCT01460160|4539122|P1|Follow-up|Withdrawal by Subject|3
1375580|NCT01460160|4539121|P2|Treatment|Subject refused to continue Chemo|0
1375581|NCT01460160|4539122|P1|Treatment|Subject refused to continue Chemo|1
1375582|NCT01460160|4539121|P2|Treatment|Family did not wish to restart after SCT|0
1375583|NCT01460160|4539122|P1|Treatment|Family did not wish to restart after SCT|1
1375584|NCT01460160|4539121|P2|Treatment|PI decision to pursue other options|1
1375585|NCT01460160|4539122|P1|Treatment|PI decision to pursue other options|1
1375586|NCT01460160|4539121|P2|Treatment|PI not to follow protocol therapy|0
1375587|NCT01460160|4539122|P1|Treatment|PI not to follow protocol therapy|1
1375588|NCT01460160|4539121|P2|Treatment|PI decision to not re-initiate after SCT|2
1375589|NCT01460160|4539122|P1|Treatment|PI decision to not re-initiate after SCT|2
1375590|NCT01460160|4539121|P2|Treatment|Death|2
1375591|NCT01460160|4539122|P1|Treatment|Death|0
1375592|NCT01460160|4539121|P2|Treatment|Withdrawal by Subject|0
1375593|NCT01460160|4539122|P1|Treatment|Withdrawal by Subject|4
1375594|NCT01460160|4539121|P2|Treatment|Adverse Event|0
1375595|NCT01460160|4539122|P1|Treatment|Adverse Event|8
1375596|NCT01460160|4539121|P2|Treatment|Study Drug Toxicity|0
1375597|NCT01460160|4539122|P1|Treatment|Study Drug Toxicity|2
1375598|NCT01460160|4539121|P2|Treatment|Lack of Efficacy|0
1375599|NCT01460160|4539122|P1|Treatment|Lack of Efficacy|3
1375600|NCT01459913|4539163|P4|Overall Study|Did Not Meet Inclusion Criteria|1
1375601|NCT01459913|4539164|P3|Overall Study|Did Not Meet Inclusion Criteria|0
1375602|NCT01459913|4539165|P2|Overall Study|Did Not Meet Inclusion Criteria|0
1375603|NCT01459913|4539166|P1|Overall Study|Did Not Meet Inclusion Criteria|0
1375604|NCT01459913|4539163|P4|Overall Study|Other|1
1375605|NCT01459913|4539164|P3|Overall Study|Other|3
1375606|NCT01459913|4539165|P2|Overall Study|Other|0
1375607|NCT01459913|4539166|P1|Overall Study|Other|0
1375608|NCT01459913|4539163|P4|Overall Study|Study Terminated by Sponsor|11
1375609|NCT01459913|4539164|P3|Overall Study|Study Terminated by Sponsor|9
1375610|NCT01459913|4539165|P2|Overall Study|Study Terminated by Sponsor|15
1375611|NCT01459913|4539166|P1|Overall Study|Study Terminated by Sponsor|30
1375612|NCT01459913|4539163|P4|Overall Study|Physician Decision|0
1375613|NCT01459913|4539164|P3|Overall Study|Physician Decision|0
1375614|NCT01459913|4539165|P2|Overall Study|Physician Decision|1
1375615|NCT01459913|4539166|P1|Overall Study|Physician Decision|0
1375616|NCT01459913|4539163|P4|Overall Study|Non- Compliance|3
1375617|NCT01459913|4539164|P3|Overall Study|Non- Compliance|0
1375618|NCT01459913|4539165|P2|Overall Study|Non- Compliance|0
1375619|NCT01459913|4539166|P1|Overall Study|Non- Compliance|0
1375620|NCT01459913|4539163|P4|Overall Study|Death|1
1375621|NCT01459913|4539164|P3|Overall Study|Death|0
1375622|NCT01459913|4539165|P2|Overall Study|Death|0
1375623|NCT01459913|4539166|P1|Overall Study|Death|0
1375624|NCT01459913|4539163|P4|Overall Study|Lost to Follow-up|8
1375625|NCT01459913|4539164|P3|Overall Study|Lost to Follow-up|1
1375626|NCT01459913|4539165|P2|Overall Study|Lost to Follow-up|4
1375627|NCT01459913|4539166|P1|Overall Study|Lost to Follow-up|7
1375628|NCT01459913|4539163|P4|Overall Study|Withdrawal by Subject|5
1375629|NCT01459913|4539164|P3|Overall Study|Withdrawal by Subject|0
1375630|NCT01459913|4539165|P2|Overall Study|Withdrawal by Subject|0
1375631|NCT01459913|4539166|P1|Overall Study|Withdrawal by Subject|4
1375632|NCT01459913|4539163|P4|Overall Study|Adverse Event|3
1375633|NCT01459913|4539164|P3|Overall Study|Adverse Event|0
1375634|NCT01459913|4539165|P2|Overall Study|Adverse Event|0
1375635|NCT01459913|4539166|P1|Overall Study|Adverse Event|0
1375636|NCT01459796|4539197|P2|Overall Study|Decision by the sponsor|108
1375637|NCT01459796|4539198|P1|Overall Study|Decision by the sponsor|75
1375638|NCT01459796|4539197|P2|Overall Study|Reason unspecified|2
1375639|NCT01459796|4539198|P1|Overall Study|Reason unspecified|1
1375640|NCT01459796|4539197|P2|Overall Study|Lost to Follow-up|4
1375641|NCT01459796|4539198|P1|Overall Study|Lost to Follow-up|5
1375642|NCT01459796|4539197|P2|Overall Study|Withdrawal by Subject|3
1375643|NCT01459796|4539198|P1|Overall Study|Withdrawal by Subject|6
1375644|NCT01459796|4539197|P2|Overall Study|Adverse Event|5
1375645|NCT01459796|4539198|P1|Overall Study|Adverse Event|5
1375646|NCT01459796|4539197|P2|Overall Study|Non compliance with protocol|4
1375647|NCT01459796|4539198|P1|Overall Study|Non compliance with protocol|2
1375648|NCT01459783|4539216|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
1375649|NCT01459783|4539217|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
1375650|NCT01459783|4539216|P2|6 Months to 12 Months|Lost to Follow-up|7
1375651|NCT01459783|4539217|P1|6 Months to 12 Months|Lost to Follow-up|2
1375652|NCT01459783|4539216|P2|6 Months to 12 Months|Withdrawal by Subject|5
1375653|NCT01459783|4539217|P1|6 Months to 12 Months|Withdrawal by Subject|6
1375654|NCT01459783|4539216|P2|6 Months to 12 Months|Death|1
1375655|NCT01459783|4539217|P1|6 Months to 12 Months|Death|0
1375656|NCT01459783|4539216|P2|Baseline to 6 Months|Lost to Follow-up|14
1375657|NCT01459783|4539217|P1|Baseline to 6 Months|Lost to Follow-up|19
1375658|NCT01459783|4539216|P2|Baseline to 6 Months|Withdrawal by Subject|6
1375659|NCT01459783|4539217|P1|Baseline to 6 Months|Withdrawal by Subject|12
1375660|NCT01459783|4539216|P2|Baseline to 6 Months|Death|0
1375661|NCT01459783|4539217|P1|Baseline to 6 Months|Death|1
1375662|NCT01459068|4539429|P2|Overall Study|Death|1
1375663|NCT01459068|4539430|P1|Overall Study|Death|0
1375664|NCT01459068|4539429|P2|Overall Study|Lost to Follow-up|15
1375665|NCT01459068|4539430|P1|Overall Study|Lost to Follow-up|31
1375666|NCT01459068|4539429|P2|Overall Study|Withdrawal by Subject|18
1375667|NCT01459068|4539430|P1|Overall Study|Withdrawal by Subject|8
1375668|NCT01459016|4539446|P1|Overall Study|Amendment Discontinuation Criteria|4
1375669|NCT01459016|4539446|P1|Overall Study|Withdrawal by Subject|11
1375670|NCT01458951|4539474|P3|Overall Study|Insufficient Clinical Response|11
1375671|NCT01458951|4539475|P2|Overall Study|Insufficient Clinical Response|0
1375672|NCT01458951|4539476|P1|Overall Study|Insufficient Clinical Response|17
1375673|NCT01458951|4539474|P3|Overall Study|Adverse Event|2
1375674|NCT01458951|4539475|P2|Overall Study|Adverse Event|0
1375675|NCT01458951|4539476|P1|Overall Study|Adverse Event|7
1375676|NCT01458951|4539474|P3|Overall Study|Withdrawal by Subject|2
1375677|NCT01458951|4539475|P2|Overall Study|Withdrawal by Subject|0
1375678|NCT01458951|4539476|P1|Overall Study|Withdrawal by Subject|2
1375679|NCT01458951|4539474|P3|Overall Study|Protocol Violation|0
1375680|NCT01458951|4539475|P2|Overall Study|Protocol Violation|1
1375681|NCT01458951|4539476|P1|Overall Study|Protocol Violation|5
1375682|NCT01458951|4539474|P3|Overall Study|Other|0
1375683|NCT01458951|4539475|P2|Overall Study|Other|0
1375684|NCT01458951|4539476|P1|Overall Study|Other|1
1375685|NCT01458639|4539501|P1|Overall Study|Inability to obtain subject blood sample|1
1375686|NCT01458639|4539501|P1|Overall Study|Equipment issue|1
1375687|NCT01458639|4539501|P1|Overall Study|Physician Decision|4
1375688|NCT01458587|4539513|P2|Overall Study|Withdrawal by Subject|0
1375689|NCT01458587|4539514|P1|Overall Study|Withdrawal by Subject|1
1375690|NCT01458574|4539677|P3|Overall Study|Randomized but not treated|0
1375691|NCT01458574|4539678|P2|Overall Study|Randomized but not treated|1
1375692|NCT01458574|4539679|P1|Overall Study|Randomized but not treated|0
1375693|NCT01458574|4539677|P3|Overall Study|Other|0
1375694|NCT01458574|4539678|P2|Overall Study|Other|1
1375695|NCT01458574|4539679|P1|Overall Study|Other|2
1375696|NCT01458574|4539677|P3|Overall Study|Withdrawal by Subject|5
1375697|NCT01458574|4539678|P2|Overall Study|Withdrawal by Subject|3
1375698|NCT01458574|4539679|P1|Overall Study|Withdrawal by Subject|6
1375699|NCT01458574|4539677|P3|Overall Study|Protocol Violation|0
1375700|NCT01458574|4539678|P2|Overall Study|Protocol Violation|1
1375701|NCT01458574|4539679|P1|Overall Study|Protocol Violation|0
1375702|NCT01458574|4539677|P3|Overall Study|Pregnancy|0
1375703|NCT01458574|4539678|P2|Overall Study|Pregnancy|1
1375704|NCT01458574|4539679|P1|Overall Study|Pregnancy|1
1375705|NCT01458574|4539677|P3|Overall Study|Lost to Follow-up|1
1375706|NCT01458574|4539678|P2|Overall Study|Lost to Follow-up|2
1375707|NCT01458574|4539679|P1|Overall Study|Lost to Follow-up|3
1375708|NCT01458574|4539677|P3|Overall Study|Lack of Efficacy|132
1375709|NCT01458574|4539678|P2|Overall Study|Lack of Efficacy|53
1375710|NCT01458574|4539679|P1|Overall Study|Lack of Efficacy|70
1375711|NCT01458574|4539677|P3|Overall Study|Adverse Event|7
1375712|NCT01458574|4539678|P2|Overall Study|Adverse Event|9
1375713|NCT01458574|4539679|P1|Overall Study|Adverse Event|5
1375714|NCT01458535|4539809|P6|Overall Study|Adverse Event|0
1375715|NCT01458535|4539810|P5|Overall Study|Adverse Event|0
1375716|NCT01458535|4539811|P4|Overall Study|Adverse Event|1
1375717|NCT01458535|4539812|P3|Overall Study|Adverse Event|0
1375718|NCT01458535|4539813|P2|Overall Study|Adverse Event|0
1375719|NCT01458535|4539814|P1|Overall Study|Adverse Event|0
1375720|NCT01458535|4539809|P6|Overall Study|Lost to Follow-up|2
1375721|NCT01458535|4539810|P5|Overall Study|Lost to Follow-up|2
1375722|NCT01458535|4539811|P4|Overall Study|Lost to Follow-up|3
1375723|NCT01458535|4539812|P3|Overall Study|Lost to Follow-up|0
1375724|NCT01458535|4539813|P2|Overall Study|Lost to Follow-up|2
1375725|NCT01458535|4539814|P1|Overall Study|Lost to Follow-up|0
1375726|NCT01458535|4539809|P6|Overall Study|Withdrawal by Subject|1
1375727|NCT01458535|4539810|P5|Overall Study|Withdrawal by Subject|1
1375728|NCT01458535|4539811|P4|Overall Study|Withdrawal by Subject|0
1375729|NCT01458535|4539812|P3|Overall Study|Withdrawal by Subject|2
1375730|NCT01458535|4539813|P2|Overall Study|Withdrawal by Subject|0
1375731|NCT01458535|4539814|P1|Overall Study|Withdrawal by Subject|0
1375732|NCT01458535|4539809|P6|Overall Study|Other|1
1375733|NCT01458535|4539810|P5|Overall Study|Other|1
1375734|NCT01458535|4539811|P4|Overall Study|Other|0
1375735|NCT01458535|4539812|P3|Overall Study|Other|0
1375736|NCT01458535|4539813|P2|Overall Study|Other|0
1375737|NCT01458535|4539814|P1|Overall Study|Other|0
1375738|NCT01458522|4539866|P2|Overall Study|Physician Decision|9
1375739|NCT01458522|4539867|P1|Overall Study|Physician Decision|1
1375740|NCT01458522|4539866|P2|Overall Study|Withdrawal by Subject|2
1375741|NCT01458522|4539867|P1|Overall Study|Withdrawal by Subject|2
1375742|NCT01458392|4539896|P3|Overall Study|Patient unwilling to comply with protoco|2
1375743|NCT01458392|4539897|P2|Overall Study|Patient unwilling to comply with protoco|0
1375744|NCT01458392|4539898|P1|Overall Study|Patient unwilling to comply with protoco|0
1375745|NCT01458392|4539896|P3|Overall Study|At the discretion of the sponsor|7
1375746|NCT01458392|4539897|P2|Overall Study|At the discretion of the sponsor|2
1375747|NCT01458392|4539898|P1|Overall Study|At the discretion of the sponsor|0
1375748|NCT01458392|4539896|P3|Overall Study|Death|22
1375749|NCT01458392|4539897|P2|Overall Study|Death|11
1375750|NCT01458392|4539898|P1|Overall Study|Death|2
1375751|NCT01458275|4539930|P3|Overall Study|Withdrawal by Subject|1
1375752|NCT01458275|4539931|P2|Overall Study|Withdrawal by Subject|2
1375753|NCT01458275|4539932|P1|Overall Study|Withdrawal by Subject|3
1375754|NCT01458275|4539930|P3|Overall Study|Protocol Violation|2
1375755|NCT01458275|4539931|P2|Overall Study|Protocol Violation|5
1375756|NCT01458275|4539932|P1|Overall Study|Protocol Violation|5
1375757|NCT01458275|4539930|P3|Overall Study|Lost to Follow-up|5
1375758|NCT01458275|4539931|P2|Overall Study|Lost to Follow-up|2
1375759|NCT01458275|4539932|P1|Overall Study|Lost to Follow-up|3
1375760|NCT01458275|4539930|P3|Overall Study|Adverse Event|1
1375761|NCT01458275|4539931|P2|Overall Study|Adverse Event|4
1375762|NCT01458275|4539932|P1|Overall Study|Adverse Event|3
1375763|NCT01458249|4539974|P1|Overall Study|Ongoing|1
1375764|NCT01458249|4539974|P1|Overall Study|Not specified|2
1375765|NCT01458249|4539974|P1|Overall Study|Adverse Event|4
1375766|NCT01458249|4539974|P1|Overall Study|Not treated|1
1375767|NCT01458210|4539993|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
1375768|NCT01458210|4539993|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
1375769|NCT01458210|4539993|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
1375770|NCT01458210|4539993|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
1375771|NCT01458171|4540010|P1|Overall Study|Adverse Event|1
1375772|NCT01458106|4540033|P2|Overall Study|Withdrawn Per Protocol|1
1375773|NCT01458106|4540034|P1|Overall Study|Withdrawn Per Protocol|0
1375774|NCT01458106|4540033|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
1375775|NCT01458106|4540034|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
1375776|NCT01458106|4540033|P2|Overall Study|Withdrawal by Subject|0
1375777|NCT01458106|4540034|P1|Overall Study|Withdrawal by Subject|2
1375778|NCT01457950|4540111|P4|Open-Label Phase|Withdrawal by Subject|0
1375779|NCT01457950|4540112|P3|Open-Label Phase|Withdrawal by Subject|2
1375780|NCT01457950|4540113|P2|Open-Label Phase|Withdrawal by Subject|0
1375781|NCT01457950|4540114|P1|Open-Label Phase|Withdrawal by Subject|0
1375782|NCT01457950|4540111|P4|Open-Label Phase|Protocol Violation|1
1375783|NCT01457950|4540112|P3|Open-Label Phase|Protocol Violation|0
1375784|NCT01457950|4540113|P2|Open-Label Phase|Protocol Violation|0
1375785|NCT01457950|4540114|P1|Open-Label Phase|Protocol Violation|0
1375786|NCT01457950|4540111|P4|Open-Label Phase|Adverse Event|1
1375787|NCT01457950|4540112|P3|Open-Label Phase|Adverse Event|0
1375788|NCT01457950|4540113|P2|Open-Label Phase|Adverse Event|0
1375789|NCT01457950|4540114|P1|Open-Label Phase|Adverse Event|0
1375790|NCT01457950|4540111|P4|Double-Blind Phase|Withdrawal by Subject|0
1375791|NCT01457950|4540112|P3|Double-Blind Phase|Withdrawal by Subject|0
1375792|NCT01457950|4540113|P2|Double-Blind Phase|Withdrawal by Subject|2
1375793|NCT01457950|4540114|P1|Double-Blind Phase|Withdrawal by Subject|6
1375794|NCT01457950|4540111|P4|Double-Blind Phase|Protocol Violation|0
1375795|NCT01457950|4540112|P3|Double-Blind Phase|Protocol Violation|0
1375796|NCT01457950|4540113|P2|Double-Blind Phase|Protocol Violation|1
1375797|NCT01457950|4540114|P1|Double-Blind Phase|Protocol Violation|2
1375798|NCT01457950|4540111|P4|Double-Blind Phase|Continuation Criteria Not Met|0
1375799|NCT01457950|4540112|P3|Double-Blind Phase|Continuation Criteria Not Met|0
1375800|NCT01457950|4540113|P2|Double-Blind Phase|Continuation Criteria Not Met|0
1375801|NCT01457950|4540114|P1|Double-Blind Phase|Continuation Criteria Not Met|1
1375802|NCT01457924|4540193|P5|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
1375803|NCT01457924|4540194|P4|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
1375804|NCT01457924|4540195|P3|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
1375805|NCT01457924|4540196|P2|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
1375806|NCT01457924|4540197|P1|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
1375807|NCT01457924|4540193|P5|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
1375808|NCT01457924|4540194|P4|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
1375809|NCT01457924|4540195|P3|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
1375810|NCT01457924|4540196|P2|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
1375811|NCT01457924|4540197|P1|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
1375812|NCT01457924|4540193|P5|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
1375813|NCT01457924|4540194|P4|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
1375814|NCT01457924|4540195|P3|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
1375815|NCT01457924|4540196|P2|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
1375816|NCT01457924|4540197|P1|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
1375817|NCT01457924|4540193|P5|FUP (Weeks 24-48)|Withdrawal by Subject|2
1375818|NCT01457924|4540194|P4|FUP (Weeks 24-48)|Withdrawal by Subject|0
1375819|NCT01457924|4540195|P3|FUP (Weeks 24-48)|Withdrawal by Subject|0
1375820|NCT01457924|4540196|P2|FUP (Weeks 24-48)|Withdrawal by Subject|1
1375821|NCT01457924|4540197|P1|FUP (Weeks 24-48)|Withdrawal by Subject|2
1375822|NCT01457924|4540193|P5|FUP (Weeks 24-48)|Lost to Follow-up|0
1375823|NCT01457924|4540194|P4|FUP (Weeks 24-48)|Lost to Follow-up|1
1375824|NCT01457924|4540195|P3|FUP (Weeks 24-48)|Lost to Follow-up|0
1375825|NCT01457924|4540196|P2|FUP (Weeks 24-48)|Lost to Follow-up|0
1375826|NCT01457924|4540197|P1|FUP (Weeks 24-48)|Lost to Follow-up|0
1375827|NCT01457924|4540193|P5|FUP (Weeks 24-48)|Physician Decision|0
1375828|NCT01457924|4540194|P4|FUP (Weeks 24-48)|Physician Decision|0
1375829|NCT01457924|4540195|P3|FUP (Weeks 24-48)|Physician Decision|1
1375830|NCT01457924|4540196|P2|FUP (Weeks 24-48)|Physician Decision|0
1375831|NCT01457924|4540197|P1|FUP (Weeks 24-48)|Physician Decision|1
1375832|NCT01457924|4540193|P5|FUP (Weeks 24-48)|Adverse Event|0
1375833|NCT01457924|4540194|P4|FUP (Weeks 24-48)|Adverse Event|0
1375834|NCT01457924|4540195|P3|FUP (Weeks 24-48)|Adverse Event|1
1375835|NCT01457924|4540196|P2|FUP (Weeks 24-48)|Adverse Event|0
1375836|NCT01457924|4540197|P1|FUP (Weeks 24-48)|Adverse Event|0
1375837|NCT01457924|4540193|P5|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
1375838|NCT01457924|4540194|P4|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
1375839|NCT01457924|4540195|P3|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
1375840|NCT01457924|4540196|P2|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
1375841|NCT01457924|4540197|P1|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
1375842|NCT01457924|4540193|P5|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
1375843|NCT01457924|4540194|P4|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
1375844|NCT01457924|4540195|P3|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
1375845|NCT01457924|4540196|P2|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
1375846|NCT01457924|4540197|P1|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
1375847|NCT01457924|4540193|P5|Treatment Phase (Weeks 0-24)|Protocol Violation|0
1375848|NCT01457924|4540194|P4|Treatment Phase (Weeks 0-24)|Protocol Violation|0
1375849|NCT01457924|4540195|P3|Treatment Phase (Weeks 0-24)|Protocol Violation|1
1375850|NCT01457924|4540196|P2|Treatment Phase (Weeks 0-24)|Protocol Violation|0
1375851|NCT01457924|4540197|P1|Treatment Phase (Weeks 0-24)|Protocol Violation|1
1375852|NCT01457924|4540193|P5|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1375853|NCT01457924|4540194|P4|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1375854|NCT01457924|4540195|P3|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1375855|NCT01457924|4540196|P2|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1375856|NCT01457924|4540197|P1|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
1375857|NCT01457924|4540193|P5|Treatment Phase (Weeks 0-24)|Physician Decision|1
1375858|NCT01457924|4540194|P4|Treatment Phase (Weeks 0-24)|Physician Decision|0
1375859|NCT01457924|4540195|P3|Treatment Phase (Weeks 0-24)|Physician Decision|0
1375860|NCT01457924|4540196|P2|Treatment Phase (Weeks 0-24)|Physician Decision|0
1375861|NCT01457924|4540197|P1|Treatment Phase (Weeks 0-24)|Physician Decision|0
1375862|NCT01457924|4540193|P5|Treatment Phase (Weeks 0-24)|Adverse Event|2
1375863|NCT01457924|4540194|P4|Treatment Phase (Weeks 0-24)|Adverse Event|0
1375864|NCT01457924|4540195|P3|Treatment Phase (Weeks 0-24)|Adverse Event|1
1375865|NCT01457924|4540196|P2|Treatment Phase (Weeks 0-24)|Adverse Event|4
1375866|NCT01457924|4540197|P1|Treatment Phase (Weeks 0-24)|Adverse Event|0
1375867|NCT01457846|4540267|P2|Overall Study|Lost to Follow-up|0
1375868|NCT01457846|4540268|P1|Overall Study|Lost to Follow-up|1
1375869|NCT01457846|4540267|P2|Overall Study|Withdrawal by Subject|1
1375870|NCT01457846|4540268|P1|Overall Study|Withdrawal by Subject|1
1375871|NCT01457846|4540267|P2|Overall Study|Unclassified reason for not completed|10
1375872|NCT01457846|4540268|P1|Overall Study|Unclassified reason for not completed|11
1375873|NCT01457846|4540267|P2|Overall Study|Death|16
1375874|NCT01457846|4540268|P1|Overall Study|Death|27
1375875|NCT01457846|4540267|P2|Overall Study|Did not receive treatment|1
1375876|NCT01457846|4540268|P1|Overall Study|Did not receive treatment|0
1375877|NCT01457846|4540267|P2|Overall Study|Death before treatment|2
1375878|NCT01457846|4540268|P1|Overall Study|Death before treatment|1
1375879|NCT01457703|4540284|P2|Overall Study|Withdrawal by Subject|4
1375880|NCT01457703|4540285|P1|Overall Study|Withdrawal by Subject|1
1375881|NCT01457703|4540284|P2|Overall Study|Screen Failure|7
1375882|NCT01457703|4540285|P1|Overall Study|Screen Failure|5
1375883|NCT01457339|4540396|P2|Period 6 (250 mg)|Personal appointment|1
1375884|NCT01457339|4540397|P1|Period 6 (250 mg)|Personal appointment|0
1375885|NCT01457339|4540396|P2|Period 6 (250 mg)|Family Emergency|0
1375886|NCT01457339|4540397|P1|Period 6 (250 mg)|Family Emergency|1
1375887|NCT01457339|4540396|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
1375888|NCT01457339|4540397|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
1375889|NCT01457339|4540396|P2|Period 3 (100 mg)|Adverse Event|1
1375890|NCT01457339|4540397|P1|Period 3 (100 mg)|Adverse Event|0
1375891|NCT01457053|4540563|P2|Overall Study|Unable to undergo selected treatment|1
1375892|NCT01457053|4540564|P1|Overall Study|Unable to undergo selected treatment|1
1375893|NCT01457014|4540570|P4|First Night|Withdrawal by Subject|0
1375894|NCT01457014|4540571|P3|First Night|Withdrawal by Subject|0
1375895|NCT01457014|4540572|P2|First Night|Withdrawal by Subject|0
1375896|NCT01457014|4540573|P1|First Night|Withdrawal by Subject|3
1375897|NCT01457014|4540570|P4|First Night|Didn't meet inclusion/exclusion criteria|0
1375898|NCT01457014|4540571|P3|First Night|Didn't meet inclusion/exclusion criteria|0
1375899|NCT01457014|4540572|P2|First Night|Didn't meet inclusion/exclusion criteria|0
1375900|NCT01457014|4540573|P1|First Night|Didn't meet inclusion/exclusion criteria|37
1375901|NCT01456962|4540590|P2|Overall Study|Lost to Follow-up|1
1375902|NCT01456962|4540591|P1|Overall Study|Lost to Follow-up|2
1375903|NCT01456936|4540601|P4|Overall Study|Randomized but not treated|21
1375904|NCT01456936|4540602|P3|Overall Study|Randomized but not treated|16
1375905|NCT01456936|4540603|P2|Overall Study|Randomized but not treated|28
1375906|NCT01456936|4540604|P1|Overall Study|Randomized but not treated|21
1375907|NCT01456936|4540601|P4|Overall Study|Death|3
1375908|NCT01456936|4540602|P3|Overall Study|Death|1
1375909|NCT01456936|4540603|P2|Overall Study|Death|3
1375910|NCT01456936|4540604|P1|Overall Study|Death|0
1375911|NCT01456936|4540601|P4|Overall Study|Adverse event (study drug unrelated)|9
1375912|NCT01456936|4540602|P3|Overall Study|Adverse event (study drug unrelated)|9
1375913|NCT01456936|4540603|P2|Overall Study|Adverse event (study drug unrelated)|7
1375914|NCT01456936|4540604|P1|Overall Study|Adverse event (study drug unrelated)|9
1375915|NCT01456936|4540601|P4|Overall Study|Adverse event (study drug)|17
1375916|NCT01456936|4540602|P3|Overall Study|Adverse event (study drug)|26
1375917|NCT01456936|4540603|P2|Overall Study|Adverse event (study drug)|21
1375918|NCT01456936|4540604|P1|Overall Study|Adverse event (study drug)|25
1375919|NCT01456936|4540601|P4|Overall Study|Medication error|1
1375920|NCT01456936|4540602|P3|Overall Study|Medication error|0
1375921|NCT01456936|4540603|P2|Overall Study|Medication error|1
1375922|NCT01456936|4540604|P1|Overall Study|Medication error|0
1375923|NCT01456936|4540601|P4|Overall Study|Lost to Follow-up|127
1375924|NCT01456936|4540602|P3|Overall Study|Lost to Follow-up|144
1375925|NCT01456936|4540603|P2|Overall Study|Lost to Follow-up|126
1375926|NCT01456936|4540604|P1|Overall Study|Lost to Follow-up|135
1375927|NCT01456936|4540601|P4|Overall Study|No longer willing to participate|248
1375928|NCT01456936|4540602|P3|Overall Study|No longer willing to participate|224
1375929|NCT01456936|4540603|P2|Overall Study|No longer willing to participate|218
1375930|NCT01456936|4540604|P1|Overall Study|No longer willing to participate|195
1375931|NCT01456936|4540601|P4|Overall Study|Insufficient clinical response|13
1375932|NCT01456936|4540602|P3|Overall Study|Insufficient clinical response|14
1375933|NCT01456936|4540603|P2|Overall Study|Insufficient clinical response|4
1375934|NCT01456936|4540604|P1|Overall Study|Insufficient clinical response|4
1375935|NCT01456936|4540601|P4|Overall Study|Pregnancy|1
1375936|NCT01456936|4540602|P3|Overall Study|Pregnancy|0
1375937|NCT01456936|4540603|P2|Overall Study|Pregnancy|0
1375938|NCT01456936|4540604|P1|Overall Study|Pregnancy|1
1375939|NCT01456936|4540601|P4|Overall Study|Protocol Violation|5
1375940|NCT01456936|4540602|P3|Overall Study|Protocol Violation|5
1375941|NCT01456936|4540603|P2|Overall Study|Protocol Violation|2
1375942|NCT01456936|4540604|P1|Overall Study|Protocol Violation|4
1375943|NCT01456936|4540601|P4|Overall Study|No longer meets eligibility criteria|5
1375944|NCT01456936|4540602|P3|Overall Study|No longer meets eligibility criteria|6
1375945|NCT01456936|4540603|P2|Overall Study|No longer meets eligibility criteria|8
1375946|NCT01456936|4540604|P1|Overall Study|No longer meets eligibility criteria|4
1375947|NCT01456936|4540601|P4|Overall Study|Other reason|33
1375948|NCT01456936|4540602|P3|Overall Study|Other reason|36
1375949|NCT01456936|4540603|P2|Overall Study|Other reason|30
1375950|NCT01456936|4540604|P1|Overall Study|Other reason|41
1375951|NCT01456780|4540713|P3|Overall Study|Lost to Follow-up|0
1375952|NCT01456780|4540714|P2|Overall Study|Lost to Follow-up|3
1375953|NCT01456780|4540715|P1|Overall Study|Lost to Follow-up|3
1375954|NCT01456195|4540748|P3|Overall Study|Other Reasons|3
1375955|NCT01456195|4540749|P2|Overall Study|Other Reasons|1
1375956|NCT01456195|4540750|P1|Overall Study|Other Reasons|2
1375957|NCT01456195|4540748|P3|Overall Study|Lack of Efficacy|0
1375958|NCT01456195|4540749|P2|Overall Study|Lack of Efficacy|1
1375959|NCT01456195|4540750|P1|Overall Study|Lack of Efficacy|0
1375960|NCT01456195|4540748|P3|Overall Study|Voluntary Withdrawal|7
1375961|NCT01456195|4540749|P2|Overall Study|Voluntary Withdrawal|3
1375962|NCT01456195|4540750|P1|Overall Study|Voluntary Withdrawal|5
1375963|NCT01456195|4540748|P3|Overall Study|Lost to Follow-up|3
1375964|NCT01456195|4540749|P2|Overall Study|Lost to Follow-up|1
1375965|NCT01456195|4540750|P1|Overall Study|Lost to Follow-up|3
1375966|NCT01456195|4540748|P3|Overall Study|Pretreatment Event/Adverse Event|1
1375967|NCT01456195|4540749|P2|Overall Study|Pretreatment Event/Adverse Event|4
1375968|NCT01456195|4540750|P1|Overall Study|Pretreatment Event/Adverse Event|1
1375969|NCT01456169|4540770|P3|Overall Study|Other|0
1375970|NCT01456169|4540771|P2|Overall Study|Other|1
1375971|NCT01456169|4540772|P1|Overall Study|Other|1
1375972|NCT01456169|4540770|P3|Overall Study|Lack of Efficacy|0
1375973|NCT01456169|4540771|P2|Overall Study|Lack of Efficacy|0
1375974|NCT01456169|4540772|P1|Overall Study|Lack of Efficacy|2
1375975|NCT01456169|4540770|P3|Overall Study|Voluntary Withdrawal|2
1375976|NCT01456169|4540771|P2|Overall Study|Voluntary Withdrawal|0
1375977|NCT01456169|4540772|P1|Overall Study|Voluntary Withdrawal|3
1375978|NCT01456169|4540770|P3|Overall Study|Major Protocol Deviation|3
1375979|NCT01456169|4540771|P2|Overall Study|Major Protocol Deviation|2
1375980|NCT01456169|4540772|P1|Overall Study|Major Protocol Deviation|3
1375981|NCT01456169|4540770|P3|Overall Study|Adverse Event|7
1375982|NCT01456169|4540771|P2|Overall Study|Adverse Event|2
1375983|NCT01456169|4540772|P1|Overall Study|Adverse Event|1
1375984|NCT01456130|4540832|P1|Overall Study|Other|1
1375985|NCT01456130|4540832|P1|Overall Study|Lack of Efficacy|4
1375986|NCT01456130|4540832|P1|Overall Study|Voluntary Withdrawal|1
1375987|NCT01456130|4540832|P1|Overall Study|Adverse Event|4
1375988|NCT01456052|4540842|P3|Overall Study|Treatment Failure|1
1375989|NCT01456052|4540843|P2|Overall Study|Treatment Failure|1
1375990|NCT01456052|4540844|P1|Overall Study|Treatment Failure|0
1375991|NCT01456052|4540842|P3|Overall Study|Physician Decision|1
1375992|NCT01456052|4540843|P2|Overall Study|Physician Decision|0
1375993|NCT01456052|4540844|P1|Overall Study|Physician Decision|1
1375994|NCT01456052|4540842|P3|Overall Study|Protocol Violation|0
1375995|NCT01456052|4540843|P2|Overall Study|Protocol Violation|1
1375996|NCT01456052|4540844|P1|Overall Study|Protocol Violation|0
1375997|NCT01456052|4540842|P3|Overall Study|Consent withdrawn|1
1375998|NCT01456052|4540843|P2|Overall Study|Consent withdrawn|2
1375999|NCT01456052|4540844|P1|Overall Study|Consent withdrawn|0
1376000|NCT01456052|4540842|P3|Overall Study|Adverse Event|2
1376001|NCT01456052|4540843|P2|Overall Study|Adverse Event|1
1376002|NCT01456052|4540844|P1|Overall Study|Adverse Event|1
1376003|NCT01456039|4540864|P3|Phase 2 (Second Step)|Other|1
1376004|NCT01456039|4540865|P2|Phase 2 (Second Step)|Other|0
1376005|NCT01456039|4540866|P1|Phase 2 (Second Step)|Other|0
1376006|NCT01456039|4540864|P3|Phase 2 (Second Step)|Protocol Violation|1
1376007|NCT01456039|4540865|P2|Phase 2 (Second Step)|Protocol Violation|0
1376008|NCT01456039|4540866|P1|Phase 2 (Second Step)|Protocol Violation|0
1376009|NCT01456039|4540864|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
1376010|NCT01456039|4540865|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
1376011|NCT01456039|4540866|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
1376012|NCT01456039|4540864|P3|Phase 2 (Second Step)|Adverse Event|10
1376013|NCT01456039|4540865|P2|Phase 2 (Second Step)|Adverse Event|0
1376014|NCT01456039|4540866|P1|Phase 2 (Second Step)|Adverse Event|0
1376015|NCT01456039|4540864|P3|Phase 2 (Second Step)|Disease Progression|17
1376016|NCT01456039|4540865|P2|Phase 2 (Second Step)|Disease Progression|0
1376017|NCT01456039|4540866|P1|Phase 2 (Second Step)|Disease Progression|0
1376018|NCT01456039|4540864|P3|Phase 1 (First Step)|Not specified|0
1376019|NCT01456039|4540865|P2|Phase 1 (First Step)|Not specified|1
1376020|NCT01456039|4540866|P1|Phase 1 (First Step)|Not specified|0
1376021|NCT01456039|4540864|P3|Phase 1 (First Step)|Adverse Event|0
1376022|NCT01456039|4540865|P2|Phase 1 (First Step)|Adverse Event|3
1376023|NCT01456039|4540866|P1|Phase 1 (First Step)|Adverse Event|0
1376024|NCT01456039|4540864|P3|Phase 1 (First Step)|Withdrawal by Subject|0
1376025|NCT01456039|4540865|P2|Phase 1 (First Step)|Withdrawal by Subject|2
1376026|NCT01456039|4540866|P1|Phase 1 (First Step)|Withdrawal by Subject|1
1376027|NCT01456039|4540864|P3|Phase 1 (First Step)|Disease Progression|0
1376028|NCT01456039|4540865|P2|Phase 1 (First Step)|Disease Progression|1
1376029|NCT01456039|4540866|P1|Phase 1 (First Step)|Disease Progression|1
1376030|NCT01455428|4541009|P2|Overall Study|Other|4
1376031|NCT01455428|4541010|P1|Overall Study|Other|2
1376032|NCT01455428|4541009|P2|Overall Study|Did not receive treatment|1
1376033|NCT01455428|4541010|P1|Overall Study|Did not receive treatment|1
1376034|NCT01455428|4541009|P2|Overall Study|Insufficient clinical response|2
1376035|NCT01455428|4541010|P1|Overall Study|Insufficient clinical response|0
1376036|NCT01455428|4541009|P2|Overall Study|Did not meet entrance criteria|2
1376037|NCT01455428|4541010|P1|Overall Study|Did not meet entrance criteria|0
1376038|NCT01455428|4541009|P2|Overall Study|Withdrawal by Subject|5
1376039|NCT01455428|4541010|P1|Overall Study|Withdrawal by Subject|2
1376040|NCT01455428|4541009|P2|Overall Study|Lost to Follow-up|1
1376041|NCT01455428|4541010|P1|Overall Study|Lost to Follow-up|1
1376042|NCT01455428|4541009|P2|Overall Study|Adverse Event|2
1376043|NCT01455428|4541010|P1|Overall Study|Adverse Event|6
1376044|NCT01455428|4541009|P2|Overall Study|Protocol Violation|1
1376045|NCT01455428|4541010|P1|Overall Study|Protocol Violation|2
1376046|NCT01455415|4541066|P2|Follow-up|Unspecified Reason|0
1376047|NCT01455415|4541067|P1|Follow-up|Unspecified Reason|1
1376048|NCT01455415|4541066|P2|Follow-up|Withdrawal by Subject|0
1376049|NCT01455415|4541067|P1|Follow-up|Withdrawal by Subject|2
1376050|NCT01455415|4541066|P2|Follow-up|Lack of Efficacy|1
1376051|NCT01455415|4541067|P1|Follow-up|Lack of Efficacy|0
1376052|NCT01455415|4541066|P2|Follow-up|AE Related to Study Drug|1
1376053|NCT01455415|4541067|P1|Follow-up|AE Related to Study Drug|0
1376054|NCT01455415|4541066|P2|Period 2|Protocol Violation|0
1376055|NCT01455415|4541067|P1|Period 2|Protocol Violation|2
1376056|NCT01455415|4541066|P2|Period 2|Unspecified Reason|3
1376057|NCT01455415|4541067|P1|Period 2|Unspecified Reason|2
1376058|NCT01455415|4541066|P2|Period 2|Withdrawal by Subject|3
1376059|NCT01455415|4541067|P1|Period 2|Withdrawal by Subject|2
1376060|NCT01455415|4541066|P2|Period 2|Lack of Efficacy|0
1376061|NCT01455415|4541067|P1|Period 2|Lack of Efficacy|2
1376062|NCT01455415|4541066|P2|Period 2|AE Not Related to Study Drug|1
1376063|NCT01455415|4541067|P1|Period 2|AE Not Related to Study Drug|2
1376064|NCT01455415|4541066|P2|Period 2|Lost to Follow-up|1
1376065|NCT01455415|4541067|P1|Period 2|Lost to Follow-up|2
1376066|NCT01455415|4541066|P2|Period 2|AE Related to Study Drug|2
1376067|NCT01455415|4541067|P1|Period 2|AE Related to Study Drug|1
1376068|NCT01455415|4541066|P2|Washout|Protocol Violation|1
1376069|NCT01455415|4541067|P1|Washout|Protocol Violation|0
1376070|NCT01455415|4541066|P2|Washout|Unspecified Reason|2
1376071|NCT01455415|4541067|P1|Washout|Unspecified Reason|1
1376072|NCT01455415|4541066|P2|Washout|AE Not Related to Study Drug|3
1376073|NCT01455415|4541067|P1|Washout|AE Not Related to Study Drug|2
1376074|NCT01455415|4541066|P2|Washout|Drug Error not Associated to AE|1
1376075|NCT01455415|4541067|P1|Washout|Drug Error not Associated to AE|2
1376076|NCT01455415|4541066|P2|Washout|Lost to Follow-up|0
1376077|NCT01455415|4541067|P1|Washout|Lost to Follow-up|1
1376078|NCT01455415|4541066|P2|Washout|AE Related to Study Drug|0
1376079|NCT01455415|4541067|P1|Washout|AE Related to Study Drug|2
1376080|NCT01455415|4541066|P2|Period 1|Protocol Violation|2
1376081|NCT01455415|4541067|P1|Period 1|Protocol Violation|0
1376082|NCT01455415|4541066|P2|Period 1|Unspecified Reason|1
1376083|NCT01455415|4541067|P1|Period 1|Unspecified Reason|1
1376084|NCT01455415|4541066|P2|Period 1|Withdrawal by Subject|5
1376085|NCT01455415|4541067|P1|Period 1|Withdrawal by Subject|4
1376086|NCT01455415|4541066|P2|Period 1|AE Not Related to Study Drug|6
1376087|NCT01455415|4541067|P1|Period 1|AE Not Related to Study Drug|2
1376088|NCT01455415|4541066|P2|Period 1|Drug Error not Associated to AE|1
1376089|NCT01455415|4541067|P1|Period 1|Drug Error not Associated to AE|0
1376090|NCT01455415|4541066|P2|Period 1|Lost To Follow-up Related to Study Drug|3
1376091|NCT01455415|4541067|P1|Period 1|Lost To Follow-up Related to Study Drug|3
1376092|NCT01455415|4541066|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
1376093|NCT01455415|4541067|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
1376094|NCT01455220|4541117|P1|Overall Study|screen fail|30
1376095|NCT01455194|4541127|P4|Overall Study|Miscellaneous|4
1376096|NCT01455194|4541128|P3|Overall Study|Miscellaneous|1
1376097|NCT01455194|4541129|P2|Overall Study|Miscellaneous|5
1376098|NCT01455194|4541130|P1|Overall Study|Miscellaneous|4
1376099|NCT01455194|4541127|P4|Overall Study|Discontinuation criterion fulfilled|2
1376100|NCT01455194|4541128|P3|Overall Study|Discontinuation criterion fulfilled|0
1376101|NCT01455194|4541129|P2|Overall Study|Discontinuation criterion fulfilled|2
1376102|NCT01455194|4541130|P1|Overall Study|Discontinuation criterion fulfilled|3
1376103|NCT01455194|4541127|P4|Overall Study|Pregnancy|0
1376104|NCT01455194|4541128|P3|Overall Study|Pregnancy|1
1376105|NCT01455194|4541129|P2|Overall Study|Pregnancy|1
1376106|NCT01455194|4541130|P1|Overall Study|Pregnancy|0
1376107|NCT01455194|4541127|P4|Overall Study|Lost to Follow-up|1
1376108|NCT01455194|4541128|P3|Overall Study|Lost to Follow-up|1
1376109|NCT01455194|4541129|P2|Overall Study|Lost to Follow-up|0
1376110|NCT01455194|4541130|P1|Overall Study|Lost to Follow-up|2
1376111|NCT01455194|4541127|P4|Overall Study|Withdrawal by Subject|9
1376112|NCT01455194|4541128|P3|Overall Study|Withdrawal by Subject|12
1376113|NCT01455194|4541129|P2|Overall Study|Withdrawal by Subject|16
1376114|NCT01455194|4541130|P1|Overall Study|Withdrawal by Subject|21
1376115|NCT01455194|4541127|P4|Overall Study|Adverse Event|3
1376116|NCT01455194|4541128|P3|Overall Study|Adverse Event|1
1376117|NCT01455194|4541129|P2|Overall Study|Adverse Event|1
1376118|NCT01455194|4541130|P1|Overall Study|Adverse Event|1
1376119|NCT01455194|4541127|P4|Overall Study|Deterioration in asthma|9
1376120|NCT01455194|4541128|P3|Overall Study|Deterioration in asthma|14
1376121|NCT01455194|4541129|P2|Overall Study|Deterioration in asthma|6
1376122|NCT01455194|4541130|P1|Overall Study|Deterioration in asthma|12
1376123|NCT01455194|4541127|P4|Overall Study|Randomisation Failure|0
1376124|NCT01455194|4541128|P3|Overall Study|Randomisation Failure|0
1376125|NCT01455194|4541129|P2|Overall Study|Randomisation Failure|0
1376126|NCT01455194|4541130|P1|Overall Study|Randomisation Failure|90
1376127|NCT01455194|4541127|P4|Overall Study|Screen Failure|0
1376128|NCT01455194|4541128|P3|Overall Study|Screen Failure|0
1376129|NCT01455194|4541129|P2|Overall Study|Screen Failure|0
1376130|NCT01455194|4541130|P1|Overall Study|Screen Failure|20
1376131|NCT01455012|4541193|P2|Overall Study|Unknown reason|0
1376132|NCT01455012|4541194|P1|Overall Study|Unknown reason|2
1376133|NCT01455012|4541193|P2|Overall Study|Withdrawal by Subject|1
1376134|NCT01455012|4541194|P1|Overall Study|Withdrawal by Subject|3
1376135|NCT01455012|4541193|P2|Overall Study|Lack of Efficacy|1
1376136|NCT01455012|4541194|P1|Overall Study|Lack of Efficacy|6
1376137|NCT01455012|4541193|P2|Overall Study|Adverse Event|2
1376138|NCT01455012|4541194|P1|Overall Study|Adverse Event|0
1376139|NCT01454934|4541261|P2|Overall Study|Ongoing, survival follow-up|2
1376140|NCT01454934|4541262|P1|Overall Study|Ongoing, survival follow-up|1
1376141|NCT01454934|4541261|P2|Overall Study|Not treated|2
1376142|NCT01454934|4541262|P1|Overall Study|Not treated|1
1376143|NCT01454934|4541261|P2|Overall Study|Not specified|16
1376144|NCT01454934|4541262|P1|Overall Study|Not specified|5
1376145|NCT01454934|4541261|P2|Overall Study|Clinical progression|25
1376146|NCT01454934|4541262|P1|Overall Study|Clinical progression|28
1376147|NCT01454934|4541261|P2|Overall Study|Withdrawn consent|5
1376148|NCT01454934|4541262|P1|Overall Study|Withdrawn consent|2
1376149|NCT01454934|4541261|P2|Overall Study|Lost to Follow-up|1
1376150|NCT01454934|4541262|P1|Overall Study|Lost to Follow-up|0
1376151|NCT01454934|4541261|P2|Overall Study|Withdrawal by Subject|15
1376152|NCT01454934|4541262|P1|Overall Study|Withdrawal by Subject|11
1376153|NCT01454934|4541261|P2|Overall Study|Adverse Event|24
1376154|NCT01454934|4541262|P1|Overall Study|Adverse Event|28
1376155|NCT01454934|4541261|P2|Overall Study|Disease progression|180
1376156|NCT01454934|4541262|P1|Overall Study|Disease progression|194
1376157|NCT01454830|4541274|P2|Overall Study|Withdrawal - no polysomnography|2
1376158|NCT01454830|4541275|P1|Overall Study|Withdrawal - no polysomnography|3
1376159|NCT01454830|4541274|P2|Overall Study|Post-allocation Exclude-other treatment|7
1376160|NCT01454830|4541275|P1|Overall Study|Post-allocation Exclude-other treatment|6
1376161|NCT01454830|4541274|P2|Overall Study|Post-allocation Exclude-refused PAP|2
1376162|NCT01454830|4541275|P1|Overall Study|Post-allocation Exclude-refused PAP|0
1376163|NCT01454830|4541274|P2|Overall Study|Post-allocation Exclude- AHI<10|12
1376164|NCT01454830|4541275|P1|Overall Study|Post-allocation Exclude- AHI<10|18
1376165|NCT01454830|4541274|P2|Overall Study|Withdrawal by Subject|4
1376166|NCT01454830|4541275|P1|Overall Study|Withdrawal by Subject|4
1376167|NCT01454778|4541306|P1|Overall Study|Death|1
1376168|NCT01454778|4541306|P1|Overall Study|Lost to Follow-up|2
1376169|NCT01454726|4541317|P2|Overall Study|Withdrawal by Subject|1
1376170|NCT01454726|4541318|P1|Overall Study|Withdrawal by Subject|0
1376171|NCT01454583|4541327|P3|3rd Year|Lost to Follow-up|297
1376172|NCT01454583|4541328|P2|3rd Year|Lost to Follow-up|512
1376173|NCT01454583|4541329|P1|3rd Year|Lost to Follow-up|1959
1376174|NCT01454583|4541327|P3|2nd Year|Lost to Follow-up|737
1376175|NCT01454583|4541328|P2|2nd Year|Lost to Follow-up|1049
1376176|NCT01454583|4541329|P1|2nd Year|Lost to Follow-up|3965
1376177|NCT01454583|4541327|P3|1st Year|Lost to Follow-up|180
1376178|NCT01454583|4541328|P2|1st Year|Lost to Follow-up|318
1376179|NCT01454583|4541329|P1|1st Year|Lost to Follow-up|1057
1376180|NCT01454531|4541397|P1|Overall Study|Other|1
1376181|NCT01454531|4541397|P1|Overall Study|Delay in IMP administration|1
1376182|NCT01454531|4541397|P1|Overall Study|Physician Decision|1
1376183|NCT01454531|4541397|P1|Overall Study|Lost to Follow-up|1
1376184|NCT01454531|4541397|P1|Overall Study|Withdrawal by Subject|5
1376185|NCT01454531|4541397|P1|Overall Study|Adverse Event|14
1376186|NCT01454401|4541433|P1|Overall Study|non-adherence|1
1376187|NCT01454401|4541433|P1|Overall Study|osteomyelitis|2
1376188|NCT01454401|4541433|P1|Overall Study|hospitalised|1
1376189|NCT01454401|4541433|P1|Overall Study|Death|1
1376190|NCT01454284|4541440|P2|Overall Study|Sponsor Decision|2
1376191|NCT01454284|4541441|P1|Overall Study|Sponsor Decision|0
1376192|NCT01454284|4541440|P2|Overall Study|Physician Decision|11
1376193|NCT01454284|4541441|P1|Overall Study|Physician Decision|16
1376194|NCT01454284|4541440|P2|Overall Study|Withdrawal by Subject|36
1376195|NCT01454284|4541441|P1|Overall Study|Withdrawal by Subject|58
1376196|NCT01454284|4541440|P2|Overall Study|Protocol Violation|6
1376197|NCT01454284|4541441|P1|Overall Study|Protocol Violation|9
1376198|NCT01454284|4541440|P2|Overall Study|Lost to Follow-up|8
1376199|NCT01454284|4541441|P1|Overall Study|Lost to Follow-up|13
1376200|NCT01454284|4541440|P2|Overall Study|Death|3
1376201|NCT01454284|4541441|P1|Overall Study|Death|0
1376202|NCT01454284|4541440|P2|Overall Study|Adverse Event|7
1376203|NCT01454284|4541441|P1|Overall Study|Adverse Event|20
1376204|NCT01454076|4541500|P5|Overall Study|Adverse Event|2
1376205|NCT01454076|4541501|P4|Overall Study|Adverse Event|0
1376206|NCT01454076|4541502|P3|Overall Study|Adverse Event|7
1376207|NCT01454076|4541503|P2|Overall Study|Adverse Event|2
1376208|NCT01454076|4541504|P1|Overall Study|Adverse Event|8
1376209|NCT01454076|4541500|P5|Overall Study|Withdrawal by Subject|2
1376210|NCT01454076|4541501|P4|Overall Study|Withdrawal by Subject|1
1376211|NCT01454076|4541502|P3|Overall Study|Withdrawal by Subject|2
1376212|NCT01454076|4541503|P2|Overall Study|Withdrawal by Subject|4
1376213|NCT01454076|4541504|P1|Overall Study|Withdrawal by Subject|3
1376214|NCT01454076|4541500|P5|Overall Study|Other|2
1376215|NCT01454076|4541501|P4|Overall Study|Other|1
1376216|NCT01454076|4541502|P3|Overall Study|Other|0
1376217|NCT01454076|4541503|P2|Overall Study|Other|0
1376218|NCT01454076|4541504|P1|Overall Study|Other|2
1376219|NCT01454063|4541557|P2|Randomized|Protocol Violation|1
1376220|NCT01454063|4541558|P1|Randomized|Protocol Violation|0
1376221|NCT01454063|4541557|P2|Randomized|Adverse Event|1
1376222|NCT01454063|4541558|P1|Randomized|Adverse Event|1
1376223|NCT01453998|4541579|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
1376224|NCT01453998|4541580|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
1376225|NCT01453998|4541581|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
1376226|NCT01453946|4541646|P1|Overall Study|Adverse Event|3
1376227|NCT01453946|4541646|P1|Overall Study|Lack of Efficacy|3
1376228|NCT01453946|4541646|P1|Overall Study|Protocol Violation|2
1376229|NCT01453946|4541646|P1|Overall Study|Did not receive drug for the taper phase|1
1376230|NCT01453855|4541663|P2|Overall Study|Other|1
1376231|NCT01453855|4541664|P1|Overall Study|Other|0
1376232|NCT01453855|4541663|P2|Overall Study|Inadequate Control of IOP|5
1376233|NCT01453855|4541664|P1|Overall Study|Inadequate Control of IOP|1
1376234|NCT01453855|4541663|P2|Overall Study|Noncompliance|0
1376235|NCT01453855|4541664|P1|Overall Study|Noncompliance|1
1376236|NCT01453855|4541663|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
1376237|NCT01453855|4541664|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
1376238|NCT01453855|4541663|P2|Overall Study|Lost to Follow-up|1
1376239|NCT01453855|4541664|P1|Overall Study|Lost to Follow-up|2
1376240|NCT01453855|4541663|P2|Overall Study|Adverse Event|4
1376241|NCT01453855|4541664|P1|Overall Study|Adverse Event|3
1376242|NCT01453725|4541672|P2|Overall Study|Physician Decision|1
1376243|NCT01453725|4541673|P1|Overall Study|Physician Decision|1
1376244|NCT01453725|4541672|P2|Overall Study|Pregnancy|0
1376245|NCT01453725|4541673|P1|Overall Study|Pregnancy|1
1376246|NCT01453725|4541672|P2|Overall Study|Pregnancy Wish|2
1376247|NCT01453725|4541673|P1|Overall Study|Pregnancy Wish|0
1376248|NCT01453725|4541672|P2|Overall Study|Withdrawal by Subject|3
1376249|NCT01453725|4541673|P1|Overall Study|Withdrawal by Subject|2
1376250|NCT01453725|4541672|P2|Overall Study|Protocol Violation|0
1376251|NCT01453725|4541673|P1|Overall Study|Protocol Violation|1
1376252|NCT01453725|4541672|P2|Overall Study|Non-compliance With Protocol|2
1376253|NCT01453725|4541673|P1|Overall Study|Non-compliance With Protocol|1
1376254|NCT01453725|4541672|P2|Overall Study|Lost to Follow-up|0
1376255|NCT01453725|4541673|P1|Overall Study|Lost to Follow-up|4
1376256|NCT01453725|4541672|P2|Overall Study|Adverse Event|3
1376257|NCT01453725|4541673|P1|Overall Study|Adverse Event|3
1376258|NCT01453595|4541696|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
1376259|NCT01453595|4541697|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
1376260|NCT01453595|4541698|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
1376261|NCT01453374|4541817|P1|Overall Study|Incarcerated|2
1376262|NCT01453374|4541817|P1|Overall Study|Withdrawal by Subject|5
1376263|NCT01453374|4541817|P1|Overall Study|Lost to Follow-up|3
1376264|NCT01453374|4541817|P1|Overall Study|Lack of Efficacy|1
1376265|NCT01453374|4541817|P1|Overall Study|Adverse Event|7
1376266|NCT01453361|4541833|P1|Overall Study|Screen-Failures|10
1376267|NCT01453361|4541833|P1|Overall Study|Disease Progression|6
1376268|NCT01453348|4541841|P3|Overall Study|Protocol Violation|0
1376269|NCT01453348|4541842|P2|Overall Study|Protocol Violation|0
1376270|NCT01453348|4541843|P1|Overall Study|Protocol Violation|1
1376271|NCT01453348|4541841|P3|Overall Study|Withdrawal by Subject|0
1376272|NCT01453348|4541842|P2|Overall Study|Withdrawal by Subject|1
1376273|NCT01453348|4541843|P1|Overall Study|Withdrawal by Subject|0
1376274|NCT01453348|4541841|P3|Overall Study|Death|1
1376275|NCT01453348|4541842|P2|Overall Study|Death|0
1376276|NCT01453348|4541843|P1|Overall Study|Death|0
1376277|NCT01453296|4541859|P2|Treatment Period 2|Withdrawal by Subject|0
1376278|NCT01453296|4541860|P1|Treatment Period 2|Withdrawal by Subject|1
1376279|NCT01453296|4541859|P2|Treatment Period 2|Adverse Event|0
1376280|NCT01453296|4541860|P1|Treatment Period 2|Adverse Event|1
1376281|NCT01453296|4541859|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
1376282|NCT01453296|4541860|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
1376283|NCT01453296|4541859|P2|Treatment Period 1|Adverse Event|1
1376284|NCT01453296|4541860|P1|Treatment Period 1|Adverse Event|0
1376285|NCT01453205|4541927|P3|Overall Study|Other|35
1376286|NCT01453205|4541928|P2|Overall Study|Other|27
1376287|NCT01453205|4541929|P1|Overall Study|Other|45
1376288|NCT01453205|4541927|P3|Overall Study|Death|18
1376289|NCT01453205|4541928|P2|Overall Study|Death|22
1376290|NCT01453205|4541929|P1|Overall Study|Death|24
1376291|NCT01453205|4541927|P3|Overall Study|Withdrawal by Subject|0
1376292|NCT01453205|4541928|P2|Overall Study|Withdrawal by Subject|3
1376293|NCT01453205|4541929|P1|Overall Study|Withdrawal by Subject|8
1376294|NCT01453205|4541927|P3|Overall Study|Lost to Follow-up|1
1376295|NCT01453205|4541928|P2|Overall Study|Lost to Follow-up|0
1376296|NCT01453205|4541929|P1|Overall Study|Lost to Follow-up|3
1376297|NCT01453049|4542013|P2|Overall Study|Randomized in Error|0
1376298|NCT01453049|4542014|P1|Overall Study|Randomized in Error|1
1376299|NCT01453049|4542013|P2|Overall Study|Withdrawal by Subject|0
1376300|NCT01453049|4542014|P1|Overall Study|Withdrawal by Subject|1
1376301|NCT01453049|4542013|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
1376302|NCT01453049|4542014|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
1376303|NCT01453049|4542013|P2|Overall Study|Lost to Follow-up|1
1376304|NCT01453049|4542014|P1|Overall Study|Lost to Follow-up|2
1376305|NCT01453049|4542013|P2|Overall Study|Protocol Violation|5
1376306|NCT01453049|4542014|P1|Overall Study|Protocol Violation|2
1376307|NCT01453036|4542087|P3|Overall Study|Lost to Follow-up|31
1376308|NCT01453036|4542088|P2|Overall Study|Lost to Follow-up|115
1376309|NCT01453036|4542089|P1|Overall Study|Lost to Follow-up|26
1376310|NCT01453023|4542097|P2|Treatment Period 2|Protocol Violation|1
1376311|NCT01453023|4542098|P1|Treatment Period 2|Protocol Violation|0
1376312|NCT01453023|4542097|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
1376313|NCT01453023|4542098|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
1376314|NCT01453023|4542097|P2|Treatment Period (TP) 1|Protocol Violation|0
1376315|NCT01453023|4542098|P1|Treatment Period (TP) 1|Protocol Violation|1
1376316|NCT01452529|4542172|P3|Double-blind (DB) Period|Administrative|7
1376317|NCT01452529|4542173|P2|Double-blind (DB) Period|Administrative|11
1376318|NCT01452529|4542174|P1|Double-blind (DB) Period|Administrative|0
1376319|NCT01452529|4542172|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
1376320|NCT01452529|4542173|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
1376321|NCT01452529|4542174|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
1376322|NCT01452529|4542172|P3|Double-blind (DB) Period|Lack of Efficacy|44
1376323|NCT01452529|4542173|P2|Double-blind (DB) Period|Lack of Efficacy|16
1376324|NCT01452529|4542174|P1|Double-blind (DB) Period|Lack of Efficacy|0
1376325|NCT01452529|4542172|P3|Double-blind (DB) Period|Lost to Follow-up|3
1376326|NCT01452529|4542173|P2|Double-blind (DB) Period|Lost to Follow-up|5
1376327|NCT01452529|4542174|P1|Double-blind (DB) Period|Lost to Follow-up|0
1376328|NCT01452529|4542172|P3|Double-blind (DB) Period|Withdrawal by Subject|14
1376329|NCT01452529|4542173|P2|Double-blind (DB) Period|Withdrawal by Subject|15
1376330|NCT01452529|4542174|P1|Double-blind (DB) Period|Withdrawal by Subject|0
1376331|NCT01452529|4542172|P3|Double-blind (DB) Period|Adverse Event|11
1376332|NCT01452529|4542173|P2|Double-blind (DB) Period|Adverse Event|18
1376333|NCT01452529|4542174|P1|Double-blind (DB) Period|Adverse Event|0
1376334|NCT01452529|4542172|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
1376335|NCT01452529|4542173|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
1376336|NCT01452529|4542174|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
1376337|NCT01452529|4542172|P3|Run-in Period|Administrative|0
1376338|NCT01452529|4542173|P2|Run-in Period|Administrative|0
1376339|NCT01452529|4542174|P1|Run-in Period|Administrative|21
1376340|NCT01452529|4542172|P3|Run-in Period|Confirmed or suspected diversion|0
1376341|NCT01452529|4542173|P2|Run-in Period|Confirmed or suspected diversion|0
1376342|NCT01452529|4542174|P1|Run-in Period|Confirmed or suspected diversion|23
1376343|NCT01452529|4542172|P3|Run-in Period|Lack of Efficacy|0
1376344|NCT01452529|4542173|P2|Run-in Period|Lack of Efficacy|0
1376345|NCT01452529|4542174|P1|Run-in Period|Lack of Efficacy|46
1376346|NCT01452529|4542172|P3|Run-in Period|Lost to Follow-up|0
1376347|NCT01452529|4542173|P2|Run-in Period|Lost to Follow-up|0
1376348|NCT01452529|4542174|P1|Run-in Period|Lost to Follow-up|19
1376349|NCT01452529|4542172|P3|Run-in Period|Withdrawal by Subject|0
1376350|NCT01452529|4542173|P2|Run-in Period|Withdrawal by Subject|0
1376351|NCT01452529|4542174|P1|Run-in Period|Withdrawal by Subject|49
1376352|NCT01452529|4542172|P3|Run-in Period|Adverse Event|0
1376353|NCT01452529|4542173|P2|Run-in Period|Adverse Event|0
1376354|NCT01452529|4542174|P1|Run-in Period|Adverse Event|96
1376355|NCT01452347|4542196|P2|Overall Study|Other reason not defined above|0
1376356|NCT01452347|4542197|P1|Overall Study|Other reason not defined above|2
1376357|NCT01452347|4542196|P2|Overall Study|Not treated|3
1376358|NCT01452347|4542197|P1|Overall Study|Not treated|6
1376359|NCT01452347|4542196|P2|Overall Study|Withdrawal by Subject|3
1376360|NCT01452347|4542197|P1|Overall Study|Withdrawal by Subject|3
1376361|NCT01452347|4542196|P2|Overall Study|Lost to Follow-up|0
1376362|NCT01452347|4542197|P1|Overall Study|Lost to Follow-up|2
1376363|NCT01452347|4542196|P2|Overall Study|Non compliance protocol|0
1376364|NCT01452347|4542197|P1|Overall Study|Non compliance protocol|2
1376365|NCT01452347|4542196|P2|Overall Study|Adverse Event|1
1376366|NCT01452347|4542197|P1|Overall Study|Adverse Event|2
1376367|NCT01452152|4542229|P3|Overall Study|Study termination by sponsor|4
1376368|NCT01452152|4542230|P2|Overall Study|Study termination by sponsor|0
1376369|NCT01452152|4542231|P1|Overall Study|Study termination by sponsor|5
1376370|NCT01451931|4542303|P3|Overall Study|Withdrawal by Subject|22
1376371|NCT01451931|4542304|P2|Overall Study|Withdrawal by Subject|22
1376372|NCT01451931|4542305|P1|Overall Study|Withdrawal by Subject|16
1376373|NCT01451931|4542303|P3|Overall Study|Lost to Follow-up|21
1376374|NCT01451931|4542304|P2|Overall Study|Lost to Follow-up|36
1376375|NCT01451931|4542305|P1|Overall Study|Lost to Follow-up|17
1376376|NCT01451827|4542329|P4|Overall Study|Withdrawal by Subject|1
1376377|NCT01451827|4542330|P3|Overall Study|Withdrawal by Subject|1
1376378|NCT01451827|4542331|P2|Overall Study|Withdrawal by Subject|0
1376379|NCT01451827|4542332|P1|Overall Study|Withdrawal by Subject|0
1376380|NCT01451827|4542329|P4|Overall Study|Participant met withdrawal criteria|0
1376381|NCT01451827|4542330|P3|Overall Study|Participant met withdrawal criteria|0
1376382|NCT01451827|4542331|P2|Overall Study|Participant met withdrawal criteria|2
1376383|NCT01451827|4542332|P1|Overall Study|Participant met withdrawal criteria|0
1376384|NCT01451827|4542329|P4|Overall Study|Lost to Follow-up|2
1376385|NCT01451827|4542330|P3|Overall Study|Lost to Follow-up|0
1376386|NCT01451827|4542331|P2|Overall Study|Lost to Follow-up|3
1376387|NCT01451827|4542332|P1|Overall Study|Lost to Follow-up|0
1376388|NCT01451827|4542329|P4|Overall Study|Protocol deviation|0
1376389|NCT01451827|4542330|P3|Overall Study|Protocol deviation|0
1376390|NCT01451827|4542331|P2|Overall Study|Protocol deviation|0
1376391|NCT01451827|4542332|P1|Overall Study|Protocol deviation|1
1376392|NCT01451827|4542329|P4|Overall Study|Adverse Event|1
1376393|NCT01451827|4542330|P3|Overall Study|Adverse Event|1
1376394|NCT01451827|4542331|P2|Overall Study|Adverse Event|0
1376395|NCT01451827|4542332|P1|Overall Study|Adverse Event|2
1376396|NCT01451814|4542352|P2|Overall Study|Lost to Follow-up|4
1376397|NCT01451814|4542353|P1|Overall Study|Lost to Follow-up|5
1376398|NCT01451814|4542352|P2|Overall Study|Withdrawal by Subject|1
1376399|NCT01451814|4542353|P1|Overall Study|Withdrawal by Subject|1
1376400|NCT01451762|4542385|P3|Overall Study|Lost to Follow-up|6
1376401|NCT01451762|4542386|P2|Overall Study|Lost to Follow-up|6
1376402|NCT01451762|4542387|P1|Overall Study|Lost to Follow-up|3
1376403|NCT01451749|4542397|P2|Overall Study|Withdrawal by Subject|1
1376404|NCT01451749|4542398|P1|Overall Study|Withdrawal by Subject|0
1376405|NCT01451749|4542397|P2|Overall Study|Adverse Event|0
1376406|NCT01451749|4542398|P1|Overall Study|Adverse Event|2
1376407|NCT01451749|4542397|P2|Overall Study|Meet the exclusion criteria,and|1
1376408|NCT01451749|4542398|P1|Overall Study|Meet the exclusion criteria,and|1
1376409|NCT01451749|4542397|P2|Overall Study|Lost to Follow-up|5
1376410|NCT01451749|4542398|P1|Overall Study|Lost to Follow-up|15
1376411|NCT01451749|4542397|P2|Overall Study|Protocol Violation|7
1376412|NCT01451749|4542398|P1|Overall Study|Protocol Violation|14
1376413|NCT01451723|4542410|P2|Overall Study|study halted|5
1376414|NCT01451723|4542411|P1|Overall Study|study halted|6
1376415|NCT01451645|4542421|P2|Overall Study|Lost to Follow-up|3
1376416|NCT01451645|4542422|P1|Overall Study|Lost to Follow-up|4
1376417|NCT01451645|4542421|P2|Overall Study|Withdrawal by Subject|2
1376418|NCT01451645|4542422|P1|Overall Study|Withdrawal by Subject|4
1376419|NCT01451645|4542421|P2|Overall Study|Adverse Event|3
1376420|NCT01451645|4542422|P1|Overall Study|Adverse Event|0
1376421|NCT01451645|4542421|P2|Overall Study|Protocol Violation|0
1376422|NCT01451645|4542422|P1|Overall Study|Protocol Violation|1
1376423|NCT01451606|4542493|P2|Overall Study|Withdrawal by Subject|3
1376424|NCT01451606|4542494|P1|Overall Study|Withdrawal by Subject|4
1376425|NCT01451554|4542504|P2|Overall Study|Withdrawal by Subject|9
1376426|NCT01451554|4542505|P1|Overall Study|Withdrawal by Subject|14
1376427|NCT01451541|4542516|P3|Overall Study|randomization error, noncompliance|8
1376428|NCT01451541|4542517|P2|Overall Study|randomization error, noncompliance|10
1376429|NCT01451541|4542518|P1|Overall Study|randomization error, noncompliance|11
1376430|NCT01451541|4542516|P3|Overall Study|Withdrawal by Subject|6
1376431|NCT01451541|4542517|P2|Overall Study|Withdrawal by Subject|8
1376432|NCT01451541|4542518|P1|Overall Study|Withdrawal by Subject|15
1376433|NCT01451541|4542516|P3|Overall Study|Lost to Follow-up|7
1376434|NCT01451541|4542517|P2|Overall Study|Lost to Follow-up|4
1376435|NCT01451541|4542518|P1|Overall Study|Lost to Follow-up|4
1376436|NCT01451541|4542516|P3|Overall Study|Lack of Efficacy|0
1376437|NCT01451541|4542517|P2|Overall Study|Lack of Efficacy|0
1376438|NCT01451541|4542518|P1|Overall Study|Lack of Efficacy|2
1376439|NCT01451541|4542516|P3|Overall Study|Adverse Event|6
1376440|NCT01451541|4542517|P2|Overall Study|Adverse Event|3
1376441|NCT01451541|4542518|P1|Overall Study|Adverse Event|4
1376442|NCT01451437|4542576|P9|Overall Study|Withdrawal by Subject|0
1376443|NCT01451437|4542577|P8|Overall Study|Withdrawal by Subject|0
1376444|NCT01451437|4542578|P7|Overall Study|Withdrawal by Subject|1
1376445|NCT01451437|4542579|P6|Overall Study|Withdrawal by Subject|0
1376446|NCT01451437|4542580|P5|Overall Study|Withdrawal by Subject|1
1376447|NCT01451437|4542581|P4|Overall Study|Withdrawal by Subject|0
1376448|NCT01451437|4542582|P3|Overall Study|Withdrawal by Subject|0
1376449|NCT01451437|4542583|P2|Overall Study|Withdrawal by Subject|0
1376450|NCT01451437|4542584|P1|Overall Study|Withdrawal by Subject|0
1376451|NCT01451437|4542576|P9|Overall Study|Protocol Violation|0
1376452|NCT01451437|4542577|P8|Overall Study|Protocol Violation|0
1376453|NCT01451437|4542578|P7|Overall Study|Protocol Violation|1
1376454|NCT01451437|4542579|P6|Overall Study|Protocol Violation|0
1376455|NCT01451437|4542580|P5|Overall Study|Protocol Violation|0
1376456|NCT01451437|4542581|P4|Overall Study|Protocol Violation|0
1376457|NCT01451437|4542582|P3|Overall Study|Protocol Violation|0
1376458|NCT01451437|4542583|P2|Overall Study|Protocol Violation|0
1376459|NCT01451437|4542584|P1|Overall Study|Protocol Violation|0
1376460|NCT01451437|4542576|P9|Overall Study|Disease Progression|3
1376461|NCT01451437|4542577|P8|Overall Study|Disease Progression|1
1376462|NCT01451437|4542578|P7|Overall Study|Disease Progression|3
1376463|NCT01451437|4542579|P6|Overall Study|Disease Progression|2
1376464|NCT01451437|4542580|P5|Overall Study|Disease Progression|3
1376465|NCT01451437|4542581|P4|Overall Study|Disease Progression|1
1376466|NCT01451437|4542582|P3|Overall Study|Disease Progression|1
1376467|NCT01451437|4542583|P2|Overall Study|Disease Progression|0
1376468|NCT01451437|4542584|P1|Overall Study|Disease Progression|0
1376469|NCT01451437|4542576|P9|Overall Study|Physician Decision|0
1376470|NCT01451437|4542577|P8|Overall Study|Physician Decision|0
1376471|NCT01451437|4542578|P7|Overall Study|Physician Decision|0
1376472|NCT01451437|4542579|P6|Overall Study|Physician Decision|0
1376473|NCT01451437|4542580|P5|Overall Study|Physician Decision|0
1376474|NCT01451437|4542581|P4|Overall Study|Physician Decision|0
1376475|NCT01451437|4542582|P3|Overall Study|Physician Decision|2
1376476|NCT01451437|4542583|P2|Overall Study|Physician Decision|1
1376477|NCT01451437|4542584|P1|Overall Study|Physician Decision|1
1376478|NCT01451437|4542576|P9|Overall Study|Adverse Event|1
1376479|NCT01451437|4542577|P8|Overall Study|Adverse Event|2
1376480|NCT01451437|4542578|P7|Overall Study|Adverse Event|1
1376481|NCT01451437|4542579|P6|Overall Study|Adverse Event|1
1376482|NCT01451437|4542580|P5|Overall Study|Adverse Event|0
1376483|NCT01451437|4542581|P4|Overall Study|Adverse Event|0
1376484|NCT01451437|4542582|P3|Overall Study|Adverse Event|0
1376485|NCT01451437|4542583|P2|Overall Study|Adverse Event|0
1376486|NCT01451437|4542584|P1|Overall Study|Adverse Event|0
1376487|NCT01451424|4542716|P4|Overall Study|Adverse Event|1
1376488|NCT01451424|4542717|P3|Overall Study|Adverse Event|0
1376489|NCT01451424|4542718|P2|Overall Study|Adverse Event|0
1376490|NCT01451424|4542719|P1|Overall Study|Adverse Event|0
1376491|NCT01451424|4542716|P4|Overall Study|Physician Decision|1
1376492|NCT01451424|4542717|P3|Overall Study|Physician Decision|1
1376493|NCT01451424|4542718|P2|Overall Study|Physician Decision|0
1376494|NCT01451424|4542719|P1|Overall Study|Physician Decision|0
1376495|NCT01451424|4542716|P4|Overall Study|Lost to Follow-up|1
1376496|NCT01451424|4542717|P3|Overall Study|Lost to Follow-up|0
1376497|NCT01451424|4542718|P2|Overall Study|Lost to Follow-up|1
1376498|NCT01451424|4542719|P1|Overall Study|Lost to Follow-up|0
1376499|NCT01451424|4542716|P4|Overall Study|Withdrawal by Subject|2
1376500|NCT01451424|4542717|P3|Overall Study|Withdrawal by Subject|0
1376501|NCT01451424|4542718|P2|Overall Study|Withdrawal by Subject|1
1376502|NCT01451424|4542719|P1|Overall Study|Withdrawal by Subject|1
1376503|NCT01451398|4542777|P2|Overall Study|Lack of Efficacy|1
1376504|NCT01451398|4542778|P1|Overall Study|Lack of Efficacy|0
1376505|NCT01451398|4542777|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
1376506|NCT01451398|4542778|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
1376507|NCT01451398|4542777|P2|Overall Study|Moved out of country|1
1376508|NCT01451398|4542778|P1|Overall Study|Moved out of country|0
1376509|NCT01451398|4542777|P2|Overall Study|Non-compliance with protocol|1
1376510|NCT01451398|4542778|P1|Overall Study|Non-compliance with protocol|1
1376511|NCT01451398|4542777|P2|Overall Study|Non-compliance with study drug|3
1376512|NCT01451398|4542778|P1|Overall Study|Non-compliance with study drug|1
1376513|NCT01451398|4542777|P2|Overall Study|Lost to Follow-up|4
1376514|NCT01451398|4542778|P1|Overall Study|Lost to Follow-up|6
1376515|NCT01451398|4542777|P2|Overall Study|Withdrawal by Subject|14
1376516|NCT01451398|4542778|P1|Overall Study|Withdrawal by Subject|10
1376517|NCT01451398|4542777|P2|Overall Study|Physician Decision|1
1376518|NCT01451398|4542778|P1|Overall Study|Physician Decision|1
1376519|NCT01451398|4542777|P2|Overall Study|Protocol Violation|2
1376520|NCT01451398|4542778|P1|Overall Study|Protocol Violation|1
1376521|NCT01451398|4542777|P2|Overall Study|Adverse Event|9
1376522|NCT01451398|4542778|P1|Overall Study|Adverse Event|7
1376523|NCT01451203|4542812|P2|Post-treatment Period|Investigator decision|1
1376524|NCT01451203|4542813|P1|Post-treatment Period|Investigator decision|0
1376525|NCT01451203|4542812|P2|Post-treatment Period|Adverse Event|1
1376526|NCT01451203|4542813|P1|Post-treatment Period|Adverse Event|0
1376527|NCT01451203|4542812|P2|Post-treatment Period|Lack of Efficacy|28
1376528|NCT01451203|4542813|P1|Post-treatment Period|Lack of Efficacy|12
1376529|NCT01451203|4542812|P2|Post-treatment Period|Consent withdrawn|4
1376530|NCT01451203|4542813|P1|Post-treatment Period|Consent withdrawn|2
1376531|NCT01451203|4542812|P2|Double-blind Treatment Period|Investigator decision|0
1376532|NCT01451203|4542813|P1|Double-blind Treatment Period|Investigator decision|2
1376533|NCT01451203|4542812|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
1376534|NCT01451203|4542813|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
1376535|NCT01451203|4542812|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
1376536|NCT01451203|4542813|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
1376537|NCT01451203|4542812|P2|Double-blind Treatment Period|Adverse Event|9
1376538|NCT01451203|4542813|P1|Double-blind Treatment Period|Adverse Event|6
1376539|NCT01451203|4542812|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
1376540|NCT01451203|4542813|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
1376541|NCT01451203|4542812|P2|Double-blind Treatment Period|Lack of Efficacy|36
1376542|NCT01451203|4542813|P1|Double-blind Treatment Period|Lack of Efficacy|71
1376543|NCT01451203|4542812|P2|Double-blind Treatment Period|Consent Withdrawn|2
1376544|NCT01451203|4542813|P1|Double-blind Treatment Period|Consent Withdrawn|3
1376545|NCT01451203|4542812|P2|Double-blind Treatment Period|Did not receive treatment|2
1376546|NCT01451203|4542813|P1|Double-blind Treatment Period|Did not receive treatment|1
1376547|NCT01450813|4542846|P4|Overall Study|Physician Decision|3
1376548|NCT01450813|4542847|P3|Overall Study|Physician Decision|0
1376549|NCT01450813|4542848|P2|Overall Study|Physician Decision|1
1376550|NCT01450813|4542849|P1|Overall Study|Physician Decision|1
1376551|NCT01450800|4542863|P2|Overall Study|Protocol Violation|3
1376552|NCT01450800|4542864|P1|Overall Study|Protocol Violation|1
1376553|NCT01450761|4542899|P2|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
1376554|NCT01450761|4542900|P1|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
1376555|NCT01450761|4542899|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
1376556|NCT01450761|4542900|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
1376557|NCT01450761|4542899|P2|Treatment With Blinded Study Therapy|Not reported|2
1376558|NCT01450761|4542900|P1|Treatment With Blinded Study Therapy|Not reported|2
1376559|NCT01450761|4542899|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
1376560|NCT01450761|4542900|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
1376561|NCT01450761|4542899|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
1376562|NCT01450761|4542900|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
1376563|NCT01450761|4542899|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
1376564|NCT01450761|4542900|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
1376565|NCT01450761|4542899|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
1376566|NCT01450761|4542900|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
1376567|NCT01450761|4542899|P2|Treatment With Blinded Study Therapy|Death|6
1376568|NCT01450761|4542900|P1|Treatment With Blinded Study Therapy|Death|5
1376569|NCT01450761|4542899|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
1376570|NCT01450761|4542900|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
1376571|NCT01450761|4542899|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
1376572|NCT01450761|4542900|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
1376573|NCT01450761|4542899|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
1376574|NCT01450761|4542900|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
1376575|NCT01450761|4542899|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
1376576|NCT01450761|4542900|P1|Treatment With Blinded Study Therapy|Study drug toxicity|87
1376577|NCT01450761|4542899|P2|Treatment With Blinded Study Therapy|Disease progression|415
1376578|NCT01450761|4542900|P1|Treatment With Blinded Study Therapy|Disease progression|318
1376579|NCT01450761|4542899|P2|Lead-in Chemotherapy|Lost to Follow-up|0
1376580|NCT01450761|4542900|P1|Lead-in Chemotherapy|Lost to Follow-up|2
1376581|NCT01450761|4542899|P2|Lead-in Chemotherapy|Other|2
1376582|NCT01450761|4542900|P1|Lead-in Chemotherapy|Other|2
1376583|NCT01450761|4542899|P2|Lead-in Chemotherapy|Death|3
1376584|NCT01450761|4542900|P1|Lead-in Chemotherapy|Death|3
1376585|NCT01450761|4542899|P2|Lead-in Chemotherapy|No longer meets study criteria|7
1376586|NCT01450761|4542900|P1|Lead-in Chemotherapy|No longer meets study criteria|3
1376587|NCT01450761|4542899|P2|Lead-in Chemotherapy|Study drug toxicity|10
1376588|NCT01450761|4542900|P1|Lead-in Chemotherapy|Study drug toxicity|6
1376589|NCT01450761|4542899|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
1376590|NCT01450761|4542900|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
1376591|NCT01450761|4542899|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
1376592|NCT01450761|4542900|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
1376593|NCT01450761|4542899|P2|Lead-in Chemotherapy|Disease progression|32
1376594|NCT01450761|4542900|P1|Lead-in Chemotherapy|Disease progression|33
1376595|NCT01450761|4542899|P2|Randomization|Other|1
1376596|NCT01450761|4542900|P1|Randomization|Other|0
1376597|NCT01450761|4542899|P2|Randomization|Adverse Event unrelated to study drug|0
1376598|NCT01450761|4542900|P1|Randomization|Adverse Event unrelated to study drug|1
1376599|NCT01450761|4542899|P2|Randomization|Disease progression|2
1376600|NCT01450761|4542900|P1|Randomization|Disease progression|0
1376601|NCT01450761|4542899|P2|Randomization|Withdrawal by Subject|0
1376602|NCT01450761|4542900|P1|Randomization|Withdrawal by Subject|2
1376603|NCT01450761|4542899|P2|Randomization|Subject no longer meets study criteria|2
1376604|NCT01450761|4542900|P1|Randomization|Subject no longer meets study criteria|1
1376605|NCT01450696|4542912|P2|Overall Study|Study Terminated by Sponsor|58
1376606|NCT01450696|4542913|P1|Overall Study|Study Terminated by Sponsor|53
1376607|NCT01450696|4542912|P2|Overall Study|Withdrawal by Subject|2
1376608|NCT01450696|4542913|P1|Overall Study|Withdrawal by Subject|13
1376609|NCT01450696|4542912|P2|Overall Study|Non-Compliance|0
1376610|NCT01450696|4542913|P1|Overall Study|Non-Compliance|1
1376611|NCT01450696|4542912|P2|Overall Study|Lost to Follow-up|3
1376612|NCT01450696|4542913|P1|Overall Study|Lost to Follow-up|3
1376613|NCT01450696|4542912|P2|Overall Study|Death|84
1376614|NCT01450696|4542913|P1|Overall Study|Death|77
1376615|NCT01450696|4542912|P2|Overall Study|Never Treated|1
1376616|NCT01450696|4542913|P1|Overall Study|Never Treated|1
1376617|NCT01450683|4542935|P1|Overall Study|Adverse Event|2
1376618|NCT01450631|4542941|P2|Overall Study|Withdrawal by Subject|0
1376619|NCT01450631|4542942|P1|Overall Study|Withdrawal by Subject|1
1376620|NCT01450631|4542941|P2|Overall Study|Lost to Follow-up|4
1376621|NCT01450631|4542942|P1|Overall Study|Lost to Follow-up|2
1376622|NCT01450007|4543073|P3|Overall Study|Adverse Event|0
1376623|NCT01450007|4543074|P2|Overall Study|Adverse Event|1
1376624|NCT01450007|4543075|P1|Overall Study|Adverse Event|0
1376625|NCT01450007|4543073|P3|Overall Study|Protocol Violation|1
1376626|NCT01450007|4543074|P2|Overall Study|Protocol Violation|1
1376627|NCT01450007|4543075|P1|Overall Study|Protocol Violation|0
1376628|NCT01450007|4543073|P3|Overall Study|Late exclusion before treatment|2
1376629|NCT01450007|4543074|P2|Overall Study|Late exclusion before treatment|3
1376630|NCT01450007|4543075|P1|Overall Study|Late exclusion before treatment|2
1376631|NCT01449955|4543094|P2|Overall Study|Withdrawal by Subject|2
1376632|NCT01449955|4543095|P1|Overall Study|Withdrawal by Subject|1
1376633|NCT01449929|4543123|P3|Extension Phase Approximately 3 Years|Lost to Follow-up|4
1376634|NCT01449929|4543124|P2|Extension Phase Approximately 3 Years|Lost to Follow-up|0
1376635|NCT01449929|4543125|P1|Extension Phase Approximately 3 Years|Lost to Follow-up|0
1376636|NCT01449929|4543123|P3|Extension Phase Approximately 3 Years|Lack of Efficacy|2
1376637|NCT01449929|4543124|P2|Extension Phase Approximately 3 Years|Lack of Efficacy|0
1376638|NCT01449929|4543125|P1|Extension Phase Approximately 3 Years|Lack of Efficacy|0
1376639|NCT01449929|4543123|P3|Extension Phase Approximately 3 Years|Adverse Event|2
1376640|NCT01449929|4543124|P2|Extension Phase Approximately 3 Years|Adverse Event|0
1376641|NCT01449929|4543125|P1|Extension Phase Approximately 3 Years|Adverse Event|0
1376642|NCT01449929|4543123|P3|Randomization Phase 96 Week|Other: study closed/terminated|0
1376643|NCT01449929|4543124|P2|Randomization Phase 96 Week|Other: study closed/terminated|1
1376644|NCT01449929|4543125|P1|Randomization Phase 96 Week|Other: study closed/terminated|0
1376645|NCT01449929|4543123|P3|Randomization Phase 96 Week|Physician Decision|0
1376646|NCT01449929|4543124|P2|Randomization Phase 96 Week|Physician Decision|3
1376647|NCT01449929|4543125|P1|Randomization Phase 96 Week|Physician Decision|2
1376648|NCT01449929|4543123|P3|Randomization Phase 96 Week|Withdrawal by Subject|0
1376649|NCT01449929|4543124|P2|Randomization Phase 96 Week|Withdrawal by Subject|8
1376650|NCT01449929|4543125|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
1376651|NCT01449929|4543123|P3|Randomization Phase 96 Week|Lost to Follow-up|0
1376652|NCT01449929|4543124|P2|Randomization Phase 96 Week|Lost to Follow-up|18
1376653|NCT01449929|4543125|P1|Randomization Phase 96 Week|Lost to Follow-up|15
1376654|NCT01449929|4543123|P3|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
1376655|NCT01449929|4543124|P2|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
1376656|NCT01449929|4543125|P1|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
1376657|NCT01449929|4543123|P3|Randomization Phase 96 Week|Protocol Violation|0
1376658|NCT01449929|4543124|P2|Randomization Phase 96 Week|Protocol Violation|6
1376659|NCT01449929|4543125|P1|Randomization Phase 96 Week|Protocol Violation|5
1376660|NCT01449929|4543123|P3|Randomization Phase 96 Week|Lack of Efficacy|0
1376661|NCT01449929|4543124|P2|Randomization Phase 96 Week|Lack of Efficacy|4
1376662|NCT01449929|4543125|P1|Randomization Phase 96 Week|Lack of Efficacy|3
1376663|NCT01449929|4543123|P3|Randomization Phase 96 Week|Adverse Event|0
1376664|NCT01449929|4543124|P2|Randomization Phase 96 Week|Adverse Event|13
1376665|NCT01449929|4543125|P1|Randomization Phase 96 Week|Adverse Event|5
1376666|NCT01449812|4543165|P3|Overall Study|Lost to Follow-up|0
1376667|NCT01449812|4543166|P2|Overall Study|Lost to Follow-up|0
1376668|NCT01449812|4543167|P1|Overall Study|Lost to Follow-up|1
1376669|NCT01449812|4543165|P3|Overall Study|Withdrawal by Subject|1
1376670|NCT01449812|4543166|P2|Overall Study|Withdrawal by Subject|0
1376671|NCT01449812|4543167|P1|Overall Study|Withdrawal by Subject|0
1376672|NCT01449812|4543165|P3|Overall Study|Migrated/moved from study area|0
1376673|NCT01449812|4543166|P2|Overall Study|Migrated/moved from study area|0
1376674|NCT01449812|4543167|P1|Overall Study|Migrated/moved from study area|1
1376675|NCT01449721|4543282|P2|Overall Study|Physician Decision|1
1376676|NCT01449721|4543283|P1|Overall Study|Physician Decision|0
1376677|NCT01449721|4543282|P2|Overall Study|Physician Decision|1
1376678|NCT01449721|4543283|P1|Overall Study|Physician Decision|0
1376679|NCT01449708|4543295|P2|Overall Study|respiratory failure|0
1376680|NCT01449708|4543296|P1|Overall Study|respiratory failure|1
1376681|NCT01449708|4543295|P2|Overall Study|surgical complication|2
1376682|NCT01449708|4543296|P1|Overall Study|surgical complication|1
1376683|NCT01449708|4543295|P2|Overall Study|Protocol Violation|1
1376684|NCT01449708|4543296|P1|Overall Study|Protocol Violation|0
1376685|NCT01449682|4543307|P2|Overall Study|Adverse Event|0
1376686|NCT01449682|4543308|P1|Overall Study|Adverse Event|1
1376687|NCT01449682|4543307|P2|Overall Study|Death|1
1376688|NCT01449682|4543308|P1|Overall Study|Death|0
1376689|NCT01449539|4543320|P1|Overall Study|Toxicity not study related|1
1376690|NCT01449539|4543320|P1|Overall Study|Withdrawal by Subject|3
1376691|NCT01449526|4543326|P2|Overall Study|Cannot maintain visits|1
1376692|NCT01449526|4543327|P1|Overall Study|Cannot maintain visits|0
1376693|NCT01449526|4543326|P2|Overall Study|Lack of Motivation|1
1376694|NCT01449526|4543327|P1|Overall Study|Lack of Motivation|0
1376695|NCT01449526|4543326|P2|Overall Study|Symptoms/complaints|1
1376696|NCT01449526|4543327|P1|Overall Study|Symptoms/complaints|0
1376697|NCT01449526|4543326|P2|Overall Study|Withdrawal by Subject|1
1376698|NCT01449526|4543327|P1|Overall Study|Withdrawal by Subject|1
1376699|NCT01449526|4543326|P2|Overall Study|Lost to Follow-up|2
1376700|NCT01449526|4543327|P1|Overall Study|Lost to Follow-up|1
1376701|NCT01449461|4543396|P6|Overall Study|Reason not specified|1
1376702|NCT01449461|4543397|P5|Overall Study|Reason not specified|0
1376703|NCT01449461|4543398|P4|Overall Study|Reason not specified|3
1376704|NCT01449461|4543399|P3|Overall Study|Reason not specified|0
1376705|NCT01449461|4543400|P2|Overall Study|Reason not specified|1
1376706|NCT01449461|4543401|P1|Overall Study|Reason not specified|0
1376707|NCT01449461|4543396|P6|Overall Study|Clinical progressive disease|3
1376708|NCT01449461|4543397|P5|Overall Study|Clinical progressive disease|3
1376709|NCT01449461|4543398|P4|Overall Study|Clinical progressive disease|0
1376710|NCT01449461|4543399|P3|Overall Study|Clinical progressive disease|0
1376711|NCT01449461|4543400|P2|Overall Study|Clinical progressive disease|1
1376712|NCT01449461|4543401|P1|Overall Study|Clinical progressive disease|2
1376713|NCT01449461|4543396|P6|Overall Study|Documented progressive disease|5
1376714|NCT01449461|4543397|P5|Overall Study|Documented progressive disease|21
1376715|NCT01449461|4543398|P4|Overall Study|Documented progressive disease|11
1376716|NCT01449461|4543399|P3|Overall Study|Documented progressive disease|14
1376717|NCT01449461|4543400|P2|Overall Study|Documented progressive disease|6
1376718|NCT01449461|4543401|P1|Overall Study|Documented progressive disease|4
1376719|NCT01449461|4543396|P6|Overall Study|Death|1
1376720|NCT01449461|4543397|P5|Overall Study|Death|4
1376721|NCT01449461|4543398|P4|Overall Study|Death|0
1376722|NCT01449461|4543399|P3|Overall Study|Death|0
1376723|NCT01449461|4543400|P2|Overall Study|Death|1
1376724|NCT01449461|4543401|P1|Overall Study|Death|0
1376725|NCT01449461|4543396|P6|Overall Study|Adverse Event|3
1376726|NCT01449461|4543397|P5|Overall Study|Adverse Event|3
1376727|NCT01449461|4543398|P4|Overall Study|Adverse Event|3
1376728|NCT01449461|4543399|P3|Overall Study|Adverse Event|2
1376729|NCT01449461|4543400|P2|Overall Study|Adverse Event|3
1376730|NCT01449461|4543401|P1|Overall Study|Adverse Event|0
1376731|NCT01449461|4543396|P6|Overall Study|Ongoing|2
1376732|NCT01449461|4543397|P5|Overall Study|Ongoing|17
1376733|NCT01449461|4543398|P4|Overall Study|Ongoing|15
1376734|NCT01449461|4543399|P3|Overall Study|Ongoing|2
1376735|NCT01449461|4543400|P2|Overall Study|Ongoing|6
1376736|NCT01449461|4543401|P1|Overall Study|Ongoing|0
1376737|NCT01449370|4543538|P25|Overall Study|Death|1
1376738|NCT01449370|4543539|P24|Overall Study|Death|0
1376739|NCT01449370|4543540|P23|Overall Study|Death|0
1376740|NCT01449370|4543541|P22|Overall Study|Death|0
1376741|NCT01449370|4543542|P21|Overall Study|Death|0
1376742|NCT01449370|4543543|P20|Overall Study|Death|0
1376743|NCT01449370|4543544|P19|Overall Study|Death|0
1376744|NCT01449370|4543545|P18|Overall Study|Death|0
1376745|NCT01449370|4543546|P17|Overall Study|Death|0
1376746|NCT01449370|4543547|P16|Overall Study|Death|0
1376747|NCT01449370|4543548|P15|Overall Study|Death|0
1376748|NCT01449370|4543549|P14|Overall Study|Death|0
1376749|NCT01449370|4543550|P13|Overall Study|Death|0
1376750|NCT01449370|4543551|P12|Overall Study|Death|0
1376751|NCT01449370|4543552|P11|Overall Study|Death|0
1376752|NCT01449370|4543553|P10|Overall Study|Death|0
1376753|NCT01449370|4543554|P9|Overall Study|Death|0
1376754|NCT01449370|4543555|P8|Overall Study|Death|0
1376755|NCT01449370|4543556|P7|Overall Study|Death|0
1376756|NCT01449370|4543557|P6|Overall Study|Death|0
1376757|NCT01449370|4543558|P5|Overall Study|Death|0
1376758|NCT01449370|4543559|P4|Overall Study|Death|0
1376759|NCT01449370|4543560|P3|Overall Study|Death|0
1376760|NCT01449370|4543561|P2|Overall Study|Death|0
1376761|NCT01449370|4543562|P1|Overall Study|Death|0
1376762|NCT01449370|4543538|P25|Overall Study|Medication Prohibited by Protocol|0
1376763|NCT01449370|4543539|P24|Overall Study|Medication Prohibited by Protocol|1
1376764|NCT01449370|4543540|P23|Overall Study|Medication Prohibited by Protocol|0
1376765|NCT01449370|4543541|P22|Overall Study|Medication Prohibited by Protocol|0
1376766|NCT01449370|4543542|P21|Overall Study|Medication Prohibited by Protocol|0
1376767|NCT01449370|4543543|P20|Overall Study|Medication Prohibited by Protocol|0
1376768|NCT01449370|4543544|P19|Overall Study|Medication Prohibited by Protocol|0
1376769|NCT01449370|4543545|P18|Overall Study|Medication Prohibited by Protocol|0
1376770|NCT01449370|4543546|P17|Overall Study|Medication Prohibited by Protocol|0
1376771|NCT01449370|4543547|P16|Overall Study|Medication Prohibited by Protocol|0
1376772|NCT01449370|4543548|P15|Overall Study|Medication Prohibited by Protocol|0
1376773|NCT01449370|4543549|P14|Overall Study|Medication Prohibited by Protocol|0
1376774|NCT01449370|4543550|P13|Overall Study|Medication Prohibited by Protocol|0
1376775|NCT01449370|4543551|P12|Overall Study|Medication Prohibited by Protocol|0
1376776|NCT01449370|4543552|P11|Overall Study|Medication Prohibited by Protocol|0
1376777|NCT01449370|4543553|P10|Overall Study|Medication Prohibited by Protocol|0
1376778|NCT01449370|4543554|P9|Overall Study|Medication Prohibited by Protocol|0
1376779|NCT01449370|4543555|P8|Overall Study|Medication Prohibited by Protocol|0
1376780|NCT01449370|4543556|P7|Overall Study|Medication Prohibited by Protocol|0
1376781|NCT01449370|4543557|P6|Overall Study|Medication Prohibited by Protocol|0
1376782|NCT01449370|4543558|P5|Overall Study|Medication Prohibited by Protocol|0
1376783|NCT01449370|4543559|P4|Overall Study|Medication Prohibited by Protocol|0
1376784|NCT01449370|4543560|P3|Overall Study|Medication Prohibited by Protocol|0
1376785|NCT01449370|4543561|P2|Overall Study|Medication Prohibited by Protocol|0
1376786|NCT01449370|4543562|P1|Overall Study|Medication Prohibited by Protocol|0
1376787|NCT01449370|4543538|P25|Overall Study|Other|0
1376788|NCT01449370|4543539|P24|Overall Study|Other|1
1376789|NCT01449370|4543540|P23|Overall Study|Other|1
1376790|NCT01449370|4543541|P22|Overall Study|Other|0
1376791|NCT01449370|4543542|P21|Overall Study|Other|0
1376792|NCT01449370|4543543|P20|Overall Study|Other|0
1376793|NCT01449370|4543544|P19|Overall Study|Other|0
1376794|NCT01449370|4543545|P18|Overall Study|Other|0
1376795|NCT01449370|4543546|P17|Overall Study|Other|0
1376796|NCT01449370|4543547|P16|Overall Study|Other|0
1376797|NCT01449370|4543548|P15|Overall Study|Other|0
1376798|NCT01449370|4543549|P14|Overall Study|Other|0
1376799|NCT01449370|4543550|P13|Overall Study|Other|0
1376800|NCT01449370|4543551|P12|Overall Study|Other|0
1376801|NCT01449370|4543552|P11|Overall Study|Other|0
1376802|NCT01449370|4543553|P10|Overall Study|Other|1
1376803|NCT01449370|4543554|P9|Overall Study|Other|1
1376804|NCT01449370|4543555|P8|Overall Study|Other|0
1376805|NCT01449370|4543556|P7|Overall Study|Other|0
1376806|NCT01449370|4543557|P6|Overall Study|Other|0
1376807|NCT01449370|4543558|P5|Overall Study|Other|0
1376808|NCT01449370|4543559|P4|Overall Study|Other|0
1376809|NCT01449370|4543560|P3|Overall Study|Other|0
1376810|NCT01449370|4543561|P2|Overall Study|Other|0
1376811|NCT01449370|4543562|P1|Overall Study|Other|0
1376812|NCT01449370|4543538|P25|Overall Study|Lost to Follow-up|0
1376813|NCT01449370|4543539|P24|Overall Study|Lost to Follow-up|0
1376814|NCT01449370|4543540|P23|Overall Study|Lost to Follow-up|0
1376815|NCT01449370|4543541|P22|Overall Study|Lost to Follow-up|0
1376816|NCT01449370|4543542|P21|Overall Study|Lost to Follow-up|1
1376817|NCT01449370|4543543|P20|Overall Study|Lost to Follow-up|0
1376818|NCT01449370|4543544|P19|Overall Study|Lost to Follow-up|0
1376819|NCT01449370|4543545|P18|Overall Study|Lost to Follow-up|0
1376820|NCT01449370|4543546|P17|Overall Study|Lost to Follow-up|0
1376821|NCT01449370|4543547|P16|Overall Study|Lost to Follow-up|0
1376822|NCT01449370|4543548|P15|Overall Study|Lost to Follow-up|0
1376823|NCT01449370|4543549|P14|Overall Study|Lost to Follow-up|0
1376824|NCT01449370|4543550|P13|Overall Study|Lost to Follow-up|0
1376825|NCT01449370|4543551|P12|Overall Study|Lost to Follow-up|0
1376826|NCT01449370|4543552|P11|Overall Study|Lost to Follow-up|0
1376827|NCT01449370|4543553|P10|Overall Study|Lost to Follow-up|0
1376828|NCT01449370|4543554|P9|Overall Study|Lost to Follow-up|0
1376829|NCT01449370|4543555|P8|Overall Study|Lost to Follow-up|0
1376830|NCT01449370|4543556|P7|Overall Study|Lost to Follow-up|0
1376831|NCT01449370|4543557|P6|Overall Study|Lost to Follow-up|0
1376832|NCT01449370|4543558|P5|Overall Study|Lost to Follow-up|0
1376833|NCT01449370|4543559|P4|Overall Study|Lost to Follow-up|0
1376834|NCT01449370|4543560|P3|Overall Study|Lost to Follow-up|0
1376835|NCT01449370|4543561|P2|Overall Study|Lost to Follow-up|0
1376836|NCT01449370|4543562|P1|Overall Study|Lost to Follow-up|0
1376837|NCT01449370|4543538|P25|Overall Study|Participant Decision|1
1376838|NCT01449370|4543539|P24|Overall Study|Participant Decision|0
1376839|NCT01449370|4543540|P23|Overall Study|Participant Decision|0
1376840|NCT01449370|4543541|P22|Overall Study|Participant Decision|1
1376841|NCT01449370|4543542|P21|Overall Study|Participant Decision|0
1376842|NCT01449370|4543543|P20|Overall Study|Participant Decision|0
1376843|NCT01449370|4543544|P19|Overall Study|Participant Decision|1
1376844|NCT01449370|4543545|P18|Overall Study|Participant Decision|0
1376845|NCT01449370|4543546|P17|Overall Study|Participant Decision|3
1376846|NCT01449370|4543547|P16|Overall Study|Participant Decision|1
1376847|NCT01449370|4543548|P15|Overall Study|Participant Decision|0
1376848|NCT01449370|4543549|P14|Overall Study|Participant Decision|1
1376849|NCT01449370|4543550|P13|Overall Study|Participant Decision|1
1376850|NCT01449370|4543551|P12|Overall Study|Participant Decision|0
1376851|NCT01449370|4543552|P11|Overall Study|Participant Decision|0
1376852|NCT01449370|4543553|P10|Overall Study|Participant Decision|0
1376853|NCT01449370|4543554|P9|Overall Study|Participant Decision|1
1376854|NCT01449370|4543555|P8|Overall Study|Participant Decision|1
1376855|NCT01449370|4543556|P7|Overall Study|Participant Decision|0
1376856|NCT01449370|4543557|P6|Overall Study|Participant Decision|0
1376857|NCT01449370|4543558|P5|Overall Study|Participant Decision|0
1376858|NCT01449370|4543559|P4|Overall Study|Participant Decision|0
1376859|NCT01449370|4543560|P3|Overall Study|Participant Decision|0
1376860|NCT01449370|4543561|P2|Overall Study|Participant Decision|0
1376861|NCT01449370|4543562|P1|Overall Study|Participant Decision|0
1376862|NCT01449370|4543538|P25|Overall Study|Adverse Event|3
1376863|NCT01449370|4543539|P24|Overall Study|Adverse Event|1
1376864|NCT01449370|4543540|P23|Overall Study|Adverse Event|0
1376865|NCT01449370|4543541|P22|Overall Study|Adverse Event|1
1376866|NCT01449370|4543542|P21|Overall Study|Adverse Event|0
1376867|NCT01449370|4543543|P20|Overall Study|Adverse Event|1
1376868|NCT01449370|4543544|P19|Overall Study|Adverse Event|1
1376869|NCT01449370|4543545|P18|Overall Study|Adverse Event|0
1376870|NCT01449370|4543546|P17|Overall Study|Adverse Event|0
1376871|NCT01449370|4543547|P16|Overall Study|Adverse Event|1
1376872|NCT01449370|4543548|P15|Overall Study|Adverse Event|0
1376873|NCT01449370|4543549|P14|Overall Study|Adverse Event|2
1376874|NCT01449370|4543550|P13|Overall Study|Adverse Event|0
1376875|NCT01449370|4543551|P12|Overall Study|Adverse Event|0
1376876|NCT01449370|4543552|P11|Overall Study|Adverse Event|0
1376877|NCT01449370|4543553|P10|Overall Study|Adverse Event|1
1376878|NCT01449370|4543554|P9|Overall Study|Adverse Event|1
1376879|NCT01449370|4543555|P8|Overall Study|Adverse Event|0
1376880|NCT01449370|4543556|P7|Overall Study|Adverse Event|0
1376881|NCT01449370|4543557|P6|Overall Study|Adverse Event|0
1376882|NCT01449370|4543558|P5|Overall Study|Adverse Event|0
1376883|NCT01449370|4543559|P4|Overall Study|Adverse Event|1
1376884|NCT01449370|4543560|P3|Overall Study|Adverse Event|0
1376885|NCT01449370|4543561|P2|Overall Study|Adverse Event|2
1376886|NCT01449370|4543562|P1|Overall Study|Adverse Event|1
1376887|NCT01449370|4543538|P25|Overall Study|Disease Progression|3
1376888|NCT01449370|4543539|P24|Overall Study|Disease Progression|7
1376889|NCT01449370|4543540|P23|Overall Study|Disease Progression|3
1376890|NCT01449370|4543541|P22|Overall Study|Disease Progression|2
1376891|NCT01449370|4543542|P21|Overall Study|Disease Progression|5
1376892|NCT01449370|4543543|P20|Overall Study|Disease Progression|2
1376893|NCT01449370|4543544|P19|Overall Study|Disease Progression|1
1376894|NCT01449370|4543545|P18|Overall Study|Disease Progression|3
1376895|NCT01449370|4543546|P17|Overall Study|Disease Progression|4
1376896|NCT01449370|4543547|P16|Overall Study|Disease Progression|1
1376897|NCT01449370|4543548|P15|Overall Study|Disease Progression|3
1376898|NCT01449370|4543549|P14|Overall Study|Disease Progression|8
1376899|NCT01449370|4543550|P13|Overall Study|Disease Progression|2
1376900|NCT01449370|4543551|P12|Overall Study|Disease Progression|3
1376901|NCT01449370|4543552|P11|Overall Study|Disease Progression|3
1376902|NCT01449370|4543553|P10|Overall Study|Disease Progression|1
1376903|NCT01449370|4543554|P9|Overall Study|Disease Progression|9
1376904|NCT01449370|4543555|P8|Overall Study|Disease Progression|2
1376905|NCT01449370|4543556|P7|Overall Study|Disease Progression|3
1376906|NCT01449370|4543557|P6|Overall Study|Disease Progression|3
1376907|NCT01449370|4543558|P5|Overall Study|Disease Progression|3
1376908|NCT01449370|4543559|P4|Overall Study|Disease Progression|3
1376909|NCT01449370|4543560|P3|Overall Study|Disease Progression|8
1376910|NCT01449370|4543561|P2|Overall Study|Disease Progression|4
1376911|NCT01449370|4543562|P1|Overall Study|Disease Progression|5
1376912|NCT01449279|4543940|P1|Overall Study|Toxicity|2
1376913|NCT01449279|4543940|P1|Overall Study|Lack of Efficacy|5
1376914|NCT01449006|4543965|P2|Overall Study|Protocol Violation|0
1376915|NCT01449006|4543966|P1|Overall Study|Protocol Violation|1
1376916|NCT01449006|4543965|P2|Overall Study|Withdrawal by Subject|0
1376917|NCT01449006|4543966|P1|Overall Study|Withdrawal by Subject|1
1376918|NCT01449006|4543965|P2|Overall Study|Lost to Follow-up|0
1376919|NCT01449006|4543966|P1|Overall Study|Lost to Follow-up|1
1376920|NCT01448850|4543980|P2|Overall Study|Other|12
1376921|NCT01448850|4543981|P1|Overall Study|Other|15
1376922|NCT01448850|4543980|P2|Overall Study|Lost to Follow-up|1
1376923|NCT01448850|4543981|P1|Overall Study|Lost to Follow-up|3
1376924|NCT01448850|4543980|P2|Overall Study|Withdrawal by Subject|21
1376925|NCT01448850|4543981|P1|Overall Study|Withdrawal by Subject|13
1376926|NCT01448850|4543980|P2|Overall Study|Death|6
1376927|NCT01448850|4543981|P1|Overall Study|Death|3
1376928|NCT01448707|4544006|P2|Overall Study|Other|4
1376929|NCT01448707|4544007|P1|Overall Study|Other|7
1376930|NCT01448707|4544006|P2|Overall Study|Withdrawal by Subject|7
1376931|NCT01448707|4544007|P1|Overall Study|Withdrawal by Subject|6
1376932|NCT01448707|4544006|P2|Overall Study|Lost to Follow-up|6
1376933|NCT01448707|4544007|P1|Overall Study|Lost to Follow-up|2
1376934|NCT01448707|4544006|P2|Overall Study|Adverse Event|1
1376935|NCT01448707|4544007|P1|Overall Study|Adverse Event|3
1376936|NCT01448616|4544028|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
1376937|NCT01448616|4544029|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
1376938|NCT01448616|4544030|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
1376939|NCT01448616|4544031|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
1376940|NCT01448616|4544028|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
1376941|NCT01448616|4544029|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
1376942|NCT01448616|4544030|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
1376943|NCT01448616|4544031|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
1376944|NCT01448616|4544028|P4|Study Drug (Treatment Phase)|Adverse Event|0
1376945|NCT01448616|4544029|P3|Study Drug (Treatment Phase)|Adverse Event|1
1376946|NCT01448616|4544030|P2|Study Drug (Treatment Phase)|Adverse Event|1
1376947|NCT01448616|4544031|P1|Study Drug (Treatment Phase)|Adverse Event|0
1376948|NCT01448616|4544028|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
1376949|NCT01448616|4544029|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
1376950|NCT01448616|4544030|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
1376951|NCT01448616|4544031|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
1376952|NCT01448616|4544028|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
1376953|NCT01448616|4544029|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
1376954|NCT01448616|4544030|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
1376955|NCT01448616|4544031|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
1376956|NCT01448213|4544078|P2|Overall Study|Protocol Violation|2
1376957|NCT01448213|4544079|P1|Overall Study|Protocol Violation|1
1376958|NCT01448213|4544078|P2|Overall Study|Adverse Event|10
1376959|NCT01448213|4544079|P1|Overall Study|Adverse Event|4
1376960|NCT01448213|4544078|P2|Overall Study|Lost to Follow-up|10
1376961|NCT01448213|4544079|P1|Overall Study|Lost to Follow-up|12
1376962|NCT01448057|4544089|P2|Overall Study|Withdrawal by Subject|0
1376963|NCT01448057|4544090|P1|Overall Study|Withdrawal by Subject|2
1376964|NCT01448057|4544089|P2|Overall Study|Adverse Event|2
1376965|NCT01448057|4544090|P1|Overall Study|Adverse Event|0
1376966|NCT01448057|4544089|P2|Overall Study|Lost to Follow-up|0
1376967|NCT01448057|4544090|P1|Overall Study|Lost to Follow-up|3
1376968|NCT01448057|4544089|P2|Overall Study|Protocol Violation|2
1376969|NCT01448057|4544090|P1|Overall Study|Protocol Violation|3
1376970|NCT01448044|4544100|P2|Follow Up Period|not specified|11
1376971|NCT01448044|4544101|P1|Follow Up Period|not specified|5
1376972|NCT01448044|4544100|P2|Follow Up Period|Lost to Follow-up|2
1376973|NCT01448044|4544101|P1|Follow Up Period|Lost to Follow-up|6
1376974|NCT01448044|4544100|P2|Follow Up Period|Withdrawal by Subject|1
1376975|NCT01448044|4544101|P1|Follow Up Period|Withdrawal by Subject|1
1376976|NCT01448044|4544100|P2|Treatment Period|Other reason|0
1376977|NCT01448044|4544101|P1|Treatment Period|Other reason|2
1376978|NCT01448044|4544100|P2|Treatment Period|Lost to Follow-up|1
1376979|NCT01448044|4544101|P1|Treatment Period|Lost to Follow-up|2
1376980|NCT01448044|4544100|P2|Treatment Period|Participant does not meet study criteria|0
1376981|NCT01448044|4544101|P1|Treatment Period|Participant does not meet study criteria|1
1376982|NCT01448044|4544100|P2|Treatment Period|Completed 24 weeks treatment period only|0
1376983|NCT01448044|4544101|P1|Treatment Period|Completed 24 weeks treatment period only|8
1376984|NCT01448044|4544100|P2|Treatment Period|Subject requested discontinue study drug|0
1376985|NCT01448044|4544101|P1|Treatment Period|Subject requested discontinue study drug|1
1376986|NCT01448044|4544100|P2|Treatment Period|Lack of Efficacy|12
1376987|NCT01448044|4544101|P1|Treatment Period|Lack of Efficacy|5
1376988|NCT01448044|4544100|P2|Treatment Period|Adverse Event|3
1376989|NCT01448044|4544101|P1|Treatment Period|Adverse Event|4
1376990|NCT01447927|4544117|P2|Overall Study|Withdrawal by Subject|0
1376991|NCT01447927|4544118|P1|Overall Study|Withdrawal by Subject|1
1376992|NCT01447927|4544117|P2|Overall Study|Adverse Event|3
1376993|NCT01447927|4544118|P1|Overall Study|Adverse Event|4
1376994|NCT01447719|4544148|P1|Overall Study|Family withdrew autopsy consent|7
1376995|NCT01447719|4544148|P1|Overall Study|Withdrawal by Subject|2
1376996|NCT01447719|4544148|P1|Overall Study|Subject still living at end of study|79
1376997|NCT01447719|4544148|P1|Overall Study|Invalid image or not imaged|3
1376998|NCT01447719|4544148|P1|Overall Study|Image acquisition failure|2
1376999|NCT01447576|4544174|P1|Overall Study|Physician Decision|6
1377000|NCT01447576|4544174|P1|Overall Study|Lack of Efficacy|68
1377001|NCT01447576|4544174|P1|Overall Study|Protocol deviation|83
1377002|NCT01447576|4544174|P1|Overall Study|Withdrawal by Subject|100
1377003|NCT01447576|4544174|P1|Overall Study|Participant met withdrawal criteria|40
1377004|NCT01447576|4544174|P1|Overall Study|Adverse Event|127
1377005|NCT01447576|4544174|P1|Overall Study|Lost to Follow-up|52
1377006|NCT01447446|4544207|P6|Overall Study|Reason not Specified|0
1377007|NCT01447446|4544208|P5|Overall Study|Reason not Specified|1
1377008|NCT01447446|4544209|P4|Overall Study|Reason not Specified|1
1377009|NCT01447446|4544210|P3|Overall Study|Reason not Specified|1
1377010|NCT01447446|4544211|P2|Overall Study|Reason not Specified|1
1377011|NCT01447446|4544212|P1|Overall Study|Reason not Specified|1
1377012|NCT01447446|4544207|P6|Overall Study|New Treatment Started|0
1377013|NCT01447446|4544208|P5|Overall Study|New Treatment Started|2
1377014|NCT01447446|4544209|P4|Overall Study|New Treatment Started|0
1377015|NCT01447446|4544210|P3|Overall Study|New Treatment Started|1
1377016|NCT01447446|4544211|P2|Overall Study|New Treatment Started|2
1377017|NCT01447446|4544212|P1|Overall Study|New Treatment Started|8
1377018|NCT01447446|4544207|P6|Overall Study|SVR12 Assessment|5
1377019|NCT01447446|4544208|P5|Overall Study|SVR12 Assessment|5
1377020|NCT01447446|4544209|P4|Overall Study|SVR12 Assessment|1
1377021|NCT01447446|4544210|P3|Overall Study|SVR12 Assessment|2
1377022|NCT01447446|4544211|P2|Overall Study|SVR12 Assessment|1
1377023|NCT01447446|4544212|P1|Overall Study|SVR12 Assessment|13
1377024|NCT01447446|4544207|P6|Overall Study|Administrative/Other|4
1377025|NCT01447446|4544208|P5|Overall Study|Administrative/Other|33
1377026|NCT01447446|4544209|P4|Overall Study|Administrative/Other|2
1377027|NCT01447446|4544210|P3|Overall Study|Administrative/Other|10
1377028|NCT01447446|4544211|P2|Overall Study|Administrative/Other|9
1377029|NCT01447446|4544212|P1|Overall Study|Administrative/Other|34
1377030|NCT01447446|4544207|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
1377031|NCT01447446|4544208|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
1377032|NCT01447446|4544209|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
1377033|NCT01447446|4544210|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
1377034|NCT01447446|4544211|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
1377035|NCT01447446|4544212|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
1377036|NCT01447446|4544207|P6|Overall Study|Failure to Return/Consent Withdrawn|9
1377037|NCT01447446|4544208|P5|Overall Study|Failure to Return/Consent Withdrawn|69
1377038|NCT01447446|4544209|P4|Overall Study|Failure to Return/Consent Withdrawn|7
1377039|NCT01447446|4544210|P3|Overall Study|Failure to Return/Consent Withdrawn|31
1377040|NCT01447446|4544211|P2|Overall Study|Failure to Return/Consent Withdrawn|78
1377041|NCT01447446|4544212|P1|Overall Study|Failure to Return/Consent Withdrawn|357
1377042|NCT01447446|4544207|P6|Overall Study|Adverse Event|0
1377043|NCT01447446|4544208|P5|Overall Study|Adverse Event|2
1377044|NCT01447446|4544209|P4|Overall Study|Adverse Event|0
1377045|NCT01447446|4544210|P3|Overall Study|Adverse Event|1
1377046|NCT01447446|4544211|P2|Overall Study|Adverse Event|0
1377047|NCT01447446|4544212|P1|Overall Study|Adverse Event|3
1377048|NCT01447446|4544207|P6|Overall Study|Death|0
1377049|NCT01447446|4544208|P5|Overall Study|Death|7
1377050|NCT01447446|4544209|P4|Overall Study|Death|1
1377051|NCT01447446|4544210|P3|Overall Study|Death|2
1377052|NCT01447446|4544211|P2|Overall Study|Death|3
1377053|NCT01447446|4544212|P1|Overall Study|Death|6
1377054|NCT01447433|4544302|P2|Overall Study|Protocol Violation|1
1377055|NCT01447433|4544303|P1|Overall Study|Protocol Violation|1
1377056|NCT01447433|4544302|P2|Overall Study|Withdrawal by Subject|3
1377057|NCT01447433|4544303|P1|Overall Study|Withdrawal by Subject|3
1377058|NCT01447433|4544302|P2|Overall Study|Lost to Follow-up|2
1377059|NCT01447433|4544303|P1|Overall Study|Lost to Follow-up|0
1377060|NCT01447420|4544330|P3|Overall Study|Lack of Efficacy|8
1377061|NCT01447420|4544331|P2|Overall Study|Lack of Efficacy|19
1377062|NCT01447420|4544332|P1|Overall Study|Lack of Efficacy|1
1377063|NCT01447420|4544330|P3|Overall Study|Withdrawal by Subject|0
1377064|NCT01447420|4544331|P2|Overall Study|Withdrawal by Subject|1
1377065|NCT01447420|4544332|P1|Overall Study|Withdrawal by Subject|4
1377066|NCT01447420|4544330|P3|Overall Study|Protocol Violation|0
1377067|NCT01447420|4544331|P2|Overall Study|Protocol Violation|3
1377068|NCT01447420|4544332|P1|Overall Study|Protocol Violation|3
1377069|NCT01447420|4544330|P3|Overall Study|Adverse Event|2
1377070|NCT01447420|4544331|P2|Overall Study|Adverse Event|4
1377071|NCT01447420|4544332|P1|Overall Study|Adverse Event|2
1377072|NCT01446874|4544448|P3|Overall Study|Withdrawal by Subject|2
1377073|NCT01446874|4544449|P2|Overall Study|Withdrawal by Subject|0
1377074|NCT01446874|4544450|P1|Overall Study|Withdrawal by Subject|0
1377075|NCT01446874|4544448|P3|Overall Study|Participant died before returning diary|1
1377076|NCT01446874|4544449|P2|Overall Study|Participant died before returning diary|0
1377077|NCT01446874|4544450|P1|Overall Study|Participant died before returning diary|0
1377078|NCT01446874|4544448|P3|Overall Study|Participant lost diary|1
1377079|NCT01446874|4544449|P2|Overall Study|Participant lost diary|0
1377080|NCT01446874|4544450|P1|Overall Study|Participant lost diary|0
1377081|NCT01446874|4544448|P3|Overall Study|Metastatic disease|2
1377082|NCT01446874|4544449|P2|Overall Study|Metastatic disease|0
1377083|NCT01446874|4544450|P1|Overall Study|Metastatic disease|0
1377084|NCT01446874|4544448|P3|Overall Study|Allergic reaction|1
1377085|NCT01446874|4544449|P2|Overall Study|Allergic reaction|0
1377086|NCT01446874|4544450|P1|Overall Study|Allergic reaction|0
1377087|NCT01446874|4544448|P3|Overall Study|Non-compliance|10
1377088|NCT01446874|4544449|P2|Overall Study|Non-compliance|4
1377089|NCT01446874|4544450|P1|Overall Study|Non-compliance|0
1377090|NCT01446874|4544448|P3|Overall Study|Did not proceed to surgery|4
1377091|NCT01446874|4544449|P2|Overall Study|Did not proceed to surgery|0
1377092|NCT01446874|4544450|P1|Overall Study|Did not proceed to surgery|1
1377093|NCT01446874|4544448|P3|Overall Study|Not eligible|0
1377094|NCT01446874|4544449|P2|Overall Study|Not eligible|0
1377095|NCT01446874|4544450|P1|Overall Study|Not eligible|1
1377096|NCT01446796|4544476|P2|Overall Study|Withdrawal by Subject|0
1377097|NCT01446796|4544477|P1|Overall Study|Withdrawal by Subject|1
1377098|NCT01446419|4544502|P2|Overall Study|Terminated per protocol|0
1377099|NCT01446419|4544503|P1|Overall Study|Terminated per protocol|3
1377100|NCT01446419|4544502|P2|Overall Study|Withdrawal by Subject|1
1377101|NCT01446419|4544503|P1|Overall Study|Withdrawal by Subject|1
1377102|NCT01446419|4544502|P2|Overall Study|Death|0
1377103|NCT01446419|4544503|P1|Overall Study|Death|1
1377104|NCT01446289|4544517|P4|Overall Study|Withdrawal by Subject|0
1377105|NCT01446289|4544518|P3|Overall Study|Withdrawal by Subject|1
1377106|NCT01446289|4544519|P2|Overall Study|Withdrawal by Subject|0
1377107|NCT01446289|4544520|P1|Overall Study|Withdrawal by Subject|1
1377108|NCT01446237|4544563|P1|Overall Study|Withdrawal by Subject|7
1377109|NCT01446237|4544563|P1|Overall Study|Lost to Follow-up|2
1377110|NCT01446237|4544563|P1|Overall Study|Adverse Event|1
1377111|NCT01446159|4544575|P4|Overall Study|Not specified|13
1377112|NCT01446159|4544576|P3|Overall Study|Not specified|14
1377113|NCT01446159|4544577|P2|Overall Study|Not specified|0
1377114|NCT01446159|4544578|P1|Overall Study|Not specified|0
1377115|NCT01446159|4544575|P4|Overall Study|Death|36
1377116|NCT01446159|4544576|P3|Overall Study|Death|43
1377117|NCT01446159|4544577|P2|Overall Study|Death|3
1377118|NCT01446159|4544578|P1|Overall Study|Death|2
1377119|NCT01446159|4544575|P4|Overall Study|Lost to Follow-up|2
1377120|NCT01446159|4544576|P3|Overall Study|Lost to Follow-up|1
1377121|NCT01446159|4544577|P2|Overall Study|Lost to Follow-up|0
1377122|NCT01446159|4544578|P1|Overall Study|Lost to Follow-up|0
1377123|NCT01446159|4544575|P4|Overall Study|Withdrawal by Subject|11
1377124|NCT01446159|4544576|P3|Overall Study|Withdrawal by Subject|14
1377125|NCT01446159|4544577|P2|Overall Study|Withdrawal by Subject|0
1377126|NCT01446159|4544578|P1|Overall Study|Withdrawal by Subject|1
1377127|NCT01446042|4544653|P3|Overall Study|Other reasons|1
1377128|NCT01446042|4544654|P2|Overall Study|Other reasons|1
1377129|NCT01446042|4544655|P1|Overall Study|Other reasons|2
1377130|NCT01446042|4544653|P3|Overall Study|Lost to Follow-up|0
1377131|NCT01446042|4544654|P2|Overall Study|Lost to Follow-up|0
1377132|NCT01446042|4544655|P1|Overall Study|Lost to Follow-up|5
1377133|NCT01446042|4544653|P3|Overall Study|Adverse Event|4
1377134|NCT01446042|4544654|P2|Overall Study|Adverse Event|0
1377135|NCT01446042|4544655|P1|Overall Study|Adverse Event|1
1377136|NCT01446042|4544653|P3|Overall Study|Withdrawal by Subject|4
1377137|NCT01446042|4544654|P2|Overall Study|Withdrawal by Subject|2
1377138|NCT01446042|4544655|P1|Overall Study|Withdrawal by Subject|12
1377139|NCT01446003|4544666|P2|Period 2|Adverse Event|0
1377140|NCT01446003|4544667|P1|Period 2|Adverse Event|1
1377141|NCT01446003|4544666|P2|Period 1|Protocol Violation|0
1377142|NCT01446003|4544667|P1|Period 1|Protocol Violation|2
1377143|NCT01445951|4544688|P3|Overall Study|Cough|0
1377144|NCT01445951|4544689|P2|Overall Study|Cough|1
1377145|NCT01445951|4544690|P1|Overall Study|Cough|0
1377146|NCT01445951|4544688|P3|Overall Study|Sponsor decision - subject travel|0
1377147|NCT01445951|4544689|P2|Overall Study|Sponsor decision - subject travel|1
1377148|NCT01445951|4544690|P1|Overall Study|Sponsor decision - subject travel|0
1377149|NCT01445951|4544688|P3|Overall Study|Non-compliance with protocol|0
1377150|NCT01445951|4544689|P2|Overall Study|Non-compliance with protocol|1
1377151|NCT01445951|4544690|P1|Overall Study|Non-compliance with protocol|0
1377152|NCT01445951|4544688|P3|Overall Study|Non-compliance with study drug|0
1377153|NCT01445951|4544689|P2|Overall Study|Non-compliance with study drug|2
1377154|NCT01445951|4544690|P1|Overall Study|Non-compliance with study drug|1
1377155|NCT01445951|4544688|P3|Overall Study|Death|1
1377156|NCT01445951|4544689|P2|Overall Study|Death|0
1377157|NCT01445951|4544690|P1|Overall Study|Death|0
1377158|NCT01445951|4544688|P3|Overall Study|Pregnancy|4
1377159|NCT01445951|4544689|P2|Overall Study|Pregnancy|1
1377160|NCT01445951|4544690|P1|Overall Study|Pregnancy|0
1377161|NCT01445951|4544688|P3|Overall Study|Lost to Follow-up|4
1377162|NCT01445951|4544689|P2|Overall Study|Lost to Follow-up|2
1377163|NCT01445951|4544690|P1|Overall Study|Lost to Follow-up|1
1377164|NCT01445951|4544688|P3|Overall Study|Physician Decision|0
1377165|NCT01445951|4544689|P2|Overall Study|Physician Decision|1
1377166|NCT01445951|4544690|P1|Overall Study|Physician Decision|3
1377167|NCT01445951|4544688|P3|Overall Study|Withdrawal by Subject|8
1377168|NCT01445951|4544689|P2|Overall Study|Withdrawal by Subject|16
1377169|NCT01445951|4544690|P1|Overall Study|Withdrawal by Subject|21
1377170|NCT01445951|4544688|P3|Overall Study|Protocol Violation|2
1377171|NCT01445951|4544689|P2|Overall Study|Protocol Violation|2
1377172|NCT01445951|4544690|P1|Overall Study|Protocol Violation|2
1377173|NCT01445951|4544688|P3|Overall Study|Adverse Event|0
1377174|NCT01445951|4544689|P2|Overall Study|Adverse Event|9
1377175|NCT01445951|4544690|P1|Overall Study|Adverse Event|16
1377176|NCT01445847|4544758|P2|Overall Study|Missed Data|0
1377177|NCT01445847|4544759|P1|Overall Study|Missed Data|1
1377178|NCT01445847|4544758|P2|Overall Study|Protocol Violation|14
1377179|NCT01445847|4544759|P1|Overall Study|Protocol Violation|13
1377180|NCT01445769|4544765|P1|Overall Study|Lost to Follow-up|5
1377181|NCT01445769|4544765|P1|Overall Study|Disease Progression|1
1377182|NCT01445769|4544765|P1|Overall Study|Consent Withdrawn|2
1377183|NCT01445678|4544785|P2|Overall Study|Withdrawal by Subject|5
1377184|NCT01445678|4544786|P1|Overall Study|Withdrawal by Subject|9
1377185|NCT01445678|4544785|P2|Overall Study|Protocol Violation|1
1377186|NCT01445678|4544786|P1|Overall Study|Protocol Violation|1
1377187|NCT01445678|4544785|P2|Overall Study|Lost to Follow-up|5
1377188|NCT01445678|4544786|P1|Overall Study|Lost to Follow-up|8
1377189|NCT01445678|4544785|P2|Overall Study|Lack of Efficacy|2
1377190|NCT01445678|4544786|P1|Overall Study|Lack of Efficacy|0
1377191|NCT01445678|4544785|P2|Overall Study|Adverse Event|8
1377192|NCT01445678|4544786|P1|Overall Study|Adverse Event|12
1377193|NCT01445652|4544804|P2|Overall Study|Adverse Event|0
1377194|NCT01445652|4544805|P1|Overall Study|Adverse Event|1
1377195|NCT01445652|4544804|P2|Overall Study|Failed teach session|0
1377196|NCT01445652|4544805|P1|Overall Study|Failed teach session|2
1377197|NCT01445652|4544804|P2|Overall Study|Failed to attend scheduled visit|3
1377198|NCT01445652|4544805|P1|Overall Study|Failed to attend scheduled visit|2
1377199|NCT01445652|4544804|P2|Overall Study|Not comfortable in lenses|0
1377200|NCT01445652|4544805|P1|Overall Study|Not comfortable in lenses|5
1377201|NCT01445613|4544823|P1|1-year Follow-up|Received a non-study stent|2
1377202|NCT01445613|4544823|P1|1-year Follow-up|Physician Decision|2
1377203|NCT01445613|4544823|P1|1-year Follow-up|Death|30
1377204|NCT01445613|4544823|P1|1-year Follow-up|Lost to Follow-up|2
1377205|NCT01445613|4544823|P1|1-year Follow-up|Missed visit|29
1377206|NCT01445613|4544823|P1|1-year Follow-up|Withdrawal by Subject|12
1377207|NCT01445613|4544823|P1|30-day Follow-up|Death|3
1377208|NCT01445613|4544823|P1|30-day Follow-up|Missed visit|23
1377209|NCT01445613|4544823|P1|30-day Follow-up|Physician Decision|3
1377210|NCT01445613|4544823|P1|30-day Follow-up|Withdrawal by Subject|6
1377211|NCT01445548|4544841|P1|Overall Study|Adverse Event|1
1377212|NCT01445301|4544865|P3|Overall Study|Withdrawal by Subject|4
1377213|NCT01445301|4544866|P2|Overall Study|Withdrawal by Subject|6
1377214|NCT01445301|4544867|P1|Overall Study|Withdrawal by Subject|5
1377215|NCT01445301|4544865|P3|Overall Study|Physician Decision|0
1377216|NCT01445301|4544866|P2|Overall Study|Physician Decision|2
1377217|NCT01445301|4544867|P1|Overall Study|Physician Decision|0
1377218|NCT01445301|4544865|P3|Overall Study|Protocol-Defined Stopping Criteria|1
1377219|NCT01445301|4544866|P2|Overall Study|Protocol-Defined Stopping Criteria|1
1377220|NCT01445301|4544867|P1|Overall Study|Protocol-Defined Stopping Criteria|0
1377221|NCT01445301|4544865|P3|Overall Study|Protocol Violation|0
1377222|NCT01445301|4544866|P2|Overall Study|Protocol Violation|0
1377223|NCT01445301|4544867|P1|Overall Study|Protocol Violation|1
1377224|NCT01445301|4544865|P3|Overall Study|Lack of Efficacy|0
1377225|NCT01445301|4544866|P2|Overall Study|Lack of Efficacy|1
1377226|NCT01445301|4544867|P1|Overall Study|Lack of Efficacy|0
1377227|NCT01445301|4544865|P3|Overall Study|Adverse Event|4
1377228|NCT01445301|4544866|P2|Overall Study|Adverse Event|25
1377229|NCT01445301|4544867|P1|Overall Study|Adverse Event|15
1377230|NCT01444898|4544937|P1|Overall Study|Withdrawal by Subject|1
1377231|NCT01444781|4544952|P3|Overall Study|Withdrawal by Subject|2
1377232|NCT01444781|4544953|P2|Overall Study|Withdrawal by Subject|1
1377233|NCT01444781|4544954|P1|Overall Study|Withdrawal by Subject|3
1377234|NCT01444781|4544952|P3|Overall Study|Lost to Follow-up|1
1377235|NCT01444781|4544953|P2|Overall Study|Lost to Follow-up|3
1377236|NCT01444781|4544954|P1|Overall Study|Lost to Follow-up|0
1377237|NCT01444742|4544992|P1|Overall Study|Death|1
1377238|NCT01444651|4544999|P2|Overall Study|Missing data|1
1377239|NCT01444651|4545000|P1|Overall Study|Missing data|1
1377240|NCT01444651|4544999|P2|Overall Study|Non-fasting|1
1377241|NCT01444651|4545000|P1|Overall Study|Non-fasting|2
1377242|NCT01444651|4544999|P2|Overall Study|Lost to Follow-up|5
1377243|NCT01444651|4545000|P1|Overall Study|Lost to Follow-up|5
1377244|NCT01444651|4544999|P2|Overall Study|Adverse Event|2
1377245|NCT01444651|4545000|P1|Overall Study|Adverse Event|3
1377246|NCT01444456|4545016|P1|Overall Study|Not treated|104
1377247|NCT01444456|4545016|P1|Overall Study|Other|18
1377248|NCT01444456|4545016|P1|Overall Study|Ineligibility determined|23
1377249|NCT01444456|4545016|P1|Overall Study|Death|73
1377250|NCT01444456|4545016|P1|Overall Study|Lost to Follow-up|37
1377251|NCT01444456|4545016|P1|Overall Study|Physician Decision|9
1377252|NCT01444456|4545016|P1|Overall Study|Withdrawal by Subject|21
1377253|NCT01444430|4545027|P2|Overall Study|CRF termination module not completed.|1
1377254|NCT01444430|4545028|P1|Overall Study|CRF termination module not completed.|0
1377255|NCT01444430|4545027|P2|Overall Study|Lost to Follow-up|0
1377256|NCT01444430|4545028|P1|Overall Study|Lost to Follow-up|2
1377257|NCT01444430|4545027|P2|Overall Study|Death|8
1377258|NCT01444430|4545028|P1|Overall Study|Death|6
1377259|NCT01444430|4545027|P2|Overall Study|Withdrawal by Subject|72
1377260|NCT01444430|4545028|P1|Overall Study|Withdrawal by Subject|53
1377261|NCT01444417|4545050|P2|Overall Study|Withdrawal by Subject|0
1377262|NCT01444417|4545051|P1|Overall Study|Withdrawal by Subject|2
1377263|NCT01444417|4545050|P2|Overall Study|Ineligibility Determined|1
1377264|NCT01444417|4545051|P1|Overall Study|Ineligibility Determined|0
1377265|NCT01444391|4545067|P1|Overall Study|Death|1
1377266|NCT01444378|4545075|P1|Overall Study|Missed Visits|10
1377267|NCT01444378|4545075|P1|Overall Study|Administrative Closure Of The Study|2
1377268|NCT01444378|4545075|P1|Overall Study|Death|3
1377269|NCT01444378|4545075|P1|Overall Study|Withdrawal by Subject|1
1377270|NCT01444378|4545075|P1|Overall Study|Lost to Follow-up|1
1377271|NCT01444300|4545187|P2|Overall Study|Adverse Event|0
1377272|NCT01444300|4545188|P1|Overall Study|Adverse Event|4
1377273|NCT01444092|4545220|P1|Overall Study|Other Eligibility criteria|7
1377274|NCT01444092|4545220|P1|Overall Study|Withdrawal by Subject|1
1377275|NCT01444092|4545220|P1|Overall Study|Protocol Violation|1
1377276|NCT01444092|4545220|P1|Overall Study|Adverse Event|8
1377277|NCT01444027|4545229|P3|Overall Study|Lost to Follow-up|14
1377278|NCT01444027|4545230|P2|Overall Study|Lost to Follow-up|20
1377279|NCT01444027|4545231|P1|Overall Study|Lost to Follow-up|26
1377280|NCT01444027|4545229|P3|Overall Study|Withdrawal by Subject|24
1377281|NCT01444027|4545230|P2|Overall Study|Withdrawal by Subject|10
1377282|NCT01444027|4545231|P1|Overall Study|Withdrawal by Subject|4
1377283|NCT01443923|4545253|P2|Overall Study|Adverse Event|0
1377284|NCT01443923|4545254|P1|Overall Study|Adverse Event|1
1377285|NCT01443858|4545271|P3|Overall Study|Lost to Follow-up|2
1377286|NCT01443858|4545272|P2|Overall Study|Lost to Follow-up|5
1377287|NCT01443858|4545273|P1|Overall Study|Lost to Follow-up|5
1377288|NCT01443858|4545271|P3|Overall Study|Lack of Efficacy|0
1377289|NCT01443858|4545272|P2|Overall Study|Lack of Efficacy|0
1377290|NCT01443858|4545273|P1|Overall Study|Lack of Efficacy|1
1377291|NCT01443858|4545271|P3|Overall Study|Withdrawal by Subject|5
1377292|NCT01443858|4545272|P2|Overall Study|Withdrawal by Subject|8
1377293|NCT01443858|4545273|P1|Overall Study|Withdrawal by Subject|9
1377294|NCT01443845|4545295|P2|Overall Study|Lost to Follow-up|13
1377295|NCT01443845|4545296|P1|Overall Study|Lost to Follow-up|9
1377296|NCT01443845|4545295|P2|Overall Study|Military Conflict - Site Terminated|21
1377297|NCT01443845|4545296|P1|Overall Study|Military Conflict - Site Terminated|20
1377298|NCT01443845|4545295|P2|Overall Study|Withdrawal by Subject|67
1377299|NCT01443845|4545296|P1|Overall Study|Withdrawal by Subject|63
1377300|NCT01443845|4545295|P2|Overall Study|Adverse Event|138
1377301|NCT01443845|4545296|P1|Overall Study|Adverse Event|64
1377302|NCT01443845|4545295|P2|Overall Study|Lack of Efficacy|5
1377303|NCT01443845|4545296|P1|Overall Study|Lack of Efficacy|10
1377304|NCT01443845|4545295|P2|Overall Study|Deterioration in pulmonary function|4
1377305|NCT01443845|4545296|P1|Overall Study|Deterioration in pulmonary function|1
1377306|NCT01443845|4545295|P2|Overall Study|Other reasons, such as COPD exacerbation|44
1377307|NCT01443845|4545296|P1|Overall Study|Other reasons, such as COPD exacerbation|44
1377308|NCT01443845|4545295|P2|Overall Study|Protocol Violation|45
1377309|NCT01443845|4545296|P1|Overall Study|Protocol Violation|43
1377310|NCT01443403|4545317|P4|Overall Study|Other - Miscellaneous|1
1377311|NCT01443403|4545318|P3|Overall Study|Other - Miscellaneous|0
1377312|NCT01443403|4545319|P2|Overall Study|Other - Miscellaneous|0
1377313|NCT01443403|4545320|P1|Overall Study|Other - Miscellaneous|1
1377314|NCT01443403|4545317|P4|Overall Study|Use of Prohibited Treatment|0
1377315|NCT01443403|4545318|P3|Overall Study|Use of Prohibited Treatment|0
1377316|NCT01443403|4545319|P2|Overall Study|Use of Prohibited Treatment|3
1377317|NCT01443403|4545320|P1|Overall Study|Use of Prohibited Treatment|2
1377318|NCT01443403|4545317|P4|Overall Study|Protocol Violation|1
1377319|NCT01443403|4545318|P3|Overall Study|Protocol Violation|1
1377320|NCT01443403|4545319|P2|Overall Study|Protocol Violation|1
1377321|NCT01443403|4545320|P1|Overall Study|Protocol Violation|2
1377322|NCT01443403|4545317|P4|Overall Study|Lost to Follow-up|1
1377323|NCT01443403|4545318|P3|Overall Study|Lost to Follow-up|0
1377324|NCT01443403|4545319|P2|Overall Study|Lost to Follow-up|0
1377325|NCT01443403|4545320|P1|Overall Study|Lost to Follow-up|0
1377326|NCT01443403|4545317|P4|Overall Study|Withdrawal by Subject|1
1377327|NCT01443403|4545318|P3|Overall Study|Withdrawal by Subject|2
1377328|NCT01443403|4545319|P2|Overall Study|Withdrawal by Subject|1
1377329|NCT01443403|4545320|P1|Overall Study|Withdrawal by Subject|0
1377330|NCT01443403|4545317|P4|Overall Study|Adverse Event|5
1377331|NCT01443403|4545318|P3|Overall Study|Adverse Event|4
1377332|NCT01443403|4545319|P2|Overall Study|Adverse Event|1
1377333|NCT01443403|4545320|P1|Overall Study|Adverse Event|1
1377334|NCT01443364|4545467|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1377335|NCT01443364|4545467|P1|Overall Study|AE, non-serious non-fatal|8
1377336|NCT01443364|4545467|P1|Overall Study|SAE, non-fatal|6
1377337|NCT01443364|4545467|P1|Overall Study|Other Reason|4
1377338|NCT01443364|4545467|P1|Overall Study|Withdrawal by Subject|5
1377339|NCT01443364|4545467|P1|Overall Study|Lost to Follow-up|3
1377340|NCT01443364|4545467|P1|Overall Study|Lack of Efficacy|14
1377341|NCT01443130|4545596|P6|Overall Study|Death of Subject's Infant|0
1377342|NCT01443130|4545597|P5|Overall Study|Death of Subject's Infant|0
1377343|NCT01443130|4545598|P4|Overall Study|Death of Subject's Infant|0
1377344|NCT01443130|4545599|P3|Overall Study|Death of Subject's Infant|11
1377345|NCT01443130|4545600|P2|Overall Study|Death of Subject's Infant|10
1377346|NCT01443130|4545601|P1|Overall Study|Death of Subject's Infant|5
1377347|NCT01443130|4545596|P6|Overall Study|Withdrawal by Subject|2
1377348|NCT01443130|4545597|P5|Overall Study|Withdrawal by Subject|7
1377349|NCT01443130|4545598|P4|Overall Study|Withdrawal by Subject|7
1377350|NCT01443130|4545599|P3|Overall Study|Withdrawal by Subject|12
1377351|NCT01443130|4545600|P2|Overall Study|Withdrawal by Subject|14
1377352|NCT01443130|4545601|P1|Overall Study|Withdrawal by Subject|15
1377353|NCT01443130|4545596|P6|Overall Study|Protocol Violation|3
1377354|NCT01443130|4545597|P5|Overall Study|Protocol Violation|2
1377355|NCT01443130|4545598|P4|Overall Study|Protocol Violation|2
1377356|NCT01443130|4545599|P3|Overall Study|Protocol Violation|3
1377357|NCT01443130|4545600|P2|Overall Study|Protocol Violation|1
1377358|NCT01443130|4545601|P1|Overall Study|Protocol Violation|2
1377359|NCT01443130|4545596|P6|Overall Study|Adverse Event|0
1377360|NCT01443130|4545597|P5|Overall Study|Adverse Event|0
1377361|NCT01443130|4545598|P4|Overall Study|Adverse Event|0
1377362|NCT01443130|4545599|P3|Overall Study|Adverse Event|1
1377363|NCT01443130|4545600|P2|Overall Study|Adverse Event|1
1377364|NCT01443130|4545601|P1|Overall Study|Adverse Event|2
1377365|NCT01443130|4545596|P6|Overall Study|Death|8
1377366|NCT01443130|4545597|P5|Overall Study|Death|10
1377367|NCT01443130|4545598|P4|Overall Study|Death|7
1377368|NCT01443130|4545599|P3|Overall Study|Death|0
1377369|NCT01443130|4545600|P2|Overall Study|Death|1
1377370|NCT01443130|4545601|P1|Overall Study|Death|0
1377371|NCT01443130|4545596|P6|Overall Study|Lost to Follow-up|21
1377372|NCT01443130|4545597|P5|Overall Study|Lost to Follow-up|25
1377373|NCT01443130|4545598|P4|Overall Study|Lost to Follow-up|23
1377374|NCT01443130|4545599|P3|Overall Study|Lost to Follow-up|50
1377375|NCT01443130|4545600|P2|Overall Study|Lost to Follow-up|42
1377376|NCT01443130|4545601|P1|Overall Study|Lost to Follow-up|44
1377377|NCT01443078|4545651|P1|Overall Study|Patient had brain mets|1
1377378|NCT01443078|4545651|P1|Overall Study|Withdrawal by Subject|1
1377379|NCT01443078|4545651|P1|Overall Study|Responded to neoadjuvant platinum txt|27
1377380|NCT01443026|4545658|P2|Overall Study|Lost to Follow-up|1
1377381|NCT01443026|4545659|P1|Overall Study|Lost to Follow-up|2
1377382|NCT01443026|4545658|P2|Overall Study|Withdrawal by Subject|3
1377383|NCT01443026|4545659|P1|Overall Study|Withdrawal by Subject|0
1377384|NCT01443026|4545658|P2|Overall Study|Death|1
1377385|NCT01443026|4545659|P1|Overall Study|Death|0
1377386|NCT01443026|4545658|P2|Overall Study|Physician Decision|0
1377387|NCT01443026|4545659|P1|Overall Study|Physician Decision|1
1377388|NCT01442779|4545674|P1|Overall Study|Non-compliance|1
1377389|NCT01442779|4545674|P1|Overall Study|Death|3
1377390|NCT01442779|4545674|P1|Overall Study|Withdrawal by Subject|3
1377391|NCT01442714|4545680|P1|Overall Study|Withdrawal by Subject|1
1377392|NCT01442714|4545680|P1|Overall Study|Death|11
1377393|NCT01442688|4545688|P2|Second Intervention|Adverse Event|0
1377394|NCT01442688|4545689|P1|Second Intervention|Adverse Event|1
1377395|NCT01442688|4545688|P2|First Intervention|subject incarcerated|0
1377396|NCT01442688|4545689|P1|First Intervention|subject incarcerated|1
1377397|NCT01442688|4545688|P2|First Intervention|Withdrawal by Subject|0
1377398|NCT01442688|4545689|P1|First Intervention|Withdrawal by Subject|1
1377399|NCT01442675|4545697|P1|Overall Study|Withdrawal by Subject|4
1377400|NCT01442675|4545697|P1|Overall Study|Lost to Follow-up|2
1377401|NCT01442675|4545697|P1|Overall Study|Protocol Violation|6
1377402|NCT01442493|4545709|P2|Overall Study|withdrawn from study|2
1377403|NCT01442493|4545710|P1|Overall Study|withdrawn from study|3
1377404|NCT01442376|4545731|P3|Overall Study|Not eligible for subsequent cycles|0
1377405|NCT01442376|4545732|P2|Overall Study|Not eligible for subsequent cycles|2
1377406|NCT01442376|4545733|P1|Overall Study|Not eligible for subsequent cycles|1
1377407|NCT01442376|4545731|P3|Overall Study|Patients not treated|1
1377408|NCT01442376|4545732|P2|Overall Study|Patients not treated|3
1377409|NCT01442376|4545733|P1|Overall Study|Patients not treated|2
1377410|NCT01442376|4545731|P3|Overall Study|Withdrawal of consent|1
1377411|NCT01442376|4545732|P2|Overall Study|Withdrawal of consent|0
1377412|NCT01442376|4545733|P1|Overall Study|Withdrawal of consent|0
1377413|NCT01442376|4545731|P3|Overall Study|Death|1
1377414|NCT01442376|4545732|P2|Overall Study|Death|1
1377415|NCT01442376|4545733|P1|Overall Study|Death|0
1377416|NCT01442376|4545731|P3|Overall Study|Adverse Event|2
1377417|NCT01442376|4545732|P2|Overall Study|Adverse Event|3
1377418|NCT01442376|4545733|P1|Overall Study|Adverse Event|0
1377419|NCT01442181|4545746|P2|Overall Study|atrial fibrillation not noted|1
1377420|NCT01442181|4545747|P1|Overall Study|atrial fibrillation not noted|0
1377421|NCT01442181|4545746|P2|Overall Study|patient in an additional study|0
1377422|NCT01442181|4545747|P1|Overall Study|patient in an additional study|1
1377423|NCT01442181|4545746|P2|Overall Study|Lost to Follow-up|1
1377424|NCT01442181|4545747|P1|Overall Study|Lost to Follow-up|1
1377425|NCT01442181|4545746|P2|Overall Study|low ejection factor|1
1377426|NCT01442181|4545747|P1|Overall Study|low ejection factor|0
1377427|NCT01442181|4545746|P2|Overall Study|no insurance for surgery|0
1377428|NCT01442181|4545747|P1|Overall Study|no insurance for surgery|1
1377429|NCT01442181|4545746|P2|Overall Study|patient refused surgery|0
1377430|NCT01442181|4545747|P1|Overall Study|patient refused surgery|1
1377431|NCT01442155|4545771|P1|Overall Study|Lost to Follow-up|2
1377432|NCT01442155|4545771|P1|Overall Study|Adverse Event|2
1377433|NCT01442155|4545771|P1|Overall Study|Recurrence|26
1377434|NCT01442155|4545771|P1|Overall Study|Complete remission|35
1377435|NCT01442103|4545787|P1|Overall Study|Lost to Follow-up|2
1377436|NCT01442064|4545797|P6|Overall Study|Condition mandated other intervention|2
1377437|NCT01442064|4545798|P5|Overall Study|Condition mandated other intervention|0
1377438|NCT01442064|4545799|P4|Overall Study|Condition mandated other intervention|0
1377439|NCT01442064|4545800|P3|Overall Study|Condition mandated other intervention|2
1377440|NCT01442064|4545801|P2|Overall Study|Condition mandated other intervention|1
1377441|NCT01442064|4545802|P1|Overall Study|Condition mandated other intervention|1
1377442|NCT01442064|4545797|P6|Overall Study|Subject non-compliance|2
1377443|NCT01442064|4545798|P5|Overall Study|Subject non-compliance|0
1377444|NCT01442064|4545799|P4|Overall Study|Subject non-compliance|0
1377445|NCT01442064|4545800|P3|Overall Study|Subject non-compliance|0
1377446|NCT01442064|4545801|P2|Overall Study|Subject non-compliance|0
1377447|NCT01442064|4545802|P1|Overall Study|Subject non-compliance|0
1377448|NCT01442064|4545797|P6|Overall Study|Sponsor decision|87
1377449|NCT01442064|4545798|P5|Overall Study|Sponsor decision|95
1377450|NCT01442064|4545799|P4|Overall Study|Sponsor decision|88
1377451|NCT01442064|4545800|P3|Overall Study|Sponsor decision|92
1377452|NCT01442064|4545801|P2|Overall Study|Sponsor decision|88
1377453|NCT01442064|4545802|P1|Overall Study|Sponsor decision|82
1377454|NCT01442064|4545797|P6|Overall Study|Withdrawal by Subject|1
1377455|NCT01442064|4545798|P5|Overall Study|Withdrawal by Subject|2
1377456|NCT01442064|4545799|P4|Overall Study|Withdrawal by Subject|2
1377457|NCT01442064|4545800|P3|Overall Study|Withdrawal by Subject|2
1377458|NCT01442064|4545801|P2|Overall Study|Withdrawal by Subject|3
1377459|NCT01442064|4545802|P1|Overall Study|Withdrawal by Subject|6
1377460|NCT01442064|4545797|P6|Overall Study|Physician Decision|1
1377461|NCT01442064|4545798|P5|Overall Study|Physician Decision|3
1377462|NCT01442064|4545799|P4|Overall Study|Physician Decision|3
1377463|NCT01442064|4545800|P3|Overall Study|Physician Decision|2
1377464|NCT01442064|4545801|P2|Overall Study|Physician Decision|1
1377465|NCT01442064|4545802|P1|Overall Study|Physician Decision|1
1377466|NCT01442064|4545797|P6|Overall Study|Lost to Follow-up|3
1377467|NCT01442064|4545798|P5|Overall Study|Lost to Follow-up|3
1377468|NCT01442064|4545799|P4|Overall Study|Lost to Follow-up|1
1377469|NCT01442064|4545800|P3|Overall Study|Lost to Follow-up|1
1377470|NCT01442064|4545801|P2|Overall Study|Lost to Follow-up|5
1377471|NCT01442064|4545802|P1|Overall Study|Lost to Follow-up|5
1377472|NCT01442064|4545797|P6|Overall Study|Death|3
1377473|NCT01442064|4545798|P5|Overall Study|Death|1
1377474|NCT01442064|4545799|P4|Overall Study|Death|3
1377475|NCT01442064|4545800|P3|Overall Study|Death|3
1377476|NCT01442064|4545801|P2|Overall Study|Death|1
1377477|NCT01442064|4545802|P1|Overall Study|Death|0
1377478|NCT01442064|4545797|P6|Overall Study|Adverse Event|0
1377479|NCT01442064|4545798|P5|Overall Study|Adverse Event|2
1377480|NCT01442064|4545799|P4|Overall Study|Adverse Event|1
1377481|NCT01442064|4545800|P3|Overall Study|Adverse Event|2
1377482|NCT01442064|4545801|P2|Overall Study|Adverse Event|2
1377483|NCT01442064|4545802|P1|Overall Study|Adverse Event|2
1377484|NCT01442038|4545839|P2|Overall Study|Study Terminated By Sponsor|3
1377485|NCT01442038|4545840|P1|Overall Study|Study Terminated By Sponsor|2
1377486|NCT01442038|4545839|P2|Overall Study|Investigator's Discretion|16
1377487|NCT01442038|4545840|P1|Overall Study|Investigator's Discretion|13
1377488|NCT01442038|4545839|P2|Overall Study|Protocol Deviation|20
1377489|NCT01442038|4545840|P1|Overall Study|Protocol Deviation|9
1377490|NCT01442038|4545839|P2|Overall Study|Adverse Event|15
1377491|NCT01442038|4545840|P1|Overall Study|Adverse Event|26
1377492|NCT01442038|4545839|P2|Overall Study|Lost to Follow-up|51
1377493|NCT01442038|4545840|P1|Overall Study|Lost to Follow-up|37
1377494|NCT01442038|4545839|P2|Overall Study|Participant Withdrew Consent|102
1377495|NCT01442038|4545840|P1|Overall Study|Participant Withdrew Consent|137
1377496|NCT01442038|4545839|P2|Overall Study|Investigator-Initiated Early Closure|43
1377497|NCT01442038|4545840|P1|Overall Study|Investigator-Initiated Early Closure|44
1377498|NCT01442038|4545839|P2|Overall Study|Death|29
1377499|NCT01442038|4545840|P1|Overall Study|Death|35
1377500|NCT01441973|4545854|P2|Overall Study|Participant withdrew consent|1
1377501|NCT01441973|4545855|P1|Overall Study|Participant withdrew consent|0
1377502|NCT01441973|4545854|P2|Overall Study|Administrative reason by sponsor|5
1377503|NCT01441973|4545855|P1|Overall Study|Administrative reason by sponsor|3
1377504|NCT01441973|4545854|P2|Overall Study|Poor compliance/noncompliance|1
1377505|NCT01441973|4545855|P1|Overall Study|Poor compliance/noncompliance|0
1377506|NCT01441973|4545854|P2|Overall Study|Participant request to discontinue|1
1377507|NCT01441973|4545855|P1|Overall Study|Participant request to discontinue|1
1377508|NCT01441973|4545854|P2|Overall Study|Adverse event unrelated to study drug|2
1377509|NCT01441973|4545855|P1|Overall Study|Adverse event unrelated to study drug|3
1377510|NCT01441973|4545854|P2|Overall Study|Disease progression|6
1377511|NCT01441973|4545855|P1|Overall Study|Disease progression|8
1377512|NCT01441960|4545877|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
1377513|NCT01441960|4545878|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
1377514|NCT01441960|4545877|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
1377515|NCT01441960|4545878|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
1377516|NCT01441960|4545877|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
1377517|NCT01441960|4545878|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
1377518|NCT01441765|4545903|P2|Overall Study|Death|0
1377519|NCT01441765|4545904|P1|Overall Study|Death|1
1377520|NCT01441596|4545921|P3|Overall Study|Not treated|1
1377521|NCT01441596|4545922|P2|Overall Study|Not treated|1
1377522|NCT01441596|4545923|P1|Overall Study|Not treated|0
1377523|NCT01441596|4545921|P3|Overall Study|Withdrawal by Subject|2
1377524|NCT01441596|4545922|P2|Overall Study|Withdrawal by Subject|0
1377525|NCT01441596|4545923|P1|Overall Study|Withdrawal by Subject|4
1377526|NCT01441596|4545921|P3|Overall Study|Other reason not defined below|1
1377527|NCT01441596|4545922|P2|Overall Study|Other reason not defined below|2
1377528|NCT01441596|4545923|P1|Overall Study|Other reason not defined below|0
1377529|NCT01441440|4545970|P3|Overall Study|Difficllty in keeping the schedule|0
1377530|NCT01441440|4545971|P2|Overall Study|Difficllty in keeping the schedule|1
1377531|NCT01441440|4545972|P1|Overall Study|Difficllty in keeping the schedule|1
1377532|NCT01441440|4545970|P3|Overall Study|Work-related matter|0
1377533|NCT01441440|4545971|P2|Overall Study|Work-related matter|1
1377534|NCT01441440|4545972|P1|Overall Study|Work-related matter|0
1377535|NCT01441440|4545970|P3|Overall Study|Moving|1
1377536|NCT01441440|4545971|P2|Overall Study|Moving|1
1377537|NCT01441440|4545972|P1|Overall Study|Moving|0
1377538|NCT01441440|4545970|P3|Overall Study|Lack of Efficacy|1
1377539|NCT01441440|4545971|P2|Overall Study|Lack of Efficacy|0
1377540|NCT01441440|4545972|P1|Overall Study|Lack of Efficacy|1
1377541|NCT01441440|4545970|P3|Overall Study|Pregnancy|0
1377542|NCT01441440|4545971|P2|Overall Study|Pregnancy|0
1377543|NCT01441440|4545972|P1|Overall Study|Pregnancy|1
1377544|NCT01441440|4545970|P3|Overall Study|Withdrawal by Subject|9
1377545|NCT01441440|4545971|P2|Overall Study|Withdrawal by Subject|9
1377546|NCT01441440|4545972|P1|Overall Study|Withdrawal by Subject|11
1377547|NCT01441440|4545970|P3|Overall Study|Lost to Follow-up|1
1377548|NCT01441440|4545971|P2|Overall Study|Lost to Follow-up|2
1377549|NCT01441440|4545972|P1|Overall Study|Lost to Follow-up|0
1377550|NCT01441440|4545970|P3|Overall Study|Adverse Event|9
1377551|NCT01441440|4545971|P2|Overall Study|Adverse Event|9
1377552|NCT01441440|4545972|P1|Overall Study|Adverse Event|2
1377553|NCT01441440|4545970|P3|Overall Study|Death|1
1377554|NCT01441440|4545971|P2|Overall Study|Death|0
1377555|NCT01441440|4545972|P1|Overall Study|Death|1
1377556|NCT01441414|4545995|P1|Overall Study|Subject refused further follow-up|1
1377557|NCT01441414|4545995|P1|Overall Study|Study terminated by sponsor|2
1377558|NCT01441414|4545995|P1|Overall Study|Other reasons|3
1377559|NCT01441414|4545995|P1|Overall Study|Participant died|9
1377560|NCT01441180|4546074|P3|Overall Study|Discontinued|2
1377561|NCT01441180|4546075|P2|Overall Study|Discontinued|0
1377562|NCT01441180|4546076|P1|Overall Study|Discontinued|0
1377563|NCT01441180|4546074|P3|Overall Study|Lost to Follow-up|1
1377564|NCT01441180|4546075|P2|Overall Study|Lost to Follow-up|1
1377565|NCT01441180|4546076|P1|Overall Study|Lost to Follow-up|1
1377566|NCT01441102|4546087|P1|Overall Study|Withdrawal by Subject|2
1377567|NCT01441102|4546087|P1|Overall Study|Adverse Event|1
1377568|NCT01440972|4546131|P2|Overall Study|Withdrawal by Subject|2
1377569|NCT01440972|4546132|P1|Overall Study|Withdrawal by Subject|3
1377570|NCT01440946|4546156|P2|Overall Study|Physician Decision|0
1377571|NCT01440946|4546157|P1|Overall Study|Physician Decision|1
1377572|NCT01440946|4546156|P2|Overall Study|Lost to Follow-up|1
1377573|NCT01440946|4546157|P1|Overall Study|Lost to Follow-up|1
1377574|NCT01440881|4546196|P2|Overall Study|Death|1
1377575|NCT01440881|4546197|P1|Overall Study|Death|0
1377576|NCT01440816|4546211|P2|Overall Study|To Be Seen By Local Oncologist|2
1377577|NCT01440816|4546212|P1|Overall Study|To Be Seen By Local Oncologist|1
1377578|NCT01440816|4546211|P2|Overall Study|Disease Progression|9
1377579|NCT01440816|4546212|P1|Overall Study|Disease Progression|0
1377580|NCT01440647|4546255|P2|Overall Study|Death|3
1377581|NCT01440647|4546256|P1|Overall Study|Death|2
1377582|NCT01440595|4546275|P3|Overall Study|Study terminated by sponsor.|1
1377583|NCT01440595|4546276|P2|Overall Study|Study terminated by sponsor.|2
1377584|NCT01440595|4546277|P1|Overall Study|Study terminated by sponsor.|1
1377585|NCT01440595|4546275|P3|Overall Study|Lost to Follow-up|0
1377586|NCT01440595|4546276|P2|Overall Study|Lost to Follow-up|1
1377587|NCT01440595|4546277|P1|Overall Study|Lost to Follow-up|0
1377588|NCT01440569|4546297|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
1377589|NCT01440569|4546298|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
1377590|NCT01440569|4546297|P2|Open-Label Rollover Phase|Lost to Follow-up|3
1377591|NCT01440569|4546298|P1|Open-Label Rollover Phase|Lost to Follow-up|26
1377592|NCT01440569|4546297|P2|Open-Label Rollover Phase|Withdrew Consent|1
1377593|NCT01440569|4546298|P1|Open-Label Rollover Phase|Withdrew Consent|11
1377594|NCT01440569|4546297|P2|Open-Label Rollover Phase|Investigator’s Discretion|1
1377595|NCT01440569|4546298|P1|Open-Label Rollover Phase|Investigator’s Discretion|3
1377596|NCT01440569|4546297|P2|Open-Label Rollover Phase|Lack of Efficacy|0
1377597|NCT01440569|4546298|P1|Open-Label Rollover Phase|Lack of Efficacy|2
1377598|NCT01440569|4546297|P2|Open-Label Rollover Phase|Pregnancy|0
1377599|NCT01440569|4546298|P1|Open-Label Rollover Phase|Pregnancy|1
1377600|NCT01440569|4546297|P2|Open-Label Rollover Phase|Adverse Event|0
1377601|NCT01440569|4546298|P1|Open-Label Rollover Phase|Adverse Event|3
1377602|NCT01440569|4546297|P2|Main Study|Protocol Violation|0
1377603|NCT01440569|4546298|P1|Main Study|Protocol Violation|1
1377604|NCT01440569|4546297|P2|Main Study|Subject Non-Compliance|0
1377605|NCT01440569|4546298|P1|Main Study|Subject Non-Compliance|3
1377606|NCT01440569|4546297|P2|Main Study|Lost to Follow-up|2
1377607|NCT01440569|4546298|P1|Main Study|Lost to Follow-up|13
1377608|NCT01440569|4546297|P2|Main Study|Withdrew Consent|1
1377609|NCT01440569|4546298|P1|Main Study|Withdrew Consent|7
1377610|NCT01440569|4546297|P2|Main Study|Investigator's Discretion|1
1377611|NCT01440569|4546298|P1|Main Study|Investigator's Discretion|1
1377612|NCT01440569|4546297|P2|Main Study|Pregnancy|0
1377613|NCT01440569|4546298|P1|Main Study|Pregnancy|1
1377614|NCT01440569|4546297|P2|Main Study|Adverse Event|0
1377615|NCT01440569|4546298|P1|Main Study|Adverse Event|9
1377616|NCT01440569|4546297|P2|Main Study|Enrolled but not treated|0
1377617|NCT01440569|4546298|P1|Main Study|Enrolled but not treated|1
1377618|NCT01440517|4546333|P1|Overall Study|Subject withdrawn prior to dosing|1
1377619|NCT01440374|4546364|P4|Part 3: Extension|Physician Decision|14
1377620|NCT01440374|4546365|P3|Part 3: Extension|Physician Decision|0
1377621|NCT01440374|4546366|P2|Part 3: Extension|Physician Decision|0
1377622|NCT01440374|4546367|P1|Part 3: Extension|Physician Decision|0
1377623|NCT01440374|4546364|P4|Part 3: Extension|Adverse Event|13
1377624|NCT01440374|4546365|P3|Part 3: Extension|Adverse Event|0
1377625|NCT01440374|4546366|P2|Part 3: Extension|Adverse Event|0
1377626|NCT01440374|4546367|P1|Part 3: Extension|Adverse Event|0
1377627|NCT01440374|4546364|P4|Part 3: Extension|Withdrawal by Subject|5
1377628|NCT01440374|4546365|P3|Part 3: Extension|Withdrawal by Subject|0
1377629|NCT01440374|4546366|P2|Part 3: Extension|Withdrawal by Subject|0
1377630|NCT01440374|4546367|P1|Part 3: Extension|Withdrawal by Subject|0
1377631|NCT01440374|4546364|P4|Part 2; Double-blind Phase|Not treated|0
1377632|NCT01440374|4546365|P3|Part 2; Double-blind Phase|Not treated|1
1377633|NCT01440374|4546366|P2|Part 2; Double-blind Phase|Not treated|0
1377634|NCT01440374|4546367|P1|Part 2; Double-blind Phase|Not treated|0
1377635|NCT01440374|4546364|P4|Part 2; Double-blind Phase|Adverse Event|0
1377636|NCT01440374|4546365|P3|Part 2; Double-blind Phase|Adverse Event|31
1377637|NCT01440374|4546366|P2|Part 2; Double-blind Phase|Adverse Event|7
1377638|NCT01440374|4546367|P1|Part 2; Double-blind Phase|Adverse Event|0
1377639|NCT01440374|4546364|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
1377640|NCT01440374|4546365|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
1377641|NCT01440374|4546366|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
1377642|NCT01440374|4546367|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
1377643|NCT01440374|4546364|P4|Part 2; Double-blind Phase|Protocol Violation|0
1377644|NCT01440374|4546365|P3|Part 2; Double-blind Phase|Protocol Violation|1
1377645|NCT01440374|4546366|P2|Part 2; Double-blind Phase|Protocol Violation|0
1377646|NCT01440374|4546367|P1|Part 2; Double-blind Phase|Protocol Violation|0
1377647|NCT01440374|4546364|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
1377648|NCT01440374|4546365|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
1377649|NCT01440374|4546366|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
1377650|NCT01440374|4546367|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
1377651|NCT01440374|4546364|P4|Part 2; Double-blind Phase|Physician Decision|0
1377652|NCT01440374|4546365|P3|Part 2; Double-blind Phase|Physician Decision|17
1377653|NCT01440374|4546366|P2|Part 2; Double-blind Phase|Physician Decision|8
1377654|NCT01440374|4546367|P1|Part 2; Double-blind Phase|Physician Decision|0
1377655|NCT01440374|4546364|P4|Part 1: Open-label Phase|Physician Decision|0
1377656|NCT01440374|4546365|P3|Part 1: Open-label Phase|Physician Decision|0
1377657|NCT01440374|4546366|P2|Part 1: Open-label Phase|Physician Decision|0
1377658|NCT01440374|4546367|P1|Part 1: Open-label Phase|Physician Decision|1
1377659|NCT01440374|4546364|P4|Part 1: Open-label Phase|Adverse Event|0
1377660|NCT01440374|4546365|P3|Part 1: Open-label Phase|Adverse Event|0
1377661|NCT01440374|4546366|P2|Part 1: Open-label Phase|Adverse Event|0
1377662|NCT01440374|4546367|P1|Part 1: Open-label Phase|Adverse Event|5
1377663|NCT01440322|4546402|P2|Overall Study|Other Non-Product Related|0
1377664|NCT01440322|4546403|P1|Overall Study|Other Non-Product Related|1
1377665|NCT01440322|4546402|P2|Overall Study|Unrelated Medical Problem|1
1377666|NCT01440322|4546403|P1|Overall Study|Unrelated Medical Problem|0
1377667|NCT01440322|4546402|P2|Overall Study|Other Product Related|0
1377668|NCT01440322|4546403|P1|Overall Study|Other Product Related|1
1377669|NCT01440322|4546402|P2|Overall Study|Unacceptable Subjective Vision|0
1377670|NCT01440322|4546403|P1|Overall Study|Unacceptable Subjective Vision|1
1377671|NCT01440322|4546402|P2|Overall Study|Symptoms and Problems|0
1377672|NCT01440322|4546403|P1|Overall Study|Symptoms and Problems|1
1377673|NCT01440322|4546402|P2|Overall Study|Biomicroscopy|0
1377674|NCT01440322|4546403|P1|Overall Study|Biomicroscopy|1
1377675|NCT01440322|4546402|P2|Overall Study|Discomfort|0
1377676|NCT01440322|4546403|P1|Overall Study|Discomfort|2
1377677|NCT01440283|4546425|P1|Overall Study|Physician Decision|3
1377678|NCT01440283|4546425|P1|Overall Study|Withdrawal by Subject|4
1377679|NCT01440283|4546425|P1|Overall Study|Death|3
1377680|NCT01440101|4546440|P3|Overall Study|Not Specified|0
1377681|NCT01440101|4546441|P2|Overall Study|Not Specified|1
1377682|NCT01440101|4546442|P1|Overall Study|Not Specified|0
1377683|NCT01440101|4546440|P3|Overall Study|Withdrawal by Subject|1
1377684|NCT01440101|4546441|P2|Overall Study|Withdrawal by Subject|3
1377685|NCT01440101|4546442|P1|Overall Study|Withdrawal by Subject|0
1377686|NCT01440101|4546440|P3|Overall Study|Adverse Event|0
1377687|NCT01440101|4546441|P2|Overall Study|Adverse Event|0
1377688|NCT01440101|4546442|P1|Overall Study|Adverse Event|2
1377689|NCT01440049|4546475|P1|Overall Study|Adverse Event|5
1377690|NCT01439971|4546507|P5|Overall Study|Required number in cohort dosed|1
1377691|NCT01439971|4546508|P4|Overall Study|Required number in cohort dosed|0
1377692|NCT01439971|4546509|P3|Overall Study|Required number in cohort dosed|2
1377693|NCT01439971|4546510|P2|Overall Study|Required number in cohort dosed|1
1377694|NCT01439971|4546511|P1|Overall Study|Required number in cohort dosed|0
1377695|NCT01439945|4546691|P4|Double-Blind Treatment Phase|Ineligible|1
1377696|NCT01439945|4546692|P3|Double-Blind Treatment Phase|Ineligible|0
1377697|NCT01439945|4546693|P2|Double-Blind Treatment Phase|Ineligible|2
1377698|NCT01439945|4546694|P1|Double-Blind Treatment Phase|Ineligible|1
1377699|NCT01439945|4546691|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
1377700|NCT01439945|4546692|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
1377701|NCT01439945|4546693|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
1377702|NCT01439945|4546694|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
1377703|NCT01439867|4546719|P2|Overall Study|Protocol-specified Criteria|0
1377704|NCT01439867|4546720|P1|Overall Study|Protocol-specified Criteria|1
1377705|NCT01439867|4546719|P2|Overall Study|Administrative Decision|5
1377706|NCT01439867|4546720|P1|Overall Study|Administrative Decision|4
1377707|NCT01439867|4546719|P2|Overall Study|Withdrawal by Subject|2
1377708|NCT01439867|4546720|P1|Overall Study|Withdrawal by Subject|1
1377709|NCT01439867|4546719|P2|Overall Study|Non-compliance|1
1377710|NCT01439867|4546720|P1|Overall Study|Non-compliance|0
1377711|NCT01439724|4546761|P2|Overall Study|missing consultation|8
1377712|NCT01439724|4546762|P1|Overall Study|missing consultation|9
1377713|NCT01439711|4546768|P1|Overall Study|No MRI|9
1377714|NCT01439711|4546768|P1|Overall Study|Noncompliance|3
1377715|NCT01439711|4546768|P1|Overall Study|Progression During Active Tx|3
1377716|NCT01439711|4546768|P1|Overall Study|Withdrawal by Subject|3
1377717|NCT01439711|4546768|P1|Overall Study|Adverse Event|5
1377718|NCT01439711|4546768|P1|Overall Study|Progression Prior to Beginning Tx|1
1377719|NCT01439711|4546768|P1|Overall Study|Cancel|3
1377720|NCT01439711|4546768|P1|Overall Study|Ineligible|13
1377721|NCT01439373|4546794|P2|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
1377722|NCT01439373|4546795|P1|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
1377723|NCT01439373|4546794|P2|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
1377724|NCT01439373|4546795|P1|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
1377725|NCT01439360|4546838|P2|Overall Study|Withdrawal by Subject|129
1377726|NCT01439360|4546839|P1|Overall Study|Withdrawal by Subject|140
1377727|NCT01439360|4546838|P2|Overall Study|Protocol Violation|0
1377728|NCT01439360|4546839|P1|Overall Study|Protocol Violation|1
1377729|NCT01439360|4546838|P2|Overall Study|Others|5
1377730|NCT01439360|4546839|P1|Overall Study|Others|10
1377731|NCT01439360|4546838|P2|Overall Study|Lost to Follow-up|58
1377732|NCT01439360|4546839|P1|Overall Study|Lost to Follow-up|43
1377733|NCT01439360|4546838|P2|Overall Study|Adverse Event|16
1377734|NCT01439360|4546839|P1|Overall Study|Adverse Event|4
1377735|NCT01439282|4546889|P2|Overall Study|Not specified|1
1377736|NCT01439282|4546890|P1|Overall Study|Not specified|1
1377737|NCT01439282|4546889|P2|Overall Study|Withdrawal by Subject|0
1377738|NCT01439282|4546890|P1|Overall Study|Withdrawal by Subject|2
1377739|NCT01439282|4546889|P2|Overall Study|Adverse Event|0
1377740|NCT01439282|4546890|P1|Overall Study|Adverse Event|5
1377741|NCT01439204|4546900|P2|Overall Study|poor/non-compliance|0
1377742|NCT01439204|4546901|P1|Overall Study|poor/non-compliance|3
1377743|NCT01439204|4546900|P2|Overall Study|No longer meets study criteria|0
1377744|NCT01439204|4546901|P1|Overall Study|No longer meets study criteria|1
1377745|NCT01439204|4546900|P2|Overall Study|Lost to Follow-up|2
1377746|NCT01439204|4546901|P1|Overall Study|Lost to Follow-up|0
1377747|NCT01439204|4546900|P2|Overall Study|Withdrawal by Subject|1
1377748|NCT01439204|4546901|P1|Overall Study|Withdrawal by Subject|0
1377749|NCT01439165|4546935|P2|Overall Study|Withdrawal by Subject|1
1377750|NCT01439165|4546936|P1|Overall Study|Withdrawal by Subject|7
1377751|NCT01439165|4546935|P2|Overall Study|Lost to Follow-up|1
1377752|NCT01439165|4546936|P1|Overall Study|Lost to Follow-up|11
1377753|NCT01439165|4546935|P2|Overall Study|Protocol Violation|0
1377754|NCT01439165|4546936|P1|Overall Study|Protocol Violation|3
1377755|NCT01439126|4546950|P2|Overall Study|Other-Miscellaneous|12
1377756|NCT01439126|4546951|P1|Overall Study|Other-Miscellaneous|12
1377757|NCT01439126|4546950|P2|Overall Study|Other-Use of prohibited treatment|2
1377758|NCT01439126|4546951|P1|Overall Study|Other-Use of prohibited treatment|0
1377759|NCT01439126|4546950|P2|Overall Study|Lost to Follow-up|3
1377760|NCT01439126|4546951|P1|Overall Study|Lost to Follow-up|6
1377761|NCT01439126|4546950|P2|Overall Study|Protocol Violation|4
1377762|NCT01439126|4546951|P1|Overall Study|Protocol Violation|6
1377763|NCT01439126|4546950|P2|Overall Study|Withdrawal by Subject|21
1377764|NCT01439126|4546951|P1|Overall Study|Withdrawal by Subject|5
1377765|NCT01439126|4546950|P2|Overall Study|Adverse Event|0
1377766|NCT01439126|4546951|P1|Overall Study|Adverse Event|2
1377767|NCT01439074|4546973|P2|Overall Study|Other|4
1377768|NCT01439074|4546974|P1|Overall Study|Other|4
1377769|NCT01439074|4546973|P2|Overall Study|Withdrawal by Subject|5
1377770|NCT01439074|4546974|P1|Overall Study|Withdrawal by Subject|1
1377771|NCT01439074|4546973|P2|Overall Study|Subject shedding|0
1377772|NCT01439074|4546974|P1|Overall Study|Subject shedding|1
1377773|NCT01439074|4546973|P2|Overall Study|Lost to Follow-up|4
1377774|NCT01439074|4546974|P1|Overall Study|Lost to Follow-up|3
1377775|NCT01438996|4546989|P3|Overall Study|Not meeting Inclusion Criteria|0
1377776|NCT01438996|4546990|P2|Overall Study|Not meeting Inclusion Criteria|1
1377777|NCT01438996|4546991|P1|Overall Study|Not meeting Inclusion Criteria|4
1377778|NCT01438840|4547025|P3|Extension Phase|Not specified|1
1377779|NCT01438840|4547026|P2|Extension Phase|Not specified|0
1377780|NCT01438840|4547027|P1|Extension Phase|Not specified|0
1377781|NCT01438840|4547025|P3|Extension Phase|Lack of Efficacy|2
1377782|NCT01438840|4547026|P2|Extension Phase|Lack of Efficacy|0
1377783|NCT01438840|4547027|P1|Extension Phase|Lack of Efficacy|0
1377784|NCT01438840|4547025|P3|Extension Phase|Withdrawal by Subject|3
1377785|NCT01438840|4547026|P2|Extension Phase|Withdrawal by Subject|0
1377786|NCT01438840|4547027|P1|Extension Phase|Withdrawal by Subject|0
1377787|NCT01438840|4547025|P3|Extension Phase|Lost to Follow-up|1
1377788|NCT01438840|4547026|P2|Extension Phase|Lost to Follow-up|0
1377789|NCT01438840|4547027|P1|Extension Phase|Lost to Follow-up|0
1377790|NCT01438840|4547025|P3|Extension Phase|Adverse Event|3
1377791|NCT01438840|4547026|P2|Extension Phase|Adverse Event|0
1377792|NCT01438840|4547027|P1|Extension Phase|Adverse Event|0
1377793|NCT01438840|4547025|P3|Core Study|Withdrawal of consent|0
1377794|NCT01438840|4547026|P2|Core Study|Withdrawal of consent|0
1377795|NCT01438840|4547027|P1|Core Study|Withdrawal of consent|1
1377796|NCT01438840|4547025|P3|Core Study|Lack of Efficacy|0
1377797|NCT01438840|4547026|P2|Core Study|Lack of Efficacy|7
1377798|NCT01438840|4547027|P1|Core Study|Lack of Efficacy|15
1377799|NCT01438840|4547025|P3|Core Study|Adverse Event|0
1377800|NCT01438840|4547026|P2|Core Study|Adverse Event|3
1377801|NCT01438840|4547027|P1|Core Study|Adverse Event|0
1377802|NCT01438814|4547040|P2|Overall Study|Not specified|4
1377803|NCT01438814|4547041|P1|Overall Study|Not specified|2
1377804|NCT01438814|4547040|P2|Overall Study|Withdrawal by Subject|2
1377805|NCT01438814|4547041|P1|Overall Study|Withdrawal by Subject|4
1377806|NCT01438814|4547040|P2|Overall Study|Lost to Follow-up|3
1377807|NCT01438814|4547041|P1|Overall Study|Lost to Follow-up|4
1377808|NCT01438814|4547040|P2|Overall Study|Protocol Violation|2
1377809|NCT01438814|4547041|P1|Overall Study|Protocol Violation|1
1377810|NCT01438814|4547040|P2|Overall Study|Adverse Event|3
1377811|NCT01438814|4547041|P1|Overall Study|Adverse Event|3
1377812|NCT01438541|4547077|P1|Overall Study|discharge from the hospital|5
1377813|NCT01438541|4547077|P1|Overall Study|Withdrawal by Subject|1
1377814|NCT01438541|4547077|P1|Overall Study|Physician Decision|1
1377815|NCT01438489|4547086|P3|Overall Study|Inadequate venous access|0
1377816|NCT01438489|4547087|P2|Overall Study|Inadequate venous access|2
1377817|NCT01438489|4547088|P1|Overall Study|Inadequate venous access|0
1377818|NCT01438489|4547086|P3|Overall Study|Did not complete all 3 follow-up visits|2
1377819|NCT01438489|4547087|P2|Overall Study|Did not complete all 3 follow-up visits|5
1377820|NCT01438489|4547088|P1|Overall Study|Did not complete all 3 follow-up visits|2
1377821|NCT01438489|4547086|P3|Overall Study|Received prohibited medication|0
1377822|NCT01438489|4547087|P2|Overall Study|Received prohibited medication|0
1377823|NCT01438489|4547088|P1|Overall Study|Received prohibited medication|1
1377824|NCT01438489|4547086|P3|Overall Study|AE/SAEs|1
1377825|NCT01438489|4547087|P2|Overall Study|AE/SAEs|1
1377826|NCT01438489|4547088|P1|Overall Study|AE/SAEs|2
1377827|NCT01438489|4547086|P3|Overall Study|Investigator decision|0
1377828|NCT01438489|4547087|P2|Overall Study|Investigator decision|1
1377829|NCT01438489|4547088|P1|Overall Study|Investigator decision|0
1377830|NCT01438489|4547086|P3|Overall Study|Subject choice/Subject moved|1
1377831|NCT01438489|4547087|P2|Overall Study|Subject choice/Subject moved|1
1377832|NCT01438489|4547088|P1|Overall Study|Subject choice/Subject moved|2
1377833|NCT01438489|4547086|P3|Overall Study|Sponsor decision|4
1377834|NCT01438489|4547087|P2|Overall Study|Sponsor decision|1
1377835|NCT01438489|4547088|P1|Overall Study|Sponsor decision|4
1377836|NCT01438489|4547086|P3|Overall Study|Death|1
1377837|NCT01438489|4547087|P2|Overall Study|Death|0
1377838|NCT01438489|4547088|P1|Overall Study|Death|0
1377839|NCT01438489|4547086|P3|Overall Study|Withdrawal by Subject|8
1377840|NCT01438489|4547087|P2|Overall Study|Withdrawal by Subject|3
1377841|NCT01438489|4547088|P1|Overall Study|Withdrawal by Subject|11
1377842|NCT01438489|4547086|P3|Overall Study|Lost to Follow-up|2
1377843|NCT01438489|4547087|P2|Overall Study|Lost to Follow-up|2
1377844|NCT01438489|4547088|P1|Overall Study|Lost to Follow-up|4
1377845|NCT01438424|4547131|P1|Overall Study|Participant noncompliance|20
1377846|NCT01438424|4547131|P1|Overall Study|No longer met inclusion criteria|1
1377847|NCT01438424|4547131|P1|Overall Study|Pregnancy|7
1377848|NCT01438424|4547131|P1|Overall Study|Need for drug prohibited by protocol|14
1377849|NCT01438424|4547131|P1|Overall Study|Abnormal laboratory test result|14
1377850|NCT01438424|4547131|P1|Overall Study|Lost to Follow-up|17
1377851|NCT01438424|4547131|P1|Overall Study|Adverse Event|17
1377852|NCT01438424|4547131|P1|Overall Study|Death|22
1377853|NCT01438424|4547131|P1|Overall Study|Progression of chronic hepatitis B|22
1377854|NCT01438424|4547131|P1|Overall Study|Withdrawal by Subject|104
1377855|NCT01438424|4547131|P1|Overall Study|Not identified|55
1377856|NCT01438424|4547131|P1|Overall Study|Minimal virologic response|95
1377857|NCT01438424|4547131|P1|Overall Study|Continuing treatment|29
1377858|NCT01438307|4547169|P2|Overall Study|Death|1
1377859|NCT01438307|4547170|P1|Overall Study|Death|1
1377860|NCT01438294|4547184|P2|Overall Study|Lost to Follow-up|7
1377861|NCT01438294|4547185|P1|Overall Study|Lost to Follow-up|3
1377862|NCT01438177|4547228|P1|Overall Study|Initiation of new therapy|1
1377863|NCT01438177|4547228|P1|Overall Study|Withdrawal by Subject|1
1377864|NCT01438151|4547234|P1|Overall Study|study terminated|8
1377865|NCT01438060|4547240|P2|On Study Beyond Week 140|Other Reason|3
1377866|NCT01438060|4547241|P1|On Study Beyond Week 140|Other Reason|0
1377867|NCT01438060|4547240|P2|On Study Beyond Week 140|Death|1
1377868|NCT01438060|4547241|P1|On Study Beyond Week 140|Death|0
1377869|NCT01438060|4547240|P2|On Study Beyond Week 140|Withdrawal by Subject|1
1377870|NCT01438060|4547241|P1|On Study Beyond Week 140|Withdrawal by Subject|0
1377871|NCT01438060|4547240|P2|On Study Beyond Week 140|Lack of Efficacy|1
1377872|NCT01438060|4547241|P1|On Study Beyond Week 140|Lack of Efficacy|0
1377873|NCT01438060|4547240|P2|On Study Beyond Week 140|Adverse Event|2
1377874|NCT01438060|4547241|P1|On Study Beyond Week 140|Adverse Event|0
1377875|NCT01438060|4547240|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
1377876|NCT01438060|4547241|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
1377877|NCT01438060|4547240|P2|Extension Phase: Week 10 to Week 130|Death|12
1377878|NCT01438060|4547241|P1|Extension Phase: Week 10 to Week 130|Death|22
1377879|NCT01438060|4547240|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
1377880|NCT01438060|4547241|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
1377881|NCT01438060|4547240|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
1377882|NCT01438060|4547241|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
1377883|NCT01438060|4547240|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
1377884|NCT01438060|4547241|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
1377885|NCT01438060|4547240|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
1377886|NCT01438060|4547241|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
1377887|NCT01438060|4547240|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
1377888|NCT01438060|4547241|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
1377889|NCT01438060|4547240|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
1377890|NCT01438060|4547241|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
1377891|NCT01438060|4547240|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
1377892|NCT01438060|4547241|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
1377893|NCT01438060|4547240|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
1377894|NCT01438060|4547241|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
1377895|NCT01438060|4547240|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
1377896|NCT01438060|4547241|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
1377897|NCT01438060|4547240|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
1377898|NCT01438060|4547241|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
1377899|NCT01438060|4547240|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
1377900|NCT01438060|4547241|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
1377901|NCT01437995|4547322|P3|Overall Study|Lost to Follow-up|20
1377902|NCT01437995|4547323|P2|Overall Study|Lost to Follow-up|18
1377903|NCT01437995|4547324|P1|Overall Study|Lost to Follow-up|11
1377904|NCT01437943|4547346|P2|Overall Study|Adverse Event|0
1377905|NCT01437943|4547347|P1|Overall Study|Adverse Event|2
1377906|NCT01437943|4547346|P2|Overall Study|Subject expressed pregnancy plans|0
1377907|NCT01437943|4547347|P1|Overall Study|Subject expressed pregnancy plans|1
1377908|NCT01437943|4547346|P2|Overall Study|Aliskiren trials terminated by Novartis|2
1377909|NCT01437943|4547347|P1|Overall Study|Aliskiren trials terminated by Novartis|4
1377910|NCT01437878|4547355|P2|Overall Study|Withdrawal by Subject|0
1377911|NCT01437878|4547356|P1|Overall Study|Withdrawal by Subject|1
1377912|NCT01437540|4547398|P2|Overall Study|Withdrawal by Subject|15
1377913|NCT01437540|4547399|P1|Overall Study|Withdrawal by Subject|31
1377914|NCT01437540|4547398|P2|Overall Study|Adverse Event|13
1377915|NCT01437540|4547399|P1|Overall Study|Adverse Event|26
1377916|NCT01437540|4547398|P2|Overall Study|Protocol Violation|12
1377917|NCT01437540|4547399|P1|Overall Study|Protocol Violation|24
1377918|NCT01437540|4547398|P2|Overall Study|Lack of Efficacy|11
1377919|NCT01437540|4547399|P1|Overall Study|Lack of Efficacy|23
1377920|NCT01437540|4547398|P2|Overall Study|Lost to Follow-up|5
1377921|NCT01437540|4547399|P1|Overall Study|Lost to Follow-up|3
1377922|NCT01437540|4547398|P2|Overall Study|COPD exacerbation|3
1377923|NCT01437540|4547399|P1|Overall Study|COPD exacerbation|13
1377924|NCT01437540|4547398|P2|Overall Study|Not listed below|6
1377925|NCT01437540|4547399|P1|Overall Study|Not listed below|7
1377926|NCT01437423|4547429|P1|Overall Study|Off label usage|3
1377927|NCT01437423|4547429|P1|Overall Study|Lost to Follow-up|12
1377928|NCT01437397|4547441|P5|Overall Study|Site termination/COPD exacerbation/other|14
1377929|NCT01437397|4547442|P4|Overall Study|Site termination/COPD exacerbation/other|9
1377930|NCT01437397|4547443|P3|Overall Study|Site termination/COPD exacerbation/other|9
1377931|NCT01437397|4547444|P2|Overall Study|Site termination/COPD exacerbation/other|8
1377932|NCT01437397|4547445|P1|Overall Study|Site termination/COPD exacerbation/other|10
1377933|NCT01437397|4547441|P5|Overall Study|Adverse Event|21
1377934|NCT01437397|4547442|P4|Overall Study|Adverse Event|14
1377935|NCT01437397|4547443|P3|Overall Study|Adverse Event|16
1377936|NCT01437397|4547444|P2|Overall Study|Adverse Event|22
1377937|NCT01437397|4547445|P1|Overall Study|Adverse Event|21
1377938|NCT01437397|4547441|P5|Overall Study|Lack of Efficacy|20
1377939|NCT01437397|4547442|P4|Overall Study|Lack of Efficacy|10
1377940|NCT01437397|4547443|P3|Overall Study|Lack of Efficacy|8
1377941|NCT01437397|4547444|P2|Overall Study|Lack of Efficacy|4
1377942|NCT01437397|4547445|P1|Overall Study|Lack of Efficacy|5
1377943|NCT01437397|4547441|P5|Overall Study|Protocol Violation|19
1377944|NCT01437397|4547442|P4|Overall Study|Protocol Violation|21
1377945|NCT01437397|4547443|P3|Overall Study|Protocol Violation|13
1377946|NCT01437397|4547444|P2|Overall Study|Protocol Violation|12
1377947|NCT01437397|4547445|P1|Overall Study|Protocol Violation|10
1377948|NCT01437397|4547441|P5|Overall Study|Withdrawal by Subject|22
1377949|NCT01437397|4547442|P4|Overall Study|Withdrawal by Subject|11
1377950|NCT01437397|4547443|P3|Overall Study|Withdrawal by Subject|24
1377951|NCT01437397|4547444|P2|Overall Study|Withdrawal by Subject|12
1377952|NCT01437397|4547445|P1|Overall Study|Withdrawal by Subject|11
1377953|NCT01437397|4547441|P5|Overall Study|Lost to Follow-up|5
1377954|NCT01437397|4547442|P4|Overall Study|Lost to Follow-up|4
1377955|NCT01437397|4547443|P3|Overall Study|Lost to Follow-up|2
1377956|NCT01437397|4547444|P2|Overall Study|Lost to Follow-up|4
1377957|NCT01437397|4547445|P1|Overall Study|Lost to Follow-up|9
1377958|NCT01437319|4547472|P3|Phase II|Protocol Violation|0
1377959|NCT01437319|4547473|P2|Phase II|Protocol Violation|1
1377960|NCT01437319|4547474|P1|Phase II|Protocol Violation|0
1377961|NCT01437319|4547472|P3|Phase II|Study related symptoms/complaints|19
1377962|NCT01437319|4547473|P2|Phase II|Study related symptoms/complaints|28
1377963|NCT01437319|4547474|P1|Phase II|Study related symptoms/complaints|0
1377964|NCT01437319|4547472|P3|Phase II|Lost to Follow-up|2
1377965|NCT01437319|4547473|P2|Phase II|Lost to Follow-up|7
1377966|NCT01437319|4547474|P1|Phase II|Lost to Follow-up|0
1377967|NCT01437319|4547472|P3|Phase II|Withdrawal by Subject|16
1377968|NCT01437319|4547473|P2|Phase II|Withdrawal by Subject|8
1377969|NCT01437319|4547474|P1|Phase II|Withdrawal by Subject|0
1377970|NCT01437319|4547472|P3|Phase I|Withdrawal by Subject|0
1377971|NCT01437319|4547473|P2|Phase I|Withdrawal by Subject|0
1377972|NCT01437319|4547474|P1|Phase I|Withdrawal by Subject|25
1377973|NCT01437319|4547472|P3|Phase I|Study related symptoms/complaints|0
1377974|NCT01437319|4547473|P2|Phase I|Study related symptoms/complaints|0
1377975|NCT01437319|4547474|P1|Phase I|Study related symptoms/complaints|27
1377976|NCT01437319|4547472|P3|Phase I|Protocol Violation|0
1377977|NCT01437319|4547473|P2|Phase I|Protocol Violation|0
1377978|NCT01437319|4547474|P1|Phase I|Protocol Violation|1
1377979|NCT01437319|4547472|P3|Phase I|Lost to Follow-up|0
1377980|NCT01437319|4547473|P2|Phase I|Lost to Follow-up|0
1377981|NCT01437319|4547474|P1|Phase I|Lost to Follow-up|2
1377982|NCT01437267|4547489|P6|Overall Study|Protocol Violation|0
1377983|NCT01437267|4547490|P5|Overall Study|Protocol Violation|0
1377984|NCT01437267|4547491|P4|Overall Study|Protocol Violation|0
1377985|NCT01437267|4547492|P3|Overall Study|Protocol Violation|0
1377986|NCT01437267|4547493|P2|Overall Study|Protocol Violation|1
1377987|NCT01437267|4547494|P1|Overall Study|Protocol Violation|0
1377988|NCT01437267|4547489|P6|Overall Study|Withdrawal by Subject|0
1377989|NCT01437267|4547490|P5|Overall Study|Withdrawal by Subject|0
1377990|NCT01437267|4547491|P4|Overall Study|Withdrawal by Subject|1
1377991|NCT01437267|4547492|P3|Overall Study|Withdrawal by Subject|0
1377992|NCT01437267|4547493|P2|Overall Study|Withdrawal by Subject|0
1377993|NCT01437267|4547494|P1|Overall Study|Withdrawal by Subject|0
1377994|NCT01437111|4547537|P1|Overall Study|Protocol Violation|1
1377995|NCT01437111|4547537|P1|Overall Study|Lost to Follow-up|5
1377996|NCT01437111|4547537|P1|Overall Study|Physician Decision|1
1377997|NCT01437111|4547537|P1|Overall Study|Not reported|5
1377998|NCT01437111|4547537|P1|Overall Study|Withdrawal by Subject|4
1377999|NCT01437111|4547537|P1|Overall Study|Adverse Event|2
1378000|NCT01436643|4547615|P4|Core Phase (16 Weeks)|Protocol Violation|0
1378001|NCT01436643|4547616|P3|Core Phase (16 Weeks)|Protocol Violation|1
1378002|NCT01436643|4547617|P2|Core Phase (16 Weeks)|Protocol Violation|1
1378003|NCT01436643|4547618|P1|Core Phase (16 Weeks)|Protocol Violation|1
1378004|NCT01436643|4547615|P4|Core Phase (16 Weeks)|Abnormal Test result|0
1378005|NCT01436643|4547616|P3|Core Phase (16 Weeks)|Abnormal Test result|1
1378006|NCT01436643|4547617|P2|Core Phase (16 Weeks)|Abnormal Test result|0
1378007|NCT01436643|4547618|P1|Core Phase (16 Weeks)|Abnormal Test result|0
1378008|NCT01436643|4547615|P4|Core Phase (16 Weeks)|Adverse Event|0
1378009|NCT01436643|4547616|P3|Core Phase (16 Weeks)|Adverse Event|1
1378010|NCT01436643|4547617|P2|Core Phase (16 Weeks)|Adverse Event|3
1378011|NCT01436643|4547618|P1|Core Phase (16 Weeks)|Adverse Event|0
1378012|NCT01436643|4547615|P4|2-week Pre-treatment|Protocol Violation|4
1378013|NCT01436643|4547616|P3|2-week Pre-treatment|Protocol Violation|0
1378014|NCT01436643|4547617|P2|2-week Pre-treatment|Protocol Violation|0
1378015|NCT01436643|4547618|P1|2-week Pre-treatment|Protocol Violation|0
1378016|NCT01436643|4547615|P4|2-week Pre-treatment|Adverse Event|5
1378017|NCT01436643|4547616|P3|2-week Pre-treatment|Adverse Event|0
1378018|NCT01436643|4547617|P2|2-week Pre-treatment|Adverse Event|0
1378019|NCT01436643|4547618|P1|2-week Pre-treatment|Adverse Event|0
1378020|NCT01436643|4547615|P4|2-week Pre-treatment|Abnormal test result|1
1378021|NCT01436643|4547616|P3|2-week Pre-treatment|Abnormal test result|0
1378022|NCT01436643|4547617|P2|2-week Pre-treatment|Abnormal test result|0
1378023|NCT01436643|4547618|P1|2-week Pre-treatment|Abnormal test result|0
1378024|NCT01436500|4547653|P5|Overall Study|not specified|0
1378025|NCT01436500|4547654|P4|Overall Study|not specified|1
1378026|NCT01436500|4547655|P3|Overall Study|not specified|0
1378027|NCT01436500|4547656|P2|Overall Study|not specified|1
1378028|NCT01436500|4547657|P1|Overall Study|not specified|0
1378029|NCT01436500|4547653|P5|Overall Study|discontinued study drug|0
1378030|NCT01436500|4547654|P4|Overall Study|discontinued study drug|0
1378031|NCT01436500|4547655|P3|Overall Study|discontinued study drug|0
1378032|NCT01436500|4547656|P2|Overall Study|discontinued study drug|0
1378033|NCT01436500|4547657|P1|Overall Study|discontinued study drug|1
1378034|NCT01436500|4547653|P5|Overall Study|initiation of dialysis|1
1378035|NCT01436500|4547654|P4|Overall Study|initiation of dialysis|0
1378036|NCT01436500|4547655|P3|Overall Study|initiation of dialysis|0
1378037|NCT01436500|4547656|P2|Overall Study|initiation of dialysis|0
1378038|NCT01436500|4547657|P1|Overall Study|initiation of dialysis|0
1378039|NCT01436500|4547653|P5|Overall Study|liver transplant|0
1378040|NCT01436500|4547654|P4|Overall Study|liver transplant|0
1378041|NCT01436500|4547655|P3|Overall Study|liver transplant|0
1378042|NCT01436500|4547656|P2|Overall Study|liver transplant|0
1378043|NCT01436500|4547657|P1|Overall Study|liver transplant|1
1378044|NCT01436500|4547653|P5|Overall Study|Physician Decision|0
1378045|NCT01436500|4547654|P4|Overall Study|Physician Decision|0
1378046|NCT01436500|4547655|P3|Overall Study|Physician Decision|1
1378047|NCT01436500|4547656|P2|Overall Study|Physician Decision|0
1378048|NCT01436500|4547657|P1|Overall Study|Physician Decision|0
1378049|NCT01436500|4547653|P5|Overall Study|Withdrawal by Subject|2
1378050|NCT01436500|4547654|P4|Overall Study|Withdrawal by Subject|0
1378051|NCT01436500|4547655|P3|Overall Study|Withdrawal by Subject|2
1378052|NCT01436500|4547656|P2|Overall Study|Withdrawal by Subject|0
1378053|NCT01436500|4547657|P1|Overall Study|Withdrawal by Subject|0
1378054|NCT01436500|4547653|P5|Overall Study|Adverse Event|1
1378055|NCT01436500|4547654|P4|Overall Study|Adverse Event|0
1378056|NCT01436500|4547655|P3|Overall Study|Adverse Event|2
1378057|NCT01436500|4547656|P2|Overall Study|Adverse Event|2
1378058|NCT01436500|4547657|P1|Overall Study|Adverse Event|0
1378059|NCT01436500|4547653|P5|Overall Study|Death|0
1378060|NCT01436500|4547654|P4|Overall Study|Death|0
1378061|NCT01436500|4547655|P3|Overall Study|Death|0
1378062|NCT01436500|4547656|P2|Overall Study|Death|0
1378063|NCT01436500|4547657|P1|Overall Study|Death|1
1378064|NCT01436370|4547707|P8|Overall Study|Lost to Follow-up|0
1378065|NCT01436370|4547708|P7|Overall Study|Lost to Follow-up|0
1378066|NCT01436370|4547709|P6|Overall Study|Lost to Follow-up|0
1378067|NCT01436370|4547710|P5|Overall Study|Lost to Follow-up|1
1378068|NCT01436370|4547711|P4|Overall Study|Lost to Follow-up|0
1378069|NCT01436370|4547712|P3|Overall Study|Lost to Follow-up|0
1378070|NCT01436370|4547713|P2|Overall Study|Lost to Follow-up|0
1378071|NCT01436370|4547714|P1|Overall Study|Lost to Follow-up|0
1378072|NCT01436305|4547795|P3|Overall Study|Withdrawal by Subject|0
1378073|NCT01436305|4547796|P2|Overall Study|Withdrawal by Subject|3
1378074|NCT01436305|4547797|P1|Overall Study|Withdrawal by Subject|1
1378075|NCT01436305|4547795|P3|Overall Study|Lost to Follow-up|0
1378076|NCT01436305|4547796|P2|Overall Study|Lost to Follow-up|1
1378077|NCT01436305|4547797|P1|Overall Study|Lost to Follow-up|0
1378078|NCT01436305|4547795|P3|Overall Study|Death|0
1378079|NCT01436305|4547796|P2|Overall Study|Death|0
1378080|NCT01436305|4547797|P1|Overall Study|Death|1
1378081|NCT01436253|4547924|P1|Overall Study|Not meeting all eligibility criteria|117
1378082|NCT01436253|4547924|P1|Overall Study|Lost to Follow-up|182
1378083|NCT01436201|4547929|P1|Overall Study|Protocol Violation|1
1378084|NCT01436201|4547929|P1|Overall Study|Withdrawal by Subject|1
1378085|NCT01436201|4547929|P1|Overall Study|Adverse Event|2
1378086|NCT01436175|4547939|P1|Overall Study|Other|826
1378087|NCT01436175|4547939|P1|Overall Study|Met blood pressure or pulse withdrawal|63
1378088|NCT01436175|4547939|P1|Overall Study|Lack of Efficacy|24
1378089|NCT01436175|4547939|P1|Overall Study|Lost to Follow-up|89
1378090|NCT01436175|4547939|P1|Overall Study|Withdrawal by Subject|108
1378091|NCT01436175|4547939|P1|Overall Study|Protocol Violation|49
1378092|NCT01436175|4547939|P1|Overall Study|Adverse Event|111
1378093|NCT01436162|4547966|P3|Randomized Phase|Not Specified|4
1378094|NCT01436162|4547967|P2|Randomized Phase|Not Specified|5
1378095|NCT01436162|4547968|P1|Randomized Phase|Not Specified|2
1378096|NCT01436162|4547966|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
1378097|NCT01436162|4547967|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
1378098|NCT01436162|4547968|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
1378099|NCT01436162|4547966|P3|Randomized Phase|Lack of Efficacy|1
1378100|NCT01436162|4547967|P2|Randomized Phase|Lack of Efficacy|1
1378101|NCT01436162|4547968|P1|Randomized Phase|Lack of Efficacy|0
1378102|NCT01436162|4547966|P3|Randomized Phase|Lost to Follow-up|4
1378103|NCT01436162|4547967|P2|Randomized Phase|Lost to Follow-up|5
1378104|NCT01436162|4547968|P1|Randomized Phase|Lost to Follow-up|17
1378105|NCT01436162|4547966|P3|Randomized Phase|Withdrawal by Subject|8
1378106|NCT01436162|4547967|P2|Randomized Phase|Withdrawal by Subject|9
1378107|NCT01436162|4547968|P1|Randomized Phase|Withdrawal by Subject|16
1378108|NCT01436162|4547966|P3|Randomized Phase|Protocol Violation|2
1378109|NCT01436162|4547967|P2|Randomized Phase|Protocol Violation|4
1378110|NCT01436162|4547968|P1|Randomized Phase|Protocol Violation|4
1378111|NCT01436162|4547966|P3|Randomized Phase|Adverse Event|6
1378112|NCT01436162|4547967|P2|Randomized Phase|Adverse Event|5
1378113|NCT01436162|4547968|P1|Randomized Phase|Adverse Event|1
1378114|NCT01436162|4547966|P3|Single-blind Lead-in Phase|Not Specified|0
1378115|NCT01436162|4547967|P2|Single-blind Lead-in Phase|Not Specified|0
1378116|NCT01436162|4547968|P1|Single-blind Lead-in Phase|Not Specified|107
1378117|NCT01436162|4547966|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1378118|NCT01436162|4547967|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1378119|NCT01436162|4547968|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
1378120|NCT01436162|4547966|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
1378121|NCT01436162|4547967|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
1378122|NCT01436162|4547968|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
1378123|NCT01436162|4547966|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
1378124|NCT01436162|4547967|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
1378125|NCT01436162|4547968|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
1378126|NCT01436162|4547966|P3|Single-blind Lead-in Phase|Protocol Violation|0
1378127|NCT01436162|4547967|P2|Single-blind Lead-in Phase|Protocol Violation|0
1378128|NCT01436162|4547968|P1|Single-blind Lead-in Phase|Protocol Violation|24
1378129|NCT01436162|4547966|P3|Single-blind Lead-in Phase|Adverse Event|0
1378130|NCT01436162|4547967|P2|Single-blind Lead-in Phase|Adverse Event|0
1378131|NCT01436162|4547968|P1|Single-blind Lead-in Phase|Adverse Event|26
1378132|NCT01436149|4548002|P3|Randomized Phase|Not Specified|11
1378133|NCT01436149|4548003|P2|Randomized Phase|Not Specified|5
1378134|NCT01436149|4548004|P1|Randomized Phase|Not Specified|12
1378135|NCT01436149|4548002|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
1378136|NCT01436149|4548003|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
1378137|NCT01436149|4548004|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
1378138|NCT01436149|4548002|P3|Randomized Phase|Lack of Efficacy|1
1378139|NCT01436149|4548003|P2|Randomized Phase|Lack of Efficacy|0
1378140|NCT01436149|4548004|P1|Randomized Phase|Lack of Efficacy|0
1378141|NCT01436149|4548002|P3|Randomized Phase|Lost to Follow-up|6
1378142|NCT01436149|4548003|P2|Randomized Phase|Lost to Follow-up|5
1378143|NCT01436149|4548004|P1|Randomized Phase|Lost to Follow-up|34
1378144|NCT01436149|4548002|P3|Randomized Phase|Withdrawal by Subject|10
1378145|NCT01436149|4548003|P2|Randomized Phase|Withdrawal by Subject|10
1378146|NCT01436149|4548004|P1|Randomized Phase|Withdrawal by Subject|16
1378147|NCT01436149|4548002|P3|Randomized Phase|Protocol Violation|0
1378148|NCT01436149|4548003|P2|Randomized Phase|Protocol Violation|5
1378149|NCT01436149|4548004|P1|Randomized Phase|Protocol Violation|4
1378150|NCT01436149|4548002|P3|Randomized Phase|Adverse Event|11
1378151|NCT01436149|4548003|P2|Randomized Phase|Adverse Event|10
1378152|NCT01436149|4548004|P1|Randomized Phase|Adverse Event|9
1378153|NCT01436149|4548002|P3|Antidepressant Lead-in Phase|Not Specified|0
1378154|NCT01436149|4548003|P2|Antidepressant Lead-in Phase|Not Specified|0
1378155|NCT01436149|4548004|P1|Antidepressant Lead-in Phase|Not Specified|119
1378156|NCT01436149|4548002|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
1378157|NCT01436149|4548003|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
1378158|NCT01436149|4548004|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
1378159|NCT01436149|4548002|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
1378160|NCT01436149|4548003|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
1378161|NCT01436149|4548004|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
1378162|NCT01436149|4548002|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1378163|NCT01436149|4548003|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1378164|NCT01436149|4548004|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
1378165|NCT01436149|4548002|P3|Antidepressant Lead-in Phase|Protocol Violation|0
1378166|NCT01436149|4548003|P2|Antidepressant Lead-in Phase|Protocol Violation|0
1378167|NCT01436149|4548004|P1|Antidepressant Lead-in Phase|Protocol Violation|29
1378168|NCT01436149|4548002|P3|Antidepressant Lead-in Phase|Adverse Event|0
1378169|NCT01436149|4548003|P2|Antidepressant Lead-in Phase|Adverse Event|0
1378170|NCT01436149|4548004|P1|Antidepressant Lead-in Phase|Adverse Event|39
1378171|NCT01436110|4548035|P3|Overall Study|Did Not Receive Trial Medication|3
1378172|NCT01436110|4548036|P2|Overall Study|Did Not Receive Trial Medication|0
1378173|NCT01436110|4548037|P1|Overall Study|Did Not Receive Trial Medication|1
1378174|NCT01436110|4548035|P3|Overall Study|Protocol Violation|1
1378175|NCT01436110|4548036|P2|Overall Study|Protocol Violation|1
1378176|NCT01436110|4548037|P1|Overall Study|Protocol Violation|3
1378177|NCT01436110|4548035|P3|Overall Study|Lost to Follow-up|3
1378178|NCT01436110|4548036|P2|Overall Study|Lost to Follow-up|1
1378179|NCT01436110|4548037|P1|Overall Study|Lost to Follow-up|1
1378180|NCT01436110|4548035|P3|Overall Study|Physician Decision|1
1378181|NCT01436110|4548036|P2|Overall Study|Physician Decision|1
1378182|NCT01436110|4548037|P1|Overall Study|Physician Decision|3
1378183|NCT01436110|4548035|P3|Overall Study|Adverse Event|2
1378184|NCT01436110|4548036|P2|Overall Study|Adverse Event|1
1378185|NCT01436110|4548037|P1|Overall Study|Adverse Event|2
1378186|NCT01436110|4548035|P3|Overall Study|Withdrawal by Subject|4
1378187|NCT01436110|4548036|P2|Overall Study|Withdrawal by Subject|8
1378188|NCT01436110|4548037|P1|Overall Study|Withdrawal by Subject|6
1378189|NCT01436110|4548035|P3|Overall Study|Lack of Efficacy|9
1378190|NCT01436110|4548036|P2|Overall Study|Lack of Efficacy|14
1378191|NCT01436110|4548037|P1|Overall Study|Lack of Efficacy|23
1378192|NCT01436084|4548060|P1|Overall Study|Early Closure of Study|1
1378193|NCT01436084|4548060|P1|Overall Study|Withdrawal by Subject|1
1378194|NCT01436084|4548060|P1|Overall Study|Disease Progression|2
1378195|NCT01436071|4548066|P2|Overall Study|Did Not Receive Trial Medication|3
1378196|NCT01436071|4548067|P1|Overall Study|Did Not Receive Trial Medication|3
1378197|NCT01436071|4548066|P2|Overall Study|Withdrawal by Subject|2
1378198|NCT01436071|4548067|P1|Overall Study|Withdrawal by Subject|2
1378199|NCT01436071|4548066|P2|Overall Study|Physician Decision|0
1378200|NCT01436071|4548067|P1|Overall Study|Physician Decision|1
1378201|NCT01436071|4548066|P2|Overall Study|Lost to Follow-up|1
1378202|NCT01436071|4548067|P1|Overall Study|Lost to Follow-up|3
1378203|NCT01436071|4548066|P2|Overall Study|Protocol Violation|1
1378204|NCT01436071|4548067|P1|Overall Study|Protocol Violation|0
1378205|NCT01436071|4548066|P2|Overall Study|Lack of Efficacy|7
1378206|NCT01436071|4548067|P1|Overall Study|Lack of Efficacy|16
1378207|NCT01436071|4548066|P2|Overall Study|Adverse Event|0
1378208|NCT01436071|4548067|P1|Overall Study|Adverse Event|1
1378209|NCT01435928|4548109|P3|Double Blind Phase - 28 Weeks|Administrative|2
1378210|NCT01435928|4548110|P2|Double Blind Phase - 28 Weeks|Administrative|5
1378211|NCT01435928|4548111|P1|Double Blind Phase - 28 Weeks|Administrative|0
1378212|NCT01435928|4548109|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
1378213|NCT01435928|4548110|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
1378214|NCT01435928|4548111|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
1378215|NCT01435928|4548109|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
1378216|NCT01435928|4548110|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
1378217|NCT01435928|4548111|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
1378218|NCT01435928|4548109|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
1378219|NCT01435928|4548110|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
1378220|NCT01435928|4548111|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
1378221|NCT01435928|4548109|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
1378222|NCT01435928|4548110|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
1378223|NCT01435928|4548111|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
1378224|NCT01435928|4548109|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
1378225|NCT01435928|4548110|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
1378226|NCT01435928|4548111|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
1378227|NCT01435928|4548109|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
1378228|NCT01435928|4548110|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
1378229|NCT01435928|4548111|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
1378230|NCT01435928|4548109|P3|Open Label Phase - up to 24 Weeks|Administrative|0
1378231|NCT01435928|4548110|P2|Open Label Phase - up to 24 Weeks|Administrative|0
1378232|NCT01435928|4548111|P1|Open Label Phase - up to 24 Weeks|Administrative|14
1378233|NCT01435928|4548109|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
1378234|NCT01435928|4548110|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
1378235|NCT01435928|4548111|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
1378236|NCT01435928|4548109|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
1378237|NCT01435928|4548110|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
1378238|NCT01435928|4548111|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
1378239|NCT01435928|4548109|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
1378240|NCT01435928|4548110|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
1378241|NCT01435928|4548111|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
1378242|NCT01435928|4548109|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
1378243|NCT01435928|4548110|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
1378244|NCT01435928|4548111|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
1378245|NCT01435928|4548109|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
1378246|NCT01435928|4548110|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
1378247|NCT01435928|4548111|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
1378416|NCT01434680|4548653|P1|Overall Study|Protocol Violation|1
1378248|NCT01435928|4548109|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
1378249|NCT01435928|4548110|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
1378250|NCT01435928|4548111|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
1378251|NCT01435928|4548109|P3|Open Label Phase - up to 24 Weeks|Death|0
1378252|NCT01435928|4548110|P2|Open Label Phase - up to 24 Weeks|Death|0
1378253|NCT01435928|4548111|P1|Open Label Phase - up to 24 Weeks|Death|1
1378254|NCT01435928|4548109|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
1378255|NCT01435928|4548110|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
1378256|NCT01435928|4548111|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
1378257|NCT01435798|4548138|P1|Overall Study|Withdrawal by Subject|1
1378258|NCT01435772|4548155|P3|Overall Study|Other - study termination|10
1378259|NCT01435772|4548156|P2|Overall Study|Other - study termination|2
1378260|NCT01435772|4548157|P1|Overall Study|Other - study termination|2
1378261|NCT01435772|4548155|P3|Overall Study|Withdrawal by Subject|3
1378262|NCT01435772|4548156|P2|Overall Study|Withdrawal by Subject|1
1378263|NCT01435772|4548157|P1|Overall Study|Withdrawal by Subject|0
1378264|NCT01435772|4548155|P3|Overall Study|Adverse Event|2
1378265|NCT01435772|4548156|P2|Overall Study|Adverse Event|0
1378266|NCT01435772|4548157|P1|Overall Study|Adverse Event|1
1378267|NCT01435759|4548207|P6|Double-blind Phase|Not Specified|0
1378268|NCT01435759|4548208|P5|Double-blind Phase|Not Specified|0
1378269|NCT01435759|4548209|P4|Double-blind Phase|Not Specified|2
1378270|NCT01435759|4548210|P3|Double-blind Phase|Not Specified|0
1378271|NCT01435759|4548211|P2|Double-blind Phase|Not Specified|2
1378272|NCT01435759|4548212|P1|Double-blind Phase|Not Specified|8
1378273|NCT01435759|4548207|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1378274|NCT01435759|4548208|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
1378275|NCT01435759|4548209|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1378276|NCT01435759|4548210|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1378277|NCT01435759|4548211|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1378278|NCT01435759|4548212|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
1378279|NCT01435759|4548207|P6|Double-blind Phase|Lost to Follow-up|3
1378280|NCT01435759|4548208|P5|Double-blind Phase|Lost to Follow-up|3
1378281|NCT01435759|4548209|P4|Double-blind Phase|Lost to Follow-up|0
1378282|NCT01435759|4548210|P3|Double-blind Phase|Lost to Follow-up|2
1378283|NCT01435759|4548211|P2|Double-blind Phase|Lost to Follow-up|1
1378284|NCT01435759|4548212|P1|Double-blind Phase|Lost to Follow-up|31
1378285|NCT01435759|4548207|P6|Double-blind Phase|Withdrawal by Subject|2
1378286|NCT01435759|4548208|P5|Double-blind Phase|Withdrawal by Subject|2
1378287|NCT01435759|4548209|P4|Double-blind Phase|Withdrawal by Subject|4
1378288|NCT01435759|4548210|P3|Double-blind Phase|Withdrawal by Subject|3
1378289|NCT01435759|4548211|P2|Double-blind Phase|Withdrawal by Subject|4
1378290|NCT01435759|4548212|P1|Double-blind Phase|Withdrawal by Subject|17
1378291|NCT01435759|4548207|P6|Double-blind Phase|Protocol Violation|1
1378292|NCT01435759|4548208|P5|Double-blind Phase|Protocol Violation|0
1378293|NCT01435759|4548209|P4|Double-blind Phase|Protocol Violation|2
1378294|NCT01435759|4548210|P3|Double-blind Phase|Protocol Violation|1
1378295|NCT01435759|4548211|P2|Double-blind Phase|Protocol Violation|0
1378296|NCT01435759|4548212|P1|Double-blind Phase|Protocol Violation|2
1378297|NCT01435759|4548207|P6|Double-blind Phase|Adverse Event|3
1378298|NCT01435759|4548208|P5|Double-blind Phase|Adverse Event|1
1378299|NCT01435759|4548209|P4|Double-blind Phase|Adverse Event|1
1378300|NCT01435759|4548210|P3|Double-blind Phase|Adverse Event|1
1378301|NCT01435759|4548211|P2|Double-blind Phase|Adverse Event|0
1378302|NCT01435759|4548212|P1|Double-blind Phase|Adverse Event|7
1378303|NCT01435759|4548207|P6|Antidepressant Lead-in Phase|Not Specified|0
1378304|NCT01435759|4548208|P5|Antidepressant Lead-in Phase|Not Specified|0
1378305|NCT01435759|4548209|P4|Antidepressant Lead-in Phase|Not Specified|0
1378306|NCT01435759|4548210|P3|Antidepressant Lead-in Phase|Not Specified|0
1378307|NCT01435759|4548211|P2|Antidepressant Lead-in Phase|Not Specified|0
1378308|NCT01435759|4548212|P1|Antidepressant Lead-in Phase|Not Specified|119
1378309|NCT01435759|4548207|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1378310|NCT01435759|4548208|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1378311|NCT01435759|4548209|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1378312|NCT01435759|4548210|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1378313|NCT01435759|4548211|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1378314|NCT01435759|4548212|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
1378315|NCT01435759|4548207|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
1378316|NCT01435759|4548208|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
1378317|NCT01435759|4548209|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
1378318|NCT01435759|4548210|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
1378319|NCT01435759|4548211|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
1378320|NCT01435759|4548212|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
1378321|NCT01435759|4548207|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1378322|NCT01435759|4548208|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1378323|NCT01435759|4548209|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1378324|NCT01435759|4548210|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1378325|NCT01435759|4548211|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1378326|NCT01435759|4548212|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
1378327|NCT01435759|4548207|P6|Antidepressant Lead-in Phase|Protocol Violation|0
1378328|NCT01435759|4548208|P5|Antidepressant Lead-in Phase|Protocol Violation|0
1378329|NCT01435759|4548209|P4|Antidepressant Lead-in Phase|Protocol Violation|0
1378330|NCT01435759|4548210|P3|Antidepressant Lead-in Phase|Protocol Violation|0
1378331|NCT01435759|4548211|P2|Antidepressant Lead-in Phase|Protocol Violation|0
1378332|NCT01435759|4548212|P1|Antidepressant Lead-in Phase|Protocol Violation|16
1378333|NCT01435759|4548207|P6|Antidepressant Lead-in Phase|Adverse Event|0
1378334|NCT01435759|4548208|P5|Antidepressant Lead-in Phase|Adverse Event|0
1378335|NCT01435759|4548209|P4|Antidepressant Lead-in Phase|Adverse Event|0
1378336|NCT01435759|4548210|P3|Antidepressant Lead-in Phase|Adverse Event|0
1378337|NCT01435759|4548211|P2|Antidepressant Lead-in Phase|Adverse Event|0
1378338|NCT01435759|4548212|P1|Antidepressant Lead-in Phase|Adverse Event|40
1378339|NCT01435655|4548239|P1|Overall Study|Other|1
1378340|NCT01435655|4548239|P1|Overall Study|Death|2
1378341|NCT01435616|4548253|P2|Overall Study|Sponsor Decision|0
1378342|NCT01435616|4548254|P1|Overall Study|Sponsor Decision|1
1378343|NCT01435616|4548253|P2|Overall Study|Physician Decision|7
1378344|NCT01435616|4548254|P1|Overall Study|Physician Decision|20
1378345|NCT01435616|4548253|P2|Overall Study|Withdrawal by Subject|24
1378346|NCT01435616|4548254|P1|Overall Study|Withdrawal by Subject|66
1378347|NCT01435616|4548253|P2|Overall Study|Protocol Violation|13
1378348|NCT01435616|4548254|P1|Overall Study|Protocol Violation|16
1378349|NCT01435616|4548253|P2|Overall Study|Lost to Follow-up|13
1378350|NCT01435616|4548254|P1|Overall Study|Lost to Follow-up|22
1378351|NCT01435616|4548253|P2|Overall Study|Death|2
1378352|NCT01435616|4548254|P1|Overall Study|Death|7
1378353|NCT01435616|4548253|P2|Overall Study|Adverse Event|21
1378354|NCT01435616|4548254|P1|Overall Study|Adverse Event|39
1378355|NCT01435577|4548309|P2|Overall Study|Alternative treatment started|1
1378356|NCT01435577|4548310|P1|Overall Study|Alternative treatment started|0
1378357|NCT01435577|4548309|P2|Overall Study|Lack of Efficacy|51
1378358|NCT01435577|4548310|P1|Overall Study|Lack of Efficacy|7
1378359|NCT01435577|4548309|P2|Overall Study|Adverse Event|0
1378360|NCT01435577|4548310|P1|Overall Study|Adverse Event|10
1378361|NCT01435460|4548360|P2|Overall Study|Did not meet eligibility criteria|0
1378362|NCT01435460|4548361|P1|Overall Study|Did not meet eligibility criteria|2
1378363|NCT01435460|4548360|P2|Overall Study|Protocol Violation|1
1378364|NCT01435460|4548361|P1|Overall Study|Protocol Violation|0
1378365|NCT01435460|4548360|P2|Overall Study|Withdrawal by Subject|3
1378366|NCT01435460|4548361|P1|Overall Study|Withdrawal by Subject|1
1378367|NCT01435460|4548360|P2|Overall Study|Lost to Follow-up|1
1378368|NCT01435460|4548361|P1|Overall Study|Lost to Follow-up|6
1378369|NCT01435460|4548360|P2|Overall Study|Adverse Event|1
1378370|NCT01435460|4548361|P1|Overall Study|Adverse Event|2
1378371|NCT01435382|4548377|P4|Overall Study|Withdrawal by Subject|1
1378372|NCT01435382|4548378|P3|Overall Study|Withdrawal by Subject|0
1378373|NCT01435382|4548379|P2|Overall Study|Withdrawal by Subject|2
1378374|NCT01435382|4548380|P1|Overall Study|Withdrawal by Subject|0
1378375|NCT01435382|4548377|P4|Overall Study|Lost to Follow-up|0
1378376|NCT01435382|4548378|P3|Overall Study|Lost to Follow-up|1
1378377|NCT01435382|4548379|P2|Overall Study|Lost to Follow-up|0
1378378|NCT01435382|4548380|P1|Overall Study|Lost to Follow-up|1
1378379|NCT01435265|4548488|P2|Overall Study|Lost to Follow-up|1
1378380|NCT01435265|4548489|P1|Overall Study|Lost to Follow-up|0
1378381|NCT01435122|4548503|P1|Overall Study|Early withdrawal due to toxicity|8
1378382|NCT01435031|4548512|P1|ITT at 4 Years|Lost to Follow-up|1
1378383|NCT01435031|4548512|P1|ITT at 4 Years|Withdrawal by Subject|2
1378384|NCT01435031|4548512|P1|ITT at 4 Years|Death|4
1378385|NCT01435031|4548512|P1|ITT at 3 Years|Lost to Follow-up|4
1378386|NCT01435031|4548512|P1|ITT at 3 Years|Withdrawal by Subject|2
1378387|NCT01435031|4548512|P1|ITT at 3 Years|Death|5
1378388|NCT01435031|4548512|P1|ITT at 2 Years|Lost to Follow-up|4
1378389|NCT01435031|4548512|P1|ITT at 2 Years|Withdrawal by Subject|2
1378390|NCT01435031|4548512|P1|ITT at 2 Years|Death|7
1378391|NCT01435031|4548512|P1|ITT at 1 Year|Lost to Follow-up|6
1378392|NCT01435031|4548512|P1|ITT at 1 Year|Withdrawal by Subject|2
1378393|NCT01435031|4548512|P1|ITT at 1 Year|Death|1
1378394|NCT01435031|4548512|P1|ITT at 6 Months|Lost to Follow-up|3
1378395|NCT01435031|4548512|P1|ITT at 6 Months|Death|2
1378396|NCT01435031|4548512|P1|ITT at 1 Month|Lost to Follow-up|4
1378397|NCT01435031|4548512|P1|ITT at 1 Month|Death|1
1378398|NCT01435031|4548512|P1|ITT at 1 Month|Withdrawal by Subject|1
1378399|NCT01434823|4548612|P2|Overall Study|Incomplete data in medical record|7
1378400|NCT01434823|4548613|P1|Overall Study|Incomplete data in medical record|4
1378401|NCT01434693|4548633|P4|Overall Study|Lost to Follow-up|0
1378402|NCT01434693|4548634|P3|Overall Study|Lost to Follow-up|0
1378403|NCT01434693|4548635|P2|Overall Study|Lost to Follow-up|0
1378404|NCT01434693|4548636|P1|Overall Study|Lost to Follow-up|1
1378405|NCT01434693|4548633|P4|Overall Study|Withdrawal by Subject|1
1378406|NCT01434693|4548634|P3|Overall Study|Withdrawal by Subject|1
1378407|NCT01434693|4548635|P2|Overall Study|Withdrawal by Subject|0
1378408|NCT01434693|4548636|P1|Overall Study|Withdrawal by Subject|1
1378409|NCT01434693|4548633|P4|Overall Study|Adverse Event|0
1378410|NCT01434693|4548634|P3|Overall Study|Adverse Event|0
1378411|NCT01434693|4548635|P2|Overall Study|Adverse Event|0
1378412|NCT01434693|4548636|P1|Overall Study|Adverse Event|1
1378413|NCT01434680|4548650|P4|Overall Study|Protocol Violation|0
1378414|NCT01434680|4548651|P3|Overall Study|Protocol Violation|0
1378415|NCT01434680|4548652|P2|Overall Study|Protocol Violation|1
1378417|NCT01434680|4548650|P4|Overall Study|Lost to Follow-up|0
1378418|NCT01434680|4548651|P3|Overall Study|Lost to Follow-up|0
1378419|NCT01434680|4548652|P2|Overall Study|Lost to Follow-up|1
1378420|NCT01434680|4548653|P1|Overall Study|Lost to Follow-up|1
1378421|NCT01434680|4548650|P4|Overall Study|Withdrawal by Subject|0
1378422|NCT01434680|4548651|P3|Overall Study|Withdrawal by Subject|2
1378423|NCT01434680|4548652|P2|Overall Study|Withdrawal by Subject|0
1378424|NCT01434680|4548653|P1|Overall Study|Withdrawal by Subject|1
1378425|NCT01434654|4548670|P2|Overall Study|Lost to Follow-up|0
1378426|NCT01434654|4548671|P1|Overall Study|Lost to Follow-up|1
1378427|NCT01434654|4548670|P2|Overall Study|Withdrawal by Subject|0
1378428|NCT01434654|4548671|P1|Overall Study|Withdrawal by Subject|1
1378429|NCT01434290|4548718|P2|Overall Study|No protocol treatment|4
1378430|NCT01434290|4548719|P1|Overall Study|No protocol treatment|2
1378431|NCT01434290|4548718|P2|Overall Study|Protocol Violation|3
1378432|NCT01434290|4548719|P1|Overall Study|Protocol Violation|6
1378433|NCT01433978|4548792|P3|Extension Phase|Study Terminated by Sponsor|4
1378434|NCT01433978|4548793|P2|Extension Phase|Study Terminated by Sponsor|0
1378435|NCT01433978|4548794|P1|Extension Phase|Study Terminated by Sponsor|0
1378436|NCT01433978|4548792|P3|Extension Phase|Lack of Efficacy|1
1378437|NCT01433978|4548793|P2|Extension Phase|Lack of Efficacy|0
1378438|NCT01433978|4548794|P1|Extension Phase|Lack of Efficacy|0
1378439|NCT01433978|4548792|P3|Extension Phase|Adverse Event, Non-Fatal|1
1378440|NCT01433978|4548793|P2|Extension Phase|Adverse Event, Non-Fatal|0
1378441|NCT01433978|4548794|P1|Extension Phase|Adverse Event, Non-Fatal|0
1378442|NCT01433978|4548792|P3|Core Study|Study Terminated by Sponsor|0
1378443|NCT01433978|4548793|P2|Core Study|Study Terminated by Sponsor|9
1378444|NCT01433978|4548794|P1|Core Study|Study Terminated by Sponsor|6
1378445|NCT01433978|4548792|P3|Core Study|Lack of Efficacy|0
1378446|NCT01433978|4548793|P2|Core Study|Lack of Efficacy|1
1378447|NCT01433978|4548794|P1|Core Study|Lack of Efficacy|5
1378448|NCT01433978|4548792|P3|Core Study|Adverse Event, Non-Fatal|0
1378449|NCT01433978|4548793|P2|Core Study|Adverse Event, Non-Fatal|1
1378450|NCT01433978|4548794|P1|Core Study|Adverse Event, Non-Fatal|0
1378451|NCT01433549|4548851|P2|Phase 2: Second Study Product|Adverse Event|1
1378452|NCT01433549|4548852|P1|Phase 2: Second Study Product|Adverse Event|0
1378453|NCT01433471|4548862|P2|Overall Study|Withdrawal by Subject|1
1378454|NCT01433471|4548863|P1|Overall Study|Withdrawal by Subject|0
1378455|NCT01433354|4548879|P1|Overall Study|Subject Withdrew Consent|3
1378456|NCT01433354|4548879|P1|Overall Study|Lack of Efficacy|17
1378457|NCT01433354|4548879|P1|Overall Study|Protocol Violation|2
1378458|NCT01433354|4548879|P1|Overall Study|Administrative problems|90
1378459|NCT01433354|4548879|P1|Overall Study|Lost to Follow-up|1
1378460|NCT01433354|4548879|P1|Overall Study|Adverse Event|6
1378461|NCT01433263|4548895|P2|Overall Study|Withdrawal by Subject|7
1378462|NCT01433263|4548896|P1|Overall Study|Withdrawal by Subject|10
1378463|NCT01433263|4548895|P2|Overall Study|Protocol Deviation|0
1378464|NCT01433263|4548896|P1|Overall Study|Protocol Deviation|1
1378465|NCT01433263|4548895|P2|Overall Study|Lost to Follow-up|1
1378466|NCT01433263|4548896|P1|Overall Study|Lost to Follow-up|0
1378467|NCT01433263|4548895|P2|Overall Study|Death|3
1378468|NCT01433263|4548896|P1|Overall Study|Death|5
1378469|NCT01433263|4548895|P2|Overall Study|Adverse Event|1
1378470|NCT01433263|4548896|P1|Overall Study|Adverse Event|3
1378471|NCT01433250|4548925|P2|Overall Study|Withdrawal by Subject|2
1378472|NCT01433250|4548926|P1|Overall Study|Withdrawal by Subject|3
1378473|NCT01433250|4548925|P2|Overall Study|Protocol Violation|1
1378474|NCT01433250|4548926|P1|Overall Study|Protocol Violation|0
1378475|NCT01433172|4548945|P3|Overall Study|Death|0
1378476|NCT01433172|4548946|P2|Overall Study|Death|2
1378477|NCT01433172|4548947|P1|Overall Study|Death|0
1378478|NCT01433172|4548945|P3|Overall Study|Disease Progression|1
1378479|NCT01433172|4548946|P2|Overall Study|Disease Progression|0
1378480|NCT01433172|4548947|P1|Overall Study|Disease Progression|0
1378481|NCT01433172|4548945|P3|Overall Study|Withdrawal by Subject|0
1378482|NCT01433172|4548946|P2|Overall Study|Withdrawal by Subject|1
1378483|NCT01433172|4548947|P1|Overall Study|Withdrawal by Subject|0
1378484|NCT01433159|4548959|P2|Overall Study|Protocol Violation|1
1378485|NCT01433159|4548960|P1|Overall Study|Protocol Violation|0
1378486|NCT01433159|4548959|P2|Overall Study|Physician Decision|0
1378487|NCT01433159|4548960|P1|Overall Study|Physician Decision|1
1378488|NCT01433159|4548959|P2|Overall Study|Adverse Event|0
1378489|NCT01433159|4548960|P1|Overall Study|Adverse Event|1
1378490|NCT01433055|4548992|P2|Overall Study|Severely elevated triglycerides at entry|0
1378491|NCT01433055|4548993|P1|Overall Study|Severely elevated triglycerides at entry|1
1378492|NCT01433055|4548992|P2|Overall Study|Diagnosed with cancer unrelated to study|0
1378493|NCT01433055|4548993|P1|Overall Study|Diagnosed with cancer unrelated to study|1
1378494|NCT01432938|4549015|P2|Second Intervention|Adverse Event|0
1378495|NCT01432938|4549016|P1|Second Intervention|Adverse Event|1
1378496|NCT01432938|4549015|P2|First Intervention|Physician Decision|0
1378497|NCT01432938|4549016|P1|First Intervention|Physician Decision|1
1378498|NCT01432938|4549015|P2|First Intervention|Protocol Violation|0
1378499|NCT01432938|4549016|P1|First Intervention|Protocol Violation|1
1378500|NCT01432756|4549046|P4|Overall Study|Lost to Follow-up|1
1378501|NCT01432756|4549047|P3|Overall Study|Lost to Follow-up|2
1378502|NCT01432756|4549048|P2|Overall Study|Lost to Follow-up|0
1378503|NCT01432756|4549049|P1|Overall Study|Lost to Follow-up|1
1378504|NCT01432626|4549057|P1|Overall Study|Imaging agent not available|1
1378505|NCT01432626|4549057|P1|Overall Study|Only 1 image competed|2
1378506|NCT01432626|4549057|P1|Overall Study|Withdrawal by Subject|2
1378507|NCT01432626|4549057|P1|Overall Study|LV function recovered|2
1378508|NCT01432600|4549064|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
1378509|NCT01432600|4549065|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
1378510|NCT01432600|4549066|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
1378511|NCT01432574|4549082|P1|Overall Study|Not interested|1
1378512|NCT01432574|4549082|P1|Overall Study|Moved|2
1378513|NCT01432457|4549128|P3|Overall Study|Did not take study drug|3
1378514|NCT01432457|4549129|P2|Overall Study|Did not take study drug|6
1378515|NCT01432457|4549130|P1|Overall Study|Did not take study drug|6
1378516|NCT01432457|4549128|P3|Overall Study|Reasons not defined|4
1378517|NCT01432457|4549129|P2|Overall Study|Reasons not defined|3
1378518|NCT01432457|4549130|P1|Overall Study|Reasons not defined|2
1378519|NCT01432457|4549128|P3|Overall Study|Withdrawal by Subject|9
1378520|NCT01432457|4549129|P2|Overall Study|Withdrawal by Subject|11
1378521|NCT01432457|4549130|P1|Overall Study|Withdrawal by Subject|6
1378522|NCT01432457|4549128|P3|Overall Study|Protocol Violation|6
1378523|NCT01432457|4549129|P2|Overall Study|Protocol Violation|2
1378524|NCT01432457|4549130|P1|Overall Study|Protocol Violation|3
1378525|NCT01432457|4549128|P3|Overall Study|Lost to Follow-up|20
1378526|NCT01432457|4549129|P2|Overall Study|Lost to Follow-up|15
1378527|NCT01432457|4549130|P1|Overall Study|Lost to Follow-up|11
1378528|NCT01432457|4549128|P3|Overall Study|Lack of Efficacy|1
1378529|NCT01432457|4549129|P2|Overall Study|Lack of Efficacy|1
1378530|NCT01432457|4549130|P1|Overall Study|Lack of Efficacy|2
1378531|NCT01432457|4549128|P3|Overall Study|Adverse Event|16
1378532|NCT01432457|4549129|P2|Overall Study|Adverse Event|10
1378533|NCT01432457|4549130|P1|Overall Study|Adverse Event|7
1378534|NCT01432444|4549159|P3|Extension Phase|Withdrawal by Subject|13
1378535|NCT01432444|4549160|P2|Extension Phase|Withdrawal by Subject|0
1378536|NCT01432444|4549161|P1|Extension Phase|Withdrawal by Subject|0
1378537|NCT01432444|4549159|P3|Extension Phase|Physician Decision|1
1378538|NCT01432444|4549160|P2|Extension Phase|Physician Decision|0
1378539|NCT01432444|4549161|P1|Extension Phase|Physician Decision|0
1378540|NCT01432444|4549159|P3|Extension Phase|Met Withdrawal Criteria|144
1378541|NCT01432444|4549160|P2|Extension Phase|Met Withdrawal Criteria|0
1378542|NCT01432444|4549161|P1|Extension Phase|Met Withdrawal Criteria|0
1378543|NCT01432444|4549159|P3|Extension Phase|Sponsor Discontinued Trial|7
1378544|NCT01432444|4549160|P2|Extension Phase|Sponsor Discontinued Trial|0
1378545|NCT01432444|4549161|P1|Extension Phase|Sponsor Discontinued Trial|0
1378546|NCT01432444|4549159|P3|Extension Phase|Adverse Event|10
1378547|NCT01432444|4549160|P2|Extension Phase|Adverse Event|0
1378548|NCT01432444|4549161|P1|Extension Phase|Adverse Event|0
1378549|NCT01432444|4549159|P3|Extension Phase|Lost to Follow-up|17
1378550|NCT01432444|4549160|P2|Extension Phase|Lost to Follow-up|0
1378551|NCT01432444|4549161|P1|Extension Phase|Lost to Follow-up|0
1378552|NCT01432444|4549159|P3|Treatment Phase|Lack of Efficacy|0
1378553|NCT01432444|4549160|P2|Treatment Phase|Lack of Efficacy|10
1378554|NCT01432444|4549161|P1|Treatment Phase|Lack of Efficacy|0
1378555|NCT01432444|4549159|P3|Treatment Phase|Protocol Deviation|0
1378556|NCT01432444|4549160|P2|Treatment Phase|Protocol Deviation|3
1378557|NCT01432444|4549161|P1|Treatment Phase|Protocol Deviation|0
1378558|NCT01432444|4549159|P3|Treatment Phase|Withdrawal by Subject|0
1378559|NCT01432444|4549160|P2|Treatment Phase|Withdrawal by Subject|41
1378560|NCT01432444|4549161|P1|Treatment Phase|Withdrawal by Subject|0
1378561|NCT01432444|4549159|P3|Treatment Phase|Physician Decision|0
1378562|NCT01432444|4549160|P2|Treatment Phase|Physician Decision|5
1378563|NCT01432444|4549161|P1|Treatment Phase|Physician Decision|0
1378564|NCT01432444|4549159|P3|Treatment Phase|Met Withdrawal Criteria|0
1378565|NCT01432444|4549160|P2|Treatment Phase|Met Withdrawal Criteria|11
1378566|NCT01432444|4549161|P1|Treatment Phase|Met Withdrawal Criteria|0
1378567|NCT01432444|4549159|P3|Treatment Phase|Adverse Event|0
1378568|NCT01432444|4549160|P2|Treatment Phase|Adverse Event|37
1378569|NCT01432444|4549161|P1|Treatment Phase|Adverse Event|0
1378570|NCT01432444|4549159|P3|Treatment Phase|Lost to Follow-up|0
1378571|NCT01432444|4549160|P2|Treatment Phase|Lost to Follow-up|33
1378572|NCT01432444|4549161|P1|Treatment Phase|Lost to Follow-up|0
1378573|NCT01432444|4549159|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
1378574|NCT01432444|4549160|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
1378575|NCT01432444|4549161|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
1378576|NCT01432444|4549159|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
1378577|NCT01432444|4549160|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
1378578|NCT01432444|4549161|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
1378579|NCT01432444|4549159|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
1378580|NCT01432444|4549160|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
1378581|NCT01432444|4549161|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
1378582|NCT01432444|4549159|P3|Tolerability/Cross-titration Phase|Physician Decision|0
1378583|NCT01432444|4549160|P2|Tolerability/Cross-titration Phase|Physician Decision|0
1378584|NCT01432444|4549161|P1|Tolerability/Cross-titration Phase|Physician Decision|8
1378585|NCT01432444|4549159|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
1378586|NCT01432444|4549160|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
1378587|NCT01432444|4549161|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
1378588|NCT01432444|4549159|P3|Tolerability/Cross-titration Phase|Adverse Event|0
1378589|NCT01432444|4549160|P2|Tolerability/Cross-titration Phase|Adverse Event|0
1378590|NCT01432444|4549161|P1|Tolerability/Cross-titration Phase|Adverse Event|16
1378591|NCT01432444|4549159|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
1378592|NCT01432444|4549160|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
1378593|NCT01432444|4549161|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
1378594|NCT01432366|4549187|P1|Overall Study|Other|14
1378595|NCT01432366|4549187|P1|Overall Study|Investigator Forget to Complete Visits|1
1378596|NCT01432366|4549187|P1|Overall Study|Site Closed|20
1378597|NCT01432366|4549187|P1|Overall Study|Lack of Efficacy|1
1378598|NCT01432366|4549187|P1|Overall Study|Lost to Follow-up|13
1378599|NCT01432366|4549187|P1|Overall Study|Pregnancy|1
1378600|NCT01432366|4549187|P1|Overall Study|Withdrawal Due to Non-Compliance|3
1378601|NCT01432366|4549187|P1|Overall Study|Adverse Event|8
1378602|NCT01432366|4549187|P1|Overall Study|Non-Responder|7
1378603|NCT01432327|4549209|P4|Posttest 1 Year|Allergic reaction|1
1378604|NCT01432327|4549210|P3|Posttest 1 Year|Allergic reaction|1
1378605|NCT01432327|4549211|P2|Posttest 1 Year|Allergic reaction|0
1378606|NCT01432327|4549212|P1|Posttest 1 Year|Allergic reaction|0
1378607|NCT01432327|4549209|P4|Posttest 1 Year|Lost to Follow-up|2
1378608|NCT01432327|4549210|P3|Posttest 1 Year|Lost to Follow-up|4
1378609|NCT01432327|4549211|P2|Posttest 1 Year|Lost to Follow-up|0
1378610|NCT01432327|4549212|P1|Posttest 1 Year|Lost to Follow-up|0
1378611|NCT01432327|4549209|P4|Posttest 1 Year|Measurement have to take place in future|20
1378612|NCT01432327|4549210|P3|Posttest 1 Year|Measurement have to take place in future|15
1378613|NCT01432327|4549211|P2|Posttest 1 Year|Measurement have to take place in future|28
1378614|NCT01432327|4549212|P1|Posttest 1 Year|Measurement have to take place in future|24
1378615|NCT01432327|4549209|P4|Posttest 6 Months|Withdrawal by Subject|0
1378616|NCT01432327|4549210|P3|Posttest 6 Months|Withdrawal by Subject|1
1378617|NCT01432327|4549211|P2|Posttest 6 Months|Withdrawal by Subject|0
1378618|NCT01432327|4549212|P1|Posttest 6 Months|Withdrawal by Subject|0
1378619|NCT01432327|4549209|P4|Posttest 6 Months|Allergic reaction|0
1378620|NCT01432327|4549210|P3|Posttest 6 Months|Allergic reaction|1
1378621|NCT01432327|4549211|P2|Posttest 6 Months|Allergic reaction|0
1378622|NCT01432327|4549212|P1|Posttest 6 Months|Allergic reaction|0
1378623|NCT01432327|4549209|P4|Posttest 6 Months|Lost to Follow-up|2
1378624|NCT01432327|4549210|P3|Posttest 6 Months|Lost to Follow-up|3
1378625|NCT01432327|4549211|P2|Posttest 6 Months|Lost to Follow-up|0
1378626|NCT01432327|4549212|P1|Posttest 6 Months|Lost to Follow-up|0
1378627|NCT01432327|4549209|P4|Posttest 3 Months|Allergic reaction|0
1378628|NCT01432327|4549210|P3|Posttest 3 Months|Allergic reaction|0
1378629|NCT01432327|4549211|P2|Posttest 3 Months|Allergic reaction|2
1378630|NCT01432327|4549212|P1|Posttest 3 Months|Allergic reaction|0
1378631|NCT01432327|4549209|P4|Posttest 3 Months|Lost to Follow-up|1
1378632|NCT01432327|4549210|P3|Posttest 3 Months|Lost to Follow-up|2
1378633|NCT01432327|4549211|P2|Posttest 3 Months|Lost to Follow-up|0
1378634|NCT01432327|4549212|P1|Posttest 3 Months|Lost to Follow-up|1
1378635|NCT01432327|4549209|P4|Posttest 3 Months|depression|0
1378636|NCT01432327|4549210|P3|Posttest 3 Months|depression|0
1378637|NCT01432327|4549211|P2|Posttest 3 Months|depression|0
1378638|NCT01432327|4549212|P1|Posttest 3 Months|depression|3
1378639|NCT01432275|4549222|P2|ADC With Calculator (10 Days)|Protocol Violation|1
1378640|NCT01432275|4549223|P1|ADC With Calculator (10 Days)|Protocol Violation|0
1378641|NCT01432275|4549222|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
1378642|NCT01432275|4549223|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
1378643|NCT01432275|4549222|P2|ADC With Calculator (10 Days)|Physician Decision|1
1378644|NCT01432275|4549223|P1|ADC With Calculator (10 Days)|Physician Decision|1
1378645|NCT01432275|4549222|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
1378646|NCT01432275|4549223|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
1378647|NCT01432275|4549222|P2|Second BG Meter System (7 Days)|Physician Decision|1
1378648|NCT01432275|4549223|P1|Second BG Meter System (7 Days)|Physician Decision|0
1378649|NCT01432275|4549222|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
1378650|NCT01432275|4549223|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
1378651|NCT01432275|4549222|P2|Second BG Meter System (7 Days)|Adverse Event|1
1378652|NCT01432275|4549223|P1|Second BG Meter System (7 Days)|Adverse Event|1
1378653|NCT01432275|4549222|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
1378654|NCT01432275|4549223|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
1378655|NCT01432275|4549222|P2|First BG Meter System (7 Days)|Adverse Event|2
1378656|NCT01432275|4549223|P1|First BG Meter System (7 Days)|Adverse Event|0
1378657|NCT01432262|4549232|P2|Overall Study|Withdrawal by Subject|1
1378658|NCT01432262|4549233|P1|Overall Study|Withdrawal by Subject|2
1378659|NCT01431976|4549327|P1|Overall Study|Withdrawal by Subject|1
1378660|NCT01431976|4549327|P1|Overall Study|Physician Decision|1
1378661|NCT01431976|4549327|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
1378662|NCT01431976|4549327|P1|Overall Study|Lack of Efficacy|2
1378663|NCT01431976|4549327|P1|Overall Study|Adverse Event|6
1378664|NCT01431963|4549338|P1|Overall Study|Withdrawal by Subject|3
1378665|NCT01431963|4549338|P1|Overall Study|Physician Decision|4
1378666|NCT01431963|4549338|P1|Overall Study|Protocol-defined Stopping Criteria|2
1378667|NCT01431963|4549338|P1|Overall Study|Protocol Violation|1
1378668|NCT01431963|4549338|P1|Overall Study|Lack of Efficacy|7
1378669|NCT01431963|4549338|P1|Overall Study|Adverse Event|18
1378670|NCT01431950|4549346|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
1378671|NCT01431950|4549347|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
1378672|NCT01431950|4549346|P2|Overall Study|Lost to Follow-up|1
1378673|NCT01431950|4549347|P1|Overall Study|Lost to Follow-up|0
1378674|NCT01431950|4549346|P2|Overall Study|Lack of Efficacy|1
1378675|NCT01431950|4549347|P1|Overall Study|Lack of Efficacy|2
1378676|NCT01431950|4549346|P2|Overall Study|Physician Decision|1
1378677|NCT01431950|4549347|P1|Overall Study|Physician Decision|2
1378678|NCT01431950|4549346|P2|Overall Study|Adverse Event|2
1378679|NCT01431950|4549347|P1|Overall Study|Adverse Event|2
1378680|NCT01431950|4549346|P2|Overall Study|Protocol Violation|3
1378681|NCT01431950|4549347|P1|Overall Study|Protocol Violation|2
1378682|NCT01431950|4549346|P2|Overall Study|Withdrawal by Subject|3
1378683|NCT01431950|4549347|P1|Overall Study|Withdrawal by Subject|4
1378684|NCT01431950|4549346|P2|Overall Study|Study Site Closed/Terminated|3
1378685|NCT01431950|4549347|P1|Overall Study|Study Site Closed/Terminated|7
1378686|NCT01431716|4549385|P1|Overall Study|Withdrawal of consent|1
1378687|NCT01431521|4549410|P4|Overall Study|Withdrawal by Subject|0
1378688|NCT01431521|4549411|P3|Overall Study|Withdrawal by Subject|1
1378689|NCT01431521|4549412|P2|Overall Study|Withdrawal by Subject|0
1378690|NCT01431521|4549413|P1|Overall Study|Withdrawal by Subject|0
1378691|NCT01431508|4549434|P1|Overall Study|Unable to Follow Protocol Procedures|1
1378692|NCT01431508|4549434|P1|Overall Study|Lack of Efficacy|1
1378693|NCT01431287|4549485|P5|Overall Study|not stated above|1
1378694|NCT01431287|4549486|P4|Overall Study|not stated above|2
1378695|NCT01431287|4549487|P3|Overall Study|not stated above|2
1378696|NCT01431287|4549488|P2|Overall Study|not stated above|2
1378697|NCT01431287|4549489|P1|Overall Study|not stated above|4
1378698|NCT01431287|4549485|P5|Overall Study|Consent withdrawn not due to AE|29
1378699|NCT01431287|4549486|P4|Overall Study|Consent withdrawn not due to AE|19
1378700|NCT01431287|4549487|P3|Overall Study|Consent withdrawn not due to AE|34
1378701|NCT01431287|4549488|P2|Overall Study|Consent withdrawn not due to AE|30
1378702|NCT01431287|4549489|P1|Overall Study|Consent withdrawn not due to AE|29
1378703|NCT01431287|4549485|P5|Overall Study|Lost to Follow-up|1
1378704|NCT01431287|4549486|P4|Overall Study|Lost to Follow-up|3
1378705|NCT01431287|4549487|P3|Overall Study|Lost to Follow-up|2
1378706|NCT01431287|4549488|P2|Overall Study|Lost to Follow-up|3
1378707|NCT01431287|4549489|P1|Overall Study|Lost to Follow-up|0
1378708|NCT01431287|4549485|P5|Overall Study|Non compliant with protocol|5
1378709|NCT01431287|4549486|P4|Overall Study|Non compliant with protocol|6
1378710|NCT01431287|4549487|P3|Overall Study|Non compliant with protocol|5
1378711|NCT01431287|4549488|P2|Overall Study|Non compliant with protocol|6
1378712|NCT01431287|4549489|P1|Overall Study|Non compliant with protocol|6
1378713|NCT01431287|4549485|P5|Overall Study|Adverse Event|41
1378714|NCT01431287|4549486|P4|Overall Study|Adverse Event|33
1378715|NCT01431287|4549487|P3|Overall Study|Adverse Event|53
1378716|NCT01431287|4549488|P2|Overall Study|Adverse Event|57
1378717|NCT01431287|4549489|P1|Overall Study|Adverse Event|59
1378718|NCT01431287|4549485|P5|Overall Study|not treated|0
1378719|NCT01431287|4549486|P4|Overall Study|not treated|0
1378720|NCT01431287|4549487|P3|Overall Study|not treated|1
1378721|NCT01431287|4549488|P2|Overall Study|not treated|0
1378722|NCT01431287|4549489|P1|Overall Study|not treated|0
1378723|NCT01431274|4549651|P5|Overall Study|Other reason not stated above|4
1378724|NCT01431274|4549652|P4|Overall Study|Other reason not stated above|2
1378725|NCT01431274|4549653|P3|Overall Study|Other reason not stated above|7
1378726|NCT01431274|4549654|P2|Overall Study|Other reason not stated above|5
1378727|NCT01431274|4549655|P1|Overall Study|Other reason not stated above|6
1378728|NCT01431274|4549651|P5|Overall Study|Lost to Follow-up|0
1378729|NCT01431274|4549652|P4|Overall Study|Lost to Follow-up|4
1378730|NCT01431274|4549653|P3|Overall Study|Lost to Follow-up|1
1378731|NCT01431274|4549654|P2|Overall Study|Lost to Follow-up|7
1378732|NCT01431274|4549655|P1|Overall Study|Lost to Follow-up|6
1378733|NCT01431274|4549651|P5|Overall Study|Non compliant with protocol|4
1378734|NCT01431274|4549652|P4|Overall Study|Non compliant with protocol|4
1378735|NCT01431274|4549653|P3|Overall Study|Non compliant with protocol|4
1378736|NCT01431274|4549654|P2|Overall Study|Non compliant with protocol|8
1378737|NCT01431274|4549655|P1|Overall Study|Non compliant with protocol|5
1378738|NCT01431274|4549651|P5|Overall Study|Consent withdrawn not due to AE|11
1378739|NCT01431274|4549652|P4|Overall Study|Consent withdrawn not due to AE|20
1378740|NCT01431274|4549653|P3|Overall Study|Consent withdrawn not due to AE|17
1378741|NCT01431274|4549654|P2|Overall Study|Consent withdrawn not due to AE|20
1378742|NCT01431274|4549655|P1|Overall Study|Consent withdrawn not due to AE|29
1378743|NCT01431274|4549651|P5|Overall Study|Adverse Event|37
1378744|NCT01431274|4549652|P4|Overall Study|Adverse Event|30
1378745|NCT01431274|4549653|P3|Overall Study|Adverse Event|43
1378746|NCT01431274|4549654|P2|Overall Study|Adverse Event|37
1378747|NCT01431274|4549655|P1|Overall Study|Adverse Event|51
1378748|NCT01431144|4549833|P2|Overall Study|Implant mobility and removal|0
1378749|NCT01431144|4549834|P1|Overall Study|Implant mobility and removal|2
1378750|NCT01431079|4549853|P2|Overall Study|Lost to Follow-up|39
1378751|NCT01431079|4549854|P1|Overall Study|Lost to Follow-up|35
1378752|NCT01430754|4549933|P2|Run-In Phase|Lost to Follow-up|0
1378753|NCT01430754|4549934|P1|Run-In Phase|Lost to Follow-up|1
1378754|NCT01430754|4549933|P2|Run-In Phase|Withdrawal by Subject|0
1378755|NCT01430754|4549934|P1|Run-In Phase|Withdrawal by Subject|2
1378756|NCT01430754|4549933|P2|Run-In Phase|Other|0
1378757|NCT01430754|4549934|P1|Run-In Phase|Other|2
1378758|NCT01430754|4549933|P2|Run-In Phase|Adverse Event|0
1378759|NCT01430754|4549934|P1|Run-In Phase|Adverse Event|2
1378760|NCT01430754|4549933|P2|Run-In Phase|Protocol Violation|0
1378761|NCT01430754|4549934|P1|Run-In Phase|Protocol Violation|6
1378762|NCT01430754|4549933|P2|Run-In Phase|Circadian Period Ineligible|0
1378763|NCT01430754|4549934|P1|Run-In Phase|Circadian Period Ineligible|24
1378764|NCT01430624|4549992|P3|Overall Study|technical or eligibility|2
1378765|NCT01430624|4549993|P2|Overall Study|technical or eligibility|5
1378766|NCT01430624|4549994|P1|Overall Study|technical or eligibility|5
1378767|NCT01430624|4549992|P3|Overall Study|Lost to Follow-up|27
1378768|NCT01430624|4549993|P2|Overall Study|Lost to Follow-up|29
1378769|NCT01430624|4549994|P1|Overall Study|Lost to Follow-up|23
1378770|NCT01430611|4550025|P2|Overall Study|Withdrawal by Subject|14
1378771|NCT01430611|4550026|P1|Overall Study|Withdrawal by Subject|15
1378772|NCT01430611|4550025|P2|Overall Study|Lost to Follow-up|0
1378773|NCT01430611|4550026|P1|Overall Study|Lost to Follow-up|1
1378774|NCT01430611|4550025|P2|Overall Study|Protocol Violation|0
1378775|NCT01430611|4550026|P1|Overall Study|Protocol Violation|1
1378776|NCT01430611|4550025|P2|Overall Study|Adverse Event|1
1378777|NCT01430611|4550026|P1|Overall Study|Adverse Event|0
1378778|NCT01430585|4550044|P1|Overall Study|Other|7
1378779|NCT01430585|4550044|P1|Overall Study|Study Terminated by Sponsor|3
1378780|NCT01430585|4550044|P1|Overall Study|Objective Progression or Relapse|3
1378781|NCT01430585|4550044|P1|Overall Study|Death|1
1378782|NCT01430468|4550079|P2|Overall Study|Withdrawal by Subject|1
1378783|NCT01430468|4550080|P1|Overall Study|Withdrawal by Subject|1
1378784|NCT01430468|4550079|P2|Overall Study|Physician Decision|1
1378785|NCT01430468|4550080|P1|Overall Study|Physician Decision|2
1378786|NCT01430455|4550086|P1|Overall Study|Switched to follow-up phase|1
1378787|NCT01430455|4550086|P1|Overall Study|Withdrawal by Subject|1
1378788|NCT01430403|4550093|P3|Overall Study|Withdrawal by Subject|3
1378789|NCT01430403|4550094|P2|Overall Study|Withdrawal by Subject|1
1378790|NCT01430403|4550095|P1|Overall Study|Withdrawal by Subject|9
1378791|NCT01430403|4550093|P3|Overall Study|Protocol Violation|2
1378792|NCT01430403|4550094|P2|Overall Study|Protocol Violation|3
1378793|NCT01430403|4550095|P1|Overall Study|Protocol Violation|2
1378794|NCT01430403|4550093|P3|Overall Study|Physician Decision|0
1378795|NCT01430403|4550094|P2|Overall Study|Physician Decision|0
1378796|NCT01430403|4550095|P1|Overall Study|Physician Decision|1
1378797|NCT01430403|4550093|P3|Overall Study|Lost to Follow-up|3
1378798|NCT01430403|4550094|P2|Overall Study|Lost to Follow-up|5
1378799|NCT01430403|4550095|P1|Overall Study|Lost to Follow-up|5
1378800|NCT01430130|4550202|P1|Overall Study|Infection on Control Side of Incision|1
1378801|NCT01430130|4550202|P1|Overall Study|Lost to Follow-up|1
1378802|NCT01430104|4550208|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
1378803|NCT01429623|4550277|P2|Overall Study|No post baseline data|4
1378804|NCT01429623|4550278|P1|Overall Study|No post baseline data|4
1378805|NCT01429623|4550277|P2|Overall Study|Conversion to Alzheimer's disease|21
1378806|NCT01429623|4550278|P1|Overall Study|Conversion to Alzheimer's disease|14
1378807|NCT01429623|4550277|P2|Overall Study|Assorted|2
1378808|NCT01429623|4550278|P1|Overall Study|Assorted|1
1378809|NCT01429623|4550277|P2|Overall Study|Protocol Violation|2
1378810|NCT01429623|4550278|P1|Overall Study|Protocol Violation|3
1378811|NCT01429623|4550277|P2|Overall Study|Physician Decision|3
1378812|NCT01429623|4550278|P1|Overall Study|Physician Decision|2
1378813|NCT01429623|4550277|P2|Overall Study|Withdrawal by Subject|13
1378814|NCT01429623|4550278|P1|Overall Study|Withdrawal by Subject|19
1378815|NCT01429623|4550277|P2|Overall Study|Adverse Event|14
1378816|NCT01429623|4550278|P1|Overall Study|Adverse Event|7
1378817|NCT01429623|4550277|P2|Overall Study|Death|0
1378818|NCT01429623|4550278|P1|Overall Study|Death|1
1378819|NCT01429584|4550292|P2|Overall Study|Protocol Violation|1
1378820|NCT01429584|4550293|P1|Overall Study|Protocol Violation|0
1378821|NCT01429584|4550292|P2|Overall Study|Withdrawal by Subject|0
1378822|NCT01429584|4550293|P1|Overall Study|Withdrawal by Subject|1
1378823|NCT01429441|4550324|P2|Overall Study|Withdrawal by Subject|18
1378824|NCT01429441|4550325|P1|Overall Study|Withdrawal by Subject|27
1378825|NCT01429441|4550324|P2|Overall Study|Physician Decision|0
1378826|NCT01429441|4550325|P1|Overall Study|Physician Decision|1
1378827|NCT01429441|4550324|P2|Overall Study|Lost to Follow-up|2
1378828|NCT01429441|4550325|P1|Overall Study|Lost to Follow-up|5
1378829|NCT01429441|4550324|P2|Overall Study|Death|2
1378830|NCT01429441|4550325|P1|Overall Study|Death|0
1378831|NCT01429441|4550324|P2|Overall Study|Adverse Event|1
1378832|NCT01429441|4550325|P1|Overall Study|Adverse Event|5
1378833|NCT01429298|4550335|P2|Overall Study|Protocol Violation|6
1378834|NCT01429298|4550336|P1|Overall Study|Protocol Violation|4
1378835|NCT01429285|4550352|P2|Overall Study|Erroneously Enrolled Twice|2
1378836|NCT01429285|4550353|P1|Overall Study|Erroneously Enrolled Twice|8
1378837|NCT01429285|4550352|P2|Overall Study|Missing Data|3
1378838|NCT01429285|4550353|P1|Overall Study|Missing Data|5
1378839|NCT01429285|4550352|P2|Overall Study|Protocol Violation|4
1378840|NCT01429285|4550353|P1|Overall Study|Protocol Violation|9
1378841|NCT01429077|4550399|P2|Overall Study|Lost to Follow-up|3
1378842|NCT01429077|4550400|P1|Overall Study|Lost to Follow-up|0
1378843|NCT01429051|4550423|P1|Tolerability Phase|Other|2
1378844|NCT01429051|4550423|P1|Tolerability Phase|Physician Decision|1
1378845|NCT01429051|4550423|P1|Tolerability Phase|Withdrawal by Subject|5
1378846|NCT01429051|4550423|P1|Tolerability Phase|Adverse Event|2
1378847|NCT01429051|4550423|P1|Tolerability Phase|Death|5
1378848|NCT01429051|4550423|P1|Efficacy Phase|Death|1
1378849|NCT01429051|4550423|P1|Efficacy Phase|Adverse Event|1
1378850|NCT01429051|4550423|P1|Titration Phase|Less than 3 BTP episodes per week|2
1378851|NCT01429051|4550423|P1|Titration Phase|Unsuccessful titration at any dose|1
1378852|NCT01429051|4550423|P1|Titration Phase|Physician Decision|1
1378853|NCT01429051|4550423|P1|Titration Phase|Withdrawal by Subject|7
1378854|NCT01429051|4550423|P1|Titration Phase|Death|1
1378855|NCT01428882|4550446|P2|Overall Study|Protocol Violation|3
1378856|NCT01428882|4550447|P1|Overall Study|Protocol Violation|4
1378857|NCT01428882|4550446|P2|Overall Study|Lack of Efficacy|7
1378858|NCT01428882|4550447|P1|Overall Study|Lack of Efficacy|2
1378859|NCT01428713|4550470|P2|Overall Study|Adverse Event|2
1378860|NCT01428713|4550471|P1|Overall Study|Adverse Event|0
1378861|NCT01428713|4550470|P2|Overall Study|Withdrawal by Subject|1
1378862|NCT01428713|4550471|P1|Overall Study|Withdrawal by Subject|1
1378863|NCT01428713|4550470|P2|Overall Study|Non-compliance|2
1378864|NCT01428713|4550471|P1|Overall Study|Non-compliance|2
1378865|NCT01428661|4550480|P3|Open Label Extension|**Various|185
1378866|NCT01428661|4550481|P2|Open Label Extension|**Various|0
1378867|NCT01428661|4550482|P1|Open Label Extension|**Various|0
1378868|NCT01428661|4550480|P3|Open Label Extension|Lack of Efficacy|24
1378869|NCT01428661|4550481|P2|Open Label Extension|Lack of Efficacy|0
1378870|NCT01428661|4550482|P1|Open Label Extension|Lack of Efficacy|0
1378871|NCT01428661|4550480|P3|Open Label Extension|Withdrawal by Subject|49
1378872|NCT01428661|4550481|P2|Open Label Extension|Withdrawal by Subject|0
1378873|NCT01428661|4550482|P1|Open Label Extension|Withdrawal by Subject|0
1378874|NCT01428661|4550480|P3|Open Label Extension|Lost to Follow-up|38
1378875|NCT01428661|4550481|P2|Open Label Extension|Lost to Follow-up|0
1378876|NCT01428661|4550482|P1|Open Label Extension|Lost to Follow-up|0
1378877|NCT01428661|4550480|P3|Open Label Extension|Adverse Event|15
1378878|NCT01428661|4550481|P2|Open Label Extension|Adverse Event|0
1378879|NCT01428661|4550482|P1|Open Label Extension|Adverse Event|0
1378880|NCT01428661|4550480|P3|Open Label Extension|Protocol Violation|9
1378881|NCT01428661|4550481|P2|Open Label Extension|Protocol Violation|0
1378882|NCT01428661|4550482|P1|Open Label Extension|Protocol Violation|0
1378883|NCT01428661|4550480|P3|Double-Masked Phase|*Various|0
1378884|NCT01428661|4550481|P2|Double-Masked Phase|*Various|6
1378885|NCT01428661|4550482|P1|Double-Masked Phase|*Various|1
1378886|NCT01428661|4550480|P3|Double-Masked Phase|Lack of Efficacy|0
1378887|NCT01428661|4550481|P2|Double-Masked Phase|Lack of Efficacy|1
1378888|NCT01428661|4550482|P1|Double-Masked Phase|Lack of Efficacy|2
1378889|NCT01428661|4550480|P3|Double-Masked Phase|Withdrawal by Subject|0
1378890|NCT01428661|4550481|P2|Double-Masked Phase|Withdrawal by Subject|20
1378891|NCT01428661|4550482|P1|Double-Masked Phase|Withdrawal by Subject|18
1378892|NCT01428661|4550480|P3|Double-Masked Phase|Lost to Follow-up|0
1378893|NCT01428661|4550481|P2|Double-Masked Phase|Lost to Follow-up|14
1378894|NCT01428661|4550482|P1|Double-Masked Phase|Lost to Follow-up|14
1378895|NCT01428661|4550480|P3|Double-Masked Phase|Adverse Event|0
1378896|NCT01428661|4550481|P2|Double-Masked Phase|Adverse Event|4
1378897|NCT01428661|4550482|P1|Double-Masked Phase|Adverse Event|13
1378898|NCT01428661|4550480|P3|Double-Masked Phase|Protocol Violation|0
1378899|NCT01428661|4550481|P2|Double-Masked Phase|Protocol Violation|4
1378900|NCT01428661|4550482|P1|Double-Masked Phase|Protocol Violation|9
1378901|NCT01428583|4550490|P1|Overall Study|Other|6
1378902|NCT01428583|4550490|P1|Overall Study|Sponsor’s request|3
1378903|NCT01428583|4550490|P1|Overall Study|Confirmed positive urine drug test|8
1378904|NCT01428583|4550490|P1|Overall Study|Non-compliant|25
1378905|NCT01428583|4550490|P1|Overall Study|Physician Decision|12
1378906|NCT01428583|4550490|P1|Overall Study|Protocol Violation|1
1378907|NCT01428583|4550490|P1|Overall Study|Pregnancy|1
1378908|NCT01428583|4550490|P1|Overall Study|Death|1
1378909|NCT01428583|4550490|P1|Overall Study|Lost to Follow-up|17
1378910|NCT01428583|4550490|P1|Overall Study|Lack of Efficacy|37
1378911|NCT01428583|4550490|P1|Overall Study|Withdrawal by Subject|51
1378912|NCT01428583|4550490|P1|Overall Study|Adverse Event|75
1378913|NCT01428258|4550527|P2|Intervention 1|Withdrawal by Subject|0
1378914|NCT01428258|4550528|P1|Intervention 1|Withdrawal by Subject|2
1378915|NCT01428219|4550546|P1|Overall Study|25 patients enrolled, 3 were not treated|3
1378916|NCT01428193|4550557|P1|Overall Study|Elevated screening liver enzymes|1
1378917|NCT01428193|4550557|P1|Overall Study|Physician Decision|1
1378918|NCT01428128|4550561|P1|Overall Study|Adverse Event|1
1378919|NCT01428128|4550561|P1|Overall Study|Received Neulasta in one cycle|2
1378920|NCT01428128|4550561|P1|Overall Study|Screen failure by p53|10
1378921|NCT01428128|4550561|P1|Overall Study|Withdrawal by Subject|4
1378922|NCT01428115|4550566|P1|Overall Study|Withdrawal by Subject|4
1378923|NCT01428115|4550566|P1|Overall Study|Protocol Violation|3
1378924|NCT01428115|4550566|P1|Overall Study|Pregnancy|1
1378925|NCT01428115|4550566|P1|Overall Study|Lost to Follow-up|10
1378926|NCT01428115|4550566|P1|Overall Study|Lack of Efficacy|3
1378927|NCT01428076|4550581|P2|Overall Study|Adverse Event|1
1378928|NCT01428076|4550582|P1|Overall Study|Adverse Event|0
1378929|NCT01428063|4550593|P3|Overall Study|No longer meets study criteria|0
1378930|NCT01428063|4550594|P2|Overall Study|No longer meets study criteria|1
1378931|NCT01428063|4550595|P1|Overall Study|No longer meets study criteria|0
1378932|NCT01428063|4550593|P3|Overall Study|Lost to Follow-up|0
1378933|NCT01428063|4550594|P2|Overall Study|Lost to Follow-up|2
1378934|NCT01428063|4550595|P1|Overall Study|Lost to Follow-up|0
1378935|NCT01428063|4550593|P3|Overall Study|Adverse Event|0
1378936|NCT01428063|4550594|P2|Overall Study|Adverse Event|3
1378937|NCT01428063|4550595|P1|Overall Study|Adverse Event|2
1378938|NCT01428063|4550593|P3|Overall Study|Lack of Efficacy|1
1378939|NCT01428063|4550594|P2|Overall Study|Lack of Efficacy|4
1378940|NCT01428063|4550595|P1|Overall Study|Lack of Efficacy|8
1378941|NCT01427933|4550666|P2|Overall Study|Investigator's Decision|0
1378942|NCT01427933|4550667|P1|Overall Study|Investigator's Decision|1
1378943|NCT01427933|4550666|P2|Overall Study|Not Specified|0
1378944|NCT01427933|4550667|P1|Overall Study|Not Specified|1
1378945|NCT01427933|4550666|P2|Overall Study|Lost to Follow-up|5
1378946|NCT01427933|4550667|P1|Overall Study|Lost to Follow-up|1
1378947|NCT01427933|4550666|P2|Overall Study|Withdrawal by Subject|8
1378948|NCT01427933|4550667|P1|Overall Study|Withdrawal by Subject|5
1378949|NCT01427920|4550687|P2|Overall Study|Unclassified|8
1378950|NCT01427920|4550688|P1|Overall Study|Unclassified|2
1378951|NCT01427920|4550687|P2|Overall Study|Withdrawal Criteria|4
1378952|NCT01427920|4550688|P1|Overall Study|Withdrawal Criteria|4
1378953|NCT01427920|4550687|P2|Overall Study|Protocol Violation|3
1378954|NCT01427920|4550688|P1|Overall Study|Protocol Violation|1
1378955|NCT01427920|4550687|P2|Overall Study|Lack of Efficacy|0
1378956|NCT01427920|4550688|P1|Overall Study|Lack of Efficacy|1
1378957|NCT01427920|4550687|P2|Overall Study|Adverse Event|2
1378958|NCT01427920|4550688|P1|Overall Study|Adverse Event|1
1378959|NCT01427907|4550708|P2|Overall Study|Withdrawal by Subject|4
1378960|NCT01427907|4550709|P1|Overall Study|Withdrawal by Subject|3
1378961|NCT01427803|4550730|P2|Overall Study|did not take product|0
1378962|NCT01427803|4550731|P1|Overall Study|did not take product|1
1378963|NCT01427803|4550730|P2|Overall Study|Physician Decision|0
1378964|NCT01427803|4550731|P1|Overall Study|Physician Decision|3
1378965|NCT01427803|4550730|P2|Overall Study|Protocol Violation|0
1378966|NCT01427803|4550731|P1|Overall Study|Protocol Violation|1
1378967|NCT01427803|4550730|P2|Overall Study|Unable to complete full treatment period|0
1378968|NCT01427803|4550731|P1|Overall Study|Unable to complete full treatment period|6
1378969|NCT01427803|4550730|P2|Overall Study|Withdrawal by Subject|0
1378970|NCT01427803|4550731|P1|Overall Study|Withdrawal by Subject|20
1378971|NCT01427803|4550730|P2|Overall Study|Lost to Follow-up|26
1378972|NCT01427803|4550731|P1|Overall Study|Lost to Follow-up|32
1378973|NCT01427751|4550745|P2|Overall Study|Other miscellaneous reasons|4
1378974|NCT01427751|4550746|P1|Overall Study|Other miscellaneous reasons|6
1378975|NCT01427751|4550745|P2|Overall Study|Death|0
1378976|NCT01427751|4550746|P1|Overall Study|Death|2
1378977|NCT01427751|4550745|P2|Overall Study|Protocol Violation|4
1378978|NCT01427751|4550746|P1|Overall Study|Protocol Violation|6
1378979|NCT01427751|4550745|P2|Overall Study|Withdrawal of consent|2
1378980|NCT01427751|4550746|P1|Overall Study|Withdrawal of consent|2
1378981|NCT01427751|4550745|P2|Overall Study|Lost to Follow-up|1
1378982|NCT01427751|4550746|P1|Overall Study|Lost to Follow-up|3
1378983|NCT01427751|4550745|P2|Overall Study|No further treatment benefit expected|1
1378984|NCT01427751|4550746|P1|Overall Study|No further treatment benefit expected|5
1378985|NCT01427751|4550745|P2|Overall Study|Adverse Event|2
1378986|NCT01427751|4550746|P1|Overall Study|Adverse Event|18
1378987|NCT01427738|4550766|P2|Overall Study|Lost to Follow-up|5
1378988|NCT01427738|4550767|P1|Overall Study|Lost to Follow-up|1
1378989|NCT01427738|4550766|P2|Overall Study|Subject not willing to adhere to reqs|2
1378990|NCT01427738|4550767|P1|Overall Study|Subject not willing to adhere to reqs|1
1378991|NCT01427738|4550766|P2|Overall Study|Withdrawal by Subject|2
1378992|NCT01427738|4550767|P1|Overall Study|Withdrawal by Subject|0
1378993|NCT01427738|4550766|P2|Overall Study|Subject unable to get to clinic|2
1378994|NCT01427738|4550767|P1|Overall Study|Subject unable to get to clinic|5
1378995|NCT01427738|4550766|P2|Overall Study|Severe debilitation, unable to continue|1
1378996|NCT01427738|4550767|P1|Overall Study|Severe debilitation, unable to continue|0
1378997|NCT01427738|4550766|P2|Overall Study|Death|9
1378998|NCT01427738|4550767|P1|Overall Study|Death|12
1378999|NCT01427309|4550830|P4|Overall Study|Withdrawal by Subject|55
1379000|NCT01427309|4550831|P3|Overall Study|Withdrawal by Subject|61
1379001|NCT01427309|4550832|P2|Overall Study|Withdrawal by Subject|148
1379002|NCT01427309|4550833|P1|Overall Study|Withdrawal by Subject|148
1379003|NCT01427309|4550830|P4|Overall Study|Serious adverse event|61
1379004|NCT01427309|4550831|P3|Overall Study|Serious adverse event|50
1379005|NCT01427309|4550832|P2|Overall Study|Serious adverse event|45
1379006|NCT01427309|4550833|P1|Overall Study|Serious adverse event|52
1379007|NCT01427309|4550830|P4|Overall Study|Adverse Event|1
1379008|NCT01427309|4550831|P3|Overall Study|Adverse Event|3
1379009|NCT01427309|4550832|P2|Overall Study|Adverse Event|0
1379010|NCT01427309|4550833|P1|Overall Study|Adverse Event|0
1379011|NCT01427309|4550830|P4|Overall Study|Protocol Violation|124
1379012|NCT01427309|4550831|P3|Overall Study|Protocol Violation|125
1379013|NCT01427309|4550832|P2|Overall Study|Protocol Violation|69
1379014|NCT01427309|4550833|P1|Overall Study|Protocol Violation|42
1379015|NCT01427309|4550830|P4|Overall Study|Lost to Follow-up|135
1379016|NCT01427309|4550831|P3|Overall Study|Lost to Follow-up|122
1379017|NCT01427309|4550832|P2|Overall Study|Lost to Follow-up|145
1379018|NCT01427309|4550833|P1|Overall Study|Lost to Follow-up|130
1379019|NCT01426958|4550880|P1|Overall Study|Adverse Event|2
1379020|NCT01426854|4550909|P2|Overall Study|Other|2
1379021|NCT01426854|4550910|P1|Overall Study|Other|3
1379022|NCT01426854|4550909|P2|Overall Study|Protocol Deviation|1
1379023|NCT01426854|4550910|P1|Overall Study|Protocol Deviation|0
1379024|NCT01426854|4550909|P2|Overall Study|Treatment Failure|16
1379025|NCT01426854|4550910|P1|Overall Study|Treatment Failure|0
1379026|NCT01426854|4550909|P2|Overall Study|Noncompliance|1
1379027|NCT01426854|4550910|P1|Overall Study|Noncompliance|0
1379028|NCT01426854|4550909|P2|Overall Study|Lost to Follow-up|0
1379029|NCT01426854|4550910|P1|Overall Study|Lost to Follow-up|3
1379030|NCT01426854|4550909|P2|Overall Study|Subject Decision Unrelated to AE|6
1379031|NCT01426854|4550910|P1|Overall Study|Subject Decision Unrelated to AE|5
1379032|NCT01426854|4550909|P2|Overall Study|Adverse Event|5
1379033|NCT01426854|4550910|P1|Overall Study|Adverse Event|1
1379034|NCT01426789|4550920|P6|Part 2|Adverse Event|0
1379035|NCT01426789|4550921|P5|Part 2|Adverse Event|1
1379036|NCT01426789|4550922|P4|Part 2|Adverse Event|0
1379037|NCT01426789|4550923|P3|Part 2|Adverse Event|2
1379038|NCT01426789|4550924|P2|Part 2|Adverse Event|0
1379039|NCT01426789|4550925|P1|Part 2|Adverse Event|0
1379040|NCT01426789|4550920|P6|Part 2|Lack of Efficacy|0
1379041|NCT01426789|4550921|P5|Part 2|Lack of Efficacy|2
1379042|NCT01426789|4550922|P4|Part 2|Lack of Efficacy|0
1379043|NCT01426789|4550923|P3|Part 2|Lack of Efficacy|5
1379044|NCT01426789|4550924|P2|Part 2|Lack of Efficacy|0
1379045|NCT01426789|4550925|P1|Part 2|Lack of Efficacy|0
1379046|NCT01426789|4550920|P6|Part 2|Withdrawal by Subject|0
1379047|NCT01426789|4550921|P5|Part 2|Withdrawal by Subject|2
1379048|NCT01426789|4550922|P4|Part 2|Withdrawal by Subject|1
1379049|NCT01426789|4550923|P3|Part 2|Withdrawal by Subject|0
1379050|NCT01426789|4550924|P2|Part 2|Withdrawal by Subject|0
1379051|NCT01426789|4550925|P1|Part 2|Withdrawal by Subject|0
1379052|NCT01426789|4550920|P6|Part 2|Lost to Follow-up|0
1379053|NCT01426789|4550921|P5|Part 2|Lost to Follow-up|1
1379054|NCT01426789|4550922|P4|Part 2|Lost to Follow-up|0
1379055|NCT01426789|4550923|P3|Part 2|Lost to Follow-up|4
1379056|NCT01426789|4550924|P2|Part 2|Lost to Follow-up|0
1379057|NCT01426789|4550925|P1|Part 2|Lost to Follow-up|0
1379058|NCT01426789|4550920|P6|Part 2|Administrative problems|0
1379059|NCT01426789|4550921|P5|Part 2|Administrative problems|1
1379060|NCT01426789|4550922|P4|Part 2|Administrative problems|0
1379061|NCT01426789|4550923|P3|Part 2|Administrative problems|2
1379062|NCT01426789|4550924|P2|Part 2|Administrative problems|0
1379063|NCT01426789|4550925|P1|Part 2|Administrative problems|0
1379064|NCT01426789|4550920|P6|Part 2|Death|0
1379065|NCT01426789|4550921|P5|Part 2|Death|1
1379066|NCT01426789|4550922|P4|Part 2|Death|0
1379067|NCT01426789|4550923|P3|Part 2|Death|1
1379068|NCT01426789|4550924|P2|Part 2|Death|0
1379069|NCT01426789|4550925|P1|Part 2|Death|0
1379070|NCT01426789|4550920|P6|Part 2|Protocol deviation|0
1379071|NCT01426789|4550921|P5|Part 2|Protocol deviation|0
1379072|NCT01426789|4550922|P4|Part 2|Protocol deviation|0
1379073|NCT01426789|4550923|P3|Part 2|Protocol deviation|1
1379074|NCT01426789|4550924|P2|Part 2|Protocol deviation|0
1379075|NCT01426789|4550925|P1|Part 2|Protocol deviation|0
1379076|NCT01426789|4550920|P6|Part 1|Adverse Event|0
1379077|NCT01426789|4550921|P5|Part 1|Adverse Event|0
1379078|NCT01426789|4550922|P4|Part 1|Adverse Event|0
1379079|NCT01426789|4550923|P3|Part 1|Adverse Event|0
1379080|NCT01426789|4550924|P2|Part 1|Adverse Event|0
1379081|NCT01426789|4550925|P1|Part 1|Adverse Event|3
1379082|NCT01426789|4550920|P6|Part 1|Lack of Efficacy|0
1379083|NCT01426789|4550921|P5|Part 1|Lack of Efficacy|0
1379084|NCT01426789|4550922|P4|Part 1|Lack of Efficacy|0
1379085|NCT01426789|4550923|P3|Part 1|Lack of Efficacy|0
1379086|NCT01426789|4550924|P2|Part 1|Lack of Efficacy|1
1379087|NCT01426789|4550925|P1|Part 1|Lack of Efficacy|2
1379088|NCT01426789|4550920|P6|Part 1|Lost to Follow-up|0
1379089|NCT01426789|4550921|P5|Part 1|Lost to Follow-up|0
1379090|NCT01426789|4550922|P4|Part 1|Lost to Follow-up|0
1379091|NCT01426789|4550923|P3|Part 1|Lost to Follow-up|0
1379092|NCT01426789|4550924|P2|Part 1|Lost to Follow-up|2
1379093|NCT01426789|4550925|P1|Part 1|Lost to Follow-up|1
1379094|NCT01426789|4550920|P6|Part 1|Protocol deviation|0
1379095|NCT01426789|4550921|P5|Part 1|Protocol deviation|0
1379096|NCT01426789|4550922|P4|Part 1|Protocol deviation|0
1379097|NCT01426789|4550923|P3|Part 1|Protocol deviation|0
1379098|NCT01426789|4550924|P2|Part 1|Protocol deviation|1
1379099|NCT01426789|4550925|P1|Part 1|Protocol deviation|0
1379100|NCT01426438|4550970|P2|Overall Study|Missed Scan|2
1379101|NCT01426438|4550971|P1|Overall Study|Missed Scan|2
1379102|NCT01426438|4550970|P2|Overall Study|Poor scan quality|2
1379103|NCT01426438|4550971|P1|Overall Study|Poor scan quality|3
1379104|NCT01426438|4550970|P2|Overall Study|Off study Treatment|3
1379105|NCT01426438|4550971|P1|Overall Study|Off study Treatment|9
1379106|NCT01426438|4550970|P2|Overall Study|Lost to Follow-up|3
1379107|NCT01426438|4550971|P1|Overall Study|Lost to Follow-up|1
1379108|NCT01426425|4551003|P1|Overall Study|Met inclusion/exclusion, not treated|2
1379109|NCT01426425|4551003|P1|Overall Study|Inclusion/exclusion criteria not met|151
1379110|NCT01426425|4551003|P1|Overall Study|Exited prior to EP study|22
1379111|NCT01426386|4551015|P6|Overall Study|Personal reasons|0
1379112|NCT01426386|4551016|P5|Overall Study|Personal reasons|1
1379113|NCT01426386|4551017|P4|Overall Study|Personal reasons|0
1379114|NCT01426386|4551018|P3|Overall Study|Personal reasons|0
1379115|NCT01426386|4551019|P2|Overall Study|Personal reasons|0
1379116|NCT01426386|4551020|P1|Overall Study|Personal reasons|0
1379117|NCT01426386|4551015|P6|Overall Study|Poor response|0
1379118|NCT01426386|4551016|P5|Overall Study|Poor response|1
1379119|NCT01426386|4551017|P4|Overall Study|Poor response|0
1379120|NCT01426386|4551018|P3|Overall Study|Poor response|2
1379121|NCT01426386|4551019|P2|Overall Study|Poor response|1
1379122|NCT01426386|4551020|P1|Overall Study|Poor response|2
1379123|NCT01426386|4551015|P6|Overall Study|Did not attend scheduled visit|1
1379124|NCT01426386|4551016|P5|Overall Study|Did not attend scheduled visit|2
1379125|NCT01426386|4551017|P4|Overall Study|Did not attend scheduled visit|0
1379126|NCT01426386|4551018|P3|Overall Study|Did not attend scheduled visit|0
1379127|NCT01426386|4551019|P2|Overall Study|Did not attend scheduled visit|4
1379128|NCT01426386|4551020|P1|Overall Study|Did not attend scheduled visit|1
1379129|NCT01426386|4551015|P6|Overall Study|Adverse Event|0
1379130|NCT01426386|4551016|P5|Overall Study|Adverse Event|0
1379131|NCT01426386|4551017|P4|Overall Study|Adverse Event|0
1379132|NCT01426386|4551018|P3|Overall Study|Adverse Event|0
1379133|NCT01426386|4551019|P2|Overall Study|Adverse Event|1
1379134|NCT01426386|4551020|P1|Overall Study|Adverse Event|0
1379135|NCT01426373|4551076|P1|Overall Study|Miscellaneous Reasons|4
1379136|NCT01426373|4551076|P1|Overall Study|Participant Convenience|10
1379137|NCT01426373|4551076|P1|Overall Study|Lost to Follow-up|14
1379138|NCT01426373|4551076|P1|Overall Study|Adverse Event|6
1379139|NCT01426347|4551109|P2|Overall Study|Withdrawal by Subject|0
1379140|NCT01426347|4551110|P1|Overall Study|Withdrawal by Subject|5
1379141|NCT01426347|4551109|P2|Overall Study|Protocol Violation|0
1379142|NCT01426347|4551110|P1|Overall Study|Protocol Violation|2
1379143|NCT01426347|4551109|P2|Overall Study|Lost to Follow-up|3
1379144|NCT01426347|4551110|P1|Overall Study|Lost to Follow-up|0
1379145|NCT01426269|4551118|P3|Period 2: 40 Weeks|Relapsed|18
1379146|NCT01426269|4551119|P2|Period 2: 40 Weeks|Relapsed|9
1379147|NCT01426269|4551120|P1|Period 2: 40 Weeks|Relapsed|0
1379148|NCT01426269|4551118|P3|Period 2: 40 Weeks|Site closed|5
1379149|NCT01426269|4551119|P2|Period 2: 40 Weeks|Site closed|6
1379150|NCT01426269|4551120|P1|Period 2: 40 Weeks|Site closed|0
1379151|NCT01426269|4551118|P3|Period 2: 40 Weeks|Lost to Follow-up|6
1379152|NCT01426269|4551119|P2|Period 2: 40 Weeks|Lost to Follow-up|8
1379153|NCT01426269|4551120|P1|Period 2: 40 Weeks|Lost to Follow-up|0
1379154|NCT01426269|4551118|P3|Period 2: 40 Weeks|Protocol Violation|5
1379155|NCT01426269|4551119|P2|Period 2: 40 Weeks|Protocol Violation|5
1379156|NCT01426269|4551120|P1|Period 2: 40 Weeks|Protocol Violation|0
1379157|NCT01426269|4551118|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
1379158|NCT01426269|4551119|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
1379159|NCT01426269|4551120|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
1379160|NCT01426269|4551118|P3|Period 2: 40 Weeks|Adverse Event|2
1379161|NCT01426269|4551119|P2|Period 2: 40 Weeks|Adverse Event|1
1379162|NCT01426269|4551120|P1|Period 2: 40 Weeks|Adverse Event|0
1379163|NCT01426269|4551118|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
1379164|NCT01426269|4551119|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
1379165|NCT01426269|4551120|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
1379166|NCT01426269|4551118|P3|Eligibility for Period 2, Randomization|Did not qualify|0
1379167|NCT01426269|4551119|P2|Eligibility for Period 2, Randomization|Did not qualify|0
1379168|NCT01426269|4551120|P1|Eligibility for Period 2, Randomization|Did not qualify|42
1379169|NCT01426269|4551118|P3|Period 1: 12 Weeks|Pregnancy|0
1379170|NCT01426269|4551119|P2|Period 1: 12 Weeks|Pregnancy|0
1379171|NCT01426269|4551120|P1|Period 1: 12 Weeks|Pregnancy|1
1379172|NCT01426269|4551118|P3|Period 1: 12 Weeks|Lost to Follow-up|0
1379173|NCT01426269|4551119|P2|Period 1: 12 Weeks|Lost to Follow-up|0
1379174|NCT01426269|4551120|P1|Period 1: 12 Weeks|Lost to Follow-up|22
1379175|NCT01426269|4551118|P3|Period 1: 12 Weeks|Protocol Violation|0
1379176|NCT01426269|4551119|P2|Period 1: 12 Weeks|Protocol Violation|0
1379177|NCT01426269|4551120|P1|Period 1: 12 Weeks|Protocol Violation|5
1379178|NCT01426269|4551118|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
1379179|NCT01426269|4551119|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
1379180|NCT01426269|4551120|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
1379181|NCT01426269|4551118|P3|Period 1: 12 Weeks|Adverse Event|0
1379182|NCT01426269|4551119|P2|Period 1: 12 Weeks|Adverse Event|0
1379183|NCT01426269|4551120|P1|Period 1: 12 Weeks|Adverse Event|5
1379184|NCT01426113|4551155|P2|Overall Study|Adverse Event|1
1379185|NCT01426113|4551156|P1|Overall Study|Adverse Event|0
1379186|NCT01426113|4551155|P2|Overall Study|Study Discontinued|1
1379187|NCT01426113|4551156|P1|Overall Study|Study Discontinued|1
1379188|NCT01426009|4551162|P1|Washout 4|Lost to Follow-up|1
1379189|NCT01426009|4551162|P1|Period 4-Fourth Intervention (7 Days)|personal reasons|1
1379190|NCT01426009|4551162|P1|Washout 3|personal reasons|1
1379191|NCT01426009|4551162|P1|Washout 2|electrive surgery|1
1379192|NCT01426009|4551162|P1|Period 2-Second Intervention (7 Days)|personal reasons|1
1379193|NCT01426009|4551162|P1|Period 2-Second Intervention (7 Days)|Adverse Event|4
1379194|NCT01426009|4551162|P1|Washout 1|Personal Reasons|1
1379195|NCT01426009|4551162|P1|Washout 1|Withdrawal by Subject|1
1379196|NCT01426009|4551162|P1|Period 1-First Intervention (7 Days)|Personal Reasons|1
1379197|NCT01426009|4551162|P1|Period 1-First Intervention (7 Days)|Adverse Event|1
1379198|NCT01425814|4551258|P6|Period 5|Stability criteria not fulfilled|1
1379199|NCT01425814|4551259|P5|Period 5|Stability criteria not fulfilled|0
1379200|NCT01425814|4551260|P4|Period 5|Stability criteria not fulfilled|0
1379201|NCT01425814|4551261|P3|Period 5|Stability criteria not fulfilled|1
1379202|NCT01425814|4551262|P2|Period 5|Stability criteria not fulfilled|0
1379203|NCT01425814|4551263|P1|Period 5|Stability criteria not fulfilled|0
1379204|NCT01425814|4551258|P6|Period 4|Adverse Event|0
1379205|NCT01425814|4551259|P5|Period 4|Adverse Event|0
1379206|NCT01425814|4551260|P4|Period 4|Adverse Event|0
1379207|NCT01425814|4551261|P3|Period 4|Adverse Event|1
1379208|NCT01425814|4551262|P2|Period 4|Adverse Event|0
1379209|NCT01425814|4551263|P1|Period 4|Adverse Event|1
1379210|NCT01425814|4551258|P6|Period 3|Adverse Event|1
1379211|NCT01425814|4551259|P5|Period 3|Adverse Event|0
1379212|NCT01425814|4551260|P4|Period 3|Adverse Event|0
1379213|NCT01425814|4551261|P3|Period 3|Adverse Event|0
1379214|NCT01425814|4551262|P2|Period 3|Adverse Event|0
1379215|NCT01425814|4551263|P1|Period 3|Adverse Event|0
1379216|NCT01425814|4551258|P6|Period 2|Stability criteria not fulfilled|0
1379217|NCT01425814|4551259|P5|Period 2|Stability criteria not fulfilled|0
1379218|NCT01425814|4551260|P4|Period 2|Stability criteria not fulfilled|0
1379219|NCT01425814|4551261|P3|Period 2|Stability criteria not fulfilled|0
1379220|NCT01425814|4551262|P2|Period 2|Stability criteria not fulfilled|1
1379221|NCT01425814|4551263|P1|Period 2|Stability criteria not fulfilled|0
1379222|NCT01425814|4551258|P6|Period 1|Stability criteria not fulfilled|0
1379223|NCT01425814|4551259|P5|Period 1|Stability criteria not fulfilled|0
1379224|NCT01425814|4551260|P4|Period 1|Stability criteria not fulfilled|0
1379225|NCT01425814|4551261|P3|Period 1|Stability criteria not fulfilled|0
1379226|NCT01425814|4551262|P2|Period 1|Stability criteria not fulfilled|1
1379227|NCT01425814|4551263|P1|Period 1|Stability criteria not fulfilled|0
1379228|NCT01425801|4551355|P6|Period 4|Not able to maintain visit schedule|0
1379229|NCT01425801|4551356|P5|Period 4|Not able to maintain visit schedule|0
1379230|NCT01425801|4551357|P4|Period 4|Not able to maintain visit schedule|0
1379231|NCT01425801|4551358|P3|Period 4|Not able to maintain visit schedule|1
1379232|NCT01425801|4551359|P2|Period 4|Not able to maintain visit schedule|0
1379233|NCT01425801|4551360|P1|Period 4|Not able to maintain visit schedule|0
1379234|NCT01425801|4551355|P6|Period 3|Stability criteria not fullfilled|0
1379235|NCT01425801|4551356|P5|Period 3|Stability criteria not fullfilled|0
1379236|NCT01425801|4551357|P4|Period 3|Stability criteria not fullfilled|0
1379237|NCT01425801|4551358|P3|Period 3|Stability criteria not fullfilled|1
1379238|NCT01425801|4551359|P2|Period 3|Stability criteria not fullfilled|0
1379239|NCT01425801|4551360|P1|Period 3|Stability criteria not fullfilled|0
1379240|NCT01425801|4551355|P6|Period 2|Withdrawal by Subject|0
1379241|NCT01425801|4551356|P5|Period 2|Withdrawal by Subject|1
1379242|NCT01425801|4551357|P4|Period 2|Withdrawal by Subject|0
1379243|NCT01425801|4551358|P3|Period 2|Withdrawal by Subject|0
1379244|NCT01425801|4551359|P2|Period 2|Withdrawal by Subject|0
1379245|NCT01425801|4551360|P1|Period 2|Withdrawal by Subject|0
1379246|NCT01425801|4551355|P6|Period 1|Withdrawal by Subject|0
1379247|NCT01425801|4551356|P5|Period 1|Withdrawal by Subject|1
1379248|NCT01425801|4551357|P4|Period 1|Withdrawal by Subject|0
1379249|NCT01425801|4551358|P3|Period 1|Withdrawal by Subject|0
1379250|NCT01425801|4551359|P2|Period 1|Withdrawal by Subject|0
1379251|NCT01425801|4551360|P1|Period 1|Withdrawal by Subject|0
1379252|NCT01425749|4551466|P2|Overall Study|progression of melanoma|1
1379253|NCT01425749|4551467|P1|Overall Study|progression of melanoma|0
1379254|NCT01425632|4551485|P3|Overall Study|Withdrawal by Subject|1
1379255|NCT01425632|4551486|P2|Overall Study|Withdrawal by Subject|0
1379256|NCT01425632|4551487|P1|Overall Study|Withdrawal by Subject|0
1379257|NCT01425632|4551485|P3|Overall Study|Protocol Violation|2
1379258|NCT01425632|4551486|P2|Overall Study|Protocol Violation|0
1379259|NCT01425632|4551487|P1|Overall Study|Protocol Violation|0
1379260|NCT01425632|4551485|P3|Overall Study|Physician Decision|0
1379261|NCT01425632|4551486|P2|Overall Study|Physician Decision|0
1379262|NCT01425632|4551487|P1|Overall Study|Physician Decision|1
1379263|NCT01425632|4551485|P3|Overall Study|Adverse Event|1
1379264|NCT01425632|4551486|P2|Overall Study|Adverse Event|1
1379265|NCT01425632|4551487|P1|Overall Study|Adverse Event|0
1379266|NCT01425528|4551497|P2|Overall Study|Withdrawal by Subject|1
1379267|NCT01425528|4551498|P1|Overall Study|Withdrawal by Subject|1
1379268|NCT01425463|4551506|P2|Overall Study|Unknown Reason|7
1379269|NCT01425463|4551507|P1|Overall Study|Unknown Reason|4
1379270|NCT01425463|4551506|P2|Overall Study|Withdrawal by Subject|5
1379271|NCT01425463|4551507|P1|Overall Study|Withdrawal by Subject|7
1379272|NCT01425463|4551506|P2|Overall Study|Lost to Follow-up|2
1379273|NCT01425463|4551507|P1|Overall Study|Lost to Follow-up|5
1379274|NCT01425463|4551506|P2|Overall Study|Protocol Violation|2
1379275|NCT01425463|4551507|P1|Overall Study|Protocol Violation|2
1379276|NCT01425463|4551506|P2|Overall Study|Lack of Efficacy|1
1379277|NCT01425463|4551507|P1|Overall Study|Lack of Efficacy|1
1379278|NCT01425463|4551506|P2|Overall Study|Adverse Event|7
1379279|NCT01425463|4551507|P1|Overall Study|Adverse Event|5
1379280|NCT01425359|4551523|P2|Overall Study|Did Not Meet Qualifying Criteria|5
1379281|NCT01425359|4551524|P1|Overall Study|Did Not Meet Qualifying Criteria|3
1379282|NCT01425359|4551523|P2|Overall Study|Investigator’s Discretion|0
1379283|NCT01425359|4551524|P1|Overall Study|Investigator’s Discretion|2
1379284|NCT01425359|4551523|P2|Overall Study|Subject Withdrew Consent|2
1379285|NCT01425359|4551524|P1|Overall Study|Subject Withdrew Consent|1
1379286|NCT01425359|4551523|P2|Overall Study|Protocol Violation|2
1379287|NCT01425359|4551524|P1|Overall Study|Protocol Violation|1
1379288|NCT01425359|4551523|P2|Overall Study|Unsatisfactory Response|0
1379289|NCT01425359|4551524|P1|Overall Study|Unsatisfactory Response|1
1379290|NCT01425359|4551523|P2|Overall Study|Death|1
1379291|NCT01425359|4551524|P1|Overall Study|Death|0
1379292|NCT01425359|4551523|P2|Overall Study|Revascularization|1
1379293|NCT01425359|4551524|P1|Overall Study|Revascularization|0
1379294|NCT01425359|4551523|P2|Overall Study|Adverse Event|8
1379295|NCT01425359|4551524|P1|Overall Study|Adverse Event|9
1379296|NCT01425359|4551523|P2|Overall Study|Randomized but Not Treated|3
1379297|NCT01425359|4551524|P1|Overall Study|Randomized but Not Treated|2
1379298|NCT01425268|4551555|P2|Overall Study|Physician Decision|0
1379299|NCT01425268|4551556|P1|Overall Study|Physician Decision|1
1379300|NCT01425268|4551555|P2|Overall Study|Sponsor Decision|0
1379301|NCT01425268|4551556|P1|Overall Study|Sponsor Decision|5
1379302|NCT01425268|4551555|P2|Overall Study|Withdrawal by Subject|0
1379303|NCT01425268|4551556|P1|Overall Study|Withdrawal by Subject|2
1379304|NCT01425203|4551577|P3|Crossover Phase|Other virologic failure criteria|3
1379305|NCT01425203|4551578|P2|Crossover Phase|Other virologic failure criteria|0
1379306|NCT01425203|4551579|P1|Crossover Phase|Other virologic failure criteria|0
1379307|NCT01425203|4551577|P3|Crossover Phase|Failure at futility timepoint|3
1379308|NCT01425203|4551578|P2|Crossover Phase|Failure at futility timepoint|0
1379309|NCT01425203|4551579|P1|Crossover Phase|Failure at futility timepoint|0
1379310|NCT01425203|4551577|P3|Treatment Phase|Did not receive treatment|0
1379311|NCT01425203|4551578|P2|Treatment Phase|Did not receive treatment|1
1379312|NCT01425203|4551579|P1|Treatment Phase|Did not receive treatment|0
1379313|NCT01425203|4551577|P3|Treatment Phase|Unidentified reasons|0
1379314|NCT01425203|4551578|P2|Treatment Phase|Unidentified reasons|5
1379315|NCT01425203|4551579|P1|Treatment Phase|Unidentified reasons|11
1379316|NCT01425203|4551577|P3|Treatment Phase|Other virologic failure criteria|0
1379317|NCT01425203|4551578|P2|Treatment Phase|Other virologic failure criteria|3
1379318|NCT01425203|4551579|P1|Treatment Phase|Other virologic failure criteria|5
1379319|NCT01425203|4551577|P3|Treatment Phase|Failure at futility timepoint|0
1379320|NCT01425203|4551578|P2|Treatment Phase|Failure at futility timepoint|27
1379321|NCT01425203|4551579|P1|Treatment Phase|Failure at futility timepoint|8
1379322|NCT01425203|4551577|P3|Treatment Phase|DC during PR Lead-in Phase|0
1379323|NCT01425203|4551578|P2|Treatment Phase|DC during PR Lead-in Phase|1
1379324|NCT01425203|4551579|P1|Treatment Phase|DC during PR Lead-in Phase|3
1379325|NCT01425190|4551596|P3|Overall Study|Full dose not consumed.|0
1379326|NCT01425190|4551597|P2|Overall Study|Full dose not consumed.|0
1379327|NCT01425190|4551598|P1|Overall Study|Full dose not consumed.|1
1379328|NCT01424930|4551634|P2|Overall Study|Reason not specified|6
1379329|NCT01424930|4551635|P1|Overall Study|Reason not specified|0
1379330|NCT01424930|4551634|P2|Overall Study|Screen Failure|1
1379331|NCT01424930|4551635|P1|Overall Study|Screen Failure|0
1379332|NCT01424930|4551634|P2|Overall Study|Progressive Disease|6
1379333|NCT01424930|4551635|P1|Overall Study|Progressive Disease|3
1379334|NCT01424930|4551634|P2|Overall Study|Death|0
1379335|NCT01424930|4551635|P1|Overall Study|Death|1
1379336|NCT01424930|4551634|P2|Overall Study|Adverse Event|1
1379337|NCT01424930|4551635|P1|Overall Study|Adverse Event|0
1379338|NCT01424813|4551649|P2|Overall Study|not specified|2
1379339|NCT01424813|4551650|P1|Overall Study|not specified|1
1379340|NCT01424813|4551649|P2|Overall Study|Protocol Violation|0
1379341|NCT01424813|4551650|P1|Overall Study|Protocol Violation|1
1379342|NCT01424813|4551649|P2|Overall Study|Withdrawal by Subject|0
1379343|NCT01424813|4551650|P1|Overall Study|Withdrawal by Subject|3
1379344|NCT01424644|4551670|P2|Overall Study|Unable to Classify|0
1379345|NCT01424644|4551671|P1|Overall Study|Unable to Classify|1
1379346|NCT01424644|4551670|P2|Overall Study|Administrative Reason|0
1379347|NCT01424644|4551671|P1|Overall Study|Administrative Reason|1
1379348|NCT01424644|4551670|P2|Overall Study|Protocol Violation|3
1379349|NCT01424644|4551671|P1|Overall Study|Protocol Violation|4
1379350|NCT01424644|4551670|P2|Overall Study|Lost to Follow-up|12
1379351|NCT01424644|4551671|P1|Overall Study|Lost to Follow-up|16
1379352|NCT01424644|4551670|P2|Overall Study|Withdrawal by Subject|12
1379353|NCT01424644|4551671|P1|Overall Study|Withdrawal by Subject|9
1379354|NCT01424644|4551670|P2|Overall Study|Adverse Event|0
1379355|NCT01424644|4551671|P1|Overall Study|Adverse Event|2
1379356|NCT01424566|4551685|P3|Double-blind Treatment|Lack of Efficacy|1
1379357|NCT01424566|4551686|P2|Double-blind Treatment|Lack of Efficacy|1
1379358|NCT01424566|4551687|P1|Double-blind Treatment|Lack of Efficacy|0
1379359|NCT01424566|4551685|P3|Double-blind Treatment|Withdrawal by Investigator|1
1379360|NCT01424566|4551686|P2|Double-blind Treatment|Withdrawal by Investigator|1
1379361|NCT01424566|4551687|P1|Double-blind Treatment|Withdrawal by Investigator|0
1379362|NCT01424566|4551685|P3|Double-blind Treatment|Withdrawal by Subject|0
1379363|NCT01424566|4551686|P2|Double-blind Treatment|Withdrawal by Subject|2
1379364|NCT01424566|4551687|P1|Double-blind Treatment|Withdrawal by Subject|0
1379365|NCT01424566|4551685|P3|Double-blind Treatment|Adverse Event|13
1379366|NCT01424566|4551686|P2|Double-blind Treatment|Adverse Event|21
1379367|NCT01424566|4551687|P1|Double-blind Treatment|Adverse Event|0
1379368|NCT01424566|4551685|P3|Single-blind Treatment|Did Not Administer Any Study Drug|0
1379369|NCT01424566|4551686|P2|Single-blind Treatment|Did Not Administer Any Study Drug|0
1379370|NCT01424566|4551687|P1|Single-blind Treatment|Did Not Administer Any Study Drug|2
1379371|NCT01424566|4551685|P3|Single-blind Treatment|Met Exclusion Criteria|0
1379372|NCT01424566|4551686|P2|Single-blind Treatment|Met Exclusion Criteria|0
1379373|NCT01424566|4551687|P1|Single-blind Treatment|Met Exclusion Criteria|1
1379374|NCT01424566|4551685|P3|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
1379375|NCT01424566|4551686|P2|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
1379376|NCT01424566|4551687|P1|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
1379377|NCT01424566|4551685|P3|Single-blind Treatment|Withdrawal by Investigator|0
1379378|NCT01424566|4551686|P2|Single-blind Treatment|Withdrawal by Investigator|0
1379379|NCT01424566|4551687|P1|Single-blind Treatment|Withdrawal by Investigator|2
1379380|NCT01424566|4551685|P3|Single-blind Treatment|Withdrawal by Subject|0
1379381|NCT01424566|4551686|P2|Single-blind Treatment|Withdrawal by Subject|0
1379382|NCT01424566|4551687|P1|Single-blind Treatment|Withdrawal by Subject|16
1379383|NCT01424566|4551685|P3|Single-blind Treatment|Adverse Event|0
1379384|NCT01424566|4551686|P2|Single-blind Treatment|Adverse Event|0
1379385|NCT01424566|4551687|P1|Single-blind Treatment|Adverse Event|71
1379386|NCT01424514|4551714|P2|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
1379387|NCT01424514|4551715|P1|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
1379388|NCT01424514|4551714|P2|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
1379389|NCT01424514|4551715|P1|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
1379390|NCT01424501|4551760|P6|Overall Study|Lost to Follow-up|0
1379391|NCT01424501|4551761|P5|Overall Study|Lost to Follow-up|0
1379392|NCT01424501|4551762|P4|Overall Study|Lost to Follow-up|0
1379393|NCT01424501|4551763|P3|Overall Study|Lost to Follow-up|1
1379394|NCT01424501|4551764|P2|Overall Study|Lost to Follow-up|1
1379395|NCT01424501|4551765|P1|Overall Study|Lost to Follow-up|0
1379396|NCT01424501|4551760|P6|Overall Study|Withdrawal by Subject|0
1379397|NCT01424501|4551761|P5|Overall Study|Withdrawal by Subject|0
1379398|NCT01424501|4551762|P4|Overall Study|Withdrawal by Subject|0
1379399|NCT01424501|4551763|P3|Overall Study|Withdrawal by Subject|1
1379400|NCT01424501|4551764|P2|Overall Study|Withdrawal by Subject|0
1379401|NCT01424501|4551765|P1|Overall Study|Withdrawal by Subject|1
1379402|NCT01424306|4551929|P6|Overall Study|Protocol Violation|0
1379403|NCT01424306|4551930|P5|Overall Study|Protocol Violation|1
1379404|NCT01424306|4551931|P4|Overall Study|Protocol Violation|0
1379405|NCT01424306|4551932|P3|Overall Study|Protocol Violation|0
1379406|NCT01424306|4551933|P2|Overall Study|Protocol Violation|0
1379407|NCT01424306|4551934|P1|Overall Study|Protocol Violation|0
1379408|NCT01424228|4551983|P2|Overall Study|Unplanned journey|1
1379409|NCT01424228|4551984|P1|Overall Study|Unplanned journey|0
1379410|NCT01424228|4551983|P2|Overall Study|Worsening of symptoms|0
1379411|NCT01424228|4551984|P1|Overall Study|Worsening of symptoms|1
1379412|NCT01424228|4551983|P2|Overall Study|Non-compliance|0
1379413|NCT01424228|4551984|P1|Overall Study|Non-compliance|2
1379414|NCT01424228|4551983|P2|Overall Study|inclusion/exclusion criteria not met|2
1379415|NCT01424228|4551984|P1|Overall Study|inclusion/exclusion criteria not met|2
1379416|NCT01424228|4551983|P2|Overall Study|Lack of Efficacy|7
1379417|NCT01424228|4551984|P1|Overall Study|Lack of Efficacy|5
1379418|NCT01424228|4551983|P2|Overall Study|Sponsor's decision|12
1379419|NCT01424228|4551984|P1|Overall Study|Sponsor's decision|9
1379420|NCT01424228|4551983|P2|Overall Study|Adverse Event|14
1379421|NCT01424228|4551984|P1|Overall Study|Adverse Event|10
1379422|NCT01424228|4551983|P2|Overall Study|Withdrawal by Subject|11
1379423|NCT01424228|4551984|P1|Overall Study|Withdrawal by Subject|27
1379424|NCT01424189|4552024|P2|Overall Study|Death|1
1379425|NCT01424189|4552025|P1|Overall Study|Death|3
1379426|NCT01424189|4552024|P2|Overall Study|Subject moved|0
1379427|NCT01424189|4552025|P1|Overall Study|Subject moved|1
1379428|NCT01424189|4552024|P2|Overall Study|Withdrawal by Subject|4
1379429|NCT01424189|4552025|P1|Overall Study|Withdrawal by Subject|4
1379430|NCT01424189|4552024|P2|Overall Study|Lost to Follow-up|1
1379431|NCT01424189|4552025|P1|Overall Study|Lost to Follow-up|4
1379432|NCT01424189|4552024|P2|Overall Study|Adverse Event|0
1379433|NCT01424189|4552025|P1|Overall Study|Adverse Event|1
1379434|NCT01423916|4552066|P3|Overall Study|Protocol Deviation|0
1379435|NCT01423916|4552067|P2|Overall Study|Protocol Deviation|0
1379436|NCT01423916|4552068|P1|Overall Study|Protocol Deviation|1
1379437|NCT01423916|4552066|P3|Overall Study|Withdrawal by Subject|3
1379438|NCT01423916|4552067|P2|Overall Study|Withdrawal by Subject|10
1379439|NCT01423916|4552068|P1|Overall Study|Withdrawal by Subject|3
1379440|NCT01423916|4552066|P3|Overall Study|Physician Decision|1
1379441|NCT01423916|4552067|P2|Overall Study|Physician Decision|0
1379442|NCT01423916|4552068|P1|Overall Study|Physician Decision|1
1379443|NCT01423916|4552066|P3|Overall Study|Met Withdrawal Criteria|1
1379444|NCT01423916|4552067|P2|Overall Study|Met Withdrawal Criteria|1
1379445|NCT01423916|4552068|P1|Overall Study|Met Withdrawal Criteria|1
1379446|NCT01423916|4552066|P3|Overall Study|Adverse Event|2
1379447|NCT01423916|4552067|P2|Overall Study|Adverse Event|9
1379448|NCT01423916|4552068|P1|Overall Study|Adverse Event|5
1379449|NCT01423812|4552124|P2|Overall Study|Withdrawal by Subject|2
1379450|NCT01423812|4552125|P1|Overall Study|Withdrawal by Subject|1
1379451|NCT01423812|4552124|P2|Overall Study|Lost to Follow-up|2
1379452|NCT01423812|4552125|P1|Overall Study|Lost to Follow-up|2
1379453|NCT01423617|4552153|P2|Overall Study|Lost to Follow-up|1
1379454|NCT01423617|4552154|P1|Overall Study|Lost to Follow-up|0
1379455|NCT01423604|4552171|P2|Randomized|Patient decision|9
1379456|NCT01423604|4552172|P1|Randomized|Patient decision|5
1379457|NCT01423604|4552171|P2|Randomized|Other - unspecified|31
1379458|NCT01423604|4552172|P1|Randomized|Other - unspecified|37
1379459|NCT01423604|4552171|P2|Randomized|Physician Decision|13
1379460|NCT01423604|4552172|P1|Randomized|Physician Decision|16
1379461|NCT01423604|4552171|P2|Randomized|Death|0
1379462|NCT01423604|4552172|P1|Randomized|Death|1
1379463|NCT01423604|4552171|P2|Randomized|Adverse Event|10
1379464|NCT01423604|4552172|P1|Randomized|Adverse Event|4
1379465|NCT01423604|4552171|P2|Safety Run-In|Patient decision|0
1379466|NCT01423604|4552172|P1|Safety Run-In|Patient decision|1
1379467|NCT01423604|4552171|P2|Safety Run-In|Disease progression|0
1379468|NCT01423604|4552172|P1|Safety Run-In|Disease progression|3
1379469|NCT01423604|4552171|P2|Safety Run-In|Physician Decision|0
1379470|NCT01423604|4552172|P1|Safety Run-In|Physician Decision|1
1379471|NCT01423604|4552171|P2|Safety Run-In|Death|0
1379472|NCT01423604|4552172|P1|Safety Run-In|Death|1
1379473|NCT01423604|4552171|P2|Safety Run-In|Adverse Event|0
1379474|NCT01423604|4552172|P1|Safety Run-In|Adverse Event|3
1379475|NCT01423253|4552187|P1|Overall Study|Withdrawal by Subject|2
1379476|NCT01423253|4552187|P1|Overall Study|Protocol Violation|2
1379477|NCT01423253|4552187|P1|Overall Study|Lost to Follow-up|1
1379478|NCT01423253|4552187|P1|Overall Study|Lack of Efficacy|2
1379479|NCT01423253|4552187|P1|Overall Study|Adverse Event|2
1379480|NCT01423084|4552209|P2|Overall Study|Withdrawal by Subject|3
1379481|NCT01423084|4552210|P1|Overall Study|Withdrawal by Subject|2
1379482|NCT01423084|4552209|P2|Overall Study|Adverse Event|1
1379483|NCT01423084|4552210|P1|Overall Study|Adverse Event|0
1379484|NCT01422915|4552240|P1|Overall Study|Adverse Event|1
1379485|NCT01422889|4552245|P1|Overall Study|No Data Entered for Study Stent|9
1379486|NCT01422876|4552260|P10|Week 52|Death|0
1379487|NCT01422876|4552261|P9|Week 52|Death|1
1379488|NCT01422876|4552262|P8|Week 52|Death|3
1379489|NCT01422876|4552263|P7|Week 52|Death|1
1379490|NCT01422876|4552264|P6|Week 52|Death|0
1379491|NCT01422876|4552265|P5|Week 52|Death|0
1379492|NCT01422876|4552266|P4|Week 52|Death|1
1379493|NCT01422876|4552267|P3|Week 52|Death|0
1379494|NCT01422876|4552268|P2|Week 52|Death|1
1379495|NCT01422876|4552269|P1|Week 52|Death|0
1379496|NCT01422876|4552260|P10|Week 52|Consent withdrawn|9
1379497|NCT01422876|4552261|P9|Week 52|Consent withdrawn|13
1379498|NCT01422876|4552262|P8|Week 52|Consent withdrawn|12
1379499|NCT01422876|4552263|P7|Week 52|Consent withdrawn|10
1379500|NCT01422876|4552264|P6|Week 52|Consent withdrawn|12
1379501|NCT01422876|4552265|P5|Week 52|Consent withdrawn|7
1379502|NCT01422876|4552266|P4|Week 52|Consent withdrawn|12
1379503|NCT01422876|4552267|P3|Week 52|Consent withdrawn|6
1379504|NCT01422876|4552268|P2|Week 52|Consent withdrawn|4
1379505|NCT01422876|4552269|P1|Week 52|Consent withdrawn|9
1379506|NCT01422876|4552260|P10|Week 52|Lost to Follow-up|8
1379507|NCT01422876|4552261|P9|Week 52|Lost to Follow-up|7
1379508|NCT01422876|4552262|P8|Week 52|Lost to Follow-up|8
1379509|NCT01422876|4552263|P7|Week 52|Lost to Follow-up|5
1379510|NCT01422876|4552264|P6|Week 52|Lost to Follow-up|5
1379511|NCT01422876|4552265|P5|Week 52|Lost to Follow-up|8
1379512|NCT01422876|4552266|P4|Week 52|Lost to Follow-up|5
1379513|NCT01422876|4552267|P3|Week 52|Lost to Follow-up|7
1379514|NCT01422876|4552268|P2|Week 52|Lost to Follow-up|5
1379515|NCT01422876|4552269|P1|Week 52|Lost to Follow-up|3
1379516|NCT01422876|4552260|P10|Week 24|Death|0
1379517|NCT01422876|4552261|P9|Week 24|Death|0
1379518|NCT01422876|4552262|P8|Week 24|Death|0
1379519|NCT01422876|4552263|P7|Week 24|Death|0
1379520|NCT01422876|4552264|P6|Week 24|Death|0
1379521|NCT01422876|4552265|P5|Week 24|Death|0
1379522|NCT01422876|4552266|P4|Week 24|Death|0
1379523|NCT01422876|4552267|P3|Week 24|Death|0
1379524|NCT01422876|4552268|P2|Week 24|Death|1
1379525|NCT01422876|4552269|P1|Week 24|Death|0
1379526|NCT01422876|4552260|P10|Week 24|Consent withdrawn|6
1379527|NCT01422876|4552261|P9|Week 24|Consent withdrawn|3
1379528|NCT01422876|4552262|P8|Week 24|Consent withdrawn|4
1379529|NCT01422876|4552263|P7|Week 24|Consent withdrawn|5
1379530|NCT01422876|4552264|P6|Week 24|Consent withdrawn|6
1379531|NCT01422876|4552265|P5|Week 24|Consent withdrawn|5
1379532|NCT01422876|4552266|P4|Week 24|Consent withdrawn|4
1379533|NCT01422876|4552267|P3|Week 24|Consent withdrawn|3
1379534|NCT01422876|4552268|P2|Week 24|Consent withdrawn|1
1379535|NCT01422876|4552269|P1|Week 24|Consent withdrawn|5
1379536|NCT01422876|4552260|P10|Week 24|Lost to Follow-up|4
1379537|NCT01422876|4552261|P9|Week 24|Lost to Follow-up|3
1379538|NCT01422876|4552262|P8|Week 24|Lost to Follow-up|3
1379539|NCT01422876|4552263|P7|Week 24|Lost to Follow-up|1
1379540|NCT01422876|4552264|P6|Week 24|Lost to Follow-up|0
1379541|NCT01422876|4552265|P5|Week 24|Lost to Follow-up|2
1379542|NCT01422876|4552266|P4|Week 24|Lost to Follow-up|4
1379543|NCT01422876|4552267|P3|Week 24|Lost to Follow-up|2
1379544|NCT01422876|4552268|P2|Week 24|Lost to Follow-up|1
1379545|NCT01422876|4552269|P1|Week 24|Lost to Follow-up|1
1379546|NCT01422850|4552316|P1|Overall Study|Physician Decision|3
1379547|NCT01422824|4552322|P1|Overall Study|Lost to Follow-up|37
1379548|NCT01422824|4552322|P1|Overall Study|Case record form not evaluated|1
1379549|NCT01422720|4552327|P1|Overall Study|Ineligibility|1
1379550|NCT01422720|4552327|P1|Overall Study|Withdrawal by Subject|4
1379551|NCT01422720|4552327|P1|Overall Study|Lack of Efficacy|1
1379552|NCT01422720|4552327|P1|Overall Study|Adverse Event|16
1379553|NCT01422538|4552338|P3|Overall Study|Missed visit|1
1379554|NCT01422538|4552339|P2|Overall Study|Missed visit|1
1379555|NCT01422538|4552340|P1|Overall Study|Missed visit|0
1379556|NCT01422538|4552338|P3|Overall Study|Lost to Follow-up|1
1379557|NCT01422538|4552339|P2|Overall Study|Lost to Follow-up|1
1379558|NCT01422538|4552340|P1|Overall Study|Lost to Follow-up|0
1379559|NCT01422408|4552384|P1|Overall Study|Withdrawal by Subject|3
1379560|NCT01422408|4552384|P1|Overall Study|Adverse Event|1
1379561|NCT01422382|4552413|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
1379562|NCT01422304|4552429|P2|Overall Study|Not Treated|11
1379563|NCT01422304|4552430|P1|Overall Study|Not Treated|3
1379564|NCT01422304|4552429|P2|Overall Study|Did Not Meet Protocol Eligibility|2
1379565|NCT01422304|4552430|P1|Overall Study|Did Not Meet Protocol Eligibility|0
1379566|NCT01422304|4552429|P2|Overall Study|Withdrawal by Subject|2
1379567|NCT01422304|4552430|P1|Overall Study|Withdrawal by Subject|4
1379568|NCT01422304|4552429|P2|Overall Study|Protocol Violation|0
1379569|NCT01422304|4552430|P1|Overall Study|Protocol Violation|1
1379570|NCT01422304|4552429|P2|Overall Study|Never Entered Follow-up|1
1379571|NCT01422304|4552430|P1|Overall Study|Never Entered Follow-up|2
1379572|NCT01422304|4552429|P2|Overall Study|Lost to Follow-up|20
1379573|NCT01422304|4552430|P1|Overall Study|Lost to Follow-up|14
1379574|NCT01422304|4552429|P2|Overall Study|Adverse Event|1
1379575|NCT01422304|4552430|P1|Overall Study|Adverse Event|0
1379576|NCT01422239|4552462|P2|Overall Study|Lost to Follow-up|3
1379577|NCT01422239|4552463|P1|Overall Study|Lost to Follow-up|4
1379578|NCT01422213|4552485|P3|Overall Study|Administrative or Other Reason(s)|2
1379579|NCT01422213|4552486|P2|Overall Study|Administrative or Other Reason(s)|4
1379580|NCT01422213|4552487|P1|Overall Study|Administrative or Other Reason(s)|5
1379581|NCT01422213|4552485|P3|Overall Study|Lost to Follow-up|5
1379582|NCT01422213|4552486|P2|Overall Study|Lost to Follow-up|3
1379583|NCT01422213|4552487|P1|Overall Study|Lost to Follow-up|3
1379584|NCT01422213|4552485|P3|Overall Study|Withdrawal of Consent|5
1379585|NCT01422213|4552486|P2|Overall Study|Withdrawal of Consent|3
1379586|NCT01422213|4552487|P1|Overall Study|Withdrawal of Consent|7
1379587|NCT01422213|4552485|P3|Overall Study|Protocol Violation|4
1379588|NCT01422213|4552486|P2|Overall Study|Protocol Violation|2
1379589|NCT01422213|4552487|P1|Overall Study|Protocol Violation|0
1379590|NCT01422213|4552485|P3|Overall Study|Non-compliance with study drug|0
1379591|NCT01422213|4552486|P2|Overall Study|Non-compliance with study drug|1
1379592|NCT01422213|4552487|P1|Overall Study|Non-compliance with study drug|0
1379593|NCT01422213|4552485|P3|Overall Study|Lack of Efficacy|2
1379594|NCT01422213|4552486|P2|Overall Study|Lack of Efficacy|2
1379595|NCT01422213|4552487|P1|Overall Study|Lack of Efficacy|10
1379596|NCT01422213|4552485|P3|Overall Study|Adverse Event|11
1379597|NCT01422213|4552486|P2|Overall Study|Adverse Event|7
1379598|NCT01422213|4552487|P1|Overall Study|Adverse Event|8
1379599|NCT01422187|4552548|P3|Overall Study|Lost to Follow-up|0
1379600|NCT01422187|4552549|P2|Overall Study|Lost to Follow-up|1
1379601|NCT01422187|4552550|P1|Overall Study|Lost to Follow-up|0
1379602|NCT01422187|4552548|P3|Overall Study|Personal reason|0
1379603|NCT01422187|4552549|P2|Overall Study|Personal reason|0
1379604|NCT01422187|4552550|P1|Overall Study|Personal reason|1
1379605|NCT01421719|4552581|P1|Overall Study|Withdrawal by Subject|4
1379606|NCT01421667|4552590|P4|Overall Study|Lost to Follow-up|0
1379607|NCT01421667|4552591|P3|Overall Study|Lost to Follow-up|0
1379608|NCT01421667|4552592|P2|Overall Study|Lost to Follow-up|1
1379609|NCT01421667|4552593|P1|Overall Study|Lost to Follow-up|0
1379610|NCT01421667|4552590|P4|Overall Study|Withdrawal by Subject|1
1379611|NCT01421667|4552591|P3|Overall Study|Withdrawal by Subject|2
1379612|NCT01421667|4552592|P2|Overall Study|Withdrawal by Subject|1
1379613|NCT01421667|4552593|P1|Overall Study|Withdrawal by Subject|0
1379614|NCT01421641|4552654|P2|Overall Study|Protocol Violation|2
1379615|NCT01421641|4552655|P1|Overall Study|Protocol Violation|2
1379616|NCT01421511|4552677|P2|Overall Study|Death|1
1379617|NCT01421511|4552678|P1|Overall Study|Death|1
1379618|NCT01421511|4552677|P2|Overall Study|Withdrawal by Subject|5
1379619|NCT01421511|4552678|P1|Overall Study|Withdrawal by Subject|6
1379620|NCT01421511|4552677|P2|Overall Study|Physician Decision|1
1379621|NCT01421511|4552678|P1|Overall Study|Physician Decision|0
1379622|NCT01421511|4552677|P2|Overall Study|Randomized but didn't receive study drug|7
1379623|NCT01421511|4552678|P1|Overall Study|Randomized but didn't receive study drug|1
1379624|NCT01421511|4552677|P2|Overall Study|Lost to Follow-up|14
1379625|NCT01421511|4552678|P1|Overall Study|Lost to Follow-up|11
1379626|NCT01421459|4552728|P2|Overall Study|Withdrawal by Subject|16
1379627|NCT01421459|4552729|P1|Overall Study|Withdrawal by Subject|12
1379628|NCT01421459|4552728|P2|Overall Study|Protocol Violation|5
1379629|NCT01421459|4552729|P1|Overall Study|Protocol Violation|8
1379630|NCT01421459|4552728|P2|Overall Study|Physician Decision|9
1379631|NCT01421459|4552729|P1|Overall Study|Physician Decision|9
1379632|NCT01421459|4552728|P2|Overall Study|Lost to Follow-up|9
1379633|NCT01421459|4552729|P1|Overall Study|Lost to Follow-up|8
1379634|NCT01421459|4552728|P2|Overall Study|Lack of Efficacy|2
1379635|NCT01421459|4552729|P1|Overall Study|Lack of Efficacy|1
1379636|NCT01421459|4552728|P2|Overall Study|Death|1
1379637|NCT01421459|4552729|P1|Overall Study|Death|1
1379638|NCT01421459|4552728|P2|Overall Study|Adverse Event|10
1379639|NCT01421459|4552729|P1|Overall Study|Adverse Event|6
1379640|NCT01421342|4552770|P3|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
1379641|NCT01421342|4552771|P2|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
1379642|NCT01421342|4552772|P1|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
1379643|NCT01421342|4552770|P3|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
1379644|NCT01421342|4552771|P2|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
1379645|NCT01421342|4552772|P1|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
1379646|NCT01421342|4552770|P3|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
1379647|NCT01421342|4552771|P2|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
1379648|NCT01421342|4552772|P1|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
1379649|NCT01421342|4552770|P3|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
1379650|NCT01421342|4552771|P2|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
1379651|NCT01421342|4552772|P1|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
1379652|NCT01421342|4552770|P3|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
1379653|NCT01421342|4552771|P2|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
1379654|NCT01421342|4552772|P1|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
1379655|NCT01421342|4552770|P3|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
1379656|NCT01421342|4552771|P2|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
1379657|NCT01421342|4552772|P1|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
1379658|NCT01421342|4552770|P3|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
1379659|NCT01421342|4552771|P2|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
1379660|NCT01421342|4552772|P1|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
1379661|NCT01421342|4552770|P3|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
1379662|NCT01421342|4552771|P2|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
1379663|NCT01421342|4552772|P1|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
1379664|NCT01421342|4552770|P3|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
1379665|NCT01421342|4552771|P2|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
1379666|NCT01421342|4552772|P1|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
1379667|NCT01421342|4552770|P3|Completed to Week 12 But Then Withdrawn|End of Study Time|2
1379668|NCT01421342|4552771|P2|Completed to Week 12 But Then Withdrawn|End of Study Time|0
1379669|NCT01421342|4552772|P1|Completed to Week 12 But Then Withdrawn|End of Study Time|0
1379670|NCT01421342|4552770|P3|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
1379671|NCT01421342|4552771|P2|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
1379672|NCT01421342|4552772|P1|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
1379673|NCT01421342|4552770|P3|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
1379674|NCT01421342|4552771|P2|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
1379675|NCT01421342|4552772|P1|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
1379676|NCT01421342|4552770|P3|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
1379677|NCT01421342|4552771|P2|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
1379678|NCT01421342|4552772|P1|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
1379679|NCT01421342|4552770|P3|Completed to Week 12 But Then Withdrawn|Non-adherence|5
1379680|NCT01421342|4552771|P2|Completed to Week 12 But Then Withdrawn|Non-adherence|4
1379681|NCT01421342|4552772|P1|Completed to Week 12 But Then Withdrawn|Non-adherence|5
1379682|NCT01421342|4552770|P3|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
1379683|NCT01421342|4552771|P2|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
1379684|NCT01421342|4552772|P1|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
1379685|NCT01421342|4552770|P3|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
1379686|NCT01421342|4552771|P2|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
1379687|NCT01421342|4552772|P1|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
1379688|NCT01421342|4552770|P3|Completed to Week 12 But Then Withdrawn|Adverse Event|6
1379689|NCT01421342|4552771|P2|Completed to Week 12 But Then Withdrawn|Adverse Event|3
1379690|NCT01421342|4552772|P1|Completed to Week 12 But Then Withdrawn|Adverse Event|4
1379691|NCT01421342|4552770|P3|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
1379692|NCT01421342|4552771|P2|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
1379693|NCT01421342|4552772|P1|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
1379694|NCT01421342|4552770|P3|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
1379695|NCT01421342|4552771|P2|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
1379696|NCT01421342|4552772|P1|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
1379697|NCT01421342|4552770|P3|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
1379698|NCT01421342|4552771|P2|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
1379699|NCT01421342|4552772|P1|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
1379700|NCT01421342|4552770|P3|Acute Treatment Phase (12 Weeks)|Participant moved away|1
1379701|NCT01421342|4552771|P2|Acute Treatment Phase (12 Weeks)|Participant moved away|6
1379702|NCT01421342|4552772|P1|Acute Treatment Phase (12 Weeks)|Participant moved away|1
1379703|NCT01421342|4552770|P3|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
1379704|NCT01421342|4552771|P2|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
1379705|NCT01421342|4552772|P1|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
1379706|NCT01421342|4552770|P3|Acute Treatment Phase (12 Weeks)|Non-adherence|13
1379707|NCT01421342|4552771|P2|Acute Treatment Phase (12 Weeks)|Non-adherence|7
1379708|NCT01421342|4552772|P1|Acute Treatment Phase (12 Weeks)|Non-adherence|15
1379709|NCT01421342|4552770|P3|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
1379710|NCT01421342|4552771|P2|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
1379711|NCT01421342|4552772|P1|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
1379712|NCT01421342|4552770|P3|Acute Treatment Phase (12 Weeks)|Death|3
1379713|NCT01421342|4552771|P2|Acute Treatment Phase (12 Weeks)|Death|0
1379714|NCT01421342|4552772|P1|Acute Treatment Phase (12 Weeks)|Death|0
1379715|NCT01421342|4552770|P3|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
1379716|NCT01421342|4552771|P2|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
1379717|NCT01421342|4552772|P1|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
1379718|NCT01421342|4552770|P3|Acute Treatment Phase (12 Weeks)|Adverse Event|27
1379719|NCT01421342|4552771|P2|Acute Treatment Phase (12 Weeks)|Adverse Event|38
1379720|NCT01421342|4552772|P1|Acute Treatment Phase (12 Weeks)|Adverse Event|53
1379721|NCT01421342|4552770|P3|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
1379722|NCT01421342|4552771|P2|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
1379723|NCT01421342|4552772|P1|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
1379724|NCT01421303|4552789|P1|Overall Study|Withdrawal by Subject|1
1379725|NCT01421303|4552789|P1|Overall Study|Other|7
1379726|NCT01421303|4552789|P1|Overall Study|Non compliance with study procedure|1
1379727|NCT01421303|4552789|P1|Overall Study|Lost to Follow-up|13
1379728|NCT01421277|4552816|P2|Overall Study|Incomplete baseline data|31
1379729|NCT01421277|4552817|P1|Overall Study|Incomplete baseline data|0
1379730|NCT01421277|4552816|P2|Overall Study|Lack of qualifying event|61
1379731|NCT01421277|4552817|P1|Overall Study|Lack of qualifying event|0
1379732|NCT01421225|4552829|P2|Overall Study|Withdrawal by Subject|1
1379733|NCT01421225|4552830|P1|Overall Study|Withdrawal by Subject|0
1379734|NCT01421147|4552844|P2|Extension Period|Withdrawal by Subject|3
1379735|NCT01421147|4552845|P1|Extension Period|Withdrawal by Subject|5
1379736|NCT01421147|4552844|P2|Extension Period|Physician Decision|0
1379737|NCT01421147|4552845|P1|Extension Period|Physician Decision|1
1379738|NCT01421147|4552844|P2|Extension Period|Lost to Follow-up|5
1379739|NCT01421147|4552845|P1|Extension Period|Lost to Follow-up|2
1379740|NCT01421147|4552844|P2|Extension Period|Death|1
1379741|NCT01421147|4552845|P1|Extension Period|Death|0
1379742|NCT01421147|4552844|P2|Extension Period|Adverse Event|2
1379743|NCT01421147|4552845|P1|Extension Period|Adverse Event|0
1379744|NCT01421147|4552844|P2|Treatment Period|Withdrawal by Subject|5
1379745|NCT01421147|4552845|P1|Treatment Period|Withdrawal by Subject|10
1379746|NCT01421147|4552844|P2|Treatment Period|Physician Decision|2
1379747|NCT01421147|4552845|P1|Treatment Period|Physician Decision|2
1379748|NCT01421147|4552844|P2|Treatment Period|Lost to Follow-up|1
1379749|NCT01421147|4552845|P1|Treatment Period|Lost to Follow-up|2
1379750|NCT01421147|4552844|P2|Treatment Period|Adverse Event|3
1379751|NCT01421147|4552845|P1|Treatment Period|Adverse Event|2
1379752|NCT01421134|4552877|P2|Overall Study|Lost to Follow-up|1
1379753|NCT01421134|4552878|P1|Overall Study|Lost to Follow-up|1
1379754|NCT01421134|4552877|P2|Overall Study|Administrative|1
1379755|NCT01421134|4552878|P1|Overall Study|Administrative|0
1379756|NCT01421134|4552877|P2|Overall Study|Withdrawal by Subject|1
1379757|NCT01421134|4552878|P1|Overall Study|Withdrawal by Subject|1
1379758|NCT01421134|4552877|P2|Overall Study|Protocol Violation|3
1379759|NCT01421134|4552878|P1|Overall Study|Protocol Violation|0
1379760|NCT01421134|4552877|P2|Overall Study|Lack of Efficacy|4
1379761|NCT01421134|4552878|P1|Overall Study|Lack of Efficacy|2
1379762|NCT01421134|4552877|P2|Overall Study|Adverse Event|5
1379763|NCT01421134|4552878|P1|Overall Study|Adverse Event|3
1379764|NCT01420926|4552898|P2|Overall Study|Continues on active treatment|3
1379765|NCT01420926|4552899|P1|Overall Study|Continues on active treatment|1
1379766|NCT01420926|4552898|P2|Overall Study|Physician Decision|5
1379767|NCT01420926|4552899|P1|Overall Study|Physician Decision|7
1379768|NCT01420926|4552898|P2|Overall Study|Non-protocol treatment|20
1379769|NCT01420926|4552899|P1|Overall Study|Non-protocol treatment|17
1379770|NCT01420926|4552898|P2|Overall Study|Withdrawal by Subject|16
1379771|NCT01420926|4552899|P1|Overall Study|Withdrawal by Subject|11
1379772|NCT01420926|4552898|P2|Overall Study|Death|17
1379773|NCT01420926|4552899|P1|Overall Study|Death|18
1379774|NCT01420926|4552898|P2|Overall Study|Adverse Event|4
1379775|NCT01420926|4552899|P1|Overall Study|Adverse Event|6
1379776|NCT01420081|4552957|P9|Overall Study|Other Reasons|0
1379777|NCT01420081|4552958|P8|Overall Study|Other Reasons|0
1379778|NCT01420081|4552959|P7|Overall Study|Other Reasons|0
1379779|NCT01420081|4552960|P6|Overall Study|Other Reasons|0
1379780|NCT01420081|4552961|P5|Overall Study|Other Reasons|0
1379781|NCT01420081|4552962|P4|Overall Study|Other Reasons|0
1379782|NCT01420081|4552963|P3|Overall Study|Other Reasons|1
1379783|NCT01420081|4552964|P2|Overall Study|Other Reasons|0
1379784|NCT01420081|4552965|P1|Overall Study|Other Reasons|0
1379785|NCT01420081|4552957|P9|Overall Study|Subject Refused Futher Follow-up|0
1379786|NCT01420081|4552958|P8|Overall Study|Subject Refused Futher Follow-up|0
1379787|NCT01420081|4552959|P7|Overall Study|Subject Refused Futher Follow-up|0
1379788|NCT01420081|4552960|P6|Overall Study|Subject Refused Futher Follow-up|0
1379789|NCT01420081|4552961|P5|Overall Study|Subject Refused Futher Follow-up|1
1379790|NCT01420081|4552962|P4|Overall Study|Subject Refused Futher Follow-up|0
1379791|NCT01420081|4552963|P3|Overall Study|Subject Refused Futher Follow-up|1
1379792|NCT01420081|4552964|P2|Overall Study|Subject Refused Futher Follow-up|0
1379793|NCT01420081|4552965|P1|Overall Study|Subject Refused Futher Follow-up|0
1379794|NCT01420081|4552957|P9|Overall Study|Study Terminated by Sponsor|2
1379795|NCT01420081|4552958|P8|Overall Study|Study Terminated by Sponsor|2
1379796|NCT01420081|4552959|P7|Overall Study|Study Terminated by Sponsor|3
1379797|NCT01420081|4552960|P6|Overall Study|Study Terminated by Sponsor|7
1379798|NCT01420081|4552961|P5|Overall Study|Study Terminated by Sponsor|11
1379799|NCT01420081|4552962|P4|Overall Study|Study Terminated by Sponsor|3
1379800|NCT01420081|4552963|P3|Overall Study|Study Terminated by Sponsor|1
1379801|NCT01420081|4552964|P2|Overall Study|Study Terminated by Sponsor|1
1379802|NCT01420081|4552965|P1|Overall Study|Study Terminated by Sponsor|2
1379803|NCT01420081|4552957|P9|Overall Study|Lost to Follow-up|0
1379804|NCT01420081|4552958|P8|Overall Study|Lost to Follow-up|0
1379805|NCT01420081|4552959|P7|Overall Study|Lost to Follow-up|0
1379806|NCT01420081|4552960|P6|Overall Study|Lost to Follow-up|1
1379807|NCT01420081|4552961|P5|Overall Study|Lost to Follow-up|1
1379808|NCT01420081|4552962|P4|Overall Study|Lost to Follow-up|0
1379809|NCT01420081|4552963|P3|Overall Study|Lost to Follow-up|0
1379810|NCT01420081|4552964|P2|Overall Study|Lost to Follow-up|0
1379811|NCT01420081|4552965|P1|Overall Study|Lost to Follow-up|0
1379812|NCT01420081|4552957|P9|Overall Study|Death|1
1379813|NCT01420081|4552958|P8|Overall Study|Death|1
1379814|NCT01420081|4552959|P7|Overall Study|Death|0
1379815|NCT01420081|4552960|P6|Overall Study|Death|12
1379816|NCT01420081|4552961|P5|Overall Study|Death|7
1379817|NCT01420081|4552962|P4|Overall Study|Death|0
1379818|NCT01420081|4552963|P3|Overall Study|Death|8
1379819|NCT01420081|4552964|P2|Overall Study|Death|0
1379820|NCT01420081|4552965|P1|Overall Study|Death|1
1379821|NCT01419769|4553084|P1|Overall Study|Not evaluable due to pigtail stents|1
1379822|NCT01419769|4553084|P1|Overall Study|Did not receive the AXIOS stent|3
1379823|NCT01419314|4553105|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
1379824|NCT01419314|4553106|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
1379825|NCT01419314|4553105|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
1379826|NCT01419314|4553106|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
1379827|NCT01419314|4553105|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
1379828|NCT01419314|4553106|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
1379829|NCT01419236|4553147|P2|Overall Study|Entry Criteria Not Met|0
1379830|NCT01419236|4553148|P1|Overall Study|Entry Criteria Not Met|1
1379831|NCT01419236|4553147|P2|Overall Study|Withdrawal by Subject|4
1379832|NCT01419236|4553148|P1|Overall Study|Withdrawal by Subject|1
1379833|NCT01419236|4553147|P2|Overall Study|Physician Decision|0
1379834|NCT01419236|4553148|P1|Overall Study|Physician Decision|1
1379835|NCT01419236|4553147|P2|Overall Study|Lost to Follow-up|0
1379836|NCT01419236|4553148|P1|Overall Study|Lost to Follow-up|1
1379837|NCT01419236|4553147|P2|Overall Study|Lack of Efficacy|1
1379838|NCT01419236|4553148|P1|Overall Study|Lack of Efficacy|0
1379839|NCT01419236|4553147|P2|Overall Study|Adverse Event|0
1379840|NCT01419236|4553148|P1|Overall Study|Adverse Event|1
1379841|NCT01419197|4553172|P2|Overall Study|Lost to Follow-up|4
1379842|NCT01419197|4553173|P1|Overall Study|Lost to Follow-up|14
1379843|NCT01419197|4553172|P2|Overall Study|Reason Not Specified|1
1379844|NCT01419197|4553173|P1|Overall Study|Reason Not Specified|0
1379845|NCT01419197|4553172|P2|Overall Study|Study Completed by Sponsor|34
1379846|NCT01419197|4553173|P1|Overall Study|Study Completed by Sponsor|103
1379847|NCT01419197|4553172|P2|Overall Study|Withdrawal by Subject|32
1379848|NCT01419197|4553173|P1|Overall Study|Withdrawal by Subject|33
1379849|NCT01419197|4553172|P2|Overall Study|Non-compliance|1
1379850|NCT01419197|4553173|P1|Overall Study|Non-compliance|3
1379851|NCT01419197|4553172|P2|Overall Study|Physician Decision|4
1379852|NCT01419197|4553173|P1|Overall Study|Physician Decision|4
1379853|NCT01419197|4553172|P2|Overall Study|Death|122
1379854|NCT01419197|4553173|P1|Overall Study|Death|247
1379855|NCT01419184|4553198|P2|Overall Study|Participant randomized, not treated|0
1379856|NCT01419184|4553199|P1|Overall Study|Participant randomized, not treated|1
1379857|NCT01419184|4553198|P2|Overall Study|No IRLOS-No adverse event treatment date|1
1379858|NCT01419184|4553199|P1|Overall Study|No IRLOS-No adverse event treatment date|0
1379859|NCT01419184|4553198|P2|Overall Study|No IRLOS-non trial antibiotic used|2
1379860|NCT01419184|4553199|P1|Overall Study|No IRLOS-non trial antibiotic used|1
1379861|NCT01419184|4553198|P2|Overall Study|No IRLOS-randomized, not treated|4
1379862|NCT01419184|4553199|P1|Overall Study|No IRLOS-randomized, not treated|2
1379863|NCT01419184|4553198|P2|Overall Study|No IRLOS-No in-patient end date reported|6
1379864|NCT01419184|4553199|P1|Overall Study|No IRLOS-No in-patient end date reported|3
1379865|NCT01419184|4553198|P2|Overall Study|Site data not available|2
1379866|NCT01419184|4553199|P1|Overall Study|Site data not available|3
1379867|NCT01418937|4553237|P1|Overall Study|Withdrawal by Subject|1
1379868|NCT01418937|4553237|P1|Overall Study|Pregnancy|1
1379869|NCT01418937|4553237|P1|Overall Study|Protocol Violation|1
1379870|NCT01418937|4553237|P1|Overall Study|Lost to Follow-up|5
1379871|NCT01418365|4553268|P2|Second Intervention|Withdrawal by Subject|1
1379872|NCT01418365|4553269|P1|Second Intervention|Withdrawal by Subject|0
1379873|NCT01418365|4553268|P2|First Intervention|Non-compliance|0
1379874|NCT01418365|4553269|P1|First Intervention|Non-compliance|1
1379875|NCT01418365|4553268|P2|First Intervention|Withdrawal by Subject|1
1379876|NCT01418365|4553269|P1|First Intervention|Withdrawal by Subject|0
1379877|NCT01418209|4553280|P3|Overall Study|Did not provide hot flash diary data|3
1379878|NCT01418209|4553281|P2|Overall Study|Did not provide hot flash diary data|3
1379879|NCT01418209|4553282|P1|Overall Study|Did not provide hot flash diary data|1
1379880|NCT01418209|4553280|P3|Overall Study|Withdrawal by Subject|1
1379881|NCT01418209|4553281|P2|Overall Study|Withdrawal by Subject|0
1379882|NCT01418209|4553282|P1|Overall Study|Withdrawal by Subject|1
1379883|NCT01417481|4553337|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
1379884|NCT01417481|4553338|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
1379885|NCT01417377|4553403|P1|Overall Study|Enrolled, but not treated|1
1379886|NCT01417377|4553403|P1|Overall Study|Lost to Follow-up|12
1379887|NCT01417195|4553412|P2|Overall Study|No transfer due to elevated progesterone|0
1379888|NCT01417195|4553413|P1|Overall Study|No transfer due to elevated progesterone|1
1379889|NCT01417195|4553412|P2|Overall Study|No transfer due to risk of OHSS|0
1379890|NCT01417195|4553413|P1|Overall Study|No transfer due to risk of OHSS|1
1379891|NCT01417195|4553412|P2|Overall Study|No embryos for transfer|1
1379892|NCT01417195|4553413|P1|Overall Study|No embryos for transfer|0
1379893|NCT01417195|4553412|P2|Overall Study|Stimulation failure|0
1379894|NCT01417195|4553413|P1|Overall Study|Stimulation failure|1
1379895|NCT01417156|4553429|P1|Overall Study|Protocol Violation|2
1379896|NCT01417156|4553429|P1|Overall Study|Adverse Event|12
1379897|NCT01417104|4553439|P2|Overall Study|Adverse Event|0
1379898|NCT01417104|4553440|P1|Overall Study|Adverse Event|1
1379899|NCT01417104|4553439|P2|Overall Study|Failure to make contact|1
1379900|NCT01417104|4553440|P1|Overall Study|Failure to make contact|0
1379901|NCT01417104|4553439|P2|Overall Study|Withdrawal by Subject|1
1379902|NCT01417104|4553440|P1|Overall Study|Withdrawal by Subject|5
1379903|NCT01417078|4553450|P1|Overall Study|Withdrawal by Subject|1
1379904|NCT01417000|4553475|P2|Overall Study|Study Terminated by Sponsor|1
1379905|NCT01417000|4553476|P1|Overall Study|Study Terminated by Sponsor|1
1379906|NCT01417000|4553475|P2|Overall Study|Lost to Follow-up|0
1379907|NCT01417000|4553476|P1|Overall Study|Lost to Follow-up|1
1379908|NCT01417000|4553475|P2|Overall Study|Death|28
1379909|NCT01417000|4553476|P1|Overall Study|Death|59
1379910|NCT01416610|4553484|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
1379911|NCT01416610|4553484|P1|Overall Study|Lost to Follow-up|7
1379912|NCT01416610|4553484|P1|Overall Study|Withdrawal by Subject|13
1379913|NCT01416610|4553484|P1|Overall Study|No reason given|5
1379914|NCT01416610|4553484|P1|Overall Study|Lack of Efficacy|4
1379915|NCT01416610|4553484|P1|Overall Study|Adverse Event -Patient decision|3
1379916|NCT01416610|4553484|P1|Overall Study|Adverse Event|4
1379917|NCT01416571|4553538|P1|Overall Study|Lost to Follow-up|2
1379918|NCT01416389|4553567|P2|Overall Study|Started New Therapy|0
1379919|NCT01416389|4553568|P1|Overall Study|Started New Therapy|2
1379920|NCT01416389|4553567|P2|Overall Study|Lost to Follow-up|0
1379921|NCT01416389|4553568|P1|Overall Study|Lost to Follow-up|1
1379922|NCT01416272|4553585|P1|Overall Study|Study related complaints|1
1379923|NCT01416272|4553585|P1|Overall Study|Lost to Follow-up|1
1379924|NCT01416272|4553585|P1|Overall Study|Unacceptable distance visual acuity|2
1379925|NCT01416181|4553593|P2|Part 2|Lost to Follow-up|2
1379926|NCT01416181|4553594|P1|Part 2|Lost to Follow-up|2
1379927|NCT01416181|4553593|P2|Part 2|Lack of Efficacy|1
1379928|NCT01416181|4553594|P1|Part 2|Lack of Efficacy|4
1379929|NCT01416181|4553593|P2|Part 2|Withdrawal by Subject|5
1379930|NCT01416181|4553594|P1|Part 2|Withdrawal by Subject|14
1379931|NCT01416181|4553593|P2|Part 2|Investigator Decision|7
1379932|NCT01416181|4553594|P1|Part 2|Investigator Decision|6
1379933|NCT01416181|4553593|P2|Part 2|Not Specified|267
1379934|NCT01416181|4553594|P1|Part 2|Not Specified|234
1379935|NCT01416181|4553593|P2|Part 2|Adverse Event|4
1379936|NCT01416181|4553594|P1|Part 2|Adverse Event|11
1379937|NCT01416181|4553593|P2|Part 1|Ongoing in Follow-Up|8
1379938|NCT01416181|4553594|P1|Part 1|Ongoing in Follow-Up|14
1379939|NCT01416181|4553593|P2|Part 1|Adverse Event|18
1379940|NCT01416181|4553594|P1|Part 1|Adverse Event|15
1379941|NCT01416181|4553593|P2|Part 1|Lost to Follow-up|1
1379942|NCT01416181|4553594|P1|Part 1|Lost to Follow-up|1
1379943|NCT01416181|4553593|P2|Part 1|Lack of Efficacy|8
1379944|NCT01416181|4553594|P1|Part 1|Lack of Efficacy|16
1379945|NCT01416181|4553593|P2|Part 1|Withdrawal by Subject|48
1379946|NCT01416181|4553594|P1|Part 1|Withdrawal by Subject|74
1379947|NCT01416181|4553593|P2|Part 1|Investigator Decision|6
1379948|NCT01416181|4553594|P1|Part 1|Investigator Decision|7
1379949|NCT01416181|4553593|P2|Part 1|Death|1
1379950|NCT01416181|4553594|P1|Part 1|Death|0
1379951|NCT01416181|4553593|P2|Part 1|Not Specified|24
1379952|NCT01416181|4553594|P1|Part 1|Not Specified|10
1379953|NCT01416155|4553656|P1|Overall Study|Not specified|7
1379954|NCT01416155|4553656|P1|Overall Study|Investigator decision|8
1379955|NCT01416155|4553656|P1|Overall Study|Withdrawal by Subject|33
1379956|NCT01416155|4553656|P1|Overall Study|Positive for anti-BG00002 antibodies|2
1379957|NCT01416155|4553656|P1|Overall Study|Adverse Event|8
1379958|NCT01416142|4553663|P3|PureVision2 HD|Inability to maintain lens wear|1
1379959|NCT01416142|4553664|P2|PureVision2 HD|Inability to maintain lens wear|0
1379960|NCT01416142|4553665|P1|PureVision2 HD|Inability to maintain lens wear|0
1379961|NCT01415986|4553692|P1|Overall Study|Lost to Follow-up|1
1379962|NCT01415921|4553709|P2|Overall Study|Other|0
1379963|NCT01415921|4553710|P1|Overall Study|Other|2
1379964|NCT01415921|4553709|P2|Overall Study|Withdrawal by Subject|1
1379965|NCT01415921|4553710|P1|Overall Study|Withdrawal by Subject|0
1379966|NCT01415921|4553709|P2|Overall Study|Physician Decision|1
1379967|NCT01415921|4553710|P1|Overall Study|Physician Decision|1
1379968|NCT01415921|4553709|P2|Overall Study|Adverse Event|1
1379969|NCT01415921|4553710|P1|Overall Study|Adverse Event|0
1379970|NCT01415908|4553720|P2|Overall Study|Withdrawal by Subject|0
1379971|NCT01415908|4553721|P1|Overall Study|Withdrawal by Subject|1
1379972|NCT01415531|4553758|P2|Overall Study|Other Reasons|2
1379973|NCT01415531|4553759|P1|Overall Study|Other Reasons|3
1379974|NCT01415531|4553758|P2|Overall Study|Lack of Compliance|4
1379975|NCT01415531|4553759|P1|Overall Study|Lack of Compliance|1
1379976|NCT01415531|4553758|P2|Overall Study|Lost to Follow-up|14
1379977|NCT01415531|4553759|P1|Overall Study|Lost to Follow-up|6
1379978|NCT01415531|4553758|P2|Overall Study|Withdrawal by Subject|4
1379979|NCT01415531|4553759|P1|Overall Study|Withdrawal by Subject|5
1379980|NCT01415531|4553758|P2|Overall Study|Protocol Violation|1
1379981|NCT01415531|4553759|P1|Overall Study|Protocol Violation|0
1379982|NCT01415531|4553758|P2|Overall Study|Lack of Efficacy|2
1379983|NCT01415531|4553759|P1|Overall Study|Lack of Efficacy|3
1379984|NCT01415531|4553758|P2|Overall Study|Adverse Event|10
1379985|NCT01415531|4553759|P1|Overall Study|Adverse Event|7
1379986|NCT01415518|4553769|P2|Overall Study|Condition under Investigation Worsened|1
1379987|NCT01415518|4553770|P1|Overall Study|Condition under Investigation Worsened|1
1379988|NCT01415518|4553769|P2|Overall Study|Death|1
1379989|NCT01415518|4553770|P1|Overall Study|Death|1
1379990|NCT01415518|4553769|P2|Overall Study|Adverse Event|4
1379991|NCT01415518|4553770|P1|Overall Study|Adverse Event|3
1379992|NCT01415518|4553769|P2|Overall Study|Lost to Follow-up|5
1379993|NCT01415518|4553770|P1|Overall Study|Lost to Follow-up|3
1379994|NCT01415518|4553769|P2|Overall Study|Protocol Violation|8
1379995|NCT01415518|4553770|P1|Overall Study|Protocol Violation|6
1379996|NCT01415518|4553769|P2|Overall Study|Withdrawal by Subject|12
1379997|NCT01415518|4553770|P1|Overall Study|Withdrawal by Subject|2
1379998|NCT01415401|4553870|P1|Overall Study|Terminated by Sponsor|1
1379999|NCT01415401|4553870|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
1380000|NCT01415401|4553870|P1|Overall Study|Adverse Event|5
1380001|NCT01415349|4553875|P2|Treatment Period 1|Withdrawal by Subject|1
1380002|NCT01415349|4553876|P1|Treatment Period 1|Withdrawal by Subject|0
1380003|NCT01415349|4553875|P2|Treatment Period 1|Adverse Event|1
1380004|NCT01415349|4553876|P1|Treatment Period 1|Adverse Event|0
1380005|NCT01414855|4553888|P1|Overall Study|Withdrawal by Subject|7
1380006|NCT01414855|4553888|P1|Overall Study|Lost to Follow-up|5
1380007|NCT01414855|4553888|P1|Overall Study|Death|17
1380008|NCT01414257|4553937|P1|Overall Study|Protocol Violation|10
1380009|NCT01414257|4553937|P1|Overall Study|No Visit After First Day of Treatment|12
1380010|NCT01414205|4553965|P2|Overall Study|Randomized but not Treated|1
1380011|NCT01414205|4553966|P1|Overall Study|Randomized but not Treated|1
1380012|NCT01414205|4553965|P2|Overall Study|Physician Decision|1
1380013|NCT01414205|4553966|P1|Overall Study|Physician Decision|0
1380014|NCT01414205|4553965|P2|Overall Study|Lost to Follow-up|4
1380015|NCT01414205|4553966|P1|Overall Study|Lost to Follow-up|1
1380016|NCT01414205|4553965|P2|Overall Study|Death|1
1380017|NCT01414205|4553966|P1|Overall Study|Death|5
1380018|NCT01414166|4554035|P2|Overall Study|Withdrawal by Subject|5
1380019|NCT01414166|4554036|P1|Overall Study|Withdrawal by Subject|3
1380020|NCT01414166|4554035|P2|Overall Study|Study terminated by Sponsor|75
1380021|NCT01414166|4554036|P1|Overall Study|Study terminated by Sponsor|68
1380022|NCT01414166|4554035|P2|Overall Study|Protocol Violation|0
1380023|NCT01414166|4554036|P1|Overall Study|Protocol Violation|2
1380024|NCT01414166|4554035|P2|Overall Study|Physician Decision|0
1380025|NCT01414166|4554036|P1|Overall Study|Physician Decision|2
1380026|NCT01414166|4554035|P2|Overall Study|Non-compliance with study drug|0
1380027|NCT01414166|4554036|P1|Overall Study|Non-compliance with study drug|2
1380028|NCT01414166|4554035|P2|Overall Study|Lost to Follow-up|1
1380029|NCT01414166|4554036|P1|Overall Study|Lost to Follow-up|4
1380030|NCT01414166|4554035|P2|Overall Study|Adverse Event|2
1380031|NCT01414166|4554036|P1|Overall Study|Adverse Event|10
1380032|NCT01414114|4554099|P1|Overall Study|Other|2
1380033|NCT01414114|4554099|P1|Overall Study|Withdrawal by Subject|1
1380034|NCT01414114|4554099|P1|Overall Study|Adverse Event|2
1380035|NCT01413958|4554155|P2|Overall Study|Lost to Follow-up|1
1380036|NCT01413958|4554156|P1|Overall Study|Lost to Follow-up|0
1380037|NCT01413542|4554207|P4|Overall Study|Adverse Event|1
1380038|NCT01413542|4554208|P3|Overall Study|Adverse Event|0
1380039|NCT01413542|4554209|P2|Overall Study|Adverse Event|0
1380040|NCT01413542|4554210|P1|Overall Study|Adverse Event|0
1380041|NCT01413542|4554207|P4|Overall Study|Physician Decision|0
1380042|NCT01413542|4554208|P3|Overall Study|Physician Decision|3
1380043|NCT01413542|4554209|P2|Overall Study|Physician Decision|0
1380044|NCT01413542|4554210|P1|Overall Study|Physician Decision|1
1380045|NCT01413360|4554232|P1|Overall Study|Adverse Event|1
1380046|NCT01413360|4554232|P1|Overall Study|Lost to Follow-up|2
1380047|NCT01413204|4554240|P3|Overall Study|Fasting plasma glucose level increased|10
1380048|NCT01413204|4554241|P2|Overall Study|Fasting plasma glucose level increased|0
1380049|NCT01413204|4554242|P1|Overall Study|Fasting plasma glucose level increased|1
1380050|NCT01413204|4554240|P3|Overall Study|Clearly not eligible for the study|1
1380051|NCT01413204|4554241|P2|Overall Study|Clearly not eligible for the study|0
1380052|NCT01413204|4554242|P1|Overall Study|Clearly not eligible for the study|0
1380053|NCT01413204|4554240|P3|Overall Study|Withdrawal by Subject|4
1380054|NCT01413204|4554241|P2|Overall Study|Withdrawal by Subject|4
1380055|NCT01413204|4554242|P1|Overall Study|Withdrawal by Subject|1
1380056|NCT01413204|4554240|P3|Overall Study|Physician Decision|2
1380057|NCT01413204|4554241|P2|Overall Study|Physician Decision|0
1380058|NCT01413204|4554242|P1|Overall Study|Physician Decision|3
1380059|NCT01413204|4554240|P3|Overall Study|Adverse Event|2
1380060|NCT01413204|4554241|P2|Overall Study|Adverse Event|2
1380061|NCT01413204|4554242|P1|Overall Study|Adverse Event|1
1380062|NCT01413191|4554250|P1|Overall Study|Death|1
1380063|NCT01413191|4554250|P1|Overall Study|Disease Progression|5
1380064|NCT01413191|4554250|P1|Overall Study|Lost to Follow-up|5
1380065|NCT01412983|4554254|P2|1st Period|Inability to maintain wear|1
1380066|NCT01412983|4554255|P1|1st Period|Inability to maintain wear|0
1380067|NCT01412983|4554254|P2|1st Period|Unacceptable lens movement|1
1380068|NCT01412983|4554255|P1|1st Period|Unacceptable lens movement|0
1380069|NCT01412983|4554254|P2|1st Period|Positive slit lamp finding|1
1380070|NCT01412983|4554255|P1|1st Period|Positive slit lamp finding|0
1380071|NCT01412983|4554254|P2|1st Period|Ineligible|1
1380072|NCT01412983|4554255|P1|1st Period|Ineligible|0
1380073|NCT01412957|4554265|P2|Overall Study|Death|133
1380074|NCT01412957|4554266|P1|Overall Study|Death|136
1380075|NCT01412957|4554265|P2|Overall Study|Lost to Follow-up|2
1380076|NCT01412957|4554266|P1|Overall Study|Lost to Follow-up|7
1380077|NCT01412957|4554265|P2|Overall Study|Withdrawal by Subject|22
1380078|NCT01412957|4554266|P1|Overall Study|Withdrawal by Subject|6
1380079|NCT01412944|4554288|P6|Entire: IV + Maintenance|Adverse Event|0
1380080|NCT01412944|4554289|P5|Entire: IV + Maintenance|Adverse Event|0
1380081|NCT01412944|4554290|P4|Entire: IV + Maintenance|Adverse Event|0
1380082|NCT01412944|4554291|P3|Entire: IV + Maintenance|Adverse Event|0
1380083|NCT01412944|4554292|P2|Entire: IV + Maintenance|Adverse Event|1
1380084|NCT01412944|4554293|P1|Entire: IV + Maintenance|Adverse Event|0
1380085|NCT01412944|4554288|P6|Entire: IV + Maintenance|Lack of Efficacy|0
1380086|NCT01412944|4554289|P5|Entire: IV + Maintenance|Lack of Efficacy|0
1380087|NCT01412944|4554290|P4|Entire: IV + Maintenance|Lack of Efficacy|0
1380088|NCT01412944|4554291|P3|Entire: IV + Maintenance|Lack of Efficacy|0
1380089|NCT01412944|4554292|P2|Entire: IV + Maintenance|Lack of Efficacy|1
1380090|NCT01412944|4554293|P1|Entire: IV + Maintenance|Lack of Efficacy|0
1380091|NCT01412944|4554288|P6|Entire: IV + Maintenance|Lost to Follow-up|0
1380092|NCT01412944|4554289|P5|Entire: IV + Maintenance|Lost to Follow-up|0
1380093|NCT01412944|4554290|P4|Entire: IV + Maintenance|Lost to Follow-up|0
1380094|NCT01412944|4554291|P3|Entire: IV + Maintenance|Lost to Follow-up|0
1380095|NCT01412944|4554292|P2|Entire: IV + Maintenance|Lost to Follow-up|1
1380096|NCT01412944|4554293|P1|Entire: IV + Maintenance|Lost to Follow-up|0
1380097|NCT01412944|4554288|P6|Entire: IV + Maintenance|Protocol deviation|0
1380098|NCT01412944|4554289|P5|Entire: IV + Maintenance|Protocol deviation|0
1380099|NCT01412944|4554290|P4|Entire: IV + Maintenance|Protocol deviation|0
1380100|NCT01412944|4554291|P3|Entire: IV + Maintenance|Protocol deviation|0
1380101|NCT01412944|4554292|P2|Entire: IV + Maintenance|Protocol deviation|1
1380102|NCT01412944|4554293|P1|Entire: IV + Maintenance|Protocol deviation|0
1380103|NCT01412944|4554288|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
1380104|NCT01412944|4554289|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
1380105|NCT01412944|4554290|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
1380106|NCT01412944|4554291|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
1380107|NCT01412944|4554292|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
1380108|NCT01412944|4554293|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
1380109|NCT01412944|4554288|P6|Entire: IV + Maintenance|Lack of Efficacy|0
1380110|NCT01412944|4554289|P5|Entire: IV + Maintenance|Lack of Efficacy|1
1380111|NCT01412944|4554290|P4|Entire: IV + Maintenance|Lack of Efficacy|0
1380112|NCT01412944|4554291|P3|Entire: IV + Maintenance|Lack of Efficacy|0
1380113|NCT01412944|4554292|P2|Entire: IV + Maintenance|Lack of Efficacy|0
1380114|NCT01412944|4554293|P1|Entire: IV + Maintenance|Lack of Efficacy|0
1380115|NCT01412944|4554288|P6|Entire: IV + Maintenance|Lost to Follow-up|1
1380116|NCT01412944|4554289|P5|Entire: IV + Maintenance|Lost to Follow-up|0
1380117|NCT01412944|4554290|P4|Entire: IV + Maintenance|Lost to Follow-up|0
1380118|NCT01412944|4554291|P3|Entire: IV + Maintenance|Lost to Follow-up|0
1380119|NCT01412944|4554292|P2|Entire: IV + Maintenance|Lost to Follow-up|0
1380120|NCT01412944|4554293|P1|Entire: IV + Maintenance|Lost to Follow-up|0
1380121|NCT01412944|4554288|P6|Entire: IV + Maintenance|Protocol deviation|1
1380122|NCT01412944|4554289|P5|Entire: IV + Maintenance|Protocol deviation|0
1380123|NCT01412944|4554290|P4|Entire: IV + Maintenance|Protocol deviation|0
1380124|NCT01412944|4554291|P3|Entire: IV + Maintenance|Protocol deviation|0
1380125|NCT01412944|4554292|P2|Entire: IV + Maintenance|Protocol deviation|0
1380126|NCT01412944|4554293|P1|Entire: IV + Maintenance|Protocol deviation|0
1380127|NCT01412944|4554288|P6|Entire: IV + Maintenance|Adverse Event|0
1380128|NCT01412944|4554289|P5|Entire: IV + Maintenance|Adverse Event|1
1380129|NCT01412944|4554290|P4|Entire: IV + Maintenance|Adverse Event|0
1380130|NCT01412944|4554291|P3|Entire: IV + Maintenance|Adverse Event|0
1380131|NCT01412944|4554292|P2|Entire: IV + Maintenance|Adverse Event|0
1380132|NCT01412944|4554293|P1|Entire: IV + Maintenance|Adverse Event|0
1380133|NCT01412944|4554288|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
1380134|NCT01412944|4554289|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
1380135|NCT01412944|4554290|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
1380136|NCT01412944|4554291|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
1380137|NCT01412944|4554292|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
1380138|NCT01412944|4554293|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
1380139|NCT01412944|4554288|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
1380140|NCT01412944|4554289|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
1380141|NCT01412944|4554290|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
1380142|NCT01412944|4554291|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
1380143|NCT01412944|4554292|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
1380144|NCT01412944|4554293|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
1380145|NCT01412944|4554288|P6|IV: Per CAIN457A2307|Protocol deviation|0
1380146|NCT01412944|4554289|P5|IV: Per CAIN457A2307|Protocol deviation|0
1380147|NCT01412944|4554290|P4|IV: Per CAIN457A2307|Protocol deviation|0
1380148|NCT01412944|4554291|P3|IV: Per CAIN457A2307|Protocol deviation|0
1380149|NCT01412944|4554292|P2|IV: Per CAIN457A2307|Protocol deviation|1
1380150|NCT01412944|4554293|P1|IV: Per CAIN457A2307|Protocol deviation|0
1380151|NCT01412944|4554288|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
1380152|NCT01412944|4554289|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
1380153|NCT01412944|4554290|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
1380154|NCT01412944|4554291|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
1380155|NCT01412944|4554292|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
1380156|NCT01412944|4554293|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
1380157|NCT01412944|4554288|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
1380158|NCT01412944|4554289|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
1380159|NCT01412944|4554290|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
1380160|NCT01412944|4554291|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
1380161|NCT01412944|4554292|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
1380162|NCT01412944|4554293|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
1380163|NCT01412944|4554288|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
1380164|NCT01412944|4554289|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
1380165|NCT01412944|4554290|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
1380166|NCT01412944|4554291|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
1380167|NCT01412944|4554292|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
1380168|NCT01412944|4554293|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
1380169|NCT01412944|4554288|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
1380170|NCT01412944|4554289|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
1380171|NCT01412944|4554290|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
1380172|NCT01412944|4554291|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
1380173|NCT01412944|4554292|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
1380174|NCT01412944|4554293|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
1380175|NCT01412879|4554339|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
1380176|NCT01412879|4554340|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
1380177|NCT01412879|4554341|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
1380178|NCT01412879|4554339|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
1380179|NCT01412879|4554340|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
1380180|NCT01412879|4554341|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
1380181|NCT01412879|4554339|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
1380182|NCT01412879|4554340|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
1380183|NCT01412879|4554341|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
1380184|NCT01412879|4554339|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
1380185|NCT01412879|4554340|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
1380186|NCT01412879|4554341|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
1380187|NCT01412879|4554339|P3|Initial Registration (Induction Therapy)|Adverse Event|0
1380188|NCT01412879|4554340|P2|Initial Registration (Induction Therapy)|Adverse Event|3
1380189|NCT01412879|4554341|P1|Initial Registration (Induction Therapy)|Adverse Event|5
1380190|NCT01412801|4554361|P6|Overall Study|Relocated to another area|0
1380191|NCT01412801|4554362|P5|Overall Study|Relocated to another area|0
1380192|NCT01412801|4554363|P4|Overall Study|Relocated to another area|0
1380193|NCT01412801|4554364|P3|Overall Study|Relocated to another area|2
1380194|NCT01412801|4554365|P2|Overall Study|Relocated to another area|0
1380195|NCT01412801|4554366|P1|Overall Study|Relocated to another area|0
1380196|NCT01412801|4554361|P6|Overall Study|Withdrawal by Subject|0
1380197|NCT01412801|4554362|P5|Overall Study|Withdrawal by Subject|0
1380198|NCT01412801|4554363|P4|Overall Study|Withdrawal by Subject|0
1380199|NCT01412801|4554364|P3|Overall Study|Withdrawal by Subject|1
1380200|NCT01412801|4554365|P2|Overall Study|Withdrawal by Subject|2
1380201|NCT01412801|4554366|P1|Overall Study|Withdrawal by Subject|3
1380202|NCT01412801|4554361|P6|Overall Study|Lost to Follow-up|1
1380203|NCT01412801|4554362|P5|Overall Study|Lost to Follow-up|1
1380204|NCT01412801|4554363|P4|Overall Study|Lost to Follow-up|0
1380205|NCT01412801|4554364|P3|Overall Study|Lost to Follow-up|4
1380206|NCT01412801|4554365|P2|Overall Study|Lost to Follow-up|2
1380207|NCT01412801|4554366|P1|Overall Study|Lost to Follow-up|1
1380208|NCT01412801|4554361|P6|Overall Study|Death|2
1380209|NCT01412801|4554362|P5|Overall Study|Death|2
1380210|NCT01412801|4554363|P4|Overall Study|Death|4
1380211|NCT01412801|4554364|P3|Overall Study|Death|0
1380212|NCT01412801|4554365|P2|Overall Study|Death|1
1380213|NCT01412801|4554366|P1|Overall Study|Death|0
1380214|NCT01412424|4554525|P1|Extension Treatment Period|Patient Request|2
1380215|NCT01412424|4554525|P1|Extension Treatment Period|Treatment Failure|2
1380216|NCT01412424|4554525|P1|Extension Treatment Period|Adverse Event|2
1380217|NCT01412424|4554525|P1|Core Treatment Period|Sponsor Request|1
1380218|NCT01412424|4554525|P1|Core Treatment Period|Lost to Follow-up|2
1380219|NCT01412424|4554525|P1|Core Treatment Period|Patient Request|5
1380220|NCT01412424|4554525|P1|Core Treatment Period|Adverse Event|21
1380221|NCT01412424|4554525|P1|Core Treatment Period|Treatment Failure|24
1380222|NCT01412333|4554543|P2|Overall Study|Lost to Follow-up|6
1380223|NCT01412333|4554544|P1|Overall Study|Lost to Follow-up|10
1380224|NCT01412333|4554543|P2|Overall Study|Adverse Event|16
1380225|NCT01412333|4554544|P1|Overall Study|Adverse Event|25
1380226|NCT01412333|4554543|P2|Overall Study|Consent withdrawn by participant|12
1380227|NCT01412333|4554544|P1|Overall Study|Consent withdrawn by participant|25
1380228|NCT01412333|4554543|P2|Overall Study|Pregnancy|0
1380229|NCT01412333|4554544|P1|Overall Study|Pregnancy|3
1380230|NCT01412333|4554543|P2|Overall Study|Lack of Efficacy|6
1380231|NCT01412333|4554544|P1|Overall Study|Lack of Efficacy|15
1380232|NCT01412333|4554543|P2|Overall Study|Non-compliance|3
1380233|NCT01412333|4554544|P1|Overall Study|Non-compliance|1
1380234|NCT01412333|4554543|P2|Overall Study|Protocol Violation|1
1380235|NCT01412333|4554544|P1|Overall Study|Protocol Violation|1
1380236|NCT01412333|4554543|P2|Overall Study|Non-compliance with study drug|1
1380237|NCT01412333|4554544|P1|Overall Study|Non-compliance with study drug|1
1380238|NCT01412333|4554543|P2|Overall Study|Reason not specified|10
1380239|NCT01412333|4554544|P1|Overall Study|Reason not specified|16
1380240|NCT01412333|4554543|P2|Overall Study|Physician Decision|1
1380241|NCT01412333|4554544|P1|Overall Study|Physician Decision|0
1380242|NCT01412333|4554543|P2|Overall Study|Death|1
1380243|NCT01412333|4554544|P1|Overall Study|Death|1
1380244|NCT01412229|4554604|P1|Overall Study|Physician Decision|1
1380245|NCT01412151|4554620|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
1380246|NCT01412151|4554620|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
1380247|NCT01412151|4554620|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
1380248|NCT01412151|4554620|P1|Week 0 - 306 - Treatment Period|Death|1
1380249|NCT01412060|4554631|P3|Double-blind Treatment Phase (DBP)|Relapse|25
1380250|NCT01412060|4554632|P2|Double-blind Treatment Phase (DBP)|Relapse|47
1380251|NCT01412060|4554633|P1|Double-blind Treatment Phase (DBP)|Relapse|0
1380252|NCT01412060|4554631|P3|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
1380253|NCT01412060|4554632|P2|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
1380254|NCT01412060|4554633|P1|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
1380255|NCT01412060|4554631|P3|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
1380256|NCT01412060|4554632|P2|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
1380257|NCT01412060|4554633|P1|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
1380258|NCT01412060|4554631|P3|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
1380259|NCT01412060|4554632|P2|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
1380260|NCT01412060|4554633|P1|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
1380261|NCT01412060|4554631|P3|Double-blind Treatment Phase (DBP)|Protocol Violation|5
1380262|NCT01412060|4554632|P2|Double-blind Treatment Phase (DBP)|Protocol Violation|4
1380263|NCT01412060|4554633|P1|Double-blind Treatment Phase (DBP)|Protocol Violation|0
1380264|NCT01412060|4554631|P3|Double-blind Treatment Phase (DBP)|Adverse Event|6
1380265|NCT01412060|4554632|P2|Double-blind Treatment Phase (DBP)|Adverse Event|5
1380266|NCT01412060|4554633|P1|Double-blind Treatment Phase (DBP)|Adverse Event|0
1380267|NCT01412060|4554631|P3|Period Between SP and DBP|Other Miscellaneous Reasons|0
1380268|NCT01412060|4554632|P2|Period Between SP and DBP|Other Miscellaneous Reasons|0
1380269|NCT01412060|4554633|P1|Period Between SP and DBP|Other Miscellaneous Reasons|55
1380270|NCT01412060|4554631|P3|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
1380271|NCT01412060|4554632|P2|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
1380272|NCT01412060|4554633|P1|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
1380273|NCT01412060|4554631|P3|Period Between SP and DBP|Lost to Follow-up|0
1380274|NCT01412060|4554632|P2|Period Between SP and DBP|Lost to Follow-up|0
1380275|NCT01412060|4554633|P1|Period Between SP and DBP|Lost to Follow-up|1
1380276|NCT01412060|4554631|P3|Period Between SP and DBP|Withdrawal of Consent|0
1380277|NCT01412060|4554632|P2|Period Between SP and DBP|Withdrawal of Consent|0
1380278|NCT01412060|4554633|P1|Period Between SP and DBP|Withdrawal of Consent|2
1380279|NCT01412060|4554631|P3|Period Between SP and DBP|Protocol Violation|0
1380280|NCT01412060|4554632|P2|Period Between SP and DBP|Protocol Violation|0
1380281|NCT01412060|4554633|P1|Period Between SP and DBP|Protocol Violation|2
1380282|NCT01412060|4554631|P3|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
1380283|NCT01412060|4554632|P2|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
1380284|NCT01412060|4554633|P1|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
1380285|NCT01412060|4554631|P3|Open-label Stabilization Period (SP)|Lost to Follow-up|0
1380286|NCT01412060|4554632|P2|Open-label Stabilization Period (SP)|Lost to Follow-up|0
1380287|NCT01412060|4554633|P1|Open-label Stabilization Period (SP)|Lost to Follow-up|9
1380288|NCT01412060|4554631|P3|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
1380289|NCT01412060|4554632|P2|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
1380290|NCT01412060|4554633|P1|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
1380291|NCT01412060|4554631|P3|Open-label Stabilization Period (SP)|Protocol Violation|0
1380292|NCT01412060|4554632|P2|Open-label Stabilization Period (SP)|Protocol Violation|0
1380293|NCT01412060|4554633|P1|Open-label Stabilization Period (SP)|Protocol Violation|14
1380294|NCT01412060|4554631|P3|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
1380295|NCT01412060|4554632|P2|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
1380296|NCT01412060|4554633|P1|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
1380297|NCT01412060|4554631|P3|Open-label Stabilization Period (SP)|Adverse Event|0
1380298|NCT01412060|4554632|P2|Open-label Stabilization Period (SP)|Adverse Event|0
1380299|NCT01412060|4554633|P1|Open-label Stabilization Period (SP)|Adverse Event|9
1380300|NCT01412060|4554631|P3|Period Between RIP and SP|Other Miscellaneous Reasons|0
1380301|NCT01412060|4554632|P2|Period Between RIP and SP|Other Miscellaneous Reasons|0
1380302|NCT01412060|4554633|P1|Period Between RIP and SP|Other Miscellaneous Reasons|23
1380303|NCT01412060|4554631|P3|Period Between RIP and SP|Lost to Follow-up|0
1380304|NCT01412060|4554632|P2|Period Between RIP and SP|Lost to Follow-up|0
1380305|NCT01412060|4554633|P1|Period Between RIP and SP|Lost to Follow-up|5
1380306|NCT01412060|4554631|P3|Period Between RIP and SP|Withdrawal of Consent|0
1380307|NCT01412060|4554632|P2|Period Between RIP and SP|Withdrawal of Consent|0
1380308|NCT01412060|4554633|P1|Period Between RIP and SP|Withdrawal of Consent|1
1380309|NCT01412060|4554631|P3|Period Between RIP and SP|Protocol Violation|0
1380310|NCT01412060|4554632|P2|Period Between RIP and SP|Protocol Violation|0
1380311|NCT01412060|4554633|P1|Period Between RIP and SP|Protocol Violation|2
1380312|NCT01412060|4554631|P3|Period Between RIP and SP|Insufficient Therapeutic Response|0
1380313|NCT01412060|4554632|P2|Period Between RIP and SP|Insufficient Therapeutic Response|0
1380314|NCT01412060|4554633|P1|Period Between RIP and SP|Insufficient Therapeutic Response|19
1380315|NCT01412060|4554631|P3|Period Between RIP and SP|Adverse Event|0
1380316|NCT01412060|4554632|P2|Period Between RIP and SP|Adverse Event|0
1380317|NCT01412060|4554633|P1|Period Between RIP and SP|Adverse Event|4
1380318|NCT01412060|4554631|P3|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
1380319|NCT01412060|4554632|P2|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
1380320|NCT01412060|4554633|P1|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
1380321|NCT01412060|4554631|P3|Open-label Run-in Period (RIP)|Lost to Follow-up|0
1380322|NCT01412060|4554632|P2|Open-label Run-in Period (RIP)|Lost to Follow-up|0
1380323|NCT01412060|4554633|P1|Open-label Run-in Period (RIP)|Lost to Follow-up|32
1380324|NCT01412060|4554631|P3|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
1380325|NCT01412060|4554632|P2|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
1380326|NCT01412060|4554633|P1|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
1380327|NCT01412060|4554631|P3|Open-label Run-in Period (RIP)|Protocol Violation|0
1380328|NCT01412060|4554632|P2|Open-label Run-in Period (RIP)|Protocol Violation|0
1380329|NCT01412060|4554633|P1|Open-label Run-in Period (RIP)|Protocol Violation|27
1380330|NCT01412060|4554631|P3|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
1380331|NCT01412060|4554632|P2|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
1380332|NCT01412060|4554633|P1|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
1380333|NCT01412060|4554631|P3|Open-label Run-in Period (RIP)|Adverse Event|0
1380334|NCT01412060|4554632|P2|Open-label Run-in Period (RIP)|Adverse Event|0
1380335|NCT01412060|4554633|P1|Open-label Run-in Period (RIP)|Adverse Event|86
1380336|NCT01411995|4554645|P2|Overall Study|Failed IUD insertion|1
1380337|NCT01411995|4554646|P1|Overall Study|Failed IUD insertion|0
1380338|NCT01411891|4554654|P2|Overall Study|Catheter dislodgement or loss to follow-|2
1380339|NCT01411891|4554655|P1|Overall Study|Catheter dislodgement or loss to follow-|3
1380340|NCT01411852|4554663|P2|Hospital Intervention Phase|Vascular access failed|0
1380341|NCT01411852|4554664|P1|Hospital Intervention Phase|Vascular access failed|1
1380342|NCT01411852|4554663|P2|Hospital Intervention Phase|Withdrawal by Subject|0
1380343|NCT01411852|4554664|P1|Hospital Intervention Phase|Withdrawal by Subject|1
1380344|NCT01411852|4554663|P2|Hospital Intervention Phase|Spinal cord injury|0
1380345|NCT01411852|4554664|P1|Hospital Intervention Phase|Spinal cord injury|2
1380346|NCT01411852|4554663|P2|Hospital Intervention Phase|Other ineligible|2
1380347|NCT01411852|4554664|P1|Hospital Intervention Phase|Other ineligible|2
1380348|NCT01411852|4554663|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
1380349|NCT01411852|4554664|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
1380350|NCT01411852|4554663|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
1380351|NCT01411852|4554664|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
1380352|NCT01411852|4554663|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
1380353|NCT01411852|4554664|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
1380354|NCT01411852|4554663|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
1380355|NCT01411852|4554664|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
1380356|NCT01411852|4554663|P2|Hospital Intervention Phase|CPR administered|1
1380357|NCT01411852|4554664|P1|Hospital Intervention Phase|CPR administered|3
1380358|NCT01411852|4554663|P2|Hospital Intervention Phase|Miscommunication error|2
1380359|NCT01411852|4554664|P1|Hospital Intervention Phase|Miscommunication error|1
1380360|NCT01411852|4554663|P2|Hospital Intervention Phase|No qualifying SBP|1
1380361|NCT01411852|4554664|P1|Hospital Intervention Phase|No qualifying SBP|5
1380362|NCT01411852|4554663|P2|Hospital Intervention Phase|Severe head injury|4
1380363|NCT01411852|4554664|P1|Hospital Intervention Phase|Severe head injury|5
1380364|NCT01411852|4554663|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
1380365|NCT01411852|4554664|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
1380366|NCT01411852|4554663|P2|Prehospital Intervention Phase|Found to be under age|1
1380367|NCT01411852|4554664|P1|Prehospital Intervention Phase|Found to be under age|0
1380368|NCT01411852|4554663|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
1380369|NCT01411852|4554664|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
1380370|NCT01411852|4554663|P2|Prehospital Intervention Phase|No qualifying SBP|4
1380371|NCT01411852|4554664|P1|Prehospital Intervention Phase|No qualifying SBP|5
1380372|NCT01411839|4554709|P2|Overall Study|Lost to Follow-up|3
1380373|NCT01411839|4554710|P1|Overall Study|Lost to Follow-up|4
1380374|NCT01411774|4554722|P2|Overall Study|Withdrawal by Subject|3
1380375|NCT01411774|4554723|P1|Overall Study|Withdrawal by Subject|0
1380376|NCT01411228|4554798|P3|Overall Study|Withdrawal by Subject|0
1380377|NCT01411228|4554799|P2|Overall Study|Withdrawal by Subject|0
1380378|NCT01411228|4554800|P1|Overall Study|Withdrawal by Subject|1
1380379|NCT01411228|4554798|P3|Overall Study|Lost to Follow-up|1
1380380|NCT01411228|4554799|P2|Overall Study|Lost to Follow-up|0
1380381|NCT01411228|4554800|P1|Overall Study|Lost to Follow-up|0
1380382|NCT01411215|4554822|P2|Overall Study|Screen failure|1
1380383|NCT01411215|4554823|P1|Overall Study|Screen failure|0
1380384|NCT01411215|4554822|P2|Overall Study|Other|17
1380385|NCT01411215|4554823|P1|Overall Study|Other|12
1380386|NCT01411215|4554822|P2|Overall Study|Withdrawal by Subject|21
1380387|NCT01411215|4554823|P1|Overall Study|Withdrawal by Subject|34
1380388|NCT01411215|4554822|P2|Overall Study|Protocol Violation|5
1380389|NCT01411215|4554823|P1|Overall Study|Protocol Violation|3
1380390|NCT01411215|4554822|P2|Overall Study|Study terminated by sponsor|15
1380391|NCT01411215|4554823|P1|Overall Study|Study terminated by sponsor|2
1380392|NCT01411215|4554822|P2|Overall Study|Did not meet entrance criteria|1
1380393|NCT01411215|4554823|P1|Overall Study|Did not meet entrance criteria|0
1380394|NCT01411215|4554822|P2|Overall Study|Lost to Follow-up|18
1380395|NCT01411215|4554823|P1|Overall Study|Lost to Follow-up|12
1380396|NCT01411215|4554822|P2|Overall Study|Lack of Efficacy|4
1380397|NCT01411215|4554823|P1|Overall Study|Lack of Efficacy|2
1380398|NCT01411215|4554822|P2|Overall Study|Adverse Event|2
1380399|NCT01411215|4554823|P1|Overall Study|Adverse Event|1
1380400|NCT01411085|4554875|P1|Overall Study|Adverse Event|1
1380401|NCT01411085|4554875|P1|Overall Study|Protocol Violation|1
1380402|NCT01411085|4554875|P1|Overall Study|Physician Decision|1
1380403|NCT01410604|4554886|P2|Overall Study|Physician Decision|1
1380404|NCT01410604|4554887|P1|Overall Study|Physician Decision|0
1380405|NCT01410604|4554886|P2|Overall Study|Lost to Follow-up|0
1380406|NCT01410604|4554887|P1|Overall Study|Lost to Follow-up|1
1380407|NCT01410604|4554886|P2|Overall Study|Adverse Event|1
1380408|NCT01410604|4554887|P1|Overall Study|Adverse Event|2
1380409|NCT01410474|4554928|P2|Overall Study|Withdrawal by Subject|1
1380410|NCT01410474|4554929|P1|Overall Study|Withdrawal by Subject|0
1380411|NCT01410448|4554952|P2|Overall Study|Death|3
1380412|NCT01410448|4554953|P1|Overall Study|Death|2
1380413|NCT01410448|4554952|P2|Overall Study|Protocol Violation|4
1380414|NCT01410448|4554953|P1|Overall Study|Protocol Violation|0
1380415|NCT01410448|4554952|P2|Overall Study|Withdrawal by Subject|2
1380416|NCT01410448|4554953|P1|Overall Study|Withdrawal by Subject|3
1380417|NCT01410448|4554952|P2|Overall Study|Lost to Follow-up|0
1380418|NCT01410448|4554953|P1|Overall Study|Lost to Follow-up|1
1380419|NCT01410448|4554952|P2|Overall Study|Administrative issues|1
1380420|NCT01410448|4554953|P1|Overall Study|Administrative issues|2
1380421|NCT01410448|4554952|P2|Overall Study|Graft loss|1
1380422|NCT01410448|4554953|P1|Overall Study|Graft loss|4
1380423|NCT01410448|4554952|P2|Overall Study|No conversion to everolimus|24
1380424|NCT01410448|4554953|P1|Overall Study|No conversion to everolimus|0
1380425|NCT01410357|4555018|P2|Overall Study|Lost to Follow-up|21
1380426|NCT01410357|4555019|P1|Overall Study|Lost to Follow-up|23
1380427|NCT01410357|4555018|P2|Overall Study|Withdrawal by Subject|2
1380428|NCT01410357|4555019|P1|Overall Study|Withdrawal by Subject|1
1380429|NCT01410357|4555018|P2|Overall Study|Death|1
1380430|NCT01410357|4555019|P1|Overall Study|Death|2
1380431|NCT01410240|4555080|P3|Overall Study|Missed week 6 assessments|1
1380432|NCT01410240|4555081|P2|Overall Study|Missed week 6 assessments|1
1380433|NCT01410240|4555082|P1|Overall Study|Missed week 6 assessments|1
1380434|NCT01410240|4555080|P3|Overall Study|Physician Decision|1
1380435|NCT01410240|4555081|P2|Overall Study|Physician Decision|0
1380436|NCT01410240|4555082|P1|Overall Study|Physician Decision|0
1380437|NCT01410227|4555153|P4|Overall Study|Met Excl. Criteria After Starting Study|0
1380438|NCT01410227|4555154|P3|Overall Study|Met Excl. Criteria After Starting Study|1
1380439|NCT01410227|4555155|P2|Overall Study|Met Excl. Criteria After Starting Study|0
1380440|NCT01410227|4555156|P1|Overall Study|Met Excl. Criteria After Starting Study|0
1380441|NCT01410227|4555153|P4|Overall Study|Pregnancy|1
1380442|NCT01410227|4555154|P3|Overall Study|Pregnancy|0
1380443|NCT01410227|4555155|P2|Overall Study|Pregnancy|0
1380444|NCT01410227|4555156|P1|Overall Study|Pregnancy|0
1380445|NCT01410227|4555153|P4|Overall Study|Withdrawal by Subject|0
1380446|NCT01410227|4555154|P3|Overall Study|Withdrawal by Subject|1
1380447|NCT01410227|4555155|P2|Overall Study|Withdrawal by Subject|0
1380448|NCT01410227|4555156|P1|Overall Study|Withdrawal by Subject|3
1380449|NCT01410227|4555153|P4|Overall Study|Adverse Event|0
1380450|NCT01410227|4555154|P3|Overall Study|Adverse Event|0
1380451|NCT01410227|4555155|P2|Overall Study|Adverse Event|0
1380452|NCT01410227|4555156|P1|Overall Study|Adverse Event|1
1380453|NCT01410110|4555228|P2|Overall Study|Withdrawal by Subject|2
1380454|NCT01410110|4555229|P1|Overall Study|Withdrawal by Subject|4
1380455|NCT01409993|4555278|P4|Overall Study|Lost to Follow-up|0
1380456|NCT01409993|4555279|P3|Overall Study|Lost to Follow-up|0
1380457|NCT01409993|4555280|P2|Overall Study|Lost to Follow-up|1
1380458|NCT01409993|4555281|P1|Overall Study|Lost to Follow-up|0
1380459|NCT01409993|4555278|P4|Overall Study|Withdrawal by Subject|4
1380460|NCT01409993|4555279|P3|Overall Study|Withdrawal by Subject|0
1380461|NCT01409993|4555280|P2|Overall Study|Withdrawal by Subject|0
1380462|NCT01409993|4555281|P1|Overall Study|Withdrawal by Subject|0
1380463|NCT01409993|4555278|P4|Overall Study|Adverse Event|1
1380464|NCT01409993|4555279|P3|Overall Study|Adverse Event|3
1380465|NCT01409993|4555280|P2|Overall Study|Adverse Event|4
1380466|NCT01409993|4555281|P1|Overall Study|Adverse Event|4
1380467|NCT01409837|4555301|P2|Overall Study|Physician Decision|1
1380468|NCT01409837|4555302|P1|Overall Study|Physician Decision|0
1380469|NCT01409837|4555301|P2|Overall Study|Lost to Follow-up|0
1380470|NCT01409837|4555302|P1|Overall Study|Lost to Follow-up|1
1380471|NCT01409837|4555301|P2|Overall Study|Withdrawal by Subject|1
1380472|NCT01409837|4555302|P1|Overall Study|Withdrawal by Subject|2
1380473|NCT01409707|4555327|P3|Overall Study|Withdrawal by Subject|16
1380474|NCT01409707|4555328|P2|Overall Study|Withdrawal by Subject|17
1380475|NCT01409707|4555329|P1|Overall Study|Withdrawal by Subject|5
1380476|NCT01409564|4555341|P2|Overall Study|brain abnormalities found in T1 MR|2
1380477|NCT01409564|4555342|P1|Overall Study|brain abnormalities found in T1 MR|1
1380478|NCT01409564|4555341|P2|Overall Study|low medication compliance|3
1380479|NCT01409564|4555342|P1|Overall Study|low medication compliance|4
1380480|NCT01409434|4555360|P1|Overall Study|Protocol Violation|4
1380481|NCT01409382|4555370|P2|Overall Study|Had a 2nd trimester loss after accident|0
1380482|NCT01409382|4555371|P1|Overall Study|Had a 2nd trimester loss after accident|1
1380483|NCT01409382|4555370|P2|Overall Study|Did not manage to get pregnant|70
1380484|NCT01409382|4555371|P1|Overall Study|Did not manage to get pregnant|64
1380485|NCT01409382|4555370|P2|Overall Study|Still pregnant when study ended|2
1380486|NCT01409382|4555371|P1|Overall Study|Still pregnant when study ended|13
1380487|NCT01409382|4555370|P2|Overall Study|Multiple pregnancy|4
1380488|NCT01409382|4555371|P1|Overall Study|Multiple pregnancy|2
1380489|NCT01409382|4555370|P2|Overall Study|Protocol Violation|3
1380490|NCT01409382|4555371|P1|Overall Study|Protocol Violation|0
1380491|NCT01409382|4555370|P2|Overall Study|Lost to Follow-up|1
1380492|NCT01409382|4555371|P1|Overall Study|Lost to Follow-up|1
1380493|NCT01408914|4555438|P3|Overall Study|Change in local TB/HIV norms|1
1380494|NCT01408914|4555439|P2|Overall Study|Change in local TB/HIV norms|1
1380495|NCT01408914|4555440|P1|Overall Study|Change in local TB/HIV norms|0
1380496|NCT01408914|4555438|P3|Overall Study|Late exclusion|3
1380497|NCT01408914|4555439|P2|Overall Study|Late exclusion|3
1380498|NCT01408914|4555440|P1|Overall Study|Late exclusion|0
1380499|NCT01408914|4555438|P3|Overall Study|Moved out of study jurisdiction|0
1380500|NCT01408914|4555439|P2|Overall Study|Moved out of study jurisdiction|1
1380501|NCT01408914|4555440|P1|Overall Study|Moved out of study jurisdiction|1
1380502|NCT01408914|4555438|P3|Overall Study|Withdrawal by Subject|1
1380503|NCT01408914|4555439|P2|Overall Study|Withdrawal by Subject|0
1380504|NCT01408914|4555440|P1|Overall Study|Withdrawal by Subject|1
1380505|NCT01408914|4555438|P3|Overall Study|Physician Decision|0
1380506|NCT01408914|4555439|P2|Overall Study|Physician Decision|1
1380507|NCT01408914|4555440|P1|Overall Study|Physician Decision|1
1380508|NCT01408914|4555438|P3|Overall Study|Lost to Follow-up|2
1380509|NCT01408914|4555439|P2|Overall Study|Lost to Follow-up|1
1380510|NCT01408914|4555440|P1|Overall Study|Lost to Follow-up|4
1380511|NCT01408914|4555438|P3|Overall Study|Could not complete tx in protocol period|6
1380512|NCT01408914|4555439|P2|Overall Study|Could not complete tx in protocol period|5
1380513|NCT01408914|4555440|P1|Overall Study|Could not complete tx in protocol period|5
1380514|NCT01408888|4555454|P2|Second Intervention|Adverse Event|0
1380515|NCT01408888|4555455|P1|Second Intervention|Adverse Event|1
1380516|NCT01408888|4555454|P2|Second Intervention|Withdrawal by Subject|0
1380517|NCT01408888|4555455|P1|Second Intervention|Withdrawal by Subject|1
1380518|NCT01408888|4555454|P2|First Intervention|Withdrawal by Subject|2
1380519|NCT01408888|4555455|P1|First Intervention|Withdrawal by Subject|0
1380520|NCT01408888|4555454|P2|First Intervention|Adverse Event|1
1380521|NCT01408888|4555455|P1|First Intervention|Adverse Event|0
1380522|NCT01408732|4555483|P2|Overall Study|Withdrawal by Subject|2
1380523|NCT01408732|4555484|P1|Overall Study|Withdrawal by Subject|2
1380524|NCT01408706|4555541|P2|Overall Study|Physician Decision|0
1380525|NCT01408706|4555542|P1|Overall Study|Physician Decision|1
1380526|NCT01408641|4555554|P2|Overall Study|Physician Decision|0
1380527|NCT01408641|4555555|P1|Overall Study|Physician Decision|1
1380528|NCT01408628|4555563|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
1380529|NCT01408628|4555563|P1|Completed 6 Month Follow-Up|Protocol Violation|6
1380530|NCT01408628|4555563|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
1380531|NCT01408628|4555563|P1|Consented|Withdrawal by Subject|12
1380532|NCT01408537|4555569|P1|Overall Study|Lost to Follow-up|3
1380533|NCT01408537|4555569|P1|Overall Study|Protocol Violation|3
1380534|NCT01408537|4555569|P1|Overall Study|Withdrawal by Subject|2
1380535|NCT01408485|4555585|P1|Overall Study|Withdrawal by Subject|21
1380536|NCT01408303|4555603|P3|Overall Study|Noncompliance|1
1380537|NCT01408303|4555604|P2|Overall Study|Noncompliance|0
1380538|NCT01408303|4555605|P1|Overall Study|Noncompliance|1
1380539|NCT01408303|4555603|P3|Overall Study|Protocol Violation|0
1380540|NCT01408303|4555604|P2|Overall Study|Protocol Violation|1
1380541|NCT01408303|4555605|P1|Overall Study|Protocol Violation|0
1380542|NCT01408303|4555603|P3|Overall Study|Withdrawal by Subject|1
1380543|NCT01408303|4555604|P2|Overall Study|Withdrawal by Subject|3
1380544|NCT01408303|4555605|P1|Overall Study|Withdrawal by Subject|2
1380545|NCT01408303|4555603|P3|Overall Study|Lost to Follow-up|2
1380546|NCT01408303|4555604|P2|Overall Study|Lost to Follow-up|1
1380547|NCT01408303|4555605|P1|Overall Study|Lost to Follow-up|0
1380548|NCT01408303|4555603|P3|Overall Study|Adverse Event|2
1380549|NCT01408303|4555604|P2|Overall Study|Adverse Event|7
1380550|NCT01408303|4555605|P1|Overall Study|Adverse Event|3
1380551|NCT01408277|4555615|P2|Overall Study|Protocol Violation|0
1380552|NCT01408277|4555616|P1|Overall Study|Protocol Violation|2
1380553|NCT01408277|4555615|P2|Overall Study|Withdrawal by Subject|0
1380554|NCT01408277|4555616|P1|Overall Study|Withdrawal by Subject|2
1380555|NCT01408277|4555615|P2|Overall Study|Lost to Follow-up|0
1380556|NCT01408277|4555616|P1|Overall Study|Lost to Follow-up|1
1380557|NCT01408277|4555615|P2|Overall Study|Adverse Event|4
1380558|NCT01408277|4555616|P1|Overall Study|Adverse Event|3
1380559|NCT01407354|4555653|P2|First Intervention|Physician Decision|0
1380560|NCT01407354|4555654|P1|First Intervention|Physician Decision|1
1380561|NCT01407354|4555653|P2|First Intervention|Adverse Event|0
1380562|NCT01407354|4555654|P1|First Intervention|Adverse Event|1
1380563|NCT01407354|4555653|P2|First Intervention|Withdrawal by Subject|2
1380564|NCT01407354|4555654|P1|First Intervention|Withdrawal by Subject|0
1380565|NCT01407276|4555670|P8|Overall Study|Withdrawal by Subject|1
1380566|NCT01407276|4555671|P7|Overall Study|Withdrawal by Subject|0
1380567|NCT01407276|4555672|P6|Overall Study|Withdrawal by Subject|0
1380568|NCT01407276|4555673|P5|Overall Study|Withdrawal by Subject|0
1380569|NCT01407276|4555674|P4|Overall Study|Withdrawal by Subject|0
1380570|NCT01407276|4555675|P3|Overall Study|Withdrawal by Subject|0
1380571|NCT01407276|4555676|P2|Overall Study|Withdrawal by Subject|0
1380572|NCT01407276|4555677|P1|Overall Study|Withdrawal by Subject|0
1380573|NCT01406938|4555816|P6|Follow up|Lost to Follow-up|1
1380574|NCT01406938|4555817|P5|Follow up|Lost to Follow-up|2
1380575|NCT01406938|4555818|P4|Follow up|Lost to Follow-up|1
1380576|NCT01406938|4555819|P3|Follow up|Lost to Follow-up|0
1380577|NCT01406938|4555820|P2|Follow up|Lost to Follow-up|1
1380578|NCT01406938|4555821|P1|Follow up|Lost to Follow-up|1
1380579|NCT01406938|4555816|P6|Follow up|Physician Decision|1
1380580|NCT01406938|4555817|P5|Follow up|Physician Decision|3
1380581|NCT01406938|4555818|P4|Follow up|Physician Decision|0
1380582|NCT01406938|4555819|P3|Follow up|Physician Decision|2
1380583|NCT01406938|4555820|P2|Follow up|Physician Decision|0
1380584|NCT01406938|4555821|P1|Follow up|Physician Decision|0
1380585|NCT01406938|4555816|P6|Follow up|Protocol Violation|0
1380586|NCT01406938|4555817|P5|Follow up|Protocol Violation|0
1380587|NCT01406938|4555818|P4|Follow up|Protocol Violation|0
1380588|NCT01406938|4555819|P3|Follow up|Protocol Violation|1
1380589|NCT01406938|4555820|P2|Follow up|Protocol Violation|0
1380590|NCT01406938|4555821|P1|Follow up|Protocol Violation|0
1380591|NCT01406938|4555816|P6|Follow up|Patient/guardian decision|1
1380592|NCT01406938|4555817|P5|Follow up|Patient/guardian decision|4
1380593|NCT01406938|4555818|P4|Follow up|Patient/guardian decision|2
1380594|NCT01406938|4555819|P3|Follow up|Patient/guardian decision|4
1380595|NCT01406938|4555820|P2|Follow up|Patient/guardian decision|2
1380596|NCT01406938|4555821|P1|Follow up|Patient/guardian decision|4
1380597|NCT01406938|4555816|P6|Follow up|Lack of Efficacy|0
1380598|NCT01406938|4555817|P5|Follow up|Lack of Efficacy|0
1380599|NCT01406938|4555818|P4|Follow up|Lack of Efficacy|0
1380600|NCT01406938|4555819|P3|Follow up|Lack of Efficacy|1
1380601|NCT01406938|4555820|P2|Follow up|Lack of Efficacy|2
1380602|NCT01406938|4555821|P1|Follow up|Lack of Efficacy|3
1380603|NCT01406938|4555816|P6|Maintenance Period|Lack of Efficacy|5
1380604|NCT01406938|4555817|P5|Maintenance Period|Lack of Efficacy|3
1380605|NCT01406938|4555818|P4|Maintenance Period|Lack of Efficacy|1
1380606|NCT01406938|4555819|P3|Maintenance Period|Lack of Efficacy|2
1380607|NCT01406938|4555820|P2|Maintenance Period|Lack of Efficacy|0
1380608|NCT01406938|4555821|P1|Maintenance Period|Lack of Efficacy|0
1380609|NCT01406938|4555816|P6|Maintenance Period|Lost to Follow-up|0
1380610|NCT01406938|4555817|P5|Maintenance Period|Lost to Follow-up|4
1380611|NCT01406938|4555818|P4|Maintenance Period|Lost to Follow-up|0
1380612|NCT01406938|4555819|P3|Maintenance Period|Lost to Follow-up|0
1380613|NCT01406938|4555820|P2|Maintenance Period|Lost to Follow-up|0
1380614|NCT01406938|4555821|P1|Maintenance Period|Lost to Follow-up|0
1380615|NCT01406938|4555816|P6|Maintenance Period|Pregnancy|0
1380616|NCT01406938|4555817|P5|Maintenance Period|Pregnancy|1
1380617|NCT01406938|4555818|P4|Maintenance Period|Pregnancy|0
1380618|NCT01406938|4555819|P3|Maintenance Period|Pregnancy|0
1380619|NCT01406938|4555820|P2|Maintenance Period|Pregnancy|0
1380620|NCT01406938|4555821|P1|Maintenance Period|Pregnancy|0
1380621|NCT01406938|4555816|P6|Maintenance Period|Protocol Violation|2
1380622|NCT01406938|4555817|P5|Maintenance Period|Protocol Violation|2
1380623|NCT01406938|4555818|P4|Maintenance Period|Protocol Violation|2
1380624|NCT01406938|4555819|P3|Maintenance Period|Protocol Violation|2
1380625|NCT01406938|4555820|P2|Maintenance Period|Protocol Violation|0
1380626|NCT01406938|4555821|P1|Maintenance Period|Protocol Violation|0
1380627|NCT01406938|4555816|P6|Maintenance Period|Subject/guardian decision|7
1380628|NCT01406938|4555817|P5|Maintenance Period|Subject/guardian decision|10
1380629|NCT01406938|4555818|P4|Maintenance Period|Subject/guardian decision|7
1380630|NCT01406938|4555819|P3|Maintenance Period|Subject/guardian decision|11
1380631|NCT01406938|4555820|P2|Maintenance Period|Subject/guardian decision|0
1380632|NCT01406938|4555821|P1|Maintenance Period|Subject/guardian decision|0
1380633|NCT01406938|4555816|P6|Maintenance Period|Death|0
1380634|NCT01406938|4555817|P5|Maintenance Period|Death|1
1380635|NCT01406938|4555818|P4|Maintenance Period|Death|0
1380636|NCT01406938|4555819|P3|Maintenance Period|Death|0
1380637|NCT01406938|4555820|P2|Maintenance Period|Death|0
1380638|NCT01406938|4555821|P1|Maintenance Period|Death|0
1380639|NCT01406938|4555816|P6|Maintenance Period|Adverse Event|2
1380640|NCT01406938|4555817|P5|Maintenance Period|Adverse Event|4
1380641|NCT01406938|4555818|P4|Maintenance Period|Adverse Event|8
1380642|NCT01406938|4555819|P3|Maintenance Period|Adverse Event|2
1380643|NCT01406938|4555820|P2|Maintenance Period|Adverse Event|0
1380644|NCT01406938|4555821|P1|Maintenance Period|Adverse Event|0
1380645|NCT01406938|4555816|P6|Induction Period|Lost to Follow-up|0
1380646|NCT01406938|4555817|P5|Induction Period|Lost to Follow-up|0
1380647|NCT01406938|4555818|P4|Induction Period|Lost to Follow-up|0
1380648|NCT01406938|4555819|P3|Induction Period|Lost to Follow-up|0
1380649|NCT01406938|4555820|P2|Induction Period|Lost to Follow-up|3
1380650|NCT01406938|4555821|P1|Induction Period|Lost to Follow-up|2
1380651|NCT01406938|4555816|P6|Induction Period|Lack of Efficacy|0
1380652|NCT01406938|4555817|P5|Induction Period|Lack of Efficacy|0
1380653|NCT01406938|4555818|P4|Induction Period|Lack of Efficacy|0
1380654|NCT01406938|4555819|P3|Induction Period|Lack of Efficacy|0
1380655|NCT01406938|4555820|P2|Induction Period|Lack of Efficacy|0
1380656|NCT01406938|4555821|P1|Induction Period|Lack of Efficacy|1
1380657|NCT01406938|4555816|P6|Induction Period|Adverse Event|0
1380658|NCT01406938|4555817|P5|Induction Period|Adverse Event|0
1380659|NCT01406938|4555818|P4|Induction Period|Adverse Event|0
1380660|NCT01406938|4555819|P3|Induction Period|Adverse Event|0
1380661|NCT01406938|4555820|P2|Induction Period|Adverse Event|9
1380662|NCT01406938|4555821|P1|Induction Period|Adverse Event|8
1380663|NCT01406938|4555816|P6|Induction Period|Protocol deviation|0
1380664|NCT01406938|4555817|P5|Induction Period|Protocol deviation|0
1380665|NCT01406938|4555818|P4|Induction Period|Protocol deviation|0
1380666|NCT01406938|4555819|P3|Induction Period|Protocol deviation|0
1380667|NCT01406938|4555820|P2|Induction Period|Protocol deviation|0
1380668|NCT01406938|4555821|P1|Induction Period|Protocol deviation|1
1380669|NCT01406938|4555816|P6|Induction Period|Subject/guardian decision|0
1380670|NCT01406938|4555817|P5|Induction Period|Subject/guardian decision|0
1380671|NCT01406938|4555818|P4|Induction Period|Subject/guardian decision|0
1380672|NCT01406938|4555819|P3|Induction Period|Subject/guardian decision|0
1380673|NCT01406938|4555820|P2|Induction Period|Subject/guardian decision|8
1380674|NCT01406938|4555821|P1|Induction Period|Subject/guardian decision|6
1380675|NCT01406873|4555939|P2|Overall Study|Withdrawal by Subject|1
1380676|NCT01406873|4555940|P1|Overall Study|Withdrawal by Subject|1
1380677|NCT01406795|4555971|P1|Overall Study|Withdrawal by Subject|1
1380678|NCT01406574|4555985|P4|Overall Study|Definite progression of primary disease|0
1380679|NCT01406574|4555986|P3|Overall Study|Definite progression of primary disease|0
1380680|NCT01406574|4555987|P2|Overall Study|Definite progression of primary disease|0
1380681|NCT01406574|4555988|P1|Overall Study|Definite progression of primary disease|1
1380682|NCT01406574|4555985|P4|Overall Study|Withdrawal by Subject|0
1380683|NCT01406574|4555986|P3|Overall Study|Withdrawal by Subject|0
1380684|NCT01406574|4555987|P2|Overall Study|Withdrawal by Subject|1
1380685|NCT01406574|4555988|P1|Overall Study|Withdrawal by Subject|0
1380686|NCT01406574|4555985|P4|Overall Study|Physician Decision|1
1380687|NCT01406574|4555986|P3|Overall Study|Physician Decision|0
1380688|NCT01406574|4555987|P2|Overall Study|Physician Decision|0
1380689|NCT01406574|4555988|P1|Overall Study|Physician Decision|0
1380690|NCT01406574|4555985|P4|Overall Study|Adverse Event|3
1380691|NCT01406574|4555986|P3|Overall Study|Adverse Event|1
1380692|NCT01406574|4555987|P2|Overall Study|Adverse Event|0
1380693|NCT01406574|4555988|P1|Overall Study|Adverse Event|0
1380694|NCT01406015|4556023|P2|Overall Study|Withdrawal by Subject|3
1380695|NCT01406015|4556024|P1|Overall Study|Withdrawal by Subject|3
1380696|NCT01405950|4556040|P4|Overall Study|Withdrawal by Subject|0
1380697|NCT01405950|4556041|P3|Overall Study|Withdrawal by Subject|0
1380698|NCT01405950|4556042|P2|Overall Study|Withdrawal by Subject|0
1380699|NCT01405950|4556043|P1|Overall Study|Withdrawal by Subject|1
1380700|NCT01405924|4556078|P1|Overall Study|Missing/Incomplete Data|2
1380701|NCT01405924|4556078|P1|Overall Study|Protocol Violation|8
1380702|NCT01405898|4556090|P2|Overall Study|Withdrawal by Subject|2
1380703|NCT01405898|4556091|P1|Overall Study|Withdrawal by Subject|2
1380704|NCT01405820|4556115|P6|Open-Label Treatment Period|Adverse Event|0
1380705|NCT01405820|4556116|P5|Open-Label Treatment Period|Adverse Event|0
1380706|NCT01405820|4556117|P4|Open-Label Treatment Period|Adverse Event|1
1380707|NCT01405820|4556118|P3|Open-Label Treatment Period|Adverse Event|0
1380708|NCT01405820|4556119|P2|Open-Label Treatment Period|Adverse Event|0
1380709|NCT01405820|4556120|P1|Open-Label Treatment Period|Adverse Event|0
1380710|NCT01405820|4556115|P6|Open-Label Treatment Period|Physician Decision|0
1380711|NCT01405820|4556116|P5|Open-Label Treatment Period|Physician Decision|1
1380712|NCT01405820|4556117|P4|Open-Label Treatment Period|Physician Decision|2
1380713|NCT01405820|4556118|P3|Open-Label Treatment Period|Physician Decision|1
1380714|NCT01405820|4556119|P2|Open-Label Treatment Period|Physician Decision|0
1380715|NCT01405820|4556120|P1|Open-Label Treatment Period|Physician Decision|0
1380716|NCT01405820|4556115|P6|Open-Label Treatment Period|Not Specified|1
1380717|NCT01405820|4556116|P5|Open-Label Treatment Period|Not Specified|1
1380718|NCT01405820|4556117|P4|Open-Label Treatment Period|Not Specified|1
1380719|NCT01405820|4556118|P3|Open-Label Treatment Period|Not Specified|1
1380720|NCT01405820|4556119|P2|Open-Label Treatment Period|Not Specified|1
1380721|NCT01405820|4556120|P1|Open-Label Treatment Period|Not Specified|1
1380722|NCT01405820|4556115|P6|Open-Label Treatment Period|Withdrawal by Subject|1
1380723|NCT01405820|4556116|P5|Open-Label Treatment Period|Withdrawal by Subject|0
1380724|NCT01405820|4556117|P4|Open-Label Treatment Period|Withdrawal by Subject|1
1380725|NCT01405820|4556118|P3|Open-Label Treatment Period|Withdrawal by Subject|1
1380726|NCT01405820|4556119|P2|Open-Label Treatment Period|Withdrawal by Subject|1
1380727|NCT01405820|4556120|P1|Open-Label Treatment Period|Withdrawal by Subject|3
1380728|NCT01405820|4556115|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
1380729|NCT01405820|4556116|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
1380730|NCT01405820|4556117|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
1380731|NCT01405820|4556118|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
1380732|NCT01405820|4556119|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
1380733|NCT01405820|4556120|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
1380734|NCT01405820|4556115|P6|Randomized Treatment Period|Death|0
1380735|NCT01405820|4556116|P5|Randomized Treatment Period|Death|0
1380736|NCT01405820|4556117|P4|Randomized Treatment Period|Death|1
1380737|NCT01405820|4556118|P3|Randomized Treatment Period|Death|0
1380738|NCT01405820|4556119|P2|Randomized Treatment Period|Death|0
1380739|NCT01405820|4556120|P1|Randomized Treatment Period|Death|0
1380740|NCT01405820|4556115|P6|Randomized Treatment Period|Treatment Arm Closed|28
1380741|NCT01405820|4556116|P5|Randomized Treatment Period|Treatment Arm Closed|33
1380742|NCT01405820|4556117|P4|Randomized Treatment Period|Treatment Arm Closed|36
1380743|NCT01405820|4556118|P3|Randomized Treatment Period|Treatment Arm Closed|20
1380744|NCT01405820|4556119|P2|Randomized Treatment Period|Treatment Arm Closed|0
1380745|NCT01405820|4556120|P1|Randomized Treatment Period|Treatment Arm Closed|0
1380746|NCT01405820|4556115|P6|Randomized Treatment Period|Incorrect Study Treatment|0
1380747|NCT01405820|4556116|P5|Randomized Treatment Period|Incorrect Study Treatment|2
1380748|NCT01405820|4556117|P4|Randomized Treatment Period|Incorrect Study Treatment|0
1380749|NCT01405820|4556118|P3|Randomized Treatment Period|Incorrect Study Treatment|3
1380750|NCT01405820|4556119|P2|Randomized Treatment Period|Incorrect Study Treatment|0
1380751|NCT01405820|4556120|P1|Randomized Treatment Period|Incorrect Study Treatment|0
1380752|NCT01405820|4556115|P6|Randomized Treatment Period|Rescue|8
1380753|NCT01405820|4556116|P5|Randomized Treatment Period|Rescue|8
1380754|NCT01405820|4556117|P4|Randomized Treatment Period|Rescue|10
1380755|NCT01405820|4556118|P3|Randomized Treatment Period|Rescue|13
1380756|NCT01405820|4556119|P2|Randomized Treatment Period|Rescue|1
1380757|NCT01405820|4556120|P1|Randomized Treatment Period|Rescue|0
1380758|NCT01405820|4556115|P6|Randomized Treatment Period|Physician Decision|0
1380759|NCT01405820|4556116|P5|Randomized Treatment Period|Physician Decision|0
1380760|NCT01405820|4556117|P4|Randomized Treatment Period|Physician Decision|0
1380761|NCT01405820|4556118|P3|Randomized Treatment Period|Physician Decision|1
1380762|NCT01405820|4556119|P2|Randomized Treatment Period|Physician Decision|2
1380763|NCT01405820|4556120|P1|Randomized Treatment Period|Physician Decision|0
1380764|NCT01405820|4556115|P6|Randomized Treatment Period|Not Specified|0
1380765|NCT01405820|4556116|P5|Randomized Treatment Period|Not Specified|0
1380766|NCT01405820|4556117|P4|Randomized Treatment Period|Not Specified|1
1380767|NCT01405820|4556118|P3|Randomized Treatment Period|Not Specified|1
1380768|NCT01405820|4556119|P2|Randomized Treatment Period|Not Specified|2
1380769|NCT01405820|4556120|P1|Randomized Treatment Period|Not Specified|2
1380770|NCT01405820|4556115|P6|Randomized Treatment Period|Withdrawal by Subject|0
1380771|NCT01405820|4556116|P5|Randomized Treatment Period|Withdrawal by Subject|0
1380772|NCT01405820|4556117|P4|Randomized Treatment Period|Withdrawal by Subject|2
1380773|NCT01405820|4556118|P3|Randomized Treatment Period|Withdrawal by Subject|2
1380774|NCT01405820|4556119|P2|Randomized Treatment Period|Withdrawal by Subject|2
1380775|NCT01405820|4556120|P1|Randomized Treatment Period|Withdrawal by Subject|6
1380776|NCT01405820|4556115|P6|Randomized Treatment Period|Adverse Event|1
1380777|NCT01405820|4556116|P5|Randomized Treatment Period|Adverse Event|2
1380778|NCT01405820|4556117|P4|Randomized Treatment Period|Adverse Event|0
1380779|NCT01405820|4556118|P3|Randomized Treatment Period|Adverse Event|3
1380780|NCT01405820|4556119|P2|Randomized Treatment Period|Adverse Event|3
1380781|NCT01405820|4556120|P1|Randomized Treatment Period|Adverse Event|3
1380782|NCT01405768|4556216|P2|Overall Study|Didn't complete questionnaire correctly|0
1380783|NCT01405768|4556217|P1|Overall Study|Didn't complete questionnaire correctly|4
1380784|NCT01405742|4556229|P2|Overall Study|Lost to Follow-up|0
1380785|NCT01405742|4556230|P1|Overall Study|Lost to Follow-up|1
1380786|NCT01405560|4556240|P1|Overall Study|Physician Decision|1
1380787|NCT01405508|4556255|P4|Overall Study|AE, non-serious non-fatal|0
1380788|NCT01405508|4556256|P3|Overall Study|AE, non-serious non-fatal|0
1380789|NCT01405508|4556257|P2|Overall Study|AE, non-serious non-fatal|1
1380790|NCT01405508|4556258|P1|Overall Study|AE, non-serious non-fatal|1
1380791|NCT01405456|4556290|P2|Overall Study|Physician Decision|0
1380792|NCT01405456|4556291|P1|Overall Study|Physician Decision|1
1380793|NCT01405456|4556290|P2|Overall Study|Lost to Follow-up|1
1380794|NCT01405456|4556291|P1|Overall Study|Lost to Follow-up|2
1380795|NCT01405196|4556331|P4|Overall Study|Lost to Follow-up|1
1380796|NCT01405196|4556332|P3|Overall Study|Lost to Follow-up|3
1380797|NCT01405196|4556333|P2|Overall Study|Lost to Follow-up|2
1380798|NCT01405196|4556334|P1|Overall Study|Lost to Follow-up|2
1380799|NCT01405196|4556331|P4|Overall Study|Death|0
1380800|NCT01405196|4556332|P3|Overall Study|Death|3
1380801|NCT01405196|4556333|P2|Overall Study|Death|0
1380802|NCT01405196|4556334|P1|Overall Study|Death|1
1380803|NCT01405196|4556331|P4|Overall Study|Adverse Event|2
1380804|NCT01405196|4556332|P3|Overall Study|Adverse Event|0
1380805|NCT01405196|4556333|P2|Overall Study|Adverse Event|2
1380806|NCT01405196|4556334|P1|Overall Study|Adverse Event|2
1380807|NCT01405196|4556331|P4|Overall Study|Withdrawal by Subject|6
1380808|NCT01405196|4556332|P3|Overall Study|Withdrawal by Subject|3
1380809|NCT01405196|4556333|P2|Overall Study|Withdrawal by Subject|6
1380810|NCT01405196|4556334|P1|Overall Study|Withdrawal by Subject|4
1380811|NCT01405196|4556331|P4|Overall Study|Other|0
1380812|NCT01405196|4556332|P3|Overall Study|Other|5
1380813|NCT01405196|4556333|P2|Overall Study|Other|2
1380814|NCT01405196|4556334|P1|Overall Study|Other|2
1380815|NCT01405196|4556331|P4|Overall Study|Study Terminated by Sponsor|0
1380816|NCT01405196|4556332|P3|Overall Study|Study Terminated by Sponsor|9
1380817|NCT01405196|4556333|P2|Overall Study|Study Terminated by Sponsor|0
1380818|NCT01405196|4556334|P1|Overall Study|Study Terminated by Sponsor|0
1380819|NCT01405027|4556421|P2|Overall Study|Other or Unknown|25
1380820|NCT01405027|4556422|P1|Overall Study|Other or Unknown|12
1380821|NCT01405027|4556421|P2|Overall Study|Death|0
1380822|NCT01405027|4556422|P1|Overall Study|Death|1
1380823|NCT01405027|4556421|P2|Overall Study|Investigator judgement|2
1380824|NCT01405027|4556422|P1|Overall Study|Investigator judgement|0
1380825|NCT01405027|4556421|P2|Overall Study|Lost to Follow-up|24
1380826|NCT01405027|4556422|P1|Overall Study|Lost to Follow-up|16
1380827|NCT01405027|4556421|P2|Overall Study|Withdrawn consent|0
1380828|NCT01405027|4556422|P1|Overall Study|Withdrawn consent|3
1380829|NCT01404988|4556439|P3|Overall Study|Lost to Follow-up|1
1380830|NCT01404988|4556440|P2|Overall Study|Lost to Follow-up|2
1380831|NCT01404988|4556441|P1|Overall Study|Lost to Follow-up|1
1380832|NCT01404988|4556439|P3|Overall Study|Withdrawal by Subject|0
1380833|NCT01404988|4556440|P2|Overall Study|Withdrawal by Subject|2
1380834|NCT01404988|4556441|P1|Overall Study|Withdrawal by Subject|2
1380835|NCT01404988|4556439|P3|Overall Study|Adverse Event|0
1380836|NCT01404988|4556440|P2|Overall Study|Adverse Event|0
1380837|NCT01404988|4556441|P1|Overall Study|Adverse Event|1
1380838|NCT01404988|4556439|P3|Overall Study|Death|2
1380839|NCT01404988|4556440|P2|Overall Study|Death|0
1380840|NCT01404988|4556441|P1|Overall Study|Death|2
1380841|NCT01404234|4556569|P1|Overall Study|Withdrawal by Subject|2
1380842|NCT01404208|4556585|P2|Overall Study|Discontinued|0
1380843|NCT01404208|4556586|P1|Overall Study|Discontinued|3
1380844|NCT01403987|4556651|P3|Overall Study|Residents forgot their secret PIN|18
1380845|NCT01403987|4556652|P2|Overall Study|Residents forgot their secret PIN|17
1380846|NCT01403987|4556653|P1|Overall Study|Residents forgot their secret PIN|18
1380847|NCT01403805|4556669|P2|Overall Study|Death|1
1380848|NCT01403805|4556670|P1|Overall Study|Death|0
1380849|NCT01403805|4556669|P2|Overall Study|Lost to Follow-up|2
1380850|NCT01403805|4556670|P1|Overall Study|Lost to Follow-up|0
1380851|NCT01403805|4556669|P2|Overall Study|Withdrawal by Subject|4
1380852|NCT01403805|4556670|P1|Overall Study|Withdrawal by Subject|0
1380853|NCT01403194|4556714|P1|Overall Study|Lost to Follow-up|8
1380854|NCT01403194|4556714|P1|Overall Study|Screen Failure|2
1380855|NCT01403116|4556722|P2|Overall Study|unable to keep appointments|2
1380856|NCT01403116|4556723|P1|Overall Study|unable to keep appointments|0
1380857|NCT01403116|4556722|P2|Overall Study|Hct >54%|0
1380858|NCT01403116|4556723|P1|Overall Study|Hct >54%|2
1380859|NCT01403116|4556722|P2|Overall Study|undisclosed Hx of Prostate Ca|0
1380860|NCT01403116|4556723|P1|Overall Study|undisclosed Hx of Prostate Ca|1
1380861|NCT01403116|4556722|P2|Overall Study|Protocol Violation|1
1380862|NCT01403116|4556723|P1|Overall Study|Protocol Violation|0
1380863|NCT01403116|4556722|P2|Overall Study|Non-compliance of study drug|0
1380864|NCT01403116|4556723|P1|Overall Study|Non-compliance of study drug|3
1380865|NCT01403116|4556722|P2|Overall Study|Withdrawal by Subject|15
1380866|NCT01403116|4556723|P1|Overall Study|Withdrawal by Subject|12
1380867|NCT01403116|4556722|P2|Overall Study|Lost to Follow-up|5
1380868|NCT01403116|4556723|P1|Overall Study|Lost to Follow-up|7
1380869|NCT01403116|4556722|P2|Overall Study|Adverse Event|4
1380870|NCT01403116|4556723|P1|Overall Study|Adverse Event|7
1380871|NCT01403051|4556736|P2|Overall Study|Lost to Follow-up|5
1380872|NCT01403051|4556737|P1|Overall Study|Lost to Follow-up|5
1380873|NCT01403051|4556736|P2|Overall Study|Withdrawal by Subject|1
1380874|NCT01403051|4556737|P1|Overall Study|Withdrawal by Subject|2
1380875|NCT01403051|4556736|P2|Overall Study|Death|0
1380876|NCT01403051|4556737|P1|Overall Study|Death|1
1380877|NCT01403051|4556736|P2|Overall Study|Protocol Violation|0
1380878|NCT01403051|4556737|P1|Overall Study|Protocol Violation|2
1380879|NCT01402986|4556773|P4|Overall Study|Other|6
1380880|NCT01402986|4556774|P3|Overall Study|Other|1
1380881|NCT01402986|4556775|P2|Overall Study|Other|5
1380882|NCT01402986|4556776|P1|Overall Study|Other|2
1380883|NCT01402986|4556773|P4|Overall Study|Lost to Follow-up|1
1380884|NCT01402986|4556774|P3|Overall Study|Lost to Follow-up|0
1380885|NCT01402986|4556775|P2|Overall Study|Lost to Follow-up|0
1380886|NCT01402986|4556776|P1|Overall Study|Lost to Follow-up|0
1380887|NCT01402986|4556773|P4|Overall Study|Death|2
1380888|NCT01402986|4556774|P3|Overall Study|Death|0
1380889|NCT01402986|4556775|P2|Overall Study|Death|0
1380890|NCT01402986|4556776|P1|Overall Study|Death|0
1380891|NCT01402986|4556773|P4|Overall Study|Withdrawal by Subject|13
1380892|NCT01402986|4556774|P3|Overall Study|Withdrawal by Subject|7
1380893|NCT01402986|4556775|P2|Overall Study|Withdrawal by Subject|10
1380894|NCT01402986|4556776|P1|Overall Study|Withdrawal by Subject|7
1380895|NCT01402947|4556911|P2|First Intervention|Adverse Event|1
1380896|NCT01402947|4556912|P1|First Intervention|Adverse Event|0
1380897|NCT01402869|4556923|P3|Overall Study|Required Tooth Extraction|1
1380898|NCT01402869|4556924|P2|Overall Study|Required Tooth Extraction|0
1380899|NCT01402869|4556925|P1|Overall Study|Required Tooth Extraction|0
1380900|NCT01402817|4556939|P1|Overall Study|Study Suspended by FDA|8
1380901|NCT01402817|4556939|P1|Overall Study|Withdrawal by Subject|3
1380902|NCT01402700|4556944|P1|Overall Study|Missed Visit|1
1380903|NCT01402700|4556944|P1|Overall Study|Withdrawal by Subject|3
1380904|NCT01402700|4556944|P1|Overall Study|Death|3
1380905|NCT01402570|4556948|P1|Overall Study|Adverse Event|1
1380906|NCT01402284|4557019|P1|Overall Study|Non compliance|2
1380907|NCT01402284|4557019|P1|Overall Study|Disease progression on study|9
1380908|NCT01402284|4557019|P1|Overall Study|Physician Decision|1
1380909|NCT01402284|4557019|P1|Overall Study|Follows up at Memorial Sloan Kettering|2
1380910|NCT01402284|4557019|P1|Overall Study|Withdrawal consent|1
1380911|NCT01402102|4557101|P2|Overall Study|Withdrawal by Subject|2
1380912|NCT01402102|4557102|P1|Overall Study|Withdrawal by Subject|0
1380913|NCT01402102|4557101|P2|Overall Study|Insufficiency of compliance|1
1380914|NCT01402102|4557102|P1|Overall Study|Insufficiency of compliance|1
1380915|NCT01402102|4557101|P2|Overall Study|Protocol Violation|0
1380916|NCT01402102|4557102|P1|Overall Study|Protocol Violation|1
1380917|NCT01402063|4557122|P2|Overall Study|Withdrawal by Subject|3
1380918|NCT01402063|4557123|P1|Overall Study|Withdrawal by Subject|3
1380919|NCT01402011|4557132|P3|Nine Month Follow-up|Withdrawal by Subject|0
1380920|NCT01402011|4557133|P2|Nine Month Follow-up|Withdrawal by Subject|1
1380921|NCT01402011|4557134|P1|Nine Month Follow-up|Withdrawal by Subject|0
1380922|NCT01402011|4557132|P3|Active Treatment Period|Withdrawal by Subject|0
1380923|NCT01402011|4557133|P2|Active Treatment Period|Withdrawal by Subject|3
1380924|NCT01402011|4557134|P1|Active Treatment Period|Withdrawal by Subject|1
1380925|NCT01402011|4557132|P3|Delayed Treatment Period|Withdrawal by Subject|0
1380926|NCT01402011|4557133|P2|Delayed Treatment Period|Withdrawal by Subject|0
1380927|NCT01402011|4557134|P1|Delayed Treatment Period|Withdrawal by Subject|1
1380928|NCT01401959|4557163|P3|Treated|Protocol Violation|0
1380929|NCT01401959|4557164|P2|Treated|Protocol Violation|1
1380930|NCT01401959|4557165|P1|Treated|Protocol Violation|0
1380931|NCT01401959|4557163|P3|Treated|Withdrawal by Subject|2
1380932|NCT01401959|4557164|P2|Treated|Withdrawal by Subject|2
1380933|NCT01401959|4557165|P1|Treated|Withdrawal by Subject|1
1380934|NCT01401959|4557163|P3|Treated|Adverse Event|2
1380935|NCT01401959|4557164|P2|Treated|Adverse Event|3
1380936|NCT01401959|4557165|P1|Treated|Adverse Event|4
1380937|NCT01401959|4557163|P3|Treated|Disease Progression|1
1380938|NCT01401959|4557164|P2|Treated|Disease Progression|2
1380939|NCT01401959|4557165|P1|Treated|Disease Progression|2
1380940|NCT01401959|4557163|P3|Enrolled|Withdrawal by Subject|0
1380941|NCT01401959|4557164|P2|Enrolled|Withdrawal by Subject|0
1380942|NCT01401959|4557165|P1|Enrolled|Withdrawal by Subject|1
1380943|NCT01401842|4557202|P2|Overall Study|other/unknown|17
1380944|NCT01401842|4557203|P1|Overall Study|other/unknown|28
1380945|NCT01401842|4557202|P2|Overall Study|on profile|5
1380946|NCT01401842|4557203|P1|Overall Study|on profile|9
1380947|NCT01401842|4557202|P2|Overall Study|invalid follow-up strength data|4
1380948|NCT01401842|4557203|P1|Overall Study|invalid follow-up strength data|1
1380949|NCT01401842|4557202|P2|Overall Study|discharged from US Army|4
1380950|NCT01401842|4557203|P1|Overall Study|discharged from US Army|3
1380951|NCT01401842|4557202|P2|Overall Study|changed companies|34
1380952|NCT01401842|4557203|P1|Overall Study|changed companies|20
1380953|NCT01401842|4557202|P2|Overall Study|academic reason|1
1380954|NCT01401842|4557203|P1|Overall Study|academic reason|4
1380955|NCT01401842|4557202|P2|Overall Study|Withdrawal by Subject|2
1380956|NCT01401842|4557203|P1|Overall Study|Withdrawal by Subject|3
1380957|NCT01401647|4557216|P3|Overall Study|Lost to Follow-up|1
1380958|NCT01401647|4557217|P2|Overall Study|Lost to Follow-up|3
1380959|NCT01401647|4557218|P1|Overall Study|Lost to Follow-up|3
1380960|NCT01401647|4557216|P3|Overall Study|Withdrawal by Subject|2
1380961|NCT01401647|4557217|P2|Overall Study|Withdrawal by Subject|5
1380962|NCT01401647|4557218|P1|Overall Study|Withdrawal by Subject|1
1380963|NCT01401478|4557273|P1|Overall Study|Serious adverse event|1
1380964|NCT01401478|4557273|P1|Overall Study|Low intact parathyroid hormone|1
1380965|NCT01401478|4557273|P1|Overall Study|Hyperphosphatemia and adverse event|1
1380966|NCT01401478|4557273|P1|Overall Study|Blood samples not available|1
1380967|NCT01401478|4557273|P1|Overall Study|Withdrawal by Subject|3
1380968|NCT01401478|4557273|P1|Overall Study|Kidney transplantation|3
1380969|NCT01401478|4557273|P1|Overall Study|Lost to Follow-up|5
1380970|NCT01401478|4557273|P1|Overall Study|Hyperphosphatemia|5
1380971|NCT01401478|4557273|P1|Overall Study|Adverse Event|5
1380972|NCT01401478|4557273|P1|Overall Study|Study drug not available|6
1380973|NCT01401465|4557286|P2|Treatment Period 2|Withdrawal by Subject|1
1380974|NCT01401465|4557287|P1|Treatment Period 2|Withdrawal by Subject|0
1380975|NCT01401465|4557286|P2|Treatment Period 2|Lost to Follow-up|1
1380976|NCT01401465|4557287|P1|Treatment Period 2|Lost to Follow-up|0
1380977|NCT01401465|4557286|P2|Treatment Period 1|Scheduling Difficulties|1
1380978|NCT01401465|4557287|P1|Treatment Period 1|Scheduling Difficulties|1
1380979|NCT01401465|4557286|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
1380980|NCT01401465|4557287|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
1380981|NCT01401465|4557286|P2|Treatment Period 1|Non-Compliance to Study Drug|0
1380982|NCT01401465|4557287|P1|Treatment Period 1|Non-Compliance to Study Drug|1
1380983|NCT01401465|4557286|P2|Treatment Period 1|Withdrawal by Subject|4
1380984|NCT01401465|4557287|P1|Treatment Period 1|Withdrawal by Subject|1
1380985|NCT01401465|4557286|P2|Treatment Period 1|Protocol Violation|0
1380986|NCT01401465|4557287|P1|Treatment Period 1|Protocol Violation|5
1380987|NCT01401465|4557286|P2|Treatment Period 1|Pregnancy|1
1380988|NCT01401465|4557287|P1|Treatment Period 1|Pregnancy|0
1380989|NCT01401465|4557286|P2|Treatment Period 1|Adverse Event|1
1380990|NCT01401465|4557287|P1|Treatment Period 1|Adverse Event|4
1380991|NCT01401452|4557350|P1|Overall Study|Participant withdrew consent|1
1380992|NCT01401452|4557350|P1|Overall Study|Subject chose to discontinue treatment|1
1380993|NCT01401452|4557350|P1|Overall Study|Subject withdrew because of Tx success|1
1380994|NCT01401452|4557350|P1|Overall Study|Unsatisfactory output|1
1380995|NCT01401452|4557350|P1|Overall Study|Treatment failure|1
1380996|NCT01401452|4557350|P1|Overall Study|Discontinuation for personal reasons|1
1380997|NCT01401452|4557350|P1|Overall Study|Participant stopped Tx|2
1380998|NCT01401452|4557350|P1|Overall Study|Psoriatic arthritis|1
1380999|NCT01401452|4557350|P1|Overall Study|Subject's wife wants to get pregnant|1
1381000|NCT01401452|4557350|P1|Overall Study|Subject moved to another city|1
1381001|NCT01401452|4557350|P1|Overall Study|Subject didn't return for routine visits|1
1381002|NCT01401452|4557350|P1|Overall Study|Subject did not come to follow up visits|2
1381003|NCT01401452|4557350|P1|Overall Study|No more visits within the 36 wk followup|4
1381004|NCT01401452|4557350|P1|Overall Study|Tx stopped by psychiatrist|1
1381005|NCT01401452|4557350|P1|Overall Study|Tx stopped due to financial reasons|1
1381006|NCT01401452|4557350|P1|Overall Study|Participant developed breast cancer|1
1381007|NCT01401452|4557350|P1|Overall Study|Lack of Efficacy|30
1381008|NCT01401452|4557350|P1|Overall Study|Lost to Follow-up|12
1381009|NCT01401452|4557350|P1|Overall Study|Adverse reaction|9
1381010|NCT01401361|4557362|P1|Overall Study|Subject/family decision post procedure|2
1381011|NCT01401361|4557362|P1|Overall Study|Lost to Follow-up|3
1381012|NCT01401361|4557362|P1|Overall Study|Physician Decision|1
1381013|NCT01401361|4557362|P1|Overall Study|Lack of Efficacy|6
1381014|NCT01401361|4557362|P1|Overall Study|Withdrawal by Subject|16
1381015|NCT01401322|4557368|P1|Overall Study|Physician Decision|1
1381016|NCT01401322|4557368|P1|Overall Study|Withdrawal by Subject|1
1381017|NCT01401283|4557374|P2|Overall Study|suspicion of malignant hyperthermia|1
1381018|NCT01401283|4557375|P1|Overall Study|suspicion of malignant hyperthermia|0
1381019|NCT01401283|4557374|P2|Overall Study|no central venous access|1
1381020|NCT01401283|4557375|P1|Overall Study|no central venous access|0
1381021|NCT01401283|4557374|P2|Overall Study|preoperative arrhythmia|0
1381022|NCT01401283|4557375|P1|Overall Study|preoperative arrhythmia|5
1381023|NCT01401283|4557374|P2|Overall Study|surgery cancelled|8
1381024|NCT01401283|4557375|P1|Overall Study|surgery cancelled|5
1381025|NCT01401153|4557441|P2|Second Test Day|illness|5
1381026|NCT01401153|4557442|P1|Second Test Day|illness|0
1381027|NCT01401153|4557441|P2|First Test Day|Learning disabilities; illness|10
1381028|NCT01401153|4557442|P1|First Test Day|Learning disabilities; illness|1
1381029|NCT01401062|4557489|P2|Overall Study|Withdrawal by Subject|1
1381030|NCT01401062|4557490|P1|Overall Study|Withdrawal by Subject|1
1381031|NCT01401062|4557489|P2|Overall Study|Physician Decision|0
1381032|NCT01401062|4557490|P1|Overall Study|Physician Decision|1
1381033|NCT01401062|4557489|P2|Overall Study|Death|7
1381034|NCT01401062|4557490|P1|Overall Study|Death|9
1381035|NCT01401010|4557517|P2|Overall Study|Could not interpret assay results|0
1381036|NCT01401010|4557518|P1|Overall Study|Could not interpret assay results|1
1381037|NCT01400958|4557543|P2|Overall Study|Adverse Event|0
1381038|NCT01400958|4557544|P1|Overall Study|Adverse Event|1
1381039|NCT01400958|4557543|P2|Overall Study|Withdrawal by Subject|1
1381040|NCT01400958|4557544|P1|Overall Study|Withdrawal by Subject|0
1381041|NCT01400958|4557543|P2|Overall Study|Physician Decision|1
1381042|NCT01400958|4557544|P1|Overall Study|Physician Decision|0
1381043|NCT01400932|4557554|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
1381044|NCT01400932|4557555|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
1381045|NCT01400932|4557554|P2|Overall Study|Protocol Deviation|1
1381046|NCT01400932|4557555|P1|Overall Study|Protocol Deviation|0
1381047|NCT01400932|4557554|P2|Overall Study|Lost to Follow-up|0
1381048|NCT01400932|4557555|P1|Overall Study|Lost to Follow-up|1
1381049|NCT01400932|4557554|P2|Overall Study|Withdrawal by Subject|6
1381050|NCT01400932|4557555|P1|Overall Study|Withdrawal by Subject|2
1381051|NCT01400932|4557554|P2|Overall Study|Lack of Efficacy|3
1381052|NCT01400932|4557555|P1|Overall Study|Lack of Efficacy|0
1381053|NCT01400932|4557554|P2|Overall Study|Adverse Event|5
1381054|NCT01400932|4557555|P1|Overall Study|Adverse Event|10
1381055|NCT01400919|4557577|P1|Overall Study|Missed visit|2
1381056|NCT01400919|4557577|P1|Overall Study|Lost to Follow-up|2
1381057|NCT01400919|4557577|P1|Overall Study|Withdrawal by Subject|4
1381058|NCT01400893|4557620|P2|Overall Study|Lost to Follow-up|6
1381059|NCT01400893|4557621|P1|Overall Study|Lost to Follow-up|0
1381060|NCT01400893|4557620|P2|Overall Study|Death|21
1381061|NCT01400893|4557621|P1|Overall Study|Death|27
1381062|NCT01400841|4557633|P1|Extended Study Phase (2 Years)|Adverse Event|2
1381063|NCT01400841|4557633|P1|Initial Study Phase (6 Months)|Death|1
1381064|NCT01400698|4557671|P6|Overall Study|Other|0
1381065|NCT01400698|4557672|P5|Overall Study|Other|1
1381066|NCT01400698|4557673|P4|Overall Study|Other|2
1381067|NCT01400698|4557674|P3|Overall Study|Other|0
1381068|NCT01400698|4557675|P2|Overall Study|Other|2
1381069|NCT01400698|4557676|P1|Overall Study|Other|4
1381070|NCT01400698|4557671|P6|Overall Study|Adverse Event|0
1381071|NCT01400698|4557672|P5|Overall Study|Adverse Event|0
1381072|NCT01400698|4557673|P4|Overall Study|Adverse Event|0
1381073|NCT01400698|4557674|P3|Overall Study|Adverse Event|0
1381074|NCT01400698|4557675|P2|Overall Study|Adverse Event|0
1381075|NCT01400698|4557676|P1|Overall Study|Adverse Event|1
1381076|NCT01400698|4557671|P6|Overall Study|Non-compliance|0
1381077|NCT01400698|4557672|P5|Overall Study|Non-compliance|0
1381078|NCT01400698|4557673|P4|Overall Study|Non-compliance|1
1381079|NCT01400698|4557674|P3|Overall Study|Non-compliance|0
1381080|NCT01400698|4557675|P2|Overall Study|Non-compliance|1
1381081|NCT01400698|4557676|P1|Overall Study|Non-compliance|0
1381082|NCT01400698|4557671|P6|Overall Study|Protocol Violation|0
1381083|NCT01400698|4557672|P5|Overall Study|Protocol Violation|1
1381084|NCT01400698|4557673|P4|Overall Study|Protocol Violation|0
1381085|NCT01400698|4557674|P3|Overall Study|Protocol Violation|0
1381086|NCT01400698|4557675|P2|Overall Study|Protocol Violation|1
1381087|NCT01400698|4557676|P1|Overall Study|Protocol Violation|0
1381088|NCT01400698|4557671|P6|Overall Study|Withdrawal by Subject|3
1381089|NCT01400698|4557672|P5|Overall Study|Withdrawal by Subject|1
1381090|NCT01400698|4557673|P4|Overall Study|Withdrawal by Subject|4
1381091|NCT01400698|4557674|P3|Overall Study|Withdrawal by Subject|0
1381092|NCT01400698|4557675|P2|Overall Study|Withdrawal by Subject|2
1381093|NCT01400698|4557676|P1|Overall Study|Withdrawal by Subject|8
1381094|NCT01400698|4557671|P6|Overall Study|Lost to Follow-up|3
1381095|NCT01400698|4557672|P5|Overall Study|Lost to Follow-up|4
1381096|NCT01400698|4557673|P4|Overall Study|Lost to Follow-up|1
1381097|NCT01400698|4557674|P3|Overall Study|Lost to Follow-up|2
1381098|NCT01400698|4557675|P2|Overall Study|Lost to Follow-up|5
1381099|NCT01400698|4557676|P1|Overall Study|Lost to Follow-up|2
1381100|NCT01400516|4557700|P2|Primary Trial|Withdrawal by Subject|2
1381101|NCT01400516|4557701|P1|Primary Trial|Withdrawal by Subject|0
1381102|NCT01400503|4557711|P1|Overall Study|Other|1
1381103|NCT01400503|4557711|P1|Overall Study|Study Terminated by Sponsor|58
1381104|NCT01400503|4557711|P1|Overall Study|Withdrawal by Subject|1
1381105|NCT01400451|4557723|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
1381106|NCT01400451|4557724|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
1381107|NCT01400451|4557725|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
1381108|NCT01400451|4557723|P3|Combination Treatment (or Intended)|Disease Progression|1
1381109|NCT01400451|4557724|P2|Combination Treatment (or Intended)|Disease Progression|1
1381110|NCT01400451|4557725|P1|Combination Treatment (or Intended)|Disease Progression|3
1381111|NCT01400451|4557723|P3|Combination Treatment (or Intended)|Adverse Event|0
1381112|NCT01400451|4557724|P2|Combination Treatment (or Intended)|Adverse Event|0
1381113|NCT01400451|4557725|P1|Combination Treatment (or Intended)|Adverse Event|1
1381114|NCT01400451|4557723|P3|Combination Treatment (or Intended)|Drug Toxicity|0
1381115|NCT01400451|4557724|P2|Combination Treatment (or Intended)|Drug Toxicity|1
1381116|NCT01400451|4557725|P1|Combination Treatment (or Intended)|Drug Toxicity|0
1381117|NCT01400451|4557723|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
1381118|NCT01400451|4557724|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
1381119|NCT01400451|4557725|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
1381120|NCT01400425|4557739|P1|Overall Study|Withdrawal by Subject|10
1381121|NCT01400412|4557752|P2|Overall Study|Never started study treatment|3
1381122|NCT01400412|4557753|P1|Overall Study|Never started study treatment|0
1381123|NCT01400412|4557752|P2|Overall Study|Unable to complete|3
1381124|NCT01400412|4557753|P1|Overall Study|Unable to complete|3
1381125|NCT01400412|4557752|P2|Overall Study|Withdrawal by Subject|4
1381126|NCT01400412|4557753|P1|Overall Study|Withdrawal by Subject|3
1381127|NCT01400412|4557752|P2|Overall Study|Lost to Follow-up|7
1381128|NCT01400412|4557753|P1|Overall Study|Lost to Follow-up|4
1381129|NCT01400243|4557799|P2|Overall Study|Protocol Violation|11
1381130|NCT01400243|4557800|P1|Overall Study|Protocol Violation|8
1381131|NCT01400139|4557822|P1|HYD Extension Period|Administrative|10
1381132|NCT01400139|4557822|P1|HYD Extension Period|Withdrawal by Subject|5
1381133|NCT01400139|4557822|P1|HYD Extension Period|Adverse Event|8
1381134|NCT01400139|4557822|P1|HYD Core Study|Did not qualify for Maintenance Period|14
1381135|NCT01400139|4557822|P1|HYD Core Study|Administrative|56
1381136|NCT01400139|4557822|P1|HYD Core Study|Confirmed or suspected diversion|20
1381137|NCT01400139|4557822|P1|HYD Core Study|Lost to Follow-up|39
1381138|NCT01400139|4557822|P1|HYD Core Study|Withdrawal by Subject|114
1381139|NCT01400139|4557822|P1|HYD Core Study|Lack of Efficacy|59
1381140|NCT01400139|4557822|P1|HYD Core Study|Adverse Event|210
1381141|NCT01400113|4557832|P2|Overall Study|Withdrawal by Subject|1
1381142|NCT01400113|4557833|P1|Overall Study|Withdrawal by Subject|1
1381143|NCT01399788|4557858|P2|First Intervention Period|Adverse Event|0
1381144|NCT01399788|4557859|P1|First Intervention Period|Adverse Event|1
1381145|NCT01399723|4557881|P2|Overall Study|Lost to Follow-up|1
1381146|NCT01399723|4557882|P1|Overall Study|Lost to Follow-up|0
1381147|NCT01399697|4557895|P3|Overall Study|Sponsor Decision|0
1381148|NCT01399697|4557896|P2|Overall Study|Sponsor Decision|0
1381149|NCT01399697|4557897|P1|Overall Study|Sponsor Decision|1
1381150|NCT01399697|4557895|P3|Overall Study|Clinical RA remission|0
1381151|NCT01399697|4557896|P2|Overall Study|Clinical RA remission|0
1381152|NCT01399697|4557897|P1|Overall Study|Clinical RA remission|1
1381153|NCT01399697|4557895|P3|Overall Study|Positive result for hepatitis B|0
1381154|NCT01399697|4557896|P2|Overall Study|Positive result for hepatitis B|0
1381155|NCT01399697|4557897|P1|Overall Study|Positive result for hepatitis B|1
1381156|NCT01399697|4557895|P3|Overall Study|Inclusion Error|0
1381157|NCT01399697|4557896|P2|Overall Study|Inclusion Error|0
1381158|NCT01399697|4557897|P1|Overall Study|Inclusion Error|2
1381159|NCT01399697|4557895|P3|Overall Study|Non-Compliant|0
1381160|NCT01399697|4557896|P2|Overall Study|Non-Compliant|0
1381161|NCT01399697|4557897|P1|Overall Study|Non-Compliant|1
1381162|NCT01399697|4557895|P3|Overall Study|Protocol Violation|0
1381163|NCT01399697|4557896|P2|Overall Study|Protocol Violation|0
1381164|NCT01399697|4557897|P1|Overall Study|Protocol Violation|2
1381165|NCT01399697|4557895|P3|Overall Study|Lack of Efficacy|1
1381166|NCT01399697|4557896|P2|Overall Study|Lack of Efficacy|0
1381167|NCT01399697|4557897|P1|Overall Study|Lack of Efficacy|9
1381168|NCT01399697|4557895|P3|Overall Study|Investigator Decisión|2
1381169|NCT01399697|4557896|P2|Overall Study|Investigator Decisión|0
1381170|NCT01399697|4557897|P1|Overall Study|Investigator Decisión|1
1381171|NCT01399697|4557895|P3|Overall Study|Withdrawal by Subject|0
1381172|NCT01399697|4557896|P2|Overall Study|Withdrawal by Subject|0
1381173|NCT01399697|4557897|P1|Overall Study|Withdrawal by Subject|8
1381174|NCT01399697|4557895|P3|Overall Study|Lost to Follow-up|0
1381175|NCT01399697|4557896|P2|Overall Study|Lost to Follow-up|0
1381176|NCT01399697|4557897|P1|Overall Study|Lost to Follow-up|2
1381177|NCT01399697|4557895|P3|Overall Study|Adverse Event|1
1381178|NCT01399697|4557896|P2|Overall Study|Adverse Event|3
1381179|NCT01399697|4557897|P1|Overall Study|Adverse Event|13
1381180|NCT01399619|4557924|P4|Overall Study|Not treated|2
1381181|NCT01399619|4557925|P3|Overall Study|Not treated|0
1381182|NCT01399619|4557926|P2|Overall Study|Not treated|0
1381183|NCT01399619|4557927|P1|Overall Study|Not treated|0
1381184|NCT01399619|4557924|P4|Overall Study|Protocol Violation|1
1381185|NCT01399619|4557925|P3|Overall Study|Protocol Violation|0
1381186|NCT01399619|4557926|P2|Overall Study|Protocol Violation|0
1381187|NCT01399619|4557927|P1|Overall Study|Protocol Violation|0
1381188|NCT01399619|4557924|P4|Overall Study|Withdrawal by Subject|4
1381189|NCT01399619|4557925|P3|Overall Study|Withdrawal by Subject|3
1381190|NCT01399619|4557926|P2|Overall Study|Withdrawal by Subject|0
1381191|NCT01399619|4557927|P1|Overall Study|Withdrawal by Subject|6
1381192|NCT01399619|4557924|P4|Overall Study|Lack of Efficacy|0
1381193|NCT01399619|4557925|P3|Overall Study|Lack of Efficacy|5
1381194|NCT01399619|4557926|P2|Overall Study|Lack of Efficacy|0
1381195|NCT01399619|4557927|P1|Overall Study|Lack of Efficacy|9
1381196|NCT01399619|4557924|P4|Overall Study|Adverse Event|10
1381197|NCT01399619|4557925|P3|Overall Study|Adverse Event|4
1381198|NCT01399619|4557926|P2|Overall Study|Adverse Event|0
1381199|NCT01399619|4557927|P1|Overall Study|Adverse Event|10
1381200|NCT01399593|4557990|P2|Overall Study|Transplantectomy|1
1381201|NCT01399593|4557991|P1|Overall Study|Transplantectomy|0
1381202|NCT01399593|4557990|P2|Overall Study|Death|1
1381203|NCT01399593|4557991|P1|Overall Study|Death|1
1381204|NCT01399593|4557990|P2|Overall Study|Adverse Event|0
1381205|NCT01399593|4557991|P1|Overall Study|Adverse Event|1
1381206|NCT01399593|4557990|P2|Overall Study|Physician Decision|0
1381207|NCT01399593|4557991|P1|Overall Study|Physician Decision|1
1381208|NCT01399190|4558024|P1|Overall Study|Physician Decision|2
1381209|NCT01399190|4558024|P1|Overall Study|Participant's Request|5
1381210|NCT01399190|4558024|P1|Overall Study|Adverse Event|8
1381211|NCT01399190|4558024|P1|Overall Study|Not Eligible for Final Analysis|5
1381212|NCT01399125|4558032|P2|Overall Study|Protocol Deviation|2
1381213|NCT01399125|4558033|P1|Overall Study|Protocol Deviation|5
1381214|NCT01399125|4558032|P2|Overall Study|Death|1
1381215|NCT01399125|4558033|P1|Overall Study|Death|0
1381216|NCT01399125|4558032|P2|Overall Study|Administrative Problems|11
1381217|NCT01399125|4558033|P1|Overall Study|Administrative Problems|7
1381218|NCT01399125|4558032|P2|Overall Study|Lost to Follow-up|3
1381219|NCT01399125|4558033|P1|Overall Study|Lost to Follow-up|2
1381220|NCT01399125|4558032|P2|Overall Study|Withdrawal by Subject|8
1381221|NCT01399125|4558033|P1|Overall Study|Withdrawal by Subject|5
1381222|NCT01399125|4558032|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
1381223|NCT01399125|4558033|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
1381224|NCT01399125|4558032|P2|Overall Study|Abnormal Lab values|1
1381225|NCT01399125|4558033|P1|Overall Study|Abnormal Lab values|0
1381226|NCT01399125|4558032|P2|Overall Study|Adverse Event|30
1381227|NCT01399125|4558033|P1|Overall Study|Adverse Event|32
1381228|NCT01399099|4558047|P1|Overall Study|Miscellaneous|4
1381229|NCT01399099|4558047|P1|Overall Study|Infection|1
1381230|NCT01399099|4558047|P1|Overall Study|Skin Irritation|13
1381231|NCT01399099|4558047|P1|Overall Study|Protocol Violation|1
1381232|NCT01399099|4558047|P1|Overall Study|Physician Decision|1
1381233|NCT01399099|4558047|P1|Overall Study|Lost to Follow-up|11
1381234|NCT01399047|4558054|P2|Overall Study|Withdrawal by Subject|1
1381235|NCT01399047|4558055|P1|Overall Study|Withdrawal by Subject|0
1381236|NCT01398956|4558083|P1|Overall Study|Subject moved a long distance|1
1381237|NCT01398956|4558083|P1|Overall Study|Withdrawal Criteria No.3|1
1381238|NCT01398956|4558083|P1|Overall Study|AE, non-serious non-fatal|4
1381239|NCT01398956|4558083|P1|Overall Study|Withdrawal by Subject|4
1381240|NCT01398787|4558115|P1|Overall Study|Adverse Event|1
1381241|NCT01398514|4558133|P2|Overall Study|Failure to show a conditioned response|3
1381242|NCT01398514|4558134|P1|Overall Study|Failure to show a conditioned response|4
1381243|NCT01398514|4558133|P2|Overall Study|Physiologic non-responsiveness|3
1381244|NCT01398514|4558134|P1|Overall Study|Physiologic non-responsiveness|1
1381245|NCT01398514|4558133|P2|Overall Study|Non-compliance with study procedures|0
1381246|NCT01398514|4558134|P1|Overall Study|Non-compliance with study procedures|2
1381247|NCT01398514|4558133|P2|Overall Study|Adverse Event|0
1381248|NCT01398514|4558134|P1|Overall Study|Adverse Event|1
1381249|NCT01398410|4558169|P2|Overall Study|Not Specified|29
1381250|NCT01398410|4558170|P1|Overall Study|Not Specified|36
1381251|NCT01398410|4558169|P2|Overall Study|Inadequate Therapeutic Effect|0
1381252|NCT01398410|4558170|P1|Overall Study|Inadequate Therapeutic Effect|2
1381253|NCT01398410|4558169|P2|Overall Study|Participants Choice|11
1381254|NCT01398410|4558170|P1|Overall Study|Participants Choice|8
1381255|NCT01398410|4558169|P2|Overall Study|Adverse Event|16
1381256|NCT01398410|4558170|P1|Overall Study|Adverse Event|12
1381257|NCT01398358|4558181|P3|Overall Study|no longer eligible|1
1381258|NCT01398358|4558182|P2|Overall Study|no longer eligible|0
1381259|NCT01398358|4558183|P1|Overall Study|no longer eligible|1
1381260|NCT01398358|4558181|P3|Overall Study|Withdrawal by Subject|2
1381261|NCT01398358|4558182|P2|Overall Study|Withdrawal by Subject|2
1381262|NCT01398358|4558183|P1|Overall Study|Withdrawal by Subject|3
1381263|NCT01398358|4558181|P3|Overall Study|Lost to Follow-up|18
1381264|NCT01398358|4558182|P2|Overall Study|Lost to Follow-up|21
1381265|NCT01398358|4558183|P1|Overall Study|Lost to Follow-up|11
1381266|NCT01398176|4558196|P2|Overall Study|Physician Decision|3
1381267|NCT01398176|4558197|P1|Overall Study|Physician Decision|2
1381268|NCT01398176|4558196|P2|Overall Study|Lost to Follow-up|3
1381269|NCT01398176|4558197|P1|Overall Study|Lost to Follow-up|1
1381270|NCT01397890|4558205|P2|Overall Study|Others|1
1381271|NCT01397890|4558206|P1|Overall Study|Others|2
1381272|NCT01397890|4558205|P2|Overall Study|Severe Non-Compliance to Protocol|1
1381273|NCT01397890|4558206|P1|Overall Study|Severe Non-Compliance to Protocol|2
1381274|NCT01397890|4558205|P2|Overall Study|Adverse Event|2
1381275|NCT01397890|4558206|P1|Overall Study|Adverse Event|1
1381276|NCT01397890|4558205|P2|Overall Study|Condition under Investigation Worsened|3
1381277|NCT01397890|4558206|P1|Overall Study|Condition under Investigation Worsened|1
1381278|NCT01397890|4558205|P2|Overall Study|Lost to Follow-up|4
1381279|NCT01397890|4558206|P1|Overall Study|Lost to Follow-up|1
1381280|NCT01397890|4558205|P2|Overall Study|Death|3
1381281|NCT01397890|4558206|P1|Overall Study|Death|2
1381282|NCT01397890|4558205|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
1381283|NCT01397890|4558206|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
1381284|NCT01397890|4558205|P2|Overall Study|Withdrawal by Subject|11
1381285|NCT01397890|4558206|P1|Overall Study|Withdrawal by Subject|7
1381286|NCT01397825|4558277|P5|Overall Study|Withdrawal by Subject|0
1381287|NCT01397825|4558278|P4|Overall Study|Withdrawal by Subject|1
1381288|NCT01397825|4558279|P3|Overall Study|Withdrawal by Subject|5
1381289|NCT01397825|4558280|P2|Overall Study|Withdrawal by Subject|0
1381290|NCT01397825|4558281|P1|Overall Study|Withdrawal by Subject|1
1381291|NCT01397825|4558277|P5|Overall Study|Adverse Event|0
1381292|NCT01397825|4558278|P4|Overall Study|Adverse Event|1
1381293|NCT01397825|4558279|P3|Overall Study|Adverse Event|5
1381294|NCT01397825|4558280|P2|Overall Study|Adverse Event|1
1381295|NCT01397825|4558281|P1|Overall Study|Adverse Event|0
1381296|NCT01397825|4558277|P5|Overall Study|Symptomatic Deterioration|0
1381297|NCT01397825|4558278|P4|Overall Study|Symptomatic Deterioration|0
1381298|NCT01397825|4558279|P3|Overall Study|Symptomatic Deterioration|4
1381299|NCT01397825|4558280|P2|Overall Study|Symptomatic Deterioration|0
1381300|NCT01397825|4558281|P1|Overall Study|Symptomatic Deterioration|2
1381301|NCT01397825|4558277|P5|Overall Study|Progressive Disease|0
1381302|NCT01397825|4558278|P4|Overall Study|Progressive Disease|1
1381303|NCT01397825|4558279|P3|Overall Study|Progressive Disease|11
1381304|NCT01397825|4558280|P2|Overall Study|Progressive Disease|3
1381305|NCT01397825|4558281|P1|Overall Study|Progressive Disease|10
1381306|NCT01397786|4558351|P3|Phase B|Lack of Efficacy|14
1381307|NCT01397786|4558352|P2|Phase B|Lack of Efficacy|7
1381308|NCT01397786|4558353|P1|Phase B|Lack of Efficacy|22
1381309|NCT01397786|4558351|P3|Phase B|Protocol Deviation|4
1381310|NCT01397786|4558352|P2|Phase B|Protocol Deviation|2
1381311|NCT01397786|4558353|P1|Phase B|Protocol Deviation|1
1381312|NCT01397786|4558351|P3|Phase B|Withdrawal by Subject|30
1381313|NCT01397786|4558352|P2|Phase B|Withdrawal by Subject|45
1381314|NCT01397786|4558353|P1|Phase B|Withdrawal by Subject|102
1381315|NCT01397786|4558351|P3|Phase B|Physician Decision|3
1381316|NCT01397786|4558352|P2|Phase B|Physician Decision|1
1381317|NCT01397786|4558353|P1|Phase B|Physician Decision|9
1381318|NCT01397786|4558351|P3|Phase B|Subject Met Withdrawal Criteria|38
1381319|NCT01397786|4558352|P2|Phase B|Subject Met Withdrawal Criteria|5
1381320|NCT01397786|4558353|P1|Phase B|Subject Met Withdrawal Criteria|38
1381321|NCT01397786|4558351|P3|Phase B|Adverse Event|27
1381322|NCT01397786|4558352|P2|Phase B|Adverse Event|23
1381323|NCT01397786|4558353|P1|Phase B|Adverse Event|109
1381324|NCT01397786|4558351|P3|Phase B|Lost to Follow-up|22
1381325|NCT01397786|4558352|P2|Phase B|Lost to Follow-up|12
1381326|NCT01397786|4558353|P1|Phase B|Lost to Follow-up|22
1381327|NCT01397786|4558351|P3|Phase A|Lack of Efficacy|1
1381328|NCT01397786|4558352|P2|Phase A|Lack of Efficacy|0
1381329|NCT01397786|4558353|P1|Phase A|Lack of Efficacy|0
1381330|NCT01397786|4558351|P3|Phase A|Withdrawal by Subject|5
1381331|NCT01397786|4558352|P2|Phase A|Withdrawal by Subject|0
1381332|NCT01397786|4558353|P1|Phase A|Withdrawal by Subject|0
1381333|NCT01397786|4558351|P3|Phase A|Physician Decision|1
1381334|NCT01397786|4558352|P2|Phase A|Physician Decision|0
1381335|NCT01397786|4558353|P1|Phase A|Physician Decision|0
1381336|NCT01397786|4558351|P3|Phase A|Subject Met Withdrawal Criteria|7
1381337|NCT01397786|4558352|P2|Phase A|Subject Met Withdrawal Criteria|0
1381338|NCT01397786|4558353|P1|Phase A|Subject Met Withdrawal Criteria|0
1381339|NCT01397786|4558351|P3|Phase A|Adverse Event|8
1381340|NCT01397786|4558352|P2|Phase A|Adverse Event|0
1381341|NCT01397786|4558353|P1|Phase A|Adverse Event|0
1381342|NCT01397786|4558351|P3|Phase A|Lost to Follow-up|6
1381343|NCT01397786|4558352|P2|Phase A|Lost to Follow-up|0
1381344|NCT01397786|4558353|P1|Phase A|Lost to Follow-up|0
1381345|NCT01397747|4558419|P1|Overall Study|FIT excluded|34
1381346|NCT01397747|4558419|P1|Overall Study|Colonoscopy excluded|304
1381347|NCT01397747|4558419|P1|Overall Study|Multitarget DNA test excluded|689
1381348|NCT01397461|4558451|P3|Overall Study|Not treated|1
1381349|NCT01397461|4558452|P2|Overall Study|Not treated|0
1381350|NCT01397461|4558453|P1|Overall Study|Not treated|0
1381351|NCT01397461|4558451|P3|Overall Study|Lack of Efficacy|0
1381352|NCT01397461|4558452|P2|Overall Study|Lack of Efficacy|3
1381353|NCT01397461|4558453|P1|Overall Study|Lack of Efficacy|0
1381354|NCT01397461|4558451|P3|Overall Study|Lost to Follow-up|1
1381355|NCT01397461|4558452|P2|Overall Study|Lost to Follow-up|2
1381356|NCT01397461|4558453|P1|Overall Study|Lost to Follow-up|0
1381357|NCT01397461|4558451|P3|Overall Study|Withdrawal by Subject|0
1381358|NCT01397461|4558452|P2|Overall Study|Withdrawal by Subject|1
1381359|NCT01397461|4558453|P1|Overall Study|Withdrawal by Subject|2
1381360|NCT01397448|4558464|P3|Overall Study|Not specified|4
1381361|NCT01397448|4558465|P2|Overall Study|Not specified|7
1381362|NCT01397448|4558466|P1|Overall Study|Not specified|8
1381363|NCT01397448|4558464|P3|Overall Study|Lack of Efficacy|5
1381364|NCT01397448|4558465|P2|Overall Study|Lack of Efficacy|0
1381365|NCT01397448|4558466|P1|Overall Study|Lack of Efficacy|2
1381366|NCT01397448|4558464|P3|Overall Study|Withdrawal by Subject|3
1381367|NCT01397448|4558465|P2|Overall Study|Withdrawal by Subject|4
1381368|NCT01397448|4558466|P1|Overall Study|Withdrawal by Subject|4
1381369|NCT01397448|4558464|P3|Overall Study|Adverse Event|6
1381370|NCT01397448|4558465|P2|Overall Study|Adverse Event|4
1381371|NCT01397448|4558466|P1|Overall Study|Adverse Event|4
1381372|NCT01397422|4558481|P4|Overall Study|Increased bradykinesia related to PD|0
1381373|NCT01397422|4558482|P3|Overall Study|Increased bradykinesia related to PD|0
1381374|NCT01397422|4558483|P2|Overall Study|Increased bradykinesia related to PD|0
1381375|NCT01397422|4558484|P1|Overall Study|Increased bradykinesia related to PD|1
1381376|NCT01397422|4558481|P4|Overall Study|Withdrawal by Subject|0
1381377|NCT01397422|4558482|P3|Overall Study|Withdrawal by Subject|0
1381378|NCT01397422|4558483|P2|Overall Study|Withdrawal by Subject|0
1381379|NCT01397422|4558484|P1|Overall Study|Withdrawal by Subject|1
1381380|NCT01397422|4558481|P4|Overall Study|Adverse Event|8
1381381|NCT01397422|4558482|P3|Overall Study|Adverse Event|3
1381382|NCT01397422|4558483|P2|Overall Study|Adverse Event|3
1381383|NCT01397422|4558484|P1|Overall Study|Adverse Event|0
1381384|NCT01397409|4558524|P10|Stage 3|Other Miscellaneous Reasons|0
1381385|NCT01397409|4558525|P9|Stage 3|Other Miscellaneous Reasons|0
1381386|NCT01397409|4558526|P8|Stage 3|Other Miscellaneous Reasons|1
1381387|NCT01397409|4558527|P7|Stage 3|Other Miscellaneous Reasons|0
1381388|NCT01397409|4558528|P6|Stage 3|Other Miscellaneous Reasons|0
1381389|NCT01397409|4558529|P5|Stage 3|Other Miscellaneous Reasons|0
1381390|NCT01397409|4558530|P4|Stage 3|Other Miscellaneous Reasons|0
1381391|NCT01397409|4558531|P3|Stage 3|Other Miscellaneous Reasons|0
1381392|NCT01397409|4558532|P2|Stage 3|Other Miscellaneous Reasons|0
1381393|NCT01397409|4558533|P1|Stage 3|Other Miscellaneous Reasons|0
1381394|NCT01397409|4558524|P10|Stage 3|Adverse Event|0
1381395|NCT01397409|4558525|P9|Stage 3|Adverse Event|0
1381396|NCT01397409|4558526|P8|Stage 3|Adverse Event|1
1381397|NCT01397409|4558527|P7|Stage 3|Adverse Event|0
1381398|NCT01397409|4558528|P6|Stage 3|Adverse Event|0
1381399|NCT01397409|4558529|P5|Stage 3|Adverse Event|0
1381400|NCT01397409|4558530|P4|Stage 3|Adverse Event|0
1381401|NCT01397409|4558531|P3|Stage 3|Adverse Event|0
1381402|NCT01397409|4558532|P2|Stage 3|Adverse Event|0
1381403|NCT01397409|4558533|P1|Stage 3|Adverse Event|0
1381404|NCT01397409|4558524|P10|Stage 2|Other Miscellaneous Reasons|0
1381405|NCT01397409|4558525|P9|Stage 2|Other Miscellaneous Reasons|0
1381406|NCT01397409|4558526|P8|Stage 2|Other Miscellaneous Reasons|0
1381407|NCT01397409|4558527|P7|Stage 2|Other Miscellaneous Reasons|0
1381408|NCT01397409|4558528|P6|Stage 2|Other Miscellaneous Reasons|1
1381409|NCT01397409|4558529|P5|Stage 2|Other Miscellaneous Reasons|1
1381410|NCT01397409|4558530|P4|Stage 2|Other Miscellaneous Reasons|0
1381411|NCT01397409|4558531|P3|Stage 2|Other Miscellaneous Reasons|0
1381412|NCT01397409|4558532|P2|Stage 2|Other Miscellaneous Reasons|0
1381413|NCT01397409|4558533|P1|Stage 2|Other Miscellaneous Reasons|0
1381414|NCT01397409|4558524|P10|Stage 2|Personal Reasons|0
1381415|NCT01397409|4558525|P9|Stage 2|Personal Reasons|0
1381416|NCT01397409|4558526|P8|Stage 2|Personal Reasons|0
1381417|NCT01397409|4558527|P7|Stage 2|Personal Reasons|0
1381418|NCT01397409|4558528|P6|Stage 2|Personal Reasons|0
1381419|NCT01397409|4558529|P5|Stage 2|Personal Reasons|1
1381420|NCT01397409|4558530|P4|Stage 2|Personal Reasons|0
1381421|NCT01397409|4558531|P3|Stage 2|Personal Reasons|0
1381422|NCT01397409|4558532|P2|Stage 2|Personal Reasons|0
1381423|NCT01397409|4558533|P1|Stage 2|Personal Reasons|0
1381424|NCT01397409|4558524|P10|Stage 2|Adverse Event|0
1381425|NCT01397409|4558525|P9|Stage 2|Adverse Event|0
1381426|NCT01397409|4558526|P8|Stage 2|Adverse Event|0
1381427|NCT01397409|4558527|P7|Stage 2|Adverse Event|0
1381428|NCT01397409|4558528|P6|Stage 2|Adverse Event|3
1381429|NCT01397409|4558529|P5|Stage 2|Adverse Event|6
1381430|NCT01397409|4558530|P4|Stage 2|Adverse Event|0
1381431|NCT01397409|4558531|P3|Stage 2|Adverse Event|0
1381432|NCT01397409|4558532|P2|Stage 2|Adverse Event|0
1381433|NCT01397409|4558533|P1|Stage 2|Adverse Event|0
1381434|NCT01397253|4558573|P2|Overall Study|Reviewed by only 1 pharmacist|149
1381435|NCT01397253|4558574|P1|Overall Study|Reviewed by only 1 pharmacist|126
1381436|NCT01397084|4558580|P1|Overall Study|Used other proton pump inhibitor|1
1381437|NCT01397084|4558580|P1|Overall Study|Lost to Follow-up|1
1381438|NCT01397084|4558580|P1|Overall Study|Withdrawal by Subject|1
1381439|NCT01397084|4558580|P1|Overall Study|Adverse Event|2
1381440|NCT01397084|4558580|P1|Overall Study|Protocol Violation|2
1381441|NCT01397084|4558580|P1|Overall Study|Severe Non-Compliance to Protocol|1
1381442|NCT01396525|4558587|P1|Overall Study|Lost to Follow-up|4
1381443|NCT01396525|4558587|P1|Overall Study|Death|14
1381444|NCT01396525|4558587|P1|Overall Study|Withdrawal by Subject|8
1381445|NCT01396512|4558687|P2|Overall Study|Withdrawal by Subject|1
1381446|NCT01396512|4558688|P1|Overall Study|Withdrawal by Subject|0
1381447|NCT01396447|4558704|P4|Overall Study|Other Miscellaneous Reasons|0
1381448|NCT01396447|4558705|P3|Overall Study|Other Miscellaneous Reasons|1
1381449|NCT01396447|4558706|P2|Overall Study|Other Miscellaneous Reasons|2
1381450|NCT01396447|4558707|P1|Overall Study|Other Miscellaneous Reasons|0
1381451|NCT01396447|4558704|P4|Overall Study|Lost to Follow-up|9
1381452|NCT01396447|4558705|P3|Overall Study|Lost to Follow-up|7
1381453|NCT01396447|4558706|P2|Overall Study|Lost to Follow-up|8
1381454|NCT01396447|4558707|P1|Overall Study|Lost to Follow-up|4
1381455|NCT01396447|4558704|P4|Overall Study|Withdrawal of Consent|15
1381456|NCT01396447|4558705|P3|Overall Study|Withdrawal of Consent|4
1381457|NCT01396447|4558706|P2|Overall Study|Withdrawal of Consent|9
1381458|NCT01396447|4558707|P1|Overall Study|Withdrawal of Consent|11
1381459|NCT01396447|4558704|P4|Overall Study|Protocol Violation|7
1381460|NCT01396447|4558705|P3|Overall Study|Protocol Violation|3
1381461|NCT01396447|4558706|P2|Overall Study|Protocol Violation|2
1381462|NCT01396447|4558707|P1|Overall Study|Protocol Violation|5
1381463|NCT01396447|4558704|P4|Overall Study|Insufficient Therapeutic Response|4
1381464|NCT01396447|4558705|P3|Overall Study|Insufficient Therapeutic Response|2
1381465|NCT01396447|4558706|P2|Overall Study|Insufficient Therapeutic Response|5
1381466|NCT01396447|4558707|P1|Overall Study|Insufficient Therapeutic Response|5
1381467|NCT01396447|4558704|P4|Overall Study|Adverse Event|17
1381468|NCT01396447|4558705|P3|Overall Study|Adverse Event|12
1381469|NCT01396447|4558706|P2|Overall Study|Adverse Event|12
1381470|NCT01396447|4558707|P1|Overall Study|Adverse Event|15
1381471|NCT01396447|4558704|P4|Overall Study|Did Not Receive Treatment|0
1381472|NCT01396447|4558705|P3|Overall Study|Did Not Receive Treatment|1
1381473|NCT01396447|4558706|P2|Overall Study|Did Not Receive Treatment|2
1381474|NCT01396447|4558707|P1|Overall Study|Did Not Receive Treatment|3
1381475|NCT01396434|4558724|P3|Overall Study|Other|0
1381476|NCT01396434|4558725|P2|Overall Study|Other|0
1381477|NCT01396434|4558726|P1|Overall Study|Other|10
1381478|NCT01396434|4558724|P3|Overall Study|Lost to Follow-up|0
1381479|NCT01396434|4558725|P2|Overall Study|Lost to Follow-up|0
1381480|NCT01396434|4558726|P1|Overall Study|Lost to Follow-up|1
1381481|NCT01396421|4558738|P4|Overall Study|Lack of Efficacy|18
1381482|NCT01396421|4558739|P3|Overall Study|Lack of Efficacy|7
1381483|NCT01396421|4558740|P2|Overall Study|Lack of Efficacy|17
1381484|NCT01396421|4558741|P1|Overall Study|Lack of Efficacy|7
1381485|NCT01396421|4558738|P4|Overall Study|Protocol Deviation|0
1381486|NCT01396421|4558739|P3|Overall Study|Protocol Deviation|1
1381487|NCT01396421|4558740|P2|Overall Study|Protocol Deviation|1
1381488|NCT01396421|4558741|P1|Overall Study|Protocol Deviation|2
1381489|NCT01396421|4558738|P4|Overall Study|Withdrawal by Subject|21
1381490|NCT01396421|4558739|P3|Overall Study|Withdrawal by Subject|13
1381491|NCT01396421|4558740|P2|Overall Study|Withdrawal by Subject|24
1381492|NCT01396421|4558741|P1|Overall Study|Withdrawal by Subject|31
1381493|NCT01396421|4558738|P4|Overall Study|Physician Decision|3
1381494|NCT01396421|4558739|P3|Overall Study|Physician Decision|0
1381495|NCT01396421|4558740|P2|Overall Study|Physician Decision|1
1381496|NCT01396421|4558741|P1|Overall Study|Physician Decision|1
1381497|NCT01396421|4558738|P4|Overall Study|Participant Met Withdrawal Criteria|0
1381498|NCT01396421|4558739|P3|Overall Study|Participant Met Withdrawal Criteria|1
1381499|NCT01396421|4558740|P2|Overall Study|Participant Met Withdrawal Criteria|0
1381500|NCT01396421|4558741|P1|Overall Study|Participant Met Withdrawal Criteria|1
1381501|NCT01396421|4558738|P4|Overall Study|Adverse Event|32
1381502|NCT01396421|4558739|P3|Overall Study|Adverse Event|12
1381503|NCT01396421|4558740|P2|Overall Study|Adverse Event|15
1381504|NCT01396421|4558741|P1|Overall Study|Adverse Event|17
1381505|NCT01396421|4558738|P4|Overall Study|Lost to Follow-up|1
1381506|NCT01396421|4558739|P3|Overall Study|Lost to Follow-up|0
1381507|NCT01396421|4558740|P2|Overall Study|Lost to Follow-up|0
1381508|NCT01396421|4558741|P1|Overall Study|Lost to Follow-up|0
1381509|NCT01396395|4558813|P2|Overall Study|Other|1
1381510|NCT01396395|4558814|P1|Overall Study|Other|0
1381511|NCT01396395|4558813|P2|Overall Study|Lost to Follow-up|11
1381512|NCT01396395|4558814|P1|Overall Study|Lost to Follow-up|17
1381513|NCT01396395|4558813|P2|Overall Study|Adverse Event|2
1381514|NCT01396395|4558814|P1|Overall Study|Adverse Event|10
1381515|NCT01396395|4558813|P2|Overall Study|Protocol Violation|1
1381516|NCT01396395|4558814|P1|Overall Study|Protocol Violation|3
1381517|NCT01396395|4558813|P2|Overall Study|Withdrawal by Subject|12
1381518|NCT01396395|4558814|P1|Overall Study|Withdrawal by Subject|10
1381519|NCT01396317|4558856|P2|Overall Study|Adverse Event|0
1381520|NCT01396317|4558857|P1|Overall Study|Adverse Event|1
1381521|NCT01396265|4558871|P1|Rifa+Afatinib|Withdrawal by Subject|1
1381522|NCT01396187|4558960|P5|Overall Study|Other|1
1381523|NCT01396187|4558961|P4|Overall Study|Other|0
1381524|NCT01396187|4558962|P3|Overall Study|Other|0
1381525|NCT01396187|4558963|P2|Overall Study|Other|1
1381526|NCT01396187|4558964|P1|Overall Study|Other|1
1381527|NCT01396187|4558960|P5|Overall Study|Withdrawal by Subject|0
1381528|NCT01396187|4558961|P4|Overall Study|Withdrawal by Subject|0
1381529|NCT01396187|4558962|P3|Overall Study|Withdrawal by Subject|1
1381530|NCT01396187|4558963|P2|Overall Study|Withdrawal by Subject|1
1381531|NCT01396187|4558964|P1|Overall Study|Withdrawal by Subject|0
1381532|NCT01396187|4558960|P5|Overall Study|Adverse Event|0
1381533|NCT01396187|4558961|P4|Overall Study|Adverse Event|0
1381534|NCT01396187|4558962|P3|Overall Study|Adverse Event|0
1381535|NCT01396187|4558963|P2|Overall Study|Adverse Event|1
1381536|NCT01396187|4558964|P1|Overall Study|Adverse Event|0
1381537|NCT01396161|4559064|P7|Overall Study|Other|1
1381538|NCT01396161|4559065|P6|Overall Study|Other|0
1381539|NCT01396161|4559066|P5|Overall Study|Other|0
1381540|NCT01396161|4559067|P4|Overall Study|Other|0
1381541|NCT01396161|4559068|P3|Overall Study|Other|0
1381542|NCT01396161|4559069|P2|Overall Study|Other|0
1381543|NCT01396161|4559070|P1|Overall Study|Other|0
1381544|NCT01396161|4559064|P7|Overall Study|Withdrawal by Subject|0
1381545|NCT01396161|4559065|P6|Overall Study|Withdrawal by Subject|0
1381546|NCT01396161|4559066|P5|Overall Study|Withdrawal by Subject|1
1381547|NCT01396161|4559067|P4|Overall Study|Withdrawal by Subject|0
1381548|NCT01396161|4559068|P3|Overall Study|Withdrawal by Subject|0
1381549|NCT01396161|4559069|P2|Overall Study|Withdrawal by Subject|0
1381550|NCT01396161|4559070|P1|Overall Study|Withdrawal by Subject|0
1381551|NCT01396148|4559123|P1|Overall Study|Patient Decision|1
1381552|NCT01396083|4559150|P2|Overall Study|Lost to Follow-up|0
1381553|NCT01396083|4559151|P1|Overall Study|Lost to Follow-up|1
1381554|NCT01396083|4559150|P2|Overall Study|Administrative problems|0
1381555|NCT01396083|4559151|P1|Overall Study|Administrative problems|1
1381556|NCT01396083|4559150|P2|Overall Study|Abnormal laboratory value(s)|0
1381557|NCT01396083|4559151|P1|Overall Study|Abnormal laboratory value(s)|1
1381558|NCT01396083|4559150|P2|Overall Study|Protocol deviation(s)|1
1381559|NCT01396083|4559151|P1|Overall Study|Protocol deviation(s)|0
1381560|NCT01396083|4559150|P2|Overall Study|Consent withdrawn|5
1381561|NCT01396083|4559151|P1|Overall Study|Consent withdrawn|4
1381562|NCT01396083|4559150|P2|Overall Study|Unsatisfactory therapeutic effect|13
1381563|NCT01396083|4559151|P1|Overall Study|Unsatisfactory therapeutic effect|2
1381564|NCT01396083|4559150|P2|Overall Study|Adverse Event|28
1381565|NCT01396083|4559151|P1|Overall Study|Adverse Event|2
1381566|NCT01396070|4559175|P1|Overall Study|Lack of Efficacy|4
1381567|NCT01396070|4559175|P1|Overall Study|Physician Decision|3
1381568|NCT01396070|4559175|P1|Overall Study|Adverse Event|8
1381569|NCT01396070|4559175|P1|Overall Study|Death|2
1381570|NCT01396070|4559175|P1|Overall Study|Withdrawal by Subject|2
1381571|NCT01396057|4559184|P2|Overall Study|Consent withdrawn|2
1381572|NCT01396057|4559185|P1|Overall Study|Consent withdrawn|3
1381573|NCT01396057|4559184|P2|Overall Study|Protocol deviation|4
1381574|NCT01396057|4559185|P1|Overall Study|Protocol deviation|4
1381575|NCT01396057|4559184|P2|Overall Study|Unsatisfactory therapeutic effect|6
1381576|NCT01396057|4559185|P1|Overall Study|Unsatisfactory therapeutic effect|2
1381577|NCT01396057|4559184|P2|Overall Study|Adverse Event|6
1381578|NCT01396057|4559185|P1|Overall Study|Adverse Event|2
1381579|NCT01396005|4559234|P2|Overall Study|Non-compliance with protocol|1
1381580|NCT01396005|4559235|P1|Overall Study|Non-compliance with protocol|0
1381581|NCT01396005|4559234|P2|Overall Study|Withdrawal by Subject|1
1381582|NCT01396005|4559235|P1|Overall Study|Withdrawal by Subject|0
1381583|NCT01395914|4559266|P2|Overall Study|Lost to Follow-up|2
1381584|NCT01395914|4559267|P1|Overall Study|Lost to Follow-up|6
1381585|NCT01395914|4559266|P2|Overall Study|Study drug-related AE|0
1381586|NCT01395914|4559267|P1|Overall Study|Study drug-related AE|1
1381587|NCT01395914|4559266|P2|Overall Study|Withdrawal by patient|14
1381588|NCT01395914|4559267|P1|Overall Study|Withdrawal by patient|27
1381589|NCT01395914|4559266|P2|Overall Study|Other|3
1381590|NCT01395914|4559267|P1|Overall Study|Other|9
1381591|NCT01395914|4559266|P2|Overall Study|Death|17
1381592|NCT01395914|4559267|P1|Overall Study|Death|23
1381593|NCT01395914|4559266|P2|Overall Study|Unrelated to study drug AE|1
1381594|NCT01395914|4559267|P1|Overall Study|Unrelated to study drug AE|6
1381595|NCT01395901|4559281|P2|Overall Study|Withdrawal of consent|0
1381596|NCT01395901|4559282|P1|Overall Study|Withdrawal of consent|1
1381597|NCT01395901|4559281|P2|Overall Study|Adverse Event|1
1381598|NCT01395901|4559282|P1|Overall Study|Adverse Event|0
1381599|NCT01395901|4559281|P2|Overall Study|Randomized but not received study drug|4
1381600|NCT01395901|4559282|P1|Overall Study|Randomized but not received study drug|5
1381601|NCT01395901|4559281|P2|Overall Study|Lost to Follow-up|0
1381602|NCT01395901|4559282|P1|Overall Study|Lost to Follow-up|4
1381603|NCT01395888|4559298|P3|Treatment Period (TP)|Withdrawal by Subject|3
1381604|NCT01395888|4559299|P2|Treatment Period (TP)|Withdrawal by Subject|2
1381605|NCT01395888|4559300|P1|Treatment Period (TP)|Withdrawal by Subject|0
1381606|NCT01395888|4559298|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
1381607|NCT01395888|4559299|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
1381608|NCT01395888|4559300|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
1381609|NCT01395888|4559298|P3|Treatment Period (TP)|Protocol Violation|5
1381610|NCT01395888|4559299|P2|Treatment Period (TP)|Protocol Violation|1
1381611|NCT01395888|4559300|P1|Treatment Period (TP)|Protocol Violation|0
1381612|NCT01395888|4559298|P3|Treatment Period (TP)|Lack of Efficacy|3
1381613|NCT01395888|4559299|P2|Treatment Period (TP)|Lack of Efficacy|4
1381614|NCT01395888|4559300|P1|Treatment Period (TP)|Lack of Efficacy|0
1381615|NCT01395888|4559298|P3|Treatment Period (TP)|Adverse Event|6
1381616|NCT01395888|4559299|P2|Treatment Period (TP)|Adverse Event|7
1381617|NCT01395888|4559300|P1|Treatment Period (TP)|Adverse Event|0
1381618|NCT01395888|4559298|P3|2-week Run-in Period|Withdrawal by Subject|0
1381619|NCT01395888|4559299|P2|2-week Run-in Period|Withdrawal by Subject|0
1381620|NCT01395888|4559300|P1|2-week Run-in Period|Withdrawal by Subject|4
1381621|NCT01395888|4559298|P3|2-week Run-in Period|Protocol Violation|0
1381622|NCT01395888|4559299|P2|2-week Run-in Period|Protocol Violation|0
1381623|NCT01395888|4559300|P1|2-week Run-in Period|Protocol Violation|2
1381624|NCT01395888|4559298|P3|2-week Run-in Period|Lost to Follow-up|0
1381625|NCT01395888|4559299|P2|2-week Run-in Period|Lost to Follow-up|0
1381626|NCT01395888|4559300|P1|2-week Run-in Period|Lost to Follow-up|1
1381627|NCT01395888|4559298|P3|2-week Run-in Period|Continuation Criteria Not Met|0
1381628|NCT01395888|4559299|P2|2-week Run-in Period|Continuation Criteria Not Met|0
1381629|NCT01395888|4559300|P1|2-week Run-in Period|Continuation Criteria Not Met|13
1381630|NCT01395888|4559298|P3|2-week Run-in Period|Adverse Event|0
1381631|NCT01395888|4559299|P2|2-week Run-in Period|Adverse Event|0
1381632|NCT01395888|4559300|P1|2-week Run-in Period|Adverse Event|2
1381633|NCT01395823|4559308|P2|Overall Study|Withdrawal by Subject|4
1381634|NCT01395823|4559309|P1|Overall Study|Withdrawal by Subject|5
1381635|NCT01395823|4559308|P2|Overall Study|GI symptoms|0
1381636|NCT01395823|4559309|P1|Overall Study|GI symptoms|1
1381637|NCT01395823|4559308|P2|Overall Study|Transplant|0
1381638|NCT01395823|4559309|P1|Overall Study|Transplant|1
1381639|NCT01395823|4559308|P2|Overall Study|Lost to Follow-up|0
1381640|NCT01395823|4559309|P1|Overall Study|Lost to Follow-up|1
1381641|NCT01395823|4559308|P2|Overall Study|Physician Decision|1
1381642|NCT01395823|4559309|P1|Overall Study|Physician Decision|3
1381643|NCT01395823|4559308|P2|Overall Study|Death|4
1381644|NCT01395823|4559309|P1|Overall Study|Death|4
1381645|NCT01395810|4559319|P4|Overall Study|Unclassified|0
1381646|NCT01395810|4559320|P3|Overall Study|Unclassified|0
1381647|NCT01395810|4559321|P2|Overall Study|Unclassified|0
1381648|NCT01395810|4559322|P1|Overall Study|Unclassified|2
1381649|NCT01395810|4559319|P4|Overall Study|Withdrawal criteria|0
1381650|NCT01395810|4559320|P3|Overall Study|Withdrawal criteria|0
1381651|NCT01395810|4559321|P2|Overall Study|Withdrawal criteria|2
1381652|NCT01395810|4559322|P1|Overall Study|Withdrawal criteria|0
1381653|NCT01395810|4559319|P4|Overall Study|Lack of Efficacy|0
1381654|NCT01395810|4559320|P3|Overall Study|Lack of Efficacy|0
1381655|NCT01395810|4559321|P2|Overall Study|Lack of Efficacy|1
1381656|NCT01395810|4559322|P1|Overall Study|Lack of Efficacy|0
1381657|NCT01395810|4559319|P4|Overall Study|Adverse Event|0
1381658|NCT01395810|4559320|P3|Overall Study|Adverse Event|0
1381659|NCT01395810|4559321|P2|Overall Study|Adverse Event|1
1381660|NCT01395810|4559322|P1|Overall Study|Adverse Event|0
1381661|NCT01395784|4559381|P1|Overall Study|Physician Decision|5
1381662|NCT01395784|4559381|P1|Overall Study|Withdrawal by Subject|3
1381663|NCT01395784|4559381|P1|Overall Study|Lost to Follow-up|7
1381664|NCT01395758|4559388|P3|Open-label Treatment Period|Withdrawal by Subject|0
1381665|NCT01395758|4559389|P2|Open-label Treatment Period|Withdrawal by Subject|0
1381666|NCT01395758|4559390|P1|Open-label Treatment Period|Withdrawal by Subject|4
1381667|NCT01395524|4559404|P3|Overall Study|Subject had spinal surgery|1
1381668|NCT01395524|4559405|P2|Overall Study|Subject had spinal surgery|0
1381669|NCT01395524|4559406|P1|Overall Study|Subject had spinal surgery|0
1381670|NCT01395524|4559404|P3|Overall Study|Did not receive treatment|3
1381671|NCT01395524|4559405|P2|Overall Study|Did not receive treatment|1
1381672|NCT01395524|4559406|P1|Overall Study|Did not receive treatment|1
1381673|NCT01395524|4559404|P3|Overall Study|Withdrawal by Subject|8
1381674|NCT01395524|4559405|P2|Overall Study|Withdrawal by Subject|8
1381675|NCT01395524|4559406|P1|Overall Study|Withdrawal by Subject|4
1381676|NCT01395524|4559404|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
1381677|NCT01395524|4559405|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
1381678|NCT01395524|4559406|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
1381679|NCT01395524|4559404|P3|Overall Study|Death|0
1381680|NCT01395524|4559405|P2|Overall Study|Death|0
1381681|NCT01395524|4559406|P1|Overall Study|Death|1
1381682|NCT01395524|4559404|P3|Overall Study|Adverse Event|3
1381683|NCT01395524|4559405|P2|Overall Study|Adverse Event|4
1381684|NCT01395524|4559406|P1|Overall Study|Adverse Event|4
1381685|NCT01395524|4559404|P3|Overall Study|Severe noncompliance with protocol|0
1381686|NCT01395524|4559405|P2|Overall Study|Severe noncompliance with protocol|0
1381687|NCT01395524|4559406|P1|Overall Study|Severe noncompliance with protocol|1
1381688|NCT01395524|4559404|P3|Overall Study|Study-Specific Withdrawal Criteria|0
1381689|NCT01395524|4559405|P2|Overall Study|Study-Specific Withdrawal Criteria|2
1381690|NCT01395524|4559406|P1|Overall Study|Study-Specific Withdrawal Criteria|1
1381691|NCT01395524|4559404|P3|Overall Study|Lost to Follow-up|1
1381692|NCT01395524|4559405|P2|Overall Study|Lost to Follow-up|1
1381693|NCT01395524|4559406|P1|Overall Study|Lost to Follow-up|3
1381694|NCT01395524|4559404|P3|Overall Study|Non-compliance with study schedule|1
1381695|NCT01395524|4559405|P2|Overall Study|Non-compliance with study schedule|0
1381696|NCT01395524|4559406|P1|Overall Study|Non-compliance with study schedule|1
1381697|NCT01395394|4559429|P3|Baseline Study Visit|Protocol Violation|0
1381698|NCT01395394|4559430|P2|Baseline Study Visit|Protocol Violation|0
1381699|NCT01395394|4559431|P1|Baseline Study Visit|Protocol Violation|1
1381700|NCT01395368|4559442|P1|Overall Study|Withdrawal by Subject|2
1381701|NCT01395368|4559442|P1|Overall Study|Physician Decision|14
1381702|NCT01395017|4559464|P2|Overall Study|Sponsor discontinued study|4
1381703|NCT01395017|4559465|P1|Overall Study|Sponsor discontinued study|1
1381704|NCT01395017|4559464|P2|Overall Study|Disease progression|58
1381705|NCT01395017|4559465|P1|Overall Study|Disease progression|42
1381706|NCT01395017|4559464|P2|Overall Study|Death|3
1381707|NCT01395017|4559465|P1|Overall Study|Death|4
1381708|NCT01395017|4559464|P2|Overall Study|Protocol deviation|2
1381709|NCT01395017|4559465|P1|Overall Study|Protocol deviation|1
1381710|NCT01395017|4559464|P2|Overall Study|Withdrawal by Subject|8
1381711|NCT01395017|4559465|P1|Overall Study|Withdrawal by Subject|14
1381712|NCT01395017|4559464|P2|Overall Study|Physician Decision|15
1381713|NCT01395017|4559465|P1|Overall Study|Physician Decision|11
1381714|NCT01395017|4559464|P2|Overall Study|Adverse Event|12
1381715|NCT01395017|4559465|P1|Overall Study|Adverse Event|26
1381716|NCT01395017|4559464|P2|Overall Study|Lost to Follow-up|0
1381717|NCT01395017|4559465|P1|Overall Study|Lost to Follow-up|1
1381718|NCT01394991|4559475|P2|Overall Study|Prematurely Termination of Trial|10
1381719|NCT01394991|4559476|P1|Overall Study|Prematurely Termination of Trial|9
1381720|NCT01394991|4559475|P2|Overall Study|Disease Progression|7
1381721|NCT01394991|4559476|P1|Overall Study|Disease Progression|7
1381722|NCT01394991|4559475|P2|Overall Study|Chemotherapy Termination|15
1381723|NCT01394991|4559476|P1|Overall Study|Chemotherapy Termination|10
1381724|NCT01394991|4559475|P2|Overall Study|Withdrawal by Subject|17
1381725|NCT01394991|4559476|P1|Overall Study|Withdrawal by Subject|20
1381726|NCT01394991|4559475|P2|Overall Study|Protocol Violation|1
1381727|NCT01394991|4559476|P1|Overall Study|Protocol Violation|1
1381728|NCT01394991|4559475|P2|Overall Study|Physician Decision|3
1381729|NCT01394991|4559476|P1|Overall Study|Physician Decision|1
1381730|NCT01394991|4559475|P2|Overall Study|Lost to Follow-up|8
1381731|NCT01394991|4559476|P1|Overall Study|Lost to Follow-up|6
1381732|NCT01394991|4559475|P2|Overall Study|Lack of Efficacy|7
1381733|NCT01394991|4559476|P1|Overall Study|Lack of Efficacy|5
1381734|NCT01394991|4559475|P2|Overall Study|Adverse Event|4
1381735|NCT01394991|4559476|P1|Overall Study|Adverse Event|0
1381736|NCT01394978|4559498|P2|Overall Study|Death|7
1381737|NCT01394978|4559499|P1|Overall Study|Death|6
1381738|NCT01394978|4559498|P2|Overall Study|Lost to Follow-up|20
1381739|NCT01394978|4559499|P1|Overall Study|Lost to Follow-up|13
1381740|NCT01394978|4559498|P2|Overall Study|Withdrawal by Subject|4
1381741|NCT01394978|4559499|P1|Overall Study|Withdrawal by Subject|2
1381742|NCT01394718|4559516|P2|Overall Study|Met protocol-specific stopping criteria|1
1381743|NCT01394718|4559517|P1|Overall Study|Met protocol-specific stopping criteria|2
1381744|NCT01394627|4559538|P2|Washout (1-3 Months)|concurrent enrollment in another study|0
1381745|NCT01394627|4559539|P1|Washout (1-3 Months)|concurrent enrollment in another study|1
1381746|NCT01394627|4559538|P2|First Intervention (1 Day)|poor intravenous access|1
1381747|NCT01394627|4559539|P1|First Intervention (1 Day)|poor intravenous access|0
1381748|NCT01394523|4559559|P3|Overall Study|Unable to place block|0
1381749|NCT01394523|4559560|P2|Overall Study|Unable to place block|0
1381750|NCT01394523|4559561|P1|Overall Study|Unable to place block|1
1381751|NCT01394276|4559575|P1|Overall Study|Symptoms of concurrent diseases|1
1381752|NCT01394276|4559575|P1|Overall Study|unavailability of drug at the Hospital|2
1381753|NCT01394276|4559575|P1|Overall Study|Pregnancy|1
1381754|NCT01394276|4559575|P1|Overall Study|Participant moved to another site|1
1381755|NCT01394276|4559575|P1|Overall Study|Lost to Follow-up|5
1381756|NCT01394276|4559575|P1|Overall Study|Insufficient compliance|9
1381757|NCT01394276|4559575|P1|Overall Study|Insufficient therapeutic effect|17
1381758|NCT01394276|4559575|P1|Overall Study|Remission of disease|2
1381759|NCT01394276|4559575|P1|Overall Study|Not related AEs|9
1381760|NCT01394276|4559575|P1|Overall Study|Related Adverse event (AEs)|15
1381761|NCT01394250|4559599|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
1381762|NCT01394250|4559600|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
1381763|NCT01394250|4559599|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
1381764|NCT01394250|4559600|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
1381765|NCT01394185|4559614|P6|Overall Study|Protocol Violation|1
1381766|NCT01394185|4559615|P5|Overall Study|Protocol Violation|0
1381767|NCT01394185|4559616|P4|Overall Study|Protocol Violation|1
1381768|NCT01394185|4559617|P3|Overall Study|Protocol Violation|0
1381769|NCT01394185|4559618|P2|Overall Study|Protocol Violation|0
1381770|NCT01394185|4559619|P1|Overall Study|Protocol Violation|1
1381771|NCT01394185|4559614|P6|Overall Study|Change in protocol|0
1381772|NCT01394185|4559615|P5|Overall Study|Change in protocol|3
1381773|NCT01394185|4559616|P4|Overall Study|Change in protocol|0
1381774|NCT01394185|4559617|P3|Overall Study|Change in protocol|0
1381775|NCT01394185|4559618|P2|Overall Study|Change in protocol|0
1381776|NCT01394185|4559619|P1|Overall Study|Change in protocol|3
1381777|NCT01394185|4559614|P6|Overall Study|Withdrawal by Subject|0
1381778|NCT01394185|4559615|P5|Overall Study|Withdrawal by Subject|1
1381779|NCT01394185|4559616|P4|Overall Study|Withdrawal by Subject|0
1381780|NCT01394185|4559617|P3|Overall Study|Withdrawal by Subject|0
1381781|NCT01394185|4559618|P2|Overall Study|Withdrawal by Subject|0
1381782|NCT01394185|4559619|P1|Overall Study|Withdrawal by Subject|2
1381783|NCT01393964|4559657|P3|Overall Study|Subject to receive non-protocol therapy|1
1381784|NCT01393964|4559658|P2|Overall Study|Subject to receive non-protocol therapy|0
1381785|NCT01393964|4559659|P1|Overall Study|Subject to receive non-protocol therapy|0
1381786|NCT01393964|4559657|P3|Overall Study|Subject converted to roll-over study|0
1381787|NCT01393964|4559658|P2|Overall Study|Subject converted to roll-over study|1
1381788|NCT01393964|4559659|P1|Overall Study|Subject converted to roll-over study|0
1381789|NCT01393964|4559657|P3|Overall Study|Investigator removed subject from study|0
1381790|NCT01393964|4559658|P2|Overall Study|Investigator removed subject from study|1
1381791|NCT01393964|4559659|P1|Overall Study|Investigator removed subject from study|0
1381792|NCT01393964|4559657|P3|Overall Study|Subject plateaued in terms of effect|0
1381793|NCT01393964|4559658|P2|Overall Study|Subject plateaued in terms of effect|0
1381794|NCT01393964|4559659|P1|Overall Study|Subject plateaued in terms of effect|1
1381795|NCT01393964|4559657|P3|Overall Study|Subject switched to commercial supply|2
1381796|NCT01393964|4559658|P2|Overall Study|Subject switched to commercial supply|0
1381797|NCT01393964|4559659|P1|Overall Study|Subject switched to commercial supply|1
1381798|NCT01393964|4559657|P3|Overall Study|Subject decided to move to transplant|0
1381799|NCT01393964|4559658|P2|Overall Study|Subject decided to move to transplant|0
1381800|NCT01393964|4559659|P1|Overall Study|Subject decided to move to transplant|1
1381801|NCT01393964|4559657|P3|Overall Study|Subject request stop study treatment|0
1381802|NCT01393964|4559658|P2|Overall Study|Subject request stop study treatment|1
1381803|NCT01393964|4559659|P1|Overall Study|Subject request stop study treatment|0
1381804|NCT01393964|4559657|P3|Overall Study|Adverse event unrelated to study drug|0
1381805|NCT01393964|4559658|P2|Overall Study|Adverse event unrelated to study drug|3
1381806|NCT01393964|4559659|P1|Overall Study|Adverse event unrelated to study drug|0
1381807|NCT01393964|4559657|P3|Overall Study|Withdrawal by Subject|1
1381808|NCT01393964|4559658|P2|Overall Study|Withdrawal by Subject|0
1381809|NCT01393964|4559659|P1|Overall Study|Withdrawal by Subject|0
1381810|NCT01393964|4559657|P3|Overall Study|Study drug toxicity|0
1381811|NCT01393964|4559658|P2|Overall Study|Study drug toxicity|0
1381812|NCT01393964|4559659|P1|Overall Study|Study drug toxicity|1
1381813|NCT01393964|4559657|P3|Overall Study|Disease Progression|5
1381814|NCT01393964|4559658|P2|Overall Study|Disease Progression|3
1381815|NCT01393964|4559659|P1|Overall Study|Disease Progression|4
1381816|NCT01393899|4559700|P3|Overall Study|Adverse Event|3
1381817|NCT01393899|4559701|P2|Overall Study|Adverse Event|5
1381818|NCT01393899|4559702|P1|Overall Study|Adverse Event|1
1381819|NCT01393899|4559700|P3|Overall Study|Lack of Efficacy|16
1381820|NCT01393899|4559701|P2|Overall Study|Lack of Efficacy|21
1381821|NCT01393899|4559702|P1|Overall Study|Lack of Efficacy|26
1381822|NCT01393899|4559700|P3|Overall Study|Does not meet entrance criteria|1
1381823|NCT01393899|4559701|P2|Overall Study|Does not meet entrance criteria|0
1381824|NCT01393899|4559702|P1|Overall Study|Does not meet entrance criteria|1
1381825|NCT01393899|4559700|P3|Overall Study|Lost to Follow-up|1
1381826|NCT01393899|4559701|P2|Overall Study|Lost to Follow-up|0
1381827|NCT01393899|4559702|P1|Overall Study|Lost to Follow-up|0
1381828|NCT01393899|4559700|P3|Overall Study|Withdrawal by Subject|1
1381829|NCT01393899|4559701|P2|Overall Study|Withdrawal by Subject|2
1381830|NCT01393899|4559702|P1|Overall Study|Withdrawal by Subject|2
1381831|NCT01393899|4559700|P3|Overall Study|Other|0
1381832|NCT01393899|4559701|P2|Overall Study|Other|0
1381833|NCT01393899|4559702|P1|Overall Study|Other|1
1381834|NCT01393899|4559700|P3|Overall Study|Study terminated by sponsor|1
1381835|NCT01393899|4559701|P2|Overall Study|Study terminated by sponsor|0
1381836|NCT01393899|4559702|P1|Overall Study|Study terminated by sponsor|1
1381837|NCT01393743|4559756|P3|Extension Phase|Not specified|14
1381838|NCT01393743|4559757|P2|Extension Phase|Not specified|0
1381839|NCT01393743|4559758|P1|Extension Phase|Not specified|0
1381840|NCT01393743|4559756|P3|Extension Phase|Pregnancy|1
1381841|NCT01393743|4559757|P2|Extension Phase|Pregnancy|0
1381842|NCT01393743|4559758|P1|Extension Phase|Pregnancy|0
1381843|NCT01393743|4559756|P3|Extension Phase|Withdrawal by Subject|8
1381844|NCT01393743|4559757|P2|Extension Phase|Withdrawal by Subject|0
1381845|NCT01393743|4559758|P1|Extension Phase|Withdrawal by Subject|0
1381846|NCT01393743|4559756|P3|Extension Phase|Inadequate therapeutic effect|7
1381847|NCT01393743|4559757|P2|Extension Phase|Inadequate therapeutic effect|0
1381848|NCT01393743|4559758|P1|Extension Phase|Inadequate therapeutic effect|0
1381849|NCT01393743|4559756|P3|Extension Phase|Participant choice|16
1381850|NCT01393743|4559757|P2|Extension Phase|Participant choice|0
1381851|NCT01393743|4559758|P1|Extension Phase|Participant choice|0
1381852|NCT01393743|4559756|P3|Extension Phase|Lost to Follow-up|2
1381853|NCT01393743|4559757|P2|Extension Phase|Lost to Follow-up|0
1381854|NCT01393743|4559758|P1|Extension Phase|Lost to Follow-up|0
1381855|NCT01393743|4559756|P3|Extension Phase|Adverse Event|12
1381856|NCT01393743|4559757|P2|Extension Phase|Adverse Event|0
1381857|NCT01393743|4559758|P1|Extension Phase|Adverse Event|0
1381858|NCT01393743|4559756|P3|Core Study|Inadequate therapeutic effect|0
1381859|NCT01393743|4559757|P2|Core Study|Inadequate therapeutic effect|0
1381860|NCT01393743|4559758|P1|Core Study|Inadequate therapeutic effect|2
1381861|NCT01393743|4559756|P3|Core Study|Participant's Choice|0
1381862|NCT01393743|4559757|P2|Core Study|Participant's Choice|3
1381863|NCT01393743|4559758|P1|Core Study|Participant's Choice|2
1381864|NCT01393743|4559756|P3|Core Study|Lost to Follow-up|0
1381865|NCT01393743|4559757|P2|Core Study|Lost to Follow-up|1
1381866|NCT01393743|4559758|P1|Core Study|Lost to Follow-up|1
1381867|NCT01393743|4559756|P3|Core Study|Adverse Event|0
1381868|NCT01393743|4559757|P2|Core Study|Adverse Event|9
1381869|NCT01393743|4559758|P1|Core Study|Adverse Event|5
1381870|NCT01393730|4559781|P1|Overall Study|Adverse Event|1
1381871|NCT01393730|4559781|P1|Overall Study|Other|2
1381872|NCT01393730|4559781|P1|Overall Study|Withdrawal by Subject|3
1381873|NCT01393626|4559827|P4|Overall Study|Protocol Violation|0
1381874|NCT01393626|4559828|P3|Overall Study|Protocol Violation|2
1381875|NCT01393626|4559829|P2|Overall Study|Protocol Violation|0
1381876|NCT01393626|4559830|P1|Overall Study|Protocol Violation|1
1381877|NCT01393626|4559827|P4|Overall Study|Other|0
1381878|NCT01393626|4559828|P3|Overall Study|Other|0
1381879|NCT01393626|4559829|P2|Overall Study|Other|0
1381880|NCT01393626|4559830|P1|Overall Study|Other|1
1381881|NCT01393626|4559827|P4|Overall Study|Withdrawal by Subject|0
1381882|NCT01393626|4559828|P3|Overall Study|Withdrawal by Subject|0
1381883|NCT01393626|4559829|P2|Overall Study|Withdrawal by Subject|4
1381884|NCT01393626|4559830|P1|Overall Study|Withdrawal by Subject|6
1381885|NCT01393626|4559827|P4|Overall Study|Lost to Follow-up|0
1381886|NCT01393626|4559828|P3|Overall Study|Lost to Follow-up|1
1381887|NCT01393626|4559829|P2|Overall Study|Lost to Follow-up|1
1381888|NCT01393626|4559830|P1|Overall Study|Lost to Follow-up|1
1381889|NCT01393626|4559827|P4|Overall Study|Lack of Efficacy|1
1381890|NCT01393626|4559828|P3|Overall Study|Lack of Efficacy|4
1381891|NCT01393626|4559829|P2|Overall Study|Lack of Efficacy|6
1381892|NCT01393626|4559830|P1|Overall Study|Lack of Efficacy|6
1381893|NCT01393626|4559827|P4|Overall Study|Did not meet entrance criteria|0
1381894|NCT01393626|4559828|P3|Overall Study|Did not meet entrance criteria|0
1381895|NCT01393626|4559829|P2|Overall Study|Did not meet entrance criteria|0
1381896|NCT01393626|4559830|P1|Overall Study|Did not meet entrance criteria|1
1381897|NCT01393626|4559827|P4|Overall Study|Adverse Event|0
1381898|NCT01393626|4559828|P3|Overall Study|Adverse Event|5
1381899|NCT01393626|4559829|P2|Overall Study|Adverse Event|1
1381900|NCT01393626|4559830|P1|Overall Study|Adverse Event|2
1381901|NCT01393613|4559910|P4|Overall Study|Lack of Efficacy|21
1381902|NCT01393613|4559911|P3|Overall Study|Lack of Efficacy|16
1381903|NCT01393613|4559912|P2|Overall Study|Lack of Efficacy|20
1381904|NCT01393613|4559913|P1|Overall Study|Lack of Efficacy|9
1381905|NCT01393613|4559910|P4|Overall Study|Protocol Deviation|0
1381906|NCT01393613|4559911|P3|Overall Study|Protocol Deviation|0
1381907|NCT01393613|4559912|P2|Overall Study|Protocol Deviation|1
1381908|NCT01393613|4559913|P1|Overall Study|Protocol Deviation|2
1381909|NCT01393613|4559910|P4|Overall Study|Withdrawal by Subject|21
1381910|NCT01393613|4559911|P3|Overall Study|Withdrawal by Subject|23
1381911|NCT01393613|4559912|P2|Overall Study|Withdrawal by Subject|25
1381912|NCT01393613|4559913|P1|Overall Study|Withdrawal by Subject|15
1381913|NCT01393613|4559910|P4|Overall Study|Physician Decision|1
1381914|NCT01393613|4559911|P3|Overall Study|Physician Decision|0
1381915|NCT01393613|4559912|P2|Overall Study|Physician Decision|0
1381916|NCT01393613|4559913|P1|Overall Study|Physician Decision|2
1381917|NCT01393613|4559910|P4|Overall Study|Participant Met Withdrawal Criteria|1
1381918|NCT01393613|4559911|P3|Overall Study|Participant Met Withdrawal Criteria|2
1381919|NCT01393613|4559912|P2|Overall Study|Participant Met Withdrawal Criteria|0
1381920|NCT01393613|4559913|P1|Overall Study|Participant Met Withdrawal Criteria|0
1381921|NCT01393613|4559910|P4|Overall Study|Adverse Event|22
1381922|NCT01393613|4559911|P3|Overall Study|Adverse Event|13
1381923|NCT01393613|4559912|P2|Overall Study|Adverse Event|11
1381924|NCT01393613|4559913|P1|Overall Study|Adverse Event|11
1381925|NCT01393600|4559975|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
1381926|NCT01393600|4559976|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
1381927|NCT01393600|4559977|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
1381928|NCT01393600|4559978|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
1381929|NCT01393600|4559975|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
1381930|NCT01393600|4559976|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
1381931|NCT01393600|4559977|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
1381932|NCT01393600|4559978|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
1381933|NCT01393600|4559975|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
1381934|NCT01393600|4559976|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
1381935|NCT01393600|4559977|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
1381936|NCT01393600|4559978|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
1382019|NCT01392547|4560178|P1|Overall Study|Withdrawal criteria|3
1381937|NCT01393600|4559975|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
1381938|NCT01393600|4559976|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
1381939|NCT01393600|4559977|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
1381940|NCT01393600|4559978|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
1381941|NCT01393600|4559975|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
1381942|NCT01393600|4559976|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
1381943|NCT01393600|4559977|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
1381944|NCT01393600|4559978|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
1381945|NCT01393600|4559975|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
1381946|NCT01393600|4559976|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
1381947|NCT01393600|4559977|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
1381948|NCT01393600|4559978|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
1381949|NCT01393600|4559975|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
1381950|NCT01393600|4559976|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
1381951|NCT01393600|4559977|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
1381952|NCT01393600|4559978|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
1381953|NCT01393444|4560014|P1|Overall Study|Determined ineligible during screening.|2
1381954|NCT01393444|4560014|P1|Overall Study|Withdrawal by Subject|1
1381955|NCT01393405|4560019|P3|Maintenance Period Week|Lost to Follow-up|0
1381956|NCT01393405|4560020|P2|Maintenance Period Week|Lost to Follow-up|1
1381957|NCT01393405|4560021|P1|Maintenance Period Week|Lost to Follow-up|0
1381958|NCT01393405|4560019|P3|Maintenance Period Week|Withdrawal by Subject|0
1381959|NCT01393405|4560020|P2|Maintenance Period Week|Withdrawal by Subject|1
1381960|NCT01393405|4560021|P1|Maintenance Period Week|Withdrawal by Subject|0
1381961|NCT01393405|4560019|P3|Maintenance Period Week|Adverse Event|2
1381962|NCT01393405|4560020|P2|Maintenance Period Week|Adverse Event|5
1381963|NCT01393405|4560021|P1|Maintenance Period Week|Adverse Event|0
1381964|NCT01393405|4560019|P3|Maintenance Period Week|Lack of Efficacy|22
1381965|NCT01393405|4560020|P2|Maintenance Period Week|Lack of Efficacy|22
1381966|NCT01393405|4560021|P1|Maintenance Period Week|Lack of Efficacy|0
1381967|NCT01393405|4560019|P3|Induction Period (week1-16)|Withdrawal by Subject|0
1381968|NCT01393405|4560020|P2|Induction Period (week1-16)|Withdrawal by Subject|0
1381969|NCT01393405|4560021|P1|Induction Period (week1-16)|Withdrawal by Subject|9
1381970|NCT01393405|4560019|P3|Induction Period (week1-16)|Adverse Event|0
1381971|NCT01393405|4560020|P2|Induction Period (week1-16)|Adverse Event|0
1381972|NCT01393405|4560021|P1|Induction Period (week1-16)|Adverse Event|16
1381973|NCT01393405|4560019|P3|Induction Period (week1-16)|Lack of Efficacy|0
1381974|NCT01393405|4560020|P2|Induction Period (week1-16)|Lack of Efficacy|0
1381975|NCT01393405|4560021|P1|Induction Period (week1-16)|Lack of Efficacy|70
1381976|NCT01393106|4560053|P1|Overall Study|Lack of Efficacy|1
1381977|NCT01393106|4560053|P1|Overall Study|Withdrawal by Subject|1
1381978|NCT01393106|4560053|P1|Overall Study|Adverse Event|3
1381979|NCT01392963|4560072|P2|Week 24 Follow-up|Lost to Follow-up|0
1381980|NCT01392963|4560073|P1|Week 24 Follow-up|Lost to Follow-up|2
1381981|NCT01392963|4560072|P2|Week 0 (First Intervention)|Withdrawal by Subject|1
1381982|NCT01392963|4560073|P1|Week 0 (First Intervention)|Withdrawal by Subject|0
1381983|NCT01392963|4560072|P2|Week 0 (First Intervention)|Lost to Follow-up|1
1381984|NCT01392963|4560073|P1|Week 0 (First Intervention)|Lost to Follow-up|0
1381985|NCT01392742|4560081|P1|Overall Study|Missing information|13
1381986|NCT01392742|4560081|P1|Overall Study|Other|3
1381987|NCT01392742|4560081|P1|Overall Study|Protocol Violation|14
1381988|NCT01392742|4560081|P1|Overall Study|Adverse event/intercurrent illness|17
1381989|NCT01392742|4560081|P1|Overall Study|ITR and Protocol deviation|1
1381990|NCT01392742|4560081|P1|Overall Study|Insufficient therapeutic response (ITR)|30
1381991|NCT01392742|4560081|P1|Overall Study|Lost to Follow-up|34
1381992|NCT01392742|4560081|P1|Overall Study|No treatment/no cooperation/withdrew|12
1381993|NCT01392742|4560081|P1|Overall Study|Failure to return|35
1381994|NCT01392742|4560081|P1|Overall Study|Premature study termination|42
1381995|NCT01392677|4560127|P2|Overall Study|Other reason|2
1381996|NCT01392677|4560128|P1|Overall Study|Other reason|3
1381997|NCT01392677|4560127|P2|Overall Study|Incorrect enrollment|3
1381998|NCT01392677|4560128|P1|Overall Study|Incorrect enrollment|2
1381999|NCT01392677|4560127|P2|Overall Study|Withdrawal by Subject|2
1382000|NCT01392677|4560128|P1|Overall Study|Withdrawal by Subject|0
1382001|NCT01392677|4560127|P2|Overall Study|Adverse Event|1
1382002|NCT01392677|4560128|P1|Overall Study|Adverse Event|3
1382003|NCT01392573|4560163|P2|Overall Study|Unclassified|6
1382004|NCT01392573|4560164|P1|Overall Study|Unclassified|9
1382005|NCT01392573|4560163|P2|Overall Study|Site closure|7
1382006|NCT01392573|4560164|P1|Overall Study|Site closure|8
1382007|NCT01392573|4560163|P2|Overall Study|Withdrawal Criteria|15
1382008|NCT01392573|4560164|P1|Overall Study|Withdrawal Criteria|13
1382009|NCT01392573|4560163|P2|Overall Study|Protocol Violation|2
1382010|NCT01392573|4560164|P1|Overall Study|Protocol Violation|0
1382011|NCT01392573|4560163|P2|Overall Study|Lack of Efficacy|2
1382012|NCT01392573|4560164|P1|Overall Study|Lack of Efficacy|1
1382013|NCT01392573|4560163|P2|Overall Study|Adverse Event|3
1382014|NCT01392573|4560164|P1|Overall Study|Adverse Event|1
1382015|NCT01392560|4560172|P1|Overall Study|discontinued during placebo run-in|2
1382016|NCT01392560|4560172|P1|Overall Study|not entered|8
1382017|NCT01392560|4560172|P1|Overall Study|Adverse Event|2
1382018|NCT01392547|4560178|P1|Overall Study|Unclassified|1
1382020|NCT01392547|4560178|P1|Overall Study|Non-compliance|2
1382021|NCT01392547|4560178|P1|Overall Study|Adverse Event|2
1382022|NCT01392495|4560192|P1|Overall Study|Adverse Event|3
1382023|NCT01392495|4560192|P1|Overall Study|Withdrawal by Subject|2
1382024|NCT01392495|4560192|P1|Overall Study|Administrative problems|8
1382025|NCT01392495|4560192|P1|Overall Study|Death|3
1382026|NCT01392378|4560209|P5|Toddler Dose|Withdrawal by Parent|1
1382027|NCT01392378|4560210|P4|Toddler Dose|Withdrawal by Parent|1
1382028|NCT01392378|4560211|P3|Toddler Dose|Withdrawal by Parent|0
1382029|NCT01392378|4560212|P2|Toddler Dose|Withdrawal by Parent|1
1382030|NCT01392378|4560213|P1|Toddler Dose|Withdrawal by Parent|0
1382031|NCT01392378|4560209|P5|Toddler Dose|Lost to Follow-up|0
1382032|NCT01392378|4560210|P4|Toddler Dose|Lost to Follow-up|1
1382033|NCT01392378|4560211|P3|Toddler Dose|Lost to Follow-up|0
1382034|NCT01392378|4560212|P2|Toddler Dose|Lost to Follow-up|0
1382035|NCT01392378|4560213|P1|Toddler Dose|Lost to Follow-up|0
1382036|NCT01392378|4560209|P5|After Infant Series|Withdrawal by Parent|1
1382037|NCT01392378|4560210|P4|After Infant Series|Withdrawal by Parent|0
1382038|NCT01392378|4560211|P3|After Infant Series|Withdrawal by Parent|1
1382039|NCT01392378|4560212|P2|After Infant Series|Withdrawal by Parent|1
1382040|NCT01392378|4560213|P1|After Infant Series|Withdrawal by Parent|0
1382041|NCT01392378|4560209|P5|After Infant Series|Lost to Follow-up|0
1382042|NCT01392378|4560210|P4|After Infant Series|Lost to Follow-up|0
1382043|NCT01392378|4560211|P3|After Infant Series|Lost to Follow-up|1
1382044|NCT01392378|4560212|P2|After Infant Series|Lost to Follow-up|0
1382045|NCT01392378|4560213|P1|After Infant Series|Lost to Follow-up|0
1382046|NCT01392378|4560209|P5|Infant Series|Withdrawal by Parent|0
1382047|NCT01392378|4560210|P4|Infant Series|Withdrawal by Parent|0
1382048|NCT01392378|4560211|P3|Infant Series|Withdrawal by Parent|0
1382049|NCT01392378|4560212|P2|Infant Series|Withdrawal by Parent|1
1382050|NCT01392378|4560213|P1|Infant Series|Withdrawal by Parent|4
1382051|NCT01392378|4560209|P5|Infant Series|Protocol Violation|0
1382052|NCT01392378|4560210|P4|Infant Series|Protocol Violation|0
1382053|NCT01392378|4560211|P3|Infant Series|Protocol Violation|0
1382054|NCT01392378|4560212|P2|Infant Series|Protocol Violation|1
1382055|NCT01392378|4560213|P1|Infant Series|Protocol Violation|0
1382056|NCT01392378|4560209|P5|Infant Series|Lost to Follow-up|0
1382057|NCT01392378|4560210|P4|Infant Series|Lost to Follow-up|1
1382058|NCT01392378|4560211|P3|Infant Series|Lost to Follow-up|0
1382059|NCT01392378|4560212|P2|Infant Series|Lost to Follow-up|0
1382060|NCT01392378|4560213|P1|Infant Series|Lost to Follow-up|0
1382061|NCT01392378|4560209|P5|Infant Series|Adverse Event|0
1382062|NCT01392378|4560210|P4|Infant Series|Adverse Event|1
1382063|NCT01392378|4560211|P3|Infant Series|Adverse Event|0
1382064|NCT01392378|4560212|P2|Infant Series|Adverse Event|0
1382065|NCT01392378|4560213|P1|Infant Series|Adverse Event|0
1382066|NCT01392326|4560353|P3|Overall Study|Adverse Event|11
1382067|NCT01392326|4560354|P2|Overall Study|Adverse Event|6
1382068|NCT01392326|4560355|P1|Overall Study|Adverse Event|9
1382069|NCT01392326|4560353|P3|Overall Study|Lack of Efficacy|15
1382070|NCT01392326|4560354|P2|Overall Study|Lack of Efficacy|10
1382071|NCT01392326|4560355|P1|Overall Study|Lack of Efficacy|14
1382072|NCT01392326|4560353|P3|Overall Study|Lost to Follow-up|4
1382073|NCT01392326|4560354|P2|Overall Study|Lost to Follow-up|3
1382074|NCT01392326|4560355|P1|Overall Study|Lost to Follow-up|1
1382075|NCT01392326|4560353|P3|Overall Study|Physician Decision|2
1382076|NCT01392326|4560354|P2|Overall Study|Physician Decision|5
1382077|NCT01392326|4560355|P1|Overall Study|Physician Decision|7
1382078|NCT01392326|4560353|P3|Overall Study|Pregnancy|1
1382079|NCT01392326|4560354|P2|Overall Study|Pregnancy|0
1382080|NCT01392326|4560355|P1|Overall Study|Pregnancy|0
1382081|NCT01392326|4560353|P3|Overall Study|Protocol Violation|0
1382082|NCT01392326|4560354|P2|Overall Study|Protocol Violation|0
1382083|NCT01392326|4560355|P1|Overall Study|Protocol Violation|2
1382084|NCT01392326|4560353|P3|Overall Study|Withdrawal by Subject|15
1382085|NCT01392326|4560354|P2|Overall Study|Withdrawal by Subject|11
1382086|NCT01392326|4560355|P1|Overall Study|Withdrawal by Subject|12
1382087|NCT01392326|4560353|P3|Overall Study|Death|0
1382088|NCT01392326|4560354|P2|Overall Study|Death|0
1382089|NCT01392326|4560355|P1|Overall Study|Death|2
1382090|NCT01392300|4560392|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
1382091|NCT01392300|4560393|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
1382092|NCT01392300|4560394|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
1382093|NCT01392300|4560392|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
1382094|NCT01392300|4560393|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
1382095|NCT01392300|4560394|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
1382096|NCT01392300|4560392|P3|Open Label Extension (OLEX) Period|Adverse Event|7
1382097|NCT01392300|4560393|P2|Open Label Extension (OLEX) Period|Adverse Event|0
1382098|NCT01392300|4560394|P1|Open Label Extension (OLEX) Period|Adverse Event|0
1382099|NCT01392300|4560392|P3|Open Label Extension (OLEX) Period|Death|4
1382100|NCT01392300|4560393|P2|Open Label Extension (OLEX) Period|Death|0
1382101|NCT01392300|4560394|P1|Open Label Extension (OLEX) Period|Death|0
1382102|NCT01392300|4560392|P3|Open Label Extension (OLEX) Period|Non-compliance|1
1382103|NCT01392300|4560393|P2|Open Label Extension (OLEX) Period|Non-compliance|0
1382104|NCT01392300|4560394|P1|Open Label Extension (OLEX) Period|Non-compliance|0
1382105|NCT01392300|4560392|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
1382106|NCT01392300|4560393|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
1382107|NCT01392300|4560394|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
1382108|NCT01392300|4560392|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
1382109|NCT01392300|4560393|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
1382110|NCT01392300|4560394|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
1382111|NCT01392300|4560392|P3|Main Period (MP)|Non-compliance|0
1382112|NCT01392300|4560393|P2|Main Period (MP)|Non-compliance|0
1382113|NCT01392300|4560394|P1|Main Period (MP)|Non-compliance|1
1382114|NCT01392300|4560392|P3|Main Period (MP)|Lost to Follow-up|0
1382115|NCT01392300|4560393|P2|Main Period (MP)|Lost to Follow-up|3
1382116|NCT01392300|4560394|P1|Main Period (MP)|Lost to Follow-up|3
1382117|NCT01392300|4560392|P3|Main Period (MP)|Withdrawal by Subject|0
1382118|NCT01392300|4560393|P2|Main Period (MP)|Withdrawal by Subject|1
1382119|NCT01392300|4560394|P1|Main Period (MP)|Withdrawal by Subject|5
1382120|NCT01392300|4560392|P3|Main Period (MP)|Predefined discontinuation criteria|0
1382121|NCT01392300|4560393|P2|Main Period (MP)|Predefined discontinuation criteria|3
1382122|NCT01392300|4560394|P1|Main Period (MP)|Predefined discontinuation criteria|2
1382123|NCT01392170|4560499|P1|Overall Study|Ineligible|1
1382124|NCT01392170|4560499|P1|Overall Study|Withdrawal by Subject|1
1382125|NCT01391819|4560547|P1|Overall Study|Other|9
1382126|NCT01391819|4560547|P1|Overall Study|Death|3
1382127|NCT01391819|4560547|P1|Overall Study|Lost to Follow-up|252
1382128|NCT01391819|4560547|P1|Overall Study|Migrated/moved from study area|82
1382129|NCT01391819|4560547|P1|Overall Study|Withdrawal by Subject|56
1382130|NCT01391663|4560578|P4|Overall Study|Withdrawal by Subject|0
1382131|NCT01391663|4560579|P3|Overall Study|Withdrawal by Subject|1
1382132|NCT01391663|4560580|P2|Overall Study|Withdrawal by Subject|0
1382133|NCT01391663|4560581|P1|Overall Study|Withdrawal by Subject|0
1382134|NCT01391546|4560625|P2|Overall Study|History of Herpes Zoster (HZ)|0
1382135|NCT01391546|4560626|P1|Overall Study|History of Herpes Zoster (HZ)|1
1382136|NCT01391507|4560648|P4|Overall Study|Protocol Violation|2
1382137|NCT01391507|4560649|P3|Overall Study|Protocol Violation|1
1382138|NCT01391507|4560650|P2|Overall Study|Protocol Violation|1
1382139|NCT01391507|4560651|P1|Overall Study|Protocol Violation|2
1382140|NCT01391507|4560648|P4|Overall Study|Lack of Efficacy|1
1382141|NCT01391507|4560649|P3|Overall Study|Lack of Efficacy|0
1382142|NCT01391507|4560650|P2|Overall Study|Lack of Efficacy|0
1382143|NCT01391507|4560651|P1|Overall Study|Lack of Efficacy|0
1382144|NCT01391507|4560648|P4|Overall Study|Withdrawal by Subject|1
1382145|NCT01391507|4560649|P3|Overall Study|Withdrawal by Subject|1
1382146|NCT01391507|4560650|P2|Overall Study|Withdrawal by Subject|2
1382147|NCT01391507|4560651|P1|Overall Study|Withdrawal by Subject|1
1382148|NCT01391507|4560648|P4|Overall Study|Adverse Event|2
1382149|NCT01391507|4560649|P3|Overall Study|Adverse Event|2
1382150|NCT01391507|4560650|P2|Overall Study|Adverse Event|1
1382151|NCT01391507|4560651|P1|Overall Study|Adverse Event|1
1382152|NCT01391507|4560648|P4|Overall Study|Death|1
1382153|NCT01391507|4560649|P3|Overall Study|Death|0
1382154|NCT01391507|4560650|P2|Overall Study|Death|0
1382155|NCT01391507|4560651|P1|Overall Study|Death|0
1382156|NCT01391000|4560830|P2|Overall Study|Lost to Follow-up|0
1382157|NCT01391000|4560831|P1|Overall Study|Lost to Follow-up|2
1382158|NCT01390948|4560844|P3|Overall Study|Withdrew consent from survival follow-up|0
1382159|NCT01390948|4560845|P2|Overall Study|Withdrew consent from survival follow-up|5
1382160|NCT01390948|4560846|P1|Overall Study|Withdrew consent from survival follow-up|3
1382161|NCT01390948|4560844|P3|Overall Study|Ongoing|0
1382162|NCT01390948|4560845|P2|Overall Study|Ongoing|6
1382163|NCT01390948|4560846|P1|Overall Study|Ongoing|6
1382164|NCT01390948|4560844|P3|Overall Study|Death|2
1382165|NCT01390948|4560845|P2|Overall Study|Death|34
1382166|NCT01390948|4560846|P1|Overall Study|Death|30
1382167|NCT01390948|4560844|P3|Overall Study|Alive in follow-up|1
1382168|NCT01390948|4560845|P2|Overall Study|Alive in follow-up|17
1382169|NCT01390948|4560846|P1|Overall Study|Alive in follow-up|20
1382170|NCT01390857|4560912|P1|Overall Study|No Visit after the First Visit|7
1382171|NCT01390857|4560912|P1|Overall Study|Lost to Follow-up|1
1382172|NCT01390857|4560912|P1|Overall Study|Protocol Violation|2
1382173|NCT01390844|4560923|P4|Follow-Up Phase|Non-Medical Reasons|0
1382174|NCT01390844|4560924|P3|Follow-Up Phase|Non-Medical Reasons|1
1382175|NCT01390844|4560925|P2|Follow-Up Phase|Non-Medical Reasons|1
1382176|NCT01390844|4560926|P1|Follow-Up Phase|Non-Medical Reasons|1
1382177|NCT01390844|4560923|P4|Treatment Phase|Non-GCP Compliant|3
1382178|NCT01390844|4560924|P3|Treatment Phase|Non-GCP Compliant|10
1382179|NCT01390844|4560925|P2|Treatment Phase|Non-GCP Compliant|0
1382180|NCT01390844|4560926|P1|Treatment Phase|Non-GCP Compliant|0
1382181|NCT01390844|4560923|P4|Treatment Phase|Non-Medical Reasons|1
1382182|NCT01390844|4560924|P3|Treatment Phase|Non-Medical Reasons|8
1382183|NCT01390844|4560925|P2|Treatment Phase|Non-Medical Reasons|1
1382184|NCT01390844|4560926|P1|Treatment Phase|Non-Medical Reasons|5
1382185|NCT01390844|4560923|P4|Treatment Phase|Treatment Failure|13
1382186|NCT01390844|4560924|P3|Treatment Phase|Treatment Failure|10
1382187|NCT01390844|4560925|P2|Treatment Phase|Treatment Failure|25
1382188|NCT01390844|4560926|P1|Treatment Phase|Treatment Failure|23
1382189|NCT01390844|4560923|P4|Treatment Phase|Adverse Event|2
1382190|NCT01390844|4560924|P3|Treatment Phase|Adverse Event|3
1382191|NCT01390844|4560925|P2|Treatment Phase|Adverse Event|2
1382192|NCT01390844|4560926|P1|Treatment Phase|Adverse Event|12
1382193|NCT01390779|4561253|P1|Overall Study|Physician Decision|1
1382194|NCT01390649|4561258|P1|Overall Study|Physician Decision|1
1382195|NCT01390441|4561268|P5|Extension Period|Protocol Violation|0
1382196|NCT01390441|4561269|P4|Extension Period|Protocol Violation|1
1382197|NCT01390441|4561270|P3|Extension Period|Protocol Violation|0
1382198|NCT01390441|4561271|P2|Extension Period|Protocol Violation|1
1382199|NCT01390441|4561272|P1|Extension Period|Protocol Violation|3
1382200|NCT01390441|4561268|P5|Treatment Period|Lost to Follow-up|0
1382201|NCT01390441|4561269|P4|Treatment Period|Lost to Follow-up|0
1382202|NCT01390441|4561270|P3|Treatment Period|Lost to Follow-up|0
1382203|NCT01390441|4561271|P2|Treatment Period|Lost to Follow-up|0
1382204|NCT01390441|4561272|P1|Treatment Period|Lost to Follow-up|1
1382205|NCT01390441|4561268|P5|Treatment Period|Withdrawal by Subject|1
1382206|NCT01390441|4561269|P4|Treatment Period|Withdrawal by Subject|0
1382207|NCT01390441|4561270|P3|Treatment Period|Withdrawal by Subject|1
1382208|NCT01390441|4561271|P2|Treatment Period|Withdrawal by Subject|0
1382209|NCT01390441|4561272|P1|Treatment Period|Withdrawal by Subject|0
1382210|NCT01390441|4561268|P5|Treatment Period|Adverse Event|2
1382211|NCT01390441|4561269|P4|Treatment Period|Adverse Event|1
1382212|NCT01390441|4561270|P3|Treatment Period|Adverse Event|1
1382213|NCT01390441|4561271|P2|Treatment Period|Adverse Event|0
1382214|NCT01390441|4561272|P1|Treatment Period|Adverse Event|0
1382215|NCT01390441|4561268|P5|Treatment Period|Unknown due to early stopping of study|7
1382216|NCT01390441|4561269|P4|Treatment Period|Unknown due to early stopping of study|11
1382217|NCT01390441|4561270|P3|Treatment Period|Unknown due to early stopping of study|8
1382218|NCT01390441|4561271|P2|Treatment Period|Unknown due to early stopping of study|0
1382219|NCT01390441|4561272|P1|Treatment Period|Unknown due to early stopping of study|0
1382220|NCT01390441|4561268|P5|Treatment Period|Lack of Efficacy|1
1382221|NCT01390441|4561269|P4|Treatment Period|Lack of Efficacy|0
1382222|NCT01390441|4561270|P3|Treatment Period|Lack of Efficacy|0
1382223|NCT01390441|4561271|P2|Treatment Period|Lack of Efficacy|0
1382224|NCT01390441|4561272|P1|Treatment Period|Lack of Efficacy|0
1382225|NCT01390441|4561268|P5|Treatment Period|Physician Decision|0
1382226|NCT01390441|4561269|P4|Treatment Period|Physician Decision|1
1382227|NCT01390441|4561270|P3|Treatment Period|Physician Decision|0
1382228|NCT01390441|4561271|P2|Treatment Period|Physician Decision|0
1382229|NCT01390441|4561272|P1|Treatment Period|Physician Decision|0
1382230|NCT01390441|4561268|P5|Treatment Period|Protocol Violation|0
1382231|NCT01390441|4561269|P4|Treatment Period|Protocol Violation|0
1382232|NCT01390441|4561270|P3|Treatment Period|Protocol Violation|0
1382233|NCT01390441|4561271|P2|Treatment Period|Protocol Violation|1
1382234|NCT01390441|4561272|P1|Treatment Period|Protocol Violation|0
1382235|NCT01390428|4561337|P6|Overall Study|Withdrawal by Subject|0
1382236|NCT01390428|4561338|P5|Overall Study|Withdrawal by Subject|0
1382237|NCT01390428|4561339|P4|Overall Study|Withdrawal by Subject|0
1382238|NCT01390428|4561340|P3|Overall Study|Withdrawal by Subject|1
1382239|NCT01390428|4561341|P2|Overall Study|Withdrawal by Subject|0
1382240|NCT01390428|4561342|P1|Overall Study|Withdrawal by Subject|0
1382241|NCT01390428|4561337|P6|Overall Study|Elective Surgery|0
1382242|NCT01390428|4561338|P5|Overall Study|Elective Surgery|1
1382243|NCT01390428|4561339|P4|Overall Study|Elective Surgery|0
1382244|NCT01390428|4561340|P3|Overall Study|Elective Surgery|0
1382245|NCT01390428|4561341|P2|Overall Study|Elective Surgery|0
1382246|NCT01390428|4561342|P1|Overall Study|Elective Surgery|0
1382247|NCT01390402|4561405|P1|Overall Study|Disease Progression|4
1382248|NCT01390402|4561405|P1|Overall Study|Death|1
1382249|NCT01390389|4561411|P2|Overall Study|Screen Fail|1
1382250|NCT01390389|4561412|P1|Overall Study|Screen Fail|2
1382251|NCT01390389|4561411|P2|Overall Study|Withdrawal by Subject|0
1382252|NCT01390389|4561412|P1|Overall Study|Withdrawal by Subject|2
1382253|NCT01390181|4561460|P1|Overall Study|Study Terminated due to Low Accrual|3
1382254|NCT01390181|4561460|P1|Overall Study|Lost to Follow-up|1
1382255|NCT01390038|4561464|P1|Overall Study|Simpliciti System Removal|2
1382256|NCT01390038|4561464|P1|Overall Study|Withdrawal by Subject|4
1382257|NCT01390038|4561464|P1|Overall Study|Lost to Follow-up|1
1382258|NCT01390038|4561464|P1|Overall Study|Death|1
1382259|NCT01389973|4561474|P1|Overall Study|Other|10
1382260|NCT01389973|4561474|P1|Overall Study|Trial Stopped by Sponsor|9
1382261|NCT01389973|4561474|P1|Overall Study|Lost to Follow-up|1
1382262|NCT01389882|4561484|P2|Overall Study|Withdrawal by Subject|1
1382263|NCT01389882|4561485|P1|Overall Study|Withdrawal by Subject|0
1382264|NCT01389882|4561484|P2|Overall Study|Respiratory rate > 80/min during study|3
1382265|NCT01389882|4561485|P1|Overall Study|Respiratory rate > 80/min during study|1
1382266|NCT01389817|4561573|P2|Overall Study|Withdrawal by Subject|0
1382267|NCT01389817|4561574|P1|Overall Study|Withdrawal by Subject|2
1382268|NCT01389817|4561573|P2|Overall Study|Lost to Follow-up|0
1382269|NCT01389817|4561574|P1|Overall Study|Lost to Follow-up|1
1382270|NCT01389817|4561573|P2|Overall Study|Physician Decision|0
1382271|NCT01389817|4561574|P1|Overall Study|Physician Decision|1
1382272|NCT01389596|4561583|P3|Overall Study|Other Unspecified|0
1382273|NCT01389596|4561584|P2|Overall Study|Other Unspecified|1
1382274|NCT01389596|4561585|P1|Overall Study|Other Unspecified|2
1382275|NCT01389596|4561583|P3|Overall Study|Death|0
1382276|NCT01389596|4561584|P2|Overall Study|Death|1
1382277|NCT01389596|4561585|P1|Overall Study|Death|0
1382278|NCT01389596|4561583|P3|Overall Study|Adverse Event|0
1382279|NCT01389596|4561584|P2|Overall Study|Adverse Event|4
1382280|NCT01389596|4561585|P1|Overall Study|Adverse Event|1
1382281|NCT01389596|4561583|P3|Overall Study|Insufficient Clinical Response|5
1382282|NCT01389596|4561584|P2|Overall Study|Insufficient Clinical Response|4
1382283|NCT01389596|4561585|P1|Overall Study|Insufficient Clinical Response|3
1382284|NCT01389596|4561583|P3|Overall Study|Withdrawal by Subject|2
1382285|NCT01389596|4561584|P2|Overall Study|Withdrawal by Subject|2
1382286|NCT01389596|4561585|P1|Overall Study|Withdrawal by Subject|1
1382287|NCT01389596|4561583|P3|Overall Study|Protocol Violation|3
1382288|NCT01389596|4561584|P2|Overall Study|Protocol Violation|4
1382289|NCT01389596|4561585|P1|Overall Study|Protocol Violation|3
1382290|NCT01389323|4561644|P1|Follow-up Period (up to 48 Weeks)|Other|3
1382291|NCT01389323|4561644|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
1382292|NCT01389323|4561644|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
1382293|NCT01389323|4561644|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
1382294|NCT01389323|4561644|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
1382295|NCT01389323|4561644|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
1382296|NCT01389323|4561644|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
1382297|NCT01389323|4561644|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
1382298|NCT01389323|4561644|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
1382299|NCT01389323|4561644|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
1382300|NCT01389323|4561644|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
1382301|NCT01389102|4561707|P6|Overall Study|Investigator Judgement|0
1382302|NCT01389102|4561708|P5|Overall Study|Investigator Judgement|0
1382303|NCT01389102|4561709|P4|Overall Study|Investigator Judgement|0
1382304|NCT01389102|4561710|P3|Overall Study|Investigator Judgement|0
1382305|NCT01389102|4561711|P2|Overall Study|Investigator Judgement|1
1382306|NCT01389102|4561712|P1|Overall Study|Investigator Judgement|0
1382307|NCT01389102|4561707|P6|Overall Study|Unavailable due to husband's illness|0
1382308|NCT01389102|4561708|P5|Overall Study|Unavailable due to husband's illness|0
1382309|NCT01389102|4561709|P4|Overall Study|Unavailable due to husband's illness|0
1382310|NCT01389102|4561710|P3|Overall Study|Unavailable due to husband's illness|0
1382311|NCT01389102|4561711|P2|Overall Study|Unavailable due to husband's illness|1
1382312|NCT01389102|4561712|P1|Overall Study|Unavailable due to husband's illness|0
1382313|NCT01389102|4561707|P6|Overall Study|Subject Moved|0
1382314|NCT01389102|4561708|P5|Overall Study|Subject Moved|0
1382315|NCT01389102|4561709|P4|Overall Study|Subject Moved|0
1382316|NCT01389102|4561710|P3|Overall Study|Subject Moved|1
1382317|NCT01389102|4561711|P2|Overall Study|Subject Moved|0
1382318|NCT01389102|4561712|P1|Overall Study|Subject Moved|2
1382319|NCT01389102|4561707|P6|Overall Study|Subject Traveling Out of Country|0
1382320|NCT01389102|4561708|P5|Overall Study|Subject Traveling Out of Country|0
1382321|NCT01389102|4561709|P4|Overall Study|Subject Traveling Out of Country|1
1382322|NCT01389102|4561710|P3|Overall Study|Subject Traveling Out of Country|0
1382323|NCT01389102|4561711|P2|Overall Study|Subject Traveling Out of Country|0
1382324|NCT01389102|4561712|P1|Overall Study|Subject Traveling Out of Country|0
1382325|NCT01389102|4561707|P6|Overall Study|Withdrawal by Subject|3
1382326|NCT01389102|4561708|P5|Overall Study|Withdrawal by Subject|3
1382327|NCT01389102|4561709|P4|Overall Study|Withdrawal by Subject|2
1382328|NCT01389102|4561710|P3|Overall Study|Withdrawal by Subject|9
1382329|NCT01389102|4561711|P2|Overall Study|Withdrawal by Subject|4
1382330|NCT01389102|4561712|P1|Overall Study|Withdrawal by Subject|7
1382331|NCT01389102|4561707|P6|Overall Study|Protocol Violation|1
1382332|NCT01389102|4561708|P5|Overall Study|Protocol Violation|1
1382333|NCT01389102|4561709|P4|Overall Study|Protocol Violation|0
1382334|NCT01389102|4561710|P3|Overall Study|Protocol Violation|3
1382335|NCT01389102|4561711|P2|Overall Study|Protocol Violation|0
1382336|NCT01389102|4561712|P1|Overall Study|Protocol Violation|0
1382337|NCT01389102|4561707|P6|Overall Study|Lost to Follow-up|1
1382338|NCT01389102|4561708|P5|Overall Study|Lost to Follow-up|4
1382339|NCT01389102|4561709|P4|Overall Study|Lost to Follow-up|2
1382340|NCT01389102|4561710|P3|Overall Study|Lost to Follow-up|1
1382341|NCT01389102|4561711|P2|Overall Study|Lost to Follow-up|1
1382342|NCT01389102|4561712|P1|Overall Study|Lost to Follow-up|4
1382343|NCT01389102|4561707|P6|Overall Study|Hurricane Katrina|1
1382344|NCT01389102|4561708|P5|Overall Study|Hurricane Katrina|3
1382345|NCT01389102|4561709|P4|Overall Study|Hurricane Katrina|0
1382346|NCT01389102|4561710|P3|Overall Study|Hurricane Katrina|3
1382347|NCT01389102|4561711|P2|Overall Study|Hurricane Katrina|2
1382348|NCT01389102|4561712|P1|Overall Study|Hurricane Katrina|4
1382349|NCT01389102|4561707|P6|Overall Study|Adverse Event|2
1382350|NCT01389102|4561708|P5|Overall Study|Adverse Event|2
1382351|NCT01389102|4561709|P4|Overall Study|Adverse Event|2
1382352|NCT01389102|4561710|P3|Overall Study|Adverse Event|2
1382353|NCT01389102|4561711|P2|Overall Study|Adverse Event|3
1382354|NCT01389102|4561712|P1|Overall Study|Adverse Event|1
1382355|NCT01388907|4561790|P2|Overall Study|Adverse Event|0
1382356|NCT01388907|4561791|P1|Overall Study|Adverse Event|2
1382357|NCT01388816|4561807|P4|Overall Study|Protocol Violation|0
1382358|NCT01388816|4561808|P3|Overall Study|Protocol Violation|2
1382359|NCT01388816|4561809|P2|Overall Study|Protocol Violation|0
1382360|NCT01388816|4561810|P1|Overall Study|Protocol Violation|0
1382361|NCT01388816|4561807|P4|Overall Study|Withdrawal by Subject|0
1382362|NCT01388816|4561808|P3|Overall Study|Withdrawal by Subject|1
1382363|NCT01388816|4561809|P2|Overall Study|Withdrawal by Subject|1
1382364|NCT01388816|4561810|P1|Overall Study|Withdrawal by Subject|2
1382365|NCT01388816|4561807|P4|Overall Study|Lost to Follow-up|0
1382366|NCT01388816|4561808|P3|Overall Study|Lost to Follow-up|0
1382367|NCT01388816|4561809|P2|Overall Study|Lost to Follow-up|1
1382368|NCT01388816|4561810|P1|Overall Study|Lost to Follow-up|0
1382369|NCT01388816|4561807|P4|Overall Study|Adverse Event|0
1382370|NCT01388816|4561808|P3|Overall Study|Adverse Event|0
1382371|NCT01388816|4561809|P2|Overall Study|Adverse Event|2
1382372|NCT01388816|4561810|P1|Overall Study|Adverse Event|0
1382373|NCT01388790|4561839|P1|Overall Study|Ongoing at data cut−off date|8
1382374|NCT01388647|4561850|P2|Overall Study|Adverse Event|2
1382375|NCT01388647|4561851|P1|Overall Study|Adverse Event|1
1382376|NCT01388530|4561862|P1|Overall Study|Lost to Follow-up|5
1382377|NCT01388491|4561871|P2|Overall Study|Pregnancy|0
1382378|NCT01388491|4561872|P1|Overall Study|Pregnancy|1
1382379|NCT01388491|4561871|P2|Overall Study|Noncompliance|0
1382380|NCT01388491|4561872|P1|Overall Study|Noncompliance|2
1382381|NCT01388491|4561871|P2|Overall Study|Protocol Violation|0
1382382|NCT01388491|4561872|P1|Overall Study|Protocol Violation|2
1382383|NCT01388491|4561871|P2|Overall Study|Lost to Follow-up|3
1382384|NCT01388491|4561872|P1|Overall Study|Lost to Follow-up|4
1382385|NCT01388491|4561871|P2|Overall Study|Withdrawal by Subject|10
1382386|NCT01388491|4561872|P1|Overall Study|Withdrawal by Subject|6
1382387|NCT01388491|4561871|P2|Overall Study|Sponsor Request|7
1382388|NCT01388491|4561872|P1|Overall Study|Sponsor Request|9
1382389|NCT01388491|4561871|P2|Overall Study|Adverse Event|9
1382390|NCT01388491|4561872|P1|Overall Study|Adverse Event|10
1382391|NCT01388361|4561907|P3|Overall Study|Unclassified|1
1382392|NCT01388361|4561908|P2|Overall Study|Unclassified|0
1382393|NCT01388361|4561909|P1|Overall Study|Unclassified|0
1382394|NCT01388361|4561907|P3|Overall Study|Withdrawal criteria|10
1382395|NCT01388361|4561908|P2|Overall Study|Withdrawal criteria|7
1382396|NCT01388361|4561909|P1|Overall Study|Withdrawal criteria|12
1382397|NCT01388361|4561907|P3|Overall Study|Protocol Violation|2
1382398|NCT01388361|4561908|P2|Overall Study|Protocol Violation|0
1382399|NCT01388361|4561909|P1|Overall Study|Protocol Violation|0
1382400|NCT01388361|4561907|P3|Overall Study|Adverse Event|1
1382401|NCT01388361|4561908|P2|Overall Study|Adverse Event|5
1382402|NCT01388361|4561909|P1|Overall Study|Adverse Event|0
1382403|NCT01388166|4561926|P1|Overall Study|Others than specified above|13
1382404|NCT01388166|4561926|P1|Overall Study|Lost to Follow-up|30
1382405|NCT01388166|4561926|P1|Overall Study|Adverse Event|16
1382406|NCT01387789|4561932|P1|Overall Study|Lost to Follow-up|1
1382407|NCT01387789|4561932|P1|Overall Study|Lack of Efficacy|2
1382408|NCT01387789|4561932|P1|Overall Study|Adverse Event|5
1382409|NCT01387737|4561946|P2|Overall Study|Clearly not eligible for the study|3
1382410|NCT01387737|4561947|P1|Overall Study|Clearly not eligible for the study|1
1382411|NCT01387737|4561946|P2|Overall Study|Withdrawal by Subject|31
1382412|NCT01387737|4561947|P1|Overall Study|Withdrawal by Subject|27
1382413|NCT01387737|4561946|P2|Overall Study|Physician Decision|10
1382414|NCT01387737|4561947|P1|Overall Study|Physician Decision|3
1382415|NCT01387737|4561946|P2|Overall Study|Lack of Efficacy|0
1382416|NCT01387737|4561947|P1|Overall Study|Lack of Efficacy|1
1382417|NCT01387737|4561946|P2|Overall Study|Adverse Event|30
1382418|NCT01387737|4561947|P1|Overall Study|Adverse Event|20
1382419|NCT01387607|4561981|P2|Overall Study|Randomized, not treated|6
1382420|NCT01387607|4561982|P1|Overall Study|Randomized, not treated|3
1382421|NCT01387607|4561981|P2|Overall Study|Other|1
1382422|NCT01387607|4561982|P1|Overall Study|Other|1
1382423|NCT01387607|4561981|P2|Overall Study|Withdrawal by Subject|14
1382424|NCT01387607|4561982|P1|Overall Study|Withdrawal by Subject|13
1382425|NCT01387607|4561981|P2|Overall Study|Protocol Violation|5
1382426|NCT01387607|4561982|P1|Overall Study|Protocol Violation|1
1382427|NCT01387607|4561981|P2|Overall Study|No longer meets eligibility criteria|1
1382428|NCT01387607|4561982|P1|Overall Study|No longer meets eligibility criteria|0
1382429|NCT01387607|4561981|P2|Overall Study|Lost to Follow-up|1
1382430|NCT01387607|4561982|P1|Overall Study|Lost to Follow-up|2
1382431|NCT01387607|4561981|P2|Overall Study|Lack of Efficacy|6
1382432|NCT01387607|4561982|P1|Overall Study|Lack of Efficacy|8
1382433|NCT01387607|4561981|P2|Overall Study|Adverse Event|11
1382434|NCT01387607|4561982|P1|Overall Study|Adverse Event|23
1382435|NCT01387594|4562036|P2|Overall Study|Lost to Follow-up|1
1382436|NCT01387594|4562037|P1|Overall Study|Lost to Follow-up|0
1382437|NCT01387594|4562036|P2|Overall Study|Withdrawal by Subject|2
1382438|NCT01387594|4562037|P1|Overall Study|Withdrawal by Subject|0
1382439|NCT01387542|4562065|P1|Overall Study|Lost to Follow-up|1
1382440|NCT01387542|4562065|P1|Overall Study|Non-compliant|1
1382441|NCT01387542|4562065|P1|Overall Study|Insufficient response|1
1382442|NCT01387542|4562065|P1|Overall Study|Changed diagnosis|1
1382443|NCT01387542|4562065|P1|Overall Study|Withdrawal by Subject|1
1382444|NCT01387542|4562065|P1|Overall Study|Adverse Event|3
1382445|NCT01387347|4562083|P2|Overall Study|Lost to Follow-up|1
1382446|NCT01387347|4562084|P1|Overall Study|Lost to Follow-up|2
1382447|NCT01387282|4562096|P2|Overall Study|Lost to Follow-up|1
1382448|NCT01387282|4562097|P1|Overall Study|Lost to Follow-up|4
1382449|NCT01387282|4562096|P2|Overall Study|Study drug-related AE|2
1382450|NCT01387282|4562097|P1|Overall Study|Study drug-related AE|2
1382451|NCT01387282|4562096|P2|Overall Study|Withdrawal by patient|23
1382452|NCT01387282|4562097|P1|Overall Study|Withdrawal by patient|33
1382453|NCT01387282|4562096|P2|Overall Study|Unrelated AE|4
1382454|NCT01387282|4562097|P1|Overall Study|Unrelated AE|6
1382455|NCT01387282|4562096|P2|Overall Study|Other|1
1382456|NCT01387282|4562097|P1|Overall Study|Other|5
1382457|NCT01387282|4562096|P2|Overall Study|Death|16
1382458|NCT01387282|4562097|P1|Overall Study|Death|47
1382459|NCT01387269|4562113|P2|Overall Study|Lost to Follow-up|0
1382460|NCT01387269|4562114|P1|Overall Study|Lost to Follow-up|1
1382461|NCT01387269|4562113|P2|Overall Study|Study drug-related AE|0
1382462|NCT01387269|4562114|P1|Overall Study|Study drug-related AE|1
1382463|NCT01387269|4562113|P2|Overall Study|Withdrawal by patient|10
1382464|NCT01387269|4562114|P1|Overall Study|Withdrawal by patient|32
1382465|NCT01387269|4562113|P2|Overall Study|Unrelated AE|3
1382466|NCT01387269|4562114|P1|Overall Study|Unrelated AE|12
1382467|NCT01387269|4562113|P2|Overall Study|Other|7
1382468|NCT01387269|4562114|P1|Overall Study|Other|8
1382469|NCT01387269|4562113|P2|Overall Study|Death|20
1382470|NCT01387269|4562114|P1|Overall Study|Death|38
1382471|NCT01387230|4562131|P3|Overall Study|Withdrawal by Subject|0
1382472|NCT01387230|4562132|P2|Overall Study|Withdrawal by Subject|1
1382473|NCT01387230|4562133|P1|Overall Study|Withdrawal by Subject|4
1382474|NCT01387230|4562131|P3|Overall Study|Lost to Follow-up|1
1382475|NCT01387230|4562132|P2|Overall Study|Lost to Follow-up|0
1382476|NCT01387230|4562133|P1|Overall Study|Lost to Follow-up|0
1382477|NCT01387230|4562131|P3|Overall Study|Protocol-defined Stopping Criteria|5
1382478|NCT01387230|4562132|P2|Overall Study|Protocol-defined Stopping Criteria|0
1382479|NCT01387230|4562133|P1|Overall Study|Protocol-defined Stopping Criteria|6
1382480|NCT01387230|4562131|P3|Overall Study|Lack of Efficacy|4
1382481|NCT01387230|4562132|P2|Overall Study|Lack of Efficacy|5
1382482|NCT01387230|4562133|P1|Overall Study|Lack of Efficacy|8
1382483|NCT01387230|4562131|P3|Overall Study|Adverse Event|3
1382484|NCT01387230|4562132|P2|Overall Study|Adverse Event|1
1382485|NCT01387230|4562133|P1|Overall Study|Adverse Event|0
1382486|NCT01387074|4562179|P1|Overall Study|Lack of Efficacy|1
1382487|NCT01387074|4562179|P1|Overall Study|Lost to Follow-up|7
1382488|NCT01387022|4562192|P2|Overall Study|Lost to Follow-up|3
1382489|NCT01387022|4562193|P1|Overall Study|Lost to Follow-up|0
1382490|NCT01387022|4562192|P2|Overall Study|Death|1
1382491|NCT01387022|4562193|P1|Overall Study|Death|1
1382492|NCT01386944|4562220|P1|Overall Study|Unspecified reason|8
1382493|NCT01386944|4562220|P1|Overall Study|Lost to Follow-up|8
1382494|NCT01386944|4562220|P1|Overall Study|Lack of Efficacy|14
1382495|NCT01386944|4562220|P1|Overall Study|Adverse Event|26
1382496|NCT01386788|4562230|P1|Overall Study|Lost to Follow-up|2
1382497|NCT01386684|4562235|P1|Overall Study|Missing|3
1382498|NCT01386684|4562235|P1|Overall Study|Protocol Violation|4
1382499|NCT01386684|4562235|P1|Overall Study|Noncompliance|8
1382500|NCT01386684|4562235|P1|Overall Study|Adverse Event|20
1382501|NCT01386684|4562235|P1|Overall Study|Disease Progression|28
1382502|NCT01386684|4562235|P1|Overall Study|Alternative Therapy Required|37
1382503|NCT01386684|4562235|P1|Overall Study|Withdrawal of Consent|44
1382504|NCT01386684|4562235|P1|Overall Study|Death|47
1382505|NCT01386684|4562235|P1|Overall Study|Not Specified|51
1382506|NCT01386684|4562235|P1|Overall Study|Lost to Follow-up|51
1382507|NCT01386606|4562289|P4|Overall Study|T levels too high|0
1382508|NCT01386606|4562290|P3|Overall Study|T levels too high|1
1382509|NCT01386606|4562291|P2|Overall Study|T levels too high|1
1382510|NCT01386606|4562292|P1|Overall Study|T levels too high|0
1382511|NCT01386606|4562289|P4|Overall Study|Unable to draw PK|0
1382512|NCT01386606|4562290|P3|Overall Study|Unable to draw PK|0
1382513|NCT01386606|4562291|P2|Overall Study|Unable to draw PK|0
1382514|NCT01386606|4562292|P1|Overall Study|Unable to draw PK|1
1382515|NCT01386606|4562289|P4|Overall Study|Subject incarcerated|0
1382516|NCT01386606|4562290|P3|Overall Study|Subject incarcerated|0
1382517|NCT01386606|4562291|P2|Overall Study|Subject incarcerated|1
1382518|NCT01386606|4562292|P1|Overall Study|Subject incarcerated|0
1382519|NCT01386606|4562289|P4|Overall Study|Lost to Follow-up|0
1382520|NCT01386606|4562290|P3|Overall Study|Lost to Follow-up|0
1382521|NCT01386606|4562291|P2|Overall Study|Lost to Follow-up|0
1382522|NCT01386606|4562292|P1|Overall Study|Lost to Follow-up|2
1382523|NCT01386606|4562289|P4|Overall Study|Protocol Violation|1
1382524|NCT01386606|4562290|P3|Overall Study|Protocol Violation|1
1382525|NCT01386606|4562291|P2|Overall Study|Protocol Violation|0
1382526|NCT01386606|4562292|P1|Overall Study|Protocol Violation|1
1382527|NCT01386606|4562289|P4|Overall Study|Withdrawal by Subject|0
1382528|NCT01386606|4562290|P3|Overall Study|Withdrawal by Subject|1
1382529|NCT01386606|4562291|P2|Overall Study|Withdrawal by Subject|1
1382530|NCT01386606|4562292|P1|Overall Study|Withdrawal by Subject|0
1382531|NCT01386606|4562289|P4|Overall Study|Adverse Event|0
1382532|NCT01386606|4562290|P3|Overall Study|Adverse Event|0
1382533|NCT01386606|4562291|P2|Overall Study|Adverse Event|1
1382534|NCT01386606|4562292|P1|Overall Study|Adverse Event|0
1382535|NCT01386125|4562351|P2|Overall Study|Participant Leaving Country|0
1382536|NCT01386125|4562352|P1|Overall Study|Participant Leaving Country|1
1382537|NCT01386125|4562351|P2|Overall Study|Lack of Efficacy|1
1382538|NCT01386125|4562352|P1|Overall Study|Lack of Efficacy|0
1382539|NCT01386125|4562351|P2|Overall Study|Adverse Event|5
1382540|NCT01386125|4562352|P1|Overall Study|Adverse Event|2
1382541|NCT01386125|4562351|P2|Overall Study|Withdrawal by Subject|12
1382542|NCT01386125|4562352|P1|Overall Study|Withdrawal by Subject|13
1382543|NCT01386125|4562351|P2|Overall Study|Disease Progress|2
1382544|NCT01386125|4562352|P1|Overall Study|Disease Progress|1
1382545|NCT01386125|4562351|P2|Overall Study|Protocol Violation|7
1382546|NCT01386125|4562352|P1|Overall Study|Protocol Violation|5
1382547|NCT01386125|4562351|P2|Overall Study|Physician Decision|1
1382548|NCT01386125|4562352|P1|Overall Study|Physician Decision|0
1382549|NCT01386125|4562351|P2|Overall Study|Lost to Follow-up|9
1382550|NCT01386125|4562352|P1|Overall Study|Lost to Follow-up|3
1382551|NCT01386008|4562360|P1|Overall Study|Adverse Event|3
1382552|NCT01386008|4562360|P1|Overall Study|exited w/o incident /study discontinued|17
1382553|NCT01385995|4562369|P2|Period 1, 2 Months|Physician Decision|0
1382554|NCT01385995|4562370|P1|Period 1, 2 Months|Physician Decision|1
1382555|NCT01385748|4562387|P3|Overall Study|Adverse Event|1
1382556|NCT01385748|4562388|P2|Overall Study|Adverse Event|2
1382557|NCT01385748|4562389|P1|Overall Study|Adverse Event|4
1382558|NCT01385748|4562387|P3|Overall Study|Not specified|1
1382559|NCT01385748|4562388|P2|Overall Study|Not specified|7
1382560|NCT01385748|4562389|P1|Overall Study|Not specified|1
1382561|NCT01385748|4562387|P3|Overall Study|Noncompliance|6
1382562|NCT01385748|4562388|P2|Overall Study|Noncompliance|1
1382563|NCT01385748|4562389|P1|Overall Study|Noncompliance|3
1382564|NCT01385748|4562387|P3|Overall Study|Withdrawal by Subject|5
1382565|NCT01385748|4562388|P2|Overall Study|Withdrawal by Subject|4
1382566|NCT01385748|4562389|P1|Overall Study|Withdrawal by Subject|7
1382567|NCT01385566|4562474|P6|Overall Study|Withdrawal by Subject|0
1382568|NCT01385566|4562475|P5|Overall Study|Withdrawal by Subject|0
1382569|NCT01385566|4562476|P4|Overall Study|Withdrawal by Subject|1
1382570|NCT01385566|4562477|P3|Overall Study|Withdrawal by Subject|0
1382571|NCT01385566|4562478|P2|Overall Study|Withdrawal by Subject|0
1382572|NCT01385566|4562479|P1|Overall Study|Withdrawal by Subject|0
1382573|NCT01385566|4562474|P6|Overall Study|Lost to Follow-up|0
1382574|NCT01385566|4562475|P5|Overall Study|Lost to Follow-up|0
1382575|NCT01385566|4562476|P4|Overall Study|Lost to Follow-up|0
1382576|NCT01385566|4562477|P3|Overall Study|Lost to Follow-up|0
1382577|NCT01385566|4562478|P2|Overall Study|Lost to Follow-up|0
1382578|NCT01385566|4562479|P1|Overall Study|Lost to Follow-up|1
1382579|NCT01385371|4562533|P2|Overall Study|Administrative|2
1382580|NCT01385371|4562534|P1|Overall Study|Administrative|2
1382581|NCT01385371|4562533|P2|Overall Study|Protocol Violation|21
1382582|NCT01385371|4562534|P1|Overall Study|Protocol Violation|25
1382583|NCT01385371|4562533|P2|Overall Study|Withdrawal by Subject|39
1382584|NCT01385371|4562534|P1|Overall Study|Withdrawal by Subject|52
1382585|NCT01385371|4562533|P2|Overall Study|Lost to Follow-up|16
1382586|NCT01385371|4562534|P1|Overall Study|Lost to Follow-up|16
1382587|NCT01385371|4562533|P2|Overall Study|Adverse Event|19
1382588|NCT01385371|4562534|P1|Overall Study|Adverse Event|54
1382589|NCT01385202|4562564|P1|Overall Study|Withdrawn|1
1382590|NCT01385202|4562564|P1|Overall Study|Not Eligible|11
1382591|NCT01385202|4562564|P1|Overall Study|Lost to Follow-up|6
1382592|NCT01385098|4562616|P1|Overall Study|Lost to Follow-up|4
1382593|NCT01385098|4562616|P1|Overall Study|Adverse Event|10
1382594|NCT01384760|4562638|P2|Overall Study|Protocol Violation|0
1382595|NCT01384760|4562639|P1|Overall Study|Protocol Violation|16
1382596|NCT01384760|4562638|P2|Overall Study|Lost to Follow-up|6
1382597|NCT01384760|4562639|P1|Overall Study|Lost to Follow-up|0
1382598|NCT01384292|4562796|P3|Part B|Severe non-compliance to protocol|0
1382599|NCT01384292|4562797|P2|Part B|Severe non-compliance to protocol|0
1382600|NCT01384292|4562798|P1|Part B|Severe non-compliance to protocol|1
1382601|NCT01384019|4562810|P2|Overall Study|MRI refusal|6
1382602|NCT01384019|4562811|P1|Overall Study|MRI refusal|6
1382603|NCT01384019|4562810|P2|Overall Study|Death|0
1382604|NCT01384019|4562811|P1|Overall Study|Death|1
1382605|NCT01384019|4562810|P2|Overall Study|Withdrawal by Subject|0
1382606|NCT01384019|4562811|P1|Overall Study|Withdrawal by Subject|3
1382607|NCT01383993|4562820|P3|Overall Study|Marketed voriconazole in post-therapy|0
1382608|NCT01383993|4562821|P2|Overall Study|Marketed voriconazole in post-therapy|0
1382609|NCT01383993|4562822|P1|Overall Study|Marketed voriconazole in post-therapy|2
1382610|NCT01383993|4562820|P3|Overall Study|Withdrawal by Subject|1
1382611|NCT01383993|4562821|P2|Overall Study|Withdrawal by Subject|0
1382612|NCT01383993|4562822|P1|Overall Study|Withdrawal by Subject|0
1382613|NCT01383993|4562820|P3|Overall Study|Adverse Event|0
1382614|NCT01383993|4562821|P2|Overall Study|Adverse Event|1
1382615|NCT01383993|4562822|P1|Overall Study|Adverse Event|1
1382616|NCT01383954|4562869|P1|Overall Study|Reason Not Specified|9
1382617|NCT01383954|4562869|P1|Overall Study|Adverse Event|1
1382618|NCT01383954|4562869|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
1382619|NCT01383954|4562869|P1|Overall Study|Lack of Efficacy|2
1382620|NCT01383928|4562877|P3|Phase 2|Unsatisfactory therapeutic response|1
1382621|NCT01383928|4562878|P2|Phase 2|Unsatisfactory therapeutic response|0
1382622|NCT01383928|4562879|P1|Phase 2|Unsatisfactory therapeutic response|0
1382623|NCT01383928|4562877|P3|Phase 2|Withdrawal by Subject|4
1382624|NCT01383928|4562878|P2|Phase 2|Withdrawal by Subject|0
1382625|NCT01383928|4562879|P1|Phase 2|Withdrawal by Subject|0
1382626|NCT01383928|4562877|P3|Phase 2|Progressive Disease|5
1382627|NCT01383928|4562878|P2|Phase 2|Progressive Disease|0
1382628|NCT01383928|4562879|P1|Phase 2|Progressive Disease|0
1382629|NCT01383928|4562877|P3|Phase 2|Other|4
1382630|NCT01383928|4562878|P2|Phase 2|Other|0
1382631|NCT01383928|4562879|P1|Phase 2|Other|0
1382632|NCT01383928|4562877|P3|Phase 2|Adverse Event|8
1382633|NCT01383928|4562878|P2|Phase 2|Adverse Event|0
1382634|NCT01383928|4562879|P1|Phase 2|Adverse Event|0
1382635|NCT01383928|4562877|P3|Phase 2|Autologous Stem Cell Transplantation|18
1382636|NCT01383928|4562878|P2|Phase 2|Autologous Stem Cell Transplantation|0
1382637|NCT01383928|4562879|P1|Phase 2|Autologous Stem Cell Transplantation|0
1382638|NCT01383928|4562877|P3|Phase 1|Progressive Disease|0
1382639|NCT01383928|4562878|P2|Phase 1|Progressive Disease|1
1382640|NCT01383928|4562879|P1|Phase 1|Progressive Disease|1
1382641|NCT01383928|4562877|P3|Phase 1|Other|0
1382642|NCT01383928|4562878|P2|Phase 1|Other|3
1382643|NCT01383928|4562879|P1|Phase 1|Other|1
1382644|NCT01383928|4562877|P3|Phase 1|Adverse Event|0
1382645|NCT01383928|4562878|P2|Phase 1|Adverse Event|2
1382646|NCT01383928|4562879|P1|Phase 1|Adverse Event|1
1382647|NCT01383928|4562877|P3|Phase 1|Autologous Stem Cell Transplantation|0
1382648|NCT01383928|4562878|P2|Phase 1|Autologous Stem Cell Transplantation|1
1382649|NCT01383928|4562879|P1|Phase 1|Autologous Stem Cell Transplantation|2
1382650|NCT01383707|4562943|P1|Overall Study|Progressive disease|23
1382651|NCT01383707|4562943|P1|Overall Study|Adverse Event|14
1382652|NCT01383707|4562943|P1|Overall Study|Sponsor's decision|2
1382653|NCT01383707|4562943|P1|Overall Study|Not specified|8
1382654|NCT01383707|4562943|P1|Overall Study|Death|19
1382655|NCT01383707|4562943|P1|Overall Study|Consent withdrawal|6
1382656|NCT01383499|4562983|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
1382657|NCT01383499|4562984|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
1382658|NCT01383499|4562985|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
1382659|NCT01383499|4562986|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
1382660|NCT01383486|4563036|P1|Overall Study|Did not take any product|6
1382661|NCT01383486|4563036|P1|Overall Study|Incomplete information for analysis|2
1382662|NCT01383486|4563036|P1|Overall Study|Lost to Follow-up|10
1382663|NCT01383356|4563113|P2|Period 1|Personal|2
1382664|NCT01383356|4563114|P1|Period 1|Personal|0
1382665|NCT01383356|4563113|P2|Period 1|Out of Range Mid-study-Test|1
1382666|NCT01383356|4563114|P1|Period 1|Out of Range Mid-study-Test|0
1382667|NCT01383356|4563113|P2|Period 1|Non-compliance|0
1382668|NCT01383356|4563114|P1|Period 1|Non-compliance|3
1382669|NCT01383356|4563113|P2|Period 1|Adverse Event|3
1382670|NCT01383356|4563114|P1|Period 1|Adverse Event|5
1382671|NCT01383317|4563126|P2|Overall Study|Adverse Event|1
1382672|NCT01383317|4563127|P1|Overall Study|Adverse Event|0
1382673|NCT01383317|4563126|P2|Overall Study|Death|0
1382674|NCT01383317|4563127|P1|Overall Study|Death|1
1382675|NCT01383317|4563126|P2|Overall Study|Lost to Follow-up|1
1382676|NCT01383317|4563127|P1|Overall Study|Lost to Follow-up|2
1382677|NCT01383174|4563169|P2|6 Month Assessment|Refused to complete|0
1382678|NCT01383174|4563170|P1|6 Month Assessment|Refused to complete|4
1382679|NCT01383174|4563169|P2|6 Month Assessment|Lost to Follow-up|1
1382680|NCT01383174|4563170|P1|6 Month Assessment|Lost to Follow-up|1
1382681|NCT01383174|4563169|P2|3 Month Assessment|Refused to complete|0
1382682|NCT01383174|4563170|P1|3 Month Assessment|Refused to complete|4
1382683|NCT01383174|4563169|P2|3 Month Assessment|Lost to Follow-up|0
1382684|NCT01383174|4563170|P1|3 Month Assessment|Lost to Follow-up|2
1382685|NCT01383174|4563169|P2|3 Month Assessment|Death|1
1382686|NCT01383174|4563170|P1|3 Month Assessment|Death|0
1382687|NCT01383161|4563196|P2|Overall Study|Lack of Efficacy|1
1382688|NCT01383161|4563197|P1|Overall Study|Lack of Efficacy|0
1382689|NCT01383161|4563196|P2|Overall Study|Withdrawal by Subject|2
1382690|NCT01383161|4563197|P1|Overall Study|Withdrawal by Subject|0
1382691|NCT01383161|4563196|P2|Overall Study|Adverse Event|1
1382692|NCT01383161|4563197|P1|Overall Study|Adverse Event|5
1382693|NCT01383096|4563216|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
1382694|NCT01383096|4563217|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
1382695|NCT01383096|4563218|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
1382696|NCT01383096|4563216|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
1382697|NCT01383096|4563217|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
1382698|NCT01383096|4563218|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
1382699|NCT01383096|4563216|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
1382700|NCT01383096|4563217|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
1382701|NCT01383096|4563218|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
1382702|NCT01383096|4563216|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
1382703|NCT01383096|4563217|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
1382704|NCT01383096|4563218|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
1382705|NCT01383096|4563216|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
1382706|NCT01383096|4563217|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
1382707|NCT01383096|4563218|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
1382708|NCT01383096|4563216|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
1382709|NCT01383096|4563217|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
1382710|NCT01383096|4563218|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
1382711|NCT01383096|4563216|P3|Third Intervention (8 Days)|Adverse Event|0
1382712|NCT01383096|4563217|P2|Third Intervention (8 Days)|Adverse Event|0
1382713|NCT01383096|4563218|P1|Third Intervention (8 Days)|Adverse Event|1
1382714|NCT01383096|4563216|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
1382715|NCT01383096|4563217|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
1382716|NCT01383096|4563218|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
1382717|NCT01383096|4563216|P3|Third Intervention (8 Days)|Elevated AST|0
1382718|NCT01383096|4563217|P2|Third Intervention (8 Days)|Elevated AST|1
1382719|NCT01383096|4563218|P1|Third Intervention (8 Days)|Elevated AST|0
1382720|NCT01383096|4563216|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
1382721|NCT01383096|4563217|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
1382722|NCT01383096|4563218|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
1382723|NCT01383096|4563216|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
1382724|NCT01383096|4563217|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
1382725|NCT01383096|4563218|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
1382726|NCT01382940|4563286|P1|Overall Study|Protocol Violation|20
1382727|NCT01382940|4563286|P1|Overall Study|Withdrawal by Subject|23
1382728|NCT01382940|4563286|P1|Overall Study|Physician Decision|7
1382729|NCT01382940|4563286|P1|Overall Study|Lost to Follow-up|4
1382730|NCT01382940|4563286|P1|Overall Study|Adverse Event|19
1382731|NCT01382602|4563348|P2|Overall Study|Withdrawal by Subject|1
1382732|NCT01382602|4563349|P1|Overall Study|Withdrawal by Subject|0
1382733|NCT01382602|4563348|P2|Overall Study|Protocol Violation|3
1382734|NCT01382602|4563349|P1|Overall Study|Protocol Violation|0
1382735|NCT01382446|4563357|P2|Overall Study|Removal from Mechanical Ventilation|3
1382736|NCT01382446|4563358|P1|Overall Study|Removal from Mechanical Ventilation|3
1382737|NCT01382446|4563357|P2|Overall Study|Withdrawal by Subject|1
1382738|NCT01382446|4563358|P1|Overall Study|Withdrawal by Subject|0
1382739|NCT01382251|4563385|P2|Overall Study|Contacted after study closed|1
1382740|NCT01382251|4563386|P1|Overall Study|Contacted after study closed|1
1382741|NCT01382251|4563385|P2|Overall Study|Lost to Follow-up|4
1382742|NCT01382251|4563386|P1|Overall Study|Lost to Follow-up|4
1382743|NCT01382251|4563385|P2|Overall Study|Surgeries cancelled or delayed|16
1382744|NCT01382251|4563386|P1|Overall Study|Surgeries cancelled or delayed|16
1382745|NCT01382225|4563399|P2|Overall Study|Other|2
1382746|NCT01382225|4563400|P1|Overall Study|Other|4
1382747|NCT01382225|4563399|P2|Overall Study|Subject Withdrew Consent|2
1382748|NCT01382225|4563400|P1|Overall Study|Subject Withdrew Consent|5
1382749|NCT01382225|4563399|P2|Overall Study|Protocol Violation|1
1382750|NCT01382225|4563400|P1|Overall Study|Protocol Violation|2
1382751|NCT01382225|4563399|P2|Overall Study|Adverse Event|2
1382752|NCT01382225|4563400|P1|Overall Study|Adverse Event|3
1382753|NCT01382212|4563422|P1|Overall Study|Withdrew consent|1
1382754|NCT01382212|4563422|P1|Overall Study|Kidney transplant|1
1382755|NCT01381926|4563485|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
1382756|NCT01381926|4563486|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
1382757|NCT01381926|4563485|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
1382758|NCT01381926|4563486|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
1382759|NCT01381900|4563499|P3|Overall Study|Early withdraw|1
1382760|NCT01381900|4563500|P2|Overall Study|Early withdraw|1
1382761|NCT01381900|4563501|P1|Overall Study|Early withdraw|3
1382762|NCT01381900|4563499|P3|Overall Study|Withdrawal by Subject|1
1382763|NCT01381900|4563500|P2|Overall Study|Withdrawal by Subject|0
1382764|NCT01381900|4563501|P1|Overall Study|Withdrawal by Subject|0
1382765|NCT01381900|4563499|P3|Overall Study|Protocol Violation|1
1382766|NCT01381900|4563500|P2|Overall Study|Protocol Violation|1
1382767|NCT01381900|4563501|P1|Overall Study|Protocol Violation|0
1382768|NCT01381900|4563499|P3|Overall Study|Physician Decision|1
1382769|NCT01381900|4563500|P2|Overall Study|Physician Decision|1
1382770|NCT01381900|4563501|P1|Overall Study|Physician Decision|0
1382771|NCT01381900|4563499|P3|Overall Study|Noncompliance with study drug|1
1382772|NCT01381900|4563500|P2|Overall Study|Noncompliance with study drug|0
1382773|NCT01381900|4563501|P1|Overall Study|Noncompliance with study drug|0
1382774|NCT01381900|4563499|P3|Overall Study|Adverse Event|7
1382775|NCT01381900|4563500|P2|Overall Study|Adverse Event|6
1382776|NCT01381900|4563501|P1|Overall Study|Adverse Event|4
1382777|NCT01381900|4563499|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
1382778|NCT01381900|4563500|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
1382779|NCT01381900|4563501|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
1382780|NCT01381874|4563524|P3|Overall Study|Other|67
1382781|NCT01381874|4563525|P2|Overall Study|Other|52
1382782|NCT01381874|4563526|P1|Overall Study|Other|67
1382783|NCT01381874|4563524|P3|Overall Study|Withdrawal by Subject|9
1382784|NCT01381874|4563525|P2|Overall Study|Withdrawal by Subject|10
1382785|NCT01381874|4563526|P1|Overall Study|Withdrawal by Subject|9
1382786|NCT01381874|4563524|P3|Overall Study|Lost to Follow-up|0
1382787|NCT01381874|4563525|P2|Overall Study|Lost to Follow-up|1
1382788|NCT01381874|4563526|P1|Overall Study|Lost to Follow-up|1
1382789|NCT01381679|4563552|P1|Overall Study|Lost to Follow-up|885
1382790|NCT01381679|4563552|P1|Overall Study|Adverse Event|3
1382791|NCT01381575|4563567|P3|Overall Study|Withdrawal by Subject|4
1382792|NCT01381575|4563568|P2|Overall Study|Withdrawal by Subject|0
1382793|NCT01381575|4563569|P1|Overall Study|Withdrawal by Subject|0
1382794|NCT01381575|4563567|P3|Overall Study|Protocol Violation|1
1382795|NCT01381575|4563568|P2|Overall Study|Protocol Violation|0
1382796|NCT01381575|4563569|P1|Overall Study|Protocol Violation|0
1382797|NCT01381575|4563567|P3|Overall Study|Lost to Follow-up|1
1382798|NCT01381575|4563568|P2|Overall Study|Lost to Follow-up|0
1382799|NCT01381575|4563569|P1|Overall Study|Lost to Follow-up|0
1382800|NCT01381575|4563567|P3|Overall Study|Adverse Event|1
1382801|NCT01381575|4563568|P2|Overall Study|Adverse Event|0
1382802|NCT01381575|4563569|P1|Overall Study|Adverse Event|0
1382803|NCT01381575|4563567|P3|Overall Study|Other|0
1382804|NCT01381575|4563568|P2|Overall Study|Other|10
1382805|NCT01381575|4563569|P1|Overall Study|Other|2
1382806|NCT01381562|4563626|P3|Overall Study|Adverse Event|0
1382807|NCT01381562|4563627|P2|Overall Study|Adverse Event|1
1382808|NCT01381562|4563628|P1|Overall Study|Adverse Event|0
1382809|NCT01381549|4563696|P3|Overall Study|Ineligible: No organisms isolated|1
1382810|NCT01381549|4563697|P2|Overall Study|Ineligible: No organisms isolated|0
1382811|NCT01381549|4563698|P1|Overall Study|Ineligible: No organisms isolated|0
1382812|NCT01381016|4563824|P2|Overall Study|Physician Decision|2
1382813|NCT01381016|4563825|P1|Overall Study|Physician Decision|0
1382814|NCT01381016|4563824|P2|Overall Study|Withdrawal by Subject|1
1382815|NCT01381016|4563825|P1|Overall Study|Withdrawal by Subject|0
1382816|NCT01381016|4563824|P2|Overall Study|Screen Failure|2
1382817|NCT01381016|4563825|P1|Overall Study|Screen Failure|2
1382818|NCT01381016|4563824|P2|Overall Study|Lost to Follow-up|1
1382819|NCT01381016|4563825|P1|Overall Study|Lost to Follow-up|1
1382820|NCT01380834|4563835|P2|Overall Study|Physician Decision|0
1382821|NCT01380834|4563836|P1|Overall Study|Physician Decision|1
1382822|NCT01380782|4563848|P4|Overall Study|Withdrawal by Subject|1
1382823|NCT01380782|4563849|P3|Overall Study|Withdrawal by Subject|1
1382824|NCT01380782|4563850|P2|Overall Study|Withdrawal by Subject|0
1382825|NCT01380782|4563851|P1|Overall Study|Withdrawal by Subject|0
1382826|NCT01380782|4563848|P4|Overall Study|Physician Decision|0
1382827|NCT01380782|4563849|P3|Overall Study|Physician Decision|0
1382828|NCT01380782|4563850|P2|Overall Study|Physician Decision|0
1382829|NCT01380782|4563851|P1|Overall Study|Physician Decision|1
1382830|NCT01380782|4563848|P4|Overall Study|Lack of Efficacy|3
1382831|NCT01380782|4563849|P3|Overall Study|Lack of Efficacy|10
1382832|NCT01380782|4563850|P2|Overall Study|Lack of Efficacy|9
1382833|NCT01380782|4563851|P1|Overall Study|Lack of Efficacy|10
1382834|NCT01380782|4563848|P4|Overall Study|Death|0
1382835|NCT01380782|4563849|P3|Overall Study|Death|0
1382836|NCT01380782|4563850|P2|Overall Study|Death|0
1382837|NCT01380782|4563851|P1|Overall Study|Death|1
1382838|NCT01380782|4563848|P4|Overall Study|Adverse Event|0
1382839|NCT01380782|4563849|P3|Overall Study|Adverse Event|0
1382840|NCT01380782|4563850|P2|Overall Study|Adverse Event|1
1382841|NCT01380782|4563851|P1|Overall Study|Adverse Event|0
1382842|NCT01380769|4563874|P2|Overall Study|Protocol Violation|1
1382843|NCT01380769|4563875|P1|Overall Study|Protocol Violation|0
1382844|NCT01380769|4563874|P2|Overall Study|Adverse Event|1
1382845|NCT01380769|4563875|P1|Overall Study|Adverse Event|1
1382846|NCT01380769|4563874|P2|Overall Study|Physician Decision|1
1382847|NCT01380769|4563875|P1|Overall Study|Physician Decision|1
1382848|NCT01380769|4563874|P2|Overall Study|Withdrawal by Subject|11
1382849|NCT01380769|4563875|P1|Overall Study|Withdrawal by Subject|7
1382850|NCT01380730|4563936|P8|Overall Study|Death|0
1382851|NCT01380730|4563937|P7|Overall Study|Death|0
1382852|NCT01380730|4563938|P6|Overall Study|Death|0
1382853|NCT01380730|4563939|P5|Overall Study|Death|1
1382854|NCT01380730|4563940|P4|Overall Study|Death|0
1382855|NCT01380730|4563941|P3|Overall Study|Death|0
1382856|NCT01380730|4563942|P2|Overall Study|Death|0
1382857|NCT01380730|4563943|P1|Overall Study|Death|0
1382858|NCT01380379|4564010|P1|Overall Study|Pregnancy|1
1382859|NCT01380327|4564023|P3|Overall Study|Questionable onset of epilepsy|1
1382860|NCT01380327|4564024|P2|Overall Study|Questionable onset of epilepsy|0
1382861|NCT01380327|4564025|P1|Overall Study|Questionable onset of epilepsy|0
1382862|NCT01380327|4564023|P3|Overall Study|Housing situation precluded ability to k|1
1382863|NCT01380327|4564024|P2|Overall Study|Housing situation precluded ability to k|0
1382864|NCT01380327|4564025|P1|Overall Study|Housing situation precluded ability to k|0
1382865|NCT01380327|4564023|P3|Overall Study|Withdrawal by Subject|1
1382866|NCT01380327|4564024|P2|Overall Study|Withdrawal by Subject|0
1382867|NCT01380327|4564025|P1|Overall Study|Withdrawal by Subject|0
1382868|NCT01380327|4564023|P3|Overall Study|Protocol Violation|3
1382869|NCT01380327|4564024|P2|Overall Study|Protocol Violation|2
1382870|NCT01380327|4564025|P1|Overall Study|Protocol Violation|3
1382871|NCT01380327|4564023|P3|Overall Study|Lost to Follow-up|1
1382872|NCT01380327|4564024|P2|Overall Study|Lost to Follow-up|1
1382873|NCT01380327|4564025|P1|Overall Study|Lost to Follow-up|0
1382874|NCT01380145|4564056|P1|Overall Study|Progressive disease|4
1382875|NCT01380093|4564064|P9|Treatment Phase: Third Intervention|Other|1
1382876|NCT01380093|4564065|P8|Treatment Phase: Third Intervention|Other|0
1382877|NCT01380093|4564066|P7|Treatment Phase: Third Intervention|Other|0
1382878|NCT01380093|4564067|P6|Treatment Phase: Third Intervention|Other|0
1382879|NCT01380093|4564068|P5|Treatment Phase: Third Intervention|Other|0
1382880|NCT01380093|4564069|P4|Treatment Phase: Third Intervention|Other|0
1382881|NCT01380093|4564070|P3|Treatment Phase: Third Intervention|Other|0
1382882|NCT01380093|4564071|P2|Treatment Phase: Third Intervention|Other|0
1382883|NCT01380093|4564072|P1|Treatment Phase: Third Intervention|Other|0
1382884|NCT01380093|4564064|P9|Treatment Phase: Third Intervention|Non-compliance|1
1382885|NCT01380093|4564065|P8|Treatment Phase: Third Intervention|Non-compliance|0
1382886|NCT01380093|4564066|P7|Treatment Phase: Third Intervention|Non-compliance|0
1382887|NCT01380093|4564067|P6|Treatment Phase: Third Intervention|Non-compliance|0
1382888|NCT01380093|4564068|P5|Treatment Phase: Third Intervention|Non-compliance|0
1382889|NCT01380093|4564069|P4|Treatment Phase: Third Intervention|Non-compliance|0
1382890|NCT01380093|4564070|P3|Treatment Phase: Third Intervention|Non-compliance|0
1382891|NCT01380093|4564071|P2|Treatment Phase: Third Intervention|Non-compliance|0
1382892|NCT01380093|4564072|P1|Treatment Phase: Third Intervention|Non-compliance|0
1382893|NCT01380093|4564064|P9|Treatment Phase: Second Intervention|Other|0
1382894|NCT01380093|4564065|P8|Treatment Phase: Second Intervention|Other|0
1382895|NCT01380093|4564066|P7|Treatment Phase: Second Intervention|Other|0
1382896|NCT01380093|4564067|P6|Treatment Phase: Second Intervention|Other|0
1382897|NCT01380093|4564068|P5|Treatment Phase: Second Intervention|Other|0
1382898|NCT01380093|4564069|P4|Treatment Phase: Second Intervention|Other|1
1382899|NCT01380093|4564070|P3|Treatment Phase: Second Intervention|Other|0
1382900|NCT01380093|4564071|P2|Treatment Phase: Second Intervention|Other|0
1382901|NCT01380093|4564072|P1|Treatment Phase: Second Intervention|Other|0
1382902|NCT01380093|4564064|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
1382903|NCT01380093|4564065|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
1382904|NCT01380093|4564066|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
1382905|NCT01380093|4564067|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
1382906|NCT01380093|4564068|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
1382907|NCT01380093|4564069|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
1382908|NCT01380093|4564070|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
1382909|NCT01380093|4564071|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
1382910|NCT01380093|4564072|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
1382911|NCT01380093|4564064|P9|Drug Discrimination Phase: Day 2|Backup participant|0
1382912|NCT01380093|4564065|P8|Drug Discrimination Phase: Day 2|Backup participant|0
1382913|NCT01380093|4564066|P7|Drug Discrimination Phase: Day 2|Backup participant|0
1382914|NCT01380093|4564067|P6|Drug Discrimination Phase: Day 2|Backup participant|0
1382915|NCT01380093|4564068|P5|Drug Discrimination Phase: Day 2|Backup participant|0
1382916|NCT01380093|4564069|P4|Drug Discrimination Phase: Day 2|Backup participant|0
1382917|NCT01380093|4564070|P3|Drug Discrimination Phase: Day 2|Backup participant|1
1382918|NCT01380093|4564071|P2|Drug Discrimination Phase: Day 2|Backup participant|0
1382919|NCT01380093|4564072|P1|Drug Discrimination Phase: Day 2|Backup participant|0
1382920|NCT01380093|4564064|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1382921|NCT01380093|4564065|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1382922|NCT01380093|4564066|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1382923|NCT01380093|4564067|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1382924|NCT01380093|4564068|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1382925|NCT01380093|4564069|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1382926|NCT01380093|4564070|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
1382927|NCT01380093|4564071|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
1382928|NCT01380093|4564072|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1382929|NCT01380093|4564064|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
1382930|NCT01380093|4564065|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
1382931|NCT01380093|4564066|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
1382932|NCT01380093|4564067|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
1382933|NCT01380093|4564068|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
1382934|NCT01380093|4564069|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
1382935|NCT01380093|4564070|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
1382936|NCT01380093|4564071|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
1382937|NCT01380093|4564072|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
1382938|NCT01380093|4564064|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1382939|NCT01380093|4564065|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1382940|NCT01380093|4564066|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1382941|NCT01380093|4564067|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1382942|NCT01380093|4564068|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1382943|NCT01380093|4564069|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1382944|NCT01380093|4564070|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1382945|NCT01380093|4564071|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
1382946|NCT01380093|4564072|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1382947|NCT01380093|4564064|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
1382948|NCT01380093|4564065|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
1382949|NCT01380093|4564066|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
1382950|NCT01380093|4564067|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
1382951|NCT01380093|4564068|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
1382952|NCT01380093|4564069|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
1382953|NCT01380093|4564070|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
1382954|NCT01380093|4564071|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
1382955|NCT01380093|4564072|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
1382956|NCT01380093|4564064|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
1382957|NCT01380093|4564065|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
1382958|NCT01380093|4564066|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
1382959|NCT01380093|4564067|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
1382960|NCT01380093|4564068|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
1382961|NCT01380093|4564069|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
1382962|NCT01380093|4564070|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
1382963|NCT01380093|4564071|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
1382964|NCT01380093|4564072|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
1382965|NCT01380093|4564064|P9|Naloxone Challenge Phase|Screen failures|0
1382966|NCT01380093|4564065|P8|Naloxone Challenge Phase|Screen failures|0
1382967|NCT01380093|4564066|P7|Naloxone Challenge Phase|Screen failures|0
1382968|NCT01380093|4564067|P6|Naloxone Challenge Phase|Screen failures|0
1382969|NCT01380093|4564068|P5|Naloxone Challenge Phase|Screen failures|0
1382970|NCT01380093|4564069|P4|Naloxone Challenge Phase|Screen failures|0
1382971|NCT01380093|4564070|P3|Naloxone Challenge Phase|Screen failures|0
1382972|NCT01380093|4564071|P2|Naloxone Challenge Phase|Screen failures|0
1382973|NCT01380093|4564072|P1|Naloxone Challenge Phase|Screen failures|21
1382974|NCT01380080|4564364|P2|Overall Study|Lost to Follow-up|0
1382975|NCT01380080|4564365|P1|Overall Study|Lost to Follow-up|2
1382976|NCT01380080|4564364|P2|Overall Study|Not willing to adhere to requirements|1
1382977|NCT01380080|4564365|P1|Overall Study|Not willing to adhere to requirements|3
1382978|NCT01380080|4564364|P2|Overall Study|Not able to get to clinic|0
1382979|NCT01380080|4564365|P1|Overall Study|Not able to get to clinic|4
1382980|NCT01380080|4564364|P2|Overall Study|Withdrawal by Subject|0
1382981|NCT01380080|4564365|P1|Overall Study|Withdrawal by Subject|4
1382982|NCT01380080|4564364|P2|Overall Study|Death|22
1382983|NCT01380080|4564365|P1|Overall Study|Death|20
1382984|NCT01379937|4564390|P4|Overall Study|Lost to Follow-up|0
1382985|NCT01379937|4564391|P3|Overall Study|Lost to Follow-up|2
1382986|NCT01379937|4564392|P2|Overall Study|Lost to Follow-up|2
1382987|NCT01379937|4564393|P1|Overall Study|Lost to Follow-up|1
1382988|NCT01379937|4564390|P4|Overall Study|Consent withdrawal|0
1382989|NCT01379937|4564391|P3|Overall Study|Consent withdrawal|0
1382990|NCT01379937|4564392|P2|Overall Study|Consent withdrawal|1
1382991|NCT01379937|4564393|P1|Overall Study|Consent withdrawal|0
1382992|NCT01379937|4564390|P4|Overall Study|Protocol Violation|1
1382993|NCT01379937|4564391|P3|Overall Study|Protocol Violation|0
1382994|NCT01379937|4564392|P2|Overall Study|Protocol Violation|0
1382995|NCT01379937|4564393|P1|Overall Study|Protocol Violation|0
1382996|NCT01379781|4564475|P2|Overall Study|Lost to Follow-up|8
1382997|NCT01379781|4564476|P1|Overall Study|Lost to Follow-up|11
1382998|NCT01379768|4564485|P3|Overall Study|Lost to Follow-up|0
1382999|NCT01379768|4564486|P2|Overall Study|Lost to Follow-up|0
1383000|NCT01379768|4564487|P1|Overall Study|Lost to Follow-up|2
1383001|NCT01379768|4564485|P3|Overall Study|Adverse Event|0
1383002|NCT01379768|4564486|P2|Overall Study|Adverse Event|1
1383003|NCT01379768|4564487|P1|Overall Study|Adverse Event|1
1383004|NCT01379703|4564510|P3|9 Months Through 18 Months|Reason Unknown|0
1383005|NCT01379703|4564511|P2|9 Months Through 18 Months|Reason Unknown|23
1383006|NCT01379703|4564512|P1|9 Months Through 18 Months|Reason Unknown|0
1383007|NCT01379703|4564510|P3|9 Months Through 18 Months|Fatigue|0
1383008|NCT01379703|4564511|P2|9 Months Through 18 Months|Fatigue|1
1383009|NCT01379703|4564512|P1|9 Months Through 18 Months|Fatigue|0
1383010|NCT01379703|4564510|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
1383011|NCT01379703|4564511|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
1383012|NCT01379703|4564512|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
1383013|NCT01379703|4564510|P3|9 Months Through 18 Months|Patient Noncompliance|0
1383014|NCT01379703|4564511|P2|9 Months Through 18 Months|Patient Noncompliance|4
1383015|NCT01379703|4564512|P1|9 Months Through 18 Months|Patient Noncompliance|0
1383016|NCT01379703|4564510|P3|9 Months Through 18 Months|Treatment failure|0
1383017|NCT01379703|4564511|P2|9 Months Through 18 Months|Treatment failure|5
1383018|NCT01379703|4564512|P1|9 Months Through 18 Months|Treatment failure|0
1383019|NCT01379703|4564510|P3|9 Months Through 18 Months|Adverse Event|0
1383020|NCT01379703|4564511|P2|9 Months Through 18 Months|Adverse Event|6
1383021|NCT01379703|4564512|P1|9 Months Through 18 Months|Adverse Event|0
1383022|NCT01379703|4564510|P3|9 Months Through 18 Months|Withdrawal by Subject|0
1383023|NCT01379703|4564511|P2|9 Months Through 18 Months|Withdrawal by Subject|11
1383024|NCT01379703|4564512|P1|9 Months Through 18 Months|Withdrawal by Subject|0
1383025|NCT01379703|4564510|P3|9 Months Through 18 Months|Lost to Follow-up|0
1383026|NCT01379703|4564511|P2|9 Months Through 18 Months|Lost to Follow-up|178
1383027|NCT01379703|4564512|P1|9 Months Through 18 Months|Lost to Follow-up|0
1383028|NCT01379703|4564510|P3|Study Start Through 9 Months|Reason unknown|24
1383029|NCT01379703|4564511|P2|Study Start Through 9 Months|Reason unknown|31
1383030|NCT01379703|4564512|P1|Study Start Through 9 Months|Reason unknown|2
1383031|NCT01379703|4564510|P3|Study Start Through 9 Months|Increased triglycerides|0
1383032|NCT01379703|4564511|P2|Study Start Through 9 Months|Increased triglycerides|1
1383033|NCT01379703|4564512|P1|Study Start Through 9 Months|Increased triglycerides|0
1383034|NCT01379703|4564510|P3|Study Start Through 9 Months|Poor general condition|0
1383035|NCT01379703|4564511|P2|Study Start Through 9 Months|Poor general condition|1
1383036|NCT01379703|4564512|P1|Study Start Through 9 Months|Poor general condition|0
1383037|NCT01379703|4564510|P3|Study Start Through 9 Months|Medication not available|1
1383038|NCT01379703|4564511|P2|Study Start Through 9 Months|Medication not available|2
1383039|NCT01379703|4564512|P1|Study Start Through 9 Months|Medication not available|0
1383040|NCT01379703|4564510|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
1383041|NCT01379703|4564511|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
1383042|NCT01379703|4564512|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
1383043|NCT01379703|4564510|P3|Study Start Through 9 Months|Patient Noncompliance|1
1383044|NCT01379703|4564511|P2|Study Start Through 9 Months|Patient Noncompliance|0
1383045|NCT01379703|4564512|P1|Study Start Through 9 Months|Patient Noncompliance|0
1383046|NCT01379703|4564510|P3|Study Start Through 9 Months|Treatment Failure|2
1383047|NCT01379703|4564511|P2|Study Start Through 9 Months|Treatment Failure|2
1383048|NCT01379703|4564512|P1|Study Start Through 9 Months|Treatment Failure|0
1383049|NCT01379703|4564510|P3|Study Start Through 9 Months|Withdrawal by Subject|1
1383050|NCT01379703|4564511|P2|Study Start Through 9 Months|Withdrawal by Subject|6
1383051|NCT01379703|4564512|P1|Study Start Through 9 Months|Withdrawal by Subject|0
1383052|NCT01379703|4564510|P3|Study Start Through 9 Months|Adverse Event|10
1383053|NCT01379703|4564511|P2|Study Start Through 9 Months|Adverse Event|14
1383054|NCT01379703|4564512|P1|Study Start Through 9 Months|Adverse Event|0
1383055|NCT01379703|4564510|P3|Study Start Through 9 Months|Lost to Follow-up|104
1383056|NCT01379703|4564511|P2|Study Start Through 9 Months|Lost to Follow-up|61
1383057|NCT01379703|4564512|P1|Study Start Through 9 Months|Lost to Follow-up|2
1383058|NCT01379534|4564612|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
1383059|NCT01379534|4564613|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
1383060|NCT01379534|4564612|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
1383061|NCT01379534|4564613|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
1383062|NCT01379534|4564612|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
1383063|NCT01379534|4564613|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
1383064|NCT01379534|4564612|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
1383065|NCT01379534|4564613|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
1383066|NCT01379534|4564612|P2|Treatment Phase|Adverse Event|7
1383067|NCT01379534|4564613|P1|Treatment Phase|Adverse Event|7
1383068|NCT01379534|4564612|P2|Treatment Phase|Progressive disease|22
1383069|NCT01379534|4564613|P1|Treatment Phase|Progressive disease|13
1383070|NCT01379534|4564612|P2|Treatment Phase|Withdrawal by Subject|2
1383071|NCT01379534|4564613|P1|Treatment Phase|Withdrawal by Subject|2
1383072|NCT01379521|4564633|P2|Post-Treatment Evaluations|Death|0
1383073|NCT01379521|4564634|P1|Post-Treatment Evaluations|Death|1
1383074|NCT01379521|4564633|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
1383075|NCT01379521|4564634|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
1383076|NCT01379521|4564633|P2|Post-Treatment Evaluations|Disease Progression|20
1383077|NCT01379521|4564634|P1|Post-Treatment Evaluations|Disease Progression|22
1383078|NCT01379521|4564633|P2|Overall Study -Treatment Period|Death|1
1383079|NCT01379521|4564634|P1|Overall Study -Treatment Period|Death|2
1383080|NCT01379521|4564633|P2|Overall Study -Treatment Period|Administrative Problems|0
1383081|NCT01379521|4564634|P1|Overall Study -Treatment Period|Administrative Problems|1
1383082|NCT01379521|4564633|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
1383083|NCT01379521|4564634|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
1383084|NCT01379521|4564633|P2|Overall Study -Treatment Period|Protocol Deviation|2
1383085|NCT01379521|4564634|P1|Overall Study -Treatment Period|Protocol Deviation|0
1383086|NCT01379521|4564633|P2|Overall Study -Treatment Period|New Cancer Therapy|0
1383087|NCT01379521|4564634|P1|Overall Study -Treatment Period|New Cancer Therapy|1
1383088|NCT01379521|4564633|P2|Overall Study -Treatment Period|Disease Progression|22
1383089|NCT01379521|4564634|P1|Overall Study -Treatment Period|Disease Progression|23
1383090|NCT01379521|4564633|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
1383091|NCT01379521|4564634|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
1383092|NCT01379521|4564633|P2|Overall Study -Treatment Period|Adverse Event|0
1383093|NCT01379521|4564634|P1|Overall Study -Treatment Period|Adverse Event|3
1383094|NCT01378975|4564704|P2|Overall Study|Withdrew Consent|3
1383095|NCT01378975|4564705|P1|Overall Study|Withdrew Consent|4
1383096|NCT01378975|4564704|P2|Overall Study|Lost to Follow-up|1
1383097|NCT01378975|4564705|P1|Overall Study|Lost to Follow-up|4
1383098|NCT01378975|4564704|P2|Overall Study|Investigator Request|0
1383099|NCT01378975|4564705|P1|Overall Study|Investigator Request|1
1383100|NCT01378975|4564704|P2|Overall Study|Death|46
1383101|NCT01378975|4564705|P1|Overall Study|Death|77
1383102|NCT01378962|4564731|P1|Overall Study|Other|2
1383103|NCT01378962|4564731|P1|Overall Study|Lost to Follow-up|1
1383104|NCT01378962|4564731|P1|Overall Study|Death|14
1383105|NCT01378429|4564757|P2|Overall Study|Noncompliance with study drug|0
1383106|NCT01378429|4564758|P1|Overall Study|Noncompliance with study drug|1
1383107|NCT01378325|4564871|P2|Overall Study|Protocol Violation|1
1383108|NCT01378325|4564872|P1|Overall Study|Protocol Violation|0
1383109|NCT01378195|4564889|P2|Overall Study|Lost to Follow-up|18
1383110|NCT01378195|4564890|P1|Overall Study|Lost to Follow-up|29
1383111|NCT01378117|4564903|P3|Overall Study|discharged before med given|1
1383112|NCT01378117|4564904|P2|Overall Study|discharged before med given|0
1383113|NCT01378117|4564905|P1|Overall Study|discharged before med given|2
1383114|NCT01378117|4564903|P3|Overall Study|withdrawal|2
1383115|NCT01378117|4564904|P2|Overall Study|withdrawal|1
1383116|NCT01378117|4564905|P1|Overall Study|withdrawal|2
1383117|NCT01378104|4564915|P2|Overall Study|Withdrawal by Subject|13
1383118|NCT01378104|4564916|P1|Overall Study|Withdrawal by Subject|12
1383119|NCT01378104|4564915|P2|Overall Study|Lack of Efficacy|5
1383120|NCT01378104|4564916|P1|Overall Study|Lack of Efficacy|7
1383121|NCT01378104|4564915|P2|Overall Study|Adverse Event|8
1383122|NCT01378104|4564916|P1|Overall Study|Adverse Event|8
1383123|NCT01377987|4564961|P2|Washout (7 Days)|Withdrawal by Subject|1
1383124|NCT01377987|4564962|P1|Washout (7 Days)|Withdrawal by Subject|1
1383125|NCT01377922|4564980|P2|Overall Study|rescue tx after part 2, entered part 4|0
1383126|NCT01377922|4564981|P1|Overall Study|rescue tx after part 2, entered part 4|1
1383127|NCT01377480|4565066|P4|Overall Study|Not specified|6
1383128|NCT01377480|4565067|P3|Overall Study|Not specified|7
1383129|NCT01377480|4565068|P2|Overall Study|Not specified|0
1383130|NCT01377480|4565069|P1|Overall Study|Not specified|0
1383131|NCT01377480|4565066|P4|Overall Study|Serious adverse event|1
1383132|NCT01377480|4565067|P3|Overall Study|Serious adverse event|1
1383133|NCT01377480|4565068|P2|Overall Study|Serious adverse event|0
1383134|NCT01377480|4565069|P1|Overall Study|Serious adverse event|0
1383135|NCT01377480|4565066|P4|Overall Study|Withdrawal by Subject|0
1383136|NCT01377480|4565067|P3|Overall Study|Withdrawal by Subject|1
1383137|NCT01377480|4565068|P2|Overall Study|Withdrawal by Subject|0
1383138|NCT01377480|4565069|P1|Overall Study|Withdrawal by Subject|0
1383139|NCT01377480|4565066|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
1383140|NCT01377480|4565067|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
1383141|NCT01377480|4565068|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
1383142|NCT01377480|4565069|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
1383143|NCT01377480|4565066|P4|Overall Study|Protocol Violation|4
1383144|NCT01377480|4565067|P3|Overall Study|Protocol Violation|0
1383145|NCT01377480|4565068|P2|Overall Study|Protocol Violation|0
1383146|NCT01377480|4565069|P1|Overall Study|Protocol Violation|0
1383147|NCT01377233|4565150|P5|Double-blind|Administrative or other|1
1383148|NCT01377233|4565151|P4|Double-blind|Administrative or other|1
1383149|NCT01377233|4565152|P3|Double-blind|Administrative or other|0
1383150|NCT01377233|4565153|P2|Double-blind|Administrative or other|0
1383151|NCT01377233|4565154|P1|Double-blind|Administrative or other|0
1383152|NCT01377233|4565150|P5|Double-blind|Withdrawal by Subject|0
1383153|NCT01377233|4565151|P4|Double-blind|Withdrawal by Subject|1
1383154|NCT01377233|4565152|P3|Double-blind|Withdrawal by Subject|0
1383155|NCT01377233|4565153|P2|Double-blind|Withdrawal by Subject|0
1383156|NCT01377233|4565154|P1|Double-blind|Withdrawal by Subject|0
1383157|NCT01377233|4565150|P5|Double-blind|Protocol Violation|1
1383158|NCT01377233|4565151|P4|Double-blind|Protocol Violation|0
1383159|NCT01377233|4565152|P3|Double-blind|Protocol Violation|0
1383160|NCT01377233|4565153|P2|Double-blind|Protocol Violation|0
1383161|NCT01377233|4565154|P1|Double-blind|Protocol Violation|0
1383162|NCT01377233|4565150|P5|Double-blind|Adverse Event|0
1383163|NCT01377233|4565151|P4|Double-blind|Adverse Event|2
1383164|NCT01377233|4565152|P3|Double-blind|Adverse Event|2
1383165|NCT01377233|4565153|P2|Double-blind|Adverse Event|1
1383166|NCT01377233|4565154|P1|Double-blind|Adverse Event|0
1383167|NCT01377233|4565150|P5|Open-label|Withdrawal by Subject|0
1383168|NCT01377233|4565151|P4|Open-label|Withdrawal by Subject|0
1383169|NCT01377233|4565152|P3|Open-label|Withdrawal by Subject|0
1383170|NCT01377233|4565153|P2|Open-label|Withdrawal by Subject|0
1383171|NCT01377233|4565154|P1|Open-label|Withdrawal by Subject|3
1383172|NCT01377233|4565150|P5|Open-label|Adverse Event|0
1383173|NCT01377233|4565151|P4|Open-label|Adverse Event|0
1383174|NCT01377233|4565152|P3|Open-label|Adverse Event|0
1383175|NCT01377233|4565153|P2|Open-label|Adverse Event|0
1383176|NCT01377233|4565154|P1|Open-label|Adverse Event|1
1383177|NCT01377194|4565181|P3|Overall Study|Lost to Follow-up|11
1383178|NCT01377194|4565182|P2|Overall Study|Lost to Follow-up|8
1383179|NCT01377194|4565183|P1|Overall Study|Lost to Follow-up|14
1383180|NCT01377194|4565181|P3|Overall Study|Withdrawal by Subject|7
1383181|NCT01377194|4565182|P2|Overall Study|Withdrawal by Subject|10
1383182|NCT01377194|4565183|P1|Overall Study|Withdrawal by Subject|8
1383183|NCT01377194|4565181|P3|Overall Study|Protocol Violation|6
1383184|NCT01377194|4565182|P2|Overall Study|Protocol Violation|10
1383185|NCT01377194|4565183|P1|Overall Study|Protocol Violation|4
1383186|NCT01377194|4565181|P3|Overall Study|Lack of Efficacy|3
1383187|NCT01377194|4565182|P2|Overall Study|Lack of Efficacy|3
1383188|NCT01377194|4565183|P1|Overall Study|Lack of Efficacy|3
1383189|NCT01377194|4565181|P3|Overall Study|Adverse Event|19
1383190|NCT01377194|4565182|P2|Overall Study|Adverse Event|12
1383191|NCT01377194|4565183|P1|Overall Study|Adverse Event|3
1383192|NCT01377012|4565197|P3|Extension Study, Weeks 104-260|Adverse Event|1
1383193|NCT01377012|4565198|P2|Extension Study, Weeks 104-260|Adverse Event|2
1383194|NCT01377012|4565199|P1|Extension Study, Weeks 104-260|Adverse Event|0
1383195|NCT01377012|4565197|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
1383196|NCT01377012|4565198|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
1383197|NCT01377012|4565199|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
1383198|NCT01377012|4565197|P3|Extension Study, Weeks 104-260|Physician Decision|0
1383199|NCT01377012|4565198|P2|Extension Study, Weeks 104-260|Physician Decision|0
1383200|NCT01377012|4565199|P1|Extension Study, Weeks 104-260|Physician Decision|1
1383201|NCT01377012|4565197|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
1383202|NCT01377012|4565198|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
1383203|NCT01377012|4565199|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
1383204|NCT01377012|4565197|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
1383205|NCT01377012|4565198|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
1383206|NCT01377012|4565199|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
1383207|NCT01377012|4565197|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
1383208|NCT01377012|4565198|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
1383209|NCT01377012|4565199|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
1383210|NCT01377012|4565197|P3|Core Study|Adverse Event|13
1383211|NCT01377012|4565198|P2|Core Study|Adverse Event|14
1383212|NCT01377012|4565199|P1|Core Study|Adverse Event|10
1383213|NCT01377012|4565197|P3|Core Study|Death|1
1383214|NCT01377012|4565198|P2|Core Study|Death|1
1383215|NCT01377012|4565199|P1|Core Study|Death|1
1383216|NCT01377012|4565197|P3|Core Study|Lack of Efficacy|37
1383217|NCT01377012|4565198|P2|Core Study|Lack of Efficacy|28
1383218|NCT01377012|4565199|P1|Core Study|Lack of Efficacy|41
1383219|NCT01377012|4565197|P3|Core Study|Lost to Follow-up|4
1383220|NCT01377012|4565198|P2|Core Study|Lost to Follow-up|5
1383221|NCT01377012|4565199|P1|Core Study|Lost to Follow-up|7
1383222|NCT01377012|4565197|P3|Core Study|No Longer require treatment|1
1383223|NCT01377012|4565198|P2|Core Study|No Longer require treatment|0
1383224|NCT01377012|4565199|P1|Core Study|No Longer require treatment|0
1383225|NCT01377012|4565197|P3|Core Study|Non-Compliant with study treatment|1
1383226|NCT01377012|4565198|P2|Core Study|Non-Compliant with study treatment|0
1383227|NCT01377012|4565199|P1|Core Study|Non-Compliant with study treatment|0
1383228|NCT01377012|4565197|P3|Core Study|Physician Decision|10
1383229|NCT01377012|4565198|P2|Core Study|Physician Decision|4
1383230|NCT01377012|4565199|P1|Core Study|Physician Decision|5
1383231|NCT01377012|4565197|P3|Core Study|Pregnancy|1
1383232|NCT01377012|4565198|P2|Core Study|Pregnancy|0
1383233|NCT01377012|4565199|P1|Core Study|Pregnancy|0
1383234|NCT01377012|4565197|P3|Core Study|Protocol Violation|2
1383235|NCT01377012|4565198|P2|Core Study|Protocol Violation|3
1383236|NCT01377012|4565199|P1|Core Study|Protocol Violation|7
1383237|NCT01377012|4565197|P3|Core Study|Withdrawal by Subject|18
1383238|NCT01377012|4565198|P2|Core Study|Withdrawal by Subject|23
1383239|NCT01377012|4565199|P1|Core Study|Withdrawal by Subject|15
1383240|NCT01377012|4565197|P3|Core Study|Technical problems|0
1383241|NCT01377012|4565198|P2|Core Study|Technical problems|0
1383242|NCT01377012|4565199|P1|Core Study|Technical problems|1
1383243|NCT01377012|4565197|P3|Core Study|Study terminated by Sponsor|46
1383244|NCT01377012|4565198|P2|Core Study|Study terminated by Sponsor|54
1383245|NCT01377012|4565199|P1|Core Study|Study terminated by Sponsor|47
1383246|NCT01376908|4565236|P2|Overall Study|Withdrawal by Subject|2
1383247|NCT01376908|4565237|P1|Overall Study|Withdrawal by Subject|1
1383248|NCT01376908|4565236|P2|Overall Study|Protocol Violation|1
1383249|NCT01376908|4565237|P1|Overall Study|Protocol Violation|1
1383250|NCT01376804|4565270|P1|Treatment Period|Patient did not receive study drug|1
1383251|NCT01376804|4565270|P1|Treatment Period|Adverse Event|6
1383252|NCT01376804|4565270|P1|Treatment Period|Withdrawal by Subject|1
1383253|NCT01376700|4565281|P1|Overall Study|Low or high titer inhibitor|8
1383254|NCT01376700|4565281|P1|Overall Study|Sponsor terminated study early|8
1383255|NCT01376388|4565343|P1|Overall Study|Withdrawal by Subject|3
1383256|NCT01376388|4565343|P1|Overall Study|Lack of Efficacy|2
1383257|NCT01376388|4565343|P1|Overall Study|Adverse Event|13
1383258|NCT01376349|4565381|P3|Raondomized Treatment|Alternative Treatment|1
1383259|NCT01376349|4565382|P2|Raondomized Treatment|Alternative Treatment|0
1383260|NCT01376349|4565383|P1|Raondomized Treatment|Alternative Treatment|0
1383261|NCT01376349|4565381|P3|Raondomized Treatment|Unkown|1
1383262|NCT01376349|4565382|P2|Raondomized Treatment|Unkown|2
1383263|NCT01376349|4565383|P1|Raondomized Treatment|Unkown|1
1383264|NCT01376349|4565381|P3|Raondomized Treatment|Adverse Event|14
1383265|NCT01376349|4565382|P2|Raondomized Treatment|Adverse Event|17
1383266|NCT01376349|4565383|P1|Raondomized Treatment|Adverse Event|13
1383267|NCT01376349|4565381|P3|Raondomized Treatment|Withdrawal by Subject|13
1383268|NCT01376349|4565382|P2|Raondomized Treatment|Withdrawal by Subject|16
1383269|NCT01376349|4565383|P1|Raondomized Treatment|Withdrawal by Subject|10
1383270|NCT01376323|4565397|P5|Overall Study|Withdrawal by Subject|0
1383271|NCT01376323|4565398|P4|Overall Study|Withdrawal by Subject|0
1383272|NCT01376323|4565399|P3|Overall Study|Withdrawal by Subject|1
1383273|NCT01376323|4565400|P2|Overall Study|Withdrawal by Subject|1
1383274|NCT01376323|4565401|P1|Overall Study|Withdrawal by Subject|0
1383275|NCT01376323|4565397|P5|Overall Study|Physician Decision|1
1383276|NCT01376323|4565398|P4|Overall Study|Physician Decision|1
1383277|NCT01376323|4565399|P3|Overall Study|Physician Decision|2
1383278|NCT01376323|4565400|P2|Overall Study|Physician Decision|0
1383279|NCT01376323|4565401|P1|Overall Study|Physician Decision|1
1383280|NCT01376323|4565397|P5|Overall Study|Lost to Follow-up|0
1383281|NCT01376323|4565398|P4|Overall Study|Lost to Follow-up|2
1383282|NCT01376323|4565399|P3|Overall Study|Lost to Follow-up|0
1383283|NCT01376323|4565400|P2|Overall Study|Lost to Follow-up|0
1383284|NCT01376323|4565401|P1|Overall Study|Lost to Follow-up|0
1383285|NCT01376323|4565397|P5|Overall Study|Adverse Event|0
1383286|NCT01376323|4565398|P4|Overall Study|Adverse Event|2
1383287|NCT01376323|4565399|P3|Overall Study|Adverse Event|0
1383288|NCT01376323|4565400|P2|Overall Study|Adverse Event|0
1383289|NCT01376323|4565401|P1|Overall Study|Adverse Event|1
1383290|NCT01376245|4565496|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
1383291|NCT01376245|4565497|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
1383292|NCT01376245|4565498|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
1383293|NCT01376245|4565499|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
1383294|NCT01376245|4565500|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
1383295|NCT01376245|4565496|P5|24-week, Double-blind Treatment Period|Physician Decision|0
1383296|NCT01376245|4565497|P4|24-week, Double-blind Treatment Period|Physician Decision|1
1383297|NCT01376245|4565498|P3|24-week, Double-blind Treatment Period|Physician Decision|1
1383298|NCT01376245|4565499|P2|24-week, Double-blind Treatment Period|Physician Decision|0
1383299|NCT01376245|4565500|P1|24-week, Double-blind Treatment Period|Physician Decision|0
1383300|NCT01376245|4565496|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
1383301|NCT01376245|4565497|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
1383302|NCT01376245|4565498|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1383303|NCT01376245|4565499|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
1383304|NCT01376245|4565500|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1383305|NCT01376245|4565496|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
1383306|NCT01376245|4565497|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
1383307|NCT01376245|4565498|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
1383308|NCT01376245|4565499|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
1383309|NCT01376245|4565500|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
1383310|NCT01376245|4565496|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
1383311|NCT01376245|4565497|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
1383312|NCT01376245|4565498|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
1383313|NCT01376245|4565499|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
1383314|NCT01376245|4565500|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
1383315|NCT01376245|4565496|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
1383316|NCT01376245|4565497|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
1383317|NCT01376245|4565498|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
1383318|NCT01376245|4565499|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
1383319|NCT01376245|4565500|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
1383320|NCT01376245|4565496|P5|24-week, Double-blind Treatment Period|Adverse Event|18
1383321|NCT01376245|4565497|P4|24-week, Double-blind Treatment Period|Adverse Event|8
1383322|NCT01376245|4565498|P3|24-week, Double-blind Treatment Period|Adverse Event|7
1383323|NCT01376245|4565499|P2|24-week, Double-blind Treatment Period|Adverse Event|16
1383324|NCT01376245|4565500|P1|24-week, Double-blind Treatment Period|Adverse Event|0
1383325|NCT01376245|4565496|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
1383326|NCT01376245|4565497|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
1383327|NCT01376245|4565498|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
1383328|NCT01376245|4565499|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
1383329|NCT01376245|4565500|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
1383330|NCT01376245|4565496|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
1383331|NCT01376245|4565497|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
1383332|NCT01376245|4565498|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
1383333|NCT01376245|4565499|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
1383334|NCT01376245|4565500|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
1383335|NCT01376245|4565496|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
1383336|NCT01376245|4565497|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
1383337|NCT01376245|4565498|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
1383338|NCT01376245|4565499|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
1383339|NCT01376245|4565500|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
1383340|NCT01376245|4565496|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
1383341|NCT01376245|4565497|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
1383342|NCT01376245|4565498|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
1383343|NCT01376245|4565499|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
1383344|NCT01376245|4565500|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
1383345|NCT01376245|4565496|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
1383346|NCT01376245|4565497|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
1383347|NCT01376245|4565498|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
1383348|NCT01376245|4565499|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
1383349|NCT01376245|4565500|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
1383350|NCT01376167|4565517|P3|Overall Study|Withdrawal by Subject|4
1383351|NCT01376167|4565518|P2|Overall Study|Withdrawal by Subject|5
1383352|NCT01376167|4565519|P1|Overall Study|Withdrawal by Subject|1
1383353|NCT01376167|4565517|P3|Overall Study|Physician Decision|0
1383354|NCT01376167|4565518|P2|Overall Study|Physician Decision|1
1383355|NCT01376167|4565519|P1|Overall Study|Physician Decision|1
1383356|NCT01376167|4565517|P3|Overall Study|Lost to Follow-up|2
1383357|NCT01376167|4565518|P2|Overall Study|Lost to Follow-up|4
1383358|NCT01376167|4565519|P1|Overall Study|Lost to Follow-up|2
1383359|NCT01376089|4565590|P2|Overall Study|Patient received no contrast media|4
1383360|NCT01376089|4565591|P1|Overall Study|Patient received no contrast media|3
1383361|NCT01376037|4565614|P2|Overall Study|Lost to Follow-up|2
1383362|NCT01376037|4565615|P1|Overall Study|Lost to Follow-up|0
1383363|NCT01375777|4565643|P9|Overall Study|Other|1
1383364|NCT01375777|4565644|P8|Overall Study|Other|0
1383365|NCT01375777|4565645|P7|Overall Study|Other|0
1383366|NCT01375777|4565646|P6|Overall Study|Other|0
1383367|NCT01375777|4565647|P5|Overall Study|Other|0
1383368|NCT01375777|4565648|P4|Overall Study|Other|0
1383369|NCT01375777|4565649|P3|Overall Study|Other|0
1383370|NCT01375777|4565650|P2|Overall Study|Other|1
1383371|NCT01375777|4565651|P1|Overall Study|Other|1
1383372|NCT01375777|4565643|P9|Overall Study|Lost to Follow-up|0
1383373|NCT01375777|4565644|P8|Overall Study|Lost to Follow-up|0
1383374|NCT01375777|4565645|P7|Overall Study|Lost to Follow-up|1
1383375|NCT01375777|4565646|P6|Overall Study|Lost to Follow-up|0
1383376|NCT01375777|4565647|P5|Overall Study|Lost to Follow-up|0
1383377|NCT01375777|4565648|P4|Overall Study|Lost to Follow-up|0
1383378|NCT01375777|4565649|P3|Overall Study|Lost to Follow-up|0
1383379|NCT01375777|4565650|P2|Overall Study|Lost to Follow-up|0
1383380|NCT01375777|4565651|P1|Overall Study|Lost to Follow-up|1
1383381|NCT01375777|4565643|P9|Overall Study|Withdrawal by Subject|1
1383382|NCT01375777|4565644|P8|Overall Study|Withdrawal by Subject|2
1383383|NCT01375777|4565645|P7|Overall Study|Withdrawal by Subject|1
1383384|NCT01375777|4565646|P6|Overall Study|Withdrawal by Subject|1
1383385|NCT01375777|4565647|P5|Overall Study|Withdrawal by Subject|1
1383386|NCT01375777|4565648|P4|Overall Study|Withdrawal by Subject|0
1383387|NCT01375777|4565649|P3|Overall Study|Withdrawal by Subject|1
1383388|NCT01375777|4565650|P2|Overall Study|Withdrawal by Subject|2
1383389|NCT01375777|4565651|P1|Overall Study|Withdrawal by Subject|0
1383390|NCT01375764|4565721|P5|Overall Study|Other|0
1383391|NCT01375764|4565722|P4|Overall Study|Other|1
1383392|NCT01375764|4565723|P3|Overall Study|Other|0
1383393|NCT01375764|4565724|P2|Overall Study|Other|0
1383394|NCT01375764|4565725|P1|Overall Study|Other|0
1383395|NCT01375764|4565721|P5|Overall Study|Withdrawal by Subject|1
1383396|NCT01375764|4565722|P4|Overall Study|Withdrawal by Subject|0
1383397|NCT01375764|4565723|P3|Overall Study|Withdrawal by Subject|0
1383398|NCT01375764|4565724|P2|Overall Study|Withdrawal by Subject|0
1383399|NCT01375764|4565725|P1|Overall Study|Withdrawal by Subject|2
1383400|NCT01375764|4565721|P5|Overall Study|Lost to Follow-up|0
1383401|NCT01375764|4565722|P4|Overall Study|Lost to Follow-up|0
1383402|NCT01375764|4565723|P3|Overall Study|Lost to Follow-up|0
1383403|NCT01375764|4565724|P2|Overall Study|Lost to Follow-up|1
1383404|NCT01375764|4565725|P1|Overall Study|Lost to Follow-up|0
1383405|NCT01375751|4565771|P3|Overall Study|Other|0
1383406|NCT01375751|4565772|P2|Overall Study|Other|1
1383407|NCT01375751|4565773|P1|Overall Study|Other|0
1383408|NCT01375608|4565817|P1|Overall Study|Withdrawal by Subject|2
1383409|NCT01375374|4565826|P1|Overall Study|Adverse Event|1
1383410|NCT01375049|4565876|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
1383411|NCT01375049|4565876|P1|Overall Study|Withdrawal by Subject|2
1383412|NCT01375049|4565876|P1|Overall Study|Lost to Follow-up|1
1383413|NCT01375049|4565876|P1|Overall Study|Adverse Event|2
1383414|NCT01374971|4565891|P1|Overall Study|Withdrawal by Subject|1
1383415|NCT01374919|4565896|P1|Overall Study|Withdrawal by Subject|2
1383416|NCT01374906|4565903|P2|Overall Study|Unsatisfactory therapeutic effect|19
1383417|NCT01374906|4565904|P1|Overall Study|Unsatisfactory therapeutic effect|11
1383418|NCT01374906|4565903|P2|Overall Study|Withdrawal by Subject|9
1383419|NCT01374906|4565904|P1|Overall Study|Withdrawal by Subject|15
1383420|NCT01374906|4565903|P2|Overall Study|Protocol Violation|2
1383421|NCT01374906|4565904|P1|Overall Study|Protocol Violation|2
1383422|NCT01374906|4565903|P2|Overall Study|Death|2
1383423|NCT01374906|4565904|P1|Overall Study|Death|0
1383424|NCT01374906|4565903|P2|Overall Study|Adverse Event|11
1383425|NCT01374906|4565904|P1|Overall Study|Adverse Event|10
1383426|NCT01374906|4565903|P2|Overall Study|Administrative problems|2
1383427|NCT01374906|4565904|P1|Overall Study|Administrative problems|2
1383428|NCT01374906|4565903|P2|Overall Study|Abnormal laboratory value(s)|3
1383429|NCT01374906|4565904|P1|Overall Study|Abnormal laboratory value(s)|0
1383430|NCT01374568|4565985|P2|Overall Study|Lab unable to analyze BTM|2
1383431|NCT01374568|4565986|P1|Overall Study|Lab unable to analyze BTM|0
1383432|NCT01374451|4565996|P2|Overall Study|Administrative problems|0
1383433|NCT01374451|4565997|P1|Overall Study|Administrative problems|1
1383434|NCT01374425|4566043|P2|Overall Study|Not Specified|43
1383435|NCT01374425|4566044|P1|Overall Study|Not Specified|41
1383436|NCT01374425|4566043|P2|Overall Study|Lost to Follow-up|1
1383437|NCT01374425|4566044|P1|Overall Study|Lost to Follow-up|2
1383438|NCT01374425|4566043|P2|Overall Study|Sponsor Decision|1
1383439|NCT01374425|4566044|P1|Overall Study|Sponsor Decision|0
1383440|NCT01374425|4566043|P2|Overall Study|Protocol Violation|3
1383441|NCT01374425|4566044|P1|Overall Study|Protocol Violation|2
1383442|NCT01374425|4566043|P2|Overall Study|Refused Treatment|24
1383443|NCT01374425|4566044|P1|Overall Study|Refused Treatment|10
1383444|NCT01374425|4566043|P2|Overall Study|Withdrawal by Subject|7
1383445|NCT01374425|4566044|P1|Overall Study|Withdrawal by Subject|6
1383446|NCT01374425|4566043|P2|Overall Study|Death (Adverse Event)|4
1383447|NCT01374425|4566044|P1|Overall Study|Death (Adverse Event)|2
1383448|NCT01374425|4566043|P2|Overall Study|Death (Progression of Disease)|0
1383449|NCT01374425|4566044|P1|Overall Study|Death (Progression of Disease)|1
1383450|NCT01374425|4566043|P2|Overall Study|Adverse Event|18
1383451|NCT01374425|4566044|P1|Overall Study|Adverse Event|29
1383452|NCT01374425|4566043|P2|Overall Study|Clinical Disease Progression|6
1383453|NCT01374425|4566044|P1|Overall Study|Clinical Disease Progression|9
1383454|NCT01374425|4566043|P2|Overall Study|Radiographic Disease Progression|81
1383455|NCT01374425|4566044|P1|Overall Study|Radiographic Disease Progression|86
1383456|NCT01374269|4566124|P2|Overall Study|closed research|2
1383457|NCT01374269|4566125|P1|Overall Study|closed research|1
1383458|NCT01374269|4566124|P2|Overall Study|Lost to Follow-up|3
1383459|NCT01374269|4566125|P1|Overall Study|Lost to Follow-up|1
1383460|NCT01374269|4566124|P2|Overall Study|Withdrawal by Subject|0
1383461|NCT01374269|4566125|P1|Overall Study|Withdrawal by Subject|4
1383462|NCT01374178|4566253|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
1383463|NCT01374178|4566254|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
1383464|NCT01374178|4566253|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
1383465|NCT01374178|4566254|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
1383466|NCT01374087|4566272|P2|Overall Study|Not provided|13
1383467|NCT01374087|4566273|P1|Overall Study|Not provided|13
1383468|NCT01374087|4566272|P2|Overall Study|Disease progression|2
1383469|NCT01374087|4566273|P1|Overall Study|Disease progression|2
1383470|NCT01374087|4566272|P2|Overall Study|Adverse Event|1
1383471|NCT01374087|4566273|P1|Overall Study|Adverse Event|0
1383472|NCT01373918|4566283|P2|Overall Study|Physician Decision|1
1383473|NCT01373918|4566284|P1|Overall Study|Physician Decision|0
1383474|NCT01373346|4566343|P1|Overall Study|Death|1
1383475|NCT01373294|4566366|P2|Overall Study|Adverse Event|0
1383476|NCT01373294|4566367|P1|Overall Study|Adverse Event|1
1383477|NCT01373281|4566376|P2|Overall Study|Serious adverse event|5
1383478|NCT01373281|4566377|P1|Overall Study|Serious adverse event|6
1383479|NCT01373281|4566376|P2|Overall Study|Adverse Event|4
1383480|NCT01373281|4566377|P1|Overall Study|Adverse Event|4
1383481|NCT01373281|4566376|P2|Overall Study|Lost to Follow-up|1
1383482|NCT01373281|4566377|P1|Overall Study|Lost to Follow-up|4
1383483|NCT01373281|4566376|P2|Overall Study|Protocol Violation|4
1383484|NCT01373281|4566377|P1|Overall Study|Protocol Violation|13
1383485|NCT01373281|4566376|P2|Overall Study|Withdrawal by Subject|31
1383486|NCT01373281|4566377|P1|Overall Study|Withdrawal by Subject|52
1383487|NCT01373229|4566393|P1|Overall Study|Physician Decision|3
1383488|NCT01373229|4566393|P1|Overall Study|Death|3
1383489|NCT01373164|4566407|P5|Overall Study|Withdrawal by Subject|2
1383490|NCT01373164|4566408|P4|Overall Study|Withdrawal by Subject|10
1383491|NCT01373164|4566409|P3|Overall Study|Withdrawal by Subject|0
1383492|NCT01373164|4566410|P2|Overall Study|Withdrawal by Subject|1
1383493|NCT01373164|4566411|P1|Overall Study|Withdrawal by Subject|0
1383494|NCT01373164|4566407|P5|Overall Study|Lost to Follow-up|0
1383495|NCT01373164|4566408|P4|Overall Study|Lost to Follow-up|2
1383496|NCT01373164|4566409|P3|Overall Study|Lost to Follow-up|1
1383497|NCT01373164|4566410|P2|Overall Study|Lost to Follow-up|0
1383498|NCT01373164|4566411|P1|Overall Study|Lost to Follow-up|0
1383499|NCT01372995|4566445|P3|Overall Study|Physician Decision|1
1383500|NCT01372995|4566446|P2|Overall Study|Physician Decision|0
1383501|NCT01372995|4566447|P1|Overall Study|Physician Decision|0
1383502|NCT01372995|4566445|P3|Overall Study|Spouse withdrew participant from study|0
1383503|NCT01372995|4566446|P2|Overall Study|Spouse withdrew participant from study|1
1383504|NCT01372995|4566447|P1|Overall Study|Spouse withdrew participant from study|0
1383505|NCT01372878|4566494|P1|Overall Study|incomplete study procedure|104
1383506|NCT01372878|4566494|P1|Overall Study|Protocol Violation|17
1383507|NCT01372878|4566494|P1|Overall Study|Withdrawal by Subject|63
1383508|NCT01372774|4566514|P2|Overall Study|Withdrawal prior to treatment|5
1383509|NCT01372774|4566515|P1|Overall Study|Withdrawal prior to treatment|4
1383510|NCT01372748|4566531|P2|Overall Study|Withdrawal by Subject|5
1383511|NCT01372748|4566532|P1|Overall Study|Withdrawal by Subject|7
1383512|NCT01372748|4566531|P2|Overall Study|Lost to Follow-up|34
1383513|NCT01372748|4566532|P1|Overall Study|Lost to Follow-up|16
1383514|NCT01372618|4566540|P1|Overall Study|PI Died. Study Terminated|9
1383515|NCT01372605|4566548|P2|Overall Study|Changed medical home|0
1383516|NCT01372605|4566549|P1|Overall Study|Changed medical home|2
1383517|NCT01372605|4566548|P2|Overall Study|Moved|0
1383518|NCT01372605|4566549|P1|Overall Study|Moved|3
1383519|NCT01372605|4566548|P2|Overall Study|Withdrawal by Subject|7
1383520|NCT01372605|4566549|P1|Overall Study|Withdrawal by Subject|4
1383521|NCT01372605|4566548|P2|Overall Study|Lost to Follow-up|1
1383522|NCT01372605|4566549|P1|Overall Study|Lost to Follow-up|2
1383523|NCT01372605|4566548|P2|Overall Study|Death|2
1383524|NCT01372605|4566549|P1|Overall Study|Death|1
1383525|NCT01372501|4566575|P1|Overall Study|Device migration|1
1383526|NCT01372501|4566575|P1|Overall Study|Adverse Event|4
1383527|NCT01372410|4566598|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
1383528|NCT01372410|4566599|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
1383529|NCT01372410|4566600|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
1383530|NCT01372410|4566601|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
1383531|NCT01372410|4566602|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
1383532|NCT01372410|4566603|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
1383533|NCT01372410|4566604|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
1383534|NCT01372410|4566605|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
1383535|NCT01372410|4566598|P8|Treatment Period 3 (7 Days)|Adverse Event|0
1383536|NCT01372410|4566599|P7|Treatment Period 3 (7 Days)|Adverse Event|0
1383537|NCT01372410|4566600|P6|Treatment Period 3 (7 Days)|Adverse Event|0
1383538|NCT01372410|4566601|P5|Treatment Period 3 (7 Days)|Adverse Event|0
1383539|NCT01372410|4566602|P4|Treatment Period 3 (7 Days)|Adverse Event|0
1383540|NCT01372410|4566603|P3|Treatment Period 3 (7 Days)|Adverse Event|1
1383541|NCT01372410|4566604|P2|Treatment Period 3 (7 Days)|Adverse Event|0
1383542|NCT01372410|4566605|P1|Treatment Period 3 (7 Days)|Adverse Event|0
1383543|NCT01372410|4566598|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
1383544|NCT01372410|4566599|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1383545|NCT01372410|4566600|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1383546|NCT01372410|4566601|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1383547|NCT01372410|4566602|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1383627|NCT01372150|4566666|P2|Overall Study|Lack of Efficacy|0
1383548|NCT01372410|4566603|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1383549|NCT01372410|4566604|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1383550|NCT01372410|4566605|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1383551|NCT01372410|4566598|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
1383552|NCT01372410|4566599|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
1383553|NCT01372410|4566600|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
1383554|NCT01372410|4566601|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
1383555|NCT01372410|4566602|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
1383556|NCT01372410|4566603|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
1383557|NCT01372410|4566604|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
1383558|NCT01372410|4566605|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
1383559|NCT01372410|4566598|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
1383560|NCT01372410|4566599|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
1383561|NCT01372410|4566600|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
1383562|NCT01372410|4566601|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
1383563|NCT01372410|4566602|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
1383564|NCT01372410|4566603|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
1383565|NCT01372410|4566604|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
1383566|NCT01372410|4566605|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
1383567|NCT01372410|4566598|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
1383568|NCT01372410|4566599|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1383569|NCT01372410|4566600|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1383570|NCT01372410|4566601|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1383571|NCT01372410|4566602|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1383572|NCT01372410|4566603|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1383573|NCT01372410|4566604|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1383574|NCT01372410|4566605|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
1383575|NCT01372410|4566598|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1383576|NCT01372410|4566599|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
1383577|NCT01372410|4566600|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1383578|NCT01372410|4566601|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1383579|NCT01372410|4566602|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1383580|NCT01372410|4566603|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1383581|NCT01372410|4566604|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1383582|NCT01372410|4566605|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1383583|NCT01372410|4566598|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1383584|NCT01372410|4566599|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1383585|NCT01372410|4566600|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1383586|NCT01372410|4566601|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
1383587|NCT01372410|4566602|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1383588|NCT01372410|4566603|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1383589|NCT01372410|4566604|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1383590|NCT01372410|4566605|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1383591|NCT01372410|4566598|P8|Treatment Period 1 (7 Days)|Adverse Event|0
1383592|NCT01372410|4566599|P7|Treatment Period 1 (7 Days)|Adverse Event|1
1383593|NCT01372410|4566600|P6|Treatment Period 1 (7 Days)|Adverse Event|0
1383594|NCT01372410|4566601|P5|Treatment Period 1 (7 Days)|Adverse Event|0
1383595|NCT01372410|4566602|P4|Treatment Period 1 (7 Days)|Adverse Event|0
1383596|NCT01372410|4566603|P3|Treatment Period 1 (7 Days)|Adverse Event|0
1383597|NCT01372410|4566604|P2|Treatment Period 1 (7 Days)|Adverse Event|1
1383598|NCT01372410|4566605|P1|Treatment Period 1 (7 Days)|Adverse Event|0
1383599|NCT01372410|4566598|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
1383600|NCT01372410|4566599|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
1383601|NCT01372410|4566600|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
1383602|NCT01372410|4566601|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
1383603|NCT01372410|4566602|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
1383604|NCT01372410|4566603|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
1383605|NCT01372410|4566604|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
1383606|NCT01372410|4566605|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
1383607|NCT01372384|4566642|P1|Overall Study|Progression of disease|3
1383608|NCT01372150|4566665|P3|Overall Study|Randomized but not treated|0
1383609|NCT01372150|4566666|P2|Overall Study|Randomized but not treated|1
1383610|NCT01372150|4566667|P1|Overall Study|Randomized but not treated|0
1383611|NCT01372150|4566665|P3|Overall Study|Adverse Event|2
1383612|NCT01372150|4566666|P2|Overall Study|Adverse Event|1
1383613|NCT01372150|4566667|P1|Overall Study|Adverse Event|2
1383614|NCT01372150|4566665|P3|Overall Study|Other|2
1383615|NCT01372150|4566666|P2|Overall Study|Other|0
1383616|NCT01372150|4566667|P1|Overall Study|Other|1
1383617|NCT01372150|4566665|P3|Overall Study|Withdrawal by Subject|2
1383618|NCT01372150|4566666|P2|Overall Study|Withdrawal by Subject|7
1383619|NCT01372150|4566667|P1|Overall Study|Withdrawal by Subject|2
1383620|NCT01372150|4566665|P3|Overall Study|Protocol Violation|3
1383621|NCT01372150|4566666|P2|Overall Study|Protocol Violation|0
1383622|NCT01372150|4566667|P1|Overall Study|Protocol Violation|1
1383623|NCT01372150|4566665|P3|Overall Study|Lost to Follow-up|6
1383624|NCT01372150|4566666|P2|Overall Study|Lost to Follow-up|5
1383625|NCT01372150|4566667|P1|Overall Study|Lost to Follow-up|4
1383626|NCT01372150|4566665|P3|Overall Study|Lack of Efficacy|1
1383628|NCT01372150|4566667|P1|Overall Study|Lack of Efficacy|3
1383629|NCT01371994|4566686|P2|Overall Study|Miscellaneous Reasons|4
1383630|NCT01371994|4566687|P1|Overall Study|Miscellaneous Reasons|6
1383631|NCT01371994|4566686|P2|Overall Study|Physician Decision|1
1383632|NCT01371994|4566687|P1|Overall Study|Physician Decision|1
1383633|NCT01371994|4566686|P2|Overall Study|Randomized but Never Received Study Drug|6
1383634|NCT01371994|4566687|P1|Overall Study|Randomized but Never Received Study Drug|6
1383635|NCT01371994|4566686|P2|Overall Study|Protocol Violation|17
1383636|NCT01371994|4566687|P1|Overall Study|Protocol Violation|24
1383637|NCT01371994|4566686|P2|Overall Study|Lost to Follow-up|1
1383638|NCT01371994|4566687|P1|Overall Study|Lost to Follow-up|1
1383639|NCT01371994|4566686|P2|Overall Study|Withdrawal by Subject|7
1383640|NCT01371994|4566687|P1|Overall Study|Withdrawal by Subject|13
1383641|NCT01371994|4566686|P2|Overall Study|Lack of Efficacy|0
1383642|NCT01371994|4566687|P1|Overall Study|Lack of Efficacy|3
1383643|NCT01371994|4566686|P2|Overall Study|Adverse Event|6
1383644|NCT01371994|4566687|P1|Overall Study|Adverse Event|3
1383645|NCT01371877|4566731|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
1383646|NCT01371877|4566732|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
1383647|NCT01371851|4566744|P2|Overall Study|Blood Pressure outside study parameters|0
1383648|NCT01371851|4566745|P1|Overall Study|Blood Pressure outside study parameters|2
1383649|NCT01371851|4566744|P2|Overall Study|non study related adverse event|0
1383650|NCT01371851|4566745|P1|Overall Study|non study related adverse event|1
1383651|NCT01371851|4566744|P2|Overall Study|was arrested and put in jail|1
1383652|NCT01371851|4566745|P1|Overall Study|was arrested and put in jail|0
1383653|NCT01371851|4566744|P2|Overall Study|Lost to Follow-up|8
1383654|NCT01371851|4566745|P1|Overall Study|Lost to Follow-up|5
1383655|NCT01371838|4566753|P2|Overall Study|Surgery|0
1383656|NCT01371838|4566754|P1|Overall Study|Surgery|1
1383657|NCT01371838|4566753|P2|Overall Study|Lack of therapeutic response|1
1383658|NCT01371838|4566754|P1|Overall Study|Lack of therapeutic response|0
1383659|NCT01371838|4566753|P2|Overall Study|Last follow-up visit not conducted|0
1383660|NCT01371838|4566754|P1|Overall Study|Last follow-up visit not conducted|2
1383661|NCT01371838|4566753|P2|Overall Study|Investigator Decision|8
1383662|NCT01371838|4566754|P1|Overall Study|Investigator Decision|3
1383663|NCT01371838|4566753|P2|Overall Study|Protocol Violation|0
1383664|NCT01371838|4566754|P1|Overall Study|Protocol Violation|3
1383665|NCT01371838|4566753|P2|Overall Study|Death|4
1383666|NCT01371838|4566754|P1|Overall Study|Death|3
1383667|NCT01371838|4566753|P2|Overall Study|Lost to Follow-up|20
1383668|NCT01371838|4566754|P1|Overall Study|Lost to Follow-up|10
1383669|NCT01371838|4566753|P2|Overall Study|Withdrawal by Subject|33
1383670|NCT01371838|4566754|P1|Overall Study|Withdrawal by Subject|27
1383671|NCT01371825|4566790|P1|Primary Efficacy Analysis Period|Death|3
1383672|NCT01371747|4566825|P6|Overall Study|Other Reasons|1
1383673|NCT01371747|4566826|P5|Overall Study|Other Reasons|0
1383674|NCT01371747|4566827|P4|Overall Study|Other Reasons|0
1383675|NCT01371747|4566828|P3|Overall Study|Other Reasons|2
1383676|NCT01371747|4566829|P2|Overall Study|Other Reasons|1
1383677|NCT01371747|4566830|P1|Overall Study|Other Reasons|2
1383678|NCT01371747|4566825|P6|Overall Study|Withdrawal by Subject|4
1383679|NCT01371747|4566826|P5|Overall Study|Withdrawal by Subject|2
1383680|NCT01371747|4566827|P4|Overall Study|Withdrawal by Subject|2
1383681|NCT01371747|4566828|P3|Overall Study|Withdrawal by Subject|5
1383682|NCT01371747|4566829|P2|Overall Study|Withdrawal by Subject|12
1383683|NCT01371747|4566830|P1|Overall Study|Withdrawal by Subject|6
1383684|NCT01371747|4566825|P6|Overall Study|Physician Decision|0
1383685|NCT01371747|4566826|P5|Overall Study|Physician Decision|1
1383686|NCT01371747|4566827|P4|Overall Study|Physician Decision|0
1383687|NCT01371747|4566828|P3|Overall Study|Physician Decision|0
1383688|NCT01371747|4566829|P2|Overall Study|Physician Decision|0
1383689|NCT01371747|4566830|P1|Overall Study|Physician Decision|0
1383690|NCT01371747|4566825|P6|Overall Study|Non-Compliance|1
1383691|NCT01371747|4566826|P5|Overall Study|Non-Compliance|0
1383692|NCT01371747|4566827|P4|Overall Study|Non-Compliance|0
1383693|NCT01371747|4566828|P3|Overall Study|Non-Compliance|3
1383694|NCT01371747|4566829|P2|Overall Study|Non-Compliance|4
1383695|NCT01371747|4566830|P1|Overall Study|Non-Compliance|3
1383696|NCT01371747|4566825|P6|Overall Study|Protocol Violation|0
1383697|NCT01371747|4566826|P5|Overall Study|Protocol Violation|0
1383698|NCT01371747|4566827|P4|Overall Study|Protocol Violation|0
1383699|NCT01371747|4566828|P3|Overall Study|Protocol Violation|1
1383700|NCT01371747|4566829|P2|Overall Study|Protocol Violation|0
1383701|NCT01371747|4566830|P1|Overall Study|Protocol Violation|0
1383702|NCT01371747|4566825|P6|Overall Study|Low Serum Potassium Results|3
1383703|NCT01371747|4566826|P5|Overall Study|Low Serum Potassium Results|0
1383704|NCT01371747|4566827|P4|Overall Study|Low Serum Potassium Results|1
1383705|NCT01371747|4566828|P3|Overall Study|Low Serum Potassium Results|1
1383706|NCT01371747|4566829|P2|Overall Study|Low Serum Potassium Results|1
1383707|NCT01371747|4566830|P1|Overall Study|Low Serum Potassium Results|1
1383708|NCT01371747|4566825|P6|Overall Study|High Serum Potassium Results|2
1383709|NCT01371747|4566826|P5|Overall Study|High Serum Potassium Results|0
1383710|NCT01371747|4566827|P4|Overall Study|High Serum Potassium Results|2
1383711|NCT01371747|4566828|P3|Overall Study|High Serum Potassium Results|1
1383712|NCT01371747|4566829|P2|Overall Study|High Serum Potassium Results|1
1383713|NCT01371747|4566830|P1|Overall Study|High Serum Potassium Results|1
1383714|NCT01371747|4566825|P6|Overall Study|Abnormal Renal Function|1
1383715|NCT01371747|4566826|P5|Overall Study|Abnormal Renal Function|0
1383716|NCT01371747|4566827|P4|Overall Study|Abnormal Renal Function|1
1383717|NCT01371747|4566828|P3|Overall Study|Abnormal Renal Function|0
1383718|NCT01371747|4566829|P2|Overall Study|Abnormal Renal Function|2
1383719|NCT01371747|4566830|P1|Overall Study|Abnormal Renal Function|0
1383720|NCT01371747|4566825|P6|Overall Study|Death|0
1383721|NCT01371747|4566826|P5|Overall Study|Death|2
1383722|NCT01371747|4566827|P4|Overall Study|Death|1
1383723|NCT01371747|4566828|P3|Overall Study|Death|4
1383724|NCT01371747|4566829|P2|Overall Study|Death|0
1383725|NCT01371747|4566830|P1|Overall Study|Death|1
1383726|NCT01371747|4566825|P6|Overall Study|Adverse Event|2
1383727|NCT01371747|4566826|P5|Overall Study|Adverse Event|2
1383728|NCT01371747|4566827|P4|Overall Study|Adverse Event|2
1383729|NCT01371747|4566828|P3|Overall Study|Adverse Event|7
1383730|NCT01371747|4566829|P2|Overall Study|Adverse Event|2
1383731|NCT01371747|4566830|P1|Overall Study|Adverse Event|4
1383732|NCT01371734|4566895|P3|Overall Study|Lack of Efficacy|0
1383733|NCT01371734|4566896|P2|Overall Study|Lack of Efficacy|2
1383734|NCT01371734|4566897|P1|Overall Study|Lack of Efficacy|2
1383735|NCT01371734|4566895|P3|Overall Study|Adverse Event|3
1383736|NCT01371734|4566896|P2|Overall Study|Adverse Event|8
1383737|NCT01371734|4566897|P1|Overall Study|Adverse Event|8
1383738|NCT01371734|4566895|P3|Overall Study|Protocol Violation|2
1383739|NCT01371734|4566896|P2|Overall Study|Protocol Violation|1
1383740|NCT01371734|4566897|P1|Overall Study|Protocol Violation|3
1383741|NCT01371734|4566895|P3|Overall Study|Lost to Follow-up|1
1383742|NCT01371734|4566896|P2|Overall Study|Lost to Follow-up|3
1383743|NCT01371734|4566897|P1|Overall Study|Lost to Follow-up|5
1383744|NCT01371734|4566895|P3|Overall Study|Withdrawal by Subject|9
1383745|NCT01371734|4566896|P2|Overall Study|Withdrawal by Subject|4
1383746|NCT01371734|4566897|P1|Overall Study|Withdrawal by Subject|3
1383747|NCT01371734|4566895|P3|Overall Study|Not specified|2
1383748|NCT01371734|4566896|P2|Overall Study|Not specified|1
1383749|NCT01371734|4566897|P1|Overall Study|Not specified|2
1383750|NCT01371721|4566917|P3|Overall Study|Randomized but not treated|0
1383751|NCT01371721|4566918|P2|Overall Study|Randomized but not treated|0
1383752|NCT01371721|4566919|P1|Overall Study|Randomized but not treated|1
1383753|NCT01371721|4566917|P3|Overall Study|Lack of Efficacy|3
1383754|NCT01371721|4566918|P2|Overall Study|Lack of Efficacy|4
1383755|NCT01371721|4566919|P1|Overall Study|Lack of Efficacy|2
1383756|NCT01371721|4566917|P3|Overall Study|Not specified|0
1383757|NCT01371721|4566918|P2|Overall Study|Not specified|3
1383758|NCT01371721|4566919|P1|Overall Study|Not specified|2
1383759|NCT01371721|4566917|P3|Overall Study|Withdrawal by Subject|11
1383760|NCT01371721|4566918|P2|Overall Study|Withdrawal by Subject|7
1383761|NCT01371721|4566919|P1|Overall Study|Withdrawal by Subject|5
1383762|NCT01371721|4566917|P3|Overall Study|Lost to Follow-up|6
1383763|NCT01371721|4566918|P2|Overall Study|Lost to Follow-up|2
1383764|NCT01371721|4566919|P1|Overall Study|Lost to Follow-up|8
1383765|NCT01371721|4566917|P3|Overall Study|Protocol Violation|5
1383766|NCT01371721|4566918|P2|Overall Study|Protocol Violation|4
1383767|NCT01371721|4566919|P1|Overall Study|Protocol Violation|6
1383768|NCT01371721|4566917|P3|Overall Study|Adverse Event|5
1383769|NCT01371721|4566918|P2|Overall Study|Adverse Event|4
1383770|NCT01371721|4566919|P1|Overall Study|Adverse Event|5
1383771|NCT01371708|4566952|P3|Overall Study|Started but did not receive treatment|1
1383772|NCT01371708|4566953|P2|Overall Study|Started but did not receive treatment|0
1383773|NCT01371708|4566954|P1|Overall Study|Started but did not receive treatment|1
1383774|NCT01371708|4566952|P3|Overall Study|Adverse Event|12
1383775|NCT01371708|4566953|P2|Overall Study|Adverse Event|8
1383776|NCT01371708|4566954|P1|Overall Study|Adverse Event|5
1383777|NCT01371708|4566952|P3|Overall Study|Not specified|4
1383778|NCT01371708|4566953|P2|Overall Study|Not specified|2
1383779|NCT01371708|4566954|P1|Overall Study|Not specified|3
1383780|NCT01371708|4566952|P3|Overall Study|Medication error/not related to AE|0
1383781|NCT01371708|4566953|P2|Overall Study|Medication error/not related to AE|1
1383782|NCT01371708|4566954|P1|Overall Study|Medication error/not related to AE|0
1383783|NCT01371708|4566952|P3|Overall Study|No longer willing to participate|13
1383784|NCT01371708|4566953|P2|Overall Study|No longer willing to participate|7
1383785|NCT01371708|4566954|P1|Overall Study|No longer willing to participate|7
1383786|NCT01371708|4566952|P3|Overall Study|Protocol Violation|2
1383787|NCT01371708|4566953|P2|Overall Study|Protocol Violation|1
1383788|NCT01371708|4566954|P1|Overall Study|Protocol Violation|2
1383789|NCT01371708|4566952|P3|Overall Study|Lost to Follow-up|7
1383790|NCT01371708|4566953|P2|Overall Study|Lost to Follow-up|9
1383791|NCT01371708|4566954|P1|Overall Study|Lost to Follow-up|5
1383792|NCT01371708|4566952|P3|Overall Study|Insufficient clinical response|0
1383793|NCT01371708|4566953|P2|Overall Study|Insufficient clinical response|2
1383794|NCT01371708|4566954|P1|Overall Study|Insufficient clinical response|3
1383795|NCT01371656|4566986|P2|Overall Study|Ineligible|3
1383796|NCT01371656|4566987|P1|Overall Study|Ineligible|4
1383797|NCT01371656|4566986|P2|Overall Study|Withdrawal by Subject|0
1383798|NCT01371656|4566987|P1|Overall Study|Withdrawal by Subject|7
1383799|NCT01371656|4566986|P2|Overall Study|Physician Decision|7
1383800|NCT01371656|4566987|P1|Overall Study|Physician Decision|46
1383801|NCT01371656|4566986|P2|Overall Study|Death|4
1383802|NCT01371656|4566987|P1|Overall Study|Death|7
1383803|NCT01371643|4567007|P2|Overall Study|Withdrawal by Subject|0
1383804|NCT01371643|4567008|P1|Overall Study|Withdrawal by Subject|3
1383805|NCT01371565|4567018|P1|Overall Study|Resection of neuroendocrine tumor|1
1383806|NCT01371565|4567018|P1|Overall Study|Death|1
1383807|NCT01371565|4567018|P1|Overall Study|Withdrawal by Subject|1
1383808|NCT01371552|4567022|P6|Part 1, First 3 Days|Inconvenience|0
1383809|NCT01371552|4567023|P5|Part 1, First 3 Days|Inconvenience|0
1383810|NCT01371552|4567024|P4|Part 1, First 3 Days|Inconvenience|0
1383811|NCT01371552|4567025|P3|Part 1, First 3 Days|Inconvenience|1
1383812|NCT01371552|4567026|P2|Part 1, First 3 Days|Inconvenience|0
1383813|NCT01371552|4567027|P1|Part 1, First 3 Days|Inconvenience|0
1383814|NCT01371539|4567054|P2|Period Two: One Week|Time/job conflict|1
1383815|NCT01371539|4567055|P1|Period Two: One Week|Time/job conflict|0
1383816|NCT01371539|4567054|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
1383817|NCT01371539|4567055|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
1383818|NCT01371539|4567054|P2|Period Two: One Week|Lost to Follow-up|1
1383819|NCT01371539|4567055|P1|Period Two: One Week|Lost to Follow-up|0
1383820|NCT01371539|4567054|P2|Period One: One Week|Lost to Follow-up|1
1383821|NCT01371539|4567055|P1|Period One: One Week|Lost to Follow-up|0
1383822|NCT01371006|4567076|P2|Overall Study|Adverse Event|0
1383823|NCT01371006|4567077|P1|Overall Study|Adverse Event|1
1383824|NCT01370863|4567118|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
1383825|NCT01370863|4567119|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
1383826|NCT01370863|4567118|P2|Overall Study|Did not want second pH/MII monitoring|1
1383827|NCT01370863|4567119|P1|Overall Study|Did not want second pH/MII monitoring|1
1383828|NCT01370863|4567118|P2|Overall Study|Adverse Event|1
1383829|NCT01370863|4567119|P1|Overall Study|Adverse Event|1
1383830|NCT01370733|4567144|P2|Overall Study|Protocol Violation|3
1383831|NCT01370733|4567145|P1|Overall Study|Protocol Violation|1
1383832|NCT01370733|4567144|P2|Overall Study|Physician Decision|2
1383833|NCT01370733|4567145|P1|Overall Study|Physician Decision|0
1383834|NCT01370733|4567144|P2|Overall Study|Lack of Efficacy|5
1383835|NCT01370733|4567145|P1|Overall Study|Lack of Efficacy|3
1383836|NCT01370733|4567144|P2|Overall Study|Adverse Event|4
1383837|NCT01370733|4567145|P1|Overall Study|Adverse Event|2
1383838|NCT01370733|4567144|P2|Overall Study|Lost to Follow-up|0
1383839|NCT01370733|4567145|P1|Overall Study|Lost to Follow-up|3
1383840|NCT01370733|4567144|P2|Overall Study|Withdrawal by Subject|8
1383841|NCT01370733|4567145|P1|Overall Study|Withdrawal by Subject|8
1383842|NCT01370694|4567167|P1|Overall Study|Progressive disease|2
1383843|NCT01370694|4567167|P1|Overall Study|Switched to rituximab|4
1383844|NCT01370655|4567189|P12|Period 2|Withdrawal by Subject|0
1383845|NCT01370655|4567190|P11|Period 2|Withdrawal by Subject|0
1383846|NCT01370655|4567191|P10|Period 2|Withdrawal by Subject|0
1383847|NCT01370655|4567192|P9|Period 2|Withdrawal by Subject|1
1383848|NCT01370655|4567193|P8|Period 2|Withdrawal by Subject|0
1383849|NCT01370655|4567194|P7|Period 2|Withdrawal by Subject|0
1383850|NCT01370655|4567195|P6|Period 2|Withdrawal by Subject|0
1383851|NCT01370655|4567196|P5|Period 2|Withdrawal by Subject|0
1383852|NCT01370655|4567197|P4|Period 2|Withdrawal by Subject|0
1383853|NCT01370655|4567198|P3|Period 2|Withdrawal by Subject|0
1383854|NCT01370655|4567199|P2|Period 2|Withdrawal by Subject|0
1383855|NCT01370655|4567200|P1|Period 2|Withdrawal by Subject|0
1383856|NCT01370655|4567189|P12|Period 2|met protocol specified stopping criteria|0
1383857|NCT01370655|4567190|P11|Period 2|met protocol specified stopping criteria|1
1383858|NCT01370655|4567191|P10|Period 2|met protocol specified stopping criteria|0
1383859|NCT01370655|4567192|P9|Period 2|met protocol specified stopping criteria|1
1383860|NCT01370655|4567193|P8|Period 2|met protocol specified stopping criteria|0
1383861|NCT01370655|4567194|P7|Period 2|met protocol specified stopping criteria|1
1383862|NCT01370655|4567195|P6|Period 2|met protocol specified stopping criteria|0
1383863|NCT01370655|4567196|P5|Period 2|met protocol specified stopping criteria|0
1383864|NCT01370655|4567197|P4|Period 2|met protocol specified stopping criteria|0
1383865|NCT01370655|4567198|P3|Period 2|met protocol specified stopping criteria|1
1383866|NCT01370655|4567199|P2|Period 2|met protocol specified stopping criteria|0
1383867|NCT01370655|4567200|P1|Period 2|met protocol specified stopping criteria|0
1383868|NCT01370655|4567189|P12|Period 2|Adverse Event|0
1383869|NCT01370655|4567190|P11|Period 2|Adverse Event|0
1383870|NCT01370655|4567191|P10|Period 2|Adverse Event|0
1383871|NCT01370655|4567192|P9|Period 2|Adverse Event|0
1383872|NCT01370655|4567193|P8|Period 2|Adverse Event|1
1383873|NCT01370655|4567194|P7|Period 2|Adverse Event|0
1383874|NCT01370655|4567195|P6|Period 2|Adverse Event|0
1383875|NCT01370655|4567196|P5|Period 2|Adverse Event|1
1383876|NCT01370655|4567197|P4|Period 2|Adverse Event|0
1383877|NCT01370655|4567198|P3|Period 2|Adverse Event|1
1383878|NCT01370655|4567199|P2|Period 2|Adverse Event|0
1383879|NCT01370655|4567200|P1|Period 2|Adverse Event|0
1383880|NCT01370655|4567189|P12|Period 1|Adverse Event|0
1383881|NCT01370655|4567190|P11|Period 1|Adverse Event|0
1383882|NCT01370655|4567191|P10|Period 1|Adverse Event|0
1383883|NCT01370655|4567192|P9|Period 1|Adverse Event|0
1383884|NCT01370655|4567193|P8|Period 1|Adverse Event|0
1383885|NCT01370655|4567194|P7|Period 1|Adverse Event|1
1383886|NCT01370655|4567195|P6|Period 1|Adverse Event|0
1383887|NCT01370655|4567196|P5|Period 1|Adverse Event|0
1383888|NCT01370655|4567197|P4|Period 1|Adverse Event|0
1383889|NCT01370655|4567198|P3|Period 1|Adverse Event|0
1383890|NCT01370655|4567199|P2|Period 1|Adverse Event|0
1383891|NCT01370655|4567200|P1|Period 1|Adverse Event|2
1383892|NCT01370642|4567237|P3|Overall Study|Withdrawal by Subject|3
1383893|NCT01370642|4567238|P2|Overall Study|Withdrawal by Subject|4
1383894|NCT01370642|4567239|P1|Overall Study|Withdrawal by Subject|2
1383895|NCT01370642|4567237|P3|Overall Study|Physician Decision|2
1383896|NCT01370642|4567238|P2|Overall Study|Physician Decision|1
1383897|NCT01370642|4567239|P1|Overall Study|Physician Decision|4
1383898|NCT01370642|4567237|P3|Overall Study|Lost to Follow-up|1
1383899|NCT01370642|4567238|P2|Overall Study|Lost to Follow-up|0
1383900|NCT01370642|4567239|P1|Overall Study|Lost to Follow-up|0
1383901|NCT01370642|4567237|P3|Overall Study|Detectable HCV RNA|22
1383902|NCT01370642|4567238|P2|Overall Study|Detectable HCV RNA|0
1383903|NCT01370642|4567239|P1|Overall Study|Detectable HCV RNA|0
1383904|NCT01370642|4567237|P3|Overall Study|Adverse Event|1
1383905|NCT01370642|4567238|P2|Overall Study|Adverse Event|1
1383906|NCT01370642|4567239|P1|Overall Study|Adverse Event|2
1383907|NCT01370616|4567270|P2|Overall Study|Withdrawal by Subject|34
1383908|NCT01370616|4567271|P1|Overall Study|Withdrawal by Subject|34
1383909|NCT01370616|4567270|P2|Overall Study|Technical Problems|5
1383910|NCT01370616|4567271|P1|Overall Study|Technical Problems|3
1383911|NCT01370616|4567270|P2|Overall Study|Recovery|0
1383912|NCT01370616|4567271|P1|Overall Study|Recovery|1
1383913|NCT01370616|4567270|P2|Overall Study|Progressive Disease|1
1383914|NCT01370616|4567271|P1|Overall Study|Progressive Disease|0
1383915|NCT01370616|4567270|P2|Overall Study|Physician Decision|6
1383916|NCT01370616|4567271|P1|Overall Study|Physician Decision|6
1383917|NCT01370616|4567270|P2|Overall Study|Lost to Follow-up|3
1383918|NCT01370616|4567271|P1|Overall Study|Lost to Follow-up|0
1383919|NCT01370616|4567270|P2|Overall Study|Lack of Efficacy|2
1383920|NCT01370616|4567271|P1|Overall Study|Lack of Efficacy|6
1383921|NCT01370616|4567270|P2|Overall Study|Death|0
1383922|NCT01370616|4567271|P1|Overall Study|Death|1
1383923|NCT01370616|4567270|P2|Overall Study|Adverse Event|16
1383924|NCT01370616|4567271|P1|Overall Study|Adverse Event|11
1383925|NCT01370603|4567295|P2|Period 2|Withdrawal by Subject|0
1383926|NCT01370603|4567296|P1|Period 2|Withdrawal by Subject|1
1383927|NCT01370603|4567295|P2|Period 2|Lost to Follow-up|0
1383928|NCT01370603|4567296|P1|Period 2|Lost to Follow-up|1
1383929|NCT01370603|4567295|P2|Period 2|Adverse Event|4
1383930|NCT01370603|4567296|P1|Period 2|Adverse Event|1
1383931|NCT01370603|4567295|P2|Crossover Washout|Non-compliance with Study Drug|2
1383932|NCT01370603|4567296|P1|Crossover Washout|Non-compliance with Study Drug|0
1383933|NCT01370603|4567295|P2|Crossover Washout|Withdrawal by Subject|1
1383934|NCT01370603|4567296|P1|Crossover Washout|Withdrawal by Subject|4
1383935|NCT01370603|4567295|P2|Crossover Washout|Protocol Violation|0
1383936|NCT01370603|4567296|P1|Crossover Washout|Protocol Violation|1
1383937|NCT01370603|4567295|P2|Crossover Washout|Lost to Follow-up|0
1383938|NCT01370603|4567296|P1|Crossover Washout|Lost to Follow-up|2
1383939|NCT01370603|4567295|P2|Crossover Washout|Adverse Event|1
1383940|NCT01370603|4567296|P1|Crossover Washout|Adverse Event|2
1383941|NCT01370603|4567295|P2|Period 1|Withdrawal by Subject|5
1383942|NCT01370603|4567296|P1|Period 1|Withdrawal by Subject|5
1383943|NCT01370603|4567295|P2|Period 1|Protocol Violation|2
1383944|NCT01370603|4567296|P1|Period 1|Protocol Violation|2
1383945|NCT01370603|4567295|P2|Period 1|Lost to Follow-up|0
1383946|NCT01370603|4567296|P1|Period 1|Lost to Follow-up|2
1383947|NCT01370603|4567295|P2|Period 1|Adverse Event|3
1383948|NCT01370603|4567296|P1|Period 1|Adverse Event|5
1383949|NCT01370590|4567314|P2|Period 2|Withdrawal by Subject|1
1383950|NCT01370590|4567315|P1|Period 2|Withdrawal by Subject|1
1383951|NCT01370590|4567314|P2|Period 2|Adverse Event|1
1383952|NCT01370590|4567315|P1|Period 2|Adverse Event|0
1383953|NCT01370590|4567314|P2|Crossover Washout Period|Withdrawal by Subject|2
1383954|NCT01370590|4567315|P1|Crossover Washout Period|Withdrawal by Subject|2
1383955|NCT01370590|4567314|P2|Crossover Washout Period|Non-compliance with Study Drug|0
1383956|NCT01370590|4567315|P1|Crossover Washout Period|Non-compliance with Study Drug|1
1383957|NCT01370590|4567314|P2|Crossover Washout Period|Lost to Follow-up|0
1383958|NCT01370590|4567315|P1|Crossover Washout Period|Lost to Follow-up|2
1383959|NCT01370590|4567314|P2|Crossover Washout Period|Adverse Event|4
1383960|NCT01370590|4567315|P1|Crossover Washout Period|Adverse Event|1
1383961|NCT01370590|4567314|P2|Period 1|Could not access randomization system|1
1383962|NCT01370590|4567315|P1|Period 1|Could not access randomization system|0
1383963|NCT01370590|4567314|P2|Period 1|Withdrawal by Subject|2
1383964|NCT01370590|4567315|P1|Period 1|Withdrawal by Subject|4
1383965|NCT01370590|4567314|P2|Period 1|Protocol Violation|2
1383966|NCT01370590|4567315|P1|Period 1|Protocol Violation|2
1383967|NCT01370590|4567314|P2|Period 1|Lost to Follow-up|2
1383968|NCT01370590|4567315|P1|Period 1|Lost to Follow-up|2
1383969|NCT01370590|4567314|P2|Period 1|Adverse Event|4
1383970|NCT01370590|4567315|P1|Period 1|Adverse Event|8
1383971|NCT01370538|4567343|P2|Overall Study|Lost to follow up|10
1383972|NCT01370538|4567344|P1|Overall Study|Lost to follow up|6
1383973|NCT01370538|4567343|P2|Overall Study|Development of study specific withdrawal|1
1383974|NCT01370538|4567344|P1|Overall Study|Development of study specific withdrawal|1
1383975|NCT01370538|4567343|P2|Overall Study|Protocol Violation|5
1383976|NCT01370538|4567344|P1|Overall Study|Protocol Violation|8
1383977|NCT01370538|4567343|P2|Overall Study|Adverse Event|0
1383978|NCT01370538|4567344|P1|Overall Study|Adverse Event|1
1383979|NCT01370538|4567343|P2|Overall Study|Eligibility criteria not fulfilled|1
1383980|NCT01370538|4567344|P1|Overall Study|Eligibility criteria not fulfilled|0
1383981|NCT01370538|4567343|P2|Overall Study|Voluntary Discontinuation by Subject|2
1383982|NCT01370538|4567344|P1|Overall Study|Voluntary Discontinuation by Subject|3
1383983|NCT01370525|4567360|P2|Overall Study|Lost to follow up|6
1383984|NCT01370525|4567361|P1|Overall Study|Lost to follow up|2
1383985|NCT01370525|4567360|P2|Overall Study|Protocol Violation|1
1383986|NCT01370525|4567361|P1|Overall Study|Protocol Violation|2
1383987|NCT01370525|4567360|P2|Overall Study|Adverse Event|1
1383988|NCT01370525|4567361|P1|Overall Study|Adverse Event|0
1383989|NCT01370525|4567360|P2|Overall Study|Eligibility criteria not fulfilled|0
1383990|NCT01370525|4567361|P1|Overall Study|Eligibility criteria not fulfilled|2
1383991|NCT01370525|4567360|P2|Overall Study|Voluntary Discontinuation by Subject|3
1383992|NCT01370525|4567361|P1|Overall Study|Voluntary Discontinuation by Subject|2
1383993|NCT01370408|4567385|P1|Overall Study|treatment failure|9
1383994|NCT01370356|4567445|P2|Overall Study|AE Not Related to Study Drug|4
1383995|NCT01370356|4567446|P1|Overall Study|AE Not Related to Study Drug|1
1383996|NCT01370356|4567445|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
1383997|NCT01370356|4567446|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
1383998|NCT01370356|4567445|P2|Overall Study|Protocol Violation|3
1383999|NCT01370356|4567446|P1|Overall Study|Protocol Violation|3
1384000|NCT01370356|4567445|P2|Overall Study|Reason not specified|43
1384001|NCT01370356|4567446|P1|Overall Study|Reason not specified|39
1384002|NCT01370356|4567445|P2|Overall Study|Withdrawal by Subject|59
1384003|NCT01370356|4567446|P1|Overall Study|Withdrawal by Subject|54
1384004|NCT01370356|4567445|P2|Overall Study|Lost to Follow-up|81
1384005|NCT01370356|4567446|P1|Overall Study|Lost to Follow-up|76
1384006|NCT01370356|4567445|P2|Overall Study|Lack of Efficacy|28
1384007|NCT01370356|4567446|P1|Overall Study|Lack of Efficacy|6
1384008|NCT01370356|4567445|P2|Overall Study|Death|0
1384009|NCT01370356|4567446|P1|Overall Study|Death|1
1384010|NCT01370265|4567460|P2|First Intervention|Adverse Event|1
1384011|NCT01370265|4567461|P1|First Intervention|Adverse Event|1
1384012|NCT01370083|4567480|P2|Overall Study|Adverse Event|1
1384013|NCT01370083|4567481|P1|Overall Study|Adverse Event|0
1384014|NCT01370083|4567480|P2|Overall Study|Lost to Follow-up|0
1384015|NCT01370083|4567481|P1|Overall Study|Lost to Follow-up|2
1384016|NCT01370005|4567494|P3|Overall Study|Other reason not defined above|2
1384017|NCT01370005|4567495|P2|Overall Study|Other reason not defined above|0
1384018|NCT01370005|4567496|P1|Overall Study|Other reason not defined above|3
1384019|NCT01370005|4567494|P3|Overall Study|Patient refusal to continue,not due toAE|0
1384020|NCT01370005|4567495|P2|Overall Study|Patient refusal to continue,not due toAE|4
1384021|NCT01370005|4567496|P1|Overall Study|Patient refusal to continue,not due toAE|5
1384022|NCT01370005|4567494|P3|Overall Study|Lost to Follow-up|1
1384023|NCT01370005|4567495|P2|Overall Study|Lost to Follow-up|1
1384024|NCT01370005|4567496|P1|Overall Study|Lost to Follow-up|1
1384025|NCT01370005|4567494|P3|Overall Study|Non compliant with protocol|2
1384026|NCT01370005|4567495|P2|Overall Study|Non compliant with protocol|1
1384027|NCT01370005|4567496|P1|Overall Study|Non compliant with protocol|0
1384028|NCT01370005|4567494|P3|Overall Study|Lack of Efficacy|0
1384029|NCT01370005|4567495|P2|Overall Study|Lack of Efficacy|0
1384030|NCT01370005|4567496|P1|Overall Study|Lack of Efficacy|1
1384031|NCT01370005|4567494|P3|Overall Study|Adverse Event|6
1384032|NCT01370005|4567495|P2|Overall Study|Adverse Event|5
1384033|NCT01370005|4567496|P1|Overall Study|Adverse Event|5
1384034|NCT01370005|4567494|P3|Overall Study|Not treated|0
1384035|NCT01370005|4567495|P2|Overall Study|Not treated|0
1384036|NCT01370005|4567496|P1|Overall Study|Not treated|1
1384037|NCT01369849|4567578|P3|Overall Study|Ineligible after receiving treatment|0
1384038|NCT01369849|4567579|P2|Overall Study|Ineligible after receiving treatment|1
1384039|NCT01369849|4567580|P1|Overall Study|Ineligible after receiving treatment|0
1384040|NCT01369849|4567578|P3|Overall Study|Ineligible prior to treatment|1
1384041|NCT01369849|4567579|P2|Overall Study|Ineligible prior to treatment|0
1384042|NCT01369849|4567580|P1|Overall Study|Ineligible prior to treatment|0
1384043|NCT01369784|4567602|P1|Overall Study|Protocol Violation|12
1384044|NCT01369680|4567690|P4|Overall Study|Lost to Follow-up|2
1384045|NCT01369680|4567691|P3|Overall Study|Lost to Follow-up|1
1384046|NCT01369680|4567692|P2|Overall Study|Lost to Follow-up|0
1384047|NCT01369680|4567693|P1|Overall Study|Lost to Follow-up|0
1384048|NCT01369641|4567714|P1|Overall Study|Withdrawal by Subject|1
1384049|NCT01369615|4567720|P2|Overall Study|Lost to Follow-up|1
1384050|NCT01369615|4567721|P1|Overall Study|Lost to Follow-up|0
1384051|NCT01369615|4567720|P2|Overall Study|Withdrawal by Subject|1
1384052|NCT01369615|4567721|P1|Overall Study|Withdrawal by Subject|0
1384053|NCT01369511|4567731|P4|Overall Study|Withdrawal by Subject|6
1384054|NCT01369511|4567732|P3|Overall Study|Withdrawal by Subject|4
1384055|NCT01369511|4567733|P2|Overall Study|Withdrawal by Subject|6
1384056|NCT01369511|4567734|P1|Overall Study|Withdrawal by Subject|5
1384057|NCT01369511|4567731|P4|Overall Study|Sponsor decision|0
1384058|NCT01369511|4567732|P3|Overall Study|Sponsor decision|1
1384059|NCT01369511|4567733|P2|Overall Study|Sponsor decision|0
1384060|NCT01369511|4567734|P1|Overall Study|Sponsor decision|2
1384061|NCT01369511|4567731|P4|Overall Study|Physician Decision|0
1384062|NCT01369511|4567732|P3|Overall Study|Physician Decision|0
1384063|NCT01369511|4567733|P2|Overall Study|Physician Decision|4
1384064|NCT01369511|4567734|P1|Overall Study|Physician Decision|3
1384065|NCT01369511|4567731|P4|Overall Study|Protocol Violation|2
1384066|NCT01369511|4567732|P3|Overall Study|Protocol Violation|0
1384067|NCT01369511|4567733|P2|Overall Study|Protocol Violation|1
1384068|NCT01369511|4567734|P1|Overall Study|Protocol Violation|0
1384069|NCT01369511|4567731|P4|Overall Study|Lost to Follow-up|2
1384070|NCT01369511|4567732|P3|Overall Study|Lost to Follow-up|1
1384071|NCT01369511|4567733|P2|Overall Study|Lost to Follow-up|1
1384072|NCT01369511|4567734|P1|Overall Study|Lost to Follow-up|0
1384073|NCT01369511|4567731|P4|Overall Study|Entry criteria not met|1
1384074|NCT01369511|4567732|P3|Overall Study|Entry criteria not met|0
1384075|NCT01369511|4567733|P2|Overall Study|Entry criteria not met|0
1384076|NCT01369511|4567734|P1|Overall Study|Entry criteria not met|2
1384077|NCT01369511|4567731|P4|Overall Study|Adverse Event|0
1384078|NCT01369511|4567732|P3|Overall Study|Adverse Event|5
1384079|NCT01369511|4567733|P2|Overall Study|Adverse Event|1
1384080|NCT01369511|4567734|P1|Overall Study|Adverse Event|1
1384081|NCT01369485|4567750|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
1384082|NCT01369485|4567751|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
1384083|NCT01369485|4567750|P2|Open Label Phase (Week 12 to Month 12)|Death|1
1384084|NCT01369485|4567751|P1|Open Label Phase (Week 12 to Month 12)|Death|0
1384085|NCT01369485|4567750|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
1384086|NCT01369485|4567751|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
1384087|NCT01369485|4567750|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
1384088|NCT01369485|4567751|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
1384089|NCT01369485|4567750|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
1384090|NCT01369485|4567751|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
1384091|NCT01369485|4567750|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
1384092|NCT01369485|4567751|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
1384093|NCT01369485|4567750|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
1384094|NCT01369485|4567751|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
1384095|NCT01369485|4567750|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
1384096|NCT01369485|4567751|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
1384097|NCT01369485|4567750|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
1384098|NCT01369485|4567751|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
1384099|NCT01369485|4567750|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
1384100|NCT01369485|4567751|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
1384101|NCT01369355|4567797|P6|Overall Study|Not Treated|0
1384102|NCT01369355|4567798|P5|Overall Study|Not Treated|0
1384103|NCT01369355|4567799|P4|Overall Study|Not Treated|0
1384104|NCT01369355|4567800|P3|Overall Study|Not Treated|1
1384105|NCT01369355|4567801|P2|Overall Study|Not Treated|0
1384106|NCT01369355|4567802|P1|Overall Study|Not Treated|0
1384107|NCT01369355|4567797|P6|Overall Study|Other|0
1384108|NCT01369355|4567798|P5|Overall Study|Other|1
1384109|NCT01369355|4567799|P4|Overall Study|Other|0
1384110|NCT01369355|4567800|P3|Overall Study|Other|0
1384111|NCT01369355|4567801|P2|Overall Study|Other|0
1384112|NCT01369355|4567802|P1|Overall Study|Other|0
1384113|NCT01369355|4567797|P6|Overall Study|Withdrawal by Subject|22
1384114|NCT01369355|4567798|P5|Overall Study|Withdrawal by Subject|8
1384115|NCT01369355|4567799|P4|Overall Study|Withdrawal by Subject|6
1384116|NCT01369355|4567800|P3|Overall Study|Withdrawal by Subject|7
1384117|NCT01369355|4567801|P2|Overall Study|Withdrawal by Subject|2
1384118|NCT01369355|4567802|P1|Overall Study|Withdrawal by Subject|6
1384119|NCT01369355|4567797|P6|Overall Study|Lost to Follow-up|6
1384120|NCT01369355|4567798|P5|Overall Study|Lost to Follow-up|5
1384121|NCT01369355|4567799|P4|Overall Study|Lost to Follow-up|2
1384122|NCT01369355|4567800|P3|Overall Study|Lost to Follow-up|1
1384123|NCT01369355|4567801|P2|Overall Study|Lost to Follow-up|0
1384124|NCT01369355|4567802|P1|Overall Study|Lost to Follow-up|1
1384125|NCT01369355|4567797|P6|Overall Study|Protocol Violation|2
1384126|NCT01369355|4567798|P5|Overall Study|Protocol Violation|0
1384127|NCT01369355|4567799|P4|Overall Study|Protocol Violation|0
1384128|NCT01369355|4567800|P3|Overall Study|Protocol Violation|1
1384129|NCT01369355|4567801|P2|Overall Study|Protocol Violation|1
1384130|NCT01369355|4567802|P1|Overall Study|Protocol Violation|0
1384131|NCT01369355|4567797|P6|Overall Study|Lack of Efficacy|217
1384132|NCT01369355|4567798|P5|Overall Study|Lack of Efficacy|126
1384133|NCT01369355|4567799|P4|Overall Study|Lack of Efficacy|15
1384134|NCT01369355|4567800|P3|Overall Study|Lack of Efficacy|15
1384135|NCT01369355|4567801|P2|Overall Study|Lack of Efficacy|14
1384136|NCT01369355|4567802|P1|Overall Study|Lack of Efficacy|15
1384137|NCT01369355|4567797|P6|Overall Study|Adverse Event|25
1384138|NCT01369355|4567798|P5|Overall Study|Adverse Event|14
1384139|NCT01369355|4567799|P4|Overall Study|Adverse Event|7
1384140|NCT01369355|4567800|P3|Overall Study|Adverse Event|6
1384141|NCT01369355|4567801|P2|Overall Study|Adverse Event|12
1384142|NCT01369355|4567802|P1|Overall Study|Adverse Event|9
1384143|NCT01369342|4567831|P3|Overall Study|Not Treated|0
1384144|NCT01369342|4567832|P2|Overall Study|Not Treated|0
1384145|NCT01369342|4567833|P1|Overall Study|Not Treated|1
1384146|NCT01369342|4567831|P3|Overall Study|Lost to Follow-up|1
1384147|NCT01369342|4567832|P2|Overall Study|Lost to Follow-up|2
1384148|NCT01369342|4567833|P1|Overall Study|Lost to Follow-up|5
1384149|NCT01369342|4567831|P3|Overall Study|Withdrawal by Subject|2
1384150|NCT01369342|4567832|P2|Overall Study|Withdrawal by Subject|7
1384151|NCT01369342|4567833|P1|Overall Study|Withdrawal by Subject|7
1384152|NCT01369329|4567856|P3|Overall Study|Other|2
1384153|NCT01369329|4567857|P2|Overall Study|Other|3
1384154|NCT01369329|4567858|P1|Overall Study|Other|2
1384155|NCT01369329|4567856|P3|Overall Study|Lost to Follow-up|2
1384156|NCT01369329|4567857|P2|Overall Study|Lost to Follow-up|2
1384157|NCT01369329|4567858|P1|Overall Study|Lost to Follow-up|2
1384158|NCT01369329|4567856|P3|Overall Study|Withdrawal by Subject|10
1384159|NCT01369329|4567857|P2|Overall Study|Withdrawal by Subject|6
1384160|NCT01369329|4567858|P1|Overall Study|Withdrawal by Subject|8
1384161|NCT01369225|4567884|P6|Overall Study|Adverse Event|0
1384162|NCT01369225|4567885|P5|Overall Study|Adverse Event|1
1384163|NCT01369225|4567886|P4|Overall Study|Adverse Event|1
1384164|NCT01369225|4567887|P3|Overall Study|Adverse Event|0
1384165|NCT01369225|4567888|P2|Overall Study|Adverse Event|0
1384166|NCT01369225|4567889|P1|Overall Study|Adverse Event|0
1384167|NCT01369225|4567884|P6|Overall Study|Other|0
1384168|NCT01369225|4567885|P5|Overall Study|Other|1
1384169|NCT01369225|4567886|P4|Overall Study|Other|0
1384170|NCT01369225|4567887|P3|Overall Study|Other|0
1384171|NCT01369225|4567888|P2|Overall Study|Other|0
1384172|NCT01369225|4567889|P1|Overall Study|Other|1
1384173|NCT01369225|4567884|P6|Overall Study|Does Not Meet Entrance Criteria|0
1384174|NCT01369225|4567885|P5|Overall Study|Does Not Meet Entrance Criteria|0
1384175|NCT01369225|4567886|P4|Overall Study|Does Not Meet Entrance Criteria|0
1384176|NCT01369225|4567887|P3|Overall Study|Does Not Meet Entrance Criteria|1
1384177|NCT01369225|4567888|P2|Overall Study|Does Not Meet Entrance Criteria|0
1384178|NCT01369225|4567889|P1|Overall Study|Does Not Meet Entrance Criteria|0
1384179|NCT01369225|4567884|P6|Overall Study|Withdrawal by Subject|0
1384180|NCT01369225|4567885|P5|Overall Study|Withdrawal by Subject|0
1384181|NCT01369225|4567886|P4|Overall Study|Withdrawal by Subject|1
1384182|NCT01369225|4567887|P3|Overall Study|Withdrawal by Subject|2
1384183|NCT01369225|4567888|P2|Overall Study|Withdrawal by Subject|0
1384184|NCT01369225|4567889|P1|Overall Study|Withdrawal by Subject|1
1384185|NCT01369199|4567981|P1|Overall Study|Lost to Follow-up|2
1384186|NCT01369199|4567981|P1|Overall Study|Withdrawal by Subject|1
1384187|NCT01368965|4568016|P1|Overall Study|Lost to Follow-up|12
1384188|NCT01368900|4568025|P1|Overall Study|Lost to Follow-up|7
1384189|NCT01368835|4568100|P1|Overall Study|Lost to Follow-up|11
1384190|NCT01368835|4568100|P1|Overall Study|Inclusion criteria/photography quality|22
1384191|NCT01368536|4568142|P3|Overall Study|Protocol deviation|1
1384192|NCT01368536|4568143|P2|Overall Study|Protocol deviation|3
1384193|NCT01368536|4568144|P1|Overall Study|Protocol deviation|0
1384194|NCT01368536|4568142|P3|Overall Study|Administrative problems|35
1384195|NCT01368536|4568143|P2|Overall Study|Administrative problems|39
1384196|NCT01368536|4568144|P1|Overall Study|Administrative problems|34
1384197|NCT01368536|4568142|P3|Overall Study|Lost to Follow-up|5
1384198|NCT01368536|4568143|P2|Overall Study|Lost to Follow-up|3
1384199|NCT01368536|4568144|P1|Overall Study|Lost to Follow-up|3
1384200|NCT01368536|4568142|P3|Overall Study|Withdrawal by Subject|4
1384201|NCT01368536|4568143|P2|Overall Study|Withdrawal by Subject|5
1384202|NCT01368536|4568144|P1|Overall Study|Withdrawal by Subject|2
1384203|NCT01368536|4568142|P3|Overall Study|No longer required study medication|1
1384204|NCT01368536|4568143|P2|Overall Study|No longer required study medication|0
1384205|NCT01368536|4568144|P1|Overall Study|No longer required study medication|0
1384206|NCT01368536|4568142|P3|Overall Study|Unsatisfactory therapeutic effect|2
1384207|NCT01368536|4568143|P2|Overall Study|Unsatisfactory therapeutic effect|2
1384208|NCT01368536|4568144|P1|Overall Study|Unsatisfactory therapeutic effect|7
1384209|NCT01368536|4568142|P3|Overall Study|Abnormal test procedure result(s)|1
1384210|NCT01368536|4568143|P2|Overall Study|Abnormal test procedure result(s)|0
1384211|NCT01368536|4568144|P1|Overall Study|Abnormal test procedure result(s)|0
1384212|NCT01368536|4568142|P3|Overall Study|Abnormal laboratory value(s)|2
1384213|NCT01368536|4568143|P2|Overall Study|Abnormal laboratory value(s)|1
1384214|NCT01368536|4568144|P1|Overall Study|Abnormal laboratory value(s)|0
1384215|NCT01368536|4568142|P3|Overall Study|Adverse Event|8
1384216|NCT01368536|4568143|P2|Overall Study|Adverse Event|6
1384217|NCT01368536|4568144|P1|Overall Study|Adverse Event|5
1384218|NCT01368497|4568165|P1|Overall Study|Lost to Follow-up|2
1384219|NCT01368432|4568193|P2|Overall Study|Lost to Follow-up|1
1384220|NCT01368432|4568194|P1|Overall Study|Lost to Follow-up|0
1384221|NCT01368406|4568228|P2|Overall Study|started working|3
1384222|NCT01368406|4568229|P1|Overall Study|started working|2
1384223|NCT01368406|4568228|P2|Overall Study|relapse of the disease|2
1384224|NCT01368406|4568229|P1|Overall Study|relapse of the disease|3
1384225|NCT01368406|4568228|P2|Overall Study|Withdrawal by Subject|4
1384226|NCT01368406|4568229|P1|Overall Study|Withdrawal by Subject|8
1384227|NCT01368406|4568228|P2|Overall Study|Lost to Follow-up|4
1384228|NCT01368406|4568229|P1|Overall Study|Lost to Follow-up|8
1384229|NCT01368276|4568237|P2|Overall Study|Death|10
1384230|NCT01368276|4568238|P1|Overall Study|Death|1
1384231|NCT01368211|4568275|P2|Second Platelets Transfusion|No need for additional transfusion|2
1384232|NCT01368211|4568276|P1|Second Platelets Transfusion|No need for additional transfusion|1
1384233|NCT01368081|4568304|P13|Overall Study|Other reason not defined above|3
1384234|NCT01368081|4568305|P12|Overall Study|Other reason not defined above|0
1384235|NCT01368081|4568306|P11|Overall Study|Other reason not defined above|0
1384236|NCT01368081|4568307|P10|Overall Study|Other reason not defined above|1
1384237|NCT01368081|4568308|P9|Overall Study|Other reason not defined above|0
1384238|NCT01368081|4568309|P8|Overall Study|Other reason not defined above|0
1384239|NCT01368081|4568310|P7|Overall Study|Other reason not defined above|2
1384240|NCT01368081|4568311|P6|Overall Study|Other reason not defined above|1
1384241|NCT01368081|4568312|P5|Overall Study|Other reason not defined above|0
1384242|NCT01368081|4568313|P4|Overall Study|Other reason not defined above|1
1384243|NCT01368081|4568314|P3|Overall Study|Other reason not defined above|0
1384244|NCT01368081|4568315|P2|Overall Study|Other reason not defined above|0
1384245|NCT01368081|4568316|P1|Overall Study|Other reason not defined above|2
1384246|NCT01368081|4568304|P13|Overall Study|Withdrawal by Subject|0
1384247|NCT01368081|4568305|P12|Overall Study|Withdrawal by Subject|2
1384248|NCT01368081|4568306|P11|Overall Study|Withdrawal by Subject|3
1384249|NCT01368081|4568307|P10|Overall Study|Withdrawal by Subject|4
1384250|NCT01368081|4568308|P9|Overall Study|Withdrawal by Subject|5
1384251|NCT01368081|4568309|P8|Overall Study|Withdrawal by Subject|2
1384252|NCT01368081|4568310|P7|Overall Study|Withdrawal by Subject|4
1384253|NCT01368081|4568311|P6|Overall Study|Withdrawal by Subject|3
1384254|NCT01368081|4568312|P5|Overall Study|Withdrawal by Subject|0
1384255|NCT01368081|4568313|P4|Overall Study|Withdrawal by Subject|1
1384256|NCT01368081|4568314|P3|Overall Study|Withdrawal by Subject|1
1384257|NCT01368081|4568315|P2|Overall Study|Withdrawal by Subject|4
1384258|NCT01368081|4568316|P1|Overall Study|Withdrawal by Subject|4
1384259|NCT01368081|4568304|P13|Overall Study|Lost to Follow-up|1
1384260|NCT01368081|4568305|P12|Overall Study|Lost to Follow-up|0
1384261|NCT01368081|4568306|P11|Overall Study|Lost to Follow-up|0
1384262|NCT01368081|4568307|P10|Overall Study|Lost to Follow-up|0
1384263|NCT01368081|4568308|P9|Overall Study|Lost to Follow-up|0
1384264|NCT01368081|4568309|P8|Overall Study|Lost to Follow-up|0
1384265|NCT01368081|4568310|P7|Overall Study|Lost to Follow-up|0
1384266|NCT01368081|4568311|P6|Overall Study|Lost to Follow-up|0
1384267|NCT01368081|4568312|P5|Overall Study|Lost to Follow-up|0
1384268|NCT01368081|4568313|P4|Overall Study|Lost to Follow-up|0
1384269|NCT01368081|4568314|P3|Overall Study|Lost to Follow-up|0
1384270|NCT01368081|4568315|P2|Overall Study|Lost to Follow-up|0
1384271|NCT01368081|4568316|P1|Overall Study|Lost to Follow-up|0
1384272|NCT01368081|4568304|P13|Overall Study|Protocol Violation|0
1384273|NCT01368081|4568305|P12|Overall Study|Protocol Violation|0
1384274|NCT01368081|4568306|P11|Overall Study|Protocol Violation|0
1384275|NCT01368081|4568307|P10|Overall Study|Protocol Violation|0
1384276|NCT01368081|4568308|P9|Overall Study|Protocol Violation|0
1384277|NCT01368081|4568309|P8|Overall Study|Protocol Violation|1
1384278|NCT01368081|4568310|P7|Overall Study|Protocol Violation|0
1384279|NCT01368081|4568311|P6|Overall Study|Protocol Violation|1
1384280|NCT01368081|4568312|P5|Overall Study|Protocol Violation|0
1384281|NCT01368081|4568313|P4|Overall Study|Protocol Violation|0
1384282|NCT01368081|4568314|P3|Overall Study|Protocol Violation|0
1384283|NCT01368081|4568315|P2|Overall Study|Protocol Violation|0
1384284|NCT01368081|4568316|P1|Overall Study|Protocol Violation|0
1384285|NCT01368081|4568304|P13|Overall Study|Lack of Efficacy|0
1384286|NCT01368081|4568305|P12|Overall Study|Lack of Efficacy|0
1384287|NCT01368081|4568306|P11|Overall Study|Lack of Efficacy|0
1384288|NCT01368081|4568307|P10|Overall Study|Lack of Efficacy|0
1384289|NCT01368081|4568308|P9|Overall Study|Lack of Efficacy|0
1384290|NCT01368081|4568309|P8|Overall Study|Lack of Efficacy|2
1384291|NCT01368081|4568310|P7|Overall Study|Lack of Efficacy|0
1384292|NCT01368081|4568311|P6|Overall Study|Lack of Efficacy|0
1384293|NCT01368081|4568312|P5|Overall Study|Lack of Efficacy|0
1384294|NCT01368081|4568313|P4|Overall Study|Lack of Efficacy|1
1384295|NCT01368081|4568314|P3|Overall Study|Lack of Efficacy|0
1384296|NCT01368081|4568315|P2|Overall Study|Lack of Efficacy|1
1384297|NCT01368081|4568316|P1|Overall Study|Lack of Efficacy|0
1384298|NCT01368081|4568304|P13|Overall Study|Adverse Event|3
1384299|NCT01368081|4568305|P12|Overall Study|Adverse Event|1
1384300|NCT01368081|4568306|P11|Overall Study|Adverse Event|6
1384301|NCT01368081|4568307|P10|Overall Study|Adverse Event|5
1384302|NCT01368081|4568308|P9|Overall Study|Adverse Event|3
1384303|NCT01368081|4568309|P8|Overall Study|Adverse Event|2
1384304|NCT01368081|4568310|P7|Overall Study|Adverse Event|6
1384305|NCT01368081|4568311|P6|Overall Study|Adverse Event|5
1384306|NCT01368081|4568312|P5|Overall Study|Adverse Event|2
1384307|NCT01368081|4568313|P4|Overall Study|Adverse Event|2
1384308|NCT01368081|4568314|P3|Overall Study|Adverse Event|3
1384309|NCT01368081|4568315|P2|Overall Study|Adverse Event|4
1384310|NCT01368081|4568316|P1|Overall Study|Adverse Event|4
1384311|NCT01368042|4568370|P1|Overall Study|Transplanted|1
1384312|NCT01368042|4568370|P1|Overall Study|Lost to Follow-up|4
1384313|NCT01368042|4568370|P1|Overall Study|Protocol Violation|11
1384314|NCT01368042|4568370|P1|Overall Study|Death|14
1384315|NCT01367886|4568390|P1|Overall Study|Death|1
1384316|NCT01367886|4568390|P1|Overall Study|Lack of Efficacy|2
1384317|NCT01367886|4568390|P1|Overall Study|Lost to Follow-up|4
1384318|NCT01367834|4568440|P2|Overall Study|Study was ended.|1
1384319|NCT01367834|4568441|P1|Overall Study|Study was ended.|0
1384320|NCT01367834|4568440|P2|Overall Study|Withdrawal by Subject|2
1384321|NCT01367834|4568441|P1|Overall Study|Withdrawal by Subject|2
1384322|NCT01367704|4568465|P2|Overall Study|Lost to Follow-up|161
1384323|NCT01367704|4568466|P1|Overall Study|Lost to Follow-up|47
1384324|NCT01367457|4568479|P3|Overall Study|Suspected DP/suspected active infection|0
1384325|NCT01367457|4568480|P2|Overall Study|Suspected DP/suspected active infection|0
1384326|NCT01367457|4568481|P1|Overall Study|Suspected DP/suspected active infection|1
1384327|NCT01367457|4568479|P3|Overall Study|Palliative. Overall decline|0
1384328|NCT01367457|4568480|P2|Overall Study|Palliative. Overall decline|0
1384329|NCT01367457|4568481|P1|Overall Study|Palliative. Overall decline|1
1384330|NCT01367457|4568479|P3|Overall Study|Patient's Wish|0
1384331|NCT01367457|4568480|P2|Overall Study|Patient's Wish|0
1384332|NCT01367457|4568481|P1|Overall Study|Patient's Wish|1
1384333|NCT01367457|4568479|P3|Overall Study|CD, Suspected disease progression (DP)|0
1384334|NCT01367457|4568480|P2|Overall Study|CD, Suspected disease progression (DP)|0
1384335|NCT01367457|4568481|P1|Overall Study|CD, Suspected disease progression (DP)|1
1384336|NCT01367457|4568479|P3|Overall Study|Death from septic shock|0
1384337|NCT01367457|4568480|P2|Overall Study|Death from septic shock|0
1384338|NCT01367457|4568481|P1|Overall Study|Death from septic shock|1
1384339|NCT01367457|4568479|P3|Overall Study|Lost to Follow-up|0
1384340|NCT01367457|4568480|P2|Overall Study|Lost to Follow-up|0
1384341|NCT01367457|4568481|P1|Overall Study|Lost to Follow-up|1
1384342|NCT01367457|4568479|P3|Overall Study|Rejection of treatment|0
1384343|NCT01367457|4568480|P2|Overall Study|Rejection of treatment|0
1384344|NCT01367457|4568481|P1|Overall Study|Rejection of treatment|1
1384345|NCT01367457|4568479|P3|Overall Study|Overall decline|0
1384346|NCT01367457|4568480|P2|Overall Study|Overall decline|0
1384347|NCT01367457|4568481|P1|Overall Study|Overall decline|1
1384348|NCT01367457|4568479|P3|Overall Study|Intestinal obstruction with necrosis|0
1384349|NCT01367457|4568480|P2|Overall Study|Intestinal obstruction with necrosis|0
1384350|NCT01367457|4568481|P1|Overall Study|Intestinal obstruction with necrosis|1
1384351|NCT01367457|4568479|P3|Overall Study|No clinical benefit|0
1384352|NCT01367457|4568480|P2|Overall Study|No clinical benefit|0
1384353|NCT01367457|4568481|P1|Overall Study|No clinical benefit|1
1384354|NCT01367457|4568479|P3|Overall Study|Stabilisation + frequent infections|0
1384355|NCT01367457|4568480|P2|Overall Study|Stabilisation + frequent infections|0
1384356|NCT01367457|4568481|P1|Overall Study|Stabilisation + frequent infections|1
1384357|NCT01367457|4568479|P3|Overall Study|Overall status worsens to grade 4|0
1384358|NCT01367457|4568480|P2|Overall Study|Overall status worsens to grade 4|0
1384359|NCT01367457|4568481|P1|Overall Study|Overall status worsens to grade 4|1
1384360|NCT01367457|4568479|P3|Overall Study|Uncontrolled pain|0
1384361|NCT01367457|4568480|P2|Overall Study|Uncontrolled pain|0
1384362|NCT01367457|4568481|P1|Overall Study|Uncontrolled pain|1
1384363|NCT01367457|4568479|P3|Overall Study|CD, associated leukaemia|0
1384364|NCT01367457|4568480|P2|Overall Study|CD, associated leukaemia|0
1384365|NCT01367457|4568481|P1|Overall Study|CD, associated leukaemia|1
1384366|NCT01367457|4568479|P3|Overall Study|Withdrawal by Subject|0
1384367|NCT01367457|4568480|P2|Overall Study|Withdrawal by Subject|0
1384368|NCT01367457|4568481|P1|Overall Study|Withdrawal by Subject|1
1384369|NCT01367457|4568479|P3|Overall Study|Choledocolithiasis and pancreatitis|0
1384370|NCT01367457|4568480|P2|Overall Study|Choledocolithiasis and pancreatitis|0
1384371|NCT01367457|4568481|P1|Overall Study|Choledocolithiasis and pancreatitis|1
1384372|NCT01367457|4568479|P3|Overall Study|low grade toxicities + stable disease|0
1384373|NCT01367457|4568480|P2|Overall Study|low grade toxicities + stable disease|0
1384374|NCT01367457|4568481|P1|Overall Study|low grade toxicities + stable disease|1
1384375|NCT01367457|4568479|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
1384376|NCT01367457|4568480|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
1384377|NCT01367457|4568481|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
1384378|NCT01367457|4568479|P3|Overall Study|Bleeding from cavernous haemangioma|0
1384379|NCT01367457|4568480|P2|Overall Study|Bleeding from cavernous haemangioma|0
1384380|NCT01367457|4568481|P1|Overall Study|Bleeding from cavernous haemangioma|1
1384381|NCT01367457|4568479|P3|Overall Study|Investigator's opinion, stable disease|0
1384382|NCT01367457|4568480|P2|Overall Study|Investigator's opinion, stable disease|0
1384383|NCT01367457|4568481|P1|Overall Study|Investigator's opinion, stable disease|1
1384384|NCT01367457|4568479|P3|Overall Study|Patient asks for rest + slow progression|0
1384385|NCT01367457|4568480|P2|Overall Study|Patient asks for rest + slow progression|0
1384386|NCT01367457|4568481|P1|Overall Study|Patient asks for rest + slow progression|1
1384387|NCT01367457|4568479|P3|Overall Study|Progression|0
1384388|NCT01367457|4568480|P2|Overall Study|Progression|0
1384389|NCT01367457|4568481|P1|Overall Study|Progression|137
1384390|NCT01367457|4568479|P3|Overall Study|Toxicity|0
1384391|NCT01367457|4568480|P2|Overall Study|Toxicity|0
1384392|NCT01367457|4568481|P1|Overall Study|Toxicity|16
1384393|NCT01367457|4568479|P3|Overall Study|Progression and death|0
1384394|NCT01367457|4568480|P2|Overall Study|Progression and death|0
1384395|NCT01367457|4568481|P1|Overall Study|Progression and death|8
1384396|NCT01367457|4568479|P3|Overall Study|Clinical decline (CD)|0
1384397|NCT01367457|4568480|P2|Overall Study|Clinical decline (CD)|0
1384398|NCT01367457|4568481|P1|Overall Study|Clinical decline (CD)|2
1384399|NCT01367457|4568479|P3|Overall Study|Investigator's decision|0
1384400|NCT01367457|4568480|P2|Overall Study|Investigator's decision|0
1384401|NCT01367457|4568481|P1|Overall Study|Investigator's decision|2
1384402|NCT01367457|4568479|P3|Overall Study|Death|0
1384403|NCT01367457|4568480|P2|Overall Study|Death|0
1384404|NCT01367457|4568481|P1|Overall Study|Death|2
1384405|NCT01367249|4568503|P2|Overall Study|Not Specified|10
1384406|NCT01367249|4568504|P1|Overall Study|Not Specified|3
1384407|NCT01367249|4568503|P2|Overall Study|Withdrawal by Subject|6
1384408|NCT01367249|4568504|P1|Overall Study|Withdrawal by Subject|6
1384409|NCT01367158|4568523|P11|Overall Study|Protocol Violation|0
1384410|NCT01367158|4568524|P10|Overall Study|Protocol Violation|0
1384411|NCT01367158|4568525|P9|Overall Study|Protocol Violation|0
1384412|NCT01367158|4568526|P8|Overall Study|Protocol Violation|0
1384413|NCT01367158|4568527|P7|Overall Study|Protocol Violation|0
1384414|NCT01367158|4568528|P6|Overall Study|Protocol Violation|0
1384415|NCT01367158|4568529|P5|Overall Study|Protocol Violation|0
1384416|NCT01367158|4568530|P4|Overall Study|Protocol Violation|0
1384417|NCT01367158|4568531|P3|Overall Study|Protocol Violation|0
1384418|NCT01367158|4568532|P2|Overall Study|Protocol Violation|1
1384419|NCT01367158|4568533|P1|Overall Study|Protocol Violation|0
1384420|NCT01367158|4568523|P11|Overall Study|Lost to Follow-up|1
1384421|NCT01367158|4568524|P10|Overall Study|Lost to Follow-up|0
1384422|NCT01367158|4568525|P9|Overall Study|Lost to Follow-up|0
1384423|NCT01367158|4568526|P8|Overall Study|Lost to Follow-up|1
1384424|NCT01367158|4568527|P7|Overall Study|Lost to Follow-up|0
1384425|NCT01367158|4568528|P6|Overall Study|Lost to Follow-up|2
1384426|NCT01367158|4568529|P5|Overall Study|Lost to Follow-up|0
1384427|NCT01367158|4568530|P4|Overall Study|Lost to Follow-up|1
1384428|NCT01367158|4568531|P3|Overall Study|Lost to Follow-up|0
1384429|NCT01367158|4568532|P2|Overall Study|Lost to Follow-up|0
1384430|NCT01367158|4568533|P1|Overall Study|Lost to Follow-up|0
1384431|NCT01367158|4568523|P11|Overall Study|Withdrew consent|0
1384432|NCT01367158|4568524|P10|Overall Study|Withdrew consent|0
1384433|NCT01367158|4568525|P9|Overall Study|Withdrew consent|0
1384434|NCT01367158|4568526|P8|Overall Study|Withdrew consent|1
1384435|NCT01367158|4568527|P7|Overall Study|Withdrew consent|0
1384436|NCT01367158|4568528|P6|Overall Study|Withdrew consent|0
1384437|NCT01367158|4568529|P5|Overall Study|Withdrew consent|2
1384438|NCT01367158|4568530|P4|Overall Study|Withdrew consent|0
1384439|NCT01367158|4568531|P3|Overall Study|Withdrew consent|1
1384440|NCT01367158|4568532|P2|Overall Study|Withdrew consent|2
1384441|NCT01367158|4568533|P1|Overall Study|Withdrew consent|0
1384442|NCT01367119|4568677|P2|Overall Study|Withdrawal by Subject|1
1384443|NCT01367119|4568678|P1|Overall Study|Withdrawal by Subject|1
1384444|NCT01367119|4568677|P2|Overall Study|Adverse Event|0
1384445|NCT01367119|4568678|P1|Overall Study|Adverse Event|1
1384446|NCT01366846|4568733|P4|Overall Study|Scheduling Conflicts|0
1384447|NCT01366846|4568734|P3|Overall Study|Scheduling Conflicts|1
1384448|NCT01366846|4568735|P2|Overall Study|Scheduling Conflicts|0
1384449|NCT01366846|4568736|P1|Overall Study|Scheduling Conflicts|0
1384450|NCT01366846|4568733|P4|Overall Study|Communication Difficulties|1
1384451|NCT01366846|4568734|P3|Overall Study|Communication Difficulties|0
1384452|NCT01366846|4568735|P2|Overall Study|Communication Difficulties|4
1384453|NCT01366846|4568736|P1|Overall Study|Communication Difficulties|1
1384454|NCT01366846|4568733|P4|Overall Study|Withdrawal by Subject|0
1384455|NCT01366846|4568734|P3|Overall Study|Withdrawal by Subject|0
1384456|NCT01366846|4568735|P2|Overall Study|Withdrawal by Subject|0
1384457|NCT01366846|4568736|P1|Overall Study|Withdrawal by Subject|2
1384458|NCT01366638|4568759|P3|Overall Study|Not specified|0
1384459|NCT01366638|4568760|P2|Overall Study|Not specified|0
1384460|NCT01366638|4568761|P1|Overall Study|Not specified|1
1384461|NCT01366638|4568759|P3|Overall Study|Withdrawal by Subject|6
1384462|NCT01366638|4568760|P2|Overall Study|Withdrawal by Subject|0
1384463|NCT01366638|4568761|P1|Overall Study|Withdrawal by Subject|0
1384464|NCT01366534|4568798|P3|Overall Study|Declined challenged|0
1384465|NCT01366534|4568799|P2|Overall Study|Declined challenged|1
1384466|NCT01366534|4568800|P1|Overall Study|Declined challenged|0
1384467|NCT01366534|4568798|P3|Overall Study|Migrated|0
1384468|NCT01366534|4568799|P2|Overall Study|Migrated|1
1384469|NCT01366534|4568800|P1|Overall Study|Migrated|1
1384470|NCT01366534|4568798|P3|Overall Study|Lost to Follow-up|0
1384471|NCT01366534|4568799|P2|Overall Study|Lost to Follow-up|0
1384472|NCT01366534|4568800|P1|Overall Study|Lost to Follow-up|1
1384473|NCT01366521|4568850|P4|Overall Study|Withdrawal by Subject|0
1384474|NCT01366521|4568851|P3|Overall Study|Withdrawal by Subject|0
1384475|NCT01366521|4568852|P2|Overall Study|Withdrawal by Subject|1
1384476|NCT01366521|4568853|P1|Overall Study|Withdrawal by Subject|0
1384477|NCT01366521|4568850|P4|Overall Study|Physician Decision|0
1384478|NCT01366521|4568851|P3|Overall Study|Physician Decision|1
1384479|NCT01366521|4568852|P2|Overall Study|Physician Decision|0
1384480|NCT01366521|4568853|P1|Overall Study|Physician Decision|0
1384481|NCT01366521|4568850|P4|Overall Study|Protocol Violation|0
1384482|NCT01366521|4568851|P3|Overall Study|Protocol Violation|1
1384483|NCT01366521|4568852|P2|Overall Study|Protocol Violation|0
1384484|NCT01366521|4568853|P1|Overall Study|Protocol Violation|0
1384485|NCT01366521|4568850|P4|Overall Study|Adverse Event|0
1384486|NCT01366521|4568851|P3|Overall Study|Adverse Event|0
1384487|NCT01366521|4568852|P2|Overall Study|Adverse Event|0
1384488|NCT01366521|4568853|P1|Overall Study|Adverse Event|1
1384489|NCT01366443|4568928|P1|Overall Study|Under 18 yo|1
1384490|NCT01366443|4568928|P1|Overall Study|Lost to Follow-up|2
1384491|NCT01366209|4568942|P2|Overall Study|Withdrew consent|3
1384492|NCT01366209|4568943|P1|Overall Study|Withdrew consent|4
1384493|NCT01366209|4568942|P2|Overall Study|Sponsors decision|1
1384494|NCT01366209|4568943|P1|Overall Study|Sponsors decision|0
1384495|NCT01366209|4568942|P2|Overall Study|Physician Decision|0
1384496|NCT01366209|4568943|P1|Overall Study|Physician Decision|1
1384497|NCT01366209|4568942|P2|Overall Study|Lost to Follow-up|1
1384498|NCT01366209|4568943|P1|Overall Study|Lost to Follow-up|2
1384499|NCT01366209|4568942|P2|Overall Study|Lung transplantation|1
1384500|NCT01366209|4568943|P1|Overall Study|Lung transplantation|6
1384501|NCT01366209|4568942|P2|Overall Study|Death|19
1384502|NCT01366209|4568943|P1|Overall Study|Death|12
1384503|NCT01366209|4568942|P2|Overall Study|Withdrawal by Subject|4
1384504|NCT01366209|4568943|P1|Overall Study|Withdrawal by Subject|4
1384505|NCT01366209|4568942|P2|Overall Study|Adverse Event|7
1384506|NCT01366209|4568943|P1|Overall Study|Adverse Event|6
1384507|NCT01366092|4568966|P1|Overall Study|Withdrawal by Subject|1
1384508|NCT01366092|4568966|P1|Overall Study|Physician Decision|1
1384509|NCT01366092|4568966|P1|Overall Study|Progressive cGVHD|2
1384510|NCT01365910|4568975|P1|Overall Study|pt did not get tx, nausea/vomiting|1
1384511|NCT01365910|4568975|P1|Overall Study|other complicating disease|1
1384512|NCT01365910|4568975|P1|Overall Study|Adverse Event|3
1384513|NCT01365910|4568975|P1|Overall Study|disease progression|18
1384514|NCT01365910|4568975|P1|Overall Study|Withdrawal by Subject|7
1384515|NCT01365546|4569111|P1|Overall Study|Study termination|1
1384516|NCT01365546|4569111|P1|Overall Study|Screen failure|9
1384517|NCT01365546|4569111|P1|Overall Study|Withdrawal by Subject|1
1384518|NCT01365507|4569121|P2|Overall Study|Unclassified|4
1384519|NCT01365507|4569122|P1|Overall Study|Unclassified|1
1384520|NCT01365507|4569121|P2|Overall Study|Withdrawal Criteria|5
1384521|NCT01365507|4569122|P1|Overall Study|Withdrawal Criteria|8
1384522|NCT01365494|4569138|P2|Overall Study|Lost to Follow-up|2
1384523|NCT01365494|4569139|P1|Overall Study|Lost to Follow-up|1
1384524|NCT01365494|4569138|P2|Overall Study|Withdrawal by Subject|1
1384525|NCT01365494|4569139|P1|Overall Study|Withdrawal by Subject|0
1384526|NCT01365494|4569138|P2|Overall Study|Adverse Event|0
1384527|NCT01365494|4569139|P1|Overall Study|Adverse Event|1
1384528|NCT01365481|4569155|P4|Overall Study|Unsatisfactory therapeutic effect|0
1384529|NCT01365481|4569156|P3|Overall Study|Unsatisfactory therapeutic effect|1
1384530|NCT01365481|4569157|P2|Overall Study|Unsatisfactory therapeutic effect|0
1384531|NCT01365481|4569158|P1|Overall Study|Unsatisfactory therapeutic effect|0
1384532|NCT01365481|4569155|P4|Overall Study|Protocol deviation|1
1384533|NCT01365481|4569156|P3|Overall Study|Protocol deviation|0
1384534|NCT01365481|4569157|P2|Overall Study|Protocol deviation|1
1384535|NCT01365481|4569158|P1|Overall Study|Protocol deviation|0
1384536|NCT01365481|4569155|P4|Overall Study|Administrative problems|0
1384537|NCT01365481|4569156|P3|Overall Study|Administrative problems|0
1384538|NCT01365481|4569157|P2|Overall Study|Administrative problems|1
1384539|NCT01365481|4569158|P1|Overall Study|Administrative problems|0
1384540|NCT01365481|4569155|P4|Overall Study|Abnormal laboratory value(s)|0
1384541|NCT01365481|4569156|P3|Overall Study|Abnormal laboratory value(s)|0
1384542|NCT01365481|4569157|P2|Overall Study|Abnormal laboratory value(s)|1
1384543|NCT01365481|4569158|P1|Overall Study|Abnormal laboratory value(s)|0
1384544|NCT01365481|4569155|P4|Overall Study|Lost to Follow-up|3
1384545|NCT01365481|4569156|P3|Overall Study|Lost to Follow-up|2
1384546|NCT01365481|4569157|P2|Overall Study|Lost to Follow-up|1
1384547|NCT01365481|4569158|P1|Overall Study|Lost to Follow-up|1
1384548|NCT01365481|4569155|P4|Overall Study|Withdrawal by Subject|1
1384549|NCT01365481|4569156|P3|Overall Study|Withdrawal by Subject|1
1384550|NCT01365481|4569157|P2|Overall Study|Withdrawal by Subject|2
1384551|NCT01365481|4569158|P1|Overall Study|Withdrawal by Subject|0
1384552|NCT01365481|4569155|P4|Overall Study|Adverse Event|2
1384553|NCT01365481|4569156|P3|Overall Study|Adverse Event|0
1384554|NCT01365481|4569157|P2|Overall Study|Adverse Event|9
1384555|NCT01365481|4569158|P1|Overall Study|Adverse Event|6
1384556|NCT01365468|4569178|P2|Overall Study|Lost to Follow-up|0
1384557|NCT01365468|4569179|P1|Overall Study|Lost to Follow-up|2
1384558|NCT01365468|4569178|P2|Overall Study|Disease progression|0
1384559|NCT01365468|4569179|P1|Overall Study|Disease progression|1
1384560|NCT01365468|4569178|P2|Overall Study|Physician Decision|0
1384561|NCT01365468|4569179|P1|Overall Study|Physician Decision|1
1384562|NCT01365455|4569194|P5|Maintenance Period|Subject/guardian decision|1
1384563|NCT01365455|4569195|P4|Maintenance Period|Subject/guardian decision|4
1384564|NCT01365455|4569196|P3|Maintenance Period|Subject/guardian decision|2
1384565|NCT01365455|4569197|P2|Maintenance Period|Subject/guardian decision|6
1384566|NCT01365455|4569198|P1|Maintenance Period|Subject/guardian decision|4
1384567|NCT01365455|4569194|P5|Maintenance Period|Protocol deviation|0
1384568|NCT01365455|4569195|P4|Maintenance Period|Protocol deviation|0
1384569|NCT01365455|4569196|P3|Maintenance Period|Protocol deviation|0
1384570|NCT01365455|4569197|P2|Maintenance Period|Protocol deviation|1
1384571|NCT01365455|4569198|P1|Maintenance Period|Protocol deviation|1
1384572|NCT01365455|4569194|P5|Maintenance Period|Pregnancy|2
1384573|NCT01365455|4569195|P4|Maintenance Period|Pregnancy|0
1384574|NCT01365455|4569196|P3|Maintenance Period|Pregnancy|0
1384575|NCT01365455|4569197|P2|Maintenance Period|Pregnancy|4
1384576|NCT01365455|4569198|P1|Maintenance Period|Pregnancy|0
1384577|NCT01365455|4569194|P5|Maintenance Period|Physician Decision|1
1384578|NCT01365455|4569195|P4|Maintenance Period|Physician Decision|0
1384579|NCT01365455|4569196|P3|Maintenance Period|Physician Decision|0
1384580|NCT01365455|4569197|P2|Maintenance Period|Physician Decision|1
1384581|NCT01365455|4569198|P1|Maintenance Period|Physician Decision|0
1384582|NCT01365455|4569194|P5|Maintenance Period|Non-compliance with study treatment|0
1384583|NCT01365455|4569195|P4|Maintenance Period|Non-compliance with study treatment|1
1384584|NCT01365455|4569196|P3|Maintenance Period|Non-compliance with study treatment|0
1384585|NCT01365455|4569197|P2|Maintenance Period|Non-compliance with study treatment|0
1384586|NCT01365455|4569198|P1|Maintenance Period|Non-compliance with study treatment|0
1384587|NCT01365455|4569194|P5|Maintenance Period|Lost to Follow-up|3
1384588|NCT01365455|4569195|P4|Maintenance Period|Lost to Follow-up|0
1384589|NCT01365455|4569196|P3|Maintenance Period|Lost to Follow-up|0
1384590|NCT01365455|4569197|P2|Maintenance Period|Lost to Follow-up|4
1384591|NCT01365455|4569198|P1|Maintenance Period|Lost to Follow-up|2
1384592|NCT01365455|4569194|P5|Maintenance Period|Lack of Efficacy|2
1384593|NCT01365455|4569195|P4|Maintenance Period|Lack of Efficacy|2
1384594|NCT01365455|4569196|P3|Maintenance Period|Lack of Efficacy|0
1384595|NCT01365455|4569197|P2|Maintenance Period|Lack of Efficacy|2
1384596|NCT01365455|4569198|P1|Maintenance Period|Lack of Efficacy|10
1384597|NCT01365455|4569194|P5|Maintenance Period|Adverse Event|4
1384598|NCT01365455|4569195|P4|Maintenance Period|Adverse Event|2
1384599|NCT01365455|4569196|P3|Maintenance Period|Adverse Event|1
1384600|NCT01365455|4569197|P2|Maintenance Period|Adverse Event|5
1384601|NCT01365455|4569198|P1|Maintenance Period|Adverse Event|12
1384602|NCT01365455|4569194|P5|Induction Period|Lost to Follow-up|0
1384603|NCT01365455|4569195|P4|Induction Period|Lost to Follow-up|0
1384604|NCT01365455|4569196|P3|Induction Period|Lost to Follow-up|3
1384605|NCT01365455|4569197|P2|Induction Period|Lost to Follow-up|0
1384606|NCT01365455|4569198|P1|Induction Period|Lost to Follow-up|0
1384607|NCT01365455|4569194|P5|Induction Period|Subject/guardian decision|0
1384608|NCT01365455|4569195|P4|Induction Period|Subject/guardian decision|0
1384609|NCT01365455|4569196|P3|Induction Period|Subject/guardian decision|8
1384610|NCT01365455|4569197|P2|Induction Period|Subject/guardian decision|1
1384611|NCT01365455|4569198|P1|Induction Period|Subject/guardian decision|9
1384612|NCT01365455|4569194|P5|Induction Period|Protocol deviation|0
1384613|NCT01365455|4569195|P4|Induction Period|Protocol deviation|0
1384614|NCT01365455|4569196|P3|Induction Period|Protocol deviation|1
1384615|NCT01365455|4569197|P2|Induction Period|Protocol deviation|1
1384616|NCT01365455|4569198|P1|Induction Period|Protocol deviation|0
1384617|NCT01365455|4569194|P5|Induction Period|Pregnancy|0
1384618|NCT01365455|4569195|P4|Induction Period|Pregnancy|0
1384619|NCT01365455|4569196|P3|Induction Period|Pregnancy|0
1384620|NCT01365455|4569197|P2|Induction Period|Pregnancy|1
1384621|NCT01365455|4569198|P1|Induction Period|Pregnancy|0
1384622|NCT01365455|4569194|P5|Induction Period|Lack of Efficacy|0
1384623|NCT01365455|4569195|P4|Induction Period|Lack of Efficacy|0
1384624|NCT01365455|4569196|P3|Induction Period|Lack of Efficacy|0
1384625|NCT01365455|4569197|P2|Induction Period|Lack of Efficacy|1
1384626|NCT01365455|4569198|P1|Induction Period|Lack of Efficacy|1
1384627|NCT01365455|4569194|P5|Induction Period|Adverse Event|0
1384628|NCT01365455|4569195|P4|Induction Period|Adverse Event|0
1384629|NCT01365455|4569196|P3|Induction Period|Adverse Event|4
1384630|NCT01365455|4569197|P2|Induction Period|Adverse Event|3
1384631|NCT01365455|4569198|P1|Induction Period|Adverse Event|5
1384632|NCT01365273|4569288|P2|Overall Study|Physician Decision|0
1384633|NCT01365273|4569289|P1|Overall Study|Physician Decision|1
1384634|NCT01365273|4569288|P2|Overall Study|Protocol Violation|1
1384635|NCT01365273|4569289|P1|Overall Study|Protocol Violation|0
1384636|NCT01365273|4569288|P2|Overall Study|Lost to Follow-up|0
1384637|NCT01365273|4569289|P1|Overall Study|Lost to Follow-up|1
1384638|NCT01365130|4569299|P1|Overall Study|Progression/worsening of Dx prior to txt|2
1384639|NCT01365091|4569308|P4|Period 2|Adverse Event|0
1384640|NCT01365091|4569309|P3|Period 2|Adverse Event|1
1384641|NCT01365091|4569310|P2|Period 2|Adverse Event|0
1384642|NCT01365091|4569311|P1|Period 2|Adverse Event|0
1384643|NCT01365091|4569308|P4|Period 2|Withdrawal by Subject|0
1384644|NCT01365091|4569309|P3|Period 2|Withdrawal by Subject|0
1384645|NCT01365091|4569310|P2|Period 2|Withdrawal by Subject|0
1384646|NCT01365091|4569311|P1|Period 2|Withdrawal by Subject|1
1384647|NCT01365091|4569308|P4|Period 1|Personal reasons|0
1384648|NCT01365091|4569309|P3|Period 1|Personal reasons|1
1384649|NCT01365091|4569310|P2|Period 1|Personal reasons|0
1384650|NCT01365091|4569311|P1|Period 1|Personal reasons|0
1384651|NCT01365091|4569308|P4|Period 1|Withdrawal by Subject|0
1384652|NCT01365091|4569309|P3|Period 1|Withdrawal by Subject|0
1384653|NCT01365091|4569310|P2|Period 1|Withdrawal by Subject|1
1384654|NCT01365091|4569311|P1|Period 1|Withdrawal by Subject|0
1384655|NCT01365091|4569308|P4|Period 1|No longer met study criteria|0
1384656|NCT01365091|4569309|P3|Period 1|No longer met study criteria|0
1384657|NCT01365091|4569310|P2|Period 1|No longer met study criteria|1
1384658|NCT01365091|4569311|P1|Period 1|No longer met study criteria|0
1384659|NCT01365091|4569308|P4|Period 1|Positive test result for drugs of abuse|0
1384660|NCT01365091|4569309|P3|Period 1|Positive test result for drugs of abuse|0
1384661|NCT01365091|4569310|P2|Period 1|Positive test result for drugs of abuse|0
1384662|NCT01365091|4569311|P1|Period 1|Positive test result for drugs of abuse|1
1384663|NCT01365091|4569308|P4|Period 1|Adverse Event|3
1384664|NCT01365091|4569309|P3|Period 1|Adverse Event|2
1384665|NCT01365091|4569310|P2|Period 1|Adverse Event|0
1384666|NCT01365091|4569311|P1|Period 1|Adverse Event|1
1384667|NCT01365052|4569339|P2|Overall Study|Adverse Event|4
1384668|NCT01365052|4569340|P1|Overall Study|Adverse Event|4
1384669|NCT01365039|4569356|P2|Overall Study|Study related symptoms and complaints|0
1384670|NCT01365039|4569357|P1|Overall Study|Study related symptoms and complaints|1
1384671|NCT01364922|4569368|P3|Double-Blind (DB) Period|Other, Unspecified|0
1384672|NCT01364922|4569369|P2|Double-Blind (DB) Period|Other, Unspecified|1
1384673|NCT01364922|4569370|P1|Double-Blind (DB) Period|Other, Unspecified|0
1384674|NCT01364922|4569368|P3|Double-Blind (DB) Period|Adverse Event|1
1384675|NCT01364922|4569369|P2|Double-Blind (DB) Period|Adverse Event|0
1384676|NCT01364922|4569370|P1|Double-Blind (DB) Period|Adverse Event|0
1384677|NCT01364922|4569368|P3|Double-Blind (DB) Period|Subject Noncompliant|0
1384678|NCT01364922|4569369|P2|Double-Blind (DB) Period|Subject Noncompliant|1
1384679|NCT01364922|4569370|P1|Double-Blind (DB) Period|Subject Noncompliant|0
1384680|NCT01364922|4569368|P3|Double-Blind (DB) Period|Lack of Efficacy|4
1384681|NCT01364922|4569369|P2|Double-Blind (DB) Period|Lack of Efficacy|3
1384682|NCT01364922|4569370|P1|Double-Blind (DB) Period|Lack of Efficacy|0
1384683|NCT01364922|4569368|P3|Open-label (OL) Period|Other, Unspecified|0
1384684|NCT01364922|4569369|P2|Open-label (OL) Period|Other, Unspecified|0
1384685|NCT01364922|4569370|P1|Open-label (OL) Period|Other, Unspecified|1
1384686|NCT01364922|4569368|P3|Open-label (OL) Period|Lost to Follow-up|0
1384687|NCT01364922|4569369|P2|Open-label (OL) Period|Lost to Follow-up|0
1384688|NCT01364922|4569370|P1|Open-label (OL) Period|Lost to Follow-up|1
1384689|NCT01364922|4569368|P3|Open-label (OL) Period|Lack of Efficacy|0
1384690|NCT01364922|4569369|P2|Open-label (OL) Period|Lack of Efficacy|0
1384691|NCT01364922|4569370|P1|Open-label (OL) Period|Lack of Efficacy|3
1384692|NCT01364922|4569368|P3|Open-label (OL) Period|Withdrawal by Subject|0
1384693|NCT01364922|4569369|P2|Open-label (OL) Period|Withdrawal by Subject|0
1384694|NCT01364922|4569370|P1|Open-label (OL) Period|Withdrawal by Subject|4
1384695|NCT01364922|4569368|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
1384696|NCT01364922|4569369|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
1384697|NCT01364922|4569370|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
1384698|NCT01364922|4569368|P3|Open-label (OL) Period|Adverse Event|0
1384699|NCT01364922|4569369|P2|Open-label (OL) Period|Adverse Event|0
1384700|NCT01364922|4569370|P1|Open-label (OL) Period|Adverse Event|7
1384701|NCT01364870|4569392|P3|Overall Study|Protocol Violation|0
1384702|NCT01364870|4569393|P2|Overall Study|Protocol Violation|0
1384703|NCT01364870|4569394|P1|Overall Study|Protocol Violation|1
1384704|NCT01364870|4569392|P3|Overall Study|Adverse Event|4
1384705|NCT01364870|4569393|P2|Overall Study|Adverse Event|6
1384706|NCT01364870|4569394|P1|Overall Study|Adverse Event|8
1384707|NCT01364870|4569392|P3|Overall Study|Withdrawal by Subject|10
1384708|NCT01364870|4569393|P2|Overall Study|Withdrawal by Subject|24
1384709|NCT01364870|4569394|P1|Overall Study|Withdrawal by Subject|13
1384710|NCT01364727|4569413|P1|Overall Study|Not Eligible|2
1384711|NCT01364649|4569421|P2|Overall Study|Other|1
1384712|NCT01364649|4569422|P1|Overall Study|Other|4
1384713|NCT01364649|4569421|P2|Overall Study|Lost to Follow-up|13
1384714|NCT01364649|4569422|P1|Overall Study|Lost to Follow-up|12
1384715|NCT01364649|4569421|P2|Overall Study|Withdrawal of Consent|7
1384716|NCT01364649|4569422|P1|Overall Study|Withdrawal of Consent|9
1384717|NCT01364649|4569421|P2|Overall Study|Protocol Deviations|8
1384718|NCT01364649|4569422|P1|Overall Study|Protocol Deviations|4
1384719|NCT01364649|4569421|P2|Overall Study|Non-compliance with Investigational Drug|0
1384720|NCT01364649|4569422|P1|Overall Study|Non-compliance with Investigational Drug|1
1384721|NCT01364649|4569421|P2|Overall Study|Lack of Efficacy|0
1384722|NCT01364649|4569422|P1|Overall Study|Lack of Efficacy|6
1384723|NCT01364649|4569421|P2|Overall Study|Pretreatment Event or Adverse Event|14
1384724|NCT01364649|4569422|P1|Overall Study|Pretreatment Event or Adverse Event|20
1384725|NCT01364428|4569481|P2|Overall Study|Other|3
1384726|NCT01364428|4569482|P1|Overall Study|Other|3
1384727|NCT01364428|4569481|P2|Overall Study|Withdrawal Criteria|10
1384728|NCT01364428|4569482|P1|Overall Study|Withdrawal Criteria|14
1384729|NCT01364428|4569481|P2|Overall Study|Protocol Violation|0
1384730|NCT01364428|4569482|P1|Overall Study|Protocol Violation|2
1384731|NCT01364428|4569481|P2|Overall Study|Adverse Event|2
1384732|NCT01364428|4569482|P1|Overall Study|Adverse Event|1
1384733|NCT01364389|4569499|P3|Overall Study|Adverse Event|0
1384734|NCT01364389|4569500|P2|Overall Study|Adverse Event|0
1384735|NCT01364389|4569501|P1|Overall Study|Adverse Event|1
1384736|NCT01364389|4569499|P3|Overall Study|Administrative problems|0
1384737|NCT01364389|4569500|P2|Overall Study|Administrative problems|0
1384738|NCT01364389|4569501|P1|Overall Study|Administrative problems|1
1384739|NCT01364389|4569499|P3|Overall Study|Protocol deviation|1
1384740|NCT01364389|4569500|P2|Overall Study|Protocol deviation|0
1384741|NCT01364389|4569501|P1|Overall Study|Protocol deviation|0
1384742|NCT01364389|4569499|P3|Overall Study|Withdrawal by Subject|0
1384743|NCT01364389|4569500|P2|Overall Study|Withdrawal by Subject|1
1384744|NCT01364389|4569501|P1|Overall Study|Withdrawal by Subject|0
1384745|NCT01364298|4569520|P2|Overall Study|Other|3
1384746|NCT01364298|4569521|P1|Overall Study|Other|1
1384747|NCT01364298|4569520|P2|Overall Study|Withdrawal by Subject|3
1384748|NCT01364298|4569521|P1|Overall Study|Withdrawal by Subject|3
1384749|NCT01364298|4569520|P2|Overall Study|Lost to Follow-up|10
1384750|NCT01364298|4569521|P1|Overall Study|Lost to Follow-up|5
1384751|NCT01364298|4569520|P2|Overall Study|Lack of Efficacy|0
1384752|NCT01364298|4569521|P1|Overall Study|Lack of Efficacy|1
1384753|NCT01364298|4569520|P2|Overall Study|Lack of adherence to treatment|3
1384754|NCT01364298|4569521|P1|Overall Study|Lack of adherence to treatment|1
1384755|NCT01364298|4569520|P2|Overall Study|Adverse Event|4
1384756|NCT01364298|4569521|P1|Overall Study|Adverse Event|3
1384757|NCT01363986|4569576|P1|Overall Study|Disease progression|1
1384758|NCT01363908|4569586|P2|Chronic Dosing (CD) Phase|Early study termination|3
1384759|NCT01363908|4569587|P1|Chronic Dosing (CD) Phase|Early study termination|9
1384760|NCT01363908|4569586|P2|Chronic Dosing (CD) Phase|Physician Decision|1
1384761|NCT01363908|4569587|P1|Chronic Dosing (CD) Phase|Physician Decision|0
1384762|NCT01363908|4569586|P2|Chronic Dosing (CD) Phase|Patient decision|1
1384763|NCT01363908|4569587|P1|Chronic Dosing (CD) Phase|Patient decision|0
1384764|NCT01363908|4569586|P2|Chronic Dosing (CD) Phase|Adverse Event|1
1384765|NCT01363908|4569587|P1|Chronic Dosing (CD) Phase|Adverse Event|1
1384766|NCT01363765|4569623|P2|Overall Study|smear during intervention|0
1384767|NCT01363765|4569624|P1|Overall Study|smear during intervention|2170
1384768|NCT01363765|4569623|P2|Overall Study|age not recorded (used for cross-linkage|354
1384769|NCT01363765|4569624|P1|Overall Study|age not recorded (used for cross-linkage|117
1384770|NCT01363765|4569623|P2|Overall Study|non-resident|76
1384771|NCT01363765|4569624|P1|Overall Study|non-resident|156
1384772|NCT01363765|4569623|P2|Overall Study|duplicate records|3177
1384773|NCT01363765|4569624|P1|Overall Study|duplicate records|736
1384774|NCT01363765|4569623|P2|Overall Study|non-diagnostic|1124
1384775|NCT01363765|4569624|P1|Overall Study|non-diagnostic|2621
1384776|NCT01363713|4569636|P1|Overall Study|Withdrawal by Subject|2
1384777|NCT01363713|4569636|P1|Overall Study|Protocol Violation|3
1384778|NCT01363713|4569636|P1|Overall Study|Adverse Event|1
1384779|NCT01363700|4569645|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
1384780|NCT01363700|4569646|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
1384781|NCT01363700|4569647|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
1384782|NCT01363700|4569648|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
1384783|NCT01363700|4569649|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
1384784|NCT01363661|4569668|P2|Overall Study|Lost to Follow-up|1
1384785|NCT01363661|4569669|P1|Overall Study|Lost to Follow-up|3
1384786|NCT01363661|4569668|P2|Overall Study|Protocol Violation|0
1384787|NCT01363661|4569669|P1|Overall Study|Protocol Violation|1
1384788|NCT01363661|4569668|P2|Overall Study|Withdrawal by Subject|1
1384789|NCT01363661|4569669|P1|Overall Study|Withdrawal by Subject|1
1384790|NCT01363661|4569668|P2|Overall Study|Adverse Event|2
1384791|NCT01363661|4569669|P1|Overall Study|Adverse Event|9
1384792|NCT01363440|4569710|P3|Overall Study|Other|2
1384793|NCT01363440|4569711|P2|Overall Study|Other|5
1384794|NCT01363440|4569712|P1|Overall Study|Other|4
1384795|NCT01363440|4569710|P3|Overall Study|Lost to Follow-up|5
1384796|NCT01363440|4569711|P2|Overall Study|Lost to Follow-up|4
1384797|NCT01363440|4569712|P1|Overall Study|Lost to Follow-up|2
1384798|NCT01363440|4569710|P3|Overall Study|Withdrawal by Subject|11
1384799|NCT01363440|4569711|P2|Overall Study|Withdrawal by Subject|11
1384800|NCT01363440|4569712|P1|Overall Study|Withdrawal by Subject|9
1384801|NCT01363440|4569710|P3|Overall Study|Death|5
1384802|NCT01363440|4569711|P2|Overall Study|Death|7
1384803|NCT01363440|4569712|P1|Overall Study|Death|3
1384804|NCT01363440|4569710|P3|Overall Study|Adverse Event|4
1384805|NCT01363440|4569711|P2|Overall Study|Adverse Event|4
1384806|NCT01363440|4569712|P1|Overall Study|Adverse Event|5
1384807|NCT01363349|4569758|P2|Overall Study|missing|2
1384808|NCT01363349|4569759|P1|Overall Study|missing|1
1384809|NCT01363349|4569758|P2|Overall Study|Not reported|37
1384810|NCT01363349|4569759|P1|Overall Study|Not reported|36
1384811|NCT01363349|4569758|P2|Overall Study|Lost to Follow-up|6
1384812|NCT01363349|4569759|P1|Overall Study|Lost to Follow-up|5
1384813|NCT01363349|4569758|P2|Overall Study|Withdrawal by Subject|6
1384814|NCT01363349|4569759|P1|Overall Study|Withdrawal by Subject|14
1384815|NCT01363349|4569758|P2|Overall Study|Non compliance/Protocol deviations|2
1384816|NCT01363349|4569759|P1|Overall Study|Non compliance/Protocol deviations|2
1384817|NCT01363349|4569758|P2|Overall Study|Lack of Efficacy|10
1384818|NCT01363349|4569759|P1|Overall Study|Lack of Efficacy|3
1384819|NCT01363349|4569758|P2|Overall Study|Adverse Event|7
1384820|NCT01363349|4569759|P1|Overall Study|Adverse Event|6
1384821|NCT01363297|4569770|P5|Overall Study|Death|30
1384822|NCT01363297|4569771|P4|Overall Study|Death|10
1384823|NCT01363297|4569772|P3|Overall Study|Death|6
1384824|NCT01363297|4569773|P2|Overall Study|Death|6
1384825|NCT01363297|4569774|P1|Overall Study|Death|3
1384826|NCT01363297|4569770|P5|Overall Study|Not specified|1
1384827|NCT01363297|4569771|P4|Overall Study|Not specified|0
1384828|NCT01363297|4569772|P3|Overall Study|Not specified|0
1384829|NCT01363297|4569773|P2|Overall Study|Not specified|0
1384830|NCT01363297|4569774|P1|Overall Study|Not specified|0
1384831|NCT01363076|4569877|P2|Overall Study|Withdrawal by Subject|1
1384832|NCT01363076|4569878|P1|Overall Study|Withdrawal by Subject|0
1384833|NCT01363011|4569910|P2|Extension Phase|Rolled Over to Another Gilead Study|1
1384834|NCT01363011|4569911|P1|Extension Phase|Rolled Over to Another Gilead Study|2
1384835|NCT01363011|4569910|P2|Extension Phase|Lost to Follow-up|2
1384836|NCT01363011|4569911|P1|Extension Phase|Lost to Follow-up|0
1384837|NCT01363011|4569910|P2|Extension Phase|Withdrew Consent|1
1384838|NCT01363011|4569911|P1|Extension Phase|Withdrew Consent|0
1384839|NCT01363011|4569910|P2|Extension Phase|Investigator's Discretion|2
1384840|NCT01363011|4569911|P1|Extension Phase|Investigator's Discretion|2
1384841|NCT01363011|4569910|P2|Extension Phase|Lack of Efficacy|1
1384842|NCT01363011|4569911|P1|Extension Phase|Lack of Efficacy|0
1384843|NCT01363011|4569910|P2|Extension Phase|Adverse Event|1
1384844|NCT01363011|4569911|P1|Extension Phase|Adverse Event|1
1384845|NCT01363011|4569910|P2|Main Study|Protocol Violation|1
1384846|NCT01363011|4569911|P1|Main Study|Protocol Violation|0
1384847|NCT01363011|4569910|P2|Main Study|Withdrew Consent|4
1384848|NCT01363011|4569911|P1|Main Study|Withdrew Consent|1
1384849|NCT01363011|4569910|P2|Main Study|Investigator's Discretion|1
1384850|NCT01363011|4569911|P1|Main Study|Investigator's Discretion|1
1384851|NCT01363011|4569910|P2|Main Study|Adverse Event|3
1384852|NCT01363011|4569911|P1|Main Study|Adverse Event|2
1384853|NCT01362608|4570036|P2|Overall Study|Adverse Event|2
1384854|NCT01362608|4570037|P1|Overall Study|Adverse Event|0
1384855|NCT01362608|4570036|P2|Overall Study|Lack of Efficacy|2
1384856|NCT01362608|4570037|P1|Overall Study|Lack of Efficacy|0
1384857|NCT01362608|4570036|P2|Overall Study|Withdrawal by Subject|2
1384858|NCT01362608|4570037|P1|Overall Study|Withdrawal by Subject|1
1384859|NCT01362608|4570036|P2|Overall Study|Lost to Follow-up|1
1384860|NCT01362608|4570037|P1|Overall Study|Lost to Follow-up|3
1384861|NCT01362608|4570036|P2|Overall Study|Protocol Violation|1
1384862|NCT01362608|4570037|P1|Overall Study|Protocol Violation|0
1384863|NCT01362530|4570075|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
1384864|NCT01362530|4570076|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
1384865|NCT01362530|4570075|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
1384866|NCT01362530|4570076|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
1384867|NCT01362530|4570075|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
1384868|NCT01362530|4570076|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
1384869|NCT01362530|4570075|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
1384870|NCT01362530|4570076|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
1384871|NCT01362530|4570075|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
1384872|NCT01362530|4570076|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
1384873|NCT01362530|4570075|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
1384874|NCT01362530|4570076|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
1384875|NCT01362530|4570075|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
1384876|NCT01362530|4570076|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
1384877|NCT01362530|4570075|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
1384878|NCT01362530|4570076|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
1384879|NCT01362530|4570075|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
1384880|NCT01362530|4570076|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
1384881|NCT01362530|4570075|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
1384882|NCT01362530|4570076|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
1384883|NCT01362530|4570075|P2|Base Study (Cycle 1)|Protocol Violation|0
1384884|NCT01362530|4570076|P1|Base Study (Cycle 1)|Protocol Violation|2
1384885|NCT01362530|4570075|P2|Base Study (Cycle 1)|Physician Decision|1
1384886|NCT01362530|4570076|P1|Base Study (Cycle 1)|Physician Decision|0
1384887|NCT01362530|4570075|P2|Base Study (Cycle 1)|Adverse Event|0
1384888|NCT01362530|4570076|P1|Base Study (Cycle 1)|Adverse Event|2
1384889|NCT01362517|4570089|P1|Overall Study|Lost to Follow-up|1
1384890|NCT01362517|4570089|P1|Overall Study|Protocol Violation|1
1384891|NCT01362491|4570100|P3|Overall Study|Ineligible|0
1384892|NCT01362491|4570101|P2|Overall Study|Ineligible|0
1384893|NCT01362491|4570102|P1|Overall Study|Ineligible|1
1384894|NCT01362439|4570150|P1|Overall Study|Participant who withdrew consent|8
1384895|NCT01362439|4570150|P1|Overall Study|Study medication non-compliant|1
1384896|NCT01362439|4570150|P1|Overall Study|Lost to Follow-up|2
1384897|NCT01362439|4570150|P1|Overall Study|Lack of Efficacy|3
1384898|NCT01362439|4570150|P1|Overall Study|Adverse Event|1
1384899|NCT01362348|4570165|P1|Overall Study|Study closed/terminated|5
1384900|NCT01362348|4570165|P1|Overall Study|Protocol-defined stopping criteria|9
1384901|NCT01362322|4570184|P2|Overall Study|Lost to Follow-up|6
1384902|NCT01362322|4570185|P1|Overall Study|Lost to Follow-up|2
1384903|NCT01362322|4570184|P2|Overall Study|Withdrawal by Subject|1
1384904|NCT01362322|4570185|P1|Overall Study|Withdrawal by Subject|3
1384905|NCT01362296|4570217|P4|Crossover Phase|Study Closed/Terminated|0
1384906|NCT01362296|4570218|P3|Crossover Phase|Study Closed/Terminated|1
1384907|NCT01362296|4570219|P2|Crossover Phase|Study Closed/Terminated|0
1384908|NCT01362296|4570220|P1|Crossover Phase|Study Closed/Terminated|0
1384909|NCT01362296|4570217|P4|Crossover Phase|Adverse Event|0
1384910|NCT01362296|4570218|P3|Crossover Phase|Adverse Event|4
1384911|NCT01362296|4570219|P2|Crossover Phase|Adverse Event|0
1384912|NCT01362296|4570220|P1|Crossover Phase|Adverse Event|0
1384913|NCT01362296|4570217|P4|Crossover Phase|Withdrawal by Subject|1
1384914|NCT01362296|4570218|P3|Crossover Phase|Withdrawal by Subject|2
1384915|NCT01362296|4570219|P2|Crossover Phase|Withdrawal by Subject|0
1384916|NCT01362296|4570220|P1|Crossover Phase|Withdrawal by Subject|0
1384917|NCT01362296|4570217|P4|Crossover Phase|PD including Death due to PD|1
1384918|NCT01362296|4570218|P3|Crossover Phase|PD including Death due to PD|16
1384919|NCT01362296|4570219|P2|Crossover Phase|PD including Death due to PD|0
1384920|NCT01362296|4570220|P1|Crossover Phase|PD including Death due to PD|0
1384921|NCT01362296|4570217|P4|Randomized Phase (RP)|Study Closed/Terminated|0
1384922|NCT01362296|4570218|P3|Randomized Phase (RP)|Study Closed/Terminated|0
1384923|NCT01362296|4570219|P2|Randomized Phase (RP)|Study Closed/Terminated|1
1384924|NCT01362296|4570220|P1|Randomized Phase (RP)|Study Closed/Terminated|8
1384925|NCT01362296|4570217|P4|Randomized Phase (RP)|Adverse Event|0
1384926|NCT01362296|4570218|P3|Randomized Phase (RP)|Adverse Event|0
1384927|NCT01362296|4570219|P2|Randomized Phase (RP)|Adverse Event|4
1384928|NCT01362296|4570220|P1|Randomized Phase (RP)|Adverse Event|20
1384929|NCT01362296|4570217|P4|Randomized Phase (RP)|Withdrawal by Subject|0
1384930|NCT01362296|4570218|P3|Randomized Phase (RP)|Withdrawal by Subject|0
1384931|NCT01362296|4570219|P2|Randomized Phase (RP)|Withdrawal by Subject|1
1384932|NCT01362296|4570220|P1|Randomized Phase (RP)|Withdrawal by Subject|2
1384933|NCT01362296|4570217|P4|Randomized Phase (RP)|Physician Decision|0
1384934|NCT01362296|4570218|P3|Randomized Phase (RP)|Physician Decision|0
1384935|NCT01362296|4570219|P2|Randomized Phase (RP)|Physician Decision|9
1384936|NCT01362296|4570220|P1|Randomized Phase (RP)|Physician Decision|1
1384937|NCT01362296|4570217|P4|Randomized Phase (RP)|PD including Death due to PD|0
1384938|NCT01362296|4570218|P3|Randomized Phase (RP)|PD including Death due to PD|0
1384939|NCT01362296|4570219|P2|Randomized Phase (RP)|PD including Death due to PD|28
1384940|NCT01362296|4570220|P1|Randomized Phase (RP)|PD including Death due to PD|56
1384941|NCT01362244|4570268|P2|Overall Study|Protocol Defined Stopping Criteria|1
1384942|NCT01362244|4570269|P1|Overall Study|Protocol Defined Stopping Criteria|0
1384943|NCT01362244|4570268|P2|Overall Study|Did not Meet Continuation Criteria|11
1384944|NCT01362244|4570269|P1|Overall Study|Did not Meet Continuation Criteria|17
1384945|NCT01362244|4570268|P2|Overall Study|Withdrawal by Subject|1
1384946|NCT01362244|4570269|P1|Overall Study|Withdrawal by Subject|2
1384947|NCT01362244|4570268|P2|Overall Study|Protocol Violation|1
1384948|NCT01362244|4570269|P1|Overall Study|Protocol Violation|5
1384949|NCT01362244|4570268|P2|Overall Study|Lost to Follow-up|2
1384950|NCT01362244|4570269|P1|Overall Study|Lost to Follow-up|0
1384951|NCT01362244|4570268|P2|Overall Study|Lack of Efficacy|11
1384952|NCT01362244|4570269|P1|Overall Study|Lack of Efficacy|5
1384953|NCT01362244|4570268|P2|Overall Study|Adverse Event|5
1384954|NCT01362244|4570269|P1|Overall Study|Adverse Event|3
1384955|NCT01362140|4570381|P2|Overall Study|Discontinued Without Receiving Treatment|1
1384956|NCT01362140|4570382|P1|Overall Study|Discontinued Without Receiving Treatment|0
1384957|NCT01362140|4570381|P2|Overall Study|Protocol-specified Criteria|2
1384958|NCT01362140|4570382|P1|Overall Study|Protocol-specified Criteria|1
1384959|NCT01362140|4570381|P2|Overall Study|Other|1
1384960|NCT01362140|4570382|P1|Overall Study|Other|1
1384961|NCT01362140|4570381|P2|Overall Study|Death|1
1384962|NCT01362140|4570382|P1|Overall Study|Death|2
1384963|NCT01362140|4570381|P2|Overall Study|Administrative Decision|1
1384964|NCT01362140|4570382|P1|Overall Study|Administrative Decision|0
1384965|NCT01362140|4570381|P2|Overall Study|Withdrawal by Subject|3
1384966|NCT01362140|4570382|P1|Overall Study|Withdrawal by Subject|3
1384967|NCT01362140|4570381|P2|Overall Study|Adverse Event|2
1384968|NCT01362140|4570382|P1|Overall Study|Adverse Event|2
1384969|NCT01362140|4570381|P2|Overall Study|Noncompliance|0
1384970|NCT01362140|4570382|P1|Overall Study|Noncompliance|1
1384971|NCT01362062|4570406|P2|Overall Study|Had significant improvement|0
1384972|NCT01362062|4570407|P1|Overall Study|Had significant improvement|9
1384973|NCT01362062|4570406|P2|Overall Study|Detected with Spondylo-arthritis|0
1384974|NCT01362062|4570407|P1|Overall Study|Detected with Spondylo-arthritis|1
1384975|NCT01362062|4570406|P2|Overall Study|Non-compliant participant|0
1384976|NCT01362062|4570407|P1|Overall Study|Non-compliant participant|2
1384977|NCT01362062|4570406|P2|Overall Study|Withdrawal by Subject|0
1384978|NCT01362062|4570407|P1|Overall Study|Withdrawal by Subject|2
1384979|NCT01362062|4570406|P2|Overall Study|Lost to Follow-up|0
1384980|NCT01362062|4570407|P1|Overall Study|Lost to Follow-up|11
1384981|NCT01362062|4570406|P2|Overall Study|Adverse Event|0
1384982|NCT01362062|4570407|P1|Overall Study|Adverse Event|1
1384983|NCT01362049|4570428|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
1384984|NCT01362049|4570429|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
1384985|NCT01362049|4570430|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
1384986|NCT01362049|4570431|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
1384987|NCT01362049|4570428|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
1384988|NCT01362049|4570429|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
1384989|NCT01362049|4570430|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
1384990|NCT01362049|4570431|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
1384991|NCT01361607|4570496|P2|Overall Study|Met Withdrawal Criteria|1
1384992|NCT01361607|4570497|P1|Overall Study|Met Withdrawal Criteria|1
1384993|NCT01361607|4570496|P2|Overall Study|Lost to Follow-up|0
1384994|NCT01361607|4570497|P1|Overall Study|Lost to Follow-up|1
1384995|NCT01361607|4570496|P2|Overall Study|Withdrawal by Investigator|3
1384996|NCT01361607|4570497|P1|Overall Study|Withdrawal by Investigator|5
1384997|NCT01361607|4570496|P2|Overall Study|Withdrawal by Subject|8
1384998|NCT01361607|4570497|P1|Overall Study|Withdrawal by Subject|19
1384999|NCT01361607|4570496|P2|Overall Study|Adverse Event|29
1385000|NCT01361607|4570497|P1|Overall Study|Adverse Event|38
1385001|NCT01361594|4570525|P2|Overall Study|Withdrawal by Subject|2
1385002|NCT01361594|4570526|P1|Overall Study|Withdrawal by Subject|1
1385003|NCT01361568|4570540|P6|Overall Study|Withdrawal by Subject|1
1385004|NCT01361568|4570541|P5|Overall Study|Withdrawal by Subject|0
1385005|NCT01361568|4570542|P4|Overall Study|Withdrawal by Subject|0
1385006|NCT01361568|4570543|P3|Overall Study|Withdrawal by Subject|0
1385007|NCT01361568|4570544|P2|Overall Study|Withdrawal by Subject|1
1385008|NCT01361568|4570545|P1|Overall Study|Withdrawal by Subject|2
1385009|NCT01361568|4570540|P6|Overall Study|Physician Decision|1
1385010|NCT01361568|4570541|P5|Overall Study|Physician Decision|0
1385011|NCT01361568|4570542|P4|Overall Study|Physician Decision|0
1385012|NCT01361568|4570543|P3|Overall Study|Physician Decision|0
1385013|NCT01361568|4570544|P2|Overall Study|Physician Decision|0
1385014|NCT01361568|4570545|P1|Overall Study|Physician Decision|0
1385015|NCT01361568|4570540|P6|Overall Study|Adverse Event|0
1385016|NCT01361568|4570541|P5|Overall Study|Adverse Event|1
1385017|NCT01361568|4570542|P4|Overall Study|Adverse Event|0
1385018|NCT01361568|4570543|P3|Overall Study|Adverse Event|0
1385019|NCT01361568|4570544|P2|Overall Study|Adverse Event|0
1385020|NCT01361568|4570545|P1|Overall Study|Adverse Event|0
1385021|NCT01361464|4570575|P1|Overall Study|Withdrawal by Subject|2
1385022|NCT01361464|4570575|P1|Overall Study|Death|1
1385023|NCT01361308|4570584|P2|Overall Study|Not Specified|1
1385024|NCT01361308|4570585|P1|Overall Study|Not Specified|0
1385025|NCT01361308|4570584|P2|Overall Study|Failed C-SSRS|2
1385026|NCT01361308|4570585|P1|Overall Study|Failed C-SSRS|5
1385027|NCT01361308|4570584|P2|Overall Study|Eligibility Criteria Not Met|3
1385028|NCT01361308|4570585|P1|Overall Study|Eligibility Criteria Not Met|2
1385029|NCT01361308|4570584|P2|Overall Study|Adverse Event|4
1385030|NCT01361308|4570585|P1|Overall Study|Adverse Event|8
1385031|NCT01361308|4570584|P2|Overall Study|Lost to Follow-up|4
1385032|NCT01361308|4570585|P1|Overall Study|Lost to Follow-up|5
1385033|NCT01361308|4570584|P2|Overall Study|Protocol Violation|0
1385034|NCT01361308|4570585|P1|Overall Study|Protocol Violation|1
1385035|NCT01361308|4570584|P2|Overall Study|Lack of Efficacy|0
1385036|NCT01361308|4570585|P1|Overall Study|Lack of Efficacy|2
1385037|NCT01361308|4570584|P2|Overall Study|Physician Decision|3
1385038|NCT01361308|4570585|P1|Overall Study|Physician Decision|3
1385039|NCT01361308|4570584|P2|Overall Study|Withdrawal by Subject|13
1385040|NCT01361308|4570585|P1|Overall Study|Withdrawal by Subject|9
1385041|NCT01361178|4570633|P2|Overall Study|Death|0
1385042|NCT01361178|4570634|P1|Overall Study|Death|13
1385043|NCT01361126|4570642|P2|Overall Study|Sponsor decision|2
1385044|NCT01361126|4570643|P1|Overall Study|Sponsor decision|0
1385045|NCT01361009|4570682|P1|Overall Study|Protocol Violation|116
1385046|NCT01360996|4570692|P3|Overall Study|Noncompliant|0
1385047|NCT01360996|4570693|P2|Overall Study|Noncompliant|0
1385048|NCT01360996|4570694|P1|Overall Study|Noncompliant|2
1385049|NCT01360996|4570692|P3|Overall Study|Withdrawal by Subject|2
1385050|NCT01360996|4570693|P2|Overall Study|Withdrawal by Subject|3
1385051|NCT01360996|4570694|P1|Overall Study|Withdrawal by Subject|4
1385052|NCT01360840|4570716|P3|Overall Study|Ongoing at data cut-off|9
1385053|NCT01360840|4570717|P2|Overall Study|Ongoing at data cut-off|10
1385054|NCT01360840|4570718|P1|Overall Study|Ongoing at data cut-off|10
1385055|NCT01360645|4570770|P4|Phase A+|Protocol Deviation|4
1385056|NCT01360645|4570771|P3|Phase A+|Protocol Deviation|0
1385057|NCT01360645|4570772|P2|Phase A+|Protocol Deviation|0
1385058|NCT01360645|4570773|P1|Phase A+|Protocol Deviation|0
1385059|NCT01360645|4570770|P4|Phase A+|Withdrawal by Subject|5
1385060|NCT01360645|4570771|P3|Phase A+|Withdrawal by Subject|0
1385061|NCT01360645|4570772|P2|Phase A+|Withdrawal by Subject|0
1385062|NCT01360645|4570773|P1|Phase A+|Withdrawal by Subject|0
1385063|NCT01360645|4570770|P4|Phase A+|Physician Decision|2
1385064|NCT01360645|4570771|P3|Phase A+|Physician Decision|0
1385065|NCT01360645|4570772|P2|Phase A+|Physician Decision|0
1385066|NCT01360645|4570773|P1|Phase A+|Physician Decision|0
1385067|NCT01360645|4570770|P4|Phase A+|Met Withdrawal Criteria|4
1385068|NCT01360645|4570771|P3|Phase A+|Met Withdrawal Criteria|0
1385069|NCT01360645|4570772|P2|Phase A+|Met Withdrawal Criteria|0
1385070|NCT01360645|4570773|P1|Phase A+|Met Withdrawal Criteria|0
1385071|NCT01360645|4570770|P4|Phase A+|Adverse Event|2
1385072|NCT01360645|4570771|P3|Phase A+|Adverse Event|0
1385073|NCT01360645|4570772|P2|Phase A+|Adverse Event|0
1385074|NCT01360645|4570773|P1|Phase A+|Adverse Event|0
1385075|NCT01360645|4570770|P4|Phase A+|Lost to Follow-up|7
1385076|NCT01360645|4570771|P3|Phase A+|Lost to Follow-up|0
1385077|NCT01360645|4570772|P2|Phase A+|Lost to Follow-up|0
1385078|NCT01360645|4570773|P1|Phase A+|Lost to Follow-up|0
1385079|NCT01360645|4570770|P4|Phase B (6 Weeks)|Protocol Deviation|0
1385080|NCT01360645|4570771|P3|Phase B (6 Weeks)|Protocol Deviation|3
1385081|NCT01360645|4570772|P2|Phase B (6 Weeks)|Protocol Deviation|1
1385082|NCT01360645|4570773|P1|Phase B (6 Weeks)|Protocol Deviation|0
1385083|NCT01360645|4570770|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
1385084|NCT01360645|4570771|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
1385085|NCT01360645|4570772|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
1385086|NCT01360645|4570773|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
1385087|NCT01360645|4570770|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
1385088|NCT01360645|4570771|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
1385089|NCT01360645|4570772|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
1385090|NCT01360645|4570773|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
1385091|NCT01360645|4570770|P4|Phase B (6 Weeks)|Adverse Event|0
1385092|NCT01360645|4570771|P3|Phase B (6 Weeks)|Adverse Event|0
1385093|NCT01360645|4570772|P2|Phase B (6 Weeks)|Adverse Event|6
1385094|NCT01360645|4570773|P1|Phase B (6 Weeks)|Adverse Event|0
1385095|NCT01360645|4570770|P4|Phase B (6 Weeks)|Lost to Follow-up|0
1385096|NCT01360645|4570771|P3|Phase B (6 Weeks)|Lost to Follow-up|0
1385097|NCT01360645|4570772|P2|Phase B (6 Weeks)|Lost to Follow-up|1
1385098|NCT01360645|4570773|P1|Phase B (6 Weeks)|Lost to Follow-up|0
1385099|NCT01360645|4570770|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
1385100|NCT01360645|4570771|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
1385101|NCT01360645|4570772|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
1385102|NCT01360645|4570773|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
1385103|NCT01360645|4570770|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
1385104|NCT01360645|4570771|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
1385105|NCT01360645|4570772|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
1385106|NCT01360645|4570773|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
1385107|NCT01360645|4570770|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
1385108|NCT01360645|4570771|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
1385109|NCT01360645|4570772|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
1385110|NCT01360645|4570773|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
1385111|NCT01360645|4570770|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
1385112|NCT01360645|4570771|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
1385113|NCT01360645|4570772|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
1385114|NCT01360645|4570773|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
1385115|NCT01360645|4570770|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
1385116|NCT01360645|4570771|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
1385117|NCT01360645|4570772|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
1385118|NCT01360645|4570773|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
1385119|NCT01360645|4570770|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
1385120|NCT01360645|4570771|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
1385121|NCT01360645|4570772|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
1385122|NCT01360645|4570773|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
1385123|NCT01360632|4570828|P5|Phase A+|Protocol Deviation|3
1385124|NCT01360632|4570829|P4|Phase A+|Protocol Deviation|0
1385125|NCT01360632|4570830|P3|Phase A+|Protocol Deviation|0
1385126|NCT01360632|4570831|P2|Phase A+|Protocol Deviation|0
1385127|NCT01360632|4570832|P1|Phase A+|Protocol Deviation|0
1385128|NCT01360632|4570828|P5|Phase A+|Withdrawal by Subject|8
1385129|NCT01360632|4570829|P4|Phase A+|Withdrawal by Subject|0
1385130|NCT01360632|4570830|P3|Phase A+|Withdrawal by Subject|0
1385131|NCT01360632|4570831|P2|Phase A+|Withdrawal by Subject|0
1385132|NCT01360632|4570832|P1|Phase A+|Withdrawal by Subject|0
1385133|NCT01360632|4570828|P5|Phase A+|Physician Decision|3
1385134|NCT01360632|4570829|P4|Phase A+|Physician Decision|0
1385135|NCT01360632|4570830|P3|Phase A+|Physician Decision|0
1385136|NCT01360632|4570831|P2|Phase A+|Physician Decision|0
1385137|NCT01360632|4570832|P1|Phase A+|Physician Decision|0
1385138|NCT01360632|4570828|P5|Phase A+|Met Withdrawal Criteria|7
1385139|NCT01360632|4570829|P4|Phase A+|Met Withdrawal Criteria|0
1385140|NCT01360632|4570830|P3|Phase A+|Met Withdrawal Criteria|0
1385141|NCT01360632|4570831|P2|Phase A+|Met Withdrawal Criteria|0
1385142|NCT01360632|4570832|P1|Phase A+|Met Withdrawal Criteria|0
1385143|NCT01360632|4570828|P5|Phase A+|Adverse Event|2
1385144|NCT01360632|4570829|P4|Phase A+|Adverse Event|0
1385145|NCT01360632|4570830|P3|Phase A+|Adverse Event|0
1385146|NCT01360632|4570831|P2|Phase A+|Adverse Event|0
1385147|NCT01360632|4570832|P1|Phase A+|Adverse Event|0
1385148|NCT01360632|4570828|P5|Phase A+|Lost to Follow-up|2
1385149|NCT01360632|4570829|P4|Phase A+|Lost to Follow-up|0
1385150|NCT01360632|4570830|P3|Phase A+|Lost to Follow-up|0
1385151|NCT01360632|4570831|P2|Phase A+|Lost to Follow-up|0
1385152|NCT01360632|4570832|P1|Phase A+|Lost to Follow-up|0
1385153|NCT01360632|4570828|P5|Phase B (6 Weeks)|Lack of Efficacy|0
1385154|NCT01360632|4570829|P4|Phase B (6 Weeks)|Lack of Efficacy|0
1385155|NCT01360632|4570830|P3|Phase B (6 Weeks)|Lack of Efficacy|0
1385156|NCT01360632|4570831|P2|Phase B (6 Weeks)|Lack of Efficacy|1
1385157|NCT01360632|4570832|P1|Phase B (6 Weeks)|Lack of Efficacy|0
1385158|NCT01360632|4570828|P5|Phase B (6 Weeks)|Protocol Deviation|0
1385159|NCT01360632|4570829|P4|Phase B (6 Weeks)|Protocol Deviation|1
1385160|NCT01360632|4570830|P3|Phase B (6 Weeks)|Protocol Deviation|4
1385161|NCT01360632|4570831|P2|Phase B (6 Weeks)|Protocol Deviation|1
1385162|NCT01360632|4570832|P1|Phase B (6 Weeks)|Protocol Deviation|0
1385163|NCT01360632|4570828|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
1385164|NCT01360632|4570829|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
1385165|NCT01360632|4570830|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
1385166|NCT01360632|4570831|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
1385167|NCT01360632|4570832|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
1385168|NCT01360632|4570828|P5|Phase B (6 Weeks)|Physician Decision|0
1385169|NCT01360632|4570829|P4|Phase B (6 Weeks)|Physician Decision|1
1385170|NCT01360632|4570830|P3|Phase B (6 Weeks)|Physician Decision|0
1385171|NCT01360632|4570831|P2|Phase B (6 Weeks)|Physician Decision|0
1385172|NCT01360632|4570832|P1|Phase B (6 Weeks)|Physician Decision|0
1385173|NCT01360632|4570828|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
1385174|NCT01360632|4570829|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
1385175|NCT01360632|4570830|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
1385176|NCT01360632|4570831|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
1385177|NCT01360632|4570832|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
1385178|NCT01360632|4570828|P5|Phase B (6 Weeks)|Adverse Event|0
1385179|NCT01360632|4570829|P4|Phase B (6 Weeks)|Adverse Event|3
1385180|NCT01360632|4570830|P3|Phase B (6 Weeks)|Adverse Event|9
1385181|NCT01360632|4570831|P2|Phase B (6 Weeks)|Adverse Event|3
1385182|NCT01360632|4570832|P1|Phase B (6 Weeks)|Adverse Event|0
1385183|NCT01360632|4570828|P5|Phase B (6 Weeks)|Lost to Follow-up|0
1385184|NCT01360632|4570829|P4|Phase B (6 Weeks)|Lost to Follow-up|0
1385185|NCT01360632|4570830|P3|Phase B (6 Weeks)|Lost to Follow-up|1
1385186|NCT01360632|4570831|P2|Phase B (6 Weeks)|Lost to Follow-up|1
1385187|NCT01360632|4570832|P1|Phase B (6 Weeks)|Lost to Follow-up|0
1385188|NCT01360632|4570828|P5|Phase A (8 Weeks)|Protocol Deviation|0
1385189|NCT01360632|4570829|P4|Phase A (8 Weeks)|Protocol Deviation|0
1385190|NCT01360632|4570830|P3|Phase A (8 Weeks)|Protocol Deviation|0
1385191|NCT01360632|4570831|P2|Phase A (8 Weeks)|Protocol Deviation|0
1385192|NCT01360632|4570832|P1|Phase A (8 Weeks)|Protocol Deviation|39
1385193|NCT01360632|4570828|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
1385194|NCT01360632|4570829|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
1385195|NCT01360632|4570830|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
1385196|NCT01360632|4570831|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
1385197|NCT01360632|4570832|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
1385198|NCT01360632|4570828|P5|Phase A (8 Weeks)|Physician Decision|0
1385199|NCT01360632|4570829|P4|Phase A (8 Weeks)|Physician Decision|0
1385200|NCT01360632|4570830|P3|Phase A (8 Weeks)|Physician Decision|0
1385201|NCT01360632|4570831|P2|Phase A (8 Weeks)|Physician Decision|0
1385202|NCT01360632|4570832|P1|Phase A (8 Weeks)|Physician Decision|10
1385203|NCT01360632|4570828|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
1385204|NCT01360632|4570829|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
1385205|NCT01360632|4570830|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
1385206|NCT01360632|4570831|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
1385207|NCT01360632|4570832|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
1385208|NCT01360632|4570828|P5|Phase A (8 Weeks)|Adverse Event|0
1385209|NCT01360632|4570829|P4|Phase A (8 Weeks)|Adverse Event|0
1385210|NCT01360632|4570830|P3|Phase A (8 Weeks)|Adverse Event|0
1385211|NCT01360632|4570831|P2|Phase A (8 Weeks)|Adverse Event|0
1385212|NCT01360632|4570832|P1|Phase A (8 Weeks)|Adverse Event|60
1385213|NCT01360632|4570828|P5|Phase A (8 Weeks)|Lost to Follow-up|0
1385214|NCT01360632|4570829|P4|Phase A (8 Weeks)|Lost to Follow-up|0
1385215|NCT01360632|4570830|P3|Phase A (8 Weeks)|Lost to Follow-up|0
1385216|NCT01360632|4570831|P2|Phase A (8 Weeks)|Lost to Follow-up|0
1385217|NCT01360632|4570832|P1|Phase A (8 Weeks)|Lost to Follow-up|27
1385218|NCT01360554|4570911|P2|Overall Study|Randomized but not treated.|3
1385219|NCT01360554|4570912|P1|Overall Study|Randomized but not treated.|3
1385220|NCT01360554|4570911|P2|Overall Study|Other, not specified|0
1385221|NCT01360554|4570912|P1|Overall Study|Other, not specified|1
1385222|NCT01360554|4570911|P2|Overall Study|Study terminated by sponsor|37
1385223|NCT01360554|4570912|P1|Overall Study|Study terminated by sponsor|49
1385224|NCT01360554|4570911|P2|Overall Study|Withdrawal by Subject|24
1385225|NCT01360554|4570912|P1|Overall Study|Withdrawal by Subject|23
1385226|NCT01360554|4570911|P2|Overall Study|Lost to Follow-up|4
1385227|NCT01360554|4570912|P1|Overall Study|Lost to Follow-up|4
1385228|NCT01360554|4570911|P2|Overall Study|Death|371
1385229|NCT01360554|4570912|P1|Overall Study|Death|359
1385230|NCT01360021|4570964|P3|Overall Study|Adverse Event|3
1385231|NCT01360021|4570965|P2|Overall Study|Adverse Event|3
1385232|NCT01360021|4570966|P1|Overall Study|Adverse Event|2
1385233|NCT01360021|4570964|P3|Overall Study|Withdrawal by Subject|2
1385234|NCT01360021|4570965|P2|Overall Study|Withdrawal by Subject|0
1385235|NCT01360021|4570966|P1|Overall Study|Withdrawal by Subject|4
1385236|NCT01360021|4570964|P3|Overall Study|Protocol Violation|1
1385237|NCT01360021|4570965|P2|Overall Study|Protocol Violation|0
1385238|NCT01360021|4570966|P1|Overall Study|Protocol Violation|0
1385239|NCT01360021|4570964|P3|Overall Study|Eligibility criteria + other|1
1385240|NCT01360021|4570965|P2|Overall Study|Eligibility criteria + other|1
1385241|NCT01360021|4570966|P1|Overall Study|Eligibility criteria + other|2
1385242|NCT01359943|4570992|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
1385243|NCT01359943|4570993|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
1385244|NCT01359943|4570994|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
1385245|NCT01359943|4570992|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
1385246|NCT01359943|4570993|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
1385247|NCT01359943|4570994|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
1385248|NCT01359943|4570992|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
1385249|NCT01359943|4570993|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
1385250|NCT01359943|4570994|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
1385251|NCT01359943|4570992|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
1385252|NCT01359943|4570993|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
1385253|NCT01359943|4570994|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
1385254|NCT01359943|4570992|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
1385255|NCT01359943|4570993|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
1385256|NCT01359943|4570994|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
1385257|NCT01359943|4570992|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
1385258|NCT01359943|4570993|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
1385259|NCT01359943|4570994|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
1385260|NCT01359943|4570992|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
1385261|NCT01359943|4570993|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
1385262|NCT01359943|4570994|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
1385263|NCT01359943|4570992|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
1385264|NCT01359943|4570993|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
1385265|NCT01359943|4570994|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
1385266|NCT01359943|4570992|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
1385267|NCT01359943|4570993|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
1385268|NCT01359943|4570994|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
1385269|NCT01359943|4570992|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
1385270|NCT01359943|4570993|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
1385271|NCT01359943|4570994|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
1385272|NCT01359943|4570992|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
1385273|NCT01359943|4570993|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
1385274|NCT01359943|4570994|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
1385275|NCT01359943|4570992|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
1385276|NCT01359943|4570993|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
1385277|NCT01359943|4570994|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
1385278|NCT01359943|4570992|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
1385279|NCT01359943|4570993|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
1385280|NCT01359943|4570994|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
1385281|NCT01359943|4570992|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
1385282|NCT01359943|4570993|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
1385283|NCT01359943|4570994|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
1385284|NCT01359943|4570992|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
1385285|NCT01359943|4570993|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
1385286|NCT01359943|4570994|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
1385287|NCT01359904|4571042|P2|Overall Study|Withdrawal by Subject|0
1385288|NCT01359904|4571043|P1|Overall Study|Withdrawal by Subject|1
1385289|NCT01359644|4571097|P10|Follow-up Period|Lost to Follow-up|0
1385290|NCT01359644|4571098|P9|Follow-up Period|Lost to Follow-up|0
1385291|NCT01359644|4571099|P8|Follow-up Period|Lost to Follow-up|2
1385292|NCT01359644|4571100|P7|Follow-up Period|Lost to Follow-up|1
1385293|NCT01359644|4571101|P6|Follow-up Period|Lost to Follow-up|0
1385294|NCT01359644|4571102|P5|Follow-up Period|Lost to Follow-up|0
1385295|NCT01359644|4571103|P4|Follow-up Period|Lost to Follow-up|0
1385296|NCT01359644|4571104|P3|Follow-up Period|Lost to Follow-up|0
1385297|NCT01359644|4571105|P2|Follow-up Period|Lost to Follow-up|0
1385298|NCT01359644|4571106|P1|Follow-up Period|Lost to Follow-up|0
1385299|NCT01359644|4571097|P10|Follow-up Period|Withdrawal by Subject|0
1385300|NCT01359644|4571098|P9|Follow-up Period|Withdrawal by Subject|0
1385301|NCT01359644|4571099|P8|Follow-up Period|Withdrawal by Subject|0
1385302|NCT01359644|4571100|P7|Follow-up Period|Withdrawal by Subject|0
1385303|NCT01359644|4571101|P6|Follow-up Period|Withdrawal by Subject|1
1385304|NCT01359644|4571102|P5|Follow-up Period|Withdrawal by Subject|0
1385305|NCT01359644|4571103|P4|Follow-up Period|Withdrawal by Subject|0
1385306|NCT01359644|4571104|P3|Follow-up Period|Withdrawal by Subject|0
1385307|NCT01359644|4571105|P2|Follow-up Period|Withdrawal by Subject|0
1385308|NCT01359644|4571106|P1|Follow-up Period|Withdrawal by Subject|0
1385309|NCT01359644|4571097|P10|Treatment Period|Lost to Follow-up|0
1385310|NCT01359644|4571098|P9|Treatment Period|Lost to Follow-up|0
1385311|NCT01359644|4571099|P8|Treatment Period|Lost to Follow-up|0
1385312|NCT01359644|4571100|P7|Treatment Period|Lost to Follow-up|0
1385313|NCT01359644|4571101|P6|Treatment Period|Lost to Follow-up|1
1385314|NCT01359644|4571102|P5|Treatment Period|Lost to Follow-up|0
1385315|NCT01359644|4571103|P4|Treatment Period|Lost to Follow-up|0
1385316|NCT01359644|4571104|P3|Treatment Period|Lost to Follow-up|0
1385317|NCT01359644|4571105|P2|Treatment Period|Lost to Follow-up|0
1385318|NCT01359644|4571106|P1|Treatment Period|Lost to Follow-up|0
1385319|NCT01359644|4571097|P10|Treatment Period|Adverse Event|0
1385320|NCT01359644|4571098|P9|Treatment Period|Adverse Event|0
1385321|NCT01359644|4571099|P8|Treatment Period|Adverse Event|0
1385322|NCT01359644|4571100|P7|Treatment Period|Adverse Event|0
1385323|NCT01359644|4571101|P6|Treatment Period|Adverse Event|1
1385324|NCT01359644|4571102|P5|Treatment Period|Adverse Event|0
1385325|NCT01359644|4571103|P4|Treatment Period|Adverse Event|0
1385326|NCT01359644|4571104|P3|Treatment Period|Adverse Event|1
1385327|NCT01359644|4571105|P2|Treatment Period|Adverse Event|0
1385328|NCT01359644|4571106|P1|Treatment Period|Adverse Event|0
1385329|NCT01359644|4571097|P10|Treatment Period|Lack of Efficacy|0
1385330|NCT01359644|4571098|P9|Treatment Period|Lack of Efficacy|0
1385331|NCT01359644|4571099|P8|Treatment Period|Lack of Efficacy|0
1385332|NCT01359644|4571100|P7|Treatment Period|Lack of Efficacy|0
1385333|NCT01359644|4571101|P6|Treatment Period|Lack of Efficacy|0
1385334|NCT01359644|4571102|P5|Treatment Period|Lack of Efficacy|0
1385335|NCT01359644|4571103|P4|Treatment Period|Lack of Efficacy|0
1385336|NCT01359644|4571104|P3|Treatment Period|Lack of Efficacy|0
1385337|NCT01359644|4571105|P2|Treatment Period|Lack of Efficacy|1
1385338|NCT01359644|4571106|P1|Treatment Period|Lack of Efficacy|0
1385339|NCT01359449|4571150|P2|Overall Study|Withdrawal by Subject|2
1385340|NCT01359449|4571151|P1|Overall Study|Withdrawal by Subject|3
1385341|NCT01359449|4571150|P2|Overall Study|Protocol Violation|2
1385342|NCT01359449|4571151|P1|Overall Study|Protocol Violation|0
1385343|NCT01359449|4571150|P2|Overall Study|Lost to Follow-up|0
1385344|NCT01359449|4571151|P1|Overall Study|Lost to Follow-up|1
1385345|NCT01359254|4571197|P2|Overall Study|Death|0
1385346|NCT01359254|4571198|P1|Overall Study|Death|1
1385347|NCT01359150|4571208|P2|Overall Study|Other|0
1385348|NCT01359150|4571209|P1|Overall Study|Other|1
1385349|NCT01359150|4571208|P2|Overall Study|Adverse Event|3
1385350|NCT01359150|4571209|P1|Overall Study|Adverse Event|4
1385351|NCT01359150|4571208|P2|Overall Study|Withdrawal by Subject|1
1385352|NCT01359150|4571209|P1|Overall Study|Withdrawal by Subject|1
1385353|NCT01359150|4571208|P2|Overall Study|Lack of Efficacy|1
1385354|NCT01359150|4571209|P1|Overall Study|Lack of Efficacy|1
1385355|NCT01358877|4571248|P2|Overall Study|Other|129
1385356|NCT01358877|4571249|P1|Overall Study|Other|142
1385357|NCT01358877|4571248|P2|Overall Study|Ongoing follow-up for overall survival|5
1385358|NCT01358877|4571249|P1|Overall Study|Ongoing follow-up for overall survival|7
1385359|NCT01358877|4571248|P2|Overall Study|Ongoing follow-up for IDFS event|2073
1385360|NCT01358877|4571249|P1|Overall Study|Ongoing follow-up for IDFS event|2084
1385361|NCT01358877|4571248|P2|Overall Study|Ongoing follow-up for post-recurrence|108
1385362|NCT01358877|4571249|P1|Overall Study|Ongoing follow-up for post-recurrence|87
1385363|NCT01358877|4571248|P2|Overall Study|Death|89
1385364|NCT01358877|4571249|P1|Overall Study|Death|80
1385365|NCT01358864|4571319|P8|Overall Study|Not treated|0
1385366|NCT01358864|4571320|P7|Overall Study|Not treated|1
1385367|NCT01358864|4571321|P6|Overall Study|Not treated|0
1385368|NCT01358864|4571322|P5|Overall Study|Not treated|0
1385369|NCT01358864|4571323|P4|Overall Study|Not treated|0
1385370|NCT01358864|4571324|P3|Overall Study|Not treated|0
1385371|NCT01358864|4571325|P2|Overall Study|Not treated|0
1385372|NCT01358864|4571326|P1|Overall Study|Not treated|0
1385373|NCT01358864|4571319|P8|Overall Study|Other reason not defined above|0
1385374|NCT01358864|4571320|P7|Overall Study|Other reason not defined above|2
1385375|NCT01358864|4571321|P6|Overall Study|Other reason not defined above|0
1385376|NCT01358864|4571322|P5|Overall Study|Other reason not defined above|0
1385377|NCT01358864|4571323|P4|Overall Study|Other reason not defined above|0
1385378|NCT01358864|4571324|P3|Overall Study|Other reason not defined above|0
1385379|NCT01358864|4571325|P2|Overall Study|Other reason not defined above|0
1385380|NCT01358864|4571326|P1|Overall Study|Other reason not defined above|2
1385381|NCT01358864|4571319|P8|Overall Study|Withdrawal by Subject|3
1385382|NCT01358864|4571320|P7|Overall Study|Withdrawal by Subject|1
1385383|NCT01358864|4571321|P6|Overall Study|Withdrawal by Subject|1
1385384|NCT01358864|4571322|P5|Overall Study|Withdrawal by Subject|0
1385385|NCT01358864|4571323|P4|Overall Study|Withdrawal by Subject|0
1385386|NCT01358864|4571324|P3|Overall Study|Withdrawal by Subject|2
1385387|NCT01358864|4571325|P2|Overall Study|Withdrawal by Subject|4
1385388|NCT01358864|4571326|P1|Overall Study|Withdrawal by Subject|3
1385389|NCT01358864|4571319|P8|Overall Study|Lost to Follow-up|1
1385390|NCT01358864|4571320|P7|Overall Study|Lost to Follow-up|0
1385391|NCT01358864|4571321|P6|Overall Study|Lost to Follow-up|0
1385392|NCT01358864|4571322|P5|Overall Study|Lost to Follow-up|0
1385393|NCT01358864|4571323|P4|Overall Study|Lost to Follow-up|0
1385394|NCT01358864|4571324|P3|Overall Study|Lost to Follow-up|1
1385395|NCT01358864|4571325|P2|Overall Study|Lost to Follow-up|0
1385396|NCT01358864|4571326|P1|Overall Study|Lost to Follow-up|0
1385397|NCT01358864|4571319|P8|Overall Study|Lack of Efficacy|44
1385398|NCT01358864|4571320|P7|Overall Study|Lack of Efficacy|49
1385399|NCT01358864|4571321|P6|Overall Study|Lack of Efficacy|4
1385400|NCT01358864|4571322|P5|Overall Study|Lack of Efficacy|7
1385401|NCT01358864|4571323|P4|Overall Study|Lack of Efficacy|19
1385402|NCT01358864|4571324|P3|Overall Study|Lack of Efficacy|4
1385403|NCT01358864|4571325|P2|Overall Study|Lack of Efficacy|3
1385404|NCT01358864|4571326|P1|Overall Study|Lack of Efficacy|26
1385405|NCT01358864|4571319|P8|Overall Study|Adverse Event|7
1385406|NCT01358864|4571320|P7|Overall Study|Adverse Event|12
1385407|NCT01358864|4571321|P6|Overall Study|Adverse Event|8
1385408|NCT01358864|4571322|P5|Overall Study|Adverse Event|4
1385409|NCT01358864|4571323|P4|Overall Study|Adverse Event|0
1385410|NCT01358864|4571324|P3|Overall Study|Adverse Event|9
1385411|NCT01358864|4571325|P2|Overall Study|Adverse Event|6
1385412|NCT01358864|4571326|P1|Overall Study|Adverse Event|0
1385413|NCT01358825|4571417|P2|Overall Study|Blood sample not drawn|1
1385414|NCT01358825|4571418|P1|Overall Study|Blood sample not drawn|0
1385415|NCT01358760|4571442|P3|Overall Study|Entry criteria not met/Non-compliance|16
1385416|NCT01358760|4571443|P2|Overall Study|Entry criteria not met/Non-compliance|12
1385417|NCT01358760|4571444|P1|Overall Study|Entry criteria not met/Non-compliance|12
1385418|NCT01358760|4571442|P3|Overall Study|Physician Decision|1
1385419|NCT01358760|4571443|P2|Overall Study|Physician Decision|0
1385420|NCT01358760|4571444|P1|Overall Study|Physician Decision|1
1385421|NCT01358760|4571442|P3|Overall Study|Withdrawal by Subject|2
1385422|NCT01358760|4571443|P2|Overall Study|Withdrawal by Subject|3
1385423|NCT01358760|4571444|P1|Overall Study|Withdrawal by Subject|5
1385424|NCT01358760|4571442|P3|Overall Study|Lost to Follow-up|3
1385425|NCT01358760|4571443|P2|Overall Study|Lost to Follow-up|1
1385426|NCT01358760|4571444|P1|Overall Study|Lost to Follow-up|1
1385427|NCT01358760|4571442|P3|Overall Study|Adverse Event|3
1385428|NCT01358760|4571443|P2|Overall Study|Adverse Event|4
1385429|NCT01358760|4571444|P1|Overall Study|Adverse Event|3
1385430|NCT01358734|4571479|P3|Overall Study|Not Specified|4
1385431|NCT01358734|4571480|P2|Overall Study|Not Specified|5
1385432|NCT01358734|4571481|P1|Overall Study|Not Specified|2
1385433|NCT01358734|4571479|P3|Overall Study|Non-compliance with study drug|1
1385434|NCT01358734|4571480|P2|Overall Study|Non-compliance with study drug|0
1385435|NCT01358734|4571481|P1|Overall Study|Non-compliance with study drug|0
1385436|NCT01358734|4571479|P3|Overall Study|Progressive Disease|13
1385437|NCT01358734|4571480|P2|Overall Study|Progressive Disease|11
1385438|NCT01358734|4571481|P1|Overall Study|Progressive Disease|5
1385439|NCT01358734|4571479|P3|Overall Study|Death|2
1385440|NCT01358734|4571480|P2|Overall Study|Death|7
1385441|NCT01358734|4571481|P1|Overall Study|Death|3
1385442|NCT01358734|4571479|P3|Overall Study|Withdrawal by Subject|3
1385443|NCT01358734|4571480|P2|Overall Study|Withdrawal by Subject|6
1385444|NCT01358734|4571481|P1|Overall Study|Withdrawal by Subject|1
1385445|NCT01358734|4571479|P3|Overall Study|Lack of Efficacy|3
1385446|NCT01358734|4571480|P2|Overall Study|Lack of Efficacy|1
1385447|NCT01358734|4571481|P1|Overall Study|Lack of Efficacy|0
1385448|NCT01358734|4571479|P3|Overall Study|Adverse Event|3
1385449|NCT01358734|4571480|P2|Overall Study|Adverse Event|7
1385450|NCT01358734|4571481|P1|Overall Study|Adverse Event|4
1385451|NCT01358708|4571500|P2|Double-Blind Treatment Phase|Protocol Violation|0
1385452|NCT01358708|4571501|P1|Double-Blind Treatment Phase|Protocol Violation|1
1385453|NCT01358708|4571500|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
1385454|NCT01358708|4571501|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
1385455|NCT01358578|4571524|P6|Follow-up Period|Physician Decision|0
1385456|NCT01358578|4571525|P5|Follow-up Period|Physician Decision|0
1385457|NCT01358578|4571526|P4|Follow-up Period|Physician Decision|2
1385458|NCT01358578|4571527|P3|Follow-up Period|Physician Decision|0
1385459|NCT01358578|4571528|P2|Follow-up Period|Physician Decision|1
1385460|NCT01358578|4571529|P1|Follow-up Period|Physician Decision|1
1385461|NCT01358578|4571524|P6|Follow-up Period|Withdrawal by Subject|0
1385462|NCT01358578|4571525|P5|Follow-up Period|Withdrawal by Subject|0
1385463|NCT01358578|4571526|P4|Follow-up Period|Withdrawal by Subject|12
1385464|NCT01358578|4571527|P3|Follow-up Period|Withdrawal by Subject|1
1385465|NCT01358578|4571528|P2|Follow-up Period|Withdrawal by Subject|3
1385466|NCT01358578|4571529|P1|Follow-up Period|Withdrawal by Subject|3
1385467|NCT01358578|4571524|P6|Follow-up Period|Pregnancy|0
1385468|NCT01358578|4571525|P5|Follow-up Period|Pregnancy|0
1385469|NCT01358578|4571526|P4|Follow-up Period|Pregnancy|0
1385470|NCT01358578|4571527|P3|Follow-up Period|Pregnancy|0
1385471|NCT01358578|4571528|P2|Follow-up Period|Pregnancy|0
1385472|NCT01358578|4571529|P1|Follow-up Period|Pregnancy|1
1385473|NCT01358578|4571524|P6|Follow-up Period|non- compliance with study treatment|0
1385474|NCT01358578|4571525|P5|Follow-up Period|non- compliance with study treatment|0
1385475|NCT01358578|4571526|P4|Follow-up Period|non- compliance with study treatment|0
1385476|NCT01358578|4571527|P3|Follow-up Period|non- compliance with study treatment|0
1385477|NCT01358578|4571528|P2|Follow-up Period|non- compliance with study treatment|0
1385478|NCT01358578|4571529|P1|Follow-up Period|non- compliance with study treatment|1
1385479|NCT01358578|4571524|P6|Follow-up Period|Lost to Follow-up|0
1385480|NCT01358578|4571525|P5|Follow-up Period|Lost to Follow-up|0
1385481|NCT01358578|4571526|P4|Follow-up Period|Lost to Follow-up|4
1385482|NCT01358578|4571527|P3|Follow-up Period|Lost to Follow-up|0
1385483|NCT01358578|4571528|P2|Follow-up Period|Lost to Follow-up|1
1385484|NCT01358578|4571529|P1|Follow-up Period|Lost to Follow-up|0
1385485|NCT01358578|4571524|P6|Follow-up Period|Lack of Efficacy|0
1385486|NCT01358578|4571525|P5|Follow-up Period|Lack of Efficacy|0
1385487|NCT01358578|4571526|P4|Follow-up Period|Lack of Efficacy|1
1385488|NCT01358578|4571527|P3|Follow-up Period|Lack of Efficacy|4
1385489|NCT01358578|4571528|P2|Follow-up Period|Lack of Efficacy|0
1385490|NCT01358578|4571529|P1|Follow-up Period|Lack of Efficacy|3
1385491|NCT01358578|4571524|P6|Follow-up Period|Adverse Event|0
1385492|NCT01358578|4571525|P5|Follow-up Period|Adverse Event|0
1385493|NCT01358578|4571526|P4|Follow-up Period|Adverse Event|0
1385494|NCT01358578|4571527|P3|Follow-up Period|Adverse Event|0
1385495|NCT01358578|4571528|P2|Follow-up Period|Adverse Event|1
1385496|NCT01358578|4571529|P1|Follow-up Period|Adverse Event|1
1385497|NCT01358578|4571524|P6|Maintenance Period|Withdrawal by Subject|3
1385498|NCT01358578|4571525|P5|Maintenance Period|Withdrawal by Subject|6
1385499|NCT01358578|4571526|P4|Maintenance Period|Withdrawal by Subject|15
1385500|NCT01358578|4571527|P3|Maintenance Period|Withdrawal by Subject|2
1385501|NCT01358578|4571528|P2|Maintenance Period|Withdrawal by Subject|7
1385502|NCT01358578|4571529|P1|Maintenance Period|Withdrawal by Subject|12
1385503|NCT01358578|4571524|P6|Maintenance Period|Protocol deviation|2
1385504|NCT01358578|4571525|P5|Maintenance Period|Protocol deviation|2
1385505|NCT01358578|4571526|P4|Maintenance Period|Protocol deviation|2
1385506|NCT01358578|4571527|P3|Maintenance Period|Protocol deviation|0
1385507|NCT01358578|4571528|P2|Maintenance Period|Protocol deviation|4
1385508|NCT01358578|4571529|P1|Maintenance Period|Protocol deviation|7
1385509|NCT01358578|4571524|P6|Maintenance Period|Pregnancy|0
1385510|NCT01358578|4571525|P5|Maintenance Period|Pregnancy|0
1385511|NCT01358578|4571526|P4|Maintenance Period|Pregnancy|0
1385512|NCT01358578|4571527|P3|Maintenance Period|Pregnancy|0
1385513|NCT01358578|4571528|P2|Maintenance Period|Pregnancy|0
1385514|NCT01358578|4571529|P1|Maintenance Period|Pregnancy|1
1385515|NCT01358578|4571524|P6|Maintenance Period|Physician Decision|0
1385516|NCT01358578|4571525|P5|Maintenance Period|Physician Decision|0
1385517|NCT01358578|4571526|P4|Maintenance Period|Physician Decision|1
1385518|NCT01358578|4571527|P3|Maintenance Period|Physician Decision|0
1385519|NCT01358578|4571528|P2|Maintenance Period|Physician Decision|1
1385520|NCT01358578|4571529|P1|Maintenance Period|Physician Decision|0
1385521|NCT01358578|4571524|P6|Maintenance Period|Non-compliance with study treatment|2
1385522|NCT01358578|4571525|P5|Maintenance Period|Non-compliance with study treatment|1
1385523|NCT01358578|4571526|P4|Maintenance Period|Non-compliance with study treatment|2
1385524|NCT01358578|4571527|P3|Maintenance Period|Non-compliance with study treatment|0
1385525|NCT01358578|4571528|P2|Maintenance Period|Non-compliance with study treatment|1
1385526|NCT01358578|4571529|P1|Maintenance Period|Non-compliance with study treatment|3
1385527|NCT01358578|4571524|P6|Maintenance Period|Lost to Follow-up|1
1385528|NCT01358578|4571525|P5|Maintenance Period|Lost to Follow-up|1
1385529|NCT01358578|4571526|P4|Maintenance Period|Lost to Follow-up|5
1385530|NCT01358578|4571527|P3|Maintenance Period|Lost to Follow-up|0
1385531|NCT01358578|4571528|P2|Maintenance Period|Lost to Follow-up|0
1385532|NCT01358578|4571529|P1|Maintenance Period|Lost to Follow-up|4
1385533|NCT01358578|4571524|P6|Maintenance Period|Lack of Efficacy|0
1385534|NCT01358578|4571525|P5|Maintenance Period|Lack of Efficacy|3
1385535|NCT01358578|4571526|P4|Maintenance Period|Lack of Efficacy|11
1385536|NCT01358578|4571527|P3|Maintenance Period|Lack of Efficacy|0
1385537|NCT01358578|4571528|P2|Maintenance Period|Lack of Efficacy|2
1385538|NCT01358578|4571529|P1|Maintenance Period|Lack of Efficacy|10
1385539|NCT01358578|4571524|P6|Maintenance Period|Adverse Event|3
1385540|NCT01358578|4571525|P5|Maintenance Period|Adverse Event|4
1385541|NCT01358578|4571526|P4|Maintenance Period|Adverse Event|6
1385542|NCT01358578|4571527|P3|Maintenance Period|Adverse Event|0
1385543|NCT01358578|4571528|P2|Maintenance Period|Adverse Event|7
1385544|NCT01358578|4571529|P1|Maintenance Period|Adverse Event|2
1385545|NCT01358578|4571524|P6|Induction Period|Withdrawal by Subject|0
1385546|NCT01358578|4571525|P5|Induction Period|Withdrawal by Subject|0
1385547|NCT01358578|4571526|P4|Induction Period|Withdrawal by Subject|6
1385548|NCT01358578|4571527|P3|Induction Period|Withdrawal by Subject|10
1385549|NCT01358578|4571528|P2|Induction Period|Withdrawal by Subject|5
1385550|NCT01358578|4571529|P1|Induction Period|Withdrawal by Subject|5
1385551|NCT01358578|4571524|P6|Induction Period|technical problems|0
1385552|NCT01358578|4571525|P5|Induction Period|technical problems|0
1385553|NCT01358578|4571526|P4|Induction Period|technical problems|1
1385554|NCT01358578|4571527|P3|Induction Period|technical problems|1
1385555|NCT01358578|4571528|P2|Induction Period|technical problems|0
1385556|NCT01358578|4571529|P1|Induction Period|technical problems|0
1385557|NCT01358578|4571524|P6|Induction Period|Protocol Deviation|0
1385558|NCT01358578|4571525|P5|Induction Period|Protocol Deviation|0
1385559|NCT01358578|4571526|P4|Induction Period|Protocol Deviation|3
1385560|NCT01358578|4571527|P3|Induction Period|Protocol Deviation|0
1385561|NCT01358578|4571528|P2|Induction Period|Protocol Deviation|5
1385562|NCT01358578|4571529|P1|Induction Period|Protocol Deviation|3
1385563|NCT01358578|4571524|P6|Induction Period|Physician Decision|0
1385564|NCT01358578|4571525|P5|Induction Period|Physician Decision|0
1385565|NCT01358578|4571526|P4|Induction Period|Physician Decision|0
1385566|NCT01358578|4571527|P3|Induction Period|Physician Decision|2
1385567|NCT01358578|4571528|P2|Induction Period|Physician Decision|1
1385568|NCT01358578|4571529|P1|Induction Period|Physician Decision|2
1385569|NCT01358578|4571524|P6|Induction Period|Lost to Follow-up|0
1385570|NCT01358578|4571525|P5|Induction Period|Lost to Follow-up|0
1385571|NCT01358578|4571526|P4|Induction Period|Lost to Follow-up|4
1385572|NCT01358578|4571527|P3|Induction Period|Lost to Follow-up|1
1385573|NCT01358578|4571528|P2|Induction Period|Lost to Follow-up|0
1385574|NCT01358578|4571529|P1|Induction Period|Lost to Follow-up|0
1385575|NCT01358578|4571524|P6|Induction Period|Lack of Efficacy|0
1385576|NCT01358578|4571525|P5|Induction Period|Lack of Efficacy|0
1385577|NCT01358578|4571526|P4|Induction Period|Lack of Efficacy|1
1385578|NCT01358578|4571527|P3|Induction Period|Lack of Efficacy|9
1385579|NCT01358578|4571528|P2|Induction Period|Lack of Efficacy|0
1385580|NCT01358578|4571529|P1|Induction Period|Lack of Efficacy|0
1385581|NCT01358578|4571524|P6|Induction Period|Adverse Event|0
1385582|NCT01358578|4571525|P5|Induction Period|Adverse Event|0
1385583|NCT01358578|4571526|P4|Induction Period|Adverse Event|6
1385584|NCT01358578|4571527|P3|Induction Period|Adverse Event|2
1385585|NCT01358578|4571528|P2|Induction Period|Adverse Event|4
1385586|NCT01358578|4571529|P1|Induction Period|Adverse Event|2
1385587|NCT01358526|4571581|P3|Double-blind Phase|Administrative|10
1385588|NCT01358526|4571582|P2|Double-blind Phase|Administrative|6
1385589|NCT01358526|4571583|P1|Double-blind Phase|Administrative|0
1385590|NCT01358526|4571581|P3|Double-blind Phase|Confirmed or suspected diversion|6
1385591|NCT01358526|4571582|P2|Double-blind Phase|Confirmed or suspected diversion|5
1385592|NCT01358526|4571583|P1|Double-blind Phase|Confirmed or suspected diversion|0
1385593|NCT01358526|4571581|P3|Double-blind Phase|Lack of Efficacy|73
1385594|NCT01358526|4571582|P2|Double-blind Phase|Lack of Efficacy|31
1385595|NCT01358526|4571583|P1|Double-blind Phase|Lack of Efficacy|0
1385596|NCT01358526|4571581|P3|Double-blind Phase|Lost to Follow-up|1
1385597|NCT01358526|4571582|P2|Double-blind Phase|Lost to Follow-up|4
1385598|NCT01358526|4571583|P1|Double-blind Phase|Lost to Follow-up|0
1385599|NCT01358526|4571581|P3|Double-blind Phase|Withdrawal by Subject|8
1385600|NCT01358526|4571582|P2|Double-blind Phase|Withdrawal by Subject|10
1385601|NCT01358526|4571583|P1|Double-blind Phase|Withdrawal by Subject|0
1385602|NCT01358526|4571581|P3|Double-blind Phase|Adverse Event|23
1385603|NCT01358526|4571582|P2|Double-blind Phase|Adverse Event|24
1385604|NCT01358526|4571583|P1|Double-blind Phase|Adverse Event|0
1385605|NCT01358526|4571581|P3|Open-label Titration Period|Did not qualify|0
1385606|NCT01358526|4571582|P2|Open-label Titration Period|Did not qualify|0
1385607|NCT01358526|4571583|P1|Open-label Titration Period|Did not qualify|178
1385608|NCT01358526|4571581|P3|Open-label Titration Period|Administrative|0
1385609|NCT01358526|4571582|P2|Open-label Titration Period|Administrative|0
1385610|NCT01358526|4571583|P1|Open-label Titration Period|Administrative|8
1385611|NCT01358526|4571581|P3|Open-label Titration Period|Confirmed or suspected diversion|0
1385612|NCT01358526|4571582|P2|Open-label Titration Period|Confirmed or suspected diversion|0
1385613|NCT01358526|4571583|P1|Open-label Titration Period|Confirmed or suspected diversion|16
1385614|NCT01358526|4571581|P3|Open-label Titration Period|Lack of Efficacy|0
1385615|NCT01358526|4571582|P2|Open-label Titration Period|Lack of Efficacy|0
1385616|NCT01358526|4571583|P1|Open-label Titration Period|Lack of Efficacy|107
1385617|NCT01358526|4571581|P3|Open-label Titration Period|Lost to Follow-up|0
1385618|NCT01358526|4571582|P2|Open-label Titration Period|Lost to Follow-up|0
1385619|NCT01358526|4571583|P1|Open-label Titration Period|Lost to Follow-up|25
1385620|NCT01358526|4571581|P3|Open-label Titration Period|Withdrawal by Subject|0
1385621|NCT01358526|4571582|P2|Open-label Titration Period|Withdrawal by Subject|0
1385622|NCT01358526|4571583|P1|Open-label Titration Period|Withdrawal by Subject|65
1385623|NCT01358526|4571581|P3|Open-label Titration Period|Adverse Event|0
1385624|NCT01358526|4571582|P2|Open-label Titration Period|Adverse Event|0
1385625|NCT01358526|4571583|P1|Open-label Titration Period|Adverse Event|95
1385626|NCT01358357|4571600|P3|Double-Blind Phase|Administrative|0
1385627|NCT01358357|4571601|P2|Double-Blind Phase|Administrative|1
1385628|NCT01358357|4571602|P1|Double-Blind Phase|Administrative|0
1385629|NCT01358357|4571600|P3|Double-Blind Phase|Recurrence of mood event|0
1385630|NCT01358357|4571601|P2|Double-Blind Phase|Recurrence of mood event|64
1385631|NCT01358357|4571602|P1|Double-Blind Phase|Recurrence of mood event|48
1385632|NCT01358357|4571600|P3|Double-Blind Phase|Terminated at study completion|0
1385633|NCT01358357|4571601|P2|Double-Blind Phase|Terminated at study completion|0
1385634|NCT01358357|4571602|P1|Double-Blind Phase|Terminated at study completion|2
1385635|NCT01358357|4571600|P3|Double-Blind Phase|Protocol Violation|0
1385636|NCT01358357|4571601|P2|Double-Blind Phase|Protocol Violation|12
1385637|NCT01358357|4571602|P1|Double-Blind Phase|Protocol Violation|16
1385638|NCT01358357|4571600|P3|Double-Blind Phase|Protocol Violation|0
1385639|NCT01358357|4571601|P2|Double-Blind Phase|Protocol Violation|11
1385640|NCT01358357|4571602|P1|Double-Blind Phase|Protocol Violation|1
1385641|NCT01358357|4571600|P3|Double-Blind Phase|Lost to Follow-up|0
1385642|NCT01358357|4571601|P2|Double-Blind Phase|Lost to Follow-up|7
1385643|NCT01358357|4571602|P1|Double-Blind Phase|Lost to Follow-up|5
1385644|NCT01358357|4571600|P3|Double-Blind Phase|Adverse Event|0
1385645|NCT01358357|4571601|P2|Double-Blind Phase|Adverse Event|5
1385646|NCT01358357|4571602|P1|Double-Blind Phase|Adverse Event|8
1385647|NCT01358357|4571600|P3|Open Label Phase|Mood episode|42
1385648|NCT01358357|4571601|P2|Open Label Phase|Mood episode|0
1385649|NCT01358357|4571602|P1|Open Label Phase|Mood episode|0
1385650|NCT01358357|4571600|P3|Open Label Phase|Terminated at study completion|5
1385651|NCT01358357|4571601|P2|Open Label Phase|Terminated at study completion|0
1385652|NCT01358357|4571602|P1|Open Label Phase|Terminated at study completion|0
1385653|NCT01358357|4571600|P3|Open Label Phase|Did not meet criteria for DB phase|16
1385654|NCT01358357|4571601|P2|Open Label Phase|Did not meet criteria for DB phase|0
1385655|NCT01358357|4571602|P1|Open Label Phase|Did not meet criteria for DB phase|0
1385656|NCT01358357|4571600|P3|Open Label Phase|Withdrawal by Subject|112
1385657|NCT01358357|4571601|P2|Open Label Phase|Withdrawal by Subject|0
1385658|NCT01358357|4571602|P1|Open Label Phase|Withdrawal by Subject|0
1385659|NCT01358357|4571600|P3|Open Label Phase|Protocol Violation|45
1385660|NCT01358357|4571601|P2|Open Label Phase|Protocol Violation|0
1385661|NCT01358357|4571602|P1|Open Label Phase|Protocol Violation|0
1385662|NCT01358357|4571600|P3|Open Label Phase|Lost to Follow-up|76
1385663|NCT01358357|4571601|P2|Open Label Phase|Lost to Follow-up|0
1385664|NCT01358357|4571602|P1|Open Label Phase|Lost to Follow-up|0
1385665|NCT01358357|4571600|P3|Open Label Phase|Lack of Efficacy|107
1385666|NCT01358357|4571601|P2|Open Label Phase|Lack of Efficacy|0
1385667|NCT01358357|4571602|P1|Open Label Phase|Lack of Efficacy|0
1385668|NCT01358357|4571600|P3|Open Label Phase|Adverse Event|59
1385669|NCT01358357|4571601|P2|Open Label Phase|Adverse Event|0
1385670|NCT01358357|4571602|P1|Open Label Phase|Adverse Event|0
1385671|NCT01358175|4571638|P3|Overall Study|Adverse Event|11
1385672|NCT01358175|4571639|P2|Overall Study|Adverse Event|11
1385673|NCT01358175|4571640|P1|Overall Study|Adverse Event|6
1385674|NCT01358175|4571638|P3|Overall Study|Lack of Efficacy|6
1385675|NCT01358175|4571639|P2|Overall Study|Lack of Efficacy|8
1385676|NCT01358175|4571640|P1|Overall Study|Lack of Efficacy|3
1385677|NCT01358175|4571638|P3|Overall Study|Lost to Follow-up|3
1385678|NCT01358175|4571639|P2|Overall Study|Lost to Follow-up|1
1385679|NCT01358175|4571640|P1|Overall Study|Lost to Follow-up|1
1385680|NCT01358175|4571638|P3|Overall Study|Non Compliance with Study Treatment|1
1385681|NCT01358175|4571639|P2|Overall Study|Non Compliance with Study Treatment|1
1385682|NCT01358175|4571640|P1|Overall Study|Non Compliance with Study Treatment|0
1385683|NCT01358175|4571638|P3|Overall Study|Physician Decision|0
1385684|NCT01358175|4571639|P2|Overall Study|Physician Decision|0
1385685|NCT01358175|4571640|P1|Overall Study|Physician Decision|1
1385686|NCT01358175|4571638|P3|Overall Study|Pregnancy|0
1385687|NCT01358175|4571639|P2|Overall Study|Pregnancy|1
1385688|NCT01358175|4571640|P1|Overall Study|Pregnancy|0
1385689|NCT01358175|4571638|P3|Overall Study|Technical issues|0
1385690|NCT01358175|4571639|P2|Overall Study|Technical issues|1
1385691|NCT01358175|4571640|P1|Overall Study|Technical issues|0
1385692|NCT01358175|4571638|P3|Overall Study|Withdrawal by Subject|10
1385693|NCT01358175|4571639|P2|Overall Study|Withdrawal by Subject|5
1385694|NCT01358175|4571640|P1|Overall Study|Withdrawal by Subject|9
1385695|NCT01358175|4571638|P3|Overall Study|Death|1
1385696|NCT01358175|4571639|P2|Overall Study|Death|0
1385697|NCT01358175|4571640|P1|Overall Study|Death|1
1385698|NCT01357980|4571677|P4|Overall Study|Consent withdrawn|0
1385699|NCT01357980|4571678|P3|Overall Study|Consent withdrawn|1
1385700|NCT01357980|4571679|P2|Overall Study|Consent withdrawn|0
1385701|NCT01357980|4571680|P1|Overall Study|Consent withdrawn|0
1385702|NCT01357980|4571677|P4|Overall Study|Lack of Efficacy|0
1385703|NCT01357980|4571678|P3|Overall Study|Lack of Efficacy|0
1385704|NCT01357980|4571679|P2|Overall Study|Lack of Efficacy|1
1385705|NCT01357980|4571680|P1|Overall Study|Lack of Efficacy|0
1385706|NCT01357915|4571724|P2|Overall Study|Lost to Follow-up|0
1385707|NCT01357915|4571725|P1|Overall Study|Lost to Follow-up|3
1385708|NCT01357889|4571740|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
1385709|NCT01357889|4571741|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
1385710|NCT01357889|4571740|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
1385711|NCT01357889|4571741|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
1385712|NCT01357889|4571740|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
1385713|NCT01357889|4571741|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
1385714|NCT01357889|4571740|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
1385715|NCT01357889|4571741|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
1385716|NCT01357889|4571740|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
1385717|NCT01357889|4571741|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
1385718|NCT01357889|4571740|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
1385719|NCT01357889|4571741|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
1385720|NCT01357889|4571740|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
1385721|NCT01357889|4571741|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
1385722|NCT01357889|4571740|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
1385723|NCT01357889|4571741|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
1385724|NCT01357889|4571740|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
1385725|NCT01357889|4571741|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
1385726|NCT01357889|4571740|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
1385727|NCT01357889|4571741|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
1385728|NCT01357889|4571740|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
1385729|NCT01357889|4571741|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
1385730|NCT01357889|4571740|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
1385731|NCT01357889|4571741|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
1385732|NCT01357889|4571740|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
1385733|NCT01357889|4571741|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
1385734|NCT01357850|4571785|P4|Overall Study|Lost to Follow-up|0
1385735|NCT01357850|4571786|P3|Overall Study|Lost to Follow-up|0
1385736|NCT01357850|4571787|P2|Overall Study|Lost to Follow-up|0
1385737|NCT01357850|4571788|P1|Overall Study|Lost to Follow-up|1
1385738|NCT01357655|4571879|P2|Overall Study|Subject Withdrew Consent|0
1385739|NCT01357655|4571880|P1|Overall Study|Subject Withdrew Consent|1
1385740|NCT01357655|4571879|P2|Overall Study|Study Drug Toxicity|0
1385741|NCT01357655|4571880|P1|Overall Study|Study Drug Toxicity|11
1385742|NCT01357655|4571879|P2|Overall Study|Reason Unspecified|0
1385743|NCT01357655|4571880|P1|Overall Study|Reason Unspecified|1
1385744|NCT01357655|4571879|P2|Overall Study|Maximum Clinical Benefit|0
1385745|NCT01357655|4571880|P1|Overall Study|Maximum Clinical Benefit|2
1385746|NCT01357655|4571879|P2|Overall Study|Lost to Follow-up|0
1385747|NCT01357655|4571880|P1|Overall Study|Lost to Follow-up|2
1385748|NCT01357655|4571879|P2|Overall Study|Disease Progression|0
1385749|NCT01357655|4571880|P1|Overall Study|Disease Progression|1
1385750|NCT01357655|4571879|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
1385751|NCT01357655|4571880|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
1385752|NCT01357655|4571879|P2|Overall Study|Administrative Reason by Sponsor|0
1385753|NCT01357655|4571880|P1|Overall Study|Administrative Reason by Sponsor|45
1385754|NCT01357616|4571897|P2|Overall Study|Withdrawal by Subject|0
1385755|NCT01357616|4571898|P1|Overall Study|Withdrawal by Subject|1
1385756|NCT01357616|4571897|P2|Overall Study|Decision Unrelated to Adverse Event|1
1385757|NCT01357616|4571898|P1|Overall Study|Decision Unrelated to Adverse Event|3
1385758|NCT01357616|4571897|P2|Overall Study|Inadequate Control of IOP|2
1385759|NCT01357616|4571898|P1|Overall Study|Inadequate Control of IOP|1
1385760|NCT01357616|4571897|P2|Overall Study|Protocol Violation|2
1385761|NCT01357616|4571898|P1|Overall Study|Protocol Violation|0
1385762|NCT01357616|4571897|P2|Overall Study|Lost to Follow-up|3
1385763|NCT01357616|4571898|P1|Overall Study|Lost to Follow-up|4
1385764|NCT01357616|4571897|P2|Overall Study|Adverse Event|1
1385765|NCT01357616|4571898|P1|Overall Study|Adverse Event|1
1385766|NCT01357551|4571912|P2|Overall Study|Lost to Follow-up|6
1385767|NCT01357551|4571913|P1|Overall Study|Lost to Follow-up|16
1385768|NCT01357551|4571912|P2|Overall Study|Death|1
1385769|NCT01357551|4571913|P1|Overall Study|Death|0
1385770|NCT01357551|4571912|P2|Overall Study|Withdrawal by Subject|4
1385771|NCT01357551|4571913|P1|Overall Study|Withdrawal by Subject|6
1385772|NCT01357239|4571940|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
1385773|NCT01357239|4571941|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
1385774|NCT01357239|4571942|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
1385775|NCT01357239|4571943|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
1385776|NCT01357239|4571940|P4|Stratum II: Partially-Methylated|Adverse Event|1
1385777|NCT01357239|4571941|P3|Stratum II: Partially-Methylated|Adverse Event|0
1385778|NCT01357239|4571942|P2|Stratum II: Partially-Methylated|Adverse Event|0
1385779|NCT01357239|4571943|P1|Stratum II: Partially-Methylated|Adverse Event|0
1385780|NCT01357239|4571940|P4|Stratum I: Fully-Methylated|Adverse Event|0
1385781|NCT01357239|4571941|P3|Stratum I: Fully-Methylated|Adverse Event|1
1385782|NCT01357239|4571942|P2|Stratum I: Fully-Methylated|Adverse Event|0
1385783|NCT01357239|4571943|P1|Stratum I: Fully-Methylated|Adverse Event|0
1385784|NCT01357239|4571940|P4|Stratum: All Patients|Subject withdrew consent|1
1385785|NCT01357239|4571941|P3|Stratum: All Patients|Subject withdrew consent|1
1385786|NCT01357239|4571942|P2|Stratum: All Patients|Subject withdrew consent|0
1385787|NCT01357239|4571943|P1|Stratum: All Patients|Subject withdrew consent|0
1385788|NCT01357239|4571940|P4|Stratum: All Patients|Adverse Event|1
1385789|NCT01357239|4571941|P3|Stratum: All Patients|Adverse Event|1
1385790|NCT01357239|4571942|P2|Stratum: All Patients|Adverse Event|0
1385791|NCT01357239|4571943|P1|Stratum: All Patients|Adverse Event|0
1385792|NCT01357161|4572001|P3|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
1385793|NCT01357161|4572002|P2|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
1385794|NCT01357161|4572003|P1|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
1385795|NCT01357161|4572001|P3|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
1385796|NCT01357161|4572002|P2|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
1385797|NCT01357161|4572003|P1|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
1385798|NCT01357161|4572001|P3|Part 2 (Double-Blind Comparison)|Progressive Disease|3
1385799|NCT01357161|4572002|P2|Part 2 (Double-Blind Comparison)|Progressive Disease|1
1385800|NCT01357161|4572003|P1|Part 2 (Double-Blind Comparison)|Progressive Disease|0
1385801|NCT01357161|4572001|P3|Part 2 (Double-Blind Comparison)|Physician Decision|4
1385802|NCT01357161|4572002|P2|Part 2 (Double-Blind Comparison)|Physician Decision|1
1385803|NCT01357161|4572003|P1|Part 2 (Double-Blind Comparison)|Physician Decision|0
1385804|NCT01357161|4572001|P3|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
1385805|NCT01357161|4572002|P2|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
1385806|NCT01357161|4572003|P1|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
1385807|NCT01357161|4572001|P3|Part 2 (Double-Blind Comparison)|Death|19
1385808|NCT01357161|4572002|P2|Part 2 (Double-Blind Comparison)|Death|22
1385809|NCT01357161|4572003|P1|Part 2 (Double-Blind Comparison)|Death|0
1385810|NCT01357161|4572001|P3|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
1385811|NCT01357161|4572002|P2|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
1385812|NCT01357161|4572003|P1|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
1385813|NCT01357161|4572001|P3|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
1385814|NCT01357161|4572002|P2|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
1385815|NCT01357161|4572003|P1|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
1385816|NCT01357161|4572001|P3|Part 1 (Open Label Run-in)|Physician Decision|0
1385817|NCT01357161|4572002|P2|Part 1 (Open Label Run-in)|Physician Decision|0
1385818|NCT01357161|4572003|P1|Part 1 (Open Label Run-in)|Physician Decision|1
1385819|NCT01357161|4572001|P3|Part 1 (Open Label Run-in)|Lost to Follow-up|0
1385820|NCT01357161|4572002|P2|Part 1 (Open Label Run-in)|Lost to Follow-up|0
1385821|NCT01357161|4572003|P1|Part 1 (Open Label Run-in)|Lost to Follow-up|3
1385822|NCT01357161|4572001|P3|Part 1 (Open Label Run-in)|Death|0
1385823|NCT01357161|4572002|P2|Part 1 (Open Label Run-in)|Death|0
1385824|NCT01357161|4572003|P1|Part 1 (Open Label Run-in)|Death|5
1385825|NCT01356966|4572055|P2|Overall Study|Physician Decision|0
1385826|NCT01356966|4572056|P1|Overall Study|Physician Decision|1
1385827|NCT01356966|4572055|P2|Overall Study|Withdrawal by Subject|2
1385828|NCT01356966|4572056|P1|Overall Study|Withdrawal by Subject|1
1385829|NCT01356940|4572068|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
1385830|NCT01356940|4572069|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
1385831|NCT01356940|4572068|P2|First Intervention (28 Days)|Adverse Event|0
1385832|NCT01356940|4572069|P1|First Intervention (28 Days)|Adverse Event|1
1385833|NCT01356602|4572096|P3|Overall Study|Adverse Event|1
1385834|NCT01356602|4572097|P2|Overall Study|Adverse Event|1
1385835|NCT01356602|4572098|P1|Overall Study|Adverse Event|0
1385836|NCT01356602|4572096|P3|Overall Study|Lack of Efficacy|4
1385837|NCT01356602|4572097|P2|Overall Study|Lack of Efficacy|1
1385838|NCT01356602|4572098|P1|Overall Study|Lack of Efficacy|0
1385839|NCT01356602|4572096|P3|Overall Study|Withdrawal by Subject|7
1385840|NCT01356602|4572097|P2|Overall Study|Withdrawal by Subject|3
1385841|NCT01356602|4572098|P1|Overall Study|Withdrawal by Subject|4
1385842|NCT01356602|4572096|P3|Overall Study|Lost to Follow-up|6
1385843|NCT01356602|4572097|P2|Overall Study|Lost to Follow-up|5
1385844|NCT01356602|4572098|P1|Overall Study|Lost to Follow-up|4
1385845|NCT01356602|4572096|P3|Overall Study|Administrative Problems|5
1385846|NCT01356602|4572097|P2|Overall Study|Administrative Problems|4
1385847|NCT01356602|4572098|P1|Overall Study|Administrative Problems|1
1385848|NCT01356602|4572096|P3|Overall Study|Protocol Deviation|1
1385849|NCT01356602|4572097|P2|Overall Study|Protocol Deviation|1
1385850|NCT01356602|4572098|P1|Overall Study|Protocol Deviation|0
1385851|NCT01356589|4572157|P1|Overall Study|Dose data not recorded|2
1385852|NCT01356589|4572157|P1|Overall Study|Enrolled, but not treated|3
1385853|NCT01356407|4572214|P2|Overall Study|Not complete Endoscopy|2
1385854|NCT01356407|4572215|P1|Overall Study|Not complete Endoscopy|2
1385855|NCT01356407|4572214|P2|Overall Study|Could not afford IMP administration|1
1385856|NCT01356407|4572215|P1|Overall Study|Could not afford IMP administration|0
1385857|NCT01356407|4572214|P2|Overall Study|Patient Withdrew Consent|1
1385858|NCT01356407|4572215|P1|Overall Study|Patient Withdrew Consent|2
1385859|NCT01356407|4572214|P2|Overall Study|Lost to Follow-up|0
1385860|NCT01356407|4572215|P1|Overall Study|Lost to Follow-up|2
1385861|NCT01355679|4572278|P1|Overall Study|benign tumor types found at biopsy|2
1385862|NCT01355627|4572287|P2|Overall Study|Other|1
1385863|NCT01355627|4572288|P1|Overall Study|Other|1
1385864|NCT01355627|4572287|P2|Overall Study|Fatal Adverse Event|23
1385865|NCT01355627|4572288|P1|Overall Study|Fatal Adverse Event|19
1385866|NCT01355627|4572287|P2|Overall Study|Lost to Follow-up|7
1385867|NCT01355627|4572288|P1|Overall Study|Lost to Follow-up|8
1385868|NCT01355627|4572287|P2|Overall Study|Request By the Patient to Discontinue|7
1385869|NCT01355627|4572288|P1|Overall Study|Request By the Patient to Discontinue|5
1385870|NCT01355523|4572327|P2|Overall Study|Adverse Event|2
1385871|NCT01355523|4572328|P1|Overall Study|Adverse Event|0
1385872|NCT01355523|4572327|P2|Overall Study|Protocol Violation|2
1385873|NCT01355523|4572328|P1|Overall Study|Protocol Violation|0
1385874|NCT01355523|4572327|P2|Overall Study|Lost to Follow-up|2
1385875|NCT01355523|4572328|P1|Overall Study|Lost to Follow-up|0
1385876|NCT01355523|4572327|P2|Overall Study|Withdrawal by Subject|4
1385877|NCT01355523|4572328|P1|Overall Study|Withdrawal by Subject|1
1385878|NCT01355302|4572404|P3|Phase 1b|Study terminated by sponsor|0
1385879|NCT01355302|4572405|P2|Phase 1b|Study terminated by sponsor|0
1385880|NCT01355302|4572406|P1|Phase 1b|Study terminated by sponsor|2
1385881|NCT01355302|4572404|P3|Phase 1b|Death|0
1385882|NCT01355302|4572405|P2|Phase 1b|Death|0
1385883|NCT01355302|4572406|P1|Phase 1b|Death|4
1385884|NCT01355289|4572421|P5|Open Label Extension|Not specified|3
1385885|NCT01355289|4572422|P4|Open Label Extension|Not specified|0
1385886|NCT01355289|4572423|P3|Open Label Extension|Not specified|0
1385887|NCT01355289|4572424|P2|Open Label Extension|Not specified|0
1385888|NCT01355289|4572425|P1|Open Label Extension|Not specified|0
1385889|NCT01355289|4572421|P5|Open Label Extension|Inadequate Therapeutic Effect|29
1385890|NCT01355289|4572422|P4|Open Label Extension|Inadequate Therapeutic Effect|0
1385891|NCT01355289|4572423|P3|Open Label Extension|Inadequate Therapeutic Effect|0
1385892|NCT01355289|4572424|P2|Open Label Extension|Inadequate Therapeutic Effect|0
1385893|NCT01355289|4572425|P1|Open Label Extension|Inadequate Therapeutic Effect|0
1385894|NCT01355289|4572421|P5|Open Label Extension|Lost to Follow-up|1
1385895|NCT01355289|4572422|P4|Open Label Extension|Lost to Follow-up|0
1385896|NCT01355289|4572423|P3|Open Label Extension|Lost to Follow-up|0
1385897|NCT01355289|4572424|P2|Open Label Extension|Lost to Follow-up|0
1385898|NCT01355289|4572425|P1|Open Label Extension|Lost to Follow-up|0
1385899|NCT01355289|4572421|P5|Open Label Extension|Adverse Event, Non-Fatal|1
1385900|NCT01355289|4572422|P4|Open Label Extension|Adverse Event, Non-Fatal|0
1385901|NCT01355289|4572423|P3|Open Label Extension|Adverse Event, Non-Fatal|0
1385902|NCT01355289|4572424|P2|Open Label Extension|Adverse Event, Non-Fatal|0
1385903|NCT01355289|4572425|P1|Open Label Extension|Adverse Event, Non-Fatal|0
1385904|NCT01355289|4572421|P5|Core Study|Not specified|0
1385905|NCT01355289|4572422|P4|Core Study|Not specified|1
1385906|NCT01355289|4572423|P3|Core Study|Not specified|0
1385907|NCT01355289|4572424|P2|Core Study|Not specified|0
1385908|NCT01355289|4572425|P1|Core Study|Not specified|0
1385909|NCT01355289|4572421|P5|Core Study|Inadequate Therapeutic Effect|0
1385910|NCT01355289|4572422|P4|Core Study|Inadequate Therapeutic Effect|1
1385911|NCT01355289|4572423|P3|Core Study|Inadequate Therapeutic Effect|0
1385912|NCT01355289|4572424|P2|Core Study|Inadequate Therapeutic Effect|0
1385913|NCT01355289|4572425|P1|Core Study|Inadequate Therapeutic Effect|0
1385914|NCT01355289|4572421|P5|Core Study|Adverse Event, Non-Fatal|0
1385915|NCT01355289|4572422|P4|Core Study|Adverse Event, Non-Fatal|0
1385916|NCT01355289|4572423|P3|Core Study|Adverse Event, Non-Fatal|0
1385917|NCT01355289|4572424|P2|Core Study|Adverse Event, Non-Fatal|0
1385918|NCT01355289|4572425|P1|Core Study|Adverse Event, Non-Fatal|1
1385919|NCT01355081|4572478|P3|Overall Study|Non Compliance with Study Medication|0
1385920|NCT01355081|4572479|P2|Overall Study|Non Compliance with Study Medication|1
1385921|NCT01355081|4572480|P1|Overall Study|Non Compliance with Study Medication|0
1385922|NCT01355081|4572478|P3|Overall Study|Lack of Efficacy|1
1385923|NCT01355081|4572479|P2|Overall Study|Lack of Efficacy|1
1385924|NCT01355081|4572480|P1|Overall Study|Lack of Efficacy|2
1385925|NCT01355081|4572478|P3|Overall Study|Withdrawal of Consent|3
1385926|NCT01355081|4572479|P2|Overall Study|Withdrawal of Consent|3
1385927|NCT01355081|4572480|P1|Overall Study|Withdrawal of Consent|2
1385928|NCT01355081|4572478|P3|Overall Study|Lost to Follow-up|1
1385929|NCT01355081|4572479|P2|Overall Study|Lost to Follow-up|0
1385930|NCT01355081|4572480|P1|Overall Study|Lost to Follow-up|0
1385931|NCT01355081|4572478|P3|Overall Study|Major Protocol Deviation|0
1385932|NCT01355081|4572479|P2|Overall Study|Major Protocol Deviation|1
1385933|NCT01355081|4572480|P1|Overall Study|Major Protocol Deviation|0
1385934|NCT01355081|4572478|P3|Overall Study|Pretreatment Event or Adverse Event|6
1385935|NCT01355081|4572479|P2|Overall Study|Pretreatment Event or Adverse Event|4
1385936|NCT01355081|4572480|P1|Overall Study|Pretreatment Event or Adverse Event|3
1385937|NCT01355068|4572503|P2|First Intervention Period|Withdrawal by Subject|1
1385938|NCT01355068|4572504|P1|First Intervention Period|Withdrawal by Subject|0
1385939|NCT01355068|4572503|P2|First Intervention Period|Adverse Event|1
1385940|NCT01355068|4572504|P1|First Intervention Period|Adverse Event|0
1385941|NCT01354938|4572527|P1|Overall Study|Lost to Follow-up|1
1385942|NCT01354899|4572533|P1|Overall Study|Protocol Violation|1
1385943|NCT01354899|4572533|P1|Overall Study|discharge from the hospital|2
1385944|NCT01354431|4572582|P3|Participants Treated|Withdrawal by Subject|1
1385945|NCT01354431|4572583|P2|Participants Treated|Withdrawal by Subject|2
1385946|NCT01354431|4572584|P1|Participants Treated|Withdrawal by Subject|1
1385947|NCT01354431|4572582|P3|Participants Treated|Adverse Event|4
1385948|NCT01354431|4572583|P2|Participants Treated|Adverse Event|2
1385949|NCT01354431|4572584|P1|Participants Treated|Adverse Event|1
1385950|NCT01354431|4572582|P3|Participants Treated|Death|0
1385951|NCT01354431|4572583|P2|Participants Treated|Death|1
1385952|NCT01354431|4572584|P1|Participants Treated|Death|0
1385953|NCT01354431|4572582|P3|Participants Treated|Study Drug Toxicity|4
1385954|NCT01354431|4572583|P2|Participants Treated|Study Drug Toxicity|7
1385955|NCT01354431|4572584|P1|Participants Treated|Study Drug Toxicity|2
1385956|NCT01354431|4572582|P3|Participants Treated|Disease Progression|41
1385957|NCT01354431|4572583|P2|Participants Treated|Disease Progression|40
1385958|NCT01354431|4572584|P1|Participants Treated|Disease Progression|49
1385959|NCT01354431|4572582|P3|Participants Treated|Continuing Treatment|4
1385960|NCT01354431|4572583|P2|Participants Treated|Continuing Treatment|2
1385961|NCT01354431|4572584|P1|Participants Treated|Continuing Treatment|6
1385962|NCT01354431|4572582|P3|Randomized to Enter Treatment Period|No longer met criteria|0
1385963|NCT01354431|4572583|P2|Randomized to Enter Treatment Period|No longer met criteria|0
1385964|NCT01354431|4572584|P1|Randomized to Enter Treatment Period|No longer met criteria|1
1385965|NCT01354314|4572608|P4|Overall Study|Less than 90% Adherence|4
1385966|NCT01354314|4572609|P3|Overall Study|Less than 90% Adherence|6
1385967|NCT01354314|4572610|P2|Overall Study|Less than 90% Adherence|2
1385968|NCT01354314|4572611|P1|Overall Study|Less than 90% Adherence|4
1385969|NCT01354314|4572608|P4|Overall Study|Protocol Violation|0
1385970|NCT01354314|4572609|P3|Overall Study|Protocol Violation|0
1385971|NCT01354314|4572610|P2|Overall Study|Protocol Violation|1
1385972|NCT01354314|4572611|P1|Overall Study|Protocol Violation|1
1385973|NCT01354314|4572608|P4|Overall Study|Adverse Event|1
1385974|NCT01354314|4572609|P3|Overall Study|Adverse Event|0
1385975|NCT01354314|4572610|P2|Overall Study|Adverse Event|0
1385976|NCT01354314|4572611|P1|Overall Study|Adverse Event|0
1385977|NCT01354314|4572608|P4|Overall Study|Withdrawal by Subject|0
1385978|NCT01354314|4572609|P3|Overall Study|Withdrawal by Subject|1
1385979|NCT01354314|4572610|P2|Overall Study|Withdrawal by Subject|0
1385980|NCT01354314|4572611|P1|Overall Study|Withdrawal by Subject|0
1385981|NCT01354314|4572608|P4|Overall Study|Lost to Follow-up|1
1385982|NCT01354314|4572609|P3|Overall Study|Lost to Follow-up|1
1385983|NCT01354314|4572610|P2|Overall Study|Lost to Follow-up|0
1385984|NCT01354314|4572611|P1|Overall Study|Lost to Follow-up|1
1385985|NCT01354223|4572747|P2|Overall Study|Withdrawal by Subject|1
1385986|NCT01354223|4572748|P1|Overall Study|Withdrawal by Subject|3
1385987|NCT01354132|4572807|P2|1 Month Post Study Medication|Withdrawal by Subject|3
1385988|NCT01354132|4572808|P1|1 Month Post Study Medication|Withdrawal by Subject|1
1385989|NCT01354132|4572807|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
1385990|NCT01354132|4572808|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
1385991|NCT01354132|4572807|P2|Double Blind (Visits 1-7)|Adverse Event|0
1385992|NCT01354132|4572808|P1|Double Blind (Visits 1-7)|Adverse Event|1
1385993|NCT01354132|4572807|P2|Randomization|Withdrawal by Subject|1
1385994|NCT01354132|4572808|P1|Randomization|Withdrawal by Subject|0
1385995|NCT01354132|4572807|P2|Randomization|Physician Decision|0
1385996|NCT01354132|4572808|P1|Randomization|Physician Decision|1
1385997|NCT01354106|4572846|P1|Overall Study|Withdrawal by Subject|2
1385998|NCT01354028|4572852|P2|Overall Study|No quiet alert state|1
1385999|NCT01354028|4572853|P1|Overall Study|No quiet alert state|0
1386000|NCT01354028|4572852|P2|Overall Study|Discharged before study start|2
1386001|NCT01354028|4572853|P1|Overall Study|Discharged before study start|2
1386002|NCT01354028|4572852|P2|Overall Study|Physician Decision|2
1386003|NCT01354028|4572853|P1|Overall Study|Physician Decision|0
1386004|NCT01353963|4572889|P1|Overall Study|Adverse Event|2
1386005|NCT01353911|4572907|P8|Overall Study|Status Not Recorded|0
1386006|NCT01353911|4572908|P7|Overall Study|Status Not Recorded|0
1386007|NCT01353911|4572909|P6|Overall Study|Status Not Recorded|0
1386008|NCT01353911|4572910|P5|Overall Study|Status Not Recorded|0
1386009|NCT01353911|4572911|P4|Overall Study|Status Not Recorded|0
1386010|NCT01353911|4572912|P3|Overall Study|Status Not Recorded|1
1386011|NCT01353911|4572913|P2|Overall Study|Status Not Recorded|0
1386012|NCT01353911|4572914|P1|Overall Study|Status Not Recorded|4
1386013|NCT01353911|4572907|P8|Overall Study|Withdrawal by Subject|9
1386014|NCT01353911|4572908|P7|Overall Study|Withdrawal by Subject|3
1386015|NCT01353911|4572909|P6|Overall Study|Withdrawal by Subject|3
1386016|NCT01353911|4572910|P5|Overall Study|Withdrawal by Subject|2
1386017|NCT01353911|4572911|P4|Overall Study|Withdrawal by Subject|2
1386018|NCT01353911|4572912|P3|Overall Study|Withdrawal by Subject|4
1386019|NCT01353911|4572913|P2|Overall Study|Withdrawal by Subject|3
1386020|NCT01353911|4572914|P1|Overall Study|Withdrawal by Subject|2
1386021|NCT01353911|4572907|P8|Overall Study|Lost to Follow-up|6
1386022|NCT01353911|4572908|P7|Overall Study|Lost to Follow-up|3
1386023|NCT01353911|4572909|P6|Overall Study|Lost to Follow-up|4
1386024|NCT01353911|4572910|P5|Overall Study|Lost to Follow-up|4
1386025|NCT01353911|4572911|P4|Overall Study|Lost to Follow-up|0
1386026|NCT01353911|4572912|P3|Overall Study|Lost to Follow-up|4
1386027|NCT01353911|4572913|P2|Overall Study|Lost to Follow-up|6
1386028|NCT01353911|4572914|P1|Overall Study|Lost to Follow-up|2
1386029|NCT01353898|4572994|P6|Overall Study|Study site terminated|1
1386030|NCT01353898|4572995|P5|Overall Study|Study site terminated|0
1386031|NCT01353898|4572996|P4|Overall Study|Study site terminated|0
1386032|NCT01353898|4572997|P3|Overall Study|Study site terminated|0
1386033|NCT01353898|4572998|P2|Overall Study|Study site terminated|0
1386034|NCT01353898|4572999|P1|Overall Study|Study site terminated|0
1386035|NCT01353859|4573025|P1|Overall Study|Lack of Efficacy|1
1386036|NCT01353859|4573025|P1|Overall Study|Adverse Event|3
1386037|NCT01353664|4573038|P1|Overall Study|Disease Progression|16
1386038|NCT01353664|4573038|P1|Overall Study|Other|3
1386039|NCT01353586|4573044|P2|Overall Study|Neurological exam not done|1
1386040|NCT01353586|4573045|P1|Overall Study|Neurological exam not done|0
1386041|NCT01353586|4573044|P2|Overall Study|Never had insertion of study catheter|1
1386042|NCT01353586|4573045|P1|Overall Study|Never had insertion of study catheter|4
1386043|NCT01353586|4573044|P2|Overall Study|Procedure terminated prior to ablation|0
1386044|NCT01353586|4573045|P1|Overall Study|Procedure terminated prior to ablation|3
1386045|NCT01353508|4573063|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
1386046|NCT01353508|4573064|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
1386047|NCT01353508|4573065|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
1386048|NCT01353508|4573066|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
1386049|NCT01353508|4573063|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
1386050|NCT01353508|4573064|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
1386051|NCT01353508|4573065|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
1386052|NCT01353508|4573066|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
1386053|NCT01353274|4573144|P1|Overall Study|No case report form (CRF) collected|28
1386054|NCT01353222|4573154|P2|Overall Study|Site closed research department|0
1386055|NCT01353222|4573155|P1|Overall Study|Site closed research department|1
1386056|NCT01353222|4573154|P2|Overall Study|Study Terminated|37
1386057|NCT01353222|4573155|P1|Overall Study|Study Terminated|31
1386058|NCT01353222|4573154|P2|Overall Study|Withdrawal by Subject|5
1386059|NCT01353222|4573155|P1|Overall Study|Withdrawal by Subject|8
1386060|NCT01353222|4573154|P2|Overall Study|Death|30
1386061|NCT01353222|4573155|P1|Overall Study|Death|30
1386062|NCT01352845|4573189|P2|Overall Study|Death|0
1386063|NCT01352845|4573190|P1|Overall Study|Death|3
1386064|NCT01352845|4573189|P2|Overall Study|Protocol Violation|6
1386065|NCT01352845|4573190|P1|Overall Study|Protocol Violation|12
1386066|NCT01352845|4573189|P2|Overall Study|Other|7
1386067|NCT01352845|4573190|P1|Overall Study|Other|17
1386068|NCT01352845|4573189|P2|Overall Study|Adverse Event|6
1386069|NCT01352845|4573190|P1|Overall Study|Adverse Event|22
1386070|NCT01352845|4573189|P2|Overall Study|Pregnancy|7
1386071|NCT01352845|4573190|P1|Overall Study|Pregnancy|27
1386072|NCT01352845|4573189|P2|Overall Study|No Longer Meets Eligibility Criteria|11
1386073|NCT01352845|4573190|P1|Overall Study|No Longer Meets Eligibility Criteria|24
1386074|NCT01352845|4573189|P2|Overall Study|Withdrawal by Subject|16
1386075|NCT01352845|4573190|P1|Overall Study|Withdrawal by Subject|48
1386076|NCT01352845|4573189|P2|Overall Study|No Longer Willing to Participate|58
1386077|NCT01352845|4573190|P1|Overall Study|No Longer Willing to Participate|205
1386078|NCT01352845|4573189|P2|Overall Study|Lost to Follow-up|92
1386079|NCT01352845|4573190|P1|Overall Study|Lost to Follow-up|313
1386080|NCT01352793|4573279|P2|Overall Study|No longer meets eligibility criteria|15
1386081|NCT01352793|4573280|P1|Overall Study|No longer meets eligibility criteria|25
1386082|NCT01352793|4573279|P2|Overall Study|Randomized but not vaccinated|0
1386083|NCT01352793|4573280|P1|Overall Study|Randomized but not vaccinated|8
1386084|NCT01352793|4573279|P2|Overall Study|Death|0
1386085|NCT01352793|4573280|P1|Overall Study|Death|1
1386086|NCT01352793|4573279|P2|Overall Study|Medication error|2
1386087|NCT01352793|4573280|P1|Overall Study|Medication error|2
1386088|NCT01352793|4573279|P2|Overall Study|Other|7
1386089|NCT01352793|4573280|P1|Overall Study|Other|25
1386090|NCT01352793|4573279|P2|Overall Study|Pregnancy|8
1386091|NCT01352793|4573280|P1|Overall Study|Pregnancy|26
1386092|NCT01352793|4573279|P2|Overall Study|Physician Decision|0
1386093|NCT01352793|4573280|P1|Overall Study|Physician Decision|1
1386094|NCT01352793|4573279|P2|Overall Study|Adverse Event|10
1386095|NCT01352793|4573280|P1|Overall Study|Adverse Event|44
1386096|NCT01352793|4573279|P2|Overall Study|Protocol Violation|23
1386097|NCT01352793|4573280|P1|Overall Study|Protocol Violation|44
1386098|NCT01352793|4573279|P2|Overall Study|Withdrawal by Subject|55
1386099|NCT01352793|4573280|P1|Overall Study|Withdrawal by Subject|120
1386100|NCT01352793|4573279|P2|Overall Study|Lost to Follow-up|125
1386101|NCT01352793|4573280|P1|Overall Study|Lost to Follow-up|289
1386102|NCT01352741|4573304|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
1386103|NCT01352741|4573305|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
1386104|NCT01352741|4573304|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
1386105|NCT01352741|4573305|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
1386106|NCT01352741|4573304|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
1386107|NCT01352741|4573305|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
1386108|NCT01352741|4573304|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
1386109|NCT01352741|4573305|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
1386110|NCT01352741|4573304|P2|Double-blind Comparative Period|Not Specified|2
1386111|NCT01352741|4573305|P1|Double-blind Comparative Period|Not Specified|1
1386112|NCT01352741|4573304|P2|Double-blind Comparative Period|Withdrawal of consent|3
1386113|NCT01352741|4573305|P1|Double-blind Comparative Period|Withdrawal of consent|8
1386114|NCT01352741|4573304|P2|Double-blind Comparative Period|Death|1
1386115|NCT01352741|4573305|P1|Double-blind Comparative Period|Death|0
1386116|NCT01352741|4573304|P2|Double-blind Comparative Period|Lost to Follow-up|0
1386117|NCT01352741|4573305|P1|Double-blind Comparative Period|Lost to Follow-up|1
1386118|NCT01352741|4573304|P2|Double-blind Comparative Period|Adverse Event|17
1386119|NCT01352741|4573305|P1|Double-blind Comparative Period|Adverse Event|16
1386120|NCT01352741|4573304|P2|Double-blind Comparative Period|Lack of Efficacy|3
1386121|NCT01352741|4573305|P1|Double-blind Comparative Period|Lack of Efficacy|0
1386122|NCT01352741|4573304|P2|Double-blind Comparative Period|Protocol Violation|0
1386123|NCT01352741|4573305|P1|Double-blind Comparative Period|Protocol Violation|2
1386124|NCT01352741|4573304|P2|Open-label Tapentadol Titration Period|Not Specified|0
1386125|NCT01352741|4573305|P1|Open-label Tapentadol Titration Period|Not Specified|4
1386126|NCT01352741|4573304|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
1386127|NCT01352741|4573305|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
1386128|NCT01352741|4573304|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
1386129|NCT01352741|4573305|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
1386130|NCT01352741|4573304|P2|Open-label Tapentadol Titration Period|Adverse Event|0
1386131|NCT01352741|4573305|P1|Open-label Tapentadol Titration Period|Adverse Event|34
1386132|NCT01352741|4573304|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
1386133|NCT01352741|4573305|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
1386134|NCT01352741|4573304|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
1386135|NCT01352741|4573305|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
1386136|NCT01352715|4573399|P2|Overall Study|major ineligibility|1
1386137|NCT01352715|4573400|P1|Overall Study|major ineligibility|2
1386138|NCT01352715|4573399|P2|Overall Study|no final visit in closeout period|12
1386139|NCT01352715|4573400|P1|Overall Study|no final visit in closeout period|15
1386140|NCT01352715|4573399|P2|Overall Study|site closure|15
1386141|NCT01352715|4573400|P1|Overall Study|site closure|16
1386142|NCT01352715|4573399|P2|Overall Study|Withdrawal by Subject|8
1386143|NCT01352715|4573400|P1|Overall Study|Withdrawal by Subject|4
1386144|NCT01352715|4573399|P2|Overall Study|Lost to Follow-up|7
1386145|NCT01352715|4573400|P1|Overall Study|Lost to Follow-up|5
1386146|NCT01352715|4573399|P2|Overall Study|Death|3
1386147|NCT01352715|4573400|P1|Overall Study|Death|3
1386148|NCT01352585|4573422|P1|Overall Study|Not specified|7
1386149|NCT01352585|4573422|P1|Overall Study|Lost to Follow-up|1
1386150|NCT01352585|4573422|P1|Overall Study|Adverse Event|3
1386151|NCT01352507|4573439|P2|Treatment Period 2|Lack of Efficacy|0
1386152|NCT01352507|4573440|P1|Treatment Period 2|Lack of Efficacy|1
1386153|NCT01352507|4573439|P2|Treatment Period 2|Withdrawal by Subject|3
1386154|NCT01352507|4573440|P1|Treatment Period 2|Withdrawal by Subject|4
1386155|NCT01352507|4573439|P2|Treatment Period 2|Entry Criteria Not Met|0
1386156|NCT01352507|4573440|P1|Treatment Period 2|Entry Criteria Not Met|1
1386157|NCT01352507|4573439|P2|Washout Period|Withdrawal by Subject|1
1386158|NCT01352507|4573440|P1|Washout Period|Withdrawal by Subject|0
1386159|NCT01352507|4573439|P2|Treatment Period 1|Physician Decision|0
1386160|NCT01352507|4573440|P1|Treatment Period 1|Physician Decision|1
1386161|NCT01352507|4573439|P2|Treatment Period 1|Withdrawal by Subject|5
1386162|NCT01352507|4573440|P1|Treatment Period 1|Withdrawal by Subject|7
1386163|NCT01352507|4573439|P2|Treatment Period 1|Lost to Follow-up|4
1386164|NCT01352507|4573440|P1|Treatment Period 1|Lost to Follow-up|3
1386165|NCT01352507|4573439|P2|Treatment Period 1|Adverse Event|0
1386166|NCT01352507|4573440|P1|Treatment Period 1|Adverse Event|3
1386167|NCT01352416|4573493|P4|Overall Study|Physician Decision|1
1386168|NCT01352416|4573494|P3|Overall Study|Physician Decision|2
1386169|NCT01352416|4573495|P2|Overall Study|Physician Decision|2
1386170|NCT01352416|4573496|P1|Overall Study|Physician Decision|1
1386171|NCT01352221|4573508|P4|Open-label Phase|Worsening of IBD|0
1386172|NCT01352221|4573509|P3|Open-label Phase|Worsening of IBD|1
1386173|NCT01352221|4573510|P2|Open-label Phase|Worsening of IBD|0
1386174|NCT01352221|4573511|P1|Open-label Phase|Worsening of IBD|0
1386175|NCT01352221|4573508|P4|Open-label Phase|Withdrawal by Subject|6
1386176|NCT01352221|4573509|P3|Open-label Phase|Withdrawal by Subject|1
1386177|NCT01352221|4573510|P2|Open-label Phase|Withdrawal by Subject|0
1386178|NCT01352221|4573511|P1|Open-label Phase|Withdrawal by Subject|0
1386179|NCT01352221|4573508|P4|Open-label Phase|Adverse Event|4
1386180|NCT01352221|4573509|P3|Open-label Phase|Adverse Event|8
1386181|NCT01352221|4573510|P2|Open-label Phase|Adverse Event|0
1386182|NCT01352221|4573511|P1|Open-label Phase|Adverse Event|0
1386183|NCT01352221|4573508|P4|Open-label Phase|Pregnancy|0
1386184|NCT01352221|4573509|P3|Open-label Phase|Pregnancy|1
1386185|NCT01352221|4573510|P2|Open-label Phase|Pregnancy|0
1386186|NCT01352221|4573511|P1|Open-label Phase|Pregnancy|0
1386187|NCT01352221|4573508|P4|Open-label Phase|Physician Decision|1
1386188|NCT01352221|4573509|P3|Open-label Phase|Physician Decision|2
1386189|NCT01352221|4573510|P2|Open-label Phase|Physician Decision|0
1386190|NCT01352221|4573511|P1|Open-label Phase|Physician Decision|0
1386191|NCT01352221|4573508|P4|Double-blind Phase|Protocol Violation|0
1386192|NCT01352221|4573509|P3|Double-blind Phase|Protocol Violation|0
1386193|NCT01352221|4573510|P2|Double-blind Phase|Protocol Violation|1
1386194|NCT01352221|4573511|P1|Double-blind Phase|Protocol Violation|0
1386195|NCT01352221|4573508|P4|Double-blind Phase|Lost to Follow-up|0
1386196|NCT01352221|4573509|P3|Double-blind Phase|Lost to Follow-up|0
1386197|NCT01352221|4573510|P2|Double-blind Phase|Lost to Follow-up|1
1386198|NCT01352221|4573511|P1|Double-blind Phase|Lost to Follow-up|0
1386199|NCT01352221|4573508|P4|Double-blind Phase|Withdrawal by Subject|0
1386200|NCT01352221|4573509|P3|Double-blind Phase|Withdrawal by Subject|0
1386201|NCT01352221|4573510|P2|Double-blind Phase|Withdrawal by Subject|5
1386202|NCT01352221|4573511|P1|Double-blind Phase|Withdrawal by Subject|3
1386203|NCT01352221|4573508|P4|Double-blind Phase|Adverse Event|0
1386204|NCT01352221|4573509|P3|Double-blind Phase|Adverse Event|0
1386205|NCT01352221|4573510|P2|Double-blind Phase|Adverse Event|4
1386206|NCT01352221|4573511|P1|Double-blind Phase|Adverse Event|6
1386207|NCT01352117|4573571|P2|Overall Study|Ineligible (no KS diagnosis)|0
1386208|NCT01352117|4573572|P1|Overall Study|Ineligible (no KS diagnosis)|1
1386209|NCT01352117|4573571|P2|Overall Study|Did not initiate study treatment|0
1386210|NCT01352117|4573572|P1|Overall Study|Did not initiate study treatment|1
1386211|NCT01352117|4573571|P2|Overall Study|Non-adherent to study requirements|0
1386212|NCT01352117|4573572|P1|Overall Study|Non-adherent to study requirements|1
1386213|NCT01352117|4573571|P2|Overall Study|Lost to Follow-up|4
1386214|NCT01352117|4573572|P1|Overall Study|Lost to Follow-up|2
1386215|NCT01352117|4573571|P2|Overall Study|Withdrawal by Subject|0
1386216|NCT01352117|4573572|P1|Overall Study|Withdrawal by Subject|1
1386217|NCT01352117|4573571|P2|Overall Study|Death|12
1386218|NCT01352117|4573572|P1|Overall Study|Death|13
1386219|NCT01352117|4573571|P2|Overall Study|On study|80
1386220|NCT01352117|4573572|P1|Overall Study|On study|49
1386221|NCT01351623|4573635|P1|Overall Study|Death|2
1386222|NCT01351623|4573635|P1|Overall Study|Withdrawal by Subject|1
1386223|NCT01351623|4573635|P1|Overall Study|Adverse Event|4
1386224|NCT01351623|4573635|P1|Overall Study|Protocol Violation|2
1386225|NCT01351415|4573661|P2|Overall Study|Never Started|5
1386226|NCT01351415|4573662|P1|Overall Study|Never Started|5
1386227|NCT01351415|4573661|P2|Overall Study|Reason unknown|2
1386228|NCT01351415|4573662|P1|Overall Study|Reason unknown|0
1386229|NCT01351415|4573661|P2|Overall Study|Physician Decision|3
1386230|NCT01351415|4573662|P1|Overall Study|Physician Decision|2
1386231|NCT01351415|4573661|P2|Overall Study|Death|187
1386232|NCT01351415|4573662|P1|Overall Study|Death|190
1386233|NCT01351415|4573661|P2|Overall Study|Lost to Follow-up|7
1386234|NCT01351415|4573662|P1|Overall Study|Lost to Follow-up|5
1386235|NCT01351415|4573661|P2|Overall Study|Trial termination by the Sponsor|19
1386236|NCT01351415|4573662|P1|Overall Study|Trial termination by the Sponsor|28
1386237|NCT01351415|4573661|P2|Overall Study|Withdrawal by Subject|17
1386238|NCT01351415|4573662|P1|Overall Study|Withdrawal by Subject|15
1386239|NCT01351025|4573740|P2|Week 24 - 44|unable to get to clinic|1
1386240|NCT01351025|4573741|P1|Week 24 - 44|unable to get to clinic|1
1386241|NCT01351025|4573740|P2|Week 24 - 44|Site closed|1
1386242|NCT01351025|4573741|P1|Week 24 - 44|Site closed|0
1386243|NCT01351025|4573740|P2|Week 24 - 44|Lost to Follow-up|2
1386244|NCT01351025|4573741|P1|Week 24 - 44|Lost to Follow-up|0
1386245|NCT01351025|4573740|P2|Week 0 - 20|Withdrawal by Subject|0
1386246|NCT01351025|4573741|P1|Week 0 - 20|Withdrawal by Subject|1
1386247|NCT01351025|4573740|P2|Week 0 - 20|Lost to Follow-up|1
1386248|NCT01351025|4573741|P1|Week 0 - 20|Lost to Follow-up|2
1386249|NCT01350999|4573774|P3|Overall Study|Difficulty Making it to Study Visit|5
1386250|NCT01350999|4573775|P2|Overall Study|Difficulty Making it to Study Visit|1
1386251|NCT01350999|4573776|P1|Overall Study|Difficulty Making it to Study Visit|1
1386252|NCT01350999|4573774|P3|Overall Study|Voluntary withdrawal|6
1386253|NCT01350999|4573775|P2|Overall Study|Voluntary withdrawal|4
1386254|NCT01350999|4573776|P1|Overall Study|Voluntary withdrawal|3
1386255|NCT01350999|4573774|P3|Overall Study|Adverse Event|10
1386256|NCT01350999|4573775|P2|Overall Study|Adverse Event|9
1386257|NCT01350999|4573776|P1|Overall Study|Adverse Event|4
1386258|NCT01350973|4573814|P3|Overall Study|Voluntary Withdrawal|1
1386259|NCT01350973|4573815|P2|Overall Study|Voluntary Withdrawal|1
1386260|NCT01350973|4573816|P1|Overall Study|Voluntary Withdrawal|2
1386261|NCT01350973|4573814|P3|Overall Study|Adverse Event|7
1386262|NCT01350973|4573815|P2|Overall Study|Adverse Event|7
1386263|NCT01350973|4573816|P1|Overall Study|Adverse Event|4
1386264|NCT01350934|4573857|P2|Extension Study|Withdrawal by Subject|1
1386265|NCT01350934|4573858|P1|Extension Study|Withdrawal by Subject|0
1386266|NCT01350934|4573857|P2|Extension Study|Lack of Efficacy|1
1386267|NCT01350934|4573858|P1|Extension Study|Lack of Efficacy|0
1386268|NCT01350934|4573857|P2|Extension Study|Protocol Violation|1
1386269|NCT01350934|4573858|P1|Extension Study|Protocol Violation|1
1386270|NCT01350934|4573857|P2|Extension Study|Lost to Follow-up|0
1386271|NCT01350934|4573858|P1|Extension Study|Lost to Follow-up|2
1386272|NCT01350934|4573857|P2|Extension Study|Adverse Event|1
1386273|NCT01350934|4573858|P1|Extension Study|Adverse Event|2
1386274|NCT01350934|4573857|P2|Base Study|Non-Compliance With Study Drug|0
1386275|NCT01350934|4573858|P1|Base Study|Non-Compliance With Study Drug|2
1386276|NCT01350934|4573857|P2|Base Study|Withdrawal by Subject|2
1386277|NCT01350934|4573858|P1|Base Study|Withdrawal by Subject|1
1386278|NCT01350934|4573857|P2|Base Study|Protocol Violation|1
1386279|NCT01350934|4573858|P1|Base Study|Protocol Violation|1
1386280|NCT01350934|4573857|P2|Base Study|Lost to Follow-up|0
1386281|NCT01350934|4573858|P1|Base Study|Lost to Follow-up|1
1386282|NCT01350934|4573857|P2|Base Study|Adverse Event|0
1386283|NCT01350934|4573858|P1|Base Study|Adverse Event|6
1386284|NCT01350804|4573880|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
1386285|NCT01350804|4573881|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
1386286|NCT01350804|4573882|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
1386287|NCT01350804|4573883|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
1386288|NCT01350804|4573880|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
1386289|NCT01350804|4573881|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
1386290|NCT01350804|4573882|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
1386291|NCT01350804|4573883|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
1386292|NCT01350804|4573880|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
1386293|NCT01350804|4573881|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
1386294|NCT01350804|4573882|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
1386295|NCT01350804|4573883|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
1386296|NCT01350804|4573880|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
1386297|NCT01350804|4573881|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
1386298|NCT01350804|4573882|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
1386299|NCT01350804|4573883|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
1386300|NCT01350804|4573880|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
1386301|NCT01350804|4573881|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
1386302|NCT01350804|4573882|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
1386303|NCT01350804|4573883|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
1386304|NCT01350804|4573880|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
1386305|NCT01350804|4573881|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
1386306|NCT01350804|4573882|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
1386307|NCT01350804|4573883|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
1386308|NCT01350804|4573880|P4|Core Study|Adverse Event|8
1386309|NCT01350804|4573881|P3|Core Study|Adverse Event|8
1386310|NCT01350804|4573882|P2|Core Study|Adverse Event|10
1386311|NCT01350804|4573883|P1|Core Study|Adverse Event|8
1386312|NCT01350804|4573880|P4|Core Study|Death|0
1386313|NCT01350804|4573881|P3|Core Study|Death|1
1386314|NCT01350804|4573882|P2|Core Study|Death|1
1386315|NCT01350804|4573883|P1|Core Study|Death|1
1386316|NCT01350804|4573880|P4|Core Study|Lack of Efficacy|5
1386317|NCT01350804|4573881|P3|Core Study|Lack of Efficacy|18
1386318|NCT01350804|4573882|P2|Core Study|Lack of Efficacy|19
1386319|NCT01350804|4573883|P1|Core Study|Lack of Efficacy|16
1386320|NCT01350804|4573880|P4|Core Study|Lost to Follow-up|1
1386321|NCT01350804|4573881|P3|Core Study|Lost to Follow-up|2
1386322|NCT01350804|4573882|P2|Core Study|Lost to Follow-up|0
1386323|NCT01350804|4573883|P1|Core Study|Lost to Follow-up|3
1386324|NCT01350804|4573880|P4|Core Study|Physician Decision|3
1386325|NCT01350804|4573881|P3|Core Study|Physician Decision|1
1386326|NCT01350804|4573882|P2|Core Study|Physician Decision|0
1386327|NCT01350804|4573883|P1|Core Study|Physician Decision|1
1386328|NCT01350804|4573880|P4|Core Study|Protocol deviation|0
1386329|NCT01350804|4573881|P3|Core Study|Protocol deviation|1
1386330|NCT01350804|4573882|P2|Core Study|Protocol deviation|0
1386331|NCT01350804|4573883|P1|Core Study|Protocol deviation|1
1386332|NCT01350804|4573880|P4|Core Study|Study terminated by Sponsor|2
1386333|NCT01350804|4573881|P3|Core Study|Study terminated by Sponsor|0
1386334|NCT01350804|4573882|P2|Core Study|Study terminated by Sponsor|0
1386335|NCT01350804|4573883|P1|Core Study|Study terminated by Sponsor|0
1386336|NCT01350804|4573880|P4|Core Study|Withdrawal by Subject|7
1386337|NCT01350804|4573881|P3|Core Study|Withdrawal by Subject|16
1386338|NCT01350804|4573882|P2|Core Study|Withdrawal by Subject|17
1386339|NCT01350804|4573883|P1|Core Study|Withdrawal by Subject|11
1386340|NCT01350544|4573980|P2|Overall Study|Lost to Follow-up|15
1386341|NCT01350544|4573981|P1|Overall Study|Lost to Follow-up|18
1386342|NCT01350544|4573980|P2|Overall Study|Incarceration|0
1386343|NCT01350544|4573981|P1|Overall Study|Incarceration|1
1386344|NCT01350544|4573980|P2|Overall Study|Withdrawal by Subject|1
1386345|NCT01350544|4573981|P1|Overall Study|Withdrawal by Subject|0
1386346|NCT01350544|4573980|P2|Overall Study|Medical Issues|1
1386347|NCT01350544|4573981|P1|Overall Study|Medical Issues|1
1386348|NCT01350544|4573980|P2|Overall Study|Moved out of LA County|2
1386349|NCT01350544|4573981|P1|Overall Study|Moved out of LA County|2
1386350|NCT01350544|4573980|P2|Overall Study|Death|2
1386351|NCT01350544|4573981|P1|Overall Study|Death|1
1386352|NCT01350544|4573980|P2|Overall Study|Administrative Withdrawal|1
1386353|NCT01350544|4573981|P1|Overall Study|Administrative Withdrawal|0
1386354|NCT01350414|4573996|P1|Overall Study|Physician Decision|2
1386355|NCT01350414|4573996|P1|Overall Study|Withdrawal by Subject|4
1386356|NCT01350414|4573996|P1|Overall Study|Lost to Follow-up|13
1386357|NCT01350271|4574045|P3|Overall Study|Lost to Follow-up|26
1386358|NCT01350271|4574046|P2|Overall Study|Lost to Follow-up|17
1386359|NCT01350271|4574047|P1|Overall Study|Lost to Follow-up|21
1386360|NCT01350141|4574089|P3|Overall Study|Randomized but not treated|0
1386361|NCT01350141|4574090|P2|Overall Study|Randomized but not treated|0
1386362|NCT01350141|4574091|P1|Overall Study|Randomized but not treated|1
1386363|NCT01350141|4574089|P3|Overall Study|Withdrawal by Subject|0
1386364|NCT01350141|4574090|P2|Overall Study|Withdrawal by Subject|0
1386365|NCT01350141|4574091|P1|Overall Study|Withdrawal by Subject|1
1386366|NCT01350141|4574089|P3|Overall Study|Lost to Follow-up|1
1386367|NCT01350141|4574090|P2|Overall Study|Lost to Follow-up|0
1386368|NCT01350141|4574091|P1|Overall Study|Lost to Follow-up|1
1386369|NCT01350128|4574125|P1|Overall Study|Lost to Follow-up|2
1386370|NCT01350128|4574125|P1|Overall Study|Physician Decision|1
1386371|NCT01350128|4574125|P1|Overall Study|Protocol discontinuation criteria|8
1386372|NCT01350128|4574125|P1|Overall Study|Withdrawal by Subject|3
1386373|NCT01350115|4574189|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
1386374|NCT01350115|4574190|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
1386375|NCT01350115|4574189|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
1386376|NCT01350115|4574190|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
1386377|NCT01350115|4574189|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
1386378|NCT01350115|4574190|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
1386379|NCT01350102|4574206|P4|Overall Study|Adverse Event|0
1386380|NCT01350102|4574207|P3|Overall Study|Adverse Event|1
1386381|NCT01350102|4574208|P2|Overall Study|Adverse Event|0
1386382|NCT01350102|4574209|P1|Overall Study|Adverse Event|0
1386383|NCT01349959|4574246|P1|Overall Study|Patients are followed for survival|7
1386384|NCT01349907|4574282|P2|Overall Study|Administrative|1
1386385|NCT01349907|4574283|P1|Overall Study|Administrative|1
1386386|NCT01349907|4574282|P2|Overall Study|Protocol Violation|13
1386387|NCT01349907|4574283|P1|Overall Study|Protocol Violation|33
1386388|NCT01349907|4574282|P2|Overall Study|Withdrawal by Subject|8
1386389|NCT01349907|4574283|P1|Overall Study|Withdrawal by Subject|30
1386390|NCT01349907|4574282|P2|Overall Study|Lost to Follow-up|6
1386391|NCT01349907|4574283|P1|Overall Study|Lost to Follow-up|25
1386392|NCT01349907|4574282|P2|Overall Study|Treatment failure|4
1386393|NCT01349907|4574283|P1|Overall Study|Treatment failure|13
1386394|NCT01349907|4574282|P2|Overall Study|Adverse Event|11
1386395|NCT01349907|4574283|P1|Overall Study|Adverse Event|37
1386396|NCT01349829|4574321|P2|Overall Study|Migrated/moved|7
1386397|NCT01349829|4574322|P1|Overall Study|Migrated/moved|2
1386398|NCT01349829|4574321|P2|Overall Study|Consent withdrawal|8
1386399|NCT01349829|4574322|P1|Overall Study|Consent withdrawal|3
1386400|NCT01349829|4574321|P2|Overall Study|Lost to Follow-up|8
1386401|NCT01349829|4574322|P1|Overall Study|Lost to Follow-up|4
1386402|NCT01349816|4574340|P1|Overall Study|Protocol-specified criteria|8
1386403|NCT01349816|4574340|P1|Overall Study|Protocol Violation|1
1386404|NCT01349816|4574340|P1|Overall Study|Lost to Follow-up|2
1386405|NCT01349816|4574340|P1|Overall Study|Adverse Event|14
1386406|NCT01349816|4574340|P1|Overall Study|Physician Decision|1
1386407|NCT01349816|4574340|P1|Overall Study|Withdrawal by Subject|4
1386408|NCT01349803|4574406|P4|Overall Study|Protocol-specified criteria|0
1386409|NCT01349803|4574407|P3|Overall Study|Protocol-specified criteria|3
1386410|NCT01349803|4574408|P2|Overall Study|Protocol-specified criteria|1
1386411|NCT01349803|4574409|P1|Overall Study|Protocol-specified criteria|0
1386412|NCT01349803|4574406|P4|Overall Study|Withdrawal by Subject|0
1386413|NCT01349803|4574407|P3|Overall Study|Withdrawal by Subject|0
1386414|NCT01349803|4574408|P2|Overall Study|Withdrawal by Subject|0
1386415|NCT01349803|4574409|P1|Overall Study|Withdrawal by Subject|1
1386416|NCT01349803|4574406|P4|Overall Study|Adverse Event|2
1386417|NCT01349803|4574407|P3|Overall Study|Adverse Event|0
1386418|NCT01349803|4574408|P2|Overall Study|Adverse Event|0
1386419|NCT01349803|4574409|P1|Overall Study|Adverse Event|0
1386420|NCT01349790|4574479|P1|Overall Study|Lost to Follow-up|1
1386421|NCT01349790|4574479|P1|Overall Study|Adverse Event|1
1386422|NCT01349790|4574479|P1|Overall Study|Withdrawal by Patient|2
1386423|NCT01349790|4574479|P1|Overall Study|Death|2
1386424|NCT01349790|4574479|P1|Overall Study|Investigator Judgement|3
1386425|NCT01349660|4574501|P3|Overall Study|Declining Performance Status|1
1386426|NCT01349660|4574502|P2|Overall Study|Declining Performance Status|0
1386427|NCT01349660|4574503|P1|Overall Study|Declining Performance Status|0
1386428|NCT01349660|4574501|P3|Overall Study|Study Compliance|1
1386429|NCT01349660|4574502|P2|Overall Study|Study Compliance|0
1386430|NCT01349660|4574503|P1|Overall Study|Study Compliance|0
1386431|NCT01349660|4574501|P3|Overall Study|Non-Permitted Interventions|2
1386432|NCT01349660|4574502|P2|Overall Study|Non-Permitted Interventions|0
1386433|NCT01349660|4574503|P1|Overall Study|Non-Permitted Interventions|0
1386434|NCT01349660|4574501|P3|Overall Study|Death|0
1386435|NCT01349660|4574502|P2|Overall Study|Death|1
1386436|NCT01349660|4574503|P1|Overall Study|Death|1
1386437|NCT01349660|4574501|P3|Overall Study|Withdrawal by Subject|9
1386438|NCT01349660|4574502|P2|Overall Study|Withdrawal by Subject|0
1386439|NCT01349660|4574503|P1|Overall Study|Withdrawal by Subject|2
1386440|NCT01349660|4574501|P3|Overall Study|Adverse Event|12
1386441|NCT01349660|4574502|P2|Overall Study|Adverse Event|1
1386442|NCT01349660|4574503|P1|Overall Study|Adverse Event|1
1386443|NCT01349660|4574501|P3|Overall Study|Disease Progression|50
1386444|NCT01349660|4574502|P2|Overall Study|Disease Progression|4
1386445|NCT01349660|4574503|P1|Overall Study|Disease Progression|2
1386446|NCT01349660|4574501|P3|Overall Study|Still Receiving Study Treatment|1
1386447|NCT01349660|4574502|P2|Overall Study|Still Receiving Study Treatment|0
1386448|NCT01349660|4574503|P1|Overall Study|Still Receiving Study Treatment|0
1386449|NCT01349595|4574521|P2|Overall Study|Lack of funding|2
1386450|NCT01349595|4574522|P1|Overall Study|Lack of funding|2
1386628|NCT01346514|4575471|P1|Overall Study|Withdrawal by Subject|7
1386451|NCT01349465|4574539|P2|Overall Study|Subject Ineligible To Continue The Trial|19
1386452|NCT01349465|4574540|P1|Overall Study|Subject Ineligible To Continue The Trial|0
1386453|NCT01349465|4574539|P2|Overall Study|Withdrawal by Subject|2
1386454|NCT01349465|4574540|P1|Overall Study|Withdrawal by Subject|4
1386455|NCT01349465|4574539|P2|Overall Study|Lost to Follow-up|1
1386456|NCT01349465|4574540|P1|Overall Study|Lost to Follow-up|10
1386457|NCT01349465|4574539|P2|Overall Study|Death|0
1386458|NCT01349465|4574540|P1|Overall Study|Death|3
1386459|NCT01349465|4574539|P2|Overall Study|Adverse Event|0
1386460|NCT01349465|4574540|P1|Overall Study|Adverse Event|1
1386461|NCT01349192|4574561|P2|Overall Study|Failure to adhere to Protocol|0
1386462|NCT01349192|4574562|P1|Overall Study|Failure to adhere to Protocol|2
1386463|NCT01349192|4574561|P2|Overall Study|Lost to Follow-up|3
1386464|NCT01349192|4574562|P1|Overall Study|Lost to Follow-up|1
1386465|NCT01349192|4574561|P2|Overall Study|Withdrawal by Subject|2
1386466|NCT01349192|4574562|P1|Overall Study|Withdrawal by Subject|0
1386467|NCT01349192|4574561|P2|Overall Study|Protocol Violation|1
1386468|NCT01349192|4574562|P1|Overall Study|Protocol Violation|0
1386469|NCT01348854|4574587|P2|Overall Study|Withdrawal by Subject|0
1386470|NCT01348854|4574588|P1|Overall Study|Withdrawal by Subject|1
1386471|NCT01348854|4574587|P2|Overall Study|Lost to Follow-up|1
1386472|NCT01348854|4574588|P1|Overall Study|Lost to Follow-up|2
1386473|NCT01348789|4574596|P1|Overall Study|Withdrawal by Subject|2
1386474|NCT01348789|4574596|P1|Overall Study|Protocol Violation|2
1386475|NCT01348776|4574607|P1|Overall Study|Lost to Follow-up|3
1386476|NCT01348425|4574638|P2|Overall Study|Imaging was not taken.|1
1386477|NCT01348425|4574639|P1|Overall Study|Imaging was not taken.|1
1386478|NCT01348347|4574647|P3|Overall Study|Progressive disease|5
1386479|NCT01348347|4574648|P2|Overall Study|Progressive disease|5
1386480|NCT01348347|4574649|P1|Overall Study|Progressive disease|2
1386481|NCT01348347|4574647|P3|Overall Study|Withdrawal by Subject|1
1386482|NCT01348347|4574648|P2|Overall Study|Withdrawal by Subject|1
1386483|NCT01348347|4574649|P1|Overall Study|Withdrawal by Subject|1
1386484|NCT01348165|4574680|P7|Overall Study|Adverse Event|1
1386485|NCT01348165|4574681|P6|Overall Study|Adverse Event|0
1386486|NCT01348165|4574682|P5|Overall Study|Adverse Event|0
1386487|NCT01348165|4574683|P4|Overall Study|Adverse Event|0
1386488|NCT01348165|4574684|P3|Overall Study|Adverse Event|0
1386489|NCT01348165|4574685|P2|Overall Study|Adverse Event|0
1386490|NCT01348165|4574686|P1|Overall Study|Adverse Event|0
1386491|NCT01348139|4574815|P6|Period 1|Adverse Event|0
1386492|NCT01348139|4574816|P5|Period 1|Adverse Event|0
1386493|NCT01348139|4574817|P4|Period 1|Adverse Event|0
1386494|NCT01348139|4574818|P3|Period 1|Adverse Event|0
1386495|NCT01348139|4574819|P2|Period 1|Adverse Event|0
1386496|NCT01348139|4574820|P1|Period 1|Adverse Event|1
1386497|NCT01348100|4574901|P7|Overall Study|Administrative Problems|1
1386498|NCT01348100|4574902|P6|Overall Study|Administrative Problems|1
1386499|NCT01348100|4574903|P5|Overall Study|Administrative Problems|0
1386500|NCT01348100|4574904|P4|Overall Study|Administrative Problems|0
1386501|NCT01348100|4574905|P3|Overall Study|Administrative Problems|0
1386502|NCT01348100|4574906|P2|Overall Study|Administrative Problems|0
1386503|NCT01348100|4574907|P1|Overall Study|Administrative Problems|0
1386504|NCT01348100|4574901|P7|Overall Study|Lost to Follow-up|1
1386505|NCT01348100|4574902|P6|Overall Study|Lost to Follow-up|0
1386506|NCT01348100|4574903|P5|Overall Study|Lost to Follow-up|0
1386507|NCT01348100|4574904|P4|Overall Study|Lost to Follow-up|0
1386508|NCT01348100|4574905|P3|Overall Study|Lost to Follow-up|0
1386509|NCT01348100|4574906|P2|Overall Study|Lost to Follow-up|0
1386510|NCT01348100|4574907|P1|Overall Study|Lost to Follow-up|0
1386511|NCT01348100|4574901|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
1386512|NCT01348100|4574902|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
1386513|NCT01348100|4574903|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
1386514|NCT01348100|4574904|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
1386515|NCT01348100|4574905|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
1386516|NCT01348100|4574906|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
1386517|NCT01348100|4574907|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
1386518|NCT01348100|4574901|P7|Overall Study|Protocol Deviation|0
1386519|NCT01348100|4574902|P6|Overall Study|Protocol Deviation|0
1386520|NCT01348100|4574903|P5|Overall Study|Protocol Deviation|0
1386521|NCT01348100|4574904|P4|Overall Study|Protocol Deviation|1
1386522|NCT01348100|4574905|P3|Overall Study|Protocol Deviation|0
1386523|NCT01348100|4574906|P2|Overall Study|Protocol Deviation|0
1386524|NCT01348100|4574907|P1|Overall Study|Protocol Deviation|0
1386525|NCT01348100|4574901|P7|Overall Study|Subject Withdrew Consent|1
1386526|NCT01348100|4574902|P6|Overall Study|Subject Withdrew Consent|0
1386527|NCT01348100|4574903|P5|Overall Study|Subject Withdrew Consent|1
1386528|NCT01348100|4574904|P4|Overall Study|Subject Withdrew Consent|0
1386529|NCT01348100|4574905|P3|Overall Study|Subject Withdrew Consent|2
1386530|NCT01348100|4574906|P2|Overall Study|Subject Withdrew Consent|0
1386531|NCT01348100|4574907|P1|Overall Study|Subject Withdrew Consent|0
1386532|NCT01348087|4574952|P1|Overall Study|Adverse Event|25
1386533|NCT01348087|4574952|P1|Overall Study|Subject withdrew consent|7
1386534|NCT01348087|4574952|P1|Overall Study|Lost to Follow-up|1
1386535|NCT01348087|4574952|P1|Overall Study|protocol deviation|1
1386536|NCT01348087|4574952|P1|Overall Study|Administrative problems|79
1386537|NCT01348087|4574952|P1|Overall Study|Unsatisfactory therapeutic effect|35
1386538|NCT01347931|4574966|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
1386539|NCT01347879|4574978|P2|Overall Study|Other|3
1386540|NCT01347879|4574979|P1|Overall Study|Other|2
1386541|NCT01347879|4574978|P2|Overall Study|Withdrawal by Subject|2
1386542|NCT01347879|4574979|P1|Overall Study|Withdrawal by Subject|3
1386543|NCT01347879|4574978|P2|Overall Study|Lost to Follow-up|0
1386544|NCT01347879|4574979|P1|Overall Study|Lost to Follow-up|2
1386545|NCT01347879|4574978|P2|Overall Study|Adverse Event|12
1386546|NCT01347879|4574979|P1|Overall Study|Adverse Event|0
1386547|NCT01347840|4575011|P1|Overall Study|Withdrawal by Subject|1
1386548|NCT01347762|4575038|P4|Overall Study|Withdrawal by Subject|3
1386549|NCT01347762|4575039|P3|Overall Study|Withdrawal by Subject|3
1386550|NCT01347762|4575040|P2|Overall Study|Withdrawal by Subject|1
1386551|NCT01347762|4575041|P1|Overall Study|Withdrawal by Subject|4
1386552|NCT01347762|4575038|P4|Overall Study|Lost to Follow-up|5
1386553|NCT01347762|4575039|P3|Overall Study|Lost to Follow-up|6
1386554|NCT01347762|4575040|P2|Overall Study|Lost to Follow-up|1
1386555|NCT01347762|4575041|P1|Overall Study|Lost to Follow-up|0
1386556|NCT01347710|4575067|P1|Overall Study|Other|3
1386557|NCT01347710|4575067|P1|Overall Study|Physician Decision|2
1386558|NCT01347710|4575067|P1|Overall Study|Lost to Follow-up|1
1386559|NCT01347710|4575067|P1|Overall Study|issue with vitals prior to dosing|1
1386560|NCT01347710|4575067|P1|Overall Study|Angio or SPECT not completed|18
1386561|NCT01347710|4575067|P1|Overall Study|Adverse Event|4
1386562|NCT01347710|4575067|P1|Overall Study|Withdrawal by Subject|2
1386563|NCT01347580|4575089|P2|Overall Study|Had other reason|6
1386564|NCT01347580|4575090|P1|Overall Study|Had other reason|9
1386565|NCT01347580|4575089|P2|Overall Study|Lost to Follow-up|1
1386566|NCT01347580|4575090|P1|Overall Study|Lost to Follow-up|3
1386567|NCT01347580|4575089|P2|Overall Study|Protocol Violation|7
1386568|NCT01347580|4575090|P1|Overall Study|Protocol Violation|10
1386569|NCT01347580|4575089|P2|Overall Study|Death|19
1386570|NCT01347580|4575090|P1|Overall Study|Death|30
1386571|NCT01347580|4575089|P2|Overall Study|Withdrawal by Subject|23
1386572|NCT01347580|4575090|P1|Overall Study|Withdrawal by Subject|13
1386573|NCT01347554|4575120|P2|Overall Study|Lack of Efficacy|11
1386574|NCT01347554|4575121|P1|Overall Study|Lack of Efficacy|7
1386575|NCT01347112|4575158|P2|Overall Study|Lost to Follow-up|5
1386576|NCT01347112|4575159|P1|Overall Study|Lost to Follow-up|3
1386577|NCT01347112|4575158|P2|Overall Study|Withdrawal by Subject|7
1386578|NCT01347112|4575159|P1|Overall Study|Withdrawal by Subject|1
1386579|NCT01347086|4575179|P10|Overall Study|failed screening visit|1
1386580|NCT01347086|4575180|P9|Overall Study|failed screening visit|0
1386581|NCT01347086|4575181|P8|Overall Study|failed screening visit|1
1386582|NCT01347086|4575182|P7|Overall Study|failed screening visit|1
1386583|NCT01347086|4575183|P6|Overall Study|failed screening visit|0
1386584|NCT01347086|4575184|P5|Overall Study|failed screening visit|0
1386585|NCT01347086|4575185|P4|Overall Study|failed screening visit|0
1386586|NCT01347086|4575186|P3|Overall Study|failed screening visit|1
1386587|NCT01347086|4575187|P2|Overall Study|failed screening visit|0
1386588|NCT01347086|4575188|P1|Overall Study|failed screening visit|0
1386589|NCT01347073|4575287|P1|Overall Study|Liver Transplant|1
1386590|NCT01347073|4575287|P1|Overall Study|Adverse Event|1
1386591|NCT01346774|4575366|P2|Overall Study|Adverse Event|2
1386592|NCT01346774|4575367|P1|Overall Study|Adverse Event|1
1386593|NCT01346774|4575366|P2|Overall Study|Protocol Violation|3
1386594|NCT01346774|4575367|P1|Overall Study|Protocol Violation|2
1386595|NCT01346774|4575366|P2|Overall Study|Withdrawal by Subject|4
1386596|NCT01346774|4575367|P1|Overall Study|Withdrawal by Subject|1
1386597|NCT01346774|4575366|P2|Overall Study|Lost to Follow-up|4
1386598|NCT01346774|4575367|P1|Overall Study|Lost to Follow-up|3
1386599|NCT01346774|4575366|P2|Overall Study|Did not take a single dose|4
1386600|NCT01346774|4575367|P1|Overall Study|Did not take a single dose|6
1386601|NCT01346592|4575376|P3|Overall Study|Unable to Classify|6
1386602|NCT01346592|4575377|P2|Overall Study|Unable to Classify|3
1386603|NCT01346592|4575378|P1|Overall Study|Unable to Classify|7
1386604|NCT01346592|4575376|P3|Overall Study|Administrative reason|0
1386605|NCT01346592|4575377|P2|Overall Study|Administrative reason|0
1386606|NCT01346592|4575378|P1|Overall Study|Administrative reason|1
1386607|NCT01346592|4575376|P3|Overall Study|Inappropriate enrollment|1
1386608|NCT01346592|4575377|P2|Overall Study|Inappropriate enrollment|1
1386609|NCT01346592|4575378|P1|Overall Study|Inappropriate enrollment|3
1386610|NCT01346592|4575376|P3|Overall Study|Withdrawal by Subject|38
1386611|NCT01346592|4575377|P2|Overall Study|Withdrawal by Subject|51
1386612|NCT01346592|4575378|P1|Overall Study|Withdrawal by Subject|77
1386613|NCT01346592|4575376|P3|Overall Study|Adverse Event|0
1386614|NCT01346592|4575377|P2|Overall Study|Adverse Event|1
1386615|NCT01346592|4575378|P1|Overall Study|Adverse Event|0
1386616|NCT01346592|4575376|P3|Overall Study|Death|4
1386617|NCT01346592|4575377|P2|Overall Study|Death|3
1386618|NCT01346592|4575378|P1|Overall Study|Death|1
1386619|NCT01346592|4575376|P3|Overall Study|Protocol Violation|0
1386620|NCT01346592|4575377|P2|Overall Study|Protocol Violation|1
1386621|NCT01346592|4575378|P1|Overall Study|Protocol Violation|2
1386622|NCT01346592|4575376|P3|Overall Study|Lost to Follow-up|29
1386623|NCT01346592|4575377|P2|Overall Study|Lost to Follow-up|29
1386624|NCT01346592|4575378|P1|Overall Study|Lost to Follow-up|62
1386625|NCT01346514|4575470|P2|Overall Study|Death|4
1386626|NCT01346514|4575471|P1|Overall Study|Death|3
1386627|NCT01346514|4575470|P2|Overall Study|Withdrawal by Subject|3
1386629|NCT01346514|4575470|P2|Overall Study|Lost to Follow-up|30
1386630|NCT01346514|4575471|P1|Overall Study|Lost to Follow-up|19
1386631|NCT01346501|4575491|P2|Overall Study|Not Specified|12
1386632|NCT01346501|4575492|P1|Overall Study|Not Specified|8
1386633|NCT01346501|4575491|P2|Overall Study|Initiated Other Biological Agents|1
1386634|NCT01346501|4575492|P1|Overall Study|Initiated Other Biological Agents|3
1386635|NCT01346475|4575525|P2|First Intervention|Lost to Follow-up|3
1386636|NCT01346475|4575526|P1|First Intervention|Lost to Follow-up|4
1386637|NCT01346410|4575538|P1|Overall Study|Death|1
1386638|NCT01346293|4575555|P2|Overall Study|Other|0
1386639|NCT01346293|4575556|P1|Overall Study|Other|1
1386640|NCT01346293|4575555|P2|Overall Study|Withdrawal by Subject|4
1386641|NCT01346293|4575556|P1|Overall Study|Withdrawal by Subject|15
1386642|NCT01346293|4575555|P2|Overall Study|Lost to Follow-up|8
1386643|NCT01346293|4575556|P1|Overall Study|Lost to Follow-up|21
1386644|NCT01346293|4575555|P2|Overall Study|Protocol Violation|9
1386645|NCT01346293|4575556|P1|Overall Study|Protocol Violation|30
1386646|NCT01346189|4575586|P4|Overall Study|Travel|3
1386647|NCT01346189|4575587|P3|Overall Study|Travel|0
1386648|NCT01346189|4575588|P2|Overall Study|Travel|0
1386649|NCT01346189|4575589|P1|Overall Study|Travel|0
1386650|NCT01346189|4575586|P4|Overall Study|Non-health system primary care physician|0
1386651|NCT01346189|4575587|P3|Overall Study|Non-health system primary care physician|0
1386652|NCT01346189|4575588|P2|Overall Study|Non-health system primary care physician|5
1386653|NCT01346189|4575589|P1|Overall Study|Non-health system primary care physician|0
1386654|NCT01346189|4575586|P4|Overall Study|Death|0
1386655|NCT01346189|4575587|P3|Overall Study|Death|0
1386656|NCT01346189|4575588|P2|Overall Study|Death|3
1386657|NCT01346189|4575589|P1|Overall Study|Death|0
1386658|NCT01346189|4575586|P4|Overall Study|Other|3
1386659|NCT01346189|4575587|P3|Overall Study|Other|7
1386660|NCT01346189|4575588|P2|Overall Study|Other|4
1386661|NCT01346189|4575589|P1|Overall Study|Other|2
1386662|NCT01346189|4575586|P4|Overall Study|Moved|0
1386663|NCT01346189|4575587|P3|Overall Study|Moved|4
1386664|NCT01346189|4575588|P2|Overall Study|Moved|0
1386665|NCT01346189|4575589|P1|Overall Study|Moved|3
1386666|NCT01346189|4575586|P4|Overall Study|Physician Decision|0
1386667|NCT01346189|4575587|P3|Overall Study|Physician Decision|0
1386668|NCT01346189|4575588|P2|Overall Study|Physician Decision|0
1386669|NCT01346189|4575589|P1|Overall Study|Physician Decision|4
1386670|NCT01346189|4575586|P4|Overall Study|Withdrawal by Subject|5
1386671|NCT01346189|4575587|P3|Overall Study|Withdrawal by Subject|3
1386672|NCT01346189|4575588|P2|Overall Study|Withdrawal by Subject|5
1386673|NCT01346189|4575589|P1|Overall Study|Withdrawal by Subject|7
1386674|NCT01346176|4575606|P3|Completed Satisfaction Survey|Lost to Follow-up|4
1386675|NCT01346176|4575607|P2|Completed Satisfaction Survey|Lost to Follow-up|4
1386676|NCT01346176|4575608|P1|Completed Satisfaction Survey|Lost to Follow-up|3
1386677|NCT01346176|4575606|P3|Completed Satisfaction Survey|Death|2
1386678|NCT01346176|4575607|P2|Completed Satisfaction Survey|Death|0
1386679|NCT01346176|4575608|P1|Completed Satisfaction Survey|Death|3
1386680|NCT01346176|4575606|P3|Completed Advance Directive|Other reason did not complete AD|7
1386681|NCT01346176|4575607|P2|Completed Advance Directive|Other reason did not complete AD|12
1386682|NCT01346176|4575608|P1|Completed Advance Directive|Other reason did not complete AD|7
1386683|NCT01346176|4575606|P3|Completed Advance Directive|Became Ineligible|1
1386684|NCT01346176|4575607|P2|Completed Advance Directive|Became Ineligible|0
1386685|NCT01346176|4575608|P1|Completed Advance Directive|Became Ineligible|3
1386686|NCT01346176|4575606|P3|Completed Advance Directive|Death|2
1386687|NCT01346176|4575607|P2|Completed Advance Directive|Death|2
1386688|NCT01346176|4575608|P1|Completed Advance Directive|Death|3
1386689|NCT01346176|4575606|P3|Recruited|Protocol Violation|0
1386690|NCT01346176|4575607|P2|Recruited|Protocol Violation|0
1386691|NCT01346176|4575608|P1|Recruited|Protocol Violation|1
1386692|NCT01346059|4575637|P2|Overall Study|Withdrawal by Subject|0
1386693|NCT01346059|4575638|P1|Overall Study|Withdrawal by Subject|1
1386694|NCT01345929|4575650|P2|Overall Study|Patient withdrawal|1
1386695|NCT01345929|4575651|P1|Overall Study|Patient withdrawal|0
1386696|NCT01345929|4575650|P2|Overall Study|40,000 CFU/ML|0
1386697|NCT01345929|4575651|P1|Overall Study|40,000 CFU/ML|1
1386698|NCT01345929|4575650|P2|Overall Study|Didn't meet eligibility criteria|0
1386699|NCT01345929|4575651|P1|Overall Study|Didn't meet eligibility criteria|2
1386700|NCT01345929|4575650|P2|Overall Study|Adverse Event|1
1386701|NCT01345929|4575651|P1|Overall Study|Adverse Event|0
1386702|NCT01345929|4575650|P2|Overall Study|Lost to Follow-up|9
1386703|NCT01345929|4575651|P1|Overall Study|Lost to Follow-up|9
1386704|NCT01345929|4575650|P2|Overall Study|Withdrawal by Subject|8
1386705|NCT01345929|4575651|P1|Overall Study|Withdrawal by Subject|9
1386706|NCT01345786|4575663|P4|Overall Study|Lost to Follow-up|2
1386707|NCT01345786|4575664|P3|Overall Study|Lost to Follow-up|0
1386708|NCT01345786|4575665|P2|Overall Study|Lost to Follow-up|0
1386709|NCT01345786|4575666|P1|Overall Study|Lost to Follow-up|0
1386710|NCT01345786|4575663|P4|Overall Study|Administrative|0
1386711|NCT01345786|4575664|P3|Overall Study|Administrative|0
1386712|NCT01345786|4575665|P2|Overall Study|Administrative|5
1386713|NCT01345786|4575666|P1|Overall Study|Administrative|3
1386714|NCT01345786|4575663|P4|Overall Study|Noncompliance with protocol|0
1386715|NCT01345786|4575664|P3|Overall Study|Noncompliance with protocol|1
1386716|NCT01345786|4575665|P2|Overall Study|Noncompliance with protocol|0
1386717|NCT01345786|4575666|P1|Overall Study|Noncompliance with protocol|1
1386718|NCT01345786|4575663|P4|Overall Study|Subject withdrew consent|0
1386719|NCT01345786|4575664|P3|Overall Study|Subject withdrew consent|1
1386720|NCT01345786|4575665|P2|Overall Study|Subject withdrew consent|2
1386721|NCT01345786|4575666|P1|Overall Study|Subject withdrew consent|2
1386722|NCT01345786|4575663|P4|Overall Study|Adverse Event|1
1386723|NCT01345786|4575664|P3|Overall Study|Adverse Event|3
1386724|NCT01345786|4575665|P2|Overall Study|Adverse Event|1
1386725|NCT01345786|4575666|P1|Overall Study|Adverse Event|0
1386726|NCT01345682|4575746|P2|Overall Study|Reason other than those specified above|3
1386727|NCT01345682|4575747|P1|Overall Study|Reason other than those specified above|4
1386728|NCT01345682|4575746|P2|Overall Study|Not treated|1
1386729|NCT01345682|4575747|P1|Overall Study|Not treated|2
1386730|NCT01345682|4575746|P2|Overall Study|Refused to continue trial medication|9
1386731|NCT01345682|4575747|P1|Overall Study|Refused to continue trial medication|16
1386732|NCT01345682|4575746|P2|Overall Study|Lost to Follow-up|1
1386733|NCT01345682|4575747|P1|Overall Study|Lost to Follow-up|0
1386734|NCT01345682|4575746|P2|Overall Study|Non-compliance with protocol|1
1386735|NCT01345682|4575747|P1|Overall Study|Non-compliance with protocol|0
1386736|NCT01345682|4575746|P2|Overall Study|Adverse Event|41
1386737|NCT01345682|4575747|P1|Overall Study|Adverse Event|51
1386738|NCT01345682|4575746|P2|Overall Study|Worsening of underlying cancer disease|12
1386739|NCT01345682|4575747|P1|Overall Study|Worsening of underlying cancer disease|23
1386740|NCT01345682|4575746|P2|Overall Study|Progressive disease per RECIST|93
1386741|NCT01345682|4575747|P1|Overall Study|Progressive disease per RECIST|226
1386742|NCT01345669|4575781|P2|Overall Study|Other Reasons|60
1386743|NCT01345669|4575782|P1|Overall Study|Other Reasons|111
1386744|NCT01345669|4575781|P2|Overall Study|Withdrawal by Subject|13
1386745|NCT01345669|4575782|P1|Overall Study|Withdrawal by Subject|52
1386746|NCT01345669|4575781|P2|Overall Study|Lost to Follow-up|1
1386747|NCT01345669|4575782|P1|Overall Study|Lost to Follow-up|1
1386748|NCT01345669|4575781|P2|Overall Study|Protocol Violation|1
1386749|NCT01345669|4575782|P1|Overall Study|Protocol Violation|3
1386750|NCT01345669|4575781|P2|Overall Study|Adverse Event|9
1386751|NCT01345669|4575782|P1|Overall Study|Adverse Event|63
1386752|NCT01345669|4575781|P2|Overall Study|Second primary tumour|3
1386753|NCT01345669|4575782|P1|Overall Study|Second primary tumour|4
1386754|NCT01345669|4575781|P2|Overall Study|Primary tumour recurrence|32
1386755|NCT01345669|4575782|P1|Overall Study|Primary tumour recurrence|53
1386756|NCT01345630|4575800|P2|Overall Study|Insufficient clinical response|11
1386757|NCT01345630|4575801|P1|Overall Study|Insufficient clinical response|48
1386758|NCT01345630|4575800|P2|Overall Study|No longer willing to participate|12
1386759|NCT01345630|4575801|P1|Overall Study|No longer willing to participate|9
1386760|NCT01345630|4575800|P2|Overall Study|Withdrawn due to pregnancy|2
1386761|NCT01345630|4575801|P1|Overall Study|Withdrawn due to pregnancy|1
1386762|NCT01345630|4575800|P2|Overall Study|Other reasons|8
1386763|NCT01345630|4575801|P1|Overall Study|Other reasons|6
1386764|NCT01345630|4575800|P2|Overall Study|Study terminated by sponsor|285
1386765|NCT01345630|4575801|P1|Overall Study|Study terminated by sponsor|254
1386766|NCT01345630|4575800|P2|Overall Study|Medication error without associated AE|1
1386767|NCT01345630|4575801|P1|Overall Study|Medication error without associated AE|0
1386768|NCT01345630|4575800|P2|Overall Study|Protocol Violation|1
1386769|NCT01345630|4575801|P1|Overall Study|Protocol Violation|4
1386770|NCT01345630|4575800|P2|Overall Study|Lost to Follow-up|16
1386771|NCT01345630|4575801|P1|Overall Study|Lost to Follow-up|17
1386772|NCT01345630|4575800|P2|Overall Study|Adverse Event|23
1386773|NCT01345630|4575801|P1|Overall Study|Adverse Event|22
1386774|NCT01345591|4575857|P1|Overall Study|Lost to Follow-up|1
1386775|NCT01345318|4575866|P1|Overall Study|Other|3
1386776|NCT01345318|4575866|P1|Overall Study|Withdrawal by Subject|41
1386777|NCT01345318|4575866|P1|Overall Study|Protocol Violation|1
1386778|NCT01345318|4575866|P1|Overall Study|Lost to Follow-up|2
1386779|NCT01345318|4575866|P1|Overall Study|Lack of Efficacy|17
1386780|NCT01345318|4575866|P1|Overall Study|Adverse Event|16
1386781|NCT01345292|4575874|P3|Overall Study|Withdrawal by Subject|1
1386782|NCT01345292|4575875|P2|Overall Study|Withdrawal by Subject|0
1386783|NCT01345292|4575876|P1|Overall Study|Withdrawal by Subject|2
1386784|NCT01345253|4575907|P2|Overall Study|Withdrawal by Subject|19
1386785|NCT01345253|4575908|P1|Overall Study|Withdrawal by Subject|9
1386786|NCT01345253|4575907|P2|Overall Study|Physician Decision|12
1386787|NCT01345253|4575908|P1|Overall Study|Physician Decision|4
1386788|NCT01345253|4575907|P2|Overall Study|Lost to Follow-up|8
1386789|NCT01345253|4575908|P1|Overall Study|Lost to Follow-up|3
1386790|NCT01345253|4575907|P2|Overall Study|Met Protocol Defined Stopping Criteria|1
1386791|NCT01345253|4575908|P1|Overall Study|Met Protocol Defined Stopping Criteria|6
1386792|NCT01345253|4575907|P2|Overall Study|Protocol Violation|5
1386793|NCT01345253|4575908|P1|Overall Study|Protocol Violation|1
1386794|NCT01345253|4575907|P2|Overall Study|Lack of Efficacy|7
1386795|NCT01345253|4575908|P1|Overall Study|Lack of Efficacy|11
1386796|NCT01345253|4575907|P2|Overall Study|Adverse Event|27
1386797|NCT01345253|4575908|P1|Overall Study|Adverse Event|22
1386798|NCT01345240|4575927|P5|Overall Study|Serious Adverse Event|1
1386799|NCT01345240|4575928|P4|Overall Study|Serious Adverse Event|2
1386800|NCT01345240|4575929|P3|Overall Study|Serious Adverse Event|2
1386801|NCT01345240|4575930|P2|Overall Study|Serious Adverse Event|2
1386802|NCT01345240|4575931|P1|Overall Study|Serious Adverse Event|1
1386803|NCT01345240|4575927|P5|Overall Study|Lost to Follow-up|6
1386804|NCT01345240|4575928|P4|Overall Study|Lost to Follow-up|8
1386805|NCT01345240|4575929|P3|Overall Study|Lost to Follow-up|8
1386806|NCT01345240|4575930|P2|Overall Study|Lost to Follow-up|12
1386807|NCT01345240|4575931|P1|Overall Study|Lost to Follow-up|1
1386808|NCT01345162|4576026|P2|Overall Study|Protocol Violation|4
1386809|NCT01345162|4576027|P1|Overall Study|Protocol Violation|2
1386810|NCT01345123|4576036|P3|Overall Study|participants no longer with health plan|88
1386811|NCT01345123|4576037|P2|Overall Study|participants no longer with health plan|85
1386812|NCT01345123|4576038|P1|Overall Study|participants no longer with health plan|79
1386813|NCT01345058|4576060|P2|Overall Study|Participant No-Show at Multiple Visits|0
1386814|NCT01345058|4576061|P1|Overall Study|Participant No-Show at Multiple Visits|1
1386815|NCT01345058|4576060|P2|Overall Study|Participant Stopped Taking Study Drug|0
1386816|NCT01345058|4576061|P1|Overall Study|Participant Stopped Taking Study Drug|1
1386817|NCT01345058|4576060|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
1386818|NCT01345058|4576061|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
1386819|NCT01345058|4576060|P2|Overall Study|Participant Reported Increase in Events|0
1386820|NCT01345058|4576061|P1|Overall Study|Participant Reported Increase in Events|1
1386821|NCT01345058|4576060|P2|Overall Study|Withdrawal by Subject|0
1386822|NCT01345058|4576061|P1|Overall Study|Withdrawal by Subject|1
1386823|NCT01345019|4576077|P2|Overall Study|Other|3
1386824|NCT01345019|4576078|P1|Overall Study|Other|1
1386825|NCT01345019|4576077|P2|Overall Study|Protocol Deviation|0
1386826|NCT01345019|4576078|P1|Overall Study|Protocol Deviation|5
1386827|NCT01345019|4576077|P2|Overall Study|Lost to Follow-up|2
1386828|NCT01345019|4576078|P1|Overall Study|Lost to Follow-up|4
1386829|NCT01345019|4576077|P2|Overall Study|Ineligibility Determined|6
1386830|NCT01345019|4576078|P1|Overall Study|Ineligibility Determined|1
1386831|NCT01345019|4576077|P2|Overall Study|Noncompliance|4
1386832|NCT01345019|4576078|P1|Overall Study|Noncompliance|4
1386833|NCT01345019|4576077|P2|Overall Study|Administrative Decision|5
1386834|NCT01345019|4576078|P1|Overall Study|Administrative Decision|8
1386835|NCT01345019|4576077|P2|Overall Study|Adverse Event|13
1386836|NCT01345019|4576078|P1|Overall Study|Adverse Event|4
1386837|NCT01345019|4576077|P2|Overall Study|Disease Progression|8
1386838|NCT01345019|4576078|P1|Overall Study|Disease Progression|11
1386839|NCT01345019|4576077|P2|Overall Study|Completed Survival Follow-up|4
1386840|NCT01345019|4576078|P1|Overall Study|Completed Survival Follow-up|16
1386841|NCT01345019|4576077|P2|Overall Study|Withdrawal by Subject|107
1386842|NCT01345019|4576078|P1|Overall Study|Withdrawal by Subject|82
1386843|NCT01345019|4576077|P2|Overall Study|Death|120
1386844|NCT01345019|4576078|P1|Overall Study|Death|127
1386845|NCT01344876|4576098|P5|Overall Study|Definite progression of primary disease|0
1386846|NCT01344876|4576099|P4|Overall Study|Definite progression of primary disease|3
1386847|NCT01344876|4576100|P3|Overall Study|Definite progression of primary disease|0
1386848|NCT01344876|4576101|P2|Overall Study|Definite progression of primary disease|0
1386849|NCT01344876|4576102|P1|Overall Study|Definite progression of primary disease|1
1386850|NCT01344876|4576098|P5|Overall Study|Withdrawal by Subject|0
1386851|NCT01344876|4576099|P4|Overall Study|Withdrawal by Subject|0
1386852|NCT01344876|4576100|P3|Overall Study|Withdrawal by Subject|1
1386853|NCT01344876|4576101|P2|Overall Study|Withdrawal by Subject|0
1386854|NCT01344876|4576102|P1|Overall Study|Withdrawal by Subject|0
1386855|NCT01344876|4576098|P5|Overall Study|Adverse Event|1
1386856|NCT01344876|4576099|P4|Overall Study|Adverse Event|0
1386857|NCT01344876|4576100|P3|Overall Study|Adverse Event|0
1386858|NCT01344876|4576101|P2|Overall Study|Adverse Event|0
1386859|NCT01344876|4576102|P1|Overall Study|Adverse Event|0
1386860|NCT01344824|4576116|P1|Overall Study|Progression|15
1386861|NCT01344824|4576116|P1|Overall Study|Other complicating disease|1
1386862|NCT01344824|4576116|P1|Overall Study|Withdrawal by Subject|6
1386863|NCT01344824|4576116|P1|Overall Study|Adverse Event|15
1386864|NCT01344759|4576124|P2|Overall Study|Patients failed to reach sedation level|2
1386865|NCT01344759|4576125|P1|Overall Study|Patients failed to reach sedation level|0
1386866|NCT01344629|4576157|P2|Crossover Period 2|Withdrawal by Subject|1
1386867|NCT01344629|4576158|P1|Crossover Period 2|Withdrawal by Subject|0
1386868|NCT01344538|4576187|P2|Overall Study|Lost to Follow-up|0
1386869|NCT01344538|4576188|P1|Overall Study|Lost to Follow-up|1
1386870|NCT01344538|4576187|P2|Overall Study|Adverse Event|1
1386871|NCT01344538|4576188|P1|Overall Study|Adverse Event|1
1386872|NCT01344460|4576194|P1|Overall Study|Lost to Follow-up|2
1386873|NCT01344460|4576194|P1|Overall Study|Withdrawal by Subject|1
1386874|NCT01344447|4576239|P1|Overall Study|Error of power injector|1
1386875|NCT01344447|4576239|P1|Overall Study|Bolus tracking failed|1
1386876|NCT01344447|4576239|P1|Overall Study|MRA unsuccessful|1
1386877|NCT01344447|4576239|P1|Overall Study|Physician Decision|1
1386878|NCT01344447|4576239|P1|Overall Study|The contrast was not seen|1
1386879|NCT01344447|4576239|P1|Overall Study|Withdrawal by Subject|1
1386880|NCT01344447|4576239|P1|Overall Study|Protocol Violation|1
1386881|NCT01344447|4576239|P1|Overall Study|Adverse Event|1
1386882|NCT01344369|4576283|P2|Second Intervention|Emesis within 2 x Tmax|1
1386883|NCT01344369|4576284|P1|Second Intervention|Emesis within 2 x Tmax|0
1386884|NCT01344369|4576283|P2|Washout of 28 Days|Physician Decision|1
1386885|NCT01344369|4576284|P1|Washout of 28 Days|Physician Decision|0
1386886|NCT01344369|4576283|P2|Washout of 28 Days|Withdrawal by Subject|0
1386887|NCT01344369|4576284|P1|Washout of 28 Days|Withdrawal by Subject|1
1386888|NCT01344161|4576302|P2|Overall Study|Protocol Violation|1
1386889|NCT01344161|4576303|P1|Overall Study|Protocol Violation|1
1386890|NCT01344161|4576302|P2|Overall Study|Pregnancy|1
1386891|NCT01344161|4576303|P1|Overall Study|Pregnancy|0
1386892|NCT01344161|4576302|P2|Overall Study|Lost to Follow-up|1
1386893|NCT01344161|4576303|P1|Overall Study|Lost to Follow-up|4
1386894|NCT01344057|4576315|P1|Overall Study|Premature Withdrawal|1
1386895|NCT01343901|4576322|P1|Overall Study|Participant decision|1
1386896|NCT01343901|4576322|P1|Overall Study|Management by another medical team|11
1386897|NCT01343901|4576322|P1|Overall Study|Lost to Follow-up|12
1386898|NCT01343901|4576322|P1|Overall Study|Physician Decision|4
1386899|NCT01343901|4576322|P1|Overall Study|Death|85
1386900|NCT01343888|4576346|P3|Overall Study|other than stated above|1
1386901|NCT01343888|4576347|P2|Overall Study|other than stated above|0
1386902|NCT01343888|4576348|P1|Overall Study|other than stated above|0
1386903|NCT01343888|4576346|P3|Overall Study|Withdrawal by Subject|2
1386904|NCT01343888|4576347|P2|Overall Study|Withdrawal by Subject|4
1386905|NCT01343888|4576348|P1|Overall Study|Withdrawal by Subject|4
1386906|NCT01343888|4576346|P3|Overall Study|Protocol Violation|0
1386907|NCT01343888|4576347|P2|Overall Study|Protocol Violation|2
1386908|NCT01343888|4576348|P1|Overall Study|Protocol Violation|0
1386909|NCT01343888|4576346|P3|Overall Study|Lost to Follow-up|1
1386910|NCT01343888|4576347|P2|Overall Study|Lost to Follow-up|2
1386911|NCT01343888|4576348|P1|Overall Study|Lost to Follow-up|0
1386912|NCT01343888|4576346|P3|Overall Study|Lack of Efficacy|13
1386913|NCT01343888|4576347|P2|Overall Study|Lack of Efficacy|9
1386914|NCT01343888|4576348|P1|Overall Study|Lack of Efficacy|9
1386915|NCT01343888|4576346|P3|Overall Study|Adverse Event|5
1386916|NCT01343888|4576347|P2|Overall Study|Adverse Event|22
1386917|NCT01343888|4576348|P1|Overall Study|Adverse Event|12
1386918|NCT01343823|4576390|P4|Overall Study|Withdrawal by Subject|0
1386919|NCT01343823|4576391|P3|Overall Study|Withdrawal by Subject|0
1386920|NCT01343823|4576392|P2|Overall Study|Withdrawal by Subject|0
1386921|NCT01343823|4576393|P1|Overall Study|Withdrawal by Subject|1
1386922|NCT01343823|4576390|P4|Overall Study|Study Terminated|1
1386923|NCT01343823|4576391|P3|Overall Study|Study Terminated|0
1386924|NCT01343823|4576392|P2|Overall Study|Study Terminated|0
1386925|NCT01343823|4576393|P1|Overall Study|Study Terminated|1
1386926|NCT01343368|4576427|P2|Overall Study|Lost to Follow-up|0
1386927|NCT01343368|4576428|P1|Overall Study|Lost to Follow-up|1
1386928|NCT01343368|4576427|P2|Overall Study|Death|0
1386929|NCT01343368|4576428|P1|Overall Study|Death|1
1386930|NCT01343277|4576464|P2|Overall Study|Subsequent anticancer therapy|0
1386931|NCT01343277|4576465|P1|Overall Study|Subsequent anticancer therapy|1
1386932|NCT01343277|4576464|P2|Overall Study|Treatment ongoing|2
1386933|NCT01343277|4576465|P1|Overall Study|Treatment ongoing|8
1386934|NCT01343277|4576464|P2|Overall Study|Randomized not treated|21
1386935|NCT01343277|4576465|P1|Overall Study|Randomized not treated|6
1386936|NCT01343277|4576464|P2|Overall Study|Disease progression|138
1386937|NCT01343277|4576465|P1|Overall Study|Disease progression|270
1386938|NCT01343277|4576464|P2|Overall Study|Adverse Event|13
1386939|NCT01343277|4576465|P1|Overall Study|Adverse Event|67
1386940|NCT01343277|4576464|P2|Overall Study|Death|1
1386941|NCT01343277|4576465|P1|Overall Study|Death|10
1386942|NCT01343277|4576464|P2|Overall Study|Physician Decision|2
1386943|NCT01343277|4576465|P1|Overall Study|Physician Decision|1
1386944|NCT01343277|4576464|P2|Overall Study|Withdrawal by Subject|13
1386945|NCT01343277|4576465|P1|Overall Study|Withdrawal by Subject|18
1386946|NCT01343277|4576464|P2|Overall Study|Other|3
1386947|NCT01343277|4576465|P1|Overall Study|Other|3
1386948|NCT01343082|4576526|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
1386949|NCT01343082|4576527|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
1386950|NCT01343082|4576528|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
1386951|NCT01343082|4576526|P3|Treatment Period , Switched to DE-111|Physician Decision|2
1386952|NCT01343082|4576527|P2|Treatment Period , Switched to DE-111|Physician Decision|2
1386953|NCT01343082|4576528|P1|Treatment Period , Switched to DE-111|Physician Decision|0
1386954|NCT01343082|4576526|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
1386955|NCT01343082|4576527|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
1386956|NCT01343082|4576528|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
1386957|NCT01343082|4576526|P3|Treatment Period , Switched to DE-111|Adverse Event|3
1386958|NCT01343082|4576527|P2|Treatment Period , Switched to DE-111|Adverse Event|4
1386959|NCT01343082|4576528|P1|Treatment Period , Switched to DE-111|Adverse Event|1
1386960|NCT01343082|4576526|P3|The run-in Period|Not meeting criteria|5
1386961|NCT01343082|4576527|P2|The run-in Period|Not meeting criteria|4
1386962|NCT01343082|4576528|P1|The run-in Period|Not meeting criteria|3
1386963|NCT01343056|4576536|P4|Overall Study|Lost to Follow-up|9
1386964|NCT01343056|4576537|P3|Overall Study|Lost to Follow-up|3
1386965|NCT01343056|4576538|P2|Overall Study|Lost to Follow-up|5
1386966|NCT01343056|4576539|P1|Overall Study|Lost to Follow-up|7
1386967|NCT01342965|4576607|P2|Overall Study|Withdrawal by Subject|9
1386968|NCT01342965|4576608|P1|Overall Study|Withdrawal by Subject|2
1386969|NCT01342965|4576607|P2|Overall Study|Other Reasons- Unspecified|38
1386970|NCT01342965|4576608|P1|Overall Study|Other Reasons- Unspecified|44
1386971|NCT01342965|4576607|P2|Overall Study|Lost to Follow-up|3
1386972|NCT01342965|4576608|P1|Overall Study|Lost to Follow-up|5
1386973|NCT01342965|4576607|P2|Overall Study|Death|57
1386974|NCT01342965|4576608|P1|Overall Study|Death|58
1386975|NCT01342926|4576626|P4|Overall Study|Withdrawal by Subject|5
1386976|NCT01342926|4576627|P3|Overall Study|Withdrawal by Subject|3
1386977|NCT01342926|4576628|P2|Overall Study|Withdrawal by Subject|4
1386978|NCT01342926|4576629|P1|Overall Study|Withdrawal by Subject|2
1386979|NCT01342926|4576626|P4|Overall Study|Investigator Discretion|0
1386980|NCT01342926|4576627|P3|Overall Study|Investigator Discretion|0
1386981|NCT01342926|4576628|P2|Overall Study|Investigator Discretion|2
1386982|NCT01342926|4576629|P1|Overall Study|Investigator Discretion|2
1386983|NCT01342926|4576626|P4|Overall Study|Lost to Follow-up|0
1386984|NCT01342926|4576627|P3|Overall Study|Lost to Follow-up|1
1386985|NCT01342926|4576628|P2|Overall Study|Lost to Follow-up|1
1386986|NCT01342926|4576629|P1|Overall Study|Lost to Follow-up|0
1386987|NCT01342926|4576626|P4|Overall Study|Adverse Event|7
1386988|NCT01342926|4576627|P3|Overall Study|Adverse Event|10
1386989|NCT01342926|4576628|P2|Overall Study|Adverse Event|8
1386990|NCT01342926|4576629|P1|Overall Study|Adverse Event|5
1386991|NCT01342913|4576709|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
1386992|NCT01342913|4576710|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
1386993|NCT01342913|4576711|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
1386994|NCT01342913|4576709|P3|Double-Blind Treatment Period|Physician Decision|0
1386995|NCT01342913|4576710|P2|Double-Blind Treatment Period|Physician Decision|2
1386996|NCT01342913|4576711|P1|Double-Blind Treatment Period|Physician Decision|0
1386997|NCT01342913|4576709|P3|Double-Blind Treatment Period|Lost to Follow-up|3
1386998|NCT01342913|4576710|P2|Double-Blind Treatment Period|Lost to Follow-up|1
1386999|NCT01342913|4576711|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1387000|NCT01342913|4576709|P3|Double-Blind Treatment Period|Protocol Violation|9
1387001|NCT01342913|4576710|P2|Double-Blind Treatment Period|Protocol Violation|6
1387002|NCT01342913|4576711|P1|Double-Blind Treatment Period|Protocol Violation|0
1387003|NCT01342913|4576709|P3|Double-Blind Treatment Period|Lack of Efficacy|3
1387004|NCT01342913|4576710|P2|Double-Blind Treatment Period|Lack of Efficacy|2
1387005|NCT01342913|4576711|P1|Double-Blind Treatment Period|Lack of Efficacy|0
1387006|NCT01342913|4576709|P3|Double-Blind Treatment Period|Adverse Event|6
1387007|NCT01342913|4576710|P2|Double-Blind Treatment Period|Adverse Event|3
1387008|NCT01342913|4576711|P1|Double-Blind Treatment Period|Adverse Event|0
1387009|NCT01342913|4576709|P3|2-week Run-in Period|Continuation Criteria Not Met|0
1387010|NCT01342913|4576710|P2|2-week Run-in Period|Continuation Criteria Not Met|0
1387011|NCT01342913|4576711|P1|2-week Run-in Period|Continuation Criteria Not Met|88
1387012|NCT01342913|4576709|P3|2-week Run-in Period|Protocol Violation|0
1387013|NCT01342913|4576710|P2|2-week Run-in Period|Protocol Violation|0
1387014|NCT01342913|4576711|P1|2-week Run-in Period|Protocol Violation|5
1387015|NCT01342913|4576709|P3|2-week Run-in Period|Adverse Event|0
1387016|NCT01342913|4576710|P2|2-week Run-in Period|Adverse Event|0
1387017|NCT01342913|4576711|P1|2-week Run-in Period|Adverse Event|2
1387018|NCT01342913|4576709|P3|2-week Run-in Period|Withdrawal by Subject|0
1387019|NCT01342913|4576710|P2|2-week Run-in Period|Withdrawal by Subject|0
1387020|NCT01342913|4576711|P1|2-week Run-in Period|Withdrawal by Subject|7
1387021|NCT01342913|4576709|P3|2-week Run-in Period|Physician Decision|0
1387022|NCT01342913|4576710|P2|2-week Run-in Period|Physician Decision|0
1387023|NCT01342913|4576711|P1|2-week Run-in Period|Physician Decision|6
1387024|NCT01342913|4576709|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
1387025|NCT01342913|4576710|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
1387026|NCT01342913|4576711|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
1387027|NCT01342887|4576721|P1|Overall Study|Death|2
1387028|NCT01342640|4576762|P1|Overall Study|Other|1
1387029|NCT01342640|4576762|P1|Overall Study|Lost to Follow-up|21
1387030|NCT01342640|4576762|P1|Overall Study|Protocol Violation|16
1387031|NCT01342640|4576762|P1|Overall Study|Adverse Event|3
1387032|NCT01342510|4576857|P4|Overall Study|Protocol Violation|11
1387033|NCT01342510|4576858|P3|Overall Study|Protocol Violation|13
1387034|NCT01342510|4576859|P2|Overall Study|Protocol Violation|6
1387035|NCT01342510|4576860|P1|Overall Study|Protocol Violation|12
1387036|NCT01342484|4576873|P3|Overall Study|Withdrawal by Subject|0
1387037|NCT01342484|4576874|P2|Overall Study|Withdrawal by Subject|0
1387038|NCT01342484|4576875|P1|Overall Study|Withdrawal by Subject|1
1387039|NCT01342484|4576873|P3|Overall Study|Protocol Violation|1
1387040|NCT01342484|4576874|P2|Overall Study|Protocol Violation|0
1387041|NCT01342484|4576875|P1|Overall Study|Protocol Violation|0
1387042|NCT01342484|4576873|P3|Overall Study|Other Reasons|0
1387043|NCT01342484|4576874|P2|Overall Study|Other Reasons|0
1387044|NCT01342484|4576875|P1|Overall Study|Other Reasons|1
1387045|NCT01342445|4576931|P2|Overall Study|Experienced side effects|2
1387046|NCT01342445|4576932|P1|Overall Study|Experienced side effects|0
1387047|NCT01342341|4576948|P2|Overall Study|Lost to Follow-up|4
1387048|NCT01342341|4576949|P1|Overall Study|Lost to Follow-up|4
1387049|NCT01342211|4576960|P5|Overall Study|Randomized, but not Treated|1
1387050|NCT01342211|4576961|P4|Overall Study|Randomized, but not Treated|0
1387051|NCT01342211|4576962|P3|Overall Study|Randomized, but not Treated|0
1387052|NCT01342211|4576963|P2|Overall Study|Randomized, but not Treated|2
1387053|NCT01342211|4576964|P1|Overall Study|Randomized, but not Treated|0
1387054|NCT01342211|4576960|P5|Overall Study|Withdrawal by Subject|0
1387055|NCT01342211|4576961|P4|Overall Study|Withdrawal by Subject|1
1387056|NCT01342211|4576962|P3|Overall Study|Withdrawal by Subject|0
1387057|NCT01342211|4576963|P2|Overall Study|Withdrawal by Subject|0
1387058|NCT01342211|4576964|P1|Overall Study|Withdrawal by Subject|0
1387059|NCT01342211|4576960|P5|Overall Study|Adverse Event|1
1387060|NCT01342211|4576961|P4|Overall Study|Adverse Event|0
1387061|NCT01342211|4576962|P3|Overall Study|Adverse Event|0
1387062|NCT01342211|4576963|P2|Overall Study|Adverse Event|0
1387063|NCT01342211|4576964|P1|Overall Study|Adverse Event|0
1387064|NCT01342211|4576960|P5|Overall Study|Lost to Follow-up|0
1387065|NCT01342211|4576961|P4|Overall Study|Lost to Follow-up|1
1387066|NCT01342211|4576962|P3|Overall Study|Lost to Follow-up|0
1387067|NCT01342211|4576963|P2|Overall Study|Lost to Follow-up|0
1387068|NCT01342211|4576964|P1|Overall Study|Lost to Follow-up|0
1387069|NCT01342094|4577045|P2|Overall Study|Withdrawal by Subject|2
1387070|NCT01342094|4577046|P1|Overall Study|Withdrawal by Subject|0
1387071|NCT01342094|4577045|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
1387072|NCT01342094|4577046|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
1387073|NCT01342094|4577045|P2|Overall Study|Adverse Event|0
1387074|NCT01342094|4577046|P1|Overall Study|Adverse Event|5
1387075|NCT01342081|4577055|P3|Overall Study|Withdrawal by Subject|0
1387076|NCT01342081|4577056|P2|Overall Study|Withdrawal by Subject|1
1387077|NCT01342081|4577057|P1|Overall Study|Withdrawal by Subject|1
1387078|NCT01342081|4577055|P3|Overall Study|Physician Decision|0
1387079|NCT01342081|4577056|P2|Overall Study|Physician Decision|1
1387080|NCT01342081|4577057|P1|Overall Study|Physician Decision|0
1387081|NCT01342081|4577055|P3|Overall Study|Adverse Event|0
1387082|NCT01342081|4577056|P2|Overall Study|Adverse Event|0
1387083|NCT01342081|4577057|P1|Overall Study|Adverse Event|1
1387084|NCT01342081|4577055|P3|Overall Study|Did not receive allocated intervention|1
1387085|NCT01342081|4577056|P2|Overall Study|Did not receive allocated intervention|0
1387086|NCT01342081|4577057|P1|Overall Study|Did not receive allocated intervention|0
1387087|NCT01341990|4577076|P2|Overall Study|Withdrawal by Subject|0
1387088|NCT01341990|4577077|P1|Overall Study|Withdrawal by Subject|2
1387089|NCT01341990|4577076|P2|Overall Study|Torn Study Lens|0
1387090|NCT01341990|4577077|P1|Overall Study|Torn Study Lens|1
1387091|NCT01341990|4577076|P2|Overall Study|Adverse Event|1
1387092|NCT01341990|4577077|P1|Overall Study|Adverse Event|0
1387093|NCT01341782|4577101|P2|Overall Study|Other|0
1387094|NCT01341782|4577102|P1|Overall Study|Other|5
1387095|NCT01341782|4577101|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
1387096|NCT01341782|4577102|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
1387097|NCT01341782|4577101|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
1387098|NCT01341782|4577102|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
1387099|NCT01341782|4577101|P2|Overall Study|Missed 3 consecutive doses|4
1387100|NCT01341782|4577102|P1|Overall Study|Missed 3 consecutive doses|0
1387101|NCT01341782|4577101|P2|Overall Study|Withdrawal by Subject|5
1387102|NCT01341782|4577102|P1|Overall Study|Withdrawal by Subject|6
1387103|NCT01341782|4577101|P2|Overall Study|Adverse Event|1
1387104|NCT01341782|4577102|P1|Overall Study|Adverse Event|1
1387105|NCT01341587|4577142|P2|Overall Study|stopped using the meters|10
1387106|NCT01341587|4577143|P1|Overall Study|stopped using the meters|2
1387107|NCT01341587|4577142|P2|Overall Study|Lost to Follow-up|0
1387108|NCT01341587|4577143|P1|Overall Study|Lost to Follow-up|2
1387109|NCT01340937|4577176|P4|Period 3: Toddler Vaccinations|Technical problem|0
1387110|NCT01340937|4577177|P3|Period 3: Toddler Vaccinations|Technical problem|1
1387111|NCT01340937|4577178|P2|Period 3: Toddler Vaccinations|Technical problem|1
1387112|NCT01340937|4577179|P1|Period 3: Toddler Vaccinations|Technical problem|1
1387113|NCT01340937|4577176|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
1387114|NCT01340937|4577177|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
1387115|NCT01340937|4577178|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
1387116|NCT01340937|4577179|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
1387117|NCT01340937|4577176|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
1387118|NCT01340937|4577177|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
1387119|NCT01340937|4577178|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
1387120|NCT01340937|4577179|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
1387121|NCT01340937|4577176|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
1387122|NCT01340937|4577177|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
1387123|NCT01340937|4577178|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
1387124|NCT01340937|4577179|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
1387125|NCT01340937|4577176|P4|Period 2: Interim Period|Technical problems|3
1387126|NCT01340937|4577177|P3|Period 2: Interim Period|Technical problems|6
1387127|NCT01340937|4577178|P2|Period 2: Interim Period|Technical problems|4
1387128|NCT01340937|4577179|P1|Period 2: Interim Period|Technical problems|4
1387129|NCT01340937|4577176|P4|Period 2: Interim Period|Protocol Violation|3
1387130|NCT01340937|4577177|P3|Period 2: Interim Period|Protocol Violation|6
1387131|NCT01340937|4577178|P2|Period 2: Interim Period|Protocol Violation|3
1387132|NCT01340937|4577179|P1|Period 2: Interim Period|Protocol Violation|5
1387133|NCT01340937|4577176|P4|Period 2: Interim Period|Physician Decision|0
1387134|NCT01340937|4577177|P3|Period 2: Interim Period|Physician Decision|1
1387135|NCT01340937|4577178|P2|Period 2: Interim Period|Physician Decision|1
1387136|NCT01340937|4577179|P1|Period 2: Interim Period|Physician Decision|0
1387137|NCT01340937|4577176|P4|Period 2: Interim Period|Lost to Follow-up|23
1387138|NCT01340937|4577177|P3|Period 2: Interim Period|Lost to Follow-up|53
1387139|NCT01340937|4577178|P2|Period 2: Interim Period|Lost to Follow-up|48
1387140|NCT01340937|4577179|P1|Period 2: Interim Period|Lost to Follow-up|29
1387141|NCT01340937|4577176|P4|Period 2: Interim Period|Adverse Event|0
1387142|NCT01340937|4577177|P3|Period 2: Interim Period|Adverse Event|1
1387143|NCT01340937|4577178|P2|Period 2: Interim Period|Adverse Event|0
1387144|NCT01340937|4577179|P1|Period 2: Interim Period|Adverse Event|1
1387145|NCT01340937|4577176|P4|Period 2: Interim Period|Withdrawal by Subject|12
1387146|NCT01340937|4577177|P3|Period 2: Interim Period|Withdrawal by Subject|17
1387147|NCT01340937|4577178|P2|Period 2: Interim Period|Withdrawal by Subject|23
1387148|NCT01340937|4577179|P1|Period 2: Interim Period|Withdrawal by Subject|28
1387149|NCT01340937|4577176|P4|Period 1: Infant Series|Randomized but not vaccinated|1
1387150|NCT01340937|4577177|P3|Period 1: Infant Series|Randomized but not vaccinated|2
1387151|NCT01340937|4577178|P2|Period 1: Infant Series|Randomized but not vaccinated|5
1387152|NCT01340937|4577179|P1|Period 1: Infant Series|Randomized but not vaccinated|0
1387153|NCT01340937|4577176|P4|Period 1: Infant Series|Withdrawal by Subject|15
1387154|NCT01340937|4577177|P3|Period 1: Infant Series|Withdrawal by Subject|30
1387155|NCT01340937|4577178|P2|Period 1: Infant Series|Withdrawal by Subject|32
1387156|NCT01340937|4577179|P1|Period 1: Infant Series|Withdrawal by Subject|33
1387157|NCT01340937|4577176|P4|Period 1: Infant Series|Protocol Violation|3
1387158|NCT01340937|4577177|P3|Period 1: Infant Series|Protocol Violation|4
1387159|NCT01340937|4577178|P2|Period 1: Infant Series|Protocol Violation|4
1387160|NCT01340937|4577179|P1|Period 1: Infant Series|Protocol Violation|1
1387161|NCT01340937|4577176|P4|Period 1: Infant Series|Physician Decision|0
1387162|NCT01340937|4577177|P3|Period 1: Infant Series|Physician Decision|1
1387163|NCT01340937|4577178|P2|Period 1: Infant Series|Physician Decision|3
1387164|NCT01340937|4577179|P1|Period 1: Infant Series|Physician Decision|2
1387165|NCT01340937|4577176|P4|Period 1: Infant Series|Lost to Follow-up|13
1387166|NCT01340937|4577177|P3|Period 1: Infant Series|Lost to Follow-up|12
1387167|NCT01340937|4577178|P2|Period 1: Infant Series|Lost to Follow-up|14
1387168|NCT01340937|4577179|P1|Period 1: Infant Series|Lost to Follow-up|20
1387169|NCT01340937|4577176|P4|Period 1: Infant Series|Death|0
1387170|NCT01340937|4577177|P3|Period 1: Infant Series|Death|2
1387171|NCT01340937|4577178|P2|Period 1: Infant Series|Death|0
1387172|NCT01340937|4577179|P1|Period 1: Infant Series|Death|2
1387173|NCT01340937|4577176|P4|Period 1: Infant Series|Adverse Event|0
1387174|NCT01340937|4577177|P3|Period 1: Infant Series|Adverse Event|4
1387175|NCT01340937|4577178|P2|Period 1: Infant Series|Adverse Event|1
1387176|NCT01340937|4577179|P1|Period 1: Infant Series|Adverse Event|0
1387177|NCT01340937|4577176|P4|Period 1: Infant Series|Other protocol criterion not met|0
1387178|NCT01340937|4577177|P3|Period 1: Infant Series|Other protocol criterion not met|1
1387179|NCT01340937|4577178|P2|Period 1: Infant Series|Other protocol criterion not met|1
1387180|NCT01340937|4577179|P1|Period 1: Infant Series|Other protocol criterion not met|0
1387181|NCT01340872|4577338|P4|Open-label Phase|Worsening of IBD|0
1387182|NCT01340872|4577339|P3|Open-label Phase|Worsening of IBD|1
1387183|NCT01340872|4577340|P2|Open-label Phase|Worsening of IBD|0
1387184|NCT01340872|4577341|P1|Open-label Phase|Worsening of IBD|0
1387185|NCT01340872|4577338|P4|Open-label Phase|Withdrawal by Subject|6
1387186|NCT01340872|4577339|P3|Open-label Phase|Withdrawal by Subject|1
1387187|NCT01340872|4577340|P2|Open-label Phase|Withdrawal by Subject|0
1387188|NCT01340872|4577341|P1|Open-label Phase|Withdrawal by Subject|0
1387189|NCT01340872|4577338|P4|Open-label Phase|Adverse Event|4
1387190|NCT01340872|4577339|P3|Open-label Phase|Adverse Event|8
1387191|NCT01340872|4577340|P2|Open-label Phase|Adverse Event|0
1387192|NCT01340872|4577341|P1|Open-label Phase|Adverse Event|0
1387193|NCT01340872|4577338|P4|Open-label Phase|Pregnancy|0
1387194|NCT01340872|4577339|P3|Open-label Phase|Pregnancy|1
1387195|NCT01340872|4577340|P2|Open-label Phase|Pregnancy|0
1387196|NCT01340872|4577341|P1|Open-label Phase|Pregnancy|0
1387197|NCT01340872|4577338|P4|Open-label Phase|Physician Decision|1
1387198|NCT01340872|4577339|P3|Open-label Phase|Physician Decision|2
1387199|NCT01340872|4577340|P2|Open-label Phase|Physician Decision|0
1387200|NCT01340872|4577341|P1|Open-label Phase|Physician Decision|0
1387201|NCT01340872|4577338|P4|Double-blind Phase|Protocol Violation|0
1387202|NCT01340872|4577339|P3|Double-blind Phase|Protocol Violation|0
1387203|NCT01340872|4577340|P2|Double-blind Phase|Protocol Violation|1
1387204|NCT01340872|4577341|P1|Double-blind Phase|Protocol Violation|0
1387205|NCT01340872|4577338|P4|Double-blind Phase|Lost to Follow-up|0
1387206|NCT01340872|4577339|P3|Double-blind Phase|Lost to Follow-up|0
1387207|NCT01340872|4577340|P2|Double-blind Phase|Lost to Follow-up|1
1387208|NCT01340872|4577341|P1|Double-blind Phase|Lost to Follow-up|0
1387209|NCT01340872|4577338|P4|Double-blind Phase|Withdrawal by Subject|0
1387210|NCT01340872|4577339|P3|Double-blind Phase|Withdrawal by Subject|0
1387211|NCT01340872|4577340|P2|Double-blind Phase|Withdrawal by Subject|5
1387212|NCT01340872|4577341|P1|Double-blind Phase|Withdrawal by Subject|3
1387213|NCT01340872|4577338|P4|Double-blind Phase|Adverse Event|0
1387214|NCT01340872|4577339|P3|Double-blind Phase|Adverse Event|0
1387215|NCT01340872|4577340|P2|Double-blind Phase|Adverse Event|4
1387216|NCT01340872|4577341|P1|Double-blind Phase|Adverse Event|6
1387217|NCT01340794|4577401|P2|Overall Study|Withdrawal by Subject|1
1387218|NCT01340794|4577402|P1|Overall Study|Withdrawal by Subject|0
1387219|NCT01340768|4577418|P2|Overall Study|Other|0
1387220|NCT01340768|4577419|P1|Overall Study|Other|2
1387221|NCT01340768|4577418|P2|Overall Study|Withdrawal by Subject|1
1387222|NCT01340768|4577419|P1|Overall Study|Withdrawal by Subject|5
1387223|NCT01340768|4577418|P2|Overall Study|Lost to Follow-up|4
1387224|NCT01340768|4577419|P1|Overall Study|Lost to Follow-up|10
1387225|NCT01340664|4577430|P3|Overall Study|Not specified|2
1387226|NCT01340664|4577431|P2|Overall Study|Not specified|2
1387227|NCT01340664|4577432|P1|Overall Study|Not specified|1
1387228|NCT01340664|4577430|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
1387229|NCT01340664|4577431|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
1387230|NCT01340664|4577432|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
1387231|NCT01340664|4577430|P3|Overall Study|Glycemic withdrawal criteria|0
1387232|NCT01340664|4577431|P2|Overall Study|Glycemic withdrawal criteria|0
1387233|NCT01340664|4577432|P1|Overall Study|Glycemic withdrawal criteria|2
1387234|NCT01340664|4577430|P3|Overall Study|Withdrawal by Subject|0
1387235|NCT01340664|4577431|P2|Overall Study|Withdrawal by Subject|4
1387236|NCT01340664|4577432|P1|Overall Study|Withdrawal by Subject|2
1387237|NCT01340664|4577430|P3|Overall Study|Lost to Follow-up|2
1387238|NCT01340664|4577431|P2|Overall Study|Lost to Follow-up|0
1387239|NCT01340664|4577432|P1|Overall Study|Lost to Follow-up|2
1387240|NCT01340664|4577430|P3|Overall Study|Adverse Event|7
1387241|NCT01340664|4577431|P2|Overall Study|Adverse Event|1
1387242|NCT01340664|4577432|P1|Overall Study|Adverse Event|0
1387243|NCT01340651|4577449|P1|Overall Study|Commercial Supply per Sponsor|12
1387244|NCT01340651|4577449|P1|Overall Study|Consent Withdrawn|2
1387245|NCT01340651|4577449|P1|Overall Study|Adverse Event|3
1387246|NCT01340625|4577465|P2|Washout Period of 28 Days|Withdrawal by Subject|0
1387247|NCT01340625|4577466|P1|Washout Period of 28 Days|Withdrawal by Subject|1
1387248|NCT01340625|4577465|P2|First Intervention|Adverse Event|0
1387249|NCT01340625|4577466|P1|First Intervention|Adverse Event|1
1387250|NCT01340495|4577571|P1|Overall Study|Withdrawal by Subject|1
1387251|NCT01340300|4577581|P4|Overall Study|Unrelated sickness|1
1387252|NCT01340300|4577582|P3|Overall Study|Unrelated sickness|0
1387253|NCT01340300|4577583|P2|Overall Study|Unrelated sickness|2
1387254|NCT01340300|4577584|P1|Overall Study|Unrelated sickness|0
1387255|NCT01340300|4577581|P4|Overall Study|Physician Decision|0
1387256|NCT01340300|4577582|P3|Overall Study|Physician Decision|0
1387257|NCT01340300|4577583|P2|Overall Study|Physician Decision|1
1387258|NCT01340300|4577584|P1|Overall Study|Physician Decision|0
1387259|NCT01340300|4577581|P4|Overall Study|Adverse Event|0
1387260|NCT01340300|4577582|P3|Overall Study|Adverse Event|4
1387261|NCT01340300|4577583|P2|Overall Study|Adverse Event|0
1387262|NCT01340300|4577584|P1|Overall Study|Adverse Event|1
1387263|NCT01340300|4577581|P4|Overall Study|Withdrawal by Subject|3
1387264|NCT01340300|4577582|P3|Overall Study|Withdrawal by Subject|6
1387265|NCT01340300|4577583|P2|Overall Study|Withdrawal by Subject|6
1387266|NCT01340300|4577584|P1|Overall Study|Withdrawal by Subject|5
1387267|NCT01340300|4577581|P4|Overall Study|Lost to Follow-up|10
1387268|NCT01340300|4577582|P3|Overall Study|Lost to Follow-up|5
1387269|NCT01340300|4577583|P2|Overall Study|Lost to Follow-up|0
1387270|NCT01340300|4577584|P1|Overall Study|Lost to Follow-up|3
1387271|NCT01340209|4577617|P3|Overall Study|Other reason not defined above|4
1387272|NCT01340209|4577618|P2|Overall Study|Other reason not defined above|5
1387273|NCT01340209|4577619|P1|Overall Study|Other reason not defined above|3
1387274|NCT01340209|4577617|P3|Overall Study|Withdrawal by Subject|1
1387275|NCT01340209|4577618|P2|Overall Study|Withdrawal by Subject|0
1387276|NCT01340209|4577619|P1|Overall Study|Withdrawal by Subject|0
1387277|NCT01340209|4577617|P3|Overall Study|Protocol Violation|1
1387278|NCT01340209|4577618|P2|Overall Study|Protocol Violation|2
1387279|NCT01340209|4577619|P1|Overall Study|Protocol Violation|1
1387280|NCT01340209|4577617|P3|Overall Study|Adverse Event|2
1387281|NCT01340209|4577618|P2|Overall Study|Adverse Event|1
1387282|NCT01340209|4577619|P1|Overall Study|Adverse Event|1
1387283|NCT01340196|4577654|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
1387284|NCT01340066|4577694|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
1387285|NCT01340066|4577695|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
1387286|NCT01340066|4577696|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
1387287|NCT01340066|4577694|P3|5 Week Double Blind Randomization Period|Physician Decision|0
1387288|NCT01340066|4577695|P2|5 Week Double Blind Randomization Period|Physician Decision|1
1387289|NCT01340066|4577696|P1|5 Week Double Blind Randomization Period|Physician Decision|0
1387290|NCT01340066|4577694|P3|5 Week Double Blind Randomization Period|Adverse Event|2
1387291|NCT01340066|4577695|P2|5 Week Double Blind Randomization Period|Adverse Event|2
1387292|NCT01340066|4577696|P1|5 Week Double Blind Randomization Period|Adverse Event|0
1387293|NCT01340066|4577694|P3|Placebo Run in Period|Screen Failures|0
1387294|NCT01340066|4577695|P2|Placebo Run in Period|Screen Failures|0
1387295|NCT01340066|4577696|P1|Placebo Run in Period|Screen Failures|27
1387296|NCT01340027|4577715|P12|Overall Study|Miscellaneous|0
1387297|NCT01340027|4577716|P11|Overall Study|Miscellaneous|1
1387298|NCT01340027|4577717|P10|Overall Study|Miscellaneous|0
1387299|NCT01340027|4577718|P9|Overall Study|Miscellaneous|0
1387300|NCT01340027|4577719|P8|Overall Study|Miscellaneous|0
1387301|NCT01340027|4577720|P7|Overall Study|Miscellaneous|0
1387302|NCT01340027|4577721|P6|Overall Study|Miscellaneous|0
1387303|NCT01340027|4577722|P5|Overall Study|Miscellaneous|0
1387304|NCT01340027|4577723|P4|Overall Study|Miscellaneous|1
1387305|NCT01340027|4577724|P3|Overall Study|Miscellaneous|0
1387306|NCT01340027|4577725|P2|Overall Study|Miscellaneous|0
1387307|NCT01340027|4577726|P1|Overall Study|Miscellaneous|0
1387308|NCT01340027|4577715|P12|Overall Study|Withdrawal by Subject|1
1387309|NCT01340027|4577716|P11|Overall Study|Withdrawal by Subject|0
1387310|NCT01340027|4577717|P10|Overall Study|Withdrawal by Subject|2
1387311|NCT01340027|4577718|P9|Overall Study|Withdrawal by Subject|1
1387312|NCT01340027|4577719|P8|Overall Study|Withdrawal by Subject|4
1387313|NCT01340027|4577720|P7|Overall Study|Withdrawal by Subject|3
1387314|NCT01340027|4577721|P6|Overall Study|Withdrawal by Subject|2
1387315|NCT01340027|4577722|P5|Overall Study|Withdrawal by Subject|3
1387316|NCT01340027|4577723|P4|Overall Study|Withdrawal by Subject|3
1387317|NCT01340027|4577724|P3|Overall Study|Withdrawal by Subject|1
1387318|NCT01340027|4577725|P2|Overall Study|Withdrawal by Subject|3
1387319|NCT01340027|4577726|P1|Overall Study|Withdrawal by Subject|4
1387320|NCT01340027|4577715|P12|Overall Study|Protocol Violation|0
1387321|NCT01340027|4577716|P11|Overall Study|Protocol Violation|0
1387322|NCT01340027|4577717|P10|Overall Study|Protocol Violation|2
1387323|NCT01340027|4577718|P9|Overall Study|Protocol Violation|2
1387324|NCT01340027|4577719|P8|Overall Study|Protocol Violation|1
1387325|NCT01340027|4577720|P7|Overall Study|Protocol Violation|0
1387326|NCT01340027|4577721|P6|Overall Study|Protocol Violation|0
1387327|NCT01340027|4577722|P5|Overall Study|Protocol Violation|6
1387328|NCT01340027|4577723|P4|Overall Study|Protocol Violation|0
1387329|NCT01340027|4577724|P3|Overall Study|Protocol Violation|0
1387330|NCT01340027|4577725|P2|Overall Study|Protocol Violation|2
1387331|NCT01340027|4577726|P1|Overall Study|Protocol Violation|1
1387332|NCT01340027|4577715|P12|Overall Study|Lost to Follow-up|0
1387333|NCT01340027|4577716|P11|Overall Study|Lost to Follow-up|0
1387334|NCT01340027|4577717|P10|Overall Study|Lost to Follow-up|1
1387335|NCT01340027|4577718|P9|Overall Study|Lost to Follow-up|0
1387336|NCT01340027|4577719|P8|Overall Study|Lost to Follow-up|0
1387337|NCT01340027|4577720|P7|Overall Study|Lost to Follow-up|1
1387338|NCT01340027|4577721|P6|Overall Study|Lost to Follow-up|0
1387339|NCT01340027|4577722|P5|Overall Study|Lost to Follow-up|0
1387340|NCT01340027|4577723|P4|Overall Study|Lost to Follow-up|0
1387341|NCT01340027|4577724|P3|Overall Study|Lost to Follow-up|0
1387342|NCT01340027|4577725|P2|Overall Study|Lost to Follow-up|1
1387343|NCT01340027|4577726|P1|Overall Study|Lost to Follow-up|0
1387344|NCT01340027|4577715|P12|Overall Study|Lack of Efficacy|0
1387345|NCT01340027|4577716|P11|Overall Study|Lack of Efficacy|0
1387346|NCT01340027|4577717|P10|Overall Study|Lack of Efficacy|0
1387347|NCT01340027|4577718|P9|Overall Study|Lack of Efficacy|1
1387348|NCT01340027|4577719|P8|Overall Study|Lack of Efficacy|1
1387349|NCT01340027|4577720|P7|Overall Study|Lack of Efficacy|1
1387350|NCT01340027|4577721|P6|Overall Study|Lack of Efficacy|0
1387351|NCT01340027|4577722|P5|Overall Study|Lack of Efficacy|0
1387352|NCT01340027|4577723|P4|Overall Study|Lack of Efficacy|0
1387353|NCT01340027|4577724|P3|Overall Study|Lack of Efficacy|0
1387354|NCT01340027|4577725|P2|Overall Study|Lack of Efficacy|0
1387355|NCT01340027|4577726|P1|Overall Study|Lack of Efficacy|0
1387356|NCT01340027|4577715|P12|Overall Study|Adverse Event|3
1387357|NCT01340027|4577716|P11|Overall Study|Adverse Event|1
1387358|NCT01340027|4577717|P10|Overall Study|Adverse Event|1
1387359|NCT01340027|4577718|P9|Overall Study|Adverse Event|4
1387360|NCT01340027|4577719|P8|Overall Study|Adverse Event|1
1387361|NCT01340027|4577720|P7|Overall Study|Adverse Event|2
1387362|NCT01340027|4577721|P6|Overall Study|Adverse Event|2
1387363|NCT01340027|4577722|P5|Overall Study|Adverse Event|1
1387364|NCT01340027|4577723|P4|Overall Study|Adverse Event|0
1387365|NCT01340027|4577724|P3|Overall Study|Adverse Event|2
1387366|NCT01340027|4577725|P2|Overall Study|Adverse Event|1
1387367|NCT01340027|4577726|P1|Overall Study|Adverse Event|0
1387368|NCT01340027|4577715|P12|Overall Study|Randomized but Never Received Study Drug|0
1387369|NCT01340027|4577716|P11|Overall Study|Randomized but Never Received Study Drug|0
1387370|NCT01340027|4577717|P10|Overall Study|Randomized but Never Received Study Drug|0
1387371|NCT01340027|4577718|P9|Overall Study|Randomized but Never Received Study Drug|0
1387372|NCT01340027|4577719|P8|Overall Study|Randomized but Never Received Study Drug|0
1387373|NCT01340027|4577720|P7|Overall Study|Randomized but Never Received Study Drug|0
1387374|NCT01340027|4577721|P6|Overall Study|Randomized but Never Received Study Drug|0
1387375|NCT01340027|4577722|P5|Overall Study|Randomized but Never Received Study Drug|0
1387376|NCT01340027|4577723|P4|Overall Study|Randomized but Never Received Study Drug|0
1387377|NCT01340027|4577724|P3|Overall Study|Randomized but Never Received Study Drug|1
1387378|NCT01340027|4577725|P2|Overall Study|Randomized but Never Received Study Drug|0
1387379|NCT01340027|4577726|P1|Overall Study|Randomized but Never Received Study Drug|0
1387380|NCT01340014|4578102|P2|Period 2, Second 7 Days|Adverse Event|1
1387381|NCT01340014|4578103|P1|Period 2, Second 7 Days|Adverse Event|0
1387382|NCT01340014|4578102|P2|Period 1, First 7 Days|Personal Reasons|0
1387383|NCT01340014|4578103|P1|Period 1, First 7 Days|Personal Reasons|1
1387384|NCT01340014|4578102|P2|Period 1, First 7 Days|Adverse Event|0
1387385|NCT01340014|4578103|P1|Period 1, First 7 Days|Adverse Event|1
1387386|NCT01339923|4578124|P7|Overall Study|Withdrawal by Subject|2
1387387|NCT01339923|4578125|P6|Overall Study|Withdrawal by Subject|3
1387388|NCT01339923|4578126|P5|Overall Study|Withdrawal by Subject|4
1387389|NCT01339923|4578127|P4|Overall Study|Withdrawal by Subject|1
1387390|NCT01339923|4578128|P3|Overall Study|Withdrawal by Subject|6
1387391|NCT01339923|4578129|P2|Overall Study|Withdrawal by Subject|11
1387392|NCT01339923|4578130|P1|Overall Study|Withdrawal by Subject|7
1387393|NCT01339923|4578124|P7|Overall Study|Unable to Classify|5
1387394|NCT01339923|4578125|P6|Overall Study|Unable to Classify|1
1387395|NCT01339923|4578126|P5|Overall Study|Unable to Classify|0
1387396|NCT01339923|4578127|P4|Overall Study|Unable to Classify|0
1387397|NCT01339923|4578128|P3|Overall Study|Unable to Classify|1
1387398|NCT01339923|4578129|P2|Overall Study|Unable to Classify|0
1387399|NCT01339923|4578130|P1|Overall Study|Unable to Classify|1
1387400|NCT01339923|4578124|P7|Overall Study|Protocol Violation|1
1387401|NCT01339923|4578125|P6|Overall Study|Protocol Violation|3
1387402|NCT01339923|4578126|P5|Overall Study|Protocol Violation|0
1387403|NCT01339923|4578127|P4|Overall Study|Protocol Violation|0
1387404|NCT01339923|4578128|P3|Overall Study|Protocol Violation|0
1387405|NCT01339923|4578129|P2|Overall Study|Protocol Violation|0
1387406|NCT01339923|4578130|P1|Overall Study|Protocol Violation|0
1387407|NCT01339923|4578124|P7|Overall Study|Lost to Follow-up|5
1387408|NCT01339923|4578125|P6|Overall Study|Lost to Follow-up|1
1387409|NCT01339923|4578126|P5|Overall Study|Lost to Follow-up|1
1387410|NCT01339923|4578127|P4|Overall Study|Lost to Follow-up|3
1387411|NCT01339923|4578128|P3|Overall Study|Lost to Follow-up|0
1387412|NCT01339923|4578129|P2|Overall Study|Lost to Follow-up|4
1387413|NCT01339923|4578130|P1|Overall Study|Lost to Follow-up|4
1387414|NCT01339923|4578124|P7|Overall Study|Inappropriate Enrollment|0
1387415|NCT01339923|4578125|P6|Overall Study|Inappropriate Enrollment|1
1387416|NCT01339923|4578126|P5|Overall Study|Inappropriate Enrollment|0
1387417|NCT01339923|4578127|P4|Overall Study|Inappropriate Enrollment|0
1387418|NCT01339923|4578128|P3|Overall Study|Inappropriate Enrollment|0
1387419|NCT01339923|4578129|P2|Overall Study|Inappropriate Enrollment|0
1387420|NCT01339923|4578130|P1|Overall Study|Inappropriate Enrollment|1
1387421|NCT01339923|4578124|P7|Overall Study|Adverse Event|1
1387422|NCT01339923|4578125|P6|Overall Study|Adverse Event|0
1387423|NCT01339923|4578126|P5|Overall Study|Adverse Event|0
1387424|NCT01339923|4578127|P4|Overall Study|Adverse Event|0
1387425|NCT01339923|4578128|P3|Overall Study|Adverse Event|1
1387426|NCT01339923|4578129|P2|Overall Study|Adverse Event|1
1387427|NCT01339923|4578130|P1|Overall Study|Adverse Event|1
1387428|NCT01339910|4578201|P2|Overall Study|Disease relapse|4
1387429|NCT01339910|4578202|P1|Overall Study|Disease relapse|1
1387430|NCT01339910|4578201|P2|Overall Study|Physician Decision|0
1387431|NCT01339910|4578202|P1|Overall Study|Physician Decision|1
1387432|NCT01339910|4578201|P2|Overall Study|Withdrawal by Subject|0
1387433|NCT01339910|4578202|P1|Overall Study|Withdrawal by Subject|1
1387434|NCT01339897|4578240|P4|Overall Study|Adverse Event|1
1387435|NCT01339897|4578241|P3|Overall Study|Adverse Event|0
1387436|NCT01339897|4578242|P2|Overall Study|Adverse Event|0
1387437|NCT01339897|4578243|P1|Overall Study|Adverse Event|1
1387438|NCT01339832|4578269|P1|Overall Study|Death|11
1387439|NCT01339832|4578269|P1|Overall Study|Lost to Follow-up|3
1387440|NCT01339429|4578280|P1|Overall Study|Physician Decision|3
1387441|NCT01339429|4578280|P1|Overall Study|Withdrawal by Subject|1
1387442|NCT01339390|4578320|P2|Overall Study|Lost to Follow-up|127
1387443|NCT01339390|4578321|P1|Overall Study|Lost to Follow-up|125
1387444|NCT01339390|4578320|P2|Overall Study|Death|29
1387445|NCT01339390|4578321|P1|Overall Study|Death|32
1387446|NCT01339052|4578379|P2|Overall Study|Physician Decision|0
1387447|NCT01339052|4578380|P1|Overall Study|Physician Decision|1
1387448|NCT01339052|4578379|P2|Overall Study|Withdrawal by Subject|3
1387449|NCT01339052|4578380|P1|Overall Study|Withdrawal by Subject|0
1387450|NCT01339052|4578379|P2|Overall Study|Adverse Event|1
1387451|NCT01339052|4578380|P1|Overall Study|Adverse Event|1
1387452|NCT01339052|4578379|P2|Overall Study|Disease progression|46
1387453|NCT01339052|4578380|P1|Overall Study|Disease progression|13
1387454|NCT01339000|4578406|P2|Overall Study|study closed due to lack of drug supply|0
1387455|NCT01339000|4578407|P1|Overall Study|study closed due to lack of drug supply|1
1387456|NCT01338870|4578427|P6|Overall Study|Adverse Event|1
1387457|NCT01338870|4578428|P5|Overall Study|Adverse Event|4
1387458|NCT01338870|4578429|P4|Overall Study|Adverse Event|5
1387459|NCT01338870|4578430|P3|Overall Study|Adverse Event|1
1387460|NCT01338870|4578431|P2|Overall Study|Adverse Event|4
1387461|NCT01338870|4578432|P1|Overall Study|Adverse Event|4
1387462|NCT01338870|4578427|P6|Overall Study|Protocol Violation|1
1387463|NCT01338870|4578428|P5|Overall Study|Protocol Violation|1
1387464|NCT01338870|4578429|P4|Overall Study|Protocol Violation|2
1387465|NCT01338870|4578430|P3|Overall Study|Protocol Violation|2
1387466|NCT01338870|4578431|P2|Overall Study|Protocol Violation|2
1387467|NCT01338870|4578432|P1|Overall Study|Protocol Violation|0
1387468|NCT01338870|4578427|P6|Overall Study|Other|2
1387469|NCT01338870|4578428|P5|Overall Study|Other|0
1387470|NCT01338870|4578429|P4|Overall Study|Other|2
1387471|NCT01338870|4578430|P3|Overall Study|Other|3
1387472|NCT01338870|4578431|P2|Overall Study|Other|3
1387473|NCT01338870|4578432|P1|Overall Study|Other|3
1387474|NCT01338870|4578427|P6|Overall Study|Withdrawal by Subject|2
1387475|NCT01338870|4578428|P5|Overall Study|Withdrawal by Subject|0
1387476|NCT01338870|4578429|P4|Overall Study|Withdrawal by Subject|0
1387477|NCT01338870|4578430|P3|Overall Study|Withdrawal by Subject|4
1387478|NCT01338870|4578431|P2|Overall Study|Withdrawal by Subject|3
1387479|NCT01338870|4578432|P1|Overall Study|Withdrawal by Subject|2
1387480|NCT01338870|4578427|P6|Overall Study|Lost to Follow-up|0
1387481|NCT01338870|4578428|P5|Overall Study|Lost to Follow-up|1
1387482|NCT01338870|4578429|P4|Overall Study|Lost to Follow-up|0
1387483|NCT01338870|4578430|P3|Overall Study|Lost to Follow-up|1
1387484|NCT01338870|4578431|P2|Overall Study|Lost to Follow-up|0
1387485|NCT01338870|4578432|P1|Overall Study|Lost to Follow-up|0
1387486|NCT01338818|4578487|P1|Overall Study|Protocol Deviation|4
1387487|NCT01338818|4578487|P1|Overall Study|Administrative problems|3
1387488|NCT01338818|4578487|P1|Overall Study|Lost to Follow-up|4
1387489|NCT01338818|4578487|P1|Overall Study|Withdrawal by Subject|11
1387490|NCT01338818|4578487|P1|Overall Study|no longer require study drug|1
1387491|NCT01338818|4578487|P1|Overall Study|Lack of Efficacy|5
1387492|NCT01338818|4578487|P1|Overall Study|Adverse Event|8
1387493|NCT01338792|4578493|P1|Overall Study|Withdrawal by Subject|1
1387494|NCT01338792|4578493|P1|Overall Study|Death|1
1387495|NCT01338792|4578493|P1|Overall Study|Adverse Event|2
1387496|NCT01338636|4578508|P1|Overall Study|Withdrawn due to lack of improvement|8
1387497|NCT01338610|4578522|P3|Overall Study|Adverse Event|0
1387498|NCT01338610|4578523|P2|Overall Study|Adverse Event|0
1387499|NCT01338610|4578524|P1|Overall Study|Adverse Event|3
1387500|NCT01338610|4578522|P3|Overall Study|Protocol Violation|1
1387501|NCT01338610|4578523|P2|Overall Study|Protocol Violation|0
1387502|NCT01338610|4578524|P1|Overall Study|Protocol Violation|1
1387503|NCT01338610|4578522|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
1387504|NCT01338610|4578523|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
1387505|NCT01338610|4578524|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
1387506|NCT01338493|4578531|P1|12 Months Follow up|Lost to Follow-up|9
1387507|NCT01338493|4578531|P1|6 Months Follow up|Missed visit|8
1387508|NCT01338493|4578531|P1|6 Months Follow up|Lost to Follow-up|11
1387509|NCT01338493|4578531|P1|Discharge|Missed visit|1
1387510|NCT01338493|4578531|P1|Discharge|Death|1
1387511|NCT01338493|4578531|P1|Enrolled|Patient not implanted|4
1387512|NCT01338493|4578531|P1|Enrolled|Withdrawal by Subject|1
1387513|NCT01338415|4578538|P2|Overall Study|Other (administrative reason)|0
1387514|NCT01338415|4578539|P1|Overall Study|Other (administrative reason)|1
1387515|NCT01338415|4578538|P2|Overall Study|Other (PAH not the main etiology of PH)|2
1387516|NCT01338415|4578539|P1|Overall Study|Other (PAH not the main etiology of PH)|0
1387517|NCT01338415|4578538|P2|Overall Study|Withdrawal by Subject|1
1387518|NCT01338415|4578539|P1|Overall Study|Withdrawal by Subject|1
1387519|NCT01338415|4578538|P2|Overall Study|Adverse Event|6
1387520|NCT01338415|4578539|P1|Overall Study|Adverse Event|8
1387521|NCT01338298|4578561|P2|Overall Study|Non-adherence|0
1387522|NCT01338298|4578562|P1|Overall Study|Non-adherence|1
1387523|NCT01338298|4578561|P2|Overall Study|Depressive symptoms and nausea|0
1387524|NCT01338298|4578562|P1|Overall Study|Depressive symptoms and nausea|1
1387525|NCT01338298|4578561|P2|Overall Study|Positive symptom worsening|0
1387526|NCT01338298|4578562|P1|Overall Study|Positive symptom worsening|1
1387527|NCT01338298|4578561|P2|Overall Study|Administrative error|1
1387528|NCT01338298|4578562|P1|Overall Study|Administrative error|0
1387529|NCT01338298|4578561|P2|Overall Study|Abdominal Pain and scheduled surgery|1
1387530|NCT01338298|4578562|P1|Overall Study|Abdominal Pain and scheduled surgery|0
1387531|NCT01338298|4578561|P2|Overall Study|Withdrawal by Subject|1
1387532|NCT01338298|4578562|P1|Overall Study|Withdrawal by Subject|1
1387533|NCT01338025|4578572|P2|Overall Study|Found ineligible after starting|0
1387534|NCT01338025|4578573|P1|Overall Study|Found ineligible after starting|1
1387535|NCT01338025|4578572|P2|Overall Study|Withdrawal by Subject|2
1387536|NCT01338025|4578573|P1|Overall Study|Withdrawal by Subject|0
1387537|NCT01338025|4578572|P2|Overall Study|Unexpected closure of study|9
1387538|NCT01338025|4578573|P1|Overall Study|Unexpected closure of study|10
1387539|NCT01338012|4578585|P1|Overall Study|Study terminated|4
1387540|NCT01338012|4578585|P1|Overall Study|Death|4
1387541|NCT01337960|4578592|P3|Overall Study|Withdrawal by Subject|0
1387542|NCT01337960|4578593|P2|Overall Study|Withdrawal by Subject|0
1387543|NCT01337960|4578594|P1|Overall Study|Withdrawal by Subject|1
1387544|NCT01337960|4578592|P3|Overall Study|Lost to Follow-up|0
1387545|NCT01337960|4578593|P2|Overall Study|Lost to Follow-up|0
1387546|NCT01337960|4578594|P1|Overall Study|Lost to Follow-up|1
1387547|NCT01337674|4578627|P4|Treatment Period 2|Withdrawal by Subject|0
1387548|NCT01337674|4578628|P3|Treatment Period 2|Withdrawal by Subject|1
1387549|NCT01337674|4578629|P2|Treatment Period 2|Withdrawal by Subject|0
1387550|NCT01337674|4578630|P1|Treatment Period 2|Withdrawal by Subject|0
1387551|NCT01337674|4578627|P4|Treatment Period 1|Discontinued due to blood draws|1
1387552|NCT01337674|4578628|P3|Treatment Period 1|Discontinued due to blood draws|0
1387553|NCT01337674|4578629|P2|Treatment Period 1|Discontinued due to blood draws|0
1387554|NCT01337674|4578630|P1|Treatment Period 1|Discontinued due to blood draws|0
1387555|NCT01337674|4578627|P4|Treatment Period 1|Adverse Event|0
1387556|NCT01337674|4578628|P3|Treatment Period 1|Adverse Event|0
1387557|NCT01337674|4578629|P2|Treatment Period 1|Adverse Event|1
1387558|NCT01337674|4578630|P1|Treatment Period 1|Adverse Event|0
1387559|NCT01337635|4578648|P2|Overall Study|Lost to Follow-up|1
1387560|NCT01337635|4578649|P1|Overall Study|Lost to Follow-up|0
1387561|NCT01337297|4578697|P2|Overall Study|Lost to Follow-up|3
1387562|NCT01337297|4578698|P1|Overall Study|Lost to Follow-up|1
1387563|NCT01337297|4578697|P2|Overall Study|They entered to single anodal tDCS|3
1387564|NCT01337297|4578698|P1|Overall Study|They entered to single anodal tDCS|4
1387565|NCT01337167|4578706|P2|Toddler Vaccinations|Withdrawal by Subject|0
1387566|NCT01337167|4578707|P1|Toddler Vaccinations|Withdrawal by Subject|3
1387567|NCT01337167|4578706|P2|Toddler Vaccinations|Protocol Violation|1
1387568|NCT01337167|4578707|P1|Toddler Vaccinations|Protocol Violation|0
1387569|NCT01337167|4578706|P2|Toddler Vaccinations|Lost to Follow-up|12
1387570|NCT01337167|4578707|P1|Toddler Vaccinations|Lost to Follow-up|11
1387571|NCT01337167|4578706|P2|Interim Period|Other protocol criterion not met|1
1387572|NCT01337167|4578707|P1|Interim Period|Other protocol criterion not met|0
1387573|NCT01337167|4578706|P2|Interim Period|Withdrawal by Subject|10
1387574|NCT01337167|4578707|P1|Interim Period|Withdrawal by Subject|18
1387575|NCT01337167|4578706|P2|Interim Period|Protocol Violation|3
1387576|NCT01337167|4578707|P1|Interim Period|Protocol Violation|5
1387577|NCT01337167|4578706|P2|Interim Period|Physician Decision|3
1387578|NCT01337167|4578707|P1|Interim Period|Physician Decision|6
1387579|NCT01337167|4578706|P2|Interim Period|Non-compliance with study drug|0
1387580|NCT01337167|4578707|P1|Interim Period|Non-compliance with study drug|1
1387581|NCT01337167|4578706|P2|Interim Period|Lost to Follow-up|23
1387582|NCT01337167|4578707|P1|Interim Period|Lost to Follow-up|51
1387583|NCT01337167|4578706|P2|Infant Series|Randomized but not vaccinated|3
1387584|NCT01337167|4578707|P1|Infant Series|Randomized but not vaccinated|5
1387585|NCT01337167|4578706|P2|Infant Series|Withdrawal by Subject|4
1387586|NCT01337167|4578707|P1|Infant Series|Withdrawal by Subject|15
1387587|NCT01337167|4578706|P2|Infant Series|Protocol Violation|9
1387588|NCT01337167|4578707|P1|Infant Series|Protocol Violation|22
1387589|NCT01337167|4578706|P2|Infant Series|Physician Decision|1
1387590|NCT01337167|4578707|P1|Infant Series|Physician Decision|3
1387591|NCT01337167|4578706|P2|Infant Series|Non-compliance with study drug|1
1387592|NCT01337167|4578707|P1|Infant Series|Non-compliance with study drug|2
1387593|NCT01337167|4578706|P2|Infant Series|Lost to Follow-up|7
1387594|NCT01337167|4578707|P1|Infant Series|Lost to Follow-up|13
1387595|NCT01337167|4578706|P2|Infant Series|Death|1
1387596|NCT01337167|4578707|P1|Infant Series|Death|1
1387597|NCT01337167|4578706|P2|Infant Series|Adverse Event|1
1387598|NCT01337167|4578707|P1|Infant Series|Adverse Event|1
1387599|NCT01337115|4578775|P2|Overall Study|Protocol Violation|0
1387600|NCT01337115|4578776|P1|Overall Study|Protocol Violation|2
1387601|NCT01337089|4578788|P1|Overall Study|Lost to Follow-up|2
1387602|NCT01337089|4578788|P1|Overall Study|Met Withdrawal Criteria|3
1387603|NCT01337089|4578788|P1|Overall Study|Withdrawal by Investigator|33
1387604|NCT01337089|4578788|P1|Overall Study|Withdrawal by Subject|129
1387605|NCT01337089|4578788|P1|Overall Study|Adverse Event|237
1387606|NCT01337050|4578803|P3|Overall Study|Participants refused further follow-up|7
1387607|NCT01337050|4578804|P2|Overall Study|Participants refused further follow-up|7
1387608|NCT01337050|4578805|P1|Overall Study|Participants refused further follow-up|0
1387609|NCT01337050|4578803|P3|Overall Study|Other|8
1387610|NCT01337050|4578804|P2|Overall Study|Other|6
1387611|NCT01337050|4578805|P1|Overall Study|Other|4
1387612|NCT01337050|4578803|P3|Overall Study|Death|4
1387613|NCT01337050|4578804|P2|Overall Study|Death|0
1387614|NCT01337050|4578805|P1|Overall Study|Death|0
1387615|NCT01336972|4578866|P3|Overall Study|Adverse Event|0
1387616|NCT01336972|4578867|P2|Overall Study|Adverse Event|1
1387617|NCT01336972|4578868|P1|Overall Study|Adverse Event|1
1387618|NCT01336894|4578914|P2|Follow-up|Study terminated prematurely|7
1387619|NCT01336894|4578915|P1|Follow-up|Study terminated prematurely|2
1387620|NCT01336764|4578935|P2|Overall Study|Withdrawal by Subject|5
1387621|NCT01336764|4578936|P1|Overall Study|Withdrawal by Subject|5
1387622|NCT01336738|4578947|P5|Overall Study|Other|4
1387623|NCT01336738|4578948|P4|Overall Study|Other|3
1387624|NCT01336738|4578949|P3|Overall Study|Other|2
1387625|NCT01336738|4578950|P2|Overall Study|Other|3
1387626|NCT01336738|4578951|P1|Overall Study|Other|3
1387627|NCT01336738|4578947|P5|Overall Study|Withdrawal by Subject|1
1387628|NCT01336738|4578948|P4|Overall Study|Withdrawal by Subject|1
1387629|NCT01336738|4578949|P3|Overall Study|Withdrawal by Subject|2
1387630|NCT01336738|4578950|P2|Overall Study|Withdrawal by Subject|0
1387631|NCT01336738|4578951|P1|Overall Study|Withdrawal by Subject|2
1387632|NCT01336738|4578947|P5|Overall Study|Protocol Violation|0
1387633|NCT01336738|4578948|P4|Overall Study|Protocol Violation|0
1387634|NCT01336738|4578949|P3|Overall Study|Protocol Violation|0
1387635|NCT01336738|4578950|P2|Overall Study|Protocol Violation|1
1387636|NCT01336738|4578951|P1|Overall Study|Protocol Violation|0
1387637|NCT01336738|4578947|P5|Overall Study|Did not meet entrance criteria|0
1387638|NCT01336738|4578948|P4|Overall Study|Did not meet entrance criteria|0
1387639|NCT01336738|4578949|P3|Overall Study|Did not meet entrance criteria|0
1387640|NCT01336738|4578950|P2|Overall Study|Did not meet entrance criteria|1
1387641|NCT01336738|4578951|P1|Overall Study|Did not meet entrance criteria|0
1387642|NCT01336738|4578947|P5|Overall Study|Lost to Follow-up|2
1387643|NCT01336738|4578948|P4|Overall Study|Lost to Follow-up|2
1387644|NCT01336738|4578949|P3|Overall Study|Lost to Follow-up|2
1387645|NCT01336738|4578950|P2|Overall Study|Lost to Follow-up|1
1387646|NCT01336738|4578951|P1|Overall Study|Lost to Follow-up|2
1387647|NCT01336738|4578947|P5|Overall Study|Adverse Event|3
1387648|NCT01336738|4578948|P4|Overall Study|Adverse Event|1
1387649|NCT01336738|4578949|P3|Overall Study|Adverse Event|2
1387650|NCT01336738|4578950|P2|Overall Study|Adverse Event|3
1387651|NCT01336738|4578951|P1|Overall Study|Adverse Event|0
1387652|NCT01336712|4578993|P1|Overall Study|Lack of Efficacy|1
1387653|NCT01336712|4578993|P1|Overall Study|Death|2
1387654|NCT01336647|4579006|P3|Overall Study|Lost to Follow-up|3
1387655|NCT01336647|4579007|P2|Overall Study|Lost to Follow-up|1
1387656|NCT01336647|4579008|P1|Overall Study|Lost to Follow-up|4
1387657|NCT01336634|4579022|P3|Overall Study|Ongoing|24
1387658|NCT01336634|4579023|P2|Overall Study|Ongoing|22
1387659|NCT01336634|4579024|P1|Overall Study|Ongoing|15
1387660|NCT01336634|4579022|P3|Overall Study|Physician Decision|0
1387661|NCT01336634|4579023|P2|Overall Study|Physician Decision|1
1387662|NCT01336634|4579024|P1|Overall Study|Physician Decision|1
1387663|NCT01336634|4579022|P3|Overall Study|Withdrawal by Subject|1
1387664|NCT01336634|4579023|P2|Overall Study|Withdrawal by Subject|0
1387665|NCT01336634|4579024|P1|Overall Study|Withdrawal by Subject|6
1387666|NCT01336634|4579022|P3|Overall Study|Lost to Follow-up|1
1387667|NCT01336634|4579023|P2|Overall Study|Lost to Follow-up|1
1387668|NCT01336634|4579024|P1|Overall Study|Lost to Follow-up|2
1387669|NCT01336634|4579022|P3|Overall Study|Death|10
1387670|NCT01336634|4579023|P2|Overall Study|Death|33
1387671|NCT01336634|4579024|P1|Overall Study|Death|60
1387672|NCT01336621|4579065|P1|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
1387673|NCT01336621|4579065|P1|SFUCP (up to 2.6 Years)|Physician Decision|1
1387674|NCT01336621|4579065|P1|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
1387675|NCT01336621|4579065|P1|SFUCP (up to 2.6 Years)|Adverse Event|1
1387676|NCT01336621|4579065|P1|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
1387677|NCT01336621|4579065|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
1387678|NCT01336621|4579065|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
1387679|NCT01336621|4579065|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
1387680|NCT01336621|4579065|P1|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
1387681|NCT01336621|4579065|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
1387682|NCT01336621|4579065|P1|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
1387683|NCT01336621|4579065|P1|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
1387684|NCT01336621|4579065|P1|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
1387685|NCT01336621|4579065|P1|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
1387686|NCT01336608|4579115|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
1387687|NCT01336608|4579116|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
1387688|NCT01336608|4579117|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
1387689|NCT01336608|4579118|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
1387690|NCT01336608|4579115|P4|24-week, Double-blind Treatment Period|Physician Decision|1
1387691|NCT01336608|4579116|P3|24-week, Double-blind Treatment Period|Physician Decision|1
1387692|NCT01336608|4579117|P2|24-week, Double-blind Treatment Period|Physician Decision|3
1387693|NCT01336608|4579118|P1|24-week, Double-blind Treatment Period|Physician Decision|0
1387694|NCT01336608|4579115|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1387695|NCT01336608|4579116|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1387696|NCT01336608|4579117|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
1387697|NCT01336608|4579118|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1387698|NCT01336608|4579115|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
1387699|NCT01336608|4579116|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
1387700|NCT01336608|4579117|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
1387701|NCT01336608|4579118|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
1387702|NCT01336608|4579115|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
1387703|NCT01336608|4579116|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
1387704|NCT01336608|4579117|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
1387705|NCT01336608|4579118|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
1387706|NCT01336608|4579115|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
1387707|NCT01336608|4579116|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
1387708|NCT01336608|4579117|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
1387709|NCT01336608|4579118|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
1387710|NCT01336608|4579115|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1387711|NCT01336608|4579116|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1387712|NCT01336608|4579117|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
1387713|NCT01336608|4579118|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1387714|NCT01336608|4579115|P4|24-week, Double-blind Treatment Period|Adverse Event|7
1387715|NCT01336608|4579116|P3|24-week, Double-blind Treatment Period|Adverse Event|6
1387716|NCT01336608|4579117|P2|24-week, Double-blind Treatment Period|Adverse Event|8
1387717|NCT01336608|4579118|P1|24-week, Double-blind Treatment Period|Adverse Event|0
1387718|NCT01336608|4579115|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1387719|NCT01336608|4579116|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1387720|NCT01336608|4579117|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1387721|NCT01336608|4579118|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
1387722|NCT01336608|4579115|P4|2-week, Single-blind Run-In Period|Physician Decision|0
1387723|NCT01336608|4579116|P3|2-week, Single-blind Run-In Period|Physician Decision|0
1387724|NCT01336608|4579117|P2|2-week, Single-blind Run-In Period|Physician Decision|0
1387725|NCT01336608|4579118|P1|2-week, Single-blind Run-In Period|Physician Decision|1
1387726|NCT01336608|4579115|P4|2-week, Single-blind Run-In Period|Adverse Event|0
1387727|NCT01336608|4579116|P3|2-week, Single-blind Run-In Period|Adverse Event|0
1387728|NCT01336608|4579117|P2|2-week, Single-blind Run-In Period|Adverse Event|0
1387729|NCT01336608|4579118|P1|2-week, Single-blind Run-In Period|Adverse Event|1
1387730|NCT01336608|4579115|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1387731|NCT01336608|4579116|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1387817|NCT01335698|4579482|P2|Treatment Stage 2|Continuing treatment|3
1387732|NCT01336608|4579117|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1387733|NCT01336608|4579118|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
1387734|NCT01336608|4579115|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1387735|NCT01336608|4579116|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1387736|NCT01336608|4579117|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1387737|NCT01336608|4579118|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
1387738|NCT01336569|4579132|P1|Overall Study|Lost to Follow-up|4
1387739|NCT01336205|4579174|P2|Overall Study|Did not receive treatment|0
1387740|NCT01336205|4579175|P1|Overall Study|Did not receive treatment|4
1387741|NCT01336205|4579174|P2|Overall Study|Withdrawal by Subject|38
1387742|NCT01336205|4579175|P1|Overall Study|Withdrawal by Subject|72
1387743|NCT01336205|4579174|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
1387744|NCT01336205|4579175|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
1387745|NCT01336205|4579174|P2|Overall Study|Death|1
1387746|NCT01336205|4579175|P1|Overall Study|Death|1
1387747|NCT01336205|4579174|P2|Overall Study|Adverse Event|6
1387748|NCT01336205|4579175|P1|Overall Study|Adverse Event|56
1387749|NCT01336205|4579174|P2|Overall Study|Severe noncompliance with protocol|2
1387750|NCT01336205|4579175|P1|Overall Study|Severe noncompliance with protocol|9
1387751|NCT01336205|4579174|P2|Overall Study|Lack of Efficacy|0
1387752|NCT01336205|4579175|P1|Overall Study|Lack of Efficacy|4
1387753|NCT01336205|4579174|P2|Overall Study|Study-Specific Withdrawal Criteria|7
1387754|NCT01336205|4579175|P1|Overall Study|Study-Specific Withdrawal Criteria|16
1387755|NCT01336205|4579174|P2|Overall Study|Lost to Follow-up|20
1387756|NCT01336205|4579175|P1|Overall Study|Lost to Follow-up|40
1387757|NCT01336205|4579174|P2|Overall Study|Other|9
1387758|NCT01336205|4579175|P1|Overall Study|Other|22
1387759|NCT01336023|4579203|P3|Week 27 to 52|Unclassified|9
1387760|NCT01336023|4579204|P2|Week 27 to 52|Unclassified|18
1387761|NCT01336023|4579205|P1|Week 27 to 52|Unclassified|13
1387762|NCT01336023|4579203|P3|Week 27 to 52|Withdrawal Criteria|16
1387763|NCT01336023|4579204|P2|Week 27 to 52|Withdrawal Criteria|19
1387764|NCT01336023|4579205|P1|Week 27 to 52|Withdrawal Criteria|14
1387765|NCT01336023|4579203|P3|Week 27 to 52|Protocol Violation|1
1387766|NCT01336023|4579204|P2|Week 27 to 52|Protocol Violation|2
1387767|NCT01336023|4579205|P1|Week 27 to 52|Protocol Violation|0
1387768|NCT01336023|4579203|P3|Week 27 to 52|Adverse Event|2
1387769|NCT01336023|4579204|P2|Week 27 to 52|Adverse Event|5
1387770|NCT01336023|4579205|P1|Week 27 to 52|Adverse Event|1
1387771|NCT01336023|4579203|P3|Week 0 to Week 26|Unclassified|9
1387772|NCT01336023|4579204|P2|Week 0 to Week 26|Unclassified|16
1387773|NCT01336023|4579205|P1|Week 0 to Week 26|Unclassified|5
1387774|NCT01336023|4579203|P3|Week 0 to Week 26|Withdrawal Criteria|40
1387775|NCT01336023|4579204|P2|Week 0 to Week 26|Withdrawal Criteria|69
1387776|NCT01336023|4579205|P1|Week 0 to Week 26|Withdrawal Criteria|34
1387777|NCT01336023|4579203|P3|Week 0 to Week 26|Protocol Violation|0
1387778|NCT01336023|4579204|P2|Week 0 to Week 26|Protocol Violation|2
1387779|NCT01336023|4579205|P1|Week 0 to Week 26|Protocol Violation|1
1387780|NCT01336023|4579203|P3|Week 0 to Week 26|Lack of Efficacy|0
1387781|NCT01336023|4579204|P2|Week 0 to Week 26|Lack of Efficacy|1
1387782|NCT01336023|4579205|P1|Week 0 to Week 26|Lack of Efficacy|0
1387783|NCT01336023|4579203|P3|Week 0 to Week 26|Adverse Event|24
1387784|NCT01336023|4579204|P2|Week 0 to Week 26|Adverse Event|10
1387785|NCT01336023|4579205|P1|Week 0 to Week 26|Adverse Event|8
1387786|NCT01335997|4579226|P2|Period III|Lost to Follow-up|0
1387787|NCT01335997|4579227|P1|Period III|Lost to Follow-up|1
1387788|NCT01335997|4579226|P2|Period III|Protocol Violation|1
1387789|NCT01335997|4579227|P1|Period III|Protocol Violation|0
1387790|NCT01335997|4579226|P2|Period III|Study Terminated by Sponsor|76
1387791|NCT01335997|4579227|P1|Period III|Study Terminated by Sponsor|77
1387792|NCT01335997|4579226|P2|Period III|Adverse Event|2
1387793|NCT01335997|4579227|P1|Period III|Adverse Event|0
1387794|NCT01335997|4579226|P2|Period I and II|Physician Decision|1
1387795|NCT01335997|4579227|P1|Period I and II|Physician Decision|2
1387796|NCT01335997|4579226|P2|Period I and II|Protocol Violation|10
1387797|NCT01335997|4579227|P1|Period I and II|Protocol Violation|9
1387798|NCT01335997|4579226|P2|Period I and II|Study Terminated by Sponsor|415
1387799|NCT01335997|4579227|P1|Period I and II|Study Terminated by Sponsor|406
1387800|NCT01335997|4579226|P2|Period I and II|Withdrawal by Subject|4
1387801|NCT01335997|4579227|P1|Period I and II|Withdrawal by Subject|9
1387802|NCT01335997|4579226|P2|Period I and II|Lost to Follow-up|5
1387803|NCT01335997|4579227|P1|Period I and II|Lost to Follow-up|3
1387804|NCT01335997|4579226|P2|Period I and II|Noncompliance with Study Drug|1
1387805|NCT01335997|4579227|P1|Period I and II|Noncompliance with Study Drug|1
1387806|NCT01335997|4579226|P2|Period I and II|Adverse Event|43
1387807|NCT01335997|4579227|P1|Period I and II|Adverse Event|63
1387808|NCT01335971|4579240|P3|Overall Study|Did not complete bronchoscopy|1
1387809|NCT01335971|4579241|P2|Overall Study|Did not complete bronchoscopy|1
1387810|NCT01335971|4579242|P1|Overall Study|Did not complete bronchoscopy|1
1387811|NCT01335971|4579240|P3|Overall Study|Withdrawal by Subject|0
1387812|NCT01335971|4579241|P2|Overall Study|Withdrawal by Subject|0
1387813|NCT01335971|4579242|P1|Overall Study|Withdrawal by Subject|1
1387814|NCT01335698|4579479|P5|Treatment Stage 2|Continuing treatment|6
1387815|NCT01335698|4579480|P4|Treatment Stage 2|Continuing treatment|19
1387816|NCT01335698|4579481|P3|Treatment Stage 2|Continuing treatment|13
1387818|NCT01335698|4579483|P1|Treatment Stage 2|Continuing treatment|11
1387819|NCT01335698|4579479|P5|Treatment Stage 2|Poor compliance/noncompliance|0
1387820|NCT01335698|4579480|P4|Treatment Stage 2|Poor compliance/noncompliance|3
1387821|NCT01335698|4579481|P3|Treatment Stage 2|Poor compliance/noncompliance|0
1387822|NCT01335698|4579482|P2|Treatment Stage 2|Poor compliance/noncompliance|0
1387823|NCT01335698|4579483|P1|Treatment Stage 2|Poor compliance/noncompliance|1
1387824|NCT01335698|4579479|P5|Treatment Stage 2|Withdrawal by Subject|0
1387825|NCT01335698|4579480|P4|Treatment Stage 2|Withdrawal by Subject|0
1387826|NCT01335698|4579481|P3|Treatment Stage 2|Withdrawal by Subject|0
1387827|NCT01335698|4579482|P2|Treatment Stage 2|Withdrawal by Subject|0
1387828|NCT01335698|4579483|P1|Treatment Stage 2|Withdrawal by Subject|1
1387829|NCT01335698|4579479|P5|Treatment Stage 2|Adverse Event|0
1387830|NCT01335698|4579480|P4|Treatment Stage 2|Adverse Event|1
1387831|NCT01335698|4579481|P3|Treatment Stage 2|Adverse Event|0
1387832|NCT01335698|4579482|P2|Treatment Stage 2|Adverse Event|0
1387833|NCT01335698|4579483|P1|Treatment Stage 2|Adverse Event|0
1387834|NCT01335698|4579479|P5|Treatment Stage 2|Lack of Efficacy|0
1387835|NCT01335698|4579480|P4|Treatment Stage 2|Lack of Efficacy|1
1387836|NCT01335698|4579481|P3|Treatment Stage 2|Lack of Efficacy|3
1387837|NCT01335698|4579482|P2|Treatment Stage 2|Lack of Efficacy|1
1387838|NCT01335698|4579483|P1|Treatment Stage 2|Lack of Efficacy|2
1387839|NCT01335698|4579479|P5|Treatment Stage 1|Not specified|0
1387840|NCT01335698|4579480|P4|Treatment Stage 1|Not specified|1
1387841|NCT01335698|4579481|P3|Treatment Stage 1|Not specified|0
1387842|NCT01335698|4579482|P2|Treatment Stage 1|Not specified|0
1387843|NCT01335698|4579483|P1|Treatment Stage 1|Not specified|1
1387844|NCT01335698|4579479|P5|Treatment Stage 1|No longer meets study criteria|0
1387845|NCT01335698|4579480|P4|Treatment Stage 1|No longer meets study criteria|1
1387846|NCT01335698|4579481|P3|Treatment Stage 1|No longer meets study criteria|0
1387847|NCT01335698|4579482|P2|Treatment Stage 1|No longer meets study criteria|1
1387848|NCT01335698|4579483|P1|Treatment Stage 1|No longer meets study criteria|1
1387849|NCT01335698|4579479|P5|Treatment Stage 1|Poor compliance/noncompliance|0
1387850|NCT01335698|4579480|P4|Treatment Stage 1|Poor compliance/noncompliance|2
1387851|NCT01335698|4579481|P3|Treatment Stage 1|Poor compliance/noncompliance|0
1387852|NCT01335698|4579482|P2|Treatment Stage 1|Poor compliance/noncompliance|1
1387853|NCT01335698|4579483|P1|Treatment Stage 1|Poor compliance/noncompliance|0
1387854|NCT01335698|4579479|P5|Treatment Stage 1|Lost to Follow-up|0
1387855|NCT01335698|4579480|P4|Treatment Stage 1|Lost to Follow-up|0
1387856|NCT01335698|4579481|P3|Treatment Stage 1|Lost to Follow-up|0
1387857|NCT01335698|4579482|P2|Treatment Stage 1|Lost to Follow-up|1
1387858|NCT01335698|4579483|P1|Treatment Stage 1|Lost to Follow-up|1
1387859|NCT01335698|4579479|P5|Treatment Stage 1|Withdrawal by Subject|0
1387860|NCT01335698|4579480|P4|Treatment Stage 1|Withdrawal by Subject|1
1387861|NCT01335698|4579481|P3|Treatment Stage 1|Withdrawal by Subject|0
1387862|NCT01335698|4579482|P2|Treatment Stage 1|Withdrawal by Subject|2
1387863|NCT01335698|4579483|P1|Treatment Stage 1|Withdrawal by Subject|1
1387864|NCT01335698|4579479|P5|Treatment Stage 1|Adverse Event|1
1387865|NCT01335698|4579480|P4|Treatment Stage 1|Adverse Event|1
1387866|NCT01335698|4579481|P3|Treatment Stage 1|Adverse Event|2
1387867|NCT01335698|4579482|P2|Treatment Stage 1|Adverse Event|2
1387868|NCT01335698|4579483|P1|Treatment Stage 1|Adverse Event|1
1387869|NCT01335698|4579479|P5|Treatment Stage 1|Lack of Efficacy|1
1387870|NCT01335698|4579480|P4|Treatment Stage 1|Lack of Efficacy|3
1387871|NCT01335698|4579481|P3|Treatment Stage 1|Lack of Efficacy|3
1387872|NCT01335698|4579482|P2|Treatment Stage 1|Lack of Efficacy|1
1387873|NCT01335698|4579483|P1|Treatment Stage 1|Lack of Efficacy|3
1387874|NCT01335685|4579534|P8|Overall Study|Reason not Specified|0
1387875|NCT01335685|4579535|P7|Overall Study|Reason not Specified|0
1387876|NCT01335685|4579536|P6|Overall Study|Reason not Specified|1
1387877|NCT01335685|4579537|P5|Overall Study|Reason not Specified|0
1387878|NCT01335685|4579538|P4|Overall Study|Reason not Specified|0
1387879|NCT01335685|4579539|P3|Overall Study|Reason not Specified|1
1387880|NCT01335685|4579540|P2|Overall Study|Reason not Specified|0
1387881|NCT01335685|4579541|P1|Overall Study|Reason not Specified|0
1387882|NCT01335685|4579534|P8|Overall Study|Withdrawal by Subject|0
1387883|NCT01335685|4579535|P7|Overall Study|Withdrawal by Subject|0
1387884|NCT01335685|4579536|P6|Overall Study|Withdrawal by Subject|0
1387885|NCT01335685|4579537|P5|Overall Study|Withdrawal by Subject|0
1387886|NCT01335685|4579538|P4|Overall Study|Withdrawal by Subject|1
1387887|NCT01335685|4579539|P3|Overall Study|Withdrawal by Subject|0
1387888|NCT01335685|4579540|P2|Overall Study|Withdrawal by Subject|0
1387889|NCT01335685|4579541|P1|Overall Study|Withdrawal by Subject|1
1387890|NCT01335685|4579534|P8|Overall Study|Study Terminated by Sponsor|3
1387891|NCT01335685|4579535|P7|Overall Study|Study Terminated by Sponsor|2
1387892|NCT01335685|4579536|P6|Overall Study|Study Terminated by Sponsor|4
1387893|NCT01335685|4579537|P5|Overall Study|Study Terminated by Sponsor|0
1387894|NCT01335685|4579538|P4|Overall Study|Study Terminated by Sponsor|10
1387895|NCT01335685|4579539|P3|Overall Study|Study Terminated by Sponsor|1
1387896|NCT01335685|4579540|P2|Overall Study|Study Terminated by Sponsor|1
1387897|NCT01335685|4579541|P1|Overall Study|Study Terminated by Sponsor|2
1387898|NCT01335477|4579654|P2|Overall Study|Reason other than those stated above|2
1387899|NCT01335477|4579655|P1|Overall Study|Reason other than those stated above|2
1387900|NCT01335477|4579654|P2|Overall Study|Not treated|2
1387901|NCT01335477|4579655|P1|Overall Study|Not treated|1
1387902|NCT01335477|4579654|P2|Overall Study|Consent withdrawn, not due to AE|9
1387903|NCT01335477|4579655|P1|Overall Study|Consent withdrawn, not due to AE|7
1387904|NCT01335477|4579654|P2|Overall Study|Lost to Follow-up|2
1387905|NCT01335477|4579655|P1|Overall Study|Lost to Follow-up|1
1387906|NCT01335477|4579654|P2|Overall Study|Non compliant with protocol|2
1387907|NCT01335477|4579655|P1|Overall Study|Non compliant with protocol|0
1387908|NCT01335477|4579654|P2|Overall Study|Adverse Event|42
1387909|NCT01335477|4579655|P1|Overall Study|Adverse Event|30
1387910|NCT01335464|4579719|P2|Overall Study|Reason other than those stated above|1
1387911|NCT01335464|4579720|P1|Overall Study|Reason other than those stated above|1
1387912|NCT01335464|4579719|P2|Overall Study|Not treated|0
1387913|NCT01335464|4579720|P1|Overall Study|Not treated|2
1387914|NCT01335464|4579719|P2|Overall Study|Consent withdrawn, not due to AE|23
1387915|NCT01335464|4579720|P1|Overall Study|Consent withdrawn, not due to AE|12
1387916|NCT01335464|4579719|P2|Overall Study|Non compliant with protocol|0
1387917|NCT01335464|4579720|P1|Overall Study|Non compliant with protocol|2
1387918|NCT01335464|4579719|P2|Overall Study|Adverse Event|25
1387919|NCT01335464|4579720|P1|Overall Study|Adverse Event|15
1387920|NCT01334918|4579889|P2|Overall Study|Withdrawal by Subject|1
1387921|NCT01334918|4579890|P1|Overall Study|Withdrawal by Subject|0
1387922|NCT01334918|4579889|P2|Overall Study|Adverse Event|0
1387923|NCT01334918|4579890|P1|Overall Study|Adverse Event|2
1387924|NCT01334918|4579889|P2|Overall Study|Did not receive study drug|0
1387925|NCT01334918|4579890|P1|Overall Study|Did not receive study drug|6
1387926|NCT01334866|4579916|P1|Overall Study|medically necessary post-procedure|1
1387927|NCT01334866|4579916|P1|Overall Study|medically necessary prior to procedure|2
1387928|NCT01334866|4579916|P1|Overall Study|Physician Decision|3
1387929|NCT01334866|4579916|P1|Overall Study|Lost to Follow-up|3
1387930|NCT01334866|4579916|P1|Overall Study|Withdrawal by Subject|10
1387931|NCT01334710|4579953|P1|Overall Study|Trial was terminated|3
1387932|NCT01334606|4579958|P1|Overall Study|Study Terminated due to slow enrolment|18
1387933|NCT01334554|4579966|P2|Overall Study|Adverse Event|2
1387934|NCT01334554|4579967|P1|Overall Study|Adverse Event|4
1387935|NCT01334515|4579977|P2|Overall Study|Withdrawal by Subject|1
1387936|NCT01334515|4579978|P1|Overall Study|Withdrawal by Subject|1
1387937|NCT01334515|4579977|P2|Overall Study|Physician Decision|1
1387938|NCT01334515|4579978|P1|Overall Study|Physician Decision|1
1387939|NCT01334515|4579977|P2|Overall Study|Lack of Efficacy|21
1387940|NCT01334515|4579978|P1|Overall Study|Lack of Efficacy|8
1387941|NCT01334515|4579977|P2|Overall Study|Death|0
1387942|NCT01334515|4579978|P1|Overall Study|Death|1
1387943|NCT01334515|4579977|P2|Overall Study|Adverse Event|6
1387944|NCT01334515|4579978|P1|Overall Study|Adverse Event|1
1387945|NCT01334125|4580016|P2|Overall Study|Lost to Follow-up|3
1387946|NCT01334125|4580017|P1|Overall Study|Lost to Follow-up|3
1387947|NCT01333956|4580033|P4|Overall Study|Withdrawal by Subject|0
1387948|NCT01333956|4580034|P3|Overall Study|Withdrawal by Subject|1
1387949|NCT01333956|4580035|P2|Overall Study|Withdrawal by Subject|2
1387950|NCT01333956|4580036|P1|Overall Study|Withdrawal by Subject|0
1387951|NCT01333956|4580033|P4|Overall Study|Unable to complete study procedure|1
1387952|NCT01333956|4580034|P3|Overall Study|Unable to complete study procedure|0
1387953|NCT01333956|4580035|P2|Overall Study|Unable to complete study procedure|0
1387954|NCT01333956|4580036|P1|Overall Study|Unable to complete study procedure|1
1387955|NCT01333956|4580033|P4|Overall Study|Lost to Follow-up|1
1387956|NCT01333956|4580034|P3|Overall Study|Lost to Follow-up|0
1387957|NCT01333956|4580035|P2|Overall Study|Lost to Follow-up|2
1387958|NCT01333956|4580036|P1|Overall Study|Lost to Follow-up|1
1387959|NCT01333943|4580072|P2|Overall Study|Known neuropathy|0
1387960|NCT01333943|4580073|P1|Overall Study|Known neuropathy|1
1387961|NCT01333865|4580089|P1|Overall Study|Adverse Event|2
1387962|NCT01333722|4580109|P2|Overall Study|Withdrawal by Subject|1
1387963|NCT01333722|4580110|P1|Overall Study|Withdrawal by Subject|0
1387964|NCT01333722|4580109|P2|Overall Study|Lack of Efficacy|2
1387965|NCT01333722|4580110|P1|Overall Study|Lack of Efficacy|0
1387966|NCT01333501|4580135|P2|Overall Study|Withdrawn consent|12
1387967|NCT01333501|4580136|P1|Overall Study|Withdrawn consent|3
1387968|NCT01333501|4580135|P2|Overall Study|Unsatisfactory therapeutic effect|7
1387969|NCT01333501|4580136|P1|Overall Study|Unsatisfactory therapeutic effect|1
1387970|NCT01333501|4580135|P2|Overall Study|Abnormal laboratory value|1
1387971|NCT01333501|4580136|P1|Overall Study|Abnormal laboratory value|2
1387972|NCT01333501|4580135|P2|Overall Study|Adverse Event|1
1387973|NCT01333501|4580136|P1|Overall Study|Adverse Event|3
1387974|NCT01333475|4580203|P2|Overall Study|Toxicity|3
1387975|NCT01333475|4580204|P1|Overall Study|Toxicity|1
1387976|NCT01333475|4580203|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
1387977|NCT01333475|4580204|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
1387978|NCT01333397|4580230|P5|Overall Study|Lost to Follow-up|0
1387979|NCT01333397|4580231|P4|Overall Study|Lost to Follow-up|1
1387980|NCT01333397|4580232|P3|Overall Study|Lost to Follow-up|0
1387981|NCT01333397|4580233|P2|Overall Study|Lost to Follow-up|0
1387982|NCT01333397|4580234|P1|Overall Study|Lost to Follow-up|1
1387983|NCT01333189|4580308|P2|Overall Study|Moved from region|1
1387984|NCT01333189|4580309|P1|Overall Study|Moved from region|0
1387985|NCT01333189|4580308|P2|Overall Study|Transportation difficulties|1
1387986|NCT01333189|4580309|P1|Overall Study|Transportation difficulties|0
1387987|NCT01333189|4580308|P2|Overall Study|Adverse Event|0
1387988|NCT01333189|4580309|P1|Overall Study|Adverse Event|1
1387989|NCT01333189|4580308|P2|Overall Study|Time constraints|0
1387990|NCT01333189|4580309|P1|Overall Study|Time constraints|1
1387991|NCT01333111|4580340|P3|Overall Study|Ineffective therapy|1
1387992|NCT01333111|4580341|P2|Overall Study|Ineffective therapy|0
1387993|NCT01333111|4580342|P1|Overall Study|Ineffective therapy|0
1387994|NCT01333111|4580340|P3|Overall Study|Non-compliance|0
1387995|NCT01333111|4580341|P2|Overall Study|Non-compliance|0
1387996|NCT01333111|4580342|P1|Overall Study|Non-compliance|1
1387997|NCT01333111|4580340|P3|Overall Study|withdrawal criteria|0
1387998|NCT01333111|4580341|P2|Overall Study|withdrawal criteria|1
1387999|NCT01333111|4580342|P1|Overall Study|withdrawal criteria|0
1388000|NCT01333111|4580340|P3|Overall Study|unclassified|0
1388001|NCT01333111|4580341|P2|Overall Study|unclassified|0
1388002|NCT01333111|4580342|P1|Overall Study|unclassified|1
1388003|NCT01333111|4580340|P3|Overall Study|personal reasons|1
1388004|NCT01333111|4580341|P2|Overall Study|personal reasons|0
1388005|NCT01333111|4580342|P1|Overall Study|personal reasons|0
1388006|NCT01333111|4580340|P3|Overall Study|patient undergoing major surgery|0
1388007|NCT01333111|4580341|P2|Overall Study|patient undergoing major surgery|2
1388008|NCT01333111|4580342|P1|Overall Study|patient undergoing major surgery|0
1388009|NCT01332994|4580366|P1|Overall Study|Not Specified|8
1388010|NCT01332994|4580366|P1|Overall Study|Administrative Problem|2
1388011|NCT01332994|4580366|P1|Overall Study|Withdrawal by Subject|15
1388012|NCT01332994|4580366|P1|Overall Study|Protocol Violation|6
1388013|NCT01332994|4580366|P1|Overall Study|Lost to Follow-up|4
1388014|NCT01332994|4580366|P1|Overall Study|Lack of Efficacy|1
1388015|NCT01332994|4580366|P1|Overall Study|Death|1
1388016|NCT01332994|4580366|P1|Overall Study|Adverse Event|34
1388017|NCT01332968|4580435|P8|Follow-Up Period|Lost to Follow-up|2
1388018|NCT01332968|4580436|P7|Follow-Up Period|Lost to Follow-up|1
1388019|NCT01332968|4580437|P6|Follow-Up Period|Lost to Follow-up|0
1388020|NCT01332968|4580438|P5|Follow-Up Period|Lost to Follow-up|0
1388021|NCT01332968|4580439|P4|Follow-Up Period|Lost to Follow-up|0
1388022|NCT01332968|4580440|P3|Follow-Up Period|Lost to Follow-up|0
1388023|NCT01332968|4580441|P2|Follow-Up Period|Lost to Follow-up|0
1388024|NCT01332968|4580442|P1|Follow-Up Period|Lost to Follow-up|0
1388025|NCT01332968|4580435|P8|Follow-Up Period|Withdrawal by Subject|2
1388026|NCT01332968|4580436|P7|Follow-Up Period|Withdrawal by Subject|1
1388027|NCT01332968|4580437|P6|Follow-Up Period|Withdrawal by Subject|0
1388028|NCT01332968|4580438|P5|Follow-Up Period|Withdrawal by Subject|0
1388029|NCT01332968|4580439|P4|Follow-Up Period|Withdrawal by Subject|0
1388030|NCT01332968|4580440|P3|Follow-Up Period|Withdrawal by Subject|0
1388031|NCT01332968|4580441|P2|Follow-Up Period|Withdrawal by Subject|0
1388032|NCT01332968|4580442|P1|Follow-Up Period|Withdrawal by Subject|0
1388033|NCT01332968|4580435|P8|Follow-Up Period|Follow-up ongoing|505
1388034|NCT01332968|4580436|P7|Follow-Up Period|Follow-up ongoing|502
1388035|NCT01332968|4580437|P6|Follow-Up Period|Follow-up ongoing|0
1388036|NCT01332968|4580438|P5|Follow-Up Period|Follow-up ongoing|0
1388037|NCT01332968|4580439|P4|Follow-Up Period|Follow-up ongoing|0
1388038|NCT01332968|4580440|P3|Follow-Up Period|Follow-up ongoing|0
1388039|NCT01332968|4580441|P2|Follow-Up Period|Follow-up ongoing|0
1388040|NCT01332968|4580442|P1|Follow-Up Period|Follow-up ongoing|0
1388041|NCT01332968|4580435|P8|Follow-Up Period|Death|22
1388042|NCT01332968|4580436|P7|Follow-Up Period|Death|38
1388043|NCT01332968|4580437|P6|Follow-Up Period|Death|0
1388044|NCT01332968|4580438|P5|Follow-Up Period|Death|0
1388045|NCT01332968|4580439|P4|Follow-Up Period|Death|0
1388046|NCT01332968|4580440|P3|Follow-Up Period|Death|0
1388047|NCT01332968|4580441|P2|Follow-Up Period|Death|0
1388048|NCT01332968|4580442|P1|Follow-Up Period|Death|0
1388049|NCT01332968|4580435|P8|Maintenance/Observation Period|Treatment ongoing|0
1388050|NCT01332968|4580436|P7|Maintenance/Observation Period|Treatment ongoing|0
1388051|NCT01332968|4580437|P6|Maintenance/Observation Period|Treatment ongoing|8
1388052|NCT01332968|4580438|P5|Maintenance/Observation Period|Treatment ongoing|10
1388053|NCT01332968|4580439|P4|Maintenance/Observation Period|Treatment ongoing|62
1388054|NCT01332968|4580440|P3|Maintenance/Observation Period|Treatment ongoing|54
1388055|NCT01332968|4580441|P2|Maintenance/Observation Period|Treatment ongoing|0
1388056|NCT01332968|4580442|P1|Maintenance/Observation Period|Treatment ongoing|0
1388057|NCT01332968|4580435|P8|Maintenance/Observation Period|Adverse Event|0
1388058|NCT01332968|4580436|P7|Maintenance/Observation Period|Adverse Event|0
1388059|NCT01332968|4580437|P6|Maintenance/Observation Period|Adverse Event|0
1388060|NCT01332968|4580438|P5|Maintenance/Observation Period|Adverse Event|0
1388061|NCT01332968|4580439|P4|Maintenance/Observation Period|Adverse Event|65
1388062|NCT01332968|4580440|P3|Maintenance/Observation Period|Adverse Event|50
1388063|NCT01332968|4580441|P2|Maintenance/Observation Period|Adverse Event|0
1388064|NCT01332968|4580442|P1|Maintenance/Observation Period|Adverse Event|0
1388065|NCT01332968|4580435|P8|Maintenance/Observation Period|Death|0
1388066|NCT01332968|4580436|P7|Maintenance/Observation Period|Death|0
1388067|NCT01332968|4580437|P6|Maintenance/Observation Period|Death|0
1388068|NCT01332968|4580438|P5|Maintenance/Observation Period|Death|0
1388069|NCT01332968|4580439|P4|Maintenance/Observation Period|Death|6
1388070|NCT01332968|4580440|P3|Maintenance/Observation Period|Death|5
1388071|NCT01332968|4580441|P2|Maintenance/Observation Period|Death|0
1388072|NCT01332968|4580442|P1|Maintenance/Observation Period|Death|0
1388073|NCT01332968|4580435|P8|Maintenance/Observation Period|Lost to Follow-up|0
1388074|NCT01332968|4580436|P7|Maintenance/Observation Period|Lost to Follow-up|0
1388075|NCT01332968|4580437|P6|Maintenance/Observation Period|Lost to Follow-up|0
1388076|NCT01332968|4580438|P5|Maintenance/Observation Period|Lost to Follow-up|0
1388077|NCT01332968|4580439|P4|Maintenance/Observation Period|Lost to Follow-up|2
1388078|NCT01332968|4580440|P3|Maintenance/Observation Period|Lost to Follow-up|1
1388079|NCT01332968|4580441|P2|Maintenance/Observation Period|Lost to Follow-up|0
1388080|NCT01332968|4580442|P1|Maintenance/Observation Period|Lost to Follow-up|0
1388081|NCT01332968|4580435|P8|Maintenance/Observation Period|Non-compliance|0
1388082|NCT01332968|4580436|P7|Maintenance/Observation Period|Non-compliance|0
1388083|NCT01332968|4580437|P6|Maintenance/Observation Period|Non-compliance|1
1388084|NCT01332968|4580438|P5|Maintenance/Observation Period|Non-compliance|0
1388085|NCT01332968|4580439|P4|Maintenance/Observation Period|Non-compliance|3
1388086|NCT01332968|4580440|P3|Maintenance/Observation Period|Non-compliance|2
1388087|NCT01332968|4580441|P2|Maintenance/Observation Period|Non-compliance|0
1388088|NCT01332968|4580442|P1|Maintenance/Observation Period|Non-compliance|0
1388089|NCT01332968|4580435|P8|Maintenance/Observation Period|Other|0
1388090|NCT01332968|4580436|P7|Maintenance/Observation Period|Other|0
1388091|NCT01332968|4580437|P6|Maintenance/Observation Period|Other|0
1388092|NCT01332968|4580438|P5|Maintenance/Observation Period|Other|0
1388093|NCT01332968|4580439|P4|Maintenance/Observation Period|Other|5
1388094|NCT01332968|4580440|P3|Maintenance/Observation Period|Other|4
1388095|NCT01332968|4580441|P2|Maintenance/Observation Period|Other|0
1388096|NCT01332968|4580442|P1|Maintenance/Observation Period|Other|0
1388097|NCT01332968|4580435|P8|Maintenance/Observation Period|Physician Decision|0
1388098|NCT01332968|4580436|P7|Maintenance/Observation Period|Physician Decision|0
1388099|NCT01332968|4580437|P6|Maintenance/Observation Period|Physician Decision|0
1388100|NCT01332968|4580438|P5|Maintenance/Observation Period|Physician Decision|0
1388101|NCT01332968|4580439|P4|Maintenance/Observation Period|Physician Decision|19
1388102|NCT01332968|4580440|P3|Maintenance/Observation Period|Physician Decision|14
1388103|NCT01332968|4580441|P2|Maintenance/Observation Period|Physician Decision|0
1388104|NCT01332968|4580442|P1|Maintenance/Observation Period|Physician Decision|0
1388105|NCT01332968|4580435|P8|Maintenance/Observation Period|Progressive disease|0
1388106|NCT01332968|4580436|P7|Maintenance/Observation Period|Progressive disease|0
1388107|NCT01332968|4580437|P6|Maintenance/Observation Period|Progressive disease|0
1388108|NCT01332968|4580438|P5|Maintenance/Observation Period|Progressive disease|0
1388109|NCT01332968|4580439|P4|Maintenance/Observation Period|Progressive disease|39
1388110|NCT01332968|4580440|P3|Maintenance/Observation Period|Progressive disease|72
1388111|NCT01332968|4580441|P2|Maintenance/Observation Period|Progressive disease|0
1388112|NCT01332968|4580442|P1|Maintenance/Observation Period|Progressive disease|0
1388113|NCT01332968|4580435|P8|Maintenance/Observation Period|Protocol Violation|0
1388114|NCT01332968|4580436|P7|Maintenance/Observation Period|Protocol Violation|0
1388115|NCT01332968|4580437|P6|Maintenance/Observation Period|Protocol Violation|0
1388116|NCT01332968|4580438|P5|Maintenance/Observation Period|Protocol Violation|0
1388117|NCT01332968|4580439|P4|Maintenance/Observation Period|Protocol Violation|1
1388118|NCT01332968|4580440|P3|Maintenance/Observation Period|Protocol Violation|1
1388119|NCT01332968|4580441|P2|Maintenance/Observation Period|Protocol Violation|0
1388120|NCT01332968|4580442|P1|Maintenance/Observation Period|Protocol Violation|0
1388121|NCT01332968|4580435|P8|Maintenance/Observation Period|Withdrawal by Subject|0
1388122|NCT01332968|4580436|P7|Maintenance/Observation Period|Withdrawal by Subject|0
1388123|NCT01332968|4580437|P6|Maintenance/Observation Period|Withdrawal by Subject|0
1388124|NCT01332968|4580438|P5|Maintenance/Observation Period|Withdrawal by Subject|0
1388125|NCT01332968|4580439|P4|Maintenance/Observation Period|Withdrawal by Subject|5
1388126|NCT01332968|4580440|P3|Maintenance/Observation Period|Withdrawal by Subject|10
1388127|NCT01332968|4580441|P2|Maintenance/Observation Period|Withdrawal by Subject|0
1388128|NCT01332968|4580442|P1|Maintenance/Observation Period|Withdrawal by Subject|0
1388129|NCT01332968|4580435|P8|Induction Period|Randomized, but not treated|0
1388130|NCT01332968|4580436|P7|Induction Period|Randomized, but not treated|0
1388131|NCT01332968|4580437|P6|Induction Period|Randomized, but not treated|0
1388132|NCT01332968|4580438|P5|Induction Period|Randomized, but not treated|0
1388133|NCT01332968|4580439|P4|Induction Period|Randomized, but not treated|0
1388134|NCT01332968|4580440|P3|Induction Period|Randomized, but not treated|0
1388135|NCT01332968|4580441|P2|Induction Period|Randomized, but not treated|7
1388136|NCT01332968|4580442|P1|Induction Period|Randomized, but not treated|4
1388137|NCT01332968|4580435|P8|Induction Period|Adverse Event|0
1388138|NCT01332968|4580436|P7|Induction Period|Adverse Event|0
1388139|NCT01332968|4580437|P6|Induction Period|Adverse Event|0
1388140|NCT01332968|4580438|P5|Induction Period|Adverse Event|0
1388141|NCT01332968|4580439|P4|Induction Period|Adverse Event|0
1388142|NCT01332968|4580440|P3|Induction Period|Adverse Event|0
1388143|NCT01332968|4580441|P2|Induction Period|Adverse Event|26
1388144|NCT01332968|4580442|P1|Induction Period|Adverse Event|23
1388145|NCT01332968|4580435|P8|Induction Period|Death|0
1388146|NCT01332968|4580436|P7|Induction Period|Death|0
1388147|NCT01332968|4580437|P6|Induction Period|Death|0
1388148|NCT01332968|4580438|P5|Induction Period|Death|0
1388149|NCT01332968|4580439|P4|Induction Period|Death|0
1388150|NCT01332968|4580440|P3|Induction Period|Death|0
1388151|NCT01332968|4580441|P2|Induction Period|Death|4
1388152|NCT01332968|4580442|P1|Induction Period|Death|1
1388153|NCT01332968|4580435|P8|Induction Period|Non-compliance|0
1388154|NCT01332968|4580436|P7|Induction Period|Non-compliance|0
1388155|NCT01332968|4580437|P6|Induction Period|Non-compliance|0
1388156|NCT01332968|4580438|P5|Induction Period|Non-compliance|0
1388157|NCT01332968|4580439|P4|Induction Period|Non-compliance|0
1388158|NCT01332968|4580440|P3|Induction Period|Non-compliance|0
1388159|NCT01332968|4580441|P2|Induction Period|Non-compliance|0
1388160|NCT01332968|4580442|P1|Induction Period|Non-compliance|1
1388161|NCT01332968|4580435|P8|Induction Period|Other|0
1388162|NCT01332968|4580436|P7|Induction Period|Other|0
1388163|NCT01332968|4580437|P6|Induction Period|Other|0
1388164|NCT01332968|4580438|P5|Induction Period|Other|0
1388165|NCT01332968|4580439|P4|Induction Period|Other|0
1388166|NCT01332968|4580440|P3|Induction Period|Other|0
1388167|NCT01332968|4580441|P2|Induction Period|Other|2
1388168|NCT01332968|4580442|P1|Induction Period|Other|2
1388169|NCT01332968|4580435|P8|Induction Period|Physician Decision|0
1388170|NCT01332968|4580436|P7|Induction Period|Physician Decision|0
1388171|NCT01332968|4580437|P6|Induction Period|Physician Decision|0
1388172|NCT01332968|4580438|P5|Induction Period|Physician Decision|0
1388173|NCT01332968|4580439|P4|Induction Period|Physician Decision|0
1388174|NCT01332968|4580440|P3|Induction Period|Physician Decision|0
1388175|NCT01332968|4580441|P2|Induction Period|Physician Decision|1
1388176|NCT01332968|4580442|P1|Induction Period|Physician Decision|6
1388177|NCT01332968|4580435|P8|Induction Period|Progressive disease|0
1388178|NCT01332968|4580436|P7|Induction Period|Progressive disease|0
1388179|NCT01332968|4580437|P6|Induction Period|Progressive disease|0
1388180|NCT01332968|4580438|P5|Induction Period|Progressive disease|0
1388181|NCT01332968|4580439|P4|Induction Period|Progressive disease|0
1388182|NCT01332968|4580440|P3|Induction Period|Progressive disease|0
1388183|NCT01332968|4580441|P2|Induction Period|Progressive disease|7
1388184|NCT01332968|4580442|P1|Induction Period|Progressive disease|15
1388185|NCT01332968|4580435|P8|Induction Period|Protocol Violation|0
1388186|NCT01332968|4580436|P7|Induction Period|Protocol Violation|0
1388187|NCT01332968|4580437|P6|Induction Period|Protocol Violation|0
1388188|NCT01332968|4580438|P5|Induction Period|Protocol Violation|0
1388189|NCT01332968|4580439|P4|Induction Period|Protocol Violation|0
1388190|NCT01332968|4580440|P3|Induction Period|Protocol Violation|0
1388191|NCT01332968|4580441|P2|Induction Period|Protocol Violation|4
1388192|NCT01332968|4580442|P1|Induction Period|Protocol Violation|3
1388193|NCT01332968|4580435|P8|Induction Period|Withdrawal by Subject|0
1388194|NCT01332968|4580436|P7|Induction Period|Withdrawal by Subject|0
1388195|NCT01332968|4580437|P6|Induction Period|Withdrawal by Subject|0
1388196|NCT01332968|4580438|P5|Induction Period|Withdrawal by Subject|0
1388197|NCT01332968|4580439|P4|Induction Period|Withdrawal by Subject|0
1388198|NCT01332968|4580440|P3|Induction Period|Withdrawal by Subject|0
1388199|NCT01332968|4580441|P2|Induction Period|Withdrawal by Subject|5
1388200|NCT01332968|4580442|P1|Induction Period|Withdrawal by Subject|3
1388201|NCT01332851|4580508|P2|Overall Study|Lost to Follow-up|11
1388202|NCT01332851|4580509|P1|Overall Study|Lost to Follow-up|7
1388203|NCT01332851|4580508|P2|Overall Study|Withdrawal by Subject|2
1388204|NCT01332851|4580509|P1|Overall Study|Withdrawal by Subject|4
1388205|NCT01332630|4580547|P1|Overall Study|Withdrawal by Subject|3
1388206|NCT01332318|4580665|P4|Overall Study|Protocol Violation|1
1388207|NCT01332318|4580666|P3|Overall Study|Protocol Violation|1
1388208|NCT01332318|4580667|P2|Overall Study|Protocol Violation|0
1388209|NCT01332318|4580668|P1|Overall Study|Protocol Violation|1
1388210|NCT01332318|4580665|P4|Overall Study|Withdrawal by Subject|1
1388211|NCT01332318|4580666|P3|Overall Study|Withdrawal by Subject|0
1388212|NCT01332318|4580667|P2|Overall Study|Withdrawal by Subject|1
1388213|NCT01332318|4580668|P1|Overall Study|Withdrawal by Subject|1
1388214|NCT01332318|4580665|P4|Overall Study|Adverse Event|0
1388215|NCT01332318|4580666|P3|Overall Study|Adverse Event|0
1388216|NCT01332318|4580667|P2|Overall Study|Adverse Event|3
1388217|NCT01332318|4580668|P1|Overall Study|Adverse Event|0
1388218|NCT01332305|4580779|P5|Overall Study|Physician Decision|0
1388219|NCT01332305|4580780|P4|Overall Study|Physician Decision|1
1388220|NCT01332305|4580781|P3|Overall Study|Physician Decision|0
1388221|NCT01332305|4580782|P2|Overall Study|Physician Decision|0
1388222|NCT01332305|4580783|P1|Overall Study|Physician Decision|0
1388223|NCT01332305|4580779|P5|Overall Study|Treatment Failure|0
1388224|NCT01332305|4580780|P4|Overall Study|Treatment Failure|0
1388225|NCT01332305|4580781|P3|Overall Study|Treatment Failure|0
1388226|NCT01332305|4580782|P2|Overall Study|Treatment Failure|1
1388227|NCT01332305|4580783|P1|Overall Study|Treatment Failure|1
1388228|NCT01332305|4580779|P5|Overall Study|Withdrawal by Sponsor|1
1388229|NCT01332305|4580780|P4|Overall Study|Withdrawal by Sponsor|1
1388230|NCT01332305|4580781|P3|Overall Study|Withdrawal by Sponsor|0
1388231|NCT01332305|4580782|P2|Overall Study|Withdrawal by Sponsor|0
1388232|NCT01332305|4580783|P1|Overall Study|Withdrawal by Sponsor|1
1388233|NCT01332305|4580779|P5|Overall Study|Protocol Violation|3
1388234|NCT01332305|4580780|P4|Overall Study|Protocol Violation|0
1388235|NCT01332305|4580781|P3|Overall Study|Protocol Violation|1
1388236|NCT01332305|4580782|P2|Overall Study|Protocol Violation|2
1388237|NCT01332305|4580783|P1|Overall Study|Protocol Violation|1
1388238|NCT01332305|4580779|P5|Overall Study|Lost to Follow-up|3
1388239|NCT01332305|4580780|P4|Overall Study|Lost to Follow-up|2
1388240|NCT01332305|4580781|P3|Overall Study|Lost to Follow-up|3
1388241|NCT01332305|4580782|P2|Overall Study|Lost to Follow-up|2
1388242|NCT01332305|4580783|P1|Overall Study|Lost to Follow-up|0
1388243|NCT01332305|4580779|P5|Overall Study|Withdrawal by Subject|0
1388244|NCT01332305|4580780|P4|Overall Study|Withdrawal by Subject|1
1388245|NCT01332305|4580781|P3|Overall Study|Withdrawal by Subject|4
1388246|NCT01332305|4580782|P2|Overall Study|Withdrawal by Subject|5
1388247|NCT01332305|4580783|P1|Overall Study|Withdrawal by Subject|6
1388248|NCT01332305|4580779|P5|Overall Study|Adverse Event|5
1388249|NCT01332305|4580780|P4|Overall Study|Adverse Event|3
1388250|NCT01332305|4580781|P3|Overall Study|Adverse Event|6
1388251|NCT01332305|4580782|P2|Overall Study|Adverse Event|4
1388252|NCT01332305|4580783|P1|Overall Study|Adverse Event|1
1388253|NCT01332292|4580805|P2|Treatment Period 2 (14 Days)|Physician Decision|1
1388254|NCT01332292|4580806|P1|Treatment Period 2 (14 Days)|Physician Decision|1
1388255|NCT01332292|4580805|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
1388256|NCT01332292|4580806|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
1388257|NCT01332292|4580805|P2|Treatment Period 1 (14 Days)|Adverse Event|0
1388258|NCT01332292|4580806|P1|Treatment Period 1 (14 Days)|Adverse Event|1
1388259|NCT01332227|4580897|P2|Overall Study|Patient began prohibited medication|1
1388260|NCT01332227|4580898|P1|Overall Study|Patient began prohibited medication|0
1388261|NCT01332227|4580897|P2|Overall Study|Patient moved from area|0
1388262|NCT01332227|4580898|P1|Overall Study|Patient moved from area|1
1388263|NCT01332227|4580897|P2|Overall Study|Poor compliance/noncompliance|1
1388264|NCT01332227|4580898|P1|Overall Study|Poor compliance/noncompliance|1
1388265|NCT01332227|4580897|P2|Overall Study|Lack of Efficacy|1
1388266|NCT01332227|4580898|P1|Overall Study|Lack of Efficacy|3
1388267|NCT01332227|4580897|P2|Overall Study|Lost to Follow-up|0
1388268|NCT01332227|4580898|P1|Overall Study|Lost to Follow-up|2
1388269|NCT01332227|4580897|P2|Overall Study|Withdrawal by Subject|1
1388270|NCT01332227|4580898|P1|Overall Study|Withdrawal by Subject|5
1388271|NCT01332227|4580897|P2|Overall Study|Adverse Event|1
1388272|NCT01332227|4580898|P1|Overall Study|Adverse Event|4
1388273|NCT01332149|4581079|P2|Overall Study|Randomized but not treated|2
1388274|NCT01332149|4581080|P1|Overall Study|Randomized but not treated|1
1388275|NCT01332149|4581079|P2|Overall Study|Did not meet entrance criteria|4
1388276|NCT01332149|4581080|P1|Overall Study|Did not meet entrance criteria|3
1388277|NCT01332149|4581079|P2|Overall Study|Insufficient clinical response|7
1388278|NCT01332149|4581080|P1|Overall Study|Insufficient clinical response|4
1388279|NCT01332149|4581079|P2|Overall Study|Lost to Follow-up|1
1388280|NCT01332149|4581080|P1|Overall Study|Lost to Follow-up|1
1388281|NCT01332149|4581079|P2|Overall Study|Withdrawal by Subject|5
1388282|NCT01332149|4581080|P1|Overall Study|Withdrawal by Subject|4
1388283|NCT01332149|4581079|P2|Overall Study|Protocol Violation|3
1388284|NCT01332149|4581080|P1|Overall Study|Protocol Violation|1
1388285|NCT01332149|4581079|P2|Overall Study|Other unspecified|7
1388286|NCT01332149|4581080|P1|Overall Study|Other unspecified|5
1388287|NCT01332149|4581079|P2|Overall Study|Adverse Event|9
1388288|NCT01332149|4581080|P1|Overall Study|Adverse Event|11
1388289|NCT01332019|4581158|P2|Overall Study|Adverse Event|22
1388290|NCT01332019|4581159|P1|Overall Study|Adverse Event|13
1388291|NCT01332019|4581158|P2|Overall Study|Lost to Follow-up|7
1388292|NCT01332019|4581159|P1|Overall Study|Lost to Follow-up|4
1388293|NCT01332019|4581158|P2|Overall Study|Withdrawal by Subject|71
1388294|NCT01332019|4581159|P1|Overall Study|Withdrawal by Subject|73
1388295|NCT01332019|4581158|P2|Overall Study|Physician Decision|3
1388296|NCT01332019|4581159|P1|Overall Study|Physician Decision|4
1388297|NCT01332019|4581158|P2|Overall Study|Death|1
1388298|NCT01332019|4581159|P1|Overall Study|Death|2
1388299|NCT01332019|4581158|P2|Overall Study|Not Specified|18
1388300|NCT01332019|4581159|P1|Overall Study|Not Specified|16
1388301|NCT01332019|4581158|P2|Overall Study|Was Not Dosed|0
1388302|NCT01332019|4581159|P1|Overall Study|Was Not Dosed|1
1388303|NCT01331837|4581243|P2|Overall Study|Withdrawal by Subject|16
1388304|NCT01331837|4581244|P1|Overall Study|Withdrawal by Subject|13
1388305|NCT01331837|4581243|P2|Overall Study|Info not recorded|16
1388306|NCT01331837|4581244|P1|Overall Study|Info not recorded|10
1388307|NCT01331837|4581243|P2|Overall Study|Lost to Follow-up|1
1388308|NCT01331837|4581244|P1|Overall Study|Lost to Follow-up|3
1388309|NCT01331837|4581243|P2|Overall Study|Death|34
1388310|NCT01331837|4581244|P1|Overall Study|Death|30
1388311|NCT01331824|4581284|P1|Overall Study|Withdrawal by Subject|1
1388312|NCT01331824|4581284|P1|Overall Study|Disease Progression|9
1388313|NCT01331824|4581284|P1|Overall Study|Death|1
1388314|NCT01331824|4581284|P1|Overall Study|Adverse Event|2
1388315|NCT01331681|4581319|P3|Overall Study|Not Received Study Treatment|2
1388316|NCT01331681|4581320|P2|Overall Study|Not Received Study Treatment|0
1388317|NCT01331681|4581321|P1|Overall Study|Not Received Study Treatment|0
1388318|NCT01331681|4581319|P3|Overall Study|Switching to other therapy|1
1388319|NCT01331681|4581320|P2|Overall Study|Switching to other therapy|0
1388320|NCT01331681|4581321|P1|Overall Study|Switching to other therapy|0
1388321|NCT01331681|4581319|P3|Overall Study|Sponsor decision|0
1388322|NCT01331681|4581320|P2|Overall Study|Sponsor decision|1
1388323|NCT01331681|4581321|P1|Overall Study|Sponsor decision|1
1388324|NCT01331681|4581319|P3|Overall Study|Therapeutic procedure required|0
1388325|NCT01331681|4581320|P2|Overall Study|Therapeutic procedure required|0
1388326|NCT01331681|4581321|P1|Overall Study|Therapeutic procedure required|1
1388327|NCT01331681|4581319|P3|Overall Study|Physician Decision|4
1388328|NCT01331681|4581320|P2|Overall Study|Physician Decision|0
1388329|NCT01331681|4581321|P1|Overall Study|Physician Decision|2
1388330|NCT01331681|4581319|P3|Overall Study|Lost to Follow-up|1
1388331|NCT01331681|4581320|P2|Overall Study|Lost to Follow-up|4
1388332|NCT01331681|4581321|P1|Overall Study|Lost to Follow-up|2
1388333|NCT01331681|4581319|P3|Overall Study|Protocol Violation|0
1388334|NCT01331681|4581320|P2|Overall Study|Protocol Violation|1
1388335|NCT01331681|4581321|P1|Overall Study|Protocol Violation|1
1388336|NCT01331681|4581319|P3|Overall Study|Withdrawal by Subject|15
1388337|NCT01331681|4581320|P2|Overall Study|Withdrawal by Subject|8
1388338|NCT01331681|4581321|P1|Overall Study|Withdrawal by Subject|12
1388339|NCT01331681|4581319|P3|Overall Study|Lack of Efficacy|0
1388340|NCT01331681|4581320|P2|Overall Study|Lack of Efficacy|1
1388341|NCT01331681|4581321|P1|Overall Study|Lack of Efficacy|0
1388342|NCT01331681|4581319|P3|Overall Study|Death|2
1388343|NCT01331681|4581320|P2|Overall Study|Death|6
1388344|NCT01331681|4581321|P1|Overall Study|Death|6
1388345|NCT01331681|4581319|P3|Overall Study|Adverse Event|10
1388346|NCT01331681|4581320|P2|Overall Study|Adverse Event|13
1388347|NCT01331681|4581321|P1|Overall Study|Adverse Event|10
1388348|NCT01331291|4581364|P2|Overall Study|Death|1
1388349|NCT01331291|4581365|P1|Overall Study|Death|0
1388350|NCT01331291|4581364|P2|Overall Study|Lack of Efficacy|8
1388351|NCT01331291|4581365|P1|Overall Study|Lack of Efficacy|2
1388352|NCT01331161|4581399|P2|Overall Study|Pregnancy|1
1388353|NCT01331161|4581400|P1|Overall Study|Pregnancy|0
1388354|NCT01331161|4581399|P2|Overall Study|Lost to Follow-up|1
1388355|NCT01331161|4581400|P1|Overall Study|Lost to Follow-up|0
1388356|NCT01331161|4581399|P2|Overall Study|Physician Decision|0
1388357|NCT01331161|4581400|P1|Overall Study|Physician Decision|1
1388358|NCT01331109|4581408|P1|Overall Study|Study Terminated by Sponsor|38
1388359|NCT01331109|4581408|P1|Overall Study|Lost to Follow-up|1
1388360|NCT01331109|4581408|P1|Overall Study|Withdrawal by Subject|7
1388361|NCT01331109|4581408|P1|Overall Study|Protocol Violation|3
1388362|NCT01331109|4581408|P1|Overall Study|Lack of Efficacy|2
1388363|NCT01331109|4581408|P1|Overall Study|Adverse Event|6
1388364|NCT01331005|4581420|P2|Overall Study|Withdrawal by Subject|3
1388365|NCT01331005|4581421|P1|Overall Study|Withdrawal by Subject|2
1388366|NCT01331005|4581420|P2|Overall Study|Lost to Follow-up|1
1388367|NCT01331005|4581421|P1|Overall Study|Lost to Follow-up|2
1388368|NCT01330914|4581482|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
1388369|NCT01330914|4581482|P1|Overall Study|Withdrawal by Subject|4
1388370|NCT01330628|4581488|P2|Overall Study|Didn't receive study treatment|0
1388371|NCT01330628|4581489|P1|Overall Study|Didn't receive study treatment|1
1388372|NCT01330628|4581488|P2|Overall Study|Withdrawn|6
1388373|NCT01330628|4581489|P1|Overall Study|Withdrawn|18
1388374|NCT01330628|4581488|P2|Overall Study|Adverse Event|25
1388375|NCT01330628|4581489|P1|Overall Study|Adverse Event|44
1388376|NCT01330628|4581488|P2|Overall Study|Lost to Follow-up|6
1388377|NCT01330628|4581489|P1|Overall Study|Lost to Follow-up|5
1388378|NCT01330628|4581488|P2|Overall Study|Death|3
1388379|NCT01330628|4581489|P1|Overall Study|Death|2
1388380|NCT01330433|4581499|P2|Overall Study|Lost to Follow-up|0
1388381|NCT01330433|4581500|P1|Overall Study|Lost to Follow-up|1
1388382|NCT01330433|4581499|P2|Overall Study|Death|3
1388383|NCT01330433|4581500|P1|Overall Study|Death|1
1388384|NCT01330381|4581539|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
1388385|NCT01330381|4581540|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
1388386|NCT01330381|4581541|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
1388387|NCT01330381|4581539|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
1388388|NCT01330381|4581540|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
1388389|NCT01330381|4581541|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
1388390|NCT01330381|4581539|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
1388391|NCT01330381|4581540|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
1388392|NCT01330381|4581541|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
1388393|NCT01330381|4581539|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
1388394|NCT01330381|4581540|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
1388395|NCT01330381|4581541|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
1388396|NCT01330381|4581539|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
1388397|NCT01330381|4581540|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
1388398|NCT01330381|4581541|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
1388399|NCT01330381|4581539|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
1388400|NCT01330381|4581540|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
1388401|NCT01330381|4581541|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
1388402|NCT01330381|4581539|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
1388403|NCT01330381|4581540|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
1388404|NCT01330381|4581541|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
1388405|NCT01330381|4581539|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
1388406|NCT01330381|4581540|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
1388407|NCT01330381|4581541|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
1388408|NCT01330381|4581539|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
1388409|NCT01330381|4581540|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
1388410|NCT01330381|4581541|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
1388411|NCT01330381|4581539|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
1388412|NCT01330381|4581540|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
1388413|NCT01330381|4581541|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
1388414|NCT01330316|4581602|P2|Overall Study|other than above|1
1388415|NCT01330316|4581603|P1|Overall Study|other than above|0
1388416|NCT01330316|4581602|P2|Overall Study|Withdrawal by Subject|1
1388417|NCT01330316|4581603|P1|Overall Study|Withdrawal by Subject|0
1388418|NCT01330316|4581602|P2|Overall Study|Lost to Follow-up|1
1388419|NCT01330316|4581603|P1|Overall Study|Lost to Follow-up|0
1388420|NCT01330316|4581602|P2|Overall Study|Lack of Efficacy|10
1388421|NCT01330316|4581603|P1|Overall Study|Lack of Efficacy|0
1388422|NCT01330316|4581602|P2|Overall Study|Adverse Event|2
1388423|NCT01330316|4581603|P1|Overall Study|Adverse Event|2
1388424|NCT01330303|4581639|P2|Period 1|Withdrawal by Subject|1
1388425|NCT01330303|4581640|P1|Period 1|Withdrawal by Subject|0
1388426|NCT01330303|4581639|P2|Period 1|Protocol Violation|1
1388427|NCT01330303|4581640|P1|Period 1|Protocol Violation|0
1388428|NCT01330303|4581639|P2|Period 1|Adverse Event|0
1388429|NCT01330303|4581640|P1|Period 1|Adverse Event|1
1388430|NCT01330108|4581687|P1|Overall Study|Withdrawal by Subject|4
1388431|NCT01330030|4581705|P2|Overall Study|Lost to Follow-up|17
1388432|NCT01330030|4581706|P1|Overall Study|Lost to Follow-up|16
1388433|NCT01330017|4581717|P5|Overall Study|Unknown Reason|2
1388434|NCT01330017|4581718|P4|Overall Study|Unknown Reason|7
1388435|NCT01330017|4581719|P3|Overall Study|Unknown Reason|5
1388436|NCT01330017|4581720|P2|Overall Study|Unknown Reason|3
1388437|NCT01330017|4581721|P1|Overall Study|Unknown Reason|5
1388438|NCT01330017|4581717|P5|Overall Study|Protocol Violation|0
1388439|NCT01330017|4581718|P4|Overall Study|Protocol Violation|1
1388440|NCT01330017|4581719|P3|Overall Study|Protocol Violation|0
1388441|NCT01330017|4581720|P2|Overall Study|Protocol Violation|0
1388442|NCT01330017|4581721|P1|Overall Study|Protocol Violation|0
1388443|NCT01330017|4581717|P5|Overall Study|Lost to Follow-up|0
1388444|NCT01330017|4581718|P4|Overall Study|Lost to Follow-up|0
1388445|NCT01330017|4581719|P3|Overall Study|Lost to Follow-up|1
1388446|NCT01330017|4581720|P2|Overall Study|Lost to Follow-up|0
1388447|NCT01330017|4581721|P1|Overall Study|Lost to Follow-up|0
1388448|NCT01330017|4581717|P5|Overall Study|Withdrawal by Subject|1
1388449|NCT01330017|4581718|P4|Overall Study|Withdrawal by Subject|0
1388450|NCT01330017|4581719|P3|Overall Study|Withdrawal by Subject|1
1388451|NCT01330017|4581720|P2|Overall Study|Withdrawal by Subject|0
1388452|NCT01330017|4581721|P1|Overall Study|Withdrawal by Subject|0
1388453|NCT01330017|4581717|P5|Overall Study|Adverse Event|0
1388454|NCT01330017|4581718|P4|Overall Study|Adverse Event|4
1388455|NCT01330017|4581719|P3|Overall Study|Adverse Event|1
1388456|NCT01330017|4581720|P2|Overall Study|Adverse Event|1
1388457|NCT01330017|4581721|P1|Overall Study|Adverse Event|0
1388458|NCT01329978|4581770|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
1388459|NCT01329978|4581771|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
1388460|NCT01329978|4581772|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
1388461|NCT01329978|4581773|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
1388462|NCT01329978|4581774|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
1388463|NCT01329978|4581770|P5|Rerandomization Treatment Period|Lost to Follow-up|3
1388464|NCT01329978|4581771|P4|Rerandomization Treatment Period|Lost to Follow-up|5
1388465|NCT01329978|4581772|P3|Rerandomization Treatment Period|Lost to Follow-up|0
1388466|NCT01329978|4581773|P2|Rerandomization Treatment Period|Lost to Follow-up|0
1388467|NCT01329978|4581774|P1|Rerandomization Treatment Period|Lost to Follow-up|0
1388468|NCT01329978|4581770|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
1388469|NCT01329978|4581771|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
1388470|NCT01329978|4581772|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
1388471|NCT01329978|4581773|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
1388472|NCT01329978|4581774|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
1388473|NCT01329978|4581770|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
1388474|NCT01329978|4581771|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
1388475|NCT01329978|4581772|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
1388476|NCT01329978|4581773|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
1388477|NCT01329978|4581774|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
1388478|NCT01329978|4581770|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
1388479|NCT01329978|4581771|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
1388480|NCT01329978|4581772|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
1388481|NCT01329978|4581773|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
1388482|NCT01329978|4581774|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
1388483|NCT01329978|4581770|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
1388484|NCT01329978|4581771|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
1388485|NCT01329978|4581772|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
1388486|NCT01329978|4581773|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
1388487|NCT01329978|4581774|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
1388488|NCT01329978|4581770|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
1388489|NCT01329978|4581771|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
1388490|NCT01329978|4581772|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
1388491|NCT01329978|4581773|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
1388492|NCT01329978|4581774|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
1388493|NCT01329939|4581848|P4|Overall Study|Adverse Event|3
1388494|NCT01329939|4581849|P3|Overall Study|Adverse Event|0
1388495|NCT01329939|4581850|P2|Overall Study|Adverse Event|0
1388496|NCT01329939|4581851|P1|Overall Study|Adverse Event|0
1388497|NCT01329939|4581848|P4|Overall Study|Withdrawal by Subject|0
1388498|NCT01329939|4581849|P3|Overall Study|Withdrawal by Subject|0
1388499|NCT01329939|4581850|P2|Overall Study|Withdrawal by Subject|1
1388500|NCT01329939|4581851|P1|Overall Study|Withdrawal by Subject|0
1388501|NCT01329939|4581848|P4|Overall Study|Lost to Follow-up|2
1388502|NCT01329939|4581849|P3|Overall Study|Lost to Follow-up|1
1388503|NCT01329939|4581850|P2|Overall Study|Lost to Follow-up|0
1388504|NCT01329939|4581851|P1|Overall Study|Lost to Follow-up|3
1388505|NCT01329562|4581915|P2|Overall Study|Physician Decision|1
1388506|NCT01329562|4581916|P1|Overall Study|Physician Decision|0
1388507|NCT01329562|4581915|P2|Overall Study|Subject withdrew due to personal issues.|2
1388508|NCT01329562|4581916|P1|Overall Study|Subject withdrew due to personal issues.|3
1388509|NCT01329562|4581915|P2|Overall Study|Lost to Follow-up|1
1388510|NCT01329562|4581916|P1|Overall Study|Lost to Follow-up|1
1388511|NCT01329562|4581915|P2|Overall Study|Protocol Violation|3
1388512|NCT01329562|4581916|P1|Overall Study|Protocol Violation|5
1388513|NCT01329549|4581965|P1|Overall Study|Adverse Event|1
1388514|NCT01329549|4581965|P1|Overall Study|Withdrawal by Subject|1
1388515|NCT01329419|4581976|P1|Overall Study|Protocol Violation|235
1388516|NCT01329263|4581984|P2|Overall Study|Withdrawal by Subject|2
1388517|NCT01329263|4581985|P1|Overall Study|Withdrawal by Subject|1
1388518|NCT01329263|4581984|P2|Overall Study|Lost to Follow-up|21
1388519|NCT01329263|4581985|P1|Overall Study|Lost to Follow-up|4
1388520|NCT01329029|4582022|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
1388521|NCT01329029|4582023|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
1388522|NCT01329029|4582022|P2|Overall Study|Lost to Follow-up|5
1388523|NCT01329029|4582023|P1|Overall Study|Lost to Follow-up|8
1388524|NCT01329029|4582022|P2|Overall Study|Physician Decision|13
1388525|NCT01329029|4582023|P1|Overall Study|Physician Decision|16
1388526|NCT01329029|4582022|P2|Overall Study|COPD Exacerbation|18
1388527|NCT01329029|4582023|P1|Overall Study|COPD Exacerbation|11
1388528|NCT01329029|4582022|P2|Overall Study|Other|20
1388529|NCT01329029|4582023|P1|Overall Study|Other|14
1388530|NCT01329029|4582022|P2|Overall Study|Death|19
1388531|NCT01329029|4582023|P1|Overall Study|Death|16
1388532|NCT01329029|4582022|P2|Overall Study|Adverse Event|29
1388533|NCT01329029|4582023|P1|Overall Study|Adverse Event|82
1388534|NCT01329029|4582022|P2|Overall Study|Withdrawal by Subject|87
1388535|NCT01329029|4582023|P1|Overall Study|Withdrawal by Subject|117
1388536|NCT01328951|4582113|P2|Overall Study|Not Specified|6
1388537|NCT01328951|4582114|P1|Overall Study|Not Specified|11
1388538|NCT01328951|4582113|P2|Overall Study|Study Closed by the Sponsor|31
1388539|NCT01328951|4582114|P1|Overall Study|Study Closed by the Sponsor|36
1388540|NCT01328951|4582113|P2|Overall Study|Withdrawal by Subject|6
1388541|NCT01328951|4582114|P1|Overall Study|Withdrawal by Subject|6
1388542|NCT01328951|4582113|P2|Overall Study|Lost to Follow-up|7
1388543|NCT01328951|4582114|P1|Overall Study|Lost to Follow-up|6
1388544|NCT01328951|4582113|P2|Overall Study|Death|258
1388545|NCT01328951|4582114|P1|Overall Study|Death|243
1388546|NCT01328951|4582113|P2|Overall Study|Adverse Event|0
1388547|NCT01328951|4582114|P1|Overall Study|Adverse Event|2
1388548|NCT01328951|4582113|P2|Overall Study|Disease Progression|14
1388549|NCT01328951|4582114|P1|Overall Study|Disease Progression|17
1388550|NCT01328756|4582183|P1|Overall Study|Other|29
1388551|NCT01328756|4582183|P1|Overall Study|Lost to Follow-up|5
1388552|NCT01328756|4582183|P1|Overall Study|Withdrawal by Subject|41
1388553|NCT01328756|4582183|P1|Overall Study|Lack of Efficacy|5
1388554|NCT01328756|4582183|P1|Overall Study|Adverse Event|39
1388555|NCT01328756|4582183|P1|Overall Study|Protocol Violation|4
1388556|NCT01328717|4582200|P1|Overall Study|Adverse Event|1
1388557|NCT01328574|4582205|P1|Overall Study|Refused further treatment|1
1388558|NCT01328548|4582219|P2|Overall Study|Protocol Violation|0
1388559|NCT01328548|4582220|P1|Overall Study|Protocol Violation|1
1388560|NCT01328548|4582219|P2|Overall Study|Death|0
1388561|NCT01328548|4582220|P1|Overall Study|Death|3
1388562|NCT01328496|4582240|P2|Overall Study|Significant Change in Health Status|0
1388563|NCT01328496|4582241|P1|Overall Study|Significant Change in Health Status|1
1388564|NCT01328444|4582259|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1388565|NCT01328444|4582260|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1388566|NCT01328444|4582261|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1388567|NCT01328444|4582262|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1388568|NCT01328444|4582263|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1388569|NCT01328444|4582264|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1388570|NCT01328444|4582259|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
1388571|NCT01328444|4582260|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
1388572|NCT01328444|4582261|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
1388573|NCT01328444|4582262|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
1388574|NCT01328444|4582263|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1388575|NCT01328444|4582264|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1388576|NCT01328444|4582259|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
1388577|NCT01328444|4582260|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
1388578|NCT01328444|4582261|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
1388579|NCT01328444|4582262|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
1388580|NCT01328444|4582263|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
1388581|NCT01328444|4582264|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
1388582|NCT01328444|4582259|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
1388583|NCT01328444|4582260|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
1388584|NCT01328444|4582261|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
1388585|NCT01328444|4582262|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
1388586|NCT01328444|4582263|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
1388587|NCT01328444|4582264|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
1388588|NCT01328444|4582259|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
1388589|NCT01328444|4582260|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
1388590|NCT01328444|4582261|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
1388591|NCT01328444|4582262|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
1388592|NCT01328444|4582263|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
1388593|NCT01328444|4582264|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
1388594|NCT01328444|4582259|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
1388595|NCT01328444|4582260|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
1388596|NCT01328444|4582261|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
1388597|NCT01328444|4582262|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
1388598|NCT01328444|4582263|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
1388599|NCT01328444|4582264|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
1388600|NCT01328444|4582259|P6|Washout Period (14 Days)|Withdrawal by Subject|1
1388601|NCT01328444|4582260|P5|Washout Period (14 Days)|Withdrawal by Subject|0
1388602|NCT01328444|4582261|P4|Washout Period (14 Days)|Withdrawal by Subject|0
1388603|NCT01328444|4582262|P3|Washout Period (14 Days)|Withdrawal by Subject|0
1388604|NCT01328444|4582263|P2|Washout Period (14 Days)|Withdrawal by Subject|0
1388605|NCT01328444|4582264|P1|Washout Period (14 Days)|Withdrawal by Subject|0
1388606|NCT01328444|4582259|P6|Washout Period (14 Days)|Lack of Efficacy|1
1388607|NCT01328444|4582260|P5|Washout Period (14 Days)|Lack of Efficacy|0
1388608|NCT01328444|4582261|P4|Washout Period (14 Days)|Lack of Efficacy|0
1388609|NCT01328444|4582262|P3|Washout Period (14 Days)|Lack of Efficacy|0
1388610|NCT01328444|4582263|P2|Washout Period (14 Days)|Lack of Efficacy|0
1388611|NCT01328444|4582264|P1|Washout Period (14 Days)|Lack of Efficacy|0
1388612|NCT01328444|4582259|P6|Washout Period (14 Days)|Adverse Event|2
1388613|NCT01328444|4582260|P5|Washout Period (14 Days)|Adverse Event|1
1388614|NCT01328444|4582261|P4|Washout Period (14 Days)|Adverse Event|1
1388615|NCT01328444|4582262|P3|Washout Period (14 Days)|Adverse Event|0
1388616|NCT01328444|4582263|P2|Washout Period (14 Days)|Adverse Event|1
1388617|NCT01328444|4582264|P1|Washout Period (14 Days)|Adverse Event|1
1388618|NCT01328444|4582259|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1388619|NCT01328444|4582260|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1388620|NCT01328444|4582261|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
1388621|NCT01328444|4582262|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1388622|NCT01328444|4582263|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
1388623|NCT01328444|4582264|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1388624|NCT01328444|4582259|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1388625|NCT01328444|4582260|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1388626|NCT01328444|4582261|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1388627|NCT01328444|4582262|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1388628|NCT01328444|4582263|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1388629|NCT01328444|4582264|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
1388630|NCT01328444|4582259|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
1388631|NCT01328444|4582260|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
1388632|NCT01328444|4582261|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
1388633|NCT01328444|4582262|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
1388634|NCT01328444|4582263|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
1388635|NCT01328444|4582264|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
1388636|NCT01328444|4582259|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
1388637|NCT01328444|4582260|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
1388638|NCT01328444|4582261|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
1388639|NCT01328444|4582262|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
1388640|NCT01328444|4582263|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
1388641|NCT01328444|4582264|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
1388642|NCT01328444|4582259|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
1388643|NCT01328444|4582260|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
1388644|NCT01328444|4582261|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
1388645|NCT01328444|4582262|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
1388646|NCT01328444|4582263|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
1388647|NCT01328444|4582264|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
1388648|NCT01328444|4582259|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
1388649|NCT01328444|4582260|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
1388650|NCT01328444|4582261|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
1388651|NCT01328444|4582262|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
1388652|NCT01328444|4582263|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
1388653|NCT01328444|4582264|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
1388654|NCT01328431|4582310|P2|12 Month (12M)|Lost to Follow-up|91
1388655|NCT01328431|4582311|P1|12 Month (12M)|Lost to Follow-up|82
1388656|NCT01328431|4582310|P2|12 Month (12M)|Death|6
1388657|NCT01328431|4582311|P1|12 Month (12M)|Death|2
1388658|NCT01328431|4582310|P2|3 Month (3M)|Lost to Follow-up|70
1388659|NCT01328431|4582311|P1|3 Month (3M)|Lost to Follow-up|75
1388660|NCT01328431|4582310|P2|3 Month (3M)|Death|2
1388661|NCT01328431|4582311|P1|3 Month (3M)|Death|2
1388662|NCT01328431|4582310|P2|1 Month (1M)|Lost to Follow-up|58
1388663|NCT01328431|4582311|P1|1 Month (1M)|Lost to Follow-up|55
1388664|NCT01328431|4582310|P2|Baseline|Protocol Violation|2
1388665|NCT01328431|4582311|P1|Baseline|Protocol Violation|0
1388666|NCT01328366|4582367|P1|Overall Study|Lost to Follow-up|7
1388667|NCT01328366|4582367|P1|Overall Study|Withdrawal by Subject|2
1388668|NCT01328366|4582367|P1|Overall Study|Death|1
1388669|NCT01328080|4582463|P1|Overall Study|Lost to Follow-up|5
1388670|NCT01328054|4582467|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
1388671|NCT01328054|4582468|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
1388672|NCT01328054|4582467|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
1388673|NCT01328054|4582468|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
1388674|NCT01328054|4582467|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
1388675|NCT01328054|4582468|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
1388676|NCT01328041|4582493|P1|Overall Study|Withdrawal by Subject|7
1388677|NCT01328041|4582493|P1|Overall Study|Physician Decision|2
1388678|NCT01328041|4582493|P1|Overall Study|Lost to Follow-up|7
1388679|NCT01328041|4582493|P1|Overall Study|Protocol Violation|7
1388680|NCT01328041|4582493|P1|Overall Study|Lack of Efficacy|27
1388681|NCT01328041|4582493|P1|Overall Study|Adverse Event|7
1388682|NCT01327885|4582542|P2|Overall Study|Ongoing|1
1388683|NCT01327885|4582543|P1|Overall Study|Ongoing|1
1388684|NCT01327885|4582542|P2|Overall Study|Not treated|1
1388685|NCT01327885|4582543|P1|Overall Study|Not treated|1
1388686|NCT01327885|4582542|P2|Overall Study|Withdrawal of consent from study|4
1388687|NCT01327885|4582543|P1|Overall Study|Withdrawal of consent from study|2
1388688|NCT01327885|4582542|P2|Overall Study|Not specified|6
1388689|NCT01327885|4582543|P1|Overall Study|Not specified|8
1388690|NCT01327885|4582542|P2|Overall Study|Subject choice|10
1388691|NCT01327885|4582543|P1|Overall Study|Subject choice|5
1388692|NCT01327885|4582542|P2|Overall Study|Adverse Event|10
1388693|NCT01327885|4582543|P1|Overall Study|Adverse Event|14
1388694|NCT01327885|4582542|P2|Overall Study|Clinical progression|27
1388695|NCT01327885|4582543|P1|Overall Study|Clinical progression|24
1388696|NCT01327885|4582542|P2|Overall Study|Disease progression-according to RECIST|165
1388697|NCT01327885|4582543|P1|Overall Study|Disease progression-according to RECIST|173
1388698|NCT01327703|4582555|P2|Second Treatment Period|Protocol Violation|1
1388699|NCT01327703|4582556|P1|Second Treatment Period|Protocol Violation|0
1388700|NCT01327703|4582555|P2|Second Treatment Period|Adverse Event|1
1388701|NCT01327703|4582556|P1|Second Treatment Period|Adverse Event|1
1388702|NCT01327651|4582612|P9|Post Study Follow-up|Lost to Follow-up|2
1388703|NCT01327651|4582613|P8|Post Study Follow-up|Lost to Follow-up|1
1388704|NCT01327651|4582614|P7|Post Study Follow-up|Lost to Follow-up|4
1388705|NCT01327651|4582615|P6|Post Study Follow-up|Lost to Follow-up|0
1388706|NCT01327651|4582616|P5|Post Study Follow-up|Lost to Follow-up|0
1388707|NCT01327651|4582617|P4|Post Study Follow-up|Lost to Follow-up|0
1388708|NCT01327651|4582618|P3|Post Study Follow-up|Lost to Follow-up|1
1388709|NCT01327651|4582619|P2|Post Study Follow-up|Lost to Follow-up|1
1388710|NCT01327651|4582620|P1|Post Study Follow-up|Lost to Follow-up|0
1388711|NCT01327651|4582612|P9|Self-administered Dosing Period|Withdrawal by Subject|1
1388712|NCT01327651|4582613|P8|Self-administered Dosing Period|Withdrawal by Subject|1
1388713|NCT01327651|4582614|P7|Self-administered Dosing Period|Withdrawal by Subject|2
1388714|NCT01327651|4582615|P6|Self-administered Dosing Period|Withdrawal by Subject|0
1388715|NCT01327651|4582616|P5|Self-administered Dosing Period|Withdrawal by Subject|0
1388716|NCT01327651|4582617|P4|Self-administered Dosing Period|Withdrawal by Subject|1
1388717|NCT01327651|4582618|P3|Self-administered Dosing Period|Withdrawal by Subject|0
1388718|NCT01327651|4582619|P2|Self-administered Dosing Period|Withdrawal by Subject|1
1388719|NCT01327651|4582620|P1|Self-administered Dosing Period|Withdrawal by Subject|0
1388720|NCT01327651|4582612|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
1388721|NCT01327651|4582613|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
1388722|NCT01327651|4582614|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
1388723|NCT01327651|4582615|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
1388724|NCT01327651|4582616|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
1388725|NCT01327651|4582617|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
1388726|NCT01327651|4582618|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
1388727|NCT01327651|4582619|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
1388728|NCT01327651|4582620|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
1388729|NCT01327651|4582612|P9|Self-administered Dosing Period|Lost to Follow-up|10
1388730|NCT01327651|4582613|P8|Self-administered Dosing Period|Lost to Follow-up|9
1388731|NCT01327651|4582614|P7|Self-administered Dosing Period|Lost to Follow-up|8
1388732|NCT01327651|4582615|P6|Self-administered Dosing Period|Lost to Follow-up|0
1388733|NCT01327651|4582616|P5|Self-administered Dosing Period|Lost to Follow-up|3
1388734|NCT01327651|4582617|P4|Self-administered Dosing Period|Lost to Follow-up|2
1388735|NCT01327651|4582618|P3|Self-administered Dosing Period|Lost to Follow-up|4
1388736|NCT01327651|4582619|P2|Self-administered Dosing Period|Lost to Follow-up|2
1388737|NCT01327651|4582620|P1|Self-administered Dosing Period|Lost to Follow-up|3
1388738|NCT01327599|4582739|P1|Overall Study|Withdrawal of Consent|1
1388739|NCT01327599|4582739|P1|Overall Study|Could Not Attend Visit|1
1388740|NCT01327599|4582739|P1|Overall Study|Adverse Event|1
1388741|NCT01327547|4582749|P2|Overall Study|By investigator in subject’s interest|1
1388742|NCT01327547|4582750|P1|Overall Study|By investigator in subject’s interest|0
1388743|NCT01327547|4582749|P2|Overall Study|Non-compliance with study procedures|0
1388744|NCT01327547|4582750|P1|Overall Study|Non-compliance with study procedures|1
1388745|NCT01327547|4582749|P2|Overall Study|Required prohibited medication|0
1388746|NCT01327547|4582750|P1|Overall Study|Required prohibited medication|2
1388747|NCT01327547|4582749|P2|Overall Study|Non-compliance due to alcohol intake|1
1388748|NCT01327547|4582750|P1|Overall Study|Non-compliance due to alcohol intake|0
1388749|NCT01327547|4582749|P2|Overall Study|Protocol Violation|0
1388750|NCT01327547|4582750|P1|Overall Study|Protocol Violation|1
1388751|NCT01327547|4582749|P2|Overall Study|Does Not Meet Entrance Criteria|2
1388752|NCT01327547|4582750|P1|Overall Study|Does Not Meet Entrance Criteria|2
1388753|NCT01327547|4582749|P2|Overall Study|Withdrawal by Subject|7
1388754|NCT01327547|4582750|P1|Overall Study|Withdrawal by Subject|3
1388755|NCT01327547|4582749|P2|Overall Study|Non-Compliance With Study Treatment|2
1388756|NCT01327547|4582750|P1|Overall Study|Non-Compliance With Study Treatment|0
1388757|NCT01327547|4582749|P2|Overall Study|Lost to Follow-up|6
1388758|NCT01327547|4582750|P1|Overall Study|Lost to Follow-up|6
1388759|NCT01327547|4582749|P2|Overall Study|Death|2
1388760|NCT01327547|4582750|P1|Overall Study|Death|1
1388761|NCT01327547|4582749|P2|Overall Study|Adverse Event|1
1388762|NCT01327547|4582750|P1|Overall Study|Adverse Event|4
1388763|NCT01327495|4582818|P6|Overall Study|Physician Decision|0
1388764|NCT01327495|4582819|P5|Overall Study|Physician Decision|2
1388765|NCT01327495|4582820|P4|Overall Study|Physician Decision|0
1388766|NCT01327495|4582821|P3|Overall Study|Physician Decision|0
1388767|NCT01327495|4582822|P2|Overall Study|Physician Decision|0
1388768|NCT01327495|4582823|P1|Overall Study|Physician Decision|0
1388769|NCT01327495|4582818|P6|Overall Study|Withdrawal by Subject|0
1388770|NCT01327495|4582819|P5|Overall Study|Withdrawal by Subject|1
1388771|NCT01327495|4582820|P4|Overall Study|Withdrawal by Subject|0
1388772|NCT01327495|4582821|P3|Overall Study|Withdrawal by Subject|1
1388773|NCT01327495|4582822|P2|Overall Study|Withdrawal by Subject|1
1388774|NCT01327495|4582823|P1|Overall Study|Withdrawal by Subject|0
1388775|NCT01327495|4582818|P6|Overall Study|Adverse Event|2
1388776|NCT01327495|4582819|P5|Overall Study|Adverse Event|0
1388777|NCT01327495|4582820|P4|Overall Study|Adverse Event|0
1388778|NCT01327495|4582821|P3|Overall Study|Adverse Event|1
1388779|NCT01327495|4582822|P2|Overall Study|Adverse Event|1
1388780|NCT01327495|4582823|P1|Overall Study|Adverse Event|2
1388781|NCT01327482|4582915|P1|Overall Study|Adverse Event|1
1388782|NCT01327339|4582920|P1|Overall Study|Protocol Violation|8
1388783|NCT01327300|4583055|P2|Washout (3 Weeks)|Withdrawal by Subject|0
1388784|NCT01327300|4583056|P1|Washout (3 Weeks)|Withdrawal by Subject|1
1388785|NCT01327053|4583096|P2|Overall Study|Untreated|1
1388786|NCT01327053|4583097|P1|Overall Study|Untreated|0
1388787|NCT01327053|4583096|P2|Overall Study|Withdrawal by Subject|28
1388788|NCT01327053|4583097|P1|Overall Study|Withdrawal by Subject|5
1388789|NCT01327053|4583096|P2|Overall Study|Protocol Violation|1
1388790|NCT01327053|4583097|P1|Overall Study|Protocol Violation|0
1388791|NCT01327053|4583096|P2|Overall Study|Progressive Disease|6
1388792|NCT01327053|4583097|P1|Overall Study|Progressive Disease|15
1388793|NCT01327053|4583096|P2|Overall Study|Physician Decision|10
1388794|NCT01327053|4583097|P1|Overall Study|Physician Decision|3
1388795|NCT01327053|4583096|P2|Overall Study|Non-compliance with study treatment|3
1388796|NCT01327053|4583097|P1|Overall Study|Non-compliance with study treatment|0
1388797|NCT01327053|4583096|P2|Overall Study|Lost to Follow-up|4
1388798|NCT01327053|4583097|P1|Overall Study|Lost to Follow-up|1
1388799|NCT01327053|4583096|P2|Overall Study|Death|4
1388800|NCT01327053|4583097|P1|Overall Study|Death|0
1388801|NCT01327053|4583096|P2|Overall Study|Adverse Event|48
1388802|NCT01327053|4583097|P1|Overall Study|Adverse Event|16
1388803|NCT01326962|4583125|P1|Overall Study|Not Specified|2
1388804|NCT01326962|4583125|P1|Overall Study|Lost to Follow-up|3
1388805|NCT01326962|4583125|P1|Overall Study|Withdrawal by Subject|1
1388806|NCT01326962|4583125|P1|Overall Study|Adverse Event|1
1388807|NCT01326910|4583143|P2|Overall Study|Protocol Violation|1
1388808|NCT01326910|4583144|P1|Overall Study|Protocol Violation|1
1388809|NCT01326910|4583143|P2|Overall Study|Withdrawal by Subject|2
1388810|NCT01326910|4583144|P1|Overall Study|Withdrawal by Subject|3
1388811|NCT01326845|4583158|P2|Overall Study|Misisng|3
1388812|NCT01326845|4583159|P1|Overall Study|Misisng|1
1388813|NCT01326845|4583158|P2|Overall Study|Adverse Event|0
1388814|NCT01326845|4583159|P1|Overall Study|Adverse Event|1
1388815|NCT01326845|4583158|P2|Overall Study|Administrative Problems|2
1388816|NCT01326845|4583159|P1|Overall Study|Administrative Problems|5
1388817|NCT01326728|4583183|P2|Overall Study|Early closure of study|9
1388818|NCT01326728|4583184|P1|Overall Study|Early closure of study|34
1388819|NCT01326728|4583183|P2|Overall Study|Death|0
1388820|NCT01326728|4583184|P1|Overall Study|Death|13
1388821|NCT01326533|4583203|P2|Overall Study|Adverse Event|0
1388822|NCT01326533|4583204|P1|Overall Study|Adverse Event|1
1388823|NCT01326533|4583203|P2|Overall Study|Withdrawal by Subject|0
1388824|NCT01326533|4583204|P1|Overall Study|Withdrawal by Subject|1
1388825|NCT01326533|4583203|P2|Overall Study|Lost to Follow-up|0
1388826|NCT01326533|4583204|P1|Overall Study|Lost to Follow-up|2
1388827|NCT01326026|4583214|P2|Overall Study|Other|3
1388828|NCT01326026|4583215|P1|Overall Study|Other|3
1388829|NCT01326026|4583214|P2|Overall Study|Withdrawal Criteria|7
1388830|NCT01326026|4583215|P1|Overall Study|Withdrawal Criteria|5
1388831|NCT01326026|4583214|P2|Overall Study|Adverse Event|3
1388832|NCT01326026|4583215|P1|Overall Study|Adverse Event|4
1388833|NCT01325701|4583280|P2|Overall Study|Rollerover Extension Study|0
1388834|NCT01325701|4583281|P1|Overall Study|Rollerover Extension Study|4
1388835|NCT01325701|4583280|P2|Overall Study|Withdrawal by Subject|1
1388836|NCT01325701|4583281|P1|Overall Study|Withdrawal by Subject|2
1388837|NCT01325701|4583280|P2|Overall Study|Physician Decision|2
1388838|NCT01325701|4583281|P1|Overall Study|Physician Decision|2
1388839|NCT01325701|4583280|P2|Overall Study|Protocol Violation|0
1388840|NCT01325701|4583281|P1|Overall Study|Protocol Violation|1
1388841|NCT01325701|4583280|P2|Overall Study|Adverse Event|0
1388842|NCT01325701|4583281|P1|Overall Study|Adverse Event|12
1388843|NCT01325623|4583291|P1|Overall Study|Withdrawal by Subject|3
1388844|NCT01325584|4583333|P1|Overall Study|Death|1
1388845|NCT01325532|4583343|P2|Overall Study|Withdrawal by Subject|0
1388846|NCT01325532|4583344|P1|Overall Study|Withdrawal by Subject|2
1388847|NCT01325493|4583356|P2|Overall Study|Allergy|0
1388848|NCT01325493|4583357|P1|Overall Study|Allergy|1
1388849|NCT01325493|4583356|P2|Overall Study|loss of neuromonitoring signals|2
1388850|NCT01325493|4583357|P1|Overall Study|loss of neuromonitoring signals|0
1388851|NCT01325493|4583356|P2|Overall Study|Protocol Violation|1
1388852|NCT01325493|4583357|P1|Overall Study|Protocol Violation|0
1388853|NCT01325428|4583369|P1|Part B|Other reason not defined above|1
1388854|NCT01325428|4583369|P1|Part B|Refused continue taking trial medication|2
1388855|NCT01325428|4583369|P1|Part A|Other reason not defined above|2
1388856|NCT01325428|4583369|P1|Part A|Refused continue taking trial medication|2
1388857|NCT01325428|4583369|P1|Part A|Other adverse event|1
1388858|NCT01325428|4583369|P1|Part A|Clinical signs, symptoms of progression|2
1388859|NCT01325428|4583369|P1|Part A|Progressive disease according to RECIST|9
1388860|NCT01325350|4583389|P5|Overall Study|Did Not Receive Treatment|1
1388861|NCT01325350|4583390|P4|Overall Study|Did Not Receive Treatment|0
1388862|NCT01325350|4583391|P3|Overall Study|Did Not Receive Treatment|1
1388863|NCT01325350|4583392|P2|Overall Study|Did Not Receive Treatment|1
1388864|NCT01325350|4583393|P1|Overall Study|Did Not Receive Treatment|0
1388865|NCT01325350|4583389|P5|Overall Study|Withdrawal by Subject|0
1388866|NCT01325350|4583390|P4|Overall Study|Withdrawal by Subject|1
1388867|NCT01325350|4583391|P3|Overall Study|Withdrawal by Subject|1
1388868|NCT01325350|4583392|P2|Overall Study|Withdrawal by Subject|0
1388869|NCT01325350|4583393|P1|Overall Study|Withdrawal by Subject|0
1388870|NCT01325350|4583389|P5|Overall Study|Protocol Violation|0
1388871|NCT01325350|4583390|P4|Overall Study|Protocol Violation|1
1388872|NCT01325350|4583391|P3|Overall Study|Protocol Violation|0
1388873|NCT01325350|4583392|P2|Overall Study|Protocol Violation|0
1388874|NCT01325350|4583393|P1|Overall Study|Protocol Violation|0
1388875|NCT01325350|4583389|P5|Overall Study|Personal Reasons|3
1388876|NCT01325350|4583390|P4|Overall Study|Personal Reasons|5
1388877|NCT01325350|4583391|P3|Overall Study|Personal Reasons|6
1388878|NCT01325350|4583392|P2|Overall Study|Personal Reasons|1
1388879|NCT01325350|4583393|P1|Overall Study|Personal Reasons|2
1388880|NCT01325350|4583389|P5|Overall Study|Lost to Follow-up|5
1388881|NCT01325350|4583390|P4|Overall Study|Lost to Follow-up|1
1388882|NCT01325350|4583391|P3|Overall Study|Lost to Follow-up|5
1388883|NCT01325350|4583392|P2|Overall Study|Lost to Follow-up|0
1388884|NCT01325350|4583393|P1|Overall Study|Lost to Follow-up|1
1388885|NCT01325350|4583389|P5|Overall Study|Pregnancy|1
1388886|NCT01325350|4583390|P4|Overall Study|Pregnancy|0
1388887|NCT01325350|4583391|P3|Overall Study|Pregnancy|1
1388888|NCT01325350|4583392|P2|Overall Study|Pregnancy|0
1388889|NCT01325350|4583393|P1|Overall Study|Pregnancy|0
1388890|NCT01325350|4583389|P5|Overall Study|Adverse Event|2
1388891|NCT01325350|4583390|P4|Overall Study|Adverse Event|1
1388892|NCT01325350|4583391|P3|Overall Study|Adverse Event|3
1388893|NCT01325350|4583392|P2|Overall Study|Adverse Event|3
1388894|NCT01325350|4583393|P1|Overall Study|Adverse Event|3
1388895|NCT01325337|4583435|P5|Overall Study|Withdrawal by Subject|1
1388896|NCT01325337|4583436|P4|Overall Study|Withdrawal by Subject|0
1388897|NCT01325337|4583437|P3|Overall Study|Withdrawal by Subject|1
1388898|NCT01325337|4583438|P2|Overall Study|Withdrawal by Subject|0
1388899|NCT01325337|4583439|P1|Overall Study|Withdrawal by Subject|1
1388900|NCT01325337|4583435|P5|Overall Study|Personal Reasons|3
1388901|NCT01325337|4583436|P4|Overall Study|Personal Reasons|8
1388902|NCT01325337|4583437|P3|Overall Study|Personal Reasons|4
1388903|NCT01325337|4583438|P2|Overall Study|Personal Reasons|5
1388904|NCT01325337|4583439|P1|Overall Study|Personal Reasons|2
1388905|NCT01325337|4583435|P5|Overall Study|Lost to Follow-up|2
1388906|NCT01325337|4583436|P4|Overall Study|Lost to Follow-up|1
1388907|NCT01325337|4583437|P3|Overall Study|Lost to Follow-up|2
1388908|NCT01325337|4583438|P2|Overall Study|Lost to Follow-up|2
1388909|NCT01325337|4583439|P1|Overall Study|Lost to Follow-up|2
1388910|NCT01325337|4583435|P5|Overall Study|Adverse Event|2
1388911|NCT01325337|4583436|P4|Overall Study|Adverse Event|1
1388912|NCT01325337|4583437|P3|Overall Study|Adverse Event|2
1388913|NCT01325337|4583438|P2|Overall Study|Adverse Event|2
1388914|NCT01325337|4583439|P1|Overall Study|Adverse Event|0
1388915|NCT01324999|4583522|P1|Overall Study|Withdrawal by Subject|2
1388916|NCT01324999|4583522|P1|Overall Study|Adverse Event|3
1388917|NCT01324947|4583533|P1|Overall Study|1 discontinued before starting drug|1
1388918|NCT01324947|4583533|P1|Overall Study|Withdrawal by Subject|3
1388919|NCT01324947|4583533|P1|Overall Study|Progressive Disease|50
1388920|NCT01324947|4583533|P1|Overall Study|Other|3
1388921|NCT01324947|4583533|P1|Overall Study|Death|10
1388922|NCT01324947|4583533|P1|Overall Study|Adverse Event|7
1388923|NCT01324622|4583589|P2|Overall Study|Lack of Efficacy|0
1388924|NCT01324622|4583590|P1|Overall Study|Lack of Efficacy|1
1388925|NCT01324622|4583589|P2|Overall Study|Death|0
1388926|NCT01324622|4583590|P1|Overall Study|Death|1
1388927|NCT01324622|4583589|P2|Overall Study|Lost to Follow-up|7
1388928|NCT01324622|4583590|P1|Overall Study|Lost to Follow-up|7
1388929|NCT01324570|4583620|P2|Overall Study|Administrative|2
1388930|NCT01324570|4583621|P1|Overall Study|Administrative|0
1388931|NCT01324570|4583620|P2|Overall Study|Confirmed or suspected diversion|1
1388932|NCT01324570|4583621|P1|Overall Study|Confirmed or suspected diversion|0
1388933|NCT01324570|4583620|P2|Overall Study|Lack of Efficacy|1
1388934|NCT01324570|4583621|P1|Overall Study|Lack of Efficacy|0
1388935|NCT01324570|4583620|P2|Overall Study|Withdrawal by Subject|3
1388936|NCT01324570|4583621|P1|Overall Study|Withdrawal by Subject|0
1388937|NCT01324570|4583620|P2|Overall Study|Adverse Event|7
1388938|NCT01324570|4583621|P1|Overall Study|Adverse Event|4
1388939|NCT01324440|4583658|P2|Overall Study|Subject moved|1
1388940|NCT01324440|4583659|P1|Overall Study|Subject moved|0
1388941|NCT01324401|4583673|P2|Overall Study|Adverse Event|3
1388942|NCT01324401|4583674|P1|Overall Study|Adverse Event|1
1388943|NCT01324401|4583673|P2|Overall Study|Withdrawn before any treatment|3
1388944|NCT01324401|4583674|P1|Overall Study|Withdrawn before any treatment|0
1388945|NCT01324388|4583685|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
1388946|NCT01324388|4583686|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
1388947|NCT01324388|4583687|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
1388948|NCT01324388|4583688|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
1388949|NCT01324388|4583685|P4|Part 2 of Study: First Intervention|Protocol Violation|1
1388950|NCT01324388|4583686|P3|Part 2 of Study: First Intervention|Protocol Violation|0
1388951|NCT01324388|4583687|P2|Part 2 of Study: First Intervention|Protocol Violation|0
1388952|NCT01324388|4583688|P1|Part 2 of Study: First Intervention|Protocol Violation|0
1388953|NCT01324388|4583685|P4|Part 1 of Study|Physician Decision|0
1388954|NCT01324388|4583686|P3|Part 1 of Study|Physician Decision|0
1388955|NCT01324388|4583687|P2|Part 1 of Study|Physician Decision|0
1388956|NCT01324388|4583688|P1|Part 1 of Study|Physician Decision|1
1388957|NCT01324388|4583685|P4|Part 1 of Study|Protocol Violation|0
1388958|NCT01324388|4583686|P3|Part 1 of Study|Protocol Violation|0
1388959|NCT01324388|4583687|P2|Part 1 of Study|Protocol Violation|2
1388960|NCT01324388|4583688|P1|Part 1 of Study|Protocol Violation|1
1388961|NCT01324388|4583685|P4|Part 1 of Study|Adverse Event|0
1388962|NCT01324388|4583686|P3|Part 1 of Study|Adverse Event|0
1388963|NCT01324388|4583687|P2|Part 1 of Study|Adverse Event|0
1388964|NCT01324388|4583688|P1|Part 1 of Study|Adverse Event|2
1388965|NCT01324349|4583709|P2|Overall Study|Withdrawal by Subject|1
1388966|NCT01324349|4583710|P1|Overall Study|Withdrawal by Subject|0
1388967|NCT01324349|4583709|P2|Overall Study|Death|1
1388968|NCT01324349|4583710|P1|Overall Study|Death|1
1388969|NCT01324323|4583720|P1|Overall Study|Withdrawal by Subject|1
1388970|NCT01324310|4583740|P1|Overall Study|Disease Progression|1
1388971|NCT01324310|4583740|P1|Overall Study|Adverse Event|1
1388972|NCT01324271|4583760|P2|Overall Study|Physician Decision|0
1388973|NCT01324271|4583761|P1|Overall Study|Physician Decision|1
1388974|NCT01324271|4583760|P2|Overall Study|Lost to Follow-up|0
1388975|NCT01324271|4583761|P1|Overall Study|Lost to Follow-up|3
1388976|NCT01324102|4583784|P2|Overall Study|illness|6
1388977|NCT01324102|4583785|P1|Overall Study|illness|1
1388978|NCT01324024|4583792|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1388979|NCT01324024|4583793|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
1388980|NCT01323972|4583831|P4|Overall Study|Lost to Follow-up|1
1388981|NCT01323972|4583832|P3|Overall Study|Lost to Follow-up|1
1388982|NCT01323972|4583833|P2|Overall Study|Lost to Follow-up|1
1388983|NCT01323972|4583834|P1|Overall Study|Lost to Follow-up|0
1388984|NCT01323972|4583831|P4|Overall Study|Migrated/moved from study area|0
1388985|NCT01323972|4583832|P3|Overall Study|Migrated/moved from study area|0
1388986|NCT01323972|4583833|P2|Overall Study|Migrated/moved from study area|2
1388987|NCT01323972|4583834|P1|Overall Study|Migrated/moved from study area|1
1388988|NCT01323972|4583831|P4|Overall Study|Withdrawal by Subject|0
1388989|NCT01323972|4583832|P3|Overall Study|Withdrawal by Subject|1
1388990|NCT01323972|4583833|P2|Overall Study|Withdrawal by Subject|0
1388991|NCT01323972|4583834|P1|Overall Study|Withdrawal by Subject|1
1388992|NCT01323920|4583927|P1|Overall Study|Withdrawal by Subject|1
1388993|NCT01323920|4583927|P1|Overall Study|Death|5
1388994|NCT01323790|4583968|P3|Overall Study|Severe non-compliance with protocol|2
1388995|NCT01323790|4583969|P2|Overall Study|Severe non-compliance with protocol|2
1388996|NCT01323790|4583970|P1|Overall Study|Severe non-compliance with protocol|2
1388997|NCT01323790|4583968|P3|Overall Study|Did Not Receive Treatment|1
1388998|NCT01323790|4583969|P2|Overall Study|Did Not Receive Treatment|0
1388999|NCT01323790|4583970|P1|Overall Study|Did Not Receive Treatment|2
1389000|NCT01323790|4583968|P3|Overall Study|Withdrawal by Subject|13
1389001|NCT01323790|4583969|P2|Overall Study|Withdrawal by Subject|20
1389002|NCT01323790|4583970|P1|Overall Study|Withdrawal by Subject|23
1389003|NCT01323790|4583968|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
1389004|NCT01323790|4583969|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
1389005|NCT01323790|4583970|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
1389006|NCT01323790|4583968|P3|Overall Study|Adverse Event|12
1389007|NCT01323790|4583969|P2|Overall Study|Adverse Event|24
1389008|NCT01323790|4583970|P1|Overall Study|Adverse Event|11
1389009|NCT01323790|4583968|P3|Overall Study|Lack of Efficacy|3
1389010|NCT01323790|4583969|P2|Overall Study|Lack of Efficacy|0
1389011|NCT01323790|4583970|P1|Overall Study|Lack of Efficacy|3
1389012|NCT01323790|4583968|P3|Overall Study|Study-Specific Withdrawal Criteria|3
1389013|NCT01323790|4583969|P2|Overall Study|Study-Specific Withdrawal Criteria|3
1389014|NCT01323790|4583970|P1|Overall Study|Study-Specific Withdrawal Criteria|0
1389015|NCT01323790|4583968|P3|Overall Study|Lost to Follow-up|9
1389016|NCT01323790|4583969|P2|Overall Study|Lost to Follow-up|9
1389017|NCT01323790|4583970|P1|Overall Study|Lost to Follow-up|11
1389018|NCT01323790|4583968|P3|Overall Study|Other|1
1389019|NCT01323790|4583969|P2|Overall Study|Other|2
1389020|NCT01323790|4583970|P1|Overall Study|Other|3
1389021|NCT01323673|4584021|P2|Overall Study|Withdrawal by Subject|3
1389022|NCT01323673|4584022|P1|Overall Study|Withdrawal by Subject|2
1389023|NCT01323673|4584021|P2|Overall Study|Protocol Violation|0
1389024|NCT01323673|4584022|P1|Overall Study|Protocol Violation|1
1389025|NCT01323673|4584021|P2|Overall Study|Lost to Follow-up|1
1389026|NCT01323673|4584022|P1|Overall Study|Lost to Follow-up|0
1389027|NCT01323673|4584021|P2|Overall Study|Adverse Event|1
1389028|NCT01323673|4584022|P1|Overall Study|Adverse Event|0
1389029|NCT01323660|4584042|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1389030|NCT01323660|4584043|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
1389031|NCT01323660|4584044|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1389032|NCT01323660|4584045|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1389033|NCT01323660|4584046|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1389034|NCT01323660|4584047|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1389035|NCT01323660|4584042|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
1389036|NCT01323660|4584043|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1389037|NCT01323660|4584044|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1389038|NCT01323660|4584045|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1389039|NCT01323660|4584046|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1389040|NCT01323660|4584047|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
1389041|NCT01323660|4584042|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
1389042|NCT01323660|4584043|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
1389043|NCT01323660|4584044|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
1389044|NCT01323660|4584045|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
1389045|NCT01323660|4584046|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
1389046|NCT01323660|4584047|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
1389047|NCT01323660|4584042|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
1389048|NCT01323660|4584043|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
1389049|NCT01323660|4584044|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
1389050|NCT01323660|4584045|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
1389051|NCT01323660|4584046|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
1389052|NCT01323660|4584047|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
1389053|NCT01323660|4584042|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
1389054|NCT01323660|4584043|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
1389055|NCT01323660|4584044|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
1389056|NCT01323660|4584045|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
1389057|NCT01323660|4584046|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
1389058|NCT01323660|4584047|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
1389059|NCT01323660|4584042|P6|Washout Period (14 Days)|Lack of Efficacy|2
1389060|NCT01323660|4584043|P5|Washout Period (14 Days)|Lack of Efficacy|2
1389061|NCT01323660|4584044|P4|Washout Period (14 Days)|Lack of Efficacy|3
1389062|NCT01323660|4584045|P3|Washout Period (14 Days)|Lack of Efficacy|1
1389063|NCT01323660|4584046|P2|Washout Period (14 Days)|Lack of Efficacy|0
1389064|NCT01323660|4584047|P1|Washout Period (14 Days)|Lack of Efficacy|0
1389065|NCT01323660|4584042|P6|Washout Period (14 Days)|Adverse Event|0
1389066|NCT01323660|4584043|P5|Washout Period (14 Days)|Adverse Event|1
1389067|NCT01323660|4584044|P4|Washout Period (14 Days)|Adverse Event|0
1389068|NCT01323660|4584045|P3|Washout Period (14 Days)|Adverse Event|0
1389069|NCT01323660|4584046|P2|Washout Period (14 Days)|Adverse Event|0
1389070|NCT01323660|4584047|P1|Washout Period (14 Days)|Adverse Event|0
1389071|NCT01323660|4584042|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1389072|NCT01323660|4584043|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
1389073|NCT01323660|4584044|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1389074|NCT01323660|4584045|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1389075|NCT01323660|4584046|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1389076|NCT01323660|4584047|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
1389077|NCT01323660|4584042|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1389078|NCT01323660|4584043|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1389079|NCT01323660|4584044|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1389080|NCT01323660|4584045|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1389081|NCT01323660|4584046|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1389082|NCT01323660|4584047|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1389083|NCT01323660|4584042|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1389084|NCT01323660|4584043|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
1389085|NCT01323660|4584044|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1389086|NCT01323660|4584045|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1389087|NCT01323660|4584046|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1389088|NCT01323660|4584047|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1389089|NCT01323660|4584042|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
1389090|NCT01323660|4584043|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
1389091|NCT01323660|4584044|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
1389092|NCT01323660|4584045|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
1389093|NCT01323660|4584046|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
1389094|NCT01323660|4584047|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
1389095|NCT01323660|4584042|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
1389096|NCT01323660|4584043|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
1389097|NCT01323660|4584044|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
1389098|NCT01323660|4584045|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
1389099|NCT01323660|4584046|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
1389100|NCT01323660|4584047|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
1389101|NCT01323660|4584042|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
1389102|NCT01323660|4584043|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
1389103|NCT01323660|4584044|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
1389104|NCT01323660|4584045|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
1389105|NCT01323660|4584046|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
1389106|NCT01323660|4584047|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
1389107|NCT01323647|4584093|P2|Overall Study|Lost to Follow-up|0
1389108|NCT01323647|4584094|P1|Overall Study|Lost to Follow-up|2
1389109|NCT01323647|4584093|P2|Overall Study|Withdrawal by Subject|0
1389110|NCT01323647|4584094|P1|Overall Study|Withdrawal by Subject|5
1389111|NCT01323647|4584093|P2|Overall Study|Migrated/moved from study area|0
1389112|NCT01323647|4584094|P1|Overall Study|Migrated/moved from study area|2
1389113|NCT01323634|4584111|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
1389114|NCT01323634|4584112|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
1389115|NCT01323634|4584113|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
1389116|NCT01323634|4584111|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
1389117|NCT01323634|4584112|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
1389118|NCT01323634|4584113|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1389119|NCT01323634|4584111|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
1389120|NCT01323634|4584112|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
1389121|NCT01323634|4584113|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
1389122|NCT01323634|4584111|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
1389123|NCT01323634|4584112|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
1389124|NCT01323634|4584113|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1389125|NCT01323634|4584111|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
1389126|NCT01323634|4584112|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
1389127|NCT01323634|4584113|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
1389128|NCT01323634|4584111|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
1389129|NCT01323634|4584112|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1389130|NCT01323634|4584113|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1389131|NCT01323634|4584111|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
1389132|NCT01323634|4584112|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
1389133|NCT01323634|4584113|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
1389134|NCT01323634|4584111|P3|2-week Run-in Period|Adverse Event|0
1389135|NCT01323634|4584112|P2|2-week Run-in Period|Adverse Event|0
1389136|NCT01323634|4584113|P1|2-week Run-in Period|Adverse Event|1
1389137|NCT01323634|4584111|P3|2-week Run-in Period|Protocol Violation|0
1389138|NCT01323634|4584112|P2|2-week Run-in Period|Protocol Violation|0
1389139|NCT01323634|4584113|P1|2-week Run-in Period|Protocol Violation|1
1389140|NCT01323634|4584111|P3|2-week Run-in Period|Physician Decision|0
1389141|NCT01323634|4584112|P2|2-week Run-in Period|Physician Decision|0
1389142|NCT01323634|4584113|P1|2-week Run-in Period|Physician Decision|5
1389143|NCT01323634|4584111|P3|2-week Run-in Period|Withdrawal by Subject|0
1389144|NCT01323634|4584112|P2|2-week Run-in Period|Withdrawal by Subject|0
1389145|NCT01323634|4584113|P1|2-week Run-in Period|Withdrawal by Subject|7
1389146|NCT01323634|4584111|P3|2-week Run-in Period|Continuation Criteria not Met|0
1389147|NCT01323634|4584112|P2|2-week Run-in Period|Continuation Criteria not Met|0
1389148|NCT01323634|4584113|P1|2-week Run-in Period|Continuation Criteria not Met|73
1389149|NCT01323634|4584111|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
1389150|NCT01323634|4584112|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
1389151|NCT01323634|4584113|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
1389152|NCT01323621|4584123|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
1389153|NCT01323621|4584124|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
1389154|NCT01323621|4584125|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
1389155|NCT01323621|4584123|P3|12-week, Double-blind Treatment Period|Physician Decision|1
1389156|NCT01323621|4584124|P2|12-week, Double-blind Treatment Period|Physician Decision|2
1389157|NCT01323621|4584125|P1|12-week, Double-blind Treatment Period|Physician Decision|0
1389158|NCT01323621|4584123|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
1389159|NCT01323621|4584124|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
1389160|NCT01323621|4584125|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
1389161|NCT01323621|4584123|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
1389162|NCT01323621|4584124|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
1389163|NCT01323621|4584125|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
1389164|NCT01323621|4584123|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
1389165|NCT01323621|4584124|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
1389166|NCT01323621|4584125|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
1389167|NCT01323621|4584123|P3|12-week, Double-blind Treatment Period|Adverse Event|5
1389168|NCT01323621|4584124|P2|12-week, Double-blind Treatment Period|Adverse Event|1
1389169|NCT01323621|4584125|P1|12-week, Double-blind Treatment Period|Adverse Event|0
1389170|NCT01323621|4584123|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
1389171|NCT01323621|4584124|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
1389172|NCT01323621|4584125|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
1389173|NCT01323621|4584123|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
1389174|NCT01323621|4584124|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
1389175|NCT01323621|4584125|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
1389176|NCT01323621|4584123|P3|2-week, Single-blind Run In Period|Protocol Violation|0
1389177|NCT01323621|4584124|P2|2-week, Single-blind Run In Period|Protocol Violation|0
1389178|NCT01323621|4584125|P1|2-week, Single-blind Run In Period|Protocol Violation|1
1389179|NCT01323621|4584123|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
1389180|NCT01323621|4584124|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
1389181|NCT01323621|4584125|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
1389182|NCT01323621|4584123|P3|2-week, Single-blind Run In Period|Physician Decision|0
1389183|NCT01323621|4584124|P2|2-week, Single-blind Run In Period|Physician Decision|0
1389184|NCT01323621|4584125|P1|2-week, Single-blind Run In Period|Physician Decision|7
1389185|NCT01323621|4584123|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
1389186|NCT01323621|4584124|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
1389187|NCT01323621|4584125|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
1389188|NCT01323582|4584146|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
1389189|NCT01323582|4584147|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
1389190|NCT01323582|4584146|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
1389191|NCT01323582|4584147|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
1389192|NCT01323582|4584146|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
1389193|NCT01323582|4584147|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
1389194|NCT01323478|4584170|P1|Overall Study|Administrative or Other Reasons|8
1389195|NCT01323478|4584170|P1|Overall Study|Withdrawal of Consent|1
1389196|NCT01323478|4584170|P1|Overall Study|Protocol Violation|1
1389197|NCT01323478|4584170|P1|Overall Study|Non-compliance With Study Product|3
1389198|NCT01323478|4584170|P1|Overall Study|Lack of Efficacy|4
1389199|NCT01323478|4584170|P1|Overall Study|Adverse Event|7
1389200|NCT01323387|4584183|P1|Overall Study|Randomized but Never Treated|16
1389201|NCT01323387|4584183|P1|Overall Study|Protocol Violation|12
1389202|NCT01323387|4584183|P1|Overall Study|Revision|14
1389203|NCT01323387|4584183|P1|Overall Study|Radiographic Data Unavailable|1
1389204|NCT01323387|4584183|P1|Overall Study|Withdrawal by Subject|41
1389205|NCT01323270|4584196|P2|Overall Study|Randomized, but not vaccinated|0
1389206|NCT01323270|4584197|P1|Overall Study|Randomized, but not vaccinated|1
1389207|NCT01323270|4584196|P2|Overall Study|Death|0
1389208|NCT01323270|4584197|P1|Overall Study|Death|1
1389209|NCT01323270|4584196|P2|Overall Study|Not eligible|1
1389210|NCT01323270|4584197|P1|Overall Study|Not eligible|1
1389211|NCT01323270|4584196|P2|Overall Study|Physician Decision|2
1389212|NCT01323270|4584197|P1|Overall Study|Physician Decision|0
1389213|NCT01323270|4584196|P2|Overall Study|Other|3
1389214|NCT01323270|4584197|P1|Overall Study|Other|0
1389215|NCT01323270|4584196|P2|Overall Study|Adverse Event|0
1389216|NCT01323270|4584197|P1|Overall Study|Adverse Event|8
1389217|NCT01323270|4584196|P2|Overall Study|Lost to Follow-up|6
1389218|NCT01323270|4584197|P1|Overall Study|Lost to Follow-up|4
1389219|NCT01323270|4584196|P2|Overall Study|Protocol Violation|7
1389220|NCT01323270|4584197|P1|Overall Study|Protocol Violation|9
1389221|NCT01323270|4584196|P2|Overall Study|Withdrawal by Subject|10
1389222|NCT01323270|4584197|P1|Overall Study|Withdrawal by Subject|19
1389223|NCT01323192|4584219|P2|Overall Study|Nonmedical reasons|1
1389224|NCT01323192|4584220|P1|Overall Study|Nonmedical reasons|0
1389225|NCT01323192|4584219|P2|Overall Study|Noncompliance with study medication|3
1389226|NCT01323192|4584220|P1|Overall Study|Noncompliance with study medication|0
1389227|NCT01323192|4584219|P2|Overall Study|Withdrawal by Subject|1
1389228|NCT01323192|4584220|P1|Overall Study|Withdrawal by Subject|3
1389229|NCT01323192|4584219|P2|Overall Study|Adverse Event|1
1389230|NCT01323192|4584220|P1|Overall Study|Adverse Event|6
1389231|NCT01322386|4584468|P2|Overall Study|Physician Decision|1
1389232|NCT01322386|4584469|P1|Overall Study|Physician Decision|0
1389233|NCT01322386|4584468|P2|Overall Study|Protocol Violation|1
1389234|NCT01322386|4584469|P1|Overall Study|Protocol Violation|0
1389235|NCT01322347|4584484|P2|Overall Study|moved/changed dialysis|4
1389236|NCT01322347|4584485|P1|Overall Study|moved/changed dialysis|2
1389237|NCT01322347|4584484|P2|Overall Study|study drug withheld > 12 wks|1
1389238|NCT01322347|4584485|P1|Overall Study|study drug withheld > 12 wks|0
1389239|NCT01322347|4584484|P2|Overall Study|kidney transplant|1
1389240|NCT01322347|4584485|P1|Overall Study|kidney transplant|3
1389241|NCT01322347|4584484|P2|Overall Study|ineligible|3
1389242|NCT01322347|4584485|P1|Overall Study|ineligible|6
1389243|NCT01322347|4584484|P2|Overall Study|sponsor decision|3
1389244|NCT01322347|4584485|P1|Overall Study|sponsor decision|1
1389245|NCT01322347|4584484|P2|Overall Study|blood transfusion|5
1389246|NCT01322347|4584485|P1|Overall Study|blood transfusion|5
1389247|NCT01322347|4584484|P2|Overall Study|non-protocol change to ESA or IV iron|6
1389248|NCT01322347|4584485|P1|Overall Study|non-protocol change to ESA or IV iron|14
1389249|NCT01322347|4584484|P2|Overall Study|Withdrawal by Subject|4
1389250|NCT01322347|4584485|P1|Overall Study|Withdrawal by Subject|1
1389251|NCT01322347|4584484|P2|Overall Study|Protocol Violation|2
1389252|NCT01322347|4584485|P1|Overall Study|Protocol Violation|5
1389253|NCT01322347|4584484|P2|Overall Study|Physician Decision|1
1389254|NCT01322347|4584485|P1|Overall Study|Physician Decision|2
1389255|NCT01322347|4584484|P2|Overall Study|Death|3
1389256|NCT01322347|4584485|P1|Overall Study|Death|5
1389257|NCT01322347|4584484|P2|Overall Study|Adverse Event|2
1389258|NCT01322347|4584485|P1|Overall Study|Adverse Event|7
1389259|NCT01322009|4584548|P2|Overall Study|ng tube discontinued|1
1389260|NCT01322009|4584549|P1|Overall Study|ng tube discontinued|0
1389261|NCT01322009|4584548|P2|Overall Study|Adverse Event|1
1389262|NCT01322009|4584549|P1|Overall Study|Adverse Event|0
1389263|NCT01322009|4584548|P2|Overall Study|Death|1
1389264|NCT01322009|4584549|P1|Overall Study|Death|0
1389265|NCT01321749|4584559|P2|Overall Study|Withdrawal by Subject|4
1389266|NCT01321749|4584560|P1|Overall Study|Withdrawal by Subject|5
1389267|NCT01321749|4584559|P2|Overall Study|Protocol Violation|7
1389268|NCT01321749|4584560|P1|Overall Study|Protocol Violation|4
1389269|NCT01321749|4584559|P2|Overall Study|Lost to Follow-up|11
1389270|NCT01321749|4584560|P1|Overall Study|Lost to Follow-up|4
1389271|NCT01321723|4584569|P3|Overall Study|Withdrawal by Subject|2
1389272|NCT01321723|4584570|P2|Overall Study|Withdrawal by Subject|0
1389273|NCT01321723|4584571|P1|Overall Study|Withdrawal by Subject|2
1389274|NCT01321723|4584569|P3|Overall Study|Adverse Event|2
1389275|NCT01321723|4584570|P2|Overall Study|Adverse Event|5
1389276|NCT01321723|4584571|P1|Overall Study|Adverse Event|3
1389277|NCT01321710|4584593|P3|Overall Study|Lost to Follow-up|0
1389278|NCT01321710|4584594|P2|Overall Study|Lost to Follow-up|5
1389279|NCT01321710|4584595|P1|Overall Study|Lost to Follow-up|4
1389280|NCT01321697|4584610|P1|Overall Study|Study Terminated|7
1389281|NCT01321606|4584616|P4|Overall Study|Lost to Follow-up|1
1389282|NCT01321606|4584617|P3|Overall Study|Lost to Follow-up|0
1389283|NCT01321606|4584618|P2|Overall Study|Lost to Follow-up|0
1389284|NCT01321606|4584619|P1|Overall Study|Lost to Follow-up|0
1389285|NCT01321554|4584639|P4|OOL Lenvatinib Treatment Period|Death|1
1389286|NCT01321554|4584640|P3|OOL Lenvatinib Treatment Period|Death|1
1389287|NCT01321554|4584641|P2|OOL Lenvatinib Treatment Period|Death|0
1389288|NCT01321554|4584642|P1|OOL Lenvatinib Treatment Period|Death|0
1389289|NCT01321554|4584639|P4|OOL Lenvatinib Treatment Period|Worsening disease|0
1389290|NCT01321554|4584640|P3|OOL Lenvatinib Treatment Period|Worsening disease|1
1389291|NCT01321554|4584641|P2|OOL Lenvatinib Treatment Period|Worsening disease|0
1389292|NCT01321554|4584642|P1|OOL Lenvatinib Treatment Period|Worsening disease|0
1389293|NCT01321554|4584639|P4|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
1389294|NCT01321554|4584640|P3|OOL Lenvatinib Treatment Period|Lost to Follow-up|1
1389295|NCT01321554|4584641|P2|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
1389296|NCT01321554|4584642|P1|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
1389297|NCT01321554|4584639|P4|OOL Lenvatinib Treatment Period|Not specified|0
1389298|NCT01321554|4584640|P3|OOL Lenvatinib Treatment Period|Not specified|5
1389299|NCT01321554|4584641|P2|OOL Lenvatinib Treatment Period|Not specified|0
1389300|NCT01321554|4584642|P1|OOL Lenvatinib Treatment Period|Not specified|0
1389301|NCT01321554|4584639|P4|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
1389302|NCT01321554|4584640|P3|OOL Lenvatinib Treatment Period|Withdrawal by Subject|1
1389303|NCT01321554|4584641|P2|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
1389304|NCT01321554|4584642|P1|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
1389305|NCT01321554|4584639|P4|OOL Lenvatinib Treatment Period|Participant choice|0
1389306|NCT01321554|4584640|P3|OOL Lenvatinib Treatment Period|Participant choice|3
1389307|NCT01321554|4584641|P2|OOL Lenvatinib Treatment Period|Participant choice|0
1389308|NCT01321554|4584642|P1|OOL Lenvatinib Treatment Period|Participant choice|0
1389309|NCT01321554|4584639|P4|OOL Lenvatinib Treatment Period|Adverse Event|1
1389310|NCT01321554|4584640|P3|OOL Lenvatinib Treatment Period|Adverse Event|16
1389311|NCT01321554|4584641|P2|OOL Lenvatinib Treatment Period|Adverse Event|0
1389312|NCT01321554|4584642|P1|OOL Lenvatinib Treatment Period|Adverse Event|0
1389313|NCT01321554|4584639|P4|Randomization Phase|Death|0
1389314|NCT01321554|4584640|P3|Randomization Phase|Death|0
1389315|NCT01321554|4584641|P2|Randomization Phase|Death|1
1389316|NCT01321554|4584642|P1|Randomization Phase|Death|0
1389317|NCT01321554|4584639|P4|Randomization Phase|Withdrawal by Subject|0
1389318|NCT01321554|4584640|P3|Randomization Phase|Withdrawal by Subject|0
1389319|NCT01321554|4584641|P2|Randomization Phase|Withdrawal by Subject|0
1389320|NCT01321554|4584642|P1|Randomization Phase|Withdrawal by Subject|4
1389321|NCT01321554|4584639|P4|Randomization Phase|Participant choice|0
1389322|NCT01321554|4584640|P3|Randomization Phase|Participant choice|0
1389323|NCT01321554|4584641|P2|Randomization Phase|Participant choice|0
1389324|NCT01321554|4584642|P1|Randomization Phase|Participant choice|4
1389325|NCT01321554|4584639|P4|Randomization Phase|Adverse Event|0
1389326|NCT01321554|4584640|P3|Randomization Phase|Adverse Event|0
1389327|NCT01321554|4584641|P2|Randomization Phase|Adverse Event|3
1389328|NCT01321554|4584642|P1|Randomization Phase|Adverse Event|37
1389329|NCT01321073|4584655|P1|Overall Study|Death|3
1389330|NCT01321073|4584655|P1|Overall Study|Did not attempt implant|4
1389331|NCT01321008|4584659|P1|Overall Study|Early Study Termination|1
1389332|NCT01320943|4584665|P2|Overall Study|Randomized but not Treated|1
1389333|NCT01320943|4584666|P1|Overall Study|Randomized but not Treated|0
1389334|NCT01320943|4584665|P2|Overall Study|Physician Decision|1
1389335|NCT01320943|4584666|P1|Overall Study|Physician Decision|0
1389336|NCT01320943|4584665|P2|Overall Study|Lost to Follow-up|0
1389337|NCT01320943|4584666|P1|Overall Study|Lost to Follow-up|1
1389338|NCT01320735|4584700|P1|Overall Study|Investigator Unable to be Contacted|17
1389339|NCT01320735|4584700|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
1389340|NCT01320735|4584700|P1|Overall Study|Not Specified|1
1389341|NCT01320735|4584700|P1|Overall Study|Protocol Violation|1
1389342|NCT01320735|4584700|P1|Overall Study|Progression/Hormone-Refractory Pca|55
1389343|NCT01320735|4584700|P1|Overall Study|Administrative Reason|6
1389344|NCT01320735|4584700|P1|Overall Study|Lost to Follow-up|13
1389345|NCT01320735|4584700|P1|Overall Study|Withdrawal by Subject|3
1389346|NCT01320735|4584700|P1|Overall Study|Adverse Event|3
1389347|NCT01320722|4584722|P5|Overall Study|Withdrew due to Health Condition|1
1389348|NCT01320722|4584723|P4|Overall Study|Withdrew due to Health Condition|0
1389349|NCT01320722|4584724|P3|Overall Study|Withdrew due to Health Condition|0
1389350|NCT01320722|4584725|P2|Overall Study|Withdrew due to Health Condition|0
1389351|NCT01320722|4584726|P1|Overall Study|Withdrew due to Health Condition|0
1389352|NCT01320722|4584722|P5|Overall Study|Started an Exclusionary Medication|1
1389353|NCT01320722|4584723|P4|Overall Study|Started an Exclusionary Medication|0
1389354|NCT01320722|4584724|P3|Overall Study|Started an Exclusionary Medication|0
1389355|NCT01320722|4584725|P2|Overall Study|Started an Exclusionary Medication|0
1389356|NCT01320722|4584726|P1|Overall Study|Started an Exclusionary Medication|0
1389357|NCT01320722|4584722|P5|Overall Study|Pregnancy|0
1389358|NCT01320722|4584723|P4|Overall Study|Pregnancy|1
1389359|NCT01320722|4584724|P3|Overall Study|Pregnancy|0
1389360|NCT01320722|4584725|P2|Overall Study|Pregnancy|0
1389361|NCT01320722|4584726|P1|Overall Study|Pregnancy|0
1389362|NCT01320722|4584722|P5|Overall Study|Not Compliant with Study Procedures|0
1389363|NCT01320722|4584723|P4|Overall Study|Not Compliant with Study Procedures|4
1389364|NCT01320722|4584724|P3|Overall Study|Not Compliant with Study Procedures|0
1389365|NCT01320722|4584725|P2|Overall Study|Not Compliant with Study Procedures|0
1389366|NCT01320722|4584726|P1|Overall Study|Not Compliant with Study Procedures|0
1389367|NCT01320722|4584722|P5|Overall Study|Adverse Event|0
1389368|NCT01320722|4584723|P4|Overall Study|Adverse Event|6
1389369|NCT01320722|4584724|P3|Overall Study|Adverse Event|3
1389370|NCT01320722|4584725|P2|Overall Study|Adverse Event|0
1389371|NCT01320722|4584726|P1|Overall Study|Adverse Event|0
1389372|NCT01320722|4584722|P5|Overall Study|Non-compliant with Medication|0
1389373|NCT01320722|4584723|P4|Overall Study|Non-compliant with Medication|0
1389374|NCT01320722|4584724|P3|Overall Study|Non-compliant with Medication|1
1389375|NCT01320722|4584725|P2|Overall Study|Non-compliant with Medication|0
1389376|NCT01320722|4584726|P1|Overall Study|Non-compliant with Medication|0
1389377|NCT01320722|4584722|P5|Overall Study|Participant Developed a Rash|1
1389378|NCT01320722|4584723|P4|Overall Study|Participant Developed a Rash|1
1389379|NCT01320722|4584724|P3|Overall Study|Participant Developed a Rash|2
1389380|NCT01320722|4584725|P2|Overall Study|Participant Developed a Rash|0
1389381|NCT01320722|4584726|P1|Overall Study|Participant Developed a Rash|0
1389382|NCT01320722|4584722|P5|Overall Study|Not Available for the 8 Week Visit|0
1389383|NCT01320722|4584723|P4|Overall Study|Not Available for the 8 Week Visit|0
1389384|NCT01320722|4584724|P3|Overall Study|Not Available for the 8 Week Visit|0
1389385|NCT01320722|4584725|P2|Overall Study|Not Available for the 8 Week Visit|3
1389386|NCT01320722|4584726|P1|Overall Study|Not Available for the 8 Week Visit|0
1389387|NCT01320722|4584722|P5|Overall Study|Lost to Follow-up|3
1389388|NCT01320722|4584723|P4|Overall Study|Lost to Follow-up|1
1389389|NCT01320722|4584724|P3|Overall Study|Lost to Follow-up|0
1389390|NCT01320722|4584725|P2|Overall Study|Lost to Follow-up|1
1389391|NCT01320722|4584726|P1|Overall Study|Lost to Follow-up|0
1389392|NCT01320722|4584722|P5|Overall Study|Did not Receive Intervention|2
1389393|NCT01320722|4584723|P4|Overall Study|Did not Receive Intervention|1
1389394|NCT01320722|4584724|P3|Overall Study|Did not Receive Intervention|1
1389395|NCT01320722|4584725|P2|Overall Study|Did not Receive Intervention|2
1389396|NCT01320722|4584726|P1|Overall Study|Did not Receive Intervention|3
1389397|NCT01320683|4584763|P1|Overall Study|Positive antibody response|1
1389398|NCT01320293|4584789|P1|Overall Study|Adverse Event|1
1389399|NCT01320293|4584789|P1|Overall Study|Lack of Efficacy|1
1389400|NCT01320202|4584797|P2|Overall Study|regained renal function|0
1389401|NCT01320202|4584798|P1|Overall Study|regained renal function|1
1389402|NCT01320202|4584797|P2|Overall Study|ineligible|0
1389403|NCT01320202|4584798|P1|Overall Study|ineligible|3
1389404|NCT01320202|4584797|P2|Overall Study|sponsor request|0
1389405|NCT01320202|4584798|P1|Overall Study|sponsor request|2
1389406|NCT01320202|4584797|P2|Overall Study|moved/changed dialysis|2
1389407|NCT01320202|4584798|P1|Overall Study|moved/changed dialysis|5
1389408|NCT01320202|4584797|P2|Overall Study|blood transfusion|7
1389409|NCT01320202|4584798|P1|Overall Study|blood transfusion|1
1389410|NCT01320202|4584797|P2|Overall Study|kidney transplant|2
1389411|NCT01320202|4584798|P1|Overall Study|kidney transplant|1
1389412|NCT01320202|4584797|P2|Overall Study|non-protocol change to ESA or IV iron|20
1389413|NCT01320202|4584798|P1|Overall Study|non-protocol change to ESA or IV iron|17
1389414|NCT01320202|4584797|P2|Overall Study|Withdrawal by Subject|3
1389415|NCT01320202|4584798|P1|Overall Study|Withdrawal by Subject|10
1389416|NCT01320202|4584797|P2|Overall Study|Protocol Violation|1
1389417|NCT01320202|4584798|P1|Overall Study|Protocol Violation|2
1389418|NCT01320202|4584797|P2|Overall Study|Physician Decision|1
1389419|NCT01320202|4584798|P1|Overall Study|Physician Decision|3
1389420|NCT01320202|4584797|P2|Overall Study|Lost to Follow-up|0
1389421|NCT01320202|4584798|P1|Overall Study|Lost to Follow-up|1
1389422|NCT01320202|4584797|P2|Overall Study|Death|3
1389423|NCT01320202|4584798|P1|Overall Study|Death|5
1389424|NCT01320202|4584797|P2|Overall Study|Adverse Event|5
1389425|NCT01320202|4584798|P1|Overall Study|Adverse Event|5
1389426|NCT01319877|4584862|P2|Overall Study|Reason Not Specified|5
1389427|NCT01319877|4584863|P1|Overall Study|Reason Not Specified|4
1389428|NCT01319877|4584862|P2|Overall Study|Withdrawal by Subject|1
1389429|NCT01319877|4584863|P1|Overall Study|Withdrawal by Subject|0
1389430|NCT01319877|4584862|P2|Overall Study|Disease Progression|2
1389431|NCT01319877|4584863|P1|Overall Study|Disease Progression|2
1389432|NCT01319877|4584862|P2|Overall Study|Physician Decision|0
1389433|NCT01319877|4584863|P1|Overall Study|Physician Decision|2
1389434|NCT01319877|4584862|P2|Overall Study|Lost to Follow-up|37
1389435|NCT01319877|4584863|P1|Overall Study|Lost to Follow-up|100
1389436|NCT01319721|4585013|P2|Overall Study|Lost to Follow-up|6
1389437|NCT01319721|4585014|P1|Overall Study|Lost to Follow-up|1
1389438|NCT01319422|4585067|P2|Overall Study|Withdrawal by Subject|0
1389439|NCT01319422|4585068|P1|Overall Study|Withdrawal by Subject|1
1389440|NCT01319383|4585086|P2|Overall Study|No in vivo response to interval doses|1
1389441|NCT01319383|4585087|P1|Overall Study|No in vivo response to interval doses|0
1389442|NCT01319383|4585086|P2|Overall Study|Lack of Efficacy|9
1389443|NCT01319383|4585087|P1|Overall Study|Lack of Efficacy|5
1389444|NCT01319383|4585086|P2|Overall Study|Physician Decision|0
1389445|NCT01319383|4585087|P1|Overall Study|Physician Decision|3
1389446|NCT01319383|4585086|P2|Overall Study|No ex vivo or in vivo response|0
1389447|NCT01319383|4585087|P1|Overall Study|No ex vivo or in vivo response|4
1389448|NCT01318993|4585126|P1|Overall Study|Withdrawal by Subject|24
1389449|NCT01318993|4585126|P1|Overall Study|Physician Decision|13
1389450|NCT01318993|4585126|P1|Overall Study|Lost to Follow-up|4
1389451|NCT01318993|4585126|P1|Overall Study|Study closed or terminated|174
1389452|NCT01318993|4585126|P1|Overall Study|Protocol based stopping criteria|6
1389453|NCT01318993|4585126|P1|Overall Study|Protocol Violation|3
1389454|NCT01318993|4585126|P1|Overall Study|Lack of Efficacy|121
1389455|NCT01318993|4585126|P1|Overall Study|Adverse Event|53
1389456|NCT01318915|4585147|P1|Overall Study|Ongoing in study|7
1389457|NCT01318915|4585147|P1|Overall Study|Lost to Follow-up|1
1389458|NCT01318876|4585151|P1|Day 29 Survey|survey not completed-don't know why|1825
1389459|NCT01318876|4585151|P1|Day 8 Survey|survey not completed-don't know why|1724
1389460|NCT01318876|4585151|P1|Day 8 Survey|email address invalid|96
1389461|NCT01318512|4585249|P1|Maintenance Period (6 Months)|Protocol Violation|9
1389462|NCT01318512|4585249|P1|Maintenance Period (6 Months)|Death|2
1389463|NCT01318499|4585268|P3|Overall Study|Not Specified|22
1389464|NCT01318499|4585269|P2|Overall Study|Not Specified|10
1389465|NCT01318499|4585270|P1|Overall Study|Not Specified|7
1389466|NCT01318499|4585268|P3|Overall Study|Patient Did Not Use Study Medication|14
1389467|NCT01318499|4585269|P2|Overall Study|Patient Did Not Use Study Medication|28
1389468|NCT01318499|4585270|P1|Overall Study|Patient Did Not Use Study Medication|18
1389469|NCT01318499|4585268|P3|Overall Study|Protocol Violation|2
1389470|NCT01318499|4585269|P2|Overall Study|Protocol Violation|4
1389471|NCT01318499|4585270|P1|Overall Study|Protocol Violation|2
1389472|NCT01318499|4585268|P3|Overall Study|Treatment Failure|101
1389473|NCT01318499|4585269|P2|Overall Study|Treatment Failure|19
1389474|NCT01318499|4585270|P1|Overall Study|Treatment Failure|19
1389475|NCT01318499|4585268|P3|Overall Study|Noncompliance|0
1389476|NCT01318499|4585269|P2|Overall Study|Noncompliance|3
1389477|NCT01318499|4585270|P1|Overall Study|Noncompliance|2
1389478|NCT01318499|4585268|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
1389479|NCT01318499|4585269|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
1389480|NCT01318499|4585270|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
1389481|NCT01318499|4585268|P3|Overall Study|Adverse Event|6
1389482|NCT01318499|4585269|P2|Overall Study|Adverse Event|11
1389483|NCT01318499|4585270|P1|Overall Study|Adverse Event|16
1389484|NCT01318382|4585293|P1|Overall Study|Protocol Violation|1
1389485|NCT01318382|4585293|P1|Overall Study|Device Malfunction|10
1389486|NCT01318382|4585293|P1|Overall Study|Physician Decision|2
1389487|NCT01318135|4585351|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
1389560|NCT01318122|4585491|P3|Enrolled - Long-Term Extension Study|Other|0
1389488|NCT01318135|4585352|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1389489|NCT01318135|4585353|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1389490|NCT01318135|4585354|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1389491|NCT01318135|4585355|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1389492|NCT01318135|4585356|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1389493|NCT01318135|4585357|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1389494|NCT01318135|4585358|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1389495|NCT01318135|4585351|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
1389496|NCT01318135|4585352|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
1389497|NCT01318135|4585353|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
1389498|NCT01318135|4585354|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
1389499|NCT01318135|4585355|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
1389500|NCT01318135|4585356|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
1389501|NCT01318135|4585357|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
1389502|NCT01318135|4585358|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
1389503|NCT01318135|4585351|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1389504|NCT01318135|4585352|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1389505|NCT01318135|4585353|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1389506|NCT01318135|4585354|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1389507|NCT01318135|4585355|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1389508|NCT01318135|4585356|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1389509|NCT01318135|4585357|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1389510|NCT01318135|4585358|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1389511|NCT01318135|4585351|P8|Entered - Long-Term Extension Study|Protocol Violation|0
1389512|NCT01318135|4585352|P7|Entered - Long-Term Extension Study|Protocol Violation|0
1389513|NCT01318135|4585353|P6|Entered - Long-Term Extension Study|Protocol Violation|0
1389514|NCT01318135|4585354|P5|Entered - Long-Term Extension Study|Protocol Violation|1
1389515|NCT01318135|4585355|P4|Entered - Long-Term Extension Study|Protocol Violation|0
1389516|NCT01318135|4585356|P3|Entered - Long-Term Extension Study|Protocol Violation|0
1389517|NCT01318135|4585357|P2|Entered - Long-Term Extension Study|Protocol Violation|1
1389518|NCT01318135|4585358|P1|Entered - Long-Term Extension Study|Protocol Violation|1
1389519|NCT01318135|4585351|P8|Entered - Long-Term Extension Study|Adverse Event|0
1389520|NCT01318135|4585352|P7|Entered - Long-Term Extension Study|Adverse Event|0
1389521|NCT01318135|4585353|P6|Entered - Long-Term Extension Study|Adverse Event|2
1389522|NCT01318135|4585354|P5|Entered - Long-Term Extension Study|Adverse Event|4
1389523|NCT01318135|4585355|P4|Entered - Long-Term Extension Study|Adverse Event|3
1389524|NCT01318135|4585356|P3|Entered - Long-Term Extension Study|Adverse Event|4
1389525|NCT01318135|4585357|P2|Entered - Long-Term Extension Study|Adverse Event|3
1389526|NCT01318135|4585358|P1|Entered - Long-Term Extension Study|Adverse Event|9
1389527|NCT01318135|4585351|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
1389528|NCT01318135|4585352|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
1389529|NCT01318135|4585353|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
1389530|NCT01318135|4585354|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
1389531|NCT01318135|4585355|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
1389532|NCT01318135|4585356|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
1389533|NCT01318135|4585357|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
1389534|NCT01318135|4585358|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
1389535|NCT01318135|4585351|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
1389536|NCT01318135|4585352|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
1389537|NCT01318135|4585353|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
1389538|NCT01318135|4585354|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
1389539|NCT01318135|4585355|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
1389540|NCT01318135|4585356|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
1389541|NCT01318135|4585357|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
1389542|NCT01318135|4585358|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
1389543|NCT01318122|4585490|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
1389544|NCT01318122|4585491|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
1389545|NCT01318122|4585492|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
1389546|NCT01318122|4585493|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
1389547|NCT01318122|4585490|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1389548|NCT01318122|4585491|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1389549|NCT01318122|4585492|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
1389550|NCT01318122|4585493|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1389551|NCT01318122|4585490|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
1389552|NCT01318122|4585491|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
1389553|NCT01318122|4585492|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
1389554|NCT01318122|4585493|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
1389555|NCT01318122|4585490|P4|Entered - Long-Term Extension Study|Adverse Event|4
1389556|NCT01318122|4585491|P3|Entered - Long-Term Extension Study|Adverse Event|2
1389557|NCT01318122|4585492|P2|Entered - Long-Term Extension Study|Adverse Event|6
1389558|NCT01318122|4585493|P1|Entered - Long-Term Extension Study|Adverse Event|6
1389559|NCT01318122|4585490|P4|Enrolled - Long-Term Extension Study|Other|0
1389561|NCT01318122|4585492|P2|Enrolled - Long-Term Extension Study|Other|0
1389562|NCT01318122|4585493|P1|Enrolled - Long-Term Extension Study|Other|1
1389563|NCT01318122|4585490|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
1389564|NCT01318122|4585491|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
1389565|NCT01318122|4585492|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
1389566|NCT01318122|4585493|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
1389567|NCT01318109|4585562|P3|Overall Study|Schedule Conflict|0
1389568|NCT01318109|4585563|P2|Overall Study|Schedule Conflict|1
1389569|NCT01318109|4585564|P1|Overall Study|Schedule Conflict|0
1389570|NCT01318109|4585562|P3|Overall Study|Withdrawal by Subject|0
1389571|NCT01318109|4585563|P2|Overall Study|Withdrawal by Subject|0
1389572|NCT01318109|4585564|P1|Overall Study|Withdrawal by Subject|1
1389573|NCT01318109|4585562|P3|Overall Study|Adverse Event|0
1389574|NCT01318109|4585563|P2|Overall Study|Adverse Event|2
1389575|NCT01318109|4585564|P1|Overall Study|Adverse Event|0
1389576|NCT01318083|4585599|P3|Overall Study|Lack of Study Medication Compliance|0
1389577|NCT01318083|4585600|P2|Overall Study|Lack of Study Medication Compliance|1
1389578|NCT01318083|4585601|P1|Overall Study|Lack of Study Medication Compliance|0
1389579|NCT01318083|4585599|P3|Overall Study|Treatment Complications|0
1389580|NCT01318083|4585600|P2|Overall Study|Treatment Complications|0
1389581|NCT01318083|4585601|P1|Overall Study|Treatment Complications|1
1389582|NCT01318083|4585599|P3|Overall Study|Lack of Efficacy|1
1389583|NCT01318083|4585600|P2|Overall Study|Lack of Efficacy|0
1389584|NCT01318083|4585601|P1|Overall Study|Lack of Efficacy|0
1389585|NCT01318083|4585599|P3|Overall Study|Withdrawal by Subject|2
1389586|NCT01318083|4585600|P2|Overall Study|Withdrawal by Subject|0
1389587|NCT01318083|4585601|P1|Overall Study|Withdrawal by Subject|1
1389588|NCT01318083|4585599|P3|Overall Study|Adverse Event|2
1389589|NCT01318083|4585600|P2|Overall Study|Adverse Event|1
1389590|NCT01318083|4585601|P1|Overall Study|Adverse Event|4
1389591|NCT01318070|4585636|P3|Overall Study|Principal Investigator Discretion|0
1389592|NCT01318070|4585637|P2|Overall Study|Principal Investigator Discretion|0
1389593|NCT01318070|4585638|P1|Overall Study|Principal Investigator Discretion|1
1389594|NCT01318070|4585636|P3|Overall Study|Lack of Efficacy|1
1389595|NCT01318070|4585637|P2|Overall Study|Lack of Efficacy|0
1389596|NCT01318070|4585638|P1|Overall Study|Lack of Efficacy|0
1389597|NCT01318070|4585636|P3|Overall Study|Withdrawal by Subject|1
1389598|NCT01318070|4585637|P2|Overall Study|Withdrawal by Subject|1
1389599|NCT01318070|4585638|P1|Overall Study|Withdrawal by Subject|0
1389600|NCT01318070|4585636|P3|Overall Study|Adverse Event|5
1389601|NCT01318070|4585637|P2|Overall Study|Adverse Event|1
1389602|NCT01318070|4585638|P1|Overall Study|Adverse Event|1
1389603|NCT01317797|4585682|P3|Overall Study|Withdrawal of Patient|1
1389604|NCT01317797|4585683|P2|Overall Study|Withdrawal of Patient|0
1389605|NCT01317797|4585684|P1|Overall Study|Withdrawal of Patient|0
1389606|NCT01317797|4585682|P3|Overall Study|Other|0
1389607|NCT01317797|4585683|P2|Overall Study|Other|1
1389608|NCT01317797|4585684|P1|Overall Study|Other|0
1389609|NCT01317641|4585761|P9|Overall Study|Withdrawal by Subject|0
1389610|NCT01317641|4585762|P8|Overall Study|Withdrawal by Subject|0
1389611|NCT01317641|4585763|P7|Overall Study|Withdrawal by Subject|1
1389612|NCT01317641|4585764|P6|Overall Study|Withdrawal by Subject|0
1389613|NCT01317641|4585765|P5|Overall Study|Withdrawal by Subject|0
1389614|NCT01317641|4585766|P4|Overall Study|Withdrawal by Subject|0
1389615|NCT01317641|4585767|P3|Overall Study|Withdrawal by Subject|0
1389616|NCT01317641|4585768|P2|Overall Study|Withdrawal by Subject|0
1389617|NCT01317641|4585769|P1|Overall Study|Withdrawal by Subject|0
1389618|NCT01317641|4585761|P9|Overall Study|Disease progression|4
1389619|NCT01317641|4585762|P8|Overall Study|Disease progression|3
1389620|NCT01317641|4585763|P7|Overall Study|Disease progression|0
1389621|NCT01317641|4585764|P6|Overall Study|Disease progression|0
1389622|NCT01317641|4585765|P5|Overall Study|Disease progression|0
1389623|NCT01317641|4585766|P4|Overall Study|Disease progression|0
1389624|NCT01317641|4585767|P3|Overall Study|Disease progression|0
1389625|NCT01317641|4585768|P2|Overall Study|Disease progression|0
1389626|NCT01317641|4585769|P1|Overall Study|Disease progression|0
1389627|NCT01317641|4585761|P9|Overall Study|Protocol Violation|0
1389628|NCT01317641|4585762|P8|Overall Study|Protocol Violation|0
1389629|NCT01317641|4585763|P7|Overall Study|Protocol Violation|0
1389630|NCT01317641|4585764|P6|Overall Study|Protocol Violation|0
1389631|NCT01317641|4585765|P5|Overall Study|Protocol Violation|0
1389632|NCT01317641|4585766|P4|Overall Study|Protocol Violation|0
1389633|NCT01317641|4585767|P3|Overall Study|Protocol Violation|0
1389634|NCT01317641|4585768|P2|Overall Study|Protocol Violation|0
1389635|NCT01317641|4585769|P1|Overall Study|Protocol Violation|1
1389636|NCT01317641|4585761|P9|Overall Study|Adverse Event|0
1389637|NCT01317641|4585762|P8|Overall Study|Adverse Event|1
1389638|NCT01317641|4585763|P7|Overall Study|Adverse Event|2
1389639|NCT01317641|4585764|P6|Overall Study|Adverse Event|0
1389640|NCT01317641|4585765|P5|Overall Study|Adverse Event|0
1389641|NCT01317641|4585766|P4|Overall Study|Adverse Event|1
1389642|NCT01317641|4585767|P3|Overall Study|Adverse Event|0
1389643|NCT01317641|4585768|P2|Overall Study|Adverse Event|1
1389644|NCT01317641|4585769|P1|Overall Study|Adverse Event|0
1389645|NCT01317641|4585761|P9|Overall Study|Not treated|1
1389646|NCT01317641|4585762|P8|Overall Study|Not treated|1
1389647|NCT01317641|4585763|P7|Overall Study|Not treated|0
1389648|NCT01317641|4585764|P6|Overall Study|Not treated|0
1389649|NCT01317641|4585765|P5|Overall Study|Not treated|0
1389650|NCT01317641|4585766|P4|Overall Study|Not treated|0
1389651|NCT01317641|4585767|P3|Overall Study|Not treated|0
1389652|NCT01317641|4585768|P2|Overall Study|Not treated|0
1389653|NCT01317641|4585769|P1|Overall Study|Not treated|0
1389654|NCT01317615|4585871|P1|Overall Study|Adverse Event|7
1389655|NCT01317615|4585871|P1|Overall Study|Abnormal laboratory value(s)|1
1389656|NCT01317615|4585871|P1|Overall Study|Withdrawal by Subject|5
1389657|NCT01317615|4585871|P1|Overall Study|Death|6
1389658|NCT01317615|4585871|P1|Overall Study|New cancer therapy|5
1389659|NCT01317615|4585871|P1|Overall Study|Disease progression|25
1389660|NCT01317199|4585884|P4|Randomized Phase 2|Patient transferred to other facility|0
1389661|NCT01317199|4585885|P3|Randomized Phase 2|Patient transferred to other facility|1
1389662|NCT01317199|4585886|P2|Randomized Phase 2|Patient transferred to other facility|0
1389663|NCT01317199|4585887|P1|Randomized Phase 2|Patient transferred to other facility|0
1389664|NCT01317199|4585884|P4|Randomized Phase 2|Patient stopped taking study drug|1
1389665|NCT01317199|4585885|P3|Randomized Phase 2|Patient stopped taking study drug|0
1389666|NCT01317199|4585886|P2|Randomized Phase 2|Patient stopped taking study drug|0
1389667|NCT01317199|4585887|P1|Randomized Phase 2|Patient stopped taking study drug|0
1389668|NCT01317199|4585884|P4|Randomized Phase 2|Disenrolled before treatment|2
1389669|NCT01317199|4585885|P3|Randomized Phase 2|Disenrolled before treatment|1
1389670|NCT01317199|4585886|P2|Randomized Phase 2|Disenrolled before treatment|1
1389671|NCT01317199|4585887|P1|Randomized Phase 2|Disenrolled before treatment|0
1389672|NCT01317199|4585884|P4|Randomized Phase 2|Rising PSA, not as defined by protocol|2
1389673|NCT01317199|4585885|P3|Randomized Phase 2|Rising PSA, not as defined by protocol|5
1389674|NCT01317199|4585886|P2|Randomized Phase 2|Rising PSA, not as defined by protocol|2
1389675|NCT01317199|4585887|P1|Randomized Phase 2|Rising PSA, not as defined by protocol|0
1389676|NCT01317199|4585884|P4|Randomized Phase 2|Comorbidities|2
1389677|NCT01317199|4585885|P3|Randomized Phase 2|Comorbidities|2
1389678|NCT01317199|4585886|P2|Randomized Phase 2|Comorbidities|2
1389679|NCT01317199|4585887|P1|Randomized Phase 2|Comorbidities|0
1389680|NCT01317199|4585884|P4|Randomized Phase 2|Adverse Event|1
1389681|NCT01317199|4585885|P3|Randomized Phase 2|Adverse Event|0
1389682|NCT01317199|4585886|P2|Randomized Phase 2|Adverse Event|0
1389683|NCT01317199|4585887|P1|Randomized Phase 2|Adverse Event|0
1389684|NCT01317199|4585884|P4|Randomized Phase 2|Withdrawal by Subject|4
1389685|NCT01317199|4585885|P3|Randomized Phase 2|Withdrawal by Subject|5
1389686|NCT01317199|4585886|P2|Randomized Phase 2|Withdrawal by Subject|3
1389687|NCT01317199|4585887|P1|Randomized Phase 2|Withdrawal by Subject|0
1389688|NCT01317199|4585884|P4|Randomized Phase 2|Disease progression|5
1389689|NCT01317199|4585885|P3|Randomized Phase 2|Disease progression|7
1389690|NCT01317199|4585886|P2|Randomized Phase 2|Disease progression|3
1389691|NCT01317199|4585887|P1|Randomized Phase 2|Disease progression|0
1389692|NCT01317199|4585884|P4|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
1389693|NCT01317199|4585885|P3|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
1389694|NCT01317199|4585886|P2|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
1389695|NCT01317199|4585887|P1|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
1389696|NCT01317199|4585884|P4|Dose-escalation Phase 1|Disease progression|0
1389697|NCT01317199|4585885|P3|Dose-escalation Phase 1|Disease progression|0
1389698|NCT01317199|4585886|P2|Dose-escalation Phase 1|Disease progression|0
1389699|NCT01317199|4585887|P1|Dose-escalation Phase 1|Disease progression|1
1389700|NCT01317199|4585884|P4|Dose-escalation Phase 1|Physician Decision|0
1389701|NCT01317199|4585885|P3|Dose-escalation Phase 1|Physician Decision|0
1389702|NCT01317199|4585886|P2|Dose-escalation Phase 1|Physician Decision|0
1389703|NCT01317199|4585887|P1|Dose-escalation Phase 1|Physician Decision|5
1389704|NCT01317160|4585916|P2|Overall Study|Withdrawal by Subject|2
1389705|NCT01317160|4585917|P1|Overall Study|Withdrawal by Subject|0
1389706|NCT01317160|4585916|P2|Overall Study|Lost to Follow-up|3
1389707|NCT01317160|4585917|P1|Overall Study|Lost to Follow-up|3
1389708|NCT01317160|4585916|P2|Overall Study|Incorrect inclusion|1
1389709|NCT01317160|4585917|P1|Overall Study|Incorrect inclusion|1
1389710|NCT01317004|4585942|P2|Overall Study|Adverse Event|3
1389711|NCT01317004|4585943|P1|Overall Study|Adverse Event|3
1389712|NCT01317004|4585942|P2|Overall Study|Protocol Violation|2
1389713|NCT01317004|4585943|P1|Overall Study|Protocol Violation|0
1389714|NCT01317004|4585942|P2|Overall Study|Withdrawal by Subject|4
1389715|NCT01317004|4585943|P1|Overall Study|Withdrawal by Subject|1
1389716|NCT01316939|4585964|P3|Overall Study|Protocol Violation|0
1389717|NCT01316939|4585965|P2|Overall Study|Protocol Violation|1
1389718|NCT01316939|4585966|P1|Overall Study|Protocol Violation|0
1389719|NCT01316939|4585964|P3|Overall Study|Met Liver chemistry stopping criteria|1
1389720|NCT01316939|4585965|P2|Overall Study|Met Liver chemistry stopping criteria|0
1389721|NCT01316939|4585966|P1|Overall Study|Met Liver chemistry stopping criteria|1
1389722|NCT01316939|4585964|P3|Overall Study|Lost to Follow-up|2
1389723|NCT01316939|4585965|P2|Overall Study|Lost to Follow-up|0
1389724|NCT01316939|4585966|P1|Overall Study|Lost to Follow-up|0
1389725|NCT01316939|4585964|P3|Overall Study|Physician Decision|1
1389726|NCT01316939|4585965|P2|Overall Study|Physician Decision|2
1389727|NCT01316939|4585966|P1|Overall Study|Physician Decision|2
1389728|NCT01316939|4585964|P3|Overall Study|Withdrawal by Subject|6
1389729|NCT01316939|4585965|P2|Overall Study|Withdrawal by Subject|3
1389730|NCT01316939|4585966|P1|Overall Study|Withdrawal by Subject|1
1389731|NCT01316939|4585964|P3|Overall Study|Adverse Event|11
1389732|NCT01316939|4585965|P2|Overall Study|Adverse Event|12
1389733|NCT01316939|4585966|P1|Overall Study|Adverse Event|9
1389734|NCT01316939|4585964|P3|Overall Study|Lack of Efficacy|25
1389735|NCT01316939|4585965|P2|Overall Study|Lack of Efficacy|25
1389736|NCT01316939|4585966|P1|Overall Study|Lack of Efficacy|24
1389737|NCT01316939|4585964|P3|Overall Study|Study closed/terminated|23
1389738|NCT01316939|4585965|P2|Overall Study|Study closed/terminated|25
1389739|NCT01316939|4585966|P1|Overall Study|Study closed/terminated|26
1389740|NCT01316913|4586061|P4|Overall Study|Withdrawal by Subject|6
1389741|NCT01316913|4586062|P3|Overall Study|Withdrawal by Subject|10
1389742|NCT01316913|4586063|P2|Overall Study|Withdrawal by Subject|9
1389743|NCT01316913|4586064|P1|Overall Study|Withdrawal by Subject|10
1389744|NCT01316913|4586061|P4|Overall Study|Lost to Follow-up|2
1389745|NCT01316913|4586062|P3|Overall Study|Lost to Follow-up|0
1389746|NCT01316913|4586063|P2|Overall Study|Lost to Follow-up|1
1389747|NCT01316913|4586064|P1|Overall Study|Lost to Follow-up|0
1389748|NCT01316913|4586061|P4|Overall Study|Protocol-defined Stopping Criteria|6
1389749|NCT01316913|4586062|P3|Overall Study|Protocol-defined Stopping Criteria|11
1389750|NCT01316913|4586063|P2|Overall Study|Protocol-defined Stopping Criteria|8
1389751|NCT01316913|4586064|P1|Overall Study|Protocol-defined Stopping Criteria|7
1389752|NCT01316913|4586061|P4|Overall Study|Protocol Violation|1
1389753|NCT01316913|4586062|P3|Overall Study|Protocol Violation|4
1389754|NCT01316913|4586063|P2|Overall Study|Protocol Violation|4
1389755|NCT01316913|4586064|P1|Overall Study|Protocol Violation|1
1389756|NCT01316913|4586061|P4|Overall Study|Lack of Efficacy|13
1389757|NCT01316913|4586062|P3|Overall Study|Lack of Efficacy|9
1389758|NCT01316913|4586063|P2|Overall Study|Lack of Efficacy|12
1389759|NCT01316913|4586064|P1|Overall Study|Lack of Efficacy|22
1389760|NCT01316913|4586061|P4|Overall Study|Adverse Event|11
1389761|NCT01316913|4586062|P3|Overall Study|Adverse Event|15
1389762|NCT01316913|4586063|P2|Overall Study|Adverse Event|20
1389763|NCT01316913|4586064|P1|Overall Study|Adverse Event|17
1389764|NCT01316900|4586086|P4|Overall Study|Withdrawal by Subject|9
1389765|NCT01316900|4586087|P3|Overall Study|Withdrawal by Subject|6
1389766|NCT01316900|4586088|P2|Overall Study|Withdrawal by Subject|8
1389767|NCT01316900|4586089|P1|Overall Study|Withdrawal by Subject|7
1389768|NCT01316900|4586086|P4|Overall Study|Lost to Follow-up|1
1389769|NCT01316900|4586087|P3|Overall Study|Lost to Follow-up|1
1389770|NCT01316900|4586088|P2|Overall Study|Lost to Follow-up|0
1389771|NCT01316900|4586089|P1|Overall Study|Lost to Follow-up|1
1389772|NCT01316900|4586086|P4|Overall Study|Protocol-defined Stopping Criteria|5
1389773|NCT01316900|4586087|P3|Overall Study|Protocol-defined Stopping Criteria|10
1389774|NCT01316900|4586088|P2|Overall Study|Protocol-defined Stopping Criteria|3
1389775|NCT01316900|4586089|P1|Overall Study|Protocol-defined Stopping Criteria|2
1389776|NCT01316900|4586086|P4|Overall Study|Protocol Violation|0
1389777|NCT01316900|4586087|P3|Overall Study|Protocol Violation|4
1389778|NCT01316900|4586088|P2|Overall Study|Protocol Violation|1
1389779|NCT01316900|4586089|P1|Overall Study|Protocol Violation|7
1389780|NCT01316900|4586086|P4|Overall Study|Lack of Efficacy|7
1389781|NCT01316900|4586087|P3|Overall Study|Lack of Efficacy|5
1389782|NCT01316900|4586088|P2|Overall Study|Lack of Efficacy|9
1389783|NCT01316900|4586089|P1|Overall Study|Lack of Efficacy|17
1389784|NCT01316900|4586086|P4|Overall Study|Adverse Event|9
1389785|NCT01316900|4586087|P3|Overall Study|Adverse Event|15
1389786|NCT01316900|4586088|P2|Overall Study|Adverse Event|10
1389787|NCT01316900|4586089|P1|Overall Study|Adverse Event|10
1389788|NCT01316887|4586110|P3|Overall Study|Withdrawal by Subject|15
1389789|NCT01316887|4586111|P2|Overall Study|Withdrawal by Subject|16
1389790|NCT01316887|4586112|P1|Overall Study|Withdrawal by Subject|8
1389791|NCT01316887|4586110|P3|Overall Study|Lost to Follow-up|5
1389792|NCT01316887|4586111|P2|Overall Study|Lost to Follow-up|7
1389793|NCT01316887|4586112|P1|Overall Study|Lost to Follow-up|1
1389794|NCT01316887|4586110|P3|Overall Study|Study Closed/Terminated|3
1389795|NCT01316887|4586111|P2|Overall Study|Study Closed/Terminated|4
1389796|NCT01316887|4586112|P1|Overall Study|Study Closed/Terminated|2
1389797|NCT01316887|4586110|P3|Overall Study|Protocol-defined Stopping Criteria|36
1389798|NCT01316887|4586111|P2|Overall Study|Protocol-defined Stopping Criteria|37
1389799|NCT01316887|4586112|P1|Overall Study|Protocol-defined Stopping Criteria|8
1389800|NCT01316887|4586110|P3|Overall Study|Protocol Violation|6
1389801|NCT01316887|4586111|P2|Overall Study|Protocol Violation|6
1389802|NCT01316887|4586112|P1|Overall Study|Protocol Violation|2
1389803|NCT01316887|4586110|P3|Overall Study|Lack of Efficacy|1
1389804|NCT01316887|4586111|P2|Overall Study|Lack of Efficacy|3
1389805|NCT01316887|4586112|P1|Overall Study|Lack of Efficacy|9
1389806|NCT01316887|4586110|P3|Overall Study|Adverse Event|17
1389807|NCT01316887|4586111|P2|Overall Study|Adverse Event|21
1389808|NCT01316887|4586112|P1|Overall Study|Adverse Event|13
1389809|NCT01316692|4586174|P1|Overall Study|Disease Progression|7
1389810|NCT01316692|4586174|P1|Overall Study|Adverse Event|5
1389811|NCT01316614|4586183|P1|Overall Study|Medically unstable|1
1389812|NCT01316614|4586183|P1|Overall Study|Inadequate number of passes|2
1389813|NCT01316614|4586183|P1|Overall Study|Cystic lesion|5
1389814|NCT01316614|4586183|P1|Overall Study|Cytology slides not available for review|4
1389815|NCT01316614|4586183|P1|Overall Study|No solid lesion and FNA not indicated|25
1389816|NCT01316575|4586200|P2|Overall Study|Required alternate treatment|1
1389817|NCT01316575|4586201|P1|Overall Study|Required alternate treatment|0
1389818|NCT01316575|4586200|P2|Overall Study|Withdrawal by Subject|0
1389819|NCT01316575|4586201|P1|Overall Study|Withdrawal by Subject|2
1389820|NCT01316419|4586224|P1|Overall Study|Lost to Follow-up|19
1389821|NCT01316419|4586224|P1|Overall Study|Violated inclusion/exclusion criterion|143
1389822|NCT01316419|4586224|P1|Overall Study|Not treated|103
1389823|NCT01316380|4586250|P3|Overall Study|Not treated|0
1389824|NCT01316380|4586251|P2|Overall Study|Not treated|0
1389825|NCT01316380|4586252|P1|Overall Study|Not treated|1
1389826|NCT01316380|4586250|P3|Overall Study|Other|1
1389827|NCT01316380|4586251|P2|Overall Study|Other|1
1389828|NCT01316380|4586252|P1|Overall Study|Other|0
1389829|NCT01316380|4586250|P3|Overall Study|Withdrawal by Subject|0
1389830|NCT01316380|4586251|P2|Overall Study|Withdrawal by Subject|2
1389831|NCT01316380|4586252|P1|Overall Study|Withdrawal by Subject|1
1389832|NCT01316380|4586250|P3|Overall Study|Protocol Violation|1
1389833|NCT01316380|4586251|P2|Overall Study|Protocol Violation|0
1389834|NCT01316380|4586252|P1|Overall Study|Protocol Violation|0
1389835|NCT01316380|4586250|P3|Overall Study|Adverse Event|1
1389836|NCT01316380|4586251|P2|Overall Study|Adverse Event|2
1389837|NCT01316380|4586252|P1|Overall Study|Adverse Event|0
1389838|NCT01316224|4586418|P1|Overall Study|Not Specified|1
1389839|NCT01316224|4586418|P1|Overall Study|Adverse Event With Treatment Failure|1
1389840|NCT01316224|4586418|P1|Overall Study|Withdrawal by Subject|1
1389841|NCT01316224|4586418|P1|Overall Study|Lack of Efficacy|1
1389842|NCT01316224|4586418|P1|Overall Study|Adverse Event|3
1389843|NCT01316224|4586418|P1|Overall Study|Protocol Violation|3
1389844|NCT01316055|4586435|P3|Overall Study|Lost to Follow-up|0
1389845|NCT01316055|4586436|P2|Overall Study|Lost to Follow-up|0
1389846|NCT01316055|4586437|P1|Overall Study|Lost to Follow-up|1
1389847|NCT01315847|4586468|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
1389848|NCT01315847|4586469|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
1389849|NCT01315847|4586468|P2|Part I, Period 1|Reached maximum number of arterial lines|0
1389850|NCT01315847|4586469|P1|Part I, Period 1|Reached maximum number of arterial lines|3
1389851|NCT01315353|4586514|P3|Overall Study|Inadvertent randomization/assignment|2
1389852|NCT01315353|4586515|P2|Overall Study|Inadvertent randomization/assignment|0
1389853|NCT01315353|4586516|P1|Overall Study|Inadvertent randomization/assignment|0
1389854|NCT01315353|4586514|P3|Overall Study|Taken off study by site in error|0
1389855|NCT01315353|4586515|P2|Overall Study|Taken off study by site in error|1
1389856|NCT01315353|4586516|P1|Overall Study|Taken off study by site in error|0
1389857|NCT01315353|4586514|P3|Overall Study|Site closing|0
1389858|NCT01315353|4586515|P2|Overall Study|Site closing|4
1389859|NCT01315353|4586516|P1|Overall Study|Site closing|7
1389860|NCT01315353|4586514|P3|Overall Study|Unwilling to adhere to requirements|4
1389861|NCT01315353|4586515|P2|Overall Study|Unwilling to adhere to requirements|5
1389862|NCT01315353|4586516|P1|Overall Study|Unwilling to adhere to requirements|5
1389863|NCT01315353|4586514|P3|Overall Study|Lost to Follow-up|6
1389864|NCT01315353|4586515|P2|Overall Study|Lost to Follow-up|6
1389865|NCT01315353|4586516|P1|Overall Study|Lost to Follow-up|13
1389866|NCT01315353|4586514|P3|Overall Study|Withdrawal by Subject|1
1389867|NCT01315353|4586515|P2|Overall Study|Withdrawal by Subject|6
1389868|NCT01315353|4586516|P1|Overall Study|Withdrawal by Subject|2
1389869|NCT01315353|4586514|P3|Overall Study|Death|0
1389870|NCT01315353|4586515|P2|Overall Study|Death|1
1389871|NCT01315353|4586516|P1|Overall Study|Death|2
1389872|NCT01315249|4586543|P2|Overall Study|Death|1
1389873|NCT01315249|4586544|P1|Overall Study|Death|0
1389874|NCT01315249|4586543|P2|Overall Study|Lost to Follow-up|2
1389875|NCT01315249|4586544|P1|Overall Study|Lost to Follow-up|0
1389876|NCT01315249|4586543|P2|Overall Study|Lack of Efficacy|1
1389877|NCT01315249|4586544|P1|Overall Study|Lack of Efficacy|0
1389878|NCT01315249|4586543|P2|Overall Study|inability to use device|0
1389879|NCT01315249|4586544|P1|Overall Study|inability to use device|1
1389880|NCT01315249|4586543|P2|Overall Study|Administrative problems|0
1389881|NCT01315249|4586544|P1|Overall Study|Administrative problems|1
1389882|NCT01315249|4586543|P2|Overall Study|Abnormal test results|2
1389883|NCT01315249|4586544|P1|Overall Study|Abnormal test results|1
1389884|NCT01315249|4586543|P2|Overall Study|Protocol Violation|5
1389885|NCT01315249|4586544|P1|Overall Study|Protocol Violation|8
1389886|NCT01315249|4586543|P2|Overall Study|Withdrawal by Subject|10
1389887|NCT01315249|4586544|P1|Overall Study|Withdrawal by Subject|11
1389888|NCT01315249|4586543|P2|Overall Study|Adverse Event|26
1389889|NCT01315249|4586544|P1|Overall Study|Adverse Event|22
1389890|NCT01315028|4586606|P2|Overall Study|Death|1
1389891|NCT01315028|4586607|P1|Overall Study|Death|0
1389892|NCT01315028|4586606|P2|Overall Study|Lost to Follow-up|0
1389893|NCT01315028|4586607|P1|Overall Study|Lost to Follow-up|1
1389894|NCT01314872|4586643|P15|Period 2|Lost to Follow-up|6
1389895|NCT01314872|4586644|P14|Period 2|Lost to Follow-up|2
1389896|NCT01314872|4586645|P13|Period 2|Lost to Follow-up|7
1389897|NCT01314872|4586646|P12|Period 2|Lost to Follow-up|6
1389898|NCT01314872|4586647|P11|Period 2|Lost to Follow-up|0
1389899|NCT01314872|4586648|P10|Period 2|Lost to Follow-up|0
1389900|NCT01314872|4586649|P9|Period 2|Lost to Follow-up|0
1389901|NCT01314872|4586650|P8|Period 2|Lost to Follow-up|0
1389902|NCT01314872|4586651|P7|Period 2|Lost to Follow-up|0
1389903|NCT01314872|4586652|P6|Period 2|Lost to Follow-up|0
1389904|NCT01314872|4586653|P5|Period 2|Lost to Follow-up|0
1389905|NCT01314872|4586654|P4|Period 2|Lost to Follow-up|0
1389906|NCT01314872|4586655|P3|Period 2|Lost to Follow-up|0
1389907|NCT01314872|4586656|P2|Period 2|Lost to Follow-up|0
1389908|NCT01314872|4586657|P1|Period 2|Lost to Follow-up|0
1389909|NCT01314872|4586643|P15|Period 2|Withdrawal by Subject|4
1389910|NCT01314872|4586644|P14|Period 2|Withdrawal by Subject|12
1389911|NCT01314872|4586645|P13|Period 2|Withdrawal by Subject|17
1389912|NCT01314872|4586646|P12|Period 2|Withdrawal by Subject|14
1389913|NCT01314872|4586647|P11|Period 2|Withdrawal by Subject|0
1389914|NCT01314872|4586648|P10|Period 2|Withdrawal by Subject|0
1389915|NCT01314872|4586649|P9|Period 2|Withdrawal by Subject|0
1389916|NCT01314872|4586650|P8|Period 2|Withdrawal by Subject|0
1389917|NCT01314872|4586651|P7|Period 2|Withdrawal by Subject|0
1389918|NCT01314872|4586652|P6|Period 2|Withdrawal by Subject|0
1389919|NCT01314872|4586653|P5|Period 2|Withdrawal by Subject|0
1389920|NCT01314872|4586654|P4|Period 2|Withdrawal by Subject|0
1389921|NCT01314872|4586655|P3|Period 2|Withdrawal by Subject|0
1389922|NCT01314872|4586656|P2|Period 2|Withdrawal by Subject|0
1389923|NCT01314872|4586657|P1|Period 2|Withdrawal by Subject|0
1389924|NCT01314872|4586643|P15|Period 2|Adverse event, non-fatal|9
1389925|NCT01314872|4586644|P14|Period 2|Adverse event, non-fatal|24
1389926|NCT01314872|4586645|P13|Period 2|Adverse event, non-fatal|16
1389927|NCT01314872|4586646|P12|Period 2|Adverse event, non-fatal|13
1389928|NCT01314872|4586647|P11|Period 2|Adverse event, non-fatal|0
1389929|NCT01314872|4586648|P10|Period 2|Adverse event, non-fatal|0
1389930|NCT01314872|4586649|P9|Period 2|Adverse event, non-fatal|0
1389931|NCT01314872|4586650|P8|Period 2|Adverse event, non-fatal|0
1389932|NCT01314872|4586651|P7|Period 2|Adverse event, non-fatal|0
1389933|NCT01314872|4586652|P6|Period 2|Adverse event, non-fatal|0
1389934|NCT01314872|4586653|P5|Period 2|Adverse event, non-fatal|0
1389935|NCT01314872|4586654|P4|Period 2|Adverse event, non-fatal|0
1389936|NCT01314872|4586655|P3|Period 2|Adverse event, non-fatal|0
1389937|NCT01314872|4586656|P2|Period 2|Adverse event, non-fatal|0
1389938|NCT01314872|4586657|P1|Period 2|Adverse event, non-fatal|0
1389939|NCT01314872|4586643|P15|Period 2|Study terminated by Sponsor|0
1389940|NCT01314872|4586644|P14|Period 2|Study terminated by Sponsor|3
1389941|NCT01314872|4586645|P13|Period 2|Study terminated by Sponsor|2
1389942|NCT01314872|4586646|P12|Period 2|Study terminated by Sponsor|2
1389943|NCT01314872|4586647|P11|Period 2|Study terminated by Sponsor|0
1389944|NCT01314872|4586648|P10|Period 2|Study terminated by Sponsor|0
1389945|NCT01314872|4586649|P9|Period 2|Study terminated by Sponsor|0
1389946|NCT01314872|4586650|P8|Period 2|Study terminated by Sponsor|0
1389947|NCT01314872|4586651|P7|Period 2|Study terminated by Sponsor|0
1389948|NCT01314872|4586652|P6|Period 2|Study terminated by Sponsor|0
1389949|NCT01314872|4586653|P5|Period 2|Study terminated by Sponsor|0
1389950|NCT01314872|4586654|P4|Period 2|Study terminated by Sponsor|0
1389951|NCT01314872|4586655|P3|Period 2|Study terminated by Sponsor|0
1389952|NCT01314872|4586656|P2|Period 2|Study terminated by Sponsor|0
1389953|NCT01314872|4586657|P1|Period 2|Study terminated by Sponsor|0
1389954|NCT01314872|4586643|P15|Period 2|Pregnancy|1
1389955|NCT01314872|4586644|P14|Period 2|Pregnancy|0
1389956|NCT01314872|4586645|P13|Period 2|Pregnancy|0
1389957|NCT01314872|4586646|P12|Period 2|Pregnancy|0
1389958|NCT01314872|4586647|P11|Period 2|Pregnancy|0
1389959|NCT01314872|4586648|P10|Period 2|Pregnancy|0
1389960|NCT01314872|4586649|P9|Period 2|Pregnancy|0
1389961|NCT01314872|4586650|P8|Period 2|Pregnancy|0
1389962|NCT01314872|4586651|P7|Period 2|Pregnancy|0
1389963|NCT01314872|4586652|P6|Period 2|Pregnancy|0
1389964|NCT01314872|4586653|P5|Period 2|Pregnancy|0
1389965|NCT01314872|4586654|P4|Period 2|Pregnancy|0
1389966|NCT01314872|4586655|P3|Period 2|Pregnancy|0
1389967|NCT01314872|4586656|P2|Period 2|Pregnancy|0
1389968|NCT01314872|4586657|P1|Period 2|Pregnancy|0
1389969|NCT01314872|4586643|P15|Period 2|Lack of Efficacy|2
1389970|NCT01314872|4586644|P14|Period 2|Lack of Efficacy|9
1389971|NCT01314872|4586645|P13|Period 2|Lack of Efficacy|12
1389972|NCT01314872|4586646|P12|Period 2|Lack of Efficacy|7
1389973|NCT01314872|4586647|P11|Period 2|Lack of Efficacy|0
1389974|NCT01314872|4586648|P10|Period 2|Lack of Efficacy|0
1389975|NCT01314872|4586649|P9|Period 2|Lack of Efficacy|0
1389976|NCT01314872|4586650|P8|Period 2|Lack of Efficacy|0
1389977|NCT01314872|4586651|P7|Period 2|Lack of Efficacy|0
1389978|NCT01314872|4586652|P6|Period 2|Lack of Efficacy|0
1389979|NCT01314872|4586653|P5|Period 2|Lack of Efficacy|0
1389980|NCT01314872|4586654|P4|Period 2|Lack of Efficacy|0
1389981|NCT01314872|4586655|P3|Period 2|Lack of Efficacy|0
1389982|NCT01314872|4586656|P2|Period 2|Lack of Efficacy|0
1389983|NCT01314872|4586657|P1|Period 2|Lack of Efficacy|0
1389984|NCT01314872|4586643|P15|Period 2|Non-compliance with study drug|2
1389985|NCT01314872|4586644|P14|Period 2|Non-compliance with study drug|1
1389986|NCT01314872|4586645|P13|Period 2|Non-compliance with study drug|3
1389987|NCT01314872|4586646|P12|Period 2|Non-compliance with study drug|3
1389988|NCT01314872|4586647|P11|Period 2|Non-compliance with study drug|0
1389989|NCT01314872|4586648|P10|Period 2|Non-compliance with study drug|0
1389990|NCT01314872|4586649|P9|Period 2|Non-compliance with study drug|0
1389991|NCT01314872|4586650|P8|Period 2|Non-compliance with study drug|0
1389992|NCT01314872|4586651|P7|Period 2|Non-compliance with study drug|0
1389993|NCT01314872|4586652|P6|Period 2|Non-compliance with study drug|0
1389994|NCT01314872|4586653|P5|Period 2|Non-compliance with study drug|0
1389995|NCT01314872|4586654|P4|Period 2|Non-compliance with study drug|0
1389996|NCT01314872|4586655|P3|Period 2|Non-compliance with study drug|0
1389997|NCT01314872|4586656|P2|Period 2|Non-compliance with study drug|0
1389998|NCT01314872|4586657|P1|Period 2|Non-compliance with study drug|0
1389999|NCT01314872|4586643|P15|Period 2|Protocol Violation|0
1390000|NCT01314872|4586644|P14|Period 2|Protocol Violation|2
1390001|NCT01314872|4586645|P13|Period 2|Protocol Violation|3
1390002|NCT01314872|4586646|P12|Period 2|Protocol Violation|3
1390003|NCT01314872|4586647|P11|Period 2|Protocol Violation|0
1390004|NCT01314872|4586648|P10|Period 2|Protocol Violation|0
1390005|NCT01314872|4586649|P9|Period 2|Protocol Violation|0
1390006|NCT01314872|4586650|P8|Period 2|Protocol Violation|0
1390007|NCT01314872|4586651|P7|Period 2|Protocol Violation|0
1390008|NCT01314872|4586652|P6|Period 2|Protocol Violation|0
1390009|NCT01314872|4586653|P5|Period 2|Protocol Violation|0
1390010|NCT01314872|4586654|P4|Period 2|Protocol Violation|0
1390011|NCT01314872|4586655|P3|Period 2|Protocol Violation|0
1390012|NCT01314872|4586656|P2|Period 2|Protocol Violation|0
1390013|NCT01314872|4586657|P1|Period 2|Protocol Violation|0
1390014|NCT01314872|4586643|P15|Treatment Period 1|Lost to Follow-up|0
1390015|NCT01314872|4586644|P14|Treatment Period 1|Lost to Follow-up|0
1390016|NCT01314872|4586645|P13|Treatment Period 1|Lost to Follow-up|0
1390017|NCT01314872|4586646|P12|Treatment Period 1|Lost to Follow-up|0
1390018|NCT01314872|4586647|P11|Treatment Period 1|Lost to Follow-up|0
1390019|NCT01314872|4586648|P10|Treatment Period 1|Lost to Follow-up|0
1390020|NCT01314872|4586649|P9|Treatment Period 1|Lost to Follow-up|1
1390021|NCT01314872|4586650|P8|Treatment Period 1|Lost to Follow-up|1
1390022|NCT01314872|4586651|P7|Treatment Period 1|Lost to Follow-up|1
1390023|NCT01314872|4586652|P6|Treatment Period 1|Lost to Follow-up|1
1390024|NCT01314872|4586653|P5|Treatment Period 1|Lost to Follow-up|1
1390025|NCT01314872|4586654|P4|Treatment Period 1|Lost to Follow-up|2
1390026|NCT01314872|4586655|P3|Treatment Period 1|Lost to Follow-up|2
1390027|NCT01314872|4586656|P2|Treatment Period 1|Lost to Follow-up|1
1390028|NCT01314872|4586657|P1|Treatment Period 1|Lost to Follow-up|0
1390029|NCT01314872|4586643|P15|Treatment Period 1|Withdrawal by Subject|0
1390030|NCT01314872|4586644|P14|Treatment Period 1|Withdrawal by Subject|0
1390031|NCT01314872|4586645|P13|Treatment Period 1|Withdrawal by Subject|0
1390032|NCT01314872|4586646|P12|Treatment Period 1|Withdrawal by Subject|0
1390033|NCT01314872|4586647|P11|Treatment Period 1|Withdrawal by Subject|1
1390034|NCT01314872|4586648|P10|Treatment Period 1|Withdrawal by Subject|2
1390035|NCT01314872|4586649|P9|Treatment Period 1|Withdrawal by Subject|2
1390036|NCT01314872|4586650|P8|Treatment Period 1|Withdrawal by Subject|2
1390037|NCT01314872|4586651|P7|Treatment Period 1|Withdrawal by Subject|3
1390038|NCT01314872|4586652|P6|Treatment Period 1|Withdrawal by Subject|1
1390039|NCT01314872|4586653|P5|Treatment Period 1|Withdrawal by Subject|3
1390040|NCT01314872|4586654|P4|Treatment Period 1|Withdrawal by Subject|2
1390041|NCT01314872|4586655|P3|Treatment Period 1|Withdrawal by Subject|0
1390042|NCT01314872|4586656|P2|Treatment Period 1|Withdrawal by Subject|1
1390043|NCT01314872|4586657|P1|Treatment Period 1|Withdrawal by Subject|3
1390044|NCT01314872|4586643|P15|Treatment Period 1|Adverse event, non-fatal|0
1390045|NCT01314872|4586644|P14|Treatment Period 1|Adverse event, non-fatal|0
1390046|NCT01314872|4586645|P13|Treatment Period 1|Adverse event, non-fatal|0
1390047|NCT01314872|4586646|P12|Treatment Period 1|Adverse event, non-fatal|0
1390048|NCT01314872|4586647|P11|Treatment Period 1|Adverse event, non-fatal|1
1390049|NCT01314872|4586648|P10|Treatment Period 1|Adverse event, non-fatal|0
1390050|NCT01314872|4586649|P9|Treatment Period 1|Adverse event, non-fatal|3
1390051|NCT01314872|4586650|P8|Treatment Period 1|Adverse event, non-fatal|2
1390052|NCT01314872|4586651|P7|Treatment Period 1|Adverse event, non-fatal|4
1390053|NCT01314872|4586652|P6|Treatment Period 1|Adverse event, non-fatal|4
1390054|NCT01314872|4586653|P5|Treatment Period 1|Adverse event, non-fatal|2
1390055|NCT01314872|4586654|P4|Treatment Period 1|Adverse event, non-fatal|2
1390056|NCT01314872|4586655|P3|Treatment Period 1|Adverse event, non-fatal|3
1390057|NCT01314872|4586656|P2|Treatment Period 1|Adverse event, non-fatal|2
1390058|NCT01314872|4586657|P1|Treatment Period 1|Adverse event, non-fatal|4
1390059|NCT01314872|4586643|P15|Treatment Period 1|Lack of Efficacy|0
1390060|NCT01314872|4586644|P14|Treatment Period 1|Lack of Efficacy|0
1390061|NCT01314872|4586645|P13|Treatment Period 1|Lack of Efficacy|0
1390062|NCT01314872|4586646|P12|Treatment Period 1|Lack of Efficacy|0
1390063|NCT01314872|4586647|P11|Treatment Period 1|Lack of Efficacy|0
1390064|NCT01314872|4586648|P10|Treatment Period 1|Lack of Efficacy|0
1390065|NCT01314872|4586649|P9|Treatment Period 1|Lack of Efficacy|0
1390066|NCT01314872|4586650|P8|Treatment Period 1|Lack of Efficacy|2
1390067|NCT01314872|4586651|P7|Treatment Period 1|Lack of Efficacy|0
1390068|NCT01314872|4586652|P6|Treatment Period 1|Lack of Efficacy|1
1390069|NCT01314872|4586653|P5|Treatment Period 1|Lack of Efficacy|0
1390070|NCT01314872|4586654|P4|Treatment Period 1|Lack of Efficacy|0
1390071|NCT01314872|4586655|P3|Treatment Period 1|Lack of Efficacy|0
1390072|NCT01314872|4586656|P2|Treatment Period 1|Lack of Efficacy|0
1390073|NCT01314872|4586657|P1|Treatment Period 1|Lack of Efficacy|1
1390074|NCT01314872|4586643|P15|Treatment Period 1|Physician Decision|0
1390075|NCT01314872|4586644|P14|Treatment Period 1|Physician Decision|0
1390076|NCT01314872|4586645|P13|Treatment Period 1|Physician Decision|0
1390077|NCT01314872|4586646|P12|Treatment Period 1|Physician Decision|0
1390078|NCT01314872|4586647|P11|Treatment Period 1|Physician Decision|0
1390079|NCT01314872|4586648|P10|Treatment Period 1|Physician Decision|1
1390080|NCT01314872|4586649|P9|Treatment Period 1|Physician Decision|0
1390081|NCT01314872|4586650|P8|Treatment Period 1|Physician Decision|0
1390082|NCT01314872|4586651|P7|Treatment Period 1|Physician Decision|0
1390083|NCT01314872|4586652|P6|Treatment Period 1|Physician Decision|0
1390084|NCT01314872|4586653|P5|Treatment Period 1|Physician Decision|0
1390085|NCT01314872|4586654|P4|Treatment Period 1|Physician Decision|1
1390086|NCT01314872|4586655|P3|Treatment Period 1|Physician Decision|0
1390087|NCT01314872|4586656|P2|Treatment Period 1|Physician Decision|1
1390088|NCT01314872|4586657|P1|Treatment Period 1|Physician Decision|0
1390089|NCT01314872|4586643|P15|Treatment Period 1|Protocol Violation|0
1390090|NCT01314872|4586644|P14|Treatment Period 1|Protocol Violation|0
1390091|NCT01314872|4586645|P13|Treatment Period 1|Protocol Violation|0
1390092|NCT01314872|4586646|P12|Treatment Period 1|Protocol Violation|0
1390093|NCT01314872|4586647|P11|Treatment Period 1|Protocol Violation|1
1390094|NCT01314872|4586648|P10|Treatment Period 1|Protocol Violation|1
1390095|NCT01314872|4586649|P9|Treatment Period 1|Protocol Violation|0
1390096|NCT01314872|4586650|P8|Treatment Period 1|Protocol Violation|0
1390097|NCT01314872|4586651|P7|Treatment Period 1|Protocol Violation|0
1390098|NCT01314872|4586652|P6|Treatment Period 1|Protocol Violation|0
1390099|NCT01314872|4586653|P5|Treatment Period 1|Protocol Violation|1
1390100|NCT01314872|4586654|P4|Treatment Period 1|Protocol Violation|0
1390101|NCT01314872|4586655|P3|Treatment Period 1|Protocol Violation|1
1390102|NCT01314872|4586656|P2|Treatment Period 1|Protocol Violation|1
1390103|NCT01314872|4586657|P1|Treatment Period 1|Protocol Violation|2
1390104|NCT01314716|4586761|P2|Open-Label Phase|Physician Decision|4
1390105|NCT01314716|4586762|P1|Open-Label Phase|Physician Decision|5
1390106|NCT01314716|4586761|P2|Open-Label Phase|Withdrawal by Subject|2
1390107|NCT01314716|4586762|P1|Open-Label Phase|Withdrawal by Subject|1
1390108|NCT01314716|4586761|P2|Open-Label Phase|Adverse Event|6
1390109|NCT01314716|4586762|P1|Open-Label Phase|Adverse Event|4
1390110|NCT01314716|4586761|P2|Double-Blind Phase|Physician Decision|1
1390111|NCT01314716|4586762|P1|Double-Blind Phase|Physician Decision|0
1390112|NCT01314716|4586761|P2|Double-Blind Phase|Sponsor request|2
1390113|NCT01314716|4586762|P1|Double-Blind Phase|Sponsor request|1
1390114|NCT01314716|4586761|P2|Double-Blind Phase|Lost to Follow-up|1
1390115|NCT01314716|4586762|P1|Double-Blind Phase|Lost to Follow-up|0
1390116|NCT01314716|4586761|P2|Double-Blind Phase|Withdrawal by Subject|6
1390117|NCT01314716|4586762|P1|Double-Blind Phase|Withdrawal by Subject|5
1390118|NCT01314716|4586761|P2|Double-Blind Phase|Adverse Event|4
1390119|NCT01314716|4586762|P1|Double-Blind Phase|Adverse Event|10
1390120|NCT01314716|4586761|P2|Double-Blind Phase|Randomized but not treated|1
1390121|NCT01314716|4586762|P1|Double-Blind Phase|Randomized but not treated|1
1390122|NCT01314703|4586774|P1|Overall Study|screen failure and closed enrollment|8
1390123|NCT01314443|4586783|P4|Overall Study|Protocol Violation|1
1390124|NCT01314443|4586784|P3|Overall Study|Protocol Violation|1
1390125|NCT01314443|4586785|P2|Overall Study|Protocol Violation|2
1390126|NCT01314443|4586786|P1|Overall Study|Protocol Violation|2
1390127|NCT01314443|4586783|P4|Overall Study|Withdrawal by Subject|1
1390128|NCT01314443|4586784|P3|Overall Study|Withdrawal by Subject|1
1390129|NCT01314443|4586785|P2|Overall Study|Withdrawal by Subject|1
1390130|NCT01314443|4586786|P1|Overall Study|Withdrawal by Subject|2
1390131|NCT01314261|4586856|P4|Overall Study|Virologic Failure|1
1390132|NCT01314261|4586857|P3|Overall Study|Virologic Failure|0
1390133|NCT01314261|4586858|P2|Overall Study|Virologic Failure|1
1390134|NCT01314261|4586859|P1|Overall Study|Virologic Failure|0
1390135|NCT01314261|4586856|P4|Overall Study|Lost to Follow-up|2
1390136|NCT01314261|4586857|P3|Overall Study|Lost to Follow-up|2
1390137|NCT01314261|4586858|P2|Overall Study|Lost to Follow-up|0
1390138|NCT01314261|4586859|P1|Overall Study|Lost to Follow-up|1
1390139|NCT01314261|4586856|P4|Overall Study|Withdrawal by Subject|0
1390140|NCT01314261|4586857|P3|Overall Study|Withdrawal by Subject|1
1390141|NCT01314261|4586858|P2|Overall Study|Withdrawal by Subject|3
1390142|NCT01314261|4586859|P1|Overall Study|Withdrawal by Subject|0
1390143|NCT01314261|4586856|P4|Overall Study|Adverse Event|0
1390144|NCT01314261|4586857|P3|Overall Study|Adverse Event|0
1390145|NCT01314261|4586858|P2|Overall Study|Adverse Event|0
1390146|NCT01314261|4586859|P1|Overall Study|Adverse Event|1
1390147|NCT01314118|4586910|P1|Overall Study|Ongoing|62
1390148|NCT01314118|4586910|P1|Overall Study|Other|2
1390149|NCT01314118|4586910|P1|Overall Study|Withdrawal by Subject|11
1390150|NCT01314118|4586910|P1|Overall Study|Protocol Violation|5
1390151|NCT01314118|4586910|P1|Overall Study|Death|4
1390152|NCT01314118|4586910|P1|Overall Study|Physician Decision|11
1390153|NCT01314118|4586910|P1|Overall Study|Progressive disease|27
1390154|NCT01314118|4586910|P1|Overall Study|Adverse Event|9
1390155|NCT01314105|4586919|P2|Overall Study|Other Adverse Event|1
1390156|NCT01314105|4586920|P1|Overall Study|Other Adverse Event|1
1390157|NCT01314105|4586919|P2|Overall Study|Refused to continue taking medication|1
1390158|NCT01314105|4586920|P1|Overall Study|Refused to continue taking medication|0
1390159|NCT01314105|4586919|P2|Overall Study|Progressive Disease|10
1390160|NCT01314105|4586920|P1|Overall Study|Progressive Disease|6
1390161|NCT01313923|4587033|P1|Overall Study|Physician Decision|3
1390162|NCT01313884|4587049|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
1390163|NCT01313858|4587057|P3|Overall Study|Lost to Follow-up|47
1390164|NCT01313858|4587058|P2|Overall Study|Lost to Follow-up|51
1390165|NCT01313858|4587059|P1|Overall Study|Lost to Follow-up|35
1390166|NCT01313858|4587057|P3|Overall Study|Premature Treatment Termination|191
1390167|NCT01313858|4587058|P2|Overall Study|Premature Treatment Termination|219
1390168|NCT01313858|4587059|P1|Overall Study|Premature Treatment Termination|251
1390169|NCT01313780|4587082|P2|Overall Study|missing data|3
1390170|NCT01313780|4587083|P1|Overall Study|missing data|3
1390171|NCT01313780|4587082|P2|Overall Study|Protocol Violation|4
1390172|NCT01313780|4587083|P1|Overall Study|Protocol Violation|10
1390173|NCT01313780|4587082|P2|Overall Study|Withdrawal by Subject|8
1390174|NCT01313780|4587083|P1|Overall Study|Withdrawal by Subject|2
1390175|NCT01313780|4587082|P2|Overall Study|Adverse Event|11
1390176|NCT01313780|4587083|P1|Overall Study|Adverse Event|6
1390177|NCT01313780|4587082|P2|Overall Study|Lack of Efficacy|2
1390178|NCT01313780|4587083|P1|Overall Study|Lack of Efficacy|4
1390179|NCT01313728|4587091|P1|Informed Consent to Baseline|Withdrawal by Subject|1
1390180|NCT01313689|4587111|P5|24-Week Randomization 2|Physician Decision|4
1390181|NCT01313689|4587112|P4|24-Week Randomization 2|Physician Decision|0
1390182|NCT01313689|4587113|P3|24-Week Randomization 2|Physician Decision|0
1390183|NCT01313689|4587114|P2|24-Week Randomization 2|Physician Decision|0
1390184|NCT01313689|4587115|P1|24-Week Randomization 2|Physician Decision|0
1390185|NCT01313689|4587111|P5|24-Week Randomization 2|Withdrawal by Subject|3
1390186|NCT01313689|4587112|P4|24-Week Randomization 2|Withdrawal by Subject|1
1390187|NCT01313689|4587113|P3|24-Week Randomization 2|Withdrawal by Subject|1
1390188|NCT01313689|4587114|P2|24-Week Randomization 2|Withdrawal by Subject|0
1390189|NCT01313689|4587115|P1|24-Week Randomization 2|Withdrawal by Subject|0
1390190|NCT01313689|4587111|P5|24-Week Randomization 2|Adverse Event|8
1390191|NCT01313689|4587112|P4|24-Week Randomization 2|Adverse Event|0
1390192|NCT01313689|4587113|P3|24-Week Randomization 2|Adverse Event|2
1390193|NCT01313689|4587114|P2|24-Week Randomization 2|Adverse Event|0
1390194|NCT01313689|4587115|P1|24-Week Randomization 2|Adverse Event|0
1390195|NCT01313689|4587111|P5|24-Week Randomization 1|Withdrawal by Subject|0
1390196|NCT01313689|4587112|P4|24-Week Randomization 1|Withdrawal by Subject|0
1390197|NCT01313689|4587113|P3|24-Week Randomization 1|Withdrawal by Subject|0
1390198|NCT01313689|4587114|P2|24-Week Randomization 1|Withdrawal by Subject|0
1390199|NCT01313689|4587115|P1|24-Week Randomization 1|Withdrawal by Subject|5
1390200|NCT01313689|4587111|P5|24-Week Randomization 1|Physician Decision|0
1390201|NCT01313689|4587112|P4|24-Week Randomization 1|Physician Decision|0
1390202|NCT01313689|4587113|P3|24-Week Randomization 1|Physician Decision|0
1390203|NCT01313689|4587114|P2|24-Week Randomization 1|Physician Decision|5
1390204|NCT01313689|4587115|P1|24-Week Randomization 1|Physician Decision|4
1390205|NCT01313689|4587111|P5|24-Week Randomization 1|Adverse Event|0
1390206|NCT01313689|4587112|P4|24-Week Randomization 1|Adverse Event|0
1390207|NCT01313689|4587113|P3|24-Week Randomization 1|Adverse Event|0
1390208|NCT01313689|4587114|P2|24-Week Randomization 1|Adverse Event|5
1390209|NCT01313689|4587115|P1|24-Week Randomization 1|Adverse Event|10
1390210|NCT01313676|4587194|P4|Overall Study|Missing|0
1390211|NCT01313676|4587195|P3|Overall Study|Missing|1
1390212|NCT01313676|4587196|P2|Overall Study|Missing|1
1390213|NCT01313676|4587197|P1|Overall Study|Missing|1
1390214|NCT01313676|4587194|P4|Overall Study|Investigator Site Closed|10
1390215|NCT01313676|4587195|P3|Overall Study|Investigator Site Closed|15
1390216|NCT01313676|4587196|P2|Overall Study|Investigator Site Closed|11
1390217|NCT01313676|4587197|P1|Overall Study|Investigator Site Closed|12
1390218|NCT01313676|4587194|P4|Overall Study|Sponsor Terminated Study Treatment|1
1390219|NCT01313676|4587195|P3|Overall Study|Sponsor Terminated Study Treatment|0
1390220|NCT01313676|4587196|P2|Overall Study|Sponsor Terminated Study Treatment|1
1390221|NCT01313676|4587197|P1|Overall Study|Sponsor Terminated Study Treatment|1
1390222|NCT01313676|4587194|P4|Overall Study|Decision by Participant or Proxy|492
1390223|NCT01313676|4587195|P3|Overall Study|Decision by Participant or Proxy|515
1390224|NCT01313676|4587196|P2|Overall Study|Decision by Participant or Proxy|527
1390225|NCT01313676|4587197|P1|Overall Study|Decision by Participant or Proxy|643
1390226|NCT01313676|4587194|P4|Overall Study|Physician Decision|48
1390227|NCT01313676|4587195|P3|Overall Study|Physician Decision|62
1390228|NCT01313676|4587196|P2|Overall Study|Physician Decision|64
1390229|NCT01313676|4587197|P1|Overall Study|Physician Decision|53
1390230|NCT01313676|4587194|P4|Overall Study|Lost to Follow-up|0
1390231|NCT01313676|4587195|P3|Overall Study|Lost to Follow-up|1
1390232|NCT01313676|4587196|P2|Overall Study|Lost to Follow-up|0
1390233|NCT01313676|4587197|P1|Overall Study|Lost to Follow-up|0
1390234|NCT01313676|4587194|P4|Overall Study|Study Closed/terminated|9
1390235|NCT01313676|4587195|P3|Overall Study|Study Closed/terminated|9
1390236|NCT01313676|4587196|P2|Overall Study|Study Closed/terminated|6
1390237|NCT01313676|4587197|P1|Overall Study|Study Closed/terminated|7
1390238|NCT01313676|4587194|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
1390239|NCT01313676|4587195|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
1390240|NCT01313676|4587196|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
1390241|NCT01313676|4587197|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
1390242|NCT01313676|4587194|P4|Overall Study|Protocol Violation|44
1390243|NCT01313676|4587195|P3|Overall Study|Protocol Violation|46
1390244|NCT01313676|4587196|P2|Overall Study|Protocol Violation|44
1390245|NCT01313676|4587197|P1|Overall Study|Protocol Violation|37
1390246|NCT01313676|4587194|P4|Overall Study|Lack of Efficacy|46
1390247|NCT01313676|4587195|P3|Overall Study|Lack of Efficacy|65
1390248|NCT01313676|4587196|P2|Overall Study|Lack of Efficacy|90
1390249|NCT01313676|4587197|P1|Overall Study|Lack of Efficacy|98
1390250|NCT01313676|4587194|P4|Overall Study|Adverse Event|333
1390251|NCT01313676|4587195|P3|Overall Study|Adverse Event|372
1390252|NCT01313676|4587196|P2|Overall Study|Adverse Event|365
1390253|NCT01313676|4587197|P1|Overall Study|Adverse Event|395
1390254|NCT01313663|4587217|P2|Overall Study|Withdrawal by Subject|1
1390255|NCT01313663|4587218|P1|Overall Study|Withdrawal by Subject|2
1390256|NCT01313663|4587217|P2|Overall Study|Physician Decision|2
1390257|NCT01313663|4587218|P1|Overall Study|Physician Decision|0
1390258|NCT01313663|4587217|P2|Overall Study|Lost to Follow-up|1
1390259|NCT01313663|4587218|P1|Overall Study|Lost to Follow-up|0
1390260|NCT01313663|4587217|P2|Overall Study|Study Closed/Terminated|4
1390261|NCT01313663|4587218|P1|Overall Study|Study Closed/Terminated|2
1390262|NCT01313650|4587256|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
1390263|NCT01313650|4587257|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
1390264|NCT01313650|4587258|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
1390265|NCT01313650|4587259|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
1390266|NCT01313650|4587256|P4|Overall Study|Protocol Violation|6
1390267|NCT01313650|4587257|P3|Overall Study|Protocol Violation|5
1390268|NCT01313650|4587258|P2|Overall Study|Protocol Violation|7
1390269|NCT01313650|4587259|P1|Overall Study|Protocol Violation|4
1390270|NCT01313650|4587256|P4|Overall Study|Withdrawal by Subject|15
1390271|NCT01313650|4587257|P3|Overall Study|Withdrawal by Subject|15
1390272|NCT01313650|4587258|P2|Overall Study|Withdrawal by Subject|20
1390273|NCT01313650|4587259|P1|Overall Study|Withdrawal by Subject|16
1390274|NCT01313650|4587256|P4|Overall Study|Lost to Follow-up|2
1390275|NCT01313650|4587257|P3|Overall Study|Lost to Follow-up|3
1390276|NCT01313650|4587258|P2|Overall Study|Lost to Follow-up|0
1390277|NCT01313650|4587259|P1|Overall Study|Lost to Follow-up|1
1390278|NCT01313650|4587256|P4|Overall Study|Lack of Efficacy|20
1390279|NCT01313650|4587257|P3|Overall Study|Lack of Efficacy|32
1390280|NCT01313650|4587258|P2|Overall Study|Lack of Efficacy|20
1390281|NCT01313650|4587259|P1|Overall Study|Lack of Efficacy|37
1390282|NCT01313650|4587256|P4|Overall Study|Adverse Event|23
1390283|NCT01313650|4587257|P3|Overall Study|Adverse Event|24
1390284|NCT01313650|4587258|P2|Overall Study|Adverse Event|34
1390285|NCT01313650|4587259|P1|Overall Study|Adverse Event|9
1390286|NCT01313637|4587285|P4|Overall Study|Withdrawal by Subject|15
1390287|NCT01313637|4587286|P3|Overall Study|Withdrawal by Subject|18
1390288|NCT01313637|4587287|P2|Overall Study|Withdrawal by Subject|13
1390289|NCT01313637|4587288|P1|Overall Study|Withdrawal by Subject|11
1390290|NCT01313637|4587285|P4|Overall Study|Lost to Follow-up|3
1390291|NCT01313637|4587286|P3|Overall Study|Lost to Follow-up|1
1390292|NCT01313637|4587287|P2|Overall Study|Lost to Follow-up|2
1390293|NCT01313637|4587288|P1|Overall Study|Lost to Follow-up|0
1390294|NCT01313637|4587285|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
1390295|NCT01313637|4587286|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
1390296|NCT01313637|4587287|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
1390297|NCT01313637|4587288|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
1390298|NCT01313637|4587285|P4|Overall Study|Protocol Violation|5
1390299|NCT01313637|4587286|P3|Overall Study|Protocol Violation|11
1390300|NCT01313637|4587287|P2|Overall Study|Protocol Violation|3
1390301|NCT01313637|4587288|P1|Overall Study|Protocol Violation|4
1390302|NCT01313637|4587285|P4|Overall Study|Lack of Efficacy|24
1390303|NCT01313637|4587286|P3|Overall Study|Lack of Efficacy|37
1390304|NCT01313637|4587287|P2|Overall Study|Lack of Efficacy|38
1390305|NCT01313637|4587288|P1|Overall Study|Lack of Efficacy|44
1390306|NCT01313637|4587285|P4|Overall Study|Adverse Event|18
1390307|NCT01313637|4587286|P3|Overall Study|Adverse Event|25
1390308|NCT01313637|4587287|P2|Overall Study|Adverse Event|24
1390309|NCT01313637|4587288|P1|Overall Study|Adverse Event|17
1390310|NCT01313624|4587312|P2|Open-Label Phase|Lost to Follow-up|1
1390311|NCT01313624|4587313|P1|Open-Label Phase|Lost to Follow-up|1
1390312|NCT01313624|4587312|P2|Open-Label Phase|Withdrawal by Subject|2
1390313|NCT01313624|4587313|P1|Open-Label Phase|Withdrawal by Subject|2
1390314|NCT01313624|4587312|P2|Open-Label Phase|Adverse Event|10
1390315|NCT01313624|4587313|P1|Open-Label Phase|Adverse Event|1
1390316|NCT01313624|4587312|P2|Double-Blind Phase|Lack of Efficacy|0
1390317|NCT01313624|4587313|P1|Double-Blind Phase|Lack of Efficacy|1
1390318|NCT01313624|4587312|P2|Double-Blind Phase|Physician Decision|0
1390319|NCT01313624|4587313|P1|Double-Blind Phase|Physician Decision|1
1390320|NCT01313624|4587312|P2|Double-Blind Phase|Lost to Follow-up|2
1390321|NCT01313624|4587313|P1|Double-Blind Phase|Lost to Follow-up|0
1390322|NCT01313624|4587312|P2|Double-Blind Phase|Withdrawal by Subject|4
1390323|NCT01313624|4587313|P1|Double-Blind Phase|Withdrawal by Subject|9
1390324|NCT01313624|4587312|P2|Double-Blind Phase|Adverse Event|4
1390325|NCT01313624|4587313|P1|Double-Blind Phase|Adverse Event|27
1390326|NCT01313559|4587327|P2|Overall Study|Rising PSA|0
1390327|NCT01313559|4587328|P1|Overall Study|Rising PSA|2
1390328|NCT01313559|4587327|P2|Overall Study|Disease progression|0
1390329|NCT01313559|4587328|P1|Overall Study|Disease progression|1
1390330|NCT01313559|4587327|P2|Overall Study|Withdrawal by Subject|2
1390331|NCT01313559|4587328|P1|Overall Study|Withdrawal by Subject|1
1390332|NCT01313312|4587424|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
1390333|NCT01313312|4587424|P1|Overall Study|Subject Withdrawn Early in Error|4
1390334|NCT01313312|4587424|P1|Overall Study|Observational Phase|1
1390335|NCT01313312|4587424|P1|Overall Study|Investigator Decision|1
1390336|NCT01313312|4587424|P1|Overall Study|Lack of Efficacy|3
1390337|NCT01313312|4587424|P1|Overall Study|Withdrawal by Subject|18
1390338|NCT01313312|4587424|P1|Overall Study|Adverse Event|5
1390339|NCT01313299|4587471|P3|Overall Study|Lack of subject compliance|1
1390340|NCT01313299|4587472|P2|Overall Study|Lack of subject compliance|0
1390341|NCT01313299|4587473|P1|Overall Study|Lack of subject compliance|0
1390342|NCT01313299|4587471|P3|Overall Study|Family reason and moved out of state|0
1390343|NCT01313299|4587472|P2|Overall Study|Family reason and moved out of state|2
1390344|NCT01313299|4587473|P1|Overall Study|Family reason and moved out of state|0
1390345|NCT01313299|4587471|P3|Overall Study|Withdrawal by Subject|2
1390346|NCT01313299|4587472|P2|Overall Study|Withdrawal by Subject|0
1390347|NCT01313299|4587473|P1|Overall Study|Withdrawal by Subject|1
1390348|NCT01313299|4587471|P3|Overall Study|Protocol Violation|0
1390349|NCT01313299|4587472|P2|Overall Study|Protocol Violation|0
1390350|NCT01313299|4587473|P1|Overall Study|Protocol Violation|2
1390351|NCT01313299|4587471|P3|Overall Study|Lost to Follow-up|0
1390352|NCT01313299|4587472|P2|Overall Study|Lost to Follow-up|0
1390353|NCT01313299|4587473|P1|Overall Study|Lost to Follow-up|1
1390354|NCT01313299|4587471|P3|Overall Study|Adverse Event|1
1390355|NCT01313299|4587472|P2|Overall Study|Adverse Event|1
1390356|NCT01313299|4587473|P1|Overall Study|Adverse Event|3
1390357|NCT01313273|4587489|P2|Overall Study|Screening Chromogranin A-in normal range|1
1390358|NCT01313273|4587490|P1|Overall Study|Screening Chromogranin A-in normal range|0
1390359|NCT01313273|4587489|P2|Overall Study|Withdrawal by Subject|0
1390360|NCT01313273|4587490|P1|Overall Study|Withdrawal by Subject|1
1390361|NCT01313273|4587489|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
1390362|NCT01313273|4587490|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
1390363|NCT01313221|4587505|P3|Overall Study|Pregnancy|2
1390364|NCT01313221|4587506|P2|Overall Study|Pregnancy|0
1390365|NCT01313221|4587507|P1|Overall Study|Pregnancy|0
1390366|NCT01313221|4587505|P3|Overall Study|Physician Decision|2
1390367|NCT01313221|4587506|P2|Overall Study|Physician Decision|0
1390368|NCT01313221|4587507|P1|Overall Study|Physician Decision|0
1390369|NCT01313221|4587505|P3|Overall Study|Disease progression|2
1390370|NCT01313221|4587506|P2|Overall Study|Disease progression|0
1390371|NCT01313221|4587507|P1|Overall Study|Disease progression|0
1390372|NCT01313221|4587505|P3|Overall Study|Adverse Event|7
1390373|NCT01313221|4587506|P2|Overall Study|Adverse Event|0
1390374|NCT01313221|4587507|P1|Overall Study|Adverse Event|0
1390375|NCT01313221|4587505|P3|Overall Study|Other|0
1390376|NCT01313221|4587506|P2|Overall Study|Other|0
1390377|NCT01313221|4587507|P1|Overall Study|Other|1
1390378|NCT01313221|4587505|P3|Overall Study|Lost to Follow-up|1
1390379|NCT01313221|4587506|P2|Overall Study|Lost to Follow-up|3
1390380|NCT01313221|4587507|P1|Overall Study|Lost to Follow-up|6
1390381|NCT01313221|4587505|P3|Overall Study|Requirement for alternative therapy|1
1390382|NCT01313221|4587506|P2|Overall Study|Requirement for alternative therapy|1
1390383|NCT01313221|4587507|P1|Overall Study|Requirement for alternative therapy|0
1390384|NCT01313221|4587505|P3|Overall Study|Withdrawal by Subject|5
1390385|NCT01313221|4587506|P2|Overall Study|Withdrawal by Subject|3
1390386|NCT01313221|4587507|P1|Overall Study|Withdrawal by Subject|2
1390387|NCT01313221|4587505|P3|Overall Study|Non-compliance|2
1390388|NCT01313221|4587506|P2|Overall Study|Non-compliance|0
1390389|NCT01313221|4587507|P1|Overall Study|Non-compliance|3
1390390|NCT01313221|4587505|P3|Overall Study|Protocol Violation|1
1390391|NCT01313221|4587506|P2|Overall Study|Protocol Violation|1
1390392|NCT01313221|4587507|P1|Overall Study|Protocol Violation|0
1390393|NCT01313208|4587559|P2|Open-label Phase (Weeks 13 - 24)|Other|0
1390394|NCT01313208|4587560|P1|Open-label Phase (Weeks 13 - 24)|Other|2
1390395|NCT01313208|4587559|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
1390396|NCT01313208|4587560|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
1390397|NCT01313208|4587559|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
1390398|NCT01313208|4587560|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
1390399|NCT01313208|4587559|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
1390400|NCT01313208|4587560|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
1390401|NCT01313208|4587559|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
1390402|NCT01313208|4587560|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
1390403|NCT01313208|4587559|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
1390404|NCT01313208|4587560|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
1390405|NCT01313208|4587559|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
1390406|NCT01313208|4587560|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
1390407|NCT01313208|4587559|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
1390408|NCT01313208|4587560|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
1390409|NCT01313208|4587559|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
1390410|NCT01313208|4587560|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
1390411|NCT01313182|4587650|P2|Overall Study|Protocol Violation|92
1390412|NCT01313182|4587651|P1|Overall Study|Protocol Violation|66
1390413|NCT01313117|4587657|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
1390414|NCT01313117|4587657|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
1390415|NCT01313078|4587664|P1|Overall Study|Withdrawal by Subject|1
1390416|NCT01313078|4587664|P1|Overall Study|Discontinued study drug|1
1390417|NCT01313078|4587664|P1|Overall Study|Death|1
1390418|NCT01313039|4587669|P1|Overall Study|Adverse Event|1
1390419|NCT01313039|4587669|P1|Overall Study|Physician Decision|1
1390420|NCT01312961|4587675|P2|Overall Study|Other than specified above|3
1390421|NCT01312961|4587676|P1|Overall Study|Other than specified above|2
1390422|NCT01312961|4587675|P2|Overall Study|Poor compliance to protocol|0
1390423|NCT01312961|4587676|P1|Overall Study|Poor compliance to protocol|1
1390424|NCT01312961|4587675|P2|Overall Study|Lack of Efficacy|1
1390425|NCT01312961|4587676|P1|Overall Study|Lack of Efficacy|11
1390426|NCT01312961|4587675|P2|Overall Study|Adverse Event|3
1390427|NCT01312961|4587676|P1|Overall Study|Adverse Event|3
1390428|NCT01312909|4587712|P3|Overall Study|Entrance criteria not met|2
1390429|NCT01312909|4587713|P2|Overall Study|Entrance criteria not met|0
1390430|NCT01312909|4587714|P1|Overall Study|Entrance criteria not met|0
1390431|NCT01312909|4587712|P3|Overall Study|Insufficient clinical response|1
1390432|NCT01312909|4587713|P2|Overall Study|Insufficient clinical response|0
1390433|NCT01312909|4587714|P1|Overall Study|Insufficient clinical response|0
1390434|NCT01312909|4587712|P3|Overall Study|Lost to Follow-up|20
1390435|NCT01312909|4587713|P2|Overall Study|Lost to Follow-up|17
1390436|NCT01312909|4587714|P1|Overall Study|Lost to Follow-up|21
1390437|NCT01312909|4587712|P3|Overall Study|Withdrawal by Subject|7
1390438|NCT01312909|4587713|P2|Overall Study|Withdrawal by Subject|10
1390439|NCT01312909|4587714|P1|Overall Study|Withdrawal by Subject|8
1390440|NCT01312909|4587712|P3|Overall Study|Other|11
1390441|NCT01312909|4587713|P2|Overall Study|Other|6
1390442|NCT01312909|4587714|P1|Overall Study|Other|9
1390443|NCT01312909|4587712|P3|Overall Study|Protocol Violation|2
1390444|NCT01312909|4587713|P2|Overall Study|Protocol Violation|0
1390445|NCT01312909|4587714|P1|Overall Study|Protocol Violation|2
1390446|NCT01312909|4587712|P3|Overall Study|Adverse Event|3
1390447|NCT01312909|4587713|P2|Overall Study|Adverse Event|0
1390448|NCT01312909|4587714|P1|Overall Study|Adverse Event|1
1390449|NCT01312909|4587712|P3|Overall Study|Randomized but not treated|1
1390450|NCT01312909|4587713|P2|Overall Study|Randomized but not treated|3
1390451|NCT01312909|4587714|P1|Overall Study|Randomized but not treated|1
1390452|NCT01312467|4587845|P1|Overall Study|Ineligible|4
1390453|NCT01312467|4587845|P1|Overall Study|Another medical condition|1
1390454|NCT01312467|4587845|P1|Overall Study|Deported to country of origin|1
1390455|NCT01312467|4587845|P1|Overall Study|Withdrawal by Subject|2
1390456|NCT01312467|4587845|P1|Overall Study|Lost to Follow-up|1
1390457|NCT01312467|4587845|P1|Overall Study|Adverse Event|4
1390458|NCT01312428|4587854|P2|Overall Study|Study Termination|4
1390459|NCT01312428|4587855|P1|Overall Study|Study Termination|3
1390460|NCT01312129|4587900|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
1390461|NCT01312129|4587901|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
1390462|NCT01311687|4587931|P2|PFS Follow-up Phase|On PFS follow-up at data cut-off|1
1390463|NCT01311687|4587932|P1|PFS Follow-up Phase|On PFS follow-up at data cut-off|3
1390464|NCT01311687|4587931|P2|Treatment Phase|On treatment at data cut-off|11
1390465|NCT01311687|4587932|P1|Treatment Phase|On treatment at data cut-off|60
1390466|NCT01311661|4587982|P1|Overall Study|Withdrawal by Subject|2
1390467|NCT01311661|4587982|P1|Overall Study|Protocol Violation|3
1390468|NCT01311661|4587982|P1|Overall Study|Adverse Event|2
1390469|NCT01311557|4588126|P2|Overall Study|Withdrawal by Subject|2
1390470|NCT01311557|4588127|P1|Overall Study|Withdrawal by Subject|1
1390471|NCT01311557|4588126|P2|Overall Study|Lost to Follow-up|1
1390472|NCT01311557|4588127|P1|Overall Study|Lost to Follow-up|0
1390473|NCT01311557|4588126|P2|Overall Study|Protocol Violation|2
1390474|NCT01311557|4588127|P1|Overall Study|Protocol Violation|4
1390475|NCT01311557|4588126|P2|Overall Study|Serious adverse event|1
1390476|NCT01311557|4588127|P1|Overall Study|Serious adverse event|0
1390477|NCT01311505|4588143|P2|First Intervention Period|Protocol Violation|1
1390478|NCT01311505|4588144|P1|First Intervention Period|Protocol Violation|0
1390479|NCT01311024|4588200|P2|Overall Study|Protocol Violation|22
1390480|NCT01311024|4588201|P1|Overall Study|Protocol Violation|35
1390481|NCT01310868|4588207|P1|Overall Study|Do not have histologically confirmed GBM|13
1390482|NCT01310803|4588224|P2|Overall Study|Subject terminated by Sponsor|0
1390483|NCT01310803|4588225|P1|Overall Study|Subject terminated by Sponsor|1
1390484|NCT01310777|4588236|P3|Overall Study|Other|2
1390485|NCT01310777|4588237|P2|Overall Study|Other|1
1390486|NCT01310777|4588238|P1|Overall Study|Other|4
1390487|NCT01310777|4588236|P3|Overall Study|Inadequate Control of IOP|10
1390488|NCT01310777|4588237|P2|Overall Study|Inadequate Control of IOP|7
1390489|NCT01310777|4588238|P1|Overall Study|Inadequate Control of IOP|5
1390490|NCT01310777|4588236|P3|Overall Study|Patient's Decision Unrelated to AE|2
1390491|NCT01310777|4588237|P2|Overall Study|Patient's Decision Unrelated to AE|1
1390492|NCT01310777|4588238|P1|Overall Study|Patient's Decision Unrelated to AE|1
1390493|NCT01310777|4588236|P3|Overall Study|Lost to Follow-up|1
1390494|NCT01310777|4588237|P2|Overall Study|Lost to Follow-up|4
1390495|NCT01310777|4588238|P1|Overall Study|Lost to Follow-up|0
1390496|NCT01310777|4588236|P3|Overall Study|Adverse Event|15
1390497|NCT01310777|4588237|P2|Overall Study|Adverse Event|1
1390498|NCT01310777|4588238|P1|Overall Study|Adverse Event|23
1390499|NCT01310699|4588248|P2|Overall Study|Patients did not complete tandem.|6
1390500|NCT01310699|4588249|P1|Overall Study|Patients did not complete tandem.|4
1390501|NCT01310413|4588276|P7|From Day U0 to Day U385|Lost to Follow-up|2
1390502|NCT01310413|4588277|P6|From Day U0 to Day U385|Lost to Follow-up|0
1390503|NCT01310413|4588278|P5|From Day U0 to Day U385|Lost to Follow-up|0
1390504|NCT01310413|4588279|P4|From Day U0 to Day U385|Lost to Follow-up|0
1390505|NCT01310413|4588280|P3|From Day U0 to Day U385|Lost to Follow-up|0
1390506|NCT01310413|4588281|P2|From Day U0 to Day U385|Lost to Follow-up|0
1390507|NCT01310413|4588282|P1|From Day U0 to Day U385|Lost to Follow-up|0
1390508|NCT01310413|4588276|P7|From Day U0 to Day U385|Withdrawal by Subject|1
1390509|NCT01310413|4588277|P6|From Day U0 to Day U385|Withdrawal by Subject|0
1390510|NCT01310413|4588278|P5|From Day U0 to Day U385|Withdrawal by Subject|0
1390511|NCT01310413|4588279|P4|From Day U0 to Day U385|Withdrawal by Subject|0
1390512|NCT01310413|4588280|P3|From Day U0 to Day U385|Withdrawal by Subject|0
1390513|NCT01310413|4588281|P2|From Day U0 to Day U385|Withdrawal by Subject|0
1390514|NCT01310413|4588282|P1|From Day U0 to Day U385|Withdrawal by Subject|0
1390515|NCT01310413|4588276|P7|Day 0 to Day 385|Other|0
1390516|NCT01310413|4588277|P6|Day 0 to Day 385|Other|0
1390517|NCT01310413|4588278|P5|Day 0 to Day 385|Other|0
1390518|NCT01310413|4588279|P4|Day 0 to Day 385|Other|0
1390519|NCT01310413|4588280|P3|Day 0 to Day 385|Other|3
1390520|NCT01310413|4588281|P2|Day 0 to Day 385|Other|0
1390521|NCT01310413|4588282|P1|Day 0 to Day 385|Other|1
1390522|NCT01310413|4588276|P7|Day 0 to Day 385|Migrated/moved from study area|0
1390523|NCT01310413|4588277|P6|Day 0 to Day 385|Migrated/moved from study area|0
1390524|NCT01310413|4588278|P5|Day 0 to Day 385|Migrated/moved from study area|1
1390525|NCT01310413|4588279|P4|Day 0 to Day 385|Migrated/moved from study area|1
1390526|NCT01310413|4588280|P3|Day 0 to Day 385|Migrated/moved from study area|1
1390527|NCT01310413|4588281|P2|Day 0 to Day 385|Migrated/moved from study area|3
1390528|NCT01310413|4588282|P1|Day 0 to Day 385|Migrated/moved from study area|3
1390529|NCT01310413|4588276|P7|Day 0 to Day 385|Lost to Follow-up|0
1390530|NCT01310413|4588277|P6|Day 0 to Day 385|Lost to Follow-up|2
1390531|NCT01310413|4588278|P5|Day 0 to Day 385|Lost to Follow-up|1
1390532|NCT01310413|4588279|P4|Day 0 to Day 385|Lost to Follow-up|5
1390533|NCT01310413|4588280|P3|Day 0 to Day 385|Lost to Follow-up|3
1390534|NCT01310413|4588281|P2|Day 0 to Day 385|Lost to Follow-up|3
1390535|NCT01310413|4588282|P1|Day 0 to Day 385|Lost to Follow-up|18
1390536|NCT01310413|4588276|P7|Day 0 to Day 385|Withdrawal by Subject|0
1390537|NCT01310413|4588277|P6|Day 0 to Day 385|Withdrawal by Subject|1
1390538|NCT01310413|4588278|P5|Day 0 to Day 385|Withdrawal by Subject|1
1390539|NCT01310413|4588279|P4|Day 0 to Day 385|Withdrawal by Subject|2
1390540|NCT01310413|4588280|P3|Day 0 to Day 385|Withdrawal by Subject|0
1390541|NCT01310413|4588281|P2|Day 0 to Day 385|Withdrawal by Subject|2
1390542|NCT01310413|4588282|P1|Day 0 to Day 385|Withdrawal by Subject|5
1390543|NCT01310127|4588464|P2|Overall Study|advanced psc cataract outlier|0
1390544|NCT01310127|4588465|P1|Overall Study|advanced psc cataract outlier|1
1390545|NCT01310127|4588464|P2|Overall Study|Protocol Violation|1
1390546|NCT01310127|4588465|P1|Overall Study|Protocol Violation|1
1390547|NCT01309997|4588479|P2|Overall Study|Withdrawal by Subject|1
1390548|NCT01309997|4588480|P1|Overall Study|Withdrawal by Subject|1
1390549|NCT01309997|4588479|P2|Overall Study|Lack of Efficacy|2
1390550|NCT01309997|4588480|P1|Overall Study|Lack of Efficacy|2
1390551|NCT01309997|4588479|P2|Overall Study|Death|3
1390552|NCT01309997|4588480|P1|Overall Study|Death|1
1390553|NCT01309997|4588479|P2|Overall Study|Adverse Event|0
1390554|NCT01309997|4588480|P1|Overall Study|Adverse Event|1
1390555|NCT01309919|4588504|P2|Overall Study|Did not receive a postpartum IUD|48
1390556|NCT01309919|4588505|P1|Overall Study|Did not receive a postpartum IUD|17
1390557|NCT01309893|4588517|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
1390558|NCT01309893|4588518|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
1390559|NCT01309893|4588517|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
1390560|NCT01309893|4588518|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
1390561|NCT01309841|4588542|P3|Overall Study|Severe non-compliance with protocol|2
1390562|NCT01309841|4588543|P2|Overall Study|Severe non-compliance with protocol|5
1390563|NCT01309841|4588544|P1|Overall Study|Severe non-compliance with protocol|0
1390564|NCT01309841|4588542|P3|Overall Study|Did Not Receive Treatment|1
1390565|NCT01309841|4588543|P2|Overall Study|Did Not Receive Treatment|0
1390566|NCT01309841|4588544|P1|Overall Study|Did Not Receive Treatment|2
1390567|NCT01309841|4588542|P3|Overall Study|Withdrawal by Subject|13
1390568|NCT01309841|4588543|P2|Overall Study|Withdrawal by Subject|6
1390569|NCT01309841|4588544|P1|Overall Study|Withdrawal by Subject|17
1390570|NCT01309841|4588542|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
1390571|NCT01309841|4588543|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
1390572|NCT01309841|4588544|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
1390573|NCT01309841|4588542|P3|Overall Study|Death|0
1390574|NCT01309841|4588543|P2|Overall Study|Death|0
1390575|NCT01309841|4588544|P1|Overall Study|Death|1
1390576|NCT01309841|4588542|P3|Overall Study|Adverse Event|11
1390577|NCT01309841|4588543|P2|Overall Study|Adverse Event|22
1390578|NCT01309841|4588544|P1|Overall Study|Adverse Event|9
1390579|NCT01309841|4588542|P3|Overall Study|Lack of Efficacy|2
1390580|NCT01309841|4588543|P2|Overall Study|Lack of Efficacy|0
1390581|NCT01309841|4588544|P1|Overall Study|Lack of Efficacy|0
1390582|NCT01309841|4588542|P3|Overall Study|Study-Specific Withdrawal Criteria|2
1390583|NCT01309841|4588543|P2|Overall Study|Study-Specific Withdrawal Criteria|1
1390584|NCT01309841|4588544|P1|Overall Study|Study-Specific Withdrawal Criteria|3
1390585|NCT01309841|4588542|P3|Overall Study|Lost to Follow-up|4
1390586|NCT01309841|4588543|P2|Overall Study|Lost to Follow-up|6
1390587|NCT01309841|4588544|P1|Overall Study|Lost to Follow-up|7
1390588|NCT01309841|4588542|P3|Overall Study|Other|1
1390589|NCT01309841|4588543|P2|Overall Study|Other|1
1390590|NCT01309841|4588544|P1|Overall Study|Other|0
1390591|NCT01309828|4588584|P2|Overall Study|Other|0
1390592|NCT01309828|4588585|P1|Overall Study|Other|1
1390593|NCT01309828|4588584|P2|Overall Study|Major Protocol Deviation|1
1390594|NCT01309828|4588585|P1|Overall Study|Major Protocol Deviation|0
1390595|NCT01309828|4588584|P2|Overall Study|Voluntary Withdrawal|4
1390596|NCT01309828|4588585|P1|Overall Study|Voluntary Withdrawal|5
1390597|NCT01309828|4588584|P2|Overall Study|Adverse Event|11
1390598|NCT01309828|4588585|P1|Overall Study|Adverse Event|10
1390599|NCT01309737|4588619|P5|Week 16 to 52|Other|0
1390600|NCT01309737|4588620|P4|Week 16 to 52|Other|2
1390601|NCT01309737|4588621|P3|Week 16 to 52|Other|0
1390602|NCT01309737|4588622|P2|Week 16 to 52|Other|12
1390603|NCT01309737|4588623|P1|Week 16 to 52|Other|10
1390604|NCT01309737|4588619|P5|Week 16 to 52|Withdrawal by Subject|2
1390605|NCT01309737|4588620|P4|Week 16 to 52|Withdrawal by Subject|0
1390606|NCT01309737|4588621|P3|Week 16 to 52|Withdrawal by Subject|0
1390607|NCT01309737|4588622|P2|Week 16 to 52|Withdrawal by Subject|6
1390608|NCT01309737|4588623|P1|Week 16 to 52|Withdrawal by Subject|5
1390609|NCT01309737|4588619|P5|Week 16 to 52|Lost to Follow-up|4
1390610|NCT01309737|4588620|P4|Week 16 to 52|Lost to Follow-up|1
1390611|NCT01309737|4588621|P3|Week 16 to 52|Lost to Follow-up|0
1390612|NCT01309737|4588622|P2|Week 16 to 52|Lost to Follow-up|2
1390613|NCT01309737|4588623|P1|Week 16 to 52|Lost to Follow-up|4
1390614|NCT01309737|4588619|P5|Week 16 to 52|Lack of Efficacy|21
1390615|NCT01309737|4588620|P4|Week 16 to 52|Lack of Efficacy|25
1390616|NCT01309737|4588621|P3|Week 16 to 52|Lack of Efficacy|0
1390617|NCT01309737|4588622|P2|Week 16 to 52|Lack of Efficacy|76
1390618|NCT01309737|4588623|P1|Week 16 to 52|Lack of Efficacy|107
1390619|NCT01309737|4588619|P5|Week 16 to 52|Adverse Event|5
1390620|NCT01309737|4588620|P4|Week 16 to 52|Adverse Event|6
1390621|NCT01309737|4588621|P3|Week 16 to 52|Adverse Event|0
1390622|NCT01309737|4588622|P2|Week 16 to 52|Adverse Event|7
1390623|NCT01309737|4588623|P1|Week 16 to 52|Adverse Event|7
1390624|NCT01309737|4588619|P5|Week 16 to 52|Death|1
1390625|NCT01309737|4588620|P4|Week 16 to 52|Death|0
1390626|NCT01309737|4588621|P3|Week 16 to 52|Death|0
1390627|NCT01309737|4588622|P2|Week 16 to 52|Death|0
1390628|NCT01309737|4588623|P1|Week 16 to 52|Death|0
1390629|NCT01309737|4588619|P5|Week 0 to 16|Randomized, but not treated|0
1390630|NCT01309737|4588620|P4|Week 0 to 16|Randomized, but not treated|0
1390631|NCT01309737|4588621|P3|Week 0 to 16|Randomized, but not treated|0
1390632|NCT01309737|4588622|P2|Week 0 to 16|Randomized, but not treated|0
1390633|NCT01309737|4588623|P1|Week 0 to 16|Randomized, but not treated|1
1390634|NCT01309737|4588619|P5|Week 0 to 16|Other|0
1390635|NCT01309737|4588620|P4|Week 0 to 16|Other|0
1390636|NCT01309737|4588621|P3|Week 0 to 16|Other|4
1390637|NCT01309737|4588622|P2|Week 0 to 16|Other|14
1390638|NCT01309737|4588623|P1|Week 0 to 16|Other|10
1390639|NCT01309737|4588619|P5|Week 0 to 16|Withdrawal by Subject|0
1390640|NCT01309737|4588620|P4|Week 0 to 16|Withdrawal by Subject|0
1390641|NCT01309737|4588621|P3|Week 0 to 16|Withdrawal by Subject|7
1390642|NCT01309737|4588622|P2|Week 0 to 16|Withdrawal by Subject|6
1390643|NCT01309737|4588623|P1|Week 0 to 16|Withdrawal by Subject|7
1390644|NCT01309737|4588619|P5|Week 0 to 16|Lost to Follow-up|0
1390645|NCT01309737|4588620|P4|Week 0 to 16|Lost to Follow-up|0
1390646|NCT01309737|4588621|P3|Week 0 to 16|Lost to Follow-up|3
1390647|NCT01309737|4588622|P2|Week 0 to 16|Lost to Follow-up|8
1390648|NCT01309737|4588623|P1|Week 0 to 16|Lost to Follow-up|7
1390649|NCT01309737|4588619|P5|Week 0 to 16|Lack of Efficacy|0
1390650|NCT01309737|4588620|P4|Week 0 to 16|Lack of Efficacy|0
1390651|NCT01309737|4588621|P3|Week 0 to 16|Lack of Efficacy|24
1390652|NCT01309737|4588622|P2|Week 0 to 16|Lack of Efficacy|2
1390653|NCT01309737|4588623|P1|Week 0 to 16|Lack of Efficacy|15
1390654|NCT01309737|4588619|P5|Week 0 to 16|Adverse Event|0
1390655|NCT01309737|4588620|P4|Week 0 to 16|Adverse Event|0
1390656|NCT01309737|4588621|P3|Week 0 to 16|Adverse Event|5
1390657|NCT01309737|4588622|P2|Week 0 to 16|Adverse Event|10
1390658|NCT01309737|4588623|P1|Week 0 to 16|Adverse Event|11
1390659|NCT01309737|4588619|P5|Week 0 to 16|Death|0
1390660|NCT01309737|4588620|P4|Week 0 to 16|Death|0
1390661|NCT01309737|4588621|P3|Week 0 to 16|Death|1
1390662|NCT01309737|4588622|P2|Week 0 to 16|Death|0
1390663|NCT01309737|4588623|P1|Week 0 to 16|Death|1
1390664|NCT01309672|4588818|P1|Overall Study|Withdrawal by Subject|3
1390665|NCT01309672|4588818|P1|Overall Study|Adverse Event|5
1390666|NCT01309672|4588818|P1|Overall Study|Other|9
1390667|NCT01309672|4588818|P1|Overall Study|Lack of Efficacy|20
1390668|NCT01309659|4588828|P2|Overall Study|Protocol Violation|1
1390669|NCT01309659|4588829|P1|Overall Study|Protocol Violation|0
1390670|NCT01309386|4588934|P2|Overall Study|Adverse Event|8
1390671|NCT01309386|4588935|P1|Overall Study|Adverse Event|5
1390672|NCT01309386|4588934|P2|Overall Study|Lack of Efficacy|1
1390673|NCT01309386|4588935|P1|Overall Study|Lack of Efficacy|3
1390674|NCT01309386|4588934|P2|Overall Study|Physician Decision|1
1390675|NCT01309386|4588935|P1|Overall Study|Physician Decision|1
1390676|NCT01309386|4588934|P2|Overall Study|Progressive disease|11
1390677|NCT01309386|4588935|P1|Overall Study|Progressive disease|9
1390678|NCT01309386|4588934|P2|Overall Study|Withdrawal by Subject|0
1390679|NCT01309386|4588935|P1|Overall Study|Withdrawal by Subject|2
1390680|NCT01309386|4588934|P2|Overall Study|Other|0
1390681|NCT01309386|4588935|P1|Overall Study|Other|2
1390682|NCT01309308|4588983|P2|Overall Study|Lost to Follow-up|4
1390683|NCT01309308|4588984|P1|Overall Study|Lost to Follow-up|6
1390684|NCT01309282|4588992|P1|Overall Study|Lost to Follow-up|1
1390685|NCT01309269|4589009|P1|Overall Study|Enrolled but not Treated|107
1390686|NCT01309269|4589009|P1|Overall Study|Study Completion Data Not Recorded|95
1390687|NCT01309269|4589009|P1|Overall Study|Other|1
1390688|NCT01309269|4589009|P1|Overall Study|Other|256
1390689|NCT01309269|4589009|P1|Overall Study|Administrative Problems|141
1390690|NCT01309269|4589009|P1|Overall Study|Kidney Transplant|25
1390691|NCT01309269|4589009|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
1390692|NCT01309269|4589009|P1|Overall Study|Lack of Acceptance|15
1390693|NCT01309269|4589009|P1|Overall Study|Withdrawal by Subject|25
1390694|NCT01309269|4589009|P1|Overall Study|Adverse Event|56
1390695|NCT01309243|4589017|P2|Extension Phase|Lost to Follow-up|0
1390696|NCT01309243|4589018|P1|Extension Phase|Lost to Follow-up|6
1390697|NCT01309243|4589017|P2|Randomized Phase Through Week 96|Protocol Violation|1
1390698|NCT01309243|4589018|P1|Randomized Phase Through Week 96|Protocol Violation|1
1390699|NCT01309243|4589017|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
1390700|NCT01309243|4589018|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
1390701|NCT01309243|4589017|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
1390702|NCT01309243|4589018|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
1390703|NCT01309243|4589017|P2|Randomized Phase Through Week 96|Withdrew Consent|18
1390704|NCT01309243|4589018|P1|Randomized Phase Through Week 96|Withdrew Consent|12
1390705|NCT01309243|4589017|P2|Randomized Phase Through Week 96|Investigators Discretion|6
1390706|NCT01309243|4589018|P1|Randomized Phase Through Week 96|Investigators Discretion|3
1390707|NCT01309243|4589017|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
1390708|NCT01309243|4589018|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
1390709|NCT01309243|4589017|P2|Randomized Phase Through Week 96|Pregnancy|0
1390710|NCT01309243|4589018|P1|Randomized Phase Through Week 96|Pregnancy|2
1390711|NCT01309243|4589017|P2|Randomized Phase Through Week 96|Death|1
1390712|NCT01309243|4589018|P1|Randomized Phase Through Week 96|Death|0
1390713|NCT01309243|4589017|P2|Randomized Phase Through Week 96|Adverse Event|43
1390714|NCT01309243|4589018|P1|Randomized Phase Through Week 96|Adverse Event|12
1390715|NCT01309243|4589017|P2|Randomized Phase Through Week 96|Randomized but not treated|7
1390716|NCT01309243|4589018|P1|Randomized Phase Through Week 96|Randomized but not treated|6
1390717|NCT01309204|4589044|P2|Overall Study|Other|1
1390718|NCT01309204|4589045|P1|Overall Study|Other|4
1390719|NCT01309204|4589044|P2|Overall Study|Inadequate control of IOP|4
1390720|NCT01309204|4589045|P1|Overall Study|Inadequate control of IOP|4
1390721|NCT01309204|4589044|P2|Overall Study|Subject's decision unrelated to an AE|10
1390722|NCT01309204|4589045|P1|Overall Study|Subject's decision unrelated to an AE|9
1390723|NCT01309204|4589044|P2|Overall Study|Lost to Follow-up|2
1390724|NCT01309204|4589045|P1|Overall Study|Lost to Follow-up|2
1390725|NCT01309204|4589044|P2|Overall Study|Adverse Event|58
1390726|NCT01309204|4589045|P1|Overall Study|Adverse Event|48
1390727|NCT01309100|4589051|P1|Overall Study|Positive Slit lamp finding|1
1390728|NCT01309100|4589051|P1|Overall Study|Protocol Violation|1
1390729|NCT01308788|4589099|P2|2-year Treatment|medication change by treating physician|11
1390730|NCT01308788|4589100|P1|2-year Treatment|medication change by treating physician|4
1390731|NCT01308762|4589135|P3|Overall Study|Protocol Violation|0
1390732|NCT01308762|4589136|P2|Overall Study|Protocol Violation|1
1390733|NCT01308762|4589137|P1|Overall Study|Protocol Violation|0
1390734|NCT01308749|4589150|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
1390735|NCT01308749|4589151|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
1390736|NCT01308749|4589150|P2|Period 2: Open Label Treatment|Adverse Event|1
1390737|NCT01308749|4589151|P1|Period 2: Open Label Treatment|Adverse Event|0
1390738|NCT01308749|4589150|P2|Period 1: Double Blind Treatment|Adverse Event|0
1390739|NCT01308749|4589151|P1|Period 1: Double Blind Treatment|Adverse Event|1
1390740|NCT01308736|4589181|P2|Overall Study|Did not attend a single session|5
1390741|NCT01308736|4589182|P1|Overall Study|Did not attend a single session|6
1390742|NCT01308580|4589205|P2|Overall Study|Lost to Follow-up|7
1390743|NCT01308580|4589206|P1|Overall Study|Lost to Follow-up|12
1390744|NCT01308567|4589249|P3|Overall Study|Lost to Follow-up|4
1390745|NCT01308567|4589250|P2|Overall Study|Lost to Follow-up|4
1390746|NCT01308567|4589251|P1|Overall Study|Lost to Follow-up|2
1390747|NCT01308476|4589291|P2|Overall Study|Other|0
1390748|NCT01308476|4589292|P1|Overall Study|Other|1
1390749|NCT01308476|4589291|P2|Overall Study|Lost to Follow-up|2
1390750|NCT01308476|4589292|P1|Overall Study|Lost to Follow-up|2
1390751|NCT01308463|4589312|P1|Overall Study|Revision|2
1390752|NCT01308463|4589312|P1|Overall Study|Death|4
1390753|NCT01308463|4589312|P1|Overall Study|Study Discontinued|23
1390754|NCT01308424|4589325|P3|Randomization|Physician Decision|1
1390755|NCT01308424|4589326|P2|Randomization|Physician Decision|1
1390756|NCT01308424|4589327|P1|Randomization|Physician Decision|0
1390757|NCT01308424|4589325|P3|Randomization|Lost to Follow-up|0
1390758|NCT01308424|4589326|P2|Randomization|Lost to Follow-up|1
1390759|NCT01308424|4589327|P1|Randomization|Lost to Follow-up|0
1390760|NCT01308424|4589325|P3|Randomization|Adverse Event|1
1390761|NCT01308424|4589326|P2|Randomization|Adverse Event|1
1390762|NCT01308424|4589327|P1|Randomization|Adverse Event|0
1390763|NCT01308424|4589325|P3|Baseline Eligibility|Screen Failures|0
1390764|NCT01308424|4589326|P2|Baseline Eligibility|Screen Failures|0
1390765|NCT01308424|4589327|P1|Baseline Eligibility|Screen Failures|71
1390766|NCT01307891|4589340|P2|Overall Study|Progressive Disease|1
1390767|NCT01307891|4589341|P1|Overall Study|Progressive Disease|3
1390768|NCT01307787|4589353|P2|Overall Study|Withdrawal by Subject|0
1390769|NCT01307787|4589354|P1|Overall Study|Withdrawal by Subject|2
1390770|NCT01307423|4589418|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1390771|NCT01307423|4589419|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
1390772|NCT01307423|4589420|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1390773|NCT01307423|4589421|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1390774|NCT01307423|4589422|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1390775|NCT01307423|4589423|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1390776|NCT01307423|4589424|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1390777|NCT01307423|4589418|P7|Active Treatment Phase (Week 25-52)|Other|0
1390778|NCT01307423|4589419|P6|Active Treatment Phase (Week 25-52)|Other|0
1390779|NCT01307423|4589420|P5|Active Treatment Phase (Week 25-52)|Other|0
1390780|NCT01307423|4589421|P4|Active Treatment Phase (Week 25-52)|Other|1
1390781|NCT01307423|4589422|P3|Active Treatment Phase (Week 25-52)|Other|0
1390782|NCT01307423|4589423|P2|Active Treatment Phase (Week 25-52)|Other|0
1390783|NCT01307423|4589424|P1|Active Treatment Phase (Week 25-52)|Other|0
1390784|NCT01307423|4589418|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1390785|NCT01307423|4589419|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1390786|NCT01307423|4589420|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1390787|NCT01307423|4589421|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
1390788|NCT01307423|4589422|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1390789|NCT01307423|4589423|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1390790|NCT01307423|4589424|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1390791|NCT01307423|4589418|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
1390792|NCT01307423|4589419|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
1390793|NCT01307423|4589420|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
1390794|NCT01307423|4589421|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
1390795|NCT01307423|4589422|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
1390796|NCT01307423|4589423|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
1390797|NCT01307423|4589424|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
1390798|NCT01307423|4589418|P7|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
1390799|NCT01307423|4589419|P6|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|1
1390800|NCT01307423|4589420|P5|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
1390801|NCT01307423|4589421|P4|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
1390802|NCT01307423|4589422|P3|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
1390803|NCT01307423|4589423|P2|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
1390804|NCT01307423|4589424|P1|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
1390805|NCT01307423|4589418|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
1390806|NCT01307423|4589419|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
1390807|NCT01307423|4589420|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
1390808|NCT01307423|4589421|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
1390809|NCT01307423|4589422|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
1390810|NCT01307423|4589423|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
1390811|NCT01307423|4589424|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
1390812|NCT01307423|4589418|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
1390813|NCT01307423|4589419|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
1390814|NCT01307423|4589420|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
1390815|NCT01307423|4589421|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
1390816|NCT01307423|4589422|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
1390817|NCT01307423|4589423|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
1390818|NCT01307423|4589424|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
1390819|NCT01307423|4589418|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1390820|NCT01307423|4589419|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1390821|NCT01307423|4589420|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1390822|NCT01307423|4589421|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1390823|NCT01307423|4589422|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
1390824|NCT01307423|4589423|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
1390825|NCT01307423|4589424|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1390826|NCT01307423|4589418|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
1390827|NCT01307423|4589419|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
1390828|NCT01307423|4589420|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
1390829|NCT01307423|4589421|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
1390830|NCT01307423|4589422|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
1390831|NCT01307423|4589423|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
1390832|NCT01307423|4589424|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
1390833|NCT01307423|4589418|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1390834|NCT01307423|4589419|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1390835|NCT01307423|4589420|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1390836|NCT01307423|4589421|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1390837|NCT01307423|4589422|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1390838|NCT01307423|4589423|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1390839|NCT01307423|4589424|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
1390840|NCT01307423|4589418|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1390841|NCT01307423|4589419|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1390999|NCT01306617|4589744|P1|Overall Study|Non-compliance|0
1390842|NCT01307423|4589420|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1390843|NCT01307423|4589421|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1390844|NCT01307423|4589422|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
1390845|NCT01307423|4589423|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
1390846|NCT01307423|4589424|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
1390847|NCT01307423|4589418|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1390848|NCT01307423|4589419|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1390849|NCT01307423|4589420|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1390850|NCT01307423|4589421|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1390851|NCT01307423|4589422|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
1390852|NCT01307423|4589423|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1390853|NCT01307423|4589424|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1390854|NCT01307423|4589418|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1390855|NCT01307423|4589419|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1390856|NCT01307423|4589420|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1390857|NCT01307423|4589421|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1390858|NCT01307423|4589422|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
1390859|NCT01307423|4589423|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
1390860|NCT01307423|4589424|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
1390861|NCT01307423|4589418|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1390862|NCT01307423|4589419|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1390863|NCT01307423|4589420|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1390864|NCT01307423|4589421|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1390865|NCT01307423|4589422|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
1390866|NCT01307423|4589423|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
1390867|NCT01307423|4589424|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
1390868|NCT01307423|4589418|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1390869|NCT01307423|4589419|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1390870|NCT01307423|4589420|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1390871|NCT01307423|4589421|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1390872|NCT01307423|4589422|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
1390873|NCT01307423|4589423|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
1390874|NCT01307423|4589424|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
1390875|NCT01307319|4589555|P3|Overall Study|Not specified|3
1390876|NCT01307319|4589556|P2|Overall Study|Not specified|4
1390877|NCT01307319|4589557|P1|Overall Study|Not specified|0
1390878|NCT01307319|4589555|P3|Overall Study|Withdrawal by Subject|2
1390879|NCT01307319|4589556|P2|Overall Study|Withdrawal by Subject|1
1390880|NCT01307319|4589557|P1|Overall Study|Withdrawal by Subject|0
1390881|NCT01307319|4589555|P3|Overall Study|Protocol Violation|0
1390882|NCT01307319|4589556|P2|Overall Study|Protocol Violation|1
1390883|NCT01307319|4589557|P1|Overall Study|Protocol Violation|1
1390884|NCT01307319|4589555|P3|Overall Study|Lost to Follow-up|1
1390885|NCT01307319|4589556|P2|Overall Study|Lost to Follow-up|0
1390886|NCT01307319|4589557|P1|Overall Study|Lost to Follow-up|1
1390887|NCT01307319|4589555|P3|Overall Study|Adverse Event|1
1390888|NCT01307319|4589556|P2|Overall Study|Adverse Event|2
1390889|NCT01307319|4589557|P1|Overall Study|Adverse Event|2
1390890|NCT01307111|4589571|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
1390891|NCT01307111|4589572|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
1390892|NCT01307111|4589571|P2|IUD Insertion|Lost to Follow-up|0
1390893|NCT01307111|4589572|P1|IUD Insertion|Lost to Follow-up|2
1390894|NCT01307046|4589582|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
1390895|NCT01307046|4589583|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
1390896|NCT01307046|4589582|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
1390897|NCT01307046|4589583|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
1390898|NCT01307046|4589582|P2|Overall Study|Withdrawal by Subject|1
1390899|NCT01307046|4589583|P1|Overall Study|Withdrawal by Subject|1
1390900|NCT01307046|4589582|P2|Overall Study|Physician Decision|0
1390901|NCT01307046|4589583|P1|Overall Study|Physician Decision|2
1390902|NCT01307046|4589582|P2|Overall Study|Lack of Efficacy|2
1390903|NCT01307046|4589583|P1|Overall Study|Lack of Efficacy|0
1390904|NCT01307046|4589582|P2|Overall Study|Adverse Event|3
1390905|NCT01307046|4589583|P1|Overall Study|Adverse Event|3
1390906|NCT01307033|4589595|P4|44-week Open-label Extension|Death|1
1390907|NCT01307033|4589596|P3|44-week Open-label Extension|Death|0
1390908|NCT01307033|4589597|P2|44-week Open-label Extension|Death|0
1390909|NCT01307033|4589598|P1|44-week Open-label Extension|Death|0
1390910|NCT01307033|4589595|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
1390911|NCT01307033|4589596|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
1390912|NCT01307033|4589597|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
1390913|NCT01307033|4589598|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
1390914|NCT01307033|4589595|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
1390915|NCT01307033|4589596|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
1390916|NCT01307033|4589597|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
1390917|NCT01307033|4589598|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
1390918|NCT01307033|4589595|P4|44-week Open-label Extension|Physician Decision|0
1390919|NCT01307033|4589596|P3|44-week Open-label Extension|Physician Decision|1
1390920|NCT01307033|4589597|P2|44-week Open-label Extension|Physician Decision|0
1390921|NCT01307033|4589598|P1|44-week Open-label Extension|Physician Decision|0
1390922|NCT01307033|4589595|P4|44-week Open-label Extension|Withdrawal by Subject|1
1390923|NCT01307033|4589596|P3|44-week Open-label Extension|Withdrawal by Subject|2
1390924|NCT01307033|4589597|P2|44-week Open-label Extension|Withdrawal by Subject|0
1390925|NCT01307033|4589598|P1|44-week Open-label Extension|Withdrawal by Subject|0
1390926|NCT01307033|4589595|P4|44-week Open-label Extension|Adverse Event|1
1390927|NCT01307033|4589596|P3|44-week Open-label Extension|Adverse Event|2
1390928|NCT01307033|4589597|P2|44-week Open-label Extension|Adverse Event|0
1390929|NCT01307033|4589598|P1|44-week Open-label Extension|Adverse Event|0
1390930|NCT01307033|4589595|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
1390931|NCT01307033|4589596|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
1390932|NCT01307033|4589597|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
1390933|NCT01307033|4589598|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
1390934|NCT01307033|4589595|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
1390935|NCT01307033|4589596|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
1390936|NCT01307033|4589597|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
1390937|NCT01307033|4589598|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
1390938|NCT01307033|4589595|P4|8-week Double-blind Period|Lack of Efficacy|0
1390939|NCT01307033|4589596|P3|8-week Double-blind Period|Lack of Efficacy|0
1390940|NCT01307033|4589597|P2|8-week Double-blind Period|Lack of Efficacy|0
1390941|NCT01307033|4589598|P1|8-week Double-blind Period|Lack of Efficacy|1
1390942|NCT01307033|4589595|P4|8-week Double-blind Period|Withdrawal by Subject|0
1390943|NCT01307033|4589596|P3|8-week Double-blind Period|Withdrawal by Subject|0
1390944|NCT01307033|4589597|P2|8-week Double-blind Period|Withdrawal by Subject|1
1390945|NCT01307033|4589598|P1|8-week Double-blind Period|Withdrawal by Subject|4
1390946|NCT01307033|4589595|P4|8-week Double-blind Period|Adverse Event|0
1390947|NCT01307033|4589596|P3|8-week Double-blind Period|Adverse Event|0
1390948|NCT01307033|4589597|P2|8-week Double-blind Period|Adverse Event|0
1390949|NCT01307033|4589598|P1|8-week Double-blind Period|Adverse Event|2
1390950|NCT01307020|4589620|P10|Overall Study|Electronic data capture failure|0
1390951|NCT01307020|4589621|P9|Overall Study|Electronic data capture failure|0
1390952|NCT01307020|4589622|P8|Overall Study|Electronic data capture failure|0
1390953|NCT01307020|4589623|P7|Overall Study|Electronic data capture failure|0
1390954|NCT01307020|4589624|P6|Overall Study|Electronic data capture failure|0
1390955|NCT01307020|4589625|P5|Overall Study|Electronic data capture failure|0
1390956|NCT01307020|4589626|P4|Overall Study|Electronic data capture failure|0
1390957|NCT01307020|4589627|P3|Overall Study|Electronic data capture failure|0
1390958|NCT01307020|4589628|P2|Overall Study|Electronic data capture failure|1
1390959|NCT01307020|4589629|P1|Overall Study|Electronic data capture failure|0
1390960|NCT01307020|4589620|P10|Overall Study|Lost to Follow-up|0
1390961|NCT01307020|4589621|P9|Overall Study|Lost to Follow-up|0
1390962|NCT01307020|4589622|P8|Overall Study|Lost to Follow-up|0
1390963|NCT01307020|4589623|P7|Overall Study|Lost to Follow-up|1
1390964|NCT01307020|4589624|P6|Overall Study|Lost to Follow-up|0
1390965|NCT01307020|4589625|P5|Overall Study|Lost to Follow-up|0
1390966|NCT01307020|4589626|P4|Overall Study|Lost to Follow-up|1
1390967|NCT01307020|4589627|P3|Overall Study|Lost to Follow-up|1
1390968|NCT01307020|4589628|P2|Overall Study|Lost to Follow-up|0
1390969|NCT01307020|4589629|P1|Overall Study|Lost to Follow-up|0
1390970|NCT01306968|4589684|P4|Overall Study|Withdrew over privacy concerns|1
1390971|NCT01306968|4589685|P3|Overall Study|Withdrew over privacy concerns|0
1390972|NCT01306968|4589686|P2|Overall Study|Withdrew over privacy concerns|0
1390973|NCT01306968|4589687|P1|Overall Study|Withdrew over privacy concerns|0
1390974|NCT01306968|4589684|P4|Overall Study|Withdrew - time commitment|2
1390975|NCT01306968|4589685|P3|Overall Study|Withdrew - time commitment|0
1390976|NCT01306968|4589686|P2|Overall Study|Withdrew - time commitment|0
1390977|NCT01306968|4589687|P1|Overall Study|Withdrew - time commitment|0
1390978|NCT01306968|4589684|P4|Overall Study|Relocated and left active duty|1
1390979|NCT01306968|4589685|P3|Overall Study|Relocated and left active duty|1
1390980|NCT01306968|4589686|P2|Overall Study|Relocated and left active duty|1
1390981|NCT01306968|4589687|P1|Overall Study|Relocated and left active duty|0
1390982|NCT01306968|4589684|P4|Overall Study|Physician Decision|0
1390983|NCT01306968|4589685|P3|Overall Study|Physician Decision|0
1390984|NCT01306968|4589686|P2|Overall Study|Physician Decision|1
1390985|NCT01306968|4589687|P1|Overall Study|Physician Decision|0
1390986|NCT01306968|4589684|P4|Overall Study|Lost to Follow-up|0
1390987|NCT01306968|4589685|P3|Overall Study|Lost to Follow-up|0
1390988|NCT01306968|4589686|P2|Overall Study|Lost to Follow-up|1
1390989|NCT01306968|4589687|P1|Overall Study|Lost to Follow-up|1
1390990|NCT01306877|4589711|P2|Overall Study|Physician Decision|1
1390991|NCT01306877|4589712|P1|Overall Study|Physician Decision|0
1390992|NCT01306877|4589711|P2|Overall Study|Lost to Follow-up|3
1390993|NCT01306877|4589712|P1|Overall Study|Lost to Follow-up|3
1390994|NCT01306643|4589730|P1|Overall Study|Other: Change in Eligibility Status|1
1390995|NCT01306643|4589730|P1|Overall Study|Disease Progression|7
1390996|NCT01306643|4589730|P1|Overall Study|Adverse Event|5
1390997|NCT01306617|4589742|P3|Overall Study|Non-compliance|0
1390998|NCT01306617|4589743|P2|Overall Study|Non-compliance|1
1391000|NCT01306617|4589742|P3|Overall Study|Virologic Failure|5
1391001|NCT01306617|4589743|P2|Overall Study|Virologic Failure|0
1391002|NCT01306617|4589744|P1|Overall Study|Virologic Failure|0
1391003|NCT01306617|4589742|P3|Overall Study|Adverse Event|0
1391004|NCT01306617|4589743|P2|Overall Study|Adverse Event|0
1391005|NCT01306617|4589744|P1|Overall Study|Adverse Event|1
1391006|NCT01306305|4589787|P2|Overall Study|Withdrew consent|0
1391007|NCT01306305|4589788|P1|Overall Study|Withdrew consent|1
1391008|NCT01306305|4589787|P2|Overall Study|Lost to Follow-up|0
1391009|NCT01306305|4589788|P1|Overall Study|Lost to Follow-up|1
1391010|NCT01306253|4589825|P2|Overall Study|Lost to Follow-up|1
1391011|NCT01306253|4589826|P1|Overall Study|Lost to Follow-up|1
1391012|NCT01306214|4589843|P3|Overall Study|Not treated|1
1391013|NCT01306214|4589844|P2|Overall Study|Not treated|1
1391014|NCT01306214|4589845|P1|Overall Study|Not treated|1
1391015|NCT01306214|4589843|P3|Overall Study|Withdrawal by Subject|16
1391016|NCT01306214|4589844|P2|Overall Study|Withdrawal by Subject|22
1391017|NCT01306214|4589845|P1|Overall Study|Withdrawal by Subject|24
1391018|NCT01306214|4589843|P3|Overall Study|Lost to Follow-up|4
1391019|NCT01306214|4589844|P2|Overall Study|Lost to Follow-up|5
1391020|NCT01306214|4589845|P1|Overall Study|Lost to Follow-up|3
1391021|NCT01306214|4589843|P3|Overall Study|Death|1
1391022|NCT01306214|4589844|P2|Overall Study|Death|0
1391023|NCT01306214|4589845|P1|Overall Study|Death|0
1391024|NCT01306201|4589862|P1|Overall Study|Files unreadable|3
1391025|NCT01306201|4589862|P1|Overall Study|Files could not be processed|3
1391026|NCT01306201|4589862|P1|Overall Study|Arrhythmia|4
1391027|NCT01306162|4589884|P4|Washout 1|Non-compliance to protocol|0
1391028|NCT01306162|4589885|P3|Washout 1|Non-compliance to protocol|0
1391029|NCT01306162|4589886|P2|Washout 1|Non-compliance to protocol|1
1391030|NCT01306162|4589887|P1|Washout 1|Non-compliance to protocol|0
1391031|NCT01306162|4589884|P4|Period 1|Adverse Event|1
1391032|NCT01306162|4589885|P3|Period 1|Adverse Event|0
1391033|NCT01306162|4589886|P2|Period 1|Adverse Event|0
1391034|NCT01306162|4589887|P1|Period 1|Adverse Event|0
1391035|NCT01306058|4589915|P1|Overall Study|Enrolled but did not get treatment|1
1391036|NCT01306058|4589915|P1|Overall Study|Death|1
1391037|NCT01306032|4589941|P6|Disease Progression/Crossover|other/symptomatic progression|0
1391038|NCT01306032|4589942|P5|Disease Progression/Crossover|other/symptomatic progression|0
1391039|NCT01306032|4589943|P4|Disease Progression/Crossover|other/symptomatic progression|2
1391040|NCT01306032|4589944|P3|Disease Progression/Crossover|other/symptomatic progression|0
1391041|NCT01306032|4589945|P2|Disease Progression/Crossover|other/symptomatic progression|2
1391042|NCT01306032|4589946|P1|Disease Progression/Crossover|other/symptomatic progression|0
1391043|NCT01306032|4589941|P6|Disease Progression/Crossover|Withdrawal by Subject|0
1391044|NCT01306032|4589942|P5|Disease Progression/Crossover|Withdrawal by Subject|0
1391045|NCT01306032|4589943|P4|Disease Progression/Crossover|Withdrawal by Subject|1
1391046|NCT01306032|4589944|P3|Disease Progression/Crossover|Withdrawal by Subject|0
1391047|NCT01306032|4589945|P2|Disease Progression/Crossover|Withdrawal by Subject|0
1391048|NCT01306032|4589946|P1|Disease Progression/Crossover|Withdrawal by Subject|0
1391049|NCT01306032|4589941|P6|First Intervention|Progressive disease|0
1391050|NCT01306032|4589942|P5|First Intervention|Progressive disease|2
1391051|NCT01306032|4589943|P4|First Intervention|Progressive disease|0
1391052|NCT01306032|4589944|P3|First Intervention|Progressive disease|0
1391053|NCT01306032|4589945|P2|First Intervention|Progressive disease|0
1391054|NCT01306032|4589946|P1|First Intervention|Progressive disease|0
1391055|NCT01306032|4589941|P6|First Intervention|Ineligible|1
1391056|NCT01306032|4589942|P5|First Intervention|Ineligible|0
1391057|NCT01306032|4589943|P4|First Intervention|Ineligible|0
1391058|NCT01306032|4589944|P3|First Intervention|Ineligible|0
1391059|NCT01306032|4589945|P2|First Intervention|Ineligible|0
1391060|NCT01306032|4589946|P1|First Intervention|Ineligible|0
1391061|NCT01306032|4589941|P6|First Intervention|Death|0
1391062|NCT01306032|4589942|P5|First Intervention|Death|0
1391063|NCT01306032|4589943|P4|First Intervention|Death|0
1391064|NCT01306032|4589944|P3|First Intervention|Death|1
1391065|NCT01306032|4589945|P2|First Intervention|Death|0
1391066|NCT01306032|4589946|P1|First Intervention|Death|0
1391067|NCT01306032|4589941|P6|First Intervention|Withdrawal by Subject|0
1391068|NCT01306032|4589942|P5|First Intervention|Withdrawal by Subject|0
1391069|NCT01306032|4589943|P4|First Intervention|Withdrawal by Subject|1
1391070|NCT01306032|4589944|P3|First Intervention|Withdrawal by Subject|0
1391071|NCT01306032|4589945|P2|First Intervention|Withdrawal by Subject|2
1391072|NCT01306032|4589946|P1|First Intervention|Withdrawal by Subject|0
1391073|NCT01306032|4589941|P6|First Intervention|Adverse Event|1
1391074|NCT01306032|4589942|P5|First Intervention|Adverse Event|0
1391075|NCT01306032|4589943|P4|First Intervention|Adverse Event|0
1391076|NCT01306032|4589944|P3|First Intervention|Adverse Event|1
1391077|NCT01306032|4589945|P2|First Intervention|Adverse Event|0
1391078|NCT01306032|4589946|P1|First Intervention|Adverse Event|1
1391079|NCT01305941|4589998|P1|Overall Study|Death|1
1391080|NCT01305941|4589998|P1|Overall Study|Withdrawal by Subject|1
1391081|NCT01305941|4589998|P1|Overall Study|Clinical decline|2
1391082|NCT01305941|4589998|P1|Overall Study|Adverse Event|6
1391083|NCT01305577|4590038|P3|Overall Study|Protocol Deviation|1
1391084|NCT01305577|4590039|P2|Overall Study|Protocol Deviation|1
1391085|NCT01305577|4590040|P1|Overall Study|Protocol Deviation|0
1391086|NCT01305577|4590038|P3|Overall Study|Lost to Follow-up|2
1391087|NCT01305577|4590039|P2|Overall Study|Lost to Follow-up|3
1391088|NCT01305577|4590040|P1|Overall Study|Lost to Follow-up|4
1391089|NCT01305577|4590038|P3|Overall Study|Withdrawal by Subject|6
1391090|NCT01305577|4590039|P2|Overall Study|Withdrawal by Subject|5
1391091|NCT01305577|4590040|P1|Overall Study|Withdrawal by Subject|7
1391092|NCT01305577|4590038|P3|Overall Study|Adverse Event|1
1391093|NCT01305577|4590039|P2|Overall Study|Adverse Event|2
1391094|NCT01305577|4590040|P1|Overall Study|Adverse Event|2
1391095|NCT01305564|4590069|P1|Overall Study|Physician Decision|3
1391096|NCT01305564|4590069|P1|Overall Study|Withdrawal by Subject|1
1391097|NCT01305564|4590069|P1|Overall Study|Lost to Follow-up|12
1391098|NCT01305564|4590069|P1|Overall Study|Death|21
1391099|NCT01305408|4590096|P2|Overall Study|Not specified|0
1391100|NCT01305408|4590097|P1|Overall Study|Not specified|1
1391101|NCT01305408|4590096|P2|Overall Study|Noncompliance with study procedures|1
1391102|NCT01305408|4590097|P1|Overall Study|Noncompliance with study procedures|0
1391103|NCT01305408|4590096|P2|Overall Study|Noncompliance with study medication|1
1391104|NCT01305408|4590097|P1|Overall Study|Noncompliance with study medication|0
1391105|NCT01305408|4590096|P2|Overall Study|Lost to Follow-up|3
1391106|NCT01305408|4590097|P1|Overall Study|Lost to Follow-up|5
1391107|NCT01305408|4590096|P2|Overall Study|Protocol Violation|6
1391108|NCT01305408|4590097|P1|Overall Study|Protocol Violation|4
1391109|NCT01305408|4590096|P2|Overall Study|Withdrawal by Subject|9
1391110|NCT01305408|4590097|P1|Overall Study|Withdrawal by Subject|9
1391111|NCT01305408|4590096|P2|Overall Study|Lack of Efficacy|4
1391112|NCT01305408|4590097|P1|Overall Study|Lack of Efficacy|3
1391113|NCT01305408|4590096|P2|Overall Study|Adverse Event|7
1391114|NCT01305408|4590097|P1|Overall Study|Adverse Event|10
1391115|NCT01305239|4590173|P1|Overall Study|Exemestane taken prior to inclusion only|1
1391116|NCT01305239|4590173|P1|Overall Study|Adverse Event|22
1391117|NCT01305200|4590203|P3|Overall Study|Death|0
1391118|NCT01305200|4590204|P2|Overall Study|Death|2
1391119|NCT01305200|4590205|P1|Overall Study|Death|0
1391120|NCT01305200|4590203|P3|Overall Study|Ineligible|1
1391121|NCT01305200|4590204|P2|Overall Study|Ineligible|2
1391122|NCT01305200|4590205|P1|Overall Study|Ineligible|1
1391123|NCT01305200|4590203|P3|Overall Study|Withdrawal by Subject|1
1391124|NCT01305200|4590204|P2|Overall Study|Withdrawal by Subject|21
1391125|NCT01305200|4590205|P1|Overall Study|Withdrawal by Subject|24
1391126|NCT01305200|4590203|P3|Overall Study|Physician Decision|1
1391127|NCT01305200|4590204|P2|Overall Study|Physician Decision|6
1391128|NCT01305200|4590205|P1|Overall Study|Physician Decision|4
1391129|NCT01305044|4590235|P2|Overall Study|Withdrawal by Subject|6
1391130|NCT01305044|4590236|P1|Overall Study|Withdrawal by Subject|3
1391131|NCT01304706|4590266|P1|Overall Study|Discontinued due to failed drug admin.|1
1391132|NCT01304706|4590266|P1|Overall Study|Lost to Follow-up|7
1391133|NCT01304706|4590266|P1|Overall Study|Withdrawal by Subject|3
1391134|NCT01304706|4590266|P1|Overall Study|Death|3
1391135|NCT01304706|4590266|P1|Overall Study|Lack of Efficacy|1
1391136|NCT01304706|4590266|P1|Overall Study|Adverse Event|2
1391137|NCT01304693|4590275|P5|Overall Study|Decision Unrelated to an Adverse Event|0
1391138|NCT01304693|4590276|P4|Overall Study|Decision Unrelated to an Adverse Event|1
1391139|NCT01304693|4590277|P3|Overall Study|Decision Unrelated to an Adverse Event|1
1391140|NCT01304693|4590278|P2|Overall Study|Decision Unrelated to an Adverse Event|0
1391141|NCT01304693|4590279|P1|Overall Study|Decision Unrelated to an Adverse Event|0
1391142|NCT01304693|4590275|P5|Overall Study|Adverse Event|1
1391143|NCT01304693|4590276|P4|Overall Study|Adverse Event|0
1391144|NCT01304693|4590277|P3|Overall Study|Adverse Event|0
1391145|NCT01304693|4590278|P2|Overall Study|Adverse Event|0
1391146|NCT01304693|4590279|P1|Overall Study|Adverse Event|0
1391147|NCT01304498|4590326|P2|Overall Study|Lost to Follow-up|1
1391148|NCT01304498|4590327|P1|Overall Study|Lost to Follow-up|2
1391149|NCT01304498|4590326|P2|Overall Study|Protocol Violation|0
1391150|NCT01304498|4590327|P1|Overall Study|Protocol Violation|1
1391151|NCT01304498|4590326|P2|Overall Study|Withdrawal by Subject|3
1391152|NCT01304498|4590327|P1|Overall Study|Withdrawal by Subject|2
1391153|NCT01304498|4590326|P2|Overall Study|Adverse Event|1
1391154|NCT01304498|4590327|P1|Overall Study|Adverse Event|1
1391155|NCT01304329|4590347|P6|Third Intervention (3 Days)|Adverse Event|0
1391156|NCT01304329|4590348|P5|Third Intervention (3 Days)|Adverse Event|0
1391157|NCT01304329|4590349|P4|Third Intervention (3 Days)|Adverse Event|0
1391158|NCT01304329|4590350|P3|Third Intervention (3 Days)|Adverse Event|0
1391159|NCT01304329|4590351|P2|Third Intervention (3 Days)|Adverse Event|1
1391160|NCT01304329|4590352|P1|Third Intervention (3 Days)|Adverse Event|0
1391161|NCT01304147|4590486|P2|Second Intervention (7days)|Withdrawal by Subject|1
1391162|NCT01304147|4590487|P1|Second Intervention (7days)|Withdrawal by Subject|1
1391163|NCT01303861|4590521|P4|Overall Study|Pregnancy|0
1391164|NCT01303861|4590522|P3|Overall Study|Pregnancy|0
1391165|NCT01303861|4590523|P2|Overall Study|Pregnancy|0
1391166|NCT01303861|4590524|P1|Overall Study|Pregnancy|1
1391167|NCT01303861|4590521|P4|Overall Study|Adverse Event|5
1391168|NCT01303861|4590522|P3|Overall Study|Adverse Event|0
1391169|NCT01303861|4590523|P2|Overall Study|Adverse Event|1
1391170|NCT01303861|4590524|P1|Overall Study|Adverse Event|4
1391171|NCT01303861|4590521|P4|Overall Study|Withdrawal by Subject|23
1391172|NCT01303861|4590522|P3|Overall Study|Withdrawal by Subject|8
1391173|NCT01303861|4590523|P2|Overall Study|Withdrawal by Subject|8
1391174|NCT01303861|4590524|P1|Overall Study|Withdrawal by Subject|16
1391175|NCT01303861|4590521|P4|Overall Study|Lack of Efficacy|0
1391176|NCT01303861|4590522|P3|Overall Study|Lack of Efficacy|1
1391177|NCT01303861|4590523|P2|Overall Study|Lack of Efficacy|2
1391178|NCT01303861|4590524|P1|Overall Study|Lack of Efficacy|3
1391179|NCT01303861|4590521|P4|Overall Study|Lost to Follow-up|31
1391180|NCT01303861|4590522|P3|Overall Study|Lost to Follow-up|27
1391181|NCT01303861|4590523|P2|Overall Study|Lost to Follow-up|14
1391182|NCT01303861|4590524|P1|Overall Study|Lost to Follow-up|34
1391183|NCT01303627|4590583|P2|Overall Study|the failure while performing URS|1
1391184|NCT01303627|4590584|P1|Overall Study|the failure while performing URS|0
1391185|NCT01303510|4590592|P2|Overall Study|Lost to Follow-up|0
1391186|NCT01303510|4590593|P1|Overall Study|Lost to Follow-up|1
1391187|NCT01303445|4590607|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
1391188|NCT01303445|4590608|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
1391189|NCT01303445|4590607|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
1391190|NCT01303445|4590608|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
1391191|NCT01303445|4590607|P2|Washout (14 Days)|Lost to Follow-up|2
1391192|NCT01303445|4590608|P1|Washout (14 Days)|Lost to Follow-up|0
1391193|NCT01303445|4590607|P2|Washout (14 Days)|Protocol Violation|0
1391194|NCT01303445|4590608|P1|Washout (14 Days)|Protocol Violation|1
1391195|NCT01303445|4590607|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
1391196|NCT01303445|4590608|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
1391197|NCT01303445|4590607|P2|Second Intervention (7 Days)|Adverse Event|2
1391198|NCT01303445|4590608|P1|Second Intervention (7 Days)|Adverse Event|0
1391199|NCT01303445|4590607|P2|First Intervention (7 Days)|Withdrawal by Subject|0
1391200|NCT01303445|4590608|P1|First Intervention (7 Days)|Withdrawal by Subject|1
1391201|NCT01303380|4590649|P1|Overall Study|Lack of compliance to study procedures|1
1391202|NCT01303159|4590708|P1|Overall Study|Study Termination|7
1391203|NCT01303159|4590708|P1|Overall Study|Death|16
1391204|NCT01302938|4590715|P2|Overall Study|Adverse Event|0
1391205|NCT01302938|4590716|P1|Overall Study|Adverse Event|1
1391206|NCT01302938|4590715|P2|Overall Study|Withdrawal by Subject|0
1391207|NCT01302938|4590716|P1|Overall Study|Withdrawal by Subject|1
1391208|NCT01302899|4590761|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
1391209|NCT01302899|4590762|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
1391210|NCT01302899|4590761|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
1391211|NCT01302899|4590762|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
1391212|NCT01302691|4590842|P2|Overall Study|Protocol Violation|0
1391213|NCT01302691|4590843|P1|Overall Study|Protocol Violation|1
1391214|NCT01302691|4590842|P2|Overall Study|Physician Decision|1
1391215|NCT01302691|4590843|P1|Overall Study|Physician Decision|0
1391216|NCT01302691|4590842|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
1391217|NCT01302691|4590843|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
1391218|NCT01302691|4590842|P2|Overall Study|Lost to Follow-up|0
1391219|NCT01302691|4590843|P1|Overall Study|Lost to Follow-up|1
1391220|NCT01302691|4590842|P2|Overall Study|Death|1
1391221|NCT01302691|4590843|P1|Overall Study|Death|0
1391222|NCT01302691|4590842|P2|Overall Study|Adverse Event|0
1391223|NCT01302691|4590843|P1|Overall Study|Adverse Event|2
1391224|NCT01302548|4590863|P2|Overall Study|Lost to Follow-up|1
1391225|NCT01302548|4590864|P1|Overall Study|Lost to Follow-up|2
1391226|NCT01302418|4590914|P1|Overall Study|Non-evaluable|9
1391227|NCT01302418|4590914|P1|Overall Study|Protocol Violation|9
1391228|NCT01302392|4590920|P2|Overall Study|Withdrawal by Subject|1
1391229|NCT01302392|4590921|P1|Overall Study|Withdrawal by Subject|6
1391230|NCT01302392|4590920|P2|Overall Study|Lost to Follow-up|0
1391231|NCT01302392|4590921|P1|Overall Study|Lost to Follow-up|1
1391232|NCT01302366|4590941|P1|Overall Study|patient choice or noncompliance|5
1391233|NCT01302119|4590949|P2|Overall Study|Non-specific|1
1391234|NCT01302119|4590950|P1|Overall Study|Non-specific|4
1391235|NCT01302119|4590949|P2|Overall Study|Non-compliance|2
1391236|NCT01302119|4590950|P1|Overall Study|Non-compliance|4
1391237|NCT01302119|4590949|P2|Overall Study|Adverse Event|1
1391238|NCT01302119|4590950|P1|Overall Study|Adverse Event|2
1391239|NCT01302119|4590949|P2|Overall Study|Lost to Follow-up|4
1391240|NCT01302119|4590950|P1|Overall Study|Lost to Follow-up|10
1391241|NCT01302119|4590949|P2|Overall Study|Withdrawal by Subject|20
1391242|NCT01302119|4590950|P1|Overall Study|Withdrawal by Subject|30
1391243|NCT01302067|4590965|P3|Overall Study|Adverse Event|45
1391244|NCT01302067|4590966|P2|Overall Study|Adverse Event|14
1391245|NCT01302067|4590967|P1|Overall Study|Adverse Event|27
1391246|NCT01302067|4590965|P3|Overall Study|Protocol Violation|8
1391247|NCT01302067|4590966|P2|Overall Study|Protocol Violation|0
1391248|NCT01302067|4590967|P1|Overall Study|Protocol Violation|11
1391249|NCT01302067|4590965|P3|Overall Study|Not specified|3
1391250|NCT01302067|4590966|P2|Overall Study|Not specified|1
1391251|NCT01302067|4590967|P1|Overall Study|Not specified|1
1391252|NCT01302067|4590965|P3|Overall Study|Withdrawal by Subject|10
1391253|NCT01302067|4590966|P2|Overall Study|Withdrawal by Subject|6
1391254|NCT01302067|4590967|P1|Overall Study|Withdrawal by Subject|13
1391255|NCT01302067|4590965|P3|Overall Study|Lost to Follow-up|15
1391256|NCT01302067|4590966|P2|Overall Study|Lost to Follow-up|4
1391257|NCT01302067|4590967|P1|Overall Study|Lost to Follow-up|9
1391258|NCT01302067|4590965|P3|Overall Study|Lack of Efficacy|2
1391259|NCT01302067|4590966|P2|Overall Study|Lack of Efficacy|4
1391260|NCT01302067|4590967|P1|Overall Study|Lack of Efficacy|8
1391261|NCT01302067|4590965|P3|Overall Study|Physician Decision|14
1391262|NCT01302067|4590966|P2|Overall Study|Physician Decision|5
1391263|NCT01302067|4590967|P1|Overall Study|Physician Decision|9
1391264|NCT01302067|4590965|P3|Overall Study|Death|1
1391265|NCT01302067|4590966|P2|Overall Study|Death|0
1391266|NCT01302067|4590967|P1|Overall Study|Death|0
1391267|NCT01302054|4591038|P3|Double-Blind Treatment Phase|Other|9
1391268|NCT01302054|4591039|P2|Double-Blind Treatment Phase|Other|4
1391269|NCT01302054|4591040|P1|Double-Blind Treatment Phase|Other|0
1391270|NCT01302054|4591038|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
1391271|NCT01302054|4591039|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
1391272|NCT01302054|4591040|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
1391273|NCT01302054|4591038|P3|Double-Blind Treatment Phase|Adverse Event|10
1391274|NCT01302054|4591039|P2|Double-Blind Treatment Phase|Adverse Event|10
1391275|NCT01302054|4591040|P1|Double-Blind Treatment Phase|Adverse Event|0
1391276|NCT01302054|4591038|P3|Double-Blind Treatment Phase|Protocol Violation|6
1391277|NCT01302054|4591039|P2|Double-Blind Treatment Phase|Protocol Violation|3
1391278|NCT01302054|4591040|P1|Double-Blind Treatment Phase|Protocol Violation|0
1391279|NCT01302054|4591038|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
1391280|NCT01302054|4591039|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
1391281|NCT01302054|4591040|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
1391282|NCT01302054|4591038|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
1391283|NCT01302054|4591039|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
1391284|NCT01302054|4591040|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
1391285|NCT01302054|4591038|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
1391286|NCT01302054|4591039|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
1391287|NCT01302054|4591040|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
1391288|NCT01302054|4591038|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
1391289|NCT01302054|4591039|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
1391290|NCT01302054|4591040|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
1391291|NCT01302054|4591038|P3|Tolterodine Open-Label Run-In Phase|Other|0
1391292|NCT01302054|4591039|P2|Tolterodine Open-Label Run-In Phase|Other|0
1391293|NCT01302054|4591040|P1|Tolterodine Open-Label Run-In Phase|Other|7
1391294|NCT01302054|4591038|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
1391295|NCT01302054|4591039|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
1391296|NCT01302054|4591040|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
1391297|NCT01302054|4591038|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
1391298|NCT01302054|4591039|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
1391299|NCT01302054|4591040|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
1391300|NCT01302054|4591038|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
1391301|NCT01302054|4591039|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
1391302|NCT01302054|4591040|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
1391303|NCT01302054|4591038|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
1391304|NCT01302054|4591039|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
1391305|NCT01302054|4591040|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
1391306|NCT01302054|4591038|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
1391307|NCT01302054|4591039|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
1391308|NCT01302054|4591040|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
1391309|NCT01302054|4591038|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
1391310|NCT01302054|4591039|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
1391311|NCT01302054|4591040|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
1391312|NCT01302041|4591067|P1|Overall Study|Other-Miscellaneous Reason|2
1391313|NCT01302041|4591067|P1|Overall Study|Other-Transitioned to 9785-CL-0123|29
1391314|NCT01302041|4591067|P1|Overall Study|Withdrawal by Subject|4
1391315|NCT01302041|4591067|P1|Overall Study|Death|5
1391316|NCT01301950|4591109|P2|Overall Study|Surgery was cancelled by patient|1
1391317|NCT01301950|4591110|P1|Overall Study|Surgery was cancelled by patient|0
1391318|NCT01301833|4591128|P4|Overall Study|Personal matter|0
1391319|NCT01301833|4591129|P3|Overall Study|Personal matter|0
1391320|NCT01301833|4591130|P2|Overall Study|Personal matter|0
1391321|NCT01301833|4591131|P1|Overall Study|Personal matter|1
1391322|NCT01301833|4591128|P4|Overall Study|Withdrawal by Subject|2
1391323|NCT01301833|4591129|P3|Overall Study|Withdrawal by Subject|1
1391324|NCT01301833|4591130|P2|Overall Study|Withdrawal by Subject|1
1391325|NCT01301833|4591131|P1|Overall Study|Withdrawal by Subject|3
1391326|NCT01301833|4591128|P4|Overall Study|Physician Decision|0
1391327|NCT01301833|4591129|P3|Overall Study|Physician Decision|1
1391328|NCT01301833|4591130|P2|Overall Study|Physician Decision|1
1391329|NCT01301833|4591131|P1|Overall Study|Physician Decision|3
1391330|NCT01301833|4591128|P4|Overall Study|Lack of Efficacy|0
1391331|NCT01301833|4591129|P3|Overall Study|Lack of Efficacy|0
1391332|NCT01301833|4591130|P2|Overall Study|Lack of Efficacy|1
1391333|NCT01301833|4591131|P1|Overall Study|Lack of Efficacy|1
1391334|NCT01301833|4591128|P4|Overall Study|Adverse Event|5
1391335|NCT01301833|4591129|P3|Overall Study|Adverse Event|5
1391336|NCT01301833|4591130|P2|Overall Study|Adverse Event|5
1391337|NCT01301833|4591131|P1|Overall Study|Adverse Event|7
1391338|NCT01301729|4591169|P1|Overall Study|Violated Selection Criteria|1
1391339|NCT01301729|4591169|P1|Overall Study|Participant did not Return for Treatment|1
1391340|NCT01301729|4591169|P1|Overall Study|Withdrawal by Subject|2
1391341|NCT01301508|4591182|P2|Overall Study|Lost to Follow-up|1
1391342|NCT01301508|4591183|P1|Overall Study|Lost to Follow-up|0
1391343|NCT01301508|4591182|P2|Overall Study|Withdrawal by Subject|2
1391344|NCT01301508|4591183|P1|Overall Study|Withdrawal by Subject|1
1391345|NCT01301456|4591213|P12|Stage 2|Adverse Event|0
1391346|NCT01301456|4591214|P11|Stage 2|Adverse Event|1
1391347|NCT01301456|4591215|P10|Stage 2|Adverse Event|0
1391348|NCT01301456|4591216|P9|Stage 2|Adverse Event|0
1391349|NCT01301456|4591217|P8|Stage 2|Adverse Event|0
1391350|NCT01301456|4591218|P7|Stage 2|Adverse Event|0
1391351|NCT01301456|4591219|P6|Stage 2|Adverse Event|0
1391352|NCT01301456|4591220|P5|Stage 2|Adverse Event|0
1391353|NCT01301456|4591221|P4|Stage 2|Adverse Event|0
1391354|NCT01301456|4591222|P3|Stage 2|Adverse Event|0
1391355|NCT01301456|4591223|P2|Stage 2|Adverse Event|0
1391356|NCT01301456|4591224|P1|Stage 2|Adverse Event|0
1391357|NCT01301456|4591213|P12|Stage 1|Randomized but not treated|0
1391358|NCT01301456|4591214|P11|Stage 1|Randomized but not treated|0
1391359|NCT01301456|4591215|P10|Stage 1|Randomized but not treated|0
1391360|NCT01301456|4591216|P9|Stage 1|Randomized but not treated|0
1391361|NCT01301456|4591217|P8|Stage 1|Randomized but not treated|0
1391362|NCT01301456|4591218|P7|Stage 1|Randomized but not treated|1
1391363|NCT01301456|4591219|P6|Stage 1|Randomized but not treated|0
1391364|NCT01301456|4591220|P5|Stage 1|Randomized but not treated|0
1391365|NCT01301456|4591221|P4|Stage 1|Randomized but not treated|0
1391366|NCT01301456|4591222|P3|Stage 1|Randomized but not treated|0
1391367|NCT01301456|4591223|P2|Stage 1|Randomized but not treated|0
1391368|NCT01301456|4591224|P1|Stage 1|Randomized but not treated|0
1391369|NCT01301456|4591213|P12|Stage 1|Withdrawal by Subject|0
1391370|NCT01301456|4591214|P11|Stage 1|Withdrawal by Subject|0
1391371|NCT01301456|4591215|P10|Stage 1|Withdrawal by Subject|0
1391372|NCT01301456|4591216|P9|Stage 1|Withdrawal by Subject|0
1391373|NCT01301456|4591217|P8|Stage 1|Withdrawal by Subject|0
1391374|NCT01301456|4591218|P7|Stage 1|Withdrawal by Subject|0
1391375|NCT01301456|4591219|P6|Stage 1|Withdrawal by Subject|0
1391376|NCT01301456|4591220|P5|Stage 1|Withdrawal by Subject|1
1391377|NCT01301456|4591221|P4|Stage 1|Withdrawal by Subject|0
1391378|NCT01301456|4591222|P3|Stage 1|Withdrawal by Subject|1
1391379|NCT01301456|4591223|P2|Stage 1|Withdrawal by Subject|0
1391380|NCT01301456|4591224|P1|Stage 1|Withdrawal by Subject|0
1391381|NCT01301274|4591452|P2|Overall Study|Physician Decision|1
1391382|NCT01301274|4591453|P1|Overall Study|Physician Decision|2
1391383|NCT01301092|4591468|P3|Overall Study|Lost to Follow-up|1
1391384|NCT01301092|4591469|P2|Overall Study|Lost to Follow-up|0
1391385|NCT01301092|4591470|P1|Overall Study|Lost to Follow-up|0
1391386|NCT01301079|4591487|P2|Overall Study|Lost to Follow-up|2
1391387|NCT01301079|4591488|P1|Overall Study|Lost to Follow-up|2
1391388|NCT01301066|4591566|P2|Overall Study|Other|0
1391389|NCT01301066|4591567|P1|Overall Study|Other|2
1391390|NCT01301066|4591566|P2|Overall Study|Physician Decision|1
1391391|NCT01301066|4591567|P1|Overall Study|Physician Decision|0
1391392|NCT01301066|4591566|P2|Overall Study|Sponsor Decision|1
1391393|NCT01301066|4591567|P1|Overall Study|Sponsor Decision|2
1391394|NCT01301066|4591566|P2|Overall Study|Adverse Event|6
1391395|NCT01301066|4591567|P1|Overall Study|Adverse Event|6
1391396|NCT01301066|4591566|P2|Overall Study|Withdrawal by Subject|9
1391397|NCT01301066|4591567|P1|Overall Study|Withdrawal by Subject|4
1391398|NCT01301066|4591566|P2|Overall Study|Protocol Violation|7
1391399|NCT01301066|4591567|P1|Overall Study|Protocol Violation|8
1391400|NCT01301066|4591566|P2|Overall Study|Lost to Follow-up|11
1391401|NCT01301066|4591567|P1|Overall Study|Lost to Follow-up|5
1391402|NCT01301027|4591575|P2|Overall Study|Volume Overload|0
1391403|NCT01301027|4591576|P1|Overall Study|Volume Overload|3
1391404|NCT01301027|4591575|P2|Overall Study|Transplant|2
1391405|NCT01301027|4591576|P1|Overall Study|Transplant|0
1391406|NCT01301027|4591575|P2|Overall Study|Fracture|3
1391407|NCT01301027|4591576|P1|Overall Study|Fracture|1
1391408|NCT01301027|4591575|P2|Overall Study|Adverse Event|2
1391409|NCT01301027|4591576|P1|Overall Study|Adverse Event|0
1391410|NCT01301027|4591575|P2|Overall Study|Withdrawal by Subject|3
1391411|NCT01301027|4591576|P1|Overall Study|Withdrawal by Subject|2
1391412|NCT01301027|4591575|P2|Overall Study|Physician Decision|0
1391413|NCT01301027|4591576|P1|Overall Study|Physician Decision|2
1391414|NCT01301001|4591588|P2|Second Intervention|Withdrawal by Subject|0
1391415|NCT01301001|4591589|P1|Second Intervention|Withdrawal by Subject|2
1391416|NCT01301001|4591588|P2|Second Intervention|Adverse Event|0
1391417|NCT01301001|4591589|P1|Second Intervention|Adverse Event|2
1391418|NCT01301001|4591588|P2|First Intervention|Protocol Violation|1
1391419|NCT01301001|4591589|P1|First Intervention|Protocol Violation|0
1391420|NCT01301001|4591588|P2|First Intervention|Adverse Event|0
1391421|NCT01301001|4591589|P1|First Intervention|Adverse Event|5
1391422|NCT01301001|4591588|P2|First Intervention|Withdrawal by Subject|4
1391423|NCT01301001|4591589|P1|First Intervention|Withdrawal by Subject|1
1391424|NCT01301001|4591588|P2|First Intervention|Lost to Follow-up|4
1391425|NCT01301001|4591589|P1|First Intervention|Lost to Follow-up|4
1391426|NCT01300923|4591599|P2|Overall Study|Physician Decision|2
1391427|NCT01300923|4591600|P1|Overall Study|Physician Decision|0
1391428|NCT01300819|4591613|P2|Overall Study|Follow up call was not done|0
1391429|NCT01300819|4591614|P1|Overall Study|Follow up call was not done|1
1391430|NCT01300819|4591613|P2|Overall Study|Safety follow up not done by mistake|1
1391431|NCT01300819|4591614|P1|Overall Study|Safety follow up not done by mistake|0
1391432|NCT01300819|4591613|P2|Overall Study|Administrative reason|1
1391433|NCT01300819|4591614|P1|Overall Study|Administrative reason|0
1391434|NCT01300819|4591613|P2|Overall Study|Refusal to down titrate study drug|1
1391435|NCT01300819|4591614|P1|Overall Study|Refusal to down titrate study drug|0
1391436|NCT01300819|4591613|P2|Overall Study|Patient was 1 month late for Visit 10|1
1391437|NCT01300819|4591614|P1|Overall Study|Patient was 1 month late for Visit 10|0
1391438|NCT01300819|4591613|P2|Overall Study|Withdrawal by Subject|12
1391439|NCT01300819|4591614|P1|Overall Study|Withdrawal by Subject|10
1391440|NCT01300819|4591613|P2|Overall Study|Lack of Efficacy|1
1391441|NCT01300819|4591614|P1|Overall Study|Lack of Efficacy|2
1391442|NCT01300819|4591613|P2|Overall Study|Adverse Event|27
1391443|NCT01300819|4591614|P1|Overall Study|Adverse Event|9
1391444|NCT01300767|4591642|P1|Overall Study|Unacceptable fit|1
1391445|NCT01300767|4591642|P1|Overall Study|Biomicroscopy|1
1391446|NCT01300767|4591642|P1|Overall Study|Discomfort|2
1391447|NCT01300741|4591670|P1|Overall Study|Discomfort|1
1391448|NCT01300741|4591670|P1|Overall Study|Lost to Follow-up|1
1391449|NCT01300741|4591670|P1|Overall Study|Lens deposits|1
1391450|NCT01300728|4591700|P2|Overall Study|Physician Decision|0
1391451|NCT01300728|4591701|P1|Overall Study|Physician Decision|1
1391452|NCT01300728|4591700|P2|Overall Study|Withdrawal by Subject|1
1391453|NCT01300728|4591701|P1|Overall Study|Withdrawal by Subject|1
1391454|NCT01300650|4591715|P1|Overall Study|Adverse Event|1
1391455|NCT01300546|4591742|P2|Overall Study|Adverse Event|1
1391456|NCT01300546|4591743|P1|Overall Study|Adverse Event|0
1391457|NCT01300546|4591742|P2|Overall Study|Lack of Efficacy|3
1391458|NCT01300546|4591743|P1|Overall Study|Lack of Efficacy|0
1391459|NCT01300546|4591742|P2|Overall Study|Lost to Follow-up|2
1391460|NCT01300546|4591743|P1|Overall Study|Lost to Follow-up|0
1391461|NCT01300546|4591742|P2|Overall Study|Withdrawal by Subject|0
1391462|NCT01300546|4591743|P1|Overall Study|Withdrawal by Subject|1
1391463|NCT01300455|4591773|P2|Washout|Withdrawal by Subject|0
1391464|NCT01300455|4591774|P1|Washout|Withdrawal by Subject|1
1391465|NCT01300351|4591794|P2|Overall Study|Withdrawal by Subject|10
1391466|NCT01300351|4591795|P1|Overall Study|Withdrawal by Subject|7
1391467|NCT01300351|4591794|P2|Overall Study|Adverse Event|4
1391468|NCT01300351|4591795|P1|Overall Study|Adverse Event|0
1391469|NCT01300351|4591794|P2|Overall Study|Lost to Follow-up|1
1391470|NCT01300351|4591795|P1|Overall Study|Lost to Follow-up|0
1391471|NCT01300351|4591794|P2|Overall Study|Ongoing treatment at data cut-off|23
1391472|NCT01300351|4591795|P1|Overall Study|Ongoing treatment at data cut-off|27
1391473|NCT01300351|4591794|P2|Overall Study|Did not receive treatment|0
1391474|NCT01300351|4591795|P1|Overall Study|Did not receive treatment|2
1391475|NCT01300338|4591811|P2|Overall Study|Lost to Follow-up|0
1391476|NCT01300338|4591812|P1|Overall Study|Lost to Follow-up|5
1391477|NCT01300286|4591820|P1|Overall Study|did not get dosed|1
1391478|NCT01300260|4591830|P2|Period 2 of Study: Second Intervention|Adverse Event|1
1391479|NCT01300260|4591831|P1|Period 2 of Study: Second Intervention|Adverse Event|0
1391480|NCT01300260|4591830|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
1391481|NCT01300260|4591831|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
1391482|NCT01300260|4591830|P2|Period 1 of Study: First Intervention|Adverse Event|1
1391483|NCT01300260|4591831|P1|Period 1 of Study: First Intervention|Adverse Event|0
1391484|NCT01300247|4591863|P2|Overall Study|Non-Compliance|1
1391485|NCT01300247|4591864|P1|Overall Study|Non-Compliance|0
1391486|NCT01300247|4591863|P2|Overall Study|Withdrawal by Subject|0
1391487|NCT01300247|4591864|P1|Overall Study|Withdrawal by Subject|1
1391488|NCT01300247|4591863|P2|Overall Study|Lost to Follow-up|0
1391489|NCT01300247|4591864|P1|Overall Study|Lost to Follow-up|2
1391490|NCT01300247|4591863|P2|Overall Study|Death|1
1391491|NCT01300247|4591864|P1|Overall Study|Death|1
1391492|NCT01300234|4591896|P2|Overall Study|Participant refused return to hospital|0
1391493|NCT01300234|4591897|P1|Overall Study|Participant refused return to hospital|1
1391494|NCT01300234|4591896|P2|Overall Study|Participant stopped medication|1
1391495|NCT01300234|4591897|P1|Overall Study|Participant stopped medication|1
1391496|NCT01300234|4591896|P2|Overall Study|Participant reached stopping critera|0
1391497|NCT01300234|4591897|P1|Overall Study|Participant reached stopping critera|2
1391498|NCT01300234|4591896|P2|Overall Study|Pregnancy|1
1391499|NCT01300234|4591897|P1|Overall Study|Pregnancy|2
1391500|NCT01300234|4591896|P2|Overall Study|Lost to Follow-up|12
1391501|NCT01300234|4591897|P1|Overall Study|Lost to Follow-up|14
1391502|NCT01300234|4591896|P2|Overall Study|Withdrawal by Subject|9
1391503|NCT01300234|4591897|P1|Overall Study|Withdrawal by Subject|5
1391504|NCT01300234|4591896|P2|Overall Study|Protocol Violation|3
1391505|NCT01300234|4591897|P1|Overall Study|Protocol Violation|2
1391506|NCT01300234|4591896|P2|Overall Study|Adverse Event|1
1391507|NCT01300234|4591897|P1|Overall Study|Adverse Event|1
1391508|NCT01300052|4591933|P2|Overall Study|Protocol Violation|1
1391509|NCT01300052|4591934|P1|Overall Study|Protocol Violation|1
1391510|NCT01300052|4591933|P2|Overall Study|Withdrawal by Subject|2
1391511|NCT01300052|4591934|P1|Overall Study|Withdrawal by Subject|2
1391512|NCT01300052|4591933|P2|Overall Study|Adverse Event|0
1391513|NCT01300052|4591934|P1|Overall Study|Adverse Event|3
1391514|NCT01299961|4591952|P1|Overall Study|Lost to Follow-up|1
1391515|NCT01299961|4591952|P1|Overall Study|Lack of Efficacy|2
1391516|NCT01299961|4591952|P1|Overall Study|Adverse Event|3
1391517|NCT01299909|4591961|P3|Overall Study|Lost to Follow-up|17
1391518|NCT01299909|4591962|P2|Overall Study|Lost to Follow-up|18
1391519|NCT01299909|4591963|P1|Overall Study|Lost to Follow-up|22
1391520|NCT01299896|4591978|P2|Overall Study|Lost to Follow-up|11
1391521|NCT01299896|4591979|P1|Overall Study|Lost to Follow-up|0
1391522|NCT01299896|4591978|P2|Overall Study|Withdrawal by Subject|7
1391523|NCT01299896|4591979|P1|Overall Study|Withdrawal by Subject|1
1391524|NCT01299805|4591987|P2|Overall Study|Adverse Event|0
1391525|NCT01299805|4591988|P1|Overall Study|Adverse Event|2
1391526|NCT01299584|4592066|P1|Overall Study|Protocol Violation|9
1391527|NCT01299571|4592073|P1|Overall Study|Protocol Violation|107
1391528|NCT01299480|4592084|P5|Overall Study|Started, but not vaccinated|0
1391529|NCT01299480|4592085|P4|Overall Study|Started, but not vaccinated|1
1391530|NCT01299480|4592086|P3|Overall Study|Started, but not vaccinated|1
1391531|NCT01299480|4592087|P2|Overall Study|Started, but not vaccinated|0
1391532|NCT01299480|4592088|P1|Overall Study|Started, but not vaccinated|0
1391533|NCT01299480|4592084|P5|Overall Study|Other|3
1391534|NCT01299480|4592085|P4|Overall Study|Other|0
1391535|NCT01299480|4592086|P3|Overall Study|Other|3
1391536|NCT01299480|4592087|P2|Overall Study|Other|2
1391537|NCT01299480|4592088|P1|Overall Study|Other|3
1391538|NCT01299480|4592084|P5|Overall Study|Lost to Follow-up|2
1391539|NCT01299480|4592085|P4|Overall Study|Lost to Follow-up|1
1391540|NCT01299480|4592086|P3|Overall Study|Lost to Follow-up|2
1391541|NCT01299480|4592087|P2|Overall Study|Lost to Follow-up|1
1391542|NCT01299480|4592088|P1|Overall Study|Lost to Follow-up|3
1391543|NCT01299480|4592084|P5|Overall Study|Physician Decision|0
1391544|NCT01299480|4592085|P4|Overall Study|Physician Decision|2
1391545|NCT01299480|4592086|P3|Overall Study|Physician Decision|0
1391546|NCT01299480|4592087|P2|Overall Study|Physician Decision|1
1391547|NCT01299480|4592088|P1|Overall Study|Physician Decision|1
1391548|NCT01299480|4592084|P5|Overall Study|Withdrawal due to pregnancy|0
1391549|NCT01299480|4592085|P4|Overall Study|Withdrawal due to pregnancy|0
1391550|NCT01299480|4592086|P3|Overall Study|Withdrawal due to pregnancy|1
1391551|NCT01299480|4592087|P2|Overall Study|Withdrawal due to pregnancy|1
1391552|NCT01299480|4592088|P1|Overall Study|Withdrawal due to pregnancy|0
1391553|NCT01299480|4592084|P5|Overall Study|Adverse Event|0
1391554|NCT01299480|4592085|P4|Overall Study|Adverse Event|4
1391555|NCT01299480|4592086|P3|Overall Study|Adverse Event|5
1391556|NCT01299480|4592087|P2|Overall Study|Adverse Event|4
1391557|NCT01299480|4592088|P1|Overall Study|Adverse Event|6
1391558|NCT01299480|4592084|P5|Overall Study|Withdrawal by Subject|4
1391559|NCT01299480|4592085|P4|Overall Study|Withdrawal by Subject|3
1391560|NCT01299480|4592086|P3|Overall Study|Withdrawal by Subject|7
1391561|NCT01299480|4592087|P2|Overall Study|Withdrawal by Subject|4
1391562|NCT01299480|4592088|P1|Overall Study|Withdrawal by Subject|3
1391563|NCT01299480|4592084|P5|Overall Study|Protocol Violation|1
1391564|NCT01299480|4592085|P4|Overall Study|Protocol Violation|1
1391565|NCT01299480|4592086|P3|Overall Study|Protocol Violation|8
1391566|NCT01299480|4592087|P2|Overall Study|Protocol Violation|5
1391567|NCT01299480|4592088|P1|Overall Study|Protocol Violation|7
1391568|NCT01299480|4592084|P5|Overall Study|No longer willing to participate|10
1391569|NCT01299480|4592085|P4|Overall Study|No longer willing to participate|13
1391570|NCT01299480|4592086|P3|Overall Study|No longer willing to participate|14
1391571|NCT01299480|4592087|P2|Overall Study|No longer willing to participate|17
1391572|NCT01299480|4592088|P1|Overall Study|No longer willing to participate|19
1391573|NCT01299389|4592290|P4|Post-observational|Other|6
1391574|NCT01299389|4592291|P3|Post-observational|Other|12
1391575|NCT01299389|4592292|P2|Post-observational|Other|0
1391576|NCT01299389|4592293|P1|Post-observational|Other|0
1391577|NCT01299389|4592290|P4|Double-blind|fail to meet “study population” criteria|0
1391578|NCT01299389|4592291|P3|Double-blind|fail to meet “study population” criteria|0
1391579|NCT01299389|4592292|P2|Double-blind|fail to meet “study population” criteria|1
1391580|NCT01299389|4592293|P1|Double-blind|fail to meet “study population” criteria|0
1391581|NCT01299389|4592290|P4|Double-blind|Other|0
1391582|NCT01299389|4592291|P3|Double-blind|Other|0
1391583|NCT01299389|4592292|P2|Double-blind|Other|1
1391584|NCT01299389|4592293|P1|Double-blind|Other|1
1391585|NCT01299389|4592290|P4|Double-blind|Withdrawal by Subject|0
1391586|NCT01299389|4592291|P3|Double-blind|Withdrawal by Subject|0
1391587|NCT01299389|4592292|P2|Double-blind|Withdrawal by Subject|13
1391588|NCT01299389|4592293|P1|Double-blind|Withdrawal by Subject|16
1391589|NCT01299389|4592290|P4|Double-blind|Lost to Follow-up|0
1391590|NCT01299389|4592291|P3|Double-blind|Lost to Follow-up|0
1391591|NCT01299389|4592292|P2|Double-blind|Lost to Follow-up|1
1391592|NCT01299389|4592293|P1|Double-blind|Lost to Follow-up|2
1391593|NCT01299389|4592290|P4|Double-blind|Lack of Efficacy|0
1391594|NCT01299389|4592291|P3|Double-blind|Lack of Efficacy|0
1391595|NCT01299389|4592292|P2|Double-blind|Lack of Efficacy|21
1391596|NCT01299389|4592293|P1|Double-blind|Lack of Efficacy|45
1391597|NCT01299389|4592290|P4|Double-blind|Adverse Event|0
1391598|NCT01299389|4592291|P3|Double-blind|Adverse Event|0
1391599|NCT01299389|4592292|P2|Double-blind|Adverse Event|27
1391600|NCT01299389|4592293|P1|Double-blind|Adverse Event|45
1391601|NCT01299376|4592315|P2|Extension (Weeks 9 to 52)|Physician Decision|0
1391602|NCT01299376|4592316|P1|Extension (Weeks 9 to 52)|Physician Decision|1
1391603|NCT01299376|4592315|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
1391604|NCT01299376|4592316|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
1391605|NCT01299376|4592315|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
1391606|NCT01299376|4592316|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
1391607|NCT01299376|4592315|P2|Extension (Weeks 9 to 52)|Adverse Event|3
1391608|NCT01299376|4592316|P1|Extension (Weeks 9 to 52)|Adverse Event|2
1391609|NCT01299376|4592315|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
1391610|NCT01299376|4592316|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
1391611|NCT01299376|4592315|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
1391612|NCT01299376|4592316|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
1391613|NCT01299376|4592315|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
1391614|NCT01299376|4592316|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
1391615|NCT01299376|4592315|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
1391616|NCT01299376|4592316|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
1391617|NCT01299376|4592315|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
1391618|NCT01299376|4592316|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
1391619|NCT01299376|4592315|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
1391620|NCT01299376|4592316|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
1391621|NCT01299376|4592315|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
1391622|NCT01299376|4592316|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
1391623|NCT01299272|4592359|P4|Double-blind (DB) Randomized Period|Sponsor Decision|1
1391624|NCT01299272|4592360|P3|Double-blind (DB) Randomized Period|Sponsor Decision|1
1391625|NCT01299272|4592361|P2|Double-blind (DB) Randomized Period|Sponsor Decision|0
1391626|NCT01299272|4592362|P1|Double-blind (DB) Randomized Period|Sponsor Decision|0
1391627|NCT01299272|4592359|P4|Double-blind (DB) Randomized Period|Physician Decision|1
1391628|NCT01299272|4592360|P3|Double-blind (DB) Randomized Period|Physician Decision|2
1391629|NCT01299272|4592361|P2|Double-blind (DB) Randomized Period|Physician Decision|0
1391630|NCT01299272|4592362|P1|Double-blind (DB) Randomized Period|Physician Decision|0
1391631|NCT01299272|4592359|P4|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
1391632|NCT01299272|4592360|P3|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
1391633|NCT01299272|4592361|P2|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
1391634|NCT01299272|4592362|P1|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
1391635|NCT01299272|4592359|P4|Double-blind (DB) Randomized Period|Lost to Follow-up|5
1391636|NCT01299272|4592360|P3|Double-blind (DB) Randomized Period|Lost to Follow-up|5
1391637|NCT01299272|4592361|P2|Double-blind (DB) Randomized Period|Lost to Follow-up|0
1391638|NCT01299272|4592362|P1|Double-blind (DB) Randomized Period|Lost to Follow-up|0
1391639|NCT01299272|4592359|P4|Double-blind (DB) Randomized Period|Protocol Violation|7
1391640|NCT01299272|4592360|P3|Double-blind (DB) Randomized Period|Protocol Violation|8
1391641|NCT01299272|4592361|P2|Double-blind (DB) Randomized Period|Protocol Violation|0
1391642|NCT01299272|4592362|P1|Double-blind (DB) Randomized Period|Protocol Violation|0
1391643|NCT01299272|4592359|P4|Double-blind (DB) Randomized Period|Adverse Event|9
1391644|NCT01299272|4592360|P3|Double-blind (DB) Randomized Period|Adverse Event|8
1391645|NCT01299272|4592361|P2|Double-blind (DB) Randomized Period|Adverse Event|0
1391646|NCT01299272|4592362|P1|Double-blind (DB) Randomized Period|Adverse Event|0
1391647|NCT01299272|4592359|P4|Double-blind (DB) Randomized Period|Lack of Efficacy|10
1391648|NCT01299272|4592360|P3|Double-blind (DB) Randomized Period|Lack of Efficacy|20
1391649|NCT01299272|4592361|P2|Double-blind (DB) Randomized Period|Lack of Efficacy|0
1391650|NCT01299272|4592362|P1|Double-blind (DB) Randomized Period|Lack of Efficacy|0
1391651|NCT01299272|4592359|P4|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
1391652|NCT01299272|4592360|P3|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
1391653|NCT01299272|4592361|P2|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
1391654|NCT01299272|4592362|P1|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
1391655|NCT01299272|4592359|P4|Stabilization Open-label (OL) Period|Physician Decision|0
1391656|NCT01299272|4592360|P3|Stabilization Open-label (OL) Period|Physician Decision|0
1391657|NCT01299272|4592361|P2|Stabilization Open-label (OL) Period|Physician Decision|3
1391658|NCT01299272|4592362|P1|Stabilization Open-label (OL) Period|Physician Decision|0
1391659|NCT01299272|4592359|P4|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
1391660|NCT01299272|4592360|P3|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
1391661|NCT01299272|4592361|P2|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
1391662|NCT01299272|4592362|P1|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
1391663|NCT01299272|4592359|P4|Stabilization Open-label (OL) Period|Lost to Follow-up|0
1391664|NCT01299272|4592360|P3|Stabilization Open-label (OL) Period|Lost to Follow-up|0
1391665|NCT01299272|4592361|P2|Stabilization Open-label (OL) Period|Lost to Follow-up|9
1391666|NCT01299272|4592362|P1|Stabilization Open-label (OL) Period|Lost to Follow-up|0
1391667|NCT01299272|4592359|P4|Stabilization Open-label (OL) Period|Lack of Efficacy|0
1391668|NCT01299272|4592360|P3|Stabilization Open-label (OL) Period|Lack of Efficacy|0
1391669|NCT01299272|4592361|P2|Stabilization Open-label (OL) Period|Lack of Efficacy|11
1391670|NCT01299272|4592362|P1|Stabilization Open-label (OL) Period|Lack of Efficacy|0
1391671|NCT01299272|4592359|P4|Stabilization Open-label (OL) Period|Sponsor Decision|0
1391672|NCT01299272|4592360|P3|Stabilization Open-label (OL) Period|Sponsor Decision|0
1391673|NCT01299272|4592361|P2|Stabilization Open-label (OL) Period|Sponsor Decision|12
1391674|NCT01299272|4592362|P1|Stabilization Open-label (OL) Period|Sponsor Decision|0
1391675|NCT01299272|4592359|P4|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
1391676|NCT01299272|4592360|P3|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
1391677|NCT01299272|4592361|P2|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
1391678|NCT01299272|4592362|P1|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
1391679|NCT01299272|4592359|P4|Stabilization Open-label (OL) Period|Adverse Event|0
1391680|NCT01299272|4592360|P3|Stabilization Open-label (OL) Period|Adverse Event|0
1391681|NCT01299272|4592361|P2|Stabilization Open-label (OL) Period|Adverse Event|42
1391682|NCT01299272|4592362|P1|Stabilization Open-label (OL) Period|Adverse Event|0
1391683|NCT01299272|4592359|P4|Stabilization Open-label (OL) Period|Protocol Violation|0
1391684|NCT01299272|4592360|P3|Stabilization Open-label (OL) Period|Protocol Violation|0
1391685|NCT01299272|4592361|P2|Stabilization Open-label (OL) Period|Protocol Violation|44
1391686|NCT01299272|4592362|P1|Stabilization Open-label (OL) Period|Protocol Violation|0
1391687|NCT01299272|4592359|P4|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
1391688|NCT01299272|4592360|P3|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
1391689|NCT01299272|4592361|P2|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
1391690|NCT01299272|4592362|P1|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
1391691|NCT01299272|4592359|P4|Acute Open-label (OL) Period|Physician Decision|0
1391692|NCT01299272|4592360|P3|Acute Open-label (OL) Period|Physician Decision|0
1391693|NCT01299272|4592361|P2|Acute Open-label (OL) Period|Physician Decision|0
1391694|NCT01299272|4592362|P1|Acute Open-label (OL) Period|Physician Decision|5
1391695|NCT01299272|4592359|P4|Acute Open-label (OL) Period|Lack of Efficacy|0
1391696|NCT01299272|4592360|P3|Acute Open-label (OL) Period|Lack of Efficacy|0
1391697|NCT01299272|4592361|P2|Acute Open-label (OL) Period|Lack of Efficacy|0
1391698|NCT01299272|4592362|P1|Acute Open-label (OL) Period|Lack of Efficacy|10
1391699|NCT01299272|4592359|P4|Acute Open-label (OL) Period|Sponsor Decision|0
1391700|NCT01299272|4592360|P3|Acute Open-label (OL) Period|Sponsor Decision|0
1391701|NCT01299272|4592361|P2|Acute Open-label (OL) Period|Sponsor Decision|0
1391702|NCT01299272|4592362|P1|Acute Open-label (OL) Period|Sponsor Decision|13
1391703|NCT01299272|4592359|P4|Acute Open-label (OL) Period|Lost to Follow-up|0
1391704|NCT01299272|4592360|P3|Acute Open-label (OL) Period|Lost to Follow-up|0
1391705|NCT01299272|4592361|P2|Acute Open-label (OL) Period|Lost to Follow-up|0
1391706|NCT01299272|4592362|P1|Acute Open-label (OL) Period|Lost to Follow-up|14
1391707|NCT01299272|4592359|P4|Acute Open-label (OL) Period|Protocol Violation|0
1391708|NCT01299272|4592360|P3|Acute Open-label (OL) Period|Protocol Violation|0
1391709|NCT01299272|4592361|P2|Acute Open-label (OL) Period|Protocol Violation|0
1391710|NCT01299272|4592362|P1|Acute Open-label (OL) Period|Protocol Violation|36
1391711|NCT01299272|4592359|P4|Acute Open-label (OL) Period|Withdrawal by Subject|0
1391712|NCT01299272|4592360|P3|Acute Open-label (OL) Period|Withdrawal by Subject|0
1391713|NCT01299272|4592361|P2|Acute Open-label (OL) Period|Withdrawal by Subject|0
1391714|NCT01299272|4592362|P1|Acute Open-label (OL) Period|Withdrawal by Subject|56
1391715|NCT01299272|4592359|P4|Acute Open-label (OL) Period|Adverse Event|0
1391716|NCT01299272|4592360|P3|Acute Open-label (OL) Period|Adverse Event|0
1391717|NCT01299272|4592361|P2|Acute Open-label (OL) Period|Adverse Event|0
1391718|NCT01299272|4592362|P1|Acute Open-label (OL) Period|Adverse Event|140
1391719|NCT01299272|4592359|P4|Acute Open-label (OL) Period|Remission Criteria Not Met|0
1391720|NCT01299272|4592360|P3|Acute Open-label (OL) Period|Remission Criteria Not Met|0
1391721|NCT01299272|4592361|P2|Acute Open-label (OL) Period|Remission Criteria Not Met|0
1391722|NCT01299272|4592362|P1|Acute Open-label (OL) Period|Remission Criteria Not Met|140
1391723|NCT01299116|4592417|P3|Overall Study|Lost to Follow-up|11
1391724|NCT01299116|4592418|P2|Overall Study|Lost to Follow-up|9
1391725|NCT01299116|4592419|P1|Overall Study|Lost to Follow-up|65
1391726|NCT01299025|4592464|P2|Overall Study|Lost to Follow-up|0
1391727|NCT01299025|4592465|P1|Overall Study|Lost to Follow-up|1
1391728|NCT01299025|4592464|P2|Overall Study|Withdrawal by Subject|1
1391729|NCT01299025|4592465|P1|Overall Study|Withdrawal by Subject|2
1391730|NCT01298778|4592479|P2|Overall Study|not meet inclusion/exclusion criteria|1
1391731|NCT01298778|4592480|P1|Overall Study|not meet inclusion/exclusion criteria|0
1391732|NCT01298778|4592479|P2|Overall Study|Protocol Violation|1
1391733|NCT01298778|4592480|P1|Overall Study|Protocol Violation|0
1391734|NCT01298778|4592479|P2|Overall Study|Withdrawal by Subject|1
1391735|NCT01298778|4592480|P1|Overall Study|Withdrawal by Subject|0
1391736|NCT01298778|4592479|P2|Overall Study|Incorrect use of VAS|0
1391737|NCT01298778|4592480|P1|Overall Study|Incorrect use of VAS|1
1391738|NCT01298778|4592479|P2|Overall Study|Lost to Follow-up|3
1391739|NCT01298778|4592480|P1|Overall Study|Lost to Follow-up|2
1391740|NCT01298765|4592500|P1|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
1391741|NCT01298765|4592500|P1|Long-Term Treatment Period|Physician Decision|1
1391742|NCT01298765|4592500|P1|Long-Term Treatment Period|Withdrawal by Subject|19
1391743|NCT01298765|4592500|P1|Long-Term Treatment Period|Lost to Follow-up|8
1391744|NCT01298765|4592500|P1|Long-Term Treatment Period|Lack of Efficacy|6
1391745|NCT01298765|4592500|P1|Long-Term Treatment Period|Adverse Event|19
1391746|NCT01298765|4592500|P1|Titration Period|Other: Not Lack of Analgesic Effect|8
1391747|NCT01298765|4592500|P1|Titration Period|Withdrawal by Subject|10
1391748|NCT01298765|4592500|P1|Titration Period|Physician Decision|1
1391749|NCT01298765|4592500|P1|Titration Period|Lost to Follow-up|9
1391750|NCT01298765|4592500|P1|Titration Period|Lack of Efficacy|21
1391751|NCT01298765|4592500|P1|Titration Period|Death|1
1391752|NCT01298765|4592500|P1|Titration Period|Adverse Event|26
1391753|NCT01298661|4592511|P3|Overall Study|Withdrawal by Subject|2
1391754|NCT01298661|4592512|P2|Overall Study|Withdrawal by Subject|0
1391755|NCT01298661|4592513|P1|Overall Study|Withdrawal by Subject|2
1391756|NCT01298648|4592591|P1|Overall Study|Lost to Follow-up|21
1391757|NCT01298648|4592591|P1|Overall Study|Withdrawal by Subject|2
1391758|NCT01298570|4592602|P2|Overall Study|Ineligibility|1
1391759|NCT01298570|4592603|P1|Overall Study|Ineligibility|0
1391760|NCT01298570|4592602|P2|Overall Study|Death|1
1391761|NCT01298570|4592603|P1|Overall Study|Death|0
1391762|NCT01298570|4592602|P2|Overall Study|Symptomatic progression/deterioration|2
1391763|NCT01298570|4592603|P1|Overall Study|Symptomatic progression/deterioration|3
1391764|NCT01298570|4592602|P2|Overall Study|Surgery|1
1391765|NCT01298570|4592603|P1|Overall Study|Surgery|2
1391766|NCT01298570|4592602|P2|Overall Study|Other complicating disease|1
1391767|NCT01298570|4592603|P1|Overall Study|Other complicating disease|2
1391768|NCT01298570|4592602|P2|Overall Study|Physician Decision|2
1391769|NCT01298570|4592603|P1|Overall Study|Physician Decision|4
1391770|NCT01298570|4592602|P2|Overall Study|Treatment delay > 4 weeks|5
1391771|NCT01298570|4592603|P1|Overall Study|Treatment delay > 4 weeks|4
1391772|NCT01298570|4592602|P2|Overall Study|Withdrawal by Subject|6
1391773|NCT01298570|4592603|P1|Overall Study|Withdrawal by Subject|21
1391774|NCT01298570|4592602|P2|Overall Study|Adverse Event|2
1391775|NCT01298570|4592603|P1|Overall Study|Adverse Event|20
1391776|NCT01298570|4592602|P2|Overall Study|Disease progression, relapse during acti|40
1391777|NCT01298570|4592603|P1|Overall Study|Disease progression, relapse during acti|64
1391778|NCT01298531|4592630|P2|Overall Study|Not specified|1
1391779|NCT01298531|4592631|P1|Overall Study|Not specified|2
1391780|NCT01298531|4592630|P2|Overall Study|Does not meet entrance criteria|1
1391781|NCT01298531|4592631|P1|Overall Study|Does not meet entrance criteria|0
1391782|NCT01298531|4592630|P2|Overall Study|Adverse Event|3
1391783|NCT01298531|4592631|P1|Overall Study|Adverse Event|4
1391784|NCT01298531|4592630|P2|Overall Study|Protocol Violation|1
1391785|NCT01298531|4592631|P1|Overall Study|Protocol Violation|1
1391786|NCT01298531|4592630|P2|Overall Study|Lost to Follow-up|0
1391787|NCT01298531|4592631|P1|Overall Study|Lost to Follow-up|2
1391788|NCT01298531|4592630|P2|Overall Study|Lack of Efficacy|1
1391789|NCT01298531|4592631|P1|Overall Study|Lack of Efficacy|0
1391790|NCT01298518|4592760|P3|Overall Study|Withdrawal by Subject|1
1391791|NCT01298518|4592761|P2|Overall Study|Withdrawal by Subject|0
1391792|NCT01298518|4592762|P1|Overall Study|Withdrawal by Subject|0
1391793|NCT01298492|4592814|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
1391794|NCT01298492|4592814|P1|Overall Study|Adverse Event(Related to Study Drug)|8
1391795|NCT01298492|4592814|P1|Overall Study|Protocol Violation|2
1391796|NCT01298492|4592814|P1|Overall Study|Withdrawn Due to Pregnancy|1
1391797|NCT01298492|4592814|P1|Overall Study|Other (Unspecified)|7
1391798|NCT01298492|4592814|P1|Overall Study|Withdrawal by Subject|47
1391799|NCT01298492|4592814|P1|Overall Study|Lost to Follow-up|12
1391800|NCT01298492|4592814|P1|Overall Study|Insufficient Clinical Response|22
1391801|NCT01298492|4592814|P1|Overall Study|Death|2
1391802|NCT01298362|4592822|P2|Overall Study|Did not provide 12month BMD measurements|43
1391803|NCT01298362|4592823|P1|Overall Study|Did not provide 12month BMD measurements|38
1391804|NCT01298323|4592843|P2|Overall Study|Eligibility criteria not fulfilled|1
1391805|NCT01298323|4592844|P1|Overall Study|Eligibility criteria not fulfilled|0
1391806|NCT01298323|4592843|P2|Overall Study|Ongoing|55
1391807|NCT01298323|4592844|P1|Overall Study|Ongoing|55
1391808|NCT01298323|4592843|P2|Overall Study|Other|9
1391809|NCT01298323|4592844|P1|Overall Study|Other|10
1391810|NCT01298323|4592843|P2|Overall Study|Protocol Violation|0
1391811|NCT01298323|4592844|P1|Overall Study|Protocol Violation|1
1391812|NCT01298323|4592843|P2|Overall Study|Withdrawal by Subject|3
1391813|NCT01298323|4592844|P1|Overall Study|Withdrawal by Subject|6
1391814|NCT01298323|4592843|P2|Overall Study|Lost to Follow-up|0
1391815|NCT01298323|4592844|P1|Overall Study|Lost to Follow-up|1
1391816|NCT01298323|4592843|P2|Overall Study|Death|16
1391817|NCT01298323|4592844|P1|Overall Study|Death|11
1391818|NCT01298323|4592843|P2|Overall Study|Adverse Event|4
1391819|NCT01298323|4592844|P1|Overall Study|Adverse Event|2
1391820|NCT01297920|4592907|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
1391821|NCT01297920|4592908|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
1391822|NCT01297920|4592909|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
1391823|NCT01297920|4592907|P3|Overall Study|Inadequate Control of IOP|17
1391824|NCT01297920|4592908|P2|Overall Study|Inadequate Control of IOP|9
1391825|NCT01297920|4592909|P1|Overall Study|Inadequate Control of IOP|7
1391826|NCT01297920|4592907|P3|Overall Study|Protocol Violation|0
1391827|NCT01297920|4592908|P2|Overall Study|Protocol Violation|3
1391828|NCT01297920|4592909|P1|Overall Study|Protocol Violation|1
1391829|NCT01297920|4592907|P3|Overall Study|Noncompliance|0
1391830|NCT01297920|4592908|P2|Overall Study|Noncompliance|0
1391831|NCT01297920|4592909|P1|Overall Study|Noncompliance|1
1391832|NCT01297920|4592907|P3|Overall Study|Patient Decision Unrelated to AE|2
1391833|NCT01297920|4592908|P2|Overall Study|Patient Decision Unrelated to AE|5
1391834|NCT01297920|4592909|P1|Overall Study|Patient Decision Unrelated to AE|6
1391835|NCT01297920|4592907|P3|Overall Study|Adverse Event|38
1391836|NCT01297920|4592908|P2|Overall Study|Adverse Event|10
1391837|NCT01297920|4592909|P1|Overall Study|Adverse Event|42
1391838|NCT01297517|4592953|P3|Overall Study|Inadequate Control of IOP|2
1391839|NCT01297517|4592954|P2|Overall Study|Inadequate Control of IOP|1
1391840|NCT01297517|4592955|P1|Overall Study|Inadequate Control of IOP|1
1391841|NCT01297517|4592953|P3|Overall Study|Protocol Violation|1
1391842|NCT01297517|4592954|P2|Overall Study|Protocol Violation|1
1391843|NCT01297517|4592955|P1|Overall Study|Protocol Violation|1
1391844|NCT01297517|4592953|P3|Overall Study|Noncompliance|0
1391845|NCT01297517|4592954|P2|Overall Study|Noncompliance|0
1391846|NCT01297517|4592955|P1|Overall Study|Noncompliance|1
1391847|NCT01297517|4592953|P3|Overall Study|Patient Decision Unrelated to AE|7
1391848|NCT01297517|4592954|P2|Overall Study|Patient Decision Unrelated to AE|3
1391849|NCT01297517|4592955|P1|Overall Study|Patient Decision Unrelated to AE|2
1391850|NCT01297517|4592953|P3|Overall Study|Lost to Follow-up|1
1391851|NCT01297517|4592954|P2|Overall Study|Lost to Follow-up|0
1391852|NCT01297517|4592955|P1|Overall Study|Lost to Follow-up|1
1391853|NCT01297517|4592953|P3|Overall Study|Adverse Event|16
1391854|NCT01297517|4592954|P2|Overall Study|Adverse Event|7
1391855|NCT01297517|4592955|P1|Overall Study|Adverse Event|21
1391856|NCT01297504|4592963|P1|Overall Study|Protocol Violation|3
1391857|NCT01297504|4592963|P1|Overall Study|Site Closure|3
1391858|NCT01297504|4592963|P1|Overall Study|Withdrawal by Subject|9
1391859|NCT01297504|4592963|P1|Overall Study|Lost to Follow-up|43
1391860|NCT01297504|4592963|P1|Overall Study|Death|3
1391861|NCT01297504|4592963|P1|Overall Study|No Study Visits|4
1391862|NCT01297504|4592963|P1|Overall Study|Received Palivizumab in Previous Season|1
1391863|NCT01297504|4592963|P1|Overall Study|Invalid Consent|1
1391864|NCT01297491|4592977|P2|Overall Study|Death|1
1391865|NCT01297491|4592978|P1|Overall Study|Death|2
1391866|NCT01297491|4592977|P2|Overall Study|Patient/Guardian decision|4
1391867|NCT01297491|4592978|P1|Overall Study|Patient/Guardian decision|3
1391868|NCT01297491|4592977|P2|Overall Study|Progressive disease|20
1391869|NCT01297491|4592978|P1|Overall Study|Progressive disease|11
1391870|NCT01297491|4592977|P2|Overall Study|Physician Decision|2
1391871|NCT01297491|4592978|P1|Overall Study|Physician Decision|3
1391872|NCT01297491|4592977|P2|Overall Study|Adverse Event|6
1391873|NCT01297491|4592978|P1|Overall Study|Adverse Event|11
1391874|NCT01297465|4592996|P2|Overall Study|Intention to Freeze all Embryos|1
1391875|NCT01297465|4592997|P1|Overall Study|Intention to Freeze all Embryos|0
1391876|NCT01297465|4592996|P2|Overall Study|All Embryos Discarded|1
1391877|NCT01297465|4592997|P1|Overall Study|All Embryos Discarded|0
1391878|NCT01297465|4592996|P2|Overall Study|No Fertilization|4
1391879|NCT01297465|4592997|P1|Overall Study|No Fertilization|6
1391880|NCT01297465|4592996|P2|Overall Study|Poor oocyte quality|1
1391881|NCT01297465|4592997|P1|Overall Study|Poor oocyte quality|0
1391882|NCT01297465|4592996|P2|Overall Study|No Oocytes Retrieved|1
1391883|NCT01297465|4592997|P1|Overall Study|No Oocytes Retrieved|1
1391884|NCT01297465|4592996|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
1391885|NCT01297465|4592997|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
1391886|NCT01297465|4592996|P2|Overall Study|Lack of Ovarian Response|1
1391887|NCT01297465|4592997|P1|Overall Study|Lack of Ovarian Response|1
1391888|NCT01297322|4593050|P2|Overall Study|Withdrawal by Subject|1
1391889|NCT01297322|4593051|P1|Overall Study|Withdrawal by Subject|0
1391890|NCT01297322|4593050|P2|Overall Study|Lost to Follow-up|0
1391891|NCT01297322|4593051|P1|Overall Study|Lost to Follow-up|1
1391892|NCT01297270|4593079|P3|Overall Study|Not treated|0
1391893|NCT01297270|4593080|P2|Overall Study|Not treated|1
1391894|NCT01297270|4593081|P1|Overall Study|Not treated|0
1391895|NCT01297270|4593079|P3|Overall Study|Other reason not defined above|1
1391896|NCT01297270|4593080|P2|Overall Study|Other reason not defined above|3
1391897|NCT01297270|4593081|P1|Overall Study|Other reason not defined above|3
1391898|NCT01297270|4593079|P3|Overall Study|Withdrawal by Subject|7
1391899|NCT01297270|4593080|P2|Overall Study|Withdrawal by Subject|15
1391900|NCT01297270|4593081|P1|Overall Study|Withdrawal by Subject|7
1391901|NCT01297270|4593079|P3|Overall Study|Protocol Violation|0
1391902|NCT01297270|4593080|P2|Overall Study|Protocol Violation|2
1391903|NCT01297270|4593081|P1|Overall Study|Protocol Violation|0
1391904|NCT01297270|4593079|P3|Overall Study|Lost to Follow-up|1
1391905|NCT01297270|4593080|P2|Overall Study|Lost to Follow-up|2
1391906|NCT01297270|4593081|P1|Overall Study|Lost to Follow-up|1
1391907|NCT01297270|4593079|P3|Overall Study|Lack of Efficacy|15
1391908|NCT01297270|4593080|P2|Overall Study|Lack of Efficacy|17
1391909|NCT01297270|4593081|P1|Overall Study|Lack of Efficacy|15
1391910|NCT01297270|4593079|P3|Overall Study|Adverse Event|5
1391911|NCT01297270|4593080|P2|Overall Study|Adverse Event|32
1391912|NCT01297270|4593081|P1|Overall Study|Adverse Event|19
1391913|NCT01297062|4593130|P7|Overall Study|Subject Decision|2
1391914|NCT01297062|4593131|P6|Overall Study|Subject Decision|1
1391915|NCT01297062|4593132|P5|Overall Study|Subject Decision|1
1391916|NCT01297062|4593133|P4|Overall Study|Subject Decision|1
1391917|NCT01297062|4593134|P3|Overall Study|Subject Decision|0
1391918|NCT01297062|4593135|P2|Overall Study|Subject Decision|1
1391919|NCT01297062|4593136|P1|Overall Study|Subject Decision|1
1391920|NCT01297062|4593130|P7|Overall Study|Protocol Violation|0
1391921|NCT01297062|4593131|P6|Overall Study|Protocol Violation|0
1391922|NCT01297062|4593132|P5|Overall Study|Protocol Violation|1
1391923|NCT01297062|4593133|P4|Overall Study|Protocol Violation|0
1391924|NCT01297062|4593134|P3|Overall Study|Protocol Violation|0
1391925|NCT01297062|4593135|P2|Overall Study|Protocol Violation|0
1391926|NCT01297062|4593136|P1|Overall Study|Protocol Violation|0
1391927|NCT01297062|4593130|P7|Overall Study|Physician Decision|6
1391928|NCT01297062|4593131|P6|Overall Study|Physician Decision|0
1391929|NCT01297062|4593132|P5|Overall Study|Physician Decision|0
1391930|NCT01297062|4593133|P4|Overall Study|Physician Decision|0
1391931|NCT01297062|4593134|P3|Overall Study|Physician Decision|1
1391932|NCT01297062|4593135|P2|Overall Study|Physician Decision|0
1391933|NCT01297062|4593136|P1|Overall Study|Physician Decision|1
1391934|NCT01297062|4593130|P7|Overall Study|Adverse Event|0
1391935|NCT01297062|4593131|P6|Overall Study|Adverse Event|0
1391936|NCT01297062|4593132|P5|Overall Study|Adverse Event|0
1391937|NCT01297062|4593133|P4|Overall Study|Adverse Event|0
1391938|NCT01297062|4593134|P3|Overall Study|Adverse Event|1
1391939|NCT01297062|4593135|P2|Overall Study|Adverse Event|0
1391940|NCT01297062|4593136|P1|Overall Study|Adverse Event|2
1391941|NCT01296698|4593198|P2|Overall Study|Study Terminated by Sponsor|12
1391942|NCT01296698|4593199|P1|Overall Study|Study Terminated by Sponsor|209
1391943|NCT01296698|4593198|P2|Overall Study|Difficulty Contacting Subject|0
1391944|NCT01296698|4593199|P1|Overall Study|Difficulty Contacting Subject|2
1391945|NCT01296698|4593198|P2|Overall Study|Withdrawal by Subject|0
1391946|NCT01296698|4593199|P1|Overall Study|Withdrawal by Subject|12
1391947|NCT01296698|4593198|P2|Overall Study|Lost to Follow-up|1
1391948|NCT01296698|4593199|P1|Overall Study|Lost to Follow-up|19
1391949|NCT01296698|4593198|P2|Overall Study|Death|0
1391950|NCT01296698|4593199|P1|Overall Study|Death|1
1391951|NCT01296698|4593198|P2|Overall Study|Adverse Event|0
1391952|NCT01296698|4593199|P1|Overall Study|Adverse Event|1
1391953|NCT01296672|4593253|P2|Overall Study|Lost to Follow-up|18
1391954|NCT01296672|4593254|P1|Overall Study|Lost to Follow-up|73
1391955|NCT01296412|4593277|P2|Overall Study|Withdrawal by Subject|13
1391956|NCT01296412|4593278|P1|Overall Study|Withdrawal by Subject|10
1391957|NCT01296412|4593277|P2|Overall Study|Pregnancy|1
1391958|NCT01296412|4593278|P1|Overall Study|Pregnancy|0
1391959|NCT01296412|4593277|P2|Overall Study|Physician Decision|3
1391960|NCT01296412|4593278|P1|Overall Study|Physician Decision|1
1391961|NCT01296412|4593277|P2|Overall Study|Other reason not specified|15
1391962|NCT01296412|4593278|P1|Overall Study|Other reason not specified|20
1391963|NCT01296412|4593277|P2|Overall Study|Non-compliance with study drug|2
1391964|NCT01296412|4593278|P1|Overall Study|Non-compliance with study drug|1
1391965|NCT01296412|4593277|P2|Overall Study|Lost to Follow-up|7
1391966|NCT01296412|4593278|P1|Overall Study|Lost to Follow-up|10
1391967|NCT01296412|4593277|P2|Overall Study|Lack of Efficacy|0
1391968|NCT01296412|4593278|P1|Overall Study|Lack of Efficacy|1
1391969|NCT01296412|4593277|P2|Overall Study|Adverse Event|29
1391970|NCT01296412|4593278|P1|Overall Study|Adverse Event|8
1391971|NCT01296152|4593308|P1|Overall Study|Unwilling to adhere to study requirement|1
1391972|NCT01296035|4593335|P1|Overall Study|Withdrawal by Subject|1
1391973|NCT01295905|4593342|P2|Overall Study|Met exclusion criteria|0
1391974|NCT01295905|4593343|P1|Overall Study|Met exclusion criteria|1
1391975|NCT01295905|4593342|P2|Overall Study|Did not meet inclusion criteria|0
1391976|NCT01295905|4593343|P1|Overall Study|Did not meet inclusion criteria|1
1391977|NCT01295814|4593377|P2|Overall Study|Withdrawal by Subject|0
1391978|NCT01295814|4593378|P1|Overall Study|Withdrawal by Subject|2
1391979|NCT01295814|4593377|P2|Overall Study|Lack of Efficacy|2
1391980|NCT01295814|4593378|P1|Overall Study|Lack of Efficacy|0
1391981|NCT01295671|4593395|P3|Overall Study|Withdrawal by Subject|0
1391982|NCT01295671|4593396|P2|Overall Study|Withdrawal by Subject|1
1391983|NCT01295671|4593397|P1|Overall Study|Withdrawal by Subject|3
1391984|NCT01295671|4593395|P3|Overall Study|Lost to Follow-up|3
1391985|NCT01295671|4593396|P2|Overall Study|Lost to Follow-up|6
1391986|NCT01295671|4593397|P1|Overall Study|Lost to Follow-up|4
1391987|NCT01295320|4593435|P1|Overall Study|Unable to travel|1
1391988|NCT01295320|4593435|P1|Overall Study|Subject was bedridden|1
1391989|NCT01295320|4593435|P1|Overall Study|Withdrawal by Subject|2
1391990|NCT01295320|4593435|P1|Overall Study|Lost to Follow-up|4
1391991|NCT01295320|4593435|P1|Overall Study|Adverse Event|2
1391992|NCT01295281|4593452|P2|First Intervention (7 Days)|Death|1
1391993|NCT01295281|4593453|P1|First Intervention (7 Days)|Death|0
1391994|NCT01295034|4593491|P2|Overall Study|Lost to Follow-up|5
1391995|NCT01295034|4593492|P1|Overall Study|Lost to Follow-up|5
1391996|NCT01294917|4593500|P1|Overall Study|Inconvenience|1
1391997|NCT01294917|4593500|P1|Overall Study|Relocation|5
1391998|NCT01294800|4593510|P4|Overall Study|Did Not Meet Protocol Eligibility|0
1391999|NCT01294800|4593511|P3|Overall Study|Did Not Meet Protocol Eligibility|1
1392000|NCT01294800|4593512|P2|Overall Study|Did Not Meet Protocol Eligibility|1
1392001|NCT01294800|4593513|P1|Overall Study|Did Not Meet Protocol Eligibility|2
1392002|NCT01294800|4593510|P4|Overall Study|Non-compliance With Protocol|0
1392003|NCT01294800|4593511|P3|Overall Study|Non-compliance With Protocol|1
1392004|NCT01294800|4593512|P2|Overall Study|Non-compliance With Protocol|1
1392005|NCT01294800|4593513|P1|Overall Study|Non-compliance With Protocol|0
1392006|NCT01294800|4593510|P4|Overall Study|Lost to Follow-up|0
1392007|NCT01294800|4593511|P3|Overall Study|Lost to Follow-up|1
1392008|NCT01294800|4593512|P2|Overall Study|Lost to Follow-up|0
1392009|NCT01294800|4593513|P1|Overall Study|Lost to Follow-up|0
1392010|NCT01294800|4593510|P4|Overall Study|Subject Withdrew Consent|11
1392011|NCT01294800|4593511|P3|Overall Study|Subject Withdrew Consent|2
1392012|NCT01294800|4593512|P2|Overall Study|Subject Withdrew Consent|2
1392013|NCT01294800|4593513|P1|Overall Study|Subject Withdrew Consent|2
1392014|NCT01294800|4593510|P4|Overall Study|Adverse Event|5
1392015|NCT01294800|4593511|P3|Overall Study|Adverse Event|12
1392016|NCT01294800|4593512|P2|Overall Study|Adverse Event|6
1392017|NCT01294800|4593513|P1|Overall Study|Adverse Event|7
1392018|NCT01294787|4593539|P6|Period 3|Adverse Event|0
1392019|NCT01294787|4593540|P5|Period 3|Adverse Event|1
1392020|NCT01294787|4593541|P4|Period 3|Adverse Event|0
1392021|NCT01294787|4593542|P3|Period 3|Adverse Event|0
1392022|NCT01294787|4593543|P2|Period 3|Adverse Event|0
1392023|NCT01294787|4593544|P1|Period 3|Adverse Event|0
1392024|NCT01294787|4593539|P6|Period 2|No longer needs study drug|0
1392025|NCT01294787|4593540|P5|Period 2|No longer needs study drug|0
1392026|NCT01294787|4593541|P4|Period 2|No longer needs study drug|1
1392027|NCT01294787|4593542|P3|Period 2|No longer needs study drug|0
1392028|NCT01294787|4593543|P2|Period 2|No longer needs study drug|0
1392029|NCT01294787|4593544|P1|Period 2|No longer needs study drug|0
1392030|NCT01294787|4593539|P6|Period 2|Adverse Event|0
1392031|NCT01294787|4593540|P5|Period 2|Adverse Event|0
1392032|NCT01294787|4593541|P4|Period 2|Adverse Event|1
1392033|NCT01294787|4593542|P3|Period 2|Adverse Event|0
1392034|NCT01294787|4593543|P2|Period 2|Adverse Event|3
1392035|NCT01294787|4593544|P1|Period 2|Adverse Event|0
1392036|NCT01294787|4593539|P6|Period 1|Administrative problem|1
1392037|NCT01294787|4593540|P5|Period 1|Administrative problem|0
1392038|NCT01294787|4593541|P4|Period 1|Administrative problem|0
1392039|NCT01294787|4593542|P3|Period 1|Administrative problem|1
1392040|NCT01294787|4593543|P2|Period 1|Administrative problem|0
1392041|NCT01294787|4593544|P1|Period 1|Administrative problem|0
1392042|NCT01294787|4593539|P6|Period 1|Withdrawal by Subject|1
1392043|NCT01294787|4593540|P5|Period 1|Withdrawal by Subject|1
1392044|NCT01294787|4593541|P4|Period 1|Withdrawal by Subject|1
1392045|NCT01294787|4593542|P3|Period 1|Withdrawal by Subject|0
1392046|NCT01294787|4593543|P2|Period 1|Withdrawal by Subject|0
1392047|NCT01294787|4593544|P1|Period 1|Withdrawal by Subject|0
1392048|NCT01294787|4593539|P6|Period 1|Adverse Event|0
1392049|NCT01294787|4593540|P5|Period 1|Adverse Event|1
1392050|NCT01294787|4593541|P4|Period 1|Adverse Event|0
1392051|NCT01294787|4593542|P3|Period 1|Adverse Event|0
1392052|NCT01294787|4593543|P2|Period 1|Adverse Event|0
1392053|NCT01294787|4593544|P1|Period 1|Adverse Event|0
1392054|NCT01294696|4593635|P1|Overall Study|Site closure|52
1392055|NCT01294696|4593635|P1|Overall Study|Missing BPI Response|7
1392056|NCT01294696|4593635|P1|Overall Study|Protocol Violation|8
1392057|NCT01294696|4593635|P1|Overall Study|Screening failures|7
1392058|NCT01294683|4593649|P2|Post Crossover (Period III)|Withdrawal by Subject|2
1392059|NCT01294683|4593650|P1|Post Crossover (Period III)|Withdrawal by Subject|3
1392060|NCT01294683|4593649|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
1392061|NCT01294683|4593650|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
1392062|NCT01294683|4593649|P2|Post Crossover (Period III)|Lost to Follow-up|3
1392063|NCT01294683|4593650|P1|Post Crossover (Period III)|Lost to Follow-up|1
1392064|NCT01294683|4593649|P2|Post Crossover (Period III)|Adverse Event|6
1392065|NCT01294683|4593650|P1|Post Crossover (Period III)|Adverse Event|6
1392066|NCT01294683|4593649|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
1392067|NCT01294683|4593650|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
1392068|NCT01294683|4593649|P2|Precrossover (Periods I/II)|Technical Problems|1
1392069|NCT01294683|4593650|P1|Precrossover (Periods I/II)|Technical Problems|0
1392070|NCT01294683|4593649|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
1392071|NCT01294683|4593650|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
1392072|NCT01294683|4593649|P2|Precrossover (Periods I/II)|Protocol Violation|5
1392073|NCT01294683|4593650|P1|Precrossover (Periods I/II)|Protocol Violation|5
1392074|NCT01294683|4593649|P2|Precrossover (Periods I/II)|Physician Decision|0
1392075|NCT01294683|4593650|P1|Precrossover (Periods I/II)|Physician Decision|1
1392076|NCT01294683|4593649|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
1392077|NCT01294683|4593650|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
1392078|NCT01294683|4593649|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
1392079|NCT01294683|4593650|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
1392080|NCT01294683|4593649|P2|Precrossover (Periods I/II)|Adverse Event|52
1392081|NCT01294683|4593650|P1|Precrossover (Periods I/II)|Adverse Event|49
1392082|NCT01294644|4593703|P3|Overall Study|Miscellaneous Reason|4
1392083|NCT01294644|4593704|P2|Overall Study|Miscellaneous Reason|1
1392084|NCT01294644|4593705|P1|Overall Study|Miscellaneous Reason|2
1392085|NCT01294644|4593703|P3|Overall Study|Lost to Follow-up|5
1392086|NCT01294644|4593704|P2|Overall Study|Lost to Follow-up|2
1392087|NCT01294644|4593705|P1|Overall Study|Lost to Follow-up|3
1392088|NCT01294644|4593703|P3|Overall Study|Withdrawal by Subject|4
1392089|NCT01294644|4593704|P2|Overall Study|Withdrawal by Subject|7
1392090|NCT01294644|4593705|P1|Overall Study|Withdrawal by Subject|3
1392091|NCT01294644|4593703|P3|Overall Study|Adverse Event|1
1392092|NCT01294644|4593704|P2|Overall Study|Adverse Event|0
1392093|NCT01294644|4593705|P1|Overall Study|Adverse Event|2
1392094|NCT01294592|4593736|P2|Overall Study|Withdrawal by Subject|28
1392095|NCT01294592|4593737|P1|Overall Study|Withdrawal by Subject|28
1392096|NCT01294592|4593736|P2|Overall Study|Physician Decision|11
1392097|NCT01294592|4593737|P1|Overall Study|Physician Decision|6
1392098|NCT01294592|4593736|P2|Overall Study|Lost to Follow-up|9
1392099|NCT01294592|4593737|P1|Overall Study|Lost to Follow-up|7
1392100|NCT01294592|4593736|P2|Overall Study|Protocol Violation|7
1392101|NCT01294592|4593737|P1|Overall Study|Protocol Violation|1
1392102|NCT01294592|4593736|P2|Overall Study|Lack of Efficacy|5
1392103|NCT01294592|4593737|P1|Overall Study|Lack of Efficacy|7
1392104|NCT01294592|4593736|P2|Overall Study|Adverse Event|13
1392105|NCT01294592|4593737|P1|Overall Study|Adverse Event|28
1392106|NCT01294579|4593765|P1|Overall Study|Withdrawal by Subject|5
1392107|NCT01294579|4593765|P1|Overall Study|Physician Decision|3
1392108|NCT01294579|4593765|P1|Overall Study|Lost to Follow-up|1
1392109|NCT01294579|4593765|P1|Overall Study|Study closed/terminated|3
1392110|NCT01294579|4593765|P1|Overall Study|Adverse Event|11
1392111|NCT01294579|4593765|P1|Overall Study|Disease progression|12
1392112|NCT01294553|4593775|P1|Overall Study|Protocol Violation|268
1392113|NCT01294553|4593775|P1|Overall Study|Duplicated Participants|1
1392114|NCT01294514|4593781|P1|Overall Study|Excluded due to Arrhythmia|1
1392115|NCT01294462|4593791|P2|Overall Study|Withdrawal by Subject|63
1392116|NCT01294462|4593792|P1|Overall Study|Withdrawal by Subject|65
1392117|NCT01294462|4593791|P2|Overall Study|Lost to Follow-up|0
1392118|NCT01294462|4593792|P1|Overall Study|Lost to Follow-up|1
1392119|NCT01294449|4593806|P2|Overall Study|Withdrawal by Subject|3
1392120|NCT01294449|4593807|P1|Overall Study|Withdrawal by Subject|1
1392121|NCT01294449|4593806|P2|Overall Study|Death|12
1392122|NCT01294449|4593807|P1|Overall Study|Death|11
1392123|NCT01294436|4593815|P2|Overall Study|poor/non-compliance|5
1392124|NCT01294436|4593816|P1|Overall Study|poor/non-compliance|2
1392125|NCT01294436|4593815|P2|Overall Study|subject no longer meets study criteria|20
1392126|NCT01294436|4593816|P1|Overall Study|subject no longer meets study criteria|5
1392127|NCT01294436|4593815|P2|Overall Study|Withdrawal by Subject|28
1392128|NCT01294436|4593816|P1|Overall Study|Withdrawal by Subject|11
1392129|NCT01294436|4593815|P2|Overall Study|Adverse Event|17
1392130|NCT01294436|4593816|P1|Overall Study|Adverse Event|10
1392131|NCT01294423|4593851|P3|Overall Study|poor/non-compliance|1
1392132|NCT01294423|4593852|P2|Overall Study|poor/non-compliance|0
1392133|NCT01294423|4593853|P1|Overall Study|poor/non-compliance|1
1392134|NCT01294423|4593851|P3|Overall Study|subject no longer meets study criteria|2
1392135|NCT01294423|4593852|P2|Overall Study|subject no longer meets study criteria|5
1392136|NCT01294423|4593853|P1|Overall Study|subject no longer meets study criteria|2
1392137|NCT01294423|4593851|P3|Overall Study|Withdrawal by Subject|2
1392138|NCT01294423|4593852|P2|Overall Study|Withdrawal by Subject|2
1392139|NCT01294423|4593853|P1|Overall Study|Withdrawal by Subject|1
1392140|NCT01294423|4593851|P3|Overall Study|Adverse Event|3
1392141|NCT01294423|4593852|P2|Overall Study|Adverse Event|2
1392142|NCT01294423|4593853|P1|Overall Study|Adverse Event|1
1392143|NCT01294397|4593867|P1|Overall Study|Administrative Decision|1
1392144|NCT01294397|4593867|P1|Overall Study|Withdrawal by Subject|1
1392145|NCT01294371|4593911|P1|Overall Study|Other|14
1392146|NCT01294371|4593911|P1|Overall Study|Administrative Reason|1
1392147|NCT01294371|4593911|P1|Overall Study|Lost to Follow-up|6
1392148|NCT01294371|4593911|P1|Overall Study|Withdrawal by Subject|12
1392149|NCT01294371|4593911|P1|Overall Study|Adverse Event|1
1392150|NCT01294150|4593993|P2|Overall Study|Physician Decision|2
1392151|NCT01294150|4593994|P1|Overall Study|Physician Decision|2
1392152|NCT01294046|4594023|P1|Overall Study|Stimulation response inadqequate|1
1392153|NCT01294046|4594023|P1|Overall Study|Eligibility criteria expanded|1
1392154|NCT01294046|4594023|P1|Overall Study|Infection and surgical explant|1
1392155|NCT01293968|4594038|P2|Overall Study|non-cooperation|3
1392156|NCT01293968|4594039|P1|Overall Study|non-cooperation|3
1392157|NCT01293695|4594059|P2|Overall Study|Lost to Follow-up|6
1392158|NCT01293695|4594060|P1|Overall Study|Lost to Follow-up|8
1392159|NCT01293695|4594059|P2|Overall Study|Withdrawal by Subject|1
1392160|NCT01293695|4594060|P1|Overall Study|Withdrawal by Subject|7
1392161|NCT01293539|4594074|P1|Overall Study|Physician Decision|1
1392162|NCT01293240|4594078|P1|Overall Study|Noncompliance|2
1392163|NCT01293084|4594093|P1|Overall Study|Withdrawal by Subject|2
1392164|NCT01293084|4594093|P1|Overall Study|Physician Decision|3
1392165|NCT01293032|4594105|P4|Treatment|Disease Progression, relapse|0
1392166|NCT01293032|4594106|P3|Treatment|Disease Progression, relapse|0
1392167|NCT01293032|4594107|P2|Treatment|Disease Progression, relapse|1
1392168|NCT01293032|4594108|P1|Treatment|Disease Progression, relapse|0
1392169|NCT01293032|4594105|P4|Treatment|Withdrawal by Subject|0
1392170|NCT01293032|4594106|P3|Treatment|Withdrawal by Subject|0
1392171|NCT01293032|4594107|P2|Treatment|Withdrawal by Subject|4
1392172|NCT01293032|4594108|P1|Treatment|Withdrawal by Subject|2
1392173|NCT01293032|4594105|P4|Treatment|Adverse Event|1
1392174|NCT01293032|4594106|P3|Treatment|Adverse Event|1
1392175|NCT01293032|4594107|P2|Treatment|Adverse Event|0
1392176|NCT01293032|4594108|P1|Treatment|Adverse Event|0
1392177|NCT01293032|4594105|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
1392178|NCT01293032|4594106|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
1392179|NCT01293032|4594107|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
1392180|NCT01293032|4594108|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
1392181|NCT01293006|4594119|P4|Period 2|Lost to Follow-up|0
1392182|NCT01293006|4594120|P3|Period 2|Lost to Follow-up|0
1392183|NCT01293006|4594121|P2|Period 2|Lost to Follow-up|0
1392184|NCT01293006|4594122|P1|Period 2|Lost to Follow-up|1
1392185|NCT01292928|4594143|P1|Overall Study|Physician Decision|2
1392186|NCT01292928|4594143|P1|Overall Study|Lost to Follow-up|6
1392187|NCT01292928|4594143|P1|Overall Study|Withdrawal by Subject|8
1392188|NCT01292928|4594143|P1|Overall Study|Death|8
1392189|NCT01292876|4594160|P1|Overall Study|Physician Decision|4
1392190|NCT01292837|4594166|P1|Overall Study|Further treatment determined|1
1392191|NCT01292837|4594166|P1|Overall Study|Adverse Event|1
1392192|NCT01292603|4594203|P6|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
1392193|NCT01292603|4594204|P5|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
1392194|NCT01292603|4594205|P4|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
1392195|NCT01292603|4594206|P3|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
1392196|NCT01292603|4594207|P2|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
1392197|NCT01292603|4594208|P1|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
1392198|NCT01292603|4594203|P6|Part 2: Survival Follow-UP|Death|3
1392199|NCT01292603|4594204|P5|Part 2: Survival Follow-UP|Death|1
1392200|NCT01292603|4594205|P4|Part 2: Survival Follow-UP|Death|0
1392201|NCT01292603|4594206|P3|Part 2: Survival Follow-UP|Death|0
1392202|NCT01292603|4594207|P2|Part 2: Survival Follow-UP|Death|0
1392203|NCT01292603|4594208|P1|Part 2: Survival Follow-UP|Death|0
1392204|NCT01292603|4594203|P6|Part 2: Regular Follow-Up|Noncompliance|0
1392205|NCT01292603|4594204|P5|Part 2: Regular Follow-Up|Noncompliance|1
1392206|NCT01292603|4594205|P4|Part 2: Regular Follow-Up|Noncompliance|0
1392207|NCT01292603|4594206|P3|Part 2: Regular Follow-Up|Noncompliance|0
1392208|NCT01292603|4594207|P2|Part 2: Regular Follow-Up|Noncompliance|0
1392209|NCT01292603|4594208|P1|Part 2: Regular Follow-Up|Noncompliance|0
1392210|NCT01292603|4594203|P6|Part 2: Regular Follow-Up|Disease Progression|4
1392211|NCT01292603|4594204|P5|Part 2: Regular Follow-Up|Disease Progression|2
1392212|NCT01292603|4594205|P4|Part 2: Regular Follow-Up|Disease Progression|0
1392213|NCT01292603|4594206|P3|Part 2: Regular Follow-Up|Disease Progression|0
1392214|NCT01292603|4594207|P2|Part 2: Regular Follow-Up|Disease Progression|0
1392215|NCT01292603|4594208|P1|Part 2: Regular Follow-Up|Disease Progression|0
1392216|NCT01292603|4594203|P6|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|72
1392217|NCT01292603|4594204|P5|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|73
1392218|NCT01292603|4594205|P4|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
1392219|NCT01292603|4594206|P3|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
1392220|NCT01292603|4594207|P2|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
1392221|NCT01292603|4594208|P1|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
1392222|NCT01292603|4594203|P6|Part 2: Regular Follow-Up|Death|2
1392223|NCT01292603|4594204|P5|Part 2: Regular Follow-Up|Death|2
1392224|NCT01292603|4594205|P4|Part 2: Regular Follow-Up|Death|0
1392225|NCT01292603|4594206|P3|Part 2: Regular Follow-Up|Death|0
1392226|NCT01292603|4594207|P2|Part 2: Regular Follow-Up|Death|0
1392227|NCT01292603|4594208|P1|Part 2: Regular Follow-Up|Death|0
1392228|NCT01292603|4594203|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
1392229|NCT01292603|4594204|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
1392230|NCT01292603|4594205|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
1392231|NCT01292603|4594206|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
1392232|NCT01292603|4594207|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
1392233|NCT01292603|4594208|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
1392234|NCT01292603|4594203|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
1392235|NCT01292603|4594204|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
1392236|NCT01292603|4594205|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
1392237|NCT01292603|4594206|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
1392238|NCT01292603|4594207|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
1392239|NCT01292603|4594208|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
1392240|NCT01292603|4594203|P6|Part 2: Dose Confirmation Period|Adverse Event|9
1392241|NCT01292603|4594204|P5|Part 2: Dose Confirmation Period|Adverse Event|7
1392242|NCT01292603|4594205|P4|Part 2: Dose Confirmation Period|Adverse Event|0
1392243|NCT01292603|4594206|P3|Part 2: Dose Confirmation Period|Adverse Event|0
1392244|NCT01292603|4594207|P2|Part 2: Dose Confirmation Period|Adverse Event|0
1392245|NCT01292603|4594208|P1|Part 2: Dose Confirmation Period|Adverse Event|0
1392246|NCT01292603|4594203|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
1392247|NCT01292603|4594204|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
1392248|NCT01292603|4594205|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
1392249|NCT01292603|4594206|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
1392250|NCT01292603|4594207|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
1392251|NCT01292603|4594208|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
1392252|NCT01292603|4594203|P6|Part 2: Dose Confirmation Period|Physician Decision|0
1392253|NCT01292603|4594204|P5|Part 2: Dose Confirmation Period|Physician Decision|2
1392254|NCT01292603|4594205|P4|Part 2: Dose Confirmation Period|Physician Decision|0
1392255|NCT01292603|4594206|P3|Part 2: Dose Confirmation Period|Physician Decision|0
1392256|NCT01292603|4594207|P2|Part 2: Dose Confirmation Period|Physician Decision|0
1392257|NCT01292603|4594208|P1|Part 2: Dose Confirmation Period|Physician Decision|0
1392258|NCT01292603|4594203|P6|Part 2: Dose Confirmation Period|Death|0
1392259|NCT01292603|4594204|P5|Part 2: Dose Confirmation Period|Death|1
1392260|NCT01292603|4594205|P4|Part 2: Dose Confirmation Period|Death|0
1392261|NCT01292603|4594206|P3|Part 2: Dose Confirmation Period|Death|0
1392262|NCT01292603|4594207|P2|Part 2: Dose Confirmation Period|Death|0
1392263|NCT01292603|4594208|P1|Part 2: Dose Confirmation Period|Death|0
1392264|NCT01292603|4594203|P6|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
1392265|NCT01292603|4594204|P5|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
1392266|NCT01292603|4594205|P4|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
1392267|NCT01292603|4594206|P3|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|1
1392268|NCT01292603|4594207|P2|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|2
1392269|NCT01292603|4594208|P1|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|3
1392270|NCT01292603|4594203|P6|Part 1: Survival Follow-Up|Death|0
1392271|NCT01292603|4594204|P5|Part 1: Survival Follow-Up|Death|0
1392272|NCT01292603|4594205|P4|Part 1: Survival Follow-Up|Death|0
1392273|NCT01292603|4594206|P3|Part 1: Survival Follow-Up|Death|1
1392274|NCT01292603|4594207|P2|Part 1: Survival Follow-Up|Death|0
1392275|NCT01292603|4594208|P1|Part 1: Survival Follow-Up|Death|1
1392276|NCT01292603|4594203|P6|Part 1: Regular Follow-Up Period|Adverse Event|0
1392277|NCT01292603|4594204|P5|Part 1: Regular Follow-Up Period|Adverse Event|0
1392278|NCT01292603|4594205|P4|Part 1: Regular Follow-Up Period|Adverse Event|0
1392279|NCT01292603|4594206|P3|Part 1: Regular Follow-Up Period|Adverse Event|0
1392280|NCT01292603|4594207|P2|Part 1: Regular Follow-Up Period|Adverse Event|0
1392281|NCT01292603|4594208|P1|Part 1: Regular Follow-Up Period|Adverse Event|1
1392282|NCT01292603|4594203|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
1392283|NCT01292603|4594204|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
1392284|NCT01292603|4594205|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
1392285|NCT01292603|4594206|P3|Part 1: Regular Follow-Up Period|Disease Progression|2
1392286|NCT01292603|4594207|P2|Part 1: Regular Follow-Up Period|Disease Progression|2
1392287|NCT01292603|4594208|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
1392288|NCT01292603|4594203|P6|Part 1: Regular Follow-Up Period|Death|0
1392289|NCT01292603|4594204|P5|Part 1: Regular Follow-Up Period|Death|0
1392290|NCT01292603|4594205|P4|Part 1: Regular Follow-Up Period|Death|0
1392291|NCT01292603|4594206|P3|Part 1: Regular Follow-Up Period|Death|2
1392292|NCT01292603|4594207|P2|Part 1: Regular Follow-Up Period|Death|0
1392293|NCT01292603|4594208|P1|Part 1: Regular Follow-Up Period|Death|1
1392294|NCT01292603|4594203|P6|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
1392295|NCT01292603|4594204|P5|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
1392296|NCT01292603|4594205|P4|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
1392297|NCT01292603|4594206|P3|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|19
1392298|NCT01292603|4594207|P2|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|15
1392299|NCT01292603|4594208|P1|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|11
1392300|NCT01292603|4594203|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
1392301|NCT01292603|4594204|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
1392302|NCT01292603|4594205|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
1392303|NCT01292603|4594206|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
1392304|NCT01292603|4594207|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
1392305|NCT01292603|4594208|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
1392306|NCT01292603|4594203|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
1392307|NCT01292603|4594204|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
1392308|NCT01292603|4594205|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
1392309|NCT01292603|4594206|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
1392310|NCT01292603|4594207|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
1392311|NCT01292603|4594208|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
1392312|NCT01292603|4594203|P6|Part 1: Pilot Dose Selection Period|Death|0
1392313|NCT01292603|4594204|P5|Part 1: Pilot Dose Selection Period|Death|0
1392314|NCT01292603|4594205|P4|Part 1: Pilot Dose Selection Period|Death|1
1392315|NCT01292603|4594206|P3|Part 1: Pilot Dose Selection Period|Death|0
1392316|NCT01292603|4594207|P2|Part 1: Pilot Dose Selection Period|Death|0
1392317|NCT01292603|4594208|P1|Part 1: Pilot Dose Selection Period|Death|0
1392318|NCT01292603|4594203|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
1392319|NCT01292603|4594204|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
1392320|NCT01292603|4594205|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
1392321|NCT01292603|4594206|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
1392322|NCT01292603|4594207|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
1392323|NCT01292603|4594208|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
1392324|NCT01292486|4594261|P1|Overall Study|Physician Decision|1
1392325|NCT01292486|4594261|P1|Overall Study|Adverse Event|1
1392326|NCT01292486|4594261|P1|Overall Study|Did not meet screening criteria|2
1392327|NCT01292486|4594261|P1|Overall Study|Protocol Violation|2
1392328|NCT01292473|4594275|P4|Overall Study|Disease Progression|6
1392329|NCT01292473|4594276|P3|Overall Study|Disease Progression|3
1392330|NCT01292473|4594277|P2|Overall Study|Disease Progression|1
1392331|NCT01292473|4594278|P1|Overall Study|Disease Progression|0
1392332|NCT01292473|4594275|P4|Overall Study|Physician Decision|0
1392333|NCT01292473|4594276|P3|Overall Study|Physician Decision|0
1392334|NCT01292473|4594277|P2|Overall Study|Physician Decision|1
1392335|NCT01292473|4594278|P1|Overall Study|Physician Decision|0
1392336|NCT01292473|4594275|P4|Overall Study|Withdrawal by Subject|3
1392337|NCT01292473|4594276|P3|Overall Study|Withdrawal by Subject|3
1392338|NCT01292473|4594277|P2|Overall Study|Withdrawal by Subject|4
1392339|NCT01292473|4594278|P1|Overall Study|Withdrawal by Subject|3
1392340|NCT01292473|4594275|P4|Overall Study|Lost to Follow-up|2
1392341|NCT01292473|4594276|P3|Overall Study|Lost to Follow-up|2
1392342|NCT01292473|4594277|P2|Overall Study|Lost to Follow-up|1
1392343|NCT01292473|4594278|P1|Overall Study|Lost to Follow-up|1
1392344|NCT01292473|4594275|P4|Overall Study|Adverse Event|1
1392345|NCT01292473|4594276|P3|Overall Study|Adverse Event|1
1392346|NCT01292473|4594277|P2|Overall Study|Adverse Event|0
1392347|NCT01292473|4594278|P1|Overall Study|Adverse Event|1
1392348|NCT01292239|4594337|P2|Overall Study|Withdrawal by Subject|6
1392349|NCT01292239|4594338|P1|Overall Study|Withdrawal by Subject|3
1392350|NCT01292239|4594337|P2|Overall Study|Not specified|1
1392351|NCT01292239|4594338|P1|Overall Study|Not specified|1
1392352|NCT01292226|4594359|P1|Overall Study|Not specified|2
1392353|NCT01292226|4594359|P1|Overall Study|Withdrawal by Subject|1
1392354|NCT01292226|4594359|P1|Overall Study|Protocol Violation|3
1392355|NCT01292226|4594359|P1|Overall Study|Graft loss|1
1392356|NCT01292226|4594359|P1|Overall Study|Death|1
1392357|NCT01292226|4594359|P1|Overall Study|Adverse Event|5
1392358|NCT01292187|4594392|P2|Overall Study|All other reasons|3
1392359|NCT01292187|4594393|P1|Overall Study|All other reasons|1
1392360|NCT01292187|4594392|P2|Overall Study|Withdrawal by Subject|5
1392361|NCT01292187|4594393|P1|Overall Study|Withdrawal by Subject|6
1392362|NCT01292187|4594392|P2|Overall Study|Adverse Event|5
1392363|NCT01292187|4594393|P1|Overall Study|Adverse Event|10
1392364|NCT01292057|4594428|P2|Overall Study|Lost to Follow-up|1
1392365|NCT01292057|4594429|P1|Overall Study|Lost to Follow-up|1
1392366|NCT01292057|4594428|P2|Overall Study|Protocol Violation|1
1392367|NCT01292057|4594429|P1|Overall Study|Protocol Violation|1
1392368|NCT01291277|4594501|P2|Overall Study|Lost to Follow-up|1
1392369|NCT01291277|4594502|P1|Overall Study|Lost to Follow-up|3
1392370|NCT01291277|4594501|P2|Overall Study|Death|2
1392371|NCT01291277|4594502|P1|Overall Study|Death|2
1392372|NCT01291225|4594514|P2|Overall Study|Lost to Follow-up|39
1392373|NCT01291225|4594515|P1|Overall Study|Lost to Follow-up|85
1392374|NCT01291173|4594529|P4|Overall Study|Excluded therapy|0
1392375|NCT01291173|4594530|P3|Overall Study|Excluded therapy|1
1392376|NCT01291173|4594531|P2|Overall Study|Excluded therapy|0
1392377|NCT01291173|4594532|P1|Overall Study|Excluded therapy|0
1392378|NCT01291173|4594529|P4|Overall Study|Subject was unblinded|0
1392379|NCT01291173|4594530|P3|Overall Study|Subject was unblinded|1
1392380|NCT01291173|4594531|P2|Overall Study|Subject was unblinded|0
1392381|NCT01291173|4594532|P1|Overall Study|Subject was unblinded|0
1392382|NCT01291173|4594529|P4|Overall Study|Lack of compliance|1
1392383|NCT01291173|4594530|P3|Overall Study|Lack of compliance|0
1392384|NCT01291173|4594531|P2|Overall Study|Lack of compliance|0
1392385|NCT01291173|4594532|P1|Overall Study|Lack of compliance|0
1392386|NCT01291173|4594529|P4|Overall Study|Unable to meet visit schedule|0
1392387|NCT01291173|4594530|P3|Overall Study|Unable to meet visit schedule|1
1392388|NCT01291173|4594531|P2|Overall Study|Unable to meet visit schedule|0
1392389|NCT01291173|4594532|P1|Overall Study|Unable to meet visit schedule|0
1392390|NCT01291173|4594529|P4|Overall Study|Lost to Follow-up|2
1392391|NCT01291173|4594530|P3|Overall Study|Lost to Follow-up|3
1392392|NCT01291173|4594531|P2|Overall Study|Lost to Follow-up|6
1392393|NCT01291173|4594532|P1|Overall Study|Lost to Follow-up|4
1392394|NCT01291173|4594529|P4|Overall Study|Withdrawal by Subject|2
1392395|NCT01291173|4594530|P3|Overall Study|Withdrawal by Subject|4
1392396|NCT01291173|4594531|P2|Overall Study|Withdrawal by Subject|4
1392397|NCT01291173|4594532|P1|Overall Study|Withdrawal by Subject|6
1392398|NCT01291173|4594529|P4|Overall Study|Protocol Violation|5
1392399|NCT01291173|4594530|P3|Overall Study|Protocol Violation|2
1392400|NCT01291173|4594531|P2|Overall Study|Protocol Violation|2
1392401|NCT01291173|4594532|P1|Overall Study|Protocol Violation|7
1392402|NCT01291173|4594529|P4|Overall Study|Adverse Event|3
1392403|NCT01291173|4594530|P3|Overall Study|Adverse Event|1
1392404|NCT01291173|4594531|P2|Overall Study|Adverse Event|3
1392405|NCT01291173|4594532|P1|Overall Study|Adverse Event|0
1392406|NCT01291017|4594641|P1|Overall Study|Withdrawal by Subject|3
1392407|NCT01291017|4594641|P1|Overall Study|Lost to Follow-up|2
1392408|NCT01290887|4594674|P2|Overall Study|Not specified|6
1392409|NCT01290887|4594675|P1|Overall Study|Not specified|3
1392410|NCT01290887|4594674|P2|Overall Study|Sponsor closure of study|476
1392411|NCT01290887|4594675|P1|Overall Study|Sponsor closure of study|420
1392412|NCT01290887|4594674|P2|Overall Study|Non-compliance to study medications|0
1392413|NCT01290887|4594675|P1|Overall Study|Non-compliance to study medications|1
1392414|NCT01290887|4594674|P2|Overall Study|Non-compliance to study procedures|1
1392415|NCT01290887|4594675|P1|Overall Study|Non-compliance to study procedures|0
1392416|NCT01290887|4594674|P2|Overall Study|Lost to Follow-up|4
1392417|NCT01290887|4594675|P1|Overall Study|Lost to Follow-up|4
1392418|NCT01290887|4594674|P2|Overall Study|Protocol Violation|1
1392419|NCT01290887|4594675|P1|Overall Study|Protocol Violation|2
1392420|NCT01290887|4594674|P2|Overall Study|Withdrawal by Subject|32
1392421|NCT01290887|4594675|P1|Overall Study|Withdrawal by Subject|26
1392422|NCT01290887|4594674|P2|Overall Study|Lack of Efficacy|5
1392423|NCT01290887|4594675|P1|Overall Study|Lack of Efficacy|4
1392424|NCT01290887|4594674|P2|Overall Study|Adverse Event|11
1392425|NCT01290887|4594675|P1|Overall Study|Adverse Event|6
1392426|NCT01290822|4594736|P1|Overall Study|Physician Decision|10
1392427|NCT01290822|4594736|P1|Overall Study|Withdrawal by Subject|1
1392428|NCT01290796|4594745|P1|Overall Study|Withdrawal by Sponsor|1
1392429|NCT01290796|4594745|P1|Overall Study|Secondary Surgical Intervention|2
1392430|NCT01290796|4594745|P1|Overall Study|Physician Decision|2
1392431|NCT01290796|4594745|P1|Overall Study|Withdrawal by Subject|4
1392432|NCT01290796|4594745|P1|Overall Study|Lost to Follow-up|21
1392433|NCT01290757|4594761|P2|Overall Study|Other|1
1392434|NCT01290757|4594762|P1|Overall Study|Other|0
1392435|NCT01290757|4594761|P2|Overall Study|Protocol Violation|1
1392436|NCT01290757|4594762|P1|Overall Study|Protocol Violation|1
1392437|NCT01290757|4594761|P2|Overall Study|Adverse Event|0
1392438|NCT01290757|4594762|P1|Overall Study|Adverse Event|1
1392439|NCT01290731|4594778|P1|Overall Study|Withdrawal by Subject|1
1392440|NCT01290718|4594790|P1|Overall Study|Early termination of the study|4
1392441|NCT01290679|4594799|P2|Overall Study|Subject Entered Another Trial|5
1392442|NCT01290679|4594800|P1|Overall Study|Subject Entered Another Trial|0
1392443|NCT01290679|4594799|P2|Overall Study|Withdrawal by Subject|5
1392444|NCT01290679|4594800|P1|Overall Study|Withdrawal by Subject|6
1392445|NCT01290679|4594799|P2|Overall Study|Protocol Violation|1
1392446|NCT01290679|4594800|P1|Overall Study|Protocol Violation|0
1392447|NCT01290679|4594799|P2|Overall Study|Lost to Follow-up|10
1392448|NCT01290679|4594800|P1|Overall Study|Lost to Follow-up|8
1392449|NCT01290679|4594799|P2|Overall Study|Adverse Event|0
1392450|NCT01290679|4594800|P1|Overall Study|Adverse Event|2
1392451|NCT01290666|4594869|P1|Overall Study|Early Termination of Study|4
1392452|NCT01290666|4594869|P1|Overall Study|Withdrawal by Subject|23
1392453|NCT01290666|4594869|P1|Overall Study|Lost to Follow-up|11
1392454|NCT01290601|4594922|P4|Overall Study|Protocol Violation|0
1392455|NCT01290601|4594923|P3|Overall Study|Protocol Violation|0
1392456|NCT01290601|4594924|P2|Overall Study|Protocol Violation|0
1392457|NCT01290601|4594925|P1|Overall Study|Protocol Violation|1
1392458|NCT01290601|4594922|P4|Overall Study|Other|0
1392459|NCT01290601|4594923|P3|Overall Study|Other|0
1392460|NCT01290601|4594924|P2|Overall Study|Other|0
1392461|NCT01290601|4594925|P1|Overall Study|Other|1
1392462|NCT01290601|4594922|P4|Overall Study|Lost to Follow-up|0
1392463|NCT01290601|4594923|P3|Overall Study|Lost to Follow-up|0
1392464|NCT01290601|4594924|P2|Overall Study|Lost to Follow-up|2
1392465|NCT01290601|4594925|P1|Overall Study|Lost to Follow-up|7
1392466|NCT01290601|4594922|P4|Overall Study|Lack of Efficacy|0
1392467|NCT01290601|4594923|P3|Overall Study|Lack of Efficacy|0
1392468|NCT01290601|4594924|P2|Overall Study|Lack of Efficacy|1
1392469|NCT01290601|4594925|P1|Overall Study|Lack of Efficacy|2
1392470|NCT01290601|4594922|P4|Overall Study|Adverse Event|0
1392471|NCT01290601|4594923|P3|Overall Study|Adverse Event|0
1392472|NCT01290601|4594924|P2|Overall Study|Adverse Event|2
1392473|NCT01290601|4594925|P1|Overall Study|Adverse Event|0
1392474|NCT01290341|4594957|P2|Overall Study|Negative baseline culture and others|11
1392475|NCT01290341|4594958|P1|Overall Study|Negative baseline culture and others|44
1392476|NCT01290341|4594957|P2|Overall Study|Withdrawal by Subject|5
1392477|NCT01290341|4594958|P1|Overall Study|Withdrawal by Subject|19
1392478|NCT01290341|4594957|P2|Overall Study|Lost to Follow-up|10
1392479|NCT01290341|4594958|P1|Overall Study|Lost to Follow-up|21
1392480|NCT01290341|4594957|P2|Overall Study|Adverse Event|0
1392481|NCT01290341|4594958|P1|Overall Study|Adverse Event|1
1392482|NCT01290341|4594957|P2|Overall Study|Protocol Violation|3
1392483|NCT01290341|4594958|P1|Overall Study|Protocol Violation|7
1392484|NCT01290315|4594970|P4|Overall Study|Withdrawal by Subject|0
1392485|NCT01290315|4594971|P3|Overall Study|Withdrawal by Subject|0
1392486|NCT01290315|4594972|P2|Overall Study|Withdrawal by Subject|1
1392487|NCT01290315|4594973|P1|Overall Study|Withdrawal by Subject|1
1392488|NCT01290315|4594970|P4|Overall Study|Lost to Follow-up|0
1392489|NCT01290315|4594971|P3|Overall Study|Lost to Follow-up|0
1392490|NCT01290315|4594972|P2|Overall Study|Lost to Follow-up|1
1392491|NCT01290315|4594973|P1|Overall Study|Lost to Follow-up|0
1392492|NCT01290315|4594970|P4|Overall Study|Selection criteria/compliance|2
1392493|NCT01290315|4594971|P3|Overall Study|Selection criteria/compliance|0
1392494|NCT01290315|4594972|P2|Overall Study|Selection criteria/compliance|1
1392495|NCT01290315|4594973|P1|Overall Study|Selection criteria/compliance|2
1392496|NCT01290315|4594970|P4|Overall Study|Adverse Event|3
1392497|NCT01290315|4594971|P3|Overall Study|Adverse Event|0
1392498|NCT01290315|4594972|P2|Overall Study|Adverse Event|0
1392499|NCT01290315|4594973|P1|Overall Study|Adverse Event|0
1392500|NCT01290263|4594995|P5|Overall Study|Participant Non-Compliance|1
1392501|NCT01290263|4594996|P4|Overall Study|Participant Non-Compliance|1
1392502|NCT01290263|4594997|P3|Overall Study|Participant Non-Compliance|0
1392503|NCT01290263|4594998|P2|Overall Study|Participant Non-Compliance|0
1392504|NCT01290263|4594999|P1|Overall Study|Participant Non-Compliance|0
1392505|NCT01290263|4594995|P5|Overall Study|Withdrawal by Subject|2
1392506|NCT01290263|4594996|P4|Overall Study|Withdrawal by Subject|1
1392507|NCT01290263|4594997|P3|Overall Study|Withdrawal by Subject|0
1392508|NCT01290263|4594998|P2|Overall Study|Withdrawal by Subject|1
1392509|NCT01290263|4594999|P1|Overall Study|Withdrawal by Subject|3
1392510|NCT01290263|4594995|P5|Overall Study|Lack of Efficacy|33
1392511|NCT01290263|4594996|P4|Overall Study|Lack of Efficacy|24
1392512|NCT01290263|4594997|P3|Overall Study|Lack of Efficacy|7
1392513|NCT01290263|4594998|P2|Overall Study|Lack of Efficacy|2
1392514|NCT01290263|4594999|P1|Overall Study|Lack of Efficacy|8
1392515|NCT01290263|4594995|P5|Overall Study|Adverse Event|1
1392516|NCT01290263|4594996|P4|Overall Study|Adverse Event|1
1392517|NCT01290263|4594997|P3|Overall Study|Adverse Event|0
1392518|NCT01290263|4594998|P2|Overall Study|Adverse Event|0
1392519|NCT01290263|4594999|P1|Overall Study|Adverse Event|0
1392520|NCT01290224|4595026|P1|Overall Study|Refused Further Treatment|4
1392521|NCT01290224|4595026|P1|Overall Study|Adverse Event|1
1392522|NCT01290094|4595037|P1|Overall Study|Lost to Follow-up|5
1392523|NCT01290094|4595037|P1|Overall Study|Withdrawal by Subject|1
1392524|NCT01290068|4595050|P2|Overall Study|Other|1
1392525|NCT01290068|4595051|P1|Overall Study|Other|3
1392526|NCT01290068|4595050|P2|Overall Study|Withdrawal by subject prior to implant|2
1392527|NCT01290068|4595051|P1|Overall Study|Withdrawal by subject prior to implant|0
1392528|NCT01290068|4595050|P2|Overall Study|Lost to Follow-up|0
1392529|NCT01290068|4595051|P1|Overall Study|Lost to Follow-up|3
1392530|NCT01290068|4595050|P2|Overall Study|Adverse Event|3
1392531|NCT01290068|4595051|P1|Overall Study|Adverse Event|1
1392532|NCT01290029|4595063|P1|Overall Study|Other|2
1392533|NCT01289990|4595089|P13|Overall Study|Not treated|0
1392534|NCT01289990|4595090|P12|Overall Study|Not treated|2
1392535|NCT01289990|4595091|P11|Overall Study|Not treated|1
1392536|NCT01289990|4595092|P10|Overall Study|Not treated|0
1392537|NCT01289990|4595093|P9|Overall Study|Not treated|1
1392538|NCT01289990|4595094|P8|Overall Study|Not treated|0
1392539|NCT01289990|4595095|P7|Overall Study|Not treated|1
1392540|NCT01289990|4595096|P6|Overall Study|Not treated|0
1392541|NCT01289990|4595097|P5|Overall Study|Not treated|0
1392542|NCT01289990|4595098|P4|Overall Study|Not treated|0
1392543|NCT01289990|4595099|P3|Overall Study|Not treated|0
1392544|NCT01289990|4595100|P2|Overall Study|Not treated|0
1392545|NCT01289990|4595101|P1|Overall Study|Not treated|0
1392546|NCT01289990|4595089|P13|Overall Study|did not continue in extension|56
1392547|NCT01289990|4595090|P12|Overall Study|did not continue in extension|34
1392548|NCT01289990|4595091|P11|Overall Study|did not continue in extension|45
1392549|NCT01289990|4595092|P10|Overall Study|did not continue in extension|48
1392550|NCT01289990|4595093|P9|Overall Study|did not continue in extension|44
1392551|NCT01289990|4595094|P8|Overall Study|did not continue in extension|36
1392552|NCT01289990|4595095|P7|Overall Study|did not continue in extension|54
1392553|NCT01289990|4595096|P6|Overall Study|did not continue in extension|50
1392554|NCT01289990|4595097|P5|Overall Study|did not continue in extension|48
1392555|NCT01289990|4595098|P4|Overall Study|did not continue in extension|51
1392556|NCT01289990|4595099|P3|Overall Study|did not continue in extension|51
1392557|NCT01289990|4595100|P2|Overall Study|did not continue in extension|45
1392558|NCT01289990|4595101|P1|Overall Study|did not continue in extension|41
1392559|NCT01289990|4595089|P13|Overall Study|discontinued in preceding trial|24
1392560|NCT01289990|4595090|P12|Overall Study|discontinued in preceding trial|17
1392561|NCT01289990|4595091|P11|Overall Study|discontinued in preceding trial|17
1392562|NCT01289990|4595092|P10|Overall Study|discontinued in preceding trial|21
1392563|NCT01289990|4595093|P9|Overall Study|discontinued in preceding trial|17
1392564|NCT01289990|4595094|P8|Overall Study|discontinued in preceding trial|8
1392565|NCT01289990|4595095|P7|Overall Study|discontinued in preceding trial|18
1392566|NCT01289990|4595096|P6|Overall Study|discontinued in preceding trial|12
1392567|NCT01289990|4595097|P5|Overall Study|discontinued in preceding trial|11
1392568|NCT01289990|4595098|P4|Overall Study|discontinued in preceding trial|17
1392569|NCT01289990|4595099|P3|Overall Study|discontinued in preceding trial|41
1392570|NCT01289990|4595100|P2|Overall Study|discontinued in preceding trial|20
1392571|NCT01289990|4595101|P1|Overall Study|discontinued in preceding trial|18
1392572|NCT01289990|4595089|P13|Overall Study|Withdrawal by Subject|16
1392573|NCT01289990|4595090|P12|Overall Study|Withdrawal by Subject|13
1392574|NCT01289990|4595091|P11|Overall Study|Withdrawal by Subject|11
1392575|NCT01289990|4595092|P10|Overall Study|Withdrawal by Subject|13
1392576|NCT01289990|4595093|P9|Overall Study|Withdrawal by Subject|12
1392577|NCT01289990|4595094|P8|Overall Study|Withdrawal by Subject|9
1392578|NCT01289990|4595095|P7|Overall Study|Withdrawal by Subject|13
1392579|NCT01289990|4595096|P6|Overall Study|Withdrawal by Subject|7
1392580|NCT01289990|4595097|P5|Overall Study|Withdrawal by Subject|8
1392581|NCT01289990|4595098|P4|Overall Study|Withdrawal by Subject|13
1392582|NCT01289990|4595099|P3|Overall Study|Withdrawal by Subject|12
1392583|NCT01289990|4595100|P2|Overall Study|Withdrawal by Subject|14
1392584|NCT01289990|4595101|P1|Overall Study|Withdrawal by Subject|15
1392585|NCT01289990|4595089|P13|Overall Study|Lost to Follow-up|2
1392586|NCT01289990|4595090|P12|Overall Study|Lost to Follow-up|1
1392587|NCT01289990|4595091|P11|Overall Study|Lost to Follow-up|2
1392588|NCT01289990|4595092|P10|Overall Study|Lost to Follow-up|4
1392589|NCT01289990|4595093|P9|Overall Study|Lost to Follow-up|1
1392590|NCT01289990|4595094|P8|Overall Study|Lost to Follow-up|2
1392591|NCT01289990|4595095|P7|Overall Study|Lost to Follow-up|2
1392592|NCT01289990|4595096|P6|Overall Study|Lost to Follow-up|4
1392593|NCT01289990|4595097|P5|Overall Study|Lost to Follow-up|3
1392594|NCT01289990|4595098|P4|Overall Study|Lost to Follow-up|5
1392595|NCT01289990|4595099|P3|Overall Study|Lost to Follow-up|5
1392596|NCT01289990|4595100|P2|Overall Study|Lost to Follow-up|2
1392597|NCT01289990|4595101|P1|Overall Study|Lost to Follow-up|3
1392598|NCT01289990|4595089|P13|Overall Study|Death|0
1392599|NCT01289990|4595090|P12|Overall Study|Death|1
1392600|NCT01289990|4595091|P11|Overall Study|Death|0
1392601|NCT01289990|4595092|P10|Overall Study|Death|0
1392602|NCT01289990|4595093|P9|Overall Study|Death|0
1392603|NCT01289990|4595094|P8|Overall Study|Death|0
1392604|NCT01289990|4595095|P7|Overall Study|Death|0
1392605|NCT01289990|4595096|P6|Overall Study|Death|1
1392606|NCT01289990|4595097|P5|Overall Study|Death|2
1392607|NCT01289990|4595098|P4|Overall Study|Death|1
1392608|NCT01289990|4595099|P3|Overall Study|Death|0
1392609|NCT01289990|4595100|P2|Overall Study|Death|0
1392610|NCT01289990|4595101|P1|Overall Study|Death|0
1392699|NCT01289041|4595685|P1|Overall Study|Death|1
1392611|NCT01289847|4595318|P1|Overall Study|Patient could not comply with visits|1
1392612|NCT01289821|4595327|P1|Survival Follow-up Period|Clinical endpoint reached|16
1392613|NCT01289821|4595327|P1|Survival Follow-up Period|Lost to Follow-up|1
1392614|NCT01289821|4595327|P1|Survival Follow-up Period|Protocol Violation|1
1392615|NCT01289821|4595327|P1|Safety Follow-up Period|Unspecified reason|1
1392616|NCT01289821|4595327|P1|Safety Follow-up Period|Protocol Violation|3
1392617|NCT01289821|4595327|P1|Safety Follow-up Period|Withdrawal by Subject|1
1392618|NCT01289821|4595327|P1|Treatment Period|Therapeutic procedure required|1
1392619|NCT01289821|4595327|P1|Treatment Period|Clinical Progression|2
1392620|NCT01289821|4595327|P1|Treatment Period|Radiological Progression|43
1392621|NCT01289821|4595327|P1|Treatment Period|Adverse Event|4
1392622|NCT01289821|4595327|P1|Treatment Period|Physician Decision|3
1392623|NCT01289821|4595327|P1|Treatment Period|Withdrawal by Subject|1
1392624|NCT01289782|4595338|P2|Overall Study|Reason not specified|2
1392625|NCT01289782|4595339|P1|Overall Study|Reason not specified|1
1392626|NCT01289782|4595338|P2|Overall Study|Sponsor's Decision|0
1392627|NCT01289782|4595339|P1|Overall Study|Sponsor's Decision|1
1392628|NCT01289782|4595338|P2|Overall Study|Withdrawal by Subject|2
1392629|NCT01289782|4595339|P1|Overall Study|Withdrawal by Subject|8
1392630|NCT01289782|4595338|P2|Overall Study|Protocol Violation|1
1392631|NCT01289782|4595339|P1|Overall Study|Protocol Violation|1
1392632|NCT01289782|4595338|P2|Overall Study|Lost to Follow-up|7
1392633|NCT01289782|4595339|P1|Overall Study|Lost to Follow-up|14
1392634|NCT01289639|4595411|P3|Overall Study|Lost to Follow-up|0
1392635|NCT01289639|4595412|P2|Overall Study|Lost to Follow-up|0
1392636|NCT01289639|4595413|P1|Overall Study|Lost to Follow-up|1
1392637|NCT01289574|4595439|P3|Overall Study|Subject wanted alternate treatment|0
1392638|NCT01289574|4595440|P2|Overall Study|Subject wanted alternate treatment|1
1392639|NCT01289574|4595441|P1|Overall Study|Subject wanted alternate treatment|0
1392640|NCT01289574|4595439|P3|Overall Study|Adverse Event|0
1392641|NCT01289574|4595440|P2|Overall Study|Adverse Event|1
1392642|NCT01289574|4595441|P1|Overall Study|Adverse Event|0
1392643|NCT01289574|4595439|P3|Overall Study|Withdrawal by Subject|1
1392644|NCT01289574|4595440|P2|Overall Study|Withdrawal by Subject|1
1392645|NCT01289574|4595441|P1|Overall Study|Withdrawal by Subject|1
1392646|NCT01289574|4595439|P3|Overall Study|Lost to Follow-up|1
1392647|NCT01289574|4595440|P2|Overall Study|Lost to Follow-up|0
1392648|NCT01289574|4595441|P1|Overall Study|Lost to Follow-up|2
1392649|NCT01289574|4595439|P3|Overall Study|Lack of Efficacy|1
1392650|NCT01289574|4595440|P2|Overall Study|Lack of Efficacy|0
1392651|NCT01289574|4595441|P1|Overall Study|Lack of Efficacy|4
1392652|NCT01289418|4595513|P1|Day 29 Survey|participants did not complete the survey|2185
1392653|NCT01289418|4595513|P1|Day 29 Survey|email address invalid|283
1392654|NCT01289418|4595513|P1|Day 8 Survey|participants did not complete the survey|1935
1392655|NCT01289418|4595513|P1|Day 8 Survey|email address invalid|283
1392656|NCT01289210|4595549|P1|Overall Study|Adverse Event|1
1392657|NCT01289119|4595559|P6|Overall Study|Other|0
1392658|NCT01289119|4595560|P5|Overall Study|Other|0
1392659|NCT01289119|4595561|P4|Overall Study|Other|0
1392660|NCT01289119|4595562|P3|Overall Study|Other|1
1392661|NCT01289119|4595563|P2|Overall Study|Other|0
1392662|NCT01289119|4595564|P1|Overall Study|Other|1
1392663|NCT01289119|4595559|P6|Overall Study|Lack of Efficacy|1
1392664|NCT01289119|4595560|P5|Overall Study|Lack of Efficacy|1
1392665|NCT01289119|4595561|P4|Overall Study|Lack of Efficacy|1
1392666|NCT01289119|4595562|P3|Overall Study|Lack of Efficacy|1
1392667|NCT01289119|4595563|P2|Overall Study|Lack of Efficacy|1
1392668|NCT01289119|4595564|P1|Overall Study|Lack of Efficacy|0
1392669|NCT01289119|4595559|P6|Overall Study|Pregnancy|0
1392670|NCT01289119|4595560|P5|Overall Study|Pregnancy|0
1392671|NCT01289119|4595561|P4|Overall Study|Pregnancy|0
1392672|NCT01289119|4595562|P3|Overall Study|Pregnancy|0
1392673|NCT01289119|4595563|P2|Overall Study|Pregnancy|1
1392674|NCT01289119|4595564|P1|Overall Study|Pregnancy|0
1392675|NCT01289119|4595559|P6|Overall Study|Withdrawal by Subject|1
1392676|NCT01289119|4595560|P5|Overall Study|Withdrawal by Subject|1
1392677|NCT01289119|4595561|P4|Overall Study|Withdrawal by Subject|3
1392678|NCT01289119|4595562|P3|Overall Study|Withdrawal by Subject|4
1392679|NCT01289119|4595563|P2|Overall Study|Withdrawal by Subject|2
1392680|NCT01289119|4595564|P1|Overall Study|Withdrawal by Subject|4
1392681|NCT01289119|4595559|P6|Overall Study|Lost to Follow-up|1
1392682|NCT01289119|4595560|P5|Overall Study|Lost to Follow-up|0
1392683|NCT01289119|4595561|P4|Overall Study|Lost to Follow-up|0
1392684|NCT01289119|4595562|P3|Overall Study|Lost to Follow-up|0
1392685|NCT01289119|4595563|P2|Overall Study|Lost to Follow-up|3
1392686|NCT01289119|4595564|P1|Overall Study|Lost to Follow-up|0
1392687|NCT01289119|4595559|P6|Overall Study|Major Protocol Deviation|1
1392688|NCT01289119|4595560|P5|Overall Study|Major Protocol Deviation|2
1392689|NCT01289119|4595561|P4|Overall Study|Major Protocol Deviation|0
1392690|NCT01289119|4595562|P3|Overall Study|Major Protocol Deviation|3
1392691|NCT01289119|4595563|P2|Overall Study|Major Protocol Deviation|1
1392692|NCT01289119|4595564|P1|Overall Study|Major Protocol Deviation|2
1392693|NCT01289119|4595559|P6|Overall Study|Adverse Event|0
1392694|NCT01289119|4595560|P5|Overall Study|Adverse Event|1
1392695|NCT01289119|4595561|P4|Overall Study|Adverse Event|2
1392696|NCT01289119|4595562|P3|Overall Study|Adverse Event|0
1392697|NCT01289119|4595563|P2|Overall Study|Adverse Event|1
1392698|NCT01289119|4595564|P1|Overall Study|Adverse Event|2
1392700|NCT01289041|4595685|P1|Overall Study|Withdrawal by Subject|3
1392701|NCT01289041|4595685|P1|Overall Study|Progressive Disease|41
1392702|NCT01289041|4595685|P1|Overall Study|Physician Decision|1
1392703|NCT01289041|4595685|P1|Overall Study|Adverse Event|24
1392704|NCT01289028|4595697|P1|Overall Study|Missing reason for discon|1
1392705|NCT01289028|4595697|P1|Overall Study|Abnormal Lab Value|1
1392706|NCT01289028|4595697|P1|Overall Study|New Cancer Therapy|2
1392707|NCT01289028|4595697|P1|Overall Study|Lost to Follow-up|2
1392708|NCT01289028|4595697|P1|Overall Study|No longer required|2
1392709|NCT01289028|4595697|P1|Overall Study|Lack of Efficacy|2
1392710|NCT01289028|4595697|P1|Overall Study|Death|4
1392711|NCT01289028|4595697|P1|Overall Study|Withdrawal by Subject|6
1392712|NCT01289028|4595697|P1|Overall Study|Adverse Event|14
1392713|NCT01289028|4595697|P1|Overall Study|Progressive Disease|49
1392714|NCT01289015|4595711|P2|Overall Study|Negative baseline culture and others|20
1392715|NCT01289015|4595712|P1|Overall Study|Negative baseline culture and others|33
1392716|NCT01289015|4595711|P2|Overall Study|Disease progression|0
1392717|NCT01289015|4595712|P1|Overall Study|Disease progression|1
1392718|NCT01289015|4595711|P2|Overall Study|Withdrawal by Subject|8
1392719|NCT01289015|4595712|P1|Overall Study|Withdrawal by Subject|17
1392720|NCT01289015|4595711|P2|Overall Study|Lost to Follow-up|17
1392721|NCT01289015|4595712|P1|Overall Study|Lost to Follow-up|33
1392722|NCT01289015|4595711|P2|Overall Study|Adverse Event|0
1392723|NCT01289015|4595712|P1|Overall Study|Adverse Event|3
1392724|NCT01289015|4595711|P2|Overall Study|Protocol Violation|9
1392725|NCT01289015|4595712|P1|Overall Study|Protocol Violation|12
1392726|NCT01288976|4595723|P3|Overall Study|Data unavailable|7
1392727|NCT01288976|4595724|P2|Overall Study|Data unavailable|9
1392728|NCT01288976|4595725|P1|Overall Study|Data unavailable|22
1392729|NCT01288976|4595723|P3|Overall Study|Death|4
1392730|NCT01288976|4595724|P2|Overall Study|Death|6
1392731|NCT01288976|4595725|P1|Overall Study|Death|98
1392732|NCT01288976|4595723|P3|Overall Study|Withdrawal by Subject|9
1392733|NCT01288976|4595724|P2|Overall Study|Withdrawal by Subject|12
1392734|NCT01288976|4595725|P1|Overall Study|Withdrawal by Subject|58
1392735|NCT01288911|4595754|P2|Overall Study|Randomized but never received study drug|2
1392736|NCT01288911|4595755|P1|Overall Study|Randomized but never received study drug|1
1392737|NCT01288911|4595754|P2|Overall Study|Miscellaneous Reason|39
1392738|NCT01288911|4595755|P1|Overall Study|Miscellaneous Reason|23
1392739|NCT01288911|4595754|P2|Overall Study|Withdrawal by Subject|21
1392740|NCT01288911|4595755|P1|Overall Study|Withdrawal by Subject|21
1392741|NCT01288911|4595754|P2|Overall Study|Protocol Violation|0
1392742|NCT01288911|4595755|P1|Overall Study|Protocol Violation|1
1392743|NCT01288911|4595754|P2|Overall Study|Progressive Disease|99
1392744|NCT01288911|4595755|P1|Overall Study|Progressive Disease|69
1392745|NCT01288911|4595754|P2|Overall Study|Lost to Follow-up|2
1392746|NCT01288911|4595755|P1|Overall Study|Lost to Follow-up|0
1392747|NCT01288911|4595754|P2|Overall Study|Death|7
1392748|NCT01288911|4595755|P1|Overall Study|Death|10
1392749|NCT01288729|4595854|P2|Overall Study|Withdrawal by Subject|0
1392750|NCT01288729|4595855|P1|Overall Study|Withdrawal by Subject|1
1392751|NCT01288612|4595864|P3|Overall Study|Unable to intubate|0
1392752|NCT01288612|4595865|P2|Overall Study|Unable to intubate|3
1392753|NCT01288612|4595866|P1|Overall Study|Unable to intubate|0
1392754|NCT01288612|4595864|P3|Overall Study|Declined|62
1392755|NCT01288612|4595865|P2|Overall Study|Declined|63
1392756|NCT01288612|4595866|P1|Overall Study|Declined|78
1392757|NCT01288612|4595864|P3|Overall Study|Unable to contact|20
1392758|NCT01288612|4595865|P2|Overall Study|Unable to contact|16
1392759|NCT01288612|4595866|P1|Overall Study|Unable to contact|11
1392760|NCT01288469|4595915|P3|Overall Study|Exclusion criteria finally met|0
1392761|NCT01288469|4595916|P2|Overall Study|Exclusion criteria finally met|0
1392762|NCT01288469|4595917|P1|Overall Study|Exclusion criteria finally met|1
1392763|NCT01288469|4595915|P3|Overall Study|Consent withdrawn by subject|1
1392764|NCT01288469|4595916|P2|Overall Study|Consent withdrawn by subject|1
1392765|NCT01288469|4595917|P1|Overall Study|Consent withdrawn by subject|1
1392766|NCT01288469|4595915|P3|Overall Study|Participant Moved|0
1392767|NCT01288469|4595916|P2|Overall Study|Participant Moved|0
1392768|NCT01288469|4595917|P1|Overall Study|Participant Moved|1
1392769|NCT01288469|4595915|P3|Overall Study|Poor compliance to protocol|0
1392770|NCT01288469|4595916|P2|Overall Study|Poor compliance to protocol|1
1392771|NCT01288469|4595917|P1|Overall Study|Poor compliance to protocol|0
1392772|NCT01288469|4595915|P3|Overall Study|Adverse Event|1
1392773|NCT01288469|4595916|P2|Overall Study|Adverse Event|1
1392774|NCT01288469|4595917|P1|Overall Study|Adverse Event|4
1392775|NCT01288443|4595949|P6|Overall Study|Other than above|0
1392776|NCT01288443|4595950|P5|Overall Study|Other than above|1
1392777|NCT01288443|4595951|P4|Overall Study|Other than above|2
1392778|NCT01288443|4595952|P3|Overall Study|Other than above|0
1392779|NCT01288443|4595953|P2|Overall Study|Other than above|0
1392780|NCT01288443|4595954|P1|Overall Study|Other than above|0
1392781|NCT01288443|4595949|P6|Overall Study|Study drug auto-injector administration|1
1392782|NCT01288443|4595950|P5|Overall Study|Study drug auto-injector administration|1
1392783|NCT01288443|4595951|P4|Overall Study|Study drug auto-injector administration|0
1392784|NCT01288443|4595952|P3|Overall Study|Study drug auto-injector administration|0
1392785|NCT01288443|4595953|P2|Overall Study|Study drug auto-injector administration|0
1392786|NCT01288443|4595954|P1|Overall Study|Study drug auto-injector administration|0
1392787|NCT01288443|4595949|P6|Overall Study|Lost to Follow-up|0
1392788|NCT01288443|4595950|P5|Overall Study|Lost to Follow-up|0
1392789|NCT01288443|4595951|P4|Overall Study|Lost to Follow-up|0
1392790|NCT01288443|4595952|P3|Overall Study|Lost to Follow-up|0
1392791|NCT01288443|4595953|P2|Overall Study|Lost to Follow-up|1
1392792|NCT01288443|4595954|P1|Overall Study|Lost to Follow-up|0
1392793|NCT01288443|4595949|P6|Overall Study|Consent withdrawn by Participant|1
1392794|NCT01288443|4595950|P5|Overall Study|Consent withdrawn by Participant|0
1392795|NCT01288443|4595951|P4|Overall Study|Consent withdrawn by Participant|0
1392796|NCT01288443|4595952|P3|Overall Study|Consent withdrawn by Participant|0
1392797|NCT01288443|4595953|P2|Overall Study|Consent withdrawn by Participant|0
1392798|NCT01288443|4595954|P1|Overall Study|Consent withdrawn by Participant|0
1392799|NCT01288443|4595949|P6|Overall Study|Participant Moved|1
1392800|NCT01288443|4595950|P5|Overall Study|Participant Moved|2
1392801|NCT01288443|4595951|P4|Overall Study|Participant Moved|1
1392802|NCT01288443|4595952|P3|Overall Study|Participant Moved|0
1392803|NCT01288443|4595953|P2|Overall Study|Participant Moved|0
1392804|NCT01288443|4595954|P1|Overall Study|Participant Moved|0
1392805|NCT01288443|4595949|P6|Overall Study|Poor compliance to protocol|1
1392806|NCT01288443|4595950|P5|Overall Study|Poor compliance to protocol|0
1392807|NCT01288443|4595951|P4|Overall Study|Poor compliance to protocol|0
1392808|NCT01288443|4595952|P3|Overall Study|Poor compliance to protocol|0
1392809|NCT01288443|4595953|P2|Overall Study|Poor compliance to protocol|0
1392810|NCT01288443|4595954|P1|Overall Study|Poor compliance to protocol|0
1392811|NCT01288443|4595949|P6|Overall Study|Adverse Event|1
1392812|NCT01288443|4595950|P5|Overall Study|Adverse Event|3
1392813|NCT01288443|4595951|P4|Overall Study|Adverse Event|1
1392814|NCT01288443|4595952|P3|Overall Study|Adverse Event|1
1392815|NCT01288443|4595953|P2|Overall Study|Adverse Event|0
1392816|NCT01288443|4595954|P1|Overall Study|Adverse Event|0
1392817|NCT01288287|4596004|P1|Overall Study|Unknown Status|7
1392818|NCT01288287|4596004|P1|Overall Study|Unknown Reason|1
1392819|NCT01288287|4596004|P1|Overall Study|Other Reason|13
1392820|NCT01288287|4596004|P1|Overall Study|Lack of Efficacy|13
1392821|NCT01288287|4596004|P1|Overall Study|Withdrawal by Subject|4
1392822|NCT01288287|4596004|P1|Overall Study|Lost to Follow-up|8
1392823|NCT01288209|4596019|P2|Overall Study|Not specified|0
1392824|NCT01288209|4596020|P1|Overall Study|Not specified|1
1392825|NCT01288209|4596019|P2|Overall Study|Withdrawal by Subject|3
1392826|NCT01288209|4596020|P1|Overall Study|Withdrawal by Subject|1
1392827|NCT01288079|4596050|P4|Overall Study|Other or Study Termination|8
1392828|NCT01288079|4596051|P3|Overall Study|Other or Study Termination|14
1392829|NCT01288079|4596052|P2|Overall Study|Other or Study Termination|15
1392830|NCT01288079|4596053|P1|Overall Study|Other or Study Termination|11
1392831|NCT01288079|4596050|P4|Overall Study|Lost to Follow-up|0
1392832|NCT01288079|4596051|P3|Overall Study|Lost to Follow-up|1
1392833|NCT01288079|4596052|P2|Overall Study|Lost to Follow-up|1
1392834|NCT01288079|4596053|P1|Overall Study|Lost to Follow-up|1
1392835|NCT01288079|4596050|P4|Overall Study|Study-Specific Withdrawal Criteria|0
1392836|NCT01288079|4596051|P3|Overall Study|Study-Specific Withdrawal Criteria|0
1392837|NCT01288079|4596052|P2|Overall Study|Study-Specific Withdrawal Criteria|1
1392838|NCT01288079|4596053|P1|Overall Study|Study-Specific Withdrawal Criteria|1
1392839|NCT01288079|4596050|P4|Overall Study|Lack of Efficacy|2
1392840|NCT01288079|4596051|P3|Overall Study|Lack of Efficacy|0
1392841|NCT01288079|4596052|P2|Overall Study|Lack of Efficacy|2
1392842|NCT01288079|4596053|P1|Overall Study|Lack of Efficacy|2
1392843|NCT01288079|4596050|P4|Overall Study|Condition under Investigation Worsened|1
1392844|NCT01288079|4596051|P3|Overall Study|Condition under Investigation Worsened|0
1392845|NCT01288079|4596052|P2|Overall Study|Condition under Investigation Worsened|0
1392846|NCT01288079|4596053|P1|Overall Study|Condition under Investigation Worsened|0
1392847|NCT01288079|4596050|P4|Overall Study|Severe Non-Compliance to Protocol|3
1392848|NCT01288079|4596051|P3|Overall Study|Severe Non-Compliance to Protocol|1
1392849|NCT01288079|4596052|P2|Overall Study|Severe Non-Compliance to Protocol|3
1392850|NCT01288079|4596053|P1|Overall Study|Severe Non-Compliance to Protocol|1
1392851|NCT01288079|4596050|P4|Overall Study|Adverse Event|3
1392852|NCT01288079|4596051|P3|Overall Study|Adverse Event|2
1392853|NCT01288079|4596052|P2|Overall Study|Adverse Event|1
1392854|NCT01288079|4596053|P1|Overall Study|Adverse Event|2
1392855|NCT01288079|4596050|P4|Overall Study|Withdrawal by Subject|0
1392856|NCT01288079|4596051|P3|Overall Study|Withdrawal by Subject|1
1392857|NCT01288079|4596052|P2|Overall Study|Withdrawal by Subject|4
1392858|NCT01288079|4596053|P1|Overall Study|Withdrawal by Subject|2
1392859|NCT01288053|4596063|P1|Overall Study|Death|1
1392860|NCT01287897|4596081|P4|Overall Study|Other|0
1392861|NCT01287897|4596082|P3|Overall Study|Other|1
1392862|NCT01287897|4596083|P2|Overall Study|Other|0
1392863|NCT01287897|4596084|P1|Overall Study|Other|1
1392864|NCT01287897|4596081|P4|Overall Study|Not meeting entrance criteria|0
1392865|NCT01287897|4596082|P3|Overall Study|Not meeting entrance criteria|0
1392866|NCT01287897|4596083|P2|Overall Study|Not meeting entrance criteria|1
1392867|NCT01287897|4596084|P1|Overall Study|Not meeting entrance criteria|1
1392868|NCT01287897|4596081|P4|Overall Study|Not consented properly|0
1392869|NCT01287897|4596082|P3|Overall Study|Not consented properly|0
1392870|NCT01287897|4596083|P2|Overall Study|Not consented properly|1
1392871|NCT01287897|4596084|P1|Overall Study|Not consented properly|0
1392872|NCT01287897|4596081|P4|Overall Study|Withdrawal by Subject|2
1392873|NCT01287897|4596082|P3|Overall Study|Withdrawal by Subject|3
1392874|NCT01287897|4596083|P2|Overall Study|Withdrawal by Subject|5
1392875|NCT01287897|4596084|P1|Overall Study|Withdrawal by Subject|1
1392876|NCT01287897|4596081|P4|Overall Study|Lost to Follow-up|0
1392877|NCT01287897|4596082|P3|Overall Study|Lost to Follow-up|2
1392878|NCT01287897|4596083|P2|Overall Study|Lost to Follow-up|0
1392879|NCT01287897|4596084|P1|Overall Study|Lost to Follow-up|0
1392880|NCT01287897|4596081|P4|Overall Study|Protocol Violation|1
1392881|NCT01287897|4596082|P3|Overall Study|Protocol Violation|0
1392882|NCT01287897|4596083|P2|Overall Study|Protocol Violation|1
1392883|NCT01287897|4596084|P1|Overall Study|Protocol Violation|1
1392884|NCT01287897|4596081|P4|Overall Study|Lack of Efficacy|0
1392885|NCT01287897|4596082|P3|Overall Study|Lack of Efficacy|0
1392886|NCT01287897|4596083|P2|Overall Study|Lack of Efficacy|0
1392887|NCT01287897|4596084|P1|Overall Study|Lack of Efficacy|2
1392888|NCT01287897|4596081|P4|Overall Study|Adverse Event|4
1392889|NCT01287897|4596082|P3|Overall Study|Adverse Event|6
1392890|NCT01287897|4596083|P2|Overall Study|Adverse Event|3
1392891|NCT01287897|4596084|P1|Overall Study|Adverse Event|5
1392892|NCT01287832|4596135|P2|Overall Study|Death|1
1392893|NCT01287832|4596136|P1|Overall Study|Death|0
1392894|NCT01287832|4596135|P2|Overall Study|Adverse Event|0
1392895|NCT01287832|4596136|P1|Overall Study|Adverse Event|1
1392896|NCT01287754|4596144|P2|Overall Study|Protocol Violation|3
1392897|NCT01287754|4596145|P1|Overall Study|Protocol Violation|0
1392898|NCT01287754|4596144|P2|Overall Study|Lost to Follow-up|6
1392899|NCT01287754|4596145|P1|Overall Study|Lost to Follow-up|1
1392900|NCT01287754|4596144|P2|Overall Study|Death|12
1392901|NCT01287754|4596145|P1|Overall Study|Death|2
1392902|NCT01287741|4596157|P2|Overall Study|Reason not specified|9
1392903|NCT01287741|4596158|P1|Overall Study|Reason not specified|14
1392904|NCT01287741|4596157|P2|Overall Study|Progressive disease|148
1392905|NCT01287741|4596158|P1|Overall Study|Progressive disease|173
1392906|NCT01287741|4596157|P2|Overall Study|Continued in the study|455
1392907|NCT01287741|4596158|P1|Overall Study|Continued in the study|446
1392908|NCT01287741|4596157|P2|Overall Study|Adverse Event|4
1392909|NCT01287741|4596158|P1|Overall Study|Adverse Event|3
1392910|NCT01287741|4596157|P2|Overall Study|Death|38
1392911|NCT01287741|4596158|P1|Overall Study|Death|31
1392912|NCT01287741|4596157|P2|Overall Study|Lost to Follow-up|8
1392913|NCT01287741|4596158|P1|Overall Study|Lost to Follow-up|5
1392914|NCT01287741|4596157|P2|Overall Study|Non-compliance|3
1392915|NCT01287741|4596158|P1|Overall Study|Non-compliance|2
1392916|NCT01287741|4596157|P2|Overall Study|Physician Decision|19
1392917|NCT01287741|4596158|P1|Overall Study|Physician Decision|12
1392918|NCT01287741|4596157|P2|Overall Study|Protocol Violation|0
1392919|NCT01287741|4596158|P1|Overall Study|Protocol Violation|1
1392920|NCT01287741|4596157|P2|Overall Study|Withdrawal by Subject|22
1392921|NCT01287741|4596158|P1|Overall Study|Withdrawal by Subject|25
1392922|NCT01287611|4596194|P2|Overall Study|Exclusion due to expanded Kerr incision|3
1392923|NCT01287611|4596195|P1|Overall Study|Exclusion due to expanded Kerr incision|4
1392924|NCT01287611|4596194|P2|Overall Study|Lost to Follow-up|16
1392925|NCT01287611|4596195|P1|Overall Study|Lost to Follow-up|29
1392926|NCT01287416|4596205|P2|6 Month Follow-up|Lost to Follow-up|2
1392927|NCT01287416|4596206|P1|6 Month Follow-up|Lost to Follow-up|3
1392928|NCT01287416|4596205|P2|Pre-post Training|Lost to Follow-up|1
1392929|NCT01287416|4596206|P1|Pre-post Training|Lost to Follow-up|5
1392930|NCT01287416|4596205|P2|Pre-post Training|Withdrawal by Subject|24
1392931|NCT01287416|4596206|P1|Pre-post Training|Withdrawal by Subject|17
1392932|NCT01287403|4596242|P1|1st Intervention (1 Day)|Adverse Event|1
1392933|NCT01287364|4596258|P2|Overall Study|Other Reason|2
1392934|NCT01287364|4596259|P1|Overall Study|Other Reason|4
1392935|NCT01287364|4596258|P2|Overall Study|Protocol Violation|5
1392936|NCT01287364|4596259|P1|Overall Study|Protocol Violation|5
1392937|NCT01287364|4596258|P2|Overall Study|Adverse Event|3
1392938|NCT01287364|4596259|P1|Overall Study|Adverse Event|0
1392939|NCT01287221|4596281|P2|Overall Study|Withdrawal by Subject|1
1392940|NCT01287221|4596282|P1|Overall Study|Withdrawal by Subject|0
1392941|NCT01287221|4596281|P2|Overall Study|Adverse Event|3
1392942|NCT01287221|4596282|P1|Overall Study|Adverse Event|3
1392943|NCT01287221|4596281|P2|Overall Study|Lack of Perceived Benefit|1
1392944|NCT01287221|4596282|P1|Overall Study|Lack of Perceived Benefit|1
1392945|NCT01287195|4596317|P1|Overall Study|Withdrawal by Subject|2
1392946|NCT01287117|4596332|P4|Overall Study|Disease Progression|5
1392947|NCT01287117|4596333|P3|Overall Study|Disease Progression|6
1392948|NCT01287117|4596334|P2|Overall Study|Disease Progression|5
1392949|NCT01287117|4596335|P1|Overall Study|Disease Progression|10
1392950|NCT01287117|4596332|P4|Overall Study|Patient/Legal Guardian's Decision|5
1392951|NCT01287117|4596333|P3|Overall Study|Patient/Legal Guardian's Decision|8
1392952|NCT01287117|4596334|P2|Overall Study|Patient/Legal Guardian's Decision|6
1392953|NCT01287117|4596335|P1|Overall Study|Patient/Legal Guardian's Decision|2
1392954|NCT01287117|4596332|P4|Overall Study|Physician Decision|1
1392955|NCT01287117|4596333|P3|Overall Study|Physician Decision|1
1392956|NCT01287117|4596334|P2|Overall Study|Physician Decision|1
1392957|NCT01287117|4596335|P1|Overall Study|Physician Decision|0
1392958|NCT01287117|4596332|P4|Overall Study|Lost to Follow-up|0
1392959|NCT01287117|4596333|P3|Overall Study|Lost to Follow-up|0
1392960|NCT01287117|4596334|P2|Overall Study|Lost to Follow-up|1
1392961|NCT01287117|4596335|P1|Overall Study|Lost to Follow-up|1
1392962|NCT01287117|4596332|P4|Overall Study|Adverse Event|1
1392963|NCT01287117|4596333|P3|Overall Study|Adverse Event|1
1392964|NCT01287117|4596334|P2|Overall Study|Adverse Event|1
1392965|NCT01287117|4596335|P1|Overall Study|Adverse Event|2
1392966|NCT01287065|4596381|P6|Treatment Period 1|Withdrawal by Subject|1
1392967|NCT01287065|4596382|P5|Treatment Period 1|Withdrawal by Subject|0
1392968|NCT01287065|4596383|P4|Treatment Period 1|Withdrawal by Subject|0
1392969|NCT01287065|4596384|P3|Treatment Period 1|Withdrawal by Subject|0
1392970|NCT01287065|4596385|P2|Treatment Period 1|Withdrawal by Subject|0
1392971|NCT01287065|4596386|P1|Treatment Period 1|Withdrawal by Subject|0
1392972|NCT01287065|4596381|P6|Treatment Period 1|Adverse Event|0
1392973|NCT01287065|4596382|P5|Treatment Period 1|Adverse Event|1
1392974|NCT01287065|4596383|P4|Treatment Period 1|Adverse Event|0
1392975|NCT01287065|4596384|P3|Treatment Period 1|Adverse Event|0
1392976|NCT01287065|4596385|P2|Treatment Period 1|Adverse Event|0
1392977|NCT01287065|4596386|P1|Treatment Period 1|Adverse Event|0
1392978|NCT01287039|4596405|P2|Overall Study|Lost to Follow-up|2
1392979|NCT01287039|4596406|P1|Overall Study|Lost to Follow-up|3
1392980|NCT01287039|4596405|P2|Overall Study|Withdrawal by Subject|11
1392981|NCT01287039|4596406|P1|Overall Study|Withdrawal by Subject|14
1392982|NCT01287039|4596405|P2|Overall Study|Adverse Event|4
1392983|NCT01287039|4596406|P1|Overall Study|Adverse Event|7
1392984|NCT01287039|4596405|P2|Overall Study|Change of residence|0
1392985|NCT01287039|4596406|P1|Overall Study|Change of residence|1
1392986|NCT01287039|4596405|P2|Overall Study|Death|0
1392987|NCT01287039|4596406|P1|Overall Study|Death|1
1392988|NCT01287039|4596405|P2|Overall Study|Problem with travel|1
1392989|NCT01287039|4596406|P1|Overall Study|Problem with travel|0
1392990|NCT01287039|4596405|P2|Overall Study|Noncompliance with study medication|1
1392991|NCT01287039|4596406|P1|Overall Study|Noncompliance with study medication|0
1392992|NCT01287039|4596405|P2|Overall Study|Excluded medication taken|0
1392993|NCT01287039|4596406|P1|Overall Study|Excluded medication taken|1
1392994|NCT01287039|4596405|P2|Overall Study|Protocol Violation|3
1392995|NCT01287039|4596406|P1|Overall Study|Protocol Violation|2
1392996|NCT01287039|4596405|P2|Overall Study|Elective surgery|1
1392997|NCT01287039|4596406|P1|Overall Study|Elective surgery|0
1392998|NCT01287039|4596405|P2|Overall Study|Change of location/residence|3
1392999|NCT01287039|4596406|P1|Overall Study|Change of location/residence|0
1393000|NCT01287039|4596405|P2|Overall Study|Noncompliance with study procedures|1
1393001|NCT01287039|4596406|P1|Overall Study|Noncompliance with study procedures|0
1393002|NCT01287013|4596439|P3|Overall Study|Non-evaluable|21
1393003|NCT01287013|4596440|P2|Overall Study|Non-evaluable|5
1393004|NCT01287013|4596441|P1|Overall Study|Non-evaluable|3
1393005|NCT01286753|4596493|P2|Overall Study|Participant to Receive Radiotherapy|0
1393006|NCT01286753|4596494|P1|Overall Study|Participant to Receive Radiotherapy|1
1393007|NCT01286753|4596493|P2|Overall Study|Discontinued to Join Extension Study|4
1393008|NCT01286753|4596494|P1|Overall Study|Discontinued to Join Extension Study|6
1393009|NCT01286753|4596493|P2|Overall Study|Withdrawal of Consent|2
1393010|NCT01286753|4596494|P1|Overall Study|Withdrawal of Consent|0
1393011|NCT01286753|4596493|P2|Overall Study|Refused Treatment|0
1393012|NCT01286753|4596494|P1|Overall Study|Refused Treatment|1
1393013|NCT01286753|4596493|P2|Overall Study|Progression|13
1393014|NCT01286753|4596494|P1|Overall Study|Progression|11
1393015|NCT01286753|4596493|P2|Overall Study|Adverse Event|6
1393016|NCT01286753|4596494|P1|Overall Study|Adverse Event|7
1393017|NCT01286740|4596512|P1|Overall Study|Protocol Violation|1
1393018|NCT01286740|4596512|P1|Overall Study|Enrolled but not treated|1
1393019|NCT01286558|4596530|P2|Overall Study|Withdrawal by Subject|1
1393020|NCT01286558|4596531|P1|Overall Study|Withdrawal by Subject|0
1393021|NCT01286558|4596530|P2|Overall Study|Adverse Event|1
1393022|NCT01286558|4596531|P1|Overall Study|Adverse Event|1
1393023|NCT01286480|4596567|P2|Overall Study|Withdrawal by Subject|3
1393024|NCT01286480|4596568|P1|Overall Study|Withdrawal by Subject|5
1393025|NCT01286311|4596654|P2|Overall Study|Physician did not want outreach sent|0
1393026|NCT01286311|4596655|P1|Overall Study|Physician did not want outreach sent|14
1393027|NCT01286207|4596672|P3|Overall Study|Other|13
1393028|NCT01286207|4596673|P2|Overall Study|Other|47
1393029|NCT01286207|4596674|P1|Overall Study|Other|37
1393030|NCT01286207|4596672|P3|Overall Study|Lack of Response|8
1393031|NCT01286207|4596673|P2|Overall Study|Lack of Response|38
1393032|NCT01286207|4596674|P1|Overall Study|Lack of Response|92
1393033|NCT01286207|4596672|P3|Overall Study|Withdrawal by Subject|41
1393034|NCT01286207|4596673|P2|Overall Study|Withdrawal by Subject|79
1393035|NCT01286207|4596674|P1|Overall Study|Withdrawal by Subject|93
1393036|NCT01286207|4596672|P3|Overall Study|Lost to Follow-up|20
1393037|NCT01286207|4596673|P2|Overall Study|Lost to Follow-up|43
1393038|NCT01286207|4596674|P1|Overall Study|Lost to Follow-up|49
1393039|NCT01286207|4596672|P3|Overall Study|Adverse Event|8
1393040|NCT01286207|4596673|P2|Overall Study|Adverse Event|41
1393041|NCT01286207|4596674|P1|Overall Study|Adverse Event|27
1393042|NCT01286168|4596694|P1|Overall Study|Surgical Drains Fell Out at Home|2
1393043|NCT01286168|4596694|P1|Overall Study|Withdrawal by Subject|1
1393044|NCT01286129|4596708|P2|Overall Study|Could not comply with study requirements|4
1393045|NCT01286129|4596709|P1|Overall Study|Could not comply with study requirements|4
1393046|NCT01286129|4596708|P2|Overall Study|Withdrawal by Subject|1
1393047|NCT01286129|4596709|P1|Overall Study|Withdrawal by Subject|4
1393048|NCT01286077|4596719|P2|Overall Study|refill medication not received in time|0
1393049|NCT01286077|4596720|P1|Overall Study|refill medication not received in time|1
1393050|NCT01286077|4596719|P2|Overall Study|Progression of disease|1
1393051|NCT01286077|4596720|P1|Overall Study|Progression of disease|0
1393052|NCT01286077|4596719|P2|Overall Study|Patient's decision to stop treatment|0
1393053|NCT01286077|4596720|P1|Overall Study|Patient's decision to stop treatment|3
1393054|NCT01286077|4596719|P2|Overall Study|The subject starts with alternative MMY|3
1393055|NCT01286077|4596720|P1|Overall Study|The subject starts with alternative MMY|0
1393056|NCT01286077|4596719|P2|Overall Study|Non-compliance|0
1393057|NCT01286077|4596720|P1|Overall Study|Non-compliance|1
1393058|NCT01286077|4596719|P2|Overall Study|Intercurrent illness|0
1393059|NCT01286077|4596720|P1|Overall Study|Intercurrent illness|1
1393060|NCT01286077|4596719|P2|Overall Study|Withdrawal by Subject|2
1393061|NCT01286077|4596720|P1|Overall Study|Withdrawal by Subject|0
1393062|NCT01286077|4596719|P2|Overall Study|Protocol Violation|1
1393063|NCT01286077|4596720|P1|Overall Study|Protocol Violation|1
1393064|NCT01286077|4596719|P2|Overall Study|Death|0
1393065|NCT01286077|4596720|P1|Overall Study|Death|1
1393066|NCT01286077|4596719|P2|Overall Study|Adverse Event|0
1393067|NCT01286077|4596720|P1|Overall Study|Adverse Event|2
1393068|NCT01286012|4596756|P2|Overall Study|peritoneal dialysis, randomized in error|3
1393069|NCT01286012|4596757|P1|Overall Study|peritoneal dialysis, randomized in error|1
1393070|NCT01286012|4596756|P2|Overall Study|Physician Decision|0
1393071|NCT01286012|4596757|P1|Overall Study|Physician Decision|2
1393072|NCT01286012|4596756|P2|Overall Study|Withdrawal by Subject|4
1393073|NCT01286012|4596757|P1|Overall Study|Withdrawal by Subject|4
1393074|NCT01286012|4596756|P2|Overall Study|Protocol Violation|1
1393075|NCT01286012|4596757|P1|Overall Study|Protocol Violation|1
1393076|NCT01286012|4596756|P2|Overall Study|Death|3
1393077|NCT01286012|4596757|P1|Overall Study|Death|2
1393078|NCT01286012|4596756|P2|Overall Study|Adverse Event|3
1393079|NCT01286012|4596757|P1|Overall Study|Adverse Event|3
1393080|NCT01285908|4596774|P3|Baseline Measurement|unable to tolerate procedure|0
1393081|NCT01285908|4596775|P2|Baseline Measurement|unable to tolerate procedure|0
1393082|NCT01285908|4596776|P1|Baseline Measurement|unable to tolerate procedure|1
1393083|NCT01285908|4596774|P3|Baseline Measurement|History of stroke, exclusion criteria|0
1393084|NCT01285908|4596775|P2|Baseline Measurement|History of stroke, exclusion criteria|0
1393085|NCT01285908|4596776|P1|Baseline Measurement|History of stroke, exclusion criteria|1
1393086|NCT01285908|4596774|P3|Baseline Measurement|unable to insert catheter|0
1393087|NCT01285908|4596775|P2|Baseline Measurement|unable to insert catheter|0
1393088|NCT01285908|4596776|P1|Baseline Measurement|unable to insert catheter|1
1393089|NCT01285609|4596870|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
1393090|NCT01285609|4596871|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
1393091|NCT01285609|4596870|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
1393092|NCT01285609|4596871|P1|Treated With Blinded Therapy|Poor/Non-Compliance|0
1393093|NCT01285609|4596870|P2|Treated With Blinded Therapy|Not Reported|4
1393094|NCT01285609|4596871|P1|Treated With Blinded Therapy|Not Reported|4
1393095|NCT01285609|4596870|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
1393096|NCT01285609|4596871|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
1393097|NCT01285609|4596870|P2|Treated With Blinded Therapy|Death|3
1393098|NCT01285609|4596871|P1|Treated With Blinded Therapy|Death|11
1393099|NCT01285609|4596870|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
1393100|NCT01285609|4596871|P1|Treated With Blinded Therapy|Withdrawal by Subject|18
1393101|NCT01285609|4596870|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
1393102|NCT01285609|4596871|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
1393103|NCT01285609|4596870|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
1393104|NCT01285609|4596871|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
1393105|NCT01285609|4596870|P2|Treated With Blinded Therapy|Progressive Disease|305
1393106|NCT01285609|4596871|P1|Treated With Blinded Therapy|Progressive Disease|220
1393107|NCT01285609|4596870|P2|Randomized|Randomized but not Treated|4
1393108|NCT01285609|4596871|P1|Randomized|Randomized but not Treated|4
1393109|NCT01285609|4596870|P2|Randomized|Undisclosed Reasons|0
1393110|NCT01285609|4596871|P1|Randomized|Undisclosed Reasons|1
1393111|NCT01285609|4596870|P2|Randomized|Subject No Longer Met Study Criteria|1
1393112|NCT01285609|4596871|P1|Randomized|Subject No Longer Met Study Criteria|1
1393113|NCT01285609|4596870|P2|Randomized|Withdrawal by Subject|11
1393114|NCT01285609|4596871|P1|Randomized|Withdrawal by Subject|8
1393115|NCT01285609|4596870|P2|Randomized|Death|7
1393116|NCT01285609|4596871|P1|Randomized|Death|5
1393117|NCT01285609|4596870|P2|Randomized|Study Drug Toxicity|14
1393118|NCT01285609|4596871|P1|Randomized|Study Drug Toxicity|13
1393119|NCT01285609|4596870|P2|Randomized|Adverse Event Unrelated to Study Drug|18
1393120|NCT01285609|4596871|P1|Randomized|Adverse Event Unrelated to Study Drug|18
1393121|NCT01285609|4596870|P2|Randomized|Progressive Disease|61
1393122|NCT01285609|4596871|P1|Randomized|Progressive Disease|41
1393123|NCT01285518|4596889|P8|Overall Study|Lost to Follow-up|0
1393124|NCT01285518|4596890|P7|Overall Study|Lost to Follow-up|0
1393125|NCT01285518|4596891|P6|Overall Study|Lost to Follow-up|1
1393126|NCT01285518|4596892|P5|Overall Study|Lost to Follow-up|0
1393127|NCT01285518|4596893|P4|Overall Study|Lost to Follow-up|0
1393128|NCT01285518|4596894|P3|Overall Study|Lost to Follow-up|0
1393129|NCT01285518|4596895|P2|Overall Study|Lost to Follow-up|0
1393130|NCT01285518|4596896|P1|Overall Study|Lost to Follow-up|0
1393131|NCT01285492|4597156|P2|Overall Study|Death|0
1393132|NCT01285492|4597157|P1|Overall Study|Death|1
1393133|NCT01285492|4597156|P2|Overall Study|Withdrawal by Subject|1
1393134|NCT01285492|4597157|P1|Overall Study|Withdrawal by Subject|2
1393135|NCT01285492|4597156|P2|Overall Study|Protocol Violation|0
1393136|NCT01285492|4597157|P1|Overall Study|Protocol Violation|3
1393137|NCT01285492|4597156|P2|Overall Study|Adverse Event|0
1393138|NCT01285492|4597157|P1|Overall Study|Adverse Event|11
1393139|NCT01285401|4597189|P2|Overall Study|Prematurely withdrawn from the study|29
1393140|NCT01285401|4597190|P1|Overall Study|Prematurely withdrawn from the study|17
1393141|NCT01285323|4597230|P2|Overall Study|Not specified|3
1393142|NCT01285323|4597231|P1|Overall Study|Not specified|1
1393143|NCT01285323|4597230|P2|Overall Study|Lost to Follow-up|1
1393144|NCT01285323|4597231|P1|Overall Study|Lost to Follow-up|1
1393145|NCT01285323|4597230|P2|Overall Study|Non-compliance with study procedures|3
1393146|NCT01285323|4597231|P1|Overall Study|Non-compliance with study procedures|2
1393147|NCT01285323|4597230|P2|Overall Study|Protocol Violation|2
1393148|NCT01285323|4597231|P1|Overall Study|Protocol Violation|1
1393149|NCT01285323|4597230|P2|Overall Study|Withdrawal by Subject|11
1393150|NCT01285323|4597231|P1|Overall Study|Withdrawal by Subject|15
1393151|NCT01285323|4597230|P2|Overall Study|Lack of Efficacy|2
1393152|NCT01285323|4597231|P1|Overall Study|Lack of Efficacy|4
1393153|NCT01285323|4597230|P2|Overall Study|Adverse Event|8
1393154|NCT01285323|4597231|P1|Overall Study|Adverse Event|9
1393155|NCT01285310|4597266|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
1393156|NCT01285310|4597267|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
1393157|NCT01285310|4597268|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
1393158|NCT01285310|4597269|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
1393159|NCT01285310|4597270|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
1393160|NCT01285310|4597266|P5|Active Treatment Phase: Weeks 25-52|Not Specified|0
1393161|NCT01285310|4597267|P4|Active Treatment Phase: Weeks 25-52|Not Specified|0
1393162|NCT01285310|4597268|P3|Active Treatment Phase: Weeks 25-52|Not Specified|0
1393163|NCT01285310|4597269|P2|Active Treatment Phase: Weeks 25-52|Not Specified|1
1393164|NCT01285310|4597270|P1|Active Treatment Phase: Weeks 25-52|Not Specified|0
1393165|NCT01285310|4597266|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
1393166|NCT01285310|4597267|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
1393167|NCT01285310|4597268|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
1393168|NCT01285310|4597269|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
1393169|NCT01285310|4597270|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
1393170|NCT01285310|4597266|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
1393171|NCT01285310|4597267|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
1393172|NCT01285310|4597268|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
1393173|NCT01285310|4597269|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
1393174|NCT01285310|4597270|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
1393175|NCT01285310|4597266|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
1393176|NCT01285310|4597267|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
1393177|NCT01285310|4597268|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
1393178|NCT01285310|4597269|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
1393179|NCT01285310|4597270|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
1393180|NCT01285310|4597266|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
1393181|NCT01285310|4597267|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
1393182|NCT01285310|4597268|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
1393183|NCT01285310|4597269|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
1393184|NCT01285310|4597270|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
1393185|NCT01285310|4597266|P5|Placebo Controlled Phase: Weeks 0-24|Not specified|0
1393186|NCT01285310|4597267|P4|Placebo Controlled Phase: Weeks 0-24|Not specified|0
1393187|NCT01285310|4597268|P3|Placebo Controlled Phase: Weeks 0-24|Not specified|1
1393188|NCT01285310|4597269|P2|Placebo Controlled Phase: Weeks 0-24|Not specified|0
1393189|NCT01285310|4597270|P1|Placebo Controlled Phase: Weeks 0-24|Not specified|1
1393190|NCT01285310|4597266|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
1393191|NCT01285310|4597267|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
1393192|NCT01285310|4597268|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
1393193|NCT01285310|4597269|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
1393194|NCT01285310|4597270|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
1393195|NCT01285310|4597266|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
1393196|NCT01285310|4597267|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
1393197|NCT01285310|4597268|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
1393198|NCT01285310|4597269|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
1393199|NCT01285310|4597270|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
1393200|NCT01285310|4597266|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
1393201|NCT01285310|4597267|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
1393202|NCT01285310|4597268|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
1393203|NCT01285310|4597269|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
1393204|NCT01285310|4597270|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
1393205|NCT01285310|4597266|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
1393206|NCT01285310|4597267|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
1393207|NCT01285310|4597268|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
1393208|NCT01285310|4597269|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
1393209|NCT01285310|4597270|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
1393210|NCT01285310|4597266|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
1393211|NCT01285310|4597267|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
1393212|NCT01285310|4597268|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
1393213|NCT01285310|4597269|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
1393214|NCT01285310|4597270|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
1393215|NCT01284959|4597535|P3|Overall Study|Adverse Event|1
1393216|NCT01284959|4597536|P2|Overall Study|Adverse Event|0
1393217|NCT01284959|4597537|P1|Overall Study|Adverse Event|0
1393218|NCT01284959|4597535|P3|Overall Study|Withdrawal by Subject|0
1393219|NCT01284959|4597536|P2|Overall Study|Withdrawal by Subject|0
1393220|NCT01284959|4597537|P1|Overall Study|Withdrawal by Subject|1
1393221|NCT01284634|4597567|P4|Overall Study|Adverse Event|1
1393222|NCT01284634|4597568|P3|Overall Study|Adverse Event|2
1393223|NCT01284634|4597569|P2|Overall Study|Adverse Event|0
1393224|NCT01284634|4597570|P1|Overall Study|Adverse Event|1
1393225|NCT01284621|4597600|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
1393226|NCT01284621|4597601|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
1393227|NCT01284621|4597602|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
1393228|NCT01284621|4597603|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
1393229|NCT01284621|4597604|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
1393230|NCT01284621|4597605|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
1393231|NCT01284491|4597673|P1|Overall Study|Study termination|13
1393232|NCT01284361|4597683|P1|Overall Study|Lost to Follow-up|2
1393233|NCT01284361|4597683|P1|Overall Study|Adverse Event|1
1393234|NCT01284361|4597683|P1|Overall Study|Protocol Violation|5
1393235|NCT01284361|4597683|P1|Overall Study|Withdrawal by Subject|1
1393236|NCT01284140|4597706|P2|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
1393237|NCT01284140|4597707|P1|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
1393238|NCT01284140|4597706|P2|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
1393239|NCT01284140|4597707|P1|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
1393240|NCT01284114|4597721|P1|Overall Study|dizziness|1
1393241|NCT01284114|4597721|P1|Overall Study|Symptomatic hypotension|1
1393242|NCT01284114|4597721|P1|Overall Study|From the results of ALLTITUDE study|1
1393243|NCT01284114|4597721|P1|Overall Study|viral infection|1
1393244|NCT01284062|4597733|P4|Overall Study|Site Closed|0
1393245|NCT01284062|4597734|P3|Overall Study|Site Closed|1
1393246|NCT01284062|4597735|P2|Overall Study|Site Closed|0
1393247|NCT01284062|4597736|P1|Overall Study|Site Closed|0
1393248|NCT01284062|4597733|P4|Overall Study|Other|1
1393249|NCT01284062|4597734|P3|Overall Study|Other|0
1393250|NCT01284062|4597735|P2|Overall Study|Other|0
1393251|NCT01284062|4597736|P1|Overall Study|Other|0
1393252|NCT01284062|4597733|P4|Overall Study|Withdrawal by Subject|5
1393253|NCT01284062|4597734|P3|Overall Study|Withdrawal by Subject|2
1393254|NCT01284062|4597735|P2|Overall Study|Withdrawal by Subject|1
1393255|NCT01284062|4597736|P1|Overall Study|Withdrawal by Subject|3
1393256|NCT01284062|4597733|P4|Overall Study|Protocol Violation|2
1393257|NCT01284062|4597734|P3|Overall Study|Protocol Violation|0
1393258|NCT01284062|4597735|P2|Overall Study|Protocol Violation|0
1393259|NCT01284062|4597736|P1|Overall Study|Protocol Violation|1
1393260|NCT01284062|4597733|P4|Overall Study|Medication error without adverse event|0
1393261|NCT01284062|4597734|P3|Overall Study|Medication error without adverse event|1
1393262|NCT01284062|4597735|P2|Overall Study|Medication error without adverse event|0
1393263|NCT01284062|4597736|P1|Overall Study|Medication error without adverse event|0
1393264|NCT01284062|4597733|P4|Overall Study|Lack of Efficacy|1
1393265|NCT01284062|4597734|P3|Overall Study|Lack of Efficacy|2
1393266|NCT01284062|4597735|P2|Overall Study|Lack of Efficacy|2
1393267|NCT01284062|4597736|P1|Overall Study|Lack of Efficacy|3
1393268|NCT01284062|4597733|P4|Overall Study|Adverse Event|5
1393269|NCT01284062|4597734|P3|Overall Study|Adverse Event|0
1393270|NCT01284062|4597735|P2|Overall Study|Adverse Event|5
1393271|NCT01284062|4597736|P1|Overall Study|Adverse Event|4
1393272|NCT01283971|4597810|P2|Overall Study|Administrative reasons|1
1393273|NCT01283971|4597811|P1|Overall Study|Administrative reasons|1
1393274|NCT01283971|4597810|P2|Overall Study|Failure to return|1
1393275|NCT01283971|4597811|P1|Overall Study|Failure to return|0
1393276|NCT01283971|4597810|P2|Overall Study|Refused treatment|1
1393277|NCT01283971|4597811|P1|Overall Study|Refused treatment|3
1393278|NCT01283971|4597810|P2|Overall Study|Protocol Violation|1
1393279|NCT01283971|4597811|P1|Overall Study|Protocol Violation|5
1393280|NCT01283971|4597810|P2|Overall Study|Insufficient therapeutic responses|3
1393281|NCT01283971|4597811|P1|Overall Study|Insufficient therapeutic responses|3
1393282|NCT01283971|4597810|P2|Overall Study|Adverse Event|5
1393283|NCT01283971|4597811|P1|Overall Study|Adverse Event|3
1393284|NCT01283581|4597858|P3|Overall Study|"Early termination"|1
1393285|NCT01283581|4597859|P2|Overall Study|"Early termination"|0
1393286|NCT01283581|4597860|P1|Overall Study|"Early termination"|0
1393287|NCT01283581|4597858|P3|Overall Study|Investigator unblinded|1
1393288|NCT01283581|4597859|P2|Overall Study|Investigator unblinded|0
1393289|NCT01283581|4597860|P1|Overall Study|Investigator unblinded|0
1393290|NCT01283581|4597858|P3|Overall Study|Noncompliance|0
1393291|NCT01283581|4597859|P2|Overall Study|Noncompliance|0
1393292|NCT01283581|4597860|P1|Overall Study|Noncompliance|1
1393293|NCT01283581|4597858|P3|Overall Study|Protocol Violation|2
1393294|NCT01283581|4597859|P2|Overall Study|Protocol Violation|1
1393295|NCT01283581|4597860|P1|Overall Study|Protocol Violation|0
1393296|NCT01283581|4597858|P3|Overall Study|Physician Decision|2
1393297|NCT01283581|4597859|P2|Overall Study|Physician Decision|1
1393298|NCT01283581|4597860|P1|Overall Study|Physician Decision|0
1393299|NCT01283581|4597858|P3|Overall Study|Adverse Event|4
1393300|NCT01283581|4597859|P2|Overall Study|Adverse Event|1
1393301|NCT01283581|4597860|P1|Overall Study|Adverse Event|1
1393302|NCT01283581|4597858|P3|Overall Study|Withdrawal by Subject|2
1393303|NCT01283581|4597859|P2|Overall Study|Withdrawal by Subject|5
1393304|NCT01283581|4597860|P1|Overall Study|Withdrawal by Subject|2
1393305|NCT01283581|4597858|P3|Overall Study|Lost to Follow-up|8
1393306|NCT01283581|4597859|P2|Overall Study|Lost to Follow-up|6
1393307|NCT01283581|4597860|P1|Overall Study|Lost to Follow-up|8
1393308|NCT01283516|4597924|P9|Overall Study|Withdrawal by Subject|11
1393309|NCT01283516|4597925|P8|Overall Study|Withdrawal by Subject|0
1393310|NCT01283516|4597926|P7|Overall Study|Withdrawal by Subject|0
1393311|NCT01283516|4597927|P6|Overall Study|Withdrawal by Subject|0
1393312|NCT01283516|4597928|P5|Overall Study|Withdrawal by Subject|1
1393313|NCT01283516|4597929|P4|Overall Study|Withdrawal by Subject|0
1393314|NCT01283516|4597930|P3|Overall Study|Withdrawal by Subject|0
1393315|NCT01283516|4597931|P2|Overall Study|Withdrawal by Subject|0
1393316|NCT01283516|4597932|P1|Overall Study|Withdrawal by Subject|0
1393317|NCT01283516|4597924|P9|Overall Study|Disease Progression|81
1393318|NCT01283516|4597925|P8|Overall Study|Disease Progression|2
1393319|NCT01283516|4597926|P7|Overall Study|Disease Progression|6
1393320|NCT01283516|4597927|P6|Overall Study|Disease Progression|7
1393321|NCT01283516|4597928|P5|Overall Study|Disease Progression|12
1393322|NCT01283516|4597929|P4|Overall Study|Disease Progression|3
1393323|NCT01283516|4597930|P3|Overall Study|Disease Progression|2
1393324|NCT01283516|4597931|P2|Overall Study|Disease Progression|2
1393325|NCT01283516|4597932|P1|Overall Study|Disease Progression|2
1393326|NCT01283516|4597924|P9|Overall Study|Death|6
1393327|NCT01283516|4597925|P8|Overall Study|Death|1
1393328|NCT01283516|4597926|P7|Overall Study|Death|0
1393329|NCT01283516|4597927|P6|Overall Study|Death|1
1393330|NCT01283516|4597928|P5|Overall Study|Death|0
1393331|NCT01283516|4597929|P4|Overall Study|Death|0
1393332|NCT01283516|4597930|P3|Overall Study|Death|0
1393333|NCT01283516|4597931|P2|Overall Study|Death|0
1393334|NCT01283516|4597932|P1|Overall Study|Death|0
1393335|NCT01283516|4597924|P9|Overall Study|Adverse Event|24
1393336|NCT01283516|4597925|P8|Overall Study|Adverse Event|0
1393337|NCT01283516|4597926|P7|Overall Study|Adverse Event|2
1393338|NCT01283516|4597927|P6|Overall Study|Adverse Event|0
1393339|NCT01283516|4597928|P5|Overall Study|Adverse Event|0
1393340|NCT01283516|4597929|P4|Overall Study|Adverse Event|0
1393341|NCT01283516|4597930|P3|Overall Study|Adverse Event|0
1393342|NCT01283516|4597931|P2|Overall Study|Adverse Event|0
1393343|NCT01283516|4597932|P1|Overall Study|Adverse Event|0
1393344|NCT01283464|4597956|P2|Overall Study|Physician Decision|0
1393345|NCT01283464|4597957|P1|Overall Study|Physician Decision|1
1393346|NCT01283464|4597956|P2|Overall Study|Withdrawal by Subject|0
1393347|NCT01283464|4597957|P1|Overall Study|Withdrawal by Subject|1
1393348|NCT01283464|4597956|P2|Overall Study|Lost to Follow-up|1
1393349|NCT01283464|4597957|P1|Overall Study|Lost to Follow-up|0
1393350|NCT01283334|4597963|P1|Overall Study|Physician Decision|1
1393351|NCT01283334|4597963|P1|Overall Study|Adverse Event|4
1393352|NCT01283334|4597963|P1|Overall Study|Inability to Swallow Everolimus Pills|1
1393353|NCT01283334|4597963|P1|Overall Study|Withdrawal by Subject|1
1393354|NCT01283282|4597986|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
1393355|NCT01283282|4597987|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
1393356|NCT01283282|4597986|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
1393357|NCT01283282|4597987|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
1393358|NCT01283282|4597986|P2|First Intervention (6 Weeks)|Physician Decision|1
1393359|NCT01283282|4597987|P1|First Intervention (6 Weeks)|Physician Decision|0
1393360|NCT01283152|4598007|P2|Overall Study|Refused HESA|0
1393361|NCT01283152|4598008|P1|Overall Study|Refused HESA|1
1393362|NCT01283152|4598007|P2|Overall Study|Discharged prior to 24 hr assessment|0
1393363|NCT01283152|4598008|P1|Overall Study|Discharged prior to 24 hr assessment|1
1393364|NCT01283139|4598022|P4|Overall Study|Participant randomized in error|0
1393365|NCT01283139|4598023|P3|Overall Study|Participant randomized in error|1
1393366|NCT01283139|4598024|P2|Overall Study|Participant randomized in error|0
1393367|NCT01283139|4598025|P1|Overall Study|Participant randomized in error|0
1393368|NCT01283139|4598022|P4|Overall Study|Missed follow-up visit|2
1393369|NCT01283139|4598023|P3|Overall Study|Missed follow-up visit|2
1393370|NCT01283139|4598024|P2|Overall Study|Missed follow-up visit|1
1393371|NCT01283139|4598025|P1|Overall Study|Missed follow-up visit|0
1393372|NCT01283139|4598022|P4|Overall Study|Pregnancy|0
1393373|NCT01283139|4598023|P3|Overall Study|Pregnancy|1
1393374|NCT01283139|4598024|P2|Overall Study|Pregnancy|1
1393375|NCT01283139|4598025|P1|Overall Study|Pregnancy|0
1393376|NCT01283139|4598022|P4|Overall Study|Participant's refusal to continue|1
1393377|NCT01283139|4598023|P3|Overall Study|Participant's refusal to continue|1
1393378|NCT01283139|4598024|P2|Overall Study|Participant's refusal to continue|3
1393379|NCT01283139|4598025|P1|Overall Study|Participant's refusal to continue|0
1393469|NCT01281306|4598438|P5|Overall Study|Lost to Follow-up|0
1393380|NCT01283139|4598022|P4|Overall Study|Early termination due to AE/SAE|0
1393381|NCT01283139|4598023|P3|Overall Study|Early termination due to AE/SAE|0
1393382|NCT01283139|4598024|P2|Overall Study|Early termination due to AE/SAE|1
1393383|NCT01283139|4598025|P1|Overall Study|Early termination due to AE/SAE|1
1393384|NCT01283139|4598022|P4|Overall Study|Lack of Efficacy|1
1393385|NCT01283139|4598023|P3|Overall Study|Lack of Efficacy|2
1393386|NCT01283139|4598024|P2|Overall Study|Lack of Efficacy|2
1393387|NCT01283139|4598025|P1|Overall Study|Lack of Efficacy|1
1393388|NCT01283139|4598022|P4|Overall Study|Death|2
1393389|NCT01283139|4598023|P3|Overall Study|Death|2
1393390|NCT01283139|4598024|P2|Overall Study|Death|0
1393391|NCT01283139|4598025|P1|Overall Study|Death|2
1393392|NCT01283139|4598022|P4|Overall Study|Withdrawal by Subject|8
1393393|NCT01283139|4598023|P3|Overall Study|Withdrawal by Subject|6
1393394|NCT01283139|4598024|P2|Overall Study|Withdrawal by Subject|8
1393395|NCT01283139|4598025|P1|Overall Study|Withdrawal by Subject|8
1393396|NCT01283139|4598022|P4|Overall Study|Lost to Follow-up|1
1393397|NCT01283139|4598023|P3|Overall Study|Lost to Follow-up|3
1393398|NCT01283139|4598024|P2|Overall Study|Lost to Follow-up|2
1393399|NCT01283139|4598025|P1|Overall Study|Lost to Follow-up|5
1393400|NCT01283035|4598067|P1|Overall Study|Subject later found ineligible|1
1393401|NCT01282866|4598082|P1|Overall Study|Adverse Event|1
1393402|NCT01282814|4598090|P2|Washout of 7 Days|Withdrawal by Subject|0
1393403|NCT01282814|4598091|P1|Washout of 7 Days|Withdrawal by Subject|2
1393404|NCT01282814|4598090|P2|First Intervention|Emesis During Dosing Interval|3
1393405|NCT01282814|4598091|P1|First Intervention|Emesis During Dosing Interval|0
1393406|NCT01282801|4598103|P2|Second Intervention|Emesis During Critical Breakfast|1
1393407|NCT01282801|4598104|P1|Second Intervention|Emesis During Critical Breakfast|0
1393408|NCT01282476|4598128|P1|Overall Study|Death|11
1393409|NCT01282424|4598134|P1|Overall Study|Investigator Request|7
1393410|NCT01282424|4598134|P1|Overall Study|Withdrew Consent|4
1393411|NCT01282424|4598134|P1|Overall Study|Adverse Event|25
1393412|NCT01282424|4598134|P1|Overall Study|Treatment Ongoing|40
1393413|NCT01282372|4598151|P1|Overall Study|Adverse Event|12
1393414|NCT01282372|4598151|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
1393415|NCT01282372|4598151|P1|Overall Study|Presence of AE, Regression of Symptoms|1
1393416|NCT01282372|4598151|P1|Overall Study|Presence of AE, Lack of Efficacy|1
1393417|NCT01282372|4598151|P1|Overall Study|Death|1
1393418|NCT01282372|4598151|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
1393419|NCT01282372|4598151|P1|Overall Study|Withdrawal by Subject|11
1393420|NCT01282372|4598151|P1|Overall Study|Lost to Follow-up|23
1393421|NCT01282372|4598151|P1|Overall Study|Lack of Efficacy / Exacerbation|25
1393422|NCT01282294|4598179|P1|Overall Study|Physician Decision|1
1393423|NCT01282294|4598179|P1|Overall Study|Patient non-compliance|2
1393424|NCT01282294|4598179|P1|Overall Study|Adverse Event|1
1393425|NCT01282294|4598179|P1|Overall Study|Screening failure|1
1393426|NCT01282294|4598179|P1|Overall Study|Lost to Follow-up|14
1393427|NCT01282229|4598208|P1|Overall Study|Protocol Violation|2
1393428|NCT01282203|4598238|P1|Overall Study|Adverse Event|1
1393429|NCT01282164|4598260|P2|Overall Study|Lack of hypoglycemia during ITT|0
1393430|NCT01282164|4598261|P1|Overall Study|Lack of hypoglycemia during ITT|1
1393431|NCT01281917|4598312|P1|Overall Study|Withdrawal by Subject|1
1393432|NCT01281865|4598324|P2|Overall Study|Lack of Efficacy|0
1393433|NCT01281865|4598325|P1|Overall Study|Lack of Efficacy|1
1393434|NCT01281865|4598324|P2|Overall Study|Withdrawal by Subject|0
1393435|NCT01281865|4598325|P1|Overall Study|Withdrawal by Subject|1
1393436|NCT01281865|4598324|P2|Overall Study|Adverse Event|1
1393437|NCT01281865|4598325|P1|Overall Study|Adverse Event|1
1393438|NCT01281839|4598333|P2|Overall Study|Reason not specified|1
1393439|NCT01281839|4598334|P1|Overall Study|Reason not specified|0
1393440|NCT01281839|4598333|P2|Overall Study|Withdrawal by Subject|10
1393441|NCT01281839|4598334|P1|Overall Study|Withdrawal by Subject|4
1393442|NCT01281839|4598333|P2|Overall Study|Lost to Follow-up|3
1393443|NCT01281839|4598334|P1|Overall Study|Lost to Follow-up|6
1393444|NCT01281644|4598395|P1|Overall Study|Withdrawal by Subject|2
1393445|NCT01281644|4598395|P1|Overall Study|Lost to Follow-up|3
1393446|NCT01281306|4598436|P7|Overall Study|Randomized in error|0
1393447|NCT01281306|4598437|P6|Overall Study|Randomized in error|0
1393448|NCT01281306|4598438|P5|Overall Study|Randomized in error|0
1393449|NCT01281306|4598439|P4|Overall Study|Randomized in error|1
1393450|NCT01281306|4598440|P3|Overall Study|Randomized in error|0
1393451|NCT01281306|4598441|P2|Overall Study|Randomized in error|0
1393452|NCT01281306|4598442|P1|Overall Study|Randomized in error|1
1393453|NCT01281306|4598436|P7|Overall Study|Adverse Event|3
1393454|NCT01281306|4598437|P6|Overall Study|Adverse Event|3
1393455|NCT01281306|4598438|P5|Overall Study|Adverse Event|5
1393456|NCT01281306|4598439|P4|Overall Study|Adverse Event|3
1393457|NCT01281306|4598440|P3|Overall Study|Adverse Event|2
1393458|NCT01281306|4598441|P2|Overall Study|Adverse Event|2
1393459|NCT01281306|4598442|P1|Overall Study|Adverse Event|3
1393460|NCT01281306|4598436|P7|Overall Study|Death|0
1393461|NCT01281306|4598437|P6|Overall Study|Death|0
1393462|NCT01281306|4598438|P5|Overall Study|Death|0
1393463|NCT01281306|4598439|P4|Overall Study|Death|0
1393464|NCT01281306|4598440|P3|Overall Study|Death|0
1393465|NCT01281306|4598441|P2|Overall Study|Death|0
1393466|NCT01281306|4598442|P1|Overall Study|Death|1
1393467|NCT01281306|4598436|P7|Overall Study|Lost to Follow-up|1
1393468|NCT01281306|4598437|P6|Overall Study|Lost to Follow-up|0
1393470|NCT01281306|4598439|P4|Overall Study|Lost to Follow-up|2
1393471|NCT01281306|4598440|P3|Overall Study|Lost to Follow-up|0
1393472|NCT01281306|4598441|P2|Overall Study|Lost to Follow-up|0
1393473|NCT01281306|4598442|P1|Overall Study|Lost to Follow-up|1
1393474|NCT01281306|4598436|P7|Overall Study|Condition no longer requires study drug|1
1393475|NCT01281306|4598437|P6|Overall Study|Condition no longer requires study drug|1
1393476|NCT01281306|4598438|P5|Overall Study|Condition no longer requires study drug|0
1393477|NCT01281306|4598439|P4|Overall Study|Condition no longer requires study drug|0
1393478|NCT01281306|4598440|P3|Overall Study|Condition no longer requires study drug|0
1393479|NCT01281306|4598441|P2|Overall Study|Condition no longer requires study drug|0
1393480|NCT01281306|4598442|P1|Overall Study|Condition no longer requires study drug|1
1393481|NCT01281306|4598436|P7|Overall Study|Protocol deviation|0
1393482|NCT01281306|4598437|P6|Overall Study|Protocol deviation|0
1393483|NCT01281306|4598438|P5|Overall Study|Protocol deviation|1
1393484|NCT01281306|4598439|P4|Overall Study|Protocol deviation|1
1393485|NCT01281306|4598440|P3|Overall Study|Protocol deviation|1
1393486|NCT01281306|4598441|P2|Overall Study|Protocol deviation|1
1393487|NCT01281306|4598442|P1|Overall Study|Protocol deviation|0
1393488|NCT01281306|4598436|P7|Overall Study|Withdrawal by Subject|1
1393489|NCT01281306|4598437|P6|Overall Study|Withdrawal by Subject|3
1393490|NCT01281306|4598438|P5|Overall Study|Withdrawal by Subject|1
1393491|NCT01281306|4598439|P4|Overall Study|Withdrawal by Subject|4
1393492|NCT01281306|4598440|P3|Overall Study|Withdrawal by Subject|2
1393493|NCT01281306|4598441|P2|Overall Study|Withdrawal by Subject|0
1393494|NCT01281306|4598442|P1|Overall Study|Withdrawal by Subject|1
1393495|NCT01281306|4598436|P7|Overall Study|Lack of Efficacy|1
1393496|NCT01281306|4598437|P6|Overall Study|Lack of Efficacy|0
1393497|NCT01281306|4598438|P5|Overall Study|Lack of Efficacy|2
1393498|NCT01281306|4598439|P4|Overall Study|Lack of Efficacy|0
1393499|NCT01281306|4598440|P3|Overall Study|Lack of Efficacy|3
1393500|NCT01281306|4598441|P2|Overall Study|Lack of Efficacy|1
1393501|NCT01281306|4598442|P1|Overall Study|Lack of Efficacy|0
1393502|NCT01281202|4598558|P2|Overall Study|Incarceration|3
1393503|NCT01281202|4598559|P1|Overall Study|Incarceration|0
1393504|NCT01281202|4598558|P2|Overall Study|Lost to Follow-up|13
1393505|NCT01281202|4598559|P1|Overall Study|Lost to Follow-up|11
1393506|NCT01281202|4598558|P2|Overall Study|Administrative|8
1393507|NCT01281202|4598559|P1|Overall Study|Administrative|2
1393508|NCT01281202|4598558|P2|Overall Study|Protocol Violation|10
1393509|NCT01281202|4598559|P1|Overall Study|Protocol Violation|11
1393510|NCT01281202|4598558|P2|Overall Study|Withdrawal by Subject|2
1393511|NCT01281202|4598559|P1|Overall Study|Withdrawal by Subject|2
1393512|NCT01281202|4598558|P2|Overall Study|Adverse Event|0
1393513|NCT01281202|4598559|P1|Overall Study|Adverse Event|2
1393514|NCT01281124|4598567|P1|Overall Study|Death|1
1393515|NCT01280981|4598582|P1|Overall Study|Study site closure|1
1393516|NCT01280981|4598582|P1|Overall Study|Elective surgery|2
1393517|NCT01280981|4598582|P1|Overall Study|Withdrawal of consent|3
1393518|NCT01280981|4598582|P1|Overall Study|Non-compliance with protocol|3
1393519|NCT01280981|4598582|P1|Overall Study|Failed to return|45
1393520|NCT01280981|4598582|P1|Overall Study|Irregular or discontinued menses|3
1393521|NCT01280981|4598582|P1|Overall Study|Adverse Event|6
1393522|NCT01280981|4598582|P1|Overall Study|Lost to Follow-up|3
1393523|NCT01280981|4598582|P1|Overall Study|Lack of Efficacy|13
1393524|NCT01280981|4598582|P1|Overall Study|Protocol Violation|2
1393525|NCT01280981|4598582|P1|Overall Study|Withdrawal by Subject|11
1393526|NCT01280968|4598593|P2|Overall Study|Unable to Smoke in Supine Position|0
1393527|NCT01280968|4598594|P1|Overall Study|Unable to Smoke in Supine Position|1
1393528|NCT01280968|4598593|P2|Overall Study|Pre-existing Neurological Condition|0
1393529|NCT01280968|4598594|P1|Overall Study|Pre-existing Neurological Condition|1
1393530|NCT01280968|4598593|P2|Overall Study|Scheduling Conflicts|1
1393531|NCT01280968|4598594|P1|Overall Study|Scheduling Conflicts|1
1393532|NCT01280968|4598593|P2|Overall Study|Adverse Event|0
1393533|NCT01280968|4598594|P1|Overall Study|Adverse Event|1
1393534|NCT01280968|4598593|P2|Overall Study|Anxiety|0
1393535|NCT01280968|4598594|P1|Overall Study|Anxiety|2
1393536|NCT01280968|4598593|P2|Overall Study|Commuting Problems|0
1393537|NCT01280968|4598594|P1|Overall Study|Commuting Problems|2
1393538|NCT01280968|4598593|P2|Overall Study|Unable to Follow Experimental Protocol|0
1393539|NCT01280968|4598594|P1|Overall Study|Unable to Follow Experimental Protocol|2
1393540|NCT01280968|4598593|P2|Overall Study|Lost to Follow-up|2
1393541|NCT01280968|4598594|P1|Overall Study|Lost to Follow-up|8
1393542|NCT01280955|4598610|P1|Overall Study|Withdrawal by Subject|1
1393543|NCT01280955|4598610|P1|Overall Study|Death|2
1393544|NCT01280903|4598654|P2|Overall Study|Lost to Follow-up|16
1393545|NCT01280903|4598655|P1|Overall Study|Lost to Follow-up|23
1393546|NCT01280656|4598768|P3|Overall Study|Other|7
1393547|NCT01280656|4598769|P2|Overall Study|Other|7
1393548|NCT01280656|4598770|P1|Overall Study|Other|1
1393549|NCT01280656|4598768|P3|Overall Study|Treatment shortening (RGT)|5
1393550|NCT01280656|4598769|P2|Overall Study|Treatment shortening (RGT)|4
1393551|NCT01280656|4598770|P1|Overall Study|Treatment shortening (RGT)|0
1393552|NCT01280656|4598768|P3|Overall Study|Lack of Efficacy|38
1393553|NCT01280656|4598769|P2|Overall Study|Lack of Efficacy|22
1393554|NCT01280656|4598770|P1|Overall Study|Lack of Efficacy|1
1393555|NCT01280656|4598768|P3|Overall Study|Adverse Event|13
1393556|NCT01280656|4598769|P2|Overall Study|Adverse Event|14
1393557|NCT01280656|4598770|P1|Overall Study|Adverse Event|1
1393558|NCT01280591|4598837|P4|Overall Study|Does not meet exclusion #27 criteria|1
1393559|NCT01280591|4598838|P3|Overall Study|Does not meet exclusion #27 criteria|0
1393560|NCT01280591|4598839|P2|Overall Study|Does not meet exclusion #27 criteria|0
1393561|NCT01280591|4598840|P1|Overall Study|Does not meet exclusion #27 criteria|0
1393562|NCT01280591|4598837|P4|Overall Study|Withdrawal by Subject|2
1393563|NCT01280591|4598838|P3|Overall Study|Withdrawal by Subject|0
1393564|NCT01280591|4598839|P2|Overall Study|Withdrawal by Subject|0
1393565|NCT01280591|4598840|P1|Overall Study|Withdrawal by Subject|0
1393566|NCT01280357|4598945|P1|Overall Study|IInsufficient data/No data supplied|12
1393567|NCT01280357|4598945|P1|Overall Study|Excluded no internal monitoring|14
1393568|NCT01280266|4598954|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
1393569|NCT01280266|4598955|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
1393570|NCT01280266|4598954|P2|First Intervention (Week 1-4)|Adverse Event|0
1393571|NCT01280266|4598955|P1|First Intervention (Week 1-4)|Adverse Event|1
1393572|NCT01279681|4599037|P2|Overall Study|Other Reason|2
1393573|NCT01279681|4599038|P1|Overall Study|Other Reason|0
1393574|NCT01279681|4599037|P2|Overall Study|Physician Decision|0
1393575|NCT01279681|4599038|P1|Overall Study|Physician Decision|1
1393576|NCT01279681|4599037|P2|Overall Study|Withdrawal Prior to Beginning Treatment|1
1393577|NCT01279681|4599038|P1|Overall Study|Withdrawal Prior to Beginning Treatment|0
1393578|NCT01279681|4599037|P2|Overall Study|Death|1
1393579|NCT01279681|4599038|P1|Overall Study|Death|0
1393580|NCT01279681|4599037|P2|Overall Study|Adverse Event|3
1393581|NCT01279681|4599038|P1|Overall Study|Adverse Event|2
1393582|NCT01279681|4599037|P2|Overall Study|Withdrawal by Subject|4
1393583|NCT01279681|4599038|P1|Overall Study|Withdrawal by Subject|3
1393584|NCT01279681|4599037|P2|Overall Study|Disease Progression|6
1393585|NCT01279681|4599038|P1|Overall Study|Disease Progression|9
1393586|NCT01279447|4599061|P2|Overall Study|Lost to Follow-up|1
1393587|NCT01279447|4599062|P1|Overall Study|Lost to Follow-up|3
1393588|NCT01279200|4599089|P2|Overall Study|Adverse Event|0
1393589|NCT01279200|4599090|P1|Overall Study|Adverse Event|1
1393590|NCT01279200|4599089|P2|Overall Study|Lost to Follow-up|1
1393591|NCT01279200|4599090|P1|Overall Study|Lost to Follow-up|0
1393592|NCT01279200|4599089|P2|Overall Study|ultrasound screening failure|1
1393593|NCT01279200|4599090|P1|Overall Study|ultrasound screening failure|0
1393594|NCT01279200|4599089|P2|Overall Study|Inconvenience of ultrasound visit|1
1393595|NCT01279200|4599090|P1|Overall Study|Inconvenience of ultrasound visit|0
1393596|NCT01279200|4599089|P2|Overall Study|Patient withdrawal due to high cost|1
1393597|NCT01279200|4599090|P1|Overall Study|Patient withdrawal due to high cost|0
1393598|NCT01279200|4599089|P2|Overall Study|Withdrawal by Subject|3
1393599|NCT01279200|4599090|P1|Overall Study|Withdrawal by Subject|1
1393600|NCT01279070|4599128|P2|Overall Study|Acute exacerbation|1
1393601|NCT01279070|4599129|P1|Overall Study|Acute exacerbation|3
1393602|NCT01279070|4599128|P2|Overall Study|Withdrawal by Subject|3
1393603|NCT01279070|4599129|P1|Overall Study|Withdrawal by Subject|2
1393604|NCT01279044|4599148|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
1393605|NCT01279044|4599149|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
1393606|NCT01279044|4599150|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
1393607|NCT01279044|4599148|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
1393608|NCT01279044|4599149|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
1393609|NCT01279044|4599150|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
1393610|NCT01279044|4599148|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
1393611|NCT01279044|4599149|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
1393612|NCT01279044|4599150|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
1393613|NCT01278797|4599224|P2|Period 1|Protocol Violation|0
1393614|NCT01278797|4599225|P1|Period 1|Protocol Violation|1
1393615|NCT01278797|4599224|P2|Period 1|Adverse Event|1
1393616|NCT01278797|4599225|P1|Period 1|Adverse Event|0
1393617|NCT01278745|4599237|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
1393618|NCT01278745|4599238|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
1393619|NCT01278745|4599239|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
1393620|NCT01278745|4599240|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
1393621|NCT01278745|4599237|P4|Overall Study|Ineligible|61
1393622|NCT01278745|4599238|P3|Overall Study|Ineligible|42
1393623|NCT01278745|4599239|P2|Overall Study|Ineligible|0
1393624|NCT01278745|4599240|P1|Overall Study|Ineligible|0
1393625|NCT01278745|4599237|P4|Overall Study|Sponsor Decision|6
1393626|NCT01278745|4599238|P3|Overall Study|Sponsor Decision|62
1393627|NCT01278745|4599239|P2|Overall Study|Sponsor Decision|0
1393628|NCT01278745|4599240|P1|Overall Study|Sponsor Decision|1
1393629|NCT01278745|4599237|P4|Overall Study|Withdrawal by Subject|1
1393630|NCT01278745|4599238|P3|Overall Study|Withdrawal by Subject|5
1393631|NCT01278745|4599239|P2|Overall Study|Withdrawal by Subject|1
1393632|NCT01278745|4599240|P1|Overall Study|Withdrawal by Subject|1
1393633|NCT01278745|4599237|P4|Overall Study|Physician Decision|9
1393634|NCT01278745|4599238|P3|Overall Study|Physician Decision|0
1393635|NCT01278745|4599239|P2|Overall Study|Physician Decision|0
1393636|NCT01278745|4599240|P1|Overall Study|Physician Decision|1
1393637|NCT01278745|4599237|P4|Overall Study|Death|0
1393638|NCT01278745|4599238|P3|Overall Study|Death|7
1393639|NCT01278745|4599239|P2|Overall Study|Death|5
1393640|NCT01278745|4599240|P1|Overall Study|Death|2
1393641|NCT01278615|4599272|P1|Overall Study|Withdrawal by Subject|2
1393642|NCT01278407|4599298|P5|Extension Phase|Not Specified|3
1393643|NCT01278407|4599299|P4|Extension Phase|Not Specified|1
1393644|NCT01278407|4599300|P3|Extension Phase|Not Specified|0
1393645|NCT01278407|4599301|P2|Extension Phase|Not Specified|0
1393646|NCT01278407|4599302|P1|Extension Phase|Not Specified|0
1393647|NCT01278407|4599298|P5|Extension Phase|Participant's Choice|11
1393648|NCT01278407|4599299|P4|Extension Phase|Participant's Choice|4
1393649|NCT01278407|4599300|P3|Extension Phase|Participant's Choice|0
1393650|NCT01278407|4599301|P2|Extension Phase|Participant's Choice|0
1393651|NCT01278407|4599302|P1|Extension Phase|Participant's Choice|0
1393652|NCT01278407|4599298|P5|Extension Phase|Adverse Event|16
1393653|NCT01278407|4599299|P4|Extension Phase|Adverse Event|7
1393654|NCT01278407|4599300|P3|Extension Phase|Adverse Event|0
1393655|NCT01278407|4599301|P2|Extension Phase|Adverse Event|0
1393656|NCT01278407|4599302|P1|Extension Phase|Adverse Event|0
1393657|NCT01278407|4599298|P5|Confirmatory Phase|Not Specified|0
1393658|NCT01278407|4599299|P4|Confirmatory Phase|Not Specified|0
1393659|NCT01278407|4599300|P3|Confirmatory Phase|Not Specified|2
1393660|NCT01278407|4599301|P2|Confirmatory Phase|Not Specified|1
1393661|NCT01278407|4599302|P1|Confirmatory Phase|Not Specified|1
1393662|NCT01278407|4599298|P5|Confirmatory Phase|Participant's Choice|0
1393663|NCT01278407|4599299|P4|Confirmatory Phase|Participant's Choice|0
1393664|NCT01278407|4599300|P3|Confirmatory Phase|Participant's Choice|3
1393665|NCT01278407|4599301|P2|Confirmatory Phase|Participant's Choice|5
1393666|NCT01278407|4599302|P1|Confirmatory Phase|Participant's Choice|3
1393667|NCT01278407|4599298|P5|Confirmatory Phase|Adverse Event|0
1393668|NCT01278407|4599299|P4|Confirmatory Phase|Adverse Event|0
1393669|NCT01278407|4599300|P3|Confirmatory Phase|Adverse Event|1
1393670|NCT01278407|4599301|P2|Confirmatory Phase|Adverse Event|10
1393671|NCT01278407|4599302|P1|Confirmatory Phase|Adverse Event|5
1393672|NCT01278394|4599315|P1|Overall Study|Lost to Follow-up|1
1393673|NCT01278342|4599328|P3|Overall Study|Other|0
1393674|NCT01278342|4599329|P2|Overall Study|Other|0
1393675|NCT01278342|4599330|P1|Overall Study|Other|1
1393676|NCT01278342|4599328|P3|Overall Study|Administrative problems|0
1393677|NCT01278342|4599329|P2|Overall Study|Administrative problems|0
1393678|NCT01278342|4599330|P1|Overall Study|Administrative problems|2
1393679|NCT01278342|4599328|P3|Overall Study|Lost to Follow-up|0
1393680|NCT01278342|4599329|P2|Overall Study|Lost to Follow-up|0
1393681|NCT01278342|4599330|P1|Overall Study|Lost to Follow-up|1
1393682|NCT01278342|4599328|P3|Overall Study|Physician Decision|0
1393683|NCT01278342|4599329|P2|Overall Study|Physician Decision|1
1393684|NCT01278342|4599330|P1|Overall Study|Physician Decision|0
1393685|NCT01278173|4599350|P1|Overall Study|Withdrawal by Subject|1
1393686|NCT01278173|4599350|P1|Overall Study|Protocol Violation|1
1393687|NCT01278173|4599350|P1|Overall Study|Administrative or other reason|4
1393688|NCT01278173|4599350|P1|Overall Study|Adverse Event|8
1393689|NCT01278173|4599350|P1|Overall Study|Lack of Efficacy|13
1393690|NCT01278160|4599357|P2|Overall Study|Unclassified|2
1393691|NCT01278160|4599358|P1|Overall Study|Unclassified|1
1393692|NCT01278160|4599357|P2|Overall Study|Withdrawal by Subject|2
1393693|NCT01278160|4599358|P1|Overall Study|Withdrawal by Subject|3
1393694|NCT01278160|4599357|P2|Overall Study|Lost to Follow-up|1
1393695|NCT01278160|4599358|P1|Overall Study|Lost to Follow-up|0
1393696|NCT01278160|4599357|P2|Overall Study|Adverse Event|1
1393697|NCT01278160|4599358|P1|Overall Study|Adverse Event|1
1393698|NCT01278030|4599374|P2|Overall Study|Withdrawal by Subject|4
1393699|NCT01278030|4599375|P1|Overall Study|Withdrawal by Subject|8
1393700|NCT01277887|4599383|P2|Post-Quit Treatment Phase|No longer interested in treatment|5
1393701|NCT01277887|4599384|P1|Post-Quit Treatment Phase|No longer interested in treatment|3
1393702|NCT01277887|4599383|P2|Pre-Quit Treatment Phase|Withdrawal by Subject|0
1393703|NCT01277887|4599384|P1|Pre-Quit Treatment Phase|Withdrawal by Subject|2
1393704|NCT01277887|4599383|P2|Pre-Quit Treatment Phase|No longer interested in treatment|0
1393705|NCT01277887|4599384|P1|Pre-Quit Treatment Phase|No longer interested in treatment|1
1393706|NCT01277861|4599396|P2|Overall Study|Physician Decision|2
1393707|NCT01277861|4599397|P1|Overall Study|Physician Decision|2
1393708|NCT01277822|4599409|P2|Overall Study|Participant moved|0
1393709|NCT01277822|4599410|P1|Overall Study|Participant moved|1
1393710|NCT01277822|4599409|P2|Overall Study|Contraindicated medication used|1
1393711|NCT01277822|4599410|P1|Overall Study|Contraindicated medication used|2
1393712|NCT01277822|4599409|P2|Overall Study|Lost to Follow-up|1
1393713|NCT01277822|4599410|P1|Overall Study|Lost to Follow-up|2
1393714|NCT01277822|4599409|P2|Overall Study|Protocol Violation|0
1393715|NCT01277822|4599410|P1|Overall Study|Protocol Violation|1
1393716|NCT01277822|4599409|P2|Overall Study|Physician Decision|1
1393717|NCT01277822|4599410|P1|Overall Study|Physician Decision|1
1393718|NCT01277822|4599409|P2|Overall Study|Withdrawal by Subject|7
1393719|NCT01277822|4599410|P1|Overall Study|Withdrawal by Subject|6
1393720|NCT01277822|4599409|P2|Overall Study|Adverse Event|1
1393721|NCT01277822|4599410|P1|Overall Study|Adverse Event|2
1393722|NCT01277757|4599430|P1|Overall Study|Withdrawal by Subject|1
1393723|NCT01277757|4599430|P1|Overall Study|Disease Progression|1
1393724|NCT01277718|4599437|P2|Period 2 - Second Intervention|Physician Decision|2
1393725|NCT01277718|4599438|P1|Period 2 - Second Intervention|Physician Decision|0
1393726|NCT01277718|4599437|P2|Period 2 - Second Intervention|Protocol Violation|1
1393727|NCT01277718|4599438|P1|Period 2 - Second Intervention|Protocol Violation|0
1393728|NCT01277666|4599452|P3|Overall Study|Death|1
1393729|NCT01277666|4599453|P2|Overall Study|Death|0
1393730|NCT01277666|4599454|P1|Overall Study|Death|0
1393731|NCT01277666|4599452|P3|Overall Study|Withdrawal by Subject|6
1393732|NCT01277666|4599453|P2|Overall Study|Withdrawal by Subject|8
1393733|NCT01277666|4599454|P1|Overall Study|Withdrawal by Subject|7
1393734|NCT01277666|4599452|P3|Overall Study|Lost to Follow-up|2
1393735|NCT01277666|4599453|P2|Overall Study|Lost to Follow-up|1
1393736|NCT01277666|4599454|P1|Overall Study|Lost to Follow-up|1
1393737|NCT01277666|4599452|P3|Overall Study|Protocol Defined Stopping criteria|6
1393738|NCT01277666|4599453|P2|Overall Study|Protocol Defined Stopping criteria|2
1393739|NCT01277666|4599454|P1|Overall Study|Protocol Defined Stopping criteria|1
1393740|NCT01277666|4599452|P3|Overall Study|Protocol Violation|2
1393741|NCT01277666|4599453|P2|Overall Study|Protocol Violation|3
1393742|NCT01277666|4599454|P1|Overall Study|Protocol Violation|2
1393743|NCT01277666|4599452|P3|Overall Study|Lack of Efficacy|12
1393744|NCT01277666|4599453|P2|Overall Study|Lack of Efficacy|20
1393745|NCT01277666|4599454|P1|Overall Study|Lack of Efficacy|8
1393746|NCT01277666|4599452|P3|Overall Study|Adverse Event|20
1393747|NCT01277666|4599453|P2|Overall Study|Adverse Event|25
1393748|NCT01277666|4599454|P1|Overall Study|Adverse Event|26
1393749|NCT01277601|4599487|P4|Overall Study|Subject Terminated from Study by Sponsor|2
1393750|NCT01277601|4599488|P3|Overall Study|Subject Terminated from Study by Sponsor|0
1393751|NCT01277601|4599489|P2|Overall Study|Subject Terminated from Study by Sponsor|1
1393752|NCT01277601|4599490|P1|Overall Study|Subject Terminated from Study by Sponsor|0
1393753|NCT01277601|4599487|P4|Overall Study|Protocol Violation|0
1393754|NCT01277601|4599488|P3|Overall Study|Protocol Violation|5
1393755|NCT01277601|4599489|P2|Overall Study|Protocol Violation|2
1393756|NCT01277601|4599490|P1|Overall Study|Protocol Violation|0
1393757|NCT01277601|4599487|P4|Overall Study|Subject Never Dosed with Study Drug|1
1393758|NCT01277601|4599488|P3|Overall Study|Subject Never Dosed with Study Drug|3
1393759|NCT01277601|4599489|P2|Overall Study|Subject Never Dosed with Study Drug|2
1393760|NCT01277601|4599490|P1|Overall Study|Subject Never Dosed with Study Drug|1
1393761|NCT01277601|4599487|P4|Overall Study|Noncompliance with Study Drug|0
1393762|NCT01277601|4599488|P3|Overall Study|Noncompliance with Study Drug|2
1393763|NCT01277601|4599489|P2|Overall Study|Noncompliance with Study Drug|3
1393764|NCT01277601|4599490|P1|Overall Study|Noncompliance with Study Drug|1
1393765|NCT01277601|4599487|P4|Overall Study|Pregnancy|1
1393766|NCT01277601|4599488|P3|Overall Study|Pregnancy|4
1393767|NCT01277601|4599489|P2|Overall Study|Pregnancy|2
1393768|NCT01277601|4599490|P1|Overall Study|Pregnancy|2
1393769|NCT01277601|4599487|P4|Overall Study|Physician Decision|6
1393770|NCT01277601|4599488|P3|Overall Study|Physician Decision|1
1393771|NCT01277601|4599489|P2|Overall Study|Physician Decision|5
1393772|NCT01277601|4599490|P1|Overall Study|Physician Decision|3
1393773|NCT01277601|4599487|P4|Overall Study|Lost to Follow-up|2
1393774|NCT01277601|4599488|P3|Overall Study|Lost to Follow-up|4
1393775|NCT01277601|4599489|P2|Overall Study|Lost to Follow-up|9
1393776|NCT01277601|4599490|P1|Overall Study|Lost to Follow-up|7
1393777|NCT01277601|4599487|P4|Overall Study|Withdrawal by Subject|17
1393778|NCT01277601|4599488|P3|Overall Study|Withdrawal by Subject|8
1393779|NCT01277601|4599489|P2|Overall Study|Withdrawal by Subject|21
1393780|NCT01277601|4599490|P1|Overall Study|Withdrawal by Subject|18
1393781|NCT01277601|4599487|P4|Overall Study|Adverse Event|7
1393782|NCT01277601|4599488|P3|Overall Study|Adverse Event|0
1393783|NCT01277601|4599489|P2|Overall Study|Adverse Event|3
1393784|NCT01277601|4599490|P1|Overall Study|Adverse Event|5
1393785|NCT01277549|4599581|P2|Overall Study|Physician Decision|1
1393786|NCT01277549|4599582|P1|Overall Study|Physician Decision|2
1393787|NCT01277549|4599581|P2|Overall Study|Protocol Violation|1
1393788|NCT01277549|4599582|P1|Overall Study|Protocol Violation|10
1393789|NCT01277549|4599581|P2|Overall Study|Withdrawal by Subject|3
1393790|NCT01277549|4599582|P1|Overall Study|Withdrawal by Subject|1
1393791|NCT01277549|4599581|P2|Overall Study|Failed to meet eligibility criteria|9
1393792|NCT01277549|4599582|P1|Overall Study|Failed to meet eligibility criteria|13
1393793|NCT01277523|4599599|P3|Overall Study|Other Reason not Defined|0
1393794|NCT01277523|4599600|P2|Overall Study|Other Reason not Defined|1
1393795|NCT01277523|4599601|P1|Overall Study|Other Reason not Defined|0
1393796|NCT01277523|4599599|P3|Overall Study|Protocol Violation|0
1393797|NCT01277523|4599600|P2|Overall Study|Protocol Violation|0
1393798|NCT01277523|4599601|P1|Overall Study|Protocol Violation|2
1393799|NCT01277523|4599599|P3|Overall Study|Adverse Event|0
1393800|NCT01277523|4599600|P2|Overall Study|Adverse Event|0
1393801|NCT01277523|4599601|P1|Overall Study|Adverse Event|1
1393802|NCT01277510|4599653|P2|Open-label Phase|Never received investigational product|0
1393803|NCT01277510|4599654|P1|Open-label Phase|Never received investigational product|2
1393804|NCT01277510|4599653|P2|Open-label Phase|Protocol-specified criteria|0
1393805|NCT01277510|4599654|P1|Open-label Phase|Protocol-specified criteria|1
1393806|NCT01277510|4599653|P2|Open-label Phase|Administrative decision|3
1393807|NCT01277510|4599654|P1|Open-label Phase|Administrative decision|4
1393808|NCT01277510|4599653|P2|Double-blind Phase|Other|1
1393809|NCT01277510|4599654|P1|Double-blind Phase|Other|1
1393810|NCT01277510|4599653|P2|Double-blind Phase|Protocol-specified criteria|6
1393811|NCT01277510|4599654|P1|Double-blind Phase|Protocol-specified criteria|2
1393812|NCT01277510|4599653|P2|Double-blind Phase|Death|1
1393813|NCT01277510|4599654|P1|Double-blind Phase|Death|0
1393814|NCT01277510|4599653|P2|Double-blind Phase|Administrative decision|9
1393815|NCT01277510|4599654|P1|Double-blind Phase|Administrative decision|7
1393816|NCT01277510|4599653|P2|Double-blind Phase|Withdrawal by Subject|0
1393817|NCT01277510|4599654|P1|Double-blind Phase|Withdrawal by Subject|2
1393818|NCT01277510|4599653|P2|Double-blind Phase|Adverse Event|0
1393819|NCT01277510|4599654|P1|Double-blind Phase|Adverse Event|1
1393820|NCT01277510|4599653|P2|Double-blind Phase|Non-compliance|1
1393821|NCT01277510|4599654|P1|Double-blind Phase|Non-compliance|0
1393822|NCT01277302|4599688|P3|8-Month Alternate Dose Regimen Period|Relocation|1
1393823|NCT01277302|4599689|P2|8-Month Alternate Dose Regimen Period|Relocation|0
1393824|NCT01277302|4599690|P1|8-Month Alternate Dose Regimen Period|Relocation|1
1393825|NCT01277302|4599688|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
1393826|NCT01277302|4599689|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
1393827|NCT01277302|4599690|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
1393828|NCT01277302|4599688|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
1393829|NCT01277302|4599689|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
1393830|NCT01277302|4599690|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
1393831|NCT01277302|4599688|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
1393832|NCT01277302|4599689|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
1393833|NCT01277302|4599690|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
1393834|NCT01277302|4599688|P3|8-Month Alternate Dose Regimen Period|Death|0
1393835|NCT01277302|4599689|P2|8-Month Alternate Dose Regimen Period|Death|1
1393836|NCT01277302|4599690|P1|8-Month Alternate Dose Regimen Period|Death|0
1393837|NCT01277302|4599688|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
1393838|NCT01277302|4599689|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
1393839|NCT01277302|4599690|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
1393840|NCT01277302|4599688|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
1393841|NCT01277302|4599689|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
1393842|NCT01277302|4599690|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
1393843|NCT01277302|4599688|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
1393844|NCT01277302|4599689|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
1393845|NCT01277302|4599690|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
1393846|NCT01277302|4599688|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
1393847|NCT01277302|4599689|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
1393848|NCT01277302|4599690|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
1393849|NCT01277211|4599722|P2|Overall Study|Discontinued prior to treatment|13
1393850|NCT01277211|4599723|P1|Overall Study|Discontinued prior to treatment|24
1393851|NCT01277211|4599722|P2|Overall Study|Pregnancy wish|2
1393852|NCT01277211|4599723|P1|Overall Study|Pregnancy wish|0
1393853|NCT01277211|4599722|P2|Overall Study|Administrative|0
1393854|NCT01277211|4599723|P1|Overall Study|Administrative|3
1393855|NCT01277211|4599722|P2|Overall Study|Did not meet protocol eligibility|0
1393856|NCT01277211|4599723|P1|Overall Study|Did not meet protocol eligibility|1
1393857|NCT01277211|4599722|P2|Overall Study|Non-compliance with protocol|4
1393858|NCT01277211|4599723|P1|Overall Study|Non-compliance with protocol|13
1393859|NCT01277211|4599722|P2|Overall Study|Withdrew Consent|9
1393860|NCT01277211|4599723|P1|Overall Study|Withdrew Consent|9
1393861|NCT01277211|4599722|P2|Overall Study|Did not wish to continue|0
1393862|NCT01277211|4599723|P1|Overall Study|Did not wish to continue|17
1393863|NCT01277211|4599722|P2|Overall Study|Lost to Follow-up|9
1393864|NCT01277211|4599723|P1|Overall Study|Lost to Follow-up|14
1393865|NCT01277211|4599722|P2|Overall Study|Pregnancy|4
1393866|NCT01277211|4599723|P1|Overall Study|Pregnancy|9
1393867|NCT01277211|4599722|P2|Overall Study|Adverse Event|22
1393868|NCT01277211|4599723|P1|Overall Study|Adverse Event|60
1393869|NCT01277042|4599775|P2|Overall Study|Withdrawal by Subject|0
1393870|NCT01277042|4599776|P1|Overall Study|Withdrawal by Subject|2
1393871|NCT01277042|4599775|P2|Overall Study|Lost to Follow-up|2
1393872|NCT01277042|4599776|P1|Overall Study|Lost to Follow-up|2
1393873|NCT01277042|4599775|P2|Overall Study|Adverse Event|3
1393874|NCT01277042|4599776|P1|Overall Study|Adverse Event|4
1393875|NCT01276847|4599801|P3|Overall Study|Withdrawal by Subject|0
1393876|NCT01276847|4599802|P2|Overall Study|Withdrawal by Subject|0
1393877|NCT01276847|4599803|P1|Overall Study|Withdrawal by Subject|1
1393878|NCT01276821|4599813|P2|Overall Study|Protocol Violation|1
1393879|NCT01276821|4599814|P1|Overall Study|Protocol Violation|0
1393880|NCT01276756|4599834|P2|Overall Study|Adverse Event|2
1393881|NCT01276756|4599835|P1|Overall Study|Adverse Event|3
1393882|NCT01276756|4599834|P2|Overall Study|Lost to Follow-up|0
1393883|NCT01276756|4599835|P1|Overall Study|Lost to Follow-up|2
1393884|NCT01276639|4599880|P5|Week 16 to 52|Other|3
1393885|NCT01276639|4599881|P4|Week 16 to 52|Other|1
1393886|NCT01276639|4599882|P3|Week 16 to 52|Other|0
1393887|NCT01276639|4599883|P2|Week 16 to 52|Other|12
1393888|NCT01276639|4599884|P1|Week 16 to 52|Other|10
1393889|NCT01276639|4599880|P5|Week 16 to 52|Withdrawal by Subject|1
1393890|NCT01276639|4599881|P4|Week 16 to 52|Withdrawal by Subject|0
1393891|NCT01276639|4599882|P3|Week 16 to 52|Withdrawal by Subject|0
1393892|NCT01276639|4599883|P2|Week 16 to 52|Withdrawal by Subject|4
1393893|NCT01276639|4599884|P1|Week 16 to 52|Withdrawal by Subject|4
1393894|NCT01276639|4599880|P5|Week 16 to 52|Lost to Follow-up|1
1393895|NCT01276639|4599881|P4|Week 16 to 52|Lost to Follow-up|0
1393896|NCT01276639|4599882|P3|Week 16 to 52|Lost to Follow-up|0
1393897|NCT01276639|4599883|P2|Week 16 to 52|Lost to Follow-up|1
1393898|NCT01276639|4599884|P1|Week 16 to 52|Lost to Follow-up|3
1393899|NCT01276639|4599880|P5|Week 16 to 52|Lack of Efficacy|13
1393900|NCT01276639|4599881|P4|Week 16 to 52|Lack of Efficacy|14
1393901|NCT01276639|4599882|P3|Week 16 to 52|Lack of Efficacy|0
1393902|NCT01276639|4599883|P2|Week 16 to 52|Lack of Efficacy|71
1393903|NCT01276639|4599884|P1|Week 16 to 52|Lack of Efficacy|99
1393904|NCT01276639|4599880|P5|Week 16 to 52|Adverse Event|3
1393905|NCT01276639|4599881|P4|Week 16 to 52|Adverse Event|1
1393906|NCT01276639|4599882|P3|Week 16 to 52|Adverse Event|0
1393907|NCT01276639|4599883|P2|Week 16 to 52|Adverse Event|13
1393908|NCT01276639|4599884|P1|Week 16 to 52|Adverse Event|10
1393909|NCT01276639|4599880|P5|Week 16 to 52|Death|0
1393910|NCT01276639|4599881|P4|Week 16 to 52|Death|0
1393911|NCT01276639|4599882|P3|Week 16 to 52|Death|0
1393912|NCT01276639|4599883|P2|Week 16 to 52|Death|0
1393913|NCT01276639|4599884|P1|Week 16 to 52|Death|1
1393914|NCT01276639|4599880|P5|Week 0 to 16|Randomized, But Not Treated|0
1393915|NCT01276639|4599881|P4|Week 0 to 16|Randomized, But Not Treated|0
1393916|NCT01276639|4599882|P3|Week 0 to 16|Randomized, But Not Treated|0
1393917|NCT01276639|4599883|P2|Week 0 to 16|Randomized, But Not Treated|1
1393918|NCT01276639|4599884|P1|Week 0 to 16|Randomized, But Not Treated|0
1393919|NCT01276639|4599880|P5|Week 0 to 16|Other|0
1393920|NCT01276639|4599881|P4|Week 0 to 16|Other|0
1393921|NCT01276639|4599882|P3|Week 0 to 16|Other|2
1393922|NCT01276639|4599883|P2|Week 0 to 16|Other|7
1393923|NCT01276639|4599884|P1|Week 0 to 16|Other|7
1393924|NCT01276639|4599880|P5|Week 0 to 16|Withdrawal by Subject|0
1393925|NCT01276639|4599881|P4|Week 0 to 16|Withdrawal by Subject|0
1393926|NCT01276639|4599882|P3|Week 0 to 16|Withdrawal by Subject|4
1393927|NCT01276639|4599883|P2|Week 0 to 16|Withdrawal by Subject|5
1393928|NCT01276639|4599884|P1|Week 0 to 16|Withdrawal by Subject|8
1393929|NCT01276639|4599880|P5|Week 0 to 16|Lost to Follow-up|0
1393930|NCT01276639|4599881|P4|Week 0 to 16|Lost to Follow-up|0
1393931|NCT01276639|4599882|P3|Week 0 to 16|Lost to Follow-up|3
1393932|NCT01276639|4599883|P2|Week 0 to 16|Lost to Follow-up|5
1393933|NCT01276639|4599884|P1|Week 0 to 16|Lost to Follow-up|3
1393934|NCT01276639|4599880|P5|Week 0 to 16|Lack of Efficacy|0
1393935|NCT01276639|4599881|P4|Week 0 to 16|Lack of Efficacy|0
1393936|NCT01276639|4599882|P3|Week 0 to 16|Lack of Efficacy|25
1393937|NCT01276639|4599883|P2|Week 0 to 16|Lack of Efficacy|15
1393938|NCT01276639|4599884|P1|Week 0 to 16|Lack of Efficacy|20
1393939|NCT01276639|4599880|P5|Week 0 to 16|Adverse Event|0
1393940|NCT01276639|4599881|P4|Week 0 to 16|Adverse Event|0
1393941|NCT01276639|4599882|P3|Week 0 to 16|Adverse Event|11
1393942|NCT01276639|4599883|P2|Week 0 to 16|Adverse Event|8
1393943|NCT01276639|4599884|P1|Week 0 to 16|Adverse Event|11
1393944|NCT01276639|4599880|P5|Week 0 to 16|Death|0
1393945|NCT01276639|4599881|P4|Week 0 to 16|Death|0
1393946|NCT01276639|4599882|P3|Week 0 to 16|Death|0
1393947|NCT01276639|4599883|P2|Week 0 to 16|Death|0
1393948|NCT01276639|4599884|P1|Week 0 to 16|Death|1
1393949|NCT01276509|4600089|P4|Overall Study|Other|0
1393950|NCT01276509|4600090|P3|Overall Study|Other|0
1393951|NCT01276509|4600091|P2|Overall Study|Other|1
1393952|NCT01276509|4600092|P1|Overall Study|Other|0
1393953|NCT01276509|4600089|P4|Overall Study|Withdrawal by Subject|0
1393954|NCT01276509|4600090|P3|Overall Study|Withdrawal by Subject|0
1393955|NCT01276509|4600091|P2|Overall Study|Withdrawal by Subject|2
1393956|NCT01276509|4600092|P1|Overall Study|Withdrawal by Subject|1
1393957|NCT01276509|4600089|P4|Overall Study|Pregnancy|0
1393958|NCT01276509|4600090|P3|Overall Study|Pregnancy|0
1393959|NCT01276509|4600091|P2|Overall Study|Pregnancy|0
1393960|NCT01276509|4600092|P1|Overall Study|Pregnancy|1
1393961|NCT01276509|4600089|P4|Overall Study|Lack of Efficacy|2
1393962|NCT01276509|4600090|P3|Overall Study|Lack of Efficacy|1
1393963|NCT01276509|4600091|P2|Overall Study|Lack of Efficacy|1
1393964|NCT01276509|4600092|P1|Overall Study|Lack of Efficacy|2
1393965|NCT01276509|4600089|P4|Overall Study|Adverse Event|3
1393966|NCT01276509|4600090|P3|Overall Study|Adverse Event|4
1393967|NCT01276509|4600091|P2|Overall Study|Adverse Event|8
1393968|NCT01276509|4600092|P1|Overall Study|Adverse Event|9
1393969|NCT01276457|4600145|P2|Extension Study|Lack of Efficacy|1
1393970|NCT01276457|4600146|P1|Extension Study|Lack of Efficacy|3
1393971|NCT01276457|4600145|P2|Extension Study|Death|1
1393972|NCT01276457|4600146|P1|Extension Study|Death|0
1393973|NCT01276457|4600145|P2|Extension Study|Lost to Follow-up|0
1393974|NCT01276457|4600146|P1|Extension Study|Lost to Follow-up|3
1393975|NCT01276457|4600145|P2|Core Study|Lack of Efficacy|12
1393976|NCT01276457|4600146|P1|Core Study|Lack of Efficacy|3
1393977|NCT01276457|4600145|P2|Core Study|Death|2
1393978|NCT01276457|4600146|P1|Core Study|Death|2
1393979|NCT01276457|4600145|P2|Core Study|Administrative problems|1
1393980|NCT01276457|4600146|P1|Core Study|Administrative problems|1
1393981|NCT01276457|4600145|P2|Core Study|Lost to Follow-up|2
1393982|NCT01276457|4600146|P1|Core Study|Lost to Follow-up|1
1393983|NCT01276457|4600145|P2|Core Study|Adverse Event|3
1393984|NCT01276457|4600146|P1|Core Study|Adverse Event|6
1393985|NCT01276353|4600160|P2|Extension|Prohibited concomitant medications|1
1393986|NCT01276353|4600161|P1|Extension|Prohibited concomitant medications|0
1393987|NCT01276353|4600160|P2|Extension|Physician Decision|0
1393988|NCT01276353|4600161|P1|Extension|Physician Decision|1
1393989|NCT01276353|4600160|P2|Extension|Withdrawal of study drug 4 days in a row|1
1393990|NCT01276353|4600161|P1|Extension|Withdrawal of study drug 4 days in a row|3
1393991|NCT01276353|4600160|P2|Extension|Withdrawal by Subject|2
1393992|NCT01276353|4600161|P1|Extension|Withdrawal by Subject|1
1393993|NCT01276353|4600160|P2|Extension|Adverse Event|5
1393994|NCT01276353|4600161|P1|Extension|Adverse Event|2
1393995|NCT01276353|4600160|P2|Double-blind|Withdrawal by Subject|0
1393996|NCT01276353|4600161|P1|Double-blind|Withdrawal by Subject|1
1393997|NCT01276353|4600160|P2|Double-blind|Adverse Event|0
1393998|NCT01276353|4600161|P1|Double-blind|Adverse Event|2
1393999|NCT01276327|4600173|P2|Overall Study|Withdrawal by Subject|0
1394000|NCT01276327|4600174|P1|Overall Study|Withdrawal by Subject|1
1394001|NCT01276327|4600173|P2|Overall Study|Adverse Event|3
1394002|NCT01276327|4600174|P1|Overall Study|Adverse Event|1
1394003|NCT01276288|4600241|P4|Overall Study|not treated|0
1394004|NCT01276288|4600242|P3|Overall Study|not treated|0
1394005|NCT01276288|4600243|P2|Overall Study|not treated|0
1394006|NCT01276288|4600244|P1|Overall Study|not treated|1
1394007|NCT01276288|4600241|P4|Overall Study|Adverse Event|0
1394008|NCT01276288|4600242|P3|Overall Study|Adverse Event|0
1394009|NCT01276288|4600243|P2|Overall Study|Adverse Event|1
1394010|NCT01276288|4600244|P1|Overall Study|Adverse Event|1
1394011|NCT01276223|4600371|P3|Overall Study|Protocol Violation|0
1394012|NCT01276223|4600372|P2|Overall Study|Protocol Violation|0
1394013|NCT01276223|4600373|P1|Overall Study|Protocol Violation|1
1394014|NCT01276223|4600371|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
1394015|NCT01276223|4600372|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
1394016|NCT01276223|4600373|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
1394017|NCT01276223|4600371|P3|Overall Study|Not specified|1
1394018|NCT01276223|4600372|P2|Overall Study|Not specified|0
1394019|NCT01276223|4600373|P1|Overall Study|Not specified|0
1394020|NCT01276223|4600371|P3|Overall Study|Lost to Follow-up|1
1394021|NCT01276223|4600372|P2|Overall Study|Lost to Follow-up|0
1394022|NCT01276223|4600373|P1|Overall Study|Lost to Follow-up|0
1394023|NCT01276223|4600371|P3|Overall Study|Adverse Event|1
1394024|NCT01276223|4600372|P2|Overall Study|Adverse Event|4
1394025|NCT01276223|4600373|P1|Overall Study|Adverse Event|7
1394026|NCT01276106|4600414|P4|Overall Study|Insufficient therapeutic effects|0
1394027|NCT01276106|4600415|P3|Overall Study|Insufficient therapeutic effects|2
1394028|NCT01276106|4600416|P2|Overall Study|Insufficient therapeutic effects|0
1394029|NCT01276106|4600417|P1|Overall Study|Insufficient therapeutic effects|0
1394030|NCT01276106|4600414|P4|Overall Study|Protocol Violation|2
1394031|NCT01276106|4600415|P3|Overall Study|Protocol Violation|0
1394032|NCT01276106|4600416|P2|Overall Study|Protocol Violation|1
1394033|NCT01276106|4600417|P1|Overall Study|Protocol Violation|1
1394034|NCT01276106|4600414|P4|Overall Study|Physician Decision|1
1394035|NCT01276106|4600415|P3|Overall Study|Physician Decision|1
1394036|NCT01276106|4600416|P2|Overall Study|Physician Decision|0
1394037|NCT01276106|4600417|P1|Overall Study|Physician Decision|0
1394038|NCT01276106|4600414|P4|Overall Study|Lost to Follow-up|0
1394039|NCT01276106|4600415|P3|Overall Study|Lost to Follow-up|1
1394040|NCT01276106|4600416|P2|Overall Study|Lost to Follow-up|1
1394041|NCT01276106|4600417|P1|Overall Study|Lost to Follow-up|2
1394042|NCT01276106|4600414|P4|Overall Study|Lack of Efficacy|1
1394043|NCT01276106|4600415|P3|Overall Study|Lack of Efficacy|0
1394044|NCT01276106|4600416|P2|Overall Study|Lack of Efficacy|1
1394045|NCT01276106|4600417|P1|Overall Study|Lack of Efficacy|0
1394046|NCT01276106|4600414|P4|Overall Study|Withdrawal by Subject|6
1394047|NCT01276106|4600415|P3|Overall Study|Withdrawal by Subject|1
1394048|NCT01276106|4600416|P2|Overall Study|Withdrawal by Subject|3
1394049|NCT01276106|4600417|P1|Overall Study|Withdrawal by Subject|6
1394050|NCT01276106|4600414|P4|Overall Study|Adverse Event|3
1394051|NCT01276106|4600415|P3|Overall Study|Adverse Event|11
1394052|NCT01276106|4600416|P2|Overall Study|Adverse Event|3
1394053|NCT01276106|4600417|P1|Overall Study|Adverse Event|3
1394054|NCT01276054|4600429|P2|Overall Study|No one to oversee trial after P.I. left|2
1394055|NCT01276054|4600430|P1|Overall Study|No one to oversee trial after P.I. left|2
1394056|NCT01275833|4600438|P2|Overall Study|Study terminated|1
1394057|NCT01275833|4600439|P1|Overall Study|Study terminated|1
1394058|NCT01275755|4600447|P2|Run-out Placebo Period|Lost to Follow-up|0
1394059|NCT01275755|4600448|P1|Run-out Placebo Period|Lost to Follow-up|1
1394060|NCT01275755|4600447|P2|Double-blind Treatment Period|Withdrawal by Subject|0
1394061|NCT01275755|4600448|P1|Double-blind Treatment Period|Withdrawal by Subject|1
1394062|NCT01275755|4600447|P2|Double-blind Treatment Period|Lost to Follow-up|1
1394063|NCT01275755|4600448|P1|Double-blind Treatment Period|Lost to Follow-up|1
1394064|NCT01275755|4600447|P2|Double-blind Treatment Period|Adverse Event|2
1394065|NCT01275755|4600448|P1|Double-blind Treatment Period|Adverse Event|0
1394066|NCT01275625|4600462|P1|Overall Study|Not specified|1
1394067|NCT01275625|4600462|P1|Overall Study|Adverse Event|4
1394068|NCT01275625|4600462|P1|Overall Study|Protocol Violation|1
1394069|NCT01275625|4600462|P1|Overall Study|Withdrawal by Subject|3
1394070|NCT01275625|4600462|P1|Overall Study|Lost to Follow-up|1
1394071|NCT01275625|4600462|P1|Overall Study|Lack of Efficacy|2
1394072|NCT01275625|4600462|P1|Overall Study|Death|1
1394073|NCT01275430|4600480|P1|Overall Study|Inability to achieve maximum p-wave|1
1394074|NCT01275430|4600480|P1|Overall Study|Device Malfunction|1
1394075|NCT01275430|4600480|P1|Overall Study|No Contrast Injection|6
1394076|NCT01275430|4600480|P1|Overall Study|Adverse Event|1
1394077|NCT01275196|4600552|P2|Overall Study|Suboptimal response/treatment failure|6
1394078|NCT01275196|4600553|P1|Overall Study|Suboptimal response/treatment failure|5
1394079|NCT01275196|4600552|P2|Overall Study|Protocol Violation|0
1394080|NCT01275196|4600553|P1|Overall Study|Protocol Violation|1
1394081|NCT01275196|4600552|P2|Overall Study|Disease Progression|5
1394082|NCT01275196|4600553|P1|Overall Study|Disease Progression|6
1394083|NCT01275196|4600552|P2|Overall Study|Lost to Follow-up|0
1394084|NCT01275196|4600553|P1|Overall Study|Lost to Follow-up|1
1394085|NCT01275196|4600552|P2|Overall Study|Withdrawal by Subject|5
1394086|NCT01275196|4600553|P1|Overall Study|Withdrawal by Subject|4
1394087|NCT01275196|4600552|P2|Overall Study|Adverse Event|5
1394088|NCT01275196|4600553|P1|Overall Study|Adverse Event|3
1394089|NCT01275131|4600596|P4|Period 2 (Crossover)|Withdrawal by Subject|2
1394090|NCT01275131|4600597|P3|Period 2 (Crossover)|Withdrawal by Subject|1
1394091|NCT01275131|4600598|P2|Period 2 (Crossover)|Withdrawal by Subject|0
1394092|NCT01275131|4600599|P1|Period 2 (Crossover)|Withdrawal by Subject|1
1394093|NCT01275131|4600596|P4|Period 2 (Crossover)|Adverse Event|0
1394094|NCT01275131|4600597|P3|Period 2 (Crossover)|Adverse Event|0
1394095|NCT01275131|4600598|P2|Period 2 (Crossover)|Adverse Event|1
1394096|NCT01275131|4600599|P1|Period 2 (Crossover)|Adverse Event|0
1394097|NCT01275131|4600596|P4|Period 1|Physician Decision|0
1394098|NCT01275131|4600597|P3|Period 1|Physician Decision|0
1394099|NCT01275131|4600598|P2|Period 1|Physician Decision|0
1394100|NCT01275131|4600599|P1|Period 1|Physician Decision|1
1394101|NCT01275131|4600596|P4|Period 1|Withdrawal by Subject|2
1394102|NCT01275131|4600597|P3|Period 1|Withdrawal by Subject|3
1394103|NCT01275131|4600598|P2|Period 1|Withdrawal by Subject|0
1394104|NCT01275131|4600599|P1|Period 1|Withdrawal by Subject|1
1394105|NCT01275066|4600642|P3|Overall Study|Not Diagnosed w/ Disease|0
1394106|NCT01275066|4600643|P2|Overall Study|Not Diagnosed w/ Disease|0
1394107|NCT01275066|4600644|P1|Overall Study|Not Diagnosed w/ Disease|1
1394108|NCT01275066|4600642|P3|Overall Study|Withdrawal by Subject|1
1394109|NCT01275066|4600643|P2|Overall Study|Withdrawal by Subject|0
1394110|NCT01275066|4600644|P1|Overall Study|Withdrawal by Subject|0
1394111|NCT01274715|4600677|P1|Overall Study|After consent, met exclusion criteria.|1
1394112|NCT01274715|4600677|P1|Overall Study|After consent, met exclusion criteria.|1
1394113|NCT01274715|4600677|P1|Overall Study|After consent, met exclusion criteria.|1
1394114|NCT01274715|4600677|P1|Overall Study|Lost to Follow-up|1
1394115|NCT01274637|4600684|P2|Overall Study|Lost to Follow-up|1
1394116|NCT01274637|4600685|P1|Overall Study|Lost to Follow-up|0
1394117|NCT01274637|4600684|P2|Overall Study|Withdrawal by Subject|1
1394118|NCT01274637|4600685|P1|Overall Study|Withdrawal by Subject|0
1394119|NCT01274559|4600724|P2|Overall Study|Withdrawal by Subject|13
1394120|NCT01274559|4600725|P1|Overall Study|Withdrawal by Subject|25
1394121|NCT01274559|4600724|P2|Overall Study|Study Terminated by Sponsor|87
1394122|NCT01274559|4600725|P1|Overall Study|Study Terminated by Sponsor|79
1394123|NCT01274559|4600724|P2|Overall Study|Protocol Violation|23
1394124|NCT01274559|4600725|P1|Overall Study|Protocol Violation|28
1394125|NCT01274559|4600724|P2|Overall Study|Physician Decision|1
1394126|NCT01274559|4600725|P1|Overall Study|Physician Decision|2
1394127|NCT01274559|4600724|P2|Overall Study|Non-compliance with Study Drug|4
1394128|NCT01274559|4600725|P1|Overall Study|Non-compliance with Study Drug|2
1394129|NCT01274559|4600724|P2|Overall Study|Lost to Follow-up|3
1394130|NCT01274559|4600725|P1|Overall Study|Lost to Follow-up|3
1394131|NCT01274559|4600724|P2|Overall Study|Death|1
1394132|NCT01274559|4600725|P1|Overall Study|Death|1
1394133|NCT01274559|4600724|P2|Overall Study|Adverse Event|13
1394134|NCT01274559|4600725|P1|Overall Study|Adverse Event|57
1394135|NCT01274533|4600775|P1|Overall Study|Disease progression|2
1394136|NCT01274533|4600775|P1|Overall Study|Non-compliance|1
1394137|NCT01274533|4600775|P1|Overall Study|Withdrawal by Subject|1
1394138|NCT01274429|4600780|P1|Overall Study|Study closed do to lack of funding|5
1394139|NCT01274182|4600788|P3|Overall Study|Death|1
1394140|NCT01274182|4600789|P2|Overall Study|Death|0
1394141|NCT01274182|4600790|P1|Overall Study|Death|1
1394142|NCT01274182|4600788|P3|Overall Study|Protocol Violation|0
1394143|NCT01274182|4600789|P2|Overall Study|Protocol Violation|2
1394144|NCT01274182|4600790|P1|Overall Study|Protocol Violation|3
1394145|NCT01274182|4600788|P3|Overall Study|Lost to Follow-up|1
1394146|NCT01274182|4600789|P2|Overall Study|Lost to Follow-up|3
1394147|NCT01274182|4600790|P1|Overall Study|Lost to Follow-up|2
1394148|NCT01274182|4600788|P3|Overall Study|Withdrawal by Subject|3
1394149|NCT01274182|4600789|P2|Overall Study|Withdrawal by Subject|5
1394150|NCT01274182|4600790|P1|Overall Study|Withdrawal by Subject|5
1394151|NCT01274182|4600788|P3|Overall Study|Adverse Event|3
1394152|NCT01274182|4600789|P2|Overall Study|Adverse Event|5
1394153|NCT01274182|4600790|P1|Overall Study|Adverse Event|4
1394154|NCT01274182|4600788|P3|Overall Study|Unsatisfactory therapeutic effect|4
1394155|NCT01274182|4600789|P2|Overall Study|Unsatisfactory therapeutic effect|3
1394156|NCT01274182|4600790|P1|Overall Study|Unsatisfactory therapeutic effect|6
1394157|NCT01273883|4600831|P2|Second Intervention|Lack of Efficacy|0
1394158|NCT01273883|4600832|P1|Second Intervention|Lack of Efficacy|1
1394159|NCT01273883|4600831|P2|Second Intervention|Lost to Follow-up|1
1394160|NCT01273883|4600832|P1|Second Intervention|Lost to Follow-up|1
1394161|NCT01273883|4600831|P2|First Intervention|Adverse Event|1
1394162|NCT01273883|4600832|P1|First Intervention|Adverse Event|2
1394163|NCT01273818|4600858|P3|Overall Study|Physician Decision|9
1394164|NCT01273818|4600859|P2|Overall Study|Physician Decision|2
1394165|NCT01273818|4600860|P1|Overall Study|Physician Decision|13
1394166|NCT01273805|4600870|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
1394167|NCT01273805|4600871|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
1394168|NCT01273623|4600902|P1|Overall Study|did not meet IVUS criteria|29
1394169|NCT01273597|4600909|P1|Overall Study|Reason Not Reported|1
1394170|NCT01273597|4600909|P1|Overall Study|Underwent Kidney Transplantation|2
1394171|NCT01273597|4600909|P1|Overall Study|Adverse Event|5
1394172|NCT01273519|4600924|P3|Overall Study|Not Specified|1
1394173|NCT01273519|4600925|P2|Overall Study|Not Specified|1
1394174|NCT01273519|4600926|P1|Overall Study|Not Specified|6
1394175|NCT01273519|4600924|P3|Overall Study|Lack of Efficacy|4
1394176|NCT01273519|4600925|P2|Overall Study|Lack of Efficacy|3
1394177|NCT01273519|4600926|P1|Overall Study|Lack of Efficacy|8
1394178|NCT01273519|4600924|P3|Overall Study|Lost to Follow-up|3
1394179|NCT01273519|4600925|P2|Overall Study|Lost to Follow-up|1
1394180|NCT01273519|4600926|P1|Overall Study|Lost to Follow-up|2
1394181|NCT01273519|4600924|P3|Overall Study|Adverse Event|0
1394182|NCT01273519|4600925|P2|Overall Study|Adverse Event|0
1394183|NCT01273519|4600926|P1|Overall Study|Adverse Event|3
1394184|NCT01273181|4600963|P4|Phase 2, Dose 2|Death during treatment|1
1394185|NCT01273181|4600964|P3|Phase 2, Dose 2|Death during treatment|0
1394186|NCT01273181|4600965|P2|Phase 2, Dose 2|Death during treatment|0
1394187|NCT01273181|4600966|P1|Phase 2, Dose 2|Death during treatment|0
1394188|NCT01273181|4600963|P4|Phase 2, Dose 1|Study termination|0
1394189|NCT01273181|4600964|P3|Phase 2, Dose 1|Study termination|1
1394190|NCT01273181|4600965|P2|Phase 2, Dose 1|Study termination|0
1394191|NCT01273181|4600966|P1|Phase 2, Dose 1|Study termination|0
1394192|NCT01273181|4600963|P4|Phase I, Dose 2|Death during treatment|0
1394193|NCT01273181|4600964|P3|Phase I, Dose 2|Death during treatment|0
1394194|NCT01273181|4600965|P2|Phase I, Dose 2|Death during treatment|1
1394195|NCT01273181|4600966|P1|Phase I, Dose 2|Death during treatment|0
1394196|NCT01273181|4600963|P4|Phase I, Dose 1|Study termination|0
1394197|NCT01273181|4600964|P3|Phase I, Dose 1|Study termination|0
1394198|NCT01273181|4600965|P2|Phase I, Dose 1|Study termination|0
1394199|NCT01273181|4600966|P1|Phase I, Dose 1|Study termination|1
1394200|NCT01273064|4600985|P5|Overall Study|Physician Decision|1
1394201|NCT01273064|4600986|P4|Overall Study|Physician Decision|0
1394202|NCT01273064|4600987|P3|Overall Study|Physician Decision|0
1394203|NCT01273064|4600988|P2|Overall Study|Physician Decision|0
1394204|NCT01273064|4600989|P1|Overall Study|Physician Decision|0
1394205|NCT01273064|4600985|P5|Overall Study|Lost to Follow-up|0
1394206|NCT01273064|4600986|P4|Overall Study|Lost to Follow-up|0
1394207|NCT01273064|4600987|P3|Overall Study|Lost to Follow-up|0
1394208|NCT01273064|4600988|P2|Overall Study|Lost to Follow-up|0
1394209|NCT01273064|4600989|P1|Overall Study|Lost to Follow-up|1
1394210|NCT01273064|4600985|P5|Overall Study|Study Termination|8
1394211|NCT01273064|4600986|P4|Overall Study|Study Termination|16
1394212|NCT01273064|4600987|P3|Overall Study|Study Termination|26
1394213|NCT01273064|4600988|P2|Overall Study|Study Termination|27
1394214|NCT01273064|4600989|P1|Overall Study|Study Termination|13
1394215|NCT01273064|4600985|P5|Overall Study|Withdrawal by Subject|0
1394216|NCT01273064|4600986|P4|Overall Study|Withdrawal by Subject|2
1394217|NCT01273064|4600987|P3|Overall Study|Withdrawal by Subject|2
1394218|NCT01273064|4600988|P2|Overall Study|Withdrawal by Subject|2
1394219|NCT01273064|4600989|P1|Overall Study|Withdrawal by Subject|4
1394220|NCT01273064|4600985|P5|Overall Study|Adverse Event|1
1394221|NCT01273064|4600986|P4|Overall Study|Adverse Event|2
1394222|NCT01273064|4600987|P3|Overall Study|Adverse Event|3
1394223|NCT01273064|4600988|P2|Overall Study|Adverse Event|1
1394224|NCT01273064|4600989|P1|Overall Study|Adverse Event|5
1394225|NCT01273038|4601008|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
1394226|NCT01273038|4601009|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
1394227|NCT01273038|4601008|P2|Second Intervention (14 Days)|Adverse Event|1
1394228|NCT01273038|4601009|P1|Second Intervention (14 Days)|Adverse Event|0
1394229|NCT01272947|4601032|P2|Overall Study|Abnormal Laboratory Value|2
1394230|NCT01272947|4601033|P1|Overall Study|Abnormal Laboratory Value|2
1394231|NCT01272934|4601043|P2|Overall Study|Abnormal Laboratory Value|1
1394232|NCT01272934|4601044|P1|Overall Study|Abnormal Laboratory Value|0
1394233|NCT01272934|4601043|P2|Overall Study|Adverse Event|1
1394234|NCT01272934|4601044|P1|Overall Study|Adverse Event|0
1394235|NCT01272921|4601054|P2|Overall Study|Protocol Violation|1
1394236|NCT01272921|4601055|P1|Overall Study|Protocol Violation|2
1394237|NCT01272908|4601063|P1|Re-Treatment Period|Withdrawal by Subject|1
1394238|NCT01272908|4601063|P1|Re-Treatment Period|Lack of Efficacy|3
1394239|NCT01272908|4601063|P1|Re-Treatment Period|Adverse Event|2
1394240|NCT01272908|4601063|P1|Initial Treatment Period|Withdrawal by Subject|1
1394241|NCT01272908|4601063|P1|Initial Treatment Period|Protocol Violation|1
1394242|NCT01272908|4601063|P1|Initial Treatment Period|Lack of Efficacy|5
1394243|NCT01272908|4601063|P1|Initial Treatment Period|Adverse Event|1
1394244|NCT01272869|4601103|P2|Period 2 (14 Days)|Adverse Event|0
1394245|NCT01272869|4601104|P1|Period 2 (14 Days)|Adverse Event|1
1394246|NCT01272804|4601131|P6|Overall Study|Adverse Event|1
1394247|NCT01272804|4601132|P5|Overall Study|Adverse Event|2
1394248|NCT01272804|4601133|P4|Overall Study|Adverse Event|0
1394249|NCT01272804|4601134|P3|Overall Study|Adverse Event|0
1394250|NCT01272804|4601135|P2|Overall Study|Adverse Event|0
1394251|NCT01272804|4601136|P1|Overall Study|Adverse Event|1
1394252|NCT01272661|4601294|P3|Overall Study|lost to followup/case closed/ no birth|72
1394253|NCT01272661|4601295|P2|Overall Study|lost to followup/case closed/ no birth|209
1394254|NCT01272661|4601296|P1|Overall Study|lost to followup/case closed/ no birth|126
1394255|NCT01272635|4601321|P4|Overall Study|Lost to Follow-up|23
1394256|NCT01272635|4601322|P3|Overall Study|Lost to Follow-up|31
1394257|NCT01272635|4601323|P2|Overall Study|Lost to Follow-up|20
1394258|NCT01272635|4601324|P1|Overall Study|Lost to Follow-up|31
1394259|NCT01272232|4601397|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
1394260|NCT01272232|4601398|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
1394261|NCT01272232|4601399|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
1394262|NCT01272232|4601397|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
1394263|NCT01272232|4601398|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
1394264|NCT01272232|4601399|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
1394265|NCT01272232|4601397|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
1394266|NCT01272232|4601398|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
1394267|NCT01272232|4601399|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
1394268|NCT01272232|4601397|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
1394269|NCT01272232|4601398|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
1394270|NCT01272232|4601399|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
1394271|NCT01272232|4601397|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
1394272|NCT01272232|4601398|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
1394273|NCT01272232|4601399|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
1394274|NCT01272232|4601397|P3|Weeks 0-56|Unclassified|12
1394275|NCT01272232|4601398|P2|Weeks 0-56|Unclassified|7
1394276|NCT01272232|4601399|P1|Weeks 0-56|Unclassified|16
1394277|NCT01272232|4601397|P3|Weeks 0-56|Withdrawal criteria|37
1394278|NCT01272232|4601398|P2|Weeks 0-56|Withdrawal criteria|14
1394279|NCT01272232|4601399|P1|Weeks 0-56|Withdrawal criteria|32
1394280|NCT01272232|4601397|P3|Weeks 0-56|Protocol Violation|13
1394281|NCT01272232|4601398|P2|Weeks 0-56|Protocol Violation|8
1394282|NCT01272232|4601399|P1|Weeks 0-56|Protocol Violation|12
1394283|NCT01272232|4601397|P3|Weeks 0-56|Lack of Efficacy|3
1394284|NCT01272232|4601398|P2|Weeks 0-56|Lack of Efficacy|0
1394285|NCT01272232|4601399|P1|Weeks 0-56|Lack of Efficacy|0
1394286|NCT01272232|4601397|P3|Weeks 0-56|Adverse Event|7
1394287|NCT01272232|4601398|P2|Weeks 0-56|Adverse Event|18
1394288|NCT01272232|4601399|P1|Weeks 0-56|Adverse Event|39
1394289|NCT01272219|4601444|P6|Main + Extension Period: Week 0-172|Unclassified|51
1394290|NCT01272219|4601445|P5|Main + Extension Period: Week 0-172|Unclassified|61
1394291|NCT01272219|4601446|P4|Main + Extension Period: Week 0-172|Unclassified|0
1394292|NCT01272219|4601447|P3|Main + Extension Period: Week 0-172|Unclassified|0
1394293|NCT01272219|4601448|P2|Main + Extension Period: Week 0-172|Unclassified|0
1394294|NCT01272219|4601449|P1|Main + Extension Period: Week 0-172|Unclassified|0
1394295|NCT01272219|4601444|P6|Main + Extension Period: Week 0-172|Missing reason|0
1394296|NCT01272219|4601445|P5|Main + Extension Period: Week 0-172|Missing reason|1
1394297|NCT01272219|4601446|P4|Main + Extension Period: Week 0-172|Missing reason|0
1394298|NCT01272219|4601447|P3|Main + Extension Period: Week 0-172|Missing reason|0
1394299|NCT01272219|4601448|P2|Main + Extension Period: Week 0-172|Missing reason|0
1394300|NCT01272219|4601449|P1|Main + Extension Period: Week 0-172|Missing reason|0
1394301|NCT01272219|4601444|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
1394302|NCT01272219|4601445|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
1394303|NCT01272219|4601446|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
1394304|NCT01272219|4601447|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
1394305|NCT01272219|4601448|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
1394306|NCT01272219|4601449|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
1394307|NCT01272219|4601444|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
1394308|NCT01272219|4601445|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
1394309|NCT01272219|4601446|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
1394310|NCT01272219|4601447|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
1394311|NCT01272219|4601448|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
1394312|NCT01272219|4601449|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
1394313|NCT01272219|4601444|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
1394314|NCT01272219|4601445|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
1394315|NCT01272219|4601446|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
1394316|NCT01272219|4601447|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
1394317|NCT01272219|4601448|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
1394318|NCT01272219|4601449|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
1394319|NCT01272219|4601444|P6|Main + Extension Period: Week 0-172|Adverse Event|43
1394320|NCT01272219|4601445|P5|Main + Extension Period: Week 0-172|Adverse Event|191
1394321|NCT01272219|4601446|P4|Main + Extension Period: Week 0-172|Adverse Event|0
1394322|NCT01272219|4601447|P3|Main + Extension Period: Week 0-172|Adverse Event|0
1394323|NCT01272219|4601448|P2|Main + Extension Period: Week 0-172|Adverse Event|0
1394324|NCT01272219|4601449|P1|Main + Extension Period: Week 0-172|Adverse Event|0
1394325|NCT01272219|4601444|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
1394326|NCT01272219|4601445|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
1394327|NCT01272219|4601446|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
1394328|NCT01272219|4601447|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
1394406|NCT01272180|4601505|P3|Overall Study|Withdrawal by Subject|3
1394329|NCT01272219|4601448|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
1394330|NCT01272219|4601449|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
1394331|NCT01272219|4601444|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
1394332|NCT01272219|4601445|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
1394333|NCT01272219|4601446|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
1394334|NCT01272219|4601447|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
1394335|NCT01272219|4601448|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
1394336|NCT01272219|4601449|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
1394337|NCT01272219|4601444|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
1394338|NCT01272219|4601445|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
1394339|NCT01272219|4601446|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
1394340|NCT01272219|4601447|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
1394341|NCT01272219|4601448|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
1394342|NCT01272219|4601449|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
1394343|NCT01272219|4601444|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
1394344|NCT01272219|4601445|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
1394345|NCT01272219|4601446|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
1394346|NCT01272219|4601447|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
1394347|NCT01272219|4601448|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
1394348|NCT01272219|4601449|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
1394349|NCT01272219|4601444|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
1394350|NCT01272219|4601445|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
1394351|NCT01272219|4601446|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
1394352|NCT01272219|4601447|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
1394353|NCT01272219|4601448|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
1394354|NCT01272219|4601449|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
1394355|NCT01272219|4601444|P6|Main Period: Week 0 to Week 56|Unclassified|34
1394356|NCT01272219|4601445|P5|Main Period: Week 0 to Week 56|Unclassified|42
1394357|NCT01272219|4601446|P4|Main Period: Week 0 to Week 56|Unclassified|29
1394358|NCT01272219|4601447|P3|Main Period: Week 0 to Week 56|Unclassified|0
1394359|NCT01272219|4601448|P2|Main Period: Week 0 to Week 56|Unclassified|0
1394360|NCT01272219|4601449|P1|Main Period: Week 0 to Week 56|Unclassified|36
1394361|NCT01272219|4601444|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
1394362|NCT01272219|4601445|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
1394363|NCT01272219|4601446|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
1394364|NCT01272219|4601447|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
1394365|NCT01272219|4601448|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
1394366|NCT01272219|4601449|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
1394367|NCT01272219|4601444|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
1394368|NCT01272219|4601445|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
1394369|NCT01272219|4601446|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
1394370|NCT01272219|4601447|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
1394371|NCT01272219|4601448|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
1394372|NCT01272219|4601449|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
1394373|NCT01272219|4601444|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
1394374|NCT01272219|4601445|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
1394375|NCT01272219|4601446|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
1394376|NCT01272219|4601447|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
1394377|NCT01272219|4601448|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
1394378|NCT01272219|4601449|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
1394379|NCT01272219|4601444|P6|Main Period: Week 0 to Week 56|Adverse Event|29
1394380|NCT01272219|4601445|P5|Main Period: Week 0 to Week 56|Adverse Event|152
1394381|NCT01272219|4601446|P4|Main Period: Week 0 to Week 56|Adverse Event|16
1394382|NCT01272219|4601447|P3|Main Period: Week 0 to Week 56|Adverse Event|0
1394383|NCT01272219|4601448|P2|Main Period: Week 0 to Week 56|Adverse Event|0
1394384|NCT01272219|4601449|P1|Main Period: Week 0 to Week 56|Adverse Event|86
1394385|NCT01272193|4601483|P2|Overall Study|Unclassified|7
1394386|NCT01272193|4601484|P1|Overall Study|Unclassified|8
1394387|NCT01272193|4601483|P2|Overall Study|Withdrawal Criteria|1
1394388|NCT01272193|4601484|P1|Overall Study|Withdrawal Criteria|1
1394389|NCT01272193|4601483|P2|Overall Study|Lack of Efficacy|3
1394390|NCT01272193|4601484|P1|Overall Study|Lack of Efficacy|0
1394391|NCT01272193|4601483|P2|Overall Study|Adverse Event|1
1394392|NCT01272193|4601484|P1|Overall Study|Adverse Event|1
1394393|NCT01272180|4601504|P4|Overall Study|Protocol Violation|1
1394394|NCT01272180|4601505|P3|Overall Study|Protocol Violation|0
1394395|NCT01272180|4601506|P2|Overall Study|Protocol Violation|1
1394396|NCT01272180|4601507|P1|Overall Study|Protocol Violation|0
1394397|NCT01272180|4601504|P4|Overall Study|Inappropriate enrollment|1
1394398|NCT01272180|4601505|P3|Overall Study|Inappropriate enrollment|1
1394399|NCT01272180|4601506|P2|Overall Study|Inappropriate enrollment|0
1394400|NCT01272180|4601507|P1|Overall Study|Inappropriate enrollment|0
1394401|NCT01272180|4601504|P4|Overall Study|Lost to Follow-up|10
1394402|NCT01272180|4601505|P3|Overall Study|Lost to Follow-up|8
1394403|NCT01272180|4601506|P2|Overall Study|Lost to Follow-up|14
1394404|NCT01272180|4601507|P1|Overall Study|Lost to Follow-up|15
1394405|NCT01272180|4601504|P4|Overall Study|Withdrawal by Subject|2
1394407|NCT01272180|4601506|P2|Overall Study|Withdrawal by Subject|6
1394408|NCT01272180|4601507|P1|Overall Study|Withdrawal by Subject|2
1394409|NCT01272180|4601504|P4|Overall Study|Adverse Event|0
1394410|NCT01272180|4601505|P3|Overall Study|Adverse Event|1
1394411|NCT01272180|4601506|P2|Overall Study|Adverse Event|0
1394412|NCT01272180|4601507|P1|Overall Study|Adverse Event|0
1394413|NCT01272011|4601556|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
1394414|NCT01272011|4601557|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
1394415|NCT01272011|4601558|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
1394416|NCT01271803|4601638|P12|Stage 2|Ongoing in the Study|14
1394417|NCT01271803|4601639|P11|Stage 2|Ongoing in the Study|6
1394418|NCT01271803|4601640|P10|Stage 2|Ongoing in the Study|0
1394419|NCT01271803|4601641|P9|Stage 2|Ongoing in the Study|0
1394420|NCT01271803|4601642|P8|Stage 2|Ongoing in the Study|0
1394421|NCT01271803|4601643|P7|Stage 2|Ongoing in the Study|0
1394422|NCT01271803|4601644|P6|Stage 2|Ongoing in the Study|0
1394423|NCT01271803|4601645|P5|Stage 2|Ongoing in the Study|0
1394424|NCT01271803|4601646|P4|Stage 2|Ongoing in the Study|0
1394425|NCT01271803|4601647|P3|Stage 2|Ongoing in the Study|0
1394426|NCT01271803|4601648|P2|Stage 2|Ongoing in the Study|0
1394427|NCT01271803|4601649|P1|Stage 2|Ongoing in the Study|0
1394428|NCT01271803|4601638|P12|Stage 2|Other|0
1394429|NCT01271803|4601639|P11|Stage 2|Other|1
1394430|NCT01271803|4601640|P10|Stage 2|Other|0
1394431|NCT01271803|4601641|P9|Stage 2|Other|0
1394432|NCT01271803|4601642|P8|Stage 2|Other|0
1394433|NCT01271803|4601643|P7|Stage 2|Other|0
1394434|NCT01271803|4601644|P6|Stage 2|Other|0
1394435|NCT01271803|4601645|P5|Stage 2|Other|0
1394436|NCT01271803|4601646|P4|Stage 2|Other|0
1394437|NCT01271803|4601647|P3|Stage 2|Other|0
1394438|NCT01271803|4601648|P2|Stage 2|Other|0
1394439|NCT01271803|4601649|P1|Stage 2|Other|0
1394440|NCT01271803|4601638|P12|Stage 2|Physician Decision|1
1394441|NCT01271803|4601639|P11|Stage 2|Physician Decision|0
1394442|NCT01271803|4601640|P10|Stage 2|Physician Decision|0
1394443|NCT01271803|4601641|P9|Stage 2|Physician Decision|0
1394444|NCT01271803|4601642|P8|Stage 2|Physician Decision|0
1394445|NCT01271803|4601643|P7|Stage 2|Physician Decision|0
1394446|NCT01271803|4601644|P6|Stage 2|Physician Decision|0
1394447|NCT01271803|4601645|P5|Stage 2|Physician Decision|0
1394448|NCT01271803|4601646|P4|Stage 2|Physician Decision|0
1394449|NCT01271803|4601647|P3|Stage 2|Physician Decision|0
1394450|NCT01271803|4601648|P2|Stage 2|Physician Decision|0
1394451|NCT01271803|4601649|P1|Stage 2|Physician Decision|0
1394452|NCT01271803|4601638|P12|Stage 2|Withdrawal by Subject|2
1394453|NCT01271803|4601639|P11|Stage 2|Withdrawal by Subject|0
1394454|NCT01271803|4601640|P10|Stage 2|Withdrawal by Subject|0
1394455|NCT01271803|4601641|P9|Stage 2|Withdrawal by Subject|0
1394456|NCT01271803|4601642|P8|Stage 2|Withdrawal by Subject|0
1394457|NCT01271803|4601643|P7|Stage 2|Withdrawal by Subject|0
1394458|NCT01271803|4601644|P6|Stage 2|Withdrawal by Subject|0
1394459|NCT01271803|4601645|P5|Stage 2|Withdrawal by Subject|0
1394460|NCT01271803|4601646|P4|Stage 2|Withdrawal by Subject|0
1394461|NCT01271803|4601647|P3|Stage 2|Withdrawal by Subject|0
1394462|NCT01271803|4601648|P2|Stage 2|Withdrawal by Subject|0
1394463|NCT01271803|4601649|P1|Stage 2|Withdrawal by Subject|0
1394464|NCT01271803|4601638|P12|Stage 2|Death|2
1394465|NCT01271803|4601639|P11|Stage 2|Death|2
1394466|NCT01271803|4601640|P10|Stage 2|Death|0
1394467|NCT01271803|4601641|P9|Stage 2|Death|0
1394468|NCT01271803|4601642|P8|Stage 2|Death|0
1394469|NCT01271803|4601643|P7|Stage 2|Death|0
1394470|NCT01271803|4601644|P6|Stage 2|Death|0
1394471|NCT01271803|4601645|P5|Stage 2|Death|0
1394472|NCT01271803|4601646|P4|Stage 2|Death|0
1394473|NCT01271803|4601647|P3|Stage 2|Death|0
1394474|NCT01271803|4601648|P2|Stage 2|Death|0
1394475|NCT01271803|4601649|P1|Stage 2|Death|0
1394476|NCT01271803|4601638|P12|Stage 2|Adverse Event|3
1394477|NCT01271803|4601639|P11|Stage 2|Adverse Event|1
1394478|NCT01271803|4601640|P10|Stage 2|Adverse Event|0
1394479|NCT01271803|4601641|P9|Stage 2|Adverse Event|0
1394480|NCT01271803|4601642|P8|Stage 2|Adverse Event|0
1394481|NCT01271803|4601643|P7|Stage 2|Adverse Event|0
1394482|NCT01271803|4601644|P6|Stage 2|Adverse Event|0
1394483|NCT01271803|4601645|P5|Stage 2|Adverse Event|0
1394484|NCT01271803|4601646|P4|Stage 2|Adverse Event|0
1394485|NCT01271803|4601647|P3|Stage 2|Adverse Event|0
1394486|NCT01271803|4601648|P2|Stage 2|Adverse Event|0
1394487|NCT01271803|4601649|P1|Stage 2|Adverse Event|0
1394488|NCT01271803|4601638|P12|Stage 2|Progressive disease|17
1394489|NCT01271803|4601639|P11|Stage 2|Progressive disease|17
1394490|NCT01271803|4601640|P10|Stage 2|Progressive disease|0
1394491|NCT01271803|4601641|P9|Stage 2|Progressive disease|0
1394492|NCT01271803|4601642|P8|Stage 2|Progressive disease|0
1394493|NCT01271803|4601643|P7|Stage 2|Progressive disease|0
1394494|NCT01271803|4601644|P6|Stage 2|Progressive disease|0
1394495|NCT01271803|4601645|P5|Stage 2|Progressive disease|0
1394496|NCT01271803|4601646|P4|Stage 2|Progressive disease|0
1394497|NCT01271803|4601647|P3|Stage 2|Progressive disease|0
1394498|NCT01271803|4601648|P2|Stage 2|Progressive disease|0
1394499|NCT01271803|4601649|P1|Stage 2|Progressive disease|0
1394500|NCT01271803|4601638|P12|Stage 1|Ongoing in the Study|0
1394501|NCT01271803|4601639|P11|Stage 1|Ongoing in the Study|0
1394502|NCT01271803|4601640|P10|Stage 1|Ongoing in the Study|0
1394503|NCT01271803|4601641|P9|Stage 1|Ongoing in the Study|1
1394504|NCT01271803|4601642|P8|Stage 1|Ongoing in the Study|1
1394505|NCT01271803|4601643|P7|Stage 1|Ongoing in the Study|1
1394506|NCT01271803|4601644|P6|Stage 1|Ongoing in the Study|0
1394507|NCT01271803|4601645|P5|Stage 1|Ongoing in the Study|3
1394508|NCT01271803|4601646|P4|Stage 1|Ongoing in the Study|1
1394509|NCT01271803|4601647|P3|Stage 1|Ongoing in the Study|11
1394510|NCT01271803|4601648|P2|Stage 1|Ongoing in the Study|1
1394511|NCT01271803|4601649|P1|Stage 1|Ongoing in the Study|0
1394512|NCT01271803|4601638|P12|Stage 1|Other|0
1394513|NCT01271803|4601639|P11|Stage 1|Other|0
1394514|NCT01271803|4601640|P10|Stage 1|Other|0
1394515|NCT01271803|4601641|P9|Stage 1|Other|0
1394516|NCT01271803|4601642|P8|Stage 1|Other|0
1394517|NCT01271803|4601643|P7|Stage 1|Other|0
1394518|NCT01271803|4601644|P6|Stage 1|Other|0
1394519|NCT01271803|4601645|P5|Stage 1|Other|0
1394520|NCT01271803|4601646|P4|Stage 1|Other|0
1394521|NCT01271803|4601647|P3|Stage 1|Other|2
1394522|NCT01271803|4601648|P2|Stage 1|Other|0
1394523|NCT01271803|4601649|P1|Stage 1|Other|0
1394524|NCT01271803|4601638|P12|Stage 1|Withdrawal by Subject|0
1394525|NCT01271803|4601639|P11|Stage 1|Withdrawal by Subject|0
1394526|NCT01271803|4601640|P10|Stage 1|Withdrawal by Subject|0
1394527|NCT01271803|4601641|P9|Stage 1|Withdrawal by Subject|0
1394528|NCT01271803|4601642|P8|Stage 1|Withdrawal by Subject|0
1394529|NCT01271803|4601643|P7|Stage 1|Withdrawal by Subject|0
1394530|NCT01271803|4601644|P6|Stage 1|Withdrawal by Subject|0
1394531|NCT01271803|4601645|P5|Stage 1|Withdrawal by Subject|0
1394532|NCT01271803|4601646|P4|Stage 1|Withdrawal by Subject|0
1394533|NCT01271803|4601647|P3|Stage 1|Withdrawal by Subject|1
1394534|NCT01271803|4601648|P2|Stage 1|Withdrawal by Subject|0
1394535|NCT01271803|4601649|P1|Stage 1|Withdrawal by Subject|0
1394536|NCT01271803|4601638|P12|Stage 1|Physician Decision|0
1394537|NCT01271803|4601639|P11|Stage 1|Physician Decision|0
1394538|NCT01271803|4601640|P10|Stage 1|Physician Decision|0
1394539|NCT01271803|4601641|P9|Stage 1|Physician Decision|0
1394540|NCT01271803|4601642|P8|Stage 1|Physician Decision|0
1394541|NCT01271803|4601643|P7|Stage 1|Physician Decision|1
1394542|NCT01271803|4601644|P6|Stage 1|Physician Decision|0
1394543|NCT01271803|4601645|P5|Stage 1|Physician Decision|0
1394544|NCT01271803|4601646|P4|Stage 1|Physician Decision|0
1394545|NCT01271803|4601647|P3|Stage 1|Physician Decision|0
1394546|NCT01271803|4601648|P2|Stage 1|Physician Decision|0
1394547|NCT01271803|4601649|P1|Stage 1|Physician Decision|1
1394548|NCT01271803|4601638|P12|Stage 1|Death|0
1394549|NCT01271803|4601639|P11|Stage 1|Death|0
1394550|NCT01271803|4601640|P10|Stage 1|Death|0
1394551|NCT01271803|4601641|P9|Stage 1|Death|0
1394552|NCT01271803|4601642|P8|Stage 1|Death|0
1394553|NCT01271803|4601643|P7|Stage 1|Death|0
1394554|NCT01271803|4601644|P6|Stage 1|Death|1
1394555|NCT01271803|4601645|P5|Stage 1|Death|0
1394556|NCT01271803|4601646|P4|Stage 1|Death|0
1394557|NCT01271803|4601647|P3|Stage 1|Death|0
1394558|NCT01271803|4601648|P2|Stage 1|Death|0
1394559|NCT01271803|4601649|P1|Stage 1|Death|1
1394560|NCT01271803|4601638|P12|Stage 1|Adverse Event|0
1394561|NCT01271803|4601639|P11|Stage 1|Adverse Event|0
1394562|NCT01271803|4601640|P10|Stage 1|Adverse Event|0
1394563|NCT01271803|4601641|P9|Stage 1|Adverse Event|0
1394564|NCT01271803|4601642|P8|Stage 1|Adverse Event|0
1394565|NCT01271803|4601643|P7|Stage 1|Adverse Event|0
1394566|NCT01271803|4601644|P6|Stage 1|Adverse Event|0
1394567|NCT01271803|4601645|P5|Stage 1|Adverse Event|0
1394568|NCT01271803|4601646|P4|Stage 1|Adverse Event|0
1394569|NCT01271803|4601647|P3|Stage 1|Adverse Event|1
1394570|NCT01271803|4601648|P2|Stage 1|Adverse Event|0
1394571|NCT01271803|4601649|P1|Stage 1|Adverse Event|0
1394572|NCT01271803|4601638|P12|Stage 1|Progressive disease|0
1394573|NCT01271803|4601639|P11|Stage 1|Progressive disease|0
1394574|NCT01271803|4601640|P10|Stage 1|Progressive disease|2
1394575|NCT01271803|4601641|P9|Stage 1|Progressive disease|4
1394576|NCT01271803|4601642|P8|Stage 1|Progressive disease|2
1394577|NCT01271803|4601643|P7|Stage 1|Progressive disease|2
1394578|NCT01271803|4601644|P6|Stage 1|Progressive disease|3
1394579|NCT01271803|4601645|P5|Stage 1|Progressive disease|1
1394580|NCT01271803|4601646|P4|Stage 1|Progressive disease|2
1394581|NCT01271803|4601647|P3|Stage 1|Progressive disease|12
1394582|NCT01271803|4601648|P2|Stage 1|Progressive disease|7
1394583|NCT01271803|4601649|P1|Stage 1|Progressive disease|3
1394584|NCT01271712|4601822|P2|Survival Follow-up|Ongoing survival follow-up|6
1394585|NCT01271712|4601823|P1|Survival Follow-up|Ongoing survival follow-up|15
1394586|NCT01271712|4601822|P2|Safety Follow-up|Progressive disease|0
1394587|NCT01271712|4601823|P1|Safety Follow-up|Progressive disease|1
1394588|NCT01271712|4601822|P2|Safety Follow-up|No follow-up|1
1394589|NCT01271712|4601823|P1|Safety Follow-up|No follow-up|1
1394590|NCT01271712|4601822|P2|Safety Follow-up|Ongoing safety follow-up|4
1394591|NCT01271712|4601823|P1|Safety Follow-up|Ongoing safety follow-up|3
1394592|NCT01271712|4601822|P2|Safety Follow-up|Protocol Violation|1
1394593|NCT01271712|4601823|P1|Safety Follow-up|Protocol Violation|1
1394594|NCT01271712|4601822|P2|Safety Follow-up|Withdrawal by Subject|2
1394595|NCT01271712|4601823|P1|Safety Follow-up|Withdrawal by Subject|4
1394596|NCT01271712|4601822|P2|Safety Follow-up|Death|7
1394597|NCT01271712|4601823|P1|Safety Follow-up|Death|11
1394598|NCT01271712|4601822|P2|Open Label Treatment|Switching to other therapy|1
1394599|NCT01271712|4601823|P1|Open Label Treatment|Switching to other therapy|2
1394600|NCT01271712|4601822|P2|Open Label Treatment|Protocol Violation|1
1394601|NCT01271712|4601823|P1|Open Label Treatment|Protocol Violation|0
1394602|NCT01271712|4601822|P2|Open Label Treatment|Non-compliance with study drug|0
1394603|NCT01271712|4601823|P1|Open Label Treatment|Non-compliance with study drug|1
1394604|NCT01271712|4601822|P2|Open Label Treatment|Ongoing with open-label treatment|1
1394605|NCT01271712|4601823|P1|Open Label Treatment|Ongoing with open-label treatment|6
1394606|NCT01271712|4601822|P2|Open Label Treatment|Progressive disease|31
1394607|NCT01271712|4601823|P1|Open Label Treatment|Progressive disease|56
1394608|NCT01271712|4601822|P2|Open Label Treatment|Adverse Event|8
1394609|NCT01271712|4601823|P1|Open Label Treatment|Adverse Event|12
1394610|NCT01271712|4601822|P2|Open Label Treatment|Physician Decision|0
1394611|NCT01271712|4601823|P1|Open Label Treatment|Physician Decision|2
1394612|NCT01271712|4601822|P2|Open Label Treatment|Withdrawal by Subject|11
1394613|NCT01271712|4601823|P1|Open Label Treatment|Withdrawal by Subject|6
1394614|NCT01271712|4601822|P2|Open Label Treatment|Death|5
1394615|NCT01271712|4601823|P1|Open Label Treatment|Death|6
1394616|NCT01271712|4601822|P2|Double Blind Treatment|receive no study drug|0
1394617|NCT01271712|4601823|P1|Double Blind Treatment|receive no study drug|1
1394618|NCT01271712|4601822|P2|Double Blind Treatment|Non compliance with study drug|0
1394619|NCT01271712|4601823|P1|Double Blind Treatment|Non compliance with study drug|2
1394620|NCT01271712|4601822|P2|Double Blind Treatment|Withdrawal by Subject|1
1394621|NCT01271712|4601823|P1|Double Blind Treatment|Withdrawal by Subject|4
1394622|NCT01271712|4601822|P2|Double Blind Treatment|Progressive disease|3
1394623|NCT01271712|4601823|P1|Double Blind Treatment|Progressive disease|23
1394624|NCT01271712|4601822|P2|Double Blind Treatment|Adverse Event|4
1394625|NCT01271712|4601823|P1|Double Blind Treatment|Adverse Event|9
1394626|NCT01271712|4601822|P2|Double Blind Treatment|Lack of Efficacy|0
1394627|NCT01271712|4601823|P1|Double Blind Treatment|Lack of Efficacy|1
1394628|NCT01271712|4601822|P2|Double Blind Treatment|Death|0
1394629|NCT01271712|4601823|P1|Double Blind Treatment|Death|2
1394630|NCT01271010|4601917|P1|Overall Study|Disease progression|27
1394631|NCT01271010|4601917|P1|Overall Study|Withdrawal by Subject|18
1394632|NCT01271010|4601917|P1|Overall Study|Progression and relapse of disease|1
1394633|NCT01271010|4601917|P1|Overall Study|Death|2
1394634|NCT01271010|4601917|P1|Overall Study|Protocol Violation|1
1394635|NCT01271010|4601917|P1|Overall Study|Start of new CLL therapy|1
1394636|NCT01271010|4601917|P1|Overall Study|Reason not specified|11
1394637|NCT01270971|4601932|P2|Overall Study|Non-specific|3
1394638|NCT01270971|4601933|P1|Overall Study|Non-specific|7
1394639|NCT01270971|4601932|P2|Overall Study|Non compliance|2
1394640|NCT01270971|4601933|P1|Overall Study|Non compliance|2
1394641|NCT01270971|4601932|P2|Overall Study|Adverse Event|2
1394642|NCT01270971|4601933|P1|Overall Study|Adverse Event|1
1394643|NCT01270971|4601932|P2|Overall Study|Lost to Follow-up|5
1394644|NCT01270971|4601933|P1|Overall Study|Lost to Follow-up|18
1394645|NCT01270971|4601932|P2|Overall Study|Withdrawal by Subject|11
1394646|NCT01270971|4601933|P1|Overall Study|Withdrawal by Subject|24
1394647|NCT01270958|4601945|P1|Overall Study|Did not meet inclusion criteria for age|2
1394648|NCT01270958|4601945|P1|Overall Study|Lost to Follow-up|2
1394649|NCT01270880|4601974|P1|Overall Study|Never rec'd treatment, but registered.|1
1394650|NCT01270841|4601999|P4|Overall Study|Enrolled in error|0
1394651|NCT01270841|4602000|P3|Overall Study|Enrolled in error|0
1394652|NCT01270841|4602001|P2|Overall Study|Enrolled in error|1
1394653|NCT01270841|4602002|P1|Overall Study|Enrolled in error|0
1394654|NCT01270841|4601999|P4|Overall Study|Protocol Violation|0
1394655|NCT01270841|4602000|P3|Overall Study|Protocol Violation|0
1394656|NCT01270841|4602001|P2|Overall Study|Protocol Violation|5
1394657|NCT01270841|4602002|P1|Overall Study|Protocol Violation|1
1394658|NCT01270841|4601999|P4|Overall Study|Did not qualify|5
1394659|NCT01270841|4602000|P3|Overall Study|Did not qualify|4
1394660|NCT01270841|4602001|P2|Overall Study|Did not qualify|3
1394661|NCT01270841|4602002|P1|Overall Study|Did not qualify|6
1394662|NCT01270841|4601999|P4|Overall Study|Physician Decision|0
1394663|NCT01270841|4602000|P3|Overall Study|Physician Decision|0
1394664|NCT01270841|4602001|P2|Overall Study|Physician Decision|1
1394665|NCT01270841|4602002|P1|Overall Study|Physician Decision|0
1394666|NCT01270841|4601999|P4|Overall Study|Lost to Follow-up|2
1394667|NCT01270841|4602000|P3|Overall Study|Lost to Follow-up|4
1394668|NCT01270841|4602001|P2|Overall Study|Lost to Follow-up|1
1394669|NCT01270841|4602002|P1|Overall Study|Lost to Follow-up|3
1394670|NCT01270841|4601999|P4|Overall Study|Withdrawal by Subject|3
1394671|NCT01270841|4602000|P3|Overall Study|Withdrawal by Subject|3
1394672|NCT01270841|4602001|P2|Overall Study|Withdrawal by Subject|2
1394673|NCT01270841|4602002|P1|Overall Study|Withdrawal by Subject|3
1394674|NCT01270841|4601999|P4|Overall Study|Adverse Event|3
1394675|NCT01270841|4602000|P3|Overall Study|Adverse Event|0
1394676|NCT01270841|4602001|P2|Overall Study|Adverse Event|1
1394677|NCT01270841|4602002|P1|Overall Study|Adverse Event|0
1394678|NCT01270828|4602026|P3|Double Blind Phase|Adverse event related to study drug|0
1394679|NCT01270828|4602027|P2|Double Blind Phase|Adverse event related to study drug|7
1394680|NCT01270828|4602028|P1|Double Blind Phase|Adverse event related to study drug|5
1394681|NCT01270828|4602026|P3|Double Blind Phase|Adverse event not related to study drug|0
1394682|NCT01270828|4602027|P2|Double Blind Phase|Adverse event not related to study drug|1
1394770|NCT01269346|4602530|P1|Extension Phase|Withdrawal by Subject|4
1394683|NCT01270828|4602028|P1|Double Blind Phase|Adverse event not related to study drug|1
1394684|NCT01270828|4602026|P3|Double Blind Phase|Lack of Efficacy|0
1394685|NCT01270828|4602027|P2|Double Blind Phase|Lack of Efficacy|11
1394686|NCT01270828|4602028|P1|Double Blind Phase|Lack of Efficacy|2
1394687|NCT01270828|4602026|P3|Double Blind Phase|Lost to Follow-up|0
1394688|NCT01270828|4602027|P2|Double Blind Phase|Lost to Follow-up|2
1394689|NCT01270828|4602028|P1|Double Blind Phase|Lost to Follow-up|1
1394690|NCT01270828|4602026|P3|Double Blind Phase|Withdrawal by Subject|0
1394691|NCT01270828|4602027|P2|Double Blind Phase|Withdrawal by Subject|15
1394692|NCT01270828|4602028|P1|Double Blind Phase|Withdrawal by Subject|6
1394693|NCT01270828|4602026|P3|Double Blind Phase|Reason Unspecified|0
1394694|NCT01270828|4602027|P2|Double Blind Phase|Reason Unspecified|4
1394695|NCT01270828|4602028|P1|Double Blind Phase|Reason Unspecified|7
1394696|NCT01270828|4602026|P3|Double Blind Phase|Protocol and GCP non-compliance|0
1394697|NCT01270828|4602027|P2|Double Blind Phase|Protocol and GCP non-compliance|3
1394698|NCT01270828|4602028|P1|Double Blind Phase|Protocol and GCP non-compliance|4
1394699|NCT01270828|4602026|P3|Double Blind Phase|Protocol Violation|0
1394700|NCT01270828|4602027|P2|Double Blind Phase|Protocol Violation|1
1394701|NCT01270828|4602028|P1|Double Blind Phase|Protocol Violation|0
1394702|NCT01270828|4602026|P3|Double Blind Phase|Death|0
1394703|NCT01270828|4602027|P2|Double Blind Phase|Death|1
1394704|NCT01270828|4602028|P1|Double Blind Phase|Death|0
1394705|NCT01270828|4602026|P3|Pregabalin CR SB|Protocol Violation|8
1394706|NCT01270828|4602027|P2|Pregabalin CR SB|Protocol Violation|0
1394707|NCT01270828|4602028|P1|Pregabalin CR SB|Protocol Violation|0
1394708|NCT01270828|4602026|P3|Pregabalin CR SB|Unrelated AE|8
1394709|NCT01270828|4602027|P2|Pregabalin CR SB|Unrelated AE|0
1394710|NCT01270828|4602028|P1|Pregabalin CR SB|Unrelated AE|0
1394711|NCT01270828|4602026|P3|Pregabalin CR SB|Lost to Follow-up|10
1394712|NCT01270828|4602027|P2|Pregabalin CR SB|Lost to Follow-up|0
1394713|NCT01270828|4602028|P1|Pregabalin CR SB|Lost to Follow-up|0
1394714|NCT01270828|4602026|P3|Pregabalin CR SB|Withdrawal by Subject|29
1394715|NCT01270828|4602027|P2|Pregabalin CR SB|Withdrawal by Subject|0
1394716|NCT01270828|4602028|P1|Pregabalin CR SB|Withdrawal by Subject|0
1394717|NCT01270828|4602026|P3|Pregabalin CR SB|Lack of Efficacy|32
1394718|NCT01270828|4602027|P2|Pregabalin CR SB|Lack of Efficacy|0
1394719|NCT01270828|4602028|P1|Pregabalin CR SB|Lack of Efficacy|0
1394720|NCT01270828|4602026|P3|Pregabalin CR SB|Related adverse event|46
1394721|NCT01270828|4602027|P2|Pregabalin CR SB|Related adverse event|0
1394722|NCT01270828|4602028|P1|Pregabalin CR SB|Related adverse event|0
1394723|NCT01270828|4602026|P3|Pregabalin CR SB|Enrolled but not treated|5
1394724|NCT01270828|4602027|P2|Pregabalin CR SB|Enrolled but not treated|0
1394725|NCT01270828|4602028|P1|Pregabalin CR SB|Enrolled but not treated|0
1394726|NCT01270828|4602026|P3|Pregabalin CR SB|Reason Unspecified|8
1394727|NCT01270828|4602027|P2|Pregabalin CR SB|Reason Unspecified|0
1394728|NCT01270828|4602028|P1|Pregabalin CR SB|Reason Unspecified|0
1394729|NCT01270802|4602070|P2|Overall Study|Lost to Follow-up|1
1394730|NCT01270802|4602071|P1|Overall Study|Lost to Follow-up|0
1394731|NCT01270802|4602070|P2|Overall Study|Adverse Event|0
1394732|NCT01270802|4602071|P1|Overall Study|Adverse Event|1
1394733|NCT01270802|4602070|P2|Overall Study|Withdrawal by Subject|0
1394734|NCT01270802|4602071|P1|Overall Study|Withdrawal by Subject|1
1394735|NCT01270620|4602218|P2|Overall Study|Withdrawal by Subject|3
1394736|NCT01270620|4602219|P1|Overall Study|Withdrawal by Subject|1
1394737|NCT01270503|4602314|P1|Overall Study|Lost to Follow-up|1
1394738|NCT01270464|4602322|P3|Overall Study|Not Specified|3
1394739|NCT01270464|4602323|P2|Overall Study|Not Specified|1
1394740|NCT01270464|4602324|P1|Overall Study|Not Specified|1
1394741|NCT01270464|4602322|P3|Overall Study|Lost to Follow-up|1
1394742|NCT01270464|4602323|P2|Overall Study|Lost to Follow-up|3
1394743|NCT01270464|4602324|P1|Overall Study|Lost to Follow-up|2
1394744|NCT01270464|4602322|P3|Overall Study|Withdrawal by Subject|4
1394745|NCT01270464|4602323|P2|Overall Study|Withdrawal by Subject|1
1394746|NCT01270464|4602324|P1|Overall Study|Withdrawal by Subject|2
1394747|NCT01270464|4602322|P3|Overall Study|Adverse Event|7
1394748|NCT01270464|4602323|P2|Overall Study|Adverse Event|1
1394749|NCT01270464|4602324|P1|Overall Study|Adverse Event|9
1394750|NCT01270464|4602322|P3|Overall Study|Lack of Efficacy|1
1394751|NCT01270464|4602323|P2|Overall Study|Lack of Efficacy|3
1394752|NCT01270464|4602324|P1|Overall Study|Lack of Efficacy|2
1394753|NCT01270464|4602322|P3|Overall Study|Protocol Violation|2
1394754|NCT01270464|4602323|P2|Overall Study|Protocol Violation|3
1394755|NCT01270464|4602324|P1|Overall Study|Protocol Violation|4
1394756|NCT01270256|4602373|P2|Overall Study|Withdrawal by Subject|0
1394757|NCT01270256|4602374|P1|Overall Study|Withdrawal by Subject|1
1394758|NCT01270139|4602383|P3|Overall Study|Lost to Follow-up|2
1394759|NCT01270139|4602384|P2|Overall Study|Lost to Follow-up|9
1394760|NCT01270139|4602385|P1|Overall Study|Lost to Follow-up|10
1394761|NCT01270139|4602383|P3|Overall Study|Adverse Event|18
1394762|NCT01270139|4602384|P2|Overall Study|Adverse Event|17
1394763|NCT01270139|4602385|P1|Overall Study|Adverse Event|8
1394764|NCT01269918|4602454|P2|Overall Study|Did not receive study drug|3
1394765|NCT01269918|4602455|P1|Overall Study|Did not receive study drug|0
1394766|NCT01269346|4602530|P1|Extension Phase|Started a prohibited con med|1
1394767|NCT01269346|4602530|P1|Extension Phase|Clinical progression|1
1394768|NCT01269346|4602530|P1|Extension Phase|Physician decision or participant choice|9
1394769|NCT01269346|4602530|P1|Extension Phase|Disease progression|22
1394771|NCT01269346|4602530|P1|Extension Phase|Adverse Event|6
1394772|NCT01269346|4602530|P1|Treatment Phase|Not specified|2
1394773|NCT01269346|4602530|P1|Treatment Phase|Withdrawal by Subject|1
1394774|NCT01269346|4602530|P1|Treatment Phase|Adverse Event|3
1394775|NCT01269346|4602530|P1|Treatment Phase|Disease progression|3
1394776|NCT01269125|4602541|P3|Overall Study|Lost to Follow-up|0
1394777|NCT01269125|4602542|P2|Overall Study|Lost to Follow-up|0
1394778|NCT01269125|4602543|P1|Overall Study|Lost to Follow-up|4
1394779|NCT01269125|4602541|P3|Overall Study|Adverse Event|0
1394780|NCT01269125|4602542|P2|Overall Study|Adverse Event|5
1394781|NCT01269125|4602543|P1|Overall Study|Adverse Event|3
1394782|NCT01268891|4602602|P2|Overall Study|Administrative or other reason(s)|0
1394783|NCT01268891|4602603|P1|Overall Study|Administrative or other reason(s)|1
1394784|NCT01268891|4602602|P2|Overall Study|Withdrawal of Consent|1
1394785|NCT01268891|4602603|P1|Overall Study|Withdrawal of Consent|3
1394786|NCT01268891|4602602|P2|Overall Study|Lack of Efficacy|0
1394787|NCT01268891|4602603|P1|Overall Study|Lack of Efficacy|1
1394788|NCT01268891|4602602|P2|Overall Study|Adverse Event|7
1394789|NCT01268891|4602603|P1|Overall Study|Adverse Event|3
1394790|NCT01268566|4602622|P1|Overall Study|Death|30
1394791|NCT01268566|4602622|P1|Overall Study|Withdrawal by Subject|12
1394792|NCT01268566|4602622|P1|Overall Study|Lost to Follow-up|1
1394793|NCT01268501|4602649|P1|Overall Study|Handling Difficulties|2
1394794|NCT01268501|4602649|P1|Overall Study|Unacceptable Subjective Vision|3
1394795|NCT01268501|4602649|P1|Overall Study|Withdrawal by Subject|3
1394796|NCT01268501|4602649|P1|Overall Study|Lost to Follow-up|1
1394797|NCT01268488|4602653|P1|Overall Study|Physician Decision|2
1394798|NCT01268488|4602653|P1|Overall Study|Adverse Event|3
1394799|NCT01268306|4602660|P1|Overall Study|Lost to Follow-up|1
1394800|NCT01268293|4602664|P1|Overall Study|Subject choice|1
1394801|NCT01268293|4602664|P1|Overall Study|Adverse Event|1
1394802|NCT01268293|4602664|P1|Overall Study|Disease progression|7
1394803|NCT01268267|4602669|P1|Overall Study|Protocol Violation|1
1394804|NCT01268150|4602690|P1|Extension Phase|Not specified|6
1394805|NCT01268150|4602690|P1|Extension Phase|Disease progression|18
1394806|NCT01268150|4602690|P1|Extension Phase|Adverse Event|3
1394807|NCT01268150|4602690|P1|Treatment Phase|Not specified|4
1394808|NCT01268150|4602690|P1|Treatment Phase|Withdrawal by Subject|3
1394809|NCT01268150|4602690|P1|Treatment Phase|Adverse Event|3
1394810|NCT01268150|4602690|P1|Treatment Phase|Progression of disease|18
1394811|NCT01268098|4602709|P2|Overall Study|Adverse Event|0
1394812|NCT01268098|4602710|P1|Overall Study|Adverse Event|1
1394813|NCT01268046|4602722|P4|Overall Study|Lost to Follow-up|0
1394814|NCT01268046|4602723|P3|Overall Study|Lost to Follow-up|1
1394815|NCT01268046|4602724|P2|Overall Study|Lost to Follow-up|0
1394816|NCT01268046|4602725|P1|Overall Study|Lost to Follow-up|0
1394817|NCT01268046|4602722|P4|Overall Study|Withdrawal by Subject|1
1394818|NCT01268046|4602723|P3|Overall Study|Withdrawal by Subject|0
1394819|NCT01268046|4602724|P2|Overall Study|Withdrawal by Subject|0
1394820|NCT01268046|4602725|P1|Overall Study|Withdrawal by Subject|1
1394821|NCT01267994|4602735|P1|Overall Study|Adverse Event|2
1394822|NCT01267825|4602773|P2|Overall Study|study terminated. no data collected.|0
1394823|NCT01267825|4602774|P1|Overall Study|study terminated. no data collected.|1
1394824|NCT01267266|4602840|P2|Lead-in Phase|Withdrawal by Subject|0
1394825|NCT01267266|4602841|P1|Lead-in Phase|Withdrawal by Subject|1
1394826|NCT01267266|4602840|P2|Lead-in Phase|Adverse Event|0
1394827|NCT01267266|4602841|P1|Lead-in Phase|Adverse Event|2
1394828|NCT01267266|4602840|P2|Lead-in Phase|Lack of Efficacy|0
1394829|NCT01267266|4602841|P1|Lead-in Phase|Lack of Efficacy|20
1394830|NCT01267266|4602840|P2|Enrollment Phase|Withdrawal by Subject|0
1394831|NCT01267266|4602841|P1|Enrollment Phase|Withdrawal by Subject|2
1394832|NCT01267253|4602854|P1|Overall Study|Inevaluable-never received study treatme|2
1394833|NCT01267253|4602854|P1|Overall Study|Ineligible - required test not done|1
1394834|NCT01267201|4602893|P6|Second Intervention Period|Withdrawal by Subject|0
1394835|NCT01267201|4602894|P5|Second Intervention Period|Withdrawal by Subject|0
1394836|NCT01267201|4602895|P4|Second Intervention Period|Withdrawal by Subject|0
1394837|NCT01267201|4602896|P3|Second Intervention Period|Withdrawal by Subject|0
1394838|NCT01267201|4602897|P2|Second Intervention Period|Withdrawal by Subject|1
1394839|NCT01267201|4602898|P1|Second Intervention Period|Withdrawal by Subject|0
1394840|NCT01267201|4602893|P6|First Intervention Period|Withdrawal by Subject|0
1394841|NCT01267201|4602894|P5|First Intervention Period|Withdrawal by Subject|0
1394842|NCT01267201|4602895|P4|First Intervention Period|Withdrawal by Subject|0
1394843|NCT01267201|4602896|P3|First Intervention Period|Withdrawal by Subject|0
1394844|NCT01267201|4602897|P2|First Intervention Period|Withdrawal by Subject|0
1394845|NCT01267201|4602898|P1|First Intervention Period|Withdrawal by Subject|1
1394846|NCT01267175|4602915|P1|Overall Study|Lost to Follow-up|1
1394847|NCT01267175|4602915|P1|Overall Study|Withdrawal by Subject|1
1394848|NCT01266967|4602987|P2|Overall Study|Withdrawal by Subject|3
1394849|NCT01266967|4602988|P1|Overall Study|Withdrawal by Subject|3
1394850|NCT01266967|4602987|P2|Overall Study|Physician Decision|1
1394851|NCT01266967|4602988|P1|Overall Study|Physician Decision|0
1394852|NCT01266967|4602987|P2|Overall Study|Lost to Follow-up|1
1394853|NCT01266967|4602988|P1|Overall Study|Lost to Follow-up|2
1394854|NCT01266967|4602987|P2|Overall Study|Study Closed/Terminated|17
1394855|NCT01266967|4602988|P1|Overall Study|Study Closed/Terminated|15
1394856|NCT01266967|4602987|P2|Overall Study|Death|61
1394857|NCT01266967|4602988|P1|Overall Study|Death|69
1394858|NCT01266876|4603040|P5|Overall Study|Adverse Event|0
1394859|NCT01266876|4603041|P4|Overall Study|Adverse Event|1
1394860|NCT01266876|4603042|P3|Overall Study|Adverse Event|0
1394861|NCT01266876|4603043|P2|Overall Study|Adverse Event|0
1394862|NCT01266876|4603044|P1|Overall Study|Adverse Event|0
1394863|NCT01266850|4603151|P5|Overall Study|Site Closure|0
1394864|NCT01266850|4603152|P4|Overall Study|Site Closure|1
1394865|NCT01266850|4603153|P3|Overall Study|Site Closure|1
1394866|NCT01266850|4603154|P2|Overall Study|Site Closure|1
1394867|NCT01266850|4603155|P1|Overall Study|Site Closure|0
1394868|NCT01266850|4603151|P5|Overall Study|Adverse Event|1
1394869|NCT01266850|4603152|P4|Overall Study|Adverse Event|0
1394870|NCT01266850|4603153|P3|Overall Study|Adverse Event|0
1394871|NCT01266850|4603154|P2|Overall Study|Adverse Event|0
1394872|NCT01266850|4603155|P1|Overall Study|Adverse Event|0
1394873|NCT01266850|4603151|P5|Overall Study|Protocol Violation|2
1394874|NCT01266850|4603152|P4|Overall Study|Protocol Violation|1
1394875|NCT01266850|4603153|P3|Overall Study|Protocol Violation|0
1394876|NCT01266850|4603154|P2|Overall Study|Protocol Violation|1
1394877|NCT01266850|4603155|P1|Overall Study|Protocol Violation|0
1394878|NCT01266850|4603151|P5|Overall Study|Physician Decision|3
1394879|NCT01266850|4603152|P4|Overall Study|Physician Decision|4
1394880|NCT01266850|4603153|P3|Overall Study|Physician Decision|4
1394881|NCT01266850|4603154|P2|Overall Study|Physician Decision|6
1394882|NCT01266850|4603155|P1|Overall Study|Physician Decision|3
1394883|NCT01266850|4603151|P5|Overall Study|Withdrawal by Subject|12
1394884|NCT01266850|4603152|P4|Overall Study|Withdrawal by Subject|9
1394885|NCT01266850|4603153|P3|Overall Study|Withdrawal by Subject|6
1394886|NCT01266850|4603154|P2|Overall Study|Withdrawal by Subject|9
1394887|NCT01266850|4603155|P1|Overall Study|Withdrawal by Subject|8
1394888|NCT01266850|4603151|P5|Overall Study|Lost to Follow-up|12
1394889|NCT01266850|4603152|P4|Overall Study|Lost to Follow-up|13
1394890|NCT01266850|4603153|P3|Overall Study|Lost to Follow-up|13
1394891|NCT01266850|4603154|P2|Overall Study|Lost to Follow-up|19
1394892|NCT01266850|4603155|P1|Overall Study|Lost to Follow-up|19
1394893|NCT01266824|4603209|P2|Overall Study|Study terminated prior to completion|3
1394894|NCT01266824|4603210|P1|Overall Study|Study terminated prior to completion|2
1394895|NCT01266317|4603231|P1|Overall Study|Withdrawal by Subject|2
1394896|NCT01266291|4603236|P1|Overall Study|Adverse Event|1
1394897|NCT01266265|4603243|P2|Overall Study|Clinical worsening|1
1394898|NCT01266265|4603244|P1|Overall Study|Clinical worsening|1
1394899|NCT01266265|4603243|P2|Overall Study|Site closed early|3
1394900|NCT01266265|4603244|P1|Overall Study|Site closed early|4
1394901|NCT01266265|4603243|P2|Overall Study|Lung transplant|5
1394902|NCT01266265|4603244|P1|Overall Study|Lung transplant|6
1394903|NCT01266265|4603243|P2|Overall Study|Non-compliance|5
1394904|NCT01266265|4603244|P1|Overall Study|Non-compliance|8
1394905|NCT01266265|4603243|P2|Overall Study|Enrolled in another clinical study|26
1394906|NCT01266265|4603244|P1|Overall Study|Enrolled in another clinical study|15
1394907|NCT01266265|4603243|P2|Overall Study|Stopped/changed PAH medication(s)|9
1394908|NCT01266265|4603244|P1|Overall Study|Stopped/changed PAH medication(s)|16
1394909|NCT01266265|4603243|P2|Overall Study|Transferred care to another provider|28
1394910|NCT01266265|4603244|P1|Overall Study|Transferred care to another provider|22
1394911|NCT01266265|4603243|P2|Overall Study|Respiratory-related adverse event|1
1394912|NCT01266265|4603244|P1|Overall Study|Respiratory-related adverse event|2
1394913|NCT01266265|4603243|P2|Overall Study|Withdrawal by Subject|11
1394914|NCT01266265|4603244|P1|Overall Study|Withdrawal by Subject|13
1394915|NCT01266265|4603243|P2|Overall Study|Lost to Follow-up|28
1394916|NCT01266265|4603244|P1|Overall Study|Lost to Follow-up|23
1394917|NCT01266265|4603243|P2|Overall Study|Death|73
1394918|NCT01266265|4603244|P1|Overall Study|Death|95
1394919|NCT01266161|4603252|P2|Overall Study|Vomited within 4 hours of dosing|0
1394920|NCT01266161|4603253|P1|Overall Study|Vomited within 4 hours of dosing|3
1394921|NCT01266161|4603252|P2|Overall Study|Lack of Efficacy|1
1394922|NCT01266161|4603253|P1|Overall Study|Lack of Efficacy|0
1394923|NCT01266161|4603252|P2|Overall Study|Ineligible|0
1394924|NCT01266161|4603253|P1|Overall Study|Ineligible|1
1394925|NCT01266148|4603285|P2|Overall Study|missing mGFR value + AE|0
1394926|NCT01266148|4603286|P1|Overall Study|missing mGFR value + AE|1
1394927|NCT01266148|4603285|P2|Overall Study|Death|3
1394928|NCT01266148|4603286|P1|Overall Study|Death|2
1394929|NCT01266148|4603285|P2|Overall Study|2 2R rejections|0
1394930|NCT01266148|4603286|P1|Overall Study|2 2R rejections|1
1394931|NCT01266148|4603285|P2|Overall Study|Ongoing rejection|0
1394932|NCT01266148|4603286|P1|Overall Study|Ongoing rejection|1
1394933|NCT01266148|4603285|P2|Overall Study|Adverse Event|0
1394934|NCT01266148|4603286|P1|Overall Study|Adverse Event|2
1394935|NCT01266122|4603314|P2|Overall Study|Lost to Follow-up|6
1394936|NCT01266122|4603315|P1|Overall Study|Lost to Follow-up|6
1394937|NCT01266070|4603323|P1|Overall Study|Protocol Violation|1
1394938|NCT01266070|4603323|P1|Overall Study|Adverse Event|3
1394939|NCT01266031|4603331|P3|Overall Study|Not treated|2
1394940|NCT01266031|4603332|P2|Overall Study|Not treated|3
1394941|NCT01266031|4603333|P1|Overall Study|Not treated|0
1394942|NCT01266018|4603360|P2|Overall Study|Progressive disease|1
1394943|NCT01266018|4603361|P1|Overall Study|Progressive disease|0
1394944|NCT01266018|4603360|P2|Overall Study|Physician Decision|0
1394945|NCT01266018|4603361|P1|Overall Study|Physician Decision|1
1394946|NCT01265992|4603372|P1|Overall Study|Did not receive treatment|1
1394947|NCT01265992|4603372|P1|Overall Study|Stopped treatment|3
1394948|NCT01265992|4603372|P1|Overall Study|Administrative reasons|2
1394949|NCT01265992|4603372|P1|Overall Study|Adverse Event|1
1394950|NCT01265992|4603372|P1|Overall Study|Withdrawal by Subject|1
1394951|NCT01265992|4603372|P1|Overall Study|Lost to Follow-up|1
1394952|NCT01265953|4603400|P2|Overall Study|Non compliance|3
1394953|NCT01265953|4603401|P1|Overall Study|Non compliance|5
1394954|NCT01265875|4603413|P1|Overall Study|Uncooperative/unreliable|1
1394955|NCT01265823|4603421|P1|Overall Study|Participant Request|1
1394956|NCT01265823|4603421|P1|Overall Study|Protocol Violation|1
1394957|NCT01265823|4603421|P1|Overall Study|Failure to Return|4
1394958|NCT01265823|4603421|P1|Overall Study|Unsatisfactory Response Efficacy|1
1394959|NCT01265797|4603450|P2|Open Label Month|Lost to Follow-up|1
1394960|NCT01265797|4603451|P1|Open Label Month|Lost to Follow-up|0
1394961|NCT01265797|4603450|P2|Blinded Month|Diary data incomplete|1
1394962|NCT01265797|4603451|P1|Blinded Month|Diary data incomplete|0
1394963|NCT01265797|4603450|P2|Blinded Month|Adverse Event|0
1394964|NCT01265797|4603451|P1|Blinded Month|Adverse Event|2
1394965|NCT01265797|4603450|P2|Blinded Month|Protocol Violation|1
1394966|NCT01265797|4603451|P1|Blinded Month|Protocol Violation|2
1394967|NCT01265797|4603450|P2|Blinded Month|Lost to Follow-up|0
1394968|NCT01265797|4603451|P1|Blinded Month|Lost to Follow-up|1
1394969|NCT01265797|4603450|P2|Blinded Month|Lack of Efficacy|0
1394970|NCT01265797|4603451|P1|Blinded Month|Lack of Efficacy|5
1394971|NCT01265797|4603450|P2|Run-in Month|1st seizure during run-in month|1
1394972|NCT01265797|4603451|P1|Run-in Month|1st seizure during run-in month|0
1394973|NCT01265797|4603450|P2|Run-in Month|Withdrawal by Subject|4
1394974|NCT01265797|4603451|P1|Run-in Month|Withdrawal by Subject|0
1394975|NCT01265784|4603482|P3|Overall Study|Incorrectly Randomized|1
1394976|NCT01265784|4603483|P2|Overall Study|Incorrectly Randomized|0
1394977|NCT01265784|4603484|P1|Overall Study|Incorrectly Randomized|0
1394978|NCT01265784|4603482|P3|Overall Study|Protocol Violation|0
1394979|NCT01265784|4603483|P2|Overall Study|Protocol Violation|0
1394980|NCT01265784|4603484|P1|Overall Study|Protocol Violation|2
1394981|NCT01265784|4603482|P3|Overall Study|Death|0
1394982|NCT01265784|4603483|P2|Overall Study|Death|0
1394983|NCT01265784|4603484|P1|Overall Study|Death|3
1394984|NCT01265784|4603482|P3|Overall Study|Adverse Event|0
1394985|NCT01265784|4603483|P2|Overall Study|Adverse Event|0
1394986|NCT01265784|4603484|P1|Overall Study|Adverse Event|1
1394987|NCT01265784|4603482|P3|Overall Study|Physician Decision|1
1394988|NCT01265784|4603483|P2|Overall Study|Physician Decision|0
1394989|NCT01265784|4603484|P1|Overall Study|Physician Decision|1
1394990|NCT01265784|4603482|P3|Overall Study|Withdrawal by Subject|0
1394991|NCT01265784|4603483|P2|Overall Study|Withdrawal by Subject|5
1394992|NCT01265784|4603484|P1|Overall Study|Withdrawal by Subject|0
1394993|NCT01265784|4603482|P3|Overall Study|Lost to Follow-up|2
1394994|NCT01265784|4603483|P2|Overall Study|Lost to Follow-up|3
1394995|NCT01265784|4603484|P1|Overall Study|Lost to Follow-up|5
1394996|NCT01265615|4603569|P4|Overall Study|Protocol Violation|3
1394997|NCT01265615|4603570|P3|Overall Study|Protocol Violation|4
1394998|NCT01265615|4603571|P2|Overall Study|Protocol Violation|2
1394999|NCT01265615|4603572|P1|Overall Study|Protocol Violation|2
1395000|NCT01265563|4603623|P5|Overall Study|Withdrawal by Subject|2
1395001|NCT01265563|4603624|P4|Overall Study|Withdrawal by Subject|0
1395002|NCT01265563|4603625|P3|Overall Study|Withdrawal by Subject|1
1395003|NCT01265563|4603626|P2|Overall Study|Withdrawal by Subject|1
1395004|NCT01265563|4603627|P1|Overall Study|Withdrawal by Subject|0
1395005|NCT01265511|4603722|P2|Overall Study|Met stopping rules|2
1395006|NCT01265511|4603723|P1|Overall Study|Met stopping rules|0
1395007|NCT01265511|4603722|P2|Overall Study|Lack of Efficacy|1
1395008|NCT01265511|4603723|P1|Overall Study|Lack of Efficacy|2
1395009|NCT01265498|4603737|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
1395010|NCT01265498|4603738|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
1395011|NCT01265420|4603874|P1|Overall Study|Lost to Follow-up|1
1395012|NCT01265394|4603878|P1|Overall Study|Subjects withdrawn|37
1395013|NCT01265056|4603885|P2|Follow up|Lost to Follow-up|3
1395014|NCT01265056|4603886|P1|Follow up|Lost to Follow-up|7
1395015|NCT01265056|4603885|P2|Initial Study Period|Withdrawal by Subject|1
1395016|NCT01265056|4603886|P1|Initial Study Period|Withdrawal by Subject|1
1395017|NCT01265056|4603885|P2|Initial Study Period|Withdrawal by Subject|1
1395018|NCT01265056|4603886|P1|Initial Study Period|Withdrawal by Subject|1
1395019|NCT01264939|4603917|P2|Overall Study|Disease Progression|11
1395020|NCT01264939|4603918|P1|Overall Study|Disease Progression|8
1395021|NCT01264939|4603917|P2|Overall Study|Patient/Guardian Decision|10
1395022|NCT01264939|4603918|P1|Overall Study|Patient/Guardian Decision|8
1395023|NCT01264939|4603917|P2|Overall Study|Physician Decision|1
1395024|NCT01264939|4603918|P1|Overall Study|Physician Decision|1
1395025|NCT01264939|4603917|P2|Overall Study|Lost to Follow-up|3
1395026|NCT01264939|4603918|P1|Overall Study|Lost to Follow-up|0
1395027|NCT01264939|4603917|P2|Overall Study|Adverse Event|3
1395028|NCT01264939|4603918|P1|Overall Study|Adverse Event|1
1395029|NCT01264887|4603944|P1|Overall Study|Not Specified|2
1395030|NCT01264887|4603944|P1|Overall Study|Sponsor Decision Administrative Reasons|2
1395031|NCT01264887|4603944|P1|Overall Study|Withdrawal by Subject|6
1395032|NCT01264887|4603944|P1|Overall Study|Physician Decision|4
1395033|NCT01264887|4603944|P1|Overall Study|Lack of Efficacy|5
1395034|NCT01264887|4603944|P1|Overall Study|Death|7
1395035|NCT01264887|4603944|P1|Overall Study|Adverse Event|5
1395036|NCT01264835|4603955|P1|Overall Study|Lost to Follow-up|1
1395037|NCT01264770|4603965|P6|Overall Study|Adverse Event|1
1395038|NCT01264770|4603966|P5|Overall Study|Adverse Event|2
1395039|NCT01264770|4603967|P4|Overall Study|Adverse Event|0
1395040|NCT01264770|4603968|P3|Overall Study|Adverse Event|8
1395041|NCT01264770|4603969|P2|Overall Study|Adverse Event|7
1395042|NCT01264770|4603970|P1|Overall Study|Adverse Event|7
1395043|NCT01264770|4603965|P6|Overall Study|Lost to Follow-up|0
1395044|NCT01264770|4603966|P5|Overall Study|Lost to Follow-up|0
1395045|NCT01264770|4603967|P4|Overall Study|Lost to Follow-up|1
1395046|NCT01264770|4603968|P3|Overall Study|Lost to Follow-up|1
1395047|NCT01264770|4603969|P2|Overall Study|Lost to Follow-up|0
1395048|NCT01264770|4603970|P1|Overall Study|Lost to Follow-up|0
1395049|NCT01264770|4603965|P6|Overall Study|Dev. of study specific discont. criteria|1
1395050|NCT01264770|4603966|P5|Overall Study|Dev. of study specific discont. criteria|1
1395051|NCT01264770|4603967|P4|Overall Study|Dev. of study specific discont. criteria|0
1395052|NCT01264770|4603968|P3|Overall Study|Dev. of study specific discont. criteria|0
1395053|NCT01264770|4603969|P2|Overall Study|Dev. of study specific discont. criteria|0
1395054|NCT01264770|4603970|P1|Overall Study|Dev. of study specific discont. criteria|2
1395055|NCT01264770|4603965|P6|Overall Study|Lack of therapeutic response|0
1395056|NCT01264770|4603966|P5|Overall Study|Lack of therapeutic response|1
1395057|NCT01264770|4603967|P4|Overall Study|Lack of therapeutic response|1
1395058|NCT01264770|4603968|P3|Overall Study|Lack of therapeutic response|2
1395059|NCT01264770|4603969|P2|Overall Study|Lack of therapeutic response|0
1395060|NCT01264770|4603970|P1|Overall Study|Lack of therapeutic response|1
1395061|NCT01264770|4603965|P6|Overall Study|Severe non-compliance to protocol|0
1395062|NCT01264770|4603966|P5|Overall Study|Severe non-compliance to protocol|0
1395063|NCT01264770|4603967|P4|Overall Study|Severe non-compliance to protocol|1
1395064|NCT01264770|4603968|P3|Overall Study|Severe non-compliance to protocol|1
1395065|NCT01264770|4603969|P2|Overall Study|Severe non-compliance to protocol|0
1395066|NCT01264770|4603970|P1|Overall Study|Severe non-compliance to protocol|0
1395067|NCT01264770|4603965|P6|Overall Study|e.g., change in circumstances|4
1395068|NCT01264770|4603966|P5|Overall Study|e.g., change in circumstances|4
1395069|NCT01264770|4603967|P4|Overall Study|e.g., change in circumstances|3
1395070|NCT01264770|4603968|P3|Overall Study|e.g., change in circumstances|3
1395071|NCT01264770|4603969|P2|Overall Study|e.g., change in circumstances|3
1395072|NCT01264770|4603970|P1|Overall Study|e.g., change in circumstances|8
1395073|NCT01264770|4603965|P6|Overall Study|Not reported|0
1395074|NCT01264770|4603966|P5|Overall Study|Not reported|0
1395075|NCT01264770|4603967|P4|Overall Study|Not reported|0
1395076|NCT01264770|4603968|P3|Overall Study|Not reported|1
1395077|NCT01264770|4603969|P2|Overall Study|Not reported|0
1395078|NCT01264770|4603970|P1|Overall Study|Not reported|0
1395079|NCT01264679|4604054|P1|Overall Study|Withdrawal by Subject|1
1395080|NCT01264679|4604054|P1|Overall Study|Sponsor's Suspension of Dosing|2
1395081|NCT01264679|4604054|P1|Overall Study|Physician Decision|1
1395082|NCT01264679|4604054|P1|Overall Study|Participation in Another Clinical Trial|1
1395083|NCT01264380|4604088|P3|Period C|Adverse Event|1
1395084|NCT01264380|4604089|P2|Period C|Adverse Event|0
1395085|NCT01264380|4604090|P1|Period C|Adverse Event|0
1395086|NCT01264380|4604088|P3|Period C|Withdrawal by Subject|1
1395087|NCT01264380|4604089|P2|Period C|Withdrawal by Subject|0
1395088|NCT01264380|4604090|P1|Period C|Withdrawal by Subject|0
1395089|NCT01264380|4604088|P3|Period C|Follow-up for survival status|6
1395090|NCT01264380|4604089|P2|Period C|Follow-up for survival status|0
1395091|NCT01264380|4604090|P1|Period C|Follow-up for survival status|0
1395092|NCT01264380|4604088|P3|Period C|Death|2
1395093|NCT01264380|4604089|P2|Period C|Death|0
1395094|NCT01264380|4604090|P1|Period C|Death|0
1395095|NCT01264380|4604088|P3|Period C|Disease Progression|4
1395096|NCT01264380|4604089|P2|Period C|Disease Progression|0
1395097|NCT01264380|4604090|P1|Period C|Disease Progression|0
1395098|NCT01264081|4604111|P1|Started Treatment|Not complete cycle 1 due to death|1
1395099|NCT01264081|4604111|P1|Started Treatment|Withdrawal by Subject|1
1395100|NCT01264081|4604111|P1|Participants Screened|Screening failures|30
1395101|NCT01264016|4604116|P1|Overall Study|Felt faint at sight of blood|1
1395102|NCT01264016|4604116|P1|Overall Study|Withdrawal by Subject|1
1395103|NCT01263925|4604124|P2|Overall Study|Withdrawal/ Not specified|1
1395104|NCT01263925|4604125|P1|Overall Study|Withdrawal/ Not specified|0
1395105|NCT01263925|4604124|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
1395106|NCT01263925|4604125|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
1395107|NCT01263925|4604124|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
1395108|NCT01263925|4604125|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
1395109|NCT01263925|4604124|P2|Overall Study|AE/ Withdrawal|4
1395110|NCT01263925|4604125|P1|Overall Study|AE/ Withdrawal|1
1395111|NCT01263925|4604124|P2|Overall Study|AE/ Unsatisfactory Compliance|2
1395112|NCT01263925|4604125|P1|Overall Study|AE/ Unsatisfactory Compliance|2
1395113|NCT01263925|4604124|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
1395114|NCT01263925|4604125|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
1395115|NCT01263925|4604124|P2|Overall Study|Lost to Follow-up|1
1395116|NCT01263925|4604125|P1|Overall Study|Lost to Follow-up|3
1395117|NCT01263925|4604124|P2|Overall Study|Not specified|4
1395118|NCT01263925|4604125|P1|Overall Study|Not specified|4
1395119|NCT01263925|4604124|P2|Overall Study|Withdrawal by Subject|8
1395120|NCT01263925|4604125|P1|Overall Study|Withdrawal by Subject|6
1395121|NCT01263925|4604124|P2|Overall Study|Unsatisfactory Compliance of Subject|5
1395122|NCT01263925|4604125|P1|Overall Study|Unsatisfactory Compliance of Subject|8
1395123|NCT01263925|4604124|P2|Overall Study|Adverse Event|22
1395124|NCT01263925|4604125|P1|Overall Study|Adverse Event|23
1395125|NCT01263925|4604124|P2|Overall Study|Lack of Efficacy|1
1395126|NCT01263925|4604125|P1|Overall Study|Lack of Efficacy|0
1395127|NCT01263925|4604124|P2|Overall Study|Protocol Violation|0
1395128|NCT01263925|4604125|P1|Overall Study|Protocol Violation|1
1395129|NCT01263873|4604159|P2|Overall Study|One provider unable to complete numbers|1
1395130|NCT01263873|4604160|P1|Overall Study|One provider unable to complete numbers|1
1395131|NCT01263704|4604201|P1|Overall Study|Principal Investigator (PI) decision|1
1395132|NCT01263704|4604201|P1|Overall Study|Colon metastases|1
1395133|NCT01263704|4604201|P1|Overall Study|Lost to Follow-up|1
1395134|NCT01263704|4604201|P1|Overall Study|Eligibility criteria not fulfilled|1
1395135|NCT01263704|4604201|P1|Overall Study|Patient withdrew consent|2
1395136|NCT01263704|4604201|P1|Overall Study|Death|2
1395137|NCT01263704|4604201|P1|Overall Study|Adverse Event|3
1395138|NCT01263704|4604201|P1|Overall Study|Progressive disease|18
1395139|NCT01263691|4604216|P6|Overall Study|Adverse Event|0
1395140|NCT01263691|4604217|P5|Overall Study|Adverse Event|0
1395141|NCT01263691|4604218|P4|Overall Study|Adverse Event|0
1395142|NCT01263691|4604219|P3|Overall Study|Adverse Event|0
1395143|NCT01263691|4604220|P2|Overall Study|Adverse Event|0
1395144|NCT01263691|4604221|P1|Overall Study|Adverse Event|1
1395145|NCT01263691|4604216|P6|Overall Study|Withdrawal by Subject|0
1395146|NCT01263691|4604217|P5|Overall Study|Withdrawal by Subject|0
1395147|NCT01263691|4604218|P4|Overall Study|Withdrawal by Subject|0
1395148|NCT01263691|4604219|P3|Overall Study|Withdrawal by Subject|0
1395149|NCT01263691|4604220|P2|Overall Study|Withdrawal by Subject|0
1395150|NCT01263691|4604221|P1|Overall Study|Withdrawal by Subject|1
1395151|NCT01263691|4604216|P6|Overall Study|Lost to Follow-up|0
1395152|NCT01263691|4604217|P5|Overall Study|Lost to Follow-up|0
1395153|NCT01263691|4604218|P4|Overall Study|Lost to Follow-up|1
1395154|NCT01263691|4604219|P3|Overall Study|Lost to Follow-up|1
1395155|NCT01263691|4604220|P2|Overall Study|Lost to Follow-up|0
1395156|NCT01263691|4604221|P1|Overall Study|Lost to Follow-up|1
1395157|NCT01263665|4604331|P1|Overall Study|Surgical Bypass|2
1395158|NCT01263665|4604331|P1|Overall Study|Amputation above the ankle|1
1395159|NCT01263665|4604331|P1|Overall Study|Death|2
1395160|NCT01263665|4604331|P1|Overall Study|Lost to Follow-up|3
1395161|NCT01263665|4604331|P1|Overall Study|Withdrew Consent|1
1395162|NCT01263639|4604338|P2|Overall Study|Exclusion =Admission greater than 7 days|9
1395163|NCT01263639|4604339|P1|Overall Study|Exclusion =Admission greater than 7 days|7
1395164|NCT01263639|4604338|P2|Overall Study|Lost to Follow-up|70
1395165|NCT01263639|4604339|P1|Overall Study|Lost to Follow-up|66
1395166|NCT01263561|4604347|P2|Overall Study|Death|2
1395167|NCT01263561|4604348|P1|Overall Study|Death|1
1395168|NCT01263509|4604360|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
1395169|NCT01263509|4604361|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
1395170|NCT01263509|4604362|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
1395171|NCT01263509|4604363|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
1395172|NCT01263509|4604360|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
1395173|NCT01263509|4604361|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
1395174|NCT01263509|4604362|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
1395175|NCT01263509|4604363|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
1395176|NCT01263509|4604360|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1395177|NCT01263509|4604361|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1395178|NCT01263509|4604362|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1395179|NCT01263509|4604363|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1395180|NCT01263509|4604360|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
1395181|NCT01263509|4604361|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
1395182|NCT01263509|4604362|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
1395183|NCT01263509|4604363|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
1395184|NCT01263509|4604360|P4|Entered - Long-Term Extension Study|Adverse Event|1
1395185|NCT01263509|4604361|P3|Entered - Long-Term Extension Study|Adverse Event|4
1395186|NCT01263509|4604362|P2|Entered - Long-Term Extension Study|Adverse Event|5
1395187|NCT01263509|4604363|P1|Entered - Long-Term Extension Study|Adverse Event|5
1395188|NCT01263496|4604492|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
1395189|NCT01263496|4604493|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
1395190|NCT01263496|4604494|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
1395191|NCT01263496|4604495|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
1395192|NCT01263496|4604496|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
1395193|NCT01263496|4604497|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
1395194|NCT01263496|4604498|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
1395195|NCT01263496|4604499|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
1395196|NCT01263496|4604500|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
1395197|NCT01263496|4604492|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
1395198|NCT01263496|4604493|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
1395199|NCT01263496|4604494|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
1395200|NCT01263496|4604495|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
1395201|NCT01263496|4604496|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
1395202|NCT01263496|4604497|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
1395203|NCT01263496|4604498|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
1395204|NCT01263496|4604499|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
1395205|NCT01263496|4604500|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
1395206|NCT01263496|4604492|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1395207|NCT01263496|4604493|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1395208|NCT01263496|4604494|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1395209|NCT01263496|4604495|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1395210|NCT01263496|4604496|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
1395211|NCT01263496|4604497|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1395212|NCT01263496|4604498|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1395213|NCT01263496|4604499|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1395214|NCT01263496|4604500|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1395215|NCT01263496|4604492|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
1395216|NCT01263496|4604493|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
1395217|NCT01263496|4604494|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
1395218|NCT01263496|4604495|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
1395219|NCT01263496|4604496|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
1395220|NCT01263496|4604497|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
1395221|NCT01263496|4604498|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
1395222|NCT01263496|4604499|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
1395223|NCT01263496|4604500|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
1395224|NCT01263496|4604492|P9|Entered - Long-Term Extension Study|Adverse Event|1
1395225|NCT01263496|4604493|P8|Entered - Long-Term Extension Study|Adverse Event|0
1395226|NCT01263496|4604494|P7|Entered - Long-Term Extension Study|Adverse Event|0
1395227|NCT01263496|4604495|P6|Entered - Long-Term Extension Study|Adverse Event|0
1395228|NCT01263496|4604496|P5|Entered - Long-Term Extension Study|Adverse Event|1
1395229|NCT01263496|4604497|P4|Entered - Long-Term Extension Study|Adverse Event|3
1395230|NCT01263496|4604498|P3|Entered - Long-Term Extension Study|Adverse Event|6
1395231|NCT01263496|4604499|P2|Entered - Long-Term Extension Study|Adverse Event|5
1395232|NCT01263496|4604500|P1|Entered - Long-Term Extension Study|Adverse Event|0
1395233|NCT01263496|4604492|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
1395234|NCT01263496|4604493|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
1395235|NCT01263496|4604494|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
1395236|NCT01263496|4604495|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
1395237|NCT01263496|4604496|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
1395238|NCT01263496|4604497|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
1395239|NCT01263496|4604498|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
1395240|NCT01263496|4604499|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
1395241|NCT01263496|4604500|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
1395242|NCT01263496|4604492|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
1395243|NCT01263496|4604493|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
1395244|NCT01263496|4604494|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
1395245|NCT01263496|4604495|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
1395246|NCT01263496|4604496|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
1395247|NCT01263496|4604497|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
1395248|NCT01263496|4604498|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
1395249|NCT01263496|4604499|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
1395250|NCT01263496|4604500|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
1395251|NCT01263483|4604795|P3|Overall Study|Participant Unavailability|1
1395252|NCT01263483|4604796|P2|Overall Study|Participant Unavailability|1
1395253|NCT01263483|4604797|P1|Overall Study|Participant Unavailability|0
1395254|NCT01263483|4604795|P3|Overall Study|Protocol Violation|1
1395255|NCT01263483|4604796|P2|Overall Study|Protocol Violation|1
1395256|NCT01263483|4604797|P1|Overall Study|Protocol Violation|0
1395257|NCT01263483|4604795|P3|Overall Study|Lack of Efficacy|0
1395258|NCT01263483|4604796|P2|Overall Study|Lack of Efficacy|0
1395259|NCT01263483|4604797|P1|Overall Study|Lack of Efficacy|2
1395260|NCT01263483|4604795|P3|Overall Study|Withdrawal by Subject|0
1395261|NCT01263483|4604796|P2|Overall Study|Withdrawal by Subject|0
1395262|NCT01263483|4604797|P1|Overall Study|Withdrawal by Subject|1
1395263|NCT01263483|4604795|P3|Overall Study|Adverse Event|3
1395264|NCT01263483|4604796|P2|Overall Study|Adverse Event|0
1395265|NCT01263483|4604797|P1|Overall Study|Adverse Event|4
1395266|NCT01263470|4604859|P6|Overall Study|Study Drug Non-compliance|0
1395267|NCT01263470|4604860|P5|Overall Study|Study Drug Non-compliance|1
1395268|NCT01263470|4604861|P4|Overall Study|Study Drug Non-compliance|0
1395269|NCT01263470|4604862|P3|Overall Study|Study Drug Non-compliance|0
1395270|NCT01263470|4604863|P2|Overall Study|Study Drug Non-compliance|0
1395271|NCT01263470|4604864|P1|Overall Study|Study Drug Non-compliance|0
1395272|NCT01263470|4604859|P6|Overall Study|Participant Unavailability|0
1395273|NCT01263470|4604860|P5|Overall Study|Participant Unavailability|0
1395274|NCT01263470|4604861|P4|Overall Study|Participant Unavailability|0
1395275|NCT01263470|4604862|P3|Overall Study|Participant Unavailability|0
1395276|NCT01263470|4604863|P2|Overall Study|Participant Unavailability|1
1395277|NCT01263470|4604864|P1|Overall Study|Participant Unavailability|0
1395278|NCT01263470|4604859|P6|Overall Study|Lack of Efficacy|0
1395279|NCT01263470|4604860|P5|Overall Study|Lack of Efficacy|0
1395280|NCT01263470|4604861|P4|Overall Study|Lack of Efficacy|0
1395281|NCT01263470|4604862|P3|Overall Study|Lack of Efficacy|2
1395282|NCT01263470|4604863|P2|Overall Study|Lack of Efficacy|0
1395283|NCT01263470|4604864|P1|Overall Study|Lack of Efficacy|0
1395284|NCT01263470|4604859|P6|Overall Study|Withdrawal by Subject|2
1395285|NCT01263470|4604860|P5|Overall Study|Withdrawal by Subject|0
1395286|NCT01263470|4604861|P4|Overall Study|Withdrawal by Subject|2
1395287|NCT01263470|4604862|P3|Overall Study|Withdrawal by Subject|1
1395288|NCT01263470|4604863|P2|Overall Study|Withdrawal by Subject|1
1395289|NCT01263470|4604864|P1|Overall Study|Withdrawal by Subject|0
1395290|NCT01263470|4604859|P6|Overall Study|Protocol Violation|1
1395291|NCT01263470|4604860|P5|Overall Study|Protocol Violation|0
1395292|NCT01263470|4604861|P4|Overall Study|Protocol Violation|0
1395293|NCT01263470|4604862|P3|Overall Study|Protocol Violation|0
1395294|NCT01263470|4604863|P2|Overall Study|Protocol Violation|1
1395295|NCT01263470|4604864|P1|Overall Study|Protocol Violation|0
1395296|NCT01263470|4604859|P6|Overall Study|Adverse Event|2
1395297|NCT01263470|4604860|P5|Overall Study|Adverse Event|2
1395298|NCT01263470|4604861|P4|Overall Study|Adverse Event|1
1395299|NCT01263470|4604862|P3|Overall Study|Adverse Event|1
1395300|NCT01263470|4604863|P2|Overall Study|Adverse Event|2
1395301|NCT01263470|4604864|P1|Overall Study|Adverse Event|2
1395302|NCT01263444|4604974|P1|Overall Study|Protocol Violation|1
1395303|NCT01263444|4604974|P1|Overall Study|Withdrawal by Subject|1
1395304|NCT01263444|4604974|P1|Overall Study|Adverse Event|8
1395305|NCT01263054|4605015|P2|Overall Study|Other|1
1395306|NCT01263054|4605016|P1|Overall Study|Other|0
1395307|NCT01263054|4605015|P2|Overall Study|Qualification Violation|0
1395308|NCT01263054|4605016|P1|Overall Study|Qualification Violation|1
1395309|NCT01263054|4605015|P2|Overall Study|Withdrawal by Subject|3
1395310|NCT01263054|4605016|P1|Overall Study|Withdrawal by Subject|1
1395311|NCT01263054|4605015|P2|Overall Study|Lost to Follow-up|2
1395312|NCT01263054|4605016|P1|Overall Study|Lost to Follow-up|2
1395313|NCT01263054|4605015|P2|Overall Study|Death|0
1395314|NCT01263054|4605016|P1|Overall Study|Death|1
1395315|NCT01263028|4605034|P1|Overall Study|Study terminated due to low enrollment.|4
1395316|NCT01263028|4605034|P1|Overall Study|Adverse Event|1
1395317|NCT01263028|4605034|P1|Overall Study|Withdrawal by Subject|1
1395318|NCT01263015|4605044|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
1395319|NCT01263015|4605045|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
1395320|NCT01263015|4605044|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
1395321|NCT01263015|4605045|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
1395322|NCT01263015|4605044|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
1395323|NCT01263015|4605045|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
1395324|NCT01263015|4605044|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
1395325|NCT01263015|4605045|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
1395326|NCT01263015|4605044|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
1395327|NCT01263015|4605045|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
1395328|NCT01263015|4605044|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
1395329|NCT01263015|4605045|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
1395330|NCT01263015|4605044|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
1395331|NCT01263015|4605045|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
1395332|NCT01263015|4605044|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
1395333|NCT01263015|4605045|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
1395334|NCT01263015|4605044|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
1395335|NCT01263015|4605045|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
1395336|NCT01263015|4605044|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
1395337|NCT01263015|4605045|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
1395338|NCT01263015|4605044|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
1395339|NCT01263015|4605045|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
1395340|NCT01263015|4605044|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
1395341|NCT01263015|4605045|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
1395342|NCT01262989|4605071|P2|Period 2|Intercurrent disease|1
1395343|NCT01262989|4605072|P1|Period 2|Intercurrent disease|0
1395344|NCT01262989|4605071|P2|Period 1|Positive answer for exclusion criteria|1
1395345|NCT01262989|4605072|P1|Period 1|Positive answer for exclusion criteria|0
1395346|NCT01262989|4605071|P2|Period 1|Intercurrent disease|1
1395347|NCT01262989|4605072|P1|Period 1|Intercurrent disease|0
1395348|NCT01262989|4605071|P2|Period 1|Lost to Follow-up|1
1395349|NCT01262989|4605072|P1|Period 1|Lost to Follow-up|1
1395350|NCT01262898|4605086|P4|Overall Study|Withdrawal by Subject|0
1395351|NCT01262898|4605087|P3|Overall Study|Withdrawal by Subject|0
1395352|NCT01262898|4605088|P2|Overall Study|Withdrawal by Subject|1
1395353|NCT01262898|4605089|P1|Overall Study|Withdrawal by Subject|1
1395354|NCT01262898|4605086|P4|Overall Study|Lost to Follow-up|0
1395355|NCT01262898|4605087|P3|Overall Study|Lost to Follow-up|0
1395356|NCT01262898|4605088|P2|Overall Study|Lost to Follow-up|0
1395357|NCT01262898|4605089|P1|Overall Study|Lost to Follow-up|1
1395358|NCT01262898|4605086|P4|Overall Study|Protocol Violation|0
1395359|NCT01262898|4605087|P3|Overall Study|Protocol Violation|0
1395360|NCT01262898|4605088|P2|Overall Study|Protocol Violation|1
1395361|NCT01262898|4605089|P1|Overall Study|Protocol Violation|1
1395362|NCT01262872|4605217|P8|Step 2|Migrated/moved from study area|3
1395363|NCT01262872|4605218|P7|Step 2|Migrated/moved from study area|2
1395364|NCT01262872|4605219|P6|Step 2|Migrated/moved from study area|6
1395365|NCT01262872|4605220|P5|Step 2|Migrated/moved from study area|2
1395366|NCT01262872|4605221|P4|Step 2|Migrated/moved from study area|3
1395367|NCT01262872|4605222|P3|Step 2|Migrated/moved from study area|4
1395368|NCT01262872|4605223|P2|Step 2|Migrated/moved from study area|0
1395369|NCT01262872|4605224|P1|Step 2|Migrated/moved from study area|0
1395370|NCT01262872|4605217|P8|Step 2|Withdrawal by Subject|1
1395371|NCT01262872|4605218|P7|Step 2|Withdrawal by Subject|2
1395372|NCT01262872|4605219|P6|Step 2|Withdrawal by Subject|1
1395373|NCT01262872|4605220|P5|Step 2|Withdrawal by Subject|3
1395374|NCT01262872|4605221|P4|Step 2|Withdrawal by Subject|6
1395375|NCT01262872|4605222|P3|Step 2|Withdrawal by Subject|4
1395376|NCT01262872|4605223|P2|Step 2|Withdrawal by Subject|0
1395377|NCT01262872|4605224|P1|Step 2|Withdrawal by Subject|0
1395378|NCT01262872|4605217|P8|Step 2|Protocol Violation|1
1395379|NCT01262872|4605218|P7|Step 2|Protocol Violation|3
1395380|NCT01262872|4605219|P6|Step 2|Protocol Violation|0
1395381|NCT01262872|4605220|P5|Step 2|Protocol Violation|0
1395382|NCT01262872|4605221|P4|Step 2|Protocol Violation|0
1395383|NCT01262872|4605222|P3|Step 2|Protocol Violation|1
1395384|NCT01262872|4605223|P2|Step 2|Protocol Violation|0
1395385|NCT01262872|4605224|P1|Step 2|Protocol Violation|0
1395386|NCT01262872|4605217|P8|Step 2|Death|1
1395387|NCT01262872|4605218|P7|Step 2|Death|2
1395388|NCT01262872|4605219|P6|Step 2|Death|2
1395389|NCT01262872|4605220|P5|Step 2|Death|0
1395390|NCT01262872|4605221|P4|Step 2|Death|1
1395391|NCT01262872|4605222|P3|Step 2|Death|0
1395392|NCT01262872|4605223|P2|Step 2|Death|0
1395393|NCT01262872|4605224|P1|Step 2|Death|0
1395394|NCT01262820|4605486|P1|Overall Study|Drug held for 21+ days|1
1395395|NCT01262820|4605486|P1|Overall Study|Lack of Efficacy|9
1395396|NCT01262820|4605486|P1|Overall Study|Adverse Event|5
1395397|NCT01262677|4605500|P3|Overall Study|Adverse Event (AE) related to study drug|3
1395398|NCT01262677|4605501|P2|Overall Study|Adverse Event (AE) related to study drug|8
1395399|NCT01262677|4605502|P1|Overall Study|Adverse Event (AE) related to study drug|3
1395400|NCT01262677|4605500|P3|Overall Study|Protocol Violation|1
1395401|NCT01262677|4605501|P2|Overall Study|Protocol Violation|1
1395402|NCT01262677|4605502|P1|Overall Study|Protocol Violation|0
1395403|NCT01262677|4605500|P3|Overall Study|Reason not provided|3
1395404|NCT01262677|4605501|P2|Overall Study|Reason not provided|1
1395405|NCT01262677|4605502|P1|Overall Study|Reason not provided|2
1395406|NCT01262677|4605500|P3|Overall Study|No longer willing to participate|2
1395407|NCT01262677|4605501|P2|Overall Study|No longer willing to participate|3
1395408|NCT01262677|4605502|P1|Overall Study|No longer willing to participate|3
1395409|NCT01262677|4605500|P3|Overall Study|Lost to Follow-up|2
1395410|NCT01262677|4605501|P2|Overall Study|Lost to Follow-up|0
1395411|NCT01262677|4605502|P1|Overall Study|Lost to Follow-up|1
1395412|NCT01262677|4605500|P3|Overall Study|Insufficient clinical response|1
1395413|NCT01262677|4605501|P2|Overall Study|Insufficient clinical response|0
1395414|NCT01262677|4605502|P1|Overall Study|Insufficient clinical response|0
1395415|NCT01262677|4605500|P3|Overall Study|Does not meet entrance criteria|0
1395416|NCT01262677|4605501|P2|Overall Study|Does not meet entrance criteria|2
1395417|NCT01262677|4605502|P1|Overall Study|Does not meet entrance criteria|0
1395418|NCT01262651|4605593|P2|Overall Study|Met Withdrawal Criteria|0
1395419|NCT01262651|4605594|P1|Overall Study|Met Withdrawal Criteria|1
1395420|NCT01262651|4605593|P2|Overall Study|Withdrawal by Investigator|2
1395421|NCT01262651|4605594|P1|Overall Study|Withdrawal by Investigator|2
1395422|NCT01262651|4605593|P2|Overall Study|Withdrawal by Subject|11
1395423|NCT01262651|4605594|P1|Overall Study|Withdrawal by Subject|15
1395424|NCT01262651|4605593|P2|Overall Study|Adverse Event|35
1395425|NCT01262651|4605594|P1|Overall Study|Adverse Event|40
1395426|NCT01262573|4605631|P2|Overall Study|Withdrawal by Subject|1
1395427|NCT01262573|4605632|P1|Overall Study|Withdrawal by Subject|0
1395428|NCT01262560|4605643|P3|Overall Study|Protocol Violation|2
1395429|NCT01262560|4605644|P2|Overall Study|Protocol Violation|1
1395430|NCT01262560|4605645|P1|Overall Study|Protocol Violation|0
1395431|NCT01262456|4605694|P3|1-Month Open-Label Extension Period|Other Reason|0
1395432|NCT01262456|4605695|P2|1-Month Open-Label Extension Period|Other Reason|1
1395433|NCT01262456|4605696|P1|1-Month Open-Label Extension Period|Other Reason|0
1395434|NCT01262456|4605694|P3|1-Month Open-Label Extension Period|Protocol Violation|2
1395435|NCT01262456|4605695|P2|1-Month Open-Label Extension Period|Protocol Violation|0
1395436|NCT01262456|4605696|P1|1-Month Open-Label Extension Period|Protocol Violation|1
1395437|NCT01262456|4605694|P3|1-Month Open-Label Extension Period|Adverse Event|2
1395438|NCT01262456|4605695|P2|1-Month Open-Label Extension Period|Adverse Event|0
1395439|NCT01262456|4605696|P1|1-Month Open-Label Extension Period|Adverse Event|2
1395440|NCT01262456|4605694|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
1395441|NCT01262456|4605695|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
1395442|NCT01262456|4605696|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
1395443|NCT01262456|4605694|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
1395444|NCT01262456|4605695|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
1395445|NCT01262456|4605696|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
1395446|NCT01262456|4605694|P3|3-Month Double-Blind Period|Protocol Violation|6
1395447|NCT01262456|4605695|P2|3-Month Double-Blind Period|Protocol Violation|6
1395448|NCT01262456|4605696|P1|3-Month Double-Blind Period|Protocol Violation|3
1395449|NCT01262456|4605694|P3|3-Month Double-Blind Period|Adverse Event|8
1395450|NCT01262456|4605695|P2|3-Month Double-Blind Period|Adverse Event|4
1395451|NCT01262456|4605696|P1|3-Month Double-Blind Period|Adverse Event|6
1395452|NCT01262456|4605694|P3|3-Month Double-Blind Period|Lost to Follow-up|3
1395453|NCT01262456|4605695|P2|3-Month Double-Blind Period|Lost to Follow-up|5
1395454|NCT01262456|4605696|P1|3-Month Double-Blind Period|Lost to Follow-up|4
1395455|NCT01262456|4605694|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
1395456|NCT01262456|4605695|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
1395457|NCT01262456|4605696|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
1395458|NCT01262365|4605740|P3|Overall Study|Patient unavailable|1
1395459|NCT01262365|4605741|P2|Overall Study|Patient unavailable|0
1395460|NCT01262365|4605742|P1|Overall Study|Patient unavailable|0
1395461|NCT01262365|4605740|P3|Overall Study|Cannot tolerate the protocol|0
1395462|NCT01262365|4605741|P2|Overall Study|Cannot tolerate the protocol|1
1395463|NCT01262365|4605742|P1|Overall Study|Cannot tolerate the protocol|0
1395464|NCT01262365|4605740|P3|Overall Study|Toxicity related to study drug|0
1395465|NCT01262365|4605741|P2|Overall Study|Toxicity related to study drug|1
1395466|NCT01262365|4605742|P1|Overall Study|Toxicity related to study drug|0
1395467|NCT01262365|4605740|P3|Overall Study|Patient pregnant|1
1395468|NCT01262365|4605741|P2|Overall Study|Patient pregnant|0
1395469|NCT01262365|4605742|P1|Overall Study|Patient pregnant|1
1395470|NCT01262365|4605740|P3|Overall Study|Suspected pregnancy|0
1395471|NCT01262365|4605741|P2|Overall Study|Suspected pregnancy|0
1395472|NCT01262365|4605742|P1|Overall Study|Suspected pregnancy|1
1395473|NCT01262365|4605740|P3|Overall Study|Non-compliance|2
1395474|NCT01262365|4605741|P2|Overall Study|Non-compliance|0
1395475|NCT01262365|4605742|P1|Overall Study|Non-compliance|1
1395476|NCT01262365|4605740|P3|Overall Study|Randomization error|2
1395477|NCT01262365|4605741|P2|Overall Study|Randomization error|0
1395478|NCT01262365|4605742|P1|Overall Study|Randomization error|1
1395479|NCT01262365|4605740|P3|Overall Study|sponsor decision|0
1395480|NCT01262365|4605741|P2|Overall Study|sponsor decision|1
1395481|NCT01262365|4605742|P1|Overall Study|sponsor decision|1
1395482|NCT01262365|4605740|P3|Overall Study|Adverse Event|11
1395483|NCT01262365|4605741|P2|Overall Study|Adverse Event|16
1395484|NCT01262365|4605742|P1|Overall Study|Adverse Event|26
1395485|NCT01262365|4605740|P3|Overall Study|Death|1
1395486|NCT01262365|4605741|P2|Overall Study|Death|2
1395487|NCT01262365|4605742|P1|Overall Study|Death|1
1395488|NCT01262365|4605740|P3|Overall Study|Withdrawal by Subject|22
1395489|NCT01262365|4605741|P2|Overall Study|Withdrawal by Subject|22
1395490|NCT01262365|4605742|P1|Overall Study|Withdrawal by Subject|17
1395491|NCT01262365|4605740|P3|Overall Study|Lost to Follow-up|6
1395492|NCT01262365|4605741|P2|Overall Study|Lost to Follow-up|7
1395493|NCT01262365|4605742|P1|Overall Study|Lost to Follow-up|3
1395494|NCT01262365|4605740|P3|Overall Study|Protocol Violation|1
1395495|NCT01262365|4605741|P2|Overall Study|Protocol Violation|1
1395496|NCT01262365|4605742|P1|Overall Study|Protocol Violation|3
1395497|NCT01262365|4605740|P3|Overall Study|Lack of Efficacy|47
1395498|NCT01262365|4605741|P2|Overall Study|Lack of Efficacy|30
1395499|NCT01262365|4605742|P1|Overall Study|Lack of Efficacy|35
1395500|NCT01262352|4605767|P2|Washout|Extended Washout|1
1395501|NCT01262352|4605768|P1|Washout|Extended Washout|0
1395502|NCT01262352|4605767|P2|Washout|Adverse Event|1
1395503|NCT01262352|4605768|P1|Washout|Adverse Event|1
1395504|NCT01262352|4605767|P2|Period 1|Illness after randomization|0
1395505|NCT01262352|4605768|P1|Period 1|Illness after randomization|1
1395506|NCT01262287|4605786|P2|Overall Study|Lost to Follow-up|1
1395507|NCT01262287|4605787|P1|Overall Study|Lost to Follow-up|2
1395508|NCT01262092|4605848|P2|Gabapentin Taper|noncompliance - missed medications|0
1395509|NCT01262092|4605849|P1|Gabapentin Taper|noncompliance - missed medications|1
1395510|NCT01262092|4605848|P2|Buprenorphine Taper|noncompliance - missed medication|1
1395511|NCT01262092|4605849|P1|Buprenorphine Taper|noncompliance - missed medication|1
1395512|NCT01262092|4605848|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
1395513|NCT01262092|4605849|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
1395514|NCT01262092|4605848|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
1395515|NCT01262092|4605849|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
1395516|NCT01262027|4605855|P1|Overall Study|Protocol Violation|1
1395517|NCT01262027|4605855|P1|Overall Study|Withdrawal by Subject|3
1395518|NCT01262027|4605855|P1|Overall Study|Adverse Event|1
1395519|NCT01261975|4605860|P1|Overall Study|Surgical complication|1
1395520|NCT01261793|4605882|P3|Overall Study|Patient unable to start IV line|1
1395521|NCT01261793|4605883|P2|Overall Study|Patient unable to start IV line|0
1395522|NCT01261793|4605884|P1|Overall Study|Patient unable to start IV line|0
1395523|NCT01261793|4605882|P3|Overall Study|Randomization error|0
1395524|NCT01261793|4605883|P2|Overall Study|Randomization error|1
1395525|NCT01261793|4605884|P1|Overall Study|Randomization error|0
1395526|NCT01261793|4605882|P3|Overall Study|Patient withdrew after cardiology visit|0
1395527|NCT01261793|4605883|P2|Overall Study|Patient withdrew after cardiology visit|1
1395528|NCT01261793|4605884|P1|Overall Study|Patient withdrew after cardiology visit|0
1395529|NCT01261793|4605882|P3|Overall Study|Lack of efficacy & patient not available|0
1395530|NCT01261793|4605883|P2|Overall Study|Lack of efficacy & patient not available|1
1395531|NCT01261793|4605884|P1|Overall Study|Lack of efficacy & patient not available|0
1395532|NCT01261793|4605882|P3|Overall Study|Outside the study area|1
1395533|NCT01261793|4605883|P2|Overall Study|Outside the study area|2
1395534|NCT01261793|4605884|P1|Overall Study|Outside the study area|0
1395535|NCT01261793|4605882|P3|Overall Study|Patient pregnant|0
1395536|NCT01261793|4605883|P2|Overall Study|Patient pregnant|0
1395537|NCT01261793|4605884|P1|Overall Study|Patient pregnant|1
1395538|NCT01261793|4605882|P3|Overall Study|Patient non-compliance|1
1395539|NCT01261793|4605883|P2|Overall Study|Patient non-compliance|0
1395540|NCT01261793|4605884|P1|Overall Study|Patient non-compliance|1
1395541|NCT01261793|4605882|P3|Overall Study|Suspected pregnancy|0
1395542|NCT01261793|4605883|P2|Overall Study|Suspected pregnancy|1
1395543|NCT01261793|4605884|P1|Overall Study|Suspected pregnancy|1
1395544|NCT01261793|4605882|P3|Overall Study|Patient non-availability|1
1395545|NCT01261793|4605883|P2|Overall Study|Patient non-availability|1
1395546|NCT01261793|4605884|P1|Overall Study|Patient non-availability|1
1395547|NCT01261793|4605882|P3|Overall Study|Adverse Event|19
1395548|NCT01261793|4605883|P2|Overall Study|Adverse Event|24
1395549|NCT01261793|4605884|P1|Overall Study|Adverse Event|9
1395550|NCT01261793|4605882|P3|Overall Study|Death|0
1395551|NCT01261793|4605883|P2|Overall Study|Death|1
1395552|NCT01261793|4605884|P1|Overall Study|Death|3
1395553|NCT01261793|4605882|P3|Overall Study|Withdrawal by Subject|14
1395554|NCT01261793|4605883|P2|Overall Study|Withdrawal by Subject|14
1395555|NCT01261793|4605884|P1|Overall Study|Withdrawal by Subject|12
1395556|NCT01261793|4605882|P3|Overall Study|Lost to Follow-up|7
1395557|NCT01261793|4605883|P2|Overall Study|Lost to Follow-up|3
1395558|NCT01261793|4605884|P1|Overall Study|Lost to Follow-up|10
1395559|NCT01261793|4605882|P3|Overall Study|Protocol Violation|6
1395560|NCT01261793|4605883|P2|Overall Study|Protocol Violation|5
1395561|NCT01261793|4605884|P1|Overall Study|Protocol Violation|3
1395562|NCT01261793|4605882|P3|Overall Study|Lack of Efficacy|32
1395563|NCT01261793|4605883|P2|Overall Study|Lack of Efficacy|37
1395564|NCT01261793|4605884|P1|Overall Study|Lack of Efficacy|44
1395565|NCT01261780|4605909|P2|Overall Study|Event not related to subject|2
1395566|NCT01261780|4605910|P1|Overall Study|Event not related to subject|1
1395567|NCT01261780|4605909|P2|Overall Study|Withdrawal by Subject|0
1395568|NCT01261780|4605910|P1|Overall Study|Withdrawal by Subject|1
1395569|NCT01261624|4605920|P2|Week 13 to Week 24|Insufficient Response|1
1395570|NCT01261624|4605921|P1|Week 13 to Week 24|Insufficient Response|0
1395571|NCT01261624|4605920|P2|Week 0 to Week 12|Insufficient Response|2
1395572|NCT01261624|4605921|P1|Week 0 to Week 12|Insufficient Response|0
1395573|NCT01261624|4605920|P2|Week 0 to Week 12|Disease Progression|1
1395574|NCT01261624|4605921|P1|Week 0 to Week 12|Disease Progression|1
1395575|NCT01261390|4605966|P4|Overall Study|Lost to Follow-up|6
1395576|NCT01261390|4605967|P3|Overall Study|Lost to Follow-up|5
1395577|NCT01261390|4605968|P2|Overall Study|Lost to Follow-up|6
1395578|NCT01261390|4605969|P1|Overall Study|Lost to Follow-up|1
1395579|NCT01261390|4605966|P4|Overall Study|Loss of Interest in the Study|0
1395580|NCT01261390|4605967|P3|Overall Study|Loss of Interest in the Study|0
1395581|NCT01261390|4605968|P2|Overall Study|Loss of Interest in the Study|1
1395582|NCT01261390|4605969|P1|Overall Study|Loss of Interest in the Study|3
1395583|NCT01261390|4605966|P4|Overall Study|Relocation|0
1395584|NCT01261390|4605967|P3|Overall Study|Relocation|0
1395585|NCT01261390|4605968|P2|Overall Study|Relocation|1
1395586|NCT01261390|4605969|P1|Overall Study|Relocation|0
1395587|NCT01261390|4605966|P4|Overall Study|Dissatisfaction with Treatment|2
1395588|NCT01261390|4605967|P3|Overall Study|Dissatisfaction with Treatment|1
1395589|NCT01261390|4605968|P2|Overall Study|Dissatisfaction with Treatment|1
1395590|NCT01261390|4605969|P1|Overall Study|Dissatisfaction with Treatment|2
1395591|NCT01261390|4605966|P4|Overall Study|Significant Concurrent Illness|0
1395592|NCT01261390|4605967|P3|Overall Study|Significant Concurrent Illness|1
1395593|NCT01261390|4605968|P2|Overall Study|Significant Concurrent Illness|0
1395594|NCT01261390|4605969|P1|Overall Study|Significant Concurrent Illness|1
1395595|NCT01261325|4606134|P3|Overall Study|AE, serious fatal|2
1395596|NCT01261325|4606135|P2|Overall Study|AE, serious fatal|0
1395597|NCT01261325|4606136|P1|Overall Study|AE, serious fatal|0
1395598|NCT01261325|4606134|P3|Overall Study|Lost to Follow-up|3
1395599|NCT01261325|4606135|P2|Overall Study|Lost to Follow-up|1
1395600|NCT01261325|4606136|P1|Overall Study|Lost to Follow-up|0
1395601|NCT01261325|4606134|P3|Overall Study|Protocol Violation|1
1395602|NCT01261325|4606135|P2|Overall Study|Protocol Violation|3
1395603|NCT01261325|4606136|P1|Overall Study|Protocol Violation|0
1395604|NCT01261325|4606134|P3|Overall Study|Randomized in Error|1
1395605|NCT01261325|4606135|P2|Overall Study|Randomized in Error|0
1395606|NCT01261325|4606136|P1|Overall Study|Randomized in Error|0
1395607|NCT01261325|4606134|P3|Overall Study|Screen Failure|0
1395608|NCT01261325|4606135|P2|Overall Study|Screen Failure|0
1395609|NCT01261325|4606136|P1|Overall Study|Screen Failure|1
1395610|NCT01261325|4606134|P3|Overall Study|Erroneously Randomized|0
1395611|NCT01261325|4606135|P2|Overall Study|Erroneously Randomized|0
1395612|NCT01261325|4606136|P1|Overall Study|Erroneously Randomized|1
1395613|NCT01261325|4606134|P3|Overall Study|Patient Randomized by Mistake|0
1395614|NCT01261325|4606135|P2|Overall Study|Patient Randomized by Mistake|1
1395615|NCT01261325|4606136|P1|Overall Study|Patient Randomized by Mistake|0
1395616|NCT01261325|4606134|P3|Overall Study|Non Compliance|0
1395617|NCT01261325|4606135|P2|Overall Study|Non Compliance|0
1395618|NCT01261325|4606136|P1|Overall Study|Non Compliance|2
1395619|NCT01261325|4606134|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1395620|NCT01261325|4606135|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1395621|NCT01261325|4606136|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
1395622|NCT01261325|4606134|P3|Overall Study|AE, non-serious non-fatal|13
1395623|NCT01261325|4606135|P2|Overall Study|AE, non-serious non-fatal|15
1395624|NCT01261325|4606136|P1|Overall Study|AE, non-serious non-fatal|9
1395625|NCT01261325|4606134|P3|Overall Study|SAE, non-fatal|1
1395626|NCT01261325|4606135|P2|Overall Study|SAE, non-fatal|5
1395627|NCT01261325|4606136|P1|Overall Study|SAE, non-fatal|1
1395628|NCT01261325|4606134|P3|Overall Study|Withdrawal by Subject|4
1395629|NCT01261325|4606135|P2|Overall Study|Withdrawal by Subject|2
1395630|NCT01261325|4606136|P1|Overall Study|Withdrawal by Subject|2
1395631|NCT01261325|4606134|P3|Overall Study|Lack of Efficacy|0
1395632|NCT01261325|4606135|P2|Overall Study|Lack of Efficacy|1
1395633|NCT01261325|4606136|P1|Overall Study|Lack of Efficacy|1
1395634|NCT01261247|4606168|P1|Overall Study|Ineligible|2
1395635|NCT01261000|4606181|P1|Overall Study|Screen failure|1
1395636|NCT01260948|4606187|P2|Second Intervention|Emesis|1
1395637|NCT01260948|4606188|P1|Second Intervention|Emesis|0
1395638|NCT01260948|4606187|P2|Washout of 28 Days|Withdrawal by Subject|3
1395639|NCT01260948|4606188|P1|Washout of 28 Days|Withdrawal by Subject|1
1395640|NCT01260922|4606198|P2|Second Intervention|Emesis|2
1395641|NCT01260922|4606199|P1|Second Intervention|Emesis|0
1395642|NCT01260922|4606198|P2|Washout of 28 Days|Withdrawal by Subject|2
1395643|NCT01260922|4606199|P1|Washout of 28 Days|Withdrawal by Subject|4
1395644|NCT01260922|4606198|P2|First Intervention|Withdrawal by Subject|1
1395645|NCT01260922|4606199|P1|First Intervention|Withdrawal by Subject|0
1395646|NCT01260896|4606209|P2|First Intervention|Withdrawn Due to Emesis|0
1395647|NCT01260896|4606210|P1|First Intervention|Withdrawn Due to Emesis|2
1395648|NCT01260701|4606268|P1|Overall Study|Did not begin protocol therapy|1
1395649|NCT01260701|4606268|P1|Overall Study|Ineligible|4
1395650|NCT01260701|4606268|P1|Overall Study|Under review|1
1395651|NCT01260701|4606268|P1|Overall Study|Not protocol specified|3
1395652|NCT01260701|4606268|P1|Overall Study|Death|2
1395653|NCT01260701|4606268|P1|Overall Study|Progression|53
1395654|NCT01260701|4606268|P1|Overall Study|Withdrawal by Subject|2
1395655|NCT01260701|4606268|P1|Overall Study|Adverse Event|9
1395656|NCT01260584|4606349|P4|Period 2|Withdrawal by Subject|0
1395657|NCT01260584|4606350|P3|Period 2|Withdrawal by Subject|0
1395658|NCT01260584|4606351|P2|Period 2|Withdrawal by Subject|1
1395659|NCT01260584|4606352|P1|Period 2|Withdrawal by Subject|0
1395660|NCT01260584|4606349|P4|Period 2|Adverse Event|0
1395661|NCT01260584|4606350|P3|Period 2|Adverse Event|2
1395662|NCT01260584|4606351|P2|Period 2|Adverse Event|0
1395663|NCT01260584|4606352|P1|Period 2|Adverse Event|1
1395664|NCT01260584|4606349|P4|Period 2|Protocol Violation|1
1395665|NCT01260584|4606350|P3|Period 2|Protocol Violation|3
1395666|NCT01260584|4606351|P2|Period 2|Protocol Violation|2
1395667|NCT01260584|4606352|P1|Period 2|Protocol Violation|0
1395668|NCT01260584|4606349|P4|Period 1|Adverse Event|0
1395669|NCT01260584|4606350|P3|Period 1|Adverse Event|1
1395670|NCT01260584|4606351|P2|Period 1|Adverse Event|0
1395671|NCT01260584|4606352|P1|Period 1|Adverse Event|0
1395672|NCT01260584|4606349|P4|Period 1|Protocol Violation|1
1395673|NCT01260584|4606350|P3|Period 1|Protocol Violation|1
1395674|NCT01260584|4606351|P2|Period 1|Protocol Violation|0
1395675|NCT01260584|4606352|P1|Period 1|Protocol Violation|0
1395676|NCT01260467|4606395|P1|Overall Study|Withdrawal by Subject|2
1395677|NCT01260350|4606427|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395678|NCT01260350|4606428|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395679|NCT01260350|4606429|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395680|NCT01260350|4606430|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395681|NCT01260350|4606431|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395682|NCT01260350|4606432|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395683|NCT01260350|4606433|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395684|NCT01260350|4606434|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395685|NCT01260350|4606435|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395686|NCT01260350|4606436|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395687|NCT01260350|4606437|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395688|NCT01260350|4606438|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395689|NCT01260350|4606439|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395690|NCT01260350|4606440|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
1395691|NCT01260350|4606441|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395692|NCT01260350|4606442|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395693|NCT01260350|4606443|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395694|NCT01260350|4606444|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395695|NCT01260350|4606445|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395696|NCT01260350|4606446|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395697|NCT01260350|4606447|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395698|NCT01260350|4606448|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
1395699|NCT01260350|4606427|P22|Overall Study|Lack of Efficacy|0
1395700|NCT01260350|4606428|P21|Overall Study|Lack of Efficacy|3
1395701|NCT01260350|4606429|P20|Overall Study|Lack of Efficacy|0
1395702|NCT01260350|4606430|P19|Overall Study|Lack of Efficacy|0
1395703|NCT01260350|4606431|P18|Overall Study|Lack of Efficacy|1
1395704|NCT01260350|4606432|P17|Overall Study|Lack of Efficacy|0
1395705|NCT01260350|4606433|P16|Overall Study|Lack of Efficacy|0
1395706|NCT01260350|4606434|P15|Overall Study|Lack of Efficacy|0
1395707|NCT01260350|4606435|P14|Overall Study|Lack of Efficacy|0
1395708|NCT01260350|4606436|P13|Overall Study|Lack of Efficacy|0
1395709|NCT01260350|4606437|P12|Overall Study|Lack of Efficacy|0
1395710|NCT01260350|4606438|P11|Overall Study|Lack of Efficacy|0
1395711|NCT01260350|4606439|P10|Overall Study|Lack of Efficacy|0
1395712|NCT01260350|4606440|P9|Overall Study|Lack of Efficacy|0
1395713|NCT01260350|4606441|P8|Overall Study|Lack of Efficacy|0
1395714|NCT01260350|4606442|P7|Overall Study|Lack of Efficacy|0
1395715|NCT01260350|4606443|P6|Overall Study|Lack of Efficacy|0
1395716|NCT01260350|4606444|P5|Overall Study|Lack of Efficacy|0
1395717|NCT01260350|4606445|P4|Overall Study|Lack of Efficacy|0
1395718|NCT01260350|4606446|P3|Overall Study|Lack of Efficacy|0
1395719|NCT01260350|4606447|P2|Overall Study|Lack of Efficacy|0
1395720|NCT01260350|4606448|P1|Overall Study|Lack of Efficacy|0
1395721|NCT01260311|4606655|P1|Overall Study|Fesoterodine Started Before Enrollment|1
1395722|NCT01260311|4606655|P1|Overall Study|Medication Stopped|1
1395723|NCT01260311|4606655|P1|Overall Study|Gone to Province|2
1395724|NCT01260311|4606655|P1|Overall Study|Financial Constraints|77
1395725|NCT01260311|4606655|P1|Overall Study|Withdrawal by Subject|6
1395726|NCT01260311|4606655|P1|Overall Study|Lost to Follow-up|25
1395727|NCT01260311|4606655|P1|Overall Study|Lack of Efficacy|4
1395728|NCT01260311|4606655|P1|Overall Study|Adverse Event|11
1395729|NCT01260194|4606686|P1|Overall Study|Withdrawal of Consent|1
1395730|NCT01260142|4606704|P6|Treatment Period 1|Withdrawal by Subject|1
1395731|NCT01260142|4606705|P5|Treatment Period 1|Withdrawal by Subject|0
1395732|NCT01260142|4606706|P4|Treatment Period 1|Withdrawal by Subject|0
1395733|NCT01260142|4606707|P3|Treatment Period 1|Withdrawal by Subject|0
1395734|NCT01260142|4606708|P2|Treatment Period 1|Withdrawal by Subject|0
1395735|NCT01260142|4606709|P1|Treatment Period 1|Withdrawal by Subject|0
1395736|NCT01260142|4606704|P6|Treatment Period 1|Unexplained elevated sys. BP|0
1395737|NCT01260142|4606705|P5|Treatment Period 1|Unexplained elevated sys. BP|1
1395738|NCT01260142|4606706|P4|Treatment Period 1|Unexplained elevated sys. BP|0
1395739|NCT01260142|4606707|P3|Treatment Period 1|Unexplained elevated sys. BP|0
1395740|NCT01260142|4606708|P2|Treatment Period 1|Unexplained elevated sys. BP|0
1395741|NCT01260142|4606709|P1|Treatment Period 1|Unexplained elevated sys. BP|0
1395742|NCT01260142|4606704|P6|Treatment Period 1|Study on hold|2
1395743|NCT01260142|4606705|P5|Treatment Period 1|Study on hold|1
1395744|NCT01260142|4606706|P4|Treatment Period 1|Study on hold|0
1395745|NCT01260142|4606707|P3|Treatment Period 1|Study on hold|0
1395746|NCT01260142|4606708|P2|Treatment Period 1|Study on hold|1
1395747|NCT01260142|4606709|P1|Treatment Period 1|Study on hold|1
1395748|NCT01259856|4606761|P2|Overall Study|Unknown/missing|2
1395749|NCT01259856|4606762|P1|Overall Study|Unknown/missing|2
1395750|NCT01259856|4606761|P2|Overall Study|Transfer to another study|1
1395751|NCT01259856|4606762|P1|Overall Study|Transfer to another study|0
1395752|NCT01259856|4606761|P2|Overall Study|Patient developed other disease|1
1395753|NCT01259856|4606762|P1|Overall Study|Patient developed other disease|0
1395754|NCT01259856|4606761|P2|Overall Study|Study closure by sponsor|41
1395755|NCT01259856|4606762|P1|Overall Study|Study closure by sponsor|40
1395756|NCT01259856|4606761|P2|Overall Study|Treatment never started|6
1395757|NCT01259856|4606762|P1|Overall Study|Treatment never started|0
1395758|NCT01259856|4606761|P2|Overall Study|Withdrawal by Subject|10
1395759|NCT01259856|4606762|P1|Overall Study|Withdrawal by Subject|9
1395760|NCT01259856|4606761|P2|Overall Study|Physician Decision|1
1395761|NCT01259856|4606762|P1|Overall Study|Physician Decision|2
1395762|NCT01259856|4606761|P2|Overall Study|Lost to Follow-up|1
1395763|NCT01259856|4606762|P1|Overall Study|Lost to Follow-up|1
1395764|NCT01259856|4606761|P2|Overall Study|Lack of Efficacy|1
1395765|NCT01259856|4606762|P1|Overall Study|Lack of Efficacy|3
1395766|NCT01259856|4606761|P2|Overall Study|Death|1
1395767|NCT01259856|4606762|P1|Overall Study|Death|0
1395768|NCT01259856|4606761|P2|Overall Study|Adverse Event|9
1395769|NCT01259856|4606762|P1|Overall Study|Adverse Event|12
1395770|NCT01259726|4606786|P4|Overall Study|Lost to Follow-up|3
1395771|NCT01259726|4606787|P3|Overall Study|Lost to Follow-up|1
1395772|NCT01259726|4606788|P2|Overall Study|Lost to Follow-up|1
1395773|NCT01259726|4606789|P1|Overall Study|Lost to Follow-up|1
1395774|NCT01259726|4606786|P4|Overall Study|Withdrawal by Subject|1
1395775|NCT01259726|4606787|P3|Overall Study|Withdrawal by Subject|2
1395776|NCT01259726|4606788|P2|Overall Study|Withdrawal by Subject|3
1395777|NCT01259726|4606789|P1|Overall Study|Withdrawal by Subject|1
1395778|NCT01259726|4606786|P4|Overall Study|Physician Decision|1
1395779|NCT01259726|4606787|P3|Overall Study|Physician Decision|1
1395780|NCT01259726|4606788|P2|Overall Study|Physician Decision|0
1395781|NCT01259726|4606789|P1|Overall Study|Physician Decision|2
1395782|NCT01259726|4606786|P4|Overall Study|Death|0
1395783|NCT01259726|4606787|P3|Overall Study|Death|0
1395784|NCT01259726|4606788|P2|Overall Study|Death|0
1395785|NCT01259726|4606789|P1|Overall Study|Death|1
1395786|NCT01259713|4606821|P2|Overall Study|Subject Withdrew Consent|7
1395787|NCT01259713|4606822|P1|Overall Study|Subject Withdrew Consent|12
1395788|NCT01259713|4606821|P2|Overall Study|Protocol Violation|4
1395789|NCT01259713|4606822|P1|Overall Study|Protocol Violation|5
1395790|NCT01259713|4606821|P2|Overall Study|Lack of Efficacy|0
1395791|NCT01259713|4606822|P1|Overall Study|Lack of Efficacy|2
1395792|NCT01259713|4606821|P2|Overall Study|Investigators Discretion|6
1395793|NCT01259713|4606822|P1|Overall Study|Investigators Discretion|14
1395794|NCT01259713|4606821|P2|Overall Study|Death Not Related to IFI|1
1395795|NCT01259713|4606822|P1|Overall Study|Death Not Related to IFI|8
1395796|NCT01259713|4606821|P2|Overall Study|Adverse Event|23
1395797|NCT01259713|4606822|P1|Overall Study|Adverse Event|54
1395798|NCT01259492|4606869|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
1395799|NCT01259492|4606870|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
1395800|NCT01259492|4606871|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
1395801|NCT01259492|4606872|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
1395802|NCT01259492|4606869|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
1395803|NCT01259492|4606870|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
1395804|NCT01259492|4606871|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
1395805|NCT01259492|4606872|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
1395806|NCT01259492|4606869|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
1395807|NCT01259492|4606870|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
1395808|NCT01259492|4606871|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
1395809|NCT01259492|4606872|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
1395810|NCT01259492|4606869|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
1395811|NCT01259492|4606870|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
1395812|NCT01259492|4606871|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
1395813|NCT01259492|4606872|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
1395814|NCT01259492|4606869|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
1395815|NCT01259492|4606870|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
1395816|NCT01259492|4606871|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
1395817|NCT01259492|4606872|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
1395818|NCT01259492|4606869|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
1395819|NCT01259492|4606870|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
1395820|NCT01259492|4606871|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
1395821|NCT01259492|4606872|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
1395822|NCT01259492|4606869|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
1395823|NCT01259492|4606870|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
1395824|NCT01259492|4606871|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
1395825|NCT01259492|4606872|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
1395826|NCT01259492|4606869|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
1395827|NCT01259492|4606870|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
1395828|NCT01259492|4606871|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
1395829|NCT01259492|4606872|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
1395830|NCT01259492|4606869|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
1395831|NCT01259492|4606870|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
1395832|NCT01259492|4606871|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
1395833|NCT01259492|4606872|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
1395834|NCT01259492|4606869|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
1395835|NCT01259492|4606870|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
1395836|NCT01259492|4606871|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
1395837|NCT01259492|4606872|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
1395838|NCT01259492|4606869|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
1395839|NCT01259492|4606870|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
1395840|NCT01259492|4606871|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
1395841|NCT01259492|4606872|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
1395842|NCT01259492|4606869|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
1395843|NCT01259492|4606870|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
1395844|NCT01259492|4606871|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
1395845|NCT01259492|4606872|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
1395846|NCT01259492|4606869|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
1395847|NCT01259492|4606870|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
1395848|NCT01259492|4606871|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
1395849|NCT01259492|4606872|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
1395850|NCT01259492|4606869|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
1395851|NCT01259492|4606870|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
1395852|NCT01259492|4606871|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
1395853|NCT01259492|4606872|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
1395854|NCT01259492|4606869|P4|Period 1 (9 Weeks)|Protocol Violation|1
1395855|NCT01259492|4606870|P3|Period 1 (9 Weeks)|Protocol Violation|3
1395856|NCT01259492|4606871|P2|Period 1 (9 Weeks)|Protocol Violation|6
1395857|NCT01259492|4606872|P1|Period 1 (9 Weeks)|Protocol Violation|5
1395858|NCT01259492|4606869|P4|Period 1 (9 Weeks)|Administrative Problems|2
1395859|NCT01259492|4606870|P3|Period 1 (9 Weeks)|Administrative Problems|1
1395860|NCT01259492|4606871|P2|Period 1 (9 Weeks)|Administrative Problems|1
1395861|NCT01259492|4606872|P1|Period 1 (9 Weeks)|Administrative Problems|0
1395862|NCT01259492|4606869|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
1395863|NCT01259492|4606870|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
1395864|NCT01259492|4606871|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
1395865|NCT01259492|4606872|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
1395866|NCT01259492|4606869|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
1395867|NCT01259492|4606870|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
1395868|NCT01259492|4606871|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
1395869|NCT01259492|4606872|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
1395870|NCT01259492|4606869|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
1395871|NCT01259492|4606870|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
1395872|NCT01259492|4606871|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
1395873|NCT01259492|4606872|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
1395874|NCT01259492|4606869|P4|Period 1 (9 Weeks)|Adverse Event|3
1395875|NCT01259492|4606870|P3|Period 1 (9 Weeks)|Adverse Event|26
1395876|NCT01259492|4606871|P2|Period 1 (9 Weeks)|Adverse Event|18
1395877|NCT01259492|4606872|P1|Period 1 (9 Weeks)|Adverse Event|13
1395878|NCT01259466|4606921|P2|Overall Study|Withdrawal by Subject|9
1395879|NCT01259466|4606922|P1|Overall Study|Withdrawal by Subject|1
1395880|NCT01259401|4606960|P2|4-month Follow-up|Lost to Follow-up|1
1395881|NCT01259401|4606961|P1|4-month Follow-up|Lost to Follow-up|0
1395882|NCT01259401|4606960|P2|4-month Follow-up|Death|1
1395883|NCT01259401|4606961|P1|4-month Follow-up|Death|0
1395884|NCT01259375|4606969|P1|Overall Study|Adverse Event|1
1395885|NCT01259297|4606986|P8|Double Blind Randomized Period|Other reasons|1
1395886|NCT01259297|4606987|P7|Double Blind Randomized Period|Other reasons|3
1395887|NCT01259297|4606988|P6|Double Blind Randomized Period|Other reasons|2
1395888|NCT01259297|4606989|P5|Double Blind Randomized Period|Other reasons|1
1395889|NCT01259297|4606990|P4|Double Blind Randomized Period|Other reasons|0
1395890|NCT01259297|4606991|P3|Double Blind Randomized Period|Other reasons|0
1395891|NCT01259297|4606992|P2|Double Blind Randomized Period|Other reasons|1
1395892|NCT01259297|4606993|P1|Double Blind Randomized Period|Other reasons|0
1395893|NCT01259297|4606986|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
1395894|NCT01259297|4606987|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
1395895|NCT01259297|4606988|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
1395896|NCT01259297|4606989|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
1395897|NCT01259297|4606990|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
1395898|NCT01259297|4606991|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
1395899|NCT01259297|4606992|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
1395900|NCT01259297|4606993|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
1395901|NCT01259297|4606986|P8|Double Blind Randomized Period|Death|1
1395902|NCT01259297|4606987|P7|Double Blind Randomized Period|Death|2
1395903|NCT01259297|4606988|P6|Double Blind Randomized Period|Death|5
1395904|NCT01259297|4606989|P5|Double Blind Randomized Period|Death|1
1395905|NCT01259297|4606990|P4|Double Blind Randomized Period|Death|2
1395906|NCT01259297|4606991|P3|Double Blind Randomized Period|Death|1
1395907|NCT01259297|4606992|P2|Double Blind Randomized Period|Death|1
1395908|NCT01259297|4606993|P1|Double Blind Randomized Period|Death|1
1395909|NCT01259284|4607024|P3|Overall Study|Study Termination|0
1395910|NCT01259284|4607025|P2|Overall Study|Study Termination|0
1395911|NCT01259284|4607026|P1|Overall Study|Study Termination|2
1395912|NCT01259245|4607036|P2|Overall Study|Death|2
1395913|NCT01259245|4607037|P1|Overall Study|Death|1
1395914|NCT01259245|4607036|P2|Overall Study|Withdrawal by Subject|24
1395915|NCT01259245|4607037|P1|Overall Study|Withdrawal by Subject|27
1395916|NCT01259115|4607061|P2|Period 2|Adverse Event|0
1395917|NCT01259115|4607062|P1|Period 2|Adverse Event|1
1395918|NCT01259115|4607061|P2|Period 1|Lost to Follow-up|1
1395919|NCT01259115|4607062|P1|Period 1|Lost to Follow-up|0
1395920|NCT01259115|4607061|P2|Period 1|Protocol Violation|0
1395921|NCT01259115|4607062|P1|Period 1|Protocol Violation|2
1395922|NCT01259115|4607061|P2|Period 1|Adverse Event|0
1395923|NCT01259115|4607062|P1|Period 1|Adverse Event|1
1395924|NCT01259102|4607098|P5|Overall Study|Other|1
1395925|NCT01259102|4607099|P4|Overall Study|Other|1
1395926|NCT01259102|4607100|P3|Overall Study|Other|1
1395927|NCT01259102|4607101|P2|Overall Study|Other|0
1395928|NCT01259102|4607102|P1|Overall Study|Other|0
1395929|NCT01259102|4607098|P5|Overall Study|Adverse Event|0
1395930|NCT01259102|4607099|P4|Overall Study|Adverse Event|1
1395931|NCT01259102|4607100|P3|Overall Study|Adverse Event|1
1395932|NCT01259102|4607101|P2|Overall Study|Adverse Event|0
1395933|NCT01259102|4607102|P1|Overall Study|Adverse Event|1
1395934|NCT01259024|4607168|P1|Overall Study|Physician Decision|1
1395935|NCT01258998|4607188|P1|Overall Study|Ineligible|1
1395936|NCT01258803|4607221|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
1395937|NCT01258803|4607222|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
1395938|NCT01258803|4607223|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
1395939|NCT01258803|4607224|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
1395940|NCT01258803|4607225|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
1395941|NCT01258803|4607226|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
1395942|NCT01258803|4607221|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1395943|NCT01258803|4607222|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1395944|NCT01258803|4607223|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1395945|NCT01258803|4607224|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1395946|NCT01258803|4607225|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
1395947|NCT01258803|4607226|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1395948|NCT01258803|4607221|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
1395949|NCT01258803|4607222|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
1395950|NCT01258803|4607223|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
1395951|NCT01258803|4607224|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
1395952|NCT01258803|4607225|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
1395953|NCT01258803|4607226|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
1395954|NCT01258738|4607263|P2|Open-label Period|Withdrawn due to pregnancy|1
1395955|NCT01258738|4607264|P1|Open-label Period|Withdrawn due to pregnancy|1
1395956|NCT01258738|4607263|P2|Open-label Period|Other Reasons|1
1395957|NCT01258738|4607264|P1|Open-label Period|Other Reasons|0
1395958|NCT01258738|4607263|P2|Open-label Period|Adverse Event|5
1395959|NCT01258738|4607264|P1|Open-label Period|Adverse Event|4
1395960|NCT01258738|4607263|P2|Open-label Period|Protocol Violation|2
1395961|NCT01258738|4607264|P1|Open-label Period|Protocol Violation|2
1395962|NCT01258738|4607263|P2|Open-label Period|Withdrawal by Subject|6
1395963|NCT01258738|4607264|P1|Open-label Period|Withdrawal by Subject|5
1395964|NCT01258738|4607263|P2|Open-label Period|Lost to Follow-up|2
1395965|NCT01258738|4607264|P1|Open-label Period|Lost to Follow-up|0
1395966|NCT01258738|4607263|P2|Open-label Period|Insufficient clinical response|3
1395967|NCT01258738|4607264|P1|Open-label Period|Insufficient clinical response|5
1395968|NCT01258738|4607263|P2|Open-label Period|Did not meet inclusion criteria|1
1395969|NCT01258738|4607264|P1|Open-label Period|Did not meet inclusion criteria|0
1395970|NCT01258738|4607263|P2|Double-blind Period|Adverse Event|1
1395971|NCT01258738|4607264|P1|Double-blind Period|Adverse Event|3
1395972|NCT01258738|4607263|P2|Double-blind Period|Protocol Violation|1
1395973|NCT01258738|4607264|P1|Double-blind Period|Protocol Violation|1
1395974|NCT01258738|4607263|P2|Double-blind Period|Withdrawal by Subject|2
1395975|NCT01258738|4607264|P1|Double-blind Period|Withdrawal by Subject|2
1395976|NCT01258738|4607263|P2|Double-blind Period|Did not meet inclusion criteria|3
1395977|NCT01258738|4607264|P1|Double-blind Period|Did not meet inclusion criteria|3
1395978|NCT01258660|4607402|P2|Overall Study|Invalid for primary analysis data set|6
1395979|NCT01258660|4607403|P1|Overall Study|Invalid for primary analysis data set|4
1395980|NCT01258660|4607402|P2|Overall Study|Protocol Violation|1
1395981|NCT01258660|4607403|P1|Overall Study|Protocol Violation|0
1395982|NCT01258660|4607402|P2|Overall Study|due to relocation|0
1395983|NCT01258660|4607403|P1|Overall Study|due to relocation|2
1395984|NCT01258660|4607402|P2|Overall Study|Withdrawal by Subject|0
1395985|NCT01258660|4607403|P1|Overall Study|Withdrawal by Subject|3
1395986|NCT01258660|4607402|P2|Overall Study|Adverse Event|4
1395987|NCT01258660|4607403|P1|Overall Study|Adverse Event|2
1395988|NCT01258595|4607422|P2|Overall Study|Withdrawal by Subject|1
1395989|NCT01258595|4607423|P1|Overall Study|Withdrawal by Subject|0
1395990|NCT01258595|4607422|P2|Overall Study|Lost to Follow-up|0
1395991|NCT01258595|4607423|P1|Overall Study|Lost to Follow-up|1
1395992|NCT01258101|4607545|P4|Overall Study|Other reason|8
1395993|NCT01258101|4607546|P3|Overall Study|Other reason|1
1395994|NCT01258101|4607547|P2|Overall Study|Other reason|8
1395995|NCT01258101|4607548|P1|Overall Study|Other reason|7
1395996|NCT01258101|4607545|P4|Overall Study|PCR positive at week 24|1
1395997|NCT01258101|4607546|P3|Overall Study|PCR positive at week 24|0
1395998|NCT01258101|4607547|P2|Overall Study|PCR positive at week 24|0
1395999|NCT01258101|4607548|P1|Overall Study|PCR positive at week 24|0
1396000|NCT01258101|4607545|P4|Overall Study|Lost to Follow-up|6
1396001|NCT01258101|4607546|P3|Overall Study|Lost to Follow-up|0
1396002|NCT01258101|4607547|P2|Overall Study|Lost to Follow-up|5
1396003|NCT01258101|4607548|P1|Overall Study|Lost to Follow-up|5
1396004|NCT01258101|4607545|P4|Overall Study|Patient´s compliance|2
1396005|NCT01258101|4607546|P3|Overall Study|Patient´s compliance|1
1396006|NCT01258101|4607547|P2|Overall Study|Patient´s compliance|3
1396007|NCT01258101|4607548|P1|Overall Study|Patient´s compliance|4
1396008|NCT01258101|4607545|P4|Overall Study|Patient is not able to attend visits|6
1396009|NCT01258101|4607546|P3|Overall Study|Patient is not able to attend visits|7
1396010|NCT01258101|4607547|P2|Overall Study|Patient is not able to attend visits|9
1396011|NCT01258101|4607548|P1|Overall Study|Patient is not able to attend visits|8
1396012|NCT01258101|4607545|P4|Overall Study|Informed consent has been withdrawn|1
1396013|NCT01258101|4607546|P3|Overall Study|Informed consent has been withdrawn|1
1396014|NCT01258101|4607547|P2|Overall Study|Informed consent has been withdrawn|2
1396015|NCT01258101|4607548|P1|Overall Study|Informed consent has been withdrawn|2
1396016|NCT01258101|4607545|P4|Overall Study|Extra exclusion criterion amended|1
1396017|NCT01258101|4607546|P3|Overall Study|Extra exclusion criterion amended|1
1396018|NCT01258101|4607547|P2|Overall Study|Extra exclusion criterion amended|1
1396019|NCT01258101|4607548|P1|Overall Study|Extra exclusion criterion amended|2
1396020|NCT01258101|4607545|P4|Overall Study|Adverse Event|0
1396021|NCT01258101|4607546|P3|Overall Study|Adverse Event|0
1396022|NCT01258101|4607547|P2|Overall Study|Adverse Event|6
1396023|NCT01258101|4607548|P1|Overall Study|Adverse Event|5
1396024|NCT01257737|4607678|P2|Overall Study|Withdrew from study|1
1396025|NCT01257737|4607679|P1|Overall Study|Withdrew from study|0
1396026|NCT01257737|4607678|P2|Overall Study|Relocation out of the country|1
1396027|NCT01257737|4607679|P1|Overall Study|Relocation out of the country|0
1396028|NCT01257737|4607678|P2|Overall Study|Liver transplant|0
1396029|NCT01257737|4607679|P1|Overall Study|Liver transplant|1
1396030|NCT01257737|4607678|P2|Overall Study|Lost to Follow-up|2
1396031|NCT01257737|4607679|P1|Overall Study|Lost to Follow-up|1
1396032|NCT01257581|4607700|P3|Overall Study|Death|4
1396033|NCT01257581|4607701|P2|Overall Study|Death|2
1396034|NCT01257581|4607702|P1|Overall Study|Death|2
1396035|NCT01257581|4607700|P3|Overall Study|Early Termination|2
1396036|NCT01257581|4607701|P2|Overall Study|Early Termination|1
1396037|NCT01257581|4607702|P1|Overall Study|Early Termination|3
1396038|NCT01257542|4607742|P2|Overall Study|Withdrawal by Subject|2
1396039|NCT01257542|4607743|P1|Overall Study|Withdrawal by Subject|0
1396040|NCT01257542|4607742|P2|Overall Study|Protocol Violation|5
1396041|NCT01257542|4607743|P1|Overall Study|Protocol Violation|3
1396042|NCT01257503|4607763|P2|Overall Study|strep culture positive at enrollment|0
1396043|NCT01257503|4607764|P1|Overall Study|strep culture positive at enrollment|1
1396044|NCT01257503|4607763|P2|Overall Study|Over 5 years old at enrollment|1
1396045|NCT01257503|4607764|P1|Overall Study|Over 5 years old at enrollment|0
1396046|NCT01257503|4607763|P2|Overall Study|Lost to Follow-up|10
1396047|NCT01257503|4607764|P1|Overall Study|Lost to Follow-up|7
1396048|NCT01257425|4607793|P2|Overall Study|Death|0
1396049|NCT01257425|4607794|P1|Overall Study|Death|1
1396050|NCT01257425|4607793|P2|Overall Study|Withdrawal by Subject|1
1396051|NCT01257425|4607794|P1|Overall Study|Withdrawal by Subject|0
1396052|NCT01257425|4607793|P2|Overall Study|Protocol Violation|1
1396053|NCT01257425|4607794|P1|Overall Study|Protocol Violation|1
1396054|NCT01257425|4607793|P2|Overall Study|Adverse Event|1
1396055|NCT01257425|4607794|P1|Overall Study|Adverse Event|1
1396056|NCT01257425|4607793|P2|Overall Study|Lack of Efficacy|3
1396057|NCT01257425|4607794|P1|Overall Study|Lack of Efficacy|3
1396058|NCT01257230|4607836|P3|Overall Study|Other reason not defined above|3
1396059|NCT01257230|4607837|P2|Overall Study|Other reason not defined above|5
1396060|NCT01257230|4607838|P1|Overall Study|Other reason not defined above|1
1396061|NCT01257230|4607836|P3|Overall Study|Withdrawal by Subject|1
1396062|NCT01257230|4607837|P2|Overall Study|Withdrawal by Subject|4
1396063|NCT01257230|4607838|P1|Overall Study|Withdrawal by Subject|0
1396064|NCT01257230|4607836|P3|Overall Study|Protocol Violation|1
1396065|NCT01257230|4607837|P2|Overall Study|Protocol Violation|0
1396066|NCT01257230|4607838|P1|Overall Study|Protocol Violation|3
1396067|NCT01257230|4607836|P3|Overall Study|Lack of Efficacy|0
1396068|NCT01257230|4607837|P2|Overall Study|Lack of Efficacy|1
1396069|NCT01257230|4607838|P1|Overall Study|Lack of Efficacy|0
1396070|NCT01257230|4607836|P3|Overall Study|Adverse Event|0
1396071|NCT01257230|4607837|P2|Overall Study|Adverse Event|0
1396072|NCT01257230|4607838|P1|Overall Study|Adverse Event|2
1396073|NCT01257230|4607836|P3|Overall Study|Not Treated|1
1396074|NCT01257230|4607837|P2|Overall Study|Not Treated|0
1396075|NCT01257230|4607838|P1|Overall Study|Not Treated|0
1396076|NCT01257204|4607915|P3|Follow-up Period (up to Week 48)|Other|5
1396077|NCT01257204|4607916|P2|Follow-up Period (up to Week 48)|Other|0
1396078|NCT01257204|4607917|P1|Follow-up Period (up to Week 48)|Other|0
1396079|NCT01257204|4607915|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
1396080|NCT01257204|4607916|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
1396081|NCT01257204|4607917|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
1396082|NCT01257204|4607915|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
1396083|NCT01257204|4607916|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
1396084|NCT01257204|4607917|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
1396085|NCT01257204|4607915|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
1396086|NCT01257204|4607916|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
1396087|NCT01257204|4607917|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
1396088|NCT01257204|4607915|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
1396089|NCT01257204|4607916|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
1396090|NCT01257204|4607917|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
1396091|NCT01257204|4607915|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
1396092|NCT01257204|4607916|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
1396093|NCT01257204|4607917|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
1396094|NCT01257204|4607915|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
1396095|NCT01257204|4607916|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
1396096|NCT01257204|4607917|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
1396097|NCT01257204|4607915|P3|Treatment Period (up to Week 24)|Adverse Event|2
1396098|NCT01257204|4607916|P2|Treatment Period (up to Week 24)|Adverse Event|1
1396099|NCT01257204|4607917|P1|Treatment Period (up to Week 24)|Adverse Event|3
1396100|NCT01257204|4607915|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
1396101|NCT01257204|4607916|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
1396102|NCT01257204|4607917|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
1396103|NCT01256684|4608028|P3|Overall Study|Entry criteria not met/non-compliance|6
1396104|NCT01256684|4608029|P2|Overall Study|Entry criteria not met/non-compliance|7
1396105|NCT01256684|4608030|P1|Overall Study|Entry criteria not met/non-compliance|4
1396106|NCT01256684|4608028|P3|Overall Study|Lack of Efficacy|1
1396107|NCT01256684|4608029|P2|Overall Study|Lack of Efficacy|1
1396108|NCT01256684|4608030|P1|Overall Study|Lack of Efficacy|0
1396109|NCT01256684|4608028|P3|Overall Study|Physician Decision|0
1396110|NCT01256684|4608029|P2|Overall Study|Physician Decision|1
1396111|NCT01256684|4608030|P1|Overall Study|Physician Decision|0
1396112|NCT01256684|4608028|P3|Overall Study|Withdrawal by Subject|2
1396113|NCT01256684|4608029|P2|Overall Study|Withdrawal by Subject|0
1396114|NCT01256684|4608030|P1|Overall Study|Withdrawal by Subject|4
1396115|NCT01256684|4608028|P3|Overall Study|Adverse Event|2
1396116|NCT01256684|4608029|P2|Overall Study|Adverse Event|4
1396117|NCT01256684|4608030|P1|Overall Study|Adverse Event|1
1396118|NCT01256671|4608062|P1|Overall Study|Non-compliance/Sponsor Decision/Other|12
1396119|NCT01256671|4608062|P1|Overall Study|Lack of Efficacy|4
1396120|NCT01256671|4608062|P1|Overall Study|Physician Decision|3
1396121|NCT01256671|4608062|P1|Overall Study|Withdrawal by Subject|31
1396122|NCT01256671|4608062|P1|Overall Study|Lost to Follow-up|16
1396123|NCT01256671|4608062|P1|Overall Study|Adverse Event|29
1396124|NCT01256658|4608075|P2|Period 1|Death|44
1396125|NCT01256658|4608076|P1|Period 1|Death|48
1396126|NCT01256658|4608075|P2|Period 1|Withdrawal by Subject|43
1396127|NCT01256658|4608076|P1|Period 1|Withdrawal by Subject|35
1396128|NCT01256658|4608075|P2|Period 1|Lost to Follow-up|661
1396129|NCT01256658|4608076|P1|Period 1|Lost to Follow-up|837
1396130|NCT01256567|4608126|P1|Overall Study|Withdrawal by Subject|1
1396131|NCT01256502|4608136|P1|Overall Study|Protocol deviation|1
1396132|NCT01256502|4608136|P1|Overall Study|Personal reasons|5
1396133|NCT01256502|4608136|P1|Overall Study|Had scaffold removed|4
1396134|NCT01256476|4608148|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
1396135|NCT01256476|4608149|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
1396136|NCT01256476|4608148|P2|Overall Study|Subject non-compliance|1
1396137|NCT01256476|4608149|P1|Overall Study|Subject non-compliance|0
1396138|NCT01256476|4608148|P2|Overall Study|Physician Decision|1
1396139|NCT01256476|4608149|P1|Overall Study|Physician Decision|0
1396140|NCT01256476|4608148|P2|Overall Study|Persistent ALT or AST elevation|0
1396141|NCT01256476|4608149|P1|Overall Study|Persistent ALT or AST elevation|1
1396142|NCT01256476|4608148|P2|Overall Study|Lost to Follow-up|2
1396143|NCT01256476|4608149|P1|Overall Study|Lost to Follow-up|1
1396144|NCT01256476|4608148|P2|Overall Study|Withdrawal by Subject|1
1396145|NCT01256476|4608149|P1|Overall Study|Withdrawal by Subject|2
1396146|NCT01256476|4608148|P2|Overall Study|Adverse Event|1
1396147|NCT01256476|4608149|P1|Overall Study|Adverse Event|2
1396148|NCT01256450|4608157|P3|Double-blind Treatment|Not specified|12
1396149|NCT01256450|4608158|P2|Double-blind Treatment|Not specified|9
1396150|NCT01256450|4608159|P1|Double-blind Treatment|Not specified|0
1396151|NCT01256450|4608157|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
1396152|NCT01256450|4608158|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
1396153|NCT01256450|4608159|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
1396154|NCT01256450|4608157|P3|Double-blind Treatment|Non-compliance|4
1396155|NCT01256450|4608158|P2|Double-blind Treatment|Non-compliance|5
1396156|NCT01256450|4608159|P1|Double-blind Treatment|Non-compliance|0
1396157|NCT01256450|4608157|P3|Double-blind Treatment|Lack of analgesic effect|6
1396158|NCT01256450|4608158|P2|Double-blind Treatment|Lack of analgesic effect|5
1396159|NCT01256450|4608159|P1|Double-blind Treatment|Lack of analgesic effect|0
1396160|NCT01256450|4608157|P3|Double-blind Treatment|Withdrawal by Subject|1
1396161|NCT01256450|4608158|P2|Double-blind Treatment|Withdrawal by Subject|0
1396162|NCT01256450|4608159|P1|Double-blind Treatment|Withdrawal by Subject|0
1396163|NCT01256450|4608157|P3|Double-blind Treatment|Lost to Follow-up|7
1396164|NCT01256450|4608158|P2|Double-blind Treatment|Lost to Follow-up|1
1396165|NCT01256450|4608159|P1|Double-blind Treatment|Lost to Follow-up|0
1396166|NCT01256450|4608157|P3|Double-blind Treatment|Adverse Event|6
1396167|NCT01256450|4608158|P2|Double-blind Treatment|Adverse Event|8
1396168|NCT01256450|4608159|P1|Double-blind Treatment|Adverse Event|0
1396169|NCT01256450|4608157|P3|Open-label Titration|Not specified|0
1396170|NCT01256450|4608158|P2|Open-label Titration|Not specified|0
1396171|NCT01256450|4608159|P1|Open-label Titration|Not specified|13
1396172|NCT01256450|4608157|P3|Open-label Titration|Screen failure|0
1396173|NCT01256450|4608158|P2|Open-label Titration|Screen failure|0
1396174|NCT01256450|4608159|P1|Open-label Titration|Screen failure|1
1396175|NCT01256450|4608157|P3|Open-label Titration|Non-compliance|0
1396176|NCT01256450|4608158|P2|Open-label Titration|Non-compliance|0
1396177|NCT01256450|4608159|P1|Open-label Titration|Non-compliance|9
1396178|NCT01256450|4608157|P3|Open-label Titration|Lack of analgesic effect|0
1396179|NCT01256450|4608158|P2|Open-label Titration|Lack of analgesic effect|0
1396180|NCT01256450|4608159|P1|Open-label Titration|Lack of analgesic effect|30
1396181|NCT01256450|4608157|P3|Open-label Titration|Lost to Follow-up|0
1396182|NCT01256450|4608158|P2|Open-label Titration|Lost to Follow-up|0
1396183|NCT01256450|4608159|P1|Open-label Titration|Lost to Follow-up|7
1396184|NCT01256450|4608157|P3|Open-label Titration|Adverse Event|0
1396185|NCT01256450|4608158|P2|Open-label Titration|Adverse Event|0
1396186|NCT01256450|4608159|P1|Open-label Titration|Adverse Event|39
1396187|NCT01256411|4608217|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
1396188|NCT01256411|4608218|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
1396189|NCT01256411|4608219|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
1396190|NCT01256411|4608220|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
1396191|NCT01256411|4608221|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
1396192|NCT01256411|4608222|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
1396193|NCT01256411|4608217|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
1396194|NCT01256411|4608218|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
1396195|NCT01256411|4608219|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
1396196|NCT01256411|4608220|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
1396197|NCT01256411|4608221|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
1396198|NCT01256411|4608222|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
1396199|NCT01256411|4608217|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
1396200|NCT01256411|4608218|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
1396201|NCT01256411|4608219|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
1396202|NCT01256411|4608220|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
1396203|NCT01256411|4608221|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
1396204|NCT01256411|4608222|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
1396205|NCT01256411|4608217|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
1396206|NCT01256411|4608218|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
1396207|NCT01256411|4608219|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
1396208|NCT01256411|4608220|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
1396209|NCT01256411|4608221|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
1396210|NCT01256411|4608222|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
1396211|NCT01256411|4608217|P6|Extension by Mono or Combination Therapy|Adverse Event|1
1396212|NCT01256411|4608218|P5|Extension by Mono or Combination Therapy|Adverse Event|6
1396213|NCT01256411|4608219|P4|Extension by Mono or Combination Therapy|Adverse Event|0
1396214|NCT01256411|4608220|P3|Extension by Mono or Combination Therapy|Adverse Event|0
1396215|NCT01256411|4608221|P2|Extension by Mono or Combination Therapy|Adverse Event|0
1396216|NCT01256411|4608222|P1|Extension by Mono or Combination Therapy|Adverse Event|0
1396217|NCT01256411|4608217|P6|Extension by Maximum Treatment|Adverse Event|0
1396218|NCT01256411|4608218|P5|Extension by Maximum Treatment|Adverse Event|0
1396219|NCT01256411|4608219|P4|Extension by Maximum Treatment|Adverse Event|0
1396220|NCT01256411|4608220|P3|Extension by Maximum Treatment|Adverse Event|1
1396221|NCT01256411|4608221|P2|Extension by Maximum Treatment|Adverse Event|2
1396222|NCT01256411|4608222|P1|Extension by Maximum Treatment|Adverse Event|4
1396223|NCT01256411|4608217|P6|Extension by Maximum Treatment|Lack of Efficacy|0
1396224|NCT01256411|4608218|P5|Extension by Maximum Treatment|Lack of Efficacy|0
1396225|NCT01256411|4608219|P4|Extension by Maximum Treatment|Lack of Efficacy|0
1396226|NCT01256411|4608220|P3|Extension by Maximum Treatment|Lack of Efficacy|1
1396227|NCT01256411|4608221|P2|Extension by Maximum Treatment|Lack of Efficacy|0
1396228|NCT01256411|4608222|P1|Extension by Maximum Treatment|Lack of Efficacy|1
1396229|NCT01256411|4608217|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
1396230|NCT01256411|4608218|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
1396231|NCT01256411|4608219|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
1396232|NCT01256411|4608220|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
1396233|NCT01256411|4608221|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
1396234|NCT01256411|4608222|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
1396235|NCT01256411|4608217|P6|Extension by Maximum Treatment|Lost to Follow-up|0
1396236|NCT01256411|4608218|P5|Extension by Maximum Treatment|Lost to Follow-up|0
1396237|NCT01256411|4608219|P4|Extension by Maximum Treatment|Lost to Follow-up|0
1396238|NCT01256411|4608220|P3|Extension by Maximum Treatment|Lost to Follow-up|0
1396239|NCT01256411|4608221|P2|Extension by Maximum Treatment|Lost to Follow-up|2
1396240|NCT01256411|4608222|P1|Extension by Maximum Treatment|Lost to Follow-up|1
1396241|NCT01256411|4608217|P6|Extension by Maximum Treatment|Protocol deviation|0
1396242|NCT01256411|4608218|P5|Extension by Maximum Treatment|Protocol deviation|0
1396243|NCT01256411|4608219|P4|Extension by Maximum Treatment|Protocol deviation|0
1396244|NCT01256411|4608220|P3|Extension by Maximum Treatment|Protocol deviation|1
1396245|NCT01256411|4608221|P2|Extension by Maximum Treatment|Protocol deviation|0
1396246|NCT01256411|4608222|P1|Extension by Maximum Treatment|Protocol deviation|0
1396247|NCT01256385|4608248|P2|Overall Study|Withdrawal by Subject|2
1396248|NCT01256385|4608249|P1|Overall Study|Withdrawal by Subject|2
1396249|NCT01256385|4608248|P2|Overall Study|Physician Decision|1
1396250|NCT01256385|4608249|P1|Overall Study|Physician Decision|1
1396251|NCT01256294|4608269|P2|Overall Study|Protocol deviation|1
1396252|NCT01256294|4608270|P1|Overall Study|Protocol deviation|2
1396253|NCT01256294|4608269|P2|Overall Study|Withdrawal by Subject|1
1396254|NCT01256294|4608270|P1|Overall Study|Withdrawal by Subject|1
1396255|NCT01256294|4608269|P2|Overall Study|Adverse Event|0
1396256|NCT01256294|4608270|P1|Overall Study|Adverse Event|1
1396257|NCT01256190|4608292|P2|Overall Study|Lost to Follow-up|0
1396258|NCT01256190|4608293|P1|Overall Study|Lost to Follow-up|2
1396259|NCT01256177|4608309|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
1396260|NCT01256177|4608310|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
1396261|NCT01256177|4608309|P2|Overall Study|Lack of Efficacy|2
1396262|NCT01256177|4608310|P1|Overall Study|Lack of Efficacy|11
1396263|NCT01256177|4608309|P2|Overall Study|Condition under Investigation Worsened|0
1396264|NCT01256177|4608310|P1|Overall Study|Condition under Investigation Worsened|1
1396265|NCT01256177|4608309|P2|Overall Study|Severe Non-Compliance to Protocol|2
1396266|NCT01256177|4608310|P1|Overall Study|Severe Non-Compliance to Protocol|4
1396267|NCT01256177|4608309|P2|Overall Study|Adverse Event|9
1396268|NCT01256177|4608310|P1|Overall Study|Adverse Event|8
1396269|NCT01256177|4608309|P2|Overall Study|Lost to Follow-up|2
1396270|NCT01256177|4608310|P1|Overall Study|Lost to Follow-up|2
1396271|NCT01256177|4608309|P2|Overall Study|Withdrawal by Subject|22
1396272|NCT01256177|4608310|P1|Overall Study|Withdrawal by Subject|23
1396273|NCT01256060|4608366|P4|Overall Study|Lost to Follow-up|0
1396274|NCT01256060|4608367|P3|Overall Study|Lost to Follow-up|0
1396275|NCT01256060|4608368|P2|Overall Study|Lost to Follow-up|1
1396276|NCT01256060|4608369|P1|Overall Study|Lost to Follow-up|0
1396277|NCT01256008|4608388|P3|Overall Study|Withdrawal by Subject|10
1396278|NCT01256008|4608389|P2|Overall Study|Withdrawal by Subject|3
1396279|NCT01256008|4608390|P1|Overall Study|Withdrawal by Subject|2
1396280|NCT01256008|4608388|P3|Overall Study|Lost to Follow-up|11
1396281|NCT01256008|4608389|P2|Overall Study|Lost to Follow-up|4
1396282|NCT01256008|4608390|P1|Overall Study|Lost to Follow-up|6
1396283|NCT01255904|4608412|P2|Overall Study|Physician Decision|4
1396284|NCT01255904|4608413|P1|Overall Study|Physician Decision|1
1396285|NCT01255787|4608423|P4|Overall Study|Noncompliance with Study Drug|0
1396286|NCT01255787|4608424|P3|Overall Study|Noncompliance with Study Drug|0
1396287|NCT01255787|4608425|P2|Overall Study|Noncompliance with Study Drug|1
1396288|NCT01255787|4608426|P1|Overall Study|Noncompliance with Study Drug|3
1396289|NCT01255787|4608423|P4|Overall Study|Lack of Efficacy|2
1396290|NCT01255787|4608424|P3|Overall Study|Lack of Efficacy|2
1396291|NCT01255787|4608425|P2|Overall Study|Lack of Efficacy|2
1396292|NCT01255787|4608426|P1|Overall Study|Lack of Efficacy|2
1396293|NCT01255787|4608423|P4|Overall Study|Pregnancy|1
1396294|NCT01255787|4608424|P3|Overall Study|Pregnancy|0
1396295|NCT01255787|4608425|P2|Overall Study|Pregnancy|0
1396296|NCT01255787|4608426|P1|Overall Study|Pregnancy|0
1396297|NCT01255787|4608423|P4|Overall Study|Withdrawal of Consent|4
1396298|NCT01255787|4608424|P3|Overall Study|Withdrawal of Consent|3
1396299|NCT01255787|4608425|P2|Overall Study|Withdrawal of Consent|9
1396300|NCT01255787|4608426|P1|Overall Study|Withdrawal of Consent|3
1396301|NCT01255787|4608423|P4|Overall Study|Lost to Follow-up|2
1396302|NCT01255787|4608424|P3|Overall Study|Lost to Follow-up|4
1396303|NCT01255787|4608425|P2|Overall Study|Lost to Follow-up|2
1396304|NCT01255787|4608426|P1|Overall Study|Lost to Follow-up|1
1396305|NCT01255787|4608423|P4|Overall Study|Major Protocol Deviation|4
1396306|NCT01255787|4608424|P3|Overall Study|Major Protocol Deviation|0
1396307|NCT01255787|4608425|P2|Overall Study|Major Protocol Deviation|1
1396308|NCT01255787|4608426|P1|Overall Study|Major Protocol Deviation|1
1396309|NCT01255787|4608423|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
1396310|NCT01255787|4608424|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
1396311|NCT01255787|4608425|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
1396312|NCT01255787|4608426|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
1396313|NCT01255761|4608454|P2|Overall Study|Other Reasons|18
1396314|NCT01255761|4608455|P1|Overall Study|Other Reasons|37
1396315|NCT01255761|4608454|P2|Overall Study|Withdrawal by Subject|27
1396316|NCT01255761|4608455|P1|Overall Study|Withdrawal by Subject|11
1396317|NCT01255761|4608454|P2|Overall Study|Lost to Follow-up|8
1396318|NCT01255761|4608455|P1|Overall Study|Lost to Follow-up|10
1396319|NCT01255761|4608454|P2|Overall Study|Protocol Violation|5
1396320|NCT01255761|4608455|P1|Overall Study|Protocol Violation|9
1396321|NCT01255761|4608454|P2|Overall Study|Lack of Efficacy|74
1396322|NCT01255761|4608455|P1|Overall Study|Lack of Efficacy|86
1396323|NCT01255761|4608454|P2|Overall Study|Adverse Event|43
1396324|NCT01255761|4608455|P1|Overall Study|Adverse Event|29
1396325|NCT01255722|4608540|P3|Overall Study|beta-blocker contraindicated|0
1396326|NCT01255722|4608541|P2|Overall Study|beta-blocker contraindicated|0
1396327|NCT01255722|4608542|P1|Overall Study|beta-blocker contraindicated|2
1396328|NCT01255722|4608540|P3|Overall Study|asymptomatic patient|0
1396329|NCT01255722|4608541|P2|Overall Study|asymptomatic patient|0
1396330|NCT01255722|4608542|P1|Overall Study|asymptomatic patient|1
1396331|NCT01255722|4608540|P3|Overall Study|Adverse Event|1
1396332|NCT01255722|4608541|P2|Overall Study|Adverse Event|1
1396333|NCT01255722|4608542|P1|Overall Study|Adverse Event|0
1396334|NCT01255631|4608567|P2|Overall Study|poor enrollment, no data analyzed|6
1396335|NCT01255631|4608568|P1|Overall Study|poor enrollment, no data analyzed|9
1396336|NCT01255592|4608586|P2|Overall Study|Other|1
1396337|NCT01255592|4608587|P1|Overall Study|Other|0
1396338|NCT01255592|4608586|P2|Overall Study|Withdrawal by Subject|0
1396339|NCT01255592|4608587|P1|Overall Study|Withdrawal by Subject|1
1396340|NCT01255592|4608586|P2|Overall Study|Adverse Event|0
1396341|NCT01255592|4608587|P1|Overall Study|Adverse Event|5
1396342|NCT01255436|4608650|P2|Overall Study|Death, stroke, or MI|3
1396343|NCT01255436|4608651|P1|Overall Study|Death, stroke, or MI|4
1396344|NCT01255436|4608650|P2|Overall Study|Lost to Follow-up|191
1396345|NCT01255436|4608651|P1|Overall Study|Lost to Follow-up|178
1396346|NCT01255423|4608665|P2|Overall Study|Use of prohibited medications|1
1396347|NCT01255423|4608666|P1|Overall Study|Use of prohibited medications|0
1396348|NCT01255423|4608665|P2|Overall Study|Abnormal Laboratory value|2
1396349|NCT01255423|4608666|P1|Overall Study|Abnormal Laboratory value|3
1396350|NCT01255306|4608682|P2|Overall Study|Physician Decision|1
1396351|NCT01255306|4608683|P1|Overall Study|Physician Decision|1
1396352|NCT01255163|4608694|P2|Overall Study|AstraZeneca stopped support of the study|3
1396353|NCT01255163|4608695|P1|Overall Study|AstraZeneca stopped support of the study|1
1396354|NCT01255163|4608694|P2|Overall Study|Adverse Event|2
1396355|NCT01255163|4608695|P1|Overall Study|Adverse Event|0
1396356|NCT01255163|4608694|P2|Overall Study|Lost to Follow-up|0
1396357|NCT01255163|4608695|P1|Overall Study|Lost to Follow-up|2
1396358|NCT01255163|4608694|P2|Overall Study|Withdrawal by Subject|0
1396359|NCT01255163|4608695|P1|Overall Study|Withdrawal by Subject|1
1396360|NCT01254890|4608724|P2|Overall Study|Disease Progression|5
1396361|NCT01254890|4608725|P1|Overall Study|Disease Progression|0
1396362|NCT01254890|4608724|P2|Overall Study|Withdrawal by Subject|2
1396363|NCT01254890|4608725|P1|Overall Study|Withdrawal by Subject|1
1396364|NCT01254890|4608724|P2|Overall Study|Ineligible|3
1396365|NCT01254890|4608725|P1|Overall Study|Ineligible|0
1396366|NCT01254747|4608787|P4|Overall Study|Discomfort|0
1396367|NCT01254747|4608788|P3|Overall Study|Discomfort|0
1396368|NCT01254747|4608789|P2|Overall Study|Discomfort|4
1396369|NCT01254747|4608790|P1|Overall Study|Discomfort|0
1396370|NCT01254747|4608787|P4|Overall Study|Biomicroscopy|0
1396371|NCT01254747|4608788|P3|Overall Study|Biomicroscopy|1
1396372|NCT01254747|4608789|P2|Overall Study|Biomicroscopy|0
1396373|NCT01254747|4608790|P1|Overall Study|Biomicroscopy|0
1396374|NCT01254747|4608787|P4|Overall Study|Lost to Follow-up|0
1396375|NCT01254747|4608788|P3|Overall Study|Lost to Follow-up|1
1396376|NCT01254747|4608789|P2|Overall Study|Lost to Follow-up|0
1396377|NCT01254747|4608790|P1|Overall Study|Lost to Follow-up|0
1396378|NCT01254747|4608787|P4|Overall Study|Symptoms and problems|0
1396379|NCT01254747|4608788|P3|Overall Study|Symptoms and problems|1
1396380|NCT01254747|4608789|P2|Overall Study|Symptoms and problems|2
1396381|NCT01254747|4608790|P1|Overall Study|Symptoms and problems|0
1396382|NCT01254747|4608787|P4|Overall Study|Difficult removal handling|0
1396383|NCT01254747|4608788|P3|Overall Study|Difficult removal handling|1
1396384|NCT01254747|4608789|P2|Overall Study|Difficult removal handling|0
1396385|NCT01254747|4608790|P1|Overall Study|Difficult removal handling|0
1396386|NCT01254747|4608787|P4|Overall Study|Unacceptable subjective vision|2
1396387|NCT01254747|4608788|P3|Overall Study|Unacceptable subjective vision|0
1396388|NCT01254747|4608789|P2|Overall Study|Unacceptable subjective vision|0
1396389|NCT01254747|4608790|P1|Overall Study|Unacceptable subjective vision|0
1396390|NCT01254721|4608830|P2|Overall Study|Wrongly randomization|1
1396391|NCT01254721|4608831|P1|Overall Study|Wrongly randomization|0
1396392|NCT01254721|4608830|P2|Overall Study|Withdrawal by Subject|11
1396393|NCT01254721|4608831|P1|Overall Study|Withdrawal by Subject|8
1396394|NCT01254721|4608830|P2|Overall Study|Adverse Event|3
1396395|NCT01254721|4608831|P1|Overall Study|Adverse Event|2
1396396|NCT01254721|4608830|P2|Overall Study|technical problum|0
1396397|NCT01254721|4608831|P1|Overall Study|technical problum|1
1396398|NCT01254721|4608830|P2|Overall Study|Death|1
1396399|NCT01254721|4608831|P1|Overall Study|Death|0
1396400|NCT01254721|4608830|P2|Overall Study|Lack of Efficacy|2
1396401|NCT01254721|4608831|P1|Overall Study|Lack of Efficacy|4
1396402|NCT01254721|4608830|P2|Overall Study|Lost to Follow-up|4
1396403|NCT01254721|4608831|P1|Overall Study|Lost to Follow-up|0
1396404|NCT01254669|4608841|P2|Overall Study|called to clinic during intervention|1
1396405|NCT01254669|4608842|P1|Overall Study|called to clinic during intervention|1
1396406|NCT01254669|4608841|P2|Overall Study|time constraint|2
1396407|NCT01254669|4608842|P1|Overall Study|time constraint|2
1396408|NCT01254669|4608841|P2|Overall Study|Withdrawal by Subject|1
1396409|NCT01254669|4608842|P1|Overall Study|Withdrawal by Subject|0
1396410|NCT01254656|4608853|P3|Overall Study|Death|0
1396411|NCT01254656|4608854|P2|Overall Study|Death|1
1396412|NCT01254656|4608855|P1|Overall Study|Death|0
1396413|NCT01254656|4608853|P3|Overall Study|Adverse Event|0
1396414|NCT01254656|4608854|P2|Overall Study|Adverse Event|1
1396415|NCT01254656|4608855|P1|Overall Study|Adverse Event|1
1396416|NCT01254656|4608853|P3|Overall Study|Pregnancy|2
1396417|NCT01254656|4608854|P2|Overall Study|Pregnancy|0
1396418|NCT01254656|4608855|P1|Overall Study|Pregnancy|0
1396419|NCT01254656|4608853|P3|Overall Study|Withdrawal by Subject|1
1396420|NCT01254656|4608854|P2|Overall Study|Withdrawal by Subject|2
1396421|NCT01254656|4608855|P1|Overall Study|Withdrawal by Subject|2
1396422|NCT01254656|4608853|P3|Overall Study|Lost to Follow-up|2
1396423|NCT01254656|4608854|P2|Overall Study|Lost to Follow-up|0
1396424|NCT01254656|4608855|P1|Overall Study|Lost to Follow-up|1
1396425|NCT01254656|4608853|P3|Overall Study|Lack of Efficacy|0
1396426|NCT01254656|4608854|P2|Overall Study|Lack of Efficacy|0
1396427|NCT01254656|4608855|P1|Overall Study|Lack of Efficacy|3
1396428|NCT01254656|4608853|P3|Overall Study|Discontinued due to termination of study|13
1396429|NCT01254656|4608854|P2|Overall Study|Discontinued due to termination of study|39
1396430|NCT01254656|4608855|P1|Overall Study|Discontinued due to termination of study|40
1396431|NCT01254643|4608881|P1|Overall Study|Withdrawal by Subject|1
1396432|NCT01254630|4608893|P4|Overall Study|Status not recorded|0
1396433|NCT01254630|4608894|P3|Overall Study|Status not recorded|1
1396434|NCT01254630|4608895|P2|Overall Study|Status not recorded|0
1396435|NCT01254630|4608896|P1|Overall Study|Status not recorded|0
1396436|NCT01254630|4608893|P4|Overall Study|Study terminated by sponsor|1010
1396437|NCT01254630|4608894|P3|Overall Study|Study terminated by sponsor|0
1396438|NCT01254630|4608895|P2|Overall Study|Study terminated by sponsor|994
1396439|NCT01254630|4608896|P1|Overall Study|Study terminated by sponsor|0
1396440|NCT01254630|4608893|P4|Overall Study|Withdrawal by Subject|89
1396441|NCT01254630|4608894|P3|Overall Study|Withdrawal by Subject|188
1396442|NCT01254630|4608895|P2|Overall Study|Withdrawal by Subject|94
1396443|NCT01254630|4608896|P1|Overall Study|Withdrawal by Subject|201
1396444|NCT01254630|4608893|P4|Overall Study|Physician Decision|7
1396445|NCT01254630|4608894|P3|Overall Study|Physician Decision|16
1396446|NCT01254630|4608895|P2|Overall Study|Physician Decision|8
1396447|NCT01254630|4608896|P1|Overall Study|Physician Decision|24
1396448|NCT01254630|4608893|P4|Overall Study|Lost to Follow-up|32
1396449|NCT01254630|4608894|P3|Overall Study|Lost to Follow-up|89
1396450|NCT01254630|4608895|P2|Overall Study|Lost to Follow-up|26
1396451|NCT01254630|4608896|P1|Overall Study|Lost to Follow-up|80
1396452|NCT01254630|4608893|P4|Overall Study|Death|139
1396453|NCT01254630|4608894|P3|Overall Study|Death|478
1396454|NCT01254630|4608895|P2|Overall Study|Death|151
1396455|NCT01254630|4608896|P1|Overall Study|Death|461
1396456|NCT01254630|4608893|P4|Overall Study|Adverse Event|8
1396457|NCT01254630|4608894|P3|Overall Study|Adverse Event|40
1396458|NCT01254630|4608895|P2|Overall Study|Adverse Event|15
1396459|NCT01254630|4608896|P1|Overall Study|Adverse Event|36
1396460|NCT01254604|4608916|P2|Overall Study|Adverse Event|2
1396461|NCT01254604|4608917|P1|Overall Study|Adverse Event|3
1396462|NCT01254604|4608916|P2|Overall Study|Withdrawal by Subject|4
1396463|NCT01254604|4608917|P1|Overall Study|Withdrawal by Subject|2
1396464|NCT01254604|4608916|P2|Overall Study|Protocol Violation|2
1396465|NCT01254604|4608917|P1|Overall Study|Protocol Violation|2
1396466|NCT01254604|4608916|P2|Overall Study|Lost to Follow-up|1
1396467|NCT01254604|4608917|P1|Overall Study|Lost to Follow-up|1
1396468|NCT01254565|4608935|P6|Overall Study|Other|0
1396469|NCT01254565|4608936|P5|Overall Study|Other|0
1396470|NCT01254565|4608937|P4|Overall Study|Other|1
1396471|NCT01254565|4608938|P3|Overall Study|Other|0
1396472|NCT01254565|4608939|P2|Overall Study|Other|0
1396473|NCT01254565|4608940|P1|Overall Study|Other|0
1396474|NCT01254565|4608935|P6|Overall Study|Did not Receive Treatment|4
1396475|NCT01254565|4608936|P5|Overall Study|Did not Receive Treatment|3
1396476|NCT01254565|4608937|P4|Overall Study|Did not Receive Treatment|0
1396477|NCT01254565|4608938|P3|Overall Study|Did not Receive Treatment|0
1396478|NCT01254565|4608939|P2|Overall Study|Did not Receive Treatment|1
1396479|NCT01254565|4608940|P1|Overall Study|Did not Receive Treatment|1
1396480|NCT01254565|4608935|P6|Overall Study|Non-compliance to Study Procedures|0
1396481|NCT01254565|4608936|P5|Overall Study|Non-compliance to Study Procedures|1
1396482|NCT01254565|4608937|P4|Overall Study|Non-compliance to Study Procedures|0
1396483|NCT01254565|4608938|P3|Overall Study|Non-compliance to Study Procedures|0
1396484|NCT01254565|4608939|P2|Overall Study|Non-compliance to Study Procedures|0
1396485|NCT01254565|4608940|P1|Overall Study|Non-compliance to Study Procedures|0
1396486|NCT01254409|4608994|P4|Overall Study|Adverse Event|0
1396487|NCT01254409|4608995|P3|Overall Study|Adverse Event|0
1396488|NCT01254409|4608996|P2|Overall Study|Adverse Event|1
1396489|NCT01254409|4608997|P1|Overall Study|Adverse Event|0
1396490|NCT01254344|4609066|P2|Overall Study|Withdrawal by Subject|6
1396491|NCT01254344|4609067|P1|Overall Study|Withdrawal by Subject|3
1396492|NCT01254344|4609066|P2|Overall Study|Protocol Violation|4
1396493|NCT01254344|4609067|P1|Overall Study|Protocol Violation|1
1396494|NCT01254344|4609066|P2|Overall Study|Physician Decision|4
1396495|NCT01254344|4609067|P1|Overall Study|Physician Decision|7
1396496|NCT01254344|4609066|P2|Overall Study|Adverse Event|5
1396497|NCT01254344|4609067|P1|Overall Study|Adverse Event|2
1396498|NCT01254331|4609075|P1|Extension Phase|Lost to Follow-up|3
1396499|NCT01254331|4609075|P1|Extension Phase|Lack of Efficacy|1
1396500|NCT01254331|4609075|P1|Initial Phase|Pregnancy|1
1396501|NCT01254331|4609075|P1|Initial Phase|Withdrawal by Subject|1
1396502|NCT01254331|4609075|P1|Initial Phase|Adverse Event|3
1396503|NCT01254318|4609093|P1|Overall Study|Death|47
1396504|NCT01254318|4609093|P1|Overall Study|Lost to Follow-up|5
1396505|NCT01254305|4609102|P3|Overall Study|Other Reasons|2
1396506|NCT01254305|4609103|P2|Overall Study|Other Reasons|0
1396507|NCT01254305|4609104|P1|Overall Study|Other Reasons|0
1396508|NCT01254305|4609102|P3|Overall Study|Lost to Follow-up|5
1396509|NCT01254305|4609103|P2|Overall Study|Lost to Follow-up|6
1396510|NCT01254305|4609104|P1|Overall Study|Lost to Follow-up|10
1396511|NCT01254305|4609102|P3|Overall Study|Withdrawal by Subject|4
1396512|NCT01254305|4609103|P2|Overall Study|Withdrawal by Subject|2
1396513|NCT01254305|4609104|P1|Overall Study|Withdrawal by Subject|4
1396514|NCT01254305|4609102|P3|Overall Study|Protocol Violation|3
1396515|NCT01254305|4609103|P2|Overall Study|Protocol Violation|7
1396516|NCT01254305|4609104|P1|Overall Study|Protocol Violation|1
1396517|NCT01254305|4609102|P3|Overall Study|Lack of Efficacy|1
1396518|NCT01254305|4609103|P2|Overall Study|Lack of Efficacy|0
1396519|NCT01254305|4609104|P1|Overall Study|Lack of Efficacy|1
1396520|NCT01254305|4609102|P3|Overall Study|Adverse Event|2
1396521|NCT01254305|4609103|P2|Overall Study|Adverse Event|3
1396522|NCT01254305|4609104|P1|Overall Study|Adverse Event|6
1396523|NCT01254292|4609120|P2|LCS12 Extension Phase|Lost to Follow-up|0
1396524|NCT01254292|4609121|P1|LCS12 Extension Phase|Lost to Follow-up|1
1396525|NCT01254292|4609120|P2|LCS12 Extension Phase|Pregnancy|0
1396526|NCT01254292|4609121|P1|LCS12 Extension Phase|Pregnancy|2
1396527|NCT01254292|4609120|P2|LCS12 Extension Phase|Other unknown|0
1396528|NCT01254292|4609121|P1|LCS12 Extension Phase|Other unknown|4
1396529|NCT01254292|4609120|P2|LCS12 Extension Phase|Withdrawal by Subject|0
1396530|NCT01254292|4609121|P1|LCS12 Extension Phase|Withdrawal by Subject|7
1396531|NCT01254292|4609120|P2|LCS12 Extension Phase|Adverse Event|0
1396532|NCT01254292|4609121|P1|LCS12 Extension Phase|Adverse Event|9
1396533|NCT01254292|4609120|P2|LCS12 Extension Phase|Wish for pregnancy|0
1396534|NCT01254292|4609121|P1|LCS12 Extension Phase|Wish for pregnancy|14
1396535|NCT01254292|4609120|P2|Comparative Phase|Wish for pregnancy|6
1396536|NCT01254292|4609121|P1|Comparative Phase|Wish for pregnancy|4
1396537|NCT01254292|4609120|P2|Comparative Phase|Protocol Violation|2
1396538|NCT01254292|4609121|P1|Comparative Phase|Protocol Violation|1
1396539|NCT01254292|4609120|P2|Comparative Phase|Withdrawal by Subject|21
1396540|NCT01254292|4609121|P1|Comparative Phase|Withdrawal by Subject|20
1396541|NCT01254292|4609120|P2|Comparative Phase|Pregnancy|6
1396542|NCT01254292|4609121|P1|Comparative Phase|Pregnancy|2
1396543|NCT01254292|4609120|P2|Comparative Phase|Lost to Follow-up|21
1396544|NCT01254292|4609121|P1|Comparative Phase|Lost to Follow-up|3
1396545|NCT01254292|4609120|P2|Comparative Phase|Adverse Event|25
1396546|NCT01254292|4609121|P1|Comparative Phase|Adverse Event|25
1396547|NCT01254188|4609198|P1|Overall Study|per investigator discretion|20
1396548|NCT01254188|4609198|P1|Overall Study|Adverse Event|43
1396549|NCT01254188|4609198|P1|Overall Study|Withdrawal by Subject|7
1396550|NCT01254188|4609198|P1|Overall Study|Lost to Follow-up|5
1396551|NCT01254188|4609198|P1|Overall Study|Death|4
1396552|NCT01254188|4609198|P1|Overall Study|Pregnancy|2
1396553|NCT01254188|4609198|P1|Overall Study|Protocol Violation|6
1396554|NCT01254188|4609198|P1|Overall Study|Disease Progression|6
1396555|NCT01254045|4609209|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
1396556|NCT01254045|4609210|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
1396557|NCT01254045|4609211|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
1396558|NCT01254045|4609212|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
1396559|NCT01254045|4609213|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
1396560|NCT01254045|4609214|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
1396561|NCT01253811|4609268|P1|Overall Study|Withdrawal criteria|1
1396562|NCT01253577|4609299|P1|Overall Study|Lost to Follow-up|3
1396563|NCT01253564|4609307|P1|Overall Study|Serious Adverse Event|1
1396564|NCT01253564|4609307|P1|Overall Study|Withdrawal by Subject|1
1396565|NCT01253564|4609307|P1|Overall Study|Disease Progression|22
1396566|NCT01253447|4609351|P1|Overall Study|Adverse Event|2
1396567|NCT01253421|4609361|P5|Drug+Scanning Visit|Physician Decision|1
1396568|NCT01253421|4609362|P4|Drug+Scanning Visit|Physician Decision|0
1396569|NCT01253421|4609363|P3|Drug+Scanning Visit|Physician Decision|0
1396570|NCT01253421|4609364|P2|Drug+Scanning Visit|Physician Decision|0
1396571|NCT01253421|4609365|P1|Drug+Scanning Visit|Physician Decision|0
1396572|NCT01253421|4609361|P5|Assessment and Scheduling|Physician Decision|0
1396573|NCT01253421|4609362|P4|Assessment and Scheduling|Physician Decision|0
1396574|NCT01253421|4609363|P3|Assessment and Scheduling|Physician Decision|0
1396575|NCT01253421|4609364|P2|Assessment and Scheduling|Physician Decision|0
1396576|NCT01253421|4609365|P1|Assessment and Scheduling|Physician Decision|1
1396577|NCT01253421|4609361|P5|Assessment and Scheduling|Withdrawal by Subject|0
1396578|NCT01253421|4609362|P4|Assessment and Scheduling|Withdrawal by Subject|0
1396579|NCT01253421|4609363|P3|Assessment and Scheduling|Withdrawal by Subject|0
1396580|NCT01253421|4609364|P2|Assessment and Scheduling|Withdrawal by Subject|0
1396581|NCT01253421|4609365|P1|Assessment and Scheduling|Withdrawal by Subject|7
1396582|NCT01253421|4609361|P5|Assessment and Scheduling|Lost to Follow-up|0
1396583|NCT01253421|4609362|P4|Assessment and Scheduling|Lost to Follow-up|0
1396584|NCT01253421|4609363|P3|Assessment and Scheduling|Lost to Follow-up|0
1396585|NCT01253421|4609364|P2|Assessment and Scheduling|Lost to Follow-up|0
1396586|NCT01253421|4609365|P1|Assessment and Scheduling|Lost to Follow-up|17
1396587|NCT01253421|4609361|P5|Assessment and Scheduling|Found to be Ineligible|0
1396588|NCT01253421|4609362|P4|Assessment and Scheduling|Found to be Ineligible|0
1396589|NCT01253421|4609363|P3|Assessment and Scheduling|Found to be Ineligible|0
1396590|NCT01253421|4609364|P2|Assessment and Scheduling|Found to be Ineligible|0
1396591|NCT01253421|4609365|P1|Assessment and Scheduling|Found to be Ineligible|74
1396592|NCT01253408|4609414|P3|Overall Study|Adverse Event|0
1396593|NCT01253408|4609415|P2|Overall Study|Adverse Event|1
1396594|NCT01253408|4609416|P1|Overall Study|Adverse Event|0
1396595|NCT01253369|4609439|P1|Overall Study|Not Evaluable|3
1396596|NCT01253369|4609439|P1|Overall Study|Progressive disease|23
1396597|NCT01253369|4609439|P1|Overall Study|Death|1
1396598|NCT01253369|4609439|P1|Overall Study|Withdrawal by Subject|2
1396599|NCT01253369|4609439|P1|Overall Study|Adverse Event|4
1396600|NCT01253317|4609469|P1|Overall Study|Adverse Event|2
1396601|NCT01253304|4609481|P4|Overall Study|Adverse Event|1
1396602|NCT01253304|4609482|P3|Overall Study|Adverse Event|0
1396603|NCT01253304|4609483|P2|Overall Study|Adverse Event|0
1396604|NCT01253304|4609484|P1|Overall Study|Adverse Event|0
1396605|NCT01253265|4609523|P5|Overall Study|Withdrawal by Subject|1
1396606|NCT01253265|4609524|P4|Overall Study|Withdrawal by Subject|0
1396607|NCT01253265|4609525|P3|Overall Study|Withdrawal by Subject|0
1396608|NCT01253265|4609526|P2|Overall Study|Withdrawal by Subject|0
1396609|NCT01253265|4609527|P1|Overall Study|Withdrawal by Subject|0
1396610|NCT01253265|4609523|P5|Overall Study|Met Predefined Discontinuation Criteria|0
1396611|NCT01253265|4609524|P4|Overall Study|Met Predefined Discontinuation Criteria|0
1396612|NCT01253265|4609525|P3|Overall Study|Met Predefined Discontinuation Criteria|0
1396613|NCT01253265|4609526|P2|Overall Study|Met Predefined Discontinuation Criteria|0
1396614|NCT01253265|4609527|P1|Overall Study|Met Predefined Discontinuation Criteria|1
1396615|NCT01253200|4609576|P5|Overall Study|Attempts|0
1396616|NCT01253200|4609577|P4|Overall Study|Attempts|2
1396617|NCT01253200|4609578|P3|Overall Study|Attempts|1
1396618|NCT01253200|4609579|P2|Overall Study|Attempts|4
1396619|NCT01253200|4609580|P1|Overall Study|Attempts|6
1396620|NCT01253200|4609576|P5|Overall Study|intents|0
1396621|NCT01253200|4609577|P4|Overall Study|intents|3
1396622|NCT01253200|4609578|P3|Overall Study|intents|1
1396623|NCT01253200|4609579|P2|Overall Study|intents|10
1396624|NCT01253200|4609580|P1|Overall Study|intents|10
1396625|NCT01253200|4609576|P5|Overall Study|Protocol Violation|5
1396626|NCT01253200|4609577|P4|Overall Study|Protocol Violation|0
1396627|NCT01253200|4609578|P3|Overall Study|Protocol Violation|0
1396628|NCT01253200|4609579|P2|Overall Study|Protocol Violation|4
1396629|NCT01253200|4609580|P1|Overall Study|Protocol Violation|1
1396630|NCT01253200|4609576|P5|Overall Study|Withdrawal by Subject|0
1396631|NCT01253200|4609577|P4|Overall Study|Withdrawal by Subject|0
1396632|NCT01253200|4609578|P3|Overall Study|Withdrawal by Subject|0
1396633|NCT01253200|4609579|P2|Overall Study|Withdrawal by Subject|0
1396634|NCT01253200|4609580|P1|Overall Study|Withdrawal by Subject|2
1396635|NCT01253200|4609576|P5|Overall Study|Lost to Follow-up|0
1396636|NCT01253200|4609577|P4|Overall Study|Lost to Follow-up|0
1396637|NCT01253200|4609578|P3|Overall Study|Lost to Follow-up|0
1396638|NCT01253200|4609579|P2|Overall Study|Lost to Follow-up|1
1396639|NCT01253200|4609580|P1|Overall Study|Lost to Follow-up|1
1396640|NCT01253200|4609576|P5|Overall Study|Death|0
1396641|NCT01253200|4609577|P4|Overall Study|Death|0
1396642|NCT01253200|4609578|P3|Overall Study|Death|0
1396643|NCT01253200|4609579|P2|Overall Study|Death|0
1396644|NCT01253200|4609580|P1|Overall Study|Death|1
1396645|NCT01253187|4609595|P6|Period 3|non-compliance|0
1396646|NCT01253187|4609596|P5|Period 3|non-compliance|1
1396647|NCT01253187|4609597|P4|Period 3|non-compliance|0
1396648|NCT01253187|4609598|P3|Period 3|non-compliance|0
1396649|NCT01253187|4609599|P2|Period 3|non-compliance|0
1396650|NCT01253187|4609600|P1|Period 3|non-compliance|0
1396651|NCT01253187|4609595|P6|Period 3|difficulty with blood sampling|0
1396652|NCT01253187|4609596|P5|Period 3|difficulty with blood sampling|0
1396653|NCT01253187|4609597|P4|Period 3|difficulty with blood sampling|0
1396654|NCT01253187|4609598|P3|Period 3|difficulty with blood sampling|0
1396655|NCT01253187|4609599|P2|Period 3|difficulty with blood sampling|1
1396656|NCT01253187|4609600|P1|Period 3|difficulty with blood sampling|0
1396657|NCT01253187|4609595|P6|Period 3|Pregnancy|0
1396658|NCT01253187|4609596|P5|Period 3|Pregnancy|0
1396659|NCT01253187|4609597|P4|Period 3|Pregnancy|0
1396660|NCT01253187|4609598|P3|Period 3|Pregnancy|0
1396661|NCT01253187|4609599|P2|Period 3|Pregnancy|0
1396662|NCT01253187|4609600|P1|Period 3|Pregnancy|1
1396663|NCT01253187|4609595|P6|Period 2|Withdrawal by Subject|0
1396664|NCT01253187|4609596|P5|Period 2|Withdrawal by Subject|1
1396665|NCT01253187|4609597|P4|Period 2|Withdrawal by Subject|0
1396666|NCT01253187|4609598|P3|Period 2|Withdrawal by Subject|0
1396667|NCT01253187|4609599|P2|Period 2|Withdrawal by Subject|0
1396668|NCT01253187|4609600|P1|Period 2|Withdrawal by Subject|0
1396669|NCT01253174|4609629|P6|Period 3|Pregnancy|0
1396670|NCT01253174|4609630|P5|Period 3|Pregnancy|0
1396671|NCT01253174|4609631|P4|Period 3|Pregnancy|0
1396672|NCT01253174|4609632|P3|Period 3|Pregnancy|1
1396673|NCT01253174|4609633|P2|Period 3|Pregnancy|0
1396674|NCT01253174|4609634|P1|Period 3|Pregnancy|0
1396675|NCT01253174|4609629|P6|Period 3|Withdrawal by Subject|0
1396676|NCT01253174|4609630|P5|Period 3|Withdrawal by Subject|1
1396677|NCT01253174|4609631|P4|Period 3|Withdrawal by Subject|0
1396678|NCT01253174|4609632|P3|Period 3|Withdrawal by Subject|0
1396679|NCT01253174|4609633|P2|Period 3|Withdrawal by Subject|1
1396680|NCT01253174|4609634|P1|Period 3|Withdrawal by Subject|0
1396681|NCT01253174|4609629|P6|Period 2|Adverse Event|0
1396682|NCT01253174|4609630|P5|Period 2|Adverse Event|0
1396683|NCT01253174|4609631|P4|Period 2|Adverse Event|0
1396684|NCT01253174|4609632|P3|Period 2|Adverse Event|1
1396685|NCT01253174|4609633|P2|Period 2|Adverse Event|0
1396686|NCT01253174|4609634|P1|Period 2|Adverse Event|0
1396687|NCT01253174|4609629|P6|Period 1|Randomized but not treated|0
1396688|NCT01253174|4609630|P5|Period 1|Randomized but not treated|1
1396689|NCT01253174|4609631|P4|Period 1|Randomized but not treated|0
1396690|NCT01253174|4609632|P3|Period 1|Randomized but not treated|1
1396691|NCT01253174|4609633|P2|Period 1|Randomized but not treated|1
1396692|NCT01253174|4609634|P1|Period 1|Randomized but not treated|0
1396693|NCT01253135|4609669|P1|Amended Protocol|Non-compliance|1
1396694|NCT01253135|4609669|P1|Original Protocol|Protocol Amendment|15
1396695|NCT01253044|4609688|P2|Overall Study|Lost to Follow-up|29
1396696|NCT01253044|4609689|P1|Overall Study|Lost to Follow-up|38
1396697|NCT01253018|4609699|P2|Overall Study|Withdrawal by Subject|1
1396698|NCT01253018|4609700|P1|Overall Study|Withdrawal by Subject|1
1396699|NCT01253018|4609699|P2|Overall Study|Robot Repair Issues|0
1396700|NCT01253018|4609700|P1|Overall Study|Robot Repair Issues|2
1396701|NCT01253018|4609699|P2|Overall Study|Lost to Follow-up|1
1396702|NCT01253018|4609700|P1|Overall Study|Lost to Follow-up|1
1396703|NCT01252966|4609714|P2|Overall Study|Withdrawal by Subject|3
1396704|NCT01252966|4609715|P1|Overall Study|Withdrawal by Subject|7
1396705|NCT01252966|4609714|P2|Overall Study|Lost to Follow-up|10
1396706|NCT01252966|4609715|P1|Overall Study|Lost to Follow-up|16
1396707|NCT01252953|4609731|P2|Overall Study|Lost to Follow-up|21
1396708|NCT01252953|4609732|P1|Overall Study|Lost to Follow-up|22
1396709|NCT01252953|4609731|P2|Overall Study|Withdrawal by Subject|17
1396710|NCT01252953|4609732|P1|Overall Study|Withdrawal by Subject|16
1396711|NCT01252940|4609746|P2|Extension Phase|Withdrawal by Subject|1
1396712|NCT01252940|4609747|P1|Extension Phase|Withdrawal by Subject|1
1396713|NCT01252940|4609746|P2|Extension Phase|Subject Non-compliance|0
1396714|NCT01252940|4609747|P1|Extension Phase|Subject Non-compliance|1
1396715|NCT01252940|4609746|P2|Extension Phase|Physician Decision|1
1396716|NCT01252940|4609747|P1|Extension Phase|Physician Decision|0
1396717|NCT01252940|4609746|P2|Extension Phase|Lost to Follow-up|0
1396718|NCT01252940|4609747|P1|Extension Phase|Lost to Follow-up|5
1396719|NCT01252940|4609746|P2|Extension Phase|Lack of Efficacy|0
1396720|NCT01252940|4609747|P1|Extension Phase|Lack of Efficacy|1
1396721|NCT01252940|4609746|P2|Extension Phase|Adverse Event|1
1396722|NCT01252940|4609747|P1|Extension Phase|Adverse Event|2
1396723|NCT01252940|4609746|P2|Main Study Phase|Subject Non-compliance|1
1396724|NCT01252940|4609747|P1|Main Study Phase|Subject Non-compliance|1
1396725|NCT01252940|4609746|P2|Main Study Phase|Withdrawal by Subject|5
1396726|NCT01252940|4609747|P1|Main Study Phase|Withdrawal by Subject|6
1396727|NCT01252940|4609746|P2|Main Study Phase|Protocol Violation|2
1396728|NCT01252940|4609747|P1|Main Study Phase|Protocol Violation|4
1396729|NCT01252940|4609746|P2|Main Study Phase|Physician Decision|0
1396730|NCT01252940|4609747|P1|Main Study Phase|Physician Decision|1
1396731|NCT01252940|4609746|P2|Main Study Phase|Lost to Follow-up|1
1396732|NCT01252940|4609747|P1|Main Study Phase|Lost to Follow-up|6
1396733|NCT01252940|4609746|P2|Main Study Phase|Lack of Efficacy|0
1396734|NCT01252940|4609747|P1|Main Study Phase|Lack of Efficacy|1
1396735|NCT01252940|4609746|P2|Main Study Phase|Adverse Event|1
1396736|NCT01252940|4609747|P1|Main Study Phase|Adverse Event|3
1396737|NCT01252940|4609746|P2|Main Study Phase|Randomized but not treated|2
1396738|NCT01252940|4609747|P1|Main Study Phase|Randomized but not treated|4
1396739|NCT01252810|4609778|P2|Overall Study|Various reasons|0
1396740|NCT01252810|4609779|P1|Overall Study|Various reasons|8
1396741|NCT01252810|4609778|P2|Overall Study|Physician Decision|1
1396742|NCT01252810|4609779|P1|Overall Study|Physician Decision|2
1396743|NCT01252810|4609778|P2|Overall Study|Lost to Follow-up|1
1396744|NCT01252810|4609779|P1|Overall Study|Lost to Follow-up|0
1396745|NCT01252810|4609778|P2|Overall Study|Withdrawal by Subject|1
1396746|NCT01252810|4609779|P1|Overall Study|Withdrawal by Subject|4
1396747|NCT01252355|4609811|P3|Overall Study|Other Than Above|7
1396748|NCT01252355|4609812|P2|Overall Study|Other Than Above|7
1396749|NCT01252355|4609813|P1|Overall Study|Other Than Above|8
1396750|NCT01252355|4609811|P3|Overall Study|Randomized but not Treated|0
1396751|NCT01252355|4609812|P2|Overall Study|Randomized but not Treated|0
1396752|NCT01252355|4609813|P1|Overall Study|Randomized but not Treated|2
1396753|NCT01252355|4609811|P3|Overall Study|Sponsor Early Termination of Study|146
1396754|NCT01252355|4609812|P2|Overall Study|Sponsor Early Termination of Study|149
1396755|NCT01252355|4609813|P1|Overall Study|Sponsor Early Termination of Study|149
1396756|NCT01252355|4609811|P3|Overall Study|Progressive Disease|0
1396757|NCT01252355|4609812|P2|Overall Study|Progressive Disease|0
1396758|NCT01252355|4609813|P1|Overall Study|Progressive Disease|2
1396759|NCT01252355|4609811|P3|Overall Study|Poor Compliance to Protocol|1
1396760|NCT01252355|4609812|P2|Overall Study|Poor Compliance to Protocol|1
1396761|NCT01252355|4609813|P1|Overall Study|Poor Compliance to Protocol|1
1396762|NCT01252355|4609811|P3|Overall Study|Lost to Follow-up|1
1396763|NCT01252355|4609812|P2|Overall Study|Lost to Follow-up|0
1396764|NCT01252355|4609813|P1|Overall Study|Lost to Follow-up|0
1396765|NCT01252355|4609811|P3|Overall Study|Lack of Efficacy|2
1396766|NCT01252355|4609812|P2|Overall Study|Lack of Efficacy|4
1396767|NCT01252355|4609813|P1|Overall Study|Lack of Efficacy|6
1396768|NCT01252355|4609811|P3|Overall Study|Adverse Event|22
1396769|NCT01252355|4609812|P2|Overall Study|Adverse Event|17
1396770|NCT01252355|4609813|P1|Overall Study|Adverse Event|9
1396771|NCT01252290|4609851|P1|Overall Study|Withdrawal by Subject|1
1396772|NCT01252251|4609867|P1|Overall Study|Withdrawal by Subject|1
1396773|NCT01252238|4609879|P3|Overall Study|Sponsor terminated study|4
1396774|NCT01252238|4609880|P2|Overall Study|Sponsor terminated study|4
1396775|NCT01252238|4609881|P1|Overall Study|Sponsor terminated study|4
1396776|NCT01252186|4609898|P3|Overall Study|Other - Miscellaneous Reasons|7
1396777|NCT01252186|4609899|P2|Overall Study|Other - Miscellaneous Reasons|5
1396778|NCT01252186|4609900|P1|Overall Study|Other - Miscellaneous Reasons|5
1396779|NCT01252186|4609898|P3|Overall Study|Lost to Follow-up|11
1396780|NCT01252186|4609899|P2|Overall Study|Lost to Follow-up|10
1396781|NCT01252186|4609900|P1|Overall Study|Lost to Follow-up|10
1396782|NCT01252186|4609898|P3|Overall Study|Sponsor Request|0
1396783|NCT01252186|4609899|P2|Overall Study|Sponsor Request|1
1396784|NCT01252186|4609900|P1|Overall Study|Sponsor Request|2
1396785|NCT01252186|4609898|P3|Overall Study|Pregnancy|0
1396786|NCT01252186|4609899|P2|Overall Study|Pregnancy|2
1396787|NCT01252186|4609900|P1|Overall Study|Pregnancy|2
1396788|NCT01252186|4609898|P3|Overall Study|Protocol Violation|1
1396789|NCT01252186|4609899|P2|Overall Study|Protocol Violation|0
1396790|NCT01252186|4609900|P1|Overall Study|Protocol Violation|0
1396791|NCT01252186|4609898|P3|Overall Study|Non-compliance|4
1396792|NCT01252186|4609899|P2|Overall Study|Non-compliance|3
1396793|NCT01252186|4609900|P1|Overall Study|Non-compliance|0
1396794|NCT01252186|4609898|P3|Overall Study|Physician Decision|1
1396795|NCT01252186|4609899|P2|Overall Study|Physician Decision|0
1396796|NCT01252186|4609900|P1|Overall Study|Physician Decision|0
1396797|NCT01252186|4609898|P3|Overall Study|Withdrawal by Subject|2
1396798|NCT01252186|4609899|P2|Overall Study|Withdrawal by Subject|5
1396799|NCT01252186|4609900|P1|Overall Study|Withdrawal by Subject|2
1396800|NCT01252186|4609898|P3|Overall Study|Adverse Event|8
1396801|NCT01252186|4609899|P2|Overall Study|Adverse Event|6
1396802|NCT01252186|4609900|P1|Overall Study|Adverse Event|9
1396803|NCT01252134|4609973|P6|Period 1, 8 Hours|Personal Reasons|0
1396804|NCT01252134|4609974|P5|Period 1, 8 Hours|Personal Reasons|0
1396805|NCT01252134|4609975|P4|Period 1, 8 Hours|Personal Reasons|0
1396806|NCT01252134|4609976|P3|Period 1, 8 Hours|Personal Reasons|1
1396807|NCT01252134|4609977|P2|Period 1, 8 Hours|Personal Reasons|1
1396808|NCT01252134|4609978|P1|Period 1, 8 Hours|Personal Reasons|0
1396809|NCT01252095|4609997|P2|Overall Study|Disease progression|0
1396810|NCT01252095|4609998|P1|Overall Study|Disease progression|1
1396811|NCT01251952|4610016|P1|Overall Study|Adverse Event|1
1396812|NCT01251770|4610022|P2|Overall Study|Protocol Violation|7
1396813|NCT01251770|4610023|P1|Overall Study|Protocol Violation|13
1396814|NCT01251653|4610074|P9|Overall Study|Other reason not mentioned above|0
1396815|NCT01251653|4610075|P8|Overall Study|Other reason not mentioned above|2
1396816|NCT01251653|4610076|P7|Overall Study|Other reason not mentioned above|0
1396817|NCT01251653|4610077|P6|Overall Study|Other reason not mentioned above|0
1396818|NCT01251653|4610078|P5|Overall Study|Other reason not mentioned above|0
1396819|NCT01251653|4610079|P4|Overall Study|Other reason not mentioned above|0
1396820|NCT01251653|4610080|P3|Overall Study|Other reason not mentioned above|0
1396821|NCT01251653|4610081|P2|Overall Study|Other reason not mentioned above|0
1396822|NCT01251653|4610082|P1|Overall Study|Other reason not mentioned above|0
1396823|NCT01251653|4610074|P9|Overall Study|Withdrawal by Subject|0
1396824|NCT01251653|4610075|P8|Overall Study|Withdrawal by Subject|1
1396825|NCT01251653|4610076|P7|Overall Study|Withdrawal by Subject|0
1396826|NCT01251653|4610077|P6|Overall Study|Withdrawal by Subject|1
1396827|NCT01251653|4610078|P5|Overall Study|Withdrawal by Subject|1
1396828|NCT01251653|4610079|P4|Overall Study|Withdrawal by Subject|0
1396829|NCT01251653|4610080|P3|Overall Study|Withdrawal by Subject|1
1396830|NCT01251653|4610081|P2|Overall Study|Withdrawal by Subject|0
1396831|NCT01251653|4610082|P1|Overall Study|Withdrawal by Subject|1
1396832|NCT01251653|4610074|P9|Overall Study|Adverse Event|1
1396833|NCT01251653|4610075|P8|Overall Study|Adverse Event|2
1396834|NCT01251653|4610076|P7|Overall Study|Adverse Event|2
1396835|NCT01251653|4610077|P6|Overall Study|Adverse Event|0
1396836|NCT01251653|4610078|P5|Overall Study|Adverse Event|1
1396837|NCT01251653|4610079|P4|Overall Study|Adverse Event|1
1396838|NCT01251653|4610080|P3|Overall Study|Adverse Event|2
1396839|NCT01251653|4610081|P2|Overall Study|Adverse Event|0
1396840|NCT01251653|4610082|P1|Overall Study|Adverse Event|1
1396841|NCT01251653|4610074|P9|Overall Study|Dose-limiting toxicity|0
1396842|NCT01251653|4610075|P8|Overall Study|Dose-limiting toxicity|0
1396843|NCT01251653|4610076|P7|Overall Study|Dose-limiting toxicity|2
1396844|NCT01251653|4610077|P6|Overall Study|Dose-limiting toxicity|0
1396845|NCT01251653|4610078|P5|Overall Study|Dose-limiting toxicity|0
1396846|NCT01251653|4610079|P4|Overall Study|Dose-limiting toxicity|1
1396847|NCT01251653|4610080|P3|Overall Study|Dose-limiting toxicity|1
1396848|NCT01251653|4610081|P2|Overall Study|Dose-limiting toxicity|1
1396849|NCT01251653|4610082|P1|Overall Study|Dose-limiting toxicity|0
1396850|NCT01251653|4610074|P9|Overall Study|Progressive Disease|5
1396851|NCT01251653|4610075|P8|Overall Study|Progressive Disease|7
1396852|NCT01251653|4610076|P7|Overall Study|Progressive Disease|14
1396853|NCT01251653|4610077|P6|Overall Study|Progressive Disease|17
1396854|NCT01251653|4610078|P5|Overall Study|Progressive Disease|0
1396855|NCT01251653|4610079|P4|Overall Study|Progressive Disease|4
1396856|NCT01251653|4610080|P3|Overall Study|Progressive Disease|16
1396857|NCT01251653|4610081|P2|Overall Study|Progressive Disease|7
1396858|NCT01251653|4610082|P1|Overall Study|Progressive Disease|1
1396859|NCT01251614|4610210|P3|Overall Study|Lost to Follow-up|0
1396860|NCT01251614|4610211|P2|Overall Study|Lost to Follow-up|1
1396861|NCT01251614|4610212|P1|Overall Study|Lost to Follow-up|0
1396862|NCT01251614|4610210|P3|Overall Study|Withdrawal by Subject|1
1396863|NCT01251614|4610211|P2|Overall Study|Withdrawal by Subject|2
1396864|NCT01251614|4610212|P1|Overall Study|Withdrawal by Subject|0
1396865|NCT01251614|4610210|P3|Overall Study|Loss of Disease Control|0
1396866|NCT01251614|4610211|P2|Overall Study|Loss of Disease Control|1
1396867|NCT01251614|4610212|P1|Overall Study|Loss of Disease Control|0
1396868|NCT01251614|4610210|P3|Overall Study|Pregnancy|2
1396869|NCT01251614|4610211|P2|Overall Study|Pregnancy|0
1396870|NCT01251614|4610212|P1|Overall Study|Pregnancy|0
1396871|NCT01251614|4610210|P3|Overall Study|Clearing of Psoriatic Lesions|0
1396872|NCT01251614|4610211|P2|Overall Study|Clearing of Psoriatic Lesions|0
1396873|NCT01251614|4610212|P1|Overall Study|Clearing of Psoriatic Lesions|1
1396874|NCT01251614|4610210|P3|Overall Study|Lack of Efficacy|4
1396875|NCT01251614|4610211|P2|Overall Study|Lack of Efficacy|9
1396876|NCT01251614|4610212|P1|Overall Study|Lack of Efficacy|1
1396877|NCT01251614|4610210|P3|Overall Study|Adverse Event|1
1396878|NCT01251614|4610211|P2|Overall Study|Adverse Event|0
1396879|NCT01251614|4610212|P1|Overall Study|Adverse Event|1
1396880|NCT01251380|4610319|P1|Overall Study|Lost to Follow-up|2
1396881|NCT01251380|4610319|P1|Overall Study|Adverse Event|1
1396882|NCT01251380|4610319|P1|Overall Study|Lack of Efficacy|1
1396883|NCT01251380|4610319|P1|Overall Study|Withdrawal by Subject|6
1396884|NCT01251380|4610319|P1|Overall Study|Other (Not otherwise specified)|12
1396885|NCT01251367|4610343|P1|Overall Study|End of Study Visit Performed in Error|1
1396976|NCT01250119|4610935|P1|Treatment Phase|Withdrawal by Subject|0
1396886|NCT01251367|4610343|P1|Overall Study|Subject had Personal or Medical Issues|4
1396887|NCT01251367|4610343|P1|Overall Study|No Study Drug Available|1
1396888|NCT01251367|4610343|P1|Overall Study|Subject Required Alternative Treatment|7
1396889|NCT01251367|4610343|P1|Overall Study|Lost to Follow-up|5
1396890|NCT01251367|4610343|P1|Overall Study|Withdrawal by Subject|36
1396891|NCT01251367|4610343|P1|Overall Study|Adverse Event|19
1396892|NCT01251367|4610343|P1|Overall Study|Lack of Efficacy|2
1396893|NCT01251367|4610343|P1|Overall Study|Protocol Violation|1
1396894|NCT01251354|4610378|P1|Overall Study|Disease Progression|4
1396895|NCT01251354|4610378|P1|Overall Study|Investigator's Decision|1
1396896|NCT01251354|4610378|P1|Overall Study|Adverse Event|1
1396897|NCT01251276|4610421|P2|Overall Study|Lost to Follow-up|1
1396898|NCT01251276|4610422|P1|Overall Study|Lost to Follow-up|0
1396899|NCT01251276|4610421|P2|Overall Study|Protocol Violation|0
1396900|NCT01251276|4610422|P1|Overall Study|Protocol Violation|1
1396901|NCT01251146|4610440|P2|Overall Study|Lost to Follow-up|10
1396902|NCT01251146|4610441|P1|Overall Study|Lost to Follow-up|3
1396903|NCT01251120|4610463|P2|Overall Study|Lack of Efficacy|1
1396904|NCT01251120|4610464|P1|Overall Study|Lack of Efficacy|0
1396905|NCT01250925|4610529|P3|Overall Study|Adverse Event|1
1396906|NCT01250925|4610530|P2|Overall Study|Adverse Event|0
1396907|NCT01250925|4610531|P1|Overall Study|Adverse Event|0
1396908|NCT01250925|4610529|P3|Overall Study|Physician Decision|1
1396909|NCT01250925|4610530|P2|Overall Study|Physician Decision|2
1396910|NCT01250925|4610531|P1|Overall Study|Physician Decision|0
1396911|NCT01250925|4610529|P3|Overall Study|Protocol Violation|0
1396912|NCT01250925|4610530|P2|Overall Study|Protocol Violation|0
1396913|NCT01250925|4610531|P1|Overall Study|Protocol Violation|2
1396914|NCT01250925|4610529|P3|Overall Study|Withdrawal by Subject|0
1396915|NCT01250925|4610530|P2|Overall Study|Withdrawal by Subject|0
1396916|NCT01250925|4610531|P1|Overall Study|Withdrawal by Subject|2
1396917|NCT01250925|4610529|P3|Overall Study|Lost to Follow-up|0
1396918|NCT01250925|4610530|P2|Overall Study|Lost to Follow-up|1
1396919|NCT01250925|4610531|P1|Overall Study|Lost to Follow-up|1
1396920|NCT01250769|4610597|P4|Overall Study|Adverse Event|0
1396921|NCT01250769|4610598|P3|Overall Study|Adverse Event|1
1396922|NCT01250769|4610599|P2|Overall Study|Adverse Event|0
1396923|NCT01250769|4610600|P1|Overall Study|Adverse Event|0
1396924|NCT01250769|4610597|P4|Overall Study|Withdrawal by Subject|0
1396925|NCT01250769|4610598|P3|Overall Study|Withdrawal by Subject|1
1396926|NCT01250769|4610599|P2|Overall Study|Withdrawal by Subject|1
1396927|NCT01250769|4610600|P1|Overall Study|Withdrawal by Subject|0
1396928|NCT01250756|4610632|P2|After Toddler Dose|Adverse Event|1
1396929|NCT01250756|4610633|P1|After Toddler Dose|Adverse Event|0
1396930|NCT01250756|4610632|P2|Toddler Dose|Adverse Event|1
1396931|NCT01250756|4610633|P1|Toddler Dose|Adverse Event|0
1396932|NCT01250756|4610632|P2|After Infant Series|Other|1
1396933|NCT01250756|4610633|P1|After Infant Series|Other|2
1396934|NCT01250756|4610632|P2|After Infant Series|Withdrawal by Subject|1
1396935|NCT01250756|4610633|P1|After Infant Series|Withdrawal by Subject|4
1396936|NCT01250756|4610632|P2|After Infant Series|Adverse Event|2
1396937|NCT01250756|4610633|P1|After Infant Series|Adverse Event|5
1396938|NCT01250756|4610632|P2|Infant Series|Other|0
1396939|NCT01250756|4610633|P1|Infant Series|Other|22
1396940|NCT01250756|4610632|P2|Infant Series|Randomized, Not Vaccinated|2
1396941|NCT01250756|4610633|P1|Infant Series|Randomized, Not Vaccinated|2
1396942|NCT01250756|4610632|P2|Infant Series|Withdrawal by Subject|5
1396943|NCT01250756|4610633|P1|Infant Series|Withdrawal by Subject|4
1396944|NCT01250509|4610750|P2|Overall Study|Lost to Follow-up|2
1396945|NCT01250509|4610751|P1|Overall Study|Lost to Follow-up|5
1396946|NCT01250418|4610765|P2|Overall Study|monitor data failure|1
1396947|NCT01250418|4610766|P1|Overall Study|monitor data failure|1
1396948|NCT01250379|4610774|P2|Overall Study|Participant noncompliance|0
1396949|NCT01250379|4610775|P1|Overall Study|Participant noncompliance|2
1396950|NCT01250379|4610774|P2|Overall Study|Not specified|4
1396951|NCT01250379|4610775|P1|Overall Study|Not specified|0
1396952|NCT01250379|4610774|P2|Overall Study|Adverse Event|4
1396953|NCT01250379|4610775|P1|Overall Study|Adverse Event|5
1396954|NCT01250379|4610774|P2|Overall Study|Lost to Follow-up|6
1396955|NCT01250379|4610775|P1|Overall Study|Lost to Follow-up|9
1396956|NCT01250379|4610774|P2|Overall Study|Protocol Violation|8
1396957|NCT01250379|4610775|P1|Overall Study|Protocol Violation|2
1396958|NCT01250379|4610774|P2|Overall Study|Physician Decision|3
1396959|NCT01250379|4610775|P1|Overall Study|Physician Decision|11
1396960|NCT01250379|4610774|P2|Overall Study|Withdrawal by Subject|20
1396961|NCT01250379|4610775|P1|Overall Study|Withdrawal by Subject|32
1396962|NCT01250379|4610774|P2|Overall Study|Death|148
1396963|NCT01250379|4610775|P1|Overall Study|Death|141
1396964|NCT01250171|4610880|P3|Overall Study|Administrative reasons|0
1396965|NCT01250171|4610881|P2|Overall Study|Administrative reasons|0
1396966|NCT01250171|4610882|P1|Overall Study|Administrative reasons|1
1396967|NCT01250145|4610913|P2|Overall Study|Withdrawal by Subject|4
1396968|NCT01250145|4610914|P1|Overall Study|Withdrawal by Subject|0
1396969|NCT01250145|4610913|P2|Overall Study|Adverse Event|1
1396970|NCT01250145|4610914|P1|Overall Study|Adverse Event|2
1396971|NCT01250119|4610934|P2|Treatment Phase|Unknown reason|4
1396972|NCT01250119|4610935|P1|Treatment Phase|Unknown reason|0
1396973|NCT01250119|4610934|P2|Treatment Phase|Adverse Event|2
1396974|NCT01250119|4610935|P1|Treatment Phase|Adverse Event|0
1396975|NCT01250119|4610934|P2|Treatment Phase|Withdrawal by Subject|1
1396977|NCT01250119|4610934|P2|Treatment Phase|Death|2
1396978|NCT01250119|4610935|P1|Treatment Phase|Death|0
1396979|NCT01250119|4610934|P2|Treatment Phase|Progressive Disease|32
1396980|NCT01250119|4610935|P1|Treatment Phase|Progressive Disease|0
1396981|NCT01250119|4610934|P2|Diagnostic Phase|Participants Not Tested|0
1396982|NCT01250119|4610935|P1|Diagnostic Phase|Participants Not Tested|44
1396983|NCT01250119|4610934|P2|Diagnostic Phase|Failed to Produce a Test Results|0
1396984|NCT01250119|4610935|P1|Diagnostic Phase|Failed to Produce a Test Results|69
1396985|NCT01250054|4610950|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
1396986|NCT01250054|4610951|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
1396987|NCT01250002|4610959|P2|Overall Study|Change to open surgical procedure|3
1396988|NCT01250002|4610960|P1|Overall Study|Change to open surgical procedure|4
1396989|NCT01249833|4611025|P2|Overall Study|Lost to Follow-up|1
1396990|NCT01249833|4611026|P1|Overall Study|Lost to Follow-up|0
1396991|NCT01249664|4611040|P2|Overall Study|Adverse Event|0
1396992|NCT01249664|4611041|P1|Overall Study|Adverse Event|1
1396993|NCT01249664|4611040|P2|Overall Study|Withdrawal by Subject|0
1396994|NCT01249664|4611041|P1|Overall Study|Withdrawal by Subject|5
1396995|NCT01249651|4611091|P1|Overall Study|Sponsor Decision|1
1396996|NCT01249651|4611091|P1|Overall Study|Protocol Violation|1
1396997|NCT01249651|4611091|P1|Overall Study|Adverse Event|1
1396998|NCT01249651|4611091|P1|Overall Study|Withdrawal by Subject|4
1396999|NCT01249417|4611101|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
1397000|NCT01249417|4611102|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
1397001|NCT01249417|4611103|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
1397002|NCT01249417|4611101|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
1397003|NCT01249417|4611102|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
1397004|NCT01249417|4611103|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
1397005|NCT01249417|4611101|P3|Treatment Phase - ITT Population|Adverse Event|1
1397006|NCT01249417|4611102|P2|Treatment Phase - ITT Population|Adverse Event|0
1397007|NCT01249417|4611103|P1|Treatment Phase - ITT Population|Adverse Event|0
1397008|NCT01249417|4611101|P3|Treatment Phase - ITT Population|Not specified|1
1397009|NCT01249417|4611102|P2|Treatment Phase - ITT Population|Not specified|0
1397010|NCT01249417|4611103|P1|Treatment Phase - ITT Population|Not specified|0
1397011|NCT01249417|4611101|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
1397012|NCT01249417|4611102|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
1397013|NCT01249417|4611103|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
1397014|NCT01249417|4611101|P3|Randomised Population|Study treatment not received|2
1397015|NCT01249417|4611102|P2|Randomised Population|Study treatment not received|0
1397016|NCT01249417|4611103|P1|Randomised Population|Study treatment not received|0
1397017|NCT01249404|4611120|P3|Overall Study|Non compliance to visit schedule|0
1397018|NCT01249404|4611121|P2|Overall Study|Non compliance to visit schedule|1
1397019|NCT01249404|4611122|P1|Overall Study|Non compliance to visit schedule|0
1397020|NCT01249404|4611120|P3|Overall Study|Botulinum toxin (BTX) in upper limb|1
1397021|NCT01249404|4611121|P2|Overall Study|Botulinum toxin (BTX) in upper limb|2
1397022|NCT01249404|4611122|P1|Overall Study|Botulinum toxin (BTX) in upper limb|1
1397023|NCT01249404|4611120|P3|Overall Study|Withdrawal by Subject|0
1397024|NCT01249404|4611121|P2|Overall Study|Withdrawal by Subject|2
1397025|NCT01249404|4611122|P1|Overall Study|Withdrawal by Subject|2
1397026|NCT01249404|4611120|P3|Overall Study|Adverse Event|2
1397027|NCT01249404|4611121|P2|Overall Study|Adverse Event|2
1397028|NCT01249404|4611122|P1|Overall Study|Adverse Event|2
1397029|NCT01249404|4611120|P3|Overall Study|No MAS Score at baseline and/or Week 4|2
1397030|NCT01249404|4611121|P2|Overall Study|No MAS Score at baseline and/or Week 4|0
1397031|NCT01249404|4611122|P1|Overall Study|No MAS Score at baseline and/or Week 4|2
1397032|NCT01249404|4611120|P3|Overall Study|Study treatment not received|2
1397033|NCT01249404|4611121|P2|Overall Study|Study treatment not received|1
1397034|NCT01249404|4611122|P1|Overall Study|Study treatment not received|0
1397035|NCT01249365|4611199|P1|Overall Study|Lost to Follow-up|1
1397036|NCT01249274|4611207|P2|Overall Study|Received inpatient substance treatment|2
1397037|NCT01249274|4611208|P1|Overall Study|Received inpatient substance treatment|1
1397038|NCT01249274|4611207|P2|Overall Study|Lost to Follow-up|4
1397039|NCT01249274|4611208|P1|Overall Study|Lost to Follow-up|3
1397040|NCT01249261|4611234|P2|Overall Study|Withdrawal by Subject|0
1397041|NCT01249261|4611235|P1|Overall Study|Withdrawal by Subject|1
1397042|NCT01249157|4611263|P1|Overall Study|Withdrawal by Subject|1
1397043|NCT01249131|4611267|P6|Washout Period of 10 Days|Adverse Event|0
1397044|NCT01249131|4611268|P5|Washout Period of 10 Days|Adverse Event|1
1397045|NCT01249131|4611269|P4|Washout Period of 10 Days|Adverse Event|0
1397046|NCT01249131|4611270|P3|Washout Period of 10 Days|Adverse Event|0
1397047|NCT01249131|4611271|P2|Washout Period of 10 Days|Adverse Event|0
1397048|NCT01249131|4611272|P1|Washout Period of 10 Days|Adverse Event|0
1397049|NCT01249118|4611292|P3|First Washout Period|Physician Decision|0
1397050|NCT01249118|4611293|P2|First Washout Period|Physician Decision|1
1397051|NCT01249118|4611294|P1|First Washout Period|Physician Decision|0
1397052|NCT01249092|4611328|P1|Overall Study|Unable to tolerate expected SE -nausea|1
1397053|NCT01249092|4611328|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
1397054|NCT01248949|4611339|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
1397055|NCT01248949|4611340|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
1397056|NCT01248949|4611341|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
1397057|NCT01248949|4611342|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
1397058|NCT01248949|4611343|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
1397059|NCT01248949|4611339|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
1397060|NCT01248949|4611340|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
1397061|NCT01248949|4611341|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
1397062|NCT01248949|4611342|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
1397063|NCT01248949|4611343|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
1397064|NCT01248949|4611339|P5|Overall Study|Pi Decision Due To Declining Status|0
1397065|NCT01248949|4611340|P4|Overall Study|Pi Decision Due To Declining Status|0
1397066|NCT01248949|4611341|P3|Overall Study|Pi Decision Due To Declining Status|1
1397067|NCT01248949|4611342|P2|Overall Study|Pi Decision Due To Declining Status|0
1397068|NCT01248949|4611343|P1|Overall Study|Pi Decision Due To Declining Status|0
1397069|NCT01248949|4611339|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
1397070|NCT01248949|4611340|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
1397071|NCT01248949|4611341|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
1397072|NCT01248949|4611342|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
1397073|NCT01248949|4611343|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
1397074|NCT01248949|4611339|P5|Overall Study|Participant Went To Hospice|0
1397075|NCT01248949|4611340|P4|Overall Study|Participant Went To Hospice|0
1397076|NCT01248949|4611341|P3|Overall Study|Participant Went To Hospice|1
1397077|NCT01248949|4611342|P2|Overall Study|Participant Went To Hospice|0
1397078|NCT01248949|4611343|P1|Overall Study|Participant Went To Hospice|0
1397079|NCT01248949|4611339|P5|Overall Study|Entered Hospice And Refused Follow Up|1
1397080|NCT01248949|4611340|P4|Overall Study|Entered Hospice And Refused Follow Up|0
1397081|NCT01248949|4611341|P3|Overall Study|Entered Hospice And Refused Follow Up|0
1397082|NCT01248949|4611342|P2|Overall Study|Entered Hospice And Refused Follow Up|0
1397083|NCT01248949|4611343|P1|Overall Study|Entered Hospice And Refused Follow Up|0
1397084|NCT01248949|4611339|P5|Overall Study|Palliative Radiation To Brain Metastases|0
1397085|NCT01248949|4611340|P4|Overall Study|Palliative Radiation To Brain Metastases|0
1397086|NCT01248949|4611341|P3|Overall Study|Palliative Radiation To Brain Metastases|0
1397087|NCT01248949|4611342|P2|Overall Study|Palliative Radiation To Brain Metastases|0
1397088|NCT01248949|4611343|P1|Overall Study|Palliative Radiation To Brain Metastases|1
1397089|NCT01248949|4611339|P5|Overall Study|Alternative Therapy.|0
1397090|NCT01248949|4611340|P4|Overall Study|Alternative Therapy.|0
1397091|NCT01248949|4611341|P3|Overall Study|Alternative Therapy.|0
1397092|NCT01248949|4611342|P2|Overall Study|Alternative Therapy.|0
1397093|NCT01248949|4611343|P1|Overall Study|Alternative Therapy.|1
1397094|NCT01248949|4611339|P5|Overall Study|Alternative Therapy|0
1397095|NCT01248949|4611340|P4|Overall Study|Alternative Therapy|0
1397096|NCT01248949|4611341|P3|Overall Study|Alternative Therapy|0
1397097|NCT01248949|4611342|P2|Overall Study|Alternative Therapy|0
1397098|NCT01248949|4611343|P1|Overall Study|Alternative Therapy|1
1397099|NCT01248949|4611339|P5|Overall Study|Death|2
1397100|NCT01248949|4611340|P4|Overall Study|Death|6
1397101|NCT01248949|4611341|P3|Overall Study|Death|21
1397102|NCT01248949|4611342|P2|Overall Study|Death|7
1397103|NCT01248949|4611343|P1|Overall Study|Death|22
1397104|NCT01248949|4611339|P5|Overall Study|Withdrawal by Subject|1
1397105|NCT01248949|4611340|P4|Overall Study|Withdrawal by Subject|3
1397106|NCT01248949|4611341|P3|Overall Study|Withdrawal by Subject|11
1397107|NCT01248949|4611342|P2|Overall Study|Withdrawal by Subject|3
1397108|NCT01248949|4611343|P1|Overall Study|Withdrawal by Subject|5
1397109|NCT01248949|4611339|P5|Overall Study|Lost to Follow-up|0
1397110|NCT01248949|4611340|P4|Overall Study|Lost to Follow-up|1
1397111|NCT01248949|4611341|P3|Overall Study|Lost to Follow-up|2
1397112|NCT01248949|4611342|P2|Overall Study|Lost to Follow-up|2
1397113|NCT01248949|4611343|P1|Overall Study|Lost to Follow-up|2
1397114|NCT01248936|4611455|P1|Overall Study|Other reason|3
1397115|NCT01248936|4611455|P1|Overall Study|Refused Treatment|1
1397116|NCT01248936|4611455|P1|Overall Study|Lost to Follow-up|7
1397117|NCT01248936|4611455|P1|Overall Study|Adverse Event|8
1397118|NCT01248936|4611455|P1|Overall Study|Withdrawal of Consent|20
1397119|NCT01248936|4611455|P1|Overall Study|Death|26
1397120|NCT01248936|4611455|P1|Overall Study|Progression of Disease|50
1397121|NCT01248936|4611455|P1|Overall Study|Sponsor Decision|259
1397122|NCT01248884|4611468|P3|Overall Study|Adverse Event|0
1397123|NCT01248884|4611469|P2|Overall Study|Adverse Event|0
1397124|NCT01248884|4611470|P1|Overall Study|Adverse Event|1
1397125|NCT01248884|4611468|P3|Overall Study|Withdrawal by Subject|1
1397126|NCT01248884|4611469|P2|Overall Study|Withdrawal by Subject|3
1397127|NCT01248884|4611470|P1|Overall Study|Withdrawal by Subject|1
1397128|NCT01248793|4611528|P2|Overall Study|Withdrawal by Subject|3
1397129|NCT01248793|4611529|P1|Overall Study|Withdrawal by Subject|3
1397130|NCT01248793|4611528|P2|Overall Study|Protocol Violation|1
1397131|NCT01248793|4611529|P1|Overall Study|Protocol Violation|0
1397132|NCT01248793|4611528|P2|Overall Study|Adverse Event|1
1397133|NCT01248793|4611529|P1|Overall Study|Adverse Event|1
1397134|NCT01248793|4611528|P2|Overall Study|Lost to Follow-up|1
1397135|NCT01248793|4611529|P1|Overall Study|Lost to Follow-up|0
1397136|NCT01248780|4611543|P2|Overall Study|Not treated|1
1397137|NCT01248780|4611544|P1|Overall Study|Not treated|0
1397138|NCT01248780|4611543|P2|Overall Study|Withdrawal by Subject|4
1397139|NCT01248780|4611544|P1|Overall Study|Withdrawal by Subject|4
1397140|NCT01248780|4611543|P2|Overall Study|Protocol Violation|1
1397141|NCT01248780|4611544|P1|Overall Study|Protocol Violation|1
1397142|NCT01248780|4611543|P2|Overall Study|Adverse Event|7
1397143|NCT01248780|4611544|P1|Overall Study|Adverse Event|2
1397144|NCT01248780|4611543|P2|Overall Study|Death|1
1397145|NCT01248780|4611544|P1|Overall Study|Death|0
1397146|NCT01248780|4611543|P2|Overall Study|Lost to Follow-up|1
1397147|NCT01248780|4611544|P1|Overall Study|Lost to Follow-up|0
1397148|NCT01248780|4611543|P2|Overall Study|Lack of Efficacy|0
1397149|NCT01248780|4611544|P1|Overall Study|Lack of Efficacy|2
1397150|NCT01248728|4611558|P2|Overall Study|Lack of Efficacy|0
1397151|NCT01248728|4611559|P1|Overall Study|Lack of Efficacy|1
1397152|NCT01248728|4611558|P2|Overall Study|Withdrawal by Subject|1
1397153|NCT01248728|4611559|P1|Overall Study|Withdrawal by Subject|2
1397154|NCT01248728|4611558|P2|Overall Study|Adverse Event|1
1397155|NCT01248728|4611559|P1|Overall Study|Adverse Event|1
1397156|NCT01248715|4611575|P2|Overall Study|Not influenza positive|510
1397157|NCT01248715|4611576|P1|Overall Study|Not influenza positive|501
1397158|NCT01248468|4611597|P3|Overall Study|Withdrawal by Subject|0
1397159|NCT01248468|4611598|P2|Overall Study|Withdrawal by Subject|2
1397160|NCT01248468|4611599|P1|Overall Study|Withdrawal by Subject|4
1397161|NCT01248468|4611597|P3|Overall Study|Pregnancy|0
1397162|NCT01248468|4611598|P2|Overall Study|Pregnancy|0
1397163|NCT01248468|4611599|P1|Overall Study|Pregnancy|1
1397164|NCT01248468|4611597|P3|Overall Study|Lost to Follow-up|4
1397165|NCT01248468|4611598|P2|Overall Study|Lost to Follow-up|12
1397166|NCT01248468|4611599|P1|Overall Study|Lost to Follow-up|9
1397167|NCT01248468|4611597|P3|Overall Study|Administrative problem|0
1397168|NCT01248468|4611598|P2|Overall Study|Administrative problem|0
1397169|NCT01248468|4611599|P1|Overall Study|Administrative problem|1
1397170|NCT01248455|4611616|P1|Overall Study|switched to alternate treatment|1
1397171|NCT01248364|4611661|P4|Overall Study|Adverse Event|0
1397172|NCT01248364|4611662|P3|Overall Study|Adverse Event|0
1397173|NCT01248364|4611663|P2|Overall Study|Adverse Event|1
1397174|NCT01248364|4611664|P1|Overall Study|Adverse Event|0
1397175|NCT01248130|4611727|P2|Overall Study|Ineligible|0
1397176|NCT01248130|4611728|P1|Overall Study|Ineligible|1
1397177|NCT01248130|4611727|P2|Overall Study|Protocol Violation|0
1397178|NCT01248130|4611728|P1|Overall Study|Protocol Violation|1
1397179|NCT01248065|4611738|P2|Overall Study|Other|5
1397180|NCT01248065|4611739|P1|Overall Study|Other|3
1397181|NCT01248065|4611738|P2|Overall Study|Third treatment failure event|1
1397182|NCT01248065|4611739|P1|Overall Study|Third treatment failure event|3
1397183|NCT01248065|4611738|P2|Overall Study|Adverse Event|0
1397184|NCT01248065|4611739|P1|Overall Study|Adverse Event|3
1397185|NCT01248065|4611738|P2|Overall Study|Withdrawal by Subject|11
1397186|NCT01248065|4611739|P1|Overall Study|Withdrawal by Subject|14
1397187|NCT01248065|4611738|P2|Overall Study|Lost to Follow-up|5
1397188|NCT01248065|4611739|P1|Overall Study|Lost to Follow-up|3
1397189|NCT01248013|4611749|P1|Overall Study|Withdrawal by Subject|14
1397190|NCT01247922|4611764|P1|Overall Study|Disease progression|4
1397191|NCT01247350|4611833|P5|Overall Study|Entry criteria not met|1
1397192|NCT01247350|4611834|P4|Overall Study|Entry criteria not met|0
1397193|NCT01247350|4611835|P3|Overall Study|Entry criteria not met|0
1397194|NCT01247350|4611836|P2|Overall Study|Entry criteria not met|0
1397195|NCT01247350|4611837|P1|Overall Study|Entry criteria not met|0
1397196|NCT01247350|4611833|P5|Overall Study|Withdrawal by Subject|0
1397197|NCT01247350|4611834|P4|Overall Study|Withdrawal by Subject|1
1397198|NCT01247350|4611835|P3|Overall Study|Withdrawal by Subject|0
1397199|NCT01247350|4611836|P2|Overall Study|Withdrawal by Subject|0
1397200|NCT01247350|4611837|P1|Overall Study|Withdrawal by Subject|0
1397201|NCT01247350|4611833|P5|Overall Study|Adverse Event|0
1397202|NCT01247350|4611834|P4|Overall Study|Adverse Event|0
1397203|NCT01247350|4611835|P3|Overall Study|Adverse Event|1
1397204|NCT01247350|4611836|P2|Overall Study|Adverse Event|0
1397205|NCT01247350|4611837|P1|Overall Study|Adverse Event|0
1397206|NCT01247324|4611895|P2|Overall Study|Lost to Follow-up|1
1397207|NCT01247324|4611896|P1|Overall Study|Lost to Follow-up|1
1397208|NCT01247324|4611895|P2|Overall Study|Adverse Event|13
1397209|NCT01247324|4611896|P1|Overall Study|Adverse Event|25
1397210|NCT01247324|4611895|P2|Overall Study|Consent withdrawn by participant|8
1397211|NCT01247324|4611896|P1|Overall Study|Consent withdrawn by participant|13
1397212|NCT01247324|4611895|P2|Overall Study|Reason not specified|8
1397213|NCT01247324|4611896|P1|Overall Study|Reason not specified|11
1397214|NCT01247324|4611895|P2|Overall Study|Protocol Violation|2
1397215|NCT01247324|4611896|P1|Overall Study|Protocol Violation|1
1397216|NCT01247324|4611895|P2|Overall Study|Pregnancy|3
1397217|NCT01247324|4611896|P1|Overall Study|Pregnancy|2
1397218|NCT01247324|4611895|P2|Overall Study|Non-compliance|0
1397219|NCT01247324|4611896|P1|Overall Study|Non-compliance|2
1397220|NCT01247324|4611895|P2|Overall Study|Lack of Efficacy|8
1397221|NCT01247324|4611896|P1|Overall Study|Lack of Efficacy|12
1397222|NCT01247324|4611895|P2|Overall Study|Non-compliance with study drug|0
1397223|NCT01247324|4611896|P1|Overall Study|Non-compliance with study drug|3
1397224|NCT01247324|4611895|P2|Overall Study|Physician Decision|1
1397225|NCT01247324|4611896|P1|Overall Study|Physician Decision|0
1397226|NCT01247324|4611895|P2|Overall Study|Death|0
1397227|NCT01247324|4611896|P1|Overall Study|Death|1
1397228|NCT01247090|4611989|P3|Overall Study|Withdrawal by Subject|0
1397229|NCT01247090|4611990|P2|Overall Study|Withdrawal by Subject|1
1397230|NCT01247090|4611991|P1|Overall Study|Withdrawal by Subject|0
1397231|NCT01247090|4611989|P3|Overall Study|Physician Decision|0
1397232|NCT01247090|4611990|P2|Overall Study|Physician Decision|0
1397233|NCT01247090|4611991|P1|Overall Study|Physician Decision|1
1397234|NCT01246999|4612020|P4|Overall Study|Withdrawal by Subject|2
1397235|NCT01246999|4612021|P3|Overall Study|Withdrawal by Subject|0
1397236|NCT01246999|4612022|P2|Overall Study|Withdrawal by Subject|0
1397237|NCT01246999|4612023|P1|Overall Study|Withdrawal by Subject|0
1397238|NCT01246999|4612020|P4|Overall Study|Lost to Follow-up|0
1397239|NCT01246999|4612021|P3|Overall Study|Lost to Follow-up|0
1397240|NCT01246999|4612022|P2|Overall Study|Lost to Follow-up|1
1397241|NCT01246999|4612023|P1|Overall Study|Lost to Follow-up|0
1397242|NCT01246973|4612058|P2|Overall Study|Withdrawal by Subject|13
1397243|NCT01246973|4612059|P1|Overall Study|Withdrawal by Subject|7
1397244|NCT01246973|4612058|P2|Overall Study|Adverse Event|9
1397245|NCT01246973|4612059|P1|Overall Study|Adverse Event|16
1397246|NCT01246973|4612058|P2|Overall Study|Other|25
1397247|NCT01246973|4612059|P1|Overall Study|Other|38
1397248|NCT01246960|4612069|P2|Overall Study|Withdrawal (by participant or physician)|3
1397249|NCT01246960|4612070|P1|Overall Study|Withdrawal (by participant or physician)|3
1397250|NCT01246960|4612069|P2|Overall Study|Lost to Follow-up|1
1397251|NCT01246960|4612070|P1|Overall Study|Lost to Follow-up|3
1397252|NCT01246206|4612178|P1|Overall Study|Patient did not receive study regiments.|1
1397253|NCT01246011|4612201|P3|Overall Study|Withdrawal by Subject|1
1397254|NCT01246011|4612202|P2|Overall Study|Withdrawal by Subject|0
1397255|NCT01246011|4612203|P1|Overall Study|Withdrawal by Subject|0
1397256|NCT01246011|4612201|P3|Overall Study|If needed warfarin clinically, withdrawn|3
1397257|NCT01246011|4612202|P2|Overall Study|If needed warfarin clinically, withdrawn|0
1397258|NCT01246011|4612203|P1|Overall Study|If needed warfarin clinically, withdrawn|0
1397259|NCT01245764|4612218|P4|Study Phase A|Lost to Follow-up|0
1397260|NCT01245764|4612219|P3|Study Phase A|Lost to Follow-up|5
1397261|NCT01245764|4612220|P2|Study Phase A|Lost to Follow-up|0
1397262|NCT01245764|4612221|P1|Study Phase A|Lost to Follow-up|0
1397263|NCT01245764|4612218|P4|Study Phase A|Protocol Violation|2
1397264|NCT01245764|4612219|P3|Study Phase A|Protocol Violation|2
1397265|NCT01245764|4612220|P2|Study Phase A|Protocol Violation|3
1397266|NCT01245764|4612221|P1|Study Phase A|Protocol Violation|6
1397267|NCT01245764|4612218|P4|Study Phase A|Other|1
1397268|NCT01245764|4612219|P3|Study Phase A|Other|3
1397269|NCT01245764|4612220|P2|Study Phase A|Other|2
1397270|NCT01245764|4612221|P1|Study Phase A|Other|3
1397271|NCT01245751|4612259|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
1397272|NCT01245751|4612260|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
1397273|NCT01245751|4612261|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
1397274|NCT01245751|4612262|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
1397275|NCT01245751|4612259|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
1397276|NCT01245751|4612260|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
1397277|NCT01245751|4612261|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
1397278|NCT01245751|4612262|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
1397279|NCT01245751|4612259|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
1397280|NCT01245751|4612260|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
1397281|NCT01245751|4612261|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
1397282|NCT01245751|4612262|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
1397283|NCT01245387|4612356|P1|Overall Study|Missing discontinuation status|369
1397284|NCT01245387|4612356|P1|Overall Study|Other|131
1397285|NCT01245387|4612356|P1|Overall Study|Death|3
1397286|NCT01245387|4612356|P1|Overall Study|Adverse Event|9
1397287|NCT01245387|4612356|P1|Overall Study|Lack of Efficacy|195
1397288|NCT01245387|4612356|P1|Overall Study|Lost to Follow-up|106
1397289|NCT01245374|4612405|P1|Overall Study|Withdrawal by Subject|3
1397290|NCT01245374|4612405|P1|Overall Study|Protocol Violation|1
1397291|NCT01245283|4612428|P3|Overall Study|Lost to Follow-up|11
1397292|NCT01245283|4612429|P2|Overall Study|Lost to Follow-up|11
1397293|NCT01245283|4612430|P1|Overall Study|Lost to Follow-up|14
1397294|NCT01245140|4612475|P2|Overall Study|Refused Treatment/Did Not Coopera|1
1397295|NCT01245140|4612476|P1|Overall Study|Refused Treatment/Did Not Coopera|0
1397296|NCT01245140|4612475|P2|Overall Study|Withdrawal by Subject|1
1397297|NCT01245140|4612476|P1|Overall Study|Withdrawal by Subject|0
1397298|NCT01245140|4612475|P2|Overall Study|Protocol Violation|1
1397299|NCT01245140|4612476|P1|Overall Study|Protocol Violation|0
1397300|NCT01245140|4612475|P2|Overall Study|Lack of Efficacy|4
1397301|NCT01245140|4612476|P1|Overall Study|Lack of Efficacy|2
1397302|NCT01245140|4612475|P2|Overall Study|Adverse Event|3
1397303|NCT01245140|4612476|P1|Overall Study|Adverse Event|1
1397304|NCT01245101|4612532|P2|Period 3 (Treatment)|Withdrawal by Subject|0
1397305|NCT01245101|4612533|P1|Period 3 (Treatment)|Withdrawal by Subject|1
1397306|NCT01245101|4612532|P2|Period 2 (Washout)|Withdrawal by Subject|0
1397307|NCT01245101|4612533|P1|Period 2 (Washout)|Withdrawal by Subject|1
1397308|NCT01245101|4612532|P2|Period 1 (Treatment)|Withdrawal by Subject|0
1397309|NCT01245101|4612533|P1|Period 1 (Treatment)|Withdrawal by Subject|2
1397310|NCT01245062|4612543|P3|Cross-over Phase|Study closed/ terminated|11
1397311|NCT01245062|4612544|P2|Cross-over Phase|Study closed/ terminated|0
1397312|NCT01245062|4612545|P1|Cross-over Phase|Study closed/ terminated|0
1397313|NCT01245062|4612543|P3|Cross-over Phase|Withdrew Consent|4
1397314|NCT01245062|4612544|P2|Cross-over Phase|Withdrew Consent|0
1397315|NCT01245062|4612545|P1|Cross-over Phase|Withdrew Consent|0
1397316|NCT01245062|4612543|P3|Cross-over Phase|Physician Decision|1
1397317|NCT01245062|4612544|P2|Cross-over Phase|Physician Decision|0
1397318|NCT01245062|4612545|P1|Cross-over Phase|Physician Decision|0
1397319|NCT01245062|4612543|P3|Cross-over Phase|Lost to Follow-up|1
1397320|NCT01245062|4612544|P2|Cross-over Phase|Lost to Follow-up|0
1397321|NCT01245062|4612545|P1|Cross-over Phase|Lost to Follow-up|0
1397322|NCT01245062|4612543|P3|Randomization and Crossover Phase|Study closed/ terminated|0
1397323|NCT01245062|4612544|P2|Randomization and Crossover Phase|Study closed/ terminated|14
1397324|NCT01245062|4612545|P1|Randomization and Crossover Phase|Study closed/ terminated|23
1397325|NCT01245062|4612543|P3|Randomization and Crossover Phase|Withdrew Consent|0
1397326|NCT01245062|4612544|P2|Randomization and Crossover Phase|Withdrew Consent|11
1397327|NCT01245062|4612545|P1|Randomization and Crossover Phase|Withdrew Consent|12
1397328|NCT01245062|4612543|P3|Randomization and Crossover Phase|Physician Decision|0
1397329|NCT01245062|4612544|P2|Randomization and Crossover Phase|Physician Decision|4
1397330|NCT01245062|4612545|P1|Randomization and Crossover Phase|Physician Decision|2
1397331|NCT01245062|4612543|P3|Randomization and Crossover Phase|Lost to Follow-up|0
1397332|NCT01245062|4612544|P2|Randomization and Crossover Phase|Lost to Follow-up|2
1397333|NCT01245062|4612545|P1|Randomization and Crossover Phase|Lost to Follow-up|4
1397334|NCT01245049|4612583|P2|Overall Study|Lost to Follow-up|2
1397335|NCT01245049|4612584|P1|Overall Study|Lost to Follow-up|1
1397336|NCT01245049|4612583|P2|Overall Study|Withdrawal by Subject|1
1397337|NCT01245049|4612584|P1|Overall Study|Withdrawal by Subject|0
1397338|NCT01245049|4612583|P2|Overall Study|Migrated/moved from study area|1
1397339|NCT01245049|4612584|P1|Overall Study|Migrated/moved from study area|0
1397340|NCT01244984|4612637|P3|Overall Study|Withdrawal by Subject|2
1397341|NCT01244984|4612638|P2|Overall Study|Withdrawal by Subject|2
1397342|NCT01244984|4612639|P1|Overall Study|Withdrawal by Subject|1
1397343|NCT01244984|4612637|P3|Overall Study|Protocol Defined Stopping Criteria|0
1397344|NCT01244984|4612638|P2|Overall Study|Protocol Defined Stopping Criteria|1
1397345|NCT01244984|4612639|P1|Overall Study|Protocol Defined Stopping Criteria|1
1397346|NCT01244984|4612637|P3|Overall Study|Protocol Violation|0
1397347|NCT01244984|4612638|P2|Overall Study|Protocol Violation|0
1397348|NCT01244984|4612639|P1|Overall Study|Protocol Violation|1
1397349|NCT01244984|4612637|P3|Overall Study|Adverse Event|2
1397350|NCT01244984|4612638|P2|Overall Study|Adverse Event|11
1397351|NCT01244984|4612639|P1|Overall Study|Adverse Event|2
1397352|NCT01244906|4612713|P1|Overall Study|Progression of disease post treatment|6
1397353|NCT01244906|4612713|P1|Overall Study|Death|2
1397354|NCT01244893|4612722|P2|1-Week Follow Up|Lost to Follow-up|0
1397355|NCT01244893|4612723|P1|1-Week Follow Up|Lost to Follow-up|1
1397356|NCT01244893|4612722|P2|Baseline|Protocol Violation|1
1397357|NCT01244893|4612723|P1|Baseline|Protocol Violation|0
1397358|NCT01244828|4612735|P1|Overall Study|Other reason (not specified)|1
1397359|NCT01244828|4612735|P1|Overall Study|Lost to Follow-up|2
1397360|NCT01244828|4612735|P1|Overall Study|Lack of Efficacy|7
1397361|NCT01244828|4612735|P1|Overall Study|Withdrawal by Subject|31
1397362|NCT01244828|4612735|P1|Overall Study|Adverse Event|37
1397363|NCT01244815|4612751|P4|Overall Study|Did Not Meet Protocol Eligibility|0
1397364|NCT01244815|4612752|P3|Overall Study|Did Not Meet Protocol Eligibility|0
1397365|NCT01244815|4612753|P2|Overall Study|Did Not Meet Protocol Eligibility|1
1397366|NCT01244815|4612754|P1|Overall Study|Did Not Meet Protocol Eligibility|0
1397367|NCT01244815|4612751|P4|Overall Study|Protocol Violation|1
1397368|NCT01244815|4612752|P3|Overall Study|Protocol Violation|3
1397369|NCT01244815|4612753|P2|Overall Study|Protocol Violation|4
1397370|NCT01244815|4612754|P1|Overall Study|Protocol Violation|7
1397371|NCT01244815|4612751|P4|Overall Study|Withdrawal by Subject|3
1397372|NCT01244815|4612752|P3|Overall Study|Withdrawal by Subject|0
1397373|NCT01244815|4612753|P2|Overall Study|Withdrawal by Subject|2
1397374|NCT01244815|4612754|P1|Overall Study|Withdrawal by Subject|0
1397375|NCT01244815|4612751|P4|Overall Study|Lost to Follow-up|2
1397376|NCT01244815|4612752|P3|Overall Study|Lost to Follow-up|3
1397377|NCT01244815|4612753|P2|Overall Study|Lost to Follow-up|2
1397378|NCT01244815|4612754|P1|Overall Study|Lost to Follow-up|3
1397379|NCT01244815|4612751|P4|Overall Study|Treatment Failure|1
1397380|NCT01244815|4612752|P3|Overall Study|Treatment Failure|0
1397381|NCT01244815|4612753|P2|Overall Study|Treatment Failure|0
1397382|NCT01244815|4612754|P1|Overall Study|Treatment Failure|0
1397383|NCT01244815|4612751|P4|Overall Study|Adverse Event|5
1397384|NCT01244815|4612752|P3|Overall Study|Adverse Event|5
1397385|NCT01244815|4612753|P2|Overall Study|Adverse Event|7
1397386|NCT01244815|4612754|P1|Overall Study|Adverse Event|4
1397387|NCT01244815|4612751|P4|Overall Study|Not Treated|0
1397388|NCT01244815|4612752|P3|Overall Study|Not Treated|0
1397389|NCT01244815|4612753|P2|Overall Study|Not Treated|1
1397390|NCT01244815|4612754|P1|Overall Study|Not Treated|0
1397391|NCT01244620|4612841|P4|Overall Study|Study terminated|4
1397392|NCT01244620|4612842|P3|Overall Study|Study terminated|4
1397393|NCT01244620|4612843|P2|Overall Study|Study terminated|4
1397394|NCT01244620|4612844|P1|Overall Study|Study terminated|4
1397395|NCT01244516|4612903|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
1397396|NCT01244516|4612904|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
1397397|NCT01244516|4612905|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
1397398|NCT01244516|4612903|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
1397399|NCT01244516|4612904|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
1397400|NCT01244516|4612905|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
1397564|NCT01242748|4613378|P1|Overall Study|Miscellaneous reasons|8
1397401|NCT01244516|4612903|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
1397402|NCT01244516|4612904|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
1397403|NCT01244516|4612905|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
1397404|NCT01244516|4612903|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
1397405|NCT01244516|4612904|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
1397406|NCT01244516|4612905|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
1397407|NCT01244516|4612903|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
1397408|NCT01244516|4612904|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
1397409|NCT01244516|4612905|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
1397410|NCT01244516|4612903|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
1397411|NCT01244516|4612904|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
1397412|NCT01244516|4612905|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
1397413|NCT01244516|4612903|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
1397414|NCT01244516|4612904|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
1397415|NCT01244516|4612905|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
1397416|NCT01244490|4612926|P3|Overall Study|Not specified|1
1397417|NCT01244490|4612927|P2|Overall Study|Not specified|0
1397418|NCT01244490|4612928|P1|Overall Study|Not specified|0
1397419|NCT01244490|4612926|P3|Overall Study|Lost to Follow-up|3
1397420|NCT01244490|4612927|P2|Overall Study|Lost to Follow-up|6
1397421|NCT01244490|4612928|P1|Overall Study|Lost to Follow-up|0
1397422|NCT01244490|4612926|P3|Overall Study|Adverse Event|5
1397423|NCT01244490|4612927|P2|Overall Study|Adverse Event|9
1397424|NCT01244490|4612928|P1|Overall Study|Adverse Event|1
1397425|NCT01244490|4612926|P3|Overall Study|Withdrawal by Subject|9
1397426|NCT01244490|4612927|P2|Overall Study|Withdrawal by Subject|4
1397427|NCT01244490|4612928|P1|Overall Study|Withdrawal by Subject|4
1397428|NCT01244490|4612926|P3|Overall Study|Lack of Efficacy|5
1397429|NCT01244490|4612927|P2|Overall Study|Lack of Efficacy|5
1397430|NCT01244490|4612928|P1|Overall Study|Lack of Efficacy|14
1397431|NCT01244425|4612996|P2|Overall Study|Adverse Event|1
1397432|NCT01244425|4612997|P1|Overall Study|Adverse Event|1
1397433|NCT01244425|4612996|P2|Overall Study|Withdrawal by Subject|2
1397434|NCT01244425|4612997|P1|Overall Study|Withdrawal by Subject|2
1397435|NCT01244126|4613029|P3|Overall Study|Protocol Violation|9
1397436|NCT01244126|4613030|P2|Overall Study|Protocol Violation|3
1397437|NCT01244126|4613031|P1|Overall Study|Protocol Violation|3
1397438|NCT01244061|4613044|P2|Overall Study|Randomized but not treated|2
1397439|NCT01244061|4613045|P1|Overall Study|Randomized but not treated|2
1397440|NCT01244061|4613044|P2|Overall Study|Adverse Event|2
1397441|NCT01244061|4613045|P1|Overall Study|Adverse Event|5
1397442|NCT01244061|4613044|P2|Overall Study|Protocol Violation|1
1397443|NCT01244061|4613045|P1|Overall Study|Protocol Violation|1
1397444|NCT01244061|4613044|P2|Overall Study|Not specified|19
1397445|NCT01244061|4613045|P1|Overall Study|Not specified|8
1397446|NCT01244061|4613044|P2|Overall Study|Withdrawal by Subject|46
1397447|NCT01244061|4613045|P1|Overall Study|Withdrawal by Subject|29
1397448|NCT01244061|4613044|P2|Overall Study|Lost to Follow-up|30
1397449|NCT01244061|4613045|P1|Overall Study|Lost to Follow-up|34
1397450|NCT01244061|4613044|P2|Overall Study|Lack of Efficacy|3
1397451|NCT01244061|4613045|P1|Overall Study|Lack of Efficacy|1
1397452|NCT01244061|4613044|P2|Overall Study|Did not meet entrance criteria|0
1397453|NCT01244061|4613045|P1|Overall Study|Did not meet entrance criteria|1
1397454|NCT01244061|4613044|P2|Overall Study|Death|0
1397455|NCT01244061|4613045|P1|Overall Study|Death|1
1397456|NCT01243944|4613059|P2|Overall Study|Physician Decision|2
1397457|NCT01243944|4613060|P1|Overall Study|Physician Decision|2
1397458|NCT01243944|4613059|P2|Overall Study|Patient decision|5
1397459|NCT01243944|4613060|P1|Overall Study|Patient decision|6
1397460|NCT01243944|4613059|P2|Overall Study|Disease progression|1
1397461|NCT01243944|4613060|P1|Overall Study|Disease progression|5
1397462|NCT01243944|4613059|P2|Overall Study|Lack of Efficacy|98
1397463|NCT01243944|4613060|P1|Overall Study|Lack of Efficacy|0
1397464|NCT01243944|4613059|P2|Overall Study|Adverse Event|2
1397465|NCT01243944|4613060|P1|Overall Study|Adverse Event|4
1397466|NCT01243892|4613084|P2|Overall Study|Did not meet eligibility criteria|0
1397467|NCT01243892|4613085|P1|Overall Study|Did not meet eligibility criteria|2
1397468|NCT01243775|4613095|P1|Overall Study|Withdrawal by Subject|2
1397469|NCT01243762|4613109|P7|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1397470|NCT01243762|4613110|P6|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1397471|NCT01243762|4613111|P5|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
1397472|NCT01243762|4613112|P4|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
1397473|NCT01243762|4613113|P3|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1397474|NCT01243762|4613114|P2|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1397475|NCT01243762|4613115|P1|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1397476|NCT01243762|4613109|P7|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
1397477|NCT01243762|4613110|P6|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
1397478|NCT01243762|4613111|P5|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
1397479|NCT01243762|4613112|P4|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
1397480|NCT01243762|4613113|P3|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
1397481|NCT01243762|4613114|P2|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
1397482|NCT01243762|4613115|P1|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
1397565|NCT01242748|4613377|P2|Overall Study|Withdrawal by Subject|2
1397483|NCT01243762|4613109|P7|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
1397484|NCT01243762|4613110|P6|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
1397485|NCT01243762|4613111|P5|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
1397486|NCT01243762|4613112|P4|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
1397487|NCT01243762|4613113|P3|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
1397488|NCT01243762|4613114|P2|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
1397489|NCT01243762|4613115|P1|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
1397490|NCT01243762|4613109|P7|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
1397491|NCT01243762|4613110|P6|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
1397492|NCT01243762|4613111|P5|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
1397493|NCT01243762|4613112|P4|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
1397494|NCT01243762|4613113|P3|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
1397495|NCT01243762|4613114|P2|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
1397496|NCT01243762|4613115|P1|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
1397497|NCT01243762|4613109|P7|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1397498|NCT01243762|4613110|P6|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1397499|NCT01243762|4613111|P5|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1397500|NCT01243762|4613112|P4|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1397501|NCT01243762|4613113|P3|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1397502|NCT01243762|4613114|P2|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
1397503|NCT01243762|4613115|P1|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1397504|NCT01243762|4613109|P7|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
1397505|NCT01243762|4613110|P6|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
1397506|NCT01243762|4613111|P5|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
1397507|NCT01243762|4613112|P4|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
1397508|NCT01243762|4613113|P3|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
1397509|NCT01243762|4613114|P2|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
1397510|NCT01243762|4613115|P1|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
1397511|NCT01243762|4613109|P7|Part 1 (Dose Escalation/MTD)|Physician Decision|0
1397512|NCT01243762|4613110|P6|Part 1 (Dose Escalation/MTD)|Physician Decision|0
1397513|NCT01243762|4613111|P5|Part 1 (Dose Escalation/MTD)|Physician Decision|0
1397514|NCT01243762|4613112|P4|Part 1 (Dose Escalation/MTD)|Physician Decision|1
1397515|NCT01243762|4613113|P3|Part 1 (Dose Escalation/MTD)|Physician Decision|0
1397516|NCT01243762|4613114|P2|Part 1 (Dose Escalation/MTD)|Physician Decision|1
1397517|NCT01243762|4613115|P1|Part 1 (Dose Escalation/MTD)|Physician Decision|0
1397518|NCT01243762|4613109|P7|Part 1 (Dose Escalation/MTD)|Adverse Event|0
1397519|NCT01243762|4613110|P6|Part 1 (Dose Escalation/MTD)|Adverse Event|1
1397520|NCT01243762|4613111|P5|Part 1 (Dose Escalation/MTD)|Adverse Event|1
1397521|NCT01243762|4613112|P4|Part 1 (Dose Escalation/MTD)|Adverse Event|0
1397522|NCT01243762|4613113|P3|Part 1 (Dose Escalation/MTD)|Adverse Event|0
1397523|NCT01243762|4613114|P2|Part 1 (Dose Escalation/MTD)|Adverse Event|2
1397524|NCT01243762|4613115|P1|Part 1 (Dose Escalation/MTD)|Adverse Event|0
1397525|NCT01243671|4613134|P1|Overall Study|Not Specified|1
1397526|NCT01243671|4613134|P1|Overall Study|Anti-adalimumab antibody positive|1
1397527|NCT01243671|4613134|P1|Overall Study|Adverse Event|3
1397528|NCT01243411|4613211|P1|Overall Study|Other|8
1397529|NCT01243411|4613211|P1|Overall Study|Adverse Event|5
1397530|NCT01243411|4613211|P1|Overall Study|Lost to Follow-up|10
1397531|NCT01243411|4613211|P1|Overall Study|Withdrawal by Subject|18
1397532|NCT01243242|4613318|P2|Overall Study|non compliance|0
1397533|NCT01243242|4613319|P1|Overall Study|non compliance|1
1397534|NCT01243242|4613318|P2|Overall Study|sponsor decision|1
1397535|NCT01243242|4613319|P1|Overall Study|sponsor decision|0
1397536|NCT01243242|4613318|P2|Overall Study|Physician Decision|1
1397537|NCT01243242|4613319|P1|Overall Study|Physician Decision|0
1397538|NCT01243242|4613318|P2|Overall Study|Withdrawal by Subject|1
1397539|NCT01243242|4613319|P1|Overall Study|Withdrawal by Subject|1
1397540|NCT01243242|4613318|P2|Overall Study|Adverse Event|1
1397541|NCT01243242|4613319|P1|Overall Study|Adverse Event|1
1397542|NCT01243177|4613333|P2|Overall Study|Other Reason|12
1397543|NCT01243177|4613334|P1|Overall Study|Other Reason|11
1397544|NCT01243177|4613333|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
1397545|NCT01243177|4613334|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1397546|NCT01243177|4613333|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
1397547|NCT01243177|4613334|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
1397548|NCT01243177|4613333|P2|Overall Study|AE, non-serious non-fatal|58
1397549|NCT01243177|4613334|P1|Overall Study|AE, non-serious non-fatal|40
1397550|NCT01243177|4613333|P2|Overall Study|SAE, non-fatal|9
1397551|NCT01243177|4613334|P1|Overall Study|SAE, non-fatal|7
1397552|NCT01243177|4613333|P2|Overall Study|AE, serious fatal|1
1397553|NCT01243177|4613334|P1|Overall Study|AE, serious fatal|0
1397554|NCT01243177|4613333|P2|Overall Study|Withdrawal by Subject|38
1397555|NCT01243177|4613334|P1|Overall Study|Withdrawal by Subject|46
1397556|NCT01243177|4613333|P2|Overall Study|Lost to Follow-up|18
1397557|NCT01243177|4613334|P1|Overall Study|Lost to Follow-up|15
1397558|NCT01243177|4613333|P2|Overall Study|Protocol Violation|10
1397559|NCT01243177|4613334|P1|Overall Study|Protocol Violation|11
1397560|NCT01243177|4613333|P2|Overall Study|Lack of Efficacy|31
1397561|NCT01243177|4613334|P1|Overall Study|Lack of Efficacy|47
1397562|NCT01242813|4613355|P1|Overall Study|Lost to Follow-up|2
1397563|NCT01242748|4613377|P2|Overall Study|Miscellaneous reasons|3
1397566|NCT01242748|4613378|P1|Overall Study|Withdrawal by Subject|10
1397567|NCT01242748|4613377|P2|Overall Study|Protocol Violation|0
1397568|NCT01242748|4613378|P1|Overall Study|Protocol Violation|1
1397569|NCT01242748|4613377|P2|Overall Study|Physician Decision|2
1397570|NCT01242748|4613378|P1|Overall Study|Physician Decision|3
1397571|NCT01242748|4613377|P2|Overall Study|Lost to Follow-up|2
1397572|NCT01242748|4613378|P1|Overall Study|Lost to Follow-up|6
1397573|NCT01242748|4613377|P2|Overall Study|Adverse Event|5
1397574|NCT01242748|4613378|P1|Overall Study|Adverse Event|10
1397575|NCT01242514|4613418|P3|Overall Study|Adverse Event|19
1397576|NCT01242514|4613419|P2|Overall Study|Adverse Event|18
1397577|NCT01242514|4613420|P1|Overall Study|Adverse Event|129
1397578|NCT01242514|4613418|P3|Overall Study|Lost to Follow-up|4
1397579|NCT01242514|4613419|P2|Overall Study|Lost to Follow-up|5
1397580|NCT01242514|4613420|P1|Overall Study|Lost to Follow-up|14
1397581|NCT01242514|4613418|P3|Overall Study|Dev. of study specific discont. criteria|5
1397582|NCT01242514|4613419|P2|Overall Study|Dev. of study specific discont. criteria|3
1397583|NCT01242514|4613420|P1|Overall Study|Dev. of study specific discont. criteria|21
1397584|NCT01242514|4613418|P3|Overall Study|Lack of therapeutic response|10
1397585|NCT01242514|4613419|P2|Overall Study|Lack of therapeutic response|16
1397586|NCT01242514|4613420|P1|Overall Study|Lack of therapeutic response|99
1397587|NCT01242514|4613418|P3|Overall Study|Severe non-compliance to protocol|1
1397588|NCT01242514|4613419|P2|Overall Study|Severe non-compliance to protocol|2
1397589|NCT01242514|4613420|P1|Overall Study|Severe non-compliance to protocol|5
1397590|NCT01242514|4613418|P3|Overall Study|Subject decision|2
1397591|NCT01242514|4613419|P2|Overall Study|Subject decision|8
1397592|NCT01242514|4613420|P1|Overall Study|Subject decision|33
1397593|NCT01242514|4613418|P3|Overall Study|e.g., project closure|171
1397594|NCT01242514|4613419|P2|Overall Study|e.g., project closure|305
1397595|NCT01242514|4613420|P1|Overall Study|e.g., project closure|1042
1397596|NCT01242371|4613439|P2|Overall Study|Protocol Violation|3
1397597|NCT01242371|4613440|P1|Overall Study|Protocol Violation|0
1397598|NCT01242371|4613439|P2|Overall Study|Withdrawal by Subject|2
1397599|NCT01242371|4613440|P1|Overall Study|Withdrawal by Subject|2
1397600|NCT01242176|4613446|P2|Washout Period of 7 Days|Non-compliant with protocol|0
1397601|NCT01242176|4613447|P1|Washout Period of 7 Days|Non-compliant with protocol|1
1397602|NCT01242176|4613446|P2|Washout Period of 7 Days|Adverse Event|2
1397603|NCT01242176|4613447|P1|Washout Period of 7 Days|Adverse Event|0
1397604|NCT01242111|4613457|P1|Overall Study|Did not consent to MOR-100 follow-up|1
1397605|NCT01242111|4613457|P1|Overall Study|Withdrawal by Subject|1
1397606|NCT01242111|4613457|P1|Overall Study|Adverse Event|1
1397607|NCT01242085|4613469|P3|Overall Study|medically unable to have surgery|0
1397608|NCT01242085|4613470|P2|Overall Study|medically unable to have surgery|5
1397609|NCT01242085|4613471|P1|Overall Study|medically unable to have surgery|4
1397610|NCT01242085|4613469|P3|Overall Study|Withdrawal by Subject|0
1397611|NCT01242085|4613470|P2|Overall Study|Withdrawal by Subject|2
1397612|NCT01242085|4613471|P1|Overall Study|Withdrawal by Subject|4
1397613|NCT01242020|4613481|P2|Overall Study|Failed screening|0
1397614|NCT01242020|4613482|P1|Overall Study|Failed screening|1
1397615|NCT01242020|4613481|P2|Overall Study|Withdrawal by Subject|0
1397616|NCT01242020|4613482|P1|Overall Study|Withdrawal by Subject|2
1397617|NCT01241760|4613512|P2|Overall Study|Not specified|1
1397618|NCT01241760|4613513|P1|Overall Study|Not specified|1
1397619|NCT01241760|4613512|P2|Overall Study|Switch To Commercially Available Medicat|4
1397620|NCT01241760|4613513|P1|Overall Study|Switch To Commercially Available Medicat|1
1397621|NCT01241760|4613512|P2|Overall Study|Withdrawal by Subject|13
1397622|NCT01241760|4613513|P1|Overall Study|Withdrawal by Subject|13
1397623|NCT01241760|4613512|P2|Overall Study|Lost to Follow-up|22
1397624|NCT01241760|4613513|P1|Overall Study|Lost to Follow-up|18
1397625|NCT01241760|4613512|P2|Overall Study|Adverse Event|0
1397626|NCT01241760|4613513|P1|Overall Study|Adverse Event|1
1397627|NCT01241591|4613536|P4|Overall Study|Adverse Event|4
1397628|NCT01241591|4613537|P3|Overall Study|Adverse Event|12
1397629|NCT01241591|4613538|P2|Overall Study|Adverse Event|11
1397630|NCT01241591|4613539|P1|Overall Study|Adverse Event|3
1397631|NCT01241591|4613536|P4|Overall Study|Not specified|1
1397632|NCT01241591|4613537|P3|Overall Study|Not specified|0
1397633|NCT01241591|4613538|P2|Overall Study|Not specified|1
1397634|NCT01241591|4613539|P1|Overall Study|Not specified|0
1397635|NCT01241591|4613536|P4|Overall Study|Withdrawal by Subject|2
1397636|NCT01241591|4613537|P3|Overall Study|Withdrawal by Subject|2
1397637|NCT01241591|4613538|P2|Overall Study|Withdrawal by Subject|4
1397638|NCT01241591|4613539|P1|Overall Study|Withdrawal by Subject|6
1397639|NCT01241591|4613536|P4|Overall Study|Screen Failure|0
1397640|NCT01241591|4613537|P3|Overall Study|Screen Failure|1
1397641|NCT01241591|4613538|P2|Overall Study|Screen Failure|2
1397642|NCT01241591|4613539|P1|Overall Study|Screen Failure|3
1397643|NCT01241591|4613536|P4|Overall Study|Lost to Follow-up|2
1397644|NCT01241591|4613537|P3|Overall Study|Lost to Follow-up|2
1397645|NCT01241591|4613538|P2|Overall Study|Lost to Follow-up|2
1397646|NCT01241591|4613539|P1|Overall Study|Lost to Follow-up|1
1397647|NCT01241591|4613536|P4|Overall Study|Protocol Violation|0
1397648|NCT01241591|4613537|P3|Overall Study|Protocol Violation|3
1397649|NCT01241591|4613538|P2|Overall Study|Protocol Violation|2
1397650|NCT01241591|4613539|P1|Overall Study|Protocol Violation|5
1397651|NCT01241591|4613536|P4|Overall Study|Lack of Efficacy|3
1397652|NCT01241591|4613537|P3|Overall Study|Lack of Efficacy|2
1397653|NCT01241591|4613538|P2|Overall Study|Lack of Efficacy|2
1397654|NCT01241591|4613539|P1|Overall Study|Lack of Efficacy|5
1397655|NCT01241552|4613742|P4|Overall Study|Lost to Follow-up|16
1397656|NCT01241552|4613743|P3|Overall Study|Lost to Follow-up|15
1397657|NCT01241552|4613744|P2|Overall Study|Lost to Follow-up|11
1397658|NCT01241552|4613745|P1|Overall Study|Lost to Follow-up|2
1397659|NCT01241552|4613742|P4|Overall Study|Physician Decision|3
1397660|NCT01241552|4613743|P3|Overall Study|Physician Decision|2
1397661|NCT01241552|4613744|P2|Overall Study|Physician Decision|4
1397662|NCT01241552|4613745|P1|Overall Study|Physician Decision|2
1397663|NCT01241552|4613742|P4|Overall Study|Withdrawal by Subject|15
1397664|NCT01241552|4613743|P3|Overall Study|Withdrawal by Subject|14
1397665|NCT01241552|4613744|P2|Overall Study|Withdrawal by Subject|15
1397666|NCT01241552|4613745|P1|Overall Study|Withdrawal by Subject|7
1397667|NCT01241552|4613742|P4|Overall Study|Protocol Violation|1
1397668|NCT01241552|4613743|P3|Overall Study|Protocol Violation|6
1397669|NCT01241552|4613744|P2|Overall Study|Protocol Violation|2
1397670|NCT01241552|4613745|P1|Overall Study|Protocol Violation|0
1397671|NCT01241552|4613742|P4|Overall Study|Progressive Disease|2
1397672|NCT01241552|4613743|P3|Overall Study|Progressive Disease|1
1397673|NCT01241552|4613744|P2|Overall Study|Progressive Disease|0
1397674|NCT01241552|4613745|P1|Overall Study|Progressive Disease|0
1397675|NCT01241552|4613742|P4|Overall Study|Technical Problems|2
1397676|NCT01241552|4613743|P3|Overall Study|Technical Problems|2
1397677|NCT01241552|4613744|P2|Overall Study|Technical Problems|0
1397678|NCT01241552|4613745|P1|Overall Study|Technical Problems|2
1397679|NCT01241552|4613742|P4|Overall Study|Adverse Event|0
1397680|NCT01241552|4613743|P3|Overall Study|Adverse Event|0
1397681|NCT01241552|4613744|P2|Overall Study|Adverse Event|1
1397682|NCT01241552|4613745|P1|Overall Study|Adverse Event|1
1397683|NCT01241552|4613742|P4|Overall Study|Death|25
1397684|NCT01241552|4613743|P3|Overall Study|Death|20
1397685|NCT01241552|4613744|P2|Overall Study|Death|30
1397686|NCT01241552|4613745|P1|Overall Study|Death|26
1397687|NCT01241552|4613742|P4|Overall Study|Lack of Efficacy|0
1397688|NCT01241552|4613743|P3|Overall Study|Lack of Efficacy|0
1397689|NCT01241552|4613744|P2|Overall Study|Lack of Efficacy|0
1397690|NCT01241552|4613745|P1|Overall Study|Lack of Efficacy|1
1397691|NCT01241461|4613840|P2|Overall Study|Progressive Disease|6
1397692|NCT01241461|4613841|P1|Overall Study|Progressive Disease|3
1397693|NCT01241448|4613861|P4|Overall Study|Excluded due to data integrity issues|2
1397694|NCT01241448|4613862|P3|Overall Study|Excluded due to data integrity issues|2
1397695|NCT01241448|4613863|P2|Overall Study|Excluded due to data integrity issues|2
1397696|NCT01241448|4613864|P1|Overall Study|Excluded due to data integrity issues|3
1397697|NCT01241448|4613861|P4|Overall Study|Withdrawal by Subject|6
1397698|NCT01241448|4613862|P3|Overall Study|Withdrawal by Subject|3
1397699|NCT01241448|4613863|P2|Overall Study|Withdrawal by Subject|5
1397700|NCT01241448|4613864|P1|Overall Study|Withdrawal by Subject|4
1397701|NCT01241448|4613861|P4|Overall Study|Sponsor Decision|6
1397702|NCT01241448|4613862|P3|Overall Study|Sponsor Decision|12
1397703|NCT01241448|4613863|P2|Overall Study|Sponsor Decision|14
1397704|NCT01241448|4613864|P1|Overall Study|Sponsor Decision|17
1397705|NCT01241448|4613861|P4|Overall Study|Protocol Violation|6
1397706|NCT01241448|4613862|P3|Overall Study|Protocol Violation|3
1397707|NCT01241448|4613863|P2|Overall Study|Protocol Violation|5
1397708|NCT01241448|4613864|P1|Overall Study|Protocol Violation|10
1397709|NCT01241448|4613861|P4|Overall Study|Physician Decision|0
1397710|NCT01241448|4613862|P3|Overall Study|Physician Decision|0
1397711|NCT01241448|4613863|P2|Overall Study|Physician Decision|2
1397712|NCT01241448|4613864|P1|Overall Study|Physician Decision|0
1397713|NCT01241448|4613861|P4|Overall Study|Lost to Follow-up|1
1397714|NCT01241448|4613862|P3|Overall Study|Lost to Follow-up|1
1397715|NCT01241448|4613863|P2|Overall Study|Lost to Follow-up|1
1397716|NCT01241448|4613864|P1|Overall Study|Lost to Follow-up|2
1397717|NCT01241448|4613861|P4|Overall Study|Adverse Event|2
1397718|NCT01241448|4613862|P3|Overall Study|Adverse Event|2
1397719|NCT01241448|4613863|P2|Overall Study|Adverse Event|0
1397720|NCT01241448|4613864|P1|Overall Study|Adverse Event|1
1397721|NCT01241292|4613930|P2|Overall Study|Participant Discontinued Treatment|2
1397722|NCT01241292|4613931|P1|Overall Study|Participant Discontinued Treatment|0
1397723|NCT01241292|4613930|P2|Overall Study|Study Drug Toxicity|1
1397724|NCT01241292|4613931|P1|Overall Study|Study Drug Toxicity|0
1397725|NCT01241292|4613930|P2|Overall Study|Disease Progression|0
1397726|NCT01241292|4613931|P1|Overall Study|Disease Progression|2
1397727|NCT01241292|4613930|P2|Overall Study|Administrative Reason by Sponsor|0
1397728|NCT01241292|4613931|P1|Overall Study|Administrative Reason by Sponsor|1
1397729|NCT01241279|4613955|P2|Overall Study|Lost to Follow-up|1
1397730|NCT01241279|4613956|P1|Overall Study|Lost to Follow-up|0
1397731|NCT01241240|4613966|P2|Overall Study|Personal Reasons|1
1397732|NCT01241240|4613967|P1|Overall Study|Personal Reasons|1
1397733|NCT01241240|4613966|P2|Overall Study|Lost to Follow-up|4
1397734|NCT01241240|4613967|P1|Overall Study|Lost to Follow-up|2
1397735|NCT01241240|4613966|P2|Overall Study|Adverse Event|4
1397736|NCT01241240|4613967|P1|Overall Study|Adverse Event|5
1397737|NCT01240915|4613985|P9|Overall Study|Insufficient Clinical Response|3
1397738|NCT01240915|4613986|P8|Overall Study|Insufficient Clinical Response|0
1397739|NCT01240915|4613987|P7|Overall Study|Insufficient Clinical Response|6
1397740|NCT01240915|4613988|P6|Overall Study|Insufficient Clinical Response|3
1397741|NCT01240915|4613989|P5|Overall Study|Insufficient Clinical Response|1
1397742|NCT01240915|4613990|P4|Overall Study|Insufficient Clinical Response|0
1397743|NCT01240915|4613991|P3|Overall Study|Insufficient Clinical Response|0
1397744|NCT01240915|4613992|P2|Overall Study|Insufficient Clinical Response|0
1397745|NCT01240915|4613993|P1|Overall Study|Insufficient Clinical Response|0
1397746|NCT01240915|4613985|P9|Overall Study|Other|0
1397747|NCT01240915|4613986|P8|Overall Study|Other|0
1397748|NCT01240915|4613987|P7|Overall Study|Other|0
1397749|NCT01240915|4613988|P6|Overall Study|Other|0
1397750|NCT01240915|4613989|P5|Overall Study|Other|2
1397751|NCT01240915|4613990|P4|Overall Study|Other|0
1397752|NCT01240915|4613991|P3|Overall Study|Other|0
1397753|NCT01240915|4613992|P2|Overall Study|Other|0
1397754|NCT01240915|4613993|P1|Overall Study|Other|0
1397755|NCT01240915|4613985|P9|Overall Study|Withdrawal by Subject|3
1397756|NCT01240915|4613986|P8|Overall Study|Withdrawal by Subject|3
1397757|NCT01240915|4613987|P7|Overall Study|Withdrawal by Subject|2
1397758|NCT01240915|4613988|P6|Overall Study|Withdrawal by Subject|4
1397759|NCT01240915|4613989|P5|Overall Study|Withdrawal by Subject|0
1397760|NCT01240915|4613990|P4|Overall Study|Withdrawal by Subject|2
1397761|NCT01240915|4613991|P3|Overall Study|Withdrawal by Subject|0
1397762|NCT01240915|4613992|P2|Overall Study|Withdrawal by Subject|1
1397763|NCT01240915|4613993|P1|Overall Study|Withdrawal by Subject|2
1397764|NCT01240915|4613985|P9|Overall Study|Lost to Follow-up|1
1397765|NCT01240915|4613986|P8|Overall Study|Lost to Follow-up|1
1397766|NCT01240915|4613987|P7|Overall Study|Lost to Follow-up|0
1397767|NCT01240915|4613988|P6|Overall Study|Lost to Follow-up|1
1397768|NCT01240915|4613989|P5|Overall Study|Lost to Follow-up|1
1397769|NCT01240915|4613990|P4|Overall Study|Lost to Follow-up|0
1397770|NCT01240915|4613991|P3|Overall Study|Lost to Follow-up|0
1397771|NCT01240915|4613992|P2|Overall Study|Lost to Follow-up|0
1397772|NCT01240915|4613993|P1|Overall Study|Lost to Follow-up|0
1397773|NCT01240915|4613985|P9|Overall Study|Adverse Event|1
1397774|NCT01240915|4613986|P8|Overall Study|Adverse Event|0
1397775|NCT01240915|4613987|P7|Overall Study|Adverse Event|0
1397776|NCT01240915|4613988|P6|Overall Study|Adverse Event|2
1397777|NCT01240915|4613989|P5|Overall Study|Adverse Event|0
1397778|NCT01240915|4613990|P4|Overall Study|Adverse Event|1
1397779|NCT01240915|4613991|P3|Overall Study|Adverse Event|0
1397780|NCT01240915|4613992|P2|Overall Study|Adverse Event|0
1397781|NCT01240915|4613993|P1|Overall Study|Adverse Event|0
1397782|NCT01240863|4614267|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
1397783|NCT01240863|4614268|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
1397784|NCT01240863|4614269|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
1397785|NCT01240863|4614267|P3|Double-blind Treatment Period (12 Weeks)|Not specified|5
1397786|NCT01240863|4614268|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
1397787|NCT01240863|4614269|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
1397788|NCT01240863|4614267|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
1397789|NCT01240863|4614268|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
1397790|NCT01240863|4614269|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
1397791|NCT01240863|4614267|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
1397792|NCT01240863|4614268|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
1397793|NCT01240863|4614269|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
1397794|NCT01240863|4614267|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
1397795|NCT01240863|4614268|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
1397796|NCT01240863|4614269|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
1397797|NCT01240863|4614267|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
1397798|NCT01240863|4614268|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
1397799|NCT01240863|4614269|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1397800|NCT01240863|4614267|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
1397801|NCT01240863|4614268|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
1397802|NCT01240863|4614269|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1397803|NCT01240863|4614267|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
1397804|NCT01240863|4614268|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
1397805|NCT01240863|4614269|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
1397806|NCT01240863|4614267|P3|Open-label Titration Period|Not specified|0
1397807|NCT01240863|4614268|P2|Open-label Titration Period|Not specified|0
1397808|NCT01240863|4614269|P1|Open-label Titration Period|Not specified|7
1397809|NCT01240863|4614267|P3|Open-label Titration Period|Dropped out prior to dosing|0
1397810|NCT01240863|4614268|P2|Open-label Titration Period|Dropped out prior to dosing|0
1397811|NCT01240863|4614269|P1|Open-label Titration Period|Dropped out prior to dosing|2
1397812|NCT01240863|4614267|P3|Open-label Titration Period|Noncompliance to study procedures|0
1397813|NCT01240863|4614268|P2|Open-label Titration Period|Noncompliance to study procedures|0
1397814|NCT01240863|4614269|P1|Open-label Titration Period|Noncompliance to study procedures|3
1397815|NCT01240863|4614267|P3|Open-label Titration Period|Noncompliance to study drug admin|0
1397816|NCT01240863|4614268|P2|Open-label Titration Period|Noncompliance to study drug admin|0
1397817|NCT01240863|4614269|P1|Open-label Titration Period|Noncompliance to study drug admin|3
1397818|NCT01240863|4614267|P3|Open-label Titration Period|Protocol Violation|0
1397819|NCT01240863|4614268|P2|Open-label Titration Period|Protocol Violation|0
1397820|NCT01240863|4614269|P1|Open-label Titration Period|Protocol Violation|7
1397821|NCT01240863|4614267|P3|Open-label Titration Period|Withdrawal by Subject|0
1397822|NCT01240863|4614268|P2|Open-label Titration Period|Withdrawal by Subject|0
1397823|NCT01240863|4614269|P1|Open-label Titration Period|Withdrawal by Subject|9
1397824|NCT01240863|4614267|P3|Open-label Titration Period|Lack of Efficacy|0
1397825|NCT01240863|4614268|P2|Open-label Titration Period|Lack of Efficacy|0
1397826|NCT01240863|4614269|P1|Open-label Titration Period|Lack of Efficacy|19
1397827|NCT01240863|4614267|P3|Open-label Titration Period|Adverse Event|0
1397828|NCT01240863|4614268|P2|Open-label Titration Period|Adverse Event|0
1397829|NCT01240863|4614269|P1|Open-label Titration Period|Adverse Event|47
1397830|NCT01240811|4614331|P3|Overall Study|Withdrawal by Subject|1
1397831|NCT01240811|4614332|P2|Overall Study|Withdrawal by Subject|0
1397832|NCT01240811|4614333|P1|Overall Study|Withdrawal by Subject|0
1397833|NCT01240811|4614331|P3|Overall Study|Physician Decision|0
1397834|NCT01240811|4614332|P2|Overall Study|Physician Decision|1
1397835|NCT01240811|4614333|P1|Overall Study|Physician Decision|0
1397836|NCT01240785|4614349|P2|Overall Study|Protocol Violation|3
1397837|NCT01240785|4614350|P1|Overall Study|Protocol Violation|0
1397838|NCT01240785|4614349|P2|Overall Study|Lost to Follow-up|0
1397839|NCT01240785|4614350|P1|Overall Study|Lost to Follow-up|1
1397840|NCT01240746|4614381|P3|Overall Study|Withdrawal by Subject|59
1397841|NCT01240746|4614382|P2|Overall Study|Withdrawal by Subject|13
1397842|NCT01240746|4614383|P1|Overall Study|Withdrawal by Subject|10
1397843|NCT01240746|4614381|P3|Overall Study|Protocol Violation|72
1397844|NCT01240746|4614382|P2|Overall Study|Protocol Violation|15
1397845|NCT01240746|4614383|P1|Overall Study|Protocol Violation|24
1397846|NCT01240746|4614381|P3|Overall Study|Lost to Follow-up|102
1397847|NCT01240746|4614382|P2|Overall Study|Lost to Follow-up|20
1397848|NCT01240746|4614383|P1|Overall Study|Lost to Follow-up|23
1397849|NCT01240746|4614381|P3|Overall Study|Adverse Event|10
1397850|NCT01240746|4614382|P2|Overall Study|Adverse Event|0
1397851|NCT01240746|4614383|P1|Overall Study|Adverse Event|2
1397852|NCT01240590|4614438|P5|Phase II|Refused further treatment|1
1397853|NCT01240590|4614439|P4|Phase II|Refused further treatment|2
1397854|NCT01240590|4614440|P3|Phase II|Refused further treatment|0
1397855|NCT01240590|4614441|P2|Phase II|Refused further treatment|0
1397856|NCT01240590|4614442|P1|Phase II|Refused further treatment|0
1397857|NCT01240590|4614438|P5|Phase I|Refused further treatment|0
1397858|NCT01240590|4614439|P4|Phase I|Refused further treatment|0
1397859|NCT01240590|4614440|P3|Phase I|Refused further treatment|3
1397860|NCT01240590|4614441|P2|Phase I|Refused further treatment|0
1397861|NCT01240590|4614442|P1|Phase I|Refused further treatment|0
1397862|NCT01240551|4614470|P2|Overall Study|Lost to Follow-up|1
1397863|NCT01240551|4614471|P1|Overall Study|Lost to Follow-up|1
1397864|NCT01240551|4614470|P2|Overall Study|Refused further treatment|2
1397865|NCT01240551|4614471|P1|Overall Study|Refused further treatment|3
1397866|NCT01240382|4614481|P2|Overall Study|Fear of adverse events|1
1397867|NCT01240382|4614482|P1|Overall Study|Fear of adverse events|0
1397868|NCT01240382|4614481|P2|Overall Study|Lack of Efficacy|2
1397869|NCT01240382|4614482|P1|Overall Study|Lack of Efficacy|0
1397870|NCT01240382|4614481|P2|Overall Study|Adverse Event|1
1397871|NCT01240382|4614482|P1|Overall Study|Adverse Event|2
1397872|NCT01240356|4614492|P2|Overall Study|MRI contraindication|0
1397873|NCT01240356|4614493|P1|Overall Study|MRI contraindication|1
1397874|NCT01240356|4614492|P2|Overall Study|Withdrawal by Subject|0
1397875|NCT01240356|4614493|P1|Overall Study|Withdrawal by Subject|2
1397876|NCT01240200|4614512|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
1397877|NCT01240200|4614513|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
1397878|NCT01240135|4614521|P2|Period Two, 14 Days of Wear|Adverse Event|1
1397879|NCT01240135|4614522|P1|Period Two, 14 Days of Wear|Adverse Event|0
1397880|NCT01240135|4614521|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
1397881|NCT01240135|4614522|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
1397882|NCT01239992|4614539|P1|Overall Study|Withdrawal by Subject|2
1397883|NCT01239797|4614548|P2|Treated Participants|Poor/Non-compliance|1
1397884|NCT01239797|4614549|P1|Treated Participants|Poor/Non-compliance|0
1397885|NCT01239797|4614548|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
1397886|NCT01239797|4614549|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
1397887|NCT01239797|4614548|P2|Treated Participants|Death|1
1397888|NCT01239797|4614549|P1|Treated Participants|Death|1
1397889|NCT01239797|4614548|P2|Treated Participants|Non-specified|11
1397890|NCT01239797|4614549|P1|Treated Participants|Non-specified|1
1397891|NCT01239797|4614548|P2|Treated Participants|Withdrawal by Subject|23
1397892|NCT01239797|4614549|P1|Treated Participants|Withdrawal by Subject|27
1397893|NCT01239797|4614548|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
1397894|NCT01239797|4614549|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
1397895|NCT01239797|4614548|P2|Treated Participants|Study Drug Toxicity|44
1397896|NCT01239797|4614549|P1|Treated Participants|Study Drug Toxicity|30
1397897|NCT01239797|4614548|P2|Treated Participants|Disease Progression|161
1397898|NCT01239797|4614549|P1|Treated Participants|Disease Progression|153
1397899|NCT01239745|4614557|P1|Overall Study|Adverse Event|1
1397900|NCT01239745|4614557|P1|Overall Study|Study terminated by sponsor|45
1397901|NCT01239732|4614568|P1|Overall Study|Other|19
1397902|NCT01239732|4614568|P1|Overall Study|Treatment failure|2
1397903|NCT01239732|4614568|P1|Overall Study|Investigator's decision|4
1397904|NCT01239732|4614568|P1|Overall Study|Study termination by sponsor|2
1397905|NCT01239732|4614568|P1|Overall Study|Participant non compliance|5
1397906|NCT01239732|4614568|P1|Overall Study|Protocol Violation|3
1397907|NCT01239732|4614568|P1|Overall Study|Adverse Event|6
1397908|NCT01239732|4614568|P1|Overall Study|Withdrawal by Subject|87
1397909|NCT01239732|4614568|P1|Overall Study|Death|226
1397910|NCT01239732|4614568|P1|Overall Study|Termination of study per protocol|667
1397911|NCT01239680|4614581|P2|Overall Study|Withdrawal by Subject|0
1397912|NCT01239680|4614582|P1|Overall Study|Withdrawal by Subject|2
1397913|NCT01239394|4614605|P1|Overall Study|Adverse Event|1
1397914|NCT01239381|4614612|P1|Overall Study|Withdrawal by Subject|1
1397915|NCT01239381|4614612|P1|Overall Study|Protocol Violation|1
1397916|NCT01239342|4614630|P2|Overall Study|Reason Unknown|1
1397917|NCT01239342|4614631|P1|Overall Study|Reason Unknown|1
1397918|NCT01239342|4614630|P2|Overall Study|Withdrawal by Subject|5
1397919|NCT01239342|4614631|P1|Overall Study|Withdrawal by Subject|1
1397920|NCT01239342|4614630|P2|Overall Study|Adverse Event|0
1397921|NCT01239342|4614631|P1|Overall Study|Adverse Event|1
1397922|NCT01239316|4614647|P1|Overall Study|Adverse Event|1
1397923|NCT01239316|4614647|P1|Overall Study|Progression/Relapse|11
1397924|NCT01239121|4614662|P3|Overall Study|Withdrawal by Subject|0
1397925|NCT01239121|4614663|P2|Overall Study|Withdrawal by Subject|4
1397926|NCT01239121|4614664|P1|Overall Study|Withdrawal by Subject|2
1397927|NCT01239043|4614686|P2|Overall Study|Protocol Violation|1
1397928|NCT01239043|4614687|P1|Overall Study|Protocol Violation|2
1397929|NCT01238991|4614715|P10|Overall Study|Admission to a nursing home|0
1397930|NCT01238991|4614716|P9|Overall Study|Admission to a nursing home|0
1397931|NCT01238991|4614717|P8|Overall Study|Admission to a nursing home|0
1397932|NCT01238991|4614718|P7|Overall Study|Admission to a nursing home|0
1397933|NCT01238991|4614719|P6|Overall Study|Admission to a nursing home|0
1397934|NCT01238991|4614720|P5|Overall Study|Admission to a nursing home|0
1397935|NCT01238991|4614721|P4|Overall Study|Admission to a nursing home|0
1397936|NCT01238991|4614722|P3|Overall Study|Admission to a nursing home|1
1397937|NCT01238991|4614723|P2|Overall Study|Admission to a nursing home|0
1397938|NCT01238991|4614724|P1|Overall Study|Admission to a nursing home|1
1397939|NCT01238991|4614715|P10|Overall Study|Caregiver's request|0
1397940|NCT01238991|4614716|P9|Overall Study|Caregiver's request|1
1397941|NCT01238991|4614717|P8|Overall Study|Caregiver's request|0
1397942|NCT01238991|4614718|P7|Overall Study|Caregiver's request|0
1397943|NCT01238991|4614719|P6|Overall Study|Caregiver's request|0
1397944|NCT01238991|4614720|P5|Overall Study|Caregiver's request|0
1397945|NCT01238991|4614721|P4|Overall Study|Caregiver's request|0
1397946|NCT01238991|4614722|P3|Overall Study|Caregiver's request|0
1397947|NCT01238991|4614723|P2|Overall Study|Caregiver's request|0
1397948|NCT01238991|4614724|P1|Overall Study|Caregiver's request|0
1397949|NCT01238991|4614715|P10|Overall Study|Study Terminated by Sponsor|2
1397950|NCT01238991|4614716|P9|Overall Study|Study Terminated by Sponsor|2
1397951|NCT01238991|4614717|P8|Overall Study|Study Terminated by Sponsor|4
1397952|NCT01238991|4614718|P7|Overall Study|Study Terminated by Sponsor|7
1397953|NCT01238991|4614719|P6|Overall Study|Study Terminated by Sponsor|0
1397954|NCT01238991|4614720|P5|Overall Study|Study Terminated by Sponsor|1
1397955|NCT01238991|4614721|P4|Overall Study|Study Terminated by Sponsor|0
1397956|NCT01238991|4614722|P3|Overall Study|Study Terminated by Sponsor|0
1397957|NCT01238991|4614723|P2|Overall Study|Study Terminated by Sponsor|0
1397958|NCT01238991|4614724|P1|Overall Study|Study Terminated by Sponsor|0
1397959|NCT01238991|4614715|P10|Overall Study|Withdrawal by Subject|0
1397960|NCT01238991|4614716|P9|Overall Study|Withdrawal by Subject|0
1397961|NCT01238991|4614717|P8|Overall Study|Withdrawal by Subject|0
1397962|NCT01238991|4614718|P7|Overall Study|Withdrawal by Subject|0
1397963|NCT01238991|4614719|P6|Overall Study|Withdrawal by Subject|0
1397964|NCT01238991|4614720|P5|Overall Study|Withdrawal by Subject|0
1397965|NCT01238991|4614721|P4|Overall Study|Withdrawal by Subject|0
1397966|NCT01238991|4614722|P3|Overall Study|Withdrawal by Subject|1
1397967|NCT01238991|4614723|P2|Overall Study|Withdrawal by Subject|0
1397968|NCT01238991|4614724|P1|Overall Study|Withdrawal by Subject|0
1397969|NCT01238991|4614715|P10|Overall Study|Lack of Efficacy|0
1397970|NCT01238991|4614716|P9|Overall Study|Lack of Efficacy|1
1397971|NCT01238991|4614717|P8|Overall Study|Lack of Efficacy|0
1397972|NCT01238991|4614718|P7|Overall Study|Lack of Efficacy|0
1397973|NCT01238991|4614719|P6|Overall Study|Lack of Efficacy|0
1397974|NCT01238991|4614720|P5|Overall Study|Lack of Efficacy|0
1397975|NCT01238991|4614721|P4|Overall Study|Lack of Efficacy|0
1397976|NCT01238991|4614722|P3|Overall Study|Lack of Efficacy|1
1397977|NCT01238991|4614723|P2|Overall Study|Lack of Efficacy|0
1397978|NCT01238991|4614724|P1|Overall Study|Lack of Efficacy|0
1397979|NCT01238991|4614715|P10|Overall Study|Death|0
1397980|NCT01238991|4614716|P9|Overall Study|Death|0
1397981|NCT01238991|4614717|P8|Overall Study|Death|0
1397982|NCT01238991|4614718|P7|Overall Study|Death|0
1397983|NCT01238991|4614719|P6|Overall Study|Death|0
1397984|NCT01238991|4614720|P5|Overall Study|Death|0
1397985|NCT01238991|4614721|P4|Overall Study|Death|1
1397986|NCT01238991|4614722|P3|Overall Study|Death|0
1397987|NCT01238991|4614723|P2|Overall Study|Death|0
1397988|NCT01238991|4614724|P1|Overall Study|Death|0
1397989|NCT01238991|4614715|P10|Overall Study|Adverse Event|0
1397990|NCT01238991|4614716|P9|Overall Study|Adverse Event|0
1397991|NCT01238991|4614717|P8|Overall Study|Adverse Event|1
1397992|NCT01238991|4614718|P7|Overall Study|Adverse Event|1
1397993|NCT01238991|4614719|P6|Overall Study|Adverse Event|0
1397994|NCT01238991|4614720|P5|Overall Study|Adverse Event|1
1397995|NCT01238991|4614721|P4|Overall Study|Adverse Event|1
1397996|NCT01238991|4614722|P3|Overall Study|Adverse Event|3
1397997|NCT01238991|4614723|P2|Overall Study|Adverse Event|0
1397998|NCT01238991|4614724|P1|Overall Study|Adverse Event|1
1397999|NCT01238900|4614811|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
1398000|NCT01238900|4614811|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
1398001|NCT01238861|4614825|P6|Overall Study|Withdrawal by Subject|9
1398002|NCT01238861|4614826|P5|Overall Study|Withdrawal by Subject|10
1398003|NCT01238861|4614827|P4|Overall Study|Withdrawal by Subject|8
1398004|NCT01238861|4614828|P3|Overall Study|Withdrawal by Subject|4
1398005|NCT01238861|4614829|P2|Overall Study|Withdrawal by Subject|5
1398006|NCT01238861|4614830|P1|Overall Study|Withdrawal by Subject|6
1398007|NCT01238861|4614825|P6|Overall Study|Adverse Event|0
1398008|NCT01238861|4614826|P5|Overall Study|Adverse Event|0
1398009|NCT01238861|4614827|P4|Overall Study|Adverse Event|0
1398010|NCT01238861|4614828|P3|Overall Study|Adverse Event|0
1398011|NCT01238861|4614829|P2|Overall Study|Adverse Event|1
1398012|NCT01238861|4614830|P1|Overall Study|Adverse Event|0
1398013|NCT01238861|4614825|P6|Overall Study|Lack of compliance|1
1398014|NCT01238861|4614826|P5|Overall Study|Lack of compliance|0
1398015|NCT01238861|4614827|P4|Overall Study|Lack of compliance|0
1398016|NCT01238861|4614828|P3|Overall Study|Lack of compliance|0
1398017|NCT01238861|4614829|P2|Overall Study|Lack of compliance|0
1398018|NCT01238861|4614830|P1|Overall Study|Lack of compliance|0
1398019|NCT01238861|4614825|P6|Overall Study|Serious adverse event|1
1398020|NCT01238861|4614826|P5|Overall Study|Serious adverse event|0
1398021|NCT01238861|4614827|P4|Overall Study|Serious adverse event|0
1398022|NCT01238861|4614828|P3|Overall Study|Serious adverse event|0
1398023|NCT01238861|4614829|P2|Overall Study|Serious adverse event|0
1398024|NCT01238861|4614830|P1|Overall Study|Serious adverse event|0
1398025|NCT01238861|4614825|P6|Overall Study|Unable to continue visits|1
1398026|NCT01238861|4614826|P5|Overall Study|Unable to continue visits|0
1398027|NCT01238861|4614827|P4|Overall Study|Unable to continue visits|1
1398028|NCT01238861|4614828|P3|Overall Study|Unable to continue visits|0
1398029|NCT01238861|4614829|P2|Overall Study|Unable to continue visits|0
1398030|NCT01238861|4614830|P1|Overall Study|Unable to continue visits|0
1398031|NCT01238861|4614825|P6|Overall Study|Personal problems|0
1398032|NCT01238861|4614826|P5|Overall Study|Personal problems|0
1398033|NCT01238861|4614827|P4|Overall Study|Personal problems|1
1398034|NCT01238861|4614828|P3|Overall Study|Personal problems|0
1398035|NCT01238861|4614829|P2|Overall Study|Personal problems|0
1398036|NCT01238861|4614830|P1|Overall Study|Personal problems|0
1398037|NCT01238861|4614825|P6|Overall Study|Strongyloides stercoralis antibodies +|0
1398038|NCT01238861|4614826|P5|Overall Study|Strongyloides stercoralis antibodies +|0
1398039|NCT01238861|4614827|P4|Overall Study|Strongyloides stercoralis antibodies +|1
1398040|NCT01238861|4614828|P3|Overall Study|Strongyloides stercoralis antibodies +|0
1398041|NCT01238861|4614829|P2|Overall Study|Strongyloides stercoralis antibodies +|0
1398042|NCT01238861|4614830|P1|Overall Study|Strongyloides stercoralis antibodies +|0
1398043|NCT01238861|4614825|P6|Overall Study|Subject moved out of state/area|0
1398044|NCT01238861|4614826|P5|Overall Study|Subject moved out of state/area|0
1398045|NCT01238861|4614827|P4|Overall Study|Subject moved out of state/area|1
1398046|NCT01238861|4614828|P3|Overall Study|Subject moved out of state/area|1
1398047|NCT01238861|4614829|P2|Overall Study|Subject moved out of state/area|0
1398048|NCT01238861|4614830|P1|Overall Study|Subject moved out of state/area|0
1398049|NCT01238861|4614825|P6|Overall Study|Subject traveled to Argentina by 1 year|0
1398050|NCT01238861|4614826|P5|Overall Study|Subject traveled to Argentina by 1 year|0
1398051|NCT01238861|4614827|P4|Overall Study|Subject traveled to Argentina by 1 year|0
1398052|NCT01238861|4614828|P3|Overall Study|Subject traveled to Argentina by 1 year|1
1398053|NCT01238861|4614829|P2|Overall Study|Subject traveled to Argentina by 1 year|0
1398054|NCT01238861|4614830|P1|Overall Study|Subject traveled to Argentina by 1 year|0
1398055|NCT01238861|4614825|P6|Overall Study|Incorrect enrollment/randomization|0
1398056|NCT01238861|4614826|P5|Overall Study|Incorrect enrollment/randomization|1
1398057|NCT01238861|4614827|P4|Overall Study|Incorrect enrollment/randomization|0
1398058|NCT01238861|4614828|P3|Overall Study|Incorrect enrollment/randomization|1
1398059|NCT01238861|4614829|P2|Overall Study|Incorrect enrollment/randomization|0
1398060|NCT01238861|4614830|P1|Overall Study|Incorrect enrollment/randomization|0
1398061|NCT01238861|4614825|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
1398062|NCT01238861|4614826|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
1398063|NCT01238861|4614827|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
1398064|NCT01238861|4614828|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
1398065|NCT01238861|4614829|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
1398066|NCT01238861|4614830|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
1398067|NCT01238861|4614825|P6|Overall Study|Unplanned surgery|0
1398068|NCT01238861|4614826|P5|Overall Study|Unplanned surgery|0
1398069|NCT01238861|4614827|P4|Overall Study|Unplanned surgery|0
1398070|NCT01238861|4614828|P3|Overall Study|Unplanned surgery|0
1398071|NCT01238861|4614829|P2|Overall Study|Unplanned surgery|0
1398072|NCT01238861|4614830|P1|Overall Study|Unplanned surgery|1
1398073|NCT01238861|4614825|P6|Overall Study|Lost to Follow-up|2
1398074|NCT01238861|4614826|P5|Overall Study|Lost to Follow-up|1
1398075|NCT01238861|4614827|P4|Overall Study|Lost to Follow-up|1
1398076|NCT01238861|4614828|P3|Overall Study|Lost to Follow-up|3
1398077|NCT01238861|4614829|P2|Overall Study|Lost to Follow-up|2
1398078|NCT01238861|4614830|P1|Overall Study|Lost to Follow-up|4
1398079|NCT01238848|4614910|P2|Overall Study|Physician Decision|5
1398080|NCT01238848|4614911|P1|Overall Study|Physician Decision|13
1398081|NCT01238822|4614919|P1|Overall Study|COULD NOT SWALLOW PILLS|3
1398082|NCT01238588|4614946|P1|Overall Study|Physician Decision|2
1398083|NCT01238588|4614946|P1|Overall Study|Withdrawal by Subject|1
1398084|NCT01238575|4614959|P2|Overall Study|Adverse Event|0
1398085|NCT01238575|4614960|P1|Overall Study|Adverse Event|2
1398086|NCT01238575|4614959|P2|Overall Study|Lack of Efficacy|4
1398087|NCT01238575|4614960|P1|Overall Study|Lack of Efficacy|2
1398088|NCT01238211|4615027|P1|Overall Study|Investigator/Patient Decision|3
1398089|NCT01238211|4615027|P1|Overall Study|Non-protocol treatment|4
1398090|NCT01238211|4615027|P1|Overall Study|Withdrawal by Subject|7
1398091|NCT01238211|4615027|P1|Overall Study|Relapse/Progression|2
1398092|NCT01238211|4615027|P1|Overall Study|Death|4
1398093|NCT01238211|4615027|P1|Overall Study|Adverse Event|7
1398094|NCT01238211|4615027|P1|Overall Study|Continues active treatment|31
1398095|NCT01237678|4615034|P3|Phase II|Randomized but were not treated|3
1398096|NCT01237678|4615035|P2|Phase II|Randomized but were not treated|4
1398097|NCT01237678|4615036|P1|Phase II|Randomized but were not treated|0
1398098|NCT01237678|4615034|P3|Phase II|Sponsor Decision/Study Closed|7
1398099|NCT01237678|4615035|P2|Phase II|Sponsor Decision/Study Closed|18
1398100|NCT01237678|4615036|P1|Phase II|Sponsor Decision/Study Closed|0
1398101|NCT01237678|4615034|P3|Phase II|Completed Cycles 4-6|21
1398102|NCT01237678|4615035|P2|Phase II|Completed Cycles 4-6|11
1398103|NCT01237678|4615036|P1|Phase II|Completed Cycles 4-6|0
1398104|NCT01237678|4615034|P3|Phase II|Withdrawal by Subject|5
1398105|NCT01237678|4615035|P2|Phase II|Withdrawal by Subject|1
1398106|NCT01237678|4615036|P1|Phase II|Withdrawal by Subject|0
1398107|NCT01237678|4615034|P3|Phase II|Lack of Efficacy|3
1398108|NCT01237678|4615035|P2|Phase II|Lack of Efficacy|25
1398109|NCT01237678|4615036|P1|Phase II|Lack of Efficacy|0
1398110|NCT01237678|4615034|P3|Phase II|Death|2
1398111|NCT01237678|4615035|P2|Phase II|Death|0
1398112|NCT01237678|4615036|P1|Phase II|Death|0
1398113|NCT01237678|4615034|P3|Phase II|Adverse Event|9
1398114|NCT01237678|4615035|P2|Phase II|Adverse Event|39
1398115|NCT01237678|4615036|P1|Phase II|Adverse Event|0
1398116|NCT01237678|4615034|P3|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
1398117|NCT01237678|4615035|P2|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
1398118|NCT01237678|4615036|P1|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
1398119|NCT01237678|4615034|P3|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
1398120|NCT01237678|4615035|P2|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
1398121|NCT01237678|4615036|P1|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
1398122|NCT01237678|4615034|P3|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
1398123|NCT01237678|4615035|P2|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
1398124|NCT01237678|4615036|P1|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
1398125|NCT01237678|4615034|P3|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
1398126|NCT01237678|4615035|P2|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
1398127|NCT01237678|4615036|P1|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
1398128|NCT01237587|4615081|P2|Taper Phase|Withdrawal by Subject|1
1398129|NCT01237587|4615082|P1|Taper Phase|Withdrawal by Subject|0
1398130|NCT01237587|4615081|P2|Taper Phase|Sponsor Decision|0
1398131|NCT01237587|4615082|P1|Taper Phase|Sponsor Decision|1
1398132|NCT01237587|4615081|P2|Taper Phase|Parent/Guardian Decision|2
1398133|NCT01237587|4615082|P1|Taper Phase|Parent/Guardian Decision|0
1398134|NCT01237587|4615081|P2|Taper Phase|Lack of Efficacy|5
1398135|NCT01237587|4615082|P1|Taper Phase|Lack of Efficacy|2
1398136|NCT01237587|4615081|P2|Taper Phase|Protocol Violation|0
1398137|NCT01237587|4615082|P1|Taper Phase|Protocol Violation|2
1398138|NCT01237587|4615081|P2|Taper Phase|Adverse Event|2
1398139|NCT01237587|4615082|P1|Taper Phase|Adverse Event|0
1398140|NCT01237587|4615081|P2|Open Label Treatment (Extension Phase)|Physician Decision|4
1398141|NCT01237587|4615082|P1|Open Label Treatment (Extension Phase)|Physician Decision|4
1398142|NCT01237587|4615081|P2|Open Label Treatment (Extension Phase)|Sponsor Decision|0
1398143|NCT01237587|4615082|P1|Open Label Treatment (Extension Phase)|Sponsor Decision|1
1398144|NCT01237587|4615081|P2|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
1398145|NCT01237587|4615082|P1|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
1398146|NCT01237587|4615081|P2|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
1398147|NCT01237587|4615082|P1|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
1398148|NCT01237587|4615081|P2|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
1398149|NCT01237587|4615082|P1|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
1398150|NCT01237587|4615081|P2|Open Label Treatment (Extension Phase)|Adverse Event|5
1398151|NCT01237587|4615082|P1|Open Label Treatment (Extension Phase)|Adverse Event|5
1398152|NCT01237587|4615081|P2|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
1398153|NCT01237587|4615082|P1|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
1398154|NCT01237587|4615081|P2|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
1398155|NCT01237587|4615082|P1|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
1398156|NCT01237587|4615081|P2|Double Blind Treatment (Acute Phase)|Protocol Violation|3
1398157|NCT01237587|4615082|P1|Double Blind Treatment (Acute Phase)|Protocol Violation|4
1398158|NCT01237587|4615081|P2|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
1398159|NCT01237587|4615082|P1|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
1398160|NCT01237587|4615081|P2|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
1398161|NCT01237587|4615082|P1|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
1398162|NCT01237587|4615081|P2|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
1398163|NCT01237587|4615082|P1|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
1398164|NCT01237587|4615081|P2|Double Blind Treatment (Acute Phase)|Adverse Event|1
1398165|NCT01237587|4615082|P1|Double Blind Treatment (Acute Phase)|Adverse Event|5
1398166|NCT01237340|4615134|P1|Overall Study|Early termination of the trial|36
1398167|NCT01237340|4615134|P1|Overall Study|Withdrawal by Subject|1
1398168|NCT01237340|4615134|P1|Overall Study|Adverse Event|3
1398169|NCT01237327|4615148|P2|Overall Study|Lost to Follow-up|0
1398170|NCT01237327|4615149|P1|Overall Study|Lost to Follow-up|3
1398171|NCT01237327|4615148|P2|Overall Study|Withdrawal by Subject|3
1398172|NCT01237327|4615149|P1|Overall Study|Withdrawal by Subject|1
1398173|NCT01237327|4615148|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
1398174|NCT01237327|4615149|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
1398175|NCT01237327|4615148|P2|Overall Study|Progression of Disease: Extension Study|13
1398176|NCT01237327|4615149|P1|Overall Study|Progression of Disease: Extension Study|15
1398177|NCT01237327|4615148|P2|Overall Study|Progression of Disease: Core Study|22
1398178|NCT01237327|4615149|P1|Overall Study|Progression of Disease: Core Study|18
1398179|NCT01237327|4615148|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
1398180|NCT01237327|4615149|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
1398181|NCT01237327|4615148|P2|Overall Study|Protocol Violation: Core Study|0
1398182|NCT01237327|4615149|P1|Overall Study|Protocol Violation: Core Study|1
1398183|NCT01237223|4615178|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
1398184|NCT01237223|4615179|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
1398185|NCT01237223|4615180|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
1398186|NCT01237223|4615181|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
1398187|NCT01237223|4615182|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
1398188|NCT01237223|4615183|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
1398189|NCT01237223|4615178|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
1398190|NCT01237223|4615179|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
1398191|NCT01237223|4615180|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
1398192|NCT01237223|4615181|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
1398193|NCT01237223|4615182|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
1398194|NCT01237223|4615183|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
1398195|NCT01237223|4615178|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
1398196|NCT01237223|4615179|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
1398197|NCT01237223|4615180|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
1398198|NCT01237223|4615181|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
1398199|NCT01237223|4615182|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
1398200|NCT01237223|4615183|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
1398201|NCT01237223|4615178|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
1398202|NCT01237223|4615179|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
1398203|NCT01237223|4615180|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
1398204|NCT01237223|4615181|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
1398205|NCT01237223|4615182|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
1398206|NCT01237223|4615183|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
1398207|NCT01237223|4615178|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
1398208|NCT01237223|4615179|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
1398209|NCT01237223|4615180|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
1398210|NCT01237223|4615181|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
1398211|NCT01237223|4615182|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
1398212|NCT01237223|4615183|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
1398213|NCT01237223|4615178|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
1398214|NCT01237223|4615179|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
1398215|NCT01237223|4615180|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
1398216|NCT01237223|4615181|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
1398217|NCT01237223|4615182|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
1398218|NCT01237223|4615183|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
1398219|NCT01237223|4615178|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
1398220|NCT01237223|4615179|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
1398221|NCT01237223|4615180|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
1398222|NCT01237223|4615181|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
1398223|NCT01237223|4615182|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
1398224|NCT01237223|4615183|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
1398225|NCT01237223|4615178|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
1398226|NCT01237223|4615179|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
1398227|NCT01237223|4615180|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
1398228|NCT01237223|4615181|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
1398229|NCT01237223|4615182|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
1398230|NCT01237223|4615183|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
1398231|NCT01237223|4615178|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
1398232|NCT01237223|4615179|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
1398233|NCT01237223|4615180|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
1398234|NCT01237223|4615181|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
1398235|NCT01237223|4615182|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
1398236|NCT01237223|4615183|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
1398237|NCT01237223|4615178|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
1398238|NCT01237223|4615179|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
1398239|NCT01237223|4615180|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
1398240|NCT01237223|4615181|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
1398241|NCT01237223|4615182|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
1398242|NCT01237223|4615183|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
1398243|NCT01237054|4615242|P1|Overall Study|imaging 10C0096|1
1398244|NCT01236573|4615307|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
1398245|NCT01236573|4615308|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1398246|NCT01236573|4615309|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1398247|NCT01236573|4615310|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1398248|NCT01236573|4615311|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1398249|NCT01236573|4615312|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1398250|NCT01236573|4615313|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1398251|NCT01236573|4615314|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1398252|NCT01236573|4615315|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1398253|NCT01236573|4615316|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1398254|NCT01236573|4615317|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1398255|NCT01236573|4615307|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1398256|NCT01236573|4615308|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1398257|NCT01236573|4615309|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
1398258|NCT01236573|4615310|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1398259|NCT01236573|4615311|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1398260|NCT01236573|4615312|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1398261|NCT01236573|4615313|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1398262|NCT01236573|4615314|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1398263|NCT01236573|4615315|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1398264|NCT01236573|4615316|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1398265|NCT01236573|4615317|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1398266|NCT01236573|4615307|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1398267|NCT01236573|4615308|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
1398268|NCT01236573|4615309|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
1398269|NCT01236573|4615310|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1398270|NCT01236573|4615311|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
1398271|NCT01236573|4615312|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1398272|NCT01236573|4615313|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1398273|NCT01236573|4615314|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1398274|NCT01236573|4615315|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1398275|NCT01236573|4615316|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1398276|NCT01236573|4615317|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1398277|NCT01236534|4615355|P2|Overall Study|Adverse Event|0
1398278|NCT01236534|4615356|P1|Overall Study|Adverse Event|3
1398279|NCT01236521|4615366|P2|Overall Study|Lost to Follow-up|7
1398280|NCT01236521|4615367|P1|Overall Study|Lost to Follow-up|7
1398281|NCT01236521|4615366|P2|Overall Study|Death|1
1398282|NCT01236521|4615367|P1|Overall Study|Death|2
1398283|NCT01236521|4615366|P2|Overall Study|Withdrawal by Subject|17
1398284|NCT01236521|4615367|P1|Overall Study|Withdrawal by Subject|12
1398285|NCT01236365|4615417|P2|Overall Study|Dropped at Randomization due to high LFT|0
1398286|NCT01236365|4615418|P1|Overall Study|Dropped at Randomization due to high LFT|1
1398287|NCT01236365|4615417|P2|Overall Study|Moved Out of State|0
1398288|NCT01236365|4615418|P1|Overall Study|Moved Out of State|1
1398289|NCT01236365|4615417|P2|Overall Study|Lost to Follow-up|2
1398290|NCT01236365|4615418|P1|Overall Study|Lost to Follow-up|0
1398291|NCT01236339|4615432|P2|Overall Study|Termination of study by sponsor|13
1398292|NCT01236339|4615433|P1|Overall Study|Termination of study by sponsor|11
1398293|NCT01236118|4615501|P3|Overall Study|Withdrawal by Subject|1
1398294|NCT01236118|4615502|P2|Overall Study|Withdrawal by Subject|0
1398295|NCT01236118|4615503|P1|Overall Study|Withdrawal by Subject|0
1398296|NCT01236118|4615501|P3|Overall Study|Physician Decision|0
1398297|NCT01236118|4615502|P2|Overall Study|Physician Decision|1
1398298|NCT01236118|4615503|P1|Overall Study|Physician Decision|0
1398299|NCT01236118|4615501|P3|Overall Study|Adverse Event|2
1398300|NCT01236118|4615502|P2|Overall Study|Adverse Event|0
1398301|NCT01236118|4615503|P1|Overall Study|Adverse Event|2
1398302|NCT01236001|4615704|P2|Overall Study|Planned Visit After End of Study|1
1398303|NCT01236001|4615705|P1|Overall Study|Planned Visit After End of Study|0
1398304|NCT01236001|4615704|P2|Overall Study|Incompliance|0
1398305|NCT01236001|4615705|P1|Overall Study|Incompliance|1
1398306|NCT01236001|4615704|P2|Overall Study|Lost to Follow-up|1
1398307|NCT01236001|4615705|P1|Overall Study|Lost to Follow-up|6
1398308|NCT01236001|4615704|P2|Overall Study|Lack of Efficacy|6
1398309|NCT01236001|4615705|P1|Overall Study|Lack of Efficacy|6
1398310|NCT01236001|4615704|P2|Overall Study|Adverse Event|14
1398311|NCT01236001|4615705|P1|Overall Study|Adverse Event|5
1398312|NCT01235975|4615737|P2|Overall Study|Lost to Follow-up|3
1398313|NCT01235975|4615738|P1|Overall Study|Lost to Follow-up|7
1398314|NCT01235975|4615737|P2|Overall Study|Migrated/moved from study area|1
1398315|NCT01235975|4615738|P1|Overall Study|Migrated/moved from study area|2
1398316|NCT01235975|4615737|P2|Overall Study|Withdrawal by Subject|2
1398317|NCT01235975|4615738|P1|Overall Study|Withdrawal by Subject|8
1398318|NCT01235975|4615737|P2|Overall Study|Serious Adverse Event|1
1398319|NCT01235975|4615738|P1|Overall Study|Serious Adverse Event|0
1398320|NCT01235741|4615795|P3|Follow-Up Post Treatment up to Month 6|not specified|0
1398321|NCT01235741|4615796|P2|Follow-Up Post Treatment up to Month 6|not specified|1
1398322|NCT01235741|4615797|P1|Follow-Up Post Treatment up to Month 6|not specified|0
1398323|NCT01235741|4615795|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
1398324|NCT01235741|4615796|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
1398325|NCT01235741|4615797|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
1398326|NCT01235741|4615795|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
1398327|NCT01235741|4615796|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
1398328|NCT01235741|4615797|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
1398329|NCT01235741|4615795|P3|Randomized to Treatment|Sponsor terminated study|34
1398330|NCT01235741|4615796|P2|Randomized to Treatment|Sponsor terminated study|35
1398331|NCT01235741|4615797|P1|Randomized to Treatment|Sponsor terminated study|0
1398332|NCT01235741|4615795|P3|Randomized to Treatment|Adverse Event|1
1398333|NCT01235741|4615796|P2|Randomized to Treatment|Adverse Event|1
1398334|NCT01235741|4615797|P1|Randomized to Treatment|Adverse Event|0
1398335|NCT01235741|4615795|P3|Randomized to Treatment|Withdrawal by Subject|1
1398336|NCT01235741|4615796|P2|Randomized to Treatment|Withdrawal by Subject|0
1398337|NCT01235741|4615797|P1|Randomized to Treatment|Withdrawal by Subject|0
1398338|NCT01235741|4615795|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
1398339|NCT01235741|4615796|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
1398340|NCT01235741|4615797|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
1398341|NCT01235741|4615795|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
1398342|NCT01235741|4615796|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
1398343|NCT01235741|4615797|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
1398344|NCT01235741|4615795|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
1398345|NCT01235741|4615796|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
1398346|NCT01235741|4615797|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
1398347|NCT01235741|4615795|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
1398348|NCT01235741|4615796|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
1398349|NCT01235741|4615797|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
1398350|NCT01235741|4615795|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
1398351|NCT01235741|4615796|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
1398352|NCT01235741|4615797|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
1398353|NCT01235741|4615795|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
1398354|NCT01235741|4615796|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
1398355|NCT01235741|4615797|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
1398356|NCT01235728|4615824|P8|Overall Study|Protocol Violation|0
1398357|NCT01235728|4615825|P7|Overall Study|Protocol Violation|0
1398358|NCT01235728|4615826|P6|Overall Study|Protocol Violation|0
1398359|NCT01235728|4615827|P5|Overall Study|Protocol Violation|0
1398360|NCT01235728|4615828|P4|Overall Study|Protocol Violation|1
1398361|NCT01235728|4615829|P3|Overall Study|Protocol Violation|0
1398362|NCT01235728|4615830|P2|Overall Study|Protocol Violation|0
1398363|NCT01235728|4615831|P1|Overall Study|Protocol Violation|0
1398364|NCT01235715|4615841|P2|Overall Study|Physician Decision|2
1398365|NCT01235715|4615842|P1|Overall Study|Physician Decision|0
1398366|NCT01235689|4615882|P2|Overall Study|Miscellaneous|5
1398367|NCT01235689|4615883|P1|Overall Study|Miscellaneous|1
1398368|NCT01235689|4615882|P2|Overall Study|Lost to Follow-up|2
1398369|NCT01235689|4615883|P1|Overall Study|Lost to Follow-up|1
1398370|NCT01235689|4615882|P2|Overall Study|Withdrawal by Subject|4
1398371|NCT01235689|4615883|P1|Overall Study|Withdrawal by Subject|3
1398372|NCT01235689|4615882|P2|Overall Study|Lack of Efficacy|5
1398373|NCT01235689|4615883|P1|Overall Study|Lack of Efficacy|12
1398374|NCT01235689|4615882|P2|Overall Study|Adverse Event|16
1398375|NCT01235689|4615883|P1|Overall Study|Adverse Event|12
1398376|NCT01235598|4615955|P2|Overall Study|Withdrawal by Subject|0
1398377|NCT01235598|4615956|P1|Overall Study|Withdrawal by Subject|1
1398378|NCT01235598|4615955|P2|Overall Study|Lack of Efficacy|1
1398379|NCT01235598|4615956|P1|Overall Study|Lack of Efficacy|0
1398380|NCT01235598|4615955|P2|Overall Study|Adverse Event|3
1398381|NCT01235598|4615956|P1|Overall Study|Adverse Event|0
1398382|NCT01235546|4616001|P2|Overall Study|Protocol Violation|1
1398383|NCT01235546|4616002|P1|Overall Study|Protocol Violation|1
1398384|NCT01235546|4616001|P2|Overall Study|Staff error, medication not administered|0
1398385|NCT01235546|4616002|P1|Overall Study|Staff error, medication not administered|1
1398386|NCT01235507|4616026|P1|Overall Study|Withdrawal by Subject|1
1398387|NCT01235507|4616026|P1|Overall Study|Adverse Event|1
1398388|NCT01235442|4616040|P2|Overall Study|Other unspecified|2
1398389|NCT01235442|4616041|P1|Overall Study|Other unspecified|1
1398390|NCT01235442|4616040|P2|Overall Study|Administrative decision|2
1398391|NCT01235442|4616041|P1|Overall Study|Administrative decision|1
1398392|NCT01235442|4616040|P2|Overall Study|Noncompliance|2
1398393|NCT01235442|4616041|P1|Overall Study|Noncompliance|1
1398394|NCT01235442|4616040|P2|Overall Study|Lack of Efficacy|3
1398395|NCT01235442|4616041|P1|Overall Study|Lack of Efficacy|1
1398396|NCT01235442|4616040|P2|Overall Study|Withdrawal by Subject|9
1398397|NCT01235442|4616041|P1|Overall Study|Withdrawal by Subject|15
1398398|NCT01235442|4616040|P2|Overall Study|Adverse Event|6
1398399|NCT01235442|4616041|P1|Overall Study|Adverse Event|4
1398400|NCT01235442|4616040|P2|Overall Study|Protocol Violation|3
1398401|NCT01235442|4616041|P1|Overall Study|Protocol Violation|3
1398402|NCT01235442|4616040|P2|Overall Study|Ineligibility determined|4
1398403|NCT01235442|4616041|P1|Overall Study|Ineligibility determined|5
1398404|NCT01235442|4616040|P2|Overall Study|Pregnancy|1
1398405|NCT01235442|4616041|P1|Overall Study|Pregnancy|1
1398406|NCT01235442|4616040|P2|Overall Study|Death|2
1398407|NCT01235442|4616041|P1|Overall Study|Death|0
1398408|NCT01235442|4616040|P2|Overall Study|Lost to Follow-up|10
1398409|NCT01235442|4616041|P1|Overall Study|Lost to Follow-up|12
1398410|NCT01235403|4616059|P1|Overall Study|Other reasons for premature termination|4
1398411|NCT01235403|4616059|P1|Overall Study|Lack of Efficacy|2
1398412|NCT01235403|4616059|P1|Overall Study|Withdrawal by Subject|4
1398413|NCT01235403|4616059|P1|Overall Study|Lost to Follow-up|2
1398414|NCT01235403|4616059|P1|Overall Study|Adverse Event|14
1398415|NCT01235338|4616076|P2|Overall Study|Prohibited meds|0
1398416|NCT01235338|4616077|P1|Overall Study|Prohibited meds|1
1398417|NCT01235338|4616076|P2|Overall Study|Positive drug screen|1
1398418|NCT01235338|4616077|P1|Overall Study|Positive drug screen|0
1398419|NCT01235338|4616076|P2|Overall Study|Exclusion criteria violations|1
1398420|NCT01235338|4616077|P1|Overall Study|Exclusion criteria violations|1
1398421|NCT01235338|4616076|P2|Overall Study|Withdrawal by Subject|0
1398422|NCT01235338|4616077|P1|Overall Study|Withdrawal by Subject|5
1398423|NCT01235338|4616076|P2|Overall Study|Protocol Violation|1
1398424|NCT01235338|4616077|P1|Overall Study|Protocol Violation|1
1398425|NCT01235338|4616076|P2|Overall Study|Adverse Event|2
1398426|NCT01235338|4616077|P1|Overall Study|Adverse Event|3
1398427|NCT01235234|4616122|P3|Overall Study|Adverse Event|1
1398428|NCT01235234|4616123|P2|Overall Study|Adverse Event|2
1398429|NCT01235234|4616124|P1|Overall Study|Adverse Event|2
1398430|NCT01234883|4616172|P2|Overall Study|Inclusion/exclusion failure|0
1398431|NCT01234883|4616173|P1|Overall Study|Inclusion/exclusion failure|1
1398432|NCT01234883|4616172|P2|Overall Study|Technical difficulties with IV infusion|1
1398433|NCT01234883|4616173|P1|Overall Study|Technical difficulties with IV infusion|0
1398434|NCT01234883|4616172|P2|Overall Study|Parent/guardian withdrew consent|2
1398435|NCT01234883|4616173|P1|Overall Study|Parent/guardian withdrew consent|1
1398436|NCT01234883|4616172|P2|Overall Study|Early treatment release|10
1398437|NCT01234883|4616173|P1|Overall Study|Early treatment release|8
1398438|NCT01234675|4616220|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
1398439|NCT01234675|4616221|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
1398440|NCT01234675|4616220|P2|First Intervention (6 Weeks)|Adverse Event|1
1398441|NCT01234675|4616221|P1|First Intervention (6 Weeks)|Adverse Event|0
1398442|NCT01234467|4616235|P1|Overall Study|Other complicating disease (stroke)|1
1398443|NCT01234467|4616235|P1|Overall Study|Physician Decision|1
1398444|NCT01234467|4616235|P1|Overall Study|Clinical deterioration|1
1398445|NCT01234467|4616235|P1|Overall Study|Disease Progression|2
1398446|NCT01234467|4616235|P1|Overall Study|Withdrawal by Subject|2
1398447|NCT01234467|4616235|P1|Overall Study|Death|2
1398448|NCT01234467|4616235|P1|Overall Study|Adverse Event|3
1398449|NCT01234337|4616246|P2|Overall Study|Withdrawal by Subject|7
1398450|NCT01234337|4616247|P1|Overall Study|Withdrawal by Subject|11
1398451|NCT01234337|4616246|P2|Overall Study|Protocol Violation|3
1398452|NCT01234337|4616247|P1|Overall Study|Protocol Violation|2
1398453|NCT01234337|4616246|P2|Overall Study|Lost to Follow-up|1
1398454|NCT01234337|4616247|P1|Overall Study|Lost to Follow-up|0
1398455|NCT01234337|4616246|P2|Overall Study|Randomized but not Treated|4
1398456|NCT01234337|4616247|P1|Overall Study|Randomized but not Treated|6
1398457|NCT01234337|4616246|P2|Overall Study|Non-compliant with study medication|2
1398458|NCT01234337|4616247|P1|Overall Study|Non-compliant with study medication|3
1398459|NCT01234337|4616246|P2|Overall Study|InvestigatorDecision notProtocolDriven|3
1398460|NCT01234337|4616247|P1|Overall Study|InvestigatorDecision notProtocolDriven|4
1398461|NCT01234337|4616246|P2|Overall Study|Ongoing|24
1398462|NCT01234337|4616247|P1|Overall Study|Ongoing|16
1398463|NCT01234337|4616246|P2|Overall Study|Adverse Event|20
1398464|NCT01234337|4616247|P1|Overall Study|Adverse Event|55
1398465|NCT01233999|4616307|P1|Overall Study|Lost to Follow-up|1
1398466|NCT01233999|4616307|P1|Overall Study|Withdrawal by Subject|1
1398467|NCT01233869|4616326|P4|Extended Treatment Period (46 Months)|Adverse Event|1
1398468|NCT01233869|4616327|P3|Extended Treatment Period (46 Months)|Adverse Event|0
1398469|NCT01233869|4616328|P2|Extended Treatment Period (46 Months)|Adverse Event|0
1398470|NCT01233869|4616329|P1|Extended Treatment Period (46 Months)|Adverse Event|1
1398471|NCT01233869|4616326|P4|Extended Treatment Period (46 Months)|Other|3
1398472|NCT01233869|4616327|P3|Extended Treatment Period (46 Months)|Other|0
1398473|NCT01233869|4616328|P2|Extended Treatment Period (46 Months)|Other|0
1398474|NCT01233869|4616329|P1|Extended Treatment Period (46 Months)|Other|3
1398475|NCT01233869|4616326|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
1398476|NCT01233869|4616327|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
1398477|NCT01233869|4616328|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
1398478|NCT01233869|4616329|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
1398479|NCT01233869|4616326|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
1398480|NCT01233869|4616327|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
1398481|NCT01233869|4616328|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
1398482|NCT01233869|4616329|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
1398483|NCT01233869|4616326|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
1398484|NCT01233869|4616327|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
1398485|NCT01233869|4616328|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
1398486|NCT01233869|4616329|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
1398487|NCT01233869|4616326|P4|Initial Treatment Period (24 Months)|Adverse Event|3
1398488|NCT01233869|4616327|P3|Initial Treatment Period (24 Months)|Adverse Event|0
1398489|NCT01233869|4616328|P2|Initial Treatment Period (24 Months)|Adverse Event|17
1398490|NCT01233869|4616329|P1|Initial Treatment Period (24 Months)|Adverse Event|9
1398491|NCT01233869|4616326|P4|Initial Treatment Period (24 Months)|Death|0
1398492|NCT01233869|4616327|P3|Initial Treatment Period (24 Months)|Death|0
1398493|NCT01233869|4616328|P2|Initial Treatment Period (24 Months)|Death|0
1398494|NCT01233869|4616329|P1|Initial Treatment Period (24 Months)|Death|1
1398495|NCT01233817|4616415|P1|Overall Study|Withdrawal by Subject|2
1398496|NCT01233817|4616415|P1|Overall Study|Lost to Follow-up|1
1398497|NCT01233687|4616462|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
1398498|NCT01233687|4616462|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
1398499|NCT01233687|4616462|P1|Phase II AMG 102 + Erlotinib|Death|1
1398500|NCT01233609|4616472|P2|Overall Study|Withdrawal by Subject|0
1398501|NCT01233609|4616473|P1|Overall Study|Withdrawal by Subject|3
1398502|NCT01233609|4616472|P2|Overall Study|Adverse Event|1
1398503|NCT01233609|4616473|P1|Overall Study|Adverse Event|2
1398504|NCT01233609|4616472|P2|Overall Study|Lost to Follow-up|1
1398505|NCT01233609|4616473|P1|Overall Study|Lost to Follow-up|3
1398506|NCT01233609|4616472|P2|Overall Study|Death|0
1398507|NCT01233609|4616473|P1|Overall Study|Death|1
1398508|NCT01233284|4616497|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
1398509|NCT01233284|4616498|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
1398510|NCT01233284|4616499|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
1398511|NCT01233284|4616500|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
1398512|NCT01233284|4616501|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
1398513|NCT01233284|4616497|P5|Period 4 (4 Weeks)|Adverse Event|0
1398514|NCT01233284|4616498|P4|Period 4 (4 Weeks)|Adverse Event|0
1398515|NCT01233284|4616499|P3|Period 4 (4 Weeks)|Adverse Event|0
1398516|NCT01233284|4616500|P2|Period 4 (4 Weeks)|Adverse Event|1
1398517|NCT01233284|4616501|P1|Period 4 (4 Weeks)|Adverse Event|0
1398518|NCT01233284|4616497|P5|Period 3 (4 Weeks)|Other|0
1398519|NCT01233284|4616498|P4|Period 3 (4 Weeks)|Other|1
1398520|NCT01233284|4616499|P3|Period 3 (4 Weeks)|Other|0
1398521|NCT01233284|4616500|P2|Period 3 (4 Weeks)|Other|0
1398522|NCT01233284|4616501|P1|Period 3 (4 Weeks)|Other|0
1398523|NCT01233284|4616497|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
1398524|NCT01233284|4616498|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
1398525|NCT01233284|4616499|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
1398526|NCT01233284|4616500|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
1398527|NCT01233284|4616501|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
1398528|NCT01233284|4616497|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
1398529|NCT01233284|4616498|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
1398530|NCT01233284|4616499|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
1398531|NCT01233284|4616500|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
1398532|NCT01233284|4616501|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
1398533|NCT01233284|4616497|P5|Period 1 (4 Weeks)|Other|0
1398534|NCT01233284|4616498|P4|Period 1 (4 Weeks)|Other|0
1398535|NCT01233284|4616499|P3|Period 1 (4 Weeks)|Other|1
1398536|NCT01233284|4616500|P2|Period 1 (4 Weeks)|Other|0
1398537|NCT01233284|4616501|P1|Period 1 (4 Weeks)|Other|0
1398538|NCT01233284|4616497|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
1398539|NCT01233284|4616498|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
1398540|NCT01233284|4616499|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
1398541|NCT01233284|4616500|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
1398542|NCT01233284|4616501|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
1398543|NCT01233284|4616497|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
1398544|NCT01233284|4616498|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
1398545|NCT01233284|4616499|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
1398546|NCT01233284|4616500|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
1398547|NCT01233284|4616501|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
1398548|NCT01233258|4616582|P6|First Intervention (6 Months)|Non-compliance with study medication|0
1398549|NCT01233258|4616583|P5|First Intervention (6 Months)|Non-compliance with study medication|0
1398550|NCT01233258|4616584|P4|First Intervention (6 Months)|Non-compliance with study medication|0
1398551|NCT01233258|4616585|P3|First Intervention (6 Months)|Non-compliance with study medication|0
1398552|NCT01233258|4616586|P2|First Intervention (6 Months)|Non-compliance with study medication|0
1398553|NCT01233258|4616587|P1|First Intervention (6 Months)|Non-compliance with study medication|1
1398554|NCT01233258|4616582|P6|First Intervention (6 Months)|Protocol Violation|0
1398555|NCT01233258|4616583|P5|First Intervention (6 Months)|Protocol Violation|0
1398556|NCT01233258|4616584|P4|First Intervention (6 Months)|Protocol Violation|0
1398557|NCT01233258|4616585|P3|First Intervention (6 Months)|Protocol Violation|1
1398558|NCT01233258|4616586|P2|First Intervention (6 Months)|Protocol Violation|0
1398559|NCT01233258|4616587|P1|First Intervention (6 Months)|Protocol Violation|0
1398560|NCT01233258|4616582|P6|First Intervention (6 Months)|Withdrawal by Subject|1
1398561|NCT01233258|4616583|P5|First Intervention (6 Months)|Withdrawal by Subject|0
1398562|NCT01233258|4616584|P4|First Intervention (6 Months)|Withdrawal by Subject|1
1398563|NCT01233258|4616585|P3|First Intervention (6 Months)|Withdrawal by Subject|0
1398564|NCT01233258|4616586|P2|First Intervention (6 Months)|Withdrawal by Subject|0
1398565|NCT01233258|4616587|P1|First Intervention (6 Months)|Withdrawal by Subject|0
1398566|NCT01233232|4616607|P3|Overall Study|Voluntary Discontinuation by Subject|0
1398567|NCT01233232|4616608|P2|Overall Study|Voluntary Discontinuation by Subject|0
1398568|NCT01233232|4616609|P1|Overall Study|Voluntary Discontinuation by Subject|1
1398569|NCT01233076|4616662|P2|Period 2, One Week|Lost to Follow-up|0
1398570|NCT01233076|4616663|P1|Period 2, One Week|Lost to Follow-up|1
1398571|NCT01233050|4616671|P2|Overall Study|protocol deviation (inclusion/exclusion)|6
1398572|NCT01233050|4616672|P1|Overall Study|protocol deviation (inclusion/exclusion)|8
1398573|NCT01232894|4616705|P2|Overall Study|Physician Decision|1
1398574|NCT01232894|4616706|P1|Overall Study|Physician Decision|2
1398575|NCT01232894|4616705|P2|Overall Study|Withdrawal by Subject|5
1398576|NCT01232894|4616706|P1|Overall Study|Withdrawal by Subject|8
1398577|NCT01232894|4616705|P2|Overall Study|Protocol Violation|1
1398578|NCT01232894|4616706|P1|Overall Study|Protocol Violation|1
1398579|NCT01232894|4616705|P2|Overall Study|Death|0
1398580|NCT01232894|4616706|P1|Overall Study|Death|1
1398581|NCT01232894|4616705|P2|Overall Study|Lost to Follow-up|1
1398582|NCT01232894|4616706|P1|Overall Study|Lost to Follow-up|0
1398583|NCT01232868|4616714|P2|Overall Study|Lost to Follow-up|4
1398584|NCT01232868|4616715|P1|Overall Study|Lost to Follow-up|2
1398585|NCT01232790|4616729|P2|Second Crossover|Withdrawal by Subject|2
1398586|NCT01232790|4616730|P1|Second Crossover|Withdrawal by Subject|1
1398587|NCT01232790|4616729|P2|First Crossover|Withdrawal by Subject|0
1398588|NCT01232790|4616730|P1|First Crossover|Withdrawal by Subject|1
1398589|NCT01232790|4616729|P2|Initial Assessment|Withdrawal by Subject|1
1398590|NCT01232790|4616730|P1|Initial Assessment|Withdrawal by Subject|0
1398591|NCT01232790|4616729|P2|Randomization|Physician Decision|1
1398592|NCT01232790|4616730|P1|Randomization|Physician Decision|0
1398593|NCT01232790|4616729|P2|Randomization|Protocol Violation|1
1398594|NCT01232790|4616730|P1|Randomization|Protocol Violation|0
1398595|NCT01232790|4616729|P2|Randomization|Withdrawal by Subject|0
1398596|NCT01232790|4616730|P1|Randomization|Withdrawal by Subject|2
1398597|NCT01232738|4616784|P1|Overall Study|Adverse Event|5
1398598|NCT01232738|4616784|P1|Overall Study|Withdrawal by Subject|2
1398599|NCT01232738|4616784|P1|Overall Study|Lost to Follow-up|1
1398600|NCT01232738|4616784|P1|Overall Study|Physician Decision|2
1398601|NCT01232738|4616784|P1|Overall Study|Death|3
1398602|NCT01232569|4616800|P4|Double-blind Treatment Period|Death|0
1398603|NCT01232569|4616801|P3|Double-blind Treatment Period|Death|0
1398604|NCT01232569|4616802|P2|Double-blind Treatment Period|Death|0
1398605|NCT01232569|4616803|P1|Double-blind Treatment Period|Death|2
1398606|NCT01232569|4616800|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
1398607|NCT01232569|4616801|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
1398608|NCT01232569|4616802|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
1398609|NCT01232569|4616803|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
1398610|NCT01232569|4616800|P4|Double-blind Treatment Period|Physician Decision|0
1398611|NCT01232569|4616801|P3|Double-blind Treatment Period|Physician Decision|0
1398612|NCT01232569|4616802|P2|Double-blind Treatment Period|Physician Decision|0
1398613|NCT01232569|4616803|P1|Double-blind Treatment Period|Physician Decision|1
1398614|NCT01232569|4616800|P4|Double-blind Treatment Period|Lack of Efficacy|0
1398615|NCT01232569|4616801|P3|Double-blind Treatment Period|Lack of Efficacy|0
1398616|NCT01232569|4616802|P2|Double-blind Treatment Period|Lack of Efficacy|2
1398617|NCT01232569|4616803|P1|Double-blind Treatment Period|Lack of Efficacy|1
1398618|NCT01232569|4616800|P4|Double-blind Treatment Period|Lost to Follow-up|0
1398619|NCT01232569|4616801|P3|Double-blind Treatment Period|Lost to Follow-up|0
1398620|NCT01232569|4616802|P2|Double-blind Treatment Period|Lost to Follow-up|0
1398621|NCT01232569|4616803|P1|Double-blind Treatment Period|Lost to Follow-up|4
1398622|NCT01232569|4616800|P4|Double-blind Treatment Period|Escape|0
1398623|NCT01232569|4616801|P3|Double-blind Treatment Period|Escape|0
1398624|NCT01232569|4616802|P2|Double-blind Treatment Period|Escape|2
1398625|NCT01232569|4616803|P1|Double-blind Treatment Period|Escape|2
1398626|NCT01232569|4616800|P4|Double-blind Treatment Period|Withdrawal by Subject|0
1398627|NCT01232569|4616801|P3|Double-blind Treatment Period|Withdrawal by Subject|0
1398628|NCT01232569|4616802|P2|Double-blind Treatment Period|Withdrawal by Subject|2
1398629|NCT01232569|4616803|P1|Double-blind Treatment Period|Withdrawal by Subject|9
1398630|NCT01232556|4616846|P2|Overall Study|Other|4
1398631|NCT01232556|4616847|P1|Overall Study|Other|6
1398632|NCT01232556|4616846|P2|Overall Study|Terminated by Sponsor|51
1398633|NCT01232556|4616847|P1|Overall Study|Terminated by Sponsor|35
1398634|NCT01232556|4616846|P2|Overall Study|Lost to Follow-up|2
1398635|NCT01232556|4616847|P1|Overall Study|Lost to Follow-up|0
1398636|NCT01232556|4616846|P2|Overall Study|Death|97
1398637|NCT01232556|4616847|P1|Overall Study|Death|97
1398638|NCT01232556|4616846|P2|Overall Study|Withdrawal by Subject|17
1398639|NCT01232556|4616847|P1|Overall Study|Withdrawal by Subject|21
1398640|NCT01232491|4616906|P2|Overall Study|Other|18
1398641|NCT01232491|4616907|P1|Overall Study|Other|21
1398642|NCT01232491|4616906|P2|Overall Study|Withdrawal Criteria|21
1398643|NCT01232491|4616907|P1|Overall Study|Withdrawal Criteria|12
1398644|NCT01232491|4616906|P2|Overall Study|Protocol Violation|11
1398645|NCT01232491|4616907|P1|Overall Study|Protocol Violation|13
1398646|NCT01232491|4616906|P2|Overall Study|Lack of Efficacy|5
1398647|NCT01232491|4616907|P1|Overall Study|Lack of Efficacy|1
1398648|NCT01232491|4616906|P2|Overall Study|Adverse Event|8
1398649|NCT01232491|4616907|P1|Overall Study|Adverse Event|13
1398650|NCT01232452|4616936|P2|Overall Study|Protocol Violation|1
1398651|NCT01232452|4616937|P1|Overall Study|Protocol Violation|0
1398652|NCT01232452|4616936|P2|Overall Study|Sponsor Decision|1
1398653|NCT01232452|4616937|P1|Overall Study|Sponsor Decision|3
1398654|NCT01232452|4616936|P2|Overall Study|Protocol entry criterion not met|2
1398655|NCT01232452|4616937|P1|Overall Study|Protocol entry criterion not met|0
1398656|NCT01232452|4616936|P2|Overall Study|Physician Decision|12
1398657|NCT01232452|4616937|P1|Overall Study|Physician Decision|8
1398658|NCT01232452|4616936|P2|Overall Study|Withdrawal by Subject|8
1398659|NCT01232452|4616937|P1|Overall Study|Withdrawal by Subject|11
1398660|NCT01232452|4616936|P2|Overall Study|Adverse Event|15
1398661|NCT01232452|4616937|P1|Overall Study|Adverse Event|17
1398662|NCT01232296|4616963|P2|Overall Study|Death|6
1398663|NCT01232296|4616964|P1|Overall Study|Death|1
1398664|NCT01232296|4616963|P2|Overall Study|Subject/guardian decision|2
1398665|NCT01232296|4616964|P1|Overall Study|Subject/guardian decision|10
1398666|NCT01232296|4616963|P2|Overall Study|Technical problems|0
1398667|NCT01232296|4616964|P1|Overall Study|Technical problems|3
1398668|NCT01232296|4616963|P2|Overall Study|Study terminated by sponsor|1
1398669|NCT01232296|4616964|P1|Overall Study|Study terminated by sponsor|0
1398670|NCT01232296|4616963|P2|Overall Study|Progressive disease|61
1398671|NCT01232296|4616964|P1|Overall Study|Progressive disease|43
1398672|NCT01232296|4616963|P2|Overall Study|Physician Decision|1
1398673|NCT01232296|4616964|P1|Overall Study|Physician Decision|1
1398674|NCT01232296|4616963|P2|Overall Study|Adverse Event|12
1398675|NCT01232296|4616964|P1|Overall Study|Adverse Event|24
1398676|NCT01232283|4616981|P10|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
1398677|NCT01232283|4616982|P9|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
1398678|NCT01232283|4616983|P8|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1398679|NCT01232283|4616984|P7|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1398680|NCT01232283|4616985|P6|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1398681|NCT01232283|4616986|P5|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1398682|NCT01232283|4616987|P4|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1398683|NCT01232283|4616988|P3|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1398684|NCT01232283|4616989|P2|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1398685|NCT01232283|4616990|P1|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1398686|NCT01232283|4616981|P10|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1398687|NCT01232283|4616982|P9|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
1398688|NCT01232283|4616983|P8|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1398689|NCT01232283|4616984|P7|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1398690|NCT01232283|4616985|P6|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1398691|NCT01232283|4616986|P5|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1398692|NCT01232283|4616987|P4|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1398693|NCT01232283|4616988|P3|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1398694|NCT01232283|4616989|P2|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1398695|NCT01232283|4616990|P1|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1398696|NCT01232283|4616981|P10|Long-Term Extension Phase (Weeks 52-260)|Death|0
1398697|NCT01232283|4616982|P9|Long-Term Extension Phase (Weeks 52-260)|Death|1
1398698|NCT01232283|4616983|P8|Long-Term Extension Phase (Weeks 52-260)|Death|0
1398699|NCT01232283|4616984|P7|Long-Term Extension Phase (Weeks 52-260)|Death|0
1398700|NCT01232283|4616985|P6|Long-Term Extension Phase (Weeks 52-260)|Death|0
1398701|NCT01232283|4616986|P5|Long-Term Extension Phase (Weeks 52-260)|Death|0
1398702|NCT01232283|4616987|P4|Long-Term Extension Phase (Weeks 52-260)|Death|0
1398703|NCT01232283|4616988|P3|Long-Term Extension Phase (Weeks 52-260)|Death|0
1398704|NCT01232283|4616989|P2|Long-Term Extension Phase (Weeks 52-260)|Death|0
1398705|NCT01232283|4616990|P1|Long-Term Extension Phase (Weeks 52-260)|Death|0
1398706|NCT01232283|4616981|P10|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
1398707|NCT01232283|4616982|P9|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
1398708|NCT01232283|4616983|P8|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1398709|NCT01232283|4616984|P7|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1398710|NCT01232283|4616985|P6|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1398711|NCT01232283|4616986|P5|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1398712|NCT01232283|4616987|P4|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1398713|NCT01232283|4616988|P3|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1398714|NCT01232283|4616989|P2|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1398715|NCT01232283|4616990|P1|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1398716|NCT01232283|4616981|P10|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
1398717|NCT01232283|4616982|P9|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
1398718|NCT01232283|4616983|P8|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1398719|NCT01232283|4616984|P7|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1398720|NCT01232283|4616985|P6|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1398721|NCT01232283|4616986|P5|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1398722|NCT01232283|4616987|P4|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1398723|NCT01232283|4616988|P3|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1398724|NCT01232283|4616989|P2|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1398725|NCT01232283|4616990|P1|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1398726|NCT01232283|4616981|P10|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
1398727|NCT01232283|4616982|P9|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
1398728|NCT01232283|4616983|P8|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1398729|NCT01232283|4616984|P7|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1398730|NCT01232283|4616985|P6|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1398731|NCT01232283|4616986|P5|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1398732|NCT01232283|4616987|P4|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1398733|NCT01232283|4616988|P3|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1398734|NCT01232283|4616989|P2|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1398735|NCT01232283|4616990|P1|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1398736|NCT01232283|4616981|P10|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
1398737|NCT01232283|4616982|P9|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
1398738|NCT01232283|4616983|P8|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1398739|NCT01232283|4616984|P7|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1398740|NCT01232283|4616985|P6|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1398741|NCT01232283|4616986|P5|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1398742|NCT01232283|4616987|P4|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1398743|NCT01232283|4616988|P3|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1398744|NCT01232283|4616989|P2|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1398745|NCT01232283|4616990|P1|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1398746|NCT01232283|4616981|P10|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
1398747|NCT01232283|4616982|P9|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
1398748|NCT01232283|4616983|P8|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1398749|NCT01232283|4616984|P7|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1398750|NCT01232283|4616985|P6|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1398751|NCT01232283|4616986|P5|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1398752|NCT01232283|4616987|P4|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1398753|NCT01232283|4616988|P3|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1398754|NCT01232283|4616989|P2|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1398755|NCT01232283|4616990|P1|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1398756|NCT01232283|4616981|P10|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1398757|NCT01232283|4616982|P9|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1398758|NCT01232283|4616983|P8|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1398759|NCT01232283|4616984|P7|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1398760|NCT01232283|4616985|P6|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
1398761|NCT01232283|4616986|P5|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1398762|NCT01232283|4616987|P4|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1398763|NCT01232283|4616988|P3|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1398764|NCT01232283|4616989|P2|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1398765|NCT01232283|4616990|P1|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1398766|NCT01232283|4616981|P10|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1398767|NCT01232283|4616982|P9|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1398768|NCT01232283|4616983|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
1398769|NCT01232283|4616984|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1398770|NCT01232283|4616985|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1398771|NCT01232283|4616986|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1398772|NCT01232283|4616987|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1398773|NCT01232283|4616988|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1398774|NCT01232283|4616989|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1398775|NCT01232283|4616990|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1398776|NCT01232283|4616981|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1398777|NCT01232283|4616982|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1398778|NCT01232283|4616983|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
1398779|NCT01232283|4616984|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
1398780|NCT01232283|4616985|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1398781|NCT01232283|4616986|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
1398782|NCT01232283|4616987|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1398783|NCT01232283|4616988|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1398784|NCT01232283|4616989|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1398785|NCT01232283|4616990|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1398786|NCT01232283|4616981|P10|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1398787|NCT01232283|4616982|P9|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1398788|NCT01232283|4616983|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1398789|NCT01232283|4616984|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1398790|NCT01232283|4616985|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1398791|NCT01232283|4616986|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
1398792|NCT01232283|4616987|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1398793|NCT01232283|4616988|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1398794|NCT01232283|4616989|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1398795|NCT01232283|4616990|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1398796|NCT01232283|4616981|P10|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1398797|NCT01232283|4616982|P9|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1398798|NCT01232283|4616983|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
1398799|NCT01232283|4616984|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
1398800|NCT01232283|4616985|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
1398801|NCT01232283|4616986|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
1398802|NCT01232283|4616987|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1398803|NCT01232283|4616988|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1398804|NCT01232283|4616989|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1398805|NCT01232283|4616990|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1398806|NCT01232283|4616981|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1398807|NCT01232283|4616982|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1398808|NCT01232283|4616983|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
1398809|NCT01232283|4616984|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
1398810|NCT01232283|4616985|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1398811|NCT01232283|4616986|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
1398812|NCT01232283|4616987|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1398813|NCT01232283|4616988|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1398814|NCT01232283|4616989|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1398815|NCT01232283|4616990|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1398816|NCT01232283|4616981|P10|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1398817|NCT01232283|4616982|P9|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1398818|NCT01232283|4616983|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
1398819|NCT01232283|4616984|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1398820|NCT01232283|4616985|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
1398821|NCT01232283|4616986|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
1398822|NCT01232283|4616987|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1398823|NCT01232283|4616988|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1398824|NCT01232283|4616989|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1398825|NCT01232283|4616990|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1398826|NCT01232283|4616981|P10|Maintenance Phase (Weeks16-32)|Other|0
1398827|NCT01232283|4616982|P9|Maintenance Phase (Weeks16-32)|Other|0
1398828|NCT01232283|4616983|P8|Maintenance Phase (Weeks16-32)|Other|0
1398829|NCT01232283|4616984|P7|Maintenance Phase (Weeks16-32)|Other|0
1398830|NCT01232283|4616985|P6|Maintenance Phase (Weeks16-32)|Other|0
1398831|NCT01232283|4616986|P5|Maintenance Phase (Weeks16-32)|Other|0
1398832|NCT01232283|4616987|P4|Maintenance Phase (Weeks16-32)|Other|0
1398833|NCT01232283|4616988|P3|Maintenance Phase (Weeks16-32)|Other|2
1398834|NCT01232283|4616989|P2|Maintenance Phase (Weeks16-32)|Other|0
1398835|NCT01232283|4616990|P1|Maintenance Phase (Weeks16-32)|Other|0
1398836|NCT01232283|4616981|P10|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1398837|NCT01232283|4616982|P9|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1398838|NCT01232283|4616983|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1398839|NCT01232283|4616984|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1398840|NCT01232283|4616985|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1398841|NCT01232283|4616986|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1398842|NCT01232283|4616987|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
1398843|NCT01232283|4616988|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
1398844|NCT01232283|4616989|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1398845|NCT01232283|4616990|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1398846|NCT01232283|4616981|P10|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1398847|NCT01232283|4616982|P9|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1398848|NCT01232283|4616983|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1398849|NCT01232283|4616984|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1398850|NCT01232283|4616985|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1398851|NCT01232283|4616986|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1398852|NCT01232283|4616987|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
1398853|NCT01232283|4616988|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
1398854|NCT01232283|4616989|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1398855|NCT01232283|4616990|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1398856|NCT01232283|4616981|P10|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1398857|NCT01232283|4616982|P9|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1398858|NCT01232283|4616983|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1398859|NCT01232283|4616984|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1398860|NCT01232283|4616985|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1398861|NCT01232283|4616986|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1398862|NCT01232283|4616987|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1398863|NCT01232283|4616988|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
1398864|NCT01232283|4616989|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1398865|NCT01232283|4616990|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1398866|NCT01232283|4616981|P10|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1398867|NCT01232283|4616982|P9|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1398868|NCT01232283|4616983|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1398869|NCT01232283|4616984|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1398870|NCT01232283|4616985|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1398871|NCT01232283|4616986|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1398872|NCT01232283|4616987|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
1398873|NCT01232283|4616988|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
1398874|NCT01232283|4616989|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1398875|NCT01232283|4616990|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1398876|NCT01232283|4616981|P10|Maintenance Phase (Weeks16-32)|Adverse Event|0
1398877|NCT01232283|4616982|P9|Maintenance Phase (Weeks16-32)|Adverse Event|0
1398878|NCT01232283|4616983|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
1398879|NCT01232283|4616984|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
1398880|NCT01232283|4616985|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
1398881|NCT01232283|4616986|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
1398882|NCT01232283|4616987|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
1398883|NCT01232283|4616988|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
1398884|NCT01232283|4616989|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
1398885|NCT01232283|4616990|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
1398886|NCT01232283|4616981|P10|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1398887|NCT01232283|4616982|P9|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1398888|NCT01232283|4616983|P8|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1398889|NCT01232283|4616984|P7|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1398890|NCT01232283|4616985|P6|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1398891|NCT01232283|4616986|P5|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1398892|NCT01232283|4616987|P4|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1398893|NCT01232283|4616988|P3|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
1398894|NCT01232283|4616989|P2|Placebo Controlled Phase (Weeks 0-16)|Not specified|1
1398895|NCT01232283|4616990|P1|Placebo Controlled Phase (Weeks 0-16)|Not specified|2
1398896|NCT01232283|4616981|P10|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1398897|NCT01232283|4616982|P9|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1398898|NCT01232283|4616983|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1398899|NCT01232283|4616984|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1398900|NCT01232283|4616985|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1398901|NCT01232283|4616986|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1398902|NCT01232283|4616987|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1398903|NCT01232283|4616988|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1398904|NCT01232283|4616989|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
1398905|NCT01232283|4616990|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
1398906|NCT01232283|4616981|P10|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1398907|NCT01232283|4616982|P9|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1398908|NCT01232283|4616983|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1398909|NCT01232283|4616984|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1398910|NCT01232283|4616985|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1398911|NCT01232283|4616986|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1398912|NCT01232283|4616987|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1398913|NCT01232283|4616988|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1398914|NCT01232283|4616989|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
1398915|NCT01232283|4616990|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
1398916|NCT01232283|4616981|P10|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1398917|NCT01232283|4616982|P9|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1398918|NCT01232283|4616983|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1398919|NCT01232283|4616984|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1398920|NCT01232283|4616985|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1398921|NCT01232283|4616986|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1398922|NCT01232283|4616987|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1398923|NCT01232283|4616988|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1398924|NCT01232283|4616989|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
1398925|NCT01232283|4616990|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
1398926|NCT01232283|4616981|P10|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1398927|NCT01232283|4616982|P9|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1398928|NCT01232283|4616983|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1398929|NCT01232283|4616984|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1398930|NCT01232283|4616985|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1398931|NCT01232283|4616986|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1398932|NCT01232283|4616987|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1398933|NCT01232283|4616988|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1398934|NCT01232283|4616989|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1398935|NCT01232283|4616990|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
1398936|NCT01232283|4616981|P10|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1398937|NCT01232283|4616982|P9|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1398938|NCT01232283|4616983|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1398939|NCT01232283|4616984|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1398940|NCT01232283|4616985|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1398941|NCT01232283|4616986|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1398942|NCT01232283|4616987|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1398943|NCT01232283|4616988|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1398944|NCT01232283|4616989|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
1398945|NCT01232283|4616990|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
1398946|NCT01232283|4616981|P10|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1398947|NCT01232283|4616982|P9|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1398948|NCT01232283|4616983|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1398949|NCT01232283|4616984|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1398950|NCT01232283|4616985|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1398951|NCT01232283|4616986|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1398952|NCT01232283|4616987|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1398953|NCT01232283|4616988|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1398954|NCT01232283|4616989|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
1398955|NCT01232283|4616990|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
1398956|NCT01232127|4617031|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
1398957|NCT01232127|4617032|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
1398958|NCT01232127|4617033|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
1398959|NCT01231984|4617057|P4|Study Period 2|Did not continue to meet I/E Criteria|1
1398960|NCT01231984|4617058|P3|Study Period 2|Did not continue to meet I/E Criteria|0
1398961|NCT01231984|4617059|P2|Study Period 2|Did not continue to meet I/E Criteria|1
1398962|NCT01231984|4617060|P1|Study Period 2|Did not continue to meet I/E Criteria|1
1398963|NCT01231984|4617057|P4|Study Period 2|Lost to Follow-up|3
1398964|NCT01231984|4617058|P3|Study Period 2|Lost to Follow-up|0
1398965|NCT01231984|4617059|P2|Study Period 2|Lost to Follow-up|0
1398966|NCT01231984|4617060|P1|Study Period 2|Lost to Follow-up|1
1398967|NCT01231984|4617057|P4|Study Period 2|Withdrawal by Subject|0
1398968|NCT01231984|4617058|P3|Study Period 2|Withdrawal by Subject|0
1398969|NCT01231984|4617059|P2|Study Period 2|Withdrawal by Subject|1
1398970|NCT01231984|4617060|P1|Study Period 2|Withdrawal by Subject|1
1398971|NCT01231984|4617057|P4|Study Period 1|Not Specified|1
1398972|NCT01231984|4617058|P3|Study Period 1|Not Specified|0
1398973|NCT01231984|4617059|P2|Study Period 1|Not Specified|0
1398974|NCT01231984|4617060|P1|Study Period 1|Not Specified|0
1398975|NCT01231984|4617057|P4|Study Period 1|Adverse Event|0
1398976|NCT01231984|4617058|P3|Study Period 1|Adverse Event|0
1398977|NCT01231984|4617059|P2|Study Period 1|Adverse Event|0
1398978|NCT01231984|4617060|P1|Study Period 1|Adverse Event|1
1398979|NCT01231984|4617057|P4|Study Period 1|Protocol Violation|3
1398980|NCT01231984|4617058|P3|Study Period 1|Protocol Violation|2
1398981|NCT01231984|4617059|P2|Study Period 1|Protocol Violation|4
1398982|NCT01231984|4617060|P1|Study Period 1|Protocol Violation|3
1398983|NCT01231984|4617057|P4|Study Period 1|Non-compliance with study requirements|1
1398984|NCT01231984|4617058|P3|Study Period 1|Non-compliance with study requirements|2
1398985|NCT01231984|4617059|P2|Study Period 1|Non-compliance with study requirements|0
1398986|NCT01231984|4617060|P1|Study Period 1|Non-compliance with study requirements|5
1398987|NCT01231984|4617057|P4|Study Period 1|Screen Failure|1
1398988|NCT01231984|4617058|P3|Study Period 1|Screen Failure|0
1398989|NCT01231984|4617059|P2|Study Period 1|Screen Failure|0
1398990|NCT01231984|4617060|P1|Study Period 1|Screen Failure|0
1398991|NCT01231984|4617057|P4|Study Period 1|Did not continue to meet I/E Criteria|2
1398992|NCT01231984|4617058|P3|Study Period 1|Did not continue to meet I/E Criteria|2
1398993|NCT01231984|4617059|P2|Study Period 1|Did not continue to meet I/E Criteria|2
1398994|NCT01231984|4617060|P1|Study Period 1|Did not continue to meet I/E Criteria|2
1398995|NCT01231984|4617057|P4|Study Period 1|Lost to Follow-up|0
1398996|NCT01231984|4617058|P3|Study Period 1|Lost to Follow-up|1
1398997|NCT01231984|4617059|P2|Study Period 1|Lost to Follow-up|1
1398998|NCT01231984|4617060|P1|Study Period 1|Lost to Follow-up|1
1398999|NCT01231984|4617057|P4|Study Period 1|Withdrawal by Subject|1
1399000|NCT01231984|4617058|P3|Study Period 1|Withdrawal by Subject|0
1399001|NCT01231984|4617059|P2|Study Period 1|Withdrawal by Subject|0
1399002|NCT01231984|4617060|P1|Study Period 1|Withdrawal by Subject|0
1399003|NCT01231620|4617129|P3|Overall Study|Lost to Follow-up|9
1399004|NCT01231620|4617130|P2|Overall Study|Lost to Follow-up|4
1399005|NCT01231620|4617131|P1|Overall Study|Lost to Follow-up|3
1399006|NCT01231620|4617129|P3|Overall Study|Withdrawal by Subject|8
1399007|NCT01231620|4617130|P2|Overall Study|Withdrawal by Subject|6
1399008|NCT01231620|4617131|P1|Overall Study|Withdrawal by Subject|6
1399009|NCT01231620|4617129|P3|Overall Study|Adverse Event|1
1399010|NCT01231620|4617130|P2|Overall Study|Adverse Event|2
1399011|NCT01231620|4617131|P1|Overall Study|Adverse Event|2
1399012|NCT01231620|4617129|P3|Overall Study|Death|11
1399013|NCT01231620|4617130|P2|Overall Study|Death|14
1399014|NCT01231620|4617131|P1|Overall Study|Death|12
1399015|NCT01231620|4617129|P3|Overall Study|Physician Decision|10
1399016|NCT01231620|4617130|P2|Overall Study|Physician Decision|5
1399017|NCT01231620|4617131|P1|Overall Study|Physician Decision|3
1399018|NCT01231607|4617237|P5|Overall Study|Withdrawal by Subject|9
1399019|NCT01231607|4617238|P4|Overall Study|Withdrawal by Subject|17
1399020|NCT01231607|4617239|P3|Overall Study|Withdrawal by Subject|14
1399021|NCT01231607|4617240|P2|Overall Study|Withdrawal by Subject|9
1399022|NCT01231607|4617241|P1|Overall Study|Withdrawal by Subject|9
1399023|NCT01231607|4617237|P5|Overall Study|Protocol Violation|2
1399024|NCT01231607|4617238|P4|Overall Study|Protocol Violation|2
1399025|NCT01231607|4617239|P3|Overall Study|Protocol Violation|0
1399026|NCT01231607|4617240|P2|Overall Study|Protocol Violation|2
1399027|NCT01231607|4617241|P1|Overall Study|Protocol Violation|3
1399028|NCT01231607|4617237|P5|Overall Study|Physician Decision|4
1399029|NCT01231607|4617238|P4|Overall Study|Physician Decision|5
1399030|NCT01231607|4617239|P3|Overall Study|Physician Decision|3
1399031|NCT01231607|4617240|P2|Overall Study|Physician Decision|4
1399032|NCT01231607|4617241|P1|Overall Study|Physician Decision|4
1399033|NCT01231607|4617237|P5|Overall Study|Lost to Follow-up|4
1399034|NCT01231607|4617238|P4|Overall Study|Lost to Follow-up|10
1399035|NCT01231607|4617239|P3|Overall Study|Lost to Follow-up|10
1399036|NCT01231607|4617240|P2|Overall Study|Lost to Follow-up|11
1399037|NCT01231607|4617241|P1|Overall Study|Lost to Follow-up|13
1399038|NCT01231607|4617237|P5|Overall Study|Adverse Event|5
1399039|NCT01231607|4617238|P4|Overall Study|Adverse Event|4
1399040|NCT01231607|4617239|P3|Overall Study|Adverse Event|4
1399041|NCT01231607|4617240|P2|Overall Study|Adverse Event|8
1399042|NCT01231607|4617241|P1|Overall Study|Adverse Event|0
1399043|NCT01231581|4617333|P2|Overall Study|Ongoing|0
1399044|NCT01231581|4617334|P1|Overall Study|Ongoing|1
1399045|NCT01231581|4617333|P2|Overall Study|Death|64
1399046|NCT01231581|4617334|P1|Overall Study|Death|65
1399047|NCT01231581|4617333|P2|Overall Study|Study Closed/Terminated|5
1399048|NCT01231581|4617334|P1|Overall Study|Study Closed/Terminated|6
1399049|NCT01231581|4617333|P2|Overall Study|Withdrawal by Subject|9
1399050|NCT01231581|4617334|P1|Overall Study|Withdrawal by Subject|6
1399051|NCT01231581|4617333|P2|Overall Study|Lost to Follow-up|2
1399052|NCT01231581|4617334|P1|Overall Study|Lost to Follow-up|2
1399053|NCT01231555|4617355|P3|Overall Study|Withdrawal by Subject|0
1399054|NCT01231555|4617356|P2|Overall Study|Withdrawal by Subject|2
1399055|NCT01231555|4617357|P1|Overall Study|Withdrawal by Subject|0
1399056|NCT01231555|4617355|P3|Overall Study|Study terminated|8
1399057|NCT01231555|4617356|P2|Overall Study|Study terminated|5
1399058|NCT01231555|4617357|P1|Overall Study|Study terminated|8
1399059|NCT01231516|4617388|P2|Open-label Phase|Ongoing at the time of analysis|23
1399060|NCT01231516|4617389|P1|Open-label Phase|Ongoing at the time of analysis|282
1399061|NCT01231516|4617388|P2|Open-label Phase|Withdrawal by Subject|0
1399062|NCT01231516|4617389|P1|Open-label Phase|Withdrawal by Subject|1
1399063|NCT01231516|4617388|P2|Open-label Phase|Lost to Follow-up|0
1399064|NCT01231516|4617389|P1|Open-label Phase|Lost to Follow-up|3
1399065|NCT01231516|4617388|P2|Open-label Phase|Protocol Violation|0
1399066|NCT01231516|4617389|P1|Open-label Phase|Protocol Violation|2
1399067|NCT01231516|4617388|P2|Open-label Phase|Lack of Efficacy|3
1399068|NCT01231516|4617389|P1|Open-label Phase|Lack of Efficacy|7
1399069|NCT01231516|4617388|P2|48 Week Double-blind Phase|Site Closed|1
1399070|NCT01231516|4617389|P1|48 Week Double-blind Phase|Site Closed|3
1399071|NCT01231516|4617388|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
1399072|NCT01231516|4617389|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
1399073|NCT01231516|4617388|P2|48 Week Double-blind Phase|Physician Decision|1
1399074|NCT01231516|4617389|P1|48 Week Double-blind Phase|Physician Decision|1
1399075|NCT01231516|4617388|P2|48 Week Double-blind Phase|Lost to Follow-up|10
1399076|NCT01231516|4617389|P1|48 Week Double-blind Phase|Lost to Follow-up|5
1399077|NCT01231516|4617388|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
1399078|NCT01231516|4617389|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
1399079|NCT01231516|4617388|P2|48 Week Double-blind Phase|Protocol Violation|6
1399080|NCT01231516|4617389|P1|48 Week Double-blind Phase|Protocol Violation|9
1399081|NCT01231516|4617388|P2|48 Week Double-blind Phase|Lack of Efficacy|42
1399082|NCT01231516|4617389|P1|48 Week Double-blind Phase|Lack of Efficacy|20
1399083|NCT01231516|4617388|P2|48 Week Double-blind Phase|Adverse Event|11
1399084|NCT01231516|4617389|P1|48 Week Double-blind Phase|Adverse Event|4
1399085|NCT01231503|4617419|P8|Overall Study|Protocol Violation|0
1399086|NCT01231503|4617420|P7|Overall Study|Protocol Violation|0
1399087|NCT01231503|4617421|P6|Overall Study|Protocol Violation|0
1399088|NCT01231503|4617422|P5|Overall Study|Protocol Violation|0
1399089|NCT01231503|4617423|P4|Overall Study|Protocol Violation|1
1399090|NCT01231503|4617424|P3|Overall Study|Protocol Violation|0
1399091|NCT01231503|4617425|P2|Overall Study|Protocol Violation|0
1399092|NCT01231503|4617426|P1|Overall Study|Protocol Violation|0
1399093|NCT01231503|4617419|P8|Overall Study|Lost to Follow-up|6
1399094|NCT01231503|4617420|P7|Overall Study|Lost to Follow-up|6
1399095|NCT01231503|4617421|P6|Overall Study|Lost to Follow-up|9
1399096|NCT01231503|4617422|P5|Overall Study|Lost to Follow-up|7
1399097|NCT01231503|4617423|P4|Overall Study|Lost to Follow-up|5
1399098|NCT01231503|4617424|P3|Overall Study|Lost to Follow-up|8
1399099|NCT01231503|4617425|P2|Overall Study|Lost to Follow-up|10
1399100|NCT01231503|4617426|P1|Overall Study|Lost to Follow-up|8
1399101|NCT01231503|4617419|P8|Overall Study|Withdrawal by Subject|2
1399102|NCT01231503|4617420|P7|Overall Study|Withdrawal by Subject|1
1399103|NCT01231503|4617421|P6|Overall Study|Withdrawal by Subject|5
1399104|NCT01231503|4617422|P5|Overall Study|Withdrawal by Subject|3
1399105|NCT01231503|4617423|P4|Overall Study|Withdrawal by Subject|1
1399106|NCT01231503|4617424|P3|Overall Study|Withdrawal by Subject|3
1399107|NCT01231503|4617425|P2|Overall Study|Withdrawal by Subject|3
1399108|NCT01231503|4617426|P1|Overall Study|Withdrawal by Subject|6
1399109|NCT01231503|4617419|P8|Overall Study|Adverse event, serious fatal|0
1399110|NCT01231503|4617420|P7|Overall Study|Adverse event, serious fatal|0
1399111|NCT01231503|4617421|P6|Overall Study|Adverse event, serious fatal|1
1399112|NCT01231503|4617422|P5|Overall Study|Adverse event, serious fatal|0
1399113|NCT01231503|4617423|P4|Overall Study|Adverse event, serious fatal|1
1399114|NCT01231503|4617424|P3|Overall Study|Adverse event, serious fatal|1
1399115|NCT01231503|4617425|P2|Overall Study|Adverse event, serious fatal|0
1399116|NCT01231503|4617426|P1|Overall Study|Adverse event, serious fatal|0
1399117|NCT01231503|4617419|P8|Overall Study|Adverse Event|0
1399118|NCT01231503|4617420|P7|Overall Study|Adverse Event|0
1399119|NCT01231503|4617421|P6|Overall Study|Adverse Event|1
1399120|NCT01231503|4617422|P5|Overall Study|Adverse Event|0
1399121|NCT01231503|4617423|P4|Overall Study|Adverse Event|0
1399122|NCT01231503|4617424|P3|Overall Study|Adverse Event|0
1399123|NCT01231503|4617425|P2|Overall Study|Adverse Event|0
1399124|NCT01231503|4617426|P1|Overall Study|Adverse Event|0
1399125|NCT01231464|4617666|P2|Overall Study|Withdrawal by Subject|2
1399126|NCT01231464|4617667|P1|Overall Study|Withdrawal by Subject|3
1399127|NCT01231464|4617666|P2|Overall Study|Lost to Follow-up|2
1399128|NCT01231464|4617667|P1|Overall Study|Lost to Follow-up|1
1399129|NCT01231464|4617666|P2|Overall Study|Protocol Violation|2
1399130|NCT01231464|4617667|P1|Overall Study|Protocol Violation|1
1399131|NCT01231464|4617666|P2|Overall Study|Adverse Event|1
1399132|NCT01231464|4617667|P1|Overall Study|Adverse Event|0
1399133|NCT01231373|4617716|P4|Overall Study|Withdrew Consent|0
1399134|NCT01231373|4617717|P3|Overall Study|Withdrew Consent|0
1399135|NCT01231373|4617718|P2|Overall Study|Withdrew Consent|0
1399136|NCT01231373|4617719|P1|Overall Study|Withdrew Consent|1
1399137|NCT01231373|4617716|P4|Overall Study|Lost to Follow-up|1
1399138|NCT01231373|4617717|P3|Overall Study|Lost to Follow-up|0
1399139|NCT01231373|4617718|P2|Overall Study|Lost to Follow-up|0
1399140|NCT01231373|4617719|P1|Overall Study|Lost to Follow-up|0
1399141|NCT01231373|4617716|P4|Overall Study|Withdrew consent prior to randomization|0
1399142|NCT01231373|4617717|P3|Overall Study|Withdrew consent prior to randomization|0
1399143|NCT01231373|4617718|P2|Overall Study|Withdrew consent prior to randomization|1
1399144|NCT01231373|4617719|P1|Overall Study|Withdrew consent prior to randomization|2
1399145|NCT01231321|4617758|P1|Overall Study|Lack of Efficacy|2
1399146|NCT01231321|4617758|P1|Overall Study|Adverse Event|3
1399147|NCT01230892|4617781|P2|Overall Study|Lost to Follow-up|0
1399148|NCT01230892|4617782|P1|Overall Study|Lost to Follow-up|2
1399149|NCT01230892|4617781|P2|Overall Study|Withdrawal by Subject|1
1399150|NCT01230892|4617782|P1|Overall Study|Withdrawal by Subject|1
1399151|NCT01230827|4617792|P4|Overall Study|Study terminated by Sponsor|63
1399152|NCT01230827|4617793|P3|Overall Study|Study terminated by Sponsor|56
1399153|NCT01230827|4617794|P2|Overall Study|Study terminated by Sponsor|2
1399154|NCT01230827|4617795|P1|Overall Study|Study terminated by Sponsor|0
1399155|NCT01230827|4617792|P4|Overall Study|Recovery|0
1399156|NCT01230827|4617793|P3|Overall Study|Recovery|0
1399157|NCT01230827|4617794|P2|Overall Study|Recovery|6
1399158|NCT01230827|4617795|P1|Overall Study|Recovery|0
1399159|NCT01230827|4617792|P4|Overall Study|Adverse Event|7
1399160|NCT01230827|4617793|P3|Overall Study|Adverse Event|3
1399161|NCT01230827|4617794|P2|Overall Study|Adverse Event|2
1399162|NCT01230827|4617795|P1|Overall Study|Adverse Event|4
1399163|NCT01230827|4617792|P4|Overall Study|Lack of Efficacy|3
1399164|NCT01230827|4617793|P3|Overall Study|Lack of Efficacy|2
1399165|NCT01230827|4617794|P2|Overall Study|Lack of Efficacy|1
1399166|NCT01230827|4617795|P1|Overall Study|Lack of Efficacy|14
1399167|NCT01230827|4617792|P4|Overall Study|Withdrawal by Subject|2
1399168|NCT01230827|4617793|P3|Overall Study|Withdrawal by Subject|3
1399169|NCT01230827|4617794|P2|Overall Study|Withdrawal by Subject|0
1399170|NCT01230827|4617795|P1|Overall Study|Withdrawal by Subject|1
1399171|NCT01230827|4617792|P4|Overall Study|Lost to Follow-up|3
1399172|NCT01230827|4617793|P3|Overall Study|Lost to Follow-up|1
1399173|NCT01230827|4617794|P2|Overall Study|Lost to Follow-up|0
1399174|NCT01230827|4617795|P1|Overall Study|Lost to Follow-up|0
1399175|NCT01230814|4617811|P2|Overall Study|Discontinued (not due to adverse event)|1
1399176|NCT01230814|4617812|P1|Overall Study|Discontinued (not due to adverse event)|2
1399177|NCT01230814|4617811|P2|Overall Study|Lost to Follow-up|3
1399178|NCT01230814|4617812|P1|Overall Study|Lost to Follow-up|11
1399179|NCT01230788|4617862|P1|Overall Study|Prescribed exclusion drug|1
1399180|NCT01230749|4617874|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
1399181|NCT01230749|4617875|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
1399182|NCT01230749|4617876|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
1399183|NCT01230749|4617877|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
1399184|NCT01230749|4617874|P4|Overall Study|Withdrawal by Subject|0
1399185|NCT01230749|4617875|P3|Overall Study|Withdrawal by Subject|0
1399186|NCT01230749|4617876|P2|Overall Study|Withdrawal by Subject|1
1399187|NCT01230749|4617877|P1|Overall Study|Withdrawal by Subject|0
1399188|NCT01230749|4617874|P4|Overall Study|Physician Decision|0
1399189|NCT01230749|4617875|P3|Overall Study|Physician Decision|1
1399190|NCT01230749|4617876|P2|Overall Study|Physician Decision|0
1399191|NCT01230749|4617877|P1|Overall Study|Physician Decision|0
1399192|NCT01230749|4617874|P4|Overall Study|Adverse Event|1
1399193|NCT01230749|4617875|P3|Overall Study|Adverse Event|0
1399194|NCT01230749|4617876|P2|Overall Study|Adverse Event|0
1399195|NCT01230749|4617877|P1|Overall Study|Adverse Event|0
1399196|NCT01230710|4617912|P1|Overall Study|Withdrawal of Consent|1
1399197|NCT01230710|4617912|P1|Overall Study|Death|4
1399198|NCT01230710|4617912|P1|Overall Study|Lost to Follow-up|3
1399199|NCT01230710|4617912|P1|Overall Study|Disease Progression|41
1399200|NCT01230489|4617952|P1|Overall Study|Treatment modality changed|1
1399201|NCT01230489|4617952|P1|Overall Study|Adverse Event|2
1399202|NCT01230489|4617952|P1|Overall Study|Death|2
1399203|NCT01230307|4617987|P2|Overall Study|LVAD Placement|2
1399204|NCT01230307|4617988|P1|Overall Study|LVAD Placement|0
1399205|NCT01230060|4618008|P1|Overall Study|Withdrawal by Subject|1
1399206|NCT01229735|4618081|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
1399207|NCT01229735|4618082|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1399208|NCT01229735|4618081|P2|Overall Study|AE, non-serious non-fatal|17
1399209|NCT01229735|4618082|P1|Overall Study|AE, non-serious non-fatal|13
1399210|NCT01229735|4618081|P2|Overall Study|SAE, non-fatal|4
1399211|NCT01229735|4618082|P1|Overall Study|SAE, non-fatal|0
1399212|NCT01229735|4618081|P2|Overall Study|Other Reason|10
1399213|NCT01229735|4618082|P1|Overall Study|Other Reason|13
1399214|NCT01229735|4618081|P2|Overall Study|Withdrawal by Subject|17
1399215|NCT01229735|4618082|P1|Overall Study|Withdrawal by Subject|18
1399216|NCT01229735|4618081|P2|Overall Study|Lost to Follow-up|2
1399217|NCT01229735|4618082|P1|Overall Study|Lost to Follow-up|0
1399218|NCT01229735|4618081|P2|Overall Study|Protocol Violation|8
1399219|NCT01229735|4618082|P1|Overall Study|Protocol Violation|13
1399220|NCT01229735|4618081|P2|Overall Study|Lack of Efficacy|8
1399221|NCT01229735|4618082|P1|Overall Study|Lack of Efficacy|8
1399222|NCT01229436|4618130|P1|Overall Study|Lost to Follow-up|3
1399223|NCT01229436|4618130|P1|Overall Study|Withdrawal by Subject|2
1399224|NCT01229397|4618192|P2|Overall Study|Migrated/moved from study area|0
1399225|NCT01229397|4618193|P1|Overall Study|Migrated/moved from study area|1
1399226|NCT01229397|4618192|P2|Overall Study|Lost to Follow-up|6
1399227|NCT01229397|4618193|P1|Overall Study|Lost to Follow-up|7
1399228|NCT01229397|4618192|P2|Overall Study|Withdrawal by Subject|3
1399229|NCT01229397|4618193|P1|Overall Study|Withdrawal by Subject|3
1399230|NCT01229371|4618211|P4|Overall Study|Withdrawal by Subject|0
1399231|NCT01229371|4618212|P3|Overall Study|Withdrawal by Subject|0
1399232|NCT01229371|4618213|P2|Overall Study|Withdrawal by Subject|1
1399233|NCT01229371|4618214|P1|Overall Study|Withdrawal by Subject|0
1399234|NCT01229267|4618241|P5|Overall Study|Lost to Follow-up|22
1399235|NCT01229267|4618242|P4|Overall Study|Lost to Follow-up|3
1399236|NCT01229267|4618243|P3|Overall Study|Lost to Follow-up|8
1399237|NCT01229267|4618244|P2|Overall Study|Lost to Follow-up|5
1399238|NCT01229267|4618245|P1|Overall Study|Lost to Follow-up|6
1399239|NCT01229267|4618241|P5|Overall Study|Physician Decision|25
1399240|NCT01229267|4618242|P4|Overall Study|Physician Decision|3
1399241|NCT01229267|4618243|P3|Overall Study|Physician Decision|8
1399242|NCT01229267|4618244|P2|Overall Study|Physician Decision|11
1399243|NCT01229267|4618245|P1|Overall Study|Physician Decision|8
1399244|NCT01229267|4618241|P5|Overall Study|Progressive disease|1
1399245|NCT01229267|4618242|P4|Overall Study|Progressive disease|0
1399246|NCT01229267|4618243|P3|Overall Study|Progressive disease|0
1399247|NCT01229267|4618244|P2|Overall Study|Progressive disease|0
1399248|NCT01229267|4618245|P1|Overall Study|Progressive disease|0
1399249|NCT01229267|4618241|P5|Overall Study|Protocol Violation|0
1399250|NCT01229267|4618242|P4|Overall Study|Protocol Violation|0
1399251|NCT01229267|4618243|P3|Overall Study|Protocol Violation|0
1399252|NCT01229267|4618244|P2|Overall Study|Protocol Violation|1
1399253|NCT01229267|4618245|P1|Overall Study|Protocol Violation|0
1399254|NCT01229267|4618241|P5|Overall Study|Withdrawal by Subject|59
1399255|NCT01229267|4618242|P4|Overall Study|Withdrawal by Subject|14
1399256|NCT01229267|4618243|P3|Overall Study|Withdrawal by Subject|32
1399257|NCT01229267|4618244|P2|Overall Study|Withdrawal by Subject|22
1399258|NCT01229267|4618245|P1|Overall Study|Withdrawal by Subject|23
1399259|NCT01229267|4618241|P5|Overall Study|Death|103
1399260|NCT01229267|4618242|P4|Overall Study|Death|13
1399261|NCT01229267|4618243|P3|Overall Study|Death|35
1399262|NCT01229267|4618244|P2|Overall Study|Death|37
1399263|NCT01229267|4618245|P1|Overall Study|Death|40
1399264|NCT01229267|4618241|P5|Overall Study|Adverse Event|10
1399265|NCT01229267|4618242|P4|Overall Study|Adverse Event|2
1399266|NCT01229267|4618243|P3|Overall Study|Adverse Event|3
1399267|NCT01229267|4618244|P2|Overall Study|Adverse Event|6
1399268|NCT01229267|4618245|P1|Overall Study|Adverse Event|4
1399269|NCT01229254|4618264|P3|Overall Study|Non-compliance with Study Drug|1
1399270|NCT01229254|4618265|P2|Overall Study|Non-compliance with Study Drug|1
1399271|NCT01229254|4618266|P1|Overall Study|Non-compliance with Study Drug|0
1399272|NCT01229254|4618264|P3|Overall Study|Withdrawal by Subject|1
1399273|NCT01229254|4618265|P2|Overall Study|Withdrawal by Subject|0
1399274|NCT01229254|4618266|P1|Overall Study|Withdrawal by Subject|1
1399275|NCT01229254|4618264|P3|Overall Study|Protocol Violation|5
1399276|NCT01229254|4618265|P2|Overall Study|Protocol Violation|6
1399277|NCT01229254|4618266|P1|Overall Study|Protocol Violation|4
1399278|NCT01229254|4618264|P3|Overall Study|Physician Decision|0
1399279|NCT01229254|4618265|P2|Overall Study|Physician Decision|3
1399280|NCT01229254|4618266|P1|Overall Study|Physician Decision|0
1399281|NCT01229254|4618264|P3|Overall Study|Lost to Follow-up|1
1399282|NCT01229254|4618265|P2|Overall Study|Lost to Follow-up|0
1399283|NCT01229254|4618266|P1|Overall Study|Lost to Follow-up|3
1399284|NCT01229254|4618264|P3|Overall Study|Adverse Event|3
1399285|NCT01229254|4618265|P2|Overall Study|Adverse Event|5
1399286|NCT01229254|4618266|P1|Overall Study|Adverse Event|4
1399287|NCT01229254|4618264|P3|Overall Study|Not Continuing Into Safety Extension|1
1399288|NCT01229254|4618265|P2|Overall Study|Not Continuing Into Safety Extension|1
1399289|NCT01229254|4618266|P1|Overall Study|Not Continuing Into Safety Extension|3
1399290|NCT01229176|4618304|P8|Overall Study|Lost to Follow-up|2
1399291|NCT01229176|4618305|P7|Overall Study|Lost to Follow-up|0
1399292|NCT01229176|4618306|P6|Overall Study|Lost to Follow-up|1
1399293|NCT01229176|4618307|P5|Overall Study|Lost to Follow-up|1
1399294|NCT01229176|4618308|P4|Overall Study|Lost to Follow-up|0
1399295|NCT01229176|4618309|P3|Overall Study|Lost to Follow-up|0
1399296|NCT01229176|4618310|P2|Overall Study|Lost to Follow-up|3
1399297|NCT01229176|4618311|P1|Overall Study|Lost to Follow-up|0
1399298|NCT01229176|4618304|P8|Overall Study|Withdrawal by Subject|1
1399299|NCT01229176|4618305|P7|Overall Study|Withdrawal by Subject|0
1399300|NCT01229176|4618306|P6|Overall Study|Withdrawal by Subject|1
1399301|NCT01229176|4618307|P5|Overall Study|Withdrawal by Subject|1
1399302|NCT01229176|4618308|P4|Overall Study|Withdrawal by Subject|1
1399303|NCT01229176|4618309|P3|Overall Study|Withdrawal by Subject|0
1399304|NCT01229176|4618310|P2|Overall Study|Withdrawal by Subject|0
1399305|NCT01229176|4618311|P1|Overall Study|Withdrawal by Subject|0
1399306|NCT01229150|4618365|P4|Overall Study|Toxicity|0
1399307|NCT01229150|4618366|P3|Overall Study|Toxicity|0
1399308|NCT01229150|4618367|P2|Overall Study|Toxicity|2
1399309|NCT01229150|4618368|P1|Overall Study|Toxicity|2
1399310|NCT01229111|4618425|P1|Overall Study|Death|1
1399311|NCT01228747|4618474|P2|Overall Study|Other Reason|5
1399312|NCT01228747|4618475|P1|Overall Study|Other Reason|2
1399313|NCT01228747|4618474|P2|Overall Study|Withdrawal by Subject|1
1399314|NCT01228747|4618475|P1|Overall Study|Withdrawal by Subject|5
1399315|NCT01228747|4618474|P2|Overall Study|Lost to Follow-up|3
1399316|NCT01228747|4618475|P1|Overall Study|Lost to Follow-up|4
1399317|NCT01228747|4618474|P2|Overall Study|Protocol Violation|5
1399318|NCT01228747|4618475|P1|Overall Study|Protocol Violation|6
1399319|NCT01228747|4618474|P2|Overall Study|Lack of Efficacy|27
1399320|NCT01228747|4618475|P1|Overall Study|Lack of Efficacy|40
1399321|NCT01228747|4618474|P2|Overall Study|Adverse Event|4
1399322|NCT01228747|4618475|P1|Overall Study|Adverse Event|8
1399323|NCT01228734|4618491|P2|Overall Study|Randomized, but not treated|4
1399324|NCT01228734|4618492|P1|Overall Study|Randomized, but not treated|0
1399325|NCT01228734|4618491|P2|Overall Study|Ongoing at clinical cut-off date|4
1399326|NCT01228734|4618492|P1|Overall Study|Ongoing at clinical cut-off date|16
1399327|NCT01228591|4618506|P2|Baseline|Lack of Efficacy|2
1399328|NCT01228591|4618507|P1|Baseline|Lack of Efficacy|1
1399329|NCT01228318|4618536|P2|Overall Study|Incarcerated|0
1399330|NCT01228318|4618537|P1|Overall Study|Incarcerated|1
1399331|NCT01228318|4618536|P2|Overall Study|Moved|2
1399332|NCT01228318|4618537|P1|Overall Study|Moved|0
1399333|NCT01228318|4618536|P2|Overall Study|Unable to contact|5
1399334|NCT01228318|4618537|P1|Overall Study|Unable to contact|2
1399335|NCT01228318|4618536|P2|Overall Study|Clinic no show to receive intervention|0
1399336|NCT01228318|4618537|P1|Overall Study|Clinic no show to receive intervention|1
1399337|NCT01228175|4618553|P2|Overall Study|Physician Decision|1
1399338|NCT01228175|4618554|P1|Overall Study|Physician Decision|1
1399339|NCT01228175|4618553|P2|Overall Study|Withdrawal by Subject|2
1399340|NCT01228175|4618554|P1|Overall Study|Withdrawal by Subject|1
1399341|NCT01228175|4618553|P2|Overall Study|Lost to Follow-up|50
1399342|NCT01228175|4618554|P1|Overall Study|Lost to Follow-up|64
1399343|NCT01228071|4618596|P1|Overall Study|Withdrawal by Subject|1
1399344|NCT01228071|4618596|P1|Overall Study|Protocol Violation|1
1399345|NCT01228019|4618602|P1|Overall Study|Violation of Entry Criterion|9
1399346|NCT01228019|4618602|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
1399347|NCT01228019|4618602|P1|Overall Study|Missing pre-treatment data|72
1399348|NCT01228019|4618602|P1|Overall Study|Duplicate enrollment|1
1399349|NCT01228019|4618602|P1|Overall Study|Dose Violation|70
1399350|NCT01227967|4618668|P2|Overall Study|Taking Additional Antiviral Drug|0
1399511|NCT01227629|4619059|P2|Overall Study|Withdrawal by Subject|0
1399351|NCT01227967|4618669|P1|Overall Study|Taking Additional Antiviral Drug|1
1399352|NCT01227967|4618668|P2|Overall Study|Never Started Treatment|4
1399353|NCT01227967|4618669|P1|Overall Study|Never Started Treatment|0
1399354|NCT01227967|4618668|P2|Overall Study|Physician Decision|1
1399355|NCT01227967|4618669|P1|Overall Study|Physician Decision|0
1399356|NCT01227967|4618668|P2|Overall Study|Withdrawal by Subject|3
1399357|NCT01227967|4618669|P1|Overall Study|Withdrawal by Subject|4
1399358|NCT01227967|4618668|P2|Overall Study|Lost to Follow-up|3
1399359|NCT01227967|4618669|P1|Overall Study|Lost to Follow-up|8
1399360|NCT01227967|4618668|P2|Overall Study|Death|1
1399361|NCT01227967|4618669|P1|Overall Study|Death|0
1399362|NCT01227967|4618668|P2|Overall Study|Protocol Violation|1
1399363|NCT01227967|4618669|P1|Overall Study|Protocol Violation|3
1399364|NCT01227954|4618703|P1|Overall Study|No protocol treatment|7
1399365|NCT01227954|4618703|P1|Overall Study|Protocol Violation|6
1399366|NCT01227928|4618717|P2|Overall Study|Death|12
1399367|NCT01227928|4618718|P1|Overall Study|Death|14
1399368|NCT01227928|4618717|P2|Overall Study|Withdrawal by Subject|3
1399369|NCT01227928|4618718|P1|Overall Study|Withdrawal by Subject|4
1399370|NCT01227928|4618717|P2|Overall Study|Lost to Follow-up|2
1399371|NCT01227928|4618718|P1|Overall Study|Lost to Follow-up|4
1399372|NCT01227902|4618756|P4|Overall Study|Withdrawal by Subject|3
1399373|NCT01227902|4618757|P3|Overall Study|Withdrawal by Subject|4
1399374|NCT01227902|4618758|P2|Overall Study|Withdrawal by Subject|2
1399375|NCT01227902|4618759|P1|Overall Study|Withdrawal by Subject|4
1399376|NCT01227902|4618756|P4|Overall Study|Physician Decision|0
1399377|NCT01227902|4618757|P3|Overall Study|Physician Decision|1
1399378|NCT01227902|4618758|P2|Overall Study|Physician Decision|1
1399379|NCT01227902|4618759|P1|Overall Study|Physician Decision|0
1399380|NCT01227902|4618756|P4|Overall Study|Lost to Follow-up|2
1399381|NCT01227902|4618757|P3|Overall Study|Lost to Follow-up|1
1399382|NCT01227902|4618758|P2|Overall Study|Lost to Follow-up|0
1399383|NCT01227902|4618759|P1|Overall Study|Lost to Follow-up|0
1399384|NCT01227902|4618756|P4|Overall Study|Protocol Violation|0
1399385|NCT01227902|4618757|P3|Overall Study|Protocol Violation|0
1399386|NCT01227902|4618758|P2|Overall Study|Protocol Violation|0
1399387|NCT01227902|4618759|P1|Overall Study|Protocol Violation|1
1399388|NCT01227902|4618756|P4|Overall Study|Lack of Efficacy|1
1399389|NCT01227902|4618757|P3|Overall Study|Lack of Efficacy|2
1399390|NCT01227902|4618758|P2|Overall Study|Lack of Efficacy|2
1399391|NCT01227902|4618759|P1|Overall Study|Lack of Efficacy|1
1399392|NCT01227902|4618756|P4|Overall Study|Adverse Event|4
1399393|NCT01227902|4618757|P3|Overall Study|Adverse Event|11
1399394|NCT01227902|4618758|P2|Overall Study|Adverse Event|8
1399395|NCT01227902|4618759|P1|Overall Study|Adverse Event|12
1399396|NCT01227889|4618852|P2|Crossover Phase|Withdrawal by Subject|1
1399397|NCT01227889|4618853|P1|Crossover Phase|Withdrawal by Subject|0
1399398|NCT01227889|4618852|P2|Crossover Phase|Study Terminated By Sponsor|1
1399399|NCT01227889|4618853|P1|Crossover Phase|Study Terminated By Sponsor|0
1399400|NCT01227889|4618852|P2|Crossover Phase|Progressive Disease|31
1399401|NCT01227889|4618853|P1|Crossover Phase|Progressive Disease|0
1399402|NCT01227889|4618852|P2|Crossover Phase|Physician Decision|3
1399403|NCT01227889|4618853|P1|Crossover Phase|Physician Decision|0
1399404|NCT01227889|4618852|P2|Crossover Phase|Adverse Event|1
1399405|NCT01227889|4618853|P1|Crossover Phase|Adverse Event|0
1399406|NCT01227889|4618852|P2|Randomized Phase (RP)|Withdrawal by Subject|3
1399407|NCT01227889|4618853|P1|Randomized Phase (RP)|Withdrawal by Subject|15
1399408|NCT01227889|4618852|P2|Randomized Phase (RP)|Missing|3
1399409|NCT01227889|4618853|P1|Randomized Phase (RP)|Missing|1
1399410|NCT01227889|4618852|P2|Randomized Phase (RP)|Study terminated by sponsor|0
1399411|NCT01227889|4618853|P1|Randomized Phase (RP)|Study terminated by sponsor|10
1399412|NCT01227889|4618852|P2|Randomized Phase (RP)|Progressive Disease|52
1399413|NCT01227889|4618853|P1|Randomized Phase (RP)|Progressive Disease|135
1399414|NCT01227889|4618852|P2|Randomized Phase (RP)|Physician Decision|5
1399415|NCT01227889|4618853|P1|Randomized Phase (RP)|Physician Decision|13
1399416|NCT01227889|4618852|P2|Randomized Phase (RP)|Adverse Event|0
1399417|NCT01227889|4618853|P1|Randomized Phase (RP)|Adverse Event|13
1399418|NCT01227824|4618880|P3|Open-label Phase: Median of 1267 Days|Physician Decision|3
1399419|NCT01227824|4618881|P2|Open-label Phase: Median of 1267 Days|Physician Decision|0
1399420|NCT01227824|4618882|P1|Open-label Phase: Median of 1267 Days|Physician Decision|0
1399421|NCT01227824|4618880|P3|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
1399422|NCT01227824|4618881|P2|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
1399423|NCT01227824|4618882|P1|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
1399424|NCT01227824|4618880|P3|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
1399425|NCT01227824|4618881|P2|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
1399426|NCT01227824|4618882|P1|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
1399427|NCT01227824|4618880|P3|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
1399428|NCT01227824|4618881|P2|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
1399429|NCT01227824|4618882|P1|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
1399430|NCT01227824|4618880|P3|Open-label Phase: Median of 1267 Days|Protocol Violation|5
1399431|NCT01227824|4618881|P2|Open-label Phase: Median of 1267 Days|Protocol Violation|0
1399432|NCT01227824|4618882|P1|Open-label Phase: Median of 1267 Days|Protocol Violation|0
1399433|NCT01227824|4618880|P3|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
1399434|NCT01227824|4618881|P2|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
1399435|NCT01227824|4618882|P1|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
1399436|NCT01227824|4618880|P3|Open-label Phase: Median of 1267 Days|Adverse Event|4
1399437|NCT01227824|4618881|P2|Open-label Phase: Median of 1267 Days|Adverse Event|0
1399438|NCT01227824|4618882|P1|Open-label Phase: Median of 1267 Days|Adverse Event|0
1399439|NCT01227824|4618880|P3|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
1399440|NCT01227824|4618881|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
1399441|NCT01227824|4618882|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
1399442|NCT01227824|4618880|P3|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
1399443|NCT01227824|4618881|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
1399444|NCT01227824|4618882|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
1399445|NCT01227824|4618880|P3|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
1399446|NCT01227824|4618881|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
1399447|NCT01227824|4618882|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
1399448|NCT01227824|4618880|P3|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
1399449|NCT01227824|4618881|P2|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
1399450|NCT01227824|4618882|P1|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
1399451|NCT01227824|4618880|P3|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
1399452|NCT01227824|4618881|P2|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
1399453|NCT01227824|4618882|P1|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
1399454|NCT01227824|4618880|P3|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
1399455|NCT01227824|4618881|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
1399456|NCT01227824|4618882|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
1399457|NCT01227824|4618880|P3|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
1399458|NCT01227824|4618881|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
1399459|NCT01227824|4618882|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
1399460|NCT01227824|4618880|P3|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
1399461|NCT01227824|4618881|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
1399462|NCT01227824|4618882|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
1399463|NCT01227707|4618977|P1|Overall Study|Death|1
1399464|NCT01227707|4618977|P1|Overall Study|Medical decision|6
1399465|NCT01227707|4618977|P1|Overall Study|Patient non-compliance|3
1399466|NCT01227707|4618977|P1|Overall Study|Withdrawal by Subject|1
1399467|NCT01227707|4618977|P1|Overall Study|Progression of disease|3
1399468|NCT01227707|4618977|P1|Overall Study|Adverse Event|10
1399469|NCT01227668|4619004|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
1399470|NCT01227668|4619005|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
1399471|NCT01227668|4619004|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
1399472|NCT01227668|4619005|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
1399473|NCT01227668|4619004|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
1399474|NCT01227668|4619005|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
1399475|NCT01227668|4619004|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
1399476|NCT01227668|4619005|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
1399477|NCT01227668|4619004|P2|Phase 2 (Randomization Phase)|Adverse Event|1
1399478|NCT01227668|4619005|P1|Phase 2 (Randomization Phase)|Adverse Event|0
1399479|NCT01227668|4619004|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
1399480|NCT01227668|4619005|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
1399481|NCT01227668|4619004|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
1399482|NCT01227668|4619005|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
1399483|NCT01227668|4619004|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
1399484|NCT01227668|4619005|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
1399485|NCT01227668|4619004|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
1399486|NCT01227668|4619005|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
1399487|NCT01227668|4619004|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
1399488|NCT01227668|4619005|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
1399489|NCT01227668|4619004|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
1399490|NCT01227668|4619005|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
1399491|NCT01227668|4619004|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
1399492|NCT01227668|4619005|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
1399493|NCT01227629|4619051|P10|Overall Study|Not Specified|1
1399494|NCT01227629|4619052|P9|Overall Study|Not Specified|2
1399495|NCT01227629|4619053|P8|Overall Study|Not Specified|0
1399496|NCT01227629|4619054|P7|Overall Study|Not Specified|0
1399497|NCT01227629|4619055|P6|Overall Study|Not Specified|0
1399498|NCT01227629|4619056|P5|Overall Study|Not Specified|0
1399499|NCT01227629|4619057|P4|Overall Study|Not Specified|1
1399500|NCT01227629|4619058|P3|Overall Study|Not Specified|0
1399501|NCT01227629|4619059|P2|Overall Study|Not Specified|0
1399502|NCT01227629|4619060|P1|Overall Study|Not Specified|0
1399503|NCT01227629|4619051|P10|Overall Study|Withdrawal by Subject|1
1399504|NCT01227629|4619052|P9|Overall Study|Withdrawal by Subject|0
1399505|NCT01227629|4619053|P8|Overall Study|Withdrawal by Subject|0
1399506|NCT01227629|4619054|P7|Overall Study|Withdrawal by Subject|2
1399507|NCT01227629|4619055|P6|Overall Study|Withdrawal by Subject|0
1399508|NCT01227629|4619056|P5|Overall Study|Withdrawal by Subject|0
1399509|NCT01227629|4619057|P4|Overall Study|Withdrawal by Subject|0
1399510|NCT01227629|4619058|P3|Overall Study|Withdrawal by Subject|0
1399512|NCT01227629|4619060|P1|Overall Study|Withdrawal by Subject|0
1399513|NCT01227629|4619051|P10|Overall Study|Lost to Follow-up|0
1399514|NCT01227629|4619052|P9|Overall Study|Lost to Follow-up|0
1399515|NCT01227629|4619053|P8|Overall Study|Lost to Follow-up|0
1399516|NCT01227629|4619054|P7|Overall Study|Lost to Follow-up|0
1399517|NCT01227629|4619055|P6|Overall Study|Lost to Follow-up|0
1399518|NCT01227629|4619056|P5|Overall Study|Lost to Follow-up|1
1399519|NCT01227629|4619057|P4|Overall Study|Lost to Follow-up|0
1399520|NCT01227629|4619058|P3|Overall Study|Lost to Follow-up|0
1399521|NCT01227629|4619059|P2|Overall Study|Lost to Follow-up|0
1399522|NCT01227629|4619060|P1|Overall Study|Lost to Follow-up|0
1399523|NCT01227629|4619051|P10|Overall Study|Protocol Violation|0
1399524|NCT01227629|4619052|P9|Overall Study|Protocol Violation|0
1399525|NCT01227629|4619053|P8|Overall Study|Protocol Violation|0
1399526|NCT01227629|4619054|P7|Overall Study|Protocol Violation|0
1399527|NCT01227629|4619055|P6|Overall Study|Protocol Violation|0
1399528|NCT01227629|4619056|P5|Overall Study|Protocol Violation|0
1399529|NCT01227629|4619057|P4|Overall Study|Protocol Violation|1
1399530|NCT01227629|4619058|P3|Overall Study|Protocol Violation|0
1399531|NCT01227629|4619059|P2|Overall Study|Protocol Violation|0
1399532|NCT01227629|4619060|P1|Overall Study|Protocol Violation|0
1399533|NCT01227629|4619051|P10|Overall Study|Adverse Event|0
1399534|NCT01227629|4619052|P9|Overall Study|Adverse Event|4
1399535|NCT01227629|4619053|P8|Overall Study|Adverse Event|6
1399536|NCT01227629|4619054|P7|Overall Study|Adverse Event|6
1399537|NCT01227629|4619055|P6|Overall Study|Adverse Event|1
1399538|NCT01227629|4619056|P5|Overall Study|Adverse Event|1
1399539|NCT01227629|4619057|P4|Overall Study|Adverse Event|6
1399540|NCT01227629|4619058|P3|Overall Study|Adverse Event|1
1399541|NCT01227629|4619059|P2|Overall Study|Adverse Event|2
1399542|NCT01227629|4619060|P1|Overall Study|Adverse Event|2
1399543|NCT01227577|4619296|P1|Overall Study|Adverse Event|17
1399544|NCT01227577|4619296|P1|Overall Study|Lack of Efficacy|5
1399545|NCT01227577|4619296|P1|Overall Study|Withdrawal by Subject|4
1399546|NCT01227577|4619296|P1|Overall Study|Lost to Follow-up|1
1399547|NCT01227577|4619296|P1|Overall Study|Administrative problems|2
1399548|NCT01227577|4619296|P1|Overall Study|Death|3
1399549|NCT01227577|4619296|P1|Overall Study|Protocol deviation|3
1399550|NCT01227564|4619311|P3|Overall Study|Participant moved to another town|1
1399551|NCT01227564|4619312|P2|Overall Study|Participant moved to another town|0
1399552|NCT01227564|4619313|P1|Overall Study|Participant moved to another town|0
1399553|NCT01227564|4619311|P3|Overall Study|No Longer Willing to Participate|5
1399554|NCT01227564|4619312|P2|Overall Study|No Longer Willing to Participate|2
1399555|NCT01227564|4619313|P1|Overall Study|No Longer Willing to Participate|4
1399556|NCT01227512|4619451|P2|Overall Study|Participant met withdrawal criteria|1
1399557|NCT01227512|4619452|P1|Overall Study|Participant met withdrawal criteria|0
1399558|NCT01227512|4619451|P2|Overall Study|Withdrawal by Subject|0
1399559|NCT01227512|4619452|P1|Overall Study|Withdrawal by Subject|3
1399560|NCT01227512|4619451|P2|Overall Study|Adverse Event|3
1399561|NCT01227512|4619452|P1|Overall Study|Adverse Event|4
1399562|NCT01227512|4619451|P2|Overall Study|Physician Decision|6
1399563|NCT01227512|4619452|P1|Overall Study|Physician Decision|6
1399564|NCT01227421|4619486|P3|Overall Study|Randomized in error|0
1399565|NCT01227421|4619487|P2|Overall Study|Randomized in error|1
1399566|NCT01227421|4619488|P1|Overall Study|Randomized in error|1
1399567|NCT01227421|4619486|P3|Overall Study|Protocol Violation|2
1399568|NCT01227421|4619487|P2|Overall Study|Protocol Violation|1
1399569|NCT01227421|4619488|P1|Overall Study|Protocol Violation|1
1399570|NCT01227421|4619486|P3|Overall Study|Withdrawal by Subject|1
1399571|NCT01227421|4619487|P2|Overall Study|Withdrawal by Subject|2
1399572|NCT01227421|4619488|P1|Overall Study|Withdrawal by Subject|1
1399573|NCT01227421|4619486|P3|Overall Study|Adverse Event|2
1399574|NCT01227421|4619487|P2|Overall Study|Adverse Event|7
1399575|NCT01227421|4619488|P1|Overall Study|Adverse Event|2
1399576|NCT01227421|4619486|P3|Overall Study|Lost to Follow-up|5
1399577|NCT01227421|4619487|P2|Overall Study|Lost to Follow-up|7
1399578|NCT01227421|4619488|P1|Overall Study|Lost to Follow-up|6
1399579|NCT01227395|4619540|P2|Overall Study|Protocol Violation|1
1399580|NCT01227395|4619541|P1|Overall Study|Protocol Violation|0
1399581|NCT01227278|4619581|P2|Overall Study|Other|2
1399582|NCT01227278|4619582|P1|Overall Study|Other|1
1399583|NCT01227278|4619581|P2|Overall Study|Death|2
1399584|NCT01227278|4619582|P1|Overall Study|Death|0
1399585|NCT01227278|4619581|P2|Overall Study|Withdrawal by Subject|4
1399586|NCT01227278|4619582|P1|Overall Study|Withdrawal by Subject|4
1399587|NCT01227265|4619609|P3|Overall Study|Adverse Event|5
1399588|NCT01227265|4619610|P2|Overall Study|Adverse Event|10
1399589|NCT01227265|4619611|P1|Overall Study|Adverse Event|6
1399590|NCT01227265|4619609|P3|Overall Study|Lost to Follow-up|3
1399591|NCT01227265|4619610|P2|Overall Study|Lost to Follow-up|0
1399592|NCT01227265|4619611|P1|Overall Study|Lost to Follow-up|2
1399593|NCT01227265|4619609|P3|Overall Study|Withdrawal by Subject|3
1399594|NCT01227265|4619610|P2|Overall Study|Withdrawal by Subject|7
1399595|NCT01227265|4619611|P1|Overall Study|Withdrawal by Subject|7
1399596|NCT01227265|4619609|P3|Overall Study|Protocol Violation|0
1399597|NCT01227265|4619610|P2|Overall Study|Protocol Violation|1
1399598|NCT01227265|4619611|P1|Overall Study|Protocol Violation|2
1399599|NCT01227265|4619609|P3|Overall Study|Did Not Meet Protocol Eligibility|1
1399600|NCT01227265|4619610|P2|Overall Study|Did Not Meet Protocol Eligibility|0
1399601|NCT01227265|4619611|P1|Overall Study|Did Not Meet Protocol Eligibility|0
1399602|NCT01227265|4619609|P3|Overall Study|Administrative|2
1399603|NCT01227265|4619610|P2|Overall Study|Administrative|0
1399604|NCT01227265|4619611|P1|Overall Study|Administrative|1
1399605|NCT01227265|4619609|P3|Overall Study|Did Not Receive Treatment|0
1399606|NCT01227265|4619610|P2|Overall Study|Did Not Receive Treatment|2
1399607|NCT01227265|4619611|P1|Overall Study|Did Not Receive Treatment|1
1399608|NCT01227018|4619650|P1|Overall Study|Withdrew after beginning treatment|4
1399609|NCT01227018|4619650|P1|Overall Study|Toxicity|2
1399610|NCT01227018|4619650|P1|Overall Study|Disease progression|9
1399611|NCT01226745|4619677|P6|Overall Study|Other|1
1399612|NCT01226745|4619678|P5|Overall Study|Other|3
1399613|NCT01226745|4619679|P4|Overall Study|Other|4
1399614|NCT01226745|4619680|P3|Overall Study|Other|8
1399615|NCT01226745|4619681|P2|Overall Study|Other|7
1399616|NCT01226745|4619682|P1|Overall Study|Other|6
1399617|NCT01226745|4619677|P6|Overall Study|Death|1
1399618|NCT01226745|4619678|P5|Overall Study|Death|0
1399619|NCT01226745|4619679|P4|Overall Study|Death|0
1399620|NCT01226745|4619680|P3|Overall Study|Death|0
1399621|NCT01226745|4619681|P2|Overall Study|Death|0
1399622|NCT01226745|4619682|P1|Overall Study|Death|1
1399623|NCT01226745|4619677|P6|Overall Study|Lost to Follow-up|2
1399624|NCT01226745|4619678|P5|Overall Study|Lost to Follow-up|1
1399625|NCT01226745|4619679|P4|Overall Study|Lost to Follow-up|1
1399626|NCT01226745|4619680|P3|Overall Study|Lost to Follow-up|6
1399627|NCT01226745|4619681|P2|Overall Study|Lost to Follow-up|6
1399628|NCT01226745|4619682|P1|Overall Study|Lost to Follow-up|2
1399629|NCT01226745|4619677|P6|Overall Study|Did not complete schedule of assessments|1
1399630|NCT01226745|4619678|P5|Overall Study|Did not complete schedule of assessments|0
1399631|NCT01226745|4619679|P4|Overall Study|Did not complete schedule of assessments|0
1399632|NCT01226745|4619680|P3|Overall Study|Did not complete schedule of assessments|6
1399633|NCT01226745|4619681|P2|Overall Study|Did not complete schedule of assessments|3
1399634|NCT01226745|4619682|P1|Overall Study|Did not complete schedule of assessments|8
1399635|NCT01226511|4619878|P2|Taper Period|Parent/Caregiver Decision|1
1399636|NCT01226511|4619879|P1|Taper Period|Parent/Caregiver Decision|1
1399637|NCT01226511|4619878|P2|Taper Period|Protocol Violation|0
1399638|NCT01226511|4619879|P1|Taper Period|Protocol Violation|1
1399639|NCT01226511|4619878|P2|Taper Period|Lost to Follow-up|2
1399640|NCT01226511|4619879|P1|Taper Period|Lost to Follow-up|2
1399641|NCT01226511|4619878|P2|Taper Period|Adverse Event|0
1399642|NCT01226511|4619879|P1|Taper Period|Adverse Event|1
1399643|NCT01226511|4619878|P2|Extension Treatment Period|Sponsor Decision|1
1399644|NCT01226511|4619879|P1|Extension Treatment Period|Sponsor Decision|1
1399645|NCT01226511|4619878|P2|Extension Treatment Period|Parent/Caregiver Decision|8
1399646|NCT01226511|4619879|P1|Extension Treatment Period|Parent/Caregiver Decision|8
1399647|NCT01226511|4619878|P2|Extension Treatment Period|Withdrawal by Subject|3
1399648|NCT01226511|4619879|P1|Extension Treatment Period|Withdrawal by Subject|1
1399649|NCT01226511|4619878|P2|Extension Treatment Period|Protocol Violation|2
1399650|NCT01226511|4619879|P1|Extension Treatment Period|Protocol Violation|2
1399651|NCT01226511|4619878|P2|Extension Treatment Period|Lost to Follow-up|3
1399652|NCT01226511|4619879|P1|Extension Treatment Period|Lost to Follow-up|4
1399653|NCT01226511|4619878|P2|Extension Treatment Period|Lack of Efficacy|2
1399654|NCT01226511|4619879|P1|Extension Treatment Period|Lack of Efficacy|3
1399655|NCT01226511|4619878|P2|Extension Treatment Period|Adverse Event|8
1399656|NCT01226511|4619879|P1|Extension Treatment Period|Adverse Event|8
1399657|NCT01226511|4619878|P2|Acute Treatment Period|Withdrawal by Subject|6
1399658|NCT01226511|4619879|P1|Acute Treatment Period|Withdrawal by Subject|10
1399659|NCT01226511|4619878|P2|Acute Treatment Period|Protocol Violation|5
1399660|NCT01226511|4619879|P1|Acute Treatment Period|Protocol Violation|5
1399661|NCT01226511|4619878|P2|Acute Treatment Period|Parent/caregiver decision|7
1399662|NCT01226511|4619879|P1|Acute Treatment Period|Parent/caregiver decision|5
1399663|NCT01226511|4619878|P2|Acute Treatment Period|Lost to Follow-up|6
1399664|NCT01226511|4619879|P1|Acute Treatment Period|Lost to Follow-up|3
1399665|NCT01226511|4619878|P2|Acute Treatment Period|Lack of Efficacy|1
1399666|NCT01226511|4619879|P1|Acute Treatment Period|Lack of Efficacy|2
1399667|NCT01226511|4619878|P2|Acute Treatment Period|Adverse Event|6
1399668|NCT01226511|4619879|P1|Acute Treatment Period|Adverse Event|7
1399669|NCT01226459|4619917|P2|Overall Study|Pregnancy|0
1399670|NCT01226459|4619918|P1|Overall Study|Pregnancy|1
1399671|NCT01226459|4619917|P2|Overall Study|Lost to Follow-up|8
1399672|NCT01226459|4619918|P1|Overall Study|Lost to Follow-up|4
1399673|NCT01226459|4619917|P2|Overall Study|Withdrawal by Subject|13
1399674|NCT01226459|4619918|P1|Overall Study|Withdrawal by Subject|10
1399675|NCT01226459|4619917|P2|Overall Study|Protocol Violation|3
1399676|NCT01226459|4619918|P1|Overall Study|Protocol Violation|4
1399677|NCT01226459|4619917|P2|Overall Study|Adverse Event|8
1399678|NCT01226459|4619918|P1|Overall Study|Adverse Event|2
1399679|NCT01226121|4619936|P3|Overall Study|Lost to Follow-up|1
1399680|NCT01226121|4619937|P2|Overall Study|Lost to Follow-up|0
1399681|NCT01226121|4619938|P1|Overall Study|Lost to Follow-up|2
1399682|NCT01226095|4619949|P1|Overall Study|Poor compliance|1
1399683|NCT01226043|4619974|P4|30-week Observational Phase|Physician Decision|2
1399684|NCT01226043|4619975|P3|30-week Observational Phase|Physician Decision|2
1399685|NCT01226043|4619976|P2|30-week Observational Phase|Physician Decision|0
1399763|NCT01225952|4620028|P1|Overall Study|Lost to Follow-up|1
1399686|NCT01226043|4619977|P1|30-week Observational Phase|Physician Decision|0
1399687|NCT01226043|4619974|P4|30-week Observational Phase|Withdrawal by Subject|7
1399688|NCT01226043|4619975|P3|30-week Observational Phase|Withdrawal by Subject|1
1399689|NCT01226043|4619976|P2|30-week Observational Phase|Withdrawal by Subject|0
1399690|NCT01226043|4619977|P1|30-week Observational Phase|Withdrawal by Subject|0
1399691|NCT01226043|4619974|P4|30-week Observational Phase|Lost to Follow-up|2
1399692|NCT01226043|4619975|P3|30-week Observational Phase|Lost to Follow-up|2
1399693|NCT01226043|4619976|P2|30-week Observational Phase|Lost to Follow-up|0
1399694|NCT01226043|4619977|P1|30-week Observational Phase|Lost to Follow-up|0
1399695|NCT01226043|4619974|P4|30-week Observational Phase|Protocol Violation|1
1399696|NCT01226043|4619975|P3|30-week Observational Phase|Protocol Violation|0
1399697|NCT01226043|4619976|P2|30-week Observational Phase|Protocol Violation|0
1399698|NCT01226043|4619977|P1|30-week Observational Phase|Protocol Violation|0
1399699|NCT01226043|4619974|P4|30-week Observational Phase|Adverse Event|1
1399700|NCT01226043|4619975|P3|30-week Observational Phase|Adverse Event|1
1399701|NCT01226043|4619976|P2|30-week Observational Phase|Adverse Event|0
1399702|NCT01226043|4619977|P1|30-week Observational Phase|Adverse Event|0
1399703|NCT01226043|4619974|P4|6-week Re-randomization Phase|completed in error|1
1399704|NCT01226043|4619975|P3|6-week Re-randomization Phase|completed in error|0
1399705|NCT01226043|4619976|P2|6-week Re-randomization Phase|completed in error|0
1399706|NCT01226043|4619977|P1|6-week Re-randomization Phase|completed in error|0
1399707|NCT01226043|4619974|P4|6-week Re-randomization Phase|Physician Decision|2
1399708|NCT01226043|4619975|P3|6-week Re-randomization Phase|Physician Decision|3
1399709|NCT01226043|4619976|P2|6-week Re-randomization Phase|Physician Decision|0
1399710|NCT01226043|4619977|P1|6-week Re-randomization Phase|Physician Decision|0
1399711|NCT01226043|4619974|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
1399712|NCT01226043|4619975|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
1399713|NCT01226043|4619976|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
1399714|NCT01226043|4619977|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
1399715|NCT01226043|4619974|P4|6-week Re-randomization Phase|Lost to Follow-up|3
1399716|NCT01226043|4619975|P3|6-week Re-randomization Phase|Lost to Follow-up|1
1399717|NCT01226043|4619976|P2|6-week Re-randomization Phase|Lost to Follow-up|0
1399718|NCT01226043|4619977|P1|6-week Re-randomization Phase|Lost to Follow-up|0
1399719|NCT01226043|4619974|P4|6-week Re-randomization Phase|Protocol Violation|1
1399720|NCT01226043|4619975|P3|6-week Re-randomization Phase|Protocol Violation|1
1399721|NCT01226043|4619976|P2|6-week Re-randomization Phase|Protocol Violation|0
1399722|NCT01226043|4619977|P1|6-week Re-randomization Phase|Protocol Violation|0
1399723|NCT01226043|4619974|P4|6-week Re-randomization Phase|Adverse Event|1
1399724|NCT01226043|4619975|P3|6-week Re-randomization Phase|Adverse Event|1
1399725|NCT01226043|4619976|P2|6-week Re-randomization Phase|Adverse Event|0
1399726|NCT01226043|4619977|P1|6-week Re-randomization Phase|Adverse Event|0
1399727|NCT01226043|4619974|P4|4-week Crossover Phase - Period 2|Physician Decision|0
1399728|NCT01226043|4619975|P3|4-week Crossover Phase - Period 2|Physician Decision|0
1399729|NCT01226043|4619976|P2|4-week Crossover Phase - Period 2|Physician Decision|5
1399730|NCT01226043|4619977|P1|4-week Crossover Phase - Period 2|Physician Decision|4
1399731|NCT01226043|4619974|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
1399732|NCT01226043|4619975|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
1399733|NCT01226043|4619976|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
1399734|NCT01226043|4619977|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
1399735|NCT01226043|4619974|P4|4-week Crossover Phase - Period 1|Physician Decision|0
1399736|NCT01226043|4619975|P3|4-week Crossover Phase - Period 1|Physician Decision|0
1399737|NCT01226043|4619976|P2|4-week Crossover Phase - Period 1|Physician Decision|6
1399738|NCT01226043|4619977|P1|4-week Crossover Phase - Period 1|Physician Decision|0
1399739|NCT01226043|4619974|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
1399740|NCT01226043|4619975|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
1399741|NCT01226043|4619976|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
1399742|NCT01226043|4619977|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
1399743|NCT01226043|4619974|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
1399744|NCT01226043|4619975|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
1399745|NCT01226043|4619976|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
1399746|NCT01226043|4619977|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
1399747|NCT01226043|4619974|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
1399748|NCT01226043|4619975|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
1399749|NCT01226043|4619976|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
1399750|NCT01226043|4619977|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
1399751|NCT01225991|4620015|P1|Overall Study|Withdrawal by Subject|6
1399752|NCT01225952|4620026|P3|Overall Study|Surgical complications|0
1399753|NCT01225952|4620027|P2|Overall Study|Surgical complications|0
1399754|NCT01225952|4620028|P1|Overall Study|Surgical complications|1
1399755|NCT01225952|4620026|P3|Overall Study|Withdrawal by Subject|5
1399756|NCT01225952|4620027|P2|Overall Study|Withdrawal by Subject|4
1399757|NCT01225952|4620028|P1|Overall Study|Withdrawal by Subject|4
1399758|NCT01225952|4620026|P3|Overall Study|Study Eye Explanted|1
1399759|NCT01225952|4620027|P2|Overall Study|Study Eye Explanted|0
1399760|NCT01225952|4620028|P1|Overall Study|Study Eye Explanted|0
1399761|NCT01225952|4620026|P3|Overall Study|Lost to Follow-up|0
1399762|NCT01225952|4620027|P2|Overall Study|Lost to Follow-up|0
1399764|NCT01225887|4620120|P1|Overall Study|Ineligible:inadequate pathology|2
1399765|NCT01225887|4620120|P1|Overall Study|Ineligible;improper pre-protocol therapy|1
1399766|NCT01225887|4620120|P1|Overall Study|Ineligible:required test not done|2
1399767|NCT01225835|4620130|P2|Overall Study|not specified|1
1399768|NCT01225835|4620131|P1|Overall Study|not specified|1
1399769|NCT01225835|4620130|P2|Overall Study|Adverse Event|1
1399770|NCT01225835|4620131|P1|Overall Study|Adverse Event|2
1399771|NCT01225835|4620130|P2|Overall Study|Did not meet hCG criterion|0
1399772|NCT01225835|4620131|P1|Overall Study|Did not meet hCG criterion|2
1399773|NCT01225835|4620130|P2|Overall Study|Completed protocol|1
1399774|NCT01225835|4620131|P1|Overall Study|Completed protocol|2
1399775|NCT01225822|4620179|P5|Overall Study|Not Specified|7
1399776|NCT01225822|4620180|P4|Overall Study|Not Specified|10
1399777|NCT01225822|4620181|P3|Overall Study|Not Specified|7
1399778|NCT01225822|4620182|P2|Overall Study|Not Specified|10
1399779|NCT01225822|4620183|P1|Overall Study|Not Specified|13
1399780|NCT01225822|4620179|P5|Overall Study|Withdrawal by Subject|6
1399781|NCT01225822|4620180|P4|Overall Study|Withdrawal by Subject|11
1399782|NCT01225822|4620181|P3|Overall Study|Withdrawal by Subject|7
1399783|NCT01225822|4620182|P2|Overall Study|Withdrawal by Subject|7
1399784|NCT01225822|4620183|P1|Overall Study|Withdrawal by Subject|6
1399785|NCT01225822|4620179|P5|Overall Study|Lost to Follow-up|0
1399786|NCT01225822|4620180|P4|Overall Study|Lost to Follow-up|1
1399787|NCT01225822|4620181|P3|Overall Study|Lost to Follow-up|0
1399788|NCT01225822|4620182|P2|Overall Study|Lost to Follow-up|0
1399789|NCT01225822|4620183|P1|Overall Study|Lost to Follow-up|0
1399790|NCT01225822|4620179|P5|Overall Study|Protocol Violation|4
1399791|NCT01225822|4620180|P4|Overall Study|Protocol Violation|7
1399792|NCT01225822|4620181|P3|Overall Study|Protocol Violation|6
1399793|NCT01225822|4620182|P2|Overall Study|Protocol Violation|8
1399794|NCT01225822|4620183|P1|Overall Study|Protocol Violation|6
1399795|NCT01225822|4620179|P5|Overall Study|Adverse Event|14
1399796|NCT01225822|4620180|P4|Overall Study|Adverse Event|23
1399797|NCT01225822|4620181|P3|Overall Study|Adverse Event|18
1399798|NCT01225822|4620182|P2|Overall Study|Adverse Event|31
1399799|NCT01225822|4620183|P1|Overall Study|Adverse Event|13
1399800|NCT01225731|4620250|P13|Part 3|Withdrawal by Subject|4
1399801|NCT01225731|4620251|P12|Part 3|Withdrawal by Subject|6
1399802|NCT01225731|4620252|P11|Part 3|Withdrawal by Subject|4
1399803|NCT01225731|4620253|P10|Part 3|Withdrawal by Subject|0
1399804|NCT01225731|4620254|P9|Part 3|Withdrawal by Subject|0
1399805|NCT01225731|4620255|P8|Part 3|Withdrawal by Subject|0
1399806|NCT01225731|4620256|P7|Part 3|Withdrawal by Subject|0
1399807|NCT01225731|4620257|P6|Part 3|Withdrawal by Subject|0
1399808|NCT01225731|4620258|P5|Part 3|Withdrawal by Subject|0
1399809|NCT01225731|4620259|P4|Part 3|Withdrawal by Subject|0
1399810|NCT01225731|4620260|P3|Part 3|Withdrawal by Subject|0
1399811|NCT01225731|4620261|P2|Part 3|Withdrawal by Subject|0
1399812|NCT01225731|4620262|P1|Part 3|Withdrawal by Subject|0
1399813|NCT01225731|4620250|P13|Part 3|Physician Decision|2
1399814|NCT01225731|4620251|P12|Part 3|Physician Decision|1
1399815|NCT01225731|4620252|P11|Part 3|Physician Decision|0
1399816|NCT01225731|4620253|P10|Part 3|Physician Decision|0
1399817|NCT01225731|4620254|P9|Part 3|Physician Decision|0
1399818|NCT01225731|4620255|P8|Part 3|Physician Decision|0
1399819|NCT01225731|4620256|P7|Part 3|Physician Decision|0
1399820|NCT01225731|4620257|P6|Part 3|Physician Decision|0
1399821|NCT01225731|4620258|P5|Part 3|Physician Decision|0
1399822|NCT01225731|4620259|P4|Part 3|Physician Decision|0
1399823|NCT01225731|4620260|P3|Part 3|Physician Decision|0
1399824|NCT01225731|4620261|P2|Part 3|Physician Decision|0
1399825|NCT01225731|4620262|P1|Part 3|Physician Decision|0
1399826|NCT01225731|4620250|P13|Part 3|Lost to Follow-up|1
1399827|NCT01225731|4620251|P12|Part 3|Lost to Follow-up|2
1399828|NCT01225731|4620252|P11|Part 3|Lost to Follow-up|1
1399829|NCT01225731|4620253|P10|Part 3|Lost to Follow-up|0
1399830|NCT01225731|4620254|P9|Part 3|Lost to Follow-up|0
1399831|NCT01225731|4620255|P8|Part 3|Lost to Follow-up|0
1399832|NCT01225731|4620256|P7|Part 3|Lost to Follow-up|0
1399833|NCT01225731|4620257|P6|Part 3|Lost to Follow-up|0
1399834|NCT01225731|4620258|P5|Part 3|Lost to Follow-up|0
1399835|NCT01225731|4620259|P4|Part 3|Lost to Follow-up|0
1399836|NCT01225731|4620260|P3|Part 3|Lost to Follow-up|0
1399837|NCT01225731|4620261|P2|Part 3|Lost to Follow-up|0
1399838|NCT01225731|4620262|P1|Part 3|Lost to Follow-up|0
1399839|NCT01225731|4620250|P13|Part 3|Adverse Event|0
1399840|NCT01225731|4620251|P12|Part 3|Adverse Event|1
1399841|NCT01225731|4620252|P11|Part 3|Adverse Event|1
1399842|NCT01225731|4620253|P10|Part 3|Adverse Event|0
1399843|NCT01225731|4620254|P9|Part 3|Adverse Event|0
1399844|NCT01225731|4620255|P8|Part 3|Adverse Event|0
1399845|NCT01225731|4620256|P7|Part 3|Adverse Event|0
1399846|NCT01225731|4620257|P6|Part 3|Adverse Event|0
1399847|NCT01225731|4620258|P5|Part 3|Adverse Event|0
1399848|NCT01225731|4620259|P4|Part 3|Adverse Event|0
1399849|NCT01225731|4620260|P3|Part 3|Adverse Event|0
1399850|NCT01225731|4620261|P2|Part 3|Adverse Event|0
1399851|NCT01225731|4620262|P1|Part 3|Adverse Event|0
1399852|NCT01225731|4620250|P13|Part 2|Withdrawal by Subject|0
1399853|NCT01225731|4620251|P12|Part 2|Withdrawal by Subject|0
1399854|NCT01225731|4620252|P11|Part 2|Withdrawal by Subject|0
1399855|NCT01225731|4620253|P10|Part 2|Withdrawal by Subject|0
1399856|NCT01225731|4620254|P9|Part 2|Withdrawal by Subject|1
1399857|NCT01225731|4620255|P8|Part 2|Withdrawal by Subject|4
1399858|NCT01225731|4620256|P7|Part 2|Withdrawal by Subject|3
1399859|NCT01225731|4620257|P6|Part 2|Withdrawal by Subject|1
1399860|NCT01225731|4620258|P5|Part 2|Withdrawal by Subject|0
1399861|NCT01225731|4620259|P4|Part 2|Withdrawal by Subject|0
1399862|NCT01225731|4620260|P3|Part 2|Withdrawal by Subject|0
1399863|NCT01225731|4620261|P2|Part 2|Withdrawal by Subject|0
1399864|NCT01225731|4620262|P1|Part 2|Withdrawal by Subject|0
1399865|NCT01225731|4620250|P13|Part 2|Physician Decision|0
1399866|NCT01225731|4620251|P12|Part 2|Physician Decision|0
1399867|NCT01225731|4620252|P11|Part 2|Physician Decision|0
1399868|NCT01225731|4620253|P10|Part 2|Physician Decision|0
1399869|NCT01225731|4620254|P9|Part 2|Physician Decision|2
1399870|NCT01225731|4620255|P8|Part 2|Physician Decision|2
1399871|NCT01225731|4620256|P7|Part 2|Physician Decision|0
1399872|NCT01225731|4620257|P6|Part 2|Physician Decision|0
1399873|NCT01225731|4620258|P5|Part 2|Physician Decision|0
1399874|NCT01225731|4620259|P4|Part 2|Physician Decision|0
1399875|NCT01225731|4620260|P3|Part 2|Physician Decision|0
1399876|NCT01225731|4620261|P2|Part 2|Physician Decision|0
1399877|NCT01225731|4620262|P1|Part 2|Physician Decision|0
1399878|NCT01225731|4620250|P13|Part 2|Lost to Follow-up|0
1399879|NCT01225731|4620251|P12|Part 2|Lost to Follow-up|0
1399880|NCT01225731|4620252|P11|Part 2|Lost to Follow-up|0
1399881|NCT01225731|4620253|P10|Part 2|Lost to Follow-up|0
1399882|NCT01225731|4620254|P9|Part 2|Lost to Follow-up|1
1399883|NCT01225731|4620255|P8|Part 2|Lost to Follow-up|3
1399884|NCT01225731|4620256|P7|Part 2|Lost to Follow-up|0
1399885|NCT01225731|4620257|P6|Part 2|Lost to Follow-up|0
1399886|NCT01225731|4620258|P5|Part 2|Lost to Follow-up|0
1399887|NCT01225731|4620259|P4|Part 2|Lost to Follow-up|0
1399888|NCT01225731|4620260|P3|Part 2|Lost to Follow-up|0
1399889|NCT01225731|4620261|P2|Part 2|Lost to Follow-up|0
1399890|NCT01225731|4620262|P1|Part 2|Lost to Follow-up|0
1399891|NCT01225731|4620250|P13|Part 2|Pregnancy|0
1399892|NCT01225731|4620251|P12|Part 2|Pregnancy|0
1399893|NCT01225731|4620252|P11|Part 2|Pregnancy|0
1399894|NCT01225731|4620253|P10|Part 2|Pregnancy|0
1399895|NCT01225731|4620254|P9|Part 2|Pregnancy|1
1399896|NCT01225731|4620255|P8|Part 2|Pregnancy|0
1399897|NCT01225731|4620256|P7|Part 2|Pregnancy|1
1399898|NCT01225731|4620257|P6|Part 2|Pregnancy|0
1399899|NCT01225731|4620258|P5|Part 2|Pregnancy|0
1399900|NCT01225731|4620259|P4|Part 2|Pregnancy|0
1399901|NCT01225731|4620260|P3|Part 2|Pregnancy|0
1399902|NCT01225731|4620261|P2|Part 2|Pregnancy|0
1399903|NCT01225731|4620262|P1|Part 2|Pregnancy|0
1399904|NCT01225731|4620250|P13|Part 2|Lack of Efficacy|0
1399905|NCT01225731|4620251|P12|Part 2|Lack of Efficacy|0
1399906|NCT01225731|4620252|P11|Part 2|Lack of Efficacy|0
1399907|NCT01225731|4620253|P10|Part 2|Lack of Efficacy|0
1399908|NCT01225731|4620254|P9|Part 2|Lack of Efficacy|3
1399909|NCT01225731|4620255|P8|Part 2|Lack of Efficacy|12
1399910|NCT01225731|4620256|P7|Part 2|Lack of Efficacy|0
1399911|NCT01225731|4620257|P6|Part 2|Lack of Efficacy|1
1399912|NCT01225731|4620258|P5|Part 2|Lack of Efficacy|0
1399913|NCT01225731|4620259|P4|Part 2|Lack of Efficacy|0
1399914|NCT01225731|4620260|P3|Part 2|Lack of Efficacy|0
1399915|NCT01225731|4620261|P2|Part 2|Lack of Efficacy|0
1399916|NCT01225731|4620262|P1|Part 2|Lack of Efficacy|0
1399917|NCT01225731|4620250|P13|Part 2|Adverse Event|0
1399918|NCT01225731|4620251|P12|Part 2|Adverse Event|0
1399919|NCT01225731|4620252|P11|Part 2|Adverse Event|0
1399920|NCT01225731|4620253|P10|Part 2|Adverse Event|0
1399921|NCT01225731|4620254|P9|Part 2|Adverse Event|2
1399922|NCT01225731|4620255|P8|Part 2|Adverse Event|4
1399923|NCT01225731|4620256|P7|Part 2|Adverse Event|4
1399924|NCT01225731|4620257|P6|Part 2|Adverse Event|0
1399925|NCT01225731|4620258|P5|Part 2|Adverse Event|0
1399926|NCT01225731|4620259|P4|Part 2|Adverse Event|0
1399927|NCT01225731|4620260|P3|Part 2|Adverse Event|0
1399928|NCT01225731|4620261|P2|Part 2|Adverse Event|0
1399929|NCT01225731|4620262|P1|Part 2|Adverse Event|0
1399930|NCT01225731|4620250|P13|Part 2|Protocol Violation|0
1399931|NCT01225731|4620251|P12|Part 2|Protocol Violation|0
1399932|NCT01225731|4620252|P11|Part 2|Protocol Violation|0
1399933|NCT01225731|4620253|P10|Part 2|Protocol Violation|0
1399934|NCT01225731|4620254|P9|Part 2|Protocol Violation|1
1399935|NCT01225731|4620255|P8|Part 2|Protocol Violation|0
1399936|NCT01225731|4620256|P7|Part 2|Protocol Violation|0
1399937|NCT01225731|4620257|P6|Part 2|Protocol Violation|1
1399938|NCT01225731|4620258|P5|Part 2|Protocol Violation|0
1399939|NCT01225731|4620259|P4|Part 2|Protocol Violation|0
1399940|NCT01225731|4620260|P3|Part 2|Protocol Violation|0
1399941|NCT01225731|4620261|P2|Part 2|Protocol Violation|0
1399942|NCT01225731|4620262|P1|Part 2|Protocol Violation|0
1399943|NCT01225731|4620250|P13|Part 1|Protocol Violation|0
1399944|NCT01225731|4620251|P12|Part 1|Protocol Violation|0
1399945|NCT01225731|4620252|P11|Part 1|Protocol Violation|0
1399946|NCT01225731|4620253|P10|Part 1|Protocol Violation|0
1399947|NCT01225731|4620254|P9|Part 1|Protocol Violation|0
1399948|NCT01225731|4620255|P8|Part 1|Protocol Violation|0
1399949|NCT01225731|4620256|P7|Part 1|Protocol Violation|0
1399950|NCT01225731|4620257|P6|Part 1|Protocol Violation|0
1399951|NCT01225731|4620258|P5|Part 1|Protocol Violation|0
1399952|NCT01225731|4620259|P4|Part 1|Protocol Violation|1
1399953|NCT01225731|4620260|P3|Part 1|Protocol Violation|0
1399954|NCT01225731|4620261|P2|Part 1|Protocol Violation|0
1399955|NCT01225731|4620262|P1|Part 1|Protocol Violation|0
1399956|NCT01225731|4620250|P13|Part 1|Withdrawal by Subject|0
1399957|NCT01225731|4620251|P12|Part 1|Withdrawal by Subject|0
1399958|NCT01225731|4620252|P11|Part 1|Withdrawal by Subject|0
1399959|NCT01225731|4620253|P10|Part 1|Withdrawal by Subject|0
1399960|NCT01225731|4620254|P9|Part 1|Withdrawal by Subject|0
1399961|NCT01225731|4620255|P8|Part 1|Withdrawal by Subject|0
1399962|NCT01225731|4620256|P7|Part 1|Withdrawal by Subject|0
1399963|NCT01225731|4620257|P6|Part 1|Withdrawal by Subject|0
1399964|NCT01225731|4620258|P5|Part 1|Withdrawal by Subject|4
1399965|NCT01225731|4620259|P4|Part 1|Withdrawal by Subject|0
1399966|NCT01225731|4620260|P3|Part 1|Withdrawal by Subject|0
1399967|NCT01225731|4620261|P2|Part 1|Withdrawal by Subject|3
1399968|NCT01225731|4620262|P1|Part 1|Withdrawal by Subject|0
1399969|NCT01225731|4620250|P13|Part 1|Adverse Event|0
1399970|NCT01225731|4620251|P12|Part 1|Adverse Event|0
1399971|NCT01225731|4620252|P11|Part 1|Adverse Event|0
1399972|NCT01225731|4620253|P10|Part 1|Adverse Event|0
1399973|NCT01225731|4620254|P9|Part 1|Adverse Event|0
1399974|NCT01225731|4620255|P8|Part 1|Adverse Event|0
1399975|NCT01225731|4620256|P7|Part 1|Adverse Event|0
1399976|NCT01225731|4620257|P6|Part 1|Adverse Event|0
1399977|NCT01225731|4620258|P5|Part 1|Adverse Event|1
1399978|NCT01225731|4620259|P4|Part 1|Adverse Event|1
1399979|NCT01225731|4620260|P3|Part 1|Adverse Event|1
1399980|NCT01225731|4620261|P2|Part 1|Adverse Event|2
1399981|NCT01225731|4620262|P1|Part 1|Adverse Event|1
1399982|NCT01225731|4620250|P13|Part 1|Did not meet eligibility criteria|0
1399983|NCT01225731|4620251|P12|Part 1|Did not meet eligibility criteria|0
1399984|NCT01225731|4620252|P11|Part 1|Did not meet eligibility criteria|0
1399985|NCT01225731|4620253|P10|Part 1|Did not meet eligibility criteria|0
1399986|NCT01225731|4620254|P9|Part 1|Did not meet eligibility criteria|0
1399987|NCT01225731|4620255|P8|Part 1|Did not meet eligibility criteria|0
1399988|NCT01225731|4620256|P7|Part 1|Did not meet eligibility criteria|0
1399989|NCT01225731|4620257|P6|Part 1|Did not meet eligibility criteria|0
1399990|NCT01225731|4620258|P5|Part 1|Did not meet eligibility criteria|1
1399991|NCT01225731|4620259|P4|Part 1|Did not meet eligibility criteria|0
1399992|NCT01225731|4620260|P3|Part 1|Did not meet eligibility criteria|0
1399993|NCT01225731|4620261|P2|Part 1|Did not meet eligibility criteria|0
1399994|NCT01225731|4620262|P1|Part 1|Did not meet eligibility criteria|1
1399995|NCT01225562|4620357|P3|Overall Study|Lost to Follow-up|1
1399996|NCT01225562|4620358|P2|Overall Study|Lost to Follow-up|6
1399997|NCT01225562|4620359|P1|Overall Study|Lost to Follow-up|3
1399998|NCT01225562|4620357|P3|Overall Study|Withdrawal by Subject|52
1399999|NCT01225562|4620358|P2|Overall Study|Withdrawal by Subject|50
1400000|NCT01225562|4620359|P1|Overall Study|Withdrawal by Subject|52
1400001|NCT01225549|4620376|P10|Period 6 - Washout|Disallowed medication|0
1400002|NCT01225549|4620377|P9|Period 6 - Washout|Disallowed medication|0
1400003|NCT01225549|4620378|P8|Period 6 - Washout|Disallowed medication|0
1400004|NCT01225549|4620379|P7|Period 6 - Washout|Disallowed medication|0
1400005|NCT01225549|4620380|P6|Period 6 - Washout|Disallowed medication|0
1400006|NCT01225549|4620381|P5|Period 6 - Washout|Disallowed medication|0
1400007|NCT01225549|4620382|P4|Period 6 - Washout|Disallowed medication|1
1400008|NCT01225549|4620383|P3|Period 6 - Washout|Disallowed medication|0
1400009|NCT01225549|4620384|P2|Period 6 - Washout|Disallowed medication|0
1400010|NCT01225549|4620385|P1|Period 6 - Washout|Disallowed medication|0
1400011|NCT01225549|4620376|P10|Period 4 - Washout|Disallowed medication|0
1400012|NCT01225549|4620377|P9|Period 4 - Washout|Disallowed medication|0
1400013|NCT01225549|4620378|P8|Period 4 - Washout|Disallowed medication|0
1400014|NCT01225549|4620379|P7|Period 4 - Washout|Disallowed medication|0
1400015|NCT01225549|4620380|P6|Period 4 - Washout|Disallowed medication|0
1400016|NCT01225549|4620381|P5|Period 4 - Washout|Disallowed medication|0
1400017|NCT01225549|4620382|P4|Period 4 - Washout|Disallowed medication|0
1400018|NCT01225549|4620383|P3|Period 4 - Washout|Disallowed medication|0
1400019|NCT01225549|4620384|P2|Period 4 - Washout|Disallowed medication|1
1400020|NCT01225549|4620385|P1|Period 4 - Washout|Disallowed medication|0
1400021|NCT01225211|4620468|P10|Overall Study|Other|1
1400022|NCT01225211|4620469|P9|Overall Study|Other|0
1400023|NCT01225211|4620470|P8|Overall Study|Other|0
1400024|NCT01225211|4620471|P7|Overall Study|Other|0
1400025|NCT01225211|4620472|P6|Overall Study|Other|0
1400026|NCT01225211|4620473|P5|Overall Study|Other|0
1400027|NCT01225211|4620474|P4|Overall Study|Other|0
1400028|NCT01225211|4620475|P3|Overall Study|Other|0
1400029|NCT01225211|4620476|P2|Overall Study|Other|0
1400030|NCT01225211|4620477|P1|Overall Study|Other|0
1400031|NCT01225211|4620468|P10|Overall Study|Withdrawal by Subject|3
1400032|NCT01225211|4620469|P9|Overall Study|Withdrawal by Subject|1
1400033|NCT01225211|4620470|P8|Overall Study|Withdrawal by Subject|0
1400034|NCT01225211|4620471|P7|Overall Study|Withdrawal by Subject|1
1400035|NCT01225211|4620472|P6|Overall Study|Withdrawal by Subject|0
1400036|NCT01225211|4620473|P5|Overall Study|Withdrawal by Subject|0
1400037|NCT01225211|4620474|P4|Overall Study|Withdrawal by Subject|0
1400038|NCT01225211|4620475|P3|Overall Study|Withdrawal by Subject|0
1400039|NCT01225211|4620476|P2|Overall Study|Withdrawal by Subject|0
1400040|NCT01225211|4620477|P1|Overall Study|Withdrawal by Subject|0
1400041|NCT01225211|4620468|P10|Overall Study|Adverse Event|1
1400042|NCT01225211|4620469|P9|Overall Study|Adverse Event|0
1400043|NCT01225211|4620470|P8|Overall Study|Adverse Event|0
1400044|NCT01225211|4620471|P7|Overall Study|Adverse Event|0
1400045|NCT01225211|4620472|P6|Overall Study|Adverse Event|0
1400046|NCT01225211|4620473|P5|Overall Study|Adverse Event|0
1400047|NCT01225211|4620474|P4|Overall Study|Adverse Event|0
1400048|NCT01225211|4620475|P3|Overall Study|Adverse Event|1
1400049|NCT01225211|4620476|P2|Overall Study|Adverse Event|0
1400050|NCT01225211|4620477|P1|Overall Study|Adverse Event|0
1400051|NCT01225159|4620580|P2|Overall Study|Change operation|0
1400052|NCT01225159|4620581|P1|Overall Study|Change operation|1
1400053|NCT01225146|4620591|P2|Overall Study|Sponsor discontinued making 2mg drug|2
1400054|NCT01225146|4620592|P1|Overall Study|Sponsor discontinued making 2mg drug|0
1400055|NCT01224821|4620658|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
1400056|NCT01224821|4620658|P1|Long-Term Follow-Up|Death|2
1400057|NCT01224821|4620658|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
1400058|NCT01224821|4620658|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
1400059|NCT01224821|4620658|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
1400060|NCT01224821|4620658|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
1400061|NCT01224821|4620658|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
1400062|NCT01224821|4620658|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
1400063|NCT01224782|4620677|P1|Overall Study|Transplantation|1
1400064|NCT01224782|4620677|P1|Overall Study|Deterioration|1
1400065|NCT01224782|4620677|P1|Overall Study|Financial Reasons|1
1400066|NCT01224782|4620677|P1|Overall Study|Change of Treatment|1
1400067|NCT01224782|4620677|P1|Overall Study|Start of Dialysis|3
1400068|NCT01224782|4620677|P1|Overall Study|Not Specified|4
1400069|NCT01224782|4620677|P1|Overall Study|Noncompliance|10
1400070|NCT01224782|4620677|P1|Overall Study|Adverse Reaction|11
1400071|NCT01224782|4620677|P1|Overall Study|Adverse Event|12
1400072|NCT01224782|4620677|P1|Overall Study|Improvement|13
1400073|NCT01224782|4620677|P1|Overall Study|Death|14
1400074|NCT01224782|4620677|P1|Overall Study|Withdrawal by Subject|16
1400075|NCT01224782|4620677|P1|Overall Study|Lost to Follow-up|177
1400076|NCT01224639|4620703|P8|Overall Study|Adverse Event|1
1400077|NCT01224639|4620704|P7|Overall Study|Adverse Event|0
1400078|NCT01224639|4620705|P6|Overall Study|Adverse Event|0
1400079|NCT01224639|4620706|P5|Overall Study|Adverse Event|0
1400080|NCT01224639|4620707|P4|Overall Study|Adverse Event|0
1400081|NCT01224639|4620708|P3|Overall Study|Adverse Event|0
1400082|NCT01224639|4620709|P2|Overall Study|Adverse Event|0
1400083|NCT01224639|4620710|P1|Overall Study|Adverse Event|0
1400084|NCT01224639|4620703|P8|Overall Study|Withdrawal by Subject|1
1400085|NCT01224639|4620704|P7|Overall Study|Withdrawal by Subject|1
1400086|NCT01224639|4620705|P6|Overall Study|Withdrawal by Subject|0
1400087|NCT01224639|4620706|P5|Overall Study|Withdrawal by Subject|2
1400088|NCT01224639|4620707|P4|Overall Study|Withdrawal by Subject|0
1400089|NCT01224639|4620708|P3|Overall Study|Withdrawal by Subject|0
1400090|NCT01224639|4620709|P2|Overall Study|Withdrawal by Subject|0
1400091|NCT01224639|4620710|P1|Overall Study|Withdrawal by Subject|0
1400092|NCT01224431|4620828|P2|Overall Study|no video record|1
1400093|NCT01224431|4620829|P1|Overall Study|no video record|0
1400094|NCT01224431|4620828|P2|Overall Study|not randomized|4
1400095|NCT01224431|4620829|P1|Overall Study|not randomized|0
1400096|NCT01224171|4620848|P2|Overall Study|Lost to Follow-up|3
1400097|NCT01224171|4620849|P1|Overall Study|Lost to Follow-up|0
1400098|NCT01224171|4620848|P2|Overall Study|Withdrawal of Consent|4
1400099|NCT01224171|4620849|P1|Overall Study|Withdrawal of Consent|2
1400100|NCT01224171|4620848|P2|Overall Study|Lack of Efficacy|1
1400101|NCT01224171|4620849|P1|Overall Study|Lack of Efficacy|5
1400102|NCT01224171|4620848|P2|Overall Study|Protocol Violation|1
1400103|NCT01224171|4620849|P1|Overall Study|Protocol Violation|0
1400104|NCT01224171|4620848|P2|Overall Study|Adverse Event|4
1400105|NCT01224171|4620849|P1|Overall Study|Adverse Event|8
1400106|NCT01223937|4620889|P2|Overall Study|Not specified|1
1400107|NCT01223937|4620890|P1|Overall Study|Not specified|4
1400108|NCT01223937|4620889|P2|Overall Study|Protocol Violation|7
1400109|NCT01223937|4620890|P1|Overall Study|Protocol Violation|8
1400110|NCT01223937|4620889|P2|Overall Study|Adverse Event|4
1400111|NCT01223937|4620890|P1|Overall Study|Adverse Event|1
1400112|NCT01223937|4620889|P2|Overall Study|Lost to Follow-up|4
1400113|NCT01223937|4620890|P1|Overall Study|Lost to Follow-up|1
1400114|NCT01223937|4620889|P2|Overall Study|Withdrawal by Subject|2
1400115|NCT01223937|4620890|P1|Overall Study|Withdrawal by Subject|3
1400116|NCT01223404|4620936|P6|Third Intervention (1 Day)|Non-compliance (slept)|0
1400117|NCT01223404|4620937|P5|Third Intervention (1 Day)|Non-compliance (slept)|0
1400118|NCT01223404|4620938|P4|Third Intervention (1 Day)|Non-compliance (slept)|1
1400119|NCT01223404|4620939|P3|Third Intervention (1 Day)|Non-compliance (slept)|0
1400120|NCT01223404|4620940|P2|Third Intervention (1 Day)|Non-compliance (slept)|0
1400121|NCT01223404|4620941|P1|Third Intervention (1 Day)|Non-compliance (slept)|0
1400122|NCT01223404|4620936|P6|Second Intervention (1 Day)|Adverse Event|0
1400123|NCT01223404|4620937|P5|Second Intervention (1 Day)|Adverse Event|0
1400124|NCT01223404|4620938|P4|Second Intervention (1 Day)|Adverse Event|0
1400125|NCT01223404|4620939|P3|Second Intervention (1 Day)|Adverse Event|0
1400126|NCT01223404|4620940|P2|Second Intervention (1 Day)|Adverse Event|0
1400127|NCT01223404|4620941|P1|Second Intervention (1 Day)|Adverse Event|1
1400128|NCT01223404|4620936|P6|First Intervention (1 Day)|Adverse Event|0
1400129|NCT01223404|4620937|P5|First Intervention (1 Day)|Adverse Event|0
1400130|NCT01223404|4620938|P4|First Intervention (1 Day)|Adverse Event|1
1400131|NCT01223404|4620939|P3|First Intervention (1 Day)|Adverse Event|0
1400132|NCT01223404|4620940|P2|First Intervention (1 Day)|Adverse Event|0
1400133|NCT01223404|4620941|P1|First Intervention (1 Day)|Adverse Event|0
1400134|NCT01223365|4621005|P1|Open-label Treatment Period|Physician Decision|2
1400135|NCT01223365|4621005|P1|Open-label Treatment Period|Starting physical therapy|1
1400136|NCT01223365|4621005|P1|Open-label Treatment Period|"Out of window"|1
1400137|NCT01223365|4621005|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
1400138|NCT01223365|4621005|P1|Open-label Treatment Period|Moved out of area|2
1400139|NCT01223365|4621005|P1|Open-label Treatment Period|Noncompliance with study procedures|6
1400140|NCT01223365|4621005|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
1400141|NCT01223365|4621005|P1|Open-label Treatment Period|Lost to Follow-up|7
1400142|NCT01223365|4621005|P1|Open-label Treatment Period|Protocol Violation|15
1400143|NCT01223365|4621005|P1|Open-label Treatment Period|Withdrawal by Subject|19
1400144|NCT01223365|4621005|P1|Open-label Treatment Period|Lack of Efficacy|2
1400145|NCT01223365|4621005|P1|Open-label Treatment Period|Adverse Event|39
1400146|NCT01223365|4621005|P1|Open-label Titration Period|Starting physical therapy|1
1400147|NCT01223365|4621005|P1|Open-label Titration Period|Noncompliance with study procedures|2
1400148|NCT01223365|4621005|P1|Open-label Titration Period|Noncompliance with study drug admin|1
1400149|NCT01223365|4621005|P1|Open-label Titration Period|Lost to Follow-up|2
1400150|NCT01223365|4621005|P1|Open-label Titration Period|Protocol Violation|1
1400151|NCT01223365|4621005|P1|Open-label Titration Period|Withdrawal by Subject|5
1400152|NCT01223365|4621005|P1|Open-label Titration Period|Lack of Efficacy|3
1400153|NCT01223365|4621005|P1|Open-label Titration Period|Adverse Event|23
1400154|NCT01223365|4621005|P1|Open-label Titration Period|Enrolled but not treated|1
1400155|NCT01223235|4621069|P1|Overall Study|Withdrawal by Subject|1
1400156|NCT01223196|4621077|P2|Overall Study|Withdrawal by Subject|0
1400157|NCT01223196|4621078|P1|Overall Study|Withdrawal by Subject|1
1400158|NCT01223196|4621077|P2|Overall Study|Physician Decision|0
1400159|NCT01223196|4621078|P1|Overall Study|Physician Decision|1
1400160|NCT01223196|4621077|P2|Overall Study|Lost to Follow-up|0
1400161|NCT01223196|4621078|P1|Overall Study|Lost to Follow-up|2
1400162|NCT01223183|4621090|P2|Washout Period (5-24 Days)|Physician Decision|0
1400163|NCT01223183|4621091|P1|Washout Period (5-24 Days)|Physician Decision|1
1400164|NCT01223183|4621090|P2|Washout Period (5-24 Days)|Lost to Follow-up|0
1400165|NCT01223183|4621091|P1|Washout Period (5-24 Days)|Lost to Follow-up|1
1400166|NCT01223183|4621090|P2|Imaging Day 1|Physician Decision|1
1400167|NCT01223183|4621091|P1|Imaging Day 1|Physician Decision|0
1400168|NCT01223027|4621101|P2|Overall Study|Study terminated by sponsor|8
1400169|NCT01223027|4621102|P1|Overall Study|Study terminated by sponsor|2
1400170|NCT01223027|4621101|P2|Overall Study|New therapy for study indication|8
1400171|NCT01223027|4621102|P1|Overall Study|New therapy for study indication|17
1400172|NCT01223027|4621101|P2|Overall Study|Subject/guardian decicion|16
1400173|NCT01223027|4621102|P1|Overall Study|Subject/guardian decicion|18
1400174|NCT01223027|4621101|P2|Overall Study|Protocol Violation|1
1400175|NCT01223027|4621102|P1|Overall Study|Protocol Violation|2
1400176|NCT01223027|4621101|P2|Overall Study|Progressive Disease|183
1400177|NCT01223027|4621102|P1|Overall Study|Progressive Disease|167
1400178|NCT01223027|4621101|P2|Overall Study|Physician Decision|8
1400179|NCT01223027|4621102|P1|Overall Study|Physician Decision|4
1400180|NCT01223027|4621101|P2|Overall Study|Lost to Follow-up|1
1400181|NCT01223027|4621102|P1|Overall Study|Lost to Follow-up|2
1400182|NCT01223027|4621101|P2|Overall Study|Death|42
1400183|NCT01223027|4621102|P1|Overall Study|Death|42
1400184|NCT01223027|4621101|P2|Overall Study|Adverse Event|10
1400185|NCT01223027|4621102|P1|Overall Study|Adverse Event|20
1400186|NCT01222715|4621164|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
1400187|NCT01222715|4621165|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
1400188|NCT01222715|4621164|P2|Overall Study|Ineligible|1
1400189|NCT01222715|4621165|P1|Overall Study|Ineligible|0
1400190|NCT01222715|4621164|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
1400191|NCT01222715|4621165|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
1400192|NCT01222715|4621164|P2|Overall Study|Refusal of further protocol therapy|4
1400193|NCT01222715|4621165|P1|Overall Study|Refusal of further protocol therapy|0
1400194|NCT01222715|4621164|P2|Overall Study|Physician Decision|2
1400195|NCT01222715|4621165|P1|Overall Study|Physician Decision|12
1400196|NCT01222715|4621164|P2|Overall Study|Lack of Efficacy|14
1400197|NCT01222715|4621165|P1|Overall Study|Lack of Efficacy|22
1400198|NCT01222715|4621164|P2|Overall Study|Death|1
1400199|NCT01222715|4621165|P1|Overall Study|Death|0
1400200|NCT01222715|4621164|P2|Overall Study|Adverse Event|4
1400201|NCT01222715|4621165|P1|Overall Study|Adverse Event|0
1400202|NCT01222533|4621204|P1|Overall Study|Other|4
1400203|NCT01222533|4621204|P1|Overall Study|Withdrawal by Subject|5
1400204|NCT01222533|4621204|P1|Overall Study|Adverse Event|5
1400205|NCT01222520|4621343|P2|Double-blind Period|Study medication stolen|0
1400206|NCT01222520|4621344|P1|Double-blind Period|Study medication stolen|1
1400207|NCT01222520|4621343|P2|Double-blind Period|Lack of Efficacy|1
1400208|NCT01222520|4621344|P1|Double-blind Period|Lack of Efficacy|0
1400209|NCT01222520|4621343|P2|Double-blind Period|Adverse Event|1
1400210|NCT01222520|4621344|P1|Double-blind Period|Adverse Event|0
1400211|NCT01222520|4621343|P2|Open-label run-in Period|Number of patients fulfilled|3
1400212|NCT01222520|4621344|P1|Open-label run-in Period|Number of patients fulfilled|0
1400213|NCT01222520|4621343|P2|Open-label run-in Period|Blood pressure criteria not met|18
1400214|NCT01222520|4621344|P1|Open-label run-in Period|Blood pressure criteria not met|0
1400215|NCT01222520|4621343|P2|Open-label run-in Period|Withdrawal by Subject|2
1400216|NCT01222520|4621344|P1|Open-label run-in Period|Withdrawal by Subject|0
1400217|NCT01222507|4621362|P1|Overall Study|Withdrawal by Subject|1
1400218|NCT01222507|4621362|P1|Overall Study|Physician Decision|1
1400219|NCT01222416|4621368|P2|Overall Study|Death|0
1400220|NCT01222416|4621369|P1|Overall Study|Death|1
1400221|NCT01222416|4621368|P2|Overall Study|missed view/scan|0
1400222|NCT01222416|4621369|P1|Overall Study|missed view/scan|1
1400223|NCT01222416|4621368|P2|Overall Study|scheduling|0
1400224|NCT01222416|4621369|P1|Overall Study|scheduling|6
1400225|NCT01222416|4621368|P2|Overall Study|Withdrawal by Subject|0
1400226|NCT01222416|4621369|P1|Overall Study|Withdrawal by Subject|5
1400227|NCT01222416|4621368|P2|Overall Study|Adverse Event|0
1400228|NCT01222416|4621369|P1|Overall Study|Adverse Event|4
1400229|NCT01222416|4621368|P2|Overall Study|ineligible;metastasis|0
1400230|NCT01222416|4621369|P1|Overall Study|ineligible;metastasis|3
1400231|NCT01222403|4621379|P2|Overall Study|Inappropriate enrollment|2
1400232|NCT01222403|4621380|P1|Overall Study|Inappropriate enrollment|0
1400233|NCT01222104|4621489|P1|Overall Study|Death|10
1400234|NCT01222104|4621489|P1|Overall Study|Lost to Follow-up|37
1400235|NCT01222078|4621512|P1|Overall Study|Early termination of the study|1
1400236|NCT01221948|4621546|P1|Overall Study|Protocol Violation|4
1400237|NCT01221948|4621546|P1|Overall Study|Death|1
1400238|NCT01221948|4621546|P1|Overall Study|not disclosed|2
1400239|NCT01221948|4621546|P1|Overall Study|Withdrawal by Subject|2
1400240|NCT01221948|4621546|P1|Overall Study|Physician Decision|5
1400241|NCT01221753|4621557|P1|Overall Study|Adverse Event|1
1400242|NCT01221727|4621564|P2|Overall Study|Withdrawal by Subject|1
1400243|NCT01221727|4621565|P1|Overall Study|Withdrawal by Subject|1
1400244|NCT01221727|4621564|P2|Overall Study|Physician Decision|0
1400245|NCT01221727|4621565|P1|Overall Study|Physician Decision|2
1400246|NCT01221623|4621586|P2|Overall Study|Other|2
1400247|NCT01221623|4621587|P1|Overall Study|Other|5
1400248|NCT01221623|4621586|P2|Overall Study|Death|0
1400249|NCT01221623|4621587|P1|Overall Study|Death|1
1400250|NCT01221623|4621586|P2|Overall Study|Adverse Event|3
1400251|NCT01221623|4621587|P1|Overall Study|Adverse Event|6
1400252|NCT01221623|4621586|P2|Overall Study|Lost to Follow-up|1
1400253|NCT01221623|4621587|P1|Overall Study|Lost to Follow-up|7
1400254|NCT01221623|4621586|P2|Overall Study|Withdrawal by Subject|8
1400255|NCT01221623|4621587|P1|Overall Study|Withdrawal by Subject|19
1400256|NCT01221597|4621611|P2|Overall Study|Death|0
1400257|NCT01221597|4621612|P1|Overall Study|Death|2
1400258|NCT01221597|4621611|P2|Overall Study|Other|4
1400259|NCT01221597|4621612|P1|Overall Study|Other|3
1400260|NCT01221597|4621611|P2|Overall Study|Protocol Violation|0
1400261|NCT01221597|4621612|P1|Overall Study|Protocol Violation|1
1400262|NCT01221597|4621611|P2|Overall Study|Lost to Follow-up|5
1400263|NCT01221597|4621612|P1|Overall Study|Lost to Follow-up|6
1400264|NCT01221597|4621611|P2|Overall Study|Withdrawal by Subject|6
1400265|NCT01221597|4621612|P1|Overall Study|Withdrawal by Subject|20
1400266|NCT01221597|4621611|P2|Overall Study|Adverse Event|1
1400267|NCT01221597|4621612|P1|Overall Study|Adverse Event|4
1400268|NCT01221363|4621669|P2|Overall Study|Withdrawal by Subject|5
1400269|NCT01221363|4621670|P1|Overall Study|Withdrawal by Subject|11
1400270|NCT01221363|4621669|P2|Overall Study|Pregnancy|0
1400271|NCT01221363|4621670|P1|Overall Study|Pregnancy|1
1400272|NCT01221350|4621680|P2|Overall Study|Withdrawal by Subject|2
1400273|NCT01221350|4621681|P1|Overall Study|Withdrawal by Subject|4
1400274|NCT01221350|4621680|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
1400275|NCT01221350|4621681|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
1400276|NCT01221350|4621680|P2|Overall Study|Discontinued intervention (GERD)|0
1400277|NCT01221350|4621681|P1|Overall Study|Discontinued intervention (GERD)|1
1400278|NCT01221285|4621740|P1|Overall Study|Withdrawal by Subject|1
1400279|NCT01221272|4621749|P2|Period 2|Adverse Event|2
1400280|NCT01221272|4621750|P1|Period 2|Adverse Event|0
1400281|NCT01221272|4621749|P2|Period 1|Significant Dosing Noncompliance|1
1400282|NCT01221272|4621750|P1|Period 1|Significant Dosing Noncompliance|0
1400283|NCT01221272|4621749|P2|Period 1|Consent Withdrawal|1
1400284|NCT01221272|4621750|P1|Period 1|Consent Withdrawal|0
1400285|NCT01221272|4621749|P2|Period 1|Adverse Event|0
1400286|NCT01221272|4621750|P1|Period 1|Adverse Event|2
1400287|NCT01221090|4621769|P4|Overall Study|Withdrawal by Subject|2
1400288|NCT01221090|4621770|P3|Overall Study|Withdrawal by Subject|27
1400289|NCT01221090|4621771|P2|Overall Study|Withdrawal by Subject|22
1400290|NCT01221090|4621772|P1|Overall Study|Withdrawal by Subject|0
1400291|NCT01221090|4621769|P4|Overall Study|Non-Compliant or Unable to Contact|20
1400292|NCT01221090|4621770|P3|Overall Study|Non-Compliant or Unable to Contact|15
1400293|NCT01221090|4621771|P2|Overall Study|Non-Compliant or Unable to Contact|12
1400294|NCT01221090|4621772|P1|Overall Study|Non-Compliant or Unable to Contact|15
1400295|NCT01220609|4621821|P1|Overall Study|Ineligible-Never treated|1
1400296|NCT01220609|4621821|P1|Overall Study|Ineligible- Wrong cell type|1
1400297|NCT01220609|4621821|P1|Overall Study|Ineligible-Wrong primary cancer site|1
1400298|NCT01220557|4621835|P2|Overall Study|attended less than 6 lessons|2
1400299|NCT01220557|4621836|P1|Overall Study|attended less than 6 lessons|1
1400300|NCT01220557|4621835|P2|Overall Study|Lost to Follow-up|3
1400301|NCT01220557|4621836|P1|Overall Study|Lost to Follow-up|5
1400302|NCT01220414|4621869|P4|Overall Study|Withdrawal by Subject|1
1400303|NCT01220414|4621870|P3|Overall Study|Withdrawal by Subject|0
1400304|NCT01220414|4621871|P2|Overall Study|Withdrawal by Subject|0
1400305|NCT01220414|4621872|P1|Overall Study|Withdrawal by Subject|1
1400306|NCT01220401|4621879|P1|Overall Study|Protocol Violation|1
1400307|NCT01220401|4621879|P1|Overall Study|Withdrawal by Subject|2
1400308|NCT01220297|4621888|P1|Overall Study|Lost to Follow-up|1
1400309|NCT01220297|4621888|P1|Overall Study|Death|2
1400310|NCT01220180|4621905|P1|Overall Study|Randomized but not treated|1
1400311|NCT01220180|4621905|P1|Overall Study|Death|1
1400312|NCT01220180|4621905|P1|Overall Study|Lack of Efficacy|22
1400313|NCT01220180|4621905|P1|Overall Study|Adverse Event|35
1400314|NCT01220180|4621905|P1|Overall Study|Other|72
1400315|NCT01220180|4621905|P1|Overall Study|Lost to Follow-up|76
1400316|NCT01220128|4621935|P7|Overall Study|Consent withdrawn by subject|0
1400317|NCT01220128|4621936|P6|Overall Study|Consent withdrawn by subject|0
1400318|NCT01220128|4621937|P5|Overall Study|Consent withdrawn by subject|0
1400319|NCT01220128|4621938|P4|Overall Study|Consent withdrawn by subject|0
1400320|NCT01220128|4621939|P3|Overall Study|Consent withdrawn by subject|0
1400321|NCT01220128|4621940|P2|Overall Study|Consent withdrawn by subject|0
1400322|NCT01220128|4621941|P1|Overall Study|Consent withdrawn by subject|1
1400323|NCT01220128|4621935|P7|Overall Study|Other|0
1400324|NCT01220128|4621936|P6|Overall Study|Other|0
1400325|NCT01220128|4621937|P5|Overall Study|Other|0
1400326|NCT01220128|4621938|P4|Overall Study|Other|0
1400327|NCT01220128|4621939|P3|Overall Study|Other|1
1400328|NCT01220128|4621940|P2|Overall Study|Other|0
1400329|NCT01220128|4621941|P1|Overall Study|Other|0
1400330|NCT01220128|4621935|P7|Overall Study|Adverse event, non-fatal|3
1400331|NCT01220128|4621936|P6|Overall Study|Adverse event, non-fatal|0
1400332|NCT01220128|4621937|P5|Overall Study|Adverse event, non-fatal|0
1400333|NCT01220128|4621938|P4|Overall Study|Adverse event, non-fatal|0
1400334|NCT01220128|4621939|P3|Overall Study|Adverse event, non-fatal|0
1400335|NCT01220128|4621940|P2|Overall Study|Adverse event, non-fatal|0
1400336|NCT01220128|4621941|P1|Overall Study|Adverse event, non-fatal|1
1400337|NCT01220128|4621935|P7|Overall Study|Adverse event, serious fatal|1
1400338|NCT01220128|4621936|P6|Overall Study|Adverse event, serious fatal|0
1400339|NCT01220128|4621937|P5|Overall Study|Adverse event, serious fatal|0
1400340|NCT01220128|4621938|P4|Overall Study|Adverse event, serious fatal|0
1400341|NCT01220128|4621939|P3|Overall Study|Adverse event, serious fatal|0
1400342|NCT01220128|4621940|P2|Overall Study|Adverse event, serious fatal|0
1400343|NCT01220128|4621941|P1|Overall Study|Adverse event, serious fatal|2
1400344|NCT01220128|4621935|P7|Overall Study|Sponsor study termination|1
1400345|NCT01220128|4621936|P6|Overall Study|Sponsor study termination|0
1400346|NCT01220128|4621937|P5|Overall Study|Sponsor study termination|0
1400347|NCT01220128|4621938|P4|Overall Study|Sponsor study termination|0
1400348|NCT01220128|4621939|P3|Overall Study|Sponsor study termination|0
1400349|NCT01220128|4621940|P2|Overall Study|Sponsor study termination|1
1400350|NCT01220128|4621941|P1|Overall Study|Sponsor study termination|0
1400351|NCT01220128|4621935|P7|Overall Study|Progressive disease|0
1400352|NCT01220128|4621936|P6|Overall Study|Progressive disease|0
1400353|NCT01220128|4621937|P5|Overall Study|Progressive disease|0
1400354|NCT01220128|4621938|P4|Overall Study|Progressive disease|0
1400355|NCT01220128|4621939|P3|Overall Study|Progressive disease|2
1400356|NCT01220128|4621940|P2|Overall Study|Progressive disease|0
1400357|NCT01220128|4621941|P1|Overall Study|Progressive disease|0
1400358|NCT01219985|4622146|P1|Overall Study|Physician Decision|20
1400359|NCT01219933|4622152|P1|Overall Study|Lack of Efficacy|1
1400360|NCT01219933|4622152|P1|Overall Study|Protocol Violation|8
1400361|NCT01219933|4622152|P1|Overall Study|Withdrawal by Subject|5
1400362|NCT01219933|4622152|P1|Overall Study|GC free|1
1400363|NCT01219933|4622152|P1|Overall Study|Lost to Follow-up|3
1400364|NCT01219933|4622152|P1|Overall Study|No LDA maintained|7
1400365|NCT01219933|4622152|P1|Overall Study|No LDA reached|5
1400366|NCT01219933|4622152|P1|Overall Study|Adverse Event|8
1400367|NCT01218867|4622362|P11|Overall Study|Death during treatment|0
1400368|NCT01218867|4622363|P10|Overall Study|Death during treatment|0
1400369|NCT01218867|4622364|P9|Overall Study|Death during treatment|0
1400370|NCT01218867|4622365|P8|Overall Study|Death during treatment|0
1400371|NCT01218867|4622366|P7|Overall Study|Death during treatment|1
1400372|NCT01218867|4622367|P6|Overall Study|Death during treatment|0
1400373|NCT01218867|4622368|P5|Overall Study|Death during treatment|0
1400374|NCT01218867|4622369|P4|Overall Study|Death during treatment|0
1400375|NCT01218867|4622370|P3|Overall Study|Death during treatment|0
1400376|NCT01218867|4622371|P2|Overall Study|Death during treatment|0
1400377|NCT01218867|4622372|P1|Overall Study|Death during treatment|0
1400378|NCT01218802|4622420|P2|Overall Study|Incarcerated|0
1400379|NCT01218802|4622421|P1|Overall Study|Incarcerated|2
1400380|NCT01218802|4622420|P2|Overall Study|Adverse Event|2
1400381|NCT01218802|4622421|P1|Overall Study|Adverse Event|0
1400382|NCT01218802|4622420|P2|Overall Study|Withdrawal by Subject|10
1400383|NCT01218802|4622421|P1|Overall Study|Withdrawal by Subject|3
1400384|NCT01218802|4622420|P2|Overall Study|Lost to Follow-up|6
1400385|NCT01218802|4622421|P1|Overall Study|Lost to Follow-up|5
1400386|NCT01218646|4622433|P4|Overall Study|Protocol Violation|1
1400387|NCT01218646|4622434|P3|Overall Study|Protocol Violation|1
1400388|NCT01218646|4622435|P2|Overall Study|Protocol Violation|0
1400389|NCT01218646|4622436|P1|Overall Study|Protocol Violation|0
1400390|NCT01218646|4622433|P4|Overall Study|Lost to Follow-up|0
1400391|NCT01218646|4622434|P3|Overall Study|Lost to Follow-up|0
1400392|NCT01218646|4622435|P2|Overall Study|Lost to Follow-up|0
1400393|NCT01218646|4622436|P1|Overall Study|Lost to Follow-up|1
1400394|NCT01218646|4622433|P4|Overall Study|Adverse Event|0
1400395|NCT01218646|4622434|P3|Overall Study|Adverse Event|1
1400396|NCT01218646|4622435|P2|Overall Study|Adverse Event|0
1400397|NCT01218646|4622436|P1|Overall Study|Adverse Event|0
1400398|NCT01218594|4622474|P1|Overall Study|Physician Decision|6
1400399|NCT01218594|4622474|P1|Overall Study|Adverse Event|2
1400400|NCT01218594|4622474|P1|Overall Study|Withdrawal by Subject|3
1400401|NCT01218594|4622474|P1|Overall Study|Death|1
1400402|NCT01218477|4622482|P4|Overall Study|Maximum clinical benefit|0
1400403|NCT01218477|4622483|P3|Overall Study|Maximum clinical benefit|0
1400404|NCT01218477|4622484|P2|Overall Study|Maximum clinical benefit|2
1400405|NCT01218477|4622485|P1|Overall Study|Maximum clinical benefit|0
1400406|NCT01218477|4622482|P4|Overall Study|Administrative reason by sponsor|0
1400407|NCT01218477|4622483|P3|Overall Study|Administrative reason by sponsor|1
1400408|NCT01218477|4622484|P2|Overall Study|Administrative reason by sponsor|0
1400409|NCT01218477|4622485|P1|Overall Study|Administrative reason by sponsor|0
1400410|NCT01218477|4622482|P4|Overall Study|Prepared for cell transplantation|0
1400411|NCT01218477|4622483|P3|Overall Study|Prepared for cell transplantation|1
1400412|NCT01218477|4622484|P2|Overall Study|Prepared for cell transplantation|1
1400413|NCT01218477|4622485|P1|Overall Study|Prepared for cell transplantation|0
1400414|NCT01218477|4622482|P4|Overall Study|Withdrawal by Subject|0
1400415|NCT01218477|4622483|P3|Overall Study|Withdrawal by Subject|1
1400416|NCT01218477|4622484|P2|Overall Study|Withdrawal by Subject|0
1400417|NCT01218477|4622485|P1|Overall Study|Withdrawal by Subject|0
1400418|NCT01218477|4622482|P4|Overall Study|No longer meets study criteria|0
1400419|NCT01218477|4622483|P3|Overall Study|No longer meets study criteria|0
1400420|NCT01218477|4622484|P2|Overall Study|No longer meets study criteria|0
1400421|NCT01218477|4622485|P1|Overall Study|No longer meets study criteria|1
1400422|NCT01218477|4622482|P4|Overall Study|Study drug toxicity|0
1400423|NCT01218477|4622483|P3|Overall Study|Study drug toxicity|5
1400424|NCT01218477|4622484|P2|Overall Study|Study drug toxicity|2
1400425|NCT01218477|4622485|P1|Overall Study|Study drug toxicity|0
1400426|NCT01218477|4622482|P4|Overall Study|Disease progression|2
1400427|NCT01218477|4622483|P3|Overall Study|Disease progression|6
1400428|NCT01218477|4622484|P2|Overall Study|Disease progression|3
1400429|NCT01218477|4622485|P1|Overall Study|Disease progression|2
1400430|NCT01218438|4622502|P1|Epoch 4|Withdrawal by Subject|2
1400431|NCT01218438|4622502|P1|Epoch 4|Physician Decision|1
1400432|NCT01218438|4622502|P1|Epoch 3|Adverse Event|1
1400433|NCT01218438|4622502|P1|Epoch 3|Withdrawal by Subject|3
1400434|NCT01218438|4622502|P1|Epoch 1|Adverse Event|1
1400435|NCT01218438|4622502|P1|Epoch 1|Physician Decision|2
1400436|NCT01218308|4622668|P2|Overall Study|Other|21
1400437|NCT01218308|4622669|P1|Overall Study|Other|14
1400438|NCT01218308|4622668|P2|Overall Study|Lost to Follow-up|31
1400439|NCT01218308|4622669|P1|Overall Study|Lost to Follow-up|27
1400440|NCT01218308|4622668|P2|Overall Study|Withdrawal by Subject|64
1400441|NCT01218308|4622669|P1|Overall Study|Withdrawal by Subject|61
1400442|NCT01218308|4622668|P2|Overall Study|Protocol Violation|2
1400443|NCT01218308|4622669|P1|Overall Study|Protocol Violation|0
1400444|NCT01218308|4622668|P2|Overall Study|Adverse Event|2
1400445|NCT01218308|4622669|P1|Overall Study|Adverse Event|1
1400446|NCT01218243|4622713|P2|Overall Study|Protocol Violation|10
1400447|NCT01218243|4622714|P1|Overall Study|Protocol Violation|5
1400448|NCT01218243|4622713|P2|Overall Study|Lost to Follow-up|3
1400449|NCT01218243|4622714|P1|Overall Study|Lost to Follow-up|3
1400450|NCT01218243|4622713|P2|Overall Study|Lack of Efficacy|1
1400451|NCT01218243|4622714|P1|Overall Study|Lack of Efficacy|1
1400452|NCT01218204|4622730|P4|Part B Pooled Treatment Arm|Protocol Violation|1
1400453|NCT01218204|4622731|P3|Part B Pooled Treatment Arm|Protocol Violation|0
1400454|NCT01218204|4622732|P2|Part B Pooled Treatment Arm|Protocol Violation|0
1400455|NCT01218204|4622733|P1|Part B Pooled Treatment Arm|Protocol Violation|0
1400456|NCT01218204|4622730|P4|Part B Pooled Treatment Arm|Adverse Event|2
1400457|NCT01218204|4622731|P3|Part B Pooled Treatment Arm|Adverse Event|0
1400458|NCT01218204|4622732|P2|Part B Pooled Treatment Arm|Adverse Event|0
1400459|NCT01218204|4622733|P1|Part B Pooled Treatment Arm|Adverse Event|0
1400460|NCT01218204|4622730|P4|Part B Run-in|Withdrawal by Subject|0
1400461|NCT01218204|4622731|P3|Part B Run-in|Withdrawal by Subject|3
1400462|NCT01218204|4622732|P2|Part B Run-in|Withdrawal by Subject|0
1400463|NCT01218204|4622733|P1|Part B Run-in|Withdrawal by Subject|0
1400464|NCT01218204|4622730|P4|Part B Run-in|Protocol Violation|0
1400465|NCT01218204|4622731|P3|Part B Run-in|Protocol Violation|2
1400466|NCT01218204|4622732|P2|Part B Run-in|Protocol Violation|0
1400467|NCT01218204|4622733|P1|Part B Run-in|Protocol Violation|0
1400468|NCT01218204|4622730|P4|Part B Run-in|Adverse Event|0
1400469|NCT01218204|4622731|P3|Part B Run-in|Adverse Event|1
1400470|NCT01218204|4622732|P2|Part B Run-in|Adverse Event|0
1400471|NCT01218204|4622733|P1|Part B Run-in|Adverse Event|0
1400472|NCT01218204|4622730|P4|Part B Washout|Did not meet continuation criteria|0
1400473|NCT01218204|4622731|P3|Part B Washout|Did not meet continuation criteria|0
1400474|NCT01218204|4622732|P2|Part B Washout|Did not meet continuation criteria|112
1400475|NCT01218204|4622733|P1|Part B Washout|Did not meet continuation criteria|0
1400476|NCT01218204|4622730|P4|Part B Washout|Reached defined stopping criteria|0
1400477|NCT01218204|4622731|P3|Part B Washout|Reached defined stopping criteria|0
1400478|NCT01218204|4622732|P2|Part B Washout|Reached defined stopping criteria|2
1400479|NCT01218204|4622733|P1|Part B Washout|Reached defined stopping criteria|0
1400480|NCT01218204|4622730|P4|Part B Washout|Withdrawal by Subject|0
1400481|NCT01218204|4622731|P3|Part B Washout|Withdrawal by Subject|0
1400482|NCT01218204|4622732|P2|Part B Washout|Withdrawal by Subject|14
1400483|NCT01218204|4622733|P1|Part B Washout|Withdrawal by Subject|0
1400484|NCT01218204|4622730|P4|Part B Washout|Physician Decision|0
1400485|NCT01218204|4622731|P3|Part B Washout|Physician Decision|0
1400486|NCT01218204|4622732|P2|Part B Washout|Physician Decision|14
1400487|NCT01218204|4622733|P1|Part B Washout|Physician Decision|0
1400488|NCT01218204|4622730|P4|Part B Washout|Lost to Follow-up|0
1400489|NCT01218204|4622731|P3|Part B Washout|Lost to Follow-up|0
1400490|NCT01218204|4622732|P2|Part B Washout|Lost to Follow-up|2
1400491|NCT01218204|4622733|P1|Part B Washout|Lost to Follow-up|0
1400492|NCT01218204|4622730|P4|Part B Washout|Adverse Event|0
1400493|NCT01218204|4622731|P3|Part B Washout|Adverse Event|0
1400494|NCT01218204|4622732|P2|Part B Washout|Adverse Event|1
1400495|NCT01218204|4622733|P1|Part B Washout|Adverse Event|0
1400496|NCT01218126|4622997|P4|Overall Study|Withdrawal by Subject|6
1400497|NCT01218126|4622998|P3|Overall Study|Withdrawal by Subject|4
1400498|NCT01218126|4622999|P2|Overall Study|Withdrawal by Subject|5
1400499|NCT01218126|4623000|P1|Overall Study|Withdrawal by Subject|2
1400500|NCT01218126|4622997|P4|Overall Study|Physician Decision|2
1400501|NCT01218126|4622998|P3|Overall Study|Physician Decision|4
1400502|NCT01218126|4622999|P2|Overall Study|Physician Decision|2
1400503|NCT01218126|4623000|P1|Overall Study|Physician Decision|1
1400504|NCT01218126|4622997|P4|Overall Study|Lost to Follow-up|2
1400505|NCT01218126|4622998|P3|Overall Study|Lost to Follow-up|0
1400506|NCT01218126|4622999|P2|Overall Study|Lost to Follow-up|0
1400507|NCT01218126|4623000|P1|Overall Study|Lost to Follow-up|0
1400508|NCT01218126|4622997|P4|Overall Study|Protocol-defined stopping criteria|0
1400509|NCT01218126|4622998|P3|Overall Study|Protocol-defined stopping criteria|0
1400510|NCT01218126|4622999|P2|Overall Study|Protocol-defined stopping criteria|1
1400511|NCT01218126|4623000|P1|Overall Study|Protocol-defined stopping criteria|1
1400512|NCT01218126|4622997|P4|Overall Study|Protocol Violation|3
1400513|NCT01218126|4622998|P3|Overall Study|Protocol Violation|2
1400514|NCT01218126|4622999|P2|Overall Study|Protocol Violation|2
1400515|NCT01218126|4623000|P1|Overall Study|Protocol Violation|5
1400516|NCT01218126|4622997|P4|Overall Study|Lack of Efficacy|6
1400517|NCT01218126|4622998|P3|Overall Study|Lack of Efficacy|2
1400518|NCT01218126|4622999|P2|Overall Study|Lack of Efficacy|2
1400519|NCT01218126|4623000|P1|Overall Study|Lack of Efficacy|7
1400520|NCT01218126|4622997|P4|Overall Study|Adverse Event|16
1400521|NCT01218126|4622998|P3|Overall Study|Adverse Event|12
1400522|NCT01218126|4622999|P2|Overall Study|Adverse Event|10
1400523|NCT01218126|4623000|P1|Overall Study|Adverse Event|8
1400524|NCT01218113|4623041|P3|Overall Study|Protocol Deviation Eligibility Criteria|1
1400525|NCT01218113|4623042|P2|Overall Study|Protocol Deviation Eligibility Criteria|0
1400526|NCT01218113|4623043|P1|Overall Study|Protocol Deviation Eligibility Criteria|0
1400527|NCT01218113|4623041|P3|Overall Study|Lost to Follow-up|4
1400528|NCT01218113|4623042|P2|Overall Study|Lost to Follow-up|1
1400529|NCT01218113|4623043|P1|Overall Study|Lost to Follow-up|4
1400530|NCT01218113|4623041|P3|Overall Study|Withdrawal by Subject|1
1400531|NCT01218113|4623042|P2|Overall Study|Withdrawal by Subject|0
1400532|NCT01218113|4623043|P1|Overall Study|Withdrawal by Subject|1
1400533|NCT01218100|4623224|P4|Overall Study|Other Reason|4
1400534|NCT01218100|4623225|P3|Overall Study|Other Reason|6
1400535|NCT01218100|4623226|P2|Overall Study|Other Reason|2
1400536|NCT01218100|4623227|P1|Overall Study|Other Reason|2
1400537|NCT01218100|4623224|P4|Overall Study|Lost to Follow-up|1
1400538|NCT01218100|4623225|P3|Overall Study|Lost to Follow-up|2
1400539|NCT01218100|4623226|P2|Overall Study|Lost to Follow-up|8
1400540|NCT01218100|4623227|P1|Overall Study|Lost to Follow-up|3
1400541|NCT01218100|4623224|P4|Overall Study|Withdrawal by Subject|7
1400542|NCT01218100|4623225|P3|Overall Study|Withdrawal by Subject|6
1400543|NCT01218100|4623226|P2|Overall Study|Withdrawal by Subject|2
1400544|NCT01218100|4623227|P1|Overall Study|Withdrawal by Subject|5
1400545|NCT01218100|4623224|P4|Overall Study|Protocol Violation|1
1400546|NCT01218100|4623225|P3|Overall Study|Protocol Violation|1
1400547|NCT01218100|4623226|P2|Overall Study|Protocol Violation|0
1400548|NCT01218100|4623227|P1|Overall Study|Protocol Violation|0
1400549|NCT01218100|4623224|P4|Overall Study|Lack of Efficacy|12
1400550|NCT01218100|4623225|P3|Overall Study|Lack of Efficacy|5
1400551|NCT01218100|4623226|P2|Overall Study|Lack of Efficacy|6
1400552|NCT01218100|4623227|P1|Overall Study|Lack of Efficacy|9
1400553|NCT01218100|4623224|P4|Overall Study|Adverse Event|7
1400554|NCT01218100|4623225|P3|Overall Study|Adverse Event|6
1400555|NCT01218100|4623226|P2|Overall Study|Adverse Event|6
1400556|NCT01218100|4623227|P1|Overall Study|Adverse Event|4
1400557|NCT01218100|4623224|P4|Overall Study|Did not meet InclusionExclusion criteria|2
1400558|NCT01218100|4623225|P3|Overall Study|Did not meet InclusionExclusion criteria|1
1400559|NCT01218100|4623226|P2|Overall Study|Did not meet InclusionExclusion criteria|1
1400560|NCT01218100|4623227|P1|Overall Study|Did not meet InclusionExclusion criteria|1
1400561|NCT01218087|4623243|P2|Overall Study|Transferred|5
1400562|NCT01218087|4623244|P1|Overall Study|Transferred|8
1400563|NCT01218087|4623243|P2|Overall Study|Withdrawal by Subject|0
1400564|NCT01218087|4623244|P1|Overall Study|Withdrawal by Subject|5
1400565|NCT01218087|4623243|P2|Overall Study|Death|1
1400566|NCT01218087|4623244|P1|Overall Study|Death|2
1400567|NCT01218009|4623266|P2|Overall Study|Sponsor terminated study|163
1400568|NCT01218009|4623267|P1|Overall Study|Sponsor terminated study|161
1400569|NCT01218009|4623266|P2|Overall Study|Withdrawal by Subject|1
1400570|NCT01218009|4623267|P1|Overall Study|Withdrawal by Subject|3
1400571|NCT01218009|4623266|P2|Overall Study|Protocol Violation|1
1400572|NCT01218009|4623267|P1|Overall Study|Protocol Violation|2
1400573|NCT01217957|4623290|P5|Phase 2|Withdrawal by Patient|1
1400574|NCT01217957|4623291|P4|Phase 2|Withdrawal by Patient|0
1400575|NCT01217957|4623292|P3|Phase 2|Withdrawal by Patient|0
1400576|NCT01217957|4623293|P2|Phase 2|Withdrawal by Patient|0
1400577|NCT01217957|4623294|P1|Phase 2|Withdrawal by Patient|0
1400578|NCT01217957|4623290|P5|Phase 1|Withdrawal by Patient|0
1400579|NCT01217957|4623291|P4|Phase 1|Withdrawal by Patient|1
1400580|NCT01217957|4623292|P3|Phase 1|Withdrawal by Patient|1
1400581|NCT01217957|4623293|P2|Phase 1|Withdrawal by Patient|0
1400582|NCT01217957|4623294|P1|Phase 1|Withdrawal by Patient|1
1400583|NCT01217944|4623353|P3|Overall Study|Lack of Efficacy|0
1400584|NCT01217944|4623354|P2|Overall Study|Lack of Efficacy|0
1400585|NCT01217944|4623355|P1|Overall Study|Lack of Efficacy|1
1400586|NCT01217944|4623353|P3|Overall Study|Withdrawal by Subject|0
1400587|NCT01217944|4623354|P2|Overall Study|Withdrawal by Subject|2
1400588|NCT01217944|4623355|P1|Overall Study|Withdrawal by Subject|1
1400589|NCT01217944|4623353|P3|Overall Study|Lost to Follow-up|0
1400590|NCT01217944|4623354|P2|Overall Study|Lost to Follow-up|1
1400591|NCT01217944|4623355|P1|Overall Study|Lost to Follow-up|3
1400592|NCT01217944|4623353|P3|Overall Study|Protocol Violation|0
1400593|NCT01217944|4623354|P2|Overall Study|Protocol Violation|1
1400594|NCT01217944|4623355|P1|Overall Study|Protocol Violation|1
1400595|NCT01217892|4623398|P4|Overall Study|Poor/Non-Compliance|0
1400596|NCT01217892|4623399|P3|Overall Study|Poor/Non-Compliance|1
1400597|NCT01217892|4623400|P2|Overall Study|Poor/Non-Compliance|0
1400598|NCT01217892|4623401|P1|Overall Study|Poor/Non-Compliance|0
1400599|NCT01217892|4623398|P4|Overall Study|Incorrect enrollment|0
1400600|NCT01217892|4623399|P3|Overall Study|Incorrect enrollment|1
1400601|NCT01217892|4623400|P2|Overall Study|Incorrect enrollment|1
1400602|NCT01217892|4623401|P1|Overall Study|Incorrect enrollment|0
1400603|NCT01217892|4623398|P4|Overall Study|Subject no longer meets study criteria|8
1400604|NCT01217892|4623399|P3|Overall Study|Subject no longer meets study criteria|4
1400605|NCT01217892|4623400|P2|Overall Study|Subject no longer meets study criteria|2
1400606|NCT01217892|4623401|P1|Overall Study|Subject no longer meets study criteria|5
1400607|NCT01217892|4623398|P4|Overall Study|Lab value|0
1400608|NCT01217892|4623399|P3|Overall Study|Lab value|1
1400609|NCT01217892|4623400|P2|Overall Study|Lab value|0
1400610|NCT01217892|4623401|P1|Overall Study|Lab value|1
1400611|NCT01217892|4623398|P4|Overall Study|Withdrawal by Subject|0
1400612|NCT01217892|4623399|P3|Overall Study|Withdrawal by Subject|1
1400613|NCT01217892|4623400|P2|Overall Study|Withdrawal by Subject|2
1400614|NCT01217892|4623401|P1|Overall Study|Withdrawal by Subject|0
1400615|NCT01217892|4623398|P4|Overall Study|Adverse Event|0
1400616|NCT01217892|4623399|P3|Overall Study|Adverse Event|1
1400617|NCT01217892|4623400|P2|Overall Study|Adverse Event|1
1400618|NCT01217892|4623401|P1|Overall Study|Adverse Event|1
1400619|NCT01217814|4623464|P3|Overall Study|Lack of Efficacy|1
1400620|NCT01217814|4623465|P2|Overall Study|Lack of Efficacy|0
1400621|NCT01217814|4623466|P1|Overall Study|Lack of Efficacy|0
1400622|NCT01217814|4623464|P3|Overall Study|Adverse Event|0
1400623|NCT01217814|4623465|P2|Overall Study|Adverse Event|1
1400624|NCT01217814|4623466|P1|Overall Study|Adverse Event|1
1400625|NCT01217801|4623492|P2|Period 1|Withdrawal by Subject|1
1400626|NCT01217801|4623493|P1|Period 1|Withdrawal by Subject|0
1400627|NCT01217801|4623492|P2|Period 1|Protocol Violation|1
1400628|NCT01217801|4623493|P1|Period 1|Protocol Violation|1
1400629|NCT01217606|4623522|P2|9-Month Masked Extension|Lack of Efficacy|0
1400630|NCT01217606|4623523|P1|9-Month Masked Extension|Lack of Efficacy|2
1400631|NCT01217606|4623522|P2|9-Month Masked Extension|Pregnancy|0
1400632|NCT01217606|4623523|P1|9-Month Masked Extension|Pregnancy|1
1400633|NCT01217606|4623522|P2|9-Month Masked Extension|Lost to Follow-up|0
1400634|NCT01217606|4623523|P1|9-Month Masked Extension|Lost to Follow-up|1
1400635|NCT01217606|4623522|P2|9-Month Masked Extension|Personal Reasons|1
1400636|NCT01217606|4623523|P1|9-Month Masked Extension|Personal Reasons|2
1400637|NCT01217606|4623522|P2|9-Month Masked Extension|Other Reasons|4
1400638|NCT01217606|4623523|P1|9-Month Masked Extension|Other Reasons|4
1400639|NCT01217606|4623522|P2|9-Month Masked Extension|Adverse Event|6
1400640|NCT01217606|4623523|P1|9-Month Masked Extension|Adverse Event|3
1400641|NCT01217606|4623522|P2|Initial Treatment Phase|Adverse Event|6
1400642|NCT01217606|4623523|P1|Initial Treatment Phase|Adverse Event|10
1400643|NCT01217606|4623522|P2|Initial Treatment Phase|Lack of Efficacy|0
1400644|NCT01217606|4623523|P1|Initial Treatment Phase|Lack of Efficacy|1
1400645|NCT01217606|4623522|P2|Initial Treatment Phase|Personal Reasons|2
1400646|NCT01217606|4623523|P1|Initial Treatment Phase|Personal Reasons|0
1400647|NCT01217606|4623522|P2|Initial Treatment Phase|Protocol Violation|2
1400648|NCT01217606|4623523|P1|Initial Treatment Phase|Protocol Violation|3
1400649|NCT01217606|4623522|P2|Initial Treatment Phase|Other Reasons|2
1400650|NCT01217606|4623523|P1|Initial Treatment Phase|Other Reasons|0
1400651|NCT01217476|4623554|P2|Overall Study|Other|0
1400652|NCT01217476|4623555|P1|Overall Study|Other|2
1400653|NCT01217476|4623554|P2|Overall Study|Protocol Deviation|0
1400654|NCT01217476|4623555|P1|Overall Study|Protocol Deviation|1
1400655|NCT01217476|4623554|P2|Overall Study|Surgery on the Target Limb|2
1400656|NCT01217476|4623555|P1|Overall Study|Surgery on the Target Limb|0
1400657|NCT01217476|4623554|P2|Overall Study|Withdrawal by Subject|3
1400658|NCT01217476|4623555|P1|Overall Study|Withdrawal by Subject|3
1400659|NCT01217476|4623554|P2|Overall Study|Physician Decision|1
1400660|NCT01217476|4623555|P1|Overall Study|Physician Decision|0
1400661|NCT01217476|4623554|P2|Overall Study|Adverse Event|1
1400662|NCT01217476|4623555|P1|Overall Study|Adverse Event|6
1400663|NCT01217463|4623565|P2|Overall Study|Other|1
1400664|NCT01217463|4623566|P1|Overall Study|Other|1
1400665|NCT01217463|4623565|P2|Overall Study|Patient Non-compliant|0
1400666|NCT01217463|4623566|P1|Overall Study|Patient Non-compliant|1
1400667|NCT01217463|4623565|P2|Overall Study|Surgery on the Target Limb|1
1400668|NCT01217463|4623566|P1|Overall Study|Surgery on the Target Limb|0
1400669|NCT01217463|4623565|P2|Overall Study|Withdrawal by Subject|0
1400670|NCT01217463|4623566|P1|Overall Study|Withdrawal by Subject|3
1400671|NCT01217463|4623565|P2|Overall Study|Physician Decision|1
1400672|NCT01217463|4623566|P1|Overall Study|Physician Decision|0
1400673|NCT01217463|4623565|P2|Overall Study|Adverse Event|5
1400674|NCT01217463|4623566|P1|Overall Study|Adverse Event|8
1400675|NCT01217307|4623586|P2|Overall Study|Withdrawal by Subject|1
1400676|NCT01217307|4623587|P1|Overall Study|Withdrawal by Subject|0
1400677|NCT01217112|4623602|P5|Overall Study|Physician Decision|1
1400678|NCT01217112|4623603|P4|Overall Study|Physician Decision|0
1400679|NCT01217112|4623604|P3|Overall Study|Physician Decision|0
1400680|NCT01217112|4623605|P2|Overall Study|Physician Decision|0
1400681|NCT01217112|4623606|P1|Overall Study|Physician Decision|0
1400682|NCT01217112|4623602|P5|Overall Study|Withdrawal by Subject|0
1400683|NCT01217112|4623603|P4|Overall Study|Withdrawal by Subject|0
1400684|NCT01217112|4623604|P3|Overall Study|Withdrawal by Subject|1
1400685|NCT01217112|4623605|P2|Overall Study|Withdrawal by Subject|0
1400686|NCT01217112|4623606|P1|Overall Study|Withdrawal by Subject|0
1400687|NCT01217112|4623602|P5|Overall Study|Adverse Event|0
1400688|NCT01217112|4623603|P4|Overall Study|Adverse Event|2
1400689|NCT01217112|4623604|P3|Overall Study|Adverse Event|0
1400690|NCT01217112|4623605|P2|Overall Study|Adverse Event|2
1400691|NCT01217112|4623606|P1|Overall Study|Adverse Event|0
1400692|NCT01217073|4623839|P8|Extension Period|Withdrawal by Subject|8
1400693|NCT01217073|4623840|P7|Extension Period|Withdrawal by Subject|30
1400694|NCT01217073|4623841|P6|Extension Period|Withdrawal by Subject|0
1400695|NCT01217073|4623842|P5|Extension Period|Withdrawal by Subject|0
1400696|NCT01217073|4623843|P4|Extension Period|Withdrawal by Subject|0
1400697|NCT01217073|4623844|P3|Extension Period|Withdrawal by Subject|0
1400698|NCT01217073|4623845|P2|Extension Period|Withdrawal by Subject|0
1400699|NCT01217073|4623846|P1|Extension Period|Withdrawal by Subject|0
1400700|NCT01217073|4623839|P8|Extension Period|Site discontinued study participation|2
1400701|NCT01217073|4623840|P7|Extension Period|Site discontinued study participation|7
1400702|NCT01217073|4623841|P6|Extension Period|Site discontinued study participation|0
1400703|NCT01217073|4623842|P5|Extension Period|Site discontinued study participation|0
1400704|NCT01217073|4623843|P4|Extension Period|Site discontinued study participation|0
1400705|NCT01217073|4623844|P3|Extension Period|Site discontinued study participation|0
1400706|NCT01217073|4623845|P2|Extension Period|Site discontinued study participation|0
1400707|NCT01217073|4623846|P1|Extension Period|Site discontinued study participation|0
1400708|NCT01217073|4623839|P8|Extension Period|Protocol Violation|1
1400709|NCT01217073|4623840|P7|Extension Period|Protocol Violation|2
1400710|NCT01217073|4623841|P6|Extension Period|Protocol Violation|0
1400711|NCT01217073|4623842|P5|Extension Period|Protocol Violation|0
1400712|NCT01217073|4623843|P4|Extension Period|Protocol Violation|0
1400713|NCT01217073|4623844|P3|Extension Period|Protocol Violation|0
1400714|NCT01217073|4623845|P2|Extension Period|Protocol Violation|0
1400715|NCT01217073|4623846|P1|Extension Period|Protocol Violation|0
1400716|NCT01217073|4623839|P8|Extension Period|Physician Decision|1
1400717|NCT01217073|4623840|P7|Extension Period|Physician Decision|4
1400718|NCT01217073|4623841|P6|Extension Period|Physician Decision|0
1400719|NCT01217073|4623842|P5|Extension Period|Physician Decision|0
1400720|NCT01217073|4623843|P4|Extension Period|Physician Decision|0
1400721|NCT01217073|4623844|P3|Extension Period|Physician Decision|0
1400722|NCT01217073|4623845|P2|Extension Period|Physician Decision|0
1400723|NCT01217073|4623846|P1|Extension Period|Physician Decision|0
1400724|NCT01217073|4623839|P8|Extension Period|Non-compliance with study drug|1
1400725|NCT01217073|4623840|P7|Extension Period|Non-compliance with study drug|0
1400726|NCT01217073|4623841|P6|Extension Period|Non-compliance with study drug|0
1400727|NCT01217073|4623842|P5|Extension Period|Non-compliance with study drug|0
1400728|NCT01217073|4623843|P4|Extension Period|Non-compliance with study drug|0
1400729|NCT01217073|4623844|P3|Extension Period|Non-compliance with study drug|0
1400730|NCT01217073|4623845|P2|Extension Period|Non-compliance with study drug|0
1400731|NCT01217073|4623846|P1|Extension Period|Non-compliance with study drug|0
1400732|NCT01217073|4623839|P8|Extension Period|Lost to Follow-up|1
1400733|NCT01217073|4623840|P7|Extension Period|Lost to Follow-up|9
1400734|NCT01217073|4623841|P6|Extension Period|Lost to Follow-up|0
1400735|NCT01217073|4623842|P5|Extension Period|Lost to Follow-up|0
1400736|NCT01217073|4623843|P4|Extension Period|Lost to Follow-up|0
1400737|NCT01217073|4623844|P3|Extension Period|Lost to Follow-up|0
1400738|NCT01217073|4623845|P2|Extension Period|Lost to Follow-up|0
1400739|NCT01217073|4623846|P1|Extension Period|Lost to Follow-up|0
1400740|NCT01217073|4623839|P8|Extension Period|Lack of Efficacy|0
1400741|NCT01217073|4623840|P7|Extension Period|Lack of Efficacy|3
1400742|NCT01217073|4623841|P6|Extension Period|Lack of Efficacy|0
1400743|NCT01217073|4623842|P5|Extension Period|Lack of Efficacy|0
1400744|NCT01217073|4623843|P4|Extension Period|Lack of Efficacy|0
1400745|NCT01217073|4623844|P3|Extension Period|Lack of Efficacy|0
1400746|NCT01217073|4623845|P2|Extension Period|Lack of Efficacy|0
1400747|NCT01217073|4623846|P1|Extension Period|Lack of Efficacy|0
1400748|NCT01217073|4623839|P8|Extension Period|Excluded medication|0
1400749|NCT01217073|4623840|P7|Extension Period|Excluded medication|2
1400750|NCT01217073|4623841|P6|Extension Period|Excluded medication|0
1400751|NCT01217073|4623842|P5|Extension Period|Excluded medication|0
1400752|NCT01217073|4623843|P4|Extension Period|Excluded medication|0
1400753|NCT01217073|4623844|P3|Extension Period|Excluded medication|0
1400754|NCT01217073|4623845|P2|Extension Period|Excluded medication|0
1400755|NCT01217073|4623846|P1|Extension Period|Excluded medication|0
1400756|NCT01217073|4623839|P8|Extension Period|Death|0
1400757|NCT01217073|4623840|P7|Extension Period|Death|1
1400758|NCT01217073|4623841|P6|Extension Period|Death|0
1400759|NCT01217073|4623842|P5|Extension Period|Death|0
1400760|NCT01217073|4623843|P4|Extension Period|Death|0
1400761|NCT01217073|4623844|P3|Extension Period|Death|0
1400762|NCT01217073|4623845|P2|Extension Period|Death|0
1400763|NCT01217073|4623846|P1|Extension Period|Death|0
1400764|NCT01217073|4623839|P8|Extension Period|Creatinine/eGFR|1
1400765|NCT01217073|4623840|P7|Extension Period|Creatinine/eGFR|11
1400766|NCT01217073|4623841|P6|Extension Period|Creatinine/eGFR|0
1400767|NCT01217073|4623842|P5|Extension Period|Creatinine/eGFR|0
1400768|NCT01217073|4623843|P4|Extension Period|Creatinine/eGFR|0
1400769|NCT01217073|4623844|P3|Extension Period|Creatinine/eGFR|0
1400770|NCT01217073|4623845|P2|Extension Period|Creatinine/eGFR|0
1400771|NCT01217073|4623846|P1|Extension Period|Creatinine/eGFR|0
1400772|NCT01217073|4623839|P8|Extension Period|Contraindication to study medication|0
1400773|NCT01217073|4623840|P7|Extension Period|Contraindication to study medication|1
1400774|NCT01217073|4623841|P6|Extension Period|Contraindication to study medication|0
1400775|NCT01217073|4623842|P5|Extension Period|Contraindication to study medication|0
1400776|NCT01217073|4623843|P4|Extension Period|Contraindication to study medication|0
1400777|NCT01217073|4623844|P3|Extension Period|Contraindication to study medication|0
1400778|NCT01217073|4623845|P2|Extension Period|Contraindication to study medication|0
1400779|NCT01217073|4623846|P1|Extension Period|Contraindication to study medication|0
1400780|NCT01217073|4623839|P8|Extension Period|ALT/AST|0
1400781|NCT01217073|4623840|P7|Extension Period|ALT/AST|2
1400782|NCT01217073|4623841|P6|Extension Period|ALT/AST|0
1400783|NCT01217073|4623842|P5|Extension Period|ALT/AST|0
1400784|NCT01217073|4623843|P4|Extension Period|ALT/AST|0
1400785|NCT01217073|4623844|P3|Extension Period|ALT/AST|0
1400786|NCT01217073|4623845|P2|Extension Period|ALT/AST|0
1400787|NCT01217073|4623846|P1|Extension Period|ALT/AST|0
1400788|NCT01217073|4623839|P8|Extension Period|Adverse Event|5
1400789|NCT01217073|4623840|P7|Extension Period|Adverse Event|19
1400790|NCT01217073|4623841|P6|Extension Period|Adverse Event|0
1400791|NCT01217073|4623842|P5|Extension Period|Adverse Event|0
1400792|NCT01217073|4623843|P4|Extension Period|Adverse Event|0
1400793|NCT01217073|4623844|P3|Extension Period|Adverse Event|0
1400794|NCT01217073|4623845|P2|Extension Period|Adverse Event|0
1400795|NCT01217073|4623846|P1|Extension Period|Adverse Event|0
1400796|NCT01217073|4623839|P8|Base Period|Withdrawal by Subject|0
1400797|NCT01217073|4623840|P7|Base Period|Withdrawal by Subject|0
1400798|NCT01217073|4623841|P6|Base Period|Withdrawal by Subject|5
1400799|NCT01217073|4623842|P5|Base Period|Withdrawal by Subject|5
1400800|NCT01217073|4623843|P4|Base Period|Withdrawal by Subject|1
1400801|NCT01217073|4623844|P3|Base Period|Withdrawal by Subject|5
1400802|NCT01217073|4623845|P2|Base Period|Withdrawal by Subject|5
1400803|NCT01217073|4623846|P1|Base Period|Withdrawal by Subject|4
1400804|NCT01217073|4623839|P8|Base Period|Protocol Violation|0
1400805|NCT01217073|4623840|P7|Base Period|Protocol Violation|0
1400806|NCT01217073|4623841|P6|Base Period|Protocol Violation|2
1400807|NCT01217073|4623842|P5|Base Period|Protocol Violation|1
1400808|NCT01217073|4623843|P4|Base Period|Protocol Violation|0
1400809|NCT01217073|4623844|P3|Base Period|Protocol Violation|0
1400810|NCT01217073|4623845|P2|Base Period|Protocol Violation|0
1400811|NCT01217073|4623846|P1|Base Period|Protocol Violation|1
1400812|NCT01217073|4623839|P8|Base Period|Physician Decision|0
1400813|NCT01217073|4623840|P7|Base Period|Physician Decision|0
1400814|NCT01217073|4623841|P6|Base Period|Physician Decision|0
1400815|NCT01217073|4623842|P5|Base Period|Physician Decision|1
1400816|NCT01217073|4623843|P4|Base Period|Physician Decision|0
1400817|NCT01217073|4623844|P3|Base Period|Physician Decision|0
1400818|NCT01217073|4623845|P2|Base Period|Physician Decision|0
1400819|NCT01217073|4623846|P1|Base Period|Physician Decision|0
1400820|NCT01217073|4623839|P8|Base Period|Lost to Follow-up|0
1400821|NCT01217073|4623840|P7|Base Period|Lost to Follow-up|0
1400822|NCT01217073|4623841|P6|Base Period|Lost to Follow-up|0
1400823|NCT01217073|4623842|P5|Base Period|Lost to Follow-up|3
1400824|NCT01217073|4623843|P4|Base Period|Lost to Follow-up|1
1400825|NCT01217073|4623844|P3|Base Period|Lost to Follow-up|1
1400826|NCT01217073|4623845|P2|Base Period|Lost to Follow-up|0
1400827|NCT01217073|4623846|P1|Base Period|Lost to Follow-up|0
1400828|NCT01217073|4623839|P8|Base Period|Lack of Efficacy|0
1400829|NCT01217073|4623840|P7|Base Period|Lack of Efficacy|0
1400830|NCT01217073|4623841|P6|Base Period|Lack of Efficacy|1
1400831|NCT01217073|4623842|P5|Base Period|Lack of Efficacy|0
1400832|NCT01217073|4623843|P4|Base Period|Lack of Efficacy|0
1400833|NCT01217073|4623844|P3|Base Period|Lack of Efficacy|0
1400834|NCT01217073|4623845|P2|Base Period|Lack of Efficacy|0
1400835|NCT01217073|4623846|P1|Base Period|Lack of Efficacy|0
1400836|NCT01217073|4623839|P8|Base Period|Excluded medication|0
1400837|NCT01217073|4623840|P7|Base Period|Excluded medication|0
1400838|NCT01217073|4623841|P6|Base Period|Excluded medication|0
1400839|NCT01217073|4623842|P5|Base Period|Excluded medication|1
1400840|NCT01217073|4623843|P4|Base Period|Excluded medication|0
1400841|NCT01217073|4623844|P3|Base Period|Excluded medication|0
1400842|NCT01217073|4623845|P2|Base Period|Excluded medication|0
1400843|NCT01217073|4623846|P1|Base Period|Excluded medication|0
1400844|NCT01217073|4623839|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
1400845|NCT01217073|4623840|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
1400846|NCT01217073|4623841|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
1400847|NCT01217073|4623842|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
1400848|NCT01217073|4623843|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
1400849|NCT01217073|4623844|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
1400850|NCT01217073|4623845|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
1400851|NCT01217073|4623846|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
1400852|NCT01217073|4623839|P8|Base Period|Adverse Event|0
1400853|NCT01217073|4623840|P7|Base Period|Adverse Event|0
1400854|NCT01217073|4623841|P6|Base Period|Adverse Event|1
1400855|NCT01217073|4623842|P5|Base Period|Adverse Event|4
1400856|NCT01217073|4623843|P4|Base Period|Adverse Event|0
1400857|NCT01217073|4623844|P3|Base Period|Adverse Event|1
1400858|NCT01217073|4623845|P2|Base Period|Adverse Event|0
1400859|NCT01217073|4623846|P1|Base Period|Adverse Event|1
1400860|NCT01216319|4624035|P1|Overall Study|Unanticipated chemo for breast cancer|2
1400861|NCT01216319|4624035|P1|Overall Study|Lost to Follow-up|2
1400862|NCT01216163|4624052|P3|Overall Study|Withdrawal by Subject|0
1400863|NCT01216163|4624053|P2|Overall Study|Withdrawal by Subject|1
1400864|NCT01216163|4624054|P1|Overall Study|Withdrawal by Subject|1
1400865|NCT01216072|4624106|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
1400866|NCT01216072|4624107|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
1400867|NCT01216072|4624106|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
1400868|NCT01216072|4624107|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
1400869|NCT01216072|4624106|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
1400870|NCT01216072|4624107|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
1400871|NCT01216072|4624106|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
1400872|NCT01216072|4624107|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
1400873|NCT01216072|4624106|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
1400874|NCT01216072|4624107|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
1400875|NCT01216072|4624106|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
1400876|NCT01216072|4624107|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
1400877|NCT01216072|4624106|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
1400878|NCT01216072|4624107|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
1400879|NCT01216072|4624106|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
1400880|NCT01216072|4624107|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
1400881|NCT01216072|4624106|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
1400882|NCT01216072|4624107|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
1400883|NCT01216072|4624106|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
1400884|NCT01216072|4624107|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
1400885|NCT01215981|4624135|P2|Overall Study|Withdrawal by Subject|0
1400886|NCT01215981|4624136|P1|Overall Study|Withdrawal by Subject|1
1400887|NCT01215981|4624135|P2|Overall Study|Protocol Violation|0
1400888|NCT01215981|4624136|P1|Overall Study|Protocol Violation|1
1400889|NCT01215981|4624135|P2|Overall Study|Physician Decision|1
1400890|NCT01215981|4624136|P1|Overall Study|Physician Decision|0
1400891|NCT01215968|4624146|P2|Overall Study|Not received study drug|1
1400892|NCT01215968|4624147|P1|Overall Study|Not received study drug|0
1400893|NCT01215968|4624146|P2|Overall Study|Protocol Violation|4
1400894|NCT01215968|4624147|P1|Overall Study|Protocol Violation|2
1400895|NCT01215968|4624146|P2|Overall Study|Adverse Event|2
1400896|NCT01215968|4624147|P1|Overall Study|Adverse Event|0
1400897|NCT01215955|4624167|P4|Overall Study|Quality Issues|2
1400898|NCT01215955|4624168|P3|Overall Study|Quality Issues|3
1400899|NCT01215955|4624169|P2|Overall Study|Quality Issues|0
1400900|NCT01215955|4624170|P1|Overall Study|Quality Issues|0
1400901|NCT01215955|4624167|P4|Overall Study|Withdrawal by Subject|9
1400902|NCT01215955|4624168|P3|Overall Study|Withdrawal by Subject|13
1400903|NCT01215955|4624169|P2|Overall Study|Withdrawal by Subject|15
1400904|NCT01215955|4624170|P1|Overall Study|Withdrawal by Subject|14
1400905|NCT01215955|4624167|P4|Overall Study|Sponsor Decision|1
1400906|NCT01215955|4624168|P3|Overall Study|Sponsor Decision|0
1400907|NCT01215955|4624169|P2|Overall Study|Sponsor Decision|2
1400908|NCT01215955|4624170|P1|Overall Study|Sponsor Decision|1
1400909|NCT01215955|4624167|P4|Overall Study|Protocol Violation|8
1400910|NCT01215955|4624168|P3|Overall Study|Protocol Violation|8
1400911|NCT01215955|4624169|P2|Overall Study|Protocol Violation|13
1400912|NCT01215955|4624170|P1|Overall Study|Protocol Violation|17
1400913|NCT01215955|4624167|P4|Overall Study|Physician Decision|11
1400914|NCT01215955|4624168|P3|Overall Study|Physician Decision|8
1400915|NCT01215955|4624169|P2|Overall Study|Physician Decision|10
1400916|NCT01215955|4624170|P1|Overall Study|Physician Decision|4
1400917|NCT01215955|4624167|P4|Overall Study|Lost to Follow-up|9
1400918|NCT01215955|4624168|P3|Overall Study|Lost to Follow-up|8
1400919|NCT01215955|4624169|P2|Overall Study|Lost to Follow-up|4
1400920|NCT01215955|4624170|P1|Overall Study|Lost to Follow-up|4
1400921|NCT01215955|4624167|P4|Overall Study|Lack of Efficacy|0
1400922|NCT01215955|4624168|P3|Overall Study|Lack of Efficacy|1
1400923|NCT01215955|4624169|P2|Overall Study|Lack of Efficacy|2
1400924|NCT01215955|4624170|P1|Overall Study|Lack of Efficacy|1
1400925|NCT01215955|4624167|P4|Overall Study|Entry Criteria Not Met|7
1400926|NCT01215955|4624168|P3|Overall Study|Entry Criteria Not Met|4
1400927|NCT01215955|4624169|P2|Overall Study|Entry Criteria Not Met|3
1400928|NCT01215955|4624170|P1|Overall Study|Entry Criteria Not Met|1
1400929|NCT01215955|4624167|P4|Overall Study|Death|3
1400930|NCT01215955|4624168|P3|Overall Study|Death|1
1400931|NCT01215955|4624169|P2|Overall Study|Death|0
1400932|NCT01215955|4624170|P1|Overall Study|Death|2
1400933|NCT01215955|4624167|P4|Overall Study|Adverse Event|3
1400934|NCT01215955|4624168|P3|Overall Study|Adverse Event|2
1400935|NCT01215955|4624169|P2|Overall Study|Adverse Event|4
1400936|NCT01215955|4624170|P1|Overall Study|Adverse Event|1
1400937|NCT01215942|4624238|P2|Post-Treatment Follow-Up Period|Sponsor Decision|61
1400938|NCT01215942|4624239|P1|Post-Treatment Follow-Up Period|Sponsor Decision|28
1400939|NCT01215942|4624238|P2|Post-Treatment Follow-Up Period|Physician Decision|2
1400940|NCT01215942|4624239|P1|Post-Treatment Follow-Up Period|Physician Decision|1
1400941|NCT01215942|4624238|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
1400942|NCT01215942|4624239|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
1400943|NCT01215942|4624238|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|13
1400944|NCT01215942|4624239|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|13
1400945|NCT01215942|4624238|P2|Post-Treatment Follow-Up Period|Death|1
1400946|NCT01215942|4624239|P1|Post-Treatment Follow-Up Period|Death|0
1400947|NCT01215942|4624238|P2|Treatment Period|Sponsor Decision|530
1400948|NCT01215942|4624239|P1|Treatment Period|Sponsor Decision|349
1400949|NCT01215942|4624238|P2|Treatment Period|Protocol Violation|1
1400950|NCT01215942|4624239|P1|Treatment Period|Protocol Violation|0
1400951|NCT01215942|4624238|P2|Treatment Period|Physician Decision|5
1400952|NCT01215942|4624239|P1|Treatment Period|Physician Decision|5
1400953|NCT01215942|4624238|P2|Treatment Period|Withdrawal by Subject|40
1400954|NCT01215942|4624239|P1|Treatment Period|Withdrawal by Subject|17
1400955|NCT01215942|4624238|P2|Treatment Period|Lost to Follow-up|4
1400956|NCT01215942|4624239|P1|Treatment Period|Lost to Follow-up|3
1400957|NCT01215942|4624238|P2|Treatment Period|Lack of Efficacy|62
1400958|NCT01215942|4624239|P1|Treatment Period|Lack of Efficacy|23
1400959|NCT01215942|4624238|P2|Treatment Period|Death|4
1400960|NCT01215942|4624239|P1|Treatment Period|Death|2
1400961|NCT01215942|4624238|P2|Treatment Period|Adverse Event|26
1400962|NCT01215942|4624239|P1|Treatment Period|Adverse Event|15
1400963|NCT01215851|4624369|P6|Follow up Period|Lost to Follow-up|1
1400964|NCT01215851|4624370|P5|Follow up Period|Lost to Follow-up|0
1400965|NCT01215851|4624371|P4|Follow up Period|Lost to Follow-up|0
1400966|NCT01215851|4624372|P3|Follow up Period|Lost to Follow-up|0
1400967|NCT01215851|4624373|P2|Follow up Period|Lost to Follow-up|0
1400968|NCT01215851|4624374|P1|Follow up Period|Lost to Follow-up|0
1400969|NCT01215851|4624369|P6|Treatment Period|Adverse Event|1
1400970|NCT01215851|4624370|P5|Treatment Period|Adverse Event|0
1400971|NCT01215851|4624371|P4|Treatment Period|Adverse Event|3
1400972|NCT01215851|4624372|P3|Treatment Period|Adverse Event|1
1400973|NCT01215851|4624373|P2|Treatment Period|Adverse Event|1
1400974|NCT01215851|4624374|P1|Treatment Period|Adverse Event|1
1400975|NCT01215734|4624433|P2|Overall Study|Death|1
1400976|NCT01215734|4624434|P1|Overall Study|Death|0
1400977|NCT01215721|4624442|P1|Overall Study|Adverse Event|2
1400978|NCT01215513|4624574|P1|Overall Study|Miscellaneous reasons (CS42A)|2
1400979|NCT01215513|4624574|P1|Overall Study|Withdrawal by subject (CS42A)|5
1400980|NCT01215513|4624574|P1|Overall Study|Physician decision (CS42A)|6
1400981|NCT01215513|4624574|P1|Overall Study|Adverse event (CS42A)|2
1400982|NCT01215513|4624574|P1|Overall Study|Not enrolled from CS42 to CS42A|21
1400983|NCT01215513|4624574|P1|Overall Study|Not completed CS42|9
1400984|NCT01215435|4624583|P2|Overall Study|Unclassified|5
1400985|NCT01215435|4624584|P1|Overall Study|Unclassified|5
1400986|NCT01215435|4624583|P2|Overall Study|Lost to Follow-up|0
1400987|NCT01215435|4624584|P1|Overall Study|Lost to Follow-up|3
1400988|NCT01215435|4624583|P2|Overall Study|Withdrawal Criteria|11
1400989|NCT01215435|4624584|P1|Overall Study|Withdrawal Criteria|8
1400990|NCT01215435|4624583|P2|Overall Study|Protocol Violation|0
1400991|NCT01215435|4624584|P1|Overall Study|Protocol Violation|2
1400992|NCT01215435|4624583|P2|Overall Study|Adverse Event|0
1400993|NCT01215435|4624584|P1|Overall Study|Adverse Event|1
1400994|NCT01215422|4624598|P4|Overall Study|Did not complete all intubations|0
1400995|NCT01215422|4624599|P3|Overall Study|Did not complete all intubations|0
1401085|NCT01214850|4624966|P3|Overall Study|Administrative reason|0
1400996|NCT01215422|4624600|P2|Overall Study|Did not complete all intubations|0
1400997|NCT01215422|4624601|P1|Overall Study|Did not complete all intubations|7
1400998|NCT01215422|4624598|P4|Overall Study|Failed intubations|8
1400999|NCT01215422|4624599|P3|Overall Study|Failed intubations|3
1401000|NCT01215422|4624600|P2|Overall Study|Failed intubations|0
1401001|NCT01215422|4624601|P1|Overall Study|Failed intubations|0
1401002|NCT01215422|4624598|P4|Overall Study|Relocation|0
1401003|NCT01215422|4624599|P3|Overall Study|Relocation|0
1401004|NCT01215422|4624600|P2|Overall Study|Relocation|0
1401005|NCT01215422|4624601|P1|Overall Study|Relocation|1
1401006|NCT01215357|4624623|P1|Overall Study|Protocol Violation|9
1401007|NCT01215357|4624623|P1|Overall Study|Withdrawal by Subject|3
1401008|NCT01215253|4624738|P2|Overall Study|Other|12
1401009|NCT01215253|4624739|P1|Overall Study|Other|14
1401010|NCT01215253|4624738|P2|Overall Study|Lost to Follow-up|4
1401011|NCT01215253|4624739|P1|Overall Study|Lost to Follow-up|6
1401012|NCT01215253|4624738|P2|Overall Study|Physician Decision|12
1401013|NCT01215253|4624739|P1|Overall Study|Physician Decision|9
1401014|NCT01215253|4624738|P2|Overall Study|Withdrawal by Subject|35
1401015|NCT01215253|4624739|P1|Overall Study|Withdrawal by Subject|57
1401016|NCT01215227|4624773|P6|Overall Study|Randomized but not treated|1
1401017|NCT01215227|4624774|P5|Overall Study|Randomized but not treated|0
1401018|NCT01215227|4624775|P4|Overall Study|Randomized but not treated|1
1401019|NCT01215227|4624776|P3|Overall Study|Randomized but not treated|1
1401020|NCT01215227|4624777|P2|Overall Study|Randomized but not treated|0
1401021|NCT01215227|4624778|P1|Overall Study|Randomized but not treated|0
1401022|NCT01215227|4624773|P6|Overall Study|Missing Status|0
1401023|NCT01215227|4624774|P5|Overall Study|Missing Status|0
1401024|NCT01215227|4624775|P4|Overall Study|Missing Status|0
1401025|NCT01215227|4624776|P3|Overall Study|Missing Status|0
1401026|NCT01215227|4624777|P2|Overall Study|Missing Status|1
1401027|NCT01215227|4624778|P1|Overall Study|Missing Status|0
1401028|NCT01215227|4624773|P6|Overall Study|Administrative|40
1401029|NCT01215227|4624774|P5|Overall Study|Administrative|28
1401030|NCT01215227|4624775|P4|Overall Study|Administrative|24
1401031|NCT01215227|4624776|P3|Overall Study|Administrative|42
1401032|NCT01215227|4624777|P2|Overall Study|Administrative|73
1401033|NCT01215227|4624778|P1|Overall Study|Administrative|83
1401034|NCT01215227|4624773|P6|Overall Study|Non-Compliance With Protocol|0
1401035|NCT01215227|4624774|P5|Overall Study|Non-Compliance With Protocol|0
1401036|NCT01215227|4624775|P4|Overall Study|Non-Compliance With Protocol|0
1401037|NCT01215227|4624776|P3|Overall Study|Non-Compliance With Protocol|1
1401038|NCT01215227|4624777|P2|Overall Study|Non-Compliance With Protocol|6
1401039|NCT01215227|4624778|P1|Overall Study|Non-Compliance With Protocol|2
1401040|NCT01215227|4624773|P6|Overall Study|Subject Withdrew Consent|8
1401041|NCT01215227|4624774|P5|Overall Study|Subject Withdrew Consent|11
1401042|NCT01215227|4624775|P4|Overall Study|Subject Withdrew Consent|10
1401043|NCT01215227|4624776|P3|Overall Study|Subject Withdrew Consent|7
1401044|NCT01215227|4624777|P2|Overall Study|Subject Withdrew Consent|20
1401045|NCT01215227|4624778|P1|Overall Study|Subject Withdrew Consent|16
1401046|NCT01215227|4624773|P6|Overall Study|Lost to Follow-up|2
1401047|NCT01215227|4624774|P5|Overall Study|Lost to Follow-up|1
1401048|NCT01215227|4624775|P4|Overall Study|Lost to Follow-up|1
1401049|NCT01215227|4624776|P3|Overall Study|Lost to Follow-up|1
1401050|NCT01215227|4624777|P2|Overall Study|Lost to Follow-up|4
1401051|NCT01215227|4624778|P1|Overall Study|Lost to Follow-up|1
1401052|NCT01215227|4624773|P6|Overall Study|Treatment Failure|1
1401053|NCT01215227|4624774|P5|Overall Study|Treatment Failure|1
1401054|NCT01215227|4624775|P4|Overall Study|Treatment Failure|5
1401055|NCT01215227|4624776|P3|Overall Study|Treatment Failure|1
1401056|NCT01215227|4624777|P2|Overall Study|Treatment Failure|4
1401057|NCT01215227|4624778|P1|Overall Study|Treatment Failure|8
1401058|NCT01215227|4624773|P6|Overall Study|Adverse Event|6
1401059|NCT01215227|4624774|P5|Overall Study|Adverse Event|7
1401060|NCT01215227|4624775|P4|Overall Study|Adverse Event|8
1401061|NCT01215227|4624776|P3|Overall Study|Adverse Event|4
1401062|NCT01215227|4624777|P2|Overall Study|Adverse Event|11
1401063|NCT01215227|4624778|P1|Overall Study|Adverse Event|11
1401064|NCT01215097|4624897|P2|Overall Study|patient's private reason|1
1401065|NCT01215097|4624898|P1|Overall Study|patient's private reason|1
1401066|NCT01215097|4624897|P2|Overall Study|patient's refusal to come|2
1401067|NCT01215097|4624898|P1|Overall Study|patient's refusal to come|2
1401068|NCT01215097|4624897|P2|Overall Study|Lack of Efficacy|3
1401069|NCT01215097|4624898|P1|Overall Study|Lack of Efficacy|0
1401070|NCT01215097|4624897|P2|Overall Study|Withdrawal by Subject|3
1401071|NCT01215097|4624898|P1|Overall Study|Withdrawal by Subject|6
1401072|NCT01215097|4624897|P2|Overall Study|Lost to Follow-up|0
1401073|NCT01215097|4624898|P1|Overall Study|Lost to Follow-up|2
1401074|NCT01215097|4624897|P2|Overall Study|Protocol Violation|2
1401075|NCT01215097|4624898|P1|Overall Study|Protocol Violation|0
1401076|NCT01215097|4624897|P2|Overall Study|Adverse Event|3
1401077|NCT01215097|4624898|P1|Overall Study|Adverse Event|1
1401078|NCT01215032|4624930|P1|Overall Study|Lack of Efficacy|17
1401079|NCT01215032|4624930|P1|Overall Study|Adverse Event|3
1401080|NCT01214915|4624955|P1|Overall Study|Lack of Efficacy|3
1401081|NCT01214915|4624955|P1|Overall Study|Adverse Event|8
1401082|NCT01214850|4624966|P3|Overall Study|Unable to classify|1
1401083|NCT01214850|4624967|P2|Overall Study|Unable to classify|1
1401084|NCT01214850|4624968|P1|Overall Study|Unable to classify|2
1401086|NCT01214850|4624967|P2|Overall Study|Administrative reason|0
1401087|NCT01214850|4624968|P1|Overall Study|Administrative reason|1
1401088|NCT01214850|4624966|P3|Overall Study|Inappropriate enrollment|0
1401089|NCT01214850|4624967|P2|Overall Study|Inappropriate enrollment|1
1401090|NCT01214850|4624968|P1|Overall Study|Inappropriate enrollment|2
1401091|NCT01214850|4624966|P3|Overall Study|Adverse event or death|3
1401092|NCT01214850|4624967|P2|Overall Study|Adverse event or death|8
1401093|NCT01214850|4624968|P1|Overall Study|Adverse event or death|11
1401094|NCT01214850|4624966|P3|Overall Study|Protocol Violation|6
1401095|NCT01214850|4624967|P2|Overall Study|Protocol Violation|5
1401096|NCT01214850|4624968|P1|Overall Study|Protocol Violation|5
1401097|NCT01214850|4624966|P3|Overall Study|Lost to Follow-up|123
1401098|NCT01214850|4624967|P2|Overall Study|Lost to Follow-up|98
1401099|NCT01214850|4624968|P1|Overall Study|Lost to Follow-up|124
1401100|NCT01214850|4624966|P3|Overall Study|Withdrawal by Subject|28
1401101|NCT01214850|4624967|P2|Overall Study|Withdrawal by Subject|31
1401102|NCT01214850|4624968|P1|Overall Study|Withdrawal by Subject|38
1401103|NCT01214837|4625052|P3|Overall Study|Unable to Classify|0
1401104|NCT01214837|4625053|P2|Overall Study|Unable to Classify|3
1401105|NCT01214837|4625054|P1|Overall Study|Unable to Classify|1
1401106|NCT01214837|4625052|P3|Overall Study|Protocol Violation|5
1401107|NCT01214837|4625053|P2|Overall Study|Protocol Violation|1
1401108|NCT01214837|4625054|P1|Overall Study|Protocol Violation|3
1401109|NCT01214837|4625052|P3|Overall Study|Administrative Reason|4
1401110|NCT01214837|4625053|P2|Overall Study|Administrative Reason|6
1401111|NCT01214837|4625054|P1|Overall Study|Administrative Reason|2
1401112|NCT01214837|4625052|P3|Overall Study|Inappropriate Enrolment|2
1401113|NCT01214837|4625053|P2|Overall Study|Inappropriate Enrolment|1
1401114|NCT01214837|4625054|P1|Overall Study|Inappropriate Enrolment|0
1401115|NCT01214837|4625052|P3|Overall Study|Lost to Follow-up|21
1401116|NCT01214837|4625053|P2|Overall Study|Lost to Follow-up|15
1401117|NCT01214837|4625054|P1|Overall Study|Lost to Follow-up|20
1401118|NCT01214837|4625052|P3|Overall Study|Withdrawal by Subject|28
1401119|NCT01214837|4625053|P2|Overall Study|Withdrawal by Subject|36
1401120|NCT01214837|4625054|P1|Overall Study|Withdrawal by Subject|27
1401121|NCT01214837|4625052|P3|Overall Study|Adverse Event|1
1401122|NCT01214837|4625053|P2|Overall Study|Adverse Event|2
1401123|NCT01214837|4625054|P1|Overall Study|Adverse Event|1
1401124|NCT01214837|4625052|P3|Overall Study|Death|1
1401125|NCT01214837|4625053|P2|Overall Study|Death|0
1401126|NCT01214837|4625054|P1|Overall Study|Death|0
1401127|NCT01214720|4625110|P2|Overall Study|Lost to Follow-up|2
1401128|NCT01214720|4625111|P1|Overall Study|Lost to Follow-up|6
1401129|NCT01214720|4625110|P2|Overall Study|Alive and in follow-up|48
1401130|NCT01214720|4625111|P1|Overall Study|Alive and in follow-up|45
1401131|NCT01214720|4625110|P2|Overall Study|Alive and still on treatment|18
1401132|NCT01214720|4625111|P1|Overall Study|Alive and still on treatment|34
1401133|NCT01214642|4625140|P12|Overall Study|Physician Decision|2
1401134|NCT01214642|4625141|P11|Overall Study|Physician Decision|0
1401135|NCT01214642|4625142|P10|Overall Study|Physician Decision|0
1401136|NCT01214642|4625143|P9|Overall Study|Physician Decision|0
1401137|NCT01214642|4625144|P8|Overall Study|Physician Decision|0
1401138|NCT01214642|4625145|P7|Overall Study|Physician Decision|0
1401139|NCT01214642|4625146|P6|Overall Study|Physician Decision|0
1401140|NCT01214642|4625147|P5|Overall Study|Physician Decision|1
1401141|NCT01214642|4625148|P4|Overall Study|Physician Decision|1
1401142|NCT01214642|4625149|P3|Overall Study|Physician Decision|1
1401143|NCT01214642|4625150|P2|Overall Study|Physician Decision|0
1401144|NCT01214642|4625151|P1|Overall Study|Physician Decision|0
1401145|NCT01214642|4625140|P12|Overall Study|Withdrawal by Subject|0
1401146|NCT01214642|4625141|P11|Overall Study|Withdrawal by Subject|1
1401147|NCT01214642|4625142|P10|Overall Study|Withdrawal by Subject|1
1401148|NCT01214642|4625143|P9|Overall Study|Withdrawal by Subject|3
1401149|NCT01214642|4625144|P8|Overall Study|Withdrawal by Subject|0
1401150|NCT01214642|4625145|P7|Overall Study|Withdrawal by Subject|0
1401151|NCT01214642|4625146|P6|Overall Study|Withdrawal by Subject|0
1401152|NCT01214642|4625147|P5|Overall Study|Withdrawal by Subject|0
1401153|NCT01214642|4625148|P4|Overall Study|Withdrawal by Subject|0
1401154|NCT01214642|4625149|P3|Overall Study|Withdrawal by Subject|1
1401155|NCT01214642|4625150|P2|Overall Study|Withdrawal by Subject|0
1401156|NCT01214642|4625151|P1|Overall Study|Withdrawal by Subject|0
1401157|NCT01214642|4625140|P12|Overall Study|Death|0
1401158|NCT01214642|4625141|P11|Overall Study|Death|1
1401159|NCT01214642|4625142|P10|Overall Study|Death|0
1401160|NCT01214642|4625143|P9|Overall Study|Death|0
1401161|NCT01214642|4625144|P8|Overall Study|Death|0
1401162|NCT01214642|4625145|P7|Overall Study|Death|0
1401163|NCT01214642|4625146|P6|Overall Study|Death|0
1401164|NCT01214642|4625147|P5|Overall Study|Death|0
1401165|NCT01214642|4625148|P4|Overall Study|Death|0
1401166|NCT01214642|4625149|P3|Overall Study|Death|1
1401167|NCT01214642|4625150|P2|Overall Study|Death|0
1401168|NCT01214642|4625151|P1|Overall Study|Death|0
1401169|NCT01214642|4625140|P12|Overall Study|Adverse Event|0
1401170|NCT01214642|4625141|P11|Overall Study|Adverse Event|1
1401171|NCT01214642|4625142|P10|Overall Study|Adverse Event|1
1401172|NCT01214642|4625143|P9|Overall Study|Adverse Event|0
1401173|NCT01214642|4625144|P8|Overall Study|Adverse Event|0
1401174|NCT01214642|4625145|P7|Overall Study|Adverse Event|1
1401175|NCT01214642|4625146|P6|Overall Study|Adverse Event|0
1401176|NCT01214642|4625147|P5|Overall Study|Adverse Event|0
1401177|NCT01214642|4625148|P4|Overall Study|Adverse Event|0
1401178|NCT01214642|4625149|P3|Overall Study|Adverse Event|0
1401179|NCT01214642|4625150|P2|Overall Study|Adverse Event|1
1401180|NCT01214642|4625151|P1|Overall Study|Adverse Event|0
1401181|NCT01214642|4625140|P12|Overall Study|Progressive Disease|4
1401182|NCT01214642|4625141|P11|Overall Study|Progressive Disease|1
1401183|NCT01214642|4625142|P10|Overall Study|Progressive Disease|2
1401184|NCT01214642|4625143|P9|Overall Study|Progressive Disease|10
1401185|NCT01214642|4625144|P8|Overall Study|Progressive Disease|3
1401186|NCT01214642|4625145|P7|Overall Study|Progressive Disease|5
1401187|NCT01214642|4625146|P6|Overall Study|Progressive Disease|3
1401188|NCT01214642|4625147|P5|Overall Study|Progressive Disease|5
1401189|NCT01214642|4625148|P4|Overall Study|Progressive Disease|5
1401190|NCT01214642|4625149|P3|Overall Study|Progressive Disease|3
1401191|NCT01214642|4625150|P2|Overall Study|Progressive Disease|2
1401192|NCT01214642|4625151|P1|Overall Study|Progressive Disease|3
1401193|NCT01214629|4625231|P11|Overall Study|Withdrawal by Subject|0
1401194|NCT01214629|4625232|P10|Overall Study|Withdrawal by Subject|1
1401195|NCT01214629|4625233|P9|Overall Study|Withdrawal by Subject|0
1401196|NCT01214629|4625234|P8|Overall Study|Withdrawal by Subject|0
1401197|NCT01214629|4625235|P7|Overall Study|Withdrawal by Subject|0
1401198|NCT01214629|4625236|P6|Overall Study|Withdrawal by Subject|0
1401199|NCT01214629|4625237|P5|Overall Study|Withdrawal by Subject|0
1401200|NCT01214629|4625238|P4|Overall Study|Withdrawal by Subject|0
1401201|NCT01214629|4625239|P3|Overall Study|Withdrawal by Subject|0
1401202|NCT01214629|4625240|P2|Overall Study|Withdrawal by Subject|0
1401203|NCT01214629|4625241|P1|Overall Study|Withdrawal by Subject|0
1401204|NCT01214629|4625231|P11|Overall Study|Physician Decision|1
1401205|NCT01214629|4625232|P10|Overall Study|Physician Decision|0
1401206|NCT01214629|4625233|P9|Overall Study|Physician Decision|0
1401207|NCT01214629|4625234|P8|Overall Study|Physician Decision|0
1401208|NCT01214629|4625235|P7|Overall Study|Physician Decision|0
1401209|NCT01214629|4625236|P6|Overall Study|Physician Decision|0
1401210|NCT01214629|4625237|P5|Overall Study|Physician Decision|0
1401211|NCT01214629|4625238|P4|Overall Study|Physician Decision|0
1401212|NCT01214629|4625239|P3|Overall Study|Physician Decision|0
1401213|NCT01214629|4625240|P2|Overall Study|Physician Decision|0
1401214|NCT01214629|4625241|P1|Overall Study|Physician Decision|0
1401215|NCT01214629|4625231|P11|Overall Study|Adverse Event|0
1401216|NCT01214629|4625232|P10|Overall Study|Adverse Event|1
1401217|NCT01214629|4625233|P9|Overall Study|Adverse Event|0
1401218|NCT01214629|4625234|P8|Overall Study|Adverse Event|0
1401219|NCT01214629|4625235|P7|Overall Study|Adverse Event|0
1401220|NCT01214629|4625236|P6|Overall Study|Adverse Event|1
1401221|NCT01214629|4625237|P5|Overall Study|Adverse Event|0
1401222|NCT01214629|4625238|P4|Overall Study|Adverse Event|1
1401223|NCT01214629|4625239|P3|Overall Study|Adverse Event|0
1401224|NCT01214629|4625240|P2|Overall Study|Adverse Event|0
1401225|NCT01214629|4625241|P1|Overall Study|Adverse Event|0
1401226|NCT01214629|4625231|P11|Overall Study|Progressive Disease|1
1401227|NCT01214629|4625232|P10|Overall Study|Progressive Disease|5
1401228|NCT01214629|4625233|P9|Overall Study|Progressive Disease|1
1401229|NCT01214629|4625234|P8|Overall Study|Progressive Disease|1
1401230|NCT01214629|4625235|P7|Overall Study|Progressive Disease|1
1401231|NCT01214629|4625236|P6|Overall Study|Progressive Disease|3
1401232|NCT01214629|4625237|P5|Overall Study|Progressive Disease|2
1401233|NCT01214629|4625238|P4|Overall Study|Progressive Disease|1
1401234|NCT01214629|4625239|P3|Overall Study|Progressive Disease|0
1401235|NCT01214629|4625240|P2|Overall Study|Progressive Disease|1
1401236|NCT01214629|4625241|P1|Overall Study|Progressive Disease|1
1401237|NCT01214616|4625306|P4|Overall Study|Withdrawal by Subject|1
1401238|NCT01214616|4625307|P3|Overall Study|Withdrawal by Subject|0
1401239|NCT01214616|4625308|P2|Overall Study|Withdrawal by Subject|0
1401240|NCT01214616|4625309|P1|Overall Study|Withdrawal by Subject|1
1401241|NCT01214616|4625306|P4|Overall Study|Other adverse events|1
1401242|NCT01214616|4625307|P3|Overall Study|Other adverse events|1
1401243|NCT01214616|4625308|P2|Overall Study|Other adverse events|1
1401244|NCT01214616|4625309|P1|Overall Study|Other adverse events|0
1401245|NCT01214616|4625306|P4|Overall Study|Dose limiting toxicity|0
1401246|NCT01214616|4625307|P3|Overall Study|Dose limiting toxicity|0
1401247|NCT01214616|4625308|P2|Overall Study|Dose limiting toxicity|2
1401248|NCT01214616|4625309|P1|Overall Study|Dose limiting toxicity|0
1401249|NCT01214616|4625306|P4|Overall Study|Progressive disease|4
1401250|NCT01214616|4625307|P3|Overall Study|Progressive disease|2
1401251|NCT01214616|4625308|P2|Overall Study|Progressive disease|2
1401252|NCT01214616|4625309|P1|Overall Study|Progressive disease|2
1401253|NCT01214434|4625345|P2|Overall Study|Site error|0
1401254|NCT01214434|4625346|P1|Overall Study|Site error|1
1401255|NCT01214434|4625345|P2|Overall Study|Lost to Follow-up|2
1401256|NCT01214434|4625346|P1|Overall Study|Lost to Follow-up|2
1401257|NCT01214434|4625345|P2|Overall Study|Withdrawal by Subject|0
1401258|NCT01214434|4625346|P1|Overall Study|Withdrawal by Subject|1
1401259|NCT01214395|4625362|P1|Overall Study|All patients had infection|5
1401260|NCT01214252|4625371|P1|Overall Study|Not eligible per protocol|82
1401261|NCT01214239|4625379|P2|Overall Study|patient's private reason|1
1401262|NCT01214239|4625380|P1|Overall Study|patient's private reason|1
1401263|NCT01214239|4625379|P2|Overall Study|Lack of Efficacy|2
1401264|NCT01214239|4625380|P1|Overall Study|Lack of Efficacy|1
1401265|NCT01214239|4625379|P2|Overall Study|Withdrawal by Subject|9
1401266|NCT01214239|4625380|P1|Overall Study|Withdrawal by Subject|4
1401267|NCT01214239|4625379|P2|Overall Study|Lost to Follow-up|1
1401268|NCT01214239|4625380|P1|Overall Study|Lost to Follow-up|1
1401269|NCT01214239|4625379|P2|Overall Study|Protocol Violation|1
1401270|NCT01214239|4625380|P1|Overall Study|Protocol Violation|2
1401271|NCT01214239|4625379|P2|Overall Study|Adverse Event|4
1401272|NCT01214239|4625380|P1|Overall Study|Adverse Event|3
1401273|NCT01214187|4625414|P2|Overall Study|Withdrawal by Subject|3
1401274|NCT01214187|4625415|P1|Overall Study|Withdrawal by Subject|0
1401275|NCT01214187|4625414|P2|Overall Study|Death|1
1401276|NCT01214187|4625415|P1|Overall Study|Death|1
1401277|NCT01214187|4625414|P2|Overall Study|Adverse Event|2
1401278|NCT01214187|4625415|P1|Overall Study|Adverse Event|6
1401279|NCT01214174|4625432|P3|Overall Study|Withdrawal by Subject|1
1401280|NCT01214174|4625433|P2|Overall Study|Withdrawal by Subject|0
1401281|NCT01214174|4625434|P1|Overall Study|Withdrawal by Subject|0
1401282|NCT01213966|4625588|P4|Overall Study|Protocol Violation|1
1401283|NCT01213966|4625589|P3|Overall Study|Protocol Violation|3
1401284|NCT01213966|4625590|P2|Overall Study|Protocol Violation|0
1401285|NCT01213966|4625591|P1|Overall Study|Protocol Violation|1
1401286|NCT01213836|4625603|P2|Period 1, First Intervention|Withdrawal by Subject|1
1401287|NCT01213836|4625604|P1|Period 1, First Intervention|Withdrawal by Subject|1
1401288|NCT01213836|4625603|P2|Period 1, First Intervention|Protocol Violation|1
1401289|NCT01213836|4625604|P1|Period 1, First Intervention|Protocol Violation|0
1401290|NCT01213836|4625603|P2|Period 1, First Intervention|Adverse Event|1
1401291|NCT01213836|4625604|P1|Period 1, First Intervention|Adverse Event|2
1401292|NCT01213264|4625717|P3|Overall Study|Lost to Follow-up|6
1401293|NCT01213264|4625718|P2|Overall Study|Lost to Follow-up|2
1401294|NCT01213264|4625719|P1|Overall Study|Lost to Follow-up|1
1401295|NCT01213264|4625717|P3|Overall Study|Adverse Event|0
1401296|NCT01213264|4625718|P2|Overall Study|Adverse Event|0
1401297|NCT01213264|4625719|P1|Overall Study|Adverse Event|1
1401298|NCT01213251|4625739|P3|Overall Study|Missed 18-Month Follow-up|1
1401299|NCT01213251|4625740|P2|Overall Study|Missed 18-Month Follow-up|0
1401300|NCT01213251|4625741|P1|Overall Study|Missed 18-Month Follow-up|0
1401301|NCT01213251|4625739|P3|Overall Study|Protocol Violation|0
1401302|NCT01213251|4625740|P2|Overall Study|Protocol Violation|1
1401303|NCT01213251|4625741|P1|Overall Study|Protocol Violation|1
1401304|NCT01213251|4625739|P3|Overall Study|Exit|8
1401305|NCT01213251|4625740|P2|Overall Study|Exit|2
1401306|NCT01213251|4625741|P1|Overall Study|Exit|3
1401307|NCT01213251|4625739|P3|Overall Study|Death|2
1401308|NCT01213251|4625740|P2|Overall Study|Death|1
1401309|NCT01213251|4625741|P1|Overall Study|Death|2
1401310|NCT01213173|4625768|P2|Overall Study|Incorrect Enrollment|3
1401311|NCT01213173|4625769|P1|Overall Study|Incorrect Enrollment|1
1401312|NCT01213173|4625768|P2|Overall Study|Withdrawal by Subject|5
1401313|NCT01213173|4625769|P1|Overall Study|Withdrawal by Subject|5
1401314|NCT01213173|4625768|P2|Overall Study|Adverse Event|8
1401315|NCT01213173|4625769|P1|Overall Study|Adverse Event|4
1401316|NCT01213173|4625768|P2|Overall Study|Protocol Violation|0
1401317|NCT01213173|4625769|P1|Overall Study|Protocol Violation|2
1401318|NCT01213082|4625802|P3|Overall Study|Physician Decision|1
1401319|NCT01213082|4625803|P2|Overall Study|Physician Decision|0
1401320|NCT01213082|4625804|P1|Overall Study|Physician Decision|0
1401321|NCT01213082|4625802|P3|Overall Study|Lost to Follow-up|4
1401322|NCT01213082|4625803|P2|Overall Study|Lost to Follow-up|7
1401323|NCT01213082|4625804|P1|Overall Study|Lost to Follow-up|6
1401324|NCT01212991|4625846|P2|Overall Study|Continuing Treatment|61
1401325|NCT01212991|4625847|P1|Overall Study|Continuing Treatment|367
1401326|NCT01212991|4625846|P2|Overall Study|Withdrawal by Subject|14
1401327|NCT01212991|4625847|P1|Overall Study|Withdrawal by Subject|4
1401328|NCT01212991|4625846|P2|Overall Study|Death|299
1401329|NCT01212991|4625847|P1|Overall Study|Death|241
1401330|NCT01212991|4625846|P2|Overall Study|Lost to Follow-up|0
1401331|NCT01212991|4625847|P1|Overall Study|Lost to Follow-up|1
1401332|NCT01212770|4625879|P9|Long-term Safety Phase (Year 5)|Death|0
1401333|NCT01212770|4625880|P8|Long-term Safety Phase (Year 5)|Death|1
1401334|NCT01212770|4625881|P7|Long-term Safety Phase (Year 5)|Death|0
1401335|NCT01212770|4625882|P6|Long-term Safety Phase (Year 5)|Death|0
1401336|NCT01212770|4625883|P5|Long-term Safety Phase (Year 5)|Death|0
1401337|NCT01212770|4625884|P4|Long-term Safety Phase (Year 5)|Death|0
1401338|NCT01212770|4625885|P3|Long-term Safety Phase (Year 5)|Death|0
1401339|NCT01212770|4625886|P2|Long-term Safety Phase (Year 5)|Death|0
1401340|NCT01212770|4625887|P1|Long-term Safety Phase (Year 5)|Death|0
1401341|NCT01212770|4625879|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1401342|NCT01212770|4625880|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
1401343|NCT01212770|4625881|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1401344|NCT01212770|4625882|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1401345|NCT01212770|4625883|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1401346|NCT01212770|4625884|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1401347|NCT01212770|4625885|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
1401348|NCT01212770|4625886|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
1401349|NCT01212770|4625887|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1401350|NCT01212770|4625879|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1401351|NCT01212770|4625880|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1401352|NCT01212770|4625881|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1401353|NCT01212770|4625882|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1401354|NCT01212770|4625883|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1401355|NCT01212770|4625884|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1401356|NCT01212770|4625885|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
1401357|NCT01212770|4625886|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1401358|NCT01212770|4625887|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1401359|NCT01212770|4625879|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
1401360|NCT01212770|4625880|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
1401361|NCT01212770|4625881|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
1401362|NCT01212770|4625882|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
1401363|NCT01212770|4625883|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
1401364|NCT01212770|4625884|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
1401365|NCT01212770|4625885|P3|Long-term Safety Phase (Year 5)|Adverse Event|2
1401366|NCT01212770|4625886|P2|Long-term Safety Phase (Year 5)|Adverse Event|0
1401367|NCT01212770|4625887|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
1401368|NCT01212770|4625879|P9|Long-term Safety Phase (Year 5)|Miscellaneous|0
1401369|NCT01212770|4625880|P8|Long-term Safety Phase (Year 5)|Miscellaneous|0
1401370|NCT01212770|4625881|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
1401371|NCT01212770|4625882|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
1401372|NCT01212770|4625883|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
1401373|NCT01212770|4625884|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
1401374|NCT01212770|4625885|P3|Long-term Safety Phase (Year 5)|Miscellaneous|3
1401375|NCT01212770|4625886|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
1401376|NCT01212770|4625887|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
1401377|NCT01212770|4625879|P9|Long-term Safety Phase (Year 5)|Missing|0
1401378|NCT01212770|4625880|P8|Long-term Safety Phase (Year 5)|Missing|0
1401379|NCT01212770|4625881|P7|Long-term Safety Phase (Year 5)|Missing|0
1401380|NCT01212770|4625882|P6|Long-term Safety Phase (Year 5)|Missing|0
1401381|NCT01212770|4625883|P5|Long-term Safety Phase (Year 5)|Missing|0
1401382|NCT01212770|4625884|P4|Long-term Safety Phase (Year 5)|Missing|0
1401383|NCT01212770|4625885|P3|Long-term Safety Phase (Year 5)|Missing|1
1401384|NCT01212770|4625886|P2|Long-term Safety Phase (Year 5)|Missing|0
1401385|NCT01212770|4625887|P1|Long-term Safety Phase (Year 5)|Missing|0
1401386|NCT01212770|4625879|P9|Long-term Safety Phase (Year 4)|Miscellaneous|1
1401387|NCT01212770|4625880|P8|Long-term Safety Phase (Year 4)|Miscellaneous|0
1401388|NCT01212770|4625881|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
1401389|NCT01212770|4625882|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
1401390|NCT01212770|4625883|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
1401391|NCT01212770|4625884|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
1401392|NCT01212770|4625885|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
1401393|NCT01212770|4625886|P2|Long-term Safety Phase (Year 4)|Miscellaneous|1
1401394|NCT01212770|4625887|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
1401395|NCT01212770|4625879|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1401396|NCT01212770|4625880|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1401397|NCT01212770|4625881|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1401398|NCT01212770|4625882|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1401399|NCT01212770|4625883|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1401400|NCT01212770|4625884|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1401401|NCT01212770|4625885|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
1401402|NCT01212770|4625886|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1401403|NCT01212770|4625887|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1401404|NCT01212770|4625879|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1401405|NCT01212770|4625880|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1401406|NCT01212770|4625881|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1401407|NCT01212770|4625882|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1401408|NCT01212770|4625883|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1401409|NCT01212770|4625884|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1401410|NCT01212770|4625885|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
1401411|NCT01212770|4625886|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
1401412|NCT01212770|4625887|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1401413|NCT01212770|4625879|P9|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1401414|NCT01212770|4625880|P8|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
1401415|NCT01212770|4625881|P7|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1401416|NCT01212770|4625882|P6|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1401417|NCT01212770|4625883|P5|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1401418|NCT01212770|4625884|P4|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1401419|NCT01212770|4625885|P3|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
1401420|NCT01212770|4625886|P2|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
1401421|NCT01212770|4625887|P1|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1401422|NCT01212770|4625879|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1401423|NCT01212770|4625880|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
1401424|NCT01212770|4625881|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1401425|NCT01212770|4625882|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1401426|NCT01212770|4625883|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1401427|NCT01212770|4625884|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1401428|NCT01212770|4625885|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
1401429|NCT01212770|4625886|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
1401430|NCT01212770|4625887|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1401431|NCT01212770|4625879|P9|Long-term Safety Phase (Year 4)|Adverse Event|1
1401432|NCT01212770|4625880|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
1401433|NCT01212770|4625881|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
1401434|NCT01212770|4625882|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
1401435|NCT01212770|4625883|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
1401436|NCT01212770|4625884|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
1401437|NCT01212770|4625885|P3|Long-term Safety Phase (Year 4)|Adverse Event|1
1401438|NCT01212770|4625886|P2|Long-term Safety Phase (Year 4)|Adverse Event|1
1401439|NCT01212770|4625887|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
1401440|NCT01212770|4625879|P9|Long-term Safety Phase (Year 3)|Miscellaneous|1
1401441|NCT01212770|4625880|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
1401442|NCT01212770|4625881|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
1401443|NCT01212770|4625882|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
1401444|NCT01212770|4625883|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
1401445|NCT01212770|4625884|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
1401446|NCT01212770|4625885|P3|Long-term Safety Phase (Year 3)|Miscellaneous|1
1401447|NCT01212770|4625886|P2|Long-term Safety Phase (Year 3)|Miscellaneous|2
1401448|NCT01212770|4625887|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
1401449|NCT01212770|4625879|P9|Long-term Safety Phase (Year 3)|Protocol Violation|0
1401450|NCT01212770|4625880|P8|Long-term Safety Phase (Year 3)|Protocol Violation|1
1401451|NCT01212770|4625881|P7|Long-term Safety Phase (Year 3)|Protocol Violation|0
1401452|NCT01212770|4625882|P6|Long-term Safety Phase (Year 3)|Protocol Violation|0
1401453|NCT01212770|4625883|P5|Long-term Safety Phase (Year 3)|Protocol Violation|0
1401454|NCT01212770|4625884|P4|Long-term Safety Phase (Year 3)|Protocol Violation|0
1401455|NCT01212770|4625885|P3|Long-term Safety Phase (Year 3)|Protocol Violation|0
1401456|NCT01212770|4625886|P2|Long-term Safety Phase (Year 3)|Protocol Violation|0
1401457|NCT01212770|4625887|P1|Long-term Safety Phase (Year 3)|Protocol Violation|0
1401458|NCT01212770|4625879|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1401459|NCT01212770|4625880|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1401460|NCT01212770|4625881|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1401461|NCT01212770|4625882|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1401462|NCT01212770|4625883|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1401463|NCT01212770|4625884|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1401464|NCT01212770|4625885|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1401465|NCT01212770|4625886|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
1401466|NCT01212770|4625887|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1401467|NCT01212770|4625879|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
1401468|NCT01212770|4625880|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
1401469|NCT01212770|4625881|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1401470|NCT01212770|4625882|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1401471|NCT01212770|4625883|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1401472|NCT01212770|4625884|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1401473|NCT01212770|4625885|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
1401474|NCT01212770|4625886|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
1401475|NCT01212770|4625887|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1401476|NCT01212770|4625879|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
1401477|NCT01212770|4625880|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
1401478|NCT01212770|4625881|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1401479|NCT01212770|4625882|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1401480|NCT01212770|4625883|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1401481|NCT01212770|4625884|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1401482|NCT01212770|4625885|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
1401483|NCT01212770|4625886|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
1401484|NCT01212770|4625887|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1401485|NCT01212770|4625879|P9|Long-term Safety Phase (Year 3)|Adverse Event|1
1401486|NCT01212770|4625880|P8|Long-term Safety Phase (Year 3)|Adverse Event|2
1401487|NCT01212770|4625881|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
1401488|NCT01212770|4625882|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
1401489|NCT01212770|4625883|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
1401490|NCT01212770|4625884|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
1401491|NCT01212770|4625885|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
1401492|NCT01212770|4625886|P2|Long-term Safety Phase (Year 3)|Adverse Event|2
1401493|NCT01212770|4625887|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
1401494|NCT01212770|4625879|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
1401495|NCT01212770|4625880|P8|Long-term Safety Phase (Year 2)|Miscellaneous|0
1401496|NCT01212770|4625881|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
1401497|NCT01212770|4625882|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
1401498|NCT01212770|4625883|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
1401499|NCT01212770|4625884|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
1401718|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 4)|Death|0
1401500|NCT01212770|4625885|P3|Long-term Safety Phase (Year 2)|Miscellaneous|1
1401501|NCT01212770|4625886|P2|Long-term Safety Phase (Year 2)|Miscellaneous|2
1401502|NCT01212770|4625887|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
1401503|NCT01212770|4625879|P9|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
1401504|NCT01212770|4625880|P8|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
1401505|NCT01212770|4625881|P7|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
1401506|NCT01212770|4625882|P6|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
1401507|NCT01212770|4625883|P5|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
1401508|NCT01212770|4625884|P4|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
1401509|NCT01212770|4625885|P3|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
1401510|NCT01212770|4625886|P2|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
1401511|NCT01212770|4625887|P1|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
1401512|NCT01212770|4625879|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
1401513|NCT01212770|4625880|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
1401514|NCT01212770|4625881|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1401515|NCT01212770|4625882|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1401516|NCT01212770|4625883|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1401517|NCT01212770|4625884|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1401518|NCT01212770|4625885|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
1401519|NCT01212770|4625886|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
1401520|NCT01212770|4625887|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1401521|NCT01212770|4625879|P9|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1401522|NCT01212770|4625880|P8|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1401523|NCT01212770|4625881|P7|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1401524|NCT01212770|4625882|P6|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1401525|NCT01212770|4625883|P5|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1401526|NCT01212770|4625884|P4|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1401527|NCT01212770|4625885|P3|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1401528|NCT01212770|4625886|P2|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
1401529|NCT01212770|4625887|P1|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1401530|NCT01212770|4625879|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
1401531|NCT01212770|4625880|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
1401532|NCT01212770|4625881|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1401533|NCT01212770|4625882|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1401534|NCT01212770|4625883|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1401535|NCT01212770|4625884|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1401536|NCT01212770|4625885|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
1401537|NCT01212770|4625886|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
1401538|NCT01212770|4625887|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1401539|NCT01212770|4625879|P9|Long-term Safety Phase (Year 2)|Adverse Event|2
1401540|NCT01212770|4625880|P8|Long-term Safety Phase (Year 2)|Adverse Event|0
1401541|NCT01212770|4625881|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
1401542|NCT01212770|4625882|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
1401543|NCT01212770|4625883|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
1401544|NCT01212770|4625884|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
1401545|NCT01212770|4625885|P3|Long-term Safety Phase (Year 2)|Adverse Event|3
1401546|NCT01212770|4625886|P2|Long-term Safety Phase (Year 2)|Adverse Event|3
1401547|NCT01212770|4625887|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
1401548|NCT01212770|4625879|P9|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1401549|NCT01212770|4625880|P8|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1401550|NCT01212770|4625881|P7|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1401551|NCT01212770|4625882|P6|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1401552|NCT01212770|4625883|P5|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1401553|NCT01212770|4625884|P4|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
1401554|NCT01212770|4625885|P3|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
1401555|NCT01212770|4625886|P2|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1401556|NCT01212770|4625887|P1|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1401557|NCT01212770|4625879|P9|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1401558|NCT01212770|4625880|P8|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1401559|NCT01212770|4625881|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1401560|NCT01212770|4625882|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1401561|NCT01212770|4625883|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1401562|NCT01212770|4625884|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
1401563|NCT01212770|4625885|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1401564|NCT01212770|4625886|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1401565|NCT01212770|4625887|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1401566|NCT01212770|4625879|P9|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1401567|NCT01212770|4625880|P8|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1401568|NCT01212770|4625881|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1401569|NCT01212770|4625882|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1401570|NCT01212770|4625883|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1401571|NCT01212770|4625884|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1401572|NCT01212770|4625885|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
1401573|NCT01212770|4625886|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1401574|NCT01212770|4625887|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1401575|NCT01212770|4625879|P9|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
1401576|NCT01212770|4625880|P8|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
1401577|NCT01212770|4625881|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
1401578|NCT01212770|4625882|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
1401579|NCT01212770|4625883|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
1401580|NCT01212770|4625884|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
1401581|NCT01212770|4625885|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
1401582|NCT01212770|4625886|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
1401583|NCT01212770|4625887|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
1401584|NCT01212770|4625879|P9|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
1401585|NCT01212770|4625880|P8|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
1401586|NCT01212770|4625881|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
1401587|NCT01212770|4625882|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
1401588|NCT01212770|4625883|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
1401589|NCT01212770|4625884|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
1401590|NCT01212770|4625885|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
1401591|NCT01212770|4625886|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
1401592|NCT01212770|4625887|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
1401593|NCT01212770|4625879|P9|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
1401594|NCT01212770|4625880|P8|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
1401595|NCT01212770|4625881|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
1401596|NCT01212770|4625882|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
1401597|NCT01212770|4625883|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
1401598|NCT01212770|4625884|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
1401599|NCT01212770|4625885|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
1401600|NCT01212770|4625886|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
1401601|NCT01212770|4625887|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
1401602|NCT01212770|4625879|P9|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1401603|NCT01212770|4625880|P8|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1401604|NCT01212770|4625881|P7|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1401605|NCT01212770|4625882|P6|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1401606|NCT01212770|4625883|P5|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1401607|NCT01212770|4625884|P4|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1401608|NCT01212770|4625885|P3|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
1401609|NCT01212770|4625886|P2|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
1401610|NCT01212770|4625887|P1|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
1401611|NCT01212770|4625879|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1401612|NCT01212770|4625880|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1401613|NCT01212770|4625881|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1401614|NCT01212770|4625882|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1401615|NCT01212770|4625883|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1401616|NCT01212770|4625884|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1401617|NCT01212770|4625885|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
1401618|NCT01212770|4625886|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1401619|NCT01212770|4625887|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1401620|NCT01212770|4625879|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1401621|NCT01212770|4625880|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1401622|NCT01212770|4625881|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1401623|NCT01212770|4625882|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1401624|NCT01212770|4625883|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1401625|NCT01212770|4625884|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1401626|NCT01212770|4625885|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
1401627|NCT01212770|4625886|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1401628|NCT01212770|4625887|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
1401629|NCT01212770|4625879|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1401630|NCT01212770|4625880|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1401631|NCT01212770|4625881|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1401632|NCT01212770|4625882|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1401633|NCT01212770|4625883|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1401634|NCT01212770|4625884|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1401635|NCT01212770|4625885|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
1401636|NCT01212770|4625886|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
1401637|NCT01212770|4625887|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
1401638|NCT01212770|4625879|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1401639|NCT01212770|4625880|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1401640|NCT01212770|4625881|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1401641|NCT01212770|4625882|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1401642|NCT01212770|4625883|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1401643|NCT01212770|4625884|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1401644|NCT01212770|4625885|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
1401645|NCT01212770|4625886|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
1401646|NCT01212770|4625887|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
1401647|NCT01212770|4625879|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1401648|NCT01212770|4625880|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1401649|NCT01212770|4625881|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1401650|NCT01212770|4625882|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1401651|NCT01212770|4625883|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1401652|NCT01212770|4625884|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1401653|NCT01212770|4625885|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
1401654|NCT01212770|4625886|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
1401655|NCT01212770|4625887|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
1401656|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1401657|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1401658|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1401659|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1401660|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1401661|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1401662|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 5)|Miscellaneous|1
1401663|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 5)|Miscellaneous|1
1401664|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1401665|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1401666|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1401667|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1401668|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1401669|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1401670|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1401671|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1401672|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
1401673|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1401674|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
1401675|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
1401676|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
1401677|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
1401678|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
1401679|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
1401680|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
1401681|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
1401682|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
1401683|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 5)|Adverse Event|0
1401684|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 5)|Adverse Event|2
1401685|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 5)|Adverse Event|0
1401686|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 5)|Adverse Event|0
1401687|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 5)|Adverse Event|0
1401688|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 5)|Adverse Event|0
1401689|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 5)|Adverse Event|2
1401690|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 5)|Adverse Event|2
1401691|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 5)|Adverse Event|0
1401692|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
1401693|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
1401694|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
1401695|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
1401696|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
1401697|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
1401698|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
1401699|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
1401700|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
1401701|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1401702|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
1401703|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1401704|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1401705|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1401706|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1401707|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1401708|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1401709|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1401710|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 4)|Death|1
1401711|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 4)|Death|0
1401712|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 4)|Death|0
1401713|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 4)|Death|0
1401714|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 4)|Death|0
1401715|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 4)|Death|0
1401716|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 4)|Death|1
1401717|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 4)|Death|0
1401719|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
1401720|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
1401721|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
1401722|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
1401723|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
1401724|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
1401725|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
1401726|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
1401727|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
1401728|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
1401729|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
1401730|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
1401731|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
1401732|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
1401733|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
1401734|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
1401735|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
1401736|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
1401737|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 4)|Adverse Event|1
1401738|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 4)|Adverse Event|1
1401739|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 4)|Adverse Event|0
1401740|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 4)|Adverse Event|0
1401741|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 4)|Adverse Event|0
1401742|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 4)|Adverse Event|0
1401743|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 4)|Adverse Event|2
1401744|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 4)|Adverse Event|1
1401745|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 4)|Adverse Event|0
1401746|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 4)|Miscellaneous|1
1401747|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1401748|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1401749|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1401750|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1401751|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1401752|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1401753|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 4)|Miscellaneous|2
1401754|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1401755|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 3)|Miscellaneous|2
1401756|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1401757|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1401758|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1401759|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1401760|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1401761|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 3)|Miscellaneous|3
1401762|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1401763|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1401764|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1401765|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1401766|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1401767|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1401768|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1401769|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1401770|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1401771|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 3)|Protocol Violation|1
1401772|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1401773|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
1401774|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1401775|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1401776|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1401777|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1401778|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1401779|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1401780|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1401781|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1401782|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
1401783|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
1401784|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
1401785|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
1401786|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
1401787|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
1401788|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
1401789|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
1401790|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
1401791|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1401792|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1401793|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1401794|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1401795|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1401796|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1401797|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
1401798|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1401799|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1401800|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
1401801|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
1401802|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
1401803|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
1401804|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
1401805|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
1401806|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
1401807|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
1401808|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
1401809|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 3)|Adverse Event|0
1401810|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 3)|Adverse Event|2
1401811|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 3)|Adverse Event|0
1401812|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 3)|Adverse Event|0
1401813|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 3)|Adverse Event|0
1401814|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 3)|Adverse Event|0
1401815|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 3)|Adverse Event|1
1401816|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 3)|Adverse Event|4
1401817|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 3)|Adverse Event|0
1401818|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1401819|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1401820|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1401821|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1401822|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1401823|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1401824|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
1401825|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1401826|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1401827|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
1401828|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
1401829|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
1401830|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
1401831|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
1401832|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
1401833|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
1401834|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
1401835|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
1401836|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1401837|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
1401838|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1401839|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1401840|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1401841|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1401842|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
1401843|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
1401844|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1401845|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 2)|Adverse Event|2
1401846|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 2)|Adverse Event|2
1401847|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 2)|Adverse Event|0
1401848|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 2)|Adverse Event|0
1401849|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 2)|Adverse Event|0
1401850|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 2)|Adverse Event|0
1401851|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 2)|Adverse Event|1
1401852|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 2)|Adverse Event|1
1401853|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 2)|Adverse Event|0
1401854|NCT01212757|4626084|P9|Long-Term Safety Phase (Year 2)|Miscellaneous|1
1401855|NCT01212757|4626085|P8|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1401856|NCT01212757|4626086|P7|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1401857|NCT01212757|4626087|P6|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1401858|NCT01212757|4626088|P5|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1401859|NCT01212757|4626089|P4|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1401860|NCT01212757|4626090|P3|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1401861|NCT01212757|4626091|P2|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1401862|NCT01212757|4626092|P1|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1401863|NCT01212757|4626084|P9|Active Treatment Phase (Weeks 24 - 52)|Other|0
1401864|NCT01212757|4626085|P8|Active Treatment Phase (Weeks 24 - 52)|Other|0
1401865|NCT01212757|4626086|P7|Active Treatment Phase (Weeks 24 - 52)|Other|0
1401866|NCT01212757|4626087|P6|Active Treatment Phase (Weeks 24 - 52)|Other|0
1401867|NCT01212757|4626088|P5|Active Treatment Phase (Weeks 24 - 52)|Other|0
1401868|NCT01212757|4626089|P4|Active Treatment Phase (Weeks 24 - 52)|Other|0
1401869|NCT01212757|4626090|P3|Active Treatment Phase (Weeks 24 - 52)|Other|1
1401870|NCT01212757|4626091|P2|Active Treatment Phase (Weeks 24 - 52)|Other|1
1401871|NCT01212757|4626092|P1|Active Treatment Phase (Weeks 24 - 52)|Other|0
1401872|NCT01212757|4626084|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1401873|NCT01212757|4626085|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1401874|NCT01212757|4626086|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1401875|NCT01212757|4626087|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1401876|NCT01212757|4626088|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
1401877|NCT01212757|4626089|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1401878|NCT01212757|4626090|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1401879|NCT01212757|4626091|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
1401880|NCT01212757|4626092|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1401881|NCT01212757|4626084|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1401882|NCT01212757|4626085|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1401883|NCT01212757|4626086|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1401884|NCT01212757|4626087|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
1401885|NCT01212757|4626088|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
1401886|NCT01212757|4626089|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
1401887|NCT01212757|4626090|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
1401888|NCT01212757|4626091|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
1401889|NCT01212757|4626092|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1401890|NCT01212757|4626084|P9|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1401891|NCT01212757|4626085|P8|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1401892|NCT01212757|4626086|P7|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1401893|NCT01212757|4626087|P6|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1401894|NCT01212757|4626088|P5|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1401895|NCT01212757|4626089|P4|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1401896|NCT01212757|4626090|P3|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
1401897|NCT01212757|4626091|P2|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1401898|NCT01212757|4626092|P1|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1401899|NCT01212757|4626084|P9|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
1401900|NCT01212757|4626085|P8|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
1401901|NCT01212757|4626086|P7|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
1401902|NCT01212757|4626087|P6|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
1401903|NCT01212757|4626088|P5|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
1401904|NCT01212757|4626089|P4|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
1401905|NCT01212757|4626090|P3|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
1401906|NCT01212757|4626091|P2|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
1401907|NCT01212757|4626092|P1|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
1401908|NCT01212757|4626084|P9|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
1401909|NCT01212757|4626085|P8|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
1401910|NCT01212757|4626086|P7|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
1401911|NCT01212757|4626087|P6|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
1401912|NCT01212757|4626088|P5|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
1401913|NCT01212757|4626089|P4|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
1401914|NCT01212757|4626090|P3|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
1401915|NCT01212757|4626091|P2|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
1401916|NCT01212757|4626092|P1|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
1401917|NCT01212757|4626084|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
1401918|NCT01212757|4626085|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
1401919|NCT01212757|4626086|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
1401920|NCT01212757|4626087|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
1401921|NCT01212757|4626088|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
1401922|NCT01212757|4626089|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
1401923|NCT01212757|4626090|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
1401924|NCT01212757|4626091|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
1401925|NCT01212757|4626092|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
1401926|NCT01212757|4626084|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1401927|NCT01212757|4626085|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1401928|NCT01212757|4626086|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1401929|NCT01212757|4626087|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1401930|NCT01212757|4626088|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1401931|NCT01212757|4626089|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1401932|NCT01212757|4626090|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
1401933|NCT01212757|4626091|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
1401934|NCT01212757|4626092|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1401935|NCT01212757|4626084|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1401936|NCT01212757|4626085|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1401937|NCT01212757|4626086|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1401938|NCT01212757|4626087|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1401939|NCT01212757|4626088|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1401940|NCT01212757|4626089|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1401941|NCT01212757|4626090|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
1401942|NCT01212757|4626091|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
1401943|NCT01212757|4626092|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
1401944|NCT01212757|4626084|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1401945|NCT01212757|4626085|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1401946|NCT01212757|4626086|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1401947|NCT01212757|4626087|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1401948|NCT01212757|4626088|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1401949|NCT01212757|4626089|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1401950|NCT01212757|4626090|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
1401951|NCT01212757|4626091|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1401952|NCT01212757|4626092|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
1401953|NCT01212757|4626084|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1401954|NCT01212757|4626085|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1401955|NCT01212757|4626086|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1401956|NCT01212757|4626087|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1401957|NCT01212757|4626088|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1401958|NCT01212757|4626089|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1401959|NCT01212757|4626090|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
1401960|NCT01212757|4626091|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
1401961|NCT01212757|4626092|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
1401962|NCT01212757|4626084|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1401963|NCT01212757|4626085|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1401964|NCT01212757|4626086|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1401965|NCT01212757|4626087|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1401966|NCT01212757|4626088|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1401967|NCT01212757|4626089|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1401968|NCT01212757|4626090|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
1401969|NCT01212757|4626091|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
1401970|NCT01212757|4626092|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
1401971|NCT01212757|4626084|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1401972|NCT01212757|4626085|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1401973|NCT01212757|4626086|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1401974|NCT01212757|4626087|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1401975|NCT01212757|4626088|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1401976|NCT01212757|4626089|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1401977|NCT01212757|4626090|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
1401978|NCT01212757|4626091|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
1401979|NCT01212757|4626092|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
1401980|NCT01212185|4626331|P2|Overall Study|Protocol Violation|1
1401981|NCT01212185|4626332|P1|Overall Study|Protocol Violation|2
1401982|NCT01212159|4626351|P2|Overall Study|Withdrawal by Subject|12
1401983|NCT01212159|4626352|P1|Overall Study|Withdrawal by Subject|12
1401984|NCT01212094|4626365|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
1401985|NCT01212094|4626366|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
1401986|NCT01212094|4626367|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
1401987|NCT01212094|4626365|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
1401988|NCT01212094|4626366|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
1401989|NCT01212094|4626367|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
1401990|NCT01212094|4626365|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
1401991|NCT01212094|4626366|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
1401992|NCT01212094|4626367|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
1401993|NCT01212094|4626365|P3|Year 1: Baseline Monitoring|Started on DMT|0
1401994|NCT01212094|4626366|P2|Year 1: Baseline Monitoring|Started on DMT|0
1401995|NCT01212094|4626367|P1|Year 1: Baseline Monitoring|Started on DMT|2
1401996|NCT01212094|4626365|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
1401997|NCT01212094|4626366|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
1401998|NCT01212094|4626367|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
1401999|NCT01212094|4626365|P3|Year 1: Baseline Monitoring|Study terminated|0
1402000|NCT01212094|4626366|P2|Year 1: Baseline Monitoring|Study terminated|0
1402001|NCT01212094|4626367|P1|Year 1: Baseline Monitoring|Study terminated|7
1402002|NCT01211769|4626414|P4|Overall Study|Adverse Event|1
1402003|NCT01211769|4626415|P3|Overall Study|Adverse Event|1
1402004|NCT01211769|4626416|P2|Overall Study|Adverse Event|1
1402005|NCT01211769|4626417|P1|Overall Study|Adverse Event|0
1402006|NCT01211769|4626414|P4|Overall Study|Physician Decision|1
1402007|NCT01211769|4626415|P3|Overall Study|Physician Decision|2
1402008|NCT01211769|4626416|P2|Overall Study|Physician Decision|0
1402009|NCT01211769|4626417|P1|Overall Study|Physician Decision|2
1402010|NCT01211769|4626414|P4|Overall Study|Lost to Follow-up|9
1402011|NCT01211769|4626415|P3|Overall Study|Lost to Follow-up|5
1402012|NCT01211769|4626416|P2|Overall Study|Lost to Follow-up|9
1402013|NCT01211769|4626417|P1|Overall Study|Lost to Follow-up|7
1402014|NCT01211665|4626456|P2|Overall Study|Death|0
1402015|NCT01211665|4626457|P1|Overall Study|Death|1
1402016|NCT01211665|4626456|P2|Overall Study|Withdrawal by Subject|0
1402017|NCT01211665|4626457|P1|Overall Study|Withdrawal by Subject|1
1402018|NCT01211613|4626484|P3|Overall Study|Withdrawal by Subject|0
1402019|NCT01211613|4626485|P2|Overall Study|Withdrawal by Subject|0
1402020|NCT01211613|4626486|P1|Overall Study|Withdrawal by Subject|1
1402021|NCT01211613|4626484|P3|Overall Study|Lost to Follow-up|2
1402022|NCT01211613|4626485|P2|Overall Study|Lost to Follow-up|2
1402023|NCT01211613|4626486|P1|Overall Study|Lost to Follow-up|2
1402024|NCT01211535|4626499|P2|Overall Study|Adverse Event|1
1402025|NCT01211535|4626500|P1|Overall Study|Adverse Event|0
1402026|NCT01211197|4626519|P6|Washout Period 2 (7 Days)|Adverse Event|0
1402027|NCT01211197|4626520|P5|Washout Period 2 (7 Days)|Adverse Event|0
1402028|NCT01211197|4626521|P4|Washout Period 2 (7 Days)|Adverse Event|0
1402029|NCT01211197|4626522|P3|Washout Period 2 (7 Days)|Adverse Event|0
1402030|NCT01211197|4626523|P2|Washout Period 2 (7 Days)|Adverse Event|0
1402031|NCT01211197|4626524|P1|Washout Period 2 (7 Days)|Adverse Event|1
1402032|NCT01211197|4626519|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1402033|NCT01211197|4626520|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1402034|NCT01211197|4626521|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1402035|NCT01211197|4626522|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1402036|NCT01211197|4626523|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1402037|NCT01211197|4626524|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1402038|NCT01211184|4626571|P3|Overall Study|Withdrawal by Subject|1
1402039|NCT01211184|4626572|P2|Overall Study|Withdrawal by Subject|2
1402040|NCT01211184|4626573|P1|Overall Study|Withdrawal by Subject|0
1402041|NCT01211145|4626588|P4|Overall Study|Patient decision|2
1402042|NCT01211145|4626589|P3|Overall Study|Patient decision|0
1402043|NCT01211145|4626590|P2|Overall Study|Patient decision|1
1402044|NCT01211145|4626591|P1|Overall Study|Patient decision|2
1402045|NCT01211145|4626588|P4|Overall Study|Eligibility criteria not fulfilled|15
1402046|NCT01211145|4626589|P3|Overall Study|Eligibility criteria not fulfilled|10
1402047|NCT01211145|4626590|P2|Overall Study|Eligibility criteria not fulfilled|12
1402048|NCT01211145|4626591|P1|Overall Study|Eligibility criteria not fulfilled|16
1402049|NCT01211145|4626588|P4|Overall Study|Severe noncompliance to protocol|0
1402050|NCT01211145|4626589|P3|Overall Study|Severe noncompliance to protocol|0
1402051|NCT01211145|4626590|P2|Overall Study|Severe noncompliance to protocol|0
1402052|NCT01211145|4626591|P1|Overall Study|Severe noncompliance to protocol|1
1402053|NCT01211145|4626588|P4|Overall Study|Study-specific withdrawal criteria|0
1402054|NCT01211145|4626589|P3|Overall Study|Study-specific withdrawal criteria|0
1402055|NCT01211145|4626590|P2|Overall Study|Study-specific withdrawal criteria|0
1402056|NCT01211145|4626591|P1|Overall Study|Study-specific withdrawal criteria|1
1402057|NCT01211145|4626588|P4|Overall Study|Lost to Follow-up|2
1402058|NCT01211145|4626589|P3|Overall Study|Lost to Follow-up|1
1402059|NCT01211145|4626590|P2|Overall Study|Lost to Follow-up|2
1402060|NCT01211145|4626591|P1|Overall Study|Lost to Follow-up|3
1402061|NCT01211145|4626588|P4|Overall Study|Reason not specified|1
1402062|NCT01211145|4626589|P3|Overall Study|Reason not specified|2
1402063|NCT01211145|4626590|P2|Overall Study|Reason not specified|2
1402064|NCT01211145|4626591|P1|Overall Study|Reason not specified|3
1402065|NCT01210807|4626645|P2|Overall Study|Not implanted bilaterally|1
1402066|NCT01210807|4626646|P1|Overall Study|Not implanted bilaterally|2
1402067|NCT01210807|4626645|P2|Overall Study|Lost to Follow-up|2
1402068|NCT01210807|4626646|P1|Overall Study|Lost to Follow-up|1
1402069|NCT01210690|4626661|P1|Overall Study|Patient could not take glucose|1
1402070|NCT01210690|4626661|P1|Overall Study|Patient refused to swallow|1
1402071|NCT01210690|4626661|P1|Overall Study|Withdrawal by Subject|1
1402072|NCT01210690|4626661|P1|Overall Study|Disease Remission|1
1402073|NCT01210690|4626661|P1|Overall Study|Lost to Follow-up|3
1402074|NCT01210690|4626661|P1|Overall Study|Lack of Efficacy|12
1402075|NCT01210690|4626661|P1|Overall Study|Adverse Event|7
1402076|NCT01210664|4626674|P4|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
1402077|NCT01210664|4626675|P3|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
1402078|NCT01210664|4626676|P2|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
1402079|NCT01210664|4626677|P1|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
1402080|NCT01210664|4626674|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
1402081|NCT01210664|4626675|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
1402082|NCT01210664|4626676|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
1402083|NCT01210664|4626677|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
1402084|NCT01210664|4626674|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
1402085|NCT01210664|4626675|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
1402086|NCT01210664|4626676|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
1402087|NCT01210664|4626677|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
1402088|NCT01210651|4626705|P2|Overall Study|Injury outside study|0
1402089|NCT01210651|4626706|P1|Overall Study|Injury outside study|2
1402090|NCT01210651|4626705|P2|Overall Study|Withdrawal by Subject|1
1402091|NCT01210651|4626706|P1|Overall Study|Withdrawal by Subject|1
1402092|NCT01210651|4626705|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
1402093|NCT01210651|4626706|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
1402094|NCT01210651|4626705|P2|Overall Study|schedule conflicts|5
1402095|NCT01210651|4626706|P1|Overall Study|schedule conflicts|1
1402096|NCT01210651|4626705|P2|Overall Study|Lost to Follow-up|1
1402097|NCT01210651|4626706|P1|Overall Study|Lost to Follow-up|1
1402098|NCT01210495|4626826|P4|Overall Study|Other unspecified|0
1402099|NCT01210495|4626827|P3|Overall Study|Other unspecified|6
1402100|NCT01210495|4626828|P2|Overall Study|Other unspecified|0
1402101|NCT01210495|4626829|P1|Overall Study|Other unspecified|0
1402102|NCT01210495|4626826|P4|Overall Study|Lost to Follow-up|1
1402103|NCT01210495|4626827|P3|Overall Study|Lost to Follow-up|1
1402104|NCT01210495|4626828|P2|Overall Study|Lost to Follow-up|0
1402105|NCT01210495|4626829|P1|Overall Study|Lost to Follow-up|0
1402106|NCT01210495|4626826|P4|Overall Study|Study Terminated by Sponsor|11
1402107|NCT01210495|4626827|P3|Overall Study|Study Terminated by Sponsor|4
1402108|NCT01210495|4626828|P2|Overall Study|Study Terminated by Sponsor|0
1402109|NCT01210495|4626829|P1|Overall Study|Study Terminated by Sponsor|0
1402110|NCT01210495|4626826|P4|Overall Study|Death|54
1402111|NCT01210495|4626827|P3|Overall Study|Death|112
1402112|NCT01210495|4626828|P2|Overall Study|Death|7
1402113|NCT01210495|4626829|P1|Overall Study|Death|14
1402114|NCT01210495|4626826|P4|Overall Study|Participant Refused Further Follow-Up|2
1402115|NCT01210495|4626827|P3|Overall Study|Participant Refused Further Follow-Up|11
1402116|NCT01210495|4626828|P2|Overall Study|Participant Refused Further Follow-Up|0
1402117|NCT01210495|4626829|P1|Overall Study|Participant Refused Further Follow-Up|1
1402118|NCT01210443|4626891|P1|Overall Study|Study terminated by sponsor|2
1402119|NCT01210222|4626899|P1|Overall Study|Never treated|1
1402120|NCT01210222|4626899|P1|Overall Study|Ineligible|2
1402121|NCT01210144|4626935|P2|Overall Study|No transfer|0
1402122|NCT01210144|4626936|P1|Overall Study|No transfer|1
1402123|NCT01210144|4626935|P2|Overall Study|No fertilization|0
1402124|NCT01210144|4626936|P1|Overall Study|No fertilization|1
1402125|NCT01210144|4626935|P2|Overall Study|Lack of ovarian response|0
1402126|NCT01210144|4626936|P1|Overall Study|Lack of ovarian response|1
1402127|NCT01210118|4626958|P2|Overall Study|Spontaneous abortion|3
1402128|NCT01210118|4626959|P1|Overall Study|Spontaneous abortion|1
1402129|NCT01210118|4626958|P2|Overall Study|Protocol Violation|1
1402130|NCT01210118|4626959|P1|Overall Study|Protocol Violation|1
1402131|NCT01210118|4626958|P2|Overall Study|Lost to Follow-up|1
1402132|NCT01210118|4626959|P1|Overall Study|Lost to Follow-up|1
1402133|NCT01210001|4626983|P3|Overall Study|Other reason not defined above|1
1402134|NCT01210001|4626984|P2|Overall Study|Other reason not defined above|2
1402135|NCT01210001|4626985|P1|Overall Study|Other reason not defined above|2
1402136|NCT01210001|4626983|P3|Overall Study|Patient refusal to continue,not due toAE|1
1402137|NCT01210001|4626984|P2|Overall Study|Patient refusal to continue,not due toAE|2
1402138|NCT01210001|4626985|P1|Overall Study|Patient refusal to continue,not due toAE|6
1402139|NCT01210001|4626983|P3|Overall Study|Lost to Follow-up|2
1402140|NCT01210001|4626984|P2|Overall Study|Lost to Follow-up|3
1402141|NCT01210001|4626985|P1|Overall Study|Lost to Follow-up|4
1402142|NCT01210001|4626983|P3|Overall Study|Non compliant with protocol|3
1402143|NCT01210001|4626984|P2|Overall Study|Non compliant with protocol|2
1402144|NCT01210001|4626985|P1|Overall Study|Non compliant with protocol|2
1402145|NCT01210001|4626983|P3|Overall Study|Adverse Event|5
1402146|NCT01210001|4626984|P2|Overall Study|Adverse Event|2
1402147|NCT01210001|4626985|P1|Overall Study|Adverse Event|4
1402148|NCT01210001|4626983|P3|Overall Study|Not treated|0
1402149|NCT01210001|4626984|P2|Overall Study|Not treated|0
1402150|NCT01210001|4626985|P1|Overall Study|Not treated|1
1402151|NCT01209949|4627005|P1|Overall Study|Lost to Follow-up|3
1402152|NCT01209780|4627015|P5|Overall Study|Inappropriate enrollment|1
1402153|NCT01209780|4627016|P4|Overall Study|Inappropriate enrollment|0
1402154|NCT01209780|4627017|P3|Overall Study|Inappropriate enrollment|0
1402155|NCT01209780|4627018|P2|Overall Study|Inappropriate enrollment|2
1402156|NCT01209780|4627019|P1|Overall Study|Inappropriate enrollment|0
1402157|NCT01209780|4627015|P5|Overall Study|Protocol Violation|0
1402158|NCT01209780|4627016|P4|Overall Study|Protocol Violation|0
1402159|NCT01209780|4627017|P3|Overall Study|Protocol Violation|0
1402160|NCT01209780|4627018|P2|Overall Study|Protocol Violation|1
1402161|NCT01209780|4627019|P1|Overall Study|Protocol Violation|0
1402162|NCT01209780|4627015|P5|Overall Study|Lost to Follow-up|4
1402163|NCT01209780|4627016|P4|Overall Study|Lost to Follow-up|9
1402164|NCT01209780|4627017|P3|Overall Study|Lost to Follow-up|3
1402165|NCT01209780|4627018|P2|Overall Study|Lost to Follow-up|12
1402166|NCT01209780|4627019|P1|Overall Study|Lost to Follow-up|17
1402167|NCT01209780|4627015|P5|Overall Study|Withdrawal by Subject|0
1402168|NCT01209780|4627016|P4|Overall Study|Withdrawal by Subject|1
1402169|NCT01209780|4627017|P3|Overall Study|Withdrawal by Subject|1
1402170|NCT01209780|4627018|P2|Overall Study|Withdrawal by Subject|2
1402171|NCT01209780|4627019|P1|Overall Study|Withdrawal by Subject|9
1402172|NCT01209780|4627015|P5|Overall Study|Adverse Event|0
1402173|NCT01209780|4627016|P4|Overall Study|Adverse Event|0
1402174|NCT01209780|4627017|P3|Overall Study|Adverse Event|0
1402175|NCT01209780|4627018|P2|Overall Study|Adverse Event|1
1402176|NCT01209780|4627019|P1|Overall Study|Adverse Event|0
1402177|NCT01209767|4627045|P1|Overall Study|Lost to Follow-up|3
1402178|NCT01209767|4627045|P1|Overall Study|Withdrawal by Subject|1
1402179|NCT01209689|4627114|P2|Overall Study|Sponsor's Decision to Stop the Study|17
1402180|NCT01209689|4627115|P1|Overall Study|Sponsor's Decision to Stop the Study|68
1402181|NCT01209689|4627114|P2|Overall Study|Failure to Return|0
1402182|NCT01209689|4627115|P1|Overall Study|Failure to Return|3
1402183|NCT01209689|4627114|P2|Overall Study|Violation of Selection Criteria at Entry|0
1402184|NCT01209689|4627115|P1|Overall Study|Violation of Selection Criteria at Entry|1
1402185|NCT01209689|4627114|P2|Overall Study|Adverse Event|0
1402186|NCT01209689|4627115|P1|Overall Study|Adverse Event|4
1402187|NCT01209689|4627114|P2|Overall Study|Refused Treatment|3
1402188|NCT01209689|4627115|P1|Overall Study|Refused Treatment|8
1402189|NCT01209689|4627114|P2|Overall Study|Insufficient Therapeutic Response|2
1402190|NCT01209689|4627115|P1|Overall Study|Insufficient Therapeutic Response|7
1402191|NCT01209624|4627121|P1|Overall Study|Other|4
1402192|NCT01209624|4627121|P1|Overall Study|Lost to Follow-up|290
1402193|NCT01209624|4627121|P1|Overall Study|Lack of Efficacy|17
1402194|NCT01209624|4627121|P1|Overall Study|Adverse Event|13
1402195|NCT01209624|4627121|P1|Overall Study|Death|2
1402196|NCT01209598|4627154|P2|Overall Study|Withdrawal by Subject|0
1402197|NCT01209598|4627155|P1|Overall Study|Withdrawal by Subject|1
1402198|NCT01209520|4627163|P1|Overall Study|Withdrawal by Subject|3
1402199|NCT01209286|4627171|P3|Overall Study|Other|0
1402200|NCT01209286|4627172|P2|Overall Study|Other|1
1402201|NCT01209286|4627173|P1|Overall Study|Other|0
1402202|NCT01209286|4627171|P3|Overall Study|Physician Decision|0
1402203|NCT01209286|4627172|P2|Overall Study|Physician Decision|2
1402204|NCT01209286|4627173|P1|Overall Study|Physician Decision|0
1402205|NCT01209286|4627171|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
1402206|NCT01209286|4627172|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
1402207|NCT01209286|4627173|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
1402208|NCT01209286|4627171|P3|Overall Study|Hematological Relapse After Remission|1
1402209|NCT01209286|4627172|P2|Overall Study|Hematological Relapse After Remission|1
1402210|NCT01209286|4627173|P1|Overall Study|Hematological Relapse After Remission|0
1402211|NCT01209286|4627171|P3|Overall Study|Adverse Event|1
1402212|NCT01209286|4627172|P2|Overall Study|Adverse Event|3
1402213|NCT01209286|4627173|P1|Overall Study|Adverse Event|4
1402214|NCT01209143|4627282|P2|Overall Study|Disease progression|16
1402215|NCT01209143|4627283|P1|Overall Study|Disease progression|11
1402216|NCT01209143|4627282|P2|Overall Study|Withdrawal by Subject|1
1402217|NCT01209143|4627283|P1|Overall Study|Withdrawal by Subject|2
1402218|NCT01209143|4627282|P2|Overall Study|Lost to Follow-up|0
1402219|NCT01209143|4627283|P1|Overall Study|Lost to Follow-up|1
1402220|NCT01209143|4627282|P2|Overall Study|Physician Decision|1
1402221|NCT01209143|4627283|P1|Overall Study|Physician Decision|3
1402222|NCT01209143|4627282|P2|Overall Study|Death|1
1402223|NCT01209143|4627283|P1|Overall Study|Death|0
1402224|NCT01209143|4627282|P2|Overall Study|Adverse Event|1
1402225|NCT01209143|4627283|P1|Overall Study|Adverse Event|2
1402226|NCT01209078|4627293|P2|Overall Study|Withdrawal by Subject|1
1402227|NCT01209078|4627294|P1|Overall Study|Withdrawal by Subject|2
1402228|NCT01209078|4627293|P2|Overall Study|Physician Decision|2
1402229|NCT01209078|4627294|P1|Overall Study|Physician Decision|5
1402230|NCT01209078|4627293|P2|Overall Study|Lost to Follow-up|0
1402231|NCT01209078|4627294|P1|Overall Study|Lost to Follow-up|4
1402232|NCT01209078|4627293|P2|Overall Study|Adverse Event|0
1402233|NCT01209078|4627294|P1|Overall Study|Adverse Event|5
1402234|NCT01208961|4627369|P2|High-Fat Period III|Protocol Violation|0
1402235|NCT01208961|4627370|P1|High-Fat Period III|Protocol Violation|1
1402236|NCT01208870|4627381|P2|Overall Study|Lost to Follow-up|8
1402237|NCT01208870|4627382|P1|Overall Study|Lost to Follow-up|2
1402238|NCT01208415|4627398|P1|Overall Study|Still be eligible for follow-up|33
1402239|NCT01208415|4627398|P1|Overall Study|Device not placed|1
1402240|NCT01208415|4627398|P1|Overall Study|Withdrawal by Subject|3
1402241|NCT01208415|4627398|P1|Overall Study|Lost to Follow-up|2
1402242|NCT01208415|4627398|P1|Overall Study|Death|1
1402243|NCT01208402|4627404|P2|Overall Study|Withdrawal by Subject|0
1402244|NCT01208402|4627405|P1|Overall Study|Withdrawal by Subject|1
1402245|NCT01208337|4627421|P1|Overall Study|Death|3
1402246|NCT01208233|4627435|P6|Overall Study|Withdrawal by Subject|2
1402247|NCT01208233|4627436|P5|Overall Study|Withdrawal by Subject|4
1402248|NCT01208233|4627437|P4|Overall Study|Withdrawal by Subject|1
1402249|NCT01208233|4627438|P3|Overall Study|Withdrawal by Subject|1
1402250|NCT01208233|4627439|P2|Overall Study|Withdrawal by Subject|0
1402251|NCT01208233|4627440|P1|Overall Study|Withdrawal by Subject|1
1402252|NCT01208233|4627435|P6|Overall Study|Other|1
1402253|NCT01208233|4627436|P5|Overall Study|Other|0
1402254|NCT01208233|4627437|P4|Overall Study|Other|0
1402255|NCT01208233|4627438|P3|Overall Study|Other|0
1402256|NCT01208233|4627439|P2|Overall Study|Other|1
1402257|NCT01208233|4627440|P1|Overall Study|Other|2
1402258|NCT01208233|4627435|P6|Overall Study|Protocol Violation|0
1402259|NCT01208233|4627436|P5|Overall Study|Protocol Violation|3
1402260|NCT01208233|4627437|P4|Overall Study|Protocol Violation|0
1402261|NCT01208233|4627438|P3|Overall Study|Protocol Violation|0
1402262|NCT01208233|4627439|P2|Overall Study|Protocol Violation|0
1402263|NCT01208233|4627440|P1|Overall Study|Protocol Violation|0
1402264|NCT01208233|4627435|P6|Overall Study|Study terminated by sponsor|7
1402265|NCT01208233|4627436|P5|Overall Study|Study terminated by sponsor|10
1402266|NCT01208233|4627437|P4|Overall Study|Study terminated by sponsor|0
1402267|NCT01208233|4627438|P3|Overall Study|Study terminated by sponsor|0
1402268|NCT01208233|4627439|P2|Overall Study|Study terminated by sponsor|0
1402269|NCT01208233|4627440|P1|Overall Study|Study terminated by sponsor|0
1402270|NCT01208233|4627435|P6|Overall Study|Medication error without adverse event|1
1402271|NCT01208233|4627436|P5|Overall Study|Medication error without adverse event|0
1402272|NCT01208233|4627437|P4|Overall Study|Medication error without adverse event|0
1402273|NCT01208233|4627438|P3|Overall Study|Medication error without adverse event|0
1402274|NCT01208233|4627439|P2|Overall Study|Medication error without adverse event|0
1402275|NCT01208233|4627440|P1|Overall Study|Medication error without adverse event|0
1402276|NCT01208233|4627435|P6|Overall Study|Did not meet entrance criteria|0
1402277|NCT01208233|4627436|P5|Overall Study|Did not meet entrance criteria|1
1402278|NCT01208233|4627437|P4|Overall Study|Did not meet entrance criteria|0
1402279|NCT01208233|4627438|P3|Overall Study|Did not meet entrance criteria|1
1402280|NCT01208233|4627439|P2|Overall Study|Did not meet entrance criteria|1
1402281|NCT01208233|4627440|P1|Overall Study|Did not meet entrance criteria|2
1402282|NCT01208233|4627435|P6|Overall Study|Death|5
1402283|NCT01208233|4627436|P5|Overall Study|Death|3
1402284|NCT01208233|4627437|P4|Overall Study|Death|0
1402285|NCT01208233|4627438|P3|Overall Study|Death|0
1402286|NCT01208233|4627439|P2|Overall Study|Death|0
1402287|NCT01208233|4627440|P1|Overall Study|Death|0
1402288|NCT01208233|4627435|P6|Overall Study|Adverse Event|5
1402289|NCT01208233|4627436|P5|Overall Study|Adverse Event|3
1402290|NCT01208233|4627437|P4|Overall Study|Adverse Event|0
1402291|NCT01208233|4627438|P3|Overall Study|Adverse Event|2
1402292|NCT01208233|4627439|P2|Overall Study|Adverse Event|1
1402293|NCT01208233|4627440|P1|Overall Study|Adverse Event|0
1402294|NCT01208207|4627565|P7|Part II|Technical Problems|0
1402295|NCT01208207|4627566|P6|Part II|Technical Problems|1
1402296|NCT01208207|4627567|P5|Part II|Technical Problems|0
1402297|NCT01208207|4627568|P4|Part II|Technical Problems|1
1402298|NCT01208207|4627569|P3|Part II|Technical Problems|0
1402299|NCT01208207|4627570|P2|Part II|Technical Problems|0
1402300|NCT01208207|4627571|P1|Part II|Technical Problems|0
1402301|NCT01208207|4627565|P7|Part II|Protocol Violation|0
1402302|NCT01208207|4627566|P6|Part II|Protocol Violation|0
1402303|NCT01208207|4627567|P5|Part II|Protocol Violation|0
1402304|NCT01208207|4627568|P4|Part II|Protocol Violation|1
1402305|NCT01208207|4627569|P3|Part II|Protocol Violation|0
1402306|NCT01208207|4627570|P2|Part II|Protocol Violation|0
1402307|NCT01208207|4627571|P1|Part II|Protocol Violation|0
1402308|NCT01208207|4627565|P7|Part II|Physician Decision|0
1402309|NCT01208207|4627566|P6|Part II|Physician Decision|2
1402310|NCT01208207|4627567|P5|Part II|Physician Decision|0
1402311|NCT01208207|4627568|P4|Part II|Physician Decision|1
1402312|NCT01208207|4627569|P3|Part II|Physician Decision|0
1402313|NCT01208207|4627570|P2|Part II|Physician Decision|0
1402314|NCT01208207|4627571|P1|Part II|Physician Decision|0
1402315|NCT01208207|4627565|P7|Part II|Non-Compliance With Study Drug|0
1402316|NCT01208207|4627566|P6|Part II|Non-Compliance With Study Drug|1
1402317|NCT01208207|4627567|P5|Part II|Non-Compliance With Study Drug|1
1402318|NCT01208207|4627568|P4|Part II|Non-Compliance With Study Drug|4
1402319|NCT01208207|4627569|P3|Part II|Non-Compliance With Study Drug|0
1402320|NCT01208207|4627570|P2|Part II|Non-Compliance With Study Drug|0
1402321|NCT01208207|4627571|P1|Part II|Non-Compliance With Study Drug|0
1402322|NCT01208207|4627565|P7|Part II|Lost to Follow-up|1
1402323|NCT01208207|4627566|P6|Part II|Lost to Follow-up|2
1402324|NCT01208207|4627567|P5|Part II|Lost to Follow-up|0
1402325|NCT01208207|4627568|P4|Part II|Lost to Follow-up|4
1402326|NCT01208207|4627569|P3|Part II|Lost to Follow-up|0
1402327|NCT01208207|4627570|P2|Part II|Lost to Follow-up|0
1402328|NCT01208207|4627571|P1|Part II|Lost to Follow-up|0
1402329|NCT01208207|4627565|P7|Part II|Lack of Efficacy|3
1402330|NCT01208207|4627566|P6|Part II|Lack of Efficacy|3
1402331|NCT01208207|4627567|P5|Part II|Lack of Efficacy|4
1402332|NCT01208207|4627568|P4|Part II|Lack of Efficacy|6
1402333|NCT01208207|4627569|P3|Part II|Lack of Efficacy|0
1402334|NCT01208207|4627570|P2|Part II|Lack of Efficacy|0
1402335|NCT01208207|4627571|P1|Part II|Lack of Efficacy|0
1402336|NCT01208207|4627565|P7|Part II|Adverse Event|2
1402337|NCT01208207|4627566|P6|Part II|Adverse Event|4
1402338|NCT01208207|4627567|P5|Part II|Adverse Event|9
1402339|NCT01208207|4627568|P4|Part II|Adverse Event|5
1402340|NCT01208207|4627569|P3|Part II|Adverse Event|0
1402341|NCT01208207|4627570|P2|Part II|Adverse Event|0
1402342|NCT01208207|4627571|P1|Part II|Adverse Event|0
1402343|NCT01208207|4627565|P7|Part II|Withdrawal by Subject|5
1402344|NCT01208207|4627566|P6|Part II|Withdrawal by Subject|3
1402345|NCT01208207|4627567|P5|Part II|Withdrawal by Subject|9
1402346|NCT01208207|4627568|P4|Part II|Withdrawal by Subject|10
1402347|NCT01208207|4627569|P3|Part II|Withdrawal by Subject|0
1402348|NCT01208207|4627570|P2|Part II|Withdrawal by Subject|0
1402349|NCT01208207|4627571|P1|Part II|Withdrawal by Subject|0
1402350|NCT01208207|4627565|P7|Part I|Withdrawal by Subject|0
1402351|NCT01208207|4627566|P6|Part I|Withdrawal by Subject|0
1402352|NCT01208207|4627567|P5|Part I|Withdrawal by Subject|0
1402353|NCT01208207|4627568|P4|Part I|Withdrawal by Subject|0
1402354|NCT01208207|4627569|P3|Part I|Withdrawal by Subject|4
1402355|NCT01208207|4627570|P2|Part I|Withdrawal by Subject|4
1402356|NCT01208207|4627571|P1|Part I|Withdrawal by Subject|14
1402357|NCT01208207|4627565|P7|Part I|Protocol Violation|0
1402358|NCT01208207|4627566|P6|Part I|Protocol Violation|0
1402359|NCT01208207|4627567|P5|Part I|Protocol Violation|0
1402360|NCT01208207|4627568|P4|Part I|Protocol Violation|0
1402361|NCT01208207|4627569|P3|Part I|Protocol Violation|2
1402362|NCT01208207|4627570|P2|Part I|Protocol Violation|0
1402363|NCT01208207|4627571|P1|Part I|Protocol Violation|8
1402364|NCT01208207|4627565|P7|Part I|Progressive Disease|0
1402365|NCT01208207|4627566|P6|Part I|Progressive Disease|0
1402366|NCT01208207|4627567|P5|Part I|Progressive Disease|0
1402367|NCT01208207|4627568|P4|Part I|Progressive Disease|0
1402368|NCT01208207|4627569|P3|Part I|Progressive Disease|0
1402369|NCT01208207|4627570|P2|Part I|Progressive Disease|0
1402370|NCT01208207|4627571|P1|Part I|Progressive Disease|1
1402371|NCT01208207|4627565|P7|Part I|Physician Decision|0
1402372|NCT01208207|4627566|P6|Part I|Physician Decision|0
1402373|NCT01208207|4627567|P5|Part I|Physician Decision|0
1402374|NCT01208207|4627568|P4|Part I|Physician Decision|0
1402375|NCT01208207|4627569|P3|Part I|Physician Decision|0
1402376|NCT01208207|4627570|P2|Part I|Physician Decision|1
1402377|NCT01208207|4627571|P1|Part I|Physician Decision|0
1402378|NCT01208207|4627565|P7|Part I|Non-Compliance With Study Drug|0
1402379|NCT01208207|4627566|P6|Part I|Non-Compliance With Study Drug|0
1402380|NCT01208207|4627567|P5|Part I|Non-Compliance With Study Drug|0
1402381|NCT01208207|4627568|P4|Part I|Non-Compliance With Study Drug|0
1402382|NCT01208207|4627569|P3|Part I|Non-Compliance With Study Drug|1
1402383|NCT01208207|4627570|P2|Part I|Non-Compliance With Study Drug|0
1402384|NCT01208207|4627571|P1|Part I|Non-Compliance With Study Drug|1
1402385|NCT01208207|4627565|P7|Part I|Lost to Follow-up|0
1402386|NCT01208207|4627566|P6|Part I|Lost to Follow-up|0
1402387|NCT01208207|4627567|P5|Part I|Lost to Follow-up|0
1402388|NCT01208207|4627568|P4|Part I|Lost to Follow-up|0
1402389|NCT01208207|4627569|P3|Part I|Lost to Follow-up|0
1402390|NCT01208207|4627570|P2|Part I|Lost to Follow-up|1
1402391|NCT01208207|4627571|P1|Part I|Lost to Follow-up|6
1402392|NCT01208207|4627565|P7|Part I|Lack of Efficacy|0
1402393|NCT01208207|4627566|P6|Part I|Lack of Efficacy|0
1402394|NCT01208207|4627567|P5|Part I|Lack of Efficacy|0
1402395|NCT01208207|4627568|P4|Part I|Lack of Efficacy|0
1402396|NCT01208207|4627569|P3|Part I|Lack of Efficacy|2
1402397|NCT01208207|4627570|P2|Part I|Lack of Efficacy|3
1402398|NCT01208207|4627571|P1|Part I|Lack of Efficacy|21
1402399|NCT01208207|4627565|P7|Part I|Adverse Event|0
1402400|NCT01208207|4627566|P6|Part I|Adverse Event|0
1402401|NCT01208207|4627567|P5|Part I|Adverse Event|0
1402402|NCT01208207|4627568|P4|Part I|Adverse Event|0
1402403|NCT01208207|4627569|P3|Part I|Adverse Event|6
1402404|NCT01208207|4627570|P2|Part I|Adverse Event|2
1402405|NCT01208207|4627571|P1|Part I|Adverse Event|19
1402406|NCT01208181|4627598|P5|Part 2|Lack of Efficacy|0
1402407|NCT01208181|4627599|P4|Part 2|Lack of Efficacy|7
1402408|NCT01208181|4627600|P3|Part 2|Lack of Efficacy|5
1402409|NCT01208181|4627601|P2|Part 2|Lack of Efficacy|0
1402410|NCT01208181|4627602|P1|Part 2|Lack of Efficacy|0
1402411|NCT01208181|4627598|P5|Part 2|Lost to Follow-up|0
1402412|NCT01208181|4627599|P4|Part 2|Lost to Follow-up|2
1402413|NCT01208181|4627600|P3|Part 2|Lost to Follow-up|1
1402414|NCT01208181|4627601|P2|Part 2|Lost to Follow-up|0
1402415|NCT01208181|4627602|P1|Part 2|Lost to Follow-up|0
1402416|NCT01208181|4627598|P5|Part 2|Non-compliance with study drug|0
1402417|NCT01208181|4627599|P4|Part 2|Non-compliance with study drug|1
1402418|NCT01208181|4627600|P3|Part 2|Non-compliance with study drug|1
1402419|NCT01208181|4627601|P2|Part 2|Non-compliance with study drug|0
1402420|NCT01208181|4627602|P1|Part 2|Non-compliance with study drug|0
1402421|NCT01208181|4627598|P5|Part 2|Physician Decision|0
1402422|NCT01208181|4627599|P4|Part 2|Physician Decision|2
1402423|NCT01208181|4627600|P3|Part 2|Physician Decision|1
1402424|NCT01208181|4627601|P2|Part 2|Physician Decision|0
1402425|NCT01208181|4627602|P1|Part 2|Physician Decision|0
1402426|NCT01208181|4627598|P5|Part 2|Protocol Violation|0
1402427|NCT01208181|4627599|P4|Part 2|Protocol Violation|0
1402428|NCT01208181|4627600|P3|Part 2|Protocol Violation|1
1402429|NCT01208181|4627601|P2|Part 2|Protocol Violation|0
1402430|NCT01208181|4627602|P1|Part 2|Protocol Violation|0
1402431|NCT01208181|4627598|P5|Part 2|Withdrawal by Subject|0
1402432|NCT01208181|4627599|P4|Part 2|Withdrawal by Subject|1
1402433|NCT01208181|4627600|P3|Part 2|Withdrawal by Subject|1
1402434|NCT01208181|4627601|P2|Part 2|Withdrawal by Subject|0
1402435|NCT01208181|4627602|P1|Part 2|Withdrawal by Subject|0
1402436|NCT01208181|4627598|P5|Part 2|Adverse Event|0
1402437|NCT01208181|4627599|P4|Part 2|Adverse Event|7
1402438|NCT01208181|4627600|P3|Part 2|Adverse Event|6
1402439|NCT01208181|4627601|P2|Part 2|Adverse Event|0
1402440|NCT01208181|4627602|P1|Part 2|Adverse Event|0
1402441|NCT01208181|4627598|P5|Part 1|Adverse Event|4
1402442|NCT01208181|4627599|P4|Part 1|Adverse Event|0
1402443|NCT01208181|4627600|P3|Part 1|Adverse Event|0
1402444|NCT01208181|4627601|P2|Part 1|Adverse Event|24
1402445|NCT01208181|4627602|P1|Part 1|Adverse Event|26
1402446|NCT01208181|4627598|P5|Part 1|Lack of Efficacy|17
1402447|NCT01208181|4627599|P4|Part 1|Lack of Efficacy|0
1402448|NCT01208181|4627600|P3|Part 1|Lack of Efficacy|0
1402449|NCT01208181|4627601|P2|Part 1|Lack of Efficacy|12
1402450|NCT01208181|4627602|P1|Part 1|Lack of Efficacy|37
1402451|NCT01208181|4627598|P5|Part 1|Lost to Follow-up|1
1402452|NCT01208181|4627599|P4|Part 1|Lost to Follow-up|0
1402453|NCT01208181|4627600|P3|Part 1|Lost to Follow-up|0
1402454|NCT01208181|4627601|P2|Part 1|Lost to Follow-up|3
1402455|NCT01208181|4627602|P1|Part 1|Lost to Follow-up|5
1402456|NCT01208181|4627598|P5|Part 1|Non-compliance with study drug|0
1402457|NCT01208181|4627599|P4|Part 1|Non-compliance with study drug|0
1402458|NCT01208181|4627600|P3|Part 1|Non-compliance with study drug|0
1402459|NCT01208181|4627601|P2|Part 1|Non-compliance with study drug|1
1402460|NCT01208181|4627602|P1|Part 1|Non-compliance with study drug|1
1402461|NCT01208181|4627598|P5|Part 1|Physician Decision|0
1402462|NCT01208181|4627599|P4|Part 1|Physician Decision|0
1402463|NCT01208181|4627600|P3|Part 1|Physician Decision|0
1402464|NCT01208181|4627601|P2|Part 1|Physician Decision|0
1402465|NCT01208181|4627602|P1|Part 1|Physician Decision|4
1402466|NCT01208181|4627598|P5|Part 1|Protocol Violation|0
1402467|NCT01208181|4627599|P4|Part 1|Protocol Violation|0
1402468|NCT01208181|4627600|P3|Part 1|Protocol Violation|0
1402469|NCT01208181|4627601|P2|Part 1|Protocol Violation|5
1402470|NCT01208181|4627602|P1|Part 1|Protocol Violation|10
1402471|NCT01208181|4627598|P5|Part 1|Technical problem|0
1402472|NCT01208181|4627599|P4|Part 1|Technical problem|0
1402473|NCT01208181|4627600|P3|Part 1|Technical problem|0
1402474|NCT01208181|4627601|P2|Part 1|Technical problem|0
1402475|NCT01208181|4627602|P1|Part 1|Technical problem|5
1402476|NCT01208181|4627598|P5|Part 1|Withdrawal by Subject|0
1402477|NCT01208181|4627599|P4|Part 1|Withdrawal by Subject|0
1402478|NCT01208181|4627600|P3|Part 1|Withdrawal by Subject|0
1402479|NCT01208181|4627601|P2|Part 1|Withdrawal by Subject|10
1402480|NCT01208181|4627602|P1|Part 1|Withdrawal by Subject|11
1402481|NCT01207687|4627659|P1|Overall Study|Withdrawal by Subject|1
1402482|NCT01207687|4627659|P1|Overall Study|Adverse Event|1
1402483|NCT01207596|4627697|P1|Overall Study|Withdrawal by Subject|1
1402484|NCT01207596|4627697|P1|Overall Study|Adverse Event|3
1402485|NCT01207596|4627697|P1|Overall Study|Lack of Efficacy|1
1402486|NCT01207596|4627697|P1|Overall Study|Physician Decision|4
1402487|NCT01207583|4627710|P3|Overall Study|Lost to Follow-up|0
1402488|NCT01207583|4627711|P2|Overall Study|Lost to Follow-up|2
1402489|NCT01207583|4627712|P1|Overall Study|Lost to Follow-up|0
1402490|NCT01207583|4627710|P3|Overall Study|Participant failed to return|0
1402491|NCT01207583|4627711|P2|Overall Study|Participant failed to return|0
1402492|NCT01207583|4627712|P1|Overall Study|Participant failed to return|1
1402493|NCT01207583|4627710|P3|Overall Study|Withdrawal by Subject|1
1402494|NCT01207583|4627711|P2|Overall Study|Withdrawal by Subject|3
1402495|NCT01207583|4627712|P1|Overall Study|Withdrawal by Subject|0
1402496|NCT01207492|4627765|P1|Overall Study|Toxicity|1
1402497|NCT01207492|4627765|P1|Overall Study|Progressive disease|3
1402498|NCT01207492|4627765|P1|Overall Study|Physician Decision|1
1402499|NCT01207492|4627765|P1|Overall Study|Withdrawal by Subject|9
1402500|NCT01207492|4627765|P1|Overall Study|Still on study|1
1402501|NCT01207453|4627780|P2|2nd Intervention|Lost to Follow-up|0
1402502|NCT01207453|4627781|P1|2nd Intervention|Lost to Follow-up|1
1402503|NCT01207453|4627780|P2|2nd Intervention|Adverse Event|2
1402504|NCT01207453|4627781|P1|2nd Intervention|Adverse Event|1
1402505|NCT01207453|4627780|P2|Washout|Lost to Follow-up|0
1402506|NCT01207453|4627781|P1|Washout|Lost to Follow-up|1
1402507|NCT01207453|4627780|P2|Washout|Adverse Event|0
1402508|NCT01207453|4627781|P1|Washout|Adverse Event|1
1402509|NCT01207453|4627780|P2|First Intervention|Adverse Event|1
1402510|NCT01207453|4627781|P1|First Intervention|Adverse Event|2
1402511|NCT01207427|4627803|P3|Double-blind Treatment Period|Withdrawal by Subject|0
1402512|NCT01207427|4627804|P2|Double-blind Treatment Period|Withdrawal by Subject|0
1402513|NCT01207427|4627805|P1|Double-blind Treatment Period|Withdrawal by Subject|1
1402514|NCT01207427|4627803|P3|Double-blind Treatment Period|Protocol Violation|1
1402515|NCT01207427|4627804|P2|Double-blind Treatment Period|Protocol Violation|1
1402516|NCT01207427|4627805|P1|Double-blind Treatment Period|Protocol Violation|2
1402517|NCT01207427|4627803|P3|Double-blind Treatment Period|Lost to Follow-up|1
1402518|NCT01207427|4627804|P2|Double-blind Treatment Period|Lost to Follow-up|0
1402519|NCT01207427|4627805|P1|Double-blind Treatment Period|Lost to Follow-up|0
1402520|NCT01207427|4627803|P3|Double-blind Treatment Period|Adverse Event|0
1402521|NCT01207427|4627804|P2|Double-blind Treatment Period|Adverse Event|1
1402522|NCT01207427|4627805|P1|Double-blind Treatment Period|Adverse Event|0
1402523|NCT01207414|4627815|P2|Overall Study|Randomized in error|0
1402524|NCT01207414|4627816|P1|Overall Study|Randomized in error|1
1402525|NCT01207414|4627815|P2|Overall Study|Protocol deviation|9
1402526|NCT01207414|4627816|P1|Overall Study|Protocol deviation|12
1402527|NCT01207414|4627815|P2|Overall Study|Administrative problems|1
1402528|NCT01207414|4627816|P1|Overall Study|Administrative problems|1
1402529|NCT01207414|4627815|P2|Overall Study|Lost to Follow-up|17
1402530|NCT01207414|4627816|P1|Overall Study|Lost to Follow-up|15
1402531|NCT01207414|4627815|P2|Overall Study|Patient withdrew consent|11
1402532|NCT01207414|4627816|P1|Overall Study|Patient withdrew consent|14
1402533|NCT01207414|4627815|P2|Overall Study|Unsatisfactory therapeutic effect|4
1402534|NCT01207414|4627816|P1|Overall Study|Unsatisfactory therapeutic effect|5
1402535|NCT01207414|4627815|P2|Overall Study|Abnormal test procedure results|1
1402536|NCT01207414|4627816|P1|Overall Study|Abnormal test procedure results|0
1402537|NCT01207414|4627815|P2|Overall Study|Adverse Event|39
1402538|NCT01207414|4627816|P1|Overall Study|Adverse Event|25
1402539|NCT01207388|4627841|P1|Overall Study|Other|1
1402540|NCT01207388|4627841|P1|Overall Study|Physician Decision|2
1402541|NCT01207388|4627841|P1|Overall Study|Disease Relapse|10
1402542|NCT01207388|4627841|P1|Overall Study|Adverse Event|20
1402543|NCT01207219|4627864|P3|Overall Study|Lost to Follow-up|6
1402544|NCT01207219|4627865|P2|Overall Study|Lost to Follow-up|8
1402545|NCT01207219|4627866|P1|Overall Study|Lost to Follow-up|6
1402546|NCT01207219|4627864|P3|Overall Study|changed diagnosis during study period|1
1402547|NCT01207219|4627865|P2|Overall Study|changed diagnosis during study period|3
1402548|NCT01207219|4627866|P1|Overall Study|changed diagnosis during study period|5
1402549|NCT01207102|4627886|P1|Overall Study|Withdrawal by Treating Physician|1
1402550|NCT01207102|4627886|P1|Overall Study|progression|2
1402551|NCT01207102|4627886|P1|Overall Study|Adverse Event|2
1402552|NCT01207102|4627886|P1|Overall Study|Withdrawal by Subject|5
1402553|NCT01206777|4627891|P1|Overall Study|Adverse Event|1
1402554|NCT01206777|4627891|P1|Overall Study|Death|1
1402555|NCT01206582|4627947|P2|Overall Study|Discontinued intervention before week 8|2
1402556|NCT01206582|4627948|P1|Overall Study|Discontinued intervention before week 8|1
1402557|NCT01206582|4627947|P2|Overall Study|Withdrew prior to study|0
1402558|NCT01206582|4627948|P1|Overall Study|Withdrew prior to study|1
1402559|NCT01206517|4627980|P6|Overall Study|Withdrawal by Subject|0
1402560|NCT01206517|4627981|P5|Overall Study|Withdrawal by Subject|1
1402561|NCT01206517|4627982|P4|Overall Study|Withdrawal by Subject|0
1402562|NCT01206517|4627983|P3|Overall Study|Withdrawal by Subject|2
1402563|NCT01206517|4627984|P2|Overall Study|Withdrawal by Subject|0
1402564|NCT01206517|4627985|P1|Overall Study|Withdrawal by Subject|0
1402565|NCT01206439|4628065|P1|Overall Study|subject did not meet inclusion criteria|1
1402566|NCT01206322|4628088|P4|Overall Study|Adverse Event|1
1402567|NCT01206322|4628089|P3|Overall Study|Adverse Event|0
1402568|NCT01206322|4628090|P2|Overall Study|Adverse Event|0
1402569|NCT01206322|4628091|P1|Overall Study|Adverse Event|0
1402570|NCT01206140|4628107|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
1402571|NCT01206140|4628108|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
1402572|NCT01206101|4628120|P2|Overall Study|Unclassified|0
1402573|NCT01206101|4628121|P1|Overall Study|Unclassified|1
1402574|NCT01206101|4628120|P2|Overall Study|Physician Decision|1
1402575|NCT01206101|4628121|P1|Overall Study|Physician Decision|0
1402576|NCT01206101|4628120|P2|Overall Study|Adverse Event|0
1402577|NCT01206101|4628121|P1|Overall Study|Adverse Event|1
1402578|NCT01205776|4628162|P2|3 Years Follow-up|Withdrawal by Subject|2
1402579|NCT01205776|4628163|P1|3 Years Follow-up|Withdrawal by Subject|1
1402580|NCT01205776|4628162|P2|3 Years Follow-up|Lost to Follow-up|22
1402581|NCT01205776|4628163|P1|3 Years Follow-up|Lost to Follow-up|15
1402582|NCT01205776|4628162|P2|2 Years Follow-up|Withdrawal by Subject|19
1402583|NCT01205776|4628163|P1|2 Years Follow-up|Withdrawal by Subject|4
1402584|NCT01205776|4628162|P2|2 Years Follow-up|Lost to Follow-up|13
1402585|NCT01205776|4628163|P1|2 Years Follow-up|Lost to Follow-up|12
1402586|NCT01205776|4628162|P2|1 Month Follow-up|Withdrawal by Subject|10
1402587|NCT01205776|4628163|P1|1 Month Follow-up|Withdrawal by Subject|5
1402588|NCT01205776|4628162|P2|1 Month Follow-up|Lost to Follow-up|2
1402589|NCT01205776|4628163|P1|1 Month Follow-up|Lost to Follow-up|0
1402590|NCT01205685|4628303|P1|Overall Study|Withdrawal by Subject|1
1402591|NCT01205685|4628303|P1|Overall Study|Disease Progression|10
1402592|NCT01205581|4628323|P6|Overall Study|Withdrawal by Subject|0
1402593|NCT01205581|4628324|P5|Overall Study|Withdrawal by Subject|0
1402594|NCT01205581|4628325|P4|Overall Study|Withdrawal by Subject|0
1402595|NCT01205581|4628326|P3|Overall Study|Withdrawal by Subject|0
1402596|NCT01205581|4628327|P2|Overall Study|Withdrawal by Subject|0
1402597|NCT01205581|4628328|P1|Overall Study|Withdrawal by Subject|1
1402598|NCT01205529|4628398|P1|Overall Study|No longer met criteria|30
1402599|NCT01205529|4628398|P1|Overall Study|Unstable post op|15
1402600|NCT01205529|4628398|P1|Overall Study|Physician Decision|4
1402601|NCT01205529|4628398|P1|Overall Study|Withdrawal by Subject|2
1402602|NCT01205529|4628398|P1|Overall Study|Procedure Cancelled|4
1402603|NCT01205451|4628421|P2|Overall Study|Withdrawal by Subject|9
1402604|NCT01205451|4628422|P1|Overall Study|Withdrawal by Subject|5
1402605|NCT01205451|4628421|P2|Overall Study|Lost to Follow-up|1
1402606|NCT01205451|4628422|P1|Overall Study|Lost to Follow-up|1
1402607|NCT01205438|4628467|P3|Overall Study|Sponsor Decision|1
1402608|NCT01205438|4628468|P2|Overall Study|Sponsor Decision|1
1402609|NCT01205438|4628469|P1|Overall Study|Sponsor Decision|0
1402610|NCT01205438|4628467|P3|Overall Study|Protocol Violation|4
1402611|NCT01205438|4628468|P2|Overall Study|Protocol Violation|7
1402612|NCT01205438|4628469|P1|Overall Study|Protocol Violation|2
1402613|NCT01205438|4628467|P3|Overall Study|Physician Decision|2
1402614|NCT01205438|4628468|P2|Overall Study|Physician Decision|3
1402615|NCT01205438|4628469|P1|Overall Study|Physician Decision|0
1402616|NCT01205438|4628467|P3|Overall Study|Withdrawal by Subject|19
1402617|NCT01205438|4628468|P2|Overall Study|Withdrawal by Subject|25
1402618|NCT01205438|4628469|P1|Overall Study|Withdrawal by Subject|19
1402619|NCT01205438|4628467|P3|Overall Study|Lost to Follow-up|8
1402620|NCT01205438|4628468|P2|Overall Study|Lost to Follow-up|7
1402621|NCT01205438|4628469|P1|Overall Study|Lost to Follow-up|6
1402622|NCT01205438|4628467|P3|Overall Study|Lack of Efficacy|14
1402623|NCT01205438|4628468|P2|Overall Study|Lack of Efficacy|11
1402624|NCT01205438|4628469|P1|Overall Study|Lack of Efficacy|14
1402625|NCT01205438|4628467|P3|Overall Study|Entry Criteria Not Met|13
1402626|NCT01205438|4628468|P2|Overall Study|Entry Criteria Not Met|15
1402627|NCT01205438|4628469|P1|Overall Study|Entry Criteria Not Met|16
1402628|NCT01205438|4628467|P3|Overall Study|Death|3
1402629|NCT01205438|4628468|P2|Overall Study|Death|1
1402630|NCT01205438|4628469|P1|Overall Study|Death|1
1402631|NCT01205438|4628467|P3|Overall Study|Adverse Event|24
1402632|NCT01205438|4628468|P2|Overall Study|Adverse Event|17
1402633|NCT01205438|4628469|P1|Overall Study|Adverse Event|19
1402634|NCT01205269|4628525|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
1402635|NCT01205269|4628526|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
1402636|NCT01205269|4628527|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
1402637|NCT01205269|4628528|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
1402638|NCT01205269|4628529|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
1402639|NCT01205269|4628530|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
1402640|NCT01205230|4628570|P2|Overall Study|Physician Decision|0
1402641|NCT01205230|4628571|P1|Overall Study|Physician Decision|1
1402642|NCT01205230|4628570|P2|Overall Study|Adverse Event|0
1402643|NCT01205230|4628571|P1|Overall Study|Adverse Event|4
1402644|NCT01205165|4628614|P1|Overall Study|Lost to Follow-up|2
1402645|NCT01205152|4628627|P1|Overall Study|Death|1
1402646|NCT01205126|4628640|P2|Maintenance Phase|Withdrawal by Subject|11
1402647|NCT01205126|4628641|P1|Maintenance Phase|Withdrawal by Subject|8
1402648|NCT01205126|4628640|P2|Maintenance Phase|Lost to Follow-up|5
1402649|NCT01205126|4628641|P1|Maintenance Phase|Lost to Follow-up|5
1402650|NCT01205126|4628640|P2|Maintenance Phase|Other|8
1402651|NCT01205126|4628641|P1|Maintenance Phase|Other|11
1402652|NCT01205126|4628640|P2|Maintenance Phase|Prohibited drugs used|0
1402653|NCT01205126|4628641|P1|Maintenance Phase|Prohibited drugs used|1
1402654|NCT01205126|4628640|P2|Maintenance Phase|More than the maximum dosage required|5
1402655|NCT01205126|4628641|P1|Maintenance Phase|More than the maximum dosage required|5
1402656|NCT01205126|4628640|P2|Maintenance Phase|Death|4
1402657|NCT01205126|4628641|P1|Maintenance Phase|Death|4
1402658|NCT01205126|4628640|P2|Maintenance Phase|Adverse Event|7
1402659|NCT01205126|4628641|P1|Maintenance Phase|Adverse Event|3
1402660|NCT01205126|4628640|P2|Between Titration & Maintenance Phase|Other|4
1402661|NCT01205126|4628641|P1|Between Titration & Maintenance Phase|Other|0
1402662|NCT01205126|4628640|P2|Titration Phase|Other|6
1402663|NCT01205126|4628641|P1|Titration Phase|Other|8
1402664|NCT01205126|4628640|P2|Titration Phase|More than maximum dosage required|3
1402665|NCT01205126|4628641|P1|Titration Phase|More than maximum dosage required|2
1402666|NCT01205126|4628640|P2|Titration Phase|No stable titration dose|0
1402667|NCT01205126|4628641|P1|Titration Phase|No stable titration dose|1
1402668|NCT01205126|4628640|P2|Titration Phase|Lost to Follow-up|2
1402669|NCT01205126|4628641|P1|Titration Phase|Lost to Follow-up|2
1402670|NCT01205126|4628640|P2|Titration Phase|Withdrawal by Subject|5
1402671|NCT01205126|4628641|P1|Titration Phase|Withdrawal by Subject|5
1402672|NCT01205126|4628640|P2|Titration Phase|Adverse Event|3
1402673|NCT01205126|4628641|P1|Titration Phase|Adverse Event|5
1402674|NCT01205035|4628659|P2|Overall Study|Physician Decision|0
1402675|NCT01205035|4628660|P1|Overall Study|Physician Decision|1
1402676|NCT01205035|4628659|P2|Overall Study|Withdrawal by Subject|0
1402677|NCT01205035|4628660|P1|Overall Study|Withdrawal by Subject|1
1402678|NCT01204918|4628677|P3|Overall Study|Withdrawal by Subject|5
1402679|NCT01204918|4628678|P2|Overall Study|Withdrawal by Subject|10
1402680|NCT01204918|4628679|P1|Overall Study|Withdrawal by Subject|4
1402681|NCT01204775|4628717|P2|Overall Study|Withdrawal by Subject|0
1402682|NCT01204775|4628718|P1|Overall Study|Withdrawal by Subject|1
1402683|NCT01204775|4628717|P2|Overall Study|Poor/non-compliance|1
1402684|NCT01204775|4628718|P1|Overall Study|Poor/non-compliance|0
1402685|NCT01204697|4628743|P2|Overall Study|Randomized, but not treated|1
1402686|NCT01204697|4628744|P1|Overall Study|Randomized, but not treated|0
1402687|NCT01204697|4628743|P2|Overall Study|Withdrawal by Subject|4
1402688|NCT01204697|4628744|P1|Overall Study|Withdrawal by Subject|2
1402689|NCT01204697|4628743|P2|Overall Study|Lost to Follow-up|4
1402690|NCT01204697|4628744|P1|Overall Study|Lost to Follow-up|3
1402691|NCT01204697|4628743|P2|Overall Study|Death|27
1402692|NCT01204697|4628744|P1|Overall Study|Death|26
1402693|NCT01204671|4628765|P5|Overall Study|Physician Decision|0
1402694|NCT01204671|4628766|P4|Overall Study|Physician Decision|1
1402695|NCT01204671|4628767|P3|Overall Study|Physician Decision|0
1402696|NCT01204671|4628768|P2|Overall Study|Physician Decision|0
1402697|NCT01204671|4628769|P1|Overall Study|Physician Decision|0
1402698|NCT01204671|4628765|P5|Overall Study|Unknown Completion Status|0
1402699|NCT01204671|4628766|P4|Overall Study|Unknown Completion Status|0
1402700|NCT01204671|4628767|P3|Overall Study|Unknown Completion Status|0
1402701|NCT01204671|4628768|P2|Overall Study|Unknown Completion Status|1
1402702|NCT01204671|4628769|P1|Overall Study|Unknown Completion Status|1
1402703|NCT01204671|4628765|P5|Overall Study|Lost to Follow-up|0
1402704|NCT01204671|4628766|P4|Overall Study|Lost to Follow-up|4
1402705|NCT01204671|4628767|P3|Overall Study|Lost to Follow-up|6
1402706|NCT01204671|4628768|P2|Overall Study|Lost to Follow-up|8
1402707|NCT01204671|4628769|P1|Overall Study|Lost to Follow-up|7
1402708|NCT01204671|4628765|P5|Overall Study|Withdrawal by Subject|3
1402709|NCT01204671|4628766|P4|Overall Study|Withdrawal by Subject|5
1402710|NCT01204671|4628767|P3|Overall Study|Withdrawal by Subject|4
1402711|NCT01204671|4628768|P2|Overall Study|Withdrawal by Subject|3
1402712|NCT01204671|4628769|P1|Overall Study|Withdrawal by Subject|2
1402713|NCT01204671|4628765|P5|Overall Study|Adverse Event|1
1402714|NCT01204671|4628766|P4|Overall Study|Adverse Event|3
1402715|NCT01204671|4628767|P3|Overall Study|Adverse Event|3
1402716|NCT01204671|4628768|P2|Overall Study|Adverse Event|3
1402717|NCT01204671|4628769|P1|Overall Study|Adverse Event|4
1402718|NCT01204658|4628831|P4|Primary Phase|Adverse Event|0
1402719|NCT01204658|4628832|P3|Primary Phase|Adverse Event|1
1402720|NCT01204658|4628833|P2|Primary Phase|Adverse Event|0
1402721|NCT01204658|4628834|P1|Primary Phase|Adverse Event|0
1402722|NCT01204398|4628944|P1|Overall Study|Adverse Event|1
1402723|NCT01204294|4628961|P7|Overall Study|Other (house moving)|0
1402724|NCT01204294|4628962|P6|Overall Study|Other (house moving)|0
1402725|NCT01204294|4628963|P5|Overall Study|Other (house moving)|0
1402726|NCT01204294|4628964|P4|Overall Study|Other (house moving)|0
1402727|NCT01204294|4628965|P3|Overall Study|Other (house moving)|1
1402728|NCT01204294|4628966|P2|Overall Study|Other (house moving)|0
1402729|NCT01204294|4628967|P1|Overall Study|Other (house moving)|0
1402730|NCT01204294|4628961|P7|Overall Study|Lack of Efficacy|0
1402731|NCT01204294|4628962|P6|Overall Study|Lack of Efficacy|0
1402732|NCT01204294|4628963|P5|Overall Study|Lack of Efficacy|0
1402733|NCT01204294|4628964|P4|Overall Study|Lack of Efficacy|2
1402734|NCT01204294|4628965|P3|Overall Study|Lack of Efficacy|0
1402735|NCT01204294|4628966|P2|Overall Study|Lack of Efficacy|0
1402736|NCT01204294|4628967|P1|Overall Study|Lack of Efficacy|0
1402737|NCT01204294|4628961|P7|Overall Study|Withdrawal by Subject|2
1402738|NCT01204294|4628962|P6|Overall Study|Withdrawal by Subject|1
1402739|NCT01204294|4628963|P5|Overall Study|Withdrawal by Subject|1
1402740|NCT01204294|4628964|P4|Overall Study|Withdrawal by Subject|1
1402741|NCT01204294|4628965|P3|Overall Study|Withdrawal by Subject|2
1402742|NCT01204294|4628966|P2|Overall Study|Withdrawal by Subject|2
1402743|NCT01204294|4628967|P1|Overall Study|Withdrawal by Subject|0
1402744|NCT01204294|4628961|P7|Overall Study|Protocol Violation|0
1402745|NCT01204294|4628962|P6|Overall Study|Protocol Violation|0
1402746|NCT01204294|4628963|P5|Overall Study|Protocol Violation|0
1402747|NCT01204294|4628964|P4|Overall Study|Protocol Violation|1
1402748|NCT01204294|4628965|P3|Overall Study|Protocol Violation|2
1402749|NCT01204294|4628966|P2|Overall Study|Protocol Violation|0
1402750|NCT01204294|4628967|P1|Overall Study|Protocol Violation|1
1402751|NCT01204294|4628961|P7|Overall Study|Adverse Event|0
1402752|NCT01204294|4628962|P6|Overall Study|Adverse Event|4
1402753|NCT01204294|4628963|P5|Overall Study|Adverse Event|1
1402754|NCT01204294|4628964|P4|Overall Study|Adverse Event|7
1402755|NCT01204294|4628965|P3|Overall Study|Adverse Event|0
1402756|NCT01204294|4628966|P2|Overall Study|Adverse Event|6
1402757|NCT01204294|4628967|P1|Overall Study|Adverse Event|2
1402758|NCT01203956|4629001|P2|Second Two-week Period|Non-compliant: no evaluable results|6
1402759|NCT01203956|4629002|P1|Second Two-week Period|Non-compliant: no evaluable results|5
1402760|NCT01203930|4629011|P2|Overall Study|Adverse Event|5
1402761|NCT01203930|4629012|P1|Overall Study|Adverse Event|17
1402762|NCT01203930|4629011|P2|Overall Study|Poor tolerance of study drug|1
1402763|NCT01203930|4629012|P1|Overall Study|Poor tolerance of study drug|0
1402764|NCT01203930|4629011|P2|Overall Study|Study Terminated by Sponsor|12
1402765|NCT01203930|4629012|P1|Overall Study|Study Terminated by Sponsor|0
1402766|NCT01203930|4629011|P2|Overall Study|Investigator Request|8
1402767|NCT01203930|4629012|P1|Overall Study|Investigator Request|0
1402768|NCT01203930|4629011|P2|Overall Study|Withdrew Consent|10
1402769|NCT01203930|4629012|P1|Overall Study|Withdrew Consent|1
1402770|NCT01203930|4629011|P2|Overall Study|Death|1
1402771|NCT01203930|4629012|P1|Overall Study|Death|3
1402772|NCT01203930|4629011|P2|Overall Study|Disease Progression|4
1402773|NCT01203930|4629012|P1|Overall Study|Disease Progression|0
1402774|NCT01203917|4629034|P1|Overall Study|Due to EGFR M+I patient|1
1402775|NCT01203917|4629034|P1|Overall Study|Due to objective disease progression|1
1402776|NCT01203917|4629034|P1|Overall Study|Withdrawal by Subject|3
1402777|NCT01203917|4629034|P1|Overall Study|Lost to Follow-up|2
1402778|NCT01203917|4629034|P1|Overall Study|Death|29
1402779|NCT01203878|4629047|P3|Overall Study|Adverse Event|2
1402780|NCT01203878|4629048|P2|Overall Study|Adverse Event|0
1402781|NCT01203878|4629049|P1|Overall Study|Adverse Event|0
1402782|NCT01203878|4629047|P3|Overall Study|Withdrawal by Subject|1
1402783|NCT01203878|4629048|P2|Overall Study|Withdrawal by Subject|0
1402784|NCT01203878|4629049|P1|Overall Study|Withdrawal by Subject|0
1402785|NCT01203852|4629060|P1|Washout 2 Weeks|Physician Decision|46
1402786|NCT01203852|4629060|P1|Metoprolol 8 Weeks|Physician Decision|470
1402787|NCT01203787|4629078|P2|Overall Study|Adverse Event|15
1402788|NCT01203787|4629079|P1|Overall Study|Adverse Event|11
1402789|NCT01203787|4629078|P2|Overall Study|Lost to Follow-up|0
1402790|NCT01203787|4629079|P1|Overall Study|Lost to Follow-up|2
1402791|NCT01203787|4629078|P2|Overall Study|Withdrawal by Subject|2
1402792|NCT01203787|4629079|P1|Overall Study|Withdrawal by Subject|6
1402793|NCT01203787|4629078|P2|Overall Study|Death|10
1402794|NCT01203787|4629079|P1|Overall Study|Death|12
1402795|NCT01203098|4629150|P3|Overall Study|Withdrawal by Subject|3
1402796|NCT01203098|4629151|P2|Overall Study|Withdrawal by Subject|1
1402797|NCT01203098|4629152|P1|Overall Study|Withdrawal by Subject|1
1402798|NCT01203098|4629150|P3|Overall Study|Physician Decision|0
1402799|NCT01203098|4629151|P2|Overall Study|Physician Decision|2
1402800|NCT01203098|4629152|P1|Overall Study|Physician Decision|2
1402801|NCT01203098|4629150|P3|Overall Study|Lost to Follow-up|1
1402802|NCT01203098|4629151|P2|Overall Study|Lost to Follow-up|0
1402803|NCT01203098|4629152|P1|Overall Study|Lost to Follow-up|0
1402804|NCT01203098|4629150|P3|Overall Study|Adverse Event|7
1402805|NCT01203098|4629151|P2|Overall Study|Adverse Event|1
1402806|NCT01203098|4629152|P1|Overall Study|Adverse Event|3
1402807|NCT01203072|4629168|P5|Overall Study|Withdrawal by Subject|3
1402808|NCT01203072|4629169|P4|Overall Study|Withdrawal by Subject|2
1402809|NCT01203072|4629170|P3|Overall Study|Withdrawal by Subject|1
1402810|NCT01203072|4629171|P2|Overall Study|Withdrawal by Subject|2
1402811|NCT01203072|4629172|P1|Overall Study|Withdrawal by Subject|2
1402812|NCT01203072|4629168|P5|Overall Study|Protocol Violation|1
1402813|NCT01203072|4629169|P4|Overall Study|Protocol Violation|0
1402814|NCT01203072|4629170|P3|Overall Study|Protocol Violation|0
1402815|NCT01203072|4629171|P2|Overall Study|Protocol Violation|0
1402816|NCT01203072|4629172|P1|Overall Study|Protocol Violation|2
1402817|NCT01203072|4629168|P5|Overall Study|Lost to Follow-up|0
1402818|NCT01203072|4629169|P4|Overall Study|Lost to Follow-up|0
1402819|NCT01203072|4629170|P3|Overall Study|Lost to Follow-up|0
1402820|NCT01203072|4629171|P2|Overall Study|Lost to Follow-up|1
1402821|NCT01203072|4629172|P1|Overall Study|Lost to Follow-up|0
1402822|NCT01203072|4629168|P5|Overall Study|Lack of Efficacy|0
1402823|NCT01203072|4629169|P4|Overall Study|Lack of Efficacy|0
1402824|NCT01203072|4629170|P3|Overall Study|Lack of Efficacy|0
1402825|NCT01203072|4629171|P2|Overall Study|Lack of Efficacy|0
1402826|NCT01203072|4629172|P1|Overall Study|Lack of Efficacy|1
1402827|NCT01203072|4629168|P5|Overall Study|Adverse Event|2
1402828|NCT01203072|4629169|P4|Overall Study|Adverse Event|4
1402829|NCT01203072|4629170|P3|Overall Study|Adverse Event|2
1402830|NCT01203072|4629171|P2|Overall Study|Adverse Event|3
1402831|NCT01203072|4629172|P1|Overall Study|Adverse Event|5
1402832|NCT01202955|4629207|P2|Period 1: 10 Days|Withdrawal by Subject|2
1402833|NCT01202955|4629208|P1|Period 1: 10 Days|Withdrawal by Subject|0
1402834|NCT01202903|4629220|P2|Overall Study|Withdrawal by Subject|4
1402835|NCT01202903|4629221|P1|Overall Study|Withdrawal by Subject|4
1402836|NCT01202903|4629220|P2|Overall Study|Adverse Event|3
1402837|NCT01202903|4629221|P1|Overall Study|Adverse Event|3
1402838|NCT01202903|4629220|P2|Overall Study|Lack of Efficacy|3
1402839|NCT01202903|4629221|P1|Overall Study|Lack of Efficacy|1
1402840|NCT01202903|4629220|P2|Overall Study|Lost to Follow-up|1
1402841|NCT01202903|4629221|P1|Overall Study|Lost to Follow-up|1
1402842|NCT01202903|4629220|P2|Overall Study|Death|0
1402843|NCT01202903|4629221|P1|Overall Study|Death|1
1402844|NCT01202903|4629220|P2|Overall Study|Protocol Violation|1
1402845|NCT01202903|4629221|P1|Overall Study|Protocol Violation|0
1402846|NCT01202903|4629220|P2|Overall Study|Administrative Probelms|4
1402847|NCT01202903|4629221|P1|Overall Study|Administrative Probelms|1
1402848|NCT01202877|4629248|P3|Overall Study|Death|1
1402849|NCT01202877|4629249|P2|Overall Study|Death|0
1402850|NCT01202877|4629250|P1|Overall Study|Death|0
1402851|NCT01202877|4629248|P3|Overall Study|Withdrawal by Subject|1
1402852|NCT01202877|4629249|P2|Overall Study|Withdrawal by Subject|0
1402853|NCT01202877|4629250|P1|Overall Study|Withdrawal by Subject|0
1402854|NCT01202877|4629248|P3|Overall Study|Adverse Event|2
1402855|NCT01202877|4629249|P2|Overall Study|Adverse Event|0
1402856|NCT01202877|4629250|P1|Overall Study|Adverse Event|0
1402857|NCT01202877|4629248|P3|Overall Study|Disease Progression|2
1402858|NCT01202877|4629249|P2|Overall Study|Disease Progression|1
1402859|NCT01202877|4629250|P1|Overall Study|Disease Progression|0
1402860|NCT01202773|4629262|P3|Overall Study|Sponsor Decision|23
1402861|NCT01202773|4629263|P2|Overall Study|Sponsor Decision|20
1402862|NCT01202773|4629264|P1|Overall Study|Sponsor Decision|19
1402863|NCT01202773|4629262|P3|Overall Study|Protocol Violation|10
1402864|NCT01202773|4629263|P2|Overall Study|Protocol Violation|6
1402865|NCT01202773|4629264|P1|Overall Study|Protocol Violation|11
1402866|NCT01202773|4629262|P3|Overall Study|Physician Decision|0
1402867|NCT01202773|4629263|P2|Overall Study|Physician Decision|0
1402868|NCT01202773|4629264|P1|Overall Study|Physician Decision|2
1402869|NCT01202773|4629262|P3|Overall Study|Withdrawal by Subject|5
1402870|NCT01202773|4629263|P2|Overall Study|Withdrawal by Subject|6
1402871|NCT01202773|4629264|P1|Overall Study|Withdrawal by Subject|13
1402872|NCT01202773|4629262|P3|Overall Study|Lost to Follow-up|2
1402873|NCT01202773|4629263|P2|Overall Study|Lost to Follow-up|2
1402874|NCT01202773|4629264|P1|Overall Study|Lost to Follow-up|1
1402875|NCT01202773|4629262|P3|Overall Study|Entry Criteria Not Met|1
1402876|NCT01202773|4629263|P2|Overall Study|Entry Criteria Not Met|0
1402877|NCT01202773|4629264|P1|Overall Study|Entry Criteria Not Met|2
1402878|NCT01202773|4629262|P3|Overall Study|Lack of Efficacy|9
1402879|NCT01202773|4629263|P2|Overall Study|Lack of Efficacy|4
1402880|NCT01202773|4629264|P1|Overall Study|Lack of Efficacy|5
1402881|NCT01202773|4629262|P3|Overall Study|Adverse Event|5
1402882|NCT01202773|4629263|P2|Overall Study|Adverse Event|5
1402883|NCT01202773|4629264|P1|Overall Study|Adverse Event|4
1402884|NCT01202760|4629341|P3|Overall Study|Sponsor Decision|0
1402885|NCT01202760|4629342|P2|Overall Study|Sponsor Decision|4
1402886|NCT01202760|4629343|P1|Overall Study|Sponsor Decision|4
1402887|NCT01202760|4629341|P3|Overall Study|Protocol Violation|2
1402888|NCT01202760|4629342|P2|Overall Study|Protocol Violation|5
1402889|NCT01202760|4629343|P1|Overall Study|Protocol Violation|7
1402890|NCT01202760|4629341|P3|Overall Study|Physician Decision|0
1402891|NCT01202760|4629342|P2|Overall Study|Physician Decision|1
1402892|NCT01202760|4629343|P1|Overall Study|Physician Decision|0
1402893|NCT01202760|4629341|P3|Overall Study|Withdrawal by Subject|14
1402894|NCT01202760|4629342|P2|Overall Study|Withdrawal by Subject|18
1402895|NCT01202760|4629343|P1|Overall Study|Withdrawal by Subject|17
1402896|NCT01202760|4629341|P3|Overall Study|Parent / Caregiver Decision|0
1402897|NCT01202760|4629342|P2|Overall Study|Parent / Caregiver Decision|1
1402898|NCT01202760|4629343|P1|Overall Study|Parent / Caregiver Decision|0
1402899|NCT01202760|4629341|P3|Overall Study|Lost to Follow-up|1
1402900|NCT01202760|4629342|P2|Overall Study|Lost to Follow-up|2
1402901|NCT01202760|4629343|P1|Overall Study|Lost to Follow-up|0
1402902|NCT01202760|4629341|P3|Overall Study|Lack of Efficacy|7
1402903|NCT01202760|4629342|P2|Overall Study|Lack of Efficacy|8
1402904|NCT01202760|4629343|P1|Overall Study|Lack of Efficacy|6
1402905|NCT01202760|4629341|P3|Overall Study|Death|0
1402906|NCT01202760|4629342|P2|Overall Study|Death|1
1402907|NCT01202760|4629343|P1|Overall Study|Death|2
1402908|NCT01202760|4629341|P3|Overall Study|Adverse Event|10
1402909|NCT01202760|4629342|P2|Overall Study|Adverse Event|9
1402910|NCT01202760|4629343|P1|Overall Study|Adverse Event|11
1402911|NCT01202760|4629341|P3|Overall Study|Entry Criteria Not Met|1
1402912|NCT01202760|4629342|P2|Overall Study|Entry Criteria Not Met|3
1402913|NCT01202760|4629343|P1|Overall Study|Entry Criteria Not Met|0
1402914|NCT01202747|4629411|P1|Overall Study|Withdrawal by Subject|1
1402915|NCT01202591|4629443|P6|Overall Study|Objective Disease Progression|0
1402916|NCT01202591|4629444|P5|Overall Study|Objective Disease Progression|2
1402917|NCT01202591|4629445|P4|Overall Study|Objective Disease Progression|0
1402918|NCT01202591|4629446|P3|Overall Study|Objective Disease Progression|0
1402919|NCT01202591|4629447|P2|Overall Study|Objective Disease Progression|0
1402920|NCT01202591|4629448|P1|Overall Study|Objective Disease Progression|0
1402921|NCT01202591|4629443|P6|Overall Study|Withdrawal by Subject|1
1402922|NCT01202591|4629444|P5|Overall Study|Withdrawal by Subject|2
1402923|NCT01202591|4629445|P4|Overall Study|Withdrawal by Subject|0
1402924|NCT01202591|4629446|P3|Overall Study|Withdrawal by Subject|0
1402925|NCT01202591|4629447|P2|Overall Study|Withdrawal by Subject|0
1402926|NCT01202591|4629448|P1|Overall Study|Withdrawal by Subject|0
1402927|NCT01202591|4629443|P6|Overall Study|Other reason as per investigator|3
1402928|NCT01202591|4629444|P5|Overall Study|Other reason as per investigator|1
1402929|NCT01202591|4629445|P4|Overall Study|Other reason as per investigator|3
1402930|NCT01202591|4629446|P3|Overall Study|Other reason as per investigator|7
1402931|NCT01202591|4629447|P2|Overall Study|Other reason as per investigator|4
1402932|NCT01202591|4629448|P1|Overall Study|Other reason as per investigator|3
1402933|NCT01202591|4629443|P6|Overall Study|Adverse Event|0
1402934|NCT01202591|4629444|P5|Overall Study|Adverse Event|0
1402935|NCT01202591|4629445|P4|Overall Study|Adverse Event|4
1402936|NCT01202591|4629446|P3|Overall Study|Adverse Event|4
1402937|NCT01202591|4629447|P2|Overall Study|Adverse Event|1
1402938|NCT01202591|4629448|P1|Overall Study|Adverse Event|2
1402939|NCT01202279|4629494|P2|Overall Study|study compliance|2
1402940|NCT01202279|4629495|P1|Overall Study|study compliance|5
1402941|NCT01202279|4629494|P2|Overall Study|Protocol Violation|1
1402942|NCT01202279|4629495|P1|Overall Study|Protocol Violation|1
1402943|NCT01202279|4629494|P2|Overall Study|Lost to Follow-up|7
1402944|NCT01202279|4629495|P1|Overall Study|Lost to Follow-up|10
1402945|NCT01202279|4629494|P2|Overall Study|Physician Decision|1
1402946|NCT01202279|4629495|P1|Overall Study|Physician Decision|0
1402947|NCT01202279|4629494|P2|Overall Study|Withdrawal by Subject|10
1402948|NCT01202279|4629495|P1|Overall Study|Withdrawal by Subject|13
1402949|NCT01202279|4629494|P2|Overall Study|Adverse Event|6
1402950|NCT01202279|4629495|P1|Overall Study|Adverse Event|8
1402951|NCT01202227|4629547|P1|Overall Study|Lack of Efficacy|1
1402952|NCT01202227|4629547|P1|Overall Study|Withdrawal by Subject|2
1402953|NCT01202227|4629547|P1|Overall Study|Adverse Event|16
1402954|NCT01202188|4629571|P5|Overall Study|Abnormal test procedure result (s)|0
1402955|NCT01202188|4629572|P4|Overall Study|Abnormal test procedure result (s)|0
1402956|NCT01202188|4629573|P3|Overall Study|Abnormal test procedure result (s)|2
1402957|NCT01202188|4629574|P2|Overall Study|Abnormal test procedure result (s)|0
1402958|NCT01202188|4629575|P1|Overall Study|Abnormal test procedure result (s)|0
1402959|NCT01202188|4629571|P5|Overall Study|Death|0
1402960|NCT01202188|4629572|P4|Overall Study|Death|1
1402961|NCT01202188|4629573|P3|Overall Study|Death|1
1402962|NCT01202188|4629574|P2|Overall Study|Death|1
1402963|NCT01202188|4629575|P1|Overall Study|Death|1
1402964|NCT01202188|4629571|P5|Overall Study|Lost to Follow-up|1
1402965|NCT01202188|4629572|P4|Overall Study|Lost to Follow-up|4
1402966|NCT01202188|4629573|P3|Overall Study|Lost to Follow-up|0
1402967|NCT01202188|4629574|P2|Overall Study|Lost to Follow-up|1
1402968|NCT01202188|4629575|P1|Overall Study|Lost to Follow-up|1
1402969|NCT01202188|4629571|P5|Overall Study|Unsatisfactory therapeutic effect|8
1402970|NCT01202188|4629572|P4|Overall Study|Unsatisfactory therapeutic effect|5
1402971|NCT01202188|4629573|P3|Overall Study|Unsatisfactory therapeutic effect|2
1402972|NCT01202188|4629574|P2|Overall Study|Unsatisfactory therapeutic effect|8
1402973|NCT01202188|4629575|P1|Overall Study|Unsatisfactory therapeutic effect|2
1402974|NCT01202188|4629571|P5|Overall Study|Administrative problems|2
1402975|NCT01202188|4629572|P4|Overall Study|Administrative problems|1
1402976|NCT01202188|4629573|P3|Overall Study|Administrative problems|1
1402977|NCT01202188|4629574|P2|Overall Study|Administrative problems|2
1402978|NCT01202188|4629575|P1|Overall Study|Administrative problems|3
1402979|NCT01202188|4629571|P5|Overall Study|Adverse Event|10
1402980|NCT01202188|4629572|P4|Overall Study|Adverse Event|10
1402981|NCT01202188|4629573|P3|Overall Study|Adverse Event|13
1402982|NCT01202188|4629574|P2|Overall Study|Adverse Event|23
1402983|NCT01202188|4629575|P1|Overall Study|Adverse Event|5
1402984|NCT01202188|4629571|P5|Overall Study|Subject withdrew consent|13
1402985|NCT01202188|4629572|P4|Overall Study|Subject withdrew consent|11
1402986|NCT01202188|4629573|P3|Overall Study|Subject withdrew consent|22
1402987|NCT01202188|4629574|P2|Overall Study|Subject withdrew consent|13
1402988|NCT01202188|4629575|P1|Overall Study|Subject withdrew consent|12
1402989|NCT01202188|4629571|P5|Overall Study|Protocol deviation|11
1402990|NCT01202188|4629572|P4|Overall Study|Protocol deviation|10
1402991|NCT01202188|4629573|P3|Overall Study|Protocol deviation|12
1402992|NCT01202188|4629574|P2|Overall Study|Protocol deviation|8
1402993|NCT01202188|4629575|P1|Overall Study|Protocol deviation|14
1402994|NCT01201967|4629722|P2|Overall Study|Lost to Follow-up|5
1402995|NCT01201967|4629723|P1|Overall Study|Lost to Follow-up|6
1402996|NCT01201915|4629748|P3|Overall Study|Target Lesion Progression|0
1402997|NCT01201915|4629749|P2|Overall Study|Target Lesion Progression|3
1402998|NCT01201915|4629750|P1|Overall Study|Target Lesion Progression|0
1402999|NCT01201915|4629748|P3|Overall Study|Subject Decision|5
1403000|NCT01201915|4629749|P2|Overall Study|Subject Decision|3
1403001|NCT01201915|4629750|P1|Overall Study|Subject Decision|3
1403002|NCT01201915|4629748|P3|Overall Study|Physician Decision|0
1403003|NCT01201915|4629749|P2|Overall Study|Physician Decision|0
1403004|NCT01201915|4629750|P1|Overall Study|Physician Decision|3
1403005|NCT01201915|4629748|P3|Overall Study|Lost to Follow-up|0
1403006|NCT01201915|4629749|P2|Overall Study|Lost to Follow-up|4
1403007|NCT01201915|4629750|P1|Overall Study|Lost to Follow-up|0
1403008|NCT01201915|4629748|P3|Overall Study|Adverse Event|1
1403009|NCT01201915|4629749|P2|Overall Study|Adverse Event|1
1403010|NCT01201915|4629750|P1|Overall Study|Adverse Event|2
1403011|NCT01201811|4629761|P1|Overall Study|Physician Decision|1
1403012|NCT01201811|4629761|P1|Overall Study|Treatment Failure|2
1403013|NCT01201811|4629761|P1|Overall Study|Death|4
1403014|NCT01201811|4629761|P1|Overall Study|Withdrawal by Subject|3
1403015|NCT01201811|4629761|P1|Overall Study|Disease progression|3
1403016|NCT01201811|4629761|P1|Overall Study|Adverse Event|6
1403017|NCT01201798|4629783|P2|Overall Study|Treatment Failure|8
1403018|NCT01201798|4629784|P1|Overall Study|Treatment Failure|1
1403019|NCT01201798|4629783|P2|Overall Study|Protocol Violation|1
1403020|NCT01201798|4629784|P1|Overall Study|Protocol Violation|1
1403021|NCT01201798|4629783|P2|Overall Study|Noncompliance|0
1403022|NCT01201798|4629784|P1|Overall Study|Noncompliance|1
1403023|NCT01201798|4629783|P2|Overall Study|Decision Unrelated to an Adverse Event|1
1403024|NCT01201798|4629784|P1|Overall Study|Decision Unrelated to an Adverse Event|1
1403025|NCT01201798|4629783|P2|Overall Study|Lost to Follow-up|5
1403026|NCT01201798|4629784|P1|Overall Study|Lost to Follow-up|3
1403027|NCT01201798|4629783|P2|Overall Study|Adverse Event|0
1403028|NCT01201798|4629784|P1|Overall Study|Adverse Event|2
1403029|NCT01201785|4629808|P1|Overall Study|Lost to Follow-up|16
1403030|NCT01201759|4629825|P2|Visit 4 Crossover|Lost to Follow-up|1
1403031|NCT01201759|4629826|P1|Visit 4 Crossover|Lost to Follow-up|0
1403032|NCT01201759|4629825|P2|Visit 3 - Washout|Lost to Follow-up|0
1403033|NCT01201759|4629826|P1|Visit 3 - Washout|Lost to Follow-up|1
1403034|NCT01201759|4629825|P2|Visit 3 - Washout|Adverse Event|3
1403035|NCT01201759|4629826|P1|Visit 3 - Washout|Adverse Event|0
1403036|NCT01201759|4629825|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
1403037|NCT01201759|4629826|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
1403038|NCT01201343|4629855|P1|Overall Study|Randomized, not treated|3
1403039|NCT01201343|4629855|P1|Overall Study|Participant wrongly included in trial|1
1403040|NCT01201343|4629855|P1|Overall Study|Lack of Efficacy|2
1403041|NCT01201343|4629855|P1|Overall Study|Lost to Follow-up|2
1403042|NCT01201343|4629855|P1|Overall Study|Withdrawal by Subject|5
1403043|NCT01201343|4629855|P1|Overall Study|Adverse Event|6
1403044|NCT01201317|4629869|P3|Overall Study|Safety, possible history of tuberculosis|1
1403045|NCT01201317|4629870|P2|Overall Study|Safety, possible history of tuberculosis|0
1403046|NCT01201317|4629871|P1|Overall Study|Safety, possible history of tuberculosis|0
1403047|NCT01201317|4629869|P3|Overall Study|Lack of Efficacy|0
1403048|NCT01201317|4629870|P2|Overall Study|Lack of Efficacy|0
1403049|NCT01201317|4629871|P1|Overall Study|Lack of Efficacy|1
1403050|NCT01201317|4629869|P3|Overall Study|Decrease in renal function|0
1403051|NCT01201317|4629870|P2|Overall Study|Decrease in renal function|1
1403052|NCT01201317|4629871|P1|Overall Study|Decrease in renal function|0
1403053|NCT01201317|4629869|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
1403054|NCT01201317|4629870|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
1403055|NCT01201317|4629871|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
1403056|NCT01201317|4629869|P3|Overall Study|Study-specific withdrawal criteria|1
1403057|NCT01201317|4629870|P2|Overall Study|Study-specific withdrawal criteria|0
1403058|NCT01201317|4629871|P1|Overall Study|Study-specific withdrawal criteria|0
1403059|NCT01201317|4629869|P3|Overall Study|Death|0
1403060|NCT01201317|4629870|P2|Overall Study|Death|1
1403061|NCT01201317|4629871|P1|Overall Study|Death|0
1403062|NCT01201317|4629869|P3|Overall Study|Protocol Violation|1
1403063|NCT01201317|4629870|P2|Overall Study|Protocol Violation|1
1403064|NCT01201317|4629871|P1|Overall Study|Protocol Violation|0
1403065|NCT01201317|4629869|P3|Overall Study|Screen failure|0
1403066|NCT01201317|4629870|P2|Overall Study|Screen failure|1
1403067|NCT01201317|4629871|P1|Overall Study|Screen failure|1
1403068|NCT01201317|4629869|P3|Overall Study|Adverse Event|2
1403069|NCT01201317|4629870|P2|Overall Study|Adverse Event|2
1403070|NCT01201317|4629871|P1|Overall Study|Adverse Event|2
1403071|NCT01201317|4629869|P3|Overall Study|Withdrawal by Subject|3
1403072|NCT01201317|4629870|P2|Overall Study|Withdrawal by Subject|0
1403073|NCT01201317|4629871|P1|Overall Study|Withdrawal by Subject|5
1403074|NCT01201265|4629891|P1|Overall Study|Disease Progression|4
1403075|NCT01201265|4629891|P1|Overall Study|Withdrawal by Subject|7
1403076|NCT01201265|4629891|P1|Overall Study|Lost to Follow-up|10
1403077|NCT01201265|4629891|P1|Overall Study|Insufficient Therapeutic Response|3
1403078|NCT01201265|4629891|P1|Overall Study|Death|14
1403079|NCT01200992|4629905|P2|Overall Study|Randomized but not treated|0
1403080|NCT01200992|4629906|P1|Overall Study|Randomized but not treated|2
1403081|NCT01200992|4629905|P2|Overall Study|Study terminated early|41
1403082|NCT01200992|4629906|P1|Overall Study|Study terminated early|35
1403083|NCT01200810|4629920|P2|Overall Study|Sponsor stopped making study drug|3
1403084|NCT01200810|4629921|P1|Overall Study|Sponsor stopped making study drug|3
1403085|NCT01200810|4629920|P2|Overall Study|Withdrawal by Subject|2
1403086|NCT01200810|4629921|P1|Overall Study|Withdrawal by Subject|1
1403087|NCT01200810|4629920|P2|Overall Study|Physician Decision|0
1403088|NCT01200810|4629921|P1|Overall Study|Physician Decision|1
1403089|NCT01200797|4629941|P1|Overall Study|Disease Progression|13
1403090|NCT01200797|4629941|P1|Overall Study|Adverse Event|4
1403091|NCT01200797|4629941|P1|Overall Study|symptomatic deterioration|2
1403092|NCT01200758|4629951|P4|Stage 2|Death|5
1403093|NCT01200758|4629952|P3|Stage 2|Death|3
1403094|NCT01200758|4629953|P2|Stage 2|Death|0
1403095|NCT01200758|4629954|P1|Stage 2|Death|0
1403096|NCT01200758|4629951|P4|Stage 2|Protocol Violation|4
1403097|NCT01200758|4629952|P3|Stage 2|Protocol Violation|1
1403098|NCT01200758|4629953|P2|Stage 2|Protocol Violation|0
1403099|NCT01200758|4629954|P1|Stage 2|Protocol Violation|0
1403100|NCT01200758|4629951|P4|Stage 2|Lost to Follow-up|1
1403101|NCT01200758|4629952|P3|Stage 2|Lost to Follow-up|3
1403102|NCT01200758|4629953|P2|Stage 2|Lost to Follow-up|0
1403103|NCT01200758|4629954|P1|Stage 2|Lost to Follow-up|0
1403104|NCT01200758|4629951|P4|Stage 2|Withdrawal by Subject|1
1403105|NCT01200758|4629952|P3|Stage 2|Withdrawal by Subject|4
1403106|NCT01200758|4629953|P2|Stage 2|Withdrawal by Subject|0
1403107|NCT01200758|4629954|P1|Stage 2|Withdrawal by Subject|0
1403108|NCT01200758|4629951|P4|Stage 2|Adverse Event|9
1403109|NCT01200758|4629952|P3|Stage 2|Adverse Event|5
1403110|NCT01200758|4629953|P2|Stage 2|Adverse Event|0
1403111|NCT01200758|4629954|P1|Stage 2|Adverse Event|0
1403112|NCT01200758|4629951|P4|Stage 2|Physician Decision|7
1403113|NCT01200758|4629952|P3|Stage 2|Physician Decision|5
1403114|NCT01200758|4629953|P2|Stage 2|Physician Decision|0
1403115|NCT01200758|4629954|P1|Stage 2|Physician Decision|0
1403116|NCT01200758|4629951|P4|Stage 2|Lack of Efficacy|2
1403117|NCT01200758|4629952|P3|Stage 2|Lack of Efficacy|4
1403118|NCT01200758|4629953|P2|Stage 2|Lack of Efficacy|0
1403119|NCT01200758|4629954|P1|Stage 2|Lack of Efficacy|0
1403120|NCT01200758|4629951|P4|Stage 2|Disease Progression|21
1403121|NCT01200758|4629952|P3|Stage 2|Disease Progression|16
1403122|NCT01200758|4629953|P2|Stage 2|Disease Progression|0
1403123|NCT01200758|4629954|P1|Stage 2|Disease Progression|0
1403124|NCT01200758|4629951|P4|Stage I|Disease Progression|0
1403125|NCT01200758|4629952|P3|Stage I|Disease Progression|0
1403126|NCT01200758|4629953|P2|Stage I|Disease Progression|7
1403127|NCT01200758|4629954|P1|Stage I|Disease Progression|9
1403128|NCT01200758|4629951|P4|Stage I|Withdrawal by Subject|0
1403129|NCT01200758|4629952|P3|Stage I|Withdrawal by Subject|0
1403130|NCT01200758|4629953|P2|Stage I|Withdrawal by Subject|2
1403131|NCT01200758|4629954|P1|Stage I|Withdrawal by Subject|1
1403132|NCT01200758|4629951|P4|Stage I|Adverse Event|0
1403133|NCT01200758|4629952|P3|Stage I|Adverse Event|0
1403134|NCT01200758|4629953|P2|Stage I|Adverse Event|5
1403135|NCT01200758|4629954|P1|Stage I|Adverse Event|5
1403136|NCT01200758|4629951|P4|Stage I|Lack of Efficacy|0
1403137|NCT01200758|4629952|P3|Stage I|Lack of Efficacy|0
1403138|NCT01200758|4629953|P2|Stage I|Lack of Efficacy|1
1403139|NCT01200758|4629954|P1|Stage I|Lack of Efficacy|2
1403140|NCT01200758|4629951|P4|Stage I|Physician Decision|0
1403141|NCT01200758|4629952|P3|Stage I|Physician Decision|0
1403142|NCT01200758|4629953|P2|Stage I|Physician Decision|1
1403143|NCT01200758|4629954|P1|Stage I|Physician Decision|1
1403144|NCT01200758|4629951|P4|Stage I|Death|0
1403145|NCT01200758|4629952|P3|Stage I|Death|0
1403146|NCT01200758|4629953|P2|Stage I|Death|1
1403147|NCT01200758|4629954|P1|Stage I|Death|0
1403148|NCT01200589|4630027|P2|Overall Study|Study terminated|172
1403149|NCT01200589|4630028|P1|Overall Study|Study terminated|170
1403150|NCT01200589|4630027|P2|Overall Study|Lost to Follow-up|4
1403151|NCT01200589|4630028|P1|Overall Study|Lost to Follow-up|5
1403152|NCT01200589|4630027|P2|Overall Study|Physician Decision|2
1403153|NCT01200589|4630028|P1|Overall Study|Physician Decision|2
1403154|NCT01200589|4630027|P2|Overall Study|Withdrawal by Subject|11
1403155|NCT01200589|4630028|P1|Overall Study|Withdrawal by Subject|13
1403156|NCT01200524|4630055|P3|Overall Study|Non availability of study nurse|1
1403157|NCT01200524|4630056|P2|Overall Study|Non availability of study nurse|0
1403158|NCT01200524|4630057|P1|Overall Study|Non availability of study nurse|0
1403159|NCT01200524|4630055|P3|Overall Study|Adverse Event|0
1403160|NCT01200524|4630056|P2|Overall Study|Adverse Event|0
1403161|NCT01200524|4630057|P1|Overall Study|Adverse Event|1
1403162|NCT01200524|4630055|P3|Overall Study|Withdrawal by Subject|3
1403163|NCT01200524|4630056|P2|Overall Study|Withdrawal by Subject|1
1403164|NCT01200524|4630057|P1|Overall Study|Withdrawal by Subject|1
1403165|NCT01200511|4630077|P1|Overall Study|Adverse Event|1
1403166|NCT01200511|4630077|P1|Overall Study|Withdrawal by Subject|1
1403167|NCT01200511|4630077|P1|Overall Study|Lost to Follow-up|3
1403168|NCT01200368|4630115|P3|Toddler Dose|Adverse Event|1
1403169|NCT01200368|4630116|P2|Toddler Dose|Adverse Event|3
1403170|NCT01200368|4630117|P1|Toddler Dose|Adverse Event|0
1403171|NCT01200368|4630115|P3|After Infant Series|Other|2
1403172|NCT01200368|4630116|P2|After Infant Series|Other|2
1403173|NCT01200368|4630117|P1|After Infant Series|Other|1
1403174|NCT01200368|4630115|P3|After Infant Series|Lost to Follow-up|0
1403175|NCT01200368|4630116|P2|After Infant Series|Lost to Follow-up|0
1403176|NCT01200368|4630117|P1|After Infant Series|Lost to Follow-up|1
1403177|NCT01200368|4630115|P3|After Infant Series|Withdrawal by Subject|4
1403178|NCT01200368|4630116|P2|After Infant Series|Withdrawal by Subject|8
1403179|NCT01200368|4630117|P1|After Infant Series|Withdrawal by Subject|10
1403180|NCT01200368|4630115|P3|After Infant Series|Adverse Event|3
1403181|NCT01200368|4630116|P2|After Infant Series|Adverse Event|6
1403182|NCT01200368|4630117|P1|After Infant Series|Adverse Event|6
1403183|NCT01200368|4630115|P3|Infant Series|Other|0
1403184|NCT01200368|4630116|P2|Infant Series|Other|0
1403185|NCT01200368|4630117|P1|Infant Series|Other|1
1403186|NCT01200368|4630115|P3|Infant Series|Randomized, not vaccinated|1
1403187|NCT01200368|4630116|P2|Infant Series|Randomized, not vaccinated|1
1403188|NCT01200368|4630117|P1|Infant Series|Randomized, not vaccinated|0
1403189|NCT01200368|4630115|P3|Infant Series|Did not meet entrance criteria|0
1403190|NCT01200368|4630116|P2|Infant Series|Did not meet entrance criteria|1
1403191|NCT01200368|4630117|P1|Infant Series|Did not meet entrance criteria|0
1403192|NCT01200368|4630115|P3|Infant Series|Withdrawal by Subject|2
1403193|NCT01200368|4630116|P2|Infant Series|Withdrawal by Subject|2
1403194|NCT01200368|4630117|P1|Infant Series|Withdrawal by Subject|0
1403195|NCT01200368|4630115|P3|Infant Series|Adverse Event|3
1403196|NCT01200368|4630116|P2|Infant Series|Adverse Event|2
1403197|NCT01200368|4630117|P1|Infant Series|Adverse Event|2
1403198|NCT01200355|4630183|P2|Overall Study|Death|2
1403199|NCT01200355|4630184|P1|Overall Study|Death|7
1403200|NCT01200342|4630198|P1|Overall Study|Disease Progression|1
1403201|NCT01200290|4630203|P1|Post-Treatment Follow-Up Period|Death|2
1403202|NCT01200290|4630203|P1|Treatment Period|Adverse Event|1
1403203|NCT01200238|4630216|P2|Overall Study|Withdrawal by Subject|1
1403204|NCT01200238|4630217|P1|Overall Study|Withdrawal by Subject|0
1403205|NCT01200238|4630216|P2|Overall Study|Progressive Disease|8
1403206|NCT01200238|4630217|P1|Overall Study|Progressive Disease|5
1403207|NCT01200238|4630216|P2|Overall Study|Adverse Event|1
1403208|NCT01200238|4630217|P1|Overall Study|Adverse Event|2
1403209|NCT01200069|4630241|P2|Overall Study|Withdrawal by Subject|1
1403210|NCT01200069|4630242|P1|Overall Study|Withdrawal by Subject|0
1403211|NCT01199939|4630311|P1|Overall Study|Reached a virologic endpoint|4
1403212|NCT01199939|4630311|P1|Overall Study|Lost to Follow-up|2
1403213|NCT01199939|4630311|P1|Overall Study|Protocol Violation|3
1403214|NCT01199939|4630311|P1|Overall Study|Adverse Event|4
1403215|NCT01199861|4630343|P2|Overall Study|Adverse Event|0
1403216|NCT01199861|4630344|P1|Overall Study|Adverse Event|1
1403217|NCT01199861|4630343|P2|Overall Study|Administrative problems|0
1403218|NCT01199861|4630344|P1|Overall Study|Administrative problems|1
1403219|NCT01199822|4630365|P3|Overall Study|Investigator discontinued therapy|0
1403220|NCT01199822|4630366|P2|Overall Study|Investigator discontinued therapy|1
1403221|NCT01199822|4630367|P1|Overall Study|Investigator discontinued therapy|0
1403222|NCT01199731|4630416|P3|Overall Study|Withdrawal by Subject|0
1403223|NCT01199731|4630417|P2|Overall Study|Withdrawal by Subject|0
1403224|NCT01199731|4630418|P1|Overall Study|Withdrawal by Subject|2
1403225|NCT01199731|4630416|P3|Overall Study|Physician Decision|1
1403226|NCT01199731|4630417|P2|Overall Study|Physician Decision|1
1403227|NCT01199731|4630418|P1|Overall Study|Physician Decision|0
1403228|NCT01199731|4630416|P3|Overall Study|Lost to Follow-up|2
1403229|NCT01199731|4630417|P2|Overall Study|Lost to Follow-up|0
1403230|NCT01199731|4630418|P1|Overall Study|Lost to Follow-up|0
1403231|NCT01199731|4630416|P3|Overall Study|Study closed/terminated|7
1403232|NCT01199731|4630417|P2|Overall Study|Study closed/terminated|9
1403233|NCT01199731|4630418|P1|Overall Study|Study closed/terminated|7
1403234|NCT01199731|4630416|P3|Overall Study|Adverse Event|0
1403235|NCT01199731|4630417|P2|Overall Study|Adverse Event|1
1403236|NCT01199731|4630418|P1|Overall Study|Adverse Event|0
1403237|NCT01199705|4630456|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
1403238|NCT01199601|4630488|P2|Overall Study|Insecurity prevented staff interviewing.|9
1403239|NCT01199601|4630489|P1|Overall Study|Insecurity prevented staff interviewing.|7
1403240|NCT01199601|4630488|P2|Overall Study|Withdrawal by Subject|3
1403241|NCT01199601|4630489|P1|Overall Study|Withdrawal by Subject|15
1403242|NCT01199601|4630488|P2|Overall Study|Lost to Follow-up|66
1403243|NCT01199601|4630489|P1|Overall Study|Lost to Follow-up|47
1403244|NCT01199471|4630499|P1|Overall Study|Physician Decision|1
1403245|NCT01199471|4630499|P1|Overall Study|Withdrawal by Subject|1
1403246|NCT01199471|4630499|P1|Overall Study|Protocol Violation|4
1403247|NCT01199042|4630531|P1|At Home (3 Months)|Lost to Follow-up|1
1403248|NCT01199042|4630531|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
1403249|NCT01199016|4630540|P1|Overall Study|Lost to Follow-up|25
1403250|NCT01199016|4630540|P1|Overall Study|Withdrawal by Subject|21
1403251|NCT01199016|4630540|P1|Overall Study|Other|13
1403252|NCT01199016|4630540|P1|Overall Study|Protocol Violation|9
1403253|NCT01199016|4630540|P1|Overall Study|Entrance criteria|5
1403254|NCT01199016|4630540|P1|Overall Study|No longer meets eligibility criteria|4
1403255|NCT01198977|4630549|P2|Overall Study|Lost to Follow-up|0
1403256|NCT01198977|4630550|P1|Overall Study|Lost to Follow-up|1
1403257|NCT01198873|4630562|P2|Overall Study|Other than above|2
1403258|NCT01198873|4630563|P1|Overall Study|Other than above|4
1403259|NCT01198873|4630562|P2|Overall Study|Study closure|23
1403260|NCT01198873|4630563|P1|Overall Study|Study closure|29
1403261|NCT01198873|4630562|P2|Overall Study|Adverse Event|7
1403262|NCT01198873|4630563|P1|Overall Study|Adverse Event|4
1403263|NCT01198795|4630577|P1|Overall Study|Other Reason|4
1403264|NCT01198795|4630577|P1|Overall Study|Protocol Violation|2
1403265|NCT01198795|4630577|P1|Overall Study|Lack of Efficacy|5
1403266|NCT01198795|4630577|P1|Overall Study|Adverse Event|9
1403267|NCT01198795|4630577|P1|Overall Study|Lost to Follow-up|15
1403268|NCT01198795|4630577|P1|Overall Study|Withdrawal by Subject|17
1403269|NCT01198795|4630577|P1|Overall Study|Did not meet InclusionExclusion criteria|30
1403270|NCT01198756|4630594|P4|Overall Study|Lost to Follow-up|18
1403271|NCT01198756|4630595|P3|Overall Study|Lost to Follow-up|23
1403272|NCT01198756|4630596|P2|Overall Study|Lost to Follow-up|36
1403273|NCT01198756|4630597|P1|Overall Study|Lost to Follow-up|29
1403274|NCT01198756|4630594|P4|Overall Study|Withdrawal by Subject|5
1403275|NCT01198756|4630595|P3|Overall Study|Withdrawal by Subject|7
1403276|NCT01198756|4630596|P2|Overall Study|Withdrawal by Subject|4
1403277|NCT01198756|4630597|P1|Overall Study|Withdrawal by Subject|9
1403278|NCT01198756|4630594|P4|Overall Study|Protocol Violation|2
1403279|NCT01198756|4630595|P3|Overall Study|Protocol Violation|0
1403280|NCT01198756|4630596|P2|Overall Study|Protocol Violation|0
1403281|NCT01198756|4630597|P1|Overall Study|Protocol Violation|0
1403282|NCT01198756|4630594|P4|Overall Study|Adverse Event|1
1403283|NCT01198756|4630595|P3|Overall Study|Adverse Event|0
1403284|NCT01198756|4630596|P2|Overall Study|Adverse Event|0
1403285|NCT01198756|4630597|P1|Overall Study|Adverse Event|0
1403286|NCT01198600|4630708|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
1403287|NCT01198600|4630709|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
1403288|NCT01198600|4630710|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
1403289|NCT01198600|4630711|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
1403290|NCT01198600|4630708|P4|Phase 2: 56 Days of Wear|Relocation|0
1403291|NCT01198600|4630709|P3|Phase 2: 56 Days of Wear|Relocation|2
1403292|NCT01198600|4630710|P2|Phase 2: 56 Days of Wear|Relocation|0
1403293|NCT01198600|4630711|P1|Phase 2: 56 Days of Wear|Relocation|0
1403294|NCT01198600|4630708|P4|Phase 2: 56 Days of Wear|Inconvenience|0
1403295|NCT01198600|4630709|P3|Phase 2: 56 Days of Wear|Inconvenience|2
1403296|NCT01198600|4630710|P2|Phase 2: 56 Days of Wear|Inconvenience|0
1403297|NCT01198600|4630711|P1|Phase 2: 56 Days of Wear|Inconvenience|0
1403298|NCT01198600|4630708|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
1403299|NCT01198600|4630709|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
1403300|NCT01198600|4630710|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
1403301|NCT01198600|4630711|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
1403302|NCT01198600|4630708|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
1403303|NCT01198600|4630709|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
1403304|NCT01198600|4630710|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
1403305|NCT01198600|4630711|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
1403306|NCT01198600|4630708|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
1403307|NCT01198600|4630709|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
1403308|NCT01198600|4630710|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
1403309|NCT01198600|4630711|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
1403310|NCT01198600|4630708|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
1403311|NCT01198600|4630709|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
1403312|NCT01198600|4630710|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
1403313|NCT01198600|4630711|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
1403314|NCT01198587|4630737|P4|Overall Study|Lost to Follow-up|0
1403315|NCT01198587|4630738|P3|Overall Study|Lost to Follow-up|9
1403316|NCT01198587|4630739|P2|Overall Study|Lost to Follow-up|0
1403317|NCT01198587|4630740|P1|Overall Study|Lost to Follow-up|8
1403318|NCT01198574|4630762|P4|Overall Study|Resigned from schools|4
1403319|NCT01198574|4630763|P3|Overall Study|Resigned from schools|1
1403320|NCT01198574|4630764|P2|Overall Study|Resigned from schools|1
1403321|NCT01198574|4630765|P1|Overall Study|Resigned from schools|4
1403322|NCT01198548|4630783|P1|Overall Study|Administrative Decision|1
1403323|NCT01198548|4630783|P1|Overall Study|Disease Progression|9
1403324|NCT01198509|4630798|P6|Overall Study|Withdrawal by Subject|0
1403325|NCT01198509|4630799|P5|Overall Study|Withdrawal by Subject|0
1403326|NCT01198509|4630800|P4|Overall Study|Withdrawal by Subject|0
1403327|NCT01198509|4630801|P3|Overall Study|Withdrawal by Subject|0
1403328|NCT01198509|4630802|P2|Overall Study|Withdrawal by Subject|0
1403329|NCT01198509|4630803|P1|Overall Study|Withdrawal by Subject|1
1403330|NCT01198275|4630879|P2|Overall Study|spontaneous return to sinus rhythm|2
1403331|NCT01198275|4630880|P1|Overall Study|spontaneous return to sinus rhythm|4
1403332|NCT01198275|4630879|P2|Overall Study|Adverse Event|3
1403333|NCT01198275|4630880|P1|Overall Study|Adverse Event|2
1403334|NCT01198145|4630888|P2|Overall Study|Withdrawal by Subject|1
1403335|NCT01198145|4630889|P1|Overall Study|Withdrawal by Subject|1
1403336|NCT01198132|4630911|P2|Overall Study|Protocol Violation|0
1403337|NCT01198132|4630912|P1|Overall Study|Protocol Violation|1
1403338|NCT01198132|4630911|P2|Overall Study|Adverse Event|1
1403339|NCT01198132|4630912|P1|Overall Study|Adverse Event|0
1403340|NCT01198132|4630911|P2|Overall Study|Abnormal/clinically significant biologic|1
1403341|NCT01198132|4630912|P1|Overall Study|Abnormal/clinically significant biologic|1
1403342|NCT01198132|4630911|P2|Overall Study|Sign/symptoms of underlying disease|1
1403343|NCT01198132|4630912|P1|Overall Study|Sign/symptoms of underlying disease|2
1403344|NCT01198132|4630911|P2|Overall Study|Lack of Efficacy|3
1403345|NCT01198132|4630912|P1|Overall Study|Lack of Efficacy|2
1403346|NCT01198132|4630911|P2|Overall Study|Other Unspecified|6
1403347|NCT01198132|4630912|P1|Overall Study|Other Unspecified|3
1403348|NCT01198132|4630911|P2|Overall Study|Physician Decision|4
1403349|NCT01198132|4630912|P1|Overall Study|Physician Decision|5
1403350|NCT01198132|4630911|P2|Overall Study|Withdrawal by Subject|5
1403351|NCT01198132|4630912|P1|Overall Study|Withdrawal by Subject|4
1403352|NCT01198002|4630939|P3|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
1403353|NCT01198002|4630940|P2|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
1403354|NCT01198002|4630941|P1|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
1403355|NCT01198002|4630939|P3|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
1403356|NCT01198002|4630940|P2|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
1403357|NCT01198002|4630941|P1|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
1403358|NCT01198002|4630939|P3|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
1403359|NCT01198002|4630940|P2|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
1403360|NCT01198002|4630941|P1|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
1403361|NCT01198002|4630939|P3|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
1403362|NCT01198002|4630940|P2|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
1403363|NCT01198002|4630941|P1|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
1403364|NCT01198002|4630939|P3|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
1403365|NCT01198002|4630940|P2|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
1403366|NCT01198002|4630941|P1|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
1403367|NCT01198002|4630939|P3|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
1403368|NCT01198002|4630940|P2|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
1403369|NCT01198002|4630941|P1|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
1403370|NCT01198002|4630939|P3|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
1403371|NCT01198002|4630940|P2|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
1403372|NCT01198002|4630941|P1|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
1403373|NCT01198002|4630939|P3|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
1403374|NCT01198002|4630940|P2|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
1403375|NCT01198002|4630941|P1|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
1403376|NCT01198002|4630939|P3|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
1403377|NCT01198002|4630940|P2|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
1403378|NCT01198002|4630941|P1|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
1403379|NCT01198002|4630939|P3|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
1403380|NCT01198002|4630940|P2|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
1403381|NCT01198002|4630941|P1|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
1403382|NCT01198002|4630939|P3|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
1403383|NCT01198002|4630940|P2|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
1403384|NCT01198002|4630941|P1|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
1403385|NCT01198002|4630939|P3|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
1403386|NCT01198002|4630940|P2|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
1403387|NCT01198002|4630941|P1|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
1403388|NCT01198002|4630939|P3|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
1403389|NCT01198002|4630940|P2|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
1403390|NCT01198002|4630941|P1|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
1403391|NCT01198002|4630939|P3|Treatment Period 1 (Weeks 0-52)|Death|1
1403392|NCT01198002|4630940|P2|Treatment Period 1 (Weeks 0-52)|Death|0
1403393|NCT01198002|4630941|P1|Treatment Period 1 (Weeks 0-52)|Death|2
1403394|NCT01198002|4630939|P3|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
1403395|NCT01198002|4630940|P2|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
1403396|NCT01198002|4630941|P1|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
1403397|NCT01197911|4631056|P3|Overall Study|Adverse Event|1
1403398|NCT01197911|4631057|P2|Overall Study|Adverse Event|0
1403399|NCT01197911|4631058|P1|Overall Study|Adverse Event|0
1403400|NCT01197794|4631173|P7|Overall Study|Other|4
1403401|NCT01197794|4631174|P6|Overall Study|Other|2
1403402|NCT01197794|4631175|P5|Overall Study|Other|2
1403403|NCT01197794|4631176|P4|Overall Study|Other|0
1403404|NCT01197794|4631177|P3|Overall Study|Other|3
1403405|NCT01197794|4631178|P2|Overall Study|Other|1
1403406|NCT01197794|4631179|P1|Overall Study|Other|1
1403407|NCT01197794|4631173|P7|Overall Study|Lost to Follow-up|0
1403408|NCT01197794|4631174|P6|Overall Study|Lost to Follow-up|1
1403409|NCT01197794|4631175|P5|Overall Study|Lost to Follow-up|0
1403410|NCT01197794|4631176|P4|Overall Study|Lost to Follow-up|1
1403411|NCT01197794|4631177|P3|Overall Study|Lost to Follow-up|0
1403412|NCT01197794|4631178|P2|Overall Study|Lost to Follow-up|1
1403413|NCT01197794|4631179|P1|Overall Study|Lost to Follow-up|1
1403414|NCT01197794|4631173|P7|Overall Study|Withdrawal by Subject|6
1403415|NCT01197794|4631174|P6|Overall Study|Withdrawal by Subject|5
1403416|NCT01197794|4631175|P5|Overall Study|Withdrawal by Subject|1
1403417|NCT01197794|4631176|P4|Overall Study|Withdrawal by Subject|1
1403418|NCT01197794|4631177|P3|Overall Study|Withdrawal by Subject|4
1403419|NCT01197794|4631178|P2|Overall Study|Withdrawal by Subject|3
1403420|NCT01197794|4631179|P1|Overall Study|Withdrawal by Subject|3
1403421|NCT01197794|4631173|P7|Overall Study|Eligibility criteria not fulfilled|6
1403422|NCT01197794|4631174|P6|Overall Study|Eligibility criteria not fulfilled|9
1403423|NCT01197794|4631175|P5|Overall Study|Eligibility criteria not fulfilled|5
1403424|NCT01197794|4631176|P4|Overall Study|Eligibility criteria not fulfilled|5
1403425|NCT01197794|4631177|P3|Overall Study|Eligibility criteria not fulfilled|2
1403426|NCT01197794|4631178|P2|Overall Study|Eligibility criteria not fulfilled|8
1403427|NCT01197794|4631179|P1|Overall Study|Eligibility criteria not fulfilled|5
1403428|NCT01197794|4631173|P7|Overall Study|Development of study withdrawal criteria|1
1403429|NCT01197794|4631174|P6|Overall Study|Development of study withdrawal criteria|0
1403430|NCT01197794|4631175|P5|Overall Study|Development of study withdrawal criteria|0
1403431|NCT01197794|4631176|P4|Overall Study|Development of study withdrawal criteria|1
1403432|NCT01197794|4631177|P3|Overall Study|Development of study withdrawal criteria|0
1403433|NCT01197794|4631178|P2|Overall Study|Development of study withdrawal criteria|0
1403434|NCT01197794|4631179|P1|Overall Study|Development of study withdrawal criteria|3
1403435|NCT01197794|4631173|P7|Overall Study|Protocol Violation|1
1403436|NCT01197794|4631174|P6|Overall Study|Protocol Violation|0
1403437|NCT01197794|4631175|P5|Overall Study|Protocol Violation|2
1403438|NCT01197794|4631176|P4|Overall Study|Protocol Violation|0
1403439|NCT01197794|4631177|P3|Overall Study|Protocol Violation|0
1403440|NCT01197794|4631178|P2|Overall Study|Protocol Violation|0
1403441|NCT01197794|4631179|P1|Overall Study|Protocol Violation|0
1403442|NCT01197794|4631173|P7|Overall Study|Adverse Event|3
1403443|NCT01197794|4631174|P6|Overall Study|Adverse Event|2
1403444|NCT01197794|4631175|P5|Overall Study|Adverse Event|4
1403445|NCT01197794|4631176|P4|Overall Study|Adverse Event|4
1403446|NCT01197794|4631177|P3|Overall Study|Adverse Event|4
1403447|NCT01197794|4631178|P2|Overall Study|Adverse Event|2
1403448|NCT01197794|4631179|P1|Overall Study|Adverse Event|3
1403449|NCT01197755|4631261|P3|Overall Study|eg, change in circumstances|2
1403450|NCT01197755|4631262|P2|Overall Study|eg, change in circumstances|3
1403451|NCT01197755|4631263|P1|Overall Study|eg, change in circumstances|7
1403452|NCT01197755|4631261|P3|Overall Study|Lost to Follow-up|1
1403453|NCT01197755|4631262|P2|Overall Study|Lost to Follow-up|0
1403454|NCT01197755|4631263|P1|Overall Study|Lost to Follow-up|0
1403455|NCT01197755|4631261|P3|Overall Study|Withdrawal by Subject|0
1403456|NCT01197755|4631262|P2|Overall Study|Withdrawal by Subject|0
1403457|NCT01197755|4631263|P1|Overall Study|Withdrawal by Subject|1
1403458|NCT01197755|4631261|P3|Overall Study|Severe non-compliance to the protocol|2
1403459|NCT01197755|4631262|P2|Overall Study|Severe non-compliance to the protocol|1
1403460|NCT01197755|4631263|P1|Overall Study|Severe non-compliance to the protocol|2
1403461|NCT01197755|4631261|P3|Overall Study|Lack of therapeutic response|4
1403462|NCT01197755|4631262|P2|Overall Study|Lack of therapeutic response|7
1403463|NCT01197755|4631263|P1|Overall Study|Lack of therapeutic response|0
1403464|NCT01197755|4631261|P3|Overall Study|Entered the long-term extension study|35
1403465|NCT01197755|4631262|P2|Overall Study|Entered the long-term extension study|21
1403466|NCT01197755|4631263|P1|Overall Study|Entered the long-term extension study|18
1403467|NCT01197755|4631261|P3|Overall Study|Study-specific discontinuation criteria|0
1403468|NCT01197755|4631262|P2|Overall Study|Study-specific discontinuation criteria|1
1403469|NCT01197755|4631263|P1|Overall Study|Study-specific discontinuation criteria|2
1403470|NCT01197755|4631261|P3|Overall Study|Adverse Event|10
1403471|NCT01197755|4631262|P2|Overall Study|Adverse Event|10
1403472|NCT01197755|4631263|P1|Overall Study|Adverse Event|8
1403473|NCT01197560|4631335|P2|Overall Study|Missing|1
1403474|NCT01197560|4631336|P1|Overall Study|Missing|0
1403475|NCT01197560|4631335|P2|Overall Study|Elected to discontinue before cycle end|2
1403476|NCT01197560|4631336|P1|Overall Study|Elected to discontinue before cycle end|0
1403477|NCT01197560|4631335|P2|Overall Study|Proceeded to transplant|1
1403478|NCT01197560|4631336|P1|Overall Study|Proceeded to transplant|1
1403479|NCT01197560|4631335|P2|Overall Study|Disease progression|35
1403480|NCT01197560|4631336|P1|Overall Study|Disease progression|39
1403481|NCT01197560|4631335|P2|Overall Study|Withdrawal by Subject|1
1403482|NCT01197560|4631336|P1|Overall Study|Withdrawal by Subject|1
1403483|NCT01197560|4631335|P2|Overall Study|Death|5
1403484|NCT01197560|4631336|P1|Overall Study|Death|1
1403485|NCT01197560|4631335|P2|Overall Study|Adverse Event|8
1403486|NCT01197560|4631336|P1|Overall Study|Adverse Event|4
1403487|NCT01197534|4631369|P3|Overall Study|Adverse Event|24
1403488|NCT01197534|4631370|P2|Overall Study|Adverse Event|36
1403489|NCT01197534|4631371|P1|Overall Study|Adverse Event|35
1403490|NCT01197534|4631369|P3|Overall Study|Lost to Follow-up|2
1403491|NCT01197534|4631370|P2|Overall Study|Lost to Follow-up|4
1403492|NCT01197534|4631371|P1|Overall Study|Lost to Follow-up|1
1403493|NCT01197534|4631369|P3|Overall Study|Dev. of study specific discont. criteria|2
1403494|NCT01197534|4631370|P2|Overall Study|Dev. of study specific discont. criteria|6
1403495|NCT01197534|4631371|P1|Overall Study|Dev. of study specific discont. criteria|13
1403496|NCT01197534|4631369|P3|Overall Study|Lack of therapeutic response|9
1403497|NCT01197534|4631370|P2|Overall Study|Lack of therapeutic response|4
1403498|NCT01197534|4631371|P1|Overall Study|Lack of therapeutic response|9
1403499|NCT01197534|4631369|P3|Overall Study|Severe non-compliance to protocol|1
1403500|NCT01197534|4631370|P2|Overall Study|Severe non-compliance to protocol|4
1403501|NCT01197534|4631371|P1|Overall Study|Severe non-compliance to protocol|3
1403502|NCT01197534|4631369|P3|Overall Study|Enrolment in long term extension|119
1403503|NCT01197534|4631370|P2|Overall Study|Enrolment in long term extension|66
1403504|NCT01197534|4631371|P1|Overall Study|Enrolment in long term extension|57
1403505|NCT01197534|4631369|P3|Overall Study|Not reported|16
1403506|NCT01197534|4631370|P2|Overall Study|Not reported|10
1403507|NCT01197534|4631371|P1|Overall Study|Not reported|16
1403508|NCT01197521|4631415|P3|Overall Study|Adverse Event|24
1403509|NCT01197521|4631416|P2|Overall Study|Adverse Event|28
1403510|NCT01197521|4631417|P1|Overall Study|Adverse Event|25
1403511|NCT01197521|4631415|P3|Overall Study|Lost to Follow-up|2
1403512|NCT01197521|4631416|P2|Overall Study|Lost to Follow-up|2
1403513|NCT01197521|4631417|P1|Overall Study|Lost to Follow-up|3
1403514|NCT01197521|4631415|P3|Overall Study|Dev. of study specific discont. criteria|2
1403515|NCT01197521|4631416|P2|Overall Study|Dev. of study specific discont. criteria|16
1403516|NCT01197521|4631417|P1|Overall Study|Dev. of study specific discont. criteria|6
1403517|NCT01197521|4631415|P3|Overall Study|Lack of therapeutic response|4
1403518|NCT01197521|4631416|P2|Overall Study|Lack of therapeutic response|3
1403519|NCT01197521|4631417|P1|Overall Study|Lack of therapeutic response|2
1403520|NCT01197521|4631415|P3|Overall Study|Severe non-compliance to protocol|3
1403521|NCT01197521|4631416|P2|Overall Study|Severe non-compliance to protocol|3
1403522|NCT01197521|4631417|P1|Overall Study|Severe non-compliance to protocol|1
1403523|NCT01197521|4631415|P3|Overall Study|Enrolment in long term extension|87
1403524|NCT01197521|4631416|P2|Overall Study|Enrolment in long term extension|36
1403525|NCT01197521|4631417|P1|Overall Study|Enrolment in long term extension|42
1403526|NCT01197521|4631415|P3|Overall Study|Not reported|21
1403527|NCT01197521|4631416|P2|Overall Study|Not reported|25
1403528|NCT01197521|4631417|P1|Overall Study|Not reported|24
1403529|NCT01197508|4631462|P4|Overall Study|Not specified|2
1403530|NCT01197508|4631463|P3|Overall Study|Not specified|2
1403531|NCT01197508|4631464|P2|Overall Study|Not specified|3
1403532|NCT01197508|4631465|P1|Overall Study|Not specified|2
1403533|NCT01197508|4631462|P4|Overall Study|Lost to Follow-up|0
1403534|NCT01197508|4631463|P3|Overall Study|Lost to Follow-up|2
1403535|NCT01197508|4631464|P2|Overall Study|Lost to Follow-up|1
1403536|NCT01197508|4631465|P1|Overall Study|Lost to Follow-up|1
1403537|NCT01197508|4631462|P4|Overall Study|Study-specific withdrawal criteria|2
1403538|NCT01197508|4631463|P3|Overall Study|Study-specific withdrawal criteria|1
1403539|NCT01197508|4631464|P2|Overall Study|Study-specific withdrawal criteria|0
1403540|NCT01197508|4631465|P1|Overall Study|Study-specific withdrawal criteria|0
1403541|NCT01197508|4631462|P4|Overall Study|Lack of Efficacy|1
1403542|NCT01197508|4631463|P3|Overall Study|Lack of Efficacy|2
1403543|NCT01197508|4631464|P2|Overall Study|Lack of Efficacy|2
1403544|NCT01197508|4631465|P1|Overall Study|Lack of Efficacy|1
1403545|NCT01197508|4631462|P4|Overall Study|Condition under investigation worsened|1
1403546|NCT01197508|4631463|P3|Overall Study|Condition under investigation worsened|1
1403547|NCT01197508|4631464|P2|Overall Study|Condition under investigation worsened|1
1403548|NCT01197508|4631465|P1|Overall Study|Condition under investigation worsened|1
1403549|NCT01197508|4631462|P4|Overall Study|Severe non-compliance to protocol|3
1403550|NCT01197508|4631463|P3|Overall Study|Severe non-compliance to protocol|1
1403551|NCT01197508|4631464|P2|Overall Study|Severe non-compliance to protocol|3
1403552|NCT01197508|4631465|P1|Overall Study|Severe non-compliance to protocol|0
1403553|NCT01197508|4631462|P4|Overall Study|Adverse Event|3
1403554|NCT01197508|4631463|P3|Overall Study|Adverse Event|23
1403555|NCT01197508|4631464|P2|Overall Study|Adverse Event|13
1403556|NCT01197508|4631465|P1|Overall Study|Adverse Event|10
1403557|NCT01197508|4631462|P4|Overall Study|Eligiblity criteria not fulfilled|0
1403558|NCT01197508|4631463|P3|Overall Study|Eligiblity criteria not fulfilled|2
1403559|NCT01197508|4631464|P2|Overall Study|Eligiblity criteria not fulfilled|0
1403560|NCT01197508|4631465|P1|Overall Study|Eligiblity criteria not fulfilled|0
1403561|NCT01197508|4631462|P4|Overall Study|Withdrawal by Subject|4
1403562|NCT01197508|4631463|P3|Overall Study|Withdrawal by Subject|15
1403563|NCT01197508|4631464|P2|Overall Study|Withdrawal by Subject|7
1403564|NCT01197508|4631465|P1|Overall Study|Withdrawal by Subject|8
1403565|NCT01197417|4631575|P2|Overall Study|No 25-hour magnesium level|2
1403566|NCT01197417|4631576|P1|Overall Study|No 25-hour magnesium level|0
1403567|NCT01197417|4631575|P2|Overall Study|Found to be ineligible|5
1403568|NCT01197417|4631576|P1|Overall Study|Found to be ineligible|2
1403569|NCT01197417|4631575|P2|Overall Study|Hypotension|2
1403570|NCT01197417|4631576|P1|Overall Study|Hypotension|1
1403571|NCT01197417|4631575|P2|Overall Study|Not consented in time to receive drug|1
1403572|NCT01197417|4631576|P1|Overall Study|Not consented in time to receive drug|0
1403573|NCT01197417|4631575|P2|Overall Study|Subject transferred to intensive care|1
1403574|NCT01197417|4631576|P1|Overall Study|Subject transferred to intensive care|0
1403575|NCT01197417|4631575|P2|Overall Study|Site miscommunication|1
1403576|NCT01197417|4631576|P1|Overall Study|Site miscommunication|0
1403577|NCT01197417|4631575|P2|Overall Study|Withdrawal by Subject|4
1403578|NCT01197417|4631576|P1|Overall Study|Withdrawal by Subject|2
1403579|NCT01197417|4631575|P2|Overall Study|Physician Decision|2
1403580|NCT01197417|4631576|P1|Overall Study|Physician Decision|3
1403581|NCT01197378|4631594|P1|Overall Study|Other|2
1403582|NCT01197378|4631594|P1|Overall Study|Physician Decision|1
1403583|NCT01197378|4631594|P1|Overall Study|Withdrawal by Subject|1
1403584|NCT01197378|4631594|P1|Overall Study|Adverse Event|3
1403585|NCT01196988|4631615|P4|Overall Study|Other|0
1403586|NCT01196988|4631616|P3|Overall Study|Other|0
1403587|NCT01196988|4631617|P2|Overall Study|Other|0
1403588|NCT01196988|4631618|P1|Overall Study|Other|2
1403589|NCT01196988|4631615|P4|Overall Study|Lost to Follow-up|1
1403590|NCT01196988|4631616|P3|Overall Study|Lost to Follow-up|21
1403591|NCT01196988|4631617|P2|Overall Study|Lost to Follow-up|29
1403592|NCT01196988|4631618|P1|Overall Study|Lost to Follow-up|16
1403593|NCT01196988|4631615|P4|Overall Study|Withdrawal by Subject|0
1403594|NCT01196988|4631616|P3|Overall Study|Withdrawal by Subject|4
1403595|NCT01196988|4631617|P2|Overall Study|Withdrawal by Subject|1
1403596|NCT01196988|4631618|P1|Overall Study|Withdrawal by Subject|5
1403597|NCT01196988|4631615|P4|Overall Study|Adverse Event|0
1403598|NCT01196988|4631616|P3|Overall Study|Adverse Event|0
1403599|NCT01196988|4631617|P2|Overall Study|Adverse Event|2
1403600|NCT01196988|4631618|P1|Overall Study|Adverse Event|1
1403601|NCT01196975|4631712|P5|Overall Study|Lost to Follow-up|11
1403602|NCT01196975|4631713|P4|Overall Study|Lost to Follow-up|5
1403603|NCT01196975|4631714|P3|Overall Study|Lost to Follow-up|5
1403604|NCT01196975|4631715|P2|Overall Study|Lost to Follow-up|6
1403605|NCT01196975|4631716|P1|Overall Study|Lost to Follow-up|11
1403606|NCT01196975|4631712|P5|Overall Study|Withdrawal by Subject|0
1403607|NCT01196975|4631713|P4|Overall Study|Withdrawal by Subject|1
1403608|NCT01196975|4631714|P3|Overall Study|Withdrawal by Subject|0
1403609|NCT01196975|4631715|P2|Overall Study|Withdrawal by Subject|1
1403610|NCT01196975|4631716|P1|Overall Study|Withdrawal by Subject|2
1403611|NCT01196975|4631712|P5|Overall Study|Adverse Event|2
1403612|NCT01196975|4631713|P4|Overall Study|Adverse Event|0
1403613|NCT01196975|4631714|P3|Overall Study|Adverse Event|0
1403614|NCT01196975|4631715|P2|Overall Study|Adverse Event|2
1403615|NCT01196975|4631716|P1|Overall Study|Adverse Event|2
1403616|NCT01196741|4631877|P2|Overall Study|Protocol Violation|1
1403617|NCT01196741|4631878|P1|Overall Study|Protocol Violation|2
1403618|NCT01196741|4631877|P2|Overall Study|Other|2
1403619|NCT01196741|4631878|P1|Overall Study|Other|3
1403620|NCT01196741|4631877|P2|Overall Study|Other reason|3
1403621|NCT01196741|4631878|P1|Overall Study|Other reason|3
1403622|NCT01196741|4631877|P2|Overall Study|Withdrawal by Subject|0
1403623|NCT01196741|4631878|P1|Overall Study|Withdrawal by Subject|3
1403624|NCT01196741|4631877|P2|Overall Study|Dose limiting Adverse Event|1
1403625|NCT01196741|4631878|P1|Overall Study|Dose limiting Adverse Event|2
1403626|NCT01196741|4631877|P2|Overall Study|Serious Adverse Event|1
1403627|NCT01196741|4631878|P1|Overall Study|Serious Adverse Event|3
1403628|NCT01196741|4631877|P2|Overall Study|Adverse Event|6
1403629|NCT01196741|4631878|P1|Overall Study|Adverse Event|10
1403630|NCT01196741|4631877|P2|Overall Study|Disease progression|14
1403631|NCT01196741|4631878|P1|Overall Study|Disease progression|34
1403632|NCT01196429|4631904|P2|Overall Study|Refused – Never Treated|0
1403633|NCT01196429|4631905|P1|Overall Study|Refused – Never Treated|1
1403634|NCT01196429|4631904|P2|Overall Study|Ineligible - wrong cell type|0
1403635|NCT01196429|4631905|P1|Overall Study|Ineligible - wrong cell type|1
1403636|NCT01196429|4631904|P2|Overall Study|Ineligible - inadequate pathology|0
1403637|NCT01196429|4631905|P1|Overall Study|Ineligible - inadequate pathology|1
1403638|NCT01196416|4631921|P1|Overall Study|Withdrawal by Subject|2
1403639|NCT01196104|4631947|P2|Overall Study|Various|1
1403640|NCT01196104|4631948|P1|Overall Study|Various|0
1403641|NCT01196104|4631947|P2|Overall Study|Withdrawal by Subject|3
1403642|NCT01196104|4631948|P1|Overall Study|Withdrawal by Subject|3
1403643|NCT01196104|4631947|P2|Overall Study|Physician Decision|1
1403644|NCT01196104|4631948|P1|Overall Study|Physician Decision|0
1403645|NCT01196104|4631947|P2|Overall Study|Lost to Follow-up|0
1403646|NCT01196104|4631948|P1|Overall Study|Lost to Follow-up|1
1403647|NCT01196091|4631991|P3|Overall Study|Randomized, No Study Drug Received|1
1403648|NCT01196091|4631992|P2|Overall Study|Randomized, No Study Drug Received|0
1403649|NCT01196091|4631993|P1|Overall Study|Randomized, No Study Drug Received|1
1403650|NCT01196091|4631991|P3|Overall Study|Excluded Site|8
1403651|NCT01196091|4631992|P2|Overall Study|Excluded Site|11
1403652|NCT01196091|4631993|P1|Overall Study|Excluded Site|5
1403653|NCT01196091|4631991|P3|Overall Study|Sponsor Decision|4
1403654|NCT01196091|4631992|P2|Overall Study|Sponsor Decision|5
1403655|NCT01196091|4631993|P1|Overall Study|Sponsor Decision|6
1403656|NCT01196091|4631991|P3|Overall Study|Protocol Violation|3
1403657|NCT01196091|4631992|P2|Overall Study|Protocol Violation|3
1403658|NCT01196091|4631993|P1|Overall Study|Protocol Violation|1
1403659|NCT01196091|4631991|P3|Overall Study|Physician Decision|4
1403660|NCT01196091|4631992|P2|Overall Study|Physician Decision|3
1403661|NCT01196091|4631993|P1|Overall Study|Physician Decision|3
1403662|NCT01196091|4631991|P3|Overall Study|Withdrawal by Subject|22
1403663|NCT01196091|4631992|P2|Overall Study|Withdrawal by Subject|19
1403664|NCT01196091|4631993|P1|Overall Study|Withdrawal by Subject|16
1403665|NCT01196091|4631991|P3|Overall Study|Parent/Caregiver Decision|1
1403666|NCT01196091|4631992|P2|Overall Study|Parent/Caregiver Decision|0
1403667|NCT01196091|4631993|P1|Overall Study|Parent/Caregiver Decision|0
1403668|NCT01196091|4631991|P3|Overall Study|Lost to Follow-up|6
1403669|NCT01196091|4631992|P2|Overall Study|Lost to Follow-up|5
1403670|NCT01196091|4631993|P1|Overall Study|Lost to Follow-up|5
1403671|NCT01196091|4631991|P3|Overall Study|Lack of Efficacy|17
1403672|NCT01196091|4631992|P2|Overall Study|Lack of Efficacy|12
1403673|NCT01196091|4631993|P1|Overall Study|Lack of Efficacy|15
1403674|NCT01196091|4631991|P3|Overall Study|Entry Criteria Not Met|10
1403675|NCT01196091|4631992|P2|Overall Study|Entry Criteria Not Met|11
1403676|NCT01196091|4631993|P1|Overall Study|Entry Criteria Not Met|11
1403677|NCT01196091|4631991|P3|Overall Study|Death|2
1403678|NCT01196091|4631992|P2|Overall Study|Death|2
1403679|NCT01196091|4631993|P1|Overall Study|Death|3
1403680|NCT01196091|4631991|P3|Overall Study|Adverse Event|26
1403681|NCT01196091|4631992|P2|Overall Study|Adverse Event|27
1403682|NCT01196091|4631993|P1|Overall Study|Adverse Event|22
1403683|NCT01196078|4632045|P2|Overall Study|Death|4
1403684|NCT01196078|4632046|P1|Overall Study|Death|6
1403685|NCT01196078|4632045|P2|Overall Study|Lost to Follow-up|0
1403686|NCT01196078|4632046|P1|Overall Study|Lost to Follow-up|1
1403687|NCT01196078|4632045|P2|Overall Study|Lack of Efficacy|23
1403688|NCT01196078|4632046|P1|Overall Study|Lack of Efficacy|17
1403689|NCT01196078|4632045|P2|Overall Study|Protocol Violation|1
1403690|NCT01196078|4632046|P1|Overall Study|Protocol Violation|2
1403691|NCT01196078|4632045|P2|Overall Study|Adverse Event|4
1403692|NCT01196078|4632046|P1|Overall Study|Adverse Event|4
1403693|NCT01196078|4632045|P2|Overall Study|Withdrawal by Subject|5
1403694|NCT01196078|4632046|P1|Overall Study|Withdrawal by Subject|3
1403695|NCT01196052|4632074|P1|Overall Study|Withdrawal by Subject|6
1403696|NCT01196052|4632074|P1|Overall Study|Reason not Specified|5
1403697|NCT01196052|4632074|P1|Overall Study|Noncompliance to Protocol Requirements|2
1403698|NCT01196052|4632074|P1|Overall Study|Lost to Follow-up|1
1403699|NCT01196052|4632074|P1|Overall Study|Adverse Event|9
1403700|NCT01196026|4632091|P6|Overall Study|Other|0
1403701|NCT01196026|4632092|P5|Overall Study|Other|0
1403702|NCT01196026|4632093|P4|Overall Study|Other|0
1403703|NCT01196026|4632094|P3|Overall Study|Other|0
1403704|NCT01196026|4632095|P2|Overall Study|Other|1
1403705|NCT01196026|4632096|P1|Overall Study|Other|0
1403706|NCT01196026|4632091|P6|Overall Study|Lost to Follow-up|0
1403707|NCT01196026|4632092|P5|Overall Study|Lost to Follow-up|1
1403708|NCT01196026|4632093|P4|Overall Study|Lost to Follow-up|0
1403709|NCT01196026|4632094|P3|Overall Study|Lost to Follow-up|0
1403710|NCT01196026|4632095|P2|Overall Study|Lost to Follow-up|3
1403711|NCT01196026|4632096|P1|Overall Study|Lost to Follow-up|0
1403712|NCT01196026|4632091|P6|Overall Study|Withdrawal by Subject|0
1403713|NCT01196026|4632092|P5|Overall Study|Withdrawal by Subject|0
1403714|NCT01196026|4632093|P4|Overall Study|Withdrawal by Subject|0
1403715|NCT01196026|4632094|P3|Overall Study|Withdrawal by Subject|0
1403716|NCT01196026|4632095|P2|Overall Study|Withdrawal by Subject|4
1403717|NCT01196026|4632096|P1|Overall Study|Withdrawal by Subject|1
1403718|NCT01195948|4632332|P3|Overall Study|Lost to Follow-up|2
1403719|NCT01195948|4632333|P2|Overall Study|Lost to Follow-up|1
1403720|NCT01195948|4632334|P1|Overall Study|Lost to Follow-up|0
1403721|NCT01195844|4632381|P1|Overall Study|Fecal sample not collected|40
1403722|NCT01195831|4632398|P2|Overall Study|Protocol Violation|2
1403723|NCT01195831|4632399|P1|Overall Study|Protocol Violation|0
1403724|NCT01195831|4632398|P2|Overall Study|Adverse Event|2
1403725|NCT01195831|4632399|P1|Overall Study|Adverse Event|4
1403726|NCT01195831|4632398|P2|Overall Study|Withdrawal by Subject|2
1403727|NCT01195831|4632399|P1|Overall Study|Withdrawal by Subject|2
1403728|NCT01195831|4632398|P2|Overall Study|Lost to Follow-up|4
1403729|NCT01195831|4632399|P1|Overall Study|Lost to Follow-up|2
1403730|NCT01195675|4632639|P1|Overall Study|Withdrawal by Subject|2
1403731|NCT01195675|4632639|P1|Overall Study|Adverse Event|1
1403732|NCT01195662|4632672|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
1403733|NCT01195662|4632673|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
1403734|NCT01195662|4632674|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
1403735|NCT01195662|4632672|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
1403736|NCT01195662|4632673|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
1403737|NCT01195662|4632674|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
1403738|NCT01195662|4632672|P3|Double Blind Treatment Period|Missing disposition information|1
1403739|NCT01195662|4632673|P2|Double Blind Treatment Period|Missing disposition information|1
1403740|NCT01195662|4632674|P1|Double Blind Treatment Period|Missing disposition information|0
1403741|NCT01195662|4632672|P3|Double Blind Treatment Period|Non-specified|0
1403742|NCT01195662|4632673|P2|Double Blind Treatment Period|Non-specified|0
1403743|NCT01195662|4632674|P1|Double Blind Treatment Period|Non-specified|3
1403744|NCT01195662|4632672|P3|Double Blind Treatment Period|Lack of Efficacy|0
1403745|NCT01195662|4632673|P2|Double Blind Treatment Period|Lack of Efficacy|0
1403746|NCT01195662|4632674|P1|Double Blind Treatment Period|Lack of Efficacy|2
1403747|NCT01195662|4632672|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
1403748|NCT01195662|4632673|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
1403749|NCT01195662|4632674|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
1403750|NCT01195662|4632672|P3|Double Blind Treatment Period|Requested discontinue treatment|1
1403751|NCT01195662|4632673|P2|Double Blind Treatment Period|Requested discontinue treatment|0
1403752|NCT01195662|4632674|P1|Double Blind Treatment Period|Requested discontinue treatment|1
1403753|NCT01195662|4632672|P3|Double Blind Treatment Period|Administrative reason|1
1403754|NCT01195662|4632673|P2|Double Blind Treatment Period|Administrative reason|1
1403755|NCT01195662|4632674|P1|Double Blind Treatment Period|Administrative reason|2
1403756|NCT01195662|4632672|P3|Double Blind Treatment Period|Lost to Follow-up|3
1403757|NCT01195662|4632673|P2|Double Blind Treatment Period|Lost to Follow-up|2
1403758|NCT01195662|4632674|P1|Double Blind Treatment Period|Lost to Follow-up|3
1403759|NCT01195662|4632672|P3|Double Blind Treatment Period|Withdrawal by Subject|4
1403760|NCT01195662|4632673|P2|Double Blind Treatment Period|Withdrawal by Subject|4
1403761|NCT01195662|4632674|P1|Double Blind Treatment Period|Withdrawal by Subject|6
1403762|NCT01195662|4632672|P3|Double Blind Treatment Period|Adverse Event|2
1403763|NCT01195662|4632673|P2|Double Blind Treatment Period|Adverse Event|1
1403764|NCT01195662|4632674|P1|Double Blind Treatment Period|Adverse Event|4
1403765|NCT01195636|4632704|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
1403766|NCT01195636|4632705|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
1403767|NCT01195636|4632704|P2|Second Intervention (3 Weeks)|Adverse Event|1
1403768|NCT01195636|4632705|P1|Second Intervention (3 Weeks)|Adverse Event|1
1403769|NCT01195636|4632704|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
1403770|NCT01195636|4632705|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
1403771|NCT01195636|4632704|P2|Washout Period (2 Weeks)|Adverse Event|1
1403772|NCT01195636|4632705|P1|Washout Period (2 Weeks)|Adverse Event|1
1403773|NCT01195636|4632704|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
1403774|NCT01195636|4632705|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
1403775|NCT01195636|4632704|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
1403776|NCT01195636|4632705|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
1403777|NCT01195636|4632704|P2|First Intervention (3 Weeks)|Protocol Violation|0
1403778|NCT01195636|4632705|P1|First Intervention (3 Weeks)|Protocol Violation|1
1403779|NCT01195636|4632704|P2|First Intervention (3 Weeks)|Adverse Event|3
1403780|NCT01195636|4632705|P1|First Intervention (3 Weeks)|Adverse Event|2
1403781|NCT01195623|4632731|P2|Overall Study|Lost to Follow-up|37
1403782|NCT01195623|4632732|P1|Overall Study|Lost to Follow-up|35
1403783|NCT01195545|4632761|P1|Overall Study|Protocol Violation|4
1403784|NCT01195415|4632773|P1|Overall Study|No repeat biopsy due to progression|2
1403785|NCT01195363|4632782|P2|Overall Study|incarceration|0
1403786|NCT01195363|4632783|P1|Overall Study|incarceration|1
1403787|NCT01195363|4632782|P2|Overall Study|Lack of Efficacy|4
1403788|NCT01195363|4632783|P1|Overall Study|Lack of Efficacy|0
1403789|NCT01195363|4632782|P2|Overall Study|Adverse Event|1
1403790|NCT01195363|4632783|P1|Overall Study|Adverse Event|3
1403791|NCT01195363|4632782|P2|Overall Study|Lost to Follow-up|4
1403792|NCT01195363|4632783|P1|Overall Study|Lost to Follow-up|7
1403793|NCT01195272|4632789|P1|Overall Study|Lack of Efficacy|3
1403794|NCT01195272|4632789|P1|Overall Study|Adverse Event|1
1403795|NCT01195103|4632818|P3|Overall Study|Withdrawal by Subject|0
1403796|NCT01195103|4632819|P2|Overall Study|Withdrawal by Subject|0
1403797|NCT01195103|4632820|P1|Overall Study|Withdrawal by Subject|1
1403798|NCT01195090|4632830|P2|Overall Study|Protocol Violation|4
1403799|NCT01195090|4632831|P1|Overall Study|Protocol Violation|3
1403800|NCT01195090|4632830|P2|Overall Study|Lost to Follow-up|2
1403801|NCT01195090|4632831|P1|Overall Study|Lost to Follow-up|2
1403802|NCT01195090|4632830|P2|Overall Study|Adverse Event|2
1403803|NCT01195090|4632831|P1|Overall Study|Adverse Event|1
1403804|NCT01194999|4632900|P1|Overall Study|Lost to Follow-up|17
1403805|NCT01194973|4632904|P1|26 Week Treatment Period|Pregnancy|1
1403806|NCT01194973|4632904|P1|26 Week Treatment Period|Lack of Efficacy|1
1403807|NCT01194973|4632904|P1|26 Week Treatment Period|Adverse Event|1
1403808|NCT01194973|4632904|P1|Screening Period|Screen Failure|3
1403809|NCT01194869|4632924|P1|Overall Study|Toxicity|2
1403810|NCT01194869|4632924|P1|Overall Study|Disease Progression|2
1403811|NCT01194830|4632955|P2|Overall Study|Other Reason|8
1403812|NCT01194830|4632956|P1|Overall Study|Other Reason|12
1403813|NCT01194830|4632955|P2|Overall Study|Non-compliance issues|4
1403814|NCT01194830|4632956|P1|Overall Study|Non-compliance issues|4
1403815|NCT01194830|4632955|P2|Overall Study|Lack of Efficacy|1
1403816|NCT01194830|4632956|P1|Overall Study|Lack of Efficacy|1
1403817|NCT01194830|4632955|P2|Overall Study|Withdrawal by Subject|1
1403818|NCT01194830|4632956|P1|Overall Study|Withdrawal by Subject|2
1403819|NCT01194830|4632955|P2|Overall Study|Lost to Follow-up|7
1403820|NCT01194830|4632956|P1|Overall Study|Lost to Follow-up|9
1403821|NCT01194830|4632955|P2|Overall Study|Protocol Violation|4
1403822|NCT01194830|4632956|P1|Overall Study|Protocol Violation|5
1403823|NCT01194830|4632955|P2|Overall Study|Adverse Event|2
1403824|NCT01194830|4632956|P1|Overall Study|Adverse Event|3
1403825|NCT01194570|4632992|P2|Overall Study|Lost to Follow-up|4
1403826|NCT01194570|4632993|P1|Overall Study|Lost to Follow-up|1
1403827|NCT01194570|4632992|P2|Overall Study|Pregnancy|1
1403828|NCT01194570|4632993|P1|Overall Study|Pregnancy|1
1403829|NCT01194570|4632992|P2|Overall Study|Withdrawal by Subject|22
1403830|NCT01194570|4632993|P1|Overall Study|Withdrawal by Subject|21
1403831|NCT01194570|4632992|P2|Overall Study|Lack of Efficacy|21
1403832|NCT01194570|4632993|P1|Overall Study|Lack of Efficacy|27
1403833|NCT01194570|4632992|P2|Overall Study|Non-compliance|2
1403834|NCT01194570|4632993|P1|Overall Study|Non-compliance|2
1403835|NCT01194570|4632992|P2|Overall Study|Adverse Event|18
1403836|NCT01194570|4632993|P1|Overall Study|Adverse Event|12
1403837|NCT01194570|4632992|P2|Overall Study|Non-compliance with study drug|2
1403838|NCT01194570|4632993|P1|Overall Study|Non-compliance with study drug|2
1403839|NCT01194570|4632992|P2|Overall Study|Protocol Violation|2
1403840|NCT01194570|4632993|P1|Overall Study|Protocol Violation|0
1403841|NCT01194570|4632992|P2|Overall Study|Reason not specified|20
1403842|NCT01194570|4632993|P1|Overall Study|Reason not specified|13
1403843|NCT01194570|4632992|P2|Overall Study|Physician Decision|6
1403844|NCT01194570|4632993|P1|Overall Study|Physician Decision|2
1403845|NCT01194570|4632992|P2|Overall Study|Ongoing at CCOD|387
1403846|NCT01194570|4632993|P1|Overall Study|Ongoing at CCOD|162
1403847|NCT01194570|4632992|P2|Overall Study|Death|3
1403848|NCT01194570|4632993|P1|Overall Study|Death|1
1403849|NCT01194531|4633013|P2|Overall Study|Physician Decision|2
1403850|NCT01194531|4633014|P1|Overall Study|Physician Decision|0
1403851|NCT01194531|4633013|P2|Overall Study|Protocol Violation|1
1403852|NCT01194531|4633014|P1|Overall Study|Protocol Violation|4
1403853|NCT01194531|4633013|P2|Overall Study|Withdrawal by Subject|0
1403854|NCT01194531|4633014|P1|Overall Study|Withdrawal by Subject|1
1403855|NCT01194440|4633058|P1|Overall Study|Lost to Follow-up|1
1403856|NCT01194440|4633058|P1|Overall Study|Withdrawal by Subject|2
1403857|NCT01194440|4633058|P1|Overall Study|Adverse Event|9
1403858|NCT01194414|4633068|P4|72 Weeks Open Label Extension|Death|2
1403859|NCT01194414|4633069|P3|72 Weeks Open Label Extension|Death|0
1403860|NCT01194414|4633070|P2|72 Weeks Open Label Extension|Death|2
1403861|NCT01194414|4633071|P1|72 Weeks Open Label Extension|Death|1
1403862|NCT01194414|4633068|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
1403863|NCT01194414|4633069|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
1403864|NCT01194414|4633070|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
1403865|NCT01194414|4633071|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
1403866|NCT01194414|4633068|P4|72 Weeks Open Label Extension|Adverse Event|12
1403867|NCT01194414|4633069|P3|72 Weeks Open Label Extension|Adverse Event|2
1403868|NCT01194414|4633070|P2|72 Weeks Open Label Extension|Adverse Event|21
1403869|NCT01194414|4633071|P1|72 Weeks Open Label Extension|Adverse Event|35
1403870|NCT01194414|4633068|P4|72 Weeks Open Label Extension|Protocol Violation|1
1403871|NCT01194414|4633069|P3|72 Weeks Open Label Extension|Protocol Violation|0
1403872|NCT01194414|4633070|P2|72 Weeks Open Label Extension|Protocol Violation|0
1403873|NCT01194414|4633071|P1|72 Weeks Open Label Extension|Protocol Violation|0
1403874|NCT01194414|4633068|P4|72 Weeks Open Label Extension|Other|0
1403875|NCT01194414|4633069|P3|72 Weeks Open Label Extension|Other|0
1403876|NCT01194414|4633070|P2|72 Weeks Open Label Extension|Other|1
1403877|NCT01194414|4633071|P1|72 Weeks Open Label Extension|Other|2
1403878|NCT01194414|4633068|P4|72 Weeks Open Label Extension|Pregnancy|1
1403879|NCT01194414|4633069|P3|72 Weeks Open Label Extension|Pregnancy|1
1403880|NCT01194414|4633070|P2|72 Weeks Open Label Extension|Pregnancy|3
1403881|NCT01194414|4633071|P1|72 Weeks Open Label Extension|Pregnancy|1
1403882|NCT01194414|4633068|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
1403883|NCT01194414|4633069|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
1403884|NCT01194414|4633070|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
1403885|NCT01194414|4633071|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
1403886|NCT01194414|4633068|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
1403887|NCT01194414|4633069|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
1403888|NCT01194414|4633070|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
1403889|NCT01194414|4633071|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
1403890|NCT01194414|4633068|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
1403891|NCT01194414|4633069|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
1403892|NCT01194414|4633070|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
1403893|NCT01194414|4633071|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
1403894|NCT01194414|4633068|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
1403895|NCT01194414|4633069|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
1403896|NCT01194414|4633070|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
1403897|NCT01194414|4633071|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
1403898|NCT01194414|4633068|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
1403899|NCT01194414|4633069|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
1403900|NCT01194414|4633070|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
1403901|NCT01194414|4633071|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
1403902|NCT01194414|4633068|P4|24 Weeks Double Blind Period|Death|0
1403903|NCT01194414|4633069|P3|24 Weeks Double Blind Period|Death|0
1403904|NCT01194414|4633070|P2|24 Weeks Double Blind Period|Death|1
1403905|NCT01194414|4633071|P1|24 Weeks Double Blind Period|Death|0
1403906|NCT01194414|4633068|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
1403907|NCT01194414|4633069|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
1403908|NCT01194414|4633070|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
1403909|NCT01194414|4633071|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
1403910|NCT01194414|4633068|P4|24 Weeks Double Blind Period|Adverse Event|0
1403911|NCT01194414|4633069|P3|24 Weeks Double Blind Period|Adverse Event|0
1403912|NCT01194414|4633070|P2|24 Weeks Double Blind Period|Adverse Event|40
1403913|NCT01194414|4633071|P1|24 Weeks Double Blind Period|Adverse Event|28
1403914|NCT01194414|4633068|P4|24 Weeks Double Blind Period|Other|0
1403915|NCT01194414|4633069|P3|24 Weeks Double Blind Period|Other|0
1403916|NCT01194414|4633070|P2|24 Weeks Double Blind Period|Other|1
1403917|NCT01194414|4633071|P1|24 Weeks Double Blind Period|Other|0
1403918|NCT01194414|4633068|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
1403919|NCT01194414|4633069|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
1403920|NCT01194414|4633070|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
1403921|NCT01194414|4633071|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
1403922|NCT01194414|4633068|P4|24 Weeks Double Blind Period|Pregnancy|0
1403923|NCT01194414|4633069|P3|24 Weeks Double Blind Period|Pregnancy|0
1403924|NCT01194414|4633070|P2|24 Weeks Double Blind Period|Pregnancy|2
1403925|NCT01194414|4633071|P1|24 Weeks Double Blind Period|Pregnancy|2
1403926|NCT01194414|4633068|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
1403927|NCT01194414|4633069|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
1403928|NCT01194414|4633070|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
1403929|NCT01194414|4633071|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
1403930|NCT01194414|4633068|P4|24 Weeks Double Blind Period|Protocol Violation|0
1403931|NCT01194414|4633069|P3|24 Weeks Double Blind Period|Protocol Violation|0
1403932|NCT01194414|4633070|P2|24 Weeks Double Blind Period|Protocol Violation|3
1403933|NCT01194414|4633071|P1|24 Weeks Double Blind Period|Protocol Violation|5
1403934|NCT01194414|4633068|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
1403935|NCT01194414|4633069|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
1403936|NCT01194414|4633070|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
1403937|NCT01194414|4633071|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
1403938|NCT01194414|4633068|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
1403939|NCT01194414|4633069|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
1403940|NCT01194414|4633070|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
1403941|NCT01194414|4633071|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
1403942|NCT01194258|4633142|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
1403943|NCT01194258|4633143|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
1403944|NCT01194258|4633144|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
1403945|NCT01194258|4633145|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
1403946|NCT01194258|4633146|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
1403947|NCT01194258|4633142|P5|Period 2 (12 Weeks)|Adverse Event|0
1403948|NCT01194258|4633143|P4|Period 2 (12 Weeks)|Adverse Event|0
1403949|NCT01194258|4633144|P3|Period 2 (12 Weeks)|Adverse Event|0
1403950|NCT01194258|4633145|P2|Period 2 (12 Weeks)|Adverse Event|1
1403951|NCT01194258|4633146|P1|Period 2 (12 Weeks)|Adverse Event|0
1403952|NCT01194258|4633142|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
1403953|NCT01194258|4633143|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
1403954|NCT01194258|4633144|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
1403955|NCT01194258|4633145|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
1403956|NCT01194258|4633146|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
1403957|NCT01194258|4633142|P5|Period 1 (12 Weeks)|Death|1
1403958|NCT01194258|4633143|P4|Period 1 (12 Weeks)|Death|0
1403959|NCT01194258|4633144|P3|Period 1 (12 Weeks)|Death|0
1403960|NCT01194258|4633145|P2|Period 1 (12 Weeks)|Death|0
1403961|NCT01194258|4633146|P1|Period 1 (12 Weeks)|Death|0
1403962|NCT01194258|4633142|P5|Titration Period|Titration failure|0
1403963|NCT01194258|4633143|P4|Titration Period|Titration failure|0
1403964|NCT01194258|4633144|P3|Titration Period|Titration failure|0
1403965|NCT01194258|4633145|P2|Titration Period|Titration failure|0
1403966|NCT01194258|4633146|P1|Titration Period|Titration failure|3
1403967|NCT01194258|4633142|P5|Titration Period|Lost to Follow-up|0
1403968|NCT01194258|4633143|P4|Titration Period|Lost to Follow-up|0
1403969|NCT01194258|4633144|P3|Titration Period|Lost to Follow-up|0
1403970|NCT01194258|4633145|P2|Titration Period|Lost to Follow-up|0
1403971|NCT01194258|4633146|P1|Titration Period|Lost to Follow-up|2
1403972|NCT01194258|4633142|P5|Titration Period|Withdrawal by Subject|0
1403973|NCT01194258|4633143|P4|Titration Period|Withdrawal by Subject|0
1403974|NCT01194258|4633144|P3|Titration Period|Withdrawal by Subject|0
1403975|NCT01194258|4633145|P2|Titration Period|Withdrawal by Subject|0
1403976|NCT01194258|4633146|P1|Titration Period|Withdrawal by Subject|6
1403977|NCT01194245|4633170|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
1403978|NCT01194245|4633171|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
1403979|NCT01194245|4633172|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
1403980|NCT01194245|4633173|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
1403981|NCT01194245|4633174|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
1403982|NCT01194245|4633170|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
1403983|NCT01194245|4633171|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
1403984|NCT01194245|4633172|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
1403985|NCT01194245|4633173|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
1403986|NCT01194245|4633174|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
1403987|NCT01194245|4633170|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
1403988|NCT01194245|4633171|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
1403989|NCT01194245|4633172|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
1403990|NCT01194245|4633173|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
1403991|NCT01194245|4633174|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
1403992|NCT01194245|4633170|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
1403993|NCT01194245|4633171|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
1403994|NCT01194245|4633172|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
1403995|NCT01194245|4633173|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
1403996|NCT01194245|4633174|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
1403997|NCT01194245|4633170|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
1403998|NCT01194245|4633171|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
1403999|NCT01194245|4633172|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
1404000|NCT01194245|4633173|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
1404001|NCT01194245|4633174|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
1404002|NCT01194245|4633170|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
1404003|NCT01194245|4633171|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
1404004|NCT01194245|4633172|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
1404005|NCT01194245|4633173|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
1404006|NCT01194245|4633174|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
1404007|NCT01194219|4633195|P10|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
1404008|NCT01194219|4633196|P9|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
1404009|NCT01194219|4633197|P8|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1404010|NCT01194219|4633198|P7|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1404011|NCT01194219|4633199|P6|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1404012|NCT01194219|4633200|P5|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1404013|NCT01194219|4633201|P4|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1404014|NCT01194219|4633202|P3|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1404015|NCT01194219|4633203|P2|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1404016|NCT01194219|4633204|P1|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1404017|NCT01194219|4633195|P10|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1404018|NCT01194219|4633196|P9|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
1404019|NCT01194219|4633197|P8|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1404020|NCT01194219|4633198|P7|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1404021|NCT01194219|4633199|P6|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1404022|NCT01194219|4633200|P5|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1404023|NCT01194219|4633201|P4|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1404024|NCT01194219|4633202|P3|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1404025|NCT01194219|4633203|P2|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1404026|NCT01194219|4633204|P1|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1404027|NCT01194219|4633195|P10|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
1404028|NCT01194219|4633196|P9|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
1404029|NCT01194219|4633197|P8|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1404030|NCT01194219|4633198|P7|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1404031|NCT01194219|4633199|P6|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1404032|NCT01194219|4633200|P5|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1404033|NCT01194219|4633201|P4|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1404034|NCT01194219|4633202|P3|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1404035|NCT01194219|4633203|P2|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1404036|NCT01194219|4633204|P1|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1404037|NCT01194219|4633195|P10|Long-Term Extension Weeks 52 to 260|Death|1
1404038|NCT01194219|4633196|P9|Long-Term Extension Weeks 52 to 260|Death|1
1404039|NCT01194219|4633197|P8|Long-Term Extension Weeks 52 to 260|Death|0
1404040|NCT01194219|4633198|P7|Long-Term Extension Weeks 52 to 260|Death|0
1404041|NCT01194219|4633199|P6|Long-Term Extension Weeks 52 to 260|Death|0
1404042|NCT01194219|4633200|P5|Long-Term Extension Weeks 52 to 260|Death|0
1404043|NCT01194219|4633201|P4|Long-Term Extension Weeks 52 to 260|Death|0
1404044|NCT01194219|4633202|P3|Long-Term Extension Weeks 52 to 260|Death|0
1404045|NCT01194219|4633203|P2|Long-Term Extension Weeks 52 to 260|Death|0
1404046|NCT01194219|4633204|P1|Long-Term Extension Weeks 52 to 260|Death|0
1404047|NCT01194219|4633195|P10|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
1404048|NCT01194219|4633196|P9|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
1404049|NCT01194219|4633197|P8|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1404050|NCT01194219|4633198|P7|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1404051|NCT01194219|4633199|P6|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1404052|NCT01194219|4633200|P5|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1404053|NCT01194219|4633201|P4|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1404054|NCT01194219|4633202|P3|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1404055|NCT01194219|4633203|P2|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1404056|NCT01194219|4633204|P1|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1404057|NCT01194219|4633195|P10|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
1404058|NCT01194219|4633196|P9|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
1404059|NCT01194219|4633197|P8|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1404060|NCT01194219|4633198|P7|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1404061|NCT01194219|4633199|P6|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1404062|NCT01194219|4633200|P5|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1404063|NCT01194219|4633201|P4|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1404064|NCT01194219|4633202|P3|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1404065|NCT01194219|4633203|P2|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1404066|NCT01194219|4633204|P1|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1404067|NCT01194219|4633195|P10|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
1404068|NCT01194219|4633196|P9|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
1404370|NCT01193920|4633281|P9|Overall Study|Withdrawal by Subject|1
1404069|NCT01194219|4633197|P8|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1404070|NCT01194219|4633198|P7|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1404071|NCT01194219|4633199|P6|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1404072|NCT01194219|4633200|P5|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1404073|NCT01194219|4633201|P4|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1404074|NCT01194219|4633202|P3|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1404075|NCT01194219|4633203|P2|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1404076|NCT01194219|4633204|P1|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1404077|NCT01194219|4633195|P10|Long-Term Extension Weeks 52 to 260|Adverse Event|14
1404078|NCT01194219|4633196|P9|Long-Term Extension Weeks 52 to 260|Adverse Event|25
1404079|NCT01194219|4633197|P8|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1404080|NCT01194219|4633198|P7|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1404081|NCT01194219|4633199|P6|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1404082|NCT01194219|4633200|P5|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1404083|NCT01194219|4633201|P4|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1404084|NCT01194219|4633202|P3|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1404085|NCT01194219|4633203|P2|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1404086|NCT01194219|4633204|P1|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1404087|NCT01194219|4633195|P10|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1404088|NCT01194219|4633196|P9|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1404089|NCT01194219|4633197|P8|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1404090|NCT01194219|4633198|P7|Randomized Withdrawal Phase-Weeks 32-52|Not specified|1
1404091|NCT01194219|4633199|P6|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1404092|NCT01194219|4633200|P5|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1404093|NCT01194219|4633201|P4|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1404094|NCT01194219|4633202|P3|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1404095|NCT01194219|4633203|P2|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1404096|NCT01194219|4633204|P1|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
1404097|NCT01194219|4633195|P10|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1404098|NCT01194219|4633196|P9|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1404099|NCT01194219|4633197|P8|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
1404100|NCT01194219|4633198|P7|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1404101|NCT01194219|4633199|P6|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1404102|NCT01194219|4633200|P5|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1404103|NCT01194219|4633201|P4|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1404104|NCT01194219|4633202|P3|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1404105|NCT01194219|4633203|P2|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1404106|NCT01194219|4633204|P1|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1404107|NCT01194219|4633195|P10|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1404108|NCT01194219|4633196|P9|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1404109|NCT01194219|4633197|P8|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1404110|NCT01194219|4633198|P7|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
1404111|NCT01194219|4633199|P6|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
1404112|NCT01194219|4633200|P5|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
1404113|NCT01194219|4633201|P4|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1404114|NCT01194219|4633202|P3|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1404115|NCT01194219|4633203|P2|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1404116|NCT01194219|4633204|P1|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1404117|NCT01194219|4633195|P10|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1404118|NCT01194219|4633196|P9|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1404119|NCT01194219|4633197|P8|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
1404120|NCT01194219|4633198|P7|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
1404121|NCT01194219|4633199|P6|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1404122|NCT01194219|4633200|P5|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
1404123|NCT01194219|4633201|P4|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1404124|NCT01194219|4633202|P3|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1404125|NCT01194219|4633203|P2|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1404126|NCT01194219|4633204|P1|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1404127|NCT01194219|4633195|P10|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1404128|NCT01194219|4633196|P9|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1404129|NCT01194219|4633197|P8|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1404130|NCT01194219|4633198|P7|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
1404131|NCT01194219|4633199|P6|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1404132|NCT01194219|4633200|P5|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
1404133|NCT01194219|4633201|P4|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1404134|NCT01194219|4633202|P3|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1404135|NCT01194219|4633203|P2|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1404136|NCT01194219|4633204|P1|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1404137|NCT01194219|4633195|P10|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1404138|NCT01194219|4633196|P9|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1404139|NCT01194219|4633197|P8|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
1404140|NCT01194219|4633198|P7|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
1404141|NCT01194219|4633199|P6|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
1404142|NCT01194219|4633200|P5|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
1404143|NCT01194219|4633201|P4|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1404144|NCT01194219|4633202|P3|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1404145|NCT01194219|4633203|P2|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1404146|NCT01194219|4633204|P1|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1404147|NCT01194219|4633195|P10|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1404148|NCT01194219|4633196|P9|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1404149|NCT01194219|4633197|P8|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
1404150|NCT01194219|4633198|P7|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
1404151|NCT01194219|4633199|P6|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
1404152|NCT01194219|4633200|P5|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1404153|NCT01194219|4633201|P4|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1404154|NCT01194219|4633202|P3|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1404155|NCT01194219|4633203|P2|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1404156|NCT01194219|4633204|P1|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1404157|NCT01194219|4633195|P10|Maintenance Phase Weeks16-32|Other|0
1404158|NCT01194219|4633196|P9|Maintenance Phase Weeks16-32|Other|0
1404159|NCT01194219|4633197|P8|Maintenance Phase Weeks16-32|Other|0
1404160|NCT01194219|4633198|P7|Maintenance Phase Weeks16-32|Other|0
1404161|NCT01194219|4633199|P6|Maintenance Phase Weeks16-32|Other|0
1404162|NCT01194219|4633200|P5|Maintenance Phase Weeks16-32|Other|0
1404163|NCT01194219|4633201|P4|Maintenance Phase Weeks16-32|Other|1
1404164|NCT01194219|4633202|P3|Maintenance Phase Weeks16-32|Other|2
1404165|NCT01194219|4633203|P2|Maintenance Phase Weeks16-32|Other|0
1404166|NCT01194219|4633204|P1|Maintenance Phase Weeks16-32|Other|0
1404167|NCT01194219|4633195|P10|Maintenance Phase Weeks16-32|Protocol Violation|0
1404168|NCT01194219|4633196|P9|Maintenance Phase Weeks16-32|Protocol Violation|0
1404169|NCT01194219|4633197|P8|Maintenance Phase Weeks16-32|Protocol Violation|0
1404170|NCT01194219|4633198|P7|Maintenance Phase Weeks16-32|Protocol Violation|0
1404171|NCT01194219|4633199|P6|Maintenance Phase Weeks16-32|Protocol Violation|0
1404172|NCT01194219|4633200|P5|Maintenance Phase Weeks16-32|Protocol Violation|0
1404173|NCT01194219|4633201|P4|Maintenance Phase Weeks16-32|Protocol Violation|1
1404174|NCT01194219|4633202|P3|Maintenance Phase Weeks16-32|Protocol Violation|0
1404175|NCT01194219|4633203|P2|Maintenance Phase Weeks16-32|Protocol Violation|0
1404176|NCT01194219|4633204|P1|Maintenance Phase Weeks16-32|Protocol Violation|0
1404177|NCT01194219|4633195|P10|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1404178|NCT01194219|4633196|P9|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1404179|NCT01194219|4633197|P8|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1404180|NCT01194219|4633198|P7|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1404181|NCT01194219|4633199|P6|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1404182|NCT01194219|4633200|P5|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1404183|NCT01194219|4633201|P4|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1404184|NCT01194219|4633202|P3|Maintenance Phase Weeks16-32|Lost to Follow-up|9
1404185|NCT01194219|4633203|P2|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1404186|NCT01194219|4633204|P1|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1404187|NCT01194219|4633195|P10|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1404188|NCT01194219|4633196|P9|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1404189|NCT01194219|4633197|P8|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1404190|NCT01194219|4633198|P7|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1404191|NCT01194219|4633199|P6|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1404192|NCT01194219|4633200|P5|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1404193|NCT01194219|4633201|P4|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
1404194|NCT01194219|4633202|P3|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
1404195|NCT01194219|4633203|P2|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1404196|NCT01194219|4633204|P1|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1404197|NCT01194219|4633195|P10|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1404198|NCT01194219|4633196|P9|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1404199|NCT01194219|4633197|P8|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1404200|NCT01194219|4633198|P7|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1404201|NCT01194219|4633199|P6|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1404202|NCT01194219|4633200|P5|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1404203|NCT01194219|4633201|P4|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
1404204|NCT01194219|4633202|P3|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
1404205|NCT01194219|4633203|P2|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1404206|NCT01194219|4633204|P1|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1404207|NCT01194219|4633195|P10|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1404208|NCT01194219|4633196|P9|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1404209|NCT01194219|4633197|P8|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1404210|NCT01194219|4633198|P7|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1404211|NCT01194219|4633199|P6|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1404371|NCT01193920|4633282|P8|Overall Study|Withdrawal by Subject|0
1404212|NCT01194219|4633200|P5|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1404213|NCT01194219|4633201|P4|Maintenance Phase Weeks16-32|Lack of Efficacy|15
1404214|NCT01194219|4633202|P3|Maintenance Phase Weeks16-32|Lack of Efficacy|37
1404215|NCT01194219|4633203|P2|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1404216|NCT01194219|4633204|P1|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1404217|NCT01194219|4633195|P10|Maintenance Phase Weeks16-32|Adverse Event|0
1404218|NCT01194219|4633196|P9|Maintenance Phase Weeks16-32|Adverse Event|0
1404219|NCT01194219|4633197|P8|Maintenance Phase Weeks16-32|Adverse Event|0
1404220|NCT01194219|4633198|P7|Maintenance Phase Weeks16-32|Adverse Event|0
1404221|NCT01194219|4633199|P6|Maintenance Phase Weeks16-32|Adverse Event|0
1404222|NCT01194219|4633200|P5|Maintenance Phase Weeks16-32|Adverse Event|0
1404223|NCT01194219|4633201|P4|Maintenance Phase Weeks16-32|Adverse Event|9
1404224|NCT01194219|4633202|P3|Maintenance Phase Weeks16-32|Adverse Event|8
1404225|NCT01194219|4633203|P2|Maintenance Phase Weeks16-32|Adverse Event|0
1404226|NCT01194219|4633204|P1|Maintenance Phase Weeks16-32|Adverse Event|0
1404227|NCT01194219|4633195|P10|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1404228|NCT01194219|4633196|P9|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1404229|NCT01194219|4633197|P8|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1404230|NCT01194219|4633198|P7|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1404231|NCT01194219|4633199|P6|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1404232|NCT01194219|4633200|P5|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1404233|NCT01194219|4633201|P4|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1404234|NCT01194219|4633202|P3|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1404235|NCT01194219|4633203|P2|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
1404236|NCT01194219|4633204|P1|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
1404237|NCT01194219|4633195|P10|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1404238|NCT01194219|4633196|P9|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1404239|NCT01194219|4633197|P8|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1404240|NCT01194219|4633198|P7|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1404241|NCT01194219|4633199|P6|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1404242|NCT01194219|4633200|P5|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1404243|NCT01194219|4633201|P4|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1404244|NCT01194219|4633202|P3|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1404245|NCT01194219|4633203|P2|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
1404246|NCT01194219|4633204|P1|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
1404247|NCT01194219|4633195|P10|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1404248|NCT01194219|4633196|P9|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1404249|NCT01194219|4633197|P8|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1404250|NCT01194219|4633198|P7|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1404251|NCT01194219|4633199|P6|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1404252|NCT01194219|4633200|P5|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1404253|NCT01194219|4633201|P4|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1404254|NCT01194219|4633202|P3|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1404255|NCT01194219|4633203|P2|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
1404256|NCT01194219|4633204|P1|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
1404257|NCT01194219|4633195|P10|Placebo-Controlled Phase Weeks 0-16|Death|0
1404258|NCT01194219|4633196|P9|Placebo-Controlled Phase Weeks 0-16|Death|0
1404259|NCT01194219|4633197|P8|Placebo-Controlled Phase Weeks 0-16|Death|0
1404260|NCT01194219|4633198|P7|Placebo-Controlled Phase Weeks 0-16|Death|0
1404261|NCT01194219|4633199|P6|Placebo-Controlled Phase Weeks 0-16|Death|0
1404262|NCT01194219|4633200|P5|Placebo-Controlled Phase Weeks 0-16|Death|0
1404263|NCT01194219|4633201|P4|Placebo-Controlled Phase Weeks 0-16|Death|0
1404264|NCT01194219|4633202|P3|Placebo-Controlled Phase Weeks 0-16|Death|0
1404265|NCT01194219|4633203|P2|Placebo-Controlled Phase Weeks 0-16|Death|1
1404266|NCT01194219|4633204|P1|Placebo-Controlled Phase Weeks 0-16|Death|0
1404267|NCT01194219|4633195|P10|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1404268|NCT01194219|4633196|P9|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1404269|NCT01194219|4633197|P8|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1404270|NCT01194219|4633198|P7|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1404271|NCT01194219|4633199|P6|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1404272|NCT01194219|4633200|P5|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1404273|NCT01194219|4633201|P4|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1404274|NCT01194219|4633202|P3|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1404275|NCT01194219|4633203|P2|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
1404276|NCT01194219|4633204|P1|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
1404277|NCT01194219|4633195|P10|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1404278|NCT01194219|4633196|P9|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1404279|NCT01194219|4633197|P8|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1404280|NCT01194219|4633198|P7|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1404281|NCT01194219|4633199|P6|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1404282|NCT01194219|4633200|P5|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1404283|NCT01194219|4633201|P4|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1404284|NCT01194219|4633202|P3|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1404285|NCT01194219|4633203|P2|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1404286|NCT01194219|4633204|P1|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
1404287|NCT01194219|4633195|P10|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1404288|NCT01194219|4633196|P9|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1404289|NCT01194219|4633197|P8|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1404290|NCT01194219|4633198|P7|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1404291|NCT01194219|4633199|P6|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1404292|NCT01194219|4633200|P5|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1404293|NCT01194219|4633201|P4|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1404294|NCT01194219|4633202|P3|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1404295|NCT01194219|4633203|P2|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
1404296|NCT01194219|4633204|P1|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
1404297|NCT01194219|4633195|P10|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1404298|NCT01194219|4633196|P9|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1404299|NCT01194219|4633197|P8|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1404300|NCT01194219|4633198|P7|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1404301|NCT01194219|4633199|P6|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1404302|NCT01194219|4633200|P5|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1404303|NCT01194219|4633201|P4|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1404304|NCT01194219|4633202|P3|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1404305|NCT01194219|4633203|P2|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
1404306|NCT01194219|4633204|P1|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
1404307|NCT01194154|4633238|P2|Overall Study|Did not receive study medication|4
1404308|NCT01194154|4633239|P1|Overall Study|Did not receive study medication|2
1404309|NCT01194154|4633238|P2|Overall Study|Other|0
1404310|NCT01194154|4633239|P1|Overall Study|Other|4
1404311|NCT01194154|4633238|P2|Overall Study|Treatment with prohibited medication|5
1404312|NCT01194154|4633239|P1|Overall Study|Treatment with prohibited medication|4
1404313|NCT01194154|4633238|P2|Overall Study|Skipping of CERA treatment at two visits|0
1404314|NCT01194154|4633239|P1|Overall Study|Skipping of CERA treatment at two visits|3
1404315|NCT01194154|4633238|P2|Overall Study|Hemoglobin increase|3
1404316|NCT01194154|4633239|P1|Overall Study|Hemoglobin increase|12
1404317|NCT01194154|4633238|P2|Overall Study|Hemoglobin decrease|1
1404318|NCT01194154|4633239|P1|Overall Study|Hemoglobin decrease|0
1404319|NCT01194154|4633238|P2|Overall Study|Blood pressure increase|3
1404320|NCT01194154|4633239|P1|Overall Study|Blood pressure increase|5
1404321|NCT01194154|4633238|P2|Overall Study|Withdrawal by Subject|6
1404322|NCT01194154|4633239|P1|Overall Study|Withdrawal by Subject|5
1404323|NCT01194154|4633238|P2|Overall Study|Protocol Violation|1
1404324|NCT01194154|4633239|P1|Overall Study|Protocol Violation|0
1404325|NCT01194154|4633238|P2|Overall Study|Lost to Follow-up|3
1404326|NCT01194154|4633239|P1|Overall Study|Lost to Follow-up|2
1404327|NCT01194154|4633238|P2|Overall Study|Adverse Event|7
1404328|NCT01194154|4633239|P1|Overall Study|Adverse Event|12
1404329|NCT01193920|4633280|P10|Overall Study|Unable to classify|0
1404330|NCT01193920|4633281|P9|Overall Study|Unable to classify|0
1404331|NCT01193920|4633282|P8|Overall Study|Unable to classify|1
1404332|NCT01193920|4633283|P7|Overall Study|Unable to classify|0
1404333|NCT01193920|4633284|P6|Overall Study|Unable to classify|0
1404334|NCT01193920|4633285|P5|Overall Study|Unable to classify|0
1404335|NCT01193920|4633286|P4|Overall Study|Unable to classify|1
1404336|NCT01193920|4633287|P3|Overall Study|Unable to classify|0
1404337|NCT01193920|4633288|P2|Overall Study|Unable to classify|0
1404338|NCT01193920|4633289|P1|Overall Study|Unable to classify|0
1404339|NCT01193920|4633280|P10|Overall Study|Death|4
1404340|NCT01193920|4633281|P9|Overall Study|Death|2
1404341|NCT01193920|4633282|P8|Overall Study|Death|3
1404342|NCT01193920|4633283|P7|Overall Study|Death|2
1404343|NCT01193920|4633284|P6|Overall Study|Death|0
1404344|NCT01193920|4633285|P5|Overall Study|Death|0
1404345|NCT01193920|4633286|P4|Overall Study|Death|1
1404346|NCT01193920|4633287|P3|Overall Study|Death|0
1404347|NCT01193920|4633288|P2|Overall Study|Death|0
1404348|NCT01193920|4633289|P1|Overall Study|Death|0
1404349|NCT01193920|4633280|P10|Overall Study|Protocol Violation|0
1404350|NCT01193920|4633281|P9|Overall Study|Protocol Violation|0
1404351|NCT01193920|4633282|P8|Overall Study|Protocol Violation|0
1404352|NCT01193920|4633283|P7|Overall Study|Protocol Violation|0
1404353|NCT01193920|4633284|P6|Overall Study|Protocol Violation|0
1404354|NCT01193920|4633285|P5|Overall Study|Protocol Violation|0
1404355|NCT01193920|4633286|P4|Overall Study|Protocol Violation|0
1404356|NCT01193920|4633287|P3|Overall Study|Protocol Violation|0
1404357|NCT01193920|4633288|P2|Overall Study|Protocol Violation|0
1404358|NCT01193920|4633289|P1|Overall Study|Protocol Violation|1
1404359|NCT01193920|4633280|P10|Overall Study|Lost to Follow-up|3
1404360|NCT01193920|4633281|P9|Overall Study|Lost to Follow-up|2
1404361|NCT01193920|4633282|P8|Overall Study|Lost to Follow-up|0
1404362|NCT01193920|4633283|P7|Overall Study|Lost to Follow-up|1
1404363|NCT01193920|4633284|P6|Overall Study|Lost to Follow-up|3
1404364|NCT01193920|4633285|P5|Overall Study|Lost to Follow-up|3
1404365|NCT01193920|4633286|P4|Overall Study|Lost to Follow-up|1
1404366|NCT01193920|4633287|P3|Overall Study|Lost to Follow-up|1
1404367|NCT01193920|4633288|P2|Overall Study|Lost to Follow-up|0
1404368|NCT01193920|4633289|P1|Overall Study|Lost to Follow-up|1
1404369|NCT01193920|4633280|P10|Overall Study|Withdrawal by Subject|0
1404372|NCT01193920|4633283|P7|Overall Study|Withdrawal by Subject|3
1404373|NCT01193920|4633284|P6|Overall Study|Withdrawal by Subject|1
1404374|NCT01193920|4633285|P5|Overall Study|Withdrawal by Subject|3
1404375|NCT01193920|4633286|P4|Overall Study|Withdrawal by Subject|1
1404376|NCT01193920|4633287|P3|Overall Study|Withdrawal by Subject|5
1404377|NCT01193920|4633288|P2|Overall Study|Withdrawal by Subject|0
1404378|NCT01193920|4633289|P1|Overall Study|Withdrawal by Subject|1
1404379|NCT01193842|4633385|P5|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
1404380|NCT01193842|4633386|P4|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
1404381|NCT01193842|4633387|P3|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
1404382|NCT01193842|4633388|P2|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
1404383|NCT01193842|4633389|P1|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
1404384|NCT01193842|4633385|P5|Phase II: Randomized Groups|Ineligible|1
1404385|NCT01193842|4633386|P4|Phase II: Randomized Groups|Ineligible|0
1404386|NCT01193842|4633387|P3|Phase II: Randomized Groups|Ineligible|0
1404387|NCT01193842|4633388|P2|Phase II: Randomized Groups|Ineligible|0
1404388|NCT01193842|4633389|P1|Phase II: Randomized Groups|Ineligible|0
1404389|NCT01193842|4633385|P5|Phase II: Randomized Groups|Withdrawal by Subject|2
1404390|NCT01193842|4633386|P4|Phase II: Randomized Groups|Withdrawal by Subject|1
1404391|NCT01193842|4633387|P3|Phase II: Randomized Groups|Withdrawal by Subject|0
1404392|NCT01193842|4633388|P2|Phase II: Randomized Groups|Withdrawal by Subject|0
1404393|NCT01193842|4633389|P1|Phase II: Randomized Groups|Withdrawal by Subject|0
1404394|NCT01193842|4633385|P5|Phase II: Randomized Groups|Adverse Event|3
1404395|NCT01193842|4633386|P4|Phase II: Randomized Groups|Adverse Event|5
1404396|NCT01193842|4633387|P3|Phase II: Randomized Groups|Adverse Event|0
1404397|NCT01193842|4633388|P2|Phase II: Randomized Groups|Adverse Event|0
1404398|NCT01193842|4633389|P1|Phase II: Randomized Groups|Adverse Event|0
1404399|NCT01193842|4633385|P5|Phase II: Randomized Groups|Death|1
1404400|NCT01193842|4633386|P4|Phase II: Randomized Groups|Death|1
1404401|NCT01193842|4633387|P3|Phase II: Randomized Groups|Death|0
1404402|NCT01193842|4633388|P2|Phase II: Randomized Groups|Death|0
1404403|NCT01193842|4633389|P1|Phase II: Randomized Groups|Death|0
1404404|NCT01193842|4633385|P5|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1404405|NCT01193842|4633386|P4|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1404406|NCT01193842|4633387|P3|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
1404407|NCT01193842|4633388|P2|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1404408|NCT01193842|4633389|P1|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1404409|NCT01193842|4633385|P5|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1404410|NCT01193842|4633386|P4|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1404411|NCT01193842|4633387|P3|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1404412|NCT01193842|4633388|P2|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1404413|NCT01193842|4633389|P1|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
1404414|NCT01193842|4633385|P5|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1404415|NCT01193842|4633386|P4|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1404416|NCT01193842|4633387|P3|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1404417|NCT01193842|4633388|P2|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
1404418|NCT01193842|4633389|P1|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1404419|NCT01193686|4633424|P2|Overall Study|Removed by Investigators; unable to matc|0
1404420|NCT01193686|4633425|P1|Overall Study|Removed by Investigators; unable to matc|3
1404421|NCT01193686|4633424|P2|Overall Study|Withdrawal by Subject|1
1404422|NCT01193686|4633425|P1|Overall Study|Withdrawal by Subject|4
1404423|NCT01193660|4633442|P3|Overall Study|Physician Decision|1
1404424|NCT01193660|4633443|P2|Overall Study|Physician Decision|0
1404425|NCT01193660|4633444|P1|Overall Study|Physician Decision|1
1404426|NCT01193660|4633442|P3|Overall Study|Death|0
1404427|NCT01193660|4633443|P2|Overall Study|Death|0
1404428|NCT01193660|4633444|P1|Overall Study|Death|1
1404429|NCT01193660|4633442|P3|Overall Study|Withdrawal by Subject|1
1404430|NCT01193660|4633443|P2|Overall Study|Withdrawal by Subject|3
1404431|NCT01193660|4633444|P1|Overall Study|Withdrawal by Subject|2
1404432|NCT01193608|4633488|P6|Overall Study|Adverse Event|0
1404433|NCT01193608|4633489|P5|Overall Study|Adverse Event|1
1404434|NCT01193608|4633490|P4|Overall Study|Adverse Event|0
1404435|NCT01193608|4633491|P3|Overall Study|Adverse Event|0
1404436|NCT01193608|4633492|P2|Overall Study|Adverse Event|0
1404437|NCT01193608|4633493|P1|Overall Study|Adverse Event|0
1404438|NCT01193608|4633488|P6|Overall Study|Lost to Follow-up|2
1404439|NCT01193608|4633489|P5|Overall Study|Lost to Follow-up|1
1404440|NCT01193608|4633490|P4|Overall Study|Lost to Follow-up|0
1404441|NCT01193608|4633491|P3|Overall Study|Lost to Follow-up|0
1404442|NCT01193608|4633492|P2|Overall Study|Lost to Follow-up|0
1404443|NCT01193608|4633493|P1|Overall Study|Lost to Follow-up|0
1404444|NCT01193608|4633488|P6|Overall Study|Withdrawal by Subject|0
1404445|NCT01193608|4633489|P5|Overall Study|Withdrawal by Subject|3
1404446|NCT01193608|4633490|P4|Overall Study|Withdrawal by Subject|3
1404447|NCT01193608|4633491|P3|Overall Study|Withdrawal by Subject|2
1404448|NCT01193608|4633492|P2|Overall Study|Withdrawal by Subject|1
1404449|NCT01193608|4633493|P1|Overall Study|Withdrawal by Subject|0
1404450|NCT01193608|4633488|P6|Overall Study|Other|0
1404451|NCT01193608|4633489|P5|Overall Study|Other|0
1404452|NCT01193608|4633490|P4|Overall Study|Other|0
1404453|NCT01193608|4633491|P3|Overall Study|Other|0
1404454|NCT01193608|4633492|P2|Overall Study|Other|1
1404455|NCT01193608|4633493|P1|Overall Study|Other|0
1404456|NCT01193582|4633730|P4|12 Month Follow-up|Withdrawal by Subject|11
1404457|NCT01193582|4633731|P3|12 Month Follow-up|Withdrawal by Subject|3
1404458|NCT01193582|4633732|P2|12 Month Follow-up|Withdrawal by Subject|0
1404459|NCT01193582|4633733|P1|12 Month Follow-up|Withdrawal by Subject|6
1404460|NCT01193582|4633730|P4|12 Month Follow-up|Death|0
1404461|NCT01193582|4633731|P3|12 Month Follow-up|Death|1
1404462|NCT01193582|4633732|P2|12 Month Follow-up|Death|0
1404463|NCT01193582|4633733|P1|12 Month Follow-up|Death|0
1404464|NCT01193582|4633730|P4|Vaccination Series|Withdrawal by Subject|3
1404465|NCT01193582|4633731|P3|Vaccination Series|Withdrawal by Subject|8
1404466|NCT01193582|4633732|P2|Vaccination Series|Withdrawal by Subject|13
1404467|NCT01193582|4633733|P1|Vaccination Series|Withdrawal by Subject|11
1404468|NCT01193556|4633763|P2|Overall Study|Study termination|25
1404469|NCT01193556|4633764|P1|Overall Study|Study termination|26
1404470|NCT01193348|4633772|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
1404471|NCT01193348|4633772|P1|Extension Treatment Period|Physician Decision|1
1404472|NCT01193348|4633772|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
1404473|NCT01193348|4633772|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
1404474|NCT01193348|4633772|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
1404475|NCT01193348|4633772|P1|Screening Period|Screen Failure|5
1404476|NCT01193335|4633792|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
1404477|NCT01193335|4633793|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
1404478|NCT01193335|4633792|P2|2-Year Follow-up|No Longer Willing to Participate|6
1404479|NCT01193335|4633793|P1|2-Year Follow-up|No Longer Willing to Participate|5
1404480|NCT01193335|4633792|P2|1-Year Follow-up|Lost to Follow-up|0
1404481|NCT01193335|4633793|P1|1-Year Follow-up|Lost to Follow-up|4
1404482|NCT01193335|4633792|P2|1-Year Follow-up|No Longer Willing to Participate|9
1404483|NCT01193335|4633793|P1|1-Year Follow-up|No Longer Willing to Participate|7
1404484|NCT01193335|4633792|P2|After Infant Series|No Longer Met Eligibility Criteria|1
1404485|NCT01193335|4633793|P1|After Infant Series|No Longer Met Eligibility Criteria|0
1404486|NCT01193335|4633792|P2|After Infant Series|Lost to Follow-up|2
1404487|NCT01193335|4633793|P1|After Infant Series|Lost to Follow-up|1
1404488|NCT01193283|4633888|P1|Overall Study|Death|1
1404489|NCT01193244|4633894|P2|Overall Study|Lost to Follow-up|15
1404490|NCT01193244|4633895|P1|Overall Study|Lost to Follow-up|6
1404491|NCT01193244|4633894|P2|Overall Study|Other|278
1404492|NCT01193244|4633895|P1|Overall Study|Other|303
1404493|NCT01193244|4633894|P2|Overall Study|Withdrawal by Subject|97
1404494|NCT01193244|4633895|P1|Overall Study|Withdrawal by Subject|79
1404495|NCT01193218|4633950|P8|12-52 Weeks|Other reason than above|0
1404496|NCT01193218|4633951|P7|12-52 Weeks|Other reason than above|0
1404497|NCT01193218|4633952|P6|12-52 Weeks|Other reason than above|0
1404498|NCT01193218|4633953|P5|12-52 Weeks|Other reason than above|1
1404499|NCT01193218|4633954|P4|12-52 Weeks|Other reason than above|1
1404500|NCT01193218|4633955|P3|12-52 Weeks|Other reason than above|0
1404501|NCT01193218|4633956|P2|12-52 Weeks|Other reason than above|0
1404502|NCT01193218|4633957|P1|12-52 Weeks|Other reason than above|1
1404503|NCT01193218|4633950|P8|12-52 Weeks|Withdrawal by Subject|2
1404504|NCT01193218|4633951|P7|12-52 Weeks|Withdrawal by Subject|1
1404505|NCT01193218|4633952|P6|12-52 Weeks|Withdrawal by Subject|2
1404506|NCT01193218|4633953|P5|12-52 Weeks|Withdrawal by Subject|0
1404507|NCT01193218|4633954|P4|12-52 Weeks|Withdrawal by Subject|0
1404508|NCT01193218|4633955|P3|12-52 Weeks|Withdrawal by Subject|3
1404509|NCT01193218|4633956|P2|12-52 Weeks|Withdrawal by Subject|0
1404510|NCT01193218|4633957|P1|12-52 Weeks|Withdrawal by Subject|3
1404511|NCT01193218|4633950|P8|12-52 Weeks|Lack of Efficacy|0
1404512|NCT01193218|4633951|P7|12-52 Weeks|Lack of Efficacy|1
1404513|NCT01193218|4633952|P6|12-52 Weeks|Lack of Efficacy|0
1404514|NCT01193218|4633953|P5|12-52 Weeks|Lack of Efficacy|0
1404515|NCT01193218|4633954|P4|12-52 Weeks|Lack of Efficacy|0
1404516|NCT01193218|4633955|P3|12-52 Weeks|Lack of Efficacy|0
1404517|NCT01193218|4633956|P2|12-52 Weeks|Lack of Efficacy|0
1404518|NCT01193218|4633957|P1|12-52 Weeks|Lack of Efficacy|0
1404519|NCT01193218|4633950|P8|12-52 Weeks|Adverse Event|2
1404520|NCT01193218|4633951|P7|12-52 Weeks|Adverse Event|1
1404521|NCT01193218|4633952|P6|12-52 Weeks|Adverse Event|3
1404522|NCT01193218|4633953|P5|12-52 Weeks|Adverse Event|3
1404523|NCT01193218|4633954|P4|12-52 Weeks|Adverse Event|2
1404524|NCT01193218|4633955|P3|12-52 Weeks|Adverse Event|1
1404525|NCT01193218|4633956|P2|12-52 Weeks|Adverse Event|0
1404526|NCT01193218|4633957|P1|12-52 Weeks|Adverse Event|1
1404527|NCT01193218|4633950|P8|0-12 Weeks|Withdrawal by Subject|0
1404528|NCT01193218|4633951|P7|0-12 Weeks|Withdrawal by Subject|1
1404529|NCT01193218|4633952|P6|0-12 Weeks|Withdrawal by Subject|0
1404530|NCT01193218|4633953|P5|0-12 Weeks|Withdrawal by Subject|0
1404531|NCT01193218|4633954|P4|0-12 Weeks|Withdrawal by Subject|0
1404532|NCT01193218|4633955|P3|0-12 Weeks|Withdrawal by Subject|2
1404533|NCT01193218|4633956|P2|0-12 Weeks|Withdrawal by Subject|0
1404534|NCT01193218|4633957|P1|0-12 Weeks|Withdrawal by Subject|3
1404535|NCT01193218|4633950|P8|0-12 Weeks|Protocol Violation|0
1404536|NCT01193218|4633951|P7|0-12 Weeks|Protocol Violation|0
1404537|NCT01193218|4633952|P6|0-12 Weeks|Protocol Violation|1
1404538|NCT01193218|4633953|P5|0-12 Weeks|Protocol Violation|1
1404539|NCT01193218|4633954|P4|0-12 Weeks|Protocol Violation|0
1404540|NCT01193218|4633955|P3|0-12 Weeks|Protocol Violation|0
1404541|NCT01193218|4633956|P2|0-12 Weeks|Protocol Violation|0
1404542|NCT01193218|4633957|P1|0-12 Weeks|Protocol Violation|0
1404543|NCT01193218|4633950|P8|0-12 Weeks|Adverse Event|0
1404544|NCT01193218|4633951|P7|0-12 Weeks|Adverse Event|2
1404545|NCT01193218|4633952|P6|0-12 Weeks|Adverse Event|2
1404546|NCT01193218|4633953|P5|0-12 Weeks|Adverse Event|0
1404547|NCT01193218|4633954|P4|0-12 Weeks|Adverse Event|0
1404548|NCT01193218|4633955|P3|0-12 Weeks|Adverse Event|1
1404549|NCT01193218|4633956|P2|0-12 Weeks|Adverse Event|0
1404550|NCT01193218|4633957|P1|0-12 Weeks|Adverse Event|6
1404551|NCT01193153|4633988|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
1404552|NCT01193153|4633989|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
1404553|NCT01193153|4633988|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
1404554|NCT01193153|4633989|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
1404555|NCT01193153|4633988|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
1404556|NCT01193153|4633989|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
1404557|NCT01193153|4633988|P2|Double Blind Relapse Prevention Period|Pregnancy|0
1404558|NCT01193153|4633989|P1|Double Blind Relapse Prevention Period|Pregnancy|1
1404559|NCT01193153|4633988|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
1404560|NCT01193153|4633989|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
1404561|NCT01193153|4633988|P2|Double Blind Relapse Prevention Period|Death|0
1404562|NCT01193153|4633989|P1|Double Blind Relapse Prevention Period|Death|2
1404563|NCT01193153|4633988|P2|Double Blind Relapse Prevention Period|Adverse Event|3
1404564|NCT01193153|4633989|P1|Double Blind Relapse Prevention Period|Adverse Event|12
1404565|NCT01193153|4633988|P2|Double Blind Relapse Prevention Period|Other|3
1404566|NCT01193153|4633989|P1|Double Blind Relapse Prevention Period|Other|2
1404567|NCT01193153|4633988|P2|Open-label Stabilization Period|Other|0
1404568|NCT01193153|4633989|P1|Open-label Stabilization Period|Other|8
1404569|NCT01193153|4633988|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
1404570|NCT01193153|4633989|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
1404571|NCT01193153|4633988|P2|Open-label Stabilization Period|Withdrawal by Subject|0
1404572|NCT01193153|4633989|P1|Open-label Stabilization Period|Withdrawal by Subject|29
1404573|NCT01193153|4633988|P2|Open-label Stabilization Period|Lack of Efficacy|0
1404574|NCT01193153|4633989|P1|Open-label Stabilization Period|Lack of Efficacy|5
1404575|NCT01193153|4633988|P2|Open-label Stabilization Period|Lost to Follow-up|0
1404576|NCT01193153|4633989|P1|Open-label Stabilization Period|Lost to Follow-up|10
1404577|NCT01193153|4633988|P2|Open-label Stabilization Period|Death|0
1404578|NCT01193153|4633989|P1|Open-label Stabilization Period|Death|2
1404579|NCT01193153|4633988|P2|Open-label Stabilization Period|Adverse Event|0
1404580|NCT01193153|4633989|P1|Open-label Stabilization Period|Adverse Event|9
1404581|NCT01193153|4633988|P2|Open-label Lead in Period|Lack of Efficacy|0
1404582|NCT01193153|4633989|P1|Open-label Lead in Period|Lack of Efficacy|26
1404583|NCT01193153|4633988|P2|Open-label Lead in Period|Death|0
1404584|NCT01193153|4633989|P1|Open-label Lead in Period|Death|1
1404585|NCT01193153|4633988|P2|Open-label Lead in Period|Adverse Event|0
1404586|NCT01193153|4633989|P1|Open-label Lead in Period|Adverse Event|41
1404587|NCT01193153|4633988|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
1404588|NCT01193153|4633989|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
1404589|NCT01193153|4633988|P2|Open-label Lead in Period|Other|0
1404590|NCT01193153|4633989|P1|Open-label Lead in Period|Other|14
1404591|NCT01193153|4633988|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
1404592|NCT01193153|4633989|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
1404593|NCT01193153|4633988|P2|Open-label Lead in Period|Withdrawal by Subject|0
1404594|NCT01193153|4633989|P1|Open-label Lead in Period|Withdrawal by Subject|69
1404595|NCT01193153|4633988|P2|Open-label Lead in Period|Pregnancy|0
1404596|NCT01193153|4633989|P1|Open-label Lead in Period|Pregnancy|1
1404597|NCT01193153|4633988|P2|Open-label Lead in Period|Lost to Follow-up|0
1404598|NCT01193153|4633989|P1|Open-label Lead in Period|Lost to Follow-up|32
1404599|NCT01193127|4634024|P4|Treated|Withdrawal by Subject|1
1404600|NCT01193127|4634025|P3|Treated|Withdrawal by Subject|0
1404601|NCT01193127|4634026|P2|Treated|Withdrawal by Subject|0
1404602|NCT01193127|4634027|P1|Treated|Withdrawal by Subject|0
1404603|NCT01193127|4634024|P4|Randomized|Surgery Cancelled|1
1404604|NCT01193127|4634025|P3|Randomized|Surgery Cancelled|0
1404605|NCT01193127|4634026|P2|Randomized|Surgery Cancelled|0
1404606|NCT01193127|4634027|P1|Randomized|Surgery Cancelled|0
1404607|NCT01193101|4634352|P4|Overall Study|Abnormal test procedure results|0
1404608|NCT01193101|4634353|P3|Overall Study|Abnormal test procedure results|0
1404609|NCT01193101|4634354|P2|Overall Study|Abnormal test procedure results|1
1404610|NCT01193101|4634355|P1|Overall Study|Abnormal test procedure results|0
1404611|NCT01193101|4634352|P4|Overall Study|Administrative problems|0
1404612|NCT01193101|4634353|P3|Overall Study|Administrative problems|1
1404613|NCT01193101|4634354|P2|Overall Study|Administrative problems|0
1404614|NCT01193101|4634355|P1|Overall Study|Administrative problems|0
1404615|NCT01193101|4634352|P4|Overall Study|Withdrawal by Subject|1
1404616|NCT01193101|4634353|P3|Overall Study|Withdrawal by Subject|1
1404617|NCT01193101|4634354|P2|Overall Study|Withdrawal by Subject|4
1404618|NCT01193101|4634355|P1|Overall Study|Withdrawal by Subject|2
1404619|NCT01193101|4634352|P4|Overall Study|Lack of Efficacy|8
1404620|NCT01193101|4634353|P3|Overall Study|Lack of Efficacy|0
1404621|NCT01193101|4634354|P2|Overall Study|Lack of Efficacy|1
1404622|NCT01193101|4634355|P1|Overall Study|Lack of Efficacy|3
1404623|NCT01193101|4634352|P4|Overall Study|Adverse Event|3
1404624|NCT01193101|4634353|P3|Overall Study|Adverse Event|1
1404625|NCT01193101|4634354|P2|Overall Study|Adverse Event|1
1404626|NCT01193101|4634355|P1|Overall Study|Adverse Event|0
1404627|NCT01192776|4634461|P4|Overall Study|Lost to Follow-up|5
1404628|NCT01192776|4634462|P3|Overall Study|Lost to Follow-up|3
1404629|NCT01192776|4634463|P2|Overall Study|Lost to Follow-up|6
1404630|NCT01192776|4634464|P1|Overall Study|Lost to Follow-up|3
1404631|NCT01192776|4634461|P4|Overall Study|Death|15
1404632|NCT01192776|4634462|P3|Overall Study|Death|18
1404633|NCT01192776|4634463|P2|Overall Study|Death|15
1404634|NCT01192776|4634464|P1|Overall Study|Death|8
1404635|NCT01192516|4634538|P3|Overall Study|Unable to follow Actiwatch instructions|0
1404636|NCT01192516|4634539|P2|Overall Study|Unable to follow Actiwatch instructions|2
1404637|NCT01192516|4634540|P1|Overall Study|Unable to follow Actiwatch instructions|4
1404638|NCT01192516|4634538|P3|Overall Study|started new treatment|0
1404639|NCT01192516|4634539|P2|Overall Study|started new treatment|1
1404640|NCT01192516|4634540|P1|Overall Study|started new treatment|5
1404641|NCT01192516|4634538|P3|Overall Study|Withdrawal by Subject|1
1404642|NCT01192516|4634539|P2|Overall Study|Withdrawal by Subject|4
1404643|NCT01192516|4634540|P1|Overall Study|Withdrawal by Subject|4
1404644|NCT01192516|4634538|P3|Overall Study|Lost to Follow-up|7
1404645|NCT01192516|4634539|P2|Overall Study|Lost to Follow-up|10
1404646|NCT01192516|4634540|P1|Overall Study|Lost to Follow-up|7
1404647|NCT01192412|4634574|P2|Overall Study|Withdrawal by Subject|1
1404648|NCT01192412|4634575|P1|Overall Study|Withdrawal by Subject|2
1404649|NCT01192412|4634574|P2|Overall Study|Lost to Follow-up|1
1404650|NCT01192412|4634575|P1|Overall Study|Lost to Follow-up|2
1404651|NCT01192399|4634583|P1|Overall Study|Lack of Efficacy|2
1404652|NCT01192347|4634593|P1|Overall Study|Patient did not show up for visits|1
1404653|NCT01192347|4634593|P1|Overall Study|Patient not visiting hospital regularly|1
1404654|NCT01192347|4634593|P1|Overall Study|Patient seen in different hospital|1
1404655|NCT01192347|4634593|P1|Overall Study|Suspected serious adverse drug reaction|1
1404656|NCT01192347|4634593|P1|Overall Study|Adverse Event|1
1404657|NCT01192347|4634593|P1|Overall Study|Withdrawal by Subject|1
1404658|NCT01192347|4634593|P1|Overall Study|Lost to Follow-up|3
1404659|NCT01192347|4634593|P1|Overall Study|Death|3
1404660|NCT01192295|4634616|P2|Overall Study|Administrative|6
1404661|NCT01192295|4634617|P1|Overall Study|Administrative|4
1404662|NCT01192295|4634616|P2|Overall Study|Lack of Efficacy|5
1404663|NCT01192295|4634617|P1|Overall Study|Lack of Efficacy|0
1404664|NCT01192295|4634616|P2|Overall Study|Lost to Follow-up|1
1404665|NCT01192295|4634617|P1|Overall Study|Lost to Follow-up|0
1404666|NCT01192295|4634616|P2|Overall Study|Withdrawal by Subject|4
1404667|NCT01192295|4634617|P1|Overall Study|Withdrawal by Subject|3
1404668|NCT01192295|4634616|P2|Overall Study|Adverse Event|7
1404669|NCT01192295|4634617|P1|Overall Study|Adverse Event|3
1404670|NCT01192204|4634651|P2|Overall Study|could not keep recall appointments|0
1404671|NCT01192204|4634652|P1|Overall Study|could not keep recall appointments|1
1404672|NCT01192191|4634664|P2|Overall Study|Withdrawal by Subject|6
1404673|NCT01192191|4634665|P1|Overall Study|Withdrawal by Subject|1
1404674|NCT01192191|4634664|P2|Overall Study|Lost to Follow-up|1
1404675|NCT01192191|4634665|P1|Overall Study|Lost to Follow-up|0
1404676|NCT01192191|4634664|P2|Overall Study|Participants Reached Stopping Criteria|2
1404677|NCT01192191|4634665|P1|Overall Study|Participants Reached Stopping Criteria|3
1404678|NCT01192191|4634664|P2|Overall Study|Adverse Event|12
1404679|NCT01192191|4634665|P1|Overall Study|Adverse Event|7
1404680|NCT01192178|4634691|P2|Overall Study|Lack of Efficacy|2
1404681|NCT01192178|4634692|P1|Overall Study|Lack of Efficacy|1
1404682|NCT01192178|4634691|P2|Overall Study|Adverse Event|1
1404683|NCT01192178|4634692|P1|Overall Study|Adverse Event|2
1404684|NCT01192178|4634691|P2|Overall Study|Lost to Follow-up|3
1404685|NCT01192178|4634692|P1|Overall Study|Lost to Follow-up|3
1404686|NCT01192178|4634691|P2|Overall Study|Physician Decision|4
1404687|NCT01192178|4634692|P1|Overall Study|Physician Decision|2
1404688|NCT01192178|4634691|P2|Overall Study|Protocol Violation|3
1404689|NCT01192178|4634692|P1|Overall Study|Protocol Violation|10
1404690|NCT01192178|4634691|P2|Overall Study|Withdrawal by Subject|10
1404691|NCT01192178|4634692|P1|Overall Study|Withdrawal by Subject|6
1404692|NCT01192152|4634712|P2|Period 3|family emergency|0
1404693|NCT01192152|4634713|P1|Period 3|family emergency|1
1404694|NCT01192152|4634712|P2|Period 1|left prematurely (while on treatment B)|1
1404695|NCT01192152|4634713|P1|Period 1|left prematurely (while on treatment B)|0
1404696|NCT01192126|4634884|P2|First Intervention (1 Week)|Lost to Follow-up|1
1404697|NCT01192126|4634885|P1|First Intervention (1 Week)|Lost to Follow-up|1
1404698|NCT01192126|4634884|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
1404699|NCT01192126|4634885|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
1404700|NCT01192022|4634897|P5|Overall Study|Parents did not allow all follow up|0
1404701|NCT01192022|4634898|P4|Overall Study|Parents did not allow all follow up|1
1404702|NCT01192022|4634899|P3|Overall Study|Parents did not allow all follow up|0
1404703|NCT01192022|4634900|P2|Overall Study|Parents did not allow all follow up|0
1404704|NCT01192022|4634901|P1|Overall Study|Parents did not allow all follow up|0
1404705|NCT01192022|4634897|P5|Overall Study|Patient needed surgery|0
1404706|NCT01192022|4634898|P4|Overall Study|Patient needed surgery|0
1404707|NCT01192022|4634899|P3|Overall Study|Patient needed surgery|0
1404708|NCT01192022|4634900|P2|Overall Study|Patient needed surgery|1
1404709|NCT01192022|4634901|P1|Overall Study|Patient needed surgery|0
1404710|NCT01192022|4634897|P5|Overall Study|Patient too sick from chemotherapy|0
1404711|NCT01192022|4634898|P4|Overall Study|Patient too sick from chemotherapy|0
1404712|NCT01192022|4634899|P3|Overall Study|Patient too sick from chemotherapy|0
1404713|NCT01192022|4634900|P2|Overall Study|Patient too sick from chemotherapy|1
1404714|NCT01192022|4634901|P1|Overall Study|Patient too sick from chemotherapy|0
1404715|NCT01192022|4634897|P5|Overall Study|Physician withdrew-patient hardship|0
1404716|NCT01192022|4634898|P4|Overall Study|Physician withdrew-patient hardship|0
1404717|NCT01192022|4634899|P3|Overall Study|Physician withdrew-patient hardship|0
1404718|NCT01192022|4634900|P2|Overall Study|Physician withdrew-patient hardship|0
1404719|NCT01192022|4634901|P1|Overall Study|Physician withdrew-patient hardship|1
1404720|NCT01192022|4634897|P5|Overall Study|Fatal Adverse Event|1
1404721|NCT01192022|4634898|P4|Overall Study|Fatal Adverse Event|0
1404722|NCT01192022|4634899|P3|Overall Study|Fatal Adverse Event|0
1404723|NCT01192022|4634900|P2|Overall Study|Fatal Adverse Event|6
1404724|NCT01192022|4634901|P1|Overall Study|Fatal Adverse Event|4
1404725|NCT01192022|4634897|P5|Overall Study|Adverse Event|0
1404726|NCT01192022|4634898|P4|Overall Study|Adverse Event|0
1404727|NCT01192022|4634899|P3|Overall Study|Adverse Event|0
1404728|NCT01192022|4634900|P2|Overall Study|Adverse Event|0
1404729|NCT01192022|4634901|P1|Overall Study|Adverse Event|1
1404730|NCT01192022|4634897|P5|Overall Study|Lost to Follow-up|0
1404731|NCT01192022|4634898|P4|Overall Study|Lost to Follow-up|1
1404732|NCT01192022|4634899|P3|Overall Study|Lost to Follow-up|1
1404733|NCT01192022|4634900|P2|Overall Study|Lost to Follow-up|2
1404734|NCT01192022|4634901|P1|Overall Study|Lost to Follow-up|4
1404735|NCT01192022|4634897|P5|Overall Study|Withdrawal of Consent|0
1404736|NCT01192022|4634898|P4|Overall Study|Withdrawal of Consent|0
1404737|NCT01192022|4634899|P3|Overall Study|Withdrawal of Consent|0
1404738|NCT01192022|4634900|P2|Overall Study|Withdrawal of Consent|1
1404739|NCT01192022|4634901|P1|Overall Study|Withdrawal of Consent|3
1404740|NCT01191944|4634924|P2|Overall Study|Other|3
1404741|NCT01191944|4634925|P1|Overall Study|Other|1
1404742|NCT01191944|4634924|P2|Overall Study|Withdrawal by Subject|2
1404743|NCT01191944|4634925|P1|Overall Study|Withdrawal by Subject|4
1404744|NCT01191944|4634924|P2|Overall Study|Protocol Violation|2
1404745|NCT01191944|4634925|P1|Overall Study|Protocol Violation|1
1404746|NCT01191944|4634924|P2|Overall Study|Adverse Event|12
1404747|NCT01191944|4634925|P1|Overall Study|Adverse Event|11
1404748|NCT01191840|4634971|P2|Overall Study|Withdrawal by Subject|0
1404749|NCT01191840|4634972|P1|Overall Study|Withdrawal by Subject|2
1404750|NCT01191840|4634971|P2|Overall Study|lab error speciation - non Staph infecti|1
1404751|NCT01191840|4634972|P1|Overall Study|lab error speciation - non Staph infecti|0
1404752|NCT01191840|4634971|P2|Overall Study|IRB approval lapse|2
1404753|NCT01191840|4634972|P1|Overall Study|IRB approval lapse|0
1404754|NCT01191840|4634971|P2|Overall Study|ineligible at enrollment|0
1404755|NCT01191840|4634972|P1|Overall Study|ineligible at enrollment|1
1404756|NCT01191840|4634971|P2|Overall Study|Non Staph Infection|3
1404757|NCT01191840|4634972|P1|Overall Study|Non Staph Infection|4
1404758|NCT01191840|4634971|P2|Overall Study|Lost to Follow-up|6
1404759|NCT01191840|4634972|P1|Overall Study|Lost to Follow-up|4
1404760|NCT01191840|4634971|P2|Overall Study|Subject discontinued treatment|2
1404761|NCT01191840|4634972|P1|Overall Study|Subject discontinued treatment|1
1404762|NCT01191840|4634971|P2|Overall Study|withdrew consent|1
1404763|NCT01191840|4634972|P1|Overall Study|withdrew consent|2
1404764|NCT01191801|4634997|P2|Overall Study|Not Provided|27
1404765|NCT01191801|4634998|P1|Overall Study|Not Provided|45
1404766|NCT01191801|4634997|P2|Overall Study|Withdrawal by Subject|4
1404767|NCT01191801|4634998|P1|Overall Study|Withdrawal by Subject|1
1404768|NCT01191801|4634997|P2|Overall Study|Physician Decision|24
1404769|NCT01191801|4634998|P1|Overall Study|Physician Decision|47
1404770|NCT01191801|4634997|P2|Overall Study|Protocol Violation|4
1404771|NCT01191801|4634998|P1|Overall Study|Protocol Violation|2
1404772|NCT01191801|4634997|P2|Overall Study|Adverse Event|8
1404773|NCT01191801|4634998|P1|Overall Study|Adverse Event|9
1404774|NCT01191801|4634997|P2|Overall Study|Lack of Efficacy|258
1404775|NCT01191801|4634998|P1|Overall Study|Lack of Efficacy|176
1404776|NCT01191801|4634997|P2|Overall Study|Death|12
1404777|NCT01191801|4634998|P1|Overall Study|Death|36
1404778|NCT01191788|4635018|P2|Overall Study|Lost to Follow-up|22
1404779|NCT01191788|4635019|P1|Overall Study|Lost to Follow-up|21
1404780|NCT01191762|4635029|P2|Overall Study|Adverse Event|0
1404781|NCT01191762|4635030|P1|Overall Study|Adverse Event|1
1404782|NCT01191268|4635188|P3|Overall Study|Sponsor Decision|0
1404783|NCT01191268|4635189|P2|Overall Study|Sponsor Decision|2
1404784|NCT01191268|4635190|P1|Overall Study|Sponsor Decision|0
1404785|NCT01191268|4635188|P3|Overall Study|Protocol Violation|1
1404786|NCT01191268|4635189|P2|Overall Study|Protocol Violation|0
1404787|NCT01191268|4635190|P1|Overall Study|Protocol Violation|1
1404788|NCT01191268|4635188|P3|Overall Study|Death|3
1404789|NCT01191268|4635189|P2|Overall Study|Death|1
1404790|NCT01191268|4635190|P1|Overall Study|Death|0
1404791|NCT01191268|4635188|P3|Overall Study|Entry Criteria Not Met|1
1404792|NCT01191268|4635189|P2|Overall Study|Entry Criteria Not Met|1
1404793|NCT01191268|4635190|P1|Overall Study|Entry Criteria Not Met|3
1404794|NCT01191268|4635188|P3|Overall Study|Lost to Follow-up|9
1404795|NCT01191268|4635189|P2|Overall Study|Lost to Follow-up|5
1404796|NCT01191268|4635190|P1|Overall Study|Lost to Follow-up|8
1404797|NCT01191268|4635188|P3|Overall Study|Physician Decision|9
1404798|NCT01191268|4635189|P2|Overall Study|Physician Decision|8
1404799|NCT01191268|4635190|P1|Overall Study|Physician Decision|6
1404800|NCT01191268|4635188|P3|Overall Study|Adverse Event|8
1404801|NCT01191268|4635189|P2|Overall Study|Adverse Event|13
1404802|NCT01191268|4635190|P1|Overall Study|Adverse Event|21
1404803|NCT01191268|4635188|P3|Overall Study|Withdrawal by Subject|21
1404804|NCT01191268|4635189|P2|Overall Study|Withdrawal by Subject|25
1404805|NCT01191268|4635190|P1|Overall Study|Withdrawal by Subject|19
1404806|NCT01191190|4635331|P1|Overall Study|Withdrawal by Subject|1
1404807|NCT01191086|4635344|P1|Overall Study|Other|1
1404808|NCT01191086|4635344|P1|Overall Study|Discontinuation criterion met|1
1404809|NCT01191086|4635344|P1|Overall Study|Withdrawal by Subject|24
1404810|NCT01191086|4635344|P1|Overall Study|Physician Decision|2
1404811|NCT01191086|4635344|P1|Overall Study|Lost to Follow-up|4
1404812|NCT01191086|4635344|P1|Overall Study|Lack of Efficacy|10
1404813|NCT01191086|4635344|P1|Overall Study|Adverse Event|20
1404814|NCT01191008|4635348|P1|Overall Study|Lost to Follow-up|8
1404815|NCT01191008|4635348|P1|Overall Study|Protocol Violation|7
1404816|NCT01190891|4635356|P2|Overall Study|Withdrawal by Subject|0
1404817|NCT01190891|4635357|P1|Overall Study|Withdrawal by Subject|5
1404818|NCT01190891|4635356|P2|Overall Study|Protocol Violation|0
1404819|NCT01190891|4635357|P1|Overall Study|Protocol Violation|1
1404820|NCT01190865|4635382|P1|Overall Study|Non-compliance|2
1404821|NCT01190865|4635382|P1|Overall Study|Withdrawal by Subject|1
1404822|NCT01190839|4635389|P2|Overall Study|Randomized but not treated|4
1404823|NCT01190839|4635390|P1|Overall Study|Randomized but not treated|2
1404824|NCT01190839|4635389|P2|Overall Study|Undefined|31
1404825|NCT01190839|4635390|P1|Overall Study|Undefined|35
1404826|NCT01190839|4635389|P2|Overall Study|Trial stopped by Sponsor|68
1404827|NCT01190839|4635390|P1|Overall Study|Trial stopped by Sponsor|71
1404828|NCT01190839|4635389|P2|Overall Study|Death|0
1404829|NCT01190839|4635390|P1|Overall Study|Death|1
1404830|NCT01190839|4635389|P2|Overall Study|Lost to Follow-up|1
1404831|NCT01190839|4635390|P1|Overall Study|Lost to Follow-up|7
1404832|NCT01190839|4635389|P2|Overall Study|Protocol Violation|2
1404833|NCT01190839|4635390|P1|Overall Study|Protocol Violation|2
1404834|NCT01190839|4635389|P2|Overall Study|Adverse Event|41
1404835|NCT01190839|4635390|P1|Overall Study|Adverse Event|32
1404836|NCT01190813|4635404|P2|Overall Study|Adverse Event|1
1404837|NCT01190813|4635405|P1|Overall Study|Adverse Event|0
1404838|NCT01190813|4635404|P2|Overall Study|Refused study treatment after randomized|0
1404839|NCT01190813|4635405|P1|Overall Study|Refused study treatment after randomized|1
1404840|NCT01190813|4635404|P2|Overall Study|Withdrawal by Subject|1
1404841|NCT01190813|4635405|P1|Overall Study|Withdrawal by Subject|2
1404842|NCT01190813|4635404|P2|Overall Study|Lost to Follow-up|2
1404843|NCT01190813|4635405|P1|Overall Study|Lost to Follow-up|1
1404844|NCT01190514|4635526|P4|Third Intervention (Period 3)|Adverse Event|0
1404845|NCT01190514|4635527|P3|Third Intervention (Period 3)|Adverse Event|0
1404846|NCT01190514|4635528|P2|Third Intervention (Period 3)|Adverse Event|0
1404847|NCT01190514|4635529|P1|Third Intervention (Period 3)|Adverse Event|1
1404848|NCT01190514|4635526|P4|First Intervention (Period 1)|Adverse Event|0
1404849|NCT01190514|4635527|P3|First Intervention (Period 1)|Adverse Event|0
1404850|NCT01190514|4635528|P2|First Intervention (Period 1)|Adverse Event|0
1404851|NCT01190514|4635529|P1|First Intervention (Period 1)|Adverse Event|1
1404852|NCT01190449|4635574|P2|Overall Study|Ineligible|4
1404853|NCT01190449|4635575|P1|Overall Study|Ineligible|0
1404854|NCT01190436|4635583|P1|Overall Study|Other|4
1404855|NCT01190436|4635583|P1|Overall Study|Lost to Follow-up|35
1404856|NCT01190267|4635608|P2|Overall Study|Protocol Violation|1
1404857|NCT01190267|4635609|P1|Overall Study|Protocol Violation|8
1404858|NCT01190267|4635608|P2|Overall Study|Withdrawal by Subject|1
1404859|NCT01190267|4635609|P1|Overall Study|Withdrawal by Subject|13
1404860|NCT01190267|4635608|P2|Overall Study|Lost to Follow-up|0
1404861|NCT01190267|4635609|P1|Overall Study|Lost to Follow-up|2
1404862|NCT01190267|4635608|P2|Overall Study|Treatment Failure|2
1404863|NCT01190267|4635609|P1|Overall Study|Treatment Failure|8
1404864|NCT01190267|4635608|P2|Overall Study|Adverse Event|0
1404865|NCT01190267|4635609|P1|Overall Study|Adverse Event|10
1404866|NCT01190254|4635620|P3|Overall Study|Did not meet protocol eligibility|0
1404867|NCT01190254|4635621|P2|Overall Study|Did not meet protocol eligibility|0
1404868|NCT01190254|4635622|P1|Overall Study|Did not meet protocol eligibility|1
1404869|NCT01190254|4635620|P3|Overall Study|Protocol Violation|2
1404870|NCT01190254|4635621|P2|Overall Study|Protocol Violation|0
1404871|NCT01190254|4635622|P1|Overall Study|Protocol Violation|2
1404872|NCT01190254|4635620|P3|Overall Study|Withdrawal by Subject|7
1404873|NCT01190254|4635621|P2|Overall Study|Withdrawal by Subject|5
1404874|NCT01190254|4635622|P1|Overall Study|Withdrawal by Subject|4
1404875|NCT01190254|4635620|P3|Overall Study|Lost to Follow-up|0
1404876|NCT01190254|4635621|P2|Overall Study|Lost to Follow-up|2
1404877|NCT01190254|4635622|P1|Overall Study|Lost to Follow-up|4
1404878|NCT01190254|4635620|P3|Overall Study|Lack of Efficacy|5
1404879|NCT01190254|4635621|P2|Overall Study|Lack of Efficacy|4
1404880|NCT01190254|4635622|P1|Overall Study|Lack of Efficacy|7
1404881|NCT01190254|4635620|P3|Overall Study|Adverse Event|8
1404882|NCT01190254|4635621|P2|Overall Study|Adverse Event|6
1404883|NCT01190254|4635622|P1|Overall Study|Adverse Event|3
1404884|NCT01190228|4635687|P3|Overall Study|Withdrawal by Subject|0
1404885|NCT01190228|4635688|P2|Overall Study|Withdrawal by Subject|0
1404886|NCT01190228|4635689|P1|Overall Study|Withdrawal by Subject|1
1404887|NCT01190228|4635687|P3|Overall Study|Protocol Violation|0
1404888|NCT01190228|4635688|P2|Overall Study|Protocol Violation|0
1404889|NCT01190228|4635689|P1|Overall Study|Protocol Violation|4
1404890|NCT01190215|4635712|P2|Up to Month 6|Lost to Follow-up|0
1404891|NCT01190215|4635713|P1|Up to Month 6|Lost to Follow-up|2
1404892|NCT01190150|4635783|P2|Washout|Difficulty in adherence|1
1404893|NCT01190150|4635784|P1|Washout|Difficulty in adherence|0
1404894|NCT01190150|4635783|P2|Washout|Withdrawal by Subject|1
1404895|NCT01190150|4635784|P1|Washout|Withdrawal by Subject|0
1404896|NCT01190150|4635783|P2|First Treatment|Withdrawal by Subject|0
1404897|NCT01190150|4635784|P1|First Treatment|Withdrawal by Subject|1
1404898|NCT01190124|4635811|P3|Overall Study|Lost to Follow-up|0
1404899|NCT01190124|4635812|P2|Overall Study|Lost to Follow-up|0
1404900|NCT01190124|4635813|P1|Overall Study|Lost to Follow-up|2
1404901|NCT01190124|4635811|P3|Overall Study|Therapeutic Failure|1
1404902|NCT01190124|4635812|P2|Overall Study|Therapeutic Failure|0
1404903|NCT01190124|4635813|P1|Overall Study|Therapeutic Failure|12
1404904|NCT01190124|4635811|P3|Overall Study|Death|0
1404905|NCT01190124|4635812|P2|Overall Study|Death|0
1404906|NCT01190124|4635813|P1|Overall Study|Death|3
1404907|NCT01190098|4635851|P2|Overall Study|Other|1
1404908|NCT01190098|4635852|P1|Overall Study|Other|0
1404909|NCT01190098|4635851|P2|Overall Study|Lack of transportation|0
1404910|NCT01190098|4635852|P1|Overall Study|Lack of transportation|1
1404911|NCT01190098|4635851|P2|Overall Study|Patient coomorbidity|1
1404912|NCT01190098|4635852|P1|Overall Study|Patient coomorbidity|0
1404913|NCT01190098|4635851|P2|Overall Study|Adverse Event|0
1404914|NCT01190098|4635852|P1|Overall Study|Adverse Event|2
1404915|NCT01190007|4635891|P1|Overall Study|Participant was arrested|1
1404916|NCT01190007|4635891|P1|Overall Study|Difficulty of visit for complications|1
1404917|NCT01190007|4635891|P1|Overall Study|Adverse Event|8
1404918|NCT01190007|4635891|P1|Overall Study|Withdrawal by Subject|4
1404919|NCT01189890|4635908|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
1404920|NCT01189890|4635909|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
1404921|NCT01189890|4635908|P2|Overall Study|Physician Decision|4
1404922|NCT01189890|4635909|P1|Overall Study|Physician Decision|5
1404923|NCT01189890|4635908|P2|Overall Study|Non Compliance|1
1404924|NCT01189890|4635909|P1|Overall Study|Non Compliance|0
1404925|NCT01189890|4635908|P2|Overall Study|Withdrawal by Subject|11
1404926|NCT01189890|4635909|P1|Overall Study|Withdrawal by Subject|15
1404927|NCT01189890|4635908|P2|Overall Study|Protocol Violation|5
1404928|NCT01189890|4635909|P1|Overall Study|Protocol Violation|1
1404929|NCT01189890|4635908|P2|Overall Study|Lost to Follow-up|7
1404930|NCT01189890|4635909|P1|Overall Study|Lost to Follow-up|1
1404931|NCT01189890|4635908|P2|Overall Study|Lack of Efficacy|2
1404932|NCT01189890|4635909|P1|Overall Study|Lack of Efficacy|7
1404933|NCT01189890|4635908|P2|Overall Study|Adverse Event|4
1404934|NCT01189890|4635909|P1|Overall Study|Adverse Event|3
1404935|NCT01189812|4635931|P2|Overall Study|Moved out of State|2
1404936|NCT01189812|4635932|P1|Overall Study|Moved out of State|1
1404937|NCT01189812|4635931|P2|Overall Study|Out of Window|3
1404938|NCT01189812|4635932|P1|Overall Study|Out of Window|4
1404939|NCT01189812|4635931|P2|Overall Study|Adverse Event|0
1404940|NCT01189812|4635932|P1|Overall Study|Adverse Event|1
1404941|NCT01189812|4635931|P2|Overall Study|Withdrawal by Subject|3
1404942|NCT01189812|4635932|P1|Overall Study|Withdrawal by Subject|2
1404943|NCT01189604|4636016|P7|Overall Study|Withdrawal by Subject|0
1404944|NCT01189604|4636017|P6|Overall Study|Withdrawal by Subject|0
1404945|NCT01189604|4636018|P5|Overall Study|Withdrawal by Subject|0
1404946|NCT01189604|4636019|P4|Overall Study|Withdrawal by Subject|0
1404947|NCT01189604|4636020|P3|Overall Study|Withdrawal by Subject|0
1404948|NCT01189604|4636021|P2|Overall Study|Withdrawal by Subject|0
1404949|NCT01189604|4636022|P1|Overall Study|Withdrawal by Subject|1
1404950|NCT01189604|4636016|P7|Overall Study|Adverse Event|1
1404951|NCT01189604|4636017|P6|Overall Study|Adverse Event|0
1404952|NCT01189604|4636018|P5|Overall Study|Adverse Event|2
1404953|NCT01189604|4636019|P4|Overall Study|Adverse Event|0
1404954|NCT01189604|4636020|P3|Overall Study|Adverse Event|0
1404955|NCT01189604|4636021|P2|Overall Study|Adverse Event|1
1404956|NCT01189604|4636022|P1|Overall Study|Adverse Event|0
1404957|NCT01189604|4636016|P7|Overall Study|Impossible to visit|0
1404958|NCT01189604|4636017|P6|Overall Study|Impossible to visit|1
1404959|NCT01189604|4636018|P5|Overall Study|Impossible to visit|0
1404960|NCT01189604|4636019|P4|Overall Study|Impossible to visit|0
1404961|NCT01189604|4636020|P3|Overall Study|Impossible to visit|0
1404962|NCT01189604|4636021|P2|Overall Study|Impossible to visit|0
1404963|NCT01189604|4636022|P1|Overall Study|Impossible to visit|0
1404964|NCT01189500|4636066|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
1404965|NCT01189500|4636066|P1|Period 1: TAMOX Alone|Adverse Event|1
1404966|NCT01189487|4636127|P1|Overall Study|Adverse Event|1
1404967|NCT01189487|4636127|P1|Overall Study|Lack of Efficacy|2
1404968|NCT01189461|4636135|P1|Overall Study|Other|8
1404969|NCT01189461|4636135|P1|Overall Study|Did not meet entrance criteria|3
1404970|NCT01189461|4636135|P1|Overall Study|Adverse Event|2
1404971|NCT01189461|4636135|P1|Overall Study|Protocol Violation|1
1404972|NCT01189461|4636135|P1|Overall Study|Withdrawal by Subject|6
1404973|NCT01189461|4636135|P1|Overall Study|Lost to Follow-up|1
1404974|NCT01189461|4636135|P1|Overall Study|Lack of Efficacy|13
1404975|NCT01189435|4636142|P1|Overall Study|Physician Decision|1
1404976|NCT01189435|4636142|P1|Overall Study|Withdrawal by Subject|1
1404977|NCT01189227|4636224|P2|Overall Study|Study terminated due to low accrual|3
1404978|NCT01189227|4636225|P1|Overall Study|Study terminated due to low accrual|6
1404979|NCT01189201|4636231|P1|Overall Study|Adverse Event|1
1404980|NCT01189032|4636334|P3|Overall Study|Protocol Violation|1
1404981|NCT01189032|4636335|P2|Overall Study|Protocol Violation|1
1404982|NCT01189032|4636336|P1|Overall Study|Protocol Violation|1
1404983|NCT01189032|4636334|P3|Overall Study|Withdrawal by Subject|1
1404984|NCT01189032|4636335|P2|Overall Study|Withdrawal by Subject|0
1404985|NCT01189032|4636336|P1|Overall Study|Withdrawal by Subject|1
1404986|NCT01189032|4636334|P3|Overall Study|Lack of Efficacy|0
1404987|NCT01189032|4636335|P2|Overall Study|Lack of Efficacy|3
1404988|NCT01189032|4636336|P1|Overall Study|Lack of Efficacy|2
1404989|NCT01189032|4636334|P3|Overall Study|Adverse Event|4
1404990|NCT01189032|4636335|P2|Overall Study|Adverse Event|3
1404991|NCT01189032|4636336|P1|Overall Study|Adverse Event|1
1404992|NCT01188967|4636346|P2|Overall Study|Lost to Follow-up|2
1404993|NCT01188967|4636347|P1|Overall Study|Lost to Follow-up|3
1404994|NCT01188967|4636346|P2|Overall Study|Physician Decision|1
1404995|NCT01188967|4636347|P1|Overall Study|Physician Decision|1
1404996|NCT01188967|4636346|P2|Overall Study|Withdrawal by Subject|1
1404997|NCT01188967|4636347|P1|Overall Study|Withdrawal by Subject|1
1404998|NCT01188811|4636400|P2|Overall Study|Adverse Event|0
1404999|NCT01188811|4636401|P1|Overall Study|Adverse Event|6
1405000|NCT01188811|4636400|P2|Overall Study|Withdrawal by Subject|2
1405001|NCT01188811|4636401|P1|Overall Study|Withdrawal by Subject|0
1405002|NCT01188798|4636413|P2|Overall Study|Protocol closure|1
1405003|NCT01188798|4636414|P1|Overall Study|Protocol closure|1
1405004|NCT01188798|4636413|P2|Overall Study|Required additional transplant|1
1405005|NCT01188798|4636414|P1|Overall Study|Required additional transplant|1
1405006|NCT01188798|4636413|P2|Overall Study|Death|1
1405007|NCT01188798|4636414|P1|Overall Study|Death|0
1405008|NCT01188772|4636426|P4|Overall Study|Withdrawal by Subject|0
1405009|NCT01188772|4636427|P3|Overall Study|Withdrawal by Subject|2
1405010|NCT01188772|4636428|P2|Overall Study|Withdrawal by Subject|0
1405011|NCT01188772|4636429|P1|Overall Study|Withdrawal by Subject|0
1405012|NCT01188772|4636426|P4|Overall Study|Virologic Failure|0
1405013|NCT01188772|4636427|P3|Overall Study|Virologic Failure|0
1405014|NCT01188772|4636428|P2|Overall Study|Virologic Failure|0
1405015|NCT01188772|4636429|P1|Overall Study|Virologic Failure|1
1405016|NCT01188772|4636426|P4|Overall Study|Treatment Failure|0
1405017|NCT01188772|4636427|P3|Overall Study|Treatment Failure|1
1405018|NCT01188772|4636428|P2|Overall Study|Treatment Failure|0
1405019|NCT01188772|4636429|P1|Overall Study|Treatment Failure|0
1405020|NCT01188772|4636426|P4|Overall Study|Terminated by Sponsor|0
1405021|NCT01188772|4636427|P3|Overall Study|Terminated by Sponsor|1
1405022|NCT01188772|4636428|P2|Overall Study|Terminated by Sponsor|0
1405023|NCT01188772|4636429|P1|Overall Study|Terminated by Sponsor|0
1405024|NCT01188772|4636426|P4|Overall Study|Physician Decision|0
1405025|NCT01188772|4636427|P3|Overall Study|Physician Decision|1
1405026|NCT01188772|4636428|P2|Overall Study|Physician Decision|0
1405027|NCT01188772|4636429|P1|Overall Study|Physician Decision|0
1405028|NCT01188772|4636426|P4|Overall Study|Non-responder|0
1405029|NCT01188772|4636427|P3|Overall Study|Non-responder|3
1405030|NCT01188772|4636428|P2|Overall Study|Non-responder|0
1405031|NCT01188772|4636429|P1|Overall Study|Non-responder|0
1405032|NCT01188772|4636426|P4|Overall Study|Lost to Follow-up|1
1405033|NCT01188772|4636427|P3|Overall Study|Lost to Follow-up|1
1405034|NCT01188772|4636428|P2|Overall Study|Lost to Follow-up|1
1405035|NCT01188772|4636429|P1|Overall Study|Lost to Follow-up|4
1405036|NCT01188772|4636426|P4|Overall Study|Adverse Event|0
1405037|NCT01188772|4636427|P3|Overall Study|Adverse Event|2
1405038|NCT01188772|4636428|P2|Overall Study|Adverse Event|1
1405039|NCT01188772|4636429|P1|Overall Study|Adverse Event|0
1405040|NCT01188772|4636426|P4|Overall Study|Randomized but Not Treated|0
1405041|NCT01188772|4636427|P3|Overall Study|Randomized but Not Treated|0
1405042|NCT01188772|4636428|P2|Overall Study|Randomized but Not Treated|1
1405043|NCT01188772|4636429|P1|Overall Study|Randomized but Not Treated|0
1405044|NCT01188681|4636501|P4|Overall Study|Withdrawal by Subject|1
1405045|NCT01188681|4636502|P3|Overall Study|Withdrawal by Subject|0
1405046|NCT01188681|4636503|P2|Overall Study|Withdrawal by Subject|0
1405047|NCT01188681|4636504|P1|Overall Study|Withdrawal by Subject|0
1405048|NCT01188681|4636501|P4|Overall Study|bladder cancer|0
1405049|NCT01188681|4636502|P3|Overall Study|bladder cancer|1
1405050|NCT01188681|4636503|P2|Overall Study|bladder cancer|0
1405051|NCT01188681|4636504|P1|Overall Study|bladder cancer|0
1405052|NCT01188668|4636518|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
1405053|NCT01188668|4636518|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
1405054|NCT01188668|4636518|P1|Period 1: ARIP Alone|Protocol Violation|2
1405055|NCT01188655|4636551|P1|Overall Study|Other|11
1405056|NCT01188655|4636551|P1|Overall Study|Lost to Follow-up|1
1405057|NCT01188655|4636551|P1|Overall Study|Lack of Efficacy|1
1405058|NCT01188564|4636595|P2|Double-blind Phase|randomized not treated|0
1405059|NCT01188564|4636596|P1|Double-blind Phase|randomized not treated|1
1405060|NCT01188551|4636608|P4|Overall Study|Pharmacy issues|0
1405061|NCT01188551|4636609|P3|Overall Study|Pharmacy issues|0
1405062|NCT01188551|4636610|P2|Overall Study|Pharmacy issues|0
1405063|NCT01188551|4636611|P1|Overall Study|Pharmacy issues|1
1405064|NCT01188538|4636627|P2|Overall Study|Lost to Follow-up|1
1405065|NCT01188538|4636628|P1|Overall Study|Lost to Follow-up|0
1405066|NCT01188343|4636715|P3|Overall Study|Withdrawal by Subject|0
1405067|NCT01188343|4636716|P2|Overall Study|Withdrawal by Subject|24
1405068|NCT01188343|4636717|P1|Overall Study|Withdrawal by Subject|1
1405069|NCT01188343|4636715|P3|Overall Study|Not vaccinated|1
1405070|NCT01188343|4636716|P2|Overall Study|Not vaccinated|2
1405071|NCT01188343|4636717|P1|Overall Study|Not vaccinated|0
1405072|NCT01188226|4636743|P1|Overall Study|Withdrawal by Subject|4
1405073|NCT01187953|4636789|P2|Overall Study|Withdrawal by Subject|3
1405074|NCT01187953|4636790|P1|Overall Study|Withdrawal by Subject|3
1405075|NCT01187953|4636789|P2|Overall Study|Lost to Follow-up|3
1405076|NCT01187953|4636790|P1|Overall Study|Lost to Follow-up|0
1405077|NCT01187953|4636789|P2|Overall Study|Adverse Event|2
1405078|NCT01187953|4636790|P1|Overall Study|Adverse Event|1
1405079|NCT01187953|4636789|P2|Overall Study|Death|13
1405080|NCT01187953|4636790|P1|Overall Study|Death|11
1405081|NCT01187901|4636804|P2|Overall Study|Pregnancy|2
1405082|NCT01187901|4636805|P1|Overall Study|Pregnancy|0
1405083|NCT01187901|4636804|P2|Overall Study|No Endpoint due to Early Study Halt|3
1405084|NCT01187901|4636805|P1|Overall Study|No Endpoint due to Early Study Halt|2
1405085|NCT01187901|4636804|P2|Overall Study|Adverse Event|0
1405086|NCT01187901|4636805|P1|Overall Study|Adverse Event|3
1405087|NCT01187901|4636804|P2|Overall Study|Suspected Allergic Reaction|1
1405088|NCT01187901|4636805|P1|Overall Study|Suspected Allergic Reaction|1
1405089|NCT01187901|4636804|P2|Overall Study|Unrelated Health Reasons|2
1405090|NCT01187901|4636805|P1|Overall Study|Unrelated Health Reasons|1
1405091|NCT01187901|4636804|P2|Overall Study|Lost to Follow-up|2
1405092|NCT01187901|4636805|P1|Overall Study|Lost to Follow-up|1
1405093|NCT01187901|4636804|P2|Overall Study|Protocol Violation|0
1405094|NCT01187901|4636805|P1|Overall Study|Protocol Violation|1
1405095|NCT01187550|4636846|P2|Overall Study|Randomized but not treated|0
1405096|NCT01187550|4636847|P1|Overall Study|Randomized but not treated|8
1405097|NCT01187550|4636846|P2|Overall Study|Other|0
1405098|NCT01187550|4636847|P1|Overall Study|Other|3
1405099|NCT01187550|4636846|P2|Overall Study|Protocol Violation|1
1405100|NCT01187550|4636847|P1|Overall Study|Protocol Violation|3
1405101|NCT01187446|4637003|P2|Overall Study|Patient started non-protocol therapy|1
1405102|NCT01187446|4637004|P1|Overall Study|Patient started non-protocol therapy|0
1405103|NCT01187433|4637020|P2|Overall Study|Withdrawal by Subject|2
1405104|NCT01187433|4637021|P1|Overall Study|Withdrawal by Subject|5
1405105|NCT01187433|4637020|P2|Overall Study|Protocol Violation|2
1405106|NCT01187433|4637021|P1|Overall Study|Protocol Violation|6
1405107|NCT01187407|4637051|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
1405108|NCT01187407|4637052|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
1405109|NCT01187407|4637053|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
1405110|NCT01187407|4637054|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
1405111|NCT01187407|4637055|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1405112|NCT01187407|4637051|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
1405113|NCT01187407|4637052|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
1405114|NCT01187407|4637053|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
1405115|NCT01187407|4637054|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
1405116|NCT01187407|4637055|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
1405117|NCT01187407|4637051|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
1405118|NCT01187407|4637052|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
1405119|NCT01187407|4637053|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
1405120|NCT01187407|4637054|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
1405121|NCT01187407|4637055|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
1405122|NCT01187407|4637051|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
1405123|NCT01187407|4637052|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
1405124|NCT01187407|4637053|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1405125|NCT01187407|4637054|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1405126|NCT01187407|4637055|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1405127|NCT01187407|4637051|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
1405128|NCT01187407|4637052|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
1405129|NCT01187407|4637053|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
1405130|NCT01187407|4637054|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
1405131|NCT01187407|4637055|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
1405132|NCT01187407|4637051|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
1405133|NCT01187407|4637052|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
1405134|NCT01187407|4637053|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
1405135|NCT01187407|4637054|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
1405136|NCT01187407|4637055|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
1405137|NCT01187407|4637051|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
1405138|NCT01187407|4637052|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
1405139|NCT01187407|4637053|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
1405140|NCT01187407|4637054|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
1405141|NCT01187407|4637055|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
1405142|NCT01187407|4637051|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1405143|NCT01187407|4637052|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1405144|NCT01187407|4637053|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1405145|NCT01187407|4637054|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1405146|NCT01187407|4637055|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
1405147|NCT01187407|4637051|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1405148|NCT01187407|4637052|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1405149|NCT01187407|4637053|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1405150|NCT01187407|4637054|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1405151|NCT01187407|4637055|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
1405152|NCT01187407|4637051|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1405153|NCT01187407|4637052|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1405154|NCT01187407|4637053|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1405155|NCT01187407|4637054|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1405156|NCT01187407|4637055|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
1405157|NCT01187407|4637051|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1405158|NCT01187407|4637052|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1405159|NCT01187407|4637053|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1405160|NCT01187407|4637054|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1405161|NCT01187407|4637055|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
1405162|NCT01187407|4637051|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1405163|NCT01187407|4637052|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1405164|NCT01187407|4637053|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1405165|NCT01187407|4637054|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1405166|NCT01187407|4637055|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
1405167|NCT01187407|4637051|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1405168|NCT01187407|4637052|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1405169|NCT01187407|4637053|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1405170|NCT01187407|4637054|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1405171|NCT01187407|4637055|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
1405172|NCT01187407|4637051|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1405173|NCT01187407|4637052|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1405174|NCT01187407|4637053|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1405175|NCT01187407|4637054|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1405176|NCT01187407|4637055|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
1405177|NCT01187043|4637168|P5|Overall Study|Unable to make scheduled visits|1
1405178|NCT01187043|4637169|P4|Overall Study|Unable to make scheduled visits|0
1405179|NCT01187043|4637170|P3|Overall Study|Unable to make scheduled visits|4
1405180|NCT01187043|4637171|P2|Overall Study|Unable to make scheduled visits|0
1405181|NCT01187043|4637172|P1|Overall Study|Unable to make scheduled visits|1
1405182|NCT01187043|4637168|P5|Overall Study|Adverse Event|1
1405183|NCT01187043|4637169|P4|Overall Study|Adverse Event|0
1405184|NCT01187043|4637170|P3|Overall Study|Adverse Event|0
1405185|NCT01187043|4637171|P2|Overall Study|Adverse Event|0
1405186|NCT01187043|4637172|P1|Overall Study|Adverse Event|0
1405187|NCT01186939|4637198|P1|Overall Study|Transformation to AML|1
1405188|NCT01186939|4637198|P1|Overall Study|Bone marrow transplant|1
1405189|NCT01186939|4637198|P1|Overall Study|Myocardial infarction|1
1405190|NCT01186939|4637198|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
1405191|NCT01186939|4637198|P1|Overall Study|Started additional treatment|1
1405192|NCT01186939|4637198|P1|Overall Study|Sponsor decision|4
1405193|NCT01186939|4637198|P1|Overall Study|Program closed|5
1405194|NCT01186939|4637198|P1|Overall Study|No longer receiving clinical benefit|17
1405195|NCT01186939|4637198|P1|Overall Study|Withdrawal by Subject|2
1405196|NCT01186939|4637198|P1|Overall Study|Death|7
1405197|NCT01186848|4637202|P1|Overall Study|Adverse Event|2
1405198|NCT01186848|4637202|P1|Overall Study|Withdrawal by Subject|2
1405199|NCT01186848|4637202|P1|Overall Study|Lost to Follow-up|4
1405200|NCT01186796|4637210|P2|Overall Study|Protocol Violation|1
1405201|NCT01186796|4637211|P1|Overall Study|Protocol Violation|0
1405202|NCT01186796|4637210|P2|Overall Study|Withdrawal by Subject|1
1405203|NCT01186796|4637211|P1|Overall Study|Withdrawal by Subject|1
1405204|NCT01186796|4637210|P2|Overall Study|Adverse Event|0
1405205|NCT01186796|4637211|P1|Overall Study|Adverse Event|3
1405206|NCT01186744|4637231|P6|Overall Study|Death|0
1405207|NCT01186744|4637232|P5|Overall Study|Death|0
1405208|NCT01186744|4637233|P4|Overall Study|Death|0
1405209|NCT01186744|4637234|P3|Overall Study|Death|0
1405210|NCT01186744|4637235|P2|Overall Study|Death|0
1405211|NCT01186744|4637236|P1|Overall Study|Death|1
1405212|NCT01186744|4637231|P6|Overall Study|Adverse Event|4
1405213|NCT01186744|4637232|P5|Overall Study|Adverse Event|1
1405214|NCT01186744|4637233|P4|Overall Study|Adverse Event|0
1405215|NCT01186744|4637234|P3|Overall Study|Adverse Event|1
1405216|NCT01186744|4637235|P2|Overall Study|Adverse Event|14
1405217|NCT01186744|4637236|P1|Overall Study|Adverse Event|10
1405218|NCT01186744|4637231|P6|Overall Study|Not specified|5
1405219|NCT01186744|4637232|P5|Overall Study|Not specified|1
1405220|NCT01186744|4637233|P4|Overall Study|Not specified|2
1405221|NCT01186744|4637234|P3|Overall Study|Not specified|1
1405222|NCT01186744|4637235|P2|Overall Study|Not specified|10
1405223|NCT01186744|4637236|P1|Overall Study|Not specified|9
1405224|NCT01186744|4637231|P6|Overall Study|Study terminated by Sponsor|0
1405225|NCT01186744|4637232|P5|Overall Study|Study terminated by Sponsor|0
1405226|NCT01186744|4637233|P4|Overall Study|Study terminated by Sponsor|0
1405227|NCT01186744|4637234|P3|Overall Study|Study terminated by Sponsor|0
1405228|NCT01186744|4637235|P2|Overall Study|Study terminated by Sponsor|0
1405229|NCT01186744|4637236|P1|Overall Study|Study terminated by Sponsor|1
1405230|NCT01186744|4637231|P6|Overall Study|Withdrawal by Subject|6
1405231|NCT01186744|4637232|P5|Overall Study|Withdrawal by Subject|0
1405232|NCT01186744|4637233|P4|Overall Study|Withdrawal by Subject|5
1405233|NCT01186744|4637234|P3|Overall Study|Withdrawal by Subject|2
1405234|NCT01186744|4637235|P2|Overall Study|Withdrawal by Subject|10
1405235|NCT01186744|4637236|P1|Overall Study|Withdrawal by Subject|14
1405236|NCT01186744|4637231|P6|Overall Study|Screen failure|0
1405237|NCT01186744|4637232|P5|Overall Study|Screen failure|0
1405238|NCT01186744|4637233|P4|Overall Study|Screen failure|1
1405239|NCT01186744|4637234|P3|Overall Study|Screen failure|0
1405240|NCT01186744|4637235|P2|Overall Study|Screen failure|1
1405241|NCT01186744|4637236|P1|Overall Study|Screen failure|1
1405242|NCT01186744|4637231|P6|Overall Study|Lost to Follow-up|4
1405243|NCT01186744|4637232|P5|Overall Study|Lost to Follow-up|1
1405244|NCT01186744|4637233|P4|Overall Study|Lost to Follow-up|1
1405245|NCT01186744|4637234|P3|Overall Study|Lost to Follow-up|2
1405246|NCT01186744|4637235|P2|Overall Study|Lost to Follow-up|16
1405247|NCT01186744|4637236|P1|Overall Study|Lost to Follow-up|15
1405248|NCT01186744|4637231|P6|Overall Study|Protocol Violation|2
1405249|NCT01186744|4637232|P5|Overall Study|Protocol Violation|1
1405250|NCT01186744|4637233|P4|Overall Study|Protocol Violation|1
1405251|NCT01186744|4637234|P3|Overall Study|Protocol Violation|0
1405252|NCT01186744|4637235|P2|Overall Study|Protocol Violation|2
1405253|NCT01186744|4637236|P1|Overall Study|Protocol Violation|1
1405254|NCT01186744|4637231|P6|Overall Study|Lack of Efficacy|5
1405255|NCT01186744|4637232|P5|Overall Study|Lack of Efficacy|2
1405256|NCT01186744|4637233|P4|Overall Study|Lack of Efficacy|2
1405257|NCT01186744|4637234|P3|Overall Study|Lack of Efficacy|0
1405258|NCT01186744|4637235|P2|Overall Study|Lack of Efficacy|99
1405259|NCT01186744|4637236|P1|Overall Study|Lack of Efficacy|156
1405260|NCT01186692|4637656|P1|Overall Study|Adverse Event|2
1405261|NCT01186692|4637656|P1|Overall Study|Futher testing contraindicated implant|19
1405262|NCT01186692|4637656|P1|Overall Study|Not Catheterized|11
1405263|NCT01186458|4637683|P1|Overall Study|Adverse Event|1
1405264|NCT01186419|4637692|P2|Overall Study|Not specified|1
1405265|NCT01186419|4637693|P1|Overall Study|Not specified|1
1405266|NCT01186419|4637692|P2|Overall Study|Physician Decision|3
1405267|NCT01186419|4637693|P1|Overall Study|Physician Decision|0
1405268|NCT01186419|4637692|P2|Overall Study|Adverse Event|2
1405269|NCT01186419|4637693|P1|Overall Study|Adverse Event|1
1405270|NCT01186419|4637692|P2|Overall Study|Withdrawal by Subject|3
1405271|NCT01186419|4637693|P1|Overall Study|Withdrawal by Subject|5
1405272|NCT01185964|4637731|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
1405273|NCT01185964|4637732|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
1405274|NCT01185964|4637733|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
1405275|NCT01185964|4637734|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
1405276|NCT01185964|4637731|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
1405277|NCT01185964|4637732|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
1405278|NCT01185964|4637733|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
1405279|NCT01185964|4637734|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
1405280|NCT01185964|4637731|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
1405281|NCT01185964|4637732|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
1405282|NCT01185964|4637733|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
1405283|NCT01185964|4637734|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
1405284|NCT01185964|4637731|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
1405285|NCT01185964|4637732|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
1405286|NCT01185964|4637733|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
1405287|NCT01185964|4637734|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
1405288|NCT01185964|4637731|P4|Phase 1b and Phase 2|Adverse Event|0
1405289|NCT01185964|4637732|P3|Phase 1b and Phase 2|Adverse Event|2
1405290|NCT01185964|4637733|P2|Phase 1b and Phase 2|Adverse Event|0
1405291|NCT01185964|4637734|P1|Phase 1b and Phase 2|Adverse Event|1
1405292|NCT01185964|4637731|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
1405293|NCT01185964|4637732|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
1405294|NCT01185964|4637733|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
1405295|NCT01185964|4637734|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
1405296|NCT01185964|4637731|P4|Phase 1b and Phase 2|Other Therapy Started|0
1405297|NCT01185964|4637732|P3|Phase 1b and Phase 2|Other Therapy Started|3
1405298|NCT01185964|4637733|P2|Phase 1b and Phase 2|Other Therapy Started|3
1405299|NCT01185964|4637734|P1|Phase 1b and Phase 2|Other Therapy Started|0
1405300|NCT01185964|4637731|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
1405301|NCT01185964|4637732|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
1405302|NCT01185964|4637733|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
1405303|NCT01185964|4637734|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
1405304|NCT01185834|4637760|P1|Overall Study|Early exit - Site error|2
1405305|NCT01185834|4637760|P1|Overall Study|Time/Job Conflict|2
1405306|NCT01185834|4637760|P1|Overall Study|Biomicroscopy|4
1405307|NCT01185834|4637760|P1|Overall Study|Discomfort|4
1405308|NCT01185834|4637760|P1|Overall Study|Lost to Follow-up|2
1405309|NCT01185821|4637770|P5|Overall Study|Administrative problems|2
1405310|NCT01185821|4637771|P4|Overall Study|Administrative problems|1
1405311|NCT01185821|4637772|P3|Overall Study|Administrative problems|1
1405312|NCT01185821|4637773|P2|Overall Study|Administrative problems|0
1405313|NCT01185821|4637774|P1|Overall Study|Administrative problems|0
1405314|NCT01185821|4637770|P5|Overall Study|Lost to Follow-up|2
1405315|NCT01185821|4637771|P4|Overall Study|Lost to Follow-up|1
1405316|NCT01185821|4637772|P3|Overall Study|Lost to Follow-up|2
1405317|NCT01185821|4637773|P2|Overall Study|Lost to Follow-up|1
1405318|NCT01185821|4637774|P1|Overall Study|Lost to Follow-up|1
1405319|NCT01185821|4637770|P5|Overall Study|Withdrawal by Subject|3
1405320|NCT01185821|4637771|P4|Overall Study|Withdrawal by Subject|1
1405321|NCT01185821|4637772|P3|Overall Study|Withdrawal by Subject|2
1405322|NCT01185821|4637773|P2|Overall Study|Withdrawal by Subject|2
1405323|NCT01185821|4637774|P1|Overall Study|Withdrawal by Subject|3
1405324|NCT01185821|4637770|P5|Overall Study|Lack of Efficacy|9
1405325|NCT01185821|4637771|P4|Overall Study|Lack of Efficacy|0
1405326|NCT01185821|4637772|P3|Overall Study|Lack of Efficacy|3
1405327|NCT01185821|4637773|P2|Overall Study|Lack of Efficacy|0
1405328|NCT01185821|4637774|P1|Overall Study|Lack of Efficacy|0
1405329|NCT01185821|4637770|P5|Overall Study|Adverse Event|5
1405330|NCT01185821|4637771|P4|Overall Study|Adverse Event|2
1405331|NCT01185821|4637772|P3|Overall Study|Adverse Event|1
1405332|NCT01185821|4637773|P2|Overall Study|Adverse Event|3
1405333|NCT01185821|4637774|P1|Overall Study|Adverse Event|2
1405334|NCT01185821|4637770|P5|Overall Study|Condition no longer required study drug|1
1405335|NCT01185821|4637771|P4|Overall Study|Condition no longer required study drug|0
1405336|NCT01185821|4637772|P3|Overall Study|Condition no longer required study drug|0
1405337|NCT01185821|4637773|P2|Overall Study|Condition no longer required study drug|0
1405338|NCT01185821|4637774|P1|Overall Study|Condition no longer required study drug|0
1405339|NCT01185821|4637770|P5|Overall Study|Death|0
1405340|NCT01185821|4637771|P4|Overall Study|Death|0
1405341|NCT01185821|4637772|P3|Overall Study|Death|0
1405342|NCT01185821|4637773|P2|Overall Study|Death|1
1405343|NCT01185821|4637774|P1|Overall Study|Death|0
1405344|NCT01185821|4637770|P5|Overall Study|Abnormal test procedure result|1
1405345|NCT01185821|4637771|P4|Overall Study|Abnormal test procedure result|0
1405346|NCT01185821|4637772|P3|Overall Study|Abnormal test procedure result|0
1405347|NCT01185821|4637773|P2|Overall Study|Abnormal test procedure result|0
1405348|NCT01185821|4637774|P1|Overall Study|Abnormal test procedure result|0
1405349|NCT01185821|4637770|P5|Overall Study|Protocol Violation|1
1405350|NCT01185821|4637771|P4|Overall Study|Protocol Violation|1
1405351|NCT01185821|4637772|P3|Overall Study|Protocol Violation|0
1405352|NCT01185821|4637773|P2|Overall Study|Protocol Violation|0
1405353|NCT01185821|4637774|P1|Overall Study|Protocol Violation|0
1405354|NCT01185821|4637770|P5|Overall Study|Abnormal laboratory value(s)|0
1405355|NCT01185821|4637771|P4|Overall Study|Abnormal laboratory value(s)|0
1405356|NCT01185821|4637772|P3|Overall Study|Abnormal laboratory value(s)|1
1405357|NCT01185821|4637773|P2|Overall Study|Abnormal laboratory value(s)|2
1405358|NCT01185821|4637774|P1|Overall Study|Abnormal laboratory value(s)|1
1405359|NCT01185782|4637825|P2|Overall Study|Randomized but not treated|4
1405360|NCT01185782|4637826|P1|Overall Study|Randomized but not treated|0
1405361|NCT01185782|4637825|P2|Overall Study|Other|5
1405362|NCT01185782|4637826|P1|Overall Study|Other|2
1405363|NCT01185782|4637825|P2|Overall Study|Poor Response to Treatment|1
1405364|NCT01185782|4637826|P1|Overall Study|Poor Response to Treatment|3
1405365|NCT01185782|4637825|P2|Overall Study|Protocol Violation|0
1405366|NCT01185782|4637826|P1|Overall Study|Protocol Violation|1
1405367|NCT01185782|4637825|P2|Overall Study|Adverse Event|1
1405368|NCT01185782|4637826|P1|Overall Study|Adverse Event|0
1405369|NCT01185704|4637854|P2|Overall Study|Ectopic pregnancy|1
1405370|NCT01185704|4637855|P1|Overall Study|Ectopic pregnancy|0
1405371|NCT01185704|4637854|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
1405372|NCT01185704|4637855|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
1405373|NCT01185704|4637854|P2|Overall Study|Lack of ovarian response|1
1405374|NCT01185704|4637855|P1|Overall Study|Lack of ovarian response|5
1405375|NCT01185704|4637854|P2|Overall Study|Randomized but not treated|3
1405376|NCT01185704|4637855|P1|Overall Study|Randomized but not treated|3
1405377|NCT01185600|4637891|P2|Overall Study|Hold by DSMB|2
1405378|NCT01185600|4637892|P1|Overall Study|Hold by DSMB|1
1405379|NCT01185600|4637891|P2|Overall Study|Withdrawal by Subject|1
1405380|NCT01185600|4637892|P1|Overall Study|Withdrawal by Subject|1
1405381|NCT01185600|4637891|P2|Overall Study|Physician Decision|35
1405382|NCT01185600|4637892|P1|Overall Study|Physician Decision|29
1405383|NCT01185600|4637891|P2|Overall Study|Lost to Follow-up|5
1405384|NCT01185600|4637892|P1|Overall Study|Lost to Follow-up|0
1405385|NCT01185600|4637891|P2|Overall Study|Death|1
1405386|NCT01185600|4637892|P1|Overall Study|Death|0
1405387|NCT01185600|4637891|P2|Overall Study|Adverse Event|1
1405388|NCT01185600|4637892|P1|Overall Study|Adverse Event|1
1405389|NCT01185561|4637914|P2|Overall Study|Withdrawal by Subject|8
1405390|NCT01185561|4637915|P1|Overall Study|Withdrawal by Subject|2
1405391|NCT01185561|4637914|P2|Overall Study|Lost to Follow-up|4
1405392|NCT01185561|4637915|P1|Overall Study|Lost to Follow-up|0
1405393|NCT01185522|4637927|P1|Overall Study|Other reasons|12
1405394|NCT01185522|4637927|P1|Overall Study|Poor tolerance|39
1405395|NCT01185522|4637927|P1|Overall Study|Withdrawal by Subject|10
1405396|NCT01185522|4637927|P1|Overall Study|Lost to Follow-up|19
1405397|NCT01185522|4637927|P1|Overall Study|Lack of Efficacy|28
1405398|NCT01185509|4637953|P2|Overall Study|Intercurrent Illness|1
1405399|NCT01185509|4637954|P1|Overall Study|Intercurrent Illness|0
1405400|NCT01185509|4637953|P2|Overall Study|Death|1
1405401|NCT01185509|4637954|P1|Overall Study|Death|0
1405402|NCT01185509|4637953|P2|Overall Study|Withdrawal by Subject|1
1405403|NCT01185509|4637954|P1|Overall Study|Withdrawal by Subject|0
1405404|NCT01185509|4637953|P2|Overall Study|Physician Decision|2
1405405|NCT01185509|4637954|P1|Overall Study|Physician Decision|2
1405406|NCT01185509|4637953|P2|Overall Study|Progression/Relapse|15
1405407|NCT01185509|4637954|P1|Overall Study|Progression/Relapse|9
1405408|NCT01185353|4637969|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
1405409|NCT01185353|4637970|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
1405410|NCT01185353|4637971|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
1405411|NCT01185353|4637972|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
1405412|NCT01185353|4637973|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
1405413|NCT01185353|4637974|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
1405414|NCT01185353|4637975|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
1405415|NCT01185353|4637976|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
1405416|NCT01185353|4637977|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
1405417|NCT01185353|4637978|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
1405418|NCT01185353|4637969|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
1405419|NCT01185353|4637970|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
1405420|NCT01185353|4637971|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
1405421|NCT01185353|4637972|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1405422|NCT01185353|4637973|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1405423|NCT01185353|4637974|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1405424|NCT01185353|4637975|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1405425|NCT01185353|4637976|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1405426|NCT01185353|4637977|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1405427|NCT01185353|4637978|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1405428|NCT01185353|4637969|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1405429|NCT01185353|4637970|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
1405430|NCT01185353|4637971|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
1405431|NCT01185353|4637972|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1405432|NCT01185353|4637973|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1405433|NCT01185353|4637974|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1405434|NCT01185353|4637975|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1405435|NCT01185353|4637976|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1405436|NCT01185353|4637977|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1405437|NCT01185353|4637978|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1405438|NCT01185353|4637969|P10|Part C (Weeks 24 Through 76)|Reason missing|0
1405439|NCT01185353|4637970|P9|Part C (Weeks 24 Through 76)|Reason missing|1
1405440|NCT01185353|4637971|P8|Part C (Weeks 24 Through 76)|Reason missing|0
1405441|NCT01185353|4637972|P7|Part C (Weeks 24 Through 76)|Reason missing|0
1405442|NCT01185353|4637973|P6|Part C (Weeks 24 Through 76)|Reason missing|0
1405443|NCT01185353|4637974|P5|Part C (Weeks 24 Through 76)|Reason missing|0
1405444|NCT01185353|4637975|P4|Part C (Weeks 24 Through 76)|Reason missing|0
1405445|NCT01185353|4637976|P3|Part C (Weeks 24 Through 76)|Reason missing|0
1405446|NCT01185353|4637977|P2|Part C (Weeks 24 Through 76)|Reason missing|0
1405447|NCT01185353|4637978|P1|Part C (Weeks 24 Through 76)|Reason missing|0
1405448|NCT01185353|4637969|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
1405449|NCT01185353|4637970|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
1405450|NCT01185353|4637971|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
1405451|NCT01185353|4637972|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
1405452|NCT01185353|4637973|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
1405453|NCT01185353|4637974|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
1405454|NCT01185353|4637975|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
1405455|NCT01185353|4637976|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
1405456|NCT01185353|4637977|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
1405457|NCT01185353|4637978|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
1405458|NCT01185353|4637969|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
1405459|NCT01185353|4637970|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1405460|NCT01185353|4637971|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1405461|NCT01185353|4637972|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1405462|NCT01185353|4637973|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1405463|NCT01185353|4637974|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1405464|NCT01185353|4637975|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1405465|NCT01185353|4637976|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1405466|NCT01185353|4637977|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1405467|NCT01185353|4637978|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1405468|NCT01185353|4637969|P10|Part C (Weeks 24 Through 76)|Death|1
1405469|NCT01185353|4637970|P9|Part C (Weeks 24 Through 76)|Death|0
1405470|NCT01185353|4637971|P8|Part C (Weeks 24 Through 76)|Death|0
1405471|NCT01185353|4637972|P7|Part C (Weeks 24 Through 76)|Death|0
1405472|NCT01185353|4637973|P6|Part C (Weeks 24 Through 76)|Death|0
1405473|NCT01185353|4637974|P5|Part C (Weeks 24 Through 76)|Death|0
1405474|NCT01185353|4637975|P4|Part C (Weeks 24 Through 76)|Death|0
1405475|NCT01185353|4637976|P3|Part C (Weeks 24 Through 76)|Death|0
1405476|NCT01185353|4637977|P2|Part C (Weeks 24 Through 76)|Death|0
1405477|NCT01185353|4637978|P1|Part C (Weeks 24 Through 76)|Death|0
1405478|NCT01185353|4637969|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1405479|NCT01185353|4637970|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
1405480|NCT01185353|4637971|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1405481|NCT01185353|4637972|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1405482|NCT01185353|4637973|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1405483|NCT01185353|4637974|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1405484|NCT01185353|4637975|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1405485|NCT01185353|4637976|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1405486|NCT01185353|4637977|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1405487|NCT01185353|4637978|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1405488|NCT01185353|4637969|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
1405489|NCT01185353|4637970|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
1405490|NCT01185353|4637971|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
1405491|NCT01185353|4637972|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1405492|NCT01185353|4637973|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1405493|NCT01185353|4637974|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1405494|NCT01185353|4637975|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1405495|NCT01185353|4637976|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1405496|NCT01185353|4637977|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1405497|NCT01185353|4637978|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1405498|NCT01185353|4637969|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
1405499|NCT01185353|4637970|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
1405500|NCT01185353|4637971|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
1405501|NCT01185353|4637972|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1405502|NCT01185353|4637973|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1405503|NCT01185353|4637974|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1405504|NCT01185353|4637975|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1405505|NCT01185353|4637976|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1405506|NCT01185353|4637977|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1405507|NCT01185353|4637978|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1405508|NCT01185353|4637969|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
1405509|NCT01185353|4637970|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
1405510|NCT01185353|4637971|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
1405511|NCT01185353|4637972|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
1405512|NCT01185353|4637973|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
1405513|NCT01185353|4637974|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
1405514|NCT01185353|4637975|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
1405515|NCT01185353|4637976|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
1405516|NCT01185353|4637977|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
1405517|NCT01185353|4637978|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
1405518|NCT01185353|4637969|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1405519|NCT01185353|4637970|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1405520|NCT01185353|4637971|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1405521|NCT01185353|4637972|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
1405522|NCT01185353|4637973|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1405523|NCT01185353|4637974|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1405524|NCT01185353|4637975|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1405525|NCT01185353|4637976|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1405526|NCT01185353|4637977|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1405527|NCT01185353|4637978|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1405528|NCT01185353|4637969|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1405529|NCT01185353|4637970|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1405530|NCT01185353|4637971|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1405531|NCT01185353|4637972|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
1405532|NCT01185353|4637973|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
1405533|NCT01185353|4637974|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1405534|NCT01185353|4637975|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
1405535|NCT01185353|4637976|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
1405536|NCT01185353|4637977|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1405537|NCT01185353|4637978|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1405538|NCT01185353|4637969|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1405539|NCT01185353|4637970|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1405540|NCT01185353|4637971|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1405541|NCT01185353|4637972|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
1405542|NCT01185353|4637973|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1405543|NCT01185353|4637974|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1405544|NCT01185353|4637975|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
1405545|NCT01185353|4637976|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1405546|NCT01185353|4637977|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1405547|NCT01185353|4637978|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1405548|NCT01185353|4637969|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1405549|NCT01185353|4637970|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1405550|NCT01185353|4637971|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1405551|NCT01185353|4637972|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1405552|NCT01185353|4637973|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1405553|NCT01185353|4637974|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1405554|NCT01185353|4637975|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
1405555|NCT01185353|4637976|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1405556|NCT01185353|4637977|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
1405557|NCT01185353|4637978|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1405558|NCT01185353|4637969|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
1405559|NCT01185353|4637970|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
1405560|NCT01185353|4637971|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
1405561|NCT01185353|4637972|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
1405562|NCT01185353|4637973|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
1405563|NCT01185353|4637974|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
1405564|NCT01185353|4637975|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
1405565|NCT01185353|4637976|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
1405566|NCT01185353|4637977|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
1405567|NCT01185353|4637978|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
1405568|NCT01185353|4637969|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1405569|NCT01185353|4637970|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1405570|NCT01185353|4637971|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1405571|NCT01185353|4637972|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1405572|NCT01185353|4637973|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1405573|NCT01185353|4637974|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
1405574|NCT01185353|4637975|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1405575|NCT01185353|4637976|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1405576|NCT01185353|4637977|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1405577|NCT01185353|4637978|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
1405578|NCT01185353|4637969|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
1405579|NCT01185353|4637970|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
1405580|NCT01185353|4637971|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
1405581|NCT01185353|4637972|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
1405582|NCT01185353|4637973|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
1405583|NCT01185353|4637974|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
1405584|NCT01185353|4637975|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
1405585|NCT01185353|4637976|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
1405586|NCT01185353|4637977|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
1405587|NCT01185353|4637978|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
1405588|NCT01185353|4637969|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
1405589|NCT01185353|4637970|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
1405590|NCT01185353|4637971|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
1405591|NCT01185353|4637972|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
1405592|NCT01185353|4637973|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
1405593|NCT01185353|4637974|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
1405594|NCT01185353|4637975|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
1405595|NCT01185353|4637976|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
1405596|NCT01185353|4637977|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
1405597|NCT01185353|4637978|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
1405598|NCT01185353|4637969|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1405599|NCT01185353|4637970|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1405600|NCT01185353|4637971|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1405601|NCT01185353|4637972|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1405602|NCT01185353|4637973|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1405603|NCT01185353|4637974|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
1405604|NCT01185353|4637975|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1405605|NCT01185353|4637976|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1405606|NCT01185353|4637977|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1405607|NCT01185353|4637978|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
1405608|NCT01185353|4637969|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1405609|NCT01185353|4637970|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1405610|NCT01185353|4637971|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1405611|NCT01185353|4637972|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1405612|NCT01185353|4637973|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1405613|NCT01185353|4637974|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
1405614|NCT01185353|4637975|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1405615|NCT01185353|4637976|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1405616|NCT01185353|4637977|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1405617|NCT01185353|4637978|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1405618|NCT01185353|4637969|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
1405619|NCT01185353|4637970|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
1405620|NCT01185353|4637971|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
1405621|NCT01185353|4637972|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
1405622|NCT01185353|4637973|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
1405623|NCT01185353|4637974|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
1405624|NCT01185353|4637975|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
1405625|NCT01185353|4637976|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
1405626|NCT01185353|4637977|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
1405627|NCT01185353|4637978|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
1405628|NCT01185340|4638139|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
1405629|NCT01185340|4638140|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
1405630|NCT01185340|4638141|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1405631|NCT01185340|4638142|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1405632|NCT01185340|4638139|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
1405633|NCT01185340|4638140|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
1405634|NCT01185340|4638141|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
1405635|NCT01185340|4638142|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
1405636|NCT01185340|4638139|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
1405637|NCT01185340|4638140|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
1405638|NCT01185340|4638141|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
1405639|NCT01185340|4638142|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
1405640|NCT01185340|4638139|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
1405641|NCT01185340|4638140|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1405642|NCT01185340|4638141|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
1405643|NCT01185340|4638142|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1405644|NCT01185340|4638139|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
1405645|NCT01185340|4638140|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
1405646|NCT01185340|4638141|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
1405647|NCT01185340|4638142|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
1405648|NCT01185340|4638139|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
1405649|NCT01185340|4638140|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
1405650|NCT01185340|4638141|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
1405651|NCT01185340|4638142|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
1405652|NCT01185340|4638139|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
1405653|NCT01185340|4638140|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
1405654|NCT01185340|4638141|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
1405655|NCT01185340|4638142|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
1405656|NCT01185340|4638139|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1405657|NCT01185340|4638140|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1405658|NCT01185340|4638141|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1405659|NCT01185340|4638142|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
1405660|NCT01185340|4638139|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1405661|NCT01185340|4638140|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1405662|NCT01185340|4638141|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1405663|NCT01185340|4638142|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
1405664|NCT01185340|4638139|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1405665|NCT01185340|4638140|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1405666|NCT01185340|4638141|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1405667|NCT01185340|4638142|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
1405668|NCT01185340|4638139|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1405669|NCT01185340|4638140|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1405670|NCT01185340|4638141|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1405671|NCT01185340|4638142|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
1405672|NCT01185340|4638139|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1405673|NCT01185340|4638140|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1405674|NCT01185340|4638141|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1405675|NCT01185340|4638142|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
1405676|NCT01185340|4638139|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1405677|NCT01185340|4638140|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1405678|NCT01185340|4638141|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1405679|NCT01185340|4638142|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
1405680|NCT01185340|4638139|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1405681|NCT01185340|4638140|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1405682|NCT01185340|4638141|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1405683|NCT01185340|4638142|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
1405684|NCT01185301|4638194|P4|Overall Study|Other Reason|2
1405685|NCT01185301|4638195|P3|Overall Study|Other Reason|2
1405686|NCT01185301|4638196|P2|Overall Study|Other Reason|2
1405687|NCT01185301|4638197|P1|Overall Study|Other Reason|3
1405688|NCT01185301|4638194|P4|Overall Study|Lost to Follow-up|1
1405689|NCT01185301|4638195|P3|Overall Study|Lost to Follow-up|0
1405690|NCT01185301|4638196|P2|Overall Study|Lost to Follow-up|0
1405691|NCT01185301|4638197|P1|Overall Study|Lost to Follow-up|2
1405692|NCT01185301|4638194|P4|Overall Study|Withdrawal by Subject|3
1405693|NCT01185301|4638195|P3|Overall Study|Withdrawal by Subject|2
1405694|NCT01185301|4638196|P2|Overall Study|Withdrawal by Subject|5
1405695|NCT01185301|4638197|P1|Overall Study|Withdrawal by Subject|7
1405696|NCT01185301|4638194|P4|Overall Study|Adverse Event|3
1405697|NCT01185301|4638195|P3|Overall Study|Adverse Event|2
1405698|NCT01185301|4638196|P2|Overall Study|Adverse Event|0
1405699|NCT01185301|4638197|P1|Overall Study|Adverse Event|3
1405700|NCT01185288|4638257|P2|Overall Study|Noncompliance|1
1405701|NCT01185288|4638258|P1|Overall Study|Noncompliance|0
1405702|NCT01185288|4638257|P2|Overall Study|Did not meet inclusion criteria|0
1405703|NCT01185288|4638258|P1|Overall Study|Did not meet inclusion criteria|1
1405704|NCT01185288|4638257|P2|Overall Study|Investigator discretion|0
1405705|NCT01185288|4638258|P1|Overall Study|Investigator discretion|1
1405706|NCT01185288|4638257|P2|Overall Study|Lack of Efficacy|0
1405707|NCT01185288|4638258|P1|Overall Study|Lack of Efficacy|2
1405708|NCT01185288|4638257|P2|Overall Study|Lost to Follow-up|5
1405709|NCT01185288|4638258|P1|Overall Study|Lost to Follow-up|2
1405710|NCT01185288|4638257|P2|Overall Study|Withdrawal by Subject|4
1405711|NCT01185288|4638258|P1|Overall Study|Withdrawal by Subject|6
1405712|NCT01185288|4638257|P2|Overall Study|Adverse Event|6
1405713|NCT01185288|4638258|P1|Overall Study|Adverse Event|7
1405714|NCT01185249|4638276|P1|Overall Study|Patients discharged or change in status|42
1405715|NCT01185080|4638284|P3|Overall Study|Personal reasons|1
1405716|NCT01185080|4638285|P2|Overall Study|Personal reasons|0
1405717|NCT01185080|4638286|P1|Overall Study|Personal reasons|0
1405718|NCT01185080|4638284|P3|Overall Study|Adverse Event|0
1405719|NCT01185080|4638285|P2|Overall Study|Adverse Event|1
1405720|NCT01185080|4638286|P1|Overall Study|Adverse Event|1
1405721|NCT01184989|4638338|P1|Overall Study|Withdrawal by Subject|1
1405722|NCT01184989|4638338|P1|Overall Study|Adverse Event|11
1405723|NCT01184872|4638358|P2|Overall Study|Protocol deviation|0
1405724|NCT01184872|4638359|P1|Overall Study|Protocol deviation|1
1405725|NCT01184872|4638358|P2|Overall Study|Administrative problems|1
1405726|NCT01184872|4638359|P1|Overall Study|Administrative problems|1
1405727|NCT01184872|4638358|P2|Overall Study|Lost to Follow-up|1
1405728|NCT01184872|4638359|P1|Overall Study|Lost to Follow-up|0
1405729|NCT01184872|4638358|P2|Overall Study|Withdrawal by Subject|0
1405730|NCT01184872|4638359|P1|Overall Study|Withdrawal by Subject|2
1405731|NCT01184872|4638358|P2|Overall Study|Unsatisfactory therapeutic effect|2
1405732|NCT01184872|4638359|P1|Overall Study|Unsatisfactory therapeutic effect|3
1405733|NCT01184872|4638358|P2|Overall Study|Adverse Event|4
1405734|NCT01184872|4638359|P1|Overall Study|Adverse Event|3
1405735|NCT01184859|4638378|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
1405736|NCT01184859|4638379|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
1405737|NCT01184859|4638380|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
1405738|NCT01184859|4638381|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
1405739|NCT01184859|4638382|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
1405740|NCT01184859|4638378|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
1405741|NCT01184859|4638379|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
1405742|NCT01184859|4638380|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
1405743|NCT01184859|4638381|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
1405744|NCT01184859|4638382|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
1405745|NCT01184859|4638378|P5|Period 1: Single Dose|Adverse Event|1
1405746|NCT01184859|4638379|P4|Period 1: Single Dose|Adverse Event|0
1405747|NCT01184859|4638380|P3|Period 1: Single Dose|Adverse Event|0
1405748|NCT01184859|4638381|P2|Period 1: Single Dose|Adverse Event|0
1405749|NCT01184859|4638382|P1|Period 1: Single Dose|Adverse Event|0
1405750|NCT01184859|4638378|P5|Period 1: Single Dose|Protocol Violation|0
1405751|NCT01184859|4638379|P4|Period 1: Single Dose|Protocol Violation|0
1405752|NCT01184859|4638380|P3|Period 1: Single Dose|Protocol Violation|0
1405753|NCT01184859|4638381|P2|Period 1: Single Dose|Protocol Violation|1
1405754|NCT01184859|4638382|P1|Period 1: Single Dose|Protocol Violation|0
1405755|NCT01184859|4638378|P5|Period 1: Single Dose|Insufficient urine production|0
1405756|NCT01184859|4638379|P4|Period 1: Single Dose|Insufficient urine production|0
1405757|NCT01184859|4638380|P3|Period 1: Single Dose|Insufficient urine production|0
1405758|NCT01184859|4638381|P2|Period 1: Single Dose|Insufficient urine production|1
1405759|NCT01184859|4638382|P1|Period 1: Single Dose|Insufficient urine production|0
1405760|NCT01184846|4638474|P1|Overall Study|Insufficient response|1
1405761|NCT01184846|4638474|P1|Overall Study|Adverse Event|2
1405762|NCT01184118|4638528|P1|Overall Study|Withdrawal by Subject|5
1405763|NCT01184118|4638528|P1|Overall Study|Exclusionary medical condition|2
1405764|NCT01184118|4638528|P1|Overall Study|FEV1 <60% predicted|2
1405765|NCT01184118|4638528|P1|Overall Study|No physiologic confirmation of asthma|8
1405766|NCT01184118|4638528|P1|Overall Study|Only asthma step 1 - screen fail|1
1405767|NCT01184079|4638536|P2|Overall Study|Lost to Follow-up|2
1405768|NCT01184079|4638537|P1|Overall Study|Lost to Follow-up|14
1405769|NCT01184053|4638547|P1|Overall Study|progression while on treatment|3
1405770|NCT01183975|4638563|P1|Overall Study|Lost to Follow-up|73
1405771|NCT01183858|4638570|P2|Overall Study|Lost to Follow-up|1
1405772|NCT01183858|4638571|P1|Overall Study|Lost to Follow-up|1
1405773|NCT01183858|4638570|P2|Overall Study|Death related to Progressive Disease|5
1405774|NCT01183858|4638571|P1|Overall Study|Death related to Progressive Disease|4
1405775|NCT01183858|4638570|P2|Overall Study|Progressive Disease|115
1405776|NCT01183858|4638571|P1|Overall Study|Progressive Disease|112
1405777|NCT01183858|4638570|P2|Overall Study|Administrative/Other|6
1405778|NCT01183858|4638571|P1|Overall Study|Administrative/Other|6
1405779|NCT01183858|4638570|P2|Overall Study|Protocol Violation|0
1405780|NCT01183858|4638571|P1|Overall Study|Protocol Violation|1
1405781|NCT01183858|4638570|P2|Overall Study|Discontinued Smoking|1
1405782|NCT01183858|4638571|P1|Overall Study|Discontinued Smoking|3
1405783|NCT01183858|4638570|P2|Overall Study|Withdrew Consent|4
1405784|NCT01183858|4638571|P1|Overall Study|Withdrew Consent|4
1405785|NCT01183858|4638570|P2|Overall Study|Refused Treatment|4
1405786|NCT01183858|4638571|P1|Overall Study|Refused Treatment|1
1405787|NCT01183858|4638570|P2|Overall Study|Insufficient Therapeutic Response|0
1405788|NCT01183858|4638571|P1|Overall Study|Insufficient Therapeutic Response|2
1405789|NCT01183858|4638570|P2|Overall Study|Investigator's Decision|3
1405790|NCT01183858|4638571|P1|Overall Study|Investigator's Decision|0
1405791|NCT01183858|4638570|P2|Overall Study|Adverse Event|11
1405792|NCT01183858|4638571|P1|Overall Study|Adverse Event|14
1405793|NCT01183858|4638570|P2|Overall Study|Death not related to Progressive Disease|6
1405794|NCT01183858|4638571|P1|Overall Study|Death not related to Progressive Disease|5
1405795|NCT01183780|4638593|P2|Overall Study|Lost to Follow-up|11
1405796|NCT01183780|4638594|P1|Overall Study|Lost to Follow-up|6
1405797|NCT01183780|4638593|P2|Overall Study|Withdrawal by Subject|14
1405798|NCT01183780|4638594|P1|Overall Study|Withdrawal by Subject|25
1405799|NCT01183468|4638727|P4|Overall Study|Withdrawal by Subject|0
1405800|NCT01183468|4638728|P3|Overall Study|Withdrawal by Subject|0
1405801|NCT01183468|4638729|P2|Overall Study|Withdrawal by Subject|1
1405802|NCT01183468|4638730|P1|Overall Study|Withdrawal by Subject|0
1405803|NCT01183468|4638727|P4|Overall Study|Physician Decision|0
1405804|NCT01183468|4638728|P3|Overall Study|Physician Decision|0
1405805|NCT01183468|4638729|P2|Overall Study|Physician Decision|0
1405806|NCT01183468|4638730|P1|Overall Study|Physician Decision|1
1405807|NCT01183468|4638727|P4|Overall Study|Lost to Follow-up|0
1405808|NCT01183468|4638728|P3|Overall Study|Lost to Follow-up|0
1405809|NCT01183468|4638729|P2|Overall Study|Lost to Follow-up|1
1405810|NCT01183468|4638730|P1|Overall Study|Lost to Follow-up|2
1405811|NCT01183390|4638740|P2|First Intervention|Adverse Event|1
1405812|NCT01183390|4638741|P1|First Intervention|Adverse Event|0
1405813|NCT01183260|4638774|P2|Overall Study|Death|0
1405814|NCT01183260|4638775|P1|Overall Study|Death|1
1405815|NCT01183260|4638774|P2|Overall Study|Revised within 30 days|1
1405816|NCT01183260|4638775|P1|Overall Study|Revised within 30 days|0
1405817|NCT01183260|4638774|P2|Overall Study|Withdrawal by Subject|1
1405818|NCT01183260|4638775|P1|Overall Study|Withdrawal by Subject|1
1405819|NCT01183260|4638774|P2|Overall Study|Intraop screen failure|0
1405820|NCT01183260|4638775|P1|Overall Study|Intraop screen failure|2
1405821|NCT01183234|4638785|P2|First Intervention|Adverse Event|0
1405822|NCT01183234|4638786|P1|First Intervention|Adverse Event|1
1405823|NCT01183143|4638878|P1|Overall Study|Subjects enrolled, but not treated|11
1405824|NCT01183143|4638878|P1|Overall Study|Subject Questionnaires not returned|5
1405825|NCT01183143|4638878|P1|Overall Study|Withdrawal by Subject|19
1405826|NCT01183143|4638878|P1|Overall Study|Protocol Violation|115
1405827|NCT01183104|4638894|P2|Overall Study|Did not receive study drug|9
1405828|NCT01183104|4638895|P1|Overall Study|Did not receive study drug|5
1405829|NCT01183104|4638894|P2|Overall Study|Nonparticipation in Extension Study|50
1405830|NCT01183104|4638895|P1|Overall Study|Nonparticipation in Extension Study|39
1405831|NCT01183104|4638894|P2|Overall Study|Withdrawal by Subject|11
1405832|NCT01183104|4638895|P1|Overall Study|Withdrawal by Subject|6
1405833|NCT01183104|4638894|P2|Overall Study|Physician Decision|8
1405834|NCT01183104|4638895|P1|Overall Study|Physician Decision|5
1405835|NCT01183104|4638894|P2|Overall Study|Lost to Follow-up|7
1405836|NCT01183104|4638895|P1|Overall Study|Lost to Follow-up|14
1405837|NCT01183104|4638894|P2|Overall Study|Death|1
1405838|NCT01183104|4638895|P1|Overall Study|Death|0
1405839|NCT01183104|4638894|P2|Overall Study|Adverse Event|6
1405840|NCT01183104|4638895|P1|Overall Study|Adverse Event|8
1405841|NCT01183065|4638911|P1|Overall Study|Patient no longer fits eligibility crite|1
1405842|NCT01183013|4638922|P7|Overall Study|Reasons other than stated above|13
1405843|NCT01183013|4638923|P6|Overall Study|Reasons other than stated above|15
1405844|NCT01183013|4638924|P5|Overall Study|Reasons other than stated above|12
1405845|NCT01183013|4638925|P4|Overall Study|Reasons other than stated above|12
1405846|NCT01183013|4638926|P3|Overall Study|Reasons other than stated above|17
1405847|NCT01183013|4638927|P2|Overall Study|Reasons other than stated above|11
1405848|NCT01183013|4638928|P1|Overall Study|Reasons other than stated above|15
1405849|NCT01183013|4638922|P7|Overall Study|Withdrawal by Subject|10
1405850|NCT01183013|4638923|P6|Overall Study|Withdrawal by Subject|9
1405851|NCT01183013|4638924|P5|Overall Study|Withdrawal by Subject|7
1405852|NCT01183013|4638925|P4|Overall Study|Withdrawal by Subject|8
1405853|NCT01183013|4638926|P3|Overall Study|Withdrawal by Subject|10
1405854|NCT01183013|4638927|P2|Overall Study|Withdrawal by Subject|13
1405855|NCT01183013|4638928|P1|Overall Study|Withdrawal by Subject|9
1405856|NCT01183013|4638922|P7|Overall Study|Lost to Follow-up|5
1405857|NCT01183013|4638923|P6|Overall Study|Lost to Follow-up|6
1405858|NCT01183013|4638924|P5|Overall Study|Lost to Follow-up|2
1405859|NCT01183013|4638925|P4|Overall Study|Lost to Follow-up|3
1405860|NCT01183013|4638926|P3|Overall Study|Lost to Follow-up|4
1405861|NCT01183013|4638927|P2|Overall Study|Lost to Follow-up|3
1405862|NCT01183013|4638928|P1|Overall Study|Lost to Follow-up|7
1405863|NCT01183013|4638922|P7|Overall Study|Protocol Violation|3
1405864|NCT01183013|4638923|P6|Overall Study|Protocol Violation|3
1405865|NCT01183013|4638924|P5|Overall Study|Protocol Violation|4
1405866|NCT01183013|4638925|P4|Overall Study|Protocol Violation|0
1405867|NCT01183013|4638926|P3|Overall Study|Protocol Violation|4
1405868|NCT01183013|4638927|P2|Overall Study|Protocol Violation|2
1405869|NCT01183013|4638928|P1|Overall Study|Protocol Violation|5
1405870|NCT01183013|4638922|P7|Overall Study|Lack of Efficacy|0
1405871|NCT01183013|4638923|P6|Overall Study|Lack of Efficacy|2
1405872|NCT01183013|4638924|P5|Overall Study|Lack of Efficacy|1
1405873|NCT01183013|4638925|P4|Overall Study|Lack of Efficacy|2
1405874|NCT01183013|4638926|P3|Overall Study|Lack of Efficacy|1
1405875|NCT01183013|4638927|P2|Overall Study|Lack of Efficacy|2
1405876|NCT01183013|4638928|P1|Overall Study|Lack of Efficacy|3
1405877|NCT01183013|4638922|P7|Overall Study|Adverse Event|6
1405878|NCT01183013|4638923|P6|Overall Study|Adverse Event|10
1405879|NCT01183013|4638924|P5|Overall Study|Adverse Event|10
1405880|NCT01183013|4638925|P4|Overall Study|Adverse Event|5
1405881|NCT01183013|4638926|P3|Overall Study|Adverse Event|5
1405882|NCT01183013|4638927|P2|Overall Study|Adverse Event|8
1405883|NCT01183013|4638928|P1|Overall Study|Adverse Event|6
1405884|NCT01182441|4639074|P2|Overall Study|Physician Decision|1
1405885|NCT01182441|4639075|P1|Overall Study|Physician Decision|1
1405886|NCT01182441|4639074|P2|Overall Study|Adverse Event|0
1405887|NCT01182441|4639075|P1|Overall Study|Adverse Event|2
1405888|NCT01182441|4639074|P2|Overall Study|Implant Not Attempted|0
1405889|NCT01182441|4639075|P1|Overall Study|Implant Not Attempted|4
1405890|NCT01182441|4639074|P2|Overall Study|Withdrawal by Subject|13
1405891|NCT01182441|4639075|P1|Overall Study|Withdrawal by Subject|6
1405892|NCT01182441|4639074|P2|Overall Study|Lost to Follow-up|8
1405893|NCT01182441|4639075|P1|Overall Study|Lost to Follow-up|5
1405894|NCT01182441|4639074|P2|Overall Study|Implant Attempt Unsuccessful|0
1405895|NCT01182441|4639075|P1|Overall Study|Implant Attempt Unsuccessful|13
1405896|NCT01182441|4639074|P2|Overall Study|Death|25
1405897|NCT01182441|4639075|P1|Overall Study|Death|37
1405898|NCT01182441|4639074|P2|Overall Study|Patient Still in Follow-up|72
1405899|NCT01182441|4639075|P1|Overall Study|Patient Still in Follow-up|152
1405900|NCT01182428|4639086|P2|Overall Study|Withdrawal by Subject|0
1405901|NCT01182428|4639087|P1|Overall Study|Withdrawal by Subject|1
1405902|NCT01182428|4639086|P2|Overall Study|Lost to Follow-up|1
1405903|NCT01182428|4639087|P1|Overall Study|Lost to Follow-up|9
1405904|NCT01182428|4639086|P2|Overall Study|Physician Decision|0
1405905|NCT01182428|4639087|P1|Overall Study|Physician Decision|1
1405906|NCT01182415|4639151|P1|Overall Study|Lost to Follow-up|1
1405907|NCT01182337|4639169|P2|Overall Study|Lost to Follow-up|1
1405908|NCT01182337|4639170|P1|Overall Study|Lost to Follow-up|0
1405909|NCT01182337|4639169|P2|Overall Study|Withdrawal by Subject|1
1405910|NCT01182337|4639170|P1|Overall Study|Withdrawal by Subject|3
1405911|NCT01182298|4639188|P1|Overall Study|Withdrawal by Subject|2
1405912|NCT01182298|4639188|P1|Overall Study|Lack of Efficacy|4
1405913|NCT01182285|4639192|P3|Third Intervention Week 11-52|Other|2
1405914|NCT01182285|4639193|P2|Third Intervention Week 11-52|Other|0
1405915|NCT01182285|4639194|P1|Third Intervention Week 11-52|Other|0
1405916|NCT01182285|4639192|P3|Third Intervention Week 11-52|Disease Progression|6
1405917|NCT01182285|4639193|P2|Third Intervention Week 11-52|Disease Progression|0
1405918|NCT01182285|4639194|P1|Third Intervention Week 11-52|Disease Progression|0
1405919|NCT01182285|4639192|P3|First Intervention Week 1-10|Non-compliance|0
1405920|NCT01182285|4639193|P2|First Intervention Week 1-10|Non-compliance|0
1405921|NCT01182285|4639194|P1|First Intervention Week 1-10|Non-compliance|1
1405922|NCT01182285|4639192|P3|First Intervention Week 1-10|Adverse Event|0
1405923|NCT01182285|4639193|P2|First Intervention Week 1-10|Adverse Event|0
1405924|NCT01182285|4639194|P1|First Intervention Week 1-10|Adverse Event|1
1405925|NCT01182285|4639192|P3|First Intervention Week 1-10|Disease progression|0
1405926|NCT01182285|4639193|P2|First Intervention Week 1-10|Disease progression|0
1405927|NCT01182285|4639194|P1|First Intervention Week 1-10|Disease progression|1
1405928|NCT01182207|4639204|P2|Second Intervention|Emeses within 1 hour of dosing|0
1405929|NCT01182207|4639205|P1|Second Intervention|Emeses within 1 hour of dosing|1
1405930|NCT01182207|4639204|P2|First Intervention|Positive Hepatitis Results|1
1405931|NCT01182207|4639205|P1|First Intervention|Positive Hepatitis Results|0
1405932|NCT01182194|4639223|P2|Washout of 28 Days|Withdrawal by Subject|0
1405933|NCT01182194|4639224|P1|Washout of 28 Days|Withdrawal by Subject|1
1405934|NCT01182181|4639242|P2|Washout of 21 Days|Withdrawal by Subject|1
1405935|NCT01182181|4639243|P1|Washout of 21 Days|Withdrawal by Subject|0
1405936|NCT01182181|4639242|P2|First Intervention|Adverse Event|0
1405937|NCT01182181|4639243|P1|First Intervention|Adverse Event|1
1405938|NCT01181986|4639268|P3|Phase 2|Medical condition|0
1405939|NCT01181986|4639269|P2|Phase 2|Medical condition|1
1405940|NCT01181986|4639270|P1|Phase 2|Medical condition|0
1405941|NCT01181986|4639268|P3|Phase 2|Adverse Event|0
1405942|NCT01181986|4639269|P2|Phase 2|Adverse Event|3
1405943|NCT01181986|4639270|P1|Phase 2|Adverse Event|0
1405944|NCT01181986|4639268|P3|Phase 1|Protocol Violation|0
1405945|NCT01181986|4639269|P2|Phase 1|Protocol Violation|0
1405946|NCT01181986|4639270|P1|Phase 1|Protocol Violation|1
1405947|NCT01181986|4639268|P3|Phase 1|Adverse Event|1
1405948|NCT01181986|4639269|P2|Phase 1|Adverse Event|0
1405949|NCT01181986|4639270|P1|Phase 1|Adverse Event|0
1405950|NCT01181986|4639268|P3|Phase 1|Lost to Follow-up|1
1405951|NCT01181986|4639269|P2|Phase 1|Lost to Follow-up|1
1405952|NCT01181986|4639270|P1|Phase 1|Lost to Follow-up|0
1405953|NCT01181921|4639291|P1|Overall Study|Lost to Follow-up|1
1405954|NCT01181895|4639298|P3|Overall Study|Withdrawal by Subject|5
1405955|NCT01181895|4639299|P2|Overall Study|Withdrawal by Subject|0
1405956|NCT01181895|4639300|P1|Overall Study|Withdrawal by Subject|3
1405957|NCT01181895|4639298|P3|Overall Study|Investigator Discretion|1
1405958|NCT01181895|4639299|P2|Overall Study|Investigator Discretion|2
1405959|NCT01181895|4639300|P1|Overall Study|Investigator Discretion|1
1405960|NCT01181895|4639298|P3|Overall Study|Lost to Follow-up|2
1405961|NCT01181895|4639299|P2|Overall Study|Lost to Follow-up|1
1405962|NCT01181895|4639300|P1|Overall Study|Lost to Follow-up|0
1405963|NCT01181895|4639298|P3|Overall Study|Protocol Violation|0
1405964|NCT01181895|4639299|P2|Overall Study|Protocol Violation|1
1405965|NCT01181895|4639300|P1|Overall Study|Protocol Violation|2
1405966|NCT01181895|4639298|P3|Overall Study|Lack of Efficacy|9
1405967|NCT01181895|4639299|P2|Overall Study|Lack of Efficacy|9
1405968|NCT01181895|4639300|P1|Overall Study|Lack of Efficacy|8
1405969|NCT01181895|4639298|P3|Overall Study|Adverse Event|1
1405970|NCT01181895|4639299|P2|Overall Study|Adverse Event|1
1405971|NCT01181895|4639300|P1|Overall Study|Adverse Event|3
1405972|NCT01181778|4639358|P1|Overall Study|Physician Decision|48
1405973|NCT01181726|4639366|P2|First Intervention|Adverse Event|0
1405974|NCT01181726|4639367|P1|First Intervention|Adverse Event|1
1405975|NCT01181609|4639413|P1|Overall Study|Death|50
1405976|NCT01181609|4639413|P1|Overall Study|Lost to Follow-up|1
1405977|NCT01181609|4639413|P1|Overall Study|Withdrawal by Subject|1
1405978|NCT01181609|4639413|P1|Overall Study|Adverse Event|1
1405979|NCT01181531|4639426|P2|Overall Study|Adverse Event|1
1405980|NCT01181531|4639427|P1|Overall Study|Adverse Event|0
1405981|NCT01181531|4639426|P2|Overall Study|Death|12
1405982|NCT01181531|4639427|P1|Overall Study|Death|9
1405983|NCT01181531|4639426|P2|Overall Study|Protocol Violation|6
1405984|NCT01181531|4639427|P1|Overall Study|Protocol Violation|6
1405985|NCT01181531|4639426|P2|Overall Study|Withdrawal by Subject|7
1405986|NCT01181531|4639427|P1|Overall Study|Withdrawal by Subject|8
1405987|NCT01181531|4639426|P2|Overall Study|Pregnancy|1
1405988|NCT01181531|4639427|P1|Overall Study|Pregnancy|0
1405989|NCT01181531|4639426|P2|Overall Study|Protocol Specified Criteria|8
1405990|NCT01181531|4639427|P1|Overall Study|Protocol Specified Criteria|15
1405991|NCT01181531|4639426|P2|Overall Study|Ineligibility determined|2
1405992|NCT01181531|4639427|P1|Overall Study|Ineligibility determined|1
1405993|NCT01181531|4639426|P2|Overall Study|Noncompliance|2
1405994|NCT01181531|4639427|P1|Overall Study|Noncompliance|2
1405995|NCT01181531|4639426|P2|Overall Study|Physician Decision|1
1405996|NCT01181531|4639427|P1|Overall Study|Physician Decision|3
1405997|NCT01181531|4639426|P2|Overall Study|Partial consent by subject withdrawn|1
1405998|NCT01181531|4639427|P1|Overall Study|Partial consent by subject withdrawn|0
1405999|NCT01181531|4639426|P2|Overall Study|Other|12
1406000|NCT01181531|4639427|P1|Overall Study|Other|17
1406001|NCT01181271|4639569|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
1406002|NCT01181271|4639569|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
1406003|NCT01181271|4639569|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
1406004|NCT01181271|4639569|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
1406005|NCT01181167|4639593|P2|Overall Study|Withdrawal by Subject|8
1406006|NCT01181167|4639594|P1|Overall Study|Withdrawal by Subject|6
1406007|NCT01181167|4639593|P2|Overall Study|Protocol Violation|0
1406008|NCT01181167|4639594|P1|Overall Study|Protocol Violation|3
1406009|NCT01181167|4639593|P2|Overall Study|Physician Decision|3
1406010|NCT01181167|4639594|P1|Overall Study|Physician Decision|2
1406011|NCT01181167|4639593|P2|Overall Study|Lost to Follow-up|0
1406012|NCT01181167|4639594|P1|Overall Study|Lost to Follow-up|1
1406013|NCT01181167|4639593|P2|Overall Study|Adverse Event|21
1406014|NCT01181167|4639594|P1|Overall Study|Adverse Event|11
1406015|NCT01181141|4639604|P2|Overall Study|Withdrawal by Subject|1
1406016|NCT01181141|4639605|P1|Overall Study|Withdrawal by Subject|3
1406017|NCT01181141|4639604|P2|Overall Study|Protocol Violation|1
1406018|NCT01181141|4639605|P1|Overall Study|Protocol Violation|3
1406019|NCT01181141|4639604|P2|Overall Study|Physician Decision|0
1406020|NCT01181141|4639605|P1|Overall Study|Physician Decision|2
1406021|NCT01181141|4639604|P2|Overall Study|Lost to Follow-up|1
1406022|NCT01181141|4639605|P1|Overall Study|Lost to Follow-up|1
1406023|NCT01181141|4639604|P2|Overall Study|Lack of Efficacy|0
1406024|NCT01181141|4639605|P1|Overall Study|Lack of Efficacy|1
1406025|NCT01181141|4639604|P2|Overall Study|Adverse Event|1
1406026|NCT01181141|4639605|P1|Overall Study|Adverse Event|2
1406027|NCT01181128|4639614|P3|Overall Study|Not Specified|1
1406028|NCT01181128|4639615|P2|Overall Study|Not Specified|1
1406029|NCT01181128|4639616|P1|Overall Study|Not Specified|1
1406030|NCT01181128|4639614|P3|Overall Study|Adverse Event|0
1406031|NCT01181128|4639615|P2|Overall Study|Adverse Event|2
1406032|NCT01181128|4639616|P1|Overall Study|Adverse Event|0
1406033|NCT01181128|4639614|P3|Overall Study|Physician Decision|0
1406034|NCT01181128|4639615|P2|Overall Study|Physician Decision|0
1406035|NCT01181128|4639616|P1|Overall Study|Physician Decision|2
1406036|NCT01181128|4639614|P3|Overall Study|Death|0
1406037|NCT01181128|4639615|P2|Overall Study|Death|0
1406038|NCT01181128|4639616|P1|Overall Study|Death|1
1406039|NCT01181128|4639614|P3|Overall Study|Withdrawal by Subject|0
1406040|NCT01181128|4639615|P2|Overall Study|Withdrawal by Subject|2
1406041|NCT01181128|4639616|P1|Overall Study|Withdrawal by Subject|2
1406042|NCT01181102|4639704|P2|Overall Study|Withdrawal by Subject|12
1406043|NCT01181102|4639705|P1|Overall Study|Withdrawal by Subject|10
1406044|NCT01181102|4639704|P2|Overall Study|Protocol Violation|6
1406045|NCT01181102|4639705|P1|Overall Study|Protocol Violation|5
1406046|NCT01181102|4639704|P2|Overall Study|Physician Decision|1
1406047|NCT01181102|4639705|P1|Overall Study|Physician Decision|3
1406048|NCT01181102|4639704|P2|Overall Study|Lost to Follow-up|0
1406049|NCT01181102|4639705|P1|Overall Study|Lost to Follow-up|2
1406050|NCT01181102|4639704|P2|Overall Study|Lack of Efficacy|1
1406051|NCT01181102|4639705|P1|Overall Study|Lack of Efficacy|3
1406052|NCT01181102|4639704|P2|Overall Study|Adverse Event|26
1406053|NCT01181102|4639705|P1|Overall Study|Adverse Event|28
1406054|NCT01181011|4639726|P1|Overall Study|Lost to Follow-up|1
1406055|NCT01181011|4639726|P1|Overall Study|Adverse Event|2
1406056|NCT01180998|4639776|P3|Overall Study|Poor lens handling|2
1406057|NCT01180998|4639777|P2|Overall Study|Poor lens handling|0
1406058|NCT01180998|4639778|P1|Overall Study|Poor lens handling|0
1406059|NCT01180998|4639776|P3|Overall Study|Poor comfort|4
1406060|NCT01180998|4639777|P2|Overall Study|Poor comfort|0
1406061|NCT01180998|4639778|P1|Overall Study|Poor comfort|3
1406062|NCT01180998|4639776|P3|Overall Study|Withdrawal by Subject|1
1406063|NCT01180998|4639777|P2|Overall Study|Withdrawal by Subject|0
1406064|NCT01180998|4639778|P1|Overall Study|Withdrawal by Subject|0
1406065|NCT01180998|4639776|P3|Overall Study|Protocol Violation|0
1406066|NCT01180998|4639777|P2|Overall Study|Protocol Violation|2
1406067|NCT01180998|4639778|P1|Overall Study|Protocol Violation|1
1406068|NCT01180998|4639776|P3|Overall Study|Lost to Follow-up|1
1406069|NCT01180998|4639777|P2|Overall Study|Lost to Follow-up|0
1406070|NCT01180998|4639778|P1|Overall Study|Lost to Follow-up|0
1406071|NCT01180998|4639776|P3|Overall Study|Poor Vision|2
1406072|NCT01180998|4639777|P2|Overall Study|Poor Vision|2
1406073|NCT01180998|4639778|P1|Overall Study|Poor Vision|0
1406074|NCT01180985|4639792|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
1406075|NCT01180985|4639793|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
1406076|NCT01180790|4639832|P7|Overall Study|Severe coronary atherosclerosis (death)|0
1406077|NCT01180790|4639833|P6|Overall Study|Severe coronary atherosclerosis (death)|0
1406078|NCT01180790|4639834|P5|Overall Study|Severe coronary atherosclerosis (death)|0
1406079|NCT01180790|4639835|P4|Overall Study|Severe coronary atherosclerosis (death)|0
1406080|NCT01180790|4639836|P3|Overall Study|Severe coronary atherosclerosis (death)|1
1406081|NCT01180790|4639837|P2|Overall Study|Severe coronary atherosclerosis (death)|0
1406082|NCT01180790|4639838|P1|Overall Study|Severe coronary atherosclerosis (death)|0
1406083|NCT01180790|4639832|P7|Overall Study|compliance|0
1406084|NCT01180790|4639833|P6|Overall Study|compliance|0
1406085|NCT01180790|4639834|P5|Overall Study|compliance|0
1406086|NCT01180790|4639835|P4|Overall Study|compliance|0
1406087|NCT01180790|4639836|P3|Overall Study|compliance|0
1406088|NCT01180790|4639837|P2|Overall Study|compliance|1
1406089|NCT01180790|4639838|P1|Overall Study|compliance|0
1406090|NCT01180790|4639832|P7|Overall Study|Lack of Efficacy|0
1406091|NCT01180790|4639833|P6|Overall Study|Lack of Efficacy|3
1406092|NCT01180790|4639834|P5|Overall Study|Lack of Efficacy|1
1406093|NCT01180790|4639835|P4|Overall Study|Lack of Efficacy|6
1406094|NCT01180790|4639836|P3|Overall Study|Lack of Efficacy|5
1406095|NCT01180790|4639837|P2|Overall Study|Lack of Efficacy|2
1406096|NCT01180790|4639838|P1|Overall Study|Lack of Efficacy|1
1406097|NCT01180790|4639832|P7|Overall Study|Physician Decision|0
1406098|NCT01180790|4639833|P6|Overall Study|Physician Decision|0
1406099|NCT01180790|4639834|P5|Overall Study|Physician Decision|0
1406100|NCT01180790|4639835|P4|Overall Study|Physician Decision|1
1406101|NCT01180790|4639836|P3|Overall Study|Physician Decision|0
1406102|NCT01180790|4639837|P2|Overall Study|Physician Decision|0
1406103|NCT01180790|4639838|P1|Overall Study|Physician Decision|1
1406104|NCT01180790|4639832|P7|Overall Study|Lost to Follow-up|1
1406105|NCT01180790|4639833|P6|Overall Study|Lost to Follow-up|0
1406106|NCT01180790|4639834|P5|Overall Study|Lost to Follow-up|1
1406107|NCT01180790|4639835|P4|Overall Study|Lost to Follow-up|2
1406108|NCT01180790|4639836|P3|Overall Study|Lost to Follow-up|0
1406109|NCT01180790|4639837|P2|Overall Study|Lost to Follow-up|1
1406110|NCT01180790|4639838|P1|Overall Study|Lost to Follow-up|3
1406111|NCT01180790|4639832|P7|Overall Study|Withdrawal by Subject|0
1406112|NCT01180790|4639833|P6|Overall Study|Withdrawal by Subject|1
1406113|NCT01180790|4639834|P5|Overall Study|Withdrawal by Subject|2
1406114|NCT01180790|4639835|P4|Overall Study|Withdrawal by Subject|0
1406115|NCT01180790|4639836|P3|Overall Study|Withdrawal by Subject|5
1406116|NCT01180790|4639837|P2|Overall Study|Withdrawal by Subject|0
1406117|NCT01180790|4639838|P1|Overall Study|Withdrawal by Subject|3
1406118|NCT01180790|4639832|P7|Overall Study|Adverse Event|0
1406119|NCT01180790|4639833|P6|Overall Study|Adverse Event|3
1406120|NCT01180790|4639834|P5|Overall Study|Adverse Event|1
1406121|NCT01180790|4639835|P4|Overall Study|Adverse Event|0
1406122|NCT01180790|4639836|P3|Overall Study|Adverse Event|2
1406123|NCT01180790|4639837|P2|Overall Study|Adverse Event|1
1406124|NCT01180790|4639838|P1|Overall Study|Adverse Event|1
1406125|NCT01180777|4639903|P1|Overall Study|Adverse Event|1
1406126|NCT01180777|4639903|P1|Overall Study|Lost to Follow-up|1
1406127|NCT01180777|4639903|P1|Overall Study|Poor lens fit|4
1406128|NCT01180777|4639903|P1|Overall Study|Protocol Violation|6
1406129|NCT01180660|4639917|P2|Overall Study|Changed to open surgery|0
1406130|NCT01180660|4639918|P1|Overall Study|Changed to open surgery|1
1406131|NCT01180647|4639928|P2|Overall Study|Lost to Follow-up|6
1406132|NCT01180647|4639929|P1|Overall Study|Lost to Follow-up|5
1406133|NCT01180400|4639964|P2|Overall Study|Not specified|1
1406134|NCT01180400|4639965|P1|Overall Study|Not specified|0
1406135|NCT01180400|4639964|P2|Overall Study|Lost to Follow-up|3
1406136|NCT01180400|4639965|P1|Overall Study|Lost to Follow-up|2
1406137|NCT01180400|4639964|P2|Overall Study|Study-specific withdrawal criteria|2
1406138|NCT01180400|4639965|P1|Overall Study|Study-specific withdrawal criteria|1
1406139|NCT01180400|4639964|P2|Overall Study|Lack of Efficacy|0
1406140|NCT01180400|4639965|P1|Overall Study|Lack of Efficacy|2
1406141|NCT01180400|4639964|P2|Overall Study|Condition under investigation worsened|1
1406142|NCT01180400|4639965|P1|Overall Study|Condition under investigation worsened|2
1406143|NCT01180400|4639964|P2|Overall Study|Severe non-compliance to protocol|2
1406144|NCT01180400|4639965|P1|Overall Study|Severe non-compliance to protocol|1
1406145|NCT01180400|4639964|P2|Overall Study|Adverse Event|10
1406146|NCT01180400|4639965|P1|Overall Study|Adverse Event|12
1406147|NCT01180400|4639964|P2|Overall Study|Eligibility criteria not fulfilled|2
1406148|NCT01180400|4639965|P1|Overall Study|Eligibility criteria not fulfilled|0
1406149|NCT01180400|4639964|P2|Overall Study|Withdrawal by Subject|6
1406150|NCT01180400|4639965|P1|Overall Study|Withdrawal by Subject|5
1406151|NCT01180296|4640013|P2|Overall Study|Protocol Violation|2
1406152|NCT01180296|4640014|P1|Overall Study|Protocol Violation|1
1406153|NCT01180244|4640022|P2|Overall Study|Lost to Follow-up|0
1406154|NCT01180244|4640023|P1|Overall Study|Lost to Follow-up|1
1406155|NCT01180244|4640022|P2|Overall Study|Protocol Violation|0
1406156|NCT01180244|4640023|P1|Overall Study|Protocol Violation|1
1406157|NCT01180244|4640022|P2|Overall Study|Withdrawal by Subject|1
1406158|NCT01180244|4640023|P1|Overall Study|Withdrawal by Subject|0
1406159|NCT01180244|4640022|P2|Overall Study|Adverse Event|0
1406160|NCT01180244|4640023|P1|Overall Study|Adverse Event|1
1406161|NCT01180244|4640022|P2|Overall Study|Physician Decision|0
1406162|NCT01180244|4640023|P1|Overall Study|Physician Decision|3
1406163|NCT01180244|4640022|P2|Overall Study|Lack of Efficacy|7
1406164|NCT01180244|4640023|P1|Overall Study|Lack of Efficacy|0
1406165|NCT01180049|4640068|P2|Overall Study|Ongoing on treatment|10
1406166|NCT01180049|4640069|P1|Overall Study|Ongoing on treatment|18
1406167|NCT01180049|4640068|P2|Overall Study|Death|28
1406168|NCT01180049|4640069|P1|Overall Study|Death|23
1406169|NCT01180049|4640068|P2|Overall Study|Lost to Follow-up|1
1406170|NCT01180049|4640069|P1|Overall Study|Lost to Follow-up|0
1406171|NCT01180049|4640068|P2|Overall Study|Participant Refused Follow Up|3
1406172|NCT01180049|4640069|P1|Overall Study|Participant Refused Follow Up|5
1406173|NCT01180049|4640068|P2|Overall Study|Enrolled to Another Clinical Trial|1
1406174|NCT01180049|4640069|P1|Overall Study|Enrolled to Another Clinical Trial|1
1406175|NCT01179919|4640095|P1|Overall Study|Adverse Event|1
1406176|NCT01179919|4640095|P1|Overall Study|Protocol Violation|1
1406177|NCT01179737|4640104|P4|Extension|The study was terminated|0
1406178|NCT01179737|4640105|P3|Extension|The study was terminated|0
1406179|NCT01179737|4640106|P2|Extension|The study was terminated|0
1406180|NCT01179737|4640107|P1|Extension|The study was terminated|3
1406181|NCT01179737|4640104|P4|Cohort 1 & Cohort 2 Expansion|Death|0
1406182|NCT01179737|4640105|P3|Cohort 1 & Cohort 2 Expansion|Death|0
1406183|NCT01179737|4640106|P2|Cohort 1 & Cohort 2 Expansion|Death|0
1406184|NCT01179737|4640107|P1|Cohort 1 & Cohort 2 Expansion|Death|1
1406185|NCT01179737|4640104|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
1406186|NCT01179737|4640105|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
1406187|NCT01179737|4640106|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
1406188|NCT01179737|4640107|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
1406189|NCT01179737|4640104|P4|Cohort 1 & Cohort 2|Death|0
1406190|NCT01179737|4640105|P3|Cohort 1 & Cohort 2|Death|1
1406191|NCT01179737|4640106|P2|Cohort 1 & Cohort 2|Death|0
1406192|NCT01179737|4640107|P1|Cohort 1 & Cohort 2|Death|0
1406193|NCT01179737|4640104|P4|Cohort 1 & Cohort 2|Administrative problems|4
1406194|NCT01179737|4640105|P3|Cohort 1 & Cohort 2|Administrative problems|2
1406195|NCT01179737|4640106|P2|Cohort 1 & Cohort 2|Administrative problems|0
1406196|NCT01179737|4640107|P1|Cohort 1 & Cohort 2|Administrative problems|0
1406197|NCT01179737|4640104|P4|Cohort 1 & Cohort 2|Withdrew consent|0
1406198|NCT01179737|4640105|P3|Cohort 1 & Cohort 2|Withdrew consent|0
1406199|NCT01179737|4640106|P2|Cohort 1 & Cohort 2|Withdrew consent|0
1406200|NCT01179737|4640107|P1|Cohort 1 & Cohort 2|Withdrew consent|2
1406201|NCT01179737|4640104|P4|Cohort 1 & Cohort 2|Adverse Event|0
1406202|NCT01179737|4640105|P3|Cohort 1 & Cohort 2|Adverse Event|1
1406203|NCT01179737|4640106|P2|Cohort 1 & Cohort 2|Adverse Event|1
1406204|NCT01179737|4640107|P1|Cohort 1 & Cohort 2|Adverse Event|3
1406205|NCT01179672|4640118|P2|Overall Study|Physician Decision|1
1406206|NCT01179672|4640119|P1|Overall Study|Physician Decision|1
1406207|NCT01179672|4640118|P2|Overall Study|Protocol Violation|2
1406208|NCT01179672|4640119|P1|Overall Study|Protocol Violation|2
1406209|NCT01179672|4640118|P2|Overall Study|Lost to Follow-up|1
1406210|NCT01179672|4640119|P1|Overall Study|Lost to Follow-up|0
1406211|NCT01179672|4640118|P2|Overall Study|Entry Criteria Not Met|2
1406212|NCT01179672|4640119|P1|Overall Study|Entry Criteria Not Met|0
1406213|NCT01179672|4640118|P2|Overall Study|Withdrawal by Subject|12
1406214|NCT01179672|4640119|P1|Overall Study|Withdrawal by Subject|10
1406215|NCT01179672|4640118|P2|Overall Study|Adverse Event|8
1406216|NCT01179672|4640119|P1|Overall Study|Adverse Event|17
1406217|NCT01179516|4640175|P3|Overall Study|Other|2
1406218|NCT01179516|4640176|P2|Overall Study|Other|0
1406219|NCT01179516|4640177|P1|Overall Study|Other|2
1406220|NCT01179516|4640175|P3|Overall Study|Lost to Follow-up|3
1406221|NCT01179516|4640176|P2|Overall Study|Lost to Follow-up|7
1406222|NCT01179516|4640177|P1|Overall Study|Lost to Follow-up|7
1406223|NCT01179516|4640175|P3|Overall Study|Withdrawal of Consent|10
1406224|NCT01179516|4640176|P2|Overall Study|Withdrawal of Consent|6
1406225|NCT01179516|4640177|P1|Overall Study|Withdrawal of Consent|2
1406226|NCT01179516|4640175|P3|Overall Study|Protocol Deviations|3
1406227|NCT01179516|4640176|P2|Overall Study|Protocol Deviations|3
1406228|NCT01179516|4640177|P1|Overall Study|Protocol Deviations|4
1406229|NCT01179516|4640175|P3|Overall Study|Noncompliance with Study Drug|1
1406230|NCT01179516|4640176|P2|Overall Study|Noncompliance with Study Drug|0
1406231|NCT01179516|4640177|P1|Overall Study|Noncompliance with Study Drug|2
1406232|NCT01179516|4640175|P3|Overall Study|Lack of Efficacy|0
1406233|NCT01179516|4640176|P2|Overall Study|Lack of Efficacy|2
1406234|NCT01179516|4640177|P1|Overall Study|Lack of Efficacy|4
1406235|NCT01179516|4640175|P3|Overall Study|Pretreatment Event or Adverse Event|12
1406236|NCT01179516|4640176|P2|Overall Study|Pretreatment Event or Adverse Event|8
1406237|NCT01179516|4640177|P1|Overall Study|Pretreatment Event or Adverse Event|6
1406238|NCT01179399|4640221|P1|Overall Study|Withdrawal by Subject|1
1406239|NCT01179399|4640221|P1|Overall Study|Lack of Efficacy|30
1406240|NCT01179399|4640221|P1|Overall Study|Adverse Event|1
1406241|NCT01179347|4640227|P2|Open-label Period (12 Weeks)|Other|4
1406242|NCT01179347|4640228|P1|Open-label Period (12 Weeks)|Other|7
1406243|NCT01179347|4640227|P2|Open-label Period (12 Weeks)|Protocol Violation|0
1406244|NCT01179347|4640228|P1|Open-label Period (12 Weeks)|Protocol Violation|1
1406245|NCT01179347|4640227|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
1406246|NCT01179347|4640228|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
1406247|NCT01179347|4640227|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
1406248|NCT01179347|4640228|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
1406249|NCT01179347|4640227|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
1406250|NCT01179347|4640228|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
1406251|NCT01179347|4640227|P2|Open-label Period (12 Weeks)|Adverse Event|9
1406252|NCT01179347|4640228|P1|Open-label Period (12 Weeks)|Adverse Event|5
1406253|NCT01179347|4640227|P2|Double-blind Period (12 Weeks)|Other|4
1406254|NCT01179347|4640228|P1|Double-blind Period (12 Weeks)|Other|2
1406255|NCT01179347|4640227|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
1406256|NCT01179347|4640228|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
1406257|NCT01179347|4640227|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
1406258|NCT01179347|4640228|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
1406259|NCT01179347|4640227|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
1406260|NCT01179347|4640228|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
1406261|NCT01179347|4640227|P2|Double-blind Period (12 Weeks)|Adverse Event|6
1406262|NCT01179347|4640228|P1|Double-blind Period (12 Weeks)|Adverse Event|2
1406263|NCT01179334|4640250|P2|Long-term Extension (LTE) Period|Adverse Event|4
1406264|NCT01179334|4640251|P1|Long-term Extension (LTE) Period|Adverse Event|2
1406265|NCT01179334|4640250|P2|Long-term Extension (LTE) Period|Death|0
1406266|NCT01179334|4640251|P1|Long-term Extension (LTE) Period|Death|3
1406267|NCT01179334|4640250|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
1406268|NCT01179334|4640251|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
1406269|NCT01179334|4640250|P2|Treatment Period|Adverse Event|0
1406270|NCT01179334|4640251|P1|Treatment Period|Adverse Event|1
1406271|NCT01179191|4640306|P1|Maintenance Phase (8 Weeks)|Other|66
1406272|NCT01179191|4640306|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
1406273|NCT01179191|4640306|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
1406274|NCT01179191|4640306|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
1406275|NCT01179191|4640306|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
1406276|NCT01179191|4640306|P1|Titration Phase (up to 6 Weeks)|Other|62
1406277|NCT01179191|4640306|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
1406278|NCT01179191|4640306|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
1406279|NCT01179191|4640306|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
1406280|NCT01179191|4640306|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
1406281|NCT01179191|4640306|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
1406282|NCT01179048|4640338|P2|Overall Study|Alive|142
1406283|NCT01179048|4640339|P1|Overall Study|Alive|127
1406284|NCT01179048|4640338|P2|Overall Study|Lost to Follow-up|9
1406285|NCT01179048|4640339|P1|Overall Study|Lost to Follow-up|8
1406286|NCT01179048|4640338|P2|Overall Study|Withdrawn - does not allow contact|8
1406287|NCT01179048|4640339|P1|Overall Study|Withdrawn - does not allow contact|4
1406288|NCT01178853|4640366|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
1406289|NCT01178853|4640367|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
1406290|NCT01178853|4640366|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
1406291|NCT01178853|4640367|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
1406292|NCT01178853|4640366|P2|Period 3 (Warfarin Titration)|Adverse Event|0
1406293|NCT01178853|4640367|P1|Period 3 (Warfarin Titration)|Adverse Event|1
1406294|NCT01178853|4640366|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
1406295|NCT01178853|4640367|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
1406296|NCT01178853|4640366|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
1406297|NCT01178853|4640367|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
1406298|NCT01178762|4640407|P1|Overall Study|Lost to Follow-up|15
1406299|NCT01178671|4640413|P2|Overall Study|Physician Decision|6
1406300|NCT01178671|4640414|P1|Overall Study|Physician Decision|4
1406301|NCT01178671|4640413|P2|Overall Study|Lost to Follow-up|1
1406302|NCT01178671|4640414|P1|Overall Study|Lost to Follow-up|3
1406303|NCT01178671|4640413|P2|Overall Study|Lack of Efficacy|1
1406304|NCT01178671|4640414|P1|Overall Study|Lack of Efficacy|0
1406305|NCT01178671|4640413|P2|Overall Study|Protocol Violation|1
1406306|NCT01178671|4640414|P1|Overall Study|Protocol Violation|1
1406307|NCT01178671|4640413|P2|Overall Study|Adverse Event|6
1406308|NCT01178671|4640414|P1|Overall Study|Adverse Event|4
1406309|NCT01178385|4640462|P2|Overall Study|Withdrawal by Subject|0
1406310|NCT01178385|4640463|P1|Overall Study|Withdrawal by Subject|2
1406311|NCT01178294|4640532|P1|Overall Study|Completion status could not be verified|1
1406312|NCT01178294|4640532|P1|Overall Study|Subject status is terminal|1
1406313|NCT01178294|4640532|P1|Overall Study|Development of inhibitors to OBI-1|1
1406314|NCT01178294|4640532|P1|Overall Study|Death|1
1406315|NCT01178294|4640532|P1|Overall Study|Lack of Efficacy|1
1406316|NCT01178294|4640532|P1|Overall Study|Lost to Follow-up|2
1406317|NCT01178294|4640532|P1|Overall Study|Adverse Event|4
1406318|NCT01178281|4640555|P2|Overall Study|Prohibited Medications|2
1406319|NCT01178281|4640556|P1|Overall Study|Prohibited Medications|0
1406320|NCT01178281|4640555|P2|Overall Study|Adverse Event|9
1406321|NCT01178281|4640556|P1|Overall Study|Adverse Event|39
1406322|NCT01178281|4640555|P2|Overall Study|Withdrawal by Subject|7
1406323|NCT01178281|4640556|P1|Overall Study|Withdrawal by Subject|18
1406324|NCT01178281|4640555|P2|Overall Study|Death|5
1406325|NCT01178281|4640556|P1|Overall Study|Death|4
1406326|NCT01178281|4640555|P2|Overall Study|Disease Progression|6
1406327|NCT01178281|4640556|P1|Overall Study|Disease Progression|18
1406328|NCT01178281|4640555|P2|Overall Study|Non-compliance to study drug|0
1406329|NCT01178281|4640556|P1|Overall Study|Non-compliance to study drug|1
1406330|NCT01178281|4640555|P2|Overall Study|Lack of Efficacy|38
1406331|NCT01178281|4640556|P1|Overall Study|Lack of Efficacy|60
1406332|NCT01178281|4640555|P2|Overall Study|Loss of Clinical Benefit|7
1406333|NCT01178281|4640556|P1|Overall Study|Loss of Clinical Benefit|5
1406334|NCT01178281|4640555|P2|Overall Study|Physician Decision|3
1406335|NCT01178281|4640556|P1|Overall Study|Physician Decision|4
1406336|NCT01178138|4640782|P1|Overall Study|Physician Decision|8
1406337|NCT01178138|4640782|P1|Overall Study|Withdrawal by Subject|7
1406338|NCT01178138|4640782|P1|Overall Study|Lost to Follow-up|8
1406339|NCT01178125|4640803|P1|Overall Study|Investigator Decision|5
1406340|NCT01178125|4640803|P1|Overall Study|Protocol Violation|17
1406341|NCT01178125|4640803|P1|Overall Study|Sponsor Decision|28
1406342|NCT01178125|4640803|P1|Overall Study|Other Reason|39
1406343|NCT01178125|4640803|P1|Overall Study|Pregnancy|55
1406344|NCT01178125|4640803|P1|Overall Study|Noncompliance|184
1406345|NCT01178125|4640803|P1|Overall Study|Withdrawal by Subject|209
1406346|NCT01178125|4640803|P1|Overall Study|Adverse Event|244
1406347|NCT01178125|4640803|P1|Overall Study|Lost to Follow-up|397
1406348|NCT01178099|4640834|P2|Overall Study|Physician Decision|1
1406349|NCT01178099|4640835|P1|Overall Study|Physician Decision|0
1406350|NCT01178073|4640876|P3|Overall Study|Missing Completion Status|0
1406351|NCT01178073|4640877|P2|Overall Study|Missing Completion Status|0
1406352|NCT01178073|4640878|P1|Overall Study|Missing Completion Status|1
1406353|NCT01178073|4640876|P3|Overall Study|Withdrawal by Subject|8
1406354|NCT01178073|4640877|P2|Overall Study|Withdrawal by Subject|6
1406355|NCT01178073|4640878|P1|Overall Study|Withdrawal by Subject|10
1406356|NCT01178073|4640876|P3|Overall Study|Physician Decision|10
1406357|NCT01178073|4640877|P2|Overall Study|Physician Decision|10
1406358|NCT01178073|4640878|P1|Overall Study|Physician Decision|14
1406359|NCT01178073|4640876|P3|Overall Study|Lost to Follow-up|3
1406360|NCT01178073|4640877|P2|Overall Study|Lost to Follow-up|0
1406361|NCT01178073|4640878|P1|Overall Study|Lost to Follow-up|2
1406362|NCT01178073|4640876|P3|Overall Study|Protocol Violation|1
1406363|NCT01178073|4640877|P2|Overall Study|Protocol Violation|1
1406364|NCT01178073|4640878|P1|Overall Study|Protocol Violation|1
1406365|NCT01178073|4640876|P3|Overall Study|Adverse Event|24
1406366|NCT01178073|4640877|P2|Overall Study|Adverse Event|27
1406367|NCT01178073|4640878|P1|Overall Study|Adverse Event|34
1406368|NCT01177969|4640909|P2|Overall Study|Withdrawal by Subject|2
1406369|NCT01177969|4640910|P1|Overall Study|Withdrawal by Subject|1
1406370|NCT01177969|4640909|P2|Overall Study|Protocol Violation|1
1406371|NCT01177969|4640910|P1|Overall Study|Protocol Violation|2
1406372|NCT01177943|4640933|P2|First Intervention|Withdrawal by Subject|0
1406373|NCT01177943|4640934|P1|First Intervention|Withdrawal by Subject|2
1406374|NCT01177813|4640947|P5|Overall Study|Other reason not defined above|2
1406375|NCT01177813|4640948|P4|Overall Study|Other reason not defined above|3
1406376|NCT01177813|4640949|P3|Overall Study|Other reason not defined above|2
1406377|NCT01177813|4640950|P2|Overall Study|Other reason not defined above|2
1406378|NCT01177813|4640951|P1|Overall Study|Other reason not defined above|5
1406379|NCT01177813|4640947|P5|Overall Study|Withdrawal by Subject|3
1406380|NCT01177813|4640948|P4|Overall Study|Withdrawal by Subject|5
1406381|NCT01177813|4640949|P3|Overall Study|Withdrawal by Subject|6
1406382|NCT01177813|4640950|P2|Overall Study|Withdrawal by Subject|7
1406383|NCT01177813|4640951|P1|Overall Study|Withdrawal by Subject|12
1406384|NCT01177813|4640947|P5|Overall Study|Lost to Follow-up|0
1406385|NCT01177813|4640948|P4|Overall Study|Lost to Follow-up|3
1406386|NCT01177813|4640949|P3|Overall Study|Lost to Follow-up|6
1406387|NCT01177813|4640950|P2|Overall Study|Lost to Follow-up|5
1406388|NCT01177813|4640951|P1|Overall Study|Lost to Follow-up|12
1406389|NCT01177813|4640947|P5|Overall Study|Protocol Violation|1
1406390|NCT01177813|4640948|P4|Overall Study|Protocol Violation|0
1406391|NCT01177813|4640949|P3|Overall Study|Protocol Violation|2
1406392|NCT01177813|4640950|P2|Overall Study|Protocol Violation|2
1406393|NCT01177813|4640951|P1|Overall Study|Protocol Violation|3
1406394|NCT01177813|4640947|P5|Overall Study|Lack of Efficacy|0
1406395|NCT01177813|4640948|P4|Overall Study|Lack of Efficacy|0
1406396|NCT01177813|4640949|P3|Overall Study|Lack of Efficacy|0
1406397|NCT01177813|4640950|P2|Overall Study|Lack of Efficacy|0
1406398|NCT01177813|4640951|P1|Overall Study|Lack of Efficacy|1
1406399|NCT01177813|4640947|P5|Overall Study|Adverse Event|3
1406400|NCT01177813|4640948|P4|Overall Study|Adverse Event|6
1406401|NCT01177813|4640949|P3|Overall Study|Adverse Event|4
1406402|NCT01177813|4640950|P2|Overall Study|Adverse Event|2
1406403|NCT01177813|4640951|P1|Overall Study|Adverse Event|8
1406404|NCT01177800|4640980|P2|Overall Study|Withdrawal of informed consent|1
1406405|NCT01177800|4640981|P1|Overall Study|Withdrawal of informed consent|0
1406406|NCT01177800|4640980|P2|Overall Study|Physician Decision|0
1406407|NCT01177800|4640981|P1|Overall Study|Physician Decision|1
1406408|NCT01177800|4640980|P2|Overall Study|Protocol Violation|1
1406409|NCT01177800|4640981|P1|Overall Study|Protocol Violation|0
1406410|NCT01177800|4640980|P2|Overall Study|Adverse Event|3
1406411|NCT01177800|4640981|P1|Overall Study|Adverse Event|9
1406412|NCT01177722|4641003|P4|Overall Study|Withdrawal by Subject|6
1406413|NCT01177722|4641004|P3|Overall Study|Withdrawal by Subject|4
1406414|NCT01177722|4641005|P2|Overall Study|Withdrawal by Subject|6
1406415|NCT01177722|4641006|P1|Overall Study|Withdrawal by Subject|10
1406416|NCT01177722|4641003|P4|Overall Study|Lost to Follow-up|1
1406417|NCT01177722|4641004|P3|Overall Study|Lost to Follow-up|3
1406418|NCT01177722|4641005|P2|Overall Study|Lost to Follow-up|4
1406419|NCT01177722|4641006|P1|Overall Study|Lost to Follow-up|3
1406420|NCT01177722|4641003|P4|Overall Study|Protocol Violation|0
1406421|NCT01177722|4641004|P3|Overall Study|Protocol Violation|1
1406422|NCT01177722|4641005|P2|Overall Study|Protocol Violation|0
1406423|NCT01177722|4641006|P1|Overall Study|Protocol Violation|0
1406424|NCT01177722|4641003|P4|Overall Study|Serious Adverse Event|0
1406425|NCT01177722|4641004|P3|Overall Study|Serious Adverse Event|1
1406426|NCT01177722|4641005|P2|Overall Study|Serious Adverse Event|0
1406427|NCT01177722|4641006|P1|Overall Study|Serious Adverse Event|0
1406428|NCT01177670|4641038|P1|Overall Study|Withdrawal by Subject|4
1406429|NCT01177670|4641038|P1|Overall Study|Physician Decision|50
1406430|NCT01177670|4641038|P1|Overall Study|Study Terminated|115
1406431|NCT01177553|4641045|P2|Overall Study|babies not yet 6 months of age|0
1406432|NCT01177553|4641046|P1|Overall Study|babies not yet 6 months of age|1
1406433|NCT01177410|4641055|P3|Overall Study|Lost to Follow-up|0
1406434|NCT01177410|4641056|P2|Overall Study|Lost to Follow-up|1
1406435|NCT01177410|4641057|P1|Overall Study|Lost to Follow-up|0
1406436|NCT01177410|4641055|P3|Overall Study|Withdrawal by Subject|3
1406437|NCT01177410|4641056|P2|Overall Study|Withdrawal by Subject|4
1406438|NCT01177410|4641057|P1|Overall Study|Withdrawal by Subject|1
1406439|NCT01177410|4641055|P3|Overall Study|Adverse Event|2
1406440|NCT01177410|4641056|P2|Overall Study|Adverse Event|2
1406441|NCT01177410|4641057|P1|Overall Study|Adverse Event|0
1406442|NCT01177384|4641070|P2|Overall Study|Withdrawal by Subject|12
1406443|NCT01177384|4641071|P1|Overall Study|Withdrawal by Subject|5
1406444|NCT01177384|4641070|P2|Overall Study|Protocol Violation|2
1406445|NCT01177384|4641071|P1|Overall Study|Protocol Violation|0
1406446|NCT01177384|4641070|P2|Overall Study|Physician Decision|3
1406447|NCT01177384|4641071|P1|Overall Study|Physician Decision|0
1406448|NCT01177384|4641070|P2|Overall Study|Lost to Follow-up|4
1406449|NCT01177384|4641071|P1|Overall Study|Lost to Follow-up|3
1406450|NCT01177384|4641070|P2|Overall Study|Lack of Efficacy|1
1406451|NCT01177384|4641071|P1|Overall Study|Lack of Efficacy|0
1406452|NCT01177384|4641070|P2|Overall Study|Adverse Event|4
1406453|NCT01177384|4641071|P1|Overall Study|Adverse Event|6
1406454|NCT01177293|4641083|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
1406455|NCT01177293|4641084|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
1406456|NCT01177228|4641102|P4|Overall Study|Withdrawal by Subject|0
1406457|NCT01177228|4641103|P3|Overall Study|Withdrawal by Subject|0
1406458|NCT01177228|4641104|P2|Overall Study|Withdrawal by Subject|1
1406459|NCT01177228|4641105|P1|Overall Study|Withdrawal by Subject|0
1406460|NCT01177228|4641102|P4|Overall Study|Worsening disease activity|0
1406461|NCT01177228|4641103|P3|Overall Study|Worsening disease activity|0
1406462|NCT01177228|4641104|P2|Overall Study|Worsening disease activity|0
1406463|NCT01177228|4641105|P1|Overall Study|Worsening disease activity|1
1406464|NCT01177228|4641102|P4|Overall Study|Positive tuberculosis test|0
1406465|NCT01177228|4641103|P3|Overall Study|Positive tuberculosis test|0
1406466|NCT01177228|4641104|P2|Overall Study|Positive tuberculosis test|1
1406467|NCT01177228|4641105|P1|Overall Study|Positive tuberculosis test|0
1406468|NCT01177007|4641162|P1|Overall Study|Change in treatment modality|21
1406469|NCT01177007|4641162|P1|Overall Study|Required additional Y90 treatment|6
1406470|NCT01177007|4641162|P1|Overall Study|Entered hospice care|5
1406471|NCT01177007|4641162|P1|Overall Study|Death|4
1406472|NCT01177007|4641162|P1|Overall Study|Lost to Follow-up|2
1406473|NCT01176968|4641176|P2|Overall Study|Reason not defined|3
1406474|NCT01176968|4641177|P1|Overall Study|Reason not defined|5
1406475|NCT01176968|4641176|P2|Overall Study|Study terminated by sponsor|1
1406476|NCT01176968|4641177|P1|Overall Study|Study terminated by sponsor|0
1406477|NCT01176968|4641176|P2|Overall Study|Did Not Meet Entrance Criteria|0
1406478|NCT01176968|4641177|P1|Overall Study|Did Not Meet Entrance Criteria|1
1406479|NCT01176968|4641176|P2|Overall Study|Protocol Violation|1
1406480|NCT01176968|4641177|P1|Overall Study|Protocol Violation|2
1406481|NCT01176968|4641176|P2|Overall Study|Withdrawal by Subject|48
1406482|NCT01176968|4641177|P1|Overall Study|Withdrawal by Subject|48
1406483|NCT01176968|4641176|P2|Overall Study|Lost to Follow-up|14
1406484|NCT01176968|4641177|P1|Overall Study|Lost to Follow-up|16
1406485|NCT01176968|4641176|P2|Overall Study|Lack of Efficacy|1
1406486|NCT01176968|4641177|P1|Overall Study|Lack of Efficacy|0
1406487|NCT01176968|4641176|P2|Overall Study|Death|3
1406488|NCT01176968|4641177|P1|Overall Study|Death|2
1406489|NCT01176968|4641176|P2|Overall Study|Adverse Event|11
1406490|NCT01176968|4641177|P1|Overall Study|Adverse Event|10
1406491|NCT01176773|4641228|P1|Overall Study|Withdrew consent|1
1406492|NCT01176773|4641228|P1|Overall Study|Screen Failure|2
1406493|NCT01176565|4641252|P2|Overall Study|Not Analyzed (any other reason)|2
1406494|NCT01176565|4641253|P1|Overall Study|Not Analyzed (any other reason)|1
1406495|NCT01176565|4641252|P2|Overall Study|Withdrawal by Subject|1
1406496|NCT01176565|4641253|P1|Overall Study|Withdrawal by Subject|7
1406497|NCT01176565|4641252|P2|Overall Study|Lost to Follow-up|16
1406498|NCT01176565|4641253|P1|Overall Study|Lost to Follow-up|12
1406499|NCT01176513|4641271|P1|Overall Study|Withdrew subjects prior to dosing|3
1406500|NCT01176292|4641299|P2|Overall Study|Has not scheduled one-year visit yet|2
1406501|NCT01176292|4641300|P1|Overall Study|Has not scheduled one-year visit yet|2
1406502|NCT01176292|4641299|P2|Overall Study|Physician Decision|2
1406503|NCT01176292|4641300|P1|Overall Study|Physician Decision|0
1406504|NCT01176292|4641299|P2|Overall Study|Adverse Event|1
1406505|NCT01176292|4641300|P1|Overall Study|Adverse Event|1
1406506|NCT01176292|4641299|P2|Overall Study|Lost to Follow-up|4
1406507|NCT01176292|4641300|P1|Overall Study|Lost to Follow-up|2
1406508|NCT01176266|4641318|P1|Overall Study|Withdrawal by Subject|3
1406509|NCT01176266|4641318|P1|Overall Study|Death|6
1406510|NCT01176240|4641342|P2|Study 306B|withdrew prior to dosing|1
1406511|NCT01176240|4641343|P1|Study 306B|withdrew prior to dosing|2
1406512|NCT01176240|4641342|P2|Study 306B|Lost to Follow-up|1
1406513|NCT01176240|4641343|P1|Study 306B|Lost to Follow-up|0
1406514|NCT01176240|4641342|P2|Study 306B|Supine Hypertension|2
1406515|NCT01176240|4641343|P1|Study 306B|Supine Hypertension|1
1406516|NCT01176240|4641342|P2|Study 306B|Physician Decision|1
1406517|NCT01176240|4641343|P1|Study 306B|Physician Decision|2
1406518|NCT01176240|4641342|P2|Study 306B|Withdrawal by Subject|1
1406519|NCT01176240|4641343|P1|Study 306B|Withdrawal by Subject|4
1406520|NCT01176240|4641342|P2|Study 306B|Protocol Violation|3
1406521|NCT01176240|4641343|P1|Study 306B|Protocol Violation|2
1406522|NCT01176240|4641342|P2|Study 306B|Adverse Event|5
1406523|NCT01176240|4641343|P1|Study 306B|Adverse Event|10
1406524|NCT01176240|4641342|P2|Study 306B|Lack of Efficacy|3
1406525|NCT01176240|4641343|P1|Study 306B|Lack of Efficacy|5
1406526|NCT01176240|4641342|P2|Study 306A|Stop due to diverse problems|0
1406527|NCT01176240|4641343|P1|Study 306A|Stop due to diverse problems|1
1406528|NCT01176240|4641342|P2|Study 306A|Withdrawal by Subject|1
1406529|NCT01176240|4641343|P1|Study 306A|Withdrawal by Subject|0
1406530|NCT01176240|4641342|P2|Study 306A|Protocol Violation|1
1406531|NCT01176240|4641343|P1|Study 306A|Protocol Violation|0
1406532|NCT01176240|4641342|P2|Study 306A|Lack of Efficacy|1
1406533|NCT01176240|4641343|P1|Study 306A|Lack of Efficacy|2
1406534|NCT01176058|4641369|P2|Overall Study|Withdrawal by Subject|0
1406535|NCT01176058|4641370|P1|Overall Study|Withdrawal by Subject|1
1406536|NCT01176058|4641369|P2|Overall Study|Insufficient mycological response|1
1406537|NCT01176058|4641370|P1|Overall Study|Insufficient mycological response|0
1406538|NCT01176058|4641369|P2|Overall Study|Insufficient clinical response|2
1406539|NCT01176058|4641370|P1|Overall Study|Insufficient clinical response|2
1406540|NCT01176058|4641369|P2|Overall Study|Adverse Event|0
1406541|NCT01176058|4641370|P1|Overall Study|Adverse Event|1
1406542|NCT01176032|4641394|P2|Overall Study|Not available|0
1406543|NCT01176032|4641395|P1|Overall Study|Not available|1
1406544|NCT01176032|4641394|P2|Overall Study|Informed consent withdrawn|0
1406545|NCT01176032|4641395|P1|Overall Study|Informed consent withdrawn|3
1406546|NCT01176032|4641394|P2|Overall Study|Protocol Violation|0
1406547|NCT01176032|4641395|P1|Overall Study|Protocol Violation|1
1406548|NCT01176032|4641394|P2|Overall Study|Unsatisfactory therapeutic effect|1
1406549|NCT01176032|4641395|P1|Overall Study|Unsatisfactory therapeutic effect|0
1406550|NCT01176032|4641394|P2|Overall Study|Adverse Event|0
1406551|NCT01176032|4641395|P1|Overall Study|Adverse Event|1
1406552|NCT01175824|4641519|P2|Overall Study|Entry Criteria Not Met|4
1406553|NCT01175824|4641520|P1|Overall Study|Entry Criteria Not Met|6
1406554|NCT01175824|4641519|P2|Overall Study|Sponsor Decision|0
1406555|NCT01175824|4641520|P1|Overall Study|Sponsor Decision|1
1406556|NCT01175824|4641519|P2|Overall Study|Withdrawal by Subject|7
1406557|NCT01175824|4641520|P1|Overall Study|Withdrawal by Subject|3
1406558|NCT01175824|4641519|P2|Overall Study|Protocol Violation|5
1406559|NCT01175824|4641520|P1|Overall Study|Protocol Violation|2
1406560|NCT01175824|4641519|P2|Overall Study|Physician Decision|4
1406561|NCT01175824|4641520|P1|Overall Study|Physician Decision|0
1406562|NCT01175824|4641519|P2|Overall Study|Lost to Follow-up|1
1406563|NCT01175824|4641520|P1|Overall Study|Lost to Follow-up|0
1406564|NCT01175824|4641519|P2|Overall Study|Lack of Efficacy|0
1406565|NCT01175824|4641520|P1|Overall Study|Lack of Efficacy|2
1406566|NCT01175824|4641519|P2|Overall Study|Adverse Event|1
1406567|NCT01175824|4641520|P1|Overall Study|Adverse Event|2
1406568|NCT01175811|4641554|P2|Overall Study|Withdrawal by Subject|7
1406569|NCT01175811|4641555|P1|Overall Study|Withdrawal by Subject|6
1406570|NCT01175811|4641554|P2|Overall Study|Protocol Violation|2
1406571|NCT01175811|4641555|P1|Overall Study|Protocol Violation|1
1406572|NCT01175811|4641554|P2|Overall Study|Physician Decision|1
1406573|NCT01175811|4641555|P1|Overall Study|Physician Decision|1
1406574|NCT01175811|4641554|P2|Overall Study|Lost to Follow-up|2
1406575|NCT01175811|4641555|P1|Overall Study|Lost to Follow-up|3
1406576|NCT01175811|4641554|P2|Overall Study|Lack of Efficacy|0
1406577|NCT01175811|4641555|P1|Overall Study|Lack of Efficacy|1
1406578|NCT01175811|4641554|P2|Overall Study|Entry criteria not met|1
1406579|NCT01175811|4641555|P1|Overall Study|Entry criteria not met|3
1406580|NCT01175811|4641554|P2|Overall Study|Adverse Event|1
1406581|NCT01175811|4641555|P1|Overall Study|Adverse Event|1
1406582|NCT01175707|4641590|P2|Overall Study|Adverse Event|6
1406583|NCT01175707|4641591|P1|Overall Study|Adverse Event|4
1406584|NCT01175668|4641627|P2|Overall Study|Withdrawal by Subject|0
1406585|NCT01175668|4641628|P1|Overall Study|Withdrawal by Subject|2
1406586|NCT01175590|4641638|P2|Overall Study|Protocol Violation|1
1406587|NCT01175590|4641639|P1|Overall Study|Protocol Violation|0
1406588|NCT01175590|4641638|P2|Overall Study|Herpes Simplex Dermatitis|0
1406589|NCT01175590|4641639|P1|Overall Study|Herpes Simplex Dermatitis|1
1406590|NCT01175590|4641638|P2|Overall Study|Treated not as randomized|2
1406591|NCT01175590|4641639|P1|Overall Study|Treated not as randomized|3
1406592|NCT01175590|4641638|P2|Overall Study|Residual Bacterial Conjunctivitis|0
1406593|NCT01175590|4641639|P1|Overall Study|Residual Bacterial Conjunctivitis|1
1406594|NCT01175590|4641638|P2|Overall Study|Lack of Efficacy|1
1406595|NCT01175590|4641639|P1|Overall Study|Lack of Efficacy|1
1406596|NCT01175590|4641638|P2|Overall Study|Physician Decision|4
1406597|NCT01175590|4641639|P1|Overall Study|Physician Decision|1
1406598|NCT01175590|4641638|P2|Overall Study|Adverse Event|0
1406599|NCT01175590|4641639|P1|Overall Study|Adverse Event|4
1406600|NCT01175590|4641638|P2|Overall Study|Withdrawal by Subject|2
1406601|NCT01175590|4641639|P1|Overall Study|Withdrawal by Subject|0
1406602|NCT01175590|4641638|P2|Overall Study|Lost to Follow-up|0
1406603|NCT01175590|4641639|P1|Overall Study|Lost to Follow-up|1
1406604|NCT01175473|4641673|P2|Overall Study|Adverse Event|2
1406605|NCT01175473|4641674|P1|Overall Study|Adverse Event|2
1406606|NCT01175382|4641715|P3|Overall Study|Unable to tolerate study meds|1
1406607|NCT01175382|4641716|P2|Overall Study|Unable to tolerate study meds|1
1406608|NCT01175382|4641717|P1|Overall Study|Unable to tolerate study meds|0
1406609|NCT01175382|4641715|P3|Overall Study|Unwilling to follow protocol|0
1406610|NCT01175382|4641716|P2|Overall Study|Unwilling to follow protocol|1
1406611|NCT01175382|4641717|P1|Overall Study|Unwilling to follow protocol|0
1406612|NCT01175382|4641715|P3|Overall Study|Unable/unwilling to attend visits|2
1406613|NCT01175382|4641716|P2|Overall Study|Unable/unwilling to attend visits|1
1406614|NCT01175382|4641717|P1|Overall Study|Unable/unwilling to attend visits|3
1406615|NCT01175382|4641715|P3|Overall Study|No longer having problem|1
1406616|NCT01175382|4641716|P2|Overall Study|No longer having problem|0
1406617|NCT01175382|4641717|P1|Overall Study|No longer having problem|1
1406618|NCT01175382|4641715|P3|Overall Study|Withdrawal by Subject|1
1406619|NCT01175382|4641716|P2|Overall Study|Withdrawal by Subject|0
1406620|NCT01175382|4641717|P1|Overall Study|Withdrawal by Subject|0
1406621|NCT01175382|4641715|P3|Overall Study|Physician Decision|0
1406622|NCT01175382|4641716|P2|Overall Study|Physician Decision|1
1406623|NCT01175382|4641717|P1|Overall Study|Physician Decision|0
1406624|NCT01175382|4641715|P3|Overall Study|Lost to Follow-up|1
1406625|NCT01175382|4641716|P2|Overall Study|Lost to Follow-up|3
1406626|NCT01175382|4641717|P1|Overall Study|Lost to Follow-up|4
1406627|NCT01175356|4641803|P1|Overall Study|Initiation other tx prior to completion|9
1406628|NCT01175356|4641803|P1|Overall Study|Inadequate stem cell for transplant|1
1406629|NCT01175356|4641803|P1|Overall Study|On other COG study w/tumor tx intent|7
1406630|NCT01175356|4641803|P1|Overall Study|Pts MIBG non-avid after enrollment|2
1406631|NCT01175356|4641803|P1|Overall Study|Refusal by patient/parent/guardian|6
1406632|NCT01175356|4641803|P1|Overall Study|Treatment Slot Not Available|18
1406633|NCT01175356|4641803|P1|Overall Study|Ineligible|1
1406634|NCT01175356|4641803|P1|Overall Study|Physician Decision|23
1406635|NCT01175356|4641803|P1|Overall Study|Lost to Follow-up|1
1406636|NCT01175356|4641803|P1|Overall Study|Lack of Efficacy|12
1406637|NCT01175356|4641803|P1|Overall Study|Death|1
1406638|NCT01175213|4641843|P2|Safety Follow-up|Adverse Event|0
1406639|NCT01175213|4641844|P1|Safety Follow-up|Adverse Event|1
1406640|NCT01175213|4641843|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
1406641|NCT01175213|4641844|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
1406642|NCT01175213|4641843|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
1406643|NCT01175213|4641844|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
1406644|NCT01175213|4641843|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
1406645|NCT01175213|4641844|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
1406646|NCT01175213|4641843|P2|IGSC, 10%/rHuPH20|Death|0
1406647|NCT01175213|4641844|P1|IGSC, 10%/rHuPH20|Death|1
1406648|NCT01175213|4641843|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
1406649|NCT01175213|4641844|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
1406650|NCT01175135|4641901|P4|Overall Study|Randomized But Not Treated|0
1406651|NCT01175135|4641902|P3|Overall Study|Randomized But Not Treated|1
1406652|NCT01175135|4641903|P2|Overall Study|Randomized But Not Treated|0
1406653|NCT01175135|4641904|P1|Overall Study|Randomized But Not Treated|0
1406654|NCT01175135|4641901|P4|Overall Study|Other|0
1406655|NCT01175135|4641902|P3|Overall Study|Other|3
1406656|NCT01175135|4641903|P2|Overall Study|Other|1
1406657|NCT01175135|4641904|P1|Overall Study|Other|3
1406658|NCT01175135|4641901|P4|Overall Study|Withdrawal by Subject|5
1406659|NCT01175135|4641902|P3|Overall Study|Withdrawal by Subject|5
1406660|NCT01175135|4641903|P2|Overall Study|Withdrawal by Subject|8
1406661|NCT01175135|4641904|P1|Overall Study|Withdrawal by Subject|4
1406662|NCT01175135|4641901|P4|Overall Study|Protocol Violation|0
1406663|NCT01175135|4641902|P3|Overall Study|Protocol Violation|0
1406664|NCT01175135|4641903|P2|Overall Study|Protocol Violation|1
1406665|NCT01175135|4641904|P1|Overall Study|Protocol Violation|1
1406666|NCT01175135|4641901|P4|Overall Study|Lost to Follow-up|0
1406667|NCT01175135|4641902|P3|Overall Study|Lost to Follow-up|0
1406668|NCT01175135|4641903|P2|Overall Study|Lost to Follow-up|2
1406669|NCT01175135|4641904|P1|Overall Study|Lost to Follow-up|1
1406670|NCT01175135|4641901|P4|Overall Study|Lack of Efficacy|5
1406671|NCT01175135|4641902|P3|Overall Study|Lack of Efficacy|0
1406672|NCT01175135|4641903|P2|Overall Study|Lack of Efficacy|5
1406673|NCT01175135|4641904|P1|Overall Study|Lack of Efficacy|4
1406674|NCT01175135|4641901|P4|Overall Study|Death|0
1406675|NCT01175135|4641902|P3|Overall Study|Death|0
1406676|NCT01175135|4641903|P2|Overall Study|Death|0
1406677|NCT01175135|4641904|P1|Overall Study|Death|1
1406678|NCT01175135|4641901|P4|Overall Study|Adverse Event|4
1406679|NCT01175135|4641902|P3|Overall Study|Adverse Event|3
1406680|NCT01175135|4641903|P2|Overall Study|Adverse Event|5
1406681|NCT01175135|4641904|P1|Overall Study|Adverse Event|2
1406682|NCT01175018|4641996|P2|Overall Study|Adverse Event|1
1406683|NCT01175018|4641997|P1|Overall Study|Adverse Event|3
1406684|NCT01174550|4642086|P2|Overall Study|Withdrawal by Subject|289
1406685|NCT01174550|4642087|P1|Overall Study|Withdrawal by Subject|543
1406686|NCT01174550|4642086|P2|Overall Study|Lost to Follow-up|510
1406687|NCT01174550|4642087|P1|Overall Study|Lost to Follow-up|652
1406688|NCT01174550|4642086|P2|Overall Study|Death|74
1406689|NCT01174550|4642087|P1|Overall Study|Death|75
1406690|NCT01174459|4642115|P1|Overall Study|case report form (CRF) not collected|5
1406691|NCT01174446|4642120|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
1406692|NCT01174446|4642121|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
1406693|NCT01174446|4642122|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
1406694|NCT01174446|4642123|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
1406695|NCT01174446|4642120|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
1406696|NCT01174446|4642121|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
1406697|NCT01174446|4642122|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
1406698|NCT01174446|4642123|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
1406699|NCT01174446|4642120|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
1406700|NCT01174446|4642121|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
1406701|NCT01174446|4642122|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
1406702|NCT01174446|4642123|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
1406703|NCT01174446|4642120|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
1406704|NCT01174446|4642121|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
1406705|NCT01174446|4642122|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
1406706|NCT01174446|4642123|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
1406707|NCT01174342|4642310|P1|Overall Study|Conversion to cesarean section|4
1406708|NCT01174264|4642317|P3|Steady-state Pharmacokinetics|Not evaluable|2
1406709|NCT01174264|4642318|P2|Steady-state Pharmacokinetics|Not evaluable|0
1406710|NCT01174264|4642319|P1|Steady-state Pharmacokinetics|Not evaluable|6
1406711|NCT01174264|4642317|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
1406712|NCT01174264|4642318|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
1406713|NCT01174264|4642319|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
1406714|NCT01174264|4642317|P3|Single Dose Pharmacokinetics|Early progressive disease|1
1406715|NCT01174264|4642318|P2|Single Dose Pharmacokinetics|Early progressive disease|0
1406716|NCT01174264|4642319|P1|Single Dose Pharmacokinetics|Early progressive disease|1
1406717|NCT01174238|4642351|P1|Overall Study|Lost to Follow-up|2
1406718|NCT01174186|4642362|P2|Overall Study|Withdrawal by Subject|2
1406719|NCT01174186|4642363|P1|Overall Study|Withdrawal by Subject|0
1406720|NCT01174186|4642362|P2|Overall Study|Lost to Follow-up|1
1406721|NCT01174186|4642363|P1|Overall Study|Lost to Follow-up|0
1406722|NCT01174173|4642370|P1|Overall Study|drug-drug interaction|1
1406723|NCT01174160|4642381|P2|Overall Study|Withdrawal by Subject|0
1406724|NCT01174160|4642382|P1|Overall Study|Withdrawal by Subject|1
1406725|NCT01174160|4642381|P2|Overall Study|Protocol Violation|6
1406726|NCT01174160|4642382|P1|Overall Study|Protocol Violation|4
1406727|NCT01174160|4642381|P2|Overall Study|Physician Decision|0
1406728|NCT01174160|4642382|P1|Overall Study|Physician Decision|1
1406729|NCT01174160|4642381|P2|Overall Study|Lost to Follow-up|0
1406730|NCT01174160|4642382|P1|Overall Study|Lost to Follow-up|1
1406731|NCT01174160|4642381|P2|Overall Study|Adverse Event|0
1406732|NCT01174160|4642382|P1|Overall Study|Adverse Event|1
1406733|NCT01174043|4642397|P1|Overall Study|Withdrawal by Subject|2
1406734|NCT01174043|4642397|P1|Overall Study|Death|1
1406735|NCT01174043|4642397|P1|Overall Study|Adverse Event|3
1406736|NCT01174043|4642397|P1|Overall Study|Disease progression|5
1406737|NCT01174004|4642436|P2|Overall Study|Physician Decision|0
1406738|NCT01174004|4642437|P1|Overall Study|Physician Decision|1
1406739|NCT01174004|4642436|P2|Overall Study|Protocol Violation|1
1406740|NCT01174004|4642437|P1|Overall Study|Protocol Violation|0
1406741|NCT01174004|4642436|P2|Overall Study|At Discretion of Sponsor|2
1406742|NCT01174004|4642437|P1|Overall Study|At Discretion of Sponsor|2
1406743|NCT01174004|4642436|P2|Overall Study|Withdrawal by Subject|3
1406744|NCT01174004|4642437|P1|Overall Study|Withdrawal by Subject|2
1406745|NCT01174004|4642436|P2|Overall Study|Adverse Event|10
1406746|NCT01174004|4642437|P1|Overall Study|Adverse Event|2
1406747|NCT01173718|4642468|P1|Overall Study|Abandonment of study graft|27
1406748|NCT01173718|4642468|P1|Overall Study|Death|17
1406749|NCT01173679|4642477|P1|Overall Study|Death|1
1406750|NCT01173653|4642485|P2|Overall Study|Pts unwilling to provide follow-up|41
1406751|NCT01173653|4642486|P1|Overall Study|Pts unwilling to provide follow-up|53
1406752|NCT01173601|4642496|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
1406753|NCT01173601|4642497|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
1406754|NCT01173601|4642498|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1406755|NCT01173601|4642499|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1406756|NCT01173601|4642500|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1406757|NCT01173601|4642496|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
1406758|NCT01173601|4642497|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
1406759|NCT01173601|4642498|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
1406760|NCT01173601|4642499|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
1406761|NCT01173601|4642500|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
1406762|NCT01173601|4642496|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
1406763|NCT01173601|4642497|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
1406764|NCT01173601|4642498|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
1406765|NCT01173601|4642499|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
1406766|NCT01173601|4642500|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
1406767|NCT01173601|4642496|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
1406768|NCT01173601|4642497|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
1406769|NCT01173601|4642498|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1406770|NCT01173601|4642499|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
1406771|NCT01173601|4642500|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1406772|NCT01173601|4642496|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
1406773|NCT01173601|4642497|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
1406774|NCT01173601|4642498|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
1406775|NCT01173601|4642499|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
1406776|NCT01173601|4642500|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
1406777|NCT01173601|4642496|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
1406778|NCT01173601|4642497|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
1406779|NCT01173601|4642498|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
1406780|NCT01173601|4642499|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
1406781|NCT01173601|4642500|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
1406782|NCT01173601|4642496|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
1406783|NCT01173601|4642497|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
1406784|NCT01173601|4642498|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
1406785|NCT01173601|4642499|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
1406786|NCT01173601|4642500|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
1406787|NCT01173601|4642496|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1406788|NCT01173601|4642497|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1406789|NCT01173601|4642498|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1406790|NCT01173601|4642499|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1406791|NCT01173601|4642500|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
1406792|NCT01173601|4642496|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1406793|NCT01173601|4642497|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1406794|NCT01173601|4642498|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1406795|NCT01173601|4642499|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1406796|NCT01173601|4642500|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
1406797|NCT01173601|4642496|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1406798|NCT01173601|4642497|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1406799|NCT01173601|4642498|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1406800|NCT01173601|4642499|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1406801|NCT01173601|4642500|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
1406802|NCT01173601|4642496|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1406803|NCT01173601|4642497|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1406804|NCT01173601|4642498|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1406805|NCT01173601|4642499|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1406806|NCT01173601|4642500|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
1406807|NCT01173601|4642496|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1406808|NCT01173601|4642497|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1406809|NCT01173601|4642498|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1406810|NCT01173601|4642499|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1406811|NCT01173601|4642500|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
1406812|NCT01173601|4642496|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1406813|NCT01173601|4642497|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1406814|NCT01173601|4642498|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1406815|NCT01173601|4642499|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1406816|NCT01173601|4642500|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
1406817|NCT01173601|4642496|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1406818|NCT01173601|4642497|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1406819|NCT01173601|4642498|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1406820|NCT01173601|4642499|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1406821|NCT01173601|4642500|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
1406822|NCT01173523|4642577|P2|Overall Study|Other|3
1406823|NCT01173523|4642578|P1|Overall Study|Other|2
1406824|NCT01173523|4642577|P2|Overall Study|Progressive Disease|8
1406825|NCT01173523|4642578|P1|Overall Study|Progressive Disease|10
1406826|NCT01173523|4642577|P2|Overall Study|Clinical Progression|1
1406827|NCT01173523|4642578|P1|Overall Study|Clinical Progression|1
1406828|NCT01173471|4642594|P4|Overall Study|Reason given as Other|0
1406829|NCT01173471|4642595|P3|Overall Study|Reason given as Other|1
1406830|NCT01173471|4642596|P2|Overall Study|Reason given as Other|0
1406831|NCT01173471|4642597|P1|Overall Study|Reason given as Other|0
1406832|NCT01173471|4642594|P4|Overall Study|Lost to Follow-up|0
1406833|NCT01173471|4642595|P3|Overall Study|Lost to Follow-up|1
1406834|NCT01173471|4642596|P2|Overall Study|Lost to Follow-up|0
1406835|NCT01173471|4642597|P1|Overall Study|Lost to Follow-up|0
1406836|NCT01173471|4642594|P4|Overall Study|Condition under investigation worsened|0
1406837|NCT01173471|4642595|P3|Overall Study|Condition under investigation worsened|0
1406838|NCT01173471|4642596|P2|Overall Study|Condition under investigation worsened|0
1406839|NCT01173471|4642597|P1|Overall Study|Condition under investigation worsened|2
1406840|NCT01173471|4642594|P4|Overall Study|Eligibility criteria not fulfilled|1
1406841|NCT01173471|4642595|P3|Overall Study|Eligibility criteria not fulfilled|1
1406842|NCT01173471|4642596|P2|Overall Study|Eligibility criteria not fulfilled|0
1406843|NCT01173471|4642597|P1|Overall Study|Eligibility criteria not fulfilled|0
1406844|NCT01173120|4642727|P1|Overall Study|Switch-Difficulty With Device|12
1406845|NCT01173120|4642727|P1|Overall Study|Switch-Participant Decision|12
1406846|NCT01173120|4642727|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
1406847|NCT01173120|4642727|P1|Overall Study|Participant Decision|2
1406848|NCT01173120|4642727|P1|Overall Study|Lost to Follow-up|1
1406849|NCT01173120|4642727|P1|Overall Study|Lack of Efficacy|2
1406850|NCT01173055|4642745|P2|Period 2 - Day 64 to 112|Adverse Event|1
1406851|NCT01173055|4642746|P1|Period 2 - Day 64 to 112|Adverse Event|0
1406852|NCT01173055|4642745|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
1406853|NCT01173055|4642746|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
1406854|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
1406855|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1406856|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1406857|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1406858|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1406859|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1406860|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1406861|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1406862|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1406863|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1406864|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1406865|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1406866|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1406867|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1406868|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1406869|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
1406870|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1406871|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1406872|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 208-260)|Death|0
1406873|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 208-260)|Death|0
1406874|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 208-260)|Death|0
1406875|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 208-260)|Death|0
1406876|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 208-260)|Death|0
1406877|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 208-260)|Death|0
1406878|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 208-260)|Death|1
1406879|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 208-260)|Death|0
1406880|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 208-260)|Death|0
1406881|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1406882|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
1406883|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1406884|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1406885|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1406886|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1406887|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
1406888|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
1406889|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1406890|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1406891|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
1407264|NCT01171976|4643419|P3|Overall Study|Adverse Event|5
1406892|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1406893|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1406894|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1406895|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1406896|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1406897|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
1406898|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1406899|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1406900|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1406901|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1406902|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1406903|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1406904|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1406905|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
1406906|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1406907|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1406908|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
1406909|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
1406910|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1406911|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1406912|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1406913|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1406914|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
1406915|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1406916|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1406917|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1406918|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
1406919|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1406920|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1406921|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1406922|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1406923|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1406924|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1406925|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1406926|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
1406927|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1406928|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1406929|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1406930|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1406931|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1406932|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
1406933|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1406934|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1406935|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
1406936|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
1406937|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
1406938|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
1406939|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
1406940|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
1406941|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
1406942|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
1406943|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
1406944|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
1406945|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
1406946|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
1406947|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
1406948|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
1406949|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
1406950|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
1406951|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
1406952|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
1406953|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1406954|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
1406955|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1406956|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1406957|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1406958|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1406959|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
1406960|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
1406961|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1406962|NCT01172938|4642785|P9|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1406963|NCT01172938|4642786|P8|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1406964|NCT01172938|4642787|P7|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1406965|NCT01172938|4642788|P6|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1406966|NCT01172938|4642789|P5|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1406967|NCT01172938|4642790|P4|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1406968|NCT01172938|4642791|P3|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
1406969|NCT01172938|4642792|P2|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1406970|NCT01172938|4642793|P1|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1406971|NCT01172938|4642785|P9|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1406972|NCT01172938|4642786|P8|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1406973|NCT01172938|4642787|P7|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1406974|NCT01172938|4642788|P6|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1406975|NCT01172938|4642789|P5|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1406976|NCT01172938|4642790|P4|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1406977|NCT01172938|4642791|P3|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1406978|NCT01172938|4642792|P2|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
1406979|NCT01172938|4642793|P1|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1406980|NCT01172938|4642785|P9|Active-Treatment Phase Weeks (104-156)|Death|0
1406981|NCT01172938|4642786|P8|Active-Treatment Phase Weeks (104-156)|Death|1
1406982|NCT01172938|4642787|P7|Active-Treatment Phase Weeks (104-156)|Death|0
1406983|NCT01172938|4642788|P6|Active-Treatment Phase Weeks (104-156)|Death|0
1406984|NCT01172938|4642789|P5|Active-Treatment Phase Weeks (104-156)|Death|0
1406985|NCT01172938|4642790|P4|Active-Treatment Phase Weeks (104-156)|Death|0
1406986|NCT01172938|4642791|P3|Active-Treatment Phase Weeks (104-156)|Death|0
1406987|NCT01172938|4642792|P2|Active-Treatment Phase Weeks (104-156)|Death|0
1406988|NCT01172938|4642793|P1|Active-Treatment Phase Weeks (104-156)|Death|0
1406989|NCT01172938|4642785|P9|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
1406990|NCT01172938|4642786|P8|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
1406991|NCT01172938|4642787|P7|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
1406992|NCT01172938|4642788|P6|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
1406993|NCT01172938|4642789|P5|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
1406994|NCT01172938|4642790|P4|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
1406995|NCT01172938|4642791|P3|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
1406996|NCT01172938|4642792|P2|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
1406997|NCT01172938|4642793|P1|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
1406998|NCT01172938|4642785|P9|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
1406999|NCT01172938|4642786|P8|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
1407000|NCT01172938|4642787|P7|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
1407001|NCT01172938|4642788|P6|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
1407002|NCT01172938|4642789|P5|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
1407003|NCT01172938|4642790|P4|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
1407004|NCT01172938|4642791|P3|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
1407005|NCT01172938|4642792|P2|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
1407006|NCT01172938|4642793|P1|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
1407007|NCT01172938|4642785|P9|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
1407008|NCT01172938|4642786|P8|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1407009|NCT01172938|4642787|P7|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1407010|NCT01172938|4642788|P6|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1407011|NCT01172938|4642789|P5|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1407012|NCT01172938|4642790|P4|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1407013|NCT01172938|4642791|P3|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1407014|NCT01172938|4642792|P2|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1407015|NCT01172938|4642793|P1|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1407016|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 52-104)|Missing|0
1407017|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 52-104)|Missing|0
1407018|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 52-104)|Missing|0
1407019|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 52-104)|Missing|0
1407020|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 52-104)|Missing|0
1407021|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 52-104)|Missing|0
1407022|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 52-104)|Missing|0
1407023|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 52-104)|Missing|1
1407024|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 52-104)|Missing|0
1407025|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
1407026|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1407027|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1407028|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1407029|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1407030|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1407031|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1407032|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
1407033|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1407034|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1407035|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
1407036|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1407037|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1407038|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1407039|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1407040|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
1407041|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
1407042|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1407043|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 52-104)|Death|0
1407044|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 52-104)|Death|0
1407045|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 52-104)|Death|0
1407046|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 52-104)|Death|0
1407047|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 52-104)|Death|0
1407048|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 52-104)|Death|0
1407049|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 52-104)|Death|1
1407050|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 52-104)|Death|0
1407051|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 52-104)|Death|0
1407052|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
1407053|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
1407054|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
1407055|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
1407056|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
1407057|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
1407058|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
1407059|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
1407060|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
1407061|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1407062|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1407063|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1407064|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1407065|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1407066|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1407067|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
1407068|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1407069|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1407070|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1407071|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
1407072|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1407073|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1407074|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1407075|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1407076|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
1407077|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
1407078|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1407079|NCT01172938|4642785|P9|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
1407080|NCT01172938|4642786|P8|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
1407081|NCT01172938|4642787|P7|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
1407082|NCT01172938|4642788|P6|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
1407083|NCT01172938|4642789|P5|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
1407084|NCT01172938|4642790|P4|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
1407085|NCT01172938|4642791|P3|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
1407086|NCT01172938|4642792|P2|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
1407087|NCT01172938|4642793|P1|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
1407088|NCT01172938|4642785|P9|Active Treatment Phase (Weeks 25-52)|Not specified|0
1407089|NCT01172938|4642786|P8|Active Treatment Phase (Weeks 25-52)|Not specified|0
1407090|NCT01172938|4642787|P7|Active Treatment Phase (Weeks 25-52)|Not specified|1
1407091|NCT01172938|4642788|P6|Active Treatment Phase (Weeks 25-52)|Not specified|1
1407092|NCT01172938|4642789|P5|Active Treatment Phase (Weeks 25-52)|Not specified|0
1407093|NCT01172938|4642790|P4|Active Treatment Phase (Weeks 25-52)|Not specified|0
1407094|NCT01172938|4642791|P3|Active Treatment Phase (Weeks 25-52)|Not specified|0
1407095|NCT01172938|4642792|P2|Active Treatment Phase (Weeks 25-52)|Not specified|0
1407096|NCT01172938|4642793|P1|Active Treatment Phase (Weeks 25-52)|Not specified|0
1407097|NCT01172938|4642785|P9|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1407098|NCT01172938|4642786|P8|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1407099|NCT01172938|4642787|P7|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1407100|NCT01172938|4642788|P6|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1407101|NCT01172938|4642789|P5|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1407102|NCT01172938|4642790|P4|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
1407103|NCT01172938|4642791|P3|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
1407104|NCT01172938|4642792|P2|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
1407105|NCT01172938|4642793|P1|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1407106|NCT01172938|4642785|P9|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
1407107|NCT01172938|4642786|P8|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
1407108|NCT01172938|4642787|P7|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
1407109|NCT01172938|4642788|P6|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
1407110|NCT01172938|4642789|P5|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
1407111|NCT01172938|4642790|P4|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
1407112|NCT01172938|4642791|P3|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
1407113|NCT01172938|4642792|P2|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
1407114|NCT01172938|4642793|P1|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
1407115|NCT01172938|4642785|P9|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1407116|NCT01172938|4642786|P8|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1407117|NCT01172938|4642787|P7|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1407118|NCT01172938|4642788|P6|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1407119|NCT01172938|4642789|P5|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1407120|NCT01172938|4642790|P4|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1407121|NCT01172938|4642791|P3|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
1407122|NCT01172938|4642792|P2|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1407123|NCT01172938|4642793|P1|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1407124|NCT01172938|4642785|P9|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
1407125|NCT01172938|4642786|P8|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
1407126|NCT01172938|4642787|P7|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
1407127|NCT01172938|4642788|P6|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
1407128|NCT01172938|4642789|P5|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
1407129|NCT01172938|4642790|P4|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
1407130|NCT01172938|4642791|P3|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
1407131|NCT01172938|4642792|P2|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
1407132|NCT01172938|4642793|P1|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
1407133|NCT01172938|4642785|P9|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
1407134|NCT01172938|4642786|P8|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
1407135|NCT01172938|4642787|P7|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
1407136|NCT01172938|4642788|P6|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
1407137|NCT01172938|4642789|P5|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
1407138|NCT01172938|4642790|P4|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
1407139|NCT01172938|4642791|P3|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
1407140|NCT01172938|4642792|P2|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
1407141|NCT01172938|4642793|P1|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
1407142|NCT01172938|4642785|P9|Placebo-controlled Phase (Week 0-24)|Not specified|0
1407143|NCT01172938|4642786|P8|Placebo-controlled Phase (Week 0-24)|Not specified|0
1407144|NCT01172938|4642787|P7|Placebo-controlled Phase (Week 0-24)|Not specified|0
1407145|NCT01172938|4642788|P6|Placebo-controlled Phase (Week 0-24)|Not specified|0
1407146|NCT01172938|4642789|P5|Placebo-controlled Phase (Week 0-24)|Not specified|0
1407147|NCT01172938|4642790|P4|Placebo-controlled Phase (Week 0-24)|Not specified|0
1407148|NCT01172938|4642791|P3|Placebo-controlled Phase (Week 0-24)|Not specified|1
1407149|NCT01172938|4642792|P2|Placebo-controlled Phase (Week 0-24)|Not specified|2
1407150|NCT01172938|4642793|P1|Placebo-controlled Phase (Week 0-24)|Not specified|0
1407151|NCT01172938|4642785|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1407152|NCT01172938|4642786|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1407153|NCT01172938|4642787|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1407154|NCT01172938|4642788|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1407155|NCT01172938|4642789|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1407156|NCT01172938|4642790|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1407157|NCT01172938|4642791|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1407158|NCT01172938|4642792|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1407159|NCT01172938|4642793|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
1407160|NCT01172938|4642785|P9|Placebo-controlled Phase (Week 0-24)|Death|0
1407161|NCT01172938|4642786|P8|Placebo-controlled Phase (Week 0-24)|Death|0
1407162|NCT01172938|4642787|P7|Placebo-controlled Phase (Week 0-24)|Death|0
1407163|NCT01172938|4642788|P6|Placebo-controlled Phase (Week 0-24)|Death|0
1407164|NCT01172938|4642789|P5|Placebo-controlled Phase (Week 0-24)|Death|0
1407165|NCT01172938|4642790|P4|Placebo-controlled Phase (Week 0-24)|Death|0
1407166|NCT01172938|4642791|P3|Placebo-controlled Phase (Week 0-24)|Death|0
1407167|NCT01172938|4642792|P2|Placebo-controlled Phase (Week 0-24)|Death|1
1407168|NCT01172938|4642793|P1|Placebo-controlled Phase (Week 0-24)|Death|0
1407169|NCT01172938|4642785|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1407170|NCT01172938|4642786|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1407171|NCT01172938|4642787|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1407172|NCT01172938|4642788|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1407173|NCT01172938|4642789|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1407174|NCT01172938|4642790|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1407175|NCT01172938|4642791|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
1407176|NCT01172938|4642792|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
1407177|NCT01172938|4642793|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
1407178|NCT01172938|4642785|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1407179|NCT01172938|4642786|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1407180|NCT01172938|4642787|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1407181|NCT01172938|4642788|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1407182|NCT01172938|4642789|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1407183|NCT01172938|4642790|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1407184|NCT01172938|4642791|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
1407185|NCT01172938|4642792|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
1407186|NCT01172938|4642793|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1407187|NCT01172938|4642785|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1407188|NCT01172938|4642786|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1407189|NCT01172938|4642787|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1407190|NCT01172938|4642788|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1407191|NCT01172938|4642789|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1407192|NCT01172938|4642790|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1407193|NCT01172938|4642791|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
1407194|NCT01172938|4642792|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
1407195|NCT01172938|4642793|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
1407196|NCT01172938|4642785|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1407197|NCT01172938|4642786|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1407198|NCT01172938|4642787|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1407199|NCT01172938|4642788|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1407200|NCT01172938|4642789|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1407201|NCT01172938|4642790|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1407202|NCT01172938|4642791|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
1407203|NCT01172938|4642792|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
1407204|NCT01172938|4642793|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
1407205|NCT01172873|4642979|P2|Overall Study|Withdrawal by Subject|2
1407206|NCT01172873|4642980|P1|Overall Study|Withdrawal by Subject|3
1407207|NCT01172847|4642990|P1|Overall Study|Withdrawal by Subject|3
1407208|NCT01172821|4643019|P4|Overall Study|Other|3
1407209|NCT01172821|4643020|P3|Overall Study|Other|5
1407210|NCT01172821|4643021|P2|Overall Study|Other|4
1407211|NCT01172821|4643022|P1|Overall Study|Other|3
1407212|NCT01172821|4643019|P4|Overall Study|Withdrawal by Subject|3
1407213|NCT01172821|4643020|P3|Overall Study|Withdrawal by Subject|3
1407214|NCT01172821|4643021|P2|Overall Study|Withdrawal by Subject|3
1407215|NCT01172821|4643022|P1|Overall Study|Withdrawal by Subject|2
1407216|NCT01172821|4643019|P4|Overall Study|Lost to Follow-up|2
1407217|NCT01172821|4643020|P3|Overall Study|Lost to Follow-up|2
1407218|NCT01172821|4643021|P2|Overall Study|Lost to Follow-up|1
1407219|NCT01172821|4643022|P1|Overall Study|Lost to Follow-up|4
1407220|NCT01172821|4643019|P4|Overall Study|Protocol Violation|2
1407221|NCT01172821|4643020|P3|Overall Study|Protocol Violation|1
1407222|NCT01172821|4643021|P2|Overall Study|Protocol Violation|2
1407223|NCT01172821|4643022|P1|Overall Study|Protocol Violation|0
1407224|NCT01172821|4643019|P4|Overall Study|Adverse Event|7
1407225|NCT01172821|4643020|P3|Overall Study|Adverse Event|2
1407226|NCT01172821|4643021|P2|Overall Study|Adverse Event|2
1407227|NCT01172821|4643022|P1|Overall Study|Adverse Event|5
1407228|NCT01172808|4643112|P4|Overall Study|Other|7
1407229|NCT01172808|4643113|P3|Overall Study|Other|9
1407230|NCT01172808|4643114|P2|Overall Study|Other|5
1407231|NCT01172808|4643115|P1|Overall Study|Other|6
1407232|NCT01172808|4643112|P4|Overall Study|Withdrawal by Subject|2
1407233|NCT01172808|4643113|P3|Overall Study|Withdrawal by Subject|3
1407234|NCT01172808|4643114|P2|Overall Study|Withdrawal by Subject|1
1407235|NCT01172808|4643115|P1|Overall Study|Withdrawal by Subject|4
1407236|NCT01172808|4643112|P4|Overall Study|Lost to Follow-up|3
1407237|NCT01172808|4643113|P3|Overall Study|Lost to Follow-up|1
1407238|NCT01172808|4643114|P2|Overall Study|Lost to Follow-up|1
1407239|NCT01172808|4643115|P1|Overall Study|Lost to Follow-up|0
1407240|NCT01172808|4643112|P4|Overall Study|Protocol Violation|0
1407241|NCT01172808|4643113|P3|Overall Study|Protocol Violation|2
1407242|NCT01172808|4643114|P2|Overall Study|Protocol Violation|2
1407243|NCT01172808|4643115|P1|Overall Study|Protocol Violation|2
1407244|NCT01172808|4643112|P4|Overall Study|Lack of Efficacy|0
1407245|NCT01172808|4643113|P3|Overall Study|Lack of Efficacy|0
1407246|NCT01172808|4643114|P2|Overall Study|Lack of Efficacy|0
1407247|NCT01172808|4643115|P1|Overall Study|Lack of Efficacy|1
1407248|NCT01172808|4643112|P4|Overall Study|Adverse Event|3
1407249|NCT01172808|4643113|P3|Overall Study|Adverse Event|8
1407250|NCT01172808|4643114|P2|Overall Study|Adverse Event|4
1407251|NCT01172808|4643115|P1|Overall Study|Adverse Event|8
1407252|NCT01172535|4643234|P1|Overall Study|Unwilling to adhere to study requirement|1
1407253|NCT01172535|4643234|P1|Overall Study|Ineligible at study entry|1
1407254|NCT01172535|4643234|P1|Overall Study|Lost to Follow-up|1
1407255|NCT01172535|4643234|P1|Overall Study|Withdrawal by Subject|2
1407256|NCT01172535|4643234|P1|Overall Study|Death|3
1407257|NCT01172288|4643287|P2|Overall Study|Protocol Violation|1
1407258|NCT01172288|4643288|P1|Overall Study|Protocol Violation|0
1407259|NCT01172288|4643287|P2|Overall Study|Adverse Event|0
1407260|NCT01172288|4643288|P1|Overall Study|Adverse Event|1
1407261|NCT01171989|4643343|P3|Overall Study|Lost to Follow-up|1
1407262|NCT01171989|4643344|P2|Overall Study|Lost to Follow-up|0
1407263|NCT01171989|4643345|P1|Overall Study|Lost to Follow-up|0
1407265|NCT01171976|4643420|P2|Overall Study|Adverse Event|2
1407266|NCT01171976|4643421|P1|Overall Study|Adverse Event|6
1407267|NCT01171976|4643419|P3|Overall Study|Abnormal test result|0
1407268|NCT01171976|4643420|P2|Overall Study|Abnormal test result|0
1407269|NCT01171976|4643421|P1|Overall Study|Abnormal test result|1
1407270|NCT01171976|4643419|P3|Overall Study|Withdrawal by Subject|6
1407271|NCT01171976|4643420|P2|Overall Study|Withdrawal by Subject|5
1407272|NCT01171976|4643421|P1|Overall Study|Withdrawal by Subject|1
1407273|NCT01171976|4643419|P3|Overall Study|Lost to Follow-up|2
1407274|NCT01171976|4643420|P2|Overall Study|Lost to Follow-up|0
1407275|NCT01171976|4643421|P1|Overall Study|Lost to Follow-up|4
1407276|NCT01171976|4643419|P3|Overall Study|Death|1
1407277|NCT01171976|4643420|P2|Overall Study|Death|4
1407278|NCT01171976|4643421|P1|Overall Study|Death|2
1407279|NCT01171976|4643419|P3|Overall Study|Protocol Violation|1
1407280|NCT01171976|4643420|P2|Overall Study|Protocol Violation|0
1407281|NCT01171976|4643421|P1|Overall Study|Protocol Violation|0
1407282|NCT01171963|4643458|P2|Overall Study|Withdrawal by Subject|129
1407283|NCT01171963|4643459|P1|Overall Study|Withdrawal by Subject|114
1407284|NCT01171963|4643458|P2|Overall Study|Other - diarrhoea|0
1407285|NCT01171963|4643459|P1|Overall Study|Other - diarrhoea|1
1407286|NCT01171963|4643458|P2|Overall Study|Lost to Follow-up|24
1407287|NCT01171963|4643459|P1|Overall Study|Lost to Follow-up|23
1407288|NCT01171963|4643458|P2|Overall Study|Adverse Event|15
1407289|NCT01171963|4643459|P1|Overall Study|Adverse Event|10
1407290|NCT01171898|4643528|P4|Overall Study|Other|2
1407291|NCT01171898|4643529|P3|Overall Study|Other|0
1407292|NCT01171898|4643530|P2|Overall Study|Other|5
1407293|NCT01171898|4643531|P1|Overall Study|Other|1
1407294|NCT01171898|4643528|P4|Overall Study|Ongoing|0
1407295|NCT01171898|4643529|P3|Overall Study|Ongoing|3
1407296|NCT01171898|4643530|P2|Overall Study|Ongoing|9
1407297|NCT01171898|4643531|P1|Overall Study|Ongoing|1
1407298|NCT01171898|4643528|P4|Overall Study|Terminated by Sponsor|0
1407299|NCT01171898|4643529|P3|Overall Study|Terminated by Sponsor|0
1407300|NCT01171898|4643530|P2|Overall Study|Terminated by Sponsor|0
1407301|NCT01171898|4643531|P1|Overall Study|Terminated by Sponsor|1
1407302|NCT01171898|4643528|P4|Overall Study|Withdrawal by Subject|3
1407303|NCT01171898|4643529|P3|Overall Study|Withdrawal by Subject|6
1407304|NCT01171898|4643530|P2|Overall Study|Withdrawal by Subject|4
1407305|NCT01171898|4643531|P1|Overall Study|Withdrawal by Subject|1
1407306|NCT01171898|4643528|P4|Overall Study|Lost to Follow-up|1
1407307|NCT01171898|4643529|P3|Overall Study|Lost to Follow-up|1
1407308|NCT01171898|4643530|P2|Overall Study|Lost to Follow-up|1
1407309|NCT01171898|4643531|P1|Overall Study|Lost to Follow-up|0
1407310|NCT01171898|4643528|P4|Overall Study|Death|0
1407311|NCT01171898|4643529|P3|Overall Study|Death|2
1407312|NCT01171898|4643530|P2|Overall Study|Death|0
1407313|NCT01171898|4643531|P1|Overall Study|Death|0
1407314|NCT01171820|4643555|P2|Overall Study|1-Year Missed Visit|1
1407315|NCT01171820|4643556|P1|Overall Study|1-Year Missed Visit|1
1407316|NCT01171820|4643555|P2|Overall Study|Physician Decision|1
1407317|NCT01171820|4643556|P1|Overall Study|Physician Decision|0
1407318|NCT01171820|4643555|P2|Overall Study|Withdrawal by Subject|0
1407319|NCT01171820|4643556|P1|Overall Study|Withdrawal by Subject|2
1407320|NCT01171820|4643555|P2|Overall Study|Lost to Follow-up|1
1407321|NCT01171820|4643556|P1|Overall Study|Lost to Follow-up|0
1407322|NCT01171820|4643555|P2|Overall Study|Death|3
1407323|NCT01171820|4643556|P1|Overall Study|Death|3
1407324|NCT01171677|4643634|P2|Overall Study|completed <70% IntenSati classes|0
1407325|NCT01171677|4643635|P1|Overall Study|completed <70% IntenSati classes|5
1407326|NCT01171677|4643634|P2|Overall Study|Adverse Event|0
1407327|NCT01171677|4643635|P1|Overall Study|Adverse Event|1
1407328|NCT01171677|4643634|P2|Overall Study|Withdrawal by Subject|3
1407329|NCT01171677|4643635|P1|Overall Study|Withdrawal by Subject|0
1407330|NCT01171612|4643667|P1|Overall Study|Lost to Follow-up|51
1407331|NCT01171534|4643677|P2|Overall Study|screen failure|1
1407332|NCT01171534|4643678|P1|Overall Study|screen failure|0
1407333|NCT01171534|4643677|P2|Overall Study|Lost to Follow-up|2
1407334|NCT01171534|4643678|P1|Overall Study|Lost to Follow-up|0
1407335|NCT01171521|4643690|P1|Overall Study|screen failure|1
1407336|NCT01171521|4643690|P1|Overall Study|Lost to Follow-up|5
1407337|NCT01171183|4643697|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
1407338|NCT01171183|4643698|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
1407339|NCT01171183|4643697|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
1407340|NCT01171183|4643698|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
1407341|NCT01171183|4643697|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
1407342|NCT01171183|4643698|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
1407343|NCT01171183|4643697|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
1407344|NCT01171183|4643698|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
1407345|NCT01171183|4643697|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
1407346|NCT01171183|4643698|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
1407347|NCT01171183|4643697|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
1407348|NCT01171183|4643698|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
1407349|NCT01170962|4643719|P3|Follow up Period|Others|3
1407350|NCT01170962|4643720|P2|Follow up Period|Others|7
1407351|NCT01170962|4643721|P1|Follow up Period|Others|10
1407352|NCT01170962|4643719|P3|Follow up Period|Death|0
1407353|NCT01170962|4643720|P2|Follow up Period|Death|2
1407354|NCT01170962|4643721|P1|Follow up Period|Death|2
1407355|NCT01170962|4643719|P3|Follow up Period|Lost to Follow-up|1
1407356|NCT01170962|4643720|P2|Follow up Period|Lost to Follow-up|8
1407357|NCT01170962|4643721|P1|Follow up Period|Lost to Follow-up|13
1407358|NCT01170962|4643719|P3|Follow up Period|Withdrawal by Subject|2
1407359|NCT01170962|4643720|P2|Follow up Period|Withdrawal by Subject|10
1407360|NCT01170962|4643721|P1|Follow up Period|Withdrawal by Subject|14
1407361|NCT01170962|4643719|P3|Treatment Period|Completed 24 Week treatment period only|0
1407362|NCT01170962|4643720|P2|Treatment Period|Completed 24 Week treatment period only|2
1407363|NCT01170962|4643721|P1|Treatment Period|Completed 24 Week treatment period only|10
1407364|NCT01170962|4643719|P3|Treatment Period|Request to discontinue treatment|1
1407365|NCT01170962|4643720|P2|Treatment Period|Request to discontinue treatment|3
1407366|NCT01170962|4643721|P1|Treatment Period|Request to discontinue treatment|7
1407367|NCT01170962|4643719|P3|Treatment Period|Participant no longer meets criteria|0
1407368|NCT01170962|4643720|P2|Treatment Period|Participant no longer meets criteria|1
1407369|NCT01170962|4643721|P1|Treatment Period|Participant no longer meets criteria|0
1407370|NCT01170962|4643719|P3|Treatment Period|Lost to Follow-up|1
1407371|NCT01170962|4643720|P2|Treatment Period|Lost to Follow-up|1
1407372|NCT01170962|4643721|P1|Treatment Period|Lost to Follow-up|1
1407373|NCT01170962|4643719|P3|Treatment Period|Withdrawal by Subject|0
1407374|NCT01170962|4643720|P2|Treatment Period|Withdrawal by Subject|1
1407375|NCT01170962|4643721|P1|Treatment Period|Withdrawal by Subject|2
1407376|NCT01170962|4643719|P3|Treatment Period|Adverse Event|3
1407377|NCT01170962|4643720|P2|Treatment Period|Adverse Event|12
1407378|NCT01170962|4643721|P1|Treatment Period|Adverse Event|11
1407379|NCT01170962|4643719|P3|Treatment Period|Lack of Efficacy|7
1407380|NCT01170962|4643720|P2|Treatment Period|Lack of Efficacy|91
1407381|NCT01170962|4643721|P1|Treatment Period|Lack of Efficacy|96
1407382|NCT01170663|4643816|P2|Overall Study|Withdrawal of consent without follow-up|11
1407383|NCT01170663|4643817|P1|Overall Study|Withdrawal of consent without follow-up|11
1407384|NCT01170663|4643816|P2|Overall Study|Lost to Follow-up|9
1407385|NCT01170663|4643817|P1|Overall Study|Lost to Follow-up|3
1407386|NCT01170598|4643845|P1|Overall Study|Refused|1
1407387|NCT01170598|4643845|P1|Overall Study|Lost to Follow-up|1
1407388|NCT01170598|4643845|P1|Overall Study|Death|3
1407389|NCT01170598|4643845|P1|Overall Study|Withdrawal by Subject|1
1407390|NCT01170364|4643908|P2|Overall Study|Protocol Violation|1
1407391|NCT01170364|4643909|P1|Overall Study|Protocol Violation|4
1407392|NCT01170273|4643917|P2|Overall Study|Adverse Event|1
1407393|NCT01170273|4643918|P1|Overall Study|Adverse Event|0
1407394|NCT01170273|4643917|P2|Overall Study|Death|0
1407395|NCT01170273|4643918|P1|Overall Study|Death|1
1407396|NCT01170273|4643917|P2|Overall Study|Protocol Violation|0
1407397|NCT01170273|4643918|P1|Overall Study|Protocol Violation|1
1407398|NCT01170273|4643917|P2|Overall Study|Lost to Follow-up|8
1407399|NCT01170273|4643918|P1|Overall Study|Lost to Follow-up|6
1407400|NCT01170221|4643935|P2|Overall Study|Randomized but not treated|0
1407401|NCT01170221|4643936|P1|Overall Study|Randomized but not treated|1
1407402|NCT01170221|4643935|P2|Overall Study|Subject completed only screening and LFU|0
1407403|NCT01170221|4643936|P1|Overall Study|Subject completed only screening and LFU|1
1407404|NCT01170221|4643935|P2|Overall Study|Withdrawal by Subject|7
1407405|NCT01170221|4643936|P1|Overall Study|Withdrawal by Subject|9
1407406|NCT01170221|4643935|P2|Overall Study|Lost to Follow-up|21
1407407|NCT01170221|4643936|P1|Overall Study|Lost to Follow-up|22
1407408|NCT01170208|4643959|P3|Overall Study|Protocol Violation|1
1407409|NCT01170208|4643960|P2|Overall Study|Protocol Violation|0
1407410|NCT01170208|4643961|P1|Overall Study|Protocol Violation|1
1407411|NCT01170208|4643959|P3|Overall Study|Withdrawal by Subject|1
1407412|NCT01170208|4643960|P2|Overall Study|Withdrawal by Subject|0
1407413|NCT01170208|4643961|P1|Overall Study|Withdrawal by Subject|5
1407414|NCT01170091|4643980|P1|Overall Study|Treatment duration is less than 4 weeks|21
1407415|NCT01170091|4643980|P1|Overall Study|Missing efficacy evaluation|3
1407416|NCT01170039|4643989|P2|Overall Study|Lack of funding, drug not available|3
1407417|NCT01170039|4643990|P1|Overall Study|Lack of funding, drug not available|3
1407418|NCT01170039|4643989|P2|Overall Study|Withdrawal by Subject|3
1407419|NCT01170039|4643990|P1|Overall Study|Withdrawal by Subject|5
1407420|NCT01169987|4644002|P1|Overall Study|Not Specified|4
1407421|NCT01169987|4644002|P1|Overall Study|Lost to Follow-up|24
1407422|NCT01169987|4644002|P1|Overall Study|Withdrawal by Subject|3
1407423|NCT01169779|4644068|P2|Overall Study|Familial and personal reasons|3
1407424|NCT01169779|4644069|P1|Overall Study|Familial and personal reasons|3
1407425|NCT01169779|4644068|P2|Overall Study|Withdrawal by Subject|2
1407426|NCT01169779|4644069|P1|Overall Study|Withdrawal by Subject|3
1407427|NCT01169779|4644068|P2|Overall Study|Protocol Violation|1
1407428|NCT01169779|4644069|P1|Overall Study|Protocol Violation|1
1407429|NCT01169779|4644068|P2|Overall Study|Lack of Efficacy|0
1407430|NCT01169779|4644069|P1|Overall Study|Lack of Efficacy|1
1407431|NCT01169779|4644068|P2|Overall Study|Adverse Event|11
1407432|NCT01169779|4644069|P1|Overall Study|Adverse Event|3
1407433|NCT01169701|4644104|P2|Overall Study|Sponsor decision|1
1407434|NCT01169701|4644105|P1|Overall Study|Sponsor decision|0
1407435|NCT01169701|4644104|P2|Overall Study|Serious adverse event|1
1407436|NCT01169701|4644105|P1|Overall Study|Serious adverse event|0
1407437|NCT01169701|4644104|P2|Overall Study|Administrative problems|1
1407438|NCT01169701|4644105|P1|Overall Study|Administrative problems|0
1407439|NCT01169701|4644104|P2|Overall Study|Death|1
1407440|NCT01169701|4644105|P1|Overall Study|Death|0
1407441|NCT01169701|4644104|P2|Overall Study|Exclusion criteria|0
1407442|NCT01169701|4644105|P1|Overall Study|Exclusion criteria|2
1407443|NCT01169701|4644104|P2|Overall Study|Adverse Event|2
1407444|NCT01169701|4644105|P1|Overall Study|Adverse Event|1
1407445|NCT01169701|4644104|P2|Overall Study|Withdrawal by Subject|3
1407446|NCT01169701|4644105|P1|Overall Study|Withdrawal by Subject|1
1407447|NCT01169701|4644104|P2|Overall Study|Lost to Follow-up|1
1407448|NCT01169701|4644105|P1|Overall Study|Lost to Follow-up|1
1407449|NCT01169675|4644142|P5|Overall Study|Other Reason Not Defined Above|1
1407450|NCT01169675|4644143|P4|Overall Study|Other Reason Not Defined Above|1
1407451|NCT01169675|4644144|P3|Overall Study|Other Reason Not Defined Above|0
1407452|NCT01169675|4644145|P2|Overall Study|Other Reason Not Defined Above|0
1407453|NCT01169675|4644146|P1|Overall Study|Other Reason Not Defined Above|0
1407454|NCT01169675|4644142|P5|Overall Study|Withdrawal by Subject|2
1407455|NCT01169675|4644143|P4|Overall Study|Withdrawal by Subject|1
1407456|NCT01169675|4644144|P3|Overall Study|Withdrawal by Subject|0
1407457|NCT01169675|4644145|P2|Overall Study|Withdrawal by Subject|0
1407458|NCT01169675|4644146|P1|Overall Study|Withdrawal by Subject|1
1407459|NCT01169675|4644142|P5|Overall Study|Adverse Event|0
1407460|NCT01169675|4644143|P4|Overall Study|Adverse Event|0
1407461|NCT01169675|4644144|P3|Overall Study|Adverse Event|2
1407462|NCT01169675|4644145|P2|Overall Study|Adverse Event|1
1407463|NCT01169675|4644146|P1|Overall Study|Adverse Event|5
1407464|NCT01169675|4644142|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
1407465|NCT01169675|4644143|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
1407466|NCT01169675|4644144|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
1407467|NCT01169675|4644145|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
1407468|NCT01169675|4644146|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
1407469|NCT01169675|4644142|P5|Overall Study|Progressive disease|1
1407470|NCT01169675|4644143|P4|Overall Study|Progressive disease|15
1407471|NCT01169675|4644144|P3|Overall Study|Progressive disease|5
1407472|NCT01169675|4644145|P2|Overall Study|Progressive disease|2
1407473|NCT01169675|4644146|P1|Overall Study|Progressive disease|13
1407474|NCT01169649|4644183|P1|Overall Study|Patient Not Treated|3
1407475|NCT01169558|4644195|P1|Overall Study|Partial response|2
1407476|NCT01169558|4644195|P1|Overall Study|Protocol Violation|2
1407477|NCT01169558|4644195|P1|Overall Study|Non-compliance|2
1407478|NCT01169558|4644195|P1|Overall Study|Need for Surgery|4
1407479|NCT01169558|4644195|P1|Overall Study|Lost to Follow-up|4
1407480|NCT01169558|4644195|P1|Overall Study|Stable Disease|4
1407481|NCT01169558|4644195|P1|Overall Study|Medical Decision|7
1407482|NCT01169558|4644195|P1|Overall Study|Withdrawal of Consent|8
1407483|NCT01169558|4644195|P1|Overall Study|Adverse Event|25
1407484|NCT01169558|4644195|P1|Overall Study|Disease progression|98
1407485|NCT01169493|4644220|P6|Period 3 (6 Months)|Physician Decision|0
1407486|NCT01169493|4644221|P5|Period 3 (6 Months)|Physician Decision|0
1407487|NCT01169493|4644222|P4|Period 3 (6 Months)|Physician Decision|0
1407488|NCT01169493|4644223|P3|Period 3 (6 Months)|Physician Decision|1
1407489|NCT01169493|4644224|P2|Period 3 (6 Months)|Physician Decision|1
1407490|NCT01169493|4644225|P1|Period 3 (6 Months)|Physician Decision|0
1407491|NCT01169493|4644220|P6|Period 3 (6 Months)|Adverse Event|0
1407492|NCT01169493|4644221|P5|Period 3 (6 Months)|Adverse Event|0
1407493|NCT01169493|4644222|P4|Period 3 (6 Months)|Adverse Event|0
1407494|NCT01169493|4644223|P3|Period 3 (6 Months)|Adverse Event|0
1407495|NCT01169493|4644224|P2|Period 3 (6 Months)|Adverse Event|1
1407496|NCT01169493|4644225|P1|Period 3 (6 Months)|Adverse Event|0
1407497|NCT01169493|4644220|P6|Period 1 (6 Months)|Withdrawal by Subject|3
1407498|NCT01169493|4644221|P5|Period 1 (6 Months)|Withdrawal by Subject|0
1407499|NCT01169493|4644222|P4|Period 1 (6 Months)|Withdrawal by Subject|0
1407500|NCT01169493|4644223|P3|Period 1 (6 Months)|Withdrawal by Subject|2
1407501|NCT01169493|4644224|P2|Period 1 (6 Months)|Withdrawal by Subject|1
1407502|NCT01169493|4644225|P1|Period 1 (6 Months)|Withdrawal by Subject|0
1407503|NCT01169350|4644271|P1|Overall Study|Lost to Follow-up|2
1407504|NCT01169350|4644271|P1|Overall Study|Physician Decision|3
1407505|NCT01169103|4644292|P2|Overall Study|Withdrawal by Subject|1
1407506|NCT01169103|4644293|P1|Overall Study|Withdrawal by Subject|3
1407507|NCT01169103|4644292|P2|Overall Study|Lost to Follow-up|3
1407508|NCT01169103|4644293|P1|Overall Study|Lost to Follow-up|3
1407509|NCT01169038|4644320|P1|Overall Study|Required antibiotic administration|1
1407510|NCT01169038|4644320|P1|Overall Study|Adverse Event|5
1407511|NCT01169038|4644320|P1|Overall Study|Death|1
1407512|NCT01168999|4644328|P4|Overall Study|Lost to Follow-up|0
1407513|NCT01168999|4644329|P3|Overall Study|Lost to Follow-up|0
1407514|NCT01168999|4644330|P2|Overall Study|Lost to Follow-up|1
1407515|NCT01168999|4644331|P1|Overall Study|Lost to Follow-up|2
1407516|NCT01168973|4644397|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
1407517|NCT01168973|4644398|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
1407518|NCT01168973|4644397|P2|Overall Study|Sponsor Decision|1
1407519|NCT01168973|4644398|P1|Overall Study|Sponsor Decision|2
1407520|NCT01168973|4644397|P2|Overall Study|Physician Decision|19
1407521|NCT01168973|4644398|P1|Overall Study|Physician Decision|37
1407522|NCT01168973|4644397|P2|Overall Study|Death|45
1407523|NCT01168973|4644398|P1|Overall Study|Death|42
1407524|NCT01168973|4644397|P2|Overall Study|Withdrawal by Subject|53
1407525|NCT01168973|4644398|P1|Overall Study|Withdrawal by Subject|90
1407526|NCT01168973|4644397|P2|Overall Study|Adverse Event|55
1407527|NCT01168973|4644398|P1|Overall Study|Adverse Event|94
1407528|NCT01168973|4644397|P2|Overall Study|Progressive Disease|429
1407529|NCT01168973|4644398|P1|Overall Study|Progressive Disease|341
1407530|NCT01168856|4644471|P2|Overall Study|Protocol Violation|6
1407531|NCT01168856|4644472|P1|Overall Study|Protocol Violation|4
1407532|NCT01168856|4644471|P2|Overall Study|Other|291
1407533|NCT01168856|4644472|P1|Overall Study|Other|1
1407534|NCT01168856|4644471|P2|Overall Study|Death|2
1407535|NCT01168856|4644472|P1|Overall Study|Death|0
1407536|NCT01168856|4644471|P2|Overall Study|Participant received anti-HCV treatment|0
1407537|NCT01168856|4644472|P1|Overall Study|Participant received anti-HCV treatment|1
1407538|NCT01168856|4644471|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
1407539|NCT01168856|4644472|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
1407540|NCT01168856|4644471|P2|Overall Study|Physician Decision|1
1407541|NCT01168856|4644472|P1|Overall Study|Physician Decision|2
1407542|NCT01168856|4644471|P2|Overall Study|Withdrawal by Subject|8
1407543|NCT01168856|4644472|P1|Overall Study|Withdrawal by Subject|6
1407544|NCT01168856|4644471|P2|Overall Study|Lost to Follow-up|34
1407545|NCT01168856|4644472|P1|Overall Study|Lost to Follow-up|4
1407546|NCT01168596|4644570|P2|Overall Study|Withdrawal by Subject|1
1407547|NCT01168596|4644571|P1|Overall Study|Withdrawal by Subject|3
1407548|NCT01168427|4644615|P1|Overall Study|Patient exited prior to implant|1
1407549|NCT01168349|4644620|P1|Overall Study|Protocol Violation|76
1407550|NCT01168349|4644620|P1|Overall Study|Other|22
1407551|NCT01168349|4644620|P1|Overall Study|Kidney transplantation|3
1407552|NCT01168349|4644620|P1|Overall Study|Withdrawal by Subject|9
1407553|NCT01168349|4644620|P1|Overall Study|Lost to Follow-up|34
1407554|NCT01168349|4644620|P1|Overall Study|Death|157
1407555|NCT01168232|4644726|P1|Overall Study|Ineligible-Inadequate pathology|1
1407556|NCT01168232|4644726|P1|Overall Study|Ineligible- Wrong cell type|6
1407557|NCT01168232|4644726|P1|Overall Study|Ineligible-Second primary cancer site|1
1407558|NCT01167907|4644754|P2|Overall Study|saphenous catheter dislodged before comp|1
1407559|NCT01167907|4644755|P1|Overall Study|saphenous catheter dislodged before comp|1
1407560|NCT01167907|4644754|P2|Overall Study|Protocol Violation|0
1407561|NCT01167907|4644755|P1|Overall Study|Protocol Violation|1
1407562|NCT01167881|4644773|P2|Overall Study|Other not defined above|55
1407563|NCT01167881|4644774|P1|Overall Study|Other not defined above|31
1407564|NCT01167881|4644773|P2|Overall Study|Not treated|0
1407565|NCT01167881|4644774|P1|Overall Study|Not treated|4
1407566|NCT01167881|4644773|P2|Overall Study|Patient refusal to cont., not due to AE|40
1407567|NCT01167881|4644774|P1|Overall Study|Patient refusal to cont., not due to AE|45
1407568|NCT01167881|4644773|P2|Overall Study|Lost to Follow-up|20
1407569|NCT01167881|4644774|P1|Overall Study|Lost to Follow-up|19
1407570|NCT01167881|4644773|P2|Overall Study|Non compliant with protocol|18
1407571|NCT01167881|4644774|P1|Overall Study|Non compliant with protocol|9
1407572|NCT01167881|4644773|P2|Overall Study|Lack of Efficacy|7
1407573|NCT01167881|4644774|P1|Overall Study|Lack of Efficacy|4
1407574|NCT01167881|4644773|P2|Overall Study|Adverse Event|51
1407575|NCT01167881|4644774|P1|Overall Study|Adverse Event|47
1407576|NCT01167634|4644828|P4|Overall Study|Withdrawal by Subject|0
1407577|NCT01167634|4644829|P3|Overall Study|Withdrawal by Subject|0
1407578|NCT01167634|4644830|P2|Overall Study|Withdrawal by Subject|1
1407579|NCT01167634|4644831|P1|Overall Study|Withdrawal by Subject|1
1407580|NCT01167634|4644828|P4|Overall Study|Lost to Follow-up|4
1407581|NCT01167634|4644829|P3|Overall Study|Lost to Follow-up|3
1407582|NCT01167634|4644830|P2|Overall Study|Lost to Follow-up|3
1407583|NCT01167634|4644831|P1|Overall Study|Lost to Follow-up|1
1407584|NCT01167582|4644852|P2|Overall Study|Lost to Follow-up|1
1407585|NCT01167582|4644853|P1|Overall Study|Lost to Follow-up|0
1407586|NCT01167426|4644875|P1|Overall Study|Sponsor Decision|1
1407587|NCT01167426|4644875|P1|Overall Study|Withdrawal by Subject|2
1407588|NCT01167426|4644875|P1|Overall Study|Protocol Violation|1
1407589|NCT01167426|4644875|P1|Overall Study|Lost to Follow-up|6
1407590|NCT01167257|4644883|P2|Overall Study|Withdrew consent|1
1407591|NCT01167257|4644884|P1|Overall Study|Withdrew consent|1
1407592|NCT01167257|4644883|P2|Overall Study|Lost to Follow-up|2
1407593|NCT01167257|4644884|P1|Overall Study|Lost to Follow-up|2
1407594|NCT01167192|4644906|P1|Overall Study|Insurance denial|1
1407595|NCT01167192|4644906|P1|Overall Study|Withdrawal by Subject|1
1407596|NCT01167192|4644906|P1|Overall Study|Death|1
1407597|NCT01167192|4644906|P1|Overall Study|Adverse Event|1
1407598|NCT01167179|4644923|P2|Overall Study|diverse|5
1407599|NCT01167179|4644924|P1|Overall Study|diverse|6
1407600|NCT01167179|4644923|P2|Overall Study|Withdrawal by Subject|2
1407601|NCT01167179|4644924|P1|Overall Study|Withdrawal by Subject|1
1407602|NCT01167179|4644923|P2|Overall Study|Death|10
1407603|NCT01167179|4644924|P1|Overall Study|Death|4
1407604|NCT01167179|4644923|P2|Overall Study|disease recurrence|4
1407605|NCT01167179|4644924|P1|Overall Study|disease recurrence|4
1407606|NCT01167153|4644934|P2|Overall Study|Subject initiation withdrawal, Other|8
1407607|NCT01167153|4644935|P1|Overall Study|Subject initiation withdrawal, Other|5
1407608|NCT01167153|4644934|P2|Overall Study|Withdrawal consent|1
1407609|NCT01167153|4644935|P1|Overall Study|Withdrawal consent|1
1407610|NCT01167153|4644934|P2|Overall Study|Investigator initiation withdrawal,Other|1
1407611|NCT01167153|4644935|P1|Overall Study|Investigator initiation withdrawal,Other|1
1407612|NCT01167153|4644934|P2|Overall Study|Non-compliance to concomitant medication|2
1407613|NCT01167153|4644935|P1|Overall Study|Non-compliance to concomitant medication|0
1407614|NCT01167153|4644934|P2|Overall Study|Lost to Follow-up|9
1407615|NCT01167153|4644935|P1|Overall Study|Lost to Follow-up|7
1407616|NCT01167153|4644934|P2|Overall Study|Hypotension|0
1407617|NCT01167153|4644935|P1|Overall Study|Hypotension|1
1407618|NCT01167153|4644934|P2|Overall Study|AE including clinical laboratory AE|8
1407619|NCT01167153|4644935|P1|Overall Study|AE including clinical laboratory AE|2
1407620|NCT01167153|4644934|P2|Overall Study|Non-effective therapy|4
1407621|NCT01167153|4644935|P1|Overall Study|Non-effective therapy|1
1407622|NCT01167140|4644953|P1|Overall Study|Withdrawal by Subject|1
1407623|NCT01167023|4644961|P3|Overall Study|Withdrawal by Subject|1
1407624|NCT01167023|4644962|P2|Overall Study|Withdrawal by Subject|0
1407625|NCT01167023|4644963|P1|Overall Study|Withdrawal by Subject|0
1407626|NCT01167023|4644961|P3|Overall Study|Sponsor Decision|0
1407627|NCT01167023|4644962|P2|Overall Study|Sponsor Decision|1
1407628|NCT01167023|4644963|P1|Overall Study|Sponsor Decision|0
1407629|NCT01167023|4644961|P3|Overall Study|Screen Failure|0
1407630|NCT01167023|4644962|P2|Overall Study|Screen Failure|1
1407631|NCT01167023|4644963|P1|Overall Study|Screen Failure|0
1407632|NCT01167023|4644961|P3|Overall Study|Lost to Follow-up|1
1407633|NCT01167023|4644962|P2|Overall Study|Lost to Follow-up|1
1407634|NCT01167023|4644963|P1|Overall Study|Lost to Follow-up|0
1407635|NCT01166958|4645003|P2|Overall Study|Withdrawal by Subject|0
1407636|NCT01166958|4645004|P1|Overall Study|Withdrawal by Subject|1
1407637|NCT01166763|4645018|P1|Overall Study|Withdrawal by Subject|3
1407638|NCT01166750|4645026|P2|Overall Study|Lost to Follow-up|0
1407639|NCT01166750|4645027|P1|Overall Study|Lost to Follow-up|1
1407640|NCT01166659|4645044|P1|Overall Study|Study Closed at Site|1
1407641|NCT01166659|4645044|P1|Overall Study|Lost to Follow-up|1
1407642|NCT01166659|4645044|P1|Overall Study|Death|1
1407643|NCT01166659|4645044|P1|Overall Study|Investigator Decision|2
1407644|NCT01166659|4645044|P1|Overall Study|Subject Decision|8
1407645|NCT01166646|4645053|P2|Overall Study|Adverse Event|0
1407646|NCT01166646|4645054|P1|Overall Study|Adverse Event|1
1407647|NCT01166646|4645053|P2|Overall Study|Protocol Violation|1
1407648|NCT01166646|4645054|P1|Overall Study|Protocol Violation|0
1407649|NCT01166438|4645072|P2|Off Treatment Follow-up Phase|Lack of Efficacy|52
1407650|NCT01166438|4645073|P1|Off Treatment Follow-up Phase|Lack of Efficacy|29
1407651|NCT01166438|4645072|P2|Off Treatment Follow-up Phase|Lost to Follow-up|2
1407652|NCT01166438|4645073|P1|Off Treatment Follow-up Phase|Lost to Follow-up|4
1407653|NCT01166438|4645072|P2|Off Treatment Follow-up Phase|Withdrawal by Subject|2
1407654|NCT01166438|4645073|P1|Off Treatment Follow-up Phase|Withdrawal by Subject|1
1407655|NCT01166438|4645072|P2|Double-blind Phase: 1st 6 Months|Not treated|1
1407656|NCT01166438|4645073|P1|Double-blind Phase: 1st 6 Months|Not treated|1
1407657|NCT01166438|4645072|P2|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
1407658|NCT01166438|4645073|P1|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
1407659|NCT01166438|4645072|P2|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
1407660|NCT01166438|4645073|P1|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
1407661|NCT01166282|4645122|P3|Open-label Period|Irregular Compliance|1
1407662|NCT01166282|4645123|P2|Open-label Period|Irregular Compliance|0
1407663|NCT01166282|4645124|P1|Open-label Period|Irregular Compliance|0
1407664|NCT01166282|4645122|P3|Open-label Period|Remission|4
1407665|NCT01166282|4645123|P2|Open-label Period|Remission|0
1407666|NCT01166282|4645124|P1|Open-label Period|Remission|0
1407667|NCT01166282|4645122|P3|Open-label Period|Lack of Efficacy|2
1407668|NCT01166282|4645123|P2|Open-label Period|Lack of Efficacy|0
1407669|NCT01166282|4645124|P1|Open-label Period|Lack of Efficacy|0
1407670|NCT01166282|4645122|P3|Open-label Period|Withdrawal by Subject|4
1407671|NCT01166282|4645123|P2|Open-label Period|Withdrawal by Subject|0
1407672|NCT01166282|4645124|P1|Open-label Period|Withdrawal by Subject|0
1407673|NCT01166282|4645122|P3|Open-label Period|Adverse Event|6
1407674|NCT01166282|4645123|P2|Open-label Period|Adverse Event|0
1407675|NCT01166282|4645124|P1|Open-label Period|Adverse Event|0
1407676|NCT01166178|4645163|P2|Overall Study|Study was terminated|8
1407677|NCT01166178|4645164|P1|Overall Study|Study was terminated|20
1407678|NCT01166178|4645163|P2|Overall Study|Withdrawal by Subject|0
1407679|NCT01166178|4645164|P1|Overall Study|Withdrawal by Subject|1
1407680|NCT01165996|4645203|P1|Overall Study|Physician Decision|1
1407681|NCT01165996|4645203|P1|Overall Study|Death|1
1407682|NCT01165684|4645270|P2|Overall Study|Unclassified|22
1407683|NCT01165684|4645271|P1|Overall Study|Unclassified|16
1407684|NCT01165684|4645270|P2|Overall Study|Withdrawal Criteria|13
1407685|NCT01165684|4645271|P1|Overall Study|Withdrawal Criteria|2
1407686|NCT01165684|4645270|P2|Overall Study|Protocol Violation|15
1407687|NCT01165684|4645271|P1|Overall Study|Protocol Violation|7
1407688|NCT01165684|4645270|P2|Overall Study|Lack of Efficacy|1
1407689|NCT01165684|4645271|P1|Overall Study|Lack of Efficacy|2
1407690|NCT01165684|4645270|P2|Overall Study|Adverse Event|1
1407691|NCT01165684|4645271|P1|Overall Study|Adverse Event|1
1407692|NCT01165554|4645305|P1|Overall Study|Withdrawal by Subject|23
1407693|NCT01165424|4645328|P1|Overall Study|Participant moved (relocated)|1
1407694|NCT01165424|4645328|P1|Overall Study|Did not meet entry criteria|1
1407695|NCT01165424|4645328|P1|Overall Study|Laboratory adverse experiences|1
1407696|NCT01165424|4645328|P1|Overall Study|Clinical adverse experiences|1
1407697|NCT01165320|4645335|P3|Overall Study|Reason unknown|0
1407698|NCT01165320|4645336|P2|Overall Study|Reason unknown|1
1407699|NCT01165320|4645337|P1|Overall Study|Reason unknown|0
1407700|NCT01165320|4645335|P3|Overall Study|Lack of Efficacy|0
1407701|NCT01165320|4645336|P2|Overall Study|Lack of Efficacy|2
1407702|NCT01165320|4645337|P1|Overall Study|Lack of Efficacy|0
1407703|NCT01165320|4645335|P3|Overall Study|Laboratory adverse experience|0
1407704|NCT01165320|4645336|P2|Overall Study|Laboratory adverse experience|0
1407705|NCT01165320|4645337|P1|Overall Study|Laboratory adverse experience|1
1407706|NCT01165320|4645335|P3|Overall Study|Clinical adverse experience|0
1407707|NCT01165320|4645336|P2|Overall Study|Clinical adverse experience|1
1407708|NCT01165320|4645337|P1|Overall Study|Clinical adverse experience|2
1407709|NCT01165307|4645347|P2|Overall Study|Subject not available for contact|0
1407710|NCT01165307|4645348|P1|Overall Study|Subject not available for contact|1
1407711|NCT01165307|4645347|P2|Overall Study|Withdrawal by Subject|0
1407712|NCT01165307|4645348|P1|Overall Study|Withdrawal by Subject|2
1407713|NCT01165307|4645347|P2|Overall Study|Lost to Follow-up|3
1407714|NCT01165307|4645348|P1|Overall Study|Lost to Follow-up|11
1407715|NCT01165281|4645378|P2|Overall Study|Other|0
1407716|NCT01165281|4645379|P1|Overall Study|Other|6
1407717|NCT01165281|4645378|P2|Overall Study|Progressive Disease|14
1407718|NCT01165281|4645379|P1|Overall Study|Progressive Disease|10
1407719|NCT01165281|4645378|P2|Overall Study|Noncompliance with Study Drug|4
1407720|NCT01165281|4645379|P1|Overall Study|Noncompliance with Study Drug|1
1407721|NCT01165281|4645378|P2|Overall Study|Withdrawal by Subject|7
1407722|NCT01165281|4645379|P1|Overall Study|Withdrawal by Subject|8
1407723|NCT01165281|4645378|P2|Overall Study|Protocol Violation|5
1407724|NCT01165281|4645379|P1|Overall Study|Protocol Violation|6
1407725|NCT01165281|4645378|P2|Overall Study|Physician Decision|1
1407726|NCT01165281|4645379|P1|Overall Study|Physician Decision|8
1407727|NCT01165281|4645378|P2|Overall Study|Lost to Follow-up|1
1407728|NCT01165281|4645379|P1|Overall Study|Lost to Follow-up|0
1407729|NCT01165281|4645378|P2|Overall Study|Lack of Efficacy|1
1407730|NCT01165281|4645379|P1|Overall Study|Lack of Efficacy|4
1407731|NCT01165281|4645378|P2|Overall Study|Death|4
1407732|NCT01165281|4645379|P1|Overall Study|Death|3
1407733|NCT01165281|4645378|P2|Overall Study|Adverse Event|14
1407734|NCT01165281|4645379|P1|Overall Study|Adverse Event|12
1407735|NCT01165242|4645400|P3|Overall Study|Lost to Follow-up|10
1407736|NCT01165242|4645401|P2|Overall Study|Lost to Follow-up|7
1407737|NCT01165242|4645402|P1|Overall Study|Lost to Follow-up|9
1407738|NCT01165242|4645400|P3|Overall Study|Extended Holiday|1
1407739|NCT01165242|4645401|P2|Overall Study|Extended Holiday|0
1407740|NCT01165242|4645402|P1|Overall Study|Extended Holiday|0
1407741|NCT01165242|4645400|P3|Overall Study|Withdrawal by Subject|2
1407742|NCT01165242|4645401|P2|Overall Study|Withdrawal by Subject|2
1407743|NCT01165242|4645402|P1|Overall Study|Withdrawal by Subject|0
1407744|NCT01165242|4645400|P3|Overall Study|Visit 2 Declined by Subject|1
1407745|NCT01165242|4645401|P2|Overall Study|Visit 2 Declined by Subject|0
1407746|NCT01165242|4645402|P1|Overall Study|Visit 2 Declined by Subject|0
1407747|NCT01165242|4645400|P3|Overall Study|Incarcerated Subjects|0
1407748|NCT01165242|4645401|P2|Overall Study|Incarcerated Subjects|1
1407749|NCT01165242|4645402|P1|Overall Study|Incarcerated Subjects|0
1407750|NCT01165242|4645400|P3|Overall Study|Unreachable Subjects|0
1407751|NCT01165242|4645401|P2|Overall Study|Unreachable Subjects|0
1407752|NCT01165242|4645402|P1|Overall Study|Unreachable Subjects|1
1407753|NCT01165229|4645436|P2|Overall Study|Screening criteria unmet|0
1407754|NCT01165229|4645437|P1|Overall Study|Screening criteria unmet|1
1407755|NCT01165229|4645436|P2|Overall Study|Lack of time|0
1407756|NCT01165229|4645437|P1|Overall Study|Lack of time|1
1407757|NCT01165229|4645436|P2|Overall Study|Missed visit|0
1407758|NCT01165229|4645437|P1|Overall Study|Missed visit|1
1407759|NCT01165229|4645436|P2|Overall Study|Sponsor study termination|0
1407760|NCT01165229|4645437|P1|Overall Study|Sponsor study termination|1
1407761|NCT01165229|4645436|P2|Overall Study|Investigator decision|2
1407762|NCT01165229|4645437|P1|Overall Study|Investigator decision|0
1407763|NCT01165229|4645436|P2|Overall Study|Personal reason|4
1407764|NCT01165229|4645437|P1|Overall Study|Personal reason|10
1407765|NCT01165229|4645436|P2|Overall Study|Site closure|20
1407766|NCT01165229|4645437|P1|Overall Study|Site closure|18
1407767|NCT01165229|4645436|P2|Overall Study|Health issues|56
1407768|NCT01165229|4645437|P1|Overall Study|Health issues|61
1407769|NCT01165229|4645436|P2|Overall Study|Patient not eligible|1
1407770|NCT01165229|4645437|P1|Overall Study|Patient not eligible|0
1407771|NCT01165229|4645436|P2|Overall Study|Page entered in error|1
1407772|NCT01165229|4645437|P1|Overall Study|Page entered in error|0
1407773|NCT01165229|4645436|P2|Overall Study|No reason from the subject|1
1407774|NCT01165229|4645437|P1|Overall Study|No reason from the subject|0
1407775|NCT01165229|4645436|P2|Overall Study|Suspected HZ Episode|2
1407776|NCT01165229|4645437|P1|Overall Study|Suspected HZ Episode|0
1407777|NCT01165229|4645436|P2|Overall Study|Lost to Follow-up|138
1407778|NCT01165229|4645437|P1|Overall Study|Lost to Follow-up|124
1407779|NCT01165229|4645436|P2|Overall Study|Migrated/moved from study area|46
1407780|NCT01165229|4645437|P1|Overall Study|Migrated/moved from study area|51
1407781|NCT01165229|4645436|P2|Overall Study|Withdrawal by Subject|403
1407782|NCT01165229|4645437|P1|Overall Study|Withdrawal by Subject|396
1407783|NCT01165229|4645436|P2|Overall Study|Protocol Violation|12
1407784|NCT01165229|4645437|P1|Overall Study|Protocol Violation|10
1407785|NCT01165229|4645436|P2|Overall Study|Non-Serious Adverse Event|15
1407786|NCT01165229|4645437|P1|Overall Study|Non-Serious Adverse Event|47
1407787|NCT01165229|4645436|P2|Overall Study|Serious Adverse Event|487
1407788|NCT01165229|4645437|P1|Overall Study|Serious Adverse Event|459
1407789|NCT01165229|4645436|P2|Overall Study|Unknown completion status|1
1407790|NCT01165229|4645437|P1|Overall Study|Unknown completion status|0
1407791|NCT01165216|4645565|P2|Overall Study|Disease progression|3
1407792|NCT01165216|4645566|P1|Overall Study|Disease progression|1
1407793|NCT01165216|4645565|P2|Overall Study|Withdrawal by Subject|1
1407794|NCT01165216|4645566|P1|Overall Study|Withdrawal by Subject|1
1407795|NCT01165216|4645565|P2|Overall Study|Adverse Event|3
1407796|NCT01165216|4645566|P1|Overall Study|Adverse Event|6
1407797|NCT01165203|4645588|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
1407798|NCT01165203|4645589|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
1407799|NCT01165203|4645588|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
1407800|NCT01165203|4645589|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
1407801|NCT01165203|4645588|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
1407802|NCT01165203|4645589|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
1407803|NCT01165203|4645588|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
1407804|NCT01165203|4645589|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
1407805|NCT01165203|4645588|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
1407806|NCT01165203|4645589|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
1407807|NCT01165203|4645588|P2|Active Phase|Lost to Follow-up|0
1407808|NCT01165203|4645589|P1|Active Phase|Lost to Follow-up|2
1407809|NCT01165203|4645588|P2|Active Phase|Migrated/moved from study area|1
1407810|NCT01165203|4645589|P1|Active Phase|Migrated/moved from study area|0
1407811|NCT01165203|4645588|P2|Active Phase|Withdrawal by Subject|1
1407812|NCT01165203|4645589|P1|Active Phase|Withdrawal by Subject|2
1407813|NCT01165203|4645588|P2|Active Phase|Serious Adverse Event|0
1407814|NCT01165203|4645589|P1|Active Phase|Serious Adverse Event|1
1407815|NCT01165177|4645679|P2|Overall Study|Death|1
1407816|NCT01165177|4645680|P1|Overall Study|Death|0
1407817|NCT01165177|4645679|P2|Overall Study|Personal Reasons|4
1407818|NCT01165177|4645680|P1|Overall Study|Personal Reasons|1
1407819|NCT01165177|4645679|P2|Overall Study|Physician Decision|1
1407820|NCT01165177|4645680|P1|Overall Study|Physician Decision|0
1407821|NCT01165177|4645679|P2|Overall Study|Non-serious Adverse Event|20
1407822|NCT01165177|4645680|P1|Overall Study|Non-serious Adverse Event|32
1407823|NCT01165177|4645679|P2|Overall Study|Migrated/moved from study area|43
1407824|NCT01165177|4645680|P1|Overall Study|Migrated/moved from study area|48
1407825|NCT01165177|4645679|P2|Overall Study|Subject missed visit|2
1407826|NCT01165177|4645680|P1|Overall Study|Subject missed visit|5
1407827|NCT01165177|4645679|P2|Overall Study|Previous health issues worsening|11
1407828|NCT01165177|4645680|P1|Overall Study|Previous health issues worsening|9
1407829|NCT01165177|4645679|P2|Overall Study|Subject non-compliant with procedures|2
1407830|NCT01165177|4645680|P1|Overall Study|Subject non-compliant with procedures|12
1407831|NCT01165177|4645679|P2|Overall Study|Site closure|5
1407832|NCT01165177|4645680|P1|Overall Study|Site closure|7
1407833|NCT01165177|4645679|P2|Overall Study|Protocol Violation|22
1407834|NCT01165177|4645680|P1|Overall Study|Protocol Violation|19
1407835|NCT01165177|4645679|P2|Overall Study|Lost to Follow-up|195
1407836|NCT01165177|4645680|P1|Overall Study|Lost to Follow-up|188
1407837|NCT01165177|4645679|P2|Overall Study|Serious Adverse Event|240
1407838|NCT01165177|4645680|P1|Overall Study|Serious Adverse Event|229
1407839|NCT01165177|4645679|P2|Overall Study|Withdrawal by Subject|356
1407840|NCT01165177|4645680|P1|Overall Study|Withdrawal by Subject|372
1407841|NCT01165138|4645805|P4|Overall Study|Withdrawal by Subject|3
1407842|NCT01165138|4645806|P3|Overall Study|Withdrawal by Subject|6
1407843|NCT01165138|4645807|P2|Overall Study|Withdrawal by Subject|6
1407844|NCT01165138|4645808|P1|Overall Study|Withdrawal by Subject|0
1407845|NCT01165138|4645805|P4|Overall Study|Physician Decision|6
1407846|NCT01165138|4645806|P3|Overall Study|Physician Decision|7
1407847|NCT01165138|4645807|P2|Overall Study|Physician Decision|6
1407848|NCT01165138|4645808|P1|Overall Study|Physician Decision|0
1407849|NCT01165138|4645805|P4|Overall Study|Lost to Follow-up|2
1407850|NCT01165138|4645806|P3|Overall Study|Lost to Follow-up|1
1407851|NCT01165138|4645807|P2|Overall Study|Lost to Follow-up|0
1407852|NCT01165138|4645808|P1|Overall Study|Lost to Follow-up|0
1407853|NCT01165138|4645805|P4|Overall Study|Protocol Violation|2
1407854|NCT01165138|4645806|P3|Overall Study|Protocol Violation|0
1407855|NCT01165138|4645807|P2|Overall Study|Protocol Violation|7
1407856|NCT01165138|4645808|P1|Overall Study|Protocol Violation|0
1407857|NCT01165138|4645805|P4|Overall Study|Lack of Efficacy|7
1407858|NCT01165138|4645806|P3|Overall Study|Lack of Efficacy|6
1407859|NCT01165138|4645807|P2|Overall Study|Lack of Efficacy|32
1407860|NCT01165138|4645808|P1|Overall Study|Lack of Efficacy|0
1407861|NCT01165138|4645805|P4|Overall Study|Adverse Event|2
1407862|NCT01165138|4645806|P3|Overall Study|Adverse Event|0
1407863|NCT01165138|4645807|P2|Overall Study|Adverse Event|1
1407864|NCT01165138|4645808|P1|Overall Study|Adverse Event|0
1407865|NCT01165021|4645878|P1|Overall Study|Death|1
1407866|NCT01164891|4645886|P1|Overall Study|Adverse Event|1
1407867|NCT01164891|4645886|P1|Overall Study|Disease Progression|5
1407868|NCT01164865|4645906|P2|Overall Study|Lost to Follow-up|1
1407869|NCT01164865|4645907|P1|Overall Study|Lost to Follow-up|2
1407870|NCT01164722|4645917|P2|Overall Study|enrolled on other study, concomitant med|3
1407871|NCT01164722|4645918|P1|Overall Study|enrolled on other study, concomitant med|1
1407872|NCT01164722|4645917|P2|Overall Study|met protocol criteria for non-treatment|1
1407873|NCT01164722|4645918|P1|Overall Study|met protocol criteria for non-treatment|11
1407874|NCT01164722|4645917|P2|Overall Study|Lost to Follow-up|6
1407875|NCT01164722|4645918|P1|Overall Study|Lost to Follow-up|3
1407876|NCT01164722|4645917|P2|Overall Study|Withdrawal by Subject|4
1407877|NCT01164722|4645918|P1|Overall Study|Withdrawal by Subject|3
1407878|NCT01164722|4645917|P2|Overall Study|Adverse Event|1
1407879|NCT01164722|4645918|P1|Overall Study|Adverse Event|0
1407880|NCT01164579|4645948|P3|Overall Study|Reason not specified|0
1407881|NCT01164579|4645949|P2|Overall Study|Reason not specified|0
1407882|NCT01164579|4645950|P1|Overall Study|Reason not specified|1
1407883|NCT01164579|4645948|P3|Overall Study|Adverse Event|5
1407884|NCT01164579|4645949|P2|Overall Study|Adverse Event|2
1407885|NCT01164579|4645950|P1|Overall Study|Adverse Event|4
1407886|NCT01164579|4645948|P3|Overall Study|Protocol Violation|2
1407887|NCT01164579|4645949|P2|Overall Study|Protocol Violation|1
1407888|NCT01164579|4645950|P1|Overall Study|Protocol Violation|0
1407889|NCT01164579|4645948|P3|Overall Study|Withdrawal by Subject|3
1407890|NCT01164579|4645949|P2|Overall Study|Withdrawal by Subject|5
1407891|NCT01164579|4645950|P1|Overall Study|Withdrawal by Subject|2
1407892|NCT01164579|4645948|P3|Overall Study|Lost to Follow-up|0
1407893|NCT01164579|4645949|P2|Overall Study|Lost to Follow-up|1
1407894|NCT01164579|4645950|P1|Overall Study|Lost to Follow-up|1
1407895|NCT01164579|4645948|P3|Overall Study|Lack of Efficacy|6
1407896|NCT01164579|4645949|P2|Overall Study|Lack of Efficacy|0
1407897|NCT01164579|4645950|P1|Overall Study|Lack of Efficacy|0
1407898|NCT01164501|4646030|P3|Overall Study|Other reason not defined above|4
1407899|NCT01164501|4646031|P2|Overall Study|Other reason not defined above|1
1407900|NCT01164501|4646032|P1|Overall Study|Other reason not defined above|9
1407901|NCT01164501|4646030|P3|Overall Study|Patient refusal to continue,not due toAE|8
1407902|NCT01164501|4646031|P2|Overall Study|Patient refusal to continue,not due toAE|4
1407903|NCT01164501|4646032|P1|Overall Study|Patient refusal to continue,not due toAE|10
1407904|NCT01164501|4646030|P3|Overall Study|Lost to Follow-up|3
1407905|NCT01164501|4646031|P2|Overall Study|Lost to Follow-up|0
1407906|NCT01164501|4646032|P1|Overall Study|Lost to Follow-up|3
1407907|NCT01164501|4646030|P3|Overall Study|Non compliant with protocol|4
1407908|NCT01164501|4646031|P2|Overall Study|Non compliant with protocol|1
1407909|NCT01164501|4646032|P1|Overall Study|Non compliant with protocol|1
1407910|NCT01164501|4646030|P3|Overall Study|Lack of Efficacy|1
1407911|NCT01164501|4646031|P2|Overall Study|Lack of Efficacy|0
1407912|NCT01164501|4646032|P1|Overall Study|Lack of Efficacy|0
1407913|NCT01164501|4646030|P3|Overall Study|Adverse Event|21
1407914|NCT01164501|4646031|P2|Overall Study|Adverse Event|4
1407915|NCT01164501|4646032|P1|Overall Study|Adverse Event|18
1407916|NCT01164501|4646030|P3|Overall Study|Not treated|1
1407917|NCT01164501|4646031|P2|Overall Study|Not treated|0
1407918|NCT01164501|4646032|P1|Overall Study|Not treated|2
1407919|NCT01164475|4646049|P2|Overall Study|Protocol Violation|0
1407920|NCT01164475|4646050|P1|Overall Study|Protocol Violation|1
1407921|NCT01164475|4646049|P2|Overall Study|Progressive disease|1
1407922|NCT01164475|4646050|P1|Overall Study|Progressive disease|0
1407923|NCT01164475|4646049|P2|Overall Study|Other|1
1407924|NCT01164475|4646050|P1|Overall Study|Other|0
1407925|NCT01164475|4646049|P2|Overall Study|Lack of Efficacy|0
1407926|NCT01164475|4646050|P1|Overall Study|Lack of Efficacy|1
1407927|NCT01164007|4646091|P1|Overall Study|Medical Decision|3
1407928|NCT01164007|4646091|P1|Overall Study|Withdrawal by Subject|1
1407929|NCT01164007|4646091|P1|Overall Study|Protocol Violation|1
1407930|NCT01164007|4646091|P1|Overall Study|Progression of Disease|30
1407931|NCT01164007|4646091|P1|Overall Study|Adverse Event|5
1407932|NCT01163916|4646117|P3|Overall Study|Other|16
1407933|NCT01163916|4646118|P2|Overall Study|Other|4
1407934|NCT01163916|4646119|P1|Overall Study|Other|24
1407935|NCT01163916|4646117|P3|Overall Study|Lack of Efficacy|1
1407936|NCT01163916|4646118|P2|Overall Study|Lack of Efficacy|0
1407937|NCT01163916|4646119|P1|Overall Study|Lack of Efficacy|2
1407938|NCT01163916|4646117|P3|Overall Study|Adverse Event|1
1407939|NCT01163916|4646118|P2|Overall Study|Adverse Event|0
1407940|NCT01163916|4646119|P1|Overall Study|Adverse Event|2
1407941|NCT01163916|4646117|P3|Overall Study|Withdrawal by Subject|2
1407942|NCT01163916|4646118|P2|Overall Study|Withdrawal by Subject|0
1407943|NCT01163916|4646119|P1|Overall Study|Withdrawal by Subject|2
1407944|NCT01163851|4646157|P2|Overall Study|Enrolled but not treated|0
1407945|NCT01163851|4646158|P1|Overall Study|Enrolled but not treated|1
1407946|NCT01163851|4646157|P2|Overall Study|Site Closure|1
1407947|NCT01163851|4646158|P1|Overall Study|Site Closure|0
1407948|NCT01163747|4646253|P2|Overall Study|Refused Treatment|4
1407949|NCT01163747|4646254|P1|Overall Study|Refused Treatment|6
1407950|NCT01163747|4646253|P2|Overall Study|Protocol Violation|1
1407951|NCT01163747|4646254|P1|Overall Study|Protocol Violation|0
1407952|NCT01163747|4646253|P2|Overall Study|Insufficient Therapeutic Response|1
1407953|NCT01163747|4646254|P1|Overall Study|Insufficient Therapeutic Response|0
1407954|NCT01163747|4646253|P2|Overall Study|Adverse Event|5
1407955|NCT01163747|4646254|P1|Overall Study|Adverse Event|0
1407956|NCT01163721|4646274|P2|Overall Study|Physician Decision|1
1407957|NCT01163721|4646275|P1|Overall Study|Physician Decision|0
1407958|NCT01163721|4646274|P2|Overall Study|Lost to Follow-up|1
1407959|NCT01163721|4646275|P1|Overall Study|Lost to Follow-up|0
1407960|NCT01163721|4646274|P2|Overall Study|Withdrawal by Subject|4
1407961|NCT01163721|4646275|P1|Overall Study|Withdrawal by Subject|3
1407962|NCT01163721|4646274|P2|Overall Study|Adverse Event|6
1407963|NCT01163721|4646275|P1|Overall Study|Adverse Event|5
1407964|NCT01163617|4646294|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1407965|NCT01163617|4646295|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1407966|NCT01163617|4646296|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1407967|NCT01163617|4646297|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1407968|NCT01163617|4646298|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1407969|NCT01163617|4646299|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
1407970|NCT01163617|4646300|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1407971|NCT01163617|4646301|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1407972|NCT01163617|4646294|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1407973|NCT01163617|4646295|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1407974|NCT01163617|4646296|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1407975|NCT01163617|4646297|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1407976|NCT01163617|4646298|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1407977|NCT01163617|4646299|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1407978|NCT01163617|4646300|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
1407979|NCT01163617|4646301|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1407980|NCT01163617|4646294|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1407981|NCT01163617|4646295|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1407982|NCT01163617|4646296|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1407983|NCT01163617|4646297|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1407984|NCT01163617|4646298|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1407985|NCT01163617|4646299|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1407986|NCT01163617|4646300|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
1407987|NCT01163617|4646301|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1407988|NCT01163474|4646330|P1|Overall Study|Lost to Follow-up|3
1407989|NCT01163474|4646330|P1|Overall Study|Tech barriers to videoteleconference vis|12
1407990|NCT01163474|4646330|P1|Overall Study|Withdrawal by Subject|1
1407991|NCT01163318|4646341|P1|Overall Study|Multiple Reasons Per Participant|224
1407992|NCT01163318|4646341|P1|Overall Study|Participants Without Case Report Form|7
1407993|NCT01163318|4646341|P1|Overall Study|History/comorbidity of malignant tumor|3
1407994|NCT01163318|4646341|P1|Overall Study|Did Not Continue Use of Adalimumab|26
1407995|NCT01163318|4646341|P1|Overall Study|Off-Label Use of Adalimumab|8
1407996|NCT01163292|4646350|P2|Overall Study|No further visits|7
1407997|NCT01163292|4646351|P1|Overall Study|No further visits|5
1407998|NCT01163292|4646350|P2|Overall Study|Economic reasons|0
1407999|NCT01163292|4646351|P1|Overall Study|Economic reasons|6
1408000|NCT01163292|4646350|P2|Overall Study|Refusal to receive adalimumab|0
1408001|NCT01163292|4646351|P1|Overall Study|Refusal to receive adalimumab|7
1408002|NCT01163292|4646350|P2|Overall Study|Sufficient response to adalimumab|0
1408003|NCT01163292|4646351|P1|Overall Study|Sufficient response to adalimumab|8
1408004|NCT01163292|4646350|P2|Overall Study|Initiation of biological therapy|15
1408005|NCT01163292|4646351|P1|Overall Study|Initiation of biological therapy|0
1408006|NCT01163292|4646350|P2|Overall Study|Adverse Event|0
1408007|NCT01163292|4646351|P1|Overall Study|Adverse Event|6
1408008|NCT01163292|4646350|P2|Overall Study|Lack of Efficacy|0
1408009|NCT01163292|4646351|P1|Overall Study|Lack of Efficacy|9
1408010|NCT01163279|4646367|P2|Overall Study|Withdrawal by Subject|0
1408011|NCT01163279|4646368|P1|Overall Study|Withdrawal by Subject|2
1408012|NCT01163266|4646397|P3|Overall Study|Other|2
1408013|NCT01163266|4646398|P2|Overall Study|Other|1
1408014|NCT01163266|4646399|P1|Overall Study|Other|1
1408015|NCT01163266|4646397|P3|Overall Study|Lost to Follow-up|10
1408016|NCT01163266|4646398|P2|Overall Study|Lost to Follow-up|7
1408017|NCT01163266|4646399|P1|Overall Study|Lost to Follow-up|7
1408018|NCT01163266|4646397|P3|Overall Study|Withdrawal of Consent|3
1408019|NCT01163266|4646398|P2|Overall Study|Withdrawal of Consent|7
1408020|NCT01163266|4646399|P1|Overall Study|Withdrawal of Consent|5
1408021|NCT01163266|4646397|P3|Overall Study|Protocol Deviations|5
1408022|NCT01163266|4646398|P2|Overall Study|Protocol Deviations|2
1408023|NCT01163266|4646399|P1|Overall Study|Protocol Deviations|2
1408024|NCT01163266|4646397|P3|Overall Study|Noncompliance with Study Drug|0
1408025|NCT01163266|4646398|P2|Overall Study|Noncompliance with Study Drug|2
1408026|NCT01163266|4646399|P1|Overall Study|Noncompliance with Study Drug|0
1408027|NCT01163266|4646397|P3|Overall Study|Lack of Efficacy|1
1408028|NCT01163266|4646398|P2|Overall Study|Lack of Efficacy|3
1408029|NCT01163266|4646399|P1|Overall Study|Lack of Efficacy|1
1408030|NCT01163266|4646397|P3|Overall Study|Pretreatment Event or Adverse Event|7
1408031|NCT01163266|4646398|P2|Overall Study|Pretreatment Event or Adverse Event|9
1408032|NCT01163266|4646399|P1|Overall Study|Pretreatment Event or Adverse Event|2
1408033|NCT01163253|4646424|P2|Overall Study|Other Unspecified|34
1408034|NCT01163253|4646425|P1|Overall Study|Other Unspecified|170
1408035|NCT01163253|4646424|P2|Overall Study|Ongoing|4
1408036|NCT01163253|4646425|P1|Overall Study|Ongoing|13
1408037|NCT01163253|4646424|P2|Overall Study|Death|5
1408038|NCT01163253|4646425|P1|Overall Study|Death|17
1408039|NCT01163253|4646424|P2|Overall Study|Adverse Event|78
1408040|NCT01163253|4646425|P1|Overall Study|Adverse Event|300
1408041|NCT01163253|4646424|P2|Overall Study|Insufficient Clinical Response|29
1408042|NCT01163253|4646425|P1|Overall Study|Insufficient Clinical Response|423
1408043|NCT01163253|4646424|P2|Overall Study|Lost to Follow-up|23
1408044|NCT01163253|4646425|P1|Overall Study|Lost to Follow-up|125
1408045|NCT01163253|4646424|P2|Overall Study|Medication Error|0
1408046|NCT01163253|4646425|P1|Overall Study|Medication Error|1
1408047|NCT01163253|4646424|P2|Overall Study|Withdrawal by Subject|50
1408048|NCT01163253|4646425|P1|Overall Study|Withdrawal by Subject|199
1408049|NCT01163253|4646424|P2|Overall Study|Protocol Violation|12
1408050|NCT01163253|4646425|P1|Overall Study|Protocol Violation|43
1408051|NCT01163253|4646424|P2|Overall Study|Study Terminated by Sponsor|349
1408052|NCT01163253|4646425|P1|Overall Study|Study Terminated by Sponsor|978
1408053|NCT01163253|4646424|P2|Overall Study|Withdrawn Due to Pregnancy|2
1408054|NCT01163253|4646425|P1|Overall Study|Withdrawn Due to Pregnancy|12
1408055|NCT01163149|4646613|P3|Extension Treatment Period|Noncompliance|1
1408056|NCT01163149|4646614|P2|Extension Treatment Period|Noncompliance|0
1408057|NCT01163149|4646615|P1|Extension Treatment Period|Noncompliance|0
1408058|NCT01163149|4646613|P3|Extension Treatment Period|Adverse Event|0
1408059|NCT01163149|4646614|P2|Extension Treatment Period|Adverse Event|1
1408060|NCT01163149|4646615|P1|Extension Treatment Period|Adverse Event|0
1408061|NCT01163149|4646613|P3|Extension Treatment Period|Withdrawal by Subject|1
1408062|NCT01163149|4646614|P2|Extension Treatment Period|Withdrawal by Subject|0
1408063|NCT01163149|4646615|P1|Extension Treatment Period|Withdrawal by Subject|2
1408064|NCT01163032|4646715|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
1408065|NCT01163032|4646716|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
1408066|NCT01163032|4646717|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
1408067|NCT01163032|4646715|P3|Open Label Extension Phase|Study Termination|7
1408068|NCT01163032|4646716|P2|Open Label Extension Phase|Study Termination|0
1408069|NCT01163032|4646717|P1|Open Label Extension Phase|Study Termination|0
1408070|NCT01163032|4646715|P3|Open Label Extension Phase|Protocol Violation|1
1408071|NCT01163032|4646716|P2|Open Label Extension Phase|Protocol Violation|0
1408072|NCT01163032|4646717|P1|Open Label Extension Phase|Protocol Violation|0
1408073|NCT01163032|4646715|P3|Open Label Extension Phase|Withdrawal by Subject|3
1408074|NCT01163032|4646716|P2|Open Label Extension Phase|Withdrawal by Subject|0
1408075|NCT01163032|4646717|P1|Open Label Extension Phase|Withdrawal by Subject|0
1408076|NCT01163032|4646715|P3|Open Label Extension Phase|Adverse Event|3
1408077|NCT01163032|4646716|P2|Open Label Extension Phase|Adverse Event|0
1408078|NCT01163032|4646717|P1|Open Label Extension Phase|Adverse Event|0
1408079|NCT01163032|4646715|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
1408080|NCT01163032|4646716|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
1408081|NCT01163032|4646717|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
1408082|NCT01163032|4646715|P3|Randomization Phase|Various*|0
1408083|NCT01163032|4646716|P2|Randomization Phase|Various*|4
1408084|NCT01163032|4646717|P1|Randomization Phase|Various*|5
1408085|NCT01163032|4646715|P3|Randomization Phase|Protocol Violation|0
1408086|NCT01163032|4646716|P2|Randomization Phase|Protocol Violation|1
1408087|NCT01163032|4646717|P1|Randomization Phase|Protocol Violation|0
1408088|NCT01163032|4646715|P3|Randomization Phase|Adverse Event|0
1408089|NCT01163032|4646716|P2|Randomization Phase|Adverse Event|3
1408090|NCT01163032|4646717|P1|Randomization Phase|Adverse Event|3
1408091|NCT01163032|4646715|P3|Randomization Phase|Withdrawal by Subject|0
1408092|NCT01163032|4646716|P2|Randomization Phase|Withdrawal by Subject|3
1408093|NCT01163032|4646717|P1|Randomization Phase|Withdrawal by Subject|2
1408094|NCT01162863|4646750|P3|Overall Study|Adverse Event|0
1408095|NCT01162863|4646751|P2|Overall Study|Adverse Event|1
1408096|NCT01162863|4646752|P1|Overall Study|Adverse Event|0
1408097|NCT01162863|4646750|P3|Overall Study|Lack of Efficacy|0
1408098|NCT01162863|4646751|P2|Overall Study|Lack of Efficacy|0
1408099|NCT01162863|4646752|P1|Overall Study|Lack of Efficacy|1
1408100|NCT01162499|4646777|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
1408101|NCT01162499|4646778|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
1408102|NCT01162473|4646800|P2|Overall Study|Withdrawal by Subject|4
1408103|NCT01162473|4646801|P1|Overall Study|Withdrawal by Subject|0
1408104|NCT01162473|4646800|P2|Overall Study|Adverse Event|1
1408105|NCT01162473|4646801|P1|Overall Study|Adverse Event|2
1408106|NCT01162421|4646809|P2|Overall Study|Not specified|3
1408107|NCT01162421|4646810|P1|Overall Study|Not specified|2
1408108|NCT01162421|4646809|P2|Overall Study|Lack of Efficacy|2
1408109|NCT01162421|4646810|P1|Overall Study|Lack of Efficacy|2
1408110|NCT01162421|4646809|P2|Overall Study|Lost to Follow-up|2
1408111|NCT01162421|4646810|P1|Overall Study|Lost to Follow-up|0
1408112|NCT01162421|4646809|P2|Overall Study|Adverse Event|5
1408113|NCT01162421|4646810|P1|Overall Study|Adverse Event|2
1408114|NCT01162421|4646809|P2|Overall Study|Did not receive study drug|1
1408115|NCT01162421|4646810|P1|Overall Study|Did not receive study drug|2
1408116|NCT01162343|4646888|P1|Overall Study|Refused psychiatrist assessment|12
1408117|NCT01162343|4646888|P1|Overall Study|Left ED prior to psychiatrist assessment|80
1408118|NCT01162304|4646903|P1|Overall Study|Beck scale to high|11
1408119|NCT01162135|4646917|P1|Overall Study|Ineligible|1
1408120|NCT01162135|4646917|P1|Overall Study|Severe back pain|1
1408121|NCT01162135|4646917|P1|Overall Study|Withdrawal by Subject|1
1408122|NCT01162122|4646923|P2|Overall Study|Missing primary reason|0
1408123|NCT01162122|4646924|P1|Overall Study|Missing primary reason|1
1408124|NCT01162122|4646923|P2|Overall Study|Unable to classify|7
1408125|NCT01162122|4646924|P1|Overall Study|Unable to classify|3
1408126|NCT01162122|4646923|P2|Overall Study|Administrative reason|1
1408127|NCT01162122|4646924|P1|Overall Study|Administrative reason|1
1408128|NCT01162122|4646923|P2|Overall Study|Inappropriate enrollment|4
1408129|NCT01162122|4646924|P1|Overall Study|Inappropriate enrollment|5
1408130|NCT01162122|4646923|P2|Overall Study|Protocol Violation|2
1408131|NCT01162122|4646924|P1|Overall Study|Protocol Violation|2
1408132|NCT01162122|4646923|P2|Overall Study|Death|46
1408133|NCT01162122|4646924|P1|Overall Study|Death|51
1408134|NCT01162122|4646923|P2|Overall Study|Adverse Event|2
1408135|NCT01162122|4646924|P1|Overall Study|Adverse Event|3
1408136|NCT01162122|4646923|P2|Overall Study|Lost to Follow-up|91
1408137|NCT01162122|4646924|P1|Overall Study|Lost to Follow-up|73
1408138|NCT01162122|4646923|P2|Overall Study|Withdrawal by Subject|43
1408139|NCT01162122|4646924|P1|Overall Study|Withdrawal by Subject|52
1408140|NCT01161628|4647019|P1|Overall Study|Lack of Efficacy|2
1408141|NCT01161628|4647019|P1|Overall Study|Death|6
1408142|NCT01161537|4647042|P1|Part B|Withdrawal by Subject|2
1408143|NCT01161498|4647060|P2|Overall Study|Disease Progression|1
1408144|NCT01161498|4647061|P1|Overall Study|Disease Progression|0
1408145|NCT01161472|4647085|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
1408146|NCT01161472|4647086|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
1408147|NCT01161472|4647087|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
1408148|NCT01161472|4647088|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
1408149|NCT01161446|4647144|P2|Overall Study|Withdrawal by Subject|1
1408150|NCT01161446|4647145|P1|Overall Study|Withdrawal by Subject|0
1408151|NCT01161446|4647144|P2|Overall Study|Lost to Follow-up|14
1408152|NCT01161446|4647145|P1|Overall Study|Lost to Follow-up|18
1408153|NCT01161407|4647171|P2|Overall Study|Protocol Violation|1
1408154|NCT01161407|4647172|P1|Overall Study|Protocol Violation|3
1408155|NCT01161173|4647227|P1|Overall Study|Reasons Not Specified|23
1408156|NCT01161173|4647227|P1|Overall Study|End of Study|2
1408157|NCT01161173|4647227|P1|Overall Study|Death|194
1408158|NCT01161173|4647227|P1|Overall Study|Unacceptable Toxicity|21
1408159|NCT01161173|4647227|P1|Overall Study|Withdrawal of Consent|5
1408160|NCT01161173|4647227|P1|Overall Study|Progressive Disease|82
1408161|NCT01161173|4647227|P1|Overall Study|Lost to Follow-up|7
1408162|NCT01161173|4647227|P1|Overall Study|Protocol Violation|13
1408163|NCT01160822|4647354|P7|Overall Study|Protocol deviation|0
1408164|NCT01160822|4647355|P6|Overall Study|Protocol deviation|0
1408165|NCT01160822|4647356|P5|Overall Study|Protocol deviation|2
1408166|NCT01160822|4647357|P4|Overall Study|Protocol deviation|0
1408167|NCT01160822|4647358|P3|Overall Study|Protocol deviation|0
1408168|NCT01160822|4647359|P2|Overall Study|Protocol deviation|0
1408169|NCT01160822|4647360|P1|Overall Study|Protocol deviation|0
1408170|NCT01160822|4647354|P7|Overall Study|Administrative problems|0
1408171|NCT01160822|4647355|P6|Overall Study|Administrative problems|0
1408172|NCT01160822|4647356|P5|Overall Study|Administrative problems|1
1408173|NCT01160822|4647357|P4|Overall Study|Administrative problems|0
1408174|NCT01160822|4647358|P3|Overall Study|Administrative problems|0
1408175|NCT01160822|4647359|P2|Overall Study|Administrative problems|0
1408176|NCT01160822|4647360|P1|Overall Study|Administrative problems|0
1408177|NCT01160822|4647354|P7|Overall Study|Lost to Follow-up|0
1408178|NCT01160822|4647355|P6|Overall Study|Lost to Follow-up|0
1408179|NCT01160822|4647356|P5|Overall Study|Lost to Follow-up|1
1408180|NCT01160822|4647357|P4|Overall Study|Lost to Follow-up|0
1408181|NCT01160822|4647358|P3|Overall Study|Lost to Follow-up|0
1408182|NCT01160822|4647359|P2|Overall Study|Lost to Follow-up|0
1408183|NCT01160822|4647360|P1|Overall Study|Lost to Follow-up|0
1408184|NCT01160822|4647354|P7|Overall Study|Withdrawal by Subject|1
1408185|NCT01160822|4647355|P6|Overall Study|Withdrawal by Subject|0
1408186|NCT01160822|4647356|P5|Overall Study|Withdrawal by Subject|0
1408187|NCT01160822|4647357|P4|Overall Study|Withdrawal by Subject|0
1408188|NCT01160822|4647358|P3|Overall Study|Withdrawal by Subject|0
1408189|NCT01160822|4647359|P2|Overall Study|Withdrawal by Subject|0
1408190|NCT01160822|4647360|P1|Overall Study|Withdrawal by Subject|0
1408191|NCT01160822|4647354|P7|Overall Study|Unsatisfactory therapeutic effect|3
1408192|NCT01160822|4647355|P6|Overall Study|Unsatisfactory therapeutic effect|5
1408193|NCT01160822|4647356|P5|Overall Study|Unsatisfactory therapeutic effect|4
1408194|NCT01160822|4647357|P4|Overall Study|Unsatisfactory therapeutic effect|0
1408195|NCT01160822|4647358|P3|Overall Study|Unsatisfactory therapeutic effect|0
1408196|NCT01160822|4647359|P2|Overall Study|Unsatisfactory therapeutic effect|0
1408197|NCT01160822|4647360|P1|Overall Study|Unsatisfactory therapeutic effect|0
1408198|NCT01160822|4647354|P7|Overall Study|Adverse Event|5
1408199|NCT01160822|4647355|P6|Overall Study|Adverse Event|2
1408200|NCT01160822|4647356|P5|Overall Study|Adverse Event|1
1408201|NCT01160822|4647357|P4|Overall Study|Adverse Event|0
1408202|NCT01160822|4647358|P3|Overall Study|Adverse Event|0
1408203|NCT01160822|4647359|P2|Overall Study|Adverse Event|0
1408204|NCT01160822|4647360|P1|Overall Study|Adverse Event|0
1408205|NCT01160770|4647449|P1|Overall Study|Other Reasons|1
1408206|NCT01160770|4647449|P1|Overall Study|Lack of Efficacy|15
1408207|NCT01160770|4647449|P1|Overall Study|Death|9
1408208|NCT01160770|4647449|P1|Overall Study|Study termination or sponsor request|1
1408209|NCT01160770|4647449|P1|Overall Study|Lost to Follow-up|7
1408210|NCT01160770|4647449|P1|Overall Study|Physician Decision|1
1408211|NCT01160770|4647449|P1|Overall Study|Subject/parent/caregiver request|33
1408212|NCT01160770|4647449|P1|Overall Study|Protocol Violation|2
1408213|NCT01160770|4647449|P1|Overall Study|Adverse Event|10
1408214|NCT01160744|4647462|P4|Overall Study|Alive and Still on Treatment|14
1408215|NCT01160744|4647463|P3|Overall Study|Alive and Still on Treatment|8
1408216|NCT01160744|4647464|P2|Overall Study|Alive and Still on Treatment|11
1408217|NCT01160744|4647465|P1|Overall Study|Alive and Still on Treatment|9
1408218|NCT01160744|4647462|P4|Overall Study|Not Specified|4
1408219|NCT01160744|4647463|P3|Overall Study|Not Specified|5
1408220|NCT01160744|4647464|P2|Overall Study|Not Specified|9
1408221|NCT01160744|4647465|P1|Overall Study|Not Specified|5
1408222|NCT01160744|4647462|P4|Overall Study|Not meet inclusion/exclusion criteria|0
1408223|NCT01160744|4647463|P3|Overall Study|Not meet inclusion/exclusion criteria|1
1408224|NCT01160744|4647464|P2|Overall Study|Not meet inclusion/exclusion criteria|0
1408225|NCT01160744|4647465|P1|Overall Study|Not meet inclusion/exclusion criteria|0
1408226|NCT01160744|4647462|P4|Overall Study|Withdrawal by Subject|4
1408227|NCT01160744|4647463|P3|Overall Study|Withdrawal by Subject|6
1408228|NCT01160744|4647464|P2|Overall Study|Withdrawal by Subject|5
1408229|NCT01160744|4647465|P1|Overall Study|Withdrawal by Subject|6
1408230|NCT01160640|4647501|P2|Overall Study|Withdrawal by Subject|3
1408231|NCT01160640|4647502|P1|Overall Study|Withdrawal by Subject|0
1408232|NCT01160640|4647501|P2|Overall Study|Incarceration|0
1408233|NCT01160640|4647502|P1|Overall Study|Incarceration|1
1408234|NCT01160640|4647501|P2|Overall Study|Physician Decision|3
1408235|NCT01160640|4647502|P1|Overall Study|Physician Decision|3
1408236|NCT01160614|4647518|P2|Overall Study|Withdrawal by Subject|2
1408237|NCT01160614|4647519|P1|Overall Study|Withdrawal by Subject|0
1408238|NCT01160484|4647567|P1|Overall Study|inclusion/exclusion criteria failure|1
1408239|NCT01160484|4647567|P1|Overall Study|Withdrawal by Subject|2
1408240|NCT01160484|4647567|P1|Overall Study|Adverse Event|6
1408241|NCT01160484|4647567|P1|Overall Study|Lack of Efficacy|9
1408242|NCT01160198|4647648|P3|Overall Study|Participant lost drug; withdrew consent|1
1408243|NCT01160198|4647649|P2|Overall Study|Participant lost drug; withdrew consent|0
1408244|NCT01160198|4647650|P1|Overall Study|Participant lost drug; withdrew consent|0
1408245|NCT01160198|4647648|P3|Overall Study|Lost to Follow-up|0
1408246|NCT01160198|4647649|P2|Overall Study|Lost to Follow-up|1
1408247|NCT01160198|4647650|P1|Overall Study|Lost to Follow-up|0
1408248|NCT01160198|4647648|P3|Overall Study|Adverse Event|0
1408249|NCT01160198|4647649|P2|Overall Study|Adverse Event|1
1408250|NCT01160198|4647650|P1|Overall Study|Adverse Event|0
1408251|NCT01160198|4647648|P3|Overall Study|Withdrawal by Subject|0
1408252|NCT01160198|4647649|P2|Overall Study|Withdrawal by Subject|1
1408253|NCT01160198|4647650|P1|Overall Study|Withdrawal by Subject|2
1408254|NCT01159938|4647672|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
1408255|NCT01159938|4647673|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
1408256|NCT01159938|4647674|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
1408257|NCT01159938|4647675|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
1408258|NCT01159938|4647676|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
1408259|NCT01159912|4647739|P3|Overall Study|Withdrawal by Subject|3
1408260|NCT01159912|4647740|P2|Overall Study|Withdrawal by Subject|3
1408261|NCT01159912|4647741|P1|Overall Study|Withdrawal by Subject|10
1408262|NCT01159912|4647739|P3|Overall Study|Physician Decision|3
1408263|NCT01159912|4647740|P2|Overall Study|Physician Decision|0
1408264|NCT01159912|4647741|P1|Overall Study|Physician Decision|0
1408265|NCT01159912|4647739|P3|Overall Study|Lost to Follow-up|0
1408266|NCT01159912|4647740|P2|Overall Study|Lost to Follow-up|0
1408267|NCT01159912|4647741|P1|Overall Study|Lost to Follow-up|4
1408268|NCT01159912|4647739|P3|Overall Study|Protocol Violation|3
1408269|NCT01159912|4647740|P2|Overall Study|Protocol Violation|2
1408270|NCT01159912|4647741|P1|Overall Study|Protocol Violation|1
1408271|NCT01159912|4647739|P3|Overall Study|Lack of Efficacy|14
1408272|NCT01159912|4647740|P2|Overall Study|Lack of Efficacy|15
1408273|NCT01159912|4647741|P1|Overall Study|Lack of Efficacy|23
1408274|NCT01159912|4647739|P3|Overall Study|Adverse Event|3
1408275|NCT01159912|4647740|P2|Overall Study|Adverse Event|2
1408276|NCT01159912|4647741|P1|Overall Study|Adverse Event|2
1408277|NCT01159769|4647764|P1|Overall Study|Adverse Event|1
1408278|NCT01159691|4647784|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
1408279|NCT01159691|4647784|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
1408280|NCT01159691|4647784|P1|Overall Study|Disc. Neupro other & unknown reasons|7
1408281|NCT01159691|4647784|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
1408282|NCT01159691|4647784|P1|Overall Study|Discontinued Neupro due to other reasons|1
1408283|NCT01159691|4647784|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
1408284|NCT01159691|4647784|P1|Overall Study|Unknown reasons|1
1408285|NCT01159691|4647784|P1|Overall Study|Lost to Follow-up|2
1408286|NCT01159665|4647797|P6|Overall Study|Withdrawal by Subject|0
1408287|NCT01159665|4647798|P5|Overall Study|Withdrawal by Subject|0
1408288|NCT01159665|4647799|P4|Overall Study|Withdrawal by Subject|0
1408289|NCT01159665|4647800|P3|Overall Study|Withdrawal by Subject|0
1408290|NCT01159665|4647801|P2|Overall Study|Withdrawal by Subject|1
1408291|NCT01159665|4647802|P1|Overall Study|Withdrawal by Subject|0
1408292|NCT01159600|4647830|P8|Overall Study|Other reason not defined above|3
1408293|NCT01159600|4647831|P7|Overall Study|Other reason not defined above|3
1408294|NCT01159600|4647832|P6|Overall Study|Other reason not defined above|7
1408295|NCT01159600|4647833|P5|Overall Study|Other reason not defined above|5
1408296|NCT01159600|4647834|P4|Overall Study|Other reason not defined above|2
1408297|NCT01159600|4647835|P3|Overall Study|Other reason not defined above|4
1408298|NCT01159600|4647836|P2|Overall Study|Other reason not defined above|0
1408299|NCT01159600|4647837|P1|Overall Study|Other reason not defined above|3
1408300|NCT01159600|4647830|P8|Overall Study|Patient refusal to continue,not due toAE|5
1408301|NCT01159600|4647831|P7|Overall Study|Patient refusal to continue,not due toAE|2
1408302|NCT01159600|4647832|P6|Overall Study|Patient refusal to continue,not due toAE|4
1408303|NCT01159600|4647833|P5|Overall Study|Patient refusal to continue,not due toAE|4
1408304|NCT01159600|4647834|P4|Overall Study|Patient refusal to continue,not due toAE|5
1408305|NCT01159600|4647835|P3|Overall Study|Patient refusal to continue,not due toAE|4
1408306|NCT01159600|4647836|P2|Overall Study|Patient refusal to continue,not due toAE|2
1408307|NCT01159600|4647837|P1|Overall Study|Patient refusal to continue,not due toAE|7
1408308|NCT01159600|4647830|P8|Overall Study|Lost to Follow-up|2
1408309|NCT01159600|4647831|P7|Overall Study|Lost to Follow-up|3
1408310|NCT01159600|4647832|P6|Overall Study|Lost to Follow-up|0
1408311|NCT01159600|4647833|P5|Overall Study|Lost to Follow-up|3
1408312|NCT01159600|4647834|P4|Overall Study|Lost to Follow-up|3
1408313|NCT01159600|4647835|P3|Overall Study|Lost to Follow-up|4
1408314|NCT01159600|4647836|P2|Overall Study|Lost to Follow-up|3
1408315|NCT01159600|4647837|P1|Overall Study|Lost to Follow-up|2
1408316|NCT01159600|4647830|P8|Overall Study|Non compliant with protocol|0
1408317|NCT01159600|4647831|P7|Overall Study|Non compliant with protocol|2
1408318|NCT01159600|4647832|P6|Overall Study|Non compliant with protocol|0
1408319|NCT01159600|4647833|P5|Overall Study|Non compliant with protocol|2
1408320|NCT01159600|4647834|P4|Overall Study|Non compliant with protocol|0
1408321|NCT01159600|4647835|P3|Overall Study|Non compliant with protocol|0
1408322|NCT01159600|4647836|P2|Overall Study|Non compliant with protocol|1
1408323|NCT01159600|4647837|P1|Overall Study|Non compliant with protocol|2
1408324|NCT01159600|4647830|P8|Overall Study|Lack of Efficacy|1
1408325|NCT01159600|4647831|P7|Overall Study|Lack of Efficacy|0
1408326|NCT01159600|4647832|P6|Overall Study|Lack of Efficacy|0
1408327|NCT01159600|4647833|P5|Overall Study|Lack of Efficacy|2
1408328|NCT01159600|4647834|P4|Overall Study|Lack of Efficacy|0
1408329|NCT01159600|4647835|P3|Overall Study|Lack of Efficacy|0
1408330|NCT01159600|4647836|P2|Overall Study|Lack of Efficacy|0
1408331|NCT01159600|4647837|P1|Overall Study|Lack of Efficacy|0
1408332|NCT01159600|4647830|P8|Overall Study|Adverse Event|5
1408333|NCT01159600|4647831|P7|Overall Study|Adverse Event|7
1408334|NCT01159600|4647832|P6|Overall Study|Adverse Event|6
1408335|NCT01159600|4647833|P5|Overall Study|Adverse Event|8
1408336|NCT01159600|4647834|P4|Overall Study|Adverse Event|1
1408337|NCT01159600|4647835|P3|Overall Study|Adverse Event|5
1408338|NCT01159600|4647836|P2|Overall Study|Adverse Event|2
1408339|NCT01159600|4647837|P1|Overall Study|Adverse Event|7
1408340|NCT01159600|4647830|P8|Overall Study|Not treated|2
1408341|NCT01159600|4647831|P7|Overall Study|Not treated|2
1408342|NCT01159600|4647832|P6|Overall Study|Not treated|1
1408343|NCT01159600|4647833|P5|Overall Study|Not treated|0
1408344|NCT01159600|4647834|P4|Overall Study|Not treated|0
1408345|NCT01159600|4647835|P3|Overall Study|Not treated|1
1408346|NCT01159600|4647836|P2|Overall Study|Not treated|0
1408347|NCT01159600|4647837|P1|Overall Study|Not treated|0
1408348|NCT01159574|4647879|P1|Follow Up Phase|still being followed for overall surviva|18
1408349|NCT01159574|4647879|P1|Follow Up Phase|Lost to Follow-up|2
1408350|NCT01159574|4647879|P1|Treatment Phase|still on treatment|2
1408351|NCT01159574|4647879|P1|Treatment Phase|Withdrawal by Subject|7
1408352|NCT01159574|4647879|P1|Treatment Phase|Physician Decision|2
1408353|NCT01159574|4647879|P1|Treatment Phase|Death|6
1408354|NCT01159574|4647879|P1|Treatment Phase|Adverse Event|3
1408355|NCT01159574|4647879|P1|Treatment Phase|non-evaluable/not included in analysis|1
1408356|NCT01159431|4647900|P2|Overall Study|Lack of Efficacy|3
1408357|NCT01159431|4647901|P1|Overall Study|Lack of Efficacy|0
1408358|NCT01159431|4647900|P2|Overall Study|non-compliance|1
1408359|NCT01159431|4647901|P1|Overall Study|non-compliance|1
1408360|NCT01159431|4647900|P2|Overall Study|Adverse Event|2
1408361|NCT01159431|4647901|P1|Overall Study|Adverse Event|1
1408362|NCT01159171|4647954|P1|Overall Study|Death|1
1408363|NCT01159171|4647954|P1|Overall Study|Medical Decision|4
1408364|NCT01159171|4647954|P1|Overall Study|Need for Surgery|5
1408365|NCT01159171|4647954|P1|Overall Study|Protocol Violation|1
1408366|NCT01159171|4647954|P1|Overall Study|Progression of Disease|28
1408367|NCT01159171|4647954|P1|Overall Study|Adverse Event|11
1408368|NCT01158924|4648028|P2|Overall Study|Lost to Follow-up|1
1408369|NCT01158924|4648029|P1|Overall Study|Lost to Follow-up|0
1408370|NCT01158924|4648028|P2|Overall Study|Withdrawal by Subject|2
1408371|NCT01158924|4648029|P1|Overall Study|Withdrawal by Subject|1
1408372|NCT01158534|4648100|P1|Overall Study|Other|1
1408373|NCT01158534|4648100|P1|Overall Study|Death|1
1408374|NCT01158534|4648100|P1|Overall Study|Withdrawal by Subject|1
1408375|NCT01158378|4648110|P2|Overall Study|Withdrawal by Subject|0
1408376|NCT01158378|4648111|P1|Overall Study|Withdrawal by Subject|4
1408377|NCT01158378|4648110|P2|Overall Study|Lost to Follow-up|4
1408378|NCT01158378|4648111|P1|Overall Study|Lost to Follow-up|2
1408379|NCT01158378|4648110|P2|Overall Study|Death|5
1408380|NCT01158378|4648111|P1|Overall Study|Death|4
1408381|NCT01158261|4648123|P1|Overall Study|Withdrawal by Subject|1
1408382|NCT01158261|4648123|P1|Overall Study|Death|7
1408383|NCT01158261|4648123|P1|Overall Study|Lost to Follow-up|9
1408384|NCT01158222|4648127|P1|Overall Study|Not eligible for intermediate phase|17
1408385|NCT01158118|4648135|P2|Overall Study|Death|1
1408386|NCT01158118|4648136|P1|Overall Study|Death|0
1408387|NCT01158118|4648135|P2|Overall Study|Suffered stroke prior to transplant|1
1408388|NCT01158118|4648136|P1|Overall Study|Suffered stroke prior to transplant|0
1408389|NCT01158118|4648135|P2|Overall Study|Donor match was a screen failure|1
1408390|NCT01158118|4648136|P1|Overall Study|Donor match was a screen failure|0
1408391|NCT01158118|4648135|P2|Overall Study|Screen failure|0
1408392|NCT01158118|4648136|P1|Overall Study|Screen failure|1
1408393|NCT01157845|4648152|P1|Overall Study|Device malfunction|1
1408394|NCT01157845|4648152|P1|Overall Study|Study was ended|1
1408395|NCT01157845|4648152|P1|Overall Study|Protocol Violation|13
1408396|NCT01157845|4648152|P1|Overall Study|Physician Decision|3
1408397|NCT01157845|4648152|P1|Overall Study|Withdrawal by Subject|12
1408398|NCT01157845|4648152|P1|Overall Study|Lost to Follow-up|5
1408399|NCT01157377|4648186|P7|Overall Study|Other Miscellaneous Reasons|1
1408400|NCT01157377|4648187|P6|Overall Study|Other Miscellaneous Reasons|1
1408401|NCT01157377|4648188|P5|Overall Study|Other Miscellaneous Reasons|1
1408402|NCT01157377|4648189|P4|Overall Study|Other Miscellaneous Reasons|0
1408403|NCT01157377|4648190|P3|Overall Study|Other Miscellaneous Reasons|0
1408404|NCT01157377|4648191|P2|Overall Study|Other Miscellaneous Reasons|2
1408405|NCT01157377|4648192|P1|Overall Study|Other Miscellaneous Reasons|0
1408406|NCT01157377|4648186|P7|Overall Study|Lack of Efficacy|1
1408407|NCT01157377|4648187|P6|Overall Study|Lack of Efficacy|0
1408408|NCT01157377|4648188|P5|Overall Study|Lack of Efficacy|0
1408409|NCT01157377|4648189|P4|Overall Study|Lack of Efficacy|0
1408410|NCT01157377|4648190|P3|Overall Study|Lack of Efficacy|0
1408411|NCT01157377|4648191|P2|Overall Study|Lack of Efficacy|0
1408412|NCT01157377|4648192|P1|Overall Study|Lack of Efficacy|0
1408413|NCT01157377|4648186|P7|Overall Study|Protocol Violation|0
1408414|NCT01157377|4648187|P6|Overall Study|Protocol Violation|1
1408415|NCT01157377|4648188|P5|Overall Study|Protocol Violation|0
1408416|NCT01157377|4648189|P4|Overall Study|Protocol Violation|0
1408417|NCT01157377|4648190|P3|Overall Study|Protocol Violation|0
1408418|NCT01157377|4648191|P2|Overall Study|Protocol Violation|0
1408419|NCT01157377|4648192|P1|Overall Study|Protocol Violation|0
1408420|NCT01157377|4648186|P7|Overall Study|Personal Reasons|0
1408421|NCT01157377|4648187|P6|Overall Study|Personal Reasons|0
1408422|NCT01157377|4648188|P5|Overall Study|Personal Reasons|0
1408423|NCT01157377|4648189|P4|Overall Study|Personal Reasons|1
1408424|NCT01157377|4648190|P3|Overall Study|Personal Reasons|0
1408425|NCT01157377|4648191|P2|Overall Study|Personal Reasons|1
1408426|NCT01157377|4648192|P1|Overall Study|Personal Reasons|2
1408427|NCT01157377|4648186|P7|Overall Study|Lost to Follow-up|0
1408428|NCT01157377|4648187|P6|Overall Study|Lost to Follow-up|1
1408429|NCT01157377|4648188|P5|Overall Study|Lost to Follow-up|1
1408430|NCT01157377|4648189|P4|Overall Study|Lost to Follow-up|0
1408431|NCT01157377|4648190|P3|Overall Study|Lost to Follow-up|1
1408432|NCT01157377|4648191|P2|Overall Study|Lost to Follow-up|0
1408433|NCT01157377|4648192|P1|Overall Study|Lost to Follow-up|0
1408434|NCT01157351|4648210|P2|Overall Study|Randomized but not Treated|2
1408435|NCT01157351|4648211|P1|Overall Study|Randomized but not Treated|4
1408436|NCT01157351|4648210|P2|Overall Study|Noncompliance with Study Drug|3
1408437|NCT01157351|4648211|P1|Overall Study|Noncompliance with Study Drug|0
1408438|NCT01157351|4648210|P2|Overall Study|Other|36
1408439|NCT01157351|4648211|P1|Overall Study|Other|32
1408440|NCT01157351|4648210|P2|Overall Study|Protocol Violation|1
1408441|NCT01157351|4648211|P1|Overall Study|Protocol Violation|0
1408442|NCT01157351|4648210|P2|Overall Study|Physician Decision|4
1408443|NCT01157351|4648211|P1|Overall Study|Physician Decision|5
1408444|NCT01157351|4648210|P2|Overall Study|Withdrawal by Subject|27
1408445|NCT01157351|4648211|P1|Overall Study|Withdrawal by Subject|37
1408446|NCT01157351|4648210|P2|Overall Study|Lost to Follow-up|55
1408447|NCT01157351|4648211|P1|Overall Study|Lost to Follow-up|53
1408448|NCT01157351|4648210|P2|Overall Study|Death|0
1408449|NCT01157351|4648211|P1|Overall Study|Death|1
1408450|NCT01157351|4648210|P2|Overall Study|Adverse Event|4
1408451|NCT01157351|4648211|P1|Overall Study|Adverse Event|5
1408452|NCT01157234|4648229|P2|Overall Study|Withdrawal by Subject|0
1408453|NCT01157234|4648230|P1|Overall Study|Withdrawal by Subject|1
1408454|NCT01157182|4648262|P2|Washout of 28 Days|Adverse Event|0
1408455|NCT01157182|4648263|P1|Washout of 28 Days|Adverse Event|2
1408456|NCT01157169|4648311|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
1408457|NCT01157169|4648312|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
1408458|NCT01157169|4648311|P2|First Intervention|Emesis Within 4 hrs of Administration|2
1408459|NCT01157169|4648312|P1|First Intervention|Emesis Within 4 hrs of Administration|4
1408460|NCT01157169|4648311|P2|First Intervention|Protocol Violation|0
1408461|NCT01157169|4648312|P1|First Intervention|Protocol Violation|0
1408462|NCT01157117|4648331|P3|Overall Study|Unknown (Pending Final Form Submission)|13
1408463|NCT01157117|4648332|P2|Overall Study|Unknown (Pending Final Form Submission)|5
1408464|NCT01157117|4648333|P1|Overall Study|Unknown (Pending Final Form Submission)|4
1408465|NCT01157117|4648331|P3|Overall Study|Lost to Follow-up|1
1408466|NCT01157117|4648332|P2|Overall Study|Lost to Follow-up|0
1408467|NCT01157117|4648333|P1|Overall Study|Lost to Follow-up|0
1408468|NCT01157117|4648331|P3|Overall Study|Lack of Efficacy|0
1408469|NCT01157117|4648332|P2|Overall Study|Lack of Efficacy|1
1408470|NCT01157117|4648333|P1|Overall Study|Lack of Efficacy|1
1408471|NCT01157117|4648331|P3|Overall Study|Withdrawal by Subject|1
1408472|NCT01157117|4648332|P2|Overall Study|Withdrawal by Subject|1
1408473|NCT01157117|4648333|P1|Overall Study|Withdrawal by Subject|4
1408474|NCT01157117|4648331|P3|Overall Study|Dosing Symptoms|0
1408475|NCT01157117|4648332|P2|Overall Study|Dosing Symptoms|4
1408476|NCT01157117|4648333|P1|Overall Study|Dosing Symptoms|0
1408477|NCT01157078|4648374|P2|Overall Study|Not specified|4
1408478|NCT01157078|4648375|P1|Overall Study|Not specified|2
1408479|NCT01157078|4648374|P2|Overall Study|Lost to Follow-up|5
1408480|NCT01157078|4648375|P1|Overall Study|Lost to Follow-up|7
1408481|NCT01157078|4648374|P2|Overall Study|Study-specific withdrawal criteria|2
1408482|NCT01157078|4648375|P1|Overall Study|Study-specific withdrawal criteria|2
1408483|NCT01157078|4648374|P2|Overall Study|Lack of Efficacy|0
1408484|NCT01157078|4648375|P1|Overall Study|Lack of Efficacy|2
1408485|NCT01157078|4648374|P2|Overall Study|Condition under investigation worsened|1
1408486|NCT01157078|4648375|P1|Overall Study|Condition under investigation worsened|0
1408487|NCT01157078|4648374|P2|Overall Study|Severe non-compliance to protocol|4
1408488|NCT01157078|4648375|P1|Overall Study|Severe non-compliance to protocol|2
1408489|NCT01157078|4648374|P2|Overall Study|Adverse Event|6
1408490|NCT01157078|4648375|P1|Overall Study|Adverse Event|6
1408491|NCT01157078|4648374|P2|Overall Study|Eligibility criteria not fulfilled|0
1408492|NCT01157078|4648375|P1|Overall Study|Eligibility criteria not fulfilled|2
1408493|NCT01157078|4648374|P2|Overall Study|Withdrawal by Subject|14
1408494|NCT01157078|4648375|P1|Overall Study|Withdrawal by Subject|12
1408495|NCT01157065|4648425|P2|Overall Study|Death|1
1408496|NCT01157065|4648426|P1|Overall Study|Death|0
1408497|NCT01156844|4648447|P4|Overall Study|Protocol deviation|0
1408498|NCT01156844|4648448|P3|Overall Study|Protocol deviation|0
1408499|NCT01156844|4648449|P2|Overall Study|Protocol deviation|0
1408500|NCT01156844|4648450|P1|Overall Study|Protocol deviation|2
1408501|NCT01156844|4648447|P4|Overall Study|Administrative problems|1
1408502|NCT01156844|4648448|P3|Overall Study|Administrative problems|0
1408503|NCT01156844|4648449|P2|Overall Study|Administrative problems|1
1408504|NCT01156844|4648450|P1|Overall Study|Administrative problems|0
1408505|NCT01156844|4648447|P4|Overall Study|Lost to Follow-up|0
1408506|NCT01156844|4648448|P3|Overall Study|Lost to Follow-up|1
1408507|NCT01156844|4648449|P2|Overall Study|Lost to Follow-up|0
1408508|NCT01156844|4648450|P1|Overall Study|Lost to Follow-up|0
1408509|NCT01156844|4648447|P4|Overall Study|Withdrawal by Subject|2
1408510|NCT01156844|4648448|P3|Overall Study|Withdrawal by Subject|2
1408511|NCT01156844|4648449|P2|Overall Study|Withdrawal by Subject|0
1408512|NCT01156844|4648450|P1|Overall Study|Withdrawal by Subject|0
1408513|NCT01156844|4648447|P4|Overall Study|Abnormal test procedure result(s)|2
1408514|NCT01156844|4648448|P3|Overall Study|Abnormal test procedure result(s)|2
1408515|NCT01156844|4648449|P2|Overall Study|Abnormal test procedure result(s)|1
1408516|NCT01156844|4648450|P1|Overall Study|Abnormal test procedure result(s)|0
1408517|NCT01156844|4648447|P4|Overall Study|Adverse Event|1
1408518|NCT01156844|4648448|P3|Overall Study|Adverse Event|1
1408519|NCT01156844|4648449|P2|Overall Study|Adverse Event|0
1408520|NCT01156844|4648450|P1|Overall Study|Adverse Event|0
1408521|NCT01156792|4648469|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
1408522|NCT01156792|4648469|P1|Overall Study|Withdrawal by Subject|9
1408523|NCT01156792|4648469|P1|Overall Study|Physician Decision|3
1408524|NCT01156792|4648469|P1|Overall Study|Lost to Follow-up|3
1408525|NCT01156792|4648469|P1|Overall Study|Protocol Violation|6
1408526|NCT01156792|4648469|P1|Overall Study|Lack of Efficacy|36
1408527|NCT01156792|4648469|P1|Overall Study|Adverse Event|1
1408528|NCT01156675|4648574|P3|Overall Study|No data|2
1408529|NCT01156675|4648575|P2|Overall Study|No data|22
1408530|NCT01156675|4648576|P1|Overall Study|No data|29
1408531|NCT01156675|4648574|P3|Overall Study|Death|0
1408532|NCT01156675|4648575|P2|Overall Study|Death|3
1408533|NCT01156675|4648576|P1|Overall Study|Death|5
1408534|NCT01156532|4648634|P1|Overall Study|Lost to Follow-up|1
1408535|NCT01156532|4648634|P1|Overall Study|Family Reasons|1
1408536|NCT01156480|4648646|P2|Overall Study|change in diagnosis|1
1408537|NCT01156480|4648647|P1|Overall Study|change in diagnosis|0
1408538|NCT01156376|4648658|P3|Overall Study|Withdrawal by Subject|3
1408539|NCT01156376|4648659|P2|Overall Study|Withdrawal by Subject|0
1408540|NCT01156376|4648660|P1|Overall Study|Withdrawal by Subject|0
1408541|NCT01156376|4648658|P3|Overall Study|Adverse Event|1
1408542|NCT01156376|4648659|P2|Overall Study|Adverse Event|0
1408543|NCT01156376|4648660|P1|Overall Study|Adverse Event|1
1408544|NCT01156363|4648881|P1|Overall Study|Other|6
1408545|NCT01156363|4648881|P1|Overall Study|Refused Treatment|4
1408546|NCT01156363|4648881|P1|Overall Study|Failure to Return|1
1408547|NCT01156363|4648881|P1|Overall Study|Insufficient Therapeutic Response|5
1408548|NCT01156363|4648881|P1|Overall Study|Adverse Event|6
1408549|NCT01156311|4648903|P4|6-month Add-on Therapy Period|Not Specified|2
1408550|NCT01156311|4648904|P3|6-month Add-on Therapy Period|Not Specified|1
1408551|NCT01156311|4648905|P2|6-month Add-on Therapy Period|Not Specified|0
1408552|NCT01156311|4648906|P1|6-month Add-on Therapy Period|Not Specified|0
1408553|NCT01156311|4648903|P4|6-month Add-on Therapy Period|Physician Decision|0
1408554|NCT01156311|4648904|P3|6-month Add-on Therapy Period|Physician Decision|1
1408555|NCT01156311|4648905|P2|6-month Add-on Therapy Period|Physician Decision|0
1408556|NCT01156311|4648906|P1|6-month Add-on Therapy Period|Physician Decision|0
1408557|NCT01156311|4648903|P4|6-month Add-on Therapy Period|Disease Activity|2
1408558|NCT01156311|4648904|P3|6-month Add-on Therapy Period|Disease Activity|1
1408559|NCT01156311|4648905|P2|6-month Add-on Therapy Period|Disease Activity|0
1408560|NCT01156311|4648906|P1|6-month Add-on Therapy Period|Disease Activity|0
1408561|NCT01156311|4648903|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
1408562|NCT01156311|4648904|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
1408563|NCT01156311|4648905|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
1408564|NCT01156311|4648906|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
1408565|NCT01156311|4648903|P4|6-month Add-on Therapy Period|Adverse Event|6
1408566|NCT01156311|4648904|P3|6-month Add-on Therapy Period|Adverse Event|7
1408567|NCT01156311|4648905|P2|6-month Add-on Therapy Period|Adverse Event|0
1408568|NCT01156311|4648906|P1|6-month Add-on Therapy Period|Adverse Event|0
1408569|NCT01156311|4648903|P4|2-Month Monotherapy Period|Not specified|0
1408570|NCT01156311|4648904|P3|2-Month Monotherapy Period|Not specified|0
1408571|NCT01156311|4648905|P2|2-Month Monotherapy Period|Not specified|0
1408572|NCT01156311|4648906|P1|2-Month Monotherapy Period|Not specified|1
1408573|NCT01156311|4648903|P4|2-Month Monotherapy Period|Physician Decision|0
1408574|NCT01156311|4648904|P3|2-Month Monotherapy Period|Physician Decision|0
1408575|NCT01156311|4648905|P2|2-Month Monotherapy Period|Physician Decision|1
1408576|NCT01156311|4648906|P1|2-Month Monotherapy Period|Physician Decision|0
1408577|NCT01156311|4648903|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
1408578|NCT01156311|4648904|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
1408579|NCT01156311|4648905|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
1408580|NCT01156311|4648906|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
1408581|NCT01156142|4648930|P2|Overall Study|Ineligible|1
1408582|NCT01156142|4648931|P1|Overall Study|Ineligible|0
1408583|NCT01156142|4648930|P2|Overall Study|Withdrawal by Subject|6
1408584|NCT01156142|4648931|P1|Overall Study|Withdrawal by Subject|8
1408585|NCT01156116|4648949|P2|Overall Study|CPAP intolerance|0
1408586|NCT01156116|4648950|P1|Overall Study|CPAP intolerance|2
1408587|NCT01156116|4648949|P2|Overall Study|Withdrawal by Subject|1
1408588|NCT01156116|4648950|P1|Overall Study|Withdrawal by Subject|3
1408589|NCT01156051|4648964|P2|Overall Study|patient not compliant with protocol|1
1408590|NCT01156051|4648965|P1|Overall Study|patient not compliant with protocol|0
1408591|NCT01156051|4648964|P2|Overall Study|Lost to Follow-up|0
1408592|NCT01156051|4648965|P1|Overall Study|Lost to Follow-up|1
1408593|NCT01156012|4648979|P2|Overall Study|Non respect of one of inclusion criteria|1
1408594|NCT01156012|4648980|P1|Overall Study|Non respect of one of inclusion criteria|2
1408595|NCT01156012|4648979|P2|Overall Study|use of commercial drug instead of study|1
1408596|NCT01156012|4648980|P1|Overall Study|use of commercial drug instead of study|0
1408597|NCT01156012|4648979|P2|Overall Study|Withdrawal by Subject|0
1408598|NCT01156012|4648980|P1|Overall Study|Withdrawal by Subject|1
1408599|NCT01156012|4648979|P2|Overall Study|Lost to Follow-up|0
1408600|NCT01156012|4648980|P1|Overall Study|Lost to Follow-up|1
1408601|NCT01156012|4648979|P2|Overall Study|Adverse Event|1
1408602|NCT01156012|4648980|P1|Overall Study|Adverse Event|3
1408603|NCT01155869|4648997|P2|Overall Study|Lost to Follow-up|1
1408604|NCT01155869|4648998|P1|Overall Study|Lost to Follow-up|3
1408605|NCT01155726|4649022|P4|Period 1, 3 Days (Masked)|Inconvenience|0
1408606|NCT01155726|4649023|P3|Period 1, 3 Days (Masked)|Inconvenience|2
1408607|NCT01155726|4649024|P2|Period 1, 3 Days (Masked)|Inconvenience|0
1408608|NCT01155726|4649025|P1|Period 1, 3 Days (Masked)|Inconvenience|1
1408609|NCT01155661|4649047|P1|Overall Study|Sponsor Decision|13
1408610|NCT01155661|4649047|P1|Overall Study|Withdrawal by Subject|73
1408611|NCT01155661|4649047|P1|Overall Study|Protocol Violation|35
1408612|NCT01155661|4649047|P1|Overall Study|Physician Decision|3
1408613|NCT01155661|4649047|P1|Overall Study|Lost to Follow-up|22
1408614|NCT01155661|4649047|P1|Overall Study|Lack of Efficacy|32
1408615|NCT01155661|4649047|P1|Overall Study|Death|1
1408616|NCT01155661|4649047|P1|Overall Study|Adverse Event|101
1408617|NCT01155570|4649073|P1|Overall Study|Other Reasons|23
1408618|NCT01155570|4649073|P1|Overall Study|Participant's Economic Reasons + Other|1
1408619|NCT01155570|4649073|P1|Overall Study|Adverse Event + Other Reasons|7
1408620|NCT01155570|4649073|P1|Overall Study|Adverse Event + Lack of Efficacy|2
1408621|NCT01155570|4649073|P1|Overall Study|No Hospital Visits|7
1408622|NCT01155570|4649073|P1|Overall Study|Participant's Economic Reasons|17
1408623|NCT01155570|4649073|P1|Overall Study|Lack of Efficacy|46
1408624|NCT01155570|4649073|P1|Overall Study|Adverse Event|39
1408625|NCT01155531|4649107|P4|Overall Study|Withdrawal by Subject|0
1408626|NCT01155531|4649108|P3|Overall Study|Withdrawal by Subject|1
1408627|NCT01155531|4649109|P2|Overall Study|Withdrawal by Subject|0
1408628|NCT01155531|4649110|P1|Overall Study|Withdrawal by Subject|1
1408629|NCT01155531|4649107|P4|Overall Study|Lost to Follow-up|1
1408630|NCT01155531|4649108|P3|Overall Study|Lost to Follow-up|0
1408631|NCT01155531|4649109|P2|Overall Study|Lost to Follow-up|0
1408632|NCT01155531|4649110|P1|Overall Study|Lost to Follow-up|0
1408633|NCT01155531|4649107|P4|Overall Study|Adverse Event|0
1408634|NCT01155531|4649108|P3|Overall Study|Adverse Event|1
1408635|NCT01155531|4649109|P2|Overall Study|Adverse Event|0
1408636|NCT01155531|4649110|P1|Overall Study|Adverse Event|0
1408637|NCT01155479|4649133|P5|Part II|Non-Compliance with Protocol|0
1408638|NCT01155479|4649134|P4|Part II|Non-Compliance with Protocol|2
1408639|NCT01155479|4649135|P3|Part II|Non-Compliance with Protocol|0
1408640|NCT01155479|4649136|P2|Part II|Non-Compliance with Protocol|1
1408641|NCT01155479|4649137|P1|Part II|Non-Compliance with Protocol|0
1408642|NCT01155479|4649133|P5|Part II|Treatment Failure|1
1408643|NCT01155479|4649134|P4|Part II|Treatment Failure|0
1408644|NCT01155479|4649135|P3|Part II|Treatment Failure|2
1408645|NCT01155479|4649136|P2|Part II|Treatment Failure|1
1408646|NCT01155479|4649137|P1|Part II|Treatment Failure|0
1408647|NCT01155479|4649133|P5|Part II|Lost to Follow-up|1
1408648|NCT01155479|4649134|P4|Part II|Lost to Follow-up|0
1408649|NCT01155479|4649135|P3|Part II|Lost to Follow-up|0
1408650|NCT01155479|4649136|P2|Part II|Lost to Follow-up|0
1408651|NCT01155479|4649137|P1|Part II|Lost to Follow-up|1
1408652|NCT01155479|4649133|P5|Part II|Withdrawal by Subject|3
1408653|NCT01155479|4649134|P4|Part II|Withdrawal by Subject|7
1408654|NCT01155479|4649135|P3|Part II|Withdrawal by Subject|12
1408655|NCT01155479|4649136|P2|Part II|Withdrawal by Subject|4
1408656|NCT01155479|4649137|P1|Part II|Withdrawal by Subject|8
1408657|NCT01155479|4649133|P5|Part II|Administrative|46
1408658|NCT01155479|4649134|P4|Part II|Administrative|38
1408659|NCT01155479|4649135|P3|Part II|Administrative|36
1408660|NCT01155479|4649136|P2|Part II|Administrative|49
1408661|NCT01155479|4649137|P1|Part II|Administrative|43
1408662|NCT01155479|4649133|P5|Part II|Adverse Event|4
1408663|NCT01155479|4649134|P4|Part II|Adverse Event|3
1408664|NCT01155479|4649135|P3|Part II|Adverse Event|8
1408665|NCT01155479|4649136|P2|Part II|Adverse Event|6
1408666|NCT01155479|4649137|P1|Part II|Adverse Event|7
1408667|NCT01155479|4649133|P5|Part I|Non-Compliance with Protocol|2
1408668|NCT01155479|4649134|P4|Part I|Non-Compliance with Protocol|3
1408669|NCT01155479|4649135|P3|Part I|Non-Compliance with Protocol|3
1408670|NCT01155479|4649136|P2|Part I|Non-Compliance with Protocol|1
1408671|NCT01155479|4649137|P1|Part I|Non-Compliance with Protocol|2
1408672|NCT01155479|4649133|P5|Part I|Did Not Receive Treatment|1
1408673|NCT01155479|4649134|P4|Part I|Did Not Receive Treatment|6
1408674|NCT01155479|4649135|P3|Part I|Did Not Receive Treatment|2
1408675|NCT01155479|4649136|P2|Part I|Did Not Receive Treatment|2
1408676|NCT01155479|4649137|P1|Part I|Did Not Receive Treatment|4
1408677|NCT01155479|4649133|P5|Part I|Treatment Failure|2
1408678|NCT01155479|4649134|P4|Part I|Treatment Failure|1
1408679|NCT01155479|4649135|P3|Part I|Treatment Failure|3
1408680|NCT01155479|4649136|P2|Part I|Treatment Failure|0
1408681|NCT01155479|4649137|P1|Part I|Treatment Failure|3
1408682|NCT01155479|4649133|P5|Part I|Lost to Follow-up|0
1408683|NCT01155479|4649134|P4|Part I|Lost to Follow-up|1
1408684|NCT01155479|4649135|P3|Part I|Lost to Follow-up|1
1408685|NCT01155479|4649136|P2|Part I|Lost to Follow-up|0
1408686|NCT01155479|4649137|P1|Part I|Lost to Follow-up|0
1408687|NCT01155479|4649133|P5|Part I|Withdrawal by Subject|9
1408688|NCT01155479|4649134|P4|Part I|Withdrawal by Subject|8
1408689|NCT01155479|4649135|P3|Part I|Withdrawal by Subject|8
1408690|NCT01155479|4649136|P2|Part I|Withdrawal by Subject|13
1408691|NCT01155479|4649137|P1|Part I|Withdrawal by Subject|11
1408692|NCT01155479|4649133|P5|Part I|Did Not Meet Protocol Eligibility|3
1408693|NCT01155479|4649134|P4|Part I|Did Not Meet Protocol Eligibility|1
1408694|NCT01155479|4649135|P3|Part I|Did Not Meet Protocol Eligibility|2
1408695|NCT01155479|4649136|P2|Part I|Did Not Meet Protocol Eligibility|1
1408696|NCT01155479|4649137|P1|Part I|Did Not Meet Protocol Eligibility|3
1408697|NCT01155479|4649133|P5|Part I|Administrative|0
1408698|NCT01155479|4649134|P4|Part I|Administrative|0
1408699|NCT01155479|4649135|P3|Part I|Administrative|2
1408700|NCT01155479|4649136|P2|Part I|Administrative|2
1408701|NCT01155479|4649137|P1|Part I|Administrative|2
1408702|NCT01155479|4649133|P5|Part I|Adverse Event|6
1408703|NCT01155479|4649134|P4|Part I|Adverse Event|7
1408704|NCT01155479|4649135|P3|Part I|Adverse Event|18
1408705|NCT01155479|4649136|P2|Part I|Adverse Event|8
1408706|NCT01155479|4649137|P1|Part I|Adverse Event|13
1408707|NCT01155466|4649189|P5|Overall Study|Randomized not treated|2
1408708|NCT01155466|4649190|P4|Overall Study|Randomized not treated|0
1408709|NCT01155466|4649191|P3|Overall Study|Randomized not treated|3
1408710|NCT01155466|4649192|P2|Overall Study|Randomized not treated|2
1408711|NCT01155466|4649193|P1|Overall Study|Randomized not treated|2
1408712|NCT01155466|4649189|P5|Overall Study|Administrative|0
1408713|NCT01155466|4649190|P4|Overall Study|Administrative|0
1408714|NCT01155466|4649191|P3|Overall Study|Administrative|0
1408715|NCT01155466|4649192|P2|Overall Study|Administrative|3
1408716|NCT01155466|4649193|P1|Overall Study|Administrative|0
1408717|NCT01155466|4649189|P5|Overall Study|Protocol Violation|1
1408718|NCT01155466|4649190|P4|Overall Study|Protocol Violation|0
1408719|NCT01155466|4649191|P3|Overall Study|Protocol Violation|2
1408720|NCT01155466|4649192|P2|Overall Study|Protocol Violation|0
1408721|NCT01155466|4649193|P1|Overall Study|Protocol Violation|0
1408722|NCT01155466|4649189|P5|Overall Study|Withdrawal by Subject|4
1408723|NCT01155466|4649190|P4|Overall Study|Withdrawal by Subject|4
1408724|NCT01155466|4649191|P3|Overall Study|Withdrawal by Subject|9
1408725|NCT01155466|4649192|P2|Overall Study|Withdrawal by Subject|5
1408726|NCT01155466|4649193|P1|Overall Study|Withdrawal by Subject|7
1408727|NCT01155466|4649189|P5|Overall Study|Lost to Follow-up|2
1408728|NCT01155466|4649190|P4|Overall Study|Lost to Follow-up|0
1408729|NCT01155466|4649191|P3|Overall Study|Lost to Follow-up|0
1408730|NCT01155466|4649192|P2|Overall Study|Lost to Follow-up|0
1408731|NCT01155466|4649193|P1|Overall Study|Lost to Follow-up|0
1408732|NCT01155466|4649189|P5|Overall Study|Adverse Event|18
1408733|NCT01155466|4649190|P4|Overall Study|Adverse Event|17
1408734|NCT01155466|4649191|P3|Overall Study|Adverse Event|6
1408735|NCT01155466|4649192|P2|Overall Study|Adverse Event|15
1408736|NCT01155466|4649193|P1|Overall Study|Adverse Event|13
1408737|NCT01155388|4649247|P2|Overall Study|Adverse Event|0
1408738|NCT01155388|4649248|P1|Overall Study|Adverse Event|1
1408739|NCT01155375|4649258|P2|Overall Study|Adverse Event|0
1408740|NCT01155375|4649259|P1|Overall Study|Adverse Event|1
1408741|NCT01155323|4649278|P2|Second Intervention|Lost to Follow-up|1
1408742|NCT01155323|4649279|P1|Second Intervention|Lost to Follow-up|1
1408743|NCT01155323|4649278|P2|First Intervention|exclusion criteria|1
1408744|NCT01155323|4649279|P1|First Intervention|exclusion criteria|1
1408745|NCT01155284|4649297|P2|Overall Study|Adverse Event|0
1408746|NCT01155284|4649298|P1|Overall Study|Adverse Event|1
1408747|NCT01155284|4649297|P2|Overall Study|Physician Decision|0
1408748|NCT01155284|4649298|P1|Overall Study|Physician Decision|1
1408749|NCT01155284|4649297|P2|Overall Study|Lost to Follow-up|2
1408750|NCT01155284|4649298|P1|Overall Study|Lost to Follow-up|1
1408751|NCT01155284|4649297|P2|Overall Study|Withdrawal by Subject|3
1408752|NCT01155284|4649298|P1|Overall Study|Withdrawal by Subject|4
1408753|NCT01155219|4649308|P2|Overall Study|non-medical reason|2
1408754|NCT01155219|4649309|P1|Overall Study|non-medical reason|1
1408755|NCT01155219|4649308|P2|Overall Study|Adverse Event|1
1408756|NCT01155219|4649309|P1|Overall Study|Adverse Event|3
1408757|NCT01155167|4649326|P2|Overall Study|Access site changed to femoral artery|0
1408758|NCT01155167|4649327|P1|Overall Study|Access site changed to femoral artery|1
1408759|NCT01155167|4649326|P2|Overall Study|Insufficient ultrasound data|0
1408760|NCT01155167|4649327|P1|Overall Study|Insufficient ultrasound data|2
1408761|NCT01155141|4649350|P1|Overall Study|Screen Failure|1
1408762|NCT01155141|4649350|P1|Overall Study|Withdrawal by Subject|1
1408763|NCT01155063|4649362|P1|Overall Study|Study terminated by sponsor|87
1408764|NCT01155063|4649362|P1|Overall Study|Withdrawal by Subject|1
1408765|NCT01155063|4649362|P1|Overall Study|Adverse Event|1
1408766|NCT01155024|4649372|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
1408767|NCT01155024|4649373|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
1408768|NCT01155024|4649372|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
1408769|NCT01155024|4649373|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
1408770|NCT01155024|4649372|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
1408771|NCT01155024|4649373|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
1408772|NCT01155011|4649383|P2|6 to 12 Months|Death|5
1408773|NCT01155011|4649384|P1|6 to 12 Months|Death|1
1408774|NCT01155011|4649383|P2|6 to 12 Months|Withdrawal by Subject|5
1408775|NCT01155011|4649384|P1|6 to 12 Months|Withdrawal by Subject|8
1408776|NCT01155011|4649383|P2|Baseline to 6 Months|Death|1
1408777|NCT01155011|4649384|P1|Baseline to 6 Months|Death|0
1408778|NCT01155011|4649383|P2|Baseline to 6 Months|investigator decision, moved|5
1408779|NCT01155011|4649384|P1|Baseline to 6 Months|investigator decision, moved|4
1408780|NCT01155011|4649383|P2|Baseline to 6 Months|Withdrawal by Subject|19
1408781|NCT01155011|4649384|P1|Baseline to 6 Months|Withdrawal by Subject|18
1408782|NCT01154816|4649425|P12|Overall Study|Adverse Event|0
1408783|NCT01154816|4649426|P11|Overall Study|Adverse Event|0
1408784|NCT01154816|4649427|P10|Overall Study|Adverse Event|0
1408785|NCT01154816|4649428|P9|Overall Study|Adverse Event|0
1408786|NCT01154816|4649429|P8|Overall Study|Adverse Event|1
1408787|NCT01154816|4649430|P7|Overall Study|Adverse Event|1
1408788|NCT01154816|4649431|P6|Overall Study|Adverse Event|0
1408789|NCT01154816|4649432|P5|Overall Study|Adverse Event|0
1408790|NCT01154816|4649433|P4|Overall Study|Adverse Event|0
1408791|NCT01154816|4649434|P3|Overall Study|Adverse Event|0
1408792|NCT01154816|4649435|P2|Overall Study|Adverse Event|2
1408793|NCT01154816|4649436|P1|Overall Study|Adverse Event|5
1408794|NCT01154816|4649425|P12|Overall Study|Physician Decision|1
1408795|NCT01154816|4649426|P11|Overall Study|Physician Decision|1
1408796|NCT01154816|4649427|P10|Overall Study|Physician Decision|1
1408797|NCT01154816|4649428|P9|Overall Study|Physician Decision|0
1408798|NCT01154816|4649429|P8|Overall Study|Physician Decision|0
1408799|NCT01154816|4649430|P7|Overall Study|Physician Decision|0
1408800|NCT01154816|4649431|P6|Overall Study|Physician Decision|0
1408801|NCT01154816|4649432|P5|Overall Study|Physician Decision|2
1408802|NCT01154816|4649433|P4|Overall Study|Physician Decision|0
1408803|NCT01154816|4649434|P3|Overall Study|Physician Decision|1
1408804|NCT01154816|4649435|P2|Overall Study|Physician Decision|0
1408805|NCT01154816|4649436|P1|Overall Study|Physician Decision|1
1408806|NCT01154816|4649425|P12|Overall Study|Progressive Disease|3
1408807|NCT01154816|4649426|P11|Overall Study|Progressive Disease|10
1408808|NCT01154816|4649427|P10|Overall Study|Progressive Disease|6
1408809|NCT01154816|4649428|P9|Overall Study|Progressive Disease|8
1408810|NCT01154816|4649429|P8|Overall Study|Progressive Disease|6
1408811|NCT01154816|4649430|P7|Overall Study|Progressive Disease|5
1408812|NCT01154816|4649431|P6|Overall Study|Progressive Disease|8
1408813|NCT01154816|4649432|P5|Overall Study|Progressive Disease|8
1408814|NCT01154816|4649433|P4|Overall Study|Progressive Disease|9
1408815|NCT01154816|4649434|P3|Overall Study|Progressive Disease|9
1408816|NCT01154816|4649435|P2|Overall Study|Progressive Disease|8
1408817|NCT01154816|4649436|P1|Overall Study|Progressive Disease|13
1408818|NCT01154816|4649425|P12|Overall Study|Withdrawal by Subject|0
1408819|NCT01154816|4649426|P11|Overall Study|Withdrawal by Subject|0
1408820|NCT01154816|4649427|P10|Overall Study|Withdrawal by Subject|3
1408821|NCT01154816|4649428|P9|Overall Study|Withdrawal by Subject|1
1408822|NCT01154816|4649429|P8|Overall Study|Withdrawal by Subject|0
1408823|NCT01154816|4649430|P7|Overall Study|Withdrawal by Subject|0
1408824|NCT01154816|4649431|P6|Overall Study|Withdrawal by Subject|0
1408825|NCT01154816|4649432|P5|Overall Study|Withdrawal by Subject|0
1408826|NCT01154816|4649433|P4|Overall Study|Withdrawal by Subject|1
1408827|NCT01154816|4649434|P3|Overall Study|Withdrawal by Subject|0
1408828|NCT01154816|4649435|P2|Overall Study|Withdrawal by Subject|0
1408829|NCT01154816|4649436|P1|Overall Study|Withdrawal by Subject|1
1408830|NCT01154673|4649513|P2|Overall Study|moved out of province|0
1408831|NCT01154673|4649514|P1|Overall Study|moved out of province|1
1408832|NCT01154673|4649513|P2|Overall Study|Lost to Follow-up|0
1408833|NCT01154673|4649514|P1|Overall Study|Lost to Follow-up|1
1408834|NCT01154452|4649569|P4|Phase II|Adverse Event|4
1408835|NCT01154452|4649570|P3|Phase II|Adverse Event|4
1408836|NCT01154452|4649571|P2|Phase II|Adverse Event|0
1408837|NCT01154452|4649572|P1|Phase II|Adverse Event|0
1408838|NCT01154452|4649569|P4|Phase II|Withdrawal by Subject|2
1408839|NCT01154452|4649570|P3|Phase II|Withdrawal by Subject|1
1408840|NCT01154452|4649571|P2|Phase II|Withdrawal by Subject|0
1408841|NCT01154452|4649572|P1|Phase II|Withdrawal by Subject|0
1408842|NCT01154452|4649569|P4|Phase Ib|Adverse Event|0
1408843|NCT01154452|4649570|P3|Phase Ib|Adverse Event|0
1408844|NCT01154452|4649571|P2|Phase Ib|Adverse Event|1
1408845|NCT01154452|4649572|P1|Phase Ib|Adverse Event|2
1408846|NCT01154452|4649569|P4|Phase Ib|Not Treated|0
1408847|NCT01154452|4649570|P3|Phase Ib|Not Treated|0
1408848|NCT01154452|4649571|P2|Phase Ib|Not Treated|0
1408849|NCT01154452|4649572|P1|Phase Ib|Not Treated|1
1408850|NCT01154296|4649604|P2|6-month Follow-up|Declined by Study Coordinator|4
1408851|NCT01154296|4649605|P1|6-month Follow-up|Declined by Study Coordinator|5
1408852|NCT01154296|4649604|P2|6-month Follow-up|Death|2
1408853|NCT01154296|4649605|P1|6-month Follow-up|Death|3
1408854|NCT01154296|4649604|P2|6-month Follow-up|Withdrew consent|15
1408855|NCT01154296|4649605|P1|6-month Follow-up|Withdrew consent|14
1408856|NCT01154296|4649604|P2|6-month Follow-up|Incarcerated|32
1408857|NCT01154296|4649605|P1|6-month Follow-up|Incarcerated|37
1408858|NCT01154296|4649604|P2|6-month Follow-up|Lost contact|275
1408859|NCT01154296|4649605|P1|6-month Follow-up|Lost contact|269
1408860|NCT01154296|4649604|P2|Randomization and Intervention|Left clinic early|0
1408861|NCT01154296|4649605|P1|Randomization and Intervention|Left clinic early|2
1408862|NCT01154296|4649604|P2|Randomization and Intervention|Left before test|1
1408863|NCT01154296|4649605|P1|Randomization and Intervention|Left before test|0
1408864|NCT01154296|4649604|P2|Randomization and Intervention|Did not return|0
1408865|NCT01154296|4649605|P1|Randomization and Intervention|Did not return|1
1408866|NCT01154296|4649604|P2|Randomization and Intervention|Declined by staff|0
1408867|NCT01154296|4649605|P1|Randomization and Intervention|Declined by staff|1
1408868|NCT01154296|4649604|P2|Randomization and Intervention|Decided to decline|1
1408869|NCT01154296|4649605|P1|Randomization and Intervention|Decided to decline|1
1408870|NCT01154283|4649623|P2|7-12 Weeks|Withdrawal by Subject|1
1408871|NCT01154283|4649624|P1|7-12 Weeks|Withdrawal by Subject|0
1408872|NCT01154283|4649623|P2|7-12 Weeks|Death|0
1408873|NCT01154283|4649624|P1|7-12 Weeks|Death|1
1408874|NCT01154283|4649623|P2|0-6 Weeks|Death|1
1408875|NCT01154283|4649624|P1|0-6 Weeks|Death|0
1408876|NCT01154283|4649623|P2|0-6 Weeks|Withdrawal by Subject|2
1408877|NCT01154283|4649624|P1|0-6 Weeks|Withdrawal by Subject|7
1408878|NCT01154231|4649636|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
1408879|NCT01154231|4649636|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
1408880|NCT01154218|4649642|P4|Fourth Intervention Period|Withdrawal by Subject|0
1408881|NCT01154218|4649643|P3|Fourth Intervention Period|Withdrawal by Subject|0
1408882|NCT01154218|4649644|P2|Fourth Intervention Period|Withdrawal by Subject|0
1408883|NCT01154218|4649645|P1|Fourth Intervention Period|Withdrawal by Subject|1
1408884|NCT01154218|4649642|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
1408885|NCT01154218|4649643|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1408886|NCT01154218|4649644|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1408887|NCT01154218|4649645|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1408888|NCT01154218|4649642|P4|Third Intervention Period|Adverse Event|0
1408889|NCT01154218|4649643|P3|Third Intervention Period|Adverse Event|0
1408890|NCT01154218|4649644|P2|Third Intervention Period|Adverse Event|1
1408891|NCT01154218|4649645|P1|Third Intervention Period|Adverse Event|0
1408892|NCT01154166|4649697|P2|Overall Study|Poor Compliance|0
1408893|NCT01154166|4649698|P1|Overall Study|Poor Compliance|1
1408894|NCT01154166|4649697|P2|Overall Study|Disease Progression|0
1408895|NCT01154166|4649698|P1|Overall Study|Disease Progression|1
1408896|NCT01154166|4649697|P2|Overall Study|Lack of Efficacy|0
1408897|NCT01154166|4649698|P1|Overall Study|Lack of Efficacy|3
1408898|NCT01154166|4649697|P2|Overall Study|Withdrawal by Subject|1
1408899|NCT01154166|4649698|P1|Overall Study|Withdrawal by Subject|10
1408900|NCT01154166|4649697|P2|Overall Study|Protocol Violation|1
1408901|NCT01154166|4649698|P1|Overall Study|Protocol Violation|4
1408902|NCT01154166|4649697|P2|Overall Study|Lost to Follow-up|1
1408903|NCT01154166|4649698|P1|Overall Study|Lost to Follow-up|1
1408904|NCT01154166|4649697|P2|Overall Study|Adverse Event|9
1408905|NCT01154166|4649698|P1|Overall Study|Adverse Event|14
1408906|NCT01154153|4649730|P2|Overall Study|Withdrew consent|0
1408907|NCT01154153|4649731|P1|Overall Study|Withdrew consent|1
1408908|NCT01154153|4649730|P2|Overall Study|Unable to use labs|3
1408909|NCT01154153|4649731|P1|Overall Study|Unable to use labs|2
1408910|NCT01154153|4649730|P2|Overall Study|Poor compliance to protocol|0
1408911|NCT01154153|4649731|P1|Overall Study|Poor compliance to protocol|2
1408912|NCT01154140|4649749|P2|Overall Study|Randomized but not treated|2
1408913|NCT01154140|4649750|P1|Overall Study|Randomized but not treated|1
1408914|NCT01154140|4649749|P2|Overall Study|Other|1
1408915|NCT01154140|4649750|P1|Overall Study|Other|3
1408916|NCT01154140|4649749|P2|Overall Study|Withdrawal by Subject|13
1408917|NCT01154140|4649750|P1|Overall Study|Withdrawal by Subject|12
1408918|NCT01154140|4649749|P2|Overall Study|Lost to Follow-up|5
1408919|NCT01154140|4649750|P1|Overall Study|Lost to Follow-up|4
1408920|NCT01154140|4649749|P2|Overall Study|Death|81
1408921|NCT01154140|4649750|P1|Overall Study|Death|71
1408922|NCT01154127|4649803|P2|Period 2 (21 Days)|Protocol Deviation|1
1408923|NCT01154127|4649804|P1|Period 2 (21 Days)|Protocol Deviation|0
1408924|NCT01154127|4649803|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
1408925|NCT01154127|4649804|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
1408926|NCT01154127|4649803|P2|Washout (14 - 28 Days)|Adverse Event|0
1408927|NCT01154127|4649804|P1|Washout (14 - 28 Days)|Adverse Event|2
1408928|NCT01154127|4649803|P2|Period 1 (21 Days)|Withdrawal by Subject|2
1408929|NCT01154127|4649804|P1|Period 1 (21 Days)|Withdrawal by Subject|0
1408930|NCT01154127|4649803|P2|Period 1 (21 Days)|Adverse Event|4
1408931|NCT01154127|4649804|P1|Period 1 (21 Days)|Adverse Event|3
1408932|NCT01154101|4649831|P5|Overall Study|Withdrawal by Subject|1
1408933|NCT01154101|4649832|P4|Overall Study|Withdrawal by Subject|0
1408934|NCT01154101|4649833|P3|Overall Study|Withdrawal by Subject|2
1408935|NCT01154101|4649834|P2|Overall Study|Withdrawal by Subject|1
1408936|NCT01154101|4649835|P1|Overall Study|Withdrawal by Subject|0
1408937|NCT01154101|4649831|P5|Overall Study|Lost to Follow-up|0
1408938|NCT01154101|4649832|P4|Overall Study|Lost to Follow-up|1
1408939|NCT01154101|4649833|P3|Overall Study|Lost to Follow-up|0
1408940|NCT01154101|4649834|P2|Overall Study|Lost to Follow-up|1
1408941|NCT01154101|4649835|P1|Overall Study|Lost to Follow-up|0
1408942|NCT01154101|4649831|P5|Overall Study|Adverse Event|0
1408943|NCT01154101|4649832|P4|Overall Study|Adverse Event|1
1408944|NCT01154101|4649833|P3|Overall Study|Adverse Event|1
1408945|NCT01154101|4649834|P2|Overall Study|Adverse Event|2
1408946|NCT01154101|4649835|P1|Overall Study|Adverse Event|0
1408947|NCT01154036|4649890|P8|Phase II|Withdrawal by Subject|4
1408948|NCT01154036|4649891|P7|Phase II|Withdrawal by Subject|5
1408949|NCT01154036|4649892|P6|Phase II|Withdrawal by Subject|2
1408950|NCT01154036|4649893|P5|Phase II|Withdrawal by Subject|4
1408951|NCT01154036|4649894|P4|Phase II|Withdrawal by Subject|0
1408952|NCT01154036|4649895|P3|Phase II|Withdrawal by Subject|0
1408953|NCT01154036|4649896|P2|Phase II|Withdrawal by Subject|0
1408954|NCT01154036|4649897|P1|Phase II|Withdrawal by Subject|0
1408955|NCT01154036|4649890|P8|Phase II|Protocol Violation|0
1408956|NCT01154036|4649891|P7|Phase II|Protocol Violation|0
1408957|NCT01154036|4649892|P6|Phase II|Protocol Violation|2
1408958|NCT01154036|4649893|P5|Phase II|Protocol Violation|1
1408959|NCT01154036|4649894|P4|Phase II|Protocol Violation|0
1408960|NCT01154036|4649895|P3|Phase II|Protocol Violation|0
1408961|NCT01154036|4649896|P2|Phase II|Protocol Violation|0
1408962|NCT01154036|4649897|P1|Phase II|Protocol Violation|0
1408963|NCT01154036|4649890|P8|Phase II|Lost to Follow-up|1
1408964|NCT01154036|4649891|P7|Phase II|Lost to Follow-up|2
1408965|NCT01154036|4649892|P6|Phase II|Lost to Follow-up|0
1408966|NCT01154036|4649893|P5|Phase II|Lost to Follow-up|2
1408967|NCT01154036|4649894|P4|Phase II|Lost to Follow-up|1
1408968|NCT01154036|4649895|P3|Phase II|Lost to Follow-up|0
1408969|NCT01154036|4649896|P2|Phase II|Lost to Follow-up|0
1408970|NCT01154036|4649897|P1|Phase II|Lost to Follow-up|0
1408971|NCT01154036|4649890|P8|Phase II|Physician Decision|0
1408972|NCT01154036|4649891|P7|Phase II|Physician Decision|1
1408973|NCT01154036|4649892|P6|Phase II|Physician Decision|0
1408974|NCT01154036|4649893|P5|Phase II|Physician Decision|0
1408975|NCT01154036|4649894|P4|Phase II|Physician Decision|0
1408976|NCT01154036|4649895|P3|Phase II|Physician Decision|0
1408977|NCT01154036|4649896|P2|Phase II|Physician Decision|0
1408978|NCT01154036|4649897|P1|Phase II|Physician Decision|0
1408979|NCT01154036|4649890|P8|Phase II|Adverse Event|1
1408980|NCT01154036|4649891|P7|Phase II|Adverse Event|1
1408981|NCT01154036|4649892|P6|Phase II|Adverse Event|1
1408982|NCT01154036|4649893|P5|Phase II|Adverse Event|1
1408983|NCT01154036|4649894|P4|Phase II|Adverse Event|0
1408984|NCT01154036|4649895|P3|Phase II|Adverse Event|0
1408985|NCT01154036|4649896|P2|Phase II|Adverse Event|0
1408986|NCT01154036|4649897|P1|Phase II|Adverse Event|0
1408987|NCT01154036|4649890|P8|Phase I|Adverse Event|0
1408988|NCT01154036|4649891|P7|Phase I|Adverse Event|0
1408989|NCT01154036|4649892|P6|Phase I|Adverse Event|0
1408990|NCT01154036|4649893|P5|Phase I|Adverse Event|0
1408991|NCT01154036|4649894|P4|Phase I|Adverse Event|0
1408992|NCT01154036|4649895|P3|Phase I|Adverse Event|12
1408993|NCT01154036|4649896|P2|Phase I|Adverse Event|11
1408994|NCT01154036|4649897|P1|Phase I|Adverse Event|1
1408995|NCT01154036|4649890|P8|Phase I|Withdrawal by Subject|0
1408996|NCT01154036|4649891|P7|Phase I|Withdrawal by Subject|0
1408997|NCT01154036|4649892|P6|Phase I|Withdrawal by Subject|0
1408998|NCT01154036|4649893|P5|Phase I|Withdrawal by Subject|0
1408999|NCT01154036|4649894|P4|Phase I|Withdrawal by Subject|0
1409000|NCT01154036|4649895|P3|Phase I|Withdrawal by Subject|29
1409001|NCT01154036|4649896|P2|Phase I|Withdrawal by Subject|10
1409002|NCT01154036|4649897|P1|Phase I|Withdrawal by Subject|2
1409003|NCT01154036|4649890|P8|Phase I|Protocol Violation|0
1409004|NCT01154036|4649891|P7|Phase I|Protocol Violation|0
1409005|NCT01154036|4649892|P6|Phase I|Protocol Violation|0
1409006|NCT01154036|4649893|P5|Phase I|Protocol Violation|0
1409007|NCT01154036|4649894|P4|Phase I|Protocol Violation|0
1409008|NCT01154036|4649895|P3|Phase I|Protocol Violation|9
1409009|NCT01154036|4649896|P2|Phase I|Protocol Violation|3
1409010|NCT01154036|4649897|P1|Phase I|Protocol Violation|0
1409011|NCT01154036|4649890|P8|Phase I|Lost to Follow-up|0
1409012|NCT01154036|4649891|P7|Phase I|Lost to Follow-up|0
1409013|NCT01154036|4649892|P6|Phase I|Lost to Follow-up|0
1409014|NCT01154036|4649893|P5|Phase I|Lost to Follow-up|0
1409015|NCT01154036|4649894|P4|Phase I|Lost to Follow-up|0
1409016|NCT01154036|4649895|P3|Phase I|Lost to Follow-up|6
1409017|NCT01154036|4649896|P2|Phase I|Lost to Follow-up|3
1409018|NCT01154036|4649897|P1|Phase I|Lost to Follow-up|0
1409019|NCT01154036|4649890|P8|Phase I|Physician Decision|0
1409020|NCT01154036|4649891|P7|Phase I|Physician Decision|0
1409021|NCT01154036|4649892|P6|Phase I|Physician Decision|0
1409022|NCT01154036|4649893|P5|Phase I|Physician Decision|0
1409023|NCT01154036|4649894|P4|Phase I|Physician Decision|0
1409024|NCT01154036|4649895|P3|Phase I|Physician Decision|0
1409025|NCT01154036|4649896|P2|Phase I|Physician Decision|1
1409026|NCT01154036|4649897|P1|Phase I|Physician Decision|0
1409027|NCT01154010|4650021|P2|Overall Study|Lost to Follow-up|1
1409028|NCT01154010|4650022|P1|Overall Study|Lost to Follow-up|0
1409029|NCT01153984|4650028|P1|Overall Study|Adverse Event|1
1409030|NCT01153984|4650028|P1|Overall Study|Withdrawal by Subject|1
1409031|NCT01153971|4650039|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
1409032|NCT01153971|4650039|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
1409033|NCT01153971|4650039|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
1409034|NCT01153971|4650039|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
1409035|NCT01153971|4650039|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
1409036|NCT01153971|4650039|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
1409037|NCT01153971|4650039|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
1409038|NCT01153958|4650062|P2|Overall Study|Study Terminated|32
1409039|NCT01153958|4650063|P1|Overall Study|Study Terminated|36
1409040|NCT01153893|4650081|P2|Overall Study|Adverse Event|0
1409041|NCT01153893|4650082|P1|Overall Study|Adverse Event|1
1409042|NCT01153841|4650108|P2|Overall Study|Lost to Follow-up|0
1409043|NCT01153841|4650109|P1|Overall Study|Lost to Follow-up|2
1409044|NCT01153841|4650108|P2|Overall Study|Protocol Violation|0
1409045|NCT01153841|4650109|P1|Overall Study|Protocol Violation|2
1409046|NCT01153841|4650108|P2|Overall Study|Withdrawal by Subject|0
1409047|NCT01153841|4650109|P1|Overall Study|Withdrawal by Subject|1
1409048|NCT01153841|4650108|P2|Overall Study|Adverse Event|0
1409049|NCT01153841|4650109|P1|Overall Study|Adverse Event|1
1409050|NCT01153815|4650125|P2|Overall Study|Withdrawal by Subject|4
1409051|NCT01153815|4650126|P1|Overall Study|Withdrawal by Subject|6
1409052|NCT01153815|4650125|P2|Overall Study|Adverse Event|1
1409053|NCT01153815|4650126|P1|Overall Study|Adverse Event|3
1409054|NCT01153763|4650148|P1|Overall Study|Withdrawal by Subject|2
1409055|NCT01153763|4650148|P1|Overall Study|Physician Decision|2
1409056|NCT01153763|4650148|P1|Overall Study|Lost to Follow-up|1
1409057|NCT01153763|4650148|P1|Overall Study|Study Closed|16
1409058|NCT01153724|4650164|P1|Treatment Period 2|Other reason not defined above|1
1409059|NCT01153724|4650164|P1|Treatment Period 2|Adverse Event|1
1409060|NCT01153724|4650164|P1|Treatment Period 1|Withdrawal by Subject|1
1409061|NCT01153698|4650204|P1|Overall Study|Not treated with Pradaxa|5
1409062|NCT01153698|4650204|P1|Overall Study|Other|2
1409063|NCT01153698|4650204|P1|Overall Study|Switch to other anticoagulants|4
1409064|NCT01153698|4650204|P1|Overall Study|Withdrawal by Subject|2
1409065|NCT01153698|4650204|P1|Overall Study|Lost to Follow-up|4
1409066|NCT01153698|4650204|P1|Overall Study|Adverse Event|12
1409067|NCT01153633|4650255|P2|Overall Study|Therapeutic failure|3
1409068|NCT01153633|4650256|P1|Overall Study|Therapeutic failure|3
1409069|NCT01153633|4650255|P2|Overall Study|Protocol Violation|1
1409070|NCT01153633|4650256|P1|Overall Study|Protocol Violation|1
1409071|NCT01153425|4650306|P2|Overall Study|Withdrawal by Subject|3
1409072|NCT01153425|4650307|P1|Overall Study|Withdrawal by Subject|3
1409073|NCT01153347|4650319|P4|Overall Study|Death|0
1409074|NCT01153347|4650320|P3|Overall Study|Death|0
1409075|NCT01153347|4650321|P2|Overall Study|Death|0
1409076|NCT01153347|4650322|P1|Overall Study|Death|1
1409077|NCT01153347|4650319|P4|Overall Study|Not specified|0
1409078|NCT01153347|4650320|P3|Overall Study|Not specified|4
1409079|NCT01153347|4650321|P2|Overall Study|Not specified|5
1409080|NCT01153347|4650322|P1|Overall Study|Not specified|5
1409081|NCT01153347|4650319|P4|Overall Study|Lost to Follow-up|8
1409082|NCT01153347|4650320|P3|Overall Study|Lost to Follow-up|11
1409083|NCT01153347|4650321|P2|Overall Study|Lost to Follow-up|9
1409084|NCT01153347|4650322|P1|Overall Study|Lost to Follow-up|4
1409085|NCT01153347|4650319|P4|Overall Study|Study-specific withdrawal criteria|2
1409086|NCT01153347|4650320|P3|Overall Study|Study-specific withdrawal criteria|1
1409087|NCT01153347|4650321|P2|Overall Study|Study-specific withdrawal criteria|3
1409088|NCT01153347|4650322|P1|Overall Study|Study-specific withdrawal criteria|4
1409089|NCT01153347|4650319|P4|Overall Study|Lack of Efficacy|4
1409090|NCT01153347|4650320|P3|Overall Study|Lack of Efficacy|0
1409091|NCT01153347|4650321|P2|Overall Study|Lack of Efficacy|2
1409092|NCT01153347|4650322|P1|Overall Study|Lack of Efficacy|2
1409093|NCT01153347|4650319|P4|Overall Study|Condition under investigation worsened|0
1409094|NCT01153347|4650320|P3|Overall Study|Condition under investigation worsened|0
1409095|NCT01153347|4650321|P2|Overall Study|Condition under investigation worsened|1
1409096|NCT01153347|4650322|P1|Overall Study|Condition under investigation worsened|1
1409097|NCT01153347|4650319|P4|Overall Study|Severe non-compliance to protocol|3
1409098|NCT01153347|4650320|P3|Overall Study|Severe non-compliance to protocol|4
1409099|NCT01153347|4650321|P2|Overall Study|Severe non-compliance to protocol|7
1409100|NCT01153347|4650322|P1|Overall Study|Severe non-compliance to protocol|6
1409101|NCT01153347|4650319|P4|Overall Study|Adverse Event|7
1409102|NCT01153347|4650320|P3|Overall Study|Adverse Event|21
1409103|NCT01153347|4650321|P2|Overall Study|Adverse Event|9
1409104|NCT01153347|4650322|P1|Overall Study|Adverse Event|3
1409105|NCT01153347|4650319|P4|Overall Study|Eligibility criteria not fulfilled|1
1409106|NCT01153347|4650320|P3|Overall Study|Eligibility criteria not fulfilled|2
1409107|NCT01153347|4650321|P2|Overall Study|Eligibility criteria not fulfilled|1
1409108|NCT01153347|4650322|P1|Overall Study|Eligibility criteria not fulfilled|0
1409109|NCT01153347|4650319|P4|Overall Study|Withdrawal by Subject|7
1409110|NCT01153347|4650320|P3|Overall Study|Withdrawal by Subject|7
1409111|NCT01153347|4650321|P2|Overall Study|Withdrawal by Subject|7
1409112|NCT01153347|4650322|P1|Overall Study|Withdrawal by Subject|7
1409113|NCT01153321|4650422|P2|Overall Study|Adverse Event|1
1409114|NCT01153321|4650423|P1|Overall Study|Adverse Event|1
1409115|NCT01153321|4650422|P2|Overall Study|Withdrawal by Subject|1
1409116|NCT01153321|4650423|P1|Overall Study|Withdrawal by Subject|0
1409117|NCT01153321|4650422|P2|Overall Study|Development of study withdrawal criteria|1
1409118|NCT01153321|4650423|P1|Overall Study|Development of study withdrawal criteria|0
1409119|NCT01153269|4650535|P1|Overall Study|Antiretroviral therapy break|1
1409120|NCT01153269|4650535|P1|Overall Study|Withdrawal by Subject|1
1409121|NCT01153009|4650598|P4|Overall Study|Other|2
1409122|NCT01153009|4650599|P3|Overall Study|Other|3
1409123|NCT01153009|4650600|P2|Overall Study|Other|1
1409124|NCT01153009|4650601|P1|Overall Study|Other|1
1409125|NCT01153009|4650598|P4|Overall Study|Lost to Follow-up|15
1409126|NCT01153009|4650599|P3|Overall Study|Lost to Follow-up|11
1409127|NCT01153009|4650600|P2|Overall Study|Lost to Follow-up|8
1409128|NCT01153009|4650601|P1|Overall Study|Lost to Follow-up|8
1409129|NCT01153009|4650598|P4|Overall Study|Withdrawal of Consent|6
1409130|NCT01153009|4650599|P3|Overall Study|Withdrawal of Consent|4
1409131|NCT01153009|4650600|P2|Overall Study|Withdrawal of Consent|5
1409132|NCT01153009|4650601|P1|Overall Study|Withdrawal of Consent|5
1409133|NCT01153009|4650598|P4|Overall Study|Protocol Deviations|2
1409134|NCT01153009|4650599|P3|Overall Study|Protocol Deviations|3
1409135|NCT01153009|4650600|P2|Overall Study|Protocol Deviations|3
1409136|NCT01153009|4650601|P1|Overall Study|Protocol Deviations|4
1409137|NCT01153009|4650598|P4|Overall Study|Noncompliance with Study Medication|1
1409138|NCT01153009|4650599|P3|Overall Study|Noncompliance with Study Medication|4
1409139|NCT01153009|4650600|P2|Overall Study|Noncompliance with Study Medication|3
1409140|NCT01153009|4650601|P1|Overall Study|Noncompliance with Study Medication|1
1409141|NCT01153009|4650598|P4|Overall Study|Lack of Efficacy|1
1409142|NCT01153009|4650599|P3|Overall Study|Lack of Efficacy|2
1409143|NCT01153009|4650600|P2|Overall Study|Lack of Efficacy|0
1409144|NCT01153009|4650601|P1|Overall Study|Lack of Efficacy|9
1409145|NCT01153009|4650598|P4|Overall Study|Adverse Event|10
1409146|NCT01153009|4650599|P3|Overall Study|Adverse Event|14
1409147|NCT01153009|4650600|P2|Overall Study|Adverse Event|14
1409148|NCT01153009|4650601|P1|Overall Study|Adverse Event|4
1409149|NCT01152996|4650631|P1|Overall Study|Elevated liver enzymes|1
1409150|NCT01152996|4650631|P1|Overall Study|Protocol Violation|22
1409151|NCT01152996|4650631|P1|Overall Study|Other|36
1409152|NCT01152996|4650631|P1|Overall Study|Noncompliance|41
1409153|NCT01152996|4650631|P1|Overall Study|Lack of Efficacy|68
1409154|NCT01152996|4650631|P1|Overall Study|Lost to Follow-up|112
1409155|NCT01152996|4650631|P1|Overall Study|Adverse Event|115
1409156|NCT01152996|4650631|P1|Overall Study|Withdrawal by Subject|142
1409157|NCT01152814|4650644|P1|Overall Study|Lost to Follow-up|2
1409158|NCT01152788|4650653|P2|Overall Study|No treatment|1
1409159|NCT01152788|4650654|P1|Overall Study|No treatment|0
1409160|NCT01152788|4650653|P2|Overall Study|Withdrawal by Subject|3
1409161|NCT01152788|4650654|P1|Overall Study|Withdrawal by Subject|0
1409162|NCT01152580|4650691|P2|Overall Study|Withdrawal by Subject|1
1409163|NCT01152580|4650692|P1|Overall Study|Withdrawal by Subject|0
1409164|NCT01152554|4650714|P2|Overall Study|Death|1
1409165|NCT01152554|4650715|P1|Overall Study|Death|1
1409166|NCT01152554|4650714|P2|Overall Study|Not specified|8
1409167|NCT01152554|4650715|P1|Overall Study|Not specified|28
1409168|NCT01152554|4650714|P2|Overall Study|Lost to Follow-up|32
1409169|NCT01152554|4650715|P1|Overall Study|Lost to Follow-up|87
1409170|NCT01152554|4650714|P2|Overall Study|Study-specific withdrawal criteria|8
1409171|NCT01152554|4650715|P1|Overall Study|Study-specific withdrawal criteria|17
1409172|NCT01152554|4650714|P2|Overall Study|Lack of Efficacy|3
1409173|NCT01152554|4650715|P1|Overall Study|Lack of Efficacy|20
1409174|NCT01152554|4650714|P2|Overall Study|Condition under investigation worsened|2
1409175|NCT01152554|4650715|P1|Overall Study|Condition under investigation worsened|5
1409176|NCT01152554|4650714|P2|Overall Study|Severe non-compliance to protocol|14
1409177|NCT01152554|4650715|P1|Overall Study|Severe non-compliance to protocol|36
1409178|NCT01152554|4650714|P2|Overall Study|Adverse Event|14
1409179|NCT01152554|4650715|P1|Overall Study|Adverse Event|67
1409180|NCT01152554|4650714|P2|Overall Study|Eligiblity criteria not fulfilled|1
1409181|NCT01152554|4650715|P1|Overall Study|Eligiblity criteria not fulfilled|0
1409182|NCT01152554|4650714|P2|Overall Study|Withdrawal by Subject|28
1409183|NCT01152554|4650715|P1|Overall Study|Withdrawal by Subject|73
1409184|NCT01152450|4650737|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
1409185|NCT01152450|4650738|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
1409186|NCT01152450|4650739|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
1409187|NCT01152450|4650740|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
1409188|NCT01152450|4650741|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
1409189|NCT01152450|4650742|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
1409190|NCT01152450|4650737|P6|Period 1 (4 Weeks)|Protocol Violation|0
1409191|NCT01152450|4650738|P5|Period 1 (4 Weeks)|Protocol Violation|1
1409192|NCT01152450|4650739|P4|Period 1 (4 Weeks)|Protocol Violation|0
1409193|NCT01152450|4650740|P3|Period 1 (4 Weeks)|Protocol Violation|0
1409194|NCT01152450|4650741|P2|Period 1 (4 Weeks)|Protocol Violation|0
1409195|NCT01152450|4650742|P1|Period 1 (4 Weeks)|Protocol Violation|0
1409196|NCT01152450|4650737|P6|Period 1 (4 Weeks)|Adverse Event|1
1409197|NCT01152450|4650738|P5|Period 1 (4 Weeks)|Adverse Event|1
1409198|NCT01152450|4650739|P4|Period 1 (4 Weeks)|Adverse Event|0
1409199|NCT01152450|4650740|P3|Period 1 (4 Weeks)|Adverse Event|0
1409200|NCT01152450|4650741|P2|Period 1 (4 Weeks)|Adverse Event|0
1409201|NCT01152450|4650742|P1|Period 1 (4 Weeks)|Adverse Event|0
1409202|NCT01152437|4650813|P3|Overall Study|Refusal to continue taking trial medicat|2
1409203|NCT01152437|4650814|P2|Overall Study|Refusal to continue taking trial medicat|0
1409204|NCT01152437|4650815|P1|Overall Study|Refusal to continue taking trial medicat|1
1409205|NCT01152437|4650813|P3|Overall Study|Progressive disease|32
1409206|NCT01152437|4650814|P2|Overall Study|Progressive disease|13
1409207|NCT01152437|4650815|P1|Overall Study|Progressive disease|27
1409208|NCT01152437|4650813|P3|Overall Study|Not treated|2
1409209|NCT01152437|4650814|P2|Overall Study|Not treated|1
1409210|NCT01152437|4650815|P1|Overall Study|Not treated|0
1409211|NCT01152437|4650813|P3|Overall Study|Other Adverse Event|7
1409212|NCT01152437|4650814|P2|Overall Study|Other Adverse Event|1
1409213|NCT01152437|4650815|P1|Overall Study|Other Adverse Event|8
1409214|NCT01152385|4650835|P4|Overall Study|Other|3
1409215|NCT01152385|4650836|P3|Overall Study|Other|2
1409216|NCT01152385|4650837|P2|Overall Study|Other|3
1409217|NCT01152385|4650838|P1|Overall Study|Other|4
1409218|NCT01152385|4650835|P4|Overall Study|Study-specific withdrawal criteria|0
1409219|NCT01152385|4650836|P3|Overall Study|Study-specific withdrawal criteria|2
1409220|NCT01152385|4650837|P2|Overall Study|Study-specific withdrawal criteria|1
1409221|NCT01152385|4650838|P1|Overall Study|Study-specific withdrawal criteria|1
1409222|NCT01152385|4650835|P4|Overall Study|Adverse Event|0
1409223|NCT01152385|4650836|P3|Overall Study|Adverse Event|0
1409224|NCT01152385|4650837|P2|Overall Study|Adverse Event|1
1409225|NCT01152385|4650838|P1|Overall Study|Adverse Event|1
1409226|NCT01152385|4650835|P4|Overall Study|Protocol Violation|1
1409227|NCT01152385|4650836|P3|Overall Study|Protocol Violation|0
1409228|NCT01152385|4650837|P2|Overall Study|Protocol Violation|0
1409229|NCT01152385|4650838|P1|Overall Study|Protocol Violation|0
1409230|NCT01152385|4650835|P4|Overall Study|Withdrawal by Subject|1
1409231|NCT01152385|4650836|P3|Overall Study|Withdrawal by Subject|1
1409232|NCT01152385|4650837|P2|Overall Study|Withdrawal by Subject|1
1409233|NCT01152385|4650838|P1|Overall Study|Withdrawal by Subject|3
1409234|NCT01152190|4650905|P2|Overall Study|Withdrawal by Subject|3
1409235|NCT01152190|4650906|P1|Overall Study|Withdrawal by Subject|1
1409236|NCT01152190|4650905|P2|Overall Study|Protocol Violation|1
1409237|NCT01152190|4650906|P1|Overall Study|Protocol Violation|1
1409238|NCT01152190|4650905|P2|Overall Study|Death|0
1409239|NCT01152190|4650906|P1|Overall Study|Death|1
1409240|NCT01152190|4650905|P2|Overall Study|Adverse Event|4
1409241|NCT01152190|4650906|P1|Overall Study|Adverse Event|2
1409242|NCT01151579|4650965|P2|Overall Study|Not meet inclusion criteria|4
1409243|NCT01151579|4650966|P1|Overall Study|Not meet inclusion criteria|6
1409244|NCT01151579|4650965|P2|Overall Study|Withdrawal by Subject|2
1409245|NCT01151579|4650966|P1|Overall Study|Withdrawal by Subject|3
1409246|NCT01151579|4650965|P2|Overall Study|Physician Decision|1
1409247|NCT01151579|4650966|P1|Overall Study|Physician Decision|3
1409248|NCT01151410|4651020|P2|Overall Study|Abnormal laboratory value(s)|1
1409249|NCT01151410|4651021|P1|Overall Study|Abnormal laboratory value(s)|0
1409250|NCT01151410|4651020|P2|Overall Study|Unsatisfactory therapeutic effect|1
1409251|NCT01151410|4651021|P1|Overall Study|Unsatisfactory therapeutic effect|1
1409252|NCT01151410|4651020|P2|Overall Study|Administrative problems|1
1409253|NCT01151410|4651021|P1|Overall Study|Administrative problems|1
1409254|NCT01151410|4651020|P2|Overall Study|Protocol deviation|1
1409255|NCT01151410|4651021|P1|Overall Study|Protocol deviation|2
1409256|NCT01151410|4651020|P2|Overall Study|Adverse Event|2
1409257|NCT01151410|4651021|P1|Overall Study|Adverse Event|1
1409258|NCT01151410|4651020|P2|Overall Study|Lost to Follow-up|4
1409259|NCT01151410|4651021|P1|Overall Study|Lost to Follow-up|3
1409260|NCT01151410|4651020|P2|Overall Study|Withdrawal by Subject|5
1409261|NCT01151410|4651021|P1|Overall Study|Withdrawal by Subject|3
1409262|NCT01151345|4651065|P2|First Intervention Period|Protocol Violation|1
1409263|NCT01151345|4651066|P1|First Intervention Period|Protocol Violation|0
1409264|NCT01151280|4651080|P1|Overall Study|Lack of Efficacy|3
1409265|NCT01151280|4651080|P1|Overall Study|Adverse Event|1
1409266|NCT01151215|4651093|P3|Overall Study|Safety as judged by the investigator|1
1409267|NCT01151215|4651094|P2|Overall Study|Safety as judged by the investigator|0
1409268|NCT01151215|4651095|P1|Overall Study|Safety as judged by the investigator|0
1409269|NCT01151215|4651093|P3|Overall Study|Disease progression|1
1409270|NCT01151215|4651094|P2|Overall Study|Disease progression|1
1409271|NCT01151215|4651095|P1|Overall Study|Disease progression|0
1409272|NCT01151215|4651093|P3|Overall Study|Withdrawal by Subject|2
1409273|NCT01151215|4651094|P2|Overall Study|Withdrawal by Subject|1
1409274|NCT01151215|4651095|P1|Overall Study|Withdrawal by Subject|3
1409275|NCT01151215|4651093|P3|Overall Study|Lost to Follow-up|3
1409276|NCT01151215|4651094|P2|Overall Study|Lost to Follow-up|0
1409277|NCT01151215|4651095|P1|Overall Study|Lost to Follow-up|0
1409278|NCT01151215|4651093|P3|Overall Study|Death|11
1409279|NCT01151215|4651094|P2|Overall Study|Death|20
1409280|NCT01151215|4651095|P1|Overall Study|Death|16
1409281|NCT01151215|4651093|P3|Overall Study|Worsening of condition under study|1
1409282|NCT01151215|4651094|P2|Overall Study|Worsening of condition under study|1
1409283|NCT01151215|4651095|P1|Overall Study|Worsening of condition under study|1
1409284|NCT01151137|4651133|P2|Overall Study|Lost to Follow-up|1
1409285|NCT01151137|4651134|P1|Overall Study|Lost to Follow-up|1
1409286|NCT01151137|4651133|P2|Overall Study|Death|27
1409287|NCT01151137|4651134|P1|Overall Study|Death|15
1409288|NCT01151098|4651152|P1|Overall Study|Miscellaneous|13
1409289|NCT01151098|4651152|P1|Overall Study|Protocol Violation|1
1409290|NCT01151098|4651152|P1|Overall Study|Lack of Efficacy|15
1409291|NCT01151098|4651152|P1|Overall Study|Lost to Follow-up|6
1409292|NCT01151098|4651152|P1|Overall Study|Adverse Event|82
1409293|NCT01151085|4651156|P1|Overall Study|Protocol Violation|25
1409294|NCT01151085|4651156|P1|Overall Study|Lost to Follow-up|31
1409295|NCT01151020|4651187|P1|Overall Study|Still be eligible for follow-up|79
1409296|NCT01151020|4651187|P1|Overall Study|Patients did not receive the device|2
1409297|NCT01151020|4651187|P1|Overall Study|Withdrawal by Subject|12
1409298|NCT01151020|4651187|P1|Overall Study|Lost to Follow-up|1
1409299|NCT01151020|4651187|P1|Overall Study|Conversion to open repair|1
1409300|NCT01151020|4651187|P1|Overall Study|Death|15
1409301|NCT01150474|4651266|P2|Overall Study|Surgery Changed|0
1409302|NCT01150474|4651267|P1|Overall Study|Surgery Changed|1
1409303|NCT01150474|4651266|P2|Overall Study|Drug not administered|0
1409304|NCT01150474|4651267|P1|Overall Study|Drug not administered|1
1409305|NCT01150474|4651266|P2|Overall Study|Drug did not arrive in time|0
1409306|NCT01150474|4651267|P1|Overall Study|Drug did not arrive in time|1
1409307|NCT01150474|4651266|P2|Overall Study|Rectotomy|0
1409308|NCT01150474|4651267|P1|Overall Study|Rectotomy|1
1409309|NCT01150474|4651266|P2|Overall Study|Multiple Studies|1
1409310|NCT01150474|4651267|P1|Overall Study|Multiple Studies|0
1409311|NCT01150474|4651266|P2|Overall Study|Cancer found|0
1409312|NCT01150474|4651267|P1|Overall Study|Cancer found|1
1409313|NCT01150474|4651266|P2|Overall Study|Withdrawal by Subject|2
1409314|NCT01150474|4651267|P1|Overall Study|Withdrawal by Subject|5
1409315|NCT01150357|4651312|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
1409316|NCT01150357|4651313|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
1409317|NCT01150357|4651314|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
1409318|NCT01150357|4651312|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
1409319|NCT01150357|4651313|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
1409320|NCT01150357|4651314|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
1409321|NCT01150357|4651312|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
1409322|NCT01150357|4651313|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
1409323|NCT01150357|4651314|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
1409324|NCT01150357|4651312|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
1409325|NCT01150357|4651313|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
1409326|NCT01150357|4651314|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
1409327|NCT01150357|4651312|P3|Dose Response Phase (Phase 1)|Adverse Event|1
1409328|NCT01150357|4651313|P2|Dose Response Phase (Phase 1)|Adverse Event|0
1409329|NCT01150357|4651314|P1|Dose Response Phase (Phase 1)|Adverse Event|0
1409330|NCT01150357|4651312|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
1409331|NCT01150357|4651313|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
1409332|NCT01150357|4651314|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
1409333|NCT01150357|4651312|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
1409334|NCT01150357|4651313|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
1409335|NCT01150357|4651314|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
1409336|NCT01150123|4651394|P18|Overall Study|Lost to Follow-up|0
1409337|NCT01150123|4651395|P17|Overall Study|Lost to Follow-up|0
1409338|NCT01150123|4651396|P16|Overall Study|Lost to Follow-up|0
1409339|NCT01150123|4651397|P15|Overall Study|Lost to Follow-up|0
1409340|NCT01150123|4651398|P14|Overall Study|Lost to Follow-up|0
1409341|NCT01150123|4651399|P13|Overall Study|Lost to Follow-up|2
1409342|NCT01150123|4651400|P12|Overall Study|Lost to Follow-up|1
1409343|NCT01150123|4651401|P11|Overall Study|Lost to Follow-up|1
1409344|NCT01150123|4651402|P10|Overall Study|Lost to Follow-up|1
1409345|NCT01150123|4651403|P9|Overall Study|Lost to Follow-up|3
1409346|NCT01150123|4651404|P8|Overall Study|Lost to Follow-up|0
1409347|NCT01150123|4651405|P7|Overall Study|Lost to Follow-up|0
1409348|NCT01150123|4651406|P6|Overall Study|Lost to Follow-up|5
1409349|NCT01150123|4651407|P5|Overall Study|Lost to Follow-up|2
1409350|NCT01150123|4651408|P4|Overall Study|Lost to Follow-up|2
1409351|NCT01150123|4651409|P3|Overall Study|Lost to Follow-up|2
1409352|NCT01150123|4651410|P2|Overall Study|Lost to Follow-up|1
1409353|NCT01150123|4651411|P1|Overall Study|Lost to Follow-up|2
1409354|NCT01150123|4651394|P18|Overall Study|Withdrawal by Subject|1
1409355|NCT01150123|4651395|P17|Overall Study|Withdrawal by Subject|0
1409356|NCT01150123|4651396|P16|Overall Study|Withdrawal by Subject|1
1409357|NCT01150123|4651397|P15|Overall Study|Withdrawal by Subject|0
1409358|NCT01150123|4651398|P14|Overall Study|Withdrawal by Subject|0
1409359|NCT01150123|4651399|P13|Overall Study|Withdrawal by Subject|1
1409360|NCT01150123|4651400|P12|Overall Study|Withdrawal by Subject|0
1409361|NCT01150123|4651401|P11|Overall Study|Withdrawal by Subject|1
1409362|NCT01150123|4651402|P10|Overall Study|Withdrawal by Subject|0
1409363|NCT01150123|4651403|P9|Overall Study|Withdrawal by Subject|2
1409364|NCT01150123|4651404|P8|Overall Study|Withdrawal by Subject|3
1409365|NCT01150123|4651405|P7|Overall Study|Withdrawal by Subject|0
1409366|NCT01150123|4651406|P6|Overall Study|Withdrawal by Subject|1
1409367|NCT01150123|4651407|P5|Overall Study|Withdrawal by Subject|1
1409368|NCT01150123|4651408|P4|Overall Study|Withdrawal by Subject|1
1409369|NCT01150123|4651409|P3|Overall Study|Withdrawal by Subject|2
1409370|NCT01150123|4651410|P2|Overall Study|Withdrawal by Subject|1
1409371|NCT01150123|4651411|P1|Overall Study|Withdrawal by Subject|1
1409372|NCT01150097|4651587|P3|Months 24 to 48 Post-transplantation|Death|0
1409373|NCT01150097|4651588|P2|Months 24 to 48 Post-transplantation|Death|0
1409374|NCT01150097|4651589|P1|Months 24 to 48 Post-transplantation|Death|2
1409375|NCT01150097|4651587|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
1409376|NCT01150097|4651588|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
1409377|NCT01150097|4651589|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
1409378|NCT01150097|4651587|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
1409379|NCT01150097|4651588|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
1409380|NCT01150097|4651589|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
1409381|NCT01150097|4651587|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
1409382|NCT01150097|4651588|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
1409383|NCT01150097|4651589|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
1409384|NCT01150097|4651587|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
1409385|NCT01150097|4651588|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
1409386|NCT01150097|4651589|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
1409387|NCT01150097|4651587|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
1409388|NCT01150097|4651588|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
1409389|NCT01150097|4651589|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
1409390|NCT01150097|4651587|P3|Months 24 to 36 Post-transplantation|Death|0
1409391|NCT01150097|4651588|P2|Months 24 to 36 Post-transplantation|Death|0
1409392|NCT01150097|4651589|P1|Months 24 to 36 Post-transplantation|Death|2
1409393|NCT01149863|4651633|P1|Overall Study|Missing data or Not receiveing studydrug|3
1409394|NCT01149655|4651710|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
1409395|NCT01149655|4651711|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
1409396|NCT01149655|4651712|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
1409397|NCT01149655|4651713|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
1409398|NCT01149655|4651710|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
1409399|NCT01149655|4651711|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
1409400|NCT01149655|4651712|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
1409401|NCT01149655|4651713|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
1409402|NCT01149655|4651710|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
1409403|NCT01149655|4651711|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
1409404|NCT01149655|4651712|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
1409405|NCT01149655|4651713|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
1409406|NCT01149655|4651710|P4|Period 3-DB Maintenance Phase|Physician Decision|0
1409407|NCT01149655|4651711|P3|Period 3-DB Maintenance Phase|Physician Decision|1
1409408|NCT01149655|4651712|P2|Period 3-DB Maintenance Phase|Physician Decision|0
1409409|NCT01149655|4651713|P1|Period 3-DB Maintenance Phase|Physician Decision|0
1409410|NCT01149655|4651710|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
1409411|NCT01149655|4651711|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
1409412|NCT01149655|4651712|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
1409413|NCT01149655|4651713|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
1409414|NCT01149655|4651710|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
1409415|NCT01149655|4651711|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
1409416|NCT01149655|4651712|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
1409417|NCT01149655|4651713|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
1409418|NCT01149655|4651710|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
1409419|NCT01149655|4651711|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
1409420|NCT01149655|4651712|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
1409421|NCT01149655|4651713|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
1409422|NCT01149655|4651710|P4|Period 2-Stabilization Phase|Physician Decision|0
1409423|NCT01149655|4651711|P3|Period 2-Stabilization Phase|Physician Decision|0
1409424|NCT01149655|4651712|P2|Period 2-Stabilization Phase|Physician Decision|3
1409425|NCT01149655|4651713|P1|Period 2-Stabilization Phase|Physician Decision|0
1409426|NCT01149655|4651710|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
1409427|NCT01149655|4651711|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
1409428|NCT01149655|4651712|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
1409429|NCT01149655|4651713|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
1409430|NCT01149655|4651710|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
1409431|NCT01149655|4651711|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
1409432|NCT01149655|4651712|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
1409433|NCT01149655|4651713|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
1409434|NCT01149655|4651710|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
1409435|NCT01149655|4651711|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
1409436|NCT01149655|4651712|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
1409437|NCT01149655|4651713|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
1409438|NCT01149655|4651710|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
1409439|NCT01149655|4651711|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
1409440|NCT01149655|4651712|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
1409441|NCT01149655|4651713|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
1409442|NCT01149655|4651710|P4|Period 1 - Conversion Phase|Physician Decision|0
1409443|NCT01149655|4651711|P3|Period 1 - Conversion Phase|Physician Decision|0
1409444|NCT01149655|4651712|P2|Period 1 - Conversion Phase|Physician Decision|0
1409445|NCT01149655|4651713|P1|Period 1 - Conversion Phase|Physician Decision|2
1409446|NCT01149655|4651710|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
1409447|NCT01149655|4651711|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
1409448|NCT01149655|4651712|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
1409449|NCT01149655|4651713|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
1409450|NCT01149655|4651710|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
1409451|NCT01149655|4651711|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
1409452|NCT01149655|4651712|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
1409453|NCT01149655|4651713|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
1409454|NCT01149655|4651710|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
1409455|NCT01149655|4651711|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
1409456|NCT01149655|4651712|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
1409457|NCT01149655|4651713|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
1409458|NCT01149538|4651756|P2|Overall Study|Withdrawal by Subject|3
1409459|NCT01149538|4651757|P1|Overall Study|Withdrawal by Subject|5
1409460|NCT01149538|4651756|P2|Overall Study|Lost to Follow-up|1
1409461|NCT01149538|4651757|P1|Overall Study|Lost to Follow-up|0
1409462|NCT01149486|4651778|P2|First Intervention|Adverse Event|1
1409463|NCT01149486|4651779|P1|First Intervention|Adverse Event|0
1409464|NCT01149473|4651803|P2|Washout of 7 Days|Withdrawal by Subject|1
1409465|NCT01149473|4651804|P1|Washout of 7 Days|Withdrawal by Subject|1
1409466|NCT01149473|4651803|P2|First Intervention|Adverse Event|1
1409467|NCT01149473|4651804|P1|First Intervention|Adverse Event|1
1409468|NCT01149460|4651822|P2|Overall Study|Withdrawal by Subject|2
1409469|NCT01149460|4651823|P1|Overall Study|Withdrawal by Subject|0
1409470|NCT01149421|4651856|P3|Overall Study|Protocol Violation|6
1409471|NCT01149421|4651857|P2|Overall Study|Protocol Violation|2
1409472|NCT01149421|4651858|P1|Overall Study|Protocol Violation|2
1409473|NCT01149421|4651856|P3|Overall Study|Entry Criteria Not Met|2
1409474|NCT01149421|4651857|P2|Overall Study|Entry Criteria Not Met|1
1409475|NCT01149421|4651858|P1|Overall Study|Entry Criteria Not Met|1
1409476|NCT01149421|4651856|P3|Overall Study|Physician Decision|6
1409477|NCT01149421|4651857|P2|Overall Study|Physician Decision|3
1409478|NCT01149421|4651858|P1|Overall Study|Physician Decision|5
1409479|NCT01149421|4651856|P3|Overall Study|Lost to Follow-up|5
1409480|NCT01149421|4651857|P2|Overall Study|Lost to Follow-up|4
1409481|NCT01149421|4651858|P1|Overall Study|Lost to Follow-up|2
1409482|NCT01149421|4651856|P3|Overall Study|Sponsor Decision|1
1409483|NCT01149421|4651857|P2|Overall Study|Sponsor Decision|1
1409484|NCT01149421|4651858|P1|Overall Study|Sponsor Decision|0
1409485|NCT01149421|4651856|P3|Overall Study|Withdrawal by Subject|13
1409486|NCT01149421|4651857|P2|Overall Study|Withdrawal by Subject|12
1409487|NCT01149421|4651858|P1|Overall Study|Withdrawal by Subject|20
1409488|NCT01149421|4651856|P3|Overall Study|Adverse Event|11
1409489|NCT01149421|4651857|P2|Overall Study|Adverse Event|6
1409490|NCT01149421|4651858|P1|Overall Study|Adverse Event|22
1409491|NCT01149343|4651941|P4|Overall Study|Recurrence / Progressive disease|0
1409492|NCT01149343|4651942|P3|Overall Study|Recurrence / Progressive disease|1
1409493|NCT01149343|4651943|P2|Overall Study|Recurrence / Progressive disease|0
1409494|NCT01149343|4651944|P1|Overall Study|Recurrence / Progressive disease|0
1409495|NCT01149343|4651941|P4|Overall Study|Sponsor study termination|2
1409496|NCT01149343|4651942|P3|Overall Study|Sponsor study termination|0
1409497|NCT01149343|4651943|P2|Overall Study|Sponsor study termination|0
1409498|NCT01149343|4651944|P1|Overall Study|Sponsor study termination|0
1409499|NCT01149343|4651941|P4|Overall Study|Other|14
1409500|NCT01149343|4651942|P3|Overall Study|Other|2
1409501|NCT01149343|4651943|P2|Overall Study|Other|10
1409502|NCT01149343|4651944|P1|Overall Study|Other|8
1409503|NCT01149343|4651941|P4|Overall Study|Lost to Follow-up|1
1409504|NCT01149343|4651942|P3|Overall Study|Lost to Follow-up|0
1409505|NCT01149343|4651943|P2|Overall Study|Lost to Follow-up|0
1409506|NCT01149343|4651944|P1|Overall Study|Lost to Follow-up|1
1409507|NCT01149343|4651941|P4|Overall Study|Death|18
1409508|NCT01149343|4651942|P3|Overall Study|Death|18
1409509|NCT01149343|4651943|P2|Overall Study|Death|13
1409510|NCT01149343|4651944|P1|Overall Study|Death|10
1409511|NCT01149343|4651941|P4|Overall Study|Withdrawal by Subject|5
1409512|NCT01149343|4651942|P3|Overall Study|Withdrawal by Subject|1
1409513|NCT01149343|4651943|P2|Overall Study|Withdrawal by Subject|1
1409514|NCT01149343|4651944|P1|Overall Study|Withdrawal by Subject|1
1409515|NCT01149148|4652029|P2|Overall Study|Death|0
1409516|NCT01149148|4652030|P1|Overall Study|Death|1
1409517|NCT01149148|4652029|P2|Overall Study|Lost to Follow-up|2
1409518|NCT01149148|4652030|P1|Overall Study|Lost to Follow-up|1
1409519|NCT01149057|4652038|P1|Overall Study|Other|6
1409520|NCT01149057|4652038|P1|Overall Study|High Parathyroid Hormone Value|1
1409521|NCT01149057|4652038|P1|Overall Study|Lost to Follow-up|1
1409522|NCT01149057|4652038|P1|Overall Study|Participant Non-Compliance|2
1409523|NCT01149057|4652038|P1|Overall Study|B Cell Depletion|4
1409524|NCT01149057|4652038|P1|Overall Study|Positive Hepatitis B Core Antibody|5
1409525|NCT01149057|4652038|P1|Overall Study|Withdrawal by Subject|9
1409526|NCT01149057|4652038|P1|Overall Study|Adverse Event|13
1409527|NCT01149057|4652038|P1|Overall Study|Lack of Efficacy|16
1409528|NCT01148979|4652065|P2|Overall Study|Lost to Follow-up|1
1409529|NCT01148979|4652066|P1|Overall Study|Lost to Follow-up|0
1409530|NCT01148862|4652072|P2|Second Intervention|Withdrawal by Subject|2
1409531|NCT01148862|4652073|P1|Second Intervention|Withdrawal by Subject|0
1409532|NCT01148771|4652105|P2|Washout Period|Withdrawal by Subject|1
1409533|NCT01148771|4652106|P1|Washout Period|Withdrawal by Subject|0
1409534|NCT01148693|4652126|P2|Overall Study|Attempts for cannulation were failed|10
1409535|NCT01148693|4652127|P1|Overall Study|Attempts for cannulation were failed|13
1409536|NCT01148537|4652147|P3|Overall Study|Adverse Event|1
1409537|NCT01148537|4652148|P2|Overall Study|Adverse Event|0
1409538|NCT01148537|4652149|P1|Overall Study|Adverse Event|2
1409539|NCT01148537|4652147|P3|Overall Study|Withdrawal by Subject|2
1409540|NCT01148537|4652148|P2|Overall Study|Withdrawal by Subject|0
1409541|NCT01148537|4652149|P1|Overall Study|Withdrawal by Subject|1
1409542|NCT01148511|4652235|P3|Randomized|Not Specified|1
1409543|NCT01148511|4652236|P2|Randomized|Not Specified|1
1409544|NCT01148511|4652237|P1|Randomized|Not Specified|0
1409545|NCT01148511|4652235|P3|Randomized|Consent withdrawal|3
1409546|NCT01148511|4652236|P2|Randomized|Consent withdrawal|5
1409547|NCT01148511|4652237|P1|Randomized|Consent withdrawal|0
1409548|NCT01148511|4652235|P3|Randomized|Lost to Follow-up|1
1409549|NCT01148511|4652236|P2|Randomized|Lost to Follow-up|1
1409550|NCT01148511|4652237|P1|Randomized|Lost to Follow-up|0
1409551|NCT01148511|4652235|P3|Randomized|Protocol Violation|1
1409552|NCT01148511|4652236|P2|Randomized|Protocol Violation|2
1409553|NCT01148511|4652237|P1|Randomized|Protocol Violation|0
1409554|NCT01148511|4652235|P3|Randomized|Adverse Event|0
1409555|NCT01148511|4652236|P2|Randomized|Adverse Event|1
1409556|NCT01148511|4652237|P1|Randomized|Adverse Event|0
1409557|NCT01148511|4652235|P3|Exposed to Study Drug|Lost to Follow-up|0
1409558|NCT01148511|4652236|P2|Exposed to Study Drug|Lost to Follow-up|0
1409559|NCT01148511|4652237|P1|Exposed to Study Drug|Lost to Follow-up|4
1409560|NCT01148511|4652235|P3|Exposed to Study Drug|Protocol Violation|0
1409561|NCT01148511|4652236|P2|Exposed to Study Drug|Protocol Violation|0
1409562|NCT01148511|4652237|P1|Exposed to Study Drug|Protocol Violation|2
1409563|NCT01148017|4652275|P4|Overall Study|Unable to classify|0
1409564|NCT01148017|4652276|P3|Overall Study|Unable to classify|0
1409565|NCT01148017|4652277|P2|Overall Study|Unable to classify|1
1409566|NCT01148017|4652278|P1|Overall Study|Unable to classify|3
1409567|NCT01148017|4652275|P4|Overall Study|Administrative reason|0
1409568|NCT01148017|4652276|P3|Overall Study|Administrative reason|0
1409569|NCT01148017|4652277|P2|Overall Study|Administrative reason|9
1409570|NCT01148017|4652278|P1|Overall Study|Administrative reason|22
1409571|NCT01148017|4652275|P4|Overall Study|Inappropriate enrollment|0
1409572|NCT01148017|4652276|P3|Overall Study|Inappropriate enrollment|0
1409573|NCT01148017|4652277|P2|Overall Study|Inappropriate enrollment|0
1409574|NCT01148017|4652278|P1|Overall Study|Inappropriate enrollment|1
1409575|NCT01148017|4652275|P4|Overall Study|Lost to Follow-up|0
1409576|NCT01148017|4652276|P3|Overall Study|Lost to Follow-up|0
1409577|NCT01148017|4652277|P2|Overall Study|Lost to Follow-up|10
1409578|NCT01148017|4652278|P1|Overall Study|Lost to Follow-up|23
1409579|NCT01148017|4652275|P4|Overall Study|Withdrawal by Subject|0
1409580|NCT01148017|4652276|P3|Overall Study|Withdrawal by Subject|0
1409581|NCT01148017|4652277|P2|Overall Study|Withdrawal by Subject|14
1409582|NCT01148017|4652278|P1|Overall Study|Withdrawal by Subject|31
1409583|NCT01147926|4652317|P2|Overall Study|Colonoscopy result|1
1409584|NCT01147926|4652318|P1|Overall Study|Colonoscopy result|0
1409585|NCT01147926|4652317|P2|Overall Study|Went on holiday|1
1409586|NCT01147926|4652318|P1|Overall Study|Went on holiday|0
1409587|NCT01147926|4652317|P2|Overall Study|Too busy, no time for study|0
1409588|NCT01147926|4652318|P1|Overall Study|Too busy, no time for study|1
1409589|NCT01147926|4652317|P2|Overall Study|Lack of Efficacy|0
1409590|NCT01147926|4652318|P1|Overall Study|Lack of Efficacy|1
1409591|NCT01147926|4652317|P2|Overall Study|Sponsor's Decision|1
1409592|NCT01147926|4652318|P1|Overall Study|Sponsor's Decision|0
1409593|NCT01147926|4652317|P2|Overall Study|Lost to Follow-up|2
1409594|NCT01147926|4652318|P1|Overall Study|Lost to Follow-up|0
1409595|NCT01147926|4652317|P2|Overall Study|Selection criteria not met|1
1409596|NCT01147926|4652318|P1|Overall Study|Selection criteria not met|3
1409597|NCT01147926|4652317|P2|Overall Study|Principal investigator left hospital|3
1409598|NCT01147926|4652318|P1|Overall Study|Principal investigator left hospital|1
1409599|NCT01147926|4652317|P2|Overall Study|Subject Non-Compliant|4
1409600|NCT01147926|4652318|P1|Overall Study|Subject Non-Compliant|5
1409601|NCT01147926|4652317|P2|Overall Study|Adverse Event|6
1409602|NCT01147926|4652318|P1|Overall Study|Adverse Event|7
1409603|NCT01147926|4652317|P2|Overall Study|Subject Withdrew Consent|10
1409604|NCT01147926|4652318|P1|Overall Study|Subject Withdrew Consent|9
1409605|NCT01147900|4652353|P3|At Year 10|Lost to Follow-up|0
1409606|NCT01147900|4652354|P2|At Year 10|Lost to Follow-up|1
1409607|NCT01147900|4652355|P1|At Year 10|Lost to Follow-up|0
1409608|NCT01147874|4652414|P1|Overall Study|Withdrawal by Subject|24
1409609|NCT01147874|4652414|P1|Overall Study|Sponsor's Decision|2
1409610|NCT01147874|4652414|P1|Overall Study|Protocol Violation|5
1409611|NCT01147874|4652414|P1|Overall Study|Other|5
1409612|NCT01147874|4652414|P1|Overall Study|Lost to Follow-up|25
1409613|NCT01147874|4652414|P1|Overall Study|Investigator’s Request|1
1409614|NCT01147874|4652414|P1|Overall Study|Adverse Event|5
1409615|NCT01147848|4652422|P3|Randomized Phase|Withdrawal by Subject|9
1409616|NCT01147848|4652423|P2|Randomized Phase|Withdrawal by Subject|7
1409617|NCT01147848|4652424|P1|Randomized Phase|Withdrawal by Subject|0
1409618|NCT01147848|4652422|P3|Randomized Phase|Physician Decision|1
1409619|NCT01147848|4652423|P2|Randomized Phase|Physician Decision|0
1409620|NCT01147848|4652424|P1|Randomized Phase|Physician Decision|0
1409621|NCT01147848|4652422|P3|Randomized Phase|Lost to Follow-up|7
1409622|NCT01147848|4652423|P2|Randomized Phase|Lost to Follow-up|5
1409623|NCT01147848|4652424|P1|Randomized Phase|Lost to Follow-up|0
1409624|NCT01147848|4652422|P3|Randomized Phase|Protocol Violation|10
1409625|NCT01147848|4652423|P2|Randomized Phase|Protocol Violation|7
1409626|NCT01147848|4652424|P1|Randomized Phase|Protocol Violation|0
1409627|NCT01147848|4652422|P3|Randomized Phase|Lack of Efficacy|11
1409628|NCT01147848|4652423|P2|Randomized Phase|Lack of Efficacy|20
1409629|NCT01147848|4652424|P1|Randomized Phase|Lack of Efficacy|0
1409630|NCT01147848|4652422|P3|Randomized Phase|Adverse Event|8
1409631|NCT01147848|4652423|P2|Randomized Phase|Adverse Event|6
1409632|NCT01147848|4652424|P1|Randomized Phase|Adverse Event|0
1409633|NCT01147848|4652422|P3|Run-in Period|Run-in Failure|0
1409634|NCT01147848|4652423|P2|Run-in Period|Run-in Failure|0
1409635|NCT01147848|4652424|P1|Run-in Period|Run-in Failure|135
1409636|NCT01147848|4652422|P3|Run-in Period|Screen Failure|0
1409637|NCT01147848|4652423|P2|Run-in Period|Screen Failure|0
1409638|NCT01147848|4652424|P1|Run-in Period|Screen Failure|623
1409639|NCT01147822|4652456|P2|Overall Study|Not Completed/Ongoing|102
1409640|NCT01147822|4652457|P1|Overall Study|Not Completed/Ongoing|111
1409641|NCT01147822|4652456|P2|Overall Study|Withdrawal by Subject|13
1409642|NCT01147822|4652457|P1|Overall Study|Withdrawal by Subject|8
1409643|NCT01147822|4652456|P2|Overall Study|Physician Decision|2
1409644|NCT01147822|4652457|P1|Overall Study|Physician Decision|0
1409645|NCT01147822|4652456|P2|Overall Study|Lost to Follow-up|2
1409646|NCT01147822|4652457|P1|Overall Study|Lost to Follow-up|3
1409647|NCT01147822|4652456|P2|Overall Study|Protocol Violation|1
1409648|NCT01147822|4652457|P1|Overall Study|Protocol Violation|0
1409649|NCT01147822|4652456|P2|Overall Study|Death|59
1409650|NCT01147822|4652457|P1|Overall Study|Death|66
1409651|NCT01147809|4652477|P6|Phase II (168 Days)|Ongoing|0
1409652|NCT01147809|4652478|P5|Phase II (168 Days)|Ongoing|1
1409653|NCT01147809|4652479|P4|Phase II (168 Days)|Ongoing|0
1409654|NCT01147809|4652480|P3|Phase II (168 Days)|Ongoing|0
1409655|NCT01147809|4652481|P2|Phase II (168 Days)|Ongoing|0
1409656|NCT01147809|4652482|P1|Phase II (168 Days)|Ongoing|0
1409657|NCT01147809|4652477|P6|Phase II (168 Days)|Withdrawal by Subject|15
1409658|NCT01147809|4652478|P5|Phase II (168 Days)|Withdrawal by Subject|7
1409659|NCT01147809|4652479|P4|Phase II (168 Days)|Withdrawal by Subject|0
1409660|NCT01147809|4652480|P3|Phase II (168 Days)|Withdrawal by Subject|0
1409661|NCT01147809|4652481|P2|Phase II (168 Days)|Withdrawal by Subject|0
1409662|NCT01147809|4652482|P1|Phase II (168 Days)|Withdrawal by Subject|0
1409663|NCT01147809|4652477|P6|Phase II (168 Days)|Physician Decision|11
1409664|NCT01147809|4652478|P5|Phase II (168 Days)|Physician Decision|5
1409665|NCT01147809|4652479|P4|Phase II (168 Days)|Physician Decision|0
1409666|NCT01147809|4652480|P3|Phase II (168 Days)|Physician Decision|0
1409667|NCT01147809|4652481|P2|Phase II (168 Days)|Physician Decision|0
1409668|NCT01147809|4652482|P1|Phase II (168 Days)|Physician Decision|0
1409669|NCT01147809|4652477|P6|Phase II (168 Days)|Protocol Violation|1
1409670|NCT01147809|4652478|P5|Phase II (168 Days)|Protocol Violation|0
1409671|NCT01147809|4652479|P4|Phase II (168 Days)|Protocol Violation|0
1409672|NCT01147809|4652480|P3|Phase II (168 Days)|Protocol Violation|0
1409673|NCT01147809|4652481|P2|Phase II (168 Days)|Protocol Violation|0
1409674|NCT01147809|4652482|P1|Phase II (168 Days)|Protocol Violation|0
1409675|NCT01147809|4652477|P6|Phase II (168 Days)|Adverse Event|6
1409676|NCT01147809|4652478|P5|Phase II (168 Days)|Adverse Event|3
1409677|NCT01147809|4652479|P4|Phase II (168 Days)|Adverse Event|0
1409678|NCT01147809|4652480|P3|Phase II (168 Days)|Adverse Event|0
1409679|NCT01147809|4652481|P2|Phase II (168 Days)|Adverse Event|0
1409680|NCT01147809|4652482|P1|Phase II (168 Days)|Adverse Event|0
1409681|NCT01147809|4652477|P6|Phase I (168 Days)|Withdrawal by Subject|0
1409682|NCT01147809|4652478|P5|Phase I (168 Days)|Withdrawal by Subject|0
1409683|NCT01147809|4652479|P4|Phase I (168 Days)|Withdrawal by Subject|3
1409684|NCT01147809|4652480|P3|Phase I (168 Days)|Withdrawal by Subject|0
1409685|NCT01147809|4652481|P2|Phase I (168 Days)|Withdrawal by Subject|0
1409686|NCT01147809|4652482|P1|Phase I (168 Days)|Withdrawal by Subject|0
1409687|NCT01147809|4652477|P6|Phase I (168 Days)|Physician Decision|0
1409688|NCT01147809|4652478|P5|Phase I (168 Days)|Physician Decision|0
1409689|NCT01147809|4652479|P4|Phase I (168 Days)|Physician Decision|0
1409690|NCT01147809|4652480|P3|Phase I (168 Days)|Physician Decision|2
1409691|NCT01147809|4652481|P2|Phase I (168 Days)|Physician Decision|1
1409692|NCT01147809|4652482|P1|Phase I (168 Days)|Physician Decision|0
1409693|NCT01147809|4652477|P6|Phase I (168 Days)|Lost to Follow-up|0
1409694|NCT01147809|4652478|P5|Phase I (168 Days)|Lost to Follow-up|0
1409695|NCT01147809|4652479|P4|Phase I (168 Days)|Lost to Follow-up|1
1409696|NCT01147809|4652480|P3|Phase I (168 Days)|Lost to Follow-up|0
1409697|NCT01147809|4652481|P2|Phase I (168 Days)|Lost to Follow-up|0
1409698|NCT01147809|4652482|P1|Phase I (168 Days)|Lost to Follow-up|1
1409699|NCT01147809|4652477|P6|Phase I (168 Days)|Adverse Event|0
1409700|NCT01147809|4652478|P5|Phase I (168 Days)|Adverse Event|0
1409701|NCT01147809|4652479|P4|Phase I (168 Days)|Adverse Event|1
1409702|NCT01147809|4652480|P3|Phase I (168 Days)|Adverse Event|0
1409703|NCT01147809|4652481|P2|Phase I (168 Days)|Adverse Event|0
1409704|NCT01147809|4652482|P1|Phase I (168 Days)|Adverse Event|0
1409705|NCT01147744|4652603|P7|Overall Study|Met Protocol-defined Stopping Criteria|0
1409706|NCT01147744|4652604|P6|Overall Study|Met Protocol-defined Stopping Criteria|1
1409707|NCT01147744|4652605|P5|Overall Study|Met Protocol-defined Stopping Criteria|0
1409708|NCT01147744|4652606|P4|Overall Study|Met Protocol-defined Stopping Criteria|0
1409709|NCT01147744|4652607|P3|Overall Study|Met Protocol-defined Stopping Criteria|0
1409710|NCT01147744|4652608|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
1409711|NCT01147744|4652609|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
1409712|NCT01147744|4652603|P7|Overall Study|Sponsor decision to amend protocol|6
1409713|NCT01147744|4652604|P6|Overall Study|Sponsor decision to amend protocol|2
1409714|NCT01147744|4652605|P5|Overall Study|Sponsor decision to amend protocol|7
1409715|NCT01147744|4652606|P4|Overall Study|Sponsor decision to amend protocol|5
1409716|NCT01147744|4652607|P3|Overall Study|Sponsor decision to amend protocol|2
1409717|NCT01147744|4652608|P2|Overall Study|Sponsor decision to amend protocol|4
1409718|NCT01147744|4652609|P1|Overall Study|Sponsor decision to amend protocol|7
1409719|NCT01147744|4652603|P7|Overall Study|Lost to Follow-up|0
1409720|NCT01147744|4652604|P6|Overall Study|Lost to Follow-up|0
1409721|NCT01147744|4652605|P5|Overall Study|Lost to Follow-up|0
1409722|NCT01147744|4652606|P4|Overall Study|Lost to Follow-up|0
1409723|NCT01147744|4652607|P3|Overall Study|Lost to Follow-up|0
1409724|NCT01147744|4652608|P2|Overall Study|Lost to Follow-up|1
1409725|NCT01147744|4652609|P1|Overall Study|Lost to Follow-up|0
1409726|NCT01147744|4652603|P7|Overall Study|Withdrawal by Subject|2
1409727|NCT01147744|4652604|P6|Overall Study|Withdrawal by Subject|5
1409728|NCT01147744|4652605|P5|Overall Study|Withdrawal by Subject|2
1409729|NCT01147744|4652606|P4|Overall Study|Withdrawal by Subject|2
1409730|NCT01147744|4652607|P3|Overall Study|Withdrawal by Subject|2
1409731|NCT01147744|4652608|P2|Overall Study|Withdrawal by Subject|4
1409732|NCT01147744|4652609|P1|Overall Study|Withdrawal by Subject|8
1409733|NCT01147744|4652603|P7|Overall Study|Adverse Event|2
1409734|NCT01147744|4652604|P6|Overall Study|Adverse Event|1
1409735|NCT01147744|4652605|P5|Overall Study|Adverse Event|2
1409736|NCT01147744|4652606|P4|Overall Study|Adverse Event|0
1409737|NCT01147744|4652607|P3|Overall Study|Adverse Event|3
1409738|NCT01147744|4652608|P2|Overall Study|Adverse Event|2
1409739|NCT01147744|4652609|P1|Overall Study|Adverse Event|1
1409740|NCT01147744|4652603|P7|Overall Study|Lack of Efficacy|7
1409741|NCT01147744|4652604|P6|Overall Study|Lack of Efficacy|8
1409742|NCT01147744|4652605|P5|Overall Study|Lack of Efficacy|13
1409743|NCT01147744|4652606|P4|Overall Study|Lack of Efficacy|11
1409744|NCT01147744|4652607|P3|Overall Study|Lack of Efficacy|9
1409745|NCT01147744|4652608|P2|Overall Study|Lack of Efficacy|11
1409746|NCT01147744|4652609|P1|Overall Study|Lack of Efficacy|11
1409747|NCT01147744|4652603|P7|Overall Study|Physician Decision|1
1409748|NCT01147744|4652604|P6|Overall Study|Physician Decision|0
1409749|NCT01147744|4652605|P5|Overall Study|Physician Decision|0
1409750|NCT01147744|4652606|P4|Overall Study|Physician Decision|0
1409751|NCT01147744|4652607|P3|Overall Study|Physician Decision|1
1409752|NCT01147744|4652608|P2|Overall Study|Physician Decision|1
1409753|NCT01147744|4652609|P1|Overall Study|Physician Decision|0
1409754|NCT01147744|4652603|P7|Overall Study|Protocol Violation|1
1409755|NCT01147744|4652604|P6|Overall Study|Protocol Violation|3
1409756|NCT01147744|4652605|P5|Overall Study|Protocol Violation|1
1409757|NCT01147744|4652606|P4|Overall Study|Protocol Violation|0
1409758|NCT01147744|4652607|P3|Overall Study|Protocol Violation|1
1409759|NCT01147744|4652608|P2|Overall Study|Protocol Violation|0
1409760|NCT01147744|4652609|P1|Overall Study|Protocol Violation|1
1409761|NCT01147653|4652704|P2|Year 2|Withdrawal by Subject|3
1409762|NCT01147653|4652705|P1|Year 2|Withdrawal by Subject|2
1409763|NCT01147640|4652766|P2|Overall Study|Didn't meet eligibility criteria|0
1409764|NCT01147640|4652767|P1|Overall Study|Didn't meet eligibility criteria|1
1409765|NCT01147640|4652766|P2|Overall Study|Lost to Follow-up|1
1409766|NCT01147640|4652767|P1|Overall Study|Lost to Follow-up|0
1409767|NCT01147640|4652766|P2|Overall Study|Withdrawal by Subject|0
1409768|NCT01147640|4652767|P1|Overall Study|Withdrawal by Subject|1
1409769|NCT01147640|4652766|P2|Overall Study|Physician Decision|0
1409770|NCT01147640|4652767|P1|Overall Study|Physician Decision|1
1409771|NCT01147640|4652766|P2|Overall Study|Adverse Event|0
1409772|NCT01147640|4652767|P1|Overall Study|Adverse Event|2
1409773|NCT01147497|4652799|P2|Overall Study|failed insertion|0
1409774|NCT01147497|4652800|P1|Overall Study|failed insertion|2
1409775|NCT01147471|4652820|P2|6 Month Follow Up|Lost to Follow-up|2
1409776|NCT01147471|4652821|P1|6 Month Follow Up|Lost to Follow-up|4
1409777|NCT01147471|4652820|P2|3 Month Follow Up|Physician Decision|1
1409778|NCT01147471|4652821|P1|3 Month Follow Up|Physician Decision|0
1409779|NCT01147471|4652820|P2|3 Month Follow Up|Lost to Follow-up|1
1409780|NCT01147471|4652821|P1|3 Month Follow Up|Lost to Follow-up|1
1409781|NCT01147471|4652820|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
1409782|NCT01147471|4652821|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
1409783|NCT01147471|4652820|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
1409784|NCT01147471|4652821|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
1409785|NCT01147471|4652820|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
1409786|NCT01147471|4652821|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
1409787|NCT01147458|4652835|P4|Second Intervention|Other|0
1409788|NCT01147458|4652836|P3|Second Intervention|Other|1
1409789|NCT01147458|4652837|P2|Second Intervention|Other|0
1409790|NCT01147458|4652838|P1|Second Intervention|Other|0
1409791|NCT01147458|4652835|P4|Second Intervention|Adverse Event|1
1409792|NCT01147458|4652836|P3|Second Intervention|Adverse Event|1
1409793|NCT01147458|4652837|P2|Second Intervention|Adverse Event|0
1409794|NCT01147458|4652838|P1|Second Intervention|Adverse Event|2
1409795|NCT01147458|4652835|P4|Second Intervention|Withdrawal by Subject|0
1409796|NCT01147458|4652836|P3|Second Intervention|Withdrawal by Subject|0
1409797|NCT01147458|4652837|P2|Second Intervention|Withdrawal by Subject|1
1409798|NCT01147458|4652838|P1|Second Intervention|Withdrawal by Subject|0
1409799|NCT01147458|4652835|P4|Second Intervention|Protocol Violation|0
1409800|NCT01147458|4652836|P3|Second Intervention|Protocol Violation|1
1409801|NCT01147458|4652837|P2|Second Intervention|Protocol Violation|1
1409802|NCT01147458|4652838|P1|Second Intervention|Protocol Violation|0
1409803|NCT01147458|4652835|P4|Second Intervention|Study terminated by sponsor|3
1409804|NCT01147458|4652836|P3|Second Intervention|Study terminated by sponsor|5
1409805|NCT01147458|4652837|P2|Second Intervention|Study terminated by sponsor|5
1409806|NCT01147458|4652838|P1|Second Intervention|Study terminated by sponsor|7
1409807|NCT01147458|4652835|P4|First Intervention|Other|0
1409808|NCT01147458|4652836|P3|First Intervention|Other|0
1409809|NCT01147458|4652837|P2|First Intervention|Other|2
1409810|NCT01147458|4652838|P1|First Intervention|Other|1
1409811|NCT01147458|4652835|P4|First Intervention|Adverse Event|3
1409812|NCT01147458|4652836|P3|First Intervention|Adverse Event|2
1409813|NCT01147458|4652837|P2|First Intervention|Adverse Event|3
1409814|NCT01147458|4652838|P1|First Intervention|Adverse Event|0
1409815|NCT01147458|4652835|P4|First Intervention|Withdrawal by Subject|0
1409816|NCT01147458|4652836|P3|First Intervention|Withdrawal by Subject|1
1409817|NCT01147458|4652837|P2|First Intervention|Withdrawal by Subject|0
1409818|NCT01147458|4652838|P1|First Intervention|Withdrawal by Subject|3
1409819|NCT01147458|4652835|P4|First Intervention|Protocol Violation|3
1409820|NCT01147458|4652836|P3|First Intervention|Protocol Violation|2
1409821|NCT01147458|4652837|P2|First Intervention|Protocol Violation|3
1409822|NCT01147458|4652838|P1|First Intervention|Protocol Violation|2
1409823|NCT01147458|4652835|P4|First Intervention|Study terminated by sponsor|8
1409824|NCT01147458|4652836|P3|First Intervention|Study terminated by sponsor|7
1409825|NCT01147458|4652837|P2|First Intervention|Study terminated by sponsor|8
1409826|NCT01147458|4652838|P1|First Intervention|Study terminated by sponsor|8
1409827|NCT01147393|4652917|P1|Dose Level -1|Dose Limited Toxicity|1
1409828|NCT01147393|4652917|P1|Dose Level 1|Dose limiting Toxicity|2
1409829|NCT01147341|4652938|P2|Open Label Period|Subject moved|0
1409830|NCT01147341|4652939|P1|Open Label Period|Subject moved|1
1409831|NCT01147341|4652938|P2|Open Label Period|Lack of Efficacy|0
1409832|NCT01147341|4652939|P1|Open Label Period|Lack of Efficacy|3
1409833|NCT01147341|4652938|P2|Double Blind Period|Withdrawal by Subject|1
1409834|NCT01147341|4652939|P1|Double Blind Period|Withdrawal by Subject|0
1409835|NCT01147341|4652938|P2|Double Blind Period|Lack of Efficacy|1
1409836|NCT01147341|4652939|P1|Double Blind Period|Lack of Efficacy|1
1409837|NCT01147250|4653002|P2|Overall Study|Other than specified|1
1409838|NCT01147250|4653003|P1|Overall Study|Other than specified|0
1409839|NCT01147250|4653002|P2|Overall Study|Site termination by sponsor|5
1409840|NCT01147250|4653003|P1|Overall Study|Site termination by sponsor|13
1409841|NCT01147250|4653002|P2|Overall Study|Withdrawal by Subject|88
1409842|NCT01147250|4653003|P1|Overall Study|Withdrawal by Subject|83
1409843|NCT01147250|4653002|P2|Overall Study|Lost to Follow-up|11
1409844|NCT01147250|4653003|P1|Overall Study|Lost to Follow-up|14
1409845|NCT01147172|4653015|P1|Overall Study|Lost to Follow-up|2
1409846|NCT01147172|4653015|P1|Overall Study|Withdrawal by Subject|2
1409847|NCT01147068|4653033|P7|Subjects That Completed Safety Follow-up|Ineligible|0
1409848|NCT01147068|4653034|P6|Subjects That Completed Safety Follow-up|Ineligible|0
1409849|NCT01147068|4653035|P5|Subjects That Completed Safety Follow-up|Ineligible|0
1409850|NCT01147068|4653036|P4|Subjects That Completed Safety Follow-up|Ineligible|0
1409851|NCT01147068|4653037|P3|Subjects That Completed Safety Follow-up|Ineligible|0
1409852|NCT01147068|4653038|P2|Subjects That Completed Safety Follow-up|Ineligible|1
1409853|NCT01147068|4653039|P1|Subjects That Completed Safety Follow-up|Ineligible|0
1409854|NCT01147068|4653033|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1409855|NCT01147068|4653034|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1409856|NCT01147068|4653035|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1409857|NCT01147068|4653036|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
1409858|NCT01147068|4653037|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1409859|NCT01147068|4653038|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1409860|NCT01147068|4653039|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1409861|NCT01147068|4653033|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
1409862|NCT01147068|4653034|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
1409863|NCT01147068|4653035|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
1409864|NCT01147068|4653036|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
1409865|NCT01147068|4653037|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
1409866|NCT01147068|4653038|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
1409867|NCT01147068|4653039|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
1409868|NCT01147068|4653033|P7|Subjects That Received 2nd Dose|Other|0
1409869|NCT01147068|4653034|P6|Subjects That Received 2nd Dose|Other|0
1409870|NCT01147068|4653035|P5|Subjects That Received 2nd Dose|Other|1
1409871|NCT01147068|4653036|P4|Subjects That Received 2nd Dose|Other|0
1409872|NCT01147068|4653037|P3|Subjects That Received 2nd Dose|Other|3
1409873|NCT01147068|4653038|P2|Subjects That Received 2nd Dose|Other|3
1409874|NCT01147068|4653039|P1|Subjects That Received 2nd Dose|Other|0
1409875|NCT01147068|4653033|P7|Subjects That Received 2nd Dose|Did not complete the study|0
1409876|NCT01147068|4653034|P6|Subjects That Received 2nd Dose|Did not complete the study|1
1409877|NCT01147068|4653035|P5|Subjects That Received 2nd Dose|Did not complete the study|0
1409878|NCT01147068|4653036|P4|Subjects That Received 2nd Dose|Did not complete the study|0
1409879|NCT01147068|4653037|P3|Subjects That Received 2nd Dose|Did not complete the study|0
1409880|NCT01147068|4653038|P2|Subjects That Received 2nd Dose|Did not complete the study|1
1409881|NCT01147068|4653039|P1|Subjects That Received 2nd Dose|Did not complete the study|0
1409882|NCT01147068|4653033|P7|Subjects That Received 2nd Dose|Ineligible|0
1409883|NCT01147068|4653034|P6|Subjects That Received 2nd Dose|Ineligible|0
1409884|NCT01147068|4653035|P5|Subjects That Received 2nd Dose|Ineligible|0
1409885|NCT01147068|4653036|P4|Subjects That Received 2nd Dose|Ineligible|0
1409886|NCT01147068|4653037|P3|Subjects That Received 2nd Dose|Ineligible|0
1409887|NCT01147068|4653038|P2|Subjects That Received 2nd Dose|Ineligible|1
1409888|NCT01147068|4653039|P1|Subjects That Received 2nd Dose|Ineligible|0
1409889|NCT01147068|4653033|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
1409890|NCT01147068|4653034|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
1409891|NCT01147068|4653035|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
1409892|NCT01147068|4653036|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
1409893|NCT01147068|4653037|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
1409894|NCT01147068|4653038|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
1409895|NCT01147068|4653039|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
1409896|NCT01147055|4653069|P2|First Intervention Period|Lost to Follow-up|0
1409897|NCT01147055|4653070|P1|First Intervention Period|Lost to Follow-up|1
1409898|NCT01146951|4653112|P2|Overall Study|Adverse Event|1
1409899|NCT01146951|4653113|P1|Overall Study|Adverse Event|4
1409900|NCT01146912|4653134|P8|Overall Study|Duplicate patient|0
1409901|NCT01146912|4653135|P7|Overall Study|Duplicate patient|0
1409902|NCT01146912|4653136|P6|Overall Study|Duplicate patient|0
1409903|NCT01146912|4653137|P5|Overall Study|Duplicate patient|0
1409904|NCT01146912|4653138|P4|Overall Study|Duplicate patient|0
1409905|NCT01146912|4653139|P3|Overall Study|Duplicate patient|1
1409906|NCT01146912|4653140|P2|Overall Study|Duplicate patient|0
1409907|NCT01146912|4653141|P1|Overall Study|Duplicate patient|0
1409908|NCT01146912|4653134|P8|Overall Study|< 14 weeks gestational age|0
1409909|NCT01146912|4653135|P7|Overall Study|< 14 weeks gestational age|0
1409910|NCT01146912|4653136|P6|Overall Study|< 14 weeks gestational age|0
1409911|NCT01146912|4653137|P5|Overall Study|< 14 weeks gestational age|0
1409912|NCT01146912|4653138|P4|Overall Study|< 14 weeks gestational age|2
1409913|NCT01146912|4653139|P3|Overall Study|< 14 weeks gestational age|3
1409914|NCT01146912|4653140|P2|Overall Study|< 14 weeks gestational age|0
1409915|NCT01146912|4653141|P1|Overall Study|< 14 weeks gestational age|0
1409916|NCT01146912|4653134|P8|Overall Study|Already received influenza vaccination|0
1409917|NCT01146912|4653135|P7|Overall Study|Already received influenza vaccination|56
1409918|NCT01146912|4653136|P6|Overall Study|Already received influenza vaccination|61
1409919|NCT01146912|4653137|P5|Overall Study|Already received influenza vaccination|41
1409920|NCT01146912|4653138|P4|Overall Study|Already received influenza vaccination|15
1409921|NCT01146912|4653139|P3|Overall Study|Already received influenza vaccination|13
1409922|NCT01146912|4653140|P2|Overall Study|Already received influenza vaccination|822
1409923|NCT01146912|4653141|P1|Overall Study|Already received influenza vaccination|817
1409924|NCT01146873|4653163|P2|Overall Study|Transfer out|6
1409925|NCT01146873|4653164|P1|Overall Study|Transfer out|0
1409926|NCT01146860|4653180|P2|Overall Study|Withdrawal by Subject|1
1409927|NCT01146860|4653181|P1|Overall Study|Withdrawal by Subject|0
1409928|NCT01146782|4653201|P1|Primary Endpoint Cohort|Physician Decision|1
1409929|NCT01146782|4653201|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
1409930|NCT01146782|4653201|P1|Safety Cohort|TST <4 hrs|14
1409931|NCT01146782|4653201|P1|Safety Cohort|Control AHI <5|4
1409932|NCT01146782|4653201|P1|Safety Cohort|Withdrawal by Subject|4
1409933|NCT01146782|4653201|P1|Safety Cohort|Screen Failure|61
1409934|NCT01146782|4653201|P1|Screening Cohort|Withdrawal by Subject|29
1409935|NCT01146782|4653201|P1|Screening Cohort|Physician Decision|1
1409936|NCT01146782|4653201|P1|Screening Cohort|Lost to Follow-up|4
1409937|NCT01146782|4653201|P1|Screening Cohort|Screen Failure|187
1409938|NCT01146613|4653210|P2|Overall Study|Outpatient detox|0
1409939|NCT01146613|4653211|P1|Overall Study|Outpatient detox|1
1409940|NCT01146613|4653210|P2|Overall Study|schedule conflict|0
1409941|NCT01146613|4653211|P1|Overall Study|schedule conflict|1
1409942|NCT01146613|4653210|P2|Overall Study|Withdrawal by Subject|3
1409943|NCT01146613|4653211|P1|Overall Study|Withdrawal by Subject|0
1409944|NCT01146613|4653210|P2|Overall Study|Physician Decision|0
1409945|NCT01146613|4653211|P1|Overall Study|Physician Decision|1
1409946|NCT01146613|4653210|P2|Overall Study|Death|0
1409947|NCT01146613|4653211|P1|Overall Study|Death|1
1409948|NCT01146613|4653210|P2|Overall Study|Lack of Efficacy|1
1409949|NCT01146613|4653211|P1|Overall Study|Lack of Efficacy|0
1409950|NCT01146613|4653210|P2|Overall Study|Lost to Follow-up|8
1409951|NCT01146613|4653211|P1|Overall Study|Lost to Follow-up|3
1409952|NCT01146288|4653302|P2|First Intervention(1 Day)|Adverse Event|1
1409953|NCT01146288|4653303|P1|First Intervention(1 Day)|Adverse Event|0
1409954|NCT01146054|4653317|P1|Overall Study|Lost to Follow-up|1
1409955|NCT01146054|4653317|P1|Overall Study|Other illness precluded treatment|2
1409956|NCT01146054|4653317|P1|Overall Study|Rapid tumor progression|2
1409957|NCT01146054|4653317|P1|Overall Study|Did not meet dose constraints for SBRT|5
1409958|NCT01145898|4653327|P2|3-year Treatment|medication change by treating physician|16
1409959|NCT01145898|4653328|P1|3-year Treatment|medication change by treating physician|3
1409960|NCT01145755|4653362|P3|Overall Study|Positive urine ethanol|0
1409961|NCT01145755|4653363|P2|Overall Study|Positive urine ethanol|1
1409962|NCT01145755|4653364|P1|Overall Study|Positive urine ethanol|0
1409963|NCT01145755|4653362|P3|Overall Study|Withdrawal by Subject|1
1409964|NCT01145755|4653363|P2|Overall Study|Withdrawal by Subject|0
1409965|NCT01145755|4653364|P1|Overall Study|Withdrawal by Subject|0
1409966|NCT01145755|4653362|P3|Overall Study|Patient could not swollow medication|1
1409967|NCT01145755|4653363|P2|Overall Study|Patient could not swollow medication|0
1409968|NCT01145755|4653364|P1|Overall Study|Patient could not swollow medication|0
1409969|NCT01145755|4653362|P3|Overall Study|Lack of Efficacy|0
1409970|NCT01145755|4653363|P2|Overall Study|Lack of Efficacy|1
1409971|NCT01145755|4653364|P1|Overall Study|Lack of Efficacy|0
1409972|NCT01145755|4653362|P3|Overall Study|Study Closure|17
1409973|NCT01145755|4653363|P2|Overall Study|Study Closure|14
1409974|NCT01145755|4653364|P1|Overall Study|Study Closure|14
1409975|NCT01145755|4653362|P3|Overall Study|Protocol Violation|1
1409976|NCT01145755|4653363|P2|Overall Study|Protocol Violation|3
1409977|NCT01145755|4653364|P1|Overall Study|Protocol Violation|0
1409978|NCT01145755|4653362|P3|Overall Study|Lost to Follow-up|1
1409979|NCT01145755|4653363|P2|Overall Study|Lost to Follow-up|3
1409980|NCT01145755|4653364|P1|Overall Study|Lost to Follow-up|2
1409981|NCT01145755|4653362|P3|Overall Study|Withdrawal by Subject|2
1409982|NCT01145755|4653363|P2|Overall Study|Withdrawal by Subject|2
1409983|NCT01145755|4653364|P1|Overall Study|Withdrawal by Subject|2
1409984|NCT01145755|4653362|P3|Overall Study|Adverse Event|2
1409985|NCT01145755|4653363|P2|Overall Study|Adverse Event|4
1409986|NCT01145755|4653364|P1|Overall Study|Adverse Event|2
1409987|NCT01145625|4653391|P2|Overall Study|Pregnancy|1
1409988|NCT01145625|4653392|P1|Overall Study|Pregnancy|0
1409989|NCT01145625|4653391|P2|Overall Study|Withdrawal by Subject|16
1409990|NCT01145625|4653392|P1|Overall Study|Withdrawal by Subject|7
1409991|NCT01145625|4653391|P2|Overall Study|Protocol Violation|1
1409992|NCT01145625|4653392|P1|Overall Study|Protocol Violation|3
1409993|NCT01145625|4653391|P2|Overall Study|Adverse Event|4
1409994|NCT01145625|4653392|P1|Overall Study|Adverse Event|6
1409995|NCT01145625|4653391|P2|Overall Study|Lost to Follow-up|9
1409996|NCT01145625|4653392|P1|Overall Study|Lost to Follow-up|8
1409997|NCT01145560|4653405|P3|Overall Study|Withdrawal of therapy|1
1409998|NCT01145560|4653406|P2|Overall Study|Withdrawal of therapy|0
1409999|NCT01145560|4653407|P1|Overall Study|Withdrawal of therapy|0
1410000|NCT01145560|4653405|P3|Overall Study|False insurance information|0
1410001|NCT01145560|4653406|P2|Overall Study|False insurance information|1
1410002|NCT01145560|4653407|P1|Overall Study|False insurance information|0
1410003|NCT01145560|4653405|P3|Overall Study|Accidental unblinding of study treatment|0
1410004|NCT01145560|4653406|P2|Overall Study|Accidental unblinding of study treatment|1
1410005|NCT01145560|4653407|P1|Overall Study|Accidental unblinding of study treatment|0
1410006|NCT01145560|4653405|P3|Overall Study|No study drug by 24h after organ failure|0
1410007|NCT01145560|4653406|P2|Overall Study|No study drug by 24h after organ failure|0
1410008|NCT01145560|4653407|P1|Overall Study|No study drug by 24h after organ failure|1
1410009|NCT01145560|4653405|P3|Overall Study|Lost to Follow-up|1
1410010|NCT01145560|4653406|P2|Overall Study|Lost to Follow-up|1
1410011|NCT01145560|4653407|P1|Overall Study|Lost to Follow-up|1
1410012|NCT01145560|4653405|P3|Overall Study|Withdrawal by Subject|0
1410013|NCT01145560|4653406|P2|Overall Study|Withdrawal by Subject|1
1410014|NCT01145560|4653407|P1|Overall Study|Withdrawal by Subject|2
1410015|NCT01145508|4653433|P2|Overall Study|Never started treatment|1
1410016|NCT01145508|4653434|P1|Overall Study|Never started treatment|1
1410017|NCT01145508|4653433|P2|Overall Study|Physician Decision|1
1410018|NCT01145508|4653434|P1|Overall Study|Physician Decision|2
1410019|NCT01145508|4653433|P2|Overall Study|Death|0
1410020|NCT01145508|4653434|P1|Overall Study|Death|1
1410021|NCT01145508|4653433|P2|Overall Study|Adverse Event|0
1410022|NCT01145508|4653434|P1|Overall Study|Adverse Event|1
1410023|NCT01145495|4653440|P1|Overall Study|Disease progression after respone|1
1410024|NCT01145495|4653440|P1|Overall Study|Withdrawal by Subject|5
1410025|NCT01145495|4653440|P1|Overall Study|Adverse Event|6
1410026|NCT01145482|4653446|P2|First Intervention (1 Day)|Withdrawal by Subject|1
1410027|NCT01145482|4653447|P1|First Intervention (1 Day)|Withdrawal by Subject|0
1410028|NCT01145417|4653457|P2|Overall Study|Other|0
1410029|NCT01145417|4653458|P1|Overall Study|Other|1
1410030|NCT01145417|4653457|P2|Overall Study|Study terminated by sponsor|43
1410031|NCT01145417|4653458|P1|Overall Study|Study terminated by sponsor|35
1410032|NCT01145417|4653457|P2|Overall Study|Adverse Event|1
1410033|NCT01145417|4653458|P1|Overall Study|Adverse Event|0
1410034|NCT01145417|4653457|P2|Overall Study|Pregnancy|0
1410035|NCT01145417|4653458|P1|Overall Study|Pregnancy|1
1410036|NCT01145417|4653457|P2|Overall Study|Withdrawal by Subject|2
1410037|NCT01145417|4653458|P1|Overall Study|Withdrawal by Subject|1
1410038|NCT01145417|4653457|P2|Overall Study|Lost to Follow-up|1
1410039|NCT01145417|4653458|P1|Overall Study|Lost to Follow-up|2
1410040|NCT01145417|4653457|P2|Overall Study|Death|0
1410041|NCT01145417|4653458|P1|Overall Study|Death|1
1410042|NCT01145352|4653491|P1|Overall Study|Syringe formulation was used|1
1410043|NCT01145352|4653491|P1|Overall Study|Treated before marketing approval|4
1410044|NCT01145352|4653491|P1|Overall Study|Found to have been registered twice|6
1410045|NCT01145053|4653499|P1|Overall Study|Other|18
1410046|NCT01145053|4653499|P1|Overall Study|Withdrawal by Subject|25
1410047|NCT01145053|4653499|P1|Overall Study|Lost to Follow-up|28
1410048|NCT01145053|4653499|P1|Overall Study|Adverse Event|22
1410049|NCT01144715|4653551|P2|Overall Study|Adverse Event|1
1410050|NCT01144715|4653552|P1|Overall Study|Adverse Event|0
1410051|NCT01144715|4653551|P2|Overall Study|Withdrawal by Subject|1
1410052|NCT01144715|4653552|P1|Overall Study|Withdrawal by Subject|2
1410053|NCT01144715|4653551|P2|Overall Study|Lost to Follow-up|1
1410054|NCT01144715|4653552|P1|Overall Study|Lost to Follow-up|2
1410055|NCT01144416|4653621|P2|Intervention Period|Other|5
1410056|NCT01144416|4653622|P1|Intervention Period|Other|7
1410057|NCT01144416|4653621|P2|Intervention Period|No/too few/bad quality embryos|3
1410058|NCT01144416|4653622|P1|Intervention Period|No/too few/bad quality embryos|3
1410059|NCT01144416|4653621|P2|Intervention Period|No or abnormal fertilization|10
1410060|NCT01144416|4653622|P1|Intervention Period|No or abnormal fertilization|25
1410061|NCT01144416|4653621|P2|Intervention Period|No/too few/bad oocytes|5
1410062|NCT01144416|4653622|P1|Intervention Period|No/too few/bad oocytes|7
1410063|NCT01144416|4653621|P2|Intervention Period|Too high ovarian response|2
1410064|NCT01144416|4653622|P1|Intervention Period|Too high ovarian response|4
1410065|NCT01144416|4653621|P2|Intervention Period|Risk of OHSS|1
1410066|NCT01144416|4653622|P1|Intervention Period|Risk of OHSS|0
1410067|NCT01144416|4653621|P2|Intervention Period|Insufficient ovarian response|17
1410068|NCT01144416|4653622|P1|Intervention Period|Insufficient ovarian response|11
1410069|NCT01144416|4653621|P2|Intervention Period|Adverse Event|6
1410070|NCT01144416|4653622|P1|Intervention Period|Adverse Event|5
1410071|NCT01144403|4653638|P1|Overall Study|Adverse Event|1
1410072|NCT01144403|4653638|P1|Overall Study|Death|1
1410073|NCT01144403|4653638|P1|Overall Study|Lost to Follow-up|3
1410074|NCT01144377|4653650|P5|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
1410075|NCT01144377|4653651|P4|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
1410076|NCT01144377|4653652|P3|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
1410077|NCT01144377|4653653|P2|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
1410078|NCT01144377|4653654|P1|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
1410079|NCT01144377|4653650|P5|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
1410080|NCT01144377|4653651|P4|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
1410081|NCT01144377|4653652|P3|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
1410082|NCT01144377|4653653|P2|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
1410083|NCT01144377|4653654|P1|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
1410084|NCT01144377|4653650|P5|Optional 40 Week Safety Follow-up Period|Adverse Event|1
1410085|NCT01144377|4653651|P4|Optional 40 Week Safety Follow-up Period|Adverse Event|0
1410086|NCT01144377|4653652|P3|Optional 40 Week Safety Follow-up Period|Adverse Event|0
1410087|NCT01144377|4653653|P2|Optional 40 Week Safety Follow-up Period|Adverse Event|1
1410088|NCT01144377|4653654|P1|Optional 40 Week Safety Follow-up Period|Adverse Event|0
1410089|NCT01144377|4653650|P5|52 Week Treatment Period|Sponsor Decision|1
1410090|NCT01144377|4653651|P4|52 Week Treatment Period|Sponsor Decision|0
1410091|NCT01144377|4653652|P3|52 Week Treatment Period|Sponsor Decision|0
1410092|NCT01144377|4653653|P2|52 Week Treatment Period|Sponsor Decision|0
1410093|NCT01144377|4653654|P1|52 Week Treatment Period|Sponsor Decision|0
1410094|NCT01144377|4653650|P5|52 Week Treatment Period|Withdrawal by Subject|0
1410095|NCT01144377|4653651|P4|52 Week Treatment Period|Withdrawal by Subject|1
1410096|NCT01144377|4653652|P3|52 Week Treatment Period|Withdrawal by Subject|1
1410097|NCT01144377|4653653|P2|52 Week Treatment Period|Withdrawal by Subject|1
1410098|NCT01144377|4653654|P1|52 Week Treatment Period|Withdrawal by Subject|4
1410099|NCT01144377|4653650|P5|52 Week Treatment Period|Lost to Follow-up|0
1410100|NCT01144377|4653651|P4|52 Week Treatment Period|Lost to Follow-up|0
1410101|NCT01144377|4653652|P3|52 Week Treatment Period|Lost to Follow-up|0
1410102|NCT01144377|4653653|P2|52 Week Treatment Period|Lost to Follow-up|0
1410103|NCT01144377|4653654|P1|52 Week Treatment Period|Lost to Follow-up|1
1410104|NCT01144377|4653650|P5|52 Week Treatment Period|Protocol Violation|1
1410105|NCT01144377|4653651|P4|52 Week Treatment Period|Protocol Violation|0
1410106|NCT01144377|4653652|P3|52 Week Treatment Period|Protocol Violation|0
1410107|NCT01144377|4653653|P2|52 Week Treatment Period|Protocol Violation|0
1410108|NCT01144377|4653654|P1|52 Week Treatment Period|Protocol Violation|0
1410109|NCT01144377|4653650|P5|52 Week Treatment Period|Entry Criteria Not Met|0
1410110|NCT01144377|4653651|P4|52 Week Treatment Period|Entry Criteria Not Met|1
1410111|NCT01144377|4653652|P3|52 Week Treatment Period|Entry Criteria Not Met|1
1410112|NCT01144377|4653653|P2|52 Week Treatment Period|Entry Criteria Not Met|0
1410113|NCT01144377|4653654|P1|52 Week Treatment Period|Entry Criteria Not Met|0
1410114|NCT01144377|4653650|P5|52 Week Treatment Period|Adverse Event|1
1410115|NCT01144377|4653651|P4|52 Week Treatment Period|Adverse Event|2
1410116|NCT01144377|4653652|P3|52 Week Treatment Period|Adverse Event|3
1410117|NCT01144377|4653653|P2|52 Week Treatment Period|Adverse Event|0
1410118|NCT01144377|4653654|P1|52 Week Treatment Period|Adverse Event|0
1410119|NCT01144364|4653703|P3|Follow-Up/Maintenance Phase|Physician Decision|1
1410120|NCT01144364|4653704|P2|Follow-Up/Maintenance Phase|Physician Decision|0
1410121|NCT01144364|4653705|P1|Follow-Up/Maintenance Phase|Physician Decision|0
1410122|NCT01144364|4653703|P3|Follow-Up/Maintenance Phase|Relapse|5
1410123|NCT01144364|4653704|P2|Follow-Up/Maintenance Phase|Relapse|5
1410124|NCT01144364|4653705|P1|Follow-Up/Maintenance Phase|Relapse|0
1410125|NCT01144364|4653703|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
1410126|NCT01144364|4653704|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
1410127|NCT01144364|4653705|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
1410128|NCT01144364|4653703|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
1410129|NCT01144364|4653704|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
1410130|NCT01144364|4653705|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
1410131|NCT01144364|4653703|P3|Follow-Up/Maintenance Phase|Death|0
1410132|NCT01144364|4653704|P2|Follow-Up/Maintenance Phase|Death|2
1410133|NCT01144364|4653705|P1|Follow-Up/Maintenance Phase|Death|0
1410134|NCT01144364|4653703|P3|Follow-Up/Maintenance Phase|Adverse Event|1
1410135|NCT01144364|4653704|P2|Follow-Up/Maintenance Phase|Adverse Event|3
1410136|NCT01144364|4653705|P1|Follow-Up/Maintenance Phase|Adverse Event|0
1410137|NCT01144364|4653703|P3|Follow-Up/Maintenance Phase|Disease progression|29
1410138|NCT01144364|4653704|P2|Follow-Up/Maintenance Phase|Disease progression|23
1410139|NCT01144364|4653705|P1|Follow-Up/Maintenance Phase|Disease progression|0
1410140|NCT01144364|4653703|P3|Induction Phase|Protocol Violation|0
1410141|NCT01144364|4653704|P2|Induction Phase|Protocol Violation|0
1410142|NCT01144364|4653705|P1|Induction Phase|Protocol Violation|1
1410143|NCT01144364|4653703|P3|Induction Phase|Secondary neoplasia|0
1410144|NCT01144364|4653704|P2|Induction Phase|Secondary neoplasia|0
1410145|NCT01144364|4653705|P1|Induction Phase|Secondary neoplasia|1
1410146|NCT01144364|4653703|P3|Induction Phase|Stable disease|0
1410147|NCT01144364|4653704|P2|Induction Phase|Stable disease|0
1410148|NCT01144364|4653705|P1|Induction Phase|Stable disease|2
1410149|NCT01144364|4653703|P3|Induction Phase|Physician Decision|0
1410150|NCT01144364|4653704|P2|Induction Phase|Physician Decision|0
1410151|NCT01144364|4653705|P1|Induction Phase|Physician Decision|1
1410152|NCT01144364|4653703|P3|Induction Phase|Lost to Follow-up|0
1410153|NCT01144364|4653704|P2|Induction Phase|Lost to Follow-up|0
1410154|NCT01144364|4653705|P1|Induction Phase|Lost to Follow-up|2
1410155|NCT01144364|4653703|P3|Induction Phase|Withdrawal by Subject|0
1410156|NCT01144364|4653704|P2|Induction Phase|Withdrawal by Subject|0
1410157|NCT01144364|4653705|P1|Induction Phase|Withdrawal by Subject|1
1410158|NCT01144364|4653703|P3|Induction Phase|Death|0
1410159|NCT01144364|4653704|P2|Induction Phase|Death|0
1410160|NCT01144364|4653705|P1|Induction Phase|Death|1
1410161|NCT01144364|4653703|P3|Induction Phase|Adverse Event|0
1410162|NCT01144364|4653704|P2|Induction Phase|Adverse Event|0
1410163|NCT01144364|4653705|P1|Induction Phase|Adverse Event|9
1410164|NCT01144364|4653703|P3|Induction Phase|Disease progression|0
1410165|NCT01144364|4653704|P2|Induction Phase|Disease progression|0
1410166|NCT01144364|4653705|P1|Induction Phase|Disease progression|14
1410167|NCT01144299|4653754|P2|Overall Study|Withdrawal by Subject|0
1410168|NCT01144299|4653755|P1|Overall Study|Withdrawal by Subject|1
1410169|NCT01144299|4653754|P2|Overall Study|Lost to Follow-up|0
1410170|NCT01144299|4653755|P1|Overall Study|Lost to Follow-up|1
1410171|NCT01144182|4653800|P2|Overall Study|Lost to Follow-up|9
1410172|NCT01144182|4653801|P1|Overall Study|Lost to Follow-up|9
1410173|NCT01144182|4653800|P2|Overall Study|Withdrawal by Subject|6
1410174|NCT01144182|4653801|P1|Overall Study|Withdrawal by Subject|3
1410175|NCT01144182|4653800|P2|Overall Study|Death|6
1410176|NCT01144182|4653801|P1|Overall Study|Death|5
1410177|NCT01144052|4653861|P2|Overall Study|Withdrawal by Subject|1
1410178|NCT01144052|4653862|P1|Overall Study|Withdrawal by Subject|1
1410179|NCT01143896|4653893|P2|Overall Study|Death|3
1410180|NCT01143896|4653894|P1|Overall Study|Death|6
1410181|NCT01143896|4653893|P2|Overall Study|Withdrawal by Subject|5
1410182|NCT01143896|4653894|P1|Overall Study|Withdrawal by Subject|13
1410183|NCT01143896|4653893|P2|Overall Study|Lost to Follow-up|13
1410184|NCT01143896|4653894|P1|Overall Study|Lost to Follow-up|18
1410185|NCT01143896|4653893|P2|Overall Study|Did not complete Baseline Interview|4
1410186|NCT01143896|4653894|P1|Overall Study|Did not complete Baseline Interview|5
1410187|NCT01143714|4654006|P2|Overall Study|wound size increased|0
1410188|NCT01143714|4654007|P1|Overall Study|wound size increased|1
1410189|NCT01143714|4654006|P2|Overall Study|wound closed = deemed healed|0
1410190|NCT01143714|4654007|P1|Overall Study|wound closed = deemed healed|1
1410191|NCT01143714|4654006|P2|Overall Study|Subject non-compliance|1
1410192|NCT01143714|4654007|P1|Overall Study|Subject non-compliance|0
1410193|NCT01143714|4654006|P2|Overall Study|Withdrawal by Subject|0
1410194|NCT01143714|4654007|P1|Overall Study|Withdrawal by Subject|1
1410195|NCT01143714|4654006|P2|Overall Study|Adverse Event|2
1410196|NCT01143714|4654007|P1|Overall Study|Adverse Event|4
1410197|NCT01143402|4654112|P3|Overall Study|Not Treated|1
1410198|NCT01143402|4654113|P2|Overall Study|Not Treated|0
1410199|NCT01143402|4654114|P1|Overall Study|Not Treated|0
1410200|NCT01143402|4654112|P3|Overall Study|Rapid clinical decline|0
1410201|NCT01143402|4654113|P2|Overall Study|Rapid clinical decline|1
1410202|NCT01143402|4654114|P1|Overall Study|Rapid clinical decline|1
1410203|NCT01143389|4654125|P2|Overall Study|Lost to Follow-up|25
1410204|NCT01143389|4654126|P1|Overall Study|Lost to Follow-up|26
1410205|NCT01143337|4654140|P3|Overall Study|Other reason|5
1410206|NCT01143337|4654141|P2|Overall Study|Other reason|0
1410207|NCT01143337|4654142|P1|Overall Study|Other reason|0
1410208|NCT01143337|4654140|P3|Overall Study|Withdrawal by Subject|1
1410209|NCT01143337|4654141|P2|Overall Study|Withdrawal by Subject|0
1410210|NCT01143337|4654142|P1|Overall Study|Withdrawal by Subject|0
1410211|NCT01143337|4654140|P3|Overall Study|Protocol Violation|0
1410212|NCT01143337|4654141|P2|Overall Study|Protocol Violation|0
1410213|NCT01143337|4654142|P1|Overall Study|Protocol Violation|1
1410214|NCT01143337|4654140|P3|Overall Study|Lack of Efficacy|1
1410215|NCT01143337|4654141|P2|Overall Study|Lack of Efficacy|2
1410216|NCT01143337|4654142|P1|Overall Study|Lack of Efficacy|6
1410217|NCT01143337|4654140|P3|Overall Study|Adverse Event|5
1410218|NCT01143337|4654141|P2|Overall Study|Adverse Event|9
1410219|NCT01143337|4654142|P1|Overall Study|Adverse Event|3
1410220|NCT01143324|4654156|P1|Overall Study|Explant of the device|4
1410221|NCT01143324|4654156|P1|Overall Study|Withdrawal by Subject|4
1410222|NCT01143324|4654156|P1|Overall Study|Lost to Follow-up|11
1410223|NCT01143259|4654195|P2|Overall Study|Screen Failure|9
1410224|NCT01143259|4654196|P1|Overall Study|Screen Failure|7
1410225|NCT01143259|4654195|P2|Overall Study|Protocol Violation|9
1410226|NCT01143259|4654196|P1|Overall Study|Protocol Violation|13
1410227|NCT01143259|4654195|P2|Overall Study|Withdrawal by Subject|2
1410228|NCT01143259|4654196|P1|Overall Study|Withdrawal by Subject|3
1410229|NCT01143207|4654204|P1|Overall Study|Lost to Follow-up|2
1410230|NCT01143090|4654224|P1|Overall Study|Administrative|1
1410231|NCT01143090|4654224|P1|Overall Study|Failure to meet eligibility criteria|1
1410232|NCT01143090|4654224|P1|Overall Study|Non-compliance with study drug|1
1410233|NCT01143090|4654224|P1|Overall Study|Withdrawal by Subject|18
1410234|NCT01143090|4654224|P1|Overall Study|Protocol Violation|2
1410235|NCT01143090|4654224|P1|Overall Study|Lost to Follow-up|9
1410236|NCT01143090|4654224|P1|Overall Study|Adverse Event|17
1410237|NCT01143090|4654224|P1|Overall Study|Lack of Efficacy|2
1410238|NCT01143077|4654231|P3|Overall Study|Principal Investigator Decision|1
1410239|NCT01143077|4654232|P2|Overall Study|Principal Investigator Decision|0
1410240|NCT01143077|4654233|P1|Overall Study|Principal Investigator Decision|2
1410241|NCT01143077|4654231|P3|Overall Study|Administrative|0
1410242|NCT01143077|4654232|P2|Overall Study|Administrative|0
1410243|NCT01143077|4654233|P1|Overall Study|Administrative|1
1410244|NCT01143077|4654231|P3|Overall Study|Non-compliance with study drug|1
1410245|NCT01143077|4654232|P2|Overall Study|Non-compliance with study drug|1
1410246|NCT01143077|4654233|P1|Overall Study|Non-compliance with study drug|0
1410247|NCT01143077|4654231|P3|Overall Study|Withdrawal by Subject|3
1410248|NCT01143077|4654232|P2|Overall Study|Withdrawal by Subject|3
1410249|NCT01143077|4654233|P1|Overall Study|Withdrawal by Subject|4
1410250|NCT01143077|4654231|P3|Overall Study|Protocol Violation|0
1410251|NCT01143077|4654232|P2|Overall Study|Protocol Violation|0
1410252|NCT01143077|4654233|P1|Overall Study|Protocol Violation|2
1410253|NCT01143077|4654231|P3|Overall Study|Lost to Follow-up|4
1410254|NCT01143077|4654232|P2|Overall Study|Lost to Follow-up|3
1410255|NCT01143077|4654233|P1|Overall Study|Lost to Follow-up|2
1410256|NCT01143077|4654231|P3|Overall Study|Adverse Event|5
1410257|NCT01143077|4654232|P2|Overall Study|Adverse Event|6
1410258|NCT01143077|4654233|P1|Overall Study|Adverse Event|5
1410259|NCT01143077|4654231|P3|Overall Study|Lack of Efficacy|1
1410260|NCT01143077|4654232|P2|Overall Study|Lack of Efficacy|2
1410261|NCT01143077|4654233|P1|Overall Study|Lack of Efficacy|0
1410262|NCT01143051|4654250|P6|3-14 Day Washout|Withdrawal by Subject|1
1410263|NCT01143051|4654251|P5|3-14 Day Washout|Withdrawal by Subject|0
1410264|NCT01143051|4654252|P4|3-14 Day Washout|Withdrawal by Subject|0
1410265|NCT01143051|4654253|P3|3-14 Day Washout|Withdrawal by Subject|0
1410266|NCT01143051|4654254|P2|3-14 Day Washout|Withdrawal by Subject|0
1410267|NCT01143051|4654255|P1|3-14 Day Washout|Withdrawal by Subject|0
1410268|NCT01143051|4654250|P6|3-14 Day Washout|Withdrawal by Subject|0
1410269|NCT01143051|4654251|P5|3-14 Day Washout|Withdrawal by Subject|0
1410270|NCT01143051|4654252|P4|3-14 Day Washout|Withdrawal by Subject|0
1410271|NCT01143051|4654253|P3|3-14 Day Washout|Withdrawal by Subject|1
1410272|NCT01143051|4654254|P2|3-14 Day Washout|Withdrawal by Subject|0
1410273|NCT01143051|4654255|P1|3-14 Day Washout|Withdrawal by Subject|0
1410274|NCT01143038|4654278|P1|Overall Study|Death|1
1410275|NCT01143038|4654278|P1|Overall Study|Protocol Deviation|1
1410276|NCT01143038|4654278|P1|Overall Study|Lost to Follow-up|2
1410277|NCT01143038|4654278|P1|Overall Study|Adverse Event|3
1410278|NCT01143038|4654278|P1|Overall Study|Requirement for alternative therapy|5
1410279|NCT01143038|4654278|P1|Overall Study|Withdrawal by Subject|4
1410280|NCT01142908|4654288|P2|Overall Study|Withdrawal by Subject|0
1410281|NCT01142908|4654289|P1|Overall Study|Withdrawal by Subject|3
1410282|NCT01142908|4654288|P2|Overall Study|Excluded - did not meet criteria|5
1410283|NCT01142908|4654289|P1|Overall Study|Excluded - did not meet criteria|9
1410284|NCT01142908|4654288|P2|Overall Study|Death|4
1410285|NCT01142908|4654289|P1|Overall Study|Death|1
1410286|NCT01142908|4654288|P2|Overall Study|Lost to Follow-up|13
1410287|NCT01142908|4654289|P1|Overall Study|Lost to Follow-up|19
1410288|NCT01142726|4654338|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
1410289|NCT01142726|4654339|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
1410290|NCT01142726|4654340|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
1410291|NCT01142726|4654338|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
1410292|NCT01142726|4654339|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
1410293|NCT01142726|4654340|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
1410294|NCT01142726|4654338|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
1410295|NCT01142726|4654339|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
1410296|NCT01142726|4654340|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
1410297|NCT01142726|4654338|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
1410298|NCT01142726|4654339|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
1410299|NCT01142726|4654340|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
1410300|NCT01142726|4654338|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
1410301|NCT01142726|4654339|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
1410302|NCT01142726|4654340|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
1410303|NCT01142726|4654338|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
1410304|NCT01142726|4654339|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
1410305|NCT01142726|4654340|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
1410306|NCT01142726|4654338|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
1410307|NCT01142726|4654339|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
1410308|NCT01142726|4654340|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
1410309|NCT01142726|4654338|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
1410310|NCT01142726|4654339|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
1410311|NCT01142726|4654340|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
1410312|NCT01142726|4654338|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
1410313|NCT01142726|4654339|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
1410314|NCT01142726|4654340|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
1410315|NCT01142726|4654338|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
1410316|NCT01142726|4654339|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
1410317|NCT01142726|4654340|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
1410318|NCT01142726|4654338|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
1410319|NCT01142726|4654339|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
1410320|NCT01142726|4654340|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
1410321|NCT01142726|4654338|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
1410322|NCT01142726|4654339|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
1410323|NCT01142726|4654340|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
1410324|NCT01142726|4654338|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
1410325|NCT01142726|4654339|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
1410326|NCT01142726|4654340|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
1410327|NCT01142726|4654338|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
1410328|NCT01142726|4654339|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
1410329|NCT01142726|4654340|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
1410330|NCT01142726|4654338|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
1410331|NCT01142726|4654339|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
1410332|NCT01142726|4654340|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
1410333|NCT01142726|4654338|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
1410334|NCT01142726|4654339|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
1410335|NCT01142726|4654340|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
1410336|NCT01142661|4654403|P1|Overall Study|Physician Decision|1
1410337|NCT01142661|4654403|P1|Overall Study|Withdrawal by Subject|1
1410338|NCT01142661|4654403|P1|Overall Study|Adverse Event|2
1410339|NCT01142596|4654410|P2|Overall Study|Other reason (not specified)|4
1410340|NCT01142596|4654411|P1|Overall Study|Other reason (not specified)|5
1410341|NCT01142596|4654410|P2|Overall Study|Lost to Follow-up|3
1410342|NCT01142596|4654411|P1|Overall Study|Lost to Follow-up|2
1410343|NCT01142596|4654410|P2|Overall Study|Lack of Efficacy|9
1410344|NCT01142596|4654411|P1|Overall Study|Lack of Efficacy|5
1410345|NCT01142596|4654410|P2|Overall Study|Adverse Event|35
1410346|NCT01142596|4654411|P1|Overall Study|Adverse Event|8
1410347|NCT01142596|4654410|P2|Overall Study|Withdrawal by Subject|35
1410348|NCT01142596|4654411|P1|Overall Study|Withdrawal by Subject|9
1410349|NCT01142466|4654463|P2|Overall Study|Withdrawal by Subject|1
1410350|NCT01142466|4654464|P1|Overall Study|Withdrawal by Subject|1
1410351|NCT01142466|4654463|P2|Overall Study|Adverse Event|1
1410352|NCT01142466|4654464|P1|Overall Study|Adverse Event|2
1410353|NCT01142388|4654484|P2|Overall Study|Never started therapy|3
1410354|NCT01142388|4654485|P1|Overall Study|Never started therapy|7
1410355|NCT01142388|4654484|P2|Overall Study|Other|1
1410356|NCT01142388|4654485|P1|Overall Study|Other|1
1410357|NCT01142388|4654484|P2|Overall Study|Other complications|2
1410358|NCT01142388|4654485|P1|Overall Study|Other complications|0
1410359|NCT01142388|4654484|P2|Overall Study|Alternative therapy|0
1410360|NCT01142388|4654485|P1|Overall Study|Alternative therapy|1
1410361|NCT01142388|4654484|P2|Overall Study|Withdrawal by Subject|3
1410362|NCT01142388|4654485|P1|Overall Study|Withdrawal by Subject|5
1410363|NCT01142388|4654484|P2|Overall Study|Death|2
1410364|NCT01142388|4654485|P1|Overall Study|Death|3
1410365|NCT01142388|4654484|P2|Overall Study|Adverse Event|5
1410366|NCT01142388|4654485|P1|Overall Study|Adverse Event|9
1410367|NCT01142388|4654484|P2|Overall Study|Lack of Efficacy|31
1410368|NCT01142388|4654485|P1|Overall Study|Lack of Efficacy|21
1410369|NCT01142336|4654497|P2|Overall Study|Lost to Follow-up|1
1410370|NCT01142336|4654498|P1|Overall Study|Lost to Follow-up|0
1410371|NCT01142336|4654497|P2|Overall Study|Adverse Event|1
1410372|NCT01142336|4654498|P1|Overall Study|Adverse Event|1
1410373|NCT01142193|4654532|P2|Overall Study|Other|2
1410374|NCT01142193|4654533|P1|Overall Study|Other|1
1410375|NCT01142193|4654532|P2|Overall Study|Protocol Discontinuation Criterion Met|0
1410376|NCT01142193|4654533|P1|Overall Study|Protocol Discontinuation Criterion Met|1
1410377|NCT01142193|4654532|P2|Overall Study|Withdrawal by Subject|3
1410378|NCT01142193|4654533|P1|Overall Study|Withdrawal by Subject|4
1410379|NCT01142193|4654532|P2|Overall Study|Physician Decision|1
1410380|NCT01142193|4654533|P1|Overall Study|Physician Decision|1
1410381|NCT01142193|4654532|P2|Overall Study|Lack of Efficacy|1
1410382|NCT01142193|4654533|P1|Overall Study|Lack of Efficacy|2
1410383|NCT01142193|4654532|P2|Overall Study|Adverse Event|4
1410384|NCT01142193|4654533|P1|Overall Study|Adverse Event|12
1410385|NCT01142128|4654561|P1|Overall Study|Withdrawal by Subject|2
1410386|NCT01142128|4654561|P1|Overall Study|Lost to Follow-up|1
1410387|NCT01142128|4654561|P1|Overall Study|Physician Decision|1
1410388|NCT01142115|4654571|P2|First Intervention|Adverse Event|0
1410389|NCT01142115|4654572|P1|First Intervention|Adverse Event|1
1410390|NCT01142115|4654571|P2|First Intervention|Lack of Efficacy|1
1410391|NCT01142115|4654572|P1|First Intervention|Lack of Efficacy|1
1410392|NCT01142089|4654589|P2|Overall Study|Patient required rescue medication|17
1410393|NCT01142089|4654590|P1|Overall Study|Patient required rescue medication|8
1410394|NCT01142089|4654589|P2|Overall Study|Noncompliance with study procedures|1
1410395|NCT01142089|4654590|P1|Overall Study|Noncompliance with study procedures|2
1410396|NCT01142089|4654589|P2|Overall Study|Use of prohibited medications|1
1410397|NCT01142089|4654590|P1|Overall Study|Use of prohibited medications|0
1410398|NCT01142089|4654589|P2|Overall Study|Withdrawal by Subject|2
1410399|NCT01142089|4654590|P1|Overall Study|Withdrawal by Subject|1
1410400|NCT01142089|4654589|P2|Overall Study|Physician Decision|0
1410401|NCT01142089|4654590|P1|Overall Study|Physician Decision|1
1410402|NCT01141712|4654612|P1|Overall Study|Disease progression|3
1410403|NCT01141660|4654633|P2|Overall Study|Physician Decision|12
1410404|NCT01141660|4654634|P1|Overall Study|Physician Decision|0
1410405|NCT01141283|4654693|P1|Overall Study|Lack of Efficacy|10
1410406|NCT01141283|4654693|P1|Overall Study|Administrative|4
1410407|NCT01141283|4654693|P1|Overall Study|Withdrawal by Subject|14
1410408|NCT01141283|4654693|P1|Overall Study|Lost to Follow-up|4
1410409|NCT01141283|4654693|P1|Overall Study|Adverse Event|56
1410410|NCT01141205|4654699|P2|Overall Study|Withdrawal by Subject|1
1410411|NCT01141205|4654700|P1|Overall Study|Withdrawal by Subject|1
1410412|NCT01141205|4654699|P2|Overall Study|Lost to Follow-up|0
1410413|NCT01141205|4654700|P1|Overall Study|Lost to Follow-up|1
1410414|NCT01141205|4654699|P2|Overall Study|Physician Decision|1
1410415|NCT01141205|4654700|P1|Overall Study|Physician Decision|1
1410416|NCT01140906|4654727|P4|Overall Study|Administrative or other reason|2
1410417|NCT01140906|4654728|P3|Overall Study|Administrative or other reason|3
1410418|NCT01140906|4654729|P2|Overall Study|Administrative or other reason|5
1410419|NCT01140906|4654730|P1|Overall Study|Administrative or other reason|0
1410420|NCT01140906|4654727|P4|Overall Study|Lost to Follow-up|2
1410421|NCT01140906|4654728|P3|Overall Study|Lost to Follow-up|0
1410422|NCT01140906|4654729|P2|Overall Study|Lost to Follow-up|1
1410423|NCT01140906|4654730|P1|Overall Study|Lost to Follow-up|1
1410424|NCT01140906|4654727|P4|Overall Study|Withdrawal of consent|2
1410425|NCT01140906|4654728|P3|Overall Study|Withdrawal of consent|2
1410426|NCT01140906|4654729|P2|Overall Study|Withdrawal of consent|6
1410427|NCT01140906|4654730|P1|Overall Study|Withdrawal of consent|6
1410428|NCT01140906|4654727|P4|Overall Study|Protocol Violation|1
1410429|NCT01140906|4654728|P3|Overall Study|Protocol Violation|2
1410430|NCT01140906|4654729|P2|Overall Study|Protocol Violation|3
1410431|NCT01140906|4654730|P1|Overall Study|Protocol Violation|5
1410432|NCT01140906|4654727|P4|Overall Study|Non-compliance|1
1410433|NCT01140906|4654728|P3|Overall Study|Non-compliance|0
1410434|NCT01140906|4654729|P2|Overall Study|Non-compliance|1
1410435|NCT01140906|4654730|P1|Overall Study|Non-compliance|0
1410436|NCT01140906|4654727|P4|Overall Study|Lack of Efficacy|1
1410437|NCT01140906|4654728|P3|Overall Study|Lack of Efficacy|2
1410438|NCT01140906|4654729|P2|Overall Study|Lack of Efficacy|8
1410439|NCT01140906|4654730|P1|Overall Study|Lack of Efficacy|6
1410440|NCT01140906|4654727|P4|Overall Study|Adverse Event|7
1410441|NCT01140906|4654728|P3|Overall Study|Adverse Event|17
1410442|NCT01140906|4654729|P2|Overall Study|Adverse Event|10
1410443|NCT01140906|4654730|P1|Overall Study|Adverse Event|7
1410444|NCT01140880|4654770|P2|Overall Study|Protocol Violation|30
1410445|NCT01140880|4654771|P1|Overall Study|Protocol Violation|0
1410446|NCT01140880|4654770|P2|Overall Study|Lost to Follow-up|10
1410447|NCT01140880|4654771|P1|Overall Study|Lost to Follow-up|8
1410448|NCT01140880|4654770|P2|Overall Study|Withdrawal by Subject|3
1410449|NCT01140880|4654771|P1|Overall Study|Withdrawal by Subject|6
1410450|NCT01140880|4654770|P2|Overall Study|Death|1
1410451|NCT01140880|4654771|P1|Overall Study|Death|0
1410452|NCT01140867|4654783|P1|Overall Study|Medication Noncompliance|2
1410453|NCT01140867|4654783|P1|Overall Study|Uncooperative patient|2
1410454|NCT01140867|4654783|P1|Overall Study|Protocol Violation|1
1410455|NCT01140867|4654783|P1|Overall Study|Withdrawal by Subject|1
1410456|NCT01140867|4654783|P1|Overall Study|Lost to Follow-up|2
1410457|NCT01140867|4654783|P1|Overall Study|Lack of Efficacy|3
1410458|NCT01140867|4654783|P1|Overall Study|Adverse Event|22
1410459|NCT01140646|4654823|P1|Overall Study|Refused Further Treatment|5
1410460|NCT01140646|4654823|P1|Overall Study|Adverse Event|4
1410461|NCT01140503|4654827|P1|Overall Study|Withdrawal by Subject|1
1410462|NCT01140477|4654835|P2|Overall Study|Subject explanted|1
1410463|NCT01140477|4654836|P1|Overall Study|Subject explanted|0
1410464|NCT01140477|4654835|P2|Overall Study|Death|1
1410465|NCT01140477|4654836|P1|Overall Study|Death|1
1410466|NCT01140477|4654835|P2|Overall Study|Surgical complication preventing implant|0
1410467|NCT01140477|4654836|P1|Overall Study|Surgical complication preventing implant|2
1410468|NCT01140477|4654835|P2|Overall Study|Withdrawal by Subject|4
1410469|NCT01140477|4654836|P1|Overall Study|Withdrawal by Subject|1
1410470|NCT01140477|4654835|P2|Overall Study|Lost to Follow-up|0
1410471|NCT01140477|4654836|P1|Overall Study|Lost to Follow-up|4
1410472|NCT01140347|4654851|P2|Overall Study|Withdrawal by Subject|8
1410473|NCT01140347|4654852|P1|Overall Study|Withdrawal by Subject|13
1410474|NCT01140347|4654851|P2|Overall Study|Lost to Follow-up|6
1410475|NCT01140347|4654852|P1|Overall Study|Lost to Follow-up|5
1410476|NCT01140061|4654905|P10|Extension|Laboratory Adverse Event|1
1410477|NCT01140061|4654906|P9|Extension|Laboratory Adverse Event|0
1410478|NCT01140061|4654907|P8|Extension|Laboratory Adverse Event|0
1410479|NCT01140061|4654908|P7|Extension|Laboratory Adverse Event|0
1410480|NCT01140061|4654909|P6|Extension|Laboratory Adverse Event|0
1410481|NCT01140061|4654910|P5|Extension|Laboratory Adverse Event|0
1410482|NCT01140061|4654911|P4|Extension|Laboratory Adverse Event|0
1410483|NCT01140061|4654912|P3|Extension|Laboratory Adverse Event|0
1410484|NCT01140061|4654913|P2|Extension|Laboratory Adverse Event|0
1410485|NCT01140061|4654914|P1|Extension|Laboratory Adverse Event|0
1410486|NCT01140061|4654905|P10|Part I|Adverse Event|0
1410487|NCT01140061|4654906|P9|Part I|Adverse Event|0
1410488|NCT01140061|4654907|P8|Part I|Adverse Event|0
1410489|NCT01140061|4654908|P7|Part I|Adverse Event|0
1410490|NCT01140061|4654909|P6|Part I|Adverse Event|0
1410491|NCT01140061|4654910|P5|Part I|Adverse Event|0
1410492|NCT01140061|4654911|P4|Part I|Adverse Event|0
1410493|NCT01140061|4654912|P3|Part I|Adverse Event|0
1410494|NCT01140061|4654913|P2|Part I|Adverse Event|0
1410495|NCT01140061|4654914|P1|Part I|Adverse Event|1
1410496|NCT01140048|4654941|P1|Overall Study|Lost to Follow-up|31
1410497|NCT01140048|4654941|P1|Overall Study|Withdrawal by Subject|13
1410498|NCT01140048|4654941|P1|Overall Study|Physician Decision|1
1410499|NCT01139775|4654981|P3|Overall Study|Physician Decision|2
1410500|NCT01139775|4654982|P2|Overall Study|Physician Decision|2
1410501|NCT01139775|4654983|P1|Overall Study|Physician Decision|0
1410502|NCT01139775|4654981|P3|Overall Study|Withdrawal by Subject|2
1410503|NCT01139775|4654982|P2|Overall Study|Withdrawal by Subject|0
1410504|NCT01139775|4654983|P1|Overall Study|Withdrawal by Subject|1
1410505|NCT01139775|4654981|P3|Overall Study|Protocol Violation|0
1410506|NCT01139775|4654982|P2|Overall Study|Protocol Violation|5
1410507|NCT01139775|4654983|P1|Overall Study|Protocol Violation|0
1410508|NCT01139775|4654981|P3|Overall Study|Adverse Event|2
1410509|NCT01139775|4654982|P2|Overall Study|Adverse Event|6
1410510|NCT01139775|4654983|P1|Overall Study|Adverse Event|0
1410511|NCT01139762|4655015|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
1410512|NCT01139762|4655016|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
1410513|NCT01139762|4655017|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
1410514|NCT01139762|4655015|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
1410515|NCT01139762|4655016|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
1410516|NCT01139762|4655017|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
1410517|NCT01139762|4655015|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
1410518|NCT01139762|4655016|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
1410519|NCT01139762|4655017|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
1410520|NCT01139762|4655015|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
1410521|NCT01139762|4655016|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
1410522|NCT01139762|4655017|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
1410523|NCT01139762|4655015|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
1410524|NCT01139762|4655016|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
1410525|NCT01139762|4655017|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
1410526|NCT01139762|4655015|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
1410527|NCT01139762|4655016|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
1410528|NCT01139762|4655017|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
1410529|NCT01139762|4655015|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
1410530|NCT01139762|4655016|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
1410531|NCT01139762|4655017|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
1410532|NCT01139762|4655015|P3|Double-Blind Randomized Active Treatment|Death|1
1410533|NCT01139762|4655016|P2|Double-Blind Randomized Active Treatment|Death|1
1410534|NCT01139762|4655017|P1|Double-Blind Randomized Active Treatment|Death|0
1410535|NCT01139762|4655015|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
1410536|NCT01139762|4655016|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
1410537|NCT01139762|4655017|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
1410538|NCT01139762|4655015|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
1410539|NCT01139762|4655016|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
1410540|NCT01139762|4655017|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
1410541|NCT01139762|4655015|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
1410542|NCT01139762|4655016|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
1410543|NCT01139762|4655017|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
1410544|NCT01139762|4655015|P3|Washout and Placebo Lead-In Period|Physician Decision|0
1410545|NCT01139762|4655016|P2|Washout and Placebo Lead-In Period|Physician Decision|0
1410546|NCT01139762|4655017|P1|Washout and Placebo Lead-In Period|Physician Decision|12
1410547|NCT01139762|4655015|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
1410548|NCT01139762|4655016|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
1410549|NCT01139762|4655017|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
1410550|NCT01139762|4655015|P3|Washout and Placebo Lead-In Period|Adverse Event|0
1410551|NCT01139762|4655016|P2|Washout and Placebo Lead-In Period|Adverse Event|0
1410552|NCT01139762|4655017|P1|Washout and Placebo Lead-In Period|Adverse Event|1
1410553|NCT01139762|4655015|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
1410554|NCT01139762|4655016|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
1410555|NCT01139762|4655017|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
1410556|NCT01139658|4655052|P2|Overall Study|Not specified|75
1410557|NCT01139658|4655053|P1|Overall Study|Not specified|28
1410558|NCT01139658|4655052|P2|Overall Study|No documentation of treatment|0
1410559|NCT01139658|4655053|P1|Overall Study|No documentation of treatment|1
1410560|NCT01139658|4655052|P2|Overall Study|Withdrawal by Subject|4
1410561|NCT01139658|4655053|P1|Overall Study|Withdrawal by Subject|2
1410562|NCT01139658|4655052|P2|Overall Study|Lack of Efficacy|7
1410563|NCT01139658|4655053|P1|Overall Study|Lack of Efficacy|15
1410564|NCT01139658|4655052|P2|Overall Study|Adverse Event|27
1410565|NCT01139658|4655053|P1|Overall Study|Adverse Event|10
1410566|NCT01139580|4655091|P2|Overall Study|Participant Randomization in Error|1
1410567|NCT01139580|4655092|P1|Overall Study|Participant Randomization in Error|0
1410568|NCT01139580|4655091|P2|Overall Study|Beginning Study Exclusion Treatment|1
1410569|NCT01139580|4655092|P1|Overall Study|Beginning Study Exclusion Treatment|0
1410570|NCT01139580|4655091|P2|Overall Study|Misrandomized|0
1410571|NCT01139580|4655092|P1|Overall Study|Misrandomized|1
1410572|NCT01139580|4655091|P2|Overall Study|Did Not Meet Exclusion Criteria|0
1410573|NCT01139580|4655092|P1|Overall Study|Did Not Meet Exclusion Criteria|1
1410574|NCT01139580|4655091|P2|Overall Study|Used Excluded Medicine After Enrollment|0
1410575|NCT01139580|4655092|P1|Overall Study|Used Excluded Medicine After Enrollment|1
1410576|NCT01139580|4655091|P2|Overall Study|Withdrawal by Subject|9
1410577|NCT01139580|4655092|P1|Overall Study|Withdrawal by Subject|6
1410578|NCT01139580|4655091|P2|Overall Study|Lack of Efficacy|2
1410579|NCT01139580|4655092|P1|Overall Study|Lack of Efficacy|0
1410580|NCT01139580|4655091|P2|Overall Study|Lost to Follow-up|1
1410581|NCT01139580|4655092|P1|Overall Study|Lost to Follow-up|9
1410582|NCT01139580|4655091|P2|Overall Study|Adverse Event|4
1410583|NCT01139580|4655092|P1|Overall Study|Adverse Event|5
1410584|NCT01139450|4655140|P3|Overall Study|Adverse Event|3
1410585|NCT01139450|4655141|P2|Overall Study|Adverse Event|2
1410586|NCT01139450|4655142|P1|Overall Study|Adverse Event|2
1410587|NCT01139450|4655140|P3|Overall Study|Administrative|1
1410588|NCT01139450|4655141|P2|Overall Study|Administrative|0
1410589|NCT01139450|4655142|P1|Overall Study|Administrative|0
1410590|NCT01139450|4655140|P3|Overall Study|Lost to Follow-up|11
1410591|NCT01139450|4655141|P2|Overall Study|Lost to Follow-up|7
1410592|NCT01139450|4655142|P1|Overall Study|Lost to Follow-up|9
1410593|NCT01139450|4655140|P3|Overall Study|Protocol Violation|2
1410594|NCT01139450|4655141|P2|Overall Study|Protocol Violation|5
1410595|NCT01139450|4655142|P1|Overall Study|Protocol Violation|6
1410596|NCT01139450|4655140|P3|Overall Study|Lack of Efficacy|8
1410597|NCT01139450|4655141|P2|Overall Study|Lack of Efficacy|1
1410598|NCT01139450|4655142|P1|Overall Study|Lack of Efficacy|3
1410599|NCT01139450|4655140|P3|Overall Study|Withdrawal by Subject|13
1410600|NCT01139450|4655141|P2|Overall Study|Withdrawal by Subject|10
1410601|NCT01139450|4655142|P1|Overall Study|Withdrawal by Subject|7
1410602|NCT01139164|4655194|P3|Overall Study|Withdrawn prior to study start|0
1410603|NCT01139164|4655195|P2|Overall Study|Withdrawn prior to study start|2
1410604|NCT01139164|4655196|P1|Overall Study|Withdrawn prior to study start|0
1410605|NCT01139125|4655210|P1|Overall Study|Withdrawal by Subject|1
1410606|NCT01139047|4655214|P1|Overall Study|Withdrawal by Subject|1
1410607|NCT01139021|4655229|P6|Overall Study|Withdrawal by Subject|0
1410608|NCT01139021|4655230|P5|Overall Study|Withdrawal by Subject|4
1410609|NCT01139021|4655231|P4|Overall Study|Withdrawal by Subject|1
1410610|NCT01139021|4655232|P3|Overall Study|Withdrawal by Subject|0
1410611|NCT01139021|4655233|P2|Overall Study|Withdrawal by Subject|0
1410612|NCT01139021|4655234|P1|Overall Study|Withdrawal by Subject|0
1410613|NCT01139021|4655229|P6|Overall Study|Protocol Violation|0
1410614|NCT01139021|4655230|P5|Overall Study|Protocol Violation|2
1410615|NCT01139021|4655231|P4|Overall Study|Protocol Violation|0
1410616|NCT01139021|4655232|P3|Overall Study|Protocol Violation|0
1410617|NCT01139021|4655233|P2|Overall Study|Protocol Violation|0
1410618|NCT01139021|4655234|P1|Overall Study|Protocol Violation|1
1410619|NCT01139021|4655229|P6|Overall Study|Lost to Follow-up|0
1410620|NCT01139021|4655230|P5|Overall Study|Lost to Follow-up|2
1410621|NCT01139021|4655231|P4|Overall Study|Lost to Follow-up|0
1410622|NCT01139021|4655232|P3|Overall Study|Lost to Follow-up|0
1410623|NCT01139021|4655233|P2|Overall Study|Lost to Follow-up|0
1410624|NCT01139021|4655234|P1|Overall Study|Lost to Follow-up|0
1410625|NCT01139021|4655229|P6|Overall Study|Adverse Event|0
1410626|NCT01139021|4655230|P5|Overall Study|Adverse Event|1
1410627|NCT01139021|4655231|P4|Overall Study|Adverse Event|0
1410628|NCT01139021|4655232|P3|Overall Study|Adverse Event|0
1410629|NCT01139021|4655233|P2|Overall Study|Adverse Event|0
1410630|NCT01139021|4655234|P1|Overall Study|Adverse Event|0
1410631|NCT01139008|4655270|P1|Overall Study|Non-compliant, lost product|1
1410632|NCT01139008|4655270|P1|Overall Study|Withdrawal by Subject|5
1410633|NCT01138826|4655303|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
1410634|NCT01138826|4655304|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
1410635|NCT01138826|4655305|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
1410636|NCT01138826|4655306|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
1410637|NCT01138826|4655307|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
1410638|NCT01138826|4655308|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
1410639|NCT01138657|4655345|P2|Overall Study|Miscellaneous Reasons|4
1410640|NCT01138657|4655346|P1|Overall Study|Miscellaneous Reasons|3
1410641|NCT01138657|4655345|P2|Overall Study|Lost to Follow-up|3
1410642|NCT01138657|4655346|P1|Overall Study|Lost to Follow-up|0
1410643|NCT01138657|4655345|P2|Overall Study|Lack of Efficacy|1
1410644|NCT01138657|4655346|P1|Overall Study|Lack of Efficacy|2
1410645|NCT01138657|4655345|P2|Overall Study|Adverse Event|10
1410646|NCT01138657|4655346|P1|Overall Study|Adverse Event|3
1410647|NCT01138501|4655409|P1|Overall Study|Withdrawal by Subject|3
1410648|NCT01138501|4655409|P1|Overall Study|Protocol Violation|2
1410649|NCT01138150|4655453|P2|Overall Study|Physician Decision|0
1410650|NCT01138150|4655454|P1|Overall Study|Physician Decision|1
1410651|NCT01138150|4655453|P2|Overall Study|blood unable to be processed|1
1410652|NCT01138150|4655454|P1|Overall Study|blood unable to be processed|0
1410653|NCT01138111|4655535|P1|Overall Study|Lost to Follow-up|2
1410654|NCT01138111|4655535|P1|Overall Study|Death|1
1410655|NCT01138111|4655535|P1|Overall Study|Adverse Event|1
1410656|NCT01138111|4655535|P1|Overall Study|Withdrawal by Subject|5
1410657|NCT01138046|4655589|P1|Overall Study|Withdrawal due to death|6
1410658|NCT01138007|4655609|P3|Overall Study|Withdrawal by Subject|15
1410659|NCT01138007|4655610|P2|Overall Study|Withdrawal by Subject|6
1410660|NCT01138007|4655611|P1|Overall Study|Withdrawal by Subject|5
1410661|NCT01138007|4655609|P3|Overall Study|Physician Decision|3
1410662|NCT01138007|4655610|P2|Overall Study|Physician Decision|5
1410663|NCT01138007|4655611|P1|Overall Study|Physician Decision|0
1410664|NCT01138007|4655609|P3|Overall Study|Lost to Follow-up|5
1410665|NCT01138007|4655610|P2|Overall Study|Lost to Follow-up|3
1410666|NCT01138007|4655611|P1|Overall Study|Lost to Follow-up|3
1410667|NCT01138007|4655609|P3|Overall Study|Protocol-Defined Stopping Criteria|8
1410668|NCT01138007|4655610|P2|Overall Study|Protocol-Defined Stopping Criteria|1
1410669|NCT01138007|4655611|P1|Overall Study|Protocol-Defined Stopping Criteria|6
1410670|NCT01138007|4655609|P3|Overall Study|Protocol Violation|2
1410671|NCT01138007|4655610|P2|Overall Study|Protocol Violation|3
1410672|NCT01138007|4655611|P1|Overall Study|Protocol Violation|2
1410673|NCT01138007|4655609|P3|Overall Study|Lack of Efficacy|6
1410674|NCT01138007|4655610|P2|Overall Study|Lack of Efficacy|0
1410675|NCT01138007|4655611|P1|Overall Study|Lack of Efficacy|2
1410676|NCT01138007|4655609|P3|Overall Study|Adverse Event|9
1410677|NCT01138007|4655610|P2|Overall Study|Adverse Event|12
1410678|NCT01138007|4655611|P1|Overall Study|Adverse Event|4
1410679|NCT01137812|4655718|P2|Overall Study|Not specified|27
1410680|NCT01137812|4655719|P1|Overall Study|Not specified|19
1410681|NCT01137812|4655718|P2|Overall Study|Patient met glycemic withdrawal criteria|85
1410682|NCT01137812|4655719|P1|Overall Study|Patient met glycemic withdrawal criteria|40
1410683|NCT01137812|4655718|P2|Overall Study|Death|0
1410684|NCT01137812|4655719|P1|Overall Study|Death|2
1410685|NCT01137812|4655718|P2|Overall Study|Withdrawal by Subject|13
1410686|NCT01137812|4655719|P1|Overall Study|Withdrawal by Subject|5
1410687|NCT01137812|4655718|P2|Overall Study|Protocol Violation|4
1410688|NCT01137812|4655719|P1|Overall Study|Protocol Violation|5
1410689|NCT01137812|4655718|P2|Overall Study|Physician Decision|17
1410690|NCT01137812|4655719|P1|Overall Study|Physician Decision|25
1410691|NCT01137812|4655718|P2|Overall Study|Lost to Follow-up|8
1410692|NCT01137812|4655719|P1|Overall Study|Lost to Follow-up|6
1410693|NCT01137812|4655718|P2|Overall Study|Adverse Event|14
1410694|NCT01137812|4655719|P1|Overall Study|Adverse Event|21
1410695|NCT01137786|4655739|P2|Overall Study|Withdrawal by Subject|1
1410696|NCT01137786|4655740|P1|Overall Study|Withdrawal by Subject|1
1410697|NCT01137786|4655739|P2|Overall Study|Lost to Follow-up|2
1410698|NCT01137786|4655740|P1|Overall Study|Lost to Follow-up|0
1410699|NCT01137773|4655750|P2|Overall Study|Lost to Follow-up|0
1410700|NCT01137773|4655751|P1|Overall Study|Lost to Follow-up|6
1410701|NCT01137773|4655750|P2|Overall Study|Death|3
1410702|NCT01137773|4655751|P1|Overall Study|Death|3
1410703|NCT01137682|4655762|P3|Overall Study|Did not receive treatment in extension|1
1410704|NCT01137682|4655763|P2|Overall Study|Did not receive treatment in extension|0
1410705|NCT01137682|4655764|P1|Overall Study|Did not receive treatment in extension|0
1410706|NCT01137682|4655762|P3|Overall Study|Did not enter extension|2
1410707|NCT01137682|4655763|P2|Overall Study|Did not enter extension|3
1410708|NCT01137682|4655764|P1|Overall Study|Did not enter extension|2
1410709|NCT01137682|4655762|P3|Overall Study|Protocol Violation-Extension|0
1410710|NCT01137682|4655763|P2|Overall Study|Protocol Violation-Extension|1
1410711|NCT01137682|4655764|P1|Overall Study|Protocol Violation-Extension|2
1410712|NCT01137682|4655762|P3|Overall Study|Death-Extension|0
1410713|NCT01137682|4655763|P2|Overall Study|Death-Extension|0
1410714|NCT01137682|4655764|P1|Overall Study|Death-Extension|2
1410715|NCT01137682|4655762|P3|Overall Study|Administrative problems-Extension|0
1410716|NCT01137682|4655763|P2|Overall Study|Administrative problems-Extension|2
1410717|NCT01137682|4655764|P1|Overall Study|Administrative problems-Extension|0
1410718|NCT01137682|4655762|P3|Overall Study|Lost to Follow Up-Extension|0
1410719|NCT01137682|4655763|P2|Overall Study|Lost to Follow Up-Extension|1
1410720|NCT01137682|4655764|P1|Overall Study|Lost to Follow Up-Extension|0
1410721|NCT01137682|4655762|P3|Overall Study|Withdrawal by Subject-Extension|8
1410722|NCT01137682|4655763|P2|Overall Study|Withdrawal by Subject-Extension|8
1410723|NCT01137682|4655764|P1|Overall Study|Withdrawal by Subject-Extension|6
1410724|NCT01137682|4655762|P3|Overall Study|Lack of Efficacy-Extension|13
1410725|NCT01137682|4655763|P2|Overall Study|Lack of Efficacy-Extension|9
1410726|NCT01137682|4655764|P1|Overall Study|Lack of Efficacy-Extension|15
1410727|NCT01137682|4655762|P3|Overall Study|Adverse Event-Extension|7
1410728|NCT01137682|4655763|P2|Overall Study|Adverse Event-Extension|8
1410729|NCT01137682|4655764|P1|Overall Study|Adverse Event-Extension|4
1410730|NCT01137682|4655762|P3|Overall Study|Protocol Violation-CORE|1
1410731|NCT01137682|4655763|P2|Overall Study|Protocol Violation-CORE|1
1410732|NCT01137682|4655764|P1|Overall Study|Protocol Violation-CORE|0
1410733|NCT01137682|4655762|P3|Overall Study|Administrative problems-CORE|0
1410734|NCT01137682|4655763|P2|Overall Study|Administrative problems-CORE|1
1410735|NCT01137682|4655764|P1|Overall Study|Administrative problems-CORE|2
1410736|NCT01137682|4655762|P3|Overall Study|Withdrawal by Subject-CORE|2
1410737|NCT01137682|4655763|P2|Overall Study|Withdrawal by Subject-CORE|2
1410738|NCT01137682|4655764|P1|Overall Study|Withdrawal by Subject-CORE|2
1410739|NCT01137682|4655762|P3|Overall Study|Adverse Event-CORE|0
1410740|NCT01137682|4655763|P2|Overall Study|Adverse Event-CORE|4
1410741|NCT01137682|4655764|P1|Overall Study|Adverse Event-CORE|2
1410742|NCT01137604|4655814|P4|Overall Study|Clinical Decline|1
1410743|NCT01137604|4655815|P3|Overall Study|Clinical Decline|1
1410744|NCT01137604|4655816|P2|Overall Study|Clinical Decline|0
1410745|NCT01137604|4655817|P1|Overall Study|Clinical Decline|0
1410746|NCT01137604|4655814|P4|Overall Study|Participant's Decision|0
1410747|NCT01137604|4655815|P3|Overall Study|Participant's Decision|0
1410748|NCT01137604|4655816|P2|Overall Study|Participant's Decision|0
1410749|NCT01137604|4655817|P1|Overall Study|Participant's Decision|1
1410750|NCT01137604|4655814|P4|Overall Study|Clinical Progression|0
1410751|NCT01137604|4655815|P3|Overall Study|Clinical Progression|1
1410752|NCT01137604|4655816|P2|Overall Study|Clinical Progression|2
1410753|NCT01137604|4655817|P1|Overall Study|Clinical Progression|0
1410754|NCT01137604|4655814|P4|Overall Study|Withdrawal by Subject|1
1410755|NCT01137604|4655815|P3|Overall Study|Withdrawal by Subject|2
1410756|NCT01137604|4655816|P2|Overall Study|Withdrawal by Subject|2
1410757|NCT01137604|4655817|P1|Overall Study|Withdrawal by Subject|0
1410758|NCT01137604|4655814|P4|Overall Study|Adverse Event|9
1410759|NCT01137604|4655815|P3|Overall Study|Adverse Event|9
1410760|NCT01137604|4655816|P2|Overall Study|Adverse Event|6
1410761|NCT01137604|4655817|P1|Overall Study|Adverse Event|1
1410762|NCT01137578|4655851|P3|Overall Study|Not Specified|6
1410763|NCT01137578|4655852|P2|Overall Study|Not Specified|2
1410764|NCT01137578|4655853|P1|Overall Study|Not Specified|12
1410765|NCT01137578|4655851|P3|Overall Study|Withdrawal by Subject|0
1410766|NCT01137578|4655852|P2|Overall Study|Withdrawal by Subject|0
1410767|NCT01137578|4655853|P1|Overall Study|Withdrawal by Subject|1
1410768|NCT01137578|4655851|P3|Overall Study|Participant requested to Discontinue|0
1410769|NCT01137578|4655852|P2|Overall Study|Participant requested to Discontinue|0
1410770|NCT01137578|4655853|P1|Overall Study|Participant requested to Discontinue|3
1410771|NCT01137474|4655902|P4|Overall Study|Administrative reason by sponsor|0
1410772|NCT01137474|4655903|P3|Overall Study|Administrative reason by sponsor|0
1410773|NCT01137474|4655904|P2|Overall Study|Administrative reason by sponsor|1
1410774|NCT01137474|4655905|P1|Overall Study|Administrative reason by sponsor|0
1410775|NCT01137474|4655902|P4|Overall Study|Pregnancy|0
1410776|NCT01137474|4655903|P3|Overall Study|Pregnancy|0
1410777|NCT01137474|4655904|P2|Overall Study|Pregnancy|1
1410778|NCT01137474|4655905|P1|Overall Study|Pregnancy|0
1410779|NCT01137474|4655902|P4|Overall Study|Not specified|0
1410780|NCT01137474|4655903|P3|Overall Study|Not specified|0
1410781|NCT01137474|4655904|P2|Overall Study|Not specified|1
1410782|NCT01137474|4655905|P1|Overall Study|Not specified|3
1410783|NCT01137474|4655902|P4|Overall Study|Lack of Efficacy|2
1410784|NCT01137474|4655903|P3|Overall Study|Lack of Efficacy|0
1410785|NCT01137474|4655904|P2|Overall Study|Lack of Efficacy|0
1410786|NCT01137474|4655905|P1|Overall Study|Lack of Efficacy|0
1410787|NCT01137474|4655902|P4|Overall Study|Lost to Follow-up|2
1410788|NCT01137474|4655903|P3|Overall Study|Lost to Follow-up|0
1410789|NCT01137474|4655904|P2|Overall Study|Lost to Follow-up|1
1410790|NCT01137474|4655905|P1|Overall Study|Lost to Follow-up|5
1410791|NCT01137474|4655902|P4|Overall Study|No longer met study criteria|5
1410792|NCT01137474|4655903|P3|Overall Study|No longer met study criteria|0
1410793|NCT01137474|4655904|P2|Overall Study|No longer met study criteria|1
1410794|NCT01137474|4655905|P1|Overall Study|No longer met study criteria|6
1410795|NCT01137474|4655902|P4|Overall Study|Withdrawal by Subject|9
1410796|NCT01137474|4655903|P3|Overall Study|Withdrawal by Subject|6
1410797|NCT01137474|4655904|P2|Overall Study|Withdrawal by Subject|2
1410798|NCT01137474|4655905|P1|Overall Study|Withdrawal by Subject|7
1410799|NCT01137474|4655902|P4|Overall Study|Adverse Event|3
1410800|NCT01137474|4655903|P3|Overall Study|Adverse Event|1
1410801|NCT01137474|4655904|P2|Overall Study|Adverse Event|5
1410802|NCT01137474|4655905|P1|Overall Study|Adverse Event|3
1410803|NCT01137435|4655923|P1|Overall Study|Off label usage|4
1410804|NCT01137435|4655923|P1|Overall Study|Lost to Follow-up|24
1410805|NCT01137292|4655950|P1|Overall Study|Other|7
1410806|NCT01137292|4655950|P1|Overall Study|Lost to Follow-up|1
1410807|NCT01137292|4655950|P1|Overall Study|Lack of Efficacy|13
1410808|NCT01137292|4655950|P1|Overall Study|Adverse Event|3
1410809|NCT01137292|4655950|P1|Overall Study|Death|30
1410810|NCT01137071|4655957|P1|Overall Study|Wrongly Included|1
1410811|NCT01137071|4655957|P1|Overall Study|Withdrawal by Subject|2
1410812|NCT01137071|4655957|P1|Overall Study|Disease Progression|11
1410813|NCT01136967|4656026|P2|Overall Study|Diagnosis of Second Primary Cancer|1
1410814|NCT01136967|4656027|P1|Overall Study|Diagnosis of Second Primary Cancer|0
1410815|NCT01136967|4656026|P2|Overall Study|Increase in Lesion Size|2
1410816|NCT01136967|4656027|P1|Overall Study|Increase in Lesion Size|0
1410817|NCT01136967|4656026|P2|Overall Study|Investigator's Choice|1
1410818|NCT01136967|4656027|P1|Overall Study|Investigator's Choice|1
1410819|NCT01136967|4656026|P2|Overall Study|Non Compliance|0
1410820|NCT01136967|4656027|P1|Overall Study|Non Compliance|1
1410821|NCT01136967|4656026|P2|Overall Study|Radiation|0
1410822|NCT01136967|4656027|P1|Overall Study|Radiation|1
1410823|NCT01136967|4656026|P2|Overall Study|Clinical Progression|5
1410824|NCT01136967|4656027|P1|Overall Study|Clinical Progression|3
1410825|NCT01136967|4656026|P2|Overall Study|Withdrawal by Subject|2
1410826|NCT01136967|4656027|P1|Overall Study|Withdrawal by Subject|1
1410827|NCT01136967|4656026|P2|Overall Study|Lost to Follow-up|1
1410828|NCT01136967|4656027|P1|Overall Study|Lost to Follow-up|0
1410829|NCT01136967|4656026|P2|Overall Study|Participant Choice|3
1410830|NCT01136967|4656027|P1|Overall Study|Participant Choice|8
1410831|NCT01136967|4656026|P2|Overall Study|Adverse Event|12
1410832|NCT01136967|4656027|P1|Overall Study|Adverse Event|9
1410833|NCT01136954|4656045|P2|Overall Study|Not Specified|3
1410834|NCT01136954|4656046|P1|Overall Study|Not Specified|1
1410835|NCT01136954|4656045|P2|Overall Study|Physician Decision|1
1410836|NCT01136954|4656046|P1|Overall Study|Physician Decision|0
1410837|NCT01136954|4656045|P2|Overall Study|Lack of Efficacy|13
1410838|NCT01136954|4656046|P1|Overall Study|Lack of Efficacy|14
1410839|NCT01136954|4656045|P2|Overall Study|Withdrawal by Subject|2
1410840|NCT01136954|4656046|P1|Overall Study|Withdrawal by Subject|6
1410841|NCT01136954|4656045|P2|Overall Study|Adverse Event|2
1410842|NCT01136954|4656046|P1|Overall Study|Adverse Event|3
1410843|NCT01136915|4656060|P2|Overall Study|Exclusion criterion met|1
1410844|NCT01136915|4656061|P1|Overall Study|Exclusion criterion met|0
1410845|NCT01136915|4656060|P2|Overall Study|Lost to Follow-up|0
1410846|NCT01136915|4656061|P1|Overall Study|Lost to Follow-up|2
1410847|NCT01136876|4656071|P2|Overall Study|Physician Decision|5
1410848|NCT01136876|4656072|P1|Overall Study|Physician Decision|3
1410849|NCT01136876|4656071|P2|Overall Study|Lost to Follow-up|1
1410850|NCT01136876|4656072|P1|Overall Study|Lost to Follow-up|0
1410851|NCT01136785|4656101|P2|Overall Study|Protocol Violation|1
1410852|NCT01136785|4656102|P1|Overall Study|Protocol Violation|2
1410853|NCT01136772|4656117|P2|Overall Study|Did not follow up after first injection|2
1410854|NCT01136772|4656118|P1|Overall Study|Did not follow up after first injection|2
1410855|NCT01136772|4656117|P2|Overall Study|Did not receive injection|7
1410856|NCT01136772|4656118|P1|Overall Study|Did not receive injection|10
1410857|NCT01136772|4656117|P2|Overall Study|Withdrawal by Subject|36
1410858|NCT01136772|4656118|P1|Overall Study|Withdrawal by Subject|33
1410859|NCT01136772|4656117|P2|Overall Study|Administrative|12
1410860|NCT01136772|4656118|P1|Overall Study|Administrative|14
1410861|NCT01136772|4656117|P2|Overall Study|Lack of Efficacy|39
1410862|NCT01136772|4656118|P1|Overall Study|Lack of Efficacy|42
1410863|NCT01136772|4656117|P2|Overall Study|Adverse Event|14
1410864|NCT01136772|4656118|P1|Overall Study|Adverse Event|15
1410865|NCT01136746|4656128|P2|Overall Study|Death|0
1410866|NCT01136746|4656129|P1|Overall Study|Death|1
1410867|NCT01136746|4656128|P2|Overall Study|Protocol Violation|1
1410868|NCT01136746|4656129|P1|Overall Study|Protocol Violation|2
1410869|NCT01136746|4656128|P2|Overall Study|Lost to Follow-up|2
1410870|NCT01136746|4656129|P1|Overall Study|Lost to Follow-up|0
1410871|NCT01136655|4656189|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
1410872|NCT01136655|4656189|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
1410873|NCT01136655|4656189|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
1410874|NCT01136655|4656189|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
1410875|NCT01136408|4656222|P3|Overall Study|Protocol Violation|1
1410876|NCT01136408|4656223|P2|Overall Study|Protocol Violation|1
1410877|NCT01136408|4656224|P1|Overall Study|Protocol Violation|1
1410878|NCT01136408|4656222|P3|Overall Study|Adverse Event|4
1410879|NCT01136408|4656223|P2|Overall Study|Adverse Event|8
1410880|NCT01136408|4656224|P1|Overall Study|Adverse Event|4
1410881|NCT01136382|4656281|P2|Overall Study|Withdrawal by Subject|1
1410882|NCT01136382|4656282|P1|Overall Study|Withdrawal by Subject|4
1410883|NCT01136382|4656281|P2|Overall Study|Severe Non-Compliance to Protocol|2
1410884|NCT01136382|4656282|P1|Overall Study|Severe Non-Compliance to Protocol|0
1410885|NCT01136382|4656281|P2|Overall Study|Study-Specific Withdrawal Criteria|25
1410886|NCT01136382|4656282|P1|Overall Study|Study-Specific Withdrawal Criteria|48
1410887|NCT01136382|4656281|P2|Overall Study|Not Specified|3
1410888|NCT01136382|4656282|P1|Overall Study|Not Specified|8
1410889|NCT01136356|4656308|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
1410890|NCT01136356|4656309|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
1410891|NCT01136356|4656308|P2|First 18-day Withdrawal|Physician Decision|0
1410892|NCT01136356|4656309|P1|First 18-day Withdrawal|Physician Decision|1
1410893|NCT01136356|4656308|P2|First 18-day Withdrawal|Withdrawal by Subject|0
1410894|NCT01136356|4656309|P1|First 18-day Withdrawal|Withdrawal by Subject|3
1410895|NCT01136291|4656320|P2|Overall Study|Lost to Follow-up|1
1410896|NCT01136291|4656321|P1|Overall Study|Lost to Follow-up|1
1410897|NCT01136174|4656339|P4|Overall Study|Adverse Event|4
1410898|NCT01136174|4656340|P3|Overall Study|Adverse Event|0
1410899|NCT01136174|4656341|P2|Overall Study|Adverse Event|0
1410900|NCT01136174|4656342|P1|Overall Study|Adverse Event|0
1410901|NCT01135992|4656422|P1|Overall Study|Unclassified|7
1410902|NCT01135992|4656422|P1|Overall Study|Withdrawal criteria|10
1410903|NCT01135992|4656422|P1|Overall Study|Protocol Violation|2
1410904|NCT01135992|4656422|P1|Overall Study|Lack of Efficacy|1
1410905|NCT01135992|4656422|P1|Overall Study|Adverse Event|1
1410906|NCT01135914|4656434|P3|Overall Study|Adverse Event|2
1410907|NCT01135914|4656435|P2|Overall Study|Adverse Event|1
1410908|NCT01135914|4656436|P1|Overall Study|Adverse Event|0
1410909|NCT01135914|4656434|P3|Overall Study|Lack of Efficacy|10
1410910|NCT01135914|4656435|P2|Overall Study|Lack of Efficacy|1
1410911|NCT01135914|4656436|P1|Overall Study|Lack of Efficacy|2
1410912|NCT01135914|4656434|P3|Overall Study|Protocol Violation|3
1410913|NCT01135914|4656435|P2|Overall Study|Protocol Violation|0
1410914|NCT01135914|4656436|P1|Overall Study|Protocol Violation|0
1410915|NCT01135914|4656434|P3|Overall Study|Lost to Follow-up|1
1410916|NCT01135914|4656435|P2|Overall Study|Lost to Follow-up|0
1410917|NCT01135914|4656436|P1|Overall Study|Lost to Follow-up|1
1410918|NCT01135914|4656434|P3|Overall Study|Withdrawal by Subject|6
1410919|NCT01135914|4656435|P2|Overall Study|Withdrawal by Subject|3
1410920|NCT01135914|4656436|P1|Overall Study|Withdrawal by Subject|1
1410921|NCT01135524|4656465|P1|Overall Study|Lack of Efficacy|8
1410922|NCT01135524|4656465|P1|Overall Study|Administrative|151
1410923|NCT01135524|4656465|P1|Overall Study|Lost to Follow-up|3
1410924|NCT01135524|4656465|P1|Overall Study|Adverse Event|20
1410925|NCT01135524|4656465|P1|Overall Study|Withdrawal by Subject|14
1410926|NCT01135511|4656478|P9|Overall Study|Withdrawal by Subject|1
1410927|NCT01135511|4656479|P8|Overall Study|Withdrawal by Subject|0
1410928|NCT01135511|4656480|P7|Overall Study|Withdrawal by Subject|1
1410929|NCT01135511|4656481|P6|Overall Study|Withdrawal by Subject|0
1410930|NCT01135511|4656482|P5|Overall Study|Withdrawal by Subject|0
1410931|NCT01135511|4656483|P4|Overall Study|Withdrawal by Subject|0
1410932|NCT01135511|4656484|P3|Overall Study|Withdrawal by Subject|0
1410933|NCT01135511|4656485|P2|Overall Study|Withdrawal by Subject|0
1410934|NCT01135511|4656486|P1|Overall Study|Withdrawal by Subject|0
1410935|NCT01135511|4656478|P9|Overall Study|noncompliance with study drug taken|0
1410936|NCT01135511|4656479|P8|Overall Study|noncompliance with study drug taken|0
1410937|NCT01135511|4656480|P7|Overall Study|noncompliance with study drug taken|0
1410938|NCT01135511|4656481|P6|Overall Study|noncompliance with study drug taken|0
1410939|NCT01135511|4656482|P5|Overall Study|noncompliance with study drug taken|1
1410940|NCT01135511|4656483|P4|Overall Study|noncompliance with study drug taken|0
1410941|NCT01135511|4656484|P3|Overall Study|noncompliance with study drug taken|0
1410942|NCT01135511|4656485|P2|Overall Study|noncompliance with study drug taken|0
1410943|NCT01135511|4656486|P1|Overall Study|noncompliance with study drug taken|0
1410944|NCT01135511|4656478|P9|Overall Study|could not visit the clinic|0
1410945|NCT01135511|4656479|P8|Overall Study|could not visit the clinic|0
1410946|NCT01135511|4656480|P7|Overall Study|could not visit the clinic|0
1410947|NCT01135511|4656481|P6|Overall Study|could not visit the clinic|0
1410948|NCT01135511|4656482|P5|Overall Study|could not visit the clinic|0
1410949|NCT01135511|4656483|P4|Overall Study|could not visit the clinic|0
1410950|NCT01135511|4656484|P3|Overall Study|could not visit the clinic|2
1410951|NCT01135511|4656485|P2|Overall Study|could not visit the clinic|1
1410952|NCT01135511|4656486|P1|Overall Study|could not visit the clinic|0
1410953|NCT01135511|4656478|P9|Overall Study|Pregnancy|0
1410954|NCT01135511|4656479|P8|Overall Study|Pregnancy|0
1410955|NCT01135511|4656480|P7|Overall Study|Pregnancy|0
1410956|NCT01135511|4656481|P6|Overall Study|Pregnancy|0
1410957|NCT01135511|4656482|P5|Overall Study|Pregnancy|0
1410958|NCT01135511|4656483|P4|Overall Study|Pregnancy|1
1410959|NCT01135511|4656484|P3|Overall Study|Pregnancy|0
1410960|NCT01135511|4656485|P2|Overall Study|Pregnancy|0
1410961|NCT01135511|4656486|P1|Overall Study|Pregnancy|0
1410962|NCT01135511|4656478|P9|Overall Study|Protocol Violation|0
1410963|NCT01135511|4656479|P8|Overall Study|Protocol Violation|0
1410964|NCT01135511|4656480|P7|Overall Study|Protocol Violation|0
1410965|NCT01135511|4656481|P6|Overall Study|Protocol Violation|0
1410966|NCT01135511|4656482|P5|Overall Study|Protocol Violation|0
1410967|NCT01135511|4656483|P4|Overall Study|Protocol Violation|0
1410968|NCT01135511|4656484|P3|Overall Study|Protocol Violation|3
1410969|NCT01135511|4656485|P2|Overall Study|Protocol Violation|0
1410970|NCT01135511|4656486|P1|Overall Study|Protocol Violation|0
1410971|NCT01135511|4656478|P9|Overall Study|Lack of Efficacy|0
1410972|NCT01135511|4656479|P8|Overall Study|Lack of Efficacy|0
1410973|NCT01135511|4656480|P7|Overall Study|Lack of Efficacy|0
1410974|NCT01135511|4656481|P6|Overall Study|Lack of Efficacy|0
1410975|NCT01135511|4656482|P5|Overall Study|Lack of Efficacy|0
1410976|NCT01135511|4656483|P4|Overall Study|Lack of Efficacy|2
1410977|NCT01135511|4656484|P3|Overall Study|Lack of Efficacy|1
1410978|NCT01135511|4656485|P2|Overall Study|Lack of Efficacy|1
1410979|NCT01135511|4656486|P1|Overall Study|Lack of Efficacy|0
1410980|NCT01135511|4656478|P9|Overall Study|Adverse Event|0
1410981|NCT01135511|4656479|P8|Overall Study|Adverse Event|1
1410982|NCT01135511|4656480|P7|Overall Study|Adverse Event|0
1410983|NCT01135511|4656481|P6|Overall Study|Adverse Event|1
1410984|NCT01135511|4656482|P5|Overall Study|Adverse Event|0
1410985|NCT01135511|4656483|P4|Overall Study|Adverse Event|0
1410986|NCT01135511|4656484|P3|Overall Study|Adverse Event|2
1410987|NCT01135511|4656485|P2|Overall Study|Adverse Event|1
1410988|NCT01135511|4656486|P1|Overall Study|Adverse Event|0
1410989|NCT01135498|4656768|P1|Overall Study|Ongoing at time of analysis|2
1410990|NCT01135498|4656768|P1|Overall Study|Death|1
1410991|NCT01135498|4656768|P1|Overall Study|Withdrawal by Subject|4
1410992|NCT01135498|4656768|P1|Overall Study|Investigator judgement|25
1410993|NCT01135498|4656768|P1|Overall Study|Progressive disease|38
1410994|NCT01135498|4656768|P1|Overall Study|Adverse Event|20
1410995|NCT01135134|4656947|P2|Overall Study|Did not meet protocol eligibility|0
1410996|NCT01135134|4656948|P1|Overall Study|Did not meet protocol eligibility|1
1410997|NCT01135134|4656947|P2|Overall Study|Adverse Event|1
1410998|NCT01135134|4656948|P1|Overall Study|Adverse Event|1
1410999|NCT01135017|4656971|P2|Overall Study|Other than above|4
1411000|NCT01135017|4656972|P1|Overall Study|Other than above|3
1411001|NCT01135017|4656971|P2|Overall Study|Adverse Event|8
1411002|NCT01135017|4656972|P1|Overall Study|Adverse Event|3
1411003|NCT01134939|4657010|P8|Overall Study|Termination page not available|0
1411004|NCT01134939|4657011|P7|Overall Study|Termination page not available|7
1411005|NCT01134939|4657012|P6|Overall Study|Termination page not available|3
1411006|NCT01134939|4657013|P5|Overall Study|Termination page not available|0
1411007|NCT01134939|4657014|P4|Overall Study|Termination page not available|8
1411008|NCT01134939|4657015|P3|Overall Study|Termination page not available|5
1411009|NCT01134939|4657016|P2|Overall Study|Termination page not available|6
1411010|NCT01134939|4657017|P1|Overall Study|Termination page not available|4
1411011|NCT01134939|4657010|P8|Overall Study|Death|0
1411012|NCT01134939|4657011|P7|Overall Study|Death|0
1411013|NCT01134939|4657012|P6|Overall Study|Death|0
1411014|NCT01134939|4657013|P5|Overall Study|Death|0
1411015|NCT01134939|4657014|P4|Overall Study|Death|0
1411016|NCT01134939|4657015|P3|Overall Study|Death|0
1411017|NCT01134939|4657016|P2|Overall Study|Death|1
1411018|NCT01134939|4657017|P1|Overall Study|Death|0
1411019|NCT01134939|4657010|P8|Overall Study|Lost to Follow-up|0
1411020|NCT01134939|4657011|P7|Overall Study|Lost to Follow-up|0
1411021|NCT01134939|4657012|P6|Overall Study|Lost to Follow-up|1
1411022|NCT01134939|4657013|P5|Overall Study|Lost to Follow-up|2
1411023|NCT01134939|4657014|P4|Overall Study|Lost to Follow-up|1
1411024|NCT01134939|4657015|P3|Overall Study|Lost to Follow-up|0
1411025|NCT01134939|4657016|P2|Overall Study|Lost to Follow-up|3
1411026|NCT01134939|4657017|P1|Overall Study|Lost to Follow-up|2
1411027|NCT01134939|4657010|P8|Overall Study|Lack of Efficacy|0
1411028|NCT01134939|4657011|P7|Overall Study|Lack of Efficacy|1
1411029|NCT01134939|4657012|P6|Overall Study|Lack of Efficacy|0
1411030|NCT01134939|4657013|P5|Overall Study|Lack of Efficacy|3
1411031|NCT01134939|4657014|P4|Overall Study|Lack of Efficacy|0
1411032|NCT01134939|4657015|P3|Overall Study|Lack of Efficacy|1
1411033|NCT01134939|4657016|P2|Overall Study|Lack of Efficacy|5
1411034|NCT01134939|4657017|P1|Overall Study|Lack of Efficacy|2
1411035|NCT01134939|4657010|P8|Overall Study|Adverse Event|0
1411036|NCT01134939|4657011|P7|Overall Study|Adverse Event|1
1411037|NCT01134939|4657012|P6|Overall Study|Adverse Event|5
1411038|NCT01134939|4657013|P5|Overall Study|Adverse Event|5
1411039|NCT01134939|4657014|P4|Overall Study|Adverse Event|5
1411040|NCT01134939|4657015|P3|Overall Study|Adverse Event|4
1411041|NCT01134939|4657016|P2|Overall Study|Adverse Event|3
1411042|NCT01134939|4657017|P1|Overall Study|Adverse Event|9
1411043|NCT01134783|4657155|P2|Overall Study|Lost to Follow-up|20
1411044|NCT01134783|4657156|P1|Overall Study|Lost to Follow-up|5
1411045|NCT01134783|4657155|P2|Overall Study|Withdrawal by Subject|9
1411046|NCT01134783|4657156|P1|Overall Study|Withdrawal by Subject|15
1411047|NCT01134783|4657155|P2|Overall Study|Pregnancy|8
1411048|NCT01134783|4657156|P1|Overall Study|Pregnancy|16
1411049|NCT01134731|4657175|P3|Overall Study|Lost to Follow-up|3
1411050|NCT01134731|4657176|P2|Overall Study|Lost to Follow-up|4
1411051|NCT01134731|4657177|P1|Overall Study|Lost to Follow-up|5
1411052|NCT01134731|4657175|P3|Overall Study|Withdrawal by Subject|1
1411053|NCT01134731|4657176|P2|Overall Study|Withdrawal by Subject|3
1411054|NCT01134731|4657177|P1|Overall Study|Withdrawal by Subject|3
1411055|NCT01134731|4657175|P3|Overall Study|Lack of Efficacy|1
1411056|NCT01134731|4657176|P2|Overall Study|Lack of Efficacy|0
1411057|NCT01134731|4657177|P1|Overall Study|Lack of Efficacy|0
1411058|NCT01134731|4657175|P3|Overall Study|Physician Decision|2
1411059|NCT01134731|4657176|P2|Overall Study|Physician Decision|2
1411060|NCT01134731|4657177|P1|Overall Study|Physician Decision|2
1411061|NCT01134731|4657175|P3|Overall Study|Adverse Event|1
1411062|NCT01134731|4657176|P2|Overall Study|Adverse Event|2
1411063|NCT01134731|4657177|P1|Overall Study|Adverse Event|3
1411064|NCT01134705|4657190|P2|Overall Study|Other|6
1411065|NCT01134705|4657191|P1|Overall Study|Other|1
1411066|NCT01134705|4657190|P2|Overall Study|Protocol Violation|1
1411067|NCT01134705|4657191|P1|Overall Study|Protocol Violation|1
1411068|NCT01134705|4657190|P2|Overall Study|Lost to Follow-up|2
1411069|NCT01134705|4657191|P1|Overall Study|Lost to Follow-up|5
1411070|NCT01134705|4657190|P2|Overall Study|Pregnancy|0
1411071|NCT01134705|4657191|P1|Overall Study|Pregnancy|1
1411072|NCT01134705|4657190|P2|Overall Study|Withdrawal by Subject|6
1411073|NCT01134705|4657191|P1|Overall Study|Withdrawal by Subject|6
1411074|NCT01134705|4657190|P2|Overall Study|Adverse Event|7
1411075|NCT01134705|4657191|P1|Overall Study|Adverse Event|1
1411076|NCT01134627|4657203|P2|Overall Study|Other|14
1411077|NCT01134627|4657204|P1|Overall Study|Other|11
1411078|NCT01134627|4657203|P2|Overall Study|Planning to become pregnant/pregnancy|0
1411079|NCT01134627|4657204|P1|Overall Study|Planning to become pregnant/pregnancy|1
1411080|NCT01134627|4657203|P2|Overall Study|Withdrawal by Subject|3
1411081|NCT01134627|4657204|P1|Overall Study|Withdrawal by Subject|4
1411082|NCT01134627|4657203|P2|Overall Study|Lack of Efficacy|12
1411083|NCT01134627|4657204|P1|Overall Study|Lack of Efficacy|2
1411084|NCT01134627|4657203|P2|Overall Study|Protocol Violation|5
1411085|NCT01134627|4657204|P1|Overall Study|Protocol Violation|3
1411086|NCT01134627|4657203|P2|Overall Study|Lost to Follow-up|2
1411087|NCT01134627|4657204|P1|Overall Study|Lost to Follow-up|1
1411088|NCT01134627|4657203|P2|Overall Study|Adverse Event|31
1411089|NCT01134627|4657204|P1|Overall Study|Adverse Event|47
1411090|NCT01134614|4657234|P2|Overall Study|Patient in hospice care|1
1411091|NCT01134614|4657235|P1|Overall Study|Patient in hospice care|0
1411092|NCT01134614|4657234|P2|Overall Study|Symptomatic deterioration|1
1411093|NCT01134614|4657235|P1|Overall Study|Symptomatic deterioration|0
1411094|NCT01134614|4657234|P2|Overall Study|Pt received tx not allowed on study|1
1411095|NCT01134614|4657235|P1|Overall Study|Pt received tx not allowed on study|0
1411096|NCT01134614|4657234|P2|Overall Study|Never started treatment|1
1411097|NCT01134614|4657235|P1|Overall Study|Never started treatment|4
1411098|NCT01134614|4657234|P2|Overall Study|Physician's decision|1
1411099|NCT01134614|4657235|P1|Overall Study|Physician's decision|0
1411100|NCT01134614|4657234|P2|Overall Study|Complicating disease|1
1411101|NCT01134614|4657235|P1|Overall Study|Complicating disease|2
1411102|NCT01134614|4657234|P2|Overall Study|Alternative therapy|0
1411103|NCT01134614|4657235|P1|Overall Study|Alternative therapy|2
1411104|NCT01134614|4657234|P2|Overall Study|Withdrawal by Subject|2
1411105|NCT01134614|4657235|P1|Overall Study|Withdrawal by Subject|3
1411106|NCT01134614|4657234|P2|Overall Study|Death|8
1411107|NCT01134614|4657235|P1|Overall Study|Death|5
1411108|NCT01134614|4657234|P2|Overall Study|Adverse Event|39
1411109|NCT01134614|4657235|P1|Overall Study|Adverse Event|26
1411110|NCT01134614|4657234|P2|Overall Study|Progressive disease|54
1411111|NCT01134614|4657235|P1|Overall Study|Progressive disease|60
1411112|NCT01134614|4657234|P2|Overall Study|Still on treatment as of March 2013|13
1411113|NCT01134614|4657235|P1|Overall Study|Still on treatment as of March 2013|21
1411114|NCT01134562|4657250|P5|Overall Study|Adverse Event|0
1411115|NCT01134562|4657251|P4|Overall Study|Adverse Event|0
1411116|NCT01134562|4657252|P3|Overall Study|Adverse Event|0
1411117|NCT01134562|4657253|P2|Overall Study|Adverse Event|1
1411118|NCT01134562|4657254|P1|Overall Study|Adverse Event|0
1411119|NCT01134393|4657426|P1|Overall Study|Other|6
1411120|NCT01134393|4657426|P1|Overall Study|Withdrawal by Subject|11
1411121|NCT01134393|4657426|P1|Overall Study|Lost to Follow-up|3
1411122|NCT01134393|4657426|P1|Overall Study|Protocol Violation|12
1411123|NCT01134393|4657426|P1|Overall Study|Lack of Efficacy|2
1411124|NCT01134393|4657426|P1|Overall Study|Adverse Event|18
1411125|NCT01134315|4657547|P2|Overall Study|Other Reason|17
1411126|NCT01134315|4657548|P1|Overall Study|Other Reason|8
1411127|NCT01134315|4657547|P2|Overall Study|Adverse Event|2
1411128|NCT01134315|4657548|P1|Overall Study|Adverse Event|1
1411129|NCT01134107|4657592|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
1411130|NCT01134107|4657593|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
1411131|NCT01134107|4657592|P2|Period 2-Second Treatment Intervention|Physician Decision|0
1411132|NCT01134107|4657593|P1|Period 2-Second Treatment Intervention|Physician Decision|1
1411133|NCT01134107|4657592|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
1411134|NCT01134107|4657593|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
1411135|NCT01134107|4657592|P2|Period 1-First Treatment Intervention|Physician Decision|0
1411136|NCT01134107|4657593|P1|Period 1-First Treatment Intervention|Physician Decision|1
1411137|NCT01134107|4657592|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
1411138|NCT01134107|4657593|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
1411139|NCT01134107|4657592|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
1411140|NCT01134107|4657593|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
1411141|NCT01134107|4657592|P2|Period 1-First Treatment Intervention|Adverse Event|0
1411142|NCT01134107|4657593|P1|Period 1-First Treatment Intervention|Adverse Event|1
1411143|NCT01134055|4657640|P7|Overall Study|Physician Decision|1
1411144|NCT01134055|4657641|P6|Overall Study|Physician Decision|0
1411145|NCT01134055|4657642|P5|Overall Study|Physician Decision|0
1411146|NCT01134055|4657643|P4|Overall Study|Physician Decision|0
1411147|NCT01134055|4657644|P3|Overall Study|Physician Decision|0
1411148|NCT01134055|4657645|P2|Overall Study|Physician Decision|0
1411149|NCT01134055|4657646|P1|Overall Study|Physician Decision|0
1411150|NCT01134055|4657640|P7|Overall Study|Protocol Violation|0
1411151|NCT01134055|4657641|P6|Overall Study|Protocol Violation|0
1411152|NCT01134055|4657642|P5|Overall Study|Protocol Violation|1
1411153|NCT01134055|4657643|P4|Overall Study|Protocol Violation|1
1411154|NCT01134055|4657644|P3|Overall Study|Protocol Violation|0
1411155|NCT01134055|4657645|P2|Overall Study|Protocol Violation|0
1411156|NCT01134055|4657646|P1|Overall Study|Protocol Violation|0
1411157|NCT01134055|4657640|P7|Overall Study|Withdrawal by Subject|8
1411158|NCT01134055|4657641|P6|Overall Study|Withdrawal by Subject|0
1411159|NCT01134055|4657642|P5|Overall Study|Withdrawal by Subject|0
1411160|NCT01134055|4657643|P4|Overall Study|Withdrawal by Subject|2
1411161|NCT01134055|4657644|P3|Overall Study|Withdrawal by Subject|1
1411162|NCT01134055|4657645|P2|Overall Study|Withdrawal by Subject|3
1411163|NCT01134055|4657646|P1|Overall Study|Withdrawal by Subject|3
1411164|NCT01134055|4657640|P7|Overall Study|Lost to Follow-up|0
1411165|NCT01134055|4657641|P6|Overall Study|Lost to Follow-up|0
1411166|NCT01134055|4657642|P5|Overall Study|Lost to Follow-up|0
1411167|NCT01134055|4657643|P4|Overall Study|Lost to Follow-up|1
1411168|NCT01134055|4657644|P3|Overall Study|Lost to Follow-up|0
1411169|NCT01134055|4657645|P2|Overall Study|Lost to Follow-up|1
1411170|NCT01134055|4657646|P1|Overall Study|Lost to Follow-up|0
1411171|NCT01134055|4657640|P7|Overall Study|Adverse Event|2
1411172|NCT01134055|4657641|P6|Overall Study|Adverse Event|7
1411173|NCT01134055|4657642|P5|Overall Study|Adverse Event|5
1411174|NCT01134055|4657643|P4|Overall Study|Adverse Event|2
1411175|NCT01134055|4657644|P3|Overall Study|Adverse Event|2
1411176|NCT01134055|4657645|P2|Overall Study|Adverse Event|2
1411177|NCT01134055|4657646|P1|Overall Study|Adverse Event|5
1411178|NCT01134042|4657780|P3|Overall Study|Withdrawal by Subject|7
1411179|NCT01134042|4657781|P2|Overall Study|Withdrawal by Subject|4
1411180|NCT01134042|4657782|P1|Overall Study|Withdrawal by Subject|13
1411181|NCT01134042|4657780|P3|Overall Study|Physician Decision|1
1411182|NCT01134042|4657781|P2|Overall Study|Physician Decision|8
1411183|NCT01134042|4657782|P1|Overall Study|Physician Decision|4
1411184|NCT01134042|4657780|P3|Overall Study|Lost to Follow-up|1
1411185|NCT01134042|4657781|P2|Overall Study|Lost to Follow-up|0
1411186|NCT01134042|4657782|P1|Overall Study|Lost to Follow-up|2
1411187|NCT01134042|4657780|P3|Overall Study|Protocol Violation|5
1411188|NCT01134042|4657781|P2|Overall Study|Protocol Violation|3
1411189|NCT01134042|4657782|P1|Overall Study|Protocol Violation|5
1411190|NCT01134042|4657780|P3|Overall Study|Lack of Efficacy|18
1411191|NCT01134042|4657781|P2|Overall Study|Lack of Efficacy|6
1411192|NCT01134042|4657782|P1|Overall Study|Lack of Efficacy|21
1411193|NCT01134042|4657780|P3|Overall Study|Adverse Event|2
1411194|NCT01134042|4657781|P2|Overall Study|Adverse Event|7
1411195|NCT01134042|4657782|P1|Overall Study|Adverse Event|3
1411196|NCT01133977|4657858|P5|Overall Study|Withdrawal by Subject|1
1411197|NCT01133977|4657859|P4|Overall Study|Withdrawal by Subject|5
1411198|NCT01133977|4657860|P3|Overall Study|Withdrawal by Subject|0
1411199|NCT01133977|4657861|P2|Overall Study|Withdrawal by Subject|0
1411200|NCT01133977|4657862|P1|Overall Study|Withdrawal by Subject|0
1411201|NCT01133977|4657858|P5|Overall Study|Lost to Follow-up|1
1411202|NCT01133977|4657859|P4|Overall Study|Lost to Follow-up|2
1411203|NCT01133977|4657860|P3|Overall Study|Lost to Follow-up|0
1411204|NCT01133977|4657861|P2|Overall Study|Lost to Follow-up|0
1411205|NCT01133977|4657862|P1|Overall Study|Lost to Follow-up|0
1411206|NCT01133977|4657858|P5|Overall Study|Started a New Line of Therapy|33
1411207|NCT01133977|4657859|P4|Overall Study|Started a New Line of Therapy|25
1411208|NCT01133977|4657860|P3|Overall Study|Started a New Line of Therapy|4
1411209|NCT01133977|4657861|P2|Overall Study|Started a New Line of Therapy|6
1411210|NCT01133977|4657862|P1|Overall Study|Started a New Line of Therapy|2
1411211|NCT01133977|4657858|P5|Overall Study|Death|3
1411212|NCT01133977|4657859|P4|Overall Study|Death|7
1411213|NCT01133977|4657860|P3|Overall Study|Death|1
1411214|NCT01133977|4657861|P2|Overall Study|Death|1
1411215|NCT01133977|4657862|P1|Overall Study|Death|1
1411216|NCT01133977|4657858|P5|Overall Study|Adverse Event|0
1411217|NCT01133977|4657859|P4|Overall Study|Adverse Event|0
1411218|NCT01133977|4657860|P3|Overall Study|Adverse Event|1
1411219|NCT01133977|4657861|P2|Overall Study|Adverse Event|0
1411220|NCT01133977|4657862|P1|Overall Study|Adverse Event|0
1411221|NCT01133847|4657889|P3|Follow-Up Phase|Lost to Follow-up|7
1411222|NCT01133847|4657890|P2|Follow-Up Phase|Lost to Follow-up|3
1411223|NCT01133847|4657891|P1|Follow-Up Phase|Lost to Follow-up|1
1411224|NCT01133847|4657889|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
1411225|NCT01133847|4657890|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
1411226|NCT01133847|4657891|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
1411227|NCT01133821|4657931|P2|Overall Study|Refused participation|3
1411228|NCT01133821|4657932|P1|Overall Study|Refused participation|1
1411229|NCT01133821|4657931|P2|Overall Study|Protocol Violation|1
1411230|NCT01133821|4657932|P1|Overall Study|Protocol Violation|0
1411231|NCT01133821|4657931|P2|Overall Study|preferred other treatment|1
1411232|NCT01133821|4657932|P1|Overall Study|preferred other treatment|1
1411233|NCT01133821|4657931|P2|Overall Study|Withdrawal by Subject|3
1411234|NCT01133821|4657932|P1|Overall Study|Withdrawal by Subject|8
1411235|NCT01133821|4657931|P2|Overall Study|Lost to Follow-up|11
1411236|NCT01133821|4657932|P1|Overall Study|Lost to Follow-up|8
1411237|NCT01133756|4657943|P3|Overall Study|Progression of Disease|1
1411238|NCT01133756|4657944|P2|Overall Study|Progression of Disease|0
1411239|NCT01133756|4657945|P1|Overall Study|Progression of Disease|0
1411240|NCT01133756|4657943|P3|Overall Study|Withdrawal by Subject|0
1411241|NCT01133756|4657944|P2|Overall Study|Withdrawal by Subject|1
1411242|NCT01133756|4657945|P1|Overall Study|Withdrawal by Subject|0
1411243|NCT01133756|4657943|P3|Overall Study|Investigator Decision|0
1411244|NCT01133756|4657944|P2|Overall Study|Investigator Decision|0
1411245|NCT01133756|4657945|P1|Overall Study|Investigator Decision|1
1411246|NCT01133756|4657943|P3|Overall Study|Adverse Event|1
1411247|NCT01133756|4657944|P2|Overall Study|Adverse Event|2
1411248|NCT01133756|4657945|P1|Overall Study|Adverse Event|1
1411249|NCT01133704|4657961|P2|Overall Study|Study Closure|0
1411250|NCT01133704|4657962|P1|Overall Study|Study Closure|1
1411251|NCT01133704|4657961|P2|Overall Study|Patient refused to continue|0
1411252|NCT01133704|4657962|P1|Overall Study|Patient refused to continue|4
1411253|NCT01133704|4657961|P2|Overall Study|Death|26
1411254|NCT01133704|4657962|P1|Overall Study|Death|44
1411255|NCT01133665|4657970|P1|Overall Study|Physician Decision|2
1411256|NCT01133626|4658014|P3|Overall Study|Not specified|0
1411257|NCT01133626|4658015|P2|Overall Study|Not specified|2
1411258|NCT01133626|4658016|P1|Overall Study|Not specified|0
1411259|NCT01133626|4658014|P3|Overall Study|Withdrawal by Subject|2
1411260|NCT01133626|4658015|P2|Overall Study|Withdrawal by Subject|2
1411261|NCT01133626|4658016|P1|Overall Study|Withdrawal by Subject|1
1411262|NCT01133626|4658014|P3|Overall Study|Adverse Event|0
1411263|NCT01133626|4658015|P2|Overall Study|Adverse Event|1
1411264|NCT01133626|4658016|P1|Overall Study|Adverse Event|0
1411265|NCT01133522|4658034|P10|Overall Study|Physician Decision|0
1411266|NCT01133522|4658035|P9|Overall Study|Physician Decision|0
1411267|NCT01133522|4658036|P8|Overall Study|Physician Decision|0
1411268|NCT01133522|4658037|P7|Overall Study|Physician Decision|0
1411269|NCT01133522|4658038|P6|Overall Study|Physician Decision|0
1411270|NCT01133522|4658039|P5|Overall Study|Physician Decision|1
1411271|NCT01133522|4658040|P4|Overall Study|Physician Decision|0
1411272|NCT01133522|4658041|P3|Overall Study|Physician Decision|0
1411273|NCT01133522|4658042|P2|Overall Study|Physician Decision|0
1411274|NCT01133522|4658043|P1|Overall Study|Physician Decision|0
1411275|NCT01133522|4658034|P10|Overall Study|Withdrawal by Subject|0
1411276|NCT01133522|4658035|P9|Overall Study|Withdrawal by Subject|0
1411277|NCT01133522|4658036|P8|Overall Study|Withdrawal by Subject|0
1411278|NCT01133522|4658037|P7|Overall Study|Withdrawal by Subject|0
1411279|NCT01133522|4658038|P6|Overall Study|Withdrawal by Subject|0
1411280|NCT01133522|4658039|P5|Overall Study|Withdrawal by Subject|0
1411281|NCT01133522|4658040|P4|Overall Study|Withdrawal by Subject|1
1411282|NCT01133522|4658041|P3|Overall Study|Withdrawal by Subject|0
1411283|NCT01133522|4658042|P2|Overall Study|Withdrawal by Subject|1
1411284|NCT01133522|4658043|P1|Overall Study|Withdrawal by Subject|0
1411285|NCT01133418|4658111|P2|Overall Study|Lost to Follow-up|6
1411286|NCT01133418|4658112|P1|Overall Study|Lost to Follow-up|5
1411287|NCT01133392|4658126|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
1411288|NCT01133392|4658127|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
1411289|NCT01133392|4658126|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
1411290|NCT01133392|4658127|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
1411291|NCT01133379|4658144|P3|Overall Study|Lost to Follow-up|1
1411292|NCT01133379|4658145|P2|Overall Study|Lost to Follow-up|1
1411293|NCT01133379|4658146|P1|Overall Study|Lost to Follow-up|1
1411294|NCT01133379|4658144|P3|Overall Study|Withdrawal by Subject|1
1411295|NCT01133379|4658145|P2|Overall Study|Withdrawal by Subject|1
1411296|NCT01133379|4658146|P1|Overall Study|Withdrawal by Subject|0
1411297|NCT01133288|4658199|P1|Intervention Allocation|study terminated|2
1411298|NCT01133288|4658199|P1|Eligibility Assessment|met exclusion criteria|5
1411299|NCT01133275|4658204|P1|Overall Study|Cerebrovascular accident (CVA)|1
1411300|NCT01133275|4658204|P1|Overall Study|Withdrawal by Subject|1
1411301|NCT01133171|4658212|P3|Overall Study|Withdrawal by Subject|0
1411302|NCT01133171|4658213|P2|Overall Study|Withdrawal by Subject|2
1411303|NCT01133171|4658214|P1|Overall Study|Withdrawal by Subject|1
1411304|NCT01133067|4658224|P1|Overall Study|Lost to Follow-up|3
1411305|NCT01133067|4658224|P1|Overall Study|Death|136
1411306|NCT01132820|4658284|P1|Overall Study|Inadequate data|1
1411307|NCT01132820|4658284|P1|Overall Study|Never treated|1
1411308|NCT01132820|4658284|P1|Overall Study|Ineligible:Inadequate pathology|1
1411309|NCT01132820|4658284|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
1411310|NCT01132820|4658284|P1|Overall Study|Ineligible: wrong cell type|1
1411311|NCT01132664|4658317|P5|BM Cohort|Withdrawal by Subject|1
1411312|NCT01132664|4658318|P4|BM Cohort|Withdrawal by Subject|0
1411313|NCT01132664|4658319|P3|BM Cohort|Withdrawal by Subject|0
1411314|NCT01132664|4658320|P2|BM Cohort|Withdrawal by Subject|0
1411315|NCT01132664|4658321|P1|BM Cohort|Withdrawal by Subject|0
1411316|NCT01132664|4658317|P5|BM Cohort|Adverse Event|1
1411317|NCT01132664|4658318|P4|BM Cohort|Adverse Event|0
1411318|NCT01132664|4658319|P3|BM Cohort|Adverse Event|0
1411319|NCT01132664|4658320|P2|BM Cohort|Adverse Event|0
1411320|NCT01132664|4658321|P1|BM Cohort|Adverse Event|0
1411321|NCT01132664|4658317|P5|BM Cohort|Disease progression|4
1411322|NCT01132664|4658318|P4|BM Cohort|Disease progression|3
1411323|NCT01132664|4658319|P3|BM Cohort|Disease progression|0
1411324|NCT01132664|4658320|P2|BM Cohort|Disease progression|0
1411325|NCT01132664|4658321|P1|BM Cohort|Disease progression|0
1411326|NCT01132664|4658317|P5|Phase ll|Disease progression|0
1411327|NCT01132664|4658318|P4|Phase ll|Disease progression|0
1411328|NCT01132664|4658319|P3|Phase ll|Disease progression|35
1411329|NCT01132664|4658320|P2|Phase ll|Disease progression|0
1411330|NCT01132664|4658321|P1|Phase ll|Disease progression|0
1411331|NCT01132664|4658317|P5|Phase ll|Withdrawal by Subject|0
1411332|NCT01132664|4658318|P4|Phase ll|Withdrawal by Subject|0
1411333|NCT01132664|4658319|P3|Phase ll|Withdrawal by Subject|3
1411334|NCT01132664|4658320|P2|Phase ll|Withdrawal by Subject|0
1411335|NCT01132664|4658321|P1|Phase ll|Withdrawal by Subject|0
1411336|NCT01132664|4658317|P5|Phase ll|Adverse Event|0
1411337|NCT01132664|4658318|P4|Phase ll|Adverse Event|0
1411338|NCT01132664|4658319|P3|Phase ll|Adverse Event|10
1411339|NCT01132664|4658320|P2|Phase ll|Adverse Event|0
1411340|NCT01132664|4658321|P1|Phase ll|Adverse Event|0
1411341|NCT01132664|4658317|P5|Phase ll|Death|0
1411342|NCT01132664|4658318|P4|Phase ll|Death|0
1411343|NCT01132664|4658319|P3|Phase ll|Death|2
1411344|NCT01132664|4658320|P2|Phase ll|Death|0
1411345|NCT01132664|4658321|P1|Phase ll|Death|0
1411346|NCT01132664|4658317|P5|Phase lb|Disease Progression|0
1411347|NCT01132664|4658318|P4|Phase lb|Disease Progression|0
1411348|NCT01132664|4658319|P3|Phase lb|Disease Progression|0
1411349|NCT01132664|4658320|P2|Phase lb|Disease Progression|9
1411350|NCT01132664|4658321|P1|Phase lb|Disease Progression|4
1411351|NCT01132664|4658317|P5|Phase lb|Withdrawal by Subject|0
1411352|NCT01132664|4658318|P4|Phase lb|Withdrawal by Subject|0
1411353|NCT01132664|4658319|P3|Phase lb|Withdrawal by Subject|0
1411354|NCT01132664|4658320|P2|Phase lb|Withdrawal by Subject|2
1411355|NCT01132664|4658321|P1|Phase lb|Withdrawal by Subject|1
1411356|NCT01132664|4658317|P5|Phase lb|Adverse Event|0
1411357|NCT01132664|4658318|P4|Phase lb|Adverse Event|0
1411358|NCT01132664|4658319|P3|Phase lb|Adverse Event|0
1411359|NCT01132664|4658320|P2|Phase lb|Adverse Event|1
1411360|NCT01132664|4658321|P1|Phase lb|Adverse Event|0
1411361|NCT01132651|4658355|P2|Overall Study|Lost to Follow-up|1
1411362|NCT01132651|4658356|P1|Overall Study|Lost to Follow-up|1
1411363|NCT01132612|4658367|P3|Overall Study|Lack of Efficacy|73
1411364|NCT01132612|4658368|P2|Overall Study|Lack of Efficacy|22
1411365|NCT01132612|4658369|P1|Overall Study|Lack of Efficacy|23
1411366|NCT01132612|4658367|P3|Overall Study|Administrative problems|52
1411367|NCT01132612|4658368|P2|Overall Study|Administrative problems|1
1411368|NCT01132612|4658369|P1|Overall Study|Administrative problems|5
1411369|NCT01132612|4658367|P3|Overall Study|Withdrawal by Subject|19
1411370|NCT01132612|4658368|P2|Overall Study|Withdrawal by Subject|8
1411371|NCT01132612|4658369|P1|Overall Study|Withdrawal by Subject|5
1411372|NCT01132612|4658367|P3|Overall Study|Adverse Event|15
1411373|NCT01132612|4658368|P2|Overall Study|Adverse Event|2
1411374|NCT01132612|4658369|P1|Overall Study|Adverse Event|5
1411375|NCT01132612|4658367|P3|Overall Study|Lost to Follow-up|7
1411376|NCT01132612|4658368|P2|Overall Study|Lost to Follow-up|2
1411377|NCT01132612|4658369|P1|Overall Study|Lost to Follow-up|2
1411378|NCT01132612|4658367|P3|Overall Study|Protocol deviation|3
1411379|NCT01132612|4658368|P2|Overall Study|Protocol deviation|0
1411380|NCT01132612|4658369|P1|Overall Study|Protocol deviation|0
1411381|NCT01132612|4658367|P3|Overall Study|Death|1
1411382|NCT01132612|4658368|P2|Overall Study|Death|0
1411383|NCT01132612|4658369|P1|Overall Study|Death|0
1411384|NCT01132547|4658385|P2|Overall Study|Death|0
1411385|NCT01132547|4658386|P1|Overall Study|Death|1
1411386|NCT01132547|4658385|P2|Overall Study|Withdrawal by Subject|1
1411387|NCT01132547|4658386|P1|Overall Study|Withdrawal by Subject|3
1411388|NCT01132495|4658456|P4|Overall Study|Various reasons|12
1411389|NCT01132495|4658457|P3|Overall Study|Various reasons|20
1411390|NCT01132495|4658458|P2|Overall Study|Various reasons|38
1411391|NCT01132495|4658459|P1|Overall Study|Various reasons|40
1411392|NCT01132326|4658472|P1|Overall Study|Subject Unable to Come To Visits|1
1411393|NCT01132326|4658472|P1|Overall Study|Death|5
1411394|NCT01132326|4658472|P1|Overall Study|Caregiver Withdrew Consent|1
1411395|NCT01132326|4658472|P1|Overall Study|Pregnancy|1
1411396|NCT01132326|4658472|P1|Overall Study|Declining Health|1
1411397|NCT01132326|4658472|P1|Overall Study|Study Termination|80
1411398|NCT01132326|4658472|P1|Overall Study|Physician Decision|10
1411399|NCT01132326|4658472|P1|Overall Study|Withdrawal by Subject|40
1411400|NCT01132326|4658472|P1|Overall Study|Lost to Follow-up|16
1411401|NCT01132326|4658472|P1|Overall Study|Protocol Violation|1
1411402|NCT01132326|4658472|P1|Overall Study|Adverse Event|37
1411403|NCT01132326|4658472|P1|Overall Study|Lack of Efficacy|25
1411404|NCT01132313|4658488|P12|Overall Study|Other reason not defined above|0
1411405|NCT01132313|4658489|P11|Overall Study|Other reason not defined above|0
1411406|NCT01132313|4658490|P10|Overall Study|Other reason not defined above|0
1411407|NCT01132313|4658491|P9|Overall Study|Other reason not defined above|0
1411408|NCT01132313|4658492|P8|Overall Study|Other reason not defined above|1
1411409|NCT01132313|4658493|P7|Overall Study|Other reason not defined above|0
1411410|NCT01132313|4658494|P6|Overall Study|Other reason not defined above|0
1411411|NCT01132313|4658495|P5|Overall Study|Other reason not defined above|0
1411412|NCT01132313|4658496|P4|Overall Study|Other reason not defined above|0
1411413|NCT01132313|4658497|P3|Overall Study|Other reason not defined above|0
1411414|NCT01132313|4658498|P2|Overall Study|Other reason not defined above|0
1411415|NCT01132313|4658499|P1|Overall Study|Other reason not defined above|0
1411416|NCT01132313|4658488|P12|Overall Study|Lack of antiviral response|0
1411417|NCT01132313|4658489|P11|Overall Study|Lack of antiviral response|1
1411418|NCT01132313|4658490|P10|Overall Study|Lack of antiviral response|0
1411419|NCT01132313|4658491|P9|Overall Study|Lack of antiviral response|0
1411420|NCT01132313|4658492|P8|Overall Study|Lack of antiviral response|0
1411421|NCT01132313|4658493|P7|Overall Study|Lack of antiviral response|21
1411422|NCT01132313|4658494|P6|Overall Study|Lack of antiviral response|18
1411423|NCT01132313|4658495|P5|Overall Study|Lack of antiviral response|18
1411424|NCT01132313|4658496|P4|Overall Study|Lack of antiviral response|18
1411425|NCT01132313|4658497|P3|Overall Study|Lack of antiviral response|12
1411426|NCT01132313|4658498|P2|Overall Study|Lack of antiviral response|0
1411427|NCT01132313|4658499|P1|Overall Study|Lack of antiviral response|0
1411428|NCT01132313|4658488|P12|Overall Study|Withdrawal by Subject|0
1411429|NCT01132313|4658489|P11|Overall Study|Withdrawal by Subject|0
1411430|NCT01132313|4658490|P10|Overall Study|Withdrawal by Subject|2
1411431|NCT01132313|4658491|P9|Overall Study|Withdrawal by Subject|0
1411432|NCT01132313|4658492|P8|Overall Study|Withdrawal by Subject|0
1411433|NCT01132313|4658493|P7|Overall Study|Withdrawal by Subject|1
1411434|NCT01132313|4658494|P6|Overall Study|Withdrawal by Subject|0
1411435|NCT01132313|4658495|P5|Overall Study|Withdrawal by Subject|6
1411436|NCT01132313|4658496|P4|Overall Study|Withdrawal by Subject|3
1411437|NCT01132313|4658497|P3|Overall Study|Withdrawal by Subject|3
1411438|NCT01132313|4658498|P2|Overall Study|Withdrawal by Subject|0
1411439|NCT01132313|4658499|P1|Overall Study|Withdrawal by Subject|0
1411440|NCT01132313|4658488|P12|Overall Study|Lost to Follow-up|0
1411441|NCT01132313|4658489|P11|Overall Study|Lost to Follow-up|0
1411442|NCT01132313|4658490|P10|Overall Study|Lost to Follow-up|0
1411443|NCT01132313|4658491|P9|Overall Study|Lost to Follow-up|0
1411444|NCT01132313|4658492|P8|Overall Study|Lost to Follow-up|1
1411445|NCT01132313|4658493|P7|Overall Study|Lost to Follow-up|0
1411446|NCT01132313|4658494|P6|Overall Study|Lost to Follow-up|0
1411447|NCT01132313|4658495|P5|Overall Study|Lost to Follow-up|0
1411448|NCT01132313|4658496|P4|Overall Study|Lost to Follow-up|0
1411449|NCT01132313|4658497|P3|Overall Study|Lost to Follow-up|1
1411450|NCT01132313|4658498|P2|Overall Study|Lost to Follow-up|0
1411451|NCT01132313|4658499|P1|Overall Study|Lost to Follow-up|0
1411452|NCT01132313|4658488|P12|Overall Study|Protocol Violation|0
1411453|NCT01132313|4658489|P11|Overall Study|Protocol Violation|0
1411454|NCT01132313|4658490|P10|Overall Study|Protocol Violation|0
1411455|NCT01132313|4658491|P9|Overall Study|Protocol Violation|0
1411456|NCT01132313|4658492|P8|Overall Study|Protocol Violation|0
1411457|NCT01132313|4658493|P7|Overall Study|Protocol Violation|0
1411458|NCT01132313|4658494|P6|Overall Study|Protocol Violation|0
1411459|NCT01132313|4658495|P5|Overall Study|Protocol Violation|0
1411460|NCT01132313|4658496|P4|Overall Study|Protocol Violation|1
1411461|NCT01132313|4658497|P3|Overall Study|Protocol Violation|0
1411462|NCT01132313|4658498|P2|Overall Study|Protocol Violation|0
1411463|NCT01132313|4658499|P1|Overall Study|Protocol Violation|0
1411464|NCT01132313|4658488|P12|Overall Study|Adverse Event|0
1411465|NCT01132313|4658489|P11|Overall Study|Adverse Event|0
1411466|NCT01132313|4658490|P10|Overall Study|Adverse Event|2
1411467|NCT01132313|4658491|P9|Overall Study|Adverse Event|7
1411468|NCT01132313|4658492|P8|Overall Study|Adverse Event|3
1411469|NCT01132313|4658493|P7|Overall Study|Adverse Event|5
1411470|NCT01132313|4658494|P6|Overall Study|Adverse Event|6
1411471|NCT01132313|4658495|P5|Overall Study|Adverse Event|19
1411472|NCT01132313|4658496|P4|Overall Study|Adverse Event|10
1411473|NCT01132313|4658497|P3|Overall Study|Adverse Event|4
1411474|NCT01132313|4658498|P2|Overall Study|Adverse Event|0
1411475|NCT01132313|4658499|P1|Overall Study|Adverse Event|0
1411476|NCT01132313|4658488|P12|Overall Study|Not treated|0
1411477|NCT01132313|4658489|P11|Overall Study|Not treated|0
1411478|NCT01132313|4658490|P10|Overall Study|Not treated|0
1411479|NCT01132313|4658491|P9|Overall Study|Not treated|0
1411480|NCT01132313|4658492|P8|Overall Study|Not treated|0
1411481|NCT01132313|4658493|P7|Overall Study|Not treated|3
1411482|NCT01132313|4658494|P6|Overall Study|Not treated|1
1411483|NCT01132313|4658495|P5|Overall Study|Not treated|2
1411484|NCT01132313|4658496|P4|Overall Study|Not treated|0
1411485|NCT01132313|4658497|P3|Overall Study|Not treated|0
1411486|NCT01132313|4658498|P2|Overall Study|Not treated|0
1411487|NCT01132313|4658499|P1|Overall Study|Not treated|2
1411488|NCT01132313|4658488|P12|Overall Study|Lack of Efficacy|0
1411489|NCT01132313|4658489|P11|Overall Study|Lack of Efficacy|0
1411490|NCT01132313|4658490|P10|Overall Study|Lack of Efficacy|16
1411491|NCT01132313|4658491|P9|Overall Study|Lack of Efficacy|14
1411492|NCT01132313|4658492|P8|Overall Study|Lack of Efficacy|3
1411493|NCT01132313|4658493|P7|Overall Study|Lack of Efficacy|0
1411494|NCT01132313|4658494|P6|Overall Study|Lack of Efficacy|0
1411495|NCT01132313|4658495|P5|Overall Study|Lack of Efficacy|0
1411496|NCT01132313|4658496|P4|Overall Study|Lack of Efficacy|0
1411497|NCT01132313|4658497|P3|Overall Study|Lack of Efficacy|0
1411498|NCT01132313|4658498|P2|Overall Study|Lack of Efficacy|0
1411499|NCT01132313|4658499|P1|Overall Study|Lack of Efficacy|1
1411500|NCT01132118|4658579|P2|Second Intervention (8 Weeks)|Adverse Event|1
1411501|NCT01132118|4658580|P1|Second Intervention (8 Weeks)|Adverse Event|0
1411502|NCT01132118|4658579|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
1411503|NCT01132118|4658580|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
1411504|NCT01132118|4658579|P2|First Intervention (8 Weeks)|Adverse Event|0
1411505|NCT01132118|4658580|P1|First Intervention (8 Weeks)|Adverse Event|1
1411506|NCT01131676|4658610|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
1411507|NCT01131676|4658611|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
1411508|NCT01131676|4658612|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
1411509|NCT01131676|4658610|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
1411510|NCT01131676|4658611|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
1411511|NCT01131676|4658612|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
1411512|NCT01131676|4658610|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
1411513|NCT01131676|4658611|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
1411514|NCT01131676|4658612|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
1411515|NCT01131676|4658610|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
1411516|NCT01131676|4658611|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
1411517|NCT01131676|4658612|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
1411518|NCT01131676|4658610|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
1411519|NCT01131676|4658611|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
1411520|NCT01131676|4658612|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
1411521|NCT01131676|4658610|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
1411522|NCT01131676|4658611|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
1411523|NCT01131676|4658612|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
1411524|NCT01131676|4658610|P3|Discontinuation From Treatment|Adverse Event|273
1411525|NCT01131676|4658611|P2|Discontinuation From Treatment|Adverse Event|267
1411526|NCT01131676|4658612|P1|Discontinuation From Treatment|Adverse Event|303
1411527|NCT01131676|4658610|P3|Discontinuation From Treatment|Other than those specified|125
1411528|NCT01131676|4658611|P2|Discontinuation From Treatment|Other than those specified|142
1411529|NCT01131676|4658612|P1|Discontinuation From Treatment|Other than those specified|162
1411530|NCT01131676|4658610|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
1411531|NCT01131676|4658611|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
1411532|NCT01131676|4658612|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
1411533|NCT01131676|4658610|P3|Discontinuation From Treatment|Lost to Follow-up|6
1411534|NCT01131676|4658611|P2|Discontinuation From Treatment|Lost to Follow-up|9
1411535|NCT01131676|4658612|P1|Discontinuation From Treatment|Lost to Follow-up|15
1411536|NCT01131676|4658610|P3|Discontinuation From Treatment|Non compliant with protocol|12
1411537|NCT01131676|4658611|P2|Discontinuation From Treatment|Non compliant with protocol|15
1411538|NCT01131676|4658612|P1|Discontinuation From Treatment|Non compliant with protocol|15
1411539|NCT01131676|4658610|P3|Discontinuation From Treatment|Lack of Efficacy|0
1411540|NCT01131676|4658611|P2|Discontinuation From Treatment|Lack of Efficacy|1
1411541|NCT01131676|4658612|P1|Discontinuation From Treatment|Lack of Efficacy|11
1411542|NCT01131676|4658610|P3|Discontinuation From Treatment|Not treated|2
1411543|NCT01131676|4658611|P2|Discontinuation From Treatment|Not treated|2
1411544|NCT01131676|4658612|P1|Discontinuation From Treatment|Not treated|4
1411545|NCT01131676|4658610|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
1411546|NCT01131676|4658611|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
1411547|NCT01131676|4658612|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
1411548|NCT01131585|4658647|P2|Overall Study|Study termination|32
1411549|NCT01131585|4658648|P1|Overall Study|Study termination|78
1411550|NCT01131585|4658647|P2|Overall Study|Administrative problems|1
1411551|NCT01131585|4658648|P1|Overall Study|Administrative problems|1
1411552|NCT01131585|4658647|P2|Overall Study|Lost to Follow-up|1
1411553|NCT01131585|4658648|P1|Overall Study|Lost to Follow-up|0
1411554|NCT01131585|4658647|P2|Overall Study|Withdrawal by Subject|3
1411555|NCT01131585|4658648|P1|Overall Study|Withdrawal by Subject|3
1411556|NCT01131585|4658647|P2|Overall Study|Protocol Violation|1
1411557|NCT01131585|4658648|P1|Overall Study|Protocol Violation|2
1411558|NCT01131585|4658647|P2|Overall Study|Unsatisfactory therapeutic effect|3
1411559|NCT01131585|4658648|P1|Overall Study|Unsatisfactory therapeutic effect|0
1411560|NCT01131585|4658647|P2|Overall Study|Abnormal laboratory value|0
1411561|NCT01131585|4658648|P1|Overall Study|Abnormal laboratory value|1
1411562|NCT01131585|4658647|P2|Overall Study|Adverse Event|2
1411563|NCT01131585|4658648|P1|Overall Study|Adverse Event|0
1411564|NCT01131520|4658656|P2|Overall Study|Subject changed history after enrollment|1
1411565|NCT01131520|4658657|P1|Overall Study|Subject changed history after enrollment|0
1411566|NCT01131520|4658656|P2|Overall Study|Counselor not available|3
1411567|NCT01131520|4658657|P1|Overall Study|Counselor not available|0
1411568|NCT01131520|4658656|P2|Overall Study|Computer problem|0
1411569|NCT01131520|4658657|P1|Overall Study|Computer problem|1
1411570|NCT01131507|4658679|P1|Overall Study|Withdrawal by Subject|1
1411571|NCT01131507|4658679|P1|Overall Study|Lost to Follow-up|1
1411572|NCT01131507|4658679|P1|Overall Study|Adverse Event|1
1411573|NCT01131494|4658684|P1|Overall Study|Withdrawal by Subject|2
1411574|NCT01131455|4658694|P3|Overall Study|Death of PI|0
1411575|NCT01131455|4658695|P2|Overall Study|Death of PI|4
1411576|NCT01131455|4658696|P1|Overall Study|Death of PI|6
1411577|NCT01131299|4658704|P2|Overall Study|Withdrawal by Subject|7
1411578|NCT01131299|4658705|P1|Overall Study|Withdrawal by Subject|4
1411579|NCT01131182|4658718|P2|Overall Study|Other Reason|0
1411580|NCT01131182|4658719|P1|Overall Study|Other Reason|1
1411581|NCT01131182|4658718|P2|Overall Study|Lost to Follow-up|15
1411582|NCT01131182|4658719|P1|Overall Study|Lost to Follow-up|14
1411583|NCT01131182|4658718|P2|Overall Study|Withdrawal by Subject|1
1411584|NCT01131182|4658719|P1|Overall Study|Withdrawal by Subject|1
1411585|NCT01131130|4658727|P1|Period 3- Crossover|+ Slit lamp finding|1
1411586|NCT01131130|4658727|P1|Period 1 - Baseline|Pregnancy|1
1411587|NCT01131104|4658740|P1|Overall Study|No Information on Index Date of Onset|1
1411588|NCT01131104|4658740|P1|Overall Study|Information Not Available|5
1411589|NCT01131104|4658740|P1|Overall Study|Physician Decision|4
1411590|NCT01131104|4658740|P1|Overall Study|Withdrawal by Subject|3
1411591|NCT01131078|4658747|P3|Overall Study|Other|0
1411592|NCT01131078|4658748|P2|Overall Study|Other|1
1411593|NCT01131078|4658749|P1|Overall Study|Other|0
1411594|NCT01131078|4658747|P3|Overall Study|Death|2
1411595|NCT01131078|4658748|P2|Overall Study|Death|0
1411596|NCT01131078|4658749|P1|Overall Study|Death|4
1411597|NCT01131078|4658747|P3|Overall Study|Physician Decision|8
1411598|NCT01131078|4658748|P2|Overall Study|Physician Decision|6
1411599|NCT01131078|4658749|P1|Overall Study|Physician Decision|10
1411600|NCT01131078|4658747|P3|Overall Study|Non-compliance|0
1411601|NCT01131078|4658748|P2|Overall Study|Non-compliance|0
1411602|NCT01131078|4658749|P1|Overall Study|Non-compliance|3
1411603|NCT01131078|4658747|P3|Overall Study|Withdrawal by Subject|3
1411604|NCT01131078|4658748|P2|Overall Study|Withdrawal by Subject|4
1411605|NCT01131078|4658749|P1|Overall Study|Withdrawal by Subject|2
1411606|NCT01131078|4658747|P3|Overall Study|Lost to Follow-up|1
1411607|NCT01131078|4658748|P2|Overall Study|Lost to Follow-up|1
1411608|NCT01131078|4658749|P1|Overall Study|Lost to Follow-up|1
1411609|NCT01131078|4658747|P3|Overall Study|Protocol Violation|0
1411610|NCT01131078|4658748|P2|Overall Study|Protocol Violation|0
1411611|NCT01131078|4658749|P1|Overall Study|Protocol Violation|1
1411612|NCT01131078|4658747|P3|Overall Study|Progressive Disease|71
1411613|NCT01131078|4658748|P2|Overall Study|Progressive Disease|77
1411614|NCT01131078|4658749|P1|Overall Study|Progressive Disease|58
1411615|NCT01131078|4658747|P3|Overall Study|Adverse Event|17
1411616|NCT01131078|4658748|P2|Overall Study|Adverse Event|12
1411617|NCT01131078|4658749|P1|Overall Study|Adverse Event|22
1411618|NCT01130974|4658836|P2|Overall Study|Ineligibility criteria|2
1411619|NCT01130974|4658837|P1|Overall Study|Ineligibility criteria|5
1411620|NCT01130974|4658836|P2|Overall Study|Withdrawal by Subject|1
1411621|NCT01130974|4658837|P1|Overall Study|Withdrawal by Subject|0
1411622|NCT01130974|4658836|P2|Overall Study|Protocol Violation|10
1411623|NCT01130974|4658837|P1|Overall Study|Protocol Violation|10
1411624|NCT01130883|4658857|P1|Overall Study|Adverse Event|3
1411625|NCT01130883|4658857|P1|Overall Study|Reason Unknown|1
1411626|NCT01130883|4658857|P1|Overall Study|Patient Noncompliance|6
1411627|NCT01130831|4658914|P1|Overall Study|Information was missing|3
1411628|NCT01130831|4658914|P1|Overall Study|Death|4
1411629|NCT01130831|4658914|P1|Overall Study|Withdrawal by Subject|7
1411630|NCT01130597|4658953|P1|Overall Study|Protocol Violation|1
1411631|NCT01130597|4658953|P1|Overall Study|Death|1
1411632|NCT01130597|4658953|P1|Overall Study|Adverse Event|4
1411633|NCT01130597|4658953|P1|Overall Study|Protocol-specified (High K+)|1
1411634|NCT01130532|4658978|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
1411635|NCT01130532|4658979|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
1411636|NCT01130532|4658980|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
1411637|NCT01130532|4658981|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
1411638|NCT01130532|4658978|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
1411639|NCT01130532|4658979|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
1411640|NCT01130532|4658980|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
1411641|NCT01130532|4658981|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
1411642|NCT01130532|4658978|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
1411643|NCT01130532|4658979|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
1411644|NCT01130532|4658980|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
1411645|NCT01130532|4658981|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
1411646|NCT01130532|4658978|P4|Period IV (Weeks 13-16)|Adverse Event|1
1411647|NCT01130532|4658979|P3|Period IV (Weeks 13-16)|Adverse Event|0
1411648|NCT01130532|4658980|P2|Period IV (Weeks 13-16)|Adverse Event|0
1411649|NCT01130532|4658981|P1|Period IV (Weeks 13-16)|Adverse Event|0
1411650|NCT01130532|4658978|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
1411651|NCT01130532|4658979|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
1411652|NCT01130532|4658980|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
1411653|NCT01130532|4658981|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
1411654|NCT01130532|4658978|P4|Period III (Weeks 0-12)|Sponsor Decision|0
1411655|NCT01130532|4658979|P3|Period III (Weeks 0-12)|Sponsor Decision|2
1411656|NCT01130532|4658980|P2|Period III (Weeks 0-12)|Sponsor Decision|4
1411657|NCT01130532|4658981|P1|Period III (Weeks 0-12)|Sponsor Decision|3
1411658|NCT01130532|4658978|P4|Period III (Weeks 0-12)|Protocol Violation|0
1411659|NCT01130532|4658979|P3|Period III (Weeks 0-12)|Protocol Violation|1
1411660|NCT01130532|4658980|P2|Period III (Weeks 0-12)|Protocol Violation|0
1411661|NCT01130532|4658981|P1|Period III (Weeks 0-12)|Protocol Violation|0
1411662|NCT01130532|4658978|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
1411663|NCT01130532|4658979|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
1411664|NCT01130532|4658980|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
1411665|NCT01130532|4658981|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
1411666|NCT01130532|4658978|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
1411667|NCT01130532|4658979|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
1411668|NCT01130532|4658980|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
1411669|NCT01130532|4658981|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
1411670|NCT01130532|4658978|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
1411671|NCT01130532|4658979|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
1411672|NCT01130532|4658980|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
1411673|NCT01130532|4658981|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
1411674|NCT01130532|4658978|P4|Period III (Weeks 0-12)|Adverse Event|0
1411675|NCT01130532|4658979|P3|Period III (Weeks 0-12)|Adverse Event|2
1411676|NCT01130532|4658980|P2|Period III (Weeks 0-12)|Adverse Event|3
1411677|NCT01130532|4658981|P1|Period III (Weeks 0-12)|Adverse Event|3
1411678|NCT01130493|4659026|P3|Part 2: OLE|Withdrawal by Subject|4
1411679|NCT01130493|4659027|P2|Part 2: OLE|Withdrawal by Subject|1
1411680|NCT01130493|4659028|P1|Part 2: OLE|Withdrawal by Subject|0
1411681|NCT01130493|4659026|P3|Part 2: OLE|Adverse Event|1
1411682|NCT01130493|4659027|P2|Part 2: OLE|Adverse Event|2
1411683|NCT01130493|4659028|P1|Part 2: OLE|Adverse Event|0
1411684|NCT01130493|4659026|P3|Part 1: Double-blind Treatment Period 2|Noncompliance|1
1411685|NCT01130493|4659027|P2|Part 1: Double-blind Treatment Period 2|Noncompliance|0
1411686|NCT01130493|4659028|P1|Part 1: Double-blind Treatment Period 2|Noncompliance|0
1411687|NCT01130493|4659026|P3|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
1411688|NCT01130493|4659027|P2|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
1411689|NCT01130493|4659028|P1|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
1411690|NCT01130493|4659026|P3|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
1411691|NCT01130493|4659027|P2|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
1411692|NCT01130493|4659028|P1|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
1411693|NCT01130493|4659026|P3|Part 1: Open-Label IPX066 Washout|Adverse Event|1
1411694|NCT01130493|4659027|P2|Part 1: Open-Label IPX066 Washout|Adverse Event|0
1411695|NCT01130493|4659028|P1|Part 1: Open-Label IPX066 Washout|Adverse Event|0
1411696|NCT01130493|4659026|P3|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
1411697|NCT01130493|4659027|P2|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
1411698|NCT01130493|4659028|P1|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
1411699|NCT01130493|4659026|P3|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
1411700|NCT01130493|4659027|P2|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
1411701|NCT01130493|4659028|P1|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
1411702|NCT01130493|4659026|P3|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
1411703|NCT01130493|4659027|P2|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
1411704|NCT01130493|4659028|P1|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
1411705|NCT01130493|4659026|P3|Open-label Dose Conversion to IPX066|Diary imcomplete|0
1411706|NCT01130493|4659027|P2|Open-label Dose Conversion to IPX066|Diary imcomplete|0
1411707|NCT01130493|4659028|P1|Open-label Dose Conversion to IPX066|Diary imcomplete|1
1411708|NCT01130493|4659026|P3|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
1411709|NCT01130493|4659027|P2|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
1411710|NCT01130493|4659028|P1|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
1411711|NCT01130493|4659026|P3|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
1411712|NCT01130493|4659027|P2|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
1411713|NCT01130493|4659028|P1|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
1411714|NCT01130493|4659026|P3|Open-label Dose Conversion to IPX066|Protocol Violation|0
1411715|NCT01130493|4659027|P2|Open-label Dose Conversion to IPX066|Protocol Violation|0
1411716|NCT01130493|4659028|P1|Open-label Dose Conversion to IPX066|Protocol Violation|3
1411717|NCT01130493|4659026|P3|Open-label Dose Conversion to IPX066|Adverse Event|0
1411718|NCT01130493|4659027|P2|Open-label Dose Conversion to IPX066|Adverse Event|0
1411719|NCT01130493|4659028|P1|Open-label Dose Conversion to IPX066|Adverse Event|1
1411720|NCT01130337|4659045|P1|Overall Study|Surgical resection (R2)|1
1411721|NCT01130337|4659045|P1|Overall Study|Toxicity, AE/intercurrent disease|7
1411722|NCT01130337|4659045|P1|Overall Study|Disease progression|1
1411723|NCT01130337|4659045|P1|Overall Study|Death|1
1411724|NCT01130337|4659045|P1|Overall Study|Principal investigator decision|1
1411725|NCT01130337|4659045|P1|Overall Study|Withdrawal by Subject|3
1411726|NCT01130168|4659052|P6|Period 1|Adverse Event|0
1411727|NCT01130168|4659053|P5|Period 1|Adverse Event|0
1411728|NCT01130168|4659054|P4|Period 1|Adverse Event|1
1411729|NCT01130168|4659055|P3|Period 1|Adverse Event|0
1411730|NCT01130168|4659056|P2|Period 1|Adverse Event|0
1411731|NCT01130168|4659057|P1|Period 1|Adverse Event|0
1411732|NCT01130168|4659052|P6|Period 1|Discontinued For Other Reason|0
1411733|NCT01130168|4659053|P5|Period 1|Discontinued For Other Reason|0
1411734|NCT01130168|4659054|P4|Period 1|Discontinued For Other Reason|1
1411735|NCT01130168|4659055|P3|Period 1|Discontinued For Other Reason|1
1411736|NCT01130168|4659056|P2|Period 1|Discontinued For Other Reason|0
1411737|NCT01130168|4659057|P1|Period 1|Discontinued For Other Reason|0
1411738|NCT01130168|4659052|P6|Period 1|Withdrawal by Subject|0
1411739|NCT01130168|4659053|P5|Period 1|Withdrawal by Subject|0
1411740|NCT01130168|4659054|P4|Period 1|Withdrawal by Subject|1
1411741|NCT01130168|4659055|P3|Period 1|Withdrawal by Subject|0
1411742|NCT01130168|4659056|P2|Period 1|Withdrawal by Subject|1
1411743|NCT01130168|4659057|P1|Period 1|Withdrawal by Subject|0
1411744|NCT01130103|4659094|P2|Maintenance Treatment|Withdrawal by Subject|0
1411745|NCT01130103|4659095|P1|Maintenance Treatment|Withdrawal by Subject|1
1411746|NCT01130103|4659094|P2|Maintenance Treatment|Lost to Follow-up|1
1411747|NCT01130103|4659095|P1|Maintenance Treatment|Lost to Follow-up|1
1411748|NCT01130103|4659094|P2|Maintenance Treatment|Lack of Efficacy|1
1411749|NCT01130103|4659095|P1|Maintenance Treatment|Lack of Efficacy|0
1411750|NCT01130103|4659094|P2|Randomized Treatment|Withdrawal by Subject|2
1411751|NCT01130103|4659095|P1|Randomized Treatment|Withdrawal by Subject|1
1411752|NCT01130103|4659094|P2|Randomized Treatment|Protocol Violation|2
1411753|NCT01130103|4659095|P1|Randomized Treatment|Protocol Violation|3
1411754|NCT01130103|4659094|P2|Randomized Treatment|Lost to Follow-up|0
1411755|NCT01130103|4659095|P1|Randomized Treatment|Lost to Follow-up|1
1411756|NCT01130103|4659094|P2|Randomized Treatment|Adverse Event|1
1411757|NCT01130103|4659095|P1|Randomized Treatment|Adverse Event|1
1411758|NCT01130051|4659109|P2|Washout Period of 14 Days|Protocol Violation|1
1411759|NCT01130051|4659110|P1|Washout Period of 14 Days|Protocol Violation|1
1411760|NCT01130051|4659109|P2|Washout Period of 14 Days|Withdrawal by Subject|1
1411761|NCT01130051|4659110|P1|Washout Period of 14 Days|Withdrawal by Subject|0
1411762|NCT01129960|4659124|P4|Overall Study|Pregnancy|0
1411763|NCT01129960|4659125|P3|Overall Study|Pregnancy|0
1411764|NCT01129960|4659126|P2|Overall Study|Pregnancy|0
1411765|NCT01129960|4659127|P1|Overall Study|Pregnancy|1
1411766|NCT01129960|4659124|P4|Overall Study|Physician Decision|0
1411767|NCT01129960|4659125|P3|Overall Study|Physician Decision|0
1411768|NCT01129960|4659126|P2|Overall Study|Physician Decision|0
1411769|NCT01129960|4659127|P1|Overall Study|Physician Decision|1
1411770|NCT01129960|4659124|P4|Overall Study|Discontinuation of the study by Sponsor|0
1411771|NCT01129960|4659125|P3|Overall Study|Discontinuation of the study by Sponsor|0
1411772|NCT01129960|4659126|P2|Overall Study|Discontinuation of the study by Sponsor|1
1411773|NCT01129960|4659127|P1|Overall Study|Discontinuation of the study by Sponsor|0
1411774|NCT01129960|4659124|P4|Overall Study|Lost to Follow-up|3
1411775|NCT01129960|4659125|P3|Overall Study|Lost to Follow-up|3
1411776|NCT01129960|4659126|P2|Overall Study|Lost to Follow-up|2
1411777|NCT01129960|4659127|P1|Overall Study|Lost to Follow-up|0
1411778|NCT01129960|4659124|P4|Overall Study|Protocol Violation|0
1411779|NCT01129960|4659125|P3|Overall Study|Protocol Violation|3
1411780|NCT01129960|4659126|P2|Overall Study|Protocol Violation|2
1411781|NCT01129960|4659127|P1|Overall Study|Protocol Violation|1
1411782|NCT01129960|4659124|P4|Overall Study|Adverse Event|7
1411783|NCT01129960|4659125|P3|Overall Study|Adverse Event|16
1411784|NCT01129960|4659126|P2|Overall Study|Adverse Event|16
1411785|NCT01129960|4659127|P1|Overall Study|Adverse Event|23
1411786|NCT01129960|4659124|P4|Overall Study|Lack of Efficacy|1
1411787|NCT01129960|4659125|P3|Overall Study|Lack of Efficacy|1
1411788|NCT01129960|4659126|P2|Overall Study|Lack of Efficacy|1
1411789|NCT01129960|4659127|P1|Overall Study|Lack of Efficacy|1
1411790|NCT01129960|4659124|P4|Overall Study|Withdrawal by Subject|2
1411791|NCT01129960|4659125|P3|Overall Study|Withdrawal by Subject|3
1411792|NCT01129960|4659126|P2|Overall Study|Withdrawal by Subject|0
1411793|NCT01129960|4659127|P1|Overall Study|Withdrawal by Subject|3
1411794|NCT01129921|4659139|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
1411795|NCT01129921|4659140|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
1411796|NCT01129921|4659139|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
1411797|NCT01129921|4659140|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
1411798|NCT01129921|4659139|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
1411799|NCT01129921|4659140|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
1411800|NCT01129921|4659139|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
1411801|NCT01129921|4659140|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
1411802|NCT01129622|4659164|P1|Overall Study|Withdrawal by Subject|2
1411803|NCT01129583|4659171|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
1411804|NCT01129583|4659172|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
1411805|NCT01129583|4659171|P2|Overall Study|Lost to Follow-up|1
1411806|NCT01129583|4659172|P1|Overall Study|Lost to Follow-up|1
1411807|NCT01129583|4659171|P2|Overall Study|Death|0
1411808|NCT01129583|4659172|P1|Overall Study|Death|1
1411809|NCT01129557|4659185|P3|Overall Study|Novartis terminated study early|2
1411810|NCT01129557|4659186|P2|Overall Study|Novartis terminated study early|3
1411811|NCT01129557|4659187|P1|Overall Study|Novartis terminated study early|3
1411812|NCT01129557|4659185|P3|Overall Study|Adverse Event|2
1411813|NCT01129557|4659186|P2|Overall Study|Adverse Event|2
1411814|NCT01129557|4659187|P1|Overall Study|Adverse Event|1
1411815|NCT01129336|4659282|P2|Overall Study|Death|4
1411816|NCT01129336|4659283|P1|Overall Study|Death|0
1411817|NCT01129336|4659282|P2|Overall Study|Missing Study Completion Status|3
1411818|NCT01129336|4659283|P1|Overall Study|Missing Study Completion Status|2
1411819|NCT01129336|4659282|P2|Overall Study|Adverse Event|1
1411820|NCT01129336|4659283|P1|Overall Study|Adverse Event|0
1411821|NCT01129336|4659282|P2|Overall Study|Withdrawal by Subject|4
1411822|NCT01129336|4659283|P1|Overall Study|Withdrawal by Subject|7
1411823|NCT01129336|4659282|P2|Overall Study|Lost to Follow-up|0
1411824|NCT01129336|4659283|P1|Overall Study|Lost to Follow-up|1
1411825|NCT01129336|4659282|P2|Overall Study|Disease Progression|4
1411826|NCT01129336|4659283|P1|Overall Study|Disease Progression|1
1411827|NCT01129336|4659282|P2|Overall Study|Protocol Violation|0
1411828|NCT01129336|4659283|P1|Overall Study|Protocol Violation|1
1411829|NCT01129284|4659298|P3|Overall Study|Adverse Event|1
1411830|NCT01129284|4659299|P2|Overall Study|Adverse Event|0
1411831|NCT01129284|4659300|P1|Overall Study|Adverse Event|2
1411832|NCT01129128|4659340|P3|Overall Study|Physician Decision|0
1411833|NCT01129128|4659341|P2|Overall Study|Physician Decision|0
1411834|NCT01129128|4659342|P1|Overall Study|Physician Decision|1
1411835|NCT01129128|4659340|P3|Overall Study|Withdrawal by Subject|3
1411836|NCT01129128|4659341|P2|Overall Study|Withdrawal by Subject|1
1411837|NCT01129128|4659342|P1|Overall Study|Withdrawal by Subject|0
1411838|NCT01129128|4659340|P3|Overall Study|Protocol Violation|0
1411839|NCT01129128|4659341|P2|Overall Study|Protocol Violation|1
1411840|NCT01129128|4659342|P1|Overall Study|Protocol Violation|0
1411841|NCT01129128|4659340|P3|Overall Study|Lost to Follow-up|1
1411842|NCT01129128|4659341|P2|Overall Study|Lost to Follow-up|2
1411843|NCT01129128|4659342|P1|Overall Study|Lost to Follow-up|2
1411844|NCT01129115|4659366|P4|Overall Study|Protocol Violation|2
1411845|NCT01129115|4659367|P3|Overall Study|Protocol Violation|2
1411846|NCT01129115|4659368|P2|Overall Study|Protocol Violation|2
1411847|NCT01129115|4659369|P1|Overall Study|Protocol Violation|0
1411848|NCT01129115|4659366|P4|Overall Study|Withdrawal by Subject|4
1411849|NCT01129115|4659367|P3|Overall Study|Withdrawal by Subject|1
1411850|NCT01129115|4659368|P2|Overall Study|Withdrawal by Subject|3
1411851|NCT01129115|4659369|P1|Overall Study|Withdrawal by Subject|1
1411852|NCT01129115|4659366|P4|Overall Study|Adverse Event|3
1411853|NCT01129115|4659367|P3|Overall Study|Adverse Event|3
1411854|NCT01129115|4659368|P2|Overall Study|Adverse Event|2
1411855|NCT01129115|4659369|P1|Overall Study|Adverse Event|1
1411856|NCT01129102|4659406|P3|Overall Study|Lost to Follow-up|0
1411857|NCT01129102|4659407|P2|Overall Study|Lost to Follow-up|0
1411858|NCT01129102|4659408|P1|Overall Study|Lost to Follow-up|2
1411859|NCT01129102|4659406|P3|Overall Study|Adverse Event|1
1411860|NCT01129102|4659407|P2|Overall Study|Adverse Event|2
1411861|NCT01129102|4659408|P1|Overall Study|Adverse Event|2
1411862|NCT01129102|4659406|P3|Overall Study|Pregnancy|1
1411863|NCT01129102|4659407|P2|Overall Study|Pregnancy|0
1411864|NCT01129102|4659408|P1|Overall Study|Pregnancy|0
1411865|NCT01129102|4659406|P3|Overall Study|Protocol Violation|1
1411866|NCT01129102|4659407|P2|Overall Study|Protocol Violation|1
1411867|NCT01129102|4659408|P1|Overall Study|Protocol Violation|0
1411868|NCT01129102|4659406|P3|Overall Study|Withdrawal by Subject|3
1411869|NCT01129102|4659407|P2|Overall Study|Withdrawal by Subject|0
1411870|NCT01129102|4659408|P1|Overall Study|Withdrawal by Subject|2
1411871|NCT01129102|4659406|P3|Overall Study|No study drug treatment|1
1411872|NCT01129102|4659407|P2|Overall Study|No study drug treatment|3
1411873|NCT01129102|4659408|P1|Overall Study|No study drug treatment|2
1411874|NCT01129011|4659419|P2|Overall Study|misc|4
1411875|NCT01129011|4659420|P1|Overall Study|misc|7
1411876|NCT01129011|4659419|P2|Overall Study|Duodenal Ulcer|8
1411877|NCT01129011|4659420|P1|Overall Study|Duodenal Ulcer|2
1411878|NCT01129011|4659419|P2|Overall Study|Lost to Follow-up|7
1411879|NCT01129011|4659420|P1|Overall Study|Lost to Follow-up|6
1411880|NCT01129011|4659419|P2|Overall Study|Withdrawal by Subject|8
1411881|NCT01129011|4659420|P1|Overall Study|Withdrawal by Subject|24
1411882|NCT01129011|4659419|P2|Overall Study|Adverse Event|30
1411883|NCT01129011|4659420|P1|Overall Study|Adverse Event|20
1411884|NCT01128959|4659475|P1|Treatment Period|Withdrawal by Subject|1
1411885|NCT01128959|4659475|P1|Treatment Period|Adverse Event|3
1411886|NCT01128959|4659475|P1|Lead in Period|Adverse Event|3
1411887|NCT01128946|4659481|P4|Period III|Protocol Violation|0
1411888|NCT01128946|4659482|P3|Period III|Protocol Violation|0
1411889|NCT01128946|4659483|P2|Period III|Protocol Violation|0
1411890|NCT01128946|4659484|P1|Period III|Protocol Violation|1
1411891|NCT01128946|4659481|P4|Period II|Withdrawal by Subject|1
1411892|NCT01128946|4659482|P3|Period II|Withdrawal by Subject|0
1411893|NCT01128946|4659483|P2|Period II|Withdrawal by Subject|0
1411894|NCT01128946|4659484|P1|Period II|Withdrawal by Subject|0
1411895|NCT01128946|4659481|P4|Period II|Protocol Violation|0
1411896|NCT01128946|4659482|P3|Period II|Protocol Violation|0
1411897|NCT01128946|4659483|P2|Period II|Protocol Violation|1
1411898|NCT01128946|4659484|P1|Period II|Protocol Violation|0
1411899|NCT01128946|4659481|P4|Period I|Withdrawal by Subject|1
1411900|NCT01128946|4659482|P3|Period I|Withdrawal by Subject|1
1411901|NCT01128946|4659483|P2|Period I|Withdrawal by Subject|0
1411902|NCT01128946|4659484|P1|Period I|Withdrawal by Subject|0
1411903|NCT01128946|4659481|P4|Period I|Protocol Violation|0
1411904|NCT01128946|4659482|P3|Period I|Protocol Violation|0
1411905|NCT01128946|4659483|P2|Period I|Protocol Violation|1
1411906|NCT01128946|4659484|P1|Period I|Protocol Violation|0
1411907|NCT01128894|4659502|P2|Overall Study|Conflicting HbA1c Results at Screening|0
1411908|NCT01128894|4659503|P1|Overall Study|Conflicting HbA1c Results at Screening|1
1411909|NCT01128894|4659502|P2|Overall Study|Physician Decision|1
1411910|NCT01128894|4659503|P1|Overall Study|Physician Decision|2
1411911|NCT01128894|4659502|P2|Overall Study|Withdrawal by Subject|12
1411912|NCT01128894|4659503|P1|Overall Study|Withdrawal by Subject|10
1411913|NCT01128894|4659502|P2|Overall Study|Lost to Follow-up|8
1411914|NCT01128894|4659503|P1|Overall Study|Lost to Follow-up|8
1411915|NCT01128894|4659502|P2|Overall Study|Noncompliance|5
1411916|NCT01128894|4659503|P1|Overall Study|Noncompliance|4
1411917|NCT01128894|4659502|P2|Overall Study|Protocol Violation|1
1411918|NCT01128894|4659503|P1|Overall Study|Protocol Violation|2
1411919|NCT01128894|4659502|P2|Overall Study|Adverse Event|41
1411920|NCT01128894|4659503|P1|Overall Study|Adverse Event|31
1411921|NCT01128738|4659528|P2|Second TP|Withdrawal by Subject|2
1411922|NCT01128738|4659529|P1|Second TP|Withdrawal by Subject|0
1411923|NCT01128738|4659528|P2|Second TP|Lost to Follow-up|1
1411924|NCT01128738|4659529|P1|Second TP|Lost to Follow-up|0
1411925|NCT01128738|4659528|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
1411926|NCT01128738|4659529|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
1411927|NCT01128738|4659528|P2|First Treatment Phase (TP)|Lost to Follow-up|0
1411928|NCT01128738|4659529|P1|First Treatment Phase (TP)|Lost to Follow-up|1
1411929|NCT01128621|4659654|P2|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
1411930|NCT01128621|4659655|P1|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
1411931|NCT01128595|4659776|P4|Treatment Period 3|Withdrawal by Subject|0
1411932|NCT01128595|4659777|P3|Treatment Period 3|Withdrawal by Subject|0
1411933|NCT01128595|4659778|P2|Treatment Period 3|Withdrawal by Subject|1
1411934|NCT01128595|4659779|P1|Treatment Period 3|Withdrawal by Subject|0
1411935|NCT01128569|4659809|P6|Treatment Period 2|Withdrawal by Subject|0
1411936|NCT01128569|4659810|P5|Treatment Period 2|Withdrawal by Subject|0
1411937|NCT01128569|4659811|P4|Treatment Period 2|Withdrawal by Subject|0
1411938|NCT01128569|4659812|P3|Treatment Period 2|Withdrawal by Subject|0
1411939|NCT01128569|4659813|P2|Treatment Period 2|Withdrawal by Subject|1
1411940|NCT01128569|4659814|P1|Treatment Period 2|Withdrawal by Subject|0
1411941|NCT01128569|4659809|P6|Washout Period 1|Adverse Event|0
1411942|NCT01128569|4659810|P5|Washout Period 1|Adverse Event|0
1411943|NCT01128569|4659811|P4|Washout Period 1|Adverse Event|0
1411944|NCT01128569|4659812|P3|Washout Period 1|Adverse Event|1
1411945|NCT01128569|4659813|P2|Washout Period 1|Adverse Event|0
1411946|NCT01128569|4659814|P1|Washout Period 1|Adverse Event|0
1411947|NCT01128543|4659831|P1|Overall Study|Protocol Violation|1
1411948|NCT01128543|4659831|P1|Overall Study|Withdrawal by Subject|3
1411949|NCT01128413|4659857|P2|Overall Study|Pt made DNR|0
1411950|NCT01128413|4659858|P1|Overall Study|Pt made DNR|1
1411951|NCT01128413|4659857|P2|Overall Study|NICOM Monitor Problems|1
1411952|NCT01128413|4659858|P1|Overall Study|NICOM Monitor Problems|2
1411953|NCT01128413|4659857|P2|Overall Study|Withdrawal by Subject|0
1411954|NCT01128413|4659858|P1|Overall Study|Withdrawal by Subject|1
1411955|NCT01128400|4659867|P3|Overall Study|Excluded due to sinus problems|0
1411956|NCT01128400|4659868|P2|Overall Study|Excluded due to sinus problems|1
1411957|NCT01128400|4659869|P1|Overall Study|Excluded due to sinus problems|0
1411958|NCT01128400|4659867|P3|Overall Study|were not invited to participate on taste|15
1411959|NCT01128400|4659868|P2|Overall Study|were not invited to participate on taste|0
1411960|NCT01128400|4659869|P1|Overall Study|were not invited to participate on taste|0
1411961|NCT01128400|4659867|P3|Overall Study|Screening failure|0
1411962|NCT01128400|4659868|P2|Overall Study|Screening failure|0
1411963|NCT01128400|4659869|P1|Overall Study|Screening failure|1
1411964|NCT01128400|4659867|P3|Overall Study|Lost to Follow-up|1
1411965|NCT01128400|4659868|P2|Overall Study|Lost to Follow-up|0
1411966|NCT01128400|4659869|P1|Overall Study|Lost to Follow-up|1
1411967|NCT01128387|4659882|P2|Overall Study|Physician Decision|1
1411968|NCT01128387|4659883|P1|Overall Study|Physician Decision|0
1411969|NCT01128361|4659893|P2|Overall Study|Withdrawal by Subject|2
1411970|NCT01128361|4659894|P1|Overall Study|Withdrawal by Subject|5
1411971|NCT01128361|4659893|P2|Overall Study|Lost to Follow-up|1
1411972|NCT01128361|4659894|P1|Overall Study|Lost to Follow-up|0
1411973|NCT01128296|4659906|P6|Overall Study|Withdrawal by Subject|2
1411974|NCT01128296|4659907|P5|Overall Study|Withdrawal by Subject|0
1411975|NCT01128296|4659908|P4|Overall Study|Withdrawal by Subject|0
1411976|NCT01128296|4659909|P3|Overall Study|Withdrawal by Subject|0
1411977|NCT01128296|4659910|P2|Overall Study|Withdrawal by Subject|0
1411978|NCT01128296|4659911|P1|Overall Study|Withdrawal by Subject|0
1411979|NCT01128296|4659906|P6|Overall Study|Physician Decision|3
1411980|NCT01128296|4659907|P5|Overall Study|Physician Decision|0
1411981|NCT01128296|4659908|P4|Overall Study|Physician Decision|0
1411982|NCT01128296|4659909|P3|Overall Study|Physician Decision|0
1411983|NCT01128296|4659910|P2|Overall Study|Physician Decision|0
1411984|NCT01128296|4659911|P1|Overall Study|Physician Decision|0
1411985|NCT01128244|4659942|P1|Overall Study|Scheduling conflict|2
1411986|NCT01128244|4659942|P1|Overall Study|Adverse Event|1
1411987|NCT01128179|4659983|P2|Overall Study|Protocol Violation|0
1411988|NCT01128179|4659984|P1|Overall Study|Protocol Violation|1
1411989|NCT01128179|4659983|P2|Overall Study|Death|0
1411990|NCT01128179|4659984|P1|Overall Study|Death|1
1411991|NCT01128153|4660004|P2|Overall Study|Developed discontinuation criteria|1
1411992|NCT01128153|4660005|P1|Overall Study|Developed discontinuation criteria|1
1411993|NCT01128153|4660004|P2|Overall Study|Protocol Violation|0
1411994|NCT01128153|4660005|P1|Overall Study|Protocol Violation|2
1411995|NCT01128153|4660004|P2|Overall Study|Incorrect enrolment to study|1
1411996|NCT01128153|4660005|P1|Overall Study|Incorrect enrolment to study|2
1411997|NCT01128153|4660004|P2|Overall Study|Withdrawal by Subject|3
1411998|NCT01128153|4660005|P1|Overall Study|Withdrawal by Subject|2
1411999|NCT01128153|4660004|P2|Overall Study|Condition under investigation worsened|7
1412000|NCT01128153|4660005|P1|Overall Study|Condition under investigation worsened|8
1412001|NCT01128153|4660004|P2|Overall Study|Adverse Event|3
1412002|NCT01128153|4660005|P1|Overall Study|Adverse Event|1
1412003|NCT01128114|4660021|P1|Overall Study|Screening Failed|2
1412004|NCT01128114|4660021|P1|Overall Study|Treatment Withdrawn|6
1412005|NCT01127763|4660038|P1|Overall Study|Physician Decision|2
1412006|NCT01127763|4660038|P1|Overall Study|Withdrawal by Subject|1
1412007|NCT01127763|4660038|P1|Overall Study|Adverse Event|2
1412008|NCT01127646|4660083|P2|Overall Study|Protocol Violation|1
1412009|NCT01127646|4660084|P1|Overall Study|Protocol Violation|0
1412010|NCT01127646|4660083|P2|Overall Study|Entry Criteria Not Met|0
1412011|NCT01127646|4660084|P1|Overall Study|Entry Criteria Not Met|1
1412012|NCT01127633|4660118|P2|Overall Study|Not treated|0
1412013|NCT01127633|4660119|P1|Overall Study|Not treated|1
1412014|NCT01127633|4660118|P2|Overall Study|Abnormal Lab/ECG Result|1
1412015|NCT01127633|4660119|P1|Overall Study|Abnormal Lab/ECG Result|0
1412016|NCT01127633|4660118|P2|Overall Study|Protocol Violation|16
1412017|NCT01127633|4660119|P1|Overall Study|Protocol Violation|8
1412018|NCT01127633|4660118|P2|Overall Study|Sponsor Decision|195
1412019|NCT01127633|4660119|P1|Overall Study|Sponsor Decision|163
1412020|NCT01127633|4660118|P2|Overall Study|Withdrawal by Subject|72
1412021|NCT01127633|4660119|P1|Overall Study|Withdrawal by Subject|57
1412022|NCT01127633|4660118|P2|Overall Study|Physician Decision|45
1412023|NCT01127633|4660119|P1|Overall Study|Physician Decision|60
1412024|NCT01127633|4660118|P2|Overall Study|Parent/Caregiver Decision|228
1412025|NCT01127633|4660119|P1|Overall Study|Parent/Caregiver Decision|246
1412026|NCT01127633|4660118|P2|Overall Study|Lost to Follow-up|0
1412027|NCT01127633|4660119|P1|Overall Study|Lost to Follow-up|4
1412028|NCT01127633|4660118|P2|Overall Study|Death|43
1412029|NCT01127633|4660119|P1|Overall Study|Death|40
1412030|NCT01127633|4660118|P2|Overall Study|Adverse Event|73
1412031|NCT01127633|4660119|P1|Overall Study|Adverse Event|74
1412032|NCT01127607|4660151|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
1412033|NCT01127607|4660152|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
1412034|NCT01127607|4660151|P2|Phase II (Between Subjects)|Lost to Follow-up|2
1412035|NCT01127607|4660152|P1|Phase II (Between Subjects)|Lost to Follow-up|0
1412036|NCT01127256|4660327|P2|Overall Study|Protocol Violation|0
1412037|NCT01127256|4660328|P1|Overall Study|Protocol Violation|1
1412038|NCT01127256|4660327|P2|Overall Study|Withdrawal by Subject|9
1412039|NCT01127256|4660328|P1|Overall Study|Withdrawal by Subject|5
1412040|NCT01127256|4660327|P2|Overall Study|Lost to Follow-up|17
1412041|NCT01127256|4660328|P1|Overall Study|Lost to Follow-up|16
1412042|NCT01127256|4660327|P2|Overall Study|Lack of Efficacy|0
1412043|NCT01127256|4660328|P1|Overall Study|Lack of Efficacy|4
1412044|NCT01127256|4660327|P2|Overall Study|Adverse Event|13
1412045|NCT01127256|4660328|P1|Overall Study|Adverse Event|13
1412046|NCT01127165|4660340|P2|Overall Study|Protocol Violation|1
1412047|NCT01127165|4660341|P1|Overall Study|Protocol Violation|0
1412048|NCT01127165|4660340|P2|Overall Study|Withdrawal by Subject|3
1412049|NCT01127165|4660341|P1|Overall Study|Withdrawal by Subject|1
1412050|NCT01127165|4660340|P2|Overall Study|Lost to Follow-up|5
1412051|NCT01127165|4660341|P1|Overall Study|Lost to Follow-up|3
1412052|NCT01127165|4660340|P2|Overall Study|Lack of Efficacy|8
1412053|NCT01127165|4660341|P1|Overall Study|Lack of Efficacy|10
1412054|NCT01127165|4660340|P2|Overall Study|Adverse Event|2
1412055|NCT01127165|4660341|P1|Overall Study|Adverse Event|2
1412056|NCT01127139|4660353|P1|Overall Study|Reason not specified|1
1412057|NCT01127139|4660353|P1|Overall Study|Lack of Efficacy|4
1412058|NCT01127139|4660353|P1|Overall Study|Incompliance|12
1412059|NCT01127139|4660353|P1|Overall Study|Adverse Event|40
1412060|NCT01126619|4660419|P1|Overall Study|Non-compliance|1
1412061|NCT01126619|4660419|P1|Overall Study|Withdrawal by Subject|9
1412062|NCT01126619|4660419|P1|Overall Study|Serious adverse event|1
1412063|NCT01126619|4660419|P1|Overall Study|Investigator decision|4
1412064|NCT01126619|4660419|P1|Overall Study|Not eligible for the study|2
1412065|NCT01126580|4660447|P3|Overall Study|Treatment Non-compliance|3
1412066|NCT01126580|4660448|P2|Overall Study|Treatment Non-compliance|2
1412067|NCT01126580|4660449|P1|Overall Study|Treatment Non-compliance|0
1412068|NCT01126580|4660447|P3|Overall Study|Lost to Follow-up|9
1412069|NCT01126580|4660448|P2|Overall Study|Lost to Follow-up|13
1412070|NCT01126580|4660449|P1|Overall Study|Lost to Follow-up|15
1412071|NCT01126580|4660447|P3|Overall Study|Protocol Violation|2
1412072|NCT01126580|4660448|P2|Overall Study|Protocol Violation|1
1412073|NCT01126580|4660449|P1|Overall Study|Protocol Violation|0
1412074|NCT01126580|4660447|P3|Overall Study|Lack of Efficacy|4
1412075|NCT01126580|4660448|P2|Overall Study|Lack of Efficacy|3
1412076|NCT01126580|4660449|P1|Overall Study|Lack of Efficacy|2
1412077|NCT01126580|4660447|P3|Overall Study|Entry Criteria Not Met|2
1412078|NCT01126580|4660448|P2|Overall Study|Entry Criteria Not Met|1
1412079|NCT01126580|4660449|P1|Overall Study|Entry Criteria Not Met|1
1412080|NCT01126580|4660447|P3|Overall Study|Physician Decision|2
1412081|NCT01126580|4660448|P2|Overall Study|Physician Decision|1
1412082|NCT01126580|4660449|P1|Overall Study|Physician Decision|1
1412083|NCT01126580|4660447|P3|Overall Study|Sponsor Decision|7
1412084|NCT01126580|4660448|P2|Overall Study|Sponsor Decision|4
1412085|NCT01126580|4660449|P1|Overall Study|Sponsor Decision|5
1412086|NCT01126580|4660447|P3|Overall Study|Withdrawal by Subject|14
1412087|NCT01126580|4660448|P2|Overall Study|Withdrawal by Subject|19
1412088|NCT01126580|4660449|P1|Overall Study|Withdrawal by Subject|11
1412089|NCT01126580|4660447|P3|Overall Study|Adverse Event|12
1412090|NCT01126580|4660448|P2|Overall Study|Adverse Event|8
1412091|NCT01126580|4660449|P1|Overall Study|Adverse Event|14
1412092|NCT01126541|4660544|P3|Overall Study|Administrative reason or other|2
1412093|NCT01126541|4660545|P2|Overall Study|Administrative reason or other|1
1412094|NCT01126541|4660546|P1|Overall Study|Administrative reason or other|1
1412095|NCT01126541|4660544|P3|Overall Study|Protocol Violation|1
1412096|NCT01126541|4660545|P2|Overall Study|Protocol Violation|0
1412097|NCT01126541|4660546|P1|Overall Study|Protocol Violation|0
1412098|NCT01126541|4660544|P3|Overall Study|Withdrawal by Subject|6
1412099|NCT01126541|4660545|P2|Overall Study|Withdrawal by Subject|5
1412100|NCT01126541|4660546|P1|Overall Study|Withdrawal by Subject|2
1412101|NCT01126541|4660544|P3|Overall Study|Lost to Follow-up|2
1412102|NCT01126541|4660545|P2|Overall Study|Lost to Follow-up|2
1412103|NCT01126541|4660546|P1|Overall Study|Lost to Follow-up|1
1412104|NCT01126541|4660544|P3|Overall Study|Lack of Efficacy|11
1412105|NCT01126541|4660545|P2|Overall Study|Lack of Efficacy|1
1412106|NCT01126541|4660546|P1|Overall Study|Lack of Efficacy|6
1412107|NCT01126541|4660544|P3|Overall Study|Death|0
1412108|NCT01126541|4660545|P2|Overall Study|Death|1
1412109|NCT01126541|4660546|P1|Overall Study|Death|0
1412110|NCT01126541|4660544|P3|Overall Study|Adverse Event|4
1412111|NCT01126541|4660545|P2|Overall Study|Adverse Event|2
1412112|NCT01126541|4660546|P1|Overall Study|Adverse Event|0
1412113|NCT01126437|4660630|P3|Overall Study|Other reason not specified|178
1412114|NCT01126437|4660631|P2|Overall Study|Other reason not specified|176
1412115|NCT01126437|4660632|P1|Overall Study|Other reason not specified|210
1412116|NCT01126437|4660630|P3|Overall Study|Withdrawal by Subject|319
1412117|NCT01126437|4660631|P2|Overall Study|Withdrawal by Subject|335
1412118|NCT01126437|4660632|P1|Overall Study|Withdrawal by Subject|331
1412119|NCT01126437|4660630|P3|Overall Study|Lost to Follow-up|55
1412120|NCT01126437|4660631|P2|Overall Study|Lost to Follow-up|63
1412121|NCT01126437|4660632|P1|Overall Study|Lost to Follow-up|52
1412122|NCT01126437|4660630|P3|Overall Study|Protocol Violation|41
1412123|NCT01126437|4660631|P2|Overall Study|Protocol Violation|66
1412124|NCT01126437|4660632|P1|Overall Study|Protocol Violation|64
1412125|NCT01126437|4660630|P3|Overall Study|Lack of Efficacy|59
1412126|NCT01126437|4660631|P2|Overall Study|Lack of Efficacy|60
1412127|NCT01126437|4660632|P1|Overall Study|Lack of Efficacy|65
1412128|NCT01126437|4660630|P3|Overall Study|Adverse Event|635
1412129|NCT01126437|4660631|P2|Overall Study|Adverse Event|606
1412130|NCT01126437|4660632|P1|Overall Study|Adverse Event|602
1412131|NCT01126437|4660630|P3|Overall Study|Sites with data irregularities/fraud|7
1412132|NCT01126437|4660631|P2|Overall Study|Sites with data irregularities/fraud|6
1412133|NCT01126437|4660632|P1|Overall Study|Sites with data irregularities/fraud|6
1412134|NCT01126437|4660630|P3|Overall Study|Not treated|19
1412135|NCT01126437|4660631|P2|Overall Study|Not treated|18
1412136|NCT01126437|4660632|P1|Overall Study|Not treated|11
1412137|NCT01126424|4660670|P6|Overall Study|Withdrawal by Subject|0
1412138|NCT01126424|4660671|P5|Overall Study|Withdrawal by Subject|1
1412139|NCT01126424|4660672|P4|Overall Study|Withdrawal by Subject|3
1412140|NCT01126424|4660673|P3|Overall Study|Withdrawal by Subject|1
1412141|NCT01126424|4660674|P2|Overall Study|Withdrawal by Subject|0
1412142|NCT01126424|4660675|P1|Overall Study|Withdrawal by Subject|0
1412143|NCT01126424|4660670|P6|Overall Study|Adverse Event|0
1412144|NCT01126424|4660671|P5|Overall Study|Adverse Event|1
1412145|NCT01126424|4660672|P4|Overall Study|Adverse Event|0
1412146|NCT01126424|4660673|P3|Overall Study|Adverse Event|0
1412147|NCT01126424|4660674|P2|Overall Study|Adverse Event|0
1412148|NCT01126424|4660675|P1|Overall Study|Adverse Event|0
1412149|NCT01126359|4660698|P2|First Intervention (20-minutes)|Physician Decision|1
1412150|NCT01126359|4660699|P1|First Intervention (20-minutes)|Physician Decision|0
1412151|NCT01126268|4660711|P1|Overall Study|Adverse Event|1
1412152|NCT01126060|4660750|P2|Overall Study|Protocol Violation|2
1412153|NCT01126060|4660751|P1|Overall Study|Protocol Violation|0
1412154|NCT01125930|4660759|P2|Overall Study|Lost to Follow-up|2
1412155|NCT01125930|4660760|P1|Overall Study|Lost to Follow-up|0
1412156|NCT01125930|4660759|P2|Overall Study|Protocol Violation|1
1412157|NCT01125930|4660760|P1|Overall Study|Protocol Violation|0
1412158|NCT01125930|4660759|P2|Overall Study|Withdrawal by Subject|6
1412159|NCT01125930|4660760|P1|Overall Study|Withdrawal by Subject|1
1412160|NCT01125930|4660759|P2|Overall Study|Adverse Event|1
1412161|NCT01125930|4660760|P1|Overall Study|Adverse Event|0
1412162|NCT01125917|4660914|P1|Overall Study|Lack of Efficacy|19
1412163|NCT01125917|4660914|P1|Overall Study|Administrative|223
1412164|NCT01125917|4660914|P1|Overall Study|Withdrawal by Subject|31
1412165|NCT01125917|4660914|P1|Overall Study|Lost to Follow-up|23
1412166|NCT01125917|4660914|P1|Overall Study|Adverse Event|43
1412167|NCT01125813|4660918|P1|Overall Study|Screen Failures|4
1412168|NCT01125813|4660918|P1|Overall Study|Withdrawal by Subject|1
1412169|NCT01125813|4660918|P1|Overall Study|Death|1
1412170|NCT01125800|4660928|P5|Phase II|Disease progression|8
1412171|NCT01125800|4660929|P4|Phase II|Disease progression|1
1412172|NCT01125800|4660930|P3|Phase II|Disease progression|0
1412173|NCT01125800|4660931|P2|Phase II|Disease progression|0
1412174|NCT01125800|4660932|P1|Phase II|Disease progression|0
1412175|NCT01125800|4660928|P5|Phase II|Adverse Event|2
1412176|NCT01125800|4660929|P4|Phase II|Adverse Event|0
1412177|NCT01125800|4660930|P3|Phase II|Adverse Event|0
1412178|NCT01125800|4660931|P2|Phase II|Adverse Event|0
1412179|NCT01125800|4660932|P1|Phase II|Adverse Event|0
1412180|NCT01125800|4660928|P5|Phase II|Protocol Violation|1
1412181|NCT01125800|4660929|P4|Phase II|Protocol Violation|0
1412182|NCT01125800|4660930|P3|Phase II|Protocol Violation|0
1412183|NCT01125800|4660931|P2|Phase II|Protocol Violation|0
1412184|NCT01125800|4660932|P1|Phase II|Protocol Violation|0
1412185|NCT01125800|4660928|P5|Phase I|Disease progression|0
1412186|NCT01125800|4660929|P4|Phase I|Disease progression|3
1412187|NCT01125800|4660930|P3|Phase I|Disease progression|1
1412188|NCT01125800|4660931|P2|Phase I|Disease progression|4
1412189|NCT01125800|4660932|P1|Phase I|Disease progression|5
1412190|NCT01125800|4660928|P5|Phase I|Withdrawal by Subject|0
1412191|NCT01125800|4660929|P4|Phase I|Withdrawal by Subject|0
1412192|NCT01125800|4660930|P3|Phase I|Withdrawal by Subject|1
1412193|NCT01125800|4660931|P2|Phase I|Withdrawal by Subject|0
1412194|NCT01125800|4660932|P1|Phase I|Withdrawal by Subject|0
1412195|NCT01125800|4660928|P5|Phase I|Administrative problems|0
1412196|NCT01125800|4660929|P4|Phase I|Administrative problems|0
1412197|NCT01125800|4660930|P3|Phase I|Administrative problems|0
1412198|NCT01125800|4660931|P2|Phase I|Administrative problems|0
1412199|NCT01125800|4660932|P1|Phase I|Administrative problems|1
1412200|NCT01125800|4660928|P5|Phase I|Adverse Event|0
1412201|NCT01125800|4660929|P4|Phase I|Adverse Event|7
1412202|NCT01125800|4660930|P3|Phase I|Adverse Event|1
1412203|NCT01125800|4660931|P2|Phase I|Adverse Event|2
1412204|NCT01125800|4660932|P1|Phase I|Adverse Event|2
1412205|NCT01125800|4660928|P5|Phase I|Protocol Violation|0
1412206|NCT01125800|4660929|P4|Phase I|Protocol Violation|1
1412207|NCT01125800|4660930|P3|Phase I|Protocol Violation|1
1412208|NCT01125800|4660931|P2|Phase I|Protocol Violation|3
1412209|NCT01125800|4660932|P1|Phase I|Protocol Violation|0
1412210|NCT01125748|4660998|P2|Overall Study|Patient Decision to Withdraw|4
1412211|NCT01125748|4660999|P1|Overall Study|Patient Decision to Withdraw|2
1412212|NCT01125748|4660998|P2|Overall Study|Physician Decision|7
1412213|NCT01125748|4660999|P1|Overall Study|Physician Decision|8
1412214|NCT01125748|4660998|P2|Overall Study|Lost to Follow-up|1
1412215|NCT01125748|4660999|P1|Overall Study|Lost to Follow-up|0
1412216|NCT01125748|4660998|P2|Overall Study|Adverse Event|2
1412217|NCT01125748|4660999|P1|Overall Study|Adverse Event|0
1412218|NCT01125722|4661009|P2|Overall Study|Lost to Follow-up|0
1412219|NCT01125722|4661010|P1|Overall Study|Lost to Follow-up|1
1412220|NCT01125722|4661009|P2|Overall Study|Withdrawal by Subject|1
1412221|NCT01125722|4661010|P1|Overall Study|Withdrawal by Subject|2
1412222|NCT01125566|4661057|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|4
1412223|NCT01125566|4661058|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
1412224|NCT01125566|4661059|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
1412225|NCT01125566|4661057|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|20
1412226|NCT01125566|4661058|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
1412227|NCT01125566|4661059|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
1412228|NCT01125566|4661057|P3|Patients Before the Switch (26Apr2013)|Other than those stated above|0
1412229|NCT01125566|4661058|P2|Patients Before the Switch (26Apr2013)|Other than those stated above|5
1412230|NCT01125566|4661059|P1|Patients Before the Switch (26Apr2013)|Other than those stated above|23
1412231|NCT01125566|4661057|P3|Patients Before the Switch (26Apr2013)|Not treated|0
1412232|NCT01125566|4661058|P2|Patients Before the Switch (26Apr2013)|Not treated|0
1412233|NCT01125566|4661059|P1|Patients Before the Switch (26Apr2013)|Not treated|2
1412234|NCT01125566|4661057|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
1412235|NCT01125566|4661058|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|21
1412236|NCT01125566|4661059|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|25
1412237|NCT01125566|4661057|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
1412238|NCT01125566|4661058|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|1
1412239|NCT01125566|4661059|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
1412240|NCT01125566|4661057|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
1412241|NCT01125566|4661058|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
1412242|NCT01125566|4661059|P1|Patients Before the Switch (26Apr2013)|Adverse Event|24
1412243|NCT01125566|4661057|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
1412244|NCT01125566|4661058|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|4
1412245|NCT01125566|4661059|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|5
1412246|NCT01125566|4661057|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
1412247|NCT01125566|4661058|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|100
1412248|NCT01125566|4661059|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|181
1412249|NCT01125514|4661072|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
1412250|NCT01125514|4661072|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
1412251|NCT01125514|4661072|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
1412252|NCT01125514|4661072|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
1412253|NCT01125514|4661072|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
1412254|NCT01125514|4661072|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
1412255|NCT01125189|4661172|P3|Follow up Period|Other reasons|5
1412256|NCT01125189|4661173|P2|Follow up Period|Other reasons|4
1412257|NCT01125189|4661174|P1|Follow up Period|Other reasons|4
1412258|NCT01125189|4661172|P3|Follow up Period|Lost to Follow-up|6
1412259|NCT01125189|4661173|P2|Follow up Period|Lost to Follow-up|9
1412260|NCT01125189|4661174|P1|Follow up Period|Lost to Follow-up|12
1412261|NCT01125189|4661172|P3|Follow up Period|Death|0
1412262|NCT01125189|4661173|P2|Follow up Period|Death|0
1412263|NCT01125189|4661174|P1|Follow up Period|Death|1
1412264|NCT01125189|4661172|P3|Follow up Period|Withdrawal by Subject|5
1412265|NCT01125189|4661173|P2|Follow up Period|Withdrawal by Subject|2
1412266|NCT01125189|4661174|P1|Follow up Period|Withdrawal by Subject|3
1412267|NCT01125189|4661172|P3|Treatment Period|Completed 24 week treatment period only|2
1412268|NCT01125189|4661173|P2|Treatment Period|Completed 24 week treatment period only|1
1412269|NCT01125189|4661174|P1|Treatment Period|Completed 24 week treatment period only|2
1412270|NCT01125189|4661172|P3|Treatment Period|Other reasons|0
1412271|NCT01125189|4661173|P2|Treatment Period|Other reasons|1
1412272|NCT01125189|4661174|P1|Treatment Period|Other reasons|1
1412273|NCT01125189|4661172|P3|Treatment Period|Participants requested to discontinue|4
1412274|NCT01125189|4661173|P2|Treatment Period|Participants requested to discontinue|3
1412275|NCT01125189|4661174|P1|Treatment Period|Participants requested to discontinue|1
1412276|NCT01125189|4661172|P3|Treatment Period|Poor compliance/noncompliance|0
1412277|NCT01125189|4661173|P2|Treatment Period|Poor compliance/noncompliance|1
1412278|NCT01125189|4661174|P1|Treatment Period|Poor compliance/noncompliance|0
1412279|NCT01125189|4661172|P3|Treatment Period|Lost to Follow-up|1
1412280|NCT01125189|4661173|P2|Treatment Period|Lost to Follow-up|2
1412281|NCT01125189|4661174|P1|Treatment Period|Lost to Follow-up|1
1412282|NCT01125189|4661172|P3|Treatment Period|Death|0
1412283|NCT01125189|4661173|P2|Treatment Period|Death|0
1412284|NCT01125189|4661174|P1|Treatment Period|Death|1
1412285|NCT01125189|4661172|P3|Treatment Period|Withdrawal by Subject|1
1412286|NCT01125189|4661173|P2|Treatment Period|Withdrawal by Subject|1
1412287|NCT01125189|4661174|P1|Treatment Period|Withdrawal by Subject|3
1412288|NCT01125189|4661172|P3|Treatment Period|Adverse Event|8
1412289|NCT01125189|4661173|P2|Treatment Period|Adverse Event|8
1412290|NCT01125189|4661174|P1|Treatment Period|Adverse Event|7
1412291|NCT01125189|4661172|P3|Treatment Period|Lack of Efficacy|25
1412292|NCT01125189|4661173|P2|Treatment Period|Lack of Efficacy|18
1412293|NCT01125189|4661174|P1|Treatment Period|Lack of Efficacy|15
1412294|NCT01124916|4661228|P2|Overall Study|Lost to Follow-up|2
1412295|NCT01124916|4661229|P1|Overall Study|Lost to Follow-up|3
1412296|NCT01124864|4661243|P6|Overall Study|Protocol Violation|0
1412297|NCT01124864|4661244|P5|Overall Study|Protocol Violation|1
1412298|NCT01124864|4661245|P4|Overall Study|Protocol Violation|0
1412299|NCT01124864|4661246|P3|Overall Study|Protocol Violation|0
1412300|NCT01124864|4661247|P2|Overall Study|Protocol Violation|0
1412301|NCT01124864|4661248|P1|Overall Study|Protocol Violation|1
1412302|NCT01124864|4661243|P6|Overall Study|Lost to Follow-up|0
1412303|NCT01124864|4661244|P5|Overall Study|Lost to Follow-up|0
1412304|NCT01124864|4661245|P4|Overall Study|Lost to Follow-up|1
1412305|NCT01124864|4661246|P3|Overall Study|Lost to Follow-up|0
1412306|NCT01124864|4661247|P2|Overall Study|Lost to Follow-up|1
1412307|NCT01124864|4661248|P1|Overall Study|Lost to Follow-up|1
1412308|NCT01124864|4661243|P6|Overall Study|Withdrawal by Subject|1
1412309|NCT01124864|4661244|P5|Overall Study|Withdrawal by Subject|2
1412310|NCT01124864|4661245|P4|Overall Study|Withdrawal by Subject|0
1412311|NCT01124864|4661246|P3|Overall Study|Withdrawal by Subject|4
1412312|NCT01124864|4661247|P2|Overall Study|Withdrawal by Subject|3
1412313|NCT01124864|4661248|P1|Overall Study|Withdrawal by Subject|2
1412314|NCT01124864|4661243|P6|Overall Study|Death|0
1412315|NCT01124864|4661244|P5|Overall Study|Death|1
1412316|NCT01124864|4661245|P4|Overall Study|Death|2
1412317|NCT01124864|4661246|P3|Overall Study|Death|6
1412318|NCT01124864|4661247|P2|Overall Study|Death|9
1412319|NCT01124864|4661248|P1|Overall Study|Death|6
1412320|NCT01124864|4661243|P6|Overall Study|Follow up phase competed as per protocol|2
1412321|NCT01124864|4661244|P5|Overall Study|Follow up phase competed as per protocol|26
1412322|NCT01124864|4661245|P4|Overall Study|Follow up phase competed as per protocol|18
1412323|NCT01124864|4661246|P3|Overall Study|Follow up phase competed as per protocol|24
1412324|NCT01124864|4661247|P2|Overall Study|Follow up phase competed as per protocol|22
1412325|NCT01124864|4661248|P1|Overall Study|Follow up phase competed as per protocol|18
1412326|NCT01124838|4661282|P2|Overall Study|Lost to Follow-up|0
1412327|NCT01124838|4661283|P1|Overall Study|Lost to Follow-up|2
1412328|NCT01124838|4661282|P2|Overall Study|Withdrawal by Subject|2
1412329|NCT01124838|4661283|P1|Overall Study|Withdrawal by Subject|3
1412330|NCT01124838|4661282|P2|Overall Study|Lack of Efficacy|0
1412331|NCT01124838|4661283|P1|Overall Study|Lack of Efficacy|2
1412332|NCT01124838|4661282|P2|Overall Study|Adverse Event|11
1412333|NCT01124838|4661283|P1|Overall Study|Adverse Event|7
1412334|NCT01124838|4661282|P2|Overall Study|Miscellaneous|2
1412335|NCT01124838|4661283|P1|Overall Study|Miscellaneous|4
1412336|NCT01124643|4661350|P1|Overall Study|Death|1
1412337|NCT01124617|4661364|P2|Overall Study|Other|1
1412338|NCT01124617|4661365|P1|Overall Study|Other|2
1412339|NCT01124617|4661364|P2|Overall Study|Withdrawal by Subject|1
1412340|NCT01124617|4661365|P1|Overall Study|Withdrawal by Subject|9
1412341|NCT01124617|4661364|P2|Overall Study|Protocol Violation|1
1412342|NCT01124617|4661365|P1|Overall Study|Protocol Violation|1
1412343|NCT01124617|4661364|P2|Overall Study|Lack of Efficacy|1
1412344|NCT01124617|4661365|P1|Overall Study|Lack of Efficacy|2
1412345|NCT01124617|4661364|P2|Overall Study|Adverse Event|2
1412346|NCT01124617|4661365|P1|Overall Study|Adverse Event|5
1412347|NCT01124604|4661397|P2|Overall Study|Disease Progression|1
1412348|NCT01124604|4661398|P1|Overall Study|Disease Progression|0
1412349|NCT01124604|4661397|P2|Overall Study|Withdrawal by Subject|0
1412350|NCT01124604|4661398|P1|Overall Study|Withdrawal by Subject|4
1412351|NCT01124604|4661397|P2|Overall Study|Lack of Efficacy|0
1412352|NCT01124604|4661398|P1|Overall Study|Lack of Efficacy|1
1412353|NCT01124604|4661397|P2|Overall Study|Adverse Event|1
1412354|NCT01124604|4661398|P1|Overall Study|Adverse Event|10
1412355|NCT01124448|4661437|P2|Overall Study|Protocol Violation|0
1412356|NCT01124448|4661438|P1|Overall Study|Protocol Violation|2
1412357|NCT01124448|4661437|P2|Overall Study|Lost to Follow-up|3
1412358|NCT01124448|4661438|P1|Overall Study|Lost to Follow-up|0
1412359|NCT01124422|4661446|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
1412360|NCT01124422|4661447|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
1412361|NCT01124422|4661448|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
1412362|NCT01124422|4661446|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
1412363|NCT01124422|4661447|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
1412364|NCT01124422|4661448|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
1412365|NCT01124422|4661446|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
1412366|NCT01124422|4661447|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
1412367|NCT01124422|4661448|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
1412368|NCT01124422|4661446|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
1412369|NCT01124422|4661447|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
1412370|NCT01124422|4661448|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
1412371|NCT01124422|4661446|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
1412372|NCT01124422|4661447|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
1412373|NCT01124422|4661448|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
1412374|NCT01124422|4661446|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
1412375|NCT01124422|4661447|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
1412376|NCT01124422|4661448|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
1412377|NCT01124422|4661446|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
1412378|NCT01124422|4661447|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
1412379|NCT01124422|4661448|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
1412380|NCT01124422|4661446|P3|4-Week Open-label Run-in Phase|Physician Decision|0
1412381|NCT01124422|4661447|P2|4-Week Open-label Run-in Phase|Physician Decision|0
1412382|NCT01124422|4661448|P1|4-Week Open-label Run-in Phase|Physician Decision|4
1412383|NCT01124422|4661446|P3|4-Week Open-label Run-in Phase|Adverse Event|0
1412384|NCT01124422|4661447|P2|4-Week Open-label Run-in Phase|Adverse Event|0
1412385|NCT01124422|4661448|P1|4-Week Open-label Run-in Phase|Adverse Event|7
1412386|NCT01124422|4661446|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
1412387|NCT01124422|4661447|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
1412388|NCT01124422|4661448|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
1412389|NCT01124292|4661518|P3|Overall Study|piercing track closed|1
1412390|NCT01124292|4661519|P2|Overall Study|piercing track closed|2
1412391|NCT01124292|4661520|P1|Overall Study|piercing track closed|0
1412392|NCT01124292|4661518|P3|Overall Study|medical issue unrelated to the study|2
1412393|NCT01124292|4661519|P2|Overall Study|medical issue unrelated to the study|0
1412394|NCT01124292|4661520|P1|Overall Study|medical issue unrelated to the study|0
1412395|NCT01124292|4661518|P3|Overall Study|Withdrawal by Subject|2
1412396|NCT01124292|4661519|P2|Overall Study|Withdrawal by Subject|6
1412397|NCT01124292|4661520|P1|Overall Study|Withdrawal by Subject|0
1412398|NCT01124292|4661518|P3|Overall Study|Physician Decision|2
1412399|NCT01124292|4661519|P2|Overall Study|Physician Decision|3
1412400|NCT01124292|4661520|P1|Overall Study|Physician Decision|0
1412401|NCT01124292|4661518|P3|Overall Study|Lost to Follow-up|3
1412402|NCT01124292|4661519|P2|Overall Study|Lost to Follow-up|4
1412403|NCT01124292|4661520|P1|Overall Study|Lost to Follow-up|2
1412404|NCT01124175|4661591|P2|Washout of 7 Days|Withdrawal by Subject|2
1412405|NCT01124175|4661592|P1|Washout of 7 Days|Withdrawal by Subject|0
1412406|NCT01124162|4661610|P2|Washout of 7 Days|Withdrawal by Subject|0
1412407|NCT01124162|4661611|P1|Washout of 7 Days|Withdrawal by Subject|1
1412408|NCT01124162|4661610|P2|First Intervention|Adverse Event|0
1412409|NCT01124162|4661611|P1|First Intervention|Adverse Event|2
1412410|NCT01124149|4661627|P1|Maintenance Phase|Non-compliance|1
1412411|NCT01124149|4661627|P1|Maintenance Phase|Coordinator error|1
1412412|NCT01124149|4661627|P1|Maintenance Phase|Protocol Violation|5
1412413|NCT01124149|4661627|P1|Maintenance Phase|Withdrawal by Subject|10
1412414|NCT01124149|4661627|P1|Maintenance Phase|Lost to Follow-up|15
1412415|NCT01124149|4661627|P1|Maintenance Phase|Adverse Event|24
1412416|NCT01124149|4661627|P1|Maintenance Phase|Lack of Efficacy|40
1412417|NCT01124149|4661627|P1|Acute Phase|Sponsor decision|1
1412418|NCT01124149|4661627|P1|Acute Phase|Travelling to another country|1
1412419|NCT01124149|4661627|P1|Acute Phase|Low hemoglobin|1
1412420|NCT01124149|4661627|P1|Acute Phase|Non-compliance|1
1412421|NCT01124149|4661627|P1|Acute Phase|UC symptoms not ameliorated|1
1412422|NCT01124149|4661627|P1|Acute Phase|Sponsor request|1
1412423|NCT01124149|4661627|P1|Acute Phase|Prolonged antibiotic therapy|1
1412424|NCT01124149|4661627|P1|Acute Phase|Lost to Follow-up|2
1412425|NCT01124149|4661627|P1|Acute Phase|Protocol Violation|14
1412426|NCT01124149|4661627|P1|Acute Phase|Lack of Efficacy|17
1412427|NCT01124149|4661627|P1|Acute Phase|Adverse Event|21
1412428|NCT01124149|4661627|P1|Acute Phase|Withdrawal by Subject|22
1412429|NCT01124097|4661647|P4|Overall Study|Physician Decision|0
1412430|NCT01124097|4661648|P3|Overall Study|Physician Decision|0
1412431|NCT01124097|4661649|P2|Overall Study|Physician Decision|1
1412432|NCT01124097|4661650|P1|Overall Study|Physician Decision|2
1412433|NCT01124097|4661647|P4|Overall Study|Protocol Violation|1
1412434|NCT01124097|4661648|P3|Overall Study|Protocol Violation|2
1412435|NCT01124097|4661649|P2|Overall Study|Protocol Violation|0
1412436|NCT01124097|4661650|P1|Overall Study|Protocol Violation|2
1412437|NCT01124097|4661647|P4|Overall Study|Adverse Event|7
1412438|NCT01124097|4661648|P3|Overall Study|Adverse Event|15
1412439|NCT01124097|4661649|P2|Overall Study|Adverse Event|15
1412440|NCT01124097|4661650|P1|Overall Study|Adverse Event|24
1412441|NCT01124097|4661647|P4|Overall Study|Lack of Efficacy|3
1412442|NCT01124097|4661648|P3|Overall Study|Lack of Efficacy|1
1412443|NCT01124097|4661649|P2|Overall Study|Lack of Efficacy|3
1412444|NCT01124097|4661650|P1|Overall Study|Lack of Efficacy|2
1412445|NCT01124097|4661647|P4|Overall Study|Withdrawal by Subject|3
1412446|NCT01124097|4661648|P3|Overall Study|Withdrawal by Subject|2
1412447|NCT01124097|4661649|P2|Overall Study|Withdrawal by Subject|3
1412448|NCT01124097|4661650|P1|Overall Study|Withdrawal by Subject|4
1412449|NCT01124045|4661662|P2|Overall Study|Physician Decision|2
1412450|NCT01124045|4661663|P1|Overall Study|Physician Decision|0
1412451|NCT01124045|4661662|P2|Overall Study|Lost to Follow-up|1
1412452|NCT01124045|4661663|P1|Overall Study|Lost to Follow-up|0
1412453|NCT01124006|4661696|P3|Overall Study|Other|1
1412454|NCT01124006|4661697|P2|Overall Study|Other|0
1412455|NCT01124006|4661698|P1|Overall Study|Other|0
1412456|NCT01124006|4661696|P3|Overall Study|Lost to Follow-up|1
1412457|NCT01124006|4661697|P2|Overall Study|Lost to Follow-up|0
1412458|NCT01124006|4661698|P1|Overall Study|Lost to Follow-up|1
1412459|NCT01124006|4661696|P3|Overall Study|Withdrawal by Subject|0
1412460|NCT01124006|4661697|P2|Overall Study|Withdrawal by Subject|2
1412461|NCT01124006|4661698|P1|Overall Study|Withdrawal by Subject|2
1412462|NCT01123980|4661726|P2|Overall Study|Unclassified|7
1412463|NCT01123980|4661727|P1|Overall Study|Unclassified|6
1412464|NCT01123980|4661726|P2|Overall Study|Withdrawal by Subject|3
1412465|NCT01123980|4661727|P1|Overall Study|Withdrawal by Subject|5
1412466|NCT01123980|4661726|P2|Overall Study|Protocol Violation|6
1412467|NCT01123980|4661727|P1|Overall Study|Protocol Violation|6
1412468|NCT01123980|4661726|P2|Overall Study|Lost to Follow-up|6
1412469|NCT01123980|4661727|P1|Overall Study|Lost to Follow-up|0
1412470|NCT01123980|4661726|P2|Overall Study|Physician Decision|1
1412471|NCT01123980|4661727|P1|Overall Study|Physician Decision|0
1412472|NCT01123980|4661726|P2|Overall Study|Lack of Efficacy|0
1412473|NCT01123980|4661727|P1|Overall Study|Lack of Efficacy|1
1412474|NCT01123980|4661726|P2|Overall Study|Adverse Event|1
1412475|NCT01123980|4661727|P1|Overall Study|Adverse Event|1
1412476|NCT01123941|4661747|P2|Overall Study|Lost to Follow-up|1
1412477|NCT01123941|4661748|P1|Overall Study|Lost to Follow-up|2
1412478|NCT01123889|4661783|P2|Overall Study|Lost to Follow-up|1
1412479|NCT01123889|4661784|P1|Overall Study|Lost to Follow-up|3
1412480|NCT01123850|4661794|P1|Overall Study|Slow enrollment|45
1412481|NCT01123642|4661799|P1|Overall Study|ineligible at baseline assessment|36
1412482|NCT01123642|4661799|P1|Overall Study|Withdrawal by Subject|9
1412483|NCT01123642|4661799|P1|Overall Study|Lost to Follow-up|23
1412484|NCT01123395|4661815|P2|Washout Period of 14 Days|Withdrawal by Subject|1
1412485|NCT01123395|4661816|P1|Washout Period of 14 Days|Withdrawal by Subject|0
1412486|NCT01123382|4661828|P2|Overall Study|Lost to Follow-up|2
1412487|NCT01123382|4661829|P1|Overall Study|Lost to Follow-up|1
1412488|NCT01123382|4661828|P2|Overall Study|Withdrawal by Subject|4
1412489|NCT01123382|4661829|P1|Overall Study|Withdrawal by Subject|1
1412490|NCT01123356|4661851|P1|Overall Study|Withdrawal by Subject|1
1412491|NCT01123356|4661851|P1|Overall Study|Lack of Efficacy|4
1412492|NCT01123356|4661851|P1|Overall Study|Adverse Event|2
1412493|NCT01123200|4661859|P1|Overall Study|Withdrawal by Subject|1
1412494|NCT01123161|4661866|P2|Overall Study|Withdrawal by Subject|0
1412495|NCT01123161|4661867|P1|Overall Study|Withdrawal by Subject|1
1412496|NCT01123161|4661866|P2|Overall Study|Lost to Follow-up|0
1412497|NCT01123161|4661867|P1|Overall Study|Lost to Follow-up|1
1412498|NCT01123148|4661885|P1|Overall Study|Didn't meet milestone criteria|1
1412499|NCT01123148|4661885|P1|Overall Study|Coughing caused unacceptable EEG quality|1
1412500|NCT01123083|4661891|P2|Overall Study|Participant/legal representative request|3
1412501|NCT01123083|4661892|P1|Overall Study|Participant/legal representative request|7
1412502|NCT01123083|4661891|P2|Overall Study|Withdrew for another reason not covered|1
1412503|NCT01123083|4661892|P1|Overall Study|Withdrew for another reason not covered|0
1412504|NCT01123083|4661891|P2|Overall Study|Adverse Event|0
1412505|NCT01123083|4661892|P1|Overall Study|Adverse Event|1
1412506|NCT01123083|4661891|P2|Overall Study|Lost to Follow-up|6
1412507|NCT01123083|4661892|P1|Overall Study|Lost to Follow-up|2
1412508|NCT01123083|4661891|P2|Overall Study|Administrative reasons|4
1412509|NCT01123083|4661892|P1|Overall Study|Administrative reasons|0
1412510|NCT01123083|4661891|P2|Overall Study|Investigator recommendation|1
1412511|NCT01123083|4661892|P1|Overall Study|Investigator recommendation|1
1412512|NCT01122927|4661916|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
1412513|NCT01122927|4661917|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
1412514|NCT01122927|4661916|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
1412515|NCT01122927|4661917|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
1412516|NCT01122927|4661916|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
1412517|NCT01122927|4661917|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
1412518|NCT01122927|4661916|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
1412519|NCT01122927|4661917|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
1412520|NCT01122927|4661916|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
1412521|NCT01122927|4661917|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
1412522|NCT01122927|4661916|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
1412523|NCT01122927|4661917|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
1412524|NCT01122927|4661916|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
1412525|NCT01122927|4661917|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
1412526|NCT01122927|4661916|P2|Period 1 - Conversion Phase|Protocol Deviation|0
1412527|NCT01122927|4661917|P1|Period 1 - Conversion Phase|Protocol Deviation|1
1412528|NCT01122927|4661916|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
1412529|NCT01122927|4661917|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
1412530|NCT01122927|4661916|P2|Period 1 - Conversion Phase|Physician Decision|0
1412531|NCT01122927|4661917|P1|Period 1 - Conversion Phase|Physician Decision|2
1412532|NCT01122927|4661916|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
1412533|NCT01122927|4661917|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
1412534|NCT01122927|4661916|P2|Period 1 - Conversion Phase|Adverse Event|0
1412535|NCT01122927|4661917|P1|Period 1 - Conversion Phase|Adverse Event|3
1412536|NCT01122862|4661969|P3|Period 2|Adverse Event|1
1412537|NCT01122862|4661970|P2|Period 2|Adverse Event|0
1412538|NCT01122862|4661971|P1|Period 2|Adverse Event|0
1412539|NCT01122862|4661969|P3|Period 1|Protocol Violation|0
1412540|NCT01122862|4661970|P2|Period 1|Protocol Violation|1
1412541|NCT01122862|4661971|P1|Period 1|Protocol Violation|0
1412542|NCT01122680|4662077|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
1412543|NCT01122680|4662078|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
1412544|NCT01122680|4662079|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
1412545|NCT01122680|4662080|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
1412546|NCT01122680|4662077|P4|Period 3 (4 Weeks)|Adverse Event|0
1412547|NCT01122680|4662078|P3|Period 3 (4 Weeks)|Adverse Event|0
1412548|NCT01122680|4662079|P2|Period 3 (4 Weeks)|Adverse Event|0
1412549|NCT01122680|4662080|P1|Period 3 (4 Weeks)|Adverse Event|1
1412550|NCT01122680|4662077|P4|Period 2 (4 Weeks)|Other|0
1412551|NCT01122680|4662078|P3|Period 2 (4 Weeks)|Other|0
1412552|NCT01122680|4662079|P2|Period 2 (4 Weeks)|Other|0
1412553|NCT01122680|4662080|P1|Period 2 (4 Weeks)|Other|1
1412554|NCT01122680|4662077|P4|Period 2 (4 Weeks)|Protocol Violation|1
1412555|NCT01122680|4662078|P3|Period 2 (4 Weeks)|Protocol Violation|0
1412556|NCT01122680|4662079|P2|Period 2 (4 Weeks)|Protocol Violation|0
1412557|NCT01122680|4662080|P1|Period 2 (4 Weeks)|Protocol Violation|0
1412558|NCT01122680|4662077|P4|Period 1 (4 Weeks)|Other|0
1412559|NCT01122680|4662078|P3|Period 1 (4 Weeks)|Other|0
1412560|NCT01122680|4662079|P2|Period 1 (4 Weeks)|Other|1
1412561|NCT01122680|4662080|P1|Period 1 (4 Weeks)|Other|1
1412562|NCT01122680|4662077|P4|Period 1 (4 Weeks)|Protocol Violation|0
1412563|NCT01122680|4662078|P3|Period 1 (4 Weeks)|Protocol Violation|0
1412564|NCT01122680|4662079|P2|Period 1 (4 Weeks)|Protocol Violation|0
1412565|NCT01122680|4662080|P1|Period 1 (4 Weeks)|Protocol Violation|1
1412566|NCT01122680|4662077|P4|Period 1 (4 Weeks)|Adverse Event|0
1412567|NCT01122680|4662078|P3|Period 1 (4 Weeks)|Adverse Event|0
1412568|NCT01122680|4662079|P2|Period 1 (4 Weeks)|Adverse Event|0
1412569|NCT01122680|4662080|P1|Period 1 (4 Weeks)|Adverse Event|1
1412570|NCT01122576|4662145|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
1412571|NCT01122576|4662146|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
1412572|NCT01122576|4662147|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
1412573|NCT01122576|4662145|P3|Post-Cataract Surgery|Central Macular Edema|1
1412574|NCT01122576|4662146|P2|Post-Cataract Surgery|Central Macular Edema|0
1412575|NCT01122576|4662147|P1|Post-Cataract Surgery|Central Macular Edema|0
1412576|NCT01122576|4662145|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
1412577|NCT01122576|4662146|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
1412578|NCT01122576|4662147|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
1412579|NCT01122394|4662301|P2|Overall Study|Adverse Event|1
1412580|NCT01122394|4662302|P1|Overall Study|Adverse Event|0
1412581|NCT01122394|4662301|P2|Overall Study|Lost to Follow-up|2
1412582|NCT01122394|4662302|P1|Overall Study|Lost to Follow-up|2
1412583|NCT01122394|4662301|P2|Overall Study|Withdrawal by Subject|1
1412584|NCT01122394|4662302|P1|Overall Study|Withdrawal by Subject|1
1412585|NCT01122381|4662318|P2|Overall Study|study terminated early|1
1412586|NCT01122381|4662319|P1|Overall Study|study terminated early|0
1412587|NCT01122264|4662328|P3|Overall Study|Lack of Efficacy|1
1412588|NCT01122264|4662329|P2|Overall Study|Lack of Efficacy|1
1412589|NCT01122264|4662330|P1|Overall Study|Lack of Efficacy|3
1412590|NCT01122264|4662328|P3|Overall Study|Physician Decision|1
1412591|NCT01122264|4662329|P2|Overall Study|Physician Decision|1
1412592|NCT01122264|4662330|P1|Overall Study|Physician Decision|3
1412593|NCT01122264|4662328|P3|Overall Study|Withdrawal by Subject|16
1412594|NCT01122264|4662329|P2|Overall Study|Withdrawal by Subject|6
1412595|NCT01122264|4662330|P1|Overall Study|Withdrawal by Subject|6
1412596|NCT01122264|4662328|P3|Overall Study|Protocol Violation|9
1412597|NCT01122264|4662329|P2|Overall Study|Protocol Violation|7
1412598|NCT01122264|4662330|P1|Overall Study|Protocol Violation|7
1412599|NCT01122264|4662328|P3|Overall Study|Entry Criteria Not Met|0
1412600|NCT01122264|4662329|P2|Overall Study|Entry Criteria Not Met|0
1412601|NCT01122264|4662330|P1|Overall Study|Entry Criteria Not Met|1
1412602|NCT01122264|4662328|P3|Overall Study|Lost to Follow-up|13
1412603|NCT01122264|4662329|P2|Overall Study|Lost to Follow-up|9
1412604|NCT01122264|4662330|P1|Overall Study|Lost to Follow-up|5
1412605|NCT01122264|4662328|P3|Overall Study|Death|0
1412606|NCT01122264|4662329|P2|Overall Study|Death|0
1412607|NCT01122264|4662330|P1|Overall Study|Death|1
1412608|NCT01122264|4662328|P3|Overall Study|Adverse Event|7
1412609|NCT01122264|4662329|P2|Overall Study|Adverse Event|5
1412610|NCT01122264|4662330|P1|Overall Study|Adverse Event|6
1412611|NCT01121991|4662656|P1|Overall Study|No Fertilization|1
1412612|NCT01121991|4662656|P1|Overall Study|No Oocytes Retrieved|3
1412613|NCT01121991|4662656|P1|Overall Study|Lack of Ovarian Response|2
1412614|NCT01121926|4662681|P2|Washout Period|Positive pregnancy test|1
1412615|NCT01121926|4662682|P1|Washout Period|Positive pregnancy test|0
1412616|NCT01121926|4662681|P2|Washout Period|Adverse Event|1
1412617|NCT01121926|4662682|P1|Washout Period|Adverse Event|0
1412618|NCT01121926|4662681|P2|First Intervention Period|Adverse Event|0
1412619|NCT01121926|4662682|P1|First Intervention Period|Adverse Event|1
1412620|NCT01121913|4662700|P4|Third Washout Period|Adverse Event|0
1412621|NCT01121913|4662701|P3|Third Washout Period|Adverse Event|0
1412622|NCT01121913|4662702|P2|Third Washout Period|Adverse Event|0
1412623|NCT01121913|4662703|P1|Third Washout Period|Adverse Event|1
1412624|NCT01121913|4662700|P4|Second Washout Period|Withdrawal by Subject|0
1412625|NCT01121913|4662701|P3|Second Washout Period|Withdrawal by Subject|1
1412626|NCT01121913|4662702|P2|Second Washout Period|Withdrawal by Subject|0
1412627|NCT01121913|4662703|P1|Second Washout Period|Withdrawal by Subject|0
1412628|NCT01121913|4662700|P4|Second Intervention Period|Adverse Event|0
1412629|NCT01121913|4662701|P3|Second Intervention Period|Adverse Event|1
1412630|NCT01121913|4662702|P2|Second Intervention Period|Adverse Event|0
1412631|NCT01121913|4662703|P1|Second Intervention Period|Adverse Event|0
1412632|NCT01121913|4662700|P4|First Washout Period|Withdrawal by Subject|0
1412633|NCT01121913|4662701|P3|First Washout Period|Withdrawal by Subject|0
1412634|NCT01121913|4662702|P2|First Washout Period|Withdrawal by Subject|0
1412635|NCT01121913|4662703|P1|First Washout Period|Withdrawal by Subject|1
1412636|NCT01121913|4662700|P4|First Intervention Period|Adverse Event|0
1412637|NCT01121913|4662701|P3|First Intervention Period|Adverse Event|1
1412638|NCT01121913|4662702|P2|First Intervention Period|Adverse Event|0
1412639|NCT01121913|4662703|P1|First Intervention Period|Adverse Event|0
1412640|NCT01121900|4662733|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1412641|NCT01121900|4662734|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1412642|NCT01121900|4662733|P2|First Intervention Period|Adverse Event|1
1412643|NCT01121900|4662734|P1|First Intervention Period|Adverse Event|1
1412644|NCT01121757|4662754|P2|Combination|Disease Progression|0
1412645|NCT01121757|4662755|P1|Combination|Disease Progression|2
1412646|NCT01121757|4662754|P2|Combination|Physician Decision|1
1412647|NCT01121757|4662755|P1|Combination|Physician Decision|0
1412648|NCT01121757|4662754|P2|First Drug|Disease Progression|2
1412649|NCT01121757|4662755|P1|First Drug|Disease Progression|0
1412650|NCT01121757|4662754|P2|First Drug|Death|0
1412651|NCT01121757|4662755|P1|First Drug|Death|1
1412652|NCT01121666|4662771|P2|Overall Study|Protocol Violation|10
1412653|NCT01121666|4662772|P1|Overall Study|Protocol Violation|29
1412654|NCT01121575|4662828|P6|Overall Study|Death|1
1412655|NCT01121575|4662829|P5|Overall Study|Death|7
1412656|NCT01121575|4662830|P4|Overall Study|Death|1
1412657|NCT01121575|4662831|P3|Overall Study|Death|0
1412658|NCT01121575|4662832|P2|Overall Study|Death|0
1412659|NCT01121575|4662833|P1|Overall Study|Death|6
1412660|NCT01121575|4662828|P6|Overall Study|Unspecified Reasons|10
1412661|NCT01121575|4662829|P5|Overall Study|Unspecified Reasons|13
1412662|NCT01121575|4662830|P4|Overall Study|Unspecified Reasons|5
1412663|NCT01121575|4662831|P3|Overall Study|Unspecified Reasons|7
1412664|NCT01121575|4662832|P2|Overall Study|Unspecified Reasons|6
1412665|NCT01121575|4662833|P1|Overall Study|Unspecified Reasons|8
1412666|NCT01121575|4662828|P6|Overall Study|Participant Refused Further Follow-Up|1
1412667|NCT01121575|4662829|P5|Overall Study|Participant Refused Further Follow-Up|5
1412668|NCT01121575|4662830|P4|Overall Study|Participant Refused Further Follow-Up|0
1412669|NCT01121575|4662831|P3|Overall Study|Participant Refused Further Follow-Up|0
1412670|NCT01121575|4662832|P2|Overall Study|Participant Refused Further Follow-Up|0
1412671|NCT01121575|4662833|P1|Overall Study|Participant Refused Further Follow-Up|0
1412672|NCT01121562|4662957|P1|Overall Study|Met study discontinuation criteria|1
1412673|NCT01121562|4662957|P1|Overall Study|Sponsor Decision|1
1412674|NCT01121562|4662957|P1|Overall Study|Adverse Event|1
1412675|NCT01121562|4662957|P1|Overall Study|Withdrawal by Subject|1
1412676|NCT01121562|4662957|P1|Overall Study|Objective progression or relapse|8
1412677|NCT01121549|4662966|P1|Overall Study|Other|58
1412678|NCT01121549|4662966|P1|Overall Study|Withdrawal by Subject|16
1412679|NCT01121549|4662966|P1|Overall Study|Protocol Violation|33
1412680|NCT01121549|4662966|P1|Overall Study|Pregnancy|1
1412681|NCT01121549|4662966|P1|Overall Study|Study terminated by sponsor|197
1412682|NCT01121549|4662966|P1|Overall Study|Did not meet entrance criteria|9
1412683|NCT01121549|4662966|P1|Overall Study|Lost to Follow-up|12
1412684|NCT01121549|4662966|P1|Overall Study|Lack of Efficacy|11
1412685|NCT01121549|4662966|P1|Overall Study|Adverse Event|10
1412686|NCT01121536|4662977|P1|Overall Study|Not specified|118
1412687|NCT01121536|4662977|P1|Overall Study|Lost to Follow-up|39
1412688|NCT01121536|4662977|P1|Overall Study|Noncompliance with study procedures|9
1412689|NCT01121536|4662977|P1|Overall Study|Noncompliance with study medication|12
1412690|NCT01121536|4662977|P1|Overall Study|Protocol Violation|20
1412691|NCT01121536|4662977|P1|Overall Study|Withdrawal by Subject|65
1412692|NCT01121536|4662977|P1|Overall Study|Lack of Efficacy|35
1412693|NCT01121536|4662977|P1|Overall Study|Adverse Event|63
1412694|NCT01121484|4662998|P2|Overall Study|Randomized, not treated|4
1412695|NCT01121484|4662999|P1|Overall Study|Randomized, not treated|1
1412696|NCT01121484|4662998|P2|Overall Study|Other|3
1412697|NCT01121484|4662999|P1|Overall Study|Other|3
1412698|NCT01121484|4662998|P2|Overall Study|Discontinuation of study by sponsor|1
1412699|NCT01121484|4662999|P1|Overall Study|Discontinuation of study by sponsor|0
1412700|NCT01121484|4662998|P2|Overall Study|Withdrawal by Subject|7
1412701|NCT01121484|4662999|P1|Overall Study|Withdrawal by Subject|8
1412702|NCT01121484|4662998|P2|Overall Study|Protocol Violation|0
1412703|NCT01121484|4662999|P1|Overall Study|Protocol Violation|1
1412704|NCT01121484|4662998|P2|Overall Study|Physician Decision|3
1412705|NCT01121484|4662999|P1|Overall Study|Physician Decision|0
1412706|NCT01121484|4662998|P2|Overall Study|Lost to Follow-up|9
1412707|NCT01121484|4662999|P1|Overall Study|Lost to Follow-up|5
1412708|NCT01121484|4662998|P2|Overall Study|Lack of Efficacy|11
1412709|NCT01121484|4662999|P1|Overall Study|Lack of Efficacy|3
1412710|NCT01121484|4662998|P2|Overall Study|Adverse Event|5
1412711|NCT01121484|4662999|P1|Overall Study|Adverse Event|12
1412712|NCT01121406|4663017|P2|Overall Study|Not treated|0
1412713|NCT01121406|4663018|P1|Overall Study|Not treated|1
1412714|NCT01121406|4663017|P2|Overall Study|Reason other than specified above|6
1412715|NCT01121406|4663018|P1|Overall Study|Reason other than specified above|2
1412716|NCT01121406|4663017|P2|Overall Study|Refused continuation of study med.|2
1412717|NCT01121406|4663018|P1|Overall Study|Refused continuation of study med.|1
1412718|NCT01121406|4663017|P2|Overall Study|Lost to Follow-up|1
1412719|NCT01121406|4663018|P1|Overall Study|Lost to Follow-up|0
1412720|NCT01121406|4663017|P2|Overall Study|Non−compliant with protocol|2
1412721|NCT01121406|4663018|P1|Overall Study|Non−compliant with protocol|0
1412722|NCT01121406|4663017|P2|Overall Study|Other AE|10
1412723|NCT01121406|4663018|P1|Overall Study|Other AE|3
1412724|NCT01121406|4663017|P2|Overall Study|Wors. or AE of underlying cancer disease|6
1412725|NCT01121406|4663018|P1|Overall Study|Wors. or AE of underlying cancer disease|4
1412726|NCT01121406|4663017|P2|Overall Study|Progressive disease RECIST|28
1412727|NCT01121406|4663018|P1|Overall Study|Progressive disease RECIST|44
1412728|NCT01121393|4663068|P2|Overall Study|Not treated|9
1412729|NCT01121393|4663069|P1|Overall Study|Not treated|3
1412730|NCT01121393|4663068|P2|Overall Study|Refused cont. medication|7
1412731|NCT01121393|4663069|P1|Overall Study|Refused cont. medication|7
1412732|NCT01121393|4663068|P2|Overall Study|Lost to Follow-up|0
1412733|NCT01121393|4663069|P1|Overall Study|Lost to Follow-up|1
1412734|NCT01121393|4663068|P2|Overall Study|Non-compliant with protocol|3
1412735|NCT01121393|4663069|P1|Overall Study|Non-compliant with protocol|0
1412736|NCT01121393|4663068|P2|Overall Study|Other Adverse events|45
1412737|NCT01121393|4663069|P1|Overall Study|Other Adverse events|22
1412738|NCT01121393|4663068|P2|Overall Study|Progressive disease|20
1412739|NCT01121393|4663069|P1|Overall Study|Progressive disease|186
1412740|NCT01121263|4663114|P2|Overall Study|Withdrawal by Subject|1
1412741|NCT01121263|4663115|P1|Overall Study|Withdrawal by Subject|0
1412742|NCT01121263|4663114|P2|Overall Study|Lost to Follow-up|12
1412743|NCT01121263|4663115|P1|Overall Study|Lost to Follow-up|22
1412744|NCT01121263|4663114|P2|Overall Study|Death|2
1412745|NCT01121263|4663115|P1|Overall Study|Death|3
1412746|NCT01121185|4663180|P2|Overall Study|Not transplanted|0
1412747|NCT01121185|4663181|P1|Overall Study|Not transplanted|1
1412748|NCT01121185|4663180|P2|Overall Study|Not infused|1
1412749|NCT01121185|4663181|P1|Overall Study|Not infused|0
1412750|NCT01121146|4663215|P2|Overall Study|Lost to Follow-up|16
1412751|NCT01121146|4663216|P1|Overall Study|Lost to Follow-up|7
1412752|NCT01121146|4663215|P2|Overall Study|Adverse Event|11
1412753|NCT01121146|4663216|P1|Overall Study|Adverse Event|2
1412754|NCT01121146|4663215|P2|Overall Study|Death|15
1412755|NCT01121146|4663216|P1|Overall Study|Death|17
1412756|NCT01120899|4663237|P1|Overall Study|Withdrawal by Subject|3
1412757|NCT01120782|4663265|P1|Overall Study|Test article shipping error|11
1412758|NCT01120717|4663271|P2|Overall Study|Abnormal Test Procedure Result(s)|0
1412759|NCT01120717|4663272|P1|Overall Study|Abnormal Test Procedure Result(s)|1
1412760|NCT01120717|4663271|P2|Overall Study|Death|1
1412761|NCT01120717|4663272|P1|Overall Study|Death|3
1412762|NCT01120717|4663271|P2|Overall Study|Lost to Follow-up|3
1412763|NCT01120717|4663272|P1|Overall Study|Lost to Follow-up|2
1412764|NCT01120717|4663271|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
1412765|NCT01120717|4663272|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
1412766|NCT01120717|4663271|P2|Overall Study|Protocol Deviation|5
1412767|NCT01120717|4663272|P1|Overall Study|Protocol Deviation|2
1412768|NCT01120717|4663271|P2|Overall Study|Adverse Event|6
1412769|NCT01120717|4663272|P1|Overall Study|Adverse Event|10
1412770|NCT01120717|4663271|P2|Overall Study|Withdrawal by Subject|6
1412771|NCT01120717|4663272|P1|Overall Study|Withdrawal by Subject|11
1412772|NCT01120691|4663378|P3|Overall Study|Abnormal laboratory value(s)|4
1412773|NCT01120691|4663379|P2|Overall Study|Abnormal laboratory value(s)|3
1412774|NCT01120691|4663380|P1|Overall Study|Abnormal laboratory value(s)|1
1412775|NCT01120691|4663378|P3|Overall Study|Patient's inability to use the device|0
1412776|NCT01120691|4663379|P2|Overall Study|Patient's inability to use the device|1
1412777|NCT01120691|4663380|P1|Overall Study|Patient's inability to use the device|3
1412778|NCT01120691|4663378|P3|Overall Study|Abnormal test procedure result(s)|1
1412779|NCT01120691|4663379|P2|Overall Study|Abnormal test procedure result(s)|2
1412780|NCT01120691|4663380|P1|Overall Study|Abnormal test procedure result(s)|3
1412781|NCT01120691|4663378|P3|Overall Study|Lost to Follow-up|4
1412782|NCT01120691|4663379|P2|Overall Study|Lost to Follow-up|6
1412783|NCT01120691|4663380|P1|Overall Study|Lost to Follow-up|5
1412784|NCT01120691|4663378|P3|Overall Study|Protocol deviation|12
1412785|NCT01120691|4663379|P2|Overall Study|Protocol deviation|12
1412786|NCT01120691|4663380|P1|Overall Study|Protocol deviation|13
1412787|NCT01120691|4663378|P3|Overall Study|Administrative problems|9
1412788|NCT01120691|4663379|P2|Overall Study|Administrative problems|8
1412789|NCT01120691|4663380|P1|Overall Study|Administrative problems|15
1412790|NCT01120691|4663378|P3|Overall Study|Unsatisfactory therapeutic effect|38
1412791|NCT01120691|4663379|P2|Overall Study|Unsatisfactory therapeutic effect|32
1412792|NCT01120691|4663380|P1|Overall Study|Unsatisfactory therapeutic effect|18
1412793|NCT01120691|4663378|P3|Overall Study|Death|24
1412794|NCT01120691|4663379|P2|Overall Study|Death|22
1412795|NCT01120691|4663380|P1|Overall Study|Death|21
1412796|NCT01120691|4663378|P3|Overall Study|Subject withdrew consent|44
1412797|NCT01120691|4663379|P2|Overall Study|Subject withdrew consent|50
1412798|NCT01120691|4663380|P1|Overall Study|Subject withdrew consent|33
1412799|NCT01120691|4663378|P3|Overall Study|Adverse Event|47
1412800|NCT01120691|4663379|P2|Overall Study|Adverse Event|67
1412801|NCT01120691|4663380|P1|Overall Study|Adverse Event|59
1412802|NCT01120626|4663424|P2|Overall Study|Withdrawal by Subject|0
1412803|NCT01120626|4663425|P1|Overall Study|Withdrawal by Subject|1
1412804|NCT01120600|4663435|P2|Overall Study|Withdrawal by Subject|11
1412805|NCT01120600|4663436|P1|Overall Study|Withdrawal by Subject|10
1412806|NCT01120600|4663435|P2|Overall Study|Protocol Violation|4
1412807|NCT01120600|4663436|P1|Overall Study|Protocol Violation|0
1412808|NCT01120600|4663435|P2|Overall Study|Physician Decision|3
1412809|NCT01120600|4663436|P1|Overall Study|Physician Decision|1
1412810|NCT01120600|4663435|P2|Overall Study|Lost to Follow-up|3
1412811|NCT01120600|4663436|P1|Overall Study|Lost to Follow-up|1
1412812|NCT01120600|4663435|P2|Overall Study|Excessive Bone Loss|4
1412813|NCT01120600|4663436|P1|Overall Study|Excessive Bone Loss|0
1412814|NCT01120600|4663435|P2|Overall Study|Adverse Event|7
1412815|NCT01120600|4663436|P1|Overall Study|Adverse Event|7
1412816|NCT01120379|4663491|P1|Four Year Timepoint|Any other reason for early termination|217
1412817|NCT01120379|4663491|P1|Four Year Timepoint|Physician Decision|5
1412818|NCT01120379|4663491|P1|Four Year Timepoint|Death|131
1412819|NCT01120379|4663491|P1|Four Year Timepoint|Lost to Follow-up|10
1412820|NCT01120379|4663491|P1|Four Year Timepoint|Withdrawal by Subject|5
1412821|NCT01120379|4663491|P1|Three Year Timepoint|Any other reason for early termination|17
1412822|NCT01120379|4663491|P1|Three Year Timepoint|Physician Decision|9
1412823|NCT01120379|4663491|P1|Three Year Timepoint|Death|120
1412824|NCT01120379|4663491|P1|Three Year Timepoint|Lost to Follow-up|43
1412825|NCT01120379|4663491|P1|Three Year Timepoint|Withdrawal by Subject|25
1412826|NCT01120379|4663491|P1|Two Year Timepoint|Any other reason for early termination|4
1412827|NCT01120379|4663491|P1|Two Year Timepoint|Physician Decision|12
1412828|NCT01120379|4663491|P1|Two Year Timepoint|Death|123
1412829|NCT01120379|4663491|P1|Two Year Timepoint|Lost to Follow-up|87
1412830|NCT01120379|4663491|P1|Two Year Timepoint|Withdrawal by Subject|11
1412831|NCT01120379|4663491|P1|One Year Timepoint|Any other reason for early termination|5
1412832|NCT01120379|4663491|P1|One Year Timepoint|Physician Decision|9
1412833|NCT01120379|4663491|P1|One Year Timepoint|Death|108
1412834|NCT01120379|4663491|P1|One Year Timepoint|Lost to Follow-up|115
1412835|NCT01120379|4663491|P1|One Year Timepoint|Withdrawal by Subject|41
1412836|NCT01120275|4663527|P1|Overall Study|Not specific|1
1412837|NCT01120275|4663527|P1|Overall Study|Refusal|1
1412838|NCT01120275|4663527|P1|Overall Study|Withdrawal by Subject|1
1412839|NCT01120275|4663527|P1|Overall Study|Ineligible|3
1412840|NCT01120275|4663527|P1|Overall Study|Progression|27
1412841|NCT01120275|4663527|P1|Overall Study|Adverse Event|3
1412842|NCT01120210|4663594|P2|MAIN INFUSION|Withdrawal by Subject|1
1412843|NCT01120210|4663595|P1|MAIN INFUSION|Withdrawal by Subject|0
1412844|NCT01120210|4663594|P2|MAIN INFUSION|Adverse Event|0
1412845|NCT01120210|4663595|P1|MAIN INFUSION|Adverse Event|1
1412846|NCT01120184|4663645|P3|Overall Study|Death|169
1412847|NCT01120184|4663646|P2|Overall Study|Death|176
1412848|NCT01120184|4663647|P1|Overall Study|Death|170
1412849|NCT01120184|4663645|P3|Overall Study|Subject/ Guardian Decision to Withdraw|25
1412850|NCT01120184|4663646|P2|Overall Study|Subject/ Guardian Decision to Withdraw|29
1412851|NCT01120184|4663647|P1|Overall Study|Subject/ Guardian Decision to Withdraw|32
1412852|NCT01120184|4663645|P3|Overall Study|Sponsor Decision to Terminate Study|143
1412853|NCT01120184|4663646|P2|Overall Study|Sponsor Decision to Terminate Study|144
1412854|NCT01120184|4663647|P1|Overall Study|Sponsor Decision to Terminate Study|133
1412855|NCT01120184|4663645|P3|Overall Study|Reason not Specified|12
1412856|NCT01120184|4663646|P2|Overall Study|Reason not Specified|3
1412857|NCT01120184|4663647|P1|Overall Study|Reason not Specified|8
1412858|NCT01120184|4663645|P3|Overall Study|Physician Decision|3
1412859|NCT01120184|4663646|P2|Overall Study|Physician Decision|1
1412860|NCT01120184|4663647|P1|Overall Study|Physician Decision|9
1412861|NCT01120184|4663645|P3|Overall Study|Lost to Follow-up|11
1412862|NCT01120184|4663646|P2|Overall Study|Lost to Follow-up|13
1412863|NCT01120184|4663647|P1|Overall Study|Lost to Follow-up|13
1412864|NCT01120184|4663645|P3|Overall Study|Adverse Event|0
1412865|NCT01120184|4663646|P2|Overall Study|Adverse Event|1
1412866|NCT01120184|4663647|P1|Overall Study|Adverse Event|0
1412867|NCT01120093|4663769|P5|Treatment Period 5|Adverse Event|0
1412868|NCT01120093|4663770|P4|Treatment Period 5|Adverse Event|1
1412869|NCT01120093|4663771|P3|Treatment Period 5|Adverse Event|0
1412870|NCT01120093|4663772|P2|Treatment Period 5|Adverse Event|1
1412871|NCT01120093|4663773|P1|Treatment Period 5|Adverse Event|0
1412872|NCT01120093|4663769|P5|Treatment Period 4|Adverse Event|0
1412873|NCT01120093|4663770|P4|Treatment Period 4|Adverse Event|0
1412874|NCT01120093|4663771|P3|Treatment Period 4|Adverse Event|0
1412875|NCT01120093|4663772|P2|Treatment Period 4|Adverse Event|0
1412876|NCT01120093|4663773|P1|Treatment Period 4|Adverse Event|1
1412877|NCT01120093|4663769|P5|Treatment Period 3|Withdrawal by Subject|0
1412878|NCT01120093|4663770|P4|Treatment Period 3|Withdrawal by Subject|0
1412879|NCT01120093|4663771|P3|Treatment Period 3|Withdrawal by Subject|1
1412880|NCT01120093|4663772|P2|Treatment Period 3|Withdrawal by Subject|0
1412881|NCT01120093|4663773|P1|Treatment Period 3|Withdrawal by Subject|0
1412882|NCT01120093|4663769|P5|Treatment Period 3|Adverse Event|1
1412883|NCT01120093|4663770|P4|Treatment Period 3|Adverse Event|0
1412884|NCT01120093|4663771|P3|Treatment Period 3|Adverse Event|0
1412885|NCT01120093|4663772|P2|Treatment Period 3|Adverse Event|0
1412886|NCT01120093|4663773|P1|Treatment Period 3|Adverse Event|0
1412887|NCT01120093|4663769|P5|Treatment Period 3|Lack of Efficacy|0
1412888|NCT01120093|4663770|P4|Treatment Period 3|Lack of Efficacy|1
1412889|NCT01120093|4663771|P3|Treatment Period 3|Lack of Efficacy|0
1412890|NCT01120093|4663772|P2|Treatment Period 3|Lack of Efficacy|0
1412891|NCT01120093|4663773|P1|Treatment Period 3|Lack of Efficacy|0
1412892|NCT01120093|4663769|P5|Treatment Period 2|Withdrawal by Subject|1
1412893|NCT01120093|4663770|P4|Treatment Period 2|Withdrawal by Subject|0
1412894|NCT01120093|4663771|P3|Treatment Period 2|Withdrawal by Subject|0
1412895|NCT01120093|4663772|P2|Treatment Period 2|Withdrawal by Subject|0
1412896|NCT01120093|4663773|P1|Treatment Period 2|Withdrawal by Subject|0
1412897|NCT01120093|4663769|P5|Treatment Period 2|Adverse Event|0
1412898|NCT01120093|4663770|P4|Treatment Period 2|Adverse Event|1
1412899|NCT01120093|4663771|P3|Treatment Period 2|Adverse Event|0
1412900|NCT01120093|4663772|P2|Treatment Period 2|Adverse Event|0
1412901|NCT01120093|4663773|P1|Treatment Period 2|Adverse Event|0
1412902|NCT01120093|4663769|P5|Treatment Period 1|Withdrawal by Subject|0
1412903|NCT01120093|4663770|P4|Treatment Period 1|Withdrawal by Subject|0
1412904|NCT01120093|4663771|P3|Treatment Period 1|Withdrawal by Subject|0
1412905|NCT01120093|4663772|P2|Treatment Period 1|Withdrawal by Subject|1
1412906|NCT01120093|4663773|P1|Treatment Period 1|Withdrawal by Subject|0
1412907|NCT01120093|4663769|P5|Treatment Period 1|Adverse Event|1
1412908|NCT01120093|4663770|P4|Treatment Period 1|Adverse Event|0
1412909|NCT01120093|4663771|P3|Treatment Period 1|Adverse Event|1
1412910|NCT01120093|4663772|P2|Treatment Period 1|Adverse Event|0
1412911|NCT01120093|4663773|P1|Treatment Period 1|Adverse Event|0
1412912|NCT01120067|4663802|P2|Overall Study|fail to engage >3 sessions|0
1412913|NCT01120067|4663803|P1|Overall Study|fail to engage >3 sessions|2
1412914|NCT01120067|4663802|P2|Overall Study|Lost to Follow-up|1
1412915|NCT01120067|4663803|P1|Overall Study|Lost to Follow-up|3
1412916|NCT01119963|4663811|P2|Overall Study|Lost to Follow-up|1
1412917|NCT01119963|4663812|P1|Overall Study|Lost to Follow-up|1
1412918|NCT01119950|4663822|P1|Overall Study|Death|1
1412919|NCT01119950|4663822|P1|Overall Study|Abnormal lab value|1
1412920|NCT01119950|4663822|P1|Overall Study|Administrative|2
1412921|NCT01119950|4663822|P1|Overall Study|Lost to Follow-up|4
1412922|NCT01119950|4663822|P1|Overall Study|Protocol Violation|5
1412923|NCT01119950|4663822|P1|Overall Study|Withdrawal by Subject|9
1412924|NCT01119950|4663822|P1|Overall Study|Adverse Event|25
1412925|NCT01119937|4664069|P2|Overall Study|Withdrawal by Subject|1
1412926|NCT01119937|4664070|P1|Overall Study|Withdrawal by Subject|2
1412927|NCT01119937|4664069|P2|Overall Study|Unsatisfactory therapeutic effect|0
1412928|NCT01119937|4664070|P1|Overall Study|Unsatisfactory therapeutic effect|3
1412929|NCT01119937|4664069|P2|Overall Study|Protocol deviation|1
1412930|NCT01119937|4664070|P1|Overall Study|Protocol deviation|3
1412931|NCT01119937|4664069|P2|Overall Study|Adverse Event|5
1412932|NCT01119937|4664070|P1|Overall Study|Adverse Event|11
1412933|NCT01119859|4664098|P2|Overall Study|Failure to return|0
1412934|NCT01119859|4664099|P1|Overall Study|Failure to return|3
1412935|NCT01119859|4664098|P2|Overall Study|Refused treatment|6
1412936|NCT01119859|4664099|P1|Overall Study|Refused treatment|3
1412937|NCT01119859|4664098|P2|Overall Study|Insufficient therapeutic response|14
1412938|NCT01119859|4664099|P1|Overall Study|Insufficient therapeutic response|7
1412939|NCT01119859|4664098|P2|Overall Study|Death|0
1412940|NCT01119859|4664099|P1|Overall Study|Death|2
1412941|NCT01119859|4664098|P2|Overall Study|Adverse Event|10
1412942|NCT01119859|4664099|P1|Overall Study|Adverse Event|9
1412943|NCT01119846|4664118|P3|Overall Study|Withdrawal by Subject|4
1412944|NCT01119846|4664119|P2|Overall Study|Withdrawal by Subject|0
1412945|NCT01119846|4664120|P1|Overall Study|Withdrawal by Subject|0
1412946|NCT01119846|4664118|P3|Overall Study|Protocol Violation|1
1412947|NCT01119846|4664119|P2|Overall Study|Protocol Violation|0
1412948|NCT01119846|4664120|P1|Overall Study|Protocol Violation|0
1412949|NCT01119846|4664118|P3|Overall Study|Physician Decision|0
1412950|NCT01119846|4664119|P2|Overall Study|Physician Decision|0
1412951|NCT01119846|4664120|P1|Overall Study|Physician Decision|1
1412952|NCT01119846|4664118|P3|Overall Study|Adverse Event|6
1412953|NCT01119846|4664119|P2|Overall Study|Adverse Event|0
1412954|NCT01119846|4664120|P1|Overall Study|Adverse Event|1
1412955|NCT01119768|4664334|P2|Treatment Period|Lack of Efficacy|25
1412956|NCT01119768|4664335|P1|Treatment Period|Lack of Efficacy|18
1412957|NCT01119703|4664391|P2|Overall Study|Adverse Event|1
1412958|NCT01119703|4664392|P1|Overall Study|Adverse Event|0
1412959|NCT01119625|4664406|P2|Overall Study|Other|1
1412960|NCT01119625|4664407|P1|Overall Study|Other|0
1412961|NCT01119625|4664406|P2|Overall Study|Withdrawal by Subject|1
1412962|NCT01119625|4664407|P1|Overall Study|Withdrawal by Subject|2
1412963|NCT01119625|4664406|P2|Overall Study|Lost to Follow-up|2
1412964|NCT01119625|4664407|P1|Overall Study|Lost to Follow-up|1
1412965|NCT01119443|4664449|P2|Crossover Period 1 (5 Days)|Adverse Event|1
1412966|NCT01119443|4664450|P1|Crossover Period 1 (5 Days)|Adverse Event|0
1412967|NCT01119287|4664493|P6|Overall Study|Patient Decision, not related to AE|0
1412968|NCT01119287|4664494|P5|Overall Study|Patient Decision, not related to AE|1
1412969|NCT01119287|4664495|P4|Overall Study|Patient Decision, not related to AE|2
1412970|NCT01119287|4664496|P3|Overall Study|Patient Decision, not related to AE|2
1412971|NCT01119287|4664497|P2|Overall Study|Patient Decision, not related to AE|0
1412972|NCT01119287|4664498|P1|Overall Study|Patient Decision, not related to AE|0
1412973|NCT01119248|4664511|P1|Overall Study|Physician Decision|5
1412974|NCT01119131|4664561|P3|Overall Study|Physician Decision|1
1412975|NCT01119131|4664562|P2|Overall Study|Physician Decision|0
1412976|NCT01119131|4664563|P1|Overall Study|Physician Decision|0
1412977|NCT01119131|4664561|P3|Overall Study|Non-Compliance|4
1412978|NCT01119131|4664562|P2|Overall Study|Non-Compliance|0
1412979|NCT01119131|4664563|P1|Overall Study|Non-Compliance|1
1412980|NCT01119131|4664561|P3|Overall Study|Adverse Event|1
1412981|NCT01119131|4664562|P2|Overall Study|Adverse Event|1
1412982|NCT01119131|4664563|P1|Overall Study|Adverse Event|1
1412983|NCT01119118|4664592|P1|Overall Study|Adverse Event|1
1412984|NCT01119001|4664604|P1|Overall Study|Withdrawal by Subject|2
1412985|NCT01118975|4664648|P2|Overall Study|Adverse Event|1
1412986|NCT01118975|4664649|P1|Overall Study|Adverse Event|0
1412987|NCT01118962|4664655|P1|Overall Study|Non-compliance with Medicinal Product|1
1412988|NCT01118962|4664655|P1|Overall Study|Pregnancy|1
1412989|NCT01118962|4664655|P1|Overall Study|Withdrawal by Subject|4
1412990|NCT01118962|4664655|P1|Overall Study|Protocol Violation|1
1412991|NCT01118962|4664655|P1|Overall Study|Lack of Efficacy|1
1412992|NCT01118962|4664655|P1|Overall Study|Adverse Event|2
1412993|NCT01118949|4664660|P1|Overall Study|Withdrawal by Subject|4
1412994|NCT01118949|4664660|P1|Overall Study|Adverse Event|5
1412995|NCT01118780|4664690|P2|Overall Study|Withdrawal by Subject|8
1412996|NCT01118780|4664691|P1|Overall Study|Withdrawal by Subject|13
1412997|NCT01118780|4664690|P2|Overall Study|Protocol Violation|6
1412998|NCT01118780|4664691|P1|Overall Study|Protocol Violation|3
1412999|NCT01118780|4664690|P2|Overall Study|Physician Decision|0
1413000|NCT01118780|4664691|P1|Overall Study|Physician Decision|2
1413001|NCT01118780|4664690|P2|Overall Study|Lack of Efficacy|6
1413002|NCT01118780|4664691|P1|Overall Study|Lack of Efficacy|2
1413003|NCT01118780|4664690|P2|Overall Study|Death|0
1413004|NCT01118780|4664691|P1|Overall Study|Death|1
1413005|NCT01118780|4664690|P2|Overall Study|Adverse Event|15
1413006|NCT01118780|4664691|P1|Overall Study|Adverse Event|15
1413007|NCT01118728|4664749|P1|Overall Study|Lost to Follow-up|4
1413008|NCT01118728|4664749|P1|Overall Study|Withdrawal by Subject|3
1413009|NCT01118728|4664749|P1|Overall Study|Sponsor's decision to discontinue study|172
1413010|NCT01118728|4664749|P1|Overall Study|Lack of Efficacy|27
1413011|NCT01118728|4664749|P1|Overall Study|Adverse Event|17
1413012|NCT01118663|4664756|P2|Overall Study|Withdrawal by Subject|1
1413013|NCT01118663|4664757|P1|Overall Study|Withdrawal by Subject|0
1413014|NCT01118663|4664756|P2|Overall Study|Adverse Event|1
1413015|NCT01118663|4664757|P1|Overall Study|Adverse Event|2
1413016|NCT01118455|4664780|P2|Baseline [Visits 1 & 2]|Adverse Event|0
1413017|NCT01118455|4664781|P1|Baseline [Visits 1 & 2]|Adverse Event|1
1413018|NCT01118377|4664809|P1|Overall Study|Failure to Return|3
1413019|NCT01118377|4664809|P1|Overall Study|Death|38
1413020|NCT01118377|4664809|P1|Overall Study|Did Not Receive Study Medication|1
1413021|NCT01118325|4664818|P3|Overall Study|Adverse Event|1
1413022|NCT01118325|4664819|P2|Overall Study|Adverse Event|0
1413023|NCT01118325|4664820|P1|Overall Study|Adverse Event|1
1413024|NCT01118312|4664866|P2|Overall Study|Withdrawal by Subject|3
1413025|NCT01118312|4664867|P1|Overall Study|Withdrawal by Subject|1
1413026|NCT01118312|4664866|P2|Overall Study|Lost to Follow-up|32
1413027|NCT01118312|4664867|P1|Overall Study|Lost to Follow-up|33
1413028|NCT01118143|4665065|P2|Overall Study|Withdrawal by Subject|5
1413029|NCT01118143|4665066|P1|Overall Study|Withdrawal by Subject|2
1413030|NCT01118117|4665076|P2|Overall Study|Missed 12 Month Visit|0
1413031|NCT01118117|4665077|P1|Overall Study|Missed 12 Month Visit|7
1413032|NCT01118117|4665076|P2|Overall Study|Lost to Follow-up|0
1413033|NCT01118117|4665077|P1|Overall Study|Lost to Follow-up|6
1413034|NCT01118117|4665076|P2|Overall Study|Death|0
1413035|NCT01118117|4665077|P1|Overall Study|Death|8
1413036|NCT01118052|4665109|P1|Overall Study|Never treated|2
1413037|NCT01117987|4665132|P2|Overall Study|Administrative problems|22
1413038|NCT01117987|4665133|P1|Overall Study|Administrative problems|25
1413039|NCT01117987|4665132|P2|Overall Study|Adverse Event|26
1413040|NCT01117987|4665133|P1|Overall Study|Adverse Event|19
1413041|NCT01117987|4665132|P2|Overall Study|Withdrawal by Subject|10
1413042|NCT01117987|4665133|P1|Overall Study|Withdrawal by Subject|5
1413043|NCT01117987|4665132|P2|Overall Study|Death|10
1413044|NCT01117987|4665133|P1|Overall Study|Death|5
1413045|NCT01117987|4665132|P2|Overall Study|Lack of Efficacy|4
1413046|NCT01117987|4665133|P1|Overall Study|Lack of Efficacy|3
1413047|NCT01117987|4665132|P2|Overall Study|Abnormal test procedure result|0
1413048|NCT01117987|4665133|P1|Overall Study|Abnormal test procedure result|2
1413049|NCT01117987|4665132|P2|Overall Study|Lost to Follow-up|1
1413050|NCT01117987|4665133|P1|Overall Study|Lost to Follow-up|1
1413051|NCT01117987|4665132|P2|Overall Study|Subject no longer requires study drug|0
1413052|NCT01117987|4665133|P1|Overall Study|Subject no longer requires study drug|1
1413053|NCT01117987|4665132|P2|Overall Study|Protocol deviation|1
1413054|NCT01117987|4665133|P1|Overall Study|Protocol deviation|0
1413055|NCT01117870|4665154|P2|Overall Study|Inability to place needle|0
1413056|NCT01117870|4665155|P1|Overall Study|Inability to place needle|1
1413057|NCT01117857|4665169|P1|Overall Study|Physician Decision|1
1413058|NCT01117857|4665169|P1|Overall Study|Withdrawal by Subject|4
1413059|NCT01117857|4665169|P1|Overall Study|Lost to Follow-up|4
1413060|NCT01117766|4665177|P2|Second Intervention|Withdrawal by Subject|1
1413061|NCT01117766|4665178|P1|Second Intervention|Withdrawal by Subject|0
1413062|NCT01117766|4665177|P2|Second Intervention|Adverse Event|2
1413063|NCT01117766|4665178|P1|Second Intervention|Adverse Event|0
1413064|NCT01117766|4665177|P2|Second Intervention|Other|2
1413065|NCT01117766|4665178|P1|Second Intervention|Other|1
1413066|NCT01117766|4665177|P2|Second Intervention|Lost to Follow-up|0
1413067|NCT01117766|4665178|P1|Second Intervention|Lost to Follow-up|1
1413068|NCT01117766|4665177|P2|Washout Period|Protocol Violation|2
1413069|NCT01117766|4665178|P1|Washout Period|Protocol Violation|0
1413070|NCT01117766|4665177|P2|First Intervention|Protocol Violation|0
1413071|NCT01117766|4665178|P1|First Intervention|Protocol Violation|1
1413072|NCT01117766|4665177|P2|First Intervention|Other|0
1413073|NCT01117766|4665178|P1|First Intervention|Other|0
1413074|NCT01117766|4665177|P2|First Intervention|Adverse Event|1
1413075|NCT01117766|4665178|P1|First Intervention|Adverse Event|0
1413076|NCT01117623|4665215|P8|Overall Study|Invest. text: completed all planned txs|0
1413077|NCT01117623|4665216|P7|Overall Study|Invest. text: completed all planned txs|0
1413078|NCT01117623|4665217|P6|Overall Study|Invest. text: completed all planned txs|1
1413079|NCT01117623|4665218|P5|Overall Study|Invest. text: completed all planned txs|0
1413080|NCT01117623|4665219|P4|Overall Study|Invest. text: completed all planned txs|0
1413081|NCT01117623|4665220|P3|Overall Study|Invest. text: completed all planned txs|0
1413082|NCT01117623|4665221|P2|Overall Study|Invest. text: completed all planned txs|0
1413083|NCT01117623|4665222|P1|Overall Study|Invest. text: completed all planned txs|0
1413084|NCT01117623|4665215|P8|Overall Study|Non-compliance with study medication|1
1413085|NCT01117623|4665216|P7|Overall Study|Non-compliance with study medication|0
1413086|NCT01117623|4665217|P6|Overall Study|Non-compliance with study medication|0
1413087|NCT01117623|4665218|P5|Overall Study|Non-compliance with study medication|0
1413088|NCT01117623|4665219|P4|Overall Study|Non-compliance with study medication|0
1413089|NCT01117623|4665220|P3|Overall Study|Non-compliance with study medication|0
1413090|NCT01117623|4665221|P2|Overall Study|Non-compliance with study medication|0
1413091|NCT01117623|4665222|P1|Overall Study|Non-compliance with study medication|0
1413092|NCT01117623|4665215|P8|Overall Study|Withdrawal by Subject|1
1413093|NCT01117623|4665216|P7|Overall Study|Withdrawal by Subject|1
1413094|NCT01117623|4665217|P6|Overall Study|Withdrawal by Subject|1
1413095|NCT01117623|4665218|P5|Overall Study|Withdrawal by Subject|0
1413096|NCT01117623|4665219|P4|Overall Study|Withdrawal by Subject|0
1413097|NCT01117623|4665220|P3|Overall Study|Withdrawal by Subject|2
1413098|NCT01117623|4665221|P2|Overall Study|Withdrawal by Subject|0
1413099|NCT01117623|4665222|P1|Overall Study|Withdrawal by Subject|0
1413100|NCT01117623|4665215|P8|Overall Study|Disease progression, recurrence, relapse|22
1413101|NCT01117623|4665216|P7|Overall Study|Disease progression, recurrence, relapse|5
1413102|NCT01117623|4665217|P6|Overall Study|Disease progression, recurrence, relapse|14
1413103|NCT01117623|4665218|P5|Overall Study|Disease progression, recurrence, relapse|8
1413104|NCT01117623|4665219|P4|Overall Study|Disease progression, recurrence, relapse|6
1413105|NCT01117623|4665220|P3|Overall Study|Disease progression, recurrence, relapse|5
1413106|NCT01117623|4665221|P2|Overall Study|Disease progression, recurrence, relapse|6
1413107|NCT01117623|4665222|P1|Overall Study|Disease progression, recurrence, relapse|3
1413108|NCT01117623|4665215|P8|Overall Study|Adverse Event|2
1413109|NCT01117623|4665216|P7|Overall Study|Adverse Event|0
1413110|NCT01117623|4665217|P6|Overall Study|Adverse Event|0
1413111|NCT01117623|4665218|P5|Overall Study|Adverse Event|2
1413112|NCT01117623|4665219|P4|Overall Study|Adverse Event|0
1413113|NCT01117623|4665220|P3|Overall Study|Adverse Event|4
1413114|NCT01117623|4665221|P2|Overall Study|Adverse Event|2
1413115|NCT01117623|4665222|P1|Overall Study|Adverse Event|0
1413116|NCT01117480|4665374|P1|Overall Study|Did Not Start Adalimumab Therapy|20
1413117|NCT01117480|4665374|P1|Overall Study|Protocol Violation|8
1413118|NCT01117454|4665382|P2|Overall Study|Pregnancy|1
1413119|NCT01117454|4665383|P1|Overall Study|Pregnancy|0
1413120|NCT01117428|4665395|P6|Overall Study|Progressive disease|17
1413121|NCT01117428|4665396|P5|Overall Study|Progressive disease|16
1413122|NCT01117428|4665397|P4|Overall Study|Progressive disease|12
1413123|NCT01117428|4665398|P3|Overall Study|Progressive disease|10
1413124|NCT01117428|4665399|P2|Overall Study|Progressive disease|27
1413125|NCT01117428|4665400|P1|Overall Study|Progressive disease|15
1413126|NCT01117428|4665395|P6|Overall Study|Withdrawal by Subject|0
1413127|NCT01117428|4665396|P5|Overall Study|Withdrawal by Subject|0
1413128|NCT01117428|4665397|P4|Overall Study|Withdrawal by Subject|0
1413129|NCT01117428|4665398|P3|Overall Study|Withdrawal by Subject|1
1413130|NCT01117428|4665399|P2|Overall Study|Withdrawal by Subject|0
1413131|NCT01117428|4665400|P1|Overall Study|Withdrawal by Subject|0
1413132|NCT01117428|4665395|P6|Overall Study|Physician Decision|0
1413133|NCT01117428|4665396|P5|Overall Study|Physician Decision|0
1413134|NCT01117428|4665397|P4|Overall Study|Physician Decision|0
1413135|NCT01117428|4665398|P3|Overall Study|Physician Decision|0
1413136|NCT01117428|4665399|P2|Overall Study|Physician Decision|1
1413137|NCT01117428|4665400|P1|Overall Study|Physician Decision|0
1413138|NCT01117428|4665395|P6|Overall Study|Death|1
1413139|NCT01117428|4665396|P5|Overall Study|Death|0
1413140|NCT01117428|4665397|P4|Overall Study|Death|0
1413141|NCT01117428|4665398|P3|Overall Study|Death|2
1413142|NCT01117428|4665399|P2|Overall Study|Death|1
1413143|NCT01117428|4665400|P1|Overall Study|Death|0
1413144|NCT01117428|4665395|P6|Overall Study|Adverse Event|2
1413145|NCT01117428|4665396|P5|Overall Study|Adverse Event|1
1413146|NCT01117428|4665397|P4|Overall Study|Adverse Event|0
1413147|NCT01117428|4665398|P3|Overall Study|Adverse Event|0
1413148|NCT01117428|4665399|P2|Overall Study|Adverse Event|0
1413149|NCT01117428|4665400|P1|Overall Study|Adverse Event|4
1413150|NCT01117428|4665395|P6|Overall Study|Lack of Efficacy|0
1413151|NCT01117428|4665396|P5|Overall Study|Lack of Efficacy|0
1413152|NCT01117428|4665397|P4|Overall Study|Lack of Efficacy|0
1413153|NCT01117428|4665398|P3|Overall Study|Lack of Efficacy|0
1413154|NCT01117428|4665399|P2|Overall Study|Lack of Efficacy|0
1413155|NCT01117428|4665400|P1|Overall Study|Lack of Efficacy|1
1413156|NCT01117350|4665434|P2|Extension Period|Prohibited medication|1
1413157|NCT01117350|4665435|P1|Extension Period|Prohibited medication|0
1413158|NCT01117350|4665434|P2|Extension Period|Inclusion criteria not respected|1
1413159|NCT01117350|4665435|P1|Extension Period|Inclusion criteria not respected|0
1413160|NCT01117350|4665434|P2|Extension Period|Lack of Efficacy|2
1413161|NCT01117350|4665435|P1|Extension Period|Lack of Efficacy|0
1413162|NCT01117350|4665434|P2|Extension Period|Withdrawal by Subject|3
1413163|NCT01117350|4665435|P1|Extension Period|Withdrawal by Subject|0
1413164|NCT01117350|4665434|P2|Extension Period|Lost to Follow-up|2
1413165|NCT01117350|4665435|P1|Extension Period|Lost to Follow-up|0
1413166|NCT01117350|4665434|P2|Extension Period|Protocol Violation|2
1413167|NCT01117350|4665435|P1|Extension Period|Protocol Violation|0
1413168|NCT01117350|4665434|P2|Extension Period|Adverse Event|2
1413169|NCT01117350|4665435|P1|Extension Period|Adverse Event|0
1413170|NCT01117350|4665434|P2|Extension Period|Not included in extension, not treated|50
1413171|NCT01117350|4665435|P1|Extension Period|Not included in extension, not treated|0
1413172|NCT01117350|4665434|P2|Comparative Period|Move to another city/country|1
1413173|NCT01117350|4665435|P1|Comparative Period|Move to another city/country|2
1413174|NCT01117350|4665434|P2|Comparative Period|Physician Decision|1
1413175|NCT01117350|4665435|P1|Comparative Period|Physician Decision|0
1413176|NCT01117350|4665434|P2|Comparative Period|Lack of Efficacy|0
1413177|NCT01117350|4665435|P1|Comparative Period|Lack of Efficacy|1
1413178|NCT01117350|4665434|P2|Comparative Period|Protocol Violation|12
1413179|NCT01117350|4665435|P1|Comparative Period|Protocol Violation|8
1413180|NCT01117350|4665434|P2|Comparative Period|Withdrawal by Subject|13
1413181|NCT01117350|4665435|P1|Comparative Period|Withdrawal by Subject|9
1413182|NCT01117350|4665434|P2|Comparative Period|Lost to Follow-up|7
1413183|NCT01117350|4665435|P1|Comparative Period|Lost to Follow-up|11
1413184|NCT01117350|4665434|P2|Comparative Period|Adverse Event|33
1413185|NCT01117350|4665435|P1|Comparative Period|Adverse Event|6
1413186|NCT01117350|4665434|P2|Comparative Period|Not Treated|8
1413187|NCT01117350|4665435|P1|Comparative Period|Not Treated|5
1413188|NCT01117337|4665467|P2|Overall Study|Lost to Follow-up|0
1413189|NCT01117337|4665468|P1|Overall Study|Lost to Follow-up|4
1413190|NCT01117181|4665489|P2|Overall Study|Withdrawal by Subject|2
1413191|NCT01117181|4665490|P1|Overall Study|Withdrawal by Subject|0
1413192|NCT01117181|4665489|P2|Overall Study|Lost to Follow-up|0
1413193|NCT01117181|4665490|P1|Overall Study|Lost to Follow-up|1
1413194|NCT01117051|4665523|P2|Overall Study|Convenience issue|0
1413195|NCT01117051|4665524|P1|Overall Study|Convenience issue|1
1413196|NCT01117051|4665523|P2|Overall Study|Randomized by mistake|1
1413197|NCT01117051|4665524|P1|Overall Study|Randomized by mistake|0
1413198|NCT01117051|4665523|P2|Overall Study|Surgical procedure|1
1413199|NCT01117051|4665524|P1|Overall Study|Surgical procedure|0
1413200|NCT01117051|4665523|P2|Overall Study|Sponsor's decision|1
1413201|NCT01117051|4665524|P1|Overall Study|Sponsor's decision|3
1413202|NCT01117051|4665523|P2|Overall Study|Did not meet in-/exclusion criteria|1
1413203|NCT01117051|4665524|P1|Overall Study|Did not meet in-/exclusion criteria|0
1413204|NCT01117051|4665523|P2|Overall Study|Lost to Follow-up|1
1413205|NCT01117051|4665524|P1|Overall Study|Lost to Follow-up|0
1413206|NCT01117051|4665523|P2|Overall Study|Adverse Event|3
1413207|NCT01117051|4665524|P1|Overall Study|Adverse Event|4
1413208|NCT01117051|4665523|P2|Overall Study|Withdrawal by Subject|3
1413209|NCT01117051|4665524|P1|Overall Study|Withdrawal by Subject|5
1413210|NCT01117012|4665534|P2|Overall Study|Undefined|3
1413211|NCT01117012|4665535|P1|Overall Study|Undefined|4
1413212|NCT01117012|4665534|P2|Overall Study|Withdrawal by Subject|0
1413213|NCT01117012|4665535|P1|Overall Study|Withdrawal by Subject|3
1413214|NCT01117012|4665534|P2|Overall Study|Death|1
1413215|NCT01117012|4665535|P1|Overall Study|Death|1
1413216|NCT01117012|4665534|P2|Overall Study|Adverse Event|1
1413217|NCT01117012|4665535|P1|Overall Study|Adverse Event|0
1413218|NCT01116882|4665676|P2|12-month|Withdrawal by Subject|8
1413219|NCT01116882|4665677|P1|12-month|Withdrawal by Subject|5
1413220|NCT01116882|4665676|P2|12-month|Other Reasons|49
1413221|NCT01116882|4665677|P1|12-month|Other Reasons|151
1413222|NCT01116882|4665676|P2|12-month|Lost to Follow-up|42
1413223|NCT01116882|4665677|P1|12-month|Lost to Follow-up|111
1413224|NCT01116882|4665676|P2|30-day|Other Reasons|6
1413225|NCT01116882|4665677|P1|30-day|Other Reasons|16
1413226|NCT01116882|4665676|P2|30-day|Withdrawal by Subject|4
1413227|NCT01116882|4665677|P1|30-day|Withdrawal by Subject|2
1413228|NCT01116882|4665676|P2|30-day|Lost to Follow-up|21
1413229|NCT01116882|4665677|P1|30-day|Lost to Follow-up|50
1413230|NCT01116687|4665715|P1|Overall Study|Withdrawal by Subject|4
1413231|NCT01116427|4665732|P2|Extension Phase|Not using appropriate birth control|0
1413232|NCT01116427|4665733|P1|Extension Phase|Not using appropriate birth control|1
1413233|NCT01116427|4665732|P2|Extension Phase|Withdrawal by Subject|1
1413234|NCT01116427|4665733|P1|Extension Phase|Withdrawal by Subject|5
1413235|NCT01116427|4665732|P2|Extension Phase|Lost to Follow-up|0
1413236|NCT01116427|4665733|P1|Extension Phase|Lost to Follow-up|2
1413237|NCT01116427|4665732|P2|Extension Phase|Adverse Event|1
1413238|NCT01116427|4665733|P1|Extension Phase|Adverse Event|1
1413239|NCT01116427|4665732|P2|Core Phase|Worsening Multiple Sclerosis|0
1413240|NCT01116427|4665733|P1|Core Phase|Worsening Multiple Sclerosis|1
1413241|NCT01116427|4665732|P2|Core Phase|Withdrawal by Subject|0
1413242|NCT01116427|4665733|P1|Core Phase|Withdrawal by Subject|3
1413243|NCT01116427|4665732|P2|Core Phase|Lost to Follow-up|0
1413244|NCT01116427|4665733|P1|Core Phase|Lost to Follow-up|1
1413245|NCT01116427|4665732|P2|Core Phase|Adverse Event|1
1413246|NCT01116427|4665733|P1|Core Phase|Adverse Event|0
1413247|NCT01116232|4665774|P1|Overall Study|Progressive diease|4
1413248|NCT01115998|4665882|P2|Overall Study|Lost to Follow-up|6
1413249|NCT01115998|4665883|P1|Overall Study|Lost to Follow-up|6
1413250|NCT01115933|4665893|P1|Overall Study|Did not receive XIENCE PRIME SV|1
1413251|NCT01115855|4665990|P2|Overall Study|Other|6
1413252|NCT01115855|4665991|P1|Overall Study|Other|8
1413253|NCT01115855|4665990|P2|Overall Study|Withdrawal by Subject|5
1413254|NCT01115855|4665991|P1|Overall Study|Withdrawal by Subject|5
1413255|NCT01115855|4665990|P2|Overall Study|Protocol Violation|1
1413256|NCT01115855|4665991|P1|Overall Study|Protocol Violation|0
1413257|NCT01115855|4665990|P2|Overall Study|Lab Abnormality|1
1413258|NCT01115855|4665991|P1|Overall Study|Lab Abnormality|1
1413259|NCT01115855|4665990|P2|Overall Study|Death|5
1413260|NCT01115855|4665991|P1|Overall Study|Death|6
1413261|NCT01115855|4665990|P2|Overall Study|Adverse Event|18
1413262|NCT01115855|4665991|P1|Overall Study|Adverse Event|16
1413263|NCT01115738|4666042|P3|Overall Study|Withdrawal by Subject|9
1413264|NCT01115738|4666043|P2|Overall Study|Withdrawal by Subject|6
1413265|NCT01115738|4666044|P1|Overall Study|Withdrawal by Subject|6
1413266|NCT01115738|4666042|P3|Overall Study|Physician Decision|17
1413267|NCT01115738|4666043|P2|Overall Study|Physician Decision|15
1413268|NCT01115738|4666044|P1|Overall Study|Physician Decision|18
1413269|NCT01115738|4666042|P3|Overall Study|Lost to Follow-up|1
1413270|NCT01115738|4666043|P2|Overall Study|Lost to Follow-up|0
1413271|NCT01115738|4666044|P1|Overall Study|Lost to Follow-up|0
1413272|NCT01115738|4666042|P3|Overall Study|Death|0
1413273|NCT01115738|4666043|P2|Overall Study|Death|0
1413274|NCT01115738|4666044|P1|Overall Study|Death|1
1413275|NCT01115569|4666242|P2|Maintenance Phase|Administrative|1
1413276|NCT01115569|4666243|P1|Maintenance Phase|Administrative|0
1413277|NCT01115569|4666242|P2|Maintenance Phase|Non-Compliance with Study Drug|48
1413278|NCT01115569|4666243|P1|Maintenance Phase|Non-Compliance with Study Drug|0
1413279|NCT01115569|4666242|P2|Maintenance Phase|Withdrawal by Subject|27
1413280|NCT01115569|4666243|P1|Maintenance Phase|Withdrawal by Subject|0
1413281|NCT01115569|4666242|P2|Maintenance Phase|Protocol Violation|9
1413282|NCT01115569|4666243|P1|Maintenance Phase|Protocol Violation|0
1413283|NCT01115569|4666242|P2|Maintenance Phase|Physician Decision|3
1413284|NCT01115569|4666243|P1|Maintenance Phase|Physician Decision|0
1413285|NCT01115569|4666242|P2|Maintenance Phase|Lost to Follow-up|8
1413286|NCT01115569|4666243|P1|Maintenance Phase|Lost to Follow-up|0
1413287|NCT01115569|4666242|P2|Maintenance Phase|Adverse Event|43
1413288|NCT01115569|4666243|P1|Maintenance Phase|Adverse Event|0
1413289|NCT01115569|4666242|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
1413290|NCT01115569|4666243|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
1413291|NCT01115569|4666242|P2|Conversion/Titration Phase|Withdrawal by Subject|0
1413292|NCT01115569|4666243|P1|Conversion/Titration Phase|Withdrawal by Subject|26
1413293|NCT01115569|4666242|P2|Conversion/Titration Phase|Protocol Violation|0
1413294|NCT01115569|4666243|P1|Conversion/Titration Phase|Protocol Violation|68
1413295|NCT01115569|4666242|P2|Conversion/Titration Phase|Physician Decision|0
1413296|NCT01115569|4666243|P1|Conversion/Titration Phase|Physician Decision|5
1413297|NCT01115569|4666242|P2|Conversion/Titration Phase|Lost to Follow-up|0
1413298|NCT01115569|4666243|P1|Conversion/Titration Phase|Lost to Follow-up|3
1413299|NCT01115569|4666242|P2|Conversion/Titration Phase|Adverse Event|0
1413300|NCT01115569|4666243|P1|Conversion/Titration Phase|Adverse Event|59
1413301|NCT01115491|4666272|P1|Overall Study|Physician Decision|1
1413302|NCT01115491|4666272|P1|Overall Study|Withdrawal by Subject|1
1413303|NCT01115491|4666272|P1|Overall Study|Lost to Follow-up|3
1413304|NCT01115491|4666272|P1|Overall Study|Adverse Event|3
1413305|NCT01115491|4666272|P1|Overall Study|Death|22
1413306|NCT01114880|4666447|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
1413307|NCT01114880|4666448|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
1413308|NCT01114880|4666447|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
1413309|NCT01114880|4666448|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
1413310|NCT01114880|4666447|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
1413311|NCT01114880|4666448|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
1413312|NCT01114880|4666447|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
1413313|NCT01114880|4666448|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
1413314|NCT01114880|4666447|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
1413315|NCT01114880|4666448|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
1413316|NCT01114880|4666447|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
1413317|NCT01114880|4666448|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
1413318|NCT01114828|4666500|P2|Overall Study|Withdrawal by Subject|1
1413319|NCT01114828|4666501|P1|Overall Study|Withdrawal by Subject|0
1413320|NCT01114828|4666500|P2|Overall Study|Protocol Violation|0
1413321|NCT01114828|4666501|P1|Overall Study|Protocol Violation|2
1413322|NCT01114828|4666500|P2|Overall Study|Lack of Efficacy|2
1413323|NCT01114828|4666501|P1|Overall Study|Lack of Efficacy|0
1413324|NCT01114828|4666500|P2|Overall Study|Adverse Event|1
1413325|NCT01114828|4666501|P1|Overall Study|Adverse Event|1
1413326|NCT01114737|4666511|P2|Open-Label Treatment Period|Difficult Personal Events|0
1413327|NCT01114737|4666512|P1|Open-Label Treatment Period|Difficult Personal Events|1
1413328|NCT01114737|4666511|P2|Open-Label Treatment Period|Lost to Follow-up|1
1413329|NCT01114737|4666512|P1|Open-Label Treatment Period|Lost to Follow-up|3
1413330|NCT01114737|4666511|P2|Open-Label Treatment Period|Withdrawal by Subject|1
1413331|NCT01114737|4666512|P1|Open-Label Treatment Period|Withdrawal by Subject|1
1413332|NCT01114737|4666511|P2|Randomized Treatment Period|Pregnancy|0
1413333|NCT01114737|4666512|P1|Randomized Treatment Period|Pregnancy|1
1413334|NCT01114737|4666511|P2|Randomized Treatment Period|Lost to Follow-up|1
1413335|NCT01114737|4666512|P1|Randomized Treatment Period|Lost to Follow-up|1
1413336|NCT01114737|4666511|P2|Randomized Treatment Period|Withdrawal by Subject|0
1413337|NCT01114737|4666512|P1|Randomized Treatment Period|Withdrawal by Subject|1
1413338|NCT01114724|4666560|P1|Overall Study|Withdrawal by Subject|1
1413339|NCT01114724|4666560|P1|Overall Study|Lost to Follow-up|1
1413340|NCT01114724|4666560|P1|Overall Study|Death|8
1413341|NCT01114672|4666580|P2|Overall Study|transplanted|0
1413342|NCT01114672|4666581|P1|Overall Study|transplanted|1
1413343|NCT01114672|4666580|P2|Overall Study|Lost to Follow-up|0
1413344|NCT01114672|4666581|P1|Overall Study|Lost to Follow-up|1
1413345|NCT01114672|4666580|P2|Overall Study|Withdrawal by Subject|1
1413346|NCT01114672|4666581|P1|Overall Study|Withdrawal by Subject|2
1413347|NCT01114672|4666580|P2|Overall Study|Death|1
1413348|NCT01114672|4666581|P1|Overall Study|Death|0
1413349|NCT01114646|4666589|P2|Overall Study|Withdrawal by Subject|2
1413350|NCT01114646|4666590|P1|Overall Study|Withdrawal by Subject|3
1413351|NCT01114529|4666641|P3|Completed Study Phase at Month 24|Missing|0
1413352|NCT01114529|4666642|P2|Completed Study Phase at Month 24|Missing|0
1413353|NCT01114529|4666643|P1|Completed Study Phase at Month 24|Missing|2
1413354|NCT01114529|4666641|P3|Completed Study Phase at Month 24|Other|0
1413355|NCT01114529|4666642|P2|Completed Study Phase at Month 24|Other|0
1413356|NCT01114529|4666643|P1|Completed Study Phase at Month 24|Other|2
1413357|NCT01114529|4666641|P3|Completed Study Phase at Month 24|Death|4
1413358|NCT01114529|4666642|P2|Completed Study Phase at Month 24|Death|5
1413359|NCT01114529|4666643|P1|Completed Study Phase at Month 24|Death|8
1413360|NCT01114529|4666641|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
1413361|NCT01114529|4666642|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
1413362|NCT01114529|4666643|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
1413363|NCT01114529|4666641|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
1413364|NCT01114529|4666642|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
1413365|NCT01114529|4666643|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
1413366|NCT01114529|4666641|P3|Completed Study Medication at Month 24|Missing|0
1413367|NCT01114529|4666642|P2|Completed Study Medication at Month 24|Missing|0
1413368|NCT01114529|4666643|P1|Completed Study Medication at Month 24|Missing|2
1413369|NCT01114529|4666641|P3|Completed Study Medication at Month 24|Protocol Violation|2
1413370|NCT01114529|4666642|P2|Completed Study Medication at Month 24|Protocol Violation|5
1413371|NCT01114529|4666643|P1|Completed Study Medication at Month 24|Protocol Violation|0
1413372|NCT01114529|4666641|P3|Completed Study Medication at Month 24|Graft loss|0
1413373|NCT01114529|4666642|P2|Completed Study Medication at Month 24|Graft loss|2
1413374|NCT01114529|4666643|P1|Completed Study Medication at Month 24|Graft loss|0
1413375|NCT01114529|4666641|P3|Completed Study Medication at Month 24|Death|2
1413376|NCT01114529|4666642|P2|Completed Study Medication at Month 24|Death|1
1413377|NCT01114529|4666643|P1|Completed Study Medication at Month 24|Death|2
1413378|NCT01114529|4666641|P3|Completed Study Medication at Month 24|Administrative problems|2
1413379|NCT01114529|4666642|P2|Completed Study Medication at Month 24|Administrative problems|1
1413380|NCT01114529|4666643|P1|Completed Study Medication at Month 24|Administrative problems|2
1413381|NCT01114529|4666641|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
1413382|NCT01114529|4666642|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
1413383|NCT01114529|4666643|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
1413384|NCT01114529|4666641|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
1413385|NCT01114529|4666642|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
1413386|NCT01114529|4666643|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
1413387|NCT01114529|4666641|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
1413388|NCT01114529|4666642|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
1413389|NCT01114529|4666643|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
1413390|NCT01114529|4666641|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
1413391|NCT01114529|4666642|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
1413392|NCT01114529|4666643|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
1413393|NCT01114529|4666641|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
1413394|NCT01114529|4666642|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
1413395|NCT01114529|4666643|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
1413396|NCT01114529|4666641|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
1413397|NCT01114529|4666642|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
1413398|NCT01114529|4666643|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
1413399|NCT01114529|4666641|P3|Completed Study Medication at Month 24|Adverse Event|17
1413400|NCT01114529|4666642|P2|Completed Study Medication at Month 24|Adverse Event|18
1413401|NCT01114529|4666643|P1|Completed Study Medication at Month 24|Adverse Event|87
1413402|NCT01114516|4666662|P2|Overall Study|Lost to Follow-up|1
1413403|NCT01114516|4666663|P1|Overall Study|Lost to Follow-up|2
1413404|NCT01114438|4666698|P1|Overall Study|Withdrawal by Subject|2
1413405|NCT01114438|4666698|P1|Overall Study|Physician Decision|1
1413406|NCT01114438|4666698|P1|Overall Study|concomitant medication|1
1413407|NCT01114438|4666698|P1|Overall Study|Adverse Event|10
1413408|NCT01114373|4666708|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
1413409|NCT01114373|4666709|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
1413410|NCT01114373|4666708|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
1413411|NCT01114373|4666709|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
1413412|NCT01114373|4666708|P2|Intervention 1 (4 Weeks)|Incarceration|0
1413413|NCT01114373|4666709|P1|Intervention 1 (4 Weeks)|Incarceration|1
1413414|NCT01114373|4666708|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
1413415|NCT01114373|4666709|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
1413416|NCT01114360|4666741|P2|Intervention 1 (4 Weeks)|Physician Decision|1
1413417|NCT01114360|4666742|P1|Intervention 1 (4 Weeks)|Physician Decision|0
1413418|NCT01114217|4666793|P2|Overall Study|Other-Withdrawal by Subject|1
1413419|NCT01114217|4666794|P1|Overall Study|Other-Withdrawal by Subject|1
1413420|NCT01114217|4666793|P2|Overall Study|Other-Lost to Follow-up|0
1413421|NCT01114217|4666794|P1|Overall Study|Other-Lost to Follow-up|1
1413422|NCT01114217|4666793|P2|Overall Study|Other-Site Stopped Communicating|0
1413423|NCT01114217|4666794|P1|Overall Study|Other-Site Stopped Communicating|2
1413424|NCT01114217|4666793|P2|Overall Study|Other-Study Withdrawn|1
1413425|NCT01114217|4666794|P1|Overall Study|Other-Study Withdrawn|1
1413426|NCT01114217|4666793|P2|Overall Study|Other-Study Termination|1
1413427|NCT01114217|4666794|P1|Overall Study|Other-Study Termination|0
1413428|NCT01114217|4666793|P2|Overall Study|Other-Sponsor Decision|12
1413429|NCT01114217|4666794|P1|Overall Study|Other-Sponsor Decision|10
1413430|NCT01114217|4666793|P2|Overall Study|Other-Physician Decision|1
1413431|NCT01114217|4666794|P1|Overall Study|Other-Physician Decision|1
1413432|NCT01114217|4666793|P2|Overall Study|Other-Non Compliance|0
1413433|NCT01114217|4666794|P1|Overall Study|Other-Non Compliance|2
1413434|NCT01114217|4666793|P2|Overall Study|Other-Lack of Efficacy|0
1413435|NCT01114217|4666794|P1|Overall Study|Other-Lack of Efficacy|1
1413436|NCT01114217|4666793|P2|Overall Study|Other-Protocol Violation|3
1413437|NCT01114217|4666794|P1|Overall Study|Other-Protocol Violation|1
1413438|NCT01114217|4666793|P2|Overall Study|Other-Pregnancy|4
1413439|NCT01114217|4666794|P1|Overall Study|Other-Pregnancy|2
1413440|NCT01114217|4666793|P2|Overall Study|Other-Procedure|1
1413441|NCT01114217|4666794|P1|Overall Study|Other-Procedure|1
1413442|NCT01114217|4666793|P2|Overall Study|Other-Early termination|10
1413443|NCT01114217|4666794|P1|Overall Study|Other-Early termination|6
1413444|NCT01114217|4666793|P2|Overall Study|Other-Clerical Error|0
1413445|NCT01114217|4666794|P1|Overall Study|Other-Clerical Error|3
1413446|NCT01114217|4666793|P2|Overall Study|Withdrawal by Subject|28
1413447|NCT01114217|4666794|P1|Overall Study|Withdrawal by Subject|21
1413448|NCT01114217|4666793|P2|Overall Study|Lost to Follow-up|33
1413449|NCT01114217|4666794|P1|Overall Study|Lost to Follow-up|17
1413450|NCT01114217|4666793|P2|Overall Study|Adverse Event|3
1413451|NCT01114217|4666794|P1|Overall Study|Adverse Event|5
1413452|NCT01114204|4666806|P2|Overall Study|Other-Protocol Violation|0
1413453|NCT01114204|4666807|P1|Overall Study|Other-Protocol Violation|1
1413454|NCT01114204|4666806|P2|Overall Study|Other-Participant request|0
1413455|NCT01114204|4666807|P1|Overall Study|Other-Participant request|2
1413456|NCT01114204|4666806|P2|Overall Study|Other-Medical monitor request|0
1413457|NCT01114204|4666807|P1|Overall Study|Other-Medical monitor request|1
1413458|NCT01114204|4666806|P2|Overall Study|Other-Personal reasons|0
1413459|NCT01114204|4666807|P1|Overall Study|Other-Personal reasons|2
1413460|NCT01114204|4666806|P2|Overall Study|Death|0
1413461|NCT01114204|4666807|P1|Overall Study|Death|1
1413462|NCT01114204|4666806|P2|Overall Study|Withdrawal by Subject|6
1413463|NCT01114204|4666807|P1|Overall Study|Withdrawal by Subject|10
1413464|NCT01114204|4666806|P2|Overall Study|Lost to Follow-up|0
1413465|NCT01114204|4666807|P1|Overall Study|Lost to Follow-up|1
1413466|NCT01114204|4666806|P2|Overall Study|Adverse Event|2
1413467|NCT01114204|4666807|P1|Overall Study|Adverse Event|3
1413468|NCT01114139|4666825|P2|Overall Study|Other-Withdrew prior to receiving dose|3
1413469|NCT01114139|4666826|P1|Overall Study|Other-Withdrew prior to receiving dose|1
1413470|NCT01114139|4666825|P2|Overall Study|Other-Physician changed treatment|0
1413471|NCT01114139|4666826|P1|Overall Study|Other-Physician changed treatment|1
1413472|NCT01114139|4666825|P2|Overall Study|Other-Participant went on hospice|1
1413473|NCT01114139|4666826|P1|Overall Study|Other-Participant went on hospice|0
1413474|NCT01114139|4666825|P2|Overall Study|Other-Participant falsified records|1
1413475|NCT01114139|4666826|P1|Overall Study|Other-Participant falsified records|0
1413476|NCT01114139|4666825|P2|Overall Study|Other-Out of window for study drug dose|0
1413477|NCT01114139|4666826|P1|Overall Study|Other-Out of window for study drug dose|1
1413478|NCT01114139|4666825|P2|Overall Study|Other-Protocol Violation|0
1413479|NCT01114139|4666826|P1|Overall Study|Other-Protocol Violation|1
1413480|NCT01114139|4666825|P2|Overall Study|Other-Missed 1 visit|0
1413481|NCT01114139|4666826|P1|Overall Study|Other-Missed 1 visit|1
1413482|NCT01114139|4666825|P2|Overall Study|Withdrawal by Subject|6
1413483|NCT01114139|4666826|P1|Overall Study|Withdrawal by Subject|17
1413484|NCT01114139|4666825|P2|Overall Study|Lost to Follow-up|3
1413485|NCT01114139|4666826|P1|Overall Study|Lost to Follow-up|15
1413486|NCT01114139|4666825|P2|Overall Study|Adverse Event|2
1413487|NCT01114139|4666826|P1|Overall Study|Adverse Event|3
1413488|NCT01113931|4666844|P2|Overall Study|Withdrawal by Subject|0
1413489|NCT01113931|4666845|P1|Overall Study|Withdrawal by Subject|3
1413490|NCT01113931|4666844|P2|Overall Study|Various|4
1413491|NCT01113931|4666845|P1|Overall Study|Various|2
1413492|NCT01113931|4666844|P2|Overall Study|Lost to Follow-up|9
1413493|NCT01113931|4666845|P1|Overall Study|Lost to Follow-up|12
1413494|NCT01113931|4666844|P2|Overall Study|Physician Decision|2
1413495|NCT01113931|4666845|P1|Overall Study|Physician Decision|0
1413496|NCT01113931|4666844|P2|Overall Study|Adverse Event|2
1413497|NCT01113931|4666845|P1|Overall Study|Adverse Event|2
1413498|NCT01113801|4666861|P4|Overall Study|Clinical Endpoint (ESRD)|5
1413499|NCT01113801|4666862|P3|Overall Study|Clinical Endpoint (ESRD)|2
1413500|NCT01113801|4666863|P2|Overall Study|Clinical Endpoint (ESRD)|4
1413501|NCT01113801|4666864|P1|Overall Study|Clinical Endpoint (ESRD)|7
1413502|NCT01113801|4666861|P4|Overall Study|Sponsor Decision|15
1413503|NCT01113801|4666862|P3|Overall Study|Sponsor Decision|20
1413504|NCT01113801|4666863|P2|Overall Study|Sponsor Decision|21
1413505|NCT01113801|4666864|P1|Overall Study|Sponsor Decision|15
1413506|NCT01113801|4666861|P4|Overall Study|Physician Decision|3
1413507|NCT01113801|4666862|P3|Overall Study|Physician Decision|3
1413508|NCT01113801|4666863|P2|Overall Study|Physician Decision|2
1413509|NCT01113801|4666864|P1|Overall Study|Physician Decision|2
1413510|NCT01113801|4666861|P4|Overall Study|Withdrawal by Subject|8
1413511|NCT01113801|4666862|P3|Overall Study|Withdrawal by Subject|7
1413512|NCT01113801|4666863|P2|Overall Study|Withdrawal by Subject|7
1413513|NCT01113801|4666864|P1|Overall Study|Withdrawal by Subject|9
1413514|NCT01113801|4666861|P4|Overall Study|Protocol Violation|0
1413515|NCT01113801|4666862|P3|Overall Study|Protocol Violation|0
1413516|NCT01113801|4666863|P2|Overall Study|Protocol Violation|1
1413517|NCT01113801|4666864|P1|Overall Study|Protocol Violation|0
1413518|NCT01113801|4666861|P4|Overall Study|Death|4
1413519|NCT01113801|4666862|P3|Overall Study|Death|3
1413520|NCT01113801|4666863|P2|Overall Study|Death|5
1413521|NCT01113801|4666864|P1|Overall Study|Death|4
1413522|NCT01113801|4666861|P4|Overall Study|Adverse Event|6
1413523|NCT01113801|4666862|P3|Overall Study|Adverse Event|2
1413524|NCT01113801|4666863|P2|Overall Study|Adverse Event|0
1413525|NCT01113801|4666864|P1|Overall Study|Adverse Event|4
1413526|NCT01113749|4666892|P2|Overall Study|Lost to Follow-up|2
1413527|NCT01113749|4666893|P1|Overall Study|Lost to Follow-up|1
1413528|NCT01113710|4666916|P1|Overall Study|Subject Did Not Receive Neupro|3
1413529|NCT01113710|4666916|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
1413530|NCT01113710|4666916|P1|Overall Study|Lack of Patient's Compliance/Other|1
1413531|NCT01113710|4666916|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
1413532|NCT01113710|4666916|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
1413533|NCT01113710|4666916|P1|Overall Study|Compliance/Efficacy/AE/Other|1
1413534|NCT01113710|4666916|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
1413535|NCT01113710|4666916|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
1413536|NCT01113710|4666916|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
1413537|NCT01113710|4666916|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
1413538|NCT01113710|4666916|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
1413539|NCT01113710|4666916|P1|Overall Study|Lack of Efficacy/Adverse Event|3
1413540|NCT01113710|4666916|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
1413541|NCT01113710|4666916|P1|Overall Study|Lack of Efficacy/Other|4
1413542|NCT01113710|4666916|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
1413543|NCT01113710|4666916|P1|Overall Study|Adverse Event/Other|5
1413544|NCT01113710|4666916|P1|Overall Study|Other|7
1413545|NCT01113710|4666916|P1|Overall Study|Lack of Patient's Compliance|8
1413546|NCT01113710|4666916|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
1413547|NCT01113710|4666916|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
1413548|NCT01113710|4666916|P1|Overall Study|Lost to Follow-up|20
1413549|NCT01113710|4666916|P1|Overall Study|Withdrawal by Subject|28
1413550|NCT01113710|4666916|P1|Overall Study|No Information Available|40
1413551|NCT01113710|4666916|P1|Overall Study|Lack of Efficacy|41
1413552|NCT01113710|4666916|P1|Overall Study|Adverse Event|64
1413553|NCT01113580|4666944|P2|Overall Study|Protocol Violation|0
1413554|NCT01113580|4666945|P1|Overall Study|Protocol Violation|1
1413555|NCT01113541|4666959|P1|Overall Study|Adverse Event|4
1413556|NCT01113541|4666959|P1|Overall Study|Study Terminated by Sponsor|7
1413557|NCT01113541|4666959|P1|Overall Study|Protocol Violation|1
1413558|NCT01113541|4666959|P1|Overall Study|Withdrawal by Subject|1
1413559|NCT01113463|4666992|P1|Overall Study|Physician Decision|5
1413560|NCT01112917|4667022|P2|Overall Study|Unable to Convert Filter|0
1413561|NCT01112917|4667023|P1|Overall Study|Unable to Convert Filter|3
1413562|NCT01112917|4667022|P2|Overall Study|Withdrawal by Subject|3
1413563|NCT01112917|4667023|P1|Overall Study|Withdrawal by Subject|1
1413564|NCT01112917|4667022|P2|Overall Study|Lost to Follow-up|1
1413565|NCT01112917|4667023|P1|Overall Study|Lost to Follow-up|1
1413566|NCT01112917|4667022|P2|Overall Study|Death|11
1413567|NCT01112917|4667023|P1|Overall Study|Death|2
1413568|NCT01112579|4667127|P2|Overall Study|Death|2
1413569|NCT01112579|4667128|P1|Overall Study|Death|0
1413570|NCT01112579|4667127|P2|Overall Study|Missed Visit|1
1413571|NCT01112579|4667128|P1|Overall Study|Missed Visit|1
1413572|NCT01112514|4667138|P1|Overall Study|Lost to Follow-up|1
1413573|NCT01112267|4667183|P2|Overall Study|Participants not receive any study drug|2
1413574|NCT01112267|4667184|P1|Overall Study|Participants not receive any study drug|1
1413575|NCT01112267|4667183|P2|Overall Study|Participants not compliant|2
1413576|NCT01112267|4667184|P1|Overall Study|Participants not compliant|1
1413577|NCT01112267|4667183|P2|Overall Study|Protocol Violation|3
1413578|NCT01112267|4667184|P1|Overall Study|Protocol Violation|5
1413579|NCT01112267|4667183|P2|Overall Study|Withdrawal by Subject|5
1413580|NCT01112267|4667184|P1|Overall Study|Withdrawal by Subject|3
1413581|NCT01112267|4667183|P2|Overall Study|Adverse Event|6
1413582|NCT01112267|4667184|P1|Overall Study|Adverse Event|24
1413583|NCT01112059|4667217|P2|Overall Study|Withdrawal by Subject|0
1413584|NCT01112059|4667218|P1|Overall Study|Withdrawal by Subject|1
1413585|NCT01111851|4667232|P2|Overall Study|All planned PET scans were not obtained.|0
1413586|NCT01111851|4667233|P1|Overall Study|All planned PET scans were not obtained.|2
1413587|NCT01111838|4667245|P1|Overall Study|Other Complicating Disease|1
1413588|NCT01111838|4667245|P1|Overall Study|Clinical deterioration|1
1413589|NCT01111838|4667245|P1|Overall Study|Not Treated|3
1413590|NCT01111838|4667245|P1|Overall Study|Patient Ineligible|2
1413591|NCT01111825|4667253|P4|Overall Study|Discontinuation by Sponsor|20
1413592|NCT01111825|4667254|P3|Overall Study|Discontinuation by Sponsor|0
1413593|NCT01111825|4667255|P2|Overall Study|Discontinuation by Sponsor|0
1413594|NCT01111825|4667256|P1|Overall Study|Discontinuation by Sponsor|0
1413595|NCT01111825|4667253|P4|Overall Study|Disease Progression|0
1413596|NCT01111825|4667254|P3|Overall Study|Disease Progression|0
1413597|NCT01111825|4667255|P2|Overall Study|Disease Progression|0
1413598|NCT01111825|4667256|P1|Overall Study|Disease Progression|1
1413599|NCT01111825|4667253|P4|Overall Study|Adverse Event|0
1413600|NCT01111825|4667254|P3|Overall Study|Adverse Event|4
1413601|NCT01111825|4667255|P2|Overall Study|Adverse Event|1
1413602|NCT01111825|4667256|P1|Overall Study|Adverse Event|2
1413603|NCT01111825|4667253|P4|Overall Study|Lost to Follow-up|1
1413604|NCT01111825|4667254|P3|Overall Study|Lost to Follow-up|3
1413605|NCT01111825|4667255|P2|Overall Study|Lost to Follow-up|0
1413606|NCT01111825|4667256|P1|Overall Study|Lost to Follow-up|0
1413607|NCT01111825|4667253|P4|Overall Study|Withdrawal by Subject|0
1413608|NCT01111825|4667254|P3|Overall Study|Withdrawal by Subject|1
1413609|NCT01111825|4667255|P2|Overall Study|Withdrawal by Subject|0
1413610|NCT01111825|4667256|P1|Overall Study|Withdrawal by Subject|0
1413611|NCT01111526|4667275|P3|Overall Study|GVHD Disease Progression|2
1413612|NCT01111526|4667276|P2|Overall Study|GVHD Disease Progression|1
1413613|NCT01111526|4667277|P1|Overall Study|GVHD Disease Progression|0
1413614|NCT01111461|4667289|P1|Overall Study|Not specified|6
1413615|NCT01111461|4667289|P1|Overall Study|Withdrawal by Subject|1
1413616|NCT01111461|4667289|P1|Overall Study|Lost to Follow-up|1
1413617|NCT01111461|4667289|P1|Overall Study|Participant choice|11
1413618|NCT01111461|4667289|P1|Overall Study|Adverse Event|32
1413619|NCT01111292|4667469|P2|Treatment|Physician Decision|1
1413620|NCT01111292|4667470|P1|Treatment|Physician Decision|1
1413621|NCT01111240|4667476|P1|Overall Study|Not Specified|312
1413622|NCT01111240|4667476|P1|Overall Study|Lack of Efficacy and Adverse Event|19
1413623|NCT01111240|4667476|P1|Overall Study|Lack of Efficacy|545
1413624|NCT01111240|4667476|P1|Overall Study|Adverse Event|190
1413625|NCT01111149|4667506|P3|Overall Study|Withdrawal by Subject|2
1413626|NCT01111149|4667507|P2|Overall Study|Withdrawal by Subject|0
1413627|NCT01111149|4667508|P1|Overall Study|Withdrawal by Subject|1
1413628|NCT01111149|4667506|P3|Overall Study|Protocol Violation|2
1413629|NCT01111149|4667507|P2|Overall Study|Protocol Violation|1
1413630|NCT01111149|4667508|P1|Overall Study|Protocol Violation|1
1413631|NCT01111123|4667584|P2|Maintenance Phase|Lost to Follow-up|2
1413632|NCT01111123|4667585|P1|Maintenance Phase|Lost to Follow-up|0
1413633|NCT01111123|4667584|P2|Open- Label Phase|Failed to be clear or almost cleared|0
1413634|NCT01111123|4667585|P1|Open- Label Phase|Failed to be clear or almost cleared|14
1413635|NCT01110915|4667619|P2|Overall Study|Withdrawal by Subject|1
1413636|NCT01110915|4667620|P1|Overall Study|Withdrawal by Subject|7
1413637|NCT01110915|4667619|P2|Overall Study|Lost to Follow-up|0
1413638|NCT01110915|4667620|P1|Overall Study|Lost to Follow-up|1
1413639|NCT01110915|4667619|P2|Overall Study|Death|1
1413640|NCT01110915|4667620|P1|Overall Study|Death|2
1413641|NCT01110707|4667637|P2|Overall Study|Protocol Violation|3
1413642|NCT01110707|4667638|P1|Overall Study|Protocol Violation|0
1413643|NCT01110408|4667718|P2|Overall Study|Protocol Violation|0
1413644|NCT01110408|4667719|P1|Overall Study|Protocol Violation|1
1413645|NCT01110382|4667739|P2|Overall Study|Protocol Violation|1
1413646|NCT01110382|4667740|P1|Overall Study|Protocol Violation|0
1413647|NCT01110382|4667739|P2|Overall Study|Withdrawal by Subject|1
1413648|NCT01110382|4667740|P1|Overall Study|Withdrawal by Subject|0
1413649|NCT01110330|4667761|P3|Overall Study|Not specified|1
1413650|NCT01110330|4667762|P2|Overall Study|Not specified|1
1413651|NCT01110330|4667763|P1|Overall Study|Not specified|1
1413652|NCT01110330|4667761|P3|Overall Study|Withdrawal by Subject|2
1413653|NCT01110330|4667762|P2|Overall Study|Withdrawal by Subject|6
1413654|NCT01110330|4667763|P1|Overall Study|Withdrawal by Subject|0
1413655|NCT01110330|4667761|P3|Overall Study|Protocol Violation|4
1413656|NCT01110330|4667762|P2|Overall Study|Protocol Violation|0
1413657|NCT01110330|4667763|P1|Overall Study|Protocol Violation|2
1413658|NCT01110330|4667761|P3|Overall Study|Physician Decision|0
1413659|NCT01110330|4667762|P2|Overall Study|Physician Decision|1
1413660|NCT01110330|4667763|P1|Overall Study|Physician Decision|0
1413661|NCT01110330|4667761|P3|Overall Study|Lost to Follow-up|15
1413662|NCT01110330|4667762|P2|Overall Study|Lost to Follow-up|10
1413663|NCT01110330|4667763|P1|Overall Study|Lost to Follow-up|9
1413664|NCT01110330|4667761|P3|Overall Study|Lack of Efficacy|1
1413665|NCT01110330|4667762|P2|Overall Study|Lack of Efficacy|1
1413666|NCT01110330|4667763|P1|Overall Study|Lack of Efficacy|3
1413667|NCT01110330|4667761|P3|Overall Study|Adverse Event|3
1413668|NCT01110330|4667762|P2|Overall Study|Adverse Event|4
1413669|NCT01110330|4667763|P1|Overall Study|Adverse Event|0
1413670|NCT01110239|4667791|P4|7.5 Min Ischemia|Withdrawal by Subject|0
1413671|NCT01110239|4667792|P3|7.5 Min Ischemia|Withdrawal by Subject|1
1413672|NCT01110239|4667793|P2|7.5 Min Ischemia|Withdrawal by Subject|0
1413673|NCT01110239|4667794|P1|7.5 Min Ischemia|Withdrawal by Subject|0
1413674|NCT01110239|4667791|P4|Sham Preconditioning|Withdrawal by Subject|0
1413675|NCT01110239|4667792|P3|Sham Preconditioning|Withdrawal by Subject|1
1413676|NCT01110239|4667793|P2|Sham Preconditioning|Withdrawal by Subject|0
1413677|NCT01110239|4667794|P1|Sham Preconditioning|Withdrawal by Subject|0
1413678|NCT01110200|4667810|P2|Overall Study|Lost to Follow-up|7
1413679|NCT01110200|4667811|P1|Overall Study|Lost to Follow-up|10
1413680|NCT01110200|4667810|P2|Overall Study|Physician Decision|17
1413681|NCT01110200|4667811|P1|Overall Study|Physician Decision|13
1413682|NCT01110200|4667810|P2|Overall Study|Protocol Violation|12
1413683|NCT01110200|4667811|P1|Overall Study|Protocol Violation|14
1413684|NCT01110200|4667810|P2|Overall Study|Lack of Efficacy|25
1413685|NCT01110200|4667811|P1|Overall Study|Lack of Efficacy|16
1413686|NCT01110200|4667810|P2|Overall Study|Withdrawal by Subject|32
1413687|NCT01110200|4667811|P1|Overall Study|Withdrawal by Subject|25
1413688|NCT01110200|4667810|P2|Overall Study|Adverse Event|28
1413689|NCT01110200|4667811|P1|Overall Study|Adverse Event|28
1413690|NCT01110005|4667842|P2|Overall Study|Withdrawal by Subject|1
1413691|NCT01110005|4667843|P1|Overall Study|Withdrawal by Subject|0
1413692|NCT01110005|4667842|P2|Overall Study|missing consent|2
1413693|NCT01110005|4667843|P1|Overall Study|missing consent|3
1413694|NCT01110005|4667842|P2|Overall Study|ineligible|2
1413695|NCT01110005|4667843|P1|Overall Study|ineligible|1
1413696|NCT01109979|4667855|P2|Overall Study|Withdrawal by Subject|1
1413697|NCT01109979|4667856|P1|Overall Study|Withdrawal by Subject|0
1413698|NCT01109979|4667855|P2|Overall Study|Physician Decision|0
1413699|NCT01109979|4667856|P1|Overall Study|Physician Decision|2
1413700|NCT01109849|4667864|P5|Adaptive Randomization: Weight Recovery|moved away|0
1413701|NCT01109849|4667865|P4|Adaptive Randomization: Weight Recovery|moved away|2
1413702|NCT01109849|4667866|P3|Adaptive Randomization: Weight Recovery|moved away|0
1413703|NCT01109849|4667867|P2|Adaptive Randomization: Weight Recovery|moved away|0
1413704|NCT01109849|4667868|P1|Adaptive Randomization: Weight Recovery|moved away|0
1413705|NCT01109849|4667864|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
1413706|NCT01109849|4667865|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
1413707|NCT01109849|4667866|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
1413708|NCT01109849|4667867|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
1413709|NCT01109849|4667868|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
1413710|NCT01109849|4667864|P5|Initial Randomization: ADHD Treatment|move away|0
1413711|NCT01109849|4667865|P4|Initial Randomization: ADHD Treatment|move away|0
1413712|NCT01109849|4667866|P3|Initial Randomization: ADHD Treatment|move away|0
1413713|NCT01109849|4667867|P2|Initial Randomization: ADHD Treatment|move away|7
1413714|NCT01109849|4667868|P1|Initial Randomization: ADHD Treatment|move away|2
1413715|NCT01109849|4667864|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
1413716|NCT01109849|4667865|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
1413717|NCT01109849|4667866|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
1413718|NCT01109849|4667867|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
1413719|NCT01109849|4667868|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
1413720|NCT01109849|4667864|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
1413721|NCT01109849|4667865|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
1413722|NCT01109849|4667866|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
1413723|NCT01109849|4667867|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
1413724|NCT01109849|4667868|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
1413725|NCT01109849|4667864|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
1413726|NCT01109849|4667865|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
1413727|NCT01109849|4667866|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
1413728|NCT01109849|4667867|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
1413729|NCT01109849|4667868|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
1413730|NCT01109524|4667937|P1|Overall Study|Not specified|5
1413731|NCT01109524|4667937|P1|Overall Study|Participant requested to end treatment|4
1413732|NCT01109524|4667937|P1|Overall Study|No longer meets criteria|2
1413733|NCT01109524|4667937|P1|Overall Study|Death|2
1413734|NCT01109524|4667937|P1|Overall Study|Maximum clinical benefit|3
1413735|NCT01109524|4667937|P1|Overall Study|Withdrawal by Subject|2
1413736|NCT01109524|4667937|P1|Overall Study|Adverse Event|4
1413737|NCT01109524|4667937|P1|Overall Study|Study Drug toxicity|6
1413738|NCT01109524|4667937|P1|Overall Study|Disease Progression|29
1413739|NCT01109316|4667959|P3|Study Period 3|Withdrawal by Subject|1
1413740|NCT01109316|4667960|P2|Study Period 3|Withdrawal by Subject|1
1413741|NCT01109316|4667961|P1|Study Period 3|Withdrawal by Subject|0
1413742|NCT01109316|4667959|P3|Study Period 3|Lost to Follow-up|0
1413743|NCT01109316|4667960|P2|Study Period 3|Lost to Follow-up|1
1413744|NCT01109316|4667961|P1|Study Period 3|Lost to Follow-up|0
1413745|NCT01109316|4667959|P3|Study Period 2|Withdrawal by Subject|0
1413746|NCT01109316|4667960|P2|Study Period 2|Withdrawal by Subject|1
1413747|NCT01109316|4667961|P1|Study Period 2|Withdrawal by Subject|1
1413748|NCT01109316|4667959|P3|Study Period 2|Protocol Violation|0
1413749|NCT01109316|4667960|P2|Study Period 2|Protocol Violation|1
1413750|NCT01109316|4667961|P1|Study Period 2|Protocol Violation|0
1413751|NCT01109316|4667959|P3|Study Period 2|Physician Decision|1
1413752|NCT01109316|4667960|P2|Study Period 2|Physician Decision|0
1413753|NCT01109316|4667961|P1|Study Period 2|Physician Decision|0
1413754|NCT01109316|4667959|P3|Study Period 2|Entry Criteria Not Met|1
1413755|NCT01109316|4667960|P2|Study Period 2|Entry Criteria Not Met|0
1413756|NCT01109316|4667961|P1|Study Period 2|Entry Criteria Not Met|0
1413757|NCT01109316|4667959|P3|Study Period 1|Sponsor Decision|2
1413758|NCT01109316|4667960|P2|Study Period 1|Sponsor Decision|0
1413759|NCT01109316|4667961|P1|Study Period 1|Sponsor Decision|0
1413760|NCT01109316|4667959|P3|Study Period 1|Withdrawal by Subject|2
1413761|NCT01109316|4667960|P2|Study Period 1|Withdrawal by Subject|1
1413762|NCT01109316|4667961|P1|Study Period 1|Withdrawal by Subject|0
1413763|NCT01109316|4667959|P3|Study Period 1|Lost to Follow-up|0
1413764|NCT01109316|4667960|P2|Study Period 1|Lost to Follow-up|2
1413765|NCT01109316|4667961|P1|Study Period 1|Lost to Follow-up|0
1413766|NCT01109316|4667959|P3|Study Period 1|Adverse Event|0
1413767|NCT01109316|4667960|P2|Study Period 1|Adverse Event|1
1413768|NCT01109316|4667961|P1|Study Period 1|Adverse Event|0
1413769|NCT01109173|4668009|P4|Overall Study|Not Specifiied|14
1413770|NCT01109173|4668010|P3|Overall Study|Not Specifiied|9
1413771|NCT01109173|4668011|P2|Overall Study|Not Specifiied|4
1413772|NCT01109173|4668012|P1|Overall Study|Not Specifiied|5
1413773|NCT01109173|4668009|P4|Overall Study|Patient Did Not Use Study Medication|7
1413774|NCT01109173|4668010|P3|Overall Study|Patient Did Not Use Study Medication|11
1413775|NCT01109173|4668011|P2|Overall Study|Patient Did Not Use Study Medication|26
1413776|NCT01109173|4668012|P1|Overall Study|Patient Did Not Use Study Medication|34
1413777|NCT01109173|4668009|P4|Overall Study|Protocol Violation|2
1413778|NCT01109173|4668010|P3|Overall Study|Protocol Violation|1
1413779|NCT01109173|4668011|P2|Overall Study|Protocol Violation|5
1413780|NCT01109173|4668012|P1|Overall Study|Protocol Violation|4
1413781|NCT01109173|4668009|P4|Overall Study|Treatment Failure|64
1413782|NCT01109173|4668010|P3|Overall Study|Treatment Failure|69
1413783|NCT01109173|4668011|P2|Overall Study|Treatment Failure|32
1413784|NCT01109173|4668012|P1|Overall Study|Treatment Failure|25
1413785|NCT01109173|4668009|P4|Overall Study|Noncompliance|0
1413786|NCT01109173|4668010|P3|Overall Study|Noncompliance|0
1413787|NCT01109173|4668011|P2|Overall Study|Noncompliance|1
1413788|NCT01109173|4668012|P1|Overall Study|Noncompliance|0
1413789|NCT01109173|4668009|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
1413790|NCT01109173|4668010|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
1413791|NCT01109173|4668011|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
1413792|NCT01109173|4668012|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
1413793|NCT01109173|4668009|P4|Overall Study|Lost to Follow-up|0
1413794|NCT01109173|4668010|P3|Overall Study|Lost to Follow-up|0
1413795|NCT01109173|4668011|P2|Overall Study|Lost to Follow-up|1
1413796|NCT01109173|4668012|P1|Overall Study|Lost to Follow-up|0
1413797|NCT01109173|4668009|P4|Overall Study|Adverse Event|6
1413798|NCT01109173|4668010|P3|Overall Study|Adverse Event|9
1413799|NCT01109173|4668011|P2|Overall Study|Adverse Event|17
1413800|NCT01109173|4668012|P1|Overall Study|Adverse Event|15
1413801|NCT01108809|4668118|P1|Overall Study|Lost to Follow-up|1
1413802|NCT01108809|4668118|P1|Overall Study|Adverse Event|3
1413803|NCT01108796|4668135|P2|Overall Study|Lost to Follow-up|6
1413804|NCT01108796|4668136|P1|Overall Study|Lost to Follow-up|7
1413805|NCT01108796|4668135|P2|Overall Study|Adverse Event|1
1413806|NCT01108796|4668136|P1|Overall Study|Adverse Event|0
1413807|NCT01108731|4668179|P2|Overall Study|Adverse Event|3
1413808|NCT01108731|4668180|P1|Overall Study|Adverse Event|3
1413809|NCT01108731|4668179|P2|Overall Study|Withdrawal by Subject|1
1413810|NCT01108731|4668180|P1|Overall Study|Withdrawal by Subject|1
1413811|NCT01108718|4668192|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
1413812|NCT01108718|4668193|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
1413813|NCT01108523|4668198|P1|Overall Study|Protocol Violation|4
1413814|NCT01108510|4668205|P2|Overall Study|Death|1
1413815|NCT01108510|4668206|P1|Overall Study|Death|1
1413816|NCT01108510|4668205|P2|Overall Study|Pregnancy|3
1413817|NCT01108510|4668206|P1|Overall Study|Pregnancy|0
1413818|NCT01108510|4668205|P2|Overall Study|Lack of Efficacy|0
1413819|NCT01108510|4668206|P1|Overall Study|Lack of Efficacy|3
1413820|NCT01108510|4668205|P2|Overall Study|Participant Noncompliance|7
1413821|NCT01108510|4668206|P1|Overall Study|Participant Noncompliance|5
1413822|NCT01108510|4668205|P2|Overall Study|Investigator’s Discretion|10
1413823|NCT01108510|4668206|P1|Overall Study|Investigator’s Discretion|12
1413824|NCT01108510|4668205|P2|Overall Study|Withdrew Consent|15
1413825|NCT01108510|4668206|P1|Overall Study|Withdrew Consent|21
1413826|NCT01108510|4668205|P2|Overall Study|Lost to Follow-up|17
1413827|NCT01108510|4668206|P1|Overall Study|Lost to Follow-up|20
1413828|NCT01108510|4668205|P2|Overall Study|Adverse Event|19
1413829|NCT01108510|4668206|P1|Overall Study|Adverse Event|26
1413830|NCT01108510|4668205|P2|Overall Study|Joined Another Gilead-sponsored Study|195
1413831|NCT01108510|4668206|P1|Overall Study|Joined Another Gilead-sponsored Study|186
1413832|NCT01108510|4668205|P2|Overall Study|Randomized but Not Treated|1
1413833|NCT01108510|4668206|P1|Overall Study|Randomized but Not Treated|5
1413834|NCT01108458|4668226|P1|Overall Study|Withdrawal by Subject|1
1413835|NCT01108341|4668278|P1|Overall Study|not specified|1
1413836|NCT01108341|4668278|P1|Overall Study|Lost to Follow-up|1
1413837|NCT01108341|4668278|P1|Overall Study|Withdrawal by Subject|1
1413838|NCT01108341|4668278|P1|Overall Study|Death|2
1413839|NCT01108263|4668285|P2|Overall Study|Adverse Event|1
1413840|NCT01108263|4668286|P1|Overall Study|Adverse Event|0
1413841|NCT01108237|4668296|P2|Overall Study|Did not meet criteria for analysis|0
1413842|NCT01108237|4668297|P1|Overall Study|Did not meet criteria for analysis|7
1413843|NCT01108237|4668296|P2|Overall Study|No alignment data|17
1413844|NCT01108237|4668297|P1|Overall Study|No alignment data|2
1413845|NCT01108185|4668303|P1|Overall Study|Lost to Follow-up|12
1413846|NCT01108185|4668303|P1|Overall Study|Non-compliance|15
1413847|NCT01108068|4668339|P2|Overall Study|5 not started, 1 stop due to side effect|0
1413848|NCT01108068|4668340|P1|Overall Study|5 not started, 1 stop due to side effect|6
1413849|NCT01108055|4668347|P1|Overall Study|Not evaluable- didn't complete treatment|4
1413850|NCT01108055|4668347|P1|Overall Study|Ineligible|11
1413851|NCT01107925|4668385|P6|Period 2|Withdrawal by Subject|1
1413852|NCT01107925|4668386|P5|Period 2|Withdrawal by Subject|0
1413853|NCT01107925|4668387|P4|Period 2|Withdrawal by Subject|0
1413854|NCT01107925|4668388|P3|Period 2|Withdrawal by Subject|0
1413855|NCT01107925|4668389|P2|Period 2|Withdrawal by Subject|1
1413856|NCT01107925|4668390|P1|Period 2|Withdrawal by Subject|0
1413857|NCT01107925|4668385|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
1413858|NCT01107925|4668386|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
1413859|NCT01107925|4668387|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
1413860|NCT01107925|4668388|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
1413861|NCT01107925|4668389|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
1413862|NCT01107925|4668390|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
1413863|NCT01107912|4668428|P6|Period 3|Withdrawal by Subject|0
1413864|NCT01107912|4668429|P5|Period 3|Withdrawal by Subject|0
1413865|NCT01107912|4668430|P4|Period 3|Withdrawal by Subject|1
1413866|NCT01107912|4668431|P3|Period 3|Withdrawal by Subject|0
1413867|NCT01107912|4668432|P2|Period 3|Withdrawal by Subject|0
1413868|NCT01107912|4668433|P1|Period 3|Withdrawal by Subject|0
1413869|NCT01107912|4668428|P6|Period 3|Adverse Event|0
1413870|NCT01107912|4668429|P5|Period 3|Adverse Event|0
1413871|NCT01107912|4668430|P4|Period 3|Adverse Event|0
1413872|NCT01107912|4668431|P3|Period 3|Adverse Event|1
1413873|NCT01107912|4668432|P2|Period 3|Adverse Event|1
1413874|NCT01107912|4668433|P1|Period 3|Adverse Event|0
1413875|NCT01107912|4668428|P6|Period 2|Physician Decision|0
1413876|NCT01107912|4668429|P5|Period 2|Physician Decision|0
1413877|NCT01107912|4668430|P4|Period 2|Physician Decision|0
1413878|NCT01107912|4668431|P3|Period 2|Physician Decision|1
1413879|NCT01107912|4668432|P2|Period 2|Physician Decision|0
1413880|NCT01107912|4668433|P1|Period 2|Physician Decision|0
1413881|NCT01107912|4668428|P6|Period 1|Withdrawal by Subject|0
1413882|NCT01107912|4668429|P5|Period 1|Withdrawal by Subject|0
1413883|NCT01107912|4668430|P4|Period 1|Withdrawal by Subject|0
1413884|NCT01107912|4668431|P3|Period 1|Withdrawal by Subject|0
1413885|NCT01107912|4668432|P2|Period 1|Withdrawal by Subject|0
1413886|NCT01107912|4668433|P1|Period 1|Withdrawal by Subject|1
1413887|NCT01107912|4668428|P6|Period 1|Physician Decision|0
1413888|NCT01107912|4668429|P5|Period 1|Physician Decision|1
1413889|NCT01107912|4668430|P4|Period 1|Physician Decision|0
1413890|NCT01107912|4668431|P3|Period 1|Physician Decision|0
1413891|NCT01107912|4668432|P2|Period 1|Physician Decision|0
1413892|NCT01107912|4668433|P1|Period 1|Physician Decision|0
1413893|NCT01107912|4668428|P6|Period 1|Adverse Event|0
1413894|NCT01107912|4668429|P5|Period 1|Adverse Event|2
1413895|NCT01107912|4668430|P4|Period 1|Adverse Event|0
1413896|NCT01107912|4668431|P3|Period 1|Adverse Event|0
1413897|NCT01107912|4668432|P2|Period 1|Adverse Event|0
1413898|NCT01107912|4668433|P1|Period 1|Adverse Event|0
1413899|NCT01107899|4668470|P3|Overall Study|Withdrawal by Subject|1
1413900|NCT01107899|4668471|P2|Overall Study|Withdrawal by Subject|0
1413901|NCT01107899|4668472|P1|Overall Study|Withdrawal by Subject|0
1413902|NCT01107899|4668470|P3|Overall Study|Physician Decision|3
1413903|NCT01107899|4668471|P2|Overall Study|Physician Decision|0
1413904|NCT01107899|4668472|P1|Overall Study|Physician Decision|5
1413905|NCT01107886|4668518|P2|Overall Study|Administrative withdrawal of consent|5
1413906|NCT01107886|4668519|P1|Overall Study|Administrative withdrawal of consent|7
1413907|NCT01107886|4668518|P2|Overall Study|Withdrawal by Subject|196
1413908|NCT01107886|4668519|P1|Overall Study|Withdrawal by Subject|180
1413909|NCT01107886|4668518|P2|Overall Study|Lost to Follow-up|13
1413910|NCT01107886|4668519|P1|Overall Study|Lost to Follow-up|15
1413911|NCT01107743|4668548|P1|Overall Study|Protocol Violation|46
1413912|NCT01107535|4668647|P1|Overall Study|Death|5
1413913|NCT01107457|4668660|P6|Part B and C|Clinical Relapse|4
1413914|NCT01107457|4668661|P5|Part B and C|Clinical Relapse|0
1413915|NCT01107457|4668662|P4|Part B and C|Clinical Relapse|0
1413916|NCT01107457|4668663|P3|Part B and C|Clinical Relapse|0
1413917|NCT01107457|4668664|P2|Part B and C|Clinical Relapse|0
1413918|NCT01107457|4668665|P1|Part B and C|Clinical Relapse|0
1413919|NCT01107457|4668660|P6|Part B and C|Withdrawal by Subject|16
1413920|NCT01107457|4668661|P5|Part B and C|Withdrawal by Subject|0
1413921|NCT01107457|4668662|P4|Part B and C|Withdrawal by Subject|0
1413922|NCT01107457|4668663|P3|Part B and C|Withdrawal by Subject|0
1413923|NCT01107457|4668664|P2|Part B and C|Withdrawal by Subject|0
1413924|NCT01107457|4668665|P1|Part B and C|Withdrawal by Subject|0
1413925|NCT01107457|4668660|P6|Part B and C|Sponsor Decision|66
1413926|NCT01107457|4668661|P5|Part B and C|Sponsor Decision|0
1413927|NCT01107457|4668662|P4|Part B and C|Sponsor Decision|0
1413928|NCT01107457|4668663|P3|Part B and C|Sponsor Decision|0
1413929|NCT01107457|4668664|P2|Part B and C|Sponsor Decision|0
1413930|NCT01107457|4668665|P1|Part B and C|Sponsor Decision|0
1413931|NCT01107457|4668660|P6|Part B and C|Protocol Violation|1
1413932|NCT01107457|4668661|P5|Part B and C|Protocol Violation|0
1413933|NCT01107457|4668662|P4|Part B and C|Protocol Violation|0
1413934|NCT01107457|4668663|P3|Part B and C|Protocol Violation|0
1413935|NCT01107457|4668664|P2|Part B and C|Protocol Violation|0
1413936|NCT01107457|4668665|P1|Part B and C|Protocol Violation|0
1413937|NCT01107457|4668660|P6|Part B and C|Lost to Follow-up|10
1413938|NCT01107457|4668661|P5|Part B and C|Lost to Follow-up|0
1413939|NCT01107457|4668662|P4|Part B and C|Lost to Follow-up|0
1413940|NCT01107457|4668663|P3|Part B and C|Lost to Follow-up|0
1413941|NCT01107457|4668664|P2|Part B and C|Lost to Follow-up|0
1413942|NCT01107457|4668665|P1|Part B and C|Lost to Follow-up|0
1413943|NCT01107457|4668660|P6|Part B and C|Lack of Efficacy|7
1413944|NCT01107457|4668661|P5|Part B and C|Lack of Efficacy|0
1413945|NCT01107457|4668662|P4|Part B and C|Lack of Efficacy|0
1413946|NCT01107457|4668663|P3|Part B and C|Lack of Efficacy|0
1413947|NCT01107457|4668664|P2|Part B and C|Lack of Efficacy|0
1413948|NCT01107457|4668665|P1|Part B and C|Lack of Efficacy|0
1413949|NCT01107457|4668660|P6|Part B and C|Physician Decision|3
1413950|NCT01107457|4668661|P5|Part B and C|Physician Decision|0
1413951|NCT01107457|4668662|P4|Part B and C|Physician Decision|0
1413952|NCT01107457|4668663|P3|Part B and C|Physician Decision|0
1413953|NCT01107457|4668664|P2|Part B and C|Physician Decision|0
1413954|NCT01107457|4668665|P1|Part B and C|Physician Decision|0
1413955|NCT01107457|4668660|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
1413956|NCT01107457|4668661|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
1413957|NCT01107457|4668662|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
1413958|NCT01107457|4668663|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
1413959|NCT01107457|4668664|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
1413960|NCT01107457|4668665|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
1413961|NCT01107457|4668660|P6|Part B and C|Adverse Event|12
1413962|NCT01107457|4668661|P5|Part B and C|Adverse Event|0
1413963|NCT01107457|4668662|P4|Part B and C|Adverse Event|0
1413964|NCT01107457|4668663|P3|Part B and C|Adverse Event|0
1413965|NCT01107457|4668664|P2|Part B and C|Adverse Event|0
1413966|NCT01107457|4668665|P1|Part B and C|Adverse Event|0
1413967|NCT01107457|4668660|P6|Part A|Protocol Violation|0
1413968|NCT01107457|4668661|P5|Part A|Protocol Violation|0
1413969|NCT01107457|4668662|P4|Part A|Protocol Violation|0
1413970|NCT01107457|4668663|P3|Part A|Protocol Violation|0
1413971|NCT01107457|4668664|P2|Part A|Protocol Violation|1
1413972|NCT01107457|4668665|P1|Part A|Protocol Violation|0
1413973|NCT01107457|4668660|P6|Part A|Lack of Efficacy|0
1413974|NCT01107457|4668661|P5|Part A|Lack of Efficacy|0
1413975|NCT01107457|4668662|P4|Part A|Lack of Efficacy|0
1413976|NCT01107457|4668663|P3|Part A|Lack of Efficacy|0
1413977|NCT01107457|4668664|P2|Part A|Lack of Efficacy|0
1413978|NCT01107457|4668665|P1|Part A|Lack of Efficacy|1
1413979|NCT01107457|4668660|P6|Part A|Lost to Follow-up|0
1413980|NCT01107457|4668661|P5|Part A|Lost to Follow-up|0
1413981|NCT01107457|4668662|P4|Part A|Lost to Follow-up|0
1413982|NCT01107457|4668663|P3|Part A|Lost to Follow-up|0
1413983|NCT01107457|4668664|P2|Part A|Lost to Follow-up|1
1413984|NCT01107457|4668665|P1|Part A|Lost to Follow-up|0
1413985|NCT01107457|4668660|P6|Part A|Withdrawal by Subject|0
1413986|NCT01107457|4668661|P5|Part A|Withdrawal by Subject|1
1413987|NCT01107457|4668662|P4|Part A|Withdrawal by Subject|3
1413988|NCT01107457|4668663|P3|Part A|Withdrawal by Subject|0
1413989|NCT01107457|4668664|P2|Part A|Withdrawal by Subject|3
1413990|NCT01107457|4668665|P1|Part A|Withdrawal by Subject|3
1413991|NCT01107457|4668660|P6|Part A|Adverse Event|0
1413992|NCT01107457|4668661|P5|Part A|Adverse Event|0
1413993|NCT01107457|4668662|P4|Part A|Adverse Event|0
1413994|NCT01107457|4668663|P3|Part A|Adverse Event|1
1413995|NCT01107457|4668664|P2|Part A|Adverse Event|2
1413996|NCT01107457|4668665|P1|Part A|Adverse Event|1
1413997|NCT01107418|4668795|P1|Overall Study|Entered Extension Study|1
1413998|NCT01107418|4668795|P1|Overall Study|Started Other Therapy|1
1413999|NCT01107418|4668795|P1|Overall Study|Study Closing|1
1414000|NCT01107418|4668795|P1|Overall Study|Withdrawal by Subject|1
1414001|NCT01107418|4668795|P1|Overall Study|Adverse Event|3
1414002|NCT01107418|4668795|P1|Overall Study|Disease Progression|45
1414003|NCT01107405|4668868|P5|Overall Study|Protocol Violation|0
1414004|NCT01107405|4668869|P4|Overall Study|Protocol Violation|1
1414005|NCT01107405|4668870|P3|Overall Study|Protocol Violation|1
1414006|NCT01107405|4668871|P2|Overall Study|Protocol Violation|0
1414007|NCT01107405|4668872|P1|Overall Study|Protocol Violation|0
1414008|NCT01107405|4668868|P5|Overall Study|Withdrawal by Subject|1
1414009|NCT01107405|4668869|P4|Overall Study|Withdrawal by Subject|2
1414010|NCT01107405|4668870|P3|Overall Study|Withdrawal by Subject|1
1414011|NCT01107405|4668871|P2|Overall Study|Withdrawal by Subject|0
1414012|NCT01107405|4668872|P1|Overall Study|Withdrawal by Subject|1
1414013|NCT01107405|4668868|P5|Overall Study|Adverse Event|2
1414014|NCT01107405|4668869|P4|Overall Study|Adverse Event|0
1414015|NCT01107405|4668870|P3|Overall Study|Adverse Event|0
1414016|NCT01107405|4668871|P2|Overall Study|Adverse Event|1
1414017|NCT01107405|4668872|P1|Overall Study|Adverse Event|1
1414018|NCT01107392|4668911|P2|Overall Study|Administrative decision|0
1414019|NCT01107392|4668912|P1|Overall Study|Administrative decision|1
1414020|NCT01107392|4668911|P2|Overall Study|Personal Reasons|3
1414021|NCT01107392|4668912|P1|Overall Study|Personal Reasons|2
1414022|NCT01107392|4668911|P2|Overall Study|Adverse Event|0
1414023|NCT01107392|4668912|P1|Overall Study|Adverse Event|2
1414024|NCT01107379|4668924|P1|Overall Study|Lost to Follow-up|3
1414025|NCT01107379|4668924|P1|Overall Study|Withdrawal by Subject|18
1414026|NCT01107353|4668935|P2|Overall Study|Positive Drug Screen|0
1414027|NCT01107353|4668936|P1|Overall Study|Positive Drug Screen|1
1414028|NCT01107197|4668944|P2|Overall Study|Withdrawal by Subject|5
1414029|NCT01107197|4668945|P1|Overall Study|Withdrawal by Subject|3
1414030|NCT01107197|4668944|P2|Overall Study|Lost to Follow-up|8
1414031|NCT01107197|4668945|P1|Overall Study|Lost to Follow-up|5
1414032|NCT01107197|4668944|P2|Overall Study|Death|10
1414033|NCT01107197|4668945|P1|Overall Study|Death|12
1414034|NCT01106976|4668980|P1|Overall Study|Lost to Follow-up|8
1414035|NCT01106911|4668994|P1|Overall Study|deemed ineligible after screening|3
1414036|NCT01106911|4668994|P1|Overall Study|Physician Decision|2
1414037|NCT01106898|4668998|P1|Overall Study|Adverse Event|6
1414038|NCT01106846|4669043|P2|Overall Study|Change in surgical procedure|1
1414039|NCT01106846|4669044|P1|Overall Study|Change in surgical procedure|0
1414040|NCT01106690|4669094|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1414041|NCT01106690|4669095|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1414042|NCT01106690|4669096|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
1414043|NCT01106690|4669094|P3|Extension Period: Week 26 to Week 52|Not specified|4
1414044|NCT01106690|4669095|P2|Extension Period: Week 26 to Week 52|Not specified|3
1414045|NCT01106690|4669096|P1|Extension Period: Week 26 to Week 52|Not specified|8
1414046|NCT01106690|4669094|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1414047|NCT01106690|4669095|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
1414048|NCT01106690|4669096|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
1414049|NCT01106690|4669094|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
1414050|NCT01106690|4669095|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
1414051|NCT01106690|4669096|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
1414052|NCT01106690|4669094|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
1414053|NCT01106690|4669095|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
1414054|NCT01106690|4669096|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
1414055|NCT01106690|4669094|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1414056|NCT01106690|4669095|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1414057|NCT01106690|4669096|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1414058|NCT01106690|4669094|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
1414059|NCT01106690|4669095|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
1414060|NCT01106690|4669096|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
1414061|NCT01106690|4669094|P3|Core Period: Baseline to Week 26|Not specified|6
1414062|NCT01106690|4669095|P2|Core Period: Baseline to Week 26|Not specified|2
1414063|NCT01106690|4669096|P1|Core Period: Baseline to Week 26|Not specified|10
1414064|NCT01106690|4669094|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
1414065|NCT01106690|4669095|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
1414066|NCT01106690|4669096|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
1414067|NCT01106690|4669094|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1414068|NCT01106690|4669095|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1414069|NCT01106690|4669096|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
1414070|NCT01106690|4669094|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1414071|NCT01106690|4669095|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
1414072|NCT01106690|4669096|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1414073|NCT01106690|4669094|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
1414074|NCT01106690|4669095|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
1414075|NCT01106690|4669096|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
1414076|NCT01106690|4669094|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
1414077|NCT01106690|4669095|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
1414078|NCT01106690|4669096|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
1414079|NCT01106690|4669094|P3|Core Period: Baseline to Week 26|Protocol Violation|0
1414080|NCT01106690|4669095|P2|Core Period: Baseline to Week 26|Protocol Violation|0
1414081|NCT01106690|4669096|P1|Core Period: Baseline to Week 26|Protocol Violation|1
1414082|NCT01106690|4669094|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
1414083|NCT01106690|4669095|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
1414084|NCT01106690|4669096|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
1414085|NCT01106690|4669094|P3|Core Period: Baseline to Week 26|Adverse Event|4
1414086|NCT01106690|4669095|P2|Core Period: Baseline to Week 26|Adverse Event|1
1414087|NCT01106690|4669096|P1|Core Period: Baseline to Week 26|Adverse Event|6
1414088|NCT01106677|4669132|P4|Extension Period: Week 26 to Week 52|Not specified|5
1414089|NCT01106677|4669133|P3|Extension Period: Week 26 to Week 52|Not specified|8
1414090|NCT01106677|4669134|P2|Extension Period: Week 26 to Week 52|Not specified|5
1414091|NCT01106677|4669135|P1|Extension Period: Week 26 to Week 52|Not specified|6
1414092|NCT01106677|4669132|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
1414093|NCT01106677|4669133|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1414094|NCT01106677|4669134|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1414095|NCT01106677|4669135|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1414096|NCT01106677|4669132|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
1414097|NCT01106677|4669133|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
1414098|NCT01106677|4669134|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
1414099|NCT01106677|4669135|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
1414100|NCT01106677|4669132|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1414101|NCT01106677|4669133|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
1414102|NCT01106677|4669134|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
1414103|NCT01106677|4669135|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1414104|NCT01106677|4669132|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
1414105|NCT01106677|4669133|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
1414106|NCT01106677|4669134|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
1414107|NCT01106677|4669135|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
1414108|NCT01106677|4669132|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
1414109|NCT01106677|4669133|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
1414110|NCT01106677|4669134|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
1414111|NCT01106677|4669135|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
1414112|NCT01106677|4669132|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
1414113|NCT01106677|4669133|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
1414114|NCT01106677|4669134|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
1414115|NCT01106677|4669135|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1414116|NCT01106677|4669132|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
1414117|NCT01106677|4669133|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
1414118|NCT01106677|4669134|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
1414119|NCT01106677|4669135|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
1414120|NCT01106677|4669132|P4|Extension Period: Week 26 to Week 52|Death|1
1414121|NCT01106677|4669133|P3|Extension Period: Week 26 to Week 52|Death|0
1414122|NCT01106677|4669134|P2|Extension Period: Week 26 to Week 52|Death|0
1414123|NCT01106677|4669135|P1|Extension Period: Week 26 to Week 52|Death|0
1414124|NCT01106677|4669132|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
1414125|NCT01106677|4669133|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
1414126|NCT01106677|4669134|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
1414127|NCT01106677|4669135|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
1414128|NCT01106677|4669132|P4|Core Period: Baseline to Week 26|Pregnancy|0
1414129|NCT01106677|4669133|P3|Core Period: Baseline to Week 26|Pregnancy|0
1414130|NCT01106677|4669134|P2|Core Period: Baseline to Week 26|Pregnancy|1
1414131|NCT01106677|4669135|P1|Core Period: Baseline to Week 26|Pregnancy|0
1414132|NCT01106677|4669132|P4|Core Period: Baseline to Week 26|Not specified|23
1414133|NCT01106677|4669133|P3|Core Period: Baseline to Week 26|Not specified|8
1414134|NCT01106677|4669134|P2|Core Period: Baseline to Week 26|Not specified|14
1414135|NCT01106677|4669135|P1|Core Period: Baseline to Week 26|Not specified|8
1414136|NCT01106677|4669132|P4|Core Period: Baseline to Week 26|Product quality complaint|0
1414137|NCT01106677|4669133|P3|Core Period: Baseline to Week 26|Product quality complaint|1
1414138|NCT01106677|4669134|P2|Core Period: Baseline to Week 26|Product quality complaint|1
1414139|NCT01106677|4669135|P1|Core Period: Baseline to Week 26|Product quality complaint|0
1414140|NCT01106677|4669132|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
1414141|NCT01106677|4669133|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
1414142|NCT01106677|4669134|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
1414143|NCT01106677|4669135|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
1414144|NCT01106677|4669132|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1414145|NCT01106677|4669133|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1414146|NCT01106677|4669134|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
1414147|NCT01106677|4669135|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
1414148|NCT01106677|4669132|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
1414149|NCT01106677|4669133|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
1414150|NCT01106677|4669134|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
1414151|NCT01106677|4669135|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
1414152|NCT01106677|4669132|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
1414153|NCT01106677|4669133|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
1414154|NCT01106677|4669134|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
1414155|NCT01106677|4669135|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
1414156|NCT01106677|4669132|P4|Core Period: Baseline to Week 26|Protocol Violation|3
1414157|NCT01106677|4669133|P3|Core Period: Baseline to Week 26|Protocol Violation|0
1414158|NCT01106677|4669134|P2|Core Period: Baseline to Week 26|Protocol Violation|1
1414159|NCT01106677|4669135|P1|Core Period: Baseline to Week 26|Protocol Violation|0
1414160|NCT01106677|4669132|P4|Core Period: Baseline to Week 26|Physician Decision|1
1414161|NCT01106677|4669133|P3|Core Period: Baseline to Week 26|Physician Decision|3
1414162|NCT01106677|4669134|P2|Core Period: Baseline to Week 26|Physician Decision|1
1414163|NCT01106677|4669135|P1|Core Period: Baseline to Week 26|Physician Decision|2
1414164|NCT01106677|4669132|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
1414165|NCT01106677|4669133|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
1414166|NCT01106677|4669134|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
1414167|NCT01106677|4669135|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
1414168|NCT01106677|4669132|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
1414169|NCT01106677|4669133|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
1414170|NCT01106677|4669134|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
1414171|NCT01106677|4669135|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
1414172|NCT01106677|4669132|P4|Core Period: Baseline to Week 26|Death|0
1414173|NCT01106677|4669133|P3|Core Period: Baseline to Week 26|Death|1
1414174|NCT01106677|4669134|P2|Core Period: Baseline to Week 26|Death|0
1414175|NCT01106677|4669135|P1|Core Period: Baseline to Week 26|Death|0
1414176|NCT01106677|4669132|P4|Core Period: Baseline to Week 26|Adverse Event|8
1414177|NCT01106677|4669133|P3|Core Period: Baseline to Week 26|Adverse Event|6
1414178|NCT01106677|4669134|P2|Core Period: Baseline to Week 26|Adverse Event|18
1414179|NCT01106677|4669135|P1|Core Period: Baseline to Week 26|Adverse Event|7
1414180|NCT01106651|4669198|P3|Overall Study|Death|0
1414181|NCT01106651|4669199|P2|Overall Study|Death|3
1414182|NCT01106651|4669200|P1|Overall Study|Death|0
1414183|NCT01106651|4669198|P3|Overall Study|Not specified|21
1414184|NCT01106651|4669199|P2|Overall Study|Not specified|31
1414185|NCT01106651|4669200|P1|Overall Study|Not specified|34
1414186|NCT01106651|4669198|P3|Overall Study|Noncompliance with study drug|2
1414187|NCT01106651|4669199|P2|Overall Study|Noncompliance with study drug|0
1414188|NCT01106651|4669200|P1|Overall Study|Noncompliance with study drug|1
1414189|NCT01106651|4669198|P3|Overall Study|Withdrawal by Subject|4
1414190|NCT01106651|4669199|P2|Overall Study|Withdrawal by Subject|7
1414191|NCT01106651|4669200|P1|Overall Study|Withdrawal by Subject|14
1414192|NCT01106651|4669198|P3|Overall Study|Protocol Violation|1
1414193|NCT01106651|4669199|P2|Overall Study|Protocol Violation|2
1414194|NCT01106651|4669200|P1|Overall Study|Protocol Violation|1
1414195|NCT01106651|4669198|P3|Overall Study|Physician Decision|1
1414196|NCT01106651|4669199|P2|Overall Study|Physician Decision|3
1414197|NCT01106651|4669200|P1|Overall Study|Physician Decision|4
1414198|NCT01106651|4669198|P3|Overall Study|Lost to Follow-up|6
1414199|NCT01106651|4669199|P2|Overall Study|Lost to Follow-up|2
1414200|NCT01106651|4669200|P1|Overall Study|Lost to Follow-up|8
1414201|NCT01106651|4669198|P3|Overall Study|Adverse Event|23
1414202|NCT01106651|4669199|P2|Overall Study|Adverse Event|9
1414203|NCT01106651|4669200|P1|Overall Study|Adverse Event|17
1414204|NCT01106625|4669253|P3|Extension Period: Week 26 to Week 52|Not specified|4
1414205|NCT01106625|4669254|P2|Extension Period: Week 26 to Week 52|Not specified|5
1414206|NCT01106625|4669255|P1|Extension Period: Week 26 to Week 52|Not specified|5
1414207|NCT01106625|4669253|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
1414208|NCT01106625|4669254|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
1414209|NCT01106625|4669255|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
1414210|NCT01106625|4669253|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
1414211|NCT01106625|4669254|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
1414212|NCT01106625|4669255|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
1414213|NCT01106625|4669253|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1414214|NCT01106625|4669254|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1414215|NCT01106625|4669255|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
1414216|NCT01106625|4669253|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
1414217|NCT01106625|4669254|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
1414218|NCT01106625|4669255|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
1414219|NCT01106625|4669253|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
1414220|NCT01106625|4669254|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
1414221|NCT01106625|4669255|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
1414222|NCT01106625|4669253|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
1414223|NCT01106625|4669254|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
1414224|NCT01106625|4669255|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
1414225|NCT01106625|4669253|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
1414226|NCT01106625|4669254|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
1414227|NCT01106625|4669255|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
1414228|NCT01106625|4669253|P3|Core Period: Baseline to Week 26|Not specified|4
1414229|NCT01106625|4669254|P2|Core Period: Baseline to Week 26|Not specified|7
1414230|NCT01106625|4669255|P1|Core Period: Baseline to Week 26|Not specified|8
1414231|NCT01106625|4669253|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1414232|NCT01106625|4669254|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
1414233|NCT01106625|4669255|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
1414234|NCT01106625|4669253|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
1414235|NCT01106625|4669254|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
1414236|NCT01106625|4669255|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
1414237|NCT01106625|4669253|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1414238|NCT01106625|4669254|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
1414239|NCT01106625|4669255|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
1414240|NCT01106625|4669253|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
1414241|NCT01106625|4669254|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
1414242|NCT01106625|4669255|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
1414243|NCT01106625|4669253|P3|Core Period: Baseline to Week 26|Protocol Violation|3
1414244|NCT01106625|4669254|P2|Core Period: Baseline to Week 26|Protocol Violation|1
1414245|NCT01106625|4669255|P1|Core Period: Baseline to Week 26|Protocol Violation|2
1414246|NCT01106625|4669253|P3|Core Period: Baseline to Week 26|Physician Decision|0
1414247|NCT01106625|4669254|P2|Core Period: Baseline to Week 26|Physician Decision|0
1414248|NCT01106625|4669255|P1|Core Period: Baseline to Week 26|Physician Decision|1
1414249|NCT01106625|4669253|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
1414250|NCT01106625|4669254|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
1414251|NCT01106625|4669255|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
1414252|NCT01106625|4669253|P3|Core Period: Baseline to Week 26|Adverse Event|8
1414253|NCT01106625|4669254|P2|Core Period: Baseline to Week 26|Adverse Event|8
1414254|NCT01106625|4669255|P1|Core Period: Baseline to Week 26|Adverse Event|6
1414255|NCT01106586|4669286|P2|Overall Study|Participant Transferred to Another Study|197
1414256|NCT01106586|4669287|P1|Overall Study|Participant Transferred to Another Study|212
1414257|NCT01106586|4669286|P2|Overall Study|Protocol Violation|0
1414258|NCT01106586|4669287|P1|Overall Study|Protocol Violation|1
1414259|NCT01106586|4669286|P2|Overall Study|Participant Noncompliance|10
1414260|NCT01106586|4669287|P1|Overall Study|Participant Noncompliance|12
1414261|NCT01106586|4669286|P2|Overall Study|Lost to Follow-up|20
1414262|NCT01106586|4669287|P1|Overall Study|Lost to Follow-up|24
1414263|NCT01106586|4669286|P2|Overall Study|Withdrew Consent|30
1414264|NCT01106586|4669287|P1|Overall Study|Withdrew Consent|18
1414265|NCT01106586|4669286|P2|Overall Study|Investigator's Discretion|8
1414266|NCT01106586|4669287|P1|Overall Study|Investigator's Discretion|5
1414267|NCT01106586|4669286|P2|Overall Study|Lack of Efficacy|0
1414268|NCT01106586|4669287|P1|Overall Study|Lack of Efficacy|1
1414269|NCT01106586|4669286|P2|Overall Study|Pregnancy|2
1414270|NCT01106586|4669287|P1|Overall Study|Pregnancy|2
1414271|NCT01106586|4669286|P2|Overall Study|Death|3
1414272|NCT01106586|4669287|P1|Overall Study|Death|1
1414273|NCT01106586|4669286|P2|Overall Study|Adverse Event|15
1414274|NCT01106586|4669287|P1|Overall Study|Adverse Event|9
1414275|NCT01106534|4669305|P1|Overall Study|Physician Decision|1
1414276|NCT01106534|4669305|P1|Overall Study|Death|16
1414277|NCT01106534|4669305|P1|Overall Study|Lost to Follow-up|2
1414278|NCT01106534|4669305|P1|Overall Study|Withdrawal by Subject|18
1414279|NCT01106430|4669337|P2|Overall Study|Withdrawal by Subject|4
1414280|NCT01106430|4669338|P1|Overall Study|Withdrawal by Subject|8
1414281|NCT01106430|4669337|P2|Overall Study|Protocol Violation|2
1414282|NCT01106430|4669338|P1|Overall Study|Protocol Violation|7
1414283|NCT01106430|4669337|P2|Overall Study|Previous Use Of Marijuana|0
1414284|NCT01106430|4669338|P1|Overall Study|Previous Use Of Marijuana|1
1414285|NCT01106430|4669337|P2|Overall Study|Hard Time Swallowing The Pills|0
1414286|NCT01106430|4669338|P1|Overall Study|Hard Time Swallowing The Pills|1
1414287|NCT01106430|4669337|P2|Overall Study|Noncompliance|1
1414288|NCT01106430|4669338|P1|Overall Study|Noncompliance|0
1414289|NCT01106430|4669337|P2|Overall Study|Refused To Take Medication|1
1414290|NCT01106430|4669338|P1|Overall Study|Refused To Take Medication|0
1414291|NCT01106430|4669337|P2|Overall Study|Moved Out Of State|1
1414292|NCT01106430|4669338|P1|Overall Study|Moved Out Of State|0
1414293|NCT01106430|4669337|P2|Overall Study|Early Termination Requested By Sponsor|0
1414294|NCT01106430|4669338|P1|Overall Study|Early Termination Requested By Sponsor|1
1414295|NCT01106430|4669337|P2|Overall Study|Lost to Follow-up|1
1414296|NCT01106430|4669338|P1|Overall Study|Lost to Follow-up|5
1414297|NCT01106430|4669337|P2|Overall Study|Lack of Efficacy|13
1414298|NCT01106430|4669338|P1|Overall Study|Lack of Efficacy|2
1414299|NCT01106430|4669337|P2|Overall Study|Adverse Event|10
1414300|NCT01106430|4669338|P1|Overall Study|Adverse Event|8
1414301|NCT01106404|4669360|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
1414302|NCT01106404|4669361|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
1414303|NCT01106404|4669360|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
1414304|NCT01106404|4669361|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
1414305|NCT01106404|4669360|P2|Period I (First 6 Weeks)|Physician Decision|0
1414306|NCT01106404|4669361|P1|Period I (First 6 Weeks)|Physician Decision|1
1414307|NCT01106404|4669360|P2|Period I (First 6 Weeks)|Adverse Event|0
1414308|NCT01106404|4669361|P1|Period I (First 6 Weeks)|Adverse Event|2
1414309|NCT01106352|4669384|P5|Overall Study|Home hospice since July 2013|0
1414310|NCT01106352|4669385|P4|Overall Study|Home hospice since July 2013|1
1414311|NCT01106352|4669386|P3|Overall Study|Home hospice since July 2013|0
1414312|NCT01106352|4669387|P2|Overall Study|Home hospice since July 2013|0
1414313|NCT01106352|4669388|P1|Overall Study|Home hospice since July 2013|0
1414314|NCT01106352|4669384|P5|Overall Study|Subject entered hospice|0
1414315|NCT01106352|4669385|P4|Overall Study|Subject entered hospice|1
1414316|NCT01106352|4669386|P3|Overall Study|Subject entered hospice|0
1414317|NCT01106352|4669387|P2|Overall Study|Subject entered hospice|0
1414318|NCT01106352|4669388|P1|Overall Study|Subject entered hospice|0
1414319|NCT01106352|4669384|P5|Overall Study|Went on hospice|0
1414320|NCT01106352|4669385|P4|Overall Study|Went on hospice|1
1414321|NCT01106352|4669386|P3|Overall Study|Went on hospice|0
1414322|NCT01106352|4669387|P2|Overall Study|Went on hospice|0
1414323|NCT01106352|4669388|P1|Overall Study|Went on hospice|0
1414324|NCT01106352|4669384|P5|Overall Study|Withdrawal by Subject|2
1414325|NCT01106352|4669385|P4|Overall Study|Withdrawal by Subject|3
1414326|NCT01106352|4669386|P3|Overall Study|Withdrawal by Subject|0
1414327|NCT01106352|4669387|P2|Overall Study|Withdrawal by Subject|0
1414328|NCT01106352|4669388|P1|Overall Study|Withdrawal by Subject|0
1414329|NCT01106352|4669384|P5|Overall Study|Disease progression|0
1414330|NCT01106352|4669385|P4|Overall Study|Disease progression|1
1414331|NCT01106352|4669386|P3|Overall Study|Disease progression|0
1414332|NCT01106352|4669387|P2|Overall Study|Disease progression|0
1414333|NCT01106352|4669388|P1|Overall Study|Disease progression|0
1414334|NCT01106352|4669384|P5|Overall Study|Death|1
1414335|NCT01106352|4669385|P4|Overall Study|Death|3
1414336|NCT01106352|4669386|P3|Overall Study|Death|1
1414337|NCT01106352|4669387|P2|Overall Study|Death|0
1414338|NCT01106352|4669388|P1|Overall Study|Death|0
1414339|NCT01106352|4669384|P5|Overall Study|Lost to Follow-up|1
1414340|NCT01106352|4669385|P4|Overall Study|Lost to Follow-up|0
1414341|NCT01106352|4669386|P3|Overall Study|Lost to Follow-up|0
1414342|NCT01106352|4669387|P2|Overall Study|Lost to Follow-up|0
1414343|NCT01106352|4669388|P1|Overall Study|Lost to Follow-up|0
1414344|NCT01106352|4669384|P5|Overall Study|Too ill to come in for the visit|0
1414345|NCT01106352|4669385|P4|Overall Study|Too ill to come in for the visit|0
1414346|NCT01106352|4669386|P3|Overall Study|Too ill to come in for the visit|1
1414347|NCT01106352|4669387|P2|Overall Study|Too ill to come in for the visit|0
1414348|NCT01106352|4669388|P1|Overall Study|Too ill to come in for the visit|0
1414349|NCT01106352|4669384|P5|Overall Study|Sponsor Decision|0
1414350|NCT01106352|4669385|P4|Overall Study|Sponsor Decision|0
1414351|NCT01106352|4669386|P3|Overall Study|Sponsor Decision|0
1414352|NCT01106352|4669387|P2|Overall Study|Sponsor Decision|0
1414353|NCT01106352|4669388|P1|Overall Study|Sponsor Decision|1
1414354|NCT01106352|4669384|P5|Overall Study|Subjects untreated|4
1414355|NCT01106352|4669385|P4|Overall Study|Subjects untreated|3
1414356|NCT01106352|4669386|P3|Overall Study|Subjects untreated|0
1414357|NCT01106352|4669387|P2|Overall Study|Subjects untreated|0
1414358|NCT01106352|4669388|P1|Overall Study|Subjects untreated|0
1414359|NCT01106287|4669484|P4|Overall Study|Adverse Event|0
1414360|NCT01106287|4669485|P3|Overall Study|Adverse Event|0
1414361|NCT01106287|4669486|P2|Overall Study|Adverse Event|0
1414362|NCT01106287|4669487|P1|Overall Study|Adverse Event|1
1414363|NCT01106248|4669507|P1|Overall Study|Administrative|2
1414364|NCT01106248|4669507|P1|Overall Study|Adverse Event|1
1414365|NCT01106157|4669515|P2|Overall Study|Withdrawal by Subject|0
1414366|NCT01106157|4669516|P1|Overall Study|Withdrawal by Subject|1
1414367|NCT01106092|4669544|P4|Overall Study|Withdrawal by Subject|1
1414368|NCT01106092|4669545|P3|Overall Study|Withdrawal by Subject|0
1414369|NCT01106092|4669546|P2|Overall Study|Withdrawal by Subject|0
1414370|NCT01106092|4669547|P1|Overall Study|Withdrawal by Subject|0
1414371|NCT01106027|4669630|P1|Overall Study|Lost graft early, discontinued|1
1414372|NCT01106014|4669636|P2|Overall Study|Lost to Follow-up|3
1414373|NCT01106014|4669637|P1|Overall Study|Lost to Follow-up|2
1414374|NCT01106014|4669636|P2|Overall Study|Administrative reason|6
1414375|NCT01106014|4669637|P1|Overall Study|Administrative reason|7
1414376|NCT01106014|4669636|P2|Overall Study|Withdrawal by Subject|37
1414377|NCT01106014|4669637|P1|Overall Study|Withdrawal by Subject|43
1414378|NCT01106014|4669636|P2|Overall Study|Adverse Event|42
1414379|NCT01106014|4669637|P1|Overall Study|Adverse Event|78
1414380|NCT01106014|4669636|P2|Overall Study|Morbidity or Mortality primary endpoint|242
1414381|NCT01106014|4669637|P1|Overall Study|Morbidity or Mortality primary endpoint|155
1414382|NCT01105975|4669657|P10|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1414383|NCT01105975|4669658|P9|Overall Study|Abnormal Lab/Electrocardiogram Result|2
1414384|NCT01105975|4669659|P8|Overall Study|Abnormal Lab/Electrocardiogram Result|1
1414385|NCT01105975|4669660|P7|Overall Study|Abnormal Lab/Electrocardiogram Result|1
1414386|NCT01105975|4669661|P6|Overall Study|Abnormal Lab/Electrocardiogram Result|2
1414387|NCT01105975|4669662|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1414388|NCT01105975|4669663|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1414389|NCT01105975|4669664|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
1414390|NCT01105975|4669665|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1414391|NCT01105975|4669666|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1414392|NCT01105975|4669657|P10|Overall Study|Protocol Violation|2
1414393|NCT01105975|4669658|P9|Overall Study|Protocol Violation|2
1414394|NCT01105975|4669659|P8|Overall Study|Protocol Violation|1
1414395|NCT01105975|4669660|P7|Overall Study|Protocol Violation|1
1414396|NCT01105975|4669661|P6|Overall Study|Protocol Violation|1
1414397|NCT01105975|4669662|P5|Overall Study|Protocol Violation|1
1414398|NCT01105975|4669663|P4|Overall Study|Protocol Violation|0
1414399|NCT01105975|4669664|P3|Overall Study|Protocol Violation|2
1414400|NCT01105975|4669665|P2|Overall Study|Protocol Violation|2
1414401|NCT01105975|4669666|P1|Overall Study|Protocol Violation|0
1414402|NCT01105975|4669657|P10|Overall Study|Physician Decision|0
1414403|NCT01105975|4669658|P9|Overall Study|Physician Decision|0
1414404|NCT01105975|4669659|P8|Overall Study|Physician Decision|0
1414405|NCT01105975|4669660|P7|Overall Study|Physician Decision|2
1414406|NCT01105975|4669661|P6|Overall Study|Physician Decision|0
1414407|NCT01105975|4669662|P5|Overall Study|Physician Decision|0
1414408|NCT01105975|4669663|P4|Overall Study|Physician Decision|0
1414409|NCT01105975|4669664|P3|Overall Study|Physician Decision|0
1414410|NCT01105975|4669665|P2|Overall Study|Physician Decision|0
1414411|NCT01105975|4669666|P1|Overall Study|Physician Decision|0
1414412|NCT01105975|4669657|P10|Overall Study|Lost to Follow-up|0
1414413|NCT01105975|4669658|P9|Overall Study|Lost to Follow-up|1
1414414|NCT01105975|4669659|P8|Overall Study|Lost to Follow-up|0
1414415|NCT01105975|4669660|P7|Overall Study|Lost to Follow-up|0
1414416|NCT01105975|4669661|P6|Overall Study|Lost to Follow-up|0
1414417|NCT01105975|4669662|P5|Overall Study|Lost to Follow-up|1
1414418|NCT01105975|4669663|P4|Overall Study|Lost to Follow-up|1
1414419|NCT01105975|4669664|P3|Overall Study|Lost to Follow-up|0
1414420|NCT01105975|4669665|P2|Overall Study|Lost to Follow-up|0
1414421|NCT01105975|4669666|P1|Overall Study|Lost to Follow-up|1
1414422|NCT01105975|4669657|P10|Overall Study|Withdrawal by Subject|3
1414423|NCT01105975|4669658|P9|Overall Study|Withdrawal by Subject|0
1414424|NCT01105975|4669659|P8|Overall Study|Withdrawal by Subject|1
1414425|NCT01105975|4669660|P7|Overall Study|Withdrawal by Subject|2
1414426|NCT01105975|4669661|P6|Overall Study|Withdrawal by Subject|1
1414427|NCT01105975|4669662|P5|Overall Study|Withdrawal by Subject|4
1414428|NCT01105975|4669663|P4|Overall Study|Withdrawal by Subject|0
1414429|NCT01105975|4669664|P3|Overall Study|Withdrawal by Subject|2
1414430|NCT01105975|4669665|P2|Overall Study|Withdrawal by Subject|2
1414431|NCT01105975|4669666|P1|Overall Study|Withdrawal by Subject|2
1414432|NCT01105975|4669657|P10|Overall Study|Adverse Event|4
1414433|NCT01105975|4669658|P9|Overall Study|Adverse Event|1
1414434|NCT01105975|4669659|P8|Overall Study|Adverse Event|4
1414435|NCT01105975|4669660|P7|Overall Study|Adverse Event|2
1414436|NCT01105975|4669661|P6|Overall Study|Adverse Event|1
1414437|NCT01105975|4669662|P5|Overall Study|Adverse Event|0
1414438|NCT01105975|4669663|P4|Overall Study|Adverse Event|1
1414439|NCT01105975|4669664|P3|Overall Study|Adverse Event|5
1414440|NCT01105975|4669665|P2|Overall Study|Adverse Event|1
1414441|NCT01105975|4669666|P1|Overall Study|Adverse Event|2
1414442|NCT01105936|4669814|P4|Period 3|Protocol Violation|0
1414443|NCT01105936|4669815|P3|Period 3|Protocol Violation|0
1414444|NCT01105936|4669816|P2|Period 3|Protocol Violation|2
1414445|NCT01105936|4669817|P1|Period 3|Protocol Violation|0
1414446|NCT01105936|4669814|P4|Period 2|Adverse Event|0
1414447|NCT01105936|4669815|P3|Period 2|Adverse Event|0
1414448|NCT01105936|4669816|P2|Period 2|Adverse Event|0
1414449|NCT01105936|4669817|P1|Period 2|Adverse Event|1
1414450|NCT01105936|4669814|P4|Period 1|Adverse Event|1
1414451|NCT01105936|4669815|P3|Period 1|Adverse Event|0
1414452|NCT01105936|4669816|P2|Period 1|Adverse Event|0
1414453|NCT01105936|4669817|P1|Period 1|Adverse Event|0
1414454|NCT01105767|4669846|P3|Overall Study|Lost to Follow-up|1184
1414455|NCT01105767|4669847|P2|Overall Study|Lost to Follow-up|1614
1414456|NCT01105767|4669848|P1|Overall Study|Lost to Follow-up|1160
1414457|NCT01105533|4669900|P9|Overall Study|Physician Decision|0
1414458|NCT01105533|4669901|P8|Overall Study|Physician Decision|1
1414459|NCT01105533|4669902|P7|Overall Study|Physician Decision|0
1414460|NCT01105533|4669903|P6|Overall Study|Physician Decision|0
1414461|NCT01105533|4669904|P5|Overall Study|Physician Decision|0
1414462|NCT01105533|4669905|P4|Overall Study|Physician Decision|0
1414463|NCT01105533|4669906|P3|Overall Study|Physician Decision|0
1414464|NCT01105533|4669907|P2|Overall Study|Physician Decision|0
1414465|NCT01105533|4669908|P1|Overall Study|Physician Decision|0
1414466|NCT01105533|4669900|P9|Overall Study|Other|2
1414467|NCT01105533|4669901|P8|Overall Study|Other|1
1414468|NCT01105533|4669902|P7|Overall Study|Other|3
1414469|NCT01105533|4669903|P6|Overall Study|Other|0
1414470|NCT01105533|4669904|P5|Overall Study|Other|1
1414471|NCT01105533|4669905|P4|Overall Study|Other|0
1414472|NCT01105533|4669906|P3|Overall Study|Other|0
1414473|NCT01105533|4669907|P2|Overall Study|Other|0
1414474|NCT01105533|4669908|P1|Overall Study|Other|0
1414475|NCT01105533|4669900|P9|Overall Study|Adverse Event|1
1414476|NCT01105533|4669901|P8|Overall Study|Adverse Event|0
1414477|NCT01105533|4669902|P7|Overall Study|Adverse Event|2
1414478|NCT01105533|4669903|P6|Overall Study|Adverse Event|2
1414479|NCT01105533|4669904|P5|Overall Study|Adverse Event|1
1414480|NCT01105533|4669905|P4|Overall Study|Adverse Event|0
1414481|NCT01105533|4669906|P3|Overall Study|Adverse Event|0
1414482|NCT01105533|4669907|P2|Overall Study|Adverse Event|0
1414483|NCT01105533|4669908|P1|Overall Study|Adverse Event|0
1414484|NCT01105533|4669900|P9|Overall Study|Lack of Efficacy|9
1414485|NCT01105533|4669901|P8|Overall Study|Lack of Efficacy|2
1414486|NCT01105533|4669902|P7|Overall Study|Lack of Efficacy|3
1414487|NCT01105533|4669903|P6|Overall Study|Lack of Efficacy|5
1414488|NCT01105533|4669904|P5|Overall Study|Lack of Efficacy|4
1414489|NCT01105533|4669905|P4|Overall Study|Lack of Efficacy|3
1414490|NCT01105533|4669906|P3|Overall Study|Lack of Efficacy|3
1414491|NCT01105533|4669907|P2|Overall Study|Lack of Efficacy|1
1414492|NCT01105533|4669908|P1|Overall Study|Lack of Efficacy|1
1414493|NCT01105533|4669900|P9|Overall Study|Death|0
1414494|NCT01105533|4669901|P8|Overall Study|Death|0
1414495|NCT01105533|4669902|P7|Overall Study|Death|0
1414496|NCT01105533|4669903|P6|Overall Study|Death|0
1414497|NCT01105533|4669904|P5|Overall Study|Death|1
1414498|NCT01105533|4669905|P4|Overall Study|Death|0
1414499|NCT01105533|4669906|P3|Overall Study|Death|0
1414500|NCT01105533|4669907|P2|Overall Study|Death|0
1414501|NCT01105533|4669908|P1|Overall Study|Death|0
1414502|NCT01105377|4669998|P2|Overall Study|Withdrawal by Subject|1
1414503|NCT01105377|4669999|P1|Overall Study|Withdrawal by Subject|0
1414504|NCT01105130|4670047|P3|Overall Study|Multiple Reasons|2
1414505|NCT01105130|4670048|P2|Overall Study|Multiple Reasons|0
1414506|NCT01105130|4670049|P1|Overall Study|Multiple Reasons|3
1414507|NCT01105130|4670047|P3|Overall Study|Toxicity|2
1414508|NCT01105130|4670048|P2|Overall Study|Toxicity|3
1414509|NCT01105130|4670049|P1|Overall Study|Toxicity|1
1414510|NCT01105130|4670047|P3|Overall Study|Never Started|4
1414511|NCT01105130|4670048|P2|Overall Study|Never Started|2
1414512|NCT01105130|4670049|P1|Overall Study|Never Started|2
1414513|NCT01105130|4670047|P3|Overall Study|Withdrawal by Subject|2
1414514|NCT01105130|4670048|P2|Overall Study|Withdrawal by Subject|6
1414515|NCT01105130|4670049|P1|Overall Study|Withdrawal by Subject|4
1414516|NCT01105091|4670079|P2|Overall Study|Death|0
1414517|NCT01105091|4670080|P1|Overall Study|Death|2
1414518|NCT01105065|4670104|P1|Overall Study|Technical Problems|1
1414519|NCT01105065|4670104|P1|Overall Study|Adverse Event|5
1414520|NCT01104870|4670113|P3|Overall Study|Withdrawal by Subject|1
1414521|NCT01104870|4670114|P2|Overall Study|Withdrawal by Subject|0
1414522|NCT01104870|4670115|P1|Overall Study|Withdrawal by Subject|0
1414523|NCT01104870|4670113|P3|Overall Study|Death|1
1414524|NCT01104870|4670114|P2|Overall Study|Death|0
1414525|NCT01104870|4670115|P1|Overall Study|Death|0
1414526|NCT01104870|4670113|P3|Overall Study|Adverse Event|0
1414527|NCT01104870|4670114|P2|Overall Study|Adverse Event|1
1414528|NCT01104870|4670115|P1|Overall Study|Adverse Event|1
1414529|NCT01104701|4670148|P4|Overall Study|Physician Decision|0
1414530|NCT01104701|4670149|P3|Overall Study|Physician Decision|0
1414531|NCT01104701|4670150|P2|Overall Study|Physician Decision|2
1414532|NCT01104701|4670151|P1|Overall Study|Physician Decision|0
1414533|NCT01104701|4670148|P4|Overall Study|Adverse Event|1
1414534|NCT01104701|4670149|P3|Overall Study|Adverse Event|0
1414535|NCT01104701|4670150|P2|Overall Study|Adverse Event|0
1414536|NCT01104701|4670151|P1|Overall Study|Adverse Event|0
1414537|NCT01104701|4670148|P4|Overall Study|Withdrawal by Subject|1
1414538|NCT01104701|4670149|P3|Overall Study|Withdrawal by Subject|2
1414539|NCT01104701|4670150|P2|Overall Study|Withdrawal by Subject|1
1414540|NCT01104701|4670151|P1|Overall Study|Withdrawal by Subject|0
1414541|NCT01104662|4670213|P8|Overall Study|Randomized but not treated|0
1414542|NCT01104662|4670214|P7|Overall Study|Randomized but not treated|0
1414543|NCT01104662|4670215|P6|Overall Study|Randomized but not treated|1
1414544|NCT01104662|4670216|P5|Overall Study|Randomized but not treated|0
1414545|NCT01104662|4670217|P4|Overall Study|Randomized but not treated|0
1414546|NCT01104662|4670218|P3|Overall Study|Randomized but not treated|1
1414547|NCT01104662|4670219|P2|Overall Study|Randomized but not treated|4
1414548|NCT01104662|4670220|P1|Overall Study|Randomized but not treated|3
1414549|NCT01104662|4670213|P8|Overall Study|Reason not specified|0
1414550|NCT01104662|4670214|P7|Overall Study|Reason not specified|0
1414551|NCT01104662|4670215|P6|Overall Study|Reason not specified|1
1414552|NCT01104662|4670216|P5|Overall Study|Reason not specified|0
1414553|NCT01104662|4670217|P4|Overall Study|Reason not specified|0
1414554|NCT01104662|4670218|P3|Overall Study|Reason not specified|0
1414555|NCT01104662|4670219|P2|Overall Study|Reason not specified|3
1414556|NCT01104662|4670220|P1|Overall Study|Reason not specified|3
1414557|NCT01104662|4670213|P8|Overall Study|Participant left investigator’s care|0
1414558|NCT01104662|4670214|P7|Overall Study|Participant left investigator’s care|0
1414559|NCT01104662|4670215|P6|Overall Study|Participant left investigator’s care|0
1414560|NCT01104662|4670216|P5|Overall Study|Participant left investigator’s care|0
1414561|NCT01104662|4670217|P4|Overall Study|Participant left investigator’s care|0
1414562|NCT01104662|4670218|P3|Overall Study|Participant left investigator’s care|0
1414563|NCT01104662|4670219|P2|Overall Study|Participant left investigator’s care|1
1414564|NCT01104662|4670220|P1|Overall Study|Participant left investigator’s care|1
1414565|NCT01104662|4670213|P8|Overall Study|Clinical Failure|0
1414566|NCT01104662|4670214|P7|Overall Study|Clinical Failure|0
1414567|NCT01104662|4670215|P6|Overall Study|Clinical Failure|1
1414568|NCT01104662|4670216|P5|Overall Study|Clinical Failure|0
1414569|NCT01104662|4670217|P4|Overall Study|Clinical Failure|0
1414570|NCT01104662|4670218|P3|Overall Study|Clinical Failure|0
1414571|NCT01104662|4670219|P2|Overall Study|Clinical Failure|0
1414572|NCT01104662|4670220|P1|Overall Study|Clinical Failure|1
1414573|NCT01104662|4670213|P8|Overall Study|Adverse Event|0
1414574|NCT01104662|4670214|P7|Overall Study|Adverse Event|0
1414575|NCT01104662|4670215|P6|Overall Study|Adverse Event|1
1414576|NCT01104662|4670216|P5|Overall Study|Adverse Event|1
1414577|NCT01104662|4670217|P4|Overall Study|Adverse Event|1
1414578|NCT01104662|4670218|P3|Overall Study|Adverse Event|0
1414579|NCT01104662|4670219|P2|Overall Study|Adverse Event|2
1414580|NCT01104662|4670220|P1|Overall Study|Adverse Event|2
1414581|NCT01104636|4670246|P1|Overall Study|Ongoing|21
1414582|NCT01104636|4670246|P1|Overall Study|Adverse Event|40
1414583|NCT01104636|4670246|P1|Overall Study|Pregnancy|2
1414584|NCT01104636|4670246|P1|Overall Study|Study terminated by sponsor|1
1414585|NCT01104636|4670246|P1|Overall Study|Other|43
1414586|NCT01104636|4670246|P1|Overall Study|Withdrawal by Subject|4
1414587|NCT01104636|4670246|P1|Overall Study|Lost to Follow-up|24
1414588|NCT01104636|4670246|P1|Overall Study|Lack of Efficacy|43
1414589|NCT01104584|4670251|P1|Overall Study|Study prematurely discontinued|2
1414590|NCT01104584|4670251|P1|Overall Study|Study drug never administered|21
1414591|NCT01104558|4670321|P1|Overall Study|Missing of genetic analysis results|1
1414592|NCT01104558|4670321|P1|Overall Study|Missing of primary efficacy assessment|10
1414593|NCT01104558|4670321|P1|Overall Study|Protocol Violation|6
1414594|NCT01104493|4670364|P2|Overall Study|Lost to Follow-up|2
1414595|NCT01104493|4670365|P1|Overall Study|Lost to Follow-up|0
1414596|NCT01104415|4670383|P1|Overall Study|Withdrawal by Subject|1
1414597|NCT01104376|4670426|P1|Overall Study|Consented but excluded after labs|13
1414598|NCT01104376|4670426|P1|Overall Study|Withdrawal by Subject|15
1414599|NCT01104311|4670432|P2|Overall Study|Adverse Event|2
1414600|NCT01104311|4670433|P1|Overall Study|Adverse Event|1
1414601|NCT01104311|4670432|P2|Overall Study|low compliance|1
1414602|NCT01104311|4670433|P1|Overall Study|low compliance|1
1414603|NCT01104311|4670432|P2|Overall Study|Physician Decision|2
1414604|NCT01104311|4670433|P1|Overall Study|Physician Decision|2
1414605|NCT01104311|4670432|P2|Overall Study|Protocol Violation|1
1414606|NCT01104311|4670433|P1|Overall Study|Protocol Violation|0
1414607|NCT01104311|4670432|P2|Overall Study|Withdrawal by Subject|6
1414608|NCT01104311|4670433|P1|Overall Study|Withdrawal by Subject|6
1414609|NCT01104246|4670460|P1|Overall Study|did not meet inclusion criteria|4
1414610|NCT01104246|4670460|P1|Overall Study|Withdrawal by Subject|1
1414611|NCT01104155|4670475|P2|Overall Study|Not specified|4
1414612|NCT01104155|4670476|P1|Overall Study|Not specified|3
1414613|NCT01104155|4670475|P2|Overall Study|Withdrawal of consent|1
1414614|NCT01104155|4670476|P1|Overall Study|Withdrawal of consent|1
1414615|NCT01104155|4670475|P2|Overall Study|Participant choice|5
1414616|NCT01104155|4670476|P1|Overall Study|Participant choice|6
1414617|NCT01104155|4670475|P2|Overall Study|Adverse Event|8
1414618|NCT01104155|4670476|P1|Overall Study|Adverse Event|15
1414619|NCT01103960|4670519|P2|Overall Study|Other|0
1414620|NCT01103960|4670520|P1|Overall Study|Other|1
1414621|NCT01103960|4670519|P2|Overall Study|Withdrawal by Subject|1
1414622|NCT01103960|4670520|P1|Overall Study|Withdrawal by Subject|2
1414623|NCT01103960|4670519|P2|Overall Study|Adverse Event|1
1414624|NCT01103960|4670520|P1|Overall Study|Adverse Event|2
1414625|NCT01103713|4670555|P1|Overall Study|Not specified|1
1414626|NCT01103713|4670555|P1|Overall Study|Study terminated by sponsor|2
1414627|NCT01103713|4670555|P1|Overall Study|Withdrawal by Subject|8
1414628|NCT01103713|4670555|P1|Overall Study|Lost to Follow-up|2
1414629|NCT01103479|4670588|P3|Overall Study|Saw non-study physician|0
1414630|NCT01103479|4670589|P2|Overall Study|Saw non-study physician|0
1414631|NCT01103479|4670590|P1|Overall Study|Saw non-study physician|2
1414632|NCT01103479|4670588|P3|Overall Study|Active cancer|0
1414633|NCT01103479|4670589|P2|Overall Study|Active cancer|0
1414634|NCT01103479|4670590|P1|Overall Study|Active cancer|1
1414635|NCT01103479|4670588|P3|Overall Study|Family history of CRC|2
1414636|NCT01103479|4670589|P2|Overall Study|Family history of CRC|0
1414637|NCT01103479|4670590|P1|Overall Study|Family history of CRC|1
1414638|NCT01103479|4670588|P3|Overall Study|Up to date with CRC screening|12
1414639|NCT01103479|4670589|P2|Overall Study|Up to date with CRC screening|9
1414640|NCT01103479|4670590|P1|Overall Study|Up to date with CRC screening|1
1414641|NCT01103466|4670603|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
1414642|NCT01103466|4670604|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
1414643|NCT01103466|4670605|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
1414644|NCT01103466|4670603|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
1414645|NCT01103466|4670604|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
1414646|NCT01103466|4670605|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
1414647|NCT01103466|4670603|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
1414648|NCT01103466|4670604|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
1414649|NCT01103466|4670605|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
1414650|NCT01103466|4670603|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
1414651|NCT01103466|4670604|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
1414652|NCT01103466|4670605|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
1414653|NCT01103466|4670603|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
1414654|NCT01103466|4670604|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
1414655|NCT01103466|4670605|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
1414656|NCT01103466|4670603|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
1414657|NCT01103466|4670604|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
1414658|NCT01103466|4670605|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
1414659|NCT01103362|4670695|P1|Overall Study|study terminated|596
1414660|NCT01103323|4670701|P2|Switched From Placebo to Regorafenib|Adverse Event|1
1414661|NCT01103323|4670702|P1|Switched From Placebo to Regorafenib|Adverse Event|0
1414662|NCT01103323|4670701|P2|Without/Before Drug Switch|Switch to Regorafenib|4
1414663|NCT01103323|4670702|P1|Without/Before Drug Switch|Switch to Regorafenib|0
1414664|NCT01103323|4670701|P2|Without/Before Drug Switch|did not receive study treatment|2
1414665|NCT01103323|4670702|P1|Without/Before Drug Switch|did not receive study treatment|5
1414666|NCT01103323|4670701|P2|Without/Before Drug Switch|Physician Decision|0
1414667|NCT01103323|4670702|P1|Without/Before Drug Switch|Physician Decision|2
1414668|NCT01103323|4670701|P2|Without/Before Drug Switch|Protocol Violation|0
1414669|NCT01103323|4670702|P1|Without/Before Drug Switch|Protocol Violation|2
1414670|NCT01103323|4670701|P2|Without/Before Drug Switch|Withdrawal by Subject|5
1414671|NCT01103323|4670702|P1|Without/Before Drug Switch|Withdrawal by Subject|17
1414672|NCT01103323|4670701|P2|Without/Before Drug Switch|Adverse Event|7
1414673|NCT01103323|4670702|P1|Without/Before Drug Switch|Adverse Event|50
1414674|NCT01103284|4670719|P2|Overall Study|Missing CRF entries for study completion|2
1414675|NCT01103284|4670720|P1|Overall Study|Missing CRF entries for study completion|0
1414676|NCT01103284|4670719|P2|Overall Study|Not described|1
1414677|NCT01103284|4670720|P1|Overall Study|Not described|2
1414678|NCT01103284|4670719|P2|Overall Study|Termination by the Sponsor|1
1414679|NCT01103284|4670720|P1|Overall Study|Termination by the Sponsor|0
1414680|NCT01103284|4670719|P2|Overall Study|Dermal Hypersensitivity|1
1414681|NCT01103284|4670720|P1|Overall Study|Dermal Hypersensitivity|0
1414682|NCT01103284|4670719|P2|Overall Study|Withdrawal by Subject|18
1414683|NCT01103284|4670720|P1|Overall Study|Withdrawal by Subject|14
1414684|NCT01103284|4670719|P2|Overall Study|Adverse Event|5
1414685|NCT01103284|4670720|P1|Overall Study|Adverse Event|0
1414686|NCT01103284|4670719|P2|Overall Study|Protocol Violation|5
1414687|NCT01103284|4670720|P1|Overall Study|Protocol Violation|12
1414688|NCT01103284|4670719|P2|Overall Study|Pregnancy|1
1414689|NCT01103284|4670720|P1|Overall Study|Pregnancy|3
1414690|NCT01103284|4670719|P2|Overall Study|Lost to Follow-up|10
1414691|NCT01103284|4670720|P1|Overall Study|Lost to Follow-up|9
1414692|NCT01103284|4670719|P2|Overall Study|Death|0
1414693|NCT01103284|4670720|P1|Overall Study|Death|2
1414694|NCT01103232|4670746|P2|Overall Study|Protocol Violation|1
1414695|NCT01103232|4670747|P1|Overall Study|Protocol Violation|0
1414696|NCT01103232|4670746|P2|Overall Study|Withdrawal by Subject|1
1414697|NCT01103232|4670747|P1|Overall Study|Withdrawal by Subject|1
1414698|NCT01103141|4670755|P2|Overall Study|Lost to Follow-up|1
1414699|NCT01103141|4670756|P1|Overall Study|Lost to Follow-up|2
1414700|NCT01103141|4670755|P2|Overall Study|Death|1
1414701|NCT01103141|4670756|P1|Overall Study|Death|0
1414702|NCT01103063|4670764|P2|Overall Study|Death|1
1414703|NCT01103063|4670765|P1|Overall Study|Death|3
1414704|NCT01103063|4670764|P2|Overall Study|Study terminated by Sponsor|342
1414705|NCT01103063|4670765|P1|Overall Study|Study terminated by Sponsor|326
1414706|NCT01103063|4670764|P2|Overall Study|Protocol Violation|0
1414707|NCT01103063|4670765|P1|Overall Study|Protocol Violation|1
1414708|NCT01103063|4670764|P2|Overall Study|Not specified|11
1414709|NCT01103063|4670765|P1|Overall Study|Not specified|16
1414710|NCT01103063|4670764|P2|Overall Study|Withdrawal by Subject|15
1414711|NCT01103063|4670765|P1|Overall Study|Withdrawal by Subject|60
1414712|NCT01103063|4670764|P2|Overall Study|Lost to Follow-up|51
1414713|NCT01103063|4670765|P1|Overall Study|Lost to Follow-up|68
1414714|NCT01103063|4670764|P2|Overall Study|Adverse Event|1
1414715|NCT01103063|4670765|P1|Overall Study|Adverse Event|3
1414716|NCT01102972|4670833|P2|Overall Study|Withdrawal by Subject|6
1414717|NCT01102972|4670834|P1|Overall Study|Withdrawal by Subject|6
1414718|NCT01102972|4670833|P2|Overall Study|Investigator Discretion|0
1414719|NCT01102972|4670834|P1|Overall Study|Investigator Discretion|2
1414720|NCT01102972|4670833|P2|Overall Study|Lost to Follow-up|5
1414721|NCT01102972|4670834|P1|Overall Study|Lost to Follow-up|10
1414722|NCT01102972|4670833|P2|Overall Study|Protocol Violation|0
1414723|NCT01102972|4670834|P1|Overall Study|Protocol Violation|1
1414724|NCT01102972|4670833|P2|Overall Study|Lack of Efficacy|1
1414725|NCT01102972|4670834|P1|Overall Study|Lack of Efficacy|2
1414726|NCT01102972|4670833|P2|Overall Study|Adverse Event|2
1414727|NCT01102972|4670834|P1|Overall Study|Adverse Event|8
1414728|NCT01102803|4670898|P2|Post to Follow-Up|Lost to Follow-up|3
1414729|NCT01102803|4670899|P1|Post to Follow-Up|Lost to Follow-up|1
1414730|NCT01102803|4670898|P2|Baseline to Post-Treatment|Lost to Follow-up|0
1414731|NCT01102803|4670899|P1|Baseline to Post-Treatment|Lost to Follow-up|3
1414732|NCT01102777|4670913|P2|Overall Study|Lost to Follow-up|10
1414733|NCT01102777|4670914|P1|Overall Study|Lost to Follow-up|7
1414734|NCT01102777|4670913|P2|Overall Study|Death|6
1414735|NCT01102777|4670914|P1|Overall Study|Death|2
1414736|NCT01102491|4670953|P2|Overall Study|Protocol Violation|12
1414737|NCT01102491|4670954|P1|Overall Study|Protocol Violation|11
1414738|NCT01102374|4670973|P2|Overall Study|Lost to Follow-up|6
1414739|NCT01102374|4670974|P1|Overall Study|Lost to Follow-up|7
1414740|NCT01102374|4670973|P2|Overall Study|Death|13
1414741|NCT01102374|4670974|P1|Overall Study|Death|9
1414742|NCT01102257|4671023|P2|Overall Study|Adverse Event|0
1414743|NCT01102257|4671024|P1|Overall Study|Adverse Event|1
1414744|NCT01102257|4671023|P2|Overall Study|Adverse Event|0
1414745|NCT01102257|4671024|P1|Overall Study|Adverse Event|1
1414746|NCT01102140|4671041|P2|Overall Study|Investigator terminated study|2
1414747|NCT01102140|4671042|P1|Overall Study|Investigator terminated study|2
1414748|NCT01102140|4671041|P2|Overall Study|Lost to Follow-up|0
1414749|NCT01102140|4671042|P1|Overall Study|Lost to Follow-up|1
1414750|NCT01101841|4671097|P2|Overall Study|Eligibility Criteria|2
1414751|NCT01101841|4671098|P1|Overall Study|Eligibility Criteria|1
1414752|NCT01101841|4671097|P2|Overall Study|Suicidality Tracking Scale|1
1414753|NCT01101841|4671098|P1|Overall Study|Suicidality Tracking Scale|3
1414754|NCT01101841|4671097|P2|Overall Study|Not Specified|1
1414755|NCT01101841|4671098|P1|Overall Study|Not Specified|0
1414756|NCT01101841|4671097|P2|Overall Study|Lack of Efficacy|2
1414757|NCT01101841|4671098|P1|Overall Study|Lack of Efficacy|0
1414758|NCT01101841|4671097|P2|Overall Study|Physician Decision|2
1414759|NCT01101841|4671098|P1|Overall Study|Physician Decision|0
1414760|NCT01101841|4671097|P2|Overall Study|Protocol Violation|1
1414761|NCT01101841|4671098|P1|Overall Study|Protocol Violation|1
1414762|NCT01101841|4671097|P2|Overall Study|Withdrawal by Subject|40
1414763|NCT01101841|4671098|P1|Overall Study|Withdrawal by Subject|21
1414764|NCT01101841|4671097|P2|Overall Study|Lost to Follow-up|3
1414765|NCT01101841|4671098|P1|Overall Study|Lost to Follow-up|9
1414766|NCT01101841|4671097|P2|Overall Study|Adverse Event|15
1414767|NCT01101841|4671098|P1|Overall Study|Adverse Event|15
1414768|NCT01101542|4671136|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
1414769|NCT01101542|4671136|P1|Year 6 Surveillance Period|Pregnancy|1
1414770|NCT01101542|4671136|P1|Year 6 Surveillance Period|Lost to Follow-up|986
1414771|NCT01101542|4671136|P1|Year 5 Surveillance Period|Pregnancy|1
1414772|NCT01101542|4671136|P1|Year 5 Surveillance Period|Lost to Follow-up|140
1414773|NCT01101542|4671136|P1|Year 4 Surveillance Period|Other|287
1414774|NCT01101542|4671136|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
1414775|NCT01101542|4671136|P1|Year 3 Surveillance Period|Lost to Follow-up|7
1414776|NCT01101477|4671152|P3|Overall Study|Protocol Violation|1
1414777|NCT01101477|4671153|P2|Overall Study|Protocol Violation|3
1414778|NCT01101477|4671154|P1|Overall Study|Protocol Violation|5
1414779|NCT01101321|4671175|P2|Period 1|Adverse Event|3
1414780|NCT01101321|4671176|P1|Period 1|Adverse Event|3
1414781|NCT01101321|4671175|P2|Period 1|Withdrawal by Subject|1
1414782|NCT01101321|4671176|P1|Period 1|Withdrawal by Subject|1
1414783|NCT01101308|4671186|P2|Period 1|Positive for cotinine|0
1414784|NCT01101308|4671187|P1|Period 1|Positive for cotinine|1
1414785|NCT01101308|4671186|P2|Period 1|Adverse Event|1
1414786|NCT01101308|4671187|P1|Period 1|Adverse Event|2
1414787|NCT01101191|4671198|P2|Period 1|Adverse Event|2
1414788|NCT01101191|4671199|P1|Period 1|Adverse Event|1
1414789|NCT01101191|4671198|P2|Period 1|Withdrawal by Subject|0
1414790|NCT01101191|4671199|P1|Period 1|Withdrawal by Subject|1
1414791|NCT01101178|4671210|P2|Period 2|Withdrawal by Subject|1
1414792|NCT01101178|4671211|P1|Period 2|Withdrawal by Subject|0
1414793|NCT01101178|4671210|P2|Period 1|Adverse Event|1
1414794|NCT01101178|4671211|P1|Period 1|Adverse Event|2
1414795|NCT01101178|4671210|P2|Period 1|Positive drug screen|1
1414796|NCT01101178|4671211|P1|Period 1|Positive drug screen|1
1414797|NCT01101178|4671210|P2|Period 1|Withdrawal by Subject|2
1414798|NCT01101178|4671211|P1|Period 1|Withdrawal by Subject|1
1414799|NCT01101165|4671222|P2|Period 2|Adverse Event|0
1414800|NCT01101165|4671223|P1|Period 2|Adverse Event|1
1414801|NCT01101165|4671222|P2|Period 2|Withdrawal by Subject|1
1414802|NCT01101165|4671223|P1|Period 2|Withdrawal by Subject|3
1414803|NCT01101165|4671222|P2|Period 1|Lost to Follow-up|0
1414804|NCT01101165|4671223|P1|Period 1|Lost to Follow-up|1
1414805|NCT01101165|4671222|P2|Period 1|Positive Drug Screen|1
1414806|NCT01101165|4671223|P1|Period 1|Positive Drug Screen|0
1414807|NCT01101165|4671222|P2|Period 1|Withdrawal by Subject|2
1414808|NCT01101165|4671223|P1|Period 1|Withdrawal by Subject|0
1414809|NCT01101165|4671222|P2|Period 1|Adverse Event|2
1414810|NCT01101165|4671223|P1|Period 1|Adverse Event|1
1414811|NCT01101035|4671235|P2|Overall Study|Reason not Specified|363
1414812|NCT01101035|4671236|P1|Overall Study|Reason not Specified|333
1414813|NCT01101035|4671235|P2|Overall Study|Voluntary Withdrawal|587
1414814|NCT01101035|4671236|P1|Overall Study|Voluntary Withdrawal|595
1414815|NCT01101035|4671235|P2|Overall Study|Lost to Follow-up|223
1414816|NCT01101035|4671236|P1|Overall Study|Lost to Follow-up|226
1414817|NCT01101035|4671235|P2|Overall Study|Major Protocol Deviation|46
1414818|NCT01101035|4671236|P1|Overall Study|Major Protocol Deviation|52
1414819|NCT01101035|4671235|P2|Overall Study|Adverse Event|172
1414820|NCT01101035|4671236|P1|Overall Study|Adverse Event|191
1414821|NCT01101022|4671256|P2|Overall Study|Vacation|1
1414822|NCT01101022|4671257|P1|Overall Study|Vacation|0
1414823|NCT01101022|4671256|P2|Overall Study|Work schedule|1
1414824|NCT01101022|4671257|P1|Overall Study|Work schedule|1
1414825|NCT01101022|4671256|P2|Overall Study|Non-compliance|0
1414826|NCT01101022|4671257|P1|Overall Study|Non-compliance|1
1414827|NCT01101022|4671256|P2|Overall Study|Sponsor decision|1
1414828|NCT01101022|4671257|P1|Overall Study|Sponsor decision|1
1414829|NCT01101022|4671256|P2|Overall Study|Lack of Efficacy|7
1414830|NCT01101022|4671257|P1|Overall Study|Lack of Efficacy|0
1414831|NCT01101022|4671256|P2|Overall Study|Lost to Follow-up|4
1414832|NCT01101022|4671257|P1|Overall Study|Lost to Follow-up|1
1414833|NCT01101022|4671256|P2|Overall Study|Withdrawal by Subject|8
1414834|NCT01101022|4671257|P1|Overall Study|Withdrawal by Subject|3
1414835|NCT01101022|4671256|P2|Overall Study|Protocol Violation|3
1414836|NCT01101022|4671257|P1|Overall Study|Protocol Violation|4
1414837|NCT01101022|4671256|P2|Overall Study|Adverse Event|2
1414838|NCT01101022|4671257|P1|Overall Study|Adverse Event|6
1414839|NCT01100944|4671291|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
1414840|NCT01100944|4671292|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
1414841|NCT01100944|4671293|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
1414842|NCT01100944|4671291|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
1414843|NCT01100944|4671292|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
1414844|NCT01100944|4671293|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
1414845|NCT01100944|4671291|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
1414846|NCT01100944|4671292|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
1414847|NCT01100944|4671293|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
1414848|NCT01100944|4671291|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
1414849|NCT01100944|4671292|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
1414850|NCT01100944|4671293|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
1414851|NCT01100853|4671351|P2|Overall Study|Withdrawal by Subject|4
1414852|NCT01100853|4671352|P1|Overall Study|Withdrawal by Subject|6
1414853|NCT01100853|4671351|P2|Overall Study|Received <4 study injections|13
1414854|NCT01100853|4671352|P1|Overall Study|Received <4 study injections|10
1414855|NCT01100853|4671351|P2|Overall Study|Lost to Follow-up|6
1414856|NCT01100853|4671352|P1|Overall Study|Lost to Follow-up|11
1414857|NCT01100658|4671398|P1|Overall Study|Withdrawal by Subject|1
1414858|NCT01100567|4671430|P2|Overall Study|Deemed ineligible after consent|1
1414859|NCT01100567|4671431|P1|Overall Study|Deemed ineligible after consent|0
1414860|NCT01100567|4671430|P2|Overall Study|Physician Decision|1
1414861|NCT01100567|4671431|P1|Overall Study|Physician Decision|0
1414862|NCT01100567|4671430|P2|Overall Study|Lost to Follow-up|2
1414863|NCT01100567|4671431|P1|Overall Study|Lost to Follow-up|1
1414864|NCT01100567|4671430|P2|Overall Study|Early Hospital Discharge|4
1414865|NCT01100567|4671431|P1|Overall Study|Early Hospital Discharge|6
1414866|NCT01100567|4671430|P2|Overall Study|Withdrawal by Subject|8
1414867|NCT01100567|4671431|P1|Overall Study|Withdrawal by Subject|5
1414868|NCT01100502|4671441|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
1414869|NCT01100502|4671442|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
1414870|NCT01100502|4671441|P2|Long-Term Follow-up|Lost to Follow-up|2
1414871|NCT01100502|4671442|P1|Long-Term Follow-up|Lost to Follow-up|5
1414872|NCT01100502|4671441|P2|Long-Term Follow-up|Withdrawal by Subject|8
1414873|NCT01100502|4671442|P1|Long-Term Follow-up|Withdrawal by Subject|10
1414874|NCT01100502|4671441|P2|Treatment Period|Progressive Disease|69
1414875|NCT01100502|4671442|P1|Treatment Period|Progressive Disease|24
1414876|NCT01100502|4671441|P2|Treatment Period|Withdrawal by Subject|4
1414877|NCT01100502|4671442|P1|Treatment Period|Withdrawal by Subject|9
1414878|NCT01100502|4671441|P2|Treatment Period|Adverse Event|10
1414879|NCT01100502|4671442|P1|Treatment Period|Adverse Event|54
1414880|NCT01100437|4671452|P3|Maintenance|Sponsor termination of study|1
1414881|NCT01100437|4671453|P2|Maintenance|Sponsor termination of study|0
1414882|NCT01100437|4671454|P1|Maintenance|Sponsor termination of study|0
1414883|NCT01100437|4671452|P3|Maintenance|Withdrawal by Subject|1
1414884|NCT01100437|4671453|P2|Maintenance|Withdrawal by Subject|0
1414885|NCT01100437|4671454|P1|Maintenance|Withdrawal by Subject|0
1414886|NCT01100437|4671452|P3|Titration/Stabilization|Sponsor canceled study|1
1414887|NCT01100437|4671453|P2|Titration/Stabilization|Sponsor canceled study|0
1414888|NCT01100437|4671454|P1|Titration/Stabilization|Sponsor canceled study|0
1414889|NCT01100437|4671452|P3|Titration/Stabilization|Non-compliance|1
1414890|NCT01100437|4671453|P2|Titration/Stabilization|Non-compliance|0
1414891|NCT01100437|4671454|P1|Titration/Stabilization|Non-compliance|0
1414892|NCT01100437|4671452|P3|Titration/Stabilization|Adverse Event|4
1414893|NCT01100437|4671453|P2|Titration/Stabilization|Adverse Event|0
1414894|NCT01100437|4671454|P1|Titration/Stabilization|Adverse Event|0
1414895|NCT01100320|4671491|P2|Period 2|Withdrawal by Subject|1
1414896|NCT01100320|4671492|P1|Period 2|Withdrawal by Subject|1
1414897|NCT01100320|4671491|P2|Period 1|Adverse Event|2
1414898|NCT01100320|4671492|P1|Period 1|Adverse Event|2
1414899|NCT01100320|4671491|P2|Period 1|Positive Drug Screen|1
1414900|NCT01100320|4671492|P1|Period 1|Positive Drug Screen|1
1414901|NCT01100320|4671491|P2|Period 1|Withdrawal by Subject|4
1414902|NCT01100320|4671492|P1|Period 1|Withdrawal by Subject|2
1414903|NCT01100307|4671504|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
1414904|NCT01100307|4671505|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
1414905|NCT01100307|4671504|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
1414906|NCT01100307|4671505|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
1414907|NCT01100307|4671504|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
1414908|NCT01100307|4671505|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
1414909|NCT01100307|4671504|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
1414910|NCT01100307|4671505|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
1414911|NCT01100307|4671504|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
1414912|NCT01100307|4671505|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
1414913|NCT01100307|4671504|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
1414914|NCT01100307|4671505|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
1414915|NCT01100086|4671574|P2|Period 1|Withdrawal by Subject|0
1414916|NCT01100086|4671575|P1|Period 1|Withdrawal by Subject|1
1414917|NCT01100073|4671585|P1|Overall Study|Missing|5
1414918|NCT01100073|4671585|P1|Overall Study|Other|8
1414919|NCT01100073|4671585|P1|Overall Study|Insufficient tolerability +patients wish|8
1414920|NCT01100073|4671585|P1|Overall Study|Lack of effect + patient's wish|2
1414921|NCT01100073|4671585|P1|Overall Study|Lost to Follow-up|39
1414922|NCT01100073|4671585|P1|Overall Study|Withdrawal by Subject|13
1414923|NCT01100073|4671585|P1|Overall Study|Insufficient Tolerability|21
1414924|NCT01100073|4671585|P1|Overall Study|Lack of Efficacy|4
1414925|NCT01099917|4671629|P1|Overall Study|Not Treated|24
1414926|NCT01099917|4671629|P1|Overall Study|Adverse Event|3
1414927|NCT01099709|4671691|P2|Period 1|Adverse Event|0
1414928|NCT01099709|4671692|P1|Period 1|Adverse Event|1
1414929|NCT01099709|4671691|P2|Period 1|Positive cotinine test|1
1414930|NCT01099709|4671692|P1|Period 1|Positive cotinine test|0
1414931|NCT01099709|4671691|P2|Period 1|Withdrawal by Subject|1
1414932|NCT01099709|4671692|P1|Period 1|Withdrawal by Subject|0
1414933|NCT01099579|4671718|P3|Stage 2 (ATV Capsule)|Adverse Event|0
1414934|NCT01099579|4671719|P2|Stage 2 (ATV Capsule)|Adverse Event|1
1414935|NCT01099579|4671720|P1|Stage 2 (ATV Capsule)|Adverse Event|0
1414936|NCT01099579|4671718|P3|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
1414937|NCT01099579|4671719|P2|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
1414938|NCT01099579|4671720|P1|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
1414939|NCT01099579|4671718|P3|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
1414940|NCT01099579|4671719|P2|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
1414941|NCT01099579|4671720|P1|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
1414942|NCT01099579|4671718|P3|Stage 2 (ATV Capsule)|Lack of Efficacy|2
1414943|NCT01099579|4671719|P2|Stage 2 (ATV Capsule)|Lack of Efficacy|0
1414944|NCT01099579|4671720|P1|Stage 2 (ATV Capsule)|Lack of Efficacy|0
1414945|NCT01099579|4671718|P3|Stage 2 (ATV Capsule)|Lost to Follow-up|1
1414946|NCT01099579|4671719|P2|Stage 2 (ATV Capsule)|Lost to Follow-up|1
1414947|NCT01099579|4671720|P1|Stage 2 (ATV Capsule)|Lost to Follow-up|1
1414948|NCT01099579|4671718|P3|Stage 2 (ATV Capsule)|No longer met study criteria|1
1414949|NCT01099579|4671719|P2|Stage 2 (ATV Capsule)|No longer met study criteria|2
1414950|NCT01099579|4671720|P1|Stage 2 (ATV Capsule)|No longer met study criteria|2
1414951|NCT01099579|4671718|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
1414952|NCT01099579|4671719|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
1414953|NCT01099579|4671720|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
1414954|NCT01099579|4671718|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
1414955|NCT01099579|4671719|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
1414956|NCT01099579|4671720|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
1414957|NCT01099579|4671718|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
1414958|NCT01099579|4671719|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
1414959|NCT01099579|4671720|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
1414960|NCT01099579|4671718|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
1414961|NCT01099579|4671719|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
1414962|NCT01099579|4671720|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
1414963|NCT01099397|4671789|P1|Overall Study|Withdrawal by Subject|5
1414964|NCT01099397|4671789|P1|Overall Study|Protocol Violation|4
1414965|NCT01099397|4671789|P1|Overall Study|Lost to Follow-up|4
1414966|NCT01099267|4671816|P1|MDS-003 Study|Secondary Malign Disease|1
1414967|NCT01099267|4671816|P1|MDS-003 Study|Loss of Response|1
1414968|NCT01099267|4671816|P1|MDS-003 Study|Non-Compliance|2
1414969|NCT01099267|4671816|P1|MDS-003 Study|Investigator Decision|2
1414970|NCT01099267|4671816|P1|MDS-003 Study|Disease Progression|7
1414971|NCT01099267|4671816|P1|MDS-003 Study|Study Closed by Sponsor|2
1414972|NCT01099267|4671816|P1|MDS-003 Study|Death|11
1414973|NCT01099267|4671816|P1|MDS-003 Study|Lost to Follow-up|1
1414974|NCT01099267|4671816|P1|MDS-003 Study|Withdrawal by Subject|8
1414975|NCT01099267|4671816|P1|MDS-003 Study|Lack of Efficacy|52
1414976|NCT01099267|4671816|P1|MDS-003 Study|Adverse Event|37
1414977|NCT01099215|4671826|P2|Overall Study|Adverse Event|1
1414978|NCT01099215|4671827|P1|Overall Study|Adverse Event|0
1414979|NCT01099215|4671826|P2|Overall Study|Withdrawal by Subject|0
1414980|NCT01099215|4671827|P1|Overall Study|Withdrawal by Subject|1
1414981|NCT01098851|4671897|P2|Overall Study|Equipment failure|0
1414982|NCT01098851|4671898|P1|Overall Study|Equipment failure|1
1414983|NCT01098812|4671909|P3|Overall Study|Lost to Follow-up|0
1414984|NCT01098812|4671910|P2|Overall Study|Lost to Follow-up|1
1414985|NCT01098812|4671911|P1|Overall Study|Lost to Follow-up|0
1414986|NCT01098812|4671909|P3|Overall Study|Death|1
1414987|NCT01098812|4671910|P2|Overall Study|Death|0
1414988|NCT01098812|4671911|P1|Overall Study|Death|2
1414989|NCT01098539|4671987|P2|Overall Study|Physician Decision|3
1414990|NCT01098539|4671988|P1|Overall Study|Physician Decision|5
1414991|NCT01098539|4671987|P2|Overall Study|Withdrawal by Subject|26
1414992|NCT01098539|4671988|P1|Overall Study|Withdrawal by Subject|12
1414993|NCT01098539|4671987|P2|Overall Study|Lost to Follow-up|4
1414994|NCT01098539|4671988|P1|Overall Study|Lost to Follow-up|4
1414995|NCT01098539|4671987|P2|Overall Study|Noncompliance|5
1414996|NCT01098539|4671988|P1|Overall Study|Noncompliance|3
1414997|NCT01098539|4671987|P2|Overall Study|Protocol Violation|4
1414998|NCT01098539|4671988|P1|Overall Study|Protocol Violation|1
1414999|NCT01098539|4671987|P2|Overall Study|Adverse Event|26
1415000|NCT01098539|4671988|P1|Overall Study|Adverse Event|26
1415001|NCT01098487|4672039|P1|Overall Study|Physician Decision|1
1415002|NCT01098487|4672039|P1|Overall Study|Lost to Follow-up|3
1415003|NCT01098487|4672039|P1|Overall Study|Withdrawal by Subject|7
1415004|NCT01098487|4672039|P1|Overall Study|Lack of Efficacy|11
1415005|NCT01098487|4672039|P1|Overall Study|Adverse Event|22
1415006|NCT01098461|4672055|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
1415007|NCT01098461|4672056|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
1415008|NCT01098461|4672057|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
1415009|NCT01098461|4672058|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
1415010|NCT01098461|4672055|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
1415011|NCT01098461|4672056|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
1415012|NCT01098461|4672057|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
1415013|NCT01098461|4672058|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
1415014|NCT01098461|4672055|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
1415015|NCT01098461|4672056|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
1415016|NCT01098461|4672057|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
1415017|NCT01098461|4672058|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
1415018|NCT01098461|4672055|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
1415019|NCT01098461|4672056|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
1415020|NCT01098461|4672057|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
1415021|NCT01098461|4672058|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
1415022|NCT01098461|4672055|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
1415023|NCT01098461|4672056|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
1415024|NCT01098461|4672057|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
1415025|NCT01098461|4672058|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
1415026|NCT01098461|4672055|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
1415027|NCT01098461|4672056|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
1415028|NCT01098461|4672057|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
1415029|NCT01098461|4672058|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
1415030|NCT01098461|4672055|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
1415031|NCT01098461|4672056|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
1415032|NCT01098461|4672057|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
1415033|NCT01098461|4672058|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
1415034|NCT01098305|4672118|P2|Overall Study|Lost to Follow-up|33
1415035|NCT01098305|4672119|P1|Overall Study|Lost to Follow-up|31
1415036|NCT01098240|4672138|P3|Double-Blind Phase|Adverse Event|3
1415037|NCT01098240|4672139|P2|Double-Blind Phase|Adverse Event|3
1415038|NCT01098240|4672140|P1|Double-Blind Phase|Adverse Event|0
1415039|NCT01098240|4672138|P3|Double-Blind Phase|Withdrawal by Subject|3
1415040|NCT01098240|4672139|P2|Double-Blind Phase|Withdrawal by Subject|1
1415041|NCT01098240|4672140|P1|Double-Blind Phase|Withdrawal by Subject|0
1415042|NCT01098240|4672138|P3|Double-Blind Phase|Insufficient Clinical Response|2
1415043|NCT01098240|4672139|P2|Double-Blind Phase|Insufficient Clinical Response|1
1415044|NCT01098240|4672140|P1|Double-Blind Phase|Insufficient Clinical Response|0
1415045|NCT01098240|4672138|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
1415046|NCT01098240|4672139|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
1415047|NCT01098240|4672140|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
1415048|NCT01098240|4672138|P3|Double-Blind Phase|Other|2
1415049|NCT01098240|4672139|P2|Double-Blind Phase|Other|2
1415050|NCT01098240|4672140|P1|Double-Blind Phase|Other|0
1415051|NCT01098240|4672138|P3|Double-Blind Phase|Lost to Follow-up|0
1415052|NCT01098240|4672139|P2|Double-Blind Phase|Lost to Follow-up|2
1415053|NCT01098240|4672140|P1|Double-Blind Phase|Lost to Follow-up|0
1415054|NCT01098240|4672138|P3|Double-Blind Phase|Protocol Violation|4
1415055|NCT01098240|4672139|P2|Double-Blind Phase|Protocol Violation|2
1415056|NCT01098240|4672140|P1|Double-Blind Phase|Protocol Violation|0
1415057|NCT01098240|4672138|P3|Double-Blind Phase|Study Terminated by Sponsor|8
1415058|NCT01098240|4672139|P2|Double-Blind Phase|Study Terminated by Sponsor|5
1415059|NCT01098240|4672140|P1|Double-Blind Phase|Study Terminated by Sponsor|0
1415060|NCT01098240|4672138|P3|Open-Label Phase|Adverse Event|0
1415061|NCT01098240|4672139|P2|Open-Label Phase|Adverse Event|0
1415062|NCT01098240|4672140|P1|Open-Label Phase|Adverse Event|12
1415063|NCT01098240|4672138|P3|Open-Label Phase|Withdrawal by Subject|0
1415064|NCT01098240|4672139|P2|Open-Label Phase|Withdrawal by Subject|0
1415065|NCT01098240|4672140|P1|Open-Label Phase|Withdrawal by Subject|9
1415066|NCT01098240|4672138|P3|Open-Label Phase|Pregnancy|0
1415067|NCT01098240|4672139|P2|Open-Label Phase|Pregnancy|0
1415068|NCT01098240|4672140|P1|Open-Label Phase|Pregnancy|1
1415069|NCT01098240|4672138|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
1415070|NCT01098240|4672139|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
1415071|NCT01098240|4672140|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
1415072|NCT01098240|4672138|P3|Open-Label Phase|Other|0
1415073|NCT01098240|4672139|P2|Open-Label Phase|Other|0
1415074|NCT01098240|4672140|P1|Open-Label Phase|Other|19
1415075|NCT01098240|4672138|P3|Open-Label Phase|Lost to Follow-up|0
1415076|NCT01098240|4672139|P2|Open-Label Phase|Lost to Follow-up|0
1415077|NCT01098240|4672140|P1|Open-Label Phase|Lost to Follow-up|13
1415078|NCT01098240|4672138|P3|Open-Label Phase|Protocol Violation|0
1415079|NCT01098240|4672139|P2|Open-Label Phase|Protocol Violation|0
1415080|NCT01098240|4672140|P1|Open-Label Phase|Protocol Violation|4
1415081|NCT01098240|4672138|P3|Open-Label Phase|Study Terminated by Sponsor|0
1415082|NCT01098240|4672139|P2|Open-Label Phase|Study Terminated by Sponsor|0
1415083|NCT01098240|4672140|P1|Open-Label Phase|Study Terminated by Sponsor|27
1415084|NCT01098162|4672170|P1|Overall Study|Reason Unknown|26
1415085|NCT01098162|4672170|P1|Overall Study|Other Reason|1
1415086|NCT01098162|4672170|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
1415087|NCT01098162|4672170|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
1415088|NCT01098162|4672170|P1|Overall Study|Adverse Event & Lost to Follow-up|2
1415089|NCT01098162|4672170|P1|Overall Study|Adverse Event & Wish of Patient|13
1415090|NCT01098162|4672170|P1|Overall Study|Adverse Event & Lack of Efficacy|6
1415091|NCT01098162|4672170|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
1415092|NCT01098162|4672170|P1|Overall Study|Lost to Follow-up|9
1415093|NCT01098162|4672170|P1|Overall Study|Wish of Patient|7
1415094|NCT01098162|4672170|P1|Overall Study|Lack of Efficacy|4
1415095|NCT01098162|4672170|P1|Overall Study|Adverse Event|37
1415096|NCT01098110|4672182|P3|Overall Study|Untreated|0
1415097|NCT01098110|4672183|P2|Overall Study|Untreated|1
1415098|NCT01098110|4672184|P1|Overall Study|Untreated|1
1415099|NCT01098110|4672182|P3|Overall Study|Not Specified|5
1415100|NCT01098110|4672183|P2|Overall Study|Not Specified|7
1415101|NCT01098110|4672184|P1|Overall Study|Not Specified|4
1415102|NCT01098110|4672182|P3|Overall Study|Lack of Efficacy|27
1415103|NCT01098110|4672183|P2|Overall Study|Lack of Efficacy|9
1415104|NCT01098110|4672184|P1|Overall Study|Lack of Efficacy|13
1415105|NCT01098110|4672182|P3|Overall Study|Adverse Event|43
1415106|NCT01098110|4672183|P2|Overall Study|Adverse Event|32
1415107|NCT01098110|4672184|P1|Overall Study|Adverse Event|30
1415108|NCT01098110|4672182|P3|Overall Study|Withdrawal by Subject|19
1415109|NCT01098110|4672183|P2|Overall Study|Withdrawal by Subject|24
1415110|NCT01098110|4672184|P1|Overall Study|Withdrawal by Subject|14
1415111|NCT01098097|4672225|P1|Overall Study|No reason reported|31
1415112|NCT01098097|4672225|P1|Overall Study|Status unknown|16
1415113|NCT01098097|4672225|P1|Overall Study|Lost to Follow-up|18
1415114|NCT01098097|4672225|P1|Overall Study|Adverse Event|17
1415115|NCT01098071|4672234|P1|Overall Study|Lost to Follow-up|13
1415116|NCT01098071|4672234|P1|Overall Study|Surgery (adenoidectomy)|2
1415117|NCT01098032|4672247|P2|Overall Study|Withdrawal by Subject|1
1415118|NCT01098032|4672248|P1|Overall Study|Withdrawal by Subject|1
1415119|NCT01097863|4672357|P3|Overall Study|Did not return for final visit|1
1415120|NCT01097863|4672358|P2|Overall Study|Did not return for final visit|0
1415121|NCT01097863|4672359|P1|Overall Study|Did not return for final visit|0
1415122|NCT01097863|4672357|P3|Overall Study|Discomfort|1
1415123|NCT01097863|4672358|P2|Overall Study|Discomfort|0
1415124|NCT01097863|4672359|P1|Overall Study|Discomfort|1
1415125|NCT01097694|4672380|P2|Overall Study|Withdrawal by Subject|1
1415126|NCT01097694|4672381|P1|Overall Study|Withdrawal by Subject|3
1415127|NCT01097694|4672380|P2|Overall Study|Lost to Follow-up|3
1415128|NCT01097694|4672381|P1|Overall Study|Lost to Follow-up|0
1415129|NCT01097694|4672380|P2|Overall Study|Adverse Event|0
1415130|NCT01097694|4672381|P1|Overall Study|Adverse Event|5
1415131|NCT01097668|4672443|P2|Overall Study|Lost to Follow-up|0
1415132|NCT01097668|4672444|P1|Overall Study|Lost to Follow-up|1
1415133|NCT01097668|4672443|P2|Overall Study|Withdrawal by Subject|2
1415134|NCT01097668|4672444|P1|Overall Study|Withdrawal by Subject|1
1415135|NCT01097655|4672454|P1|Overall Study|Did Not Meet Inclusion Criteria|8
1415136|NCT01097655|4672454|P1|Overall Study|Subject Documented Twice|1
1415137|NCT01097655|4672454|P1|Overall Study|Withdrawal by Subject|1
1415138|NCT01097629|4672464|P8|DB RO Phase|Lost to Follow-up|0
1415139|NCT01097629|4672465|P7|DB RO Phase|Lost to Follow-up|2
1415140|NCT01097629|4672466|P6|DB RO Phase|Lost to Follow-up|0
1415141|NCT01097629|4672467|P5|DB RO Phase|Lost to Follow-up|0
1415142|NCT01097629|4672468|P4|DB RO Phase|Lost to Follow-up|0
1415143|NCT01097629|4672469|P3|DB RO Phase|Lost to Follow-up|0
1415144|NCT01097629|4672470|P2|DB RO Phase|Lost to Follow-up|0
1415145|NCT01097629|4672471|P1|DB RO Phase|Lost to Follow-up|0
1415146|NCT01097629|4672464|P8|DB RO Phase|Protocol Violation|0
1415147|NCT01097629|4672465|P7|DB RO Phase|Protocol Violation|1
1415148|NCT01097629|4672466|P6|DB RO Phase|Protocol Violation|1
1415149|NCT01097629|4672467|P5|DB RO Phase|Protocol Violation|0
1415150|NCT01097629|4672468|P4|DB RO Phase|Protocol Violation|1
1415151|NCT01097629|4672469|P3|DB RO Phase|Protocol Violation|0
1415152|NCT01097629|4672470|P2|DB RO Phase|Protocol Violation|0
1415153|NCT01097629|4672471|P1|DB RO Phase|Protocol Violation|0
1415154|NCT01097629|4672464|P8|DB RO Phase|Withdrawal by Subject|1
1415155|NCT01097629|4672465|P7|DB RO Phase|Withdrawal by Subject|0
1415156|NCT01097629|4672466|P6|DB RO Phase|Withdrawal by Subject|0
1415157|NCT01097629|4672467|P5|DB RO Phase|Withdrawal by Subject|0
1415158|NCT01097629|4672468|P4|DB RO Phase|Withdrawal by Subject|0
1415159|NCT01097629|4672469|P3|DB RO Phase|Withdrawal by Subject|0
1415160|NCT01097629|4672470|P2|DB RO Phase|Withdrawal by Subject|0
1415161|NCT01097629|4672471|P1|DB RO Phase|Withdrawal by Subject|0
1415162|NCT01097629|4672464|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1415163|NCT01097629|4672465|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1415164|NCT01097629|4672466|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1415165|NCT01097629|4672467|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1415166|NCT01097629|4672468|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1415167|NCT01097629|4672469|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
1415168|NCT01097629|4672470|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
1415169|NCT01097629|4672471|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
1415170|NCT01097629|4672464|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1415171|NCT01097629|4672465|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1415172|NCT01097629|4672466|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1415173|NCT01097629|4672467|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1415174|NCT01097629|4672468|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1415175|NCT01097629|4672469|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1415176|NCT01097629|4672470|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
1415177|NCT01097629|4672471|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
1415178|NCT01097629|4672464|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1415179|NCT01097629|4672465|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1415180|NCT01097629|4672466|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1415181|NCT01097629|4672467|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1415182|NCT01097629|4672468|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1415183|NCT01097629|4672469|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
1415184|NCT01097629|4672470|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
1415185|NCT01097629|4672471|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
1415186|NCT01097629|4672464|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1415187|NCT01097629|4672465|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1415188|NCT01097629|4672466|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1415189|NCT01097629|4672467|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1415190|NCT01097629|4672468|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1415191|NCT01097629|4672469|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
1415192|NCT01097629|4672470|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
1415193|NCT01097629|4672471|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
1415194|NCT01097629|4672464|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1415195|NCT01097629|4672465|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1415196|NCT01097629|4672466|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1415197|NCT01097629|4672467|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1415198|NCT01097629|4672468|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1415199|NCT01097629|4672469|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
1415200|NCT01097629|4672470|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
1415201|NCT01097629|4672471|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
1415202|NCT01097629|4672464|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1415203|NCT01097629|4672465|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1415204|NCT01097629|4672466|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1415205|NCT01097629|4672467|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1415206|NCT01097629|4672468|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1415207|NCT01097629|4672469|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
1415208|NCT01097629|4672470|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
1415209|NCT01097629|4672471|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
1415210|NCT01097629|4672464|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1415211|NCT01097629|4672465|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1415212|NCT01097629|4672466|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1415213|NCT01097629|4672467|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1415214|NCT01097629|4672468|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1415215|NCT01097629|4672469|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
1415216|NCT01097629|4672470|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
1415217|NCT01097629|4672471|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
1415218|NCT01097616|4672522|P8|DB RO Phase|Not Treated in RO|0
1415219|NCT01097616|4672523|P7|DB RO Phase|Not Treated in RO|0
1415220|NCT01097616|4672524|P6|DB RO Phase|Not Treated in RO|1
1415221|NCT01097616|4672525|P5|DB RO Phase|Not Treated in RO|0
1415222|NCT01097616|4672526|P4|DB RO Phase|Not Treated in RO|0
1415223|NCT01097616|4672527|P3|DB RO Phase|Not Treated in RO|0
1415224|NCT01097616|4672528|P2|DB RO Phase|Not Treated in RO|0
1415225|NCT01097616|4672529|P1|DB RO Phase|Not Treated in RO|0
1415226|NCT01097616|4672522|P8|DB RO Phase|Lost to Follow-up|1
1415227|NCT01097616|4672523|P7|DB RO Phase|Lost to Follow-up|0
1415228|NCT01097616|4672524|P6|DB RO Phase|Lost to Follow-up|0
1415229|NCT01097616|4672525|P5|DB RO Phase|Lost to Follow-up|1
1415230|NCT01097616|4672526|P4|DB RO Phase|Lost to Follow-up|1
1415231|NCT01097616|4672527|P3|DB RO Phase|Lost to Follow-up|0
1415232|NCT01097616|4672528|P2|DB RO Phase|Lost to Follow-up|0
1415233|NCT01097616|4672529|P1|DB RO Phase|Lost to Follow-up|0
1415234|NCT01097616|4672522|P8|DB RO Phase|Withdrawal by Subject|0
1415235|NCT01097616|4672523|P7|DB RO Phase|Withdrawal by Subject|0
1415236|NCT01097616|4672524|P6|DB RO Phase|Withdrawal by Subject|1
1415237|NCT01097616|4672525|P5|DB RO Phase|Withdrawal by Subject|0
1415238|NCT01097616|4672526|P4|DB RO Phase|Withdrawal by Subject|0
1415239|NCT01097616|4672527|P3|DB RO Phase|Withdrawal by Subject|0
1415240|NCT01097616|4672528|P2|DB RO Phase|Withdrawal by Subject|0
1415241|NCT01097616|4672529|P1|DB RO Phase|Withdrawal by Subject|0
1415242|NCT01097616|4672522|P8|DB RO Phase|Adverse Event|0
1415243|NCT01097616|4672523|P7|DB RO Phase|Adverse Event|1
1415244|NCT01097616|4672524|P6|DB RO Phase|Adverse Event|0
1415245|NCT01097616|4672525|P5|DB RO Phase|Adverse Event|0
1415246|NCT01097616|4672526|P4|DB RO Phase|Adverse Event|0
1415247|NCT01097616|4672527|P3|DB RO Phase|Adverse Event|0
1415248|NCT01097616|4672528|P2|DB RO Phase|Adverse Event|0
1415249|NCT01097616|4672529|P1|DB RO Phase|Adverse Event|0
1415250|NCT01097616|4672522|P8|Optional DB EXT Phase|Physician Decision|0
1415251|NCT01097616|4672523|P7|Optional DB EXT Phase|Physician Decision|0
1415252|NCT01097616|4672524|P6|Optional DB EXT Phase|Physician Decision|0
1415253|NCT01097616|4672525|P5|Optional DB EXT Phase|Physician Decision|0
1415254|NCT01097616|4672526|P4|Optional DB EXT Phase|Physician Decision|0
1415255|NCT01097616|4672527|P3|Optional DB EXT Phase|Physician Decision|0
1415256|NCT01097616|4672528|P2|Optional DB EXT Phase|Physician Decision|0
1415257|NCT01097616|4672529|P1|Optional DB EXT Phase|Physician Decision|1
1415258|NCT01097616|4672522|P8|Optional DB EXT Phase|Lack of Efficacy|0
1415259|NCT01097616|4672523|P7|Optional DB EXT Phase|Lack of Efficacy|0
1415260|NCT01097616|4672524|P6|Optional DB EXT Phase|Lack of Efficacy|0
1415261|NCT01097616|4672525|P5|Optional DB EXT Phase|Lack of Efficacy|0
1415262|NCT01097616|4672526|P4|Optional DB EXT Phase|Lack of Efficacy|0
1415263|NCT01097616|4672527|P3|Optional DB EXT Phase|Lack of Efficacy|1
1415264|NCT01097616|4672528|P2|Optional DB EXT Phase|Lack of Efficacy|1
1415265|NCT01097616|4672529|P1|Optional DB EXT Phase|Lack of Efficacy|1
1415266|NCT01097616|4672522|P8|Optional DB EXT Phase|Lost to Follow-up|0
1415267|NCT01097616|4672523|P7|Optional DB EXT Phase|Lost to Follow-up|0
1415268|NCT01097616|4672524|P6|Optional DB EXT Phase|Lost to Follow-up|0
1415269|NCT01097616|4672525|P5|Optional DB EXT Phase|Lost to Follow-up|0
1415270|NCT01097616|4672526|P4|Optional DB EXT Phase|Lost to Follow-up|0
1415271|NCT01097616|4672527|P3|Optional DB EXT Phase|Lost to Follow-up|1
1415272|NCT01097616|4672528|P2|Optional DB EXT Phase|Lost to Follow-up|5
1415273|NCT01097616|4672529|P1|Optional DB EXT Phase|Lost to Follow-up|1
1415274|NCT01097616|4672522|P8|Optional DB EXT Phase|Protocol Violation|0
1415275|NCT01097616|4672523|P7|Optional DB EXT Phase|Protocol Violation|0
1415276|NCT01097616|4672524|P6|Optional DB EXT Phase|Protocol Violation|0
1415277|NCT01097616|4672525|P5|Optional DB EXT Phase|Protocol Violation|0
1415278|NCT01097616|4672526|P4|Optional DB EXT Phase|Protocol Violation|0
1415279|NCT01097616|4672527|P3|Optional DB EXT Phase|Protocol Violation|3
1415280|NCT01097616|4672528|P2|Optional DB EXT Phase|Protocol Violation|2
1415281|NCT01097616|4672529|P1|Optional DB EXT Phase|Protocol Violation|0
1415282|NCT01097616|4672522|P8|Optional DB EXT Phase|Withdrawal by Subject|0
1415283|NCT01097616|4672523|P7|Optional DB EXT Phase|Withdrawal by Subject|0
1415284|NCT01097616|4672524|P6|Optional DB EXT Phase|Withdrawal by Subject|0
1415285|NCT01097616|4672525|P5|Optional DB EXT Phase|Withdrawal by Subject|0
1415286|NCT01097616|4672526|P4|Optional DB EXT Phase|Withdrawal by Subject|0
1415287|NCT01097616|4672527|P3|Optional DB EXT Phase|Withdrawal by Subject|3
1415288|NCT01097616|4672528|P2|Optional DB EXT Phase|Withdrawal by Subject|6
1415289|NCT01097616|4672529|P1|Optional DB EXT Phase|Withdrawal by Subject|12
1415290|NCT01097616|4672522|P8|Optional DB EXT Phase|Adverse Event|0
1415291|NCT01097616|4672523|P7|Optional DB EXT Phase|Adverse Event|0
1415292|NCT01097616|4672524|P6|Optional DB EXT Phase|Adverse Event|0
1415293|NCT01097616|4672525|P5|Optional DB EXT Phase|Adverse Event|0
1415294|NCT01097616|4672526|P4|Optional DB EXT Phase|Adverse Event|0
1415295|NCT01097616|4672527|P3|Optional DB EXT Phase|Adverse Event|2
1415296|NCT01097616|4672528|P2|Optional DB EXT Phase|Adverse Event|7
1415297|NCT01097616|4672529|P1|Optional DB EXT Phase|Adverse Event|0
1415298|NCT01097616|4672522|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1415299|NCT01097616|4672523|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1415300|NCT01097616|4672524|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1415301|NCT01097616|4672525|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1415302|NCT01097616|4672526|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1415303|NCT01097616|4672527|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
1415304|NCT01097616|4672528|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1415305|NCT01097616|4672529|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1415306|NCT01097616|4672522|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1415307|NCT01097616|4672523|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1415308|NCT01097616|4672524|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1415309|NCT01097616|4672525|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1415310|NCT01097616|4672526|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1415311|NCT01097616|4672527|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1415312|NCT01097616|4672528|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
1415313|NCT01097616|4672529|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
1415314|NCT01097616|4672522|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1415315|NCT01097616|4672523|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1415316|NCT01097616|4672524|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1415317|NCT01097616|4672525|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1415318|NCT01097616|4672526|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1415319|NCT01097616|4672527|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1415320|NCT01097616|4672528|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
1415321|NCT01097616|4672529|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
1415322|NCT01097616|4672522|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1415323|NCT01097616|4672523|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1415324|NCT01097616|4672524|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1415325|NCT01097616|4672525|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1415326|NCT01097616|4672526|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1415327|NCT01097616|4672527|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
1415328|NCT01097616|4672528|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
1415329|NCT01097616|4672529|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
1415330|NCT01097616|4672522|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1415331|NCT01097616|4672523|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1415332|NCT01097616|4672524|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1415333|NCT01097616|4672525|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1415334|NCT01097616|4672526|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1415335|NCT01097616|4672527|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1415336|NCT01097616|4672528|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
1415337|NCT01097616|4672529|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
1415338|NCT01097616|4672522|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1415339|NCT01097616|4672523|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1415340|NCT01097616|4672524|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1415341|NCT01097616|4672525|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1415342|NCT01097616|4672526|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1415343|NCT01097616|4672527|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
1415344|NCT01097616|4672528|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
1415345|NCT01097616|4672529|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
1415346|NCT01097616|4672522|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1415347|NCT01097616|4672523|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1415348|NCT01097616|4672524|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1415349|NCT01097616|4672525|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1415350|NCT01097616|4672526|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1415351|NCT01097616|4672527|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
1415352|NCT01097616|4672528|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
1415353|NCT01097616|4672529|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
1415354|NCT01097616|4672522|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1415355|NCT01097616|4672523|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1415356|NCT01097616|4672524|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1415357|NCT01097616|4672525|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1415358|NCT01097616|4672526|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1415359|NCT01097616|4672527|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
1415360|NCT01097616|4672528|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
1415361|NCT01097616|4672529|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
1415362|NCT01097421|4672604|P1|Overall Study|Withdrawal by Subject|3
1415363|NCT01097421|4672604|P1|Overall Study|Lost to Follow-up|1
1415364|NCT01097421|4672604|P1|Overall Study|Protocol Violation|2
1415365|NCT01097421|4672604|P1|Overall Study|Adverse Event|8
1415366|NCT01097057|4672628|P1|Overall Study|Physician Decision|3
1415367|NCT01097005|4672635|P1|Overall Study|Discontinuance by complication|50
1415368|NCT01097005|4672635|P1|Overall Study|Adverse Event|14
1415369|NCT01097005|4672635|P1|Overall Study|Deviation from exclusion criteria|37
1415370|NCT01097005|4672635|P1|Overall Study|No examination data available|244
1415371|NCT01097005|4672635|P1|Overall Study|Poor medication compliance|1
1415372|NCT01097005|4672635|P1|Overall Study|Subjects cannot visit the hospital|1
1415373|NCT01097005|4672635|P1|Overall Study|Case Report Form not collected|18
1415374|NCT01096849|4672659|P3|Overall Study|Lost to Follow-up|1
1415375|NCT01096849|4672660|P2|Overall Study|Lost to Follow-up|3
1415376|NCT01096849|4672661|P1|Overall Study|Lost to Follow-up|1
1415377|NCT01096849|4672659|P3|Overall Study|Administrative Reasons|2
1415378|NCT01096849|4672660|P2|Overall Study|Administrative Reasons|1
1415379|NCT01096849|4672661|P1|Overall Study|Administrative Reasons|0
1415380|NCT01096849|4672659|P3|Overall Study|Investigator or Medical Monitor Decision|0
1415381|NCT01096849|4672660|P2|Overall Study|Investigator or Medical Monitor Decision|1
1415382|NCT01096849|4672661|P1|Overall Study|Investigator or Medical Monitor Decision|0
1415383|NCT01096849|4672659|P3|Overall Study|Unacceptable/ Intolerable AE(s)|1
1415384|NCT01096849|4672660|P2|Overall Study|Unacceptable/ Intolerable AE(s)|1
1415385|NCT01096849|4672661|P1|Overall Study|Unacceptable/ Intolerable AE(s)|0
1415386|NCT01096849|4672659|P3|Overall Study|Lack of Efficacy|0
1415387|NCT01096849|4672660|P2|Overall Study|Lack of Efficacy|2
1415388|NCT01096849|4672661|P1|Overall Study|Lack of Efficacy|0
1415389|NCT01096849|4672659|P3|Overall Study|Consent Withdrawn|2
1415390|NCT01096849|4672660|P2|Overall Study|Consent Withdrawn|4
1415391|NCT01096849|4672661|P1|Overall Study|Consent Withdrawn|1
1415392|NCT01096784|4672737|P2|Overall Study|Other Unspecified|1
1415393|NCT01096784|4672738|P1|Overall Study|Other Unspecified|0
1415394|NCT01096784|4672737|P2|Overall Study|Administrative Decision|1
1415395|NCT01096784|4672738|P1|Overall Study|Administrative Decision|0
1415396|NCT01096784|4672737|P2|Overall Study|Protocol Deviation|2
1415397|NCT01096784|4672738|P1|Overall Study|Protocol Deviation|2
1415398|NCT01096784|4672737|P2|Overall Study|Adverse Event|9
1415399|NCT01096784|4672738|P1|Overall Study|Adverse Event|11
1415400|NCT01096784|4672737|P2|Overall Study|Withdrawal by Subject|1
1415401|NCT01096784|4672738|P1|Overall Study|Withdrawal by Subject|2
1415402|NCT01096667|4672843|P5|Overall Study|Not treated|0
1415403|NCT01096667|4672844|P4|Overall Study|Not treated|0
1415404|NCT01096667|4672845|P3|Overall Study|Not treated|0
1415405|NCT01096667|4672846|P2|Overall Study|Not treated|0
1415406|NCT01096667|4672847|P1|Overall Study|Not treated|1
1415407|NCT01096667|4672843|P5|Overall Study|Protocol Violation|0
1415408|NCT01096667|4672844|P4|Overall Study|Protocol Violation|1
1415409|NCT01096667|4672845|P3|Overall Study|Protocol Violation|0
1415410|NCT01096667|4672846|P2|Overall Study|Protocol Violation|0
1415411|NCT01096667|4672847|P1|Overall Study|Protocol Violation|0
1415412|NCT01096667|4672843|P5|Overall Study|Reason not available|0
1415413|NCT01096667|4672844|P4|Overall Study|Reason not available|1
1415414|NCT01096667|4672845|P3|Overall Study|Reason not available|1
1415415|NCT01096667|4672846|P2|Overall Study|Reason not available|1
1415416|NCT01096667|4672847|P1|Overall Study|Reason not available|0
1415417|NCT01096667|4672843|P5|Overall Study|Withdrawal by Subject|0
1415418|NCT01096667|4672844|P4|Overall Study|Withdrawal by Subject|1
1415419|NCT01096667|4672845|P3|Overall Study|Withdrawal by Subject|0
1415420|NCT01096667|4672846|P2|Overall Study|Withdrawal by Subject|0
1415421|NCT01096667|4672847|P1|Overall Study|Withdrawal by Subject|1
1415422|NCT01096667|4672843|P5|Overall Study|Lost to Follow-up|0
1415423|NCT01096667|4672844|P4|Overall Study|Lost to Follow-up|0
1415424|NCT01096667|4672845|P3|Overall Study|Lost to Follow-up|1
1415425|NCT01096667|4672846|P2|Overall Study|Lost to Follow-up|1
1415426|NCT01096667|4672847|P1|Overall Study|Lost to Follow-up|1
1415427|NCT01096589|4672989|P4|Overall Study|found treatment exhausting|1
1415428|NCT01096589|4672990|P3|Overall Study|found treatment exhausting|0
1415429|NCT01096589|4672991|P2|Overall Study|found treatment exhausting|0
1415430|NCT01096589|4672992|P1|Overall Study|found treatment exhausting|0
1415431|NCT01096589|4672989|P4|Overall Study|Compliance with protocol|0
1415432|NCT01096589|4672990|P3|Overall Study|Compliance with protocol|1
1415433|NCT01096589|4672991|P2|Overall Study|Compliance with protocol|0
1415434|NCT01096589|4672992|P1|Overall Study|Compliance with protocol|0
1415435|NCT01096589|4672989|P4|Overall Study|Withdrawal by Subject|1
1415436|NCT01096589|4672990|P3|Overall Study|Withdrawal by Subject|1
1415437|NCT01096589|4672991|P2|Overall Study|Withdrawal by Subject|1
1415438|NCT01096589|4672992|P1|Overall Study|Withdrawal by Subject|2
1415439|NCT01096589|4672989|P4|Overall Study|Adverse Event|1
1415440|NCT01096589|4672990|P3|Overall Study|Adverse Event|2
1415441|NCT01096589|4672991|P2|Overall Study|Adverse Event|1
1415442|NCT01096589|4672992|P1|Overall Study|Adverse Event|2
1415443|NCT01096550|4673004|P2|Overall Study|Lost to Follow-up|9
1415444|NCT01096550|4673005|P1|Overall Study|Lost to Follow-up|12
1415445|NCT01096550|4673004|P2|Overall Study|non-African American participant|6
1415446|NCT01096550|4673005|P1|Overall Study|non-African American participant|13
1415447|NCT01096550|4673004|P2|Overall Study|Withdrawal by Subject|1
1415448|NCT01096550|4673005|P1|Overall Study|Withdrawal by Subject|0
1415449|NCT01096550|4673004|P2|Overall Study|clinic readmission|1
1415450|NCT01096550|4673005|P1|Overall Study|clinic readmission|1
1415451|NCT01096550|4673004|P2|Overall Study|non-regular treatment track at clinic|1
1415452|NCT01096550|4673005|P1|Overall Study|non-regular treatment track at clinic|1
1415453|NCT01096550|4673004|P2|Overall Study|discontinued site|11
1415454|NCT01096550|4673005|P1|Overall Study|discontinued site|10
1415455|NCT01096446|4673013|P2|Overall Study|Protocol Violation|0
1415456|NCT01096446|4673014|P1|Overall Study|Protocol Violation|2
1415457|NCT01096446|4673013|P2|Overall Study|Death|0
1415458|NCT01096446|4673014|P1|Overall Study|Death|1
1415459|NCT01096342|4673019|P1|Overall Study|Protocol Violation|1
1415460|NCT01096316|4673027|P2|Overall Study|Lost to Follow-up|9
1415461|NCT01096316|4673028|P1|Overall Study|Lost to Follow-up|15
1415462|NCT01096186|4673038|P1|Overall Study|Noncompliance with study drug|1
1415463|NCT01096186|4673038|P1|Overall Study|Physician Decision|1
1415464|NCT01096186|4673038|P1|Overall Study|Withdrawal by Subject|22
1415465|NCT01096186|4673038|P1|Overall Study|Lost to Follow-up|2
1415466|NCT01096186|4673038|P1|Overall Study|Lack of Efficacy|4
1415467|NCT01096186|4673038|P1|Overall Study|Death|4
1415468|NCT01096186|4673038|P1|Overall Study|Adverse Event|16
1415469|NCT01096056|4673046|P2|Overall Study|Lost to Follow-up|1
1415470|NCT01096056|4673047|P1|Overall Study|Lost to Follow-up|0
1415471|NCT01096017|4673079|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
1415472|NCT01096017|4673080|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
1415473|NCT01095978|4673108|P1|Overall Study|Adverse Event|1
1415474|NCT01095978|4673108|P1|Overall Study|Did not take Klacid SR|2
1415475|NCT01095835|4673142|P3|Overall Study|Protocol Violation|0
1415476|NCT01095835|4673143|P2|Overall Study|Protocol Violation|2
1415477|NCT01095835|4673144|P1|Overall Study|Protocol Violation|1
1415478|NCT01095835|4673142|P3|Overall Study|Non study compliance|1
1415479|NCT01095835|4673143|P2|Overall Study|Non study compliance|0
1415480|NCT01095835|4673144|P1|Overall Study|Non study compliance|0
1415481|NCT01095835|4673142|P3|Overall Study|Withdrawal by Subject|0
1415482|NCT01095835|4673143|P2|Overall Study|Withdrawal by Subject|3
1415483|NCT01095835|4673144|P1|Overall Study|Withdrawal by Subject|1
1415484|NCT01095835|4673142|P3|Overall Study|Physician Decision|1
1415485|NCT01095835|4673143|P2|Overall Study|Physician Decision|0
1415486|NCT01095835|4673144|P1|Overall Study|Physician Decision|0
1415487|NCT01095835|4673142|P3|Overall Study|Lack of Efficacy|0
1415488|NCT01095835|4673143|P2|Overall Study|Lack of Efficacy|1
1415489|NCT01095835|4673144|P1|Overall Study|Lack of Efficacy|0
1415490|NCT01095835|4673142|P3|Overall Study|Adverse Event|6
1415491|NCT01095835|4673143|P2|Overall Study|Adverse Event|6
1415492|NCT01095835|4673144|P1|Overall Study|Adverse Event|8
1415493|NCT01095796|4673182|P2|Overall Study|Participant Transferred to Another Study|200
1415494|NCT01095796|4673183|P1|Overall Study|Participant Transferred to Another Study|215
1415495|NCT01095796|4673182|P2|Overall Study|Protocol Violation|0
1415496|NCT01095796|4673183|P1|Overall Study|Protocol Violation|1
1415497|NCT01095796|4673182|P2|Overall Study|Participant Noncompliance|10
1415498|NCT01095796|4673183|P1|Overall Study|Participant Noncompliance|5
1415499|NCT01095796|4673182|P2|Overall Study|Lost to Follow-up|29
1415500|NCT01095796|4673183|P1|Overall Study|Lost to Follow-up|27
1415501|NCT01095796|4673182|P2|Overall Study|Withdrew Consent|22
1415502|NCT01095796|4673183|P1|Overall Study|Withdrew Consent|16
1415503|NCT01095796|4673182|P2|Overall Study|Investigator's Discretion|2
1415504|NCT01095796|4673183|P1|Overall Study|Investigator's Discretion|7
1415505|NCT01095796|4673182|P2|Overall Study|Lack of Efficacy|3
1415506|NCT01095796|4673183|P1|Overall Study|Lack of Efficacy|5
1415507|NCT01095796|4673182|P2|Overall Study|Pregnancy|0
1415508|NCT01095796|4673183|P1|Overall Study|Pregnancy|2
1415509|NCT01095796|4673182|P2|Overall Study|Death|2
1415510|NCT01095796|4673183|P1|Overall Study|Death|3
1415511|NCT01095796|4673182|P2|Overall Study|Adverse Event|19
1415512|NCT01095796|4673183|P1|Overall Study|Adverse Event|9
1415513|NCT01095796|4673182|P2|Overall Study|Randomized but Not Treated|2
1415514|NCT01095796|4673183|P1|Overall Study|Randomized but Not Treated|5
1415515|NCT01095666|4673213|P3|Overall Study|Non-compliance, not met criteria etc.|2
1415516|NCT01095666|4673214|P2|Overall Study|Non-compliance, not met criteria etc.|2
1415517|NCT01095666|4673215|P1|Overall Study|Non-compliance, not met criteria etc.|7
1415518|NCT01095666|4673213|P3|Overall Study|Withdrawal by Subject|1
1415519|NCT01095666|4673214|P2|Overall Study|Withdrawal by Subject|6
1415520|NCT01095666|4673215|P1|Overall Study|Withdrawal by Subject|6
1415521|NCT01095666|4673213|P3|Overall Study|Lost to Follow-up|0
1415522|NCT01095666|4673214|P2|Overall Study|Lost to Follow-up|2
1415523|NCT01095666|4673215|P1|Overall Study|Lost to Follow-up|2
1415524|NCT01095666|4673213|P3|Overall Study|Adverse Event|3
1415525|NCT01095666|4673214|P2|Overall Study|Adverse Event|1
1415526|NCT01095666|4673215|P1|Overall Study|Adverse Event|2
1415527|NCT01095666|4673213|P3|Overall Study|Lack of Efficacy|1
1415528|NCT01095666|4673214|P2|Overall Study|Lack of Efficacy|0
1415529|NCT01095666|4673215|P1|Overall Study|Lack of Efficacy|0
1415530|NCT01095653|4673238|P3|Overall Study|non-compliance, not met criteria, etc.|5
1415531|NCT01095653|4673239|P2|Overall Study|non-compliance, not met criteria, etc.|6
1415532|NCT01095653|4673240|P1|Overall Study|non-compliance, not met criteria, etc.|10
1415533|NCT01095653|4673238|P3|Overall Study|Withdrawal by Subject|3
1415534|NCT01095653|4673239|P2|Overall Study|Withdrawal by Subject|5
1415535|NCT01095653|4673240|P1|Overall Study|Withdrawal by Subject|4
1415536|NCT01095653|4673238|P3|Overall Study|Lost to Follow-up|4
1415537|NCT01095653|4673239|P2|Overall Study|Lost to Follow-up|0
1415538|NCT01095653|4673240|P1|Overall Study|Lost to Follow-up|1
1415539|NCT01095653|4673238|P3|Overall Study|Adverse Event|4
1415540|NCT01095653|4673239|P2|Overall Study|Adverse Event|4
1415541|NCT01095653|4673240|P1|Overall Study|Adverse Event|1
1415542|NCT01095653|4673238|P3|Overall Study|Lack of Efficacy|0
1415543|NCT01095653|4673239|P2|Overall Study|Lack of Efficacy|0
1415544|NCT01095653|4673240|P1|Overall Study|Lack of Efficacy|3
1415545|NCT01095250|4673298|P4|Overall Study|Withdrawal by Subject|0
1415546|NCT01095250|4673299|P3|Overall Study|Withdrawal by Subject|1
1415547|NCT01095250|4673300|P2|Overall Study|Withdrawal by Subject|0
1415548|NCT01095250|4673301|P1|Overall Study|Withdrawal by Subject|0
1415549|NCT01095250|4673298|P4|Overall Study|administrative reasons|5
1415550|NCT01095250|4673299|P3|Overall Study|administrative reasons|7
1415551|NCT01095250|4673300|P2|Overall Study|administrative reasons|10
1415552|NCT01095250|4673301|P1|Overall Study|administrative reasons|8
1415553|NCT01095094|4673331|P1|Overall Study|Physician Decision|1
1415554|NCT01095094|4673331|P1|Overall Study|Death|1
1415555|NCT01095094|4673331|P1|Overall Study|Withdrawal by Subject|1
1415556|NCT01094886|4673336|P1|Overall Study|Withdrawal by Subject|5
1415557|NCT01094886|4673336|P1|Overall Study|Adverse Event|2
1415558|NCT01094808|4673346|P3|Overall Study|Withdrawal by Subject|0
1415559|NCT01094808|4673347|P2|Overall Study|Withdrawal by Subject|1
1415560|NCT01094808|4673348|P1|Overall Study|Withdrawal by Subject|1
1415561|NCT01094782|4673389|P6|Overall Study|Noncompliance With Study Schedule|0
1415562|NCT01094782|4673390|P5|Overall Study|Noncompliance With Study Schedule|0
1415563|NCT01094782|4673391|P4|Overall Study|Noncompliance With Study Schedule|1
1415564|NCT01094782|4673392|P3|Overall Study|Noncompliance With Study Schedule|0
1415565|NCT01094782|4673393|P2|Overall Study|Noncompliance With Study Schedule|0
1415566|NCT01094782|4673394|P1|Overall Study|Noncompliance With Study Schedule|0
1415567|NCT01094782|4673389|P6|Overall Study|Low Visual Analog Scale (VAS) Score|0
1415568|NCT01094782|4673390|P5|Overall Study|Low Visual Analog Scale (VAS) Score|1
1415569|NCT01094782|4673391|P4|Overall Study|Low Visual Analog Scale (VAS) Score|0
1415570|NCT01094782|4673392|P3|Overall Study|Low Visual Analog Scale (VAS) Score|0
1415571|NCT01094782|4673393|P2|Overall Study|Low Visual Analog Scale (VAS) Score|0
1415572|NCT01094782|4673394|P1|Overall Study|Low Visual Analog Scale (VAS) Score|0
1415573|NCT01094782|4673389|P6|Overall Study|Recent Interventional Injection|1
1415574|NCT01094782|4673390|P5|Overall Study|Recent Interventional Injection|0
1415575|NCT01094782|4673391|P4|Overall Study|Recent Interventional Injection|0
1415576|NCT01094782|4673392|P3|Overall Study|Recent Interventional Injection|0
1415577|NCT01094782|4673393|P2|Overall Study|Recent Interventional Injection|0
1415578|NCT01094782|4673394|P1|Overall Study|Recent Interventional Injection|0
1415579|NCT01094782|4673389|P6|Overall Study|Wrong Pain Condition|1
1415580|NCT01094782|4673390|P5|Overall Study|Wrong Pain Condition|1
1415581|NCT01094782|4673391|P4|Overall Study|Wrong Pain Condition|2
1415582|NCT01094782|4673392|P3|Overall Study|Wrong Pain Condition|0
1415583|NCT01094782|4673393|P2|Overall Study|Wrong Pain Condition|0
1415584|NCT01094782|4673394|P1|Overall Study|Wrong Pain Condition|0
1415585|NCT01094782|4673389|P6|Overall Study|Hypertension|0
1415586|NCT01094782|4673390|P5|Overall Study|Hypertension|0
1415587|NCT01094782|4673391|P4|Overall Study|Hypertension|0
1415588|NCT01094782|4673392|P3|Overall Study|Hypertension|1
1415589|NCT01094782|4673393|P2|Overall Study|Hypertension|0
1415590|NCT01094782|4673394|P1|Overall Study|Hypertension|0
1415591|NCT01094782|4673389|P6|Overall Study|Healthy Subject Had Pain|0
1415592|NCT01094782|4673390|P5|Overall Study|Healthy Subject Had Pain|0
1415593|NCT01094782|4673391|P4|Overall Study|Healthy Subject Had Pain|0
1415594|NCT01094782|4673392|P3|Overall Study|Healthy Subject Had Pain|0
1415595|NCT01094782|4673393|P2|Overall Study|Healthy Subject Had Pain|1
1415596|NCT01094782|4673394|P1|Overall Study|Healthy Subject Had Pain|0
1415597|NCT01094782|4673389|P6|Overall Study|Unable to Complete Questionnaires|0
1415598|NCT01094782|4673390|P5|Overall Study|Unable to Complete Questionnaires|0
1415599|NCT01094782|4673391|P4|Overall Study|Unable to Complete Questionnaires|0
1415600|NCT01094782|4673392|P3|Overall Study|Unable to Complete Questionnaires|0
1415601|NCT01094782|4673393|P2|Overall Study|Unable to Complete Questionnaires|1
1415602|NCT01094782|4673394|P1|Overall Study|Unable to Complete Questionnaires|0
1415603|NCT01094782|4673389|P6|Overall Study|Sensory Deficit at Site of QST|0
1415604|NCT01094782|4673390|P5|Overall Study|Sensory Deficit at Site of QST|0
1415605|NCT01094782|4673391|P4|Overall Study|Sensory Deficit at Site of QST|0
1415606|NCT01094782|4673392|P3|Overall Study|Sensory Deficit at Site of QST|0
1415607|NCT01094782|4673393|P2|Overall Study|Sensory Deficit at Site of QST|1
1415608|NCT01094782|4673394|P1|Overall Study|Sensory Deficit at Site of QST|0
1415609|NCT01094782|4673389|P6|Overall Study|Positive Drug Screen|2
1415610|NCT01094782|4673390|P5|Overall Study|Positive Drug Screen|3
1415611|NCT01094782|4673391|P4|Overall Study|Positive Drug Screen|1
1415612|NCT01094782|4673392|P3|Overall Study|Positive Drug Screen|1
1415613|NCT01094782|4673393|P2|Overall Study|Positive Drug Screen|2
1415614|NCT01094782|4673394|P1|Overall Study|Positive Drug Screen|2
1415615|NCT01094782|4673389|P6|Overall Study|Lost to Follow-up|4
1415616|NCT01094782|4673390|P5|Overall Study|Lost to Follow-up|1
1415617|NCT01094782|4673391|P4|Overall Study|Lost to Follow-up|2
1415618|NCT01094782|4673392|P3|Overall Study|Lost to Follow-up|0
1415619|NCT01094782|4673393|P2|Overall Study|Lost to Follow-up|0
1415620|NCT01094782|4673394|P1|Overall Study|Lost to Follow-up|1
1415621|NCT01094782|4673389|P6|Overall Study|Withdrawal by Subject|0
1415622|NCT01094782|4673390|P5|Overall Study|Withdrawal by Subject|5
1415623|NCT01094782|4673391|P4|Overall Study|Withdrawal by Subject|5
1415624|NCT01094782|4673392|P3|Overall Study|Withdrawal by Subject|1
1415625|NCT01094782|4673393|P2|Overall Study|Withdrawal by Subject|5
1415626|NCT01094782|4673394|P1|Overall Study|Withdrawal by Subject|5
1415627|NCT01094743|4673438|P1|Period 1|Unsatisfactory comfort at lens fitting|2
1415628|NCT01094730|4673455|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
1415629|NCT01094730|4673456|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
1415630|NCT01094730|4673455|P2|Period 2 (14 Days)|Adverse Event|1
1415631|NCT01094730|4673456|P1|Period 2 (14 Days)|Adverse Event|0
1415632|NCT01094730|4673455|P2|Period 2 (14 Days)|No time for the follow-up visit|0
1415633|NCT01094730|4673456|P1|Period 2 (14 Days)|No time for the follow-up visit|1
1415634|NCT01094730|4673455|P2|Period 2 (14 Days)|Protocol Violation|0
1415635|NCT01094730|4673456|P1|Period 2 (14 Days)|Protocol Violation|2
1415636|NCT01094730|4673455|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
1415637|NCT01094730|4673456|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
1415638|NCT01094730|4673455|P2|Period 1 (14 Days)|No time for the follow-up visit|0
1415639|NCT01094730|4673456|P1|Period 1 (14 Days)|No time for the follow-up visit|1
1415640|NCT01094730|4673455|P2|Period 1 (14 Days)|Withdrawal by Subject|1
1415641|NCT01094730|4673456|P1|Period 1 (14 Days)|Withdrawal by Subject|0
1415642|NCT01094730|4673455|P2|Period 1 (14 Days)|Lost to Follow-up|1
1415643|NCT01094730|4673456|P1|Period 1 (14 Days)|Lost to Follow-up|0
1415644|NCT01094184|4673575|P2|Overall Study|Death|11
1415645|NCT01094184|4673576|P1|Overall Study|Death|35
1415646|NCT01094171|4673810|P1|Overall Study|Other|1
1415647|NCT01094171|4673810|P1|Overall Study|Migration from the study area|3
1415648|NCT01094171|4673810|P1|Overall Study|Informed consent withdrawal|4
1415649|NCT01094171|4673810|P1|Overall Study|Lost to Follow-up|2
1415650|NCT01094119|4673819|P2|Overall Study|Lack of Efficacy|4
1415651|NCT01094119|4673820|P1|Overall Study|Lack of Efficacy|2
1415652|NCT01093846|4673835|P3|Overall Study|Administrative Problems|15
1415653|NCT01093846|4673836|P2|Overall Study|Administrative Problems|17
1415654|NCT01093846|4673837|P1|Overall Study|Administrative Problems|18
1415655|NCT01093846|4673835|P3|Overall Study|Condition no longer required study drug|1
1415656|NCT01093846|4673836|P2|Overall Study|Condition no longer required study drug|1
1415657|NCT01093846|4673837|P1|Overall Study|Condition no longer required study drug|1
1415658|NCT01093846|4673835|P3|Overall Study|Lack of Efficacy|4
1415659|NCT01093846|4673836|P2|Overall Study|Lack of Efficacy|0
1415660|NCT01093846|4673837|P1|Overall Study|Lack of Efficacy|0
1415661|NCT01093846|4673835|P3|Overall Study|Adverse Event|1
1415662|NCT01093846|4673836|P2|Overall Study|Adverse Event|0
1415663|NCT01093846|4673837|P1|Overall Study|Adverse Event|0
1415664|NCT01093755|4673862|P2|Overall Study|Withdrawal by Subject|4
1415665|NCT01093755|4673863|P1|Overall Study|Withdrawal by Subject|3
1415666|NCT01093625|4673903|P2|1-Year Visit|Lost to Follow-up|3
1415667|NCT01093625|4673904|P1|1-Year Visit|Lost to Follow-up|5
1415668|NCT01093625|4673903|P2|6-Month Visit|Lost to Follow-up|2
1415669|NCT01093625|4673904|P1|6-Month Visit|Lost to Follow-up|2
1415670|NCT01093625|4673903|P2|6-Month Visit|Withdrawal by Subject|7
1415671|NCT01093625|4673904|P1|6-Month Visit|Withdrawal by Subject|6
1415672|NCT01093625|4673903|P2|3-Month Visit|Lost to Follow-up|0
1415673|NCT01093625|4673904|P1|3-Month Visit|Lost to Follow-up|2
1415674|NCT01093625|4673903|P2|1-Month Visit|Lost to Follow-up|0
1415675|NCT01093625|4673904|P1|1-Month Visit|Lost to Follow-up|2
1415676|NCT01093625|4673903|P2|2-Week Visit|Withdrawal by Subject|0
1415677|NCT01093625|4673904|P1|2-Week Visit|Withdrawal by Subject|1
1415678|NCT01093625|4673903|P2|Baseline and Dispensed|Withdrawal by Subject|0
1415679|NCT01093625|4673904|P1|Baseline and Dispensed|Withdrawal by Subject|2
1415680|NCT01093599|4673924|P2|Overall Study|Lost to Follow-up|46
1415681|NCT01093599|4673925|P1|Overall Study|Lost to Follow-up|32
1415682|NCT01093534|4673934|P3|Overall Study|Other|4
1415683|NCT01093534|4673935|P2|Overall Study|Other|3
1415684|NCT01093534|4673936|P1|Overall Study|Other|1
1415685|NCT01093534|4673934|P3|Overall Study|Withdrawal by Subject|2
1415686|NCT01093534|4673935|P2|Overall Study|Withdrawal by Subject|7
1415687|NCT01093534|4673936|P1|Overall Study|Withdrawal by Subject|5
1415688|NCT01093534|4673934|P3|Overall Study|Lack of Efficacy|1
1415689|NCT01093534|4673935|P2|Overall Study|Lack of Efficacy|1
1415690|NCT01093534|4673936|P1|Overall Study|Lack of Efficacy|2
1415691|NCT01093534|4673934|P3|Overall Study|Adverse Event|2
1415692|NCT01093534|4673935|P2|Overall Study|Adverse Event|5
1415693|NCT01093534|4673936|P1|Overall Study|Adverse Event|2
1415694|NCT01093222|4674084|P1|Overall Study|Not protocol specified|1
1415695|NCT01093222|4674084|P1|Overall Study|Death|2
1415696|NCT01093222|4674084|P1|Overall Study|Progression/relapse|24
1415697|NCT01093222|4674084|P1|Overall Study|Adverse Event|7
1415698|NCT01093222|4674084|P1|Overall Study|Ineligible|6
1415699|NCT01092832|4674157|P2|Overall Study|Not specified|0
1415700|NCT01092832|4674158|P1|Overall Study|Not specified|1
1415701|NCT01092780|4674170|P4|Washout Period 2|Adverse Event|0
1415702|NCT01092780|4674171|P3|Washout Period 2|Adverse Event|1
1415703|NCT01092780|4674172|P2|Washout Period 2|Adverse Event|1
1415704|NCT01092780|4674173|P1|Washout Period 2|Adverse Event|0
1415705|NCT01092780|4674170|P4|Washout Period 1|Noncompliance with nCPAP|0
1415706|NCT01092780|4674171|P3|Washout Period 1|Noncompliance with nCPAP|0
1415707|NCT01092780|4674172|P2|Washout Period 1|Noncompliance with nCPAP|0
1415708|NCT01092780|4674173|P1|Washout Period 1|Noncompliance with nCPAP|1
1415709|NCT01092780|4674170|P4|Washout Period 1|Adverse Event|0
1415710|NCT01092780|4674171|P3|Washout Period 1|Adverse Event|0
1415711|NCT01092780|4674172|P2|Washout Period 1|Adverse Event|1
1415712|NCT01092780|4674173|P1|Washout Period 1|Adverse Event|0
1415713|NCT01092728|4674209|P2|Overall Study|Prohibited Concomitant Medications|0
1415714|NCT01092728|4674210|P1|Overall Study|Prohibited Concomitant Medications|1
1415715|NCT01092728|4674209|P2|Overall Study|Disease Progression|13
1415716|NCT01092728|4674210|P1|Overall Study|Disease Progression|1
1415717|NCT01092728|4674209|P2|Overall Study|Adverse Event|1
1415718|NCT01092728|4674210|P1|Overall Study|Adverse Event|0
1415719|NCT01092728|4674209|P2|Overall Study|Withdrawal by Subject|0
1415720|NCT01092728|4674210|P1|Overall Study|Withdrawal by Subject|2
1415721|NCT01092702|4674218|P1|Overall Study|Lost to Follow-up|2
1415722|NCT01092702|4674218|P1|Overall Study|Withdrawal by Subject|7
1415723|NCT01092663|4674224|P2|Overall Study|Protocol Violation|1
1415724|NCT01092663|4674225|P1|Overall Study|Protocol Violation|0
1415725|NCT01092663|4674224|P2|Overall Study|Adverse Event|1
1415726|NCT01092663|4674225|P1|Overall Study|Adverse Event|1
1415727|NCT01092663|4674224|P2|Overall Study|High fasting triglyceride|0
1415728|NCT01092663|4674225|P1|Overall Study|High fasting triglyceride|2
1415729|NCT01092663|4674224|P2|Overall Study|Glucose >300mg/dL|0
1415730|NCT01092663|4674225|P1|Overall Study|Glucose >300mg/dL|1
1415731|NCT01092663|4674224|P2|Overall Study|Withdrawal by Subject|2
1415732|NCT01092663|4674225|P1|Overall Study|Withdrawal by Subject|3
1415733|NCT01092637|4674273|P2|Overall Study|Death|49
1415734|NCT01092637|4674274|P1|Overall Study|Death|47
1415735|NCT01092546|4674289|P1|Overall Study|Subjects withdrawn prior to dosing|4
1415736|NCT01092507|4674296|P2|Overall Study|Withdrawal by Subject|0
1415737|NCT01092507|4674297|P1|Overall Study|Withdrawal by Subject|2
1415738|NCT01092416|4674332|P1|12-Month Follow-up|Data collected after close of 1Y window|2
1415739|NCT01092416|4674332|P1|12-Month Follow-up|Missed 1-year follow-up|1
1415740|NCT01092416|4674332|P1|12-Month Follow-up|Withdrawal by Subject|2
1415741|NCT01092416|4674332|P1|12-Month Follow-up|Lost to Follow-up|4
1415742|NCT01092416|4674332|P1|12-Month Follow-up|Death|16
1415743|NCT01092416|4674332|P1|30-Day Follow-up|Data collected after close of 30D window|5
1415744|NCT01092416|4674332|P1|30-Day Follow-up|Missed 30-day follow-up|3
1415745|NCT01092416|4674332|P1|30-Day Follow-up|Death|2
1415746|NCT01092416|4674332|P1|Enrollment|Atherectomy device not inserted|3
1415747|NCT01091974|4674369|P4|Overall Study|side-effects|2
1415748|NCT01091974|4674370|P3|Overall Study|side-effects|0
1415749|NCT01091974|4674371|P2|Overall Study|side-effects|1
1415750|NCT01091974|4674372|P1|Overall Study|side-effects|1
1415751|NCT01091974|4674369|P4|Overall Study|Withdrawal by Subject|2
1415752|NCT01091974|4674370|P3|Overall Study|Withdrawal by Subject|2
1415753|NCT01091974|4674371|P2|Overall Study|Withdrawal by Subject|3
1415754|NCT01091974|4674372|P1|Overall Study|Withdrawal by Subject|1
1415755|NCT01091974|4674369|P4|Overall Study|resumed sleep medication|2
1415756|NCT01091974|4674370|P3|Overall Study|resumed sleep medication|1
1415757|NCT01091974|4674371|P2|Overall Study|resumed sleep medication|0
1415758|NCT01091974|4674372|P1|Overall Study|resumed sleep medication|0
1415759|NCT01091974|4674369|P4|Overall Study|Did not start intervention|1
1415760|NCT01091974|4674370|P3|Overall Study|Did not start intervention|3
1415761|NCT01091974|4674371|P2|Overall Study|Did not start intervention|1
1415762|NCT01091974|4674372|P1|Overall Study|Did not start intervention|3
1415763|NCT01091675|4674407|P1|Overall Study|Lack of Efficacy|27
1415764|NCT01091675|4674407|P1|Overall Study|Adverse Event|7
1415765|NCT01091662|4674413|P2|Overall Study|unable to swallow capsule|1
1415766|NCT01091662|4674414|P1|Overall Study|unable to swallow capsule|0
1415767|NCT01091662|4674413|P2|Overall Study|Protocol Violation|2
1415768|NCT01091662|4674414|P1|Overall Study|Protocol Violation|0
1415769|NCT01091662|4674413|P2|Overall Study|Pregnancy|1
1415770|NCT01091662|4674414|P1|Overall Study|Pregnancy|0
1415771|NCT01091662|4674413|P2|Overall Study|Lost to Follow-up|1
1415772|NCT01091662|4674414|P1|Overall Study|Lost to Follow-up|0
1415773|NCT01091662|4674413|P2|Overall Study|met exclusion criteria|0
1415774|NCT01091662|4674414|P1|Overall Study|met exclusion criteria|1
1415775|NCT01091662|4674413|P2|Overall Study|met exit criteria|13
1415776|NCT01091662|4674414|P1|Overall Study|met exit criteria|7
1415777|NCT01091662|4674413|P2|Overall Study|Withdrawal by Subject|6
1415778|NCT01091662|4674414|P1|Overall Study|Withdrawal by Subject|7
1415779|NCT01091662|4674413|P2|Overall Study|Physician Decision|1
1415780|NCT01091662|4674414|P1|Overall Study|Physician Decision|1
1415781|NCT01091662|4674413|P2|Overall Study|Adverse Event|9
1415782|NCT01091662|4674414|P1|Overall Study|Adverse Event|1
1415783|NCT01091519|4674452|P2|Overall Study|Randomized not treated|4
1415784|NCT01091519|4674453|P1|Overall Study|Randomized not treated|4
1415785|NCT01091519|4674452|P2|Overall Study|Other|8
1415786|NCT01091519|4674453|P1|Overall Study|Other|6
1415787|NCT01091519|4674452|P2|Overall Study|Withdrawal by Subject|2
1415788|NCT01091519|4674453|P1|Overall Study|Withdrawal by Subject|2
1415789|NCT01091519|4674452|P2|Overall Study|Lost to Follow-up|24
1415790|NCT01091519|4674453|P1|Overall Study|Lost to Follow-up|14
1415791|NCT01091519|4674452|P2|Overall Study|Lack of Efficacy|19
1415792|NCT01091519|4674453|P1|Overall Study|Lack of Efficacy|16
1415793|NCT01091519|4674452|P2|Overall Study|Death|0
1415794|NCT01091519|4674453|P1|Overall Study|Death|1
1415795|NCT01091519|4674452|P2|Overall Study|Adverse Event|16
1415796|NCT01091519|4674453|P1|Overall Study|Adverse Event|12
1415797|NCT01091454|4674465|P1|Overall Study|Ineligible|1
1415798|NCT01091428|4674478|P4|Phase 2|Physician Decision|0
1415799|NCT01091428|4674479|P3|Phase 2|Physician Decision|2
1415800|NCT01091428|4674480|P2|Phase 2|Physician Decision|0
1415801|NCT01091428|4674481|P1|Phase 2|Physician Decision|0
1415802|NCT01091428|4674478|P4|Phase 2|Reason not specified|3
1415803|NCT01091428|4674479|P3|Phase 2|Reason not specified|4
1415804|NCT01091428|4674480|P2|Phase 2|Reason not specified|0
1415805|NCT01091428|4674481|P1|Phase 2|Reason not specified|0
1415806|NCT01091428|4674478|P4|Phase 2|Unsatisfactory Therapeutic Response|1
1415807|NCT01091428|4674479|P3|Phase 2|Unsatisfactory Therapeutic Response|1
1415808|NCT01091428|4674480|P2|Phase 2|Unsatisfactory Therapeutic Response|0
1415809|NCT01091428|4674481|P1|Phase 2|Unsatisfactory Therapeutic Response|0
1415810|NCT01091428|4674478|P4|Phase 2|Withdrawal by Subject|8
1415811|NCT01091428|4674479|P3|Phase 2|Withdrawal by Subject|9
1415812|NCT01091428|4674480|P2|Phase 2|Withdrawal by Subject|0
1415813|NCT01091428|4674481|P1|Phase 2|Withdrawal by Subject|0
1415814|NCT01091428|4674478|P4|Phase 2|Adverse Event|5
1415815|NCT01091428|4674479|P3|Phase 2|Adverse Event|12
1415816|NCT01091428|4674480|P2|Phase 2|Adverse Event|0
1415817|NCT01091428|4674481|P1|Phase 2|Adverse Event|0
1415818|NCT01091428|4674478|P4|Phase 2|Symptomatic Deterioration|6
1415819|NCT01091428|4674479|P3|Phase 2|Symptomatic Deterioration|1
1415820|NCT01091428|4674480|P2|Phase 2|Symptomatic Deterioration|0
1415821|NCT01091428|4674481|P1|Phase 2|Symptomatic Deterioration|0
1415822|NCT01091428|4674478|P4|Phase 2|Progressive Disease|46
1415823|NCT01091428|4674479|P3|Phase 2|Progressive Disease|44
1415824|NCT01091428|4674480|P2|Phase 2|Progressive Disease|0
1415825|NCT01091428|4674481|P1|Phase 2|Progressive Disease|0
1415826|NCT01091428|4674478|P4|Phase 1|Single-Patient IND|0
1415827|NCT01091428|4674479|P3|Phase 1|Single-Patient IND|0
1415828|NCT01091428|4674480|P2|Phase 1|Single-Patient IND|0
1415829|NCT01091428|4674481|P1|Phase 1|Single-Patient IND|2
1415830|NCT01091428|4674478|P4|Phase 1|Reason not specified|0
1415831|NCT01091428|4674479|P3|Phase 1|Reason not specified|0
1415832|NCT01091428|4674480|P2|Phase 1|Reason not specified|1
1415833|NCT01091428|4674481|P1|Phase 1|Reason not specified|0
1415834|NCT01091428|4674478|P4|Phase 1|Withdrawal by Subject|0
1415835|NCT01091428|4674479|P3|Phase 1|Withdrawal by Subject|0
1415836|NCT01091428|4674480|P2|Phase 1|Withdrawal by Subject|0
1415837|NCT01091428|4674481|P1|Phase 1|Withdrawal by Subject|7
1415838|NCT01091428|4674478|P4|Phase 1|Adverse Event|0
1415839|NCT01091428|4674479|P3|Phase 1|Adverse Event|0
1415840|NCT01091428|4674480|P2|Phase 1|Adverse Event|0
1415841|NCT01091428|4674481|P1|Phase 1|Adverse Event|2
1415842|NCT01091428|4674478|P4|Phase 1|Symptomatic Deterioration|0
1415843|NCT01091428|4674479|P3|Phase 1|Symptomatic Deterioration|0
1415844|NCT01091428|4674480|P2|Phase 1|Symptomatic Deterioration|2
1415845|NCT01091428|4674481|P1|Phase 1|Symptomatic Deterioration|3
1415846|NCT01091428|4674478|P4|Phase 1|Progressive Disease|0
1415847|NCT01091428|4674479|P3|Phase 1|Progressive Disease|0
1415848|NCT01091428|4674480|P2|Phase 1|Progressive Disease|8
1415849|NCT01091428|4674481|P1|Phase 1|Progressive Disease|24
1415850|NCT01091259|4674582|P1|Overall Study|Lack of Efficacy|2
1415851|NCT01091259|4674582|P1|Overall Study|Adverse Event|3
1415852|NCT01091246|4674593|P3|Overall Study|Subject not dosed|1
1415853|NCT01091246|4674594|P2|Overall Study|Subject not dosed|0
1415854|NCT01091246|4674595|P1|Overall Study|Subject not dosed|2
1415855|NCT01091246|4674593|P3|Overall Study|Withdrawal by Subject|4
1415856|NCT01091246|4674594|P2|Overall Study|Withdrawal by Subject|5
1415857|NCT01091246|4674595|P1|Overall Study|Withdrawal by Subject|9
1415858|NCT01091246|4674593|P3|Overall Study|Adverse Event|1
1415859|NCT01091246|4674594|P2|Overall Study|Adverse Event|0
1415860|NCT01091246|4674595|P1|Overall Study|Adverse Event|1
1415861|NCT01091246|4674593|P3|Overall Study|Lost to Follow-up|7
1415862|NCT01091246|4674594|P2|Overall Study|Lost to Follow-up|11
1415863|NCT01091246|4674595|P1|Overall Study|Lost to Follow-up|23
1415864|NCT01091103|4674734|P1|Overall Study|Progressive Disease|3
1415865|NCT01091103|4674734|P1|Overall Study|Adverse Event|1
1415866|NCT01090973|4674754|P1|Overall Study|Disease progression|1
1415867|NCT01090765|4674770|P6|Overall Study|Vasovagal reaction with first infusion|0
1415868|NCT01090765|4674771|P5|Overall Study|Vasovagal reaction with first infusion|1
1415869|NCT01090765|4674772|P4|Overall Study|Vasovagal reaction with first infusion|0
1415870|NCT01090765|4674773|P3|Overall Study|Vasovagal reaction with first infusion|0
1415871|NCT01090765|4674774|P2|Overall Study|Vasovagal reaction with first infusion|0
1415872|NCT01090765|4674775|P1|Overall Study|Vasovagal reaction with first infusion|0
1415873|NCT01090765|4674770|P6|Overall Study|Developed a DVT, needed anticoagulation|0
1415874|NCT01090765|4674771|P5|Overall Study|Developed a DVT, needed anticoagulation|0
1415875|NCT01090765|4674772|P4|Overall Study|Developed a DVT, needed anticoagulation|1
1415876|NCT01090765|4674773|P3|Overall Study|Developed a DVT, needed anticoagulation|0
1415877|NCT01090765|4674774|P2|Overall Study|Developed a DVT, needed anticoagulation|0
1415878|NCT01090765|4674775|P1|Overall Study|Developed a DVT, needed anticoagulation|0
1415879|NCT01090765|4674770|P6|Overall Study|Patient withdrew consent|1
1415880|NCT01090765|4674771|P5|Overall Study|Patient withdrew consent|1
1415881|NCT01090765|4674772|P4|Overall Study|Patient withdrew consent|0
1415882|NCT01090765|4674773|P3|Overall Study|Patient withdrew consent|0
1415883|NCT01090765|4674774|P2|Overall Study|Patient withdrew consent|0
1415884|NCT01090765|4674775|P1|Overall Study|Patient withdrew consent|0
1415885|NCT01090739|4674821|P1|36 Month Follow-up|Visit still pending|17
1415886|NCT01090739|4674821|P1|36 Month Follow-up|Withdrawal by Subject|6
1415887|NCT01090739|4674821|P1|24 Month Follow-up|Death|1
1415888|NCT01090739|4674821|P1|24 Month Follow-up|Lost to Follow-up|1
1415889|NCT01090739|4674821|P1|24 Month Follow-up|Withdrawal by Subject|7
1415890|NCT01090739|4674821|P1|12 Month Follow-up|Death|1
1415891|NCT01090739|4674821|P1|12 Month Follow-up|Physician Decision|1
1415892|NCT01090739|4674821|P1|12 Month Follow-up|Lost to Follow-up|1
1415893|NCT01090739|4674821|P1|12 Month Follow-up|Withdrawal by Subject|2
1415894|NCT01090739|4674821|P1|Enrollment|Adverse Event|1
1415895|NCT01090739|4674821|P1|Enrollment|Study implant limit reached|2
1415896|NCT01090739|4674821|P1|Enrollment|Sponsor termination of site|4
1415897|NCT01090739|4674821|P1|Enrollment|Physician Decision|5
1415898|NCT01090739|4674821|P1|Enrollment|Lost to Follow-up|5
1415899|NCT01090739|4674821|P1|Enrollment|Protocol Violation|14
1415900|NCT01090739|4674821|P1|Enrollment|Withdrawal by Subject|24
1415901|NCT01090492|4674846|P8|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1415902|NCT01090492|4674847|P7|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
1415903|NCT01090492|4674848|P6|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1415904|NCT01090492|4674849|P5|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1415905|NCT01090492|4674850|P4|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1415906|NCT01090492|4674851|P3|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1415907|NCT01090492|4674852|P2|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1415908|NCT01090492|4674853|P1|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1415909|NCT01090492|4674846|P8|Second Intervention Period (4 Weeks)|Adverse Event|1
1415910|NCT01090492|4674847|P7|Second Intervention Period (4 Weeks)|Adverse Event|7
1415911|NCT01090492|4674848|P6|Second Intervention Period (4 Weeks)|Adverse Event|1
1415912|NCT01090492|4674849|P5|Second Intervention Period (4 Weeks)|Adverse Event|1
1415913|NCT01090492|4674850|P4|Second Intervention Period (4 Weeks)|Adverse Event|0
1415914|NCT01090492|4674851|P3|Second Intervention Period (4 Weeks)|Adverse Event|1
1415915|NCT01090492|4674852|P2|Second Intervention Period (4 Weeks)|Adverse Event|0
1415916|NCT01090492|4674853|P1|Second Intervention Period (4 Weeks)|Adverse Event|0
1415917|NCT01090492|4674846|P8|Second Intervention Period (4 Weeks)|Other|0
1415918|NCT01090492|4674847|P7|Second Intervention Period (4 Weeks)|Other|0
1415919|NCT01090492|4674848|P6|Second Intervention Period (4 Weeks)|Other|0
1415920|NCT01090492|4674849|P5|Second Intervention Period (4 Weeks)|Other|0
1415921|NCT01090492|4674850|P4|Second Intervention Period (4 Weeks)|Other|0
1415922|NCT01090492|4674851|P3|Second Intervention Period (4 Weeks)|Other|1
1415923|NCT01090492|4674852|P2|Second Intervention Period (4 Weeks)|Other|1
1415924|NCT01090492|4674853|P1|Second Intervention Period (4 Weeks)|Other|0
1415925|NCT01090492|4674846|P8|Second Intervention Period (4 Weeks)|Non-compliance|0
1415926|NCT01090492|4674847|P7|Second Intervention Period (4 Weeks)|Non-compliance|0
1415927|NCT01090492|4674848|P6|Second Intervention Period (4 Weeks)|Non-compliance|0
1415928|NCT01090492|4674849|P5|Second Intervention Period (4 Weeks)|Non-compliance|0
1415929|NCT01090492|4674850|P4|Second Intervention Period (4 Weeks)|Non-compliance|0
1415930|NCT01090492|4674851|P3|Second Intervention Period (4 Weeks)|Non-compliance|0
1415931|NCT01090492|4674852|P2|Second Intervention Period (4 Weeks)|Non-compliance|1
1415932|NCT01090492|4674853|P1|Second Intervention Period (4 Weeks)|Non-compliance|0
1415933|NCT01090492|4674846|P8|Second Intervention Period (4 Weeks)|Protocol Violation|1
1415934|NCT01090492|4674847|P7|Second Intervention Period (4 Weeks)|Protocol Violation|1
1415935|NCT01090492|4674848|P6|Second Intervention Period (4 Weeks)|Protocol Violation|0
1415936|NCT01090492|4674849|P5|Second Intervention Period (4 Weeks)|Protocol Violation|1
1415937|NCT01090492|4674850|P4|Second Intervention Period (4 Weeks)|Protocol Violation|0
1415938|NCT01090492|4674851|P3|Second Intervention Period (4 Weeks)|Protocol Violation|0
1415939|NCT01090492|4674852|P2|Second Intervention Period (4 Weeks)|Protocol Violation|0
1415940|NCT01090492|4674853|P1|Second Intervention Period (4 Weeks)|Protocol Violation|1
1415941|NCT01090492|4674846|P8|First Intervention Period (4 Weeks)|Adverse Event|5
1415942|NCT01090492|4674847|P7|First Intervention Period (4 Weeks)|Adverse Event|0
1415943|NCT01090492|4674848|P6|First Intervention Period (4 Weeks)|Adverse Event|2
1415944|NCT01090492|4674849|P5|First Intervention Period (4 Weeks)|Adverse Event|1
1415945|NCT01090492|4674850|P4|First Intervention Period (4 Weeks)|Adverse Event|3
1415946|NCT01090492|4674851|P3|First Intervention Period (4 Weeks)|Adverse Event|0
1415947|NCT01090492|4674852|P2|First Intervention Period (4 Weeks)|Adverse Event|2
1415948|NCT01090492|4674853|P1|First Intervention Period (4 Weeks)|Adverse Event|0
1415949|NCT01090492|4674846|P8|First Intervention Period (4 Weeks)|Pregnancy|0
1415950|NCT01090492|4674847|P7|First Intervention Period (4 Weeks)|Pregnancy|0
1415951|NCT01090492|4674848|P6|First Intervention Period (4 Weeks)|Pregnancy|0
1415952|NCT01090492|4674849|P5|First Intervention Period (4 Weeks)|Pregnancy|1
1415953|NCT01090492|4674850|P4|First Intervention Period (4 Weeks)|Pregnancy|0
1415954|NCT01090492|4674851|P3|First Intervention Period (4 Weeks)|Pregnancy|0
1415955|NCT01090492|4674852|P2|First Intervention Period (4 Weeks)|Pregnancy|0
1415956|NCT01090492|4674853|P1|First Intervention Period (4 Weeks)|Pregnancy|0
1415957|NCT01090492|4674846|P8|First Intervention Period (4 Weeks)|Other|0
1415958|NCT01090492|4674847|P7|First Intervention Period (4 Weeks)|Other|0
1415959|NCT01090492|4674848|P6|First Intervention Period (4 Weeks)|Other|0
1415960|NCT01090492|4674849|P5|First Intervention Period (4 Weeks)|Other|2
1415961|NCT01090492|4674850|P4|First Intervention Period (4 Weeks)|Other|1
1415962|NCT01090492|4674851|P3|First Intervention Period (4 Weeks)|Other|1
1415963|NCT01090492|4674852|P2|First Intervention Period (4 Weeks)|Other|0
1415964|NCT01090492|4674853|P1|First Intervention Period (4 Weeks)|Other|0
1415965|NCT01090492|4674846|P8|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1415966|NCT01090492|4674847|P7|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1415967|NCT01090492|4674848|P6|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1415968|NCT01090492|4674849|P5|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1415969|NCT01090492|4674850|P4|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1415970|NCT01090492|4674851|P3|First Intervention Period (4 Weeks)|Lost to Follow-up|1
1415971|NCT01090492|4674852|P2|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1415972|NCT01090492|4674853|P1|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1415973|NCT01090492|4674846|P8|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
1415974|NCT01090492|4674847|P7|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1415975|NCT01090492|4674848|P6|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1415976|NCT01090492|4674849|P5|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1415977|NCT01090492|4674850|P4|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1415978|NCT01090492|4674851|P3|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1415979|NCT01090492|4674852|P2|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
1415980|NCT01090492|4674853|P1|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1415981|NCT01090492|4674846|P8|First Intervention Period (4 Weeks)|Protocol Violation|0
1415982|NCT01090492|4674847|P7|First Intervention Period (4 Weeks)|Protocol Violation|1
1415983|NCT01090492|4674848|P6|First Intervention Period (4 Weeks)|Protocol Violation|0
1415984|NCT01090492|4674849|P5|First Intervention Period (4 Weeks)|Protocol Violation|0
1415985|NCT01090492|4674850|P4|First Intervention Period (4 Weeks)|Protocol Violation|2
1415986|NCT01090492|4674851|P3|First Intervention Period (4 Weeks)|Protocol Violation|1
1415987|NCT01090492|4674852|P2|First Intervention Period (4 Weeks)|Protocol Violation|1
1415988|NCT01090492|4674853|P1|First Intervention Period (4 Weeks)|Protocol Violation|1
1415989|NCT01090453|4674921|P2|Overall Study|Eligibility Criteria|1
1415990|NCT01090453|4674922|P1|Overall Study|Eligibility Criteria|0
1415991|NCT01090453|4674921|P2|Overall Study|Other|4
1415992|NCT01090453|4674922|P1|Overall Study|Other|2
1415993|NCT01090453|4674921|P2|Overall Study|Protocol Violation|0
1415994|NCT01090453|4674922|P1|Overall Study|Protocol Violation|2
1415995|NCT01090453|4674921|P2|Overall Study|Non serious AEs|0
1415996|NCT01090453|4674922|P1|Overall Study|Non serious AEs|1
1415997|NCT01090453|4674921|P2|Overall Study|Lost to Follow-up|7
1415998|NCT01090453|4674922|P1|Overall Study|Lost to Follow-up|7
1415999|NCT01090453|4674921|P2|Overall Study|Withdrawal by Subject|2
1416000|NCT01090453|4674922|P1|Overall Study|Withdrawal by Subject|1
1416001|NCT01090427|4674973|P7|After Controlled Period|Adverse Event|0
1416002|NCT01090427|4674974|P6|After Controlled Period|Adverse Event|1
1416003|NCT01090427|4674975|P5|After Controlled Period|Adverse Event|0
1416004|NCT01090427|4674976|P4|After Controlled Period|Adverse Event|2
1416005|NCT01090427|4674977|P3|After Controlled Period|Adverse Event|0
1416006|NCT01090427|4674978|P2|After Controlled Period|Adverse Event|0
1416007|NCT01090427|4674979|P1|After Controlled Period|Adverse Event|0
1416008|NCT01090427|4674973|P7|After Controlled Period|Lack of Efficacy|2
1416009|NCT01090427|4674974|P6|After Controlled Period|Lack of Efficacy|3
1416010|NCT01090427|4674975|P5|After Controlled Period|Lack of Efficacy|0
1416011|NCT01090427|4674976|P4|After Controlled Period|Lack of Efficacy|0
1416012|NCT01090427|4674977|P3|After Controlled Period|Lack of Efficacy|0
1416013|NCT01090427|4674978|P2|After Controlled Period|Lack of Efficacy|0
1416014|NCT01090427|4674979|P1|After Controlled Period|Lack of Efficacy|0
1416015|NCT01090427|4674973|P7|After Controlled Period|Death|0
1416016|NCT01090427|4674974|P6|After Controlled Period|Death|1
1416017|NCT01090427|4674975|P5|After Controlled Period|Death|0
1416018|NCT01090427|4674976|P4|After Controlled Period|Death|0
1416019|NCT01090427|4674977|P3|After Controlled Period|Death|0
1416020|NCT01090427|4674978|P2|After Controlled Period|Death|0
1416021|NCT01090427|4674979|P1|After Controlled Period|Death|0
1416022|NCT01090323|4675014|P2|Overall Study|Stopped end of extension 1#|1
1416023|NCT01090323|4675015|P1|Overall Study|Stopped end of extension 1#|3
1416024|NCT01090323|4675014|P2|Overall Study|Stopped end of core|0
1416025|NCT01090323|4675015|P1|Overall Study|Stopped end of core|7
1416026|NCT01090323|4675014|P2|Overall Study|Death|2
1416027|NCT01090323|4675015|P1|Overall Study|Death|1
1416028|NCT01090323|4675014|P2|Overall Study|Administrative problems|4
1416029|NCT01090323|4675015|P1|Overall Study|Administrative problems|6
1416030|NCT01090323|4675014|P2|Overall Study|Lost to Follow-up|6
1416031|NCT01090323|4675015|P1|Overall Study|Lost to Follow-up|11
1416032|NCT01090323|4675014|P2|Overall Study|Withdrew consent|11
1416033|NCT01090323|4675015|P1|Overall Study|Withdrew consent|33
1416034|NCT01090323|4675014|P2|Overall Study|Protocol Violation|1
1416035|NCT01090323|4675015|P1|Overall Study|Protocol Violation|2
1416036|NCT01090323|4675014|P2|Overall Study|Condition no longer requires drug|4
1416037|NCT01090323|4675015|P1|Overall Study|Condition no longer requires drug|5
1416038|NCT01090323|4675014|P2|Overall Study|Unsatisfactory therapeutic effect|2
1416039|NCT01090323|4675015|P1|Overall Study|Unsatisfactory therapeutic effect|4
1416040|NCT01090323|4675014|P2|Overall Study|Abnormal Test Procedure Results|0
1416041|NCT01090323|4675015|P1|Overall Study|Abnormal Test Procedure Results|2
1416042|NCT01090323|4675014|P2|Overall Study|Abnormal Lab Values|1
1416043|NCT01090323|4675015|P1|Overall Study|Abnormal Lab Values|3
1416044|NCT01090323|4675014|P2|Overall Study|Adverse Event|2
1416045|NCT01090323|4675015|P1|Overall Study|Adverse Event|12
1416046|NCT01090310|4675027|P4|Extension Study|Subject withdrew consent|0
1416047|NCT01090310|4675028|P3|Extension Study|Subject withdrew consent|0
1416048|NCT01090310|4675029|P2|Extension Study|Subject withdrew consent|1
1416049|NCT01090310|4675030|P1|Extension Study|Subject withdrew consent|0
1416050|NCT01090310|4675027|P4|Extension Study|Unsatisfactory therapeutic effect|1
1416051|NCT01090310|4675028|P3|Extension Study|Unsatisfactory therapeutic effect|1
1416052|NCT01090310|4675029|P2|Extension Study|Unsatisfactory therapeutic effect|0
1416053|NCT01090310|4675030|P1|Extension Study|Unsatisfactory therapeutic effect|1
1416054|NCT01090310|4675027|P4|Extension Study|Adverse Event|1
1416055|NCT01090310|4675028|P3|Extension Study|Adverse Event|0
1416056|NCT01090310|4675029|P2|Extension Study|Adverse Event|0
1416057|NCT01090310|4675030|P1|Extension Study|Adverse Event|0
1416058|NCT01090310|4675027|P4|Extension Study|Aministrative problems|18
1416059|NCT01090310|4675028|P3|Extension Study|Aministrative problems|14
1416060|NCT01090310|4675029|P2|Extension Study|Aministrative problems|15
1416061|NCT01090310|4675030|P1|Extension Study|Aministrative problems|13
1416062|NCT01090310|4675027|P4|Core Study|Protocol deviation|1
1416063|NCT01090310|4675028|P3|Core Study|Protocol deviation|0
1416064|NCT01090310|4675029|P2|Core Study|Protocol deviation|0
1416065|NCT01090310|4675030|P1|Core Study|Protocol deviation|1
1416066|NCT01090310|4675027|P4|Core Study|Administrative reasons|4
1416067|NCT01090310|4675028|P3|Core Study|Administrative reasons|4
1416068|NCT01090310|4675029|P2|Core Study|Administrative reasons|6
1416069|NCT01090310|4675030|P1|Core Study|Administrative reasons|5
1416070|NCT01090310|4675027|P4|Core Study|Abnormal test procedure result|0
1416071|NCT01090310|4675028|P3|Core Study|Abnormal test procedure result|1
1416072|NCT01090310|4675029|P2|Core Study|Abnormal test procedure result|0
1416073|NCT01090310|4675030|P1|Core Study|Abnormal test procedure result|0
1416074|NCT01090310|4675027|P4|Core Study|Subject withdrew consent|1
1416075|NCT01090310|4675028|P3|Core Study|Subject withdrew consent|1
1416076|NCT01090310|4675029|P2|Core Study|Subject withdrew consent|3
1416077|NCT01090310|4675030|P1|Core Study|Subject withdrew consent|0
1416078|NCT01090310|4675027|P4|Core Study|Adverse Event|1
1416079|NCT01090310|4675028|P3|Core Study|Adverse Event|1
1416080|NCT01090310|4675029|P2|Core Study|Adverse Event|2
1416081|NCT01090310|4675030|P1|Core Study|Adverse Event|2
1416082|NCT01090102|4675069|P2|Second 12 Weeks|Withdrawal by Subject|1
1416083|NCT01090102|4675070|P1|Second 12 Weeks|Withdrawal by Subject|0
1416084|NCT01090102|4675069|P2|First 12 Weeks|Death|1
1416085|NCT01090102|4675070|P1|First 12 Weeks|Death|1
1416086|NCT01090102|4675069|P2|First 12 Weeks|Adverse Event|0
1416087|NCT01090102|4675070|P1|First 12 Weeks|Adverse Event|2
1416088|NCT01090102|4675069|P2|First 12 Weeks|Withdrawal by Subject|1
1416089|NCT01090102|4675070|P1|First 12 Weeks|Withdrawal by Subject|1
1416090|NCT01090076|4675080|P2|Overall Study|Withdrawal by Subject|1
1416091|NCT01090076|4675081|P1|Overall Study|Withdrawal by Subject|0
1416092|NCT01090076|4675080|P2|Overall Study|Death|1
1416093|NCT01090076|4675081|P1|Overall Study|Death|1
1416094|NCT01090063|4675091|P1|Treatment|Withdrawal by Subject|4
1416095|NCT01090063|4675091|P1|Screen|Screen Failed|4
1416096|NCT01090050|4675107|P2|Overall Study|Physician Decision|1
1416097|NCT01090050|4675108|P1|Overall Study|Physician Decision|0
1416098|NCT01090050|4675107|P2|Overall Study|Lack of Efficacy|5
1416099|NCT01090050|4675108|P1|Overall Study|Lack of Efficacy|1
1416100|NCT01090050|4675107|P2|Overall Study|Lost to Follow-up|1
1416101|NCT01090050|4675108|P1|Overall Study|Lost to Follow-up|0
1416102|NCT01090011|4675128|P1|Overall Study|Other reason not defined above|5
1416103|NCT01090011|4675128|P1|Overall Study|Refusal to start/continue medication|5
1416104|NCT01090011|4675128|P1|Overall Study|Protocol Violation|1
1416105|NCT01090011|4675128|P1|Overall Study|Adverse Event|32
1416106|NCT01090011|4675128|P1|Overall Study|Progressive disease|128
1416107|NCT01089608|4675221|P2|Overall Study|Lost to Follow-up|2
1416108|NCT01089608|4675222|P1|Overall Study|Lost to Follow-up|0
1416109|NCT01089608|4675221|P2|Overall Study|Adverse Event|4
1416110|NCT01089608|4675222|P1|Overall Study|Adverse Event|0
1416111|NCT01089582|4675239|P1|Overall Study|Withdrawal by Subject|1
1416112|NCT01089582|4675239|P1|Overall Study|Other|4
1416113|NCT01089582|4675239|P1|Overall Study|Lost to Follow-up|8
1416114|NCT01089582|4675239|P1|Overall Study|Adverse Event|15
1416115|NCT01089582|4675239|P1|Overall Study|Death|2
1416116|NCT01089556|4675282|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
1416117|NCT01089556|4675283|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
1416118|NCT01089556|4675284|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
1416119|NCT01089556|4675285|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
1416120|NCT01089556|4675286|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
1416121|NCT01089556|4675287|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
1416122|NCT01089556|4675282|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
1416123|NCT01089556|4675283|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
1416124|NCT01089556|4675284|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
1416125|NCT01089556|4675285|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
1416126|NCT01089556|4675286|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
1416127|NCT01089556|4675287|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
1416128|NCT01089556|4675282|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
1416129|NCT01089556|4675283|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
1416130|NCT01089556|4675284|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
1416131|NCT01089556|4675285|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
1416132|NCT01089556|4675286|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
1416133|NCT01089556|4675287|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
1416134|NCT01089556|4675282|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
1416135|NCT01089556|4675283|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
1416136|NCT01089556|4675284|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
1416137|NCT01089556|4675285|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
1416138|NCT01089556|4675286|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
1416139|NCT01089556|4675287|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
1416140|NCT01089556|4675282|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
1416141|NCT01089556|4675283|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
1416142|NCT01089556|4675284|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
1416143|NCT01089556|4675285|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
1416144|NCT01089556|4675286|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
1416145|NCT01089556|4675287|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
1416146|NCT01089556|4675282|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
1416147|NCT01089556|4675283|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
1416148|NCT01089556|4675284|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
1416149|NCT01089556|4675285|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
1416150|NCT01089556|4675286|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
1416151|NCT01089556|4675287|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
1416152|NCT01089556|4675282|P6|Study Period III (Weeks 9-16)|Adverse Event|3
1416153|NCT01089556|4675283|P5|Study Period III (Weeks 9-16)|Adverse Event|4
1416154|NCT01089556|4675284|P4|Study Period III (Weeks 9-16)|Adverse Event|2
1416155|NCT01089556|4675285|P3|Study Period III (Weeks 9-16)|Adverse Event|4
1416156|NCT01089556|4675286|P2|Study Period III (Weeks 9-16)|Adverse Event|0
1416157|NCT01089556|4675287|P1|Study Period III (Weeks 9-16)|Adverse Event|0
1416158|NCT01089556|4675282|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
1416159|NCT01089556|4675283|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
1416160|NCT01089556|4675284|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
1416161|NCT01089556|4675285|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
1416162|NCT01089556|4675286|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
1416163|NCT01089556|4675287|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
1416164|NCT01089556|4675282|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
1416165|NCT01089556|4675283|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
1416166|NCT01089556|4675284|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
1416167|NCT01089556|4675285|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
1416168|NCT01089556|4675286|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
1416169|NCT01089556|4675287|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
1416170|NCT01089556|4675282|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
1416171|NCT01089556|4675283|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
1416172|NCT01089556|4675284|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
1416173|NCT01089556|4675285|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
1416174|NCT01089556|4675286|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
1416175|NCT01089556|4675287|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
1416176|NCT01089556|4675282|P6|Study Period II (Weeks 1-8)|Physician Decision|0
1416177|NCT01089556|4675283|P5|Study Period II (Weeks 1-8)|Physician Decision|0
1416178|NCT01089556|4675284|P4|Study Period II (Weeks 1-8)|Physician Decision|0
1416179|NCT01089556|4675285|P3|Study Period II (Weeks 1-8)|Physician Decision|0
1416180|NCT01089556|4675286|P2|Study Period II (Weeks 1-8)|Physician Decision|0
1416181|NCT01089556|4675287|P1|Study Period II (Weeks 1-8)|Physician Decision|4
1416182|NCT01089556|4675282|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
1416183|NCT01089556|4675283|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
1416184|NCT01089556|4675284|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
1416185|NCT01089556|4675285|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
1416186|NCT01089556|4675286|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
1416187|NCT01089556|4675287|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
1416188|NCT01089556|4675282|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
1416189|NCT01089556|4675283|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
1416190|NCT01089556|4675284|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
1416191|NCT01089556|4675285|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
1416192|NCT01089556|4675286|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
1416193|NCT01089556|4675287|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
1416194|NCT01089556|4675282|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
1416195|NCT01089556|4675283|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
1416196|NCT01089556|4675284|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
1416197|NCT01089556|4675285|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
1416198|NCT01089556|4675286|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
1416199|NCT01089556|4675287|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
1416200|NCT01089556|4675282|P6|Study Period II (Weeks 1-8)|Adverse Event|0
1416201|NCT01089556|4675283|P5|Study Period II (Weeks 1-8)|Adverse Event|0
1416202|NCT01089556|4675284|P4|Study Period II (Weeks 1-8)|Adverse Event|0
1416203|NCT01089556|4675285|P3|Study Period II (Weeks 1-8)|Adverse Event|0
1416204|NCT01089556|4675286|P2|Study Period II (Weeks 1-8)|Adverse Event|39
1416205|NCT01089556|4675287|P1|Study Period II (Weeks 1-8)|Adverse Event|35
1416206|NCT01089543|4675361|P4|Overall Study|Adverse Event|0
1416207|NCT01089543|4675362|P3|Overall Study|Adverse Event|0
1416208|NCT01089543|4675363|P2|Overall Study|Adverse Event|1
1416209|NCT01089543|4675364|P1|Overall Study|Adverse Event|0
1416210|NCT01089543|4675361|P4|Overall Study|Physician Decision|1
1416211|NCT01089543|4675362|P3|Overall Study|Physician Decision|0
1416212|NCT01089543|4675363|P2|Overall Study|Physician Decision|0
1416213|NCT01089543|4675364|P1|Overall Study|Physician Decision|1
1416214|NCT01089543|4675361|P4|Overall Study|Withdrawal by Subject|1
1416215|NCT01089543|4675362|P3|Overall Study|Withdrawal by Subject|3
1416216|NCT01089543|4675363|P2|Overall Study|Withdrawal by Subject|3
1416217|NCT01089543|4675364|P1|Overall Study|Withdrawal by Subject|2
1416218|NCT01089504|4675399|P2|Overall Study|Withdrawal by Subject|0
1416219|NCT01089504|4675400|P1|Overall Study|Withdrawal by Subject|2
1416220|NCT01089504|4675399|P2|Overall Study|Lost to Follow-up|1
1416221|NCT01089504|4675400|P1|Overall Study|Lost to Follow-up|1
1416222|NCT01089413|4675413|P1|Overall Study|Other|71
1416223|NCT01089413|4675413|P1|Overall Study|Metastasectomy|13
1416224|NCT01089413|4675413|P1|Overall Study|Death|10
1416225|NCT01089413|4675413|P1|Overall Study|Unacceptable Toxicity|12
1416226|NCT01089413|4675413|P1|Overall Study|Participant Withdrew Consent|1
1416227|NCT01089413|4675413|P1|Overall Study|Progressive Disease|93
1416228|NCT01089413|4675413|P1|Overall Study|Lost to Follow-up|1
1416229|NCT01089361|4675432|P2|Overall Study|Death|0
1416230|NCT01089361|4675433|P1|Overall Study|Death|1
1416231|NCT01089127|4675482|P6|Overall Study|Protocol deviation|0
1416232|NCT01089127|4675483|P5|Overall Study|Protocol deviation|1
1416233|NCT01089127|4675484|P4|Overall Study|Protocol deviation|0
1416234|NCT01089127|4675485|P3|Overall Study|Protocol deviation|0
1416235|NCT01089127|4675486|P2|Overall Study|Protocol deviation|1
1416236|NCT01089127|4675487|P1|Overall Study|Protocol deviation|0
1416237|NCT01089127|4675482|P6|Overall Study|Lost to Follow-up|0
1416238|NCT01089127|4675483|P5|Overall Study|Lost to Follow-up|1
1416239|NCT01089127|4675484|P4|Overall Study|Lost to Follow-up|0
1416240|NCT01089127|4675485|P3|Overall Study|Lost to Follow-up|0
1416241|NCT01089127|4675486|P2|Overall Study|Lost to Follow-up|1
1416242|NCT01089127|4675487|P1|Overall Study|Lost to Follow-up|1
1416243|NCT01089127|4675482|P6|Overall Study|Abnormal test procedure result(s)|0
1416244|NCT01089127|4675483|P5|Overall Study|Abnormal test procedure result(s)|0
1416245|NCT01089127|4675484|P4|Overall Study|Abnormal test procedure result(s)|0
1416246|NCT01089127|4675485|P3|Overall Study|Abnormal test procedure result(s)|0
1416247|NCT01089127|4675486|P2|Overall Study|Abnormal test procedure result(s)|1
1416248|NCT01089127|4675487|P1|Overall Study|Abnormal test procedure result(s)|2
1416249|NCT01089127|4675482|P6|Overall Study|Subject withdrew consent|2
1416250|NCT01089127|4675483|P5|Overall Study|Subject withdrew consent|0
1416251|NCT01089127|4675484|P4|Overall Study|Subject withdrew consent|1
1416252|NCT01089127|4675485|P3|Overall Study|Subject withdrew consent|1
1416253|NCT01089127|4675486|P2|Overall Study|Subject withdrew consent|1
1416254|NCT01089127|4675487|P1|Overall Study|Subject withdrew consent|0
1416255|NCT01089127|4675482|P6|Overall Study|Adverse Event|1
1416256|NCT01089127|4675483|P5|Overall Study|Adverse Event|0
1416257|NCT01089127|4675484|P4|Overall Study|Adverse Event|0
1416258|NCT01089127|4675485|P3|Overall Study|Adverse Event|1
1416259|NCT01089127|4675486|P2|Overall Study|Adverse Event|1
1416260|NCT01089127|4675487|P1|Overall Study|Adverse Event|5
1416261|NCT01089023|4675541|P1|Overall Study|Lack of Efficacy|1
1416262|NCT01089023|4675541|P1|Overall Study|Protocol Violation|1
1416263|NCT01089023|4675541|P1|Overall Study|Withdrawal by Subject|1
1416264|NCT01089023|4675541|P1|Overall Study|Adverse Event|1
1416265|NCT01089023|4675541|P1|Overall Study|Lost to Follow-up|3
1416266|NCT01088997|4675555|P2|Overall Study|Excluded prior to receiving drug|1
1416267|NCT01088997|4675556|P1|Overall Study|Excluded prior to receiving drug|1
1416268|NCT01088997|4675555|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
1416269|NCT01088997|4675556|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
1416270|NCT01088997|4675555|P2|Overall Study|Physician Decision|1
1416271|NCT01088997|4675556|P1|Overall Study|Physician Decision|1
1416272|NCT01088984|4675567|P2|Phase 2|Not Specified|1
1416273|NCT01088984|4675568|P1|Phase 2|Not Specified|0
1416274|NCT01088984|4675567|P2|Phase 2|DIsease Progression|25
1416275|NCT01088984|4675568|P1|Phase 2|DIsease Progression|0
1416276|NCT01088984|4675567|P2|Phase 2|Withdrawal by Subject|1
1416277|NCT01088984|4675568|P1|Phase 2|Withdrawal by Subject|0
1416278|NCT01088984|4675567|P2|Phase 2|Death|5
1416279|NCT01088984|4675568|P1|Phase 2|Death|0
1416280|NCT01088984|4675567|P2|Phase 1|Not Specified|1
1416281|NCT01088984|4675568|P1|Phase 1|Not Specified|1
1416282|NCT01088984|4675567|P2|Phase 1|Disease Progression|4
1416283|NCT01088984|4675568|P1|Phase 1|Disease Progression|2
1416284|NCT01088984|4675567|P2|Phase 1|Death|1
1416285|NCT01088984|4675568|P1|Phase 1|Death|2
1416286|NCT01088529|4675629|P2|Overall Study|Did not receive study treatment|1
1416287|NCT01088529|4675630|P1|Overall Study|Did not receive study treatment|0
1416288|NCT01088503|4675643|P3|Overall Study|Death|7
1416289|NCT01088503|4675644|P2|Overall Study|Death|358
1416290|NCT01088503|4675645|P1|Overall Study|Death|64
1416291|NCT01088503|4675643|P3|Overall Study|Withdrawal by Subject|10
1416292|NCT01088503|4675644|P2|Overall Study|Withdrawal by Subject|327
1416293|NCT01088503|4675645|P1|Overall Study|Withdrawal by Subject|118
1416294|NCT01088438|4675723|P2|Overall Study|Lost to Follow-up|30
1416295|NCT01088438|4675724|P1|Overall Study|Lost to Follow-up|18
1416296|NCT01088438|4675723|P2|Overall Study|Withdrawal by Subject|6
1416297|NCT01088438|4675724|P1|Overall Study|Withdrawal by Subject|11
1416298|NCT01088399|4675737|P3|Overall Study|Study summary visit not completed|80
1416299|NCT01088399|4675738|P2|Overall Study|Study summary visit not completed|283
1416300|NCT01088399|4675739|P1|Overall Study|Study summary visit not completed|2398
1416301|NCT01088399|4675737|P3|Overall Study|Enrollment criteria not met|70
1416302|NCT01088399|4675738|P2|Overall Study|Enrollment criteria not met|119
1416303|NCT01088399|4675739|P1|Overall Study|Enrollment criteria not met|48
1416304|NCT01088399|4675737|P3|Overall Study|Protocol Violation|0
1416305|NCT01088399|4675738|P2|Overall Study|Protocol Violation|1
1416306|NCT01088399|4675739|P1|Overall Study|Protocol Violation|10
1416307|NCT01088399|4675737|P3|Overall Study|Sponsor decision|7
1416308|NCT01088399|4675738|P2|Overall Study|Sponsor decision|298
1416309|NCT01088399|4675739|P1|Overall Study|Sponsor decision|1573
1416310|NCT01088399|4675737|P3|Overall Study|Change to or start of somatropin therapy|12
1416311|NCT01088399|4675738|P2|Overall Study|Change to or start of somatropin therapy|17
1416312|NCT01088399|4675739|P1|Overall Study|Change to or start of somatropin therapy|234
1416313|NCT01088399|4675737|P3|Overall Study|Withdrawal by Subject|33
1416314|NCT01088399|4675738|P2|Overall Study|Withdrawal by Subject|195
1416315|NCT01088399|4675739|P1|Overall Study|Withdrawal by Subject|544
1416316|NCT01088399|4675737|P3|Overall Study|Physician Decision|16
1416317|NCT01088399|4675738|P2|Overall Study|Physician Decision|88
1416318|NCT01088399|4675739|P1|Overall Study|Physician Decision|531
1416319|NCT01088399|4675737|P3|Overall Study|Lost to Follow-up|58
1416320|NCT01088399|4675738|P2|Overall Study|Lost to Follow-up|278
1416321|NCT01088399|4675739|P1|Overall Study|Lost to Follow-up|1070
1416322|NCT01088399|4675737|P3|Overall Study|Lack of Efficacy|5
1416323|NCT01088399|4675738|P2|Overall Study|Lack of Efficacy|7
1416324|NCT01088399|4675739|P1|Overall Study|Lack of Efficacy|298
1416325|NCT01088399|4675737|P3|Overall Study|Death|0
1416326|NCT01088399|4675738|P2|Overall Study|Death|45
1416327|NCT01088399|4675739|P1|Overall Study|Death|204
1416328|NCT01088399|4675737|P3|Overall Study|Adverse Event|0
1416329|NCT01088399|4675738|P2|Overall Study|Adverse Event|16
1416330|NCT01088399|4675739|P1|Overall Study|Adverse Event|211
1416331|NCT01088243|4675768|P2|Overall Study|Adverse Event|0
1416332|NCT01088243|4675769|P1|Overall Study|Adverse Event|1
1416333|NCT01087970|4675810|P1|Overall Study|Protocol Violation|2
1416334|NCT01087957|4675822|P2|Overall Study|Physician Decision|9
1416335|NCT01087957|4675823|P1|Overall Study|Physician Decision|5
1416336|NCT01087957|4675822|P2|Overall Study|Withdrawal by Subject|15
1416337|NCT01087957|4675823|P1|Overall Study|Withdrawal by Subject|18
1416338|NCT01087957|4675822|P2|Overall Study|Protocol Violation|25
1416339|NCT01087957|4675823|P1|Overall Study|Protocol Violation|13
1416340|NCT01087957|4675822|P2|Overall Study|Lost to Follow-up|4
1416341|NCT01087957|4675823|P1|Overall Study|Lost to Follow-up|3
1416342|NCT01087957|4675822|P2|Overall Study|Death|2
1416343|NCT01087957|4675823|P1|Overall Study|Death|2
1416344|NCT01087944|4675849|P2|Period 2 (Week 4-6)|Adverse Event|2
1416345|NCT01087944|4675850|P1|Period 2 (Week 4-6)|Adverse Event|0
1416346|NCT01087944|4675849|P2|Period 1 (Week 1-3)|Adverse Event|0
1416347|NCT01087944|4675850|P1|Period 1 (Week 1-3)|Adverse Event|1
1416348|NCT01087905|4675930|P8|Overall Study|Withdrawal by Subject|5
1416349|NCT01087905|4675931|P7|Overall Study|Withdrawal by Subject|3
1416350|NCT01087905|4675932|P6|Overall Study|Withdrawal by Subject|3
1416351|NCT01087905|4675933|P5|Overall Study|Withdrawal by Subject|4
1416352|NCT01087905|4675934|P4|Overall Study|Withdrawal by Subject|5
1416353|NCT01087905|4675935|P3|Overall Study|Withdrawal by Subject|4
1416354|NCT01087905|4675936|P2|Overall Study|Withdrawal by Subject|4
1416355|NCT01087905|4675937|P1|Overall Study|Withdrawal by Subject|5
1416356|NCT01087905|4675930|P8|Overall Study|Lost to Follow-up|24
1416357|NCT01087905|4675931|P7|Overall Study|Lost to Follow-up|20
1416358|NCT01087905|4675932|P6|Overall Study|Lost to Follow-up|25
1416359|NCT01087905|4675933|P5|Overall Study|Lost to Follow-up|27
1416360|NCT01087905|4675934|P4|Overall Study|Lost to Follow-up|31
1416361|NCT01087905|4675935|P3|Overall Study|Lost to Follow-up|18
1416362|NCT01087905|4675936|P2|Overall Study|Lost to Follow-up|28
1416363|NCT01087905|4675937|P1|Overall Study|Lost to Follow-up|24
1416364|NCT01087814|4675959|P2|Second Intervention (5 Days)|Physician Decision|0
1416365|NCT01087814|4675960|P1|Second Intervention (5 Days)|Physician Decision|1
1416366|NCT01087814|4675959|P2|First Intervention (5 Days)|Withdrawal by Subject|1
1416367|NCT01087814|4675960|P1|First Intervention (5 Days)|Withdrawal by Subject|3
1416368|NCT01087788|4675978|P3|Open-Label Period (OL-P)|Personal reasons|1
1416369|NCT01087788|4675979|P2|Open-Label Period (OL-P)|Personal reasons|0
1416370|NCT01087788|4675980|P1|Open-Label Period (OL-P)|Personal reasons|0
1416371|NCT01087788|4675978|P3|Open-Label Period (OL-P)|No participation in study extension|1
1416372|NCT01087788|4675979|P2|Open-Label Period (OL-P)|No participation in study extension|0
1416373|NCT01087788|4675980|P1|Open-Label Period (OL-P)|No participation in study extension|0
1416374|NCT01087788|4675978|P3|Open-Label Period (OL-P)|Principal investigator decision|2
1416375|NCT01087788|4675979|P2|Open-Label Period (OL-P)|Principal investigator decision|1
1416376|NCT01087788|4675980|P1|Open-Label Period (OL-P)|Principal investigator decision|0
1416377|NCT01087788|4675978|P3|Open-Label Period (OL-P)|Sponsor request|0
1416378|NCT01087788|4675979|P2|Open-Label Period (OL-P)|Sponsor request|0
1416379|NCT01087788|4675980|P1|Open-Label Period (OL-P)|Sponsor request|1
1416380|NCT01087788|4675978|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
1416381|NCT01087788|4675979|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
1416382|NCT01087788|4675980|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
1416383|NCT01087788|4675978|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
1416384|NCT01087788|4675979|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
1416385|NCT01087788|4675980|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
1416386|NCT01087788|4675978|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
1416387|NCT01087788|4675979|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
1416388|NCT01087788|4675980|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
1416389|NCT01087788|4675978|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
1416390|NCT01087788|4675979|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
1416391|NCT01087788|4675980|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
1416392|NCT01087788|4675978|P3|Open-Label Period (OL-P)|AE, serious fatal|1
1416393|NCT01087788|4675979|P2|Open-Label Period (OL-P)|AE, serious fatal|0
1416394|NCT01087788|4675980|P1|Open-Label Period (OL-P)|AE, serious fatal|2
1416395|NCT01087788|4675978|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
1416396|NCT01087788|4675979|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
1416397|NCT01087788|4675980|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
1416398|NCT01087788|4675978|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
1416399|NCT01087788|4675979|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
1416400|NCT01087788|4675980|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
1416401|NCT01087788|4675978|P3|Open-Label Period (OL-P)|Protocol Violation|0
1416402|NCT01087788|4675979|P2|Open-Label Period (OL-P)|Protocol Violation|1
1416403|NCT01087788|4675980|P1|Open-Label Period (OL-P)|Protocol Violation|2
1416404|NCT01087788|4675978|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
1416405|NCT01087788|4675979|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
1416406|NCT01087788|4675980|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
1416407|NCT01087788|4675978|P3|24-weeks Dose-blind Period|Patient moved|1
1416408|NCT01087788|4675979|P2|24-weeks Dose-blind Period|Patient moved|0
1416409|NCT01087788|4675980|P1|24-weeks Dose-blind Period|Patient moved|0
1416410|NCT01087788|4675978|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
1416411|NCT01087788|4675979|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
1416412|NCT01087788|4675980|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
1416413|NCT01087788|4675978|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
1416414|NCT01087788|4675979|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
1416415|NCT01087788|4675980|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
1416416|NCT01087788|4675978|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
1416417|NCT01087788|4675979|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
1416418|NCT01087788|4675980|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
1416419|NCT01087788|4675978|P3|24-weeks Dose-blind Period|AE, serious fatal|0
1416420|NCT01087788|4675979|P2|24-weeks Dose-blind Period|AE, serious fatal|1
1416421|NCT01087788|4675980|P1|24-weeks Dose-blind Period|AE, serious fatal|0
1416422|NCT01087788|4675978|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
1416423|NCT01087788|4675979|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
1416424|NCT01087788|4675980|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
1416425|NCT01087788|4675978|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
1416426|NCT01087788|4675979|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
1416427|NCT01087788|4675980|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
1416428|NCT01087788|4675978|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
1416429|NCT01087788|4675979|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
1416430|NCT01087788|4675980|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
1416431|NCT01087788|4675978|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
1416432|NCT01087788|4675979|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
1416433|NCT01087788|4675980|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
1416434|NCT01087788|4675978|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
1416435|NCT01087788|4675979|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
1416436|NCT01087788|4675980|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
1416437|NCT01087788|4675978|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
1416438|NCT01087788|4675979|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
1416439|NCT01087788|4675980|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
1416440|NCT01087788|4675978|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
1416441|NCT01087788|4675979|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
1416442|NCT01087788|4675980|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
1416443|NCT01087788|4675978|P3|24-weeks Double-blind Period|AE, unknown type|1
1416444|NCT01087788|4675979|P2|24-weeks Double-blind Period|AE, unknown type|0
1416445|NCT01087788|4675980|P1|24-weeks Double-blind Period|AE, unknown type|0
1416446|NCT01087788|4675978|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
1416447|NCT01087788|4675979|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
1416448|NCT01087788|4675980|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
1416449|NCT01087788|4675978|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
1416450|NCT01087788|4675979|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
1416451|NCT01087788|4675980|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
1416452|NCT01087788|4675978|P3|24-weeks Double-blind Period|AE, serious fatal|1
1416453|NCT01087788|4675979|P2|24-weeks Double-blind Period|AE, serious fatal|1
1416454|NCT01087788|4675980|P1|24-weeks Double-blind Period|AE, serious fatal|0
1416455|NCT01087788|4675978|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
1416456|NCT01087788|4675979|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
1416457|NCT01087788|4675980|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
1416458|NCT01087788|4675978|P3|24-weeks Double-blind Period|Lost to Follow-up|1
1416459|NCT01087788|4675979|P2|24-weeks Double-blind Period|Lost to Follow-up|1
1416460|NCT01087788|4675980|P1|24-weeks Double-blind Period|Lost to Follow-up|4
1416461|NCT01087788|4675978|P3|24-weeks Double-blind Period|Protocol Violation|0
1416462|NCT01087788|4675979|P2|24-weeks Double-blind Period|Protocol Violation|1
1416463|NCT01087788|4675980|P1|24-weeks Double-blind Period|Protocol Violation|0
1416464|NCT01087788|4675978|P3|24-weeks Double-blind Period|Lack of Efficacy|1
1416465|NCT01087788|4675979|P2|24-weeks Double-blind Period|Lack of Efficacy|0
1416466|NCT01087788|4675980|P1|24-weeks Double-blind Period|Lack of Efficacy|2
1416467|NCT01087762|4676010|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
1416468|NCT01087762|4676011|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
1416469|NCT01087762|4676012|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
1416470|NCT01087762|4676013|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
1416471|NCT01087762|4676014|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
1416472|NCT01087762|4676010|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
1416473|NCT01087762|4676011|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
1416474|NCT01087762|4676012|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
1416475|NCT01087762|4676013|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
1416476|NCT01087762|4676014|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
1416477|NCT01087762|4676010|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
1416478|NCT01087762|4676011|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
1416479|NCT01087762|4676012|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
1416480|NCT01087762|4676013|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
1416481|NCT01087762|4676014|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
1416482|NCT01087762|4676010|P5|Open-Label Period (Weeks 48-204)|Other|4
1416483|NCT01087762|4676011|P4|Open-Label Period (Weeks 48-204)|Other|2
1416484|NCT01087762|4676012|P3|Open-Label Period (Weeks 48-204)|Other|0
1416485|NCT01087762|4676013|P2|Open-Label Period (Weeks 48-204)|Other|0
1416486|NCT01087762|4676014|P1|Open-Label Period (Weeks 48-204)|Other|0
1416487|NCT01087762|4676010|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
1416488|NCT01087762|4676011|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
1416489|NCT01087762|4676012|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
1416490|NCT01087762|4676013|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
1416491|NCT01087762|4676014|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
1416492|NCT01087762|4676010|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
1416493|NCT01087762|4676011|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
1416494|NCT01087762|4676012|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
1416495|NCT01087762|4676013|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
1416496|NCT01087762|4676014|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
1416497|NCT01087762|4676010|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
1416498|NCT01087762|4676011|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
1416499|NCT01087762|4676012|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
1416500|NCT01087762|4676013|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
1416501|NCT01087762|4676014|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
1416502|NCT01087762|4676010|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
1416503|NCT01087762|4676011|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
1416504|NCT01087762|4676012|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
1416505|NCT01087762|4676013|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
1416506|NCT01087762|4676014|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
1416507|NCT01087762|4676010|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
1416508|NCT01087762|4676011|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
1416509|NCT01087762|4676012|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
1416510|NCT01087762|4676013|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
1416511|NCT01087762|4676014|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
1416512|NCT01087762|4676010|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
1416513|NCT01087762|4676011|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
1416514|NCT01087762|4676012|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
1416515|NCT01087762|4676013|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
1416516|NCT01087762|4676014|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
1416517|NCT01087762|4676010|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
1416518|NCT01087762|4676011|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
1416519|NCT01087762|4676012|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
1416520|NCT01087762|4676013|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
1416521|NCT01087762|4676014|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
1416522|NCT01087762|4676010|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
1416523|NCT01087762|4676011|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
1416524|NCT01087762|4676012|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
1416525|NCT01087762|4676013|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
1416526|NCT01087762|4676014|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
1416527|NCT01087762|4676010|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
1416528|NCT01087762|4676011|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
1416529|NCT01087762|4676012|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
1416530|NCT01087762|4676013|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
1416531|NCT01087762|4676014|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
1416532|NCT01087736|4676062|P2|Overall Study|Withdrawal by Subject|1
1416533|NCT01087736|4676063|P1|Overall Study|Withdrawal by Subject|0
1416534|NCT01087736|4676062|P2|Overall Study|Death|1
1416535|NCT01087736|4676063|P1|Overall Study|Death|0
1416536|NCT01087736|4676062|P2|Overall Study|Lost to Follow-up|0
1416537|NCT01087736|4676063|P1|Overall Study|Lost to Follow-up|1
1416538|NCT01087723|4676073|P2|Overall Study|Reason Not Specified|2
1416539|NCT01087723|4676074|P1|Overall Study|Reason Not Specified|1
1416540|NCT01087723|4676073|P2|Overall Study|Lost to Follow-up|4
1416541|NCT01087723|4676074|P1|Overall Study|Lost to Follow-up|1
1416542|NCT01087723|4676073|P2|Overall Study|Physician Decision|0
1416543|NCT01087723|4676074|P1|Overall Study|Physician Decision|2
1416544|NCT01087723|4676073|P2|Overall Study|Withdrawal by Subject|13
1416545|NCT01087723|4676074|P1|Overall Study|Withdrawal by Subject|10
1416546|NCT01087723|4676073|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
1416547|NCT01087723|4676074|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
1416548|NCT01087528|4676115|P1|Overall Study|Incomplete CE procedure|6
1416549|NCT01087528|4676115|P1|Overall Study|Withdrawal by Subject|1
1416550|NCT01087502|4676121|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
1416551|NCT01087502|4676122|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
1416552|NCT01087502|4676121|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
1416553|NCT01087502|4676122|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
1416554|NCT01087502|4676121|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
1416555|NCT01087502|4676122|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
1416556|NCT01087502|4676121|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
1416557|NCT01087502|4676122|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
1416558|NCT01087502|4676121|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
1416559|NCT01087502|4676122|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
1416560|NCT01087502|4676121|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
1416561|NCT01087502|4676122|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
1416562|NCT01087502|4676121|P2|Up to Final Analysis (Week 52)|Adverse Event|10
1416563|NCT01087502|4676122|P1|Up to Final Analysis (Week 52)|Adverse Event|17
1416564|NCT01087502|4676121|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
1416565|NCT01087502|4676122|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
1416566|NCT01087502|4676121|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
1416567|NCT01087502|4676122|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
1416568|NCT01087502|4676121|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
1416569|NCT01087502|4676122|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
1416570|NCT01087502|4676121|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
1416571|NCT01087502|4676122|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
1416572|NCT01087502|4676121|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
1416573|NCT01087502|4676122|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
1416574|NCT01087489|4676141|P2|Overall Study|unable to survey by telephone|1
1416575|NCT01087489|4676142|P1|Overall Study|unable to survey by telephone|0
1416576|NCT01087489|4676141|P2|Overall Study|Death|1
1416577|NCT01087489|4676142|P1|Overall Study|Death|0
1416578|NCT01087489|4676141|P2|Overall Study|enrolled in another VA study|1
1416579|NCT01087489|4676142|P1|Overall Study|enrolled in another VA study|0
1416580|NCT01086969|4676155|P3|Overall Study|Withdrawal by Subject|0
1416581|NCT01086969|4676156|P2|Overall Study|Withdrawal by Subject|2
1416582|NCT01086969|4676157|P1|Overall Study|Withdrawal by Subject|1
1416583|NCT01086423|4676267|P3|Overall Study|Lost to Follow-up|1
1416584|NCT01086423|4676268|P2|Overall Study|Lost to Follow-up|0
1416585|NCT01086423|4676269|P1|Overall Study|Lost to Follow-up|0
1416586|NCT01086423|4676267|P3|Overall Study|Withdrawal by Subject|3
1416587|NCT01086423|4676268|P2|Overall Study|Withdrawal by Subject|1
1416588|NCT01086423|4676269|P1|Overall Study|Withdrawal by Subject|5
1416589|NCT01086423|4676267|P3|Overall Study|Adverse event, non-fatal|0
1416590|NCT01086423|4676268|P2|Overall Study|Adverse event, non-fatal|1
1416591|NCT01086423|4676269|P1|Overall Study|Adverse event, non-fatal|2
1416592|NCT01086423|4676267|P3|Overall Study|Adverse event, fatal|0
1416593|NCT01086423|4676268|P2|Overall Study|Adverse event, fatal|1
1416594|NCT01086423|4676269|P1|Overall Study|Adverse event, fatal|1
1416595|NCT01086423|4676267|P3|Overall Study|Migrated/moved from study area|4
1416596|NCT01086423|4676268|P2|Overall Study|Migrated/moved from study area|0
1416597|NCT01086423|4676269|P1|Overall Study|Migrated/moved from study area|2
1416598|NCT01086423|4676267|P3|Overall Study|Protocol Violation|1
1416599|NCT01086423|4676268|P2|Overall Study|Protocol Violation|0
1416600|NCT01086423|4676269|P1|Overall Study|Protocol Violation|0
1416601|NCT01086410|4676314|P4|Overall Study|Lost to Follow-up|0
1416602|NCT01086410|4676315|P3|Overall Study|Lost to Follow-up|1
1416603|NCT01086410|4676316|P2|Overall Study|Lost to Follow-up|0
1416604|NCT01086410|4676317|P1|Overall Study|Lost to Follow-up|0
1416605|NCT01086410|4676314|P4|Overall Study|Protocol Violation|0
1416606|NCT01086410|4676315|P3|Overall Study|Protocol Violation|0
1416607|NCT01086410|4676316|P2|Overall Study|Protocol Violation|1
1416608|NCT01086410|4676317|P1|Overall Study|Protocol Violation|1
1416609|NCT01086410|4676314|P4|Overall Study|Lack of Efficacy|0
1416610|NCT01086410|4676315|P3|Overall Study|Lack of Efficacy|0
1416611|NCT01086410|4676316|P2|Overall Study|Lack of Efficacy|1
1416612|NCT01086410|4676317|P1|Overall Study|Lack of Efficacy|1
1416613|NCT01086410|4676314|P4|Overall Study|Adverse Event|2
1416614|NCT01086410|4676315|P3|Overall Study|Adverse Event|0
1416615|NCT01086410|4676316|P2|Overall Study|Adverse Event|0
1416616|NCT01086410|4676317|P1|Overall Study|Adverse Event|1
1416617|NCT01086384|4676413|P3|Treatment Period|Received Treatment in Error|0
1416618|NCT01086384|4676414|P2|Treatment Period|Received Treatment in Error|1
1416619|NCT01086384|4676415|P1|Treatment Period|Received Treatment in Error|0
1416620|NCT01086384|4676413|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
1416621|NCT01086384|4676414|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
1416622|NCT01086384|4676415|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
1416623|NCT01086384|4676413|P3|Treatment Period|Study Closed/Terminated|8
1416624|NCT01086384|4676414|P2|Treatment Period|Study Closed/Terminated|7
1416625|NCT01086384|4676415|P1|Treatment Period|Study Closed/Terminated|0
1416626|NCT01086384|4676413|P3|Treatment Period|Physician Decision|6
1416627|NCT01086384|4676414|P2|Treatment Period|Physician Decision|9
1416628|NCT01086384|4676415|P1|Treatment Period|Physician Decision|0
1416629|NCT01086384|4676413|P3|Treatment Period|Lost to Follow-up|9
1416630|NCT01086384|4676414|P2|Treatment Period|Lost to Follow-up|11
1416631|NCT01086384|4676415|P1|Treatment Period|Lost to Follow-up|0
1416632|NCT01086384|4676413|P3|Treatment Period|Adverse Event|15
1416633|NCT01086384|4676414|P2|Treatment Period|Adverse Event|19
1416634|NCT01086384|4676415|P1|Treatment Period|Adverse Event|0
1416635|NCT01086384|4676413|P3|Treatment Period|Lack of Efficacy|13
1416636|NCT01086384|4676414|P2|Treatment Period|Lack of Efficacy|22
1416637|NCT01086384|4676415|P1|Treatment Period|Lack of Efficacy|0
1416638|NCT01086384|4676413|P3|Treatment Period|Protocol Violation|17
1416639|NCT01086384|4676414|P2|Treatment Period|Protocol Violation|26
1416640|NCT01086384|4676415|P1|Treatment Period|Protocol Violation|0
1416641|NCT01086384|4676413|P3|Treatment Period|Withdrawal by Subject|55
1416642|NCT01086384|4676414|P2|Treatment Period|Withdrawal by Subject|53
1416643|NCT01086384|4676415|P1|Treatment Period|Withdrawal by Subject|0
1416644|NCT01086384|4676413|P3|2-week Run-in Period|Randomized in Error|0
1416645|NCT01086384|4676414|P2|2-week Run-in Period|Randomized in Error|0
1416646|NCT01086384|4676415|P1|2-week Run-in Period|Randomized in Error|1
1416647|NCT01086384|4676413|P3|2-week Run-in Period|Continuation Criteria Not Met|0
1416648|NCT01086384|4676414|P2|2-week Run-in Period|Continuation Criteria Not Met|0
1416649|NCT01086384|4676415|P1|2-week Run-in Period|Continuation Criteria Not Met|92
1416650|NCT01086384|4676413|P3|2-week Run-in Period|Study Closed/Terminated|0
1416651|NCT01086384|4676414|P2|2-week Run-in Period|Study Closed/Terminated|0
1416652|NCT01086384|4676415|P1|2-week Run-in Period|Study Closed/Terminated|42
1416653|NCT01086384|4676413|P3|2-week Run-in Period|Withdrawal by Subject|0
1416654|NCT01086384|4676414|P2|2-week Run-in Period|Withdrawal by Subject|0
1416655|NCT01086384|4676415|P1|2-week Run-in Period|Withdrawal by Subject|19
1416656|NCT01086384|4676413|P3|2-week Run-in Period|Physician Decision|0
1416657|NCT01086384|4676414|P2|2-week Run-in Period|Physician Decision|0
1416658|NCT01086384|4676415|P1|2-week Run-in Period|Physician Decision|6
1416659|NCT01086384|4676413|P3|2-week Run-in Period|Lost to Follow-up|0
1416660|NCT01086384|4676414|P2|2-week Run-in Period|Lost to Follow-up|0
1416661|NCT01086384|4676415|P1|2-week Run-in Period|Lost to Follow-up|1
1416662|NCT01086384|4676413|P3|2-week Run-in Period|Protocol Violation|0
1416663|NCT01086384|4676414|P2|2-week Run-in Period|Protocol Violation|0
1416664|NCT01086384|4676415|P1|2-week Run-in Period|Protocol Violation|1
1416665|NCT01086384|4676413|P3|2-week Run-in Period|Adverse Event|0
1416666|NCT01086384|4676414|P2|2-week Run-in Period|Adverse Event|0
1416667|NCT01086384|4676415|P1|2-week Run-in Period|Adverse Event|1
1416668|NCT01086358|4676425|P2|Second Intervention|Lost to Follow-up|4
1416669|NCT01086358|4676426|P1|Second Intervention|Lost to Follow-up|4
1416670|NCT01086358|4676425|P2|First Intervention|Withdrawal by Subject|1
1416671|NCT01086358|4676426|P1|First Intervention|Withdrawal by Subject|0
1416672|NCT01086358|4676425|P2|First Intervention|Lost to Follow-up|4
1416673|NCT01086358|4676426|P1|First Intervention|Lost to Follow-up|9
1416674|NCT01086215|4676496|P4|Overall Study|Lost to Follow-up|2
1416675|NCT01086215|4676497|P3|Overall Study|Lost to Follow-up|18
1416676|NCT01086215|4676498|P2|Overall Study|Lost to Follow-up|39
1416677|NCT01086215|4676499|P1|Overall Study|Lost to Follow-up|22
1416678|NCT01086215|4676496|P4|Overall Study|Death|1
1416679|NCT01086215|4676497|P3|Overall Study|Death|8
1416680|NCT01086215|4676498|P2|Overall Study|Death|8
1416681|NCT01086215|4676499|P1|Overall Study|Death|14
1416682|NCT01086033|4676517|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
1416683|NCT01086033|4676517|P1|Overall Study|AE and Other Reason|1
1416684|NCT01086033|4676517|P1|Overall Study|AE and Lost to Follow-up|1
1416685|NCT01086033|4676517|P1|Overall Study|Death|1
1416686|NCT01086033|4676517|P1|Overall Study|AE and Lack of Efficacy|4
1416687|NCT01086033|4676517|P1|Overall Study|Withdrew consent and Other Reason|4
1416688|NCT01086033|4676517|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
1416689|NCT01086033|4676517|P1|Overall Study|AE and Withdrew Consent|5
1416690|NCT01086033|4676517|P1|Overall Study|Other|13
1416691|NCT01086033|4676517|P1|Overall Study|Other|14
1416692|NCT01086033|4676517|P1|Overall Study|Withdrawal by Subject|41
1416693|NCT01086033|4676517|P1|Overall Study|Adverse Event|42
1416694|NCT01086033|4676517|P1|Overall Study|Lost to Follow-up|86
1416695|NCT01086033|4676517|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
1416696|NCT01085734|4676623|P2|Overall Study|Withdrawal by Subject|1
1416697|NCT01085734|4676624|P1|Overall Study|Withdrawal by Subject|0
1416698|NCT01085734|4676623|P2|Overall Study|Lost to Follow-up|1
1416699|NCT01085734|4676624|P1|Overall Study|Lost to Follow-up|0
1416700|NCT01085734|4676623|P2|Overall Study|Death|0
1416701|NCT01085734|4676624|P1|Overall Study|Death|1
1416702|NCT01085734|4676623|P2|Overall Study|Adverse Event|2
1416703|NCT01085734|4676624|P1|Overall Study|Adverse Event|0
1416704|NCT01085682|4676636|P2|Overall Study|Withdrawal by Subject|25
1416705|NCT01085682|4676637|P1|Overall Study|Withdrawal by Subject|25
1416706|NCT01085591|4676655|P3|Overall Study|Not Properly Consented|0
1416707|NCT01085591|4676656|P2|Overall Study|Not Properly Consented|0
1416708|NCT01085591|4676657|P1|Overall Study|Not Properly Consented|1
1416709|NCT01085591|4676655|P3|Overall Study|Other|0
1416710|NCT01085591|4676656|P2|Overall Study|Other|1
1416711|NCT01085591|4676657|P1|Overall Study|Other|0
1416712|NCT01085591|4676655|P3|Overall Study|Protocol Violation|1
1416713|NCT01085591|4676656|P2|Overall Study|Protocol Violation|1
1416714|NCT01085591|4676657|P1|Overall Study|Protocol Violation|1
1416715|NCT01085591|4676655|P3|Overall Study|Lost to Follow-up|1
1416716|NCT01085591|4676656|P2|Overall Study|Lost to Follow-up|1
1416717|NCT01085591|4676657|P1|Overall Study|Lost to Follow-up|0
1416718|NCT01085591|4676655|P3|Overall Study|Withdrawal by Subject|1
1416719|NCT01085591|4676656|P2|Overall Study|Withdrawal by Subject|2
1416720|NCT01085591|4676657|P1|Overall Study|Withdrawal by Subject|0
1416721|NCT01085591|4676655|P3|Overall Study|Physician Decision|1
1416722|NCT01085591|4676656|P2|Overall Study|Physician Decision|0
1416723|NCT01085591|4676657|P1|Overall Study|Physician Decision|1
1416724|NCT01085591|4676655|P3|Overall Study|Adverse Event|3
1416725|NCT01085591|4676656|P2|Overall Study|Adverse Event|1
1416726|NCT01085591|4676657|P1|Overall Study|Adverse Event|0
1416727|NCT01085357|4676708|P2|Overall Study|Lost to Follow-up|0
1416728|NCT01085357|4676709|P1|Overall Study|Lost to Follow-up|2
1416729|NCT01085357|4676708|P2|Overall Study|Death|1
1416730|NCT01085357|4676709|P1|Overall Study|Death|11
1416731|NCT01085357|4676708|P2|Overall Study|Investigator Decision|1
1416732|NCT01085357|4676709|P1|Overall Study|Investigator Decision|1
1416733|NCT01085357|4676708|P2|Overall Study|Subject Decision|3
1416734|NCT01085357|4676709|P1|Overall Study|Subject Decision|4
1416735|NCT01085357|4676708|P2|Overall Study|Adverse Event|1
1416736|NCT01085357|4676709|P1|Overall Study|Adverse Event|1
1416737|NCT01085214|4676772|P1|Overall Study|Alternate treatment required|1
1416738|NCT01085201|4676784|P5|Overall Study|Fond ineligible after consent|0
1416739|NCT01085201|4676785|P4|Overall Study|Fond ineligible after consent|0
1416740|NCT01085201|4676786|P3|Overall Study|Fond ineligible after consent|1
1416741|NCT01085201|4676787|P2|Overall Study|Fond ineligible after consent|1
1416742|NCT01085201|4676788|P1|Overall Study|Fond ineligible after consent|0
1416743|NCT01085201|4676784|P5|Overall Study|Unknown- no study drug|0
1416744|NCT01085201|4676785|P4|Overall Study|Unknown- no study drug|0
1416745|NCT01085201|4676786|P3|Overall Study|Unknown- no study drug|0
1416746|NCT01085201|4676787|P2|Overall Study|Unknown- no study drug|0
1416747|NCT01085201|4676788|P1|Overall Study|Unknown- no study drug|2
1416748|NCT01085201|4676784|P5|Overall Study|Scheduling conflict|0
1416749|NCT01085201|4676785|P4|Overall Study|Scheduling conflict|0
1416750|NCT01085201|4676786|P3|Overall Study|Scheduling conflict|1
1416751|NCT01085201|4676787|P2|Overall Study|Scheduling conflict|0
1416752|NCT01085201|4676788|P1|Overall Study|Scheduling conflict|1
1416753|NCT01085136|4676810|P3|Part B|Other reason not defined above|3
1416754|NCT01085136|4676811|P2|Part B|Other reason not defined above|6
1416755|NCT01085136|4676812|P1|Part B|Other reason not defined above|0
1416756|NCT01085136|4676810|P3|Part B|Not treated|8
1416757|NCT01085136|4676811|P2|Part B|Not treated|4
1416758|NCT01085136|4676812|P1|Part B|Not treated|0
1416759|NCT01085136|4676810|P3|Part B|Refusal to continue trial medication|7
1416760|NCT01085136|4676811|P2|Part B|Refusal to continue trial medication|12
1416761|NCT01085136|4676812|P1|Part B|Refusal to continue trial medication|0
1416762|NCT01085136|4676810|P3|Part B|Other AE|8
1416763|NCT01085136|4676811|P2|Part B|Other AE|29
1416764|NCT01085136|4676812|P1|Part B|Other AE|0
1416765|NCT01085136|4676810|P3|Part A|Other reason not defined above|0
1416766|NCT01085136|4676811|P2|Part A|Other reason not defined above|0
1416767|NCT01085136|4676812|P1|Part A|Other reason not defined above|30
1416768|NCT01085136|4676810|P3|Part A|Refusal to continue trial medication|0
1416769|NCT01085136|4676811|P2|Part A|Refusal to continue trial medication|0
1416770|NCT01085136|4676812|P1|Part A|Refusal to continue trial medication|64
1416771|NCT01085136|4676810|P3|Part A|Lost to Follow-up|0
1416772|NCT01085136|4676811|P2|Part A|Lost to Follow-up|0
1416773|NCT01085136|4676812|P1|Part A|Lost to Follow-up|3
1416774|NCT01085136|4676810|P3|Part A|Protocol Violation|0
1416775|NCT01085136|4676811|P2|Part A|Protocol Violation|0
1416776|NCT01085136|4676812|P1|Part A|Protocol Violation|3
1416777|NCT01085136|4676810|P3|Part A|Other Adverse event|0
1416778|NCT01085136|4676811|P2|Part A|Other Adverse event|0
1416779|NCT01085136|4676812|P1|Part A|Other Adverse event|223
1416780|NCT01085045|4676828|P1|Part B|Adverse Event|6
1416781|NCT01085045|4676828|P1|Part B|Lost to Follow-up|1
1416782|NCT01085045|4676828|P1|Part B|Protocol Specified Criteria|6
1416783|NCT01085045|4676828|P1|Part B|Withdrawal by Subject|2
1416784|NCT01085045|4676828|P1|Part A|Protocol Specified Criteria|7
1416785|NCT01085045|4676828|P1|Part A|Protocol Violation|1
1416786|NCT01085045|4676828|P1|Part A|Adverse Event|6
1416787|NCT01085045|4676828|P1|Part A|Withdrawal by Subject|4
1416788|NCT01084707|4676943|P1|Overall Study|Withdrawal by Subject|6
1416789|NCT01084668|4676977|P1|Overall Study|Non-compliance|1
1416790|NCT01084668|4676977|P1|Overall Study|Pregnancy|1
1416791|NCT01084668|4676977|P1|Overall Study|Withdrawal by Subject|2
1416792|NCT01084668|4676977|P1|Overall Study|Lack of Efficacy|5
1416793|NCT01084603|4676986|P1|Washout Period 4|Adverse Event|1
1416794|NCT01084603|4676986|P1|Oral Nicotine 1|Withdrawal by Subject|1
1416795|NCT01084603|4676986|P1|Nicorette® Gum|Withdrawal by Subject|1
1416796|NCT01084603|4676986|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
1416797|NCT01084603|4676986|P1|Baseline|Withdrawal by Subject|2
1416798|NCT01084551|4677022|P3|Overall Study|Physician Decision|0
1416799|NCT01084551|4677023|P2|Overall Study|Physician Decision|0
1416800|NCT01084551|4677024|P1|Overall Study|Physician Decision|1
1416801|NCT01084551|4677022|P3|Overall Study|Lost to Follow-up|3
1416802|NCT01084551|4677023|P2|Overall Study|Lost to Follow-up|0
1416803|NCT01084551|4677024|P1|Overall Study|Lost to Follow-up|0
1416804|NCT01084551|4677022|P3|Overall Study|Protocol Violation|0
1416805|NCT01084551|4677023|P2|Overall Study|Protocol Violation|4
1416806|NCT01084551|4677024|P1|Overall Study|Protocol Violation|2
1416807|NCT01084551|4677022|P3|Overall Study|Withdrawal by Subject|0
1416808|NCT01084551|4677023|P2|Overall Study|Withdrawal by Subject|1
1416809|NCT01084551|4677024|P1|Overall Study|Withdrawal by Subject|2
1416810|NCT01084551|4677022|P3|Overall Study|Lack of Efficacy|1
1416811|NCT01084551|4677023|P2|Overall Study|Lack of Efficacy|0
1416812|NCT01084551|4677024|P1|Overall Study|Lack of Efficacy|2
1416813|NCT01084551|4677022|P3|Overall Study|Adverse Event|4
1416814|NCT01084551|4677023|P2|Overall Study|Adverse Event|9
1416815|NCT01084551|4677024|P1|Overall Study|Adverse Event|2
1416816|NCT01084538|4677062|P1|Overall Study|Reason unknown|8
1416817|NCT01084538|4677062|P1|Overall Study|Over-suppression of parathyroid gland|2
1416818|NCT01084538|4677062|P1|Overall Study|Change of residence|2
1416819|NCT01084538|4677062|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
1416820|NCT01084538|4677062|P1|Overall Study|Hyperphosphatemia|2
1416821|NCT01084538|4677062|P1|Overall Study|Patient noncompliance|2
1416822|NCT01084538|4677062|P1|Overall Study|Lack of effectiveness|2
1416823|NCT01084538|4677062|P1|Overall Study|Serious Adverse Event|3
1416824|NCT01084538|4677062|P1|Overall Study|Kidney transplant|6
1416825|NCT01084538|4677062|P1|Overall Study|Adverse Event|9
1416826|NCT01084538|4677062|P1|Overall Study|Drug not available|30
1416827|NCT01084239|4677173|P2|28-Day Follow-up|Lost to Follow-up|9
1416828|NCT01084239|4677174|P1|28-Day Follow-up|Lost to Follow-up|4
1416829|NCT01084174|4677192|P2|Overall Study|Participant noncompliance|1
1416830|NCT01084174|4677193|P1|Overall Study|Participant noncompliance|0
1416831|NCT01084174|4677192|P2|Overall Study|Anaphylaxis|1
1416832|NCT01084174|4677193|P1|Overall Study|Anaphylaxis|0
1416833|NCT01084174|4677192|P2|Overall Study|Eosinophilic esophagitis|1
1416834|NCT01084174|4677193|P1|Overall Study|Eosinophilic esophagitis|0
1416835|NCT01084174|4677192|P2|Overall Study|gastrointestinal symptoms|1
1416836|NCT01084174|4677193|P1|Overall Study|gastrointestinal symptoms|1
1416837|NCT01084135|4677226|P2|20 Week|Physician Decision|1
1416838|NCT01084135|4677227|P1|20 Week|Physician Decision|0
1416839|NCT01084083|4677237|P1|Overall Study|Never started assigned therapy|1
1416840|NCT01084083|4677237|P1|Overall Study|Other|2
1416841|NCT01084083|4677237|P1|Overall Study|Complicating disease|1
1416842|NCT01084083|4677237|P1|Overall Study|Withdrawal by Subject|2
1416843|NCT01084083|4677237|P1|Overall Study|Death|1
1416844|NCT01084083|4677237|P1|Overall Study|Adverse Event|5
1416845|NCT01084005|4677245|P2|Overall Study|Withdrawal by Subject|1
1416846|NCT01084005|4677246|P1|Overall Study|Withdrawal by Subject|1
1416847|NCT01084005|4677245|P2|Overall Study|Protocol Violation|7
1416848|NCT01084005|4677246|P1|Overall Study|Protocol Violation|3
1416849|NCT01084005|4677245|P2|Overall Study|Adverse Event|8
1416850|NCT01084005|4677246|P1|Overall Study|Adverse Event|1
1416851|NCT01083810|4677327|P3|Overall Study|Virologic failure|0
1416852|NCT01083810|4677328|P2|Overall Study|Virologic failure|8
1416853|NCT01083810|4677329|P1|Overall Study|Virologic failure|1
1416854|NCT01083810|4677327|P3|Overall Study|Therapy break|2
1416855|NCT01083810|4677328|P2|Overall Study|Therapy break|2
1416856|NCT01083810|4677329|P1|Overall Study|Therapy break|1
1416857|NCT01083810|4677327|P3|Overall Study|Participation in study|0
1416858|NCT01083810|4677328|P2|Overall Study|Participation in study|0
1416859|NCT01083810|4677329|P1|Overall Study|Participation in study|1
1416860|NCT01083810|4677327|P3|Overall Study|Co-morbidities|0
1416861|NCT01083810|4677328|P2|Overall Study|Co-morbidities|0
1416862|NCT01083810|4677329|P1|Overall Study|Co-morbidities|1
1416863|NCT01083810|4677327|P3|Overall Study|Death|3
1416864|NCT01083810|4677328|P2|Overall Study|Death|2
1416865|NCT01083810|4677329|P1|Overall Study|Death|2
1416866|NCT01083810|4677327|P3|Overall Study|Simplification|0
1416867|NCT01083810|4677328|P2|Overall Study|Simplification|1
1416868|NCT01083810|4677329|P1|Overall Study|Simplification|4
1416869|NCT01083810|4677327|P3|Overall Study|Non-compliance|2
1416870|NCT01083810|4677328|P2|Overall Study|Non-compliance|7
1416871|NCT01083810|4677329|P1|Overall Study|Non-compliance|4
1416872|NCT01083810|4677327|P3|Overall Study|Reason not reported|1
1416873|NCT01083810|4677328|P2|Overall Study|Reason not reported|1
1416874|NCT01083810|4677329|P1|Overall Study|Reason not reported|6
1416875|NCT01083810|4677327|P3|Overall Study|Withdrawal by Subject|4
1416876|NCT01083810|4677328|P2|Overall Study|Withdrawal by Subject|2
1416877|NCT01083810|4677329|P1|Overall Study|Withdrawal by Subject|7
1416878|NCT01083810|4677327|P3|Overall Study|Adverse Event|4
1416879|NCT01083810|4677328|P2|Overall Study|Adverse Event|11
1416880|NCT01083810|4677329|P1|Overall Study|Adverse Event|15
1416881|NCT01083810|4677327|P3|Overall Study|Lost to Follow-up|4
1416882|NCT01083810|4677328|P2|Overall Study|Lost to Follow-up|11
1416883|NCT01083810|4677329|P1|Overall Study|Lost to Follow-up|23
1416884|NCT01083771|4677350|P1|Overall Study|Withdrawal by Subject|3
1416885|NCT01083771|4677350|P1|Overall Study|non-compliant|2
1416886|NCT01083693|4677451|P3|Overall Study|Reason unknown|1
1416887|NCT01083693|4677452|P2|Overall Study|Reason unknown|0
1416888|NCT01083693|4677453|P1|Overall Study|Reason unknown|0
1416889|NCT01083693|4677451|P3|Overall Study|Withdrawal by Subject|2
1416890|NCT01083693|4677452|P2|Overall Study|Withdrawal by Subject|0
1416891|NCT01083693|4677453|P1|Overall Study|Withdrawal by Subject|3
1416892|NCT01083693|4677451|P3|Overall Study|Other medical condition/surgery|0
1416893|NCT01083693|4677452|P2|Overall Study|Other medical condition/surgery|1
1416894|NCT01083693|4677453|P1|Overall Study|Other medical condition/surgery|1
1416895|NCT01083693|4677451|P3|Overall Study|Complete remission|0
1416896|NCT01083693|4677452|P2|Overall Study|Complete remission|1
1416897|NCT01083693|4677453|P1|Overall Study|Complete remission|0
1416898|NCT01083693|4677451|P3|Overall Study|Patient Moved|0
1416899|NCT01083693|4677452|P2|Overall Study|Patient Moved|1
1416900|NCT01083693|4677453|P1|Overall Study|Patient Moved|0
1416901|NCT01083693|4677451|P3|Overall Study|Lack of effectiveness|2
1416902|NCT01083693|4677452|P2|Overall Study|Lack of effectiveness|2
1416903|NCT01083693|4677453|P1|Overall Study|Lack of effectiveness|13
1416904|NCT01083693|4677451|P3|Overall Study|Lost to Follow-up|2
1416905|NCT01083693|4677452|P2|Overall Study|Lost to Follow-up|0
1416906|NCT01083693|4677453|P1|Overall Study|Lost to Follow-up|2
1416907|NCT01083693|4677451|P3|Overall Study|Adverse Event|0
1416908|NCT01083693|4677452|P2|Overall Study|Adverse Event|1
1416909|NCT01083693|4677453|P1|Overall Study|Adverse Event|1
1416910|NCT01083680|4677488|P1|Overall Study|Withdrawal by Subject|1086
1416911|NCT01083680|4677488|P1|Overall Study|Lost to Follow-up|2758
1416912|NCT01083641|4677511|P1|Overall Study|Withdrawal by Subject|2
1416913|NCT01083602|4677518|P1|Overall Study|Lack of Efficacy|36
1416914|NCT01083602|4677518|P1|Overall Study|Withdrawal by Subject|5
1416915|NCT01083602|4677518|P1|Overall Study|Death|1
1416916|NCT01083602|4677518|P1|Overall Study|New Cancer Therapy|2
1416917|NCT01083602|4677518|P1|Overall Study|Adverse Event|11
1416918|NCT01083576|4677529|P2|Overall Study|Treatment Failure|1
1416919|NCT01083576|4677530|P1|Overall Study|Treatment Failure|6
1416920|NCT01083485|4677560|P2|Overall Study|Other|0
1416921|NCT01083485|4677561|P1|Overall Study|Other|1
1416922|NCT01083485|4677560|P2|Overall Study|Withdrawal by Subject|2
1416923|NCT01083485|4677561|P1|Overall Study|Withdrawal by Subject|5
1416924|NCT01083485|4677560|P2|Overall Study|Protocol Violation|0
1416925|NCT01083485|4677561|P1|Overall Study|Protocol Violation|1
1416926|NCT01083485|4677560|P2|Overall Study|Adverse Event|1
1416927|NCT01083485|4677561|P1|Overall Study|Adverse Event|0
1416928|NCT01083316|4677578|P1|Overall Study|Withdrawal by Subject|1
1416929|NCT01083316|4677578|P1|Overall Study|Adverse Event|2
1416930|NCT01083186|4677589|P1|Overall Study|Non-compliance to Study Treatment|1
1416931|NCT01083186|4677589|P1|Overall Study|Administrative Reasons|2
1416932|NCT01083186|4677589|P1|Overall Study|Hemodialysis Initiation|28
1416933|NCT01083186|4677589|P1|Overall Study|Lack of Efficacy|2
1416934|NCT01083186|4677589|P1|Overall Study|Adverse Event|3
1416935|NCT01083186|4677589|P1|Overall Study|Death|3
1416936|NCT01083186|4677589|P1|Overall Study|Consent Withdrawal|7
1416937|NCT01083186|4677589|P1|Overall Study|Lost to Follow-up|48
1416938|NCT01083173|4677630|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
1416939|NCT01083173|4677631|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
1416940|NCT01083173|4677630|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
1416941|NCT01083173|4677631|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
1416942|NCT01083173|4677630|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
1416943|NCT01083173|4677631|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
1416944|NCT01083173|4677630|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
1416945|NCT01083173|4677631|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
1416946|NCT01083173|4677630|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
1416947|NCT01083173|4677631|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
1416948|NCT01083173|4677630|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
1416949|NCT01083173|4677631|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
1416950|NCT01083173|4677630|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
1416951|NCT01083173|4677631|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
1416952|NCT01083173|4677630|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
1416953|NCT01083173|4677631|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
1416954|NCT01083173|4677630|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
1416955|NCT01083173|4677631|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
1416956|NCT01083173|4677630|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
1416957|NCT01083173|4677631|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
1416958|NCT01083173|4677630|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
1416959|NCT01083173|4677631|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
1416960|NCT01083160|4677649|P1|Overall Study|Adverse Event|1
1416961|NCT01083121|4677656|P1|Overall Study|Use of Humira outside the approved label|81
1416962|NCT01082965|4677666|P2|Overall Study|Other|1
1416963|NCT01082965|4677667|P1|Overall Study|Other|1
1416964|NCT01082965|4677666|P2|Overall Study|Protocol Violation|1
1416965|NCT01082965|4677667|P1|Overall Study|Protocol Violation|0
1416966|NCT01082874|4677704|P4|Overall Study|Withdrawal by Subject|3
1416967|NCT01082874|4677705|P3|Overall Study|Withdrawal by Subject|5
1416968|NCT01082874|4677706|P2|Overall Study|Withdrawal by Subject|2
1416969|NCT01082874|4677707|P1|Overall Study|Withdrawal by Subject|1
1416970|NCT01082874|4677704|P4|Overall Study|Lost to Follow-up|10
1416971|NCT01082874|4677705|P3|Overall Study|Lost to Follow-up|6
1416972|NCT01082874|4677706|P2|Overall Study|Lost to Follow-up|10
1416973|NCT01082874|4677707|P1|Overall Study|Lost to Follow-up|10
1416974|NCT01082640|4677720|P3|Overall Study|Other|3
1416975|NCT01082640|4677721|P2|Overall Study|Other|1
1416976|NCT01082640|4677722|P1|Overall Study|Other|2
1416977|NCT01082640|4677720|P3|Overall Study|Lost to Follow-up|0
1416978|NCT01082640|4677721|P2|Overall Study|Lost to Follow-up|3
1416979|NCT01082640|4677722|P1|Overall Study|Lost to Follow-up|0
1416980|NCT01082640|4677720|P3|Overall Study|Major protocol deviation|0
1416981|NCT01082640|4677721|P2|Overall Study|Major protocol deviation|3
1416982|NCT01082640|4677722|P1|Overall Study|Major protocol deviation|3
1416983|NCT01082640|4677720|P3|Overall Study|Withdrawal by Subject|2
1416984|NCT01082640|4677721|P2|Overall Study|Withdrawal by Subject|3
1416985|NCT01082640|4677722|P1|Overall Study|Withdrawal by Subject|3
1416986|NCT01082640|4677720|P3|Overall Study|Adverse Event|3
1416987|NCT01082640|4677721|P2|Overall Study|Adverse Event|5
1416988|NCT01082640|4677722|P1|Overall Study|Adverse Event|9
1416989|NCT01082614|4677744|P2|Overall Study|Physician Decision|0
1416990|NCT01082614|4677745|P1|Overall Study|Physician Decision|2
1416991|NCT01082614|4677744|P2|Overall Study|Equipment Malfunction|1
1416992|NCT01082614|4677745|P1|Overall Study|Equipment Malfunction|0
1416993|NCT01082614|4677744|P2|Overall Study|Adverse Event|4
1416994|NCT01082614|4677745|P1|Overall Study|Adverse Event|1
1416995|NCT01082367|4677816|P2|Follow-up (F-U) Period|Adverse Event|1
1416996|NCT01082367|4677817|P1|Follow-up (F-U) Period|Adverse Event|0
1416997|NCT01082367|4677816|P2|Follow-up (F-U) Period|Abnormal lab values|0
1416998|NCT01082367|4677817|P1|Follow-up (F-U) Period|Abnormal lab values|1
1416999|NCT01082367|4677816|P2|Follow-up (F-U) Period|Administrative problems|0
1417000|NCT01082367|4677817|P1|Follow-up (F-U) Period|Administrative problems|1
1417001|NCT01082367|4677816|P2|Double-blind Period|Adverse Event|1
1417002|NCT01082367|4677817|P1|Double-blind Period|Adverse Event|0
1417003|NCT01082367|4677816|P2|Double-blind Period|Lack of Efficacy|11
1417004|NCT01082367|4677817|P1|Double-blind Period|Lack of Efficacy|5
1417005|NCT01082367|4677816|P2|Double-blind Period|Administrative problems|1
1417006|NCT01082367|4677817|P1|Double-blind Period|Administrative problems|0
1417007|NCT01082328|4677831|P1|Overall Study|Adverse Event|1
1417008|NCT01082211|4677840|P1|Overall Study|No protocol treatment received|3
1417009|NCT01082211|4677840|P1|Overall Study|Protocol Violation|4
1417010|NCT01082081|4677861|P3|Overall Study|Other Reason|0
1417011|NCT01082081|4677862|P2|Overall Study|Other Reason|1
1417012|NCT01082081|4677863|P1|Overall Study|Other Reason|0
1417013|NCT01082081|4677861|P3|Overall Study|Withdrawal by Subject|1
1417014|NCT01082081|4677862|P2|Overall Study|Withdrawal by Subject|0
1417015|NCT01082081|4677863|P1|Overall Study|Withdrawal by Subject|0
1417016|NCT01082081|4677861|P3|Overall Study|Lost to Follow-up|1
1417017|NCT01082081|4677862|P2|Overall Study|Lost to Follow-up|0
1417018|NCT01082081|4677863|P1|Overall Study|Lost to Follow-up|0
1417019|NCT01081951|4677915|P2|Overall Study|Lost to Follow-up|1
1417020|NCT01081951|4677916|P1|Overall Study|Lost to Follow-up|0
1417021|NCT01081951|4677915|P2|Overall Study|Allocated treatment but did not take it|1
1417022|NCT01081951|4677916|P1|Overall Study|Allocated treatment but did not take it|0
1417023|NCT01081951|4677915|P2|Overall Study|Withdrawal by Subject|6
1417024|NCT01081951|4677916|P1|Overall Study|Withdrawal by Subject|2
1417025|NCT01081951|4677915|P2|Overall Study|Death|47
1417026|NCT01081951|4677916|P1|Overall Study|Death|54
1417027|NCT01081912|4677926|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
1417028|NCT01081912|4677927|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
1417029|NCT01081912|4677928|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
1417030|NCT01081912|4677926|P3|Maintenance Treatment|Non-Compliance|7
1417031|NCT01081912|4677927|P2|Maintenance Treatment|Non-Compliance|4
1417032|NCT01081912|4677928|P1|Maintenance Treatment|Non-Compliance|0
1417033|NCT01081912|4677926|P3|Maintenance Treatment|Withdrawal by Subject|5
1417034|NCT01081912|4677927|P2|Maintenance Treatment|Withdrawal by Subject|5
1417035|NCT01081912|4677928|P1|Maintenance Treatment|Withdrawal by Subject|0
1417036|NCT01081912|4677926|P3|Maintenance Treatment|Protocol Violation|2
1417037|NCT01081912|4677927|P2|Maintenance Treatment|Protocol Violation|1
1417038|NCT01081912|4677928|P1|Maintenance Treatment|Protocol Violation|0
1417039|NCT01081912|4677926|P3|Maintenance Treatment|Physician Decision|1
1417040|NCT01081912|4677927|P2|Maintenance Treatment|Physician Decision|0
1417041|NCT01081912|4677928|P1|Maintenance Treatment|Physician Decision|0
1417042|NCT01081912|4677926|P3|Maintenance Treatment|Lost to Follow-up|0
1417043|NCT01081912|4677927|P2|Maintenance Treatment|Lost to Follow-up|1
1417044|NCT01081912|4677928|P1|Maintenance Treatment|Lost to Follow-up|0
1417045|NCT01081912|4677926|P3|Maintenance Treatment|Lack of Efficacy|64
1417046|NCT01081912|4677927|P2|Maintenance Treatment|Lack of Efficacy|14
1417047|NCT01081912|4677928|P1|Maintenance Treatment|Lack of Efficacy|0
1417048|NCT01081912|4677926|P3|Maintenance Treatment|Adverse Event|12
1417049|NCT01081912|4677927|P2|Maintenance Treatment|Adverse Event|2
1417050|NCT01081912|4677928|P1|Maintenance Treatment|Adverse Event|0
1417051|NCT01081912|4677926|P3|Conversion/Titration|Non-Compliance|0
1417052|NCT01081912|4677927|P2|Conversion/Titration|Non-Compliance|0
1417053|NCT01081912|4677928|P1|Conversion/Titration|Non-Compliance|47
1417054|NCT01081912|4677926|P3|Conversion/Titration|Withdrawal by Subject|0
1417055|NCT01081912|4677927|P2|Conversion/Titration|Withdrawal by Subject|0
1417056|NCT01081912|4677928|P1|Conversion/Titration|Withdrawal by Subject|23
1417057|NCT01081912|4677926|P3|Conversion/Titration|Protocol Violation|0
1417058|NCT01081912|4677927|P2|Conversion/Titration|Protocol Violation|0
1417059|NCT01081912|4677928|P1|Conversion/Titration|Protocol Violation|67
1417060|NCT01081912|4677926|P3|Conversion/Titration|Physician Decision|0
1417061|NCT01081912|4677927|P2|Conversion/Titration|Physician Decision|0
1417062|NCT01081912|4677928|P1|Conversion/Titration|Physician Decision|2
1417063|NCT01081912|4677926|P3|Conversion/Titration|Lost to Follow-up|0
1417064|NCT01081912|4677927|P2|Conversion/Titration|Lost to Follow-up|0
1417065|NCT01081912|4677928|P1|Conversion/Titration|Lost to Follow-up|5
1417066|NCT01081912|4677926|P3|Conversion/Titration|Lack of Efficacy|0
1417067|NCT01081912|4677927|P2|Conversion/Titration|Lack of Efficacy|0
1417068|NCT01081912|4677928|P1|Conversion/Titration|Lack of Efficacy|17
1417069|NCT01081912|4677926|P3|Conversion/Titration|Adverse Event|0
1417070|NCT01081912|4677927|P2|Conversion/Titration|Adverse Event|0
1417071|NCT01081912|4677928|P1|Conversion/Titration|Adverse Event|47
1417072|NCT01081886|4677937|P2|Overall Study|Study termination|13
1417073|NCT01081886|4677938|P1|Overall Study|Study termination|11
1417074|NCT01081873|4677946|P1|Overall Study|Other|47
1417075|NCT01081873|4677946|P1|Overall Study|Progression of prostate cancer|13
1417076|NCT01081873|4677946|P1|Overall Study|Lost to Follow-up|142
1417077|NCT01081873|4677946|P1|Overall Study|Withdrawal by Subject|10
1417078|NCT01081873|4677946|P1|Overall Study|Death|86
1417079|NCT01081834|4678018|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
1417080|NCT01081834|4678019|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
1417081|NCT01081834|4678020|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
1417082|NCT01081834|4678021|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
1417083|NCT01081834|4678022|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
1417084|NCT01081834|4678018|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
1417085|NCT01081834|4678019|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
1417086|NCT01081834|4678020|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
1417087|NCT01081834|4678021|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
1417088|NCT01081834|4678022|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
1417089|NCT01081834|4678018|P5|Extension Period: Week 26 to Week 52|Not specified|0
1417090|NCT01081834|4678019|P4|Extension Period: Week 26 to Week 52|Not specified|0
1417091|NCT01081834|4678020|P3|Extension Period: Week 26 to Week 52|Not specified|4
1417092|NCT01081834|4678021|P2|Extension Period: Week 26 to Week 52|Not specified|5
1417093|NCT01081834|4678022|P1|Extension Period: Week 26 to Week 52|Not specified|4
1417094|NCT01081834|4678018|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
1417095|NCT01081834|4678019|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
1417096|NCT01081834|4678020|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
1417097|NCT01081834|4678021|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
1417098|NCT01081834|4678022|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
1417254|NCT01081301|4678196|P1|Overall Study|Patient too ill|2
1417099|NCT01081834|4678018|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1417100|NCT01081834|4678019|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1417101|NCT01081834|4678020|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
1417102|NCT01081834|4678021|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1417103|NCT01081834|4678022|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
1417104|NCT01081834|4678018|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1417105|NCT01081834|4678019|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1417106|NCT01081834|4678020|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1417107|NCT01081834|4678021|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
1417108|NCT01081834|4678022|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1417109|NCT01081834|4678018|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
1417110|NCT01081834|4678019|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
1417111|NCT01081834|4678020|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
1417112|NCT01081834|4678021|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
1417113|NCT01081834|4678022|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
1417114|NCT01081834|4678018|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1417115|NCT01081834|4678019|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1417116|NCT01081834|4678020|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1417117|NCT01081834|4678021|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
1417118|NCT01081834|4678022|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
1417119|NCT01081834|4678018|P5|Extension Period: Week 26 to Week 52|Death|0
1417120|NCT01081834|4678019|P4|Extension Period: Week 26 to Week 52|Death|0
1417121|NCT01081834|4678020|P3|Extension Period: Week 26 to Week 52|Death|0
1417122|NCT01081834|4678021|P2|Extension Period: Week 26 to Week 52|Death|0
1417123|NCT01081834|4678022|P1|Extension Period: Week 26 to Week 52|Death|1
1417124|NCT01081834|4678018|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
1417125|NCT01081834|4678019|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
1417126|NCT01081834|4678020|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
1417127|NCT01081834|4678021|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
1417128|NCT01081834|4678022|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
1417129|NCT01081834|4678018|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
1417130|NCT01081834|4678019|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
1417131|NCT01081834|4678020|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
1417132|NCT01081834|4678021|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
1417133|NCT01081834|4678022|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
1417134|NCT01081834|4678018|P5|Core Period: Baseline to Week 26|Not specified|0
1417135|NCT01081834|4678019|P4|Core Period: Baseline to Week 26|Not specified|1
1417136|NCT01081834|4678020|P3|Core Period: Baseline to Week 26|Not specified|3
1417137|NCT01081834|4678021|P2|Core Period: Baseline to Week 26|Not specified|4
1417138|NCT01081834|4678022|P1|Core Period: Baseline to Week 26|Not specified|4
1417139|NCT01081834|4678018|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1417140|NCT01081834|4678019|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1417141|NCT01081834|4678020|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1417142|NCT01081834|4678021|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1417143|NCT01081834|4678022|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
1417144|NCT01081834|4678018|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1417145|NCT01081834|4678019|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
1417146|NCT01081834|4678020|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
1417147|NCT01081834|4678021|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
1417148|NCT01081834|4678022|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
1417149|NCT01081834|4678018|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
1417150|NCT01081834|4678019|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
1417151|NCT01081834|4678020|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
1417152|NCT01081834|4678021|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
1417153|NCT01081834|4678022|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
1417154|NCT01081834|4678018|P5|Core Period: Baseline to Week 26|Protocol Violation|2
1417155|NCT01081834|4678019|P4|Core Period: Baseline to Week 26|Protocol Violation|0
1417156|NCT01081834|4678020|P3|Core Period: Baseline to Week 26|Protocol Violation|0
1417157|NCT01081834|4678021|P2|Core Period: Baseline to Week 26|Protocol Violation|4
1417158|NCT01081834|4678022|P1|Core Period: Baseline to Week 26|Protocol Violation|0
1417159|NCT01081834|4678018|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
1417160|NCT01081834|4678019|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
1417161|NCT01081834|4678020|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
1417162|NCT01081834|4678021|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
1417163|NCT01081834|4678022|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
1417164|NCT01081834|4678018|P5|Core Period: Baseline to Week 26|Death|0
1417165|NCT01081834|4678019|P4|Core Period: Baseline to Week 26|Death|0
1417166|NCT01081834|4678020|P3|Core Period: Baseline to Week 26|Death|0
1417167|NCT01081834|4678021|P2|Core Period: Baseline to Week 26|Death|0
1417168|NCT01081834|4678022|P1|Core Period: Baseline to Week 26|Death|1
1417169|NCT01081834|4678018|P5|Core Period: Baseline to Week 26|Adverse Event|1
1417255|NCT01081301|4678196|P1|Overall Study|Too busy|5
1417170|NCT01081834|4678019|P4|Core Period: Baseline to Week 26|Adverse Event|1
1417171|NCT01081834|4678020|P3|Core Period: Baseline to Week 26|Adverse Event|3
1417172|NCT01081834|4678021|P2|Core Period: Baseline to Week 26|Adverse Event|5
1417173|NCT01081834|4678022|P1|Core Period: Baseline to Week 26|Adverse Event|2
1417174|NCT01081834|4678018|P5|Core Period: Baseline to Week 26|Pregnancy|0
1417175|NCT01081834|4678019|P4|Core Period: Baseline to Week 26|Pregnancy|0
1417176|NCT01081834|4678020|P3|Core Period: Baseline to Week 26|Pregnancy|0
1417177|NCT01081834|4678021|P2|Core Period: Baseline to Week 26|Pregnancy|0
1417178|NCT01081834|4678022|P1|Core Period: Baseline to Week 26|Pregnancy|1
1417179|NCT01081795|4678083|P3|Overall Study|Other|0
1417180|NCT01081795|4678084|P2|Overall Study|Other|2
1417181|NCT01081795|4678085|P1|Overall Study|Other|1
1417182|NCT01081795|4678083|P3|Overall Study|Using drug with restricted days of use|2
1417183|NCT01081795|4678084|P2|Overall Study|Using drug with restricted days of use|3
1417184|NCT01081795|4678085|P1|Overall Study|Using drug with restricted days of use|2
1417185|NCT01081795|4678083|P3|Overall Study|Use of a prohibited concomitant drug|1
1417186|NCT01081795|4678084|P2|Overall Study|Use of a prohibited concomitant drug|1
1417187|NCT01081795|4678085|P1|Overall Study|Use of a prohibited concomitant drug|1
1417188|NCT01081795|4678083|P3|Overall Study|Ineligible for participation|0
1417189|NCT01081795|4678084|P2|Overall Study|Ineligible for participation|0
1417190|NCT01081795|4678085|P1|Overall Study|Ineligible for participation|1
1417191|NCT01081795|4678083|P3|Overall Study|Revocation of informed consent|0
1417192|NCT01081795|4678084|P2|Overall Study|Revocation of informed consent|0
1417193|NCT01081795|4678085|P1|Overall Study|Revocation of informed consent|2
1417194|NCT01081795|4678083|P3|Overall Study|Subject’s schedule|2
1417195|NCT01081795|4678084|P2|Overall Study|Subject’s schedule|1
1417196|NCT01081795|4678085|P1|Overall Study|Subject’s schedule|1
1417197|NCT01081795|4678083|P3|Overall Study|Lack of Efficacy|19
1417198|NCT01081795|4678084|P2|Overall Study|Lack of Efficacy|5
1417199|NCT01081795|4678085|P1|Overall Study|Lack of Efficacy|7
1417200|NCT01081795|4678083|P3|Overall Study|Adverse Event|6
1417201|NCT01081795|4678084|P2|Overall Study|Adverse Event|23
1417202|NCT01081795|4678085|P1|Overall Study|Adverse Event|18
1417203|NCT01081769|4678122|P2|CORE Intent-To-Treat|Patient Moved|2
1417204|NCT01081769|4678123|P1|CORE Intent-To-Treat|Patient Moved|2
1417205|NCT01081769|4678122|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
1417206|NCT01081769|4678123|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
1417207|NCT01081769|4678122|P2|CORE Intent-To-Treat|Ineligibility|4
1417208|NCT01081769|4678123|P1|CORE Intent-To-Treat|Ineligibility|3
1417209|NCT01081769|4678122|P2|CORE Intent-To-Treat|Other|1
1417210|NCT01081769|4678123|P1|CORE Intent-To-Treat|Other|0
1417211|NCT01081769|4678122|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
1417212|NCT01081769|4678123|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
1417213|NCT01081769|4678122|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
1417214|NCT01081769|4678123|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
1417215|NCT01081769|4678122|P2|CORE Intent-To-Treat|Pregnancy|0
1417216|NCT01081769|4678123|P1|CORE Intent-To-Treat|Pregnancy|1
1417217|NCT01081769|4678122|P2|CORE Intent-To-Treat|Lost to Follow-up|5
1417218|NCT01081769|4678123|P1|CORE Intent-To-Treat|Lost to Follow-up|4
1417219|NCT01081769|4678122|P2|CORE Intent-To-Treat|Lack of Efficacy|6
1417220|NCT01081769|4678123|P1|CORE Intent-To-Treat|Lack of Efficacy|2
1417221|NCT01081769|4678122|P2|CORE Intent-To-Treat|Death|1
1417222|NCT01081769|4678123|P1|CORE Intent-To-Treat|Death|1
1417223|NCT01081769|4678122|P2|CORE Intent-To-Treat|Adverse Event|11
1417224|NCT01081769|4678123|P1|CORE Intent-To-Treat|Adverse Event|14
1417225|NCT01081769|4678122|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
1417226|NCT01081769|4678123|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
1417227|NCT01081769|4678122|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
1417228|NCT01081769|4678123|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
1417229|NCT01081769|4678122|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
1417230|NCT01081769|4678123|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
1417231|NCT01081769|4678122|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
1417232|NCT01081769|4678123|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
1417233|NCT01081665|4678157|P1|Overall Study|Lack of Efficacy|1
1417234|NCT01081665|4678157|P1|Overall Study|Adverse Event|1
1417235|NCT01081665|4678157|P1|Overall Study|Change in renal replacement therapy|2
1417236|NCT01081665|4678157|P1|Overall Study|Regulation of iPTH|5
1417237|NCT01081665|4678157|P1|Overall Study|Change of dialysis unit|10
1417238|NCT01081665|4678157|P1|Overall Study|Withdrawal by Subject|17
1417239|NCT01081665|4678157|P1|Overall Study|Lost to Follow-up|18
1417240|NCT01081665|4678157|P1|Overall Study|Death|41
1417241|NCT01081626|4678169|P2|Overall Study|Other|30
1417242|NCT01081626|4678170|P1|Overall Study|Other|33
1417243|NCT01081626|4678169|P2|Overall Study|Lost to Follow-up|1
1417244|NCT01081626|4678170|P1|Overall Study|Lost to Follow-up|0
1417245|NCT01081626|4678169|P2|Overall Study|Overstimulation|1
1417246|NCT01081626|4678170|P1|Overall Study|Overstimulation|0
1417247|NCT01081626|4678169|P2|Overall Study|Low antral follicle count|0
1417248|NCT01081626|4678170|P1|Overall Study|Low antral follicle count|1
1417249|NCT01081626|4678169|P2|Overall Study|Missing Estradiol|28
1417250|NCT01081626|4678170|P1|Overall Study|Missing Estradiol|25
1417251|NCT01081626|4678169|P2|Overall Study|Dosing error|1
1417252|NCT01081626|4678170|P1|Overall Study|Dosing error|1
1417253|NCT01081301|4678196|P1|Overall Study|Lost to Follow-up|4
1417256|NCT01081301|4678196|P1|Overall Study|Bereaved|3
1417257|NCT01081249|4678234|P2|Overall Study|Diagnosed with Bipolar Disorder|1
1417258|NCT01081249|4678235|P1|Overall Study|Diagnosed with Bipolar Disorder|0
1417259|NCT01081145|4678241|P2|Double-Blind Randomized-Withdrawal Phase|Not specified|3
1417260|NCT01081145|4678242|P1|Double-Blind Randomized-Withdrawal Phase|Not specified|4
1417261|NCT01081145|4678241|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
1417262|NCT01081145|4678242|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
1417263|NCT01081145|4678241|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
1417264|NCT01081145|4678242|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
1417265|NCT01081145|4678241|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
1417266|NCT01081145|4678242|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
1417267|NCT01081145|4678241|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
1417268|NCT01081145|4678242|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
1417269|NCT01081145|4678241|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
1417270|NCT01081145|4678242|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
1417271|NCT01081145|4678241|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
1417272|NCT01081145|4678242|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
1417273|NCT01081145|4678241|P2|Open-Label Phase|Protocol Violation|0
1417274|NCT01081145|4678242|P1|Open-Label Phase|Protocol Violation|4
1417275|NCT01081145|4678241|P2|Open-Label Phase|Lost to Follow-up|0
1417276|NCT01081145|4678242|P1|Open-Label Phase|Lost to Follow-up|11
1417277|NCT01081145|4678241|P2|Open-Label Phase|Not specified|0
1417278|NCT01081145|4678242|P1|Open-Label Phase|Not specified|12
1417279|NCT01081145|4678241|P2|Open-Label Phase|Withdrawal by Subject|0
1417280|NCT01081145|4678242|P1|Open-Label Phase|Withdrawal by Subject|41
1417281|NCT01081145|4678241|P2|Open-Label Phase|Adverse Event|0
1417282|NCT01081145|4678242|P1|Open-Label Phase|Adverse Event|42
1417283|NCT01081145|4678241|P2|Open-Label Phase|Response criteria not met|0
1417284|NCT01081145|4678242|P1|Open-Label Phase|Response criteria not met|46
1417285|NCT01081145|4678241|P2|Open-Label Phase|Lack of Efficacy|0
1417286|NCT01081145|4678242|P1|Open-Label Phase|Lack of Efficacy|56
1417287|NCT01081132|4678270|P2|Overall Study|Protocol Violation|1
1417288|NCT01081132|4678271|P1|Overall Study|Protocol Violation|3
1417289|NCT01081132|4678270|P2|Overall Study|Declined Taper Phase|1
1417290|NCT01081132|4678271|P1|Overall Study|Declined Taper Phase|0
1417291|NCT01081132|4678270|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
1417292|NCT01081132|4678271|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
1417293|NCT01081132|4678270|P2|Overall Study|Stopped Taking Meds|0
1417294|NCT01081132|4678271|P1|Overall Study|Stopped Taking Meds|2
1417295|NCT01081132|4678270|P2|Overall Study|Missed Visits|1
1417296|NCT01081132|4678271|P1|Overall Study|Missed Visits|1
1417297|NCT01081132|4678270|P2|Overall Study|Lack Of Compliance|1
1417298|NCT01081132|4678271|P1|Overall Study|Lack Of Compliance|0
1417299|NCT01081132|4678270|P2|Overall Study|Non Compliance|2
1417300|NCT01081132|4678271|P1|Overall Study|Non Compliance|4
1417301|NCT01081132|4678270|P2|Overall Study|Adverse Event|9
1417302|NCT01081132|4678271|P1|Overall Study|Adverse Event|3
1417303|NCT01081132|4678270|P2|Overall Study|Lost to Follow-up|11
1417304|NCT01081132|4678271|P1|Overall Study|Lost to Follow-up|4
1417305|NCT01081132|4678270|P2|Overall Study|Withdrawal by Subject|16
1417306|NCT01081132|4678271|P1|Overall Study|Withdrawal by Subject|13
1417307|NCT01081132|4678270|P2|Overall Study|Lack of Efficacy|9
1417308|NCT01081132|4678271|P1|Overall Study|Lack of Efficacy|25
1417309|NCT01080807|4678355|P2|Overall Study|Moved away without notifying center|0
1417310|NCT01080807|4678356|P1|Overall Study|Moved away without notifying center|1
1417311|NCT01080807|4678355|P2|Overall Study|Switched to first shift|0
1417312|NCT01080807|4678356|P1|Overall Study|Switched to first shift|1
1417313|NCT01080807|4678355|P2|Overall Study|Work schedule and travel|1
1417314|NCT01080807|4678356|P1|Overall Study|Work schedule and travel|0
1417315|NCT01080807|4678355|P2|Overall Study|Work schedule changing|1
1417316|NCT01080807|4678356|P1|Overall Study|Work schedule changing|1
1417317|NCT01080807|4678355|P2|Overall Study|Stopped working consistent night shifts|1
1417318|NCT01080807|4678356|P1|Overall Study|Stopped working consistent night shifts|0
1417319|NCT01080807|4678355|P2|Overall Study|Laid off or terminated from job|2
1417320|NCT01080807|4678356|P1|Overall Study|Laid off or terminated from job|1
1417321|NCT01080807|4678355|P2|Overall Study|Began working day shift|2
1417322|NCT01080807|4678356|P1|Overall Study|Began working day shift|0
1417323|NCT01080807|4678355|P2|Overall Study|Noncompliance to study procedures|1
1417324|NCT01080807|4678356|P1|Overall Study|Noncompliance to study procedures|1
1417325|NCT01080807|4678355|P2|Overall Study|Noncompliance with drug administration|1
1417326|NCT01080807|4678356|P1|Overall Study|Noncompliance with drug administration|1
1417327|NCT01080807|4678355|P2|Overall Study|Lost to Follow-up|4
1417328|NCT01080807|4678356|P1|Overall Study|Lost to Follow-up|6
1417329|NCT01080807|4678355|P2|Overall Study|Protocol Violation|6
1417330|NCT01080807|4678356|P1|Overall Study|Protocol Violation|7
1417331|NCT01080807|4678355|P2|Overall Study|Withdrawal by Subject|2
1417332|NCT01080807|4678356|P1|Overall Study|Withdrawal by Subject|7
1417333|NCT01080807|4678355|P2|Overall Study|Lack of Efficacy|1
1417334|NCT01080807|4678356|P1|Overall Study|Lack of Efficacy|0
1417335|NCT01080807|4678355|P2|Overall Study|Adverse Event|1
1417336|NCT01080807|4678356|P1|Overall Study|Adverse Event|9
1417337|NCT01080768|4678465|P2|Overall Study|Protocol Deviation|1
1417338|NCT01080768|4678466|P1|Overall Study|Protocol Deviation|2
1417339|NCT01080625|4678497|P3|Overall Study|Physician Decision|1
1417340|NCT01080625|4678498|P2|Overall Study|Physician Decision|2
1417341|NCT01080625|4678499|P1|Overall Study|Physician Decision|0
1417342|NCT01080391|4678509|P2|Overall Study|Withdrawal by Subject|10
1417343|NCT01080391|4678510|P1|Overall Study|Withdrawal by Subject|19
1417344|NCT01080391|4678509|P2|Overall Study|Lost to Follow-up|3
1417345|NCT01080391|4678510|P1|Overall Study|Lost to Follow-up|4
1417346|NCT01080326|4678528|P1|Overall Study|Surgeon decision|1
1417347|NCT01080326|4678528|P1|Overall Study|Patient deterioration prior to procedure|3
1417348|NCT01080300|4678534|P2|Overall Study|Reasons not specified|6
1417349|NCT01080300|4678535|P1|Overall Study|Reasons not specified|4
1417350|NCT01080300|4678534|P2|Overall Study|Withdrawal by Subject|28
1417351|NCT01080300|4678535|P1|Overall Study|Withdrawal by Subject|12
1417352|NCT01080300|4678534|P2|Overall Study|Death|1
1417353|NCT01080300|4678535|P1|Overall Study|Death|0
1417354|NCT01080300|4678534|P2|Overall Study|Lost to Follow-up|6
1417355|NCT01080300|4678535|P1|Overall Study|Lost to Follow-up|10
1417356|NCT01080300|4678534|P2|Overall Study|Protocol Violation|13
1417357|NCT01080300|4678535|P1|Overall Study|Protocol Violation|7
1417358|NCT01080300|4678534|P2|Overall Study|Lack of Efficacy|15
1417359|NCT01080300|4678535|P1|Overall Study|Lack of Efficacy|12
1417360|NCT01080300|4678534|P2|Overall Study|Adverse Event|35
1417361|NCT01080300|4678535|P1|Overall Study|Adverse Event|49
1417362|NCT01080131|4678620|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
1417363|NCT01080131|4678621|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
1417364|NCT01080131|4678620|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
1417365|NCT01080131|4678621|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
1417366|NCT01080131|4678620|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
1417367|NCT01080131|4678621|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
1417368|NCT01080131|4678620|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
1417369|NCT01080131|4678621|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
1417370|NCT01080131|4678620|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
1417371|NCT01080131|4678621|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
1417372|NCT01080131|4678620|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
1417373|NCT01080131|4678621|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
1417374|NCT01080131|4678620|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
1417375|NCT01080131|4678621|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
1417376|NCT01080131|4678620|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
1417377|NCT01080131|4678621|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
1417378|NCT01080131|4678620|P2|Core Study (0- 12 Weeks)|Death|0
1417379|NCT01080131|4678621|P1|Core Study (0- 12 Weeks)|Death|1
1417380|NCT01080131|4678620|P2|Core Study (0- 12 Weeks)|Administrative problems|1
1417381|NCT01080131|4678621|P1|Core Study (0- 12 Weeks)|Administrative problems|0
1417382|NCT01080131|4678620|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
1417383|NCT01080131|4678621|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
1417384|NCT01080131|4678620|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
1417385|NCT01080131|4678621|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
1417386|NCT01080131|4678620|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
1417387|NCT01080131|4678621|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
1417388|NCT01079988|4678716|P5|Overall Study|Other|1
1417389|NCT01079988|4678717|P4|Overall Study|Other|2
1417390|NCT01079988|4678718|P3|Overall Study|Other|0
1417391|NCT01079988|4678719|P2|Overall Study|Other|0
1417392|NCT01079988|4678720|P1|Overall Study|Other|0
1417393|NCT01079988|4678716|P5|Overall Study|Lack of Efficacy|0
1417394|NCT01079988|4678717|P4|Overall Study|Lack of Efficacy|0
1417395|NCT01079988|4678718|P3|Overall Study|Lack of Efficacy|0
1417396|NCT01079988|4678719|P2|Overall Study|Lack of Efficacy|0
1417397|NCT01079988|4678720|P1|Overall Study|Lack of Efficacy|1
1417398|NCT01079988|4678716|P5|Overall Study|Lost to Follow-up|0
1417399|NCT01079988|4678717|P4|Overall Study|Lost to Follow-up|1
1417400|NCT01079988|4678718|P3|Overall Study|Lost to Follow-up|0
1417401|NCT01079988|4678719|P2|Overall Study|Lost to Follow-up|0
1417402|NCT01079988|4678720|P1|Overall Study|Lost to Follow-up|0
1417403|NCT01079962|4678739|P2|Overall Study|Due to arrhythmia/bradycardia|1
1417404|NCT01079962|4678740|P1|Overall Study|Due to arrhythmia/bradycardia|1
1417405|NCT01079962|4678739|P2|Overall Study|Participant not returning for next visit|0
1417406|NCT01079962|4678740|P1|Overall Study|Participant not returning for next visit|1
1417407|NCT01079962|4678739|P2|Overall Study|Inclusion/exclusion criteria|3
1417408|NCT01079962|4678740|P1|Overall Study|Inclusion/exclusion criteria|1
1417409|NCT01079962|4678739|P2|Overall Study|No blood pressure (BP) control|0
1417410|NCT01079962|4678740|P1|Overall Study|No blood pressure (BP) control|3
1417411|NCT01079962|4678739|P2|Overall Study|Protocol Violation|2
1417412|NCT01079962|4678740|P1|Overall Study|Protocol Violation|2
1417413|NCT01079962|4678739|P2|Overall Study|Withdrawal by Subject|7
1417414|NCT01079962|4678740|P1|Overall Study|Withdrawal by Subject|5
1417415|NCT01079962|4678739|P2|Overall Study|Adverse Event|2
1417416|NCT01079962|4678740|P1|Overall Study|Adverse Event|2
1417417|NCT01079949|4678768|P2|Overall Study|Randomized but not treated|0
1417418|NCT01079949|4678769|P1|Overall Study|Randomized but not treated|1
1417419|NCT01079949|4678768|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
1417420|NCT01079949|4678769|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
1417421|NCT01079949|4678768|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
1417422|NCT01079949|4678769|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
1417423|NCT01079949|4678768|P2|Overall Study|Withdrawal before r-hCG administration|3
1417424|NCT01079949|4678769|P1|Overall Study|Withdrawal before r-hCG administration|2
1417425|NCT01079936|4678815|P5|Phase II|Insurance Issue|1
1417426|NCT01079936|4678816|P4|Phase II|Insurance Issue|0
1417427|NCT01079936|4678817|P3|Phase II|Insurance Issue|0
1417428|NCT01079936|4678818|P2|Phase II|Insurance Issue|0
1417429|NCT01079936|4678819|P1|Phase II|Insurance Issue|0
1417430|NCT01079936|4678815|P5|Phase II|Adverse Event|0
1417431|NCT01079936|4678816|P4|Phase II|Adverse Event|0
1417432|NCT01079936|4678817|P3|Phase II|Adverse Event|1
1417433|NCT01079936|4678818|P2|Phase II|Adverse Event|0
1417434|NCT01079936|4678819|P1|Phase II|Adverse Event|0
1417435|NCT01079936|4678815|P5|Phase I: MTD|No Stem Cell Transplantation|0
1417436|NCT01079936|4678816|P4|Phase I: MTD|No Stem Cell Transplantation|0
1417437|NCT01079936|4678817|P3|Phase I: MTD|No Stem Cell Transplantation|0
1417438|NCT01079936|4678818|P2|Phase I: MTD|No Stem Cell Transplantation|0
1417439|NCT01079936|4678819|P1|Phase I: MTD|No Stem Cell Transplantation|2
1417440|NCT01079936|4678815|P5|Phase I: MTD|First Remission Status|0
1417441|NCT01079936|4678816|P4|Phase I: MTD|First Remission Status|0
1417442|NCT01079936|4678817|P3|Phase I: MTD|First Remission Status|0
1417443|NCT01079936|4678818|P2|Phase I: MTD|First Remission Status|0
1417444|NCT01079936|4678819|P1|Phase I: MTD|First Remission Status|2
1417445|NCT01079832|4678838|P1|Overall Study|Withdrawal by Subject|1
1417446|NCT01079806|4678848|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|2
1417447|NCT01079806|4678849|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|0
1417448|NCT01079806|4678848|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
1417449|NCT01079806|4678849|P1|Day 1 to Week 96|Poor compliance or noncompliance|1
1417450|NCT01079806|4678848|P2|Day 1 to Week 96|Pregnancy|1
1417451|NCT01079806|4678849|P1|Day 1 to Week 96|Pregnancy|0
1417452|NCT01079806|4678848|P2|Day 1 to Week 96|Withdrawal by Subject|1
1417453|NCT01079806|4678849|P1|Day 1 to Week 96|Withdrawal by Subject|3
1417454|NCT01079806|4678848|P2|Day 1 to Week 96|Adverse Event|2
1417455|NCT01079806|4678849|P1|Day 1 to Week 96|Adverse Event|0
1417456|NCT01079741|4678874|P5|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
1417457|NCT01079741|4678875|P4|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
1417458|NCT01079741|4678876|P3|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
1417459|NCT01079741|4678877|P2|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
1417460|NCT01079741|4678878|P1|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
1417461|NCT01079741|4678874|P5|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
1417462|NCT01079741|4678875|P4|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
1417463|NCT01079741|4678876|P3|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
1417464|NCT01079741|4678877|P2|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
1417465|NCT01079741|4678878|P1|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
1417466|NCT01079234|4678926|P4|Extension: Week 27 to 52|Unclassified|7
1417467|NCT01079234|4678927|P3|Extension: Week 27 to 52|Unclassified|4
1417468|NCT01079234|4678928|P2|Extension: Week 27 to 52|Unclassified|0
1417469|NCT01079234|4678929|P1|Extension: Week 27 to 52|Unclassified|0
1417470|NCT01079234|4678926|P4|Extension: Week 27 to 52|Withdrawal criteria|2
1417471|NCT01079234|4678927|P3|Extension: Week 27 to 52|Withdrawal criteria|4
1417472|NCT01079234|4678928|P2|Extension: Week 27 to 52|Withdrawal criteria|0
1417473|NCT01079234|4678929|P1|Extension: Week 27 to 52|Withdrawal criteria|0
1417474|NCT01079234|4678926|P4|Extension: Week 27 to 52|Protocol Violation|5
1417475|NCT01079234|4678927|P3|Extension: Week 27 to 52|Protocol Violation|2
1417476|NCT01079234|4678928|P2|Extension: Week 27 to 52|Protocol Violation|0
1417477|NCT01079234|4678929|P1|Extension: Week 27 to 52|Protocol Violation|0
1417478|NCT01079234|4678926|P4|Extension: Week 27 to 52|Lack of Efficacy|2
1417479|NCT01079234|4678927|P3|Extension: Week 27 to 52|Lack of Efficacy|0
1417480|NCT01079234|4678928|P2|Extension: Week 27 to 52|Lack of Efficacy|0
1417481|NCT01079234|4678929|P1|Extension: Week 27 to 52|Lack of Efficacy|0
1417482|NCT01079234|4678926|P4|Extension: Week 27 to 52|Adverse Event|0
1417483|NCT01079234|4678927|P3|Extension: Week 27 to 52|Adverse Event|1
1417484|NCT01079234|4678928|P2|Extension: Week 27 to 52|Adverse Event|0
1417485|NCT01079234|4678929|P1|Extension: Week 27 to 52|Adverse Event|0
1417486|NCT01079234|4678926|P4|Main: Week 0 to 26|Unclassified|0
1417487|NCT01079234|4678927|P3|Main: Week 0 to 26|Unclassified|4
1417488|NCT01079234|4678928|P2|Main: Week 0 to 26|Unclassified|13
1417489|NCT01079234|4678929|P1|Main: Week 0 to 26|Unclassified|7
1417490|NCT01079234|4678926|P4|Main: Week 0 to 26|Withdrawal criteria|0
1417491|NCT01079234|4678927|P3|Main: Week 0 to 26|Withdrawal criteria|2
1417492|NCT01079234|4678928|P2|Main: Week 0 to 26|Withdrawal criteria|6
1417493|NCT01079234|4678929|P1|Main: Week 0 to 26|Withdrawal criteria|6
1417494|NCT01079234|4678926|P4|Main: Week 0 to 26|Protocol Violation|0
1417495|NCT01079234|4678927|P3|Main: Week 0 to 26|Protocol Violation|4
1417496|NCT01079234|4678928|P2|Main: Week 0 to 26|Protocol Violation|2
1417497|NCT01079234|4678929|P1|Main: Week 0 to 26|Protocol Violation|6
1417498|NCT01079234|4678926|P4|Main: Week 0 to 26|Lack of Efficacy|0
1417499|NCT01079234|4678927|P3|Main: Week 0 to 26|Lack of Efficacy|1
1417500|NCT01079234|4678928|P2|Main: Week 0 to 26|Lack of Efficacy|1
1417501|NCT01079234|4678929|P1|Main: Week 0 to 26|Lack of Efficacy|2
1417502|NCT01079234|4678926|P4|Main: Week 0 to 26|Adverse Event|0
1417503|NCT01079234|4678927|P3|Main: Week 0 to 26|Adverse Event|1
1417504|NCT01079234|4678928|P2|Main: Week 0 to 26|Adverse Event|4
1417505|NCT01079234|4678929|P1|Main: Week 0 to 26|Adverse Event|5
1417506|NCT01079195|4678947|P1|Overall Study|Non-compliance|2
1417507|NCT01079195|4678947|P1|Overall Study|No Follow-up Documentation Available|4
1417508|NCT01079195|4678947|P1|Overall Study|Improved Status of Participant|4
1417509|NCT01079195|4678947|P1|Overall Study|Physician Decision|4
1417510|NCT01079195|4678947|P1|Overall Study|Lack of Effectiveness|12
1417511|NCT01079195|4678947|P1|Overall Study|Financial Reasons|15
1417512|NCT01079195|4678947|P1|Overall Study|Withdrawal by Subject|18
1417513|NCT01079195|4678947|P1|Overall Study|Reason Unknown|39
1417514|NCT01079195|4678947|P1|Overall Study|Adverse Event|157
1417515|NCT01079195|4678947|P1|Overall Study|No Documentation Available|437
1417516|NCT01079195|4678947|P1|Overall Study|No Documentation of Tarka Therapy|739
1417517|NCT01079182|4678953|P1|Overall Study|Reasons not Evaluated|271
1417518|NCT01079182|4678953|P1|Overall Study|ADR and Lack of Effectiveness|39
1417519|NCT01079182|4678953|P1|Overall Study|Lack of Efficacy|514
1417520|NCT01079182|4678953|P1|Overall Study|Adverse Drug Reaction (ADR)|261
1417521|NCT01079182|4678953|P1|Overall Study|Lost to Follow-up|1634
1417522|NCT01079130|4679061|P6|Overall Study|Lost to Follow-up|0
1417523|NCT01079130|4679062|P5|Overall Study|Lost to Follow-up|1
1417524|NCT01079130|4679063|P4|Overall Study|Lost to Follow-up|0
1417525|NCT01079130|4679064|P3|Overall Study|Lost to Follow-up|0
1417526|NCT01079130|4679065|P2|Overall Study|Lost to Follow-up|0
1417527|NCT01079130|4679066|P1|Overall Study|Lost to Follow-up|0
1417528|NCT01079130|4679061|P6|Overall Study|Unsatisfactory therapeutic effect|0
1417529|NCT01079130|4679062|P5|Overall Study|Unsatisfactory therapeutic effect|0
1417530|NCT01079130|4679063|P4|Overall Study|Unsatisfactory therapeutic effect|2
1417531|NCT01079130|4679064|P3|Overall Study|Unsatisfactory therapeutic effect|0
1417532|NCT01079130|4679065|P2|Overall Study|Unsatisfactory therapeutic effect|0
1417533|NCT01079130|4679066|P1|Overall Study|Unsatisfactory therapeutic effect|0
1417534|NCT01079130|4679061|P6|Overall Study|Abnormal test procedure result(s)|0
1417535|NCT01079130|4679062|P5|Overall Study|Abnormal test procedure result(s)|1
1417536|NCT01079130|4679063|P4|Overall Study|Abnormal test procedure result(s)|0
1417537|NCT01079130|4679064|P3|Overall Study|Abnormal test procedure result(s)|0
1417538|NCT01079130|4679065|P2|Overall Study|Abnormal test procedure result(s)|0
1417539|NCT01079130|4679066|P1|Overall Study|Abnormal test procedure result(s)|0
1417540|NCT01079130|4679061|P6|Overall Study|Protocol deviation|0
1417541|NCT01079130|4679062|P5|Overall Study|Protocol deviation|0
1417542|NCT01079130|4679063|P4|Overall Study|Protocol deviation|2
1417543|NCT01079130|4679064|P3|Overall Study|Protocol deviation|1
1417544|NCT01079130|4679065|P2|Overall Study|Protocol deviation|2
1417545|NCT01079130|4679066|P1|Overall Study|Protocol deviation|0
1417546|NCT01079130|4679061|P6|Overall Study|Withdrawal by Subject|3
1417547|NCT01079130|4679062|P5|Overall Study|Withdrawal by Subject|1
1417548|NCT01079130|4679063|P4|Overall Study|Withdrawal by Subject|0
1417549|NCT01079130|4679064|P3|Overall Study|Withdrawal by Subject|0
1417550|NCT01079130|4679065|P2|Overall Study|Withdrawal by Subject|1
1417551|NCT01079130|4679066|P1|Overall Study|Withdrawal by Subject|0
1417552|NCT01079130|4679061|P6|Overall Study|Administrative problems|1
1417553|NCT01079130|4679062|P5|Overall Study|Administrative problems|0
1417554|NCT01079130|4679063|P4|Overall Study|Administrative problems|0
1417555|NCT01079130|4679064|P3|Overall Study|Administrative problems|0
1417556|NCT01079130|4679065|P2|Overall Study|Administrative problems|3
1417557|NCT01079130|4679066|P1|Overall Study|Administrative problems|1
1417558|NCT01079130|4679061|P6|Overall Study|Adverse Event|1
1417559|NCT01079130|4679062|P5|Overall Study|Adverse Event|5
1417560|NCT01079130|4679063|P4|Overall Study|Adverse Event|1
1417561|NCT01079130|4679064|P3|Overall Study|Adverse Event|0
1417562|NCT01079130|4679065|P2|Overall Study|Adverse Event|1
1417563|NCT01079130|4679066|P1|Overall Study|Adverse Event|1
1417564|NCT01078974|4679086|P1|Overall Study|Adverse Event|3
1417565|NCT01078922|4679091|P1|Overall Study|Adverse Event|1
1417566|NCT01078805|4679132|P1|Overall Study|Didn't take study drug|82
1417567|NCT01078805|4679132|P1|Overall Study|Other|173
1417568|NCT01078805|4679132|P1|Overall Study|Withdrawal by Subject|739
1417569|NCT01078805|4679132|P1|Overall Study|Sponsor decision|46
1417570|NCT01078805|4679132|P1|Overall Study|Serious adverse event|26
1417571|NCT01078805|4679132|P1|Overall Study|Physician Decision|169
1417572|NCT01078805|4679132|P1|Overall Study|Lost to Follow-up|676
1417573|NCT01078805|4679132|P1|Overall Study|Death|134
1417574|NCT01078805|4679132|P1|Overall Study|Clinically significant abnormal lab|5
1417575|NCT01078675|4679159|P2|Overall Study|Adverse Event|0
1417576|NCT01078675|4679160|P1|Overall Study|Adverse Event|3
1417577|NCT01078675|4679159|P2|Overall Study|Provided in CRF for specific reasons|3
1417578|NCT01078675|4679160|P1|Overall Study|Provided in CRF for specific reasons|2
1417579|NCT01078675|4679159|P2|Overall Study|Protocol Violation|0
1417580|NCT01078675|4679160|P1|Overall Study|Protocol Violation|56
1417581|NCT01078675|4679159|P2|Overall Study|Withdrawal by Subject|3
1417582|NCT01078675|4679160|P1|Overall Study|Withdrawal by Subject|7
1417583|NCT01078662|4679182|P5|Overall Study|Lost to Follow-up|0
1417584|NCT01078662|4679183|P4|Overall Study|Lost to Follow-up|0
1417585|NCT01078662|4679184|P3|Overall Study|Lost to Follow-up|0
1417586|NCT01078662|4679185|P2|Overall Study|Lost to Follow-up|0
1417587|NCT01078662|4679186|P1|Overall Study|Lost to Follow-up|1
1417588|NCT01078662|4679182|P5|Overall Study|Protocol Violation|0
1417589|NCT01078662|4679183|P4|Overall Study|Protocol Violation|0
1417590|NCT01078662|4679184|P3|Overall Study|Protocol Violation|0
1417591|NCT01078662|4679185|P2|Overall Study|Protocol Violation|1
1417592|NCT01078662|4679186|P1|Overall Study|Protocol Violation|0
1417593|NCT01078662|4679182|P5|Overall Study|Withdrawal by Subject|0
1417594|NCT01078662|4679183|P4|Overall Study|Withdrawal by Subject|0
1417595|NCT01078662|4679184|P3|Overall Study|Withdrawal by Subject|1
1417596|NCT01078662|4679185|P2|Overall Study|Withdrawal by Subject|11
1417597|NCT01078662|4679186|P1|Overall Study|Withdrawal by Subject|4
1417598|NCT01078662|4679182|P5|Overall Study|Patients reached data cut-off|3
1417599|NCT01078662|4679183|P4|Overall Study|Patients reached data cut-off|2
1417600|NCT01078662|4679184|P3|Overall Study|Patients reached data cut-off|2
1417601|NCT01078662|4679185|P2|Overall Study|Patients reached data cut-off|53
1417602|NCT01078662|4679186|P1|Overall Study|Patients reached data cut-off|12
1417603|NCT01078662|4679182|P5|Overall Study|Death|8
1417604|NCT01078662|4679183|P4|Overall Study|Death|5
1417605|NCT01078662|4679184|P3|Overall Study|Death|18
1417606|NCT01078662|4679185|P2|Overall Study|Death|103
1417607|NCT01078662|4679186|P1|Overall Study|Death|41
1417608|NCT01078623|4679225|P20|Treatment Period 4|Withdrawal by Subject|0
1417609|NCT01078623|4679226|P19|Treatment Period 4|Withdrawal by Subject|0
1417610|NCT01078623|4679227|P18|Treatment Period 4|Withdrawal by Subject|0
1417611|NCT01078623|4679228|P17|Treatment Period 4|Withdrawal by Subject|0
1417612|NCT01078623|4679229|P16|Treatment Period 4|Withdrawal by Subject|1
1417613|NCT01078623|4679230|P15|Treatment Period 4|Withdrawal by Subject|0
1417614|NCT01078623|4679231|P14|Treatment Period 4|Withdrawal by Subject|0
1417615|NCT01078623|4679232|P13|Treatment Period 4|Withdrawal by Subject|0
1417616|NCT01078623|4679233|P12|Treatment Period 4|Withdrawal by Subject|0
1417617|NCT01078623|4679234|P11|Treatment Period 4|Withdrawal by Subject|0
1417618|NCT01078623|4679235|P10|Treatment Period 4|Withdrawal by Subject|0
1417619|NCT01078623|4679236|P9|Treatment Period 4|Withdrawal by Subject|0
1417620|NCT01078623|4679237|P8|Treatment Period 4|Withdrawal by Subject|0
1417621|NCT01078623|4679238|P7|Treatment Period 4|Withdrawal by Subject|0
1417622|NCT01078623|4679239|P6|Treatment Period 4|Withdrawal by Subject|0
1417623|NCT01078623|4679240|P5|Treatment Period 4|Withdrawal by Subject|0
1417624|NCT01078623|4679241|P4|Treatment Period 4|Withdrawal by Subject|0
1417625|NCT01078623|4679242|P3|Treatment Period 4|Withdrawal by Subject|0
1417626|NCT01078623|4679243|P2|Treatment Period 4|Withdrawal by Subject|0
1417627|NCT01078623|4679244|P1|Treatment Period 4|Withdrawal by Subject|0
1417628|NCT01078623|4679225|P20|Treatment Period 4|Adverse Event|0
1417629|NCT01078623|4679226|P19|Treatment Period 4|Adverse Event|0
1417630|NCT01078623|4679227|P18|Treatment Period 4|Adverse Event|0
1417631|NCT01078623|4679228|P17|Treatment Period 4|Adverse Event|0
1417632|NCT01078623|4679229|P16|Treatment Period 4|Adverse Event|0
1417633|NCT01078623|4679230|P15|Treatment Period 4|Adverse Event|0
1417634|NCT01078623|4679231|P14|Treatment Period 4|Adverse Event|0
1417635|NCT01078623|4679232|P13|Treatment Period 4|Adverse Event|0
1417636|NCT01078623|4679233|P12|Treatment Period 4|Adverse Event|0
1417637|NCT01078623|4679234|P11|Treatment Period 4|Adverse Event|0
1417638|NCT01078623|4679235|P10|Treatment Period 4|Adverse Event|0
1417639|NCT01078623|4679236|P9|Treatment Period 4|Adverse Event|0
1417640|NCT01078623|4679237|P8|Treatment Period 4|Adverse Event|0
1417641|NCT01078623|4679238|P7|Treatment Period 4|Adverse Event|0
1417642|NCT01078623|4679239|P6|Treatment Period 4|Adverse Event|0
1417643|NCT01078623|4679240|P5|Treatment Period 4|Adverse Event|0
1417644|NCT01078623|4679241|P4|Treatment Period 4|Adverse Event|0
1417645|NCT01078623|4679242|P3|Treatment Period 4|Adverse Event|1
1417646|NCT01078623|4679243|P2|Treatment Period 4|Adverse Event|0
1417647|NCT01078623|4679244|P1|Treatment Period 4|Adverse Event|0
1417648|NCT01078623|4679225|P20|Treatment Period 3|Adverse Event|0
1417649|NCT01078623|4679226|P19|Treatment Period 3|Adverse Event|0
1417650|NCT01078623|4679227|P18|Treatment Period 3|Adverse Event|0
1417651|NCT01078623|4679228|P17|Treatment Period 3|Adverse Event|0
1417652|NCT01078623|4679229|P16|Treatment Period 3|Adverse Event|0
1417653|NCT01078623|4679230|P15|Treatment Period 3|Adverse Event|0
1417654|NCT01078623|4679231|P14|Treatment Period 3|Adverse Event|1
1417655|NCT01078623|4679232|P13|Treatment Period 3|Adverse Event|0
1417656|NCT01078623|4679233|P12|Treatment Period 3|Adverse Event|0
1417657|NCT01078623|4679234|P11|Treatment Period 3|Adverse Event|0
1417658|NCT01078623|4679235|P10|Treatment Period 3|Adverse Event|0
1417659|NCT01078623|4679236|P9|Treatment Period 3|Adverse Event|0
1417660|NCT01078623|4679237|P8|Treatment Period 3|Adverse Event|0
1417661|NCT01078623|4679238|P7|Treatment Period 3|Adverse Event|0
1417662|NCT01078623|4679239|P6|Treatment Period 3|Adverse Event|0
1417663|NCT01078623|4679240|P5|Treatment Period 3|Adverse Event|1
1417664|NCT01078623|4679241|P4|Treatment Period 3|Adverse Event|0
1417665|NCT01078623|4679242|P3|Treatment Period 3|Adverse Event|0
1417666|NCT01078623|4679243|P2|Treatment Period 3|Adverse Event|0
1417667|NCT01078623|4679244|P1|Treatment Period 3|Adverse Event|0
1417668|NCT01078623|4679225|P20|Treatment Period 2|Withdrawal by Subject|0
1417669|NCT01078623|4679226|P19|Treatment Period 2|Withdrawal by Subject|0
1417670|NCT01078623|4679227|P18|Treatment Period 2|Withdrawal by Subject|0
1417671|NCT01078623|4679228|P17|Treatment Period 2|Withdrawal by Subject|0
1417672|NCT01078623|4679229|P16|Treatment Period 2|Withdrawal by Subject|0
1417673|NCT01078623|4679230|P15|Treatment Period 2|Withdrawal by Subject|0
1417674|NCT01078623|4679231|P14|Treatment Period 2|Withdrawal by Subject|0
1417675|NCT01078623|4679232|P13|Treatment Period 2|Withdrawal by Subject|0
1417676|NCT01078623|4679233|P12|Treatment Period 2|Withdrawal by Subject|0
1417677|NCT01078623|4679234|P11|Treatment Period 2|Withdrawal by Subject|0
1417678|NCT01078623|4679235|P10|Treatment Period 2|Withdrawal by Subject|0
1417679|NCT01078623|4679236|P9|Treatment Period 2|Withdrawal by Subject|0
1417680|NCT01078623|4679237|P8|Treatment Period 2|Withdrawal by Subject|0
1417681|NCT01078623|4679238|P7|Treatment Period 2|Withdrawal by Subject|0
1417682|NCT01078623|4679239|P6|Treatment Period 2|Withdrawal by Subject|1
1417683|NCT01078623|4679240|P5|Treatment Period 2|Withdrawal by Subject|0
1417684|NCT01078623|4679241|P4|Treatment Period 2|Withdrawal by Subject|0
1417685|NCT01078623|4679242|P3|Treatment Period 2|Withdrawal by Subject|0
1417686|NCT01078623|4679243|P2|Treatment Period 2|Withdrawal by Subject|0
1417687|NCT01078623|4679244|P1|Treatment Period 2|Withdrawal by Subject|0
1417688|NCT01078623|4679225|P20|Treatment Period 2|Adverse Event|0
1417689|NCT01078623|4679226|P19|Treatment Period 2|Adverse Event|1
1417690|NCT01078623|4679227|P18|Treatment Period 2|Adverse Event|0
1417691|NCT01078623|4679228|P17|Treatment Period 2|Adverse Event|0
1417692|NCT01078623|4679229|P16|Treatment Period 2|Adverse Event|0
1417693|NCT01078623|4679230|P15|Treatment Period 2|Adverse Event|0
1417694|NCT01078623|4679231|P14|Treatment Period 2|Adverse Event|0
1417695|NCT01078623|4679232|P13|Treatment Period 2|Adverse Event|0
1417696|NCT01078623|4679233|P12|Treatment Period 2|Adverse Event|0
1417697|NCT01078623|4679234|P11|Treatment Period 2|Adverse Event|0
1417698|NCT01078623|4679235|P10|Treatment Period 2|Adverse Event|0
1417699|NCT01078623|4679236|P9|Treatment Period 2|Adverse Event|0
1417700|NCT01078623|4679237|P8|Treatment Period 2|Adverse Event|0
1417701|NCT01078623|4679238|P7|Treatment Period 2|Adverse Event|1
1417702|NCT01078623|4679239|P6|Treatment Period 2|Adverse Event|0
1417703|NCT01078623|4679240|P5|Treatment Period 2|Adverse Event|0
1417704|NCT01078623|4679241|P4|Treatment Period 2|Adverse Event|0
1417705|NCT01078623|4679242|P3|Treatment Period 2|Adverse Event|0
1417706|NCT01078623|4679243|P2|Treatment Period 2|Adverse Event|0
1417707|NCT01078623|4679244|P1|Treatment Period 2|Adverse Event|0
1417708|NCT01078623|4679225|P20|Treatment Period 1|Protocol Violation|0
1417709|NCT01078623|4679226|P19|Treatment Period 1|Protocol Violation|0
1417710|NCT01078623|4679227|P18|Treatment Period 1|Protocol Violation|0
1417711|NCT01078623|4679228|P17|Treatment Period 1|Protocol Violation|0
1417712|NCT01078623|4679229|P16|Treatment Period 1|Protocol Violation|0
1417713|NCT01078623|4679230|P15|Treatment Period 1|Protocol Violation|0
1417714|NCT01078623|4679231|P14|Treatment Period 1|Protocol Violation|0
1417715|NCT01078623|4679232|P13|Treatment Period 1|Protocol Violation|0
1417716|NCT01078623|4679233|P12|Treatment Period 1|Protocol Violation|0
1417717|NCT01078623|4679234|P11|Treatment Period 1|Protocol Violation|0
1417718|NCT01078623|4679235|P10|Treatment Period 1|Protocol Violation|0
1417719|NCT01078623|4679236|P9|Treatment Period 1|Protocol Violation|0
1417720|NCT01078623|4679237|P8|Treatment Period 1|Protocol Violation|0
1417721|NCT01078623|4679238|P7|Treatment Period 1|Protocol Violation|0
1417722|NCT01078623|4679239|P6|Treatment Period 1|Protocol Violation|1
1417723|NCT01078623|4679240|P5|Treatment Period 1|Protocol Violation|0
1417724|NCT01078623|4679241|P4|Treatment Period 1|Protocol Violation|0
1417725|NCT01078623|4679242|P3|Treatment Period 1|Protocol Violation|0
1417726|NCT01078623|4679243|P2|Treatment Period 1|Protocol Violation|0
1417727|NCT01078623|4679244|P1|Treatment Period 1|Protocol Violation|0
1417728|NCT01078623|4679225|P20|Treatment Period 1|Withdrawal by Subject|0
1417729|NCT01078623|4679226|P19|Treatment Period 1|Withdrawal by Subject|0
1417730|NCT01078623|4679227|P18|Treatment Period 1|Withdrawal by Subject|0
1417731|NCT01078623|4679228|P17|Treatment Period 1|Withdrawal by Subject|0
1417732|NCT01078623|4679229|P16|Treatment Period 1|Withdrawal by Subject|0
1417733|NCT01078623|4679230|P15|Treatment Period 1|Withdrawal by Subject|0
1417734|NCT01078623|4679231|P14|Treatment Period 1|Withdrawal by Subject|0
1417735|NCT01078623|4679232|P13|Treatment Period 1|Withdrawal by Subject|0
1417736|NCT01078623|4679233|P12|Treatment Period 1|Withdrawal by Subject|0
1417737|NCT01078623|4679234|P11|Treatment Period 1|Withdrawal by Subject|1
1417738|NCT01078623|4679235|P10|Treatment Period 1|Withdrawal by Subject|0
1417739|NCT01078623|4679236|P9|Treatment Period 1|Withdrawal by Subject|0
1417740|NCT01078623|4679237|P8|Treatment Period 1|Withdrawal by Subject|1
1417741|NCT01078623|4679238|P7|Treatment Period 1|Withdrawal by Subject|0
1417742|NCT01078623|4679239|P6|Treatment Period 1|Withdrawal by Subject|0
1417743|NCT01078623|4679240|P5|Treatment Period 1|Withdrawal by Subject|0
1417744|NCT01078623|4679241|P4|Treatment Period 1|Withdrawal by Subject|0
1417745|NCT01078623|4679242|P3|Treatment Period 1|Withdrawal by Subject|0
1417746|NCT01078623|4679243|P2|Treatment Period 1|Withdrawal by Subject|0
1417747|NCT01078623|4679244|P1|Treatment Period 1|Withdrawal by Subject|0
1417748|NCT01078623|4679225|P20|Treatment Period 1|Adverse Event|0
1417749|NCT01078623|4679226|P19|Treatment Period 1|Adverse Event|0
1417750|NCT01078623|4679227|P18|Treatment Period 1|Adverse Event|0
1417751|NCT01078623|4679228|P17|Treatment Period 1|Adverse Event|0
1417752|NCT01078623|4679229|P16|Treatment Period 1|Adverse Event|0
1417753|NCT01078623|4679230|P15|Treatment Period 1|Adverse Event|0
1417754|NCT01078623|4679231|P14|Treatment Period 1|Adverse Event|0
1417755|NCT01078623|4679232|P13|Treatment Period 1|Adverse Event|0
1417756|NCT01078623|4679233|P12|Treatment Period 1|Adverse Event|0
1417757|NCT01078623|4679234|P11|Treatment Period 1|Adverse Event|0
1417758|NCT01078623|4679235|P10|Treatment Period 1|Adverse Event|1
1417759|NCT01078623|4679236|P9|Treatment Period 1|Adverse Event|1
1417760|NCT01078623|4679237|P8|Treatment Period 1|Adverse Event|0
1417761|NCT01078623|4679238|P7|Treatment Period 1|Adverse Event|1
1417762|NCT01078623|4679239|P6|Treatment Period 1|Adverse Event|0
1417763|NCT01078623|4679240|P5|Treatment Period 1|Adverse Event|0
1417764|NCT01078623|4679241|P4|Treatment Period 1|Adverse Event|0
1417765|NCT01078623|4679242|P3|Treatment Period 1|Adverse Event|1
1417766|NCT01078623|4679243|P2|Treatment Period 1|Adverse Event|1
1417767|NCT01078623|4679244|P1|Treatment Period 1|Adverse Event|1
1417768|NCT01078584|4679266|P1|Overall Study|Multiple Reasons|2
1417769|NCT01078584|4679266|P1|Overall Study|Serious Adverse Event|27
1417770|NCT01078584|4679266|P1|Overall Study|Protocol Violation|75
1417771|NCT01078584|4679266|P1|Overall Study|Lack of Efficacy|98
1417772|NCT01078584|4679266|P1|Overall Study|Physician Discontinued Patient|12
1417773|NCT01078584|4679266|P1|Overall Study|Physician Switched Medication|26
1417774|NCT01078584|4679266|P1|Overall Study|Blood Pressure Controlled|49
1417775|NCT01078584|4679266|P1|Overall Study|Non-compliance|67
1417776|NCT01078584|4679266|P1|Overall Study|Physician Withdrew from Study|90
1417777|NCT01078584|4679266|P1|Overall Study|Withdrawal of Consent|244
1417778|NCT01078584|4679266|P1|Overall Study|Non-serious Adverse Event|577
1417779|NCT01078584|4679266|P1|Overall Study|Lost to Follow-up|670
1417780|NCT01078584|4679266|P1|Overall Study|Final Status Unknown|1073
1417781|NCT01078571|4679347|P1|Overall Study|Protocol Violation|2
1417782|NCT01078571|4679347|P1|Overall Study|Lost to Follow-up|8
1417783|NCT01078571|4679347|P1|Overall Study|Withdrawal by Subject|12
1417784|NCT01078571|4679347|P1|Overall Study|Reason not reported|21
1417785|NCT01078571|4679347|P1|Overall Study|Lack of effectiveness|36
1417786|NCT01078571|4679347|P1|Overall Study|Adverse Event|36
1417787|NCT01078545|4679363|P1|Overall Study|Participant moved to another physician|1
1417788|NCT01078545|4679363|P1|Overall Study|Death|3
1417789|NCT01078545|4679363|P1|Overall Study|Withdrawal by Subject|3
1417790|NCT01078545|4679363|P1|Overall Study|Physician Decision|6
1417791|NCT01078545|4679363|P1|Overall Study|Lost to Follow-up|13
1417792|NCT01078454|4679373|P2|Overall Study|Death|1
1417793|NCT01078454|4679374|P1|Overall Study|Death|0
1417794|NCT01078454|4679373|P2|Overall Study|Adverse Event|1
1417795|NCT01078454|4679374|P1|Overall Study|Adverse Event|1
1417796|NCT01078441|4679380|P1|Overall Study|Withdrawal by Subject|1
1417797|NCT01078389|4679420|P2|Overall Study|Other|2
1417798|NCT01078389|4679421|P1|Overall Study|Other|9
1417799|NCT01078389|4679420|P2|Overall Study|Voluntary Withdrawal|36
1417800|NCT01078389|4679421|P1|Overall Study|Voluntary Withdrawal|20
1417801|NCT01078389|4679420|P2|Overall Study|Lost to Follow-up|23
1417802|NCT01078389|4679421|P1|Overall Study|Lost to Follow-up|23
1417803|NCT01078389|4679420|P2|Overall Study|Major Protocol Deviation|0
1417804|NCT01078389|4679421|P1|Overall Study|Major Protocol Deviation|2
1417805|NCT01078389|4679420|P2|Overall Study|Adverse Event|6
1417806|NCT01078389|4679421|P1|Overall Study|Adverse Event|10
1417807|NCT01078298|4679582|P2|Overall Study|Other|32
1417808|NCT01078298|4679583|P1|Overall Study|Other|24
1417809|NCT01078298|4679582|P2|Overall Study|Did not meet entrance criteria|1
1417810|NCT01078298|4679583|P1|Overall Study|Did not meet entrance criteria|0
1417811|NCT01078298|4679582|P2|Overall Study|Death|0
1417812|NCT01078298|4679583|P1|Overall Study|Death|2
1417813|NCT01078298|4679582|P2|Overall Study|Adverse Event|5
1417814|NCT01078298|4679583|P1|Overall Study|Adverse Event|6
1417815|NCT01078298|4679582|P2|Overall Study|Protocol Violation|6
1417816|NCT01078298|4679583|P1|Overall Study|Protocol Violation|6
1417817|NCT01078298|4679582|P2|Overall Study|Withdrawal by Subject|33
1417818|NCT01078298|4679583|P1|Overall Study|Withdrawal by Subject|31
1417819|NCT01078298|4679582|P2|Overall Study|Lost to Follow-up|13
1417820|NCT01078298|4679583|P1|Overall Study|Lost to Follow-up|12
1417821|NCT01078168|4679693|P2|Overall Study|Physician Decision|1
1417822|NCT01078168|4679694|P1|Overall Study|Physician Decision|0
1417823|NCT01078155|4679700|P1|Overall Study|Lost to Follow-up|15
1417824|NCT01078155|4679700|P1|Overall Study|Participant's Decision|6
1417825|NCT01078155|4679700|P1|Overall Study|Lack of Efficacy|16
1417826|NCT01078155|4679700|P1|Overall Study|Adverse Event|7
1417827|NCT01078116|4679716|P1|Overall Study|Case report form not completed|3
1417828|NCT01078116|4679716|P1|Overall Study|Lack of effectiveness|15
1417829|NCT01078116|4679716|P1|Overall Study|Withdrawal by Subject|8
1417830|NCT01078116|4679716|P1|Overall Study|Adverse Event|5
1417831|NCT01078116|4679716|P1|Overall Study|Lost to Follow-up|17
1417832|NCT01078090|4679724|P1|Overall Study|Other|523
1417833|NCT01078090|4679724|P1|Overall Study|ADR and lack of efficacy|61
1417834|NCT01078090|4679724|P1|Overall Study|Lack of Efficacy|1193
1417835|NCT01078090|4679724|P1|Overall Study|Adverse drug reaction (ADR)|453
1417836|NCT01078090|4679724|P1|Overall Study|Lost to Follow-up|2363
1417837|NCT01077960|4679818|P1|Overall Study|Reason unspecified|1
1417838|NCT01077960|4679818|P1|Overall Study|Subject decision|1
1417839|NCT01077960|4679818|P1|Overall Study|Lost to Follow-up|5
1417840|NCT01077960|4679818|P1|Overall Study|Protocol Violation|3
1417841|NCT01077960|4679818|P1|Overall Study|Adverse Event|6
1417842|NCT01077804|4680068|P1|Overall Study|Other|18
1417843|NCT01077804|4680068|P1|Overall Study|Refused to continue|79
1417844|NCT01077804|4680068|P1|Overall Study|Unreachable|102
1417845|NCT01077739|4680077|P2|Overall Study|Not specified|2
1417846|NCT01077739|4680078|P1|Overall Study|Not specified|2
1417847|NCT01077739|4680077|P2|Overall Study|Unacceptable toxicity|2
1417848|NCT01077739|4680078|P1|Overall Study|Unacceptable toxicity|1
1417849|NCT01077739|4680077|P2|Overall Study|Death|3
1417850|NCT01077739|4680078|P1|Overall Study|Death|0
1417851|NCT01077739|4680077|P2|Overall Study|Withdrawal by Subject|0
1417852|NCT01077739|4680078|P1|Overall Study|Withdrawal by Subject|1
1417853|NCT01077739|4680077|P2|Overall Study|Premature withdrawal|3
1417854|NCT01077739|4680078|P1|Overall Study|Premature withdrawal|1
1417855|NCT01077713|4680092|P2|Overall Study|Other|2
1417856|NCT01077713|4680093|P1|Overall Study|Other|4
1417857|NCT01077713|4680092|P2|Overall Study|Adverse Event|1
1417858|NCT01077713|4680093|P1|Overall Study|Adverse Event|2
1417859|NCT01077713|4680092|P2|Overall Study|Lost to Follow-up|1
1417860|NCT01077713|4680093|P1|Overall Study|Lost to Follow-up|1
1417861|NCT01077713|4680092|P2|Overall Study|Death|29
1417862|NCT01077713|4680093|P1|Overall Study|Death|28
1417863|NCT01077713|4680092|P2|Overall Study|Progressive Disease (PD)|1
1417864|NCT01077713|4680093|P1|Overall Study|Progressive Disease (PD)|0
1417865|NCT01077713|4680092|P2|Overall Study|Withdrawal by Subject|2
1417866|NCT01077713|4680093|P1|Overall Study|Withdrawal by Subject|1
1417867|NCT01077622|4680117|P1|Overall Study|Withdrawal by Subject|1
1417868|NCT01077622|4680117|P1|Overall Study|Physician Decision|2
1417869|NCT01077544|4680237|P2|Overall Study|Disease Progression|1
1417870|NCT01077544|4680238|P1|Overall Study|Disease Progression|0
1417871|NCT01077544|4680237|P2|Overall Study|Adverse Event|1
1417872|NCT01077544|4680238|P1|Overall Study|Adverse Event|0
1417873|NCT01077544|4680237|P2|Overall Study|New Cancer Therapy|3
1417874|NCT01077544|4680238|P1|Overall Study|New Cancer Therapy|3
1417875|NCT01077375|4680279|P2|Overall Study|Other Reason|1
1417876|NCT01077375|4680280|P1|Overall Study|Other Reason|0
1417877|NCT01077375|4680279|P2|Overall Study|Lost to Follow-up|5
1417878|NCT01077375|4680280|P1|Overall Study|Lost to Follow-up|2
1417879|NCT01077375|4680279|P2|Overall Study|Withdrawal by Subject|6
1417880|NCT01077375|4680280|P1|Overall Study|Withdrawal by Subject|0
1417881|NCT01077375|4680279|P2|Overall Study|Lack of Efficacy|8
1417882|NCT01077375|4680280|P1|Overall Study|Lack of Efficacy|6
1417883|NCT01077375|4680279|P2|Overall Study|Adverse Event|15
1417884|NCT01077375|4680280|P1|Overall Study|Adverse Event|2
1417885|NCT01077362|4680291|P3|Overall Study|Not Specified|2
1417886|NCT01077362|4680292|P2|Overall Study|Not Specified|1
1417887|NCT01077362|4680293|P1|Overall Study|Not Specified|0
1417888|NCT01077362|4680291|P3|Overall Study|Withdrawal by Subject|5
1417889|NCT01077362|4680292|P2|Overall Study|Withdrawal by Subject|3
1417890|NCT01077362|4680293|P1|Overall Study|Withdrawal by Subject|5
1417891|NCT01077362|4680291|P3|Overall Study|Adverse Event|4
1417892|NCT01077362|4680292|P2|Overall Study|Adverse Event|7
1417893|NCT01077362|4680293|P1|Overall Study|Adverse Event|12
1417894|NCT01077362|4680291|P3|Overall Study|Lost to Follow-up|3
1417895|NCT01077362|4680292|P2|Overall Study|Lost to Follow-up|0
1417896|NCT01077362|4680293|P1|Overall Study|Lost to Follow-up|1
1417897|NCT01077362|4680291|P3|Overall Study|Lack of Efficacy|10
1417898|NCT01077362|4680292|P2|Overall Study|Lack of Efficacy|8
1417899|NCT01077362|4680293|P1|Overall Study|Lack of Efficacy|13
1417900|NCT01077323|4680329|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
1417901|NCT01077323|4680330|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
1417902|NCT01077323|4680331|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
1417903|NCT01077323|4680329|P3|Overall Study|Dispensing of drug in baseline period|256446
1417904|NCT01077323|4680330|P2|Overall Study|Dispensing of drug in baseline period|120229
1417905|NCT01077323|4680331|P1|Overall Study|Dispensing of drug in baseline period|0
1417906|NCT01077323|4680329|P3|Overall Study|<9 months enroll before drug dispensed|11655523
1417907|NCT01077323|4680330|P2|Overall Study|<9 months enroll before drug dispensed|263954
1417908|NCT01077323|4680331|P1|Overall Study|<9 months enroll before drug dispensed|11226
1417909|NCT01077284|4680374|P3|Overall Study|Other|1
1417910|NCT01077284|4680375|P2|Overall Study|Other|0
1417911|NCT01077284|4680376|P1|Overall Study|Other|0
1417912|NCT01077284|4680374|P3|Overall Study|Withdrawal by Subject|1
1417913|NCT01077284|4680375|P2|Overall Study|Withdrawal by Subject|3
1417914|NCT01077284|4680376|P1|Overall Study|Withdrawal by Subject|2
1417915|NCT01077284|4680374|P3|Overall Study|Lost to Follow-up|0
1417916|NCT01077284|4680375|P2|Overall Study|Lost to Follow-up|2
1417917|NCT01077284|4680376|P1|Overall Study|Lost to Follow-up|1
1417918|NCT01077284|4680374|P3|Overall Study|Adverse Event|1
1417919|NCT01077284|4680375|P2|Overall Study|Adverse Event|0
1417920|NCT01077284|4680376|P1|Overall Study|Adverse Event|2
1417921|NCT01077271|4680397|P1|Overall Study|Mother unconvinced of the necessity|1
1417922|NCT01077271|4680397|P1|Overall Study|End of RSV season nearly reached|1
1417923|NCT01077271|4680397|P1|Overall Study|Parents thought too many injections|2
1417924|NCT01077271|4680397|P1|Overall Study|Changed doctors|2
1417925|NCT01077271|4680397|P1|Overall Study|Quota used up (insurance reimb issue)|2
1417926|NCT01077271|4680397|P1|Overall Study|Noncompliance|2
1417927|NCT01077271|4680397|P1|Overall Study|Screen failure, did not take palivizumab|4
1417928|NCT01077271|4680397|P1|Overall Study|Parental desire|8
1417929|NCT01077258|4680435|P1|Overall Study|Other reasons|260
1417930|NCT01077258|4680435|P1|Overall Study|Clinical remission|37
1417931|NCT01077258|4680435|P1|Overall Study|Lack of Efficacy|663
1417932|NCT01077258|4680435|P1|Overall Study|Adverse drug reaction|218
1417933|NCT01077258|4680435|P1|Overall Study|Lost to Follow-up|1390
1417934|NCT01077193|4680471|P1|Overall Study|Study Terminated by Sponsor|40
1417935|NCT01077193|4680471|P1|Overall Study|Lack of Efficacy|1
1417936|NCT01077193|4680471|P1|Overall Study|Withdrawal by Subject|2
1417937|NCT01077193|4680471|P1|Overall Study|Lost to Follow-up|1
1417938|NCT01077128|4680475|P1|Overall Study|Not available|54
1417939|NCT01077128|4680475|P1|Overall Study|Lack of efficacy/disease exacerbation|1
1417940|NCT01077128|4680475|P1|Overall Study|Adverse event and disease exacerbation|1
1417941|NCT01077128|4680475|P1|Overall Study|Adverse event and consent withdrawal|1
1417942|NCT01077128|4680475|P1|Overall Study|Disease exacerbation|1
1417943|NCT01077128|4680475|P1|Overall Study|Lack of Efficacy|1
1417944|NCT01077128|4680475|P1|Overall Study|Adverse Event|8
1417945|NCT01077076|4680533|P6|Third Intervention|Death in the participant's family|1
1417946|NCT01077076|4680534|P5|Third Intervention|Death in the participant's family|0
1417947|NCT01077076|4680535|P4|Third Intervention|Death in the participant's family|0
1417948|NCT01077076|4680536|P3|Third Intervention|Death in the participant's family|0
1417949|NCT01077076|4680537|P2|Third Intervention|Death in the participant's family|0
1417950|NCT01077076|4680538|P1|Third Intervention|Death in the participant's family|0
1417951|NCT01077076|4680533|P6|First Intervention|Withdrawal by Subject|0
1417952|NCT01077076|4680534|P5|First Intervention|Withdrawal by Subject|0
1417953|NCT01077076|4680535|P4|First Intervention|Withdrawal by Subject|0
1417954|NCT01077076|4680536|P3|First Intervention|Withdrawal by Subject|0
1417955|NCT01077076|4680537|P2|First Intervention|Withdrawal by Subject|0
1417956|NCT01077076|4680538|P1|First Intervention|Withdrawal by Subject|1
1417957|NCT01077063|4680548|P2|Overall Study|Withdrawal by Subject|2
1417958|NCT01077063|4680549|P1|Overall Study|Withdrawal by Subject|0
1417959|NCT01077063|4680548|P2|Overall Study|Death|1
1417960|NCT01077063|4680549|P1|Overall Study|Death|1
1417961|NCT01077063|4680548|P2|Overall Study|Adverse Event|0
1417962|NCT01077063|4680549|P1|Overall Study|Adverse Event|3
1417963|NCT01077050|4680555|P1|Overall Study|Screen failure|8
1417964|NCT01077050|4680555|P1|Overall Study|Subjects signed ICF could not be located|1
1417965|NCT01077024|4680561|P2|Overall Study|Other|4
1417966|NCT01077024|4680562|P1|Overall Study|Other|4
1417967|NCT01077024|4680561|P2|Overall Study|Incarcerated|8
1417968|NCT01077024|4680562|P1|Overall Study|Incarcerated|7
1417969|NCT01077024|4680561|P2|Overall Study|Withdrawal by Subject|2
1417970|NCT01077024|4680562|P1|Overall Study|Withdrawal by Subject|0
1417971|NCT01077024|4680561|P2|Overall Study|Lost to Follow-up|14
1417972|NCT01077024|4680562|P1|Overall Study|Lost to Follow-up|20
1417973|NCT01076959|4680601|P1|Overall Study|Other|119
1417974|NCT01076959|4680601|P1|Overall Study|Lost to Follow-up|241
1417975|NCT01076959|4680601|P1|Overall Study|Non-compliance|274
1417976|NCT01076959|4680601|P1|Overall Study|Lack of Efficacy|849
1417977|NCT01076959|4680601|P1|Overall Study|Adverse Event|767
1417978|NCT01076647|4680637|P2|Overall Study|Unclassified|12
1417979|NCT01076647|4680638|P1|Overall Study|Unclassified|12
1417980|NCT01076647|4680637|P2|Overall Study|Withdrawal criteria|2
1417981|NCT01076647|4680638|P1|Overall Study|Withdrawal criteria|2
1417982|NCT01076647|4680637|P2|Overall Study|Protocol Violation|9
1417983|NCT01076647|4680638|P1|Overall Study|Protocol Violation|7
1417984|NCT01076647|4680637|P2|Overall Study|Lack of Efficacy|1
1417985|NCT01076647|4680638|P1|Overall Study|Lack of Efficacy|0
1417986|NCT01076647|4680637|P2|Overall Study|Adverse Event|1
1417987|NCT01076647|4680638|P1|Overall Study|Adverse Event|4
1417988|NCT01076400|4680669|P3|Overall Study|Progressive Disease|0
1417989|NCT01076400|4680670|P2|Overall Study|Progressive Disease|0
1417990|NCT01076400|4680671|P1|Overall Study|Progressive Disease|5
1417991|NCT01076400|4680669|P3|Overall Study|Adverse Event|0
1417992|NCT01076400|4680670|P2|Overall Study|Adverse Event|0
1417993|NCT01076400|4680671|P1|Overall Study|Adverse Event|2
1417994|NCT01076361|4680677|P1|Overall Study|22 leads were excluded from analysis|21
1417995|NCT01076335|4680685|P1|Overall Study|Withdrawal without treatment|1
1417996|NCT01076335|4680685|P1|Overall Study|Withdrawal by Subject|3
1417997|NCT01076192|4680737|P1|Overall Study|Not specified|197
1417998|NCT01076179|4680752|P1|Overall Study|Withdrawal by Subject|1
1417999|NCT01076166|4680775|P1|Overall Study|Symptoms improved/resolved|6
1418000|NCT01076166|4680775|P1|Overall Study|Adverse Event|3
1418001|NCT01076153|4680782|P1|Overall Study|Adverse Event|1
1418002|NCT01076153|4680782|P1|Overall Study|Symptoms improved/resolved|10
1418003|NCT01076088|4680796|P6|Overall Study|Other protocol specified criteria|1
1418004|NCT01076088|4680797|P5|Overall Study|Other protocol specified criteria|0
1418005|NCT01076088|4680798|P4|Overall Study|Other protocol specified criteria|0
1418006|NCT01076088|4680799|P3|Overall Study|Other protocol specified criteria|0
1418007|NCT01076088|4680800|P2|Overall Study|Other protocol specified criteria|0
1418008|NCT01076088|4680801|P1|Overall Study|Other protocol specified criteria|0
1418009|NCT01076088|4680796|P6|Overall Study|Withdrawal by Subject|17
1418010|NCT01076088|4680797|P5|Overall Study|Withdrawal by Subject|11
1418011|NCT01076088|4680798|P4|Overall Study|Withdrawal by Subject|10
1418012|NCT01076088|4680799|P3|Overall Study|Withdrawal by Subject|14
1418013|NCT01076088|4680800|P2|Overall Study|Withdrawal by Subject|8
1418014|NCT01076088|4680801|P1|Overall Study|Withdrawal by Subject|8
1418015|NCT01076088|4680796|P6|Overall Study|Physician Decision|0
1418016|NCT01076088|4680797|P5|Overall Study|Physician Decision|1
1418017|NCT01076088|4680798|P4|Overall Study|Physician Decision|1
1418018|NCT01076088|4680799|P3|Overall Study|Physician Decision|0
1418019|NCT01076088|4680800|P2|Overall Study|Physician Decision|3
1418020|NCT01076088|4680801|P1|Overall Study|Physician Decision|1
1418021|NCT01076088|4680796|P6|Overall Study|Non-compliance with study drug|0
1418022|NCT01076088|4680797|P5|Overall Study|Non-compliance with study drug|0
1418023|NCT01076088|4680798|P4|Overall Study|Non-compliance with study drug|1
1418024|NCT01076088|4680799|P3|Overall Study|Non-compliance with study drug|0
1418025|NCT01076088|4680800|P2|Overall Study|Non-compliance with study drug|0
1418026|NCT01076088|4680801|P1|Overall Study|Non-compliance with study drug|0
1418027|NCT01076088|4680796|P6|Overall Study|Lost to Follow-up|2
1418028|NCT01076088|4680797|P5|Overall Study|Lost to Follow-up|1
1418029|NCT01076088|4680798|P4|Overall Study|Lost to Follow-up|1
1418030|NCT01076088|4680799|P3|Overall Study|Lost to Follow-up|0
1418031|NCT01076088|4680800|P2|Overall Study|Lost to Follow-up|1
1418032|NCT01076088|4680801|P1|Overall Study|Lost to Follow-up|1
1418033|NCT01076088|4680796|P6|Overall Study|Adverse Event|3
1418034|NCT01076088|4680797|P5|Overall Study|Adverse Event|3
1418035|NCT01076088|4680798|P4|Overall Study|Adverse Event|2
1418036|NCT01076088|4680799|P3|Overall Study|Adverse Event|3
1418037|NCT01076088|4680800|P2|Overall Study|Adverse Event|6
1418038|NCT01076088|4680801|P1|Overall Study|Adverse Event|1
1418039|NCT01076075|4680829|P2|Overall Study|Withdrawal by Subject|19
1418040|NCT01076075|4680830|P1|Overall Study|Withdrawal by Subject|8
1418041|NCT01076075|4680829|P2|Overall Study|Protocol Violation|1
1418042|NCT01076075|4680830|P1|Overall Study|Protocol Violation|0
1418043|NCT01076075|4680829|P2|Overall Study|other|9
1418044|NCT01076075|4680830|P1|Overall Study|other|19
1418045|NCT01076075|4680829|P2|Overall Study|Lost to Follow-up|5
1418046|NCT01076075|4680830|P1|Overall Study|Lost to Follow-up|6
1418047|NCT01076075|4680829|P2|Overall Study|Lack of Efficacy|4
1418048|NCT01076075|4680830|P1|Overall Study|Lack of Efficacy|5
1418049|NCT01076075|4680829|P2|Overall Study|Adverse Event|9
1418050|NCT01076075|4680830|P1|Overall Study|Adverse Event|3
1418051|NCT01076036|4680844|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
1418052|NCT01075984|4680854|P5|Follow-up Phase|Treatment failure|4
1418053|NCT01075984|4680855|P4|Follow-up Phase|Treatment failure|0
1418054|NCT01075984|4680856|P3|Follow-up Phase|Treatment failure|0
1418055|NCT01075984|4680857|P2|Follow-up Phase|Treatment failure|0
1418056|NCT01075984|4680858|P1|Follow-up Phase|Treatment failure|0
1418057|NCT01075984|4680854|P5|Follow-up Phase|Progression of disease|2
1418058|NCT01075984|4680855|P4|Follow-up Phase|Progression of disease|0
1418059|NCT01075984|4680856|P3|Follow-up Phase|Progression of disease|0
1418060|NCT01075984|4680857|P2|Follow-up Phase|Progression of disease|0
1418061|NCT01075984|4680858|P1|Follow-up Phase|Progression of disease|0
1418062|NCT01075984|4680854|P5|Follow-up Phase|Withdrawal by Subject|10
1418063|NCT01075984|4680855|P4|Follow-up Phase|Withdrawal by Subject|0
1418064|NCT01075984|4680856|P3|Follow-up Phase|Withdrawal by Subject|0
1418065|NCT01075984|4680857|P2|Follow-up Phase|Withdrawal by Subject|0
1418066|NCT01075984|4680858|P1|Follow-up Phase|Withdrawal by Subject|0
1418067|NCT01075984|4680854|P5|Follow-up Phase|Administrative|1
1418068|NCT01075984|4680855|P4|Follow-up Phase|Administrative|0
1418069|NCT01075984|4680856|P3|Follow-up Phase|Administrative|0
1418070|NCT01075984|4680857|P2|Follow-up Phase|Administrative|0
1418071|NCT01075984|4680858|P1|Follow-up Phase|Administrative|0
1418072|NCT01075984|4680854|P5|Follow-up Phase|Adverse Event|27
1418073|NCT01075984|4680855|P4|Follow-up Phase|Adverse Event|2
1418074|NCT01075984|4680856|P3|Follow-up Phase|Adverse Event|0
1418075|NCT01075984|4680857|P2|Follow-up Phase|Adverse Event|0
1418076|NCT01075984|4680858|P1|Follow-up Phase|Adverse Event|0
1418077|NCT01075984|4680854|P5|Follow-up Phase|Protocol Violation|3
1418078|NCT01075984|4680855|P4|Follow-up Phase|Protocol Violation|0
1418079|NCT01075984|4680856|P3|Follow-up Phase|Protocol Violation|1
1418080|NCT01075984|4680857|P2|Follow-up Phase|Protocol Violation|0
1418081|NCT01075984|4680858|P1|Follow-up Phase|Protocol Violation|0
1418082|NCT01075984|4680854|P5|Treatment Phase|Progression of disease|2
1418083|NCT01075984|4680855|P4|Treatment Phase|Progression of disease|0
1418084|NCT01075984|4680856|P3|Treatment Phase|Progression of disease|0
1418085|NCT01075984|4680857|P2|Treatment Phase|Progression of disease|0
1418086|NCT01075984|4680858|P1|Treatment Phase|Progression of disease|0
1418087|NCT01075984|4680854|P5|Treatment Phase|Treatment Failure|5
1418088|NCT01075984|4680855|P4|Treatment Phase|Treatment Failure|0
1418089|NCT01075984|4680856|P3|Treatment Phase|Treatment Failure|1
1418090|NCT01075984|4680857|P2|Treatment Phase|Treatment Failure|0
1418091|NCT01075984|4680858|P1|Treatment Phase|Treatment Failure|0
1418092|NCT01075984|4680854|P5|Treatment Phase|Withdrawal by Subject|15
1418093|NCT01075984|4680855|P4|Treatment Phase|Withdrawal by Subject|0
1418094|NCT01075984|4680856|P3|Treatment Phase|Withdrawal by Subject|2
1418095|NCT01075984|4680857|P2|Treatment Phase|Withdrawal by Subject|0
1418096|NCT01075984|4680858|P1|Treatment Phase|Withdrawal by Subject|0
1418097|NCT01075984|4680854|P5|Treatment Phase|Protocol Violation|3
1418098|NCT01075984|4680855|P4|Treatment Phase|Protocol Violation|0
1418099|NCT01075984|4680856|P3|Treatment Phase|Protocol Violation|1
1418100|NCT01075984|4680857|P2|Treatment Phase|Protocol Violation|0
1418101|NCT01075984|4680858|P1|Treatment Phase|Protocol Violation|0
1418102|NCT01075984|4680854|P5|Treatment Phase|Adverse Event|35
1418103|NCT01075984|4680855|P4|Treatment Phase|Adverse Event|7
1418104|NCT01075984|4680856|P3|Treatment Phase|Adverse Event|3
1418105|NCT01075984|4680857|P2|Treatment Phase|Adverse Event|1
1418106|NCT01075984|4680858|P1|Treatment Phase|Adverse Event|0
1418107|NCT01075958|4680916|P1|Overall Study|Blood sample could not be obtained|44
1418108|NCT01075815|4680932|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
1418109|NCT01075815|4680933|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
1418110|NCT01075815|4680932|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
1418111|NCT01075815|4680933|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
1418112|NCT01075815|4680932|P2|Overall Study|Withdrawal before r-hCG administration|1
1418113|NCT01075815|4680933|P1|Overall Study|Withdrawal before r-hCG administration|6
1418114|NCT01075763|4680971|P2|Overall Study|Withdrawal by Subject|2
1418115|NCT01075763|4680972|P1|Overall Study|Withdrawal by Subject|2
1418116|NCT01075763|4680971|P2|Overall Study|Lack of Efficacy|1
1418117|NCT01075763|4680972|P1|Overall Study|Lack of Efficacy|0
1418118|NCT01075763|4680971|P2|Overall Study|Lost to Follow-up|1
1418119|NCT01075763|4680972|P1|Overall Study|Lost to Follow-up|2
1418120|NCT01075685|4680996|P2|Overall Study|Lost to Follow-up|220
1418121|NCT01075685|4680997|P1|Overall Study|Lost to Follow-up|563
1418122|NCT01075685|4680996|P2|Overall Study|Withdrawal by Subject|5
1418123|NCT01075685|4680997|P1|Overall Study|Withdrawal by Subject|20
1418124|NCT01075685|4680996|P2|Overall Study|Protocol Violation|1
1418125|NCT01075685|4680997|P1|Overall Study|Protocol Violation|9
1418126|NCT01075646|4681013|P4|Overall Study|Lost to Follow-up|2
1418127|NCT01075646|4681014|P3|Overall Study|Lost to Follow-up|1
1418128|NCT01075646|4681015|P2|Overall Study|Lost to Follow-up|3
1418129|NCT01075646|4681016|P1|Overall Study|Lost to Follow-up|4
1418130|NCT01075412|4681048|P2|Overall Study|Withdrawal by Subject|1
1418131|NCT01075412|4681049|P1|Overall Study|Withdrawal by Subject|0
1418132|NCT01075282|4681077|P3|Overall Study|Death|2
1418133|NCT01075282|4681078|P2|Overall Study|Death|1
1418134|NCT01075282|4681079|P1|Overall Study|Death|0
1418135|NCT01075282|4681077|P3|Overall Study|Protocol Violation|1
1418136|NCT01075282|4681078|P2|Overall Study|Protocol Violation|2
1418137|NCT01075282|4681079|P1|Overall Study|Protocol Violation|0
1418138|NCT01075282|4681077|P3|Overall Study|Treatment Non-compliance|2
1418139|NCT01075282|4681078|P2|Overall Study|Treatment Non-compliance|2
1418140|NCT01075282|4681079|P1|Overall Study|Treatment Non-compliance|1
1418141|NCT01075282|4681077|P3|Overall Study|Lack of Efficacy|0
1418142|NCT01075282|4681078|P2|Overall Study|Lack of Efficacy|1
1418143|NCT01075282|4681079|P1|Overall Study|Lack of Efficacy|1
1418144|NCT01075282|4681077|P3|Overall Study|Physician Decision|3
1418145|NCT01075282|4681078|P2|Overall Study|Physician Decision|3
1418146|NCT01075282|4681079|P1|Overall Study|Physician Decision|3
1418147|NCT01075282|4681077|P3|Overall Study|Lost to Follow-up|3
1418148|NCT01075282|4681078|P2|Overall Study|Lost to Follow-up|3
1418149|NCT01075282|4681079|P1|Overall Study|Lost to Follow-up|3
1418150|NCT01075282|4681077|P3|Overall Study|Entry Criteria Not Met|0
1418151|NCT01075282|4681078|P2|Overall Study|Entry Criteria Not Met|2
1418152|NCT01075282|4681079|P1|Overall Study|Entry Criteria Not Met|3
1418153|NCT01075282|4681077|P3|Overall Study|Adverse Event|5
1418154|NCT01075282|4681078|P2|Overall Study|Adverse Event|8
1418155|NCT01075282|4681079|P1|Overall Study|Adverse Event|9
1418156|NCT01075282|4681077|P3|Overall Study|Withdrawal by Subject|11
1418157|NCT01075282|4681078|P2|Overall Study|Withdrawal by Subject|7
1418158|NCT01075282|4681079|P1|Overall Study|Withdrawal by Subject|11
1418159|NCT01075256|4681162|P3|Overall Study|Withdrawal by Subject|0
1418160|NCT01075256|4681163|P2|Overall Study|Withdrawal by Subject|0
1418161|NCT01075256|4681164|P1|Overall Study|Withdrawal by Subject|1
1418162|NCT01075243|4681196|P3|Overall Study|Withdrawal by Subject|0
1418163|NCT01075243|4681197|P2|Overall Study|Withdrawal by Subject|1
1418164|NCT01075243|4681198|P1|Overall Study|Withdrawal by Subject|1
1418165|NCT01075243|4681196|P3|Overall Study|Lost to Follow-up|0
1418166|NCT01075243|4681197|P2|Overall Study|Lost to Follow-up|2
1418167|NCT01075243|4681198|P1|Overall Study|Lost to Follow-up|5
1418168|NCT01075217|4681250|P2|Overall Study|Physician Decision|0
1418169|NCT01075217|4681251|P1|Overall Study|Physician Decision|1
1418170|NCT01075217|4681250|P2|Overall Study|Adverse Event|1
1418171|NCT01075217|4681251|P1|Overall Study|Adverse Event|1
1418172|NCT01075191|4681284|P1|Overall Study|Unknown Reasons|1
1418173|NCT01075191|4681284|P1|Overall Study|Patient's Wish|2
1418174|NCT01075191|4681284|P1|Overall Study|Therapy Break|3
1418175|NCT01075191|4681284|P1|Overall Study|Noncompliance|3
1418176|NCT01075191|4681284|P1|Overall Study|Adverse Event|4
1418177|NCT01075191|4681284|P1|Overall Study|Co-morbidities|1
1418178|NCT01075191|4681284|P1|Overall Study|Intensification|3
1418179|NCT01075191|4681284|P1|Overall Study|Death|1
1418180|NCT01075178|4681295|P2|Subject Chart Review|matched partner excluded (reasons above)|3
1418181|NCT01075178|4681296|P1|Subject Chart Review|matched partner excluded (reasons above)|6
1418182|NCT01075178|4681295|P2|Subject Chart Review|no data collected due to site closure|4
1418183|NCT01075178|4681296|P1|Subject Chart Review|no data collected due to site closure|3
1418184|NCT01075178|4681295|P2|Subject Chart Review|died before chart review period|2
1418185|NCT01075178|4681296|P1|Subject Chart Review|died before chart review period|0
1418186|NCT01075178|4681295|P2|Subject Matching|eligible but not matched|403
1418187|NCT01075178|4681296|P1|Subject Matching|eligible but not matched|130
1418188|NCT01075152|4681310|P2|Overall Study|Withdrawal by Subject|0
1418189|NCT01075152|4681311|P1|Overall Study|Withdrawal by Subject|1
1418190|NCT01075100|4681337|P2|Overall Study|Other|1
1418191|NCT01075100|4681338|P1|Overall Study|Other|3
1418192|NCT01075100|4681337|P2|Overall Study|Disease Progression|29
1418193|NCT01075100|4681338|P1|Overall Study|Disease Progression|25
1418194|NCT01075100|4681337|P2|Overall Study|Investigator Request|1
1418195|NCT01075100|4681338|P1|Overall Study|Investigator Request|2
1418196|NCT01075100|4681337|P2|Overall Study|Patient Request|4
1418197|NCT01075100|4681338|P1|Overall Study|Patient Request|4
1418198|NCT01075100|4681337|P2|Overall Study|Adverse Event|18
1418199|NCT01075100|4681338|P1|Overall Study|Adverse Event|15
1418200|NCT01075074|4681368|P3|Overall Study|Surgeon changed to open incisional case|2
1418201|NCT01075074|4681369|P2|Overall Study|Surgeon changed to open incisional case|2
1418202|NCT01075074|4681370|P1|Overall Study|Surgeon changed to open incisional case|1
1418203|NCT01074944|4681387|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
1418204|NCT01074944|4681388|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
1418205|NCT01074944|4681389|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
1418206|NCT01074944|4681390|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
1418207|NCT01074944|4681391|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
1418208|NCT01074944|4681387|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
1418209|NCT01074944|4681388|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
1418210|NCT01074944|4681389|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
1418211|NCT01074944|4681390|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
1418212|NCT01074944|4681391|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
1418213|NCT01074944|4681387|P5|Long Term Treatment|Withdrawal by Subject|0
1418214|NCT01074944|4681388|P4|Long Term Treatment|Withdrawal by Subject|2
1418215|NCT01074944|4681389|P3|Long Term Treatment|Withdrawal by Subject|0
1418216|NCT01074944|4681390|P2|Long Term Treatment|Withdrawal by Subject|0
1418217|NCT01074944|4681391|P1|Long Term Treatment|Withdrawal by Subject|0
1418218|NCT01074944|4681387|P5|Long Term Treatment|Entered in Period, But Not Treated|0
1418219|NCT01074944|4681388|P4|Long Term Treatment|Entered in Period, But Not Treated|1
1418220|NCT01074944|4681389|P3|Long Term Treatment|Entered in Period, But Not Treated|0
1418221|NCT01074944|4681390|P2|Long Term Treatment|Entered in Period, But Not Treated|0
1418222|NCT01074944|4681391|P1|Long Term Treatment|Entered in Period, But Not Treated|0
1418223|NCT01074944|4681387|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
1418224|NCT01074944|4681388|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
1418225|NCT01074944|4681389|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
1418226|NCT01074944|4681390|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
1418227|NCT01074944|4681391|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
1418228|NCT01074944|4681387|P5|Long Term Treatment|Lost to Follow-up|0
1418229|NCT01074944|4681388|P4|Long Term Treatment|Lost to Follow-up|2
1418230|NCT01074944|4681389|P3|Long Term Treatment|Lost to Follow-up|0
1418231|NCT01074944|4681390|P2|Long Term Treatment|Lost to Follow-up|0
1418232|NCT01074944|4681391|P1|Long Term Treatment|Lost to Follow-up|0
1418233|NCT01074944|4681387|P5|Long Term Treatment|Adverse Event|0
1418234|NCT01074944|4681388|P4|Long Term Treatment|Adverse Event|3
1418235|NCT01074944|4681389|P3|Long Term Treatment|Adverse Event|0
1418236|NCT01074944|4681390|P2|Long Term Treatment|Adverse Event|0
1418237|NCT01074944|4681391|P1|Long Term Treatment|Adverse Event|0
1418238|NCT01074944|4681387|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
1418239|NCT01074944|4681388|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
1418240|NCT01074944|4681389|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
1418241|NCT01074944|4681390|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
1418242|NCT01074944|4681391|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
1418243|NCT01074944|4681387|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
1418244|NCT01074944|4681388|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
1418245|NCT01074944|4681389|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
1418246|NCT01074944|4681390|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
1418247|NCT01074944|4681391|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
1418248|NCT01074944|4681387|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
1418249|NCT01074944|4681388|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
1418250|NCT01074944|4681389|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
1418251|NCT01074944|4681390|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
1418252|NCT01074944|4681391|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
1418253|NCT01074944|4681387|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
1418254|NCT01074944|4681388|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
1418255|NCT01074944|4681389|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
1418256|NCT01074944|4681390|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
1418257|NCT01074944|4681391|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
1418258|NCT01074944|4681387|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
1418259|NCT01074944|4681388|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
1418260|NCT01074944|4681389|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
1418261|NCT01074944|4681390|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
1418262|NCT01074944|4681391|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
1418263|NCT01074944|4681387|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
1418264|NCT01074944|4681388|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
1418265|NCT01074944|4681389|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
1418266|NCT01074944|4681390|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
1418267|NCT01074944|4681391|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
1418268|NCT01074944|4681387|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
1418269|NCT01074944|4681388|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
1418270|NCT01074944|4681389|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
1418271|NCT01074944|4681390|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
1418272|NCT01074944|4681391|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
1418273|NCT01074944|4681387|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
1418274|NCT01074944|4681388|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
1418275|NCT01074944|4681389|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
1418276|NCT01074944|4681390|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
1418277|NCT01074944|4681391|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
1418278|NCT01074944|4681387|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
1418279|NCT01074944|4681388|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
1418280|NCT01074944|4681389|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
1418281|NCT01074944|4681390|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
1418282|NCT01074944|4681391|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
1418283|NCT01074931|4681445|P1|Overall Study|Death|5
1418284|NCT01074931|4681445|P1|Overall Study|Economic reasons|1
1418285|NCT01074658|4681457|P1|Overall Study|No implant attempted|19
1418286|NCT01074554|4681465|P2|Overall Study|Lost to Follow-up|1
1418287|NCT01074554|4681466|P1|Overall Study|Lost to Follow-up|0
1418288|NCT01074554|4681465|P2|Overall Study|Adverse Event|3
1418289|NCT01074554|4681466|P1|Overall Study|Adverse Event|3
1418290|NCT01074502|4681476|P1|Overall Study|Withdrawal by Subject|1
1418291|NCT01074450|4681500|P2|Second Intervention|Physician Decision|1
1418292|NCT01074450|4681501|P1|Second Intervention|Physician Decision|0
1418293|NCT01074450|4681500|P2|Second Intervention|Protocol Violation|0
1418294|NCT01074450|4681501|P1|Second Intervention|Protocol Violation|1
1418295|NCT01074450|4681500|P2|First Intervention|Emesis in Dosing Interval|2
1418296|NCT01074450|4681501|P1|First Intervention|Emesis in Dosing Interval|0
1418297|NCT01074307|4681522|P2|Overall Study|Protocol Violation|5
1418298|NCT01074307|4681523|P1|Overall Study|Protocol Violation|8
1418299|NCT01074307|4681522|P2|Overall Study|Exclusion criterion|1
1418300|NCT01074307|4681523|P1|Overall Study|Exclusion criterion|0
1418301|NCT01074307|4681522|P2|Overall Study|No primary endpoint evaluation|6
1418302|NCT01074307|4681523|P1|Overall Study|No primary endpoint evaluation|14
1418303|NCT01074268|4681545|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
1418304|NCT01074268|4681546|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
1418305|NCT01074268|4681545|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
1418306|NCT01074268|4681546|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
1418307|NCT01074268|4681545|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
1418308|NCT01074268|4681546|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
1418309|NCT01074268|4681545|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
1418310|NCT01074268|4681546|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
1418311|NCT01074268|4681545|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
1418312|NCT01074268|4681546|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
1418313|NCT01074268|4681545|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
1418314|NCT01074268|4681546|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
1418315|NCT01074268|4681545|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
1418316|NCT01074268|4681546|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
1418317|NCT01074268|4681545|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
1418318|NCT01074268|4681546|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
1418319|NCT01074268|4681545|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
1418320|NCT01074268|4681546|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
1418321|NCT01074255|4681572|P1|Overall Study|Did not receive EMEND|2
1418322|NCT01074242|4681576|P1|Overall Study|Duplicate Case Report Form|5
1418323|NCT01074242|4681576|P1|Overall Study|Violation of vaccine dose or dosage|351
1418324|NCT01074242|4681576|P1|Overall Study|Case report unclear|6
1418325|NCT01074242|4681576|P1|Overall Study|Lost to Follow-up|1
1418326|NCT01074242|4681576|P1|Overall Study|Case report before date of contract|40
1418327|NCT01074229|4681584|P3|Overall Study|Change to open surgical procedure|4
1418328|NCT01074229|4681585|P2|Overall Study|Change to open surgical procedure|3
1418329|NCT01074229|4681586|P1|Overall Study|Change to open surgical procedure|1
1418330|NCT01074229|4681584|P3|Overall Study|Lost to Follow-up|0
1418331|NCT01074229|4681585|P2|Overall Study|Lost to Follow-up|0
1418332|NCT01074229|4681586|P1|Overall Study|Lost to Follow-up|1
1418333|NCT01074216|4681597|P1|Overall Study|Not Treated|12
1418334|NCT01074216|4681597|P1|Overall Study|Physician Decision|1
1418335|NCT01074047|4681661|P2|Extension Phase|Death|0
1418336|NCT01074047|4681662|P1|Extension Phase|Death|5
1418337|NCT01074047|4681661|P2|Extension Phase|Withdrawal by Subject|0
1418338|NCT01074047|4681662|P1|Extension Phase|Withdrawal by Subject|2
1418339|NCT01074047|4681661|P2|Extension Phase|Disease Progression|0
1418340|NCT01074047|4681662|P1|Extension Phase|Disease Progression|9
1418341|NCT01074047|4681661|P2|Extension Phase|Adverse Event|0
1418342|NCT01074047|4681662|P1|Extension Phase|Adverse Event|5
1418343|NCT01074047|4681661|P2|Extension Phase|Physician Decision|0
1418344|NCT01074047|4681662|P1|Extension Phase|Physician Decision|1
1418345|NCT01074047|4681661|P2|Survival Follow-Up Phase|Alive at study closure|3
1418346|NCT01074047|4681662|P1|Survival Follow-Up Phase|Alive at study closure|1
1418347|NCT01074047|4681661|P2|Survival Follow-Up Phase|Death|124
1418348|NCT01074047|4681662|P1|Survival Follow-Up Phase|Death|116
1418349|NCT01074047|4681661|P2|Survival Follow-Up Phase|Lost to Follow-up|1
1418350|NCT01074047|4681662|P1|Survival Follow-Up Phase|Lost to Follow-up|2
1418351|NCT01074047|4681661|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
1418352|NCT01074047|4681662|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
1418353|NCT01074047|4681661|P2|Treatment Phase|Miscellaneous|39
1418354|NCT01074047|4681662|P1|Treatment Phase|Miscellaneous|32
1418355|NCT01074047|4681661|P2|Treatment Phase|Protocol Violation|1
1418356|NCT01074047|4681662|P1|Treatment Phase|Protocol Violation|0
1418357|NCT01074047|4681661|P2|Treatment Phase|Lost to Follow-up|1
1418358|NCT01074047|4681662|P1|Treatment Phase|Lost to Follow-up|0
1418359|NCT01074047|4681661|P2|Treatment Phase|Death|58
1418360|NCT01074047|4681662|P1|Treatment Phase|Death|53
1418361|NCT01074047|4681661|P2|Treatment Phase|Withdrawal by Subject|48
1418362|NCT01074047|4681662|P1|Treatment Phase|Withdrawal by Subject|27
1418363|NCT01074047|4681661|P2|Treatment Phase|Disease Progression|21
1418364|NCT01074047|4681662|P1|Treatment Phase|Disease Progression|16
1418365|NCT01074047|4681661|P2|Treatment Phase|Adverse Event|66
1418366|NCT01074047|4681662|P1|Treatment Phase|Adverse Event|89
1418367|NCT01074008|4681750|P9|Overall Study|Lost to Follow-up|4
1418368|NCT01074008|4681751|P8|Overall Study|Lost to Follow-up|0
1418369|NCT01074008|4681752|P7|Overall Study|Lost to Follow-up|1
1418370|NCT01074008|4681753|P6|Overall Study|Lost to Follow-up|0
1418371|NCT01074008|4681754|P5|Overall Study|Lost to Follow-up|1
1418372|NCT01074008|4681755|P4|Overall Study|Lost to Follow-up|1
1418373|NCT01074008|4681756|P3|Overall Study|Lost to Follow-up|1
1418374|NCT01074008|4681757|P2|Overall Study|Lost to Follow-up|1
1418375|NCT01074008|4681758|P1|Overall Study|Lost to Follow-up|0
1418376|NCT01074008|4681750|P9|Overall Study|Withdrawal by Subject|0
1418377|NCT01074008|4681751|P8|Overall Study|Withdrawal by Subject|0
1418378|NCT01074008|4681752|P7|Overall Study|Withdrawal by Subject|0
1418379|NCT01074008|4681753|P6|Overall Study|Withdrawal by Subject|0
1418380|NCT01074008|4681754|P5|Overall Study|Withdrawal by Subject|1
1418381|NCT01074008|4681755|P4|Overall Study|Withdrawal by Subject|0
1418382|NCT01074008|4681756|P3|Overall Study|Withdrawal by Subject|1
1418383|NCT01074008|4681757|P2|Overall Study|Withdrawal by Subject|1
1418384|NCT01074008|4681758|P1|Overall Study|Withdrawal by Subject|1
1418385|NCT01074008|4681750|P9|Overall Study|Adverse Event|0
1418386|NCT01074008|4681751|P8|Overall Study|Adverse Event|0
1418387|NCT01074008|4681752|P7|Overall Study|Adverse Event|0
1418388|NCT01074008|4681753|P6|Overall Study|Adverse Event|0
1418389|NCT01074008|4681754|P5|Overall Study|Adverse Event|0
1418390|NCT01074008|4681755|P4|Overall Study|Adverse Event|0
1418391|NCT01074008|4681756|P3|Overall Study|Adverse Event|0
1418392|NCT01074008|4681757|P2|Overall Study|Adverse Event|1
1418393|NCT01074008|4681758|P1|Overall Study|Adverse Event|0
1418394|NCT01073943|4681868|P2|Overall Study|Could not tolerate prep|0
1418395|NCT01073943|4681869|P1|Overall Study|Could not tolerate prep|1
1418396|NCT01073943|4681868|P2|Overall Study|Unable to return for follow-up|1
1418397|NCT01073943|4681869|P1|Overall Study|Unable to return for follow-up|0
1418398|NCT01073943|4681868|P2|Overall Study|Subject forgot|1
1418399|NCT01073943|4681869|P1|Overall Study|Subject forgot|0
1418400|NCT01073943|4681868|P2|Overall Study|Power outage; colonoscopy not done|0
1418401|NCT01073943|4681869|P1|Overall Study|Power outage; colonoscopy not done|1
1418402|NCT01073943|4681868|P2|Overall Study|Lost to Follow-up|2
1418403|NCT01073943|4681869|P1|Overall Study|Lost to Follow-up|0
1418404|NCT01073943|4681868|P2|Overall Study|Adverse Event|1
1418405|NCT01073943|4681869|P1|Overall Study|Adverse Event|1
1418406|NCT01073943|4681868|P2|Overall Study|Protocol Violation|1
1418407|NCT01073943|4681869|P1|Overall Study|Protocol Violation|2
1418408|NCT01073943|4681868|P2|Overall Study|Withdrawal by Subject|2
1418409|NCT01073943|4681869|P1|Overall Study|Withdrawal by Subject|8
1418410|NCT01073930|4681895|P2|Overall Study|Inadequate prep; unable to do procedure|1
1418411|NCT01073930|4681896|P1|Overall Study|Inadequate prep; unable to do procedure|0
1418412|NCT01073930|4681895|P2|Overall Study|Noncompliance with study drug|1
1418413|NCT01073930|4681896|P1|Overall Study|Noncompliance with study drug|0
1418414|NCT01073930|4681895|P2|Overall Study|Adverse Event|1
1418415|NCT01073930|4681896|P1|Overall Study|Adverse Event|0
1418416|NCT01073930|4681895|P2|Overall Study|Lost to Follow-up|1
1418417|NCT01073930|4681896|P1|Overall Study|Lost to Follow-up|0
1418418|NCT01073930|4681895|P2|Overall Study|Withdrawal by Subject|2
1418419|NCT01073930|4681896|P1|Overall Study|Withdrawal by Subject|3
1418420|NCT01073865|4681920|P2|Overall Study|Withdrawal by Subject|5
1418421|NCT01073865|4681921|P1|Overall Study|Withdrawal by Subject|5
1418422|NCT01073865|4681920|P2|Overall Study|Death|2
1418423|NCT01073865|4681921|P1|Overall Study|Death|3
1418424|NCT01073865|4681920|P2|Overall Study|Lost to Follow-up|1
1418425|NCT01073865|4681921|P1|Overall Study|Lost to Follow-up|1
1418426|NCT01073865|4681920|P2|Overall Study|Reasons other than below|31
1418427|NCT01073865|4681921|P1|Overall Study|Reasons other than below|19
1418428|NCT01073631|4681940|P1|Overall Study|Other|63
1418429|NCT01073631|4681940|P1|Overall Study|Adverse Event|24
1418430|NCT01073631|4681940|P1|Overall Study|Death|82
1418431|NCT01073618|4681945|P1|Overall Study|Other|80
1418432|NCT01073618|4681945|P1|Overall Study|Adverse Event|19
1418433|NCT01073618|4681945|P1|Overall Study|Death|208
1418434|NCT01073605|4681953|P3|Overall Study|Randomized But Not Treated|1
1418435|NCT01073605|4681954|P2|Overall Study|Randomized But Not Treated|1
1418436|NCT01073605|4681955|P1|Overall Study|Randomized But Not Treated|0
1418437|NCT01073605|4681953|P3|Overall Study|Withdrawal by Subject|22
1418438|NCT01073605|4681954|P2|Overall Study|Withdrawal by Subject|39
1418439|NCT01073605|4681955|P1|Overall Study|Withdrawal by Subject|31
1418440|NCT01073605|4681953|P3|Overall Study|Other|29
1418441|NCT01073605|4681954|P2|Overall Study|Other|21
1418442|NCT01073605|4681955|P1|Overall Study|Other|25
1418443|NCT01073605|4681953|P3|Overall Study|Lost to Follow-up|9
1418444|NCT01073605|4681954|P2|Overall Study|Lost to Follow-up|4
1418445|NCT01073605|4681955|P1|Overall Study|Lost to Follow-up|3
1418446|NCT01073605|4681953|P3|Overall Study|Adverse Event|0
1418447|NCT01073605|4681954|P2|Overall Study|Adverse Event|1
1418448|NCT01073605|4681955|P1|Overall Study|Adverse Event|2
1418449|NCT01073605|4681953|P3|Overall Study|Ongoing at Cutoff Date|0
1418450|NCT01073605|4681954|P2|Overall Study|Ongoing at Cutoff Date|1
1418451|NCT01073605|4681955|P1|Overall Study|Ongoing at Cutoff Date|1
1418452|NCT01073566|4682001|P2|Period 2 (6 Weeks)|Adverse Event|0
1418453|NCT01073566|4682002|P1|Period 2 (6 Weeks)|Adverse Event|1
1418454|NCT01073462|4682014|P1|Overall Study|Lost to Follow-up|7
1418455|NCT01073462|4682014|P1|Overall Study|Serious adverse event|2
1418456|NCT01073462|4682014|P1|Overall Study|Low parathyroid hormone levels|8
1418457|NCT01073462|4682014|P1|Overall Study|Kidney transplant|10
1418458|NCT01073462|4682014|P1|Overall Study|Death|14
1418459|NCT01073293|4682033|P2|Overall Study|Withdrawal by Subject|10
1418460|NCT01073293|4682034|P1|Overall Study|Withdrawal by Subject|5
1418461|NCT01073293|4682033|P2|Overall Study|Lost to Follow-up|1
1418462|NCT01073293|4682034|P1|Overall Study|Lost to Follow-up|0
1418463|NCT01073267|4682056|P1|Overall Study|Disease Progression|3
1418464|NCT01073163|4682060|P1|Overall Study|Early termination|1
1418465|NCT01073163|4682060|P1|Overall Study|Disease Progression|1
1418466|NCT01073163|4682060|P1|Overall Study|Adverse Event|1
1418467|NCT01072929|4682083|P3|Overall Study|Not specified|0
1418468|NCT01072929|4682084|P2|Overall Study|Not specified|3
1418469|NCT01072929|4682085|P1|Overall Study|Not specified|0
1418470|NCT01072929|4682083|P3|Overall Study|Noncompliance with study procedures|1
1418471|NCT01072929|4682084|P2|Overall Study|Noncompliance with study procedures|0
1418472|NCT01072929|4682085|P1|Overall Study|Noncompliance with study procedures|1
1418473|NCT01072929|4682083|P3|Overall Study|Noncompliance with study medication|0
1418474|NCT01072929|4682084|P2|Overall Study|Noncompliance with study medication|3
1418475|NCT01072929|4682085|P1|Overall Study|Noncompliance with study medication|0
1418476|NCT01072929|4682083|P3|Overall Study|Lost to Follow-up|1
1418477|NCT01072929|4682084|P2|Overall Study|Lost to Follow-up|4
1418478|NCT01072929|4682085|P1|Overall Study|Lost to Follow-up|8
1418479|NCT01072929|4682083|P3|Overall Study|Protocol Violation|2
1418480|NCT01072929|4682084|P2|Overall Study|Protocol Violation|11
1418481|NCT01072929|4682085|P1|Overall Study|Protocol Violation|13
1418482|NCT01072929|4682083|P3|Overall Study|Withdrawal by Subject|3
1418483|NCT01072929|4682084|P2|Overall Study|Withdrawal by Subject|15
1418484|NCT01072929|4682085|P1|Overall Study|Withdrawal by Subject|7
1418485|NCT01072929|4682083|P3|Overall Study|Lack of Efficacy|0
1418486|NCT01072929|4682084|P2|Overall Study|Lack of Efficacy|4
1418487|NCT01072929|4682085|P1|Overall Study|Lack of Efficacy|7
1418488|NCT01072929|4682083|P3|Overall Study|Adverse Event|2
1418489|NCT01072929|4682084|P2|Overall Study|Adverse Event|11
1418490|NCT01072929|4682085|P1|Overall Study|Adverse Event|8
1418491|NCT01072877|4682164|P5|Overall Study|Lost to Follow-up|0
1418492|NCT01072877|4682165|P4|Overall Study|Lost to Follow-up|2
1418493|NCT01072877|4682166|P3|Overall Study|Lost to Follow-up|0
1418494|NCT01072877|4682167|P2|Overall Study|Lost to Follow-up|1
1418495|NCT01072877|4682168|P1|Overall Study|Lost to Follow-up|1
1418496|NCT01072630|4682231|P3|Overall Study|Not specified|1
1418497|NCT01072630|4682232|P2|Overall Study|Not specified|2
1418498|NCT01072630|4682233|P1|Overall Study|Not specified|3
1418499|NCT01072630|4682231|P3|Overall Study|Noncompliance with study procedures|1
1418500|NCT01072630|4682232|P2|Overall Study|Noncompliance with study procedures|2
1418501|NCT01072630|4682233|P1|Overall Study|Noncompliance with study procedures|1
1418502|NCT01072630|4682231|P3|Overall Study|Noncompliance with study medication|1
1418503|NCT01072630|4682232|P2|Overall Study|Noncompliance with study medication|1
1418504|NCT01072630|4682233|P1|Overall Study|Noncompliance with study medication|1
1418505|NCT01072630|4682231|P3|Overall Study|Lost to Follow-up|1
1418506|NCT01072630|4682232|P2|Overall Study|Lost to Follow-up|11
1418507|NCT01072630|4682233|P1|Overall Study|Lost to Follow-up|11
1418508|NCT01072630|4682231|P3|Overall Study|Protocol Violation|4
1418509|NCT01072630|4682232|P2|Overall Study|Protocol Violation|8
1418510|NCT01072630|4682233|P1|Overall Study|Protocol Violation|10
1418511|NCT01072630|4682231|P3|Overall Study|Withdrawal by Subject|2
1418512|NCT01072630|4682232|P2|Overall Study|Withdrawal by Subject|7
1418513|NCT01072630|4682233|P1|Overall Study|Withdrawal by Subject|8
1418514|NCT01072630|4682231|P3|Overall Study|Lack of Efficacy|1
1418515|NCT01072630|4682232|P2|Overall Study|Lack of Efficacy|10
1418516|NCT01072630|4682233|P1|Overall Study|Lack of Efficacy|10
1418517|NCT01072630|4682231|P3|Overall Study|Adverse Event|2
1418518|NCT01072630|4682232|P2|Overall Study|Adverse Event|19
1418519|NCT01072630|4682233|P1|Overall Study|Adverse Event|11
1418520|NCT01072539|4682314|P1|Overall Study|Protocol Violation|2
1418521|NCT01072539|4682314|P1|Overall Study|Treated prior to the Site Initiation|1
1418522|NCT01072500|4682338|P2|Overall Study|Withdrawal by Subject|10
1418523|NCT01072500|4682339|P1|Overall Study|Withdrawal by Subject|17
1418524|NCT01072500|4682338|P2|Overall Study|Lost to Follow-up|2
1418525|NCT01072500|4682339|P1|Overall Study|Lost to Follow-up|5
1418526|NCT01072500|4682338|P2|Overall Study|Death|2
1418527|NCT01072500|4682339|P1|Overall Study|Death|2
1418528|NCT01072448|4682349|P2|Overall Study|Death|2
1418529|NCT01072448|4682350|P1|Overall Study|Death|0
1418530|NCT01072448|4682349|P2|Overall Study|Abnormal laboratory value(s)|1
1418531|NCT01072448|4682350|P1|Overall Study|Abnormal laboratory value(s)|0
1418532|NCT01072448|4682349|P2|Overall Study|Lost to Follow-up|1
1418533|NCT01072448|4682350|P1|Overall Study|Lost to Follow-up|1
1418534|NCT01072448|4682349|P2|Overall Study|Unsatisfactory therapeutic effect|3
1418535|NCT01072448|4682350|P1|Overall Study|Unsatisfactory therapeutic effect|1
1418536|NCT01072448|4682349|P2|Overall Study|Abnormal test procedure result(s)|0
1418537|NCT01072448|4682350|P1|Overall Study|Abnormal test procedure result(s)|1
1418538|NCT01072448|4682349|P2|Overall Study|Protocol deviation|4
1418539|NCT01072448|4682350|P1|Overall Study|Protocol deviation|3
1418540|NCT01072448|4682349|P2|Overall Study|Subject withdrew consent|9
1418541|NCT01072448|4682350|P1|Overall Study|Subject withdrew consent|4
1418542|NCT01072448|4682349|P2|Overall Study|Adverse Event|10
1418543|NCT01072448|4682350|P1|Overall Study|Adverse Event|9
1418544|NCT01072396|4682364|P2|Period Two|Lost to Follow-up|0
1418545|NCT01072396|4682365|P1|Period Two|Lost to Follow-up|1
1418546|NCT01072396|4682364|P2|Period Two|Adverse Event|3
1418547|NCT01072396|4682365|P1|Period Two|Adverse Event|0
1418548|NCT01072396|4682364|P2|Washout Period|Missing termination information|1
1418549|NCT01072396|4682365|P1|Washout Period|Missing termination information|0
1418550|NCT01072396|4682364|P2|Period One|Withdrawal by Subject|0
1418551|NCT01072396|4682365|P1|Period One|Withdrawal by Subject|2
1418552|NCT01072396|4682364|P2|Period One|Protocol Violation|1
1418553|NCT01072396|4682365|P1|Period One|Protocol Violation|2
1418554|NCT01072396|4682364|P2|Period One|Adverse Event|1
1418555|NCT01072396|4682365|P1|Period One|Adverse Event|1
1418556|NCT01072357|4682377|P2|Overall Study|Lost to Follow-up|1
1418557|NCT01072357|4682378|P1|Overall Study|Lost to Follow-up|0
1418558|NCT01072344|4682388|P2|Overall Study|Lost to Follow-up|4
1418559|NCT01072344|4682389|P1|Overall Study|Lost to Follow-up|3
1418560|NCT01072344|4682388|P2|Overall Study|Protocol Violation|2
1418561|NCT01072344|4682389|P1|Overall Study|Protocol Violation|1
1418562|NCT01072344|4682388|P2|Overall Study|Relasped-reached end point|12
1418563|NCT01072344|4682389|P1|Overall Study|Relasped-reached end point|7
1418564|NCT01072201|4682427|P2|Overall Study|Lost to Follow-up|1
1418565|NCT01072201|4682428|P1|Overall Study|Lost to Follow-up|0
1418566|NCT01072175|4682461|P13|Part D (HPMC Capsules)|Ongoing|34
1418567|NCT01072175|4682462|P12|Part D (HPMC Capsules)|Ongoing|34
1418568|NCT01072175|4682463|P11|Part D (HPMC Capsules)|Ongoing|12
1418569|NCT01072175|4682464|P10|Part D (HPMC Capsules)|Ongoing|10
1418570|NCT01072175|4682465|P9|Part D (HPMC Capsules)|Ongoing|0
1418571|NCT01072175|4682466|P8|Part D (HPMC Capsules)|Ongoing|0
1418572|NCT01072175|4682467|P7|Part D (HPMC Capsules)|Ongoing|0
1418573|NCT01072175|4682468|P6|Part D (HPMC Capsules)|Ongoing|0
1418574|NCT01072175|4682469|P5|Part D (HPMC Capsules)|Ongoing|0
1418575|NCT01072175|4682470|P4|Part D (HPMC Capsules)|Ongoing|0
1418576|NCT01072175|4682471|P3|Part D (HPMC Capsules)|Ongoing|0
1418577|NCT01072175|4682472|P2|Part D (HPMC Capsules)|Ongoing|0
1418578|NCT01072175|4682473|P1|Part D (HPMC Capsules)|Ongoing|0
1418579|NCT01072175|4682461|P13|Part D (HPMC Capsules)|Death|5
1418580|NCT01072175|4682462|P12|Part D (HPMC Capsules)|Death|6
1418581|NCT01072175|4682463|P11|Part D (HPMC Capsules)|Death|4
1418582|NCT01072175|4682464|P10|Part D (HPMC Capsules)|Death|2
1418583|NCT01072175|4682465|P9|Part D (HPMC Capsules)|Death|0
1418584|NCT01072175|4682466|P8|Part D (HPMC Capsules)|Death|0
1418585|NCT01072175|4682467|P7|Part D (HPMC Capsules)|Death|0
1418586|NCT01072175|4682468|P6|Part D (HPMC Capsules)|Death|0
1418587|NCT01072175|4682469|P5|Part D (HPMC Capsules)|Death|0
1418588|NCT01072175|4682470|P4|Part D (HPMC Capsules)|Death|0
1418589|NCT01072175|4682471|P3|Part D (HPMC Capsules)|Death|0
1418590|NCT01072175|4682472|P2|Part D (HPMC Capsules)|Death|0
1418591|NCT01072175|4682473|P1|Part D (HPMC Capsules)|Death|0
1418592|NCT01072175|4682461|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
1418593|NCT01072175|4682462|P12|Part D (HPMC Capsules)|Withdrawal by Subject|1
1418594|NCT01072175|4682463|P11|Part D (HPMC Capsules)|Withdrawal by Subject|0
1418595|NCT01072175|4682464|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
1418596|NCT01072175|4682465|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
1418597|NCT01072175|4682466|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
1418598|NCT01072175|4682467|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
1418599|NCT01072175|4682468|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
1418600|NCT01072175|4682469|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
1418601|NCT01072175|4682470|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
1418602|NCT01072175|4682471|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
1418603|NCT01072175|4682472|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
1418604|NCT01072175|4682473|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
1418605|NCT01072175|4682461|P13|Part D (HPMC Capsules)|Lost to Follow-up|0
1418606|NCT01072175|4682462|P12|Part D (HPMC Capsules)|Lost to Follow-up|2
1418607|NCT01072175|4682463|P11|Part D (HPMC Capsules)|Lost to Follow-up|0
1418608|NCT01072175|4682464|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
1418609|NCT01072175|4682465|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
1418610|NCT01072175|4682466|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
1418611|NCT01072175|4682467|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
1418612|NCT01072175|4682468|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
1418613|NCT01072175|4682469|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
1418614|NCT01072175|4682470|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
1418615|NCT01072175|4682471|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
1418616|NCT01072175|4682472|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
1418617|NCT01072175|4682473|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
1418618|NCT01072175|4682461|P13|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1418619|NCT01072175|4682462|P12|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1418620|NCT01072175|4682463|P11|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1418621|NCT01072175|4682464|P10|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1418622|NCT01072175|4682465|P9|Part C (Phase II: Crossover Phase [CP])|Ongoing|28
1418623|NCT01072175|4682466|P8|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1418624|NCT01072175|4682467|P7|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1418625|NCT01072175|4682468|P6|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1418626|NCT01072175|4682469|P5|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1418627|NCT01072175|4682470|P4|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1418628|NCT01072175|4682471|P3|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1418629|NCT01072175|4682472|P2|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1418630|NCT01072175|4682473|P1|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
1418631|NCT01072175|4682461|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
1418632|NCT01072175|4682462|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
1418633|NCT01072175|4682463|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
1418634|NCT01072175|4682464|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
1418635|NCT01072175|4682465|P9|Part C (Phase II: Crossover Phase [CP])|Death|15
1418636|NCT01072175|4682466|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
1418637|NCT01072175|4682467|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
1418638|NCT01072175|4682468|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
1418639|NCT01072175|4682469|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
1418640|NCT01072175|4682470|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
1418641|NCT01072175|4682471|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
1418642|NCT01072175|4682472|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
1418643|NCT01072175|4682473|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
1418644|NCT01072175|4682461|P13|Part C (Phase II: Randomized Phase)|Ongoing|0
1418645|NCT01072175|4682462|P12|Part C (Phase II: Randomized Phase)|Ongoing|0
1418646|NCT01072175|4682463|P11|Part C (Phase II: Randomized Phase)|Ongoing|0
1418647|NCT01072175|4682464|P10|Part C (Phase II: Randomized Phase)|Ongoing|0
1418648|NCT01072175|4682465|P9|Part C (Phase II: Randomized Phase)|Ongoing|0
1418649|NCT01072175|4682466|P8|Part C (Phase II: Randomized Phase)|Ongoing|40
1418650|NCT01072175|4682467|P7|Part C (Phase II: Randomized Phase)|Ongoing|32
1418651|NCT01072175|4682468|P6|Part C (Phase II: Randomized Phase)|Ongoing|35
1418652|NCT01072175|4682469|P5|Part C (Phase II: Randomized Phase)|Ongoing|0
1418653|NCT01072175|4682470|P4|Part C (Phase II: Randomized Phase)|Ongoing|0
1418654|NCT01072175|4682471|P3|Part C (Phase II: Randomized Phase)|Ongoing|0
1418655|NCT01072175|4682472|P2|Part C (Phase II: Randomized Phase)|Ongoing|0
1418656|NCT01072175|4682473|P1|Part C (Phase II: Randomized Phase)|Ongoing|0
1418657|NCT01072175|4682461|P13|Part C (Phase II: Randomized Phase)|Death|0
1418658|NCT01072175|4682462|P12|Part C (Phase II: Randomized Phase)|Death|0
1418659|NCT01072175|4682463|P11|Part C (Phase II: Randomized Phase)|Death|0
1418660|NCT01072175|4682464|P10|Part C (Phase II: Randomized Phase)|Death|0
1418661|NCT01072175|4682465|P9|Part C (Phase II: Randomized Phase)|Death|0
1418662|NCT01072175|4682466|P8|Part C (Phase II: Randomized Phase)|Death|14
1418663|NCT01072175|4682467|P7|Part C (Phase II: Randomized Phase)|Death|18
1418664|NCT01072175|4682468|P6|Part C (Phase II: Randomized Phase)|Death|19
1418665|NCT01072175|4682469|P5|Part C (Phase II: Randomized Phase)|Death|0
1418666|NCT01072175|4682470|P4|Part C (Phase II: Randomized Phase)|Death|0
1418667|NCT01072175|4682471|P3|Part C (Phase II: Randomized Phase)|Death|0
1418668|NCT01072175|4682472|P2|Part C (Phase II: Randomized Phase)|Death|0
1418669|NCT01072175|4682473|P1|Part C (Phase II: Randomized Phase)|Death|0
1418670|NCT01072175|4682461|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1418671|NCT01072175|4682462|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1418672|NCT01072175|4682463|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1418673|NCT01072175|4682464|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1418674|NCT01072175|4682465|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1418675|NCT01072175|4682466|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1418676|NCT01072175|4682467|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|4
1418677|NCT01072175|4682468|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1418678|NCT01072175|4682469|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1418679|NCT01072175|4682470|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1418680|NCT01072175|4682471|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1418681|NCT01072175|4682472|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1418682|NCT01072175|4682473|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1418683|NCT01072175|4682461|P13|Part B (Dose Escalation and Expansion)|Ongoing|0
1418684|NCT01072175|4682462|P12|Part B (Dose Escalation and Expansion)|Ongoing|0
1418685|NCT01072175|4682463|P11|Part B (Dose Escalation and Expansion)|Ongoing|0
1418686|NCT01072175|4682464|P10|Part B (Dose Escalation and Expansion)|Ongoing|0
1418687|NCT01072175|4682465|P9|Part B (Dose Escalation and Expansion)|Ongoing|0
1418688|NCT01072175|4682466|P8|Part B (Dose Escalation and Expansion)|Ongoing|0
1418993|NCT01071317|4682832|P2|Overall Study|Lost to Follow-up|2
1418689|NCT01072175|4682467|P7|Part B (Dose Escalation and Expansion)|Ongoing|0
1418690|NCT01072175|4682468|P6|Part B (Dose Escalation and Expansion)|Ongoing|0
1418691|NCT01072175|4682469|P5|Part B (Dose Escalation and Expansion)|Ongoing|28
1418692|NCT01072175|4682470|P4|Part B (Dose Escalation and Expansion)|Ongoing|9
1418693|NCT01072175|4682471|P3|Part B (Dose Escalation and Expansion)|Ongoing|10
1418694|NCT01072175|4682472|P2|Part B (Dose Escalation and Expansion)|Ongoing|2
1418695|NCT01072175|4682473|P1|Part B (Dose Escalation and Expansion)|Ongoing|0
1418696|NCT01072175|4682461|P13|Part B (Dose Escalation and Expansion)|Death|0
1418697|NCT01072175|4682462|P12|Part B (Dose Escalation and Expansion)|Death|0
1418698|NCT01072175|4682463|P11|Part B (Dose Escalation and Expansion)|Death|0
1418699|NCT01072175|4682464|P10|Part B (Dose Escalation and Expansion)|Death|0
1418700|NCT01072175|4682465|P9|Part B (Dose Escalation and Expansion)|Death|0
1418701|NCT01072175|4682466|P8|Part B (Dose Escalation and Expansion)|Death|0
1418702|NCT01072175|4682467|P7|Part B (Dose Escalation and Expansion)|Death|0
1418703|NCT01072175|4682468|P6|Part B (Dose Escalation and Expansion)|Death|0
1418704|NCT01072175|4682469|P5|Part B (Dose Escalation and Expansion)|Death|36
1418705|NCT01072175|4682470|P4|Part B (Dose Escalation and Expansion)|Death|12
1418706|NCT01072175|4682471|P3|Part B (Dose Escalation and Expansion)|Death|10
1418707|NCT01072175|4682472|P2|Part B (Dose Escalation and Expansion)|Death|3
1418708|NCT01072175|4682473|P1|Part B (Dose Escalation and Expansion)|Death|0
1418709|NCT01072175|4682461|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1418710|NCT01072175|4682462|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1418711|NCT01072175|4682463|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1418712|NCT01072175|4682464|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1418713|NCT01072175|4682465|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1418714|NCT01072175|4682466|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1418715|NCT01072175|4682467|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1418716|NCT01072175|4682468|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1418717|NCT01072175|4682469|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
1418718|NCT01072175|4682470|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
1418719|NCT01072175|4682471|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1418720|NCT01072175|4682472|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1418721|NCT01072175|4682473|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1418722|NCT01072175|4682461|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
1418723|NCT01072175|4682462|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
1418724|NCT01072175|4682463|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
1418725|NCT01072175|4682464|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
1418726|NCT01072175|4682465|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
1418727|NCT01072175|4682466|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
1418728|NCT01072175|4682467|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
1418729|NCT01072175|4682468|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
1418730|NCT01072175|4682469|P5|Part B (Dose Escalation and Expansion)|Physician Decision|13
1418731|NCT01072175|4682470|P4|Part B (Dose Escalation and Expansion)|Physician Decision|4
1418732|NCT01072175|4682471|P3|Part B (Dose Escalation and Expansion)|Physician Decision|3
1418733|NCT01072175|4682472|P2|Part B (Dose Escalation and Expansion)|Physician Decision|1
1418734|NCT01072175|4682473|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
1418735|NCT01072175|4682461|P13|Part A (Drug-Drug Interaction)|Death|0
1418736|NCT01072175|4682462|P12|Part A (Drug-Drug Interaction)|Death|0
1418737|NCT01072175|4682463|P11|Part A (Drug-Drug Interaction)|Death|0
1418738|NCT01072175|4682464|P10|Part A (Drug-Drug Interaction)|Death|0
1418739|NCT01072175|4682465|P9|Part A (Drug-Drug Interaction)|Death|0
1418740|NCT01072175|4682466|P8|Part A (Drug-Drug Interaction)|Death|0
1418741|NCT01072175|4682467|P7|Part A (Drug-Drug Interaction)|Death|0
1418742|NCT01072175|4682468|P6|Part A (Drug-Drug Interaction)|Death|0
1418743|NCT01072175|4682469|P5|Part A (Drug-Drug Interaction)|Death|0
1418744|NCT01072175|4682470|P4|Part A (Drug-Drug Interaction)|Death|0
1418745|NCT01072175|4682471|P3|Part A (Drug-Drug Interaction)|Death|0
1418746|NCT01072175|4682472|P2|Part A (Drug-Drug Interaction)|Death|0
1418747|NCT01072175|4682473|P1|Part A (Drug-Drug Interaction)|Death|1
1418748|NCT01072175|4682461|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1418749|NCT01072175|4682462|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1418750|NCT01072175|4682463|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1418751|NCT01072175|4682464|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1418752|NCT01072175|4682465|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1418753|NCT01072175|4682466|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1418754|NCT01072175|4682467|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1418755|NCT01072175|4682468|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1418756|NCT01072175|4682469|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1418757|NCT01072175|4682470|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1418758|NCT01072175|4682471|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1418759|NCT01072175|4682472|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1418760|NCT01072175|4682473|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
1418761|NCT01072175|4682461|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
1418762|NCT01072175|4682462|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
1418763|NCT01072175|4682463|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
1418764|NCT01072175|4682464|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
1418765|NCT01072175|4682465|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
1418766|NCT01072175|4682466|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
1418767|NCT01072175|4682467|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
1418768|NCT01072175|4682468|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
1418769|NCT01072175|4682469|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
1418770|NCT01072175|4682470|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
1418771|NCT01072175|4682471|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
1418772|NCT01072175|4682472|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
1418773|NCT01072175|4682473|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
1418774|NCT01072149|4682656|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418775|NCT01072149|4682657|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418776|NCT01072149|4682658|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418777|NCT01072149|4682659|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418778|NCT01072149|4682660|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
1418779|NCT01072149|4682661|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418780|NCT01072149|4682662|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418781|NCT01072149|4682663|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418782|NCT01072149|4682664|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418783|NCT01072149|4682665|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418784|NCT01072149|4682666|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418785|NCT01072149|4682667|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418786|NCT01072149|4682668|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418787|NCT01072149|4682669|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418788|NCT01072149|4682670|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418789|NCT01072149|4682671|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
1418790|NCT01072149|4682672|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418791|NCT01072149|4682673|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1418792|NCT01072149|4682656|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418793|NCT01072149|4682657|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418794|NCT01072149|4682658|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418795|NCT01072149|4682659|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418796|NCT01072149|4682660|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418797|NCT01072149|4682661|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
1418798|NCT01072149|4682662|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418799|NCT01072149|4682663|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418800|NCT01072149|4682664|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418801|NCT01072149|4682665|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418802|NCT01072149|4682666|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418803|NCT01072149|4682667|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418804|NCT01072149|4682668|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418805|NCT01072149|4682669|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418806|NCT01072149|4682670|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418807|NCT01072149|4682671|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418808|NCT01072149|4682672|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418809|NCT01072149|4682673|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
1418810|NCT01072149|4682656|P18|Washout Period 2 (14 Days)|Adverse Event|0
1418811|NCT01072149|4682657|P17|Washout Period 2 (14 Days)|Adverse Event|0
1418812|NCT01072149|4682658|P16|Washout Period 2 (14 Days)|Adverse Event|1
1418813|NCT01072149|4682659|P15|Washout Period 2 (14 Days)|Adverse Event|0
1418814|NCT01072149|4682660|P14|Washout Period 2 (14 Days)|Adverse Event|0
1418815|NCT01072149|4682661|P13|Washout Period 2 (14 Days)|Adverse Event|0
1418816|NCT01072149|4682662|P12|Washout Period 2 (14 Days)|Adverse Event|0
1418817|NCT01072149|4682663|P11|Washout Period 2 (14 Days)|Adverse Event|0
1418818|NCT01072149|4682664|P10|Washout Period 2 (14 Days)|Adverse Event|0
1418819|NCT01072149|4682665|P9|Washout Period 2 (14 Days)|Adverse Event|0
1418820|NCT01072149|4682666|P8|Washout Period 2 (14 Days)|Adverse Event|0
1418821|NCT01072149|4682667|P7|Washout Period 2 (14 Days)|Adverse Event|0
1418822|NCT01072149|4682668|P6|Washout Period 2 (14 Days)|Adverse Event|0
1418823|NCT01072149|4682669|P5|Washout Period 2 (14 Days)|Adverse Event|0
1418824|NCT01072149|4682670|P4|Washout Period 2 (14 Days)|Adverse Event|0
1418825|NCT01072149|4682671|P3|Washout Period 2 (14 Days)|Adverse Event|0
1418826|NCT01072149|4682672|P2|Washout Period 2 (14 Days)|Adverse Event|0
1418827|NCT01072149|4682673|P1|Washout Period 2 (14 Days)|Adverse Event|0
1418828|NCT01072149|4682656|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418829|NCT01072149|4682657|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418830|NCT01072149|4682658|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
1418831|NCT01072149|4682659|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418832|NCT01072149|4682660|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418833|NCT01072149|4682661|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418834|NCT01072149|4682662|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418835|NCT01072149|4682663|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418836|NCT01072149|4682664|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418837|NCT01072149|4682665|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418838|NCT01072149|4682666|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418839|NCT01072149|4682667|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418840|NCT01072149|4682668|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418841|NCT01072149|4682669|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418842|NCT01072149|4682670|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418843|NCT01072149|4682671|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418844|NCT01072149|4682672|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418845|NCT01072149|4682673|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1418846|NCT01072149|4682656|P18|Washout Period 2 (14 Days)|Physician Decision|0
1418847|NCT01072149|4682657|P17|Washout Period 2 (14 Days)|Physician Decision|0
1418848|NCT01072149|4682658|P16|Washout Period 2 (14 Days)|Physician Decision|0
1418849|NCT01072149|4682659|P15|Washout Period 2 (14 Days)|Physician Decision|0
1418850|NCT01072149|4682660|P14|Washout Period 2 (14 Days)|Physician Decision|0
1418851|NCT01072149|4682661|P13|Washout Period 2 (14 Days)|Physician Decision|0
1418852|NCT01072149|4682662|P12|Washout Period 2 (14 Days)|Physician Decision|0
1418853|NCT01072149|4682663|P11|Washout Period 2 (14 Days)|Physician Decision|0
1418854|NCT01072149|4682664|P10|Washout Period 2 (14 Days)|Physician Decision|0
1418855|NCT01072149|4682665|P9|Washout Period 2 (14 Days)|Physician Decision|0
1418856|NCT01072149|4682666|P8|Washout Period 2 (14 Days)|Physician Decision|0
1418857|NCT01072149|4682667|P7|Washout Period 2 (14 Days)|Physician Decision|0
1418858|NCT01072149|4682668|P6|Washout Period 2 (14 Days)|Physician Decision|0
1418859|NCT01072149|4682669|P5|Washout Period 2 (14 Days)|Physician Decision|0
1418860|NCT01072149|4682670|P4|Washout Period 2 (14 Days)|Physician Decision|0
1418861|NCT01072149|4682671|P3|Washout Period 2 (14 Days)|Physician Decision|0
1418862|NCT01072149|4682672|P2|Washout Period 2 (14 Days)|Physician Decision|0
1418863|NCT01072149|4682673|P1|Washout Period 2 (14 Days)|Physician Decision|1
1418864|NCT01072149|4682656|P18|Treatment Period 2 (28 Days)|Physician Decision|0
1418865|NCT01072149|4682657|P17|Treatment Period 2 (28 Days)|Physician Decision|0
1418866|NCT01072149|4682658|P16|Treatment Period 2 (28 Days)|Physician Decision|0
1418867|NCT01072149|4682659|P15|Treatment Period 2 (28 Days)|Physician Decision|0
1418868|NCT01072149|4682660|P14|Treatment Period 2 (28 Days)|Physician Decision|0
1418869|NCT01072149|4682661|P13|Treatment Period 2 (28 Days)|Physician Decision|0
1418870|NCT01072149|4682662|P12|Treatment Period 2 (28 Days)|Physician Decision|0
1418871|NCT01072149|4682663|P11|Treatment Period 2 (28 Days)|Physician Decision|0
1418872|NCT01072149|4682664|P10|Treatment Period 2 (28 Days)|Physician Decision|0
1418873|NCT01072149|4682665|P9|Treatment Period 2 (28 Days)|Physician Decision|0
1418874|NCT01072149|4682666|P8|Treatment Period 2 (28 Days)|Physician Decision|1
1418875|NCT01072149|4682667|P7|Treatment Period 2 (28 Days)|Physician Decision|0
1418876|NCT01072149|4682668|P6|Treatment Period 2 (28 Days)|Physician Decision|0
1418877|NCT01072149|4682669|P5|Treatment Period 2 (28 Days)|Physician Decision|0
1418878|NCT01072149|4682670|P4|Treatment Period 2 (28 Days)|Physician Decision|0
1418879|NCT01072149|4682671|P3|Treatment Period 2 (28 Days)|Physician Decision|0
1418880|NCT01072149|4682672|P2|Treatment Period 2 (28 Days)|Physician Decision|0
1418881|NCT01072149|4682673|P1|Treatment Period 2 (28 Days)|Physician Decision|0
1418882|NCT01072149|4682656|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418883|NCT01072149|4682657|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418884|NCT01072149|4682658|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418885|NCT01072149|4682659|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418886|NCT01072149|4682660|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418887|NCT01072149|4682661|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418888|NCT01072149|4682662|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418889|NCT01072149|4682663|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418890|NCT01072149|4682664|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418891|NCT01072149|4682665|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418892|NCT01072149|4682666|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418893|NCT01072149|4682667|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418894|NCT01072149|4682668|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418895|NCT01072149|4682669|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418896|NCT01072149|4682670|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418897|NCT01072149|4682671|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
1418898|NCT01072149|4682672|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418899|NCT01072149|4682673|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1418900|NCT01072149|4682656|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418901|NCT01072149|4682657|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418902|NCT01072149|4682658|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418903|NCT01072149|4682659|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418904|NCT01072149|4682660|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418905|NCT01072149|4682661|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418906|NCT01072149|4682662|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418907|NCT01072149|4682663|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418908|NCT01072149|4682664|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418909|NCT01072149|4682665|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418910|NCT01072149|4682666|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418911|NCT01072149|4682667|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418912|NCT01072149|4682668|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418913|NCT01072149|4682669|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418914|NCT01072149|4682670|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418915|NCT01072149|4682671|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418916|NCT01072149|4682672|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
1418917|NCT01072149|4682673|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1418918|NCT01072149|4682656|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418919|NCT01072149|4682657|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418920|NCT01072149|4682658|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418921|NCT01072149|4682659|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418922|NCT01072149|4682660|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418923|NCT01072149|4682661|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418924|NCT01072149|4682662|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418925|NCT01072149|4682663|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
1418926|NCT01072149|4682664|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418927|NCT01072149|4682665|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418928|NCT01072149|4682666|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418929|NCT01072149|4682667|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418930|NCT01072149|4682668|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418931|NCT01072149|4682669|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418932|NCT01072149|4682670|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418933|NCT01072149|4682671|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418934|NCT01072149|4682672|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418935|NCT01072149|4682673|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1418936|NCT01072149|4682656|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
1418937|NCT01072149|4682657|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
1418938|NCT01072149|4682658|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
1418939|NCT01072149|4682659|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
1418940|NCT01072149|4682660|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
1418941|NCT01072149|4682661|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
1418942|NCT01072149|4682662|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
1418943|NCT01072149|4682663|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
1418944|NCT01072149|4682664|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
1418945|NCT01072149|4682665|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
1418946|NCT01072149|4682666|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
1418947|NCT01072149|4682667|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
1418948|NCT01072149|4682668|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
1418949|NCT01072149|4682669|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
1418950|NCT01072149|4682670|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
1418951|NCT01072149|4682671|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
1418952|NCT01072149|4682672|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
1418953|NCT01072149|4682673|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
1418954|NCT01072149|4682656|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418955|NCT01072149|4682657|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418956|NCT01072149|4682658|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418957|NCT01072149|4682659|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418958|NCT01072149|4682660|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418959|NCT01072149|4682661|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418960|NCT01072149|4682662|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418961|NCT01072149|4682663|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418962|NCT01072149|4682664|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418963|NCT01072149|4682665|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418964|NCT01072149|4682666|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418965|NCT01072149|4682667|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418966|NCT01072149|4682668|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418967|NCT01072149|4682669|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418968|NCT01072149|4682670|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418969|NCT01072149|4682671|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1418970|NCT01072149|4682672|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418971|NCT01072149|4682673|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1418972|NCT01071915|4682762|P1|Overall Study|Miscellaneous Reasons|2
1418973|NCT01071915|4682762|P1|Overall Study|Withdrawal by Subject|2
1418974|NCT01071915|4682762|P1|Overall Study|Physician Decision|2
1418975|NCT01071915|4682762|P1|Overall Study|Adverse Event|3
1418976|NCT01071798|4682772|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
1418977|NCT01071798|4682772|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
1418978|NCT01071798|4682772|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
1418979|NCT01071798|4682772|P1|Subpopulation Who Received Two Cycles|Remission|1
1418980|NCT01071798|4682772|P1|Participants Who Received One Cycle|Severe concomitant disease|2
1418981|NCT01071798|4682772|P1|Participants Who Received One Cycle|Change of therapy|6
1418982|NCT01071798|4682772|P1|Participants Who Received One Cycle|Death|5
1418983|NCT01071798|4682772|P1|Participants Who Received One Cycle|Patient requirement|20
1418984|NCT01071798|4682772|P1|Participants Who Received One Cycle|Lack of tolerability|14
1418985|NCT01071798|4682772|P1|Participants Who Received One Cycle|Lack of Efficacy|18
1418986|NCT01071512|4682802|P1|Overall Study|positive anti-JC virus antibody test|2
1418987|NCT01071512|4682802|P1|Overall Study|Development of antibodies to drug|2
1418988|NCT01071512|4682802|P1|Overall Study|Adverse Event|1
1418989|NCT01071395|4682812|P2|Overall Study|Adverse Event|1
1418990|NCT01071395|4682813|P1|Overall Study|Adverse Event|3
1418991|NCT01071395|4682812|P2|Overall Study|Withdrawal by Subject|1
1418992|NCT01071395|4682813|P1|Overall Study|Withdrawal by Subject|2
1418994|NCT01071317|4682833|P1|Overall Study|Lost to Follow-up|2
1418995|NCT01071278|4682845|P1|Overall Study|Completion Status Unknown|459
1418996|NCT01071278|4682845|P1|Overall Study|Premature Discontinuation|254
1418997|NCT01071252|4682856|P5|Overall Study|Death|1
1418998|NCT01071252|4682857|P4|Overall Study|Death|0
1418999|NCT01071252|4682858|P3|Overall Study|Death|0
1419000|NCT01071252|4682859|P2|Overall Study|Death|0
1419001|NCT01071252|4682860|P1|Overall Study|Death|0
1419002|NCT01071252|4682856|P5|Overall Study|Adverse Event|0
1419003|NCT01071252|4682857|P4|Overall Study|Adverse Event|1
1419004|NCT01071252|4682858|P3|Overall Study|Adverse Event|0
1419005|NCT01071252|4682859|P2|Overall Study|Adverse Event|1
1419006|NCT01071252|4682860|P1|Overall Study|Adverse Event|1
1419007|NCT01071252|4682856|P5|Overall Study|Lost to Follow-up|0
1419008|NCT01071252|4682857|P4|Overall Study|Lost to Follow-up|2
1419009|NCT01071252|4682858|P3|Overall Study|Lost to Follow-up|1
1419010|NCT01071252|4682859|P2|Overall Study|Lost to Follow-up|0
1419011|NCT01071252|4682860|P1|Overall Study|Lost to Follow-up|1
1419012|NCT01071252|4682856|P5|Overall Study|administrative problems|1
1419013|NCT01071252|4682857|P4|Overall Study|administrative problems|2
1419014|NCT01071252|4682858|P3|Overall Study|administrative problems|0
1419015|NCT01071252|4682859|P2|Overall Study|administrative problems|1
1419016|NCT01071252|4682860|P1|Overall Study|administrative problems|1
1419017|NCT01071252|4682856|P5|Overall Study|Withdrawal by Subject|3
1419018|NCT01071252|4682857|P4|Overall Study|Withdrawal by Subject|2
1419019|NCT01071252|4682858|P3|Overall Study|Withdrawal by Subject|1
1419020|NCT01071252|4682859|P2|Overall Study|Withdrawal by Subject|2
1419021|NCT01071252|4682860|P1|Overall Study|Withdrawal by Subject|8
1419022|NCT01071252|4682856|P5|Overall Study|unsatisfactory therapeutic effect|6
1419023|NCT01071252|4682857|P4|Overall Study|unsatisfactory therapeutic effect|0
1419024|NCT01071252|4682858|P3|Overall Study|unsatisfactory therapeutic effect|2
1419025|NCT01071252|4682859|P2|Overall Study|unsatisfactory therapeutic effect|6
1419026|NCT01071252|4682860|P1|Overall Study|unsatisfactory therapeutic effect|4
1419027|NCT01071200|4682888|P2|Overall Study|No viable embryos|1
1419028|NCT01071200|4682889|P1|Overall Study|No viable embryos|0
1419029|NCT01071200|4682888|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
1419030|NCT01071200|4682889|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
1419031|NCT01071200|4682888|P2|Overall Study|No oocytes retrieved|1
1419032|NCT01071200|4682889|P1|Overall Study|No oocytes retrieved|1
1419033|NCT01071200|4682888|P2|Overall Study|No fertilization|0
1419034|NCT01071200|4682889|P1|Overall Study|No fertilization|4
1419035|NCT01071200|4682888|P2|Overall Study|Lack of ovarian response|1
1419036|NCT01071200|4682889|P1|Overall Study|Lack of ovarian response|1
1419037|NCT01071096|4682921|P2|First Intervention (90 Days)|Lost to Follow-up|0
1419038|NCT01071096|4682922|P1|First Intervention (90 Days)|Lost to Follow-up|1
1419039|NCT01071083|4682946|P5|Overall Study|Subject Refused to Continue|0
1419040|NCT01071083|4682947|P4|Overall Study|Subject Refused to Continue|0
1419041|NCT01071083|4682948|P3|Overall Study|Subject Refused to Continue|0
1419042|NCT01071083|4682949|P2|Overall Study|Subject Refused to Continue|0
1419043|NCT01071083|4682950|P1|Overall Study|Subject Refused to Continue|1
1419044|NCT01071083|4682946|P5|Overall Study|Did Not Want Per Protocol Treatment|1
1419045|NCT01071083|4682947|P4|Overall Study|Did Not Want Per Protocol Treatment|0
1419046|NCT01071083|4682948|P3|Overall Study|Did Not Want Per Protocol Treatment|1
1419047|NCT01071083|4682949|P2|Overall Study|Did Not Want Per Protocol Treatment|0
1419048|NCT01071083|4682950|P1|Overall Study|Did Not Want Per Protocol Treatment|0
1419049|NCT01071083|4682946|P5|Overall Study|Did Not Meet Eligibility Criteria|1
1419050|NCT01071083|4682947|P4|Overall Study|Did Not Meet Eligibility Criteria|1
1419051|NCT01071083|4682948|P3|Overall Study|Did Not Meet Eligibility Criteria|1
1419052|NCT01071083|4682949|P2|Overall Study|Did Not Meet Eligibility Criteria|0
1419053|NCT01071083|4682950|P1|Overall Study|Did Not Meet Eligibility Criteria|0
1419054|NCT01071083|4682946|P5|Overall Study|Images Not Usable (Motion)|0
1419055|NCT01071083|4682947|P4|Overall Study|Images Not Usable (Motion)|0
1419056|NCT01071083|4682948|P3|Overall Study|Images Not Usable (Motion)|0
1419057|NCT01071083|4682949|P2|Overall Study|Images Not Usable (Motion)|1
1419058|NCT01071083|4682950|P1|Overall Study|Images Not Usable (Motion)|0
1419059|NCT01071083|4682946|P5|Overall Study|Subject Moved|0
1419060|NCT01071083|4682947|P4|Overall Study|Subject Moved|0
1419061|NCT01071083|4682948|P3|Overall Study|Subject Moved|0
1419062|NCT01071083|4682949|P2|Overall Study|Subject Moved|1
1419063|NCT01071083|4682950|P1|Overall Study|Subject Moved|0
1419064|NCT01071083|4682946|P5|Overall Study|Early Rescue|1
1419065|NCT01071083|4682947|P4|Overall Study|Early Rescue|0
1419066|NCT01071083|4682948|P3|Overall Study|Early Rescue|0
1419067|NCT01071083|4682949|P2|Overall Study|Early Rescue|0
1419068|NCT01071083|4682950|P1|Overall Study|Early Rescue|1
1419069|NCT01071083|4682946|P5|Overall Study|Physician Decision|1
1419070|NCT01071083|4682947|P4|Overall Study|Physician Decision|1
1419071|NCT01071083|4682948|P3|Overall Study|Physician Decision|0
1419072|NCT01071083|4682949|P2|Overall Study|Physician Decision|0
1419073|NCT01071083|4682950|P1|Overall Study|Physician Decision|1
1419074|NCT01071083|4682946|P5|Overall Study|Withdrawal by Subject|3
1419075|NCT01071083|4682947|P4|Overall Study|Withdrawal by Subject|0
1419076|NCT01071083|4682948|P3|Overall Study|Withdrawal by Subject|2
1419077|NCT01071083|4682949|P2|Overall Study|Withdrawal by Subject|0
1419078|NCT01071083|4682950|P1|Overall Study|Withdrawal by Subject|3
1419079|NCT01071083|4682946|P5|Overall Study|Adverse Event|1
1419080|NCT01071083|4682947|P4|Overall Study|Adverse Event|0
1419081|NCT01071083|4682948|P3|Overall Study|Adverse Event|1
1419082|NCT01071083|4682949|P2|Overall Study|Adverse Event|0
1419083|NCT01071083|4682950|P1|Overall Study|Adverse Event|1
1419084|NCT01071070|4682969|P2|Overall Study|Hypercalcemia|0
1419085|NCT01071070|4682970|P1|Overall Study|Hypercalcemia|1
1419086|NCT01071070|4682969|P2|Overall Study|Missed 3 consecutive doses of study drug|0
1419087|NCT01071070|4682970|P1|Overall Study|Missed 3 consecutive doses of study drug|2
1419088|NCT01071070|4682969|P2|Overall Study|Withdrawal by Subject|0
1419089|NCT01071070|4682970|P1|Overall Study|Withdrawal by Subject|1
1419090|NCT01071070|4682969|P2|Overall Study|Adverse Event|3
1419091|NCT01071070|4682970|P1|Overall Study|Adverse Event|0
1419092|NCT01070979|4683016|P3|Overall Study|No study drug taken|0
1419093|NCT01070979|4683017|P2|Overall Study|No study drug taken|1
1419094|NCT01070979|4683018|P1|Overall Study|No study drug taken|0
1419095|NCT01070979|4683016|P3|Overall Study|Withdrawal by Subject|1
1419096|NCT01070979|4683017|P2|Overall Study|Withdrawal by Subject|1
1419097|NCT01070979|4683018|P1|Overall Study|Withdrawal by Subject|3
1419098|NCT01070979|4683016|P3|Overall Study|Surgery, moving, personal, abn. labs|2
1419099|NCT01070979|4683017|P2|Overall Study|Surgery, moving, personal, abn. labs|4
1419100|NCT01070979|4683018|P1|Overall Study|Surgery, moving, personal, abn. labs|4
1419101|NCT01070979|4683016|P3|Overall Study|Protocol Violation|6
1419102|NCT01070979|4683017|P2|Overall Study|Protocol Violation|2
1419103|NCT01070979|4683018|P1|Overall Study|Protocol Violation|0
1419104|NCT01070979|4683016|P3|Overall Study|Lost to Follow-up|1
1419105|NCT01070979|4683017|P2|Overall Study|Lost to Follow-up|1
1419106|NCT01070979|4683018|P1|Overall Study|Lost to Follow-up|2
1419107|NCT01070979|4683016|P3|Overall Study|Adverse Event|3
1419108|NCT01070979|4683017|P2|Overall Study|Adverse Event|3
1419109|NCT01070979|4683018|P1|Overall Study|Adverse Event|2
1419110|NCT01070966|4683044|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
1419111|NCT01070966|4683044|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
1419112|NCT01070966|4683044|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
1419113|NCT01070966|4683044|P1|Participants for Safety Evaluation|TMT given before date of contract|3
1419114|NCT01070966|4683044|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
1419115|NCT01070966|4683044|P1|Participants for Safety Evaluation|Duplicate Participants|4
1419116|NCT01070966|4683044|P1|Participants for Safety Evaluation|Off-label use|9
1419117|NCT01070966|4683044|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
1419118|NCT01070953|4683055|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
1419119|NCT01070953|4683055|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
1419120|NCT01070953|4683055|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
1419121|NCT01070953|4683055|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
1419122|NCT01070953|4683055|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
1419123|NCT01070953|4683055|P1|Participants for Safety Evaluation|Uncontracted participants|4
1419124|NCT01070953|4683055|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
1419125|NCT01070953|4683055|P1|Participants for Safety Evaluation|Duplicated participants|22
1419126|NCT01070953|4683055|P1|Participants for Safety Evaluation|Off-label use|283
1419127|NCT01070953|4683055|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
1419128|NCT01070888|4683068|P2|Washout (14 Days)|Physician Decision|0
1419129|NCT01070888|4683069|P1|Washout (14 Days)|Physician Decision|1
1419130|NCT01070888|4683068|P2|First Intervention (14 Days)|Lost to Follow-up|1
1419131|NCT01070888|4683069|P1|First Intervention (14 Days)|Lost to Follow-up|0
1419132|NCT01070888|4683068|P2|First Intervention (14 Days)|Adverse Event|1
1419133|NCT01070888|4683069|P1|First Intervention (14 Days)|Adverse Event|0
1419134|NCT01070784|4683094|P2|Overall Study|Adverse Event|9
1419135|NCT01070784|4683095|P1|Overall Study|Adverse Event|14
1419136|NCT01070784|4683094|P2|Overall Study|Withdrawal by Subject|9
1419137|NCT01070784|4683095|P1|Overall Study|Withdrawal by Subject|6
1419138|NCT01070771|4683183|P1|Overall Study|Protocol Violation|1
1419139|NCT01070771|4683183|P1|Overall Study|Adverse Event|2
1419140|NCT01070550|4683203|P6|Overall Study|Withdrawal by Subject|0
1419141|NCT01070550|4683204|P5|Overall Study|Withdrawal by Subject|0
1419142|NCT01070550|4683205|P4|Overall Study|Withdrawal by Subject|0
1419143|NCT01070550|4683206|P3|Overall Study|Withdrawal by Subject|3
1419144|NCT01070550|4683207|P2|Overall Study|Withdrawal by Subject|0
1419145|NCT01070550|4683208|P1|Overall Study|Withdrawal by Subject|35
1419146|NCT01070550|4683203|P6|Overall Study|Other|0
1419147|NCT01070550|4683204|P5|Overall Study|Other|0
1419148|NCT01070550|4683205|P4|Overall Study|Other|1
1419149|NCT01070550|4683206|P3|Overall Study|Other|0
1419150|NCT01070550|4683207|P2|Overall Study|Other|0
1419151|NCT01070550|4683208|P1|Overall Study|Other|5
1419152|NCT01070550|4683203|P6|Overall Study|Treatment was stopped early|0
1419153|NCT01070550|4683204|P5|Overall Study|Treatment was stopped early|0
1419154|NCT01070550|4683205|P4|Overall Study|Treatment was stopped early|0
1419155|NCT01070550|4683206|P3|Overall Study|Treatment was stopped early|0
1419156|NCT01070550|4683207|P2|Overall Study|Treatment was stopped early|0
1419157|NCT01070550|4683208|P1|Overall Study|Treatment was stopped early|7
1419158|NCT01070550|4683203|P6|Overall Study|Treatment unavailable|0
1419159|NCT01070550|4683204|P5|Overall Study|Treatment unavailable|0
1419160|NCT01070550|4683205|P4|Overall Study|Treatment unavailable|0
1419161|NCT01070550|4683206|P3|Overall Study|Treatment unavailable|0
1419162|NCT01070550|4683207|P2|Overall Study|Treatment unavailable|0
1419163|NCT01070550|4683208|P1|Overall Study|Treatment unavailable|1
1419164|NCT01070550|4683203|P6|Overall Study|Treatment stopped|0
1419165|NCT01070550|4683204|P5|Overall Study|Treatment stopped|0
1419166|NCT01070550|4683205|P4|Overall Study|Treatment stopped|0
1419167|NCT01070550|4683206|P3|Overall Study|Treatment stopped|0
1419168|NCT01070550|4683207|P2|Overall Study|Treatment stopped|0
1419169|NCT01070550|4683208|P1|Overall Study|Treatment stopped|3
1419170|NCT01070550|4683203|P6|Overall Study|Treatment restarted|0
1419171|NCT01070550|4683204|P5|Overall Study|Treatment restarted|0
1419172|NCT01070550|4683205|P4|Overall Study|Treatment restarted|0
1419173|NCT01070550|4683206|P3|Overall Study|Treatment restarted|0
1419174|NCT01070550|4683207|P2|Overall Study|Treatment restarted|1
1419175|NCT01070550|4683208|P1|Overall Study|Treatment restarted|0
1419176|NCT01070550|4683203|P6|Overall Study|Treatment not started|0
1419177|NCT01070550|4683204|P5|Overall Study|Treatment not started|0
1419178|NCT01070550|4683205|P4|Overall Study|Treatment not started|0
1419179|NCT01070550|4683206|P3|Overall Study|Treatment not started|4
1419180|NCT01070550|4683207|P2|Overall Study|Treatment not started|2
1419181|NCT01070550|4683208|P1|Overall Study|Treatment not started|14
1419182|NCT01070550|4683203|P6|Overall Study|Treatment interrupted|0
1419183|NCT01070550|4683204|P5|Overall Study|Treatment interrupted|0
1419184|NCT01070550|4683205|P4|Overall Study|Treatment interrupted|1
1419185|NCT01070550|4683206|P3|Overall Study|Treatment interrupted|1
1419186|NCT01070550|4683207|P2|Overall Study|Treatment interrupted|0
1419187|NCT01070550|4683208|P1|Overall Study|Treatment interrupted|7
1419188|NCT01070550|4683203|P6|Overall Study|Treatment duration shortened|0
1419189|NCT01070550|4683204|P5|Overall Study|Treatment duration shortened|0
1419190|NCT01070550|4683205|P4|Overall Study|Treatment duration shortened|0
1419191|NCT01070550|4683206|P3|Overall Study|Treatment duration shortened|0
1419192|NCT01070550|4683207|P2|Overall Study|Treatment duration shortened|0
1419193|NCT01070550|4683208|P1|Overall Study|Treatment duration shortened|1
1419194|NCT01070550|4683203|P6|Overall Study|Sponsor decision|0
1419195|NCT01070550|4683204|P5|Overall Study|Sponsor decision|0
1419196|NCT01070550|4683205|P4|Overall Study|Sponsor decision|0
1419197|NCT01070550|4683206|P3|Overall Study|Sponsor decision|0
1419198|NCT01070550|4683207|P2|Overall Study|Sponsor decision|0
1419199|NCT01070550|4683208|P1|Overall Study|Sponsor decision|1
1419200|NCT01070550|4683203|P6|Overall Study|Screen failure|0
1419201|NCT01070550|4683204|P5|Overall Study|Screen failure|0
1419202|NCT01070550|4683205|P4|Overall Study|Screen failure|0
1419203|NCT01070550|4683206|P3|Overall Study|Screen failure|0
1419204|NCT01070550|4683207|P2|Overall Study|Screen failure|0
1419205|NCT01070550|4683208|P1|Overall Study|Screen failure|1
1419206|NCT01070550|4683203|P6|Overall Study|Result not available|0
1419207|NCT01070550|4683204|P5|Overall Study|Result not available|0
1419208|NCT01070550|4683205|P4|Overall Study|Result not available|0
1419209|NCT01070550|4683206|P3|Overall Study|Result not available|3
1419210|NCT01070550|4683207|P2|Overall Study|Result not available|1
1419211|NCT01070550|4683208|P1|Overall Study|Result not available|3
1419212|NCT01070550|4683203|P6|Overall Study|Relapse|0
1419213|NCT01070550|4683204|P5|Overall Study|Relapse|0
1419214|NCT01070550|4683205|P4|Overall Study|Relapse|4
1419215|NCT01070550|4683206|P3|Overall Study|Relapse|14
1419216|NCT01070550|4683207|P2|Overall Study|Relapse|5
1419217|NCT01070550|4683208|P1|Overall Study|Relapse|44
1419218|NCT01070550|4683203|P6|Overall Study|Protocol Violation|0
1419219|NCT01070550|4683204|P5|Overall Study|Protocol Violation|0
1419220|NCT01070550|4683205|P4|Overall Study|Protocol Violation|1
1419221|NCT01070550|4683206|P3|Overall Study|Protocol Violation|1
1419222|NCT01070550|4683207|P2|Overall Study|Protocol Violation|1
1419223|NCT01070550|4683208|P1|Overall Study|Protocol Violation|15
1419224|NCT01070550|4683203|P6|Overall Study|Not categorized|1
1419225|NCT01070550|4683204|P5|Overall Study|Not categorized|0
1419226|NCT01070550|4683205|P4|Overall Study|Not categorized|1
1419227|NCT01070550|4683206|P3|Overall Study|Not categorized|6
1419228|NCT01070550|4683207|P2|Overall Study|Not categorized|2
1419229|NCT01070550|4683208|P1|Overall Study|Not categorized|33
1419230|NCT01070550|4683203|P6|Overall Study|Non-responders|2
1419231|NCT01070550|4683204|P5|Overall Study|Non-responders|0
1419232|NCT01070550|4683205|P4|Overall Study|Non-responders|20
1419233|NCT01070550|4683206|P3|Overall Study|Non-responders|21
1419234|NCT01070550|4683207|P2|Overall Study|Non-responders|4
1419235|NCT01070550|4683208|P1|Overall Study|Non-responders|493
1419236|NCT01070550|4683203|P6|Overall Study|New treatment started|0
1419237|NCT01070550|4683204|P5|Overall Study|New treatment started|0
1419238|NCT01070550|4683205|P4|Overall Study|New treatment started|2
1419239|NCT01070550|4683206|P3|Overall Study|New treatment started|0
1419240|NCT01070550|4683207|P2|Overall Study|New treatment started|1
1419241|NCT01070550|4683208|P1|Overall Study|New treatment started|3
1419242|NCT01070550|4683203|P6|Overall Study|Miscellaneous|0
1419243|NCT01070550|4683204|P5|Overall Study|Miscellaneous|0
1419244|NCT01070550|4683205|P4|Overall Study|Miscellaneous|1
1419245|NCT01070550|4683206|P3|Overall Study|Miscellaneous|3
1419246|NCT01070550|4683207|P2|Overall Study|Miscellaneous|2
1419247|NCT01070550|4683208|P1|Overall Study|Miscellaneous|12
1419248|NCT01070550|4683203|P6|Overall Study|Lack of Efficacy|1
1419249|NCT01070550|4683204|P5|Overall Study|Lack of Efficacy|0
1419250|NCT01070550|4683205|P4|Overall Study|Lack of Efficacy|5
1419251|NCT01070550|4683206|P3|Overall Study|Lack of Efficacy|5
1419252|NCT01070550|4683207|P2|Overall Study|Lack of Efficacy|1
1419253|NCT01070550|4683208|P1|Overall Study|Lack of Efficacy|65
1419254|NCT01070550|4683203|P6|Overall Study|Lab test not done|1
1419255|NCT01070550|4683204|P5|Overall Study|Lab test not done|0
1419256|NCT01070550|4683205|P4|Overall Study|Lab test not done|1
1419257|NCT01070550|4683206|P3|Overall Study|Lab test not done|4
1419258|NCT01070550|4683207|P2|Overall Study|Lab test not done|3
1419259|NCT01070550|4683208|P1|Overall Study|Lab test not done|22
1419260|NCT01070550|4683203|P6|Overall Study|Incomplete treatment|0
1419261|NCT01070550|4683204|P5|Overall Study|Incomplete treatment|0
1419262|NCT01070550|4683205|P4|Overall Study|Incomplete treatment|0
1419263|NCT01070550|4683206|P3|Overall Study|Incomplete treatment|0
1419264|NCT01070550|4683207|P2|Overall Study|Incomplete treatment|0
1419265|NCT01070550|4683208|P1|Overall Study|Incomplete treatment|2
1419266|NCT01070550|4683203|P6|Overall Study|Failed to return|2
1419267|NCT01070550|4683204|P5|Overall Study|Failed to return|1
1419268|NCT01070550|4683205|P4|Overall Study|Failed to return|40
1419269|NCT01070550|4683206|P3|Overall Study|Failed to return|144
1419270|NCT01070550|4683207|P2|Overall Study|Failed to return|33
1419271|NCT01070550|4683208|P1|Overall Study|Failed to return|450
1419272|NCT01070550|4683203|P6|Overall Study|Early termination|0
1419273|NCT01070550|4683204|P5|Overall Study|Early termination|0
1419274|NCT01070550|4683205|P4|Overall Study|Early termination|0
1419275|NCT01070550|4683206|P3|Overall Study|Early termination|0
1419276|NCT01070550|4683207|P2|Overall Study|Early termination|0
1419277|NCT01070550|4683208|P1|Overall Study|Early termination|3
1419278|NCT01070550|4683203|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
1419279|NCT01070550|4683204|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
1419280|NCT01070550|4683205|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
1419281|NCT01070550|4683206|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
1419282|NCT01070550|4683207|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
1419283|NCT01070550|4683208|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
1419284|NCT01070550|4683203|P6|Overall Study|Death|0
1419285|NCT01070550|4683204|P5|Overall Study|Death|0
1419286|NCT01070550|4683205|P4|Overall Study|Death|0
1419287|NCT01070550|4683206|P3|Overall Study|Death|3
1419288|NCT01070550|4683207|P2|Overall Study|Death|4
1419289|NCT01070550|4683208|P1|Overall Study|Death|20
1419290|NCT01070550|4683203|P6|Overall Study|Adverse Event|0
1419291|NCT01070550|4683204|P5|Overall Study|Adverse Event|0
1419292|NCT01070550|4683205|P4|Overall Study|Adverse Event|0
1419293|NCT01070550|4683206|P3|Overall Study|Adverse Event|3
1419294|NCT01070550|4683207|P2|Overall Study|Adverse Event|1
1419295|NCT01070550|4683208|P1|Overall Study|Adverse Event|43
1419296|NCT01070394|4683348|P1|Overall Study|Withdrawal by Subject|1
1419297|NCT01070394|4683348|P1|Overall Study|Adverse Event|6
1419298|NCT01070381|4683359|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
1419299|NCT01070381|4683360|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
1419300|NCT01070381|4683359|P2|Period 2, 1 Week of Wear|Handling|1
1419301|NCT01070381|4683360|P1|Period 2, 1 Week of Wear|Handling|0
1419302|NCT01070329|4683368|P2|Overall Study|Sponsor Decision|1
1419303|NCT01070329|4683369|P1|Overall Study|Sponsor Decision|0
1419304|NCT01070329|4683368|P2|Overall Study|Entry Criteria Not Met|0
1419305|NCT01070329|4683369|P1|Overall Study|Entry Criteria Not Met|1
1419306|NCT01070329|4683368|P2|Overall Study|Physician Decision|1
1419307|NCT01070329|4683369|P1|Overall Study|Physician Decision|2
1419308|NCT01070329|4683368|P2|Overall Study|Lack of Efficacy|6
1419309|NCT01070329|4683369|P1|Overall Study|Lack of Efficacy|2
1419310|NCT01070329|4683368|P2|Overall Study|Protocol Violation|8
1419311|NCT01070329|4683369|P1|Overall Study|Protocol Violation|3
1419312|NCT01070329|4683368|P2|Overall Study|Withdrawal by Subject|11
1419313|NCT01070329|4683369|P1|Overall Study|Withdrawal by Subject|9
1419314|NCT01070329|4683368|P2|Overall Study|Lost to Follow-up|12
1419315|NCT01070329|4683369|P1|Overall Study|Lost to Follow-up|22
1419316|NCT01070329|4683368|P2|Overall Study|Adverse Event|10
1419317|NCT01070329|4683369|P1|Overall Study|Adverse Event|13
1419318|NCT01070316|4683401|P1|Extension Phase|Withdrawal by Subject|1
1419319|NCT01070316|4683401|P1|Extension Phase|Lack of Efficacy|3
1419320|NCT01070303|4683408|P1|Overall Study|Other|18
1419321|NCT01070303|4683408|P1|Overall Study|Administrative Reason|1
1419322|NCT01070303|4683408|P1|Overall Study|Lack of Efficacy|2
1419323|NCT01070303|4683408|P1|Overall Study|Protocol Violation|0
1419324|NCT01070303|4683408|P1|Overall Study|Lost to Follow-up|9
1419325|NCT01070303|4683408|P1|Overall Study|Withdrawal by Subject|20
1419326|NCT01070303|4683408|P1|Overall Study|Adverse Event|39
1419327|NCT01070043|4683482|P3|Double-Blind Treatment|Adverse Event|2
1419328|NCT01070043|4683483|P2|Double-Blind Treatment|Adverse Event|0
1419329|NCT01070043|4683484|P1|Double-Blind Treatment|Adverse Event|0
1419330|NCT01070043|4683482|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
1419331|NCT01070043|4683483|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
1419332|NCT01070043|4683484|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
1419333|NCT01069939|4683500|P2|Randomised and Included in the Analyses|Removal|0
1419334|NCT01069939|4683501|P1|Randomised and Included in the Analyses|Removal|1
1419335|NCT01069939|4683500|P2|Randomised and Included in the Analyses|Physician Decision|2
1419336|NCT01069939|4683501|P1|Randomised and Included in the Analyses|Physician Decision|0
1419337|NCT01069939|4683500|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
1419338|NCT01069939|4683501|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
1419339|NCT01069939|4683500|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
1419340|NCT01069939|4683501|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
1419341|NCT01069939|4683500|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
1419342|NCT01069939|4683501|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
1419343|NCT01069939|4683500|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
1419344|NCT01069939|4683501|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
1419345|NCT01069939|4683500|P2|Randomised and Included in the Analyses|Protocol Violation|1
1419346|NCT01069939|4683501|P1|Randomised and Included in the Analyses|Protocol Violation|0
1419347|NCT01069939|4683500|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
1419348|NCT01069939|4683501|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
1419349|NCT01069939|4683500|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
1419350|NCT01069939|4683501|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
1419351|NCT01069939|4683500|P2|Randomised and Included in the Analyses|Adverse Event|22
1419352|NCT01069939|4683501|P1|Randomised and Included in the Analyses|Adverse Event|17
1419353|NCT01069900|4683527|P2|Overall Study|Insufficient Therapeutic effect|0
1419354|NCT01069900|4683528|P1|Overall Study|Insufficient Therapeutic effect|1
1419355|NCT01069900|4683527|P2|Overall Study|Protocol Violation|1
1419356|NCT01069900|4683528|P1|Overall Study|Protocol Violation|4
1419357|NCT01069900|4683527|P2|Overall Study|Withdrawal by Subject|1
1419358|NCT01069900|4683528|P1|Overall Study|Withdrawal by Subject|6
1419359|NCT01069900|4683527|P2|Overall Study|Lost to Follow-up|1
1419360|NCT01069900|4683528|P1|Overall Study|Lost to Follow-up|7
1419361|NCT01069900|4683527|P2|Overall Study|Technical problems|1
1419362|NCT01069900|4683528|P1|Overall Study|Technical problems|0
1419363|NCT01069861|4683572|P1|Overall Study|Did not meet entrance criteria|1
1419364|NCT01069861|4683572|P1|Overall Study|Adverse Event|1
1419365|NCT01069861|4683572|P1|Overall Study|Death|1
1419366|NCT01069627|4683585|P1|Overall Study|Protocol Violation|1
1419367|NCT01069627|4683585|P1|Overall Study|Adverse Event|12
1419368|NCT01069627|4683585|P1|Overall Study|Disease progression|7
1419369|NCT01069523|4683635|P2|Overall Study|Withdrawal by Subject|7
1419370|NCT01069523|4683636|P1|Overall Study|Withdrawal by Subject|4
1419371|NCT01069484|4683646|P2|Overall Study|Illness mother or child|1
1419372|NCT01069484|4683647|P1|Overall Study|Illness mother or child|3
1419373|NCT01069484|4683646|P2|Overall Study|No specific reason|2
1419374|NCT01069484|4683647|P1|Overall Study|No specific reason|8
1419375|NCT01069484|4683646|P2|Overall Study|Death-in-near-family|0
1419376|NCT01069484|4683647|P1|Overall Study|Death-in-near-family|1
1419377|NCT01069419|4683655|P1|Overall Study|Missing termination information|13
1419378|NCT01069419|4683655|P1|Overall Study|Other Reason|43
1419379|NCT01069419|4683655|P1|Overall Study|Withdrawal by Subject|34
1419380|NCT01069419|4683655|P1|Overall Study|Remission of disease|11
1419381|NCT01069419|4683655|P1|Overall Study|Lost to Follow-up|49
1419382|NCT01069419|4683655|P1|Overall Study|Lack of Efficacy|332
1419383|NCT01069419|4683655|P1|Overall Study|Adverse Event|233
1419384|NCT01069341|4683684|P1|Overall Study|Lost to Follow-up|1
1419385|NCT01069289|4683697|P2|Overall Study|Due to deteriorating health condition|0
1419386|NCT01069289|4683698|P1|Overall Study|Due to deteriorating health condition|1
1419387|NCT01069289|4683697|P2|Overall Study|Severe non-compliance to protocol|2
1419388|NCT01069289|4683698|P1|Overall Study|Severe non-compliance to protocol|3
1419389|NCT01069289|4683697|P2|Overall Study|Eligibility criteria not fulfilled|0
1419390|NCT01069289|4683698|P1|Overall Study|Eligibility criteria not fulfilled|2
1419391|NCT01069289|4683697|P2|Overall Study|Adverse Event|28
1419392|NCT01069289|4683698|P1|Overall Study|Adverse Event|21
1419393|NCT01069289|4683697|P2|Overall Study|Withdrawal by Subject|26
1419394|NCT01069289|4683698|P1|Overall Study|Withdrawal by Subject|15
1419395|NCT01069172|4683747|P2|Overall Study|Withdrawal by Subject|0
1419396|NCT01069172|4683748|P1|Overall Study|Withdrawal by Subject|1
1419397|NCT01069120|4683758|P1|Overall Study|Study prematurely terminated|27
1419398|NCT01068912|4683795|P3|Overall Study|other underlying illness|3
1419399|NCT01068912|4683796|P2|Overall Study|other underlying illness|3
1419400|NCT01068912|4683797|P1|Overall Study|other underlying illness|0
1419401|NCT01068912|4683795|P3|Overall Study|aggravation influenza|1
1419402|NCT01068912|4683796|P2|Overall Study|aggravation influenza|1
1419403|NCT01068912|4683797|P1|Overall Study|aggravation influenza|1
1419404|NCT01068912|4683795|P3|Overall Study|Protocol Violation|0
1419405|NCT01068912|4683796|P2|Overall Study|Protocol Violation|2
1419406|NCT01068912|4683797|P1|Overall Study|Protocol Violation|0
1419407|NCT01068912|4683795|P3|Overall Study|Lost to Follow-up|3
1419408|NCT01068912|4683796|P2|Overall Study|Lost to Follow-up|7
1419409|NCT01068912|4683797|P1|Overall Study|Lost to Follow-up|3
1419410|NCT01068912|4683795|P3|Overall Study|Withdrawal by Subject|6
1419411|NCT01068912|4683796|P2|Overall Study|Withdrawal by Subject|6
1419412|NCT01068912|4683797|P1|Overall Study|Withdrawal by Subject|5
1419413|NCT01068912|4683795|P3|Overall Study|Adverse Event|2
1419414|NCT01068912|4683796|P2|Overall Study|Adverse Event|3
1419415|NCT01068912|4683797|P1|Overall Study|Adverse Event|2
1419416|NCT01068860|4683815|P10|Overall Study|Lost to Follow-up|0
1419417|NCT01068860|4683816|P9|Overall Study|Lost to Follow-up|0
1419418|NCT01068860|4683817|P8|Overall Study|Lost to Follow-up|0
1419419|NCT01068860|4683818|P7|Overall Study|Lost to Follow-up|0
1419420|NCT01068860|4683819|P6|Overall Study|Lost to Follow-up|0
1419421|NCT01068860|4683820|P5|Overall Study|Lost to Follow-up|0
1419422|NCT01068860|4683821|P4|Overall Study|Lost to Follow-up|0
1419423|NCT01068860|4683822|P3|Overall Study|Lost to Follow-up|0
1419424|NCT01068860|4683823|P2|Overall Study|Lost to Follow-up|1
1419425|NCT01068860|4683824|P1|Overall Study|Lost to Follow-up|0
1419426|NCT01068860|4683815|P10|Overall Study|Administrative problems; misrandomized|1
1419427|NCT01068860|4683816|P9|Overall Study|Administrative problems; misrandomized|0
1419428|NCT01068860|4683817|P8|Overall Study|Administrative problems; misrandomized|0
1419429|NCT01068860|4683818|P7|Overall Study|Administrative problems; misrandomized|0
1419430|NCT01068860|4683819|P6|Overall Study|Administrative problems; misrandomized|0
1419431|NCT01068860|4683820|P5|Overall Study|Administrative problems; misrandomized|0
1419432|NCT01068860|4683821|P4|Overall Study|Administrative problems; misrandomized|1
1419433|NCT01068860|4683822|P3|Overall Study|Administrative problems; misrandomized|0
1419434|NCT01068860|4683823|P2|Overall Study|Administrative problems; misrandomized|0
1419435|NCT01068860|4683824|P1|Overall Study|Administrative problems; misrandomized|0
1419436|NCT01068860|4683815|P10|Overall Study|Withdrawal by Subject|3
1419437|NCT01068860|4683816|P9|Overall Study|Withdrawal by Subject|0
1419438|NCT01068860|4683817|P8|Overall Study|Withdrawal by Subject|0
1419439|NCT01068860|4683818|P7|Overall Study|Withdrawal by Subject|0
1419440|NCT01068860|4683819|P6|Overall Study|Withdrawal by Subject|2
1419441|NCT01068860|4683820|P5|Overall Study|Withdrawal by Subject|0
1419442|NCT01068860|4683821|P4|Overall Study|Withdrawal by Subject|0
1419443|NCT01068860|4683822|P3|Overall Study|Withdrawal by Subject|0
1419444|NCT01068860|4683823|P2|Overall Study|Withdrawal by Subject|0
1419445|NCT01068860|4683824|P1|Overall Study|Withdrawal by Subject|0
1419446|NCT01068769|4684007|P1|Overall Study|Ineligible|1
1419447|NCT01068743|4684012|P4|Period 3|Adverse Event|0
1419448|NCT01068743|4684013|P3|Period 3|Adverse Event|0
1419449|NCT01068743|4684014|P2|Period 3|Adverse Event|1
1419450|NCT01068743|4684015|P1|Period 3|Adverse Event|0
1419451|NCT01068730|4684089|P4|Period 4|Family emergency|0
1419452|NCT01068730|4684090|P3|Period 4|Family emergency|0
1419453|NCT01068730|4684091|P2|Period 4|Family emergency|1
1419454|NCT01068730|4684092|P1|Period 4|Family emergency|0
1419455|NCT01068730|4684089|P4|Period 3|Personal reason|0
1419456|NCT01068730|4684090|P3|Period 3|Personal reason|0
1419457|NCT01068730|4684091|P2|Period 3|Personal reason|0
1419458|NCT01068730|4684092|P1|Period 3|Personal reason|1
1419459|NCT01068717|4684146|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
1419460|NCT01068717|4684147|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
1419461|NCT01068717|4684148|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
1419462|NCT01068717|4684149|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
1419463|NCT01068678|4684205|P2|Overall Study|Unclassified|15
1419464|NCT01068678|4684206|P1|Overall Study|Unclassified|18
1419465|NCT01068678|4684205|P2|Overall Study|Withdrawal criteria|6
1419466|NCT01068678|4684206|P1|Overall Study|Withdrawal criteria|12
1419467|NCT01068678|4684205|P2|Overall Study|Protocol Violation|1
1419468|NCT01068678|4684206|P1|Overall Study|Protocol Violation|5
1419469|NCT01068678|4684205|P2|Overall Study|Lack of Efficacy|2
1419470|NCT01068678|4684206|P1|Overall Study|Lack of Efficacy|3
1419471|NCT01068665|4684216|P2|Overall Study|Other|12
1419472|NCT01068665|4684217|P1|Overall Study|Other|17
1419473|NCT01068665|4684216|P2|Overall Study|Withdrawal Criteria|9
1419474|NCT01068665|4684217|P1|Overall Study|Withdrawal Criteria|3
1419475|NCT01068665|4684216|P2|Overall Study|Protocol Violation|2
1419476|NCT01068665|4684217|P1|Overall Study|Protocol Violation|5
1419477|NCT01068665|4684216|P2|Overall Study|Lack of Efficacy|2
1419478|NCT01068665|4684217|P1|Overall Study|Lack of Efficacy|0
1419479|NCT01068665|4684216|P2|Overall Study|Adverse Event|4
1419480|NCT01068665|4684217|P1|Overall Study|Adverse Event|5
1419481|NCT01068652|4684227|P2|Overall Study|Unclassified|4
1419482|NCT01068652|4684228|P1|Overall Study|Unclassified|7
1419483|NCT01068652|4684227|P2|Overall Study|Patient was not eligible|0
1419484|NCT01068652|4684228|P1|Overall Study|Patient was not eligible|1
1419485|NCT01068652|4684227|P2|Overall Study|Withdrawal criteria|2
1419486|NCT01068652|4684228|P1|Overall Study|Withdrawal criteria|1
1419487|NCT01068652|4684227|P2|Overall Study|Protocol Violation|6
1419488|NCT01068652|4684228|P1|Overall Study|Protocol Violation|3
1419489|NCT01068652|4684227|P2|Overall Study|Lost to Follow-up|1
1419490|NCT01068652|4684228|P1|Overall Study|Lost to Follow-up|2
1419491|NCT01068652|4684227|P2|Overall Study|Lack of Efficacy|2
1419492|NCT01068652|4684228|P1|Overall Study|Lack of Efficacy|0
1419493|NCT01068652|4684227|P2|Overall Study|Adverse Event|0
1419494|NCT01068652|4684228|P1|Overall Study|Adverse Event|4
1419495|NCT01068626|4684268|P2|Overall Study|Withdrawal by Subject|2
1419496|NCT01068626|4684269|P1|Overall Study|Withdrawal by Subject|0
1419497|NCT01068626|4684268|P2|Overall Study|Adverse Event|0
1419498|NCT01068626|4684269|P1|Overall Study|Adverse Event|3
1419499|NCT01068600|4684287|P2|Overall Study|Administrative problems|1
1419500|NCT01068600|4684288|P1|Overall Study|Administrative problems|0
1419501|NCT01068600|4684287|P2|Overall Study|Unsatisfactory therapeutic effect|4
1419502|NCT01068600|4684288|P1|Overall Study|Unsatisfactory therapeutic effect|0
1419503|NCT01068600|4684287|P2|Overall Study|Protocol deviation|1
1419504|NCT01068600|4684288|P1|Overall Study|Protocol deviation|1
1419505|NCT01068600|4684287|P2|Overall Study|Lost to Follow-up|2
1419506|NCT01068600|4684288|P1|Overall Study|Lost to Follow-up|1
1419507|NCT01068600|4684287|P2|Overall Study|Abnormal laboratory value(s)|0
1419508|NCT01068600|4684288|P1|Overall Study|Abnormal laboratory value(s)|1
1419509|NCT01068600|4684287|P2|Overall Study|Adverse Event|3
1419510|NCT01068600|4684288|P1|Overall Study|Adverse Event|3
1419511|NCT01068600|4684287|P2|Overall Study|Withdrawal by Subject|6
1419512|NCT01068600|4684288|P1|Overall Study|Withdrawal by Subject|5
1419513|NCT01068509|4684308|P3|Overall Study|Reason Not Specified|0
1419514|NCT01068509|4684309|P2|Overall Study|Reason Not Specified|1
1419515|NCT01068509|4684310|P1|Overall Study|Reason Not Specified|0
1419516|NCT01068509|4684308|P3|Overall Study|Withdrew Consent|2
1419517|NCT01068509|4684309|P2|Overall Study|Withdrew Consent|1
1419518|NCT01068509|4684310|P1|Overall Study|Withdrew Consent|0
1419519|NCT01068509|4684308|P3|Overall Study|Lost to Follow-up|0
1419520|NCT01068509|4684309|P2|Overall Study|Lost to Follow-up|0
1419521|NCT01068509|4684310|P1|Overall Study|Lost to Follow-up|1
1419522|NCT01068509|4684308|P3|Overall Study|Disease Progression|18
1419523|NCT01068509|4684309|P2|Overall Study|Disease Progression|20
1419524|NCT01068509|4684310|P1|Overall Study|Disease Progression|5
1419525|NCT01068509|4684308|P3|Overall Study|Death|1
1419526|NCT01068509|4684309|P2|Overall Study|Death|0
1419527|NCT01068509|4684310|P1|Overall Study|Death|0
1419528|NCT01068418|4684323|P1|Overall Study|Physician Decision|12
1419529|NCT01068262|4684332|P4|Overall Study|Withdrawal by Subject|0
1419530|NCT01068262|4684333|P3|Overall Study|Withdrawal by Subject|0
1419531|NCT01068262|4684334|P2|Overall Study|Withdrawal by Subject|1
1419532|NCT01068262|4684335|P1|Overall Study|Withdrawal by Subject|0
1419533|NCT01068262|4684332|P4|Overall Study|Protocol Violation|0
1419534|NCT01068262|4684333|P3|Overall Study|Protocol Violation|0
1419535|NCT01068262|4684334|P2|Overall Study|Protocol Violation|0
1419536|NCT01068262|4684335|P1|Overall Study|Protocol Violation|1
1419537|NCT01068262|4684332|P4|Overall Study|Adverse Event|0
1419538|NCT01068262|4684333|P3|Overall Study|Adverse Event|1
1419539|NCT01068262|4684334|P2|Overall Study|Adverse Event|0
1419540|NCT01068262|4684335|P1|Overall Study|Adverse Event|2
1419541|NCT01068158|4684365|P2|Overall Study|Protocol Violation|2
1419542|NCT01068158|4684366|P1|Overall Study|Protocol Violation|0
1419543|NCT01068158|4684365|P2|Overall Study|Lost to Follow-up|0
1419544|NCT01068158|4684366|P1|Overall Study|Lost to Follow-up|7
1419545|NCT01068158|4684365|P2|Overall Study|Withdrawal by Subject|2
1419546|NCT01068158|4684366|P1|Overall Study|Withdrawal by Subject|1
1419547|NCT01067976|4684378|P1|Overall Study|Study prematurely discontinued|2
1419548|NCT01067976|4684378|P1|Overall Study|Study drug never administered|20
1419549|NCT01067846|4684439|P2|Overall Study|participation in other tx study|0
1419550|NCT01067846|4684440|P1|Overall Study|participation in other tx study|1
1419551|NCT01067846|4684439|P2|Overall Study|Withdrawal by Subject|0
1419552|NCT01067846|4684440|P1|Overall Study|Withdrawal by Subject|1
1419553|NCT01067846|4684439|P2|Overall Study|Lost to Follow-up|19
1419554|NCT01067846|4684440|P1|Overall Study|Lost to Follow-up|17
1419555|NCT01067352|4684512|P3|Overall Study|Physician Decision|0
1419556|NCT01067352|4684513|P2|Overall Study|Physician Decision|1
1419557|NCT01067352|4684514|P1|Overall Study|Physician Decision|0
1419558|NCT01067352|4684512|P3|Overall Study|Withdrawal by Subject|1
1419559|NCT01067352|4684513|P2|Overall Study|Withdrawal by Subject|2
1419560|NCT01067352|4684514|P1|Overall Study|Withdrawal by Subject|1
1419561|NCT01067339|4684530|P2|Overall Study|Withdrawal by Subject|5
1419562|NCT01067339|4684531|P1|Overall Study|Withdrawal by Subject|6
1419563|NCT01067326|4684541|P2|Overall Study|Early Study Termination|1
1419564|NCT01067326|4684542|P1|Overall Study|Early Study Termination|1
1419565|NCT01067326|4684541|P2|Overall Study|Withdrawal by Subject|0
1419566|NCT01067326|4684542|P1|Overall Study|Withdrawal by Subject|1
1419567|NCT01067326|4684541|P2|Overall Study|Adverse Event|2
1419568|NCT01067326|4684542|P1|Overall Study|Adverse Event|0
1419569|NCT01067144|4684556|P2|Follow-up|Death|1
1419570|NCT01067144|4684557|P1|Follow-up|Death|0
1419571|NCT01067144|4684556|P2|Follow-up|Surgery cancelled|1
1419572|NCT01067144|4684557|P1|Follow-up|Surgery cancelled|0
1419573|NCT01067144|4684556|P2|Follow-up|Withdrawal by Subject|14
1419574|NCT01067144|4684557|P1|Follow-up|Withdrawal by Subject|18
1419575|NCT01067144|4684556|P2|Follow-up|Censored owing to second surgery|28
1419576|NCT01067144|4684557|P1|Follow-up|Censored owing to second surgery|19
1419577|NCT01067144|4684556|P2|Follow-up|Lost to Follow-up|12
1419578|NCT01067144|4684557|P1|Follow-up|Lost to Follow-up|22
1419579|NCT01067144|4684556|P2|Treatment|Did not receive allocated intervention|7
1419580|NCT01067144|4684557|P1|Treatment|Did not receive allocated intervention|4
1419581|NCT01067105|4684565|P1|Overall Study|Other|31
1419582|NCT01067105|4684565|P1|Overall Study|Physician Decision|6
1419583|NCT01067105|4684565|P1|Overall Study|Lost to Follow-up|6
1419584|NCT01067105|4684565|P1|Overall Study|Withdrawal by Subject|36
1419585|NCT01067105|4684565|P1|Overall Study|Protocol Violation|48
1419586|NCT01067105|4684565|P1|Overall Study|Adverse Event|14
1419587|NCT01066923|4684586|P4|Overall Study|Withdrawal by Subject|8
1419588|NCT01066923|4684587|P3|Overall Study|Withdrawal by Subject|8
1419589|NCT01066923|4684588|P2|Overall Study|Withdrawal by Subject|3
1419590|NCT01066923|4684589|P1|Overall Study|Withdrawal by Subject|3
1419591|NCT01066897|4684613|P2|Overall Study|stopped study after developing the flu.|0
1419592|NCT01066897|4684614|P1|Overall Study|stopped study after developing the flu.|1
1419593|NCT01066897|4684613|P2|Overall Study|Withdrawal by Subject|0
1419594|NCT01066897|4684614|P1|Overall Study|Withdrawal by Subject|1
1419595|NCT01066871|4684628|P4|Overall Study|Other|2
1419596|NCT01066871|4684629|P3|Overall Study|Other|1
1419597|NCT01066871|4684630|P2|Overall Study|Other|2
1419598|NCT01066871|4684631|P1|Overall Study|Other|0
1419599|NCT01066871|4684628|P4|Overall Study|Withdrawal by Subject|0
1419600|NCT01066871|4684629|P3|Overall Study|Withdrawal by Subject|0
1419601|NCT01066871|4684630|P2|Overall Study|Withdrawal by Subject|1
1419602|NCT01066871|4684631|P1|Overall Study|Withdrawal by Subject|3
1419603|NCT01066871|4684628|P4|Overall Study|Lack of Efficacy|1
1419604|NCT01066871|4684629|P3|Overall Study|Lack of Efficacy|0
1419605|NCT01066871|4684630|P2|Overall Study|Lack of Efficacy|0
1419606|NCT01066871|4684631|P1|Overall Study|Lack of Efficacy|0
1419607|NCT01066871|4684628|P4|Overall Study|Protocol Violation|2
1419608|NCT01066871|4684629|P3|Overall Study|Protocol Violation|3
1419609|NCT01066871|4684630|P2|Overall Study|Protocol Violation|0
1419610|NCT01066871|4684631|P1|Overall Study|Protocol Violation|1
1419611|NCT01066871|4684628|P4|Overall Study|Lost to Follow-up|0
1419612|NCT01066871|4684629|P3|Overall Study|Lost to Follow-up|2
1419613|NCT01066871|4684630|P2|Overall Study|Lost to Follow-up|2
1419614|NCT01066871|4684631|P1|Overall Study|Lost to Follow-up|0
1419615|NCT01066819|4684695|P6|Overall Study|Other|0
1419616|NCT01066819|4684696|P5|Overall Study|Other|0
1419617|NCT01066819|4684697|P4|Overall Study|Other|0
1419618|NCT01066819|4684698|P3|Overall Study|Other|1
1419619|NCT01066819|4684699|P2|Overall Study|Other|1
1419620|NCT01066819|4684700|P1|Overall Study|Other|5
1419621|NCT01066819|4684695|P6|Overall Study|Treatment stopped|0
1419622|NCT01066819|4684696|P5|Overall Study|Treatment stopped|0
1419623|NCT01066819|4684697|P4|Overall Study|Treatment stopped|1
1419624|NCT01066819|4684698|P3|Overall Study|Treatment stopped|2
1419625|NCT01066819|4684699|P2|Overall Study|Treatment stopped|1
1419626|NCT01066819|4684700|P1|Overall Study|Treatment stopped|12
1419627|NCT01066819|4684695|P6|Overall Study|Treatment never started|2
1419628|NCT01066819|4684696|P5|Overall Study|Treatment never started|2
1419629|NCT01066819|4684697|P4|Overall Study|Treatment never started|3
1419630|NCT01066819|4684698|P3|Overall Study|Treatment never started|19
1419631|NCT01066819|4684699|P2|Overall Study|Treatment never started|19
1419632|NCT01066819|4684700|P1|Overall Study|Treatment never started|85
1419633|NCT01066819|4684695|P6|Overall Study|Spontaneous cure|0
1419634|NCT01066819|4684696|P5|Overall Study|Spontaneous cure|0
1419635|NCT01066819|4684697|P4|Overall Study|Spontaneous cure|0
1419636|NCT01066819|4684698|P3|Overall Study|Spontaneous cure|0
1419637|NCT01066819|4684699|P2|Overall Study|Spontaneous cure|0
1419638|NCT01066819|4684700|P1|Overall Study|Spontaneous cure|1
1419639|NCT01066819|4684695|P6|Overall Study|Screen failure|0
1419640|NCT01066819|4684696|P5|Overall Study|Screen failure|0
1419641|NCT01066819|4684697|P4|Overall Study|Screen failure|0
1419642|NCT01066819|4684698|P3|Overall Study|Screen failure|0
1419643|NCT01066819|4684699|P2|Overall Study|Screen failure|0
1419644|NCT01066819|4684700|P1|Overall Study|Screen failure|1
1419645|NCT01066819|4684695|P6|Overall Study|Results not available|0
1419646|NCT01066819|4684696|P5|Overall Study|Results not available|0
1419647|NCT01066819|4684697|P4|Overall Study|Results not available|0
1419648|NCT01066819|4684698|P3|Overall Study|Results not available|0
1419649|NCT01066819|4684699|P2|Overall Study|Results not available|0
1419650|NCT01066819|4684700|P1|Overall Study|Results not available|1
1419651|NCT01066819|4684695|P6|Overall Study|Relapse|0
1419652|NCT01066819|4684696|P5|Overall Study|Relapse|0
1419653|NCT01066819|4684697|P4|Overall Study|Relapse|0
1419654|NCT01066819|4684698|P3|Overall Study|Relapse|3
1419655|NCT01066819|4684699|P2|Overall Study|Relapse|4
1419656|NCT01066819|4684700|P1|Overall Study|Relapse|16
1419657|NCT01066819|4684695|P6|Overall Study|Not categorised|0
1419658|NCT01066819|4684696|P5|Overall Study|Not categorised|0
1419659|NCT01066819|4684697|P4|Overall Study|Not categorised|1
1419660|NCT01066819|4684698|P3|Overall Study|Not categorised|6
1419661|NCT01066819|4684699|P2|Overall Study|Not categorised|2
1419662|NCT01066819|4684700|P1|Overall Study|Not categorised|9
1419663|NCT01066819|4684695|P6|Overall Study|Non responders|1
1419664|NCT01066819|4684696|P5|Overall Study|Non responders|0
1419665|NCT01066819|4684697|P4|Overall Study|Non responders|2
1419666|NCT01066819|4684698|P3|Overall Study|Non responders|7
1419667|NCT01066819|4684699|P2|Overall Study|Non responders|2
1419668|NCT01066819|4684700|P1|Overall Study|Non responders|123
1419669|NCT01066819|4684695|P6|Overall Study|Miscellaneous|0
1419670|NCT01066819|4684696|P5|Overall Study|Miscellaneous|0
1419671|NCT01066819|4684697|P4|Overall Study|Miscellaneous|1
1419672|NCT01066819|4684698|P3|Overall Study|Miscellaneous|18
1419673|NCT01066819|4684699|P2|Overall Study|Miscellaneous|10
1419674|NCT01066819|4684700|P1|Overall Study|Miscellaneous|28
1419675|NCT01066819|4684695|P6|Overall Study|Lab test not done|0
1419676|NCT01066819|4684696|P5|Overall Study|Lab test not done|0
1419677|NCT01066819|4684697|P4|Overall Study|Lab test not done|1
1419678|NCT01066819|4684698|P3|Overall Study|Lab test not done|2
1419679|NCT01066819|4684699|P2|Overall Study|Lab test not done|0
1419680|NCT01066819|4684700|P1|Overall Study|Lab test not done|9
1419681|NCT01066819|4684695|P6|Overall Study|Failed to return|3
1419682|NCT01066819|4684696|P5|Overall Study|Failed to return|2
1419683|NCT01066819|4684697|P4|Overall Study|Failed to return|7
1419684|NCT01066819|4684698|P3|Overall Study|Failed to return|68
1419685|NCT01066819|4684699|P2|Overall Study|Failed to return|107
1419686|NCT01066819|4684700|P1|Overall Study|Failed to return|298
1419687|NCT01066819|4684695|P6|Overall Study|Early termination|0
1419688|NCT01066819|4684696|P5|Overall Study|Early termination|0
1419689|NCT01066819|4684697|P4|Overall Study|Early termination|0
1419690|NCT01066819|4684698|P3|Overall Study|Early termination|0
1419691|NCT01066819|4684699|P2|Overall Study|Early termination|0
1419692|NCT01066819|4684700|P1|Overall Study|Early termination|2
1419693|NCT01066819|4684695|P6|Overall Study|Not met inclusion/exclusion criteria|0
1419694|NCT01066819|4684696|P5|Overall Study|Not met inclusion/exclusion criteria|0
1419695|NCT01066819|4684697|P4|Overall Study|Not met inclusion/exclusion criteria|0
1419696|NCT01066819|4684698|P3|Overall Study|Not met inclusion/exclusion criteria|0
1419697|NCT01066819|4684699|P2|Overall Study|Not met inclusion/exclusion criteria|0
1419698|NCT01066819|4684700|P1|Overall Study|Not met inclusion/exclusion criteria|1
1419699|NCT01066819|4684695|P6|Overall Study|Administrative|0
1419700|NCT01066819|4684696|P5|Overall Study|Administrative|0
1419701|NCT01066819|4684697|P4|Overall Study|Administrative|0
1419702|NCT01066819|4684698|P3|Overall Study|Administrative|2
1419703|NCT01066819|4684699|P2|Overall Study|Administrative|4
1419704|NCT01066819|4684700|P1|Overall Study|Administrative|6
1419705|NCT01066819|4684695|P6|Overall Study|Withdrawal by Subject|0
1419706|NCT01066819|4684696|P5|Overall Study|Withdrawal by Subject|0
1419707|NCT01066819|4684697|P4|Overall Study|Withdrawal by Subject|0
1419708|NCT01066819|4684698|P3|Overall Study|Withdrawal by Subject|6
1419709|NCT01066819|4684699|P2|Overall Study|Withdrawal by Subject|11
1419710|NCT01066819|4684700|P1|Overall Study|Withdrawal by Subject|29
1419711|NCT01066819|4684695|P6|Overall Study|Protocol Violation|0
1419712|NCT01066819|4684696|P5|Overall Study|Protocol Violation|0
1419713|NCT01066819|4684697|P4|Overall Study|Protocol Violation|0
1419714|NCT01066819|4684698|P3|Overall Study|Protocol Violation|0
1419715|NCT01066819|4684699|P2|Overall Study|Protocol Violation|6
1419716|NCT01066819|4684700|P1|Overall Study|Protocol Violation|12
1419717|NCT01066819|4684695|P6|Overall Study|Physician Decision|0
1419718|NCT01066819|4684696|P5|Overall Study|Physician Decision|0
1419719|NCT01066819|4684697|P4|Overall Study|Physician Decision|0
1419720|NCT01066819|4684698|P3|Overall Study|Physician Decision|3
1419721|NCT01066819|4684699|P2|Overall Study|Physician Decision|2
1419722|NCT01066819|4684700|P1|Overall Study|Physician Decision|6
1419723|NCT01066819|4684695|P6|Overall Study|Lack of Efficacy|0
1419724|NCT01066819|4684696|P5|Overall Study|Lack of Efficacy|0
1419725|NCT01066819|4684697|P4|Overall Study|Lack of Efficacy|1
1419726|NCT01066819|4684698|P3|Overall Study|Lack of Efficacy|2
1419727|NCT01066819|4684699|P2|Overall Study|Lack of Efficacy|1
1419728|NCT01066819|4684700|P1|Overall Study|Lack of Efficacy|22
1419729|NCT01066819|4684695|P6|Overall Study|Death|0
1419730|NCT01066819|4684696|P5|Overall Study|Death|0
1419731|NCT01066819|4684697|P4|Overall Study|Death|0
1419732|NCT01066819|4684698|P3|Overall Study|Death|1
1419733|NCT01066819|4684699|P2|Overall Study|Death|0
1419734|NCT01066819|4684700|P1|Overall Study|Death|5
1419735|NCT01066819|4684695|P6|Overall Study|Adverse Event|0
1419736|NCT01066819|4684696|P5|Overall Study|Adverse Event|0
1419737|NCT01066819|4684697|P4|Overall Study|Adverse Event|0
1419738|NCT01066819|4684698|P3|Overall Study|Adverse Event|6
1419739|NCT01066819|4684699|P2|Overall Study|Adverse Event|1
1419740|NCT01066819|4684700|P1|Overall Study|Adverse Event|18
1419741|NCT01066793|4684841|P6|Overall Study|Treatment Stopped|0
1419742|NCT01066793|4684842|P5|Overall Study|Treatment Stopped|0
1419743|NCT01066793|4684843|P4|Overall Study|Treatment Stopped|1
1419744|NCT01066793|4684844|P3|Overall Study|Treatment Stopped|0
1419745|NCT01066793|4684845|P2|Overall Study|Treatment Stopped|1
1419746|NCT01066793|4684846|P1|Overall Study|Treatment Stopped|2
1419747|NCT01066793|4684841|P6|Overall Study|Treatment Never Started|0
1419748|NCT01066793|4684842|P5|Overall Study|Treatment Never Started|0
1419749|NCT01066793|4684843|P4|Overall Study|Treatment Never Started|1
1419750|NCT01066793|4684844|P3|Overall Study|Treatment Never Started|4
1419751|NCT01066793|4684845|P2|Overall Study|Treatment Never Started|5
1419752|NCT01066793|4684846|P1|Overall Study|Treatment Never Started|18
1419753|NCT01066793|4684841|P6|Overall Study|Treatment Interrupted|0
1419754|NCT01066793|4684842|P5|Overall Study|Treatment Interrupted|0
1419755|NCT01066793|4684843|P4|Overall Study|Treatment Interrupted|0
1419756|NCT01066793|4684844|P3|Overall Study|Treatment Interrupted|0
1419757|NCT01066793|4684845|P2|Overall Study|Treatment Interrupted|1
1419758|NCT01066793|4684846|P1|Overall Study|Treatment Interrupted|1
1419759|NCT01066793|4684841|P6|Overall Study|Result Not Available|0
1419760|NCT01066793|4684842|P5|Overall Study|Result Not Available|0
1419761|NCT01066793|4684843|P4|Overall Study|Result Not Available|0
1419762|NCT01066793|4684844|P3|Overall Study|Result Not Available|0
1419763|NCT01066793|4684845|P2|Overall Study|Result Not Available|0
1419764|NCT01066793|4684846|P1|Overall Study|Result Not Available|1
1419765|NCT01066793|4684841|P6|Overall Study|Relapse|0
1419766|NCT01066793|4684842|P5|Overall Study|Relapse|0
1419767|NCT01066793|4684843|P4|Overall Study|Relapse|3
1419768|NCT01066793|4684844|P3|Overall Study|Relapse|2
1419769|NCT01066793|4684845|P2|Overall Study|Relapse|8
1419770|NCT01066793|4684846|P1|Overall Study|Relapse|20
1419771|NCT01066793|4684841|P6|Overall Study|Other|0
1419772|NCT01066793|4684842|P5|Overall Study|Other|0
1419773|NCT01066793|4684843|P4|Overall Study|Other|2
1419774|NCT01066793|4684844|P3|Overall Study|Other|6
1419775|NCT01066793|4684845|P2|Overall Study|Other|5
1419776|NCT01066793|4684846|P1|Overall Study|Other|15
1419777|NCT01066793|4684841|P6|Overall Study|Non-responders|0
1419778|NCT01066793|4684842|P5|Overall Study|Non-responders|0
1419779|NCT01066793|4684843|P4|Overall Study|Non-responders|25
1419780|NCT01066793|4684844|P3|Overall Study|Non-responders|11
1419781|NCT01066793|4684845|P2|Overall Study|Non-responders|5
1419782|NCT01066793|4684846|P1|Overall Study|Non-responders|104
1419783|NCT01066793|4684841|P6|Overall Study|Miscellaneous|0
1419784|NCT01066793|4684842|P5|Overall Study|Miscellaneous|0
1419785|NCT01066793|4684843|P4|Overall Study|Miscellaneous|0
1419786|NCT01066793|4684844|P3|Overall Study|Miscellaneous|6
1419787|NCT01066793|4684845|P2|Overall Study|Miscellaneous|5
1419788|NCT01066793|4684846|P1|Overall Study|Miscellaneous|4
1419789|NCT01066793|4684841|P6|Overall Study|Lab test not done|0
1419790|NCT01066793|4684842|P5|Overall Study|Lab test not done|0
1419791|NCT01066793|4684843|P4|Overall Study|Lab test not done|1
1419792|NCT01066793|4684844|P3|Overall Study|Lab test not done|0
1419793|NCT01066793|4684845|P2|Overall Study|Lab test not done|0
1419794|NCT01066793|4684846|P1|Overall Study|Lab test not done|7
1419795|NCT01066793|4684841|P6|Overall Study|Early Termination|0
1419796|NCT01066793|4684842|P5|Overall Study|Early Termination|0
1419797|NCT01066793|4684843|P4|Overall Study|Early Termination|0
1419798|NCT01066793|4684844|P3|Overall Study|Early Termination|0
1419799|NCT01066793|4684845|P2|Overall Study|Early Termination|0
1419800|NCT01066793|4684846|P1|Overall Study|Early Termination|3
1419801|NCT01066793|4684841|P6|Overall Study|Withdrawal by Subject|0
1419802|NCT01066793|4684842|P5|Overall Study|Withdrawal by Subject|0
1419803|NCT01066793|4684843|P4|Overall Study|Withdrawal by Subject|0
1419804|NCT01066793|4684844|P3|Overall Study|Withdrawal by Subject|1
1419805|NCT01066793|4684845|P2|Overall Study|Withdrawal by Subject|4
1419806|NCT01066793|4684846|P1|Overall Study|Withdrawal by Subject|7
1419807|NCT01066793|4684841|P6|Overall Study|Protocol Violation|0
1419808|NCT01066793|4684842|P5|Overall Study|Protocol Violation|0
1419809|NCT01066793|4684843|P4|Overall Study|Protocol Violation|0
1419810|NCT01066793|4684844|P3|Overall Study|Protocol Violation|2
1419811|NCT01066793|4684845|P2|Overall Study|Protocol Violation|2
1419812|NCT01066793|4684846|P1|Overall Study|Protocol Violation|3
1419813|NCT01066793|4684841|P6|Overall Study|Physician Decision|0
1419814|NCT01066793|4684842|P5|Overall Study|Physician Decision|0
1419815|NCT01066793|4684843|P4|Overall Study|Physician Decision|0
1419816|NCT01066793|4684844|P3|Overall Study|Physician Decision|0
1419817|NCT01066793|4684845|P2|Overall Study|Physician Decision|0
1419818|NCT01066793|4684846|P1|Overall Study|Physician Decision|3
1419819|NCT01066793|4684841|P6|Overall Study|Lost to Follow-up|1
1419820|NCT01066793|4684842|P5|Overall Study|Lost to Follow-up|0
1419821|NCT01066793|4684843|P4|Overall Study|Lost to Follow-up|16
1419822|NCT01066793|4684844|P3|Overall Study|Lost to Follow-up|82
1419823|NCT01066793|4684845|P2|Overall Study|Lost to Follow-up|39
1419824|NCT01066793|4684846|P1|Overall Study|Lost to Follow-up|180
1419825|NCT01066793|4684841|P6|Overall Study|Lack of Efficacy|0
1419826|NCT01066793|4684842|P5|Overall Study|Lack of Efficacy|0
1419827|NCT01066793|4684843|P4|Overall Study|Lack of Efficacy|0
1419828|NCT01066793|4684844|P3|Overall Study|Lack of Efficacy|0
1419829|NCT01066793|4684845|P2|Overall Study|Lack of Efficacy|1
1419830|NCT01066793|4684846|P1|Overall Study|Lack of Efficacy|2
1419831|NCT01066793|4684841|P6|Overall Study|Death|0
1419832|NCT01066793|4684842|P5|Overall Study|Death|0
1419833|NCT01066793|4684843|P4|Overall Study|Death|0
1419834|NCT01066793|4684844|P3|Overall Study|Death|1
1419835|NCT01066793|4684845|P2|Overall Study|Death|1
1419836|NCT01066793|4684846|P1|Overall Study|Death|4
1419837|NCT01066780|4684986|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
1419838|NCT01066780|4684987|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
1419839|NCT01066585|4685006|P2|Overall Study|Withdrawal by Subject|3
1419840|NCT01066585|4685007|P1|Overall Study|Withdrawal by Subject|0
1419841|NCT01066585|4685006|P2|Overall Study|Protocol Violation|0
1419842|NCT01066585|4685007|P1|Overall Study|Protocol Violation|1
1419843|NCT01066546|4685019|P1|Overall Study|Study terminated by sponsor|5
1419844|NCT01066156|4685049|P1|Overall Study|Withdrawal by Subject|1
1419845|NCT01066156|4685049|P1|Overall Study|Lost to Follow-up|7
1419846|NCT01066156|4685049|P1|Overall Study|ineligible|2
1419847|NCT01066143|4685053|P1|Overall Study|ineligible for the study|8
1419848|NCT01066104|4685059|P2|Overall Study|Protocol Violation|0
1419849|NCT01066104|4685060|P1|Overall Study|Protocol Violation|1
1419850|NCT01066104|4685059|P2|Overall Study|Adverse Event|1
1419851|NCT01066104|4685060|P1|Overall Study|Adverse Event|1
1419852|NCT01066039|4685068|P1|Overall Study|Drug/Dose Adjustment Required|1
1419853|NCT01066039|4685068|P1|Overall Study|Failure to Control Blood Pressure|1
1419854|NCT01066039|4685068|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
1419855|NCT01066039|4685068|P1|Overall Study|Additional Antihypertensive Required|4
1419856|NCT01066039|4685068|P1|Overall Study|Dropout due to Insulin Administration|1
1419857|NCT01066039|4685068|P1|Overall Study|Investigator’s Request|1
1419858|NCT01066039|4685068|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
1419859|NCT01066039|4685068|P1|Overall Study|Protocol Violation|2
1419860|NCT01066039|4685068|P1|Overall Study|Withdrawal by Subject|17
1419861|NCT01066039|4685068|P1|Overall Study|Adverse Event|6
1419862|NCT01066000|4685081|P1|Overall Study|Adverse Event|1
1419863|NCT01066000|4685081|P1|Overall Study|Withdrawal by Subject|1
1419864|NCT01066000|4685081|P1|Overall Study|Death|3
1419865|NCT01066000|4685081|P1|Overall Study|Protocol Violation|4
1419866|NCT01065844|4685092|P1|Overall Study|Adverse Event|5
1419867|NCT01065818|4685096|P1|Overall Study|Not a candidate for surgery|1
1419868|NCT01065818|4685096|P1|Overall Study|Withdrawal by Subject|1
1419869|NCT01065779|4685100|P1|Overall Study|Inclusion Criteria Violation|7
1419870|NCT01065779|4685100|P1|Overall Study|Failed to Follow-up|10
1419871|NCT01065779|4685100|P1|Overall Study|Not Administered With Study Drug|17
1419872|NCT01065779|4685100|P1|Overall Study|Non-enrollment Period Administration|10
1419873|NCT01065779|4685100|P1|Overall Study|Investigation Before Contract Date|37
1419874|NCT01065779|4685100|P1|Overall Study|Duplicate Investigation|1
1419875|NCT01065766|4685111|P1|Overall Study|Violated dosage/administration|25
1419876|NCT01065766|4685111|P1|Overall Study|Contraindication to administration|6
1419877|NCT01065766|4685111|P1|Overall Study|Assessed before the contracted date|1
1419878|NCT01065597|4685130|P1|Overall Study|Adverse Event|1
1419879|NCT01065454|4685164|P4|Follow up|study ongoing|41
1419880|NCT01065454|4685165|P3|Follow up|study ongoing|15
1419881|NCT01065454|4685166|P2|Follow up|study ongoing|22
1419882|NCT01065454|4685167|P1|Follow up|study ongoing|37
1419883|NCT01065454|4685164|P4|Follow up|Withdrawal by Subject|0
1419884|NCT01065454|4685165|P3|Follow up|Withdrawal by Subject|1
1419885|NCT01065454|4685166|P2|Follow up|Withdrawal by Subject|1
1419886|NCT01065454|4685167|P1|Follow up|Withdrawal by Subject|1
1419887|NCT01065454|4685164|P4|Follow up|Progressive disease|1
1419888|NCT01065454|4685165|P3|Follow up|Progressive disease|0
1419889|NCT01065454|4685166|P2|Follow up|Progressive disease|0
1419890|NCT01065454|4685167|P1|Follow up|Progressive disease|0
1419891|NCT01065454|4685164|P4|Follow up|Lost to Follow-up|1
1419892|NCT01065454|4685165|P3|Follow up|Lost to Follow-up|0
1419893|NCT01065454|4685166|P2|Follow up|Lost to Follow-up|0
1419894|NCT01065454|4685167|P1|Follow up|Lost to Follow-up|0
1419895|NCT01065454|4685164|P4|Follow up|Death|0
1419896|NCT01065454|4685165|P3|Follow up|Death|1
1419897|NCT01065454|4685166|P2|Follow up|Death|1
1419898|NCT01065454|4685167|P1|Follow up|Death|0
1419899|NCT01065454|4685164|P4|Follow up|Adverse Event|1
1419900|NCT01065454|4685165|P3|Follow up|Adverse Event|0
1419901|NCT01065454|4685166|P2|Follow up|Adverse Event|0
1419902|NCT01065454|4685167|P1|Follow up|Adverse Event|1
1419903|NCT01065454|4685164|P4|Treatment|Withdrawal by Subject|3
1419904|NCT01065454|4685165|P3|Treatment|Withdrawal by Subject|2
1419905|NCT01065454|4685166|P2|Treatment|Withdrawal by Subject|1
1419906|NCT01065454|4685167|P1|Treatment|Withdrawal by Subject|3
1419907|NCT01065454|4685164|P4|Treatment|Protocol Violation|0
1419908|NCT01065454|4685165|P3|Treatment|Protocol Violation|1
1419909|NCT01065454|4685166|P2|Treatment|Protocol Violation|0
1419910|NCT01065454|4685167|P1|Treatment|Protocol Violation|1
1419911|NCT01065454|4685164|P4|Treatment|Protocol Decision|2
1419912|NCT01065454|4685165|P3|Treatment|Protocol Decision|3
1419913|NCT01065454|4685166|P2|Treatment|Protocol Decision|0
1419914|NCT01065454|4685167|P1|Treatment|Protocol Decision|0
1419915|NCT01065454|4685164|P4|Treatment|Non-compliance|1
1419916|NCT01065454|4685165|P3|Treatment|Non-compliance|0
1419917|NCT01065454|4685166|P2|Treatment|Non-compliance|0
1419918|NCT01065454|4685167|P1|Treatment|Non-compliance|1
1419919|NCT01065454|4685164|P4|Treatment|Death|0
1419920|NCT01065454|4685165|P3|Treatment|Death|0
1419921|NCT01065454|4685166|P2|Treatment|Death|0
1419922|NCT01065454|4685167|P1|Treatment|Death|1
1419923|NCT01065454|4685164|P4|Treatment|Adverse Event|6
1419924|NCT01065454|4685165|P3|Treatment|Adverse Event|3
1419925|NCT01065454|4685166|P2|Treatment|Adverse Event|4
1419926|NCT01065454|4685167|P1|Treatment|Adverse Event|7
1419927|NCT01065350|4685290|P2|Overall Study|Received incorrect drug allocation|1
1419928|NCT01065350|4685291|P1|Overall Study|Received incorrect drug allocation|0
1419929|NCT01064947|4685352|P1|Overall Study|negative culture|41
1419930|NCT01064856|4685393|P4|Open-label (OL) Period|Not specified|7
1419931|NCT01064856|4685394|P3|Open-label (OL) Period|Not specified|7
1419932|NCT01064856|4685395|P2|Open-label (OL) Period|Not specified|0
1419933|NCT01064856|4685396|P1|Open-label (OL) Period|Not specified|0
1419934|NCT01064856|4685393|P4|Open-label (OL) Period|Lost to Follow-up|1
1419935|NCT01064856|4685394|P3|Open-label (OL) Period|Lost to Follow-up|2
1419936|NCT01064856|4685395|P2|Open-label (OL) Period|Lost to Follow-up|0
1419937|NCT01064856|4685396|P1|Open-label (OL) Period|Lost to Follow-up|0
1419938|NCT01064856|4685393|P4|Open-label (OL) Period|Consent withdrawn by participant|6
1419939|NCT01064856|4685394|P3|Open-label (OL) Period|Consent withdrawn by participant|5
1419940|NCT01064856|4685395|P2|Open-label (OL) Period|Consent withdrawn by participant|0
1419941|NCT01064856|4685396|P1|Open-label (OL) Period|Consent withdrawn by participant|0
1419942|NCT01064856|4685393|P4|Open-label (OL) Period|Adverse Event|6
1419943|NCT01064856|4685394|P3|Open-label (OL) Period|Adverse Event|12
1419944|NCT01064856|4685395|P2|Open-label (OL) Period|Adverse Event|0
1419945|NCT01064856|4685396|P1|Open-label (OL) Period|Adverse Event|0
1419946|NCT01064856|4685393|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
1419947|NCT01064856|4685394|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
1419948|NCT01064856|4685395|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
1419949|NCT01064856|4685396|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
1419950|NCT01064856|4685393|P4|Double-blind (DB) Period|Adverse Event|0
1419951|NCT01064856|4685394|P3|Double-blind (DB) Period|Adverse Event|0
1419952|NCT01064856|4685395|P2|Double-blind (DB) Period|Adverse Event|0
1419953|NCT01064856|4685396|P1|Double-blind (DB) Period|Adverse Event|1
1419954|NCT01064817|4685440|P2|Study Completion|Withdrawal by Subject|0
1419955|NCT01064817|4685441|P1|Study Completion|Withdrawal by Subject|1
1419956|NCT01064817|4685440|P2|Study Completion|Physician Decision|0
1419957|NCT01064817|4685441|P1|Study Completion|Physician Decision|1
1419958|NCT01064739|4685453|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
1419959|NCT01064687|4685524|P4|Overall Study|Treatment Noncompliance|0
1419960|NCT01064687|4685525|P3|Overall Study|Treatment Noncompliance|1
1419961|NCT01064687|4685526|P2|Overall Study|Treatment Noncompliance|1
1419962|NCT01064687|4685527|P1|Overall Study|Treatment Noncompliance|1
1419963|NCT01064687|4685524|P4|Overall Study|Withdrawal by Subject|5
1419964|NCT01064687|4685525|P3|Overall Study|Withdrawal by Subject|12
1419965|NCT01064687|4685526|P2|Overall Study|Withdrawal by Subject|7
1419966|NCT01064687|4685527|P1|Overall Study|Withdrawal by Subject|9
1419967|NCT01064687|4685524|P4|Overall Study|Sponsor Decision|0
1419968|NCT01064687|4685525|P3|Overall Study|Sponsor Decision|3
1419969|NCT01064687|4685526|P2|Overall Study|Sponsor Decision|0
1419970|NCT01064687|4685527|P1|Overall Study|Sponsor Decision|0
1419971|NCT01064687|4685524|P4|Overall Study|Protocol Violation|1
1419972|NCT01064687|4685525|P3|Overall Study|Protocol Violation|0
1419973|NCT01064687|4685526|P2|Overall Study|Protocol Violation|1
1419974|NCT01064687|4685527|P1|Overall Study|Protocol Violation|1
1419975|NCT01064687|4685524|P4|Overall Study|Physician Decision|0
1419976|NCT01064687|4685525|P3|Overall Study|Physician Decision|0
1419977|NCT01064687|4685526|P2|Overall Study|Physician Decision|2
1419978|NCT01064687|4685527|P1|Overall Study|Physician Decision|2
1419979|NCT01064687|4685524|P4|Overall Study|Lost to Follow-up|5
1419980|NCT01064687|4685525|P3|Overall Study|Lost to Follow-up|13
1419981|NCT01064687|4685526|P2|Overall Study|Lost to Follow-up|10
1419982|NCT01064687|4685527|P1|Overall Study|Lost to Follow-up|7
1419983|NCT01064687|4685524|P4|Overall Study|Lack of Efficacy|3
1419984|NCT01064687|4685525|P3|Overall Study|Lack of Efficacy|2
1419985|NCT01064687|4685526|P2|Overall Study|Lack of Efficacy|0
1419986|NCT01064687|4685527|P1|Overall Study|Lack of Efficacy|1
1419987|NCT01064687|4685524|P4|Overall Study|Entry Criteria Not Met|0
1419988|NCT01064687|4685525|P3|Overall Study|Entry Criteria Not Met|0
1419989|NCT01064687|4685526|P2|Overall Study|Entry Criteria Not Met|0
1419990|NCT01064687|4685527|P1|Overall Study|Entry Criteria Not Met|3
1419991|NCT01064687|4685524|P4|Overall Study|Death|0
1419992|NCT01064687|4685525|P3|Overall Study|Death|0
1419993|NCT01064687|4685526|P2|Overall Study|Death|1
1419994|NCT01064687|4685527|P1|Overall Study|Death|1
1419995|NCT01064687|4685524|P4|Overall Study|Adverse Event|3
1419996|NCT01064687|4685525|P3|Overall Study|Adverse Event|10
1419997|NCT01064687|4685526|P2|Overall Study|Adverse Event|4
1419998|NCT01064687|4685527|P1|Overall Study|Adverse Event|9
1419999|NCT01064622|4685707|P2|Randomized Phase II|Protocol Violation|1
1420000|NCT01064622|4685708|P1|Randomized Phase II|Protocol Violation|0
1420001|NCT01064622|4685707|P2|Randomized Phase II|Withdrawal by Subject|2
1420002|NCT01064622|4685708|P1|Randomized Phase II|Withdrawal by Subject|2
1420003|NCT01064414|4685732|P3|Extension Period: Week 26 to Week 52|Not specified|1
1420004|NCT01064414|4685733|P2|Extension Period: Week 26 to Week 52|Not specified|2
1420005|NCT01064414|4685734|P1|Extension Period: Week 26 to Week 52|Not specified|5
1420006|NCT01064414|4685732|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
1420007|NCT01064414|4685733|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
1420008|NCT01064414|4685734|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
1420009|NCT01064414|4685732|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
1420010|NCT01064414|4685733|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
1420011|NCT01064414|4685734|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
1420012|NCT01064414|4685732|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1420013|NCT01064414|4685733|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1420014|NCT01064414|4685734|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1420015|NCT01064414|4685732|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
1420016|NCT01064414|4685733|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
1420017|NCT01064414|4685734|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
1420018|NCT01064414|4685732|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1420019|NCT01064414|4685733|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1420020|NCT01064414|4685734|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
1420021|NCT01064414|4685732|P3|Extension Period: Week 26 to Week 52|Death|0
1420022|NCT01064414|4685733|P2|Extension Period: Week 26 to Week 52|Death|1
1420023|NCT01064414|4685734|P1|Extension Period: Week 26 to Week 52|Death|0
1420024|NCT01064414|4685732|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
1420025|NCT01064414|4685733|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
1420026|NCT01064414|4685734|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
1420027|NCT01064414|4685732|P3|Core Period: Baseline to Week 26|Not specified|2
1420028|NCT01064414|4685733|P2|Core Period: Baseline to Week 26|Not specified|7
1420029|NCT01064414|4685734|P1|Core Period: Baseline to Week 26|Not specified|4
1420030|NCT01064414|4685732|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1420031|NCT01064414|4685733|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
1420032|NCT01064414|4685734|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1420033|NCT01064414|4685732|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
1420034|NCT01064414|4685733|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
1420035|NCT01064414|4685734|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
1420036|NCT01064414|4685732|P3|Core Period: Baseline to Week 26|Protocol Violation|1
1420037|NCT01064414|4685733|P2|Core Period: Baseline to Week 26|Protocol Violation|0
1420038|NCT01064414|4685734|P1|Core Period: Baseline to Week 26|Protocol Violation|1
1420039|NCT01064414|4685732|P3|Core Period: Baseline to Week 26|Death|0
1420040|NCT01064414|4685733|P2|Core Period: Baseline to Week 26|Death|1
1420041|NCT01064414|4685734|P1|Core Period: Baseline to Week 26|Death|0
1420042|NCT01064414|4685732|P3|Core Period: Baseline to Week 26|Adverse Event|2
1420043|NCT01064414|4685733|P2|Core Period: Baseline to Week 26|Adverse Event|4
1420044|NCT01064414|4685734|P1|Core Period: Baseline to Week 26|Adverse Event|4
1420045|NCT01064401|4685753|P2|Overall Study|Not Specified|1
1420046|NCT01064401|4685754|P1|Overall Study|Not Specified|2
1420047|NCT01064401|4685753|P2|Overall Study|Site Closure|5
1420048|NCT01064401|4685754|P1|Overall Study|Site Closure|4
1420049|NCT01064401|4685753|P2|Overall Study|Noncompliance|8
1420050|NCT01064401|4685754|P1|Overall Study|Noncompliance|7
1420051|NCT01064401|4685753|P2|Overall Study|Pregnancy|7
1420052|NCT01064401|4685754|P1|Overall Study|Pregnancy|4
1420053|NCT01064401|4685753|P2|Overall Study|Death|0
1420054|NCT01064401|4685754|P1|Overall Study|Death|4
1420055|NCT01064401|4685753|P2|Overall Study|Investigator Decision|6
1420056|NCT01064401|4685754|P1|Overall Study|Investigator Decision|4
1420057|NCT01064401|4685753|P2|Overall Study|Consent Withdrawn|80
1420058|NCT01064401|4685754|P1|Overall Study|Consent Withdrawn|98
1420059|NCT01064401|4685753|P2|Overall Study|Lost to Follow-up|9
1420060|NCT01064401|4685754|P1|Overall Study|Lost to Follow-up|12
1420061|NCT01064401|4685753|P2|Overall Study|Lack of Efficacy|23
1420062|NCT01064401|4685754|P1|Overall Study|Lack of Efficacy|46
1420063|NCT01064401|4685753|P2|Overall Study|Adverse Event|56
1420064|NCT01064401|4685754|P1|Overall Study|Adverse Event|47
1420065|NCT01064310|4685803|P3|Open Label Pazopinib|Physician Decision|20
1420066|NCT01064310|4685804|P2|Open Label Pazopinib|Physician Decision|0
1420067|NCT01064310|4685805|P1|Open Label Pazopinib|Physician Decision|0
1420068|NCT01064310|4685803|P3|Open Label Pazopinib|Lack of Efficacy|51
1420069|NCT01064310|4685804|P2|Open Label Pazopinib|Lack of Efficacy|0
1420070|NCT01064310|4685805|P1|Open Label Pazopinib|Lack of Efficacy|0
1420071|NCT01064310|4685803|P3|Open Label Pazopinib|Adverse Event|12
1420072|NCT01064310|4685804|P2|Open Label Pazopinib|Adverse Event|0
1420073|NCT01064310|4685805|P1|Open Label Pazopinib|Adverse Event|0
1420074|NCT01064310|4685803|P3|Open Label Pazopinib|Withdrawal by Subject|1
1420075|NCT01064310|4685804|P2|Open Label Pazopinib|Withdrawal by Subject|0
1420076|NCT01064310|4685805|P1|Open Label Pazopinib|Withdrawal by Subject|0
1420077|NCT01064310|4685803|P3|Period 2|Lack of Efficacy|0
1420078|NCT01064310|4685804|P2|Period 2|Lack of Efficacy|4
1420079|NCT01064310|4685805|P1|Period 2|Lack of Efficacy|1
1420080|NCT01064310|4685803|P3|Period 2|Entered Open-label Period|0
1420081|NCT01064310|4685804|P2|Period 2|Entered Open-label Period|0
1420082|NCT01064310|4685805|P1|Period 2|Entered Open-label Period|1
1420083|NCT01064310|4685803|P3|Period 2|Physician Decision|0
1420084|NCT01064310|4685804|P2|Period 2|Physician Decision|1
1420085|NCT01064310|4685805|P1|Period 2|Physician Decision|0
1420086|NCT01064310|4685803|P3|Period 2|Adverse Event|0
1420087|NCT01064310|4685804|P2|Period 2|Adverse Event|1
1420088|NCT01064310|4685805|P1|Period 2|Adverse Event|2
1420089|NCT01064310|4685803|P3|Period 1|Entered Open-label Period|0
1420090|NCT01064310|4685804|P2|Period 1|Entered Open-label Period|1
1420091|NCT01064310|4685805|P1|Period 1|Entered Open-label Period|1
1420092|NCT01064310|4685803|P3|Period 1|Lack of Efficacy|0
1420093|NCT01064310|4685804|P2|Period 1|Lack of Efficacy|5
1420094|NCT01064310|4685805|P1|Period 1|Lack of Efficacy|3
1420095|NCT01064310|4685803|P3|Period 1|Withdrawal by Subject|0
1420096|NCT01064310|4685804|P2|Period 1|Withdrawal by Subject|2
1420097|NCT01064310|4685805|P1|Period 1|Withdrawal by Subject|2
1420098|NCT01064310|4685803|P3|Period 1|Physician Decision|0
1420099|NCT01064310|4685804|P2|Period 1|Physician Decision|0
1420100|NCT01064310|4685805|P1|Period 1|Physician Decision|1
1420101|NCT01064310|4685803|P3|Period 1|Adverse Event|0
1420102|NCT01064310|4685804|P2|Period 1|Adverse Event|10
1420103|NCT01064310|4685805|P1|Period 1|Adverse Event|7
1420104|NCT01064297|4685835|P3|Overall Study|Lost to Follow-up|133
1420105|NCT01064297|4685836|P2|Overall Study|Lost to Follow-up|48
1420106|NCT01064297|4685837|P1|Overall Study|Lost to Follow-up|791
1420107|NCT01064167|4685906|P2|Overall Study|Protocol Violation|15
1420108|NCT01064167|4685907|P1|Overall Study|Protocol Violation|14
1420109|NCT01063881|4685954|P3|Overall Study|Reason for not completed not specified|0
1420110|NCT01063881|4685955|P2|Overall Study|Reason for not completed not specified|1
1420111|NCT01063881|4685956|P1|Overall Study|Reason for not completed not specified|5
1420112|NCT01063881|4685954|P3|Overall Study|Withdrawal by Subject|0
1420113|NCT01063881|4685955|P2|Overall Study|Withdrawal by Subject|1
1420114|NCT01063881|4685956|P1|Overall Study|Withdrawal by Subject|25
1420115|NCT01063881|4685954|P3|Overall Study|Lost to Follow-up|1
1420116|NCT01063881|4685955|P2|Overall Study|Lost to Follow-up|7
1420117|NCT01063881|4685956|P1|Overall Study|Lost to Follow-up|13
1420118|NCT01063881|4685954|P3|Overall Study|Adverse Event|0
1420119|NCT01063881|4685955|P2|Overall Study|Adverse Event|2
1420120|NCT01063881|4685956|P1|Overall Study|Adverse Event|12
1420121|NCT01063868|4685980|P2|Overall Study|Study Terminated By Sponsor|4
1420122|NCT01063868|4685981|P1|Overall Study|Study Terminated By Sponsor|23
1420123|NCT01063868|4685980|P2|Overall Study|Withdrawal by Subject|1
1420124|NCT01063868|4685981|P1|Overall Study|Withdrawal by Subject|3
1420125|NCT01063868|4685980|P2|Overall Study|Adverse Event|7
1420126|NCT01063868|4685981|P1|Overall Study|Adverse Event|9
1420127|NCT01063855|4685989|P2|Overall Study|Reason not specified|11
1420128|NCT01063855|4685990|P1|Overall Study|Reason not specified|13
1420129|NCT01063855|4685989|P2|Overall Study|Withdrawal by Subject|8
1420130|NCT01063855|4685990|P1|Overall Study|Withdrawal by Subject|11
1420131|NCT01063855|4685989|P2|Overall Study|Lack of Efficacy|1
1420132|NCT01063855|4685990|P1|Overall Study|Lack of Efficacy|0
1420133|NCT01063855|4685989|P2|Overall Study|Pregnancy|0
1420134|NCT01063855|4685990|P1|Overall Study|Pregnancy|1
1420135|NCT01063855|4685989|P2|Overall Study|Lost to Follow-up|4
1420136|NCT01063855|4685990|P1|Overall Study|Lost to Follow-up|8
1420137|NCT01063855|4685989|P2|Overall Study|Death|1
1420138|NCT01063855|4685990|P1|Overall Study|Death|0
1420139|NCT01063855|4685989|P2|Overall Study|Adverse Event|4
1420140|NCT01063855|4685990|P1|Overall Study|Adverse Event|4
1420141|NCT01063764|4686037|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
1420142|NCT01063764|4686037|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
1420143|NCT01063764|4686037|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
1420144|NCT01063764|4686037|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
1420145|NCT01063764|4686037|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
1420146|NCT01063764|4686037|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
1420147|NCT01063764|4686037|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
1420148|NCT01063595|4686056|P2|First Intervention|Reason not Specified|1
1420149|NCT01063595|4686057|P1|First Intervention|Reason not Specified|0
1420150|NCT01063595|4686056|P2|First Intervention|Withdrawal by Subject|0
1420151|NCT01063595|4686057|P1|First Intervention|Withdrawal by Subject|1
1420152|NCT01063595|4686056|P2|First Intervention|Adverse Event|4
1420153|NCT01063595|4686057|P1|First Intervention|Adverse Event|1
1420154|NCT01063595|4686056|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
1420155|NCT01063595|4686057|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
1420156|NCT01063595|4686056|P2|Enrolled in Study and Randomized|Adverse Event|1
1420157|NCT01063595|4686057|P1|Enrolled in Study and Randomized|Adverse Event|0
1420158|NCT01063595|4686056|P2|Enrolled in Study and Randomized|Reason not Specified|0
1420159|NCT01063595|4686057|P1|Enrolled in Study and Randomized|Reason not Specified|1
1420160|NCT01063517|4686069|P2|Overall Study|Death|48
1420161|NCT01063517|4686070|P1|Overall Study|Death|33
1420162|NCT01063517|4686069|P2|Overall Study|Withdrawal by Subject|2
1420163|NCT01063517|4686070|P1|Overall Study|Withdrawal by Subject|1
1420164|NCT01063517|4686069|P2|Overall Study|Lost to Follow-up|3
1420165|NCT01063517|4686070|P1|Overall Study|Lost to Follow-up|4
1420166|NCT01063517|4686069|P2|Overall Study|Study reached data cut-off|7
1420167|NCT01063517|4686070|P1|Overall Study|Study reached data cut-off|19
1420168|NCT01063517|4686069|P2|Overall Study|Consent withdrawal|0
1420169|NCT01063517|4686070|P1|Overall Study|Consent withdrawal|1
1420170|NCT01063348|4686110|P2|Overall Study|Lost to Follow-up|10
1420171|NCT01063348|4686111|P1|Overall Study|Lost to Follow-up|3
1420172|NCT01063153|4686121|P2|Overall Study|Physician Decision|4
1420173|NCT01063153|4686122|P1|Overall Study|Physician Decision|0
1420174|NCT01063153|4686121|P2|Overall Study|Withdrawal by Subject|1
1420175|NCT01063153|4686122|P1|Overall Study|Withdrawal by Subject|0
1420176|NCT01063153|4686121|P2|Overall Study|Lost to Follow-up|7
1420177|NCT01063153|4686122|P1|Overall Study|Lost to Follow-up|0
1420178|NCT01063153|4686121|P2|Overall Study|Found Ineligible During Screening|0
1420179|NCT01063153|4686122|P1|Overall Study|Found Ineligible During Screening|2
1420180|NCT01063062|4686153|P2|Overall Study|Miscellaneous reason|1
1420181|NCT01063062|4686154|P1|Overall Study|Miscellaneous reason|0
1420182|NCT01063062|4686153|P2|Overall Study|Lost to Follow-up|2
1420183|NCT01063062|4686154|P1|Overall Study|Lost to Follow-up|0
1420184|NCT01063062|4686153|P2|Overall Study|Investigator's request|0
1420185|NCT01063062|4686154|P1|Overall Study|Investigator's request|1
1420186|NCT01063062|4686153|P2|Overall Study|Protocol Violation|4
1420187|NCT01063062|4686154|P1|Overall Study|Protocol Violation|5
1420188|NCT01063062|4686153|P2|Overall Study|Adverse Event|4
1420189|NCT01063062|4686154|P1|Overall Study|Adverse Event|2
1420190|NCT01063062|4686153|P2|Overall Study|Patient withdrew consent|1
1420191|NCT01063062|4686154|P1|Overall Study|Patient withdrew consent|0
1420192|NCT01063036|4686208|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
1420193|NCT01063036|4686208|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
1420194|NCT01063036|4686208|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
1420195|NCT01063036|4686208|P1|Participants Treated With Study Drug|Pregnancy|1
1420196|NCT01063036|4686208|P1|Participants Treated With Study Drug|Lost to Follow-up|1
1420197|NCT01063036|4686208|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
1420198|NCT01063036|4686208|P1|Participants Treated With Study Drug|Protocol Violation|1
1420199|NCT01063036|4686208|P1|Participants Treated With Study Drug|Adverse Event|1
1420200|NCT01062841|4686224|P2|Overall Study|Withdrawal by Study|0
1420201|NCT01062841|4686225|P1|Overall Study|Withdrawal by Study|3
1420202|NCT01062841|4686224|P2|Overall Study|Withdrawal by Subject|0
1420203|NCT01062841|4686225|P1|Overall Study|Withdrawal by Subject|2
1420204|NCT01062841|4686224|P2|Overall Study|Death|5
1420205|NCT01062841|4686225|P1|Overall Study|Death|3
1420206|NCT01062841|4686224|P2|Overall Study|Indwelling Device Removed|48
1420207|NCT01062841|4686225|P1|Overall Study|Indwelling Device Removed|41
1420208|NCT01062763|4686255|P2|Overall Study|Adverse Event|4
1420209|NCT01062763|4686256|P1|Overall Study|Adverse Event|3
1420210|NCT01062425|4686268|P2|Overall Study|Protocol Violation|6
1420211|NCT01062425|4686269|P1|Overall Study|Protocol Violation|3
1420212|NCT01062399|4686286|P5|Overall Study|Protocol Violation|4
1420213|NCT01062399|4686287|P4|Overall Study|Protocol Violation|6
1420214|NCT01062399|4686288|P3|Overall Study|Protocol Violation|0
1420215|NCT01062399|4686289|P2|Overall Study|Protocol Violation|1
1420216|NCT01062399|4686290|P1|Overall Study|Protocol Violation|0
1420217|NCT01062256|4686334|P3|Overall Study|Administrative|0
1420218|NCT01062256|4686335|P2|Overall Study|Administrative|2
1420219|NCT01062256|4686336|P1|Overall Study|Administrative|0
1420220|NCT01062256|4686334|P3|Overall Study|Ineligible|3
1420221|NCT01062256|4686335|P2|Overall Study|Ineligible|4
1420222|NCT01062256|4686336|P1|Overall Study|Ineligible|1
1420223|NCT01062256|4686334|P3|Overall Study|Withdrawal by Subject|1
1420224|NCT01062256|4686335|P2|Overall Study|Withdrawal by Subject|1
1420225|NCT01062256|4686336|P1|Overall Study|Withdrawal by Subject|1
1420226|NCT01062256|4686334|P3|Overall Study|Adverse Event|0
1420227|NCT01062256|4686335|P2|Overall Study|Adverse Event|0
1420228|NCT01062256|4686336|P1|Overall Study|Adverse Event|1
1420229|NCT01062113|4686370|P3|Overall Study|Withdrawal by Subject|0
1420230|NCT01062113|4686371|P2|Overall Study|Withdrawal by Subject|0
1420231|NCT01062113|4686372|P1|Overall Study|Withdrawal by Subject|1
1420232|NCT01062113|4686370|P3|Overall Study|Lack of Efficacy|31
1420233|NCT01062113|4686371|P2|Overall Study|Lack of Efficacy|22
1420234|NCT01062113|4686372|P1|Overall Study|Lack of Efficacy|38
1420235|NCT01062113|4686370|P3|Overall Study|Adverse Event|0
1420236|NCT01062113|4686371|P2|Overall Study|Adverse Event|0
1420237|NCT01062113|4686372|P1|Overall Study|Adverse Event|1
1420238|NCT01062061|4686390|P1|Overall Study|Failed to meet inclusion criteria|2
1420239|NCT01062061|4686390|P1|Overall Study|Outside chief indications|10
1420240|NCT01062061|4686390|P1|Overall Study|Investigated before study start|13
1420241|NCT01062061|4686390|P1|Overall Study|Enrolled more than once|2
1420242|NCT01061866|4686404|P1|Overall Study|Adverse Event|2
1420243|NCT01061775|4686408|P1|Overall Study|Lost to Follow-up|1
1420244|NCT01061775|4686408|P1|Overall Study|Physician Decision|2
1420245|NCT01061736|4686425|P10|Overall Study|Other than specified above|21
1420246|NCT01061736|4686426|P9|Overall Study|Other than specified above|15
1420247|NCT01061736|4686427|P8|Overall Study|Other than specified above|18
1420248|NCT01061736|4686428|P7|Overall Study|Other than specified above|0
1420249|NCT01061736|4686429|P6|Overall Study|Other than specified above|0
1420250|NCT01061736|4686430|P5|Overall Study|Other than specified above|1
1420251|NCT01061736|4686431|P4|Overall Study|Other than specified above|0
1420252|NCT01061736|4686432|P3|Overall Study|Other than specified above|2
1420253|NCT01061736|4686433|P2|Overall Study|Other than specified above|1
1420254|NCT01061736|4686434|P1|Overall Study|Other than specified above|0
1420255|NCT01061736|4686425|P10|Overall Study|Not treated|0
1420256|NCT01061736|4686426|P9|Overall Study|Not treated|1
1420257|NCT01061736|4686427|P8|Overall Study|Not treated|2
1420258|NCT01061736|4686428|P7|Overall Study|Not treated|0
1420259|NCT01061736|4686429|P6|Overall Study|Not treated|0
1420260|NCT01061736|4686430|P5|Overall Study|Not treated|1
1420261|NCT01061736|4686431|P4|Overall Study|Not treated|0
1420262|NCT01061736|4686432|P3|Overall Study|Not treated|0
1420263|NCT01061736|4686433|P2|Overall Study|Not treated|0
1420264|NCT01061736|4686434|P1|Overall Study|Not treated|0
1420265|NCT01061736|4686425|P10|Overall Study|Poor compliance to protocol|9
1420266|NCT01061736|4686426|P9|Overall Study|Poor compliance to protocol|5
1420267|NCT01061736|4686427|P8|Overall Study|Poor compliance to protocol|2
1420268|NCT01061736|4686428|P7|Overall Study|Poor compliance to protocol|0
1420269|NCT01061736|4686429|P6|Overall Study|Poor compliance to protocol|0
1420270|NCT01061736|4686430|P5|Overall Study|Poor compliance to protocol|0
1420271|NCT01061736|4686431|P4|Overall Study|Poor compliance to protocol|0
1420272|NCT01061736|4686432|P3|Overall Study|Poor compliance to protocol|0
1420273|NCT01061736|4686433|P2|Overall Study|Poor compliance to protocol|0
1420274|NCT01061736|4686434|P1|Overall Study|Poor compliance to protocol|0
1420275|NCT01061736|4686425|P10|Overall Study|Lack of Efficacy|10
1420276|NCT01061736|4686426|P9|Overall Study|Lack of Efficacy|9
1420277|NCT01061736|4686427|P8|Overall Study|Lack of Efficacy|9
1420278|NCT01061736|4686428|P7|Overall Study|Lack of Efficacy|1
1420279|NCT01061736|4686429|P6|Overall Study|Lack of Efficacy|2
1420280|NCT01061736|4686430|P5|Overall Study|Lack of Efficacy|1
1420281|NCT01061736|4686431|P4|Overall Study|Lack of Efficacy|1
1420282|NCT01061736|4686432|P3|Overall Study|Lack of Efficacy|1
1420283|NCT01061736|4686433|P2|Overall Study|Lack of Efficacy|2
1420284|NCT01061736|4686434|P1|Overall Study|Lack of Efficacy|0
1420285|NCT01061736|4686425|P10|Overall Study|Adverse Event|34
1420286|NCT01061736|4686426|P9|Overall Study|Adverse Event|67
1420287|NCT01061736|4686427|P8|Overall Study|Adverse Event|63
1420288|NCT01061736|4686428|P7|Overall Study|Adverse Event|4
1420289|NCT01061736|4686429|P6|Overall Study|Adverse Event|1
1420290|NCT01061736|4686430|P5|Overall Study|Adverse Event|4
1420291|NCT01061736|4686431|P4|Overall Study|Adverse Event|2
1420292|NCT01061736|4686432|P3|Overall Study|Adverse Event|3
1420293|NCT01061736|4686433|P2|Overall Study|Adverse Event|1
1420294|NCT01061736|4686434|P1|Overall Study|Adverse Event|13
1420295|NCT01061736|4686425|P10|Overall Study|Dose regimen not selected|0
1420296|NCT01061736|4686426|P9|Overall Study|Dose regimen not selected|0
1420297|NCT01061736|4686427|P8|Overall Study|Dose regimen not selected|0
1420298|NCT01061736|4686428|P7|Overall Study|Dose regimen not selected|79
1420299|NCT01061736|4686429|P6|Overall Study|Dose regimen not selected|0
1420300|NCT01061736|4686430|P5|Overall Study|Dose regimen not selected|0
1420301|NCT01061736|4686431|P4|Overall Study|Dose regimen not selected|0
1420302|NCT01061736|4686432|P3|Overall Study|Dose regimen not selected|0
1420303|NCT01061736|4686433|P2|Overall Study|Dose regimen not selected|0
1420304|NCT01061736|4686434|P1|Overall Study|Dose regimen not selected|0
1420305|NCT01061723|4686473|P6|Overall Study|Other than specified above|1
1420306|NCT01061723|4686474|P5|Overall Study|Other than specified above|0
1420307|NCT01061723|4686475|P4|Overall Study|Other than specified above|1
1420308|NCT01061723|4686476|P3|Overall Study|Other than specified above|1
1420309|NCT01061723|4686477|P2|Overall Study|Other than specified above|1
1420310|NCT01061723|4686478|P1|Overall Study|Other than specified above|2
1420311|NCT01061723|4686473|P6|Overall Study|Randomized but not treated|1
1420312|NCT01061723|4686474|P5|Overall Study|Randomized but not treated|0
1420313|NCT01061723|4686475|P4|Overall Study|Randomized but not treated|0
1420314|NCT01061723|4686476|P3|Overall Study|Randomized but not treated|0
1420315|NCT01061723|4686477|P2|Overall Study|Randomized but not treated|0
1420316|NCT01061723|4686478|P1|Overall Study|Randomized but not treated|0
1420317|NCT01061723|4686473|P6|Overall Study|Lack of Efficacy|1
1420318|NCT01061723|4686474|P5|Overall Study|Lack of Efficacy|1
1420319|NCT01061723|4686475|P4|Overall Study|Lack of Efficacy|2
1420320|NCT01061723|4686476|P3|Overall Study|Lack of Efficacy|4
1420321|NCT01061723|4686477|P2|Overall Study|Lack of Efficacy|3
1420322|NCT01061723|4686478|P1|Overall Study|Lack of Efficacy|2
1420323|NCT01061723|4686473|P6|Overall Study|Adverse Event|6
1420324|NCT01061723|4686474|P5|Overall Study|Adverse Event|2
1420325|NCT01061723|4686475|P4|Overall Study|Adverse Event|5
1420326|NCT01061723|4686476|P3|Overall Study|Adverse Event|5
1420327|NCT01061723|4686477|P2|Overall Study|Adverse Event|2
1420328|NCT01061723|4686478|P1|Overall Study|Adverse Event|0
1420329|NCT01061710|4686558|P1|Overall Study|Protocol Violation|14
1420330|NCT01061671|4686568|P2|Overall Study|Death|30
1420331|NCT01061671|4686569|P1|Overall Study|Death|28
1420332|NCT01061671|4686568|P2|Overall Study|Lost to Follow-up|5
1420333|NCT01061671|4686569|P1|Overall Study|Lost to Follow-up|3
1420334|NCT01061671|4686568|P2|Overall Study|Withdrawal by Subject|20
1420335|NCT01061671|4686569|P1|Overall Study|Withdrawal by Subject|16
1420336|NCT01061606|4686581|P1|Overall Study|alternative therapy|2
1420337|NCT01061606|4686581|P1|Overall Study|Disease Progression|4
1420338|NCT01061606|4686581|P1|Overall Study|Death|1
1420339|NCT01061606|4686581|P1|Overall Study|Adverse Event|1
1420340|NCT01061567|4686590|P1|Overall Study|Other reason than stated above|3
1420341|NCT01061567|4686590|P1|Overall Study|Withdrawal by Subject|11
1420342|NCT01061567|4686590|P1|Overall Study|Protocol Violation|1
1420343|NCT01061567|4686590|P1|Overall Study|Lost to Follow-up|24
1420344|NCT01061567|4686590|P1|Overall Study|Lack of Efficacy|3
1420345|NCT01061567|4686590|P1|Overall Study|Death|2
1420346|NCT01061567|4686590|P1|Overall Study|Adverse Event|32
1420347|NCT01061385|4686614|P2|Overall Study|subject decision not related to AE|1
1420348|NCT01061385|4686615|P1|Overall Study|subject decision not related to AE|0
1420349|NCT01061385|4686614|P2|Overall Study|Lost to Follow-up|0
1420350|NCT01061385|4686615|P1|Overall Study|Lost to Follow-up|1
1420351|NCT01061359|4686623|P1|Overall Study|Secondary neoplasm|11
1420352|NCT01061359|4686623|P1|Overall Study|Relapse|187
1420353|NCT01061359|4686623|P1|Overall Study|Lost to Follow-up|1072
1420354|NCT01061359|4686623|P1|Overall Study|Death|32
1420355|NCT01061333|4686629|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
1420356|NCT01061333|4686630|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
1420357|NCT01061177|4686668|P1|Overall Study|Death|4
1420358|NCT01061177|4686668|P1|Overall Study|Administratie problems|4
1420359|NCT01061177|4686668|P1|Overall Study|Abnormal test procedure results|4
1420360|NCT01061177|4686668|P1|Overall Study|Abnormal laboratory values|6
1420361|NCT01061177|4686668|P1|Overall Study|New cancer therapy|9
1420362|NCT01061177|4686668|P1|Overall Study|Lost to Follow-up|9
1420363|NCT01061177|4686668|P1|Overall Study|Protocol Violation|11
1420364|NCT01061177|4686668|P1|Overall Study|Disease progression|17
1420365|NCT01061177|4686668|P1|Overall Study|Withdrawal by Subject|27
1420366|NCT01061177|4686668|P1|Overall Study|Adverse Event|117
1420367|NCT01061151|4686691|P4|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
1420368|NCT01061151|4686692|P3|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
1420369|NCT01061151|4686693|P2|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
1420370|NCT01061151|4686694|P1|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
1420371|NCT01061151|4686691|P4|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
1420372|NCT01061151|4686692|P3|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
1420373|NCT01061151|4686693|P2|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
1420374|NCT01061151|4686694|P1|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
1420375|NCT01061151|4686691|P4|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
1420376|NCT01061151|4686692|P3|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
1420377|NCT01061151|4686693|P2|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
1420378|NCT01061151|4686694|P1|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
1420379|NCT01061151|4686691|P4|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
1420380|NCT01061151|4686692|P3|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
1420381|NCT01061151|4686693|P2|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
1420462|NCT01060384|4686825|P1|Overall Study|Death|0
1420382|NCT01061151|4686694|P1|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
1420383|NCT01061151|4686691|P4|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
1420384|NCT01061151|4686692|P3|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
1420385|NCT01061151|4686693|P2|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
1420386|NCT01061151|4686694|P1|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
1420387|NCT01061151|4686691|P4|Protocol Version 3.0: 10/2012-10/2014|Death|1
1420388|NCT01061151|4686692|P3|Protocol Version 3.0: 10/2012-10/2014|Death|1
1420389|NCT01061151|4686693|P2|Protocol Version 3.0: 10/2012-10/2014|Death|5
1420390|NCT01061151|4686694|P1|Protocol Version 3.0: 10/2012-10/2014|Death|3
1420391|NCT01061151|4686691|P4|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
1420392|NCT01061151|4686692|P3|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
1420393|NCT01061151|4686693|P2|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
1420394|NCT01061151|4686694|P1|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
1420395|NCT01061151|4686691|P4|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
1420396|NCT01061151|4686692|P3|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
1420397|NCT01061151|4686693|P2|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
1420398|NCT01061151|4686694|P1|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
1420399|NCT01061151|4686691|P4|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
1420400|NCT01061151|4686692|P3|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
1420401|NCT01061151|4686693|P2|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
1420402|NCT01061151|4686694|P1|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
1420403|NCT01061151|4686691|P4|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
1420404|NCT01061151|4686692|P3|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
1420405|NCT01061151|4686693|P2|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
1420406|NCT01061151|4686694|P1|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
1420407|NCT01061151|4686691|P4|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
1420408|NCT01061151|4686692|P3|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
1420409|NCT01061151|4686693|P2|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
1420410|NCT01061151|4686694|P1|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
1420411|NCT01061151|4686691|P4|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
1420412|NCT01061151|4686692|P3|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
1420413|NCT01061151|4686693|P2|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
1420414|NCT01061151|4686694|P1|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
1420415|NCT01061151|4686691|P4|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
1420416|NCT01061151|4686692|P3|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
1420417|NCT01061151|4686693|P2|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
1420418|NCT01061151|4686694|P1|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
1420419|NCT01061151|4686691|P4|Protocol Version 2.0: 04/2011-09/2012|Death|2
1420420|NCT01061151|4686692|P3|Protocol Version 2.0: 04/2011-09/2012|Death|1
1420421|NCT01061151|4686693|P2|Protocol Version 2.0: 04/2011-09/2012|Death|9
1420422|NCT01061151|4686694|P1|Protocol Version 2.0: 04/2011-09/2012|Death|6
1420423|NCT01061151|4686691|P4|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
1420424|NCT01061151|4686692|P3|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
1420425|NCT01061151|4686693|P2|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
1420426|NCT01061151|4686694|P1|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
1420427|NCT01061008|4686753|P2|Overall Study|Adverse Event|1
1420428|NCT01061008|4686754|P1|Overall Study|Adverse Event|0
1420429|NCT01061008|4686753|P2|Overall Study|Unable to exercise following surgery|0
1420430|NCT01061008|4686754|P1|Overall Study|Unable to exercise following surgery|1
1420431|NCT01061008|4686753|P2|Overall Study|Withdrawal by Subject|3
1420432|NCT01061008|4686754|P1|Overall Study|Withdrawal by Subject|1
1420433|NCT01061008|4686753|P2|Overall Study|Death|0
1420434|NCT01061008|4686754|P1|Overall Study|Death|1
1420435|NCT01061008|4686753|P2|Overall Study|Badiocephalic fistula failed|2
1420436|NCT01061008|4686754|P1|Overall Study|Badiocephalic fistula failed|3
1420437|NCT01060670|4686762|P2|Run In|screen failure|238
1420438|NCT01060670|4686763|P1|Run In|screen failure|0
1420439|NCT01060553|4686798|P2|Overall Study|Lack of Efficacy|0
1420440|NCT01060553|4686799|P1|Overall Study|Lack of Efficacy|1
1420441|NCT01060553|4686798|P2|Overall Study|Withdrawal by Subject|5
1420442|NCT01060553|4686799|P1|Overall Study|Withdrawal by Subject|5
1420443|NCT01060553|4686798|P2|Overall Study|Lost to Follow-up|5
1420444|NCT01060553|4686799|P1|Overall Study|Lost to Follow-up|3
1420445|NCT01060540|4686806|P2|Overall Study|Physician Decision|1
1420446|NCT01060540|4686807|P1|Overall Study|Physician Decision|0
1420447|NCT01060540|4686806|P2|Overall Study|Death|1
1420448|NCT01060540|4686807|P1|Overall Study|Death|2
1420449|NCT01060540|4686806|P2|Overall Study|Lost to Follow-up|43
1420450|NCT01060540|4686807|P1|Overall Study|Lost to Follow-up|52
1420451|NCT01060540|4686806|P2|Overall Study|Withdrawal by Subject|20
1420452|NCT01060540|4686807|P1|Overall Study|Withdrawal by Subject|10
1420453|NCT01060384|4686821|P5|Overall Study|Intercurrent illness|1
1420454|NCT01060384|4686822|P4|Overall Study|Intercurrent illness|0
1420455|NCT01060384|4686823|P3|Overall Study|Intercurrent illness|0
1420456|NCT01060384|4686824|P2|Overall Study|Intercurrent illness|0
1420457|NCT01060384|4686825|P1|Overall Study|Intercurrent illness|0
1420458|NCT01060384|4686821|P5|Overall Study|Death|1
1420459|NCT01060384|4686822|P4|Overall Study|Death|0
1420460|NCT01060384|4686823|P3|Overall Study|Death|0
1420461|NCT01060384|4686824|P2|Overall Study|Death|0
1420463|NCT01060384|4686821|P5|Overall Study|Withdrawal by Subject|0
1420464|NCT01060384|4686822|P4|Overall Study|Withdrawal by Subject|0
1420465|NCT01060384|4686823|P3|Overall Study|Withdrawal by Subject|0
1420466|NCT01060384|4686824|P2|Overall Study|Withdrawal by Subject|1
1420467|NCT01060384|4686825|P1|Overall Study|Withdrawal by Subject|0
1420468|NCT01060150|4686834|P1|Overall Study|Enrolled, but not treated|2
1420469|NCT01060150|4686834|P1|Overall Study|Withdrawal by Subject|8
1420470|NCT01060150|4686834|P1|Overall Study|Protocol Violation|6
1420471|NCT01060150|4686834|P1|Overall Study|Lost to Follow-up|1
1420472|NCT01060150|4686834|P1|Overall Study|Adverse Event|6
1420473|NCT01060124|4686849|P1|Overall Study|Withdrawal by Subject|7
1420474|NCT01060124|4686849|P1|Overall Study|Adverse Event|14
1420475|NCT01060124|4686849|P1|Overall Study|Other|16
1420476|NCT01060111|4686860|P3|Overall Study|Other|4
1420477|NCT01060111|4686861|P2|Overall Study|Other|3
1420478|NCT01060111|4686862|P1|Overall Study|Other|2
1420479|NCT01060111|4686860|P3|Overall Study|Participants' non-cooperation|0
1420480|NCT01060111|4686861|P2|Overall Study|Participants' non-cooperation|0
1420481|NCT01060111|4686862|P1|Overall Study|Participants' non-cooperation|1
1420482|NCT01060111|4686860|P3|Overall Study|Adverse event and insufficient effect|0
1420483|NCT01060111|4686861|P2|Overall Study|Adverse event and insufficient effect|1
1420484|NCT01060111|4686862|P1|Overall Study|Adverse event and insufficient effect|0
1420485|NCT01060111|4686860|P3|Overall Study|Participants' non-cooperation|6
1420486|NCT01060111|4686861|P2|Overall Study|Participants' non-cooperation|6
1420487|NCT01060111|4686862|P1|Overall Study|Participants' non-cooperation|8
1420488|NCT01060111|4686860|P3|Overall Study|Participants' evasion for hospital visit|2
1420489|NCT01060111|4686861|P2|Overall Study|Participants' evasion for hospital visit|3
1420490|NCT01060111|4686862|P1|Overall Study|Participants' evasion for hospital visit|0
1420491|NCT01060111|4686860|P3|Overall Study|Inappropriate participant|5
1420492|NCT01060111|4686861|P2|Overall Study|Inappropriate participant|4
1420493|NCT01060111|4686862|P1|Overall Study|Inappropriate participant|5
1420494|NCT01060111|4686860|P3|Overall Study|Lack of Efficacy|0
1420495|NCT01060111|4686861|P2|Overall Study|Lack of Efficacy|1
1420496|NCT01060111|4686862|P1|Overall Study|Lack of Efficacy|2
1420497|NCT01060111|4686860|P3|Overall Study|Adverse Event|18
1420498|NCT01060111|4686861|P2|Overall Study|Adverse Event|5
1420499|NCT01060111|4686862|P1|Overall Study|Adverse Event|9
1420500|NCT01060072|4686881|P2|Overall Study|Excluded Medications|1
1420501|NCT01060072|4686882|P1|Overall Study|Excluded Medications|0
1420502|NCT01060072|4686881|P2|Overall Study|Acute cholecystitis|0
1420503|NCT01060072|4686882|P1|Overall Study|Acute cholecystitis|1
1420504|NCT01060072|4686881|P2|Overall Study|Protocol Violation|1
1420505|NCT01060072|4686882|P1|Overall Study|Protocol Violation|0
1420506|NCT01060072|4686881|P2|Overall Study|Physician Decision|2
1420507|NCT01060072|4686882|P1|Overall Study|Physician Decision|0
1420508|NCT01060072|4686881|P2|Overall Study|Adverse Event|1
1420509|NCT01060072|4686882|P1|Overall Study|Adverse Event|1
1420510|NCT01060059|4686898|P2|Overall Study|lack of compliance|2
1420511|NCT01060059|4686899|P1|Overall Study|lack of compliance|5
1420512|NCT01060059|4686898|P2|Overall Study|lack of glycemic control|1
1420513|NCT01060059|4686899|P1|Overall Study|lack of glycemic control|2
1420514|NCT01060059|4686898|P2|Overall Study|Withdrawal by Subject|23
1420515|NCT01060059|4686899|P1|Overall Study|Withdrawal by Subject|35
1420516|NCT01060059|4686898|P2|Overall Study|entry criteria not met|3
1420517|NCT01060059|4686899|P1|Overall Study|entry criteria not met|4
1420518|NCT01060059|4686898|P2|Overall Study|Lost to Follow-up|34
1420519|NCT01060059|4686899|P1|Overall Study|Lost to Follow-up|18
1420520|NCT01060059|4686898|P2|Overall Study|Death|3
1420521|NCT01060059|4686899|P1|Overall Study|Death|2
1420522|NCT01060059|4686898|P2|Overall Study|Adverse Event|1
1420523|NCT01060059|4686899|P1|Overall Study|Adverse Event|1
1420524|NCT01060007|4686957|P1|Overall Study|Inevaluable for response at surgery|3
1420525|NCT01060007|4686957|P1|Overall Study|Withdrawal by Subject|1
1420526|NCT01059903|4687025|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
1420527|NCT01059903|4687026|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
1420528|NCT01059864|4687060|P3|Double-Blind Treatment Phase|Adverse Event|3
1420529|NCT01059864|4687061|P2|Double-Blind Treatment Phase|Adverse Event|3
1420530|NCT01059864|4687062|P1|Double-Blind Treatment Phase|Adverse Event|0
1420531|NCT01059864|4687060|P3|Open-Label Run-In Phase|Protocol Violation|0
1420532|NCT01059864|4687061|P2|Open-Label Run-In Phase|Protocol Violation|0
1420533|NCT01059864|4687062|P1|Open-Label Run-In Phase|Protocol Violation|2
1420534|NCT01059864|4687060|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
1420535|NCT01059864|4687061|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
1420536|NCT01059864|4687062|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
1420537|NCT01059864|4687060|P3|Open-Label Run-In Phase|Lost to Follow-up|0
1420538|NCT01059864|4687061|P2|Open-Label Run-In Phase|Lost to Follow-up|0
1420539|NCT01059864|4687062|P1|Open-Label Run-In Phase|Lost to Follow-up|2
1420540|NCT01059864|4687060|P3|Open-Label Run-In Phase|Lack of Efficacy|0
1420541|NCT01059864|4687061|P2|Open-Label Run-In Phase|Lack of Efficacy|0
1420542|NCT01059864|4687062|P1|Open-Label Run-In Phase|Lack of Efficacy|1
1420543|NCT01059864|4687060|P3|Open-Label Run-In Phase|Adverse Event|0
1420544|NCT01059864|4687061|P2|Open-Label Run-In Phase|Adverse Event|0
1420545|NCT01059864|4687062|P1|Open-Label Run-In Phase|Adverse Event|7
1420546|NCT01059825|4687136|P7|Treatment Period|Adverse event not related to study drug|0
1420547|NCT01059825|4687137|P6|Treatment Period|Adverse event not related to study drug|1
1420548|NCT01059825|4687138|P5|Treatment Period|Adverse event not related to study drug|1
1420549|NCT01059825|4687139|P4|Treatment Period|Adverse event not related to study drug|1
1420550|NCT01059825|4687140|P3|Treatment Period|Adverse event not related to study drug|2
1420551|NCT01059825|4687141|P2|Treatment Period|Adverse event not related to study drug|1
1420552|NCT01059825|4687142|P1|Treatment Period|Adverse event not related to study drug|0
1420553|NCT01059825|4687136|P7|Treatment Period|Insufficient clinical response|0
1420554|NCT01059825|4687137|P6|Treatment Period|Insufficient clinical response|0
1420555|NCT01059825|4687138|P5|Treatment Period|Insufficient clinical response|0
1420556|NCT01059825|4687139|P4|Treatment Period|Insufficient clinical response|0
1420557|NCT01059825|4687140|P3|Treatment Period|Insufficient clinical response|0
1420558|NCT01059825|4687141|P2|Treatment Period|Insufficient clinical response|0
1420559|NCT01059825|4687142|P1|Treatment Period|Insufficient clinical response|3
1420560|NCT01059825|4687136|P7|Treatment Period|Adverse event related to study drug|0
1420561|NCT01059825|4687137|P6|Treatment Period|Adverse event related to study drug|0
1420562|NCT01059825|4687138|P5|Treatment Period|Adverse event related to study drug|0
1420563|NCT01059825|4687139|P4|Treatment Period|Adverse event related to study drug|1
1420564|NCT01059825|4687140|P3|Treatment Period|Adverse event related to study drug|1
1420565|NCT01059825|4687141|P2|Treatment Period|Adverse event related to study drug|0
1420566|NCT01059825|4687142|P1|Treatment Period|Adverse event related to study drug|1
1420567|NCT01059825|4687136|P7|Treatment Period|Protocol Violation|0
1420568|NCT01059825|4687137|P6|Treatment Period|Protocol Violation|1
1420569|NCT01059825|4687138|P5|Treatment Period|Protocol Violation|1
1420570|NCT01059825|4687139|P4|Treatment Period|Protocol Violation|1
1420571|NCT01059825|4687140|P3|Treatment Period|Protocol Violation|1
1420572|NCT01059825|4687141|P2|Treatment Period|Protocol Violation|0
1420573|NCT01059825|4687142|P1|Treatment Period|Protocol Violation|0
1420574|NCT01059825|4687136|P7|Treatment Period|Other reason not specified|0
1420575|NCT01059825|4687137|P6|Treatment Period|Other reason not specified|0
1420576|NCT01059825|4687138|P5|Treatment Period|Other reason not specified|0
1420577|NCT01059825|4687139|P4|Treatment Period|Other reason not specified|2
1420578|NCT01059825|4687140|P3|Treatment Period|Other reason not specified|1
1420579|NCT01059825|4687141|P2|Treatment Period|Other reason not specified|2
1420580|NCT01059825|4687142|P1|Treatment Period|Other reason not specified|1
1420581|NCT01059825|4687136|P7|Treatment Period|Withdrawal by Subject|0
1420582|NCT01059825|4687137|P6|Treatment Period|Withdrawal by Subject|1
1420583|NCT01059825|4687138|P5|Treatment Period|Withdrawal by Subject|4
1420584|NCT01059825|4687139|P4|Treatment Period|Withdrawal by Subject|5
1420585|NCT01059825|4687140|P3|Treatment Period|Withdrawal by Subject|1
1420586|NCT01059825|4687141|P2|Treatment Period|Withdrawal by Subject|0
1420587|NCT01059825|4687142|P1|Treatment Period|Withdrawal by Subject|3
1420588|NCT01059825|4687136|P7|Treatment Period|Lost to Follow-up|0
1420589|NCT01059825|4687137|P6|Treatment Period|Lost to Follow-up|0
1420590|NCT01059825|4687138|P5|Treatment Period|Lost to Follow-up|2
1420591|NCT01059825|4687139|P4|Treatment Period|Lost to Follow-up|1
1420592|NCT01059825|4687140|P3|Treatment Period|Lost to Follow-up|0
1420593|NCT01059825|4687141|P2|Treatment Period|Lost to Follow-up|1
1420594|NCT01059825|4687142|P1|Treatment Period|Lost to Follow-up|2
1420595|NCT01059825|4687136|P7|Enrolled, Run-in Period|Protocol Violation|5
1420596|NCT01059825|4687137|P6|Enrolled, Run-in Period|Protocol Violation|0
1420597|NCT01059825|4687138|P5|Enrolled, Run-in Period|Protocol Violation|0
1420598|NCT01059825|4687139|P4|Enrolled, Run-in Period|Protocol Violation|0
1420599|NCT01059825|4687140|P3|Enrolled, Run-in Period|Protocol Violation|0
1420600|NCT01059825|4687141|P2|Enrolled, Run-in Period|Protocol Violation|0
1420601|NCT01059825|4687142|P1|Enrolled, Run-in Period|Protocol Violation|0
1420602|NCT01059825|4687136|P7|Enrolled, Run-in Period|Other reason not specified|7
1420603|NCT01059825|4687137|P6|Enrolled, Run-in Period|Other reason not specified|0
1420604|NCT01059825|4687138|P5|Enrolled, Run-in Period|Other reason not specified|0
1420605|NCT01059825|4687139|P4|Enrolled, Run-in Period|Other reason not specified|0
1420606|NCT01059825|4687140|P3|Enrolled, Run-in Period|Other reason not specified|0
1420607|NCT01059825|4687141|P2|Enrolled, Run-in Period|Other reason not specified|0
1420608|NCT01059825|4687142|P1|Enrolled, Run-in Period|Other reason not specified|0
1420609|NCT01059825|4687136|P7|Enrolled, Run-in Period|Withdrawal by Subject|13
1420610|NCT01059825|4687137|P6|Enrolled, Run-in Period|Withdrawal by Subject|0
1420611|NCT01059825|4687138|P5|Enrolled, Run-in Period|Withdrawal by Subject|0
1420612|NCT01059825|4687139|P4|Enrolled, Run-in Period|Withdrawal by Subject|0
1420613|NCT01059825|4687140|P3|Enrolled, Run-in Period|Withdrawal by Subject|0
1420614|NCT01059825|4687141|P2|Enrolled, Run-in Period|Withdrawal by Subject|0
1420615|NCT01059825|4687142|P1|Enrolled, Run-in Period|Withdrawal by Subject|0
1420616|NCT01059825|4687136|P7|Enrolled, Run-in Period|Lost to Follow-up|5
1420617|NCT01059825|4687137|P6|Enrolled, Run-in Period|Lost to Follow-up|0
1420618|NCT01059825|4687138|P5|Enrolled, Run-in Period|Lost to Follow-up|0
1420619|NCT01059825|4687139|P4|Enrolled, Run-in Period|Lost to Follow-up|0
1420620|NCT01059825|4687140|P3|Enrolled, Run-in Period|Lost to Follow-up|0
1420621|NCT01059825|4687141|P2|Enrolled, Run-in Period|Lost to Follow-up|0
1420622|NCT01059825|4687142|P1|Enrolled, Run-in Period|Lost to Follow-up|0
1420623|NCT01059825|4687136|P7|Enrolled, Run-in Period|Did not meet entrance criteria|14
1420624|NCT01059825|4687137|P6|Enrolled, Run-in Period|Did not meet entrance criteria|0
1420625|NCT01059825|4687138|P5|Enrolled, Run-in Period|Did not meet entrance criteria|0
1420626|NCT01059825|4687139|P4|Enrolled, Run-in Period|Did not meet entrance criteria|0
1420627|NCT01059825|4687140|P3|Enrolled, Run-in Period|Did not meet entrance criteria|0
1420628|NCT01059825|4687141|P2|Enrolled, Run-in Period|Did not meet entrance criteria|0
1420629|NCT01059825|4687142|P1|Enrolled, Run-in Period|Did not meet entrance criteria|0
1420630|NCT01059825|4687136|P7|Enrolled, Run-in Period|Adverse event not related to study drug|3
1420631|NCT01059825|4687137|P6|Enrolled, Run-in Period|Adverse event not related to study drug|0
1420632|NCT01059825|4687138|P5|Enrolled, Run-in Period|Adverse event not related to study drug|0
1420633|NCT01059825|4687139|P4|Enrolled, Run-in Period|Adverse event not related to study drug|0
1420634|NCT01059825|4687140|P3|Enrolled, Run-in Period|Adverse event not related to study drug|0
1420635|NCT01059825|4687141|P2|Enrolled, Run-in Period|Adverse event not related to study drug|0
1420636|NCT01059825|4687142|P1|Enrolled, Run-in Period|Adverse event not related to study drug|0
1420637|NCT01059812|4687329|P2|Overall Study|Unclassified|4
1420638|NCT01059812|4687330|P1|Overall Study|Unclassified|14
1420639|NCT01059812|4687329|P2|Overall Study|Withdrawal Criteria|4
1420640|NCT01059812|4687330|P1|Overall Study|Withdrawal Criteria|9
1420641|NCT01059812|4687329|P2|Overall Study|Protocol Violation|1
1420642|NCT01059812|4687330|P1|Overall Study|Protocol Violation|3
1420643|NCT01059812|4687329|P2|Overall Study|Lack of Efficacy|2
1420644|NCT01059812|4687330|P1|Overall Study|Lack of Efficacy|2
1420645|NCT01059812|4687329|P2|Overall Study|Adverse Event|5
1420646|NCT01059812|4687330|P1|Overall Study|Adverse Event|9
1420647|NCT01059799|4687346|P2|Overall Study|Other|3
1420648|NCT01059799|4687347|P1|Overall Study|Other|12
1420649|NCT01059799|4687346|P2|Overall Study|Withdrawal criteria|2
1420650|NCT01059799|4687347|P1|Overall Study|Withdrawal criteria|13
1420651|NCT01059799|4687346|P2|Overall Study|Protocol Violation|2
1420652|NCT01059799|4687347|P1|Overall Study|Protocol Violation|3
1420653|NCT01059799|4687346|P2|Overall Study|Lack of Efficacy|0
1420654|NCT01059799|4687347|P1|Overall Study|Lack of Efficacy|1
1420655|NCT01059799|4687346|P2|Overall Study|Adverse Event|3
1420656|NCT01059799|4687347|P1|Overall Study|Adverse Event|2
1420657|NCT01059773|4687361|P2|Overall Study|Other|3
1420658|NCT01059773|4687362|P1|Overall Study|Other|1
1420659|NCT01059773|4687361|P2|Overall Study|Ineligible follow TB screening criteria|1
1420660|NCT01059773|4687362|P1|Overall Study|Ineligible follow TB screening criteria|0
1420661|NCT01059773|4687361|P2|Overall Study|Malignancy including squamous cell skin|1
1420662|NCT01059773|4687362|P1|Overall Study|Malignancy including squamous cell skin|0
1420663|NCT01059773|4687361|P2|Overall Study|Death|1
1420664|NCT01059773|4687362|P1|Overall Study|Death|0
1420665|NCT01059773|4687361|P2|Overall Study|Lack of Efficacy|3
1420666|NCT01059773|4687362|P1|Overall Study|Lack of Efficacy|3
1420667|NCT01059773|4687361|P2|Overall Study|Physician Decision|4
1420668|NCT01059773|4687362|P1|Overall Study|Physician Decision|5
1420669|NCT01059773|4687361|P2|Overall Study|Protocol Violation|2
1420670|NCT01059773|4687362|P1|Overall Study|Protocol Violation|6
1420671|NCT01059773|4687361|P2|Overall Study|Pregnancy|1
1420672|NCT01059773|4687362|P1|Overall Study|Pregnancy|1
1420673|NCT01059773|4687361|P2|Overall Study|Lost to Follow-up|1
1420674|NCT01059773|4687362|P1|Overall Study|Lost to Follow-up|1
1420675|NCT01059773|4687361|P2|Overall Study|Withdrawal by Subject|5
1420676|NCT01059773|4687362|P1|Overall Study|Withdrawal by Subject|1
1420677|NCT01059773|4687361|P2|Overall Study|Adverse Event|2
1420678|NCT01059773|4687362|P1|Overall Study|Adverse Event|2
1420679|NCT01059643|4687501|P1|Overall Study|Physician Decision|1
1420680|NCT01059643|4687501|P1|Overall Study|Withdrawal by Subject|2
1420681|NCT01059643|4687501|P1|Overall Study|Adverse Event|3
1420682|NCT01059630|4687516|P2|Maintenance Period (up to 2 Years)|Other|3
1420683|NCT01059630|4687517|P1|Maintenance Period (up to 2 Years)|Other|0
1420684|NCT01059630|4687516|P2|Maintenance Period (up to 2 Years)|Physician Decision|2
1420685|NCT01059630|4687517|P1|Maintenance Period (up to 2 Years)|Physician Decision|0
1420686|NCT01059630|4687516|P2|Maintenance Period (up to 2 Years)|Death|2
1420687|NCT01059630|4687517|P1|Maintenance Period (up to 2 Years)|Death|0
1420688|NCT01059630|4687516|P2|Maintenance Period (up to 2 Years)|Withdrawal by Subject|3
1420689|NCT01059630|4687517|P1|Maintenance Period (up to 2 Years)|Withdrawal by Subject|0
1420690|NCT01059630|4687516|P2|Maintenance Period (up to 2 Years)|Progressive Disease|44
1420691|NCT01059630|4687517|P1|Maintenance Period (up to 2 Years)|Progressive Disease|0
1420692|NCT01059630|4687516|P2|Maintenance Period (up to 2 Years)|Adverse Event|8
1420693|NCT01059630|4687517|P1|Maintenance Period (up to 2 Years)|Adverse Event|0
1420694|NCT01059630|4687516|P2|Maintenance Period (up to 2 Years)|Maintenance ongoing|46
1420695|NCT01059630|4687517|P1|Maintenance Period (up to 2 Years)|Maintenance ongoing|0
1420696|NCT01059630|4687516|P2|Induction Period (6 Months)|Randomized but not Treated|0
1420697|NCT01059630|4687517|P1|Induction Period (6 Months)|Randomized but not Treated|4
1420698|NCT01059630|4687516|P2|Induction Period (6 Months)|Other|0
1420699|NCT01059630|4687517|P1|Induction Period (6 Months)|Other|1
1420700|NCT01059630|4687516|P2|Induction Period (6 Months)|Physician Decision|4
1420701|NCT01059630|4687517|P1|Induction Period (6 Months)|Physician Decision|2
1420702|NCT01059630|4687516|P2|Induction Period (6 Months)|Death|2
1420703|NCT01059630|4687517|P1|Induction Period (6 Months)|Death|2
1420704|NCT01059630|4687516|P2|Induction Period (6 Months)|Withdrawal by Subject|2
1420705|NCT01059630|4687517|P1|Induction Period (6 Months)|Withdrawal by Subject|7
1420706|NCT01059630|4687516|P2|Induction Period (6 Months)|Progressive Disease|9
1420707|NCT01059630|4687517|P1|Induction Period (6 Months)|Progressive Disease|14
1420708|NCT01059630|4687516|P2|Induction Period (6 Months)|Adverse Event|15
1420709|NCT01059630|4687517|P1|Induction Period (6 Months)|Adverse Event|30
1420710|NCT01059630|4687516|P2|Induction Period (6 Months)|Induction ongoing|6
1420711|NCT01059630|4687517|P1|Induction Period (6 Months)|Induction ongoing|13
1420712|NCT01059617|4687577|P4|Overall Study|Other|6
1420713|NCT01059617|4687578|P3|Overall Study|Other|8
1420714|NCT01059617|4687579|P2|Overall Study|Other|1
1420715|NCT01059617|4687580|P1|Overall Study|Other|7
1420716|NCT01059565|4687750|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
1420717|NCT01059565|4687751|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
1420718|NCT01059565|4687750|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
1420719|NCT01059565|4687751|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
1420720|NCT01059565|4687750|P2|24-Week Open-Label Phase|Subject noncompliance|0
1420721|NCT01059565|4687751|P1|24-Week Open-Label Phase|Subject noncompliance|1
1420722|NCT01059565|4687750|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
1420723|NCT01059565|4687751|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
1420724|NCT01059565|4687750|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
1420725|NCT01059565|4687751|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
1420726|NCT01059565|4687750|P2|24-Week Open-Label Phase|Adverse Event|0
1420727|NCT01059565|4687751|P1|24-Week Open-Label Phase|Adverse Event|2
1420728|NCT01059565|4687750|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
1420729|NCT01059565|4687751|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
1420730|NCT01059565|4687750|P2|24-Week Randomized Phase|Lost to Follow-up|1
1420731|NCT01059565|4687751|P1|24-Week Randomized Phase|Lost to Follow-up|0
1420732|NCT01059565|4687750|P2|24-Week Randomized Phase|Withdrawal by Subject|1
1420733|NCT01059565|4687751|P1|24-Week Randomized Phase|Withdrawal by Subject|3
1420734|NCT01059565|4687750|P2|24-Week Randomized Phase|Adverse Event|0
1420735|NCT01059565|4687751|P1|24-Week Randomized Phase|Adverse Event|5
1420736|NCT01059565|4687750|P2|24-Week Randomized Phase|Randomized but not treated|0
1420737|NCT01059565|4687751|P1|24-Week Randomized Phase|Randomized but not treated|1
1420738|NCT01059526|4687787|P2|Overall Study|Patient found to be dermatographic|0
1420739|NCT01059526|4687788|P1|Overall Study|Patient found to be dermatographic|1
1420740|NCT01059526|4687787|P2|Overall Study|Lost to Follow-up|1
1420741|NCT01059526|4687788|P1|Overall Study|Lost to Follow-up|4
1420742|NCT01059526|4687787|P2|Overall Study|Withdrawal by Subject|1
1420743|NCT01059526|4687788|P1|Overall Study|Withdrawal by Subject|3
1420744|NCT01059526|4687787|P2|Overall Study|Protocol Violation|1
1420745|NCT01059526|4687788|P1|Overall Study|Protocol Violation|0
1420746|NCT01059526|4687787|P2|Overall Study|Adverse Event|2
1420747|NCT01059526|4687788|P1|Overall Study|Adverse Event|2
1420748|NCT01059526|4687787|P2|Overall Study|Patient enrolled but not treated|17
1420749|NCT01059526|4687788|P1|Overall Study|Patient enrolled but not treated|20
1420750|NCT01059344|4687798|P2|Overall Study|Other|6
1420751|NCT01059344|4687799|P1|Overall Study|Other|3
1420752|NCT01059344|4687798|P2|Overall Study|Lost to Follow-up|1
1420753|NCT01059344|4687799|P1|Overall Study|Lost to Follow-up|1
1420754|NCT01059344|4687798|P2|Overall Study|Withdrawal by Subject|9
1420755|NCT01059344|4687799|P1|Overall Study|Withdrawal by Subject|6
1420756|NCT01059344|4687798|P2|Overall Study|Adverse Event|30
1420757|NCT01059344|4687799|P1|Overall Study|Adverse Event|12
1420758|NCT01059175|4687823|P2|Overall Study|Lost to Follow-up|1
1420759|NCT01059175|4687824|P1|Overall Study|Lost to Follow-up|0
1420760|NCT01059175|4687823|P2|Overall Study|Adverse Event|2
1420761|NCT01059175|4687824|P1|Overall Study|Adverse Event|4
1420762|NCT01059175|4687823|P2|Overall Study|Death|17
1420763|NCT01059175|4687824|P1|Overall Study|Death|17
1420764|NCT01059071|4687846|P4|Overall Study|Physician Decision|1
1420765|NCT01059071|4687847|P3|Overall Study|Physician Decision|0
1420766|NCT01059071|4687848|P2|Overall Study|Physician Decision|0
1420767|NCT01059071|4687849|P1|Overall Study|Physician Decision|0
1420768|NCT01059071|4687846|P4|Overall Study|Withdrawal by Subject|2
1420769|NCT01059071|4687847|P3|Overall Study|Withdrawal by Subject|0
1420770|NCT01059071|4687848|P2|Overall Study|Withdrawal by Subject|0
1420771|NCT01059071|4687849|P1|Overall Study|Withdrawal by Subject|1
1420772|NCT01059071|4687846|P4|Overall Study|Lack of Efficacy|3
1420773|NCT01059071|4687847|P3|Overall Study|Lack of Efficacy|2
1420774|NCT01059071|4687848|P2|Overall Study|Lack of Efficacy|4
1420775|NCT01059071|4687849|P1|Overall Study|Lack of Efficacy|1
1420776|NCT01058863|4687876|P1|Overall Study|Randomized in error|1
1420777|NCT01058863|4687876|P1|Overall Study|Sponsor requested withdrawal|1
1420778|NCT01058863|4687876|P1|Overall Study|Withdrawal by Subject|1
1420779|NCT01058863|4687876|P1|Overall Study|Lost to Follow-up|1
1420780|NCT01058668|4687897|P3|Double-blind Treatment Phase|Other Unspecified|0
1420781|NCT01058668|4687898|P2|Double-blind Treatment Phase|Other Unspecified|1
1420782|NCT01058668|4687899|P1|Double-blind Treatment Phase|Other Unspecified|1
1420783|NCT01058668|4687897|P3|Double-blind Treatment Phase|Lost to Follow-up|1
1420784|NCT01058668|4687898|P2|Double-blind Treatment Phase|Lost to Follow-up|1
1420785|NCT01058668|4687899|P1|Double-blind Treatment Phase|Lost to Follow-up|0
1420786|NCT01058668|4687897|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
1420787|NCT01058668|4687898|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
1420788|NCT01058668|4687899|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
1420789|NCT01058668|4687897|P3|Double-blind Treatment Phase|Protocol Violation|2
1420790|NCT01058668|4687898|P2|Double-blind Treatment Phase|Protocol Violation|1
1420791|NCT01058668|4687899|P1|Double-blind Treatment Phase|Protocol Violation|1
1420792|NCT01058668|4687897|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
1420793|NCT01058668|4687898|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
1420794|NCT01058668|4687899|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
1420795|NCT01058668|4687897|P3|Double-blind Treatment Phase|Adverse Event|25
1420796|NCT01058668|4687898|P2|Double-blind Treatment Phase|Adverse Event|15
1420797|NCT01058668|4687899|P1|Double-blind Treatment Phase|Adverse Event|8
1420798|NCT01058655|4687914|P4|Overall Study|Other|4
1420799|NCT01058655|4687915|P3|Overall Study|Other|0
1420800|NCT01058655|4687916|P2|Overall Study|Other|0
1420801|NCT01058655|4687917|P1|Overall Study|Other|0
1420802|NCT01058655|4687914|P4|Overall Study|Disease Progression|24
1420803|NCT01058655|4687915|P3|Overall Study|Disease Progression|4
1420804|NCT01058655|4687916|P2|Overall Study|Disease Progression|2
1420805|NCT01058655|4687917|P1|Overall Study|Disease Progression|1
1420806|NCT01058655|4687914|P4|Overall Study|Death|0
1420807|NCT01058655|4687915|P3|Overall Study|Death|1
1420808|NCT01058655|4687916|P2|Overall Study|Death|1
1420809|NCT01058655|4687917|P1|Overall Study|Death|0
1420810|NCT01058655|4687914|P4|Overall Study|Clinical Progression (non-RECIST)|7
1420811|NCT01058655|4687915|P3|Overall Study|Clinical Progression (non-RECIST)|0
1420812|NCT01058655|4687916|P2|Overall Study|Clinical Progression (non-RECIST)|0
1420813|NCT01058655|4687917|P1|Overall Study|Clinical Progression (non-RECIST)|1
1420814|NCT01058655|4687914|P4|Overall Study|Symptomatic Deterioration|1
1420815|NCT01058655|4687915|P3|Overall Study|Symptomatic Deterioration|0
1420816|NCT01058655|4687916|P2|Overall Study|Symptomatic Deterioration|0
1420817|NCT01058655|4687917|P1|Overall Study|Symptomatic Deterioration|0
1420818|NCT01058655|4687914|P4|Overall Study|Prolonged Treatment Delay|2
1420819|NCT01058655|4687915|P3|Overall Study|Prolonged Treatment Delay|0
1420820|NCT01058655|4687916|P2|Overall Study|Prolonged Treatment Delay|0
1420821|NCT01058655|4687917|P1|Overall Study|Prolonged Treatment Delay|0
1420822|NCT01058655|4687914|P4|Overall Study|Withdrawal by Subject|4
1420823|NCT01058655|4687915|P3|Overall Study|Withdrawal by Subject|3
1420824|NCT01058655|4687916|P2|Overall Study|Withdrawal by Subject|0
1420825|NCT01058655|4687917|P1|Overall Study|Withdrawal by Subject|1
1420826|NCT01058642|4687935|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
1420827|NCT01058642|4687936|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
1420828|NCT01058642|4687937|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
1420829|NCT01058642|4687938|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
1420830|NCT01058642|4687935|P4|Treatment Period 1|Protocol Violation|1
1420831|NCT01058642|4687936|P3|Treatment Period 1|Protocol Violation|0
1420832|NCT01058642|4687937|P2|Treatment Period 1|Protocol Violation|0
1420833|NCT01058642|4687938|P1|Treatment Period 1|Protocol Violation|0
1420834|NCT01058642|4687935|P4|Treatment Period 1|Lack of Efficacy|1
1420835|NCT01058642|4687936|P3|Treatment Period 1|Lack of Efficacy|0
1420836|NCT01058642|4687937|P2|Treatment Period 1|Lack of Efficacy|0
1420837|NCT01058642|4687938|P1|Treatment Period 1|Lack of Efficacy|0
1420838|NCT01058642|4687935|P4|Treatment Period 1|Withdrawal by Subject|0
1420839|NCT01058642|4687936|P3|Treatment Period 1|Withdrawal by Subject|0
1420840|NCT01058642|4687937|P2|Treatment Period 1|Withdrawal by Subject|0
1420841|NCT01058642|4687938|P1|Treatment Period 1|Withdrawal by Subject|1
1420842|NCT01058642|4687935|P4|Treatment Period 1|Physician Decision|0
1420843|NCT01058642|4687936|P3|Treatment Period 1|Physician Decision|1
1420844|NCT01058642|4687937|P2|Treatment Period 1|Physician Decision|0
1420845|NCT01058642|4687938|P1|Treatment Period 1|Physician Decision|0
1420846|NCT01058642|4687935|P4|Treatment Period 1|Adverse Event|0
1420847|NCT01058642|4687936|P3|Treatment Period 1|Adverse Event|1
1420848|NCT01058642|4687937|P2|Treatment Period 1|Adverse Event|1
1420849|NCT01058642|4687938|P1|Treatment Period 1|Adverse Event|0
1420850|NCT01058421|4687948|P2|6 Month Outcomes|Remained in Other Facility|3
1420851|NCT01058421|4687949|P1|6 Month Outcomes|Remained in Other Facility|1
1420852|NCT01058421|4687948|P2|6 Month Outcomes|Lost to Follow-up|21
1420853|NCT01058421|4687949|P1|6 Month Outcomes|Lost to Follow-up|16
1420854|NCT01058421|4687948|P2|6 Month Outcomes|Death|2
1420855|NCT01058421|4687949|P1|6 Month Outcomes|Death|2
1420856|NCT01058421|4687948|P2|3 Month Outcomes|Remained in Other Facility|8
1420857|NCT01058421|4687949|P1|3 Month Outcomes|Remained in Other Facility|5
1420858|NCT01058421|4687948|P2|3 Month Outcomes|Remained in Hospital|2
1420859|NCT01058421|4687949|P1|3 Month Outcomes|Remained in Hospital|0
1420860|NCT01058421|4687948|P2|3 Month Outcomes|Lost to Follow-up|11
1420861|NCT01058421|4687949|P1|3 Month Outcomes|Lost to Follow-up|12
1420862|NCT01058421|4687948|P2|3 Month Outcomes|Death|5
1420863|NCT01058421|4687949|P1|3 Month Outcomes|Death|3
1420864|NCT01058421|4687948|P2|1 Month Outcomes|Remained in Other Facility|17
1420865|NCT01058421|4687949|P1|1 Month Outcomes|Remained in Other Facility|16
1420866|NCT01058421|4687948|P2|1 Month Outcomes|Remained in Hospital|12
1420867|NCT01058421|4687949|P1|1 Month Outcomes|Remained in Hospital|5
1420868|NCT01058421|4687948|P2|1 Month Outcomes|Lost to Follow-up|7
1420869|NCT01058421|4687949|P1|1 Month Outcomes|Lost to Follow-up|8
1420870|NCT01058421|4687948|P2|1 Month Outcomes|Death|6
1420871|NCT01058421|4687949|P1|1 Month Outcomes|Death|10
1420872|NCT01058356|4687971|P1|Overall Study|Lost to Follow-up|4
1420873|NCT01058356|4687971|P1|Overall Study|Withdrawal by Subject|21
1420874|NCT01058356|4687971|P1|Overall Study|Administration of contraindicated drugs|12
1420875|NCT01058356|4687971|P1|Overall Study|Adverse Event|5
1420876|NCT01058304|4687978|P2|Overall Study|Developed exclusion criterion|12
1420877|NCT01058304|4687979|P1|Overall Study|Developed exclusion criterion|6
1420878|NCT01058304|4687978|P2|Overall Study|Lost to Follow-up|16
1420879|NCT01058304|4687979|P1|Overall Study|Lost to Follow-up|13
1420880|NCT01058304|4687978|P2|Overall Study|Withdrawal by Subject|5
1420881|NCT01058304|4687979|P1|Overall Study|Withdrawal by Subject|8
1420882|NCT01058265|4687989|P2|Overall Study|Lost to Follow-up|12
1420883|NCT01058265|4687990|P1|Overall Study|Lost to Follow-up|11
1420884|NCT01058096|4688009|P2|Double-blind Treatment Phase|Other Unspecified|0
1420885|NCT01058096|4688010|P1|Double-blind Treatment Phase|Other Unspecified|2
1420886|NCT01058096|4688009|P2|Double-blind Treatment Phase|Lost to Follow-up|1
1420887|NCT01058096|4688010|P1|Double-blind Treatment Phase|Lost to Follow-up|0
1420888|NCT01058096|4688009|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
1420889|NCT01058096|4688010|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
1420890|NCT01058096|4688009|P2|Double-blind Treatment Phase|Protocol Violation|1
1420891|NCT01058096|4688010|P1|Double-blind Treatment Phase|Protocol Violation|2
1420892|NCT01058096|4688009|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
1420893|NCT01058096|4688010|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
1420894|NCT01058096|4688009|P2|Double-blind Treatment Phase|Adverse Event|15
1420895|NCT01058096|4688010|P1|Double-blind Treatment Phase|Adverse Event|11
1420896|NCT01058005|4688026|P3|Overall Study|Reason Missing|1
1420897|NCT01058005|4688027|P2|Overall Study|Reason Missing|3
1420898|NCT01058005|4688028|P1|Overall Study|Reason Missing|5
1420899|NCT01058005|4688026|P3|Overall Study|Withdrawn Due to Study Termination|7
1420900|NCT01058005|4688027|P2|Overall Study|Withdrawn Due to Study Termination|13
1420901|NCT01058005|4688028|P1|Overall Study|Withdrawn Due to Study Termination|27
1420902|NCT01058005|4688026|P3|Overall Study|Withdrawal by Subject|11
1420903|NCT01058005|4688027|P2|Overall Study|Withdrawal by Subject|5
1420904|NCT01058005|4688028|P1|Overall Study|Withdrawal by Subject|4
1420905|NCT01058005|4688026|P3|Overall Study|Physician Decision|0
1420906|NCT01058005|4688027|P2|Overall Study|Physician Decision|2
1420907|NCT01058005|4688028|P1|Overall Study|Physician Decision|2
1420908|NCT01058005|4688026|P3|Overall Study|Adverse Event|1
1420909|NCT01058005|4688027|P2|Overall Study|Adverse Event|2
1420910|NCT01058005|4688028|P1|Overall Study|Adverse Event|0
1420911|NCT01057862|4688063|P2|Overall Study|Withdrawal by Subject|2
1420912|NCT01057862|4688064|P1|Overall Study|Withdrawal by Subject|1
1420913|NCT01057810|4688074|P2|Overall Study|Other|14
1420914|NCT01057810|4688075|P1|Overall Study|Other|7
1420915|NCT01057810|4688074|P2|Overall Study|No longer met study criteria|1
1420916|NCT01057810|4688075|P1|Overall Study|No longer met study criteria|0
1420917|NCT01057810|4688074|P2|Overall Study|Poor/non-compliance|1
1420918|NCT01057810|4688075|P1|Overall Study|Poor/non-compliance|0
1420919|NCT01057810|4688074|P2|Overall Study|Maximum clinical benefit|5
1420920|NCT01057810|4688075|P1|Overall Study|Maximum clinical benefit|5
1420921|NCT01057810|4688074|P2|Overall Study|Death|12
1420922|NCT01057810|4688075|P1|Overall Study|Death|2
1420923|NCT01057810|4688074|P2|Overall Study|Withdrawal by Subject|25
1420924|NCT01057810|4688075|P1|Overall Study|Withdrawal by Subject|10
1420925|NCT01057810|4688074|P2|Overall Study|Adverse event unrelated to study drug|29
1420926|NCT01057810|4688075|P1|Overall Study|Adverse event unrelated to study drug|13
1420927|NCT01057810|4688074|P2|Overall Study|Study drug toxicity|114
1420928|NCT01057810|4688075|P1|Overall Study|Study drug toxicity|5
1420929|NCT01057810|4688074|P2|Overall Study|Disease progression|197
1420930|NCT01057810|4688075|P1|Overall Study|Disease progression|156
1420931|NCT01057693|4688091|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
1420932|NCT01057693|4688092|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
1420933|NCT01057693|4688093|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
1420934|NCT01057693|4688091|P3|Double-Blind Phase (Week 7 to Week 19)|Other|0
1420935|NCT01057693|4688092|P2|Double-Blind Phase (Week 7 to Week 19)|Other|1
1420936|NCT01057693|4688093|P1|Double-Blind Phase (Week 7 to Week 19)|Other|0
1420937|NCT01057693|4688091|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
1420938|NCT01057693|4688092|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
1420939|NCT01057693|4688093|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
1420940|NCT01057693|4688091|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
1420941|NCT01057693|4688092|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
1420942|NCT01057693|4688093|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
1420943|NCT01057693|4688091|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
1420944|NCT01057693|4688092|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
1420945|NCT01057693|4688093|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
1420946|NCT01057693|4688091|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
1420947|NCT01057693|4688092|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
1420948|NCT01057693|4688093|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
1420949|NCT01057693|4688091|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
1420950|NCT01057693|4688092|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
1420951|NCT01057693|4688093|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
1420952|NCT01057693|4688091|P3|Between Single-Blind and Double-Blind|Other|0
1420953|NCT01057693|4688092|P2|Between Single-Blind and Double-Blind|Other|0
1420954|NCT01057693|4688093|P1|Between Single-Blind and Double-Blind|Other|6
1421039|NCT01056510|4688373|P1|Overall Study|Not Specified|10
1420955|NCT01057693|4688091|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
1420956|NCT01057693|4688092|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
1420957|NCT01057693|4688093|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
1420958|NCT01057693|4688091|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
1420959|NCT01057693|4688092|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
1420960|NCT01057693|4688093|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
1420961|NCT01057693|4688091|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
1420962|NCT01057693|4688092|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
1420963|NCT01057693|4688093|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
1420964|NCT01057693|4688091|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
1420965|NCT01057693|4688092|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
1420966|NCT01057693|4688093|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
1420967|NCT01057693|4688091|P3|Between Single-Blind and Double-Blind|Adverse Event|0
1420968|NCT01057693|4688092|P2|Between Single-Blind and Double-Blind|Adverse Event|0
1420969|NCT01057693|4688093|P1|Between Single-Blind and Double-Blind|Adverse Event|5
1420970|NCT01057693|4688091|P3|Single-Blind Phase (Up to Week 6)|Other|0
1420971|NCT01057693|4688092|P2|Single-Blind Phase (Up to Week 6)|Other|0
1420972|NCT01057693|4688093|P1|Single-Blind Phase (Up to Week 6)|Other|2
1420973|NCT01057693|4688091|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
1420974|NCT01057693|4688092|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
1420975|NCT01057693|4688093|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
1420976|NCT01057693|4688091|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
1420977|NCT01057693|4688092|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
1420978|NCT01057693|4688093|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
1420979|NCT01057693|4688091|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
1420980|NCT01057693|4688092|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
1420981|NCT01057693|4688093|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
1420982|NCT01057693|4688091|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
1420983|NCT01057693|4688092|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
1420984|NCT01057693|4688093|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
1420985|NCT01057693|4688091|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
1420986|NCT01057693|4688092|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
1420987|NCT01057693|4688093|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
1420988|NCT01057589|4688139|P1|Overall Study|Lost to Follow-up|1
1420989|NCT01057589|4688139|P1|Overall Study|Death|8
1420990|NCT01057589|4688139|P1|Overall Study|Sponsor Decision|1
1420991|NCT01057589|4688139|P1|Overall Study|Withdrawal by Subject|3
1420992|NCT01057589|4688139|P1|Overall Study|Physician Decision|8
1420993|NCT01057589|4688139|P1|Overall Study|Adverse Event|10
1420994|NCT01057589|4688139|P1|Overall Study|Disease Progression|35
1420995|NCT01057433|4688148|P1|Overall Study|Adverse Event|1
1420996|NCT01057394|4688152|P2|Overall Study|Not eligible|2
1420997|NCT01057394|4688153|P1|Overall Study|Not eligible|0
1420998|NCT01057251|4688163|P2|Overall Study|Other Reason|1
1420999|NCT01057251|4688164|P1|Overall Study|Other Reason|1
1421000|NCT01057251|4688163|P2|Overall Study|Lost to Follow-up|6
1421001|NCT01057251|4688164|P1|Overall Study|Lost to Follow-up|7
1421002|NCT01057251|4688163|P2|Overall Study|Withdrawal by Subject|5
1421003|NCT01057251|4688164|P1|Overall Study|Withdrawal by Subject|4
1421004|NCT01057251|4688163|P2|Overall Study|Protocol Violation|2
1421005|NCT01057251|4688164|P1|Overall Study|Protocol Violation|6
1421006|NCT01057251|4688163|P2|Overall Study|Lack of Efficacy|11
1421007|NCT01057251|4688164|P1|Overall Study|Lack of Efficacy|2
1421008|NCT01057251|4688163|P2|Overall Study|Adverse Event|2
1421009|NCT01057251|4688164|P1|Overall Study|Adverse Event|4
1421010|NCT01057251|4688163|P2|Overall Study|Did not meet InclusionExclusion criteria|2
1421011|NCT01057251|4688164|P1|Overall Study|Did not meet InclusionExclusion criteria|4
1421012|NCT01056822|4688242|P2|Overall Study|Lost to Follow-up|0
1421013|NCT01056822|4688243|P1|Overall Study|Lost to Follow-up|1
1421014|NCT01056822|4688242|P2|Overall Study|Withdrawal by Subject|1
1421015|NCT01056822|4688243|P1|Overall Study|Withdrawal by Subject|1
1421016|NCT01056822|4688242|P2|Overall Study|Protocol Violation|5
1421017|NCT01056822|4688243|P1|Overall Study|Protocol Violation|6
1421018|NCT01056822|4688242|P2|Overall Study|Adverse Event|1
1421019|NCT01056822|4688243|P1|Overall Study|Adverse Event|0
1421020|NCT01056718|4688292|P1|Overall Study|Ischemia on baseline stress test|1
1421021|NCT01056718|4688292|P1|Overall Study|Withdrawal by Subject|2
1421022|NCT01056653|4688325|P3|Overall Study|Lost to Follow-up|2
1421023|NCT01056653|4688326|P2|Overall Study|Lost to Follow-up|0
1421024|NCT01056653|4688327|P1|Overall Study|Lost to Follow-up|0
1421025|NCT01056640|4688343|P2|Overall Study|Death|4
1421026|NCT01056640|4688344|P1|Overall Study|Death|15
1421027|NCT01056640|4688343|P2|Overall Study|Withdrawal by Subject|8
1421028|NCT01056640|4688344|P1|Overall Study|Withdrawal by Subject|11
1421029|NCT01056523|4688356|P7|Overall Study|Death|1
1421030|NCT01056523|4688357|P6|Overall Study|Death|0
1421031|NCT01056523|4688358|P5|Overall Study|Death|0
1421032|NCT01056523|4688359|P4|Overall Study|Death|3
1421033|NCT01056523|4688360|P3|Overall Study|Death|2
1421034|NCT01056523|4688361|P2|Overall Study|Death|0
1421035|NCT01056523|4688362|P1|Overall Study|Death|1
1421036|NCT01056510|4688372|P2|Overall Study|Missing|1
1421037|NCT01056510|4688373|P1|Overall Study|Missing|0
1421038|NCT01056510|4688372|P2|Overall Study|Not Specified|12
1421040|NCT01056510|4688372|P2|Overall Study|Lost to Follow-up|6
1421041|NCT01056510|4688373|P1|Overall Study|Lost to Follow-up|5
1421042|NCT01056510|4688372|P2|Overall Study|Physician Decision|5
1421043|NCT01056510|4688373|P1|Overall Study|Physician Decision|4
1421044|NCT01056510|4688372|P2|Overall Study|Noncompliance|3
1421045|NCT01056510|4688373|P1|Overall Study|Noncompliance|1
1421046|NCT01056510|4688372|P2|Overall Study|Death|34
1421047|NCT01056510|4688373|P1|Overall Study|Death|29
1421048|NCT01056510|4688372|P2|Overall Study|Withdrawal by Subject|2
1421049|NCT01056510|4688373|P1|Overall Study|Withdrawal by Subject|4
1421050|NCT01056510|4688372|P2|Overall Study|Dropout Before Start of Treatment|1
1421051|NCT01056510|4688373|P1|Overall Study|Dropout Before Start of Treatment|1
1421052|NCT01056484|4688419|P2|Follow up - Non-randomized|Withdrawal by Subject|2
1421053|NCT01056484|4688420|P1|Follow up - Non-randomized|Withdrawal by Subject|0
1421054|NCT01056484|4688419|P2|Randomized Controlled Trial|Physician Decision|0
1421055|NCT01056484|4688420|P1|Randomized Controlled Trial|Physician Decision|1
1421056|NCT01056484|4688419|P2|Randomized Controlled Trial|Withdrawal by Subject|1
1421057|NCT01056484|4688420|P1|Randomized Controlled Trial|Withdrawal by Subject|6
1421058|NCT01056380|4688436|P2|Overall Study|Lost to Follow-up|3
1421059|NCT01056380|4688437|P1|Overall Study|Lost to Follow-up|2
1421060|NCT01056341|4688464|P5|Overall Study|Other reasons|5
1421061|NCT01056341|4688465|P4|Overall Study|Other reasons|9
1421062|NCT01056341|4688466|P3|Overall Study|Other reasons|8
1421063|NCT01056341|4688467|P2|Overall Study|Other reasons|4
1421064|NCT01056341|4688468|P1|Overall Study|Other reasons|4
1421065|NCT01056341|4688464|P5|Overall Study|Lack of Efficacy|9
1421066|NCT01056341|4688465|P4|Overall Study|Lack of Efficacy|25
1421067|NCT01056341|4688466|P3|Overall Study|Lack of Efficacy|7
1421068|NCT01056341|4688467|P2|Overall Study|Lack of Efficacy|30
1421069|NCT01056341|4688468|P1|Overall Study|Lack of Efficacy|32
1421070|NCT01056341|4688464|P5|Overall Study|Treatment Intolerance|0
1421071|NCT01056341|4688465|P4|Overall Study|Treatment Intolerance|2
1421072|NCT01056341|4688466|P3|Overall Study|Treatment Intolerance|0
1421073|NCT01056341|4688467|P2|Overall Study|Treatment Intolerance|2
1421074|NCT01056341|4688468|P1|Overall Study|Treatment Intolerance|0
1421075|NCT01056289|4688541|P4|Double-blind Phase|Physician Decision|0
1421076|NCT01056289|4688542|P3|Double-blind Phase|Physician Decision|1
1421077|NCT01056289|4688543|P2|Double-blind Phase|Physician Decision|0
1421078|NCT01056289|4688544|P1|Double-blind Phase|Physician Decision|0
1421079|NCT01056289|4688541|P4|Double-blind Phase|Discontinuation symptom|2
1421080|NCT01056289|4688542|P3|Double-blind Phase|Discontinuation symptom|2
1421081|NCT01056289|4688543|P2|Double-blind Phase|Discontinuation symptom|1
1421082|NCT01056289|4688544|P1|Double-blind Phase|Discontinuation symptom|0
1421083|NCT01056289|4688541|P4|Double-blind Phase|Withdrawal by Subject|2
1421084|NCT01056289|4688542|P3|Double-blind Phase|Withdrawal by Subject|4
1421085|NCT01056289|4688543|P2|Double-blind Phase|Withdrawal by Subject|0
1421086|NCT01056289|4688544|P1|Double-blind Phase|Withdrawal by Subject|0
1421087|NCT01056289|4688541|P4|Double-blind Phase|Protocol Violation|1
1421088|NCT01056289|4688542|P3|Double-blind Phase|Protocol Violation|1
1421089|NCT01056289|4688543|P2|Double-blind Phase|Protocol Violation|0
1421090|NCT01056289|4688544|P1|Double-blind Phase|Protocol Violation|0
1421091|NCT01056289|4688541|P4|Double-blind Phase|Other|2
1421092|NCT01056289|4688542|P3|Double-blind Phase|Other|1
1421093|NCT01056289|4688543|P2|Double-blind Phase|Other|0
1421094|NCT01056289|4688544|P1|Double-blind Phase|Other|0
1421095|NCT01056289|4688541|P4|Double-blind Phase|Lost to Follow-up|2
1421096|NCT01056289|4688542|P3|Double-blind Phase|Lost to Follow-up|2
1421097|NCT01056289|4688543|P2|Double-blind Phase|Lost to Follow-up|2
1421098|NCT01056289|4688544|P1|Double-blind Phase|Lost to Follow-up|0
1421099|NCT01056289|4688541|P4|Double-blind Phase|Adverse Event|1
1421100|NCT01056289|4688542|P3|Double-blind Phase|Adverse Event|2
1421101|NCT01056289|4688543|P2|Double-blind Phase|Adverse Event|1
1421102|NCT01056289|4688544|P1|Double-blind Phase|Adverse Event|0
1421103|NCT01056289|4688541|P4|Open-label Phase|Not randomized to Double-blind phase|0
1421104|NCT01056289|4688542|P3|Open-label Phase|Not randomized to Double-blind phase|0
1421105|NCT01056289|4688543|P2|Open-label Phase|Not randomized to Double-blind phase|0
1421106|NCT01056289|4688544|P1|Open-label Phase|Not randomized to Double-blind phase|1
1421107|NCT01056289|4688541|P4|Open-label Phase|Lack of Efficacy|0
1421108|NCT01056289|4688542|P3|Open-label Phase|Lack of Efficacy|0
1421109|NCT01056289|4688543|P2|Open-label Phase|Lack of Efficacy|0
1421110|NCT01056289|4688544|P1|Open-label Phase|Lack of Efficacy|18
1421111|NCT01056289|4688541|P4|Open-label Phase|Withdrawal by Subject|0
1421112|NCT01056289|4688542|P3|Open-label Phase|Withdrawal by Subject|0
1421113|NCT01056289|4688543|P2|Open-label Phase|Withdrawal by Subject|0
1421114|NCT01056289|4688544|P1|Open-label Phase|Withdrawal by Subject|26
1421115|NCT01056289|4688541|P4|Open-label Phase|Protocol Violation|0
1421116|NCT01056289|4688542|P3|Open-label Phase|Protocol Violation|0
1421117|NCT01056289|4688543|P2|Open-label Phase|Protocol Violation|0
1421118|NCT01056289|4688544|P1|Open-label Phase|Protocol Violation|6
1421119|NCT01056289|4688541|P4|Open-label Phase|Other|0
1421120|NCT01056289|4688542|P3|Open-label Phase|Other|0
1421121|NCT01056289|4688543|P2|Open-label Phase|Other|0
1421122|NCT01056289|4688544|P1|Open-label Phase|Other|9
1421123|NCT01056289|4688541|P4|Open-label Phase|Lost to Follow-up|0
1421124|NCT01056289|4688542|P3|Open-label Phase|Lost to Follow-up|0
1421125|NCT01056289|4688543|P2|Open-label Phase|Lost to Follow-up|0
1421126|NCT01056289|4688544|P1|Open-label Phase|Lost to Follow-up|30
1421127|NCT01056289|4688541|P4|Open-label Phase|Adverse Event|0
1421128|NCT01056289|4688542|P3|Open-label Phase|Adverse Event|0
1421129|NCT01056289|4688543|P2|Open-label Phase|Adverse Event|0
1421130|NCT01056289|4688544|P1|Open-label Phase|Adverse Event|29
1421131|NCT01056276|4688561|P2|Maintenance Therapy|Continuing maintenance therapy|14
1421132|NCT01056276|4688562|P1|Maintenance Therapy|Continuing maintenance therapy|0
1421133|NCT01056276|4688561|P2|Maintenance Therapy|Intercurrent Illness|1
1421134|NCT01056276|4688562|P1|Maintenance Therapy|Intercurrent Illness|0
1421135|NCT01056276|4688561|P2|Maintenance Therapy|Withdrawal by Subject|1
1421136|NCT01056276|4688562|P1|Maintenance Therapy|Withdrawal by Subject|0
1421137|NCT01056276|4688561|P2|Maintenance Therapy|Physician Decision|1
1421138|NCT01056276|4688562|P1|Maintenance Therapy|Physician Decision|0
1421139|NCT01056276|4688561|P2|Maintenance Therapy|Progressive Disease|9
1421140|NCT01056276|4688562|P1|Maintenance Therapy|Progressive Disease|0
1421141|NCT01056276|4688561|P2|Maintenance Therapy|Toxicity|2
1421142|NCT01056276|4688562|P1|Maintenance Therapy|Toxicity|0
1421143|NCT01056276|4688561|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
1421144|NCT01056276|4688562|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
1421145|NCT01056276|4688561|P2|Treatment Period-Cycles 1-8|Death|1
1421146|NCT01056276|4688562|P1|Treatment Period-Cycles 1-8|Death|3
1421147|NCT01056276|4688561|P2|Treatment Period-Cycles 1-8|Physician Decision|0
1421148|NCT01056276|4688562|P1|Treatment Period-Cycles 1-8|Physician Decision|3
1421149|NCT01056276|4688561|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
1421150|NCT01056276|4688562|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
1421151|NCT01056276|4688561|P2|Treatment Period-Cycles 1-8|Disease Progression|2
1421152|NCT01056276|4688562|P1|Treatment Period-Cycles 1-8|Disease Progression|2
1421153|NCT01056276|4688561|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
1421154|NCT01056276|4688562|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
1421155|NCT01056276|4688561|P2|Treatment Period-Cycles 1-8|Toxicity|1
1421156|NCT01056276|4688562|P1|Treatment Period-Cycles 1-8|Toxicity|2
1421157|NCT01056263|4688576|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
1421158|NCT01056263|4688576|P1|Overall Study|Objective progression or relapse|1
1421159|NCT01056263|4688576|P1|Overall Study|Neoplasm progression|1
1421160|NCT01056263|4688576|P1|Overall Study|Progressive disease|2
1421161|NCT01056263|4688576|P1|Overall Study|Lack of Efficacy|29
1421162|NCT01056263|4688576|P1|Overall Study|Withdrawal by Subject|1
1421163|NCT01056263|4688576|P1|Overall Study|Death|1
1421164|NCT01056263|4688576|P1|Overall Study|Adverse Event|12
1421165|NCT01056107|4688599|P4|Overall Study|Withdrawal by Subject|0
1421166|NCT01056107|4688600|P3|Overall Study|Withdrawal by Subject|3
1421167|NCT01056107|4688601|P2|Overall Study|Withdrawal by Subject|1
1421168|NCT01056107|4688602|P1|Overall Study|Withdrawal by Subject|0
1421169|NCT01055886|4688659|P2|Overall Study|Withdrawal by PI|1
1421170|NCT01055886|4688660|P1|Overall Study|Withdrawal by PI|0
1421171|NCT01055886|4688659|P2|Overall Study|Lost to Follow-up|1
1421172|NCT01055886|4688660|P1|Overall Study|Lost to Follow-up|1
1421173|NCT01055886|4688659|P2|Overall Study|Withdrawal by Subject|9
1421174|NCT01055886|4688660|P1|Overall Study|Withdrawal by Subject|4
1421175|NCT01055834|4688672|P2|Treatment Period I|Adverse Event|0
1421176|NCT01055834|4688673|P1|Treatment Period I|Adverse Event|1
1421177|NCT01055639|4688758|P2|Overall Study|Withdrawal by Subject|11
1421178|NCT01055639|4688759|P1|Overall Study|Withdrawal by Subject|8
1421179|NCT01055639|4688758|P2|Overall Study|Protocol Violation|5
1421180|NCT01055639|4688759|P1|Overall Study|Protocol Violation|5
1421181|NCT01055639|4688758|P2|Overall Study|Lost to Follow-up|11
1421182|NCT01055639|4688759|P1|Overall Study|Lost to Follow-up|8
1421183|NCT01055639|4688758|P2|Overall Study|Lack of Efficacy|1
1421184|NCT01055639|4688759|P1|Overall Study|Lack of Efficacy|0
1421185|NCT01055639|4688758|P2|Overall Study|Adverse Event|1
1421186|NCT01055639|4688759|P1|Overall Study|Adverse Event|0
1421187|NCT01055613|4688783|P2|Overall Study|Subject Disinterest|1
1421188|NCT01055613|4688784|P1|Overall Study|Subject Disinterest|1
1421189|NCT01055613|4688783|P2|Overall Study|Protocol Violation|1
1421190|NCT01055613|4688784|P1|Overall Study|Protocol Violation|1
1421191|NCT01055613|4688783|P2|Overall Study|Lost to Follow-up|1
1421192|NCT01055613|4688784|P1|Overall Study|Lost to Follow-up|1
1421193|NCT01055613|4688783|P2|Overall Study|Discomfort|1
1421194|NCT01055613|4688784|P1|Overall Study|Discomfort|2
1421195|NCT01055613|4688783|P2|Overall Study|Unacceptable lens fit|0
1421196|NCT01055613|4688784|P1|Overall Study|Unacceptable lens fit|1
1421197|NCT01055613|4688783|P2|Overall Study|No Longer Meets Eligibility Criteria|0
1421198|NCT01055613|4688784|P1|Overall Study|No Longer Meets Eligibility Criteria|3
1421199|NCT01055457|4688802|P10|Overall Study|Adverse Event|0
1421200|NCT01055457|4688803|P9|Overall Study|Adverse Event|0
1421201|NCT01055457|4688804|P8|Overall Study|Adverse Event|0
1421202|NCT01055457|4688805|P7|Overall Study|Adverse Event|0
1421203|NCT01055457|4688806|P6|Overall Study|Adverse Event|0
1421204|NCT01055457|4688807|P5|Overall Study|Adverse Event|0
1421205|NCT01055457|4688808|P4|Overall Study|Adverse Event|1
1421206|NCT01055457|4688809|P3|Overall Study|Adverse Event|0
1421207|NCT01055457|4688810|P2|Overall Study|Adverse Event|0
1421208|NCT01055457|4688811|P1|Overall Study|Adverse Event|0
1421209|NCT01055457|4688802|P10|Overall Study|Pregnancy|0
1421210|NCT01055457|4688803|P9|Overall Study|Pregnancy|0
1421211|NCT01055457|4688804|P8|Overall Study|Pregnancy|0
1421212|NCT01055457|4688805|P7|Overall Study|Pregnancy|0
1421213|NCT01055457|4688806|P6|Overall Study|Pregnancy|0
1421214|NCT01055457|4688807|P5|Overall Study|Pregnancy|0
1421215|NCT01055457|4688808|P4|Overall Study|Pregnancy|1
1421216|NCT01055457|4688809|P3|Overall Study|Pregnancy|0
1421217|NCT01055457|4688810|P2|Overall Study|Pregnancy|0
1421218|NCT01055457|4688811|P1|Overall Study|Pregnancy|0
1421219|NCT01055457|4688802|P10|Overall Study|Discomfort|0
1421220|NCT01055457|4688803|P9|Overall Study|Discomfort|0
1421221|NCT01055457|4688804|P8|Overall Study|Discomfort|0
1421222|NCT01055457|4688805|P7|Overall Study|Discomfort|0
1421223|NCT01055457|4688806|P6|Overall Study|Discomfort|0
1421224|NCT01055457|4688807|P5|Overall Study|Discomfort|1
1421225|NCT01055457|4688808|P4|Overall Study|Discomfort|0
1421226|NCT01055457|4688809|P3|Overall Study|Discomfort|0
1421227|NCT01055457|4688810|P2|Overall Study|Discomfort|0
1421228|NCT01055457|4688811|P1|Overall Study|Discomfort|0
1421229|NCT01055457|4688802|P10|Overall Study|Subject Ineligible|0
1421230|NCT01055457|4688803|P9|Overall Study|Subject Ineligible|0
1421231|NCT01055457|4688804|P8|Overall Study|Subject Ineligible|0
1421232|NCT01055457|4688805|P7|Overall Study|Subject Ineligible|0
1421233|NCT01055457|4688806|P6|Overall Study|Subject Ineligible|0
1421234|NCT01055457|4688807|P5|Overall Study|Subject Ineligible|1
1421235|NCT01055457|4688808|P4|Overall Study|Subject Ineligible|0
1421236|NCT01055457|4688809|P3|Overall Study|Subject Ineligible|1
1421237|NCT01055457|4688810|P2|Overall Study|Subject Ineligible|0
1421238|NCT01055457|4688811|P1|Overall Study|Subject Ineligible|1
1421239|NCT01055457|4688802|P10|Overall Study|Subject Disinterest|0
1421240|NCT01055457|4688803|P9|Overall Study|Subject Disinterest|0
1421241|NCT01055457|4688804|P8|Overall Study|Subject Disinterest|1
1421242|NCT01055457|4688805|P7|Overall Study|Subject Disinterest|0
1421243|NCT01055457|4688806|P6|Overall Study|Subject Disinterest|0
1421244|NCT01055457|4688807|P5|Overall Study|Subject Disinterest|0
1421245|NCT01055457|4688808|P4|Overall Study|Subject Disinterest|0
1421246|NCT01055457|4688809|P3|Overall Study|Subject Disinterest|0
1421247|NCT01055457|4688810|P2|Overall Study|Subject Disinterest|0
1421248|NCT01055457|4688811|P1|Overall Study|Subject Disinterest|0
1421249|NCT01055457|4688802|P10|Overall Study|Protocol Violation|1
1421250|NCT01055457|4688803|P9|Overall Study|Protocol Violation|0
1421251|NCT01055457|4688804|P8|Overall Study|Protocol Violation|0
1421252|NCT01055457|4688805|P7|Overall Study|Protocol Violation|1
1421253|NCT01055457|4688806|P6|Overall Study|Protocol Violation|2
1421254|NCT01055457|4688807|P5|Overall Study|Protocol Violation|1
1421255|NCT01055457|4688808|P4|Overall Study|Protocol Violation|1
1421256|NCT01055457|4688809|P3|Overall Study|Protocol Violation|1
1421257|NCT01055457|4688810|P2|Overall Study|Protocol Violation|0
1421258|NCT01055457|4688811|P1|Overall Study|Protocol Violation|0
1421259|NCT01055457|4688802|P10|Overall Study|Lost to Follow-up|0
1421260|NCT01055457|4688803|P9|Overall Study|Lost to Follow-up|0
1421261|NCT01055457|4688804|P8|Overall Study|Lost to Follow-up|0
1421262|NCT01055457|4688805|P7|Overall Study|Lost to Follow-up|0
1421263|NCT01055457|4688806|P6|Overall Study|Lost to Follow-up|1
1421264|NCT01055457|4688807|P5|Overall Study|Lost to Follow-up|0
1421265|NCT01055457|4688808|P4|Overall Study|Lost to Follow-up|0
1421266|NCT01055457|4688809|P3|Overall Study|Lost to Follow-up|0
1421267|NCT01055457|4688810|P2|Overall Study|Lost to Follow-up|1
1421268|NCT01055457|4688811|P1|Overall Study|Lost to Follow-up|0
1421269|NCT01055314|4688845|P2|Overall Study|No treatment|0
1421270|NCT01055314|4688846|P1|Overall Study|No treatment|1
1421271|NCT01055314|4688845|P2|Overall Study|Refusal of further protocol therapy|4
1421272|NCT01055314|4688846|P1|Overall Study|Refusal of further protocol therapy|10
1421273|NCT01055314|4688845|P2|Overall Study|Ineligible|5
1421274|NCT01055314|4688846|P1|Overall Study|Ineligible|3
1421275|NCT01055314|4688845|P2|Overall Study|Withdrawal by Subject|0
1421276|NCT01055314|4688846|P1|Overall Study|Withdrawal by Subject|1
1421277|NCT01055314|4688845|P2|Overall Study|Physician Decision|5
1421278|NCT01055314|4688846|P1|Overall Study|Physician Decision|10
1421279|NCT01055314|4688845|P2|Overall Study|Lack of Efficacy|19
1421280|NCT01055314|4688846|P1|Overall Study|Lack of Efficacy|11
1421281|NCT01055314|4688845|P2|Overall Study|Death|1
1421282|NCT01055314|4688846|P1|Overall Study|Death|2
1421283|NCT01055314|4688845|P2|Overall Study|Adverse Event|4
1421284|NCT01055314|4688846|P1|Overall Study|Adverse Event|7
1421285|NCT01055262|4688858|P1|Overall Study|Uncooperativeness|1
1421286|NCT01055262|4688858|P1|Overall Study|Protocol Violation|3
1421287|NCT01055262|4688858|P1|Overall Study|Adverse Event|5
1421288|NCT01055197|4688899|P2|Overall Study|Withdrawal by Subject|0
1421289|NCT01055197|4688900|P1|Overall Study|Withdrawal by Subject|2
1421290|NCT01055197|4688899|P2|Overall Study|Protocol Violation|2
1421291|NCT01055197|4688900|P1|Overall Study|Protocol Violation|7
1421292|NCT01055132|4688927|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
1421293|NCT01055132|4688928|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
1421294|NCT01055132|4688927|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
1421295|NCT01055132|4688928|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
1421296|NCT01055028|4688941|P2|Inter-treatment Period|Did not start Cycle 4|3
1421297|NCT01055028|4688942|P1|Inter-treatment Period|Did not start Cycle 4|0
1421298|NCT01055028|4688941|P2|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
1421299|NCT01055028|4688942|P1|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
1421300|NCT01055028|4688941|P2|Treatment Cycles 1 to 3|Adverse Event|1
1421301|NCT01055028|4688942|P1|Treatment Cycles 1 to 3|Adverse Event|0
1421302|NCT01055028|4688941|P2|Screening|Screen Failure|1
1421303|NCT01055028|4688942|P1|Screening|Screen Failure|1
1421304|NCT01054976|4688956|P1|Overall Study|Not specified|8
1421305|NCT01054976|4688956|P1|Overall Study|Withdrawal by Subject|4
1421306|NCT01054976|4688956|P1|Overall Study|Uncooperative participations to study|7
1421307|NCT01054976|4688956|P1|Overall Study|Adverse Event|16
1421308|NCT01054885|4688977|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
1421309|NCT01054885|4688978|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
1421310|NCT01054885|4688979|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
1421311|NCT01054885|4688980|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
1421312|NCT01054885|4688981|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
1421313|NCT01054885|4688982|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
1421314|NCT01054885|4688983|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
1421315|NCT01054885|4688977|P7|24-week, Double-blind Treatment Period|Physician Decision|1
1421316|NCT01054885|4688978|P6|24-week, Double-blind Treatment Period|Physician Decision|1
1421317|NCT01054885|4688979|P5|24-week, Double-blind Treatment Period|Physician Decision|3
1421318|NCT01054885|4688980|P4|24-week, Double-blind Treatment Period|Physician Decision|6
1421319|NCT01054885|4688981|P3|24-week, Double-blind Treatment Period|Physician Decision|1
1421320|NCT01054885|4688982|P2|24-week, Double-blind Treatment Period|Physician Decision|4
1421321|NCT01054885|4688983|P1|24-week, Double-blind Treatment Period|Physician Decision|0
1421322|NCT01054885|4688977|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
1421323|NCT01054885|4688978|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
1421324|NCT01054885|4688979|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1421325|NCT01054885|4688980|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1421326|NCT01054885|4688981|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
1421327|NCT01054885|4688982|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
1421328|NCT01054885|4688983|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1421329|NCT01054885|4688977|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
1421330|NCT01054885|4688978|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
1421331|NCT01054885|4688979|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
1421332|NCT01054885|4688980|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
1421333|NCT01054885|4688981|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
1421334|NCT01054885|4688982|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
1421335|NCT01054885|4688983|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
1421336|NCT01054885|4688977|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
1421337|NCT01054885|4688978|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
1421338|NCT01054885|4688979|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
1421339|NCT01054885|4688980|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
1421340|NCT01054885|4688981|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
1421341|NCT01054885|4688982|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
1421342|NCT01054885|4688983|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
1421343|NCT01054885|4688977|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
1421344|NCT01054885|4688978|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
1421345|NCT01054885|4688979|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
1421346|NCT01054885|4688980|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
1421347|NCT01054885|4688981|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
1421348|NCT01054885|4688982|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
1421349|NCT01054885|4688983|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
1421350|NCT01054885|4688977|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
1421351|NCT01054885|4688978|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
1421352|NCT01054885|4688979|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
1421353|NCT01054885|4688980|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
1421354|NCT01054885|4688981|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
1421355|NCT01054885|4688982|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
1421356|NCT01054885|4688983|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
1421357|NCT01054885|4688977|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1421358|NCT01054885|4688978|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
1421359|NCT01054885|4688979|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1421360|NCT01054885|4688980|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
1421361|NCT01054885|4688981|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
1421362|NCT01054885|4688982|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1421363|NCT01054885|4688983|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1421364|NCT01054885|4688977|P7|24-week, Double-blind Treatment Period|Adverse Event|19
1421365|NCT01054885|4688978|P6|24-week, Double-blind Treatment Period|Adverse Event|17
1421366|NCT01054885|4688979|P5|24-week, Double-blind Treatment Period|Adverse Event|15
1421367|NCT01054885|4688980|P4|24-week, Double-blind Treatment Period|Adverse Event|15
1421368|NCT01054885|4688981|P3|24-week, Double-blind Treatment Period|Adverse Event|12
1421369|NCT01054885|4688982|P2|24-week, Double-blind Treatment Period|Adverse Event|18
1421370|NCT01054885|4688983|P1|24-week, Double-blind Treatment Period|Adverse Event|0
1421371|NCT01054885|4688977|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1421372|NCT01054885|4688978|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1421373|NCT01054885|4688979|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1421374|NCT01054885|4688980|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1421375|NCT01054885|4688981|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1421376|NCT01054885|4688982|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1421377|NCT01054885|4688983|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
1421378|NCT01054885|4688977|P7|2-week, Single-blind Run-In Period|Adverse Event|0
1421379|NCT01054885|4688978|P6|2-week, Single-blind Run-In Period|Adverse Event|0
1421380|NCT01054885|4688979|P5|2-week, Single-blind Run-In Period|Adverse Event|0
1421381|NCT01054885|4688980|P4|2-week, Single-blind Run-In Period|Adverse Event|0
1421382|NCT01054885|4688981|P3|2-week, Single-blind Run-In Period|Adverse Event|0
1421383|NCT01054885|4688982|P2|2-week, Single-blind Run-In Period|Adverse Event|0
1421384|NCT01054885|4688983|P1|2-week, Single-blind Run-In Period|Adverse Event|7
1421385|NCT01054885|4688977|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1421386|NCT01054885|4688978|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1421387|NCT01054885|4688979|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1421388|NCT01054885|4688980|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1421389|NCT01054885|4688981|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1421390|NCT01054885|4688982|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1421391|NCT01054885|4688983|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
1421392|NCT01054885|4688977|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1421393|NCT01054885|4688978|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1421394|NCT01054885|4688979|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1421395|NCT01054885|4688980|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1421396|NCT01054885|4688981|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1421397|NCT01054885|4688982|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1421398|NCT01054885|4688983|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
1421399|NCT01054885|4688977|P7|2-week, Single-blind Run-In Period|Physician Decision|0
1421400|NCT01054885|4688978|P6|2-week, Single-blind Run-In Period|Physician Decision|0
1421401|NCT01054885|4688979|P5|2-week, Single-blind Run-In Period|Physician Decision|0
1421402|NCT01054885|4688980|P4|2-week, Single-blind Run-In Period|Physician Decision|0
1421403|NCT01054885|4688981|P3|2-week, Single-blind Run-In Period|Physician Decision|0
1421404|NCT01054885|4688982|P2|2-week, Single-blind Run-In Period|Physician Decision|0
1421405|NCT01054885|4688983|P1|2-week, Single-blind Run-In Period|Physician Decision|6
1421406|NCT01054885|4688977|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1421407|NCT01054885|4688978|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1421408|NCT01054885|4688979|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1421409|NCT01054885|4688980|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1421410|NCT01054885|4688981|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1421411|NCT01054885|4688982|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1421412|NCT01054885|4688983|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
1421413|NCT01054846|4689023|P2|Overall Study|Lost to Follow-up|17
1421414|NCT01054846|4689024|P1|Overall Study|Lost to Follow-up|76
1421415|NCT01054820|4689031|P1|Overall Study|Withdrawal by Subject|2
1421416|NCT01054729|4689053|P4|Overall Study|Lack of Efficacy|1
1421417|NCT01054729|4689054|P3|Overall Study|Lack of Efficacy|0
1421418|NCT01054729|4689055|P2|Overall Study|Lack of Efficacy|0
1421419|NCT01054729|4689056|P1|Overall Study|Lack of Efficacy|0
1421420|NCT01054729|4689053|P4|Overall Study|Subject moved|0
1421421|NCT01054729|4689054|P3|Overall Study|Subject moved|1
1421422|NCT01054729|4689055|P2|Overall Study|Subject moved|0
1421423|NCT01054729|4689056|P1|Overall Study|Subject moved|0
1421424|NCT01054729|4689053|P4|Overall Study|Personal/Obligations|0
1421425|NCT01054729|4689054|P3|Overall Study|Personal/Obligations|0
1421426|NCT01054729|4689055|P2|Overall Study|Personal/Obligations|1
1421427|NCT01054729|4689056|P1|Overall Study|Personal/Obligations|0
1421428|NCT01054729|4689053|P4|Overall Study|PEG/RBV Non-responder|0
1421429|NCT01054729|4689054|P3|Overall Study|PEG/RBV Non-responder|1
1421430|NCT01054729|4689055|P2|Overall Study|PEG/RBV Non-responder|0
1421431|NCT01054729|4689056|P1|Overall Study|PEG/RBV Non-responder|1
1421432|NCT01054729|4689053|P4|Overall Study|Non-responder|1
1421433|NCT01054729|4689054|P3|Overall Study|Non-responder|1
1421434|NCT01054729|4689055|P2|Overall Study|Non-responder|0
1421435|NCT01054729|4689056|P1|Overall Study|Non-responder|1
1421436|NCT01054729|4689053|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
1421437|NCT01054729|4689054|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
1421438|NCT01054729|4689055|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
1421439|NCT01054729|4689056|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
1421440|NCT01054729|4689053|P4|Overall Study|Lost to Follow-up|0
1421441|NCT01054729|4689054|P3|Overall Study|Lost to Follow-up|0
1421442|NCT01054729|4689055|P2|Overall Study|Lost to Follow-up|1
1421443|NCT01054729|4689056|P1|Overall Study|Lost to Follow-up|0
1421444|NCT01054729|4689053|P4|Overall Study|Withdrawal by Subject|0
1421445|NCT01054729|4689054|P3|Overall Study|Withdrawal by Subject|1
1421446|NCT01054729|4689055|P2|Overall Study|Withdrawal by Subject|0
1421447|NCT01054729|4689056|P1|Overall Study|Withdrawal by Subject|1
1421448|NCT01054729|4689053|P4|Overall Study|Adverse Event|1
1421449|NCT01054729|4689054|P3|Overall Study|Adverse Event|2
1421450|NCT01054729|4689055|P2|Overall Study|Adverse Event|1
1421451|NCT01054729|4689056|P1|Overall Study|Adverse Event|1
1421452|NCT01054729|4689053|P4|Overall Study|Randomized but Not Treated|0
1421453|NCT01054729|4689054|P3|Overall Study|Randomized but Not Treated|0
1421454|NCT01054729|4689055|P2|Overall Study|Randomized but Not Treated|1
1421455|NCT01054729|4689056|P1|Overall Study|Randomized but Not Treated|0
1421456|NCT01054599|4689154|P2|Overall Study|Withdrawal by Subject|1
1421457|NCT01054599|4689155|P1|Overall Study|Withdrawal by Subject|0
1421458|NCT01054599|4689154|P2|Overall Study|Adverse Event|1
1421459|NCT01054599|4689155|P1|Overall Study|Adverse Event|0
1421460|NCT01054599|4689154|P2|Overall Study|Lost to Follow-up|2
1421461|NCT01054599|4689155|P1|Overall Study|Lost to Follow-up|0
1421462|NCT01054599|4689154|P2|Overall Study|Visual impairment, WTAR <80|1
1421463|NCT01054599|4689155|P1|Overall Study|Visual impairment, WTAR <80|0
1421464|NCT01054599|4689154|P2|Overall Study|Timing/scheduling difficulties|1
1421465|NCT01054599|4689155|P1|Overall Study|Timing/scheduling difficulties|1
1421466|NCT01054599|4689154|P2|Overall Study|Spells/seizure-like episodes|1
1421467|NCT01054599|4689155|P1|Overall Study|Spells/seizure-like episodes|1
1421468|NCT01054599|4689154|P2|Overall Study|Protocol Violation|0
1421469|NCT01054599|4689155|P1|Overall Study|Protocol Violation|1
1421470|NCT01054599|4689154|P2|Overall Study|Dizziness due to phenytoin toxicity|0
1421471|NCT01054599|4689155|P1|Overall Study|Dizziness due to phenytoin toxicity|1
1421472|NCT01054573|4689262|P4|Overall Study|Withdrawal by Subject|1
1421473|NCT01054573|4689263|P3|Overall Study|Withdrawal by Subject|2
1421474|NCT01054573|4689264|P2|Overall Study|Withdrawal by Subject|2
1421475|NCT01054573|4689265|P1|Overall Study|Withdrawal by Subject|0
1421476|NCT01054573|4689262|P4|Overall Study|Lost to Follow-up|0
1421477|NCT01054573|4689263|P3|Overall Study|Lost to Follow-up|0
1421478|NCT01054573|4689264|P2|Overall Study|Lost to Follow-up|2
1421479|NCT01054573|4689265|P1|Overall Study|Lost to Follow-up|0
1421480|NCT01054573|4689262|P4|Overall Study|Adverse Event|1
1421481|NCT01054573|4689263|P3|Overall Study|Adverse Event|1
1421482|NCT01054573|4689264|P2|Overall Study|Adverse Event|0
1421483|NCT01054573|4689265|P1|Overall Study|Adverse Event|1
1421484|NCT01054560|4689311|P2|Overall Study|Physician Decision|0
1421485|NCT01054560|4689312|P1|Overall Study|Physician Decision|1
1421486|NCT01054560|4689311|P2|Overall Study|Withdrawal by Subject|2
1421487|NCT01054560|4689312|P1|Overall Study|Withdrawal by Subject|0
1421488|NCT01054560|4689311|P2|Overall Study|Lost to Follow-up|5
1421489|NCT01054560|4689312|P1|Overall Study|Lost to Follow-up|2
1421490|NCT01054560|4689311|P2|Overall Study|Death|21
1421491|NCT01054560|4689312|P1|Overall Study|Death|10
1421492|NCT01054222|4689362|P1|Overall Study|Withdrawal by Subject|6
1421493|NCT01054222|4689362|P1|Overall Study|Lost to Follow-up|4
1421494|NCT01054222|4689362|P1|Overall Study|Lack of Efficacy|1
1421495|NCT01054170|4689394|P2|Overall Study|Adverse Event|4
1421496|NCT01054170|4689395|P1|Overall Study|Adverse Event|0
1421497|NCT01054170|4689394|P2|Overall Study|Withdrawal by Subject|2
1421498|NCT01054170|4689395|P1|Overall Study|Withdrawal by Subject|3
1421499|NCT01054170|4689394|P2|Overall Study|Protocol Violation|0
1421500|NCT01054170|4689395|P1|Overall Study|Protocol Violation|1
1421501|NCT01053988|4689460|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
1421502|NCT01053988|4689461|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
1421503|NCT01053988|4689462|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
1421504|NCT01053988|4689463|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
1421505|NCT01053988|4689464|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
1421506|NCT01053988|4689465|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
1421507|NCT01053988|4689460|P6|24-week, Double-blind Treatment Period|Physician Decision|4
1421508|NCT01053988|4689461|P5|24-week, Double-blind Treatment Period|Physician Decision|5
1421509|NCT01053988|4689462|P4|24-week, Double-blind Treatment Period|Physician Decision|5
1421510|NCT01053988|4689463|P3|24-week, Double-blind Treatment Period|Physician Decision|2
1421511|NCT01053988|4689464|P2|24-week, Double-blind Treatment Period|Physician Decision|5
1421512|NCT01053988|4689465|P1|24-week, Double-blind Treatment Period|Physician Decision|0
1421513|NCT01053988|4689460|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
1421514|NCT01053988|4689461|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
1421515|NCT01053988|4689462|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
1421516|NCT01053988|4689463|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1421517|NCT01053988|4689464|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
1421518|NCT01053988|4689465|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1421519|NCT01053988|4689460|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
1421520|NCT01053988|4689461|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
1421521|NCT01053988|4689462|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
1421522|NCT01053988|4689463|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
1421523|NCT01053988|4689464|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
1421524|NCT01053988|4689465|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
1421525|NCT01053988|4689460|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
1421526|NCT01053988|4689461|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
1421527|NCT01053988|4689462|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
1421528|NCT01053988|4689463|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
1421529|NCT01053988|4689464|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
1421530|NCT01053988|4689465|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
1421531|NCT01053988|4689460|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
1421532|NCT01053988|4689461|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
1421533|NCT01053988|4689462|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
1421534|NCT01053988|4689463|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
1421535|NCT01053988|4689464|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
1421536|NCT01053988|4689465|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
1421537|NCT01053988|4689460|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1421538|NCT01053988|4689461|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
1421539|NCT01053988|4689462|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
1421540|NCT01053988|4689463|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
1421541|NCT01053988|4689464|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
1421542|NCT01053988|4689465|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1421543|NCT01053988|4689460|P6|24-week, Double-blind Treatment Period|Adverse Event|14
1421544|NCT01053988|4689461|P5|24-week, Double-blind Treatment Period|Adverse Event|17
1421545|NCT01053988|4689462|P4|24-week, Double-blind Treatment Period|Adverse Event|24
1421546|NCT01053988|4689463|P3|24-week, Double-blind Treatment Period|Adverse Event|23
1421547|NCT01053988|4689464|P2|24-week, Double-blind Treatment Period|Adverse Event|15
1421548|NCT01053988|4689465|P1|24-week, Double-blind Treatment Period|Adverse Event|0
1421549|NCT01053988|4689460|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1421550|NCT01053988|4689461|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1421551|NCT01053988|4689462|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1421552|NCT01053988|4689463|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1421553|NCT01053988|4689464|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1421554|NCT01053988|4689465|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
1421555|NCT01053988|4689460|P6|2-week, Single-blind Run-In Period|Physician Decision|0
1421556|NCT01053988|4689461|P5|2-week, Single-blind Run-In Period|Physician Decision|0
1421557|NCT01053988|4689462|P4|2-week, Single-blind Run-In Period|Physician Decision|0
1421558|NCT01053988|4689463|P3|2-week, Single-blind Run-In Period|Physician Decision|0
1421559|NCT01053988|4689464|P2|2-week, Single-blind Run-In Period|Physician Decision|0
1421560|NCT01053988|4689465|P1|2-week, Single-blind Run-In Period|Physician Decision|5
1421561|NCT01053988|4689460|P6|2-week, Single-blind Run-In Period|Adverse Event|0
1421562|NCT01053988|4689461|P5|2-week, Single-blind Run-In Period|Adverse Event|0
1421563|NCT01053988|4689462|P4|2-week, Single-blind Run-In Period|Adverse Event|0
1421564|NCT01053988|4689463|P3|2-week, Single-blind Run-In Period|Adverse Event|0
1421565|NCT01053988|4689464|P2|2-week, Single-blind Run-In Period|Adverse Event|0
1421566|NCT01053988|4689465|P1|2-week, Single-blind Run-In Period|Adverse Event|6
1421567|NCT01053988|4689460|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1421568|NCT01053988|4689461|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1421569|NCT01053988|4689462|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1421570|NCT01053988|4689463|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1421571|NCT01053988|4689464|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1421572|NCT01053988|4689465|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
1421573|NCT01053988|4689460|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1421574|NCT01053988|4689461|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1421575|NCT01053988|4689462|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1421576|NCT01053988|4689463|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1421577|NCT01053988|4689464|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1421578|NCT01053988|4689465|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
1421579|NCT01053988|4689460|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1421580|NCT01053988|4689461|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1421581|NCT01053988|4689462|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1421582|NCT01053988|4689463|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1421583|NCT01053988|4689464|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1421584|NCT01053988|4689465|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
1421585|NCT01053741|4689516|P2|2nd Study Intervention|Physician Decision|1
1421586|NCT01053741|4689517|P1|2nd Study Intervention|Physician Decision|0
1421587|NCT01053663|4689526|P1|Overall Study|Negative Influenza Diagnosis|1
1421588|NCT01053663|4689526|P1|Overall Study|Transferred to Another Hospital|1
1421589|NCT01053663|4689526|P1|Overall Study|Poor IV Access|1
1421590|NCT01053663|4689526|P1|Overall Study|Lost to Follow-up|1
1421591|NCT01053663|4689526|P1|Overall Study|Death|2
1421592|NCT01053429|4689584|P1|Overall Study|Other|309
1421593|NCT01053429|4689584|P1|Overall Study|Adverse Event|64
1421594|NCT01053247|4689614|P3|Overall Study|Adverse Event|3
1421595|NCT01053247|4689615|P2|Overall Study|Adverse Event|9
1421596|NCT01053247|4689616|P1|Overall Study|Adverse Event|0
1421597|NCT01053247|4689614|P3|Overall Study|Lost to Follow-up|7
1421598|NCT01053247|4689615|P2|Overall Study|Lost to Follow-up|5
1421599|NCT01053247|4689616|P1|Overall Study|Lost to Follow-up|8
1421600|NCT01053247|4689614|P3|Overall Study|Protocol Violation|2
1421601|NCT01053247|4689615|P2|Overall Study|Protocol Violation|1
1421602|NCT01053247|4689616|P1|Overall Study|Protocol Violation|2
1421603|NCT01053247|4689614|P3|Overall Study|Lack of Efficacy|1
1421604|NCT01053247|4689615|P2|Overall Study|Lack of Efficacy|0
1421605|NCT01053247|4689616|P1|Overall Study|Lack of Efficacy|1
1421606|NCT01053247|4689614|P3|Overall Study|Withdrawal by Subject|15
1421607|NCT01053247|4689615|P2|Overall Study|Withdrawal by Subject|4
1421608|NCT01053247|4689616|P1|Overall Study|Withdrawal by Subject|9
1421609|NCT01052844|4689710|P2|Overall Study|Adverse Event|1
1421610|NCT01052844|4689711|P1|Overall Study|Adverse Event|0
1421611|NCT01052779|4689732|P2|Overall Study|Other-Missed Week 5 Visit|0
1421612|NCT01052779|4689733|P1|Overall Study|Other-Missed Week 5 Visit|2
1421613|NCT01052779|4689732|P2|Overall Study|Other-Surgery|2
1421614|NCT01052779|4689733|P1|Overall Study|Other-Surgery|0
1421615|NCT01052779|4689732|P2|Overall Study|Other-Protocol Violation|1
1421616|NCT01052779|4689733|P1|Overall Study|Other-Protocol Violation|1
1421617|NCT01052779|4689732|P2|Overall Study|Withdrawal by Subject|2
1421618|NCT01052779|4689733|P1|Overall Study|Withdrawal by Subject|1
1421619|NCT01052779|4689732|P2|Overall Study|Adverse Event|4
1421620|NCT01052779|4689733|P1|Overall Study|Adverse Event|1
1421621|NCT01052714|4689743|P3|Overall Study|Withdrawal by Subject|1
1421622|NCT01052714|4689744|P2|Overall Study|Withdrawal by Subject|12
1421623|NCT01052714|4689745|P1|Overall Study|Withdrawal by Subject|7
1421624|NCT01052714|4689743|P3|Overall Study|Physician Decision|1
1421625|NCT01052714|4689744|P2|Overall Study|Physician Decision|9
1421626|NCT01052714|4689745|P1|Overall Study|Physician Decision|9
1421627|NCT01052714|4689743|P3|Overall Study|Lost to Follow-up|0
1421628|NCT01052714|4689744|P2|Overall Study|Lost to Follow-up|3
1421629|NCT01052714|4689745|P1|Overall Study|Lost to Follow-up|2
1421630|NCT01052714|4689743|P3|Overall Study|Death|0
1421631|NCT01052714|4689744|P2|Overall Study|Death|2
1421632|NCT01052714|4689745|P1|Overall Study|Death|1
1421633|NCT01052714|4689743|P3|Overall Study|Adverse Event|0
1421634|NCT01052714|4689744|P2|Overall Study|Adverse Event|3
1421635|NCT01052714|4689745|P1|Overall Study|Adverse Event|6
1421636|NCT01052662|4689799|P3|Overall Study|Administrative|0
1421637|NCT01052662|4689800|P2|Overall Study|Administrative|3
1421638|NCT01052662|4689801|P1|Overall Study|Administrative|0
1421639|NCT01052662|4689799|P3|Overall Study|Legal Problem|0
1421640|NCT01052662|4689800|P2|Overall Study|Legal Problem|0
1421641|NCT01052662|4689801|P1|Overall Study|Legal Problem|2
1421642|NCT01052662|4689799|P3|Overall Study|Adverse Event|0
1421643|NCT01052662|4689800|P2|Overall Study|Adverse Event|1
1421644|NCT01052662|4689801|P1|Overall Study|Adverse Event|1
1421645|NCT01052662|4689799|P3|Overall Study|Pharmacy issue|3
1421646|NCT01052662|4689800|P2|Overall Study|Pharmacy issue|3
1421647|NCT01052662|4689801|P1|Overall Study|Pharmacy issue|1
1421648|NCT01052662|4689799|P3|Overall Study|Withdrawal by Subject|1
1421649|NCT01052662|4689800|P2|Overall Study|Withdrawal by Subject|2
1421650|NCT01052662|4689801|P1|Overall Study|Withdrawal by Subject|3
1421651|NCT01052662|4689799|P3|Overall Study|Lost to Follow-up|18
1421652|NCT01052662|4689800|P2|Overall Study|Lost to Follow-up|13
1421653|NCT01052662|4689801|P1|Overall Study|Lost to Follow-up|15
1421654|NCT01052480|4689832|P2|Overall Study|Death|5
1421655|NCT01052480|4689833|P1|Overall Study|Death|1
1421656|NCT01052480|4689832|P2|Overall Study|Physician Decision|2
1421657|NCT01052480|4689833|P1|Overall Study|Physician Decision|0
1421658|NCT01052480|4689832|P2|Overall Study|Withdrawal by Subject|7
1421659|NCT01052480|4689833|P1|Overall Study|Withdrawal by Subject|3
1421660|NCT01052480|4689832|P2|Overall Study|Protocol Violation|0
1421661|NCT01052480|4689833|P1|Overall Study|Protocol Violation|1
1421662|NCT01052480|4689832|P2|Overall Study|Lost to Follow-up|3
1421663|NCT01052480|4689833|P1|Overall Study|Lost to Follow-up|3
1421664|NCT01052428|4689883|P2|Overall Study|Withdrawal by Subject|1
1421665|NCT01052428|4689884|P1|Overall Study|Withdrawal by Subject|0
1421666|NCT01052428|4689883|P2|Overall Study|Death|0
1421667|NCT01052428|4689884|P1|Overall Study|Death|1
1421668|NCT01052272|4689906|P4|Overall Study|decline in health|0
1421669|NCT01052272|4689907|P3|Overall Study|decline in health|1
1421670|NCT01052272|4689908|P2|Overall Study|decline in health|0
1421671|NCT01052272|4689909|P1|Overall Study|decline in health|0
1421672|NCT01052272|4689906|P4|Overall Study|placed in long-term care|0
1421673|NCT01052272|4689907|P3|Overall Study|placed in long-term care|1
1421674|NCT01052272|4689908|P2|Overall Study|placed in long-term care|0
1421675|NCT01052272|4689909|P1|Overall Study|placed in long-term care|0
1421676|NCT01052272|4689906|P4|Overall Study|Withdrawal by Subject|2
1421677|NCT01052272|4689907|P3|Overall Study|Withdrawal by Subject|3
1421678|NCT01052272|4689908|P2|Overall Study|Withdrawal by Subject|2
1421679|NCT01052272|4689909|P1|Overall Study|Withdrawal by Subject|0
1421680|NCT01052272|4689906|P4|Overall Study|patient refuses follow-up|4
1421681|NCT01052272|4689907|P3|Overall Study|patient refuses follow-up|2
1421682|NCT01052272|4689908|P2|Overall Study|patient refuses follow-up|4
1421683|NCT01052272|4689909|P1|Overall Study|patient refuses follow-up|5
1421684|NCT01052272|4689906|P4|Overall Study|Physician Decision|0
1421685|NCT01052272|4689907|P3|Overall Study|Physician Decision|0
1421686|NCT01052272|4689908|P2|Overall Study|Physician Decision|1
1421687|NCT01052272|4689909|P1|Overall Study|Physician Decision|0
1421688|NCT01052272|4689906|P4|Overall Study|Death|1
1421689|NCT01052272|4689907|P3|Overall Study|Death|1
1421690|NCT01052272|4689908|P2|Overall Study|Death|0
1421691|NCT01052272|4689909|P1|Overall Study|Death|0
1421692|NCT01052116|4689954|P2|Overall Study|Spirometry not performed|4
1421693|NCT01052116|4689955|P1|Overall Study|Spirometry not performed|0
1421694|NCT01052116|4689954|P2|Overall Study|Withdrawal by Subject|6
1421695|NCT01052116|4689955|P1|Overall Study|Withdrawal by Subject|3
1421696|NCT01052116|4689954|P2|Overall Study|Lost to Follow-up|17
1421697|NCT01052116|4689955|P1|Overall Study|Lost to Follow-up|11
1421698|NCT01052077|4689963|P4|Phase A+|Withdrawal by Subject|7
1421699|NCT01052077|4689964|P3|Phase A+|Withdrawal by Subject|0
1421700|NCT01052077|4689965|P2|Phase A+|Withdrawal by Subject|0
1421701|NCT01052077|4689966|P1|Phase A+|Withdrawal by Subject|0
1421702|NCT01052077|4689963|P4|Phase A+|Met Withdrawal Criteria|2
1421703|NCT01052077|4689964|P3|Phase A+|Met Withdrawal Criteria|0
1421704|NCT01052077|4689965|P2|Phase A+|Met Withdrawal Criteria|0
1421705|NCT01052077|4689966|P1|Phase A+|Met Withdrawal Criteria|0
1421706|NCT01052077|4689963|P4|Phase A+|Adverse Event|4
1421707|NCT01052077|4689964|P3|Phase A+|Adverse Event|0
1421708|NCT01052077|4689965|P2|Phase A+|Adverse Event|0
1421709|NCT01052077|4689966|P1|Phase A+|Adverse Event|0
1421710|NCT01052077|4689963|P4|Phase A+|Lost to Follow-up|8
1421711|NCT01052077|4689964|P3|Phase A+|Lost to Follow-up|0
1421712|NCT01052077|4689965|P2|Phase A+|Lost to Follow-up|0
1421713|NCT01052077|4689966|P1|Phase A+|Lost to Follow-up|0
1421714|NCT01052077|4689963|P4|Phase B|Lack of Efficacy|0
1421715|NCT01052077|4689964|P3|Phase B|Lack of Efficacy|0
1421716|NCT01052077|4689965|P2|Phase B|Lack of Efficacy|1
1421717|NCT01052077|4689966|P1|Phase B|Lack of Efficacy|0
1421718|NCT01052077|4689963|P4|Phase B|Protocol Deviation|0
1421719|NCT01052077|4689964|P3|Phase B|Protocol Deviation|4
1421720|NCT01052077|4689965|P2|Phase B|Protocol Deviation|3
1421721|NCT01052077|4689966|P1|Phase B|Protocol Deviation|0
1421722|NCT01052077|4689963|P4|Phase B|Withdrawal by Subject|0
1421723|NCT01052077|4689964|P3|Phase B|Withdrawal by Subject|5
1421724|NCT01052077|4689965|P2|Phase B|Withdrawal by Subject|0
1421725|NCT01052077|4689966|P1|Phase B|Withdrawal by Subject|0
1421726|NCT01052077|4689963|P4|Phase B|Physician Decision|0
1421727|NCT01052077|4689964|P3|Phase B|Physician Decision|1
1421728|NCT01052077|4689965|P2|Phase B|Physician Decision|1
1421729|NCT01052077|4689966|P1|Phase B|Physician Decision|0
1421730|NCT01052077|4689963|P4|Phase B|Met Withdrawal Criteria|0
1421731|NCT01052077|4689964|P3|Phase B|Met Withdrawal Criteria|1
1421732|NCT01052077|4689965|P2|Phase B|Met Withdrawal Criteria|2
1421733|NCT01052077|4689966|P1|Phase B|Met Withdrawal Criteria|0
1421734|NCT01052077|4689963|P4|Phase B|Adverse Event|0
1421735|NCT01052077|4689964|P3|Phase B|Adverse Event|2
1421736|NCT01052077|4689965|P2|Phase B|Adverse Event|9
1421737|NCT01052077|4689966|P1|Phase B|Adverse Event|0
1421738|NCT01052077|4689963|P4|Phase B|Lost to Follow-up|0
1421739|NCT01052077|4689964|P3|Phase B|Lost to Follow-up|3
1421740|NCT01052077|4689965|P2|Phase B|Lost to Follow-up|2
1421741|NCT01052077|4689966|P1|Phase B|Lost to Follow-up|0
1421742|NCT01052077|4689963|P4|Phase A|Protocol Deviation|0
1421743|NCT01052077|4689964|P3|Phase A|Protocol Deviation|0
1421744|NCT01052077|4689965|P2|Phase A|Protocol Deviation|0
1421745|NCT01052077|4689966|P1|Phase A|Protocol Deviation|27
1421746|NCT01052077|4689963|P4|Phase A|Withdrawal by Subject|0
1421747|NCT01052077|4689964|P3|Phase A|Withdrawal by Subject|0
1421748|NCT01052077|4689965|P2|Phase A|Withdrawal by Subject|0
1421749|NCT01052077|4689966|P1|Phase A|Withdrawal by Subject|29
1421750|NCT01052077|4689963|P4|Phase A|Physician Decision|0
1421751|NCT01052077|4689964|P3|Phase A|Physician Decision|0
1421752|NCT01052077|4689965|P2|Phase A|Physician Decision|0
1421753|NCT01052077|4689966|P1|Phase A|Physician Decision|10
1421754|NCT01052077|4689963|P4|Phase A|Met Withdrawal Criteria|0
1421755|NCT01052077|4689964|P3|Phase A|Met Withdrawal Criteria|0
1421756|NCT01052077|4689965|P2|Phase A|Met Withdrawal Criteria|0
1421757|NCT01052077|4689966|P1|Phase A|Met Withdrawal Criteria|26
1421758|NCT01052077|4689963|P4|Phase A|Adverse Event|0
1421759|NCT01052077|4689964|P3|Phase A|Adverse Event|0
1421760|NCT01052077|4689965|P2|Phase A|Adverse Event|0
1421761|NCT01052077|4689966|P1|Phase A|Adverse Event|32
1421762|NCT01052077|4689963|P4|Phase A|Lost to Follow-up|0
1421763|NCT01052077|4689964|P3|Phase A|Lost to Follow-up|0
1421764|NCT01052077|4689965|P2|Phase A|Lost to Follow-up|0
1421765|NCT01052077|4689966|P1|Phase A|Lost to Follow-up|22
1421766|NCT01052038|4689993|P3|Overall Study|Protocol Violation|3
1421767|NCT01052038|4689994|P2|Overall Study|Protocol Violation|3
1421768|NCT01052038|4689995|P1|Overall Study|Protocol Violation|2
1421769|NCT01052038|4689993|P3|Overall Study|Lost to Follow-up|1
1421770|NCT01052038|4689994|P2|Overall Study|Lost to Follow-up|3
1421771|NCT01052038|4689995|P1|Overall Study|Lost to Follow-up|2
1421772|NCT01051986|4690017|P2|Overall Study|Protocol Violation|3
1421773|NCT01051986|4690018|P1|Overall Study|Protocol Violation|2
1421774|NCT01051986|4690017|P2|Overall Study|Withdrawal by Subject|1
1421775|NCT01051986|4690018|P1|Overall Study|Withdrawal by Subject|2
1421776|NCT01051986|4690017|P2|Overall Study|Death|0
1421777|NCT01051986|4690018|P1|Overall Study|Death|1
1421778|NCT01051921|4690032|P1|Overall Study|patient moved|1
1421779|NCT01051921|4690032|P1|Overall Study|virological failure|1
1421780|NCT01051921|4690032|P1|Overall Study|Lost to Follow-up|4
1421781|NCT01051921|4690032|P1|Overall Study|Withdrawal by Subject|7
1421782|NCT01051921|4690032|P1|Overall Study|Adverse Event|8
1421783|NCT01051921|4690032|P1|Overall Study|Physician Decision|9
1421784|NCT01051856|4690039|P2|Overall Study|Withdrawal by Subject|0
1421785|NCT01051856|4690040|P1|Overall Study|Withdrawal by Subject|1
1421786|NCT01051817|4690050|P2|Overall Study|Protocol Violation|1
1421787|NCT01051817|4690051|P1|Overall Study|Protocol Violation|0
1421788|NCT01051817|4690050|P2|Overall Study|Withdrawal by Subject|5
1421789|NCT01051817|4690051|P1|Overall Study|Withdrawal by Subject|3
1421790|NCT01051817|4690050|P2|Overall Study|Abnormal Test Proceedure reults|1
1421791|NCT01051817|4690051|P1|Overall Study|Abnormal Test Proceedure reults|0
1421792|NCT01051817|4690050|P2|Overall Study|Adverse Event|2
1421793|NCT01051817|4690051|P1|Overall Study|Adverse Event|0
1421794|NCT01051791|4690061|P1|Overall Study|Withdrawal by Subject|1
1421795|NCT01051791|4690061|P1|Overall Study|Failed screening|3
1421796|NCT01051739|4690079|P2|Overall Study|Withdrawal by Subject|10
1421797|NCT01051739|4690080|P1|Overall Study|Withdrawal by Subject|25
1421798|NCT01051739|4690079|P2|Overall Study|Death|3
1421799|NCT01051739|4690080|P1|Overall Study|Death|3
1421800|NCT01051557|4690097|P7|Overall Study|Adverse Event|4
1421801|NCT01051557|4690098|P6|Overall Study|Adverse Event|3
1421802|NCT01051557|4690099|P5|Overall Study|Adverse Event|1
1421803|NCT01051557|4690100|P4|Overall Study|Adverse Event|1
1421804|NCT01051557|4690101|P3|Overall Study|Adverse Event|0
1421805|NCT01051557|4690102|P2|Overall Study|Adverse Event|0
1421806|NCT01051557|4690103|P1|Overall Study|Adverse Event|0
1421807|NCT01051557|4690097|P7|Overall Study|Withdrawal by Subject|1
1421808|NCT01051557|4690098|P6|Overall Study|Withdrawal by Subject|0
1421809|NCT01051557|4690099|P5|Overall Study|Withdrawal by Subject|2
1421810|NCT01051557|4690100|P4|Overall Study|Withdrawal by Subject|0
1421811|NCT01051557|4690101|P3|Overall Study|Withdrawal by Subject|1
1421812|NCT01051557|4690102|P2|Overall Study|Withdrawal by Subject|0
1421813|NCT01051557|4690103|P1|Overall Study|Withdrawal by Subject|0
1421814|NCT01051557|4690097|P7|Overall Study|disease progression|1
1421815|NCT01051557|4690098|P6|Overall Study|disease progression|3
1421816|NCT01051557|4690099|P5|Overall Study|disease progression|4
1421817|NCT01051557|4690100|P4|Overall Study|disease progression|2
1421818|NCT01051557|4690101|P3|Overall Study|disease progression|5
1421819|NCT01051557|4690102|P2|Overall Study|disease progression|3
1421820|NCT01051557|4690103|P1|Overall Study|disease progression|3
1421821|NCT01051557|4690097|P7|Overall Study|Physician Decision|0
1421822|NCT01051557|4690098|P6|Overall Study|Physician Decision|0
1421823|NCT01051557|4690099|P5|Overall Study|Physician Decision|0
1421824|NCT01051557|4690100|P4|Overall Study|Physician Decision|0
1421825|NCT01051557|4690101|P3|Overall Study|Physician Decision|0
1421826|NCT01051557|4690102|P2|Overall Study|Physician Decision|0
1421827|NCT01051557|4690103|P1|Overall Study|Physician Decision|1
1421828|NCT01051466|4690122|P2|Overall Study|Physician Decision|0
1421829|NCT01051466|4690123|P1|Overall Study|Physician Decision|1
1421830|NCT01051466|4690122|P2|Overall Study|Entry Criteria Not Met|3
1421831|NCT01051466|4690123|P1|Overall Study|Entry Criteria Not Met|0
1421832|NCT01051466|4690122|P2|Overall Study|Withdrawal by Subject|1
1421833|NCT01051466|4690123|P1|Overall Study|Withdrawal by Subject|5
1421834|NCT01051466|4690122|P2|Overall Study|Lost to Follow-up|1
1421835|NCT01051466|4690123|P1|Overall Study|Lost to Follow-up|1
1421836|NCT01051466|4690122|P2|Overall Study|Adverse Event|0
1421837|NCT01051466|4690123|P1|Overall Study|Adverse Event|1
1421838|NCT01051323|4690170|P1|Overall Study|Missing|37
1421839|NCT01051323|4690170|P1|Overall Study|Other|148
1421840|NCT01051323|4690170|P1|Overall Study|Hospitalization|28
1421841|NCT01051323|4690170|P1|Overall Study|Death|129
1421842|NCT01051323|4690170|P1|Overall Study|Lost to Follow-up|31
1421843|NCT01051323|4690170|P1|Overall Study|Withdrawal by Subject|13
1421844|NCT01051323|4690170|P1|Overall Study|Dialysis dependency|22
1421845|NCT01051323|4690170|P1|Overall Study|Transplantation|28
1421846|NCT01051323|4690170|P1|Overall Study|Discontinuation of treatment|103
1421847|NCT01050998|4690197|P5|Overall Study|Data integrity issues|4
1421848|NCT01050998|4690198|P4|Overall Study|Data integrity issues|1
1421849|NCT01050998|4690199|P3|Overall Study|Data integrity issues|1
1421850|NCT01050998|4690200|P2|Overall Study|Data integrity issues|0
1421851|NCT01050998|4690201|P1|Overall Study|Data integrity issues|0
1421852|NCT01050998|4690197|P5|Overall Study|Other|5
1421853|NCT01050998|4690198|P4|Overall Study|Other|1
1421854|NCT01050998|4690199|P3|Overall Study|Other|1
1421855|NCT01050998|4690200|P2|Overall Study|Other|2
1421856|NCT01050998|4690201|P1|Overall Study|Other|3
1421857|NCT01050998|4690197|P5|Overall Study|Withdrawal by Subject|3
1421858|NCT01050998|4690198|P4|Overall Study|Withdrawal by Subject|1
1421859|NCT01050998|4690199|P3|Overall Study|Withdrawal by Subject|0
1421860|NCT01050998|4690200|P2|Overall Study|Withdrawal by Subject|0
1421861|NCT01050998|4690201|P1|Overall Study|Withdrawal by Subject|0
1421862|NCT01050998|4690197|P5|Overall Study|Adverse Event|2
1421863|NCT01050998|4690198|P4|Overall Study|Adverse Event|0
1421864|NCT01050998|4690199|P3|Overall Study|Adverse Event|1
1421865|NCT01050998|4690200|P2|Overall Study|Adverse Event|0
1421866|NCT01050998|4690201|P1|Overall Study|Adverse Event|1
1421867|NCT01050816|4690535|P1|Overall Study|patient's refusal|2
1421868|NCT01050816|4690535|P1|Overall Study|Lost to Follow-up|2
1421869|NCT01050790|4690541|P1|Overall Study|Adverse Event|1
1421870|NCT01050764|4690551|P1|Overall Study|Death after HSCT, before T-cell infusion|1
1421871|NCT01050764|4690551|P1|Overall Study|Donor mobilization failure, death|1
1421872|NCT01050764|4690551|P1|Overall Study|Death, before HSCT|1
1421873|NCT01050673|4690562|P2|Overall Study|Physician Decision|5
1421874|NCT01050673|4690563|P1|Overall Study|Physician Decision|4
1421875|NCT01050634|4690631|P1|Overall Study|Ongoing at Date of Cut-Off|5
1421876|NCT01050634|4690631|P1|Overall Study|Other|21
1421877|NCT01050634|4690631|P1|Overall Study|Lost to Follow-up|2
1421878|NCT01050634|4690631|P1|Overall Study|Adverse Event|42
1421879|NCT01050634|4690631|P1|Overall Study|Death|2
1421880|NCT01050634|4690631|P1|Overall Study|Enrolled, but Not Treated|56
1421881|NCT01050569|4690655|P3|Overall Study|Physician Decision|3
1421882|NCT01050569|4690656|P2|Overall Study|Physician Decision|3
1421883|NCT01050569|4690657|P1|Overall Study|Physician Decision|3
1421884|NCT01050569|4690655|P3|Overall Study|Adverse Event|0
1421885|NCT01050569|4690656|P2|Overall Study|Adverse Event|0
1421886|NCT01050569|4690657|P1|Overall Study|Adverse Event|1
1421887|NCT01050569|4690655|P3|Overall Study|Lack of Efficacy|3
1421888|NCT01050569|4690656|P2|Overall Study|Lack of Efficacy|4
1421889|NCT01050569|4690657|P1|Overall Study|Lack of Efficacy|5
1421890|NCT01050569|4690655|P3|Overall Study|Withdrawal by Subject|11
1421891|NCT01050569|4690656|P2|Overall Study|Withdrawal by Subject|3
1421892|NCT01050569|4690657|P1|Overall Study|Withdrawal by Subject|9
1421893|NCT01050569|4690655|P3|Overall Study|Lost to Follow-up|16
1421894|NCT01050569|4690656|P2|Overall Study|Lost to Follow-up|14
1421895|NCT01050569|4690657|P1|Overall Study|Lost to Follow-up|20
1421896|NCT01050543|4690676|P2|Overall Study|Administrative|1
1421897|NCT01050543|4690677|P1|Overall Study|Administrative|4
1421898|NCT01050543|4690676|P2|Overall Study|Protocol Violation|1
1421899|NCT01050543|4690677|P1|Overall Study|Protocol Violation|0
1421900|NCT01050543|4690676|P2|Overall Study|Withdrawal by Subject|2
1421901|NCT01050543|4690677|P1|Overall Study|Withdrawal by Subject|0
1421902|NCT01050530|4690685|P2|Overall Study|Protocol Violation|0
1421903|NCT01050530|4690686|P1|Overall Study|Protocol Violation|1
1421904|NCT01050530|4690685|P2|Overall Study|Withdrawal by Subject|3
1421905|NCT01050530|4690686|P1|Overall Study|Withdrawal by Subject|0
1421906|NCT01050530|4690685|P2|Overall Study|Lack of Efficacy|4
1421907|NCT01050530|4690686|P1|Overall Study|Lack of Efficacy|1
1421908|NCT01050530|4690685|P2|Overall Study|Adverse Event|3
1421909|NCT01050530|4690686|P1|Overall Study|Adverse Event|6
1421910|NCT01050257|4690697|P3|Overall Study|Death|1
1421911|NCT01050257|4690698|P2|Overall Study|Death|0
1421912|NCT01050257|4690699|P1|Overall Study|Death|0
1421913|NCT01050257|4690697|P3|Overall Study|Failure to return|0
1421914|NCT01050257|4690698|P2|Overall Study|Failure to return|2
1421915|NCT01050257|4690699|P1|Overall Study|Failure to return|0
1421916|NCT01050257|4690697|P3|Overall Study|Violation criteria|0
1421917|NCT01050257|4690698|P2|Overall Study|Violation criteria|1
1421918|NCT01050257|4690699|P1|Overall Study|Violation criteria|0
1421919|NCT01050257|4690697|P3|Overall Study|Refused treatment/ Did not Cooperate|0
1421920|NCT01050257|4690698|P2|Overall Study|Refused treatment/ Did not Cooperate|1
1421921|NCT01050257|4690699|P1|Overall Study|Refused treatment/ Did not Cooperate|1
1421922|NCT01050257|4690697|P3|Overall Study|No reason specified|2
1421923|NCT01050257|4690698|P2|Overall Study|No reason specified|0
1421924|NCT01050257|4690699|P1|Overall Study|No reason specified|0
1421925|NCT01050257|4690697|P3|Overall Study|Withdrawal by Subject|0
1421926|NCT01050257|4690698|P2|Overall Study|Withdrawal by Subject|3
1421927|NCT01050257|4690699|P1|Overall Study|Withdrawal by Subject|0
1421928|NCT01050257|4690697|P3|Overall Study|Admin/Other (did not switch to oral)|2
1421929|NCT01050257|4690698|P2|Overall Study|Admin/Other (did not switch to oral)|2
1421930|NCT01050257|4690699|P1|Overall Study|Admin/Other (did not switch to oral)|6
1421931|NCT01050257|4690697|P3|Overall Study|Adverse Event|2
1421932|NCT01050257|4690698|P2|Overall Study|Adverse Event|4
1421933|NCT01050257|4690699|P1|Overall Study|Adverse Event|4
1421934|NCT01050218|4690734|P1|Overall Study|Family emergency|1
1421935|NCT01050218|4690734|P1|Overall Study|Serious Adverse Event|1
1421936|NCT01050218|4690734|P1|Overall Study|Failed to return|7
1421937|NCT01050218|4690734|P1|Overall Study|Compliance|2
1421938|NCT01050218|4690734|P1|Overall Study|Discontinued by sponsor|18
1421939|NCT01050218|4690734|P1|Overall Study|Withdrawal by Subject|18
1421940|NCT01050218|4690734|P1|Overall Study|Protocol Violation|3
1421941|NCT01050218|4690734|P1|Overall Study|Lack of Efficacy|8
1421942|NCT01050218|4690734|P1|Overall Study|Adverse Event|37
1421943|NCT01050205|4690740|P2|Overall Study|Discontinued Intervention|0
1421944|NCT01050205|4690741|P1|Overall Study|Discontinued Intervention|2
1421945|NCT01050205|4690740|P2|Overall Study|Relocated from area|2
1421946|NCT01050205|4690741|P1|Overall Study|Relocated from area|1
1421947|NCT01050205|4690740|P2|Overall Study|Withdrawal by Subject|1
1421948|NCT01050205|4690741|P1|Overall Study|Withdrawal by Subject|1
1421949|NCT01050205|4690740|P2|Overall Study|Lost to Follow-up|1
1421950|NCT01050205|4690741|P1|Overall Study|Lost to Follow-up|7
1421951|NCT01050062|4690798|P2|Overall Study|Others|11
1421952|NCT01050062|4690799|P1|Overall Study|Others|17
1421953|NCT01050062|4690798|P2|Overall Study|Physician Decision|9
1421954|NCT01050062|4690799|P1|Overall Study|Physician Decision|74
1421955|NCT01050062|4690798|P2|Overall Study|Lack of Efficacy|35
1421956|NCT01050062|4690799|P1|Overall Study|Lack of Efficacy|22
1421957|NCT01050062|4690798|P2|Overall Study|Lost to Follow-up|35
1421958|NCT01050062|4690799|P1|Overall Study|Lost to Follow-up|83
1421959|NCT01050062|4690798|P2|Overall Study|Adverse Event|22
1421960|NCT01050062|4690799|P1|Overall Study|Adverse Event|75
1421961|NCT01049984|4690821|P2|Overall Study|Treatment failure|2
1421962|NCT01049984|4690822|P1|Overall Study|Treatment failure|0
1421963|NCT01049984|4690821|P2|Overall Study|Adverse Event|7
1421964|NCT01049984|4690822|P1|Overall Study|Adverse Event|13
1421965|NCT01049984|4690821|P2|Overall Study|Lost to Follow-up|1
1421966|NCT01049984|4690822|P1|Overall Study|Lost to Follow-up|2
1421967|NCT01049984|4690821|P2|Overall Study|Protocol Violation|4
1421968|NCT01049984|4690822|P1|Overall Study|Protocol Violation|3
1421969|NCT01049984|4690821|P2|Overall Study|Withdrawal by Subject|5
1421970|NCT01049984|4690822|P1|Overall Study|Withdrawal by Subject|1
1421971|NCT01049581|4690882|P2|Overall Study|Lost to Follow-up|1
1421972|NCT01049581|4690883|P1|Overall Study|Lost to Follow-up|2
1421973|NCT01049503|4690898|P6|Overall Study|Lost to Follow-up|8
1421974|NCT01049503|4690899|P5|Overall Study|Lost to Follow-up|27
1421975|NCT01049503|4690900|P4|Overall Study|Lost to Follow-up|26
1421976|NCT01049503|4690901|P3|Overall Study|Lost to Follow-up|24
1421977|NCT01049503|4690902|P2|Overall Study|Lost to Follow-up|12
1421978|NCT01049503|4690903|P1|Overall Study|Lost to Follow-up|11
1421979|NCT01049412|4690934|P2|Period II|Lost to Follow-up|0
1421980|NCT01049412|4690935|P1|Period II|Lost to Follow-up|1
1421981|NCT01049412|4690934|P2|Period II|Adverse Event|0
1421982|NCT01049412|4690935|P1|Period II|Adverse Event|1
1421983|NCT01049412|4690934|P2|Period II|Withdrawal by Subject|3
1421984|NCT01049412|4690935|P1|Period II|Withdrawal by Subject|2
1421985|NCT01049412|4690934|P2|Period I|Adverse Event|0
1421986|NCT01049412|4690935|P1|Period I|Adverse Event|1
1421987|NCT01049412|4690934|P2|Period I|Protocol Violation|2
1421988|NCT01049412|4690935|P1|Period I|Protocol Violation|1
1421989|NCT01049412|4690934|P2|Period I|Physician Decision|3
1421990|NCT01049412|4690935|P1|Period I|Physician Decision|0
1421991|NCT01049412|4690934|P2|Period I|Lost to Follow-up|2
1421992|NCT01049412|4690935|P1|Period I|Lost to Follow-up|2
1421993|NCT01049412|4690934|P2|Period I|Withdrawal by Subject|6
1421994|NCT01049412|4690935|P1|Period I|Withdrawal by Subject|4
1421995|NCT01049373|4690964|P2|Overall Study|Non-cooperation|1
1421996|NCT01049373|4690965|P1|Overall Study|Non-cooperation|0
1421997|NCT01049373|4690964|P2|Overall Study|Not specified|1
1421998|NCT01049373|4690965|P1|Overall Study|Not specified|1
1421999|NCT01049373|4690964|P2|Overall Study|no evaluable study values|21
1422000|NCT01049373|4690965|P1|Overall Study|no evaluable study values|9
1422001|NCT01049373|4690964|P2|Overall Study|Lost to Follow-up|4
1422002|NCT01049373|4690965|P1|Overall Study|Lost to Follow-up|9
1422003|NCT01049373|4690964|P2|Overall Study|Adverse Event|3
1422004|NCT01049373|4690965|P1|Overall Study|Adverse Event|3
1422005|NCT01049373|4690964|P2|Overall Study|Withdrawal by Subject|5
1422006|NCT01049373|4690965|P1|Overall Study|Withdrawal by Subject|8
1422007|NCT01049373|4690964|P2|Overall Study|Protocol Violation|9
1422008|NCT01049373|4690965|P1|Overall Study|Protocol Violation|9
1422009|NCT01049360|4690979|P20|Period 4|Withdrawal by Subject|0
1422010|NCT01049360|4690980|P19|Period 4|Withdrawal by Subject|0
1422011|NCT01049360|4690981|P18|Period 4|Withdrawal by Subject|0
1422012|NCT01049360|4690982|P17|Period 4|Withdrawal by Subject|0
1422013|NCT01049360|4690983|P16|Period 4|Withdrawal by Subject|0
1422014|NCT01049360|4690984|P15|Period 4|Withdrawal by Subject|0
1422015|NCT01049360|4690985|P14|Period 4|Withdrawal by Subject|0
1422016|NCT01049360|4690986|P13|Period 4|Withdrawal by Subject|0
1422017|NCT01049360|4690987|P12|Period 4|Withdrawal by Subject|0
1422018|NCT01049360|4690988|P11|Period 4|Withdrawal by Subject|0
1422019|NCT01049360|4690989|P10|Period 4|Withdrawal by Subject|0
1422020|NCT01049360|4690990|P9|Period 4|Withdrawal by Subject|0
1422021|NCT01049360|4690991|P8|Period 4|Withdrawal by Subject|0
1422022|NCT01049360|4690992|P7|Period 4|Withdrawal by Subject|0
1422023|NCT01049360|4690993|P6|Period 4|Withdrawal by Subject|0
1422024|NCT01049360|4690994|P5|Period 4|Withdrawal by Subject|0
1422025|NCT01049360|4690995|P4|Period 4|Withdrawal by Subject|1
1422026|NCT01049360|4690996|P3|Period 4|Withdrawal by Subject|0
1422027|NCT01049360|4690997|P2|Period 4|Withdrawal by Subject|0
1422028|NCT01049360|4690998|P1|Period 4|Withdrawal by Subject|0
1422029|NCT01049360|4690979|P20|Period 4|Protocol Violation|0
1422030|NCT01049360|4690980|P19|Period 4|Protocol Violation|0
1422031|NCT01049360|4690981|P18|Period 4|Protocol Violation|1
1422032|NCT01049360|4690982|P17|Period 4|Protocol Violation|0
1422033|NCT01049360|4690983|P16|Period 4|Protocol Violation|0
1422034|NCT01049360|4690984|P15|Period 4|Protocol Violation|0
1422035|NCT01049360|4690985|P14|Period 4|Protocol Violation|0
1422036|NCT01049360|4690986|P13|Period 4|Protocol Violation|0
1422037|NCT01049360|4690987|P12|Period 4|Protocol Violation|0
1422038|NCT01049360|4690988|P11|Period 4|Protocol Violation|0
1422039|NCT01049360|4690989|P10|Period 4|Protocol Violation|0
1422040|NCT01049360|4690990|P9|Period 4|Protocol Violation|0
1422041|NCT01049360|4690991|P8|Period 4|Protocol Violation|0
1422042|NCT01049360|4690992|P7|Period 4|Protocol Violation|0
1422043|NCT01049360|4690993|P6|Period 4|Protocol Violation|0
1422044|NCT01049360|4690994|P5|Period 4|Protocol Violation|0
1422045|NCT01049360|4690995|P4|Period 4|Protocol Violation|0
1422046|NCT01049360|4690996|P3|Period 4|Protocol Violation|0
1422047|NCT01049360|4690997|P2|Period 4|Protocol Violation|0
1422048|NCT01049360|4690998|P1|Period 4|Protocol Violation|0
1422049|NCT01049360|4690979|P20|Period 2|Lack of Efficacy|0
1422050|NCT01049360|4690980|P19|Period 2|Lack of Efficacy|0
1422051|NCT01049360|4690981|P18|Period 2|Lack of Efficacy|0
1422052|NCT01049360|4690982|P17|Period 2|Lack of Efficacy|0
1422053|NCT01049360|4690983|P16|Period 2|Lack of Efficacy|0
1422054|NCT01049360|4690984|P15|Period 2|Lack of Efficacy|0
1422055|NCT01049360|4690985|P14|Period 2|Lack of Efficacy|0
1422056|NCT01049360|4690986|P13|Period 2|Lack of Efficacy|0
1422057|NCT01049360|4690987|P12|Period 2|Lack of Efficacy|0
1422058|NCT01049360|4690988|P11|Period 2|Lack of Efficacy|0
1422059|NCT01049360|4690989|P10|Period 2|Lack of Efficacy|0
1422060|NCT01049360|4690990|P9|Period 2|Lack of Efficacy|0
1422061|NCT01049360|4690991|P8|Period 2|Lack of Efficacy|0
1422062|NCT01049360|4690992|P7|Period 2|Lack of Efficacy|0
1422063|NCT01049360|4690993|P6|Period 2|Lack of Efficacy|1
1422064|NCT01049360|4690994|P5|Period 2|Lack of Efficacy|0
1422065|NCT01049360|4690995|P4|Period 2|Lack of Efficacy|0
1422066|NCT01049360|4690996|P3|Period 2|Lack of Efficacy|0
1422067|NCT01049360|4690997|P2|Period 2|Lack of Efficacy|0
1422068|NCT01049360|4690998|P1|Period 2|Lack of Efficacy|0
1422069|NCT01049360|4690979|P20|Period 2|Withdrawal by Subject|1
1422070|NCT01049360|4690980|P19|Period 2|Withdrawal by Subject|0
1422071|NCT01049360|4690981|P18|Period 2|Withdrawal by Subject|0
1422072|NCT01049360|4690982|P17|Period 2|Withdrawal by Subject|0
1422073|NCT01049360|4690983|P16|Period 2|Withdrawal by Subject|0
1422074|NCT01049360|4690984|P15|Period 2|Withdrawal by Subject|1
1422075|NCT01049360|4690985|P14|Period 2|Withdrawal by Subject|0
1422076|NCT01049360|4690986|P13|Period 2|Withdrawal by Subject|0
1422077|NCT01049360|4690987|P12|Period 2|Withdrawal by Subject|0
1422078|NCT01049360|4690988|P11|Period 2|Withdrawal by Subject|0
1422079|NCT01049360|4690989|P10|Period 2|Withdrawal by Subject|0
1422080|NCT01049360|4690990|P9|Period 2|Withdrawal by Subject|0
1422081|NCT01049360|4690991|P8|Period 2|Withdrawal by Subject|0
1422082|NCT01049360|4690992|P7|Period 2|Withdrawal by Subject|0
1422083|NCT01049360|4690993|P6|Period 2|Withdrawal by Subject|0
1422084|NCT01049360|4690994|P5|Period 2|Withdrawal by Subject|0
1422085|NCT01049360|4690995|P4|Period 2|Withdrawal by Subject|1
1422086|NCT01049360|4690996|P3|Period 2|Withdrawal by Subject|0
1422087|NCT01049360|4690997|P2|Period 2|Withdrawal by Subject|0
1422088|NCT01049360|4690998|P1|Period 2|Withdrawal by Subject|0
1422089|NCT01049360|4690979|P20|Period 2|Adverse Event|1
1422090|NCT01049360|4690980|P19|Period 2|Adverse Event|0
1422091|NCT01049360|4690981|P18|Period 2|Adverse Event|0
1422092|NCT01049360|4690982|P17|Period 2|Adverse Event|0
1422093|NCT01049360|4690983|P16|Period 2|Adverse Event|0
1422094|NCT01049360|4690984|P15|Period 2|Adverse Event|0
1422095|NCT01049360|4690985|P14|Period 2|Adverse Event|0
1422096|NCT01049360|4690986|P13|Period 2|Adverse Event|0
1422097|NCT01049360|4690987|P12|Period 2|Adverse Event|0
1422098|NCT01049360|4690988|P11|Period 2|Adverse Event|0
1422099|NCT01049360|4690989|P10|Period 2|Adverse Event|0
1422100|NCT01049360|4690990|P9|Period 2|Adverse Event|1
1422101|NCT01049360|4690991|P8|Period 2|Adverse Event|0
1422102|NCT01049360|4690992|P7|Period 2|Adverse Event|0
1422103|NCT01049360|4690993|P6|Period 2|Adverse Event|0
1422104|NCT01049360|4690994|P5|Period 2|Adverse Event|0
1422105|NCT01049360|4690995|P4|Period 2|Adverse Event|0
1422106|NCT01049360|4690996|P3|Period 2|Adverse Event|0
1422107|NCT01049360|4690997|P2|Period 2|Adverse Event|1
1422108|NCT01049360|4690998|P1|Period 2|Adverse Event|0
1422109|NCT01049360|4690979|P20|Period 2|Protocol Violation|0
1422110|NCT01049360|4690980|P19|Period 2|Protocol Violation|0
1422111|NCT01049360|4690981|P18|Period 2|Protocol Violation|0
1422112|NCT01049360|4690982|P17|Period 2|Protocol Violation|0
1422113|NCT01049360|4690983|P16|Period 2|Protocol Violation|1
1422114|NCT01049360|4690984|P15|Period 2|Protocol Violation|1
1422115|NCT01049360|4690985|P14|Period 2|Protocol Violation|0
1422116|NCT01049360|4690986|P13|Period 2|Protocol Violation|0
1422117|NCT01049360|4690987|P12|Period 2|Protocol Violation|0
1422118|NCT01049360|4690988|P11|Period 2|Protocol Violation|0
1422119|NCT01049360|4690989|P10|Period 2|Protocol Violation|0
1422120|NCT01049360|4690990|P9|Period 2|Protocol Violation|0
1422121|NCT01049360|4690991|P8|Period 2|Protocol Violation|0
1422122|NCT01049360|4690992|P7|Period 2|Protocol Violation|0
1422123|NCT01049360|4690993|P6|Period 2|Protocol Violation|0
1422124|NCT01049360|4690994|P5|Period 2|Protocol Violation|0
1422125|NCT01049360|4690995|P4|Period 2|Protocol Violation|1
1422126|NCT01049360|4690996|P3|Period 2|Protocol Violation|0
1422127|NCT01049360|4690997|P2|Period 2|Protocol Violation|0
1422128|NCT01049360|4690998|P1|Period 2|Protocol Violation|0
1422129|NCT01049360|4690979|P20|Period 1|Withdrawal by Subject|0
1422130|NCT01049360|4690980|P19|Period 1|Withdrawal by Subject|0
1422131|NCT01049360|4690981|P18|Period 1|Withdrawal by Subject|0
1422132|NCT01049360|4690982|P17|Period 1|Withdrawal by Subject|0
1422133|NCT01049360|4690983|P16|Period 1|Withdrawal by Subject|0
1422134|NCT01049360|4690984|P15|Period 1|Withdrawal by Subject|0
1422135|NCT01049360|4690985|P14|Period 1|Withdrawal by Subject|0
1422136|NCT01049360|4690986|P13|Period 1|Withdrawal by Subject|1
1422137|NCT01049360|4690987|P12|Period 1|Withdrawal by Subject|0
1422138|NCT01049360|4690988|P11|Period 1|Withdrawal by Subject|1
1422139|NCT01049360|4690989|P10|Period 1|Withdrawal by Subject|0
1422140|NCT01049360|4690990|P9|Period 1|Withdrawal by Subject|1
1422141|NCT01049360|4690991|P8|Period 1|Withdrawal by Subject|0
1422142|NCT01049360|4690992|P7|Period 1|Withdrawal by Subject|0
1422143|NCT01049360|4690993|P6|Period 1|Withdrawal by Subject|0
1422144|NCT01049360|4690994|P5|Period 1|Withdrawal by Subject|0
1422145|NCT01049360|4690995|P4|Period 1|Withdrawal by Subject|0
1422146|NCT01049360|4690996|P3|Period 1|Withdrawal by Subject|0
1422147|NCT01049360|4690997|P2|Period 1|Withdrawal by Subject|0
1422148|NCT01049360|4690998|P1|Period 1|Withdrawal by Subject|0
1422149|NCT01049360|4690979|P20|Period 1|Did not meet inc/exc criteria|0
1422150|NCT01049360|4690980|P19|Period 1|Did not meet inc/exc criteria|0
1422151|NCT01049360|4690981|P18|Period 1|Did not meet inc/exc criteria|0
1422152|NCT01049360|4690982|P17|Period 1|Did not meet inc/exc criteria|0
1422153|NCT01049360|4690983|P16|Period 1|Did not meet inc/exc criteria|0
1422154|NCT01049360|4690984|P15|Period 1|Did not meet inc/exc criteria|0
1422155|NCT01049360|4690985|P14|Period 1|Did not meet inc/exc criteria|0
1422156|NCT01049360|4690986|P13|Period 1|Did not meet inc/exc criteria|0
1422157|NCT01049360|4690987|P12|Period 1|Did not meet inc/exc criteria|0
1422158|NCT01049360|4690988|P11|Period 1|Did not meet inc/exc criteria|0
1422159|NCT01049360|4690989|P10|Period 1|Did not meet inc/exc criteria|0
1422160|NCT01049360|4690990|P9|Period 1|Did not meet inc/exc criteria|1
1422161|NCT01049360|4690991|P8|Period 1|Did not meet inc/exc criteria|1
1422162|NCT01049360|4690992|P7|Period 1|Did not meet inc/exc criteria|0
1422163|NCT01049360|4690993|P6|Period 1|Did not meet inc/exc criteria|0
1422164|NCT01049360|4690994|P5|Period 1|Did not meet inc/exc criteria|0
1422165|NCT01049360|4690995|P4|Period 1|Did not meet inc/exc criteria|0
1422166|NCT01049360|4690996|P3|Period 1|Did not meet inc/exc criteria|0
1422167|NCT01049360|4690997|P2|Period 1|Did not meet inc/exc criteria|0
1422168|NCT01049360|4690998|P1|Period 1|Did not meet inc/exc criteria|0
1422169|NCT01049360|4690979|P20|Period 1|Adverse Event|0
1422170|NCT01049360|4690980|P19|Period 1|Adverse Event|1
1422171|NCT01049360|4690981|P18|Period 1|Adverse Event|0
1422172|NCT01049360|4690982|P17|Period 1|Adverse Event|1
1422173|NCT01049360|4690983|P16|Period 1|Adverse Event|0
1422174|NCT01049360|4690984|P15|Period 1|Adverse Event|0
1422175|NCT01049360|4690985|P14|Period 1|Adverse Event|1
1422176|NCT01049360|4690986|P13|Period 1|Adverse Event|1
1422177|NCT01049360|4690987|P12|Period 1|Adverse Event|0
1422178|NCT01049360|4690988|P11|Period 1|Adverse Event|0
1422179|NCT01049360|4690989|P10|Period 1|Adverse Event|0
1422180|NCT01049360|4690990|P9|Period 1|Adverse Event|0
1422181|NCT01049360|4690991|P8|Period 1|Adverse Event|1
1422182|NCT01049360|4690992|P7|Period 1|Adverse Event|0
1422183|NCT01049360|4690993|P6|Period 1|Adverse Event|0
1422184|NCT01049360|4690994|P5|Period 1|Adverse Event|0
1422185|NCT01049360|4690995|P4|Period 1|Adverse Event|1
1422186|NCT01049360|4690996|P3|Period 1|Adverse Event|0
1422187|NCT01049360|4690997|P2|Period 1|Adverse Event|1
1422188|NCT01049360|4690998|P1|Period 1|Adverse Event|0
1422189|NCT01049334|4691022|P2|Overall Study|Protocol Violation|1
1422190|NCT01049334|4691023|P1|Overall Study|Protocol Violation|0
1422191|NCT01049334|4691022|P2|Overall Study|Physician Decision|0
1422192|NCT01049334|4691023|P1|Overall Study|Physician Decision|2
1422193|NCT01049334|4691022|P2|Overall Study|Adverse Event|3
1422194|NCT01049334|4691023|P1|Overall Study|Adverse Event|2
1422195|NCT01049334|4691022|P2|Overall Study|Withdrawal by Subject|3
1422196|NCT01049334|4691023|P1|Overall Study|Withdrawal by Subject|5
1422197|NCT01049308|4691059|P1|Pill Counts|Withdrawal by Subject|83
1422198|NCT01049217|4691073|P2|Overall Study|Randomized but not Treated|2
1422199|NCT01049217|4691074|P1|Overall Study|Randomized but not Treated|0
1422200|NCT01049217|4691073|P2|Overall Study|Other|2
1422201|NCT01049217|4691074|P1|Overall Study|Other|1
1422202|NCT01049217|4691073|P2|Overall Study|Study Terminated by Sponsor|43
1422203|NCT01049217|4691074|P1|Overall Study|Study Terminated by Sponsor|43
1422204|NCT01049217|4691073|P2|Overall Study|Pregnancy|0
1422205|NCT01049217|4691074|P1|Overall Study|Pregnancy|1
1422206|NCT01049217|4691073|P2|Overall Study|Protocol Violation|3
1422207|NCT01049217|4691074|P1|Overall Study|Protocol Violation|1
1422208|NCT01049217|4691073|P2|Overall Study|Withdrawal by Subject|3
1422209|NCT01049217|4691074|P1|Overall Study|Withdrawal by Subject|4
1422210|NCT01049217|4691073|P2|Overall Study|Lost to Follow-up|8
1422211|NCT01049217|4691074|P1|Overall Study|Lost to Follow-up|3
1422212|NCT01049217|4691073|P2|Overall Study|Lack of Efficacy|1
1422213|NCT01049217|4691074|P1|Overall Study|Lack of Efficacy|1
1422214|NCT01049217|4691073|P2|Overall Study|Adverse Event|1
1422215|NCT01049217|4691074|P1|Overall Study|Adverse Event|2
1422216|NCT01049009|4691146|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
1422217|NCT01049009|4691147|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
1422218|NCT01049009|4691146|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
1422219|NCT01049009|4691147|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
1422220|NCT01049009|4691146|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1422221|NCT01049009|4691147|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1422222|NCT01049009|4691146|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
1422223|NCT01049009|4691147|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
1422224|NCT01048944|4691159|P4|Overall Study|Protocol Violation|2
1422225|NCT01048944|4691160|P3|Overall Study|Protocol Violation|10
1422226|NCT01048944|4691161|P2|Overall Study|Protocol Violation|10
1422227|NCT01048944|4691162|P1|Overall Study|Protocol Violation|8
1422228|NCT01048866|4691194|P2|Overall Study|not specified|1
1422229|NCT01048866|4691195|P1|Overall Study|not specified|1
1422230|NCT01048866|4691194|P2|Overall Study|Lost to Follow-up|2
1422231|NCT01048866|4691195|P1|Overall Study|Lost to Follow-up|0
1422232|NCT01048866|4691194|P2|Overall Study|Withdrawal by Subject|2
1422233|NCT01048866|4691195|P1|Overall Study|Withdrawal by Subject|0
1422234|NCT01048866|4691194|P2|Overall Study|Physician Decision|0
1422235|NCT01048866|4691195|P1|Overall Study|Physician Decision|1
1422236|NCT01048866|4691194|P2|Overall Study|Protocol Violation|0
1422237|NCT01048866|4691195|P1|Overall Study|Protocol Violation|1
1422238|NCT01048866|4691194|P2|Overall Study|Adverse Event|0
1422239|NCT01048866|4691195|P1|Overall Study|Adverse Event|1
1422240|NCT01048788|4691240|P3|Overall Study|Withdrawal by Subject|0
1422241|NCT01048788|4691241|P2|Overall Study|Withdrawal by Subject|1
1422242|NCT01048788|4691242|P1|Overall Study|Withdrawal by Subject|0
1422243|NCT01048788|4691240|P3|Overall Study|Lack of Efficacy|1
1422244|NCT01048788|4691241|P2|Overall Study|Lack of Efficacy|0
1422245|NCT01048788|4691242|P1|Overall Study|Lack of Efficacy|0
1422246|NCT01048788|4691240|P3|Overall Study|Adverse Event|1
1422247|NCT01048788|4691241|P2|Overall Study|Adverse Event|1
1422248|NCT01048788|4691242|P1|Overall Study|Adverse Event|5
1422249|NCT01048671|4691264|P3|Overall Study|Protocol Violation|1
1422250|NCT01048671|4691265|P2|Overall Study|Protocol Violation|1
1422251|NCT01048671|4691266|P1|Overall Study|Protocol Violation|0
1422252|NCT01048541|4691334|P2|Overall Study|Withdrawal by Subject|0
1422253|NCT01048541|4691335|P1|Overall Study|Withdrawal by Subject|1
1422254|NCT01048502|4691345|P4|Overall Study|Physician Decision|1
1422255|NCT01048502|4691346|P3|Overall Study|Physician Decision|0
1422256|NCT01048502|4691347|P2|Overall Study|Physician Decision|3
1422257|NCT01048502|4691348|P1|Overall Study|Physician Decision|0
1422258|NCT01048502|4691345|P4|Overall Study|Withdrawal by Subject|3
1422259|NCT01048502|4691346|P3|Overall Study|Withdrawal by Subject|5
1422260|NCT01048502|4691347|P2|Overall Study|Withdrawal by Subject|4
1422261|NCT01048502|4691348|P1|Overall Study|Withdrawal by Subject|1
1422262|NCT01048502|4691345|P4|Overall Study|Adverse Event|0
1422263|NCT01048502|4691346|P3|Overall Study|Adverse Event|0
1422264|NCT01048502|4691347|P2|Overall Study|Adverse Event|0
1422265|NCT01048502|4691348|P1|Overall Study|Adverse Event|1
1422266|NCT01048502|4691345|P4|Overall Study|Lost to Follow-up|0
1422267|NCT01048502|4691346|P3|Overall Study|Lost to Follow-up|0
1422268|NCT01048502|4691347|P2|Overall Study|Lost to Follow-up|0
1422269|NCT01048502|4691348|P1|Overall Study|Lost to Follow-up|2
1422270|NCT01048333|4691384|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
1422271|NCT01048333|4691385|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
1422272|NCT01048333|4691386|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
1422273|NCT01048333|4691387|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
1422274|NCT01048333|4691388|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
1422275|NCT01048333|4691389|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
1422276|NCT01048242|4691411|P2|Overall Study|See study flow chart|2
1422277|NCT01048242|4691412|P1|Overall Study|See study flow chart|4
1422278|NCT01048099|4691427|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
1422279|NCT01048099|4691427|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
1422280|NCT01047553|4691457|P2|Overall Study|PI's decision|1
1422281|NCT01047553|4691458|P1|Overall Study|PI's decision|0
1422282|NCT01047553|4691457|P2|Overall Study|Sever Non-Compliance to Protocol|0
1422283|NCT01047553|4691458|P1|Overall Study|Sever Non-Compliance to Protocol|1
1422284|NCT01047553|4691457|P2|Overall Study|Lost to Follow-up|0
1422285|NCT01047553|4691458|P1|Overall Study|Lost to Follow-up|1
1422286|NCT01047553|4691457|P2|Overall Study|Development of Study-Specific Withdrawal|1
1422287|NCT01047553|4691458|P1|Overall Study|Development of Study-Specific Withdrawal|1
1422288|NCT01047553|4691457|P2|Overall Study|Withdrawal by Subject|2
1422289|NCT01047553|4691458|P1|Overall Study|Withdrawal by Subject|4
1422290|NCT01047553|4691457|P2|Overall Study|Adverse Event|5
1422291|NCT01047553|4691458|P1|Overall Study|Adverse Event|10
1422292|NCT01047436|4691565|P2|Overall Study|Protocol Violation|0
1422293|NCT01047436|4691566|P1|Overall Study|Protocol Violation|1
1422294|NCT01047345|4691591|P3|Extension|Lost to Follow-up|5
1422295|NCT01047345|4691592|P2|Extension|Lost to Follow-up|0
1422296|NCT01047345|4691593|P1|Extension|Lost to Follow-up|0
1422297|NCT01047345|4691591|P3|Extension|Withdrawal by Subject|1
1422298|NCT01047345|4691592|P2|Extension|Withdrawal by Subject|0
1422299|NCT01047345|4691593|P1|Extension|Withdrawal by Subject|0
1422300|NCT01047345|4691591|P3|Base Study|Withdrawal by Subject|0
1422301|NCT01047345|4691592|P2|Base Study|Withdrawal by Subject|4
1422302|NCT01047345|4691593|P1|Base Study|Withdrawal by Subject|12
1422303|NCT01047345|4691591|P3|Base Study|Protocol Violation|0
1422304|NCT01047345|4691592|P2|Base Study|Protocol Violation|1
1422305|NCT01047345|4691593|P1|Base Study|Protocol Violation|3
1422306|NCT01047345|4691591|P3|Base Study|Lost to Follow-up|0
1422307|NCT01047345|4691592|P2|Base Study|Lost to Follow-up|1
1422308|NCT01047345|4691593|P1|Base Study|Lost to Follow-up|4
1422309|NCT01047345|4691591|P3|Base Study|Adverse Event|0
1422310|NCT01047345|4691592|P2|Base Study|Adverse Event|0
1422311|NCT01047345|4691593|P1|Base Study|Adverse Event|3
1422312|NCT01047332|4691615|P2|Overall Study|Lost to Follow-up|3
1422313|NCT01047332|4691616|P1|Overall Study|Lost to Follow-up|8
1422314|NCT01047332|4691615|P2|Overall Study|Died Unobstructed|41
1422315|NCT01047332|4691616|P1|Overall Study|Died Unobstructed|38
1422316|NCT01047332|4691615|P2|Overall Study|SEMS Obstruction|20
1422317|NCT01047332|4691616|P1|Overall Study|SEMS Obstruction|11
1422318|NCT01047306|4691630|P2|Overall Study|Lost to Follow-up|0
1422319|NCT01047306|4691631|P1|Overall Study|Lost to Follow-up|1
1422320|NCT01047306|4691630|P2|Overall Study|Withdrawal by Subject|0
1422321|NCT01047306|4691631|P1|Overall Study|Withdrawal by Subject|2
1422322|NCT01047293|4691705|P4|Overall Study|DLT criteria not fulfilled|0
1422323|NCT01047293|4691706|P3|Overall Study|DLT criteria not fulfilled|0
1422324|NCT01047293|4691707|P2|Overall Study|DLT criteria not fulfilled|1
1422325|NCT01047293|4691708|P1|Overall Study|DLT criteria not fulfilled|1
1422326|NCT01047007|4691739|P4|Overall Study|Progressive Disease|0
1422327|NCT01047007|4691740|P3|Overall Study|Progressive Disease|1
1422328|NCT01047007|4691741|P2|Overall Study|Progressive Disease|4
1422329|NCT01047007|4691742|P1|Overall Study|Progressive Disease|2
1422330|NCT01047007|4691739|P4|Overall Study|Adverse Event|0
1422331|NCT01047007|4691740|P3|Overall Study|Adverse Event|1
1422332|NCT01047007|4691741|P2|Overall Study|Adverse Event|2
1422333|NCT01047007|4691742|P1|Overall Study|Adverse Event|0
1422334|NCT01046903|4691753|P1|Overall Study|Other|5
1422335|NCT01046903|4691753|P1|Overall Study|Withdrawal by Subject|3
1422336|NCT01046903|4691753|P1|Overall Study|Adverse Event|4
1422337|NCT01046903|4691753|P1|Overall Study|Lost to Follow-up|16
1422338|NCT01046877|4691766|P1|Overall Study|Exited voluntarily after tube extrusion|11
1422339|NCT01046877|4691766|P1|Overall Study|Exited voluntarily before tube extrusion|7
1422340|NCT01046695|4691782|P2|Overall Study|TENS interfered with the cardiac monitor|1
1422341|NCT01046695|4691783|P1|Overall Study|TENS interfered with the cardiac monitor|0
1422342|NCT01046695|4691782|P2|Overall Study|Subject had a pacemaker|1
1422343|NCT01046695|4691783|P1|Overall Study|Subject had a pacemaker|0
1422344|NCT01046682|4691795|P2|Overall Study|Adverse Event|0
1422345|NCT01046682|4691796|P1|Overall Study|Adverse Event|2
1422346|NCT01046643|4691804|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
1422347|NCT01046643|4691805|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
1422348|NCT01046643|4691806|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
1422349|NCT01046643|4691807|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
1422350|NCT01046565|4691829|P1|Overall Study|Withdrawal by Subject|7
1422351|NCT01046565|4691829|P1|Overall Study|Adverse Event|2
1422352|NCT01046396|4691838|P1|Overall Study|Withdrawal by Subject|5
1422353|NCT01046253|4691849|P2|Second Intervention|Protocol Violation|1
1422354|NCT01046253|4691850|P1|Second Intervention|Protocol Violation|0
1422355|NCT01046253|4691849|P2|Second Intervention|Adverse Event|1
1422356|NCT01046253|4691850|P1|Second Intervention|Adverse Event|0
1422357|NCT01046136|4691862|P2|Overall Study|Lost to Follow-up|3
1422358|NCT01046136|4691863|P1|Overall Study|Lost to Follow-up|3
1422359|NCT01046136|4691862|P2|Overall Study|Physician Decision|1
1422360|NCT01046136|4691863|P1|Overall Study|Physician Decision|1
1422361|NCT01046136|4691862|P2|Overall Study|Withdrawal by Subject|4
1422362|NCT01046136|4691863|P1|Overall Study|Withdrawal by Subject|0
1422363|NCT01046110|4691875|P2|Overall Study|Unclassified|35
1422364|NCT01046110|4691876|P1|Overall Study|Unclassified|36
1422365|NCT01046110|4691875|P2|Overall Study|Withdrawal Criteria|5
1422366|NCT01046110|4691876|P1|Overall Study|Withdrawal Criteria|3
1422367|NCT01046110|4691875|P2|Overall Study|Protocol Violation|12
1422368|NCT01046110|4691876|P1|Overall Study|Protocol Violation|7
1422369|NCT01046110|4691875|P2|Overall Study|Lack of Efficacy|1
1422370|NCT01046110|4691876|P1|Overall Study|Lack of Efficacy|0
1422371|NCT01046110|4691875|P2|Overall Study|Adverse Event|2
1422372|NCT01046110|4691876|P1|Overall Study|Adverse Event|9
1422373|NCT01046084|4691886|P2|Third Washout of 7 Days|Withdrawal by Subject|0
1422374|NCT01046084|4691887|P1|Third Washout of 7 Days|Withdrawal by Subject|2
1422375|NCT01045993|4691901|P4|Overall Study|Treated-later found eligibility not met|0
1422376|NCT01045993|4691902|P3|Overall Study|Treated-later found eligibility not met|0
1422377|NCT01045993|4691903|P2|Overall Study|Treated-later found eligibility not met|1
1422378|NCT01045993|4691904|P1|Overall Study|Treated-later found eligibility not met|0
1422379|NCT01045967|4691980|P2|Second Intervention|Protocol Violation|1
1422380|NCT01045967|4691981|P1|Second Intervention|Protocol Violation|0
1422381|NCT01045798|4691993|P2|Overall Study|Received Systemic Antifungal Prestudy|1
1422382|NCT01045798|4691994|P1|Overall Study|Received Systemic Antifungal Prestudy|0
1422383|NCT01045798|4691993|P2|Overall Study|Changed to Other Antifungal Therapy|2
1422384|NCT01045798|4691994|P1|Overall Study|Changed to Other Antifungal Therapy|1
1422385|NCT01045798|4691993|P2|Overall Study|Invasive Fungal Infection at Baseline|1
1422386|NCT01045798|4691994|P1|Overall Study|Invasive Fungal Infection at Baseline|0
1422387|NCT01045798|4691993|P2|Overall Study|Changed to Open-Label Caspofungin|0
1422388|NCT01045798|4691994|P1|Overall Study|Changed to Open-Label Caspofungin|1
1422389|NCT01045707|4692002|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
1422390|NCT01045707|4692003|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
1422391|NCT01045707|4692002|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
1422392|NCT01045707|4692003|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
1422393|NCT01045707|4692002|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
1422394|NCT01045707|4692003|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
1422395|NCT01045707|4692002|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
1422396|NCT01045707|4692003|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
1422397|NCT01045707|4692002|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
1422398|NCT01045707|4692003|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
1422399|NCT01045707|4692002|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
1422400|NCT01045707|4692003|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
1422401|NCT01045707|4692002|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
1422402|NCT01045707|4692003|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
1422403|NCT01045707|4692002|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
1422404|NCT01045707|4692003|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
1422405|NCT01045707|4692002|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
1422406|NCT01045707|4692003|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
1422407|NCT01045694|4692019|P1|Overall Study|Withdrawal by Subject|2
1422408|NCT01045447|4692035|P2|Overall Study|Unclassified|13
1422409|NCT01045447|4692036|P1|Overall Study|Unclassified|17
1422410|NCT01045447|4692035|P2|Overall Study|Withdrawal Criteria|10
1422411|NCT01045447|4692036|P1|Overall Study|Withdrawal Criteria|10
1422412|NCT01045447|4692035|P2|Overall Study|Protocol Violation|3
1422413|NCT01045447|4692036|P1|Overall Study|Protocol Violation|6
1422414|NCT01045447|4692035|P2|Overall Study|Lack of Efficacy|1
1422415|NCT01045447|4692036|P1|Overall Study|Lack of Efficacy|3
1422416|NCT01045447|4692035|P2|Overall Study|Adverse Event|1
1422417|NCT01045447|4692036|P1|Overall Study|Adverse Event|0
1422418|NCT01045421|4692050|P11|Phase 2|Other|1
1422419|NCT01045421|4692051|P10|Phase 2|Other|0
1422420|NCT01045421|4692052|P9|Phase 2|Other|0
1422421|NCT01045421|4692053|P8|Phase 2|Other|3
1422422|NCT01045421|4692054|P7|Phase 2|Other|0
1422423|NCT01045421|4692055|P6|Phase 2|Other|0
1422424|NCT01045421|4692056|P5|Phase 2|Other|0
1422425|NCT01045421|4692057|P4|Phase 2|Other|0
1422426|NCT01045421|4692058|P3|Phase 2|Other|0
1422427|NCT01045421|4692059|P2|Phase 2|Other|0
1422428|NCT01045421|4692060|P1|Phase 2|Other|0
1422429|NCT01045421|4692050|P11|Phase 2|Death|0
1422430|NCT01045421|4692051|P10|Phase 2|Death|2
1422431|NCT01045421|4692052|P9|Phase 2|Death|1
1422432|NCT01045421|4692053|P8|Phase 2|Death|1
1422433|NCT01045421|4692054|P7|Phase 2|Death|0
1422434|NCT01045421|4692055|P6|Phase 2|Death|0
1422435|NCT01045421|4692056|P5|Phase 2|Death|0
1422436|NCT01045421|4692057|P4|Phase 2|Death|0
1422437|NCT01045421|4692058|P3|Phase 2|Death|0
1422438|NCT01045421|4692059|P2|Phase 2|Death|0
1422439|NCT01045421|4692060|P1|Phase 2|Death|0
1422440|NCT01045421|4692050|P11|Phase 2|Progressive Disease|1
1422441|NCT01045421|4692051|P10|Phase 2|Progressive Disease|1
1422442|NCT01045421|4692052|P9|Phase 2|Progressive Disease|1
1422443|NCT01045421|4692053|P8|Phase 2|Progressive Disease|1
1422444|NCT01045421|4692054|P7|Phase 2|Progressive Disease|0
1422445|NCT01045421|4692055|P6|Phase 2|Progressive Disease|0
1422446|NCT01045421|4692056|P5|Phase 2|Progressive Disease|0
1422447|NCT01045421|4692057|P4|Phase 2|Progressive Disease|0
1422448|NCT01045421|4692058|P3|Phase 2|Progressive Disease|0
1422449|NCT01045421|4692059|P2|Phase 2|Progressive Disease|0
1422450|NCT01045421|4692060|P1|Phase 2|Progressive Disease|0
1422451|NCT01045421|4692050|P11|Phase 1|Withdrawal by Subject|0
1422452|NCT01045421|4692051|P10|Phase 1|Withdrawal by Subject|0
1422453|NCT01045421|4692052|P9|Phase 1|Withdrawal by Subject|0
1422454|NCT01045421|4692053|P8|Phase 1|Withdrawal by Subject|0
1422455|NCT01045421|4692054|P7|Phase 1|Withdrawal by Subject|0
1422456|NCT01045421|4692055|P6|Phase 1|Withdrawal by Subject|0
1422457|NCT01045421|4692056|P5|Phase 1|Withdrawal by Subject|0
1422458|NCT01045421|4692057|P4|Phase 1|Withdrawal by Subject|1
1422459|NCT01045421|4692058|P3|Phase 1|Withdrawal by Subject|0
1422460|NCT01045421|4692059|P2|Phase 1|Withdrawal by Subject|0
1422461|NCT01045421|4692060|P1|Phase 1|Withdrawal by Subject|0
1422462|NCT01045421|4692050|P11|Phase 1|Progressive Disease|0
1422463|NCT01045421|4692051|P10|Phase 1|Progressive Disease|0
1422464|NCT01045421|4692052|P9|Phase 1|Progressive Disease|0
1422465|NCT01045421|4692053|P8|Phase 1|Progressive Disease|0
1422466|NCT01045421|4692054|P7|Phase 1|Progressive Disease|0
1422467|NCT01045421|4692055|P6|Phase 1|Progressive Disease|0
1422468|NCT01045421|4692056|P5|Phase 1|Progressive Disease|1
1422469|NCT01045421|4692057|P4|Phase 1|Progressive Disease|0
1422470|NCT01045421|4692058|P3|Phase 1|Progressive Disease|0
1422471|NCT01045421|4692059|P2|Phase 1|Progressive Disease|0
1422472|NCT01045421|4692060|P1|Phase 1|Progressive Disease|0
1422473|NCT01045161|4692154|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
1422474|NCT01045161|4692155|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
1422475|NCT01045161|4692156|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
1422476|NCT01045161|4692154|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
1422477|NCT01045161|4692155|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
1422478|NCT01045161|4692156|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
1422479|NCT01045161|4692154|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
1422480|NCT01045161|4692155|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
1422481|NCT01045161|4692156|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
1422482|NCT01045161|4692154|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
1422483|NCT01045161|4692155|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
1422484|NCT01045161|4692156|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
1422485|NCT01045161|4692154|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
1422486|NCT01045161|4692155|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
1422487|NCT01045161|4692156|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
1422488|NCT01045161|4692154|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
1422489|NCT01045161|4692155|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
1422490|NCT01045161|4692156|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
1422491|NCT01045161|4692154|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
1422492|NCT01045161|4692155|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
1422493|NCT01045161|4692156|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
1422494|NCT01045161|4692154|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
1422495|NCT01045161|4692155|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
1422496|NCT01045161|4692156|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
1422497|NCT01045161|4692154|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
1422498|NCT01045161|4692155|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
1422499|NCT01045161|4692156|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
1422500|NCT01045161|4692154|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
1422501|NCT01045161|4692155|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
1422502|NCT01045161|4692156|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
1422503|NCT01045161|4692154|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
1422504|NCT01045161|4692155|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
1422505|NCT01045161|4692156|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
1422506|NCT01045161|4692154|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
1422507|NCT01045161|4692155|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
1422508|NCT01045161|4692156|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
1422509|NCT01045161|4692154|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
1422510|NCT01045161|4692155|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
1422511|NCT01045161|4692156|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
1422512|NCT01045161|4692154|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
1422513|NCT01045161|4692155|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
1422514|NCT01045161|4692156|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
1422515|NCT01045096|4692186|P3|Overall Study|Other|0
1422516|NCT01045096|4692187|P2|Overall Study|Other|0
1422517|NCT01045096|4692188|P1|Overall Study|Other|1
1422518|NCT01045096|4692186|P3|Overall Study|Withdrawal by Subject|0
1422519|NCT01045096|4692187|P2|Overall Study|Withdrawal by Subject|0
1422520|NCT01045096|4692188|P1|Overall Study|Withdrawal by Subject|2
1422521|NCT01044732|4692299|P2|Overall Study|Technical error or malfunction|14
1422522|NCT01044732|4692300|P1|Overall Study|Technical error or malfunction|15
1422523|NCT01044732|4692299|P2|Overall Study|Inability to reach cecum|2
1422524|NCT01044732|4692300|P1|Overall Study|Inability to reach cecum|5
1422525|NCT01044732|4692299|P2|Overall Study|Inadequate bowel preparation|17
1422526|NCT01044732|4692300|P1|Overall Study|Inadequate bowel preparation|11
1422527|NCT01044732|4692299|P2|Overall Study|Withdrawal by Subject|1
1422528|NCT01044732|4692300|P1|Overall Study|Withdrawal by Subject|0
1422529|NCT01044732|4692299|P2|Overall Study|Protocol Violation|12
1422530|NCT01044732|4692300|P1|Overall Study|Protocol Violation|11
1422531|NCT01044732|4692299|P2|Overall Study|Physician Decision|3
1422532|NCT01044732|4692300|P1|Overall Study|Physician Decision|5
1422533|NCT01044732|4692299|P2|Overall Study|Lost to Follow-up|1
1422534|NCT01044732|4692300|P1|Overall Study|Lost to Follow-up|2
1422535|NCT01044498|4692489|P2|Overall Study|Not specified|0
1422536|NCT01044498|4692490|P1|Overall Study|Not specified|1
1422537|NCT01044498|4692489|P2|Overall Study|Adverse Event|1
1422538|NCT01044498|4692490|P1|Overall Study|Adverse Event|1
1422539|NCT01044498|4692489|P2|Overall Study|Withdrew consent|1
1422540|NCT01044498|4692490|P1|Overall Study|Withdrew consent|1
1422541|NCT01044459|4692516|P2|Overall Study|Lost to Follow-up|12
1422542|NCT01044459|4692517|P1|Overall Study|Lost to Follow-up|18
1422543|NCT01044459|4692516|P2|Overall Study|COPD exacerbation|8
1422544|NCT01044459|4692517|P1|Overall Study|COPD exacerbation|9
1422545|NCT01044459|4692516|P2|Overall Study|Other Reason|14
1422546|NCT01044459|4692517|P1|Overall Study|Other Reason|7
1422547|NCT01044459|4692516|P2|Overall Study|Protocol Violation|16
1422548|NCT01044459|4692517|P1|Overall Study|Protocol Violation|11
1422549|NCT01044459|4692516|P2|Overall Study|Lack of Efficacy|12
1422550|NCT01044459|4692517|P1|Overall Study|Lack of Efficacy|23
1422551|NCT01044459|4692516|P2|Overall Study|Adverse Event|20
1422552|NCT01044459|4692517|P1|Overall Study|Adverse Event|22
1422553|NCT01044459|4692516|P2|Overall Study|Terminated by Sponsor|21
1422554|NCT01044459|4692517|P1|Overall Study|Terminated by Sponsor|22
1422555|NCT01044459|4692516|P2|Overall Study|Withdrawal by Subject|28
1422556|NCT01044459|4692517|P1|Overall Study|Withdrawal by Subject|21
1422557|NCT01044303|4692525|P1|Overall Study|Lost to Follow-up|2
1422558|NCT01044290|4692535|P3|Follow-Up 2|Withdrawal by Subject|1
1422559|NCT01044290|4692536|P2|Follow-Up 2|Withdrawal by Subject|1
1422560|NCT01044290|4692537|P1|Follow-Up 2|Withdrawal by Subject|0
1422561|NCT01044290|4692535|P3|Follow-Up 2|Death|1
1422562|NCT01044290|4692536|P2|Follow-Up 2|Death|1
1422563|NCT01044290|4692537|P1|Follow-Up 2|Death|0
1422564|NCT01044290|4692535|P3|Follow-up 1|Withdrawal by Subject|0
1422565|NCT01044290|4692536|P2|Follow-up 1|Withdrawal by Subject|2
1422566|NCT01044290|4692537|P1|Follow-up 1|Withdrawal by Subject|2
1422567|NCT01044290|4692535|P3|Follow-up 1|Death|1
1422568|NCT01044290|4692536|P2|Follow-up 1|Death|3
1422569|NCT01044290|4692537|P1|Follow-up 1|Death|3
1422570|NCT01043874|4692657|P1|Overall Study|Administrative Problems|1
1422571|NCT01043874|4692657|P1|Overall Study|Lack of Efficacy|1
1422572|NCT01043874|4692657|P1|Overall Study|Withdrawal by Subject|1
1422573|NCT01043874|4692657|P1|Overall Study|Adverse Event|3
1422574|NCT01043705|4692667|P3|Overall Study|Other|25
1422575|NCT01043705|4692668|P2|Overall Study|Other|19
1422576|NCT01043705|4692669|P1|Overall Study|Other|0
1422577|NCT01043705|4692667|P3|Overall Study|Screen Fail|0
1422578|NCT01043705|4692668|P2|Overall Study|Screen Fail|0
1422579|NCT01043705|4692669|P1|Overall Study|Screen Fail|21
1422580|NCT01043705|4692667|P3|Overall Study|Adverse Event|0
1422581|NCT01043705|4692668|P2|Overall Study|Adverse Event|2
1422582|NCT01043705|4692669|P1|Overall Study|Adverse Event|0
1422583|NCT01043705|4692667|P3|Overall Study|Subsequent Procedure|29
1422584|NCT01043705|4692668|P2|Overall Study|Subsequent Procedure|24
1422585|NCT01043705|4692669|P1|Overall Study|Subsequent Procedure|9
1422586|NCT01043705|4692667|P3|Overall Study|Site Closure|0
1422587|NCT01043705|4692668|P2|Overall Study|Site Closure|0
1422588|NCT01043705|4692669|P1|Overall Study|Site Closure|8
1422589|NCT01043705|4692667|P3|Overall Study|Withdrawal by Subject|0
1422590|NCT01043705|4692668|P2|Overall Study|Withdrawal by Subject|6
1422591|NCT01043705|4692669|P1|Overall Study|Withdrawal by Subject|8
1422592|NCT01043705|4692667|P3|Overall Study|Protocol Violation|0
1422593|NCT01043705|4692668|P2|Overall Study|Protocol Violation|1
1422594|NCT01043705|4692669|P1|Overall Study|Protocol Violation|2
1422595|NCT01043705|4692667|P3|Overall Study|Multiple Reasons|0
1422596|NCT01043705|4692668|P2|Overall Study|Multiple Reasons|7
1422597|NCT01043705|4692669|P1|Overall Study|Multiple Reasons|4
1422598|NCT01043705|4692667|P3|Overall Study|Lost to Follow-up|0
1422599|NCT01043705|4692668|P2|Overall Study|Lost to Follow-up|12
1422600|NCT01043705|4692669|P1|Overall Study|Lost to Follow-up|27
1422601|NCT01043705|4692667|P3|Overall Study|Death|26
1422602|NCT01043705|4692668|P2|Overall Study|Death|60
1422603|NCT01043705|4692669|P1|Overall Study|Death|28
1422604|NCT01043185|4692758|P10|Period 6 - Third Washout Period|Protocol Violation|0
1422605|NCT01043185|4692759|P9|Period 6 - Third Washout Period|Protocol Violation|1
1422606|NCT01043185|4692760|P8|Period 6 - Third Washout Period|Protocol Violation|0
1422607|NCT01043185|4692761|P7|Period 6 - Third Washout Period|Protocol Violation|0
1422608|NCT01043185|4692762|P6|Period 6 - Third Washout Period|Protocol Violation|0
1422609|NCT01043185|4692763|P5|Period 6 - Third Washout Period|Protocol Violation|0
1422610|NCT01043185|4692764|P4|Period 6 - Third Washout Period|Protocol Violation|0
1422611|NCT01043185|4692765|P3|Period 6 - Third Washout Period|Protocol Violation|0
1422612|NCT01043185|4692766|P2|Period 6 - Third Washout Period|Protocol Violation|0
1422613|NCT01043185|4692767|P1|Period 6 - Third Washout Period|Protocol Violation|0
1422614|NCT01042977|4692843|P2|Overall Study|Various|0
1422615|NCT01042977|4692844|P1|Overall Study|Various|3
1422616|NCT01042977|4692843|P2|Overall Study|Administrative reason by sponsor|1
1422617|NCT01042977|4692844|P1|Overall Study|Administrative reason by sponsor|0
1422618|NCT01042977|4692843|P2|Overall Study|Safety|2
1422619|NCT01042977|4692844|P1|Overall Study|Safety|0
1422620|NCT01042977|4692843|P2|Overall Study|Incorrect enrollment|4
1422621|NCT01042977|4692844|P1|Overall Study|Incorrect enrollment|6
1422622|NCT01042977|4692843|P2|Overall Study|Subject no longer meets study criteria|13
1422623|NCT01042977|4692844|P1|Overall Study|Subject no longer meets study criteria|15
1422624|NCT01042977|4692843|P2|Overall Study|Poor/non-compliance|4
1422625|NCT01042977|4692844|P1|Overall Study|Poor/non-compliance|3
1422626|NCT01042977|4692843|P2|Overall Study|Lost to Follow-up|2
1422627|NCT01042977|4692844|P1|Overall Study|Lost to Follow-up|0
1422628|NCT01042977|4692843|P2|Overall Study|Withdrawal by Subject|16
1422629|NCT01042977|4692844|P1|Overall Study|Withdrawal by Subject|8
1422630|NCT01042977|4692843|P2|Overall Study|Death|1
1422631|NCT01042977|4692844|P1|Overall Study|Death|2
1422632|NCT01042977|4692843|P2|Overall Study|Adverse Event|12
1422633|NCT01042977|4692844|P1|Overall Study|Adverse Event|4
1422634|NCT01042938|4692864|P2|Overall Study|Ineligible: RTOG study conflict|0
1422635|NCT01042938|4692865|P1|Overall Study|Ineligible: RTOG study conflict|1
1422636|NCT01042938|4692864|P2|Overall Study|Protocol Violation|1
1422637|NCT01042938|4692865|P1|Overall Study|Protocol Violation|1
1422638|NCT01042938|4692864|P2|Overall Study|Withdrawal by Subject|1
1422639|NCT01042938|4692865|P1|Overall Study|Withdrawal by Subject|1
1422640|NCT01042678|4692884|P6|Overall Study|Physician Decision|0
1422641|NCT01042678|4692885|P5|Overall Study|Physician Decision|0
1422642|NCT01042678|4692886|P4|Overall Study|Physician Decision|0
1422643|NCT01042678|4692887|P3|Overall Study|Physician Decision|0
1422644|NCT01042678|4692888|P2|Overall Study|Physician Decision|0
1422645|NCT01042678|4692889|P1|Overall Study|Physician Decision|1
1422646|NCT01042600|4692927|P2|Overall Study|Ineligible|0
1422647|NCT01042600|4692928|P1|Overall Study|Ineligible|1
1422648|NCT01042535|4692936|P1|Overall Study|complications from other disease|2
1422649|NCT01042535|4692936|P1|Overall Study|disease progression during treatment|3
1422650|NCT01042535|4692936|P1|Overall Study|disease progression prior to treatment|3
1422651|NCT01042392|4692970|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
1422652|NCT01042392|4692971|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
1422653|NCT01042392|4692972|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
1422654|NCT01042392|4692973|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
1422655|NCT01042392|4692970|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
1422656|NCT01042392|4692971|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
1422657|NCT01042392|4692972|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
1422735|NCT01041859|4693127|P3|Double-Blind Maintenance|Lost to Follow-up|0
1422658|NCT01042392|4692973|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
1422659|NCT01042392|4692970|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
1422660|NCT01042392|4692971|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
1422661|NCT01042392|4692972|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
1422662|NCT01042392|4692973|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
1422663|NCT01042392|4692970|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
1422664|NCT01042392|4692971|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
1422665|NCT01042392|4692972|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
1422666|NCT01042392|4692973|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
1422667|NCT01042392|4692970|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
1422668|NCT01042392|4692971|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
1422669|NCT01042392|4692972|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
1422670|NCT01042392|4692973|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
1422671|NCT01042392|4692970|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
1422672|NCT01042392|4692971|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
1422673|NCT01042392|4692972|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
1422674|NCT01042392|4692973|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
1422675|NCT01042392|4692970|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
1422676|NCT01042392|4692971|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
1422677|NCT01042392|4692972|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
1422678|NCT01042392|4692973|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
1422679|NCT01042392|4692970|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
1422680|NCT01042392|4692971|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
1422681|NCT01042392|4692972|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
1422682|NCT01042392|4692973|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
1422683|NCT01042392|4692970|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
1422684|NCT01042392|4692971|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
1422685|NCT01042392|4692972|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
1422686|NCT01042392|4692973|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
1422687|NCT01042236|4693021|P6|Treatment Period 3|Protocol Violation|0
1422688|NCT01042236|4693022|P5|Treatment Period 3|Protocol Violation|0
1422689|NCT01042236|4693023|P4|Treatment Period 3|Protocol Violation|1
1422690|NCT01042236|4693024|P3|Treatment Period 3|Protocol Violation|0
1422691|NCT01042236|4693025|P2|Treatment Period 3|Protocol Violation|0
1422692|NCT01042236|4693026|P1|Treatment Period 3|Protocol Violation|0
1422693|NCT01042236|4693021|P6|Treatment Period 3|Adverse Event|0
1422694|NCT01042236|4693022|P5|Treatment Period 3|Adverse Event|0
1422695|NCT01042236|4693023|P4|Treatment Period 3|Adverse Event|1
1422696|NCT01042236|4693024|P3|Treatment Period 3|Adverse Event|0
1422697|NCT01042236|4693025|P2|Treatment Period 3|Adverse Event|0
1422698|NCT01042236|4693026|P1|Treatment Period 3|Adverse Event|0
1422699|NCT01042236|4693021|P6|Treatment Period 1|Adverse Event|0
1422700|NCT01042236|4693022|P5|Treatment Period 1|Adverse Event|1
1422701|NCT01042236|4693023|P4|Treatment Period 1|Adverse Event|0
1422702|NCT01042236|4693024|P3|Treatment Period 1|Adverse Event|0
1422703|NCT01042236|4693025|P2|Treatment Period 1|Adverse Event|1
1422704|NCT01042236|4693026|P1|Treatment Period 1|Adverse Event|0
1422705|NCT01042158|4693063|P1|Overall Study|Physician Decision|1
1422706|NCT01042093|4693093|P4|Overall Study|Withdrawal by Subject|1
1422707|NCT01042093|4693094|P3|Overall Study|Withdrawal by Subject|0
1422708|NCT01042093|4693095|P2|Overall Study|Withdrawal by Subject|0
1422709|NCT01042093|4693096|P1|Overall Study|Withdrawal by Subject|0
1422710|NCT01042093|4693093|P4|Overall Study|Protocol Violation|3
1422711|NCT01042093|4693094|P3|Overall Study|Protocol Violation|2
1422712|NCT01042093|4693095|P2|Overall Study|Protocol Violation|2
1422713|NCT01042093|4693096|P1|Overall Study|Protocol Violation|2
1422714|NCT01041976|4693116|P2|Overall Study|Death|4
1422715|NCT01041976|4693117|P1|Overall Study|Death|0
1422716|NCT01041976|4693116|P2|Overall Study|Incarceration|0
1422717|NCT01041976|4693117|P1|Overall Study|Incarceration|2
1422718|NCT01041976|4693116|P2|Overall Study|Withdrawal by Subject|0
1422719|NCT01041976|4693117|P1|Overall Study|Withdrawal by Subject|3
1422720|NCT01041859|4693127|P3|Double-Blind Maintenance|Withdrawal by Subject|9
1422721|NCT01041859|4693128|P2|Double-Blind Maintenance|Withdrawal by Subject|8
1422722|NCT01041859|4693129|P1|Double-Blind Maintenance|Withdrawal by Subject|0
1422723|NCT01041859|4693127|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
1422724|NCT01041859|4693128|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
1422725|NCT01041859|4693129|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
1422726|NCT01041859|4693127|P3|Double-Blind Maintenance|Other|2
1422727|NCT01041859|4693128|P2|Double-Blind Maintenance|Other|6
1422728|NCT01041859|4693129|P1|Double-Blind Maintenance|Other|0
1422729|NCT01041859|4693127|P3|Double-Blind Maintenance|Protocol Violation|3
1422730|NCT01041859|4693128|P2|Double-Blind Maintenance|Protocol Violation|1
1422731|NCT01041859|4693129|P1|Double-Blind Maintenance|Protocol Violation|0
1422732|NCT01041859|4693127|P3|Double-Blind Maintenance|Physician Decision|1
1422733|NCT01041859|4693128|P2|Double-Blind Maintenance|Physician Decision|2
1422734|NCT01041859|4693129|P1|Double-Blind Maintenance|Physician Decision|0
1422736|NCT01041859|4693128|P2|Double-Blind Maintenance|Lost to Follow-up|1
1422737|NCT01041859|4693129|P1|Double-Blind Maintenance|Lost to Follow-up|0
1422738|NCT01041859|4693127|P3|Double-Blind Maintenance|Lack of Efficacy|11
1422739|NCT01041859|4693128|P2|Double-Blind Maintenance|Lack of Efficacy|3
1422740|NCT01041859|4693129|P1|Double-Blind Maintenance|Lack of Efficacy|0
1422741|NCT01041859|4693127|P3|Double-Blind Maintenance|Adverse Event|13
1422742|NCT01041859|4693128|P2|Double-Blind Maintenance|Adverse Event|23
1422743|NCT01041859|4693129|P1|Double-Blind Maintenance|Adverse Event|0
1422744|NCT01041859|4693127|P3|Open-Label Titration|Withdrawal by Subject|0
1422745|NCT01041859|4693128|P2|Open-Label Titration|Withdrawal by Subject|0
1422746|NCT01041859|4693129|P1|Open-Label Titration|Withdrawal by Subject|11
1422747|NCT01041859|4693127|P3|Open-Label Titration|Noncompliance With Study Drug|0
1422748|NCT01041859|4693128|P2|Open-Label Titration|Noncompliance With Study Drug|0
1422749|NCT01041859|4693129|P1|Open-Label Titration|Noncompliance With Study Drug|8
1422750|NCT01041859|4693127|P3|Open-Label Titration|Other|0
1422751|NCT01041859|4693128|P2|Open-Label Titration|Other|0
1422752|NCT01041859|4693129|P1|Open-Label Titration|Other|7
1422753|NCT01041859|4693127|P3|Open-Label Titration|Protocol Violation|0
1422754|NCT01041859|4693128|P2|Open-Label Titration|Protocol Violation|0
1422755|NCT01041859|4693129|P1|Open-Label Titration|Protocol Violation|1
1422756|NCT01041859|4693127|P3|Open-Label Titration|Physician Decision|0
1422757|NCT01041859|4693128|P2|Open-Label Titration|Physician Decision|0
1422758|NCT01041859|4693129|P1|Open-Label Titration|Physician Decision|1
1422759|NCT01041859|4693127|P3|Open-Label Titration|Lost to Follow-up|0
1422760|NCT01041859|4693128|P2|Open-Label Titration|Lost to Follow-up|0
1422761|NCT01041859|4693129|P1|Open-Label Titration|Lost to Follow-up|1
1422762|NCT01041859|4693127|P3|Open-Label Titration|Lack of Efficacy|0
1422763|NCT01041859|4693128|P2|Open-Label Titration|Lack of Efficacy|0
1422764|NCT01041859|4693129|P1|Open-Label Titration|Lack of Efficacy|3
1422765|NCT01041859|4693127|P3|Open-Label Titration|Adverse Event|0
1422766|NCT01041859|4693128|P2|Open-Label Titration|Adverse Event|0
1422767|NCT01041859|4693129|P1|Open-Label Titration|Adverse Event|69
1422768|NCT01041638|4693165|P1|Overall Study|Withdrawal by Subject|11
1422769|NCT01041638|4693165|P1|Overall Study|Physician Decision|4
1422770|NCT01041638|4693165|P1|Overall Study|Lack of Efficacy|7
1422771|NCT01041638|4693165|P1|Overall Study|Death|1
1422772|NCT01041638|4693165|P1|Overall Study|Adverse Event|4
1422773|NCT01041573|4693173|P4|Overall Study|positive to anti-HCV|0
1422774|NCT01041573|4693174|P3|Overall Study|positive to anti-HCV|0
1422775|NCT01041573|4693175|P2|Overall Study|positive to anti-HCV|0
1422776|NCT01041573|4693176|P1|Overall Study|positive to anti-HCV|1
1422777|NCT01041573|4693173|P4|Overall Study|further blood extraction|0
1422778|NCT01041573|4693174|P3|Overall Study|further blood extraction|0
1422779|NCT01041573|4693175|P2|Overall Study|further blood extraction|1
1422780|NCT01041573|4693176|P1|Overall Study|further blood extraction|0
1422781|NCT01041573|4693173|P4|Overall Study|relocation|1
1422782|NCT01041573|4693174|P3|Overall Study|relocation|3
1422783|NCT01041573|4693175|P2|Overall Study|relocation|4
1422784|NCT01041573|4693176|P1|Overall Study|relocation|1
1422785|NCT01041573|4693173|P4|Overall Study|Adverse Event|0
1422786|NCT01041573|4693174|P3|Overall Study|Adverse Event|0
1422787|NCT01041573|4693175|P2|Overall Study|Adverse Event|2
1422788|NCT01041573|4693176|P1|Overall Study|Adverse Event|0
1422789|NCT01041573|4693173|P4|Overall Study|Lost to Follow-up|1
1422790|NCT01041573|4693174|P3|Overall Study|Lost to Follow-up|2
1422791|NCT01041573|4693175|P2|Overall Study|Lost to Follow-up|1
1422792|NCT01041573|4693176|P1|Overall Study|Lost to Follow-up|0
1422793|NCT01041573|4693173|P4|Overall Study|Death|0
1422794|NCT01041573|4693174|P3|Overall Study|Death|0
1422795|NCT01041573|4693175|P2|Overall Study|Death|0
1422796|NCT01041573|4693176|P1|Overall Study|Death|1
1422797|NCT01041573|4693173|P4|Overall Study|Withdrawal by Subject|0
1422798|NCT01041573|4693174|P3|Overall Study|Withdrawal by Subject|2
1422799|NCT01041573|4693175|P2|Overall Study|Withdrawal by Subject|5
1422800|NCT01041573|4693176|P1|Overall Study|Withdrawal by Subject|2
1422801|NCT01041417|4693188|P2|Overall Study|Death|0
1422802|NCT01041417|4693189|P1|Overall Study|Death|1
1422803|NCT01041417|4693188|P2|Overall Study|Lost to Follow-up|1
1422804|NCT01041417|4693189|P1|Overall Study|Lost to Follow-up|1
1422805|NCT01041417|4693188|P2|Overall Study|Adverse Event|2
1422806|NCT01041417|4693189|P1|Overall Study|Adverse Event|5
1422807|NCT01041404|4693227|P2|Overall Study|Not Specified|23
1422808|NCT01041404|4693228|P1|Overall Study|Not Specified|11
1422809|NCT01041404|4693227|P2|Overall Study|Failure to Return|2
1422810|NCT01041404|4693228|P1|Overall Study|Failure to Return|1
1422811|NCT01041404|4693227|P2|Overall Study|Withdrawal by Subject|23
1422812|NCT01041404|4693228|P1|Overall Study|Withdrawal by Subject|29
1422813|NCT01041404|4693227|P2|Overall Study|Protocol Violation|0
1422814|NCT01041404|4693228|P1|Overall Study|Protocol Violation|4
1422815|NCT01041404|4693227|P2|Overall Study|Violation of Selection Criteria|1
1422816|NCT01041404|4693228|P1|Overall Study|Violation of Selection Criteria|0
1422817|NCT01041404|4693227|P2|Overall Study|Lack of Efficacy|210
1422818|NCT01041404|4693228|P1|Overall Study|Lack of Efficacy|200
1422819|NCT01041404|4693227|P2|Overall Study|Adverse Event|35
1422820|NCT01041404|4693228|P1|Overall Study|Adverse Event|45
1422821|NCT01041287|4693269|P2|Treatment Period 2 (3 Months)|Adverse Event|2
1422822|NCT01041287|4693270|P1|Treatment Period 2 (3 Months)|Adverse Event|0
1422823|NCT01041287|4693269|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
1422824|NCT01041287|4693270|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
1422825|NCT01040871|4693293|P2|Overall Study|Randomized and Not Treated|1
1422826|NCT01040871|4693294|P1|Overall Study|Randomized and Not Treated|2
1422827|NCT01040871|4693293|P2|Overall Study|drug supply issue|0
1422828|NCT01040871|4693294|P1|Overall Study|drug supply issue|1
1422829|NCT01040871|4693293|P2|Overall Study|Lack of Efficacy|1
1422830|NCT01040871|4693294|P1|Overall Study|Lack of Efficacy|1
1422831|NCT01040871|4693293|P2|Overall Study|Death|3
1422832|NCT01040871|4693294|P1|Overall Study|Death|1
1422833|NCT01040871|4693293|P2|Overall Study|Withdrawal by Subject|0
1422834|NCT01040871|4693294|P1|Overall Study|Withdrawal by Subject|2
1422835|NCT01040871|4693293|P2|Overall Study|Adverse Event|2
1422836|NCT01040871|4693294|P1|Overall Study|Adverse Event|6
1422837|NCT01040845|4693345|P2|Overall Study|Physician Decision|0
1422838|NCT01040845|4693346|P1|Overall Study|Physician Decision|1
1422839|NCT01040845|4693345|P2|Overall Study|Withdrawal by Subject|1
1422840|NCT01040845|4693346|P1|Overall Study|Withdrawal by Subject|1
1422841|NCT01040832|4693361|P2|Overall Study|Other|1
1422842|NCT01040832|4693362|P1|Overall Study|Other|2
1422843|NCT01040832|4693361|P2|Overall Study|Symptomatic deterioration|5
1422844|NCT01040832|4693362|P1|Overall Study|Symptomatic deterioration|2
1422845|NCT01040832|4693361|P2|Overall Study|Progressive disease|17
1422846|NCT01040832|4693362|P1|Overall Study|Progressive disease|32
1422847|NCT01040832|4693361|P2|Overall Study|Withdrawal by Subject|3
1422848|NCT01040832|4693362|P1|Overall Study|Withdrawal by Subject|2
1422849|NCT01040832|4693361|P2|Overall Study|Death|6
1422850|NCT01040832|4693362|P1|Overall Study|Death|4
1422851|NCT01040832|4693361|P2|Overall Study|Adverse Event|5
1422852|NCT01040832|4693362|P1|Overall Study|Adverse Event|4
1422853|NCT01040793|4693385|P6|Overall Study|Other reasons not listed above|0
1422854|NCT01040793|4693386|P5|Overall Study|Other reasons not listed above|1
1422855|NCT01040793|4693387|P4|Overall Study|Other reasons not listed above|0
1422856|NCT01040793|4693388|P3|Overall Study|Other reasons not listed above|1
1422857|NCT01040793|4693389|P2|Overall Study|Other reasons not listed above|0
1422858|NCT01040793|4693390|P1|Overall Study|Other reasons not listed above|0
1422859|NCT01040793|4693385|P6|Overall Study|Withdrawal by Subject|0
1422860|NCT01040793|4693386|P5|Overall Study|Withdrawal by Subject|0
1422861|NCT01040793|4693387|P4|Overall Study|Withdrawal by Subject|2
1422862|NCT01040793|4693388|P3|Overall Study|Withdrawal by Subject|0
1422863|NCT01040793|4693389|P2|Overall Study|Withdrawal by Subject|0
1422864|NCT01040793|4693390|P1|Overall Study|Withdrawal by Subject|0
1422865|NCT01040793|4693385|P6|Overall Study|Lost to Follow-up|0
1422866|NCT01040793|4693386|P5|Overall Study|Lost to Follow-up|0
1422867|NCT01040793|4693387|P4|Overall Study|Lost to Follow-up|0
1422868|NCT01040793|4693388|P3|Overall Study|Lost to Follow-up|1
1422869|NCT01040793|4693389|P2|Overall Study|Lost to Follow-up|1
1422870|NCT01040793|4693390|P1|Overall Study|Lost to Follow-up|0
1422871|NCT01040793|4693385|P6|Overall Study|Protocol Violation|0
1422872|NCT01040793|4693386|P5|Overall Study|Protocol Violation|1
1422873|NCT01040793|4693387|P4|Overall Study|Protocol Violation|0
1422874|NCT01040793|4693388|P3|Overall Study|Protocol Violation|1
1422875|NCT01040793|4693389|P2|Overall Study|Protocol Violation|1
1422876|NCT01040793|4693390|P1|Overall Study|Protocol Violation|1
1422877|NCT01040793|4693385|P6|Overall Study|Adverse Event|1
1422878|NCT01040793|4693386|P5|Overall Study|Adverse Event|2
1422879|NCT01040793|4693387|P4|Overall Study|Adverse Event|2
1422880|NCT01040793|4693388|P3|Overall Study|Adverse Event|0
1422881|NCT01040793|4693389|P2|Overall Study|Adverse Event|3
1422882|NCT01040793|4693390|P1|Overall Study|Adverse Event|5
1422883|NCT01040780|4693469|P2|Overall Study|Protocol Violation|3
1422884|NCT01040780|4693470|P1|Overall Study|Protocol Violation|1
1422885|NCT01040728|4693484|P4|Overall Study|Other reasons not listed above|0
1422886|NCT01040728|4693485|P3|Overall Study|Other reasons not listed above|0
1422887|NCT01040728|4693486|P2|Overall Study|Other reasons not listed above|1
1422888|NCT01040728|4693487|P1|Overall Study|Other reasons not listed above|0
1422889|NCT01040728|4693484|P4|Overall Study|Lack of Efficacy|1
1422890|NCT01040728|4693485|P3|Overall Study|Lack of Efficacy|0
1422891|NCT01040728|4693486|P2|Overall Study|Lack of Efficacy|1
1422892|NCT01040728|4693487|P1|Overall Study|Lack of Efficacy|0
1422893|NCT01040728|4693484|P4|Overall Study|Protocol Violation|1
1422894|NCT01040728|4693485|P3|Overall Study|Protocol Violation|0
1422895|NCT01040728|4693486|P2|Overall Study|Protocol Violation|0
1422896|NCT01040728|4693487|P1|Overall Study|Protocol Violation|0
1422897|NCT01040728|4693484|P4|Overall Study|Withdrawal by Subject|0
1422898|NCT01040728|4693485|P3|Overall Study|Withdrawal by Subject|1
1422899|NCT01040728|4693486|P2|Overall Study|Withdrawal by Subject|1
1422900|NCT01040728|4693487|P1|Overall Study|Withdrawal by Subject|0
1422901|NCT01040728|4693484|P4|Overall Study|Adverse Event|4
1422902|NCT01040728|4693485|P3|Overall Study|Adverse Event|0
1422903|NCT01040728|4693486|P2|Overall Study|Adverse Event|8
1422904|NCT01040728|4693487|P1|Overall Study|Adverse Event|4
1422905|NCT01040689|4693557|P4|Overall Study|Other reasons not listed above|0
1422906|NCT01040689|4693558|P3|Overall Study|Other reasons not listed above|0
1422907|NCT01040689|4693559|P2|Overall Study|Other reasons not listed above|1
1422908|NCT01040689|4693560|P1|Overall Study|Other reasons not listed above|0
1422909|NCT01040689|4693557|P4|Overall Study|Withdrawal by Subject|0
1422910|NCT01040689|4693558|P3|Overall Study|Withdrawal by Subject|1
1422911|NCT01040689|4693559|P2|Overall Study|Withdrawal by Subject|1
1422912|NCT01040689|4693560|P1|Overall Study|Withdrawal by Subject|2
1422913|NCT01040689|4693557|P4|Overall Study|Lost to Follow-up|0
1422914|NCT01040689|4693558|P3|Overall Study|Lost to Follow-up|0
1422915|NCT01040689|4693559|P2|Overall Study|Lost to Follow-up|0
1422916|NCT01040689|4693560|P1|Overall Study|Lost to Follow-up|1
1422917|NCT01040689|4693557|P4|Overall Study|Lack of Efficacy|0
1422918|NCT01040689|4693558|P3|Overall Study|Lack of Efficacy|1
1422919|NCT01040689|4693559|P2|Overall Study|Lack of Efficacy|0
1422920|NCT01040689|4693560|P1|Overall Study|Lack of Efficacy|0
1422921|NCT01040689|4693557|P4|Overall Study|Adverse Event|4
1422922|NCT01040689|4693558|P3|Overall Study|Adverse Event|2
1422923|NCT01040689|4693559|P2|Overall Study|Adverse Event|0
1422924|NCT01040689|4693560|P1|Overall Study|Adverse Event|0
1422925|NCT01040403|4693639|P1|Overall Study|Other reason not defined above|6
1422926|NCT01040403|4693639|P1|Overall Study|Not treated|1
1422927|NCT01040403|4693639|P1|Overall Study|Lost to Follow-up|1
1422928|NCT01040403|4693639|P1|Overall Study|Protocol Violation|2
1422929|NCT01040403|4693639|P1|Overall Study|Adverse Event|10
1422930|NCT01040351|4693827|P2|Overall Study|poor ovarian response|2
1422931|NCT01040351|4693828|P1|Overall Study|poor ovarian response|1
1422932|NCT01040260|4693838|P2|Overall Study|Lost to Follow-up|5
1422933|NCT01040260|4693839|P1|Overall Study|Lost to Follow-up|3
1422934|NCT01040260|4693838|P2|Overall Study|Withdrawal by Subject|6
1422935|NCT01040260|4693839|P1|Overall Study|Withdrawal by Subject|12
1422936|NCT01040169|4693866|P2|Overall Study|Lost to Follow-up|8
1422937|NCT01040169|4693867|P1|Overall Study|Lost to Follow-up|3
1422938|NCT01040130|4693875|P6|Overall Study|Other reasons not listed above|0
1422939|NCT01040130|4693876|P5|Overall Study|Other reasons not listed above|0
1422940|NCT01040130|4693877|P4|Overall Study|Other reasons not listed above|0
1422941|NCT01040130|4693878|P3|Overall Study|Other reasons not listed above|0
1422942|NCT01040130|4693879|P2|Overall Study|Other reasons not listed above|0
1422943|NCT01040130|4693880|P1|Overall Study|Other reasons not listed above|2
1422944|NCT01040130|4693875|P6|Overall Study|Withdrawal by Subject|1
1422945|NCT01040130|4693876|P5|Overall Study|Withdrawal by Subject|0
1422946|NCT01040130|4693877|P4|Overall Study|Withdrawal by Subject|0
1422947|NCT01040130|4693878|P3|Overall Study|Withdrawal by Subject|0
1422948|NCT01040130|4693879|P2|Overall Study|Withdrawal by Subject|2
1422949|NCT01040130|4693880|P1|Overall Study|Withdrawal by Subject|0
1422950|NCT01040130|4693875|P6|Overall Study|Protocol Violation|0
1422951|NCT01040130|4693876|P5|Overall Study|Protocol Violation|0
1422952|NCT01040130|4693877|P4|Overall Study|Protocol Violation|0
1422953|NCT01040130|4693878|P3|Overall Study|Protocol Violation|2
1422954|NCT01040130|4693879|P2|Overall Study|Protocol Violation|0
1422955|NCT01040130|4693880|P1|Overall Study|Protocol Violation|0
1422956|NCT01040130|4693875|P6|Overall Study|Adverse Event|3
1422957|NCT01040130|4693876|P5|Overall Study|Adverse Event|0
1422958|NCT01040130|4693877|P4|Overall Study|Adverse Event|5
1422959|NCT01040130|4693878|P3|Overall Study|Adverse Event|0
1422960|NCT01040130|4693879|P2|Overall Study|Adverse Event|1
1422961|NCT01040130|4693880|P1|Overall Study|Adverse Event|1
1422962|NCT01039688|4693973|P3|Overall Study|Death|0
1422963|NCT01039688|4693974|P2|Overall Study|Death|0
1422964|NCT01039688|4693975|P1|Overall Study|Death|2
1422965|NCT01039688|4693973|P3|Overall Study|Withdrawal by Subject|13
1422966|NCT01039688|4693974|P2|Overall Study|Withdrawal by Subject|27
1422967|NCT01039688|4693975|P1|Overall Study|Withdrawal by Subject|23
1422968|NCT01039688|4693973|P3|Overall Study|Not specified|12
1422969|NCT01039688|4693974|P2|Overall Study|Not specified|25
1422970|NCT01039688|4693975|P1|Overall Study|Not specified|13
1422971|NCT01039688|4693973|P3|Overall Study|Lost to Follow-up|5
1422972|NCT01039688|4693974|P2|Overall Study|Lost to Follow-up|9
1422973|NCT01039688|4693975|P1|Overall Study|Lost to Follow-up|11
1422974|NCT01039688|4693973|P3|Overall Study|Lack of Efficacy|26
1422975|NCT01039688|4693974|P2|Overall Study|Lack of Efficacy|11
1422976|NCT01039688|4693975|P1|Overall Study|Lack of Efficacy|20
1422977|NCT01039688|4693973|P3|Overall Study|Adverse Event|24
1422978|NCT01039688|4693974|P2|Overall Study|Adverse Event|39
1422979|NCT01039688|4693975|P1|Overall Study|Adverse Event|38
1422980|NCT01039675|4694246|P2|Overall Study|Physician Decision|1
1422981|NCT01039675|4694247|P1|Overall Study|Physician Decision|0
1422982|NCT01039675|4694246|P2|Overall Study|Lost to Follow-up|1
1422983|NCT01039675|4694247|P1|Overall Study|Lost to Follow-up|0
1422984|NCT01039675|4694246|P2|Overall Study|Withdrawal by Subject|1
1422985|NCT01039675|4694247|P1|Overall Study|Withdrawal by Subject|0
1422986|NCT01039675|4694246|P2|Overall Study|Lack of Efficacy|2
1422987|NCT01039675|4694247|P1|Overall Study|Lack of Efficacy|0
1422988|NCT01039675|4694246|P2|Overall Study|Adverse Event|2
1422989|NCT01039675|4694247|P1|Overall Study|Adverse Event|0
1422990|NCT01039584|4694260|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
1422991|NCT01039584|4694261|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
1422992|NCT01039584|4694262|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
1422993|NCT01039584|4694260|P3|Overall Study|Pap smear with significant pathology|3
1422994|NCT01039584|4694261|P2|Overall Study|Pap smear with significant pathology|10
1422995|NCT01039584|4694262|P1|Overall Study|Pap smear with significant pathology|10
1422996|NCT01039584|4694260|P3|Overall Study|other|1
1422997|NCT01039584|4694261|P2|Overall Study|other|3
1422998|NCT01039584|4694262|P1|Overall Study|other|1
1422999|NCT01039584|4694260|P3|Overall Study|Lack of Efficacy|10
1423000|NCT01039584|4694261|P2|Overall Study|Lack of Efficacy|6
1423001|NCT01039584|4694262|P1|Overall Study|Lack of Efficacy|7
1423002|NCT01039584|4694260|P3|Overall Study|Negative Baseline culture for Candida|24
1423003|NCT01039584|4694261|P2|Overall Study|Negative Baseline culture for Candida|59
1423004|NCT01039584|4694262|P1|Overall Study|Negative Baseline culture for Candida|59
1423005|NCT01039584|4694260|P3|Overall Study|Lost to Follow-up|4
1423006|NCT01039584|4694261|P2|Overall Study|Lost to Follow-up|3
1423007|NCT01039584|4694262|P1|Overall Study|Lost to Follow-up|5
1423008|NCT01039584|4694260|P3|Overall Study|Protocol Violation|6
1423009|NCT01039584|4694261|P2|Overall Study|Protocol Violation|4
1423010|NCT01039584|4694262|P1|Overall Study|Protocol Violation|10
1423011|NCT01039584|4694260|P3|Overall Study|Withdrawal by Subject|1
1423012|NCT01039584|4694261|P2|Overall Study|Withdrawal by Subject|2
1423013|NCT01039584|4694262|P1|Overall Study|Withdrawal by Subject|4
1423014|NCT01039519|4694276|P1|Survival Follow-up|Sponsor decision|4
1423015|NCT01039519|4694276|P1|Survival Follow-up|Death|23
1423016|NCT01039519|4694276|P1|Treatment|Physician Decision|2
1423017|NCT01039519|4694276|P1|Treatment|Adverse Event|3
1423018|NCT01039519|4694276|P1|Treatment|Treatment failure|2
1423019|NCT01039519|4694276|P1|Treatment|Progressive disease|20
1423020|NCT01039428|4694287|P2|Overall Study|Withdrawal by Subject|0
1423021|NCT01039428|4694288|P1|Overall Study|Withdrawal by Subject|1
1423022|NCT01039428|4694287|P2|Overall Study|Protocol Violation|0
1423023|NCT01039428|4694288|P1|Overall Study|Protocol Violation|1
1423024|NCT01039376|4694312|P2|Overall Study|Ongoing|182
1423025|NCT01039376|4694313|P1|Overall Study|Ongoing|189
1423026|NCT01039376|4694312|P2|Overall Study|Withdrawal by Subject|17
1423027|NCT01039376|4694313|P1|Overall Study|Withdrawal by Subject|11
1423028|NCT01039376|4694312|P2|Overall Study|Physician Decision|2
1423029|NCT01039376|4694313|P1|Overall Study|Physician Decision|4
1423030|NCT01039376|4694312|P2|Overall Study|Lost to Follow-up|1
1423031|NCT01039376|4694313|P1|Overall Study|Lost to Follow-up|2
1423032|NCT01038921|4694381|P2|Overall Study|Physician Decision|0
1423033|NCT01038921|4694382|P1|Overall Study|Physician Decision|1
1423034|NCT01038921|4694381|P2|Overall Study|Withdrawal by Subject|0
1423035|NCT01038921|4694382|P1|Overall Study|Withdrawal by Subject|1
1423036|NCT01038869|4694388|P1|Overall Study|Lost to Follow-up|6
1423037|NCT01038869|4694388|P1|Overall Study|Withdrawal by Subject|1
1423038|NCT01038856|4694396|P1|Overall Study|Adverse Event|2
1423039|NCT01038752|4694405|P2|Overall Study|Lost to Follow-up|3
1423040|NCT01038752|4694406|P1|Overall Study|Lost to Follow-up|3
1423041|NCT01038752|4694405|P2|Overall Study|Tumor Progression|2
1423042|NCT01038752|4694406|P1|Overall Study|Tumor Progression|2
1423043|NCT01038713|4694429|P3|Overall Study|Autoimmune Pancreatitis|0
1423044|NCT01038713|4694430|P2|Overall Study|Autoimmune Pancreatitis|0
1423045|NCT01038713|4694431|P1|Overall Study|Autoimmune Pancreatitis|1
1423046|NCT01038713|4694429|P3|Overall Study|died from PEP|0
1423047|NCT01038713|4694430|P2|Overall Study|died from PEP|1
1423048|NCT01038713|4694431|P1|Overall Study|died from PEP|0
1423049|NCT01038713|4694429|P3|Overall Study|Neuroendocrine Tumor|0
1423050|NCT01038713|4694430|P2|Overall Study|Neuroendocrine Tumor|1
1423051|NCT01038713|4694431|P1|Overall Study|Neuroendocrine Tumor|0
1423052|NCT01038713|4694429|P3|Overall Study|Lost to Follow-up|0
1423053|NCT01038713|4694430|P2|Overall Study|Lost to Follow-up|0
1423054|NCT01038713|4694431|P1|Overall Study|Lost to Follow-up|3
1423055|NCT01038713|4694429|P3|Overall Study|Patient to hospice|1
1423056|NCT01038713|4694430|P2|Overall Study|Patient to hospice|1
1423057|NCT01038713|4694431|P1|Overall Study|Patient to hospice|1
1423058|NCT01038635|4694460|P9|Overall Study|Death|2
1423059|NCT01038635|4694461|P8|Overall Study|Death|1
1423060|NCT01038635|4694462|P7|Overall Study|Death|1
1423061|NCT01038635|4694463|P6|Overall Study|Death|0
1423062|NCT01038635|4694464|P5|Overall Study|Death|1
1423063|NCT01038635|4694465|P4|Overall Study|Death|0
1423064|NCT01038635|4694466|P3|Overall Study|Death|0
1423065|NCT01038635|4694467|P2|Overall Study|Death|0
1423066|NCT01038635|4694468|P1|Overall Study|Death|0
1423067|NCT01038635|4694460|P9|Overall Study|Disease Progression|0
1423068|NCT01038635|4694461|P8|Overall Study|Disease Progression|4
1423069|NCT01038635|4694462|P7|Overall Study|Disease Progression|1
1423070|NCT01038635|4694463|P6|Overall Study|Disease Progression|0
1423071|NCT01038635|4694464|P5|Overall Study|Disease Progression|0
1423072|NCT01038635|4694465|P4|Overall Study|Disease Progression|0
1423073|NCT01038635|4694466|P3|Overall Study|Disease Progression|0
1423074|NCT01038635|4694467|P2|Overall Study|Disease Progression|0
1423075|NCT01038635|4694468|P1|Overall Study|Disease Progression|2
1423076|NCT01038609|4694494|P5|Overall Study|Refusal of Blood Draws|0
1423077|NCT01038609|4694495|P4|Overall Study|Refusal of Blood Draws|0
1423078|NCT01038609|4694496|P3|Overall Study|Refusal of Blood Draws|0
1423079|NCT01038609|4694497|P2|Overall Study|Refusal of Blood Draws|1
1423080|NCT01038609|4694498|P1|Overall Study|Refusal of Blood Draws|0
1423081|NCT01038609|4694494|P5|Overall Study|Death in the Family|0
1423082|NCT01038609|4694495|P4|Overall Study|Death in the Family|0
1423083|NCT01038609|4694496|P3|Overall Study|Death in the Family|0
1423084|NCT01038609|4694497|P2|Overall Study|Death in the Family|0
1423085|NCT01038609|4694498|P1|Overall Study|Death in the Family|1
1423086|NCT01038609|4694494|P5|Overall Study|Dosing Error|1
1423087|NCT01038609|4694495|P4|Overall Study|Dosing Error|1
1423088|NCT01038609|4694496|P3|Overall Study|Dosing Error|0
1423089|NCT01038609|4694497|P2|Overall Study|Dosing Error|0
1423090|NCT01038609|4694498|P1|Overall Study|Dosing Error|0
1423091|NCT01038609|4694494|P5|Overall Study|Adverse Event|0
1423092|NCT01038609|4694495|P4|Overall Study|Adverse Event|0
1423093|NCT01038609|4694496|P3|Overall Study|Adverse Event|1
1423094|NCT01038609|4694497|P2|Overall Study|Adverse Event|0
1423095|NCT01038609|4694498|P1|Overall Study|Adverse Event|0
1423096|NCT01038323|4694577|P3|Overall Study|Withdrawal by Subject|4
1423097|NCT01038323|4694578|P2|Overall Study|Withdrawal by Subject|2
1423098|NCT01038323|4694579|P1|Overall Study|Withdrawal by Subject|3
1423099|NCT01038128|4694593|P1|Overall Study|Withdrawal by Subject|2
1423100|NCT01038128|4694593|P1|Overall Study|Lost to Follow-up|1
1423101|NCT01038128|4694593|P1|Overall Study|Lack of Efficacy|1
1423102|NCT01037244|4694677|P4|Overall Study|Various|1
1423103|NCT01037244|4694678|P3|Overall Study|Various|1
1423104|NCT01037244|4694679|P2|Overall Study|Various|2
1423105|NCT01037244|4694680|P1|Overall Study|Various|3
1423106|NCT01037244|4694677|P4|Overall Study|Partner Withdrew Consent|0
1423107|NCT01037244|4694678|P3|Overall Study|Partner Withdrew Consent|0
1423108|NCT01037244|4694679|P2|Overall Study|Partner Withdrew Consent|1
1423109|NCT01037244|4694680|P1|Overall Study|Partner Withdrew Consent|2
1423110|NCT01037244|4694677|P4|Overall Study|Withdrawal by Subject|5
1423111|NCT01037244|4694678|P3|Overall Study|Withdrawal by Subject|3
1423112|NCT01037244|4694679|P2|Overall Study|Withdrawal by Subject|5
1423113|NCT01037244|4694680|P1|Overall Study|Withdrawal by Subject|1
1423114|NCT01037244|4694677|P4|Overall Study|Lost to Follow-up|4
1423115|NCT01037244|4694678|P3|Overall Study|Lost to Follow-up|4
1423116|NCT01037244|4694679|P2|Overall Study|Lost to Follow-up|3
1423117|NCT01037244|4694680|P1|Overall Study|Lost to Follow-up|3
1423118|NCT01037244|4694677|P4|Overall Study|Lack of Efficacy|1
1423119|NCT01037244|4694678|P3|Overall Study|Lack of Efficacy|0
1423120|NCT01037244|4694679|P2|Overall Study|Lack of Efficacy|1
1423121|NCT01037244|4694680|P1|Overall Study|Lack of Efficacy|1
1423122|NCT01037244|4694677|P4|Overall Study|Adverse Event|3
1423123|NCT01037244|4694678|P3|Overall Study|Adverse Event|6
1423124|NCT01037244|4694679|P2|Overall Study|Adverse Event|2
1423125|NCT01037244|4694680|P1|Overall Study|Adverse Event|3
1423126|NCT01037218|4694742|P4|Overall Study|Various|1
1423127|NCT01037218|4694743|P3|Overall Study|Various|3
1423128|NCT01037218|4694744|P2|Overall Study|Various|2
1423129|NCT01037218|4694745|P1|Overall Study|Various|3
1423130|NCT01037218|4694742|P4|Overall Study|Protocol Violation|2
1423131|NCT01037218|4694743|P3|Overall Study|Protocol Violation|2
1423132|NCT01037218|4694744|P2|Overall Study|Protocol Violation|0
1423133|NCT01037218|4694745|P1|Overall Study|Protocol Violation|0
1423134|NCT01037218|4694742|P4|Overall Study|Partner Withdrew Consent|1
1423135|NCT01037218|4694743|P3|Overall Study|Partner Withdrew Consent|2
1423136|NCT01037218|4694744|P2|Overall Study|Partner Withdrew Consent|3
1423137|NCT01037218|4694745|P1|Overall Study|Partner Withdrew Consent|0
1423138|NCT01037218|4694742|P4|Overall Study|Withdrawal by Subject|4
1423139|NCT01037218|4694743|P3|Overall Study|Withdrawal by Subject|7
1423140|NCT01037218|4694744|P2|Overall Study|Withdrawal by Subject|7
1423141|NCT01037218|4694745|P1|Overall Study|Withdrawal by Subject|6
1423142|NCT01037218|4694742|P4|Overall Study|Lost to Follow-up|2
1423143|NCT01037218|4694743|P3|Overall Study|Lost to Follow-up|4
1423144|NCT01037218|4694744|P2|Overall Study|Lost to Follow-up|5
1423145|NCT01037218|4694745|P1|Overall Study|Lost to Follow-up|3
1423146|NCT01037218|4694742|P4|Overall Study|Lack of Efficacy|5
1423147|NCT01037218|4694743|P3|Overall Study|Lack of Efficacy|1
1423148|NCT01037218|4694744|P2|Overall Study|Lack of Efficacy|2
1423149|NCT01037218|4694745|P1|Overall Study|Lack of Efficacy|0
1423150|NCT01037218|4694742|P4|Overall Study|Adverse Event|1
1423151|NCT01037218|4694743|P3|Overall Study|Adverse Event|2
1423152|NCT01037218|4694744|P2|Overall Study|Adverse Event|2
1423153|NCT01037218|4694745|P1|Overall Study|Adverse Event|4
1423154|NCT01037127|4694816|P2|Overall Study|Study Closed Terminated|17
1423155|NCT01037127|4694817|P1|Overall Study|Study Closed Terminated|2
1423156|NCT01037127|4694816|P2|Overall Study|Physician Decision|0
1423157|NCT01037127|4694817|P1|Overall Study|Physician Decision|1
1423158|NCT01037127|4694816|P2|Overall Study|Lost to Follow-up|4
1423159|NCT01037127|4694817|P1|Overall Study|Lost to Follow-up|2
1423160|NCT01037114|4694849|P1|Year 20|Others|1
1423161|NCT01037088|4694862|P1|Overall Study|Withdrawal by Subject|3
1423162|NCT01036763|4694894|P1|Overall Study|Other reason (not specified)|40
1423163|NCT01036763|4694894|P1|Overall Study|Lost to Follow-up|28
1423164|NCT01036763|4694894|P1|Overall Study|Adverse Event|25
1423165|NCT01036724|4694906|P2|Overall Study|Protocol Violation|5
1423166|NCT01036724|4694907|P1|Overall Study|Protocol Violation|4
1423167|NCT01036724|4694906|P2|Overall Study|Lack of Efficacy|1
1423168|NCT01036724|4694907|P1|Overall Study|Lack of Efficacy|1
1423169|NCT01036724|4694906|P2|Overall Study|Adverse Event|2
1423170|NCT01036724|4694907|P1|Overall Study|Adverse Event|1
1423171|NCT01036529|4694917|P2|Overall Study|Sponsor study termination|12
1423172|NCT01036529|4694918|P1|Overall Study|Sponsor study termination|11
1423173|NCT01036529|4694917|P2|Overall Study|Withdrawal by Subject|1
1423174|NCT01036529|4694918|P1|Overall Study|Withdrawal by Subject|1
1423175|NCT01036529|4694917|P2|Overall Study|Physician Decision|0
1423176|NCT01036529|4694918|P1|Overall Study|Physician Decision|1
1423177|NCT01036529|4694917|P2|Overall Study|Lost to Follow-up|1
1423178|NCT01036529|4694918|P1|Overall Study|Lost to Follow-up|0
1423179|NCT01036529|4694917|P2|Overall Study|Adverse Event|1
1423180|NCT01036529|4694918|P1|Overall Study|Adverse Event|0
1423181|NCT01036438|4694945|P2|Overall Study|No effect of study treatment|1
1423182|NCT01036438|4694946|P1|Overall Study|No effect of study treatment|3
1423183|NCT01036438|4694945|P2|Overall Study|Death|1
1423184|NCT01036438|4694946|P1|Overall Study|Death|0
1423185|NCT01036438|4694945|P2|Overall Study|Adverse Event|8
1423186|NCT01036438|4694946|P1|Overall Study|Adverse Event|7
1423187|NCT01036321|4694954|P2|Overall Study|Adverse Event|1
1423188|NCT01036321|4694955|P1|Overall Study|Adverse Event|2
1423189|NCT01036321|4694954|P2|Overall Study|Withdrawal by Subject|2
1423190|NCT01036321|4694955|P1|Overall Study|Withdrawal by Subject|3
1423191|NCT01036321|4694954|P2|Overall Study|Ineligible after randomization|1
1423192|NCT01036321|4694955|P1|Overall Study|Ineligible after randomization|0
1423193|NCT01036165|4694979|P1|Overall Study|Problems finding proper area to inject|1
1423194|NCT01036165|4694979|P1|Overall Study|Device Related Issues|3
1423195|NCT01036165|4694979|P1|Overall Study|Withdrawal by Subject|3
1423196|NCT01036165|4694979|P1|Overall Study|Lost to Follow-up|2
1423197|NCT01036165|4694979|P1|Overall Study|Adverse Event|6
1423198|NCT01036022|4694990|P6|Overall Study|Withdrawal by Subject|0
1423199|NCT01036022|4694991|P5|Overall Study|Withdrawal by Subject|2
1423200|NCT01036022|4694992|P4|Overall Study|Withdrawal by Subject|1
1423201|NCT01036022|4694993|P3|Overall Study|Withdrawal by Subject|0
1423202|NCT01036022|4694994|P2|Overall Study|Withdrawal by Subject|0
1423203|NCT01036022|4694995|P1|Overall Study|Withdrawal by Subject|0
1423204|NCT01036022|4694990|P6|Overall Study|Physician Decision|0
1423205|NCT01036022|4694991|P5|Overall Study|Physician Decision|0
1423206|NCT01036022|4694992|P4|Overall Study|Physician Decision|0
1423207|NCT01036022|4694993|P3|Overall Study|Physician Decision|1
1423208|NCT01036022|4694994|P2|Overall Study|Physician Decision|0
1423209|NCT01036022|4694995|P1|Overall Study|Physician Decision|0
1423210|NCT01036022|4694990|P6|Overall Study|Lack of Efficacy|1
1423211|NCT01036022|4694991|P5|Overall Study|Lack of Efficacy|1
1423212|NCT01036022|4694992|P4|Overall Study|Lack of Efficacy|0
1423213|NCT01036022|4694993|P3|Overall Study|Lack of Efficacy|1
1423214|NCT01036022|4694994|P2|Overall Study|Lack of Efficacy|1
1423215|NCT01036022|4694995|P1|Overall Study|Lack of Efficacy|1
1423216|NCT01036022|4694990|P6|Overall Study|Adverse Event|2
1423217|NCT01036022|4694991|P5|Overall Study|Adverse Event|0
1423218|NCT01036022|4694992|P4|Overall Study|Adverse Event|1
1423219|NCT01036022|4694993|P3|Overall Study|Adverse Event|2
1423220|NCT01036022|4694994|P2|Overall Study|Adverse Event|3
1423221|NCT01036022|4694995|P1|Overall Study|Adverse Event|1
1423222|NCT01035905|4695131|P2|Overall Study|Lack of Efficacy|1
1423223|NCT01035905|4695132|P1|Overall Study|Lack of Efficacy|1
1423224|NCT01035606|4695305|P3|Overall Study|change in health, job demands,family|4
1423225|NCT01035606|4695306|P2|Overall Study|change in health, job demands,family|3
1423226|NCT01035606|4695307|P1|Overall Study|change in health, job demands,family|3
1423227|NCT01035255|4695349|P2|Overall Study|patient's request|13
1423228|NCT01035255|4695350|P1|Overall Study|patient's request|15
1423229|NCT01035255|4695349|P2|Overall Study|Lost to Follow-up|5
1423230|NCT01035255|4695350|P1|Overall Study|Lost to Follow-up|2
1423231|NCT01035255|4695349|P2|Overall Study|Death|844
1423232|NCT01035255|4695350|P1|Overall Study|Death|724
1423233|NCT01035229|4695368|P2|Overall Study|Disease Progression|152
1423234|NCT01035229|4695369|P1|Overall Study|Disease Progression|261
1423235|NCT01035229|4695368|P2|Overall Study|Sponsor's decision to end study|3
1423236|NCT01035229|4695369|P1|Overall Study|Sponsor's decision to end study|3
1423237|NCT01035229|4695368|P2|Overall Study|Protocol Violation|2
1423238|NCT01035229|4695369|P1|Overall Study|Protocol Violation|0
1423239|NCT01035229|4695368|P2|Overall Study|New cancer therapy|0
1423240|NCT01035229|4695369|P1|Overall Study|New cancer therapy|2
1423241|NCT01035229|4695368|P2|Overall Study|Death|5
1423242|NCT01035229|4695369|P1|Overall Study|Death|13
1423243|NCT01035229|4695368|P2|Overall Study|Administrative problems|1
1423244|NCT01035229|4695369|P1|Overall Study|Administrative problems|1
1423245|NCT01035229|4695368|P2|Overall Study|Lost to Follow-up|0
1423246|NCT01035229|4695369|P1|Overall Study|Lost to Follow-up|1
1423247|NCT01035229|4695368|P2|Overall Study|Withdrawal by Subject|7
1423248|NCT01035229|4695369|P1|Overall Study|Withdrawal by Subject|20
1423249|NCT01035229|4695368|P2|Overall Study|Adverse Event|14
1423250|NCT01035229|4695369|P1|Overall Study|Adverse Event|61
1423251|NCT01035138|4695390|P3|Overall Study|Lost to Follow-up|1
1423252|NCT01035138|4695391|P2|Overall Study|Lost to Follow-up|0
1423253|NCT01035138|4695392|P1|Overall Study|Lost to Follow-up|0
1423254|NCT01035138|4695390|P3|Overall Study|Sponsor Decision|42
1423255|NCT01035138|4695391|P2|Overall Study|Sponsor Decision|60
1423256|NCT01035138|4695392|P1|Overall Study|Sponsor Decision|66
1423257|NCT01035138|4695390|P3|Overall Study|Physician Decision|1
1423258|NCT01035138|4695391|P2|Overall Study|Physician Decision|0
1423259|NCT01035138|4695392|P1|Overall Study|Physician Decision|0
1423260|NCT01035138|4695390|P3|Overall Study|Withdrawal by Subject|0
1423261|NCT01035138|4695391|P2|Overall Study|Withdrawal by Subject|0
1423262|NCT01035138|4695392|P1|Overall Study|Withdrawal by Subject|1
1423263|NCT01035138|4695390|P3|Overall Study|Caregiver Decision|1
1423264|NCT01035138|4695391|P2|Overall Study|Caregiver Decision|0
1423265|NCT01035138|4695392|P1|Overall Study|Caregiver Decision|2
1423266|NCT01035138|4695390|P3|Overall Study|Adverse Event|2
1423267|NCT01035138|4695391|P2|Overall Study|Adverse Event|0
1423268|NCT01035138|4695392|P1|Overall Study|Adverse Event|4
1423269|NCT01035060|4695448|P2|Overall Study|Physician Decision|0
1423270|NCT01035060|4695449|P1|Overall Study|Physician Decision|2
1423271|NCT01035060|4695448|P2|Overall Study|Withdrawal by Subject|6
1423272|NCT01035060|4695449|P1|Overall Study|Withdrawal by Subject|8
1423273|NCT01035060|4695448|P2|Overall Study|Did not quality after 2nd screening|1
1423274|NCT01035060|4695449|P1|Overall Study|Did not quality after 2nd screening|14
1423275|NCT01035060|4695448|P2|Overall Study|Lost to Follow-up|7
1423276|NCT01035060|4695449|P1|Overall Study|Lost to Follow-up|0
1423277|NCT01034709|4695474|P2|Overall Study|Protocol Violation|16
1423278|NCT01034709|4695475|P1|Overall Study|Protocol Violation|9
1423279|NCT01034657|4695481|P3|Randomized Phase|Adverse Event|1
1423280|NCT01034657|4695482|P2|Randomized Phase|Adverse Event|2
1423281|NCT01034657|4695483|P1|Randomized Phase|Adverse Event|0
1423282|NCT01034657|4695481|P3|Randomized Phase|Abnormal laboratory value|0
1423283|NCT01034657|4695482|P2|Randomized Phase|Abnormal laboratory value|1
1423284|NCT01034657|4695483|P1|Randomized Phase|Abnormal laboratory value|0
1423285|NCT01034657|4695481|P3|Randomized Phase|Lack of Efficacy|0
1423286|NCT01034657|4695482|P2|Randomized Phase|Lack of Efficacy|1
1423287|NCT01034657|4695483|P1|Randomized Phase|Lack of Efficacy|5
1423288|NCT01034657|4695481|P3|Randomized Phase|Withdrawal by Subject|0
1423289|NCT01034657|4695482|P2|Randomized Phase|Withdrawal by Subject|2
1423290|NCT01034657|4695483|P1|Randomized Phase|Withdrawal by Subject|0
1423291|NCT01034657|4695481|P3|Core Phase|Protocol Violation|0
1423292|NCT01034657|4695482|P2|Core Phase|Protocol Violation|0
1423293|NCT01034657|4695483|P1|Core Phase|Protocol Violation|2
1423294|NCT01034657|4695481|P3|Core Phase|Adverse Event|0
1423295|NCT01034657|4695482|P2|Core Phase|Adverse Event|0
1423296|NCT01034657|4695483|P1|Core Phase|Adverse Event|8
1423297|NCT01034657|4695481|P3|Core Phase|Abnormal laboratory value|0
1423298|NCT01034657|4695482|P2|Core Phase|Abnormal laboratory value|0
1423299|NCT01034657|4695483|P1|Core Phase|Abnormal laboratory value|1
1423300|NCT01034657|4695481|P3|Core Phase|Lack of Efficacy|0
1423301|NCT01034657|4695482|P2|Core Phase|Lack of Efficacy|0
1423302|NCT01034657|4695483|P1|Core Phase|Lack of Efficacy|2
1423303|NCT01034657|4695481|P3|Core Phase|Withdrawal by Subject|0
1423304|NCT01034657|4695482|P2|Core Phase|Withdrawal by Subject|0
1423305|NCT01034657|4695483|P1|Core Phase|Withdrawal by Subject|1
1423306|NCT01034631|4695524|P3|Phase II|Determined Ineligible per protocol|0
1423307|NCT01034631|4695525|P2|Phase II|Determined Ineligible per protocol|1
1423308|NCT01034631|4695526|P1|Phase II|Determined Ineligible per protocol|0
1423309|NCT01034631|4695524|P3|Phase II|Not Evaluable per protocol|2
1423310|NCT01034631|4695525|P2|Phase II|Not Evaluable per protocol|0
1423311|NCT01034631|4695526|P1|Phase II|Not Evaluable per protocol|0
1423312|NCT01034631|4695524|P3|Phase I|Symptomatic Deterioration before Treatme|0
1423313|NCT01034631|4695525|P2|Phase I|Symptomatic Deterioration before Treatme|0
1423314|NCT01034631|4695526|P1|Phase I|Symptomatic Deterioration before Treatme|3
1423315|NCT01034540|4695593|P2|Overall Study|Adverse Event|1
1423316|NCT01034540|4695594|P1|Overall Study|Adverse Event|0
1423317|NCT01034462|4695604|P2|Overall Study|Other reasons|2
1423318|NCT01034462|4695605|P1|Overall Study|Other reasons|1
1423319|NCT01034462|4695604|P2|Overall Study|Lost to Follow-up|16
1423320|NCT01034462|4695605|P1|Overall Study|Lost to Follow-up|14
1423321|NCT01034462|4695604|P2|Overall Study|Withdrawal by Subject|8
1423322|NCT01034462|4695605|P1|Overall Study|Withdrawal by Subject|9
1423323|NCT01034462|4695604|P2|Overall Study|Protocol Violation|7
1423324|NCT01034462|4695605|P1|Overall Study|Protocol Violation|10
1423325|NCT01034462|4695604|P2|Overall Study|Lack of Efficacy|4
1423326|NCT01034462|4695605|P1|Overall Study|Lack of Efficacy|4
1423327|NCT01034462|4695604|P2|Overall Study|Adverse Event|17
1423328|NCT01034462|4695605|P1|Overall Study|Adverse Event|7
1423329|NCT01034397|4695615|P2|Overall Study|Not specified|1
1423330|NCT01034397|4695616|P1|Overall Study|Not specified|0
1423331|NCT01034397|4695615|P2|Overall Study|Adverse Event|0
1423332|NCT01034397|4695616|P1|Overall Study|Adverse Event|4
1423333|NCT01034397|4695615|P2|Overall Study|Lack of Efficacy|0
1423334|NCT01034397|4695616|P1|Overall Study|Lack of Efficacy|3
1423335|NCT01034397|4695615|P2|Overall Study|Lack of compliance|1
1423336|NCT01034397|4695616|P1|Overall Study|Lack of compliance|0
1423337|NCT01034358|4695765|P1|Overall Study|Protocol Violation|1
1423338|NCT01034358|4695765|P1|Overall Study|Withdrawal by Subject|1
1423339|NCT01034306|4695771|P2|Overall Study|Noncomplience|0
1423340|NCT01034306|4695772|P1|Overall Study|Noncomplience|1
1423341|NCT01034306|4695771|P2|Overall Study|hospitalized and decided to stop|0
1423342|NCT01034306|4695772|P1|Overall Study|hospitalized and decided to stop|1
1423343|NCT01034306|4695771|P2|Overall Study|Withdrawal by Subject|2
1423344|NCT01034306|4695772|P1|Overall Study|Withdrawal by Subject|2
1423345|NCT01034306|4695771|P2|Overall Study|Lost to Follow-up|1
1423346|NCT01034306|4695772|P1|Overall Study|Lost to Follow-up|0
1423347|NCT01034306|4695771|P2|Overall Study|Adverse Event|0
1423348|NCT01034306|4695772|P1|Overall Study|Adverse Event|1
1423349|NCT01034176|4695780|P2|Overall Study|Lost to Follow-up|1
1423350|NCT01034176|4695781|P1|Overall Study|Lost to Follow-up|0
1423351|NCT01034176|4695780|P2|Overall Study|Withdrawal by Subject|1
1423352|NCT01034176|4695781|P1|Overall Study|Withdrawal by Subject|0
1423353|NCT01034176|4695780|P2|Overall Study|Physician Decision|0
1423354|NCT01034176|4695781|P1|Overall Study|Physician Decision|2
1423355|NCT01034163|4695791|P2|Overall Study|Abnormal laboratory value|0
1423356|NCT01034163|4695792|P1|Overall Study|Abnormal laboratory value|1
1423357|NCT01034163|4695791|P2|Overall Study|Administrative problems|1
1423358|NCT01034163|4695792|P1|Overall Study|Administrative problems|0
1423359|NCT01034163|4695791|P2|Overall Study|Adverse Event|0
1423360|NCT01034163|4695792|P1|Overall Study|Adverse Event|6
1423361|NCT01034163|4695791|P2|Overall Study|Disease progression|4
1423362|NCT01034163|4695792|P1|Overall Study|Disease progression|3
1423363|NCT01034163|4695791|P2|Overall Study|Protocol deviation|0
1423364|NCT01034163|4695792|P1|Overall Study|Protocol deviation|1
1423365|NCT01034163|4695791|P2|Overall Study|Withdrawal by Subject|2
1423366|NCT01034163|4695792|P1|Overall Study|Withdrawal by Subject|8
1423367|NCT01034163|4695791|P2|Overall Study|Treatment completed as per protocol|7
1423368|NCT01034163|4695792|P1|Overall Study|Treatment completed as per protocol|8
1423369|NCT01034137|4695801|P3|Overall Study|Administrative or other|4
1423370|NCT01034137|4695802|P2|Overall Study|Administrative or other|3
1423371|NCT01034137|4695803|P1|Overall Study|Administrative or other|2
1423372|NCT01034137|4695801|P3|Overall Study|Refused treatment or did not cooperate|1
1423373|NCT01034137|4695802|P2|Overall Study|Refused treatment or did not cooperate|0
1423374|NCT01034137|4695803|P1|Overall Study|Refused treatment or did not cooperate|2
1423375|NCT01034137|4695801|P3|Overall Study|Protocol Violation|1
1423376|NCT01034137|4695802|P2|Overall Study|Protocol Violation|2
1423377|NCT01034137|4695803|P1|Overall Study|Protocol Violation|2
1423378|NCT01034137|4695801|P3|Overall Study|Lack of Efficacy|13
1423379|NCT01034137|4695802|P2|Overall Study|Lack of Efficacy|4
1423380|NCT01034137|4695803|P1|Overall Study|Lack of Efficacy|9
1423381|NCT01034137|4695801|P3|Overall Study|Withdrawal by Subject|3
1423382|NCT01034137|4695802|P2|Overall Study|Withdrawal by Subject|3
1423383|NCT01034137|4695803|P1|Overall Study|Withdrawal by Subject|4
1423384|NCT01034137|4695801|P3|Overall Study|Adverse Event|8
1423385|NCT01034137|4695802|P2|Overall Study|Adverse Event|10
1423386|NCT01034137|4695803|P1|Overall Study|Adverse Event|9
1423387|NCT01033942|4695942|P3|Overall Study|Enrolled in Extension Study|0
1423388|NCT01033942|4695943|P2|Overall Study|Enrolled in Extension Study|3
1423389|NCT01033942|4695944|P1|Overall Study|Enrolled in Extension Study|0
1423390|NCT01033942|4695942|P3|Overall Study|Lost to Follow-up|0
1423391|NCT01033942|4695943|P2|Overall Study|Lost to Follow-up|0
1423392|NCT01033942|4695944|P1|Overall Study|Lost to Follow-up|1
1423393|NCT01033942|4695942|P3|Overall Study|Withdrawal by Subject|1
1423394|NCT01033942|4695943|P2|Overall Study|Withdrawal by Subject|1
1423395|NCT01033942|4695944|P1|Overall Study|Withdrawal by Subject|1
1423396|NCT01033851|4696242|P2|Overall Study|Withdrawal by Subject|7
1423397|NCT01033851|4696243|P1|Overall Study|Withdrawal by Subject|3
1423398|NCT01033825|4696258|P7|Overall Study|Other|0
1423399|NCT01033825|4696259|P6|Overall Study|Other|0
1423400|NCT01033825|4696260|P5|Overall Study|Other|1
1423401|NCT01033825|4696261|P4|Overall Study|Other|0
1423402|NCT01033825|4696262|P3|Overall Study|Other|0
1423403|NCT01033825|4696263|P2|Overall Study|Other|0
1423404|NCT01033825|4696264|P1|Overall Study|Other|0
1423405|NCT01033825|4696258|P7|Overall Study|Protocol Violation|0
1423406|NCT01033825|4696259|P6|Overall Study|Protocol Violation|0
1423407|NCT01033825|4696260|P5|Overall Study|Protocol Violation|0
1423408|NCT01033825|4696261|P4|Overall Study|Protocol Violation|0
1423409|NCT01033825|4696262|P3|Overall Study|Protocol Violation|0
1423410|NCT01033825|4696263|P2|Overall Study|Protocol Violation|0
1423411|NCT01033825|4696264|P1|Overall Study|Protocol Violation|1
1423412|NCT01033825|4696258|P7|Overall Study|Adverse Event|0
1423413|NCT01033825|4696259|P6|Overall Study|Adverse Event|0
1423414|NCT01033825|4696260|P5|Overall Study|Adverse Event|0
1423415|NCT01033825|4696261|P4|Overall Study|Adverse Event|1
1423416|NCT01033825|4696262|P3|Overall Study|Adverse Event|0
1423417|NCT01033825|4696263|P2|Overall Study|Adverse Event|0
1423418|NCT01033825|4696264|P1|Overall Study|Adverse Event|0
1423419|NCT01033825|4696258|P7|Overall Study|Withdrawal by Subject|0
1423420|NCT01033825|4696259|P6|Overall Study|Withdrawal by Subject|0
1423421|NCT01033825|4696260|P5|Overall Study|Withdrawal by Subject|1
1423422|NCT01033825|4696261|P4|Overall Study|Withdrawal by Subject|1
1423423|NCT01033825|4696262|P3|Overall Study|Withdrawal by Subject|2
1423424|NCT01033825|4696263|P2|Overall Study|Withdrawal by Subject|3
1423425|NCT01033825|4696264|P1|Overall Study|Withdrawal by Subject|2
1423426|NCT01033747|4696485|P2|Overall Study|Stopped at end of Extension 1|0
1423427|NCT01033747|4696486|P1|Overall Study|Stopped at end of Extension 1|2
1423428|NCT01033747|4696485|P2|Overall Study|Stopped at end of prolongation visit 1|0
1423429|NCT01033747|4696486|P1|Overall Study|Stopped at end of prolongation visit 1|1
1423430|NCT01033747|4696485|P2|Overall Study|Withdrawal by Subject|6
1423431|NCT01033747|4696486|P1|Overall Study|Withdrawal by Subject|9
1423432|NCT01033747|4696485|P2|Overall Study|Protocol Violation|0
1423433|NCT01033747|4696486|P1|Overall Study|Protocol Violation|1
1423434|NCT01033747|4696485|P2|Overall Study|Unsatisfactory therapeutic effect|4
1423435|NCT01033747|4696486|P1|Overall Study|Unsatisfactory therapeutic effect|14
1423436|NCT01033747|4696485|P2|Overall Study|Abnormal test procedure|1
1423437|NCT01033747|4696486|P1|Overall Study|Abnormal test procedure|0
1423438|NCT01033747|4696485|P2|Overall Study|Abnormal Laboratory Value|0
1423439|NCT01033747|4696486|P1|Overall Study|Abnormal Laboratory Value|1
1423440|NCT01033747|4696485|P2|Overall Study|Adverse Event|4
1423441|NCT01033747|4696486|P1|Overall Study|Adverse Event|9
1423442|NCT01033734|4696494|P1|Overall Study|Withdrawal by Subject|1
1423443|NCT01033487|4696550|P10|Fourth Intervention Period|Adverse Event|0
1423444|NCT01033487|4696551|P9|Fourth Intervention Period|Adverse Event|1
1423445|NCT01033487|4696552|P8|Fourth Intervention Period|Adverse Event|0
1423446|NCT01033487|4696553|P7|Fourth Intervention Period|Adverse Event|0
1423447|NCT01033487|4696554|P6|Fourth Intervention Period|Adverse Event|0
1423448|NCT01033487|4696555|P5|Fourth Intervention Period|Adverse Event|0
1423449|NCT01033487|4696556|P4|Fourth Intervention Period|Adverse Event|0
1423450|NCT01033487|4696557|P3|Fourth Intervention Period|Adverse Event|0
1423451|NCT01033487|4696558|P2|Fourth Intervention Period|Adverse Event|0
1423452|NCT01033487|4696559|P1|Fourth Intervention Period|Adverse Event|0
1423453|NCT01033448|4696613|P1|Overall Study|Unknown disposition|1
1423454|NCT01033448|4696613|P1|Overall Study|Withdrew due to other reasons|3
1423455|NCT01033448|4696613|P1|Overall Study|Lost to Follow-up|3
1423456|NCT01033448|4696613|P1|Overall Study|Positive HCV-RNA at week 48|1
1423457|NCT01033448|4696613|P1|Overall Study|Withdrawal by Subject|4
1423458|NCT01033136|4696659|P2|Follow-Up (3 Month)|Lost to Follow-up|2
1423459|NCT01033136|4696660|P1|Follow-Up (3 Month)|Lost to Follow-up|2
1423460|NCT01033071|4696671|P3|Overall Study|Other|3
1423461|NCT01033071|4696672|P2|Overall Study|Other|4
1423462|NCT01033071|4696673|P1|Overall Study|Other|6
1423463|NCT01033071|4696671|P3|Overall Study|Lack of Efficacy|1
1423464|NCT01033071|4696672|P2|Overall Study|Lack of Efficacy|1
1423465|NCT01033071|4696673|P1|Overall Study|Lack of Efficacy|0
1423466|NCT01033071|4696671|P3|Overall Study|Withdrawal by Subject|11
1423467|NCT01033071|4696672|P2|Overall Study|Withdrawal by Subject|14
1423468|NCT01033071|4696673|P1|Overall Study|Withdrawal by Subject|17
1423469|NCT01033071|4696671|P3|Overall Study|Lost to Follow-up|5
1423470|NCT01033071|4696672|P2|Overall Study|Lost to Follow-up|5
1423471|NCT01033071|4696673|P1|Overall Study|Lost to Follow-up|4
1423472|NCT01033071|4696671|P3|Overall Study|Protocol Violation|1
1423473|NCT01033071|4696672|P2|Overall Study|Protocol Violation|2
1423474|NCT01033071|4696673|P1|Overall Study|Protocol Violation|0
1423475|NCT01033071|4696671|P3|Overall Study|Adverse Event|26
1423476|NCT01033071|4696672|P2|Overall Study|Adverse Event|51
1423477|NCT01033071|4696673|P1|Overall Study|Adverse Event|28
1423478|NCT01033019|4696744|P2|Overall Study|Withdrawal by Subject|0
1423479|NCT01033019|4696745|P1|Overall Study|Withdrawal by Subject|1
1423480|NCT01032915|4696783|P4|Overall Study|Protocol Violation|1
1423481|NCT01032915|4696784|P3|Overall Study|Protocol Violation|0
1423482|NCT01032915|4696785|P2|Overall Study|Protocol Violation|0
1423483|NCT01032915|4696786|P1|Overall Study|Protocol Violation|1
1423484|NCT01032915|4696783|P4|Overall Study|Administrative reasons|4
1423485|NCT01032915|4696784|P3|Overall Study|Administrative reasons|4
1423486|NCT01032915|4696785|P2|Overall Study|Administrative reasons|6
1423487|NCT01032915|4696786|P1|Overall Study|Administrative reasons|5
1423488|NCT01032915|4696783|P4|Overall Study|Withdrawal by Subject|1
1423489|NCT01032915|4696784|P3|Overall Study|Withdrawal by Subject|1
1423490|NCT01032915|4696785|P2|Overall Study|Withdrawal by Subject|3
1423491|NCT01032915|4696786|P1|Overall Study|Withdrawal by Subject|0
1423492|NCT01032915|4696783|P4|Overall Study|Abnormal test procedure result|0
1423493|NCT01032915|4696784|P3|Overall Study|Abnormal test procedure result|1
1423494|NCT01032915|4696785|P2|Overall Study|Abnormal test procedure result|0
1423495|NCT01032915|4696786|P1|Overall Study|Abnormal test procedure result|0
1423496|NCT01032915|4696783|P4|Overall Study|Adverse Event|1
1423497|NCT01032915|4696784|P3|Overall Study|Adverse Event|1
1423498|NCT01032915|4696785|P2|Overall Study|Adverse Event|2
1423499|NCT01032915|4696786|P1|Overall Study|Adverse Event|2
1423500|NCT01032889|4696811|P3|Overall Study|Miscellaneous Reasons|1
1423501|NCT01032889|4696812|P2|Overall Study|Miscellaneous Reasons|1
1423502|NCT01032889|4696813|P1|Overall Study|Miscellaneous Reasons|2
1423503|NCT01032889|4696811|P3|Overall Study|Lack of Submental Fat|1
1423504|NCT01032889|4696812|P2|Overall Study|Lack of Submental Fat|8
1423505|NCT01032889|4696813|P1|Overall Study|Lack of Submental Fat|2
1423506|NCT01032889|4696811|P3|Overall Study|Lost to Follow-up|0
1423507|NCT01032889|4696812|P2|Overall Study|Lost to Follow-up|1
1423508|NCT01032889|4696813|P1|Overall Study|Lost to Follow-up|1
1423509|NCT01032889|4696811|P3|Overall Study|Patient Request|0
1423510|NCT01032889|4696812|P2|Overall Study|Patient Request|1
1423511|NCT01032889|4696813|P1|Overall Study|Patient Request|0
1423512|NCT01032889|4696811|P3|Overall Study|Withdrawal of Consent|1
1423513|NCT01032889|4696812|P2|Overall Study|Withdrawal of Consent|2
1423514|NCT01032889|4696813|P1|Overall Study|Withdrawal of Consent|1
1423515|NCT01032889|4696811|P3|Overall Study|Adverse Event|0
1423516|NCT01032889|4696812|P2|Overall Study|Adverse Event|2
1423517|NCT01032889|4696813|P1|Overall Study|Adverse Event|2
1423518|NCT01032837|4696844|P4|Overall Study|Refused treatment|1
1423519|NCT01032837|4696845|P3|Overall Study|Refused treatment|0
1423520|NCT01032837|4696846|P2|Overall Study|Refused treatment|0
1423521|NCT01032837|4696847|P1|Overall Study|Refused treatment|0
1423522|NCT01032837|4696844|P4|Overall Study|Failed to return|0
1423523|NCT01032837|4696845|P3|Overall Study|Failed to return|1
1423524|NCT01032837|4696846|P2|Overall Study|Failed to return|0
1423525|NCT01032837|4696847|P1|Overall Study|Failed to return|0
1423526|NCT01032837|4696844|P4|Overall Study|Withdrew consent|1
1423527|NCT01032837|4696845|P3|Overall Study|Withdrew consent|0
1423528|NCT01032837|4696846|P2|Overall Study|Withdrew consent|2
1423529|NCT01032837|4696847|P1|Overall Study|Withdrew consent|0
1423530|NCT01032837|4696844|P4|Overall Study|Adverse event/internal illness|1
1423531|NCT01032837|4696845|P3|Overall Study|Adverse event/internal illness|0
1423532|NCT01032837|4696846|P2|Overall Study|Adverse event/internal illness|1
1423533|NCT01032837|4696847|P1|Overall Study|Adverse event/internal illness|0
1423534|NCT01032382|4696952|P2|Overall Study|Index lesion relapse|3
1423535|NCT01032382|4696953|P1|Overall Study|Index lesion relapse|1
1423536|NCT01032382|4696952|P2|Overall Study|Treatment failure|1
1423537|NCT01032382|4696953|P1|Overall Study|Treatment failure|3
1423538|NCT01032382|4696952|P2|Overall Study|Disease dissemination|1
1423539|NCT01032382|4696953|P1|Overall Study|Disease dissemination|1
1423540|NCT01032291|4696982|P3|Proof of Concept|Never Received Study Drug|0
1423541|NCT01032291|4696983|P2|Proof of Concept|Never Received Study Drug|1
1423542|NCT01032291|4696984|P1|Proof of Concept|Never Received Study Drug|0
1423543|NCT01032291|4696982|P3|Proof of Concept|Lack of Efficacy|0
1423544|NCT01032291|4696983|P2|Proof of Concept|Lack of Efficacy|1
1423545|NCT01032291|4696984|P1|Proof of Concept|Lack of Efficacy|0
1423546|NCT01032291|4696982|P3|Proof of Concept|Death|2
1423547|NCT01032291|4696983|P2|Proof of Concept|Death|1
1423548|NCT01032291|4696984|P1|Proof of Concept|Death|0
1423549|NCT01032291|4696982|P3|Proof of Concept|Adverse Event|1
1423550|NCT01032291|4696983|P2|Proof of Concept|Adverse Event|5
1423551|NCT01032291|4696984|P1|Proof of Concept|Adverse Event|0
1423552|NCT01032291|4696982|P3|Safety Lead-in|Death|0
1423553|NCT01032291|4696983|P2|Safety Lead-in|Death|0
1423554|NCT01032291|4696984|P1|Safety Lead-in|Death|1
1423555|NCT01032291|4696982|P3|Safety Lead-in|Adverse Event|0
1423556|NCT01032291|4696983|P2|Safety Lead-in|Adverse Event|0
1423557|NCT01032291|4696984|P1|Safety Lead-in|Adverse Event|1
1423558|NCT01032239|4697031|P2|Overall Study|Protocol Violation|0
1423559|NCT01032239|4697032|P1|Overall Study|Protocol Violation|1
1423560|NCT01032239|4697031|P2|Overall Study|Death|0
1423561|NCT01032239|4697032|P1|Overall Study|Death|1
1423562|NCT01032239|4697031|P2|Overall Study|Withdrawal by Subject|3
1423563|NCT01032239|4697032|P1|Overall Study|Withdrawal by Subject|2
1423564|NCT01032239|4697031|P2|Overall Study|Lost to Follow-up|2
1423565|NCT01032239|4697032|P1|Overall Study|Lost to Follow-up|3
1423566|NCT01032200|4697062|P2|Overall Study|Multiple|1
1423567|NCT01032200|4697063|P1|Overall Study|Multiple|1
1423568|NCT01032200|4697062|P2|Overall Study|Progression|0
1423569|NCT01032200|4697063|P1|Overall Study|Progression|1
1423570|NCT01032200|4697062|P2|Overall Study|Toxicity|2
1423571|NCT01032200|4697063|P1|Overall Study|Toxicity|0
1423572|NCT01032200|4697062|P2|Overall Study|Withdrawal by Subject|3
1423573|NCT01032200|4697063|P1|Overall Study|Withdrawal by Subject|1
1423574|NCT01032200|4697062|P2|Overall Study|Death|1
1423575|NCT01032200|4697063|P1|Overall Study|Death|1
1423576|NCT01032174|4697079|P2|Overall Study|Adverse Event|1
1423577|NCT01032174|4697080|P1|Overall Study|Adverse Event|0
1423578|NCT01032070|4697320|P2|Overall Study|Withdrawal by Subject|2
1423579|NCT01032070|4697321|P1|Overall Study|Withdrawal by Subject|0
1423580|NCT01032070|4697320|P2|Overall Study|Medical or ethical reasons|2
1423581|NCT01032070|4697321|P1|Overall Study|Medical or ethical reasons|0
1423582|NCT01032070|4697320|P2|Overall Study|Disease progression|8
1423583|NCT01032070|4697321|P1|Overall Study|Disease progression|13
1423584|NCT01032044|4697350|P2|Overall Study|Lost to Follow-up|11
1423585|NCT01032044|4697351|P1|Overall Study|Lost to Follow-up|11
1423586|NCT01032044|4697350|P2|Overall Study|Adverse Event|1
1423587|NCT01032044|4697351|P1|Overall Study|Adverse Event|0
1423588|NCT01032044|4697350|P2|Overall Study|Protocol Violation|8
1423589|NCT01032044|4697351|P1|Overall Study|Protocol Violation|14
1423590|NCT01032018|4697359|P2|Overall Study|Death|1
1423591|NCT01032018|4697360|P1|Overall Study|Death|0
1423592|NCT01032018|4697359|P2|Overall Study|Lost to Follow-up|5
1423593|NCT01032018|4697360|P1|Overall Study|Lost to Follow-up|6
1423594|NCT01031979|4697370|P2|Overall Study|Lost to Follow-up|4
1423595|NCT01031979|4697371|P1|Overall Study|Lost to Follow-up|5
1423596|NCT01031706|4697409|P2|Overall Study|Withdrawal by Subject|1
1423597|NCT01031706|4697410|P1|Overall Study|Withdrawal by Subject|1
1423598|NCT01031706|4697409|P2|Overall Study|Adverse Event|0
1423599|NCT01031706|4697410|P1|Overall Study|Adverse Event|1
1423600|NCT01031680|4697420|P2|Overall Study|Various|2
1423601|NCT01031680|4697421|P1|Overall Study|Various|0
1423602|NCT01031680|4697420|P2|Overall Study|Administrative Reason by Sponsor|1
1423603|NCT01031680|4697421|P1|Overall Study|Administrative Reason by Sponsor|0
1423604|NCT01031680|4697420|P2|Overall Study|Incorrect Enrolment|2
1423605|NCT01031680|4697421|P1|Overall Study|Incorrect Enrolment|1
1423606|NCT01031680|4697420|P2|Overall Study|Safety|0
1423607|NCT01031680|4697421|P1|Overall Study|Safety|1
1423608|NCT01031680|4697420|P2|Overall Study|Poor/Non-compliance|6
1423609|NCT01031680|4697421|P1|Overall Study|Poor/Non-compliance|5
1423610|NCT01031680|4697420|P2|Overall Study|Subject No Longer Meets Study Criteria|17
1423611|NCT01031680|4697421|P1|Overall Study|Subject No Longer Meets Study Criteria|26
1423612|NCT01031680|4697420|P2|Overall Study|Death|1
1423613|NCT01031680|4697421|P1|Overall Study|Death|2
1423614|NCT01031680|4697420|P2|Overall Study|Withdrawal by Subject|16
1423615|NCT01031680|4697421|P1|Overall Study|Withdrawal by Subject|12
1423616|NCT01031680|4697420|P2|Overall Study|Lost to Follow-up|10
1423617|NCT01031680|4697421|P1|Overall Study|Lost to Follow-up|2
1423618|NCT01031680|4697420|P2|Overall Study|Adverse Event|3
1423619|NCT01031680|4697421|P1|Overall Study|Adverse Event|8
1423620|NCT01031628|4697441|P4|Overall Study|Study terminated early|0
1423621|NCT01031628|4697442|P3|Overall Study|Study terminated early|3
1423622|NCT01031628|4697443|P2|Overall Study|Study terminated early|1
1423623|NCT01031628|4697444|P1|Overall Study|Study terminated early|0
1423624|NCT01031537|4697469|P1|Overall Study|PI removal, no longer met eligibility|12
1423625|NCT01031537|4697469|P1|Overall Study|Withdrawal by Subject|5
1423626|NCT01031537|4697469|P1|Overall Study|moved, met exclusion criteria|10
1423627|NCT01031537|4697469|P1|Overall Study|retired from NIH, met exclusion criteria|1
1423628|NCT01031537|4697469|P1|Overall Study|Lack of Efficacy|1
1423629|NCT01031537|4697469|P1|Overall Study|medical reasons not related to study|3
1423630|NCT01031446|4697487|P1|Overall Study|Still on treatment|1
1423631|NCT01031446|4697487|P1|Overall Study|Withdrawal by Subject|3
1423632|NCT01031446|4697487|P1|Overall Study|Physician Decision|4
1423633|NCT01031446|4697487|P1|Overall Study|Adverse Event|9
1423634|NCT01031446|4697487|P1|Overall Study|Disease Progression|38
1423635|NCT01031381|4697496|P1|Overall Study|Withdrawal by Subject|6
1423636|NCT01031381|4697496|P1|Overall Study|Physician Decision|3
1423637|NCT01031004|4697527|P2|Overall Study|Lost to Follow-up|0
1423638|NCT01031004|4697528|P1|Overall Study|Lost to Follow-up|1
1423639|NCT01031004|4697527|P2|Overall Study|Protocol Violation|1
1423640|NCT01031004|4697528|P1|Overall Study|Protocol Violation|0
1423641|NCT01030965|4697572|P4|Overall Study|Withdrawal by Subject|2
1423642|NCT01030965|4697573|P3|Overall Study|Withdrawal by Subject|0
1423643|NCT01030965|4697574|P2|Overall Study|Withdrawal by Subject|1
1423644|NCT01030965|4697575|P1|Overall Study|Withdrawal by Subject|0
1423645|NCT01030965|4697572|P4|Overall Study|Protocol-defined Stopping Criteria|0
1423646|NCT01030965|4697573|P3|Overall Study|Protocol-defined Stopping Criteria|1
1423647|NCT01030965|4697574|P2|Overall Study|Protocol-defined Stopping Criteria|1
1423648|NCT01030965|4697575|P1|Overall Study|Protocol-defined Stopping Criteria|0
1423649|NCT01030965|4697572|P4|Overall Study|Adverse Event|1
1423650|NCT01030965|4697573|P3|Overall Study|Adverse Event|2
1423651|NCT01030965|4697574|P2|Overall Study|Adverse Event|1
1423652|NCT01030965|4697575|P1|Overall Study|Adverse Event|0
1423653|NCT01030965|4697572|P4|Overall Study|Protocol Violation|1
1423654|NCT01030965|4697573|P3|Overall Study|Protocol Violation|1
1423655|NCT01030965|4697574|P2|Overall Study|Protocol Violation|1
1423656|NCT01030965|4697575|P1|Overall Study|Protocol Violation|1
1423657|NCT01030965|4697572|P4|Overall Study|Lack of Efficacy|3
1423658|NCT01030965|4697573|P3|Overall Study|Lack of Efficacy|0
1423659|NCT01030965|4697574|P2|Overall Study|Lack of Efficacy|2
1423660|NCT01030965|4697575|P1|Overall Study|Lack of Efficacy|3
1423661|NCT01030952|4697595|P2|Overall Study|Unexplained|1
1423662|NCT01030952|4697596|P1|Overall Study|Unexplained|1
1423663|NCT01030952|4697595|P2|Overall Study|Lost to Follow-up|1
1423664|NCT01030952|4697596|P1|Overall Study|Lost to Follow-up|0
1423665|NCT01030952|4697595|P2|Overall Study|Informed consent withdrawal|0
1423666|NCT01030952|4697596|P1|Overall Study|Informed consent withdrawal|1
1423667|NCT01030952|4697595|P2|Overall Study|Protocol Violation|1
1423668|NCT01030952|4697596|P1|Overall Study|Protocol Violation|0
1423669|NCT01030822|4697633|P3|Overall Study|Lost to Follow-up|7
1423670|NCT01030822|4697634|P2|Overall Study|Lost to Follow-up|4
1423671|NCT01030822|4697635|P1|Overall Study|Lost to Follow-up|9
1423672|NCT01030822|4697633|P3|Overall Study|Withdrawal by Subject|16
1423673|NCT01030822|4697634|P2|Overall Study|Withdrawal by Subject|13
1423674|NCT01030822|4697635|P1|Overall Study|Withdrawal by Subject|16
1423675|NCT01030822|4697633|P3|Overall Study|Moved/migrated from study area|3
1423676|NCT01030822|4697634|P2|Overall Study|Moved/migrated from study area|7
1423677|NCT01030822|4697635|P1|Overall Study|Moved/migrated from study area|6
1423678|NCT01030718|4697690|P3|Study CA180-036 Only|Other Reasons|0
1423679|NCT01030718|4697691|P2|Study CA180-036 Only|Other Reasons|2
1423680|NCT01030718|4697692|P1|Study CA180-036 Only|Other Reasons|0
1423681|NCT01030718|4697690|P3|Study CA180-036 Only|Death|0
1423682|NCT01030718|4697691|P2|Study CA180-036 Only|Death|1
1423683|NCT01030718|4697692|P1|Study CA180-036 Only|Death|0
1423684|NCT01030718|4697690|P3|Study CA180-036 Only|Adverse Event|0
1423685|NCT01030718|4697691|P2|Study CA180-036 Only|Adverse Event|3
1423686|NCT01030718|4697692|P1|Study CA180-036 Only|Adverse Event|2
1423687|NCT01030718|4697690|P3|Study CA180-036 Only|insufficient effect|5
1423688|NCT01030718|4697691|P2|Study CA180-036 Only|insufficient effect|1
1423689|NCT01030718|4697692|P1|Study CA180-036 Only|insufficient effect|1
1423690|NCT01030718|4697690|P3|Studies CA180-031 and -036 Combined|other reasons|0
1423691|NCT01030718|4697691|P2|Studies CA180-031 and -036 Combined|other reasons|2
1423692|NCT01030718|4697692|P1|Studies CA180-031 and -036 Combined|other reasons|0
1423693|NCT01030718|4697690|P3|Studies CA180-031 and -036 Combined|Death|0
1423694|NCT01030718|4697691|P2|Studies CA180-031 and -036 Combined|Death|1
1423695|NCT01030718|4697692|P1|Studies CA180-031 and -036 Combined|Death|0
1423696|NCT01030718|4697690|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
1423697|NCT01030718|4697691|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
1423698|NCT01030718|4697692|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
1423699|NCT01030718|4697690|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
1423700|NCT01030718|4697691|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
1423701|NCT01030718|4697692|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
1423702|NCT01030666|4697753|P2|Overall Study|Lost to Follow-up|2
1423703|NCT01030666|4697754|P1|Overall Study|Lost to Follow-up|3
1423704|NCT01030536|4697779|P5|Overall Study|Death|0
1423705|NCT01030536|4697780|P4|Overall Study|Death|0
1423706|NCT01030536|4697781|P3|Overall Study|Death|0
1423707|NCT01030536|4697782|P2|Overall Study|Death|1
1423708|NCT01030536|4697783|P1|Overall Study|Death|0
1423709|NCT01030536|4697779|P5|Overall Study|Progressive disease|0
1423710|NCT01030536|4697780|P4|Overall Study|Progressive disease|2
1423711|NCT01030536|4697781|P3|Overall Study|Progressive disease|3
1423712|NCT01030536|4697782|P2|Overall Study|Progressive disease|2
1423713|NCT01030536|4697783|P1|Overall Study|Progressive disease|6
1423714|NCT01030536|4697779|P5|Overall Study|Adverse Event|1
1423715|NCT01030536|4697780|P4|Overall Study|Adverse Event|0
1423716|NCT01030536|4697781|P3|Overall Study|Adverse Event|1
1423717|NCT01030536|4697782|P2|Overall Study|Adverse Event|3
1423718|NCT01030536|4697783|P1|Overall Study|Adverse Event|0
1423719|NCT01030536|4697779|P5|Overall Study|undefined|0
1423720|NCT01030536|4697780|P4|Overall Study|undefined|1
1423721|NCT01030536|4697781|P3|Overall Study|undefined|1
1423722|NCT01030536|4697782|P2|Overall Study|undefined|0
1423723|NCT01030536|4697783|P1|Overall Study|undefined|1
1423724|NCT01030536|4697779|P5|Overall Study|Withdrawal by Subject|0
1423725|NCT01030536|4697780|P4|Overall Study|Withdrawal by Subject|0
1423726|NCT01030536|4697781|P3|Overall Study|Withdrawal by Subject|1
1423727|NCT01030536|4697782|P2|Overall Study|Withdrawal by Subject|0
1423728|NCT01030536|4697783|P1|Overall Study|Withdrawal by Subject|0
1423729|NCT01030458|4697888|P2|Overall Study|Side effect of medication|1
1423730|NCT01030458|4697889|P1|Overall Study|Side effect of medication|1
1423731|NCT01030458|4697888|P2|Overall Study|Moved or changed job|13
1423732|NCT01030458|4697889|P1|Overall Study|Moved or changed job|6
1423733|NCT01030458|4697888|P2|Overall Study|Logistical reasons|5
1423734|NCT01030458|4697889|P1|Overall Study|Logistical reasons|9
1423735|NCT01030458|4697888|P2|Overall Study|Withdrawal by Subject|3
1423736|NCT01030458|4697889|P1|Overall Study|Withdrawal by Subject|2
1423737|NCT01030458|4697888|P2|Overall Study|Lost to Follow-up|10
1423738|NCT01030458|4697889|P1|Overall Study|Lost to Follow-up|9
1423739|NCT01029925|4697917|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
1423740|NCT01029925|4697917|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
1423741|NCT01029925|4697917|P1|Completion of Cycle 1 (28 Days)|Death|2
1423742|NCT01029886|4697936|P2|Overall Study|Loss Glucose Control|1
1423743|NCT01029886|4697937|P1|Overall Study|Loss Glucose Control|7
1423744|NCT01029886|4697936|P2|Overall Study|Sponsor Decision|0
1423745|NCT01029886|4697937|P1|Overall Study|Sponsor Decision|1
1423746|NCT01029886|4697936|P2|Overall Study|Entry Criteria Not Met|5
1423747|NCT01029886|4697937|P1|Overall Study|Entry Criteria Not Met|13
1423748|NCT01029886|4697936|P2|Overall Study|Withdrawal by Subject|18
1423749|NCT01029886|4697937|P1|Overall Study|Withdrawal by Subject|8
1423750|NCT01029886|4697936|P2|Overall Study|Protocol Violation|5
1423751|NCT01029886|4697937|P1|Overall Study|Protocol Violation|17
1423752|NCT01029886|4697936|P2|Overall Study|Physician Decision|6
1423753|NCT01029886|4697937|P1|Overall Study|Physician Decision|2
1423754|NCT01029886|4697936|P2|Overall Study|Lost to Follow-up|0
1423755|NCT01029886|4697937|P1|Overall Study|Lost to Follow-up|1
1423756|NCT01029886|4697936|P2|Overall Study|Adverse Event|25
1423757|NCT01029886|4697937|P1|Overall Study|Adverse Event|12
1423758|NCT01029795|4697965|P2|Overall Study|Withdrawal by Subject|3
1423759|NCT01029795|4697966|P1|Overall Study|Withdrawal by Subject|1
1423760|NCT01029795|4697965|P2|Overall Study|Sponsor Decision|17
1423761|NCT01029795|4697966|P1|Overall Study|Sponsor Decision|11
1423762|NCT01029795|4697965|P2|Overall Study|Physician Decision|1
1423763|NCT01029795|4697966|P1|Overall Study|Physician Decision|2
1423764|NCT01029795|4697965|P2|Overall Study|Entry Criteria Not Met|1
1423765|NCT01029795|4697966|P1|Overall Study|Entry Criteria Not Met|2
1423766|NCT01029782|4698020|P2|Overall Study|Withdrawal by Subject|1
1423767|NCT01029782|4698021|P1|Overall Study|Withdrawal by Subject|0
1423768|NCT01029782|4698020|P2|Overall Study|Protocol Violation|2
1423769|NCT01029782|4698021|P1|Overall Study|Protocol Violation|0
1423770|NCT01029782|4698020|P2|Overall Study|Physician Decision|1
1423771|NCT01029782|4698021|P1|Overall Study|Physician Decision|0
1423772|NCT01029782|4698020|P2|Overall Study|Adverse Event|1
1423773|NCT01029782|4698021|P1|Overall Study|Adverse Event|0
1423774|NCT01029782|4698020|P2|Overall Study|Diagnosis changed|1
1423775|NCT01029782|4698021|P1|Overall Study|Diagnosis changed|1
1423776|NCT01029782|4698020|P2|Overall Study|Lost to Follow-up|2
1423777|NCT01029782|4698021|P1|Overall Study|Lost to Follow-up|2
1423778|NCT01029691|4698073|P3|Continued APAP to Delivery|Death|1
1423779|NCT01029691|4698074|P2|Continued APAP to Delivery|Death|0
1423780|NCT01029691|4698075|P1|Continued APAP to Delivery|Death|0
1423781|NCT01029652|4698100|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
1423782|NCT01029652|4698101|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
1423783|NCT01029652|4698100|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
1423784|NCT01029652|4698101|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
1423785|NCT01029652|4698100|P2|Extension Study 2 (25-72 Weeks)|Death|1
1423786|NCT01029652|4698101|P1|Extension Study 2 (25-72 Weeks)|Death|1
1423787|NCT01029652|4698100|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
1423788|NCT01029652|4698101|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
1423789|NCT01029652|4698100|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
1423790|NCT01029652|4698101|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
1423791|NCT01029652|4698100|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
1423792|NCT01029652|4698101|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
1423793|NCT01029652|4698100|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
1423794|NCT01029652|4698101|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
1423795|NCT01029652|4698100|P2|Core Study (0-12 Weeks)|Death|1
1423796|NCT01029652|4698101|P1|Core Study (0-12 Weeks)|Death|0
1423797|NCT01029652|4698100|P2|Core Study (0-12 Weeks)|Administrative problems|1
1423798|NCT01029652|4698101|P1|Core Study (0-12 Weeks)|Administrative problems|2
1423799|NCT01029652|4698100|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
1423800|NCT01029652|4698101|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
1423801|NCT01029652|4698100|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
1423802|NCT01029652|4698101|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
1423803|NCT01029652|4698100|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
1423804|NCT01029652|4698101|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
1423805|NCT01029535|4698179|P1|Overall Study|Death|1
1423806|NCT01029535|4698179|P1|Overall Study|Use of Another Treatment|1
1423807|NCT01029535|4698179|P1|Overall Study|Adverse Event|1
1423808|NCT01029535|4698179|P1|Overall Study|Participant Withdrew Consent|2
1423809|NCT01029535|4698179|P1|Overall Study|Protocol Violation|2
1423810|NCT01029535|4698179|P1|Overall Study|Lost to Follow-up|24
1423811|NCT01029405|4698208|P4|Overall Study|Other|1
1423812|NCT01029405|4698209|P3|Overall Study|Other|0
1423813|NCT01029405|4698210|P2|Overall Study|Other|1
1423814|NCT01029405|4698211|P1|Overall Study|Other|0
1423815|NCT01029405|4698208|P4|Overall Study|Lost to Follow-up|2
1423816|NCT01029405|4698209|P3|Overall Study|Lost to Follow-up|1
1423817|NCT01029405|4698210|P2|Overall Study|Lost to Follow-up|1
1423818|NCT01029405|4698211|P1|Overall Study|Lost to Follow-up|2
1423819|NCT01029405|4698208|P4|Overall Study|Adverse Event|1
1423820|NCT01029405|4698209|P3|Overall Study|Adverse Event|1
1423821|NCT01029405|4698210|P2|Overall Study|Adverse Event|0
1423822|NCT01029405|4698211|P1|Overall Study|Adverse Event|0
1423823|NCT01029405|4698208|P4|Overall Study|Protocol Violation|1
1423824|NCT01029405|4698209|P3|Overall Study|Protocol Violation|0
1423825|NCT01029405|4698210|P2|Overall Study|Protocol Violation|0
1423826|NCT01029405|4698211|P1|Overall Study|Protocol Violation|0
1423827|NCT01029405|4698208|P4|Overall Study|Withdrawal by Subject|0
1423828|NCT01029405|4698209|P3|Overall Study|Withdrawal by Subject|2
1423829|NCT01029405|4698210|P2|Overall Study|Withdrawal by Subject|1
1423830|NCT01029405|4698211|P1|Overall Study|Withdrawal by Subject|0
1423831|NCT01029392|4698223|P2|Overall Study|Physician Decision|0
1423832|NCT01029392|4698224|P1|Overall Study|Physician Decision|2
1423833|NCT01029392|4698223|P2|Overall Study|Withdrawal by Subject|11
1423834|NCT01029392|4698224|P1|Overall Study|Withdrawal by Subject|18
1423835|NCT01029366|4698234|P2|Overall Study|manufacturing failure|1
1423836|NCT01029366|4698235|P1|Overall Study|manufacturing failure|0
1423837|NCT01029366|4698234|P2|Overall Study|disease progression|0
1423838|NCT01029366|4698235|P1|Overall Study|disease progression|2
1423839|NCT01029366|4698234|P2|Overall Study|Death|1
1423840|NCT01029366|4698235|P1|Overall Study|Death|1
1423841|NCT01029366|4698234|P2|Overall Study|Withdrawal by Subject|0
1423842|NCT01029366|4698235|P1|Overall Study|Withdrawal by Subject|1
1423843|NCT01029340|4698247|P6|Extension Period|Physician Decision|1
1423844|NCT01029340|4698248|P5|Extension Period|Physician Decision|0
1423845|NCT01029340|4698249|P4|Extension Period|Physician Decision|0
1423846|NCT01029340|4698250|P3|Extension Period|Physician Decision|0
1423847|NCT01029340|4698251|P2|Extension Period|Physician Decision|0
1423848|NCT01029340|4698252|P1|Extension Period|Physician Decision|0
1423849|NCT01029340|4698247|P6|Extension Period|Withdrawal by Subject|1
1423850|NCT01029340|4698248|P5|Extension Period|Withdrawal by Subject|0
1423851|NCT01029340|4698249|P4|Extension Period|Withdrawal by Subject|0
1423852|NCT01029340|4698250|P3|Extension Period|Withdrawal by Subject|0
1423853|NCT01029340|4698251|P2|Extension Period|Withdrawal by Subject|0
1423854|NCT01029340|4698252|P1|Extension Period|Withdrawal by Subject|0
1423855|NCT01029340|4698247|P6|Extension Period|non-compliance|1
1423856|NCT01029340|4698248|P5|Extension Period|non-compliance|0
1423857|NCT01029340|4698249|P4|Extension Period|non-compliance|0
1423858|NCT01029340|4698250|P3|Extension Period|non-compliance|0
1423859|NCT01029340|4698251|P2|Extension Period|non-compliance|0
1423860|NCT01029340|4698252|P1|Extension Period|non-compliance|0
1423861|NCT01029340|4698247|P6|Extension Period|starting another study|8
1423862|NCT01029340|4698248|P5|Extension Period|starting another study|0
1423863|NCT01029340|4698249|P4|Extension Period|starting another study|0
1423864|NCT01029340|4698250|P3|Extension Period|starting another study|0
1423865|NCT01029340|4698251|P2|Extension Period|starting another study|0
1423866|NCT01029340|4698252|P1|Extension Period|starting another study|0
1423867|NCT01029340|4698247|P6|Extension Period|Adverse Event|1
1423868|NCT01029340|4698248|P5|Extension Period|Adverse Event|0
1423869|NCT01029340|4698249|P4|Extension Period|Adverse Event|0
1423870|NCT01029340|4698250|P3|Extension Period|Adverse Event|0
1423871|NCT01029340|4698251|P2|Extension Period|Adverse Event|0
1423872|NCT01029340|4698252|P1|Extension Period|Adverse Event|0
1423873|NCT01029340|4698247|P6|Part B Treatment Period|Protocol Violation|0
1423874|NCT01029340|4698248|P5|Part B Treatment Period|Protocol Violation|0
1423875|NCT01029340|4698249|P4|Part B Treatment Period|Protocol Violation|0
1423876|NCT01029340|4698250|P3|Part B Treatment Period|Protocol Violation|1
1423877|NCT01029340|4698251|P2|Part B Treatment Period|Protocol Violation|0
1423878|NCT01029340|4698252|P1|Part B Treatment Period|Protocol Violation|0
1423879|NCT01029340|4698247|P6|Part B Treatment Period|Withdrawal by Subject|0
1423880|NCT01029340|4698248|P5|Part B Treatment Period|Withdrawal by Subject|0
1423881|NCT01029340|4698249|P4|Part B Treatment Period|Withdrawal by Subject|0
1423882|NCT01029340|4698250|P3|Part B Treatment Period|Withdrawal by Subject|1
1423883|NCT01029340|4698251|P2|Part B Treatment Period|Withdrawal by Subject|0
1423884|NCT01029340|4698252|P1|Part B Treatment Period|Withdrawal by Subject|0
1423885|NCT01029262|4698283|P2|Overall Study|Other|5
1423886|NCT01029262|4698284|P1|Overall Study|Other|1
1423887|NCT01029262|4698283|P2|Overall Study|Protocol Violation|3
1423888|NCT01029262|4698284|P1|Overall Study|Protocol Violation|2
1423889|NCT01029262|4698283|P2|Overall Study|Withdrawal by Subject|16
1423890|NCT01029262|4698284|P1|Overall Study|Withdrawal by Subject|10
1423891|NCT01029262|4698283|P2|Overall Study|Lack of therapeutic effect|69
1423892|NCT01029262|4698284|P1|Overall Study|Lack of therapeutic effect|56
1423893|NCT01029262|4698283|P2|Overall Study|Adverse Event|52
1423894|NCT01029262|4698284|P1|Overall Study|Adverse Event|9
1423895|NCT01028651|4698442|P1|Overall Study|Adverse Event|1
1423896|NCT01028651|4698442|P1|Overall Study|Death|2
1423897|NCT01028391|4698465|P2|Overall Study|Needed excluded medication|1
1423898|NCT01028391|4698466|P1|Overall Study|Needed excluded medication|1
1423899|NCT01028391|4698465|P2|Overall Study|Withdrawal by Subject|3
1423900|NCT01028391|4698466|P1|Overall Study|Withdrawal by Subject|6
1423901|NCT01028391|4698465|P2|Overall Study|Physician Decision|1
1423902|NCT01028391|4698466|P1|Overall Study|Physician Decision|0
1423903|NCT01028391|4698465|P2|Overall Study|Lost to Follow-up|4
1423904|NCT01028391|4698466|P1|Overall Study|Lost to Follow-up|3
1423905|NCT01028391|4698465|P2|Overall Study|Lack of Efficacy|2
1423906|NCT01028391|4698466|P1|Overall Study|Lack of Efficacy|0
1423907|NCT01028391|4698465|P2|Overall Study|Adverse Event|0
1423908|NCT01028391|4698466|P1|Overall Study|Adverse Event|4
1423909|NCT01028378|4698474|P1|Overall Study|Adminstrative Reasons|4
1423910|NCT01028378|4698474|P1|Overall Study|Withdrawal by Subject|1
1423911|NCT01028378|4698474|P1|Overall Study|Lost to Follow-up|12
1423912|NCT01028352|4698486|P1|Overall Study|Withdrawal by Subject|1
1423913|NCT01028352|4698486|P1|Overall Study|Ineligible due to baseline average pain|5
1423914|NCT01028300|4698491|P1|Overall Study|Study Terminated|4
1423915|NCT01028222|4698500|P2|Overall Study|Adverse Event|0
1423916|NCT01028222|4698501|P1|Overall Study|Adverse Event|2
1423917|NCT01028222|4698500|P2|Overall Study|Crossover to nilotinib w/out progression|2
1423918|NCT01028222|4698501|P1|Overall Study|Crossover to nilotinib w/out progression|0
1423919|NCT01028222|4698500|P2|Overall Study|Withdrawal by Subject|0
1423920|NCT01028222|4698501|P1|Overall Study|Withdrawal by Subject|1
1423921|NCT01028222|4698500|P2|Overall Study|Lost to Follow-up|1
1423922|NCT01028222|4698501|P1|Overall Study|Lost to Follow-up|0
1423923|NCT01028222|4698500|P2|Overall Study|Administrative problems|1
1423924|NCT01028222|4698501|P1|Overall Study|Administrative problems|1
1423925|NCT01028222|4698500|P2|Overall Study|Disease progression|9
1423926|NCT01028222|4698501|P1|Overall Study|Disease progression|33
1423927|NCT01028222|4698500|P2|Overall Study|Protocol deviation|0
1423928|NCT01028222|4698501|P1|Overall Study|Protocol deviation|1
1423929|NCT01028053|4698543|P1|Overall Study|Various reasons|4
1423930|NCT01028053|4698543|P1|Overall Study|Terminated by Sponsor|1
1423931|NCT01028053|4698543|P1|Overall Study|Technical Problem|1
1423932|NCT01028053|4698543|P1|Overall Study|Physician Decision|2
1423933|NCT01028053|4698543|P1|Overall Study|Protocol Violation|1
1423934|NCT01028053|4698543|P1|Overall Study|Patient Request|11
1423935|NCT01028053|4698543|P1|Overall Study|Screen Failure|113
1423936|NCT01028027|4698551|P2|Overall Study|Lack of Efficacy|1
1423937|NCT01028027|4698552|P1|Overall Study|Lack of Efficacy|0
1423938|NCT01028027|4698551|P2|Overall Study|Protocol Violation|1
1423939|NCT01028027|4698552|P1|Overall Study|Protocol Violation|3
1423940|NCT01028027|4698551|P2|Overall Study|Adverse Event|7
1423941|NCT01028027|4698552|P1|Overall Study|Adverse Event|4
1423942|NCT01028027|4698551|P2|Overall Study|Withdrawal by Subject|3
1423943|NCT01028027|4698552|P1|Overall Study|Withdrawal by Subject|5
1423944|NCT01028027|4698551|P2|Overall Study|Lost to Follow-up|1
1423945|NCT01028027|4698552|P1|Overall Study|Lost to Follow-up|4
1423946|NCT01028014|4698574|P6|Overall Study|Lost to Follow-up|2
1423947|NCT01028014|4698575|P5|Overall Study|Lost to Follow-up|1
1423948|NCT01028014|4698576|P4|Overall Study|Lost to Follow-up|1
1423949|NCT01028014|4698577|P3|Overall Study|Lost to Follow-up|0
1423950|NCT01028014|4698578|P2|Overall Study|Lost to Follow-up|2
1423951|NCT01028014|4698579|P1|Overall Study|Lost to Follow-up|1
1423952|NCT01027897|4698620|P1|Overall Study|Withdrawal by Subject|1
1423953|NCT01027897|4698620|P1|Overall Study|Protocol Violation|1
1423954|NCT01027884|4698628|P2|Overall Study|Spinal fixation surgery|3
1423955|NCT01027884|4698629|P1|Overall Study|Spinal fixation surgery|0
1423956|NCT01027884|4698628|P2|Overall Study|Lost to Follow-up|1
1423957|NCT01027884|4698629|P1|Overall Study|Lost to Follow-up|0
1423958|NCT01027884|4698628|P2|Overall Study|Withdrawal by Subject|1
1423959|NCT01027884|4698629|P1|Overall Study|Withdrawal by Subject|0
1423960|NCT01027884|4698628|P2|Overall Study|Non-compliance|1
1423961|NCT01027884|4698629|P1|Overall Study|Non-compliance|1
1423962|NCT01027884|4698628|P2|Overall Study|Protocol Violation|0
1423963|NCT01027884|4698629|P1|Overall Study|Protocol Violation|1
1423964|NCT01027884|4698628|P2|Overall Study|Adverse Event|1
1423965|NCT01027884|4698629|P1|Overall Study|Adverse Event|2
1423966|NCT01027871|4698646|P3|Overall Study|Discontinued Prior to Treatment|1
1423967|NCT01027871|4698647|P2|Overall Study|Discontinued Prior to Treatment|0
1423968|NCT01027871|4698648|P1|Overall Study|Discontinued Prior to Treatment|0
1423969|NCT01027871|4698646|P3|Overall Study|Sponsor Decision|0
1423970|NCT01027871|4698647|P2|Overall Study|Sponsor Decision|2
1423971|NCT01027871|4698648|P1|Overall Study|Sponsor Decision|0
1423972|NCT01027871|4698646|P3|Overall Study|Adverse Event|2
1423973|NCT01027871|4698647|P2|Overall Study|Adverse Event|2
1423974|NCT01027871|4698648|P1|Overall Study|Adverse Event|0
1423975|NCT01027871|4698646|P3|Overall Study|Withdrawal by Subject|2
1423976|NCT01027871|4698647|P2|Overall Study|Withdrawal by Subject|2
1423977|NCT01027871|4698648|P1|Overall Study|Withdrawal by Subject|1
1423978|NCT01027871|4698646|P3|Overall Study|Protocol Violation|2
1423979|NCT01027871|4698647|P2|Overall Study|Protocol Violation|2
1423980|NCT01027871|4698648|P1|Overall Study|Protocol Violation|0
1423981|NCT01027871|4698646|P3|Overall Study|Physician Decision|0
1423982|NCT01027871|4698647|P2|Overall Study|Physician Decision|5
1423983|NCT01027871|4698648|P1|Overall Study|Physician Decision|1
1423984|NCT01027702|4698727|P7|Overall Study|Death|0
1423985|NCT01027702|4698728|P6|Overall Study|Death|0
1423986|NCT01027702|4698729|P5|Overall Study|Death|0
1423987|NCT01027702|4698730|P4|Overall Study|Death|0
1423988|NCT01027702|4698731|P3|Overall Study|Death|1
1423989|NCT01027702|4698732|P2|Overall Study|Death|0
1423990|NCT01027702|4698733|P1|Overall Study|Death|0
1423991|NCT01027702|4698727|P7|Overall Study|Received subsequent therapy|1
1423992|NCT01027702|4698728|P6|Overall Study|Received subsequent therapy|0
1423993|NCT01027702|4698729|P5|Overall Study|Received subsequent therapy|1
1423994|NCT01027702|4698730|P4|Overall Study|Received subsequent therapy|4
1423995|NCT01027702|4698731|P3|Overall Study|Received subsequent therapy|0
1423996|NCT01027702|4698732|P2|Overall Study|Received subsequent therapy|2
1423997|NCT01027702|4698733|P1|Overall Study|Received subsequent therapy|1
1423998|NCT01027650|4698759|P8|Overall Study|Lack of Efficacy|0
1423999|NCT01027650|4698760|P7|Overall Study|Lack of Efficacy|0
1424000|NCT01027650|4698761|P6|Overall Study|Lack of Efficacy|1
1424001|NCT01027650|4698762|P5|Overall Study|Lack of Efficacy|0
1424002|NCT01027650|4698763|P4|Overall Study|Lack of Efficacy|0
1424003|NCT01027650|4698764|P3|Overall Study|Lack of Efficacy|0
1424004|NCT01027650|4698765|P2|Overall Study|Lack of Efficacy|0
1424005|NCT01027650|4698766|P1|Overall Study|Lack of Efficacy|0
1424006|NCT01027650|4698759|P8|Overall Study|Lost to Follow-up|0
1424007|NCT01027650|4698760|P7|Overall Study|Lost to Follow-up|1
1424008|NCT01027650|4698761|P6|Overall Study|Lost to Follow-up|0
1424009|NCT01027650|4698762|P5|Overall Study|Lost to Follow-up|0
1424010|NCT01027650|4698763|P4|Overall Study|Lost to Follow-up|0
1424011|NCT01027650|4698764|P3|Overall Study|Lost to Follow-up|0
1424012|NCT01027650|4698765|P2|Overall Study|Lost to Follow-up|0
1424013|NCT01027650|4698766|P1|Overall Study|Lost to Follow-up|0
1424014|NCT01027650|4698759|P8|Overall Study|Personal Reasons|0
1424015|NCT01027650|4698760|P7|Overall Study|Personal Reasons|0
1424016|NCT01027650|4698761|P6|Overall Study|Personal Reasons|1
1424017|NCT01027650|4698762|P5|Overall Study|Personal Reasons|2
1424018|NCT01027650|4698763|P4|Overall Study|Personal Reasons|0
1424019|NCT01027650|4698764|P3|Overall Study|Personal Reasons|0
1424020|NCT01027650|4698765|P2|Overall Study|Personal Reasons|0
1424021|NCT01027650|4698766|P1|Overall Study|Personal Reasons|0
1424022|NCT01027416|4698842|P2|Overall Study|Physician Decision|4
1424023|NCT01027416|4698843|P1|Overall Study|Physician Decision|1
1424024|NCT01027416|4698842|P2|Overall Study|Withdrawal by Subject|1
1424025|NCT01027416|4698843|P1|Overall Study|Withdrawal by Subject|0
1424026|NCT01027364|4698855|P4|Overall Study|Withdrawal by Subject|0
1424027|NCT01027364|4698856|P3|Overall Study|Withdrawal by Subject|0
1424028|NCT01027364|4698857|P2|Overall Study|Withdrawal by Subject|2
1424029|NCT01027364|4698858|P1|Overall Study|Withdrawal by Subject|1
1424030|NCT01027364|4698855|P4|Overall Study|Protocol Violation|1
1424031|NCT01027364|4698856|P3|Overall Study|Protocol Violation|0
1424032|NCT01027364|4698857|P2|Overall Study|Protocol Violation|0
1424033|NCT01027364|4698858|P1|Overall Study|Protocol Violation|1
1424034|NCT01027364|4698855|P4|Overall Study|Lost to Follow-up|0
1424035|NCT01027364|4698856|P3|Overall Study|Lost to Follow-up|0
1424036|NCT01027364|4698857|P2|Overall Study|Lost to Follow-up|0
1424037|NCT01027364|4698858|P1|Overall Study|Lost to Follow-up|1
1424038|NCT01027364|4698855|P4|Overall Study|Adverse Event|0
1424039|NCT01027364|4698856|P3|Overall Study|Adverse Event|1
1424040|NCT01027364|4698857|P2|Overall Study|Adverse Event|0
1424041|NCT01027364|4698858|P1|Overall Study|Adverse Event|1
1424042|NCT01027351|4698953|P6|Overall Study|Protocol Violation|0
1424043|NCT01027351|4698954|P5|Overall Study|Protocol Violation|1
1424044|NCT01027351|4698955|P4|Overall Study|Protocol Violation|1
1424045|NCT01027351|4698956|P3|Overall Study|Protocol Violation|0
1424046|NCT01027351|4698957|P2|Overall Study|Protocol Violation|0
1424047|NCT01027351|4698958|P1|Overall Study|Protocol Violation|1
1424048|NCT01027351|4698953|P6|Overall Study|Inappropriate enrollment|0
1424049|NCT01027351|4698954|P5|Overall Study|Inappropriate enrollment|1
1424050|NCT01027351|4698955|P4|Overall Study|Inappropriate enrollment|0
1424051|NCT01027351|4698956|P3|Overall Study|Inappropriate enrollment|0
1424052|NCT01027351|4698957|P2|Overall Study|Inappropriate enrollment|0
1424053|NCT01027351|4698958|P1|Overall Study|Inappropriate enrollment|0
1424054|NCT01027351|4698953|P6|Overall Study|Lost to Follow-up|0
1424055|NCT01027351|4698954|P5|Overall Study|Lost to Follow-up|6
1424056|NCT01027351|4698955|P4|Overall Study|Lost to Follow-up|1
1424057|NCT01027351|4698956|P3|Overall Study|Lost to Follow-up|0
1424058|NCT01027351|4698957|P2|Overall Study|Lost to Follow-up|1
1424059|NCT01027351|4698958|P1|Overall Study|Lost to Follow-up|1
1424060|NCT01027351|4698953|P6|Overall Study|Withdrawal by Subject|5
1424061|NCT01027351|4698954|P5|Overall Study|Withdrawal by Subject|3
1424062|NCT01027351|4698955|P4|Overall Study|Withdrawal by Subject|0
1424063|NCT01027351|4698956|P3|Overall Study|Withdrawal by Subject|1
1424064|NCT01027351|4698957|P2|Overall Study|Withdrawal by Subject|0
1424065|NCT01027351|4698958|P1|Overall Study|Withdrawal by Subject|1
1424066|NCT01027286|4699042|P2|Overall Study|Lost to Follow-up|1
1424067|NCT01027286|4699043|P1|Overall Study|Lost to Follow-up|0
1424068|NCT01027286|4699042|P2|Overall Study|Unable to Obtain Required Blood Volume|0
1424069|NCT01027286|4699043|P1|Overall Study|Unable to Obtain Required Blood Volume|1
1424070|NCT01027273|4699063|P2|Overall Study|Death|2
1424071|NCT01027273|4699064|P1|Overall Study|Death|2
1424072|NCT01027273|4699063|P2|Overall Study|Lost to Follow-up|31
1424073|NCT01027273|4699064|P1|Overall Study|Lost to Follow-up|57
1424074|NCT01026974|4699111|P4|Overall Study|Inappropriate enrollment|0
1424075|NCT01026974|4699112|P3|Overall Study|Inappropriate enrollment|1
1424076|NCT01026974|4699113|P2|Overall Study|Inappropriate enrollment|0
1424077|NCT01026974|4699114|P1|Overall Study|Inappropriate enrollment|0
1424078|NCT01026974|4699111|P4|Overall Study|Adverse Event|1
1424079|NCT01026974|4699112|P3|Overall Study|Adverse Event|0
1424080|NCT01026974|4699113|P2|Overall Study|Adverse Event|0
1424081|NCT01026974|4699114|P1|Overall Study|Adverse Event|0
1424082|NCT01026974|4699111|P4|Overall Study|Lost to Follow-up|0
1424083|NCT01026974|4699112|P3|Overall Study|Lost to Follow-up|4
1424084|NCT01026974|4699113|P2|Overall Study|Lost to Follow-up|1
1424085|NCT01026974|4699114|P1|Overall Study|Lost to Follow-up|1
1424086|NCT01026974|4699111|P4|Overall Study|Withdrawal by Subject|2
1424087|NCT01026974|4699112|P3|Overall Study|Withdrawal by Subject|7
1424088|NCT01026974|4699113|P2|Overall Study|Withdrawal by Subject|1
1424089|NCT01026974|4699114|P1|Overall Study|Withdrawal by Subject|0
1424090|NCT01026948|4699171|P1|Overall Study|Physician Decision|8
1424091|NCT01026831|4699204|P2|Overall Study|Withdrawal by Subject|5
1424092|NCT01026831|4699205|P1|Overall Study|Withdrawal by Subject|7
1424093|NCT01026831|4699204|P2|Overall Study|Protocol Violation|2
1424094|NCT01026831|4699205|P1|Overall Study|Protocol Violation|0
1424095|NCT01026831|4699204|P2|Overall Study|Physician Decision|1
1424096|NCT01026831|4699205|P1|Overall Study|Physician Decision|1
1424097|NCT01026831|4699204|P2|Overall Study|Lost to Follow-up|0
1424098|NCT01026831|4699205|P1|Overall Study|Lost to Follow-up|2
1424099|NCT01026831|4699204|P2|Overall Study|Adverse Event|3
1424100|NCT01026831|4699205|P1|Overall Study|Adverse Event|4
1424101|NCT01026818|4699216|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
1424102|NCT01026818|4699217|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
1424103|NCT01026818|4699218|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
1424104|NCT01026818|4699219|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
1424105|NCT01026818|4699216|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
1424106|NCT01026818|4699217|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
1424107|NCT01026818|4699218|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
1424108|NCT01026818|4699219|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
1424109|NCT01026818|4699216|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
1424110|NCT01026818|4699217|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
1424111|NCT01026818|4699218|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
1424112|NCT01026818|4699219|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
1424113|NCT01026818|4699216|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
1424114|NCT01026818|4699217|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
1424115|NCT01026818|4699218|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
1424116|NCT01026818|4699219|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
1424117|NCT01026818|4699216|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
1424118|NCT01026818|4699217|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
1424119|NCT01026818|4699218|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
1424120|NCT01026818|4699219|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
1424121|NCT01026818|4699216|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
1424122|NCT01026818|4699217|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
1424123|NCT01026818|4699218|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
1424124|NCT01026818|4699219|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
1424125|NCT01026818|4699216|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
1424126|NCT01026818|4699217|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
1424127|NCT01026818|4699218|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
1424128|NCT01026818|4699219|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
1424129|NCT01026818|4699216|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
1424130|NCT01026818|4699217|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
1424131|NCT01026818|4699218|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
1424132|NCT01026818|4699219|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
1424133|NCT01026818|4699216|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
1424134|NCT01026818|4699217|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
1424135|NCT01026818|4699218|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
1424136|NCT01026818|4699219|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
1424137|NCT01026818|4699216|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
1424138|NCT01026818|4699217|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
1424139|NCT01026818|4699218|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
1424140|NCT01026818|4699219|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
1424141|NCT01026818|4699216|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
1424142|NCT01026818|4699217|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
1424143|NCT01026818|4699218|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
1424144|NCT01026818|4699219|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
1424145|NCT01026818|4699216|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
1424146|NCT01026818|4699217|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
1424147|NCT01026818|4699218|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
1424148|NCT01026818|4699219|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
1424149|NCT01026818|4699216|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
1424150|NCT01026818|4699217|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
1424151|NCT01026818|4699218|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
1424152|NCT01026818|4699219|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
1424153|NCT01026818|4699216|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
1424154|NCT01026818|4699217|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
1424155|NCT01026818|4699218|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
1424156|NCT01026818|4699219|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
1424157|NCT01026818|4699216|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
1424158|NCT01026818|4699217|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
1424159|NCT01026818|4699218|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
1424160|NCT01026818|4699219|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
1424161|NCT01026818|4699216|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
1424162|NCT01026818|4699217|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
1424163|NCT01026818|4699218|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
1424164|NCT01026818|4699219|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
1424165|NCT01026818|4699216|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
1424166|NCT01026818|4699217|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
1424167|NCT01026818|4699218|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
1424168|NCT01026818|4699219|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
1424169|NCT01026818|4699216|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
1424170|NCT01026818|4699217|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
1424171|NCT01026818|4699218|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
1424172|NCT01026818|4699219|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
1424173|NCT01026818|4699216|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
1424174|NCT01026818|4699217|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
1424175|NCT01026818|4699218|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
1424176|NCT01026818|4699219|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
1424177|NCT01026818|4699216|P4|Screening Period|Physician Decision|0
1424178|NCT01026818|4699217|P3|Screening Period|Physician Decision|0
1424179|NCT01026818|4699218|P2|Screening Period|Physician Decision|0
1424180|NCT01026818|4699219|P1|Screening Period|Physician Decision|1
1424181|NCT01026818|4699216|P4|Screening Period|Adverse Event|0
1424182|NCT01026818|4699217|P3|Screening Period|Adverse Event|0
1424183|NCT01026818|4699218|P2|Screening Period|Adverse Event|0
1424184|NCT01026818|4699219|P1|Screening Period|Adverse Event|2
1424185|NCT01026818|4699216|P4|Screening Period|Protocol Deviation|0
1424186|NCT01026818|4699217|P3|Screening Period|Protocol Deviation|0
1424187|NCT01026818|4699218|P2|Screening Period|Protocol Deviation|0
1424188|NCT01026818|4699219|P1|Screening Period|Protocol Deviation|3
1424189|NCT01026818|4699216|P4|Screening Period|Withdrawal by Subject|0
1424190|NCT01026818|4699217|P3|Screening Period|Withdrawal by Subject|0
1424191|NCT01026818|4699218|P2|Screening Period|Withdrawal by Subject|0
1424192|NCT01026818|4699219|P1|Screening Period|Withdrawal by Subject|49
1424193|NCT01026818|4699216|P4|Screening Period|Entry Criteria Not Met|0
1424194|NCT01026818|4699217|P3|Screening Period|Entry Criteria Not Met|0
1424195|NCT01026818|4699218|P2|Screening Period|Entry Criteria Not Met|0
1424196|NCT01026818|4699219|P1|Screening Period|Entry Criteria Not Met|105
1424197|NCT01026792|4699307|P1|Overall Study|Protocol Violation|1
1424198|NCT01026493|4699319|P8|Overall Study|Protocol Violation|1
1424199|NCT01026493|4699320|P7|Overall Study|Protocol Violation|4
1424200|NCT01026493|4699321|P6|Overall Study|Protocol Violation|3
1424201|NCT01026493|4699322|P5|Overall Study|Protocol Violation|2
1424202|NCT01026493|4699323|P4|Overall Study|Protocol Violation|0
1424203|NCT01026493|4699324|P3|Overall Study|Protocol Violation|0
1424204|NCT01026493|4699325|P2|Overall Study|Protocol Violation|1
1424205|NCT01026493|4699326|P1|Overall Study|Protocol Violation|0
1424206|NCT01026454|4699354|P2|Second Intervention|Pregnancy|1
1424207|NCT01026454|4699355|P1|Second Intervention|Pregnancy|1
1424208|NCT01026389|4699704|P2|Overall Study|change of treatment, patient moved|2
1424209|NCT01026389|4699705|P1|Overall Study|change of treatment, patient moved|4
1424210|NCT01026389|4699704|P2|Overall Study|Withdrawal by Subject|3
1424211|NCT01026389|4699705|P1|Overall Study|Withdrawal by Subject|1
1424212|NCT01026324|4699720|P3|Follow up/Survival|Withdrawal by Subject|0
1424213|NCT01026324|4699721|P2|Follow up/Survival|Withdrawal by Subject|0
1424214|NCT01026324|4699722|P1|Follow up/Survival|Withdrawal by Subject|1
1424215|NCT01026220|4699732|P3|Consolidation Maintenance|Withdrawal by Subject|6
1424216|NCT01026220|4699733|P2|Consolidation Maintenance|Withdrawal by Subject|2
1424217|NCT01026220|4699734|P1|Consolidation Maintenance|Withdrawal by Subject|0
1424218|NCT01026220|4699732|P3|Consolidation Maintenance|Physician Decision|7
1424219|NCT01026220|4699733|P2|Consolidation Maintenance|Physician Decision|2
1424220|NCT01026220|4699734|P1|Consolidation Maintenance|Physician Decision|0
1424221|NCT01026220|4699732|P3|Consolidation Maintenance|Lack of Efficacy|1
1424222|NCT01026220|4699733|P2|Consolidation Maintenance|Lack of Efficacy|1
1424223|NCT01026220|4699734|P1|Consolidation Maintenance|Lack of Efficacy|0
1424224|NCT01026220|4699732|P3|Consolidation Maintenance|Death|0
1424225|NCT01026220|4699733|P2|Consolidation Maintenance|Death|1
1424226|NCT01026220|4699734|P1|Consolidation Maintenance|Death|0
1424227|NCT01026220|4699732|P3|Induction|Ineligible|0
1424228|NCT01026220|4699733|P2|Induction|Ineligible|0
1424229|NCT01026220|4699734|P1|Induction|Ineligible|1
1424230|NCT01026220|4699732|P3|Induction|Withdrawal by Subject|0
1424231|NCT01026220|4699733|P2|Induction|Withdrawal by Subject|0
1424232|NCT01026220|4699734|P1|Induction|Withdrawal by Subject|9
1424233|NCT01026220|4699732|P3|Induction|Physician Decision|0
1424234|NCT01026220|4699733|P2|Induction|Physician Decision|0
1424235|NCT01026220|4699734|P1|Induction|Physician Decision|12
1424236|NCT01026220|4699732|P3|Induction|Lack of Efficacy|0
1424237|NCT01026220|4699733|P2|Induction|Lack of Efficacy|0
1424238|NCT01026220|4699734|P1|Induction|Lack of Efficacy|2
1424239|NCT01026220|4699732|P3|Induction|Death|0
1424240|NCT01026220|4699733|P2|Induction|Death|0
1424241|NCT01026220|4699734|P1|Induction|Death|1
1424242|NCT01026194|4699758|P2|Period 2：Open-label Period|Withdrawal by Subject|4
1424243|NCT01026194|4699759|P1|Period 2：Open-label Period|Withdrawal by Subject|0
1424244|NCT01026194|4699758|P2|Period 2：Open-label Period|Physician Decision|1
1424245|NCT01026194|4699759|P1|Period 2：Open-label Period|Physician Decision|3
1424246|NCT01026194|4699758|P2|Period 2：Open-label Period|Adverse Event|5
1424247|NCT01026194|4699759|P1|Period 2：Open-label Period|Adverse Event|4
1424248|NCT01026194|4699758|P2|Period 1：Double Blind Period|Physician Decision|4
1424249|NCT01026194|4699759|P1|Period 1：Double Blind Period|Physician Decision|0
1424250|NCT01026194|4699758|P2|Period 1：Double Blind Period|Lack of Efficacy|0
1424251|NCT01026194|4699759|P1|Period 1：Double Blind Period|Lack of Efficacy|1
1424252|NCT01026194|4699758|P2|Period 1：Double Blind Period|Adverse Event|1
1424253|NCT01026194|4699759|P1|Period 1：Double Blind Period|Adverse Event|2
1424254|NCT01026142|4699791|P2|Overall Study|Withdrew consent or lost to follow-up|29
1424255|NCT01026142|4699792|P1|Overall Study|Withdrew consent or lost to follow-up|36
1424256|NCT01026142|4699791|P2|Overall Study|Death|134
1424257|NCT01026142|4699792|P1|Overall Study|Death|136
1424258|NCT01026103|4699814|P1|Overall Study|did not receive study device bc of error|1
1424259|NCT01026103|4699814|P1|Overall Study|Physician Decision|1
1424260|NCT01026038|4699824|P3|Overall Study|Lost to Follow-up|0
1424261|NCT01026038|4699825|P2|Overall Study|Lost to Follow-up|1
1424262|NCT01026038|4699826|P1|Overall Study|Lost to Follow-up|1
1424263|NCT01025843|4699875|P10|Washout 4|Withdrawal by Subject|0
1424264|NCT01025843|4699876|P9|Washout 4|Withdrawal by Subject|0
1424265|NCT01025843|4699877|P8|Washout 4|Withdrawal by Subject|0
1424266|NCT01025843|4699878|P7|Washout 4|Withdrawal by Subject|0
1424267|NCT01025843|4699879|P6|Washout 4|Withdrawal by Subject|0
1424268|NCT01025843|4699880|P5|Washout 4|Withdrawal by Subject|0
1424269|NCT01025843|4699881|P4|Washout 4|Withdrawal by Subject|1
1424270|NCT01025843|4699882|P3|Washout 4|Withdrawal by Subject|1
1424271|NCT01025843|4699883|P2|Washout 4|Withdrawal by Subject|0
1424272|NCT01025843|4699884|P1|Washout 4|Withdrawal by Subject|0
1424273|NCT01025817|4699978|P2|Completed Study|Lost to Follow-up|1
1424274|NCT01025817|4699979|P1|Completed Study|Lost to Follow-up|0
1424275|NCT01025817|4699978|P2|Completed Study|Missing|0
1424276|NCT01025817|4699979|P1|Completed Study|Missing|2
1424277|NCT01025817|4699978|P2|Completed Study|Death|5
1424278|NCT01025817|4699979|P1|Completed Study|Death|6
1424279|NCT01025817|4699978|P2|Completed Study|Withdrawal by Subject|16
1424280|NCT01025817|4699979|P1|Completed Study|Withdrawal by Subject|8
1424281|NCT01025817|4699978|P2|Completed Study Medication|Lost to Follow-up|1
1424282|NCT01025817|4699979|P1|Completed Study Medication|Lost to Follow-up|0
1424283|NCT01025817|4699978|P2|Completed Study Medication|Subject no longer required study drug|1
1424284|NCT01025817|4699979|P1|Completed Study Medication|Subject no longer required study drug|0
1424285|NCT01025817|4699978|P2|Completed Study Medication|Abnormal lab values|2
1424286|NCT01025817|4699979|P1|Completed Study Medication|Abnormal lab values|0
1424287|NCT01025817|4699978|P2|Completed Study Medication|Death|2
1424288|NCT01025817|4699979|P1|Completed Study Medication|Death|2
1424289|NCT01025817|4699978|P2|Completed Study Medication|Graft loss|5
1424290|NCT01025817|4699979|P1|Completed Study Medication|Graft loss|2
1424291|NCT01025817|4699978|P2|Completed Study Medication|Abnormal test procedure|0
1424292|NCT01025817|4699979|P1|Completed Study Medication|Abnormal test procedure|4
1424293|NCT01025817|4699978|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
1424294|NCT01025817|4699979|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
1424295|NCT01025817|4699978|P2|Completed Study Medication|Administrative problems|5
1424296|NCT01025817|4699979|P1|Completed Study Medication|Administrative problems|7
1424297|NCT01025817|4699978|P2|Completed Study Medication|Withdrawal by Subject|9
1424298|NCT01025817|4699979|P1|Completed Study Medication|Withdrawal by Subject|8
1424299|NCT01025817|4699978|P2|Completed Study Medication|Protocol Deviation|8
1424300|NCT01025817|4699979|P1|Completed Study Medication|Protocol Deviation|9
1424301|NCT01025817|4699978|P2|Completed Study Medication|Adverse Event|39
1424302|NCT01025817|4699979|P1|Completed Study Medication|Adverse Event|66
1424303|NCT01025752|4699999|P2|Overall Study|Physician Decision|3
1424304|NCT01025752|4700000|P1|Overall Study|Physician Decision|1
1424305|NCT01025752|4699999|P2|Overall Study|Lost to Follow-up|10
1424306|NCT01025752|4700000|P1|Overall Study|Lost to Follow-up|7
1424307|NCT01025635|4700020|P2|Overall Study|Reason not known|2
1424308|NCT01025635|4700021|P1|Overall Study|Reason not known|4
1424309|NCT01025635|4700020|P2|Overall Study|Lost to Follow-up|13
1424310|NCT01025635|4700021|P1|Overall Study|Lost to Follow-up|9
1424311|NCT01025635|4700020|P2|Overall Study|Lack of Efficacy|1
1424312|NCT01025635|4700021|P1|Overall Study|Lack of Efficacy|0
1424313|NCT01025635|4700020|P2|Overall Study|Protocol Violation|2
1424314|NCT01025635|4700021|P1|Overall Study|Protocol Violation|4
1424315|NCT01025635|4700020|P2|Overall Study|Withdrawal by Subject|7
1424316|NCT01025635|4700021|P1|Overall Study|Withdrawal by Subject|6
1424317|NCT01025336|4700049|P5|Overall Study|Protocol Violation|0
1424318|NCT01025336|4700050|P4|Overall Study|Protocol Violation|2
1424319|NCT01025336|4700051|P3|Overall Study|Protocol Violation|0
1424320|NCT01025336|4700052|P2|Overall Study|Protocol Violation|0
1424321|NCT01025336|4700053|P1|Overall Study|Protocol Violation|0
1424322|NCT01025284|4700108|P3|Overall Study|Withdrawal by Subject|0
1424323|NCT01025284|4700109|P2|Overall Study|Withdrawal by Subject|1
1424324|NCT01025284|4700110|P1|Overall Study|Withdrawal by Subject|0
1424325|NCT01025284|4700108|P3|Overall Study|Investigator Decision|0
1424326|NCT01025284|4700109|P2|Overall Study|Investigator Decision|1
1424327|NCT01025284|4700110|P1|Overall Study|Investigator Decision|0
1424328|NCT01025232|4700135|P2|Overall Study|Study drug no longer available|6
1424329|NCT01025232|4700136|P1|Overall Study|Study drug no longer available|3
1424330|NCT01025193|4700154|P1|Overall Study|Adverse Event|3
1424331|NCT01025193|4700154|P1|Overall Study|Protocol Violation|1
1424332|NCT01025154|4700164|P1|Overall Study|Withdrawal by Subject|1
1424333|NCT01025154|4700164|P1|Overall Study|Lost to Follow-up|1
1424334|NCT01025037|4700173|P1|Overall Study|Withdrawal by Subject|1
1424335|NCT01025037|4700173|P1|Overall Study|Lost to Follow-up|7
1424336|NCT01025037|4700173|P1|Overall Study|Adverse Event|3
1424337|NCT01024959|4700195|P1|Overall Study|missing results required for analysis|17
1424338|NCT01024959|4700195|P1|Overall Study|results not evaluable|12
1424339|NCT01024959|4700195|P1|Overall Study|ineligible|12
1424340|NCT01024946|4700204|P1|Overall Study|Adverse Event|1
1424341|NCT01024946|4700204|P1|Overall Study|Withdrawal by Subject|1
1424342|NCT01024946|4700204|P1|Overall Study|Screen Failure|3
1424343|NCT01024855|4700208|P1|Overall Study|Inclusion/exclusion criteria|1
1424344|NCT01024751|4700215|P2|Eligible Participants|Ineligible|1
1424345|NCT01024751|4700216|P1|Eligible Participants|Ineligible|0
1424346|NCT01024751|4700215|P2|Eligible Participants|Lost to Follow-up|1
1424347|NCT01024751|4700216|P1|Eligible Participants|Lost to Follow-up|0
1424348|NCT01024751|4700215|P2|Eligible Participants|Withdrawal by Subject|1
1424349|NCT01024751|4700216|P1|Eligible Participants|Withdrawal by Subject|0
1424350|NCT01024751|4700215|P2|Enrolled Participants|Ineligible at baseline|4
1424351|NCT01024751|4700216|P1|Enrolled Participants|Ineligible at baseline|3
1424352|NCT01024608|4700239|P2|Overall Study|Never received study treatment|0
1424353|NCT01024608|4700240|P1|Overall Study|Never received study treatment|2
1424354|NCT01024608|4700239|P2|Overall Study|Protocol Violation|3
1424355|NCT01024608|4700240|P1|Overall Study|Protocol Violation|0
1424356|NCT01024608|4700239|P2|Overall Study|Lost to Follow-up|1
1424357|NCT01024608|4700240|P1|Overall Study|Lost to Follow-up|0
1424358|NCT01024608|4700239|P2|Overall Study|Withdrawal by Subject|0
1424359|NCT01024608|4700240|P1|Overall Study|Withdrawal by Subject|1
1424360|NCT01024608|4700239|P2|Overall Study|Adverse Event|0
1424361|NCT01024608|4700240|P1|Overall Study|Adverse Event|1
1424362|NCT01024465|4700252|P1|Overall Study|Physician Decision|1
1424363|NCT01024465|4700252|P1|Overall Study|Adverse Event|2
1424364|NCT01024387|4700256|P1|Overall Study|Other|5
1424365|NCT01024387|4700256|P1|Overall Study|Adverse Event|3
1424366|NCT01024387|4700256|P1|Overall Study|Prolonged Treatment Delay|1
1424367|NCT01024387|4700256|P1|Overall Study|Death|2
1424368|NCT01024387|4700256|P1|Overall Study|Withdrawal by Subject|5
1424369|NCT01024387|4700256|P1|Overall Study|Physician Decision|5
1424370|NCT01024387|4700256|P1|Overall Study|Symptomatic Progression|10
1424371|NCT01024387|4700256|P1|Overall Study|Radiographic Progression|29
1424372|NCT01024309|4700277|P2|Overall Study|Withdrawal by Subject|4
1424373|NCT01024309|4700278|P1|Overall Study|Withdrawal by Subject|4
1424374|NCT01024309|4700277|P2|Overall Study|Physician Decision|0
1424375|NCT01024309|4700278|P1|Overall Study|Physician Decision|4
1424376|NCT01024244|4700310|P5|Overall Study|Withdrawal by Subject|0
1424377|NCT01024244|4700311|P4|Overall Study|Withdrawal by Subject|0
1424378|NCT01024244|4700312|P3|Overall Study|Withdrawal by Subject|0
1424379|NCT01024244|4700313|P2|Overall Study|Withdrawal by Subject|1
1424380|NCT01024244|4700314|P1|Overall Study|Withdrawal by Subject|0
1424381|NCT01024244|4700310|P5|Overall Study|Sponsor Decision|10
1424382|NCT01024244|4700311|P4|Overall Study|Sponsor Decision|12
1424383|NCT01024244|4700312|P3|Overall Study|Sponsor Decision|14
1424384|NCT01024244|4700313|P2|Overall Study|Sponsor Decision|7
1424385|NCT01024244|4700314|P1|Overall Study|Sponsor Decision|14
1424386|NCT01024244|4700310|P5|Overall Study|Protocol Violation|2
1424387|NCT01024244|4700311|P4|Overall Study|Protocol Violation|0
1424388|NCT01024244|4700312|P3|Overall Study|Protocol Violation|0
1424389|NCT01024244|4700313|P2|Overall Study|Protocol Violation|0
1424390|NCT01024244|4700314|P1|Overall Study|Protocol Violation|1
1424391|NCT01024244|4700310|P5|Overall Study|Lack of Efficacy|0
1424392|NCT01024244|4700311|P4|Overall Study|Lack of Efficacy|0
1424393|NCT01024244|4700312|P3|Overall Study|Lack of Efficacy|0
1424394|NCT01024244|4700313|P2|Overall Study|Lack of Efficacy|0
1424395|NCT01024244|4700314|P1|Overall Study|Lack of Efficacy|1
1424396|NCT01024244|4700310|P5|Overall Study|Entry Criteria Not Met|0
1424397|NCT01024244|4700311|P4|Overall Study|Entry Criteria Not Met|0
1424398|NCT01024244|4700312|P3|Overall Study|Entry Criteria Not Met|0
1424399|NCT01024244|4700313|P2|Overall Study|Entry Criteria Not Met|1
1424400|NCT01024244|4700314|P1|Overall Study|Entry Criteria Not Met|0
1424401|NCT01024244|4700310|P5|Overall Study|Adverse Event|2
1424402|NCT01024244|4700311|P4|Overall Study|Adverse Event|1
1424403|NCT01024244|4700312|P3|Overall Study|Adverse Event|0
1424404|NCT01024244|4700313|P2|Overall Study|Adverse Event|2
1424405|NCT01024244|4700314|P1|Overall Study|Adverse Event|1
1424406|NCT01024036|4700428|P2|Follow-Up Period|Adverse Event|1
1424407|NCT01024036|4700429|P1|Follow-Up Period|Adverse Event|4
1424408|NCT01024036|4700428|P2|Follow-Up Period|Withdrawal by Subject|1
1424409|NCT01024036|4700429|P1|Follow-Up Period|Withdrawal by Subject|0
1424410|NCT01024036|4700428|P2|Follow-Up Period|Lost to Follow-up|1
1424411|NCT01024036|4700429|P1|Follow-Up Period|Lost to Follow-up|1
1424412|NCT01024036|4700428|P2|Unblinded Treatment|Lack of Efficacy|2
1424413|NCT01024036|4700429|P1|Unblinded Treatment|Lack of Efficacy|0
1424414|NCT01024036|4700428|P2|Unblinded Treatment|Adverse Event|1
1424415|NCT01024036|4700429|P1|Unblinded Treatment|Adverse Event|0
1424416|NCT01024036|4700428|P2|Blinded Treatment|Withdrawal by Subject|3
1424417|NCT01024036|4700429|P1|Blinded Treatment|Withdrawal by Subject|4
1424418|NCT01024036|4700428|P2|Blinded Treatment|Death|2
1424419|NCT01024036|4700429|P1|Blinded Treatment|Death|0
1424420|NCT01024036|4700428|P2|Blinded Treatment|Physician Decision|0
1424421|NCT01024036|4700429|P1|Blinded Treatment|Physician Decision|1
1424422|NCT01024036|4700428|P2|Blinded Treatment|Lack of Efficacy|14
1424423|NCT01024036|4700429|P1|Blinded Treatment|Lack of Efficacy|16
1424424|NCT01024036|4700428|P2|Blinded Treatment|Adverse Event|1
1424425|NCT01024036|4700429|P1|Blinded Treatment|Adverse Event|1
1424426|NCT01023958|4700460|P1|Overall Study|Refused to continue medication|1
1424427|NCT01023958|4700460|P1|Overall Study|Other adverse event|1
1424428|NCT01023958|4700460|P1|Overall Study|Progressive disease|48
1424429|NCT01023815|4700508|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
1424430|NCT01023815|4700509|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
1424431|NCT01023815|4700510|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
1424432|NCT01023815|4700511|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
1424433|NCT01023815|4700508|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
1424434|NCT01023815|4700509|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
1424435|NCT01023815|4700510|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
1424436|NCT01023815|4700511|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
1424437|NCT01023815|4700508|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
1424438|NCT01023815|4700509|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
1424439|NCT01023815|4700510|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
1424440|NCT01023815|4700511|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
1424441|NCT01023815|4700508|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
1424442|NCT01023815|4700509|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
1424443|NCT01023815|4700510|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
1424444|NCT01023815|4700511|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
1424445|NCT01023815|4700508|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
1424446|NCT01023815|4700509|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
1424447|NCT01023815|4700510|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
1424448|NCT01023815|4700511|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
1424449|NCT01023789|4700530|P1|3 - Year Visit|Lost to Follow-up|13
1424450|NCT01023789|4700530|P1|3 - Year Visit|Withdrawal of consent|1
1424451|NCT01023789|4700530|P1|3 - Year Visit|Death|29
1424452|NCT01023672|4700616|P1|Overall Study|Death|1
1424453|NCT01023672|4700616|P1|Overall Study|Worsening disease|2
1424454|NCT01023659|4700623|P3|Overall Study|Lost to Follow-up|99
1424455|NCT01023659|4700624|P2|Overall Study|Lost to Follow-up|228
1424456|NCT01023659|4700625|P1|Overall Study|Lost to Follow-up|73
1424457|NCT01023581|4700641|P7|Overall Study|Other|0
1424458|NCT01023581|4700642|P6|Overall Study|Other|0
1424459|NCT01023581|4700643|P5|Overall Study|Other|1
1424460|NCT01023581|4700644|P4|Overall Study|Other|0
1424461|NCT01023581|4700645|P3|Overall Study|Other|1
1424462|NCT01023581|4700646|P2|Overall Study|Other|0
1424463|NCT01023581|4700647|P1|Overall Study|Other|1
1424464|NCT01023581|4700641|P7|Overall Study|Physician Decision|1
1424465|NCT01023581|4700642|P6|Overall Study|Physician Decision|1
1424466|NCT01023581|4700643|P5|Overall Study|Physician Decision|1
1424467|NCT01023581|4700644|P4|Overall Study|Physician Decision|1
1424468|NCT01023581|4700645|P3|Overall Study|Physician Decision|2
1424469|NCT01023581|4700646|P2|Overall Study|Physician Decision|0
1424470|NCT01023581|4700647|P1|Overall Study|Physician Decision|2
1424471|NCT01023581|4700641|P7|Overall Study|Lack of Efficacy|1
1424472|NCT01023581|4700642|P6|Overall Study|Lack of Efficacy|2
1424473|NCT01023581|4700643|P5|Overall Study|Lack of Efficacy|1
1424474|NCT01023581|4700644|P4|Overall Study|Lack of Efficacy|2
1424475|NCT01023581|4700645|P3|Overall Study|Lack of Efficacy|6
1424476|NCT01023581|4700646|P2|Overall Study|Lack of Efficacy|3
1424477|NCT01023581|4700647|P1|Overall Study|Lack of Efficacy|9
1424478|NCT01023581|4700641|P7|Overall Study|Pregnancy|0
1424479|NCT01023581|4700642|P6|Overall Study|Pregnancy|1
1424480|NCT01023581|4700643|P5|Overall Study|Pregnancy|0
1424481|NCT01023581|4700644|P4|Overall Study|Pregnancy|2
1424482|NCT01023581|4700645|P3|Overall Study|Pregnancy|0
1424483|NCT01023581|4700646|P2|Overall Study|Pregnancy|0
1424484|NCT01023581|4700647|P1|Overall Study|Pregnancy|0
1424485|NCT01023581|4700641|P7|Overall Study|Withdrawal by Subject|5
1424486|NCT01023581|4700642|P6|Overall Study|Withdrawal by Subject|8
1424487|NCT01023581|4700643|P5|Overall Study|Withdrawal by Subject|6
1424488|NCT01023581|4700644|P4|Overall Study|Withdrawal by Subject|10
1424489|NCT01023581|4700645|P3|Overall Study|Withdrawal by Subject|16
1424490|NCT01023581|4700646|P2|Overall Study|Withdrawal by Subject|8
1424491|NCT01023581|4700647|P1|Overall Study|Withdrawal by Subject|13
1424492|NCT01023581|4700641|P7|Overall Study|Lost to Follow-up|2
1424493|NCT01023581|4700642|P6|Overall Study|Lost to Follow-up|2
1424494|NCT01023581|4700643|P5|Overall Study|Lost to Follow-up|5
1424495|NCT01023581|4700644|P4|Overall Study|Lost to Follow-up|2
1424496|NCT01023581|4700645|P3|Overall Study|Lost to Follow-up|7
1424497|NCT01023581|4700646|P2|Overall Study|Lost to Follow-up|8
1424498|NCT01023581|4700647|P1|Overall Study|Lost to Follow-up|4
1424499|NCT01023581|4700641|P7|Overall Study|Major protocol deviation|0
1424500|NCT01023581|4700642|P6|Overall Study|Major protocol deviation|0
1424501|NCT01023581|4700643|P5|Overall Study|Major protocol deviation|0
1424502|NCT01023581|4700644|P4|Overall Study|Major protocol deviation|0
1424503|NCT01023581|4700645|P3|Overall Study|Major protocol deviation|3
1424504|NCT01023581|4700646|P2|Overall Study|Major protocol deviation|0
1424505|NCT01023581|4700647|P1|Overall Study|Major protocol deviation|2
1424506|NCT01023581|4700641|P7|Overall Study|Adverse Event|11
1424507|NCT01023581|4700642|P6|Overall Study|Adverse Event|5
1424508|NCT01023581|4700643|P5|Overall Study|Adverse Event|2
1424509|NCT01023581|4700644|P4|Overall Study|Adverse Event|3
1424510|NCT01023581|4700645|P3|Overall Study|Adverse Event|7
1424511|NCT01023581|4700646|P2|Overall Study|Adverse Event|4
1424512|NCT01023581|4700647|P1|Overall Study|Adverse Event|4
1424513|NCT01023516|4700704|P2|Overall Study|Incorrect enrolment|2
1424514|NCT01023516|4700705|P1|Overall Study|Incorrect enrolment|4
1424515|NCT01023516|4700704|P2|Overall Study|Study-specific criteria|2
1424516|NCT01023516|4700705|P1|Overall Study|Study-specific criteria|4
1424517|NCT01023516|4700704|P2|Overall Study|Safety reason|3
1424518|NCT01023516|4700705|P1|Overall Study|Safety reason|0
1424519|NCT01023516|4700704|P2|Overall Study|Adverse Event|6
1424520|NCT01023516|4700705|P1|Overall Study|Adverse Event|9
1424521|NCT01023516|4700704|P2|Overall Study|Voluntary discontinuation|5
1424522|NCT01023516|4700705|P1|Overall Study|Voluntary discontinuation|7
1424523|NCT01023308|4700787|P2|Overall Study|Withdrawal by Subject|18
1424524|NCT01023308|4700788|P1|Overall Study|Withdrawal by Subject|34
1424525|NCT01023308|4700787|P2|Overall Study|Lost to Follow-up|0
1424526|NCT01023308|4700788|P1|Overall Study|Lost to Follow-up|1
1424527|NCT01023308|4700787|P2|Overall Study|Untreated|5
1424528|NCT01023308|4700788|P1|Overall Study|Untreated|5
1424529|NCT01023308|4700787|P2|Overall Study|Protocol Violation|4
1424530|NCT01023308|4700788|P1|Overall Study|Protocol Violation|3
1424531|NCT01023308|4700787|P2|Overall Study|New Cancer therapy|7
1424532|NCT01023308|4700788|P1|Overall Study|New Cancer therapy|4
1424533|NCT01023308|4700787|P2|Overall Study|Disease progression|153
1424534|NCT01023308|4700788|P1|Overall Study|Disease progression|82
1424535|NCT01023308|4700787|P2|Overall Study|Death|17
1424536|NCT01023308|4700788|P1|Overall Study|Death|21
1424537|NCT01023308|4700787|P2|Overall Study|Adverse Event|66
1424538|NCT01023308|4700788|P1|Overall Study|Adverse Event|130
1424539|NCT01023308|4700787|P2|Overall Study|Administrative problems|1
1424540|NCT01023308|4700788|P1|Overall Study|Administrative problems|2
1424541|NCT01023308|4700787|P2|Overall Study|Abnormal test proceedure results|8
1424542|NCT01023308|4700788|P1|Overall Study|Abnormal test proceedure results|3
1424543|NCT01023256|4700818|P4|Overall Study|Withdrawal by Subject|2
1424544|NCT01023256|4700819|P3|Overall Study|Withdrawal by Subject|0
1424545|NCT01023256|4700820|P2|Overall Study|Withdrawal by Subject|0
1424546|NCT01023256|4700821|P1|Overall Study|Withdrawal by Subject|0
1424547|NCT01023256|4700818|P4|Overall Study|Adverse Event|1
1424548|NCT01023256|4700819|P3|Overall Study|Adverse Event|0
1424549|NCT01023256|4700820|P2|Overall Study|Adverse Event|0
1424550|NCT01023256|4700821|P1|Overall Study|Adverse Event|0
1424551|NCT01023256|4700818|P4|Overall Study|Not specified|2
1424552|NCT01023256|4700819|P3|Overall Study|Not specified|0
1424553|NCT01023256|4700820|P2|Overall Study|Not specified|0
1424554|NCT01023256|4700821|P1|Overall Study|Not specified|1
1424555|NCT01023256|4700818|P4|Overall Study|Randomized but not treated|0
1424556|NCT01023256|4700819|P3|Overall Study|Randomized but not treated|1
1424557|NCT01023256|4700820|P2|Overall Study|Randomized but not treated|0
1424558|NCT01023256|4700821|P1|Overall Study|Randomized but not treated|1
1424559|NCT01023256|4700818|P4|Overall Study|Protocol Violation|0
1424560|NCT01023256|4700819|P3|Overall Study|Protocol Violation|0
1424561|NCT01023256|4700820|P2|Overall Study|Protocol Violation|3
1424562|NCT01023256|4700821|P1|Overall Study|Protocol Violation|2
1424563|NCT01023217|4700863|P2|Overall Study|Withdrawal by Subject|0
1424564|NCT01023217|4700864|P1|Overall Study|Withdrawal by Subject|1
1424565|NCT01023061|4700902|P1|Overall Study|Withdrawal prior to treatment|2
1424566|NCT01023035|4700911|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
1424567|NCT01023035|4700912|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
1424568|NCT01023035|4700913|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
1424569|NCT01023035|4700911|P3|Follow-up Period (up to Week 72)|Adverse Event|1
1424570|NCT01023035|4700912|P2|Follow-up Period (up to Week 72)|Adverse Event|0
1424571|NCT01023035|4700913|P1|Follow-up Period (up to Week 72)|Adverse Event|2
1424572|NCT01023035|4700911|P3|Treatment Period|Treatment Failure|24
1424573|NCT01023035|4700912|P2|Treatment Period|Treatment Failure|31
1424574|NCT01023035|4700913|P1|Treatment Period|Treatment Failure|26
1424575|NCT01023035|4700911|P3|Treatment Period|Non-Medical Reasons|44
1424576|NCT01023035|4700912|P2|Treatment Period|Non-Medical Reasons|22
1424577|NCT01023035|4700913|P1|Treatment Period|Non-Medical Reasons|19
1424578|NCT01023035|4700911|P3|Treatment Period|Adverse Event|50
1424579|NCT01023035|4700912|P2|Treatment Period|Adverse Event|32
1424580|NCT01023035|4700913|P1|Treatment Period|Adverse Event|27
1424581|NCT01023022|4700923|P1|Overall Study|due to technical issues|2
1424582|NCT01023022|4700923|P1|Overall Study|Lost to Follow-up|7
1424583|NCT01023022|4700923|P1|Overall Study|Death|5
1424584|NCT01022996|4700929|P1|Overall Study|Protocol Violation|1
1424585|NCT01022996|4700929|P1|Overall Study|Disease Progression|32
1424586|NCT01022996|4700929|P1|Overall Study|Administrative problems|6
1424587|NCT01022996|4700929|P1|Overall Study|Lost to Follow-up|1
1424588|NCT01022996|4700929|P1|Overall Study|Withdrawal by Subject|3
1424589|NCT01022996|4700929|P1|Overall Study|Adverse Event|14
1424590|NCT01022853|4700943|P5|Overall Study|Other not stated above|0
1424591|NCT01022853|4700944|P4|Overall Study|Other not stated above|0
1424592|NCT01022853|4700945|P3|Overall Study|Other not stated above|1
1424593|NCT01022853|4700946|P2|Overall Study|Other not stated above|0
1424594|NCT01022853|4700947|P1|Overall Study|Other not stated above|1
1424595|NCT01022853|4700943|P5|Overall Study|Withdrawal by Subject|0
1424596|NCT01022853|4700944|P4|Overall Study|Withdrawal by Subject|1
1424597|NCT01022853|4700945|P3|Overall Study|Withdrawal by Subject|1
1424598|NCT01022853|4700946|P2|Overall Study|Withdrawal by Subject|1
1424599|NCT01022853|4700947|P1|Overall Study|Withdrawal by Subject|0
1424600|NCT01022853|4700943|P5|Overall Study|Dose-limiting toxicity|1
1424601|NCT01022853|4700944|P4|Overall Study|Dose-limiting toxicity|0
1424602|NCT01022853|4700945|P3|Overall Study|Dose-limiting toxicity|0
1424603|NCT01022853|4700946|P2|Overall Study|Dose-limiting toxicity|0
1424604|NCT01022853|4700947|P1|Overall Study|Dose-limiting toxicity|0
1424605|NCT01022853|4700943|P5|Overall Study|Progressive disease|1
1424606|NCT01022853|4700944|P4|Overall Study|Progressive disease|7
1424607|NCT01022853|4700945|P3|Overall Study|Progressive disease|11
1424608|NCT01022853|4700946|P2|Overall Study|Progressive disease|3
1424609|NCT01022853|4700947|P1|Overall Study|Progressive disease|2
1424610|NCT01022762|4701026|P2|Overall Study|Unclassified|20
1424611|NCT01022762|4701027|P1|Overall Study|Unclassified|12
1424612|NCT01022762|4701026|P2|Overall Study|Protocol Violation|6
1424613|NCT01022762|4701027|P1|Overall Study|Protocol Violation|7
1424614|NCT01022762|4701026|P2|Overall Study|Lack of Efficacy|1
1424615|NCT01022762|4701027|P1|Overall Study|Lack of Efficacy|0
1424616|NCT01022762|4701026|P2|Overall Study|Adverse Event|1
1424617|NCT01022762|4701027|P1|Overall Study|Adverse Event|3
1424618|NCT01022502|4701062|P1|Overall Study|Withdrawal by Subject|1
1424619|NCT01022502|4701062|P1|Overall Study|employment related reasons|1
1424620|NCT01022502|4701062|P1|Overall Study|Adverse Event|1
1424621|NCT01022424|4701076|P1|Overall Study|eGFR under the withdrawal criteria|2
1424622|NCT01022424|4701076|P1|Overall Study|Physician Decision|1
1424623|NCT01022424|4701076|P1|Overall Study|Adverse Event|1
1424624|NCT01022398|4701091|P2|Overall Study|Study terminated|2
1424625|NCT01022398|4701092|P1|Overall Study|Study terminated|2
1424626|NCT01022203|4701117|P2|Follow-Up Assessment|Lost to Follow-up|2
1424627|NCT01022203|4701118|P1|Follow-Up Assessment|Lost to Follow-up|2
1424628|NCT01022203|4701117|P2|Post Treatment Assessment|Adverse Event|2
1424629|NCT01022203|4701118|P1|Post Treatment Assessment|Adverse Event|0
1424630|NCT01022203|4701117|P2|Post Treatment Assessment|Physician Decision|0
1424631|NCT01022203|4701118|P1|Post Treatment Assessment|Physician Decision|2
1424632|NCT01022203|4701117|P2|Post Treatment Assessment|Withdrawal by Subject|12
1424633|NCT01022203|4701118|P1|Post Treatment Assessment|Withdrawal by Subject|12
1424634|NCT01022112|4701137|P5|Overall Study|Fasting plasma glucose level increased|7
1424635|NCT01022112|4701138|P4|Overall Study|Fasting plasma glucose level increased|0
1424636|NCT01022112|4701139|P3|Overall Study|Fasting plasma glucose level increased|0
1424637|NCT01022112|4701140|P2|Overall Study|Fasting plasma glucose level increased|0
1424638|NCT01022112|4701141|P1|Overall Study|Fasting plasma glucose level increased|1
1424639|NCT01022112|4701137|P5|Overall Study|Withdrawal by Subject|1
1424640|NCT01022112|4701138|P4|Overall Study|Withdrawal by Subject|2
1424641|NCT01022112|4701139|P3|Overall Study|Withdrawal by Subject|2
1424642|NCT01022112|4701140|P2|Overall Study|Withdrawal by Subject|1
1424643|NCT01022112|4701141|P1|Overall Study|Withdrawal by Subject|0
1424644|NCT01022112|4701137|P5|Overall Study|Physician Decision|1
1424645|NCT01022112|4701138|P4|Overall Study|Physician Decision|0
1424646|NCT01022112|4701139|P3|Overall Study|Physician Decision|1
1424647|NCT01022112|4701140|P2|Overall Study|Physician Decision|0
1424648|NCT01022112|4701141|P1|Overall Study|Physician Decision|0
1424649|NCT01022112|4701137|P5|Overall Study|Lack of Efficacy|1
1424650|NCT01022112|4701138|P4|Overall Study|Lack of Efficacy|0
1424651|NCT01022112|4701139|P3|Overall Study|Lack of Efficacy|0
1424652|NCT01022112|4701140|P2|Overall Study|Lack of Efficacy|0
1424653|NCT01022112|4701141|P1|Overall Study|Lack of Efficacy|1
1424654|NCT01022112|4701137|P5|Overall Study|Adverse Event|0
1424655|NCT01022112|4701138|P4|Overall Study|Adverse Event|1
1424656|NCT01022112|4701139|P3|Overall Study|Adverse Event|0
1424657|NCT01022112|4701140|P2|Overall Study|Adverse Event|2
1424658|NCT01022112|4701141|P1|Overall Study|Adverse Event|1
1424659|NCT01021878|4701164|P2|Overall Study|Transplantation|1
1424660|NCT01021878|4701165|P1|Overall Study|Transplantation|6
1424661|NCT01021878|4701164|P2|Overall Study|Adverse Event|5
1424662|NCT01021878|4701165|P1|Overall Study|Adverse Event|6
1424663|NCT01021878|4701164|P2|Overall Study|Death|1
1424664|NCT01021878|4701165|P1|Overall Study|Death|0
1424665|NCT01021878|4701164|P2|Overall Study|Lost to Follow-up|3
1424666|NCT01021878|4701165|P1|Overall Study|Lost to Follow-up|4
1424667|NCT01021852|4701187|P8|Treatment Period 2|Withdrawal by Subject|2
1424668|NCT01021852|4701188|P7|Treatment Period 2|Withdrawal by Subject|1
1424669|NCT01021852|4701189|P6|Treatment Period 2|Withdrawal by Subject|0
1424670|NCT01021852|4701190|P5|Treatment Period 2|Withdrawal by Subject|0
1424671|NCT01021852|4701191|P4|Treatment Period 2|Withdrawal by Subject|0
1424672|NCT01021852|4701192|P3|Treatment Period 2|Withdrawal by Subject|0
1424673|NCT01021852|4701193|P2|Treatment Period 2|Withdrawal by Subject|0
1424674|NCT01021852|4701194|P1|Treatment Period 2|Withdrawal by Subject|0
1424675|NCT01021852|4701187|P8|Treatment Period 2|Protocol Violation|0
1424676|NCT01021852|4701188|P7|Treatment Period 2|Protocol Violation|1
1424677|NCT01021852|4701189|P6|Treatment Period 2|Protocol Violation|0
1424678|NCT01021852|4701190|P5|Treatment Period 2|Protocol Violation|1
1424679|NCT01021852|4701191|P4|Treatment Period 2|Protocol Violation|0
1424680|NCT01021852|4701192|P3|Treatment Period 2|Protocol Violation|0
1424681|NCT01021852|4701193|P2|Treatment Period 2|Protocol Violation|0
1424682|NCT01021852|4701194|P1|Treatment Period 2|Protocol Violation|0
1424683|NCT01021852|4701187|P8|Treatment Period 2|Physician Decision|0
1424684|NCT01021852|4701188|P7|Treatment Period 2|Physician Decision|0
1424685|NCT01021852|4701189|P6|Treatment Period 2|Physician Decision|0
1424686|NCT01021852|4701190|P5|Treatment Period 2|Physician Decision|0
1424687|NCT01021852|4701191|P4|Treatment Period 2|Physician Decision|0
1424688|NCT01021852|4701192|P3|Treatment Period 2|Physician Decision|1
1424689|NCT01021852|4701193|P2|Treatment Period 2|Physician Decision|0
1424690|NCT01021852|4701194|P1|Treatment Period 2|Physician Decision|0
1424691|NCT01021852|4701187|P8|Treatment Period 2|Lack of Efficacy|0
1424692|NCT01021852|4701188|P7|Treatment Period 2|Lack of Efficacy|0
1424693|NCT01021852|4701189|P6|Treatment Period 2|Lack of Efficacy|1
1424694|NCT01021852|4701190|P5|Treatment Period 2|Lack of Efficacy|0
1424695|NCT01021852|4701191|P4|Treatment Period 2|Lack of Efficacy|0
1424696|NCT01021852|4701192|P3|Treatment Period 2|Lack of Efficacy|0
1424697|NCT01021852|4701193|P2|Treatment Period 2|Lack of Efficacy|0
1424698|NCT01021852|4701194|P1|Treatment Period 2|Lack of Efficacy|0
1424699|NCT01021852|4701187|P8|Treatment Period 2|Adverse Event|0
1424700|NCT01021852|4701188|P7|Treatment Period 2|Adverse Event|1
1424701|NCT01021852|4701189|P6|Treatment Period 2|Adverse Event|0
1424702|NCT01021852|4701190|P5|Treatment Period 2|Adverse Event|1
1424703|NCT01021852|4701191|P4|Treatment Period 2|Adverse Event|0
1424704|NCT01021852|4701192|P3|Treatment Period 2|Adverse Event|0
1424705|NCT01021852|4701193|P2|Treatment Period 2|Adverse Event|1
1424706|NCT01021852|4701194|P1|Treatment Period 2|Adverse Event|0
1424707|NCT01021852|4701187|P8|Washout Period-No Drug|Adverse Event|0
1424708|NCT01021852|4701188|P7|Washout Period-No Drug|Adverse Event|0
1424709|NCT01021852|4701189|P6|Washout Period-No Drug|Adverse Event|1
1424710|NCT01021852|4701190|P5|Washout Period-No Drug|Adverse Event|0
1424711|NCT01021852|4701191|P4|Washout Period-No Drug|Adverse Event|0
1424712|NCT01021852|4701192|P3|Washout Period-No Drug|Adverse Event|0
1424713|NCT01021852|4701193|P2|Washout Period-No Drug|Adverse Event|0
1424714|NCT01021852|4701194|P1|Washout Period-No Drug|Adverse Event|1
1424715|NCT01021852|4701187|P8|Washout Period-Placebo|Protocol Violation|0
1424716|NCT01021852|4701188|P7|Washout Period-Placebo|Protocol Violation|1
1424717|NCT01021852|4701189|P6|Washout Period-Placebo|Protocol Violation|0
1424718|NCT01021852|4701190|P5|Washout Period-Placebo|Protocol Violation|0
1424719|NCT01021852|4701191|P4|Washout Period-Placebo|Protocol Violation|0
1424720|NCT01021852|4701192|P3|Washout Period-Placebo|Protocol Violation|0
1424721|NCT01021852|4701193|P2|Washout Period-Placebo|Protocol Violation|0
1424722|NCT01021852|4701194|P1|Washout Period-Placebo|Protocol Violation|0
1424723|NCT01021852|4701187|P8|Washout Period-Placebo|Lost to Follow-up|0
1424724|NCT01021852|4701188|P7|Washout Period-Placebo|Lost to Follow-up|0
1424725|NCT01021852|4701189|P6|Washout Period-Placebo|Lost to Follow-up|0
1424726|NCT01021852|4701190|P5|Washout Period-Placebo|Lost to Follow-up|1
1424727|NCT01021852|4701191|P4|Washout Period-Placebo|Lost to Follow-up|0
1424728|NCT01021852|4701192|P3|Washout Period-Placebo|Lost to Follow-up|0
1424729|NCT01021852|4701193|P2|Washout Period-Placebo|Lost to Follow-up|0
1424730|NCT01021852|4701194|P1|Washout Period-Placebo|Lost to Follow-up|0
1424731|NCT01021852|4701187|P8|Washout Period-Placebo|Adverse Event|0
1424732|NCT01021852|4701188|P7|Washout Period-Placebo|Adverse Event|0
1424733|NCT01021852|4701189|P6|Washout Period-Placebo|Adverse Event|1
1424734|NCT01021852|4701190|P5|Washout Period-Placebo|Adverse Event|0
1424735|NCT01021852|4701191|P4|Washout Period-Placebo|Adverse Event|1
1424736|NCT01021852|4701192|P3|Washout Period-Placebo|Adverse Event|0
1424737|NCT01021852|4701193|P2|Washout Period-Placebo|Adverse Event|0
1424738|NCT01021852|4701194|P1|Washout Period-Placebo|Adverse Event|0
1424739|NCT01021852|4701187|P8|Treatment Period 1|Not Treated|0
1424740|NCT01021852|4701188|P7|Treatment Period 1|Not Treated|0
1424741|NCT01021852|4701189|P6|Treatment Period 1|Not Treated|0
1424742|NCT01021852|4701190|P5|Treatment Period 1|Not Treated|0
1424743|NCT01021852|4701191|P4|Treatment Period 1|Not Treated|2
1424744|NCT01021852|4701192|P3|Treatment Period 1|Not Treated|0
1424745|NCT01021852|4701193|P2|Treatment Period 1|Not Treated|0
1424746|NCT01021852|4701194|P1|Treatment Period 1|Not Treated|0
1424747|NCT01021852|4701187|P8|Treatment Period 1|Withdrawal by Subject|1
1424748|NCT01021852|4701188|P7|Treatment Period 1|Withdrawal by Subject|0
1424749|NCT01021852|4701189|P6|Treatment Period 1|Withdrawal by Subject|0
1424750|NCT01021852|4701190|P5|Treatment Period 1|Withdrawal by Subject|1
1424751|NCT01021852|4701191|P4|Treatment Period 1|Withdrawal by Subject|0
1424752|NCT01021852|4701192|P3|Treatment Period 1|Withdrawal by Subject|0
1424753|NCT01021852|4701193|P2|Treatment Period 1|Withdrawal by Subject|0
1424754|NCT01021852|4701194|P1|Treatment Period 1|Withdrawal by Subject|0
1424755|NCT01021852|4701187|P8|Treatment Period 1|Pregnancy|0
1424756|NCT01021852|4701188|P7|Treatment Period 1|Pregnancy|0
1424757|NCT01021852|4701189|P6|Treatment Period 1|Pregnancy|0
1424758|NCT01021852|4701190|P5|Treatment Period 1|Pregnancy|0
1424759|NCT01021852|4701191|P4|Treatment Period 1|Pregnancy|0
1424760|NCT01021852|4701192|P3|Treatment Period 1|Pregnancy|1
1424761|NCT01021852|4701193|P2|Treatment Period 1|Pregnancy|0
1424762|NCT01021852|4701194|P1|Treatment Period 1|Pregnancy|0
1424763|NCT01021852|4701187|P8|Treatment Period 1|Adverse Event|0
1424764|NCT01021852|4701188|P7|Treatment Period 1|Adverse Event|0
1424765|NCT01021852|4701189|P6|Treatment Period 1|Adverse Event|2
1424766|NCT01021852|4701190|P5|Treatment Period 1|Adverse Event|2
1424767|NCT01021852|4701191|P4|Treatment Period 1|Adverse Event|0
1424768|NCT01021852|4701192|P3|Treatment Period 1|Adverse Event|1
1424769|NCT01021852|4701193|P2|Treatment Period 1|Adverse Event|1
1424770|NCT01021852|4701194|P1|Treatment Period 1|Adverse Event|3
1424771|NCT01021813|4701230|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
1424772|NCT01021813|4701231|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
1424773|NCT01021813|4701232|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
1424774|NCT01021813|4701233|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
1424775|NCT01021813|4701234|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
1424776|NCT01021813|4701230|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
1424777|NCT01021813|4701231|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
1424778|NCT01021813|4701232|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
1424779|NCT01021813|4701233|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
1424780|NCT01021813|4701234|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
1424781|NCT01021813|4701230|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
1424782|NCT01021813|4701231|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
1424783|NCT01021813|4701232|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
1424784|NCT01021813|4701233|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
1424785|NCT01021813|4701234|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
1424786|NCT01021813|4701230|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
1424787|NCT01021813|4701231|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
1424788|NCT01021813|4701232|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
1424789|NCT01021813|4701233|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
1424790|NCT01021813|4701234|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
1424791|NCT01021813|4701230|P5|DB Randomized Discontinuation Phase|Adverse Event|1
1424792|NCT01021813|4701231|P4|DB Randomized Discontinuation Phase|Adverse Event|3
1424793|NCT01021813|4701232|P3|DB Randomized Discontinuation Phase|Adverse Event|0
1424794|NCT01021813|4701233|P2|DB Randomized Discontinuation Phase|Adverse Event|0
1424795|NCT01021813|4701234|P1|DB Randomized Discontinuation Phase|Adverse Event|0
1424796|NCT01021813|4701230|P5|DB Treatment Phase|Withdrawal by Subject|0
1424797|NCT01021813|4701231|P4|DB Treatment Phase|Withdrawal by Subject|0
1424798|NCT01021813|4701232|P3|DB Treatment Phase|Withdrawal by Subject|0
1424799|NCT01021813|4701233|P2|DB Treatment Phase|Withdrawal by Subject|24
1424800|NCT01021813|4701234|P1|DB Treatment Phase|Withdrawal by Subject|60
1424801|NCT01021813|4701230|P5|DB Treatment Phase|Protocol Violation|0
1424802|NCT01021813|4701231|P4|DB Treatment Phase|Protocol Violation|0
1424803|NCT01021813|4701232|P3|DB Treatment Phase|Protocol Violation|0
1424804|NCT01021813|4701233|P2|DB Treatment Phase|Protocol Violation|3
1424805|NCT01021813|4701234|P1|DB Treatment Phase|Protocol Violation|4
1424806|NCT01021813|4701230|P5|DB Treatment Phase|Pregnancy|0
1424807|NCT01021813|4701231|P4|DB Treatment Phase|Pregnancy|0
1424808|NCT01021813|4701232|P3|DB Treatment Phase|Pregnancy|0
1424809|NCT01021813|4701233|P2|DB Treatment Phase|Pregnancy|0
1424810|NCT01021813|4701234|P1|DB Treatment Phase|Pregnancy|1
1424811|NCT01021813|4701230|P5|DB Treatment Phase|Physician Decision|0
1424812|NCT01021813|4701231|P4|DB Treatment Phase|Physician Decision|0
1424813|NCT01021813|4701232|P3|DB Treatment Phase|Physician Decision|0
1424814|NCT01021813|4701233|P2|DB Treatment Phase|Physician Decision|8
1424815|NCT01021813|4701234|P1|DB Treatment Phase|Physician Decision|17
1424816|NCT01021813|4701230|P5|DB Treatment Phase|Lost to Follow-up|0
1424817|NCT01021813|4701231|P4|DB Treatment Phase|Lost to Follow-up|0
1424818|NCT01021813|4701232|P3|DB Treatment Phase|Lost to Follow-up|0
1424819|NCT01021813|4701233|P2|DB Treatment Phase|Lost to Follow-up|12
1424820|NCT01021813|4701234|P1|DB Treatment Phase|Lost to Follow-up|14
1424821|NCT01021813|4701230|P5|DB Treatment Phase|Lack of Efficacy|0
1424822|NCT01021813|4701231|P4|DB Treatment Phase|Lack of Efficacy|0
1424823|NCT01021813|4701232|P3|DB Treatment Phase|Lack of Efficacy|0
1424824|NCT01021813|4701233|P2|DB Treatment Phase|Lack of Efficacy|28
1424825|NCT01021813|4701234|P1|DB Treatment Phase|Lack of Efficacy|44
1424826|NCT01021813|4701230|P5|DB Treatment Phase|Adverse Event|0
1424827|NCT01021813|4701231|P4|DB Treatment Phase|Adverse Event|0
1424828|NCT01021813|4701232|P3|DB Treatment Phase|Adverse Event|0
1424829|NCT01021813|4701233|P2|DB Treatment Phase|Adverse Event|22
1424830|NCT01021813|4701234|P1|DB Treatment Phase|Adverse Event|60
1424831|NCT01021748|4701295|P9|Overall Study|Not Treated|0
1424832|NCT01021748|4701296|P8|Overall Study|Not Treated|0
1424833|NCT01021748|4701297|P7|Overall Study|Not Treated|0
1424834|NCT01021748|4701298|P6|Overall Study|Not Treated|0
1424835|NCT01021748|4701299|P5|Overall Study|Not Treated|0
1424836|NCT01021748|4701300|P4|Overall Study|Not Treated|0
1424837|NCT01021748|4701301|P3|Overall Study|Not Treated|0
1424838|NCT01021748|4701302|P2|Overall Study|Not Treated|1
1424839|NCT01021748|4701303|P1|Overall Study|Not Treated|0
1424840|NCT01021748|4701295|P9|Overall Study|Withdrawal by Subject|1
1424841|NCT01021748|4701296|P8|Overall Study|Withdrawal by Subject|0
1424842|NCT01021748|4701297|P7|Overall Study|Withdrawal by Subject|1
1424843|NCT01021748|4701298|P6|Overall Study|Withdrawal by Subject|0
1424844|NCT01021748|4701299|P5|Overall Study|Withdrawal by Subject|0
1424845|NCT01021748|4701300|P4|Overall Study|Withdrawal by Subject|0
1424846|NCT01021748|4701301|P3|Overall Study|Withdrawal by Subject|0
1424847|NCT01021748|4701302|P2|Overall Study|Withdrawal by Subject|0
1424848|NCT01021748|4701303|P1|Overall Study|Withdrawal by Subject|0
1424849|NCT01021748|4701295|P9|Overall Study|Progressive Disease|6
1424850|NCT01021748|4701296|P8|Overall Study|Progressive Disease|5
1424851|NCT01021748|4701297|P7|Overall Study|Progressive Disease|0
1424852|NCT01021748|4701298|P6|Overall Study|Progressive Disease|3
1424853|NCT01021748|4701299|P5|Overall Study|Progressive Disease|7
1424854|NCT01021748|4701300|P4|Overall Study|Progressive Disease|6
1424855|NCT01021748|4701301|P3|Overall Study|Progressive Disease|4
1424856|NCT01021748|4701302|P2|Overall Study|Progressive Disease|3
1424857|NCT01021748|4701303|P1|Overall Study|Progressive Disease|3
1424858|NCT01021748|4701295|P9|Overall Study|Physician Decision|2
1424859|NCT01021748|4701296|P8|Overall Study|Physician Decision|1
1424860|NCT01021748|4701297|P7|Overall Study|Physician Decision|1
1424861|NCT01021748|4701298|P6|Overall Study|Physician Decision|0
1424862|NCT01021748|4701299|P5|Overall Study|Physician Decision|0
1424863|NCT01021748|4701300|P4|Overall Study|Physician Decision|1
1424864|NCT01021748|4701301|P3|Overall Study|Physician Decision|1
1424865|NCT01021748|4701302|P2|Overall Study|Physician Decision|0
1424866|NCT01021748|4701303|P1|Overall Study|Physician Decision|1
1424867|NCT01021748|4701295|P9|Overall Study|Adverse Event|7
1424868|NCT01021748|4701296|P8|Overall Study|Adverse Event|0
1424869|NCT01021748|4701297|P7|Overall Study|Adverse Event|1
1424870|NCT01021748|4701298|P6|Overall Study|Adverse Event|0
1424871|NCT01021748|4701299|P5|Overall Study|Adverse Event|2
1424872|NCT01021748|4701300|P4|Overall Study|Adverse Event|0
1424873|NCT01021748|4701301|P3|Overall Study|Adverse Event|2
1424874|NCT01021748|4701302|P2|Overall Study|Adverse Event|1
1424875|NCT01021748|4701303|P1|Overall Study|Adverse Event|2
1424876|NCT01021683|4701350|P1|Overall Study|Other|8
1424877|NCT01021683|4701350|P1|Overall Study|Recovery of neutrophil count|51
1424878|NCT01021683|4701350|P1|Overall Study|Lack of Efficacy|12
1424879|NCT01021553|4701376|P3|Overall Study|Withdrawal by Subject|0
1424880|NCT01021553|4701377|P2|Overall Study|Withdrawal by Subject|1
1424881|NCT01021553|4701378|P1|Overall Study|Withdrawal by Subject|1
1424882|NCT01021553|4701376|P3|Overall Study|Lost to Follow-up|1
1424883|NCT01021553|4701377|P2|Overall Study|Lost to Follow-up|0
1424884|NCT01021553|4701378|P1|Overall Study|Lost to Follow-up|0
1424885|NCT01021553|4701376|P3|Overall Study|Protocol Violation|2
1424886|NCT01021553|4701377|P2|Overall Study|Protocol Violation|2
1424887|NCT01021553|4701378|P1|Overall Study|Protocol Violation|0
1424888|NCT01021553|4701376|P3|Overall Study|Lack of Efficacy|0
1424889|NCT01021553|4701377|P2|Overall Study|Lack of Efficacy|2
1424890|NCT01021553|4701378|P1|Overall Study|Lack of Efficacy|2
1424891|NCT01021553|4701376|P3|Overall Study|Adverse Event|0
1424892|NCT01021553|4701377|P2|Overall Study|Adverse Event|0
1424893|NCT01021553|4701378|P1|Overall Study|Adverse Event|1
1424894|NCT01021423|4701432|P2|Overall Study|Study terminated|5
1424895|NCT01021423|4701433|P1|Overall Study|Study terminated|4
1424896|NCT01021332|4701449|P1|Overall Study|Miscellaneous|3
1424897|NCT01021332|4701449|P1|Overall Study|Protocol Violation|9
1424898|NCT01021332|4701449|P1|Overall Study|Lost to Follow-up|4
1424899|NCT01021332|4701449|P1|Overall Study|Withdrawal of Consent|23
1424900|NCT01021332|4701449|P1|Overall Study|Lack of Efficacy|19
1424901|NCT01021332|4701449|P1|Overall Study|Adverse Event|43
1424902|NCT01021332|4701449|P1|Overall Study|Not fulfilling incl./excl.criteria|5
1424903|NCT01021293|4701510|P2|Overall Study|Lost to Follow-up|1
1424904|NCT01021293|4701511|P1|Overall Study|Lost to Follow-up|1
1424905|NCT01021293|4701510|P2|Overall Study|Migrated/moved from study area|18
1424906|NCT01021293|4701511|P1|Overall Study|Migrated/moved from study area|6
1424907|NCT01021293|4701510|P2|Overall Study|Withdrawal by Subject|3
1424908|NCT01021293|4701511|P1|Overall Study|Withdrawal by Subject|1
1424909|NCT01021293|4701510|P2|Overall Study|Adverse Event|1
1424910|NCT01021293|4701511|P1|Overall Study|Adverse Event|2
1424911|NCT01021293|4701510|P2|Overall Study|Serious Adverse Event|1
1424912|NCT01021293|4701511|P1|Overall Study|Serious Adverse Event|2
1424913|NCT01021215|4701530|P2|Overall Study|Lost to Follow-up|0
1424914|NCT01021215|4701531|P1|Overall Study|Lost to Follow-up|3
1424915|NCT01021020|4701546|P1|14 Day Washout Period A|Physician Decision|1
1424916|NCT01021020|4701546|P1|Period I|Withdrawal by Subject|1
1424917|NCT01021020|4701546|P1|Period I|Protocol Violation|1
1424918|NCT01021007|4701562|P2|Overall Study|Adverse Event|3
1424919|NCT01021007|4701563|P1|Overall Study|Adverse Event|1
1424920|NCT01021007|4701562|P2|Overall Study|Lost to Follow-up|1
1424921|NCT01021007|4701563|P1|Overall Study|Lost to Follow-up|1
1424922|NCT01020981|4701575|P2|Overall Study|Participant declined to complete survey|0
1424923|NCT01020981|4701576|P1|Overall Study|Participant declined to complete survey|2
1424924|NCT01020981|4701575|P2|Overall Study|Survey returned undeliverable|32
1424925|NCT01020981|4701576|P1|Overall Study|Survey returned undeliverable|8
1424926|NCT01020981|4701575|P2|Overall Study|Did not return mailed survey|58
1424927|NCT01020981|4701576|P1|Overall Study|Did not return mailed survey|74
1424928|NCT01020877|4701597|P2|Second Intervention|Withdrawal by Subject|0
1424929|NCT01020877|4701598|P1|Second Intervention|Withdrawal by Subject|1
1424930|NCT01020838|4701608|P1|Overall Study|Most common: Study ended by sponsor|77
1424931|NCT01020838|4701608|P1|Overall Study|Lost to Follow-up|6
1424932|NCT01020838|4701608|P1|Overall Study|Withdrawal by Subject|9
1424933|NCT01020838|4701608|P1|Overall Study|Adverse Event|1
1424934|NCT01020838|4701608|P1|Overall Study|Death|90
1424935|NCT01020812|4701623|P1|Overall Study|Protocol Violation|1
1424936|NCT01020812|4701623|P1|Overall Study|Withdrawal by Subject|1
1424937|NCT01020812|4701623|P1|Overall Study|Physician Decision|1
1424938|NCT01020799|4701633|P3|Overall Study|Lost to Follow-up|2
1424939|NCT01020799|4701634|P2|Overall Study|Lost to Follow-up|4
1424940|NCT01020799|4701635|P1|Overall Study|Lost to Follow-up|6
1424941|NCT01020799|4701633|P3|Overall Study|Withdrawal by Subject|3
1424942|NCT01020799|4701634|P2|Overall Study|Withdrawal by Subject|2
1424943|NCT01020799|4701635|P1|Overall Study|Withdrawal by Subject|2
1424944|NCT01020799|4701633|P3|Overall Study|Protocol Violation|0
1424945|NCT01020799|4701634|P2|Overall Study|Protocol Violation|2
1424946|NCT01020799|4701635|P1|Overall Study|Protocol Violation|3
1424947|NCT01020799|4701633|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
1424948|NCT01020799|4701634|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
1424949|NCT01020799|4701635|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
1424950|NCT01020799|4701633|P3|Overall Study|Adverse Event|2
1424951|NCT01020799|4701634|P2|Overall Study|Adverse Event|3
1424952|NCT01020799|4701635|P1|Overall Study|Adverse Event|4
1424953|NCT01020786|4701658|P1|Maintenance Period|Sponsor Decision|1
1424954|NCT01020786|4701658|P1|Maintenance Period|Withdrawal by Subject|8
1424955|NCT01020786|4701658|P1|Maintenance Period|Progressive Disease|43
1424956|NCT01020786|4701658|P1|Maintenance Period|Adverse Event|8
1424957|NCT01020786|4701658|P1|Induction Period|Withdrawal by Subject|3
1424958|NCT01020786|4701658|P1|Induction Period|Investigator Decision|3
1424959|NCT01020786|4701658|P1|Induction Period|Progressive Disease|31
1424960|NCT01020786|4701658|P1|Induction Period|Adverse Event|10
1424961|NCT01020786|4701658|P1|Induction Period|Entry Criteria Not Met|2
1424962|NCT01020773|4701672|P2|Overall Study|Withdrawal by Subject|3
1424963|NCT01020773|4701673|P1|Overall Study|Withdrawal by Subject|4
1424964|NCT01020747|4701679|P1|Overall Study|Withdrawal by Subject|1
1424965|NCT01020526|4701695|P1|Overall Study|Adverse Event|2
1424966|NCT01020526|4701695|P1|Overall Study|Lost to Follow-up|1
1424967|NCT01020526|4701695|P1|Overall Study|Insufficient clinical response|3
1424968|NCT01020526|4701695|P1|Overall Study|Other reasons|3
1424969|NCT01020526|4701695|P1|Overall Study|Withdrawal by Subject|5
1424970|NCT01020474|4701701|P2|Overall Study|Insufficient Clinical Response|3
1424971|NCT01020474|4701702|P1|Overall Study|Insufficient Clinical Response|0
1424972|NCT01020474|4701701|P2|Overall Study|Other Reasons|1
1424973|NCT01020474|4701702|P1|Overall Study|Other Reasons|1
1424974|NCT01020474|4701701|P2|Overall Study|Withdrawal by Subject|7
1424975|NCT01020474|4701702|P1|Overall Study|Withdrawal by Subject|5
1424976|NCT01020474|4701701|P2|Overall Study|Protocol Violation|2
1424977|NCT01020474|4701702|P1|Overall Study|Protocol Violation|0
1424978|NCT01020474|4701701|P2|Overall Study|Adverse Event|4
1424979|NCT01020474|4701702|P1|Overall Study|Adverse Event|4
1424980|NCT01020448|4701722|P1|Treatment|Lost to Follow-up|2
1424981|NCT01020448|4701722|P1|Treatment|Lack of Efficacy|8
1424982|NCT01020448|4701722|P1|Treatment|Disease Progression|2
1424983|NCT01020448|4701722|P1|Treatment|Consent Withdrawn|3
1424984|NCT01020448|4701722|P1|Treatment|Adverse Event|11
1424985|NCT01020448|4701722|P1|Pre-assignment|Does Not Meet Entry Criteria|2
1424986|NCT01020448|4701722|P1|Pre-assignment|Withdrawal by Subject|5
1424987|NCT01020448|4701722|P1|Pre-assignment|Adverse Event|6
1424988|NCT01020435|4701733|P2|Overall Study|Lost to Follow-up|1
1424989|NCT01020435|4701734|P1|Overall Study|Lost to Follow-up|0
1424990|NCT01020305|4701742|P1|Overall Study|Adverse Event|2
1424991|NCT01020123|4701753|P7|Extention Period|Lost to Follow-up|0
1424992|NCT01020123|4701754|P6|Extention Period|Lost to Follow-up|2
1424993|NCT01020123|4701755|P5|Extention Period|Lost to Follow-up|0
1424994|NCT01020123|4701756|P4|Extention Period|Lost to Follow-up|0
1424995|NCT01020123|4701757|P3|Extention Period|Lost to Follow-up|0
1424996|NCT01020123|4701758|P2|Extention Period|Lost to Follow-up|0
1424997|NCT01020123|4701759|P1|Extention Period|Lost to Follow-up|0
1424998|NCT01020123|4701753|P7|Extention Period|Protocol Violation|1
1424999|NCT01020123|4701754|P6|Extention Period|Protocol Violation|0
1425000|NCT01020123|4701755|P5|Extention Period|Protocol Violation|0
1425001|NCT01020123|4701756|P4|Extention Period|Protocol Violation|0
1425002|NCT01020123|4701757|P3|Extention Period|Protocol Violation|1
1425003|NCT01020123|4701758|P2|Extention Period|Protocol Violation|1
1425004|NCT01020123|4701759|P1|Extention Period|Protocol Violation|1
1425005|NCT01020123|4701753|P7|Extention Period|Adverse Event|0
1425006|NCT01020123|4701754|P6|Extention Period|Adverse Event|0
1425007|NCT01020123|4701755|P5|Extention Period|Adverse Event|0
1425008|NCT01020123|4701756|P4|Extention Period|Adverse Event|1
1425009|NCT01020123|4701757|P3|Extention Period|Adverse Event|0
1425010|NCT01020123|4701758|P2|Extention Period|Adverse Event|0
1425011|NCT01020123|4701759|P1|Extention Period|Adverse Event|0
1425012|NCT01020123|4701753|P7|Extention Period|Withdrawal by Subject|0
1425013|NCT01020123|4701754|P6|Extention Period|Withdrawal by Subject|0
1425014|NCT01020123|4701755|P5|Extention Period|Withdrawal by Subject|0
1425015|NCT01020123|4701756|P4|Extention Period|Withdrawal by Subject|0
1425016|NCT01020123|4701757|P3|Extention Period|Withdrawal by Subject|1
1425017|NCT01020123|4701758|P2|Extention Period|Withdrawal by Subject|1
1425018|NCT01020123|4701759|P1|Extention Period|Withdrawal by Subject|2
1425019|NCT01020123|4701753|P7|Main Period|Unclasified|6
1425020|NCT01020123|4701754|P6|Main Period|Unclasified|3
1425021|NCT01020123|4701755|P5|Main Period|Unclasified|1
1425022|NCT01020123|4701756|P4|Main Period|Unclasified|0
1425023|NCT01020123|4701757|P3|Main Period|Unclasified|1
1425024|NCT01020123|4701758|P2|Main Period|Unclasified|0
1425025|NCT01020123|4701759|P1|Main Period|Unclasified|2
1425026|NCT01020123|4701753|P7|Main Period|Lost to Follow-up|0
1425027|NCT01020123|4701754|P6|Main Period|Lost to Follow-up|0
1425028|NCT01020123|4701755|P5|Main Period|Lost to Follow-up|0
1425029|NCT01020123|4701756|P4|Main Period|Lost to Follow-up|0
1425030|NCT01020123|4701757|P3|Main Period|Lost to Follow-up|0
1425031|NCT01020123|4701758|P2|Main Period|Lost to Follow-up|2
1425032|NCT01020123|4701759|P1|Main Period|Lost to Follow-up|0
1425033|NCT01020123|4701753|P7|Main Period|Protocol Violation|2
1425034|NCT01020123|4701754|P6|Main Period|Protocol Violation|3
1425035|NCT01020123|4701755|P5|Main Period|Protocol Violation|2
1425036|NCT01020123|4701756|P4|Main Period|Protocol Violation|5
1425037|NCT01020123|4701757|P3|Main Period|Protocol Violation|2
1425038|NCT01020123|4701758|P2|Main Period|Protocol Violation|4
1425039|NCT01020123|4701759|P1|Main Period|Protocol Violation|4
1425040|NCT01020123|4701753|P7|Main Period|Adverse Event|1
1425041|NCT01020123|4701754|P6|Main Period|Adverse Event|2
1425042|NCT01020123|4701755|P5|Main Period|Adverse Event|1
1425043|NCT01020123|4701756|P4|Main Period|Adverse Event|1
1425044|NCT01020123|4701757|P3|Main Period|Adverse Event|2
1425045|NCT01020123|4701758|P2|Main Period|Adverse Event|2
1425046|NCT01020123|4701759|P1|Main Period|Adverse Event|5
1425047|NCT01020123|4701753|P7|Main Period|Eligibility Criteria not fullfilled|0
1425048|NCT01020123|4701754|P6|Main Period|Eligibility Criteria not fullfilled|0
1425049|NCT01020123|4701755|P5|Main Period|Eligibility Criteria not fullfilled|1
1425050|NCT01020123|4701756|P4|Main Period|Eligibility Criteria not fullfilled|0
1425051|NCT01020123|4701757|P3|Main Period|Eligibility Criteria not fullfilled|0
1425052|NCT01020123|4701758|P2|Main Period|Eligibility Criteria not fullfilled|1
1425053|NCT01020123|4701759|P1|Main Period|Eligibility Criteria not fullfilled|0
1425054|NCT01020123|4701753|P7|Main Period|Withdrawal by Subject|2
1425055|NCT01020123|4701754|P6|Main Period|Withdrawal by Subject|3
1425056|NCT01020123|4701755|P5|Main Period|Withdrawal by Subject|6
1425057|NCT01020123|4701756|P4|Main Period|Withdrawal by Subject|1
1425058|NCT01020123|4701757|P3|Main Period|Withdrawal by Subject|3
1425059|NCT01020123|4701758|P2|Main Period|Withdrawal by Subject|5
1425060|NCT01020123|4701759|P1|Main Period|Withdrawal by Subject|6
1425061|NCT01020019|4701954|P2|Overall Study|moving|2
1425062|NCT01020019|4701955|P1|Overall Study|moving|0
1425063|NCT01020019|4701954|P2|Overall Study|not interested in treatment|4
1425064|NCT01020019|4701955|P1|Overall Study|not interested in treatment|4
1425065|NCT01020019|4701954|P2|Overall Study|Adverse Event|5
1425066|NCT01020019|4701955|P1|Overall Study|Adverse Event|1
1425067|NCT01020019|4701954|P2|Overall Study|Lost to Follow-up|18
1425068|NCT01020019|4701955|P1|Overall Study|Lost to Follow-up|21
1425069|NCT01019980|4701976|P2|Overall Study|Drug not available.|0
1425070|NCT01019980|4701977|P1|Overall Study|Drug not available.|2
1425071|NCT01019694|4702040|P3|Overall Study|Other reason (not specified)|6
1425072|NCT01019694|4702041|P2|Overall Study|Other reason (not specified)|5
1425073|NCT01019694|4702042|P1|Overall Study|Other reason (not specified)|1
1425074|NCT01019694|4702040|P3|Overall Study|Not treated|3
1425075|NCT01019694|4702041|P2|Overall Study|Not treated|2
1425076|NCT01019694|4702042|P1|Overall Study|Not treated|0
1425077|NCT01019694|4702040|P3|Overall Study|Withdrawal by Subject|12
1425078|NCT01019694|4702041|P2|Overall Study|Withdrawal by Subject|6
1425079|NCT01019694|4702042|P1|Overall Study|Withdrawal by Subject|4
1425080|NCT01019694|4702040|P3|Overall Study|Lost to Follow-up|3
1425081|NCT01019694|4702041|P2|Overall Study|Lost to Follow-up|3
1425082|NCT01019694|4702042|P1|Overall Study|Lost to Follow-up|5
1425083|NCT01019694|4702040|P3|Overall Study|Protocol Violation|4
1425084|NCT01019694|4702041|P2|Overall Study|Protocol Violation|6
1425085|NCT01019694|4702042|P1|Overall Study|Protocol Violation|2
1425086|NCT01019694|4702040|P3|Overall Study|Adverse Event|19
1425087|NCT01019694|4702041|P2|Overall Study|Adverse Event|16
1425088|NCT01019694|4702042|P1|Overall Study|Adverse Event|12
1425089|NCT01019486|4702167|P3|Overall Study|Withdrawal by Subject|1
1425090|NCT01019486|4702168|P2|Overall Study|Withdrawal by Subject|1
1425091|NCT01019486|4702169|P1|Overall Study|Withdrawal by Subject|1
1425092|NCT01019369|4702183|P2|Overall Study|Withdrawal by Subject|1
1425093|NCT01019369|4702184|P1|Overall Study|Withdrawal by Subject|0
1425094|NCT01019369|4702183|P2|Overall Study|Lost to Follow-up|6
1425095|NCT01019369|4702184|P1|Overall Study|Lost to Follow-up|10
1425096|NCT01019317|4702192|P1|Overall Study|Not Eligible|4
1425097|NCT01019252|4702198|P2|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
1425098|NCT01019252|4702199|P1|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
1425099|NCT01019252|4702198|P2|Wait List Cross-over to CBT for ADHD|Time constraints|2
1425100|NCT01019252|4702199|P1|Wait List Cross-over to CBT for ADHD|Time constraints|0
1425101|NCT01019252|4702198|P2|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
1425102|NCT01019252|4702199|P1|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
1425103|NCT01019252|4702198|P2|Initial CBT for ADHD vs. Wait List|Time constraints|0
1425104|NCT01019252|4702199|P1|Initial CBT for ADHD vs. Wait List|Time constraints|2
1425105|NCT01019135|4702212|P3|Overall Study|Did not attend CR|6
1425106|NCT01019135|4702213|P2|Overall Study|Did not attend CR|13
1425107|NCT01019135|4702214|P1|Overall Study|Did not attend CR|8
1425108|NCT01019135|4702212|P3|Overall Study|Did not receive allocated intervention|25
1425109|NCT01019135|4702213|P2|Overall Study|Did not receive allocated intervention|6
1425110|NCT01019135|4702214|P1|Overall Study|Did not receive allocated intervention|12
1425111|NCT01018992|4702242|P2|Overall Study|Lost to Follow-up|1
1425112|NCT01018992|4702243|P1|Overall Study|Lost to Follow-up|5
1425113|NCT01018992|4702242|P2|Overall Study|Protocol Violation|4
1425114|NCT01018992|4702243|P1|Overall Study|Protocol Violation|0
1425115|NCT01018992|4702242|P2|Overall Study|Withdrawal by Subject|8
1425116|NCT01018992|4702243|P1|Overall Study|Withdrawal by Subject|3
1425117|NCT01018992|4702242|P2|Overall Study|Adverse Event|3
1425118|NCT01018992|4702243|P1|Overall Study|Adverse Event|8
1425119|NCT01018979|4702257|P2|Overall Study|Not received at least one dose|1
1425120|NCT01018979|4702258|P1|Overall Study|Not received at least one dose|0
1425121|NCT01018979|4702257|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
1425122|NCT01018979|4702258|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
1425123|NCT01018953|4702288|P1|Overall Study|Study termination by sponsor|5
1425124|NCT01018953|4702288|P1|Overall Study|Withdrawal by Subject|1
1425125|NCT01018953|4702288|P1|Overall Study|Adverse Event|2
1425126|NCT01018862|4702301|P3|Overall Study|administrative problems|4
1425127|NCT01018862|4702302|P2|Overall Study|administrative problems|4
1425128|NCT01018862|4702303|P1|Overall Study|administrative problems|5
1425129|NCT01018862|4702301|P3|Overall Study|Withdrawal by Subject|1
1425130|NCT01018862|4702302|P2|Overall Study|Withdrawal by Subject|2
1425131|NCT01018862|4702303|P1|Overall Study|Withdrawal by Subject|1
1425132|NCT01018862|4702301|P3|Overall Study|Protocol Violation|3
1425133|NCT01018862|4702302|P2|Overall Study|Protocol Violation|3
1425134|NCT01018862|4702303|P1|Overall Study|Protocol Violation|1
1425135|NCT01018862|4702301|P3|Overall Study|Lost to Follow-up|0
1425136|NCT01018862|4702302|P2|Overall Study|Lost to Follow-up|1
1425137|NCT01018862|4702303|P1|Overall Study|Lost to Follow-up|3
1425138|NCT01018862|4702301|P3|Overall Study|Lack of Efficacy|2
1425139|NCT01018862|4702302|P2|Overall Study|Lack of Efficacy|0
1425140|NCT01018862|4702303|P1|Overall Study|Lack of Efficacy|1
1425141|NCT01018862|4702301|P3|Overall Study|Adverse Event|6
1425142|NCT01018862|4702302|P2|Overall Study|Adverse Event|0
1425143|NCT01018862|4702303|P1|Overall Study|Adverse Event|2
1425144|NCT01018810|4702325|P5|Overall Study|Sponsor Decision|1
1425145|NCT01018810|4702326|P4|Overall Study|Sponsor Decision|1
1425146|NCT01018810|4702327|P3|Overall Study|Sponsor Decision|1
1425147|NCT01018810|4702328|P2|Overall Study|Sponsor Decision|0
1425148|NCT01018810|4702329|P1|Overall Study|Sponsor Decision|2
1425149|NCT01018810|4702325|P5|Overall Study|Withdrawal by Subject|0
1425150|NCT01018810|4702326|P4|Overall Study|Withdrawal by Subject|0
1425151|NCT01018810|4702327|P3|Overall Study|Withdrawal by Subject|0
1425152|NCT01018810|4702328|P2|Overall Study|Withdrawal by Subject|1
1425153|NCT01018810|4702329|P1|Overall Study|Withdrawal by Subject|0
1425154|NCT01018732|4702389|P3|Overall Study|Unable to Classify|1
1425155|NCT01018732|4702390|P2|Overall Study|Unable to Classify|0
1425156|NCT01018732|4702391|P1|Overall Study|Unable to Classify|0
1425157|NCT01018732|4702389|P3|Overall Study|Inappropriate Enrollment|0
1425158|NCT01018732|4702390|P2|Overall Study|Inappropriate Enrollment|1
1425159|NCT01018732|4702391|P1|Overall Study|Inappropriate Enrollment|0
1425160|NCT01018732|4702389|P3|Overall Study|Protocol Violation|0
1425161|NCT01018732|4702390|P2|Overall Study|Protocol Violation|1
1425162|NCT01018732|4702391|P1|Overall Study|Protocol Violation|1
1425163|NCT01018732|4702389|P3|Overall Study|Lost to Follow-up|3
1425164|NCT01018732|4702390|P2|Overall Study|Lost to Follow-up|0
1425165|NCT01018732|4702391|P1|Overall Study|Lost to Follow-up|0
1425166|NCT01018680|4702425|P2|Overall Study|Physician Decision|1
1425167|NCT01018680|4702426|P1|Overall Study|Physician Decision|3
1425168|NCT01018680|4702425|P2|Overall Study|Entry Criteria Not Met|4
1425169|NCT01018680|4702426|P1|Overall Study|Entry Criteria Not Met|1
1425170|NCT01018680|4702425|P2|Overall Study|Lost to Follow-up|3
1425171|NCT01018680|4702426|P1|Overall Study|Lost to Follow-up|5
1425172|NCT01018680|4702425|P2|Overall Study|Lack of Efficacy|2
1425173|NCT01018680|4702426|P1|Overall Study|Lack of Efficacy|8
1425174|NCT01018680|4702425|P2|Overall Study|Sponsor Decision|7
1425175|NCT01018680|4702426|P1|Overall Study|Sponsor Decision|6
1425176|NCT01018680|4702425|P2|Overall Study|Protocol Violation|8
1425177|NCT01018680|4702426|P1|Overall Study|Protocol Violation|5
1425178|NCT01018680|4702425|P2|Overall Study|Withdrawal by Subject|10
1425179|NCT01018680|4702426|P1|Overall Study|Withdrawal by Subject|10
1425180|NCT01018680|4702425|P2|Overall Study|Adverse Event|40
1425181|NCT01018680|4702426|P1|Overall Study|Adverse Event|23
1425182|NCT01020487|4702469|P3|Part 2 Open-label Period|Adverse Event|1
1425183|NCT01020487|4702470|P2|Part 2 Open-label Period|Adverse Event|4
1425184|NCT01020487|4702471|P1|Part 2 Open-label Period|Adverse Event|0
1425185|NCT01020487|4702469|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
1425186|NCT01020487|4702470|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
1425187|NCT01020487|4702471|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
1425188|NCT01020487|4702469|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
1425189|NCT01020487|4702470|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
1425190|NCT01020487|4702471|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
1425191|NCT01020487|4702469|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
1425192|NCT01020487|4702470|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
1425193|NCT01020487|4702471|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
1425194|NCT01020487|4702469|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
1425195|NCT01020487|4702470|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
1425196|NCT01020487|4702471|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
1425197|NCT01018511|4702496|P4|Overall Study|Miscellaneous|0
1425198|NCT01018511|4702497|P3|Overall Study|Miscellaneous|0
1425199|NCT01018511|4702498|P2|Overall Study|Miscellaneous|2
1425200|NCT01018511|4702499|P1|Overall Study|Miscellaneous|0
1425201|NCT01018511|4702496|P4|Overall Study|Protocol Violation|9
1425202|NCT01018511|4702497|P3|Overall Study|Protocol Violation|7
1425203|NCT01018511|4702498|P2|Overall Study|Protocol Violation|8
1425204|NCT01018511|4702499|P1|Overall Study|Protocol Violation|5
1425205|NCT01018511|4702496|P4|Overall Study|Lost to Follow-up|0
1425206|NCT01018511|4702497|P3|Overall Study|Lost to Follow-up|1
1425207|NCT01018511|4702498|P2|Overall Study|Lost to Follow-up|0
1425208|NCT01018511|4702499|P1|Overall Study|Lost to Follow-up|0
1425209|NCT01018511|4702496|P4|Overall Study|Withdrawal by Subject|9
1425210|NCT01018511|4702497|P3|Overall Study|Withdrawal by Subject|11
1425211|NCT01018511|4702498|P2|Overall Study|Withdrawal by Subject|5
1425212|NCT01018511|4702499|P1|Overall Study|Withdrawal by Subject|6
1425213|NCT01018511|4702496|P4|Overall Study|Lack of Efficacy|2
1425214|NCT01018511|4702497|P3|Overall Study|Lack of Efficacy|1
1425215|NCT01018511|4702498|P2|Overall Study|Lack of Efficacy|1
1425216|NCT01018511|4702499|P1|Overall Study|Lack of Efficacy|4
1425217|NCT01018511|4702496|P4|Overall Study|Adverse Event|10
1425218|NCT01018511|4702497|P3|Overall Study|Adverse Event|13
1425219|NCT01018511|4702498|P2|Overall Study|Adverse Event|9
1425220|NCT01018511|4702499|P1|Overall Study|Adverse Event|5
1425221|NCT01018511|4702496|P4|Overall Study|Not fulfilling eligibility criteria|3
1425222|NCT01018511|4702497|P3|Overall Study|Not fulfilling eligibility criteria|7
1425223|NCT01018511|4702498|P2|Overall Study|Not fulfilling eligibility criteria|7
1425224|NCT01018511|4702499|P1|Overall Study|Not fulfilling eligibility criteria|6
1425225|NCT01018394|4702696|P2|Overall Study|Lost to Follow-up|3
1425226|NCT01018394|4702697|P1|Overall Study|Lost to Follow-up|4
1425227|NCT01018394|4702696|P2|Overall Study|Withdrawal by Subject|5
1425228|NCT01018394|4702697|P1|Overall Study|Withdrawal by Subject|5
1425229|NCT01018264|4702707|P2|Overall Study|Lost to Follow-up|1
1425230|NCT01018264|4702708|P1|Overall Study|Lost to Follow-up|0
1425231|NCT01018264|4702707|P2|Overall Study|Withdrawal by Subject|0
1425232|NCT01018264|4702708|P1|Overall Study|Withdrawal by Subject|1
1425233|NCT01018186|4702725|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
1425234|NCT01018186|4702726|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
1425235|NCT01018186|4702727|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
1425236|NCT01018186|4702728|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
1425237|NCT01018186|4702725|P4|52-week Double-blind Treatment Period|Physician Decision|3
1425238|NCT01018186|4702726|P3|52-week Double-blind Treatment Period|Physician Decision|0
1425239|NCT01018186|4702727|P2|52-week Double-blind Treatment Period|Physician Decision|1
1425240|NCT01018186|4702728|P1|52-week Double-blind Treatment Period|Physician Decision|0
1425241|NCT01018186|4702725|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
1425242|NCT01018186|4702726|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
1425243|NCT01018186|4702727|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
1425244|NCT01018186|4702728|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
1425245|NCT01018186|4702725|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
1425246|NCT01018186|4702726|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
1425247|NCT01018186|4702727|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
1425400|NCT01017575|4703088|P3|Overall Study|Lack of Efficacy|0
1425248|NCT01018186|4702728|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
1425249|NCT01018186|4702725|P4|52-week Double-blind Treatment Period|Protocol Violation|2
1425250|NCT01018186|4702726|P3|52-week Double-blind Treatment Period|Protocol Violation|8
1425251|NCT01018186|4702727|P2|52-week Double-blind Treatment Period|Protocol Violation|8
1425252|NCT01018186|4702728|P1|52-week Double-blind Treatment Period|Protocol Violation|0
1425253|NCT01018186|4702725|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
1425254|NCT01018186|4702726|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
1425255|NCT01018186|4702727|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
1425256|NCT01018186|4702728|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
1425257|NCT01018186|4702725|P4|52-week Double-blind Treatment Period|Adverse Event|6
1425258|NCT01018186|4702726|P3|52-week Double-blind Treatment Period|Adverse Event|3
1425259|NCT01018186|4702727|P2|52-week Double-blind Treatment Period|Adverse Event|5
1425260|NCT01018186|4702728|P1|52-week Double-blind Treatment Period|Adverse Event|0
1425261|NCT01018186|4702725|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1425262|NCT01018186|4702726|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1425263|NCT01018186|4702727|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1425264|NCT01018186|4702728|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
1425265|NCT01018186|4702725|P4|2-week Run-in Period|Withdrawal by Subject|0
1425266|NCT01018186|4702726|P3|2-week Run-in Period|Withdrawal by Subject|0
1425267|NCT01018186|4702727|P2|2-week Run-in Period|Withdrawal by Subject|0
1425268|NCT01018186|4702728|P1|2-week Run-in Period|Withdrawal by Subject|11
1425269|NCT01018186|4702725|P4|2-week Run-in Period|Physician Decision|0
1425270|NCT01018186|4702726|P3|2-week Run-in Period|Physician Decision|0
1425271|NCT01018186|4702727|P2|2-week Run-in Period|Physician Decision|0
1425272|NCT01018186|4702728|P1|2-week Run-in Period|Physician Decision|3
1425273|NCT01018186|4702725|P4|2-week Run-in Period|Lost to Follow-up|0
1425274|NCT01018186|4702726|P3|2-week Run-in Period|Lost to Follow-up|0
1425275|NCT01018186|4702727|P2|2-week Run-in Period|Lost to Follow-up|0
1425276|NCT01018186|4702728|P1|2-week Run-in Period|Lost to Follow-up|2
1425277|NCT01018186|4702725|P4|2-week Run-in Period|Protocol Violation|0
1425278|NCT01018186|4702726|P3|2-week Run-in Period|Protocol Violation|0
1425279|NCT01018186|4702727|P2|2-week Run-in Period|Protocol Violation|0
1425280|NCT01018186|4702728|P1|2-week Run-in Period|Protocol Violation|1
1425281|NCT01018030|4702929|P3|Overall Study|Did Not Receive Study Drug|0
1425282|NCT01018030|4702930|P2|Overall Study|Did Not Receive Study Drug|3
1425283|NCT01018030|4702931|P1|Overall Study|Did Not Receive Study Drug|1
1425284|NCT01018030|4702929|P3|Overall Study|Lack of Efficacy|0
1425285|NCT01018030|4702930|P2|Overall Study|Lack of Efficacy|0
1425286|NCT01018030|4702931|P1|Overall Study|Lack of Efficacy|1
1425287|NCT01018030|4702929|P3|Overall Study|Physician Decision|1
1425288|NCT01018030|4702930|P2|Overall Study|Physician Decision|0
1425289|NCT01018030|4702931|P1|Overall Study|Physician Decision|1
1425290|NCT01018030|4702929|P3|Overall Study|Protocol Violation|0
1425291|NCT01018030|4702930|P2|Overall Study|Protocol Violation|1
1425292|NCT01018030|4702931|P1|Overall Study|Protocol Violation|2
1425293|NCT01018030|4702929|P3|Overall Study|Lost to Follow-up|3
1425294|NCT01018030|4702930|P2|Overall Study|Lost to Follow-up|0
1425295|NCT01018030|4702931|P1|Overall Study|Lost to Follow-up|2
1425296|NCT01018030|4702929|P3|Overall Study|Withdrawal by Subject|4
1425297|NCT01018030|4702930|P2|Overall Study|Withdrawal by Subject|2
1425298|NCT01018030|4702931|P1|Overall Study|Withdrawal by Subject|2
1425299|NCT01018030|4702929|P3|Overall Study|Adverse Event|5
1425300|NCT01018030|4702930|P2|Overall Study|Adverse Event|5
1425301|NCT01018030|4702931|P1|Overall Study|Adverse Event|10
1425302|NCT01017952|4702982|P5|52-week, Double-blind Treatment Period|Physician Decision|7
1425303|NCT01017952|4702983|P4|52-week, Double-blind Treatment Period|Physician Decision|9
1425304|NCT01017952|4702984|P3|52-week, Double-blind Treatment Period|Physician Decision|8
1425305|NCT01017952|4702985|P2|52-week, Double-blind Treatment Period|Physician Decision|10
1425306|NCT01017952|4702986|P1|52-week, Double-blind Treatment Period|Physician Decision|0
1425307|NCT01017952|4702982|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
1425308|NCT01017952|4702983|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
1425309|NCT01017952|4702984|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
1425310|NCT01017952|4702985|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
1425311|NCT01017952|4702986|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
1425312|NCT01017952|4702982|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1425313|NCT01017952|4702983|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1425314|NCT01017952|4702984|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
1425315|NCT01017952|4702985|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
1425316|NCT01017952|4702986|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1425317|NCT01017952|4702982|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
1425318|NCT01017952|4702983|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
1425319|NCT01017952|4702984|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
1425320|NCT01017952|4702985|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
1425321|NCT01017952|4702986|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
1425322|NCT01017952|4702982|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
1425323|NCT01017952|4702983|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
1425324|NCT01017952|4702984|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
1425325|NCT01017952|4702985|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
1425326|NCT01017952|4702986|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
1425327|NCT01017952|4702982|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
1425328|NCT01017952|4702983|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
1425329|NCT01017952|4702984|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
1425330|NCT01017952|4702985|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
1425331|NCT01017952|4702986|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
1425332|NCT01017952|4702982|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
1425333|NCT01017952|4702983|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
1425334|NCT01017952|4702984|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
1425335|NCT01017952|4702985|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
1425336|NCT01017952|4702986|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
1425337|NCT01017952|4702982|P5|52-week, Double-blind Treatment Period|Adverse Event|30
1425338|NCT01017952|4702983|P4|52-week, Double-blind Treatment Period|Adverse Event|35
1425339|NCT01017952|4702984|P3|52-week, Double-blind Treatment Period|Adverse Event|32
1425340|NCT01017952|4702985|P2|52-week, Double-blind Treatment Period|Adverse Event|25
1425341|NCT01017952|4702986|P1|52-week, Double-blind Treatment Period|Adverse Event|0
1425342|NCT01017952|4702982|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1425343|NCT01017952|4702983|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1425344|NCT01017952|4702984|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1425345|NCT01017952|4702985|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1425346|NCT01017952|4702986|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
1425347|NCT01017952|4702982|P5|4-week, Open-label Run-In Period|Physician Decision|0
1425348|NCT01017952|4702983|P4|4-week, Open-label Run-In Period|Physician Decision|0
1425349|NCT01017952|4702984|P3|4-week, Open-label Run-In Period|Physician Decision|0
1425350|NCT01017952|4702985|P2|4-week, Open-label Run-In Period|Physician Decision|0
1425351|NCT01017952|4702986|P1|4-week, Open-label Run-In Period|Physician Decision|10
1425352|NCT01017952|4702982|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
1425353|NCT01017952|4702983|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
1425354|NCT01017952|4702984|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
1425355|NCT01017952|4702985|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
1425356|NCT01017952|4702986|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
1425357|NCT01017952|4702982|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
1425358|NCT01017952|4702983|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
1425359|NCT01017952|4702984|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
1425360|NCT01017952|4702985|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
1425361|NCT01017952|4702986|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
1425362|NCT01017952|4702982|P5|4-week, Open-label Run-In Period|Adverse Event|0
1425363|NCT01017952|4702983|P4|4-week, Open-label Run-In Period|Adverse Event|0
1425364|NCT01017952|4702984|P3|4-week, Open-label Run-In Period|Adverse Event|0
1425365|NCT01017952|4702985|P2|4-week, Open-label Run-In Period|Adverse Event|0
1425366|NCT01017952|4702986|P1|4-week, Open-label Run-In Period|Adverse Event|23
1425367|NCT01017952|4702982|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1425368|NCT01017952|4702983|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1425369|NCT01017952|4702984|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1425370|NCT01017952|4702985|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1425371|NCT01017952|4702986|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
1425372|NCT01017874|4703010|P2|Overall Study|Physician Decision|3
1425373|NCT01017874|4703011|P1|Overall Study|Physician Decision|1
1425374|NCT01017874|4703010|P2|Overall Study|Lost to Follow-up|2
1425375|NCT01017874|4703011|P1|Overall Study|Lost to Follow-up|3
1425376|NCT01017874|4703010|P2|Overall Study|Sponsor decision|1
1425377|NCT01017874|4703011|P1|Overall Study|Sponsor decision|3
1425378|NCT01017874|4703010|P2|Overall Study|Withdrawal by Subject|20
1425379|NCT01017874|4703011|P1|Overall Study|Withdrawal by Subject|23
1425380|NCT01017731|4703029|P1|Overall Study|Adverse Event|1
1425381|NCT01017731|4703029|P1|Overall Study|Physician Decision|2
1425382|NCT01017731|4703029|P1|Overall Study|Withdrawal by Subject|3
1425383|NCT01017731|4703029|P1|Overall Study|Lost to Follow-up|2
1425384|NCT01017601|4703058|P2|Overall Study|Withdrawal by Subject|1
1425385|NCT01017601|4703059|P1|Overall Study|Withdrawal by Subject|0
1425386|NCT01017601|4703058|P2|Overall Study|Disease Progression|12
1425387|NCT01017601|4703059|P1|Overall Study|Disease Progression|12
1425388|NCT01017575|4703086|P5|Overall Study|Withdrawal by Subject|0
1425389|NCT01017575|4703087|P4|Overall Study|Withdrawal by Subject|0
1425390|NCT01017575|4703088|P3|Overall Study|Withdrawal by Subject|0
1425391|NCT01017575|4703089|P2|Overall Study|Withdrawal by Subject|0
1425392|NCT01017575|4703090|P1|Overall Study|Withdrawal by Subject|1
1425393|NCT01017575|4703086|P5|Overall Study|Adverse Event|2
1425394|NCT01017575|4703087|P4|Overall Study|Adverse Event|0
1425395|NCT01017575|4703088|P3|Overall Study|Adverse Event|0
1425396|NCT01017575|4703089|P2|Overall Study|Adverse Event|1
1425397|NCT01017575|4703090|P1|Overall Study|Adverse Event|0
1425398|NCT01017575|4703086|P5|Overall Study|Lack of Efficacy|1
1425399|NCT01017575|4703087|P4|Overall Study|Lack of Efficacy|1
1425401|NCT01017575|4703089|P2|Overall Study|Lack of Efficacy|1
1425402|NCT01017575|4703090|P1|Overall Study|Lack of Efficacy|0
1425403|NCT01017549|4703127|P1|One-year Follow-up|Withdrawal by Subject|5
1425404|NCT01017549|4703127|P1|One-year Follow-up|Lost to Follow-up|2
1425405|NCT01017549|4703127|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
1425406|NCT01017263|4703158|P1|Overall Study|not eligible|12
1425407|NCT01017146|4703239|P2|Overall Study|Change in Work Situation|0
1425408|NCT01017146|4703240|P1|Overall Study|Change in Work Situation|1
1425409|NCT01017146|4703239|P2|Overall Study|Did Not Meet Eligibility Criteria|2
1425410|NCT01017146|4703240|P1|Overall Study|Did Not Meet Eligibility Criteria|1
1425411|NCT01017146|4703239|P2|Overall Study|Took Excluded Medication|0
1425412|NCT01017146|4703240|P1|Overall Study|Took Excluded Medication|2
1425413|NCT01017146|4703239|P2|Overall Study|Protocol Violation|0
1425414|NCT01017146|4703240|P1|Overall Study|Protocol Violation|2
1425415|NCT01017146|4703239|P2|Overall Study|Pregnancy|1
1425416|NCT01017146|4703240|P1|Overall Study|Pregnancy|2
1425417|NCT01017146|4703239|P2|Overall Study|Relocation|4
1425418|NCT01017146|4703240|P1|Overall Study|Relocation|0
1425419|NCT01017146|4703239|P2|Overall Study|Withdrawal by Subject|16
1425420|NCT01017146|4703240|P1|Overall Study|Withdrawal by Subject|32
1425421|NCT01017146|4703239|P2|Overall Study|Noncompliance with Study Product|1
1425422|NCT01017146|4703240|P1|Overall Study|Noncompliance with Study Product|1
1425423|NCT01017146|4703239|P2|Overall Study|Lost to Follow-up|14
1425424|NCT01017146|4703240|P1|Overall Study|Lost to Follow-up|14
1425425|NCT01017146|4703239|P2|Overall Study|Adverse Event|1
1425426|NCT01017146|4703240|P1|Overall Study|Adverse Event|11
1425427|NCT01017120|4703278|P2|Overall Study|Parent Unable to Provide Transportation|0
1425428|NCT01017120|4703279|P1|Overall Study|Parent Unable to Provide Transportation|1
1425429|NCT01017120|4703278|P2|Overall Study|Protocol Violation|0
1425430|NCT01017120|4703279|P1|Overall Study|Protocol Violation|1
1425431|NCT01017120|4703278|P2|Overall Study|Relocated Out of Town|2
1425432|NCT01017120|4703279|P1|Overall Study|Relocated Out of Town|0
1425433|NCT01017120|4703278|P2|Overall Study|Did Not Meet Eligibility Criteria|0
1425434|NCT01017120|4703279|P1|Overall Study|Did Not Meet Eligibility Criteria|1
1425435|NCT01017120|4703278|P2|Overall Study|Pregnancy|1
1425436|NCT01017120|4703279|P1|Overall Study|Pregnancy|1
1425437|NCT01017120|4703278|P2|Overall Study|Withdrawal by Subject|21
1425438|NCT01017120|4703279|P1|Overall Study|Withdrawal by Subject|39
1425439|NCT01017120|4703278|P2|Overall Study|Lack of Efficacy|0
1425440|NCT01017120|4703279|P1|Overall Study|Lack of Efficacy|1
1425441|NCT01017120|4703278|P2|Overall Study|Lost to Follow-up|11
1425442|NCT01017120|4703279|P1|Overall Study|Lost to Follow-up|13
1425443|NCT01017120|4703278|P2|Overall Study|Adverse Event|0
1425444|NCT01017120|4703279|P1|Overall Study|Adverse Event|9
1425445|NCT01017029|4703340|P2|Overall Study|Death|1
1425446|NCT01017029|4703341|P1|Overall Study|Death|3
1425447|NCT01017029|4703340|P2|Overall Study|Administrative problem|1
1425448|NCT01017029|4703341|P1|Overall Study|Administrative problem|0
1425449|NCT01017029|4703340|P2|Overall Study|Lost to Follow-up|0
1425450|NCT01017029|4703341|P1|Overall Study|Lost to Follow-up|1
1425451|NCT01016977|4703369|P2|Overall Study|Withdrawal by Subject|2
1425452|NCT01016977|4703370|P1|Overall Study|Withdrawal by Subject|2
1425453|NCT01016977|4703369|P2|Overall Study|Lost to Follow-up|0
1425454|NCT01016977|4703370|P1|Overall Study|Lost to Follow-up|1
1425455|NCT01016964|4703406|P2|Overall Study|Lost to Follow-up|3
1425456|NCT01016964|4703407|P1|Overall Study|Lost to Follow-up|3
1425457|NCT01016912|4703423|P5|Follow-up Period|Other reason|0
1425458|NCT01016912|4703424|P4|Follow-up Period|Other reason|1
1425459|NCT01016912|4703425|P3|Follow-up Period|Other reason|1
1425460|NCT01016912|4703426|P2|Follow-up Period|Other reason|0
1425461|NCT01016912|4703427|P1|Follow-up Period|Other reason|0
1425462|NCT01016912|4703423|P5|End of Treatment Period|Completed double-blind period only|0
1425463|NCT01016912|4703424|P4|End of Treatment Period|Completed double-blind period only|0
1425464|NCT01016912|4703425|P3|End of Treatment Period|Completed double-blind period only|0
1425465|NCT01016912|4703426|P2|End of Treatment Period|Completed double-blind period only|1
1425466|NCT01016912|4703427|P1|End of Treatment Period|Completed double-blind period only|0
1425467|NCT01016912|4703423|P5|End of Treatment Period|Adverse Event|0
1425468|NCT01016912|4703424|P4|End of Treatment Period|Adverse Event|0
1425469|NCT01016912|4703425|P3|End of Treatment Period|Adverse Event|1
1425470|NCT01016912|4703426|P2|End of Treatment Period|Adverse Event|1
1425471|NCT01016912|4703427|P1|End of Treatment Period|Adverse Event|0
1425472|NCT01016912|4703423|P5|End of Treatment Period|Lack of Efficacy|4
1425473|NCT01016912|4703424|P4|End of Treatment Period|Lack of Efficacy|4
1425474|NCT01016912|4703425|P3|End of Treatment Period|Lack of Efficacy|0
1425475|NCT01016912|4703426|P2|End of Treatment Period|Lack of Efficacy|1
1425476|NCT01016912|4703427|P1|End of Treatment Period|Lack of Efficacy|0
1425477|NCT01016600|4703588|P4|Overall Study|Did not start treatment|0
1425478|NCT01016600|4703589|P3|Overall Study|Did not start treatment|0
1425479|NCT01016600|4703590|P2|Overall Study|Did not start treatment|0
1425480|NCT01016600|4703591|P1|Overall Study|Did not start treatment|1
1425481|NCT01016132|4703776|P1|Overall Study|Discomfort|1
1425482|NCT01016067|4703791|P2|Overall Study|Withdrew due to Relocation|1
1425483|NCT01016067|4703792|P1|Overall Study|Withdrew due to Relocation|0
1425484|NCT01016067|4703791|P2|Overall Study|Physician Decision|1
1425485|NCT01016067|4703792|P1|Overall Study|Physician Decision|1
1425486|NCT01016067|4703791|P2|Overall Study|Lost to Follow-up|2
1425487|NCT01016067|4703792|P1|Overall Study|Lost to Follow-up|1
1425488|NCT01016015|4703810|P1|Overall Study|Adverse Event|15
1425489|NCT01016015|4703810|P1|Overall Study|Withdrawal by Subject|1
1425490|NCT01016015|4703810|P1|Overall Study|Not Treated|3
1425491|NCT01015833|4703821|P2|Overall Study|Did not start treatment|0
1425492|NCT01015833|4703822|P1|Overall Study|Did not start treatment|1
1425493|NCT01015833|4703821|P2|Overall Study|Motor Vehicle Accidents|0
1425494|NCT01015833|4703822|P1|Overall Study|Motor Vehicle Accidents|1
1425495|NCT01015833|4703821|P2|Overall Study|Other|1
1425496|NCT01015833|4703822|P1|Overall Study|Other|5
1425497|NCT01015833|4703821|P2|Overall Study|Symptomatic deterioration|1
1425498|NCT01015833|4703822|P1|Overall Study|Symptomatic deterioration|0
1425499|NCT01015833|4703821|P2|Overall Study|Physician Decision|0
1425500|NCT01015833|4703822|P1|Overall Study|Physician Decision|2
1425501|NCT01015833|4703821|P2|Overall Study|Adverse Event|1
1425502|NCT01015833|4703822|P1|Overall Study|Adverse Event|0
1425503|NCT01015833|4703821|P2|Overall Study|Withdrawal by Subject|2
1425504|NCT01015833|4703822|P1|Overall Study|Withdrawal by Subject|3
1425505|NCT01015833|4703821|P2|Overall Study|Death|0
1425506|NCT01015833|4703822|P1|Overall Study|Death|1
1425507|NCT01015820|4703838|P2|Overall Study|Suboptimal measurements|0
1425508|NCT01015820|4703839|P1|Overall Study|Suboptimal measurements|1
1425509|NCT01015703|4703874|P5|Overall Study|Protocol Violation|0
1425510|NCT01015703|4703875|P4|Overall Study|Protocol Violation|0
1425511|NCT01015703|4703876|P3|Overall Study|Protocol Violation|0
1425512|NCT01015703|4703877|P2|Overall Study|Protocol Violation|0
1425513|NCT01015703|4703878|P1|Overall Study|Protocol Violation|1
1425514|NCT01015703|4703874|P5|Overall Study|Adverse Event|0
1425515|NCT01015703|4703875|P4|Overall Study|Adverse Event|0
1425516|NCT01015703|4703876|P3|Overall Study|Adverse Event|0
1425517|NCT01015703|4703877|P2|Overall Study|Adverse Event|0
1425518|NCT01015703|4703878|P1|Overall Study|Adverse Event|1
1425519|NCT01015703|4703874|P5|Overall Study|Withdrawal by Subject|0
1425520|NCT01015703|4703875|P4|Overall Study|Withdrawal by Subject|0
1425521|NCT01015703|4703876|P3|Overall Study|Withdrawal by Subject|0
1425522|NCT01015703|4703877|P2|Overall Study|Withdrawal by Subject|1
1425523|NCT01015703|4703878|P1|Overall Study|Withdrawal by Subject|0
1425524|NCT01015677|4703893|P3|Overall Study|Withdrawal by Subject|0
1425525|NCT01015677|4703894|P2|Overall Study|Withdrawal by Subject|1
1425526|NCT01015677|4703895|P1|Overall Study|Withdrawal by Subject|1
1425527|NCT01015677|4703893|P3|Overall Study|Protocol Violation|0
1425528|NCT01015677|4703894|P2|Overall Study|Protocol Violation|1
1425529|NCT01015677|4703895|P1|Overall Study|Protocol Violation|0
1425530|NCT01015677|4703893|P3|Overall Study|Lack of Efficacy|0
1425531|NCT01015677|4703894|P2|Overall Study|Lack of Efficacy|1
1425532|NCT01015677|4703895|P1|Overall Study|Lack of Efficacy|0
1425533|NCT01015677|4703893|P3|Overall Study|Adverse Event|0
1425534|NCT01015677|4703894|P2|Overall Study|Adverse Event|1
1425535|NCT01015677|4703895|P1|Overall Study|Adverse Event|0
1425536|NCT01015638|4703917|P2|Overall Study|Withdrawal by Subject|0
1425537|NCT01015638|4703918|P1|Overall Study|Withdrawal by Subject|1
1425538|NCT01015560|4703946|P1|Overall Study|Withdrawal by Subject|1
1425539|NCT01015560|4703946|P1|Overall Study|Not protocol specified|1
1425540|NCT01015560|4703946|P1|Overall Study|Adverse Event|1
1425541|NCT01015287|4703995|P2|Overall Study|Protocol Violation|1
1425542|NCT01015287|4703996|P1|Overall Study|Protocol Violation|1
1425543|NCT01015287|4703995|P2|Overall Study|Lost to Follow-up|1
1425544|NCT01015287|4703996|P1|Overall Study|Lost to Follow-up|2
1425545|NCT01015287|4703995|P2|Overall Study|Entry Criteria not Met|14
1425546|NCT01015287|4703996|P1|Overall Study|Entry Criteria not Met|11
1425547|NCT01015287|4703995|P2|Overall Study|Withdrawal by Subject|19
1425548|NCT01015287|4703996|P1|Overall Study|Withdrawal by Subject|14
1425549|NCT01015287|4703995|P2|Overall Study|Physician Decision|21
1425550|NCT01015287|4703996|P1|Overall Study|Physician Decision|19
1425551|NCT01015287|4703995|P2|Overall Study|Sponsor Decision|7
1425552|NCT01015287|4703996|P1|Overall Study|Sponsor Decision|3
1425553|NCT01015287|4703995|P2|Overall Study|Adverse Event|0
1425554|NCT01015287|4703996|P1|Overall Study|Adverse Event|1
1425555|NCT01015287|4703995|P2|Overall Study|Death|16
1425556|NCT01015287|4703996|P1|Overall Study|Death|21
1425557|NCT01015131|4704028|P1|Overall Study|Other Protocol Specified Criteria|4
1425558|NCT01015131|4704028|P1|Overall Study|Withdrawal by Subject|2
1425559|NCT01015131|4704028|P1|Overall Study|Protocol Violation|1
1425560|NCT01015131|4704028|P1|Overall Study|Physician Decision|1
1425561|NCT01015118|4704044|P2|Overall Study|Other than stated above|23
1425562|NCT01015118|4704045|P1|Overall Study|Other than stated above|42
1425563|NCT01015118|4704044|P2|Overall Study|Not treated|5
1425564|NCT01015118|4704045|P1|Overall Study|Not treated|9
1425565|NCT01015118|4704044|P2|Overall Study|Progressive disease|229
1425566|NCT01015118|4704045|P1|Overall Study|Progressive disease|364
1425567|NCT01015118|4704044|P2|Overall Study|Worsening or AE of underlying disease|4
1425568|NCT01015118|4704045|P1|Overall Study|Worsening or AE of underlying disease|5
1425569|NCT01015118|4704044|P2|Overall Study|Other Adverse Event (AE)|33
1425570|NCT01015118|4704045|P1|Overall Study|Other Adverse Event (AE)|141
1425571|NCT01015118|4704044|P2|Overall Study|Withdrawal by Subject|27
1425572|NCT01015118|4704045|P1|Overall Study|Withdrawal by Subject|103
1425573|NCT01015118|4704044|P2|Overall Study|Protocol Violation|6
1425574|NCT01015118|4704045|P1|Overall Study|Protocol Violation|5
1425575|NCT01014988|4704073|P6|Overall Study|Withdrawal by Subject|0
1425576|NCT01014988|4704074|P5|Overall Study|Withdrawal by Subject|0
1425577|NCT01014988|4704075|P4|Overall Study|Withdrawal by Subject|0
1425578|NCT01014988|4704076|P3|Overall Study|Withdrawal by Subject|0
1425579|NCT01014988|4704077|P2|Overall Study|Withdrawal by Subject|0
1425580|NCT01014988|4704078|P1|Overall Study|Withdrawal by Subject|1
1425581|NCT01014988|4704073|P6|Overall Study|Physician Decision|0
1425582|NCT01014988|4704074|P5|Overall Study|Physician Decision|0
1425583|NCT01014988|4704075|P4|Overall Study|Physician Decision|0
1425584|NCT01014988|4704076|P3|Overall Study|Physician Decision|0
1425585|NCT01014988|4704077|P2|Overall Study|Physician Decision|0
1425586|NCT01014988|4704078|P1|Overall Study|Physician Decision|1
1425587|NCT01014988|4704073|P6|Overall Study|Lost to Follow-up|0
1425588|NCT01014988|4704074|P5|Overall Study|Lost to Follow-up|0
1425589|NCT01014988|4704075|P4|Overall Study|Lost to Follow-up|0
1425590|NCT01014988|4704076|P3|Overall Study|Lost to Follow-up|1
1425591|NCT01014988|4704077|P2|Overall Study|Lost to Follow-up|0
1425592|NCT01014988|4704078|P1|Overall Study|Lost to Follow-up|1
1425593|NCT01014988|4704073|P6|Overall Study|Adverse Event|3
1425594|NCT01014988|4704074|P5|Overall Study|Adverse Event|1
1425595|NCT01014988|4704075|P4|Overall Study|Adverse Event|0
1425596|NCT01014988|4704076|P3|Overall Study|Adverse Event|1
1425597|NCT01014988|4704077|P2|Overall Study|Adverse Event|0
1425598|NCT01014988|4704078|P1|Overall Study|Adverse Event|20
1425599|NCT01014975|4704250|P3|Overall Study|Lost to Follow-up|1
1425600|NCT01014975|4704251|P2|Overall Study|Lost to Follow-up|0
1425601|NCT01014975|4704252|P1|Overall Study|Lost to Follow-up|0
1425602|NCT01014975|4704250|P3|Overall Study|Death|4
1425603|NCT01014975|4704251|P2|Overall Study|Death|3
1425604|NCT01014975|4704252|P1|Overall Study|Death|3
1425605|NCT01014975|4704250|P3|Overall Study|Withdrawal by Subject|1
1425606|NCT01014975|4704251|P2|Overall Study|Withdrawal by Subject|0
1425607|NCT01014975|4704252|P1|Overall Study|Withdrawal by Subject|1
1425608|NCT01014910|4704757|P2|Overall Study|Withdrawal by Subject|2
1425609|NCT01014910|4704758|P1|Overall Study|Withdrawal by Subject|0
1425610|NCT01014689|4704802|P2|Overall Study|Pregnancy|0
1425611|NCT01014689|4704803|P1|Overall Study|Pregnancy|1
1425612|NCT01014689|4704802|P2|Overall Study|Lost to Follow-up|7
1425613|NCT01014689|4704803|P1|Overall Study|Lost to Follow-up|3
1425614|NCT01014689|4704802|P2|Overall Study|Protocol Violation|1
1425615|NCT01014689|4704803|P1|Overall Study|Protocol Violation|1
1425616|NCT01014689|4704802|P2|Overall Study|Withdrawal by Subject|4
1425617|NCT01014689|4704803|P1|Overall Study|Withdrawal by Subject|5
1425618|NCT01014689|4704802|P2|Overall Study|Adverse Event|0
1425619|NCT01014689|4704803|P1|Overall Study|Adverse Event|3
1425620|NCT01014689|4704802|P2|Overall Study|Lack of Efficacy|1
1425621|NCT01014689|4704803|P1|Overall Study|Lack of Efficacy|0
1425622|NCT01014585|4704838|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
1425623|NCT01014585|4704839|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
1425624|NCT01014585|4704840|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
1425625|NCT01014585|4704841|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
1425626|NCT01014585|4704838|P4|Overall Study|Lost to Follow-up|2
1425627|NCT01014585|4704839|P3|Overall Study|Lost to Follow-up|0
1425628|NCT01014585|4704840|P2|Overall Study|Lost to Follow-up|0
1425629|NCT01014585|4704841|P1|Overall Study|Lost to Follow-up|0
1425630|NCT01014585|4704838|P4|Overall Study|Withdrawal by Subject|3
1425631|NCT01014585|4704839|P3|Overall Study|Withdrawal by Subject|1
1425632|NCT01014585|4704840|P2|Overall Study|Withdrawal by Subject|0
1425633|NCT01014585|4704841|P1|Overall Study|Withdrawal by Subject|2
1425634|NCT01014585|4704838|P4|Overall Study|Adverse Event|3
1425635|NCT01014585|4704839|P3|Overall Study|Adverse Event|0
1425636|NCT01014585|4704840|P2|Overall Study|Adverse Event|2
1425637|NCT01014585|4704841|P1|Overall Study|Adverse Event|0
1425638|NCT01014533|4704861|P2|Overall Study|unable to come to appointment|3
1425639|NCT01014533|4704862|P1|Overall Study|unable to come to appointment|0
1425640|NCT01014533|4704861|P2|Overall Study|Withdrawal by Subject|0
1425641|NCT01014533|4704862|P1|Overall Study|Withdrawal by Subject|2
1425642|NCT01014533|4704861|P2|Overall Study|Protocol Violation|2
1425643|NCT01014533|4704862|P1|Overall Study|Protocol Violation|3
1425644|NCT01014442|4704883|P2|Overall Study|Unspecified Reason|1
1425645|NCT01014442|4704884|P1|Overall Study|Unspecified Reason|1
1425646|NCT01014442|4704883|P2|Overall Study|Lack of Compliance|1
1425647|NCT01014442|4704884|P1|Overall Study|Lack of Compliance|0
1425648|NCT01014442|4704883|P2|Overall Study|Protocol Violation|5
1425649|NCT01014442|4704884|P1|Overall Study|Protocol Violation|2
1425650|NCT01014442|4704883|P2|Overall Study|Withdrawal by Subject|4
1425651|NCT01014442|4704884|P1|Overall Study|Withdrawal by Subject|4
1425652|NCT01014442|4704883|P2|Overall Study|Adverse Event|8
1425653|NCT01014442|4704884|P1|Overall Study|Adverse Event|0
1425654|NCT01014208|4705004|P2|Overall Study|Study Closed/terminated|83
1425655|NCT01014208|4705005|P1|Overall Study|Study Closed/terminated|78
1425656|NCT01014208|4705004|P2|Overall Study|Did Not Receive Study Drug|0
1425657|NCT01014208|4705005|P1|Overall Study|Did Not Receive Study Drug|2
1425658|NCT01014208|4705004|P2|Overall Study|Participant Withdrew Consent|12
1425659|NCT01014208|4705005|P1|Overall Study|Participant Withdrew Consent|12
1425660|NCT01014208|4705004|P2|Overall Study|Lost to Follow-up|5
1425661|NCT01014208|4705005|P1|Overall Study|Lost to Follow-up|2
1425662|NCT01014143|4705047|P3|Second Intervention|Lost to Follow-up|0
1425663|NCT01014143|4705048|P2|Second Intervention|Lost to Follow-up|0
1425664|NCT01014143|4705049|P1|Second Intervention|Lost to Follow-up|2
1425665|NCT01014013|4705144|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
1425666|NCT01014013|4705145|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
1425667|NCT01014013|4705144|P2|Overall Study|Appendectomy|0
1425668|NCT01014013|4705145|P1|Overall Study|Appendectomy|1
1425669|NCT01014013|4705144|P2|Overall Study|Another antibiotic therapy required|1
1425670|NCT01014013|4705145|P1|Overall Study|Another antibiotic therapy required|0
1425671|NCT01014013|4705144|P2|Overall Study|Physician Decision|1
1425672|NCT01014013|4705145|P1|Overall Study|Physician Decision|0
1425673|NCT01014013|4705144|P2|Overall Study|Pathogen resistant|4
1425674|NCT01014013|4705145|P1|Overall Study|Pathogen resistant|7
1425675|NCT01014013|4705144|P2|Overall Study|Negative urine culture|0
1425676|NCT01014013|4705145|P1|Overall Study|Negative urine culture|2
1425677|NCT01014013|4705144|P2|Overall Study|Pathogen culture = no growth|34
1425678|NCT01014013|4705145|P1|Overall Study|Pathogen culture = no growth|26
1425679|NCT01014013|4705144|P2|Overall Study|Clinical/microbiologic failure|2
1425680|NCT01014013|4705145|P1|Overall Study|Clinical/microbiologic failure|1
1425681|NCT01014013|4705144|P2|Overall Study|Withdrawal by Subject|4
1425682|NCT01014013|4705145|P1|Overall Study|Withdrawal by Subject|7
1425683|NCT01014013|4705144|P2|Overall Study|Protocol Violation|3
1425684|NCT01014013|4705145|P1|Overall Study|Protocol Violation|1
1425685|NCT01014013|4705144|P2|Overall Study|Laboratory adverse experience|1
1425686|NCT01014013|4705145|P1|Overall Study|Laboratory adverse experience|1
1425687|NCT01014013|4705144|P2|Overall Study|Clinical adverse experience|2
1425688|NCT01014013|4705145|P1|Overall Study|Clinical adverse experience|4
1425689|NCT01014013|4705144|P2|Overall Study|Inclusion/Exclusion criteria not met|3
1425690|NCT01014013|4705145|P1|Overall Study|Inclusion/Exclusion criteria not met|1
1425691|NCT01013961|4705157|P2|Overall Study|Physician Decision|1
1425692|NCT01013961|4705158|P1|Overall Study|Physician Decision|0
1425693|NCT01013961|4705157|P2|Overall Study|Withdrawal by Subject|0
1425694|NCT01013961|4705158|P1|Overall Study|Withdrawal by Subject|1
1425695|NCT01013961|4705157|P2|Overall Study|Adverse Event|2
1425696|NCT01013961|4705158|P1|Overall Study|Adverse Event|2
1425697|NCT01013883|4705176|P2|Overall Study|Lost to Follow-up|2
1425698|NCT01013883|4705177|P1|Overall Study|Lost to Follow-up|2
1425699|NCT01013870|4705189|P2|Overall Study|Lost to Follow-up|3
1425700|NCT01013870|4705190|P1|Overall Study|Lost to Follow-up|1
1425701|NCT01013792|4705239|P2|Overall Study|Lost to Follow-up|1
1425702|NCT01013792|4705240|P1|Overall Study|Lost to Follow-up|0
1425703|NCT01013792|4705239|P2|Overall Study|Adverse Event|3
1425704|NCT01013792|4705240|P1|Overall Study|Adverse Event|0
1425705|NCT01013792|4705239|P2|Overall Study|Study suspended|1
1425706|NCT01013792|4705240|P1|Overall Study|Study suspended|2
1425707|NCT01013753|4705246|P1|Overall Study|Other|2
1425708|NCT01013753|4705246|P1|Overall Study|Withdrawal by Subject|2
1425709|NCT01013753|4705246|P1|Overall Study|Lost to Follow-up|1
1425710|NCT01013753|4705246|P1|Overall Study|Protocol Violation|3
1425711|NCT01013753|4705246|P1|Overall Study|Adverse Event|8
1425712|NCT01013740|4705442|P2|Overall Study|Ongoing: Study records not completed|2
1425713|NCT01013740|4705443|P1|Overall Study|Ongoing: Study records not completed|0
1425714|NCT01013740|4705442|P2|Overall Study|Missing|1
1425715|NCT01013740|4705443|P1|Overall Study|Missing|2
1425716|NCT01013740|4705442|P2|Overall Study|study close / terminated : done in error|1
1425717|NCT01013740|4705443|P1|Overall Study|study close / terminated : done in error|2
1425718|NCT01013740|4705442|P2|Overall Study|Withdrawal by Subject|10
1425719|NCT01013740|4705443|P1|Overall Study|Withdrawal by Subject|2
1425720|NCT01013740|4705442|P2|Overall Study|Physician Decision|0
1425721|NCT01013740|4705443|P1|Overall Study|Physician Decision|2
1425722|NCT01013740|4705442|P2|Overall Study|Lost to Follow-up|5
1425723|NCT01013740|4705443|P1|Overall Study|Lost to Follow-up|3
1425724|NCT01013701|4705467|P1|Overall Study|study prematurely terminated|7
1425725|NCT01013597|4705474|P1|Overall Study|Withdrawal by Subject|1
1425726|NCT01013207|4705484|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
1425727|NCT01012999|4705502|P1|Overall Study|Protocol Violation|1
1425728|NCT01012973|4705508|P2|Overall Study|Withdrawal by Subject|6
1425729|NCT01012973|4705509|P1|Overall Study|Withdrawal by Subject|4
1425730|NCT01012973|4705508|P2|Overall Study|Protocol Violation|2
1425731|NCT01012973|4705509|P1|Overall Study|Protocol Violation|5
1425732|NCT01012973|4705508|P2|Overall Study|Increase in vis. acuity, never injected|1
1425733|NCT01012973|4705509|P1|Overall Study|Increase in vis. acuity, never injected|0
1425734|NCT01012973|4705508|P2|Overall Study|(Overseas travel - indefinite period)|0
1425735|NCT01012973|4705509|P1|Overall Study|(Overseas travel - indefinite period)|1
1425736|NCT01012973|4705508|P2|Overall Study|Lost to Follow-up|0
1425737|NCT01012973|4705509|P1|Overall Study|Lost to Follow-up|1
1425738|NCT01012973|4705508|P2|Overall Study|Lack of Efficacy|5
1425739|NCT01012973|4705509|P1|Overall Study|Lack of Efficacy|0
1425740|NCT01012973|4705508|P2|Overall Study|Adverse Event|5
1425741|NCT01012973|4705509|P1|Overall Study|Adverse Event|5
1425742|NCT01012947|4705534|P5|Overall Study|Lost to Follow-up|142
1425743|NCT01012947|4705535|P4|Overall Study|Lost to Follow-up|118
1425744|NCT01012947|4705536|P3|Overall Study|Lost to Follow-up|130
1425745|NCT01012947|4705537|P2|Overall Study|Lost to Follow-up|135
1425746|NCT01012947|4705538|P1|Overall Study|Lost to Follow-up|131
1425747|NCT01012765|4705559|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
1425748|NCT01012765|4705560|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
1425749|NCT01012765|4705561|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
1425750|NCT01012765|4705562|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
1425751|NCT01012765|4705563|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
1425752|NCT01012765|4705564|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
1425753|NCT01012765|4705559|P6|Treatment Period 2|Adverse Event|0
1425754|NCT01012765|4705560|P5|Treatment Period 2|Adverse Event|0
1425755|NCT01012765|4705561|P4|Treatment Period 2|Adverse Event|0
1425756|NCT01012765|4705562|P3|Treatment Period 2|Adverse Event|1
1425757|NCT01012765|4705563|P2|Treatment Period 2|Adverse Event|1
1425758|NCT01012765|4705564|P1|Treatment Period 2|Adverse Event|0
1425759|NCT01012765|4705559|P6|Treatment Period 2|Abnormal laboratory value(s)|1
1425760|NCT01012765|4705560|P5|Treatment Period 2|Abnormal laboratory value(s)|0
1425761|NCT01012765|4705561|P4|Treatment Period 2|Abnormal laboratory value(s)|0
1425762|NCT01012765|4705562|P3|Treatment Period 2|Abnormal laboratory value(s)|0
1425763|NCT01012765|4705563|P2|Treatment Period 2|Abnormal laboratory value(s)|0
1425764|NCT01012765|4705564|P1|Treatment Period 2|Abnormal laboratory value(s)|0
1425765|NCT01012765|4705559|P6|Treatment Period 2|Withdrawal by Subject|0
1425766|NCT01012765|4705560|P5|Treatment Period 2|Withdrawal by Subject|1
1425767|NCT01012765|4705561|P4|Treatment Period 2|Withdrawal by Subject|0
1425768|NCT01012765|4705562|P3|Treatment Period 2|Withdrawal by Subject|1
1425769|NCT01012765|4705563|P2|Treatment Period 2|Withdrawal by Subject|0
1425770|NCT01012765|4705564|P1|Treatment Period 2|Withdrawal by Subject|1
1425771|NCT01012765|4705559|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
1425772|NCT01012765|4705560|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
1425773|NCT01012765|4705561|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
1425774|NCT01012765|4705562|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
1425775|NCT01012765|4705563|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
1425776|NCT01012765|4705564|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
1425777|NCT01012765|4705559|P6|Treatment Period 1|Protocol Violation|0
1425778|NCT01012765|4705560|P5|Treatment Period 1|Protocol Violation|1
1425779|NCT01012765|4705561|P4|Treatment Period 1|Protocol Violation|2
1425780|NCT01012765|4705562|P3|Treatment Period 1|Protocol Violation|0
1425781|NCT01012765|4705563|P2|Treatment Period 1|Protocol Violation|0
1425782|NCT01012765|4705564|P1|Treatment Period 1|Protocol Violation|0
1425783|NCT01012765|4705559|P6|Treatment Period 1|Administrative problems|0
1425784|NCT01012765|4705560|P5|Treatment Period 1|Administrative problems|1
1425785|NCT01012765|4705561|P4|Treatment Period 1|Administrative problems|1
1425786|NCT01012765|4705562|P3|Treatment Period 1|Administrative problems|1
1425787|NCT01012765|4705563|P2|Treatment Period 1|Administrative problems|0
1425788|NCT01012765|4705564|P1|Treatment Period 1|Administrative problems|0
1425789|NCT01012765|4705559|P6|Treatment Period 1|Withdrawal by Subject|0
1425790|NCT01012765|4705560|P5|Treatment Period 1|Withdrawal by Subject|0
1425791|NCT01012765|4705561|P4|Treatment Period 1|Withdrawal by Subject|0
1425792|NCT01012765|4705562|P3|Treatment Period 1|Withdrawal by Subject|0
1425793|NCT01012765|4705563|P2|Treatment Period 1|Withdrawal by Subject|0
1425794|NCT01012765|4705564|P1|Treatment Period 1|Withdrawal by Subject|2
1425795|NCT01012765|4705559|P6|Treatment Period 1|Adverse Event|0
1425796|NCT01012765|4705560|P5|Treatment Period 1|Adverse Event|0
1425797|NCT01012765|4705561|P4|Treatment Period 1|Adverse Event|0
1425798|NCT01012765|4705562|P3|Treatment Period 1|Adverse Event|1
1425799|NCT01012765|4705563|P2|Treatment Period 1|Adverse Event|0
1425800|NCT01012765|4705564|P1|Treatment Period 1|Adverse Event|1
1425801|NCT01012739|4705593|P4|Treatment Period 2|Abnormal test procedure results|1
1425802|NCT01012739|4705594|P3|Treatment Period 2|Abnormal test procedure results|0
1425803|NCT01012739|4705595|P2|Treatment Period 2|Abnormal test procedure results|0
1425804|NCT01012739|4705596|P1|Treatment Period 2|Abnormal test procedure results|0
1425805|NCT01012739|4705593|P4|Treatment Period 1|Adverse Event|1
1425806|NCT01012739|4705594|P3|Treatment Period 1|Adverse Event|0
1425807|NCT01012739|4705595|P2|Treatment Period 1|Adverse Event|0
1425808|NCT01012739|4705596|P1|Treatment Period 1|Adverse Event|0
1425809|NCT01012713|4705624|P1|Overall Study|Lack of Efficacy|3
1425810|NCT01012622|4705650|P1|Overall Study|withdrawal of consent by a parent|2
1425811|NCT01012622|4705650|P1|Overall Study|screening failure|1
1425812|NCT01012622|4705650|P1|Overall Study|Other|1
1425813|NCT01012622|4705650|P1|Overall Study|non-compliance with the drug|9
1425814|NCT01012622|4705650|P1|Overall Study|Adverse Event|7
1425815|NCT01012622|4705650|P1|Overall Study|Lost to Follow-up|5
1425816|NCT01012622|4705650|P1|Overall Study|Withdrawal by Subject|6
1425817|NCT01012440|4705674|P1|Overall Study|Withdrawal by Subject|2
1425818|NCT01012414|4705678|P1|Overall Study|Trial was stopped before completed|7
1425819|NCT01012414|4705678|P1|Overall Study|Lost to Follow-up|1
1425820|NCT01012414|4705678|P1|Overall Study|Withdrawal by Subject|2
1425821|NCT01012323|4705719|P1|Overall Study|Investigator Judgment|1
1425822|NCT01012258|4705756|P1|Overall Study|Ongoing|29
1425823|NCT01012258|4705756|P1|Overall Study|Another Tumor Discovered|1
1425824|NCT01012258|4705756|P1|Overall Study|Another Anti-cancer Drug Received|1
1425825|NCT01012258|4705756|P1|Overall Study|Symptomatic Deterioration|1
1425826|NCT01012258|4705756|P1|Overall Study|Progressive Disease (PD)|18
1425827|NCT01012258|4705756|P1|Overall Study|Adverse Event|1
1425828|NCT01012258|4705756|P1|Overall Study|Lost to Follow-up|1
1425829|NCT01012258|4705756|P1|Overall Study|Death|14
1425830|NCT01012219|4705803|P1|Period 2|Withdrawal by Subject|1
1425831|NCT01012219|4705803|P1|Period 1|Withdrawal by Subject|1
1425832|NCT01012037|4706094|P3|Overall Study|Other reason (not specified)|1
1425833|NCT01012037|4706095|P2|Overall Study|Other reason (not specified)|1
1425834|NCT01012037|4706096|P1|Overall Study|Other reason (not specified)|1
1425835|NCT01012037|4706094|P3|Overall Study|Withdrawal by Subject|1
1425836|NCT01012037|4706095|P2|Overall Study|Withdrawal by Subject|4
1425837|NCT01012037|4706096|P1|Overall Study|Withdrawal by Subject|0
1425838|NCT01012037|4706094|P3|Overall Study|Protocol Violation|5
1425839|NCT01012037|4706095|P2|Overall Study|Protocol Violation|3
1425840|NCT01012037|4706096|P1|Overall Study|Protocol Violation|0
1425841|NCT01012037|4706094|P3|Overall Study|Adverse Event|3
1425842|NCT01012037|4706095|P2|Overall Study|Adverse Event|8
1425843|NCT01012037|4706096|P1|Overall Study|Adverse Event|0
1425844|NCT01011946|4706131|P1|Overall Study|No pathological lab value|1
1425845|NCT01011946|4706131|P1|Overall Study|Transferred to another hospital|2
1425846|NCT01011933|4706135|P1|Overall Study|Never treated|1
1425847|NCT01011933|4706135|P1|Overall Study|Inadequate pathology|1
1425848|NCT01011933|4706135|P1|Overall Study|Improper pre-protocol Rx|1
1425849|NCT01011933|4706135|P1|Overall Study|Wrong cell type|1
1425850|NCT01011907|4706152|P2|Overall Study|Adverse Event|4
1425851|NCT01011907|4706153|P1|Overall Study|Adverse Event|1
1425852|NCT01011907|4706152|P2|Overall Study|Withdrawal by Subject|11
1425853|NCT01011907|4706153|P1|Overall Study|Withdrawal by Subject|13
1425854|NCT01011868|4706170|P3|After Week 78 Follow-up|Other reason not defined above|16
1425855|NCT01011868|4706171|P2|After Week 78 Follow-up|Other reason not defined above|5
1425856|NCT01011868|4706172|P1|After Week 78 Follow-up|Other reason not defined above|5
1425857|NCT01011868|4706170|P3|After Week 78 Follow-up|Withdrawal by Subject|1
1425858|NCT01011868|4706171|P2|After Week 78 Follow-up|Withdrawal by Subject|8
1425859|NCT01011868|4706172|P1|After Week 78 Follow-up|Withdrawal by Subject|9
1425860|NCT01011868|4706170|P3|After Week 78 Follow-up|Lost to Follow-up|4
1425861|NCT01011868|4706171|P2|After Week 78 Follow-up|Lost to Follow-up|6
1425862|NCT01011868|4706172|P1|After Week 78 Follow-up|Lost to Follow-up|11
1425863|NCT01011868|4706170|P3|After Week 78 Follow-up|Protocol Violation|2
1425864|NCT01011868|4706171|P2|After Week 78 Follow-up|Protocol Violation|1
1425865|NCT01011868|4706172|P1|After Week 78 Follow-up|Protocol Violation|9
1425866|NCT01011868|4706170|P3|After Week 78 Follow-up|Lack of Efficacy|0
1425867|NCT01011868|4706171|P2|After Week 78 Follow-up|Lack of Efficacy|0
1425868|NCT01011868|4706172|P1|After Week 78 Follow-up|Lack of Efficacy|4
1425869|NCT01011868|4706170|P3|After Week 78 Follow-up|Adverse Event|21
1425870|NCT01011868|4706171|P2|After Week 78 Follow-up|Adverse Event|18
1425871|NCT01011868|4706172|P1|After Week 78 Follow-up|Adverse Event|14
1425872|NCT01011868|4706170|P3|After Week 18 Follow-up|Other reason not defined above|12
1425873|NCT01011868|4706171|P2|After Week 18 Follow-up|Other reason not defined above|3
1425874|NCT01011868|4706172|P1|After Week 18 Follow-up|Other reason not defined above|2
1425875|NCT01011868|4706170|P3|After Week 18 Follow-up|Withdrawal by Subject|0
1425876|NCT01011868|4706171|P2|After Week 18 Follow-up|Withdrawal by Subject|3
1425877|NCT01011868|4706172|P1|After Week 18 Follow-up|Withdrawal by Subject|6
1425878|NCT01011868|4706170|P3|After Week 18 Follow-up|Lost to Follow-up|0
1425879|NCT01011868|4706171|P2|After Week 18 Follow-up|Lost to Follow-up|3
1425880|NCT01011868|4706172|P1|After Week 18 Follow-up|Lost to Follow-up|5
1425881|NCT01011868|4706170|P3|After Week 18 Follow-up|Protocol Violation|1
1425882|NCT01011868|4706171|P2|After Week 18 Follow-up|Protocol Violation|1
1425883|NCT01011868|4706172|P1|After Week 18 Follow-up|Protocol Violation|1
1425884|NCT01011868|4706170|P3|After Week 18 Follow-up|Lack of Efficacy|0
1425885|NCT01011868|4706171|P2|After Week 18 Follow-up|Lack of Efficacy|0
1425886|NCT01011868|4706172|P1|After Week 18 Follow-up|Lack of Efficacy|1
1425887|NCT01011868|4706170|P3|After Week 18 Follow-up|Adverse Event|13
1425888|NCT01011868|4706171|P2|After Week 18 Follow-up|Adverse Event|6
1425889|NCT01011868|4706172|P1|After Week 18 Follow-up|Adverse Event|8
1425890|NCT01011738|4706234|P3|Overall Study|Unknown reasons|17
1425891|NCT01011738|4706235|P2|Overall Study|Unknown reasons|291
1425892|NCT01011738|4706236|P1|Overall Study|Unknown reasons|312
1425893|NCT01011738|4706234|P3|Overall Study|Death|0
1425894|NCT01011738|4706235|P2|Overall Study|Death|3
1425895|NCT01011738|4706236|P1|Overall Study|Death|12
1425896|NCT01011673|4706276|P2|24 Hour Follow-up|Lost to Follow-up|3
1425897|NCT01011673|4706277|P1|24 Hour Follow-up|Lost to Follow-up|3
1425898|NCT01011673|4706276|P2|Randomized|Secondary headache|1
1425899|NCT01011673|4706277|P1|Randomized|Secondary headache|2
1425900|NCT01011556|4706300|P4|Overall Study|Inclusion/exclusion criteria not met|5
1425901|NCT01011556|4706301|P3|Overall Study|Inclusion/exclusion criteria not met|3
1425902|NCT01011556|4706302|P2|Overall Study|Inclusion/exclusion criteria not met|1
1425903|NCT01011556|4706303|P1|Overall Study|Inclusion/exclusion criteria not met|2
1425904|NCT01011556|4706300|P4|Overall Study|Sponsor decision|2
1425905|NCT01011556|4706301|P3|Overall Study|Sponsor decision|1
1425906|NCT01011556|4706302|P2|Overall Study|Sponsor decision|1
1425907|NCT01011556|4706303|P1|Overall Study|Sponsor decision|0
1425908|NCT01011556|4706300|P4|Overall Study|Withdrawal by Subject|4
1425909|NCT01011556|4706301|P3|Overall Study|Withdrawal by Subject|4
1425910|NCT01011556|4706302|P2|Overall Study|Withdrawal by Subject|2
1425911|NCT01011556|4706303|P1|Overall Study|Withdrawal by Subject|1
1425912|NCT01011556|4706300|P4|Overall Study|Protocol Violation|0
1425913|NCT01011556|4706301|P3|Overall Study|Protocol Violation|0
1425914|NCT01011556|4706302|P2|Overall Study|Protocol Violation|1
1425915|NCT01011556|4706303|P1|Overall Study|Protocol Violation|0
1425916|NCT01011556|4706300|P4|Overall Study|Physician Decision|1
1425917|NCT01011556|4706301|P3|Overall Study|Physician Decision|0
1425918|NCT01011556|4706302|P2|Overall Study|Physician Decision|0
1425919|NCT01011556|4706303|P1|Overall Study|Physician Decision|1
1425920|NCT01011556|4706300|P4|Overall Study|Lost to Follow-up|0
1425921|NCT01011556|4706301|P3|Overall Study|Lost to Follow-up|0
1425922|NCT01011556|4706302|P2|Overall Study|Lost to Follow-up|0
1425923|NCT01011556|4706303|P1|Overall Study|Lost to Follow-up|1
1425924|NCT01011556|4706300|P4|Overall Study|Adverse Event|1
1425925|NCT01011556|4706301|P3|Overall Study|Adverse Event|2
1425926|NCT01011556|4706302|P2|Overall Study|Adverse Event|3
1425927|NCT01011556|4706303|P1|Overall Study|Adverse Event|1
1425928|NCT01011465|4706381|P8|Overall Study|Withdrawal by Subject|0
1425929|NCT01011465|4706382|P7|Overall Study|Withdrawal by Subject|1
1425930|NCT01011465|4706383|P6|Overall Study|Withdrawal by Subject|0
1425931|NCT01011465|4706384|P5|Overall Study|Withdrawal by Subject|1
1425932|NCT01011465|4706385|P4|Overall Study|Withdrawal by Subject|0
1425933|NCT01011465|4706386|P3|Overall Study|Withdrawal by Subject|0
1425934|NCT01011465|4706387|P2|Overall Study|Withdrawal by Subject|1
1425935|NCT01011465|4706388|P1|Overall Study|Withdrawal by Subject|2
1425936|NCT01011387|4706416|P1|Overall Study|Protocol Violation|1
1425937|NCT01011387|4706416|P1|Overall Study|Adverse Event|2
1425938|NCT01011387|4706416|P1|Overall Study|Withdrawal by Subject|3
1425939|NCT01011335|4706424|P13|Overall Study|Adverse Event|1
1425940|NCT01011335|4706425|P12|Overall Study|Adverse Event|0
1425941|NCT01011335|4706426|P11|Overall Study|Adverse Event|4
1425942|NCT01011335|4706427|P10|Overall Study|Adverse Event|0
1425943|NCT01011335|4706428|P9|Overall Study|Adverse Event|0
1425944|NCT01011335|4706429|P8|Overall Study|Adverse Event|0
1425945|NCT01011335|4706430|P7|Overall Study|Adverse Event|0
1425946|NCT01011335|4706431|P6|Overall Study|Adverse Event|0
1425947|NCT01011335|4706432|P5|Overall Study|Adverse Event|0
1425948|NCT01011335|4706433|P4|Overall Study|Adverse Event|0
1425949|NCT01011335|4706434|P3|Overall Study|Adverse Event|0
1425950|NCT01011335|4706435|P2|Overall Study|Adverse Event|0
1425951|NCT01011335|4706436|P1|Overall Study|Adverse Event|0
1425952|NCT01011335|4706424|P13|Overall Study|Moved/deployed or no booster|0
1425953|NCT01011335|4706425|P12|Overall Study|Moved/deployed or no booster|0
1425954|NCT01011335|4706426|P11|Overall Study|Moved/deployed or no booster|2
1425955|NCT01011335|4706427|P10|Overall Study|Moved/deployed or no booster|0
1425956|NCT01011335|4706428|P9|Overall Study|Moved/deployed or no booster|1
1425957|NCT01011335|4706429|P8|Overall Study|Moved/deployed or no booster|0
1425958|NCT01011335|4706430|P7|Overall Study|Moved/deployed or no booster|1
1425959|NCT01011335|4706431|P6|Overall Study|Moved/deployed or no booster|0
1425960|NCT01011335|4706432|P5|Overall Study|Moved/deployed or no booster|0
1425961|NCT01011335|4706433|P4|Overall Study|Moved/deployed or no booster|1
1425962|NCT01011335|4706434|P3|Overall Study|Moved/deployed or no booster|0
1425963|NCT01011335|4706435|P2|Overall Study|Moved/deployed or no booster|0
1425964|NCT01011335|4706436|P1|Overall Study|Moved/deployed or no booster|1
1425965|NCT01011335|4706424|P13|Overall Study|Protocol Violation|0
1425966|NCT01011335|4706425|P12|Overall Study|Protocol Violation|0
1425967|NCT01011335|4706426|P11|Overall Study|Protocol Violation|0
1425968|NCT01011335|4706427|P10|Overall Study|Protocol Violation|0
1425969|NCT01011335|4706428|P9|Overall Study|Protocol Violation|0
1425970|NCT01011335|4706429|P8|Overall Study|Protocol Violation|0
1425971|NCT01011335|4706430|P7|Overall Study|Protocol Violation|0
1425972|NCT01011335|4706431|P6|Overall Study|Protocol Violation|0
1425973|NCT01011335|4706432|P5|Overall Study|Protocol Violation|0
1425974|NCT01011335|4706433|P4|Overall Study|Protocol Violation|0
1425975|NCT01011335|4706434|P3|Overall Study|Protocol Violation|0
1425976|NCT01011335|4706435|P2|Overall Study|Protocol Violation|1
1425977|NCT01011335|4706436|P1|Overall Study|Protocol Violation|0
1425978|NCT01011335|4706424|P13|Overall Study|Lost to Follow-up|2
1425979|NCT01011335|4706425|P12|Overall Study|Lost to Follow-up|1
1425980|NCT01011335|4706426|P11|Overall Study|Lost to Follow-up|0
1425981|NCT01011335|4706427|P10|Overall Study|Lost to Follow-up|0
1425982|NCT01011335|4706428|P9|Overall Study|Lost to Follow-up|1
1425983|NCT01011335|4706429|P8|Overall Study|Lost to Follow-up|2
1425984|NCT01011335|4706430|P7|Overall Study|Lost to Follow-up|2
1425985|NCT01011335|4706431|P6|Overall Study|Lost to Follow-up|1
1425986|NCT01011335|4706432|P5|Overall Study|Lost to Follow-up|1
1425987|NCT01011335|4706433|P4|Overall Study|Lost to Follow-up|1
1425988|NCT01011335|4706434|P3|Overall Study|Lost to Follow-up|1
1425989|NCT01011335|4706435|P2|Overall Study|Lost to Follow-up|0
1425990|NCT01011335|4706436|P1|Overall Study|Lost to Follow-up|0
1425991|NCT01011309|4706476|P3|Overall Study|Protocol Violation|3
1425992|NCT01011309|4706477|P2|Overall Study|Protocol Violation|1
1425993|NCT01011309|4706478|P1|Overall Study|Protocol Violation|0
1425994|NCT01011309|4706476|P3|Overall Study|Lack of Efficacy|0
1425995|NCT01011309|4706477|P2|Overall Study|Lack of Efficacy|1
1425996|NCT01011309|4706478|P1|Overall Study|Lack of Efficacy|0
1425997|NCT01011309|4706476|P3|Overall Study|Adverse Event|2
1425998|NCT01011309|4706477|P2|Overall Study|Adverse Event|1
1425999|NCT01011309|4706478|P1|Overall Study|Adverse Event|2
1426000|NCT01011283|4706494|P2|Overall Study|Not Specified|2
1426001|NCT01011283|4706495|P1|Overall Study|Not Specified|2
1426002|NCT01011283|4706494|P2|Overall Study|Terminated by Sponsor|5
1426003|NCT01011283|4706495|P1|Overall Study|Terminated by Sponsor|5
1426004|NCT01011283|4706494|P2|Overall Study|Progressive Disease|2
1426005|NCT01011283|4706495|P1|Overall Study|Progressive Disease|0
1426006|NCT01011283|4706494|P2|Overall Study|Adverse Event|2
1426007|NCT01011283|4706495|P1|Overall Study|Adverse Event|4
1426008|NCT01011153|4706515|P3|Overall Study|Less than 78 cases completed|9
1426009|NCT01011153|4706516|P2|Overall Study|Less than 78 cases completed|11
1426010|NCT01011153|4706517|P1|Overall Study|Less than 78 cases completed|8
1426011|NCT01011049|4706546|P4|Overall Study|Withdrawal by Subject|0
1426012|NCT01011049|4706547|P3|Overall Study|Withdrawal by Subject|1
1426013|NCT01011049|4706548|P2|Overall Study|Withdrawal by Subject|0
1426014|NCT01011049|4706549|P1|Overall Study|Withdrawal by Subject|0
1426015|NCT01011049|4706546|P4|Overall Study|Lost to Follow-up|0
1426016|NCT01011049|4706547|P3|Overall Study|Lost to Follow-up|1
1426017|NCT01011049|4706548|P2|Overall Study|Lost to Follow-up|2
1426018|NCT01011049|4706549|P1|Overall Study|Lost to Follow-up|1
1426019|NCT01011049|4706546|P4|Overall Study|Protocol Violation|0
1426020|NCT01011049|4706547|P3|Overall Study|Protocol Violation|2
1426021|NCT01011049|4706548|P2|Overall Study|Protocol Violation|0
1426022|NCT01011049|4706549|P1|Overall Study|Protocol Violation|0
1426023|NCT01010971|4706579|P3|Overall Study|Other|2
1426024|NCT01010971|4706580|P2|Overall Study|Other|0
1426025|NCT01010971|4706581|P1|Overall Study|Other|1
1426026|NCT01010971|4706579|P3|Overall Study|Lost to Follow-up|3
1426027|NCT01010971|4706580|P2|Overall Study|Lost to Follow-up|2
1426028|NCT01010971|4706581|P1|Overall Study|Lost to Follow-up|0
1426029|NCT01010971|4706579|P3|Overall Study|Withdrawal by Subject|5
1426030|NCT01010971|4706580|P2|Overall Study|Withdrawal by Subject|2
1426031|NCT01010971|4706581|P1|Overall Study|Withdrawal by Subject|0
1426032|NCT01010971|4706579|P3|Overall Study|Adverse Event|3
1426033|NCT01010971|4706580|P2|Overall Study|Adverse Event|4
1426034|NCT01010971|4706581|P1|Overall Study|Adverse Event|2
1426035|NCT01010867|4706709|P1|Overall Study|< 50% adherence to probiotic|1
1426036|NCT01010776|4706721|P1|Extension Phase|Not specified|3
1426037|NCT01010776|4706721|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
1426038|NCT01010776|4706721|P1|Main Phase|Did not received study medication|5
1426039|NCT01010776|4706721|P1|Main Phase|Not specified|1
1426040|NCT01010776|4706721|P1|Main Phase|Inform consent withdrawal|1
1426041|NCT01010776|4706721|P1|Main Phase|Selection failure|2
1426042|NCT01010776|4706721|P1|Main Phase|Non-compliance to study medication|5
1426043|NCT01010776|4706721|P1|Main Phase|Lost to Follow-up|6
1426044|NCT01010776|4706721|P1|Main Phase|Adverse Event|7
1426045|NCT01010776|4706721|P1|Main Phase|Lack of Efficacy|8
1426046|NCT01010776|4706721|P1|Main Phase|Withdrawal by Subject|14
1426047|NCT01010750|4706749|P6|Second Intervention|Adverse Event|0
1426048|NCT01010750|4706750|P5|Second Intervention|Adverse Event|0
1426049|NCT01010750|4706751|P4|Second Intervention|Adverse Event|0
1426050|NCT01010750|4706752|P3|Second Intervention|Adverse Event|0
1426051|NCT01010750|4706753|P2|Second Intervention|Adverse Event|1
1426052|NCT01010750|4706754|P1|Second Intervention|Adverse Event|0
1426053|NCT01010633|4706779|P2|Overall Study|Investigator decision|1
1426054|NCT01010633|4706780|P1|Overall Study|Investigator decision|0
1426055|NCT01010633|4706779|P2|Overall Study|Withdrawal by Subject|1
1426056|NCT01010633|4706780|P1|Overall Study|Withdrawal by Subject|2
1426057|NCT01010633|4706779|P2|Overall Study|Protocol Violation|2
1426058|NCT01010633|4706780|P1|Overall Study|Protocol Violation|1
1426059|NCT01010633|4706779|P2|Overall Study|Adverse Event|1
1426060|NCT01010633|4706780|P1|Overall Study|Adverse Event|1
1426061|NCT01010503|4706807|P1|Overall Study|Death|1
1426062|NCT01010503|4706807|P1|Overall Study|Adverse Event|1
1426063|NCT01010230|4706866|P2|Overall Study|Lost to Follow-up|2
1426064|NCT01010230|4706867|P1|Overall Study|Lost to Follow-up|4
1426065|NCT01010230|4706866|P2|Overall Study|Withdrawal by Subject|5
1426066|NCT01010230|4706867|P1|Overall Study|Withdrawal by Subject|6
1426067|NCT01010204|4706899|P2|Overall Study|psychiatric hospitalization|1
1426068|NCT01010204|4706900|P1|Overall Study|psychiatric hospitalization|2
1426069|NCT01010204|4706899|P2|Overall Study|Withdrawal by Subject|3
1426070|NCT01010204|4706900|P1|Overall Study|Withdrawal by Subject|2
1426071|NCT01010204|4706899|P2|Overall Study|Adverse Event|3
1426072|NCT01010204|4706900|P1|Overall Study|Adverse Event|1
1426073|NCT01010204|4706899|P2|Overall Study|Lost to Follow-up|2
1426074|NCT01010204|4706900|P1|Overall Study|Lost to Follow-up|2
1426075|NCT01010061|4706912|P2|Overall Study|Failure to Return|2
1426076|NCT01010061|4706913|P1|Overall Study|Failure to Return|3
1426077|NCT01010061|4706912|P2|Overall Study|Refused Treatment/Did Not Cooperate|1
1426078|NCT01010061|4706913|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
1426079|NCT01010061|4706912|P2|Overall Study|Administrative/Other|14
1426080|NCT01010061|4706913|P1|Overall Study|Administrative/Other|19
1426081|NCT01010061|4706912|P2|Overall Study|Death|7
1426082|NCT01010061|4706913|P1|Overall Study|Death|23
1426083|NCT01010061|4706912|P2|Overall Study|Withdrew Consent|4
1426084|NCT01010061|4706913|P1|Overall Study|Withdrew Consent|9
1426085|NCT01010061|4706912|P2|Overall Study|Progression of Disease|63
1426086|NCT01010061|4706913|P1|Overall Study|Progression of Disease|71
1426087|NCT01010061|4706912|P2|Overall Study|Adverse Events or Intercurrent Illness|4
1426088|NCT01010061|4706913|P1|Overall Study|Adverse Events or Intercurrent Illness|7
1426089|NCT01009983|4706963|P1|Overall Study|necessary scans not completed|1
1426250|NCT01008696|4707457|P2|Overall Study|Other|2
1426090|NCT01009840|4706976|P1|Overall Study|Subject Withdrew Consent to Participate|1
1426091|NCT01009840|4706976|P1|Overall Study|Subject was Withdrawn by Investigator|1
1426092|NCT01009840|4706976|P1|Overall Study|Subject Met Withdrawal Criteria|7
1426093|NCT01009840|4706976|P1|Overall Study|Adverse Event|4
1426094|NCT01009840|4706976|P1|Overall Study|Lost to Follow-up|1
1426095|NCT01009645|4707006|P4|Overall Study|Lost to Follow-up|5
1426096|NCT01009645|4707007|P3|Overall Study|Lost to Follow-up|4
1426097|NCT01009645|4707008|P2|Overall Study|Lost to Follow-up|8
1426098|NCT01009645|4707009|P1|Overall Study|Lost to Follow-up|2
1426099|NCT01009580|4707046|P2|Overall Study|Unclassified|21
1426100|NCT01009580|4707047|P1|Overall Study|Unclassified|17
1426101|NCT01009580|4707046|P2|Overall Study|Withdrawal Criteria|6
1426102|NCT01009580|4707047|P1|Overall Study|Withdrawal Criteria|4
1426103|NCT01009580|4707046|P2|Overall Study|Protocol Violation|3
1426104|NCT01009580|4707047|P1|Overall Study|Protocol Violation|2
1426105|NCT01009580|4707046|P2|Overall Study|Lack of Efficacy|1
1426106|NCT01009580|4707047|P1|Overall Study|Lack of Efficacy|0
1426107|NCT01009580|4707046|P2|Overall Study|Adverse Event|4
1426108|NCT01009580|4707047|P1|Overall Study|Adverse Event|4
1426109|NCT01009554|4707061|P2|Overall Study|Noncompliant with Study Product|3
1426110|NCT01009554|4707062|P1|Overall Study|Noncompliant with Study Product|0
1426111|NCT01009554|4707061|P2|Overall Study|Withdrawal by Subject|3
1426112|NCT01009554|4707062|P1|Overall Study|Withdrawal by Subject|1
1426113|NCT01009554|4707061|P2|Overall Study|Adverse Event|1
1426114|NCT01009554|4707062|P1|Overall Study|Adverse Event|1
1426115|NCT01009515|4707194|P1|Overall Study|Withdrawal by Subject|3
1426116|NCT01009463|4707205|P5|52-week, Double-blind Treatment Period|Physician Decision|8
1426117|NCT01009463|4707206|P4|52-week, Double-blind Treatment Period|Physician Decision|6
1426118|NCT01009463|4707207|P3|52-week, Double-blind Treatment Period|Physician Decision|6
1426119|NCT01009463|4707208|P2|52-week, Double-blind Treatment Period|Physician Decision|4
1426120|NCT01009463|4707209|P1|52-week, Double-blind Treatment Period|Physician Decision|0
1426121|NCT01009463|4707205|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
1426122|NCT01009463|4707206|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
1426123|NCT01009463|4707207|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
1426124|NCT01009463|4707208|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
1426125|NCT01009463|4707209|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
1426126|NCT01009463|4707205|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1426127|NCT01009463|4707206|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
1426128|NCT01009463|4707207|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1426129|NCT01009463|4707208|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
1426130|NCT01009463|4707209|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1426131|NCT01009463|4707205|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
1426132|NCT01009463|4707206|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
1426133|NCT01009463|4707207|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
1426134|NCT01009463|4707208|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
1426135|NCT01009463|4707209|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
1426136|NCT01009463|4707205|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
1426137|NCT01009463|4707206|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
1426138|NCT01009463|4707207|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
1426139|NCT01009463|4707208|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
1426140|NCT01009463|4707209|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
1426141|NCT01009463|4707205|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
1426142|NCT01009463|4707206|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
1426143|NCT01009463|4707207|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
1426144|NCT01009463|4707208|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
1426145|NCT01009463|4707209|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
1426146|NCT01009463|4707205|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
1426147|NCT01009463|4707206|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
1426148|NCT01009463|4707207|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
1426149|NCT01009463|4707208|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
1426150|NCT01009463|4707209|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
1426151|NCT01009463|4707205|P5|52-week, Double-blind Treatment Period|Adverse Event|31
1426152|NCT01009463|4707206|P4|52-week, Double-blind Treatment Period|Adverse Event|29
1426153|NCT01009463|4707207|P3|52-week, Double-blind Treatment Period|Adverse Event|25
1426154|NCT01009463|4707208|P2|52-week, Double-blind Treatment Period|Adverse Event|22
1426155|NCT01009463|4707209|P1|52-week, Double-blind Treatment Period|Adverse Event|0
1426156|NCT01009463|4707205|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1426157|NCT01009463|4707206|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1426158|NCT01009463|4707207|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1426159|NCT01009463|4707208|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1426160|NCT01009463|4707209|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
1426161|NCT01009463|4707205|P5|4-week, Open-label Run-In Period|Physician Decision|0
1426162|NCT01009463|4707206|P4|4-week, Open-label Run-In Period|Physician Decision|0
1426163|NCT01009463|4707207|P3|4-week, Open-label Run-In Period|Physician Decision|0
1426164|NCT01009463|4707208|P2|4-week, Open-label Run-In Period|Physician Decision|0
1426165|NCT01009463|4707209|P1|4-week, Open-label Run-In Period|Physician Decision|10
1426166|NCT01009463|4707205|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
1426167|NCT01009463|4707206|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
1426168|NCT01009463|4707207|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
1426169|NCT01009463|4707208|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
1426170|NCT01009463|4707209|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
1426171|NCT01009463|4707205|P5|4-week, Open-label Run-In Period|Adverse Event|0
1426172|NCT01009463|4707206|P4|4-week, Open-label Run-In Period|Adverse Event|0
1426173|NCT01009463|4707207|P3|4-week, Open-label Run-In Period|Adverse Event|0
1426174|NCT01009463|4707208|P2|4-week, Open-label Run-In Period|Adverse Event|0
1426175|NCT01009463|4707209|P1|4-week, Open-label Run-In Period|Adverse Event|10
1426176|NCT01009463|4707205|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1426177|NCT01009463|4707206|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1426178|NCT01009463|4707207|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1426179|NCT01009463|4707208|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1426180|NCT01009463|4707209|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
1426181|NCT01009346|4707231|P1|Overall Study|Adverse Event|4
1426182|NCT01009203|4707255|P1|Overall Study|Treatment-unrelated death|1
1426183|NCT01009203|4707255|P1|Overall Study|Adverse Event|5
1426184|NCT01009203|4707255|P1|Overall Study|Withdrawal by Subject|1
1426185|NCT01009099|4707295|P2|Overall Study|Death|1
1426186|NCT01009099|4707296|P1|Overall Study|Death|0
1426187|NCT01009099|4707295|P2|Overall Study|Withdrawal by Subject|1
1426188|NCT01009099|4707296|P1|Overall Study|Withdrawal by Subject|1
1426189|NCT01009099|4707295|P2|Overall Study|Physician Decision|2
1426190|NCT01009099|4707296|P1|Overall Study|Physician Decision|3
1426191|NCT01009099|4707295|P2|Overall Study|Lost to Follow-up|0
1426192|NCT01009099|4707296|P1|Overall Study|Lost to Follow-up|1
1426193|NCT01009086|4707305|P3|Overall Study|Other|1
1426194|NCT01009086|4707306|P2|Overall Study|Other|5
1426195|NCT01009086|4707307|P1|Overall Study|Other|3
1426196|NCT01009086|4707305|P3|Overall Study|Withdrawal by Subject|13
1426197|NCT01009086|4707306|P2|Overall Study|Withdrawal by Subject|11
1426198|NCT01009086|4707307|P1|Overall Study|Withdrawal by Subject|9
1426199|NCT01009086|4707305|P3|Overall Study|Adverse Event|8
1426200|NCT01009086|4707306|P2|Overall Study|Adverse Event|11
1426201|NCT01009086|4707307|P1|Overall Study|Adverse Event|12
1426202|NCT01009086|4707305|P3|Overall Study|Lost to Follow-up|3
1426203|NCT01009086|4707306|P2|Overall Study|Lost to Follow-up|5
1426204|NCT01009086|4707307|P1|Overall Study|Lost to Follow-up|4
1426205|NCT01009086|4707305|P3|Overall Study|Lack of Efficacy|9
1426206|NCT01009086|4707306|P2|Overall Study|Lack of Efficacy|15
1426207|NCT01009086|4707307|P1|Overall Study|Lack of Efficacy|16
1426208|NCT01009060|4707342|P2|Overall Study|Withdrawal by Subject|1
1426209|NCT01009060|4707343|P1|Overall Study|Withdrawal by Subject|1
1426210|NCT01009060|4707342|P2|Overall Study|Physician Decision|1
1426211|NCT01009060|4707343|P1|Overall Study|Physician Decision|1
1426212|NCT01009060|4707342|P2|Overall Study|Lost to Follow-up|0
1426213|NCT01009060|4707343|P1|Overall Study|Lost to Follow-up|1
1426214|NCT01009060|4707342|P2|Overall Study|Protocol Violation|1
1426215|NCT01009060|4707343|P1|Overall Study|Protocol Violation|0
1426216|NCT01009060|4707342|P2|Overall Study|Adverse Event|2
1426217|NCT01009060|4707343|P1|Overall Study|Adverse Event|1
1426218|NCT01009047|4707381|P2|Overall Study|Other|2
1426219|NCT01009047|4707382|P1|Overall Study|Other|3
1426220|NCT01009047|4707381|P2|Overall Study|Withdrawal by consent|11
1426221|NCT01009047|4707382|P1|Overall Study|Withdrawal by consent|16
1426222|NCT01009047|4707381|P2|Overall Study|Lack of Efficacy|11
1426223|NCT01009047|4707382|P1|Overall Study|Lack of Efficacy|4
1426224|NCT01009047|4707381|P2|Overall Study|Lost to Follow-up|2
1426225|NCT01009047|4707382|P1|Overall Study|Lost to Follow-up|0
1426226|NCT01009047|4707381|P2|Overall Study|Adverse Event|0
1426227|NCT01009047|4707382|P1|Overall Study|Adverse Event|5
1426228|NCT01009034|4707404|P1|Overall Study|Withdrawal by Subject|2
1426229|NCT01009034|4707404|P1|Overall Study|Lost to Follow-up|2
1426230|NCT01008995|4707412|P4|After Controlled Period|Not specified|0
1426231|NCT01008995|4707413|P3|After Controlled Period|Not specified|1
1426232|NCT01008995|4707414|P2|After Controlled Period|Not specified|0
1426233|NCT01008995|4707415|P1|After Controlled Period|Not specified|0
1426234|NCT01008995|4707412|P4|After Controlled Period|Adverse Event|1
1426235|NCT01008995|4707413|P3|After Controlled Period|Adverse Event|1
1426236|NCT01008995|4707414|P2|After Controlled Period|Adverse Event|0
1426237|NCT01008995|4707415|P1|After Controlled Period|Adverse Event|0
1426238|NCT01008995|4707412|P4|Controlled Period|Not specified|0
1426239|NCT01008995|4707413|P3|Controlled Period|Not specified|0
1426240|NCT01008995|4707414|P2|Controlled Period|Not specified|1
1426241|NCT01008995|4707415|P1|Controlled Period|Not specified|2
1426242|NCT01008995|4707412|P4|Controlled Period|Adverse Event|0
1426243|NCT01008995|4707413|P3|Controlled Period|Adverse Event|0
1426244|NCT01008995|4707414|P2|Controlled Period|Adverse Event|2
1426245|NCT01008995|4707415|P1|Controlled Period|Adverse Event|1
1426246|NCT01008943|4707432|P1|Overall Study|Withdrawal by Subject|1
1426247|NCT01008904|4707439|P1|Overall Study|unexpected unrelated surgery|1
1426248|NCT01008904|4707439|P1|Overall Study|Adverse Event|2
1426249|NCT01008904|4707439|P1|Overall Study|Lost to Follow-up|1
1426251|NCT01008696|4707458|P1|Overall Study|Other|0
1426252|NCT01008696|4707457|P2|Overall Study|Other|3
1426253|NCT01008696|4707458|P1|Overall Study|Other|2
1426254|NCT01008696|4707457|P2|Overall Study|Participants' non-cooperation|3
1426255|NCT01008696|4707458|P1|Overall Study|Participants' non-cooperation|2
1426256|NCT01008696|4707457|P2|Overall Study|Adverse Event|0
1426257|NCT01008696|4707458|P1|Overall Study|Adverse Event|1
1426258|NCT01008696|4707457|P2|Overall Study|Physician Decision|1
1426259|NCT01008696|4707458|P1|Overall Study|Physician Decision|5
1426260|NCT01008696|4707457|P2|Overall Study|Withdrawal by Subject|4
1426261|NCT01008696|4707458|P1|Overall Study|Withdrawal by Subject|2
1426262|NCT01008696|4707457|P2|Overall Study|Participant's evasion of hospital visit|4
1426263|NCT01008696|4707458|P1|Overall Study|Participant's evasion of hospital visit|5
1426264|NCT01008618|4707468|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
1426265|NCT01008618|4707469|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
1426266|NCT01008618|4707470|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
1426267|NCT01008618|4707468|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
1426268|NCT01008618|4707469|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
1426269|NCT01008618|4707470|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
1426270|NCT01008618|4707468|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
1426271|NCT01008618|4707469|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
1426272|NCT01008618|4707470|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
1426273|NCT01008618|4707468|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
1426274|NCT01008618|4707469|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
1426275|NCT01008618|4707470|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
1426276|NCT01008618|4707468|P3|Period 2 (Double-Blind Period)|Physician Decision|0
1426277|NCT01008618|4707469|P2|Period 2 (Double-Blind Period)|Physician Decision|1
1426278|NCT01008618|4707470|P1|Period 2 (Double-Blind Period)|Physician Decision|0
1426279|NCT01008618|4707468|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
1426280|NCT01008618|4707469|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
1426281|NCT01008618|4707470|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
1426282|NCT01008618|4707468|P3|Period 2 (Double-Blind Period)|Adverse Event|2
1426283|NCT01008618|4707469|P2|Period 2 (Double-Blind Period)|Adverse Event|11
1426284|NCT01008618|4707470|P1|Period 2 (Double-Blind Period)|Adverse Event|0
1426285|NCT01008618|4707468|P3|Period 1 (Titration Period)|Aggravated symptom|0
1426286|NCT01008618|4707469|P2|Period 1 (Titration Period)|Aggravated symptom|0
1426287|NCT01008618|4707470|P1|Period 1 (Titration Period)|Aggravated symptom|2
1426288|NCT01008618|4707468|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
1426289|NCT01008618|4707469|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
1426290|NCT01008618|4707470|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
1426291|NCT01008618|4707468|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
1426292|NCT01008618|4707469|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
1426293|NCT01008618|4707470|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
1426294|NCT01008618|4707468|P3|Period 1 (Titration Period)|Adverse Event|0
1426295|NCT01008618|4707469|P2|Period 1 (Titration Period)|Adverse Event|0
1426296|NCT01008618|4707470|P1|Period 1 (Titration Period)|Adverse Event|33
1426297|NCT01008618|4707468|P3|Period 1 (Titration Period)|Physician Decision|0
1426298|NCT01008618|4707469|P2|Period 1 (Titration Period)|Physician Decision|0
1426299|NCT01008618|4707470|P1|Period 1 (Titration Period)|Physician Decision|2
1426300|NCT01008553|4707519|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
1426301|NCT01008553|4707520|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
1426302|NCT01008553|4707521|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
1426303|NCT01008553|4707519|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
1426304|NCT01008553|4707520|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
1426305|NCT01008553|4707521|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
1426306|NCT01008553|4707519|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
1426307|NCT01008553|4707520|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
1426308|NCT01008553|4707521|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
1426309|NCT01008553|4707519|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
1426310|NCT01008553|4707520|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
1426311|NCT01008553|4707521|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
1426312|NCT01008553|4707519|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
1426313|NCT01008553|4707520|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
1426314|NCT01008553|4707521|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
1426315|NCT01008553|4707519|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
1426316|NCT01008553|4707520|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
1426317|NCT01008553|4707521|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
1426318|NCT01008553|4707519|P3|Period 2 (Double-Blind Period)|Adverse Event|4
1426319|NCT01008553|4707520|P2|Period 2 (Double-Blind Period)|Adverse Event|14
1426320|NCT01008553|4707521|P1|Period 2 (Double-Blind Period)|Adverse Event|0
1426321|NCT01008553|4707519|P3|Period 2 (Double-Blind Period)|Physician Decision|2
1426322|NCT01008553|4707520|P2|Period 2 (Double-Blind Period)|Physician Decision|1
1426323|NCT01008553|4707521|P1|Period 2 (Double-Blind Period)|Physician Decision|0
1426324|NCT01008553|4707519|P3|Period 1 (Titration Period)|Not appropriate for this study|0
1426325|NCT01008553|4707520|P2|Period 1 (Titration Period)|Not appropriate for this study|0
1426326|NCT01008553|4707521|P1|Period 1 (Titration Period)|Not appropriate for this study|1
1426327|NCT01008553|4707519|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
1426328|NCT01008553|4707520|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
1426329|NCT01008553|4707521|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
1426330|NCT01008553|4707519|P3|Period 1 (Titration Period)|Determined to increase dosage|0
1426331|NCT01008553|4707520|P2|Period 1 (Titration Period)|Determined to increase dosage|0
1426332|NCT01008553|4707521|P1|Period 1 (Titration Period)|Determined to increase dosage|3
1426333|NCT01008553|4707519|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
1426334|NCT01008553|4707520|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
1426335|NCT01008553|4707521|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
1426336|NCT01008553|4707519|P3|Period 1 (Titration Period)|Adverse Event|0
1426337|NCT01008553|4707520|P2|Period 1 (Titration Period)|Adverse Event|0
1426338|NCT01008553|4707521|P1|Period 1 (Titration Period)|Adverse Event|33
1426339|NCT01008553|4707519|P3|Period 1 (Titration Period)|Physician Decision|0
1426340|NCT01008553|4707520|P2|Period 1 (Titration Period)|Physician Decision|0
1426341|NCT01008553|4707521|P1|Period 1 (Titration Period)|Physician Decision|2
1426342|NCT01008475|4707553|P7|Overall Study|Ongoing treatment at data cut-off date|4
1426343|NCT01008475|4707554|P6|Overall Study|Ongoing treatment at data cut-off date|6
1426344|NCT01008475|4707555|P5|Overall Study|Ongoing treatment at data cut-off date|5
1426345|NCT01008475|4707556|P4|Overall Study|Ongoing treatment at data cut-off date|0
1426346|NCT01008475|4707557|P3|Overall Study|Ongoing treatment at data cut-off date|0
1426347|NCT01008475|4707558|P2|Overall Study|Ongoing treatment at data cut-off date|0
1426348|NCT01008475|4707559|P1|Overall Study|Ongoing treatment at data cut-off date|0
1426349|NCT01008449|4707589|P2|Overall Study|Lost to Follow-up|19
1426350|NCT01008449|4707590|P1|Overall Study|Lost to Follow-up|29
1426351|NCT01007916|4707636|P2|Period 2, 4 Weeks of Wear|Relocation|0
1426352|NCT01007916|4707637|P1|Period 2, 4 Weeks of Wear|Relocation|1
1426353|NCT01007916|4707636|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
1426354|NCT01007916|4707637|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
1426355|NCT01007942|4707645|P2|Overall Study|Patients untreated|3
1426356|NCT01007942|4707646|P1|Overall Study|Patients untreated|4
1426357|NCT01007942|4707645|P2|Overall Study|Death|2
1426358|NCT01007942|4707646|P1|Overall Study|Death|3
1426359|NCT01007942|4707645|P2|Overall Study|Administrative problems|0
1426360|NCT01007942|4707646|P1|Overall Study|Administrative problems|2
1426361|NCT01007942|4707645|P2|Overall Study|Lost to Follow-up|0
1426362|NCT01007942|4707646|P1|Overall Study|Lost to Follow-up|1
1426363|NCT01007942|4707645|P2|Overall Study|Withdrawal by Subject|14
1426364|NCT01007942|4707646|P1|Overall Study|Withdrawal by Subject|19
1426365|NCT01007942|4707645|P2|Overall Study|Protocol Violation|1
1426366|NCT01007942|4707646|P1|Overall Study|Protocol Violation|1
1426367|NCT01007942|4707645|P2|Overall Study|New cancer therapy|1
1426368|NCT01007942|4707646|P1|Overall Study|New cancer therapy|5
1426369|NCT01007942|4707645|P2|Overall Study|Disease progression|242
1426370|NCT01007942|4707646|P1|Overall Study|Disease progression|217
1426371|NCT01007942|4707645|P2|Overall Study|Abnormal test procedure|1
1426372|NCT01007942|4707646|P1|Overall Study|Abnormal test procedure|0
1426373|NCT01007942|4707645|P2|Overall Study|Adverse Event|14
1426374|NCT01007942|4707646|P1|Overall Study|Adverse Event|29
1426375|NCT01007838|4707672|P4|Overall Study|Started home haemodialysis|0
1426376|NCT01007838|4707673|P3|Overall Study|Started home haemodialysis|0
1426377|NCT01007838|4707674|P2|Overall Study|Started home haemodialysis|0
1426378|NCT01007838|4707675|P1|Overall Study|Started home haemodialysis|1
1426379|NCT01007838|4707672|P4|Overall Study|Physician Decision|0
1426380|NCT01007838|4707673|P3|Overall Study|Physician Decision|0
1426381|NCT01007838|4707674|P2|Overall Study|Physician Decision|0
1426382|NCT01007838|4707675|P1|Overall Study|Physician Decision|1
1426383|NCT01007838|4707672|P4|Overall Study|Withdrawal by Subject|0
1426384|NCT01007838|4707673|P3|Overall Study|Withdrawal by Subject|0
1426385|NCT01007838|4707674|P2|Overall Study|Withdrawal by Subject|0
1426386|NCT01007838|4707675|P1|Overall Study|Withdrawal by Subject|1
1426387|NCT01007812|4707685|P2|Period 1, One Week|Discomfort|0
1426388|NCT01007812|4707686|P1|Period 1, One Week|Discomfort|1
1426389|NCT01007812|4707685|P2|Period 1, One Week|Lost to Follow-up|1
1426390|NCT01007812|4707686|P1|Period 1, One Week|Lost to Follow-up|0
1426391|NCT01007552|4707719|P1|Overall Study|Withdrawal by Subject|1
1426392|NCT01007435|4707733|P4|Overall Study|Reason not Specified|1
1426393|NCT01007435|4707734|P3|Overall Study|Reason not Specified|2
1426394|NCT01007435|4707735|P2|Overall Study|Reason not Specified|1
1426395|NCT01007435|4707736|P1|Overall Study|Reason not Specified|1
1426396|NCT01007435|4707733|P4|Overall Study|Failure to Return|6
1426397|NCT01007435|4707734|P3|Overall Study|Failure to Return|3
1426398|NCT01007435|4707735|P2|Overall Study|Failure to Return|4
1426399|NCT01007435|4707736|P1|Overall Study|Failure to Return|5
1426400|NCT01007435|4707733|P4|Overall Study|Refused Treatment|8
1426401|NCT01007435|4707734|P3|Overall Study|Refused Treatment|5
1426402|NCT01007435|4707735|P2|Overall Study|Refused Treatment|13
1426403|NCT01007435|4707736|P1|Overall Study|Refused Treatment|13
1426404|NCT01007435|4707733|P4|Overall Study|Other Protocol Violation|0
1426405|NCT01007435|4707734|P3|Overall Study|Other Protocol Violation|1
1426406|NCT01007435|4707735|P2|Overall Study|Other Protocol Violation|0
1426407|NCT01007435|4707736|P1|Overall Study|Other Protocol Violation|2
1426408|NCT01007435|4707733|P4|Overall Study|Violation of Selection Criteria at Entry|0
1426409|NCT01007435|4707734|P3|Overall Study|Violation of Selection Criteria at Entry|2
1426410|NCT01007435|4707735|P2|Overall Study|Violation of Selection Criteria at Entry|5
1426411|NCT01007435|4707736|P1|Overall Study|Violation of Selection Criteria at Entry|3
1426412|NCT01007435|4707733|P4|Overall Study|Insufficient Therapeutic Response|9
1426413|NCT01007435|4707734|P3|Overall Study|Insufficient Therapeutic Response|2
1426414|NCT01007435|4707735|P2|Overall Study|Insufficient Therapeutic Response|7
1426415|NCT01007435|4707736|P1|Overall Study|Insufficient Therapeutic Response|21
1426416|NCT01007435|4707733|P4|Overall Study|Death|1
1426417|NCT01007435|4707734|P3|Overall Study|Death|2
1426418|NCT01007435|4707735|P2|Overall Study|Death|4
1426419|NCT01007435|4707736|P1|Overall Study|Death|2
1426420|NCT01007435|4707733|P4|Overall Study|Adverse Event|31
1426421|NCT01007435|4707734|P3|Overall Study|Adverse Event|47
1426422|NCT01007435|4707735|P2|Overall Study|Adverse Event|25
1426423|NCT01007435|4707736|P1|Overall Study|Adverse Event|16
1426424|NCT01007396|4707778|P1|Overall Study|Lost to Follow-up|47
1426425|NCT01007253|4707783|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
1426426|NCT01007253|4707784|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
1426427|NCT01007253|4707785|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
1426428|NCT01007253|4707786|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
1426429|NCT01007149|4707818|P2|Overall Study|Administrative problems|1
1426430|NCT01007149|4707819|P1|Overall Study|Administrative problems|0
1426431|NCT01007123|4707845|P4|Overall Study|Lost to Follow-up|0
1426432|NCT01007123|4707846|P3|Overall Study|Lost to Follow-up|0
1426433|NCT01007123|4707847|P2|Overall Study|Lost to Follow-up|1
1426434|NCT01007123|4707848|P1|Overall Study|Lost to Follow-up|0
1426435|NCT01007123|4707845|P4|Overall Study|Withdrawal by Subject|0
1426436|NCT01007123|4707846|P3|Overall Study|Withdrawal by Subject|1
1426437|NCT01007123|4707847|P2|Overall Study|Withdrawal by Subject|0
1426438|NCT01007123|4707848|P1|Overall Study|Withdrawal by Subject|1
1426439|NCT01007123|4707845|P4|Overall Study|Protocol Violation|1
1426440|NCT01007123|4707846|P3|Overall Study|Protocol Violation|2
1426441|NCT01007123|4707847|P2|Overall Study|Protocol Violation|1
1426442|NCT01007123|4707848|P1|Overall Study|Protocol Violation|1
1426443|NCT01007123|4707845|P4|Overall Study|Lack of Efficacy|4
1426444|NCT01007123|4707846|P3|Overall Study|Lack of Efficacy|1
1426445|NCT01007123|4707847|P2|Overall Study|Lack of Efficacy|0
1426446|NCT01007123|4707848|P1|Overall Study|Lack of Efficacy|1
1426447|NCT01007123|4707845|P4|Overall Study|Adverse Event|1
1426448|NCT01007123|4707846|P3|Overall Study|Adverse Event|7
1426449|NCT01007123|4707847|P2|Overall Study|Adverse Event|4
1426450|NCT01007123|4707848|P1|Overall Study|Adverse Event|3
1426451|NCT01006980|4707907|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
1426452|NCT01006980|4707908|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
1426453|NCT01006980|4707907|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
1426454|NCT01006980|4707908|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
1426455|NCT01006980|4707907|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
1426456|NCT01006980|4707908|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
1426457|NCT01006980|4707907|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
1426458|NCT01006980|4707908|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
1426459|NCT01006980|4707907|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
1426460|NCT01006980|4707908|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
1426461|NCT01006980|4707907|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
1426462|NCT01006980|4707908|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
1426463|NCT01006980|4707907|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
1426464|NCT01006980|4707908|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
1426465|NCT01006980|4707907|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
1426466|NCT01006980|4707908|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
1426467|NCT01006980|4707907|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
1426468|NCT01006980|4707908|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
1426469|NCT01006980|4707907|P2|Vemurafenib and Dacarbazine|Progression|218
1426470|NCT01006980|4707908|P1|Vemurafenib and Dacarbazine|Progression|257
1426471|NCT01006980|4707907|P2|Vemurafenib and Dacarbazine|Death|12
1426472|NCT01006980|4707908|P1|Vemurafenib and Dacarbazine|Death|13
1426473|NCT01006980|4707907|P2|Vemurafenib and Dacarbazine|Adverse Event|5
1426474|NCT01006980|4707908|P1|Vemurafenib and Dacarbazine|Adverse Event|25
1426475|NCT01006980|4707907|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
1426476|NCT01006980|4707908|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
1426477|NCT01006889|4707947|P1|Overall Study|Withdrawal by Subject|3
1426478|NCT01006707|4707958|P3|Study Session 1|Could not tolerate withdrawal in scanner|0
1426479|NCT01006707|4707959|P2|Study Session 1|Could not tolerate withdrawal in scanner|0
1426480|NCT01006707|4707960|P1|Study Session 1|Could not tolerate withdrawal in scanner|3
1426481|NCT01006707|4707958|P3|Study Session 1|Lost to Follow-up|0
1426482|NCT01006707|4707959|P2|Study Session 1|Lost to Follow-up|0
1426483|NCT01006707|4707960|P1|Study Session 1|Lost to Follow-up|2
1426484|NCT01006629|4707980|P1|Overall Study|Parent unable to perform site visit|4
1426485|NCT01006629|4707980|P1|Overall Study|Parent refused to continue participation|1
1426486|NCT01006629|4707980|P1|Overall Study|Adverse Event|1
1426487|NCT01006616|4707995|P4|Period 2 (18 Months)|Study Terminated|70
1426488|NCT01006616|4707996|P3|Period 2 (18 Months)|Study Terminated|44
1426489|NCT01006616|4707997|P2|Period 2 (18 Months)|Study Terminated|46
1426490|NCT01006616|4707998|P1|Period 2 (18 Months)|Study Terminated|63
1426491|NCT01006616|4707995|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
1426492|NCT01006616|4707996|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
1426493|NCT01006616|4707997|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
1426494|NCT01006616|4707998|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
1426495|NCT01006616|4707995|P4|Period 2 (18 Months)|Withdrawal by Subject|1
1426496|NCT01006616|4707996|P3|Period 2 (18 Months)|Withdrawal by Subject|0
1426497|NCT01006616|4707997|P2|Period 2 (18 Months)|Withdrawal by Subject|4
1426498|NCT01006616|4707998|P1|Period 2 (18 Months)|Withdrawal by Subject|1
1426499|NCT01006616|4707995|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
1426500|NCT01006616|4707996|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
1426501|NCT01006616|4707997|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
1426502|NCT01006616|4707998|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
1426503|NCT01006616|4707995|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
1426504|NCT01006616|4707996|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
1426505|NCT01006616|4707997|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
1426506|NCT01006616|4707998|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
1426507|NCT01006616|4707995|P4|Period 2 (18 Months)|Lost to Follow-up|0
1426508|NCT01006616|4707996|P3|Period 2 (18 Months)|Lost to Follow-up|0
1426509|NCT01006616|4707997|P2|Period 2 (18 Months)|Lost to Follow-up|0
1426510|NCT01006616|4707998|P1|Period 2 (18 Months)|Lost to Follow-up|2
1426511|NCT01006616|4707995|P4|Period 2 (18 Months)|Lack of Efficacy|2
1426512|NCT01006616|4707996|P3|Period 2 (18 Months)|Lack of Efficacy|1
1426513|NCT01006616|4707997|P2|Period 2 (18 Months)|Lack of Efficacy|0
1426514|NCT01006616|4707998|P1|Period 2 (18 Months)|Lack of Efficacy|0
1426515|NCT01006616|4707995|P4|Period 2 (18 Months)|Adverse Event|4
1426516|NCT01006616|4707996|P3|Period 2 (18 Months)|Adverse Event|6
1426517|NCT01006616|4707997|P2|Period 2 (18 Months)|Adverse Event|6
1426518|NCT01006616|4707998|P1|Period 2 (18 Months)|Adverse Event|6
1426519|NCT01006616|4707995|P4|Period 1 (6 Months)|Not Treated|1
1426520|NCT01006616|4707996|P3|Period 1 (6 Months)|Not Treated|1
1426521|NCT01006616|4707997|P2|Period 1 (6 Months)|Not Treated|0
1426522|NCT01006616|4707998|P1|Period 1 (6 Months)|Not Treated|0
1426523|NCT01006616|4707995|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
1426524|NCT01006616|4707996|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
1426525|NCT01006616|4707997|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
1426526|NCT01006616|4707998|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
1426527|NCT01006616|4707995|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
1426528|NCT01006616|4707996|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
1426529|NCT01006616|4707997|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
1426530|NCT01006616|4707998|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
1426531|NCT01006616|4707995|P4|Period 1 (6 Months)|Withdrawal by Subject|0
1426532|NCT01006616|4707996|P3|Period 1 (6 Months)|Withdrawal by Subject|2
1426533|NCT01006616|4707997|P2|Period 1 (6 Months)|Withdrawal by Subject|2
1426534|NCT01006616|4707998|P1|Period 1 (6 Months)|Withdrawal by Subject|2
1426535|NCT01006616|4707995|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
1426536|NCT01006616|4707996|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
1426537|NCT01006616|4707997|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
1426538|NCT01006616|4707998|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
1426539|NCT01006616|4707995|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
1426540|NCT01006616|4707996|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
1426541|NCT01006616|4707997|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
1426542|NCT01006616|4707998|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
1426543|NCT01006616|4707995|P4|Period 1 (6 Months)|Lost to Follow-up|0
1426544|NCT01006616|4707996|P3|Period 1 (6 Months)|Lost to Follow-up|1
1426545|NCT01006616|4707997|P2|Period 1 (6 Months)|Lost to Follow-up|0
1426546|NCT01006616|4707998|P1|Period 1 (6 Months)|Lost to Follow-up|0
1426547|NCT01006616|4707995|P4|Period 1 (6 Months)|Lack of Efficacy|4
1426548|NCT01006616|4707996|P3|Period 1 (6 Months)|Lack of Efficacy|0
1426549|NCT01006616|4707997|P2|Period 1 (6 Months)|Lack of Efficacy|4
1426550|NCT01006616|4707998|P1|Period 1 (6 Months)|Lack of Efficacy|3
1426551|NCT01006616|4707995|P4|Period 1 (6 Months)|Adverse Event|9
1426552|NCT01006616|4707996|P3|Period 1 (6 Months)|Adverse Event|37
1426553|NCT01006616|4707997|P2|Period 1 (6 Months)|Adverse Event|31
1426554|NCT01006616|4707998|P1|Period 1 (6 Months)|Adverse Event|10
1426555|NCT01006603|4708134|P2|Overall Study|Other|7
1426556|NCT01006603|4708135|P1|Overall Study|Other|3
1426557|NCT01006603|4708134|P2|Overall Study|Study specific discontinuation criteria|34
1426558|NCT01006603|4708135|P1|Overall Study|Study specific discontinuation criteria|33
1426559|NCT01006603|4708134|P2|Overall Study|Death|1
1426560|NCT01006603|4708135|P1|Overall Study|Death|1
1426561|NCT01006603|4708134|P2|Overall Study|Adverse Event|7
1426562|NCT01006603|4708135|P1|Overall Study|Adverse Event|15
1426563|NCT01006603|4708134|P2|Overall Study|Incorrect enrolment|2
1426564|NCT01006603|4708135|P1|Overall Study|Incorrect enrolment|0
1426565|NCT01006603|4708134|P2|Overall Study|Protocol Violation|3
1426566|NCT01006603|4708135|P1|Overall Study|Protocol Violation|1
1426567|NCT01006603|4708134|P2|Overall Study|Safety reason|1
1426568|NCT01006603|4708135|P1|Overall Study|Safety reason|1
1426569|NCT01006603|4708134|P2|Overall Study|Lost to Follow-up|1
1426570|NCT01006603|4708135|P1|Overall Study|Lost to Follow-up|0
1426571|NCT01006603|4708134|P2|Overall Study|Withdrawal by Subject|19
1426572|NCT01006603|4708135|P1|Overall Study|Withdrawal by Subject|17
1426573|NCT01006590|4708155|P2|Overall Study|Not specified|2
1426574|NCT01006590|4708156|P1|Overall Study|Not specified|3
1426575|NCT01006590|4708155|P2|Overall Study|Study specific discontinuation criteria|23
1426576|NCT01006590|4708156|P1|Overall Study|Study specific discontinuation criteria|16
1426577|NCT01006590|4708155|P2|Overall Study|Withdrawal by Subject|2
1426578|NCT01006590|4708156|P1|Overall Study|Withdrawal by Subject|4
1426579|NCT01006590|4708155|P2|Overall Study|Protocol Violation|0
1426580|NCT01006590|4708156|P1|Overall Study|Protocol Violation|1
1426581|NCT01006590|4708155|P2|Overall Study|Lost to Follow-up|1
1426582|NCT01006590|4708156|P1|Overall Study|Lost to Follow-up|1
1426583|NCT01006590|4708155|P2|Overall Study|Death|1
1426584|NCT01006590|4708156|P1|Overall Study|Death|1
1426585|NCT01006590|4708155|P2|Overall Study|Adverse Event|3
1426586|NCT01006590|4708156|P1|Overall Study|Adverse Event|2
1426587|NCT01006356|4708172|P1|Overall Study|Other|23
1426588|NCT01006356|4708172|P1|Overall Study|Protocol Violation|3
1426589|NCT01006356|4708172|P1|Overall Study|Choice by participants|2
1426590|NCT01006356|4708172|P1|Overall Study|Withdrawal by Subject|1
1426591|NCT01006356|4708172|P1|Overall Study|Paticipants did not cooperate|6
1426592|NCT01006356|4708172|P1|Overall Study|Physician Decision|1
1426593|NCT01006356|4708172|P1|Overall Study|Adverse Event|6
1426594|NCT01006291|4708187|P3|Overall Study|Other|17
1426595|NCT01006291|4708188|P2|Overall Study|Other|14
1426596|NCT01006291|4708189|P1|Overall Study|Other|14
1426597|NCT01006291|4708187|P3|Overall Study|Withdrawal criteria|4
1426598|NCT01006291|4708188|P2|Overall Study|Withdrawal criteria|4
1426599|NCT01006291|4708189|P1|Overall Study|Withdrawal criteria|5
1426600|NCT01006291|4708187|P3|Overall Study|Protocol Violation|3
1426601|NCT01006291|4708188|P2|Overall Study|Protocol Violation|3
1426602|NCT01006291|4708189|P1|Overall Study|Protocol Violation|3
1426603|NCT01006291|4708187|P3|Overall Study|Lack of Efficacy|1
1426604|NCT01006291|4708188|P2|Overall Study|Lack of Efficacy|2
1426605|NCT01006291|4708189|P1|Overall Study|Lack of Efficacy|2
1426606|NCT01006291|4708187|P3|Overall Study|Adverse Event|2
1426607|NCT01006291|4708188|P2|Overall Study|Adverse Event|1
1426608|NCT01006291|4708189|P1|Overall Study|Adverse Event|2
1426609|NCT01006135|4708239|P1|Overall Study|Other|72
1426610|NCT01006135|4708239|P1|Overall Study|Lost to Follow-up|32
1426611|NCT01006135|4708239|P1|Overall Study|Protocol Violation|14
1426612|NCT01006135|4708239|P1|Overall Study|Adverse Event|22
1426613|NCT01006122|4708246|P2|Second Double-blind Intervention Period|Death|1
1426614|NCT01006122|4708247|P1|Second Double-blind Intervention Period|Death|0
1426615|NCT01006122|4708246|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
1426616|NCT01006122|4708247|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
1426617|NCT01006122|4708246|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
1426618|NCT01006122|4708247|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
1426619|NCT01006122|4708246|P2|Second Double-blind Intervention Period|Protocol Violation|0
1426620|NCT01006122|4708247|P1|Second Double-blind Intervention Period|Protocol Violation|1
1426621|NCT01006122|4708246|P2|Second Double-blind Intervention Period|Adverse Event|1
1426622|NCT01006122|4708247|P1|Second Double-blind Intervention Period|Adverse Event|1
1426623|NCT01006122|4708246|P2|First Double-blind Intervention Period|Adverse Event|4
1426624|NCT01006122|4708247|P1|First Double-blind Intervention Period|Adverse Event|0
1426625|NCT01006122|4708246|P2|First Double-blind Intervention Period|Other|0
1426626|NCT01006122|4708247|P1|First Double-blind Intervention Period|Other|3
1426627|NCT01006122|4708246|P2|First Double-blind Intervention Period|Lack of Efficacy|1
1426628|NCT01006122|4708247|P1|First Double-blind Intervention Period|Lack of Efficacy|2
1426629|NCT01006122|4708246|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
1426630|NCT01006122|4708247|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
1426631|NCT01006122|4708246|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
1426632|NCT01006122|4708247|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
1426633|NCT01006122|4708246|P2|First Double-blind Intervention Period|Pregnancy|1
1426634|NCT01006122|4708247|P1|First Double-blind Intervention Period|Pregnancy|0
1426635|NCT01006122|4708246|P2|First Double-blind Intervention Period|Protocol Violation|1
1426636|NCT01006122|4708247|P1|First Double-blind Intervention Period|Protocol Violation|1
1426637|NCT01006122|4708246|P2|First Double-blind Intervention Period|Lost to Follow-up|2
1426638|NCT01006122|4708247|P1|First Double-blind Intervention Period|Lost to Follow-up|0
1426639|NCT01005966|4708298|P5|Treatment Period 4 (14 Days)|Other Reason|1
1426640|NCT01005966|4708299|P4|Treatment Period 4 (14 Days)|Other Reason|0
1426641|NCT01005966|4708300|P3|Treatment Period 4 (14 Days)|Other Reason|0
1426642|NCT01005966|4708301|P2|Treatment Period 4 (14 Days)|Other Reason|0
1426643|NCT01005966|4708302|P1|Treatment Period 4 (14 Days)|Other Reason|0
1426644|NCT01005966|4708298|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
1426645|NCT01005966|4708299|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
1426646|NCT01005966|4708300|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
1426647|NCT01005966|4708301|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
1426648|NCT01005966|4708302|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
1426649|NCT01005966|4708298|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
1426650|NCT01005966|4708299|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
1426651|NCT01005966|4708300|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
1426652|NCT01005966|4708301|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
1426653|NCT01005966|4708302|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
1426654|NCT01005966|4708298|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1426655|NCT01005966|4708299|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1426656|NCT01005966|4708300|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
1426657|NCT01005966|4708301|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1426658|NCT01005966|4708302|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1426659|NCT01005966|4708298|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
1426660|NCT01005966|4708299|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
1426661|NCT01005966|4708300|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
1426662|NCT01005966|4708301|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
1426663|NCT01005966|4708302|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
1426664|NCT01005966|4708298|P5|Treatment Period 2 (14 Days)|Adverse Event|0
1426665|NCT01005966|4708299|P4|Treatment Period 2 (14 Days)|Adverse Event|0
1426666|NCT01005966|4708300|P3|Treatment Period 2 (14 Days)|Adverse Event|1
1426667|NCT01005966|4708301|P2|Treatment Period 2 (14 Days)|Adverse Event|1
1426668|NCT01005966|4708302|P1|Treatment Period 2 (14 Days)|Adverse Event|0
1426669|NCT01005966|4708298|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
1426670|NCT01005966|4708299|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
1426671|NCT01005966|4708300|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
1426672|NCT01005966|4708301|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
1426673|NCT01005966|4708302|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
1426674|NCT01005966|4708298|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
1426675|NCT01005966|4708299|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
1426676|NCT01005966|4708300|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
1426677|NCT01005966|4708301|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
1426678|NCT01005966|4708302|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
1426679|NCT01005966|4708298|P5|Treatment Period 1 (14 Days)|Adverse Event|0
1426680|NCT01005966|4708299|P4|Treatment Period 1 (14 Days)|Adverse Event|0
1426681|NCT01005966|4708300|P3|Treatment Period 1 (14 Days)|Adverse Event|0
1426682|NCT01005966|4708301|P2|Treatment Period 1 (14 Days)|Adverse Event|0
1426683|NCT01005966|4708302|P1|Treatment Period 1 (14 Days)|Adverse Event|1
1426684|NCT01005914|4708322|P1|Overall Study|Withdrawal by Subject|1
1426685|NCT01005914|4708322|P1|Overall Study|Lack of Efficacy|1
1426686|NCT01005914|4708322|P1|Overall Study|Death|4
1426687|NCT01005914|4708322|P1|Overall Study|Adverse Event|4
1426688|NCT01005901|4708328|P2|Overall Study|No longer requires study drug|1
1426689|NCT01005901|4708329|P1|Overall Study|No longer requires study drug|0
1426690|NCT01005901|4708328|P2|Overall Study|Patient's inability to use the device|1
1426691|NCT01005901|4708329|P1|Overall Study|Patient's inability to use the device|1
1426692|NCT01005901|4708328|P2|Overall Study|Lost to Follow-up|2
1426693|NCT01005901|4708329|P1|Overall Study|Lost to Follow-up|1
1426694|NCT01005901|4708328|P2|Overall Study|Death|3
1426695|NCT01005901|4708329|P1|Overall Study|Death|2
1426696|NCT01005901|4708328|P2|Overall Study|Protocol Violation|3
1426697|NCT01005901|4708329|P1|Overall Study|Protocol Violation|4
1426698|NCT01005901|4708328|P2|Overall Study|Unsatisfactory therapeutic effect|5
1426699|NCT01005901|4708329|P1|Overall Study|Unsatisfactory therapeutic effect|5
1426700|NCT01005901|4708328|P2|Overall Study|Administrative problems|13
1426701|NCT01005901|4708329|P1|Overall Study|Administrative problems|21
1426702|NCT01005901|4708328|P2|Overall Study|Adverse Event|16
1426703|NCT01005901|4708329|P1|Overall Study|Adverse Event|30
1426704|NCT01005901|4708328|P2|Overall Study|Withdrawal by Subject|14
1426705|NCT01005901|4708329|P1|Overall Study|Withdrawal by Subject|38
1426706|NCT01005875|4708392|P1|Overall Study|Death|3
1426707|NCT01005745|4708400|P1|Overall Study|Inappropriate antidiuretic hormone|1
1426708|NCT01005745|4708400|P1|Overall Study|Death prior to treatment|1
1426709|NCT01005745|4708400|P1|Overall Study|Disease progressed during TIL growth|3
1426710|NCT01005745|4708400|P1|Overall Study|No TIL growth|1
1426711|NCT01005732|4708405|P1|Overall Study|Death|1
1426712|NCT01005732|4708405|P1|Overall Study|Lost to Follow-up|10
1426713|NCT01005719|4708421|P6|Period 2|Adverse Event|1
1426714|NCT01005719|4708422|P5|Period 2|Adverse Event|1
1426715|NCT01005719|4708423|P4|Period 2|Adverse Event|0
1426716|NCT01005719|4708424|P3|Period 2|Adverse Event|0
1426717|NCT01005719|4708425|P2|Period 2|Adverse Event|0
1426718|NCT01005719|4708426|P1|Period 2|Adverse Event|0
1426719|NCT01005719|4708421|P6|Period 1|Delay in completing study procedures|1
1426720|NCT01005719|4708422|P5|Period 1|Delay in completing study procedures|0
1426721|NCT01005719|4708423|P4|Period 1|Delay in completing study procedures|0
1426722|NCT01005719|4708424|P3|Period 1|Delay in completing study procedures|0
1426723|NCT01005719|4708425|P2|Period 1|Delay in completing study procedures|0
1426724|NCT01005719|4708426|P1|Period 1|Delay in completing study procedures|0
1426725|NCT01005719|4708421|P6|Period 1|Adverse Event|0
1426726|NCT01005719|4708422|P5|Period 1|Adverse Event|0
1426727|NCT01005719|4708423|P4|Period 1|Adverse Event|1
1426728|NCT01005719|4708424|P3|Period 1|Adverse Event|0
1426729|NCT01005719|4708425|P2|Period 1|Adverse Event|0
1426730|NCT01005719|4708426|P1|Period 1|Adverse Event|0
1426731|NCT01005680|4708493|P2|Overall Study|Physician Decision|1
1426732|NCT01005680|4708494|P1|Overall Study|Physician Decision|1
1426733|NCT01005680|4708493|P2|Overall Study|Withdrawal by Subject|4
1426734|NCT01005680|4708494|P1|Overall Study|Withdrawal by Subject|1
1426735|NCT01005680|4708493|P2|Overall Study|Lost to Follow-up|6
1426736|NCT01005680|4708494|P1|Overall Study|Lost to Follow-up|4
1426737|NCT01005602|4708518|P2|Overall Study|Excluded due to unreliable clinical data|0
1426738|NCT01005602|4708519|P1|Overall Study|Excluded due to unreliable clinical data|1
1426739|NCT01005329|4708607|P1|Overall Study|Ineligible or received no protocol trt.|4
1426740|NCT01005316|4708620|P4|Overall Study|Retransplanted|0
1426741|NCT01005316|4708621|P3|Overall Study|Retransplanted|0
1426742|NCT01005316|4708622|P2|Overall Study|Retransplanted|1
1426743|NCT01005316|4708623|P1|Overall Study|Retransplanted|0
1426744|NCT01005316|4708620|P4|Overall Study|Transferred Care|3
1426745|NCT01005316|4708621|P3|Overall Study|Transferred Care|1
1426746|NCT01005316|4708622|P2|Overall Study|Transferred Care|0
1426747|NCT01005316|4708623|P1|Overall Study|Transferred Care|1
1426748|NCT01005316|4708620|P4|Overall Study|Delisted|0
1426749|NCT01005316|4708621|P3|Overall Study|Delisted|0
1426750|NCT01005316|4708622|P2|Overall Study|Delisted|0
1426751|NCT01005316|4708623|P1|Overall Study|Delisted|8
1426752|NCT01005316|4708620|P4|Overall Study|Consented to Another Study|0
1426753|NCT01005316|4708621|P3|Overall Study|Consented to Another Study|0
1426754|NCT01005316|4708622|P2|Overall Study|Consented to Another Study|0
1426755|NCT01005316|4708623|P1|Overall Study|Consented to Another Study|2
1426756|NCT01005316|4708620|P4|Overall Study|Withdrawal by Subject|2
1426757|NCT01005316|4708621|P3|Overall Study|Withdrawal by Subject|0
1426758|NCT01005316|4708622|P2|Overall Study|Withdrawal by Subject|1
1426759|NCT01005316|4708623|P1|Overall Study|Withdrawal by Subject|1
1426760|NCT01005316|4708620|P4|Overall Study|Sponsor Decision|0
1426761|NCT01005316|4708621|P3|Overall Study|Sponsor Decision|0
1426762|NCT01005316|4708622|P2|Overall Study|Sponsor Decision|3
1426763|NCT01005316|4708623|P1|Overall Study|Sponsor Decision|6
1426764|NCT01005316|4708620|P4|Overall Study|Physician Decision|0
1426765|NCT01005316|4708621|P3|Overall Study|Physician Decision|0
1426766|NCT01005316|4708622|P2|Overall Study|Physician Decision|0
1426767|NCT01005316|4708623|P1|Overall Study|Physician Decision|6
1426768|NCT01005316|4708620|P4|Overall Study|Lost to Follow-up|2
1426769|NCT01005316|4708621|P3|Overall Study|Lost to Follow-up|0
1426770|NCT01005316|4708622|P2|Overall Study|Lost to Follow-up|3
1426771|NCT01005316|4708623|P1|Overall Study|Lost to Follow-up|1
1426772|NCT01005316|4708620|P4|Overall Study|Study Termination|85
1426773|NCT01005316|4708621|P3|Overall Study|Study Termination|9
1426774|NCT01005316|4708622|P2|Overall Study|Study Termination|63
1426775|NCT01005316|4708623|P1|Overall Study|Study Termination|5
1426776|NCT01005316|4708620|P4|Overall Study|Death|15
1426777|NCT01005316|4708621|P3|Overall Study|Death|1
1426778|NCT01005316|4708622|P2|Overall Study|Death|5
1426779|NCT01005316|4708623|P1|Overall Study|Death|20
1426780|NCT01005316|4708620|P4|Overall Study|Adverse Event|1
1426781|NCT01005316|4708621|P3|Overall Study|Adverse Event|0
1426782|NCT01005316|4708622|P2|Overall Study|Adverse Event|0
1426783|NCT01005316|4708623|P1|Overall Study|Adverse Event|0
1426784|NCT01005251|4708690|P5|Overall Study|Lack of Efficacy|0
1426785|NCT01005251|4708691|P4|Overall Study|Lack of Efficacy|1
1426786|NCT01005251|4708692|P3|Overall Study|Lack of Efficacy|1
1426787|NCT01005251|4708693|P2|Overall Study|Lack of Efficacy|0
1426788|NCT01005251|4708694|P1|Overall Study|Lack of Efficacy|0
1426789|NCT01005251|4708690|P5|Overall Study|Randomized in error|0
1426790|NCT01005251|4708691|P4|Overall Study|Randomized in error|1
1426791|NCT01005251|4708692|P3|Overall Study|Randomized in error|1
1426792|NCT01005251|4708693|P2|Overall Study|Randomized in error|0
1426793|NCT01005251|4708694|P1|Overall Study|Randomized in error|0
1426794|NCT01005251|4708690|P5|Overall Study|Wrong drug dispensed|0
1426795|NCT01005251|4708691|P4|Overall Study|Wrong drug dispensed|0
1426796|NCT01005251|4708692|P3|Overall Study|Wrong drug dispensed|0
1426797|NCT01005251|4708693|P2|Overall Study|Wrong drug dispensed|1
1426798|NCT01005251|4708694|P1|Overall Study|Wrong drug dispensed|0
1426799|NCT01005251|4708690|P5|Overall Study|Patient moved|0
1426800|NCT01005251|4708691|P4|Overall Study|Patient moved|0
1426801|NCT01005251|4708692|P3|Overall Study|Patient moved|0
1426802|NCT01005251|4708693|P2|Overall Study|Patient moved|0
1426803|NCT01005251|4708694|P1|Overall Study|Patient moved|1
1426804|NCT01005251|4708690|P5|Overall Study|Physician Decision|2
1426805|NCT01005251|4708691|P4|Overall Study|Physician Decision|0
1426806|NCT01005251|4708692|P3|Overall Study|Physician Decision|0
1426807|NCT01005251|4708693|P2|Overall Study|Physician Decision|0
1426808|NCT01005251|4708694|P1|Overall Study|Physician Decision|0
1426809|NCT01005251|4708690|P5|Overall Study|Lost to Follow-up|0
1426810|NCT01005251|4708691|P4|Overall Study|Lost to Follow-up|0
1426811|NCT01005251|4708692|P3|Overall Study|Lost to Follow-up|2
1426812|NCT01005251|4708693|P2|Overall Study|Lost to Follow-up|4
1426813|NCT01005251|4708694|P1|Overall Study|Lost to Follow-up|1
1426814|NCT01005251|4708690|P5|Overall Study|Developed study-specific withdrawal crit|1
1426815|NCT01005251|4708691|P4|Overall Study|Developed study-specific withdrawal crit|0
1426816|NCT01005251|4708692|P3|Overall Study|Developed study-specific withdrawal crit|3
1426817|NCT01005251|4708693|P2|Overall Study|Developed study-specific withdrawal crit|0
1426818|NCT01005251|4708694|P1|Overall Study|Developed study-specific withdrawal crit|2
1426819|NCT01005251|4708690|P5|Overall Study|Protocol Violation|2
1426820|NCT01005251|4708691|P4|Overall Study|Protocol Violation|0
1426821|NCT01005251|4708692|P3|Overall Study|Protocol Violation|0
1426822|NCT01005251|4708693|P2|Overall Study|Protocol Violation|0
1426823|NCT01005251|4708694|P1|Overall Study|Protocol Violation|1
1426824|NCT01005251|4708690|P5|Overall Study|Adverse Event|4
1426825|NCT01005251|4708691|P4|Overall Study|Adverse Event|5
1426826|NCT01005251|4708692|P3|Overall Study|Adverse Event|8
1426827|NCT01005251|4708693|P2|Overall Study|Adverse Event|6
1426828|NCT01005251|4708694|P1|Overall Study|Adverse Event|2
1426829|NCT01005251|4708690|P5|Overall Study|Eligibility criteria not fulfilled|0
1426830|NCT01005251|4708691|P4|Overall Study|Eligibility criteria not fulfilled|1
1426831|NCT01005251|4708692|P3|Overall Study|Eligibility criteria not fulfilled|4
1426832|NCT01005251|4708693|P2|Overall Study|Eligibility criteria not fulfilled|0
1426833|NCT01005251|4708694|P1|Overall Study|Eligibility criteria not fulfilled|4
1426834|NCT01005251|4708690|P5|Overall Study|Withdrawal by Subject|9
1426835|NCT01005251|4708691|P4|Overall Study|Withdrawal by Subject|4
1426836|NCT01005251|4708692|P3|Overall Study|Withdrawal by Subject|3
1426837|NCT01005251|4708693|P2|Overall Study|Withdrawal by Subject|5
1426838|NCT01005251|4708694|P1|Overall Study|Withdrawal by Subject|2
1426839|NCT01004848|4708767|P2|Overall Study|Lost to Follow-up|45
1426840|NCT01004848|4708768|P1|Overall Study|Lost to Follow-up|55
1426841|NCT01004822|4708806|P8|Overall Study|Other|0
1426842|NCT01004822|4708807|P7|Overall Study|Other|0
1426843|NCT01004822|4708808|P6|Overall Study|Other|1
1426844|NCT01004822|4708809|P5|Overall Study|Other|0
1426845|NCT01004822|4708810|P4|Overall Study|Other|1
1426846|NCT01004822|4708811|P3|Overall Study|Other|4
1426847|NCT01004822|4708812|P2|Overall Study|Other|0
1426848|NCT01004822|4708813|P1|Overall Study|Other|0
1426849|NCT01004822|4708806|P8|Overall Study|Adverse Event|1
1426850|NCT01004822|4708807|P7|Overall Study|Adverse Event|1
1426851|NCT01004822|4708808|P6|Overall Study|Adverse Event|0
1426852|NCT01004822|4708809|P5|Overall Study|Adverse Event|0
1426853|NCT01004822|4708810|P4|Overall Study|Adverse Event|0
1426854|NCT01004822|4708811|P3|Overall Study|Adverse Event|0
1426855|NCT01004822|4708812|P2|Overall Study|Adverse Event|0
1426856|NCT01004822|4708813|P1|Overall Study|Adverse Event|0
1426857|NCT01004822|4708806|P8|Overall Study|No longer willing to continue|0
1426858|NCT01004822|4708807|P7|Overall Study|No longer willing to continue|1
1426859|NCT01004822|4708808|P6|Overall Study|No longer willing to continue|1
1426860|NCT01004822|4708809|P5|Overall Study|No longer willing to continue|2
1426861|NCT01004822|4708810|P4|Overall Study|No longer willing to continue|1
1426862|NCT01004822|4708811|P3|Overall Study|No longer willing to continue|0
1426863|NCT01004822|4708812|P2|Overall Study|No longer willing to continue|0
1426864|NCT01004822|4708813|P1|Overall Study|No longer willing to continue|0
1426865|NCT01004822|4708806|P8|Overall Study|Global deterioration of health status|0
1426866|NCT01004822|4708807|P7|Overall Study|Global deterioration of health status|1
1426867|NCT01004822|4708808|P6|Overall Study|Global deterioration of health status|0
1426868|NCT01004822|4708809|P5|Overall Study|Global deterioration of health status|0
1426869|NCT01004822|4708810|P4|Overall Study|Global deterioration of health status|1
1426870|NCT01004822|4708811|P3|Overall Study|Global deterioration of health status|0
1426871|NCT01004822|4708812|P2|Overall Study|Global deterioration of health status|0
1426872|NCT01004822|4708813|P1|Overall Study|Global deterioration of health status|0
1426873|NCT01004822|4708806|P8|Overall Study|Objective progression or relapse|4
1426874|NCT01004822|4708807|P7|Overall Study|Objective progression or relapse|1
1426875|NCT01004822|4708808|P6|Overall Study|Objective progression or relapse|2
1426876|NCT01004822|4708809|P5|Overall Study|Objective progression or relapse|2
1426877|NCT01004822|4708810|P4|Overall Study|Objective progression or relapse|1
1426878|NCT01004822|4708811|P3|Overall Study|Objective progression or relapse|0
1426879|NCT01004822|4708812|P2|Overall Study|Objective progression or relapse|3
1426880|NCT01004822|4708813|P1|Overall Study|Objective progression or relapse|3
1426881|NCT01004614|4708978|P4|Washout|Withdrawal by Subject|0
1426882|NCT01004614|4708979|P3|Washout|Withdrawal by Subject|0
1426883|NCT01004614|4708980|P2|Washout|Withdrawal by Subject|1
1426884|NCT01004614|4708981|P1|Washout|Withdrawal by Subject|0
1426885|NCT01004510|4709015|P1|Overall Study|Adverse Event|1
1426886|NCT01004432|4709019|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
1426887|NCT01004432|4709020|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
1426888|NCT01004432|4709021|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
1426889|NCT01004432|4709022|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
1426890|NCT01004432|4709023|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
1426891|NCT01004432|4709019|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
1426892|NCT01004432|4709020|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
1426893|NCT01004432|4709021|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
1426894|NCT01004432|4709022|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
1426895|NCT01004432|4709023|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
1426896|NCT01004432|4709019|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
1426897|NCT01004432|4709020|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
1426898|NCT01004432|4709021|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
1426899|NCT01004432|4709022|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
1426900|NCT01004432|4709023|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
1426901|NCT01004432|4709019|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
1426902|NCT01004432|4709020|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
1426903|NCT01004432|4709021|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
1426904|NCT01004432|4709022|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
1426905|NCT01004432|4709023|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
1426906|NCT01004432|4709019|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
1426907|NCT01004432|4709020|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
1426908|NCT01004432|4709021|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
1426909|NCT01004432|4709022|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
1426910|NCT01004432|4709023|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
1426911|NCT01004432|4709019|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
1426912|NCT01004432|4709020|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
1426913|NCT01004432|4709021|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
1426914|NCT01004432|4709022|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
1426915|NCT01004432|4709023|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
1426916|NCT01004432|4709019|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
1426917|NCT01004432|4709020|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
1426918|NCT01004432|4709021|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
1426919|NCT01004432|4709022|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
1426920|NCT01004432|4709023|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
1426921|NCT01004432|4709019|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
1426922|NCT01004432|4709020|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
1426923|NCT01004432|4709021|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
1426924|NCT01004432|4709022|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
1426925|NCT01004432|4709023|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
1426926|NCT01004432|4709019|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
1426927|NCT01004432|4709020|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
1426928|NCT01004432|4709021|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
1426929|NCT01004432|4709022|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
1426930|NCT01004432|4709023|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
1426931|NCT01004432|4709019|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
1426932|NCT01004432|4709020|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
1426933|NCT01004432|4709021|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
1426934|NCT01004432|4709022|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
1426935|NCT01004432|4709023|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
1426936|NCT01004432|4709019|P5|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
1426937|NCT01004432|4709020|P4|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
1426938|NCT01004432|4709021|P3|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
1426939|NCT01004432|4709022|P2|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
1426940|NCT01004432|4709023|P1|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|2
1426941|NCT01004432|4709019|P5|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
1426942|NCT01004432|4709020|P4|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
1426943|NCT01004432|4709021|P3|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
1426944|NCT01004432|4709022|P2|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
1426945|NCT01004432|4709023|P1|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|15
1426946|NCT01004432|4709019|P5|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
1426947|NCT01004432|4709020|P4|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
1426948|NCT01004432|4709021|P3|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
1426949|NCT01004432|4709022|P2|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
1426950|NCT01004432|4709023|P1|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|17
1426951|NCT01004432|4709019|P5|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
1426952|NCT01004432|4709020|P4|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
1426953|NCT01004432|4709021|P3|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
1426954|NCT01004432|4709022|P2|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
1426955|NCT01004432|4709023|P1|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|29
1426956|NCT01004432|4709019|P5|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
1426957|NCT01004432|4709020|P4|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
1426958|NCT01004432|4709021|P3|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
1426959|NCT01004432|4709022|P2|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
1426960|NCT01004432|4709023|P1|Open-label (OL) Period (Week 0 – 16)|Adverse Event|20
1426961|NCT01004263|4709066|P1|Overall Study|Lack of Qualifying Event|2
1426962|NCT01004263|4709066|P1|Overall Study|Physician Decision|15
1426963|NCT01004263|4709066|P1|Overall Study|Pregnancy|2
1426964|NCT01004263|4709066|P1|Overall Study|Lack of Efficacy|13
1426965|NCT01004263|4709066|P1|Overall Study|Lost to Follow-up|64
1426966|NCT01004263|4709066|P1|Overall Study|Protocol Violation|10
1426967|NCT01004263|4709066|P1|Overall Study|Withdrawal by Subject|58
1426968|NCT01004263|4709066|P1|Overall Study|Adverse Event|15
1426969|NCT01004250|4709074|P1|Follow-Up (FU) Period|Lost to Follow-up|1
1426970|NCT01004250|4709074|P1|Maintenance Therapy Period|Physician Decision|4
1426971|NCT01004250|4709074|P1|Maintenance Therapy Period|Withdrawal by Subject|5
1426972|NCT01004250|4709074|P1|Maintenance Therapy Period|Protocol Violation|1
1426973|NCT01004250|4709074|P1|Maintenance Therapy Period|Lost to Follow-up|1
1426974|NCT01004250|4709074|P1|Maintenance Therapy Period|Adverse Event|15
1426975|NCT01004250|4709074|P1|Induction Therapy Period|Physician Decision|2
1426976|NCT01004250|4709074|P1|Induction Therapy Period|Withdrawal by Subject|2
1426977|NCT01004250|4709074|P1|Induction Therapy Period|Entry Criteria Not Met|1
1426978|NCT01004250|4709074|P1|Induction Therapy Period|Adverse Event|10
1426979|NCT01004185|4709086|P2|Overall Study|Withdrawal by Subject|1
1426980|NCT01004185|4709087|P1|Overall Study|Withdrawal by Subject|2
1426981|NCT01004185|4709086|P2|Overall Study|Sponsor Terminated Study|5
1426982|NCT01004185|4709087|P1|Overall Study|Sponsor Terminated Study|4
1426983|NCT01004185|4709086|P2|Overall Study|Lack of Efficacy|1
1426984|NCT01004185|4709087|P1|Overall Study|Lack of Efficacy|2
1426985|NCT01004185|4709086|P2|Overall Study|Lost to Follow-up|1
1426986|NCT01004185|4709087|P1|Overall Study|Lost to Follow-up|0
1426987|NCT01004185|4709086|P2|Overall Study|Adverse Event|1
1426988|NCT01004185|4709087|P1|Overall Study|Adverse Event|1
1426989|NCT01004172|4709095|P1|Overall Study|Symptomatic Deterioration|2
1426990|NCT01004172|4709095|P1|Overall Study|Physician Decision|1
1426991|NCT01004172|4709095|P1|Overall Study|Adverse Event|1
1426992|NCT01004172|4709095|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
1426993|NCT01004172|4709095|P1|Overall Study|Progressive Disease in Non-CNS Only|16
1426994|NCT01004172|4709095|P1|Overall Study|Progressive Disease in CNS Only|16
1426995|NCT01004159|4709101|P1|Overall Study|Disease Progression|18
1426996|NCT01004159|4709101|P1|Overall Study|Adverse Event|2
1426997|NCT01004146|4709108|P2|Overall Study|Withdrawal by Subject|5
1426998|NCT01004146|4709109|P1|Overall Study|Withdrawal by Subject|4
1426999|NCT01004003|4709203|P9|Overall Study|Other|0
1427000|NCT01004003|4709204|P8|Overall Study|Other|0
1427001|NCT01004003|4709205|P7|Overall Study|Other|0
1427002|NCT01004003|4709206|P6|Overall Study|Other|1
1427003|NCT01004003|4709207|P5|Overall Study|Other|0
1427004|NCT01004003|4709208|P4|Overall Study|Other|0
1427005|NCT01004003|4709209|P3|Overall Study|Other|0
1427006|NCT01004003|4709210|P2|Overall Study|Other|0
1427007|NCT01004003|4709211|P1|Overall Study|Other|0
1427008|NCT01004003|4709203|P9|Overall Study|Refused to continue taking trial med.|2
1427009|NCT01004003|4709204|P8|Overall Study|Refused to continue taking trial med.|0
1427010|NCT01004003|4709205|P7|Overall Study|Refused to continue taking trial med.|0
1427011|NCT01004003|4709206|P6|Overall Study|Refused to continue taking trial med.|0
1427012|NCT01004003|4709207|P5|Overall Study|Refused to continue taking trial med.|0
1427013|NCT01004003|4709208|P4|Overall Study|Refused to continue taking trial med.|0
1427014|NCT01004003|4709209|P3|Overall Study|Refused to continue taking trial med.|0
1427015|NCT01004003|4709210|P2|Overall Study|Refused to continue taking trial med.|0
1427016|NCT01004003|4709211|P1|Overall Study|Refused to continue taking trial med.|0
1427017|NCT01004003|4709203|P9|Overall Study|Adverse Event|6
1427018|NCT01004003|4709204|P8|Overall Study|Adverse Event|21
1427019|NCT01004003|4709205|P7|Overall Study|Adverse Event|7
1427020|NCT01004003|4709206|P6|Overall Study|Adverse Event|2
1427021|NCT01004003|4709207|P5|Overall Study|Adverse Event|2
1427022|NCT01004003|4709208|P4|Overall Study|Adverse Event|3
1427023|NCT01004003|4709209|P3|Overall Study|Adverse Event|3
1427024|NCT01004003|4709210|P2|Overall Study|Adverse Event|2
1427025|NCT01004003|4709211|P1|Overall Study|Adverse Event|4
1427026|NCT01004003|4709203|P9|Overall Study|Progressive disease|22
1427027|NCT01004003|4709204|P8|Overall Study|Progressive disease|39
1427028|NCT01004003|4709205|P7|Overall Study|Progressive disease|1
1427029|NCT01004003|4709206|P6|Overall Study|Progressive disease|1
1427030|NCT01004003|4709207|P5|Overall Study|Progressive disease|2
1427031|NCT01004003|4709208|P4|Overall Study|Progressive disease|0
1427032|NCT01004003|4709209|P3|Overall Study|Progressive disease|1
1427033|NCT01004003|4709210|P2|Overall Study|Progressive disease|1
1427034|NCT01004003|4709211|P1|Overall Study|Progressive disease|2
1427035|NCT01003990|4709242|P3|Overall Study|Subject Withdrew Consent|7
1427036|NCT01003990|4709243|P2|Overall Study|Subject Withdrew Consent|5
1427037|NCT01003990|4709244|P1|Overall Study|Subject Withdrew Consent|12
1427038|NCT01003990|4709242|P3|Overall Study|No Longer Met Study Criteria|0
1427039|NCT01003990|4709243|P2|Overall Study|No Longer Met Study Criteria|1
1427040|NCT01003990|4709244|P1|Overall Study|No Longer Met Study Criteria|4
1427041|NCT01003990|4709242|P3|Overall Study|Pregnancy|4
1427042|NCT01003990|4709243|P2|Overall Study|Pregnancy|2
1427043|NCT01003990|4709244|P1|Overall Study|Pregnancy|10
1427044|NCT01003990|4709242|P3|Overall Study|Poor/Non-compliance|2
1427045|NCT01003990|4709243|P2|Overall Study|Poor/Non-compliance|3
1427046|NCT01003990|4709244|P1|Overall Study|Poor/Non-compliance|4
1427047|NCT01003990|4709242|P3|Overall Study|Reasons Not Identified|8
1427048|NCT01003990|4709243|P2|Overall Study|Reasons Not Identified|13
1427049|NCT01003990|4709244|P1|Overall Study|Reasons Not Identified|14
1427050|NCT01003990|4709242|P3|Overall Study|Lost to Follow-up|7
1427051|NCT01003990|4709243|P2|Overall Study|Lost to Follow-up|12
1427052|NCT01003990|4709244|P1|Overall Study|Lost to Follow-up|30
1427053|NCT01003990|4709242|P3|Overall Study|Lack of Efficacy|3
1427054|NCT01003990|4709243|P2|Overall Study|Lack of Efficacy|2
1427055|NCT01003990|4709244|P1|Overall Study|Lack of Efficacy|10
1427056|NCT01003990|4709242|P3|Overall Study|Death|1
1427057|NCT01003990|4709243|P2|Overall Study|Death|8
1427058|NCT01003990|4709244|P1|Overall Study|Death|0
1427059|NCT01003990|4709242|P3|Overall Study|Adverse Event|11
1427060|NCT01003990|4709243|P2|Overall Study|Adverse Event|5
1427061|NCT01003990|4709244|P1|Overall Study|Adverse Event|8
1427062|NCT01003899|4709261|P1|Overall Study|Progressive disease|34
1427063|NCT01003899|4709261|P1|Overall Study|Not treated|1
1427064|NCT01003899|4709261|P1|Overall Study|Not entered|4
1427065|NCT01003899|4709261|P1|Overall Study|Other Adverse Event|8
1427066|NCT01003886|4709270|P1|Overall Study|Adverse Event|3
1427067|NCT01003886|4709270|P1|Overall Study|Other|14
1427068|NCT01003886|4709270|P1|Overall Study|Withdrawal by Subject|39
1427069|NCT01003886|4709270|P1|Overall Study|Lost to Follow-up|169
1427070|NCT01003886|4709270|P1|Overall Study|Lack of Efficacy|5
1427071|NCT01003249|4709304|P2|Second Intervention (4 Weeks)|Adverse Event|0
1427072|NCT01003249|4709305|P1|Second Intervention (4 Weeks)|Adverse Event|1
1427073|NCT01003249|4709304|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1427074|NCT01003249|4709305|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|0
1427075|NCT01003249|4709304|P2|First Intervention (4 Weeks)|Non-Serious Event|1
1427076|NCT01003249|4709305|P1|First Intervention (4 Weeks)|Non-Serious Event|1
1427077|NCT01003249|4709304|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
1427078|NCT01003249|4709305|P1|First Intervention (4 Weeks)|Withdrawal by Subject|1
1427079|NCT01003210|4709323|P2|Overall Study|Lost to Follow-up|3
1427080|NCT01003210|4709324|P1|Overall Study|Lost to Follow-up|1
1427081|NCT01003184|4709336|P2|Overall Study|Physician Decision|0
1427082|NCT01003184|4709337|P1|Overall Study|Physician Decision|1
1427083|NCT01003184|4709336|P2|Overall Study|Withdrawal by Subject|6
1427084|NCT01003184|4709337|P1|Overall Study|Withdrawal by Subject|1
1427085|NCT01003184|4709336|P2|Overall Study|Protocol Violation|0
1427086|NCT01003184|4709337|P1|Overall Study|Protocol Violation|3
1427087|NCT01003184|4709336|P2|Overall Study|Loss of glucose control|1
1427088|NCT01003184|4709337|P1|Overall Study|Loss of glucose control|1
1427089|NCT01003184|4709336|P2|Overall Study|Lost to Follow-up|0
1427090|NCT01003184|4709337|P1|Overall Study|Lost to Follow-up|1
1427091|NCT01003184|4709336|P2|Overall Study|Adverse Event|5
1427092|NCT01003184|4709337|P1|Overall Study|Adverse Event|12
1427093|NCT01002989|4709420|P1|Overall Study|exclusion criteria, no consent|5
1427094|NCT01002742|4709429|P2|Overall Study|Determined to be ineligible|1
1427095|NCT01002742|4709430|P1|Overall Study|Determined to be ineligible|0
1427096|NCT01002573|4709466|P2|Overall Study|Subject did not receive at least 1 dose|7
1427097|NCT01002573|4709467|P1|Overall Study|Subject did not receive at least 1 dose|11
1427098|NCT01002482|4709487|P2|Overall Study|Included twice|0
1427099|NCT01002482|4709488|P1|Overall Study|Included twice|1
1427100|NCT01002482|4709487|P2|Overall Study|Withdrawal by Subject|21
1427101|NCT01002482|4709488|P1|Overall Study|Withdrawal by Subject|14
1427102|NCT01002339|4709522|P3|Overall Study|Randomized. Not transplanted|1
1427103|NCT01002339|4709523|P2|Overall Study|Randomized. Not transplanted|0
1427104|NCT01002339|4709524|P1|Overall Study|Randomized. Not transplanted|0
1427105|NCT01002339|4709522|P3|Overall Study|Lung cancer detected before transplant|1
1427106|NCT01002339|4709523|P2|Overall Study|Lung cancer detected before transplant|0
1427107|NCT01002339|4709524|P1|Overall Study|Lung cancer detected before transplant|0
1427108|NCT01002339|4709522|P3|Overall Study|Protocol Violation|2
1427109|NCT01002339|4709523|P2|Overall Study|Protocol Violation|0
1427110|NCT01002339|4709524|P1|Overall Study|Protocol Violation|0
1427111|NCT01002339|4709522|P3|Overall Study|Incorrect treatment assignment|1
1427112|NCT01002339|4709523|P2|Overall Study|Incorrect treatment assignment|0
1427113|NCT01002339|4709524|P1|Overall Study|Incorrect treatment assignment|0
1427114|NCT01002339|4709522|P3|Overall Study|Withdrawal by Subject|0
1427115|NCT01002339|4709523|P2|Overall Study|Withdrawal by Subject|1
1427116|NCT01002339|4709524|P1|Overall Study|Withdrawal by Subject|0
1427117|NCT01002105|4709600|P2|Overall Study|condition worsened|2
1427118|NCT01002105|4709601|P1|Overall Study|condition worsened|4
1427119|NCT01002105|4709600|P2|Overall Study|non compliance|3
1427120|NCT01002105|4709601|P1|Overall Study|non compliance|5
1427121|NCT01002105|4709600|P2|Overall Study|Lost to Follow-up|16
1427122|NCT01002105|4709601|P1|Overall Study|Lost to Follow-up|10
1427123|NCT01001988|4709617|P1|Overall Study|Lost to Follow-up|15
1427124|NCT01001988|4709617|P1|Overall Study|Withdrawal by Subject|18
1427125|NCT01001988|4709617|P1|Overall Study|Protocol Violation|84
1427126|NCT01001832|4709635|P2|Follow-up Period|Not specified|1
1427127|NCT01001832|4709636|P1|Follow-up Period|Not specified|2
1427128|NCT01001832|4709635|P2|Follow-up Period|Follow-up no longer required /protocol|20
1427129|NCT01001832|4709636|P1|Follow-up Period|Follow-up no longer required /protocol|15
1427130|NCT01001832|4709635|P2|Follow-up Period|Withdrawal by Subject|0
1427131|NCT01001832|4709636|P1|Follow-up Period|Withdrawal by Subject|1
1427132|NCT01001832|4709635|P2|Long-term Period|Not specified|2
1427133|NCT01001832|4709636|P1|Long-term Period|Not specified|1
1427134|NCT01001832|4709635|P2|Long-term Period|Lack of Efficacy|2
1427135|NCT01001832|4709636|P1|Long-term Period|Lack of Efficacy|0
1427136|NCT01001832|4709635|P2|Long-term Period|Withdrawal by Subject|0
1427137|NCT01001832|4709636|P1|Long-term Period|Withdrawal by Subject|1
1427138|NCT01001832|4709635|P2|Long-term Period|Adverse Event|1
1427139|NCT01001832|4709636|P1|Long-term Period|Adverse Event|2
1427140|NCT01001832|4709635|P2|Short-term Period|Adverse Event|3
1427141|NCT01001832|4709636|P1|Short-term Period|Adverse Event|2
1427142|NCT01001767|4709694|P2|Overall Study|Physician Decision|0
1427143|NCT01001767|4709695|P1|Overall Study|Physician Decision|1
1427144|NCT01001767|4709694|P2|Overall Study|Lost to Follow-up|0
1427145|NCT01001767|4709695|P1|Overall Study|Lost to Follow-up|1
1427146|NCT01001767|4709694|P2|Overall Study|Protocol Violation|0
1427147|NCT01001767|4709695|P1|Overall Study|Protocol Violation|1
1427148|NCT01001767|4709694|P2|Overall Study|no baseline study performed|0
1427149|NCT01001767|4709695|P1|Overall Study|no baseline study performed|1
1427150|NCT01001702|4709701|P1|Overall Study|Lack of Efficacy per Investigator|3
1427151|NCT01001702|4709701|P1|Overall Study|Withdrawal by Subject|19
1427152|NCT01001702|4709701|P1|Overall Study|Investigator withdrew Subject|10
1427153|NCT01001702|4709701|P1|Overall Study|Subject met Withdrawal Criteria|22
1427154|NCT01001702|4709701|P1|Overall Study|Sponsor Discontinued Study|4
1427155|NCT01001702|4709701|P1|Overall Study|Adverse Event|7
1427156|NCT01001702|4709701|P1|Overall Study|Lost to Follow-up|7
1427157|NCT01001572|4709714|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
1427158|NCT01001572|4709715|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
1427159|NCT01001572|4709716|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
1427160|NCT01001572|4709714|P3|Double-Blind Treatment Phase|Protocol deviation|1
1427161|NCT01001572|4709715|P2|Double-Blind Treatment Phase|Protocol deviation|0
1427162|NCT01001572|4709716|P1|Double-Blind Treatment Phase|Protocol deviation|0
1427163|NCT01001572|4709714|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
1427164|NCT01001572|4709715|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
1427165|NCT01001572|4709716|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
1427166|NCT01001572|4709714|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
1427167|NCT01001572|4709715|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
1427168|NCT01001572|4709716|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
1427169|NCT01001572|4709714|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
1427170|NCT01001572|4709715|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
1427171|NCT01001572|4709716|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
1427172|NCT01001572|4709714|P3|Double-Blind Treatment Phase|Adverse Event|2
1427173|NCT01001572|4709715|P2|Double-Blind Treatment Phase|Adverse Event|2
1427174|NCT01001572|4709716|P1|Double-Blind Treatment Phase|Adverse Event|0
1427175|NCT01001572|4709714|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
1427176|NCT01001572|4709715|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
1427177|NCT01001572|4709716|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
1427178|NCT01001572|4709714|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
1427179|NCT01001572|4709715|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
1427180|NCT01001572|4709716|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
1427181|NCT01001572|4709714|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
1427182|NCT01001572|4709715|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
1427183|NCT01001572|4709716|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
1427184|NCT01001572|4709714|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
1427185|NCT01001572|4709715|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
1427186|NCT01001572|4709716|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
1427187|NCT01001572|4709714|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
1427188|NCT01001572|4709715|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
1427189|NCT01001572|4709716|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
1427190|NCT01001572|4709714|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
1427191|NCT01001572|4709715|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
1427192|NCT01001572|4709716|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
1427193|NCT01001572|4709714|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
1427194|NCT01001572|4709715|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
1427195|NCT01001572|4709716|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
1427196|NCT01001572|4709714|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
1427197|NCT01001572|4709715|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
1427198|NCT01001572|4709716|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
1427199|NCT01001520|4709754|P2|Medication Period 2|Withdrawal by Subject|3
1427200|NCT01001520|4709755|P1|Medication Period 2|Withdrawal by Subject|0
1427201|NCT01001520|4709754|P2|Washout Period|Withdrawal by Subject|1
1427202|NCT01001520|4709755|P1|Washout Period|Withdrawal by Subject|2
1427203|NCT01001520|4709754|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
1427204|NCT01001520|4709755|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
1427205|NCT01001520|4709754|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
1427206|NCT01001520|4709755|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
1427207|NCT01001520|4709754|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
1427208|NCT01001520|4709755|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
1427209|NCT01001520|4709754|P2|Medication Period 1|Withdrawal by Subject|2
1427210|NCT01001520|4709755|P1|Medication Period 1|Withdrawal by Subject|2
1427211|NCT01001494|4709782|P3|Overall Study|Other|3
1427212|NCT01001494|4709783|P2|Overall Study|Other|1
1427213|NCT01001494|4709784|P1|Overall Study|Other|0
1427214|NCT01001494|4709782|P3|Overall Study|Lack of Efficacy|8
1427215|NCT01001494|4709783|P2|Overall Study|Lack of Efficacy|0
1427216|NCT01001494|4709784|P1|Overall Study|Lack of Efficacy|2
1427217|NCT01001494|4709782|P3|Overall Study|COPD exacerbation|5
1427218|NCT01001494|4709783|P2|Overall Study|COPD exacerbation|4
1427219|NCT01001494|4709784|P1|Overall Study|COPD exacerbation|3
1427220|NCT01001494|4709782|P3|Overall Study|Withdrawal by Subject|17
1427221|NCT01001494|4709783|P2|Overall Study|Withdrawal by Subject|7
1427222|NCT01001494|4709784|P1|Overall Study|Withdrawal by Subject|9
1427223|NCT01001494|4709782|P3|Overall Study|Lost to Follow-up|1
1427224|NCT01001494|4709783|P2|Overall Study|Lost to Follow-up|0
1427225|NCT01001494|4709784|P1|Overall Study|Lost to Follow-up|2
1427226|NCT01001494|4709782|P3|Overall Study|Protocol Violation|1
1427227|NCT01001494|4709783|P2|Overall Study|Protocol Violation|1
1427228|NCT01001494|4709784|P1|Overall Study|Protocol Violation|0
1427229|NCT01001494|4709782|P3|Overall Study|Adverse Event|6
1427230|NCT01001494|4709783|P2|Overall Study|Adverse Event|4
1427231|NCT01001494|4709784|P1|Overall Study|Adverse Event|8
1427232|NCT01001429|4709869|P2|Overall Study|surgery cancelled|1
1427233|NCT01001429|4709870|P1|Overall Study|surgery cancelled|0
1427234|NCT01001390|4709909|P2|Overall Study|Failure to wear AFO device|0
1427235|NCT01001390|4709910|P1|Overall Study|Failure to wear AFO device|2
1427236|NCT01001377|4709918|P2|Overall Study|Death|384
1427237|NCT01001377|4709919|P1|Overall Study|Death|391
1427238|NCT01001377|4709918|P2|Overall Study|Lost to Follow-up|17
1427239|NCT01001377|4709919|P1|Overall Study|Lost to Follow-up|14
1427240|NCT01001377|4709918|P2|Overall Study|Withdrawal by Subject|20
1427241|NCT01001377|4709919|P1|Overall Study|Withdrawal by Subject|19
1427242|NCT01001377|4709918|P2|Overall Study|Ineligibility determined|0
1427243|NCT01001377|4709919|P1|Overall Study|Ineligibility determined|2
1427244|NCT01001325|4709949|P2|Overall Study|Protocol Violation|0
1427245|NCT01001325|4709950|P1|Overall Study|Protocol Violation|2
1427246|NCT01001325|4709949|P2|Overall Study|Lost to Follow-up|10
1427247|NCT01001325|4709950|P1|Overall Study|Lost to Follow-up|16
1427248|NCT01001299|4709956|P1|Overall Study|Withdrew Consent|1
1427249|NCT01001299|4709956|P1|Overall Study|Began Taking Commercially Available Drug|2
1427250|NCT01001299|4709956|P1|Overall Study|Death|1
1427251|NCT01001299|4709956|P1|Overall Study|Adverse event or Intercurrent Illness|1
1427252|NCT01001299|4709956|P1|Overall Study|Insufficient Therapeutic Response|20
1427253|NCT01001234|4709985|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
1427254|NCT01001234|4709986|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
1427255|NCT01001234|4709987|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
1427256|NCT01001234|4709988|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
1427257|NCT01001234|4709989|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
1427258|NCT01001234|4709985|P5|Overall Study|Not Treated: Physician Decision|0
1427259|NCT01001234|4709986|P4|Overall Study|Not Treated: Physician Decision|0
1427260|NCT01001234|4709987|P3|Overall Study|Not Treated: Physician Decision|0
1427261|NCT01001234|4709988|P2|Overall Study|Not Treated: Physician Decision|4
1427262|NCT01001234|4709989|P1|Overall Study|Not Treated: Physician Decision|37
1427263|NCT01001234|4709985|P5|Overall Study|Not Treated: Pregnancy|0
1427264|NCT01001234|4709986|P4|Overall Study|Not Treated: Pregnancy|0
1427265|NCT01001234|4709987|P3|Overall Study|Not Treated: Pregnancy|0
1427266|NCT01001234|4709988|P2|Overall Study|Not Treated: Pregnancy|0
1427267|NCT01001234|4709989|P1|Overall Study|Not Treated: Pregnancy|3
1427268|NCT01001234|4709985|P5|Overall Study|Not Treated: Lost to Follow-up|0
1427269|NCT01001234|4709986|P4|Overall Study|Not Treated: Lost to Follow-up|5
1427270|NCT01001234|4709987|P3|Overall Study|Not Treated: Lost to Follow-up|7
1427271|NCT01001234|4709988|P2|Overall Study|Not Treated: Lost to Follow-up|4
1427272|NCT01001234|4709989|P1|Overall Study|Not Treated: Lost to Follow-up|53
1427273|NCT01001234|4709985|P5|Overall Study|Not Treated: Protocol Violation|0
1427274|NCT01001234|4709986|P4|Overall Study|Not Treated: Protocol Violation|0
1427275|NCT01001234|4709987|P3|Overall Study|Not Treated: Protocol Violation|0
1427276|NCT01001234|4709988|P2|Overall Study|Not Treated: Protocol Violation|0
1427277|NCT01001234|4709989|P1|Overall Study|Not Treated: Protocol Violation|3
1427278|NCT01001234|4709985|P5|Overall Study|Not Treated: Withdrawal by Subject|0
1427279|NCT01001234|4709986|P4|Overall Study|Not Treated: Withdrawal by Subject|0
1427280|NCT01001234|4709987|P3|Overall Study|Not Treated: Withdrawal by Subject|2
1427281|NCT01001234|4709988|P2|Overall Study|Not Treated: Withdrawal by Subject|2
1427282|NCT01001234|4709989|P1|Overall Study|Not Treated: Withdrawal by Subject|23
1427283|NCT01001234|4709985|P5|Overall Study|Not Treated: Adverse Event|0
1427284|NCT01001234|4709986|P4|Overall Study|Not Treated: Adverse Event|0
1427285|NCT01001234|4709987|P3|Overall Study|Not Treated: Adverse Event|0
1427286|NCT01001234|4709988|P2|Overall Study|Not Treated: Adverse Event|0
1427287|NCT01001234|4709989|P1|Overall Study|Not Treated: Adverse Event|1
1427288|NCT01001234|4709985|P5|Overall Study|Physician Decision|0
1427289|NCT01001234|4709986|P4|Overall Study|Physician Decision|0
1427290|NCT01001234|4709987|P3|Overall Study|Physician Decision|0
1427291|NCT01001234|4709988|P2|Overall Study|Physician Decision|0
1427292|NCT01001234|4709989|P1|Overall Study|Physician Decision|1
1427293|NCT01001234|4709985|P5|Overall Study|Lost to Follow-up|0
1427294|NCT01001234|4709986|P4|Overall Study|Lost to Follow-up|2
1427295|NCT01001234|4709987|P3|Overall Study|Lost to Follow-up|1
1427296|NCT01001234|4709988|P2|Overall Study|Lost to Follow-up|0
1427297|NCT01001234|4709989|P1|Overall Study|Lost to Follow-up|0
1427298|NCT01001234|4709985|P5|Overall Study|Protocol Violation|0
1427299|NCT01001234|4709986|P4|Overall Study|Protocol Violation|18
1427300|NCT01001234|4709987|P3|Overall Study|Protocol Violation|19
1427301|NCT01001234|4709988|P2|Overall Study|Protocol Violation|3
1427302|NCT01001234|4709989|P1|Overall Study|Protocol Violation|34
1427303|NCT01001234|4709985|P5|Overall Study|Withdrawal by Subject|0
1427304|NCT01001234|4709986|P4|Overall Study|Withdrawal by Subject|0
1427305|NCT01001234|4709987|P3|Overall Study|Withdrawal by Subject|3
1427306|NCT01001234|4709988|P2|Overall Study|Withdrawal by Subject|0
1427307|NCT01001234|4709989|P1|Overall Study|Withdrawal by Subject|2
1427308|NCT01001221|4710005|P5|Overall Study|Not treated; protocol exclusion|0
1427309|NCT01001221|4710006|P4|Overall Study|Not treated; protocol exclusion|0
1427310|NCT01001221|4710007|P3|Overall Study|Not treated; protocol exclusion|1
1427311|NCT01001221|4710008|P2|Overall Study|Not treated; protocol exclusion|0
1427312|NCT01001221|4710009|P1|Overall Study|Not treated; protocol exclusion|0
1427313|NCT01001221|4710005|P5|Overall Study|Not specified|0
1427314|NCT01001221|4710006|P4|Overall Study|Not specified|0
1427315|NCT01001221|4710007|P3|Overall Study|Not specified|0
1427316|NCT01001221|4710008|P2|Overall Study|Not specified|1
1427317|NCT01001221|4710009|P1|Overall Study|Not specified|1
1427318|NCT01001221|4710005|P5|Overall Study|Disease progression|0
1427319|NCT01001221|4710006|P4|Overall Study|Disease progression|4
1427320|NCT01001221|4710007|P3|Overall Study|Disease progression|2
1427321|NCT01001221|4710008|P2|Overall Study|Disease progression|2
1427322|NCT01001221|4710009|P1|Overall Study|Disease progression|3
1427323|NCT01001221|4710005|P5|Overall Study|Adverse Event|0
1427324|NCT01001221|4710006|P4|Overall Study|Adverse Event|2
1427325|NCT01001221|4710007|P3|Overall Study|Adverse Event|0
1427326|NCT01001221|4710008|P2|Overall Study|Adverse Event|2
1427327|NCT01001221|4710009|P1|Overall Study|Adverse Event|1
1427328|NCT01001208|4710184|P2|Overall Study|Other|2
1427329|NCT01001208|4710185|P1|Overall Study|Other|0
1427330|NCT01001208|4710184|P2|Overall Study|Disease Progression|3
1427331|NCT01001208|4710185|P1|Overall Study|Disease Progression|0
1427332|NCT01001208|4710184|P2|Overall Study|Noncompliance|7
1427333|NCT01001208|4710185|P1|Overall Study|Noncompliance|4
1427334|NCT01001208|4710184|P2|Overall Study|Ineligibility Determined|2
1427335|NCT01001208|4710185|P1|Overall Study|Ineligibility Determined|4
1427336|NCT01001208|4710184|P2|Overall Study|Withdrawal by Subject|5
1427337|NCT01001208|4710185|P1|Overall Study|Withdrawal by Subject|4
1427338|NCT01001208|4710184|P2|Overall Study|Physician Decision|0
1427339|NCT01001208|4710185|P1|Overall Study|Physician Decision|1
1427340|NCT01001208|4710184|P2|Overall Study|Lost to Follow-up|9
1427341|NCT01001208|4710185|P1|Overall Study|Lost to Follow-up|5
1427342|NCT01001208|4710184|P2|Overall Study|Adverse Event|5
1427343|NCT01001208|4710185|P1|Overall Study|Adverse Event|10
1427344|NCT01001169|4710228|P2|Overall Study|Withdrawal by Subject|1
1427345|NCT01001169|4710229|P1|Overall Study|Withdrawal by Subject|2
1427346|NCT01001104|4710337|P4|Overall Study|Withdrawal by Subject|2
1427347|NCT01001104|4710338|P3|Overall Study|Withdrawal by Subject|0
1427348|NCT01001104|4710339|P2|Overall Study|Withdrawal by Subject|0
1427349|NCT01001104|4710340|P1|Overall Study|Withdrawal by Subject|0
1427350|NCT01001104|4710337|P4|Overall Study|Entry Criteria Not Met|1
1427351|NCT01001104|4710338|P3|Overall Study|Entry Criteria Not Met|0
1427352|NCT01001104|4710339|P2|Overall Study|Entry Criteria Not Met|0
1427353|NCT01001104|4710340|P1|Overall Study|Entry Criteria Not Met|0
1427354|NCT01001104|4710337|P4|Overall Study|Lost to Follow-up|0
1427355|NCT01001104|4710338|P3|Overall Study|Lost to Follow-up|1
1427356|NCT01001104|4710339|P2|Overall Study|Lost to Follow-up|0
1427357|NCT01001104|4710340|P1|Overall Study|Lost to Follow-up|0
1427358|NCT01001104|4710337|P4|Overall Study|Adverse Event|0
1427359|NCT01001104|4710338|P3|Overall Study|Adverse Event|0
1427360|NCT01001104|4710339|P2|Overall Study|Adverse Event|1
1427361|NCT01001104|4710340|P1|Overall Study|Adverse Event|2
1427362|NCT01000974|4710431|P3|Booster Vaccination Phase|Other|4
1427363|NCT01000974|4710432|P2|Booster Vaccination Phase|Other|6
1427364|NCT01000974|4710433|P1|Booster Vaccination Phase|Other|24
1427365|NCT01000974|4710431|P3|Booster Vaccination Phase|Lost to Follow-up|7
1427366|NCT01000974|4710432|P2|Booster Vaccination Phase|Lost to Follow-up|5
1427367|NCT01000974|4710433|P1|Booster Vaccination Phase|Lost to Follow-up|40
1427368|NCT01000974|4710431|P3|Booster Vaccination Phase|Withdrawal by Subject|1
1427369|NCT01000974|4710432|P2|Booster Vaccination Phase|Withdrawal by Subject|1
1427370|NCT01000974|4710433|P1|Booster Vaccination Phase|Withdrawal by Subject|3
1427371|NCT01000974|4710431|P3|Booster Vaccination Phase|Protocol Violation|2
1427372|NCT01000974|4710432|P2|Booster Vaccination Phase|Protocol Violation|0
1427373|NCT01000974|4710433|P1|Booster Vaccination Phase|Protocol Violation|0
1427374|NCT01000974|4710431|P3|Primary Vaccination Phase|Other|12
1427375|NCT01000974|4710432|P2|Primary Vaccination Phase|Other|9
1427376|NCT01000974|4710433|P1|Primary Vaccination Phase|Other|4
1427377|NCT01000974|4710431|P3|Primary Vaccination Phase|Adverse Event|2
1427378|NCT01000974|4710432|P2|Primary Vaccination Phase|Adverse Event|2
1427379|NCT01000974|4710433|P1|Primary Vaccination Phase|Adverse Event|14
1427380|NCT01000974|4710431|P3|Primary Vaccination Phase|Protocol Violation|2
1427381|NCT01000974|4710432|P2|Primary Vaccination Phase|Protocol Violation|3
1427382|NCT01000974|4710433|P1|Primary Vaccination Phase|Protocol Violation|40
1427383|NCT01000974|4710431|P3|Primary Vaccination Phase|Lost to Follow-up|26
1427384|NCT01000974|4710432|P2|Primary Vaccination Phase|Lost to Follow-up|19
1427385|NCT01000974|4710433|P1|Primary Vaccination Phase|Lost to Follow-up|171
1427386|NCT01000974|4710431|P3|Primary Vaccination Phase|Withdrawal by Subject|21
1427387|NCT01000974|4710432|P2|Primary Vaccination Phase|Withdrawal by Subject|17
1427388|NCT01000974|4710433|P1|Primary Vaccination Phase|Withdrawal by Subject|109
1427389|NCT01000961|4710540|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
1427390|NCT01000961|4710541|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
1427391|NCT01000961|4710540|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
1427392|NCT01000961|4710541|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
1427393|NCT01000805|4710564|P2|Overall Study|Sponsor Decision|1
1427394|NCT01000805|4710565|P1|Overall Study|Sponsor Decision|0
1427395|NCT01000805|4710564|P2|Overall Study|Withdrawal by Subject|6
1427396|NCT01000805|4710565|P1|Overall Study|Withdrawal by Subject|16
1427397|NCT01000805|4710564|P2|Overall Study|Protocol Violation|8
1427398|NCT01000805|4710565|P1|Overall Study|Protocol Violation|12
1427399|NCT01000805|4710564|P2|Overall Study|Physician Decision|1
1427400|NCT01000805|4710565|P1|Overall Study|Physician Decision|0
1427401|NCT01000805|4710564|P2|Overall Study|Lost to Follow-up|21
1427402|NCT01000805|4710565|P1|Overall Study|Lost to Follow-up|16
1427403|NCT01000805|4710564|P2|Overall Study|Lack of Efficacy|16
1427404|NCT01000805|4710565|P1|Overall Study|Lack of Efficacy|5
1427405|NCT01000805|4710564|P2|Overall Study|Adverse Event|9
1427406|NCT01000805|4710565|P1|Overall Study|Adverse Event|21
1427407|NCT01000727|4710599|P2|Overall Study|Study closed/terminated|24
1427408|NCT01000727|4710600|P1|Overall Study|Study closed/terminated|23
1427409|NCT01000727|4710599|P2|Overall Study|Withdrawal by Subject|109
1427410|NCT01000727|4710600|P1|Overall Study|Withdrawal by Subject|111
1427411|NCT01000727|4710599|P2|Overall Study|Lost to Follow-up|43
1427412|NCT01000727|4710600|P1|Overall Study|Lost to Follow-up|41
1427413|NCT01000649|4710641|P4|Overall Study|Lost to Follow-up|2
1427414|NCT01000649|4710642|P3|Overall Study|Lost to Follow-up|0
1427415|NCT01000649|4710643|P2|Overall Study|Lost to Follow-up|2
1427416|NCT01000649|4710644|P1|Overall Study|Lost to Follow-up|0
1427417|NCT01000649|4710641|P4|Overall Study|Adverse Event|4
1427418|NCT01000649|4710642|P3|Overall Study|Adverse Event|2
1427419|NCT01000649|4710643|P2|Overall Study|Adverse Event|1
1427420|NCT01000649|4710644|P1|Overall Study|Adverse Event|5
1427421|NCT01000610|4710725|P1|Overall Study|Treatment failure|1
1427422|NCT01000610|4710725|P1|Overall Study|Lost to Follow-up|4
1427423|NCT01000610|4710725|P1|Overall Study|Adverse Event|1
1427424|NCT01000506|4710736|P4|Overall Study|Withdrawal by Subject|7
1427425|NCT01000506|4710737|P3|Overall Study|Withdrawal by Subject|2
1427426|NCT01000506|4710738|P2|Overall Study|Withdrawal by Subject|8
1427427|NCT01000506|4710739|P1|Overall Study|Withdrawal by Subject|11
1427428|NCT01000506|4710736|P4|Overall Study|Physician Decision|3
1427429|NCT01000506|4710737|P3|Overall Study|Physician Decision|3
1427430|NCT01000506|4710738|P2|Overall Study|Physician Decision|3
1427431|NCT01000506|4710739|P1|Overall Study|Physician Decision|1
1427432|NCT01000506|4710736|P4|Overall Study|Lost to Follow-up|0
1427433|NCT01000506|4710737|P3|Overall Study|Lost to Follow-up|4
1427434|NCT01000506|4710738|P2|Overall Study|Lost to Follow-up|1
1427435|NCT01000506|4710739|P1|Overall Study|Lost to Follow-up|1
1427436|NCT01000506|4710736|P4|Overall Study|Protocol Violation|0
1427437|NCT01000506|4710737|P3|Overall Study|Protocol Violation|0
1427438|NCT01000506|4710738|P2|Overall Study|Protocol Violation|1
1427439|NCT01000506|4710739|P1|Overall Study|Protocol Violation|1
1427440|NCT01000506|4710736|P4|Overall Study|Lack of Efficacy|4
1427441|NCT01000506|4710737|P3|Overall Study|Lack of Efficacy|4
1427442|NCT01000506|4710738|P2|Overall Study|Lack of Efficacy|6
1427443|NCT01000506|4710739|P1|Overall Study|Lack of Efficacy|8
1427444|NCT01000506|4710736|P4|Overall Study|Adverse Event|9
1427445|NCT01000506|4710737|P3|Overall Study|Adverse Event|8
1427446|NCT01000506|4710738|P2|Overall Study|Adverse Event|5
1427447|NCT01000506|4710739|P1|Overall Study|Adverse Event|6
1427448|NCT01000493|4710783|P2|Overall Study|Withdrawal by Subject|7
1427449|NCT01000493|4710784|P1|Overall Study|Withdrawal by Subject|3
1427450|NCT01000493|4710783|P2|Overall Study|Physician Decision|1
1427451|NCT01000493|4710784|P1|Overall Study|Physician Decision|1
1427452|NCT01000493|4710783|P2|Overall Study|Lost to Follow-up|9
1427453|NCT01000493|4710784|P1|Overall Study|Lost to Follow-up|5
1427454|NCT01000493|4710783|P2|Overall Study|Study closed/terminated|23
1427455|NCT01000493|4710784|P1|Overall Study|Study closed/terminated|25
1427456|NCT01000493|4710783|P2|Overall Study|Protocol Violation|8
1427457|NCT01000493|4710784|P1|Overall Study|Protocol Violation|1
1427458|NCT01000493|4710783|P2|Overall Study|Lack of Efficacy|1
1427459|NCT01000493|4710784|P1|Overall Study|Lack of Efficacy|1
1427460|NCT01000493|4710783|P2|Overall Study|Adverse Event|6
1427461|NCT01000493|4710784|P1|Overall Study|Adverse Event|3
1427462|NCT01000480|4710834|P1|Concurrent Therapy Phase|Physician Decision|1
1427463|NCT01000480|4710834|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
1427464|NCT01000480|4710834|P1|Concurrent Therapy Phase|Protocol Violation|2
1427465|NCT01000480|4710834|P1|Concurrent Therapy Phase|Adverse Event|4
1427466|NCT01000480|4710834|P1|Induction Phase|Entry Criteria Not Met|3
1427467|NCT01000480|4710834|P1|Induction Phase|Physician Decision|1
1427468|NCT01000480|4710834|P1|Induction Phase|Lost to Follow-up|1
1427469|NCT01000480|4710834|P1|Induction Phase|Adverse Event|2
1427470|NCT01000376|4710842|P2|Cycle 1 Day 1|Progressive Disease|0
1427471|NCT01000376|4710843|P1|Cycle 1 Day 1|Progressive Disease|1
1427472|NCT01000376|4710842|P2|Cycle 1 Day 1|Adverse Event|0
1427473|NCT01000376|4710843|P1|Cycle 1 Day 1|Adverse Event|1
1427474|NCT01000337|4710853|P2|Overall Study|Lost to Follow-up|3
1427475|NCT01000337|4710854|P1|Overall Study|Lost to Follow-up|4
1427476|NCT01000311|4710872|P2|Overall Study|Administrative reason|15
1427477|NCT01000311|4710873|P1|Overall Study|Administrative reason|9
1427478|NCT01000311|4710872|P2|Overall Study|Inappropriate enrollment|0
1427479|NCT01000311|4710873|P1|Overall Study|Inappropriate enrollment|2
1427480|NCT01000311|4710872|P2|Overall Study|Protocol Violation|2
1427481|NCT01000311|4710873|P1|Overall Study|Protocol Violation|1
1427482|NCT01000311|4710872|P2|Overall Study|Lost to Follow-up|24
1427483|NCT01000311|4710873|P1|Overall Study|Lost to Follow-up|15
1427484|NCT01000311|4710872|P2|Overall Study|Withdrawal by Subject|24
1427485|NCT01000311|4710873|P1|Overall Study|Withdrawal by Subject|16
1427486|NCT01000311|4710872|P2|Overall Study|Adverse Event|5
1427487|NCT01000311|4710873|P1|Overall Study|Adverse Event|2
1427488|NCT01000155|4710923|P1|Overall Study|Adverse Event|1
1427489|NCT01000155|4710923|P1|Overall Study|Withdrawal by Subject|1
1427490|NCT01000064|4710929|P2|Overall Study|Withdrawal by Subject|1
1427491|NCT01000064|4710930|P1|Overall Study|Withdrawal by Subject|1
1427492|NCT01000025|4710953|P2|Overall Study|Intercurrent Illness|7
1427493|NCT01000025|4710954|P1|Overall Study|Intercurrent Illness|26
1427494|NCT01000025|4710953|P2|Overall Study|Lack of Efficacy|208
1427495|NCT01000025|4710954|P1|Overall Study|Lack of Efficacy|363
1427496|NCT01000025|4710953|P2|Overall Study|Death|13
1427497|NCT01000025|4710954|P1|Overall Study|Death|23
1427498|NCT01000025|4710953|P2|Overall Study|Withdrawal by Subject|8
1427499|NCT01000025|4710954|P1|Overall Study|Withdrawal by Subject|13
1427500|NCT01000025|4710953|P2|Overall Study|Adverse Event|2
1427501|NCT01000025|4710954|P1|Overall Study|Adverse Event|43
1427502|NCT00999921|4710972|P2|Overall Study|Lost to Follow-up|19
1427503|NCT00999921|4710973|P1|Overall Study|Lost to Follow-up|10
1427504|NCT00999908|4710983|P3|Treatment Period 2|Protocol Violation|0
1427505|NCT00999908|4710984|P2|Treatment Period 2|Protocol Violation|0
1427506|NCT00999908|4710985|P1|Treatment Period 2|Protocol Violation|1
1427507|NCT00999908|4710983|P3|Treatment Period 1|Subject withdrew consent|0
1427508|NCT00999908|4710984|P2|Treatment Period 1|Subject withdrew consent|0
1427509|NCT00999908|4710985|P1|Treatment Period 1|Subject withdrew consent|2
1427510|NCT00999804|4711014|P2|Overall Study|Ineligible|0
1427511|NCT00999804|4711015|P1|Overall Study|Ineligible|3
1427512|NCT00999804|4711014|P2|Overall Study|Death|0
1427513|NCT00999804|4711015|P1|Overall Study|Death|1
1427514|NCT00999804|4711014|P2|Overall Study|Withdrawal by Subject|0
1427515|NCT00999804|4711015|P1|Overall Study|Withdrawal by Subject|4
1427516|NCT00999804|4711014|P2|Overall Study|Adverse Event|3
1427517|NCT00999804|4711015|P1|Overall Study|Adverse Event|4
1427518|NCT00999804|4711014|P2|Overall Study|Lack of Efficacy|2
1427519|NCT00999804|4711015|P1|Overall Study|Lack of Efficacy|9
1427520|NCT00999713|4711029|P2|Overall Study|Physician Decision|0
1427521|NCT00999713|4711030|P1|Overall Study|Physician Decision|2
1427522|NCT00999687|4711044|P1|Second Intervention|Lack of Efficacy|1
1427523|NCT00999687|4711044|P1|Second Intervention|Withdrawal by Subject|2
1427524|NCT00999687|4711044|P1|First Intervention|Withdrawal by Subject|1
1427525|NCT00999661|4711051|P1|Overall Study|Not meeting eligibility criteria|9
1427526|NCT00999661|4711051|P1|Overall Study|Withdrawal by Subject|1
1427527|NCT00999661|4711051|P1|Overall Study|Adverse Event|1
1427528|NCT00999661|4711051|P1|Overall Study|Lost to Follow-up|59
1427529|NCT00999596|4711072|P1|Overall Study|Statistical population not required|101
1427530|NCT00999544|4711077|P1|Overall Study|Withdrawal by Subject|1
1427531|NCT00999466|4711113|P3|Main Part|Adverse Event|2
1427532|NCT00999466|4711114|P2|Main Part|Adverse Event|4
1427533|NCT00999466|4711115|P1|Main Part|Adverse Event|0
1427534|NCT00999466|4711113|P3|Main Part|Withdrawal by Subject|2
1427535|NCT00999466|4711114|P2|Main Part|Withdrawal by Subject|0
1427536|NCT00999466|4711115|P1|Main Part|Withdrawal by Subject|0
1427537|NCT00999167|4711392|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
1427538|NCT00999167|4711393|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
1427539|NCT00999167|4711394|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
1427540|NCT00999167|4711392|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
1427541|NCT00999167|4711393|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
1427542|NCT00999167|4711394|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
1427543|NCT00999167|4711392|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
1427544|NCT00999167|4711393|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
1427545|NCT00999167|4711394|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
1427546|NCT00999167|4711392|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
1427547|NCT00999167|4711393|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
1427548|NCT00999167|4711394|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
1427549|NCT00999167|4711392|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
1427550|NCT00999167|4711393|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
1427551|NCT00999167|4711394|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
1427552|NCT00999167|4711392|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
1427553|NCT00999167|4711393|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
1427554|NCT00999167|4711394|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
1427555|NCT00999167|4711392|P3|Part A: Open Label Safety run-in|Adverse Event|0
1427556|NCT00999167|4711393|P2|Part A: Open Label Safety run-in|Adverse Event|0
1427557|NCT00999167|4711394|P1|Part A: Open Label Safety run-in|Adverse Event|3
1427558|NCT00999167|4711392|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
1427559|NCT00999167|4711393|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
1427560|NCT00999167|4711394|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
1427561|NCT00998985|4711517|P14|Overall Study|Protocol Violation|0
1427562|NCT00998985|4711518|P13|Overall Study|Protocol Violation|0
1427563|NCT00998985|4711519|P12|Overall Study|Protocol Violation|0
1427564|NCT00998985|4711520|P11|Overall Study|Protocol Violation|0
1427565|NCT00998985|4711521|P10|Overall Study|Protocol Violation|0
1427566|NCT00998985|4711522|P9|Overall Study|Protocol Violation|0
1427567|NCT00998985|4711523|P8|Overall Study|Protocol Violation|0
1427568|NCT00998985|4711524|P7|Overall Study|Protocol Violation|0
1427569|NCT00998985|4711525|P6|Overall Study|Protocol Violation|1
1427570|NCT00998985|4711526|P5|Overall Study|Protocol Violation|0
1427571|NCT00998985|4711527|P4|Overall Study|Protocol Violation|0
1427572|NCT00998985|4711528|P3|Overall Study|Protocol Violation|0
1427573|NCT00998985|4711529|P2|Overall Study|Protocol Violation|0
1427574|NCT00998985|4711530|P1|Overall Study|Protocol Violation|0
1427575|NCT00998985|4711517|P14|Overall Study|Withdrawal by Subject|0
1427576|NCT00998985|4711518|P13|Overall Study|Withdrawal by Subject|0
1427577|NCT00998985|4711519|P12|Overall Study|Withdrawal by Subject|0
1427578|NCT00998985|4711520|P11|Overall Study|Withdrawal by Subject|0
1427579|NCT00998985|4711521|P10|Overall Study|Withdrawal by Subject|0
1427580|NCT00998985|4711522|P9|Overall Study|Withdrawal by Subject|1
1427581|NCT00998985|4711523|P8|Overall Study|Withdrawal by Subject|0
1427582|NCT00998985|4711524|P7|Overall Study|Withdrawal by Subject|0
1427583|NCT00998985|4711525|P6|Overall Study|Withdrawal by Subject|0
1427584|NCT00998985|4711526|P5|Overall Study|Withdrawal by Subject|0
1427585|NCT00998985|4711527|P4|Overall Study|Withdrawal by Subject|0
1427586|NCT00998985|4711528|P3|Overall Study|Withdrawal by Subject|0
1427587|NCT00998985|4711529|P2|Overall Study|Withdrawal by Subject|0
1427588|NCT00998985|4711530|P1|Overall Study|Withdrawal by Subject|0
1427589|NCT00998881|4711598|P2|Overall Study|Personal matter|0
1427590|NCT00998881|4711599|P1|Overall Study|Personal matter|1
1427591|NCT00998881|4711598|P2|Overall Study|Withdrawal by Subject|0
1427592|NCT00998881|4711599|P1|Overall Study|Withdrawal by Subject|1
1427593|NCT00998881|4711598|P2|Overall Study|Physician Decision|0
1427594|NCT00998881|4711599|P1|Overall Study|Physician Decision|3
1427595|NCT00998881|4711598|P2|Overall Study|Lack of Efficacy|0
1427596|NCT00998881|4711599|P1|Overall Study|Lack of Efficacy|1
1427597|NCT00998881|4711598|P2|Overall Study|Adverse Event|2
1427598|NCT00998881|4711599|P1|Overall Study|Adverse Event|2
1427599|NCT00998764|4711620|P2|Overall Study|Recurrent Episode of vasogenic edema|0
1427600|NCT00998764|4711621|P1|Overall Study|Recurrent Episode of vasogenic edema|1
1427601|NCT00998764|4711620|P2|Overall Study|Not specified|4
1427602|NCT00998764|4711621|P1|Overall Study|Not specified|4
1427603|NCT00998764|4711620|P2|Overall Study|Loss of Caregiver|3
1427604|NCT00998764|4711621|P1|Overall Study|Loss of Caregiver|0
1427605|NCT00998764|4711620|P2|Overall Study|Lost to Follow-up|1
1427606|NCT00998764|4711621|P1|Overall Study|Lost to Follow-up|1
1427607|NCT00998764|4711620|P2|Overall Study|Failed to Return|1
1427608|NCT00998764|4711621|P1|Overall Study|Failed to Return|1
1427609|NCT00998764|4711620|P2|Overall Study|Protocol Violation|1
1427610|NCT00998764|4711621|P1|Overall Study|Protocol Violation|0
1427611|NCT00998764|4711620|P2|Overall Study|Discontinuation of Study by Sponsor|217
1427612|NCT00998764|4711621|P1|Overall Study|Discontinuation of Study by Sponsor|164
1427613|NCT00998764|4711620|P2|Overall Study|Death|1
1427614|NCT00998764|4711621|P1|Overall Study|Death|3
1427615|NCT00998764|4711620|P2|Overall Study|Physician Decision|3
1427616|NCT00998764|4711621|P1|Overall Study|Physician Decision|3
1427617|NCT00998764|4711620|P2|Overall Study|Withdrawal by Subject|25
1427618|NCT00998764|4711621|P1|Overall Study|Withdrawal by Subject|19
1427619|NCT00998764|4711620|P2|Overall Study|Adverse Event|12
1427620|NCT00998764|4711621|P1|Overall Study|Adverse Event|17
1427621|NCT00998764|4711620|P2|Overall Study|Lack of Efficacy|6
1427622|NCT00998764|4711621|P1|Overall Study|Lack of Efficacy|3
1427623|NCT00998738|4711643|P1|Overall Study|Uknown|1
1427624|NCT00998335|4711726|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
1427625|NCT00998335|4711727|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
1427626|NCT00998309|4711755|P1|Overall Study|Protocol Violation|4
1427627|NCT00998296|4711822|P11|Overall Study|Reason other than those specified above|0
1427628|NCT00998296|4711823|P10|Overall Study|Reason other than those specified above|1
1427629|NCT00998296|4711824|P9|Overall Study|Reason other than those specified above|0
1427630|NCT00998296|4711825|P8|Overall Study|Reason other than those specified above|0
1427631|NCT00998296|4711826|P7|Overall Study|Reason other than those specified above|0
1427632|NCT00998296|4711827|P6|Overall Study|Reason other than those specified above|0
1427633|NCT00998296|4711828|P5|Overall Study|Reason other than those specified above|0
1427634|NCT00998296|4711829|P4|Overall Study|Reason other than those specified above|0
1427635|NCT00998296|4711830|P3|Overall Study|Reason other than those specified above|0
1427636|NCT00998296|4711831|P2|Overall Study|Reason other than those specified above|0
1427637|NCT00998296|4711832|P1|Overall Study|Reason other than those specified above|0
1427638|NCT00998296|4711822|P11|Overall Study|Refused to continue taking trial med.|0
1427639|NCT00998296|4711823|P10|Overall Study|Refused to continue taking trial med.|2
1427640|NCT00998296|4711824|P9|Overall Study|Refused to continue taking trial med.|0
1427641|NCT00998296|4711825|P8|Overall Study|Refused to continue taking trial med.|0
1427642|NCT00998296|4711826|P7|Overall Study|Refused to continue taking trial med.|0
1427643|NCT00998296|4711827|P6|Overall Study|Refused to continue taking trial med.|0
1427644|NCT00998296|4711828|P5|Overall Study|Refused to continue taking trial med.|0
1427645|NCT00998296|4711829|P4|Overall Study|Refused to continue taking trial med.|0
1427646|NCT00998296|4711830|P3|Overall Study|Refused to continue taking trial med.|0
1427647|NCT00998296|4711831|P2|Overall Study|Refused to continue taking trial med.|0
1427648|NCT00998296|4711832|P1|Overall Study|Refused to continue taking trial med.|0
1427649|NCT00998296|4711822|P11|Overall Study|Other adverse event|2
1427650|NCT00998296|4711823|P10|Overall Study|Other adverse event|1
1427651|NCT00998296|4711824|P9|Overall Study|Other adverse event|0
1427652|NCT00998296|4711825|P8|Overall Study|Other adverse event|0
1427653|NCT00998296|4711826|P7|Overall Study|Other adverse event|0
1427654|NCT00998296|4711827|P6|Overall Study|Other adverse event|0
1427655|NCT00998296|4711828|P5|Overall Study|Other adverse event|1
1427656|NCT00998296|4711829|P4|Overall Study|Other adverse event|0
1427657|NCT00998296|4711830|P3|Overall Study|Other adverse event|0
1427658|NCT00998296|4711831|P2|Overall Study|Other adverse event|0
1427659|NCT00998296|4711832|P1|Overall Study|Other adverse event|0
1427660|NCT00998296|4711822|P11|Overall Study|Dose limiting or dose reducing toxicity|0
1427661|NCT00998296|4711823|P10|Overall Study|Dose limiting or dose reducing toxicity|0
1427662|NCT00998296|4711824|P9|Overall Study|Dose limiting or dose reducing toxicity|2
1427663|NCT00998296|4711825|P8|Overall Study|Dose limiting or dose reducing toxicity|2
1427664|NCT00998296|4711826|P7|Overall Study|Dose limiting or dose reducing toxicity|0
1427665|NCT00998296|4711827|P6|Overall Study|Dose limiting or dose reducing toxicity|0
1427666|NCT00998296|4711828|P5|Overall Study|Dose limiting or dose reducing toxicity|1
1427667|NCT00998296|4711829|P4|Overall Study|Dose limiting or dose reducing toxicity|0
1427668|NCT00998296|4711830|P3|Overall Study|Dose limiting or dose reducing toxicity|0
1427669|NCT00998296|4711831|P2|Overall Study|Dose limiting or dose reducing toxicity|0
1427670|NCT00998296|4711832|P1|Overall Study|Dose limiting or dose reducing toxicity|0
1427671|NCT00998296|4711822|P11|Overall Study|Progressive disease|5
1427672|NCT00998296|4711823|P10|Overall Study|Progressive disease|14
1427673|NCT00998296|4711824|P9|Overall Study|Progressive disease|0
1427674|NCT00998296|4711825|P8|Overall Study|Progressive disease|0
1427675|NCT00998296|4711826|P7|Overall Study|Progressive disease|1
1427676|NCT00998296|4711827|P6|Overall Study|Progressive disease|0
1427677|NCT00998296|4711828|P5|Overall Study|Progressive disease|0
1427678|NCT00998296|4711829|P4|Overall Study|Progressive disease|0
1427679|NCT00998296|4711830|P3|Overall Study|Progressive disease|0
1427680|NCT00998296|4711831|P2|Overall Study|Progressive disease|1
1427681|NCT00998296|4711832|P1|Overall Study|Progressive disease|0
1427682|NCT00997984|4711927|P3|Overall Study|Work schedule|2
1427683|NCT00997984|4711928|P2|Overall Study|Work schedule|0
1427684|NCT00997984|4711929|P1|Overall Study|Work schedule|0
1427685|NCT00997984|4711927|P3|Overall Study|Suicidal ideation|1
1427686|NCT00997984|4711928|P2|Overall Study|Suicidal ideation|0
1427687|NCT00997984|4711929|P1|Overall Study|Suicidal ideation|0
1427688|NCT00997984|4711927|P3|Overall Study|Wrong medication dispensed|0
1427689|NCT00997984|4711928|P2|Overall Study|Wrong medication dispensed|1
1427690|NCT00997984|4711929|P1|Overall Study|Wrong medication dispensed|0
1427691|NCT00997984|4711927|P3|Overall Study|non-compliance|3
1427692|NCT00997984|4711928|P2|Overall Study|non-compliance|2
1427693|NCT00997984|4711929|P1|Overall Study|non-compliance|0
1427694|NCT00997984|4711927|P3|Overall Study|Met exclusion criteria|0
1427695|NCT00997984|4711928|P2|Overall Study|Met exclusion criteria|0
1427696|NCT00997984|4711929|P1|Overall Study|Met exclusion criteria|1
1427697|NCT00997984|4711927|P3|Overall Study|Lack of Efficacy|3
1427698|NCT00997984|4711928|P2|Overall Study|Lack of Efficacy|6
1427699|NCT00997984|4711929|P1|Overall Study|Lack of Efficacy|20
1427700|NCT00997984|4711927|P3|Overall Study|Lost to Follow-up|4
1427701|NCT00997984|4711928|P2|Overall Study|Lost to Follow-up|5
1427702|NCT00997984|4711929|P1|Overall Study|Lost to Follow-up|8
1427703|NCT00997984|4711927|P3|Overall Study|Withdrawal by Subject|5
1427704|NCT00997984|4711928|P2|Overall Study|Withdrawal by Subject|9
1427705|NCT00997984|4711929|P1|Overall Study|Withdrawal by Subject|6
1427706|NCT00997984|4711927|P3|Overall Study|Protocol Violation|0
1427707|NCT00997984|4711928|P2|Overall Study|Protocol Violation|3
1427708|NCT00997984|4711929|P1|Overall Study|Protocol Violation|1
1427709|NCT00997984|4711927|P3|Overall Study|Adverse Event|8
1427710|NCT00997984|4711928|P2|Overall Study|Adverse Event|8
1427711|NCT00997984|4711929|P1|Overall Study|Adverse Event|1
1427712|NCT00997503|4712087|P1|Overall Study|Other reason|13
1427713|NCT00997503|4712087|P1|Overall Study|Missed 12-month follow-up|85
1427714|NCT00997503|4712087|P1|Overall Study|Physician Decision|10
1427715|NCT00997503|4712087|P1|Overall Study|Adverse Event|3
1427716|NCT00997503|4712087|P1|Overall Study|Lost to Follow-up|33
1427717|NCT00997503|4712087|P1|Overall Study|Withdrawal by Subject|76
1427718|NCT00997503|4712087|P1|Overall Study|Death|53
1427719|NCT00997438|4712130|P3|Overall Study|Exclusion criteria at visit 1|3
1427720|NCT00997438|4712131|P2|Overall Study|Exclusion criteria at visit 1|2
1427721|NCT00997438|4712132|P1|Overall Study|Exclusion criteria at visit 1|2
1427722|NCT00997438|4712130|P3|Overall Study|Withdrawal by Subject|0
1427723|NCT00997438|4712131|P2|Overall Study|Withdrawal by Subject|1
1427724|NCT00997438|4712132|P1|Overall Study|Withdrawal by Subject|1
1427725|NCT00997438|4712130|P3|Overall Study|Blood draw difficulty|1
1427726|NCT00997438|4712131|P2|Overall Study|Blood draw difficulty|0
1427727|NCT00997438|4712132|P1|Overall Study|Blood draw difficulty|2
1427728|NCT00997373|4712174|P2|Overall Study|could not have hysterectomy|0
1427729|NCT00997373|4712175|P1|Overall Study|could not have hysterectomy|6
1427730|NCT00997373|4712174|P2|Overall Study|wrong tumor type|0
1427731|NCT00997373|4712175|P1|Overall Study|wrong tumor type|4
1427732|NCT00997373|4712174|P2|Overall Study|Withdrawal by Subject|0
1427733|NCT00997373|4712175|P1|Overall Study|Withdrawal by Subject|5
1427734|NCT00997334|4712181|P1|Overall Study|Ineligible|1
1427735|NCT00997334|4712181|P1|Overall Study|No lesion amenable|1
1427736|NCT00997334|4712181|P1|Overall Study|Urgent Palliative Care|2
1427737|NCT00997334|4712181|P1|Overall Study|Death|2
1427738|NCT00997334|4712181|P1|Overall Study|Withdrawal by Subject|3
1427739|NCT00997334|4712181|P1|Overall Study|Patient non-compliance|1
1427740|NCT00997334|4712181|P1|Overall Study|Adverse Event|3
1427741|NCT00997334|4712181|P1|Overall Study|still on therapy|12
1427742|NCT00997321|4712190|P2|Overall Study|did not undergo sedation after enrollmen|3
1427743|NCT00997321|4712191|P1|Overall Study|did not undergo sedation after enrollmen|0
1427744|NCT00997243|4712203|P1|Overall Study|Early termination of study by sponsor|7
1427745|NCT00997126|4712235|P2|Overall Study|Physician Decision|11
1427746|NCT00997126|4712236|P1|Overall Study|Physician Decision|7
1427747|NCT00997035|4712265|P2|3-month Follow-up Visit|Lost to Follow-up|6
1427748|NCT00997035|4712266|P1|3-month Follow-up Visit|Lost to Follow-up|12
1427749|NCT00997035|4712265|P2|3-week Followup Visit|Lost to Follow-up|6
1427750|NCT00997035|4712266|P1|3-week Followup Visit|Lost to Follow-up|9
1427751|NCT00996996|4712286|P1|Overall Study|Did Not Receive Study Medications|1
1427752|NCT00996996|4712286|P1|Overall Study|Death|5
1427753|NCT00996996|4712286|P1|Overall Study|Lost to Follow-up|9
1427754|NCT00996996|4712286|P1|Overall Study|Non-compliance|8
1427755|NCT00996996|4712286|P1|Overall Study|Progressive Disease|10
1427756|NCT00996944|4712320|P2|Long-term Treatment Period|Study Closed/Terminated|5
1427757|NCT00996944|4712321|P1|Long-term Treatment Period|Study Closed/Terminated|12
1427758|NCT00996944|4712320|P2|Double-blind Treatment Period|Withdrawal by Subject|1
1427759|NCT00996944|4712321|P1|Double-blind Treatment Period|Withdrawal by Subject|1
1427760|NCT00996944|4712320|P2|Double-blind Treatment Period|Study Closed/Terminated|5
1427761|NCT00996944|4712321|P1|Double-blind Treatment Period|Study Closed/Terminated|6
1427762|NCT00996944|4712320|P2|Double-blind Treatment Period|Protocol Violation|0
1427763|NCT00996944|4712321|P1|Double-blind Treatment Period|Protocol Violation|1
1427764|NCT00996944|4712320|P2|Double-blind Treatment Period|Adverse Event|1
1427765|NCT00996944|4712321|P1|Double-blind Treatment Period|Adverse Event|2
1427766|NCT00996918|4712373|P5|Overall Study|Not Specified|0
1427767|NCT00996918|4712374|P4|Overall Study|Not Specified|0
1427768|NCT00996918|4712375|P3|Overall Study|Not Specified|0
1427769|NCT00996918|4712376|P2|Overall Study|Not Specified|1
1427770|NCT00996918|4712377|P1|Overall Study|Not Specified|3
1427771|NCT00996918|4712373|P5|Overall Study|Loss of Caregiver|0
1427772|NCT00996918|4712374|P4|Overall Study|Loss of Caregiver|0
1427773|NCT00996918|4712375|P3|Overall Study|Loss of Caregiver|0
1427774|NCT00996918|4712376|P2|Overall Study|Loss of Caregiver|1
1427775|NCT00996918|4712377|P1|Overall Study|Loss of Caregiver|0
1427776|NCT00996918|4712373|P5|Overall Study|Discontinuation of Study by Sponsor|2
1427777|NCT00996918|4712374|P4|Overall Study|Discontinuation of Study by Sponsor|45
1427778|NCT00996918|4712375|P3|Overall Study|Discontinuation of Study by Sponsor|30
1427779|NCT00996918|4712376|P2|Overall Study|Discontinuation of Study by Sponsor|54
1427780|NCT00996918|4712377|P1|Overall Study|Discontinuation of Study by Sponsor|31
1427781|NCT00996918|4712373|P5|Overall Study|Physician Decision|0
1427782|NCT00996918|4712374|P4|Overall Study|Physician Decision|0
1427783|NCT00996918|4712375|P3|Overall Study|Physician Decision|0
1427784|NCT00996918|4712376|P2|Overall Study|Physician Decision|0
1427785|NCT00996918|4712377|P1|Overall Study|Physician Decision|1
1427786|NCT00996918|4712373|P5|Overall Study|Withdrawal by Subject|2
1427787|NCT00996918|4712374|P4|Overall Study|Withdrawal by Subject|3
1427788|NCT00996918|4712375|P3|Overall Study|Withdrawal by Subject|3
1427789|NCT00996918|4712376|P2|Overall Study|Withdrawal by Subject|4
1427790|NCT00996918|4712377|P1|Overall Study|Withdrawal by Subject|1
1427791|NCT00996918|4712373|P5|Overall Study|Adverse Event|0
1427792|NCT00996918|4712374|P4|Overall Study|Adverse Event|6
1427793|NCT00996918|4712375|P3|Overall Study|Adverse Event|2
1427794|NCT00996918|4712376|P2|Overall Study|Adverse Event|5
1427795|NCT00996918|4712377|P1|Overall Study|Adverse Event|2
1427796|NCT00996918|4712373|P5|Overall Study|Lack of Efficacy|0
1427797|NCT00996918|4712374|P4|Overall Study|Lack of Efficacy|2
1427798|NCT00996918|4712375|P3|Overall Study|Lack of Efficacy|2
1427799|NCT00996918|4712376|P2|Overall Study|Lack of Efficacy|1
1427800|NCT00996918|4712377|P1|Overall Study|Lack of Efficacy|1
1427801|NCT00996892|4712421|P20|Expansion Stage 2A|Disease Progression|31
1427802|NCT00996892|4712422|P19|Expansion Stage 2A|Disease Progression|0
1427803|NCT00996892|4712423|P18|Expansion Stage 2A|Disease Progression|0
1427804|NCT00996892|4712424|P17|Expansion Stage 2A|Disease Progression|0
1427805|NCT00996892|4712425|P16|Expansion Stage 2A|Disease Progression|0
1427806|NCT00996892|4712426|P15|Expansion Stage 2A|Disease Progression|0
1427807|NCT00996892|4712427|P14|Expansion Stage 2A|Disease Progression|0
1427808|NCT00996892|4712428|P13|Expansion Stage 2A|Disease Progression|0
1427809|NCT00996892|4712429|P12|Expansion Stage 2A|Disease Progression|0
1427810|NCT00996892|4712430|P11|Expansion Stage 2A|Disease Progression|0
1427811|NCT00996892|4712431|P10|Expansion Stage 2A|Disease Progression|0
1427812|NCT00996892|4712432|P9|Expansion Stage 2A|Disease Progression|0
1427813|NCT00996892|4712433|P8|Expansion Stage 2A|Disease Progression|0
1427814|NCT00996892|4712434|P7|Expansion Stage 2A|Disease Progression|0
1427815|NCT00996892|4712435|P6|Expansion Stage 2A|Disease Progression|0
1427816|NCT00996892|4712436|P5|Expansion Stage 2A|Disease Progression|0
1427817|NCT00996892|4712437|P4|Expansion Stage 2A|Disease Progression|0
1427818|NCT00996892|4712438|P3|Expansion Stage 2A|Disease Progression|0
1427819|NCT00996892|4712439|P2|Expansion Stage 2A|Disease Progression|0
1427820|NCT00996892|4712440|P1|Expansion Stage 2A|Disease Progression|0
1427821|NCT00996892|4712421|P20|Expansion Stage 2A|Withdrawal by Subject|4
1427822|NCT00996892|4712422|P19|Expansion Stage 2A|Withdrawal by Subject|0
1427823|NCT00996892|4712423|P18|Expansion Stage 2A|Withdrawal by Subject|0
1427824|NCT00996892|4712424|P17|Expansion Stage 2A|Withdrawal by Subject|0
1427825|NCT00996892|4712425|P16|Expansion Stage 2A|Withdrawal by Subject|0
1427826|NCT00996892|4712426|P15|Expansion Stage 2A|Withdrawal by Subject|0
1427827|NCT00996892|4712427|P14|Expansion Stage 2A|Withdrawal by Subject|0
1427828|NCT00996892|4712428|P13|Expansion Stage 2A|Withdrawal by Subject|0
1427829|NCT00996892|4712429|P12|Expansion Stage 2A|Withdrawal by Subject|0
1427830|NCT00996892|4712430|P11|Expansion Stage 2A|Withdrawal by Subject|0
1427831|NCT00996892|4712431|P10|Expansion Stage 2A|Withdrawal by Subject|0
1427832|NCT00996892|4712432|P9|Expansion Stage 2A|Withdrawal by Subject|0
1427833|NCT00996892|4712433|P8|Expansion Stage 2A|Withdrawal by Subject|0
1427834|NCT00996892|4712434|P7|Expansion Stage 2A|Withdrawal by Subject|0
1427835|NCT00996892|4712435|P6|Expansion Stage 2A|Withdrawal by Subject|0
1427836|NCT00996892|4712436|P5|Expansion Stage 2A|Withdrawal by Subject|0
1427837|NCT00996892|4712437|P4|Expansion Stage 2A|Withdrawal by Subject|0
1427838|NCT00996892|4712438|P3|Expansion Stage 2A|Withdrawal by Subject|0
1427839|NCT00996892|4712439|P2|Expansion Stage 2A|Withdrawal by Subject|0
1427840|NCT00996892|4712440|P1|Expansion Stage 2A|Withdrawal by Subject|0
1427841|NCT00996892|4712421|P20|Expansion Stage 2A|Physician Decision|2
1427842|NCT00996892|4712422|P19|Expansion Stage 2A|Physician Decision|0
1427843|NCT00996892|4712423|P18|Expansion Stage 2A|Physician Decision|0
1427844|NCT00996892|4712424|P17|Expansion Stage 2A|Physician Decision|0
1427845|NCT00996892|4712425|P16|Expansion Stage 2A|Physician Decision|0
1427846|NCT00996892|4712426|P15|Expansion Stage 2A|Physician Decision|0
1427847|NCT00996892|4712427|P14|Expansion Stage 2A|Physician Decision|0
1427848|NCT00996892|4712428|P13|Expansion Stage 2A|Physician Decision|0
1427849|NCT00996892|4712429|P12|Expansion Stage 2A|Physician Decision|0
1427850|NCT00996892|4712430|P11|Expansion Stage 2A|Physician Decision|0
1427851|NCT00996892|4712431|P10|Expansion Stage 2A|Physician Decision|0
1427852|NCT00996892|4712432|P9|Expansion Stage 2A|Physician Decision|0
1427853|NCT00996892|4712433|P8|Expansion Stage 2A|Physician Decision|0
1427854|NCT00996892|4712434|P7|Expansion Stage 2A|Physician Decision|0
1427855|NCT00996892|4712435|P6|Expansion Stage 2A|Physician Decision|0
1427856|NCT00996892|4712436|P5|Expansion Stage 2A|Physician Decision|0
1427857|NCT00996892|4712437|P4|Expansion Stage 2A|Physician Decision|0
1427858|NCT00996892|4712438|P3|Expansion Stage 2A|Physician Decision|0
1427859|NCT00996892|4712439|P2|Expansion Stage 2A|Physician Decision|0
1427860|NCT00996892|4712440|P1|Expansion Stage 2A|Physician Decision|0
1427861|NCT00996892|4712421|P20|Expansion Stage 2A|Adverse Event|8
1427862|NCT00996892|4712422|P19|Expansion Stage 2A|Adverse Event|0
1427863|NCT00996892|4712423|P18|Expansion Stage 2A|Adverse Event|0
1427864|NCT00996892|4712424|P17|Expansion Stage 2A|Adverse Event|0
1427865|NCT00996892|4712425|P16|Expansion Stage 2A|Adverse Event|0
1427866|NCT00996892|4712426|P15|Expansion Stage 2A|Adverse Event|0
1427867|NCT00996892|4712427|P14|Expansion Stage 2A|Adverse Event|0
1427868|NCT00996892|4712428|P13|Expansion Stage 2A|Adverse Event|0
1427869|NCT00996892|4712429|P12|Expansion Stage 2A|Adverse Event|0
1427870|NCT00996892|4712430|P11|Expansion Stage 2A|Adverse Event|0
1427871|NCT00996892|4712431|P10|Expansion Stage 2A|Adverse Event|0
1427872|NCT00996892|4712432|P9|Expansion Stage 2A|Adverse Event|0
1427873|NCT00996892|4712433|P8|Expansion Stage 2A|Adverse Event|0
1427874|NCT00996892|4712434|P7|Expansion Stage 2A|Adverse Event|0
1427875|NCT00996892|4712435|P6|Expansion Stage 2A|Adverse Event|0
1427876|NCT00996892|4712436|P5|Expansion Stage 2A|Adverse Event|0
1427877|NCT00996892|4712437|P4|Expansion Stage 2A|Adverse Event|0
1427878|NCT00996892|4712438|P3|Expansion Stage 2A|Adverse Event|0
1427879|NCT00996892|4712439|P2|Expansion Stage 2A|Adverse Event|0
1427880|NCT00996892|4712440|P1|Expansion Stage 2A|Adverse Event|0
1427881|NCT00996892|4712421|P20|Expansion Stage 2|Disease Progression|0
1427882|NCT00996892|4712422|P19|Expansion Stage 2|Disease Progression|28
1427883|NCT00996892|4712423|P18|Expansion Stage 2|Disease Progression|0
1427884|NCT00996892|4712424|P17|Expansion Stage 2|Disease Progression|0
1427885|NCT00996892|4712425|P16|Expansion Stage 2|Disease Progression|0
1427886|NCT00996892|4712426|P15|Expansion Stage 2|Disease Progression|0
1427887|NCT00996892|4712427|P14|Expansion Stage 2|Disease Progression|0
1427888|NCT00996892|4712428|P13|Expansion Stage 2|Disease Progression|0
1427889|NCT00996892|4712429|P12|Expansion Stage 2|Disease Progression|0
1427890|NCT00996892|4712430|P11|Expansion Stage 2|Disease Progression|0
1427891|NCT00996892|4712431|P10|Expansion Stage 2|Disease Progression|0
1427892|NCT00996892|4712432|P9|Expansion Stage 2|Disease Progression|0
1427893|NCT00996892|4712433|P8|Expansion Stage 2|Disease Progression|0
1427894|NCT00996892|4712434|P7|Expansion Stage 2|Disease Progression|0
1427895|NCT00996892|4712435|P6|Expansion Stage 2|Disease Progression|0
1427896|NCT00996892|4712436|P5|Expansion Stage 2|Disease Progression|0
1427897|NCT00996892|4712437|P4|Expansion Stage 2|Disease Progression|0
1427898|NCT00996892|4712438|P3|Expansion Stage 2|Disease Progression|0
1427899|NCT00996892|4712439|P2|Expansion Stage 2|Disease Progression|0
1427900|NCT00996892|4712440|P1|Expansion Stage 2|Disease Progression|0
1427901|NCT00996892|4712421|P20|Expansion Stage 2|Withdrawal by Subject|0
1427902|NCT00996892|4712422|P19|Expansion Stage 2|Withdrawal by Subject|1
1427903|NCT00996892|4712423|P18|Expansion Stage 2|Withdrawal by Subject|0
1427904|NCT00996892|4712424|P17|Expansion Stage 2|Withdrawal by Subject|0
1427905|NCT00996892|4712425|P16|Expansion Stage 2|Withdrawal by Subject|0
1427906|NCT00996892|4712426|P15|Expansion Stage 2|Withdrawal by Subject|0
1427907|NCT00996892|4712427|P14|Expansion Stage 2|Withdrawal by Subject|0
1427908|NCT00996892|4712428|P13|Expansion Stage 2|Withdrawal by Subject|0
1427909|NCT00996892|4712429|P12|Expansion Stage 2|Withdrawal by Subject|0
1427910|NCT00996892|4712430|P11|Expansion Stage 2|Withdrawal by Subject|0
1427911|NCT00996892|4712431|P10|Expansion Stage 2|Withdrawal by Subject|0
1427912|NCT00996892|4712432|P9|Expansion Stage 2|Withdrawal by Subject|0
1427913|NCT00996892|4712433|P8|Expansion Stage 2|Withdrawal by Subject|0
1427914|NCT00996892|4712434|P7|Expansion Stage 2|Withdrawal by Subject|0
1427915|NCT00996892|4712435|P6|Expansion Stage 2|Withdrawal by Subject|0
1427916|NCT00996892|4712436|P5|Expansion Stage 2|Withdrawal by Subject|0
1427917|NCT00996892|4712437|P4|Expansion Stage 2|Withdrawal by Subject|0
1427918|NCT00996892|4712438|P3|Expansion Stage 2|Withdrawal by Subject|0
1427919|NCT00996892|4712439|P2|Expansion Stage 2|Withdrawal by Subject|0
1427920|NCT00996892|4712440|P1|Expansion Stage 2|Withdrawal by Subject|0
1427921|NCT00996892|4712421|P20|Expansion Stage 2|Physician Decision|0
1427922|NCT00996892|4712422|P19|Expansion Stage 2|Physician Decision|1
1427923|NCT00996892|4712423|P18|Expansion Stage 2|Physician Decision|0
1427924|NCT00996892|4712424|P17|Expansion Stage 2|Physician Decision|0
1427925|NCT00996892|4712425|P16|Expansion Stage 2|Physician Decision|0
1427926|NCT00996892|4712426|P15|Expansion Stage 2|Physician Decision|0
1427927|NCT00996892|4712427|P14|Expansion Stage 2|Physician Decision|0
1427928|NCT00996892|4712428|P13|Expansion Stage 2|Physician Decision|0
1427929|NCT00996892|4712429|P12|Expansion Stage 2|Physician Decision|0
1427930|NCT00996892|4712430|P11|Expansion Stage 2|Physician Decision|0
1427931|NCT00996892|4712431|P10|Expansion Stage 2|Physician Decision|0
1427932|NCT00996892|4712432|P9|Expansion Stage 2|Physician Decision|0
1427933|NCT00996892|4712433|P8|Expansion Stage 2|Physician Decision|0
1427934|NCT00996892|4712434|P7|Expansion Stage 2|Physician Decision|0
1427935|NCT00996892|4712435|P6|Expansion Stage 2|Physician Decision|0
1427936|NCT00996892|4712436|P5|Expansion Stage 2|Physician Decision|0
1427937|NCT00996892|4712437|P4|Expansion Stage 2|Physician Decision|0
1427938|NCT00996892|4712438|P3|Expansion Stage 2|Physician Decision|0
1427939|NCT00996892|4712439|P2|Expansion Stage 2|Physician Decision|0
1427940|NCT00996892|4712440|P1|Expansion Stage 2|Physician Decision|0
1427941|NCT00996892|4712421|P20|Expansion Stage 2|Death|0
1427942|NCT00996892|4712422|P19|Expansion Stage 2|Death|2
1427943|NCT00996892|4712423|P18|Expansion Stage 2|Death|0
1427944|NCT00996892|4712424|P17|Expansion Stage 2|Death|0
1427945|NCT00996892|4712425|P16|Expansion Stage 2|Death|0
1427946|NCT00996892|4712426|P15|Expansion Stage 2|Death|0
1427947|NCT00996892|4712427|P14|Expansion Stage 2|Death|0
1427948|NCT00996892|4712428|P13|Expansion Stage 2|Death|0
1427949|NCT00996892|4712429|P12|Expansion Stage 2|Death|0
1427950|NCT00996892|4712430|P11|Expansion Stage 2|Death|0
1427951|NCT00996892|4712431|P10|Expansion Stage 2|Death|0
1427952|NCT00996892|4712432|P9|Expansion Stage 2|Death|0
1427953|NCT00996892|4712433|P8|Expansion Stage 2|Death|0
1427954|NCT00996892|4712434|P7|Expansion Stage 2|Death|0
1427955|NCT00996892|4712435|P6|Expansion Stage 2|Death|0
1427956|NCT00996892|4712436|P5|Expansion Stage 2|Death|0
1427957|NCT00996892|4712437|P4|Expansion Stage 2|Death|0
1427958|NCT00996892|4712438|P3|Expansion Stage 2|Death|0
1427959|NCT00996892|4712439|P2|Expansion Stage 2|Death|0
1427960|NCT00996892|4712440|P1|Expansion Stage 2|Death|0
1427961|NCT00996892|4712421|P20|Expansion Stage 2|Adverse Event|0
1427962|NCT00996892|4712422|P19|Expansion Stage 2|Adverse Event|3
1427963|NCT00996892|4712423|P18|Expansion Stage 2|Adverse Event|0
1427964|NCT00996892|4712424|P17|Expansion Stage 2|Adverse Event|0
1427965|NCT00996892|4712425|P16|Expansion Stage 2|Adverse Event|0
1427966|NCT00996892|4712426|P15|Expansion Stage 2|Adverse Event|0
1427967|NCT00996892|4712427|P14|Expansion Stage 2|Adverse Event|0
1427968|NCT00996892|4712428|P13|Expansion Stage 2|Adverse Event|0
1427969|NCT00996892|4712429|P12|Expansion Stage 2|Adverse Event|0
1427970|NCT00996892|4712430|P11|Expansion Stage 2|Adverse Event|0
1427971|NCT00996892|4712431|P10|Expansion Stage 2|Adverse Event|0
1427972|NCT00996892|4712432|P9|Expansion Stage 2|Adverse Event|0
1427973|NCT00996892|4712433|P8|Expansion Stage 2|Adverse Event|0
1427974|NCT00996892|4712434|P7|Expansion Stage 2|Adverse Event|0
1427975|NCT00996892|4712435|P6|Expansion Stage 2|Adverse Event|0
1427976|NCT00996892|4712436|P5|Expansion Stage 2|Adverse Event|0
1427977|NCT00996892|4712437|P4|Expansion Stage 2|Adverse Event|0
1427978|NCT00996892|4712438|P3|Expansion Stage 2|Adverse Event|0
1427979|NCT00996892|4712439|P2|Expansion Stage 2|Adverse Event|0
1427980|NCT00996892|4712440|P1|Expansion Stage 2|Adverse Event|0
1427981|NCT00996892|4712421|P20|Dose-Escalation Stage 1B|Disease Progression|0
1427982|NCT00996892|4712422|P19|Dose-Escalation Stage 1B|Disease Progression|0
1427983|NCT00996892|4712423|P18|Dose-Escalation Stage 1B|Disease Progression|3
1427984|NCT00996892|4712424|P17|Dose-Escalation Stage 1B|Disease Progression|3
1427985|NCT00996892|4712425|P16|Dose-Escalation Stage 1B|Disease Progression|3
1427986|NCT00996892|4712426|P15|Dose-Escalation Stage 1B|Disease Progression|4
1427987|NCT00996892|4712427|P14|Dose-Escalation Stage 1B|Disease Progression|0
1427988|NCT00996892|4712428|P13|Dose-Escalation Stage 1B|Disease Progression|0
1427989|NCT00996892|4712429|P12|Dose-Escalation Stage 1B|Disease Progression|0
1427990|NCT00996892|4712430|P11|Dose-Escalation Stage 1B|Disease Progression|0
1427991|NCT00996892|4712431|P10|Dose-Escalation Stage 1B|Disease Progression|0
1427992|NCT00996892|4712432|P9|Dose-Escalation Stage 1B|Disease Progression|0
1427993|NCT00996892|4712433|P8|Dose-Escalation Stage 1B|Disease Progression|0
1427994|NCT00996892|4712434|P7|Dose-Escalation Stage 1B|Disease Progression|0
1427995|NCT00996892|4712435|P6|Dose-Escalation Stage 1B|Disease Progression|0
1427996|NCT00996892|4712436|P5|Dose-Escalation Stage 1B|Disease Progression|0
1427997|NCT00996892|4712437|P4|Dose-Escalation Stage 1B|Disease Progression|0
1427998|NCT00996892|4712438|P3|Dose-Escalation Stage 1B|Disease Progression|0
1427999|NCT00996892|4712439|P2|Dose-Escalation Stage 1B|Disease Progression|0
1428000|NCT00996892|4712440|P1|Dose-Escalation Stage 1B|Disease Progression|0
1428001|NCT00996892|4712421|P20|Dose-Escalation Stage 1B|Physician Decision|0
1428002|NCT00996892|4712422|P19|Dose-Escalation Stage 1B|Physician Decision|0
1428003|NCT00996892|4712423|P18|Dose-Escalation Stage 1B|Physician Decision|2
1428004|NCT00996892|4712424|P17|Dose-Escalation Stage 1B|Physician Decision|0
1428005|NCT00996892|4712425|P16|Dose-Escalation Stage 1B|Physician Decision|0
1428006|NCT00996892|4712426|P15|Dose-Escalation Stage 1B|Physician Decision|0
1428007|NCT00996892|4712427|P14|Dose-Escalation Stage 1B|Physician Decision|0
1428008|NCT00996892|4712428|P13|Dose-Escalation Stage 1B|Physician Decision|0
1428009|NCT00996892|4712429|P12|Dose-Escalation Stage 1B|Physician Decision|0
1428010|NCT00996892|4712430|P11|Dose-Escalation Stage 1B|Physician Decision|0
1428011|NCT00996892|4712431|P10|Dose-Escalation Stage 1B|Physician Decision|0
1428012|NCT00996892|4712432|P9|Dose-Escalation Stage 1B|Physician Decision|0
1428013|NCT00996892|4712433|P8|Dose-Escalation Stage 1B|Physician Decision|0
1428014|NCT00996892|4712434|P7|Dose-Escalation Stage 1B|Physician Decision|0
1428015|NCT00996892|4712435|P6|Dose-Escalation Stage 1B|Physician Decision|0
1428016|NCT00996892|4712436|P5|Dose-Escalation Stage 1B|Physician Decision|0
1428017|NCT00996892|4712437|P4|Dose-Escalation Stage 1B|Physician Decision|0
1428018|NCT00996892|4712438|P3|Dose-Escalation Stage 1B|Physician Decision|0
1428019|NCT00996892|4712439|P2|Dose-Escalation Stage 1B|Physician Decision|0
1428020|NCT00996892|4712440|P1|Dose-Escalation Stage 1B|Physician Decision|0
1428021|NCT00996892|4712421|P20|Dose-Escalation Stage 1A|Disease Progression|0
1428022|NCT00996892|4712422|P19|Dose-Escalation Stage 1A|Disease Progression|0
1428023|NCT00996892|4712423|P18|Dose-Escalation Stage 1A|Disease Progression|0
1428024|NCT00996892|4712424|P17|Dose-Escalation Stage 1A|Disease Progression|0
1428025|NCT00996892|4712425|P16|Dose-Escalation Stage 1A|Disease Progression|0
1428026|NCT00996892|4712426|P15|Dose-Escalation Stage 1A|Disease Progression|0
1428027|NCT00996892|4712427|P14|Dose-Escalation Stage 1A|Disease Progression|4
1428028|NCT00996892|4712428|P13|Dose-Escalation Stage 1A|Disease Progression|6
1428029|NCT00996892|4712429|P12|Dose-Escalation Stage 1A|Disease Progression|7
1428030|NCT00996892|4712430|P11|Dose-Escalation Stage 1A|Disease Progression|5
1428031|NCT00996892|4712431|P10|Dose-Escalation Stage 1A|Disease Progression|1
1428032|NCT00996892|4712432|P9|Dose-Escalation Stage 1A|Disease Progression|3
1428033|NCT00996892|4712433|P8|Dose-Escalation Stage 1A|Disease Progression|2
1428034|NCT00996892|4712434|P7|Dose-Escalation Stage 1A|Disease Progression|0
1428035|NCT00996892|4712435|P6|Dose-Escalation Stage 1A|Disease Progression|0
1428036|NCT00996892|4712436|P5|Dose-Escalation Stage 1A|Disease Progression|0
1428037|NCT00996892|4712437|P4|Dose-Escalation Stage 1A|Disease Progression|0
1428038|NCT00996892|4712438|P3|Dose-Escalation Stage 1A|Disease Progression|0
1428039|NCT00996892|4712439|P2|Dose-Escalation Stage 1A|Disease Progression|0
1428040|NCT00996892|4712440|P1|Dose-Escalation Stage 1A|Disease Progression|0
1428041|NCT00996892|4712421|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428042|NCT00996892|4712422|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428043|NCT00996892|4712423|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428044|NCT00996892|4712424|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428045|NCT00996892|4712425|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428046|NCT00996892|4712426|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428047|NCT00996892|4712427|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428048|NCT00996892|4712428|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
1428049|NCT00996892|4712429|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
1428050|NCT00996892|4712430|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
1428051|NCT00996892|4712431|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
1428052|NCT00996892|4712432|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428053|NCT00996892|4712433|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428054|NCT00996892|4712434|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428055|NCT00996892|4712435|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428056|NCT00996892|4712436|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428057|NCT00996892|4712437|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428058|NCT00996892|4712438|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428059|NCT00996892|4712439|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428060|NCT00996892|4712440|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1428061|NCT00996892|4712421|P20|Dose-Escalation Stage 1A|Physician Decision|0
1428062|NCT00996892|4712422|P19|Dose-Escalation Stage 1A|Physician Decision|0
1428063|NCT00996892|4712423|P18|Dose-Escalation Stage 1A|Physician Decision|0
1428064|NCT00996892|4712424|P17|Dose-Escalation Stage 1A|Physician Decision|0
1428065|NCT00996892|4712425|P16|Dose-Escalation Stage 1A|Physician Decision|0
1428066|NCT00996892|4712426|P15|Dose-Escalation Stage 1A|Physician Decision|0
1428067|NCT00996892|4712427|P14|Dose-Escalation Stage 1A|Physician Decision|0
1428068|NCT00996892|4712428|P13|Dose-Escalation Stage 1A|Physician Decision|0
1428069|NCT00996892|4712429|P12|Dose-Escalation Stage 1A|Physician Decision|0
1428070|NCT00996892|4712430|P11|Dose-Escalation Stage 1A|Physician Decision|0
1428071|NCT00996892|4712431|P10|Dose-Escalation Stage 1A|Physician Decision|0
1428072|NCT00996892|4712432|P9|Dose-Escalation Stage 1A|Physician Decision|0
1428073|NCT00996892|4712433|P8|Dose-Escalation Stage 1A|Physician Decision|1
1428074|NCT00996892|4712434|P7|Dose-Escalation Stage 1A|Physician Decision|0
1428075|NCT00996892|4712435|P6|Dose-Escalation Stage 1A|Physician Decision|0
1428076|NCT00996892|4712436|P5|Dose-Escalation Stage 1A|Physician Decision|0
1428077|NCT00996892|4712437|P4|Dose-Escalation Stage 1A|Physician Decision|0
1428078|NCT00996892|4712438|P3|Dose-Escalation Stage 1A|Physician Decision|0
1428079|NCT00996892|4712439|P2|Dose-Escalation Stage 1A|Physician Decision|0
1428080|NCT00996892|4712440|P1|Dose-Escalation Stage 1A|Physician Decision|0
1428081|NCT00996892|4712421|P20|Dose-Escalation Stage 1A|Death|0
1428082|NCT00996892|4712422|P19|Dose-Escalation Stage 1A|Death|0
1428083|NCT00996892|4712423|P18|Dose-Escalation Stage 1A|Death|0
1428084|NCT00996892|4712424|P17|Dose-Escalation Stage 1A|Death|0
1428085|NCT00996892|4712425|P16|Dose-Escalation Stage 1A|Death|0
1428086|NCT00996892|4712426|P15|Dose-Escalation Stage 1A|Death|0
1428087|NCT00996892|4712427|P14|Dose-Escalation Stage 1A|Death|0
1428088|NCT00996892|4712428|P13|Dose-Escalation Stage 1A|Death|1
1428089|NCT00996892|4712429|P12|Dose-Escalation Stage 1A|Death|1
1428090|NCT00996892|4712430|P11|Dose-Escalation Stage 1A|Death|0
1428091|NCT00996892|4712431|P10|Dose-Escalation Stage 1A|Death|2
1428092|NCT00996892|4712432|P9|Dose-Escalation Stage 1A|Death|0
1428093|NCT00996892|4712433|P8|Dose-Escalation Stage 1A|Death|0
1428094|NCT00996892|4712434|P7|Dose-Escalation Stage 1A|Death|0
1428095|NCT00996892|4712435|P6|Dose-Escalation Stage 1A|Death|0
1428096|NCT00996892|4712436|P5|Dose-Escalation Stage 1A|Death|0
1428097|NCT00996892|4712437|P4|Dose-Escalation Stage 1A|Death|0
1428098|NCT00996892|4712438|P3|Dose-Escalation Stage 1A|Death|0
1428099|NCT00996892|4712439|P2|Dose-Escalation Stage 1A|Death|0
1428100|NCT00996892|4712440|P1|Dose-Escalation Stage 1A|Death|0
1428101|NCT00996892|4712421|P20|Dose-Escalation Stage 1A|Adverse Event|0
1428102|NCT00996892|4712422|P19|Dose-Escalation Stage 1A|Adverse Event|0
1428103|NCT00996892|4712423|P18|Dose-Escalation Stage 1A|Adverse Event|0
1428104|NCT00996892|4712424|P17|Dose-Escalation Stage 1A|Adverse Event|0
1428105|NCT00996892|4712425|P16|Dose-Escalation Stage 1A|Adverse Event|0
1428106|NCT00996892|4712426|P15|Dose-Escalation Stage 1A|Adverse Event|0
1428107|NCT00996892|4712427|P14|Dose-Escalation Stage 1A|Adverse Event|1
1428108|NCT00996892|4712428|P13|Dose-Escalation Stage 1A|Adverse Event|0
1428109|NCT00996892|4712429|P12|Dose-Escalation Stage 1A|Adverse Event|0
1428110|NCT00996892|4712430|P11|Dose-Escalation Stage 1A|Adverse Event|1
1428111|NCT00996892|4712431|P10|Dose-Escalation Stage 1A|Adverse Event|0
1428112|NCT00996892|4712432|P9|Dose-Escalation Stage 1A|Adverse Event|0
1428113|NCT00996892|4712433|P8|Dose-Escalation Stage 1A|Adverse Event|0
1428114|NCT00996892|4712434|P7|Dose-Escalation Stage 1A|Adverse Event|0
1428115|NCT00996892|4712435|P6|Dose-Escalation Stage 1A|Adverse Event|0
1428116|NCT00996892|4712436|P5|Dose-Escalation Stage 1A|Adverse Event|0
1428117|NCT00996892|4712437|P4|Dose-Escalation Stage 1A|Adverse Event|0
1428118|NCT00996892|4712438|P3|Dose-Escalation Stage 1A|Adverse Event|0
1428119|NCT00996892|4712439|P2|Dose-Escalation Stage 1A|Adverse Event|0
1428120|NCT00996892|4712440|P1|Dose-Escalation Stage 1A|Adverse Event|0
1428121|NCT00996892|4712421|P20|Dose-Escalation Stage 1|Disease Progression|0
1428122|NCT00996892|4712422|P19|Dose-Escalation Stage 1|Disease Progression|0
1428123|NCT00996892|4712423|P18|Dose-Escalation Stage 1|Disease Progression|0
1428124|NCT00996892|4712424|P17|Dose-Escalation Stage 1|Disease Progression|0
1428125|NCT00996892|4712425|P16|Dose-Escalation Stage 1|Disease Progression|0
1428126|NCT00996892|4712426|P15|Dose-Escalation Stage 1|Disease Progression|0
1428127|NCT00996892|4712427|P14|Dose-Escalation Stage 1|Disease Progression|0
1428128|NCT00996892|4712428|P13|Dose-Escalation Stage 1|Disease Progression|0
1428129|NCT00996892|4712429|P12|Dose-Escalation Stage 1|Disease Progression|0
1428130|NCT00996892|4712430|P11|Dose-Escalation Stage 1|Disease Progression|0
1428131|NCT00996892|4712431|P10|Dose-Escalation Stage 1|Disease Progression|0
1428132|NCT00996892|4712432|P9|Dose-Escalation Stage 1|Disease Progression|0
1428133|NCT00996892|4712433|P8|Dose-Escalation Stage 1|Disease Progression|0
1428134|NCT00996892|4712434|P7|Dose-Escalation Stage 1|Disease Progression|0
1428135|NCT00996892|4712435|P6|Dose-Escalation Stage 1|Disease Progression|7
1428136|NCT00996892|4712436|P5|Dose-Escalation Stage 1|Disease Progression|10
1428137|NCT00996892|4712437|P4|Dose-Escalation Stage 1|Disease Progression|4
1428138|NCT00996892|4712438|P3|Dose-Escalation Stage 1|Disease Progression|3
1428139|NCT00996892|4712439|P2|Dose-Escalation Stage 1|Disease Progression|2
1428140|NCT00996892|4712440|P1|Dose-Escalation Stage 1|Disease Progression|2
1428141|NCT00996892|4712421|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
1428142|NCT00996892|4712422|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
1428143|NCT00996892|4712423|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
1428144|NCT00996892|4712424|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
1428145|NCT00996892|4712425|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
1428146|NCT00996892|4712426|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
1428147|NCT00996892|4712427|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
1428148|NCT00996892|4712428|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
1428149|NCT00996892|4712429|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
1428150|NCT00996892|4712430|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
1428151|NCT00996892|4712431|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
1428152|NCT00996892|4712432|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
1428153|NCT00996892|4712433|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
1428154|NCT00996892|4712434|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
1428155|NCT00996892|4712435|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
1428156|NCT00996892|4712436|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
1428157|NCT00996892|4712437|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
1428158|NCT00996892|4712438|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
1428159|NCT00996892|4712439|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
1428160|NCT00996892|4712440|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
1428161|NCT00996892|4712421|P20|Dose-Escalation Stage 1|Physician Decision|0
1428162|NCT00996892|4712422|P19|Dose-Escalation Stage 1|Physician Decision|0
1428163|NCT00996892|4712423|P18|Dose-Escalation Stage 1|Physician Decision|0
1428164|NCT00996892|4712424|P17|Dose-Escalation Stage 1|Physician Decision|0
1428165|NCT00996892|4712425|P16|Dose-Escalation Stage 1|Physician Decision|0
1428166|NCT00996892|4712426|P15|Dose-Escalation Stage 1|Physician Decision|0
1428167|NCT00996892|4712427|P14|Dose-Escalation Stage 1|Physician Decision|0
1428168|NCT00996892|4712428|P13|Dose-Escalation Stage 1|Physician Decision|0
1428169|NCT00996892|4712429|P12|Dose-Escalation Stage 1|Physician Decision|0
1428170|NCT00996892|4712430|P11|Dose-Escalation Stage 1|Physician Decision|0
1428171|NCT00996892|4712431|P10|Dose-Escalation Stage 1|Physician Decision|0
1428172|NCT00996892|4712432|P9|Dose-Escalation Stage 1|Physician Decision|0
1428173|NCT00996892|4712433|P8|Dose-Escalation Stage 1|Physician Decision|0
1428174|NCT00996892|4712434|P7|Dose-Escalation Stage 1|Physician Decision|2
1428175|NCT00996892|4712435|P6|Dose-Escalation Stage 1|Physician Decision|1
1428176|NCT00996892|4712436|P5|Dose-Escalation Stage 1|Physician Decision|0
1428177|NCT00996892|4712437|P4|Dose-Escalation Stage 1|Physician Decision|1
1428178|NCT00996892|4712438|P3|Dose-Escalation Stage 1|Physician Decision|0
1428179|NCT00996892|4712439|P2|Dose-Escalation Stage 1|Physician Decision|0
1428180|NCT00996892|4712440|P1|Dose-Escalation Stage 1|Physician Decision|1
1428181|NCT00996892|4712421|P20|Dose-Escalation Stage 1|Death|0
1428182|NCT00996892|4712422|P19|Dose-Escalation Stage 1|Death|0
1428183|NCT00996892|4712423|P18|Dose-Escalation Stage 1|Death|0
1428184|NCT00996892|4712424|P17|Dose-Escalation Stage 1|Death|0
1428185|NCT00996892|4712425|P16|Dose-Escalation Stage 1|Death|0
1428186|NCT00996892|4712426|P15|Dose-Escalation Stage 1|Death|0
1428187|NCT00996892|4712427|P14|Dose-Escalation Stage 1|Death|0
1428188|NCT00996892|4712428|P13|Dose-Escalation Stage 1|Death|0
1428189|NCT00996892|4712429|P12|Dose-Escalation Stage 1|Death|0
1428190|NCT00996892|4712430|P11|Dose-Escalation Stage 1|Death|0
1428191|NCT00996892|4712431|P10|Dose-Escalation Stage 1|Death|0
1428192|NCT00996892|4712432|P9|Dose-Escalation Stage 1|Death|0
1428193|NCT00996892|4712433|P8|Dose-Escalation Stage 1|Death|0
1428194|NCT00996892|4712434|P7|Dose-Escalation Stage 1|Death|0
1428195|NCT00996892|4712435|P6|Dose-Escalation Stage 1|Death|1
1428196|NCT00996892|4712436|P5|Dose-Escalation Stage 1|Death|0
1428197|NCT00996892|4712437|P4|Dose-Escalation Stage 1|Death|0
1428198|NCT00996892|4712438|P3|Dose-Escalation Stage 1|Death|0
1428199|NCT00996892|4712439|P2|Dose-Escalation Stage 1|Death|0
1428200|NCT00996892|4712440|P1|Dose-Escalation Stage 1|Death|1
1428201|NCT00996892|4712421|P20|Dose-Escalation Stage 1|Adverse Event|0
1428202|NCT00996892|4712422|P19|Dose-Escalation Stage 1|Adverse Event|0
1428203|NCT00996892|4712423|P18|Dose-Escalation Stage 1|Adverse Event|0
1428204|NCT00996892|4712424|P17|Dose-Escalation Stage 1|Adverse Event|0
1428205|NCT00996892|4712425|P16|Dose-Escalation Stage 1|Adverse Event|0
1428206|NCT00996892|4712426|P15|Dose-Escalation Stage 1|Adverse Event|0
1428207|NCT00996892|4712427|P14|Dose-Escalation Stage 1|Adverse Event|0
1428208|NCT00996892|4712428|P13|Dose-Escalation Stage 1|Adverse Event|0
1428209|NCT00996892|4712429|P12|Dose-Escalation Stage 1|Adverse Event|0
1428210|NCT00996892|4712430|P11|Dose-Escalation Stage 1|Adverse Event|0
1428211|NCT00996892|4712431|P10|Dose-Escalation Stage 1|Adverse Event|0
1428212|NCT00996892|4712432|P9|Dose-Escalation Stage 1|Adverse Event|0
1428213|NCT00996892|4712433|P8|Dose-Escalation Stage 1|Adverse Event|0
1428214|NCT00996892|4712434|P7|Dose-Escalation Stage 1|Adverse Event|1
1428215|NCT00996892|4712435|P6|Dose-Escalation Stage 1|Adverse Event|0
1428216|NCT00996892|4712436|P5|Dose-Escalation Stage 1|Adverse Event|0
1428217|NCT00996892|4712437|P4|Dose-Escalation Stage 1|Adverse Event|2
1428218|NCT00996892|4712438|P3|Dose-Escalation Stage 1|Adverse Event|0
1428219|NCT00996892|4712439|P2|Dose-Escalation Stage 1|Adverse Event|0
1428220|NCT00996892|4712440|P1|Dose-Escalation Stage 1|Adverse Event|0
1428221|NCT00996840|4713034|P5|Overall Study|Withdrawal by Subject|0
1428222|NCT00996840|4713035|P4|Overall Study|Withdrawal by Subject|0
1428223|NCT00996840|4713036|P3|Overall Study|Withdrawal by Subject|0
1428224|NCT00996840|4713037|P2|Overall Study|Withdrawal by Subject|1
1428225|NCT00996840|4713038|P1|Overall Study|Withdrawal by Subject|1
1428226|NCT00996840|4713034|P5|Overall Study|Physician Decision|2
1428227|NCT00996840|4713035|P4|Overall Study|Physician Decision|1
1428228|NCT00996840|4713036|P3|Overall Study|Physician Decision|1
1428229|NCT00996840|4713037|P2|Overall Study|Physician Decision|0
1428230|NCT00996840|4713038|P1|Overall Study|Physician Decision|0
1428231|NCT00996840|4713034|P5|Overall Study|Adverse Event|0
1428232|NCT00996840|4713035|P4|Overall Study|Adverse Event|0
1428233|NCT00996840|4713036|P3|Overall Study|Adverse Event|0
1428234|NCT00996840|4713037|P2|Overall Study|Adverse Event|1
1428235|NCT00996840|4713038|P1|Overall Study|Adverse Event|0
1428236|NCT00996801|4713188|P6|Overall Study|Withdrawal by Subject|9
1428237|NCT00996801|4713189|P5|Overall Study|Withdrawal by Subject|5
1428238|NCT00996801|4713190|P4|Overall Study|Withdrawal by Subject|5
1428239|NCT00996801|4713191|P3|Overall Study|Withdrawal by Subject|9
1428240|NCT00996801|4713192|P2|Overall Study|Withdrawal by Subject|6
1428241|NCT00996801|4713193|P1|Overall Study|Withdrawal by Subject|8
1428242|NCT00996801|4713188|P6|Overall Study|Study Terminated by Sponsor|0
1428243|NCT00996801|4713189|P5|Overall Study|Study Terminated by Sponsor|46
1428244|NCT00996801|4713190|P4|Overall Study|Study Terminated by Sponsor|0
1428245|NCT00996801|4713191|P3|Overall Study|Study Terminated by Sponsor|0
1428246|NCT00996801|4713192|P2|Overall Study|Study Terminated by Sponsor|1
1428247|NCT00996801|4713193|P1|Overall Study|Study Terminated by Sponsor|0
1428248|NCT00996801|4713188|P6|Overall Study|Protocol Violation|4
1428249|NCT00996801|4713189|P5|Overall Study|Protocol Violation|3
1428250|NCT00996801|4713190|P4|Overall Study|Protocol Violation|2
1428251|NCT00996801|4713191|P3|Overall Study|Protocol Violation|1
1428252|NCT00996801|4713192|P2|Overall Study|Protocol Violation|4
1428253|NCT00996801|4713193|P1|Overall Study|Protocol Violation|3
1428254|NCT00996801|4713188|P6|Overall Study|Progressive Disease|0
1428255|NCT00996801|4713189|P5|Overall Study|Progressive Disease|0
1428256|NCT00996801|4713190|P4|Overall Study|Progressive Disease|0
1428257|NCT00996801|4713191|P3|Overall Study|Progressive Disease|0
1428258|NCT00996801|4713192|P2|Overall Study|Progressive Disease|1
1428259|NCT00996801|4713193|P1|Overall Study|Progressive Disease|0
1428260|NCT00996801|4713188|P6|Overall Study|Physician Decision|0
1428261|NCT00996801|4713189|P5|Overall Study|Physician Decision|0
1428262|NCT00996801|4713190|P4|Overall Study|Physician Decision|1
1428263|NCT00996801|4713191|P3|Overall Study|Physician Decision|0
1428264|NCT00996801|4713192|P2|Overall Study|Physician Decision|0
1428265|NCT00996801|4713193|P1|Overall Study|Physician Decision|0
1428266|NCT00996801|4713188|P6|Overall Study|Lost to Follow-up|2
1428267|NCT00996801|4713189|P5|Overall Study|Lost to Follow-up|3
1428268|NCT00996801|4713190|P4|Overall Study|Lost to Follow-up|3
1428269|NCT00996801|4713191|P3|Overall Study|Lost to Follow-up|0
1428270|NCT00996801|4713192|P2|Overall Study|Lost to Follow-up|0
1428271|NCT00996801|4713193|P1|Overall Study|Lost to Follow-up|0
1428272|NCT00996801|4713188|P6|Overall Study|Lack of Efficacy|1
1428273|NCT00996801|4713189|P5|Overall Study|Lack of Efficacy|0
1428274|NCT00996801|4713190|P4|Overall Study|Lack of Efficacy|3
1428275|NCT00996801|4713191|P3|Overall Study|Lack of Efficacy|1
1428276|NCT00996801|4713192|P2|Overall Study|Lack of Efficacy|0
1428277|NCT00996801|4713193|P1|Overall Study|Lack of Efficacy|3
1428278|NCT00996801|4713188|P6|Overall Study|Adverse Event|3
1428279|NCT00996801|4713189|P5|Overall Study|Adverse Event|31
1428280|NCT00996801|4713190|P4|Overall Study|Adverse Event|17
1428281|NCT00996801|4713191|P3|Overall Study|Adverse Event|12
1428282|NCT00996801|4713192|P2|Overall Study|Adverse Event|4
1428283|NCT00996801|4713193|P1|Overall Study|Adverse Event|6
1428284|NCT00996736|4713305|P2|Overall Study|Visit not within 3-month window|3
1428285|NCT00996736|4713306|P1|Overall Study|Visit not within 3-month window|5
1428286|NCT00996736|4713305|P2|Overall Study|Lost to Follow-up|14
1428287|NCT00996736|4713306|P1|Overall Study|Lost to Follow-up|15
1428288|NCT00996736|4713305|P2|Overall Study|Death|1
1428289|NCT00996736|4713306|P1|Overall Study|Death|1
1428290|NCT00996658|4713326|P2|Overall Study|Other|7
1428291|NCT00996658|4713327|P1|Overall Study|Other|9
1428292|NCT00996658|4713326|P2|Overall Study|Non-compliance issues|3
1428293|NCT00996658|4713327|P1|Overall Study|Non-compliance issues|3
1428294|NCT00996658|4713326|P2|Overall Study|Lost to Follow-up|5
1428295|NCT00996658|4713327|P1|Overall Study|Lost to Follow-up|2
1428296|NCT00996658|4713326|P2|Overall Study|Protocol Violation|1
1428297|NCT00996658|4713327|P1|Overall Study|Protocol Violation|0
1428298|NCT00996658|4713326|P2|Overall Study|Adverse Event|5
1428299|NCT00996658|4713327|P1|Overall Study|Adverse Event|2
1428300|NCT00996632|4713355|P2|Overall Study|Physician Decision|0
1428301|NCT00996632|4713356|P1|Overall Study|Physician Decision|0
1428302|NCT00996606|4713364|P1|Overall Study|Withdrawal by Subject|3
1428303|NCT00996606|4713364|P1|Overall Study|Protocol Violation|1
1428304|NCT00996606|4713364|P1|Overall Study|Insufficient Therapeutic Response|2
1428305|NCT00996606|4713364|P1|Overall Study|Adverse Event or Intercurrent Illness|2
1428306|NCT00996593|4713458|P1|Long-Term Follow-Up|Site Closed|1
1428307|NCT00996593|4713458|P1|Long-Term Follow-Up|Withdrawal by Subject|2
1428308|NCT00996593|4713458|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
1428309|NCT00996593|4713458|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
1428310|NCT00996593|4713458|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
1428311|NCT00996593|4713458|P1|Dosimetric and Therapeutic Treatment|Death|1
1428312|NCT00996593|4713458|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
1428313|NCT00996593|4713458|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
1428314|NCT00996593|4713458|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
1428315|NCT00996580|4713486|P1|Overall Study|Not specified|29
1428316|NCT00996580|4713486|P1|Overall Study|Withdrawal by Subject|217
1428317|NCT00996580|4713486|P1|Overall Study|Sponsor requested participant withdrawal|35
1428318|NCT00996580|4713486|P1|Overall Study|Protocol Violation|16
1428319|NCT00996580|4713486|P1|Overall Study|Pregnancy|68
1428320|NCT00996580|4713486|P1|Overall Study|Physician Decision|5
1428321|NCT00996580|4713486|P1|Overall Study|Noncompliance with the protocol|137
1428322|NCT00996580|4713486|P1|Overall Study|Lost to Follow-up|480
1428323|NCT00996580|4713486|P1|Overall Study|Adverse Event|466
1428324|NCT00996476|4713523|P5|Overall Study|Adverse Event|1
1428325|NCT00996476|4713524|P4|Overall Study|Adverse Event|0
1428326|NCT00996476|4713525|P3|Overall Study|Adverse Event|0
1428327|NCT00996476|4713526|P2|Overall Study|Adverse Event|1
1428328|NCT00996476|4713527|P1|Overall Study|Adverse Event|0
1428329|NCT00996476|4713523|P5|Overall Study|Withdrawal by Subject|1
1428330|NCT00996476|4713524|P4|Overall Study|Withdrawal by Subject|0
1428331|NCT00996476|4713525|P3|Overall Study|Withdrawal by Subject|1
1428332|NCT00996476|4713526|P2|Overall Study|Withdrawal by Subject|2
1428333|NCT00996476|4713527|P1|Overall Study|Withdrawal by Subject|1
1428334|NCT00996437|4713595|P2|Overall Study|Missed|5
1428335|NCT00996437|4713596|P1|Overall Study|Missed|2
1428336|NCT00996437|4713595|P2|Overall Study|Dropped|2
1428337|NCT00996437|4713596|P1|Overall Study|Dropped|2
1428338|NCT00996437|4713595|P2|Overall Study|Death|0
1428339|NCT00996437|4713596|P1|Overall Study|Death|1
1428340|NCT00996333|4713641|P1|Overall Study|Other|5
1428341|NCT00996333|4713641|P1|Overall Study|Physician Decision|1
1428342|NCT00996333|4713641|P1|Overall Study|Adverse Event|1
1428343|NCT00996333|4713641|P1|Overall Study|Death|4
1428344|NCT00996333|4713641|P1|Overall Study|Withdrawal by Subject|1
1428345|NCT00996333|4713641|P1|Overall Study|Screen failure|1
1428346|NCT00996307|4713651|P4|Overall Study|Unable to classify|1
1428347|NCT00996307|4713652|P3|Overall Study|Unable to classify|2
1428348|NCT00996307|4713653|P2|Overall Study|Unable to classify|0
1428349|NCT00996307|4713654|P1|Overall Study|Unable to classify|4
1428350|NCT00996307|4713651|P4|Overall Study|Administrative reason|0
1428351|NCT00996307|4713652|P3|Overall Study|Administrative reason|0
1428352|NCT00996307|4713653|P2|Overall Study|Administrative reason|1
1428353|NCT00996307|4713654|P1|Overall Study|Administrative reason|0
1428354|NCT00996307|4713651|P4|Overall Study|Lost to Follow-up|15
1428355|NCT00996307|4713652|P3|Overall Study|Lost to Follow-up|7
1428356|NCT00996307|4713653|P2|Overall Study|Lost to Follow-up|13
1428357|NCT00996307|4713654|P1|Overall Study|Lost to Follow-up|13
1428358|NCT00996307|4713651|P4|Overall Study|Withdrawal by Subject|5
1428359|NCT00996307|4713652|P3|Overall Study|Withdrawal by Subject|5
1428360|NCT00996307|4713653|P2|Overall Study|Withdrawal by Subject|2
1428361|NCT00996307|4713654|P1|Overall Study|Withdrawal by Subject|3
1428362|NCT00996307|4713651|P4|Overall Study|Adverse Event|0
1428363|NCT00996307|4713652|P3|Overall Study|Adverse Event|0
1428364|NCT00996307|4713653|P2|Overall Study|Adverse Event|1
1428365|NCT00996307|4713654|P1|Overall Study|Adverse Event|0
1428366|NCT00996281|4713714|P2|Overall Study|Other|7
1428367|NCT00996281|4713715|P1|Overall Study|Other|5
1428368|NCT00996281|4713714|P2|Overall Study|Lack of Efficacy|2
1428369|NCT00996281|4713715|P1|Overall Study|Lack of Efficacy|0
1428370|NCT00996281|4713714|P2|Overall Study|Withdrawal by Subject|20
1428371|NCT00996281|4713715|P1|Overall Study|Withdrawal by Subject|31
1428372|NCT00996281|4713714|P2|Overall Study|Lost to Follow-up|16
1428373|NCT00996281|4713715|P1|Overall Study|Lost to Follow-up|14
1428374|NCT00996281|4713714|P2|Overall Study|Major Protocol Deviation|7
1428375|NCT00996281|4713715|P1|Overall Study|Major Protocol Deviation|6
1428376|NCT00996281|4713714|P2|Overall Study|Adverse Event|37
1428377|NCT00996281|4713715|P1|Overall Study|Adverse Event|75
1428378|NCT00996216|4713723|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
1428379|NCT00996216|4713723|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
1428380|NCT00996216|4713723|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
1428381|NCT00996203|4713739|P1|Overall Study|Protocol Violation|2
1428382|NCT00996203|4713739|P1|Overall Study|Lack of Efficacy|1
1428383|NCT00996203|4713739|P1|Overall Study|Lost to Follow-up|1
1428384|NCT00996203|4713739|P1|Overall Study|Adverse Event|3
1428385|NCT00996125|4713771|P2|Overall Study|Withdrawal by Subject|3
1428386|NCT00996125|4713772|P1|Overall Study|Withdrawal by Subject|4
1428387|NCT00996125|4713771|P2|Overall Study|Lost to Follow-up|6
1428388|NCT00996125|4713772|P1|Overall Study|Lost to Follow-up|1
1428389|NCT00996125|4713771|P2|Overall Study|Adverse Event|2
1428390|NCT00996125|4713772|P1|Overall Study|Adverse Event|0
1428391|NCT00996034|4713792|P1|Overall Study|withdrawn by PI|1
1428392|NCT00996034|4713792|P1|Overall Study|Lost to Follow-up|2
1428393|NCT00995930|4713798|P2|Overall Study|Adverse Event|14
1428394|NCT00995930|4713799|P1|Overall Study|Adverse Event|11
1428395|NCT00995930|4713798|P2|Overall Study|Withdrawal by Subject|4
1428396|NCT00995930|4713799|P1|Overall Study|Withdrawal by Subject|3
1428397|NCT00995930|4713798|P2|Overall Study|Lost to Follow-up|2
1428398|NCT00995930|4713799|P1|Overall Study|Lost to Follow-up|1
1428399|NCT00995930|4713798|P2|Overall Study|Administrative problems|2
1428400|NCT00995930|4713799|P1|Overall Study|Administrative problems|4
1428401|NCT00995930|4713798|P2|Overall Study|Death|1
1428402|NCT00995930|4713799|P1|Overall Study|Death|0
1428403|NCT00995930|4713798|P2|Overall Study|Protocol deviation|5
1428404|NCT00995930|4713799|P1|Overall Study|Protocol deviation|2
1428405|NCT00995865|4713850|P3|Overall Study|Lost to Follow-up|1
1428406|NCT00995865|4713851|P2|Overall Study|Lost to Follow-up|0
1428407|NCT00995865|4713852|P1|Overall Study|Lost to Follow-up|0
1428408|NCT00995865|4713850|P3|Overall Study|Protocol Violation|0
1428409|NCT00995865|4713851|P2|Overall Study|Protocol Violation|0
1428410|NCT00995865|4713852|P1|Overall Study|Protocol Violation|2
1428411|NCT00995774|4713874|P2|Training Period 2|Withdrawal by Subject|0
1428412|NCT00995774|4713875|P1|Training Period 2|Withdrawal by Subject|2
1428413|NCT00995709|4713907|P3|Overall Study|Protocol Violation|0
1428414|NCT00995709|4713908|P2|Overall Study|Protocol Violation|1
1428415|NCT00995709|4713909|P1|Overall Study|Protocol Violation|2
1428416|NCT00995709|4713907|P3|Overall Study|Death|0
1428417|NCT00995709|4713908|P2|Overall Study|Death|1
1428418|NCT00995709|4713909|P1|Overall Study|Death|0
1428419|NCT00995709|4713907|P3|Overall Study|Lost to Follow-up|0
1428420|NCT00995709|4713908|P2|Overall Study|Lost to Follow-up|0
1428421|NCT00995709|4713909|P1|Overall Study|Lost to Follow-up|1
1428422|NCT00995709|4713907|P3|Overall Study|Withdrawal by Subject|1
1428423|NCT00995709|4713908|P2|Overall Study|Withdrawal by Subject|4
1428424|NCT00995709|4713909|P1|Overall Study|Withdrawal by Subject|0
1428425|NCT00995709|4713907|P3|Overall Study|Lack of Efficacy|4
1428426|NCT00995709|4713908|P2|Overall Study|Lack of Efficacy|1
1428427|NCT00995709|4713909|P1|Overall Study|Lack of Efficacy|0
1428428|NCT00995709|4713907|P3|Overall Study|Adverse Event|0
1428429|NCT00995709|4713908|P2|Overall Study|Adverse Event|2
1428430|NCT00995709|4713909|P1|Overall Study|Adverse Event|4
1428431|NCT00995670|4713935|P3|Overall Study|Failed arterial cannulation|3
1428432|NCT00995670|4713936|P2|Overall Study|Failed arterial cannulation|0
1428433|NCT00995670|4713937|P1|Overall Study|Failed arterial cannulation|1
1428434|NCT00995566|4713945|P1|Overall Study|Early study termination|52
1428435|NCT00995566|4713945|P1|Overall Study|Adverse Event|2
1428436|NCT00995553|4713959|P2|Overall Study|Withdrawal by Subject|6
1428437|NCT00995553|4713960|P1|Overall Study|Withdrawal by Subject|2
1428438|NCT00995488|4714009|P1|Overall Study|Withdrawal by Subject|1
1428439|NCT00995436|4714032|P3|Overall Study|Withdrawal by Subject|0
1428440|NCT00995436|4714033|P2|Overall Study|Withdrawal by Subject|5
1428441|NCT00995436|4714034|P1|Overall Study|Withdrawal by Subject|2
1428442|NCT00995410|4714042|P1|Overall Study|Misc|28
1428443|NCT00995410|4714042|P1|Overall Study|Lost to Follow-up|2
1428444|NCT00995410|4714042|P1|Overall Study|Withdrawal by Subject|7
1428445|NCT00995410|4714042|P1|Overall Study|Adverse Event|51
1428446|NCT00995371|4714049|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
1428447|NCT00995371|4714050|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
1428448|NCT00995345|4714068|P5|Overall Study|all other reasons combined|3
1428449|NCT00995345|4714069|P4|Overall Study|all other reasons combined|1
1428450|NCT00995345|4714070|P3|Overall Study|all other reasons combined|2
1428451|NCT00995345|4714071|P2|Overall Study|all other reasons combined|2
1428452|NCT00995345|4714072|P1|Overall Study|all other reasons combined|2
1428453|NCT00995345|4714068|P5|Overall Study|Lost to Follow-up|0
1428454|NCT00995345|4714069|P4|Overall Study|Lost to Follow-up|1
1428455|NCT00995345|4714070|P3|Overall Study|Lost to Follow-up|2
1428456|NCT00995345|4714071|P2|Overall Study|Lost to Follow-up|2
1428457|NCT00995345|4714072|P1|Overall Study|Lost to Follow-up|2
1428458|NCT00995345|4714068|P5|Overall Study|Adverse Event|1
1428459|NCT00995345|4714069|P4|Overall Study|Adverse Event|0
1428460|NCT00995345|4714070|P3|Overall Study|Adverse Event|2
1428461|NCT00995345|4714071|P2|Overall Study|Adverse Event|1
1428462|NCT00995345|4714072|P1|Overall Study|Adverse Event|3
1428463|NCT00995345|4714068|P5|Overall Study|Withdrawal by Subject|1
1428464|NCT00995345|4714069|P4|Overall Study|Withdrawal by Subject|3
1428465|NCT00995345|4714070|P3|Overall Study|Withdrawal by Subject|1
1428466|NCT00995345|4714071|P2|Overall Study|Withdrawal by Subject|2
1428467|NCT00995345|4714072|P1|Overall Study|Withdrawal by Subject|4
1428468|NCT00995085|4714099|P1|Overall Study|Withdrawal by Subject|5
1428469|NCT00995020|4714105|P2|Overall Study|specimen fragmentation, thermal damage|2
1428470|NCT00995020|4714106|P1|Overall Study|specimen fragmentation, thermal damage|1
1428471|NCT00995020|4714105|P2|Overall Study|margin analysis not performed|5
1428472|NCT00995020|4714106|P1|Overall Study|margin analysis not performed|2
1428473|NCT00995007|4714116|P2|Overall Study|Toxicity|0
1428474|NCT00995007|4714117|P1|Overall Study|Toxicity|8
1428475|NCT00995007|4714116|P2|Overall Study|Refused further treatment|2
1428476|NCT00995007|4714117|P1|Overall Study|Refused further treatment|8
1428477|NCT00995007|4714116|P2|Overall Study|Withdrew consent|0
1428478|NCT00995007|4714117|P1|Overall Study|Withdrew consent|1
1428479|NCT00994682|4714180|P2|Pioglitazone Open Label|Physician Decision|1
1428480|NCT00994682|4714181|P1|Pioglitazone Open Label|Physician Decision|6
1428481|NCT00994682|4714180|P2|Pioglitazone Open Label|Lost to Follow-up|2
1428482|NCT00994682|4714181|P1|Pioglitazone Open Label|Lost to Follow-up|3
1428483|NCT00994682|4714180|P2|Pioglitazone Open Label|Withdrawal by Subject|4
1428484|NCT00994682|4714181|P1|Pioglitazone Open Label|Withdrawal by Subject|4
1428485|NCT00994682|4714180|P2|Double Bilnd|Adverse Event|0
1428486|NCT00994682|4714181|P1|Double Bilnd|Adverse Event|1
1428487|NCT00994682|4714180|P2|Double Bilnd|Lost to Follow-up|3
1428488|NCT00994682|4714181|P1|Double Bilnd|Lost to Follow-up|3
1428489|NCT00994682|4714180|P2|Double Bilnd|Withdrawal by Subject|6
1428490|NCT00994682|4714181|P1|Double Bilnd|Withdrawal by Subject|5
1428491|NCT00994643|4714225|P1|Overall Study|Withdrawal by Subject|1
1428492|NCT00994461|4714239|P3|Overall Study|Adverse Event|0
1428493|NCT00994461|4714240|P2|Overall Study|Adverse Event|1
1428494|NCT00994461|4714241|P1|Overall Study|Adverse Event|2
1428495|NCT00994448|4714269|P2|Overall Study|Physician Decision|0
1428496|NCT00994448|4714270|P1|Overall Study|Physician Decision|1
1428497|NCT00994448|4714269|P2|Overall Study|Withdrawal by Subject|1
1428498|NCT00994448|4714270|P1|Overall Study|Withdrawal by Subject|1
1428499|NCT00994448|4714269|P2|Overall Study|Lost to Follow-up|1
1428500|NCT00994448|4714270|P1|Overall Study|Lost to Follow-up|5
1428501|NCT00994448|4714269|P2|Overall Study|Adverse Event|0
1428502|NCT00994448|4714270|P1|Overall Study|Adverse Event|1
1428503|NCT00994422|4714278|P2|Overall Study|Lost to Follow-up|1
1428504|NCT00994422|4714279|P1|Overall Study|Lost to Follow-up|7
1428505|NCT00994279|4714304|P2|Overall Study|Multiple reasons|3
1428506|NCT00994279|4714305|P1|Overall Study|Multiple reasons|1
1428507|NCT00994279|4714304|P2|Overall Study|Toxicity|0
1428508|NCT00994279|4714305|P1|Overall Study|Toxicity|1
1428509|NCT00994279|4714304|P2|Overall Study|Withdrawal by Subject|2
1428510|NCT00994279|4714305|P1|Overall Study|Withdrawal by Subject|2
1428511|NCT00994240|4714315|P2|Overall Study|study termination|3
1428512|NCT00994240|4714316|P1|Overall Study|study termination|2
1428513|NCT00994240|4714315|P2|Overall Study|Withdrawal by Subject|0
1428514|NCT00994240|4714316|P1|Overall Study|Withdrawal by Subject|1
1428515|NCT00994240|4714315|P2|Overall Study|Lost to Follow-up|2
1428516|NCT00994240|4714316|P1|Overall Study|Lost to Follow-up|3
1428517|NCT00994214|4714326|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
1428518|NCT00994214|4714327|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
1428519|NCT00994214|4714328|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
1428520|NCT00994214|4714329|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
1428521|NCT00994214|4714326|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
1428522|NCT00994214|4714327|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
1428523|NCT00994214|4714328|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
1428524|NCT00994214|4714329|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
1428525|NCT00994214|4714326|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
1428526|NCT00994214|4714327|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
1428527|NCT00994214|4714328|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
1428528|NCT00994214|4714329|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
1428529|NCT00994214|4714326|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
1428530|NCT00994214|4714327|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
1428531|NCT00994214|4714328|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
1428532|NCT00994214|4714329|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
1428533|NCT00994214|4714326|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
1428534|NCT00994214|4714327|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
1428535|NCT00994214|4714328|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
1428536|NCT00994214|4714329|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
1428537|NCT00994214|4714326|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
1428538|NCT00994214|4714327|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
1428539|NCT00994214|4714328|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
1428540|NCT00994214|4714329|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
1428541|NCT00994110|4714408|P2|Overall Study|Pt not eligible|5
1428542|NCT00994110|4714409|P1|Overall Study|Pt not eligible|10
1428543|NCT00994110|4714408|P2|Overall Study|Patient not resected|52
1428544|NCT00994110|4714409|P1|Overall Study|Patient not resected|41
1428545|NCT00994110|4714408|P2|Overall Study|Adverse Event|0
1428546|NCT00994110|4714409|P1|Overall Study|Adverse Event|1
1428547|NCT00994110|4714408|P2|Overall Study|Not Treated|8
1428548|NCT00994110|4714409|P1|Overall Study|Not Treated|4
1428549|NCT00994110|4714408|P2|Overall Study|Withdrawal by Subject|9
1428550|NCT00994110|4714409|P1|Overall Study|Withdrawal by Subject|9
1428551|NCT00993967|4714415|P1|Overall Study|Protocol Violation|2
1428552|NCT00993967|4714415|P1|Overall Study|Withdrawal by Subject|36
1428553|NCT00993967|4714415|P1|Overall Study|Lost to Follow-up|14
1428554|NCT00993967|4714415|P1|Overall Study|Death|1
1428555|NCT00993967|4714415|P1|Overall Study|Adverse Event|8
1428556|NCT00993954|4714422|P2|Overall Study|Protocol Violation|2
1428557|NCT00993954|4714423|P1|Overall Study|Protocol Violation|21
1428558|NCT00993928|4714436|P2|Overall Study|ineligible|0
1428559|NCT00993928|4714437|P1|Overall Study|ineligible|1
1428560|NCT00993928|4714436|P2|Overall Study|Withdrawal by Subject|7
1428561|NCT00993928|4714437|P1|Overall Study|Withdrawal by Subject|4
1428562|NCT00993915|4714451|P1|Overall Study|Ongoing|3
1428563|NCT00993915|4714451|P1|Overall Study|Not specified|1
1428564|NCT00993915|4714451|P1|Overall Study|Withdrawal by Subject|2
1428565|NCT00993915|4714451|P1|Overall Study|Insufficient clinical response|3
1428566|NCT00993668|4714477|P2|Open-Label Period|Lost to Follow-up|1
1428567|NCT00993668|4714478|P1|Open-Label Period|Lost to Follow-up|6
1428568|NCT00993668|4714477|P2|Open-Label Period|Withdrawal by Subject|3
1428569|NCT00993668|4714478|P1|Open-Label Period|Withdrawal by Subject|4
1428570|NCT00993668|4714477|P2|Open-Label Period|Lack of Efficacy|3
1428571|NCT00993668|4714478|P1|Open-Label Period|Lack of Efficacy|4
1428572|NCT00993668|4714477|P2|Open-Label Period|Adverse Event|8
1428573|NCT00993668|4714478|P1|Open-Label Period|Adverse Event|9
1428574|NCT00993668|4714477|P2|Single-Blind Period|Lost to Follow-up|1
1428575|NCT00993668|4714478|P1|Single-Blind Period|Lost to Follow-up|3
1428576|NCT00993668|4714477|P2|Single-Blind Period|Lack of Efficacy|1
1428577|NCT00993668|4714478|P1|Single-Blind Period|Lack of Efficacy|0
1428578|NCT00993668|4714477|P2|Single-Blind Period|Adverse Event|1
1428579|NCT00993668|4714478|P1|Single-Blind Period|Adverse Event|1
1428580|NCT00993616|4714522|P1|Overall Study|Never treated|1
1428581|NCT00993616|4714522|P1|Overall Study|No tumor at entry|1
1428582|NCT00993499|4714540|P6|Discontinued After Starting Course 3|Other adverse event|0
1428583|NCT00993499|4714541|P5|Discontinued After Starting Course 3|Other adverse event|0
1428584|NCT00993499|4714542|P4|Discontinued After Starting Course 3|Other adverse event|0
1428585|NCT00993499|4714543|P3|Discontinued After Starting Course 3|Other adverse event|1
1428586|NCT00993499|4714544|P2|Discontinued After Starting Course 3|Other adverse event|0
1428587|NCT00993499|4714545|P1|Discontinued After Starting Course 3|Other adverse event|1
1428588|NCT00993499|4714540|P6|Discontinued After Starting Course 3|DLT|0
1428589|NCT00993499|4714541|P5|Discontinued After Starting Course 3|DLT|0
1428590|NCT00993499|4714542|P4|Discontinued After Starting Course 3|DLT|1
1428591|NCT00993499|4714543|P3|Discontinued After Starting Course 3|DLT|2
1428592|NCT00993499|4714544|P2|Discontinued After Starting Course 3|DLT|0
1428593|NCT00993499|4714545|P1|Discontinued After Starting Course 3|DLT|1
1428594|NCT00993499|4714540|P6|Discontinued After Starting Course 3|Progressive Disease|3
1428595|NCT00993499|4714541|P5|Discontinued After Starting Course 3|Progressive Disease|3
1428596|NCT00993499|4714542|P4|Discontinued After Starting Course 3|Progressive Disease|1
1428597|NCT00993499|4714543|P3|Discontinued After Starting Course 3|Progressive Disease|3
1428598|NCT00993499|4714544|P2|Discontinued After Starting Course 3|Progressive Disease|4
1428599|NCT00993499|4714545|P1|Discontinued After Starting Course 3|Progressive Disease|6
1428600|NCT00993499|4714540|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
1428601|NCT00993499|4714541|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
1428602|NCT00993499|4714542|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
1428603|NCT00993499|4714543|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
1428604|NCT00993499|4714544|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
1428605|NCT00993499|4714545|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
1428606|NCT00993499|4714540|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
1428607|NCT00993499|4714541|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
1428608|NCT00993499|4714542|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
1428609|NCT00993499|4714543|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
1428610|NCT00993499|4714544|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
1428611|NCT00993499|4714545|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
1428612|NCT00993499|4714540|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
1428613|NCT00993499|4714541|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
1428614|NCT00993499|4714542|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
1428615|NCT00993499|4714543|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
1428616|NCT00993499|4714544|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
1428617|NCT00993499|4714545|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
1428618|NCT00993499|4714540|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
1428619|NCT00993499|4714541|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
1428620|NCT00993499|4714542|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
1428621|NCT00993499|4714543|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
1428622|NCT00993499|4714544|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
1428623|NCT00993499|4714545|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
1428624|NCT00993499|4714540|P6|Discontinued Before Starting Course 3|Progressive Disease|0
1428625|NCT00993499|4714541|P5|Discontinued Before Starting Course 3|Progressive Disease|0
1428626|NCT00993499|4714542|P4|Discontinued Before Starting Course 3|Progressive Disease|0
1428627|NCT00993499|4714543|P3|Discontinued Before Starting Course 3|Progressive Disease|0
1428628|NCT00993499|4714544|P2|Discontinued Before Starting Course 3|Progressive Disease|2
1428629|NCT00993499|4714545|P1|Discontinued Before Starting Course 3|Progressive Disease|2
1428630|NCT00993499|4714540|P6|Run-in Period (8 Days)|Progressive disease|0
1428631|NCT00993499|4714541|P5|Run-in Period (8 Days)|Progressive disease|0
1428632|NCT00993499|4714542|P4|Run-in Period (8 Days)|Progressive disease|0
1428633|NCT00993499|4714543|P3|Run-in Period (8 Days)|Progressive disease|1
1428634|NCT00993499|4714544|P2|Run-in Period (8 Days)|Progressive disease|1
1428635|NCT00993499|4714545|P1|Run-in Period (8 Days)|Progressive disease|0
1428636|NCT00993499|4714540|P6|Run-in Period (8 Days)|Consent withdrawn|0
1428637|NCT00993499|4714541|P5|Run-in Period (8 Days)|Consent withdrawn|0
1428638|NCT00993499|4714542|P4|Run-in Period (8 Days)|Consent withdrawn|0
1428639|NCT00993499|4714543|P3|Run-in Period (8 Days)|Consent withdrawn|0
1428640|NCT00993499|4714544|P2|Run-in Period (8 Days)|Consent withdrawn|1
1428641|NCT00993499|4714545|P1|Run-in Period (8 Days)|Consent withdrawn|0
1428642|NCT00993499|4714540|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
1428643|NCT00993499|4714541|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
1428644|NCT00993499|4714542|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
1428645|NCT00993499|4714543|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
1428646|NCT00993499|4714544|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
1428647|NCT00993499|4714545|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
1428648|NCT00993499|4714540|P6|Run-in Period (8 Days)|Adverse Event|0
1428649|NCT00993499|4714541|P5|Run-in Period (8 Days)|Adverse Event|0
1428650|NCT00993499|4714542|P4|Run-in Period (8 Days)|Adverse Event|0
1428651|NCT00993499|4714543|P3|Run-in Period (8 Days)|Adverse Event|0
1428652|NCT00993499|4714544|P2|Run-in Period (8 Days)|Adverse Event|1
1428653|NCT00993499|4714545|P1|Run-in Period (8 Days)|Adverse Event|0
1428654|NCT00993473|4714627|P2|Overall Study|Family event|0
1428655|NCT00993473|4714628|P1|Overall Study|Family event|1
1428656|NCT00993473|4714627|P2|Overall Study|Technical problem with CGM device|1
1428657|NCT00993473|4714628|P1|Overall Study|Technical problem with CGM device|0
1428658|NCT00993473|4714627|P2|Overall Study|Withdrawal by Subject|5
1428659|NCT00993473|4714628|P1|Overall Study|Withdrawal by Subject|1
1428660|NCT00993473|4714627|P2|Overall Study|Lost to Follow-up|0
1428661|NCT00993473|4714628|P1|Overall Study|Lost to Follow-up|1
1428662|NCT00993473|4714627|P2|Overall Study|Protocol Violation|2
1428663|NCT00993473|4714628|P1|Overall Study|Protocol Violation|1
1428664|NCT00993473|4714627|P2|Overall Study|Adverse Event|2
1428665|NCT00993473|4714628|P1|Overall Study|Adverse Event|0
1428666|NCT00993447|4714666|P2|Overall Study|Adverse Event|0
1428667|NCT00993447|4714667|P1|Overall Study|Adverse Event|1
1428668|NCT00993447|4714666|P2|Overall Study|Lost to Follow-up|3
1428669|NCT00993447|4714667|P1|Overall Study|Lost to Follow-up|1
1428670|NCT00993447|4714666|P2|Overall Study|Protocol Violation|8
1428671|NCT00993447|4714667|P1|Overall Study|Protocol Violation|12
1428672|NCT00993447|4714666|P2|Overall Study|Withdrawal by Subject|8
1428673|NCT00993447|4714667|P1|Overall Study|Withdrawal by Subject|23
1428674|NCT00993421|4714704|P7|Overall Study|Protocol Violation|1
1428675|NCT00993421|4714705|P6|Overall Study|Protocol Violation|2
1428676|NCT00993421|4714706|P5|Overall Study|Protocol Violation|0
1428677|NCT00993421|4714707|P4|Overall Study|Protocol Violation|0
1428678|NCT00993421|4714708|P3|Overall Study|Protocol Violation|0
1428679|NCT00993421|4714709|P2|Overall Study|Protocol Violation|0
1428680|NCT00993421|4714710|P1|Overall Study|Protocol Violation|0
1428681|NCT00993421|4714704|P7|Overall Study|Physician Decision|1
1428682|NCT00993421|4714705|P6|Overall Study|Physician Decision|1
1428683|NCT00993421|4714706|P5|Overall Study|Physician Decision|0
1428684|NCT00993421|4714707|P4|Overall Study|Physician Decision|0
1428685|NCT00993421|4714708|P3|Overall Study|Physician Decision|0
1428686|NCT00993421|4714709|P2|Overall Study|Physician Decision|0
1428687|NCT00993421|4714710|P1|Overall Study|Physician Decision|0
1428688|NCT00993421|4714704|P7|Overall Study|Entry Criteria Exclusion|0
1428689|NCT00993421|4714705|P6|Overall Study|Entry Criteria Exclusion|1
1428690|NCT00993421|4714706|P5|Overall Study|Entry Criteria Exclusion|0
1428691|NCT00993421|4714707|P4|Overall Study|Entry Criteria Exclusion|3
1428692|NCT00993421|4714708|P3|Overall Study|Entry Criteria Exclusion|1
1428693|NCT00993421|4714709|P2|Overall Study|Entry Criteria Exclusion|0
1428694|NCT00993421|4714710|P1|Overall Study|Entry Criteria Exclusion|0
1428695|NCT00993421|4714704|P7|Overall Study|Death|1
1428696|NCT00993421|4714705|P6|Overall Study|Death|0
1428697|NCT00993421|4714706|P5|Overall Study|Death|0
1428698|NCT00993421|4714707|P4|Overall Study|Death|0
1428699|NCT00993421|4714708|P3|Overall Study|Death|0
1428700|NCT00993421|4714709|P2|Overall Study|Death|0
1428701|NCT00993421|4714710|P1|Overall Study|Death|0
1428702|NCT00993421|4714704|P7|Overall Study|Withdrawal by Subject|3
1428703|NCT00993421|4714705|P6|Overall Study|Withdrawal by Subject|5
1428704|NCT00993421|4714706|P5|Overall Study|Withdrawal by Subject|3
1428705|NCT00993421|4714707|P4|Overall Study|Withdrawal by Subject|3
1428706|NCT00993421|4714708|P3|Overall Study|Withdrawal by Subject|3
1428707|NCT00993421|4714709|P2|Overall Study|Withdrawal by Subject|2
1428708|NCT00993421|4714710|P1|Overall Study|Withdrawal by Subject|3
1428709|NCT00993421|4714704|P7|Overall Study|Lost to Follow-up|6
1428710|NCT00993421|4714705|P6|Overall Study|Lost to Follow-up|0
1428711|NCT00993421|4714706|P5|Overall Study|Lost to Follow-up|0
1428712|NCT00993421|4714707|P4|Overall Study|Lost to Follow-up|0
1428713|NCT00993421|4714708|P3|Overall Study|Lost to Follow-up|5
1428714|NCT00993421|4714709|P2|Overall Study|Lost to Follow-up|5
1428715|NCT00993421|4714710|P1|Overall Study|Lost to Follow-up|3
1428716|NCT00993421|4714704|P7|Overall Study|Sponsor Decision|29
1428717|NCT00993421|4714705|P6|Overall Study|Sponsor Decision|30
1428718|NCT00993421|4714706|P5|Overall Study|Sponsor Decision|38
1428719|NCT00993421|4714707|P4|Overall Study|Sponsor Decision|30
1428720|NCT00993421|4714708|P3|Overall Study|Sponsor Decision|28
1428721|NCT00993421|4714709|P2|Overall Study|Sponsor Decision|31
1428722|NCT00993421|4714710|P1|Overall Study|Sponsor Decision|36
1428723|NCT00993421|4714704|P7|Overall Study|Adverse Event|1
1428724|NCT00993421|4714705|P6|Overall Study|Adverse Event|7
1428725|NCT00993421|4714706|P5|Overall Study|Adverse Event|5
1428726|NCT00993421|4714707|P4|Overall Study|Adverse Event|9
1428727|NCT00993421|4714708|P3|Overall Study|Adverse Event|6
1428728|NCT00993421|4714709|P2|Overall Study|Adverse Event|7
1428729|NCT00993421|4714710|P1|Overall Study|Adverse Event|2
1428730|NCT00993317|4714861|P2|Overall Study|Early study termination at the site|0
1428731|NCT00993317|4714862|P1|Overall Study|Early study termination at the site|1
1428732|NCT00993317|4714861|P2|Overall Study|Investigator's opinion|1
1428733|NCT00993317|4714862|P1|Overall Study|Investigator's opinion|0
1428734|NCT00993317|4714861|P2|Overall Study|Withdrawal by Subject|2
1428735|NCT00993317|4714862|P1|Overall Study|Withdrawal by Subject|0
1428736|NCT00993317|4714861|P2|Overall Study|Lack of Efficacy|18
1428737|NCT00993317|4714862|P1|Overall Study|Lack of Efficacy|18
1428738|NCT00993317|4714861|P2|Overall Study|Adverse Event|4
1428739|NCT00993317|4714862|P1|Overall Study|Adverse Event|2
1428740|NCT00993291|4714880|P1|Overall Study|Withdrawal by Subject|1
1428741|NCT00993265|4714886|P2|Overall Study|Non-compliant with study medication|0
1428742|NCT00993265|4714887|P1|Overall Study|Non-compliant with study medication|1
1428743|NCT00993265|4714886|P2|Overall Study|Changed dose of concomitant drug|0
1428744|NCT00993265|4714887|P1|Overall Study|Changed dose of concomitant drug|2
1428745|NCT00993265|4714886|P2|Overall Study|Adverse Event|0
1428746|NCT00993265|4714887|P1|Overall Study|Adverse Event|1
1428747|NCT00993148|4714939|P1|Overall Study|never initiated treatment|1
1428748|NCT00993148|4714939|P1|Overall Study|Lost to Follow-up|2
1428749|NCT00993044|4714951|P1|Irinotecan 50 mg|Physician Decision|1
1428750|NCT00993031|4714958|P2|Overall Study|Lost to Follow-up|13
1428751|NCT00993031|4714959|P1|Overall Study|Lost to Follow-up|19
1428752|NCT00993031|4714958|P2|Overall Study|Withdrawal by Subject|3
1428753|NCT00993031|4714959|P1|Overall Study|Withdrawal by Subject|3
1428754|NCT00993031|4714958|P2|Overall Study|Physician Decision|2
1428755|NCT00993031|4714959|P1|Overall Study|Physician Decision|0
1428756|NCT00993031|4714958|P2|Overall Study|Death|1
1428757|NCT00993031|4714959|P1|Overall Study|Death|0
1428758|NCT00992992|4714977|P1|Overall Study|Sponsor Closed the Study|4
1428759|NCT00992992|4714977|P1|Overall Study|GlaxoSmithKline Closed the Study|2
1428760|NCT00992992|4714977|P1|Overall Study|Death|16
1428761|NCT00992992|4714977|P1|Overall Study|Lost to Follow-up|3
1428762|NCT00992836|4715008|P1|Overall Study|Protocol Violation|2
1428763|NCT00992836|4715008|P1|Overall Study|Withdrawal by Subject|2
1428764|NCT00992836|4715008|P1|Overall Study|Lost to Follow-up|1
1428765|NCT00992784|4715023|P3|Overall Study|Withdrawal by Subject|1
1428766|NCT00992784|4715024|P2|Overall Study|Withdrawal by Subject|1
1428767|NCT00992784|4715025|P1|Overall Study|Withdrawal by Subject|1
1428768|NCT00992784|4715023|P3|Overall Study|Adverse Event|0
1428769|NCT00992784|4715024|P2|Overall Study|Adverse Event|1
1428770|NCT00992784|4715025|P1|Overall Study|Adverse Event|2
1428771|NCT00992589|4715137|P4|Double-Blind Phase|Not specified|3
1428772|NCT00992589|4715138|P3|Double-Blind Phase|Not specified|6
1428773|NCT00992589|4715139|P2|Double-Blind Phase|Not specified|1
1428774|NCT00992589|4715140|P1|Double-Blind Phase|Not specified|0
1428775|NCT00992589|4715137|P4|Double-Blind Phase|Lost to Follow-up|2
1428776|NCT00992589|4715138|P3|Double-Blind Phase|Lost to Follow-up|0
1428777|NCT00992589|4715139|P2|Double-Blind Phase|Lost to Follow-up|0
1428778|NCT00992589|4715140|P1|Double-Blind Phase|Lost to Follow-up|0
1428779|NCT00992589|4715137|P4|Double-Blind Phase|Withdrawal by Subject|2
1428780|NCT00992589|4715138|P3|Double-Blind Phase|Withdrawal by Subject|5
1428781|NCT00992589|4715139|P2|Double-Blind Phase|Withdrawal by Subject|6
1428782|NCT00992589|4715140|P1|Double-Blind Phase|Withdrawal by Subject|0
1428783|NCT00992589|4715137|P4|Double-Blind Phase|Adverse Event|3
1428784|NCT00992589|4715138|P3|Double-Blind Phase|Adverse Event|2
1428785|NCT00992589|4715139|P2|Double-Blind Phase|Adverse Event|6
1428786|NCT00992589|4715140|P1|Double-Blind Phase|Adverse Event|0
1428787|NCT00992589|4715137|P4|Open-Label Phase|Not specified|0
1428788|NCT00992589|4715138|P3|Open-Label Phase|Not specified|0
1428789|NCT00992589|4715139|P2|Open-Label Phase|Not specified|0
1428790|NCT00992589|4715140|P1|Open-Label Phase|Not specified|45
1428791|NCT00992589|4715137|P4|Open-Label Phase|Physician Decision|0
1428792|NCT00992589|4715138|P3|Open-Label Phase|Physician Decision|0
1428793|NCT00992589|4715139|P2|Open-Label Phase|Physician Decision|0
1428794|NCT00992589|4715140|P1|Open-Label Phase|Physician Decision|4
1428795|NCT00992589|4715137|P4|Open-Label Phase|Protocol Violation|0
1428796|NCT00992589|4715138|P3|Open-Label Phase|Protocol Violation|0
1428797|NCT00992589|4715139|P2|Open-Label Phase|Protocol Violation|0
1428798|NCT00992589|4715140|P1|Open-Label Phase|Protocol Violation|3
1428799|NCT00992589|4715137|P4|Open-Label Phase|Lost to Follow-up|0
1428800|NCT00992589|4715138|P3|Open-Label Phase|Lost to Follow-up|0
1428801|NCT00992589|4715139|P2|Open-Label Phase|Lost to Follow-up|0
1428802|NCT00992589|4715140|P1|Open-Label Phase|Lost to Follow-up|1
1428803|NCT00992589|4715137|P4|Open-Label Phase|Withdrawal by Subject|0
1428804|NCT00992589|4715138|P3|Open-Label Phase|Withdrawal by Subject|0
1428805|NCT00992589|4715139|P2|Open-Label Phase|Withdrawal by Subject|0
1428806|NCT00992589|4715140|P1|Open-Label Phase|Withdrawal by Subject|20
1428807|NCT00992589|4715137|P4|Open-Label Phase|Adverse Event|0
1428808|NCT00992589|4715138|P3|Open-Label Phase|Adverse Event|0
1428809|NCT00992589|4715139|P2|Open-Label Phase|Adverse Event|0
1428810|NCT00992589|4715140|P1|Open-Label Phase|Adverse Event|4
1428811|NCT00992459|4715184|P2|Overall Study|Adverse Event|0
1428812|NCT00992459|4715185|P1|Overall Study|Adverse Event|1
1428813|NCT00992459|4715184|P2|Overall Study|Withdrawal by Subject|1
1428814|NCT00992459|4715185|P1|Overall Study|Withdrawal by Subject|0
1428815|NCT00992446|4715209|P1|Overall Study|Maintenance Therapy Screen Fail|5
1428816|NCT00992446|4715209|P1|Overall Study|Withdrawal by Subject|2
1428817|NCT00992446|4715209|P1|Overall Study|Disease Progression|1
1428818|NCT00992407|4715281|P2|Overall Study|Study medication not administered|13
1428819|NCT00992407|4715282|P1|Overall Study|Study medication not administered|17
1428820|NCT00992407|4715281|P2|Overall Study|Loss of follow-up & Adverse events|1
1428821|NCT00992407|4715282|P1|Overall Study|Loss of follow-up & Adverse events|2
1428822|NCT00992407|4715281|P2|Overall Study|Other|0
1428823|NCT00992407|4715282|P1|Overall Study|Other|2
1428824|NCT00992407|4715281|P2|Overall Study|protocol Violation & Adverse events|4
1428825|NCT00992407|4715282|P1|Overall Study|protocol Violation & Adverse events|2
1428826|NCT00992407|4715281|P2|Overall Study|Adverse Event|2
1428827|NCT00992407|4715282|P1|Overall Study|Adverse Event|3
1428828|NCT00992407|4715281|P2|Overall Study|Lost to Follow-up|3
1428829|NCT00992407|4715282|P1|Overall Study|Lost to Follow-up|3
1428830|NCT00992407|4715281|P2|Overall Study|Protocol Violation|1
1428831|NCT00992407|4715282|P1|Overall Study|Protocol Violation|2
1428832|NCT00992394|4715332|P2|Overall Study|Other event|0
1428833|NCT00992394|4715333|P1|Overall Study|Other event|1
1428834|NCT00992394|4715332|P2|Overall Study|Lost to Follow-up|0
1428835|NCT00992394|4715333|P1|Overall Study|Lost to Follow-up|2
1428836|NCT00992394|4715332|P2|Overall Study|Protocol Violation|4
1428837|NCT00992394|4715333|P1|Overall Study|Protocol Violation|2
1428838|NCT00992394|4715332|P2|Overall Study|Physician Decision|0
1428839|NCT00992394|4715333|P1|Overall Study|Physician Decision|1
1428840|NCT00992394|4715332|P2|Overall Study|Withdrawal by Subject|2
1428841|NCT00992394|4715333|P1|Overall Study|Withdrawal by Subject|8
1428842|NCT00992394|4715332|P2|Overall Study|Adverse Event|5
1428843|NCT00992394|4715333|P1|Overall Study|Adverse Event|4
1428844|NCT00992394|4715332|P2|Overall Study|Lack of Efficacy|3
1428845|NCT00992394|4715333|P1|Overall Study|Lack of Efficacy|6
1428846|NCT00992225|4715420|P1|Overall Study|Adverse Event|2
1428847|NCT00992225|4715420|P1|Overall Study|Entry Criteria Not Met|8
1428848|NCT00992186|4715430|P1|Overall Study|Refusal To Receive Study Agent|3
1428849|NCT00992186|4715430|P1|Overall Study|Progressive Disease|30
1428850|NCT00992186|4715430|P1|Overall Study|Adverse Event|9
1428851|NCT00992186|4715430|P1|Overall Study|Physician Decision|1
1428852|NCT00992186|4715430|P1|Overall Study|Protocol Violation|1
1428853|NCT00992186|4715430|P1|Overall Study|Withdrawal by Subject|2
1428854|NCT00992108|4715449|P2|Overall Study|Lost to Follow-up|1
1428855|NCT00992108|4715450|P1|Overall Study|Lost to Follow-up|0
1428856|NCT00992056|4715464|P2|Washout Period (2 Weeks)|Physician Decision|0
1428857|NCT00992056|4715465|P1|Washout Period (2 Weeks)|Physician Decision|1
1428858|NCT00992056|4715464|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
1428859|NCT00992056|4715465|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
1428860|NCT00992017|4715471|P1|Overall Study|Not adhere to study requirements|1
1428861|NCT00992017|4715471|P1|Overall Study|Unable to get to clinic|5
1428862|NCT00992017|4715471|P1|Overall Study|Withdrawal by Subject|2
1428863|NCT00992017|4715471|P1|Overall Study|Lost to Follow-up|2
1428864|NCT00991952|4715486|P2|Overall Study|Adverse Event|1
1428865|NCT00991952|4715487|P1|Overall Study|Adverse Event|0
1428866|NCT00991939|4715495|P2|Overall Study|Entire study terminated|1
1428867|NCT00991939|4715496|P1|Overall Study|Entire study terminated|4
1428868|NCT00991939|4715495|P2|Overall Study|Withdrawal by Subject|0
1428869|NCT00991939|4715496|P1|Overall Study|Withdrawal by Subject|1
1428870|NCT00991939|4715495|P2|Overall Study|Lost to Follow-up|1
1428871|NCT00991939|4715496|P1|Overall Study|Lost to Follow-up|0
1428872|NCT00991887|4715530|P2|Overall Study|Lost to Follow-up|1
1428873|NCT00991887|4715531|P1|Overall Study|Lost to Follow-up|2
1428874|NCT00991510|4715550|P2|Period III (Days 29-112)|Adverse Event|1
1428875|NCT00991510|4715551|P1|Period III (Days 29-112)|Adverse Event|1
1428876|NCT00991510|4715550|P2|Period I (Days 1-14)|Adverse Event|0
1428877|NCT00991510|4715551|P1|Period I (Days 1-14)|Adverse Event|1
1428878|NCT00991341|4715597|P2|Overall Study|Withdrawal by Subject|4
1428879|NCT00991341|4715598|P1|Overall Study|Withdrawal by Subject|3
1428880|NCT00991341|4715597|P2|Overall Study|Physician Decision|2
1428881|NCT00991341|4715598|P1|Overall Study|Physician Decision|1
1428882|NCT00991341|4715597|P2|Overall Study|no RBCs received 96hrs after randomized|155
1428883|NCT00991341|4715598|P1|Overall Study|no RBCs received 96hrs after randomized|186
1428884|NCT00991341|4715597|P2|Overall Study|Death|0
1428885|NCT00991341|4715598|P1|Overall Study|Death|3
1428886|NCT00991341|4715597|P2|Overall Study|no surgery w/in 30 days of randomization|18
1428887|NCT00991341|4715598|P1|Overall Study|no surgery w/in 30 days of randomization|11
1428888|NCT00991302|4715636|P2|Overall Study|Lost to Follow-up|12
1428889|NCT00991302|4715637|P1|Overall Study|Lost to Follow-up|14
1428890|NCT00991302|4715636|P2|Overall Study|Death|1
1428891|NCT00991302|4715637|P1|Overall Study|Death|0
1428892|NCT00991289|4715653|P1|Overall Study|Protocol Violation|2
1428893|NCT00991289|4715653|P1|Overall Study|Lost to Follow-up|4
1428894|NCT00991289|4715653|P1|Overall Study|Withdrawal by Subject|3
1428895|NCT00991289|4715653|P1|Overall Study|Physician Decision|2
1428896|NCT00991289|4715653|P1|Overall Study|Adverse Event|1
1428897|NCT00991276|4715673|P6|Third Intervention Period|Withdrawal by Subject|0
1428898|NCT00991276|4715674|P5|Third Intervention Period|Withdrawal by Subject|0
1428899|NCT00991276|4715675|P4|Third Intervention Period|Withdrawal by Subject|1
1428900|NCT00991276|4715676|P3|Third Intervention Period|Withdrawal by Subject|0
1428901|NCT00991276|4715677|P2|Third Intervention Period|Withdrawal by Subject|0
1428902|NCT00991276|4715678|P1|Third Intervention Period|Withdrawal by Subject|0
1428903|NCT00991276|4715673|P6|Third Intervention Period|Adverse Event|0
1428904|NCT00991276|4715674|P5|Third Intervention Period|Adverse Event|0
1428905|NCT00991276|4715675|P4|Third Intervention Period|Adverse Event|0
1428906|NCT00991276|4715676|P3|Third Intervention Period|Adverse Event|1
1428907|NCT00991276|4715677|P2|Third Intervention Period|Adverse Event|0
1428908|NCT00991276|4715678|P1|Third Intervention Period|Adverse Event|0
1428909|NCT00991276|4715673|P6|Third Intervention Period|Other|1
1428910|NCT00991276|4715674|P5|Third Intervention Period|Other|0
1428911|NCT00991276|4715675|P4|Third Intervention Period|Other|0
1428912|NCT00991276|4715676|P3|Third Intervention Period|Other|0
1428913|NCT00991276|4715677|P2|Third Intervention Period|Other|0
1428914|NCT00991276|4715678|P1|Third Intervention Period|Other|0
1428915|NCT00991276|4715673|P6|Third Intervention Period|Protocol Violation|0
1428916|NCT00991276|4715674|P5|Third Intervention Period|Protocol Violation|0
1428917|NCT00991276|4715675|P4|Third Intervention Period|Protocol Violation|0
1428918|NCT00991276|4715676|P3|Third Intervention Period|Protocol Violation|0
1428919|NCT00991276|4715677|P2|Third Intervention Period|Protocol Violation|0
1428920|NCT00991276|4715678|P1|Third Intervention Period|Protocol Violation|1
1428921|NCT00991276|4715673|P6|Second Intervention Period|Other|1
1428922|NCT00991276|4715674|P5|Second Intervention Period|Other|0
1428923|NCT00991276|4715675|P4|Second Intervention Period|Other|1
1428924|NCT00991276|4715676|P3|Second Intervention Period|Other|0
1428925|NCT00991276|4715677|P2|Second Intervention Period|Other|0
1428926|NCT00991276|4715678|P1|Second Intervention Period|Other|0
1428927|NCT00991276|4715673|P6|Second Intervention Period|Protocol Violation|0
1428928|NCT00991276|4715674|P5|Second Intervention Period|Protocol Violation|0
1428929|NCT00991276|4715675|P4|Second Intervention Period|Protocol Violation|0
1428930|NCT00991276|4715676|P3|Second Intervention Period|Protocol Violation|0
1428931|NCT00991276|4715677|P2|Second Intervention Period|Protocol Violation|0
1428932|NCT00991276|4715678|P1|Second Intervention Period|Protocol Violation|1
1428933|NCT00991276|4715673|P6|Second Intervention Period|Adverse Event|0
1428934|NCT00991276|4715674|P5|Second Intervention Period|Adverse Event|1
1428935|NCT00991276|4715675|P4|Second Intervention Period|Adverse Event|1
1428936|NCT00991276|4715676|P3|Second Intervention Period|Adverse Event|0
1428937|NCT00991276|4715677|P2|Second Intervention Period|Adverse Event|2
1428938|NCT00991276|4715678|P1|Second Intervention Period|Adverse Event|0
1428939|NCT00991276|4715673|P6|First Intervention Period|Lost to Follow-up|0
1428940|NCT00991276|4715674|P5|First Intervention Period|Lost to Follow-up|0
1428941|NCT00991276|4715675|P4|First Intervention Period|Lost to Follow-up|1
1428942|NCT00991276|4715676|P3|First Intervention Period|Lost to Follow-up|0
1428943|NCT00991276|4715677|P2|First Intervention Period|Lost to Follow-up|1
1428944|NCT00991276|4715678|P1|First Intervention Period|Lost to Follow-up|0
1428945|NCT00991276|4715673|P6|First Intervention Period|Withdrawal by Subject|1
1428946|NCT00991276|4715674|P5|First Intervention Period|Withdrawal by Subject|0
1428947|NCT00991276|4715675|P4|First Intervention Period|Withdrawal by Subject|1
1428948|NCT00991276|4715676|P3|First Intervention Period|Withdrawal by Subject|0
1428949|NCT00991276|4715677|P2|First Intervention Period|Withdrawal by Subject|1
1428950|NCT00991276|4715678|P1|First Intervention Period|Withdrawal by Subject|0
1428951|NCT00991276|4715673|P6|First Intervention Period|Other|0
1428952|NCT00991276|4715674|P5|First Intervention Period|Other|1
1428953|NCT00991276|4715675|P4|First Intervention Period|Other|1
1428954|NCT00991276|4715676|P3|First Intervention Period|Other|0
1428955|NCT00991276|4715677|P2|First Intervention Period|Other|0
1428956|NCT00991276|4715678|P1|First Intervention Period|Other|0
1428957|NCT00991276|4715673|P6|First Intervention Period|Insufficient clinical response|0
1428958|NCT00991276|4715674|P5|First Intervention Period|Insufficient clinical response|1
1428959|NCT00991276|4715675|P4|First Intervention Period|Insufficient clinical response|0
1428960|NCT00991276|4715676|P3|First Intervention Period|Insufficient clinical response|0
1428961|NCT00991276|4715677|P2|First Intervention Period|Insufficient clinical response|0
1428962|NCT00991276|4715678|P1|First Intervention Period|Insufficient clinical response|0
1428963|NCT00991276|4715673|P6|First Intervention Period|Protocol Violation|0
1428964|NCT00991276|4715674|P5|First Intervention Period|Protocol Violation|2
1428965|NCT00991276|4715675|P4|First Intervention Period|Protocol Violation|0
1428966|NCT00991276|4715676|P3|First Intervention Period|Protocol Violation|0
1428967|NCT00991276|4715677|P2|First Intervention Period|Protocol Violation|0
1428968|NCT00991276|4715678|P1|First Intervention Period|Protocol Violation|0
1428969|NCT00991276|4715673|P6|First Intervention Period|Adverse Event|0
1428970|NCT00991276|4715674|P5|First Intervention Period|Adverse Event|0
1428971|NCT00991276|4715675|P4|First Intervention Period|Adverse Event|1
1428972|NCT00991276|4715676|P3|First Intervention Period|Adverse Event|0
1428973|NCT00991276|4715677|P2|First Intervention Period|Adverse Event|1
1428974|NCT00991276|4715678|P1|First Intervention Period|Adverse Event|0
1428975|NCT00990821|4715835|P14|Overall Study|Withdrawal by Subject|1
1428976|NCT00990821|4715836|P13|Overall Study|Withdrawal by Subject|2
1428977|NCT00990821|4715837|P12|Overall Study|Withdrawal by Subject|5
1428978|NCT00990821|4715838|P11|Overall Study|Withdrawal by Subject|3
1428979|NCT00990821|4715839|P10|Overall Study|Withdrawal by Subject|1
1428980|NCT00990821|4715840|P9|Overall Study|Withdrawal by Subject|0
1428981|NCT00990821|4715841|P8|Overall Study|Withdrawal by Subject|0
1428982|NCT00990821|4715842|P7|Overall Study|Withdrawal by Subject|1
1428983|NCT00990821|4715843|P6|Overall Study|Withdrawal by Subject|3
1428984|NCT00990821|4715844|P5|Overall Study|Withdrawal by Subject|3
1428985|NCT00990821|4715845|P4|Overall Study|Withdrawal by Subject|0
1428986|NCT00990821|4715846|P3|Overall Study|Withdrawal by Subject|0
1428987|NCT00990821|4715847|P2|Overall Study|Withdrawal by Subject|2
1428988|NCT00990821|4715848|P1|Overall Study|Withdrawal by Subject|0
1428989|NCT00990704|4715885|P2|Overall Study|Physician Decision|1
1428990|NCT00990704|4715886|P1|Overall Study|Physician Decision|0
1428991|NCT00990704|4715885|P2|Overall Study|Adverse Event|1
1428992|NCT00990704|4715886|P1|Overall Study|Adverse Event|1
1428993|NCT00990652|4715906|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
1428994|NCT00990652|4715906|P1|Pre-surgical Bortezomib|Adverse Event|1
1428995|NCT00990340|4715940|P2|First 14-day Treatment|Protocol Violation|2
1428996|NCT00990340|4715941|P1|First 14-day Treatment|Protocol Violation|2
1428997|NCT00990340|4715940|P2|First 14-day Treatment|Lost to Follow-up|1
1428998|NCT00990340|4715941|P1|First 14-day Treatment|Lost to Follow-up|2
1428999|NCT00990340|4715940|P2|First 14-day Treatment|Not Compliant|1
1429000|NCT00990340|4715941|P1|First 14-day Treatment|Not Compliant|2
1429001|NCT00990249|4715988|P1|Overall Study|Not treated|2
1429002|NCT00990249|4715988|P1|Overall Study|Death|2
1429003|NCT00990249|4715988|P1|Overall Study|Non-Compliance|1
1429004|NCT00990249|4715988|P1|Overall Study|Disease Progression|8
1429005|NCT00990184|4715992|P1|Overall Study|Physician Decision|1
1429006|NCT00990106|4716000|P2|Overall Study|scheduling conflicts|2
1429007|NCT00990106|4716001|P1|Overall Study|scheduling conflicts|0
1429008|NCT00990106|4716000|P2|Overall Study|planned major surgery|1
1429009|NCT00990106|4716001|P1|Overall Study|planned major surgery|0
1429010|NCT00990106|4716000|P2|Overall Study|started exclusionary medication|1
1429011|NCT00990106|4716001|P1|Overall Study|started exclusionary medication|0
1429012|NCT00990106|4716000|P2|Overall Study|relocation/deployment|1
1429013|NCT00990106|4716001|P1|Overall Study|relocation/deployment|4
1429014|NCT00990106|4716000|P2|Overall Study|opted for open label prazosin|1
1429015|NCT00990106|4716001|P1|Overall Study|opted for open label prazosin|1
1429016|NCT00990106|4716000|P2|Overall Study|Withdrawal by Subject|1
1429017|NCT00990106|4716001|P1|Overall Study|Withdrawal by Subject|2
1429018|NCT00990106|4716000|P2|Overall Study|Lost to Follow-up|3
1429019|NCT00990106|4716001|P1|Overall Study|Lost to Follow-up|1
1429020|NCT00990106|4716000|P2|Overall Study|"too busy to continue"|2
1429021|NCT00990106|4716001|P1|Overall Study|"too busy to continue"|1
1429022|NCT00990093|4716011|P2|Test Period 2 (15-28 Days)|Not specified|1
1429023|NCT00990093|4716012|P1|Test Period 2 (15-28 Days)|Not specified|0
1429024|NCT00990093|4716011|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
1429025|NCT00990093|4716012|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
1429026|NCT00990093|4716011|P2|Test Period 2 (15-28 Days)|Adverse Event|0
1429027|NCT00990093|4716012|P1|Test Period 2 (15-28 Days)|Adverse Event|1
1429028|NCT00990093|4716011|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
1429029|NCT00990093|4716012|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
1429030|NCT00990093|4716011|P2|Test Period 1 (1-14 Days)|Not Specified|0
1429031|NCT00990093|4716012|P1|Test Period 1 (1-14 Days)|Not Specified|1
1429032|NCT00990093|4716011|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
1429033|NCT00990093|4716012|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
1429034|NCT00990093|4716011|P2|Test Period 1 (1-14 Days)|Adverse Event|0
1429035|NCT00990093|4716012|P1|Test Period 1 (1-14 Days)|Adverse Event|1
1429036|NCT00989950|4716065|P4|Randomized Phase|Adverse Event|0
1429037|NCT00989950|4716066|P3|Randomized Phase|Adverse Event|0
1429038|NCT00989950|4716067|P2|Randomized Phase|Adverse Event|1
1429039|NCT00989950|4716068|P1|Randomized Phase|Adverse Event|0
1429040|NCT00989950|4716065|P4|Randomized Phase|Protocol Violation|0
1429041|NCT00989950|4716066|P3|Randomized Phase|Protocol Violation|0
1429042|NCT00989950|4716067|P2|Randomized Phase|Protocol Violation|0
1429043|NCT00989950|4716068|P1|Randomized Phase|Protocol Violation|1
1429044|NCT00989833|4716085|P3|Overall Study|Incorrectly randomized|0
1429045|NCT00989833|4716086|P2|Overall Study|Incorrectly randomized|0
1429046|NCT00989833|4716087|P1|Overall Study|Incorrectly randomized|1
1429047|NCT00989833|4716085|P3|Overall Study|Withdrawal by Subject|1
1429048|NCT00989833|4716086|P2|Overall Study|Withdrawal by Subject|0
1429049|NCT00989833|4716087|P1|Overall Study|Withdrawal by Subject|0
1429050|NCT00989833|4716085|P3|Overall Study|Protocol Violation|1
1429051|NCT00989833|4716086|P2|Overall Study|Protocol Violation|2
1429052|NCT00989833|4716087|P1|Overall Study|Protocol Violation|1
1429053|NCT00989833|4716085|P3|Overall Study|Lost to Follow-up|0
1429054|NCT00989833|4716086|P2|Overall Study|Lost to Follow-up|1
1429055|NCT00989833|4716087|P1|Overall Study|Lost to Follow-up|0
1429056|NCT00989781|4716118|P2|Ovarian Response to hCG|Lost to Follow-up|2
1429057|NCT00989781|4716119|P1|Ovarian Response to hCG|Lost to Follow-up|3
1429058|NCT00989664|4716149|P1|Long-Term Follow-Up|Death|3
1429059|NCT00989664|4716149|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
1429060|NCT00989664|4716149|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
1429061|NCT00989664|4716149|P1|Dosimetric and Therapeutic Treatment|Death|1
1429062|NCT00989664|4716149|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
1429063|NCT00989664|4716149|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
1429064|NCT00989664|4716149|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
1429065|NCT00989287|4716195|P2|Overall Study|Lost to Follow-up|1
1429066|NCT00989287|4716196|P1|Overall Study|Lost to Follow-up|0
1429067|NCT00989287|4716195|P2|Overall Study|Adverse Event|0
1429068|NCT00989287|4716196|P1|Overall Study|Adverse Event|1
1429069|NCT00989235|4716298|P2|Overall Study|Lost to Follow-up|1
1429070|NCT00989235|4716299|P1|Overall Study|Lost to Follow-up|0
1429071|NCT00989235|4716298|P2|Overall Study|Randomized by Mistake|2
1429072|NCT00989235|4716299|P1|Overall Study|Randomized by Mistake|0
1429073|NCT00989235|4716298|P2|Overall Study|Desire to Become Pregnant|0
1429074|NCT00989235|4716299|P1|Overall Study|Desire to Become Pregnant|1
1429075|NCT00989235|4716298|P2|Overall Study|Withdrawal of Consent|1
1429076|NCT00989235|4716299|P1|Overall Study|Withdrawal of Consent|1
1429077|NCT00989235|4716298|P2|Overall Study|Lack of Efficacy|0
1429078|NCT00989235|4716299|P1|Overall Study|Lack of Efficacy|1
1429079|NCT00989235|4716298|P2|Overall Study|Adverse Event|1
1429080|NCT00989235|4716299|P1|Overall Study|Adverse Event|0
1429081|NCT00989235|4716298|P2|Overall Study|Death|1
1429082|NCT00989235|4716299|P1|Overall Study|Death|0
1429083|NCT00989196|4716344|P2|Treatment Period|Lost to Follow-up|0
1429084|NCT00989196|4716345|P1|Treatment Period|Lost to Follow-up|1
1429085|NCT00989092|4716383|P2|Overall Study|Did not receive study drug|0
1429086|NCT00989092|4716384|P1|Overall Study|Did not receive study drug|2
1429087|NCT00989092|4716383|P2|Overall Study|Erythropoietin therapy initiated|0
1429088|NCT00989092|4716384|P1|Overall Study|Erythropoietin therapy initiated|2
1429089|NCT00989092|4716383|P2|Overall Study|Protocol deviation|0
1429090|NCT00989092|4716384|P1|Overall Study|Protocol deviation|2
1429091|NCT00989092|4716383|P2|Overall Study|Other|1
1429092|NCT00989092|4716384|P1|Overall Study|Other|3
1429093|NCT00989092|4716383|P2|Overall Study|Lost to Follow-up|2
1429094|NCT00989092|4716384|P1|Overall Study|Lost to Follow-up|6
1429095|NCT00989092|4716383|P2|Overall Study|Ineligibility determined|3
1429096|NCT00989092|4716384|P1|Overall Study|Ineligibility determined|3
1429097|NCT00989092|4716383|P2|Overall Study|Death|2
1429098|NCT00989092|4716384|P1|Overall Study|Death|14
1429099|NCT00989092|4716383|P2|Overall Study|Withdrawal by Subject|9
1429100|NCT00989092|4716384|P1|Overall Study|Withdrawal by Subject|17
1429101|NCT00989092|4716383|P2|Overall Study|Chemotherapy initiated|4
1429102|NCT00989092|4716384|P1|Overall Study|Chemotherapy initiated|12
1429103|NCT00989092|4716383|P2|Overall Study|Adverse Event|1
1429104|NCT00989092|4716384|P1|Overall Study|Adverse Event|20
1429105|NCT00989092|4716383|P2|Overall Study|Physician Decision|6
1429106|NCT00989092|4716384|P1|Overall Study|Physician Decision|9
1429107|NCT00988884|4716436|P2|Overall Study|Withdrawal by Subject|18
1429108|NCT00988884|4716437|P1|Overall Study|Withdrawal by Subject|15
1429109|NCT00988884|4716436|P2|Overall Study|Protocol Violation|1
1429110|NCT00988884|4716437|P1|Overall Study|Protocol Violation|0
1429111|NCT00988884|4716436|P2|Overall Study|Lost to Follow-up|16
1429112|NCT00988884|4716437|P1|Overall Study|Lost to Follow-up|20
1429113|NCT00988884|4716436|P2|Overall Study|Adverse Event|1
1429114|NCT00988884|4716437|P1|Overall Study|Adverse Event|0
1429115|NCT00988858|4716459|P1|Overall Study|Sponsor Decision|1
1429116|NCT00988858|4716459|P1|Overall Study|Physician Decision|1
1429117|NCT00988858|4716459|P1|Overall Study|Death|1
1429118|NCT00988858|4716459|P1|Overall Study|Adverse Event|7
1429119|NCT00988637|4716508|P2|Overall Study|non-compliance with study drug|1
1429120|NCT00988637|4716509|P1|Overall Study|non-compliance with study drug|0
1429121|NCT00988637|4716508|P2|Overall Study|Withdrawal by Subject|1
1429122|NCT00988637|4716509|P1|Overall Study|Withdrawal by Subject|1
1429123|NCT00988637|4716508|P2|Overall Study|Lost to Follow-up|1
1429124|NCT00988637|4716509|P1|Overall Study|Lost to Follow-up|2
1429125|NCT00988559|4716543|P4|Overall Study|Lost to Follow-up|0
1429126|NCT00988559|4716544|P3|Overall Study|Lost to Follow-up|1
1429127|NCT00988559|4716545|P2|Overall Study|Lost to Follow-up|0
1429128|NCT00988559|4716546|P1|Overall Study|Lost to Follow-up|0
1429129|NCT00988559|4716543|P4|Overall Study|Pregnancy|0
1429130|NCT00988559|4716544|P3|Overall Study|Pregnancy|1
1429131|NCT00988559|4716545|P2|Overall Study|Pregnancy|1
1429132|NCT00988559|4716546|P1|Overall Study|Pregnancy|0
1429133|NCT00988559|4716543|P4|Overall Study|Withdrawal by Subject|1
1429134|NCT00988559|4716544|P3|Overall Study|Withdrawal by Subject|0
1429135|NCT00988559|4716545|P2|Overall Study|Withdrawal by Subject|1
1429136|NCT00988559|4716546|P1|Overall Study|Withdrawal by Subject|1
1429137|NCT00988533|4716560|P1|Overall Study|Lost to Follow-up|3
1429138|NCT00988442|4716574|P2|Overall Study|Early Study Closure|25
1429139|NCT00988442|4716575|P1|Overall Study|Early Study Closure|29
1429140|NCT00988442|4716574|P2|Overall Study|Lost to Follow-up|1
1429141|NCT00988442|4716575|P1|Overall Study|Lost to Follow-up|0
1429142|NCT00988442|4716574|P2|Overall Study|Death|2
1429143|NCT00988442|4716575|P1|Overall Study|Death|1
1429144|NCT00988429|4716638|P3|Overall Study|other reasons|1
1429145|NCT00988429|4716639|P2|Overall Study|other reasons|8
1429146|NCT00988429|4716640|P1|Overall Study|other reasons|8
1429147|NCT00988429|4716638|P3|Overall Study|Administrative Reasons|1
1429148|NCT00988429|4716639|P2|Overall Study|Administrative Reasons|2
1429149|NCT00988429|4716640|P1|Overall Study|Administrative Reasons|1
1429150|NCT00988429|4716638|P3|Overall Study|Withdrawal by Subject|12
1429151|NCT00988429|4716639|P2|Overall Study|Withdrawal by Subject|7
1429152|NCT00988429|4716640|P1|Overall Study|Withdrawal by Subject|7
1429153|NCT00988429|4716638|P3|Overall Study|Protocol Violation|3
1429154|NCT00988429|4716639|P2|Overall Study|Protocol Violation|3
1429155|NCT00988429|4716640|P1|Overall Study|Protocol Violation|4
1429156|NCT00988429|4716638|P3|Overall Study|Pregnancy|0
1429157|NCT00988429|4716639|P2|Overall Study|Pregnancy|1
1429158|NCT00988429|4716640|P1|Overall Study|Pregnancy|2
1429159|NCT00988429|4716638|P3|Overall Study|Physician Decision|3
1429160|NCT00988429|4716639|P2|Overall Study|Physician Decision|0
1429161|NCT00988429|4716640|P1|Overall Study|Physician Decision|1
1429162|NCT00988429|4716638|P3|Overall Study|Non-Compliance with Study Drug|3
1429163|NCT00988429|4716639|P2|Overall Study|Non-Compliance with Study Drug|1
1429164|NCT00988429|4716640|P1|Overall Study|Non-Compliance with Study Drug|5
1429165|NCT00988429|4716638|P3|Overall Study|Lack of Efficacy|1
1429166|NCT00988429|4716639|P2|Overall Study|Lack of Efficacy|0
1429167|NCT00988429|4716640|P1|Overall Study|Lack of Efficacy|0
1429168|NCT00988429|4716638|P3|Overall Study|Adverse Event|45
1429169|NCT00988429|4716639|P2|Overall Study|Adverse Event|21
1429170|NCT00988429|4716640|P1|Overall Study|Adverse Event|9
1429171|NCT00988351|4716653|P2|Overall Study|not using CPAP|3
1429172|NCT00988351|4716654|P1|Overall Study|not using CPAP|5
1429173|NCT00988351|4716653|P2|Overall Study|Lost to Follow-up|9
1429174|NCT00988351|4716654|P1|Overall Study|Lost to Follow-up|6
1429175|NCT00988351|4716653|P2|Overall Study|Withdrawal by Subject|0
1429176|NCT00988351|4716654|P1|Overall Study|Withdrawal by Subject|8
1429177|NCT00988247|4716731|P2|Overall Study|Not specified|0
1429178|NCT00988247|4716732|P1|Overall Study|Not specified|3
1429179|NCT00988247|4716731|P2|Overall Study|Sponsor requested withdrawal|1
1429180|NCT00988247|4716732|P1|Overall Study|Sponsor requested withdrawal|3
1429181|NCT00988247|4716731|P2|Overall Study|Protocol Violation|5
1429182|NCT00988247|4716732|P1|Overall Study|Protocol Violation|4
1429183|NCT00988247|4716731|P2|Overall Study|Lost to Follow-up|2
1429184|NCT00988247|4716732|P1|Overall Study|Lost to Follow-up|11
1429185|NCT00988247|4716731|P2|Overall Study|Pregnancy|2
1429186|NCT00988247|4716732|P1|Overall Study|Pregnancy|1
1429187|NCT00988247|4716731|P2|Overall Study|Withdrawal by Subject|13
1429188|NCT00988247|4716732|P1|Overall Study|Withdrawal by Subject|44
1429189|NCT00988247|4716731|P2|Overall Study|Adverse Event|3
1429190|NCT00988247|4716732|P1|Overall Study|Adverse Event|17
1429191|NCT00988221|4716751|P4|Part III|Refused Treatment|0
1429192|NCT00988221|4716752|P3|Part III|Refused Treatment|1
1429193|NCT00988221|4716753|P2|Part III|Refused Treatment|0
1429194|NCT00988221|4716754|P1|Part III|Refused Treatment|0
1429195|NCT00988221|4716751|P4|Part III|Insufficient Therapeutic Response|0
1429196|NCT00988221|4716752|P3|Part III|Insufficient Therapeutic Response|1
1429197|NCT00988221|4716753|P2|Part III|Insufficient Therapeutic Response|1
1429198|NCT00988221|4716754|P1|Part III|Insufficient Therapeutic Response|0
1429199|NCT00988221|4716751|P4|Part III|Adverse Event|0
1429200|NCT00988221|4716752|P3|Part III|Adverse Event|1
1429201|NCT00988221|4716753|P2|Part III|Adverse Event|0
1429202|NCT00988221|4716754|P1|Part III|Adverse Event|1
1429203|NCT00988221|4716751|P4|Part II|Reason not Specified|0
1429204|NCT00988221|4716752|P3|Part II|Reason not Specified|1
1429205|NCT00988221|4716753|P2|Part II|Reason not Specified|0
1429206|NCT00988221|4716754|P1|Part II|Reason not Specified|0
1429207|NCT00988221|4716751|P4|Part II|Withdrawal by Subject|2
1429208|NCT00988221|4716752|P3|Part II|Withdrawal by Subject|2
1429209|NCT00988221|4716753|P2|Part II|Withdrawal by Subject|0
1429210|NCT00988221|4716754|P1|Part II|Withdrawal by Subject|0
1429211|NCT00988221|4716751|P4|Part II|Adverse Event|1
1429212|NCT00988221|4716752|P3|Part II|Adverse Event|0
1429213|NCT00988221|4716753|P2|Part II|Adverse Event|0
1429214|NCT00988221|4716754|P1|Part II|Adverse Event|1
1429215|NCT00988221|4716751|P4|Part I|Lost to Follow-up|0
1429216|NCT00988221|4716752|P3|Part I|Lost to Follow-up|0
1429217|NCT00988221|4716753|P2|Part I|Lost to Follow-up|1
1429218|NCT00988221|4716754|P1|Part I|Lost to Follow-up|0
1429219|NCT00988221|4716751|P4|Part I|Refused Treatment|0
1429220|NCT00988221|4716752|P3|Part I|Refused Treatment|1
1429221|NCT00988221|4716753|P2|Part I|Refused Treatment|2
1429222|NCT00988221|4716754|P1|Part I|Refused Treatment|0
1429223|NCT00988221|4716751|P4|Part I|Insufficient Therapeutic Response|0
1429224|NCT00988221|4716752|P3|Part I|Insufficient Therapeutic Response|5
1429225|NCT00988221|4716753|P2|Part I|Insufficient Therapeutic Response|6
1429226|NCT00988221|4716754|P1|Part I|Insufficient Therapeutic Response|4
1429227|NCT00988221|4716751|P4|Part I|Adverse Event|0
1429228|NCT00988221|4716752|P3|Part I|Adverse Event|2
1429229|NCT00988221|4716753|P2|Part I|Adverse Event|1
1429230|NCT00988221|4716754|P1|Part I|Adverse Event|0
1429231|NCT00988208|4716927|P2|Overall Study|Other|3
1429232|NCT00988208|4716928|P1|Overall Study|Other|8
1429233|NCT00988208|4716927|P2|Overall Study|Subject Decision/Investigator Discretion|32
1429234|NCT00988208|4716928|P1|Overall Study|Subject Decision/Investigator Discretion|32
1429235|NCT00988208|4716927|P2|Overall Study|Clinical Deterioration|14
1429236|NCT00988208|4716928|P1|Overall Study|Clinical Deterioration|7
1429237|NCT00988208|4716927|P2|Overall Study|Biochemical Progression|7
1429238|NCT00988208|4716928|P1|Overall Study|Biochemical Progression|21
1429239|NCT00988208|4716927|P2|Overall Study|Clinical Progression|16
1429240|NCT00988208|4716928|P1|Overall Study|Clinical Progression|17
1429241|NCT00988208|4716927|P2|Overall Study|Sponsor Decision|78
1429242|NCT00988208|4716928|P1|Overall Study|Sponsor Decision|102
1429243|NCT00988208|4716927|P2|Overall Study|Protocol Violation|2
1429244|NCT00988208|4716928|P1|Overall Study|Protocol Violation|9
1429245|NCT00988208|4716927|P2|Overall Study|Lost to Follow-up|3
1429246|NCT00988208|4716928|P1|Overall Study|Lost to Follow-up|2
1429247|NCT00988208|4716927|P2|Overall Study|Death|15
1429248|NCT00988208|4716928|P1|Overall Study|Death|9
1429249|NCT00988208|4716927|P2|Overall Study|Withdrawal by Subject|57
1429250|NCT00988208|4716928|P1|Overall Study|Withdrawal by Subject|50
1429251|NCT00988208|4716927|P2|Overall Study|Disease Progression|89
1429252|NCT00988208|4716928|P1|Overall Study|Disease Progression|103
1429253|NCT00988208|4716927|P2|Overall Study|Adverse Event|122
1429254|NCT00988208|4716928|P1|Overall Study|Adverse Event|71
1429255|NCT00988169|4716946|P1|Overall Study|Withdrawal by Subject|1
1429256|NCT00988117|4716998|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
1429257|NCT00988117|4716998|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
1429258|NCT00988091|4717007|P2|Open-label Period|Not specified|3
1429259|NCT00988091|4717008|P1|Open-label Period|Not specified|2
1429260|NCT00988091|4717007|P2|Open-label Period|Lost to Follow-up|5
1429261|NCT00988091|4717008|P1|Open-label Period|Lost to Follow-up|3
1429262|NCT00988091|4717007|P2|Open-label Period|Withdrawal by Subject|16
1429263|NCT00988091|4717008|P1|Open-label Period|Withdrawal by Subject|10
1429264|NCT00988091|4717007|P2|Open-label Period|Protocol Violation|1
1429265|NCT00988091|4717008|P1|Open-label Period|Protocol Violation|1
1429266|NCT00988091|4717007|P2|Open-label Period|Use of exclusionary medication|1
1429267|NCT00988091|4717008|P1|Open-label Period|Use of exclusionary medication|1
1429268|NCT00988091|4717007|P2|Open-label Period|Adverse Event|7
1429269|NCT00988091|4717008|P1|Open-label Period|Adverse Event|4
1429270|NCT00988091|4717007|P2|Double-blind Period|Use of exclusionary medication|3
1429271|NCT00988091|4717008|P1|Double-blind Period|Use of exclusionary medication|2
1429272|NCT00988091|4717007|P2|Double-blind Period|Adverse Event|9
1429273|NCT00988091|4717008|P1|Double-blind Period|Adverse Event|6
1429274|NCT00988091|4717007|P2|Double-blind Period|Not specified|8
1429275|NCT00988091|4717008|P1|Double-blind Period|Not specified|8
1429276|NCT00988091|4717007|P2|Double-blind Period|Lost to Follow-up|14
1429277|NCT00988091|4717008|P1|Double-blind Period|Lost to Follow-up|12
1429278|NCT00988091|4717007|P2|Double-blind Period|Withdrawal by Subject|13
1429279|NCT00988091|4717008|P1|Double-blind Period|Withdrawal by Subject|15
1429280|NCT00988065|4717030|P3|Overall Study|Noncompliance with protocol|9
1429281|NCT00988065|4717031|P2|Overall Study|Noncompliance with protocol|6
1429282|NCT00988065|4717032|P1|Overall Study|Noncompliance with protocol|5
1429283|NCT00988065|4717030|P3|Overall Study|Subject withdrew consent|2
1429284|NCT00988065|4717031|P2|Overall Study|Subject withdrew consent|5
1429285|NCT00988065|4717032|P1|Overall Study|Subject withdrew consent|3
1429286|NCT00988065|4717030|P3|Overall Study|Lost to Follow-up|2
1429287|NCT00988065|4717031|P2|Overall Study|Lost to Follow-up|2
1429288|NCT00988065|4717032|P1|Overall Study|Lost to Follow-up|1
1429289|NCT00988065|4717030|P3|Overall Study|Adverse Event|2
1429290|NCT00988065|4717031|P2|Overall Study|Adverse Event|10
1429291|NCT00988065|4717032|P1|Overall Study|Adverse Event|4
1429292|NCT00987935|4717066|P9|Overall Study|Reason other than those specified above|1
1429293|NCT00987935|4717067|P8|Overall Study|Reason other than those specified above|0
1429294|NCT00987935|4717068|P7|Overall Study|Reason other than those specified above|0
1429295|NCT00987935|4717069|P6|Overall Study|Reason other than those specified above|0
1429296|NCT00987935|4717070|P5|Overall Study|Reason other than those specified above|0
1429297|NCT00987935|4717071|P4|Overall Study|Reason other than those specified above|0
1429298|NCT00987935|4717072|P3|Overall Study|Reason other than those specified above|0
1429299|NCT00987935|4717073|P2|Overall Study|Reason other than those specified above|0
1429300|NCT00987935|4717074|P1|Overall Study|Reason other than those specified above|0
1429301|NCT00987935|4717066|P9|Overall Study|Refused to continue taking trial med.|2
1429302|NCT00987935|4717067|P8|Overall Study|Refused to continue taking trial med.|4
1429303|NCT00987935|4717068|P7|Overall Study|Refused to continue taking trial med.|4
1429304|NCT00987935|4717069|P6|Overall Study|Refused to continue taking trial med.|0
1429305|NCT00987935|4717070|P5|Overall Study|Refused to continue taking trial med.|1
1429306|NCT00987935|4717071|P4|Overall Study|Refused to continue taking trial med.|0
1429307|NCT00987935|4717072|P3|Overall Study|Refused to continue taking trial med.|0
1429308|NCT00987935|4717073|P2|Overall Study|Refused to continue taking trial med.|0
1429309|NCT00987935|4717074|P1|Overall Study|Refused to continue taking trial med.|1
1429310|NCT00987935|4717066|P9|Overall Study|Adverse Event|6
1429311|NCT00987935|4717067|P8|Overall Study|Adverse Event|10
1429312|NCT00987935|4717068|P7|Overall Study|Adverse Event|2
1429313|NCT00987935|4717069|P6|Overall Study|Adverse Event|0
1429314|NCT00987935|4717070|P5|Overall Study|Adverse Event|1
1429315|NCT00987935|4717071|P4|Overall Study|Adverse Event|1
1429316|NCT00987935|4717072|P3|Overall Study|Adverse Event|0
1429317|NCT00987935|4717073|P2|Overall Study|Adverse Event|1
1429318|NCT00987935|4717074|P1|Overall Study|Adverse Event|0
1429319|NCT00987935|4717066|P9|Overall Study|Progressive disease|23
1429320|NCT00987935|4717067|P8|Overall Study|Progressive disease|48
1429321|NCT00987935|4717068|P7|Overall Study|Progressive disease|9
1429322|NCT00987935|4717069|P6|Overall Study|Progressive disease|3
1429323|NCT00987935|4717070|P5|Overall Study|Progressive disease|5
1429324|NCT00987935|4717071|P4|Overall Study|Progressive disease|2
1429325|NCT00987935|4717072|P3|Overall Study|Progressive disease|3
1429326|NCT00987935|4717073|P2|Overall Study|Progressive disease|2
1429327|NCT00987935|4717074|P1|Overall Study|Progressive disease|3
1429328|NCT00987831|4717130|P3|Overall Study|Lost to Follow-up|0
1429329|NCT00987831|4717131|P2|Overall Study|Lost to Follow-up|3
1429330|NCT00987831|4717132|P1|Overall Study|Lost to Follow-up|0
1429331|NCT00987831|4717130|P3|Overall Study|Never flared in 12 months|0
1429332|NCT00987831|4717131|P2|Overall Study|Never flared in 12 months|0
1429333|NCT00987831|4717132|P1|Overall Study|Never flared in 12 months|1
1429334|NCT00987623|4717154|P2|Overall Study|Influenza|1
1429335|NCT00987623|4717155|P1|Overall Study|Influenza|0
1429336|NCT00987623|4717154|P2|Overall Study|Biomicroscopy|1
1429337|NCT00987623|4717155|P1|Overall Study|Biomicroscopy|0
1429338|NCT00987623|4717154|P2|Overall Study|Discomfort|0
1429339|NCT00987623|4717155|P1|Overall Study|Discomfort|1
1429340|NCT00987623|4717154|P2|Overall Study|Time/job conflict|0
1429341|NCT00987623|4717155|P1|Overall Study|Time/job conflict|2
1429342|NCT00987623|4717154|P2|Overall Study|Lost to Follow-up|1
1429343|NCT00987623|4717155|P1|Overall Study|Lost to Follow-up|2
1429344|NCT00987467|4717184|P1|Overall Study|Lost to Follow-up|2
1429345|NCT00987402|4717208|P2|Overall Study|Insufficient data entry|98
1429346|NCT00987402|4717209|P1|Overall Study|Insufficient data entry|86
1429347|NCT00987337|4717218|P3|Overall Study|Participant Relapsed|5
1429348|NCT00987337|4717219|P2|Overall Study|Participant Relapsed|20
1429349|NCT00987337|4717220|P1|Overall Study|Participant Relapsed|18
1429350|NCT00987337|4717218|P3|Overall Study|Protocol Violation|2
1429351|NCT00987337|4717219|P2|Overall Study|Protocol Violation|0
1429352|NCT00987337|4717220|P1|Overall Study|Protocol Violation|1
1429353|NCT00987337|4717218|P3|Overall Study|Other|5
1429354|NCT00987337|4717219|P2|Overall Study|Other|2
1429355|NCT00987337|4717220|P1|Overall Study|Other|0
1429356|NCT00987337|4717218|P3|Overall Study|Withdrawal by Subject|9
1429357|NCT00987337|4717219|P2|Overall Study|Withdrawal by Subject|9
1429358|NCT00987337|4717220|P1|Overall Study|Withdrawal by Subject|6
1429359|NCT00987337|4717218|P3|Overall Study|Lost to Follow-up|2
1429360|NCT00987337|4717219|P2|Overall Study|Lost to Follow-up|6
1429361|NCT00987337|4717220|P1|Overall Study|Lost to Follow-up|10
1429362|NCT00987337|4717218|P3|Overall Study|Virologic Breakthrough|8
1429363|NCT00987337|4717219|P2|Overall Study|Virologic Breakthrough|2
1429364|NCT00987337|4717220|P1|Overall Study|Virologic Breakthrough|2
1429365|NCT00987337|4717218|P3|Overall Study|Insufficient Virologic Response|12
1429366|NCT00987337|4717219|P2|Overall Study|Insufficient Virologic Response|7
1429367|NCT00987337|4717220|P1|Overall Study|Insufficient Virologic Response|10
1429368|NCT00987337|4717218|P3|Overall Study|Adverse Event|8
1429369|NCT00987337|4717219|P2|Overall Study|Adverse Event|9
1429370|NCT00987337|4717220|P1|Overall Study|Adverse Event|10
1429371|NCT00986986|4717275|P2|Overall Study|Lost to Follow-up|1
1429372|NCT00986986|4717276|P1|Overall Study|Lost to Follow-up|0
1429373|NCT00986973|4717286|P1|Overall Study|Withdrawn by study team|1
1429374|NCT00986921|4717312|P2|Overall Study|Physician Decision|0
1429375|NCT00986921|4717313|P1|Overall Study|Physician Decision|1
1429376|NCT00986674|4717349|P3|Overall Study|unknown/not specify|9
1429377|NCT00986674|4717350|P2|Overall Study|unknown/not specify|7
1429378|NCT00986674|4717351|P1|Overall Study|unknown/not specify|0
1429379|NCT00986674|4717349|P3|Overall Study|not start protocol therapy|1
1429380|NCT00986674|4717350|P2|Overall Study|not start protocol therapy|3
1429381|NCT00986674|4717351|P1|Overall Study|not start protocol therapy|4
1429382|NCT00986674|4717349|P3|Overall Study|alternative therapy|1
1429383|NCT00986674|4717350|P2|Overall Study|alternative therapy|0
1429384|NCT00986674|4717351|P1|Overall Study|alternative therapy|0
1429385|NCT00986674|4717349|P3|Overall Study|Withdrawal by Subject|1
1429386|NCT00986674|4717350|P2|Overall Study|Withdrawal by Subject|2
1429387|NCT00986674|4717351|P1|Overall Study|Withdrawal by Subject|6
1429388|NCT00986674|4717349|P3|Overall Study|Death|4
1429389|NCT00986674|4717350|P2|Overall Study|Death|0
1429390|NCT00986674|4717351|P1|Overall Study|Death|5
1429391|NCT00986674|4717349|P3|Overall Study|Adverse Event|9
1429392|NCT00986674|4717350|P2|Overall Study|Adverse Event|8
1429393|NCT00986674|4717351|P1|Overall Study|Adverse Event|4
1429394|NCT00986674|4717349|P3|Overall Study|Lack of Efficacy|23
1429395|NCT00986674|4717350|P2|Overall Study|Lack of Efficacy|25
1429396|NCT00986674|4717351|P1|Overall Study|Lack of Efficacy|28
1429397|NCT00986570|4717384|P1|Overall Study|Potential bias for objective assessment|1
1429398|NCT00986570|4717384|P1|Overall Study|Lost to Follow-up|6
1429399|NCT00986479|4717401|P2|Period 1|Administrative reasons|0
1429400|NCT00986479|4717402|P1|Period 1|Administrative reasons|1
1429401|NCT00986479|4717401|P2|Period 1|Improved mood|0
1429402|NCT00986479|4717402|P1|Period 1|Improved mood|1
1429403|NCT00986427|4717448|P2|Overall Study|Withdrawal by Subject|0
1429404|NCT00986427|4717449|P1|Overall Study|Withdrawal by Subject|1
1429405|NCT00986427|4717448|P2|Overall Study|Lack of Efficacy|0
1429406|NCT00986427|4717449|P1|Overall Study|Lack of Efficacy|1
1429407|NCT00986427|4717448|P2|Overall Study|Lost to Follow-up|0
1429408|NCT00986427|4717449|P1|Overall Study|Lost to Follow-up|2
1429409|NCT00986362|4717477|P2|Overall Study|Lost to Follow-up|1
1429410|NCT00986362|4717478|P1|Overall Study|Lost to Follow-up|0
1429411|NCT00986362|4717477|P2|Overall Study|Death|0
1429412|NCT00986362|4717478|P1|Overall Study|Death|2
1429413|NCT00986349|4717484|P1|Overall Study|device migration|1
1429414|NCT00986349|4717484|P1|Overall Study|Physician Decision|1
1429415|NCT00986349|4717484|P1|Overall Study|Adverse Event|2
1429416|NCT00986349|4717484|P1|Overall Study|Unsuccessful implant procedure|3
1429417|NCT00986258|4717497|P1|Maintenance Period|Withdrawal by Subject|2
1429418|NCT00986258|4717497|P1|Maintenance Period|Lack of Efficacy|2
1429419|NCT00986258|4717497|P1|Maintenance Period|Adverse Event|5
1429420|NCT00986258|4717497|P1|Titration and Optimal Dose Period|Other|1
1429421|NCT00986258|4717497|P1|Titration and Optimal Dose Period|Non-Compliance|1
1429422|NCT00986258|4717497|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
1429423|NCT00986258|4717497|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
1429424|NCT00986258|4717497|P1|Titration and Optimal Dose Period|Adverse Event|15
1429425|NCT00986258|4717497|P1|Observation Period|Not eligible to be dosed|11
1429426|NCT00986245|4717525|P2|Second Intervention|Protocol Violation|1
1429427|NCT00986245|4717526|P1|Second Intervention|Protocol Violation|0
1429428|NCT00986245|4717525|P2|Second Intervention|Lost to Follow-up|0
1429429|NCT00986245|4717526|P1|Second Intervention|Lost to Follow-up|1
1429430|NCT00986245|4717525|P2|Second Intervention|Poor compliance|0
1429431|NCT00986245|4717526|P1|Second Intervention|Poor compliance|1
1429432|NCT00986245|4717525|P2|First Intervention|Out of indication|0
1429433|NCT00986245|4717526|P1|First Intervention|Out of indication|1
1429434|NCT00986245|4717525|P2|First Intervention|Protocol Violation|1
1429435|NCT00986245|4717526|P1|First Intervention|Protocol Violation|0
1429436|NCT00986245|4717525|P2|First Intervention|Withdrawal by Subject|1
1429437|NCT00986245|4717526|P1|First Intervention|Withdrawal by Subject|0
1429438|NCT00986245|4717525|P2|First Intervention|Lack of Efficacy|2
1429439|NCT00986245|4717526|P1|First Intervention|Lack of Efficacy|1
1429440|NCT00986245|4717525|P2|First Intervention|Poor compliance|4
1429441|NCT00986245|4717526|P1|First Intervention|Poor compliance|8
1429442|NCT00986232|4717563|P4|Overall Study|Incomplete safety follow-up|2
1429443|NCT00986232|4717564|P3|Overall Study|Incomplete safety follow-up|2
1429444|NCT00986232|4717565|P2|Overall Study|Incomplete safety follow-up|7
1429445|NCT00986232|4717566|P1|Overall Study|Incomplete safety follow-up|3
1429446|NCT00986232|4717563|P4|Overall Study|Missed one or more bleeds|7
1429447|NCT00986232|4717564|P3|Overall Study|Missed one or more bleeds|6
1429448|NCT00986232|4717565|P2|Overall Study|Missed one or more bleeds|10
1429449|NCT00986232|4717566|P1|Overall Study|Missed one or more bleeds|13
1429450|NCT00986232|4717563|P4|Overall Study|Withdrawal by Subject|3
1429451|NCT00986232|4717564|P3|Overall Study|Withdrawal by Subject|12
1429452|NCT00986232|4717565|P2|Overall Study|Withdrawal by Subject|16
1429453|NCT00986232|4717566|P1|Overall Study|Withdrawal by Subject|13
1429454|NCT00986232|4717563|P4|Overall Study|Protocol Violation|1
1429455|NCT00986232|4717564|P3|Overall Study|Protocol Violation|0
1429456|NCT00986232|4717565|P2|Overall Study|Protocol Violation|3
1429457|NCT00986232|4717566|P1|Overall Study|Protocol Violation|2
1429458|NCT00986232|4717563|P4|Overall Study|Lost to Follow-up|7
1429459|NCT00986232|4717564|P3|Overall Study|Lost to Follow-up|12
1429460|NCT00986232|4717565|P2|Overall Study|Lost to Follow-up|12
1429461|NCT00986232|4717566|P1|Overall Study|Lost to Follow-up|19
1429462|NCT00986232|4717563|P4|Overall Study|Adverse Event|0
1429463|NCT00986232|4717564|P3|Overall Study|Adverse Event|3
1429464|NCT00986232|4717565|P2|Overall Study|Adverse Event|2
1429465|NCT00986232|4717566|P1|Overall Study|Adverse Event|1
1429466|NCT00986180|4717640|P2|Overall Study|Miscellanies|11
1429467|NCT00986180|4717641|P1|Overall Study|Miscellanies|10
1429468|NCT00986180|4717640|P2|Overall Study|Withdrawal by Subject|9
1429469|NCT00986180|4717641|P1|Overall Study|Withdrawal by Subject|1
1429470|NCT00986180|4717640|P2|Overall Study|Protocol Violation|0
1429471|NCT00986180|4717641|P1|Overall Study|Protocol Violation|2
1429472|NCT00986180|4717640|P2|Overall Study|Physician Decision|3
1429473|NCT00986180|4717641|P1|Overall Study|Physician Decision|1
1429474|NCT00986180|4717640|P2|Overall Study|Lost to Follow-up|7
1429475|NCT00986180|4717641|P1|Overall Study|Lost to Follow-up|5
1429476|NCT00986180|4717640|P2|Overall Study|Lack of Efficacy|3
1429477|NCT00986180|4717641|P1|Overall Study|Lack of Efficacy|4
1429478|NCT00986180|4717640|P2|Overall Study|Adverse Event|23
1429479|NCT00986180|4717641|P1|Overall Study|Adverse Event|21
1429480|NCT00986154|4717719|P2|Overall Study|never received study drug|27
1429481|NCT00986154|4717720|P1|Overall Study|never received study drug|25
1429482|NCT00986154|4717719|P2|Overall Study|investigator/subject decide not continue|3
1429483|NCT00986154|4717720|P1|Overall Study|investigator/subject decide not continue|6
1429484|NCT00986154|4717719|P2|Overall Study|Withdrawal by Subject|33
1429485|NCT00986154|4717720|P1|Overall Study|Withdrawal by Subject|32
1429486|NCT00986154|4717719|P2|Overall Study|Lost to Follow-up|4
1429487|NCT00986154|4717720|P1|Overall Study|Lost to Follow-up|7
1429488|NCT00986154|4717719|P2|Overall Study|Death|127
1429489|NCT00986154|4717720|P1|Overall Study|Death|136
1429490|NCT00986102|4717734|P4|Overall Study|Withdrawal by Subject|0
1429491|NCT00986102|4717735|P3|Overall Study|Withdrawal by Subject|0
1429492|NCT00986102|4717736|P2|Overall Study|Withdrawal by Subject|1
1429493|NCT00986102|4717737|P1|Overall Study|Withdrawal by Subject|1
1429494|NCT00986102|4717734|P4|Overall Study|Lost to Follow-up|1
1429495|NCT00986102|4717735|P3|Overall Study|Lost to Follow-up|0
1429496|NCT00986102|4717736|P2|Overall Study|Lost to Follow-up|1
1429497|NCT00986102|4717737|P1|Overall Study|Lost to Follow-up|0
1429498|NCT00985985|4717787|P4|Overall Study|Other Reason|2
1429499|NCT00985985|4717788|P3|Overall Study|Other Reason|4
1429500|NCT00985985|4717789|P2|Overall Study|Other Reason|1
1429501|NCT00985985|4717790|P1|Overall Study|Other Reason|6
1429502|NCT00985985|4717787|P4|Overall Study|Withdrawal by Subject|2
1429503|NCT00985985|4717788|P3|Overall Study|Withdrawal by Subject|2
1429504|NCT00985985|4717789|P2|Overall Study|Withdrawal by Subject|2
1429505|NCT00985985|4717790|P1|Overall Study|Withdrawal by Subject|4
1429506|NCT00985985|4717787|P4|Overall Study|Lack of Efficacy|3
1429507|NCT00985985|4717788|P3|Overall Study|Lack of Efficacy|1
1429508|NCT00985985|4717789|P2|Overall Study|Lack of Efficacy|6
1429509|NCT00985985|4717790|P1|Overall Study|Lack of Efficacy|5
1429510|NCT00985985|4717787|P4|Overall Study|Protocol Violation|1
1429511|NCT00985985|4717788|P3|Overall Study|Protocol Violation|0
1429512|NCT00985985|4717789|P2|Overall Study|Protocol Violation|2
1429513|NCT00985985|4717790|P1|Overall Study|Protocol Violation|1
1429514|NCT00985985|4717787|P4|Overall Study|Lost to Follow-up|3
1429515|NCT00985985|4717788|P3|Overall Study|Lost to Follow-up|2
1429516|NCT00985985|4717789|P2|Overall Study|Lost to Follow-up|11
1429517|NCT00985985|4717790|P1|Overall Study|Lost to Follow-up|4
1429518|NCT00985985|4717787|P4|Overall Study|Adverse Event|2
1429519|NCT00985985|4717788|P3|Overall Study|Adverse Event|2
1429520|NCT00985985|4717789|P2|Overall Study|Adverse Event|2
1429521|NCT00985985|4717790|P1|Overall Study|Adverse Event|4
1429522|NCT00985959|4717831|P3|Overall Study|Other|11
1429523|NCT00985959|4717832|P2|Overall Study|Other|0
1429524|NCT00985959|4717833|P1|Overall Study|Other|0
1429525|NCT00985959|4717831|P3|Overall Study|Complete response observed over 2 cycles|4
1429526|NCT00985959|4717832|P2|Overall Study|Complete response observed over 2 cycles|1
1429527|NCT00985959|4717833|P1|Overall Study|Complete response observed over 2 cycles|0
1429528|NCT00985959|4717831|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
1429529|NCT00985959|4717832|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
1429530|NCT00985959|4717833|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
1429531|NCT00985959|4717831|P3|Overall Study|Unrecovered toxicity|7
1429532|NCT00985959|4717832|P2|Overall Study|Unrecovered toxicity|0
1429533|NCT00985959|4717833|P1|Overall Study|Unrecovered toxicity|0
1429534|NCT00985959|4717831|P3|Overall Study|Progressive disease|8
1429535|NCT00985959|4717832|P2|Overall Study|Progressive disease|2
1429536|NCT00985959|4717833|P1|Overall Study|Progressive disease|1
1429537|NCT00985959|4717831|P3|Overall Study|Withdrawal by Subject|8
1429538|NCT00985959|4717832|P2|Overall Study|Withdrawal by Subject|0
1429539|NCT00985959|4717833|P1|Overall Study|Withdrawal by Subject|0
1429540|NCT00985959|4717831|P3|Overall Study|Adverse Event|19
1429541|NCT00985959|4717832|P2|Overall Study|Adverse Event|0
1429542|NCT00985959|4717833|P1|Overall Study|Adverse Event|0
1429543|NCT00985946|4717856|P1|Overall Study|Withdrawal by Subject|1
1429544|NCT00985946|4717856|P1|Overall Study|Lost to Follow-up|6
1429545|NCT00985790|4717875|P2|Overall Study|Lost to Follow-up|7
1429546|NCT00985790|4717876|P1|Overall Study|Lost to Follow-up|6
1429547|NCT00985790|4717875|P2|Overall Study|Withdrawal by Subject|1
1429548|NCT00985790|4717876|P1|Overall Study|Withdrawal by Subject|1
1429549|NCT00985751|4717917|P5|Overall Study|Adverse Event|1
1429550|NCT00985751|4717918|P4|Overall Study|Adverse Event|0
1429551|NCT00985751|4717919|P3|Overall Study|Adverse Event|0
1429552|NCT00985751|4717920|P2|Overall Study|Adverse Event|0
1429553|NCT00985751|4717921|P1|Overall Study|Adverse Event|0
1429554|NCT00985738|4717984|P2|Overall Study|Study closed prematurely|8
1429555|NCT00985738|4717985|P1|Overall Study|Study closed prematurely|8
1429556|NCT00985725|4717993|P2|Overall Study|Out-of-window visits|1
1429557|NCT00985725|4717994|P1|Overall Study|Out-of-window visits|0
1429558|NCT00985725|4717993|P2|Overall Study|Non-compliance|2
1429559|NCT00985725|4717994|P1|Overall Study|Non-compliance|1
1429560|NCT00985725|4717993|P2|Overall Study|Lack of Efficacy|1
1429561|NCT00985725|4717994|P1|Overall Study|Lack of Efficacy|0
1429562|NCT00985725|4717993|P2|Overall Study|Lost to Follow-up|1
1429563|NCT00985725|4717994|P1|Overall Study|Lost to Follow-up|1
1429564|NCT00985725|4717993|P2|Overall Study|Withdrawal by Subject|4
1429565|NCT00985725|4717994|P1|Overall Study|Withdrawal by Subject|4
1429566|NCT00985725|4717993|P2|Overall Study|Protocol Violation|3
1429567|NCT00985725|4717994|P1|Overall Study|Protocol Violation|1
1429568|NCT00985725|4717993|P2|Overall Study|Adverse Event|1
1429569|NCT00985725|4717994|P1|Overall Study|Adverse Event|4
1429570|NCT00985712|4718030|P2|Overall Study|Sponsor decision|2
1429571|NCT00985712|4718031|P1|Overall Study|Sponsor decision|0
1429572|NCT00985712|4718030|P2|Overall Study|Withdrawal by Subject|1
1429573|NCT00985712|4718031|P1|Overall Study|Withdrawal by Subject|4
1429574|NCT00985712|4718030|P2|Overall Study|Protocol Violation|1
1429575|NCT00985712|4718031|P1|Overall Study|Protocol Violation|0
1429576|NCT00985712|4718030|P2|Overall Study|Lost to Follow-up|2
1429577|NCT00985712|4718031|P1|Overall Study|Lost to Follow-up|2
1429578|NCT00985712|4718030|P2|Overall Study|Adverse Event|1
1429579|NCT00985712|4718031|P1|Overall Study|Adverse Event|0
1429580|NCT00985686|4718049|P4|Overall Study|Lost to Follow-up|2
1429581|NCT00985686|4718050|P3|Overall Study|Lost to Follow-up|0
1429582|NCT00985686|4718051|P2|Overall Study|Lost to Follow-up|1
1429583|NCT00985686|4718052|P1|Overall Study|Lost to Follow-up|1
1429584|NCT00985673|4718066|P6|Overall Study|Other|0
1429585|NCT00985673|4718067|P5|Overall Study|Other|1
1429586|NCT00985673|4718068|P4|Overall Study|Other|0
1429587|NCT00985673|4718069|P3|Overall Study|Other|1
1429588|NCT00985673|4718070|P2|Overall Study|Other|0
1429589|NCT00985673|4718071|P1|Overall Study|Other|1
1429590|NCT00985673|4718066|P6|Overall Study|Withdrawal by Subject|3
1429591|NCT00985673|4718067|P5|Overall Study|Withdrawal by Subject|2
1429592|NCT00985673|4718068|P4|Overall Study|Withdrawal by Subject|2
1429593|NCT00985673|4718069|P3|Overall Study|Withdrawal by Subject|5
1429594|NCT00985673|4718070|P2|Overall Study|Withdrawal by Subject|4
1429595|NCT00985673|4718071|P1|Overall Study|Withdrawal by Subject|0
1429596|NCT00985673|4718066|P6|Overall Study|Lost to Follow-up|3
1429597|NCT00985673|4718067|P5|Overall Study|Lost to Follow-up|5
1429598|NCT00985673|4718068|P4|Overall Study|Lost to Follow-up|10
1429599|NCT00985673|4718069|P3|Overall Study|Lost to Follow-up|6
1429600|NCT00985673|4718070|P2|Overall Study|Lost to Follow-up|7
1429601|NCT00985673|4718071|P1|Overall Study|Lost to Follow-up|6
1429602|NCT00985504|4718333|P2|Optimization Period|Withdrawal by Subject|8
1429603|NCT00985504|4718334|P1|Optimization Period|Withdrawal by Subject|10
1429604|NCT00985504|4718333|P2|Optimization Period|Protocol Violation|1
1429605|NCT00985504|4718334|P1|Optimization Period|Protocol Violation|3
1429606|NCT00985504|4718333|P2|Optimization Period|Physician Decision|0
1429607|NCT00985504|4718334|P1|Optimization Period|Physician Decision|1
1429608|NCT00985504|4718333|P2|Optimization Period|Lost to Follow-up|1
1429609|NCT00985504|4718334|P1|Optimization Period|Lost to Follow-up|0
1429610|NCT00985504|4718333|P2|Optimization Period|Lack of Efficacy|3
1429611|NCT00985504|4718334|P1|Optimization Period|Lack of Efficacy|5
1429612|NCT00985504|4718333|P2|Optimization Period|Death|1
1429613|NCT00985504|4718334|P1|Optimization Period|Death|0
1429614|NCT00985504|4718333|P2|Optimization Period|Adverse Event|9
1429615|NCT00985504|4718334|P1|Optimization Period|Adverse Event|7
1429616|NCT00985504|4718333|P2|Acute Treatment Period|Withdrawal by Subject|5
1429617|NCT00985504|4718334|P1|Acute Treatment Period|Withdrawal by Subject|9
1429618|NCT00985504|4718333|P2|Acute Treatment Period|Sponsor Decision|1
1429619|NCT00985504|4718334|P1|Acute Treatment Period|Sponsor Decision|0
1429620|NCT00985504|4718333|P2|Acute Treatment Period|Protocol Violation|0
1429621|NCT00985504|4718334|P1|Acute Treatment Period|Protocol Violation|2
1429622|NCT00985504|4718333|P2|Acute Treatment Period|Entry Criteria Not Met|2
1429623|NCT00985504|4718334|P1|Acute Treatment Period|Entry Criteria Not Met|1
1429624|NCT00985504|4718333|P2|Acute Treatment Period|Adverse Event|4
1429625|NCT00985504|4718334|P1|Acute Treatment Period|Adverse Event|3
1429626|NCT00985491|4718360|P1|Overall Study|implant failure|3
1429627|NCT00985491|4718360|P1|Overall Study|Withdrawal by Subject|1
1429628|NCT00985491|4718360|P1|Overall Study|device migration|7
1429629|NCT00985491|4718360|P1|Overall Study|Adverse Event|8
1429630|NCT00985439|4718369|P4|Overall Study|Adverse Event|0
1429631|NCT00985439|4718370|P3|Overall Study|Adverse Event|1
1429632|NCT00985439|4718371|P2|Overall Study|Adverse Event|0
1429633|NCT00985439|4718372|P1|Overall Study|Adverse Event|0
1429634|NCT00985231|4718388|P2|Overall Study|Study related symptoms & complaints|2
1429635|NCT00985231|4718389|P1|Overall Study|Study related symptoms & complaints|0
1429636|NCT00985231|4718388|P2|Overall Study|Lost to Follow-up|1
1429637|NCT00985231|4718389|P1|Overall Study|Lost to Follow-up|0
1429638|NCT00985231|4718388|P2|Overall Study|Withdrawal by Subject|0
1429639|NCT00985231|4718389|P1|Overall Study|Withdrawal by Subject|1
1429640|NCT00985231|4718388|P2|Overall Study|Protocol Violation|0
1429641|NCT00985231|4718389|P1|Overall Study|Protocol Violation|1
1429642|NCT00985231|4718388|P2|Overall Study|ineligible|0
1429643|NCT00985231|4718389|P1|Overall Study|ineligible|1
1429644|NCT00985192|4718397|P1|Overall Study|Determined to be Ineligible During Trial|2
1429645|NCT00985192|4718397|P1|Overall Study|Disease Progression|1
1429646|NCT00985192|4718397|P1|Overall Study|Withdrawal by Subject|1
1429647|NCT00985166|4718409|P3|Overall Study|Other|1
1429648|NCT00985166|4718410|P2|Overall Study|Other|0
1429649|NCT00985166|4718411|P1|Overall Study|Other|1
1429650|NCT00985166|4718409|P3|Overall Study|Test not done|4
1429651|NCT00985166|4718410|P2|Overall Study|Test not done|0
1429652|NCT00985166|4718411|P1|Overall Study|Test not done|2
1429653|NCT00985166|4718409|P3|Overall Study|Withdrawal by Subject|0
1429654|NCT00985166|4718410|P2|Overall Study|Withdrawal by Subject|2
1429655|NCT00985166|4718411|P1|Overall Study|Withdrawal by Subject|3
1429656|NCT00985166|4718409|P3|Overall Study|Lost to Follow-up|2
1429657|NCT00985166|4718410|P2|Overall Study|Lost to Follow-up|2
1429658|NCT00985166|4718411|P1|Overall Study|Lost to Follow-up|3
1429659|NCT00985153|4718431|P4|Overall Study|Incomplete Safety Follow-up|4
1429660|NCT00985153|4718432|P3|Overall Study|Incomplete Safety Follow-up|4
1429661|NCT00985153|4718433|P2|Overall Study|Incomplete Safety Follow-up|5
1429662|NCT00985153|4718434|P1|Overall Study|Incomplete Safety Follow-up|3
1429663|NCT00985153|4718431|P4|Overall Study|Missed One or More Bleeds|10
1429664|NCT00985153|4718432|P3|Overall Study|Missed One or More Bleeds|8
1429665|NCT00985153|4718433|P2|Overall Study|Missed One or More Bleeds|7
1429666|NCT00985153|4718434|P1|Overall Study|Missed One or More Bleeds|7
1429667|NCT00985153|4718431|P4|Overall Study|Withdrawal by Subject|10
1429668|NCT00985153|4718432|P3|Overall Study|Withdrawal by Subject|11
1429669|NCT00985153|4718433|P2|Overall Study|Withdrawal by Subject|11
1429670|NCT00985153|4718434|P1|Overall Study|Withdrawal by Subject|6
1429671|NCT00985153|4718431|P4|Overall Study|Protocol Violation|3
1429672|NCT00985153|4718432|P3|Overall Study|Protocol Violation|4
1429673|NCT00985153|4718433|P2|Overall Study|Protocol Violation|2
1429674|NCT00985153|4718434|P1|Overall Study|Protocol Violation|3
1429675|NCT00985153|4718431|P4|Overall Study|Lost to Follow-up|20
1429676|NCT00985153|4718432|P3|Overall Study|Lost to Follow-up|17
1429677|NCT00985153|4718433|P2|Overall Study|Lost to Follow-up|19
1429678|NCT00985153|4718434|P1|Overall Study|Lost to Follow-up|16
1429679|NCT00985114|4718482|P2|Overall Study|Withdrawal by Subject|2
1429680|NCT00985114|4718483|P1|Overall Study|Withdrawal by Subject|0
1429681|NCT00985114|4718482|P2|Overall Study|Adverse Event|0
1429682|NCT00985114|4718483|P1|Overall Study|Adverse Event|1
1429683|NCT00985088|4718497|P8|Overall Study|Lost to Follow-up|2
1429684|NCT00985088|4718498|P7|Overall Study|Lost to Follow-up|3
1429685|NCT00985088|4718499|P6|Overall Study|Lost to Follow-up|5
1429686|NCT00985088|4718500|P5|Overall Study|Lost to Follow-up|6
1429687|NCT00985088|4718501|P4|Overall Study|Lost to Follow-up|6
1429688|NCT00985088|4718502|P3|Overall Study|Lost to Follow-up|2
1429689|NCT00985088|4718503|P2|Overall Study|Lost to Follow-up|1
1429690|NCT00985088|4718504|P1|Overall Study|Lost to Follow-up|6
1429691|NCT00985088|4718497|P8|Overall Study|Migrated/moved from study area|1
1429692|NCT00985088|4718498|P7|Overall Study|Migrated/moved from study area|0
1429693|NCT00985088|4718499|P6|Overall Study|Migrated/moved from study area|0
1429694|NCT00985088|4718500|P5|Overall Study|Migrated/moved from study area|0
1429695|NCT00985088|4718501|P4|Overall Study|Migrated/moved from study area|0
1429696|NCT00985088|4718502|P3|Overall Study|Migrated/moved from study area|1
1429697|NCT00985088|4718503|P2|Overall Study|Migrated/moved from study area|0
1429698|NCT00985088|4718504|P1|Overall Study|Migrated/moved from study area|0
1429699|NCT00985088|4718497|P8|Overall Study|Withdrawal by Subject|2
1429700|NCT00985088|4718498|P7|Overall Study|Withdrawal by Subject|1
1429701|NCT00985088|4718499|P6|Overall Study|Withdrawal by Subject|2
1429702|NCT00985088|4718500|P5|Overall Study|Withdrawal by Subject|3
1429703|NCT00985088|4718501|P4|Overall Study|Withdrawal by Subject|1
1429704|NCT00985088|4718502|P3|Overall Study|Withdrawal by Subject|0
1429705|NCT00985088|4718503|P2|Overall Study|Withdrawal by Subject|0
1429706|NCT00985088|4718504|P1|Overall Study|Withdrawal by Subject|4
1429707|NCT00985088|4718497|P8|Overall Study|Adverse Event|0
1429708|NCT00985088|4718498|P7|Overall Study|Adverse Event|0
1429709|NCT00985088|4718499|P6|Overall Study|Adverse Event|0
1429710|NCT00985088|4718500|P5|Overall Study|Adverse Event|0
1429711|NCT00985088|4718501|P4|Overall Study|Adverse Event|0
1429712|NCT00985088|4718502|P3|Overall Study|Adverse Event|1
1429713|NCT00985088|4718503|P2|Overall Study|Adverse Event|0
1429714|NCT00985088|4718504|P1|Overall Study|Adverse Event|0
1429715|NCT00985088|4718497|P8|Overall Study|Serious Adverse Event|1
1429716|NCT00985088|4718498|P7|Overall Study|Serious Adverse Event|0
1429717|NCT00985088|4718499|P6|Overall Study|Serious Adverse Event|0
1429718|NCT00985088|4718500|P5|Overall Study|Serious Adverse Event|0
1429719|NCT00985088|4718501|P4|Overall Study|Serious Adverse Event|0
1429720|NCT00985088|4718502|P3|Overall Study|Serious Adverse Event|0
1429721|NCT00985088|4718503|P2|Overall Study|Serious Adverse Event|1
1429722|NCT00985088|4718504|P1|Overall Study|Serious Adverse Event|1
1429723|NCT00984867|4718773|P2|Overall Study|lack of efficacy and subject compliance|0
1429724|NCT00984867|4718774|P1|Overall Study|lack of efficacy and subject compliance|1
1429725|NCT00984867|4718773|P2|Overall Study|site closing|0
1429726|NCT00984867|4718774|P1|Overall Study|site closing|1
1429727|NCT00984867|4718773|P2|Overall Study|Subject no longer meets study criteria|1
1429728|NCT00984867|4718774|P1|Overall Study|Subject no longer meets study criteria|1
1429729|NCT00984867|4718773|P2|Overall Study|Poor/non-compliance|1
1429730|NCT00984867|4718774|P1|Overall Study|Poor/non-compliance|0
1429731|NCT00984867|4718773|P2|Overall Study|Lost to Follow-up|4
1429732|NCT00984867|4718774|P1|Overall Study|Lost to Follow-up|3
1429733|NCT00984867|4718773|P2|Overall Study|Withdrawal by Subject|4
1429734|NCT00984867|4718774|P1|Overall Study|Withdrawal by Subject|13
1429735|NCT00984867|4718773|P2|Overall Study|Death|0
1429736|NCT00984867|4718774|P1|Overall Study|Death|1
1429737|NCT00984867|4718773|P2|Overall Study|Adverse Event|7
1429738|NCT00984867|4718774|P1|Overall Study|Adverse Event|3
1429739|NCT00984659|4718814|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
1429740|NCT00984659|4718815|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
1429741|NCT00984659|4718816|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
1429742|NCT00984659|4718817|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
1429743|NCT00984659|4718814|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
1429744|NCT00984659|4718815|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
1429745|NCT00984659|4718816|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
1429746|NCT00984659|4718817|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
1429747|NCT00984659|4718814|P4|6-week Double-blind Treatment Period|Protocol Violation|4
1429748|NCT00984659|4718815|P3|6-week Double-blind Treatment Period|Protocol Violation|0
1429749|NCT00984659|4718816|P2|6-week Double-blind Treatment Period|Protocol Violation|0
1429750|NCT00984659|4718817|P1|6-week Double-blind Treatment Period|Protocol Violation|0
1429751|NCT00984659|4718814|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
1429752|NCT00984659|4718815|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
1429753|NCT00984659|4718816|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
1429754|NCT00984659|4718817|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
1429755|NCT00984659|4718814|P4|6-week Double-blind Treatment Period|Adverse Event|7
1429756|NCT00984659|4718815|P3|6-week Double-blind Treatment Period|Adverse Event|3
1429757|NCT00984659|4718816|P2|6-week Double-blind Treatment Period|Adverse Event|3
1429758|NCT00984659|4718817|P1|6-week Double-blind Treatment Period|Adverse Event|0
1429759|NCT00984659|4718814|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1429760|NCT00984659|4718815|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1429761|NCT00984659|4718816|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1429762|NCT00984659|4718817|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
1429763|NCT00984659|4718814|P4|2-week Run-in Period|Withdrawal by Subject|0
1429764|NCT00984659|4718815|P3|2-week Run-in Period|Withdrawal by Subject|0
1429765|NCT00984659|4718816|P2|2-week Run-in Period|Withdrawal by Subject|0
1429766|NCT00984659|4718817|P1|2-week Run-in Period|Withdrawal by Subject|10
1429767|NCT00984659|4718814|P4|2-week Run-in Period|Physician Decision|0
1429768|NCT00984659|4718815|P3|2-week Run-in Period|Physician Decision|0
1429769|NCT00984659|4718816|P2|2-week Run-in Period|Physician Decision|0
1429770|NCT00984659|4718817|P1|2-week Run-in Period|Physician Decision|10
1429771|NCT00984659|4718814|P4|2-week Run-in Period|Lost to Follow-up|0
1429772|NCT00984659|4718815|P3|2-week Run-in Period|Lost to Follow-up|0
1429773|NCT00984659|4718816|P2|2-week Run-in Period|Lost to Follow-up|0
1429774|NCT00984659|4718817|P1|2-week Run-in Period|Lost to Follow-up|3
1429775|NCT00984659|4718814|P4|2-week Run-in Period|Study Closed/Terminated|0
1429776|NCT00984659|4718815|P3|2-week Run-in Period|Study Closed/Terminated|0
1429777|NCT00984659|4718816|P2|2-week Run-in Period|Study Closed/Terminated|0
1429778|NCT00984659|4718817|P1|2-week Run-in Period|Study Closed/Terminated|2
1429779|NCT00984659|4718814|P4|2-week Run-in Period|Protocol Violation|0
1429780|NCT00984659|4718815|P3|2-week Run-in Period|Protocol Violation|0
1429781|NCT00984659|4718816|P2|2-week Run-in Period|Protocol Violation|0
1429782|NCT00984659|4718817|P1|2-week Run-in Period|Protocol Violation|5
1429783|NCT00984659|4718814|P4|2-week Run-in Period|Adverse Event|0
1429784|NCT00984659|4718815|P3|2-week Run-in Period|Adverse Event|0
1429785|NCT00984659|4718816|P2|2-week Run-in Period|Adverse Event|0
1429786|NCT00984659|4718817|P1|2-week Run-in Period|Adverse Event|8
1429787|NCT00984620|4718844|P2|Overall Study|reason other than listed above|4
1429788|NCT00984620|4718845|P1|Overall Study|reason other than listed above|0
1429789|NCT00984620|4718844|P2|Overall Study|Withdrawal by Subject|2
1429790|NCT00984620|4718845|P1|Overall Study|Withdrawal by Subject|0
1429791|NCT00984620|4718844|P2|Overall Study|Lost to Follow-up|1
1429792|NCT00984620|4718845|P1|Overall Study|Lost to Follow-up|1
1429793|NCT00984620|4718844|P2|Overall Study|Adverse Event|5
1429794|NCT00984620|4718845|P1|Overall Study|Adverse Event|5
1429795|NCT00984594|4718883|P2|Overall Study|Withdrawal by Subject|1
1429796|NCT00984594|4718884|P1|Overall Study|Withdrawal by Subject|0
1429797|NCT00984594|4718883|P2|Overall Study|Lost to Follow-up|0
1429798|NCT00984594|4718884|P1|Overall Study|Lost to Follow-up|1
1429799|NCT00984568|4718900|P2|Overall Study|Unknown Reason|3
1429800|NCT00984568|4718901|P1|Overall Study|Unknown Reason|1
1429801|NCT00984568|4718900|P2|Overall Study|Opportunistic Infection|0
1429802|NCT00984568|4718901|P1|Overall Study|Opportunistic Infection|1
1429803|NCT00984568|4718900|P2|Overall Study|Lost to Follow-up|1
1429804|NCT00984568|4718901|P1|Overall Study|Lost to Follow-up|0
1429805|NCT00984568|4718900|P2|Overall Study|Did Not Meet Randomization Criteria|0
1429806|NCT00984568|4718901|P1|Overall Study|Did Not Meet Randomization Criteria|1
1429807|NCT00984568|4718900|P2|Overall Study|Adverse Event|0
1429808|NCT00984568|4718901|P1|Overall Study|Adverse Event|2
1429809|NCT00984568|4718900|P2|Overall Study|Lack of Efficacy|0
1429810|NCT00984568|4718901|P1|Overall Study|Lack of Efficacy|2
1429811|NCT00984568|4718900|P2|Overall Study|Withdrawal by Subject|2
1429812|NCT00984568|4718901|P1|Overall Study|Withdrawal by Subject|1
1429813|NCT00984542|4718909|P1|Overall Study|clinical deterioration|2
1429814|NCT00984542|4718909|P1|Overall Study|Withdrawal by Subject|3
1429815|NCT00984542|4718909|P1|Overall Study|complicating disease|3
1429816|NCT00984542|4718909|P1|Overall Study|Death|7
1429817|NCT00984542|4718909|P1|Overall Study|toxicity|7
1429818|NCT00984542|4718909|P1|Overall Study|disease progression|19
1429819|NCT00984295|4718959|P3|Overall Study|Incomplete safety follow-up|3
1429820|NCT00984295|4718960|P2|Overall Study|Incomplete safety follow-up|2
1429821|NCT00984295|4718961|P1|Overall Study|Incomplete safety follow-up|11
1429822|NCT00984295|4718959|P3|Overall Study|Missed one or more blood samplings|2
1429823|NCT00984295|4718960|P2|Overall Study|Missed one or more blood samplings|7
1429824|NCT00984295|4718961|P1|Overall Study|Missed one or more blood samplings|3
1429825|NCT00984295|4718959|P3|Overall Study|CAE – discontinued test vaccine|3
1429826|NCT00984295|4718960|P2|Overall Study|CAE – discontinued test vaccine|1
1429827|NCT00984295|4718961|P1|Overall Study|CAE – discontinued test vaccine|0
1429828|NCT00984295|4718959|P3|Overall Study|Withdrawal by Subject|12
1429829|NCT00984295|4718960|P2|Overall Study|Withdrawal by Subject|9
1429830|NCT00984295|4718961|P1|Overall Study|Withdrawal by Subject|18
1429831|NCT00984295|4718959|P3|Overall Study|Protocol Violation|4
1429832|NCT00984295|4718960|P2|Overall Study|Protocol Violation|1
1429833|NCT00984295|4718961|P1|Overall Study|Protocol Violation|2
1429834|NCT00984295|4718959|P3|Overall Study|Lost to Follow-up|13
1429835|NCT00984295|4718960|P2|Overall Study|Lost to Follow-up|12
1429836|NCT00984295|4718961|P1|Overall Study|Lost to Follow-up|31
1429837|NCT00984282|4719028|P2|Long Term Follow-up|Ongoing with treatment|26
1429838|NCT00984282|4719029|P1|Long Term Follow-up|Ongoing with treatment|33
1429839|NCT00984282|4719028|P2|Long Term Follow-up|Lost to Follow-up|4
1429840|NCT00984282|4719029|P1|Long Term Follow-up|Lost to Follow-up|8
1429841|NCT00984282|4719028|P2|Long Term Follow-up|Death|72
1429842|NCT00984282|4719029|P1|Long Term Follow-up|Death|55
1429843|NCT00984282|4719028|P2|Long Term Follow-up|Withdrawal by Subject|15
1429844|NCT00984282|4719029|P1|Long Term Follow-up|Withdrawal by Subject|18
1429845|NCT00984282|4719028|P2|Open-label Treatment|Target lesion removed|1
1429846|NCT00984282|4719029|P1|Open-label Treatment|Target lesion removed|0
1429847|NCT00984282|4719028|P2|Open-label Treatment|Non-compliant with study medication|0
1429848|NCT00984282|4719029|P1|Open-label Treatment|Non-compliant with study medication|1
1429849|NCT00984282|4719028|P2|Open-label Treatment|Ongoing with treatment|18
1429850|NCT00984282|4719029|P1|Open-label Treatment|Ongoing with treatment|19
1429851|NCT00984282|4719028|P2|Open-label Treatment|Lost to Follow-up|0
1429852|NCT00984282|4719029|P1|Open-label Treatment|Lost to Follow-up|1
1429853|NCT00984282|4719028|P2|Open-label Treatment|Progression, recurrence or relapse|77
1429854|NCT00984282|4719029|P1|Open-label Treatment|Progression, recurrence or relapse|37
1429855|NCT00984282|4719028|P2|Open-label Treatment|Death|15
1429856|NCT00984282|4719029|P1|Open-label Treatment|Death|5
1429857|NCT00984282|4719028|P2|Open-label Treatment|Withdrawal by Subject|21
1429858|NCT00984282|4719029|P1|Open-label Treatment|Withdrawal by Subject|6
1429859|NCT00984282|4719028|P2|Open-label Treatment|Adverse Event|29
1429860|NCT00984282|4719029|P1|Open-label Treatment|Adverse Event|17
1429861|NCT00984282|4719028|P2|Double Blind Treatment|Switched to follow-up|4
1429862|NCT00984282|4719029|P1|Double Blind Treatment|Switched to follow-up|12
1429863|NCT00984282|4719028|P2|Double Blind Treatment|Not treated|1
1429864|NCT00984282|4719029|P1|Double Blind Treatment|Not treated|0
1429865|NCT00984282|4719028|P2|Double Blind Treatment|Death|4
1429866|NCT00984282|4719029|P1|Double Blind Treatment|Death|8
1429867|NCT00984282|4719028|P2|Double Blind Treatment|Lost to Follow-up|0
1429868|NCT00984282|4719029|P1|Double Blind Treatment|Lost to Follow-up|3
1429869|NCT00984282|4719028|P2|Double Blind Treatment|Withdrawal by Subject|18
1429870|NCT00984282|4719029|P1|Double Blind Treatment|Withdrawal by Subject|14
1429871|NCT00984282|4719028|P2|Double Blind Treatment|Progression by clinical judgment|0
1429872|NCT00984282|4719029|P1|Double Blind Treatment|Progression by clinical judgment|1
1429873|NCT00984282|4719028|P2|Double Blind Treatment|Noncompliance with study medication|0
1429874|NCT00984282|4719029|P1|Double Blind Treatment|Noncompliance with study medication|3
1429875|NCT00984282|4719028|P2|Double Blind Treatment|Physician Decision|2
1429876|NCT00984282|4719029|P1|Double Blind Treatment|Physician Decision|1
1429877|NCT00984282|4719028|P2|Double Blind Treatment|Progression, recurrence or relapse|3
1429878|NCT00984282|4719029|P1|Double Blind Treatment|Progression, recurrence or relapse|24
1429879|NCT00984282|4719028|P2|Double Blind Treatment|Adverse Event|6
1429880|NCT00984282|4719029|P1|Double Blind Treatment|Adverse Event|38
1429881|NCT00984256|4719052|P2|Overall Study|Withdrawal by Subject|1
1429882|NCT00984256|4719053|P1|Overall Study|Withdrawal by Subject|0
1429883|NCT00984204|4719073|P1|Overall Study|Lack of Efficacy|10
1429884|NCT00984204|4719073|P1|Overall Study|Lost to Follow-up|4
1429885|NCT00984204|4719073|P1|Overall Study|Death|1
1429886|NCT00984165|4719083|P4|Overall Study|removed with a pair recipient|1
1429887|NCT00984165|4719084|P3|Overall Study|removed with a pair recipient|0
1429888|NCT00984165|4719085|P2|Overall Study|removed with a pair recipient|0
1429889|NCT00984165|4719086|P1|Overall Study|removed with a pair recipient|0
1429890|NCT00984165|4719083|P4|Overall Study|P+/donor pair removed from protocol|1
1429891|NCT00984165|4719084|P3|Overall Study|P+/donor pair removed from protocol|0
1429892|NCT00984165|4719085|P2|Overall Study|P+/donor pair removed from protocol|0
1429893|NCT00984165|4719086|P1|Overall Study|P+/donor pair removed from protocol|0
1429894|NCT00984165|4719083|P4|Overall Study|New protocol|1
1429895|NCT00984165|4719084|P3|Overall Study|New protocol|0
1429896|NCT00984165|4719085|P2|Overall Study|New protocol|0
1429897|NCT00984165|4719086|P1|Overall Study|New protocol|0
1429898|NCT00984165|4719083|P4|Overall Study|Death of recipient|1
1429899|NCT00984165|4719084|P3|Overall Study|Death of recipient|0
1429900|NCT00984165|4719085|P2|Overall Study|Death of recipient|0
1429901|NCT00984165|4719086|P1|Overall Study|Death of recipient|0
1429902|NCT00984165|4719083|P4|Overall Study|Disease progression on study|0
1429903|NCT00984165|4719084|P3|Overall Study|Disease progression on study|0
1429904|NCT00984165|4719085|P2|Overall Study|Disease progression on study|1
1429905|NCT00984165|4719086|P1|Overall Study|Disease progression on study|5
1429906|NCT00984165|4719083|P4|Overall Study|Death on study|0
1429907|NCT00984165|4719084|P3|Overall Study|Death on study|0
1429908|NCT00984165|4719085|P2|Overall Study|Death on study|0
1429909|NCT00984165|4719086|P1|Overall Study|Death on study|2
1429910|NCT00984126|4719115|P4|Overall Study|Withdrawal criteria|9
1429911|NCT00984126|4719116|P3|Overall Study|Withdrawal criteria|3
1429912|NCT00984126|4719117|P2|Overall Study|Withdrawal criteria|1
1429913|NCT00984126|4719118|P1|Overall Study|Withdrawal criteria|0
1429914|NCT00984126|4719115|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
1429915|NCT00984126|4719116|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
1429916|NCT00984126|4719117|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
1429917|NCT00984126|4719118|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
1429918|NCT00984126|4719115|P4|Overall Study|Adverse Event|2
1429919|NCT00984126|4719116|P3|Overall Study|Adverse Event|0
1429920|NCT00984126|4719117|P2|Overall Study|Adverse Event|0
1429921|NCT00984126|4719118|P1|Overall Study|Adverse Event|0
1429922|NCT00984126|4719115|P4|Overall Study|Protocol Violation|2
1429923|NCT00984126|4719116|P3|Overall Study|Protocol Violation|1
1429924|NCT00984126|4719117|P2|Overall Study|Protocol Violation|0
1429925|NCT00984126|4719118|P1|Overall Study|Protocol Violation|0
1429926|NCT00984061|4719143|P1|Clarithromycin Alone|Protocol Violation|1
1429927|NCT00984022|4719156|P2|Overall Study|Lost to Follow-up|14
1429928|NCT00984022|4719157|P1|Overall Study|Lost to Follow-up|10
1429929|NCT00984009|4719167|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
1429930|NCT00983957|4719200|P1|Overall Study|Personal Reasons|1
1429931|NCT00983957|4719200|P1|Overall Study|Adverse Event|1
1429932|NCT00983931|4719234|P1|14 Day Washout Period|Physician Decision|1
1429933|NCT00983918|4719248|P4|Overall Study|conversion to open cholecystectomy|2
1429934|NCT00983918|4719249|P3|Overall Study|conversion to open cholecystectomy|2
1429935|NCT00983918|4719250|P2|Overall Study|conversion to open cholecystectomy|2
1429936|NCT00983918|4719251|P1|Overall Study|conversion to open cholecystectomy|0
1429937|NCT00983905|4719261|P1|Colchicine Alone|Adverse Event|2
1429938|NCT00983905|4719261|P1|Theophylline Alone|Adverse Event|1
1429939|NCT00983892|4719274|P2|Overall Study|Withdrawal by Subject|12
1429940|NCT00983892|4719275|P1|Overall Study|Withdrawal by Subject|10
1429941|NCT00983853|4719287|P6|Overall Study|Unable to come to study follow-up visits|0
1429942|NCT00983853|4719288|P5|Overall Study|Unable to come to study follow-up visits|0
1429943|NCT00983853|4719289|P4|Overall Study|Unable to come to study follow-up visits|0
1429944|NCT00983853|4719290|P3|Overall Study|Unable to come to study follow-up visits|0
1429945|NCT00983853|4719291|P2|Overall Study|Unable to come to study follow-up visits|1
1429946|NCT00983853|4719292|P1|Overall Study|Unable to come to study follow-up visits|0
1429947|NCT00983853|4719287|P6|Overall Study|Withdrawal by Subject|0
1429948|NCT00983853|4719288|P5|Overall Study|Withdrawal by Subject|1
1429949|NCT00983853|4719289|P4|Overall Study|Withdrawal by Subject|0
1429950|NCT00983853|4719290|P3|Overall Study|Withdrawal by Subject|1
1429951|NCT00983853|4719291|P2|Overall Study|Withdrawal by Subject|0
1429952|NCT00983853|4719292|P1|Overall Study|Withdrawal by Subject|0
1429953|NCT00983853|4719287|P6|Overall Study|Lost to Follow-up|1
1429954|NCT00983853|4719288|P5|Overall Study|Lost to Follow-up|2
1429955|NCT00983853|4719289|P4|Overall Study|Lost to Follow-up|2
1429956|NCT00983853|4719290|P3|Overall Study|Lost to Follow-up|2
1429957|NCT00983853|4719291|P2|Overall Study|Lost to Follow-up|1
1429958|NCT00983853|4719292|P1|Overall Study|Lost to Follow-up|1
1429959|NCT00983827|4719320|P1|Overall Study|Withdrawal by Subject|1
1429960|NCT00983749|4719338|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
1429961|NCT00983749|4719339|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
1429962|NCT00983580|4719364|P2|Overall Study|Ineligible|0
1429963|NCT00983580|4719365|P1|Overall Study|Ineligible|3
1429964|NCT00983580|4719364|P2|Overall Study|Protocol Violation|1
1429965|NCT00983580|4719365|P1|Overall Study|Protocol Violation|1
1429966|NCT00983580|4719364|P2|Overall Study|Cancel Prior to treatment|3
1429967|NCT00983580|4719365|P1|Overall Study|Cancel Prior to treatment|1
1429968|NCT00983515|4719391|P1|Colchicine With Ritonavir|Lost to Follow-up|1
1429969|NCT00983515|4719391|P1|Ritonavir Alone|liver panel out of range|6
1429970|NCT00983476|4719418|P3|Overall Study|Did not receive intervention|0
1429971|NCT00983476|4719419|P2|Overall Study|Did not receive intervention|22
1429972|NCT00983476|4719420|P1|Overall Study|Did not receive intervention|17
1429973|NCT00983437|4719452|P1|Overall Study|Other Reason|26
1429974|NCT00983437|4719452|P1|Overall Study|Lost to Follow-up|2
1429975|NCT00983437|4719452|P1|Overall Study|Noncompliance to Study Procedures|1
1429976|NCT00983437|4719452|P1|Overall Study|Withdrawal by Subject|8
1429977|NCT00983437|4719452|P1|Overall Study|Lack of Efficacy|1
1429978|NCT00983437|4719452|P1|Overall Study|Adverse Event|9
1429979|NCT00983385|4719471|P1|Observation Period|Not Evaluable due to Non Compliance|12
1429980|NCT00983385|4719471|P1|Observation Period|Not eligible to be dosed|20
1429981|NCT00983372|4719516|P1|Diltiazem ER Alone|Adverse Event|1
1429982|NCT00983372|4719516|P1|Diltiazem ER Alone|missed diltiazem dose|2
1429983|NCT00983372|4719516|P1|14 Day Washout Period|Withdrawal by Subject|1
1429984|NCT00983294|4719543|P1|Colchicine With Azithromycin|Adverse Event|1
1429985|NCT00983294|4719543|P1|14 Day Washout Period|Withdrawal by Subject|2
1429986|NCT00983073|4719585|P1|Maintenance Period|Other Reason|7
1429987|NCT00983073|4719585|P1|Maintenance Period|Lack of Efficacy|2
1429988|NCT00983073|4719585|P1|Maintenance Period|Withdrawal by Subject|2
1429989|NCT00983073|4719585|P1|Maintenance Period|Adverse Event|5
1429990|NCT00983073|4719585|P1|Titration and Optimal Dose Period|Other reason|4
1429991|NCT00983073|4719585|P1|Titration and Optimal Dose Period|Non-Compliance|1
1429992|NCT00983073|4719585|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
1429993|NCT00983073|4719585|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
1429994|NCT00983073|4719585|P1|Titration and Optimal Dose Period|Adverse Event|19
1429995|NCT00982735|4719611|P1|Overall Study|Patient ineligible for trial|224
1429996|NCT00982735|4719611|P1|Overall Study|Lost to Follow-up|6
1429997|NCT00982657|4719621|P4|Overall Study|On going at date of cut-off|1
1429998|NCT00982657|4719622|P3|Overall Study|On going at date of cut-off|0
1429999|NCT00982657|4719623|P2|Overall Study|On going at date of cut-off|0
1430000|NCT00982657|4719624|P1|Overall Study|On going at date of cut-off|0
1430001|NCT00982657|4719621|P4|Overall Study|Other|4
1430002|NCT00982657|4719622|P3|Overall Study|Other|0
1430003|NCT00982657|4719623|P2|Overall Study|Other|0
1430004|NCT00982657|4719624|P1|Overall Study|Other|0
1430005|NCT00982657|4719621|P4|Overall Study|Withdrawal by Subject|3
1430006|NCT00982657|4719622|P3|Overall Study|Withdrawal by Subject|1
1430007|NCT00982657|4719623|P2|Overall Study|Withdrawal by Subject|0
1430008|NCT00982657|4719624|P1|Overall Study|Withdrawal by Subject|0
1430009|NCT00982657|4719621|P4|Overall Study|Death|1
1430010|NCT00982657|4719622|P3|Overall Study|Death|1
1430011|NCT00982657|4719623|P2|Overall Study|Death|0
1430012|NCT00982657|4719624|P1|Overall Study|Death|1
1430013|NCT00982644|4719665|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
1430014|NCT00982644|4719666|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
1430015|NCT00982644|4719665|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
1430016|NCT00982644|4719666|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
1430017|NCT00982644|4719665|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
1430018|NCT00982644|4719666|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
1430019|NCT00982644|4719665|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
1430020|NCT00982644|4719666|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
1430021|NCT00982644|4719665|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
1430022|NCT00982644|4719666|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
1430023|NCT00982644|4719665|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
1430024|NCT00982644|4719666|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
1430025|NCT00982644|4719665|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
1430026|NCT00982644|4719666|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
1430027|NCT00982644|4719665|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
1430028|NCT00982644|4719666|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
1430029|NCT00982644|4719665|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
1430030|NCT00982644|4719666|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
1430031|NCT00982644|4719665|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
1430032|NCT00982644|4719666|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
1430033|NCT00982488|4719717|P5|Overall Study|Withdrawal by Subject|0
1430034|NCT00982488|4719718|P4|Overall Study|Withdrawal by Subject|0
1430035|NCT00982488|4719719|P3|Overall Study|Withdrawal by Subject|1
1430036|NCT00982488|4719720|P2|Overall Study|Withdrawal by Subject|1
1430037|NCT00982488|4719721|P1|Overall Study|Withdrawal by Subject|5
1430038|NCT00982488|4719717|P5|Overall Study|Study drug toxicity|0
1430039|NCT00982488|4719718|P4|Overall Study|Study drug toxicity|0
1430040|NCT00982488|4719719|P3|Overall Study|Study drug toxicity|6
1430041|NCT00982488|4719720|P2|Overall Study|Study drug toxicity|1
1430042|NCT00982488|4719721|P1|Overall Study|Study drug toxicity|34
1430043|NCT00982488|4719717|P5|Overall Study|Stem cell transplant|0
1430044|NCT00982488|4719718|P4|Overall Study|Stem cell transplant|1
1430045|NCT00982488|4719719|P3|Overall Study|Stem cell transplant|0
1430046|NCT00982488|4719720|P2|Overall Study|Stem cell transplant|0
1430047|NCT00982488|4719721|P1|Overall Study|Stem cell transplant|2
1430048|NCT00982488|4719717|P5|Overall Study|Poor compliance/noncompliance|0
1430049|NCT00982488|4719718|P4|Overall Study|Poor compliance/noncompliance|0
1430050|NCT00982488|4719719|P3|Overall Study|Poor compliance/noncompliance|0
1430051|NCT00982488|4719720|P2|Overall Study|Poor compliance/noncompliance|1
1430052|NCT00982488|4719721|P1|Overall Study|Poor compliance/noncompliance|0
1430053|NCT00982488|4719717|P5|Overall Study|Not specified|0
1430054|NCT00982488|4719718|P4|Overall Study|Not specified|1
1430055|NCT00982488|4719719|P3|Overall Study|Not specified|3
1430056|NCT00982488|4719720|P2|Overall Study|Not specified|1
1430057|NCT00982488|4719721|P1|Overall Study|Not specified|15
1430058|NCT00982488|4719717|P5|Overall Study|Maximum clinical benefit|0
1430059|NCT00982488|4719718|P4|Overall Study|Maximum clinical benefit|0
1430060|NCT00982488|4719719|P3|Overall Study|Maximum clinical benefit|1
1430061|NCT00982488|4719720|P2|Overall Study|Maximum clinical benefit|1
1430062|NCT00982488|4719721|P1|Overall Study|Maximum clinical benefit|1
1430063|NCT00982488|4719717|P5|Overall Study|Lost to Follow-up|0
1430064|NCT00982488|4719718|P4|Overall Study|Lost to Follow-up|0
1430065|NCT00982488|4719719|P3|Overall Study|Lost to Follow-up|0
1430066|NCT00982488|4719720|P2|Overall Study|Lost to Follow-up|0
1430067|NCT00982488|4719721|P1|Overall Study|Lost to Follow-up|1
1430068|NCT00982488|4719717|P5|Overall Study|Disease progression|1
1430069|NCT00982488|4719718|P4|Overall Study|Disease progression|1
1430070|NCT00982488|4719719|P3|Overall Study|Disease progression|10
1430071|NCT00982488|4719720|P2|Overall Study|Disease progression|5
1430072|NCT00982488|4719721|P1|Overall Study|Disease progression|30
1430073|NCT00982488|4719717|P5|Overall Study|Death|0
1430074|NCT00982488|4719718|P4|Overall Study|Death|0
1430075|NCT00982488|4719719|P3|Overall Study|Death|2
1430076|NCT00982488|4719720|P2|Overall Study|Death|0
1430077|NCT00982488|4719721|P1|Overall Study|Death|11
1430078|NCT00982488|4719717|P5|Overall Study|Adverse event unrelated to study drug|0
1430079|NCT00982488|4719718|P4|Overall Study|Adverse event unrelated to study drug|0
1430080|NCT00982488|4719719|P3|Overall Study|Adverse event unrelated to study drug|0
1430081|NCT00982488|4719720|P2|Overall Study|Adverse event unrelated to study drug|1
1430082|NCT00982488|4719721|P1|Overall Study|Adverse event unrelated to study drug|5
1430083|NCT00982488|4719717|P5|Overall Study|Administrative reason by sponsor|0
1430084|NCT00982488|4719718|P4|Overall Study|Administrative reason by sponsor|0
1430085|NCT00982488|4719719|P3|Overall Study|Administrative reason by sponsor|11
1430086|NCT00982488|4719720|P2|Overall Study|Administrative reason by sponsor|3
1430087|NCT00982488|4719721|P1|Overall Study|Administrative reason by sponsor|81
1430088|NCT00982410|4719754|P2|12-month Follow-up Assessment|scheduled, no-show|0
1430089|NCT00982410|4719755|P1|12-month Follow-up Assessment|scheduled, no-show|1
1430090|NCT00982410|4719754|P2|12-month Follow-up Assessment|incarceration|1
1430091|NCT00982410|4719755|P1|12-month Follow-up Assessment|incarceration|2
1430092|NCT00982410|4719754|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
1430093|NCT00982410|4719755|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
1430094|NCT00982410|4719754|P2|12-month Follow-up Assessment|could not reach to schedule|5
1430095|NCT00982410|4719755|P1|12-month Follow-up Assessment|could not reach to schedule|6
1430096|NCT00982410|4719754|P2|12-month Follow-up Assessment|Death|2
1430097|NCT00982410|4719755|P1|12-month Follow-up Assessment|Death|0
1430098|NCT00982410|4719754|P2|6-month Follow-up Assessment|scheduled, no-show|1
1430099|NCT00982410|4719755|P1|6-month Follow-up Assessment|scheduled, no-show|0
1430100|NCT00982410|4719754|P2|6-month Follow-up Assessment|patent surgery|1
1430101|NCT00982410|4719755|P1|6-month Follow-up Assessment|patent surgery|0
1430102|NCT00982410|4719754|P2|6-month Follow-up Assessment|incarceration|2
1430103|NCT00982410|4719755|P1|6-month Follow-up Assessment|incarceration|0
1430104|NCT00982410|4719754|P2|6-month Follow-up Assessment|participant no transportation|0
1430105|NCT00982410|4719755|P1|6-month Follow-up Assessment|participant no transportation|1
1430106|NCT00982410|4719754|P2|6-month Follow-up Assessment|Could not reach to schedule|7
1430107|NCT00982410|4719755|P1|6-month Follow-up Assessment|Could not reach to schedule|5
1430108|NCT00982410|4719754|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
1430109|NCT00982410|4719755|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
1430110|NCT00982410|4719754|P2|3-month Follow-up Assessment|Scheduled, no-show|2
1430111|NCT00982410|4719755|P1|3-month Follow-up Assessment|Scheduled, no-show|1
1430112|NCT00982410|4719754|P2|3-month Follow-up Assessment|Could not reach to schedule|9
1430113|NCT00982410|4719755|P1|3-month Follow-up Assessment|Could not reach to schedule|8
1430114|NCT00982319|4719796|P2|Overall Study|Pregnancy|1
1430115|NCT00982319|4719797|P1|Overall Study|Pregnancy|0
1430116|NCT00982319|4719796|P2|Overall Study|Preop values out of acceptable range|1
1430117|NCT00982319|4719797|P1|Overall Study|Preop values out of acceptable range|1
1430118|NCT00982319|4719796|P2|Overall Study|Surgery date change|0
1430119|NCT00982319|4719797|P1|Overall Study|Surgery date change|1
1430120|NCT00982280|4719803|P1|Maintenance Period|Adverse Event|1
1430121|NCT00982280|4719803|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
1430122|NCT00982280|4719803|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
1430123|NCT00982280|4719803|P1|Titration and Optimal Dose Period|Adverse Event|5
1430124|NCT00982280|4719803|P1|Observation Period|Not eligible to be dosed|19
1430125|NCT00982228|4719828|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
1430126|NCT00982228|4719829|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
1430127|NCT00982228|4719828|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
1430128|NCT00982228|4719829|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
1430129|NCT00982228|4719828|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
1430130|NCT00982228|4719829|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
1430131|NCT00982228|4719828|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
1430132|NCT00982228|4719829|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
1430133|NCT00982228|4719828|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
1430134|NCT00982228|4719829|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
1430135|NCT00982228|4719828|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
1430136|NCT00982228|4719829|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
1430137|NCT00982228|4719828|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
1430138|NCT00982228|4719829|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
1430139|NCT00982228|4719828|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
1430140|NCT00982228|4719829|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
1430141|NCT00982228|4719828|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
1430142|NCT00982228|4719829|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
1430143|NCT00982228|4719828|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
1430144|NCT00982228|4719829|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
1430145|NCT00982137|4719888|P4|Overall Study|Withdrawal by Subject|0
1430146|NCT00982137|4719889|P3|Overall Study|Withdrawal by Subject|0
1430147|NCT00982137|4719890|P2|Overall Study|Withdrawal by Subject|1
1430148|NCT00982137|4719891|P1|Overall Study|Withdrawal by Subject|0
1430149|NCT00982137|4719888|P4|Overall Study|Lost to Follow-up|1
1430150|NCT00982137|4719889|P3|Overall Study|Lost to Follow-up|0
1430151|NCT00982137|4719890|P2|Overall Study|Lost to Follow-up|0
1430152|NCT00982137|4719891|P1|Overall Study|Lost to Follow-up|0
1430153|NCT00982111|4719923|P2|Overall Study|Withdrawal by Subject|17
1430154|NCT00982111|4719924|P1|Overall Study|Withdrawal by Subject|16
1430155|NCT00982111|4719923|P2|Overall Study|On Study Treatment at Conclusion|0
1430156|NCT00982111|4719924|P1|Overall Study|On Study Treatment at Conclusion|7
1430157|NCT00982111|4719923|P2|Overall Study|New Anti-Cancer Therapy|5
1430158|NCT00982111|4719924|P1|Overall Study|New Anti-Cancer Therapy|5
1430159|NCT00982111|4719923|P2|Overall Study|Lost to Follow-up|6
1430160|NCT00982111|4719924|P1|Overall Study|Lost to Follow-up|9
1430161|NCT00982111|4719923|P2|Overall Study|Progressive Disease|37
1430162|NCT00982111|4719924|P1|Overall Study|Progressive Disease|37
1430163|NCT00982111|4719923|P2|Overall Study|Adverse Event|1
1430164|NCT00982111|4719924|P1|Overall Study|Adverse Event|1
1430165|NCT00982020|4719957|P2|Overall Study|Clinical Relapse|1
1430166|NCT00982020|4719958|P1|Overall Study|Clinical Relapse|0
1430167|NCT00982020|4719957|P2|Overall Study|Protocol Violation|2
1430168|NCT00982020|4719958|P1|Overall Study|Protocol Violation|0
1430169|NCT00982020|4719957|P2|Overall Study|Entry Criteria Not Met|1
1430170|NCT00982020|4719958|P1|Overall Study|Entry Criteria Not Met|2
1430171|NCT00982020|4719957|P2|Overall Study|Physician Decision|5
1430172|NCT00982020|4719958|P1|Overall Study|Physician Decision|2
1430173|NCT00982020|4719957|P2|Overall Study|Treatment Non-compliance|6
1430174|NCT00982020|4719958|P1|Overall Study|Treatment Non-compliance|3
1430175|NCT00982020|4719957|P2|Overall Study|Parent/Caregiver Decision|5
1430176|NCT00982020|4719958|P1|Overall Study|Parent/Caregiver Decision|5
1430177|NCT00982020|4719957|P2|Overall Study|Lack of Efficacy|4
1430178|NCT00982020|4719958|P1|Overall Study|Lack of Efficacy|10
1430179|NCT00982020|4719957|P2|Overall Study|Lost to Follow-up|11
1430180|NCT00982020|4719958|P1|Overall Study|Lost to Follow-up|5
1430181|NCT00982020|4719957|P2|Overall Study|Withdrawal by Subject|14
1430182|NCT00982020|4719958|P1|Overall Study|Withdrawal by Subject|11
1430183|NCT00982020|4719957|P2|Overall Study|Adverse Event|15
1430184|NCT00982020|4719958|P1|Overall Study|Adverse Event|19
1430185|NCT00981526|4720058|P2|Overall Study|Physician Decision|4
1430186|NCT00981526|4720059|P1|Overall Study|Physician Decision|4
1430187|NCT00981526|4720058|P2|Overall Study|Withdrawal by Subject|2
1430188|NCT00981526|4720059|P1|Overall Study|Withdrawal by Subject|0
1430189|NCT00981461|4720077|P2|Overall Study|Lost to Follow-up|2
1430190|NCT00981461|4720078|P1|Overall Study|Lost to Follow-up|5
1430191|NCT00981409|4720102|P2|Overall Study|Prostate Cancer Treatment before Trial|0
1430192|NCT00981409|4720103|P1|Overall Study|Prostate Cancer Treatment before Trial|2
1430193|NCT00981409|4720102|P2|Overall Study|Protocol Violation|1
1430194|NCT00981409|4720103|P1|Overall Study|Protocol Violation|0
1430195|NCT00981409|4720102|P2|Overall Study|Adverse Event|0
1430196|NCT00981409|4720103|P1|Overall Study|Adverse Event|4
1430197|NCT00981292|4720142|P6|Day 3|Protocol Violation|1
1430198|NCT00981292|4720143|P5|Day 3|Protocol Violation|0
1430199|NCT00981292|4720144|P4|Day 3|Protocol Violation|0
1430200|NCT00981292|4720145|P3|Day 3|Protocol Violation|0
1430201|NCT00981292|4720146|P2|Day 3|Protocol Violation|0
1430202|NCT00981292|4720147|P1|Day 3|Protocol Violation|0
1430203|NCT00981292|4720142|P6|Day 2|Protocol Violation|0
1430204|NCT00981292|4720143|P5|Day 2|Protocol Violation|0
1430205|NCT00981292|4720144|P4|Day 2|Protocol Violation|0
1430206|NCT00981292|4720145|P3|Day 2|Protocol Violation|0
1430207|NCT00981292|4720146|P2|Day 2|Protocol Violation|0
1430208|NCT00981292|4720147|P1|Day 2|Protocol Violation|2
1430209|NCT00981292|4720142|P6|Day 1|Protocol Violation|2
1430210|NCT00981292|4720143|P5|Day 1|Protocol Violation|0
1430211|NCT00981292|4720144|P4|Day 1|Protocol Violation|0
1430212|NCT00981292|4720145|P3|Day 1|Protocol Violation|0
1430213|NCT00981292|4720146|P2|Day 1|Protocol Violation|0
1430214|NCT00981292|4720147|P1|Day 1|Protocol Violation|1
1430215|NCT00981175|4720231|P2|Booster Dose Vaccination|Lost to Follow-up|3
1430216|NCT00981175|4720232|P1|Booster Dose Vaccination|Lost to Follow-up|2
1430217|NCT00981175|4720231|P2|Primary Dose Vaccination|Lost to Follow-up|1
1430218|NCT00981175|4720232|P1|Primary Dose Vaccination|Lost to Follow-up|2
1430219|NCT00981175|4720231|P2|Primary Dose Vaccination|Protocol Violation|1
1430220|NCT00981175|4720232|P1|Primary Dose Vaccination|Protocol Violation|0
1430221|NCT00981175|4720231|P2|Primary Dose Vaccination|Adverse Event|0
1430222|NCT00981175|4720232|P1|Primary Dose Vaccination|Adverse Event|1
1430223|NCT00981149|4720257|P2|Overall Study|Withdrawal by Subject|1
1430224|NCT00981149|4720258|P1|Overall Study|Withdrawal by Subject|1
1430225|NCT00981149|4720257|P2|Overall Study|Lost to Follow-up|2
1430226|NCT00981149|4720258|P1|Overall Study|Lost to Follow-up|1
1430227|NCT00981084|4720268|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
1430228|NCT00981084|4720269|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
1430229|NCT00981084|4720268|P2|Post Intervention (Data Analysis)|poor effort|1
1430230|NCT00981084|4720269|P1|Post Intervention (Data Analysis)|poor effort|1
1430231|NCT00981058|4720285|P2|Overall Study|On study treatment at conclusion|0
1430232|NCT00981058|4720286|P1|Overall Study|On study treatment at conclusion|9
1430233|NCT00981058|4720285|P2|Overall Study|Withdrawal by Subject|23
1430234|NCT00981058|4720286|P1|Overall Study|Withdrawal by Subject|25
1430235|NCT00981058|4720285|P2|Overall Study|Randomization Error|2
1430236|NCT00981058|4720286|P1|Overall Study|Randomization Error|1
1430237|NCT00981058|4720285|P2|Overall Study|Radiologist Error|1
1430238|NCT00981058|4720286|P1|Overall Study|Radiologist Error|0
1430239|NCT00981058|4720285|P2|Overall Study|Noncompliance|0
1430240|NCT00981058|4720286|P1|Overall Study|Noncompliance|1
1430241|NCT00981058|4720285|P2|Overall Study|New Anticancer Therapy|6
1430242|NCT00981058|4720286|P1|Overall Study|New Anticancer Therapy|6
1430243|NCT00981058|4720285|P2|Overall Study|Lost to Follow-up|15
1430244|NCT00981058|4720286|P1|Overall Study|Lost to Follow-up|16
1430245|NCT00981058|4720285|P2|Overall Study|Progressive Disease|49
1430246|NCT00981058|4720286|P1|Overall Study|Progressive Disease|61
1430247|NCT00981058|4720285|P2|Overall Study|Adverse Event|1
1430248|NCT00981058|4720286|P1|Overall Study|Adverse Event|1
1430249|NCT00981019|4720317|P1|Overall Study|Hit the survey after closure|79
1430250|NCT00981019|4720317|P1|Overall Study|Inadvertent exclusion|239
1430251|NCT00981019|4720317|P1|Overall Study|Did not match target population|94
1430252|NCT00981019|4720317|P1|Overall Study|Did not respond|65
1430253|NCT00980980|4720324|P3|Overall Study|Withdrawal by Hospital|0
1430254|NCT00980980|4720325|P2|Overall Study|Withdrawal by Hospital|1
1430255|NCT00980980|4720326|P1|Overall Study|Withdrawal by Hospital|0
1430256|NCT00980798|4720357|P2|Overall Study|Other|1
1430257|NCT00980798|4720358|P1|Overall Study|Other|0
1430258|NCT00980798|4720357|P2|Overall Study|Withdrawal by Subject|11
1430259|NCT00980798|4720358|P1|Overall Study|Withdrawal by Subject|8
1430260|NCT00980798|4720357|P2|Overall Study|Physician Decision|1
1430261|NCT00980798|4720358|P1|Overall Study|Physician Decision|2
1430262|NCT00980798|4720357|P2|Overall Study|Lost to Follow-up|1
1430263|NCT00980798|4720358|P1|Overall Study|Lost to Follow-up|0
1430264|NCT00980798|4720357|P2|Overall Study|Lack of Efficacy|5
1430265|NCT00980798|4720358|P1|Overall Study|Lack of Efficacy|16
1430266|NCT00980798|4720357|P2|Overall Study|Adverse Event|36
1430267|NCT00980798|4720358|P1|Overall Study|Adverse Event|7
1430268|NCT00980655|4720399|P2|Overall Study|Other|1
1430269|NCT00980655|4720400|P1|Overall Study|Other|0
1430270|NCT00980655|4720399|P2|Overall Study|Parent/legal guardian request|0
1430271|NCT00980655|4720400|P1|Overall Study|Parent/legal guardian request|1
1430272|NCT00980655|4720399|P2|Overall Study|Lost to Follow-up|1
1430273|NCT00980655|4720400|P1|Overall Study|Lost to Follow-up|0
1430274|NCT00980655|4720399|P2|Overall Study|Withdrawal by Subject|4
1430275|NCT00980655|4720400|P1|Overall Study|Withdrawal by Subject|0
1430276|NCT00980655|4720399|P2|Overall Study|Protocol Violation|7
1430277|NCT00980655|4720400|P1|Overall Study|Protocol Violation|2
1430278|NCT00980655|4720399|P2|Overall Study|Death|7
1430279|NCT00980655|4720400|P1|Overall Study|Death|0
1430280|NCT00980655|4720399|P2|Overall Study|Adverse Event|31
1430281|NCT00980655|4720400|P1|Overall Study|Adverse Event|13
1430282|NCT00980343|4720476|P2|Overall Study|no tumor at surgery - treatment effect|3
1430283|NCT00980343|4720477|P1|Overall Study|no tumor at surgery - treatment effect|1
1430284|NCT00980330|4720501|P7|Overall Study|(not specified)|0
1430285|NCT00980330|4720502|P6|Overall Study|(not specified)|1
1430286|NCT00980330|4720503|P5|Overall Study|(not specified)|1
1430287|NCT00980330|4720504|P4|Overall Study|(not specified)|1
1430288|NCT00980330|4720505|P3|Overall Study|(not specified)|0
1430289|NCT00980330|4720506|P2|Overall Study|(not specified)|0
1430290|NCT00980330|4720507|P1|Overall Study|(not specified)|2
1430291|NCT00980330|4720501|P7|Overall Study|Withdrawal by Subject|5
1430292|NCT00980330|4720502|P6|Overall Study|Withdrawal by Subject|2
1430293|NCT00980330|4720503|P5|Overall Study|Withdrawal by Subject|3
1430294|NCT00980330|4720504|P4|Overall Study|Withdrawal by Subject|1
1430295|NCT00980330|4720505|P3|Overall Study|Withdrawal by Subject|4
1430296|NCT00980330|4720506|P2|Overall Study|Withdrawal by Subject|4
1430297|NCT00980330|4720507|P1|Overall Study|Withdrawal by Subject|2
1430298|NCT00980330|4720501|P7|Overall Study|Lost to Follow-up|2
1430299|NCT00980330|4720502|P6|Overall Study|Lost to Follow-up|1
1430300|NCT00980330|4720503|P5|Overall Study|Lost to Follow-up|1
1430301|NCT00980330|4720504|P4|Overall Study|Lost to Follow-up|2
1430302|NCT00980330|4720505|P3|Overall Study|Lost to Follow-up|4
1430303|NCT00980330|4720506|P2|Overall Study|Lost to Follow-up|1
1430304|NCT00980330|4720507|P1|Overall Study|Lost to Follow-up|1
1430305|NCT00980330|4720501|P7|Overall Study|Adverse Event|0
1430306|NCT00980330|4720502|P6|Overall Study|Adverse Event|0
1430307|NCT00980330|4720503|P5|Overall Study|Adverse Event|0
1430308|NCT00980330|4720504|P4|Overall Study|Adverse Event|1
1430309|NCT00980330|4720505|P3|Overall Study|Adverse Event|0
1430310|NCT00980330|4720506|P2|Overall Study|Adverse Event|0
1430311|NCT00980330|4720507|P1|Overall Study|Adverse Event|0
1430312|NCT00980200|4720622|P5|7-day Treatment Period 3|Lack of Efficacy|1
1430313|NCT00980200|4720623|P4|7-day Treatment Period 3|Lack of Efficacy|0
1430314|NCT00980200|4720624|P3|7-day Treatment Period 3|Lack of Efficacy|0
1430315|NCT00980200|4720625|P2|7-day Treatment Period 3|Lack of Efficacy|1
1430316|NCT00980200|4720626|P1|7-day Treatment Period 3|Lack of Efficacy|0
1430317|NCT00980200|4720622|P5|7-day Treatment Period 1|Withdrawal by Subject|0
1430318|NCT00980200|4720623|P4|7-day Treatment Period 1|Withdrawal by Subject|0
1430319|NCT00980200|4720624|P3|7-day Treatment Period 1|Withdrawal by Subject|0
1430320|NCT00980200|4720625|P2|7-day Treatment Period 1|Withdrawal by Subject|1
1430321|NCT00980200|4720626|P1|7-day Treatment Period 1|Withdrawal by Subject|0
1430322|NCT00980174|4720645|P2|Overall Study|Other|1
1430323|NCT00980174|4720646|P1|Overall Study|Other|0
1430324|NCT00980174|4720645|P2|Overall Study|Death|1
1430325|NCT00980174|4720646|P1|Overall Study|Death|1
1430326|NCT00980174|4720645|P2|Overall Study|Ineligibility determined|1
1430327|NCT00980174|4720646|P1|Overall Study|Ineligibility determined|2
1430328|NCT00980174|4720645|P2|Overall Study|Adverse Event|3
1430329|NCT00980174|4720646|P1|Overall Study|Adverse Event|0
1430330|NCT00980174|4720645|P2|Overall Study|Withdrawal by Subject|4
1430331|NCT00980174|4720646|P1|Overall Study|Withdrawal by Subject|1
1430332|NCT00980148|4720664|P2|Overall Study|Various other reasons|9
1430333|NCT00980148|4720665|P1|Overall Study|Various other reasons|8
1430334|NCT00980148|4720664|P2|Overall Study|Negative for chlamydia at enrollment|9
1430335|NCT00980148|4720665|P1|Overall Study|Negative for chlamydia at enrollment|12
1430336|NCT00980148|4720664|P2|Overall Study|Received other antichlamydia treatment|14
1430337|NCT00980148|4720665|P1|Overall Study|Received other antichlamydia treatment|20
1430338|NCT00980148|4720664|P2|Overall Study|Discharged from facility|96
1430339|NCT00980148|4720665|P1|Overall Study|Discharged from facility|89
1430340|NCT00980044|4720674|P3|Overall Study|Protocol Violation|2
1430341|NCT00980044|4720675|P2|Overall Study|Protocol Violation|0
1430342|NCT00980044|4720676|P1|Overall Study|Protocol Violation|0
1430343|NCT00980044|4720674|P3|Overall Study|Withdrawal by Subject|3
1430344|NCT00980044|4720675|P2|Overall Study|Withdrawal by Subject|7
1430345|NCT00980044|4720676|P1|Overall Study|Withdrawal by Subject|5
1430346|NCT00980005|4720695|P2|Overall Study|Other|3
1430347|NCT00980005|4720696|P1|Overall Study|Other|4
1430348|NCT00980005|4720695|P2|Overall Study|Lost to Follow-up|43
1430349|NCT00980005|4720696|P1|Overall Study|Lost to Follow-up|37
1430350|NCT00980005|4720695|P2|Overall Study|Withdrawal by Subject|17
1430351|NCT00980005|4720696|P1|Overall Study|Withdrawal by Subject|6
1430352|NCT00979992|4720736|P1|Overall Study|Refused – Never Treated|2
1430353|NCT00979992|4720736|P1|Overall Study|Ineligible - wrong cell type|2
1430354|NCT00979992|4720736|P1|Overall Study|Ineligible - inadequate pathology|1
1430355|NCT00979953|4720748|P4|Overall Study|Protocol Violation|2
1430356|NCT00979953|4720749|P3|Overall Study|Protocol Violation|2
1430357|NCT00979953|4720750|P2|Overall Study|Protocol Violation|0
1430358|NCT00979953|4720751|P1|Overall Study|Protocol Violation|1
1430359|NCT00979953|4720748|P4|Overall Study|Withdrawal by Subject|1
1430360|NCT00979953|4720749|P3|Overall Study|Withdrawal by Subject|2
1430361|NCT00979953|4720750|P2|Overall Study|Withdrawal by Subject|0
1430362|NCT00979953|4720751|P1|Overall Study|Withdrawal by Subject|0
1430363|NCT00979953|4720748|P4|Overall Study|Lost to Follow-up|0
1430364|NCT00979953|4720749|P3|Overall Study|Lost to Follow-up|1
1430365|NCT00979953|4720750|P2|Overall Study|Lost to Follow-up|1
1430366|NCT00979953|4720751|P1|Overall Study|Lost to Follow-up|1
1430367|NCT00979953|4720748|P4|Overall Study|Lack of Efficacy|0
1430368|NCT00979953|4720749|P3|Overall Study|Lack of Efficacy|0
1430369|NCT00979953|4720750|P2|Overall Study|Lack of Efficacy|2
1430370|NCT00979953|4720751|P1|Overall Study|Lack of Efficacy|1
1430371|NCT00979953|4720748|P4|Overall Study|Adverse Event|4
1430372|NCT00979953|4720749|P3|Overall Study|Adverse Event|17
1430373|NCT00979953|4720750|P2|Overall Study|Adverse Event|2
1430374|NCT00979953|4720751|P1|Overall Study|Adverse Event|5
1430375|NCT00979901|4720774|P4|Overall Study|Treatment Group Terminated by Sponsor|112
1430376|NCT00979901|4720775|P3|Overall Study|Treatment Group Terminated by Sponsor|0
1430377|NCT00979901|4720776|P2|Overall Study|Treatment Group Terminated by Sponsor|0
1430378|NCT00979901|4720777|P1|Overall Study|Treatment Group Terminated by Sponsor|0
1430379|NCT00979901|4720774|P4|Overall Study|Left Country|0
1430380|NCT00979901|4720775|P3|Overall Study|Left Country|1
1430381|NCT00979901|4720776|P2|Overall Study|Left Country|0
1430382|NCT00979901|4720777|P1|Overall Study|Left Country|0
1430383|NCT00979901|4720774|P4|Overall Study|Discontinued in Error|0
1430384|NCT00979901|4720775|P3|Overall Study|Discontinued in Error|0
1430385|NCT00979901|4720776|P2|Overall Study|Discontinued in Error|1
1430386|NCT00979901|4720777|P1|Overall Study|Discontinued in Error|0
1430387|NCT00979901|4720774|P4|Overall Study|elevated lab values pre-randomization|0
1430388|NCT00979901|4720775|P3|Overall Study|elevated lab values pre-randomization|0
1430389|NCT00979901|4720776|P2|Overall Study|elevated lab values pre-randomization|0
1430390|NCT00979901|4720777|P1|Overall Study|elevated lab values pre-randomization|1
1430391|NCT00979901|4720774|P4|Overall Study|vacation|0
1430392|NCT00979901|4720775|P3|Overall Study|vacation|0
1430393|NCT00979901|4720776|P2|Overall Study|vacation|0
1430394|NCT00979901|4720777|P1|Overall Study|vacation|1
1430395|NCT00979901|4720774|P4|Overall Study|out-of-state|0
1430396|NCT00979901|4720775|P3|Overall Study|out-of-state|0
1430397|NCT00979901|4720776|P2|Overall Study|out-of-state|0
1430398|NCT00979901|4720777|P1|Overall Study|out-of-state|1
1430399|NCT00979901|4720774|P4|Overall Study|Noncompliance|0
1430400|NCT00979901|4720775|P3|Overall Study|Noncompliance|0
1430401|NCT00979901|4720776|P2|Overall Study|Noncompliance|0
1430402|NCT00979901|4720777|P1|Overall Study|Noncompliance|1
1430403|NCT00979901|4720774|P4|Overall Study|Withdrawal by Subject|1
1430404|NCT00979901|4720775|P3|Overall Study|Withdrawal by Subject|1
1430405|NCT00979901|4720776|P2|Overall Study|Withdrawal by Subject|1
1430406|NCT00979901|4720777|P1|Overall Study|Withdrawal by Subject|2
1430407|NCT00979901|4720774|P4|Overall Study|Protocol Violation|1
1430408|NCT00979901|4720775|P3|Overall Study|Protocol Violation|7
1430409|NCT00979901|4720776|P2|Overall Study|Protocol Violation|2
1430410|NCT00979901|4720777|P1|Overall Study|Protocol Violation|2
1430411|NCT00979901|4720774|P4|Overall Study|Lost to Follow-up|0
1430412|NCT00979901|4720775|P3|Overall Study|Lost to Follow-up|2
1430413|NCT00979901|4720776|P2|Overall Study|Lost to Follow-up|1
1430414|NCT00979901|4720777|P1|Overall Study|Lost to Follow-up|1
1430415|NCT00979901|4720774|P4|Overall Study|Lack of Efficacy|0
1430416|NCT00979901|4720775|P3|Overall Study|Lack of Efficacy|9
1430417|NCT00979901|4720776|P2|Overall Study|Lack of Efficacy|4
1430418|NCT00979901|4720777|P1|Overall Study|Lack of Efficacy|8
1430419|NCT00979901|4720774|P4|Overall Study|Adverse Event|2
1430420|NCT00979901|4720775|P3|Overall Study|Adverse Event|9
1430421|NCT00979901|4720776|P2|Overall Study|Adverse Event|3
1430422|NCT00979901|4720777|P1|Overall Study|Adverse Event|1
1430423|NCT00979654|4720850|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
1430424|NCT00979654|4720850|P1|Overall Study|Serious Adverse Event|1
1430425|NCT00979654|4720850|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
1430426|NCT00979654|4720850|P1|Overall Study|Per Principal Investigator’s Discretion|1
1430427|NCT00979654|4720850|P1|Overall Study|Adverse Event of Diverticulitis|1
1430428|NCT00979654|4720850|P1|Overall Study|Adverse Event|1
1430429|NCT00979654|4720850|P1|Overall Study|Lack of Efficacy|6
1430430|NCT00979654|4720850|P1|Overall Study|Death|1
1430431|NCT00979654|4720850|P1|Overall Study|Withdrawal by Subject|22
1430432|NCT00979654|4720850|P1|Overall Study|Lost to Follow-up|1
1430433|NCT00979628|4720865|P3|Overall Study|transferred to ICU|1
1430434|NCT00979628|4720866|P2|Overall Study|transferred to ICU|2
1430435|NCT00979628|4720867|P1|Overall Study|transferred to ICU|1
1430436|NCT00979628|4720865|P3|Overall Study|received steroids|0
1430437|NCT00979628|4720866|P2|Overall Study|received steroids|1
1430438|NCT00979628|4720867|P1|Overall Study|received steroids|1
1430439|NCT00979628|4720865|P3|Overall Study|received regimen < 24 hours|5
1430440|NCT00979628|4720866|P2|Overall Study|received regimen < 24 hours|6
1430441|NCT00979628|4720867|P1|Overall Study|received regimen < 24 hours|7
1430442|NCT00979602|4720894|P2|Overall Study|Others|3
1430443|NCT00979602|4720895|P1|Overall Study|Others|3
1430444|NCT00979602|4720894|P2|Overall Study|Migrated/moved from study area|6
1430445|NCT00979602|4720895|P1|Overall Study|Migrated/moved from study area|3
1430446|NCT00979602|4720894|P2|Overall Study|Lost to Follow-up|96
1430447|NCT00979602|4720895|P1|Overall Study|Lost to Follow-up|100
1430448|NCT00979602|4720894|P2|Overall Study|Withdrawal by Subject|25
1430449|NCT00979602|4720895|P1|Overall Study|Withdrawal by Subject|31
1430450|NCT00979602|4720894|P2|Overall Study|Protocol Violation|0
1430451|NCT00979602|4720895|P1|Overall Study|Protocol Violation|3
1430452|NCT00979602|4720894|P2|Overall Study|Serious Adverse Event|3
1430453|NCT00979602|4720895|P1|Overall Study|Serious Adverse Event|5
1430454|NCT00979576|4721066|P3|Combination Followed by Monotherapy|Progressive Disease|1
1430455|NCT00979576|4721067|P2|Combination Followed by Monotherapy|Progressive Disease|2
1430456|NCT00979576|4721068|P1|Combination Followed by Monotherapy|Progressive Disease|0
1430457|NCT00979576|4721066|P3|Combination Treatment Phase|Adverse Event|2
1430458|NCT00979576|4721067|P2|Combination Treatment Phase|Adverse Event|2
1430459|NCT00979576|4721068|P1|Combination Treatment Phase|Adverse Event|0
1430460|NCT00979576|4721066|P3|Combination Treatment Phase|Dose limiting toxicity|2
1430461|NCT00979576|4721067|P2|Combination Treatment Phase|Dose limiting toxicity|3
1430462|NCT00979576|4721068|P1|Combination Treatment Phase|Dose limiting toxicity|0
1430463|NCT00979576|4721066|P3|Combination Treatment Phase|Progressive disease|5
1430464|NCT00979576|4721067|P2|Combination Treatment Phase|Progressive disease|1
1430465|NCT00979576|4721068|P1|Combination Treatment Phase|Progressive disease|3
1430466|NCT00979420|4721125|P4|Overall Study|Other reasons not related to Viramune|1
1430467|NCT00979420|4721126|P3|Overall Study|Other reasons not related to Viramune|0
1430468|NCT00979420|4721127|P2|Overall Study|Other reasons not related to Viramune|0
1430469|NCT00979420|4721128|P1|Overall Study|Other reasons not related to Viramune|3
1430470|NCT00979420|4721125|P4|Overall Study|Lack of Efficacy|1
1430471|NCT00979420|4721126|P3|Overall Study|Lack of Efficacy|1
1430472|NCT00979420|4721127|P2|Overall Study|Lack of Efficacy|0
1430473|NCT00979420|4721128|P1|Overall Study|Lack of Efficacy|3
1430474|NCT00979420|4721125|P4|Overall Study|Adverse Event|0
1430475|NCT00979420|4721126|P3|Overall Study|Adverse Event|0
1430476|NCT00979420|4721127|P2|Overall Study|Adverse Event|0
1430477|NCT00979420|4721128|P1|Overall Study|Adverse Event|1
1430478|NCT00979407|4721198|P2|Overall Study|Lost to Follow-up|3
1430479|NCT00979407|4721199|P1|Overall Study|Lost to Follow-up|3
1430480|NCT00979407|4721198|P2|Overall Study|Withdrawal by Subject|4
1430481|NCT00979407|4721199|P1|Overall Study|Withdrawal by Subject|3
1430482|NCT00979212|4721252|P2|Overall Study|No protocol therapy received|0
1430483|NCT00979212|4721253|P1|Overall Study|No protocol therapy received|1
1430484|NCT00979212|4721252|P2|Overall Study|Protocol Violation|8
1430485|NCT00979212|4721253|P1|Overall Study|Protocol Violation|1
1430486|NCT00978757|4721313|P2|Overall Study|Physician Decision|3
1430487|NCT00978757|4721314|P1|Overall Study|Physician Decision|1
1430488|NCT00978731|4721324|P4|Overall Study|No response|0
1430489|NCT00978731|4721325|P3|Overall Study|No response|0
1430490|NCT00978731|4721326|P2|Overall Study|No response|0
1430491|NCT00978731|4721327|P1|Overall Study|No response|1
1430492|NCT00978731|4721324|P4|Overall Study|Study closure|1
1430493|NCT00978731|4721325|P3|Overall Study|Study closure|1
1430494|NCT00978731|4721326|P2|Overall Study|Study closure|4
1430495|NCT00978731|4721327|P1|Overall Study|Study closure|3
1430496|NCT00978731|4721324|P4|Overall Study|Disease progression/relapse|2
1430497|NCT00978731|4721325|P3|Overall Study|Disease progression/relapse|2
1430498|NCT00978731|4721326|P2|Overall Study|Disease progression/relapse|4
1430499|NCT00978731|4721327|P1|Overall Study|Disease progression/relapse|5
1430500|NCT00978731|4721324|P4|Overall Study|Deterioration without progression|0
1430501|NCT00978731|4721325|P3|Overall Study|Deterioration without progression|0
1430502|NCT00978731|4721326|P2|Overall Study|Deterioration without progression|1
1430503|NCT00978731|4721327|P1|Overall Study|Deterioration without progression|0
1430504|NCT00978731|4721324|P4|Overall Study|Administrative reason|0
1430505|NCT00978731|4721325|P3|Overall Study|Administrative reason|1
1430506|NCT00978731|4721326|P2|Overall Study|Administrative reason|3
1430507|NCT00978731|4721327|P1|Overall Study|Administrative reason|3
1430508|NCT00978731|4721324|P4|Overall Study|Participant's request|0
1430509|NCT00978731|4721325|P3|Overall Study|Participant's request|0
1430510|NCT00978731|4721326|P2|Overall Study|Participant's request|0
1430511|NCT00978731|4721327|P1|Overall Study|Participant's request|1
1430512|NCT00978731|4721324|P4|Overall Study|Adverse Event|0
1430513|NCT00978731|4721325|P3|Overall Study|Adverse Event|0
1430514|NCT00978731|4721326|P2|Overall Study|Adverse Event|2
1430515|NCT00978731|4721327|P1|Overall Study|Adverse Event|5
1430516|NCT00978731|4721324|P4|Overall Study|Lost to Follow-up|1
1430517|NCT00978731|4721325|P3|Overall Study|Lost to Follow-up|0
1430518|NCT00978731|4721326|P2|Overall Study|Lost to Follow-up|0
1430519|NCT00978731|4721327|P1|Overall Study|Lost to Follow-up|0
1430520|NCT00978731|4721324|P4|Overall Study|Death|0
1430521|NCT00978731|4721325|P3|Overall Study|Death|1
1430522|NCT00978731|4721326|P2|Overall Study|Death|1
1430523|NCT00978731|4721327|P1|Overall Study|Death|4
1430524|NCT00978627|4721367|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
1430525|NCT00978627|4721368|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
1430526|NCT00978627|4721367|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
1430527|NCT00978627|4721368|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
1430528|NCT00978627|4721367|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
1430529|NCT00978627|4721368|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
1430530|NCT00978627|4721367|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
1430531|NCT00978627|4721368|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
1430532|NCT00978627|4721367|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
1430533|NCT00978627|4721368|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
1430534|NCT00978627|4721367|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
1430535|NCT00978627|4721368|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
1430536|NCT00978627|4721367|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
1430537|NCT00978627|4721368|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
1430538|NCT00978627|4721367|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
1430539|NCT00978627|4721368|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
1430540|NCT00978627|4721367|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
1430541|NCT00978627|4721368|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
1430542|NCT00978432|4721406|P3|Overall Study|Adverse Event|1
1430543|NCT00978432|4721407|P2|Overall Study|Adverse Event|0
1430544|NCT00978432|4721408|P1|Overall Study|Adverse Event|2
1430545|NCT00978432|4721406|P3|Overall Study|Lack of Efficacy|3
1430546|NCT00978432|4721407|P2|Overall Study|Lack of Efficacy|1
1430547|NCT00978432|4721408|P1|Overall Study|Lack of Efficacy|1
1430548|NCT00978432|4721406|P3|Overall Study|Withdrawal by Subject|1
1430549|NCT00978432|4721407|P2|Overall Study|Withdrawal by Subject|0
1430550|NCT00978432|4721408|P1|Overall Study|Withdrawal by Subject|0
1430551|NCT00978380|4721459|P1|Overall Study|Unclassified|8
1430552|NCT00978380|4721459|P1|Overall Study|Withdrawal criteria|9
1430553|NCT00978380|4721459|P1|Overall Study|Protocol Violation|2
1430554|NCT00978341|4721465|P2|Washout Period of 2 Weeks|Adverse Event|0
1430555|NCT00978341|4721466|P1|Washout Period of 2 Weeks|Adverse Event|1
1430556|NCT00978120|4721488|P4|Overall Study|Moved out of state|1
1430557|NCT00978120|4721489|P3|Overall Study|Moved out of state|0
1430558|NCT00978120|4721490|P2|Overall Study|Moved out of state|0
1430559|NCT00978120|4721491|P1|Overall Study|Moved out of state|0
1430560|NCT00978120|4721488|P4|Overall Study|Withdrawal by Subject|0
1430561|NCT00978120|4721489|P3|Overall Study|Withdrawal by Subject|0
1430562|NCT00978120|4721490|P2|Overall Study|Withdrawal by Subject|0
1430563|NCT00978120|4721491|P1|Overall Study|Withdrawal by Subject|2
1430564|NCT00978120|4721488|P4|Overall Study|Lost to Follow-up|0
1430565|NCT00978120|4721489|P3|Overall Study|Lost to Follow-up|3
1430566|NCT00978120|4721490|P2|Overall Study|Lost to Follow-up|0
1430567|NCT00978120|4721491|P1|Overall Study|Lost to Follow-up|0
1430568|NCT00978120|4721488|P4|Overall Study|Death|1
1430569|NCT00978120|4721489|P3|Overall Study|Death|0
1430570|NCT00978120|4721490|P2|Overall Study|Death|0
1430571|NCT00978120|4721491|P1|Overall Study|Death|0
1430572|NCT00978042|4721543|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
1430573|NCT00978042|4721544|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
1430574|NCT00978042|4721543|P2|Initial Treatment Period|Consent withdrawn|9
1430575|NCT00978042|4721544|P1|Initial Treatment Period|Consent withdrawn|22
1430576|NCT00978042|4721543|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
1430577|NCT00978042|4721544|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
1430578|NCT00978042|4721543|P2|Initial Treatment Period|Adverse Event|0
1430579|NCT00978042|4721544|P1|Initial Treatment Period|Adverse Event|2
1430580|NCT00978042|4721543|P2|Initial Treatment Period|Lost to Follow-up|3
1430581|NCT00978042|4721544|P1|Initial Treatment Period|Lost to Follow-up|21
1430582|NCT00978042|4721543|P2|Initial Treatment Period|Ineligibility|0
1430583|NCT00978042|4721544|P1|Initial Treatment Period|Ineligibility|1
1430584|NCT00978042|4721543|P2|Initial Treatment Period|Treated in Error|3
1430585|NCT00978042|4721544|P1|Initial Treatment Period|Treated in Error|0
1430586|NCT00978029|4721557|P3|Overall Study|Protocol Violation|0
1430587|NCT00978029|4721558|P2|Overall Study|Protocol Violation|1
1430588|NCT00978029|4721559|P1|Overall Study|Protocol Violation|0
1430589|NCT00978029|4721557|P3|Overall Study|Withdrawal by Subject|1
1430590|NCT00978029|4721558|P2|Overall Study|Withdrawal by Subject|0
1430591|NCT00978029|4721559|P1|Overall Study|Withdrawal by Subject|0
1430592|NCT00978029|4721557|P3|Overall Study|Adverse Event|5
1430593|NCT00978029|4721558|P2|Overall Study|Adverse Event|2
1430594|NCT00978029|4721559|P1|Overall Study|Adverse Event|1
1430595|NCT00977938|4721586|P4|Observation (30-33 mo. Post Procedure)|Other|0
1430596|NCT00977938|4721587|P3|Observation (30-33 mo. Post Procedure)|Other|0
1430597|NCT00977938|4721588|P2|Observation (30-33 mo. Post Procedure)|Other|4
1430598|NCT00977938|4721589|P1|Observation (30-33 mo. Post Procedure)|Other|8
1430599|NCT00977938|4721586|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
1430600|NCT00977938|4721587|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
1430601|NCT00977938|4721588|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
1430602|NCT00977938|4721589|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
1430603|NCT00977938|4721586|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
1430604|NCT00977938|4721587|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
1430605|NCT00977938|4721588|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
1430606|NCT00977938|4721589|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
1430607|NCT00977938|4721586|P4|Treatment (12-30 mo. Post Procedure)|Other|4
1430608|NCT00977938|4721587|P3|Treatment (12-30 mo. Post Procedure)|Other|3
1430609|NCT00977938|4721588|P2|Treatment (12-30 mo. Post Procedure)|Other|18
1430610|NCT00977938|4721589|P1|Treatment (12-30 mo. Post Procedure)|Other|17
1430611|NCT00977938|4721586|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
1430612|NCT00977938|4721587|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
1430613|NCT00977938|4721588|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
1430614|NCT00977938|4721589|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
1430615|NCT00977938|4721586|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
1430616|NCT00977938|4721587|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
1430617|NCT00977938|4721588|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
1430618|NCT00977938|4721589|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
1430619|NCT00977665|4721653|P2|Overall Study|Treatment failure|1
1430620|NCT00977665|4721654|P1|Overall Study|Treatment failure|0
1430621|NCT00977665|4721653|P2|Overall Study|Adverse Event|7
1430622|NCT00977665|4721654|P1|Overall Study|Adverse Event|14
1430623|NCT00977665|4721653|P2|Overall Study|Death|2
1430624|NCT00977665|4721654|P1|Overall Study|Death|3
1430625|NCT00977665|4721653|P2|Overall Study|Lost to Follow-up|0
1430626|NCT00977665|4721654|P1|Overall Study|Lost to Follow-up|1
1430627|NCT00977665|4721653|P2|Overall Study|Sponsor requested withdrawal|1
1430628|NCT00977665|4721654|P1|Overall Study|Sponsor requested withdrawal|0
1430629|NCT00977665|4721653|P2|Overall Study|Physician Decision|1
1430630|NCT00977665|4721654|P1|Overall Study|Physician Decision|2
1430631|NCT00977665|4721653|P2|Overall Study|Withdrawal by Subject|3
1430632|NCT00977665|4721654|P1|Overall Study|Withdrawal by Subject|1
1430633|NCT00977613|4721686|P1|Overall Study|Lost to Follow-up|16
1430634|NCT00977574|4721693|P3|Overall Study|Never Treated|4
1430635|NCT00977574|4721694|P2|Overall Study|Never Treated|2
1430636|NCT00977574|4721695|P1|Overall Study|Never Treated|4
1430637|NCT00977561|4721714|P2|Overall Study|Other|0
1430638|NCT00977561|4721715|P1|Overall Study|Other|2
1430639|NCT00977561|4721714|P2|Overall Study|Study terminated|2
1430640|NCT00977561|4721715|P1|Overall Study|Study terminated|0
1430641|NCT00977561|4721714|P2|Overall Study|Death|2
1430642|NCT00977561|4721715|P1|Overall Study|Death|3
1430643|NCT00977548|4721742|P1|Overall Study|Withdrawal by Subject|1
1430644|NCT00977548|4721742|P1|Overall Study|Adverse Event|8
1430645|NCT00977548|4721742|P1|Overall Study|Ineligible|4
1430646|NCT00977470|4721751|P2|Overall Study|Still on-study|0
1430647|NCT00977470|4721752|P1|Overall Study|Still on-study|2
1430648|NCT00977470|4721751|P2|Overall Study|prolonged recovery post-surgery|1
1430649|NCT00977470|4721752|P1|Overall Study|prolonged recovery post-surgery|0
1430650|NCT00977470|4721751|P2|Overall Study|clinical decline|1
1430651|NCT00977470|4721752|P1|Overall Study|clinical decline|0
1430652|NCT00977470|4721751|P2|Overall Study|Death|2
1430653|NCT00977470|4721752|P1|Overall Study|Death|0
1430654|NCT00977470|4721751|P2|Overall Study|Withdrawal by Subject|2
1430655|NCT00977470|4721752|P1|Overall Study|Withdrawal by Subject|0
1430656|NCT00977470|4721751|P2|Overall Study|Protocol Violation|0
1430657|NCT00977470|4721752|P1|Overall Study|Protocol Violation|1
1430658|NCT00977470|4721751|P2|Overall Study|Adverse Event|2
1430659|NCT00977470|4721752|P1|Overall Study|Adverse Event|1
1430660|NCT00977470|4721751|P2|Overall Study|Physician Decision|0
1430661|NCT00977470|4721752|P1|Overall Study|Physician Decision|2
1430662|NCT00977470|4721751|P2|Overall Study|Lack of Efficacy|30
1430663|NCT00977470|4721752|P1|Overall Study|Lack of Efficacy|32
1430664|NCT00977379|4721772|P2|Overall Study|Randomization Error|1
1430665|NCT00977379|4721773|P1|Overall Study|Randomization Error|0
1430666|NCT00977379|4721772|P2|Overall Study|Participant Moving House|1
1430667|NCT00977379|4721773|P1|Overall Study|Participant Moving House|0
1430668|NCT00977379|4721772|P2|Overall Study|Premature Study Termination|0
1430669|NCT00977379|4721773|P1|Overall Study|Premature Study Termination|4
1430670|NCT00977379|4721772|P2|Overall Study|Death|9
1430671|NCT00977379|4721773|P1|Overall Study|Death|7
1430672|NCT00977379|4721772|P2|Overall Study|Withdrawal by Subject|1
1430673|NCT00977379|4721773|P1|Overall Study|Withdrawal by Subject|1
1430674|NCT00977314|4721809|P2|Overall Study|Physician Decision|0
1430675|NCT00977314|4721810|P1|Overall Study|Physician Decision|1
1430676|NCT00977314|4721809|P2|Overall Study|Withdrawal by Subject|0
1430677|NCT00977314|4721810|P1|Overall Study|Withdrawal by Subject|1
1430678|NCT00977197|4721818|P2|Overall Study|Nonadherence|1
1430679|NCT00977197|4721819|P1|Overall Study|Nonadherence|1
1430680|NCT00977197|4721818|P2|Overall Study|Lost to Follow-up|3
1430681|NCT00977197|4721819|P1|Overall Study|Lost to Follow-up|1
1430682|NCT00977197|4721818|P2|Overall Study|Lack of Efficacy|0
1430683|NCT00977197|4721819|P1|Overall Study|Lack of Efficacy|1
1430684|NCT00977197|4721818|P2|Overall Study|Adverse Event|1
1430685|NCT00977197|4721819|P1|Overall Study|Adverse Event|3
1430686|NCT00977197|4721818|P2|Overall Study|Withdrawal by Subject|4
1430687|NCT00977197|4721819|P1|Overall Study|Withdrawal by Subject|3
1430688|NCT00977106|4721882|P2|Overall Study|Not specified|0
1430689|NCT00977106|4721883|P1|Overall Study|Not specified|1
1430690|NCT00977106|4721882|P2|Overall Study|Protocol Violation|1
1430691|NCT00977106|4721883|P1|Overall Study|Protocol Violation|0
1430692|NCT00977106|4721882|P2|Overall Study|Lack of Efficacy|2
1430693|NCT00977106|4721883|P1|Overall Study|Lack of Efficacy|2
1430694|NCT00977106|4721882|P2|Overall Study|Withdrawal by Subject|2
1430695|NCT00977106|4721883|P1|Overall Study|Withdrawal by Subject|2
1430696|NCT00977106|4721882|P2|Overall Study|Adverse Event|6
1430697|NCT00977106|4721883|P1|Overall Study|Adverse Event|5
1430698|NCT00977080|4721975|P4|Overall Study|Travel for family reasons|0
1430699|NCT00977080|4721976|P3|Overall Study|Travel for family reasons|0
1430700|NCT00977080|4721977|P2|Overall Study|Travel for family reasons|0
1430701|NCT00977080|4721978|P1|Overall Study|Travel for family reasons|1
1430702|NCT00977080|4721975|P4|Overall Study|Required kidney transplantation|1
1430703|NCT00977080|4721976|P3|Overall Study|Required kidney transplantation|3
1430704|NCT00977080|4721977|P2|Overall Study|Required kidney transplantation|3
1430705|NCT00977080|4721978|P1|Overall Study|Required kidney transplantation|1
1430706|NCT00977080|4721975|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
1430707|NCT00977080|4721976|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
1430708|NCT00977080|4721977|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
1430709|NCT00977080|4721978|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
1430710|NCT00977080|4721975|P4|Overall Study|Noncompliance|0
1430711|NCT00977080|4721976|P3|Overall Study|Noncompliance|1
1430712|NCT00977080|4721977|P2|Overall Study|Noncompliance|2
1430713|NCT00977080|4721978|P1|Overall Study|Noncompliance|0
1430714|NCT00977080|4721975|P4|Overall Study|Protocol Violation|3
1430715|NCT00977080|4721976|P3|Overall Study|Protocol Violation|4
1430716|NCT00977080|4721977|P2|Overall Study|Protocol Violation|3
1430717|NCT00977080|4721978|P1|Overall Study|Protocol Violation|7
1430718|NCT00977080|4721975|P4|Overall Study|Withdrawal by Subject|5
1430719|NCT00977080|4721976|P3|Overall Study|Withdrawal by Subject|1
1430720|NCT00977080|4721977|P2|Overall Study|Withdrawal by Subject|5
1430721|NCT00977080|4721978|P1|Overall Study|Withdrawal by Subject|1
1430722|NCT00977080|4721975|P4|Overall Study|Adverse Event|7
1430723|NCT00977080|4721976|P3|Overall Study|Adverse Event|7
1430724|NCT00977080|4721977|P2|Overall Study|Adverse Event|7
1430725|NCT00977080|4721978|P1|Overall Study|Adverse Event|2
1430726|NCT00976989|4722011|P3|Overall Study|Other|1
1430727|NCT00976989|4722012|P2|Overall Study|Other|0
1430728|NCT00976989|4722013|P1|Overall Study|Other|1
1430729|NCT00976989|4722011|P3|Overall Study|Recurrence of Disease|0
1430730|NCT00976989|4722012|P2|Overall Study|Recurrence of Disease|1
1430731|NCT00976989|4722013|P1|Overall Study|Recurrence of Disease|0
1430732|NCT00976989|4722011|P3|Overall Study|Failure to Return|0
1430733|NCT00976989|4722012|P2|Overall Study|Failure to Return|1
1430734|NCT00976989|4722013|P1|Overall Study|Failure to Return|2
1430735|NCT00976989|4722011|P3|Overall Study|Refused Treatment|5
1430736|NCT00976989|4722012|P2|Overall Study|Refused Treatment|3
1430737|NCT00976989|4722013|P1|Overall Study|Refused Treatment|4
1430738|NCT00976989|4722011|P3|Overall Study|Death|10
1430739|NCT00976989|4722012|P2|Overall Study|Death|7
1430740|NCT00976989|4722013|P1|Overall Study|Death|5
1430741|NCT00976989|4722011|P3|Overall Study|Violation of Selection Criteria at Entry|1
1430742|NCT00976989|4722012|P2|Overall Study|Violation of Selection Criteria at Entry|0
1430743|NCT00976989|4722013|P1|Overall Study|Violation of Selection Criteria at Entry|1
1430744|NCT00976950|4722054|P1|Overall Study|Events with no relationship to Aptivus|3
1430745|NCT00976950|4722054|P1|Overall Study|Adverse Event|3
1430746|NCT00976937|4722062|P2|Overall Study|Personal and Familial Reason|2
1430747|NCT00976937|4722063|P1|Overall Study|Personal and Familial Reason|2
1430748|NCT00976937|4722062|P2|Overall Study|Poor compliance to protocol|0
1430749|NCT00976937|4722063|P1|Overall Study|Poor compliance to protocol|3
1430750|NCT00976937|4722062|P2|Overall Study|Withdrawal by Subject|3
1430751|NCT00976937|4722063|P1|Overall Study|Withdrawal by Subject|5
1430752|NCT00976937|4722062|P2|Overall Study|Lost to Follow-up|1
1430753|NCT00976937|4722063|P1|Overall Study|Lost to Follow-up|2
1430754|NCT00976937|4722062|P2|Overall Study|Adverse Event|5
1430755|NCT00976937|4722063|P1|Overall Study|Adverse Event|4
1430756|NCT00976911|4722105|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
1430757|NCT00976911|4722106|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
1430758|NCT00976911|4722105|P2|Overall Study|Not Specified|9
1430759|NCT00976911|4722106|P1|Overall Study|Not Specified|8
1430760|NCT00976911|4722105|P2|Overall Study|Protocol Violation|0
1430761|NCT00976911|4722106|P1|Overall Study|Protocol Violation|2
1430762|NCT00976911|4722105|P2|Overall Study|Adverse Event|1
1430763|NCT00976911|4722106|P1|Overall Study|Adverse Event|0
1430764|NCT00976911|4722105|P2|Overall Study|Death|126
1430765|NCT00976911|4722106|P1|Overall Study|Death|138
1430766|NCT00976911|4722105|P2|Overall Study|Withdrawal by Subject|6
1430767|NCT00976911|4722106|P1|Overall Study|Withdrawal by Subject|4
1430768|NCT00976898|4722124|P1|Overall Study|Progressive Disease|1
1430769|NCT00976898|4722124|P1|Overall Study|Liver Transplant|1
1430770|NCT00976898|4722124|P1|Overall Study|Physician Decision|1
1430771|NCT00976898|4722124|P1|Overall Study|Adverse Event|1
1430772|NCT00976898|4722124|P1|Overall Study|Protocol Violation|1
1430773|NCT00976820|4722135|P4|Overall Study|Withdrawal by Subject|4
1430774|NCT00976820|4722136|P3|Overall Study|Withdrawal by Subject|1
1430775|NCT00976820|4722137|P2|Overall Study|Withdrawal by Subject|4
1430776|NCT00976820|4722138|P1|Overall Study|Withdrawal by Subject|2
1430777|NCT00976820|4722135|P4|Overall Study|Poor Compliance. Numerous Visits Booked|0
1430778|NCT00976820|4722136|P3|Overall Study|Poor Compliance. Numerous Visits Booked|1
1430779|NCT00976820|4722137|P2|Overall Study|Poor Compliance. Numerous Visits Booked|0
1430780|NCT00976820|4722138|P1|Overall Study|Poor Compliance. Numerous Visits Booked|1
1430781|NCT00976820|4722135|P4|Overall Study|Lost to Follow-up|3
1430782|NCT00976820|4722136|P3|Overall Study|Lost to Follow-up|2
1430783|NCT00976820|4722137|P2|Overall Study|Lost to Follow-up|16
1430784|NCT00976820|4722138|P1|Overall Study|Lost to Follow-up|5
1430785|NCT00976716|4722474|P1|Overall Study|Adverse Event|1
1430786|NCT00976703|4722492|P2|Overall Study|ineligible for study|2
1430787|NCT00976703|4722493|P1|Overall Study|ineligible for study|2
1430788|NCT00976703|4722492|P2|Overall Study|Physician Decision|1
1430789|NCT00976703|4722493|P1|Overall Study|Physician Decision|1
1430790|NCT00976677|4722507|P2|Overall Study|Unknown/Missing|0
1430791|NCT00976677|4722508|P1|Overall Study|Unknown/Missing|1
1430792|NCT00976677|4722507|P2|Overall Study|Trial unblinded|2
1430793|NCT00976677|4722508|P1|Overall Study|Trial unblinded|2
1430794|NCT00976677|4722507|P2|Overall Study|Disease progression|1
1430795|NCT00976677|4722508|P1|Overall Study|Disease progression|1
1430796|NCT00976677|4722507|P2|Overall Study|Withdrawal by Subject|2
1430797|NCT00976677|4722508|P1|Overall Study|Withdrawal by Subject|0
1430798|NCT00976677|4722507|P2|Overall Study|Adverse Event|0
1430799|NCT00976677|4722508|P1|Overall Study|Adverse Event|1
1430800|NCT00976573|4722716|P2|Overall Study|Cancel prior to receiving treatment|2
1430801|NCT00976573|4722717|P1|Overall Study|Cancel prior to receiving treatment|4
1430802|NCT00976573|4722716|P2|Overall Study|Ineligible|1
1430803|NCT00976573|4722717|P1|Overall Study|Ineligible|0
1430804|NCT00976560|4722731|P2|Overall Study|Withdrawal by Subject|3
1430805|NCT00976560|4722732|P1|Overall Study|Withdrawal by Subject|2
1430806|NCT00976560|4722731|P2|Overall Study|Physician Decision|0
1430807|NCT00976560|4722732|P1|Overall Study|Physician Decision|2
1430808|NCT00976560|4722731|P2|Overall Study|Lost to Follow-up|0
1430809|NCT00976560|4722732|P1|Overall Study|Lost to Follow-up|1
1430810|NCT00976560|4722731|P2|Overall Study|Protocol Violation|0
1430811|NCT00976560|4722732|P1|Overall Study|Protocol Violation|1
1430812|NCT00976560|4722731|P2|Overall Study|Lack of Efficacy|5
1430813|NCT00976560|4722732|P1|Overall Study|Lack of Efficacy|3
1430814|NCT00976560|4722731|P2|Overall Study|Adverse Event|5
1430815|NCT00976560|4722732|P1|Overall Study|Adverse Event|5
1430816|NCT00976508|4722801|P2|Overall Study|Terminated by the Sponsor|1
1430817|NCT00976508|4722802|P1|Overall Study|Terminated by the Sponsor|0
1430818|NCT00976508|4722801|P2|Overall Study|Subject Enrolled in Hospice|0
1430819|NCT00976508|4722802|P1|Overall Study|Subject Enrolled in Hospice|1
1430820|NCT00976508|4722801|P2|Overall Study|Disease Progression|4
1430821|NCT00976508|4722802|P1|Overall Study|Disease Progression|4
1430822|NCT00976508|4722801|P2|Overall Study|Withdrawal by Subject|0
1430823|NCT00976508|4722802|P1|Overall Study|Withdrawal by Subject|1
1430824|NCT00976508|4722801|P2|Overall Study|Lost to Follow-up|0
1430825|NCT00976508|4722802|P1|Overall Study|Lost to Follow-up|1
1430826|NCT00976508|4722801|P2|Overall Study|Death|1
1430827|NCT00976508|4722802|P1|Overall Study|Death|7
1430828|NCT00976495|4722835|P3|Overall Study|Withdrawal by Subject|0
1430829|NCT00976495|4722836|P2|Overall Study|Withdrawal by Subject|1
1430830|NCT00976495|4722837|P1|Overall Study|Withdrawal by Subject|0
1430831|NCT00976482|4722854|P1|Overall Study|Protocol Violation|5
1430832|NCT00976482|4722854|P1|Overall Study|Center terminated|1
1430833|NCT00976482|4722854|P1|Overall Study|Withdrawal by Subject|45
1430834|NCT00976482|4722854|P1|Overall Study|Death|208
1430835|NCT00976456|4722860|P2|Overall Study|screening failure, unknown|4
1430836|NCT00976456|4722861|P1|Overall Study|screening failure, unknown|11
1430837|NCT00976456|4722860|P2|Overall Study|Withdrawal by Subject|1
1430838|NCT00976456|4722861|P1|Overall Study|Withdrawal by Subject|3
1430839|NCT00976456|4722860|P2|Overall Study|Lack of Efficacy|2
1430840|NCT00976456|4722861|P1|Overall Study|Lack of Efficacy|5
1430841|NCT00976456|4722860|P2|Overall Study|Death|9
1430842|NCT00976456|4722861|P1|Overall Study|Death|7
1430843|NCT00976456|4722860|P2|Overall Study|Adverse Event|22
1430844|NCT00976456|4722861|P1|Overall Study|Adverse Event|17
1430845|NCT00976391|4722888|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
1430846|NCT00976391|4722889|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
1430847|NCT00976391|4722888|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
1430848|NCT00976391|4722889|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
1430849|NCT00976391|4722888|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
1430850|NCT00976391|4722889|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
1430851|NCT00976391|4722888|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
1430852|NCT00976391|4722889|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
1430853|NCT00976391|4722888|P2|Follow-up Period (8 Weeks)|Noncompliance|2
1430854|NCT00976391|4722889|P1|Follow-up Period (8 Weeks)|Noncompliance|2
1430855|NCT00976391|4722888|P2|Follow-up Period (8 Weeks)|Adverse Event|1
1430856|NCT00976391|4722889|P1|Follow-up Period (8 Weeks)|Adverse Event|3
1430857|NCT00976391|4722888|P2|Treatment Period (52 Weeks)|Pregnancy|0
1430858|NCT00976391|4722889|P1|Treatment Period (52 Weeks)|Pregnancy|1
1430859|NCT00976391|4722888|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
1430860|NCT00976391|4722889|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
1430861|NCT00976391|4722888|P2|Treatment Period (52 Weeks)|Physician Decision|1
1430862|NCT00976391|4722889|P1|Treatment Period (52 Weeks)|Physician Decision|1
1430863|NCT00976391|4722888|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
1430864|NCT00976391|4722889|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
1430865|NCT00976391|4722888|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
1430866|NCT00976391|4722889|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
1430867|NCT00976391|4722888|P2|Treatment Period (52 Weeks)|Noncompliance|4
1430868|NCT00976391|4722889|P1|Treatment Period (52 Weeks)|Noncompliance|4
1430869|NCT00976391|4722888|P2|Treatment Period (52 Weeks)|Protocol Violation|1
1430870|NCT00976391|4722889|P1|Treatment Period (52 Weeks)|Protocol Violation|1
1430871|NCT00976391|4722888|P2|Treatment Period (52 Weeks)|Adverse Event|2
1430872|NCT00976391|4722889|P1|Treatment Period (52 Weeks)|Adverse Event|16
1430873|NCT00976274|4722937|P2|Overall Study|Physician Decision|2
1430874|NCT00976274|4722938|P1|Overall Study|Physician Decision|1
1430875|NCT00976274|4722937|P2|Overall Study|Withdrawal by Subject|1
1430876|NCT00976274|4722938|P1|Overall Study|Withdrawal by Subject|1
1430877|NCT00976274|4722937|P2|Overall Study|Lost to Follow-up|5
1430878|NCT00976274|4722938|P1|Overall Study|Lost to Follow-up|5
1430879|NCT00976209|4722954|P2|Treatment Period 2|Lost to Follow-up|1
1430880|NCT00976209|4722955|P1|Treatment Period 2|Lost to Follow-up|0
1430881|NCT00976209|4722954|P2|Treatment Period 2|Withdrawal by Subject|1
1430882|NCT00976209|4722955|P1|Treatment Period 2|Withdrawal by Subject|0
1430883|NCT00976209|4722954|P2|Wash-out Period|Other|0
1430884|NCT00976209|4722955|P1|Wash-out Period|Other|1
1430885|NCT00976209|4722954|P2|Wash-out Period|Protocol Violation|0
1430886|NCT00976209|4722955|P1|Wash-out Period|Protocol Violation|1
1430887|NCT00976209|4722954|P2|Wash-out Period|Lost to Follow-up|0
1430888|NCT00976209|4722955|P1|Wash-out Period|Lost to Follow-up|1
1430889|NCT00976209|4722954|P2|Wash-out Period|Adverse Event|2
1430890|NCT00976209|4722955|P1|Wash-out Period|Adverse Event|1
1430891|NCT00976209|4722954|P2|Treatment Period 1|Other|1
1430892|NCT00976209|4722955|P1|Treatment Period 1|Other|0
1430893|NCT00976209|4722954|P2|Treatment Period 1|Lost to Follow-up|0
1430894|NCT00976209|4722955|P1|Treatment Period 1|Lost to Follow-up|2
1430895|NCT00976209|4722954|P2|Treatment Period 1|Protocol Violation|0
1430896|NCT00976209|4722955|P1|Treatment Period 1|Protocol Violation|1
1430897|NCT00976027|4722968|P2|Overall Study|Withdrawal by Subject|66
1430898|NCT00976027|4722969|P1|Overall Study|Withdrawal by Subject|107
1430899|NCT00976027|4722968|P2|Overall Study|Lost to Follow-up|103
1430900|NCT00976027|4722969|P1|Overall Study|Lost to Follow-up|208
1430901|NCT00976027|4722968|P2|Overall Study|Protocol Violation|27
1430902|NCT00976027|4722969|P1|Overall Study|Protocol Violation|60
1430903|NCT00976027|4722968|P2|Overall Study|Adverse Event|2
1430904|NCT00976027|4722969|P1|Overall Study|Adverse Event|0
1430905|NCT00976027|4722968|P2|Overall Study|Serious Adverse Event|17
1430906|NCT00976027|4722969|P1|Overall Study|Serious Adverse Event|36
1430907|NCT00975975|4722981|P1|Overall Study|Death|6
1430908|NCT00975923|4722989|P2|Overall Study|Withdrawal by Subject|1
1430909|NCT00975923|4722990|P1|Overall Study|Withdrawal by Subject|0
1430910|NCT00975806|4723001|P3|Overall Study|Physician decision and disease related|1
1430911|NCT00975806|4723002|P2|Overall Study|Physician decision and disease related|0
1430912|NCT00975806|4723003|P1|Overall Study|Physician decision and disease related|1
1430913|NCT00975806|4723001|P3|Overall Study|Death|0
1430914|NCT00975806|4723002|P2|Overall Study|Death|1
1430915|NCT00975806|4723003|P1|Overall Study|Death|0
1430916|NCT00975806|4723001|P3|Overall Study|Withdrawal by Subject|0
1430917|NCT00975806|4723002|P2|Overall Study|Withdrawal by Subject|0
1430918|NCT00975806|4723003|P1|Overall Study|Withdrawal by Subject|1
1430919|NCT00975806|4723001|P3|Overall Study|Disease Progression|1
1430920|NCT00975806|4723002|P2|Overall Study|Disease Progression|5
1430921|NCT00975806|4723003|P1|Overall Study|Disease Progression|1
1430922|NCT00975806|4723001|P3|Overall Study|Adverse Event|2
1430923|NCT00975806|4723002|P2|Overall Study|Adverse Event|1
1430924|NCT00975806|4723003|P1|Overall Study|Adverse Event|2
1430925|NCT00975780|4723027|P2|Follow Up|Discharged from Facility|12
1430926|NCT00975780|4723028|P1|Follow Up|Discharged from Facility|7
1430927|NCT00975780|4723027|P2|Follow Up|Facility Withdrawal|23
1430928|NCT00975780|4723028|P1|Follow Up|Facility Withdrawal|7
1430929|NCT00975780|4723027|P2|Follow Up|Death|122
1430930|NCT00975780|4723028|P1|Follow Up|Death|88
1430931|NCT00975715|4723038|P2|Maintenance Period|Adverse Event|1
1430932|NCT00975715|4723039|P1|Maintenance Period|Adverse Event|2
1430933|NCT00975715|4723038|P2|Titration Period|Protocol Violation|0
1430934|NCT00975715|4723039|P1|Titration Period|Protocol Violation|1
1430935|NCT00975715|4723038|P2|Titration Period|Adverse Event|0
1430936|NCT00975715|4723039|P1|Titration Period|Adverse Event|6
1430937|NCT00975689|4723055|P2|Overall Study|Physician Decision|0
1430938|NCT00975689|4723056|P1|Overall Study|Physician Decision|1
1430939|NCT00975689|4723055|P2|Overall Study|Withdrawal by Subject|0
1430940|NCT00975689|4723056|P1|Overall Study|Withdrawal by Subject|1
1430941|NCT00975689|4723055|P2|Overall Study|Adverse Event|3
1430942|NCT00975689|4723056|P1|Overall Study|Adverse Event|0
1430943|NCT00975611|4723125|P1|Overall Study|Physician Decision|1
1430944|NCT00975611|4723125|P1|Overall Study|Screen Fail|16
1430945|NCT00975585|4723131|P2|Overall Study|Lens issue|2
1430946|NCT00975585|4723132|P1|Overall Study|Lens issue|2
1430947|NCT00975585|4723131|P2|Overall Study|Withdrawal by Subject|1
1430948|NCT00975585|4723132|P1|Overall Study|Withdrawal by Subject|2
1430949|NCT00975585|4723131|P2|Overall Study|Lost to Follow-up|5
1430950|NCT00975585|4723132|P1|Overall Study|Lost to Follow-up|3
1430951|NCT00975585|4723131|P2|Overall Study|Adverse Event|4
1430952|NCT00975585|4723132|P1|Overall Study|Adverse Event|0
1430953|NCT00975507|4723152|P2|Overall Study|Withdrawal by Subject|3
1430954|NCT00975507|4723153|P1|Overall Study|Withdrawal by Subject|10
1430955|NCT00975507|4723152|P2|Overall Study|Protocol Violation|0
1430956|NCT00975507|4723153|P1|Overall Study|Protocol Violation|2
1430957|NCT00975507|4723152|P2|Overall Study|Lost to Follow-up|1
1430958|NCT00975507|4723153|P1|Overall Study|Lost to Follow-up|7
1430959|NCT00975507|4723152|P2|Overall Study|Adverse Event|0
1430960|NCT00975507|4723153|P1|Overall Study|Adverse Event|1
1430961|NCT00975481|4723173|P6|Fifth Intervention Period|Withdrawal by Subject|0
1430962|NCT00975481|4723174|P5|Fifth Intervention Period|Withdrawal by Subject|1
1430963|NCT00975481|4723175|P4|Fifth Intervention Period|Withdrawal by Subject|0
1430964|NCT00975481|4723176|P3|Fifth Intervention Period|Withdrawal by Subject|0
1430965|NCT00975481|4723177|P2|Fifth Intervention Period|Withdrawal by Subject|0
1430966|NCT00975481|4723178|P1|Fifth Intervention Period|Withdrawal by Subject|0
1430967|NCT00975481|4723173|P6|Fourth Intervention Period|Withdrawal by Subject|0
1430968|NCT00975481|4723174|P5|Fourth Intervention Period|Withdrawal by Subject|0
1430969|NCT00975481|4723175|P4|Fourth Intervention Period|Withdrawal by Subject|1
1430970|NCT00975481|4723176|P3|Fourth Intervention Period|Withdrawal by Subject|1
1430971|NCT00975481|4723177|P2|Fourth Intervention Period|Withdrawal by Subject|0
1430972|NCT00975481|4723178|P1|Fourth Intervention Period|Withdrawal by Subject|0
1430973|NCT00975481|4723173|P6|Second Intervention Period|Withdrawal by Subject|0
1430974|NCT00975481|4723174|P5|Second Intervention Period|Withdrawal by Subject|0
1430975|NCT00975481|4723175|P4|Second Intervention Period|Withdrawal by Subject|0
1430976|NCT00975481|4723176|P3|Second Intervention Period|Withdrawal by Subject|1
1430977|NCT00975481|4723177|P2|Second Intervention Period|Withdrawal by Subject|0
1430978|NCT00975481|4723178|P1|Second Intervention Period|Withdrawal by Subject|0
1430979|NCT00975481|4723173|P6|Second Intervention Period|Adverse Event|0
1430980|NCT00975481|4723174|P5|Second Intervention Period|Adverse Event|0
1430981|NCT00975481|4723175|P4|Second Intervention Period|Adverse Event|0
1430982|NCT00975481|4723176|P3|Second Intervention Period|Adverse Event|0
1430983|NCT00975481|4723177|P2|Second Intervention Period|Adverse Event|1
1430984|NCT00975481|4723178|P1|Second Intervention Period|Adverse Event|2
1430985|NCT00975416|4723278|P2|Overall Study|early discharge from tx|5
1430986|NCT00975416|4723279|P1|Overall Study|early discharge from tx|3
1430987|NCT00975286|4723288|P2|Overall Study|Sponsor Decision|2
1430988|NCT00975286|4723289|P1|Overall Study|Sponsor Decision|0
1430989|NCT00975286|4723288|P2|Overall Study|Poor Compliance to Protocol|2
1430990|NCT00975286|4723289|P1|Overall Study|Poor Compliance to Protocol|0
1430991|NCT00975286|4723288|P2|Overall Study|Familial and Personal Reasons|2
1430992|NCT00975286|4723289|P1|Overall Study|Familial and Personal Reasons|2
1430993|NCT00975286|4723288|P2|Overall Study|Withdrawal by Subject|2
1430994|NCT00975286|4723289|P1|Overall Study|Withdrawal by Subject|0
1430995|NCT00975286|4723288|P2|Overall Study|Protocol Violation|2
1430996|NCT00975286|4723289|P1|Overall Study|Protocol Violation|1
1430997|NCT00975286|4723288|P2|Overall Study|Adverse Event|19
1430998|NCT00975286|4723289|P1|Overall Study|Adverse Event|9
1430999|NCT00975221|4723321|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
1431000|NCT00975221|4723322|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
1431001|NCT00975221|4723321|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
1431002|NCT00975221|4723322|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
1431003|NCT00975221|4723321|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
1431004|NCT00975221|4723322|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
1431005|NCT00975221|4723321|P2|Titration Phase (Weeks 1-12)|Other|1
1431006|NCT00975221|4723322|P1|Titration Phase (Weeks 1-12)|Other|0
1431007|NCT00975221|4723321|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
1431008|NCT00975221|4723322|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
1431009|NCT00975221|4723321|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
1431010|NCT00975221|4723322|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
1431011|NCT00975195|4723338|P2|Overall Study|Not treated|2
1431012|NCT00975195|4723339|P1|Overall Study|Not treated|1
1431013|NCT00975195|4723338|P2|Overall Study|Other reason not defined above|33
1431014|NCT00975195|4723339|P1|Overall Study|Other reason not defined above|29
1431015|NCT00975195|4723338|P2|Overall Study|Withdrawal by Subject|61
1431016|NCT00975195|4723339|P1|Overall Study|Withdrawal by Subject|48
1431017|NCT00975195|4723338|P2|Overall Study|Lost to Follow-up|7
1431018|NCT00975195|4723339|P1|Overall Study|Lost to Follow-up|9
1431019|NCT00975195|4723338|P2|Overall Study|Protocol Violation|23
1431020|NCT00975195|4723339|P1|Overall Study|Protocol Violation|27
1431021|NCT00975195|4723338|P2|Overall Study|Lack of Efficacy|6
1431022|NCT00975195|4723339|P1|Overall Study|Lack of Efficacy|6
1431023|NCT00975195|4723338|P2|Overall Study|Adverse Event|101
1431024|NCT00975195|4723339|P1|Overall Study|Adverse Event|108
1431025|NCT00975156|4723399|P2|Overall Study|Protocol Violation|1
1431026|NCT00975156|4723400|P1|Overall Study|Protocol Violation|0
1431027|NCT00975143|4723412|P2|Overall Study|Details not available|4
1431028|NCT00975143|4723413|P1|Overall Study|Details not available|10
1431029|NCT00975143|4723412|P2|Overall Study|Physician Decision|2
1431030|NCT00975143|4723413|P1|Overall Study|Physician Decision|1
1431031|NCT00975143|4723412|P2|Overall Study|Non-compliance|8
1431032|NCT00975143|4723413|P1|Overall Study|Non-compliance|5
1431033|NCT00975143|4723412|P2|Overall Study|Lost to Follow-up|16
1431034|NCT00975143|4723413|P1|Overall Study|Lost to Follow-up|20
1431035|NCT00975143|4723412|P2|Overall Study|Withdrawal by Subject|15
1431036|NCT00975143|4723413|P1|Overall Study|Withdrawal by Subject|15
1431037|NCT00975143|4723412|P2|Overall Study|Adverse Event|15
1431038|NCT00975143|4723413|P1|Overall Study|Adverse Event|19
1431039|NCT00975130|4723423|P3|Study Part 2|Protocol Violation|1
1431040|NCT00975130|4723424|P2|Study Part 2|Protocol Violation|0
1431041|NCT00975130|4723425|P1|Study Part 2|Protocol Violation|0
1431042|NCT00975130|4723423|P3|Study Part 2|Administrative|0
1431043|NCT00975130|4723424|P2|Study Part 2|Administrative|1
1431044|NCT00975130|4723425|P1|Study Part 2|Administrative|0
1431045|NCT00975130|4723423|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
1431046|NCT00975130|4723424|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
1431047|NCT00975130|4723425|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
1431048|NCT00975130|4723423|P3|Study Part 2|Withdrew Consent|2
1431049|NCT00975130|4723424|P2|Study Part 2|Withdrew Consent|6
1431050|NCT00975130|4723425|P1|Study Part 2|Withdrew Consent|0
1431051|NCT00975130|4723423|P3|Study Part 2|Withdrawal by Subject|5
1431052|NCT00975130|4723424|P2|Study Part 2|Withdrawal by Subject|13
1431053|NCT00975130|4723425|P1|Study Part 2|Withdrawal by Subject|0
1431054|NCT00975130|4723423|P3|Study Part 2|Lost to Follow-up|1
1431055|NCT00975130|4723424|P2|Study Part 2|Lost to Follow-up|0
1431056|NCT00975130|4723425|P1|Study Part 2|Lost to Follow-up|0
1431057|NCT00975130|4723423|P3|Study Part 2|Adverse Event|7
1431058|NCT00975130|4723424|P2|Study Part 2|Adverse Event|14
1431059|NCT00975130|4723425|P1|Study Part 2|Adverse Event|0
1431060|NCT00975130|4723423|P3|Study Part 1|Withdrew Consent|0
1431061|NCT00975130|4723424|P2|Study Part 1|Withdrew Consent|0
1431062|NCT00975130|4723425|P1|Study Part 1|Withdrew Consent|24
1431063|NCT00975130|4723423|P3|Study Part 1|Administrative|0
1431064|NCT00975130|4723424|P2|Study Part 1|Administrative|0
1431065|NCT00975130|4723425|P1|Study Part 1|Administrative|4
1431066|NCT00975130|4723423|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
1431067|NCT00975130|4723424|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
1431068|NCT00975130|4723425|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
1431069|NCT00975130|4723423|P3|Study Part 1|Protocol Violation|0
1431070|NCT00975130|4723424|P2|Study Part 1|Protocol Violation|0
1431071|NCT00975130|4723425|P1|Study Part 1|Protocol Violation|13
1431072|NCT00975130|4723423|P3|Study Part 1|Withdrawal by Subject|0
1431073|NCT00975130|4723424|P2|Study Part 1|Withdrawal by Subject|0
1431074|NCT00975130|4723425|P1|Study Part 1|Withdrawal by Subject|61
1431075|NCT00975130|4723423|P3|Study Part 1|Lost to Follow-up|0
1431076|NCT00975130|4723424|P2|Study Part 1|Lost to Follow-up|0
1431077|NCT00975130|4723425|P1|Study Part 1|Lost to Follow-up|19
1431078|NCT00975130|4723423|P3|Study Part 1|Adverse Event|0
1431079|NCT00975130|4723424|P2|Study Part 1|Adverse Event|0
1431080|NCT00975130|4723425|P1|Study Part 1|Adverse Event|150
1431081|NCT00975000|4723609|P2|Overall Study|Non-compliance|1
1431082|NCT00975000|4723610|P1|Overall Study|Non-compliance|0
1431083|NCT00975000|4723609|P2|Overall Study|Protocol-specified Criteria|0
1431084|NCT00975000|4723610|P1|Overall Study|Protocol-specified Criteria|1
1431085|NCT00975000|4723609|P2|Overall Study|Lost to Follow-up|1
1431086|NCT00975000|4723610|P1|Overall Study|Lost to Follow-up|0
1431087|NCT00975000|4723609|P2|Overall Study|Withdrawal by Subject|2
1431088|NCT00975000|4723610|P1|Overall Study|Withdrawal by Subject|2
1431089|NCT00975000|4723609|P2|Overall Study|Adverse Event|1
1431090|NCT00975000|4723610|P1|Overall Study|Adverse Event|1
1431091|NCT00975000|4723609|P2|Overall Study|Other|0
1431092|NCT00975000|4723610|P1|Overall Study|Other|1
1431093|NCT00974974|4723634|P2|Maintenance - Double Blind Treatment|Various|0
1431094|NCT00974974|4723635|P1|Maintenance - Double Blind Treatment|Various|4
1431095|NCT00974974|4723634|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
1431096|NCT00974974|4723635|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
1431097|NCT00974974|4723634|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
1431098|NCT00974974|4723635|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
1431099|NCT00974974|4723634|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
1431100|NCT00974974|4723635|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
1431101|NCT00974974|4723634|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
1431102|NCT00974974|4723635|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
1431103|NCT00974974|4723634|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
1431104|NCT00974974|4723635|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
1431105|NCT00974974|4723634|P2|Maintenance - Double Blind Treatment|Adverse Event|3
1431106|NCT00974974|4723635|P1|Maintenance - Double Blind Treatment|Adverse Event|3
1431107|NCT00974974|4723634|P2|IPX066 Dose Conversion|Protocol Violation|0
1431108|NCT00974974|4723635|P1|IPX066 Dose Conversion|Protocol Violation|4
1431109|NCT00974974|4723634|P2|IPX066 Dose Conversion|Various|0
1431110|NCT00974974|4723635|P1|IPX066 Dose Conversion|Various|3
1431111|NCT00974974|4723634|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
1431112|NCT00974974|4723635|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
1431113|NCT00974974|4723634|P2|IPX066 Dose Conversion|Lack of Efficacy|0
1431114|NCT00974974|4723635|P1|IPX066 Dose Conversion|Lack of Efficacy|13
1431115|NCT00974974|4723634|P2|IPX066 Dose Conversion|Death|0
1431116|NCT00974974|4723635|P1|IPX066 Dose Conversion|Death|2
1431117|NCT00974974|4723634|P2|IPX066 Dose Conversion|Adverse Event|0
1431118|NCT00974974|4723635|P1|IPX066 Dose Conversion|Adverse Event|23
1431119|NCT00974974|4723634|P2|IR CD-LD Dose Adjustment|Various|9
1431120|NCT00974974|4723635|P1|IR CD-LD Dose Adjustment|Various|0
1431121|NCT00974974|4723634|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
1431122|NCT00974974|4723635|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
1431123|NCT00974974|4723634|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
1431124|NCT00974974|4723635|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
1431125|NCT00974974|4723634|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
1431126|NCT00974974|4723635|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
1431127|NCT00974974|4723634|P2|IR CD-LD Dose Adjustment|Adverse Event|3
1431128|NCT00974974|4723635|P1|IR CD-LD Dose Adjustment|Adverse Event|0
1431129|NCT00974922|4723645|P1|Overall Study|study terminated|24
1431130|NCT00974675|4723663|P4|Overall Study|Participant on holiday; unable to attend|1
1431131|NCT00974675|4723664|P3|Overall Study|Participant on holiday; unable to attend|0
1431132|NCT00974675|4723665|P2|Overall Study|Participant on holiday; unable to attend|0
1431133|NCT00974675|4723666|P1|Overall Study|Participant on holiday; unable to attend|0
1431134|NCT00974675|4723663|P4|Overall Study|Physician Decision|0
1431135|NCT00974675|4723664|P3|Overall Study|Physician Decision|1
1431136|NCT00974675|4723665|P2|Overall Study|Physician Decision|0
1431137|NCT00974675|4723666|P1|Overall Study|Physician Decision|0
1431138|NCT00974675|4723663|P4|Overall Study|Adverse Event|1
1431139|NCT00974675|4723664|P3|Overall Study|Adverse Event|1
1431140|NCT00974675|4723665|P2|Overall Study|Adverse Event|1
1431141|NCT00974675|4723666|P1|Overall Study|Adverse Event|2
1431142|NCT00974571|4723715|P3|Overall Study|Other|10
1431143|NCT00974571|4723716|P2|Overall Study|Other|0
1431144|NCT00974571|4723717|P1|Overall Study|Other|4
1431145|NCT00974571|4723715|P3|Overall Study|Patient Moved|1
1431146|NCT00974571|4723716|P2|Overall Study|Patient Moved|0
1431147|NCT00974571|4723717|P1|Overall Study|Patient Moved|1
1431148|NCT00974571|4723715|P3|Overall Study|Withdrawal by Subject|16
1431149|NCT00974571|4723716|P2|Overall Study|Withdrawal by Subject|5
1431150|NCT00974571|4723717|P1|Overall Study|Withdrawal by Subject|14
1431151|NCT00974571|4723715|P3|Overall Study|Protocol Violation|18
1431152|NCT00974571|4723716|P2|Overall Study|Protocol Violation|4
1431153|NCT00974571|4723717|P1|Overall Study|Protocol Violation|13
1431154|NCT00974571|4723715|P3|Overall Study|Lost to Follow-up|2
1431155|NCT00974571|4723716|P2|Overall Study|Lost to Follow-up|1
1431156|NCT00974571|4723717|P1|Overall Study|Lost to Follow-up|2
1431157|NCT00974571|4723715|P3|Overall Study|Lack of Efficacy|9
1431158|NCT00974571|4723716|P2|Overall Study|Lack of Efficacy|2
1431159|NCT00974571|4723717|P1|Overall Study|Lack of Efficacy|3
1431160|NCT00974571|4723715|P3|Overall Study|Adverse Event|27
1431161|NCT00974571|4723716|P2|Overall Study|Adverse Event|4
1431162|NCT00974571|4723717|P1|Overall Study|Adverse Event|31
1431163|NCT00974311|4723814|P2|Overall Study|Continuing Treatment|19
1431164|NCT00974311|4723815|P1|Overall Study|Continuing Treatment|231
1431165|NCT00974311|4723814|P2|Overall Study|Withdrawal of consent|5
1431166|NCT00974311|4723815|P1|Overall Study|Withdrawal of consent|9
1431167|NCT00974311|4723814|P2|Overall Study|Death|211
1431168|NCT00974311|4723815|P1|Overall Study|Death|305
1431169|NCT00974311|4723814|P2|Overall Study|Lost to Follow-up|1
1431170|NCT00974311|4723815|P1|Overall Study|Lost to Follow-up|1
1431171|NCT00974233|4723845|P1|Maintenance Lenalidomide|Adverse Event|8
1431172|NCT00974233|4723845|P1|Maintenance Lenalidomide|Lack of Efficacy|5
1431173|NCT00974233|4723845|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
1431174|NCT00974233|4723845|P1|Induction Chemoimmunotherapy|Adverse Event|7
1431175|NCT00974233|4723845|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
1431176|NCT00974233|4723845|P1|Induction Chemoimmunotherapy|Death|2
1431177|NCT00974220|4723860|P2|Treatment Period 1|noncompliant subjects|1
1431178|NCT00974220|4723861|P1|Treatment Period 1|noncompliant subjects|0
1431179|NCT00974220|4723860|P2|Treatment Period 1|Adverse Event|1
1431180|NCT00974220|4723861|P1|Treatment Period 1|Adverse Event|2
1431181|NCT00974090|4723906|P2|Period 2: Open-label Period|Withdrawal by Subject|0
1431182|NCT00974090|4723907|P1|Period 2: Open-label Period|Withdrawal by Subject|1
1431183|NCT00974090|4723906|P2|Period 2: Open-label Period|Physician Decision|3
1431184|NCT00974090|4723907|P1|Period 2: Open-label Period|Physician Decision|0
1431185|NCT00974090|4723906|P2|Period 2: Open-label Period|Lack of Efficacy|1
1431186|NCT00974090|4723907|P1|Period 2: Open-label Period|Lack of Efficacy|3
1431187|NCT00974090|4723906|P2|Period 2: Open-label Period|Adverse Event|6
1431188|NCT00974090|4723907|P1|Period 2: Open-label Period|Adverse Event|4
1431189|NCT00974090|4723906|P2|Period 1: Double Blind Period|Physician Decision|0
1431190|NCT00974090|4723907|P1|Period 1: Double Blind Period|Physician Decision|1
1431191|NCT00974090|4723906|P2|Period 1: Double Blind Period|Adverse Event|1
1431192|NCT00974090|4723907|P1|Period 1: Double Blind Period|Adverse Event|2
1431193|NCT00973921|4723941|P1|Overall Study|IVUS results were not available|9
1431194|NCT00973765|4723950|P2|Overall Study|Lost to Follow-up|14
1431195|NCT00973765|4723951|P1|Overall Study|Lost to Follow-up|8
1431196|NCT00973700|4723973|P5|Overall Study|Unable to Classify|1
1431197|NCT00973700|4723974|P4|Overall Study|Unable to Classify|2
1431198|NCT00973700|4723975|P3|Overall Study|Unable to Classify|1
1431199|NCT00973700|4723976|P2|Overall Study|Unable to Classify|0
1431200|NCT00973700|4723977|P1|Overall Study|Unable to Classify|0
1431201|NCT00973700|4723973|P5|Overall Study|Inappropriate enrolment|0
1431202|NCT00973700|4723974|P4|Overall Study|Inappropriate enrolment|4
1431203|NCT00973700|4723975|P3|Overall Study|Inappropriate enrolment|0
1431204|NCT00973700|4723976|P2|Overall Study|Inappropriate enrolment|0
1431205|NCT00973700|4723977|P1|Overall Study|Inappropriate enrolment|0
1431206|NCT00973700|4723973|P5|Overall Study|Lost to Follow-up|5
1431207|NCT00973700|4723974|P4|Overall Study|Lost to Follow-up|8
1431208|NCT00973700|4723975|P3|Overall Study|Lost to Follow-up|1
1431209|NCT00973700|4723976|P2|Overall Study|Lost to Follow-up|0
1431210|NCT00973700|4723977|P1|Overall Study|Lost to Follow-up|5
1431211|NCT00973700|4723973|P5|Overall Study|Withdrawal by Subject|4
1431212|NCT00973700|4723974|P4|Overall Study|Withdrawal by Subject|4
1431213|NCT00973700|4723975|P3|Overall Study|Withdrawal by Subject|8
1431214|NCT00973700|4723976|P2|Overall Study|Withdrawal by Subject|2
1431215|NCT00973700|4723977|P1|Overall Study|Withdrawal by Subject|2
1431216|NCT00973622|4724026|P2|Overall Study|did not complete rTMS sessions|2
1431217|NCT00973622|4724027|P1|Overall Study|did not complete rTMS sessions|11
1431218|NCT00973622|4724026|P2|Overall Study|did not pass MRI screen|0
1431219|NCT00973622|4724027|P1|Overall Study|did not pass MRI screen|6
1431220|NCT00973622|4724026|P2|Overall Study|did not attend MRI|3
1431221|NCT00973622|4724027|P1|Overall Study|did not attend MRI|14
1431222|NCT00973479|4724035|P2|Overall Study|Not Specified|7
1431223|NCT00973479|4724036|P1|Overall Study|Not Specified|1
1431224|NCT00973479|4724035|P2|Overall Study|Protocol Violation|2
1431225|NCT00973479|4724036|P1|Overall Study|Protocol Violation|2
1431226|NCT00973479|4724035|P2|Overall Study|Adverse Event|32
1431227|NCT00973479|4724036|P1|Overall Study|Adverse Event|12
1431228|NCT00973479|4724035|P2|Overall Study|Lack of Efficacy|7
1431229|NCT00973479|4724036|P1|Overall Study|Lack of Efficacy|5
1431230|NCT00973479|4724035|P2|Overall Study|Withdrawal by Subject|16
1431231|NCT00973479|4724036|P1|Overall Study|Withdrawal by Subject|15
1431232|NCT00973479|4724035|P2|Overall Study|Death|2
1431233|NCT00973479|4724036|P1|Overall Study|Death|2
1431234|NCT00973479|4724035|P2|Overall Study|Lost to Follow-up|3
1431235|NCT00973479|4724036|P1|Overall Study|Lost to Follow-up|0
1431236|NCT00973362|4724054|P2|3-Year Follow-up|Lost to Follow-up|0
1431237|NCT00973362|4724055|P1|3-Year Follow-up|Lost to Follow-up|17
1431238|NCT00973362|4724054|P2|Baseline Evaluation|Inevaluable|223
1431239|NCT00973362|4724055|P1|Baseline Evaluation|Inevaluable|686
1431240|NCT00973362|4724054|P2|Baseline Evaluation|No colposcopy visit|0
1431241|NCT00973362|4724055|P1|Baseline Evaluation|No colposcopy visit|62
1431242|NCT00973362|4724054|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
1431243|NCT00973362|4724055|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
1431244|NCT00973349|4724080|P16|Overall Study|Unable to classify|0
1431245|NCT00973349|4724081|P15|Overall Study|Unable to classify|0
1431246|NCT00973349|4724082|P14|Overall Study|Unable to classify|0
1431247|NCT00973349|4724083|P13|Overall Study|Unable to classify|0
1431248|NCT00973349|4724084|P12|Overall Study|Unable to classify|0
1431249|NCT00973349|4724085|P11|Overall Study|Unable to classify|0
1431250|NCT00973349|4724086|P10|Overall Study|Unable to classify|1
1431251|NCT00973349|4724087|P9|Overall Study|Unable to classify|0
1431252|NCT00973349|4724088|P8|Overall Study|Unable to classify|0
1431253|NCT00973349|4724089|P7|Overall Study|Unable to classify|0
1431254|NCT00973349|4724090|P6|Overall Study|Unable to classify|1
1431255|NCT00973349|4724091|P5|Overall Study|Unable to classify|1
1431256|NCT00973349|4724092|P4|Overall Study|Unable to classify|0
1431257|NCT00973349|4724093|P3|Overall Study|Unable to classify|0
1431258|NCT00973349|4724094|P2|Overall Study|Unable to classify|0
1431259|NCT00973349|4724095|P1|Overall Study|Unable to classify|0
1431260|NCT00973349|4724080|P16|Overall Study|Protocol Violation|0
1431261|NCT00973349|4724081|P15|Overall Study|Protocol Violation|0
1431262|NCT00973349|4724082|P14|Overall Study|Protocol Violation|0
1431263|NCT00973349|4724083|P13|Overall Study|Protocol Violation|0
1431264|NCT00973349|4724084|P12|Overall Study|Protocol Violation|0
1431265|NCT00973349|4724085|P11|Overall Study|Protocol Violation|0
1431266|NCT00973349|4724086|P10|Overall Study|Protocol Violation|0
1431267|NCT00973349|4724087|P9|Overall Study|Protocol Violation|1
1431268|NCT00973349|4724088|P8|Overall Study|Protocol Violation|0
1431269|NCT00973349|4724089|P7|Overall Study|Protocol Violation|0
1431270|NCT00973349|4724090|P6|Overall Study|Protocol Violation|0
1431271|NCT00973349|4724091|P5|Overall Study|Protocol Violation|0
1431272|NCT00973349|4724092|P4|Overall Study|Protocol Violation|0
1431273|NCT00973349|4724093|P3|Overall Study|Protocol Violation|0
1431274|NCT00973349|4724094|P2|Overall Study|Protocol Violation|0
1431275|NCT00973349|4724095|P1|Overall Study|Protocol Violation|0
1431276|NCT00973349|4724080|P16|Overall Study|Inappropriate enrolment|1
1431277|NCT00973349|4724081|P15|Overall Study|Inappropriate enrolment|1
1431278|NCT00973349|4724082|P14|Overall Study|Inappropriate enrolment|0
1431279|NCT00973349|4724083|P13|Overall Study|Inappropriate enrolment|1
1431280|NCT00973349|4724084|P12|Overall Study|Inappropriate enrolment|0
1431281|NCT00973349|4724085|P11|Overall Study|Inappropriate enrolment|0
1431282|NCT00973349|4724086|P10|Overall Study|Inappropriate enrolment|2
1431283|NCT00973349|4724087|P9|Overall Study|Inappropriate enrolment|0
1431284|NCT00973349|4724088|P8|Overall Study|Inappropriate enrolment|0
1431285|NCT00973349|4724089|P7|Overall Study|Inappropriate enrolment|0
1431286|NCT00973349|4724090|P6|Overall Study|Inappropriate enrolment|0
1431287|NCT00973349|4724091|P5|Overall Study|Inappropriate enrolment|0
1431288|NCT00973349|4724092|P4|Overall Study|Inappropriate enrolment|0
1431289|NCT00973349|4724093|P3|Overall Study|Inappropriate enrolment|1
1431290|NCT00973349|4724094|P2|Overall Study|Inappropriate enrolment|0
1431291|NCT00973349|4724095|P1|Overall Study|Inappropriate enrolment|0
1431292|NCT00973349|4724080|P16|Overall Study|Lost to Follow-up|1
1431293|NCT00973349|4724081|P15|Overall Study|Lost to Follow-up|0
1431294|NCT00973349|4724082|P14|Overall Study|Lost to Follow-up|0
1431295|NCT00973349|4724083|P13|Overall Study|Lost to Follow-up|0
1431296|NCT00973349|4724084|P12|Overall Study|Lost to Follow-up|1
1431297|NCT00973349|4724085|P11|Overall Study|Lost to Follow-up|0
1431298|NCT00973349|4724086|P10|Overall Study|Lost to Follow-up|1
1431299|NCT00973349|4724087|P9|Overall Study|Lost to Follow-up|2
1431300|NCT00973349|4724088|P8|Overall Study|Lost to Follow-up|1
1431301|NCT00973349|4724089|P7|Overall Study|Lost to Follow-up|0
1431302|NCT00973349|4724090|P6|Overall Study|Lost to Follow-up|3
1431303|NCT00973349|4724091|P5|Overall Study|Lost to Follow-up|1
1431304|NCT00973349|4724092|P4|Overall Study|Lost to Follow-up|2
1431305|NCT00973349|4724093|P3|Overall Study|Lost to Follow-up|2
1431306|NCT00973349|4724094|P2|Overall Study|Lost to Follow-up|1
1431307|NCT00973349|4724095|P1|Overall Study|Lost to Follow-up|3
1431308|NCT00973349|4724080|P16|Overall Study|Withdrawal by Subject|0
1431309|NCT00973349|4724081|P15|Overall Study|Withdrawal by Subject|0
1431310|NCT00973349|4724082|P14|Overall Study|Withdrawal by Subject|0
1431311|NCT00973349|4724083|P13|Overall Study|Withdrawal by Subject|0
1431312|NCT00973349|4724084|P12|Overall Study|Withdrawal by Subject|1
1431313|NCT00973349|4724085|P11|Overall Study|Withdrawal by Subject|0
1431314|NCT00973349|4724086|P10|Overall Study|Withdrawal by Subject|2
1431315|NCT00973349|4724087|P9|Overall Study|Withdrawal by Subject|0
1431316|NCT00973349|4724088|P8|Overall Study|Withdrawal by Subject|2
1431317|NCT00973349|4724089|P7|Overall Study|Withdrawal by Subject|2
1431318|NCT00973349|4724090|P6|Overall Study|Withdrawal by Subject|0
1431319|NCT00973349|4724091|P5|Overall Study|Withdrawal by Subject|2
1431320|NCT00973349|4724092|P4|Overall Study|Withdrawal by Subject|3
1431321|NCT00973349|4724093|P3|Overall Study|Withdrawal by Subject|2
1431322|NCT00973349|4724094|P2|Overall Study|Withdrawal by Subject|2
1431323|NCT00973349|4724095|P1|Overall Study|Withdrawal by Subject|1
1431324|NCT00973349|4724080|P16|Overall Study|Adverse Event|0
1431325|NCT00973349|4724081|P15|Overall Study|Adverse Event|1
1431326|NCT00973349|4724082|P14|Overall Study|Adverse Event|0
1431327|NCT00973349|4724083|P13|Overall Study|Adverse Event|0
1431328|NCT00973349|4724084|P12|Overall Study|Adverse Event|0
1431329|NCT00973349|4724085|P11|Overall Study|Adverse Event|0
1431330|NCT00973349|4724086|P10|Overall Study|Adverse Event|0
1431331|NCT00973349|4724087|P9|Overall Study|Adverse Event|1
1431332|NCT00973349|4724088|P8|Overall Study|Adverse Event|0
1431333|NCT00973349|4724089|P7|Overall Study|Adverse Event|0
1431334|NCT00973349|4724090|P6|Overall Study|Adverse Event|0
1431335|NCT00973349|4724091|P5|Overall Study|Adverse Event|1
1431336|NCT00973349|4724092|P4|Overall Study|Adverse Event|0
1431337|NCT00973349|4724093|P3|Overall Study|Adverse Event|0
1431338|NCT00973349|4724094|P2|Overall Study|Adverse Event|0
1431339|NCT00973349|4724095|P1|Overall Study|Adverse Event|0
1431340|NCT00972816|4724216|P8|Overall Study|Unable to classify|0
1431341|NCT00972816|4724217|P7|Overall Study|Unable to classify|0
1431342|NCT00972816|4724218|P6|Overall Study|Unable to classify|0
1431343|NCT00972816|4724219|P5|Overall Study|Unable to classify|1
1431344|NCT00972816|4724220|P4|Overall Study|Unable to classify|0
1431345|NCT00972816|4724221|P3|Overall Study|Unable to classify|0
1431346|NCT00972816|4724222|P2|Overall Study|Unable to classify|0
1431347|NCT00972816|4724223|P1|Overall Study|Unable to classify|2
1431348|NCT00972816|4724216|P8|Overall Study|Inappropriate enrolment|0
1431349|NCT00972816|4724217|P7|Overall Study|Inappropriate enrolment|2
1431350|NCT00972816|4724218|P6|Overall Study|Inappropriate enrolment|0
1431351|NCT00972816|4724219|P5|Overall Study|Inappropriate enrolment|0
1431352|NCT00972816|4724220|P4|Overall Study|Inappropriate enrolment|0
1431353|NCT00972816|4724221|P3|Overall Study|Inappropriate enrolment|0
1431354|NCT00972816|4724222|P2|Overall Study|Inappropriate enrolment|0
1431355|NCT00972816|4724223|P1|Overall Study|Inappropriate enrolment|0
1431356|NCT00972816|4724216|P8|Overall Study|Lost to Follow-up|7
1431357|NCT00972816|4724217|P7|Overall Study|Lost to Follow-up|7
1431358|NCT00972816|4724218|P6|Overall Study|Lost to Follow-up|10
1431359|NCT00972816|4724219|P5|Overall Study|Lost to Follow-up|11
1431360|NCT00972816|4724220|P4|Overall Study|Lost to Follow-up|5
1431361|NCT00972816|4724221|P3|Overall Study|Lost to Follow-up|7
1431362|NCT00972816|4724222|P2|Overall Study|Lost to Follow-up|9
1431363|NCT00972816|4724223|P1|Overall Study|Lost to Follow-up|11
1431364|NCT00972816|4724216|P8|Overall Study|Withdrawal by Subject|2
1431365|NCT00972816|4724217|P7|Overall Study|Withdrawal by Subject|1
1431366|NCT00972816|4724218|P6|Overall Study|Withdrawal by Subject|1
1431367|NCT00972816|4724219|P5|Overall Study|Withdrawal by Subject|0
1431368|NCT00972816|4724220|P4|Overall Study|Withdrawal by Subject|3
1431369|NCT00972816|4724221|P3|Overall Study|Withdrawal by Subject|1
1431370|NCT00972816|4724222|P2|Overall Study|Withdrawal by Subject|2
1431371|NCT00972816|4724223|P1|Overall Study|Withdrawal by Subject|4
1431372|NCT00972816|4724216|P8|Overall Study|Adverse Event|0
1431373|NCT00972816|4724217|P7|Overall Study|Adverse Event|0
1431374|NCT00972816|4724218|P6|Overall Study|Adverse Event|0
1431375|NCT00972816|4724219|P5|Overall Study|Adverse Event|0
1431376|NCT00972816|4724220|P4|Overall Study|Adverse Event|0
1431377|NCT00972816|4724221|P3|Overall Study|Adverse Event|1
1431378|NCT00972816|4724222|P2|Overall Study|Adverse Event|0
1431379|NCT00972816|4724223|P1|Overall Study|Adverse Event|0
1431380|NCT00972777|4724307|P2|Overall Study|Missed visit|0
1431381|NCT00972777|4724308|P1|Overall Study|Missed visit|1
1431382|NCT00972777|4724307|P2|Overall Study|Screening Failure|1
1431383|NCT00972777|4724308|P1|Overall Study|Screening Failure|2
1431384|NCT00972777|4724307|P2|Overall Study|Protocol Violation|2
1431385|NCT00972777|4724308|P1|Overall Study|Protocol Violation|0
1431386|NCT00972777|4724307|P2|Overall Study|Physician Decision|0
1431387|NCT00972777|4724308|P1|Overall Study|Physician Decision|4
1431388|NCT00972777|4724307|P2|Overall Study|Withdrawal by Subject|5
1431389|NCT00972777|4724308|P1|Overall Study|Withdrawal by Subject|4
1431390|NCT00972777|4724307|P2|Overall Study|Lost to Follow-up|4
1431391|NCT00972777|4724308|P1|Overall Study|Lost to Follow-up|0
1431392|NCT00972777|4724307|P2|Overall Study|Adverse Event|2
1431393|NCT00972777|4724308|P1|Overall Study|Adverse Event|3
1431394|NCT00972738|4724323|P3|Overall Study|Other|1
1431395|NCT00972738|4724324|P2|Overall Study|Other|2
1431396|NCT00972738|4724325|P1|Overall Study|Other|1
1431397|NCT00972738|4724323|P3|Overall Study|Moved|1
1431398|NCT00972738|4724324|P2|Overall Study|Moved|0
1431399|NCT00972738|4724325|P1|Overall Study|Moved|0
1431400|NCT00972738|4724323|P3|Overall Study|Withdrawal by Subject|4
1431401|NCT00972738|4724324|P2|Overall Study|Withdrawal by Subject|1
1431402|NCT00972738|4724325|P1|Overall Study|Withdrawal by Subject|5
1431403|NCT00972738|4724323|P3|Overall Study|Lack of Efficacy|11
1431404|NCT00972738|4724324|P2|Overall Study|Lack of Efficacy|1
1431405|NCT00972738|4724325|P1|Overall Study|Lack of Efficacy|5
1431406|NCT00972738|4724323|P3|Overall Study|Lost to Follow-up|1
1431407|NCT00972738|4724324|P2|Overall Study|Lost to Follow-up|0
1431408|NCT00972738|4724325|P1|Overall Study|Lost to Follow-up|1
1431409|NCT00972738|4724323|P3|Overall Study|Protocol Violation|3
1431410|NCT00972738|4724324|P2|Overall Study|Protocol Violation|1
1431411|NCT00972738|4724325|P1|Overall Study|Protocol Violation|2
1431412|NCT00972738|4724323|P3|Overall Study|Adverse Event|8
1431413|NCT00972738|4724324|P2|Overall Study|Adverse Event|1
1431414|NCT00972738|4724325|P1|Overall Study|Adverse Event|7
1431415|NCT00972595|4724442|P2|Period 1|Adverse Event|0
1431416|NCT00972595|4724443|P1|Period 1|Adverse Event|1
1431417|NCT00972543|4724453|P2|Overall Study|Early study termination by sponsor|1
1431418|NCT00972543|4724454|P1|Overall Study|Early study termination by sponsor|4
1431419|NCT00972543|4724453|P2|Overall Study|Adverse Event|0
1431420|NCT00972543|4724454|P1|Overall Study|Adverse Event|1
1431421|NCT00972504|4724537|P1|Overall Study|Investigator discretion|1
1431422|NCT00972504|4724537|P1|Overall Study|Adverse Event|2
1431423|NCT00972478|4724569|P2|Overall Study|Not start protocol treatment|2
1431424|NCT00972478|4724570|P1|Overall Study|Not start protocol treatment|1
1431425|NCT00972478|4724569|P2|Overall Study|Ineligible|7
1431426|NCT00972478|4724570|P1|Overall Study|Ineligible|1
1431427|NCT00972478|4724569|P2|Overall Study|Not protocol specified|1
1431428|NCT00972478|4724570|P1|Overall Study|Not protocol specified|1
1431429|NCT00972478|4724569|P2|Overall Study|Death|2
1431430|NCT00972478|4724570|P1|Overall Study|Death|0
1431431|NCT00972478|4724569|P2|Overall Study|Progression/Relapse|2
1431432|NCT00972478|4724570|P1|Overall Study|Progression/Relapse|0
1431433|NCT00972478|4724569|P2|Overall Study|Withdrawal by Subject|8
1431434|NCT00972478|4724570|P1|Overall Study|Withdrawal by Subject|1
1431435|NCT00972478|4724569|P2|Overall Study|Adverse Event|16
1431436|NCT00972478|4724570|P1|Overall Study|Adverse Event|3
1431437|NCT00972322|4724615|P2|Overall Study|Consistently high glucose values|0
1431438|NCT00972322|4724616|P1|Overall Study|Consistently high glucose values|1
1431439|NCT00972322|4724615|P2|Overall Study|Lost to Follow-up|1
1431440|NCT00972322|4724616|P1|Overall Study|Lost to Follow-up|0
1431441|NCT00972322|4724615|P2|Overall Study|Positive drug screen|1
1431442|NCT00972322|4724616|P1|Overall Study|Positive drug screen|0
1431443|NCT00972322|4724615|P2|Overall Study|Adverse Event|1
1431444|NCT00972322|4724616|P1|Overall Study|Adverse Event|2
1431445|NCT00972283|4724628|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
1431446|NCT00972283|4724629|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
1431447|NCT00972283|4724628|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
1431448|NCT00972283|4724629|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
1431449|NCT00972283|4724628|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
1431450|NCT00972283|4724629|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
1431451|NCT00972283|4724628|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
1431452|NCT00972283|4724629|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
1431453|NCT00972283|4724628|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
1431454|NCT00972283|4724629|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
1431455|NCT00972283|4724628|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
1431456|NCT00972283|4724629|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
1431457|NCT00972283|4724628|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
1431458|NCT00972283|4724629|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
1431459|NCT00972283|4724628|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
1431460|NCT00972283|4724629|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
1431461|NCT00972283|4724628|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
1431462|NCT00972283|4724629|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
1431463|NCT00972283|4724628|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
1431464|NCT00972283|4724629|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
1431465|NCT00972244|4724656|P5|Overall Study|Various|2
1431466|NCT00972244|4724657|P4|Overall Study|Various|0
1431467|NCT00972244|4724658|P3|Overall Study|Various|0
1431468|NCT00972244|4724659|P2|Overall Study|Various|0
1431469|NCT00972244|4724660|P1|Overall Study|Various|0
1431470|NCT00972244|4724656|P5|Overall Study|Death|0
1431471|NCT00972244|4724657|P4|Overall Study|Death|0
1431472|NCT00972244|4724658|P3|Overall Study|Death|0
1431473|NCT00972244|4724659|P2|Overall Study|Death|0
1431474|NCT00972244|4724660|P1|Overall Study|Death|1
1431475|NCT00972244|4724656|P5|Overall Study|Safety|1
1431476|NCT00972244|4724657|P4|Overall Study|Safety|0
1431477|NCT00972244|4724658|P3|Overall Study|Safety|0
1431478|NCT00972244|4724659|P2|Overall Study|Safety|0
1431479|NCT00972244|4724660|P1|Overall Study|Safety|0
1431480|NCT00972244|4724656|P5|Overall Study|Withdrawal by Subject|1
1431481|NCT00972244|4724657|P4|Overall Study|Withdrawal by Subject|0
1431482|NCT00972244|4724658|P3|Overall Study|Withdrawal by Subject|1
1431483|NCT00972244|4724659|P2|Overall Study|Withdrawal by Subject|2
1431484|NCT00972244|4724660|P1|Overall Study|Withdrawal by Subject|1
1431485|NCT00972244|4724656|P5|Overall Study|Subject No Longer Meets Study Criteria|5
1431486|NCT00972244|4724657|P4|Overall Study|Subject No Longer Meets Study Criteria|0
1431487|NCT00972244|4724658|P3|Overall Study|Subject No Longer Meets Study Criteria|0
1431488|NCT00972244|4724659|P2|Overall Study|Subject No Longer Meets Study Criteria|2
1431489|NCT00972244|4724660|P1|Overall Study|Subject No Longer Meets Study Criteria|2
1431490|NCT00972244|4724656|P5|Overall Study|Adverse Event|0
1431491|NCT00972244|4724657|P4|Overall Study|Adverse Event|0
1431492|NCT00972244|4724658|P3|Overall Study|Adverse Event|1
1431493|NCT00972244|4724659|P2|Overall Study|Adverse Event|1
1431494|NCT00972244|4724660|P1|Overall Study|Adverse Event|0
1431495|NCT00972244|4724656|P5|Overall Study|Incorrect Enrolment|0
1431496|NCT00972244|4724657|P4|Overall Study|Incorrect Enrolment|0
1431497|NCT00972244|4724658|P3|Overall Study|Incorrect Enrolment|0
1431498|NCT00972244|4724659|P2|Overall Study|Incorrect Enrolment|0
1431499|NCT00972244|4724660|P1|Overall Study|Incorrect Enrolment|1
1431500|NCT00972153|4724692|P3|Overall Study|Equipment malfunction during case|0
1431501|NCT00972153|4724693|P2|Overall Study|Equipment malfunction during case|1
1431502|NCT00972153|4724694|P1|Overall Study|Equipment malfunction during case|0
1431503|NCT00972023|4724709|P1|Overall Study|Withdrawal by Subject|1
1431504|NCT00971997|4724716|P1|Overall Study|Physician Decision|7
1431505|NCT00971997|4724716|P1|Overall Study|Withdrawal by Subject|5
1431506|NCT00971997|4724716|P1|Overall Study|Protocol Violation|4
1431507|NCT00971997|4724716|P1|Overall Study|Death|1
1431508|NCT00971997|4724716|P1|Overall Study|Adverse Event|2
1431509|NCT00971932|4724734|P1|Overall Study|Ongoing|4
1431510|NCT00971932|4724734|P1|Overall Study|Investigator's decision|2
1431511|NCT00971932|4724734|P1|Overall Study|Withdrawal by Subject|1
1431512|NCT00971425|4724814|P2|Overall Study|Withdrawal by Subject|1
1431513|NCT00971425|4724815|P1|Overall Study|Withdrawal by Subject|0
1431514|NCT00971425|4724814|P2|Overall Study|Adverse Event|1
1431515|NCT00971425|4724815|P1|Overall Study|Adverse Event|1
1431516|NCT00971243|4724879|P5|Open-label Period|Other reason|2
1431517|NCT00971243|4724880|P4|Open-label Period|Other reason|0
1431518|NCT00971243|4724881|P3|Open-label Period|Other reason|0
1431519|NCT00971243|4724882|P2|Open-label Period|Other reason|0
1431520|NCT00971243|4724883|P1|Open-label Period|Other reason|0
1431521|NCT00971243|4724879|P5|Open-label Period|Withdrawal by Subject|1
1431522|NCT00971243|4724880|P4|Open-label Period|Withdrawal by Subject|2
1431523|NCT00971243|4724881|P3|Open-label Period|Withdrawal by Subject|0
1431524|NCT00971243|4724882|P2|Open-label Period|Withdrawal by Subject|0
1431525|NCT00971243|4724883|P1|Open-label Period|Withdrawal by Subject|1
1431526|NCT00971243|4724879|P5|Open-label Period|Protocol Violation|1
1431527|NCT00971243|4724880|P4|Open-label Period|Protocol Violation|0
1431528|NCT00971243|4724881|P3|Open-label Period|Protocol Violation|1
1431529|NCT00971243|4724882|P2|Open-label Period|Protocol Violation|1
1431530|NCT00971243|4724883|P1|Open-label Period|Protocol Violation|1
1431531|NCT00971243|4724879|P5|Open-label Period|Physician Decision|2
1431532|NCT00971243|4724880|P4|Open-label Period|Physician Decision|7
1431533|NCT00971243|4724881|P3|Open-label Period|Physician Decision|3
1431534|NCT00971243|4724882|P2|Open-label Period|Physician Decision|9
1431535|NCT00971243|4724883|P1|Open-label Period|Physician Decision|5
1431536|NCT00971243|4724879|P5|Open-label Period|Adverse Event|0
1431537|NCT00971243|4724880|P4|Open-label Period|Adverse Event|1
1431538|NCT00971243|4724881|P3|Open-label Period|Adverse Event|1
1431539|NCT00971243|4724882|P2|Open-label Period|Adverse Event|0
1431540|NCT00971243|4724883|P1|Open-label Period|Adverse Event|1
1431541|NCT00971243|4724879|P5|Double Blind Period|Other reasons|1
1431542|NCT00971243|4724880|P4|Double Blind Period|Other reasons|0
1431543|NCT00971243|4724881|P3|Double Blind Period|Other reasons|2
1431544|NCT00971243|4724882|P2|Double Blind Period|Other reasons|0
1431545|NCT00971243|4724883|P1|Double Blind Period|Other reasons|1
1431546|NCT00971243|4724879|P5|Double Blind Period|Withdrawal by Subject|4
1431547|NCT00971243|4724880|P4|Double Blind Period|Withdrawal by Subject|4
1431548|NCT00971243|4724881|P3|Double Blind Period|Withdrawal by Subject|4
1431549|NCT00971243|4724882|P2|Double Blind Period|Withdrawal by Subject|1
1431550|NCT00971243|4724883|P1|Double Blind Period|Withdrawal by Subject|4
1431551|NCT00971243|4724879|P5|Double Blind Period|Protocol Violation|2
1431552|NCT00971243|4724880|P4|Double Blind Period|Protocol Violation|2
1431553|NCT00971243|4724881|P3|Double Blind Period|Protocol Violation|3
1431554|NCT00971243|4724882|P2|Double Blind Period|Protocol Violation|0
1431555|NCT00971243|4724883|P1|Double Blind Period|Protocol Violation|2
1431556|NCT00971243|4724879|P5|Double Blind Period|Physician Decision|7
1431557|NCT00971243|4724880|P4|Double Blind Period|Physician Decision|6
1431558|NCT00971243|4724881|P3|Double Blind Period|Physician Decision|7
1431559|NCT00971243|4724882|P2|Double Blind Period|Physician Decision|6
1431560|NCT00971243|4724883|P1|Double Blind Period|Physician Decision|10
1431561|NCT00971243|4724879|P5|Double Blind Period|Lost to Follow-up|1
1431562|NCT00971243|4724880|P4|Double Blind Period|Lost to Follow-up|0
1431563|NCT00971243|4724881|P3|Double Blind Period|Lost to Follow-up|1
1431564|NCT00971243|4724882|P2|Double Blind Period|Lost to Follow-up|1
1431565|NCT00971243|4724883|P1|Double Blind Period|Lost to Follow-up|0
1431566|NCT00971243|4724879|P5|Double Blind Period|Adverse Event|3
1431567|NCT00971243|4724880|P4|Double Blind Period|Adverse Event|2
1431568|NCT00971243|4724881|P3|Double Blind Period|Adverse Event|2
1431569|NCT00971243|4724882|P2|Double Blind Period|Adverse Event|3
1431570|NCT00971243|4724883|P1|Double Blind Period|Adverse Event|2
1431571|NCT00971204|4724900|P1|Overall Study|Lost to Follow-up|10
1431572|NCT00971204|4724900|P1|Overall Study|Did not meet all criteria-not treated|14
1431573|NCT00971048|4724908|P4|Overall Study|Physician Decision|1
1431574|NCT00971048|4724909|P3|Overall Study|Physician Decision|0
1431575|NCT00971048|4724910|P2|Overall Study|Physician Decision|0
1431576|NCT00971048|4724911|P1|Overall Study|Physician Decision|0
1431577|NCT00971048|4724908|P4|Overall Study|Adverse Event|0
1431578|NCT00971048|4724909|P3|Overall Study|Adverse Event|1
1431579|NCT00971048|4724910|P2|Overall Study|Adverse Event|0
1431580|NCT00971048|4724911|P1|Overall Study|Adverse Event|0
1431581|NCT00971048|4724908|P4|Overall Study|Protocol Violation|1
1431582|NCT00971048|4724909|P3|Overall Study|Protocol Violation|0
1431583|NCT00971048|4724910|P2|Overall Study|Protocol Violation|2
1431584|NCT00971048|4724911|P1|Overall Study|Protocol Violation|1
1431585|NCT00970944|4724935|P2|Overall Study|Physician Decision|2
1431586|NCT00970944|4724936|P1|Overall Study|Physician Decision|0
1431587|NCT00970944|4724935|P2|Overall Study|Death|0
1431588|NCT00970944|4724936|P1|Overall Study|Death|1
1431589|NCT00970684|4724988|P1|Overall Study|Withdrawal by Subject|1
1431590|NCT00970684|4724988|P1|Overall Study|Adverse Event|4
1431591|NCT00970684|4724988|P1|Overall Study|Lack of Efficacy|5
1431592|NCT00970632|4724997|P3|Overall Study|Sponsor decision|1
1431593|NCT00970632|4724998|P2|Overall Study|Sponsor decision|0
1431594|NCT00970632|4724999|P1|Overall Study|Sponsor decision|1
1431595|NCT00970632|4724997|P3|Overall Study|Entry criteria not met|2
1431596|NCT00970632|4724998|P2|Overall Study|Entry criteria not met|2
1431597|NCT00970632|4724999|P1|Overall Study|Entry criteria not met|0
1431598|NCT00970632|4724997|P3|Overall Study|Withdrawal by Subject|4
1431599|NCT00970632|4724998|P2|Overall Study|Withdrawal by Subject|6
1431600|NCT00970632|4724999|P1|Overall Study|Withdrawal by Subject|7
1431601|NCT00970632|4724997|P3|Overall Study|Protocol Violation|8
1431602|NCT00970632|4724998|P2|Overall Study|Protocol Violation|5
1431603|NCT00970632|4724999|P1|Overall Study|Protocol Violation|8
1431604|NCT00970632|4724997|P3|Overall Study|Lost to Follow-up|2
1431605|NCT00970632|4724998|P2|Overall Study|Lost to Follow-up|0
1431606|NCT00970632|4724999|P1|Overall Study|Lost to Follow-up|3
1431607|NCT00970632|4724997|P3|Overall Study|Lack of Efficacy|0
1431608|NCT00970632|4724998|P2|Overall Study|Lack of Efficacy|0
1431609|NCT00970632|4724999|P1|Overall Study|Lack of Efficacy|3
1431610|NCT00970632|4724997|P3|Overall Study|Adverse Event|1
1431611|NCT00970632|4724998|P2|Overall Study|Adverse Event|2
1431612|NCT00970632|4724999|P1|Overall Study|Adverse Event|2
1431613|NCT00970502|4725064|P1|Overall Study|Withdrawal by Subject|1
1431614|NCT00970489|4725075|P2|Overall Study|Death/Withdrew/Criteria Violation|41
1431615|NCT00970489|4725076|P1|Overall Study|Death/Withdrew/Criteria Violation|54
1431616|NCT00970359|4725088|P1|Overall Study|Not Treated|4
1431617|NCT00970307|4725118|P3|Overall Study|Withdrawal by Subject|2
1431618|NCT00970307|4725119|P2|Overall Study|Withdrawal by Subject|3
1431619|NCT00970307|4725120|P1|Overall Study|Withdrawal by Subject|2
1431620|NCT00970307|4725118|P3|Overall Study|Serious Adverse Event|0
1431621|NCT00970307|4725119|P2|Overall Study|Serious Adverse Event|0
1431622|NCT00970307|4725120|P1|Overall Study|Serious Adverse Event|1
1431623|NCT00970294|4725194|P1|Overall Study|Withdrawal by Subject|1
1431624|NCT00970294|4725194|P1|Overall Study|Physician Decision|4
1431625|NCT00970281|4725202|P2|Overall Study|Physician Decision|1
1431626|NCT00970281|4725203|P1|Overall Study|Physician Decision|1
1431627|NCT00970281|4725202|P2|Overall Study|Withdrawal by Subject|1
1431628|NCT00970281|4725203|P1|Overall Study|Withdrawal by Subject|0
1431629|NCT00970281|4725202|P2|Overall Study|Lack of Efficacy|14
1431630|NCT00970281|4725203|P1|Overall Study|Lack of Efficacy|1
1431631|NCT00970268|4725221|P2|Overall Study|Inclusion/Exclusion Criteria|0
1431632|NCT00970268|4725222|P1|Overall Study|Inclusion/Exclusion Criteria|1
1431633|NCT00970268|4725221|P2|Overall Study|Lost to Follow-up|2
1431634|NCT00970268|4725222|P1|Overall Study|Lost to Follow-up|1
1431635|NCT00970268|4725221|P2|Overall Study|COPD Exacerbation|2
1431636|NCT00970268|4725222|P1|Overall Study|COPD Exacerbation|4
1431637|NCT00970268|4725221|P2|Overall Study|Other Reason|1
1431638|NCT00970268|4725222|P1|Overall Study|Other Reason|3
1431639|NCT00970268|4725221|P2|Overall Study|Protocol Violation|7
1431640|NCT00970268|4725222|P1|Overall Study|Protocol Violation|4
1431641|NCT00970268|4725221|P2|Overall Study|Lack of Efficacy|6
1431642|NCT00970268|4725222|P1|Overall Study|Lack of Efficacy|3
1431643|NCT00970268|4725221|P2|Overall Study|Adverse Event|12
1431644|NCT00970268|4725222|P1|Overall Study|Adverse Event|15
1431645|NCT00970268|4725221|P2|Overall Study|Withdrawal by Subject|19
1431646|NCT00970268|4725222|P1|Overall Study|Withdrawal by Subject|12
1431647|NCT00969709|4725255|P4|Overall Study|Other reasons|0
1431648|NCT00969709|4725256|P3|Overall Study|Other reasons|3
1431649|NCT00969709|4725257|P2|Overall Study|Other reasons|0
1431650|NCT00969709|4725258|P1|Overall Study|Other reasons|0
1431651|NCT00969709|4725255|P4|Overall Study|Lost to Follow-up|15
1431652|NCT00969709|4725256|P3|Overall Study|Lost to Follow-up|8
1431653|NCT00969709|4725257|P2|Overall Study|Lost to Follow-up|14
1431654|NCT00969709|4725258|P1|Overall Study|Lost to Follow-up|10
1431655|NCT00969709|4725255|P4|Overall Study|Withdrawal by Subject|23
1431656|NCT00969709|4725256|P3|Overall Study|Withdrawal by Subject|11
1431657|NCT00969709|4725257|P2|Overall Study|Withdrawal by Subject|12
1431658|NCT00969709|4725258|P1|Overall Study|Withdrawal by Subject|9
1431659|NCT00969709|4725255|P4|Overall Study|Protocol Violation|10
1431660|NCT00969709|4725256|P3|Overall Study|Protocol Violation|9
1431661|NCT00969709|4725257|P2|Overall Study|Protocol Violation|5
1431662|NCT00969709|4725258|P1|Overall Study|Protocol Violation|9
1431663|NCT00969709|4725255|P4|Overall Study|Lack of Efficacy|3
1431664|NCT00969709|4725256|P3|Overall Study|Lack of Efficacy|1
1431665|NCT00969709|4725257|P2|Overall Study|Lack of Efficacy|4
1431666|NCT00969709|4725258|P1|Overall Study|Lack of Efficacy|7
1431667|NCT00969709|4725255|P4|Overall Study|Adverse Event|12
1431668|NCT00969709|4725256|P3|Overall Study|Adverse Event|26
1431669|NCT00969709|4725257|P2|Overall Study|Adverse Event|13
1431670|NCT00969709|4725258|P1|Overall Study|Adverse Event|3
1431671|NCT00969618|4725272|P1|Overall Study|Withdrawal by Subject|27
1431672|NCT00969618|4725272|P1|Overall Study|Protocol Violation|9
1431673|NCT00969618|4725272|P1|Overall Study|Physician Decision|1
1431674|NCT00969618|4725272|P1|Overall Study|Lost to Follow-up|7
1431675|NCT00969618|4725272|P1|Overall Study|Lack of Efficacy|2
1431676|NCT00969618|4725272|P1|Overall Study|Entry Criteria Not Met|3
1431677|NCT00969618|4725272|P1|Overall Study|Adverse Event|29
1431678|NCT00969540|4725285|P2|Overall Study|Lost to Follow-up|1
1431679|NCT00969540|4725286|P1|Overall Study|Lost to Follow-up|1
1431680|NCT00969436|4725311|P3|Overall Study|Lost to Follow-up|5
1431681|NCT00969436|4725312|P2|Overall Study|Lost to Follow-up|8
1431682|NCT00969436|4725313|P1|Overall Study|Lost to Follow-up|8
1431683|NCT00969436|4725311|P3|Overall Study|Withdrawal by Subject|2
1431684|NCT00969436|4725312|P2|Overall Study|Withdrawal by Subject|0
1431685|NCT00969436|4725313|P1|Overall Study|Withdrawal by Subject|3
1431686|NCT00969436|4725311|P3|Overall Study|Subject eliminated (other vaccine)|0
1431687|NCT00969436|4725312|P2|Overall Study|Subject eliminated (other vaccine)|0
1431688|NCT00969436|4725313|P1|Overall Study|Subject eliminated (other vaccine)|1
1431689|NCT00969436|4725311|P3|Overall Study|Parents personal problem|1
1431690|NCT00969436|4725312|P2|Overall Study|Parents personal problem|0
1431691|NCT00969436|4725313|P1|Overall Study|Parents personal problem|0
1431692|NCT00969436|4725311|P3|Overall Study|Father - serious health problem|1
1431693|NCT00969436|4725312|P2|Overall Study|Father - serious health problem|0
1431694|NCT00969436|4725313|P1|Overall Study|Father - serious health problem|0
1431695|NCT00969436|4725311|P3|Overall Study|Migrated/moved from study area|2
1431696|NCT00969436|4725312|P2|Overall Study|Migrated/moved from study area|10
1431697|NCT00969436|4725313|P1|Overall Study|Migrated/moved from study area|12
1431698|NCT00969436|4725311|P3|Overall Study|Protocol Violation|0
1431699|NCT00969436|4725312|P2|Overall Study|Protocol Violation|3
1431700|NCT00969436|4725313|P1|Overall Study|Protocol Violation|1
1431701|NCT00969280|4725347|P2|Overall Study|infection of influenza A(H1N1)|1
1431702|NCT00969280|4725348|P1|Overall Study|infection of influenza A(H1N1)|0
1431703|NCT00969280|4725347|P2|Overall Study|Withdrawal by Subject|1
1431704|NCT00969280|4725348|P1|Overall Study|Withdrawal by Subject|0
1431705|NCT00969280|4725347|P2|Overall Study|Protocol Violation|1
1431706|NCT00969280|4725348|P1|Overall Study|Protocol Violation|2
1431707|NCT00969228|4725356|P2|Overall Study|Porcine circovirus detection in vaccine|14
1431708|NCT00969228|4725357|P1|Overall Study|Porcine circovirus detection in vaccine|38
1431709|NCT00969228|4725356|P2|Overall Study|Withdrawal by Subject|0
1431710|NCT00969228|4725357|P1|Overall Study|Withdrawal by Subject|4
1431711|NCT00969228|4725356|P2|Overall Study|Adverse Event|0
1431712|NCT00969228|4725357|P1|Overall Study|Adverse Event|1
1431713|NCT00969150|4725375|P2|Overall Study|Other reasons|0
1431714|NCT00969150|4725376|P1|Overall Study|Other reasons|1
1431715|NCT00969150|4725375|P2|Overall Study|Lost to Follow-up|4
1431716|NCT00969150|4725376|P1|Overall Study|Lost to Follow-up|5
1431717|NCT00969150|4725375|P2|Overall Study|Withdrawal by Subject|9
1431718|NCT00969150|4725376|P1|Overall Study|Withdrawal by Subject|13
1431719|NCT00969150|4725375|P2|Overall Study|Protocol Violation|12
1431720|NCT00969150|4725376|P1|Overall Study|Protocol Violation|9
1431721|NCT00969150|4725375|P2|Overall Study|Lack of Efficacy|1
1431722|NCT00969150|4725376|P1|Overall Study|Lack of Efficacy|1
1431723|NCT00969150|4725375|P2|Overall Study|Adverse Event|14
1431724|NCT00969150|4725376|P1|Overall Study|Adverse Event|4
1431725|NCT00969124|4725384|P1|Overall Study|Technical error|1
1431726|NCT00969124|4725384|P1|Overall Study|Previously unrecognized disease|3
1431727|NCT00969124|4725384|P1|Overall Study|Inability to reach cecum|9
1431728|NCT00969124|4725384|P1|Overall Study|Inadequate bowel preparation|15
1431729|NCT00969124|4725384|P1|Overall Study|Protocol Violation|2
1431730|NCT00968981|4725393|P3|Overall Study|Withdrawal by Subject|3
1431731|NCT00968981|4725394|P2|Overall Study|Withdrawal by Subject|3
1431732|NCT00968981|4725395|P1|Overall Study|Withdrawal by Subject|1
1431733|NCT00968981|4725393|P3|Overall Study|Physician Decision|5
1431734|NCT00968981|4725394|P2|Overall Study|Physician Decision|3
1431735|NCT00968981|4725395|P1|Overall Study|Physician Decision|5
1431736|NCT00968981|4725393|P3|Overall Study|Lost to Follow-up|1
1431737|NCT00968981|4725394|P2|Overall Study|Lost to Follow-up|0
1431738|NCT00968981|4725395|P1|Overall Study|Lost to Follow-up|0
1431739|NCT00968981|4725393|P3|Overall Study|Disease Progression|13
1431740|NCT00968981|4725394|P2|Overall Study|Disease Progression|16
1431741|NCT00968981|4725395|P1|Overall Study|Disease Progression|14
1431742|NCT00968981|4725393|P3|Overall Study|Adverse Event|0
1431743|NCT00968981|4725394|P2|Overall Study|Adverse Event|0
1431744|NCT00968981|4725395|P1|Overall Study|Adverse Event|2
1431745|NCT00968864|4725462|P1|Overall Study|Protocol exception/ not evaluable|1
1431746|NCT00968812|4725490|P3|Overall Study|Not specified|40
1431747|NCT00968812|4725491|P2|Overall Study|Not specified|37
1431748|NCT00968812|4725492|P1|Overall Study|Not specified|25
1431749|NCT00968812|4725490|P3|Overall Study|Unable to take rescue therapy|17
1431750|NCT00968812|4725491|P2|Overall Study|Unable to take rescue therapy|12
1431751|NCT00968812|4725492|P1|Overall Study|Unable to take rescue therapy|12
1431752|NCT00968812|4725490|P3|Overall Study|Noncompliance with study drug|6
1431753|NCT00968812|4725491|P2|Overall Study|Noncompliance with study drug|1
1431754|NCT00968812|4725492|P1|Overall Study|Noncompliance with study drug|4
1431755|NCT00968812|4725490|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
1431756|NCT00968812|4725491|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
1431757|NCT00968812|4725492|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
1431758|NCT00968812|4725490|P3|Overall Study|Withdrawal by Subject|25
1431759|NCT00968812|4725491|P2|Overall Study|Withdrawal by Subject|23
1431760|NCT00968812|4725492|P1|Overall Study|Withdrawal by Subject|17
1431761|NCT00968812|4725490|P3|Overall Study|Protocol Violation|3
1431762|NCT00968812|4725491|P2|Overall Study|Protocol Violation|4
1431763|NCT00968812|4725492|P1|Overall Study|Protocol Violation|7
1431764|NCT00968812|4725490|P3|Overall Study|Physician Decision|9
1431765|NCT00968812|4725491|P2|Overall Study|Physician Decision|5
1431766|NCT00968812|4725492|P1|Overall Study|Physician Decision|8
1431767|NCT00968812|4725490|P3|Overall Study|Lost to Follow-up|11
1431768|NCT00968812|4725491|P2|Overall Study|Lost to Follow-up|12
1431769|NCT00968812|4725492|P1|Overall Study|Lost to Follow-up|17
1431770|NCT00968812|4725490|P3|Overall Study|Lack of Efficacy|16
1431771|NCT00968812|4725491|P2|Overall Study|Lack of Efficacy|7
1431772|NCT00968812|4725492|P1|Overall Study|Lack of Efficacy|9
1431773|NCT00968812|4725490|P3|Overall Study|Death|1
1431774|NCT00968812|4725491|P2|Overall Study|Death|2
1431775|NCT00968812|4725492|P1|Overall Study|Death|2
1431776|NCT00968812|4725490|P3|Overall Study|Adverse Event|33
1431777|NCT00968812|4725491|P2|Overall Study|Adverse Event|46
1431778|NCT00968812|4725492|P1|Overall Study|Adverse Event|30
1431779|NCT00968799|4725512|P1|Overall Study|Advanced disease, HIPEC not applicable|2
1431780|NCT00968708|4725522|P2|Overall Study|Other|34
1431781|NCT00968708|4725523|P1|Overall Study|Other|26
1431782|NCT00968708|4725522|P2|Overall Study|Investigator Discretion|1
1431783|NCT00968708|4725523|P1|Overall Study|Investigator Discretion|0
1431784|NCT00968708|4725522|P2|Overall Study|Voluntary Withdrawal|101
1431785|NCT00968708|4725523|P1|Overall Study|Voluntary Withdrawal|104
1431786|NCT00968708|4725522|P2|Overall Study|Lost to Follow-up|11
1431787|NCT00968708|4725523|P1|Overall Study|Lost to Follow-up|19
1431788|NCT00968708|4725522|P2|Overall Study|Major Protocol Deviation|1
1431789|NCT00968708|4725523|P1|Overall Study|Major Protocol Deviation|0
1431790|NCT00968708|4725522|P2|Overall Study|Adverse Event|150
1431791|NCT00968708|4725523|P1|Overall Study|Adverse Event|169
1431792|NCT00968669|4725535|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
1431793|NCT00968669|4725536|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
1431794|NCT00968669|4725537|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
1431795|NCT00968669|4725538|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
1431796|NCT00968669|4725535|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
1431797|NCT00968669|4725536|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
1431798|NCT00968669|4725537|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
1431799|NCT00968669|4725538|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
1431800|NCT00968669|4725535|P4|Overall Study|SUBJECT INCARCERATED|0
1431801|NCT00968669|4725536|P3|Overall Study|SUBJECT INCARCERATED|0
1431802|NCT00968669|4725537|P2|Overall Study|SUBJECT INCARCERATED|1
1431803|NCT00968669|4725538|P1|Overall Study|SUBJECT INCARCERATED|0
1431804|NCT00968669|4725535|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
1431805|NCT00968669|4725536|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
1431806|NCT00968669|4725537|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
1431807|NCT00968669|4725538|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
1431808|NCT00968669|4725535|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
1431809|NCT00968669|4725536|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
1431810|NCT00968669|4725537|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
1431811|NCT00968669|4725538|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
1431812|NCT00968669|4725535|P4|Overall Study|SPONSOR DECISION|0
1431813|NCT00968669|4725536|P3|Overall Study|SPONSOR DECISION|0
1431814|NCT00968669|4725537|P2|Overall Study|SPONSOR DECISION|1
1431815|NCT00968669|4725538|P1|Overall Study|SPONSOR DECISION|0
1431816|NCT00968669|4725535|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
1431817|NCT00968669|4725536|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
1431818|NCT00968669|4725537|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
1431819|NCT00968669|4725538|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
1431820|NCT00968669|4725535|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
1431821|NCT00968669|4725536|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
1431822|NCT00968669|4725537|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
1431823|NCT00968669|4725538|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
1431824|NCT00968669|4725535|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
1431825|NCT00968669|4725536|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
1431826|NCT00968669|4725537|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
1431827|NCT00968669|4725538|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
1431828|NCT00968669|4725535|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
1431829|NCT00968669|4725536|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
1431830|NCT00968669|4725537|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
1431831|NCT00968669|4725538|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
1431832|NCT00968669|4725535|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
1431833|NCT00968669|4725536|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
1431834|NCT00968669|4725537|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
1431835|NCT00968669|4725538|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
1431836|NCT00968669|4725535|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
1431837|NCT00968669|4725536|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
1431838|NCT00968669|4725537|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
1431839|NCT00968669|4725538|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
1431840|NCT00968669|4725535|P4|Overall Study|EARLY WITHDRAWAL|0
1431841|NCT00968669|4725536|P3|Overall Study|EARLY WITHDRAWAL|0
1431842|NCT00968669|4725537|P2|Overall Study|EARLY WITHDRAWAL|1
1431843|NCT00968669|4725538|P1|Overall Study|EARLY WITHDRAWAL|0
1431844|NCT00968669|4725535|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
1431845|NCT00968669|4725536|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
1431846|NCT00968669|4725537|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
1431847|NCT00968669|4725538|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
1431848|NCT00968669|4725535|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
1431849|NCT00968669|4725536|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
1431850|NCT00968669|4725537|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
1431851|NCT00968669|4725538|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
1431852|NCT00968669|4725535|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
1431853|NCT00968669|4725536|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
1431854|NCT00968669|4725537|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
1431855|NCT00968669|4725538|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
1431856|NCT00968669|4725535|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
1431857|NCT00968669|4725536|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
1431858|NCT00968669|4725537|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
1431859|NCT00968669|4725538|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
1431860|NCT00968669|4725535|P4|Overall Study|AE|0
1431861|NCT00968669|4725536|P3|Overall Study|AE|0
1431862|NCT00968669|4725537|P2|Overall Study|AE|0
1431863|NCT00968669|4725538|P1|Overall Study|AE|1
1431864|NCT00968669|4725535|P4|Overall Study|Pregnancy|0
1431865|NCT00968669|4725536|P3|Overall Study|Pregnancy|2
1431866|NCT00968669|4725537|P2|Overall Study|Pregnancy|0
1431867|NCT00968669|4725538|P1|Overall Study|Pregnancy|0
1431868|NCT00968669|4725535|P4|Overall Study|Withdrawal by Subject|3
1431869|NCT00968669|4725536|P3|Overall Study|Withdrawal by Subject|5
1431870|NCT00968669|4725537|P2|Overall Study|Withdrawal by Subject|7
1431871|NCT00968669|4725538|P1|Overall Study|Withdrawal by Subject|9
1431872|NCT00968669|4725535|P4|Overall Study|Lost to Follow-up|4
1431873|NCT00968669|4725536|P3|Overall Study|Lost to Follow-up|1
1431874|NCT00968669|4725537|P2|Overall Study|Lost to Follow-up|2
1431875|NCT00968669|4725538|P1|Overall Study|Lost to Follow-up|5
1431876|NCT00968617|4725628|P1|Overall Study|Study terminated by sponsor|6
1431877|NCT00968539|4725642|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
1431878|NCT00968539|4725643|P1|Overall Study|Lost to follow-up (incompl. vaccination)|1
1431879|NCT00968253|4725704|P3|Overall Study|Adverse Event|1
1431880|NCT00968253|4725705|P2|Overall Study|Adverse Event|0
1431881|NCT00968253|4725706|P1|Overall Study|Adverse Event|0
1431882|NCT00968253|4725704|P3|Overall Study|Disease Progression|3
1431883|NCT00968253|4725705|P2|Overall Study|Disease Progression|3
1431884|NCT00968253|4725706|P1|Overall Study|Disease Progression|0
1431885|NCT00968253|4725704|P3|Overall Study|Withdrawal by Subject|1
1431886|NCT00968253|4725705|P2|Overall Study|Withdrawal by Subject|0
1431887|NCT00968253|4725706|P1|Overall Study|Withdrawal by Subject|0
1431888|NCT00968253|4725704|P3|Overall Study|Death|2
1431889|NCT00968253|4725705|P2|Overall Study|Death|0
1431890|NCT00968253|4725706|P1|Overall Study|Death|0
1431891|NCT00968201|4725727|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
1431892|NCT00968201|4725728|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
1431893|NCT00968201|4725729|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
1431894|NCT00968201|4725727|P3|Extension Study - (Period III)|Not Specified|2
1431895|NCT00968201|4725728|P2|Extension Study - (Period III)|Not Specified|0
1431896|NCT00968201|4725729|P1|Extension Study - (Period III)|Not Specified|0
1431897|NCT00968201|4725727|P3|Extension Study - (Period III)|Noncompliance|3
1431898|NCT00968201|4725728|P2|Extension Study - (Period III)|Noncompliance|0
1431899|NCT00968201|4725729|P1|Extension Study - (Period III)|Noncompliance|0
1431900|NCT00968201|4725727|P3|Extension Study - (Period III)|Patient Relocated|1
1431901|NCT00968201|4725728|P2|Extension Study - (Period III)|Patient Relocated|1
1431902|NCT00968201|4725729|P1|Extension Study - (Period III)|Patient Relocated|0
1431903|NCT00968201|4725727|P3|Extension Study - (Period III)|Withdrawal by Subject|40
1431904|NCT00968201|4725728|P2|Extension Study - (Period III)|Withdrawal by Subject|20
1431905|NCT00968201|4725729|P1|Extension Study - (Period III)|Withdrawal by Subject|0
1431906|NCT00968201|4725727|P3|Extension Study - (Period III)|Protocol Violation|14
1431907|NCT00968201|4725728|P2|Extension Study - (Period III)|Protocol Violation|17
1431908|NCT00968201|4725729|P1|Extension Study - (Period III)|Protocol Violation|0
1431909|NCT00968201|4725727|P3|Extension Study - (Period III)|Lost to Follow-up|13
1431910|NCT00968201|4725728|P2|Extension Study - (Period III)|Lost to Follow-up|7
1431911|NCT00968201|4725729|P1|Extension Study - (Period III)|Lost to Follow-up|0
1431912|NCT00968201|4725727|P3|Extension Study - (Period III)|Adverse Event|22
1431913|NCT00968201|4725728|P2|Extension Study - (Period III)|Adverse Event|5
1431914|NCT00968201|4725729|P1|Extension Study - (Period III)|Adverse Event|0
1431915|NCT00968201|4725727|P3|Base Study - (Period II)|Site Error|1
1431916|NCT00968201|4725728|P2|Base Study - (Period II)|Site Error|0
1431917|NCT00968201|4725729|P1|Base Study - (Period II)|Site Error|0
1431918|NCT00968201|4725727|P3|Base Study - (Period II)|Withdrawal by Subject|8
1431919|NCT00968201|4725728|P2|Base Study - (Period II)|Withdrawal by Subject|0
1431920|NCT00968201|4725729|P1|Base Study - (Period II)|Withdrawal by Subject|4
1431921|NCT00968201|4725727|P3|Base Study - (Period II)|Protocol Violation|12
1431922|NCT00968201|4725728|P2|Base Study - (Period II)|Protocol Violation|0
1431923|NCT00968201|4725729|P1|Base Study - (Period II)|Protocol Violation|12
1431924|NCT00968201|4725727|P3|Base Study - (Period II)|Lost to Follow-up|7
1431925|NCT00968201|4725728|P2|Base Study - (Period II)|Lost to Follow-up|0
1431926|NCT00968201|4725729|P1|Base Study - (Period II)|Lost to Follow-up|2
1431927|NCT00968201|4725727|P3|Base Study - (Period II)|Lack of Efficacy|1
1431928|NCT00968201|4725728|P2|Base Study - (Period II)|Lack of Efficacy|0
1431929|NCT00968201|4725729|P1|Base Study - (Period II)|Lack of Efficacy|0
1431930|NCT00968201|4725727|P3|Base Study - (Period II)|Adverse Event|16
1431931|NCT00968201|4725728|P2|Base Study - (Period II)|Adverse Event|0
1431932|NCT00968201|4725729|P1|Base Study - (Period II)|Adverse Event|8
1431933|NCT00968149|4725790|P2|Overall Study|Withdrawal by Subject|0
1431934|NCT00968149|4725791|P1|Overall Study|Withdrawal by Subject|2
1431935|NCT00968149|4725790|P2|Overall Study|Protocol Violation|0
1431936|NCT00968149|4725791|P1|Overall Study|Protocol Violation|4
1431937|NCT00968149|4725790|P2|Overall Study|Lost to Follow-up|1
1431938|NCT00968149|4725791|P1|Overall Study|Lost to Follow-up|0
1431939|NCT00968149|4725790|P2|Overall Study|Lack of Efficacy|4
1431940|NCT00968149|4725791|P1|Overall Study|Lack of Efficacy|0
1431941|NCT00968149|4725790|P2|Overall Study|Adverse Event|1
1431942|NCT00968149|4725791|P1|Overall Study|Adverse Event|5
1431943|NCT00967798|4725846|P2|Overall Study|Lost to Follow-up|1
1431944|NCT00967798|4725847|P1|Overall Study|Lost to Follow-up|4
1431945|NCT00967798|4725846|P2|Overall Study|Withdrawal by Subject|2
1431946|NCT00967798|4725847|P1|Overall Study|Withdrawal by Subject|5
1431947|NCT00967694|4725861|P1|Overall Study|Withdrawal by Subject|6
1431948|NCT00967668|4725868|P3|Overall Study|Pregnancy|0
1431949|NCT00967668|4725869|P2|Overall Study|Pregnancy|0
1431950|NCT00967668|4725870|P1|Overall Study|Pregnancy|1
1431951|NCT00967668|4725868|P3|Overall Study|Refused 12-mo assessment|9
1431952|NCT00967668|4725869|P2|Overall Study|Refused 12-mo assessment|1
1431953|NCT00967668|4725870|P1|Overall Study|Refused 12-mo assessment|3
1431954|NCT00967668|4725868|P3|Overall Study|Lost to Follow-up|16
1431955|NCT00967668|4725869|P2|Overall Study|Lost to Follow-up|9
1431956|NCT00967668|4725870|P1|Overall Study|Lost to Follow-up|15
1431957|NCT00967668|4725868|P3|Overall Study|Lost to follow-up at 12-mo|26
1431958|NCT00967668|4725869|P2|Overall Study|Lost to follow-up at 12-mo|29
1431959|NCT00967668|4725870|P1|Overall Study|Lost to follow-up at 12-mo|27
1431960|NCT00967668|4725868|P3|Overall Study|Refused Year 2|4
1431961|NCT00967668|4725869|P2|Overall Study|Refused Year 2|6
1431962|NCT00967668|4725870|P1|Overall Study|Refused Year 2|11
1431963|NCT00967668|4725868|P3|Overall Study|Removed due to behavior|2
1431964|NCT00967668|4725869|P2|Overall Study|Removed due to behavior|1
1431965|NCT00967668|4725870|P1|Overall Study|Removed due to behavior|1
1431966|NCT00967668|4725868|P3|Overall Study|Death|4
1431967|NCT00967668|4725869|P2|Overall Study|Death|2
1431968|NCT00967668|4725870|P1|Overall Study|Death|0
1431969|NCT00967668|4725868|P3|Overall Study|Withdrawal by Subject|8
1431970|NCT00967668|4725869|P2|Overall Study|Withdrawal by Subject|8
1431971|NCT00967668|4725870|P1|Overall Study|Withdrawal by Subject|13
1431972|NCT00967330|4725916|P2|Overall Study|Severe protocol deviation|1
1431973|NCT00967330|4725917|P1|Overall Study|Severe protocol deviation|0
1431974|NCT00967330|4725916|P2|Overall Study|Death|51
1431975|NCT00967330|4725917|P1|Overall Study|Death|102
1431976|NCT00967330|4725916|P2|Overall Study|Lost to Follow-up|1
1431977|NCT00967330|4725917|P1|Overall Study|Lost to Follow-up|1
1431978|NCT00967330|4725916|P2|Overall Study|Withdrawal by Subject|0
1431979|NCT00967330|4725917|P1|Overall Study|Withdrawal by Subject|6
1431980|NCT00967330|4725916|P2|Overall Study|Regular|3
1431981|NCT00967330|4725917|P1|Overall Study|Regular|10
1431982|NCT00967330|4725916|P2|Overall Study|Protocol Violation|4
1431983|NCT00967330|4725917|P1|Overall Study|Protocol Violation|3
1431984|NCT00967226|4725947|P2|Overall Study|Physician Decision|1
1431985|NCT00967226|4725948|P1|Overall Study|Physician Decision|0
1431986|NCT00967226|4725947|P2|Overall Study|Protocol Violation|0
1431987|NCT00967226|4725948|P1|Overall Study|Protocol Violation|2
1431988|NCT00967226|4725947|P2|Overall Study|Adverse Event|5
1431989|NCT00967226|4725948|P1|Overall Study|Adverse Event|0
1431990|NCT00967018|4725982|P1|Overall Study|Miscellaneous Reasons|9
1431991|NCT00967018|4725982|P1|Overall Study|Withdrawal by Subject|1
1431992|NCT00967018|4725982|P1|Overall Study|Lost to Follow-up|2
1431993|NCT00967018|4725982|P1|Overall Study|Physician Decision|7
1431994|NCT00967018|4725982|P1|Overall Study|Adverse Event|2
1431995|NCT00967005|4725991|P2|Overall Study|Lost to Follow-up|10
1431996|NCT00967005|4725992|P1|Overall Study|Lost to Follow-up|7
1431997|NCT00966940|4726078|P2|Period 1, First 6 Weeks|Protocol Violation|0
1431998|NCT00966940|4726079|P1|Period 1, First 6 Weeks|Protocol Violation|1
1431999|NCT00966940|4726078|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
1432000|NCT00966940|4726079|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
1432001|NCT00966875|4726106|P9|Part B|Entry Criteria|1
1432002|NCT00966875|4726107|P8|Part B|Entry Criteria|0
1432003|NCT00966875|4726108|P7|Part B|Entry Criteria|1
1432004|NCT00966875|4726109|P6|Part B|Entry Criteria|0
1432005|NCT00966875|4726110|P5|Part B|Entry Criteria|0
1432006|NCT00966875|4726111|P4|Part B|Entry Criteria|0
1432007|NCT00966875|4726112|P3|Part B|Entry Criteria|0
1432008|NCT00966875|4726113|P2|Part B|Entry Criteria|0
1432009|NCT00966875|4726114|P1|Part B|Entry Criteria|0
1432010|NCT00966875|4726106|P9|Part B|Withdrawal by Subject|5
1432011|NCT00966875|4726107|P8|Part B|Withdrawal by Subject|5
1432012|NCT00966875|4726108|P7|Part B|Withdrawal by Subject|4
1432013|NCT00966875|4726109|P6|Part B|Withdrawal by Subject|1
1432014|NCT00966875|4726110|P5|Part B|Withdrawal by Subject|2
1432015|NCT00966875|4726111|P4|Part B|Withdrawal by Subject|1
1432016|NCT00966875|4726112|P3|Part B|Withdrawal by Subject|2
1432017|NCT00966875|4726113|P2|Part B|Withdrawal by Subject|1
1432018|NCT00966875|4726114|P1|Part B|Withdrawal by Subject|2
1432019|NCT00966875|4726106|P9|Part B|Sponsor Decision|1
1432020|NCT00966875|4726107|P8|Part B|Sponsor Decision|2
1432021|NCT00966875|4726108|P7|Part B|Sponsor Decision|0
1432022|NCT00966875|4726109|P6|Part B|Sponsor Decision|1
1432023|NCT00966875|4726110|P5|Part B|Sponsor Decision|0
1432024|NCT00966875|4726111|P4|Part B|Sponsor Decision|0
1432025|NCT00966875|4726112|P3|Part B|Sponsor Decision|0
1432026|NCT00966875|4726113|P2|Part B|Sponsor Decision|0
1432027|NCT00966875|4726114|P1|Part B|Sponsor Decision|1
1432028|NCT00966875|4726106|P9|Part B|Physician Decision|2
1432029|NCT00966875|4726107|P8|Part B|Physician Decision|0
1432030|NCT00966875|4726108|P7|Part B|Physician Decision|0
1432031|NCT00966875|4726109|P6|Part B|Physician Decision|1
1432032|NCT00966875|4726110|P5|Part B|Physician Decision|2
1432033|NCT00966875|4726111|P4|Part B|Physician Decision|0
1432034|NCT00966875|4726112|P3|Part B|Physician Decision|1
1432035|NCT00966875|4726113|P2|Part B|Physician Decision|0
1432036|NCT00966875|4726114|P1|Part B|Physician Decision|0
1432037|NCT00966875|4726106|P9|Part B|Lost to Follow-up|1
1432038|NCT00966875|4726107|P8|Part B|Lost to Follow-up|0
1432039|NCT00966875|4726108|P7|Part B|Lost to Follow-up|0
1432040|NCT00966875|4726109|P6|Part B|Lost to Follow-up|0
1432041|NCT00966875|4726110|P5|Part B|Lost to Follow-up|0
1432042|NCT00966875|4726111|P4|Part B|Lost to Follow-up|1
1432043|NCT00966875|4726112|P3|Part B|Lost to Follow-up|0
1432044|NCT00966875|4726113|P2|Part B|Lost to Follow-up|0
1432045|NCT00966875|4726114|P1|Part B|Lost to Follow-up|0
1432046|NCT00966875|4726106|P9|Part B|Lack of Efficacy|6
1432047|NCT00966875|4726107|P8|Part B|Lack of Efficacy|9
1432048|NCT00966875|4726108|P7|Part B|Lack of Efficacy|12
1432049|NCT00966875|4726109|P6|Part B|Lack of Efficacy|3
1432050|NCT00966875|4726110|P5|Part B|Lack of Efficacy|2
1432051|NCT00966875|4726111|P4|Part B|Lack of Efficacy|1
1432052|NCT00966875|4726112|P3|Part B|Lack of Efficacy|1
1432053|NCT00966875|4726113|P2|Part B|Lack of Efficacy|1
1432054|NCT00966875|4726114|P1|Part B|Lack of Efficacy|2
1432055|NCT00966875|4726106|P9|Part B|Death|0
1432056|NCT00966875|4726107|P8|Part B|Death|1
1432057|NCT00966875|4726108|P7|Part B|Death|0
1432058|NCT00966875|4726109|P6|Part B|Death|0
1432059|NCT00966875|4726110|P5|Part B|Death|0
1432060|NCT00966875|4726111|P4|Part B|Death|0
1432061|NCT00966875|4726112|P3|Part B|Death|1
1432062|NCT00966875|4726113|P2|Part B|Death|0
1432063|NCT00966875|4726114|P1|Part B|Death|0
1432064|NCT00966875|4726106|P9|Part B|Adverse Event|2
1432065|NCT00966875|4726107|P8|Part B|Adverse Event|2
1432066|NCT00966875|4726108|P7|Part B|Adverse Event|5
1432067|NCT00966875|4726109|P6|Part B|Adverse Event|0
1432068|NCT00966875|4726110|P5|Part B|Adverse Event|1
1432069|NCT00966875|4726111|P4|Part B|Adverse Event|0
1432070|NCT00966875|4726112|P3|Part B|Adverse Event|1
1432071|NCT00966875|4726113|P2|Part B|Adverse Event|1
1432072|NCT00966875|4726114|P1|Part B|Adverse Event|0
1432073|NCT00966875|4726106|P9|Part A|Protocol Violation|1
1432074|NCT00966875|4726107|P8|Part A|Protocol Violation|1
1432075|NCT00966875|4726108|P7|Part A|Protocol Violation|2
1432076|NCT00966875|4726109|P6|Part A|Protocol Violation|0
1432077|NCT00966875|4726110|P5|Part A|Protocol Violation|0
1432078|NCT00966875|4726111|P4|Part A|Protocol Violation|0
1432079|NCT00966875|4726112|P3|Part A|Protocol Violation|0
1432080|NCT00966875|4726113|P2|Part A|Protocol Violation|0
1432081|NCT00966875|4726114|P1|Part A|Protocol Violation|0
1432082|NCT00966875|4726106|P9|Part A|Withdrawal by Subject|1
1432083|NCT00966875|4726107|P8|Part A|Withdrawal by Subject|1
1432084|NCT00966875|4726108|P7|Part A|Withdrawal by Subject|5
1432085|NCT00966875|4726109|P6|Part A|Withdrawal by Subject|0
1432086|NCT00966875|4726110|P5|Part A|Withdrawal by Subject|3
1432087|NCT00966875|4726111|P4|Part A|Withdrawal by Subject|1
1432088|NCT00966875|4726112|P3|Part A|Withdrawal by Subject|1
1432089|NCT00966875|4726113|P2|Part A|Withdrawal by Subject|2
1432090|NCT00966875|4726114|P1|Part A|Withdrawal by Subject|2
1432091|NCT00966875|4726106|P9|Part A|Sponsor Decision|1
1432092|NCT00966875|4726107|P8|Part A|Sponsor Decision|2
1432093|NCT00966875|4726108|P7|Part A|Sponsor Decision|0
1432094|NCT00966875|4726109|P6|Part A|Sponsor Decision|0
1432095|NCT00966875|4726110|P5|Part A|Sponsor Decision|1
1432096|NCT00966875|4726111|P4|Part A|Sponsor Decision|0
1432097|NCT00966875|4726112|P3|Part A|Sponsor Decision|1
1432098|NCT00966875|4726113|P2|Part A|Sponsor Decision|0
1432099|NCT00966875|4726114|P1|Part A|Sponsor Decision|0
1432100|NCT00966875|4726106|P9|Part A|Physician Decision|2
1432101|NCT00966875|4726107|P8|Part A|Physician Decision|0
1432102|NCT00966875|4726108|P7|Part A|Physician Decision|1
1432103|NCT00966875|4726109|P6|Part A|Physician Decision|0
1432104|NCT00966875|4726110|P5|Part A|Physician Decision|1
1432105|NCT00966875|4726111|P4|Part A|Physician Decision|0
1432106|NCT00966875|4726112|P3|Part A|Physician Decision|0
1432107|NCT00966875|4726113|P2|Part A|Physician Decision|0
1432108|NCT00966875|4726114|P1|Part A|Physician Decision|0
1432109|NCT00966875|4726106|P9|Part A|Parent/Caregiver Decision|0
1432110|NCT00966875|4726107|P8|Part A|Parent/Caregiver Decision|0
1432111|NCT00966875|4726108|P7|Part A|Parent/Caregiver Decision|0
1432112|NCT00966875|4726109|P6|Part A|Parent/Caregiver Decision|0
1432113|NCT00966875|4726110|P5|Part A|Parent/Caregiver Decision|0
1432114|NCT00966875|4726111|P4|Part A|Parent/Caregiver Decision|1
1432115|NCT00966875|4726112|P3|Part A|Parent/Caregiver Decision|0
1432116|NCT00966875|4726113|P2|Part A|Parent/Caregiver Decision|0
1432117|NCT00966875|4726114|P1|Part A|Parent/Caregiver Decision|0
1432118|NCT00966875|4726106|P9|Part A|Lost to Follow-up|0
1432119|NCT00966875|4726107|P8|Part A|Lost to Follow-up|0
1432120|NCT00966875|4726108|P7|Part A|Lost to Follow-up|0
1432121|NCT00966875|4726109|P6|Part A|Lost to Follow-up|1
1432122|NCT00966875|4726110|P5|Part A|Lost to Follow-up|0
1432123|NCT00966875|4726111|P4|Part A|Lost to Follow-up|0
1432124|NCT00966875|4726112|P3|Part A|Lost to Follow-up|0
1432125|NCT00966875|4726113|P2|Part A|Lost to Follow-up|0
1432126|NCT00966875|4726114|P1|Part A|Lost to Follow-up|2
1432127|NCT00966875|4726106|P9|Part A|Lack of Efficacy|0
1432128|NCT00966875|4726107|P8|Part A|Lack of Efficacy|0
1432129|NCT00966875|4726108|P7|Part A|Lack of Efficacy|4
1432130|NCT00966875|4726109|P6|Part A|Lack of Efficacy|0
1432131|NCT00966875|4726110|P5|Part A|Lack of Efficacy|0
1432132|NCT00966875|4726111|P4|Part A|Lack of Efficacy|0
1432133|NCT00966875|4726112|P3|Part A|Lack of Efficacy|0
1432134|NCT00966875|4726113|P2|Part A|Lack of Efficacy|1
1432135|NCT00966875|4726114|P1|Part A|Lack of Efficacy|0
1432136|NCT00966875|4726106|P9|Part A|Entry Criteria|0
1432137|NCT00966875|4726107|P8|Part A|Entry Criteria|0
1432138|NCT00966875|4726108|P7|Part A|Entry Criteria|0
1432139|NCT00966875|4726109|P6|Part A|Entry Criteria|2
1432140|NCT00966875|4726110|P5|Part A|Entry Criteria|0
1432141|NCT00966875|4726111|P4|Part A|Entry Criteria|0
1432142|NCT00966875|4726112|P3|Part A|Entry Criteria|0
1432143|NCT00966875|4726113|P2|Part A|Entry Criteria|0
1432144|NCT00966875|4726114|P1|Part A|Entry Criteria|0
1432145|NCT00966875|4726106|P9|Part A|Adverse Event|3
1432146|NCT00966875|4726107|P8|Part A|Adverse Event|3
1432147|NCT00966875|4726108|P7|Part A|Adverse Event|0
1432148|NCT00966875|4726109|P6|Part A|Adverse Event|1
1432149|NCT00966875|4726110|P5|Part A|Adverse Event|0
1432150|NCT00966875|4726111|P4|Part A|Adverse Event|1
1432151|NCT00966875|4726112|P3|Part A|Adverse Event|0
1432152|NCT00966875|4726113|P2|Part A|Adverse Event|1
1432153|NCT00966875|4726114|P1|Part A|Adverse Event|2
1432154|NCT00966654|4726441|P1|Overall Study|Study was terminated,PI left institution|12
1432155|NCT00966355|4726487|P3|Overall Study|Lost to Follow-up|3
1432156|NCT00966355|4726488|P2|Overall Study|Lost to Follow-up|4
1432157|NCT00966355|4726489|P1|Overall Study|Lost to Follow-up|5
1432158|NCT00966355|4726487|P3|Overall Study|newly diagnosed advanced HCC|10
1432159|NCT00966355|4726488|P2|Overall Study|newly diagnosed advanced HCC|12
1432160|NCT00966355|4726489|P1|Overall Study|newly diagnosed advanced HCC|11
1432161|NCT00966355|4726487|P3|Overall Study|non-variceal bleeding on endoscopy|71
1432162|NCT00966355|4726488|P2|Overall Study|non-variceal bleeding on endoscopy|70
1432163|NCT00966355|4726489|P1|Overall Study|non-variceal bleeding on endoscopy|68
1432164|NCT00966277|4726502|P2|Overall Study|Treatment Plan Changed|1
1432165|NCT00966277|4726503|P1|Overall Study|Treatment Plan Changed|0
1432166|NCT00966277|4726502|P2|Overall Study|Ineligible|3
1432167|NCT00966277|4726503|P1|Overall Study|Ineligible|1
1432168|NCT00966277|4726502|P2|Overall Study|Withdrawal by Subject|0
1432169|NCT00966277|4726503|P1|Overall Study|Withdrawal by Subject|3
1432170|NCT00966264|4726511|P2|Overall Study|Lost to Follow-up|3
1432171|NCT00966264|4726512|P1|Overall Study|Lost to Follow-up|4
1432172|NCT00965848|4726558|P3|Overall Study|Other|1
1432173|NCT00965848|4726559|P2|Overall Study|Other|0
1432174|NCT00965848|4726560|P1|Overall Study|Other|5
1432175|NCT00965848|4726558|P3|Overall Study|Not Clinically Evaluable|1
1432176|NCT00965848|4726559|P2|Overall Study|Not Clinically Evaluable|1
1432177|NCT00965848|4726560|P1|Overall Study|Not Clinically Evaluable|7
1432178|NCT00965848|4726558|P3|Overall Study|Indeterminate Clinical Outcome|1
1432179|NCT00965848|4726559|P2|Overall Study|Indeterminate Clinical Outcome|0
1432180|NCT00965848|4726560|P1|Overall Study|Indeterminate Clinical Outcome|2
1432181|NCT00965848|4726558|P3|Overall Study|Withdrawal by Subject|0
1432182|NCT00965848|4726559|P2|Overall Study|Withdrawal by Subject|0
1432183|NCT00965848|4726560|P1|Overall Study|Withdrawal by Subject|1
1432184|NCT00965848|4726558|P3|Overall Study|Lost to Follow-up|1
1432185|NCT00965848|4726559|P2|Overall Study|Lost to Follow-up|0
1432186|NCT00965848|4726560|P1|Overall Study|Lost to Follow-up|0
1432187|NCT00965848|4726558|P3|Overall Study|Death|5
1432188|NCT00965848|4726559|P2|Overall Study|Death|1
1432189|NCT00965848|4726560|P1|Overall Study|Death|11
1432190|NCT00965848|4726558|P3|Overall Study|Protocol Violation|1
1432191|NCT00965848|4726559|P2|Overall Study|Protocol Violation|0
1432192|NCT00965848|4726560|P1|Overall Study|Protocol Violation|3
1432193|NCT00965757|4726579|P4|Extension Phase|Not Specified|1
1432194|NCT00965757|4726580|P3|Extension Phase|Not Specified|2
1432195|NCT00965757|4726581|P2|Extension Phase|Not Specified|0
1432196|NCT00965757|4726582|P1|Extension Phase|Not Specified|0
1432197|NCT00965757|4726579|P4|Extension Phase|Protocol Violation|1
1432198|NCT00965757|4726580|P3|Extension Phase|Protocol Violation|0
1432199|NCT00965757|4726581|P2|Extension Phase|Protocol Violation|0
1432200|NCT00965757|4726582|P1|Extension Phase|Protocol Violation|0
1432201|NCT00965757|4726579|P4|Extension Phase|Ineligible after Taking Study Drug|3
1432202|NCT00965757|4726580|P3|Extension Phase|Ineligible after Taking Study Drug|3
1432203|NCT00965757|4726581|P2|Extension Phase|Ineligible after Taking Study Drug|0
1432204|NCT00965757|4726582|P1|Extension Phase|Ineligible after Taking Study Drug|0
1432205|NCT00965757|4726579|P4|Extension Phase|Lost to Follow-up|1
1432206|NCT00965757|4726580|P3|Extension Phase|Lost to Follow-up|0
1432207|NCT00965757|4726581|P2|Extension Phase|Lost to Follow-up|0
1432208|NCT00965757|4726582|P1|Extension Phase|Lost to Follow-up|0
1432209|NCT00965757|4726579|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
1432210|NCT00965757|4726580|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
1432211|NCT00965757|4726581|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
1432212|NCT00965757|4726582|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
1432213|NCT00965757|4726579|P4|Extension Phase|Lack of Efficacy|12
1432214|NCT00965757|4726580|P3|Extension Phase|Lack of Efficacy|8
1432215|NCT00965757|4726581|P2|Extension Phase|Lack of Efficacy|0
1432216|NCT00965757|4726582|P1|Extension Phase|Lack of Efficacy|0
1432217|NCT00965757|4726579|P4|Extension Phase|Abnormal Laboratory Value|1
1432218|NCT00965757|4726580|P3|Extension Phase|Abnormal Laboratory Value|6
1432219|NCT00965757|4726581|P2|Extension Phase|Abnormal Laboratory Value|0
1432220|NCT00965757|4726582|P1|Extension Phase|Abnormal Laboratory Value|0
1432221|NCT00965757|4726579|P4|Extension Phase|Adverse drug reaction|3
1432222|NCT00965757|4726580|P3|Extension Phase|Adverse drug reaction|6
1432223|NCT00965757|4726581|P2|Extension Phase|Adverse drug reaction|0
1432224|NCT00965757|4726582|P1|Extension Phase|Adverse drug reaction|0
1432225|NCT00965757|4726579|P4|Extension Phase|Progression of concomitant disease|2
1432226|NCT00965757|4726580|P3|Extension Phase|Progression of concomitant disease|4
1432227|NCT00965757|4726581|P2|Extension Phase|Progression of concomitant disease|0
1432228|NCT00965757|4726582|P1|Extension Phase|Progression of concomitant disease|0
1432229|NCT00965757|4726579|P4|Double-blind Phase|Not specified|0
1432230|NCT00965757|4726580|P3|Double-blind Phase|Not specified|0
1432231|NCT00965757|4726581|P2|Double-blind Phase|Not specified|0
1432232|NCT00965757|4726582|P1|Double-blind Phase|Not specified|1
1432233|NCT00965757|4726579|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
1432234|NCT00965757|4726580|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
1432235|NCT00965757|4726581|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
1432236|NCT00965757|4726582|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
1432237|NCT00965757|4726579|P4|Double-blind Phase|Lost to Follow-up|0
1432238|NCT00965757|4726580|P3|Double-blind Phase|Lost to Follow-up|0
1432239|NCT00965757|4726581|P2|Double-blind Phase|Lost to Follow-up|1
1432240|NCT00965757|4726582|P1|Double-blind Phase|Lost to Follow-up|0
1432241|NCT00965757|4726579|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
1432242|NCT00965757|4726580|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
1432243|NCT00965757|4726581|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
1432244|NCT00965757|4726582|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
1432245|NCT00965757|4726579|P4|Double-blind Phase|Lack of Efficacy|0
1432246|NCT00965757|4726580|P3|Double-blind Phase|Lack of Efficacy|0
1432247|NCT00965757|4726581|P2|Double-blind Phase|Lack of Efficacy|11
1432248|NCT00965757|4726582|P1|Double-blind Phase|Lack of Efficacy|7
1432249|NCT00965757|4726579|P4|Double-blind Phase|Abnormal Laboratory Value|0
1432250|NCT00965757|4726580|P3|Double-blind Phase|Abnormal Laboratory Value|0
1432251|NCT00965757|4726581|P2|Double-blind Phase|Abnormal Laboratory Value|0
1432252|NCT00965757|4726582|P1|Double-blind Phase|Abnormal Laboratory Value|2
1432253|NCT00965757|4726579|P4|Double-blind Phase|Adverse drug reaction|0
1432254|NCT00965757|4726580|P3|Double-blind Phase|Adverse drug reaction|0
1432255|NCT00965757|4726581|P2|Double-blind Phase|Adverse drug reaction|1
1432256|NCT00965757|4726582|P1|Double-blind Phase|Adverse drug reaction|2
1432257|NCT00965757|4726579|P4|Double-blind Phase|Progression of concomitant disease|0
1432258|NCT00965757|4726580|P3|Double-blind Phase|Progression of concomitant disease|0
1432259|NCT00965757|4726581|P2|Double-blind Phase|Progression of concomitant disease|2
1432260|NCT00965757|4726582|P1|Double-blind Phase|Progression of concomitant disease|1
1432261|NCT00965731|4726616|P2|Overall Study|Not specified|15
1432262|NCT00965731|4726617|P1|Overall Study|Not specified|7
1432263|NCT00965731|4726616|P2|Overall Study|Withdrawal by Subject|1
1432264|NCT00965731|4726617|P1|Overall Study|Withdrawal by Subject|0
1432265|NCT00965731|4726616|P2|Overall Study|Death|4
1432266|NCT00965731|4726617|P1|Overall Study|Death|0
1432267|NCT00965718|4726681|P1|Overall Study|Withdrawal by Subject|4
1432268|NCT00965562|4726694|P3|Overall Study|Withdrawal by Subject|0
1432269|NCT00965562|4726695|P2|Overall Study|Withdrawal by Subject|2
1432270|NCT00965562|4726696|P1|Overall Study|Withdrawal by Subject|2
1432271|NCT00965562|4726694|P3|Overall Study|Lost to Follow-up|3
1432272|NCT00965562|4726695|P2|Overall Study|Lost to Follow-up|2
1432273|NCT00965562|4726696|P1|Overall Study|Lost to Follow-up|1
1432274|NCT00965523|4726734|P1|Study 224|Physician Decision|1
1432275|NCT00965523|4726734|P1|Study 224|Progressive Disease|5
1432276|NCT00965523|4726734|P1|Study 221|Physician Decision|3
1432277|NCT00965523|4726734|P1|Study 221|Progressive Disease|4
1432278|NCT00965497|4726739|P1|Overall Study|Physician Decision|1
1432279|NCT00965484|4726744|P1|Overall Study|Withdrawal by Subject|1
1432280|NCT00965484|4726744|P1|Overall Study|Protocol Violation|1
1432281|NCT00965458|4726753|P2|Overall Study|Withdrawal by Subject|1
1432282|NCT00965458|4726754|P1|Overall Study|Withdrawal by Subject|0
1432283|NCT00965458|4726753|P2|Overall Study|Lost to Follow-up|3
1432284|NCT00965458|4726754|P1|Overall Study|Lost to Follow-up|1
1432285|NCT00965458|4726753|P2|Overall Study|Adverse Event|0
1432286|NCT00965458|4726754|P1|Overall Study|Adverse Event|1
1432287|NCT00965419|4726770|P1|Follow-up Phase|Lack of Efficacy|28
1432288|NCT00965419|4726770|P1|Follow-up Phase|Parent/Caregiver Decision|9
1432289|NCT00965419|4726770|P1|Follow-up Phase|Physician Decision|4
1432290|NCT00965419|4726770|P1|Follow-up Phase|Withdrawal by Subject|8
1432291|NCT00965419|4726770|P1|Follow-up Phase|Protocol Violation|4
1432292|NCT00965419|4726770|P1|Follow-up Phase|Adverse Event|9
1432293|NCT00965419|4726770|P1|Open Label Treatment for Responders|Lost to Follow-up|46
1432294|NCT00965419|4726770|P1|Open Label Treatment for Responders|Lack of Efficacy|67
1432295|NCT00965419|4726770|P1|Open Label Treatment for Responders|Parent/Caregiver Decision|41
1432296|NCT00965419|4726770|P1|Open Label Treatment for Responders|Sponsor Decision|5
1432297|NCT00965419|4726770|P1|Open Label Treatment for Responders|Physician Decision|6
1432298|NCT00965419|4726770|P1|Open Label Treatment for Responders|Withdrawal by Subject|27
1432299|NCT00965419|4726770|P1|Open Label Treatment for Responders|Protocol Violation|21
1432300|NCT00965419|4726770|P1|Open Label Treatment for Responders|Entry Criteria Not Met|1
1432301|NCT00965419|4726770|P1|Open Label Treatment for Responders|Adverse Event|33
1432302|NCT00965341|4726816|P2|Overall Study|Transportation issues|3
1432303|NCT00965341|4726817|P1|Overall Study|Transportation issues|4
1432304|NCT00965341|4726816|P2|Overall Study|Lost to Follow-up|0
1432305|NCT00965341|4726817|P1|Overall Study|Lost to Follow-up|1
1432306|NCT00965341|4726816|P2|Overall Study|Withdrew consent|5
1432307|NCT00965341|4726817|P1|Overall Study|Withdrew consent|1
1432308|NCT00965263|4726827|P2|Overall Study|Protocol Violation|2
1432309|NCT00965263|4726828|P1|Overall Study|Protocol Violation|0
1432310|NCT00965263|4726827|P2|Overall Study|Family emergency|1
1432311|NCT00965263|4726828|P1|Overall Study|Family emergency|0
1432312|NCT00965263|4726827|P2|Overall Study|Physician Decision|0
1432313|NCT00965263|4726828|P1|Overall Study|Physician Decision|2
1432314|NCT00965185|4726888|P2|Overall Study|Withdrawal by Subject|1
1432315|NCT00965185|4726889|P1|Overall Study|Withdrawal by Subject|0
1432316|NCT00965185|4726888|P2|Overall Study|Lost to Follow-up|0
1432317|NCT00965185|4726889|P1|Overall Study|Lost to Follow-up|2
1432318|NCT00965146|4726909|P1|Overall Study|Overall Study Termination|145
1432319|NCT00965146|4726909|P1|Overall Study|Revision / Removal of Study Implant|6
1432320|NCT00965146|4726909|P1|Overall Study|Intercurrent illness|1
1432321|NCT00965146|4726909|P1|Overall Study|Unwilling to return|11
1432322|NCT00965146|4726909|P1|Overall Study|Unable to return|1
1432323|NCT00965146|4726909|P1|Overall Study|Withdrawal by Subject|17
1432324|NCT00965146|4726909|P1|Overall Study|Lost to Follow-up|22
1432325|NCT00965146|4726909|P1|Overall Study|Death|7
1432326|NCT00965094|4726916|P2|Overall Study|Lost to Follow-up|1
1432327|NCT00965094|4726917|P1|Overall Study|Lost to Follow-up|0
1432328|NCT00965094|4726916|P2|Overall Study|Adverse Event|0
1432329|NCT00965094|4726917|P1|Overall Study|Adverse Event|5
1432330|NCT00965081|4726933|P2|Overall Study|Switched to Rescue Arm|12
1432331|NCT00965081|4726934|P1|Overall Study|Switched to Rescue Arm|5
1432332|NCT00965081|4726933|P2|Overall Study|Withdrawal by Subject|7
1432333|NCT00965081|4726934|P1|Overall Study|Withdrawal by Subject|4
1432334|NCT00965081|4726933|P2|Overall Study|Sponsor Decision|0
1432335|NCT00965081|4726934|P1|Overall Study|Sponsor Decision|1
1432336|NCT00965081|4726933|P2|Overall Study|Protocol Violation|5
1432337|NCT00965081|4726934|P1|Overall Study|Protocol Violation|2
1432338|NCT00965081|4726933|P2|Overall Study|Physician Decision|0
1432339|NCT00965081|4726934|P1|Overall Study|Physician Decision|2
1432340|NCT00965081|4726933|P2|Overall Study|Lost to Follow-up|5
1432341|NCT00965081|4726934|P1|Overall Study|Lost to Follow-up|4
1432342|NCT00965081|4726933|P2|Overall Study|Lack of Efficacy|5
1432343|NCT00965081|4726934|P1|Overall Study|Lack of Efficacy|2
1432344|NCT00965081|4726933|P2|Overall Study|Adverse Event|9
1432345|NCT00965081|4726934|P1|Overall Study|Adverse Event|14
1432346|NCT00964886|4726961|P4|Overall Study|Protocol Violation|0
1432347|NCT00964886|4726962|P3|Overall Study|Protocol Violation|0
1432348|NCT00964886|4726963|P2|Overall Study|Protocol Violation|2
1432349|NCT00964886|4726964|P1|Overall Study|Protocol Violation|0
1432350|NCT00964886|4726961|P4|Overall Study|Adverse Event|2
1432351|NCT00964886|4726962|P3|Overall Study|Adverse Event|5
1432352|NCT00964886|4726963|P2|Overall Study|Adverse Event|1
1432353|NCT00964886|4726964|P1|Overall Study|Adverse Event|3
1432354|NCT00964886|4726961|P4|Overall Study|Withdrawal by Subject|3
1432355|NCT00964886|4726962|P3|Overall Study|Withdrawal by Subject|5
1432356|NCT00964886|4726963|P2|Overall Study|Withdrawal by Subject|2
1432357|NCT00964886|4726964|P1|Overall Study|Withdrawal by Subject|6
1432358|NCT00964886|4726961|P4|Overall Study|Lost to Follow-up|4
1432359|NCT00964886|4726962|P3|Overall Study|Lost to Follow-up|6
1432360|NCT00964886|4726963|P2|Overall Study|Lost to Follow-up|2
1432361|NCT00964886|4726964|P1|Overall Study|Lost to Follow-up|2
1432362|NCT00964860|4726980|P2|Overall Study|Withdrawal by Subject|1
1432363|NCT00964860|4726981|P1|Overall Study|Withdrawal by Subject|0
1432364|NCT00964795|4726989|P1|Overall Study|Other|23
1432365|NCT00964795|4726989|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
1432366|NCT00964795|4726989|P1|Overall Study|Termination of Study by Sponsor|169
1432367|NCT00964795|4726989|P1|Overall Study|Lost to Follow-up|7
1432368|NCT00964795|4726989|P1|Overall Study|Death|14
1432369|NCT00964795|4726989|P1|Overall Study|Adverse Event|12
1432370|NCT00964795|4726989|P1|Overall Study|Withdrawal by Subject|79
1432371|NCT00964743|4726996|P1|Overall Study|Neither patient completed 8 weeks of tre|2
1432372|NCT00964678|4727004|P1|Overall Study|Physician Decision|4
1432373|NCT00964392|4727068|P2|Overall Study|Not completed|168
1432374|NCT00964392|4727069|P1|Overall Study|Not completed|44
1432375|NCT00964392|4727068|P2|Overall Study|Early Termination, non-study arrhythmia|6
1432376|NCT00964392|4727069|P1|Overall Study|Early Termination, non-study arrhythmia|1
1432377|NCT00964392|4727068|P2|Overall Study|Lost to Follow-up|10
1432378|NCT00964392|4727069|P1|Overall Study|Lost to Follow-up|4
1432379|NCT00964392|4727068|P2|Overall Study|Withdrawal by Subject|6
1432380|NCT00964392|4727069|P1|Overall Study|Withdrawal by Subject|4
1432381|NCT00964366|4727079|P2|Overall Study|Withdrawal by Subject|1
1432382|NCT00964366|4727080|P1|Overall Study|Withdrawal by Subject|0
1432383|NCT00964366|4727079|P2|Overall Study|Did not qualify at Day 1|0
1432384|NCT00964366|4727080|P1|Overall Study|Did not qualify at Day 1|1
1432385|NCT00964223|4727094|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
1432386|NCT00964158|4727162|P3|Overall Study|Withdrawal by Subject|6
1432387|NCT00964158|4727163|P2|Overall Study|Withdrawal by Subject|0
1432388|NCT00964158|4727164|P1|Overall Study|Withdrawal by Subject|0
1432389|NCT00964158|4727162|P3|Overall Study|Lost to Follow-up|2
1432390|NCT00964158|4727163|P2|Overall Study|Lost to Follow-up|1
1432391|NCT00964158|4727164|P1|Overall Study|Lost to Follow-up|0
1432392|NCT00964028|4727239|P2|Overall Study|Withdrawal by Subject|1
1432393|NCT00964028|4727240|P1|Overall Study|Withdrawal by Subject|0
1432394|NCT00963937|4727255|P3|Overall Study|Physician Decision|4
1432395|NCT00963937|4727256|P2|Overall Study|Physician Decision|10
1432396|NCT00963937|4727257|P1|Overall Study|Physician Decision|18
1432397|NCT00963937|4727255|P3|Overall Study|Protocol Violation|0
1432398|NCT00963937|4727256|P2|Overall Study|Protocol Violation|1
1432399|NCT00963937|4727257|P1|Overall Study|Protocol Violation|1
1432400|NCT00963924|4727295|P2|Overall Study|Lost to Follow-up|1
1432401|NCT00963924|4727296|P1|Overall Study|Lost to Follow-up|0
1432402|NCT00963924|4727295|P2|Overall Study|Changed antipsychotic|1
1432403|NCT00963924|4727296|P1|Overall Study|Changed antipsychotic|0
1432404|NCT00963924|4727295|P2|Overall Study|Withdrawal by Subject|1
1432405|NCT00963924|4727296|P1|Overall Study|Withdrawal by Subject|0
1432406|NCT00963924|4727295|P2|Overall Study|Adverse Event|0
1432407|NCT00963924|4727296|P1|Overall Study|Adverse Event|1
1432408|NCT00963820|4727370|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
1432409|NCT00963820|4727371|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
1432410|NCT00963820|4727372|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
1432411|NCT00963820|4727373|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
1432412|NCT00963820|4727374|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
1432413|NCT00963820|4727375|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
1432414|NCT00963820|4727376|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
1432415|NCT00963820|4727377|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
1432416|NCT00963820|4727378|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
1432417|NCT00963820|4727379|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
1432418|NCT00963820|4727380|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
1432419|NCT00963820|4727381|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
1432420|NCT00963820|4727370|P12|Expansion Phase|Withdrawal by Subject|1
1432421|NCT00963820|4727371|P11|Expansion Phase|Withdrawal by Subject|1
1432422|NCT00963820|4727372|P10|Expansion Phase|Withdrawal by Subject|0
1432423|NCT00963820|4727373|P9|Expansion Phase|Withdrawal by Subject|1
1432424|NCT00963820|4727374|P8|Expansion Phase|Withdrawal by Subject|0
1432425|NCT00963820|4727375|P7|Expansion Phase|Withdrawal by Subject|0
1432426|NCT00963820|4727376|P6|Expansion Phase|Withdrawal by Subject|0
1432427|NCT00963820|4727377|P5|Expansion Phase|Withdrawal by Subject|0
1432428|NCT00963820|4727378|P4|Expansion Phase|Withdrawal by Subject|0
1432429|NCT00963820|4727379|P3|Expansion Phase|Withdrawal by Subject|0
1432430|NCT00963820|4727380|P2|Expansion Phase|Withdrawal by Subject|0
1432431|NCT00963820|4727381|P1|Expansion Phase|Withdrawal by Subject|0
1432432|NCT00963820|4727370|P12|Expansion Phase|Adverse Event|0
1432433|NCT00963820|4727371|P11|Expansion Phase|Adverse Event|0
1432434|NCT00963820|4727372|P10|Expansion Phase|Adverse Event|3
1432435|NCT00963820|4727373|P9|Expansion Phase|Adverse Event|1
1432436|NCT00963820|4727374|P8|Expansion Phase|Adverse Event|0
1432437|NCT00963820|4727375|P7|Expansion Phase|Adverse Event|0
1432438|NCT00963820|4727376|P6|Expansion Phase|Adverse Event|0
1432439|NCT00963820|4727377|P5|Expansion Phase|Adverse Event|0
1432440|NCT00963820|4727378|P4|Expansion Phase|Adverse Event|0
1432441|NCT00963820|4727379|P3|Expansion Phase|Adverse Event|0
1432442|NCT00963820|4727380|P2|Expansion Phase|Adverse Event|0
1432443|NCT00963820|4727381|P1|Expansion Phase|Adverse Event|0
1432444|NCT00963820|4727370|P12|Expansion Phase|Progressive Disease|2
1432445|NCT00963820|4727371|P11|Expansion Phase|Progressive Disease|4
1432446|NCT00963820|4727372|P10|Expansion Phase|Progressive Disease|6
1432447|NCT00963820|4727373|P9|Expansion Phase|Progressive Disease|8
1432448|NCT00963820|4727374|P8|Expansion Phase|Progressive Disease|0
1432449|NCT00963820|4727375|P7|Expansion Phase|Progressive Disease|0
1432450|NCT00963820|4727376|P6|Expansion Phase|Progressive Disease|0
1432451|NCT00963820|4727377|P5|Expansion Phase|Progressive Disease|0
1432452|NCT00963820|4727378|P4|Expansion Phase|Progressive Disease|0
1432453|NCT00963820|4727379|P3|Expansion Phase|Progressive Disease|0
1432454|NCT00963820|4727380|P2|Expansion Phase|Progressive Disease|0
1432455|NCT00963820|4727381|P1|Expansion Phase|Progressive Disease|0
1432456|NCT00963820|4727370|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1432457|NCT00963820|4727371|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1432458|NCT00963820|4727372|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1432459|NCT00963820|4727373|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1432460|NCT00963820|4727374|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1432461|NCT00963820|4727375|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
1432462|NCT00963820|4727376|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1432463|NCT00963820|4727377|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1432464|NCT00963820|4727378|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1432465|NCT00963820|4727379|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1432466|NCT00963820|4727380|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1432467|NCT00963820|4727381|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1432468|NCT00963820|4727370|P12|Dose Escalation Phase|Withdrawal by Subject|0
1432469|NCT00963820|4727371|P11|Dose Escalation Phase|Withdrawal by Subject|0
1432470|NCT00963820|4727372|P10|Dose Escalation Phase|Withdrawal by Subject|0
1432471|NCT00963820|4727373|P9|Dose Escalation Phase|Withdrawal by Subject|0
1432472|NCT00963820|4727374|P8|Dose Escalation Phase|Withdrawal by Subject|2
1432473|NCT00963820|4727375|P7|Dose Escalation Phase|Withdrawal by Subject|1
1432474|NCT00963820|4727376|P6|Dose Escalation Phase|Withdrawal by Subject|0
1432475|NCT00963820|4727377|P5|Dose Escalation Phase|Withdrawal by Subject|0
1432476|NCT00963820|4727378|P4|Dose Escalation Phase|Withdrawal by Subject|0
1432477|NCT00963820|4727379|P3|Dose Escalation Phase|Withdrawal by Subject|0
1432478|NCT00963820|4727380|P2|Dose Escalation Phase|Withdrawal by Subject|0
1432479|NCT00963820|4727381|P1|Dose Escalation Phase|Withdrawal by Subject|0
1432480|NCT00963820|4727370|P12|Dose Escalation Phase|Adverse Event|0
1432481|NCT00963820|4727371|P11|Dose Escalation Phase|Adverse Event|0
1432482|NCT00963820|4727372|P10|Dose Escalation Phase|Adverse Event|0
1432483|NCT00963820|4727373|P9|Dose Escalation Phase|Adverse Event|0
1432484|NCT00963820|4727374|P8|Dose Escalation Phase|Adverse Event|1
1432485|NCT00963820|4727375|P7|Dose Escalation Phase|Adverse Event|3
1432486|NCT00963820|4727376|P6|Dose Escalation Phase|Adverse Event|0
1432487|NCT00963820|4727377|P5|Dose Escalation Phase|Adverse Event|0
1432488|NCT00963820|4727378|P4|Dose Escalation Phase|Adverse Event|0
1432489|NCT00963820|4727379|P3|Dose Escalation Phase|Adverse Event|0
1432490|NCT00963820|4727380|P2|Dose Escalation Phase|Adverse Event|0
1432491|NCT00963820|4727381|P1|Dose Escalation Phase|Adverse Event|0
1432492|NCT00963820|4727370|P12|Dose Escalation Phase|Progressive Disease|0
1432493|NCT00963820|4727371|P11|Dose Escalation Phase|Progressive Disease|0
1432494|NCT00963820|4727372|P10|Dose Escalation Phase|Progressive Disease|0
1432495|NCT00963820|4727373|P9|Dose Escalation Phase|Progressive Disease|0
1432496|NCT00963820|4727374|P8|Dose Escalation Phase|Progressive Disease|2
1432497|NCT00963820|4727375|P7|Dose Escalation Phase|Progressive Disease|3
1432498|NCT00963820|4727376|P6|Dose Escalation Phase|Progressive Disease|3
1432499|NCT00963820|4727377|P5|Dose Escalation Phase|Progressive Disease|4
1432500|NCT00963820|4727378|P4|Dose Escalation Phase|Progressive Disease|3
1432501|NCT00963820|4727379|P3|Dose Escalation Phase|Progressive Disease|3
1432502|NCT00963820|4727380|P2|Dose Escalation Phase|Progressive Disease|3
1432503|NCT00963820|4727381|P1|Dose Escalation Phase|Progressive Disease|3
1432504|NCT00963807|4727517|P1|Overall Study|Disease progression|15
1432505|NCT00963807|4727517|P1|Overall Study|Reaction to study chemotherapy regimen|1
1432506|NCT00963807|4727517|P1|Overall Study|Physician Decision|2
1432507|NCT00963599|4727550|P4|Overall Study|Withdrawal by Subject|3
1432508|NCT00963599|4727551|P3|Overall Study|Withdrawal by Subject|3
1432509|NCT00963599|4727552|P2|Overall Study|Withdrawal by Subject|1
1432510|NCT00963599|4727553|P1|Overall Study|Withdrawal by Subject|2
1432511|NCT00963599|4727550|P4|Overall Study|Protocol Violation|4
1432512|NCT00963599|4727551|P3|Overall Study|Protocol Violation|3
1432513|NCT00963599|4727552|P2|Overall Study|Protocol Violation|2
1432514|NCT00963599|4727553|P1|Overall Study|Protocol Violation|2
1432515|NCT00963599|4727550|P4|Overall Study|Lost to Follow-up|1
1432516|NCT00963599|4727551|P3|Overall Study|Lost to Follow-up|1
1432517|NCT00963599|4727552|P2|Overall Study|Lost to Follow-up|1
1432518|NCT00963599|4727553|P1|Overall Study|Lost to Follow-up|0
1432519|NCT00963599|4727550|P4|Overall Study|Lack of Efficacy|4
1432520|NCT00963599|4727551|P3|Overall Study|Lack of Efficacy|1
1432521|NCT00963599|4727552|P2|Overall Study|Lack of Efficacy|2
1432522|NCT00963599|4727553|P1|Overall Study|Lack of Efficacy|0
1432523|NCT00963599|4727550|P4|Overall Study|Adverse Event|2
1432524|NCT00963599|4727551|P3|Overall Study|Adverse Event|1
1432525|NCT00963599|4727552|P2|Overall Study|Adverse Event|0
1432526|NCT00963599|4727553|P1|Overall Study|Adverse Event|2
1432527|NCT00963469|4727643|P3|Overall Study|Site closed (local pollen Season ended)|3
1432528|NCT00963469|4727644|P2|Overall Study|Site closed (local pollen Season ended)|1
1432529|NCT00963469|4727645|P1|Overall Study|Site closed (local pollen Season ended)|4
1432530|NCT00963469|4727643|P3|Overall Study|Moved|0
1432531|NCT00963469|4727644|P2|Overall Study|Moved|0
1432532|NCT00963469|4727645|P1|Overall Study|Moved|1
1432533|NCT00963469|4727643|P3|Overall Study|Pre-randomization Adverse Event|0
1432534|NCT00963469|4727644|P2|Overall Study|Pre-randomization Adverse Event|2
1432535|NCT00963469|4727645|P1|Overall Study|Pre-randomization Adverse Event|1
1432536|NCT00963469|4727643|P3|Overall Study|Withdrawal by Subject|1
1432537|NCT00963469|4727644|P2|Overall Study|Withdrawal by Subject|1
1432538|NCT00963469|4727645|P1|Overall Study|Withdrawal by Subject|4
1432539|NCT00963469|4727643|P3|Overall Study|Protocol Violation|3
1432540|NCT00963469|4727644|P2|Overall Study|Protocol Violation|5
1432541|NCT00963469|4727645|P1|Overall Study|Protocol Violation|5
1432542|NCT00963469|4727643|P3|Overall Study|Lost to Follow-up|0
1432543|NCT00963469|4727644|P2|Overall Study|Lost to Follow-up|1
1432544|NCT00963469|4727645|P1|Overall Study|Lost to Follow-up|1
1432545|NCT00963469|4727643|P3|Overall Study|Lack of Efficacy|2
1432546|NCT00963469|4727644|P2|Overall Study|Lack of Efficacy|7
1432547|NCT00963469|4727645|P1|Overall Study|Lack of Efficacy|10
1432548|NCT00963469|4727643|P3|Overall Study|Adverse Event|1
1432549|NCT00963469|4727644|P2|Overall Study|Adverse Event|11
1432550|NCT00963469|4727645|P1|Overall Study|Adverse Event|15
1432551|NCT00963235|4727712|P1|Overall Study|Other|1
1432552|NCT00963235|4727712|P1|Overall Study|Physician Decision|2
1432553|NCT00963235|4727712|P1|Overall Study|Adverse Event|5
1432554|NCT00963235|4727712|P1|Overall Study|Protocol Violation|7
1432555|NCT00963235|4727712|P1|Overall Study|Failed to return|9
1432556|NCT00963235|4727712|P1|Overall Study|Lost to Follow-up|14
1432557|NCT00963235|4727712|P1|Overall Study|Withdrawal by Subject|22
1432558|NCT00962780|4727970|P2|Overall Study|Other|1
1432559|NCT00962780|4727971|P1|Overall Study|Other|0
1432560|NCT00962780|4727970|P2|Overall Study|Withdrawal by Subject|8
1432561|NCT00962780|4727971|P1|Overall Study|Withdrawal by Subject|1
1432562|NCT00962780|4727970|P2|Overall Study|Protocol Violation|4
1432563|NCT00962780|4727971|P1|Overall Study|Protocol Violation|9
1432564|NCT00962780|4727970|P2|Overall Study|Death|1
1432565|NCT00962780|4727971|P1|Overall Study|Death|0
1432566|NCT00962741|4728046|P1|Overall Study|drug ineffective+prohibited drug taken|1
1432567|NCT00962741|4728046|P1|Overall Study|Lack of Efficacy|1
1432568|NCT00962741|4728046|P1|Overall Study|Withdrawal by Subject|1
1432569|NCT00962741|4728046|P1|Overall Study|Lost to Follow-up|2
1432570|NCT00962741|4728046|P1|Overall Study|Failed to return|3
1432571|NCT00962650|4728137|P1|Overall Study|Transgastric DP was not completed|2
1432572|NCT00962585|4728156|P4|Overall Study|Withdrew Consent|0
1432573|NCT00962585|4728157|P3|Overall Study|Withdrew Consent|0
1432574|NCT00962585|4728158|P2|Overall Study|Withdrew Consent|0
1432575|NCT00962585|4728159|P1|Overall Study|Withdrew Consent|2
1432576|NCT00962585|4728156|P4|Overall Study|Withdrawal by Subject|0
1432577|NCT00962585|4728157|P3|Overall Study|Withdrawal by Subject|0
1432578|NCT00962585|4728158|P2|Overall Study|Withdrawal by Subject|0
1432579|NCT00962585|4728159|P1|Overall Study|Withdrawal by Subject|1
1432580|NCT00962585|4728156|P4|Overall Study|Protocol Violation|0
1432581|NCT00962585|4728157|P3|Overall Study|Protocol Violation|1
1432582|NCT00962585|4728158|P2|Overall Study|Protocol Violation|0
1432583|NCT00962585|4728159|P1|Overall Study|Protocol Violation|0
1432584|NCT00962585|4728156|P4|Overall Study|Lost to Follow-up|0
1432585|NCT00962585|4728157|P3|Overall Study|Lost to Follow-up|1
1432586|NCT00962585|4728158|P2|Overall Study|Lost to Follow-up|0
1432587|NCT00962585|4728159|P1|Overall Study|Lost to Follow-up|3
1432588|NCT00962585|4728156|P4|Overall Study|Adverse Event|0
1432589|NCT00962585|4728157|P3|Overall Study|Adverse Event|1
1432590|NCT00962585|4728158|P2|Overall Study|Adverse Event|2
1432591|NCT00962585|4728159|P1|Overall Study|Adverse Event|0
1432592|NCT00962390|4728221|P4|Overall Study|Withdrawal by Subject|0
1432593|NCT00962390|4728222|P3|Overall Study|Withdrawal by Subject|1
1432594|NCT00962390|4728223|P2|Overall Study|Withdrawal by Subject|1
1432595|NCT00962390|4728224|P1|Overall Study|Withdrawal by Subject|1
1432596|NCT00962390|4728221|P4|Overall Study|Protocol Violation|0
1432597|NCT00962390|4728222|P3|Overall Study|Protocol Violation|0
1432598|NCT00962390|4728223|P2|Overall Study|Protocol Violation|0
1432599|NCT00962390|4728224|P1|Overall Study|Protocol Violation|1
1432600|NCT00962390|4728221|P4|Overall Study|Lost to Follow-up|0
1432601|NCT00962390|4728222|P3|Overall Study|Lost to Follow-up|0
1432602|NCT00962390|4728223|P2|Overall Study|Lost to Follow-up|2
1432603|NCT00962390|4728224|P1|Overall Study|Lost to Follow-up|2
1432604|NCT00962390|4728221|P4|Overall Study|Adverse Event|1
1432605|NCT00962390|4728222|P3|Overall Study|Adverse Event|3
1432606|NCT00962390|4728223|P2|Overall Study|Adverse Event|0
1432607|NCT00962390|4728224|P1|Overall Study|Adverse Event|0
1432608|NCT00962247|4728286|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
1432609|NCT00962247|4728286|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
1432610|NCT00962247|4728286|P1|Usual Sedentary|Withdrawal by Subject|5
1432611|NCT00962247|4728286|P1|Usual Sedentary|Protocol Violation|13
1432612|NCT00962208|4728297|P2|Overall Study|Lost to Follow-up|9
1432613|NCT00962208|4728298|P1|Overall Study|Lost to Follow-up|0
1432614|NCT00962208|4728297|P2|Overall Study|Contraindicated to continue study|1
1432615|NCT00962208|4728298|P1|Overall Study|Contraindicated to continue study|5
1432616|NCT00962208|4728297|P2|Overall Study|Could not achieve good vision|0
1432617|NCT00962208|4728298|P1|Overall Study|Could not achieve good vision|9
1432618|NCT00962104|4728306|P2|Overall Study|Other|0
1432619|NCT00962104|4728307|P1|Overall Study|Other|2
1432620|NCT00962104|4728306|P2|Overall Study|Withdrawal by Subject|6
1432621|NCT00962104|4728307|P1|Overall Study|Withdrawal by Subject|10
1432622|NCT00962104|4728306|P2|Overall Study|Sponsor Decision|1
1432623|NCT00962104|4728307|P1|Overall Study|Sponsor Decision|0
1432624|NCT00962104|4728306|P2|Overall Study|Protocol Violation|8
1432625|NCT00962104|4728307|P1|Overall Study|Protocol Violation|6
1432626|NCT00962104|4728306|P2|Overall Study|Physician Decision|0
1432627|NCT00962104|4728307|P1|Overall Study|Physician Decision|1
1432628|NCT00962104|4728306|P2|Overall Study|Lost to Follow-up|4
1432629|NCT00962104|4728307|P1|Overall Study|Lost to Follow-up|10
1432630|NCT00962104|4728306|P2|Overall Study|Lack of Efficacy|1
1432631|NCT00962104|4728307|P1|Overall Study|Lack of Efficacy|0
1432632|NCT00962104|4728306|P2|Overall Study|Entry Criteria Not Met|2
1432633|NCT00962104|4728307|P1|Overall Study|Entry Criteria Not Met|1
1432634|NCT00962104|4728306|P2|Overall Study|Adverse Event|3
1432635|NCT00962104|4728307|P1|Overall Study|Adverse Event|10
1432636|NCT00962013|4728361|P1|Overall Study|No 5 year evaluation|6
1432637|NCT00962013|4728361|P1|Overall Study|Site Termination|24
1432638|NCT00962013|4728361|P1|Overall Study|Removal of study device|3
1432639|NCT00962013|4728361|P1|Overall Study|Withdrawal by Subject|8
1432640|NCT00962013|4728361|P1|Overall Study|Unable/Unwilling to return|6
1432641|NCT00962013|4728361|P1|Overall Study|Lost to Follow-up|12
1432642|NCT00962013|4728361|P1|Overall Study|Death|8
1432643|NCT00962013|4728361|P1|Overall Study|Did not have surgery|1
1432644|NCT00961896|4728384|P3|Overall Study|Abnormal laboratory value|1
1432645|NCT00961896|4728385|P2|Overall Study|Abnormal laboratory value|0
1432646|NCT00961896|4728386|P1|Overall Study|Abnormal laboratory value|0
1432647|NCT00961649|4728453|P4|Overall Study|Study terminated by sponsor|1
1432648|NCT00961649|4728454|P3|Overall Study|Study terminated by sponsor|4
1432649|NCT00961649|4728455|P2|Overall Study|Study terminated by sponsor|4
1432650|NCT00961649|4728456|P1|Overall Study|Study terminated by sponsor|4
1432651|NCT00961649|4728453|P4|Overall Study|Patient left to Mexico-family emergency|0
1432652|NCT00961649|4728454|P3|Overall Study|Patient left to Mexico-family emergency|0
1432653|NCT00961649|4728455|P2|Overall Study|Patient left to Mexico-family emergency|0
1432654|NCT00961649|4728456|P1|Overall Study|Patient left to Mexico-family emergency|1
1432655|NCT00961649|4728453|P4|Overall Study|Patient has travel plans during holidays|0
1432656|NCT00961649|4728454|P3|Overall Study|Patient has travel plans during holidays|1
1432657|NCT00961649|4728455|P2|Overall Study|Patient has travel plans during holidays|0
1432658|NCT00961649|4728456|P1|Overall Study|Patient has travel plans during holidays|0
1432659|NCT00961649|4728453|P4|Overall Study|Inadequate control of IOP|1
1432660|NCT00961649|4728454|P3|Overall Study|Inadequate control of IOP|0
1432661|NCT00961649|4728455|P2|Overall Study|Inadequate control of IOP|0
1432662|NCT00961649|4728456|P1|Overall Study|Inadequate control of IOP|0
1432663|NCT00961649|4728453|P4|Overall Study|Adverse Event|2
1432664|NCT00961649|4728454|P3|Overall Study|Adverse Event|0
1432665|NCT00961649|4728455|P2|Overall Study|Adverse Event|0
1432666|NCT00961649|4728456|P1|Overall Study|Adverse Event|4
1432667|NCT00961636|4728470|P3|Overall Study|Withdrawal by Subject|13
1432668|NCT00961636|4728471|P2|Overall Study|Withdrawal by Subject|22
1432669|NCT00961636|4728472|P1|Overall Study|Withdrawal by Subject|29
1432670|NCT00961636|4728470|P3|Overall Study|Protocol Violation|1
1432671|NCT00961636|4728471|P2|Overall Study|Protocol Violation|5
1432672|NCT00961636|4728472|P1|Overall Study|Protocol Violation|9
1432673|NCT00961636|4728470|P3|Overall Study|Physician Decision|1
1432674|NCT00961636|4728471|P2|Overall Study|Physician Decision|1
1432675|NCT00961636|4728472|P1|Overall Study|Physician Decision|3
1432676|NCT00961636|4728470|P3|Overall Study|Lost to Follow-up|1
1432677|NCT00961636|4728471|P2|Overall Study|Lost to Follow-up|3
1432678|NCT00961636|4728472|P1|Overall Study|Lost to Follow-up|2
1432679|NCT00961636|4728470|P3|Overall Study|Flushing Symptoms|3
1432680|NCT00961636|4728471|P2|Overall Study|Flushing Symptoms|46
1432681|NCT00961636|4728472|P1|Overall Study|Flushing Symptoms|29
1432682|NCT00961636|4728470|P3|Overall Study|Adverse Event|13
1432683|NCT00961636|4728471|P2|Overall Study|Adverse Event|54
1432684|NCT00961636|4728472|P1|Overall Study|Adverse Event|35
1432685|NCT00961571|4728483|P1|Overall Study|Physician Decision|39
1432686|NCT00961415|4728511|P3|Maintenance Treatment Phase|Other reason|3
1432687|NCT00961415|4728512|P2|Maintenance Treatment Phase|Other reason|1
1432688|NCT00961415|4728513|P1|Maintenance Treatment Phase|Other reason|0
1432689|NCT00961415|4728511|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
1432690|NCT00961415|4728512|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
1432691|NCT00961415|4728513|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
1432692|NCT00961415|4728511|P3|Maintenance Treatment Phase|Investigators decision|0
1432693|NCT00961415|4728512|P2|Maintenance Treatment Phase|Investigators decision|2
1432694|NCT00961415|4728513|P1|Maintenance Treatment Phase|Investigators decision|0
1432695|NCT00961415|4728511|P3|Maintenance Treatment Phase|Death|34
1432696|NCT00961415|4728512|P2|Maintenance Treatment Phase|Death|42
1432697|NCT00961415|4728513|P1|Maintenance Treatment Phase|Death|0
1432698|NCT00961415|4728511|P3|Induction Treatment Phase|Other Reason|0
1432699|NCT00961415|4728512|P2|Induction Treatment Phase|Other Reason|0
1432700|NCT00961415|4728513|P1|Induction Treatment Phase|Other Reason|5
1432701|NCT00961415|4728511|P3|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
1432702|NCT00961415|4728512|P2|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
1432703|NCT00961415|4728513|P1|Induction Treatment Phase|Didn’t meet maintenance phase criteria|27
1432704|NCT00961415|4728511|P3|Induction Treatment Phase|Physician Decision|0
1432705|NCT00961415|4728512|P2|Induction Treatment Phase|Physician Decision|0
1432706|NCT00961415|4728513|P1|Induction Treatment Phase|Physician Decision|2
1432707|NCT00961415|4728511|P3|Induction Treatment Phase|Protocol Violation|0
1432708|NCT00961415|4728512|P2|Induction Treatment Phase|Protocol Violation|0
1432709|NCT00961415|4728513|P1|Induction Treatment Phase|Protocol Violation|1
1432710|NCT00961415|4728511|P3|Induction Treatment Phase|Death|0
1432711|NCT00961415|4728512|P2|Induction Treatment Phase|Death|0
1432712|NCT00961415|4728513|P1|Induction Treatment Phase|Death|77
1432713|NCT00961415|4728511|P3|Induction Treatment Phase|Withdrawal by Subject|0
1432714|NCT00961415|4728512|P2|Induction Treatment Phase|Withdrawal by Subject|0
1432715|NCT00961415|4728513|P1|Induction Treatment Phase|Withdrawal by Subject|11
1432716|NCT00961350|4728553|P2|Overall Study|Misc|21
1432717|NCT00961350|4728554|P1|Overall Study|Misc|16
1432718|NCT00961350|4728553|P2|Overall Study|Lost to Follow-up|3
1432719|NCT00961350|4728554|P1|Overall Study|Lost to Follow-up|3
1432720|NCT00961350|4728553|P2|Overall Study|Withdrawal by Subject|10
1432721|NCT00961350|4728554|P1|Overall Study|Withdrawal by Subject|10
1432722|NCT00961350|4728553|P2|Overall Study|Adverse Event|33
1432723|NCT00961350|4728554|P1|Overall Study|Adverse Event|18
1432724|NCT00961298|4728575|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
1432725|NCT00961298|4728575|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
1432726|NCT00961298|4728575|P1|Two Week Placebo Run in|Withdrawal by Subject|1
1432727|NCT00961259|4728582|P3|Washout Period of 7 Days|due to concomitant medication used|0
1432728|NCT00961259|4728583|P2|Washout Period of 7 Days|due to concomitant medication used|1
1432729|NCT00961259|4728584|P1|Washout Period of 7 Days|due to concomitant medication used|0
1432730|NCT00961220|4728612|P1|Overall Study|Complete Response prior to 12 courses|1
1432731|NCT00961220|4728612|P1|Overall Study|O6BG no longer supplied|1
1432732|NCT00961220|4728612|P1|Overall Study|No IV access for O6BG|1
1432733|NCT00961220|4728612|P1|Overall Study|Lack of Efficacy|1
1432734|NCT00961220|4728612|P1|Overall Study|Adverse Event|3
1432735|NCT00961181|4728628|P1|Overall Study|Lost to Follow-up|1
1432736|NCT00961181|4728628|P1|Overall Study|Withdrawal by Subject|2
1432737|NCT00961181|4728628|P1|Overall Study|Death|2
1432738|NCT00961116|4728641|P2|Washout Period of 7 Days|Protocol Violation|1
1432739|NCT00961116|4728642|P1|Washout Period of 7 Days|Protocol Violation|0
1432740|NCT00961116|4728641|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1432741|NCT00961116|4728642|P1|Washout Period of 7 Days|Withdrawal by Subject|1
1432742|NCT00961116|4728641|P2|Washout Period of 7 Days|Adverse Event|1
1432743|NCT00961116|4728642|P1|Washout Period of 7 Days|Adverse Event|1
1432744|NCT00960999|4728665|P2|Overall Study|RT dose constraints not met|0
1432745|NCT00960999|4728666|P1|Overall Study|RT dose constraints not met|2
1432746|NCT00960999|4728665|P2|Overall Study|Protocol Violation|2
1432747|NCT00960999|4728666|P1|Overall Study|Protocol Violation|5
1432748|NCT00960999|4728665|P2|Overall Study|Withdrawal by Subject|0
1432749|NCT00960999|4728666|P1|Overall Study|Withdrawal by Subject|1
1432750|NCT00960986|4728676|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
1432751|NCT00960986|4728677|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
1432752|NCT00960986|4728678|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
1432753|NCT00960986|4728679|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
1432754|NCT00960986|4728676|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
1432755|NCT00960986|4728677|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
1432756|NCT00960986|4728678|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
1432757|NCT00960986|4728679|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
1432758|NCT00960986|4728676|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
1432759|NCT00960986|4728677|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
1432760|NCT00960986|4728678|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
1432761|NCT00960986|4728679|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
1432762|NCT00960986|4728676|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
1432763|NCT00960986|4728677|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
1432764|NCT00960986|4728678|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
1432765|NCT00960986|4728679|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
1432766|NCT00960986|4728676|P4|Period 3 (7-week Therapy Period)|Death|0
1432767|NCT00960986|4728677|P3|Period 3 (7-week Therapy Period)|Death|1
1432768|NCT00960986|4728678|P2|Period 3 (7-week Therapy Period)|Death|0
1432769|NCT00960986|4728679|P1|Period 3 (7-week Therapy Period)|Death|0
1432770|NCT00960986|4728676|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
1432771|NCT00960986|4728677|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
1432772|NCT00960986|4728678|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
1432773|NCT00960986|4728679|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
1432774|NCT00960986|4728676|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
1432775|NCT00960986|4728677|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
1432776|NCT00960986|4728678|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
1432777|NCT00960986|4728679|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
1432778|NCT00960986|4728676|P4|Period 1 (Screening and Washout)|Protocol Violation|0
1432779|NCT00960986|4728677|P3|Period 1 (Screening and Washout)|Protocol Violation|0
1432780|NCT00960986|4728678|P2|Period 1 (Screening and Washout)|Protocol Violation|0
1432781|NCT00960986|4728679|P1|Period 1 (Screening and Washout)|Protocol Violation|1
1432782|NCT00960986|4728676|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
1432783|NCT00960986|4728677|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
1432784|NCT00960986|4728678|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
1432785|NCT00960986|4728679|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
1432786|NCT00960986|4728676|P4|Period 1 (Screening and Washout)|Adverse Event|1
1432787|NCT00960986|4728677|P3|Period 1 (Screening and Washout)|Adverse Event|1
1432788|NCT00960986|4728678|P2|Period 1 (Screening and Washout)|Adverse Event|2
1432789|NCT00960986|4728679|P1|Period 1 (Screening and Washout)|Adverse Event|1
1432790|NCT00960934|4728755|P6|Overall Study|Study Terminated by Sponsor|49
1432791|NCT00960934|4728756|P5|Overall Study|Study Terminated by Sponsor|49
1432792|NCT00960934|4728757|P4|Overall Study|Study Terminated by Sponsor|50
1432793|NCT00960934|4728758|P3|Overall Study|Study Terminated by Sponsor|52
1432794|NCT00960934|4728759|P2|Overall Study|Study Terminated by Sponsor|46
1432795|NCT00960934|4728760|P1|Overall Study|Study Terminated by Sponsor|50
1432796|NCT00960934|4728755|P6|Overall Study|Withdrawal by Subject|7
1432797|NCT00960934|4728756|P5|Overall Study|Withdrawal by Subject|5
1432798|NCT00960934|4728757|P4|Overall Study|Withdrawal by Subject|5
1432799|NCT00960934|4728758|P3|Overall Study|Withdrawal by Subject|4
1432800|NCT00960934|4728759|P2|Overall Study|Withdrawal by Subject|6
1432801|NCT00960934|4728760|P1|Overall Study|Withdrawal by Subject|5
1432802|NCT00960934|4728755|P6|Overall Study|Protocol Violation|2
1432803|NCT00960934|4728756|P5|Overall Study|Protocol Violation|3
1432804|NCT00960934|4728757|P4|Overall Study|Protocol Violation|3
1432805|NCT00960934|4728758|P3|Overall Study|Protocol Violation|0
1432806|NCT00960934|4728759|P2|Overall Study|Protocol Violation|4
1432807|NCT00960934|4728760|P1|Overall Study|Protocol Violation|3
1432808|NCT00960934|4728755|P6|Overall Study|Progressive Disease|1
1432809|NCT00960934|4728756|P5|Overall Study|Progressive Disease|1
1432810|NCT00960934|4728757|P4|Overall Study|Progressive Disease|0
1432811|NCT00960934|4728758|P3|Overall Study|Progressive Disease|0
1432812|NCT00960934|4728759|P2|Overall Study|Progressive Disease|1
1432813|NCT00960934|4728760|P1|Overall Study|Progressive Disease|1
1432814|NCT00960934|4728755|P6|Overall Study|Physician Decision|0
1432815|NCT00960934|4728756|P5|Overall Study|Physician Decision|0
1432816|NCT00960934|4728757|P4|Overall Study|Physician Decision|0
1432817|NCT00960934|4728758|P3|Overall Study|Physician Decision|0
1432818|NCT00960934|4728759|P2|Overall Study|Physician Decision|1
1432819|NCT00960934|4728760|P1|Overall Study|Physician Decision|0
1432820|NCT00960934|4728755|P6|Overall Study|Not Specified|2
1432821|NCT00960934|4728756|P5|Overall Study|Not Specified|2
1432822|NCT00960934|4728757|P4|Overall Study|Not Specified|4
1432823|NCT00960934|4728758|P3|Overall Study|Not Specified|5
1432824|NCT00960934|4728759|P2|Overall Study|Not Specified|1
1432825|NCT00960934|4728760|P1|Overall Study|Not Specified|2
1432826|NCT00960934|4728755|P6|Overall Study|Lost to Follow-up|0
1432827|NCT00960934|4728756|P5|Overall Study|Lost to Follow-up|0
1432828|NCT00960934|4728757|P4|Overall Study|Lost to Follow-up|0
1432829|NCT00960934|4728758|P3|Overall Study|Lost to Follow-up|0
1432830|NCT00960934|4728759|P2|Overall Study|Lost to Follow-up|1
1432831|NCT00960934|4728760|P1|Overall Study|Lost to Follow-up|0
1432832|NCT00960934|4728755|P6|Overall Study|Lack of Efficacy|0
1432833|NCT00960934|4728756|P5|Overall Study|Lack of Efficacy|0
1432834|NCT00960934|4728757|P4|Overall Study|Lack of Efficacy|0
1432835|NCT00960934|4728758|P3|Overall Study|Lack of Efficacy|0
1432836|NCT00960934|4728759|P2|Overall Study|Lack of Efficacy|0
1432837|NCT00960934|4728760|P1|Overall Study|Lack of Efficacy|1
1432838|NCT00960934|4728755|P6|Overall Study|Adverse Event|3
1432839|NCT00960934|4728756|P5|Overall Study|Adverse Event|4
1432840|NCT00960934|4728757|P4|Overall Study|Adverse Event|2
1432841|NCT00960934|4728758|P3|Overall Study|Adverse Event|3
1432842|NCT00960934|4728759|P2|Overall Study|Adverse Event|3
1432843|NCT00960934|4728760|P1|Overall Study|Adverse Event|2
1432844|NCT00960869|4728872|P2|Overall Study|Misc|18
1432845|NCT00960869|4728873|P1|Overall Study|Misc|19
1432846|NCT00960869|4728872|P2|Overall Study|Lost to Follow-up|4
1432847|NCT00960869|4728873|P1|Overall Study|Lost to Follow-up|1
1432848|NCT00960869|4728872|P2|Overall Study|Withdrawal by Subject|14
1432849|NCT00960869|4728873|P1|Overall Study|Withdrawal by Subject|16
1432850|NCT00960869|4728872|P2|Overall Study|Adverse Event|26
1432851|NCT00960869|4728873|P1|Overall Study|Adverse Event|17
1432852|NCT00960856|4728887|P4|Washout Period of 7 Days|Adverse Event|0
1432853|NCT00960856|4728888|P3|Washout Period of 7 Days|Adverse Event|1
1432854|NCT00960856|4728889|P2|Washout Period of 7 Days|Adverse Event|0
1432855|NCT00960856|4728890|P1|Washout Period of 7 Days|Adverse Event|0
1432856|NCT00960856|4728887|P4|Washout Period of 7 Days|Withdrawal by Subject|0
1432857|NCT00960856|4728888|P3|Washout Period of 7 Days|Withdrawal by Subject|0
1432858|NCT00960856|4728889|P2|Washout Period of 7 Days|Withdrawal by Subject|2
1432859|NCT00960856|4728890|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1432860|NCT00960843|4728910|P2|Overall Study|Repeated needle dislodgment|1
1432861|NCT00960843|4728911|P1|Overall Study|Repeated needle dislodgment|0
1432862|NCT00960843|4728910|P2|Overall Study|Protocol Violation|4
1432863|NCT00960843|4728911|P1|Overall Study|Protocol Violation|0
1432864|NCT00960843|4728910|P2|Overall Study|Lost to Follow-up|0
1432865|NCT00960843|4728911|P1|Overall Study|Lost to Follow-up|2
1432866|NCT00960687|4728921|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1432867|NCT00960687|4728922|P1|Washout Period of 7 Days|Withdrawal by Subject|1
1432868|NCT00960687|4728921|P2|Washout Period of 7 Days|Adverse Event|2
1432869|NCT00960687|4728922|P1|Washout Period of 7 Days|Adverse Event|3
1432870|NCT00960661|4728934|P3|Interventional Phase|Lack of Efficacy|0
1432871|NCT00960661|4728935|P2|Interventional Phase|Lack of Efficacy|2
1432872|NCT00960661|4728936|P1|Interventional Phase|Lack of Efficacy|0
1432873|NCT00960661|4728934|P3|Interventional Phase|sponsor decision|0
1432874|NCT00960661|4728935|P2|Interventional Phase|sponsor decision|1
1432875|NCT00960661|4728936|P1|Interventional Phase|sponsor decision|0
1432876|NCT00960661|4728934|P3|Interventional Phase|Physician Decision|5
1432877|NCT00960661|4728935|P2|Interventional Phase|Physician Decision|3
1432878|NCT00960661|4728936|P1|Interventional Phase|Physician Decision|0
1432879|NCT00960661|4728934|P3|Interventional Phase|Withdrawal by Subject|29
1432880|NCT00960661|4728935|P2|Interventional Phase|Withdrawal by Subject|18
1432881|NCT00960661|4728936|P1|Interventional Phase|Withdrawal by Subject|0
1432882|NCT00960661|4728934|P3|Interventional Phase|Protocol Violation|2
1432883|NCT00960661|4728935|P2|Interventional Phase|Protocol Violation|7
1432884|NCT00960661|4728936|P1|Interventional Phase|Protocol Violation|0
1432885|NCT00960661|4728934|P3|Interventional Phase|entry criteria not met|0
1432886|NCT00960661|4728935|P2|Interventional Phase|entry criteria not met|3
1432887|NCT00960661|4728936|P1|Interventional Phase|entry criteria not met|0
1432888|NCT00960661|4728934|P3|Interventional Phase|Lost to Follow-up|2
1432889|NCT00960661|4728935|P2|Interventional Phase|Lost to Follow-up|0
1432890|NCT00960661|4728936|P1|Interventional Phase|Lost to Follow-up|0
1432891|NCT00960661|4728934|P3|Interventional Phase|Death|0
1432892|NCT00960661|4728935|P2|Interventional Phase|Death|1
1432893|NCT00960661|4728936|P1|Interventional Phase|Death|0
1432894|NCT00960661|4728934|P3|Interventional Phase|Adverse Event|8
1432895|NCT00960661|4728935|P2|Interventional Phase|Adverse Event|17
1432896|NCT00960661|4728936|P1|Interventional Phase|Adverse Event|0
1432897|NCT00960661|4728934|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
1432898|NCT00960661|4728935|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
1432899|NCT00960661|4728936|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
1432900|NCT00960661|4728934|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
1432901|NCT00960661|4728935|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
1432902|NCT00960661|4728936|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
1432903|NCT00960661|4728934|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
1432904|NCT00960661|4728935|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
1432905|NCT00960661|4728936|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
1432906|NCT00960661|4728934|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
1432907|NCT00960661|4728935|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
1432908|NCT00960661|4728936|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
1432909|NCT00960661|4728934|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
1432910|NCT00960661|4728935|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
1432911|NCT00960661|4728936|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
1432912|NCT00960661|4728934|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
1432913|NCT00960661|4728935|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
1432914|NCT00960661|4728936|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
1432915|NCT00960570|4728975|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
1432916|NCT00960570|4728975|P1|1 Day Period Between Dosing|Adverse Event|2
1432917|NCT00960570|4728975|P1|21 Day Washout Period|Withdrawal by Subject|1
1432918|NCT00960570|4728975|P1|21 Day Washout Period|Adverse Event|1
1432919|NCT00960531|4728996|P10|Overall Study|Reason not Specified|1
1432920|NCT00960531|4728997|P9|Overall Study|Reason not Specified|8
1432921|NCT00960531|4728998|P8|Overall Study|Reason not Specified|0
1432922|NCT00960531|4728999|P7|Overall Study|Reason not Specified|16
1432923|NCT00960531|4729000|P6|Overall Study|Reason not Specified|0
1432924|NCT00960531|4729001|P5|Overall Study|Reason not Specified|2
1432925|NCT00960531|4729002|P4|Overall Study|Reason not Specified|1
1432926|NCT00960531|4729003|P3|Overall Study|Reason not Specified|13
1432927|NCT00960531|4729004|P2|Overall Study|Reason not Specified|1
1432928|NCT00960531|4729005|P1|Overall Study|Reason not Specified|2
1432929|NCT00960531|4728996|P10|Overall Study|Adverse Event (AE)|0
1432930|NCT00960531|4728997|P9|Overall Study|Adverse Event (AE)|2
1432931|NCT00960531|4728998|P8|Overall Study|Adverse Event (AE)|0
1432932|NCT00960531|4728999|P7|Overall Study|Adverse Event (AE)|2
1432933|NCT00960531|4729000|P6|Overall Study|Adverse Event (AE)|1
1432934|NCT00960531|4729001|P5|Overall Study|Adverse Event (AE)|0
1432935|NCT00960531|4729002|P4|Overall Study|Adverse Event (AE)|0
1432936|NCT00960531|4729003|P3|Overall Study|Adverse Event (AE)|0
1432937|NCT00960531|4729004|P2|Overall Study|Adverse Event (AE)|0
1432938|NCT00960531|4729005|P1|Overall Study|Adverse Event (AE)|2
1432939|NCT00960531|4728996|P10|Overall Study|Failed to Return|0
1432940|NCT00960531|4728997|P9|Overall Study|Failed to Return|0
1432941|NCT00960531|4728998|P8|Overall Study|Failed to Return|2
1432942|NCT00960531|4728999|P7|Overall Study|Failed to Return|0
1432943|NCT00960531|4729000|P6|Overall Study|Failed to Return|0
1432944|NCT00960531|4729001|P5|Overall Study|Failed to Return|0
1432945|NCT00960531|4729002|P4|Overall Study|Failed to Return|0
1432946|NCT00960531|4729003|P3|Overall Study|Failed to Return|0
1432947|NCT00960531|4729004|P2|Overall Study|Failed to Return|0
1432948|NCT00960531|4729005|P1|Overall Study|Failed to Return|2
1432949|NCT00960531|4728996|P10|Overall Study|Lost to Follow-up|0
1432950|NCT00960531|4728997|P9|Overall Study|Lost to Follow-up|0
1432951|NCT00960531|4728998|P8|Overall Study|Lost to Follow-up|0
1432952|NCT00960531|4728999|P7|Overall Study|Lost to Follow-up|1
1432953|NCT00960531|4729000|P6|Overall Study|Lost to Follow-up|0
1432954|NCT00960531|4729001|P5|Overall Study|Lost to Follow-up|0
1432955|NCT00960531|4729002|P4|Overall Study|Lost to Follow-up|0
1432956|NCT00960531|4729003|P3|Overall Study|Lost to Follow-up|1
1432957|NCT00960531|4729004|P2|Overall Study|Lost to Follow-up|0
1432958|NCT00960531|4729005|P1|Overall Study|Lost to Follow-up|0
1432959|NCT00960531|4728996|P10|Overall Study|Discontinuation of Study by Sponsor|0
1432960|NCT00960531|4728997|P9|Overall Study|Discontinuation of Study by Sponsor|0
1432961|NCT00960531|4728998|P8|Overall Study|Discontinuation of Study by Sponsor|1
1432962|NCT00960531|4728999|P7|Overall Study|Discontinuation of Study by Sponsor|0
1432963|NCT00960531|4729000|P6|Overall Study|Discontinuation of Study by Sponsor|0
1432964|NCT00960531|4729001|P5|Overall Study|Discontinuation of Study by Sponsor|0
1432965|NCT00960531|4729002|P4|Overall Study|Discontinuation of Study by Sponsor|0
1432966|NCT00960531|4729003|P3|Overall Study|Discontinuation of Study by Sponsor|0
1432967|NCT00960531|4729004|P2|Overall Study|Discontinuation of Study by Sponsor|0
1432968|NCT00960531|4729005|P1|Overall Study|Discontinuation of Study by Sponsor|0
1432969|NCT00960531|4728996|P10|Overall Study|Investigator Request|0
1432970|NCT00960531|4728997|P9|Overall Study|Investigator Request|0
1432971|NCT00960531|4728998|P8|Overall Study|Investigator Request|0
1432972|NCT00960531|4728999|P7|Overall Study|Investigator Request|0
1432973|NCT00960531|4729000|P6|Overall Study|Investigator Request|0
1432974|NCT00960531|4729001|P5|Overall Study|Investigator Request|0
1432975|NCT00960531|4729002|P4|Overall Study|Investigator Request|0
1432976|NCT00960531|4729003|P3|Overall Study|Investigator Request|1
1432977|NCT00960531|4729004|P2|Overall Study|Investigator Request|0
1432978|NCT00960531|4729005|P1|Overall Study|Investigator Request|0
1432979|NCT00960531|4728996|P10|Overall Study|Caregiver Request|0
1432980|NCT00960531|4728997|P9|Overall Study|Caregiver Request|3
1432981|NCT00960531|4728998|P8|Overall Study|Caregiver Request|1
1432982|NCT00960531|4728999|P7|Overall Study|Caregiver Request|3
1432983|NCT00960531|4729000|P6|Overall Study|Caregiver Request|2
1432984|NCT00960531|4729001|P5|Overall Study|Caregiver Request|0
1432985|NCT00960531|4729002|P4|Overall Study|Caregiver Request|5
1432986|NCT00960531|4729003|P3|Overall Study|Caregiver Request|6
1432987|NCT00960531|4729004|P2|Overall Study|Caregiver Request|0
1432988|NCT00960531|4729005|P1|Overall Study|Caregiver Request|2
1432989|NCT00960531|4728996|P10|Overall Study|Withdrawal by Subject|0
1432990|NCT00960531|4728997|P9|Overall Study|Withdrawal by Subject|1
1432991|NCT00960531|4728998|P8|Overall Study|Withdrawal by Subject|0
1432992|NCT00960531|4728999|P7|Overall Study|Withdrawal by Subject|2
1432993|NCT00960531|4729000|P6|Overall Study|Withdrawal by Subject|0
1432994|NCT00960531|4729001|P5|Overall Study|Withdrawal by Subject|0
1432995|NCT00960531|4729002|P4|Overall Study|Withdrawal by Subject|2
1432996|NCT00960531|4729003|P3|Overall Study|Withdrawal by Subject|5
1432997|NCT00960531|4729004|P2|Overall Study|Withdrawal by Subject|0
1432998|NCT00960531|4729005|P1|Overall Study|Withdrawal by Subject|1
1432999|NCT00960531|4728996|P10|Overall Study|Lack of Efficacy|0
1433000|NCT00960531|4728997|P9|Overall Study|Lack of Efficacy|0
1433001|NCT00960531|4728998|P8|Overall Study|Lack of Efficacy|0
1433002|NCT00960531|4728999|P7|Overall Study|Lack of Efficacy|0
1433003|NCT00960531|4729000|P6|Overall Study|Lack of Efficacy|0
1433004|NCT00960531|4729001|P5|Overall Study|Lack of Efficacy|0
1433005|NCT00960531|4729002|P4|Overall Study|Lack of Efficacy|0
1433006|NCT00960531|4729003|P3|Overall Study|Lack of Efficacy|0
1433007|NCT00960531|4729004|P2|Overall Study|Lack of Efficacy|0
1433008|NCT00960531|4729005|P1|Overall Study|Lack of Efficacy|1
1433009|NCT00960440|4729053|P4|Overall Study|Other|0
1433010|NCT00960440|4729054|P3|Overall Study|Other|1
1433011|NCT00960440|4729055|P2|Overall Study|Other|1
1433012|NCT00960440|4729056|P1|Overall Study|Other|1
1433013|NCT00960440|4729053|P4|Overall Study|Withdrawal by Subject|1
1433014|NCT00960440|4729054|P3|Overall Study|Withdrawal by Subject|2
1433015|NCT00960440|4729055|P2|Overall Study|Withdrawal by Subject|5
1433016|NCT00960440|4729056|P1|Overall Study|Withdrawal by Subject|9
1433017|NCT00960440|4729053|P4|Overall Study|Protocol Violation|4
1433018|NCT00960440|4729054|P3|Overall Study|Protocol Violation|3
1433019|NCT00960440|4729055|P2|Overall Study|Protocol Violation|8
1433020|NCT00960440|4729056|P1|Overall Study|Protocol Violation|2
1433021|NCT00960440|4729053|P4|Overall Study|Lack of Efficacy|8
1433022|NCT00960440|4729054|P3|Overall Study|Lack of Efficacy|3
1433023|NCT00960440|4729055|P2|Overall Study|Lack of Efficacy|5
1433024|NCT00960440|4729056|P1|Overall Study|Lack of Efficacy|2
1433025|NCT00960440|4729053|P4|Overall Study|Adverse Event|4
1433026|NCT00960440|4729054|P3|Overall Study|Adverse Event|4
1433027|NCT00960440|4729055|P2|Overall Study|Adverse Event|12
1433028|NCT00960440|4729056|P1|Overall Study|Adverse Event|12
1433029|NCT00960440|4729053|P4|Overall Study|Death|1
1433030|NCT00960440|4729054|P3|Overall Study|Death|0
1433031|NCT00960440|4729055|P2|Overall Study|Death|0
1433032|NCT00960440|4729056|P1|Overall Study|Death|0
1433033|NCT00960375|4729228|P2|Overall Study|Lost to Follow-up|22
1433034|NCT00960375|4729229|P1|Overall Study|Lost to Follow-up|20
1433035|NCT00960323|4729237|P1|Atorvastatin Alone|Withdrawal by Subject|1
1433036|NCT00960297|4729248|P1|Overall Study|Disease progression|1
1433037|NCT00960297|4729248|P1|Overall Study|Venous port infection|1
1433038|NCT00960297|4729248|P1|Overall Study|Physician Decision|1
1433039|NCT00960206|4729255|P3|Overall Study|Missing 10 year data|1
1433040|NCT00960206|4729256|P2|Overall Study|Missing 10 year data|1
1433041|NCT00960206|4729257|P1|Overall Study|Missing 10 year data|20
1433042|NCT00960206|4729255|P3|Overall Study|Revision of study component|2
1433043|NCT00960206|4729256|P2|Overall Study|Revision of study component|2
1433044|NCT00960206|4729257|P1|Overall Study|Revision of study component|2
1433045|NCT00960206|4729255|P3|Overall Study|Withdrawal by Subject|0
1433046|NCT00960206|4729256|P2|Overall Study|Withdrawal by Subject|4
1433047|NCT00960206|4729257|P1|Overall Study|Withdrawal by Subject|2
1433048|NCT00960206|4729255|P3|Overall Study|Lost to Follow-up|8
1433049|NCT00960206|4729256|P2|Overall Study|Lost to Follow-up|14
1433050|NCT00960206|4729257|P1|Overall Study|Lost to Follow-up|8
1433051|NCT00960206|4729255|P3|Overall Study|Unwilling/Unable to return|0
1433052|NCT00960206|4729256|P2|Overall Study|Unwilling/Unable to return|2
1433053|NCT00960206|4729257|P1|Overall Study|Unwilling/Unable to return|1
1433054|NCT00960206|4729255|P3|Overall Study|Death|1
1433055|NCT00960206|4729256|P2|Overall Study|Death|4
1433056|NCT00960206|4729257|P1|Overall Study|Death|7
1433057|NCT00960193|4729275|P1|14 Day Washout Period|Withdrawal by Subject|1
1433058|NCT00960154|4729288|P2|Overall Study|Study termination|25
1433059|NCT00960154|4729289|P1|Overall Study|Study termination|25
1433060|NCT00960141|4729300|P3|Overall Study|Withdrawal by Subject|1
1433061|NCT00960141|4729301|P2|Overall Study|Withdrawal by Subject|2
1433062|NCT00960141|4729302|P1|Overall Study|Withdrawal by Subject|1
1433063|NCT00960141|4729300|P3|Overall Study|Protocol Violation|2
1433064|NCT00960141|4729301|P2|Overall Study|Protocol Violation|3
1433065|NCT00960141|4729302|P1|Overall Study|Protocol Violation|1
1433066|NCT00960141|4729300|P3|Overall Study|Lost to Follow-up|0
1433067|NCT00960141|4729301|P2|Overall Study|Lost to Follow-up|0
1433068|NCT00960141|4729302|P1|Overall Study|Lost to Follow-up|1
1433069|NCT00960141|4729300|P3|Overall Study|Lack of Efficacy|2
1433070|NCT00960141|4729301|P2|Overall Study|Lack of Efficacy|4
1433071|NCT00960141|4729302|P1|Overall Study|Lack of Efficacy|3
1433072|NCT00960141|4729300|P3|Overall Study|Adverse Event|2
1433073|NCT00960141|4729301|P2|Overall Study|Adverse Event|8
1433074|NCT00960141|4729302|P1|Overall Study|Adverse Event|4
1433075|NCT00960115|4729327|P2|Overall Study|Ongoing treatment at data cut-off date|15
1433076|NCT00960115|4729328|P1|Overall Study|Ongoing treatment at data cut-off date|19
1433077|NCT00960076|4729342|P2|Overall Study|Did not attend the termination visit|1
1433078|NCT00960076|4729343|P1|Overall Study|Did not attend the termination visit|0
1433079|NCT00960076|4729342|P2|Overall Study|Hyperglycemia|5
1433080|NCT00960076|4729343|P1|Overall Study|Hyperglycemia|1
1433081|NCT00960076|4729342|P2|Overall Study|Severe non-compliance to protocol|2
1433082|NCT00960076|4729343|P1|Overall Study|Severe non-compliance to protocol|1
1433083|NCT00960076|4729342|P2|Overall Study|Lost to Follow-up|3
1433084|NCT00960076|4729343|P1|Overall Study|Lost to Follow-up|3
1433085|NCT00960076|4729342|P2|Overall Study|Withdrawal by Subject|2
1433086|NCT00960076|4729343|P1|Overall Study|Withdrawal by Subject|1
1433087|NCT00960076|4729342|P2|Overall Study|No longer met study criteria|5
1433088|NCT00960076|4729343|P1|Overall Study|No longer met study criteria|1
1433089|NCT00960076|4729342|P2|Overall Study|Adverse Event|7
1433090|NCT00960076|4729343|P1|Overall Study|Adverse Event|1
1433091|NCT00960063|4729358|P3|Overall Study|Progression of Disease|3
1433092|NCT00960063|4729359|P2|Overall Study|Progression of Disease|0
1433093|NCT00960063|4729360|P1|Overall Study|Progression of Disease|0
1433094|NCT00960063|4729358|P3|Overall Study|Adverse Event|0
1433095|NCT00960063|4729359|P2|Overall Study|Adverse Event|0
1433096|NCT00960063|4729360|P1|Overall Study|Adverse Event|1
1433097|NCT00959946|4729451|P8|Overall Study|Withdrawal by Subject|0
1433098|NCT00959946|4729452|P7|Overall Study|Withdrawal by Subject|0
1433099|NCT00959946|4729453|P6|Overall Study|Withdrawal by Subject|1
1433100|NCT00959946|4729454|P5|Overall Study|Withdrawal by Subject|0
1433101|NCT00959946|4729455|P4|Overall Study|Withdrawal by Subject|0
1433102|NCT00959946|4729456|P3|Overall Study|Withdrawal by Subject|0
1433103|NCT00959946|4729457|P2|Overall Study|Withdrawal by Subject|0
1433104|NCT00959946|4729458|P1|Overall Study|Withdrawal by Subject|0
1433105|NCT00959946|4729451|P8|Overall Study|Disease Progression|2
1433106|NCT00959946|4729452|P7|Overall Study|Disease Progression|2
1433107|NCT00959946|4729453|P6|Overall Study|Disease Progression|6
1433108|NCT00959946|4729454|P5|Overall Study|Disease Progression|4
1433109|NCT00959946|4729455|P4|Overall Study|Disease Progression|4
1433110|NCT00959946|4729456|P3|Overall Study|Disease Progression|2
1433111|NCT00959946|4729457|P2|Overall Study|Disease Progression|4
1433112|NCT00959946|4729458|P1|Overall Study|Disease Progression|2
1433113|NCT00959946|4729451|P8|Overall Study|Death|0
1433114|NCT00959946|4729452|P7|Overall Study|Death|0
1433115|NCT00959946|4729453|P6|Overall Study|Death|1
1433116|NCT00959946|4729454|P5|Overall Study|Death|0
1433117|NCT00959946|4729455|P4|Overall Study|Death|0
1433118|NCT00959946|4729456|P3|Overall Study|Death|0
1433119|NCT00959946|4729457|P2|Overall Study|Death|0
1433120|NCT00959946|4729458|P1|Overall Study|Death|0
1433121|NCT00959946|4729451|P8|Overall Study|Adverse Event|0
1433122|NCT00959946|4729452|P7|Overall Study|Adverse Event|0
1433123|NCT00959946|4729453|P6|Overall Study|Adverse Event|1
1433124|NCT00959946|4729454|P5|Overall Study|Adverse Event|0
1433125|NCT00959946|4729455|P4|Overall Study|Adverse Event|1
1433126|NCT00959946|4729456|P3|Overall Study|Adverse Event|2
1433127|NCT00959946|4729457|P2|Overall Study|Adverse Event|0
1433128|NCT00959946|4729458|P1|Overall Study|Adverse Event|0
1433129|NCT00959907|4729522|P2|Overall Study|Withdrawal by Subject|0
1433130|NCT00959907|4729523|P1|Overall Study|Withdrawal by Subject|2
1433131|NCT00959907|4729522|P2|Overall Study|Adverse Event|0
1433132|NCT00959907|4729523|P1|Overall Study|Adverse Event|1
1433133|NCT00959907|4729522|P2|Overall Study|Protocol Violation|1
1433134|NCT00959907|4729523|P1|Overall Study|Protocol Violation|0
1433135|NCT00959894|4729533|P1|Overall Study|Subject moved out of town|1
1433136|NCT00959894|4729533|P1|Overall Study|Need for contraindicated medication|1
1433137|NCT00959894|4729533|P1|Overall Study|Withdrawal by Subject|1
1433138|NCT00959894|4729533|P1|Overall Study|Adverse Event|3
1433139|NCT00959894|4729533|P1|Overall Study|Lost to Follow-up|10
1433140|NCT00959751|4729582|P2|Overall Study|No migraine headache without aura|7
1433141|NCT00959751|4729583|P1|Overall Study|No migraine headache without aura|7
1433142|NCT00959751|4729582|P2|Overall Study|Non-compliance to Study Procedures|1
1433143|NCT00959751|4729583|P1|Overall Study|Non-compliance to Study Procedures|0
1433144|NCT00959751|4729582|P2|Overall Study|Consent Withdrawn|1
1433145|NCT00959751|4729583|P1|Overall Study|Consent Withdrawn|0
1433146|NCT00959751|4729582|P2|Overall Study|Lost to Follow-up|3
1433147|NCT00959751|4729583|P1|Overall Study|Lost to Follow-up|2
1433148|NCT00959699|4729605|P2|Follow-up Period|Withdrawal by Subject|4
1433149|NCT00959699|4729606|P1|Follow-up Period|Withdrawal by Subject|3
1433150|NCT00959699|4729605|P2|Follow-up Period|Lost to Follow-up|2
1433151|NCT00959699|4729606|P1|Follow-up Period|Lost to Follow-up|3
1433152|NCT00959699|4729605|P2|Treatment Period|Futility/crossover to boceprevir|0
1433153|NCT00959699|4729606|P1|Treatment Period|Futility/crossover to boceprevir|4
1433154|NCT00959699|4729605|P2|Treatment Period|Did not receive treatment|1
1433155|NCT00959699|4729606|P1|Treatment Period|Did not receive treatment|0
1433156|NCT00959699|4729605|P2|Treatment Period|Non-Compliance with Protocol|1
1433157|NCT00959699|4729606|P1|Treatment Period|Non-Compliance with Protocol|0
1433158|NCT00959699|4729605|P2|Treatment Period|Withdrawal by Subject|3
1433159|NCT00959699|4729606|P1|Treatment Period|Withdrawal by Subject|1
1433160|NCT00959699|4729605|P2|Treatment Period|Lost to Follow-up|1
1433161|NCT00959699|4729606|P1|Treatment Period|Lost to Follow-up|0
1433162|NCT00959699|4729605|P2|Treatment Period|Lack of Efficacy|6
1433163|NCT00959699|4729606|P1|Treatment Period|Lack of Efficacy|15
1433164|NCT00959699|4729605|P2|Treatment Period|Adverse Event|13
1433165|NCT00959699|4729606|P1|Treatment Period|Adverse Event|3
1433166|NCT00959647|4729652|P1|Overall Study|Withdrawal by Subject|7
1433167|NCT00959647|4729652|P1|Overall Study|Study terminated by sponsor|4
1433168|NCT00959647|4729652|P1|Overall Study|Progressive disease|6
1433169|NCT00959647|4729652|P1|Overall Study|Adverse Event|2
1433170|NCT00959374|4729657|P1|Overall Study|Physician Decision|1
1433171|NCT00959374|4729657|P1|Overall Study|Implant Removed/Not Replaced|4
1433172|NCT00959374|4729657|P1|Overall Study|Protocol Violation|1
1433173|NCT00959374|4729657|P1|Overall Study|Death|1
1433174|NCT00959374|4729657|P1|Overall Study|Lost to Follow-up|14
1433175|NCT00959374|4729657|P1|Overall Study|Withdrawal by Subject|2
1433176|NCT00959192|4729671|P4|Overall Study|Caregiver Request|1
1433177|NCT00959192|4729672|P3|Overall Study|Caregiver Request|2
1433178|NCT00959192|4729673|P2|Overall Study|Caregiver Request|0
1433179|NCT00959192|4729674|P1|Overall Study|Caregiver Request|0
1433180|NCT00959192|4729671|P4|Overall Study|Investigator Request|0
1433181|NCT00959192|4729672|P3|Overall Study|Investigator Request|0
1433182|NCT00959192|4729673|P2|Overall Study|Investigator Request|0
1433183|NCT00959192|4729674|P1|Overall Study|Investigator Request|1
1433184|NCT00959192|4729671|P4|Overall Study|Adverse Event|0
1433185|NCT00959192|4729672|P3|Overall Study|Adverse Event|1
1433186|NCT00959192|4729673|P2|Overall Study|Adverse Event|1
1433187|NCT00959192|4729674|P1|Overall Study|Adverse Event|1
1433188|NCT00959049|4729722|P6|Overall Study|Withdrawal by Subject|0
1433189|NCT00959049|4729723|P5|Overall Study|Withdrawal by Subject|0
1433190|NCT00959049|4729724|P4|Overall Study|Withdrawal by Subject|0
1433191|NCT00959049|4729725|P3|Overall Study|Withdrawal by Subject|0
1433192|NCT00959049|4729726|P2|Overall Study|Withdrawal by Subject|2
1433193|NCT00959049|4729727|P1|Overall Study|Withdrawal by Subject|0
1433194|NCT00959049|4729722|P6|Overall Study|Contraindicated medication|0
1433195|NCT00959049|4729723|P5|Overall Study|Contraindicated medication|0
1433196|NCT00959049|4729724|P4|Overall Study|Contraindicated medication|1
1433197|NCT00959049|4729725|P3|Overall Study|Contraindicated medication|0
1433198|NCT00959049|4729726|P2|Overall Study|Contraindicated medication|0
1433199|NCT00959049|4729727|P1|Overall Study|Contraindicated medication|0
1433200|NCT00959049|4729722|P6|Overall Study|Lost to Follow-up|1
1433201|NCT00959049|4729723|P5|Overall Study|Lost to Follow-up|9
1433202|NCT00959049|4729724|P4|Overall Study|Lost to Follow-up|10
1433203|NCT00959049|4729725|P3|Overall Study|Lost to Follow-up|1
1433204|NCT00959049|4729726|P2|Overall Study|Lost to Follow-up|5
1433205|NCT00959049|4729727|P1|Overall Study|Lost to Follow-up|17
1433206|NCT00959049|4729722|P6|Overall Study|Adverse Event|0
1433207|NCT00959049|4729723|P5|Overall Study|Adverse Event|0
1433208|NCT00959049|4729724|P4|Overall Study|Adverse Event|0
1433209|NCT00959049|4729725|P3|Overall Study|Adverse Event|0
1433210|NCT00959049|4729726|P2|Overall Study|Adverse Event|0
1433211|NCT00959049|4729727|P1|Overall Study|Adverse Event|1
1433212|NCT00958893|4729792|P1|Overall Study|Study prematurely terminated|4
1433213|NCT00958880|4729798|P2|Overall Study|Lost to Follow-up|2
1433214|NCT00958880|4729799|P1|Overall Study|Lost to Follow-up|2
1433215|NCT00958841|4729807|P1|Overall Study|Discontinued prior to M*|28
1433216|NCT00958841|4729807|P1|Overall Study|Completed M6/did not enter extension|27
1433217|NCT00958841|4729807|P1|Overall Study|Unsatisfactory therapeutic effect|22
1433218|NCT00958841|4729807|P1|Overall Study|Withdrawal by Subject|1
1433219|NCT00958841|4729807|P1|Overall Study|New cancer therapy|5
1433220|NCT00958841|4729807|P1|Overall Study|Adverse Event|8
1433221|NCT00958841|4729807|P1|Overall Study|Administrative problems|1
1433222|NCT00958841|4729807|P1|Overall Study|Abnormal test procedure result(s)|3
1433223|NCT00958841|4729807|P1|Overall Study|Abnormal laboratory value(s)|1
1433224|NCT00958828|4729825|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
1433225|NCT00958828|4729826|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
1433226|NCT00958828|4729825|P2|Period 1, 1 Week of Wear|Randomization break|1
1433227|NCT00958828|4729826|P1|Period 1, 1 Week of Wear|Randomization break|0
1433228|NCT00958789|4729832|P1|Overall Study|Revision|7
1433229|NCT00958789|4729832|P1|Overall Study|Subject terminated|3
1433230|NCT00958789|4729832|P1|Overall Study|2 yr. Knee Society Score not calculable|2
1433231|NCT00958789|4729832|P1|Overall Study|No 2 yr. Knee Society Score data|12
1433232|NCT00958789|4729832|P1|Overall Study|Withdrawal by Subject|16
1433233|NCT00958789|4729832|P1|Overall Study|Lost to Follow-up|7
1433234|NCT00958789|4729832|P1|Overall Study|Death|3
1433235|NCT00958776|4729839|P2|Overall Study|Missing|1
1433236|NCT00958776|4729840|P1|Overall Study|Missing|1
1433237|NCT00958776|4729839|P2|Overall Study|Noncompliance; Protocol Deviations|3
1433238|NCT00958776|4729840|P1|Overall Study|Noncompliance; Protocol Deviations|2
1433239|NCT00958776|4729839|P2|Overall Study|Death|1
1433240|NCT00958776|4729840|P1|Overall Study|Death|2
1433241|NCT00958776|4729839|P2|Overall Study|Protocol Violation|1
1433242|NCT00958776|4729840|P1|Overall Study|Protocol Violation|1
1433243|NCT00958776|4729839|P2|Overall Study|Withdrawal by Subject|16
1433244|NCT00958776|4729840|P1|Overall Study|Withdrawal by Subject|7
1433245|NCT00958776|4729839|P2|Overall Study|Lost to Follow-up|6
1433246|NCT00958776|4729840|P1|Overall Study|Lost to Follow-up|2
1433247|NCT00958776|4729839|P2|Overall Study|Physician Decision|0
1433248|NCT00958776|4729840|P1|Overall Study|Physician Decision|1
1433249|NCT00958776|4729839|P2|Overall Study|Adverse Event|1
1433250|NCT00958776|4729840|P1|Overall Study|Adverse Event|0
1433251|NCT00958724|4729870|P1|Overall Study|Disease Progression|6
1433252|NCT00958568|4729899|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
1433253|NCT00958568|4729900|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
1433254|NCT00958568|4729901|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
1433255|NCT00958568|4729902|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
1433256|NCT00958568|4729899|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
1433257|NCT00958568|4729900|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
1433258|NCT00958568|4729901|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
1433259|NCT00958568|4729902|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
1433260|NCT00958568|4729899|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
1433261|NCT00958568|4729900|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
1433262|NCT00958568|4729901|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
1433263|NCT00958568|4729902|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
1433264|NCT00958568|4729899|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
1433265|NCT00958568|4729900|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
1433266|NCT00958568|4729901|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
1433267|NCT00958568|4729902|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
1433268|NCT00958568|4729899|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
1433269|NCT00958568|4729900|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
1433270|NCT00958568|4729901|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
1433271|NCT00958568|4729902|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
1433272|NCT00958568|4729899|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
1433273|NCT00958568|4729900|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
1433274|NCT00958568|4729901|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
1433275|NCT00958568|4729902|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
1433276|NCT00958568|4729899|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
1433277|NCT00958568|4729900|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
1433278|NCT00958568|4729901|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
1433279|NCT00958568|4729902|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
1433280|NCT00958568|4729899|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
1433281|NCT00958568|4729900|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
1433282|NCT00958568|4729901|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
1433283|NCT00958568|4729902|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
1433284|NCT00958568|4729899|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
1433285|NCT00958568|4729900|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
1433286|NCT00958568|4729901|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
1433287|NCT00958568|4729902|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
1433288|NCT00958568|4729899|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
1433289|NCT00958568|4729900|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
1433290|NCT00958568|4729901|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
1433291|NCT00958568|4729902|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
1433292|NCT00958568|4729899|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
1433293|NCT00958568|4729900|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
1433294|NCT00958568|4729901|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
1433295|NCT00958568|4729902|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
1433296|NCT00958568|4729899|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
1433297|NCT00958568|4729900|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
1433298|NCT00958568|4729901|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
1433299|NCT00958568|4729902|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
1433300|NCT00958568|4729899|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
1433301|NCT00958568|4729900|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
1433302|NCT00958568|4729901|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
1433303|NCT00958568|4729902|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
1433304|NCT00958568|4729899|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
1433305|NCT00958568|4729900|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
1433306|NCT00958568|4729901|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
1433307|NCT00958568|4729902|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
1433308|NCT00958568|4729899|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
1433309|NCT00958568|4729900|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
1433310|NCT00958568|4729901|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
1433311|NCT00958568|4729902|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
1433312|NCT00958568|4729899|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
1433313|NCT00958568|4729900|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
1433314|NCT00958568|4729901|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
1433315|NCT00958568|4729902|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
1433316|NCT00958568|4729899|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
1433317|NCT00958568|4729900|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
1433318|NCT00958568|4729901|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
1433319|NCT00958568|4729902|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
1433320|NCT00958568|4729899|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
1433321|NCT00958568|4729900|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
1433322|NCT00958568|4729901|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
1433323|NCT00958568|4729902|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
1433324|NCT00958568|4729899|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
1433325|NCT00958568|4729900|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
1433326|NCT00958568|4729901|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
1433327|NCT00958568|4729902|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
1433328|NCT00958568|4729899|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
1433329|NCT00958568|4729900|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
1433330|NCT00958568|4729901|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
1433331|NCT00958568|4729902|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
1433332|NCT00958568|4729899|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
1433333|NCT00958568|4729900|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
1433334|NCT00958568|4729901|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
1433335|NCT00958568|4729902|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
1433336|NCT00958568|4729899|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
1433337|NCT00958568|4729900|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
1433338|NCT00958568|4729901|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
1433339|NCT00958568|4729902|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
1433340|NCT00958568|4729899|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
1433341|NCT00958568|4729900|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
1433342|NCT00958568|4729901|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
1433343|NCT00958568|4729902|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
1433344|NCT00958568|4729899|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
1433345|NCT00958568|4729900|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
1433346|NCT00958568|4729901|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
1433347|NCT00958568|4729902|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
1433348|NCT00958568|4729899|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
1433349|NCT00958568|4729900|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
1433350|NCT00958568|4729901|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
1433351|NCT00958568|4729902|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
1433352|NCT00958568|4729899|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
1433353|NCT00958568|4729900|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
1433354|NCT00958568|4729901|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
1433355|NCT00958568|4729902|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
1433356|NCT00958568|4729899|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
1433357|NCT00958568|4729900|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
1433358|NCT00958568|4729901|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
1433359|NCT00958568|4729902|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
1433360|NCT00958568|4729899|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
1433361|NCT00958568|4729900|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
1433362|NCT00958568|4729901|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
1433363|NCT00958568|4729902|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
1433364|NCT00958568|4729899|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
1433365|NCT00958568|4729900|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
1433366|NCT00958568|4729901|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
1433367|NCT00958568|4729902|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
1433368|NCT00958438|4730139|P3|Overall Study|Other than specified above|2
1433369|NCT00958438|4730140|P2|Overall Study|Other than specified above|3
1433370|NCT00958438|4730141|P1|Overall Study|Other than specified above|2
1433371|NCT00958438|4730139|P3|Overall Study|Physician Decision|1
1433372|NCT00958438|4730140|P2|Overall Study|Physician Decision|0
1433373|NCT00958438|4730141|P1|Overall Study|Physician Decision|1
1433374|NCT00958438|4730139|P3|Overall Study|Adverse Event|0
1433375|NCT00958438|4730140|P2|Overall Study|Adverse Event|3
1433376|NCT00958438|4730141|P1|Overall Study|Adverse Event|0
1433377|NCT00958438|4730139|P3|Overall Study|Withdrawal by Subject|1
1433378|NCT00958438|4730140|P2|Overall Study|Withdrawal by Subject|2
1433379|NCT00958438|4730141|P1|Overall Study|Withdrawal by Subject|4
1433380|NCT00958438|4730139|P3|Overall Study|Protocol Violation|2
1433381|NCT00958438|4730140|P2|Overall Study|Protocol Violation|2
1433382|NCT00958438|4730141|P1|Overall Study|Protocol Violation|3
1433383|NCT00958360|4730166|P2|Overall Study|Lost to Follow-up|1
1433384|NCT00958360|4730167|P1|Overall Study|Lost to Follow-up|0
1433385|NCT00958360|4730166|P2|Overall Study|Physician Decision|1
1433386|NCT00958360|4730167|P1|Overall Study|Physician Decision|2
1433387|NCT00958360|4730166|P2|Overall Study|Death|7
1433388|NCT00958360|4730167|P1|Overall Study|Death|6
1433389|NCT00958360|4730166|P2|Overall Study|Withdrawal by Subject|1
1433390|NCT00958360|4730167|P1|Overall Study|Withdrawal by Subject|3
1433391|NCT00958347|4730181|P1|Overall Study|study termination|135
1433392|NCT00958347|4730181|P1|Overall Study|revision/removal|10
1433393|NCT00958347|4730181|P1|Overall Study|Lost to Follow-up|15
1433394|NCT00958347|4730181|P1|Overall Study|Withdrawal by Subject|23
1433395|NCT00958347|4730181|P1|Overall Study|Death|43
1433396|NCT00958256|4730222|P1|Overall Study|Adverse Event|3
1433397|NCT00958243|4730232|P6|Overall Study|Lost to Follow-up|5
1433398|NCT00958243|4730233|P5|Overall Study|Lost to Follow-up|8
1433399|NCT00958243|4730234|P4|Overall Study|Lost to Follow-up|2
1433400|NCT00958243|4730235|P3|Overall Study|Lost to Follow-up|11
1433401|NCT00958243|4730236|P2|Overall Study|Lost to Follow-up|5
1433402|NCT00958243|4730237|P1|Overall Study|Lost to Follow-up|2
1433403|NCT00958243|4730232|P6|Overall Study|Withdrawal by Subject|5
1433404|NCT00958243|4730233|P5|Overall Study|Withdrawal by Subject|1
1433405|NCT00958243|4730234|P4|Overall Study|Withdrawal by Subject|1
1433406|NCT00958243|4730235|P3|Overall Study|Withdrawal by Subject|3
1433407|NCT00958243|4730236|P2|Overall Study|Withdrawal by Subject|1
1433408|NCT00958243|4730237|P1|Overall Study|Withdrawal by Subject|0
1433409|NCT00958217|4730295|P2|Overall Study|Inpatient hospitalization|1
1433410|NCT00958217|4730296|P1|Overall Study|Inpatient hospitalization|0
1433411|NCT00958217|4730295|P2|Overall Study|Moved out of area|1
1433412|NCT00958217|4730296|P1|Overall Study|Moved out of area|1
1433413|NCT00958217|4730295|P2|Overall Study|Lost to Follow-up|19
1433414|NCT00958217|4730296|P1|Overall Study|Lost to Follow-up|17
1433415|NCT00958217|4730295|P2|Overall Study|Withdrawal by Subject|3
1433416|NCT00958217|4730296|P1|Overall Study|Withdrawal by Subject|4
1433417|NCT00958217|4730295|P2|Overall Study|Death|1
1433418|NCT00958217|4730296|P1|Overall Study|Death|2
1433419|NCT00958191|4730307|P1|Overall Study|No 5 yr x-rays|56
1433420|NCT00958191|4730307|P1|Overall Study|Site termination|11
1433421|NCT00958191|4730307|P1|Overall Study|Revision of study device|4
1433422|NCT00958191|4730307|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
1433423|NCT00958191|4730307|P1|Overall Study|Inadequate 5 yr x-ray quality|10
1433424|NCT00958191|4730307|P1|Overall Study|Lost to Follow-up|5
1433425|NCT00958191|4730307|P1|Overall Study|Death|4
1433426|NCT00958165|4730322|P1|Overall Study|Not eligible|9
1433427|NCT00958165|4730322|P1|Overall Study|Lost to Follow-up|5
1433428|NCT00958126|4730334|P8|Overall Study|Other Reason|0
1433429|NCT00958126|4730335|P7|Overall Study|Other Reason|0
1433430|NCT00958126|4730336|P6|Overall Study|Other Reason|1
1433431|NCT00958126|4730337|P5|Overall Study|Other Reason|0
1433432|NCT00958126|4730338|P4|Overall Study|Other Reason|1
1433433|NCT00958126|4730339|P3|Overall Study|Other Reason|0
1433434|NCT00958126|4730340|P2|Overall Study|Other Reason|0
1433435|NCT00958126|4730341|P1|Overall Study|Other Reason|0
1433436|NCT00958126|4730334|P8|Overall Study|Sponsor/Investigator decision|0
1433437|NCT00958126|4730335|P7|Overall Study|Sponsor/Investigator decision|0
1433438|NCT00958126|4730336|P6|Overall Study|Sponsor/Investigator decision|0
1433439|NCT00958126|4730337|P5|Overall Study|Sponsor/Investigator decision|0
1433440|NCT00958126|4730338|P4|Overall Study|Sponsor/Investigator decision|1
1433441|NCT00958126|4730339|P3|Overall Study|Sponsor/Investigator decision|0
1433442|NCT00958126|4730340|P2|Overall Study|Sponsor/Investigator decision|0
1433443|NCT00958126|4730341|P1|Overall Study|Sponsor/Investigator decision|0
1433444|NCT00958126|4730334|P8|Overall Study|Lost to Follow-up|0
1433445|NCT00958126|4730335|P7|Overall Study|Lost to Follow-up|0
1433446|NCT00958126|4730336|P6|Overall Study|Lost to Follow-up|0
1433447|NCT00958126|4730337|P5|Overall Study|Lost to Follow-up|0
1433448|NCT00958126|4730338|P4|Overall Study|Lost to Follow-up|8
1433449|NCT00958126|4730339|P3|Overall Study|Lost to Follow-up|9
1433450|NCT00958126|4730340|P2|Overall Study|Lost to Follow-up|5
1433451|NCT00958126|4730341|P1|Overall Study|Lost to Follow-up|1
1433452|NCT00958126|4730334|P8|Overall Study|Moved away from study area|0
1433453|NCT00958126|4730335|P7|Overall Study|Moved away from study area|0
1433454|NCT00958126|4730336|P6|Overall Study|Moved away from study area|0
1433455|NCT00958126|4730337|P5|Overall Study|Moved away from study area|0
1433456|NCT00958126|4730338|P4|Overall Study|Moved away from study area|1
1433457|NCT00958126|4730339|P3|Overall Study|Moved away from study area|1
1433458|NCT00958126|4730340|P2|Overall Study|Moved away from study area|0
1433459|NCT00958126|4730341|P1|Overall Study|Moved away from study area|0
1433460|NCT00958126|4730334|P8|Overall Study|Withdrawal by Subject|0
1433461|NCT00958126|4730335|P7|Overall Study|Withdrawal by Subject|0
1433462|NCT00958126|4730336|P6|Overall Study|Withdrawal by Subject|0
1433463|NCT00958126|4730337|P5|Overall Study|Withdrawal by Subject|0
1433464|NCT00958126|4730338|P4|Overall Study|Withdrawal by Subject|0
1433465|NCT00958126|4730339|P3|Overall Study|Withdrawal by Subject|0
1433466|NCT00958126|4730340|P2|Overall Study|Withdrawal by Subject|2
1433467|NCT00958126|4730341|P1|Overall Study|Withdrawal by Subject|0
1433468|NCT00958126|4730334|P8|Overall Study|Serious Adverse Event|0
1433469|NCT00958126|4730335|P7|Overall Study|Serious Adverse Event|1
1433470|NCT00958126|4730336|P6|Overall Study|Serious Adverse Event|0
1433471|NCT00958126|4730337|P5|Overall Study|Serious Adverse Event|0
1433472|NCT00958126|4730338|P4|Overall Study|Serious Adverse Event|0
1433473|NCT00958126|4730339|P3|Overall Study|Serious Adverse Event|0
1433474|NCT00958126|4730340|P2|Overall Study|Serious Adverse Event|2
1433475|NCT00958126|4730341|P1|Overall Study|Serious Adverse Event|0
1433476|NCT00958074|4730413|P2|Overall Study|Withdrawal by Subject|1
1433477|NCT00958074|4730414|P1|Overall Study|Withdrawal by Subject|0
1433478|NCT00958009|4730429|P1|Overall Study|Subject found device difficult to use|1
1433479|NCT00958009|4730429|P1|Overall Study|Adverse Event|1
1433480|NCT00957996|4730436|P2|Overall Study|Noncompliance; Protocol Deviations|6
1433481|NCT00957996|4730437|P1|Overall Study|Noncompliance; Protocol Deviations|5
1433482|NCT00957996|4730436|P2|Overall Study|Missing|0
1433483|NCT00957996|4730437|P1|Overall Study|Missing|1
1433484|NCT00957996|4730436|P2|Overall Study|Influenza-related complication|1
1433485|NCT00957996|4730437|P1|Overall Study|Influenza-related complication|0
1433486|NCT00957996|4730436|P2|Overall Study|Physician Decision|1
1433487|NCT00957996|4730437|P1|Overall Study|Physician Decision|1
1433488|NCT00957996|4730436|P2|Overall Study|Adverse Event|1
1433489|NCT00957996|4730437|P1|Overall Study|Adverse Event|2
1433490|NCT00957996|4730436|P2|Overall Study|Withdrawal by Subject|2
1433491|NCT00957996|4730437|P1|Overall Study|Withdrawal by Subject|9
1433492|NCT00957996|4730436|P2|Overall Study|Lost to Follow-up|7
1433493|NCT00957996|4730437|P1|Overall Study|Lost to Follow-up|4
1433494|NCT00957996|4730436|P2|Overall Study|Death|10
1433495|NCT00957996|4730437|P1|Overall Study|Death|4
1433496|NCT00957944|4730469|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
1433497|NCT00957944|4730470|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
1433498|NCT00957931|4730504|P1|Overall Study|Death|4
1433499|NCT00957905|4730514|P2|Part B|Protocol Violation|1
1433500|NCT00957905|4730515|P1|Part B|Protocol Violation|0
1433501|NCT00957905|4730514|P2|Part B|Death|1
1433502|NCT00957905|4730515|P1|Part B|Death|0
1433503|NCT00957905|4730514|P2|Part B|Physician Decision|1
1433504|NCT00957905|4730515|P1|Part B|Physician Decision|0
1433505|NCT00957905|4730514|P2|Part B|Not Treated|1
1433506|NCT00957905|4730515|P1|Part B|Not Treated|0
1433507|NCT00957801|4730525|P4|Overall Study|Withdrawal by Subject|1
1433508|NCT00957801|4730526|P3|Overall Study|Withdrawal by Subject|0
1433509|NCT00957801|4730527|P2|Overall Study|Withdrawal by Subject|0
1433510|NCT00957801|4730528|P1|Overall Study|Withdrawal by Subject|0
1433511|NCT00957723|4730694|P1|Overall Study|2yr ROM Data Not Evaluable|25
1433512|NCT00957723|4730694|P1|Overall Study|Intercurrent Illness|2
1433513|NCT00957723|4730694|P1|Overall Study|Investigative Site Terminated|55
1433514|NCT00957723|4730694|P1|Overall Study|Did not undergo surgery|3
1433515|NCT00957723|4730694|P1|Overall Study|Withdrawal by Subject|23
1433516|NCT00957723|4730694|P1|Overall Study|Lost to Follow-up|7
1433517|NCT00957723|4730694|P1|Overall Study|Revision/ Removal of Study Implant|3
1433518|NCT00957723|4730694|P1|Overall Study|Death|3
1433519|NCT00957658|4730780|P1|Overall Study|Protocol Violation|5
1433520|NCT00957658|4730780|P1|Overall Study|surgery cancelled|2
1433521|NCT00957658|4730780|P1|Overall Study|unwilling/unable to return|2
1433522|NCT00957658|4730780|P1|Overall Study|Site termination|10
1433523|NCT00957658|4730780|P1|Overall Study|Incomplete 2 yr data|28
1433524|NCT00957658|4730780|P1|Overall Study|Revision|1
1433525|NCT00957658|4730780|P1|Overall Study|Withdrawal by Subject|12
1433526|NCT00957658|4730780|P1|Overall Study|Lost to Follow-up|4
1433527|NCT00957658|4730780|P1|Overall Study|Death|1
1433528|NCT00957580|4730805|P3|Overall Study|Enrolled but not treated|0
1433529|NCT00957580|4730806|P2|Overall Study|Enrolled but not treated|1
1433530|NCT00957580|4730807|P1|Overall Study|Enrolled but not treated|0
1433531|NCT00957580|4730805|P3|Overall Study|Ongoing at data cut-off|0
1433532|NCT00957580|4730806|P2|Overall Study|Ongoing at data cut-off|1
1433533|NCT00957580|4730807|P1|Overall Study|Ongoing at data cut-off|0
1433534|NCT00957528|4730954|P3|Overall Study|Withdrawal by Subject|1
1433535|NCT00957528|4730955|P2|Overall Study|Withdrawal by Subject|0
1433536|NCT00957528|4730956|P1|Overall Study|Withdrawal by Subject|0
1433537|NCT00957528|4730954|P3|Overall Study|Protocol Violation|0
1433538|NCT00957528|4730955|P2|Overall Study|Protocol Violation|1
1433539|NCT00957528|4730956|P1|Overall Study|Protocol Violation|0
1433540|NCT00957424|4730979|P1|Overall Study|Withdrawal by Subject|1
1433541|NCT00957424|4730979|P1|Overall Study|Protocol Violation|3
1433542|NCT00957424|4730979|P1|Overall Study|Lost to Follow-up|19
1433543|NCT00957372|4730989|P4|PART II|Patient non-compliance|4
1433544|NCT00957372|4730990|P3|PART II|Patient non-compliance|0
1433545|NCT00957372|4730991|P2|PART II|Patient non-compliance|0
1433546|NCT00957372|4730992|P1|PART II|Patient non-compliance|0
1433547|NCT00957372|4730989|P4|PART II|Adverse Event|10
1433548|NCT00957372|4730990|P3|PART II|Adverse Event|0
1433549|NCT00957372|4730991|P2|PART II|Adverse Event|0
1433550|NCT00957372|4730992|P1|PART II|Adverse Event|0
1433551|NCT00957372|4730989|P4|PART II|Not Know|20
1433552|NCT00957372|4730990|P3|PART II|Not Know|0
1433553|NCT00957372|4730991|P2|PART II|Not Know|0
1433554|NCT00957372|4730992|P1|PART II|Not Know|0
1433555|NCT00957372|4730989|P4|PART II|Pregnancy|1
1433556|NCT00957372|4730990|P3|PART II|Pregnancy|0
1433557|NCT00957372|4730991|P2|PART II|Pregnancy|0
1433558|NCT00957372|4730992|P1|PART II|Pregnancy|0
1433559|NCT00957372|4730989|P4|PART II|Physician Decision|1
1433560|NCT00957372|4730990|P3|PART II|Physician Decision|0
1433561|NCT00957372|4730991|P2|PART II|Physician Decision|0
1433562|NCT00957372|4730992|P1|PART II|Physician Decision|0
1433563|NCT00957372|4730989|P4|PART II|Withdrawal by Subject|8
1433564|NCT00957372|4730990|P3|PART II|Withdrawal by Subject|0
1433565|NCT00957372|4730991|P2|PART II|Withdrawal by Subject|0
1433566|NCT00957372|4730992|P1|PART II|Withdrawal by Subject|0
1433567|NCT00957372|4730989|P4|PART I|Lost to Follow-up|0
1433568|NCT00957372|4730990|P3|PART I|Lost to Follow-up|1
1433569|NCT00957372|4730991|P2|PART I|Lost to Follow-up|0
1433570|NCT00957372|4730992|P1|PART I|Lost to Follow-up|0
1433571|NCT00957268|4731017|P5|Overall Study|Voluntary Withdrawal|0
1433572|NCT00957268|4731018|P4|Overall Study|Voluntary Withdrawal|0
1433573|NCT00957268|4731019|P3|Overall Study|Voluntary Withdrawal|1
1433574|NCT00957268|4731020|P2|Overall Study|Voluntary Withdrawal|0
1433575|NCT00957268|4731021|P1|Overall Study|Voluntary Withdrawal|0
1433576|NCT00957034|4731143|P3|Overall Study|Withdrawal by Subject|0
1433577|NCT00957034|4731144|P2|Overall Study|Withdrawal by Subject|2
1433578|NCT00957034|4731145|P1|Overall Study|Withdrawal by Subject|0
1433579|NCT00957034|4731143|P3|Overall Study|Sponsor Terminated Study|5
1433580|NCT00957034|4731144|P2|Overall Study|Sponsor Terminated Study|1
1433581|NCT00957034|4731145|P1|Overall Study|Sponsor Terminated Study|6
1433582|NCT00957034|4731143|P3|Overall Study|Adverse Event|1
1433583|NCT00957034|4731144|P2|Overall Study|Adverse Event|1
1433584|NCT00957034|4731145|P1|Overall Study|Adverse Event|0
1433585|NCT00957021|4731168|P1|Overall Study|Termination due to language issue|2
1433586|NCT00957021|4731168|P1|Overall Study|Surgery Cancelled|9
1433587|NCT00957021|4731168|P1|Overall Study|Site Termination by the 2 yr visit|16
1433588|NCT00957021|4731168|P1|Overall Study|Revised study component by 2 yr visit|8
1433589|NCT00957021|4731168|P1|Overall Study|No 2 yr ROM data|35
1433590|NCT00957021|4731168|P1|Overall Study|Withdrawal by Subject|34
1433591|NCT00957021|4731168|P1|Overall Study|Lost to Follow-up|8
1433592|NCT00957021|4731168|P1|Overall Study|Death|5
1433593|NCT00957008|4731181|P4|Overall Study|Relocated; Family conflict|3
1433594|NCT00957008|4731182|P3|Overall Study|Relocated; Family conflict|1
1433595|NCT00957008|4731183|P2|Overall Study|Relocated; Family conflict|1
1433596|NCT00957008|4731184|P1|Overall Study|Relocated; Family conflict|4
1433597|NCT00957008|4731181|P4|Overall Study|Physician Decision|1
1433598|NCT00957008|4731182|P3|Overall Study|Physician Decision|1
1433599|NCT00957008|4731183|P2|Overall Study|Physician Decision|0
1433600|NCT00957008|4731184|P1|Overall Study|Physician Decision|1
1433601|NCT00957008|4731181|P4|Overall Study|Lost to Follow-up|4
1433602|NCT00957008|4731182|P3|Overall Study|Lost to Follow-up|3
1433603|NCT00957008|4731183|P2|Overall Study|Lost to Follow-up|1
1433604|NCT00957008|4731184|P1|Overall Study|Lost to Follow-up|3
1433605|NCT00957008|4731181|P4|Overall Study|Withdrawal by Subject|16
1433606|NCT00957008|4731182|P3|Overall Study|Withdrawal by Subject|12
1433607|NCT00957008|4731183|P2|Overall Study|Withdrawal by Subject|10
1433608|NCT00957008|4731184|P1|Overall Study|Withdrawal by Subject|13
1433609|NCT00956943|4731212|P2|Overall Study|Lost to Follow-up|10
1433610|NCT00956943|4731213|P1|Overall Study|Lost to Follow-up|9
1433611|NCT00956839|4731224|P3|Overall Study|Lost to Follow-up|3
1433612|NCT00956839|4731225|P2|Overall Study|Lost to Follow-up|0
1433613|NCT00956839|4731226|P1|Overall Study|Lost to Follow-up|3
1433614|NCT00956813|4731239|P2|Flaxseed and Placebo|Ineligible|1
1433615|NCT00956813|4731240|P1|Flaxseed and Placebo|Ineligible|3
1433616|NCT00956813|4731239|P2|Flaxseed and Placebo|Withdrawal by Subject|4
1433617|NCT00956813|4731240|P1|Flaxseed and Placebo|Withdrawal by Subject|5
1433618|NCT00956592|4731292|P2|Overall Study|Protocol Violation|3
1433619|NCT00956592|4731293|P1|Overall Study|Protocol Violation|1
1433620|NCT00956293|4731328|P3|Follow-up Period|Follow-up period was terminated.|0
1433621|NCT00956293|4731329|P2|Follow-up Period|Follow-up period was terminated.|32
1433622|NCT00956293|4731330|P1|Follow-up Period|Follow-up period was terminated.|20
1433623|NCT00956293|4731328|P3|Main Period (Randomization)|Adverse Event|0
1433624|NCT00956293|4731329|P2|Main Period (Randomization)|Adverse Event|15
1433625|NCT00956293|4731330|P1|Main Period (Randomization)|Adverse Event|0
1433626|NCT00956293|4731328|P3|Main Period (Randomization)|Lack of Efficacy|0
1433627|NCT00956293|4731329|P2|Main Period (Randomization)|Lack of Efficacy|10
1433628|NCT00956293|4731330|P1|Main Period (Randomization)|Lack of Efficacy|1
1433629|NCT00956293|4731328|P3|Main Period (Randomization)|Abnormal laboratory value|0
1433630|NCT00956293|4731329|P2|Main Period (Randomization)|Abnormal laboratory value|2
1433631|NCT00956293|4731330|P1|Main Period (Randomization)|Abnormal laboratory value|0
1433632|NCT00956293|4731328|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
1433633|NCT00956293|4731329|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
1433634|NCT00956293|4731330|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
1433635|NCT00956293|4731328|P3|Main Period (Pre-randomization)|Adverse Event|36
1433636|NCT00956293|4731329|P2|Main Period (Pre-randomization)|Adverse Event|0
1433637|NCT00956293|4731330|P1|Main Period (Pre-randomization)|Adverse Event|0
1433638|NCT00956293|4731328|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
1433639|NCT00956293|4731329|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
1433640|NCT00956293|4731330|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
1433641|NCT00956293|4731328|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
1433642|NCT00956293|4731329|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
1433643|NCT00956293|4731330|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
1433644|NCT00956293|4731328|P3|Main Period (Pre-randomization)|Graft loss|7
1433645|NCT00956293|4731329|P2|Main Period (Pre-randomization)|Graft loss|0
1433646|NCT00956293|4731330|P1|Main Period (Pre-randomization)|Graft loss|0
1433647|NCT00956293|4731328|P3|Main Period (Pre-randomization)|Administrative problems|6
1433648|NCT00956293|4731329|P2|Main Period (Pre-randomization)|Administrative problems|0
1433649|NCT00956293|4731330|P1|Main Period (Pre-randomization)|Administrative problems|0
1433650|NCT00956293|4731328|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
1433651|NCT00956293|4731329|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
1433652|NCT00956293|4731330|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
1433653|NCT00956293|4731328|P3|Main Period (Pre-randomization)|Protocol Violation|1
1433654|NCT00956293|4731329|P2|Main Period (Pre-randomization)|Protocol Violation|0
1433655|NCT00956293|4731330|P1|Main Period (Pre-randomization)|Protocol Violation|0
1433656|NCT00956293|4731328|P3|Main Period (Pre-randomization)|Death|1
1433657|NCT00956293|4731329|P2|Main Period (Pre-randomization)|Death|0
1433658|NCT00956293|4731330|P1|Main Period (Pre-randomization)|Death|0
1433659|NCT00956293|4731328|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
1433660|NCT00956293|4731329|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
1433661|NCT00956293|4731330|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
1433662|NCT00955968|4731385|P2|Overall Study|Site closed|52
1433663|NCT00955968|4731386|P1|Overall Study|Site closed|55
1433664|NCT00955968|4731385|P2|Overall Study|Lost to Follow-up|39
1433665|NCT00955968|4731386|P1|Overall Study|Lost to Follow-up|45
1433666|NCT00955968|4731385|P2|Overall Study|Withdrawal by Subject|31
1433667|NCT00955968|4731386|P1|Overall Study|Withdrawal by Subject|35
1433668|NCT00955968|4731385|P2|Overall Study|Death|4
1433669|NCT00955968|4731386|P1|Overall Study|Death|2
1433670|NCT00955955|4731420|P3|Overall Study|Lost to Follow-up|0
1433671|NCT00955955|4731421|P2|Overall Study|Lost to Follow-up|0
1433672|NCT00955955|4731422|P1|Overall Study|Lost to Follow-up|2
1433673|NCT00955825|4731506|P2|Overall Study|Any other reason not above-mentioned|9
1433674|NCT00955825|4731507|P1|Overall Study|Any other reason not above-mentioned|7
1433675|NCT00955825|4731506|P2|Overall Study|Withdrawal by Subject|6
1433676|NCT00955825|4731507|P1|Overall Study|Withdrawal by Subject|4
1433677|NCT00955825|4731506|P2|Overall Study|Adverse Event|2
1433678|NCT00955825|4731507|P1|Overall Study|Adverse Event|15
1433679|NCT00955721|4731524|P2|Overall Study|Withdrawal by Subject|0
1433680|NCT00955721|4731525|P1|Overall Study|Withdrawal by Subject|1
1433681|NCT00955721|4731524|P2|Overall Study|Death|0
1433682|NCT00955721|4731525|P1|Overall Study|Death|1
1433683|NCT00955721|4731524|P2|Overall Study|Physician Decision|0
1433684|NCT00955721|4731525|P1|Overall Study|Physician Decision|1
1433685|NCT00955617|4731535|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
1433686|NCT00955617|4731536|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
1433687|NCT00955617|4731535|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
1433688|NCT00955617|4731536|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
1433689|NCT00955617|4731535|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
1433690|NCT00955617|4731536|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
1433691|NCT00955617|4731535|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
1433692|NCT00955617|4731536|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
1433693|NCT00955474|4731600|P2|Overall Study|Physician Decision|5
1433694|NCT00955474|4731601|P1|Overall Study|Physician Decision|7
1433695|NCT00955357|4731637|P2|Maintenance Phase|Non compliance to study procedures|0
1433696|NCT00955357|4731638|P1|Maintenance Phase|Non compliance to study procedures|1
1433697|NCT00955357|4731637|P2|Maintenance Phase|Patient moving out of area|1
1433698|NCT00955357|4731638|P1|Maintenance Phase|Patient moving out of area|0
1433699|NCT00955357|4731637|P2|Maintenance Phase|Withdrawal by Subject|4
1433700|NCT00955357|4731638|P1|Maintenance Phase|Withdrawal by Subject|4
1433701|NCT00955357|4731637|P2|Maintenance Phase|Lost to Follow-up|7
1433702|NCT00955357|4731638|P1|Maintenance Phase|Lost to Follow-up|2
1433703|NCT00955357|4731637|P2|Maintenance Phase|Protocol Violation|6
1433704|NCT00955357|4731638|P1|Maintenance Phase|Protocol Violation|2
1433705|NCT00955357|4731637|P2|Maintenance Phase|Lack of Efficacy|4
1433706|NCT00955357|4731638|P1|Maintenance Phase|Lack of Efficacy|0
1433707|NCT00955357|4731637|P2|Maintenance Phase|Adverse Event|23
1433708|NCT00955357|4731638|P1|Maintenance Phase|Adverse Event|3
1433709|NCT00955357|4731637|P2|Titration Phase|Non compliance to study procedures|1
1433710|NCT00955357|4731638|P1|Titration Phase|Non compliance to study procedures|0
1433711|NCT00955357|4731637|P2|Titration Phase|Study medication not tolerated|1
1433712|NCT00955357|4731638|P1|Titration Phase|Study medication not tolerated|0
1433800|NCT00954512|4731813|P4|Overall Study|Symptomatic Deterioration|0
1433713|NCT00955357|4731637|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
1433714|NCT00955357|4731638|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
1433715|NCT00955357|4731637|P2|Titration Phase|Withdrawal by Subject|5
1433716|NCT00955357|4731638|P1|Titration Phase|Withdrawal by Subject|3
1433717|NCT00955357|4731637|P2|Titration Phase|Lost to Follow-up|3
1433718|NCT00955357|4731638|P1|Titration Phase|Lost to Follow-up|1
1433719|NCT00955357|4731637|P2|Titration Phase|Protocol Violation|7
1433720|NCT00955357|4731638|P1|Titration Phase|Protocol Violation|3
1433721|NCT00955357|4731637|P2|Titration Phase|Lack of Efficacy|2
1433722|NCT00955357|4731638|P1|Titration Phase|Lack of Efficacy|0
1433723|NCT00955357|4731637|P2|Titration Phase|Adverse Event|46
1433724|NCT00955357|4731638|P1|Titration Phase|Adverse Event|9
1433725|NCT00955305|4731646|P2|Overall Study|Ineligible|7
1433726|NCT00955305|4731647|P1|Overall Study|Ineligible|5
1433727|NCT00955305|4731646|P2|Overall Study|Never started protocol treatment|5
1433728|NCT00955305|4731647|P1|Overall Study|Never started protocol treatment|5
1433729|NCT00955305|4731646|P2|Overall Study|No off-treatment reason submitted|0
1433730|NCT00955305|4731647|P1|Overall Study|No off-treatment reason submitted|1
1433731|NCT00955305|4731646|P2|Overall Study|Lost to Follow-up|1
1433732|NCT00955305|4731647|P1|Overall Study|Lost to Follow-up|0
1433733|NCT00955305|4731646|P2|Overall Study|Maximum response achieved|1
1433734|NCT00955305|4731647|P1|Overall Study|Maximum response achieved|0
1433735|NCT00955305|4731646|P2|Overall Study|Functional decline|0
1433736|NCT00955305|4731647|P1|Overall Study|Functional decline|2
1433737|NCT00955305|4731646|P2|Overall Study|Continued presence of residual disease|1
1433738|NCT00955305|4731647|P1|Overall Study|Continued presence of residual disease|0
1433739|NCT00955305|4731646|P2|Overall Study|Physician Decision|0
1433740|NCT00955305|4731647|P1|Overall Study|Physician Decision|1
1433741|NCT00955305|4731646|P2|Overall Study|Other complicating disease|4
1433742|NCT00955305|4731647|P1|Overall Study|Other complicating disease|2
1433743|NCT00955305|4731646|P2|Overall Study|Alternative therapy|0
1433744|NCT00955305|4731647|P1|Overall Study|Alternative therapy|4
1433745|NCT00955305|4731646|P2|Overall Study|Withdrawal by Subject|4
1433746|NCT00955305|4731647|P1|Overall Study|Withdrawal by Subject|5
1433747|NCT00955305|4731646|P2|Overall Study|Death|1
1433748|NCT00955305|4731647|P1|Overall Study|Death|2
1433749|NCT00955305|4731646|P2|Overall Study|Adverse Event|22
1433750|NCT00955305|4731647|P1|Overall Study|Adverse Event|22
1433751|NCT00955305|4731646|P2|Overall Study|Disease progression|41
1433752|NCT00955305|4731647|P1|Overall Study|Disease progression|39
1433753|NCT00955279|4731660|P3|Overall Study|Withdrawal by Subject|3
1433754|NCT00955279|4731661|P2|Overall Study|Withdrawal by Subject|0
1433755|NCT00955279|4731662|P1|Overall Study|Withdrawal by Subject|2
1433756|NCT00955279|4731660|P3|Overall Study|Lost to Follow-up|1
1433757|NCT00955279|4731661|P2|Overall Study|Lost to Follow-up|3
1433758|NCT00955279|4731662|P1|Overall Study|Lost to Follow-up|0
1433759|NCT00955279|4731660|P3|Overall Study|Death|1
1433760|NCT00955279|4731661|P2|Overall Study|Death|1
1433761|NCT00955279|4731662|P1|Overall Study|Death|1
1433762|NCT00955279|4731660|P3|Overall Study|Other|3
1433763|NCT00955279|4731661|P2|Overall Study|Other|0
1433764|NCT00955279|4731662|P1|Overall Study|Other|0
1433765|NCT00955110|4731699|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
1433766|NCT00955110|4731699|P1|Treatment Phase|Non-compliance with study restrictions|1
1433767|NCT00955110|4731699|P1|Treatment Phase|Administrative reasons|2
1433768|NCT00955110|4731699|P1|Treatment Phase|Adverse Event|2
1433769|NCT00955110|4731699|P1|Qualification Phase|Did not meet eligibility criteria|24
1433770|NCT00954941|4731746|P2|Overall Study|Adverse Event|1
1433771|NCT00954941|4731747|P1|Overall Study|Adverse Event|0
1433772|NCT00954941|4731746|P2|Overall Study|Ineligible|2
1433773|NCT00954941|4731747|P1|Overall Study|Ineligible|2
1433774|NCT00954941|4731746|P2|Overall Study|Physician Decision|2
1433775|NCT00954941|4731747|P1|Overall Study|Physician Decision|2
1433776|NCT00954941|4731746|P2|Overall Study|Insurance Denial|2
1433777|NCT00954941|4731747|P1|Overall Study|Insurance Denial|2
1433778|NCT00954941|4731746|P2|Overall Study|Withdrawal by Subject|0
1433779|NCT00954941|4731747|P1|Overall Study|Withdrawal by Subject|1
1433780|NCT00954941|4731746|P2|Overall Study|Received treatment at home|0
1433781|NCT00954941|4731747|P1|Overall Study|Received treatment at home|1
1433782|NCT00954733|4731763|P1|Overall Study|blood gas machine did not work|1
1433783|NCT00954707|4731767|P1|Overall Study|Lost to Follow-up|33
1433784|NCT00954707|4731767|P1|Overall Study|Withdrawal by Subject|100
1433785|NCT00954707|4731767|P1|Overall Study|Death|34
1433786|NCT00954538|4731789|P6|Part III|Withdrawal by Subject|0
1433787|NCT00954538|4731790|P5|Part III|Withdrawal by Subject|1
1433788|NCT00954538|4731791|P4|Part III|Withdrawal by Subject|0
1433789|NCT00954538|4731792|P3|Part III|Withdrawal by Subject|0
1433790|NCT00954538|4731793|P2|Part III|Withdrawal by Subject|0
1433791|NCT00954538|4731794|P1|Part III|Withdrawal by Subject|0
1433792|NCT00954512|4731811|P6|Overall Study|Progression of Disease|1
1433793|NCT00954512|4731812|P5|Overall Study|Progression of Disease|1
1433794|NCT00954512|4731813|P4|Overall Study|Progression of Disease|1
1433795|NCT00954512|4731814|P3|Overall Study|Progression of Disease|0
1433796|NCT00954512|4731815|P2|Overall Study|Progression of Disease|1
1433797|NCT00954512|4731816|P1|Overall Study|Progression of Disease|2
1433798|NCT00954512|4731811|P6|Overall Study|Symptomatic Deterioration|0
1433799|NCT00954512|4731812|P5|Overall Study|Symptomatic Deterioration|2
1433801|NCT00954512|4731814|P3|Overall Study|Symptomatic Deterioration|0
1433802|NCT00954512|4731815|P2|Overall Study|Symptomatic Deterioration|1
1433803|NCT00954512|4731816|P1|Overall Study|Symptomatic Deterioration|0
1433804|NCT00954512|4731811|P6|Overall Study|Physician Decision|0
1433805|NCT00954512|4731812|P5|Overall Study|Physician Decision|0
1433806|NCT00954512|4731813|P4|Overall Study|Physician Decision|1
1433807|NCT00954512|4731814|P3|Overall Study|Physician Decision|0
1433808|NCT00954512|4731815|P2|Overall Study|Physician Decision|1
1433809|NCT00954512|4731816|P1|Overall Study|Physician Decision|0
1433810|NCT00954512|4731811|P6|Overall Study|Adverse Event|2
1433811|NCT00954512|4731812|P5|Overall Study|Adverse Event|1
1433812|NCT00954512|4731813|P4|Overall Study|Adverse Event|0
1433813|NCT00954512|4731814|P3|Overall Study|Adverse Event|0
1433814|NCT00954512|4731815|P2|Overall Study|Adverse Event|0
1433815|NCT00954512|4731816|P1|Overall Study|Adverse Event|0
1433816|NCT00954512|4731811|P6|Overall Study|Withdrawal by Subject|1
1433817|NCT00954512|4731812|P5|Overall Study|Withdrawal by Subject|0
1433818|NCT00954512|4731813|P4|Overall Study|Withdrawal by Subject|0
1433819|NCT00954512|4731814|P3|Overall Study|Withdrawal by Subject|0
1433820|NCT00954512|4731815|P2|Overall Study|Withdrawal by Subject|0
1433821|NCT00954512|4731816|P1|Overall Study|Withdrawal by Subject|0
1433822|NCT00954447|4731837|P2|Overall Study|Other|18
1433823|NCT00954447|4731838|P1|Overall Study|Other|21
1433824|NCT00954447|4731837|P2|Overall Study|Withdrawal by Subject|21
1433825|NCT00954447|4731838|P1|Overall Study|Withdrawal by Subject|26
1433826|NCT00954447|4731837|P2|Overall Study|Lost to Follow-up|14
1433827|NCT00954447|4731838|P1|Overall Study|Lost to Follow-up|8
1433828|NCT00954447|4731837|P2|Overall Study|Protocol Violation|7
1433829|NCT00954447|4731838|P1|Overall Study|Protocol Violation|5
1433830|NCT00954447|4731837|P2|Overall Study|Lack of Efficacy|3
1433831|NCT00954447|4731838|P1|Overall Study|Lack of Efficacy|17
1433832|NCT00954447|4731837|P2|Overall Study|Adverse Event|25
1433833|NCT00954447|4731838|P1|Overall Study|Adverse Event|33
1433834|NCT00954421|4731874|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
1433835|NCT00954421|4731874|P1|6 Months of DBS|Withdrawal by Subject|1
1433836|NCT00954421|4731874|P1|Screening|screen failures|3
1433837|NCT00954122|4731920|P1|Overall Study|Safety Reason|1
1433838|NCT00954122|4731920|P1|Overall Study|Adverse Event|1
1433839|NCT00954122|4731920|P1|Overall Study|Withdrawal by Subject|5
1433840|NCT00953927|4731937|P2|Overall Study|Other study discontinuation|1
1433841|NCT00953927|4731938|P1|Overall Study|Other study discontinuation|1
1433842|NCT00953927|4731937|P2|Overall Study|Death|4
1433843|NCT00953927|4731938|P1|Overall Study|Death|7
1433844|NCT00953927|4731937|P2|Overall Study|Withdrawal by Subject|25
1433845|NCT00953927|4731938|P1|Overall Study|Withdrawal by Subject|36
1433846|NCT00953927|4731937|P2|Overall Study|Lost to Follow-up|65
1433847|NCT00953927|4731938|P1|Overall Study|Lost to Follow-up|61
1433848|NCT00953745|4731993|P2|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
1433849|NCT00953745|4731994|P1|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
1433850|NCT00953745|4731993|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
1433851|NCT00953745|4731994|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
1433852|NCT00953745|4731993|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
1433853|NCT00953745|4731994|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
1433854|NCT00953745|4731993|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
1433855|NCT00953745|4731994|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
1433856|NCT00953745|4731993|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
1433857|NCT00953745|4731994|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
1433858|NCT00953745|4731993|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
1433859|NCT00953745|4731994|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
1433860|NCT00953706|4732027|P4|Part B (96-Week Open-Label Extension)|Other|2
1433861|NCT00953706|4732028|P3|Part B (96-Week Open-Label Extension)|Other|0
1433862|NCT00953706|4732029|P2|Part B (96-Week Open-Label Extension)|Other|0
1433863|NCT00953706|4732030|P1|Part B (96-Week Open-Label Extension)|Other|0
1433864|NCT00953706|4732027|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
1433865|NCT00953706|4732028|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
1433866|NCT00953706|4732029|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
1433867|NCT00953706|4732030|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
1433868|NCT00953706|4732027|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
1433869|NCT00953706|4732028|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
1433870|NCT00953706|4732029|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
1433871|NCT00953706|4732030|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
1433872|NCT00953706|4732027|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
1433873|NCT00953706|4732028|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
1433874|NCT00953706|4732029|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
1433875|NCT00953706|4732030|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
1433876|NCT00953706|4732027|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
1433877|NCT00953706|4732028|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
1433878|NCT00953706|4732029|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
1433879|NCT00953706|4732030|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
1433880|NCT00953706|4732027|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
1433881|NCT00953706|4732028|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
1433882|NCT00953706|4732029|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
1433883|NCT00953706|4732030|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
1433884|NCT00953706|4732027|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
1433885|NCT00953706|4732028|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
1433886|NCT00953706|4732029|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
1433887|NCT00953706|4732030|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
1433888|NCT00953706|4732027|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
1433889|NCT00953706|4732028|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
1433890|NCT00953706|4732029|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
1433891|NCT00953706|4732030|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
1433892|NCT00953706|4732027|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
1433893|NCT00953706|4732028|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
1433894|NCT00953706|4732029|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
1433895|NCT00953706|4732030|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
1433896|NCT00953706|4732027|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
1433897|NCT00953706|4732028|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
1433898|NCT00953706|4732029|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
1433899|NCT00953706|4732030|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
1433900|NCT00953706|4732027|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
1433901|NCT00953706|4732028|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
1433902|NCT00953706|4732029|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
1433903|NCT00953706|4732030|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
1433904|NCT00953680|4732062|P2|Period 1|Withdrawal by Subject|1
1433905|NCT00953680|4732063|P1|Period 1|Withdrawal by Subject|0
1433906|NCT00953667|4732075|P1|Overall Study|poor venous access,unable to draw blood|4
1433907|NCT00953667|4732075|P1|Overall Study|Adverse Event|10
1433908|NCT00953667|4732075|P1|Overall Study|Withdrawal by Subject|63
1433909|NCT00953667|4732075|P1|Overall Study|Physician Decision|35
1433910|NCT00953667|4732075|P1|Overall Study|Lost to Follow-up|11
1433911|NCT00953615|4732096|P1|Overall Study|Adverse Event|1
1433912|NCT00953524|4732107|P4|Overall Study|Withdrawal by Subject|0
1433913|NCT00953524|4732108|P3|Overall Study|Withdrawal by Subject|1
1433914|NCT00953524|4732109|P2|Overall Study|Withdrawal by Subject|4
1433915|NCT00953524|4732110|P1|Overall Study|Withdrawal by Subject|2
1433916|NCT00953524|4732107|P4|Overall Study|Lost to Follow-up|0
1433917|NCT00953524|4732108|P3|Overall Study|Lost to Follow-up|1
1433918|NCT00953524|4732109|P2|Overall Study|Lost to Follow-up|1
1433919|NCT00953524|4732110|P1|Overall Study|Lost to Follow-up|0
1433920|NCT00953524|4732107|P4|Overall Study|Protocol Violation|6
1433921|NCT00953524|4732108|P3|Overall Study|Protocol Violation|11
1433922|NCT00953524|4732109|P2|Overall Study|Protocol Violation|10
1433923|NCT00953524|4732110|P1|Overall Study|Protocol Violation|18
1433924|NCT00953524|4732107|P4|Overall Study|Adverse Event|2
1433925|NCT00953524|4732108|P3|Overall Study|Adverse Event|1
1433926|NCT00953524|4732109|P2|Overall Study|Adverse Event|0
1433927|NCT00953524|4732110|P1|Overall Study|Adverse Event|2
1433928|NCT00953407|4732153|P5|Overall Study|Lost to Follow-up|0
1433929|NCT00953407|4732154|P4|Overall Study|Lost to Follow-up|1
1433930|NCT00953407|4732155|P3|Overall Study|Lost to Follow-up|0
1433931|NCT00953407|4732156|P2|Overall Study|Lost to Follow-up|0
1433932|NCT00953407|4732157|P1|Overall Study|Lost to Follow-up|0
1433933|NCT00953407|4732153|P5|Overall Study|Failed inclusion criteria|1
1433934|NCT00953407|4732154|P4|Overall Study|Failed inclusion criteria|1
1433935|NCT00953407|4732155|P3|Overall Study|Failed inclusion criteria|1
1433936|NCT00953407|4732156|P2|Overall Study|Failed inclusion criteria|1
1433937|NCT00953407|4732157|P1|Overall Study|Failed inclusion criteria|1
1433938|NCT00953329|4732169|P1|Overall Study|Lack of Efficacy|1
1433939|NCT00953225|4732182|P2|Overall Study|Withdrawal by Subject|0
1433940|NCT00953225|4732183|P1|Overall Study|Withdrawal by Subject|2
1433941|NCT00953160|4732267|P1|Overall Study|Withdrawal by Subject|4
1433942|NCT00953160|4732267|P1|Overall Study|Lost to Follow-up|23
1433943|NCT00953147|4732276|P3|Overall Study|Other|13
1433944|NCT00953147|4732277|P2|Overall Study|Other|11
1433945|NCT00953147|4732278|P1|Overall Study|Other|4
1433946|NCT00953147|4732276|P3|Overall Study|Physician Decision|3
1433947|NCT00953147|4732277|P2|Overall Study|Physician Decision|7
1433948|NCT00953147|4732278|P1|Overall Study|Physician Decision|2
1433949|NCT00953147|4732276|P3|Overall Study|Lost to Follow-up|4
1433950|NCT00953147|4732277|P2|Overall Study|Lost to Follow-up|9
1433951|NCT00953147|4732278|P1|Overall Study|Lost to Follow-up|8
1433952|NCT00953147|4732276|P3|Overall Study|Withdrawal by Subject|12
1433953|NCT00953147|4732277|P2|Overall Study|Withdrawal by Subject|15
1433954|NCT00953147|4732278|P1|Overall Study|Withdrawal by Subject|13
1433955|NCT00953147|4732276|P3|Overall Study|Protocol Violation|4
1433956|NCT00953147|4732277|P2|Overall Study|Protocol Violation|8
1433957|NCT00953147|4732278|P1|Overall Study|Protocol Violation|2
1433958|NCT00953147|4732276|P3|Overall Study|Adverse Event|6
1433959|NCT00953147|4732277|P2|Overall Study|Adverse Event|16
1433960|NCT00953147|4732278|P1|Overall Study|Adverse Event|8
1433961|NCT00953056|4732356|P6|Overall Study|Serious Adverse Event|1
1433962|NCT00953056|4732357|P5|Overall Study|Serious Adverse Event|0
1433963|NCT00953056|4732358|P4|Overall Study|Serious Adverse Event|0
1433964|NCT00953056|4732359|P3|Overall Study|Serious Adverse Event|0
1433965|NCT00953056|4732360|P2|Overall Study|Serious Adverse Event|0
1433966|NCT00953056|4732361|P1|Overall Study|Serious Adverse Event|0
1433967|NCT00953056|4732356|P6|Overall Study|Withdrew Consent|3
1433968|NCT00953056|4732357|P5|Overall Study|Withdrew Consent|2
1433969|NCT00953056|4732358|P4|Overall Study|Withdrew Consent|0
1433970|NCT00953056|4732359|P3|Overall Study|Withdrew Consent|0
1433971|NCT00953056|4732360|P2|Overall Study|Withdrew Consent|0
1433972|NCT00953056|4732361|P1|Overall Study|Withdrew Consent|0
1433973|NCT00953043|4732385|P2|Overall Study|Physician Decision|2
1433974|NCT00953043|4732386|P1|Overall Study|Physician Decision|0
1433975|NCT00953043|4732385|P2|Overall Study|Withdrawal by Subject|0
1433976|NCT00953043|4732386|P1|Overall Study|Withdrawal by Subject|4
1433977|NCT00953017|4732410|P4|Overall Study|Brown stool prior to procedure|0
1433978|NCT00953017|4732411|P3|Overall Study|Brown stool prior to procedure|1
1433979|NCT00953017|4732412|P2|Overall Study|Brown stool prior to procedure|0
1433980|NCT00953017|4732413|P1|Overall Study|Brown stool prior to procedure|0
1433981|NCT00953017|4732410|P4|Overall Study|Procedure incomplete due to pain/looping|1
1433982|NCT00953017|4732411|P3|Overall Study|Procedure incomplete due to pain/looping|0
1433983|NCT00953017|4732412|P2|Overall Study|Procedure incomplete due to pain/looping|1
1433984|NCT00953017|4732413|P1|Overall Study|Procedure incomplete due to pain/looping|0
1433985|NCT00953017|4732410|P4|Overall Study|Incomplete data|0
1433986|NCT00953017|4732411|P3|Overall Study|Incomplete data|0
1433987|NCT00953017|4732412|P2|Overall Study|Incomplete data|1
1433988|NCT00953017|4732413|P1|Overall Study|Incomplete data|1
1433989|NCT00953017|4732410|P4|Overall Study|DId not show up for colonoscopy|4
1433990|NCT00953017|4732411|P3|Overall Study|DId not show up for colonoscopy|5
1433991|NCT00953017|4732412|P2|Overall Study|DId not show up for colonoscopy|4
1433992|NCT00953017|4732413|P1|Overall Study|DId not show up for colonoscopy|4
1433993|NCT00952848|4732435|P1|Overall Study|Withdrawal by Subject|4
1433994|NCT00952822|4732442|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
1433995|NCT00952822|4732443|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
1433996|NCT00952822|4732444|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
1433997|NCT00952822|4732445|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
1433998|NCT00952822|4732442|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
1433999|NCT00952822|4732443|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
1434000|NCT00952822|4732444|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
1434001|NCT00952822|4732445|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
1434002|NCT00952731|4732477|P2|Overall Study|Drug supply expired|0
1434003|NCT00952731|4732478|P1|Overall Study|Drug supply expired|1
1434004|NCT00952705|4732497|P3|Overall Study|Exclusion criteria not met pre dose|0
1434005|NCT00952705|4732498|P2|Overall Study|Exclusion criteria not met pre dose|1
1434006|NCT00952705|4732499|P1|Overall Study|Exclusion criteria not met pre dose|0
1434007|NCT00952705|4732497|P3|Overall Study|Incarcerated post dose|0
1434008|NCT00952705|4732498|P2|Overall Study|Incarcerated post dose|0
1434009|NCT00952705|4732499|P1|Overall Study|Incarcerated post dose|5
1434010|NCT00952705|4732497|P3|Overall Study|Death|0
1434011|NCT00952705|4732498|P2|Overall Study|Death|0
1434012|NCT00952705|4732499|P1|Overall Study|Death|2
1434013|NCT00952705|4732497|P3|Overall Study|Withdrawal by Subject|1
1434014|NCT00952705|4732498|P2|Overall Study|Withdrawal by Subject|1
1434015|NCT00952705|4732499|P1|Overall Study|Withdrawal by Subject|2
1434016|NCT00952705|4732497|P3|Overall Study|Lost to Follow-up|9
1434017|NCT00952705|4732498|P2|Overall Study|Lost to Follow-up|8
1434018|NCT00952705|4732499|P1|Overall Study|Lost to Follow-up|24
1434019|NCT00952614|4732586|P1|Overall Study|other reason|1
1434020|NCT00952614|4732586|P1|Overall Study|Lost to Follow-up|3
1434021|NCT00952614|4732586|P1|Overall Study|Death|3
1434022|NCT00952588|4732593|P2|Overall Study|Lack of Efficacy|2
1434023|NCT00952588|4732594|P1|Overall Study|Lack of Efficacy|2
1434024|NCT00952588|4732593|P2|Overall Study|Physician Decision|1
1434025|NCT00952588|4732594|P1|Overall Study|Physician Decision|0
1434026|NCT00952588|4732593|P2|Overall Study|Lost to Follow-up|0
1434027|NCT00952588|4732594|P1|Overall Study|Lost to Follow-up|2
1434028|NCT00952588|4732593|P2|Overall Study|Adverse Event|3
1434029|NCT00952588|4732594|P1|Overall Study|Adverse Event|2
1434030|NCT00952588|4732593|P2|Overall Study|Withdrawal by Subject|5
1434031|NCT00952588|4732594|P1|Overall Study|Withdrawal by Subject|2
1434032|NCT00952588|4732593|P2|Overall Study|Death|13
1434033|NCT00952588|4732594|P1|Overall Study|Death|28
1434034|NCT00952523|4732612|P1|Overall Study|Withdrawal by Subject|7
1434035|NCT00952484|4732621|P3|Overall Study|Withdrawal by Subject|0
1434036|NCT00952484|4732622|P2|Overall Study|Withdrawal by Subject|1
1434037|NCT00952484|4732623|P1|Overall Study|Withdrawal by Subject|0
1434038|NCT00952419|4732650|P3|Overall Study|Withdrawal by Subject|0
1434039|NCT00952419|4732651|P2|Overall Study|Withdrawal by Subject|3
1434040|NCT00952419|4732652|P1|Overall Study|Withdrawal by Subject|1
1434041|NCT00952419|4732650|P3|Overall Study|Protocol Violation|0
1434042|NCT00952419|4732651|P2|Overall Study|Protocol Violation|7
1434043|NCT00952419|4732652|P1|Overall Study|Protocol Violation|3
1434044|NCT00952419|4732650|P3|Overall Study|Adverse Event|0
1434045|NCT00952419|4732651|P2|Overall Study|Adverse Event|0
1434046|NCT00952419|4732652|P1|Overall Study|Adverse Event|2
1434047|NCT00952367|4732688|P1|Overall Study|Protocol Violation|3
1434048|NCT00952367|4732688|P1|Overall Study|Noncoordination|1
1434049|NCT00952367|4732688|P1|Overall Study|Withdrawal by Subject|2
1434050|NCT00952341|4732703|P2|Cycle 2|Progressive Disease|1
1434051|NCT00952341|4732704|P1|Cycle 2|Progressive Disease|0
1434052|NCT00952341|4732703|P2|Cycle 2|Physician Decision|1
1434053|NCT00952341|4732704|P1|Cycle 2|Physician Decision|1
1434054|NCT00952341|4732703|P2|Cycle 2|Lost to Follow-up|9
1434055|NCT00952341|4732704|P1|Cycle 2|Lost to Follow-up|6
1434056|NCT00952341|4732703|P2|Cycle 2|Protocol Violation|0
1434057|NCT00952341|4732704|P1|Cycle 2|Protocol Violation|1
1434058|NCT00952341|4732703|P2|Cycle 2|Withdrawal by Subject|1
1434059|NCT00952341|4732704|P1|Cycle 2|Withdrawal by Subject|1
1434060|NCT00952341|4732703|P2|Cycle 1|Physician Decision|1
1434061|NCT00952341|4732704|P1|Cycle 1|Physician Decision|0
1434062|NCT00952341|4732703|P2|Cycle 1|Lost to Follow-up|2
1434063|NCT00952341|4732704|P1|Cycle 1|Lost to Follow-up|11
1434064|NCT00952341|4732703|P2|Cycle 1|Protocol Violation|1
1434065|NCT00952341|4732704|P1|Cycle 1|Protocol Violation|2
1434066|NCT00952341|4732703|P2|Cycle 1|Withdrawal by Subject|8
1434067|NCT00952341|4732704|P1|Cycle 1|Withdrawal by Subject|3
1434068|NCT00952341|4732703|P2|Cycle 1|Adverse Event|1
1434069|NCT00952341|4732704|P1|Cycle 1|Adverse Event|4
1434070|NCT00952289|4732726|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
1434071|NCT00952289|4732727|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
1434072|NCT00952289|4732726|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
1434073|NCT00952289|4732727|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
1434074|NCT00952289|4732726|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
1434075|NCT00952289|4732727|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
1434076|NCT00952289|4732726|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
1434077|NCT00952289|4732727|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
1434078|NCT00952289|4732726|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
1434079|NCT00952289|4732727|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
1434080|NCT00952289|4732726|P2|All Participants|Data lost during site relocation|1
1434081|NCT00952289|4732727|P1|All Participants|Data lost during site relocation|0
1434082|NCT00952289|4732726|P2|All Participants|Withdrawal by Subject|10
1434083|NCT00952289|4732727|P1|All Participants|Withdrawal by Subject|1
1434084|NCT00952289|4732726|P2|All Participants|Disease progression|12
1434085|NCT00952289|4732727|P1|All Participants|Disease progression|3
1434086|NCT00952289|4732726|P2|All Participants|Adverse Event|8
1434087|NCT00952289|4732727|P1|All Participants|Adverse Event|8
1434088|NCT00952289|4732726|P2|All Participants|Death|9
1434089|NCT00952289|4732727|P1|All Participants|Death|9
1434090|NCT00952276|4732756|P5|Overall Study|Withdrawal by Subject|0
1434091|NCT00952276|4732757|P4|Overall Study|Withdrawal by Subject|1
1434092|NCT00952276|4732758|P3|Overall Study|Withdrawal by Subject|0
1434093|NCT00952276|4732759|P2|Overall Study|Withdrawal by Subject|0
1434094|NCT00952276|4732760|P1|Overall Study|Withdrawal by Subject|1
1434095|NCT00952068|4732846|P1|Overall Study|Withdrawal by Subject|4
1434096|NCT00952068|4732846|P1|Overall Study|Adverse Event|3
1434097|NCT00951912|4732857|P3|Overall Study|Other: Stroke|0
1434098|NCT00951912|4732858|P2|Overall Study|Other: Stroke|1
1434099|NCT00951912|4732859|P1|Overall Study|Other: Stroke|0
1434100|NCT00951912|4732857|P3|Overall Study|Other: Colon cancer|0
1434101|NCT00951912|4732858|P2|Overall Study|Other: Colon cancer|0
1434102|NCT00951912|4732859|P1|Overall Study|Other: Colon cancer|1
1434103|NCT00951912|4732857|P3|Overall Study|Other:Depression|0
1434104|NCT00951912|4732858|P2|Overall Study|Other:Depression|0
1434105|NCT00951912|4732859|P1|Overall Study|Other:Depression|1
1434106|NCT00951912|4732857|P3|Overall Study|Withdrawal by Subject|0
1434107|NCT00951912|4732858|P2|Overall Study|Withdrawal by Subject|1
1434108|NCT00951912|4732859|P1|Overall Study|Withdrawal by Subject|1
1434109|NCT00951912|4732857|P3|Overall Study|Physician Decision|1
1434110|NCT00951912|4732858|P2|Overall Study|Physician Decision|0
1434111|NCT00951912|4732859|P1|Overall Study|Physician Decision|1
1434112|NCT00951912|4732857|P3|Overall Study|Lost to Follow-up|0
1434113|NCT00951912|4732858|P2|Overall Study|Lost to Follow-up|2
1434114|NCT00951912|4732859|P1|Overall Study|Lost to Follow-up|2
1434115|NCT00951912|4732857|P3|Overall Study|Adverse Event|1
1434116|NCT00951912|4732858|P2|Overall Study|Adverse Event|1
1434117|NCT00951912|4732859|P1|Overall Study|Adverse Event|0
1434118|NCT00951912|4732857|P3|Overall Study|Lack of Efficacy|0
1434119|NCT00951912|4732858|P2|Overall Study|Lack of Efficacy|0
1434120|NCT00951912|4732859|P1|Overall Study|Lack of Efficacy|1
1434121|NCT00951665|4732959|P6|Phase 2a|Disease Progression|5
1434122|NCT00951665|4732960|P5|Phase 2a|Disease Progression|6
1434123|NCT00951665|4732961|P4|Phase 2a|Disease Progression|0
1434124|NCT00951665|4732962|P3|Phase 2a|Disease Progression|0
1434125|NCT00951665|4732963|P2|Phase 2a|Disease Progression|0
1434126|NCT00951665|4732964|P1|Phase 2a|Disease Progression|0
1434127|NCT00951665|4732959|P6|Phase 2a|Withdrawal by Subject|0
1434128|NCT00951665|4732960|P5|Phase 2a|Withdrawal by Subject|2
1434129|NCT00951665|4732961|P4|Phase 2a|Withdrawal by Subject|0
1434130|NCT00951665|4732962|P3|Phase 2a|Withdrawal by Subject|0
1434131|NCT00951665|4732963|P2|Phase 2a|Withdrawal by Subject|0
1434132|NCT00951665|4732964|P1|Phase 2a|Withdrawal by Subject|0
1434133|NCT00951665|4732959|P6|Phase 2a|Physician Decision|1
1434134|NCT00951665|4732960|P5|Phase 2a|Physician Decision|0
1434135|NCT00951665|4732961|P4|Phase 2a|Physician Decision|0
1434136|NCT00951665|4732962|P3|Phase 2a|Physician Decision|0
1434137|NCT00951665|4732963|P2|Phase 2a|Physician Decision|0
1434138|NCT00951665|4732964|P1|Phase 2a|Physician Decision|0
1434139|NCT00951665|4732959|P6|Phase 2a|Lost to Follow-up|0
1434140|NCT00951665|4732960|P5|Phase 2a|Lost to Follow-up|1
1434141|NCT00951665|4732961|P4|Phase 2a|Lost to Follow-up|0
1434142|NCT00951665|4732962|P3|Phase 2a|Lost to Follow-up|0
1434143|NCT00951665|4732963|P2|Phase 2a|Lost to Follow-up|0
1434144|NCT00951665|4732964|P1|Phase 2a|Lost to Follow-up|0
1434145|NCT00951665|4732959|P6|Phase 2a|Death|1
1434146|NCT00951665|4732960|P5|Phase 2a|Death|1
1434147|NCT00951665|4732961|P4|Phase 2a|Death|0
1434148|NCT00951665|4732962|P3|Phase 2a|Death|0
1434149|NCT00951665|4732963|P2|Phase 2a|Death|0
1434150|NCT00951665|4732964|P1|Phase 2a|Death|0
1434151|NCT00951665|4732959|P6|Phase 2a|Adverse Event|0
1434152|NCT00951665|4732960|P5|Phase 2a|Adverse Event|2
1434153|NCT00951665|4732961|P4|Phase 2a|Adverse Event|0
1434154|NCT00951665|4732962|P3|Phase 2a|Adverse Event|0
1434155|NCT00951665|4732963|P2|Phase 2a|Adverse Event|0
1434156|NCT00951665|4732964|P1|Phase 2a|Adverse Event|0
1434157|NCT00951665|4732959|P6|Phase 1b|Protocol Violation|0
1434158|NCT00951665|4732960|P5|Phase 1b|Protocol Violation|0
1434159|NCT00951665|4732961|P4|Phase 1b|Protocol Violation|0
1434160|NCT00951665|4732962|P3|Phase 1b|Protocol Violation|0
1434161|NCT00951665|4732963|P2|Phase 1b|Protocol Violation|0
1434162|NCT00951665|4732964|P1|Phase 1b|Protocol Violation|2
1434163|NCT00951665|4732959|P6|Phase 1b|Disease Progression|0
1434164|NCT00951665|4732960|P5|Phase 1b|Disease Progression|0
1434165|NCT00951665|4732961|P4|Phase 1b|Disease Progression|0
1434166|NCT00951665|4732962|P3|Phase 1b|Disease Progression|14
1434167|NCT00951665|4732963|P2|Phase 1b|Disease Progression|2
1434168|NCT00951665|4732964|P1|Phase 1b|Disease Progression|13
1434169|NCT00951665|4732959|P6|Phase 1b|Withdrawal by Subject|0
1434170|NCT00951665|4732960|P5|Phase 1b|Withdrawal by Subject|0
1434171|NCT00951665|4732961|P4|Phase 1b|Withdrawal by Subject|0
1434172|NCT00951665|4732962|P3|Phase 1b|Withdrawal by Subject|0
1434173|NCT00951665|4732963|P2|Phase 1b|Withdrawal by Subject|1
1434174|NCT00951665|4732964|P1|Phase 1b|Withdrawal by Subject|0
1434175|NCT00951665|4732959|P6|Phase 1b|Physician Decision|0
1434176|NCT00951665|4732960|P5|Phase 1b|Physician Decision|0
1434177|NCT00951665|4732961|P4|Phase 1b|Physician Decision|0
1434178|NCT00951665|4732962|P3|Phase 1b|Physician Decision|1
1434179|NCT00951665|4732963|P2|Phase 1b|Physician Decision|0
1434180|NCT00951665|4732964|P1|Phase 1b|Physician Decision|4
1434181|NCT00951665|4732959|P6|Phase 1b|Death|0
1434182|NCT00951665|4732960|P5|Phase 1b|Death|0
1434183|NCT00951665|4732961|P4|Phase 1b|Death|0
1434184|NCT00951665|4732962|P3|Phase 1b|Death|2
1434185|NCT00951665|4732963|P2|Phase 1b|Death|0
1434186|NCT00951665|4732964|P1|Phase 1b|Death|1
1434187|NCT00951665|4732959|P6|Phase 1b|Adverse Event|0
1434188|NCT00951665|4732960|P5|Phase 1b|Adverse Event|0
1434189|NCT00951665|4732961|P4|Phase 1b|Adverse Event|1
1434190|NCT00951665|4732962|P3|Phase 1b|Adverse Event|0
1434191|NCT00951665|4732963|P2|Phase 1b|Adverse Event|1
1434192|NCT00951665|4732964|P1|Phase 1b|Adverse Event|2
1434193|NCT00951509|4733073|P1|Overall Study|Withdrawal by Subject|2
1434194|NCT00951496|4733084|P3|Overall Study|Did not initiate study treatment|13
1434195|NCT00951496|4733085|P2|Overall Study|Did not initiate study treatment|8
1434196|NCT00951496|4733086|P1|Overall Study|Did not initiate study treatment|10
1434197|NCT00951483|4733114|P2|Overall Study|Withdrawal by Subject|0
1434198|NCT00951483|4733115|P1|Overall Study|Withdrawal by Subject|15
1434199|NCT00951483|4733114|P2|Overall Study|Physician Decision|0
1434200|NCT00951483|4733115|P1|Overall Study|Physician Decision|4
1434201|NCT00951379|4733135|P2|Overall Study|Disease Progression|1
1434202|NCT00951379|4733136|P1|Overall Study|Disease Progression|0
1434203|NCT00951379|4733135|P2|Overall Study|Noncompliance|0
1434204|NCT00951379|4733136|P1|Overall Study|Noncompliance|1
1434205|NCT00951379|4733135|P2|Overall Study|Withdrawal by Subject|0
1434206|NCT00951379|4733136|P1|Overall Study|Withdrawal by Subject|1
1434207|NCT00951379|4733135|P2|Overall Study|Adverse Event|1
1434208|NCT00951379|4733136|P1|Overall Study|Adverse Event|4
1434209|NCT00951275|4733178|P1|Overall Study|Protocol Violation|1
1434210|NCT00951275|4733178|P1|Overall Study|Withdrawal by Subject|4
1434211|NCT00951275|4733178|P1|Overall Study|Adverse Event|7
1434212|NCT00951275|4733178|P1|Overall Study|Administrative Reason|1
1434213|NCT00951171|4733210|P2|Overall Study|Adverse Event|0
1434214|NCT00951171|4733211|P1|Overall Study|Adverse Event|2
1434215|NCT00951015|4733245|P5|Open-label Phase|Physician Decision|8
1434216|NCT00951015|4733246|P4|Open-label Phase|Physician Decision|0
1434217|NCT00951015|4733247|P3|Open-label Phase|Physician Decision|0
1434218|NCT00951015|4733248|P2|Open-label Phase|Physician Decision|0
1434219|NCT00951015|4733249|P1|Open-label Phase|Physician Decision|0
1434220|NCT00951015|4733245|P5|Open-label Phase|Withdrawal by Subject|14
1434221|NCT00951015|4733246|P4|Open-label Phase|Withdrawal by Subject|0
1434222|NCT00951015|4733247|P3|Open-label Phase|Withdrawal by Subject|0
1434223|NCT00951015|4733248|P2|Open-label Phase|Withdrawal by Subject|0
1434224|NCT00951015|4733249|P1|Open-label Phase|Withdrawal by Subject|0
1434225|NCT00951015|4733245|P5|Open-label Phase|Lost to Follow-up|12
1434226|NCT00951015|4733246|P4|Open-label Phase|Lost to Follow-up|0
1434227|NCT00951015|4733247|P3|Open-label Phase|Lost to Follow-up|0
1434228|NCT00951015|4733248|P2|Open-label Phase|Lost to Follow-up|0
1434229|NCT00951015|4733249|P1|Open-label Phase|Lost to Follow-up|0
1434230|NCT00951015|4733245|P5|Open-label Phase|Protocol Violation|12
1434231|NCT00951015|4733246|P4|Open-label Phase|Protocol Violation|0
1434232|NCT00951015|4733247|P3|Open-label Phase|Protocol Violation|0
1434233|NCT00951015|4733248|P2|Open-label Phase|Protocol Violation|0
1434234|NCT00951015|4733249|P1|Open-label Phase|Protocol Violation|0
1434235|NCT00951015|4733245|P5|Open-label Phase|Lack of Efficacy|1
1434236|NCT00951015|4733246|P4|Open-label Phase|Lack of Efficacy|0
1434237|NCT00951015|4733247|P3|Open-label Phase|Lack of Efficacy|0
1434238|NCT00951015|4733248|P2|Open-label Phase|Lack of Efficacy|0
1434239|NCT00951015|4733249|P1|Open-label Phase|Lack of Efficacy|0
1434240|NCT00951015|4733245|P5|Open-label Phase|Adverse Event|3
1434241|NCT00951015|4733246|P4|Open-label Phase|Adverse Event|0
1434242|NCT00951015|4733247|P3|Open-label Phase|Adverse Event|0
1434243|NCT00951015|4733248|P2|Open-label Phase|Adverse Event|0
1434244|NCT00951015|4733249|P1|Open-label Phase|Adverse Event|0
1434245|NCT00951015|4733245|P5|Randomization Phase 96 Week|Withdrawal by Subject|0
1434246|NCT00951015|4733246|P4|Randomization Phase 96 Week|Withdrawal by Subject|2
1434247|NCT00951015|4733247|P3|Randomization Phase 96 Week|Withdrawal by Subject|1
1434248|NCT00951015|4733248|P2|Randomization Phase 96 Week|Withdrawal by Subject|1
1434249|NCT00951015|4733249|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
1434250|NCT00951015|4733245|P5|Randomization Phase 96 Week|Lost to Follow-up|0
1434251|NCT00951015|4733246|P4|Randomization Phase 96 Week|Lost to Follow-up|2
1434252|NCT00951015|4733247|P3|Randomization Phase 96 Week|Lost to Follow-up|1
1434253|NCT00951015|4733248|P2|Randomization Phase 96 Week|Lost to Follow-up|3
1434254|NCT00951015|4733249|P1|Randomization Phase 96 Week|Lost to Follow-up|0
1434255|NCT00951015|4733245|P5|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
1434256|NCT00951015|4733246|P4|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
1434257|NCT00951015|4733247|P3|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
1434258|NCT00951015|4733248|P2|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
1434259|NCT00951015|4733249|P1|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
1434260|NCT00951015|4733245|P5|Randomization Phase 96 Week|Protocol Violation|0
1434261|NCT00951015|4733246|P4|Randomization Phase 96 Week|Protocol Violation|0
1434262|NCT00951015|4733247|P3|Randomization Phase 96 Week|Protocol Violation|1
1434263|NCT00951015|4733248|P2|Randomization Phase 96 Week|Protocol Violation|1
1434264|NCT00951015|4733249|P1|Randomization Phase 96 Week|Protocol Violation|1
1434265|NCT00951015|4733245|P5|Randomization Phase 96 Week|Lack of Efficacy|0
1434266|NCT00951015|4733246|P4|Randomization Phase 96 Week|Lack of Efficacy|0
1434267|NCT00951015|4733247|P3|Randomization Phase 96 Week|Lack of Efficacy|0
1434268|NCT00951015|4733248|P2|Randomization Phase 96 Week|Lack of Efficacy|1
1434269|NCT00951015|4733249|P1|Randomization Phase 96 Week|Lack of Efficacy|1
1434270|NCT00951015|4733245|P5|Randomization Phase 96 Week|Adverse Event|0
1434271|NCT00951015|4733246|P4|Randomization Phase 96 Week|Adverse Event|5
1434272|NCT00951015|4733247|P3|Randomization Phase 96 Week|Adverse Event|2
1434273|NCT00951015|4733248|P2|Randomization Phase 96 Week|Adverse Event|1
1434274|NCT00951015|4733249|P1|Randomization Phase 96 Week|Adverse Event|1
1434275|NCT00950963|4733346|P2|Overall Study|Lost to Follow-up|24
1434276|NCT00950963|4733347|P1|Overall Study|Lost to Follow-up|29
1434277|NCT00950911|4733382|P2|Overall Study|Poor performance status|1
1434278|NCT00950911|4733383|P1|Overall Study|Poor performance status|0
1434279|NCT00950911|4733382|P2|Overall Study|Noncompliance|0
1434280|NCT00950911|4733383|P1|Overall Study|Noncompliance|1
1434281|NCT00950911|4733382|P2|Overall Study|Ineligibility determined|0
1434282|NCT00950911|4733383|P1|Overall Study|Ineligibility determined|1
1434283|NCT00950911|4733382|P2|Overall Study|Administrative decision|1
1434284|NCT00950911|4733383|P1|Overall Study|Administrative decision|3
1434285|NCT00950911|4733382|P2|Overall Study|Consent withdrawn|3
1434286|NCT00950911|4733383|P1|Overall Study|Consent withdrawn|1
1434287|NCT00950911|4733382|P2|Overall Study|Disease progression|2
1434288|NCT00950911|4733383|P1|Overall Study|Disease progression|2
1434289|NCT00950911|4733382|P2|Overall Study|Death|6
1434290|NCT00950911|4733383|P1|Overall Study|Death|4
1434291|NCT00950911|4733382|P2|Overall Study|Adverse Event|2
1434292|NCT00950911|4733383|P1|Overall Study|Adverse Event|0
1434293|NCT00950872|4733389|P1|Overall Study|Did not have surgery|2
1434294|NCT00950872|4733389|P1|Overall Study|Withdrawal by Subject|1
1434295|NCT00950859|4733398|P2|Overall Study|Lost to Follow-up|3
1434296|NCT00950859|4733399|P1|Overall Study|Lost to Follow-up|0
1434297|NCT00950859|4733398|P2|Overall Study|Protocol Violation|1
1434298|NCT00950859|4733399|P1|Overall Study|Protocol Violation|1
1434299|NCT00950859|4733398|P2|Overall Study|Insufficient Viral Load Response|3
1434300|NCT00950859|4733399|P1|Overall Study|Insufficient Viral Load Response|12
1434301|NCT00950859|4733398|P2|Overall Study|Adverse Event|3
1434302|NCT00950859|4733399|P1|Overall Study|Adverse Event|3
1434303|NCT00950807|4733498|P10|Treatment Period 3|Adverse Event|0
1434304|NCT00950807|4733499|P9|Treatment Period 3|Adverse Event|0
1434305|NCT00950807|4733500|P8|Treatment Period 3|Adverse Event|0
1434306|NCT00950807|4733501|P7|Treatment Period 3|Adverse Event|1
1434307|NCT00950807|4733502|P6|Treatment Period 3|Adverse Event|0
1434308|NCT00950807|4733503|P5|Treatment Period 3|Adverse Event|0
1434309|NCT00950807|4733504|P4|Treatment Period 3|Adverse Event|0
1434310|NCT00950807|4733505|P3|Treatment Period 3|Adverse Event|0
1434311|NCT00950807|4733506|P2|Treatment Period 3|Adverse Event|0
1434312|NCT00950807|4733507|P1|Treatment Period 3|Adverse Event|0
1434313|NCT00950807|4733498|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
1434314|NCT00950807|4733499|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
1434315|NCT00950807|4733500|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
1434316|NCT00950807|4733501|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
1434317|NCT00950807|4733502|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
1434318|NCT00950807|4733503|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
1434319|NCT00950807|4733504|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
1434320|NCT00950807|4733505|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
1434321|NCT00950807|4733506|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
1434322|NCT00950807|4733507|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
1434323|NCT00950807|4733498|P10|Treatment Period 3|Withdrawal by Subject|1
1434324|NCT00950807|4733499|P9|Treatment Period 3|Withdrawal by Subject|0
1434325|NCT00950807|4733500|P8|Treatment Period 3|Withdrawal by Subject|0
1434326|NCT00950807|4733501|P7|Treatment Period 3|Withdrawal by Subject|0
1434327|NCT00950807|4733502|P6|Treatment Period 3|Withdrawal by Subject|0
1434328|NCT00950807|4733503|P5|Treatment Period 3|Withdrawal by Subject|0
1434329|NCT00950807|4733504|P4|Treatment Period 3|Withdrawal by Subject|0
1434330|NCT00950807|4733505|P3|Treatment Period 3|Withdrawal by Subject|0
1434331|NCT00950807|4733506|P2|Treatment Period 3|Withdrawal by Subject|0
1434332|NCT00950807|4733507|P1|Treatment Period 3|Withdrawal by Subject|0
1434333|NCT00950807|4733498|P10|Washout Period 2|Adverse Event|0
1434334|NCT00950807|4733499|P9|Washout Period 2|Adverse Event|0
1434335|NCT00950807|4733500|P8|Washout Period 2|Adverse Event|0
1434336|NCT00950807|4733501|P7|Washout Period 2|Adverse Event|0
1434337|NCT00950807|4733502|P6|Washout Period 2|Adverse Event|0
1434338|NCT00950807|4733503|P5|Washout Period 2|Adverse Event|0
1434339|NCT00950807|4733504|P4|Washout Period 2|Adverse Event|1
1434340|NCT00950807|4733505|P3|Washout Period 2|Adverse Event|0
1434341|NCT00950807|4733506|P2|Washout Period 2|Adverse Event|0
1434342|NCT00950807|4733507|P1|Washout Period 2|Adverse Event|3
1434343|NCT00950807|4733498|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
1434344|NCT00950807|4733499|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
1434345|NCT00950807|4733500|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
1434346|NCT00950807|4733501|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
1434347|NCT00950807|4733502|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
1434348|NCT00950807|4733503|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
1434349|NCT00950807|4733504|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
1434350|NCT00950807|4733505|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
1434351|NCT00950807|4733506|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
1434352|NCT00950807|4733507|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
1434353|NCT00950807|4733498|P10|Washout Period 2|Lack of Efficacy|0
1434354|NCT00950807|4733499|P9|Washout Period 2|Lack of Efficacy|0
1434355|NCT00950807|4733500|P8|Washout Period 2|Lack of Efficacy|0
1434356|NCT00950807|4733501|P7|Washout Period 2|Lack of Efficacy|0
1434357|NCT00950807|4733502|P6|Washout Period 2|Lack of Efficacy|0
1434358|NCT00950807|4733503|P5|Washout Period 2|Lack of Efficacy|0
1434359|NCT00950807|4733504|P4|Washout Period 2|Lack of Efficacy|0
1434360|NCT00950807|4733505|P3|Washout Period 2|Lack of Efficacy|0
1434361|NCT00950807|4733506|P2|Washout Period 2|Lack of Efficacy|0
1434362|NCT00950807|4733507|P1|Washout Period 2|Lack of Efficacy|1
1434363|NCT00950807|4733498|P10|Treatment Period 2|Adverse Event|0
1434364|NCT00950807|4733499|P9|Treatment Period 2|Adverse Event|0
1434365|NCT00950807|4733500|P8|Treatment Period 2|Adverse Event|1
1434366|NCT00950807|4733501|P7|Treatment Period 2|Adverse Event|0
1434367|NCT00950807|4733502|P6|Treatment Period 2|Adverse Event|1
1434368|NCT00950807|4733503|P5|Treatment Period 2|Adverse Event|0
1434369|NCT00950807|4733504|P4|Treatment Period 2|Adverse Event|1
1434370|NCT00950807|4733505|P3|Treatment Period 2|Adverse Event|0
1434371|NCT00950807|4733506|P2|Treatment Period 2|Adverse Event|1
1434372|NCT00950807|4733507|P1|Treatment Period 2|Adverse Event|0
1434373|NCT00950807|4733498|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
1434374|NCT00950807|4733499|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
1434375|NCT00950807|4733500|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
1434376|NCT00950807|4733501|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
1434377|NCT00950807|4733502|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
1434378|NCT00950807|4733503|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
1434379|NCT00950807|4733504|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
1434380|NCT00950807|4733505|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
1434381|NCT00950807|4733506|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
1434382|NCT00950807|4733507|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
1434383|NCT00950807|4733498|P10|Treatment Period 2|Withdrawal by Subject|0
1434384|NCT00950807|4733499|P9|Treatment Period 2|Withdrawal by Subject|0
1434385|NCT00950807|4733500|P8|Treatment Period 2|Withdrawal by Subject|2
1434386|NCT00950807|4733501|P7|Treatment Period 2|Withdrawal by Subject|1
1434387|NCT00950807|4733502|P6|Treatment Period 2|Withdrawal by Subject|0
1434388|NCT00950807|4733503|P5|Treatment Period 2|Withdrawal by Subject|0
1434389|NCT00950807|4733504|P4|Treatment Period 2|Withdrawal by Subject|0
1434390|NCT00950807|4733505|P3|Treatment Period 2|Withdrawal by Subject|0
1434391|NCT00950807|4733506|P2|Treatment Period 2|Withdrawal by Subject|0
1434392|NCT00950807|4733507|P1|Treatment Period 2|Withdrawal by Subject|0
1434393|NCT00950807|4733498|P10|Treatment Period 2|Lack of Efficacy|0
1434394|NCT00950807|4733499|P9|Treatment Period 2|Lack of Efficacy|0
1434395|NCT00950807|4733500|P8|Treatment Period 2|Lack of Efficacy|0
1434396|NCT00950807|4733501|P7|Treatment Period 2|Lack of Efficacy|0
1434397|NCT00950807|4733502|P6|Treatment Period 2|Lack of Efficacy|0
1434398|NCT00950807|4733503|P5|Treatment Period 2|Lack of Efficacy|0
1434399|NCT00950807|4733504|P4|Treatment Period 2|Lack of Efficacy|0
1434400|NCT00950807|4733505|P3|Treatment Period 2|Lack of Efficacy|0
1434401|NCT00950807|4733506|P2|Treatment Period 2|Lack of Efficacy|0
1434402|NCT00950807|4733507|P1|Treatment Period 2|Lack of Efficacy|1
1434403|NCT00950807|4733498|P10|Washout Period 1|Adverse Event|0
1434404|NCT00950807|4733499|P9|Washout Period 1|Adverse Event|0
1434405|NCT00950807|4733500|P8|Washout Period 1|Adverse Event|0
1434406|NCT00950807|4733501|P7|Washout Period 1|Adverse Event|0
1434407|NCT00950807|4733502|P6|Washout Period 1|Adverse Event|0
1434408|NCT00950807|4733503|P5|Washout Period 1|Adverse Event|1
1434409|NCT00950807|4733504|P4|Washout Period 1|Adverse Event|1
1434410|NCT00950807|4733505|P3|Washout Period 1|Adverse Event|0
1434411|NCT00950807|4733506|P2|Washout Period 1|Adverse Event|0
1434412|NCT00950807|4733507|P1|Washout Period 1|Adverse Event|2
1434413|NCT00950807|4733498|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
1434414|NCT00950807|4733499|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
1434415|NCT00950807|4733500|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
1434416|NCT00950807|4733501|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
1434417|NCT00950807|4733502|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
1434418|NCT00950807|4733503|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
1434419|NCT00950807|4733504|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
1434420|NCT00950807|4733505|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
1434421|NCT00950807|4733506|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
1434422|NCT00950807|4733507|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
1434423|NCT00950807|4733498|P10|Washout Period 1|Withdrawal by Subject|0
1434424|NCT00950807|4733499|P9|Washout Period 1|Withdrawal by Subject|1
1434425|NCT00950807|4733500|P8|Washout Period 1|Withdrawal by Subject|0
1434426|NCT00950807|4733501|P7|Washout Period 1|Withdrawal by Subject|0
1434427|NCT00950807|4733502|P6|Washout Period 1|Withdrawal by Subject|0
1434428|NCT00950807|4733503|P5|Washout Period 1|Withdrawal by Subject|0
1434429|NCT00950807|4733504|P4|Washout Period 1|Withdrawal by Subject|0
1434430|NCT00950807|4733505|P3|Washout Period 1|Withdrawal by Subject|0
1434431|NCT00950807|4733506|P2|Washout Period 1|Withdrawal by Subject|0
1434432|NCT00950807|4733507|P1|Washout Period 1|Withdrawal by Subject|0
1434433|NCT00950807|4733498|P10|Washout Period 1|Lack of Efficacy|0
1434434|NCT00950807|4733499|P9|Washout Period 1|Lack of Efficacy|0
1434435|NCT00950807|4733500|P8|Washout Period 1|Lack of Efficacy|0
1434436|NCT00950807|4733501|P7|Washout Period 1|Lack of Efficacy|1
1434437|NCT00950807|4733502|P6|Washout Period 1|Lack of Efficacy|0
1434438|NCT00950807|4733503|P5|Washout Period 1|Lack of Efficacy|0
1434439|NCT00950807|4733504|P4|Washout Period 1|Lack of Efficacy|0
1434440|NCT00950807|4733505|P3|Washout Period 1|Lack of Efficacy|0
1434441|NCT00950807|4733506|P2|Washout Period 1|Lack of Efficacy|0
1434442|NCT00950807|4733507|P1|Washout Period 1|Lack of Efficacy|0
1434443|NCT00950807|4733498|P10|Treatment Period 1|Adverse Event|0
1434444|NCT00950807|4733499|P9|Treatment Period 1|Adverse Event|0
1434445|NCT00950807|4733500|P8|Treatment Period 1|Adverse Event|0
1434446|NCT00950807|4733501|P7|Treatment Period 1|Adverse Event|0
1434447|NCT00950807|4733502|P6|Treatment Period 1|Adverse Event|1
1434448|NCT00950807|4733503|P5|Treatment Period 1|Adverse Event|0
1434449|NCT00950807|4733504|P4|Treatment Period 1|Adverse Event|0
1434450|NCT00950807|4733505|P3|Treatment Period 1|Adverse Event|0
1434451|NCT00950807|4733506|P2|Treatment Period 1|Adverse Event|0
1434452|NCT00950807|4733507|P1|Treatment Period 1|Adverse Event|0
1434453|NCT00950807|4733498|P10|Treatment Period 1|Withdrawal by Subject|0
1434454|NCT00950807|4733499|P9|Treatment Period 1|Withdrawal by Subject|1
1434455|NCT00950807|4733500|P8|Treatment Period 1|Withdrawal by Subject|0
1434456|NCT00950807|4733501|P7|Treatment Period 1|Withdrawal by Subject|0
1434457|NCT00950807|4733502|P6|Treatment Period 1|Withdrawal by Subject|0
1434458|NCT00950807|4733503|P5|Treatment Period 1|Withdrawal by Subject|1
1434459|NCT00950807|4733504|P4|Treatment Period 1|Withdrawal by Subject|0
1434460|NCT00950807|4733505|P3|Treatment Period 1|Withdrawal by Subject|0
1434461|NCT00950807|4733506|P2|Treatment Period 1|Withdrawal by Subject|0
1434462|NCT00950807|4733507|P1|Treatment Period 1|Withdrawal by Subject|1
1434463|NCT00950807|4733498|P10|Treatment Period 1|Lost to Follow-up|0
1434464|NCT00950807|4733499|P9|Treatment Period 1|Lost to Follow-up|0
1434465|NCT00950807|4733500|P8|Treatment Period 1|Lost to Follow-up|0
1434466|NCT00950807|4733501|P7|Treatment Period 1|Lost to Follow-up|0
1434467|NCT00950807|4733502|P6|Treatment Period 1|Lost to Follow-up|0
1434468|NCT00950807|4733503|P5|Treatment Period 1|Lost to Follow-up|0
1434469|NCT00950807|4733504|P4|Treatment Period 1|Lost to Follow-up|0
1434470|NCT00950807|4733505|P3|Treatment Period 1|Lost to Follow-up|1
1434471|NCT00950807|4733506|P2|Treatment Period 1|Lost to Follow-up|0
1434472|NCT00950807|4733507|P1|Treatment Period 1|Lost to Follow-up|0
1434473|NCT00950807|4733498|P10|Treatment Period 1|Protocol Violation|0
1434474|NCT00950807|4733499|P9|Treatment Period 1|Protocol Violation|0
1434475|NCT00950807|4733500|P8|Treatment Period 1|Protocol Violation|0
1434476|NCT00950807|4733501|P7|Treatment Period 1|Protocol Violation|0
1434477|NCT00950807|4733502|P6|Treatment Period 1|Protocol Violation|0
1434478|NCT00950807|4733503|P5|Treatment Period 1|Protocol Violation|0
1434479|NCT00950807|4733504|P4|Treatment Period 1|Protocol Violation|0
1434480|NCT00950807|4733505|P3|Treatment Period 1|Protocol Violation|0
1434481|NCT00950807|4733506|P2|Treatment Period 1|Protocol Violation|0
1434482|NCT00950807|4733507|P1|Treatment Period 1|Protocol Violation|1
1434483|NCT00950807|4733498|P10|Treatment Period 1|Lack of Efficacy|0
1434484|NCT00950807|4733499|P9|Treatment Period 1|Lack of Efficacy|0
1434485|NCT00950807|4733500|P8|Treatment Period 1|Lack of Efficacy|0
1434486|NCT00950807|4733501|P7|Treatment Period 1|Lack of Efficacy|0
1434487|NCT00950807|4733502|P6|Treatment Period 1|Lack of Efficacy|1
1434488|NCT00950807|4733503|P5|Treatment Period 1|Lack of Efficacy|0
1434489|NCT00950807|4733504|P4|Treatment Period 1|Lack of Efficacy|0
1434490|NCT00950807|4733505|P3|Treatment Period 1|Lack of Efficacy|0
1434491|NCT00950807|4733506|P2|Treatment Period 1|Lack of Efficacy|0
1434492|NCT00950807|4733507|P1|Treatment Period 1|Lack of Efficacy|1
1434493|NCT00950755|4733549|P1|Long-Term Follow-Up|Death|8
1434494|NCT00950755|4733549|P1|Long-Term Follow-Up|Lost to Follow-up|1
1434495|NCT00950755|4733549|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
1434496|NCT00950755|4733549|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
1434497|NCT00950755|4733549|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
1434498|NCT00950755|4733549|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
1434499|NCT00950755|4733549|P1|Dosimetric and Therapeutic Treatment|Death|1
1434500|NCT00950755|4733549|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
1434501|NCT00950755|4733549|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
1434502|NCT00950755|4733549|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
1434503|NCT00950742|4733575|P2|Overall Study|Dose limiting toxicity|0
1434504|NCT00950742|4733576|P1|Overall Study|Dose limiting toxicity|6
1434505|NCT00950742|4733575|P2|Overall Study|Progressive Disease|2
1434506|NCT00950742|4733576|P1|Overall Study|Progressive Disease|6
1434507|NCT00950742|4733575|P2|Overall Study|Withdrawal by Subject|0
1434508|NCT00950742|4733576|P1|Overall Study|Withdrawal by Subject|3
1434509|NCT00950742|4733575|P2|Overall Study|Other Adverse Event|0
1434510|NCT00950742|4733576|P1|Overall Study|Other Adverse Event|1
1434511|NCT00950690|4733597|P1|Overall Study|Other|163
1434512|NCT00950690|4733597|P1|Overall Study|Lost to Follow-up|40
1434513|NCT00950690|4733597|P1|Overall Study|Lack of Efficacy|22
1434514|NCT00950690|4733597|P1|Overall Study|Adverse Event|15
1434515|NCT00950690|4733597|P1|Overall Study|Death|4
1434516|NCT00950664|4733604|P2|First Intervention|Withdrawal by Subject|2
1434517|NCT00950664|4733605|P1|First Intervention|Withdrawal by Subject|2
1434518|NCT00950664|4733604|P2|First Intervention|Lost to Follow-up|3
1434519|NCT00950664|4733605|P1|First Intervention|Lost to Follow-up|1
1434520|NCT00950651|4733625|P2|Overall Study|Withdrawal by Subject|9
1434521|NCT00950651|4733626|P1|Overall Study|Withdrawal by Subject|8
1434522|NCT00950651|4733625|P2|Overall Study|Protocol Violation|4
1434523|NCT00950651|4733626|P1|Overall Study|Protocol Violation|3
1434524|NCT00950651|4733625|P2|Overall Study|Lack of Efficacy|2
1434525|NCT00950651|4733626|P1|Overall Study|Lack of Efficacy|2
1434526|NCT00950651|4733625|P2|Overall Study|Death|0
1434527|NCT00950651|4733626|P1|Overall Study|Death|1
1434528|NCT00950651|4733625|P2|Overall Study|Adverse Event|20
1434529|NCT00950651|4733626|P1|Overall Study|Adverse Event|17
1434530|NCT00950599|4733719|P10|Follow-Up Period|Subject withdrew Consent|1
1434531|NCT00950599|4733720|P9|Follow-Up Period|Subject withdrew Consent|2
1434532|NCT00950599|4733721|P8|Follow-Up Period|Subject withdrew Consent|0
1434533|NCT00950599|4733722|P7|Follow-Up Period|Subject withdrew Consent|0
1434534|NCT00950599|4733723|P6|Follow-Up Period|Subject withdrew Consent|0
1434535|NCT00950599|4733724|P5|Follow-Up Period|Subject withdrew Consent|0
1434536|NCT00950599|4733725|P4|Follow-Up Period|Subject withdrew Consent|0
1434537|NCT00950599|4733726|P3|Follow-Up Period|Subject withdrew Consent|0
1434538|NCT00950599|4733727|P2|Follow-Up Period|Subject withdrew Consent|0
1434539|NCT00950599|4733728|P1|Follow-Up Period|Subject withdrew Consent|0
1434540|NCT00950599|4733719|P10|Follow-Up Period|Poor/Noncompliance|0
1434541|NCT00950599|4733720|P9|Follow-Up Period|Poor/Noncompliance|1
1434542|NCT00950599|4733721|P8|Follow-Up Period|Poor/Noncompliance|0
1434543|NCT00950599|4733722|P7|Follow-Up Period|Poor/Noncompliance|0
1434544|NCT00950599|4733723|P6|Follow-Up Period|Poor/Noncompliance|0
1434545|NCT00950599|4733724|P5|Follow-Up Period|Poor/Noncompliance|0
1434546|NCT00950599|4733725|P4|Follow-Up Period|Poor/Noncompliance|0
1434547|NCT00950599|4733726|P3|Follow-Up Period|Poor/Noncompliance|0
1434548|NCT00950599|4733727|P2|Follow-Up Period|Poor/Noncompliance|0
1434549|NCT00950599|4733728|P1|Follow-Up Period|Poor/Noncompliance|0
1434550|NCT00950599|4733719|P10|Follow-Up Period|Physician Decision|0
1434551|NCT00950599|4733720|P9|Follow-Up Period|Physician Decision|1
1434552|NCT00950599|4733721|P8|Follow-Up Period|Physician Decision|0
1434553|NCT00950599|4733722|P7|Follow-Up Period|Physician Decision|0
1434554|NCT00950599|4733723|P6|Follow-Up Period|Physician Decision|0
1434555|NCT00950599|4733724|P5|Follow-Up Period|Physician Decision|0
1434556|NCT00950599|4733725|P4|Follow-Up Period|Physician Decision|0
1434557|NCT00950599|4733726|P3|Follow-Up Period|Physician Decision|0
1434558|NCT00950599|4733727|P2|Follow-Up Period|Physician Decision|0
1434559|NCT00950599|4733728|P1|Follow-Up Period|Physician Decision|0
1434560|NCT00950599|4733719|P10|Follow-Up Period|Lost to Follow-up|1
1434561|NCT00950599|4733720|P9|Follow-Up Period|Lost to Follow-up|5
1434562|NCT00950599|4733721|P8|Follow-Up Period|Lost to Follow-up|0
1434563|NCT00950599|4733722|P7|Follow-Up Period|Lost to Follow-up|0
1434564|NCT00950599|4733723|P6|Follow-Up Period|Lost to Follow-up|0
1434565|NCT00950599|4733724|P5|Follow-Up Period|Lost to Follow-up|0
1434566|NCT00950599|4733725|P4|Follow-Up Period|Lost to Follow-up|0
1434567|NCT00950599|4733726|P3|Follow-Up Period|Lost to Follow-up|0
1434568|NCT00950599|4733727|P2|Follow-Up Period|Lost to Follow-up|0
1434569|NCT00950599|4733728|P1|Follow-Up Period|Lost to Follow-up|0
1434570|NCT00950599|4733719|P10|Follow-Up Period|Lack of Efficacy|0
1434571|NCT00950599|4733720|P9|Follow-Up Period|Lack of Efficacy|3
1434572|NCT00950599|4733721|P8|Follow-Up Period|Lack of Efficacy|0
1434573|NCT00950599|4733722|P7|Follow-Up Period|Lack of Efficacy|0
1434574|NCT00950599|4733723|P6|Follow-Up Period|Lack of Efficacy|0
1434575|NCT00950599|4733724|P5|Follow-Up Period|Lack of Efficacy|0
1434576|NCT00950599|4733725|P4|Follow-Up Period|Lack of Efficacy|0
1434577|NCT00950599|4733726|P3|Follow-Up Period|Lack of Efficacy|0
1434578|NCT00950599|4733727|P2|Follow-Up Period|Lack of Efficacy|0
1434579|NCT00950599|4733728|P1|Follow-Up Period|Lack of Efficacy|0
1434580|NCT00950599|4733719|P10|Follow-Up Period|Adverse Event|0
1434581|NCT00950599|4733720|P9|Follow-Up Period|Adverse Event|1
1434582|NCT00950599|4733721|P8|Follow-Up Period|Adverse Event|0
1434583|NCT00950599|4733722|P7|Follow-Up Period|Adverse Event|0
1434584|NCT00950599|4733723|P6|Follow-Up Period|Adverse Event|0
1434585|NCT00950599|4733724|P5|Follow-Up Period|Adverse Event|0
1434586|NCT00950599|4733725|P4|Follow-Up Period|Adverse Event|0
1434587|NCT00950599|4733726|P3|Follow-Up Period|Adverse Event|0
1434588|NCT00950599|4733727|P2|Follow-Up Period|Adverse Event|0
1434589|NCT00950599|4733728|P1|Follow-Up Period|Adverse Event|0
1434590|NCT00950599|4733719|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
1434591|NCT00950599|4733720|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
1434592|NCT00950599|4733721|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
1434593|NCT00950599|4733722|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
1434594|NCT00950599|4733723|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
1434595|NCT00950599|4733724|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
1434596|NCT00950599|4733725|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
1434597|NCT00950599|4733726|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
1434598|NCT00950599|4733727|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
1434599|NCT00950599|4733728|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
1434600|NCT00950599|4733719|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1434601|NCT00950599|4733720|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1434602|NCT00950599|4733721|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1434603|NCT00950599|4733722|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1434604|NCT00950599|4733723|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
1434605|NCT00950599|4733724|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
1434606|NCT00950599|4733725|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1434607|NCT00950599|4733726|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1434608|NCT00950599|4733727|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1434609|NCT00950599|4733728|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1434610|NCT00950599|4733719|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
1434611|NCT00950599|4733720|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
1434612|NCT00950599|4733721|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
1434613|NCT00950599|4733722|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
1434614|NCT00950599|4733723|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
1434615|NCT00950599|4733724|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
1434616|NCT00950599|4733725|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
1434617|NCT00950599|4733726|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
1434618|NCT00950599|4733727|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
1434619|NCT00950599|4733728|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
1434620|NCT00950599|4733719|P10|Double-Blind Treatment Period|Lost to Follow-up|0
1434621|NCT00950599|4733720|P9|Double-Blind Treatment Period|Lost to Follow-up|0
1434622|NCT00950599|4733721|P8|Double-Blind Treatment Period|Lost to Follow-up|1
1434623|NCT00950599|4733722|P7|Double-Blind Treatment Period|Lost to Follow-up|0
1434624|NCT00950599|4733723|P6|Double-Blind Treatment Period|Lost to Follow-up|2
1434625|NCT00950599|4733724|P5|Double-Blind Treatment Period|Lost to Follow-up|1
1434626|NCT00950599|4733725|P4|Double-Blind Treatment Period|Lost to Follow-up|1
1434627|NCT00950599|4733726|P3|Double-Blind Treatment Period|Lost to Follow-up|0
1434628|NCT00950599|4733727|P2|Double-Blind Treatment Period|Lost to Follow-up|0
1434629|NCT00950599|4733728|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1434630|NCT00950599|4733719|P10|Double-Blind Treatment Period|Lack of Efficacy|0
1434631|NCT00950599|4733720|P9|Double-Blind Treatment Period|Lack of Efficacy|0
1434632|NCT00950599|4733721|P8|Double-Blind Treatment Period|Lack of Efficacy|1
1434633|NCT00950599|4733722|P7|Double-Blind Treatment Period|Lack of Efficacy|0
1434634|NCT00950599|4733723|P6|Double-Blind Treatment Period|Lack of Efficacy|6
1434635|NCT00950599|4733724|P5|Double-Blind Treatment Period|Lack of Efficacy|3
1434636|NCT00950599|4733725|P4|Double-Blind Treatment Period|Lack of Efficacy|7
1434637|NCT00950599|4733726|P3|Double-Blind Treatment Period|Lack of Efficacy|5
1434638|NCT00950599|4733727|P2|Double-Blind Treatment Period|Lack of Efficacy|5
1434639|NCT00950599|4733728|P1|Double-Blind Treatment Period|Lack of Efficacy|2
1434640|NCT00950599|4733719|P10|Double-Blind Treatment Period|Adverse Event|0
1434641|NCT00950599|4733720|P9|Double-Blind Treatment Period|Adverse Event|0
1434642|NCT00950599|4733721|P8|Double-Blind Treatment Period|Adverse Event|0
1434643|NCT00950599|4733722|P7|Double-Blind Treatment Period|Adverse Event|0
1434644|NCT00950599|4733723|P6|Double-Blind Treatment Period|Adverse Event|1
1434645|NCT00950599|4733724|P5|Double-Blind Treatment Period|Adverse Event|1
1434646|NCT00950599|4733725|P4|Double-Blind Treatment Period|Adverse Event|1
1434647|NCT00950599|4733726|P3|Double-Blind Treatment Period|Adverse Event|1
1434648|NCT00950599|4733727|P2|Double-Blind Treatment Period|Adverse Event|1
1434649|NCT00950599|4733728|P1|Double-Blind Treatment Period|Adverse Event|0
1434650|NCT00950599|4733719|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
1434651|NCT00950599|4733720|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
1434652|NCT00950599|4733721|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
1434653|NCT00950599|4733722|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
1434654|NCT00950599|4733723|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
1434655|NCT00950599|4733724|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
1434656|NCT00950599|4733725|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
1434657|NCT00950599|4733726|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
1434658|NCT00950599|4733727|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
1434659|NCT00950599|4733728|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
1434660|NCT00950300|4734301|P2|SFU Period|Withdrawal by Subject|8
1434661|NCT00950300|4734302|P1|SFU Period|Withdrawal by Subject|4
1434662|NCT00950300|4734301|P2|SFU Period|Lost to Follow-up|28
1434663|NCT00950300|4734302|P1|SFU Period|Lost to Follow-up|30
1434664|NCT00950300|4734301|P2|SFU Period|Death|42
1434665|NCT00950300|4734302|P1|SFU Period|Death|44
1434666|NCT00950300|4734301|P2|TFFU Period|Not Specified|3
1434667|NCT00950300|4734302|P1|TFFU Period|Not Specified|4
1434668|NCT00950300|4734301|P2|TFFU Period|Recurrence of Disease|72
1434669|NCT00950300|4734302|P1|TFFU Period|Recurrence of Disease|63
1434670|NCT00950300|4734301|P2|TFFU Period|Failure to Return|16
1434671|NCT00950300|4734302|P1|TFFU Period|Failure to Return|16
1434672|NCT00950300|4734301|P2|TFFU Period|Refused Treatment|11
1434673|NCT00950300|4734302|P1|TFFU Period|Refused Treatment|10
1434674|NCT00950300|4734301|P2|TFFU Period|Death|1
1434675|NCT00950300|4734302|P1|TFFU Period|Death|4
1434676|NCT00950300|4734301|P2|TFFU Period|Adverse Event or Intercurrent Illness|4
1434677|NCT00950300|4734302|P1|TFFU Period|Adverse Event or Intercurrent Illness|3
1434678|NCT00950300|4734301|P2|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
1434679|NCT00950300|4734302|P1|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
1434680|NCT00950300|4734301|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
1434681|NCT00950300|4734302|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
1434682|NCT00950300|4734301|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
1434683|NCT00950300|4734302|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
1434684|NCT00950300|4734301|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
1434685|NCT00950300|4734302|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
1434686|NCT00950300|4734301|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
1434687|NCT00950300|4734302|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
1434688|NCT00950300|4734301|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
1434689|NCT00950300|4734302|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
1434690|NCT00950300|4734301|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
1434691|NCT00950300|4734302|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
1434692|NCT00950300|4734301|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
1434693|NCT00950300|4734302|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
1434694|NCT00950300|4734301|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
1434695|NCT00950300|4734302|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
1434696|NCT00950300|4734301|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
1434697|NCT00950300|4734302|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
1434698|NCT00949975|4734374|P4|Overall Study|Other|0
1434699|NCT00949975|4734375|P3|Overall Study|Other|0
1434700|NCT00949975|4734376|P2|Overall Study|Other|0
1434701|NCT00949975|4734377|P1|Overall Study|Other|1
1434702|NCT00949975|4734374|P4|Overall Study|Lost to Follow-up|3
1434703|NCT00949975|4734375|P3|Overall Study|Lost to Follow-up|1
1434704|NCT00949975|4734376|P2|Overall Study|Lost to Follow-up|0
1434705|NCT00949975|4734377|P1|Overall Study|Lost to Follow-up|1
1434706|NCT00949975|4734374|P4|Overall Study|Severe non-compliance|2
1434707|NCT00949975|4734375|P3|Overall Study|Severe non-compliance|0
1434708|NCT00949975|4734376|P2|Overall Study|Severe non-compliance|1
1434709|NCT00949975|4734377|P1|Overall Study|Severe non-compliance|3
1434710|NCT00949975|4734374|P4|Overall Study|Incorrect enrolment|7
1434711|NCT00949975|4734375|P3|Overall Study|Incorrect enrolment|4
1434712|NCT00949975|4734376|P2|Overall Study|Incorrect enrolment|10
1434713|NCT00949975|4734377|P1|Overall Study|Incorrect enrolment|5
1434714|NCT00949975|4734374|P4|Overall Study|Study-specific criteria|0
1434715|NCT00949975|4734375|P3|Overall Study|Study-specific criteria|1
1434716|NCT00949975|4734376|P2|Overall Study|Study-specific criteria|1
1434717|NCT00949975|4734377|P1|Overall Study|Study-specific criteria|0
1434718|NCT00949975|4734374|P4|Overall Study|Safety reason|0
1434719|NCT00949975|4734375|P3|Overall Study|Safety reason|0
1434720|NCT00949975|4734376|P2|Overall Study|Safety reason|1
1434721|NCT00949975|4734377|P1|Overall Study|Safety reason|0
1434722|NCT00949975|4734374|P4|Overall Study|Adverse Event|10
1434723|NCT00949975|4734375|P3|Overall Study|Adverse Event|10
1434724|NCT00949975|4734376|P2|Overall Study|Adverse Event|11
1434725|NCT00949975|4734377|P1|Overall Study|Adverse Event|11
1434726|NCT00949975|4734374|P4|Overall Study|Voluntary discontinuation|6
1434727|NCT00949975|4734375|P3|Overall Study|Voluntary discontinuation|3
1434728|NCT00949975|4734376|P2|Overall Study|Voluntary discontinuation|5
1434729|NCT00949975|4734377|P1|Overall Study|Voluntary discontinuation|6
1434730|NCT00949910|4734495|P1|Overall Study|No Data|9
1434731|NCT00949910|4734495|P1|Overall Study|Other|4
1434732|NCT00949910|4734495|P1|Overall Study|Physician/Participant Decision|7
1434733|NCT00949910|4734495|P1|Overall Study|Serious Adverse Event|6
1434734|NCT00949910|4734495|P1|Overall Study|Adverse Event|83
1434735|NCT00949910|4734495|P1|Overall Study|Prolonged Dosing Interruption|4
1434736|NCT00949910|4734495|P1|Overall Study|Non-Compliance|10
1434737|NCT00949910|4734495|P1|Overall Study|Logistical Reasons|13
1434738|NCT00949910|4734495|P1|Overall Study|Violation of Eligibility|23
1434739|NCT00949910|4734495|P1|Overall Study|Switched to Commercial Treatment|4
1434740|NCT00949910|4734495|P1|Overall Study|Switched to Compassionate/Other Use|174
1434741|NCT00949910|4734495|P1|Overall Study|Unspecified Progression/Deterioration|13
1434742|NCT00949910|4734495|P1|Overall Study|Death from Unknown Cause|5
1434743|NCT00949910|4734495|P1|Overall Study|Death Due to Toxicity|3
1434744|NCT00949910|4734495|P1|Overall Study|Death Due to Adverse Event|115
1434745|NCT00949910|4734495|P1|Overall Study|Death Due to Progression/Deterioration|4
1434746|NCT00949910|4734495|P1|Overall Study|Death Due to Malignant Disease|456
1434747|NCT00949910|4734495|P1|Overall Study|Participant Refusal|390
1434748|NCT00949910|4734495|P1|Overall Study|Study Drug-Related Adverse Event|315
1434749|NCT00949910|4734495|P1|Overall Study|Lost to Follow-up|100
1434750|NCT00949910|4734495|P1|Overall Study|Symptomatic Deterioration|1088
1434751|NCT00949910|4734495|P1|Overall Study|Progressive Disease|3750
1434752|NCT00949884|4734508|P3|Overall Study|Study terminated by sponsor|1
1434753|NCT00949884|4734509|P2|Overall Study|Study terminated by sponsor|0
1434754|NCT00949884|4734510|P1|Overall Study|Study terminated by sponsor|0
1434755|NCT00949884|4734508|P3|Overall Study|Lack of Efficacy|7
1434756|NCT00949884|4734509|P2|Overall Study|Lack of Efficacy|2
1434757|NCT00949884|4734510|P1|Overall Study|Lack of Efficacy|4
1434758|NCT00949884|4734508|P3|Overall Study|Withdrawal by Subject|16
1434759|NCT00949884|4734509|P2|Overall Study|Withdrawal by Subject|4
1434760|NCT00949884|4734510|P1|Overall Study|Withdrawal by Subject|13
1434761|NCT00949884|4734508|P3|Overall Study|Treatment non-compliance|8
1434762|NCT00949884|4734509|P2|Overall Study|Treatment non-compliance|0
1434763|NCT00949884|4734510|P1|Overall Study|Treatment non-compliance|5
1434764|NCT00949884|4734508|P3|Overall Study|Physician Decision|6
1434765|NCT00949884|4734509|P2|Overall Study|Physician Decision|0
1434766|NCT00949884|4734510|P1|Overall Study|Physician Decision|5
1434767|NCT00949884|4734508|P3|Overall Study|Lost to Follow-up|5
1434768|NCT00949884|4734509|P2|Overall Study|Lost to Follow-up|5
1434769|NCT00949884|4734510|P1|Overall Study|Lost to Follow-up|7
1434770|NCT00949884|4734508|P3|Overall Study|Did not meet inclusion/exclusion|3
1434771|NCT00949884|4734509|P2|Overall Study|Did not meet inclusion/exclusion|1
1434772|NCT00949884|4734510|P1|Overall Study|Did not meet inclusion/exclusion|2
1434773|NCT00949884|4734508|P3|Overall Study|Adverse Event|12
1434774|NCT00949884|4734509|P2|Overall Study|Adverse Event|3
1434775|NCT00949884|4734510|P1|Overall Study|Adverse Event|14
1434776|NCT00949715|4734565|P2|Overall Study|Missing 24 month LVEF measurement|0
1434777|NCT00949715|4734566|P1|Overall Study|Missing 24 month LVEF measurement|2
1434778|NCT00949715|4734565|P2|Overall Study|Lost to Follow-up|0
1434779|NCT00949715|4734566|P1|Overall Study|Lost to Follow-up|1
1434780|NCT00949715|4734565|P2|Overall Study|Physician Decision|0
1434781|NCT00949715|4734566|P1|Overall Study|Physician Decision|1
1434782|NCT00949702|4734577|P1|Overall Study|Withdrawal of consent|1
1434783|NCT00949702|4734577|P1|Overall Study|Disease progression|7
1434784|NCT00949702|4734577|P1|Overall Study|Death|40
1434785|NCT00949650|4734594|P2|Overall Study|Other not specified above|0
1434786|NCT00949650|4734595|P1|Overall Study|Other not specified above|5
1434787|NCT00949650|4734594|P2|Overall Study|Not treated|4
1434788|NCT00949650|4734595|P1|Overall Study|Not treated|1
1434789|NCT00949650|4734594|P2|Overall Study|Refusal to continue medication|11
1434790|NCT00949650|4734595|P1|Overall Study|Refusal to continue medication|7
1434791|NCT00949650|4734594|P2|Overall Study|Protocol Violation|4
1434792|NCT00949650|4734595|P1|Overall Study|Protocol Violation|1
1434793|NCT00949650|4734594|P2|Overall Study|Other Adverse Event (AE)|17
1434794|NCT00949650|4734595|P1|Overall Study|Other Adverse Event (AE)|28
1434795|NCT00949650|4734594|P2|Overall Study|Completed 6 courses of chemotherapy|60
1434796|NCT00949650|4734595|P1|Overall Study|Completed 6 courses of chemotherapy|0
1434797|NCT00949650|4734594|P2|Overall Study|Progressive disease|19
1434798|NCT00949650|4734595|P1|Overall Study|Progressive disease|188
1434799|NCT00949533|4734633|P2|Overall Study|Lost to Follow-up|1
1434800|NCT00949533|4734634|P1|Overall Study|Lost to Follow-up|0
1434801|NCT00949117|4734652|P2|Overall Study|Adverse Event|1
1434802|NCT00949117|4734653|P1|Overall Study|Adverse Event|0
1434803|NCT00949117|4734652|P2|Overall Study|Protocol Violation|1
1434804|NCT00949117|4734653|P1|Overall Study|Protocol Violation|1
1434805|NCT00949117|4734652|P2|Overall Study|Lack of Efficacy|3
1434806|NCT00949117|4734653|P1|Overall Study|Lack of Efficacy|2
1434807|NCT00948896|4734700|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1434808|NCT00948896|4734701|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1434809|NCT00948896|4734702|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1434810|NCT00948896|4734703|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1434811|NCT00948896|4734704|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
1434812|NCT00948896|4734705|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1434813|NCT00948896|4734706|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1434814|NCT00948896|4734707|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1434815|NCT00948896|4734700|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
1434816|NCT00948896|4734701|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
1434817|NCT00948896|4734702|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
1434818|NCT00948896|4734703|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
1434819|NCT00948896|4734704|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
1434820|NCT00948896|4734705|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
1434821|NCT00948896|4734706|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
1434822|NCT00948896|4734707|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
1434823|NCT00948896|4734700|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
1434824|NCT00948896|4734701|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
1434825|NCT00948896|4734702|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
1434826|NCT00948896|4734703|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
1434827|NCT00948896|4734704|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
1434828|NCT00948896|4734705|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
1434829|NCT00948896|4734706|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
1434830|NCT00948896|4734707|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
1434831|NCT00948896|4734700|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
1434832|NCT00948896|4734701|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
1434833|NCT00948896|4734702|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
1434834|NCT00948896|4734703|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
1434835|NCT00948896|4734704|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
1434836|NCT00948896|4734705|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
1434837|NCT00948896|4734706|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
1434838|NCT00948896|4734707|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
1434839|NCT00948896|4734700|P8|24 Months of Age to 36 Months of Age|Death|0
1434840|NCT00948896|4734701|P7|24 Months of Age to 36 Months of Age|Death|0
1434841|NCT00948896|4734702|P6|24 Months of Age to 36 Months of Age|Death|1
1434842|NCT00948896|4734703|P5|24 Months of Age to 36 Months of Age|Death|0
1434843|NCT00948896|4734704|P4|24 Months of Age to 36 Months of Age|Death|0
1434844|NCT00948896|4734705|P3|24 Months of Age to 36 Months of Age|Death|2
1434845|NCT00948896|4734706|P2|24 Months of Age to 36 Months of Age|Death|2
1434846|NCT00948896|4734707|P1|24 Months of Age to 36 Months of Age|Death|0
1434847|NCT00948896|4734700|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
1434848|NCT00948896|4734701|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
1434849|NCT00948896|4734702|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
1434850|NCT00948896|4734703|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
1434851|NCT00948896|4734704|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
1434852|NCT00948896|4734705|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
1434853|NCT00948896|4734706|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
1434854|NCT00948896|4734707|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
1434855|NCT00948896|4734700|P8|Randomization to 24 Months of Age|Protocol Violation|1
1434856|NCT00948896|4734701|P7|Randomization to 24 Months of Age|Protocol Violation|1
1434857|NCT00948896|4734702|P6|Randomization to 24 Months of Age|Protocol Violation|0
1434858|NCT00948896|4734703|P5|Randomization to 24 Months of Age|Protocol Violation|0
1434859|NCT00948896|4734704|P4|Randomization to 24 Months of Age|Protocol Violation|1
1434860|NCT00948896|4734705|P3|Randomization to 24 Months of Age|Protocol Violation|0
1434861|NCT00948896|4734706|P2|Randomization to 24 Months of Age|Protocol Violation|1
1434862|NCT00948896|4734707|P1|Randomization to 24 Months of Age|Protocol Violation|0
1434863|NCT00948896|4734700|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
1434864|NCT00948896|4734701|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
1434865|NCT00948896|4734702|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
1434866|NCT00948896|4734703|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
1434867|NCT00948896|4734704|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
1434868|NCT00948896|4734705|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
1434869|NCT00948896|4734706|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
1434870|NCT00948896|4734707|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
1434871|NCT00948896|4734700|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
1434872|NCT00948896|4734701|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
1434873|NCT00948896|4734702|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
1434874|NCT00948896|4734703|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
1434875|NCT00948896|4734704|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
1434876|NCT00948896|4734705|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
1434877|NCT00948896|4734706|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
1434878|NCT00948896|4734707|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
1434879|NCT00948896|4734700|P8|Randomization to 24 Months of Age|Death|1
1434880|NCT00948896|4734701|P7|Randomization to 24 Months of Age|Death|2
1434881|NCT00948896|4734702|P6|Randomization to 24 Months of Age|Death|1
1434882|NCT00948896|4734703|P5|Randomization to 24 Months of Age|Death|2
1434883|NCT00948896|4734704|P4|Randomization to 24 Months of Age|Death|0
1434884|NCT00948896|4734705|P3|Randomization to 24 Months of Age|Death|0
1434885|NCT00948896|4734706|P2|Randomization to 24 Months of Age|Death|0
1434886|NCT00948896|4734707|P1|Randomization to 24 Months of Age|Death|1
1434887|NCT00948857|4734743|P2|Overall Study|Lost to Follow-up|0
1434888|NCT00948857|4734744|P1|Overall Study|Lost to Follow-up|1
1434889|NCT00948818|4734752|P2|Overall Study|Other Reason|5
1434890|NCT00948818|4734753|P1|Overall Study|Other Reason|4
1434891|NCT00948818|4734752|P2|Overall Study|Lack of Efficacy|5
1434892|NCT00948818|4734753|P1|Overall Study|Lack of Efficacy|4
1434893|NCT00948818|4734752|P2|Overall Study|Lost to Follow-up|17
1434894|NCT00948818|4734753|P1|Overall Study|Lost to Follow-up|10
1434895|NCT00948818|4734752|P2|Overall Study|Withdrawal by Subject|25
1434896|NCT00948818|4734753|P1|Overall Study|Withdrawal by Subject|25
1434897|NCT00948818|4734752|P2|Overall Study|Protocol Violation|10
1434898|NCT00948818|4734753|P1|Overall Study|Protocol Violation|9
1434899|NCT00948818|4734752|P2|Overall Study|Adverse Event|32
1434900|NCT00948818|4734753|P1|Overall Study|Adverse Event|10
1434901|NCT00948766|4734800|P2|Extension Study|Death|0
1434902|NCT00948766|4734801|P1|Extension Study|Death|4
1434903|NCT00948766|4734800|P2|Extension Study|Administrative Problems|0
1434904|NCT00948766|4734801|P1|Extension Study|Administrative Problems|1
1434905|NCT00948766|4734800|P2|Extension Study|Lost to Follow-up|0
1434906|NCT00948766|4734801|P1|Extension Study|Lost to Follow-up|8
1434907|NCT00948766|4734800|P2|Extension Study|Patient Withdrew Consent|0
1434908|NCT00948766|4734801|P1|Extension Study|Patient Withdrew Consent|32
1434909|NCT00948766|4734800|P2|Extension Study|Study Drug No Longer Required|0
1434910|NCT00948766|4734801|P1|Extension Study|Study Drug No Longer Required|1
1434911|NCT00948766|4734800|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
1434912|NCT00948766|4734801|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
1434913|NCT00948766|4734800|P2|Extension Study|Adverse Event|0
1434914|NCT00948766|4734801|P1|Extension Study|Adverse Event|43
1434915|NCT00948766|4734800|P2|Core Study|Protocol Deviation|10
1434916|NCT00948766|4734801|P1|Core Study|Protocol Deviation|8
1434917|NCT00948766|4734800|P2|Core Study|Death|1
1434918|NCT00948766|4734801|P1|Core Study|Death|1
1434919|NCT00948766|4734800|P2|Core Study|Administrative Problems|2
1434920|NCT00948766|4734801|P1|Core Study|Administrative Problems|2
1434921|NCT00948766|4734800|P2|Core Study|Lost to Follow-up|2
1434922|NCT00948766|4734801|P1|Core Study|Lost to Follow-up|3
1434923|NCT00948766|4734800|P2|Core Study|Patient Withdrew Consent|46
1434924|NCT00948766|4734801|P1|Core Study|Patient Withdrew Consent|27
1434925|NCT00948766|4734800|P2|Core Study|Unsatisfactory Therapeutic Effect|14
1434926|NCT00948766|4734801|P1|Core Study|Unsatisfactory Therapeutic Effect|13
1434927|NCT00948766|4734800|P2|Core Study|Adverse Event|51
1434928|NCT00948766|4734801|P1|Core Study|Adverse Event|73
1434929|NCT00948688|4734817|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
1434930|NCT00948688|4734818|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
1434931|NCT00948688|4734817|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
1434932|NCT00948688|4734818|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
1434933|NCT00948688|4734817|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
1434934|NCT00948688|4734818|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
1434935|NCT00948675|4734832|P2|Overall Study|Treatment ongoing|4
1434936|NCT00948675|4734833|P1|Overall Study|Treatment ongoing|5
1434937|NCT00948675|4734832|P2|Overall Study|Lost to Follow-up|0
1434938|NCT00948675|4734833|P1|Overall Study|Lost to Follow-up|2
1434939|NCT00948506|4734860|P2|Overall Study|Withdrawal by Subject|1
1434940|NCT00948506|4734861|P1|Overall Study|Withdrawal by Subject|3
1434941|NCT00948441|4734872|P2|Overall Study|no longer meet inclusion criteria|4
1434942|NCT00948441|4734873|P1|Overall Study|no longer meet inclusion criteria|1
1434943|NCT00948389|4734886|P5|Overall Study|Both Progression and Toxicity|0
1434944|NCT00948389|4734887|P4|Overall Study|Both Progression and Toxicity|0
1434945|NCT00948389|4734888|P3|Overall Study|Both Progression and Toxicity|0
1434946|NCT00948389|4734889|P2|Overall Study|Both Progression and Toxicity|0
1434947|NCT00948389|4734890|P1|Overall Study|Both Progression and Toxicity|1
1434948|NCT00948389|4734886|P5|Overall Study|Thrombocytopenia, Grade 4|0
1434949|NCT00948389|4734887|P4|Overall Study|Thrombocytopenia, Grade 4|1
1434950|NCT00948389|4734888|P3|Overall Study|Thrombocytopenia, Grade 4|0
1434951|NCT00948389|4734889|P2|Overall Study|Thrombocytopenia, Grade 4|0
1434952|NCT00948389|4734890|P1|Overall Study|Thrombocytopenia, Grade 4|2
1434953|NCT00948389|4734886|P5|Overall Study|Disease Progression/Relapse/Death|1
1434954|NCT00948389|4734887|P4|Overall Study|Disease Progression/Relapse/Death|8
1434955|NCT00948389|4734888|P3|Overall Study|Disease Progression/Relapse/Death|7
1434956|NCT00948389|4734889|P2|Overall Study|Disease Progression/Relapse/Death|3
1434957|NCT00948389|4734890|P1|Overall Study|Disease Progression/Relapse/Death|3
1434958|NCT00948246|4734938|P1|Overall Study|Withdrawal by Subject|1
1434959|NCT00948246|4734938|P1|Overall Study|Death|1
1434960|NCT00948246|4734938|P1|Overall Study|Adverse Event|11
1434961|NCT00948246|4734938|P1|Overall Study|Lost to Follow-up|11
1434962|NCT00948155|4734947|P2|Washout 14 Days|Lost to Follow-up|2
1434963|NCT00948155|4734948|P1|Washout 14 Days|Lost to Follow-up|1
1434964|NCT00948155|4734947|P2|First Intervention 21 Days|Lost to Follow-up|2
1434965|NCT00948155|4734948|P1|First Intervention 21 Days|Lost to Follow-up|2
1434966|NCT00948064|4734995|P3|Phase II|Withdrawal by Subject|0
1434967|NCT00948064|4734996|P2|Phase II|Withdrawal by Subject|1
1434968|NCT00948064|4734997|P1|Phase II|Withdrawal by Subject|0
1434969|NCT00948064|4734995|P3|Phase II|Physician Decision|1
1434970|NCT00948064|4734996|P2|Phase II|Physician Decision|0
1434971|NCT00948064|4734997|P1|Phase II|Physician Decision|0
1434972|NCT00948064|4734995|P3|Phase I|No treatment received|0
1434973|NCT00948064|4734996|P2|Phase I|No treatment received|0
1434974|NCT00948064|4734997|P1|Phase I|No treatment received|1
1434975|NCT00947882|4735012|P4|Overall Study|Trial Terminated by Sponsor|70
1434976|NCT00947882|4735013|P3|Overall Study|Trial Terminated by Sponsor|62
1434977|NCT00947882|4735014|P2|Overall Study|Trial Terminated by Sponsor|61
1434978|NCT00947882|4735015|P1|Overall Study|Trial Terminated by Sponsor|62
1434979|NCT00947882|4735012|P4|Overall Study|Other/Unknown|6
1434980|NCT00947882|4735013|P3|Overall Study|Other/Unknown|3
1434981|NCT00947882|4735014|P2|Overall Study|Other/Unknown|13
1434982|NCT00947882|4735015|P1|Overall Study|Other/Unknown|10
1434983|NCT00947882|4735012|P4|Overall Study|Lost to Follow-up|0
1434984|NCT00947882|4735013|P3|Overall Study|Lost to Follow-up|1
1434985|NCT00947882|4735014|P2|Overall Study|Lost to Follow-up|2
1434986|NCT00947882|4735015|P1|Overall Study|Lost to Follow-up|0
1434987|NCT00947882|4735012|P4|Overall Study|Protocol Violation|0
1434988|NCT00947882|4735013|P3|Overall Study|Protocol Violation|1
1434989|NCT00947882|4735014|P2|Overall Study|Protocol Violation|0
1434990|NCT00947882|4735015|P1|Overall Study|Protocol Violation|0
1434991|NCT00947882|4735012|P4|Overall Study|Withdrawal by Subject|2
1434992|NCT00947882|4735013|P3|Overall Study|Withdrawal by Subject|8
1434993|NCT00947882|4735014|P2|Overall Study|Withdrawal by Subject|0
1434994|NCT00947882|4735015|P1|Overall Study|Withdrawal by Subject|2
1434995|NCT00947882|4735012|P4|Overall Study|Adverse Event|4
1434996|NCT00947882|4735013|P3|Overall Study|Adverse Event|4
1434997|NCT00947882|4735014|P2|Overall Study|Adverse Event|1
1434998|NCT00947882|4735015|P1|Overall Study|Adverse Event|0
1434999|NCT00947856|4735043|P2|Follow-up Period|Withdrawal by Subject|0
1435000|NCT00947856|4735044|P1|Follow-up Period|Withdrawal by Subject|1
1435001|NCT00947856|4735043|P2|Follow-up Period|Patient unavailable for site visits|0
1435002|NCT00947856|4735044|P1|Follow-up Period|Patient unavailable for site visits|1
1435003|NCT00947856|4735043|P2|Follow-up Period|Lost to Follow-up|0
1435004|NCT00947856|4735044|P1|Follow-up Period|Lost to Follow-up|7
1435005|NCT00947856|4735043|P2|Follow-up Period|Re-enrolled for Retreatment|3
1435006|NCT00947856|4735044|P1|Follow-up Period|Re-enrolled for Retreatment|2
1435007|NCT00947856|4735043|P2|Follow-up Period|Study Stopped by Sponsor|20
1435008|NCT00947856|4735044|P1|Follow-up Period|Study Stopped by Sponsor|40
1435009|NCT00947856|4735043|P2|Treatment Period|Withdrawal by Subject|1
1435010|NCT00947856|4735044|P1|Treatment Period|Withdrawal by Subject|12
1435011|NCT00947856|4735043|P2|Treatment Period|Study Stopped by Sponsor|4
1435012|NCT00947856|4735044|P1|Treatment Period|Study Stopped by Sponsor|4
1435013|NCT00947856|4735043|P2|Treatment Period|Physician Decision|6
1435014|NCT00947856|4735044|P1|Treatment Period|Physician Decision|14
1435015|NCT00947856|4735043|P2|Treatment Period|Adverse Event|9
1435016|NCT00947856|4735044|P1|Treatment Period|Adverse Event|15
1435017|NCT00947856|4735043|P2|Treatment Period|Progressive Disease|12
1435018|NCT00947856|4735044|P1|Treatment Period|Progressive Disease|33
1435019|NCT00947544|4735133|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
1435020|NCT00947544|4735134|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
1435021|NCT00947531|4735160|P2|Overall Study|Other|1
1435022|NCT00947531|4735161|P1|Overall Study|Other|1
1435023|NCT00947531|4735160|P2|Overall Study|Lack of Efficacy|0
1435024|NCT00947531|4735161|P1|Overall Study|Lack of Efficacy|1
1435025|NCT00947531|4735160|P2|Overall Study|Adverse Event|2
1435026|NCT00947531|4735161|P1|Overall Study|Adverse Event|2
1435027|NCT00947531|4735160|P2|Overall Study|Administrative Reason|1
1435028|NCT00947531|4735161|P1|Overall Study|Administrative Reason|0
1435029|NCT00947531|4735160|P2|Overall Study|Withdrawal by Subject|7
1435030|NCT00947531|4735161|P1|Overall Study|Withdrawal by Subject|10
1435031|NCT00947427|4735197|P2|Overall Study|Protocol Violation|1
1435032|NCT00947427|4735198|P1|Overall Study|Protocol Violation|0
1435033|NCT00947427|4735197|P2|Overall Study|Withdrawal by Subject|3
1435034|NCT00947427|4735198|P1|Overall Study|Withdrawal by Subject|1
1435035|NCT00947349|4735208|P4|Overall Study Standard of Care|not specified|1
1435036|NCT00947349|4735209|P3|Overall Study Standard of Care|not specified|0
1435037|NCT00947349|4735210|P2|Overall Study Standard of Care|not specified|0
1435038|NCT00947349|4735211|P1|Overall Study Standard of Care|not specified|0
1435039|NCT00947349|4735208|P4|Overall Study Standard of Care|Withdrawal by Subject|0
1435040|NCT00947349|4735209|P3|Overall Study Standard of Care|Withdrawal by Subject|1
1435041|NCT00947349|4735210|P2|Overall Study Standard of Care|Withdrawal by Subject|0
1435042|NCT00947349|4735211|P1|Overall Study Standard of Care|Withdrawal by Subject|0
1435043|NCT00947349|4735208|P4|Overall Study Standard of Care|Lack of Efficacy|1
1435044|NCT00947349|4735209|P3|Overall Study Standard of Care|Lack of Efficacy|1
1435045|NCT00947349|4735210|P2|Overall Study Standard of Care|Lack of Efficacy|0
1435046|NCT00947349|4735211|P1|Overall Study Standard of Care|Lack of Efficacy|0
1435047|NCT00947349|4735208|P4|Triple Treatment Combination Period|Adverse Event|0
1435048|NCT00947349|4735209|P3|Triple Treatment Combination Period|Adverse Event|0
1435049|NCT00947349|4735210|P2|Triple Treatment Combination Period|Adverse Event|1
1435050|NCT00947349|4735211|P1|Triple Treatment Combination Period|Adverse Event|0
1435051|NCT00947154|4735425|P1|Overall Study|Lost to Follow-up|1
1435052|NCT00947115|4735435|P3|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|8
1435053|NCT00947115|4735436|P2|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|12
1435054|NCT00947115|4735437|P1|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|11
1435055|NCT00947115|4735435|P3|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|4
1435056|NCT00947115|4735436|P2|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|3
1435057|NCT00947115|4735437|P1|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|1
1435058|NCT00947115|4735435|P3|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
1435059|NCT00947115|4735436|P2|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
1435060|NCT00947115|4735437|P1|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|2
1435061|NCT00947115|4735435|P3|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
1435062|NCT00947115|4735436|P2|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
1435063|NCT00947115|4735437|P1|Year 0 (Month 0) - Year 10 (Month 120)|Death|0
1435064|NCT00947115|4735435|P3|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
1435065|NCT00947115|4735436|P2|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|2
1435066|NCT00947115|4735437|P1|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
1435067|NCT00947115|4735435|P3|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|2
1435068|NCT00947115|4735436|P2|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|4
1435069|NCT00947115|4735437|P1|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|3
1435070|NCT00947011|4735499|P1|Overall Study|Study was terminated,PI left institution|12
1435071|NCT00946998|4735509|P2|Overall Study|Exited prior to first outcome assessment|3
1435072|NCT00946998|4735510|P1|Overall Study|Exited prior to first outcome assessment|5
1435073|NCT00946985|4735524|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
1435074|NCT00946985|4735524|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
1435075|NCT00946985|4735524|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
1435076|NCT00946985|4735524|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
1435077|NCT00946985|4735524|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
1435078|NCT00946985|4735524|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
1435079|NCT00946985|4735524|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
1435080|NCT00946985|4735524|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
1435081|NCT00946985|4735524|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
1435082|NCT00946920|4735530|P2|Overall Study|Miscellaneous reasons|3
1435083|NCT00946920|4735531|P1|Overall Study|Miscellaneous reasons|18
1435084|NCT00946920|4735530|P2|Overall Study|Protocol Violation|8
1435085|NCT00946920|4735531|P1|Overall Study|Protocol Violation|16
1435086|NCT00946920|4735530|P2|Overall Study|Adverse Event|14
1435087|NCT00946920|4735531|P1|Overall Study|Adverse Event|41
1435088|NCT00946920|4735530|P2|Overall Study|Physician Decision|2
1435089|NCT00946920|4735531|P1|Overall Study|Physician Decision|5
1435090|NCT00946920|4735530|P2|Overall Study|Lost to Follow-up|2
1435091|NCT00946920|4735531|P1|Overall Study|Lost to Follow-up|2
1435092|NCT00946920|4735530|P2|Overall Study|Withdrawal by Subject|15
1435093|NCT00946920|4735531|P1|Overall Study|Withdrawal by Subject|28
1435094|NCT00946881|4735546|P1|Retreatment|Withdrawal by Subject|1
1435095|NCT00946881|4735546|P1|First Treatment|Patient relocated to another state|1
1435096|NCT00946881|4735546|P1|First Treatment|Withdrawal by Subject|1
1435097|NCT00946530|4735579|P4|Overall Study|Physician Decision|1
1435098|NCT00946530|4735580|P3|Overall Study|Physician Decision|1
1435099|NCT00946530|4735581|P2|Overall Study|Physician Decision|1
1435100|NCT00946530|4735582|P1|Overall Study|Physician Decision|1
1435101|NCT00946530|4735579|P4|Overall Study|Withdrawal by Subject|3
1435102|NCT00946530|4735580|P3|Overall Study|Withdrawal by Subject|0
1435103|NCT00946530|4735581|P2|Overall Study|Withdrawal by Subject|3
1435104|NCT00946530|4735582|P1|Overall Study|Withdrawal by Subject|0
1435105|NCT00946322|4735614|P1|Post-treatment|participant failure to follow up|2
1435106|NCT00946322|4735614|P1|Pre-treatment|participant failure to follow up|1
1435107|NCT00946309|4735627|P2|Overall Study|Procedure cancelled/discontinued|3
1435108|NCT00946309|4735628|P1|Overall Study|Procedure cancelled/discontinued|0
1435109|NCT00946309|4735627|P2|Overall Study|Lost to Follow-up|1
1435110|NCT00946309|4735628|P1|Overall Study|Lost to Follow-up|0
1435111|NCT00946309|4735627|P2|Overall Study|Protocol Violation|0
1435112|NCT00946309|4735628|P1|Overall Study|Protocol Violation|1
1435113|NCT00946296|4735646|P2|Overall Study|Physician Decision|0
1435114|NCT00946296|4735647|P1|Overall Study|Physician Decision|3
1435115|NCT00946114|4735655|P2|Overall Study|Withdrawal by Subject|0
1435116|NCT00946114|4735656|P1|Overall Study|Withdrawal by Subject|2
1435117|NCT00946114|4735655|P2|Overall Study|Other|0
1435118|NCT00946114|4735656|P1|Overall Study|Other|1
1435119|NCT00946114|4735655|P2|Overall Study|Death|2
1435120|NCT00946114|4735656|P1|Overall Study|Death|5
1435121|NCT00946101|4735664|P2|Overall Study|Physician Decision|1
1435122|NCT00946101|4735665|P1|Overall Study|Physician Decision|0
1435123|NCT00946101|4735664|P2|Overall Study|Withdrawal of consent|0
1435124|NCT00946101|4735665|P1|Overall Study|Withdrawal of consent|2
1435125|NCT00946101|4735664|P2|Overall Study|Lost to Follow-up|1
1435126|NCT00946101|4735665|P1|Overall Study|Lost to Follow-up|2
1435127|NCT00946088|4735731|P2|Overall Study|Withdrawal by Subject|1
1435128|NCT00946088|4735732|P1|Overall Study|Withdrawal by Subject|0
1435129|NCT00945945|4735776|P2|Overall Study|Entry Criteria Not Met|1
1435130|NCT00945945|4735777|P1|Overall Study|Entry Criteria Not Met|0
1435131|NCT00945945|4735776|P2|Overall Study|Protocol Violation|2
1435132|NCT00945945|4735777|P1|Overall Study|Protocol Violation|4
1435133|NCT00945945|4735776|P2|Overall Study|Lack of Efficacy|2
1435134|NCT00945945|4735777|P1|Overall Study|Lack of Efficacy|6
1435135|NCT00945945|4735776|P2|Overall Study|Lost to Follow-up|5
1435136|NCT00945945|4735777|P1|Overall Study|Lost to Follow-up|4
1435137|NCT00945945|4735776|P2|Overall Study|Withdrawal by Subject|10
1435138|NCT00945945|4735777|P1|Overall Study|Withdrawal by Subject|7
1435139|NCT00945945|4735776|P2|Overall Study|Adverse Event|35
1435140|NCT00945945|4735777|P1|Overall Study|Adverse Event|15
1435141|NCT00945906|4735803|P1|Overall Study|Moved to another country|2
1435142|NCT00945906|4735803|P1|Overall Study|Unable to return for last visit|2
1435143|NCT00945906|4735803|P1|Overall Study|Did not want to return for last visit|2
1435144|NCT00945906|4735803|P1|Overall Study|Withdrawal by Subject|1
1435145|NCT00945893|4735814|P2|Overall Study|Withdrawal of consent|2
1435146|NCT00945893|4735815|P1|Overall Study|Withdrawal of consent|1
1435147|NCT00945893|4735814|P2|Overall Study|Lost to Follow-up|8
1435148|NCT00945893|4735815|P1|Overall Study|Lost to Follow-up|2
1435149|NCT00945815|4735892|P1|Overall Study|Did not begin protocol therapy|1
1435150|NCT00945815|4735892|P1|Overall Study|Ineligible|3
1435151|NCT00945815|4735892|P1|Overall Study|Not protocol specified|1
1435152|NCT00945815|4735892|P1|Overall Study|Death|3
1435153|NCT00945555|4735921|P1|Overall Study|Other|1
1435154|NCT00945555|4735921|P1|Overall Study|Death|18
1435155|NCT00945555|4735921|P1|Overall Study|Participant continued treatment at home|1
1435156|NCT00945555|4735921|P1|Overall Study|Withdrawal by Subject|2
1435157|NCT00945555|4735921|P1|Overall Study|Worsening condition, intensive care unit|1
1435158|NCT00945555|4735921|P1|Overall Study|Referred to another hospital|5
1435159|NCT00945477|4735932|P1|Overall Study|Withdrawal by Subject|1
1435160|NCT00945477|4735932|P1|Overall Study|Lack of Efficacy|2
1435161|NCT00945477|4735932|P1|Overall Study|Adverse Event|3
1435162|NCT00945321|4735948|P6|Period 4|Lost to Follow-up|1
1435163|NCT00945321|4735949|P5|Period 4|Lost to Follow-up|0
1435164|NCT00945321|4735950|P4|Period 4|Lost to Follow-up|0
1435165|NCT00945321|4735951|P3|Period 4|Lost to Follow-up|0
1435166|NCT00945321|4735952|P2|Period 4|Lost to Follow-up|0
1435167|NCT00945321|4735953|P1|Period 4|Lost to Follow-up|0
1435168|NCT00945321|4735948|P6|Period 1|Adverse Event|0
1435169|NCT00945321|4735949|P5|Period 1|Adverse Event|1
1435170|NCT00945321|4735950|P4|Period 1|Adverse Event|0
1435171|NCT00945321|4735951|P3|Period 1|Adverse Event|0
1435172|NCT00945321|4735952|P2|Period 1|Adverse Event|0
1435173|NCT00945321|4735953|P1|Period 1|Adverse Event|0
1435174|NCT00945243|4736005|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
1435175|NCT00944697|4736162|P2|Overall Study|Administrative|1
1435176|NCT00944697|4736163|P1|Overall Study|Administrative|1
1435177|NCT00944697|4736162|P2|Overall Study|Adverse Event|3
1435178|NCT00944697|4736163|P1|Overall Study|Adverse Event|0
1435179|NCT00944697|4736162|P2|Overall Study|Withdrawal by Subject|1
1435180|NCT00944697|4736163|P1|Overall Study|Withdrawal by Subject|1
1435181|NCT00944645|4736193|P2|Period 2|Withdrawal by Subject|6
1435182|NCT00944645|4736194|P1|Period 2|Withdrawal by Subject|7
1435183|NCT00944645|4736193|P2|Period 2|Lost to Follow-up|3
1435184|NCT00944645|4736194|P1|Period 2|Lost to Follow-up|0
1435185|NCT00944645|4736193|P2|Period 2|Adverse Event|0
1435186|NCT00944645|4736194|P1|Period 2|Adverse Event|1
1435187|NCT00944229|4736224|P1|Overall Study|Physician Decision|14
1435188|NCT00944229|4736224|P1|Overall Study|Withdrawal by Subject|11
1435189|NCT00944125|4736230|P2|6 Months to Study Completion|Withdrawal by Subject|2
1435190|NCT00944125|4736231|P1|6 Months to Study Completion|Withdrawal by Subject|0
1435191|NCT00944125|4736230|P2|3 to 6 Months|Withdrawal by Subject|2
1435192|NCT00944125|4736231|P1|3 to 6 Months|Withdrawal by Subject|0
1435193|NCT00944034|4736334|P12|Overall Study|Administrative reason|0
1435194|NCT00944034|4736335|P11|Overall Study|Administrative reason|0
1435195|NCT00944034|4736336|P10|Overall Study|Administrative reason|0
1435196|NCT00944034|4736337|P9|Overall Study|Administrative reason|0
1435197|NCT00944034|4736338|P8|Overall Study|Administrative reason|0
1435198|NCT00944034|4736339|P7|Overall Study|Administrative reason|1
1435199|NCT00944034|4736340|P6|Overall Study|Administrative reason|0
1435200|NCT00944034|4736341|P5|Overall Study|Administrative reason|0
1435201|NCT00944034|4736342|P4|Overall Study|Administrative reason|0
1435202|NCT00944034|4736343|P3|Overall Study|Administrative reason|0
1435203|NCT00944034|4736344|P2|Overall Study|Administrative reason|0
1435204|NCT00944034|4736345|P1|Overall Study|Administrative reason|0
1435205|NCT00944034|4736334|P12|Overall Study|Unable to classify|0
1435206|NCT00944034|4736335|P11|Overall Study|Unable to classify|0
1435207|NCT00944034|4736336|P10|Overall Study|Unable to classify|0
1435208|NCT00944034|4736337|P9|Overall Study|Unable to classify|0
1435209|NCT00944034|4736338|P8|Overall Study|Unable to classify|1
1435210|NCT00944034|4736339|P7|Overall Study|Unable to classify|1
1435211|NCT00944034|4736340|P6|Overall Study|Unable to classify|1
1435212|NCT00944034|4736341|P5|Overall Study|Unable to classify|0
1435213|NCT00944034|4736342|P4|Overall Study|Unable to classify|0
1435214|NCT00944034|4736343|P3|Overall Study|Unable to classify|0
1435215|NCT00944034|4736344|P2|Overall Study|Unable to classify|0
1435216|NCT00944034|4736345|P1|Overall Study|Unable to classify|0
1435217|NCT00944034|4736334|P12|Overall Study|Protocol Violation|0
1435218|NCT00944034|4736335|P11|Overall Study|Protocol Violation|0
1435219|NCT00944034|4736336|P10|Overall Study|Protocol Violation|4
1435220|NCT00944034|4736337|P9|Overall Study|Protocol Violation|1
1435221|NCT00944034|4736338|P8|Overall Study|Protocol Violation|1
1435222|NCT00944034|4736339|P7|Overall Study|Protocol Violation|0
1435223|NCT00944034|4736340|P6|Overall Study|Protocol Violation|3
1435224|NCT00944034|4736341|P5|Overall Study|Protocol Violation|2
1435225|NCT00944034|4736342|P4|Overall Study|Protocol Violation|1
1435226|NCT00944034|4736343|P3|Overall Study|Protocol Violation|0
1435227|NCT00944034|4736344|P2|Overall Study|Protocol Violation|0
1435228|NCT00944034|4736345|P1|Overall Study|Protocol Violation|2
1435229|NCT00944034|4736334|P12|Overall Study|Death|0
1435230|NCT00944034|4736335|P11|Overall Study|Death|0
1435231|NCT00944034|4736336|P10|Overall Study|Death|0
1435232|NCT00944034|4736337|P9|Overall Study|Death|0
1435233|NCT00944034|4736338|P8|Overall Study|Death|0
1435234|NCT00944034|4736339|P7|Overall Study|Death|0
1435235|NCT00944034|4736340|P6|Overall Study|Death|0
1435236|NCT00944034|4736341|P5|Overall Study|Death|0
1435237|NCT00944034|4736342|P4|Overall Study|Death|0
1435238|NCT00944034|4736343|P3|Overall Study|Death|1
1435239|NCT00944034|4736344|P2|Overall Study|Death|0
1435240|NCT00944034|4736345|P1|Overall Study|Death|0
1435241|NCT00944034|4736334|P12|Overall Study|Lost to Follow-up|0
1435242|NCT00944034|4736335|P11|Overall Study|Lost to Follow-up|1
1435243|NCT00944034|4736336|P10|Overall Study|Lost to Follow-up|1
1435244|NCT00944034|4736337|P9|Overall Study|Lost to Follow-up|5
1435245|NCT00944034|4736338|P8|Overall Study|Lost to Follow-up|1
1435246|NCT00944034|4736339|P7|Overall Study|Lost to Follow-up|0
1435247|NCT00944034|4736340|P6|Overall Study|Lost to Follow-up|7
1435248|NCT00944034|4736341|P5|Overall Study|Lost to Follow-up|5
1435249|NCT00944034|4736342|P4|Overall Study|Lost to Follow-up|0
1435250|NCT00944034|4736343|P3|Overall Study|Lost to Follow-up|2
1435251|NCT00944034|4736344|P2|Overall Study|Lost to Follow-up|4
1435252|NCT00944034|4736345|P1|Overall Study|Lost to Follow-up|0
1435253|NCT00944034|4736334|P12|Overall Study|Withdrawal by Subject|4
1435254|NCT00944034|4736335|P11|Overall Study|Withdrawal by Subject|0
1435255|NCT00944034|4736336|P10|Overall Study|Withdrawal by Subject|4
1435256|NCT00944034|4736337|P9|Overall Study|Withdrawal by Subject|3
1435257|NCT00944034|4736338|P8|Overall Study|Withdrawal by Subject|2
1435258|NCT00944034|4736339|P7|Overall Study|Withdrawal by Subject|2
1435259|NCT00944034|4736340|P6|Overall Study|Withdrawal by Subject|8
1435260|NCT00944034|4736341|P5|Overall Study|Withdrawal by Subject|5
1435261|NCT00944034|4736342|P4|Overall Study|Withdrawal by Subject|2
1435262|NCT00944034|4736343|P3|Overall Study|Withdrawal by Subject|6
1435263|NCT00944034|4736344|P2|Overall Study|Withdrawal by Subject|2
1435264|NCT00944034|4736345|P1|Overall Study|Withdrawal by Subject|3
1435265|NCT00944034|4736334|P12|Overall Study|Inappropriate enrollment|0
1435266|NCT00944034|4736335|P11|Overall Study|Inappropriate enrollment|0
1435267|NCT00944034|4736336|P10|Overall Study|Inappropriate enrollment|1
1435268|NCT00944034|4736337|P9|Overall Study|Inappropriate enrollment|1
1435269|NCT00944034|4736338|P8|Overall Study|Inappropriate enrollment|0
1435270|NCT00944034|4736339|P7|Overall Study|Inappropriate enrollment|0
1435271|NCT00944034|4736340|P6|Overall Study|Inappropriate enrollment|1
1435272|NCT00944034|4736341|P5|Overall Study|Inappropriate enrollment|2
1435273|NCT00944034|4736342|P4|Overall Study|Inappropriate enrollment|1
1435274|NCT00944034|4736343|P3|Overall Study|Inappropriate enrollment|0
1435275|NCT00944034|4736344|P2|Overall Study|Inappropriate enrollment|1
1435276|NCT00944034|4736345|P1|Overall Study|Inappropriate enrollment|0
1435277|NCT00943917|4736491|P15|Stage II Continuation|A1C elevation|0
1435278|NCT00943917|4736492|P14|Stage II Continuation|A1C elevation|1
1435279|NCT00943917|4736493|P13|Stage II Continuation|A1C elevation|0
1435280|NCT00943917|4736494|P12|Stage II Continuation|A1C elevation|0
1435281|NCT00943917|4736495|P11|Stage II Continuation|A1C elevation|0
1435282|NCT00943917|4736496|P10|Stage II Continuation|A1C elevation|0
1435283|NCT00943917|4736497|P9|Stage II Continuation|A1C elevation|0
1435284|NCT00943917|4736498|P8|Stage II Continuation|A1C elevation|0
1435285|NCT00943917|4736499|P7|Stage II Continuation|A1C elevation|0
1435286|NCT00943917|4736500|P6|Stage II Continuation|A1C elevation|0
1435287|NCT00943917|4736501|P5|Stage II Continuation|A1C elevation|0
1435288|NCT00943917|4736502|P4|Stage II Continuation|A1C elevation|0
1435289|NCT00943917|4736503|P3|Stage II Continuation|A1C elevation|0
1435290|NCT00943917|4736504|P2|Stage II Continuation|A1C elevation|0
1435291|NCT00943917|4736505|P1|Stage II Continuation|A1C elevation|0
1435292|NCT00943917|4736491|P15|Stage II Continuation|hypoglycemia|0
1435293|NCT00943917|4736492|P14|Stage II Continuation|hypoglycemia|0
1435294|NCT00943917|4736493|P13|Stage II Continuation|hypoglycemia|1
1435295|NCT00943917|4736494|P12|Stage II Continuation|hypoglycemia|0
1435296|NCT00943917|4736495|P11|Stage II Continuation|hypoglycemia|0
1435297|NCT00943917|4736496|P10|Stage II Continuation|hypoglycemia|0
1435298|NCT00943917|4736497|P9|Stage II Continuation|hypoglycemia|0
1435299|NCT00943917|4736498|P8|Stage II Continuation|hypoglycemia|0
1435300|NCT00943917|4736499|P7|Stage II Continuation|hypoglycemia|0
1435301|NCT00943917|4736500|P6|Stage II Continuation|hypoglycemia|0
1435302|NCT00943917|4736501|P5|Stage II Continuation|hypoglycemia|0
1435303|NCT00943917|4736502|P4|Stage II Continuation|hypoglycemia|0
1435304|NCT00943917|4736503|P3|Stage II Continuation|hypoglycemia|0
1435305|NCT00943917|4736504|P2|Stage II Continuation|hypoglycemia|0
1435306|NCT00943917|4736505|P1|Stage II Continuation|hypoglycemia|0
1435307|NCT00943917|4736491|P15|Stage II Continuation|Protocol Violation|0
1435308|NCT00943917|4736492|P14|Stage II Continuation|Protocol Violation|0
1435309|NCT00943917|4736493|P13|Stage II Continuation|Protocol Violation|0
1435310|NCT00943917|4736494|P12|Stage II Continuation|Protocol Violation|1
1435311|NCT00943917|4736495|P11|Stage II Continuation|Protocol Violation|0
1435312|NCT00943917|4736496|P10|Stage II Continuation|Protocol Violation|1
1435313|NCT00943917|4736497|P9|Stage II Continuation|Protocol Violation|0
1435314|NCT00943917|4736498|P8|Stage II Continuation|Protocol Violation|0
1435315|NCT00943917|4736499|P7|Stage II Continuation|Protocol Violation|0
1435316|NCT00943917|4736500|P6|Stage II Continuation|Protocol Violation|0
1435317|NCT00943917|4736501|P5|Stage II Continuation|Protocol Violation|0
1435318|NCT00943917|4736502|P4|Stage II Continuation|Protocol Violation|0
1435319|NCT00943917|4736503|P3|Stage II Continuation|Protocol Violation|0
1435320|NCT00943917|4736504|P2|Stage II Continuation|Protocol Violation|0
1435321|NCT00943917|4736505|P1|Stage II Continuation|Protocol Violation|0
1435322|NCT00943917|4736491|P15|Stage II Continuation|Withdrawal by Subject|3
1435323|NCT00943917|4736492|P14|Stage II Continuation|Withdrawal by Subject|1
1435324|NCT00943917|4736493|P13|Stage II Continuation|Withdrawal by Subject|0
1435325|NCT00943917|4736494|P12|Stage II Continuation|Withdrawal by Subject|0
1435326|NCT00943917|4736495|P11|Stage II Continuation|Withdrawal by Subject|0
1435327|NCT00943917|4736496|P10|Stage II Continuation|Withdrawal by Subject|0
1435328|NCT00943917|4736497|P9|Stage II Continuation|Withdrawal by Subject|0
1435329|NCT00943917|4736498|P8|Stage II Continuation|Withdrawal by Subject|0
1435330|NCT00943917|4736499|P7|Stage II Continuation|Withdrawal by Subject|0
1435331|NCT00943917|4736500|P6|Stage II Continuation|Withdrawal by Subject|0
1435332|NCT00943917|4736501|P5|Stage II Continuation|Withdrawal by Subject|0
1435333|NCT00943917|4736502|P4|Stage II Continuation|Withdrawal by Subject|0
1435334|NCT00943917|4736503|P3|Stage II Continuation|Withdrawal by Subject|0
1435335|NCT00943917|4736504|P2|Stage II Continuation|Withdrawal by Subject|0
1435336|NCT00943917|4736505|P1|Stage II Continuation|Withdrawal by Subject|0
1435337|NCT00943917|4736491|P15|Stage II Continuation|Adverse Event|1
1435338|NCT00943917|4736492|P14|Stage II Continuation|Adverse Event|1
1435339|NCT00943917|4736493|P13|Stage II Continuation|Adverse Event|2
1435340|NCT00943917|4736494|P12|Stage II Continuation|Adverse Event|1
1435341|NCT00943917|4736495|P11|Stage II Continuation|Adverse Event|0
1435342|NCT00943917|4736496|P10|Stage II Continuation|Adverse Event|0
1435343|NCT00943917|4736497|P9|Stage II Continuation|Adverse Event|0
1435344|NCT00943917|4736498|P8|Stage II Continuation|Adverse Event|0
1435345|NCT00943917|4736499|P7|Stage II Continuation|Adverse Event|0
1435346|NCT00943917|4736500|P6|Stage II Continuation|Adverse Event|0
1435347|NCT00943917|4736501|P5|Stage II Continuation|Adverse Event|0
1435348|NCT00943917|4736502|P4|Stage II Continuation|Adverse Event|0
1435349|NCT00943917|4736503|P3|Stage II Continuation|Adverse Event|0
1435350|NCT00943917|4736504|P2|Stage II Continuation|Adverse Event|0
1435351|NCT00943917|4736505|P1|Stage II Continuation|Adverse Event|0
1435352|NCT00943917|4736491|P15|Stage II|Pregnancy|0
1435353|NCT00943917|4736492|P14|Stage II|Pregnancy|0
1435354|NCT00943917|4736493|P13|Stage II|Pregnancy|0
1435355|NCT00943917|4736494|P12|Stage II|Pregnancy|0
1435356|NCT00943917|4736495|P11|Stage II|Pregnancy|0
1435357|NCT00943917|4736496|P10|Stage II|Pregnancy|0
1435358|NCT00943917|4736497|P9|Stage II|Pregnancy|0
1435359|NCT00943917|4736498|P8|Stage II|Pregnancy|0
1435360|NCT00943917|4736499|P7|Stage II|Pregnancy|0
1435361|NCT00943917|4736500|P6|Stage II|Pregnancy|1
1435362|NCT00943917|4736501|P5|Stage II|Pregnancy|0
1435363|NCT00943917|4736502|P4|Stage II|Pregnancy|0
1435364|NCT00943917|4736503|P3|Stage II|Pregnancy|0
1435365|NCT00943917|4736504|P2|Stage II|Pregnancy|0
1435366|NCT00943917|4736505|P1|Stage II|Pregnancy|0
1435367|NCT00943917|4736491|P15|Stage II|Withdrawal by Subject|0
1435368|NCT00943917|4736492|P14|Stage II|Withdrawal by Subject|0
1435369|NCT00943917|4736493|P13|Stage II|Withdrawal by Subject|0
1435370|NCT00943917|4736494|P12|Stage II|Withdrawal by Subject|0
1435371|NCT00943917|4736495|P11|Stage II|Withdrawal by Subject|0
1435372|NCT00943917|4736496|P10|Stage II|Withdrawal by Subject|0
1435373|NCT00943917|4736497|P9|Stage II|Withdrawal by Subject|0
1435374|NCT00943917|4736498|P8|Stage II|Withdrawal by Subject|0
1435375|NCT00943917|4736499|P7|Stage II|Withdrawal by Subject|0
1435376|NCT00943917|4736500|P6|Stage II|Withdrawal by Subject|1
1435377|NCT00943917|4736501|P5|Stage II|Withdrawal by Subject|0
1435378|NCT00943917|4736502|P4|Stage II|Withdrawal by Subject|0
1435379|NCT00943917|4736503|P3|Stage II|Withdrawal by Subject|0
1435380|NCT00943917|4736504|P2|Stage II|Withdrawal by Subject|0
1435381|NCT00943917|4736505|P1|Stage II|Withdrawal by Subject|0
1435382|NCT00943917|4736491|P15|Stage II|Adverse Event|0
1435383|NCT00943917|4736492|P14|Stage II|Adverse Event|0
1435384|NCT00943917|4736493|P13|Stage II|Adverse Event|0
1435385|NCT00943917|4736494|P12|Stage II|Adverse Event|0
1435386|NCT00943917|4736495|P11|Stage II|Adverse Event|0
1435387|NCT00943917|4736496|P10|Stage II|Adverse Event|0
1435388|NCT00943917|4736497|P9|Stage II|Adverse Event|1
1435389|NCT00943917|4736498|P8|Stage II|Adverse Event|0
1435390|NCT00943917|4736499|P7|Stage II|Adverse Event|3
1435391|NCT00943917|4736500|P6|Stage II|Adverse Event|1
1435392|NCT00943917|4736501|P5|Stage II|Adverse Event|0
1435393|NCT00943917|4736502|P4|Stage II|Adverse Event|0
1435394|NCT00943917|4736503|P3|Stage II|Adverse Event|0
1435395|NCT00943917|4736504|P2|Stage II|Adverse Event|0
1435396|NCT00943917|4736505|P1|Stage II|Adverse Event|0
1435397|NCT00943917|4736491|P15|Stage I|Withdrawal by Subject|0
1435398|NCT00943917|4736492|P14|Stage I|Withdrawal by Subject|0
1435399|NCT00943917|4736493|P13|Stage I|Withdrawal by Subject|0
1435400|NCT00943917|4736494|P12|Stage I|Withdrawal by Subject|0
1435401|NCT00943917|4736495|P11|Stage I|Withdrawal by Subject|0
1435402|NCT00943917|4736496|P10|Stage I|Withdrawal by Subject|0
1435403|NCT00943917|4736497|P9|Stage I|Withdrawal by Subject|0
1435404|NCT00943917|4736498|P8|Stage I|Withdrawal by Subject|0
1435405|NCT00943917|4736499|P7|Stage I|Withdrawal by Subject|0
1435406|NCT00943917|4736500|P6|Stage I|Withdrawal by Subject|0
1435407|NCT00943917|4736501|P5|Stage I|Withdrawal by Subject|0
1435408|NCT00943917|4736502|P4|Stage I|Withdrawal by Subject|0
1435409|NCT00943917|4736503|P3|Stage I|Withdrawal by Subject|2
1435410|NCT00943917|4736504|P2|Stage I|Withdrawal by Subject|1
1435411|NCT00943917|4736505|P1|Stage I|Withdrawal by Subject|2
1435412|NCT00943917|4736491|P15|Stage I|A1C elevation|0
1435413|NCT00943917|4736492|P14|Stage I|A1C elevation|0
1435414|NCT00943917|4736493|P13|Stage I|A1C elevation|0
1435415|NCT00943917|4736494|P12|Stage I|A1C elevation|0
1435416|NCT00943917|4736495|P11|Stage I|A1C elevation|0
1435417|NCT00943917|4736496|P10|Stage I|A1C elevation|0
1435418|NCT00943917|4736497|P9|Stage I|A1C elevation|0
1435419|NCT00943917|4736498|P8|Stage I|A1C elevation|0
1435420|NCT00943917|4736499|P7|Stage I|A1C elevation|0
1435421|NCT00943917|4736500|P6|Stage I|A1C elevation|0
1435422|NCT00943917|4736501|P5|Stage I|A1C elevation|0
1435423|NCT00943917|4736502|P4|Stage I|A1C elevation|0
1435424|NCT00943917|4736503|P3|Stage I|A1C elevation|0
1435425|NCT00943917|4736504|P2|Stage I|A1C elevation|0
1435426|NCT00943917|4736505|P1|Stage I|A1C elevation|1
1435427|NCT00943917|4736491|P15|Stage I|hyperglycemia|0
1435428|NCT00943917|4736492|P14|Stage I|hyperglycemia|0
1435429|NCT00943917|4736493|P13|Stage I|hyperglycemia|0
1435430|NCT00943917|4736494|P12|Stage I|hyperglycemia|0
1435431|NCT00943917|4736495|P11|Stage I|hyperglycemia|0
1435432|NCT00943917|4736496|P10|Stage I|hyperglycemia|0
1435433|NCT00943917|4736497|P9|Stage I|hyperglycemia|0
1435434|NCT00943917|4736498|P8|Stage I|hyperglycemia|0
1435435|NCT00943917|4736499|P7|Stage I|hyperglycemia|0
1435436|NCT00943917|4736500|P6|Stage I|hyperglycemia|0
1435437|NCT00943917|4736501|P5|Stage I|hyperglycemia|0
1435438|NCT00943917|4736502|P4|Stage I|hyperglycemia|0
1435439|NCT00943917|4736503|P3|Stage I|hyperglycemia|1
1435440|NCT00943917|4736504|P2|Stage I|hyperglycemia|0
1435441|NCT00943917|4736505|P1|Stage I|hyperglycemia|0
1435442|NCT00943917|4736491|P15|Stage I|Lost to Follow-up|0
1435443|NCT00943917|4736492|P14|Stage I|Lost to Follow-up|0
1435444|NCT00943917|4736493|P13|Stage I|Lost to Follow-up|0
1435445|NCT00943917|4736494|P12|Stage I|Lost to Follow-up|0
1435446|NCT00943917|4736495|P11|Stage I|Lost to Follow-up|0
1435447|NCT00943917|4736496|P10|Stage I|Lost to Follow-up|0
1435448|NCT00943917|4736497|P9|Stage I|Lost to Follow-up|0
1435449|NCT00943917|4736498|P8|Stage I|Lost to Follow-up|0
1435450|NCT00943917|4736499|P7|Stage I|Lost to Follow-up|0
1435451|NCT00943917|4736500|P6|Stage I|Lost to Follow-up|0
1435452|NCT00943917|4736501|P5|Stage I|Lost to Follow-up|0
1435453|NCT00943917|4736502|P4|Stage I|Lost to Follow-up|0
1435454|NCT00943917|4736503|P3|Stage I|Lost to Follow-up|1
1435455|NCT00943917|4736504|P2|Stage I|Lost to Follow-up|0
1435456|NCT00943917|4736505|P1|Stage I|Lost to Follow-up|0
1435457|NCT00943917|4736491|P15|Stage I|Adverse Event|0
1435458|NCT00943917|4736492|P14|Stage I|Adverse Event|0
1435459|NCT00943917|4736493|P13|Stage I|Adverse Event|0
1435460|NCT00943917|4736494|P12|Stage I|Adverse Event|0
1435461|NCT00943917|4736495|P11|Stage I|Adverse Event|0
1435462|NCT00943917|4736496|P10|Stage I|Adverse Event|0
1435463|NCT00943917|4736497|P9|Stage I|Adverse Event|0
1435464|NCT00943917|4736498|P8|Stage I|Adverse Event|0
1435465|NCT00943917|4736499|P7|Stage I|Adverse Event|0
1435466|NCT00943917|4736500|P6|Stage I|Adverse Event|0
1435467|NCT00943917|4736501|P5|Stage I|Adverse Event|0
1435468|NCT00943917|4736502|P4|Stage I|Adverse Event|0
1435469|NCT00943917|4736503|P3|Stage I|Adverse Event|2
1435470|NCT00943917|4736504|P2|Stage I|Adverse Event|2
1435471|NCT00943917|4736505|P1|Stage I|Adverse Event|1
1435472|NCT00943852|4736681|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
1435473|NCT00943852|4736682|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
1435474|NCT00943852|4736683|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
1435475|NCT00943852|4736684|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
1435476|NCT00943852|4736685|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
1435477|NCT00943852|4736686|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
1435478|NCT00943852|4736687|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
1435479|NCT00943852|4736688|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
1435480|NCT00943852|4736689|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
1435481|NCT00943852|4736690|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
1435482|NCT00943852|4736681|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1435483|NCT00943852|4736682|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1435484|NCT00943852|4736683|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
1435485|NCT00943852|4736684|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1435486|NCT00943852|4736685|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1435487|NCT00943852|4736686|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1435488|NCT00943852|4736687|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1435489|NCT00943852|4736688|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1435490|NCT00943852|4736689|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1435491|NCT00943852|4736690|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1435492|NCT00943852|4736681|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1435493|NCT00943852|4736682|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1435494|NCT00943852|4736683|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1435495|NCT00943852|4736684|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
1435496|NCT00943852|4736685|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1435497|NCT00943852|4736686|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1435498|NCT00943852|4736687|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1435499|NCT00943852|4736688|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1435500|NCT00943852|4736689|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1435501|NCT00943852|4736690|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1435502|NCT00943852|4736681|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
1435503|NCT00943852|4736682|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
1435504|NCT00943852|4736683|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
1435505|NCT00943852|4736684|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
1435506|NCT00943852|4736685|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
1435507|NCT00943852|4736686|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
1435508|NCT00943852|4736687|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
1435509|NCT00943852|4736688|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
1435510|NCT00943852|4736689|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
1435511|NCT00943852|4736690|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
1435512|NCT00943852|4736681|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1435513|NCT00943852|4736682|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1435514|NCT00943852|4736683|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1435515|NCT00943852|4736684|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1435516|NCT00943852|4736685|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1435517|NCT00943852|4736686|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1435518|NCT00943852|4736687|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
1435519|NCT00943852|4736688|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1435520|NCT00943852|4736689|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1435521|NCT00943852|4736690|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1435522|NCT00943826|4736703|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
1435523|NCT00943826|4736704|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
1435524|NCT00943826|4736703|P2|After Primary Overall Survival Analysis|Progression of Disease|4
1435525|NCT00943826|4736704|P1|After Primary Overall Survival Analysis|Progression of Disease|2
1435526|NCT00943826|4736703|P2|After Primary Overall Survival Analysis|Administrative reasons|16
1435527|NCT00943826|4736704|P1|After Primary Overall Survival Analysis|Administrative reasons|10
1435528|NCT00943826|4736703|P2|After Primary Overall Survival Analysis|Adverse Event|0
1435529|NCT00943826|4736704|P1|After Primary Overall Survival Analysis|Adverse Event|11
1435530|NCT00943826|4736703|P2|Monotherapy Phase|Failure to return|1
1435531|NCT00943826|4736704|P1|Monotherapy Phase|Failure to return|2
1435532|NCT00943826|4736703|P2|Monotherapy Phase|Withdrew Consent|3
1435533|NCT00943826|4736704|P1|Monotherapy Phase|Withdrew Consent|2
1435534|NCT00943826|4736703|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
1435535|NCT00943826|4736704|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
1435536|NCT00943826|4736703|P2|Monotherapy Phase|Administrative reasons|5
1435537|NCT00943826|4736704|P1|Monotherapy Phase|Administrative reasons|11
1435538|NCT00943826|4736703|P2|Monotherapy Phase|Adverse Event|5
1435539|NCT00943826|4736704|P1|Monotherapy Phase|Adverse Event|42
1435540|NCT00943826|4736703|P2|Maintenance Phase|Failure to return|1
1435541|NCT00943826|4736704|P1|Maintenance Phase|Failure to return|0
1435542|NCT00943826|4736703|P2|Maintenance Phase|Administrative reasons|1
1435543|NCT00943826|4736704|P1|Maintenance Phase|Administrative reasons|4
1435544|NCT00943826|4736703|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
1435545|NCT00943826|4736704|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
1435546|NCT00943826|4736703|P2|Maintenance Phase|Withdrew consent|4
1435547|NCT00943826|4736704|P1|Maintenance Phase|Withdrew consent|2
1435548|NCT00943826|4736703|P2|Maintenance Phase|Adverse Event|30
1435549|NCT00943826|4736704|P1|Maintenance Phase|Adverse Event|31
1435550|NCT00943826|4736703|P2|Concurrent Phase|Protocol Violation|0
1435551|NCT00943826|4736704|P1|Concurrent Phase|Protocol Violation|1
1435552|NCT00943826|4736703|P2|Concurrent Phase|Administrative reasons|1
1435553|NCT00943826|4736704|P1|Concurrent Phase|Administrative reasons|2
1435554|NCT00943826|4736703|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
1435555|NCT00943826|4736704|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
1435556|NCT00943826|4736703|P2|Concurrent Phase|Withdrew consent|7
1435557|NCT00943826|4736704|P1|Concurrent Phase|Withdrew consent|3
1435558|NCT00943826|4736703|P2|Concurrent Phase|Adverse Event|27
1435559|NCT00943826|4736704|P1|Concurrent Phase|Adverse Event|50
1435560|NCT00943787|4736722|P1|Overall Study|Withdrawal by Subject|3
1435561|NCT00943787|4736722|P1|Overall Study|Physician Decision|4
1435562|NCT00943761|4736729|P2|Overall Study|Withdrawal by Subject|1
1435563|NCT00943761|4736730|P1|Overall Study|Withdrawal by Subject|2
1435564|NCT00943761|4736729|P2|Overall Study|Lost to Follow-up|0
1435565|NCT00943761|4736730|P1|Overall Study|Lost to Follow-up|2
1435566|NCT00943735|4736742|P1|Overall Study|Other|3
1435567|NCT00943735|4736742|P1|Overall Study|Other|8
1435568|NCT00943735|4736742|P1|Overall Study|Death|1
1435569|NCT00943735|4736742|P1|Overall Study|Withdrawal by Subject|8
1435570|NCT00943735|4736742|P1|Overall Study|Adverse Event|12
1435571|NCT00943722|4736780|P5|Overall Study|Withdrawal by Subject|8
1435572|NCT00943722|4736781|P4|Overall Study|Withdrawal by Subject|13
1435573|NCT00943722|4736782|P3|Overall Study|Withdrawal by Subject|2
1435574|NCT00943722|4736783|P2|Overall Study|Withdrawal by Subject|13
1435575|NCT00943722|4736784|P1|Overall Study|Withdrawal by Subject|12
1435576|NCT00943722|4736780|P5|Overall Study|Protocol Violation|2
1435577|NCT00943722|4736781|P4|Overall Study|Protocol Violation|0
1435578|NCT00943722|4736782|P3|Overall Study|Protocol Violation|0
1435579|NCT00943722|4736783|P2|Overall Study|Protocol Violation|1
1435580|NCT00943722|4736784|P1|Overall Study|Protocol Violation|0
1435581|NCT00943722|4736780|P5|Overall Study|Pregnancy|0
1435582|NCT00943722|4736781|P4|Overall Study|Pregnancy|0
1435583|NCT00943722|4736782|P3|Overall Study|Pregnancy|1
1435584|NCT00943722|4736783|P2|Overall Study|Pregnancy|0
1435585|NCT00943722|4736784|P1|Overall Study|Pregnancy|0
1435586|NCT00943722|4736780|P5|Overall Study|Physician Decision|1
1435587|NCT00943722|4736781|P4|Overall Study|Physician Decision|0
1435588|NCT00943722|4736782|P3|Overall Study|Physician Decision|0
1435589|NCT00943722|4736783|P2|Overall Study|Physician Decision|0
1435590|NCT00943722|4736784|P1|Overall Study|Physician Decision|1
1435591|NCT00943722|4736780|P5|Overall Study|Lost to Follow-up|11
1435592|NCT00943722|4736781|P4|Overall Study|Lost to Follow-up|8
1435593|NCT00943722|4736782|P3|Overall Study|Lost to Follow-up|10
1435594|NCT00943722|4736783|P2|Overall Study|Lost to Follow-up|8
1435595|NCT00943722|4736784|P1|Overall Study|Lost to Follow-up|12
1435596|NCT00943722|4736780|P5|Overall Study|Adverse Event|0
1435597|NCT00943722|4736781|P4|Overall Study|Adverse Event|1
1435598|NCT00943722|4736782|P3|Overall Study|Adverse Event|0
1435599|NCT00943722|4736783|P2|Overall Study|Adverse Event|0
1435600|NCT00943722|4736784|P1|Overall Study|Adverse Event|0
1435601|NCT00943683|4736814|P2|Overall Study|Patient Moved|0
1435602|NCT00943683|4736815|P1|Overall Study|Patient Moved|1
1435603|NCT00943683|4736814|P2|Overall Study|Withdrawal by Subject|0
1435604|NCT00943683|4736815|P1|Overall Study|Withdrawal by Subject|1
1435605|NCT00943683|4736814|P2|Overall Study|Protocol Violation|2
1435606|NCT00943683|4736815|P1|Overall Study|Protocol Violation|1
1435607|NCT00943683|4736814|P2|Overall Study|Lost to Follow-up|1
1435608|NCT00943683|4736815|P1|Overall Study|Lost to Follow-up|1
1435609|NCT00943683|4736814|P2|Overall Study|Adverse Event|3
1435610|NCT00943683|4736815|P1|Overall Study|Adverse Event|3
1435611|NCT00943670|4736821|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
1435612|NCT00943670|4736821|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
1435613|NCT00943670|4736821|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
1435614|NCT00943670|4736821|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
1435615|NCT00943670|4736821|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
1435616|NCT00943670|4736821|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
1435617|NCT00943670|4736821|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
1435618|NCT00943670|4736821|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
1435619|NCT00943670|4736821|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
1435620|NCT00943670|4736821|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
1435621|NCT00943605|4736910|P2|Overall Study|Study termination|30
1435622|NCT00943605|4736911|P1|Overall Study|Study termination|30
1435623|NCT00943592|4736921|P1|Overall Study|Death|3
1435624|NCT00943579|4736934|P2|Overall Study|Lack of Efficacy|2
1435625|NCT00943579|4736935|P1|Overall Study|Lack of Efficacy|2
1435626|NCT00943579|4736934|P2|Overall Study|Adverse Event|3
1435627|NCT00943579|4736935|P1|Overall Study|Adverse Event|4
1435628|NCT00943397|4737036|P2|Overall Study|Site terminated and other|56
1435629|NCT00943397|4737037|P1|Overall Study|Site terminated and other|12
1435630|NCT00943397|4737036|P2|Overall Study|Withdrawal by Subject|1
1435631|NCT00943397|4737037|P1|Overall Study|Withdrawal by Subject|1
1435632|NCT00943397|4737036|P2|Overall Study|Protocol Violation|5
1435633|NCT00943397|4737037|P1|Overall Study|Protocol Violation|2
1435634|NCT00943397|4737036|P2|Overall Study|Lost to Follow-up|4
1435635|NCT00943397|4737037|P1|Overall Study|Lost to Follow-up|0
1435636|NCT00943397|4737036|P2|Overall Study|Adverse Event|6
1435637|NCT00943397|4737037|P1|Overall Study|Adverse Event|0
1435638|NCT00943384|4737043|P1|Overall Study|Withdrawal by Subject|5
1435639|NCT00943384|4737043|P1|Overall Study|Lost to Follow-up|16
1435640|NCT00943384|4737043|P1|Overall Study|Treated off protocol-protocol violation|5
1435641|NCT00943384|4737043|P1|Overall Study|Dispositioned prior to treatment|23
1435642|NCT00943306|4737057|P1|Overall Study|Sponsor decision due to non-compliance|1
1435643|NCT00943306|4737057|P1|Overall Study|Death|1
1435644|NCT00943306|4737057|P1|Overall Study|Physician Decision|1
1435645|NCT00943124|4737359|P2|Period 1|Personal Reasons|1
1435646|NCT00943124|4737360|P1|Period 1|Personal Reasons|0
1435647|NCT00943124|4737359|P2|Period 1|Did Not Follow Study Procedures|0
1435648|NCT00943124|4737360|P1|Period 1|Did Not Follow Study Procedures|1
1435649|NCT00943124|4737359|P2|Period 1|Withdrawal by Subject|1
1435650|NCT00943124|4737360|P1|Period 1|Withdrawal by Subject|1
1435651|NCT00943111|4737382|P3|5 Years Long-term Treatment Period|Other than specified above|2
1435652|NCT00943111|4737383|P2|5 Years Long-term Treatment Period|Other than specified above|0
1435653|NCT00943111|4737384|P1|5 Years Long-term Treatment Period|Other than specified above|0
1435654|NCT00943111|4737382|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
1435655|NCT00943111|4737383|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
1435656|NCT00943111|4737384|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
1435657|NCT00943111|4737382|P3|5 Years Long-term Treatment Period|Pregnancy|4
1435658|NCT00943111|4737383|P2|5 Years Long-term Treatment Period|Pregnancy|0
1435659|NCT00943111|4737384|P1|5 Years Long-term Treatment Period|Pregnancy|0
1435660|NCT00943111|4737382|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
1435661|NCT00943111|4737383|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
1435662|NCT00943111|4737384|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
1435663|NCT00943111|4737382|P3|5 Years Long-term Treatment Period|Adverse Event|9
1435664|NCT00943111|4737383|P2|5 Years Long-term Treatment Period|Adverse Event|0
1435665|NCT00943111|4737384|P1|5 Years Long-term Treatment Period|Adverse Event|0
1435666|NCT00943111|4737382|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
1435667|NCT00943111|4737383|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
1435668|NCT00943111|4737384|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
1435669|NCT00943111|4737382|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
1435670|NCT00943111|4737383|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
1435671|NCT00943111|4737384|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
1435672|NCT00943111|4737382|P3|52-Weeks Primary Analysis Period|Adverse Event|0
1435673|NCT00943111|4737383|P2|52-Weeks Primary Analysis Period|Adverse Event|1
1435674|NCT00943111|4737384|P1|52-Weeks Primary Analysis Period|Adverse Event|2
1435675|NCT00943072|4737452|P2|Overall Study|Other|1
1435676|NCT00943072|4737453|P1|Overall Study|Other|1
1435677|NCT00943072|4737452|P2|Overall Study|Lack of Efficacy|4
1435678|NCT00943072|4737453|P1|Overall Study|Lack of Efficacy|0
1435679|NCT00943072|4737452|P2|Overall Study|Lost to Follow-up|2
1435680|NCT00943072|4737453|P1|Overall Study|Lost to Follow-up|1
1435681|NCT00943072|4737452|P2|Overall Study|Protocol Violation|1
1435682|NCT00943072|4737453|P1|Overall Study|Protocol Violation|0
1435683|NCT00943072|4737452|P2|Overall Study|Withdrawal by Subject|1
1435684|NCT00943072|4737453|P1|Overall Study|Withdrawal by Subject|3
1435685|NCT00943072|4737452|P2|Overall Study|Death|2
1435686|NCT00943072|4737453|P1|Overall Study|Death|0
1435687|NCT00943072|4737452|P2|Overall Study|Adverse Event|3
1435688|NCT00943072|4737453|P1|Overall Study|Adverse Event|0
1435689|NCT00942994|4737471|P2|Overall Study|Protocol deviation|2
1435690|NCT00942994|4737472|P1|Overall Study|Protocol deviation|1
1435691|NCT00942994|4737471|P2|Overall Study|Lost to Follow-up|4
1435692|NCT00942994|4737472|P1|Overall Study|Lost to Follow-up|1
1435693|NCT00942994|4737471|P2|Overall Study|Patient withdrew consent|8
1435694|NCT00942994|4737472|P1|Overall Study|Patient withdrew consent|5
1435695|NCT00942994|4737471|P2|Overall Study|Unsatisfactory therapeutic effect|1
1435696|NCT00942994|4737472|P1|Overall Study|Unsatisfactory therapeutic effect|1
1435697|NCT00942994|4737471|P2|Overall Study|Abnormal laboratory value(s)|0
1435698|NCT00942994|4737472|P1|Overall Study|Abnormal laboratory value(s)|1
1435699|NCT00942994|4737471|P2|Overall Study|Adverse Event|4
1435700|NCT00942994|4737472|P1|Overall Study|Adverse Event|7
1435701|NCT00942968|4737488|P1|Overall Study|Deep vein thrombosis (DVT)|2
1435702|NCT00942968|4737488|P1|Overall Study|Participant required pancreatic biopsy|1
1435703|NCT00942968|4737488|P1|Overall Study|Pulmonary embolism (PE)|1
1435704|NCT00942968|4737488|P1|Overall Study|Inferior vena cava filter placement|4
1435705|NCT00942968|4737488|P1|Overall Study|Progression of disease|12
1435706|NCT00942968|4737488|P1|Overall Study|Physician Decision|11
1435707|NCT00942968|4737488|P1|Overall Study|Sponsor request|5
1435708|NCT00942968|4737488|P1|Overall Study|Withdrawal by Subject|44
1435709|NCT00942968|4737488|P1|Overall Study|Lost to Follow-up|4
1435710|NCT00942968|4737488|P1|Overall Study|Protocol Violation|9
1435711|NCT00942968|4737488|P1|Overall Study|Death|76
1435712|NCT00942968|4737488|P1|Overall Study|Adverse Event|60
1435713|NCT00942734|4737566|P1|Overall Study|Physician Decision|1
1435714|NCT00942734|4737566|P1|Overall Study|Disease Progression|2
1435715|NCT00942734|4737566|P1|Overall Study|Protocol Violation|3
1435716|NCT00942734|4737566|P1|Overall Study|Adverse Event|2
1435717|NCT00942604|4737572|P2|Overall Study|Patient relocation|1
1435718|NCT00942604|4737573|P1|Overall Study|Patient relocation|1
1435719|NCT00942604|4737572|P2|Overall Study|Withdrawal by Subject|1
1435720|NCT00942604|4737573|P1|Overall Study|Withdrawal by Subject|0
1435721|NCT00942604|4737572|P2|Overall Study|Adverse Event|1
1435722|NCT00942604|4737573|P1|Overall Study|Adverse Event|0
1435723|NCT00942604|4737572|P2|Overall Study|Protocol Violation|1
1435724|NCT00942604|4737573|P1|Overall Study|Protocol Violation|1
1435725|NCT00942422|4737650|P1|Overall Study|Progressive diease|1
1435726|NCT00942422|4737650|P1|Overall Study|Death|1
1435727|NCT00942422|4737650|P1|Overall Study|Withdrawal by Subject|1
1435728|NCT00942409|4737654|P1|Overall Study|study drug unavailable|2
1435729|NCT00942409|4737654|P1|Overall Study|Lack of Efficacy|1
1435730|NCT00942266|4737660|P2|Overall Study|medical deterioration (pneumonia)|1
1435731|NCT00942266|4737661|P1|Overall Study|medical deterioration (pneumonia)|0
1435732|NCT00942266|4737660|P2|Overall Study|Physician Decision|0
1435733|NCT00942266|4737661|P1|Overall Study|Physician Decision|2
1435734|NCT00942266|4737660|P2|Overall Study|Intercurrent illness|1
1435735|NCT00942266|4737661|P1|Overall Study|Intercurrent illness|0
1435736|NCT00942266|4737660|P2|Overall Study|Failure to thrive and pt withdrawal|1
1435737|NCT00942266|4737661|P1|Overall Study|Failure to thrive and pt withdrawal|0
1435738|NCT00942266|4737660|P2|Overall Study|Disease Progression|11
1435739|NCT00942266|4737661|P1|Overall Study|Disease Progression|38
1435740|NCT00942266|4737660|P2|Overall Study|Adverse Event|1
1435741|NCT00942266|4737661|P1|Overall Study|Adverse Event|2
1435742|NCT00942266|4737660|P2|Overall Study|Withdrawal by Subject|0
1435743|NCT00942266|4737661|P1|Overall Study|Withdrawal by Subject|1
1435744|NCT00942188|4737683|P4|Overall Study|Sponsor Decision|1
1435745|NCT00942188|4737684|P3|Overall Study|Sponsor Decision|0
1435746|NCT00942188|4737685|P2|Overall Study|Sponsor Decision|2
1435747|NCT00942188|4737686|P1|Overall Study|Sponsor Decision|0
1435748|NCT00942188|4737683|P4|Overall Study|Physician Decision|0
1435749|NCT00942188|4737684|P3|Overall Study|Physician Decision|1
1435750|NCT00942188|4737685|P2|Overall Study|Physician Decision|0
1435751|NCT00942188|4737686|P1|Overall Study|Physician Decision|0
1435752|NCT00942188|4737683|P4|Overall Study|Withdrawal by Subject|2
1435753|NCT00942188|4737684|P3|Overall Study|Withdrawal by Subject|4
1435754|NCT00942188|4737685|P2|Overall Study|Withdrawal by Subject|3
1435755|NCT00942188|4737686|P1|Overall Study|Withdrawal by Subject|1
1435756|NCT00942188|4737683|P4|Overall Study|Lost to Follow-up|0
1435757|NCT00942188|4737684|P3|Overall Study|Lost to Follow-up|2
1435758|NCT00942188|4737685|P2|Overall Study|Lost to Follow-up|1
1435759|NCT00942188|4737686|P1|Overall Study|Lost to Follow-up|2
1435760|NCT00942188|4737683|P4|Overall Study|Protocol Violation|0
1435761|NCT00942188|4737684|P3|Overall Study|Protocol Violation|0
1435762|NCT00942188|4737685|P2|Overall Study|Protocol Violation|1
1435763|NCT00942188|4737686|P1|Overall Study|Protocol Violation|1
1435764|NCT00942188|4737683|P4|Overall Study|Lack of Efficacy|1
1435765|NCT00942188|4737684|P3|Overall Study|Lack of Efficacy|0
1435766|NCT00942188|4737685|P2|Overall Study|Lack of Efficacy|0
1435767|NCT00942188|4737686|P1|Overall Study|Lack of Efficacy|0
1435768|NCT00942188|4737683|P4|Overall Study|Adverse Event|0
1435769|NCT00942188|4737684|P3|Overall Study|Adverse Event|2
1435770|NCT00942188|4737685|P2|Overall Study|Adverse Event|3
1435771|NCT00942188|4737686|P1|Overall Study|Adverse Event|0
1435772|NCT00942175|4737725|P4|Overall Study|Low Platelet Count|0
1435773|NCT00942175|4737726|P3|Overall Study|Low Platelet Count|0
1435774|NCT00942175|4737727|P2|Overall Study|Low Platelet Count|2
1435775|NCT00942175|4737728|P1|Overall Study|Low Platelet Count|0
1435776|NCT00942175|4737725|P4|Overall Study|Elevated Alanine Amino Transferase|1
1435777|NCT00942175|4737726|P3|Overall Study|Elevated Alanine Amino Transferase|0
1435778|NCT00942175|4737727|P2|Overall Study|Elevated Alanine Amino Transferase|0
1435779|NCT00942175|4737728|P1|Overall Study|Elevated Alanine Amino Transferase|0
1435780|NCT00942175|4737725|P4|Overall Study|Pregnancy|1
1435781|NCT00942175|4737726|P3|Overall Study|Pregnancy|0
1435782|NCT00942175|4737727|P2|Overall Study|Pregnancy|0
1435783|NCT00942175|4737728|P1|Overall Study|Pregnancy|0
1435784|NCT00942175|4737725|P4|Overall Study|Protocol Violation|0
1435785|NCT00942175|4737726|P3|Overall Study|Protocol Violation|2
1435786|NCT00942175|4737727|P2|Overall Study|Protocol Violation|1
1435787|NCT00942175|4737728|P1|Overall Study|Protocol Violation|0
1435788|NCT00942175|4737725|P4|Overall Study|Adverse Event|0
1435789|NCT00942175|4737726|P3|Overall Study|Adverse Event|0
1435790|NCT00942175|4737727|P2|Overall Study|Adverse Event|1
1435791|NCT00942175|4737728|P1|Overall Study|Adverse Event|2
1435792|NCT00942084|4737782|P1|Overall Study|Death|2
1435793|NCT00941928|4737799|P1|Overall Study|Disease Progression|1
1435794|NCT00941928|4737799|P1|Overall Study|Withdrawal by Subject|1
1435795|NCT00941863|4737817|P5|Continued After PCD|Disease progression, recurrence, relapse|18
1435796|NCT00941863|4737818|P4|Continued After PCD|Disease progression, recurrence, relapse|0
1435797|NCT00941863|4737819|P3|Continued After PCD|Disease progression, recurrence, relapse|0
1435798|NCT00941863|4737820|P2|Continued After PCD|Disease progression, recurrence, relapse|0
1435799|NCT00941863|4737821|P1|Continued After PCD|Disease progression, recurrence, relapse|0
1435800|NCT00941863|4737817|P5|Continued After PCD|Withdrawal by Subject|1
1435801|NCT00941863|4737818|P4|Continued After PCD|Withdrawal by Subject|0
1435802|NCT00941863|4737819|P3|Continued After PCD|Withdrawal by Subject|0
1435803|NCT00941863|4737820|P2|Continued After PCD|Withdrawal by Subject|0
1435804|NCT00941863|4737821|P1|Continued After PCD|Withdrawal by Subject|0
1435805|NCT00941863|4737817|P5|Until Primary Completion Date (PCD)|Disease progression|73
1435887|NCT00941603|4737993|P6|Overall Study|Withdrawal by Subject|1
1435806|NCT00941863|4737818|P4|Until Primary Completion Date (PCD)|Disease progression|14
1435807|NCT00941863|4737819|P3|Until Primary Completion Date (PCD)|Disease progression|8
1435808|NCT00941863|4737820|P2|Until Primary Completion Date (PCD)|Disease progression|1
1435809|NCT00941863|4737821|P1|Until Primary Completion Date (PCD)|Disease progression|6
1435810|NCT00941863|4737817|P5|Until Primary Completion Date (PCD)|Death|7
1435811|NCT00941863|4737818|P4|Until Primary Completion Date (PCD)|Death|2
1435812|NCT00941863|4737819|P3|Until Primary Completion Date (PCD)|Death|1
1435813|NCT00941863|4737820|P2|Until Primary Completion Date (PCD)|Death|0
1435814|NCT00941863|4737821|P1|Until Primary Completion Date (PCD)|Death|0
1435815|NCT00941863|4737817|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
1435816|NCT00941863|4737818|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
1435817|NCT00941863|4737819|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
1435818|NCT00941863|4737820|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
1435819|NCT00941863|4737821|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
1435820|NCT00941863|4737817|P5|Until Primary Completion Date (PCD)|Physician Decision|1
1435821|NCT00941863|4737818|P4|Until Primary Completion Date (PCD)|Physician Decision|0
1435822|NCT00941863|4737819|P3|Until Primary Completion Date (PCD)|Physician Decision|0
1435823|NCT00941863|4737820|P2|Until Primary Completion Date (PCD)|Physician Decision|0
1435824|NCT00941863|4737821|P1|Until Primary Completion Date (PCD)|Physician Decision|0
1435825|NCT00941863|4737817|P5|Until Primary Completion Date (PCD)|Adverse Event|5
1435826|NCT00941863|4737818|P4|Until Primary Completion Date (PCD)|Adverse Event|1
1435827|NCT00941863|4737819|P3|Until Primary Completion Date (PCD)|Adverse Event|2
1435828|NCT00941863|4737820|P2|Until Primary Completion Date (PCD)|Adverse Event|2
1435829|NCT00941863|4737821|P1|Until Primary Completion Date (PCD)|Adverse Event|1
1435830|NCT00941798|4737848|P2|Overall Study|Death|1
1435831|NCT00941798|4737849|P1|Overall Study|Death|0
1435832|NCT00941798|4737848|P2|Overall Study|Abnormal laboratory values|2
1435833|NCT00941798|4737849|P1|Overall Study|Abnormal laboratory values|1
1435834|NCT00941798|4737848|P2|Overall Study|Abnormal test procedure results|1
1435835|NCT00941798|4737849|P1|Overall Study|Abnormal test procedure results|3
1435836|NCT00941798|4737848|P2|Overall Study|Patient's inability to use device|1
1435837|NCT00941798|4737849|P1|Overall Study|Patient's inability to use device|6
1435838|NCT00941798|4737848|P2|Overall Study|Lack of Efficacy|17
1435839|NCT00941798|4737849|P1|Overall Study|Lack of Efficacy|10
1435840|NCT00941798|4737848|P2|Overall Study|Administrative problems|23
1435841|NCT00941798|4737849|P1|Overall Study|Administrative problems|13
1435842|NCT00941798|4737848|P2|Overall Study|Protocol Violation|20
1435843|NCT00941798|4737849|P1|Overall Study|Protocol Violation|17
1435844|NCT00941798|4737848|P2|Overall Study|Lost to Follow-up|23
1435845|NCT00941798|4737849|P1|Overall Study|Lost to Follow-up|29
1435846|NCT00941798|4737848|P2|Overall Study|Adverse Event|23
1435847|NCT00941798|4737849|P1|Overall Study|Adverse Event|43
1435848|NCT00941798|4737848|P2|Overall Study|Withdrawal by Subject|74
1435849|NCT00941798|4737849|P1|Overall Study|Withdrawal by Subject|72
1435850|NCT00941733|4737879|P2|Overall Study|Protocol Violation|6
1435851|NCT00941733|4737880|P1|Overall Study|Protocol Violation|15
1435852|NCT00941733|4737879|P2|Overall Study|Lost to Follow-up|2
1435853|NCT00941733|4737880|P1|Overall Study|Lost to Follow-up|1
1435854|NCT00941733|4737879|P2|Overall Study|Adverse Event|4
1435855|NCT00941733|4737880|P1|Overall Study|Adverse Event|20
1435856|NCT00941733|4737879|P2|Overall Study|Withdrawal by Subject|6
1435857|NCT00941733|4737880|P1|Overall Study|Withdrawal by Subject|14
1435858|NCT00941733|4737879|P2|Overall Study|Death|10
1435859|NCT00941733|4737880|P1|Overall Study|Death|24
1435860|NCT00941720|4737920|P1|Overall Study|ineligible|2
1435861|NCT00941720|4737920|P1|Overall Study|Insurance denied participation|11
1435862|NCT00941720|4737920|P1|Overall Study|Withdrawal by Subject|1
1435863|NCT00941655|4737967|P2|Overall Study|non-compliant|1
1435864|NCT00941655|4737968|P1|Overall Study|non-compliant|0
1435865|NCT00941655|4737967|P2|Overall Study|withdrew consent|1
1435866|NCT00941655|4737968|P1|Overall Study|withdrew consent|0
1435867|NCT00941655|4737967|P2|Overall Study|refused further treatment|1
1435868|NCT00941655|4737968|P1|Overall Study|refused further treatment|0
1435869|NCT00941655|4737967|P2|Overall Study|progressed while on chemo|2
1435870|NCT00941655|4737968|P1|Overall Study|progressed while on chemo|0
1435871|NCT00941655|4737967|P2|Overall Study|not meet criteria for chemo foll surgery|0
1435872|NCT00941655|4737968|P1|Overall Study|not meet criteria for chemo foll surgery|4
1435873|NCT00941655|4737967|P2|Overall Study|received some chemo, 4 and 9 cycles|0
1435874|NCT00941655|4737968|P1|Overall Study|received some chemo, 4 and 9 cycles|1
1435875|NCT00941603|4737993|P6|Overall Study|Did not meet protocol eligibility|0
1435876|NCT00941603|4737994|P5|Overall Study|Did not meet protocol eligibility|0
1435877|NCT00941603|4737995|P4|Overall Study|Did not meet protocol eligibility|0
1435878|NCT00941603|4737996|P3|Overall Study|Did not meet protocol eligibility|0
1435879|NCT00941603|4737997|P2|Overall Study|Did not meet protocol eligibility|0
1435880|NCT00941603|4737998|P1|Overall Study|Did not meet protocol eligibility|1
1435881|NCT00941603|4737993|P6|Overall Study|Protocol Violation|0
1435882|NCT00941603|4737994|P5|Overall Study|Protocol Violation|0
1435883|NCT00941603|4737995|P4|Overall Study|Protocol Violation|0
1435884|NCT00941603|4737996|P3|Overall Study|Protocol Violation|0
1435885|NCT00941603|4737997|P2|Overall Study|Protocol Violation|1
1435886|NCT00941603|4737998|P1|Overall Study|Protocol Violation|0
1435888|NCT00941603|4737994|P5|Overall Study|Withdrawal by Subject|0
1435889|NCT00941603|4737995|P4|Overall Study|Withdrawal by Subject|2
1435890|NCT00941603|4737996|P3|Overall Study|Withdrawal by Subject|0
1435891|NCT00941603|4737997|P2|Overall Study|Withdrawal by Subject|0
1435892|NCT00941603|4737998|P1|Overall Study|Withdrawal by Subject|0
1435893|NCT00941603|4737993|P6|Overall Study|Lost to Follow-up|2
1435894|NCT00941603|4737994|P5|Overall Study|Lost to Follow-up|0
1435895|NCT00941603|4737995|P4|Overall Study|Lost to Follow-up|1
1435896|NCT00941603|4737996|P3|Overall Study|Lost to Follow-up|0
1435897|NCT00941603|4737997|P2|Overall Study|Lost to Follow-up|0
1435898|NCT00941603|4737998|P1|Overall Study|Lost to Follow-up|0
1435899|NCT00941603|4737993|P6|Overall Study|Adverse Event|0
1435900|NCT00941603|4737994|P5|Overall Study|Adverse Event|4
1435901|NCT00941603|4737995|P4|Overall Study|Adverse Event|1
1435902|NCT00941603|4737996|P3|Overall Study|Adverse Event|5
1435903|NCT00941603|4737997|P2|Overall Study|Adverse Event|15
1435904|NCT00941603|4737998|P1|Overall Study|Adverse Event|10
1435905|NCT00941330|4738020|P2|Overall Study|Physician Decision|2
1435906|NCT00941330|4738021|P1|Overall Study|Physician Decision|0
1435907|NCT00941330|4738020|P2|Overall Study|Other|0
1435908|NCT00941330|4738021|P1|Overall Study|Other|1
1435909|NCT00941304|4738034|P5|Overall Study|Lost to Follow-up|0
1435910|NCT00941304|4738035|P4|Overall Study|Lost to Follow-up|0
1435911|NCT00941304|4738036|P3|Overall Study|Lost to Follow-up|0
1435912|NCT00941304|4738037|P2|Overall Study|Lost to Follow-up|0
1435913|NCT00941304|4738038|P1|Overall Study|Lost to Follow-up|1
1435914|NCT00941070|4738100|P1|Overall Study|Patient non-compliant|1
1435915|NCT00941031|4738120|P7|Maintenance Period|Lack of Efficacy|13
1435916|NCT00941031|4738121|P6|Maintenance Period|Lack of Efficacy|0
1435917|NCT00941031|4738122|P5|Maintenance Period|Lack of Efficacy|0
1435918|NCT00941031|4738123|P4|Maintenance Period|Lack of Efficacy|0
1435919|NCT00941031|4738124|P3|Maintenance Period|Lack of Efficacy|0
1435920|NCT00941031|4738125|P2|Maintenance Period|Lack of Efficacy|0
1435921|NCT00941031|4738126|P1|Maintenance Period|Lack of Efficacy|0
1435922|NCT00941031|4738120|P7|Maintenance Period|Lost to Follow-up|7
1435923|NCT00941031|4738121|P6|Maintenance Period|Lost to Follow-up|2
1435924|NCT00941031|4738122|P5|Maintenance Period|Lost to Follow-up|2
1435925|NCT00941031|4738123|P4|Maintenance Period|Lost to Follow-up|0
1435926|NCT00941031|4738124|P3|Maintenance Period|Lost to Follow-up|0
1435927|NCT00941031|4738125|P2|Maintenance Period|Lost to Follow-up|0
1435928|NCT00941031|4738126|P1|Maintenance Period|Lost to Follow-up|0
1435929|NCT00941031|4738120|P7|Maintenance Period|Adverse Event|8
1435930|NCT00941031|4738121|P6|Maintenance Period|Adverse Event|2
1435931|NCT00941031|4738122|P5|Maintenance Period|Adverse Event|0
1435932|NCT00941031|4738123|P4|Maintenance Period|Adverse Event|0
1435933|NCT00941031|4738124|P3|Maintenance Period|Adverse Event|0
1435934|NCT00941031|4738125|P2|Maintenance Period|Adverse Event|0
1435935|NCT00941031|4738126|P1|Maintenance Period|Adverse Event|0
1435936|NCT00941031|4738120|P7|Maintenance Period|Protocol Violation|1
1435937|NCT00941031|4738121|P6|Maintenance Period|Protocol Violation|0
1435938|NCT00941031|4738122|P5|Maintenance Period|Protocol Violation|0
1435939|NCT00941031|4738123|P4|Maintenance Period|Protocol Violation|0
1435940|NCT00941031|4738124|P3|Maintenance Period|Protocol Violation|0
1435941|NCT00941031|4738125|P2|Maintenance Period|Protocol Violation|0
1435942|NCT00941031|4738126|P1|Maintenance Period|Protocol Violation|0
1435943|NCT00941031|4738120|P7|Maintenance Period|Administrative Problems|1
1435944|NCT00941031|4738121|P6|Maintenance Period|Administrative Problems|0
1435945|NCT00941031|4738122|P5|Maintenance Period|Administrative Problems|1
1435946|NCT00941031|4738123|P4|Maintenance Period|Administrative Problems|0
1435947|NCT00941031|4738124|P3|Maintenance Period|Administrative Problems|0
1435948|NCT00941031|4738125|P2|Maintenance Period|Administrative Problems|0
1435949|NCT00941031|4738126|P1|Maintenance Period|Administrative Problems|0
1435950|NCT00941031|4738120|P7|Maintenance Period|Withdrawal by Subject|13
1435951|NCT00941031|4738121|P6|Maintenance Period|Withdrawal by Subject|2
1435952|NCT00941031|4738122|P5|Maintenance Period|Withdrawal by Subject|6
1435953|NCT00941031|4738123|P4|Maintenance Period|Withdrawal by Subject|0
1435954|NCT00941031|4738124|P3|Maintenance Period|Withdrawal by Subject|0
1435955|NCT00941031|4738125|P2|Maintenance Period|Withdrawal by Subject|0
1435956|NCT00941031|4738126|P1|Maintenance Period|Withdrawal by Subject|0
1435957|NCT00941031|4738120|P7|Induction Period|Adverse Event|0
1435958|NCT00941031|4738121|P6|Induction Period|Adverse Event|0
1435959|NCT00941031|4738122|P5|Induction Period|Adverse Event|0
1435960|NCT00941031|4738123|P4|Induction Period|Adverse Event|2
1435961|NCT00941031|4738124|P3|Induction Period|Adverse Event|3
1435962|NCT00941031|4738125|P2|Induction Period|Adverse Event|0
1435963|NCT00941031|4738126|P1|Induction Period|Adverse Event|1
1435964|NCT00941031|4738120|P7|Induction Period|Adminstative Problems|0
1435965|NCT00941031|4738121|P6|Induction Period|Adminstative Problems|0
1435966|NCT00941031|4738122|P5|Induction Period|Adminstative Problems|0
1435967|NCT00941031|4738123|P4|Induction Period|Adminstative Problems|0
1435968|NCT00941031|4738124|P3|Induction Period|Adminstative Problems|1
1435969|NCT00941031|4738125|P2|Induction Period|Adminstative Problems|1
1435970|NCT00941031|4738126|P1|Induction Period|Adminstative Problems|1
1435971|NCT00941031|4738120|P7|Induction Period|Withdrawal by Subject|0
1435972|NCT00941031|4738121|P6|Induction Period|Withdrawal by Subject|0
1435973|NCT00941031|4738122|P5|Induction Period|Withdrawal by Subject|0
1435974|NCT00941031|4738123|P4|Induction Period|Withdrawal by Subject|2
1435975|NCT00941031|4738124|P3|Induction Period|Withdrawal by Subject|2
1435976|NCT00941031|4738125|P2|Induction Period|Withdrawal by Subject|2
1435977|NCT00941031|4738126|P1|Induction Period|Withdrawal by Subject|1
1435978|NCT00941031|4738120|P7|Induction Period|Lack of Efficacy|0
1435979|NCT00941031|4738121|P6|Induction Period|Lack of Efficacy|0
1435980|NCT00941031|4738122|P5|Induction Period|Lack of Efficacy|0
1435981|NCT00941031|4738123|P4|Induction Period|Lack of Efficacy|5
1435982|NCT00941031|4738124|P3|Induction Period|Lack of Efficacy|0
1435983|NCT00941031|4738125|P2|Induction Period|Lack of Efficacy|1
1435984|NCT00941031|4738126|P1|Induction Period|Lack of Efficacy|2
1435985|NCT00940992|4738152|P3|Overall Study|Lost to Follow-up|1
1435986|NCT00940992|4738153|P2|Overall Study|Lost to Follow-up|1
1435987|NCT00940992|4738154|P1|Overall Study|Lost to Follow-up|0
1435988|NCT00940992|4738152|P3|Overall Study|subject request|0
1435989|NCT00940992|4738153|P2|Overall Study|subject request|1
1435990|NCT00940992|4738154|P1|Overall Study|subject request|2
1435991|NCT00940992|4738152|P3|Overall Study|Adverse Event|1
1435992|NCT00940992|4738153|P2|Overall Study|Adverse Event|0
1435993|NCT00940992|4738154|P1|Overall Study|Adverse Event|2
1435994|NCT00940888|4738183|P1|Overall Study|Lost to Follow-up|6
1435995|NCT00940888|4738183|P1|Overall Study|Withdrawn - Non-Death|364
1435996|NCT00940888|4738183|P1|Overall Study|Death|461
1435997|NCT00940888|4738183|P1|Overall Study|Unsuccessful Implant|4
1435998|NCT00940875|4738190|P2|Post-Study Treatment|Disease Progression|2
1435999|NCT00940875|4738191|P1|Post-Study Treatment|Disease Progression|0
1436000|NCT00940875|4738190|P2|Post-Study Treatment|Death|1
1436001|NCT00940875|4738191|P1|Post-Study Treatment|Death|0
1436002|NCT00940875|4738190|P2|Treatment Phase|Physician Decision|0
1436003|NCT00940875|4738191|P1|Treatment Phase|Physician Decision|1
1436004|NCT00940875|4738190|P2|Treatment Phase|Disease progression|11
1436005|NCT00940875|4738191|P1|Treatment Phase|Disease progression|9
1436006|NCT00940875|4738190|P2|Treatment Phase|Withdrawal by Subject|0
1436007|NCT00940875|4738191|P1|Treatment Phase|Withdrawal by Subject|3
1436008|NCT00940875|4738190|P2|Treatment Phase|Lack of Efficacy|0
1436009|NCT00940875|4738191|P1|Treatment Phase|Lack of Efficacy|1
1436010|NCT00940875|4738190|P2|Treatment Phase|Death|5
1436011|NCT00940875|4738191|P1|Treatment Phase|Death|3
1436012|NCT00940875|4738190|P2|Treatment Phase|Adverse Event|3
1436013|NCT00940875|4738191|P1|Treatment Phase|Adverse Event|9
1436014|NCT00940823|4738211|P2|Overall Study|Lost to Follow-up|20
1436015|NCT00940823|4738212|P1|Overall Study|Lost to Follow-up|27
1436016|NCT00940823|4738211|P2|Overall Study|Death|12
1436017|NCT00940823|4738212|P1|Overall Study|Death|8
1436018|NCT00940485|4738263|P2|Overall Study|Others|1
1436019|NCT00940485|4738264|P1|Overall Study|Others|1
1436020|NCT00940485|4738263|P2|Overall Study|Withdrawal by Subject|1
1436021|NCT00940485|4738264|P1|Overall Study|Withdrawal by Subject|1
1436022|NCT00940485|4738263|P2|Overall Study|Adverse Event|0
1436023|NCT00940485|4738264|P1|Overall Study|Adverse Event|8
1436024|NCT00940485|4738263|P2|Overall Study|Lost to Follow-up|3
1436025|NCT00940485|4738264|P1|Overall Study|Lost to Follow-up|2
1436026|NCT00940485|4738263|P2|Overall Study|HBeAb positive at Baseline|2
1436027|NCT00940485|4738264|P1|Overall Study|HBeAb positive at Baseline|3
1436028|NCT00940108|4738320|P4|Overall Study|Diagnosed with H1N1|1
1436029|NCT00940108|4738321|P3|Overall Study|Diagnosed with H1N1|0
1436030|NCT00940108|4738322|P2|Overall Study|Diagnosed with H1N1|0
1436031|NCT00940108|4738323|P1|Overall Study|Diagnosed with H1N1|0
1436032|NCT00940108|4738320|P4|Overall Study|Viral illness after Dose 1|0
1436033|NCT00940108|4738321|P3|Overall Study|Viral illness after Dose 1|0
1436034|NCT00940108|4738322|P2|Overall Study|Viral illness after Dose 1|1
1436035|NCT00940108|4738323|P1|Overall Study|Viral illness after Dose 1|0
1436036|NCT00940108|4738320|P4|Overall Study|Refused - pyrexia after Dose 1|0
1436037|NCT00940108|4738321|P3|Overall Study|Refused - pyrexia after Dose 1|0
1436038|NCT00940108|4738322|P2|Overall Study|Refused - pyrexia after Dose 1|1
1436039|NCT00940108|4738323|P1|Overall Study|Refused - pyrexia after Dose 1|0
1436040|NCT00940108|4738320|P4|Overall Study|Declined further vaccination|0
1436041|NCT00940108|4738321|P3|Overall Study|Declined further vaccination|3
1436042|NCT00940108|4738322|P2|Overall Study|Declined further vaccination|1
1436043|NCT00940108|4738323|P1|Overall Study|Declined further vaccination|0
1436044|NCT00940108|4738320|P4|Overall Study|Dose 2 contraindicated|1
1436045|NCT00940108|4738321|P3|Overall Study|Dose 2 contraindicated|0
1436046|NCT00940108|4738322|P2|Overall Study|Dose 2 contraindicated|1
1436047|NCT00940108|4738323|P1|Overall Study|Dose 2 contraindicated|1
1436048|NCT00940108|4738320|P4|Overall Study|Withdrew Consent|1
1436049|NCT00940108|4738321|P3|Overall Study|Withdrew Consent|0
1436050|NCT00940108|4738322|P2|Overall Study|Withdrew Consent|1
1436051|NCT00940108|4738323|P1|Overall Study|Withdrew Consent|2
1436052|NCT00940108|4738320|P4|Overall Study|Adverse Event|2
1436053|NCT00940108|4738321|P3|Overall Study|Adverse Event|0
1436054|NCT00940108|4738322|P2|Overall Study|Adverse Event|4
1436055|NCT00940108|4738323|P1|Overall Study|Adverse Event|2
1436056|NCT00940017|4738373|P1|Overall Study|Adverse Event|1
1436057|NCT00940017|4738373|P1|Overall Study|did not meet entrance criteria|3
1436058|NCT00939809|4738429|P1|Overall Study|Death|1
1436059|NCT00939809|4738429|P1|Overall Study|Adverse Event|2
1436060|NCT00939783|4738444|P1|Overall Study|Enrolled but not treated|1
1436061|NCT00939783|4738444|P1|Overall Study|Protocol Violation|3
1436062|NCT00939783|4738444|P1|Overall Study|Lost to Follow-up|8
1436063|NCT00939783|4738444|P1|Overall Study|Other|16
1436064|NCT00939783|4738444|P1|Overall Study|Withdrawal by Subject|78
1436065|NCT00939783|4738444|P1|Overall Study|Study Terminated by Sponsor|498
1436066|NCT00939783|4738444|P1|Overall Study|Adverse Event|39
1436067|NCT00939783|4738444|P1|Overall Study|Death|6
1436068|NCT00939692|4738485|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
1436069|NCT00939692|4738486|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
1436070|NCT00939692|4738485|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
1436071|NCT00939692|4738486|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
1436072|NCT00939627|4738498|P3|Overall Study|No off-tx reason given|0
1436073|NCT00939627|4738499|P2|Overall Study|No off-tx reason given|2
1436074|NCT00939627|4738500|P1|Overall Study|No off-tx reason given|0
1436075|NCT00939627|4738498|P3|Overall Study|Not compliant|0
1436076|NCT00939627|4738499|P2|Overall Study|Not compliant|0
1436077|NCT00939627|4738500|P1|Overall Study|Not compliant|2
1436078|NCT00939627|4738498|P3|Overall Study|Other complicating disease|0
1436079|NCT00939627|4738499|P2|Overall Study|Other complicating disease|1
1436080|NCT00939627|4738500|P1|Overall Study|Other complicating disease|1
1436081|NCT00939627|4738498|P3|Overall Study|Withdrawal by Subject|0
1436082|NCT00939627|4738499|P2|Overall Study|Withdrawal by Subject|4
1436083|NCT00939627|4738500|P1|Overall Study|Withdrawal by Subject|2
1436084|NCT00939627|4738498|P3|Overall Study|Death|0
1436085|NCT00939627|4738499|P2|Overall Study|Death|2
1436086|NCT00939627|4738500|P1|Overall Study|Death|0
1436087|NCT00939627|4738498|P3|Overall Study|Adverse Event|0
1436088|NCT00939627|4738499|P2|Overall Study|Adverse Event|7
1436089|NCT00939627|4738500|P1|Overall Study|Adverse Event|6
1436090|NCT00939627|4738498|P3|Overall Study|Disease Progression|0
1436091|NCT00939627|4738499|P2|Overall Study|Disease Progression|12
1436092|NCT00939627|4738500|P1|Overall Study|Disease Progression|16
1436093|NCT00939510|4738540|P1|Overall Study|Withdrawal by Subject|1
1436094|NCT00939484|4738549|P3|Overall Study|Progression/Relapse|3
1436095|NCT00939484|4738550|P2|Overall Study|Progression/Relapse|20
1436096|NCT00939484|4738551|P1|Overall Study|Progression/Relapse|8
1436097|NCT00939393|4738577|P2|Overall Study|Lost to Follow-up|0
1436098|NCT00939393|4738578|P1|Overall Study|Lost to Follow-up|3
1436099|NCT00939393|4738577|P2|Overall Study|Withdrawal by Subject|0
1436100|NCT00939393|4738578|P1|Overall Study|Withdrawal by Subject|1
1436101|NCT00939341|4738609|P1|Overall Study|Incorrect enrolment|8
1436102|NCT00939341|4738609|P1|Overall Study|Protocol Violation|6
1436103|NCT00939341|4738609|P1|Overall Study|Withdrawal by Subject|13
1436104|NCT00939341|4738609|P1|Overall Study|Lost to Follow-up|23
1436105|NCT00939341|4738609|P1|Overall Study|Pregnancy|1
1436106|NCT00939341|4738609|P1|Overall Study|Adverse Event|15
1436107|NCT00939185|4738696|P1|Overall Study|Randomized But Did Not Receive Treatment|10
1436108|NCT00939185|4738696|P1|Overall Study|Withdrawal by Subject|2
1436109|NCT00939185|4738696|P1|Overall Study|Other|3
1436110|NCT00939185|4738696|P1|Overall Study|Lost to Follow-up|6
1436111|NCT00939185|4738696|P1|Overall Study|Lack of Efficacy|1
1436112|NCT00939185|4738696|P1|Overall Study|Adverse Event|3
1436113|NCT00939107|4738734|P2|Overall Study|Lost to Follow-up|12
1436114|NCT00939107|4738735|P1|Overall Study|Lost to Follow-up|14
1436115|NCT00939094|4738749|P2|Overall Study|Abnormal ECG findings|0
1436116|NCT00939094|4738750|P1|Overall Study|Abnormal ECG findings|1
1436117|NCT00939094|4738749|P2|Overall Study|Study stopped by sponsor|2
1436118|NCT00939094|4738750|P1|Overall Study|Study stopped by sponsor|0
1436119|NCT00939094|4738749|P2|Overall Study|Severe non-compliance to protocol|1
1436120|NCT00939094|4738750|P1|Overall Study|Severe non-compliance to protocol|0
1436121|NCT00939094|4738749|P2|Overall Study|Eligibility criteria not fulfilled|0
1436122|NCT00939094|4738750|P1|Overall Study|Eligibility criteria not fulfilled|2
1436123|NCT00939094|4738749|P2|Overall Study|Lost to Follow-up|1
1436124|NCT00939094|4738750|P1|Overall Study|Lost to Follow-up|1
1436125|NCT00939094|4738749|P2|Overall Study|Withdrawal by Subject|6
1436126|NCT00939094|4738750|P1|Overall Study|Withdrawal by Subject|1
1436127|NCT00939094|4738749|P2|Overall Study|Adverse Event|0
1436128|NCT00939094|4738750|P1|Overall Study|Adverse Event|9
1436129|NCT00939055|4738772|P2|Overall Study|Discontinuation prior to procedure|0
1436130|NCT00939055|4738773|P1|Overall Study|Discontinuation prior to procedure|4
1436131|NCT00939029|4738783|P2|Overall Study|Adverse Event|1
1436132|NCT00939029|4738784|P1|Overall Study|Adverse Event|0
1436133|NCT00939029|4738783|P2|Overall Study|Lost to Follow-up|4
1436134|NCT00939029|4738784|P1|Overall Study|Lost to Follow-up|3
1436135|NCT00939029|4738783|P2|Overall Study|Withdrawal by Subject|7
1436136|NCT00939029|4738784|P1|Overall Study|Withdrawal by Subject|3
1436137|NCT00939003|4738796|P2|Open-label Treatment Period|Site Closure|4
1436138|NCT00939003|4738797|P1|Open-label Treatment Period|Site Closure|3
1436139|NCT00939003|4738796|P2|Open-label Treatment Period|Exclusion Criteria|0
1436140|NCT00939003|4738797|P1|Open-label Treatment Period|Exclusion Criteria|1
1436141|NCT00939003|4738796|P2|Open-label Treatment Period|Pregnancy|1
1436142|NCT00939003|4738797|P1|Open-label Treatment Period|Pregnancy|1
1436143|NCT00939003|4738796|P2|Open-label Treatment Period|Lack of Efficacy|9
1436144|NCT00939003|4738797|P1|Open-label Treatment Period|Lack of Efficacy|6
1436145|NCT00939003|4738796|P2|Open-label Treatment Period|Withdrawal by Subject|7
1436146|NCT00939003|4738797|P1|Open-label Treatment Period|Withdrawal by Subject|14
1436147|NCT00939003|4738796|P2|Open-label Treatment Period|Adverse Event|8
1436148|NCT00939003|4738797|P1|Open-label Treatment Period|Adverse Event|4
1436149|NCT00939003|4738796|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
1436150|NCT00939003|4738797|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
1436151|NCT00939003|4738796|P2|Double-blind Treatment Period|Pregnancy|1
1436152|NCT00939003|4738797|P1|Double-blind Treatment Period|Pregnancy|0
1436153|NCT00939003|4738796|P2|Double-blind Treatment Period|Lack of Efficacy|1
1436154|NCT00939003|4738797|P1|Double-blind Treatment Period|Lack of Efficacy|0
1436155|NCT00939003|4738796|P2|Double-blind Treatment Period|Adverse Event|1
1436156|NCT00939003|4738797|P1|Double-blind Treatment Period|Adverse Event|1
1436157|NCT00938964|4738834|P2|Overall Study|Found to Meet Exclusion Criteria|4
1436158|NCT00938964|4738835|P1|Overall Study|Found to Meet Exclusion Criteria|3
1436159|NCT00938964|4738834|P2|Overall Study|Withdrawal by Subject|18
1436160|NCT00938964|4738835|P1|Overall Study|Withdrawal by Subject|22
1436161|NCT00938964|4738834|P2|Overall Study|Lost to Follow-up|3
1436162|NCT00938964|4738835|P1|Overall Study|Lost to Follow-up|2
1436163|NCT00938964|4738834|P2|Overall Study|Death|3
1436164|NCT00938964|4738835|P1|Overall Study|Death|3
1436165|NCT00938886|4738899|P2|Overall Study|Lost to Follow-up|2
1436166|NCT00938886|4738900|P1|Overall Study|Lost to Follow-up|3
1436167|NCT00938886|4738899|P2|Overall Study|Withdrawal by Subject|7
1436168|NCT00938886|4738900|P1|Overall Study|Withdrawal by Subject|4
1436169|NCT00938886|4738899|P2|Overall Study|Death|1
1436170|NCT00938886|4738900|P1|Overall Study|Death|0
1436171|NCT00938860|4738910|P2|Overall Study|Protocol Violation|1
1436172|NCT00938860|4738911|P1|Overall Study|Protocol Violation|3
1436173|NCT00938860|4738910|P2|Overall Study|Death|1
1436174|NCT00938860|4738911|P1|Overall Study|Death|1
1436175|NCT00938860|4738910|P2|Overall Study|Administration problems|0
1436176|NCT00938860|4738911|P1|Overall Study|Administration problems|2
1436177|NCT00938860|4738910|P2|Overall Study|Lost to Follow-up|4
1436178|NCT00938860|4738911|P1|Overall Study|Lost to Follow-up|4
1436179|NCT00938860|4738910|P2|Overall Study|Withdrawal by Subject|8
1436180|NCT00938860|4738911|P1|Overall Study|Withdrawal by Subject|11
1436181|NCT00938860|4738910|P2|Overall Study|Abnormal laboratory values|2
1436182|NCT00938860|4738911|P1|Overall Study|Abnormal laboratory values|2
1436183|NCT00938860|4738910|P2|Overall Study|Adverse Event|1
1436184|NCT00938860|4738911|P1|Overall Study|Adverse Event|2
1436185|NCT00938717|4738944|P2|Overall Study|Other reason|2
1436186|NCT00938717|4738945|P1|Overall Study|Other reason|5
1436187|NCT00938717|4738944|P2|Overall Study|Lack of Efficacy|15
1436188|NCT00938717|4738945|P1|Overall Study|Lack of Efficacy|33
1436189|NCT00938717|4738944|P2|Overall Study|Lost to Follow-up|18
1436190|NCT00938717|4738945|P1|Overall Study|Lost to Follow-up|13
1436191|NCT00938717|4738944|P2|Overall Study|Withdrawal by Subject|24
1436192|NCT00938717|4738945|P1|Overall Study|Withdrawal by Subject|26
1436193|NCT00938717|4738944|P2|Overall Study|Protocol Violation|8
1436194|NCT00938717|4738945|P1|Overall Study|Protocol Violation|11
1436195|NCT00938717|4738944|P2|Overall Study|Adverse Event|41
1436196|NCT00938717|4738945|P1|Overall Study|Adverse Event|10
1436197|NCT00938639|4738996|P2|Overall Study|Participant noncompliance|0
1436198|NCT00938639|4738997|P1|Overall Study|Participant noncompliance|1
1436199|NCT00938639|4738996|P2|Overall Study|Family issues|1
1436200|NCT00938639|4738997|P1|Overall Study|Family issues|1
1436201|NCT00938639|4738996|P2|Overall Study|Lost to Follow-up|2
1436202|NCT00938639|4738997|P1|Overall Study|Lost to Follow-up|1
1436203|NCT00938639|4738996|P2|Overall Study|Moved away from study area|1
1436204|NCT00938639|4738997|P1|Overall Study|Moved away from study area|0
1436205|NCT00938470|4739080|P2|Overall Study|Other Reason|1
1436206|NCT00938470|4739081|P1|Overall Study|Other Reason|0
1436207|NCT00938470|4739080|P2|Overall Study|Death|2
1436208|NCT00938470|4739081|P1|Overall Study|Death|3
1436209|NCT00938470|4739080|P2|Overall Study|Alternate Treatment|0
1436210|NCT00938470|4739081|P1|Overall Study|Alternate Treatment|1
1436211|NCT00938470|4739080|P2|Overall Study|Disease Progression|0
1436212|NCT00938470|4739081|P1|Overall Study|Disease Progression|3
1436213|NCT00938431|4739111|P3|Overall Study|Reached maximum dose early|1
1436214|NCT00938431|4739112|P2|Overall Study|Reached maximum dose early|0
1436215|NCT00938431|4739113|P1|Overall Study|Reached maximum dose early|0
1436216|NCT00938431|4739111|P3|Overall Study|Dosing compliance issue|1
1436217|NCT00938431|4739112|P2|Overall Study|Dosing compliance issue|0
1436218|NCT00938431|4739113|P1|Overall Study|Dosing compliance issue|0
1436219|NCT00938431|4739111|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
1436220|NCT00938431|4739112|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
1436221|NCT00938431|4739113|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
1436222|NCT00938431|4739111|P3|Overall Study|Lack of Efficacy|0
1436223|NCT00938431|4739112|P2|Overall Study|Lack of Efficacy|1
1436224|NCT00938431|4739113|P1|Overall Study|Lack of Efficacy|0
1436225|NCT00938431|4739111|P3|Overall Study|Adverse Event|6
1436226|NCT00938431|4739112|P2|Overall Study|Adverse Event|8
1436227|NCT00938431|4739113|P1|Overall Study|Adverse Event|5
1436228|NCT00938392|4739140|P2|Overall Study|Lost to Follow-up|2
1436229|NCT00938392|4739141|P1|Overall Study|Lost to Follow-up|2
1436230|NCT00938392|4739140|P2|Overall Study|Withdrawal by Subject|1
1436231|NCT00938392|4739141|P1|Overall Study|Withdrawal by Subject|0
1436232|NCT00938392|4739140|P2|Overall Study|Adverse Event|1
1436233|NCT00938392|4739141|P1|Overall Study|Adverse Event|0
1436234|NCT00938366|4739167|P2|Overall Study|Withdrawal by Subject|0
1436235|NCT00938366|4739168|P1|Overall Study|Withdrawal by Subject|1
1436236|NCT00938327|4739188|P1|Overall Study|Vaccine not received as out of stock|9
1436237|NCT00938327|4739188|P1|Overall Study|2nd dose received outside of the study|7
1436238|NCT00938327|4739188|P1|Overall Study|Lost to Follow-up|37
1436239|NCT00938327|4739188|P1|Overall Study|Withdrawal by Subject|4
1436240|NCT00938327|4739188|P1|Overall Study|Protocol Violation|1
1436241|NCT00938327|4739188|P1|Overall Study|Adverse Event|2
1436242|NCT00938041|4739256|P1|Overall Study|Adrenal Insufficiency|3
1436243|NCT00938041|4739256|P1|Overall Study|Death|12
1436244|NCT00938041|4739256|P1|Overall Study|Progressive Disease|5
1436245|NCT00938041|4739256|P1|Overall Study|Received Alternative Therapy|1
1436246|NCT00938041|4739256|P1|Overall Study|Lost to Follow-up|6
1436247|NCT00938015|4739265|P1|Overall Study|Reason not related to Etanercept|29
1436248|NCT00938015|4739265|P1|Overall Study|Non-responder|52
1436249|NCT00938015|4739265|P1|Overall Study|Adverse Event|32
1436250|NCT00938015|4739265|P1|Overall Study|Lost to Follow-up|32
1436251|NCT00938015|4739265|P1|Overall Study|Death|2
1436252|NCT00937950|4739281|P1|Overall Study|Others|18
1436253|NCT00937950|4739281|P1|Overall Study|Missing confirmed|4
1436254|NCT00937950|4739281|P1|Overall Study|Lost to Follow-up|144
1436255|NCT00937950|4739281|P1|Overall Study|Migrated/moved from study area|27
1436256|NCT00937950|4739281|P1|Overall Study|Withdrawal by Subject|23
1436257|NCT00937937|4739297|P1|Overall Study|Not specified|2
1436258|NCT00937937|4739297|P1|Overall Study|Death|1
1436259|NCT00937937|4739297|P1|Overall Study|Progression/relapse|61
1436260|NCT00937937|4739297|P1|Overall Study|Withdrawal by Subject|2
1436261|NCT00937937|4739297|P1|Overall Study|Adverse Event|6
1436262|NCT00937833|4739306|P2|Overall Study|Withdrawal by Subject|6
1436263|NCT00937833|4739307|P1|Overall Study|Withdrawal by Subject|4
1436264|NCT00937833|4739306|P2|Overall Study|Lost to Follow-up|8
1436265|NCT00937833|4739307|P1|Overall Study|Lost to Follow-up|10
1436266|NCT00937833|4739306|P2|Overall Study|Procedure delayed; enrollment closed|1
1436267|NCT00937833|4739307|P1|Overall Study|Procedure delayed; enrollment closed|0
1436268|NCT00937833|4739306|P2|Overall Study|Protocol Violation|2
1436269|NCT00937833|4739307|P1|Overall Study|Protocol Violation|1
1436270|NCT00937768|4739320|P2|Overall Study|No Further Funding|4
1436271|NCT00937768|4739321|P1|Overall Study|No Further Funding|4
1436272|NCT00937768|4739320|P2|Overall Study|Alternate Treatment|1
1436273|NCT00937768|4739321|P1|Overall Study|Alternate Treatment|0
1436274|NCT00937768|4739320|P2|Overall Study|Disease Progression|1
1436275|NCT00937768|4739321|P1|Overall Study|Disease Progression|1
1436276|NCT00937768|4739320|P2|Overall Study|Refused Further Treatment|2
1436277|NCT00937768|4739321|P1|Overall Study|Refused Further Treatment|3
1436278|NCT00937560|4739327|P1|Maintenance Treatment|According to protocol|1
1436279|NCT00937560|4739327|P1|Maintenance Treatment|Withdraw consent|5
1436280|NCT00937560|4739327|P1|Maintenance Treatment|Death|12
1436281|NCT00937560|4739327|P1|Initial Treatment|No end of study page|10
1436282|NCT00937560|4739327|P1|Initial Treatment|Lost to Follow-up|1
1436283|NCT00937560|4739327|P1|Initial Treatment|Adverse Event|1
1436284|NCT00937560|4739327|P1|Initial Treatment|Withdraw consent|3
1436285|NCT00937560|4739327|P1|Initial Treatment|Death|6
1436286|NCT00937547|4739338|P3|Overall Study|misdiagnosis|7
1436287|NCT00937547|4739339|P2|Overall Study|misdiagnosis|6
1436288|NCT00937547|4739340|P1|Overall Study|misdiagnosis|1
1436289|NCT00937521|4739377|P8|Booster Phase|Protocol Deviation|0
1436290|NCT00937521|4739378|P7|Booster Phase|Protocol Deviation|1
1436291|NCT00937521|4739379|P6|Booster Phase|Protocol Deviation|0
1436292|NCT00937521|4739380|P5|Booster Phase|Protocol Deviation|0
1436293|NCT00937521|4739381|P4|Booster Phase|Protocol Deviation|0
1436294|NCT00937521|4739382|P3|Booster Phase|Protocol Deviation|0
1436295|NCT00937521|4739383|P2|Booster Phase|Protocol Deviation|0
1436296|NCT00937521|4739384|P1|Booster Phase|Protocol Deviation|0
1436297|NCT00937521|4739377|P8|Booster Phase|Administrative Reason|0
1436298|NCT00937521|4739378|P7|Booster Phase|Administrative Reason|0
1436299|NCT00937521|4739379|P6|Booster Phase|Administrative Reason|1
1436300|NCT00937521|4739380|P5|Booster Phase|Administrative Reason|1
1436301|NCT00937521|4739381|P4|Booster Phase|Administrative Reason|0
1436302|NCT00937521|4739382|P3|Booster Phase|Administrative Reason|1
1436303|NCT00937521|4739383|P2|Booster Phase|Administrative Reason|0
1436304|NCT00937521|4739384|P1|Booster Phase|Administrative Reason|0
1436305|NCT00937521|4739377|P8|Booster Phase|Lost to Follow-up|0
1436306|NCT00937521|4739378|P7|Booster Phase|Lost to Follow-up|3
1436307|NCT00937521|4739379|P6|Booster Phase|Lost to Follow-up|4
1436308|NCT00937521|4739380|P5|Booster Phase|Lost to Follow-up|4
1436309|NCT00937521|4739381|P4|Booster Phase|Lost to Follow-up|2
1436310|NCT00937521|4739382|P3|Booster Phase|Lost to Follow-up|4
1436311|NCT00937521|4739383|P2|Booster Phase|Lost to Follow-up|2
1436312|NCT00937521|4739384|P1|Booster Phase|Lost to Follow-up|2
1436313|NCT00937521|4739377|P8|Booster Phase|Withdrawal by Subject|2
1436314|NCT00937521|4739378|P7|Booster Phase|Withdrawal by Subject|0
1436315|NCT00937521|4739379|P6|Booster Phase|Withdrawal by Subject|0
1436316|NCT00937521|4739380|P5|Booster Phase|Withdrawal by Subject|0
1436317|NCT00937521|4739381|P4|Booster Phase|Withdrawal by Subject|1
1436318|NCT00937521|4739382|P3|Booster Phase|Withdrawal by Subject|0
1436319|NCT00937521|4739383|P2|Booster Phase|Withdrawal by Subject|0
1436320|NCT00937521|4739384|P1|Booster Phase|Withdrawal by Subject|1
1436321|NCT00937521|4739377|P8|Booster Phase|Adverse Event|0
1436322|NCT00937521|4739378|P7|Booster Phase|Adverse Event|1
1436323|NCT00937521|4739379|P6|Booster Phase|Adverse Event|0
1436324|NCT00937521|4739380|P5|Booster Phase|Adverse Event|0
1436325|NCT00937521|4739381|P4|Booster Phase|Adverse Event|0
1436326|NCT00937521|4739382|P3|Booster Phase|Adverse Event|0
1436327|NCT00937521|4739383|P2|Booster Phase|Adverse Event|0
1436328|NCT00937521|4739384|P1|Booster Phase|Adverse Event|0
1436329|NCT00937521|4739377|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1436330|NCT00937521|4739378|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
1436331|NCT00937521|4739379|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1436332|NCT00937521|4739380|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1436333|NCT00937521|4739381|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1436334|NCT00937521|4739382|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1436335|NCT00937521|4739383|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1436336|NCT00937521|4739384|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
1436337|NCT00937521|4739377|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
1436338|NCT00937521|4739378|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
1436339|NCT00937521|4739379|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
1436340|NCT00937521|4739380|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
1436341|NCT00937521|4739381|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
1436342|NCT00937521|4739382|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
1436343|NCT00937521|4739383|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
1436344|NCT00937521|4739384|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
1436345|NCT00937521|4739377|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1436346|NCT00937521|4739378|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1436347|NCT00937521|4739379|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1436348|NCT00937521|4739380|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1436349|NCT00937521|4739381|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
1436350|NCT00937521|4739382|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
1436351|NCT00937521|4739383|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1436352|NCT00937521|4739384|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1436353|NCT00937521|4739377|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
1436354|NCT00937521|4739378|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
1436355|NCT00937521|4739379|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
1436356|NCT00937521|4739380|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
1436357|NCT00937521|4739381|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
1436358|NCT00937521|4739382|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
1436359|NCT00937521|4739383|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
1436360|NCT00937521|4739384|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
1436361|NCT00937521|4739377|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
1436362|NCT00937521|4739378|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
1436363|NCT00937521|4739379|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
1436364|NCT00937521|4739380|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
1436365|NCT00937521|4739381|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
1436366|NCT00937521|4739382|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
1436367|NCT00937521|4739383|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
1436368|NCT00937521|4739384|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
1436369|NCT00937495|4739490|P1|Overall Study|Protocol Violation|2
1436370|NCT00937391|4739498|P1|Stage 2|Withdrawal by Subject|1
1436371|NCT00937326|4739554|P5|Overall Study|Chest X-ray showed a suspicious shadow|0
1436372|NCT00937326|4739555|P4|Overall Study|Chest X-ray showed a suspicious shadow|0
1436373|NCT00937326|4739556|P3|Overall Study|Chest X-ray showed a suspicious shadow|1
1436374|NCT00937326|4739557|P2|Overall Study|Chest X-ray showed a suspicious shadow|0
1436375|NCT00937326|4739558|P1|Overall Study|Chest X-ray showed a suspicious shadow|0
1436376|NCT00937326|4739554|P5|Overall Study|Withdrawal by Subject|3
1436377|NCT00937326|4739555|P4|Overall Study|Withdrawal by Subject|4
1436378|NCT00937326|4739556|P3|Overall Study|Withdrawal by Subject|1
1436379|NCT00937326|4739557|P2|Overall Study|Withdrawal by Subject|4
1436380|NCT00937326|4739558|P1|Overall Study|Withdrawal by Subject|3
1436381|NCT00937326|4739554|P5|Overall Study|Death|0
1436382|NCT00937326|4739555|P4|Overall Study|Death|0
1436383|NCT00937326|4739556|P3|Overall Study|Death|1
1436384|NCT00937326|4739557|P2|Overall Study|Death|0
1436385|NCT00937326|4739558|P1|Overall Study|Death|0
1436386|NCT00937326|4739554|P5|Overall Study|Adverse Event|2
1436387|NCT00937326|4739555|P4|Overall Study|Adverse Event|1
1436388|NCT00937326|4739556|P3|Overall Study|Adverse Event|1
1436389|NCT00937326|4739557|P2|Overall Study|Adverse Event|3
1436390|NCT00937326|4739558|P1|Overall Study|Adverse Event|0
1436391|NCT00937157|4739807|P1|Overall Study|Lost to Follow-up|3
1436392|NCT00937157|4739807|P1|Overall Study|Pregnancy|1
1436393|NCT00937040|4739838|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
1436394|NCT00937040|4739839|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
1436395|NCT00937040|4739838|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
1436396|NCT00937040|4739839|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
1436397|NCT00937040|4739838|P2|Overall Study|Withdrawal by Subject|7
1436398|NCT00937040|4739839|P1|Overall Study|Withdrawal by Subject|13
1436399|NCT00937040|4739838|P2|Overall Study|Protocol Violation|0
1436400|NCT00937040|4739839|P1|Overall Study|Protocol Violation|3
1436401|NCT00937040|4739838|P2|Overall Study|Lost to Follow-up|12
1436402|NCT00937040|4739839|P1|Overall Study|Lost to Follow-up|12
1436403|NCT00937040|4739838|P2|Overall Study|Adverse Event|8
1436404|NCT00937040|4739839|P1|Overall Study|Adverse Event|5
1436405|NCT00936975|4739881|P1|Overall Study|Post-Tx scan uninterpretable|2
1436406|NCT00936975|4739881|P1|Overall Study|Disease progression|3
1436407|NCT00936975|4739881|P1|Overall Study|Withdrawal by Subject|1
1436408|NCT00936910|4739890|P1|Overall Study|Lack of Efficacy|3
1436409|NCT00936897|4739899|P2|Overall Study|Death|1
1436410|NCT00936897|4739900|P1|Overall Study|Death|0
1436411|NCT00936897|4739899|P2|Overall Study|Noncompliance|2
1436412|NCT00936897|4739900|P1|Overall Study|Noncompliance|0
1436413|NCT00936897|4739899|P2|Overall Study|Ineligibility Determined|3
1436414|NCT00936897|4739900|P1|Overall Study|Ineligibility Determined|0
1436415|NCT00936897|4739899|P2|Overall Study|Protocol Violation|1
1436416|NCT00936897|4739900|P1|Overall Study|Protocol Violation|1
1436417|NCT00936897|4739899|P2|Overall Study|Administrative Decision|2
1436418|NCT00936897|4739900|P1|Overall Study|Administrative Decision|1
1436419|NCT00936897|4739899|P2|Overall Study|Lost to Follow-up|10
1436420|NCT00936897|4739900|P1|Overall Study|Lost to Follow-up|1
1436421|NCT00936897|4739899|P2|Overall Study|Other|9
1436422|NCT00936897|4739900|P1|Overall Study|Other|3
1436423|NCT00936897|4739899|P2|Overall Study|Adverse Event|13
1436424|NCT00936897|4739900|P1|Overall Study|Adverse Event|4
1436425|NCT00936897|4739899|P2|Overall Study|Withdrawal by Subject|19
1436426|NCT00936897|4739900|P1|Overall Study|Withdrawal by Subject|9
1436427|NCT00936715|4739917|P1|Overall Study|Safety or Tolerability Reasons|4
1436428|NCT00936715|4739917|P1|Overall Study|Protocol Violation|1
1436429|NCT00936715|4739917|P1|Overall Study|Investigators Discretion|1
1436430|NCT00936702|4739921|P1|Overall Study|Other|1
1436431|NCT00936702|4739921|P1|Overall Study|Alternative Treatment|1
1436432|NCT00936702|4739921|P1|Overall Study|Withdrawal by Subject|2
1436433|NCT00936702|4739921|P1|Overall Study|Adverse Event|8
1436434|NCT00936702|4739921|P1|Overall Study|Disease progression|34
1436435|NCT00936598|4739954|P2|Overall Study|Ineligible after consent|0
1436436|NCT00936598|4739955|P1|Overall Study|Ineligible after consent|1
1436437|NCT00936598|4739954|P2|Overall Study|Withdrawal by Subject|0
1436438|NCT00936598|4739955|P1|Overall Study|Withdrawal by Subject|1
1436439|NCT00936221|4740044|P2|Overall Study|Withdrawal by Subject|1
1436440|NCT00936221|4740045|P1|Overall Study|Withdrawal by Subject|1
1436441|NCT00936208|4740059|P2|Overall Study|Protocol Violation|22
1436442|NCT00936208|4740060|P1|Overall Study|Protocol Violation|37
1436443|NCT00936117|4740078|P1|Overall Study|Unable to continue oral medication|3
1436444|NCT00936117|4740078|P1|Overall Study|Adverse Event|7
1436445|NCT00936065|4740086|P3|Overall Study|Withdrawal by Subject|4
1436446|NCT00936065|4740087|P2|Overall Study|Withdrawal by Subject|2
1436447|NCT00936065|4740088|P1|Overall Study|Withdrawal by Subject|0
1436448|NCT00936065|4740086|P3|Overall Study|Protocol Violation|1
1436449|NCT00936065|4740087|P2|Overall Study|Protocol Violation|2
1436450|NCT00936065|4740088|P1|Overall Study|Protocol Violation|1
1436451|NCT00936065|4740086|P3|Overall Study|Lost to Follow-up|0
1436452|NCT00936065|4740087|P2|Overall Study|Lost to Follow-up|0
1436453|NCT00936065|4740088|P1|Overall Study|Lost to Follow-up|1
1436454|NCT00936065|4740086|P3|Overall Study|Lack of Efficacy|1
1436455|NCT00936065|4740087|P2|Overall Study|Lack of Efficacy|0
1436456|NCT00936065|4740088|P1|Overall Study|Lack of Efficacy|1
1436457|NCT00936065|4740086|P3|Overall Study|Adverse Event|1
1436458|NCT00936065|4740087|P2|Overall Study|Adverse Event|0
1436459|NCT00936065|4740088|P1|Overall Study|Adverse Event|1
1436460|NCT00935883|4740194|P2|Treatment Period|Withdrawal by Subject|2
1436461|NCT00935883|4740195|P1|Treatment Period|Withdrawal by Subject|0
1436462|NCT00935883|4740194|P2|Treatment Period|Physician Decision|0
1436463|NCT00935883|4740195|P1|Treatment Period|Physician Decision|1
1436464|NCT00935818|4740222|P2|Overall Study|Physician Decision|1
1436465|NCT00935818|4740223|P1|Overall Study|Physician Decision|0
1436466|NCT00935818|4740222|P2|Overall Study|Adverse Event|7
1436467|NCT00935818|4740223|P1|Overall Study|Adverse Event|6
1436468|NCT00935818|4740222|P2|Overall Study|Lost to Follow-up|42
1436469|NCT00935818|4740223|P1|Overall Study|Lost to Follow-up|40
1436470|NCT00935818|4740222|P2|Overall Study|Withdrawal by Subject|50
1436471|NCT00935818|4740223|P1|Overall Study|Withdrawal by Subject|45
1436472|NCT00935701|4740274|P1|Overall Study|Failure to Transition to Acupuncture|1
1436473|NCT00935584|4740291|P2|Overall Study|Provider dropped out of study|4
1436474|NCT00935584|4740292|P1|Overall Study|Provider dropped out of study|14
1436475|NCT00935584|4740291|P2|Overall Study|Patient changed provider|0
1436476|NCT00935584|4740292|P1|Overall Study|Patient changed provider|3
1436477|NCT00935584|4740291|P2|Overall Study|Relocated|0
1436478|NCT00935584|4740292|P1|Overall Study|Relocated|3
1436479|NCT00935584|4740291|P2|Overall Study|No show|0
1436480|NCT00935584|4740292|P1|Overall Study|No show|9
1436481|NCT00935584|4740291|P2|Overall Study|Lost to Follow-up|0
1436482|NCT00935584|4740292|P1|Overall Study|Lost to Follow-up|8
1436483|NCT00935584|4740291|P2|Overall Study|Death|0
1436484|NCT00935584|4740292|P1|Overall Study|Death|3
1436485|NCT00935584|4740291|P2|Overall Study|Withdrawal by Subject|0
1436486|NCT00935584|4740292|P1|Overall Study|Withdrawal by Subject|9
1436487|NCT00935532|4740304|P2|Overall Study|Loss Glucose Control|0
1436488|NCT00935532|4740305|P1|Overall Study|Loss Glucose Control|4
1436489|NCT00935532|4740304|P2|Overall Study|Sponsor Decision|1
1436490|NCT00935532|4740305|P1|Overall Study|Sponsor Decision|0
1436491|NCT00935532|4740304|P2|Overall Study|Subject Decision|1
1436492|NCT00935532|4740305|P1|Overall Study|Subject Decision|2
1436493|NCT00935532|4740304|P2|Overall Study|Protocol Violation|1
1436494|NCT00935532|4740305|P1|Overall Study|Protocol Violation|2
1436495|NCT00935532|4740304|P2|Overall Study|Physician Decision|2
1436496|NCT00935532|4740305|P1|Overall Study|Physician Decision|1
1436497|NCT00935532|4740304|P2|Overall Study|Lost to Follow-up|0
1436498|NCT00935532|4740305|P1|Overall Study|Lost to Follow-up|1
1436499|NCT00935532|4740304|P2|Overall Study|Death|0
1436500|NCT00935532|4740305|P1|Overall Study|Death|1
1436501|NCT00935532|4740304|P2|Overall Study|Adverse Event|6
1436502|NCT00935532|4740305|P1|Overall Study|Adverse Event|11
1436503|NCT00935493|4740334|P3|Overall Study|Treatment Discontinued|0
1436504|NCT00935493|4740335|P2|Overall Study|Treatment Discontinued|1
1436505|NCT00935493|4740336|P1|Overall Study|Treatment Discontinued|0
1436506|NCT00935493|4740334|P3|Overall Study|Lost to Follow-up|1
1436507|NCT00935493|4740335|P2|Overall Study|Lost to Follow-up|1
1436508|NCT00935493|4740336|P1|Overall Study|Lost to Follow-up|1
1436509|NCT00935272|4740374|P2|Overall Study|Protocol Violation|1
1436510|NCT00935272|4740375|P1|Overall Study|Protocol Violation|0
1436511|NCT00935272|4740374|P2|Overall Study|Physician Decision|0
1436512|NCT00935272|4740375|P1|Overall Study|Physician Decision|1
1436513|NCT00935272|4740374|P2|Overall Study|Withdrawal by Subject|2
1436514|NCT00935272|4740375|P1|Overall Study|Withdrawal by Subject|8
1436515|NCT00935272|4740374|P2|Overall Study|Lost to Follow-up|3
1436516|NCT00935272|4740375|P1|Overall Study|Lost to Follow-up|10
1436517|NCT00935259|4740384|P2|Period 1|Administrative (scheduling conflict)|1
1436518|NCT00935259|4740385|P1|Period 1|Administrative (scheduling conflict)|1
1436519|NCT00935220|4740399|P1|Overall Study|Other reason (not specified)|1
1436520|NCT00935220|4740399|P1|Overall Study|Adverse Event|1
1436521|NCT00934947|4740430|P2|Overall Study|Adverse Event|2
1436522|NCT00934947|4740431|P1|Overall Study|Adverse Event|0
1436523|NCT00934856|4740460|P6|Extension Part|Non-compliance with drug|1
1436524|NCT00934856|4740461|P5|Extension Part|Non-compliance with drug|0
1436525|NCT00934856|4740462|P4|Extension Part|Non-compliance with drug|0
1436526|NCT00934856|4740463|P3|Extension Part|Non-compliance with drug|0
1436527|NCT00934856|4740464|P2|Extension Part|Non-compliance with drug|0
1436528|NCT00934856|4740465|P1|Extension Part|Non-compliance with drug|0
1436529|NCT00934856|4740460|P6|Extension Part|Progressive disease|0
1436530|NCT00934856|4740461|P5|Extension Part|Progressive disease|0
1436531|NCT00934856|4740462|P4|Extension Part|Progressive disease|1
1436532|NCT00934856|4740463|P3|Extension Part|Progressive disease|0
1436533|NCT00934856|4740464|P2|Extension Part|Progressive disease|0
1436534|NCT00934856|4740465|P1|Extension Part|Progressive disease|0
1436535|NCT00934856|4740460|P6|Extension Part|Adverse Event|4
1436536|NCT00934856|4740461|P5|Extension Part|Adverse Event|4
1436537|NCT00934856|4740462|P4|Extension Part|Adverse Event|1
1436538|NCT00934856|4740463|P3|Extension Part|Adverse Event|0
1436539|NCT00934856|4740464|P2|Extension Part|Adverse Event|0
1436540|NCT00934856|4740465|P1|Extension Part|Adverse Event|0
1436541|NCT00934856|4740460|P6|Feasibility Part|Withdrawal by Subject|1
1436542|NCT00934856|4740461|P5|Feasibility Part|Withdrawal by Subject|0
1436543|NCT00934856|4740462|P4|Feasibility Part|Withdrawal by Subject|1
1436544|NCT00934856|4740463|P3|Feasibility Part|Withdrawal by Subject|0
1436545|NCT00934856|4740464|P2|Feasibility Part|Withdrawal by Subject|0
1436546|NCT00934856|4740465|P1|Feasibility Part|Withdrawal by Subject|0
1436547|NCT00934856|4740460|P6|Feasibility Part|Adverse Event|2
1436548|NCT00934856|4740461|P5|Feasibility Part|Adverse Event|0
1436549|NCT00934856|4740462|P4|Feasibility Part|Adverse Event|1
1436550|NCT00934856|4740463|P3|Feasibility Part|Adverse Event|0
1436551|NCT00934856|4740464|P2|Feasibility Part|Adverse Event|1
1436552|NCT00934856|4740465|P1|Feasibility Part|Adverse Event|1
1436553|NCT00934856|4740460|P6|Feasibility Part|Physician Decision|0
1436554|NCT00934856|4740461|P5|Feasibility Part|Physician Decision|0
1436555|NCT00934856|4740462|P4|Feasibility Part|Physician Decision|0
1436556|NCT00934856|4740463|P3|Feasibility Part|Physician Decision|1
1436557|NCT00934856|4740464|P2|Feasibility Part|Physician Decision|0
1436558|NCT00934856|4740465|P1|Feasibility Part|Physician Decision|0
1436559|NCT00934856|4740460|P6|Feasibility Part|Progressive disease|0
1436560|NCT00934856|4740461|P5|Feasibility Part|Progressive disease|0
1436561|NCT00934856|4740462|P4|Feasibility Part|Progressive disease|3
1436562|NCT00934856|4740463|P3|Feasibility Part|Progressive disease|2
1436563|NCT00934856|4740464|P2|Feasibility Part|Progressive disease|4
1436564|NCT00934856|4740465|P1|Feasibility Part|Progressive disease|4
1436565|NCT00934843|4740563|P2|Overall Study|Protocol Violation|1
1436566|NCT00934843|4740564|P1|Overall Study|Protocol Violation|0
1436567|NCT00934791|4740580|P2|Overall Study|Withdrawal by Subject|0
1436568|NCT00934791|4740581|P1|Overall Study|Withdrawal by Subject|1
1436569|NCT00934661|4740589|P2|Overall Study|Failure of Combined/Spinal Epidural|0
1436570|NCT00934661|4740590|P1|Overall Study|Failure of Combined/Spinal Epidural|1
1436571|NCT00934648|4740610|P1|Overall Study|Withdrawal by Subject|1
1436572|NCT00934648|4740610|P1|Overall Study|Failure to return|8
1436573|NCT00934622|4740654|P1|Overall Study|2nd Intraoperative exclusion criteria|1
1436574|NCT00934622|4740654|P1|Overall Study|Lost to Follow-up|7
1436575|NCT00934544|4740692|P2|Overall Study|Entered Extension phase INC424|18
1436576|NCT00934544|4740693|P1|Overall Study|Entered Extension phase INC424|29
1436577|NCT00934544|4740692|P2|Overall Study|Other Reasons|7
1436578|NCT00934544|4740693|P1|Overall Study|Other Reasons|7
1436579|NCT00934544|4740692|P2|Overall Study|Non-compliance with study procedures|1
1436580|NCT00934544|4740693|P1|Overall Study|Non-compliance with study procedures|0
1436581|NCT00934544|4740692|P2|Overall Study|Non-compliance with study Medication|0
1436582|NCT00934544|4740693|P1|Overall Study|Non-compliance with study Medication|2
1436583|NCT00934544|4740692|P2|Overall Study|Disease Progression|3
1436584|NCT00934544|4740693|P1|Overall Study|Disease Progression|1
1436585|NCT00934544|4740692|P2|Overall Study|Protocol Violation|0
1436586|NCT00934544|4740693|P1|Overall Study|Protocol Violation|2
1436587|NCT00934544|4740692|P2|Overall Study|Withdrawal by Subject|9
1436588|NCT00934544|4740693|P1|Overall Study|Withdrawal by Subject|2
1436589|NCT00934544|4740692|P2|Overall Study|Adverse Event|4
1436590|NCT00934544|4740693|P1|Overall Study|Adverse Event|12
1436591|NCT00934440|4740707|P1|Overall Study|Lost to Follow-up|1
1436592|NCT00934362|4740723|P2|Overall Study|Adverse Event|0
1436593|NCT00934362|4740724|P1|Overall Study|Adverse Event|1
1436594|NCT00934128|4740774|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
1436595|NCT00934128|4740775|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
1436596|NCT00934128|4740774|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
1436597|NCT00934128|4740775|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
1436598|NCT00934128|4740774|P2|Washout Period (1 Hour)|Too tired|0
1436599|NCT00934128|4740775|P1|Washout Period (1 Hour)|Too tired|1
1436600|NCT00934128|4740774|P2|Washout Period (1 Hour)|Pain|0
1436601|NCT00934128|4740775|P1|Washout Period (1 Hour)|Pain|1
1436602|NCT00934128|4740774|P2|Washout Period (1 Hour)|Patient preference|3
1436603|NCT00934128|4740775|P1|Washout Period (1 Hour)|Patient preference|1
1436604|NCT00934128|4740774|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
1436605|NCT00934128|4740775|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
1436606|NCT00934128|4740774|P2|First Intervention (2 Hours)|Adverse Event|1
1436607|NCT00934128|4740775|P1|First Intervention (2 Hours)|Adverse Event|4
1436608|NCT00934128|4740774|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
1436609|NCT00934128|4740775|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
1436610|NCT00934102|4740783|P3|Period 1, One Night of Wear|Personal Reasons|0
1436611|NCT00934102|4740784|P2|Period 1, One Night of Wear|Personal Reasons|0
1436612|NCT00934102|4740785|P1|Period 1, One Night of Wear|Personal Reasons|1
1436613|NCT00934050|4740799|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
1436614|NCT00934050|4740800|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
1436615|NCT00934050|4740801|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
1436616|NCT00934050|4740802|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
1436617|NCT00934050|4740803|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
1436618|NCT00934050|4740804|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
1436619|NCT00934050|4740799|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
1436620|NCT00934050|4740800|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
1436621|NCT00934050|4740801|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
1436622|NCT00934050|4740802|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
1436623|NCT00934050|4740803|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
1436624|NCT00934050|4740804|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
1436625|NCT00934050|4740799|P6|Enrolled After 15 Dec 2009|Death|1
1436626|NCT00934050|4740800|P5|Enrolled After 15 Dec 2009|Death|0
1436627|NCT00934050|4740801|P4|Enrolled After 15 Dec 2009|Death|0
1436628|NCT00934050|4740802|P3|Enrolled After 15 Dec 2009|Death|0
1436629|NCT00934050|4740803|P2|Enrolled After 15 Dec 2009|Death|0
1436630|NCT00934050|4740804|P1|Enrolled After 15 Dec 2009|Death|0
1436631|NCT00934050|4740799|P6|Enrolled After 15 Dec 2009|Adverse Event|0
1436632|NCT00934050|4740800|P5|Enrolled After 15 Dec 2009|Adverse Event|3
1436633|NCT00934050|4740801|P4|Enrolled After 15 Dec 2009|Adverse Event|0
1436634|NCT00934050|4740802|P3|Enrolled After 15 Dec 2009|Adverse Event|0
1436635|NCT00934050|4740803|P2|Enrolled After 15 Dec 2009|Adverse Event|0
1436636|NCT00934050|4740804|P1|Enrolled After 15 Dec 2009|Adverse Event|0
1436637|NCT00934050|4740799|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
1436638|NCT00934050|4740800|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
1436639|NCT00934050|4740801|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
1436640|NCT00934050|4740802|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
1436641|NCT00934050|4740803|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
1436642|NCT00934050|4740804|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
1436643|NCT00934050|4740799|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
1436644|NCT00934050|4740800|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
1436645|NCT00934050|4740801|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
1436646|NCT00934050|4740802|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
1436647|NCT00934050|4740803|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
1436648|NCT00934050|4740804|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
1436649|NCT00934050|4740799|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
1436650|NCT00934050|4740800|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
1436651|NCT00934050|4740801|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
1436652|NCT00934050|4740802|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
1436653|NCT00934050|4740803|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
1436654|NCT00934050|4740804|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
1436655|NCT00933933|4740819|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
1436656|NCT00933933|4740820|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
1436657|NCT00933933|4740821|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
1436658|NCT00933933|4740819|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
1436659|NCT00933933|4740820|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
1436660|NCT00933933|4740821|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
1436661|NCT00933686|4740839|P2|Overall Study|Failure to show up at endpoint visits|2
1436662|NCT00933686|4740840|P1|Overall Study|Failure to show up at endpoint visits|0
1436663|NCT00933686|4740839|P2|Overall Study|Physician Decision|0
1436664|NCT00933686|4740840|P1|Overall Study|Physician Decision|1
1436665|NCT00933686|4740839|P2|Overall Study|Adverse Event|1
1436666|NCT00933686|4740840|P1|Overall Study|Adverse Event|1
1436667|NCT00933686|4740839|P2|Overall Study|Withdrawal by Subject|5
1436668|NCT00933686|4740840|P1|Overall Study|Withdrawal by Subject|6
1436669|NCT00933686|4740839|P2|Overall Study|Lost to Follow-up|2
1436670|NCT00933686|4740840|P1|Overall Study|Lost to Follow-up|2
1436671|NCT00933686|4740839|P2|Overall Study|Protocol Violation|1
1436672|NCT00933686|4740840|P1|Overall Study|Protocol Violation|0
1436673|NCT00933608|4740860|P2|Overall Study|Physician Decision|0
1436674|NCT00933608|4740861|P1|Overall Study|Physician Decision|1
1436675|NCT00933608|4740860|P2|Overall Study|Adverse Event|2
1436676|NCT00933608|4740861|P1|Overall Study|Adverse Event|4
1436677|NCT00933543|4740869|P2|Overall Study|Other|1
1436678|NCT00933543|4740870|P1|Overall Study|Other|1
1436679|NCT00933543|4740869|P2|Overall Study|Lack of Efficacy|3
1436680|NCT00933543|4740870|P1|Overall Study|Lack of Efficacy|0
1436681|NCT00933543|4740869|P2|Overall Study|Withdrawal by Subject|1
1436682|NCT00933543|4740870|P1|Overall Study|Withdrawal by Subject|0
1436683|NCT00933543|4740869|P2|Overall Study|Lost to Follow-up|1
1436684|NCT00933543|4740870|P1|Overall Study|Lost to Follow-up|0
1436685|NCT00933543|4740869|P2|Overall Study|Adverse Event|1
1436686|NCT00933543|4740870|P1|Overall Study|Adverse Event|2
1436687|NCT00933335|4740939|P2|Overall Study|Co-morbid Illness|0
1436688|NCT00933335|4740940|P1|Overall Study|Co-morbid Illness|1
1436689|NCT00933335|4740939|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
1436690|NCT00933335|4740940|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
1436691|NCT00933335|4740939|P2|Overall Study|Progressive Disease|11
1436692|NCT00933335|4740940|P1|Overall Study|Progressive Disease|0
1436693|NCT00933335|4740939|P2|Overall Study|Withdrawal by Subject|1
1436694|NCT00933335|4740940|P1|Overall Study|Withdrawal by Subject|0
1436695|NCT00933335|4740939|P2|Overall Study|Lost to Follow-up|3
1436696|NCT00933335|4740940|P1|Overall Study|Lost to Follow-up|1
1436697|NCT00933270|4741010|P1|Overall Study|Moved or would not return|10
1436698|NCT00933270|4741010|P1|Overall Study|Death|24
1436699|NCT00933270|4741010|P1|Overall Study|Missed Visit|2
1436700|NCT00933270|4741010|P1|Overall Study|Adverse Event|1
1436701|NCT00933270|4741010|P1|Overall Study|Lost to Follow-up|14
1436702|NCT00933270|4741010|P1|Overall Study|Insufficient Follow-up|10
1436703|NCT00933270|4741010|P1|Overall Study|Withdrawal by Subject|26
1436704|NCT00933244|4741104|P3|Overall Study|Withdrawal by Subject|3
1436705|NCT00933244|4741105|P2|Overall Study|Withdrawal by Subject|1
1436706|NCT00933244|4741106|P1|Overall Study|Withdrawal by Subject|5
1436707|NCT00933166|4741123|P1|Overall Study|Withdrawal by Subject|1
1436708|NCT00933166|4741123|P1|Overall Study|Unavailable|4
1436709|NCT00933166|4741123|P1|Overall Study|Lack of Efficacy|9
1436710|NCT00933166|4741123|P1|Overall Study|Lost to Follow-up|4
1436711|NCT00932893|4741129|P2|Overall Study|Other|144
1436712|NCT00932893|4741130|P1|Overall Study|Other|5
1436713|NCT00932893|4741129|P2|Overall Study|Withdrawal by Subject|2
1436714|NCT00932893|4741130|P1|Overall Study|Withdrawal by Subject|5
1436715|NCT00932893|4741129|P2|Overall Study|Lost to Follow-up|0
1436716|NCT00932893|4741130|P1|Overall Study|Lost to Follow-up|8
1436717|NCT00932893|4741129|P2|Overall Study|Death|24
1436718|NCT00932893|4741130|P1|Overall Study|Death|115
1436719|NCT00932646|4741172|P4|Overall Study|Withdrawal by Subject|0
1436720|NCT00932646|4741173|P3|Overall Study|Withdrawal by Subject|3
1436721|NCT00932646|4741174|P2|Overall Study|Withdrawal by Subject|1
1436722|NCT00932646|4741175|P1|Overall Study|Withdrawal by Subject|1
1436723|NCT00932646|4741172|P4|Overall Study|Lost to Follow-up|0
1436724|NCT00932646|4741173|P3|Overall Study|Lost to Follow-up|0
1436725|NCT00932646|4741174|P2|Overall Study|Lost to Follow-up|1
1436726|NCT00932646|4741175|P1|Overall Study|Lost to Follow-up|2
1436727|NCT00932646|4741172|P4|Overall Study|Adverse Event|1
1436728|NCT00932646|4741173|P3|Overall Study|Adverse Event|1
1436729|NCT00932646|4741174|P2|Overall Study|Adverse Event|1
1436730|NCT00932646|4741175|P1|Overall Study|Adverse Event|2
1436731|NCT00932451|4741262|P1|Overall Study|Other reasons|5
1436732|NCT00932451|4741262|P1|Overall Study|Death|726
1436733|NCT00932451|4741262|P1|Overall Study|Lost to Follow-up|22
1436734|NCT00932451|4741262|P1|Overall Study|Withdrawal by Subject|69
1436735|NCT00932425|4741286|P2|Overall Study|Withdrawal by Subject|1
1436736|NCT00932425|4741287|P1|Overall Study|Withdrawal by Subject|0
1436737|NCT00932425|4741286|P2|Overall Study|Lost to Follow-up|1
1436738|NCT00932425|4741287|P1|Overall Study|Lost to Follow-up|0
1436739|NCT00932373|4741320|P11|Overall Study|Lack of Efficacy|0
1436740|NCT00932373|4741321|P10|Overall Study|Lack of Efficacy|1
1436741|NCT00932373|4741322|P9|Overall Study|Lack of Efficacy|0
1436742|NCT00932373|4741323|P8|Overall Study|Lack of Efficacy|0
1436743|NCT00932373|4741324|P7|Overall Study|Lack of Efficacy|0
1436744|NCT00932373|4741325|P6|Overall Study|Lack of Efficacy|0
1436745|NCT00932373|4741326|P5|Overall Study|Lack of Efficacy|0
1436746|NCT00932373|4741327|P4|Overall Study|Lack of Efficacy|0
1436747|NCT00932373|4741328|P3|Overall Study|Lack of Efficacy|0
1436748|NCT00932373|4741329|P2|Overall Study|Lack of Efficacy|0
1436749|NCT00932373|4741330|P1|Overall Study|Lack of Efficacy|0
1436750|NCT00932373|4741320|P11|Overall Study|Clinical progression|0
1436751|NCT00932373|4741321|P10|Overall Study|Clinical progression|0
1436752|NCT00932373|4741322|P9|Overall Study|Clinical progression|0
1436753|NCT00932373|4741323|P8|Overall Study|Clinical progression|0
1436754|NCT00932373|4741324|P7|Overall Study|Clinical progression|1
1436755|NCT00932373|4741325|P6|Overall Study|Clinical progression|0
1436756|NCT00932373|4741326|P5|Overall Study|Clinical progression|0
1436757|NCT00932373|4741327|P4|Overall Study|Clinical progression|0
1436758|NCT00932373|4741328|P3|Overall Study|Clinical progression|0
1436759|NCT00932373|4741329|P2|Overall Study|Clinical progression|0
1436760|NCT00932373|4741330|P1|Overall Study|Clinical progression|0
1436761|NCT00932373|4741320|P11|Overall Study|Withdrawal by Subject|0
1436762|NCT00932373|4741321|P10|Overall Study|Withdrawal by Subject|0
1436763|NCT00932373|4741322|P9|Overall Study|Withdrawal by Subject|1
1436764|NCT00932373|4741323|P8|Overall Study|Withdrawal by Subject|0
1436765|NCT00932373|4741324|P7|Overall Study|Withdrawal by Subject|0
1436766|NCT00932373|4741325|P6|Overall Study|Withdrawal by Subject|0
1436767|NCT00932373|4741326|P5|Overall Study|Withdrawal by Subject|0
1436768|NCT00932373|4741327|P4|Overall Study|Withdrawal by Subject|0
1436769|NCT00932373|4741328|P3|Overall Study|Withdrawal by Subject|0
1436770|NCT00932373|4741329|P2|Overall Study|Withdrawal by Subject|0
1436771|NCT00932373|4741330|P1|Overall Study|Withdrawal by Subject|0
1436772|NCT00932373|4741320|P11|Overall Study|Dose limiting toxicity|0
1436773|NCT00932373|4741321|P10|Overall Study|Dose limiting toxicity|0
1436774|NCT00932373|4741322|P9|Overall Study|Dose limiting toxicity|0
1436775|NCT00932373|4741323|P8|Overall Study|Dose limiting toxicity|0
1436776|NCT00932373|4741324|P7|Overall Study|Dose limiting toxicity|0
1436777|NCT00932373|4741325|P6|Overall Study|Dose limiting toxicity|1
1436778|NCT00932373|4741326|P5|Overall Study|Dose limiting toxicity|0
1436779|NCT00932373|4741327|P4|Overall Study|Dose limiting toxicity|0
1436780|NCT00932373|4741328|P3|Overall Study|Dose limiting toxicity|0
1436781|NCT00932373|4741329|P2|Overall Study|Dose limiting toxicity|0
1436782|NCT00932373|4741330|P1|Overall Study|Dose limiting toxicity|0
1436783|NCT00932373|4741320|P11|Overall Study|Physician Decision|0
1436784|NCT00932373|4741321|P10|Overall Study|Physician Decision|1
1436785|NCT00932373|4741322|P9|Overall Study|Physician Decision|0
1436786|NCT00932373|4741323|P8|Overall Study|Physician Decision|0
1436787|NCT00932373|4741324|P7|Overall Study|Physician Decision|0
1436788|NCT00932373|4741325|P6|Overall Study|Physician Decision|0
1436789|NCT00932373|4741326|P5|Overall Study|Physician Decision|2
1436790|NCT00932373|4741327|P4|Overall Study|Physician Decision|0
1436791|NCT00932373|4741328|P3|Overall Study|Physician Decision|1
1436792|NCT00932373|4741329|P2|Overall Study|Physician Decision|0
1436793|NCT00932373|4741330|P1|Overall Study|Physician Decision|0
1436794|NCT00932373|4741320|P11|Overall Study|Adverse Event|1
1436795|NCT00932373|4741321|P10|Overall Study|Adverse Event|2
1436796|NCT00932373|4741322|P9|Overall Study|Adverse Event|0
1436797|NCT00932373|4741323|P8|Overall Study|Adverse Event|1
1436798|NCT00932373|4741324|P7|Overall Study|Adverse Event|0
1436799|NCT00932373|4741325|P6|Overall Study|Adverse Event|1
1436800|NCT00932373|4741326|P5|Overall Study|Adverse Event|2
1436801|NCT00932373|4741327|P4|Overall Study|Adverse Event|0
1436802|NCT00932373|4741328|P3|Overall Study|Adverse Event|0
1436803|NCT00932373|4741329|P2|Overall Study|Adverse Event|0
1436804|NCT00932373|4741330|P1|Overall Study|Adverse Event|0
1436805|NCT00932373|4741320|P11|Overall Study|Progressive disease|2
1436806|NCT00932373|4741321|P10|Overall Study|Progressive disease|9
1436807|NCT00932373|4741322|P9|Overall Study|Progressive disease|1
1436808|NCT00932373|4741323|P8|Overall Study|Progressive disease|2
1436809|NCT00932373|4741324|P7|Overall Study|Progressive disease|0
1436810|NCT00932373|4741325|P6|Overall Study|Progressive disease|1
1436811|NCT00932373|4741326|P5|Overall Study|Progressive disease|10
1436812|NCT00932373|4741327|P4|Overall Study|Progressive disease|0
1436813|NCT00932373|4741328|P3|Overall Study|Progressive disease|0
1436814|NCT00932373|4741329|P2|Overall Study|Progressive disease|1
1436815|NCT00932373|4741330|P1|Overall Study|Progressive disease|3
1436816|NCT00932165|4741458|P1|Overall Study|Lost to Follow-up|1
1436817|NCT00932126|4741482|P8|Overall Study|Other|2
1436818|NCT00932126|4741483|P7|Overall Study|Other|1
1436819|NCT00932126|4741484|P6|Overall Study|Other|0
1436820|NCT00932126|4741485|P5|Overall Study|Other|1
1436821|NCT00932126|4741486|P4|Overall Study|Other|0
1436822|NCT00932126|4741487|P3|Overall Study|Other|0
1436823|NCT00932126|4741488|P2|Overall Study|Other|0
1436824|NCT00932126|4741489|P1|Overall Study|Other|0
1436825|NCT00932126|4741482|P8|Overall Study|Objective progression or relapse|5
1436826|NCT00932126|4741483|P7|Overall Study|Objective progression or relapse|3
1436827|NCT00932126|4741484|P6|Overall Study|Objective progression or relapse|3
1436828|NCT00932126|4741485|P5|Overall Study|Objective progression or relapse|3
1436829|NCT00932126|4741486|P4|Overall Study|Objective progression or relapse|3
1436830|NCT00932126|4741487|P3|Overall Study|Objective progression or relapse|2
1436831|NCT00932126|4741488|P2|Overall Study|Objective progression or relapse|3
1436832|NCT00932126|4741489|P1|Overall Study|Objective progression or relapse|3
1436833|NCT00932126|4741482|P8|Overall Study|Withdrawal by Subject|1
1436834|NCT00932126|4741483|P7|Overall Study|Withdrawal by Subject|0
1436835|NCT00932126|4741484|P6|Overall Study|Withdrawal by Subject|0
1436836|NCT00932126|4741485|P5|Overall Study|Withdrawal by Subject|0
1436837|NCT00932126|4741486|P4|Overall Study|Withdrawal by Subject|0
1436838|NCT00932126|4741487|P3|Overall Study|Withdrawal by Subject|1
1436839|NCT00932126|4741488|P2|Overall Study|Withdrawal by Subject|0
1436840|NCT00932126|4741489|P1|Overall Study|Withdrawal by Subject|0
1436841|NCT00932126|4741482|P8|Overall Study|Protocol Violation|0
1436842|NCT00932126|4741483|P7|Overall Study|Protocol Violation|0
1436843|NCT00932126|4741484|P6|Overall Study|Protocol Violation|0
1436844|NCT00932126|4741485|P5|Overall Study|Protocol Violation|1
1436845|NCT00932126|4741486|P4|Overall Study|Protocol Violation|0
1436846|NCT00932126|4741487|P3|Overall Study|Protocol Violation|0
1436847|NCT00932126|4741488|P2|Overall Study|Protocol Violation|0
1436848|NCT00932126|4741489|P1|Overall Study|Protocol Violation|0
1436849|NCT00932126|4741482|P8|Overall Study|Adverse Event|2
1436850|NCT00932126|4741483|P7|Overall Study|Adverse Event|1
1436851|NCT00932126|4741484|P6|Overall Study|Adverse Event|0
1436852|NCT00932126|4741485|P5|Overall Study|Adverse Event|0
1436853|NCT00932126|4741486|P4|Overall Study|Adverse Event|0
1436854|NCT00932126|4741487|P3|Overall Study|Adverse Event|0
1436855|NCT00932126|4741488|P2|Overall Study|Adverse Event|0
1436856|NCT00932126|4741489|P1|Overall Study|Adverse Event|0
1436857|NCT00932113|4741527|P2|Overall Study|Lost to Follow-up|0
1436858|NCT00932113|4741528|P1|Overall Study|Lost to Follow-up|1
1436859|NCT00931918|4741580|P2|Overall Study|Did not receive study drug|2
1436860|NCT00931918|4741581|P1|Overall Study|Did not receive study drug|3
1436861|NCT00931918|4741580|P2|Overall Study|Other Reason not Specified|4
1436862|NCT00931918|4741581|P1|Overall Study|Other Reason not Specified|4
1436863|NCT00931918|4741580|P2|Overall Study|Withdrawal by Patient|4
1436864|NCT00931918|4741581|P1|Overall Study|Withdrawal by Patient|3
1436865|NCT00931918|4741580|P2|Overall Study|Symptomatic Deterioration|0
1436866|NCT00931918|4741581|P1|Overall Study|Symptomatic Deterioration|1
1436867|NCT00931918|4741580|P2|Overall Study|Progressive Disease|1
1436868|NCT00931918|4741581|P1|Overall Study|Progressive Disease|2
1436869|NCT00931918|4741580|P2|Overall Study|Adverse Event|6
1436870|NCT00931918|4741581|P1|Overall Study|Adverse Event|4
1436871|NCT00931801|4741633|P3|Overall Study|Confirmed Virologic Failure|3
1436872|NCT00931801|4741634|P2|Overall Study|Confirmed Virologic Failure|0
1436873|NCT00931801|4741635|P1|Overall Study|Confirmed Virologic Failure|0
1436874|NCT00931801|4741633|P3|Overall Study|Withdrawal by Subject|0
1436875|NCT00931801|4741634|P2|Overall Study|Withdrawal by Subject|0
1436876|NCT00931801|4741635|P1|Overall Study|Withdrawal by Subject|1
1436877|NCT00931801|4741633|P3|Overall Study|Lost to Follow-up|0
1436878|NCT00931801|4741634|P2|Overall Study|Lost to Follow-up|1
1436879|NCT00931801|4741635|P1|Overall Study|Lost to Follow-up|0
1436880|NCT00931801|4741633|P3|Overall Study|Adverse Event|1
1436881|NCT00931801|4741634|P2|Overall Study|Adverse Event|0
1436882|NCT00931801|4741635|P1|Overall Study|Adverse Event|0
1436883|NCT00931723|4741658|P2|Overall Study|Late hospital discharge|0
1436884|NCT00931723|4741659|P1|Overall Study|Late hospital discharge|1
1436885|NCT00931723|4741658|P2|Overall Study|Sponsor decision|0
1436886|NCT00931723|4741659|P1|Overall Study|Sponsor decision|1
1436887|NCT00931723|4741658|P2|Overall Study|Lack or insufficient theraputic response|5
1436888|NCT00931723|4741659|P1|Overall Study|Lack or insufficient theraputic response|2
1436889|NCT00931723|4741658|P2|Overall Study|Took prohibited concomitant medication|1
1436890|NCT00931723|4741659|P1|Overall Study|Took prohibited concomitant medication|0
1436891|NCT00931723|4741658|P2|Overall Study|Safety reasons|1
1436892|NCT00931723|4741659|P1|Overall Study|Safety reasons|0
1436893|NCT00931723|4741658|P2|Overall Study|Severe non-compliance to protocol|0
1436894|NCT00931723|4741659|P1|Overall Study|Severe non-compliance to protocol|2
1436895|NCT00931723|4741658|P2|Overall Study|Study-specific discontinuation criteria|1
1436896|NCT00931723|4741659|P1|Overall Study|Study-specific discontinuation criteria|1
1436897|NCT00931723|4741658|P2|Overall Study|Lost to Follow-up|2
1436898|NCT00931723|4741659|P1|Overall Study|Lost to Follow-up|1
1436899|NCT00931723|4741658|P2|Overall Study|Condition under investigation worsened|2
1436900|NCT00931723|4741659|P1|Overall Study|Condition under investigation worsened|1
1436901|NCT00931723|4741658|P2|Overall Study|Lithium found in blood|1
1436902|NCT00931723|4741659|P1|Overall Study|Lithium found in blood|0
1436903|NCT00931723|4741658|P2|Overall Study|Adverse Event|13
1436904|NCT00931723|4741659|P1|Overall Study|Adverse Event|6
1436905|NCT00931723|4741658|P2|Overall Study|Withdrawal by Subject|13
1436906|NCT00931723|4741659|P1|Overall Study|Withdrawal by Subject|11
1436907|NCT00931710|4741707|P2|Overall Study|Protocol deviation|2
1436908|NCT00931710|4741708|P1|Overall Study|Protocol deviation|1
1436909|NCT00931710|4741707|P2|Overall Study|Lost to Follow-up|5
1436910|NCT00931710|4741708|P1|Overall Study|Lost to Follow-up|6
1436911|NCT00931710|4741707|P2|Overall Study|Patient withdrew consent|9
1436912|NCT00931710|4741708|P1|Overall Study|Patient withdrew consent|4
1436913|NCT00931710|4741707|P2|Overall Study|Unsatisfactory therapeutic effects|12
1436914|NCT00931710|4741708|P1|Overall Study|Unsatisfactory therapeutic effects|5
1436915|NCT00931710|4741707|P2|Overall Study|Abnormal test procedure results|0
1436916|NCT00931710|4741708|P1|Overall Study|Abnormal test procedure results|2
1436917|NCT00931710|4741707|P2|Overall Study|Adverse Event|10
1436918|NCT00931710|4741708|P1|Overall Study|Adverse Event|16
1436919|NCT00931632|4741726|P2|Overall Study|Adverse Event|15
1436920|NCT00931632|4741727|P1|Overall Study|Adverse Event|19
1436921|NCT00931632|4741726|P2|Overall Study|Withdrawal by Subject|3
1436922|NCT00931632|4741727|P1|Overall Study|Withdrawal by Subject|2
1436923|NCT00931528|4741749|P2|Overall Study|Assessment outside of Time Frame|23
1436924|NCT00931528|4741750|P1|Overall Study|Assessment outside of Time Frame|22
1436925|NCT00931528|4741749|P2|Overall Study|Lost to Follow-up|13
1436926|NCT00931528|4741750|P1|Overall Study|Lost to Follow-up|6
1436927|NCT00931528|4741749|P2|Overall Study|Withdrawal by Subject|12
1436928|NCT00931528|4741750|P1|Overall Study|Withdrawal by Subject|4
1436929|NCT00931528|4741749|P2|Overall Study|Protocol Violation|12
1436930|NCT00931528|4741750|P1|Overall Study|Protocol Violation|9
1436931|NCT00931515|4741770|P2|Overall Study|Lost to Follow-up|5
1436932|NCT00931515|4741771|P1|Overall Study|Lost to Follow-up|2
1436933|NCT00931463|4741801|P2|Overall Study|Lost to Follow-up|1
1436934|NCT00931463|4741802|P1|Overall Study|Lost to Follow-up|4
1436935|NCT00931463|4741801|P2|Overall Study|Withdrawal by Subject|0
1436936|NCT00931463|4741802|P1|Overall Study|Withdrawal by Subject|5
1436937|NCT00931463|4741801|P2|Overall Study|Death|4
1436938|NCT00931463|4741802|P1|Overall Study|Death|8
1436939|NCT00931411|4741818|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
1436940|NCT00931411|4741819|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
1436941|NCT00931411|4741818|P2|First Intervention - 42 Days|Lost to Follow-up|0
1436942|NCT00931411|4741819|P1|First Intervention - 42 Days|Lost to Follow-up|2
1436943|NCT00931411|4741818|P2|First Intervention - 42 Days|Adverse Event|3
1436944|NCT00931411|4741819|P1|First Intervention - 42 Days|Adverse Event|2
1436945|NCT00931385|4741840|P4|Overall Study|Lost to Follow-up|1
1436946|NCT00931385|4741841|P3|Overall Study|Lost to Follow-up|0
1436947|NCT00931385|4741842|P2|Overall Study|Lost to Follow-up|0
1436948|NCT00931385|4741843|P1|Overall Study|Lost to Follow-up|0
1436949|NCT00931385|4741840|P4|Overall Study|Withdrawal by Subject|1
1436950|NCT00931385|4741841|P3|Overall Study|Withdrawal by Subject|0
1436951|NCT00931385|4741842|P2|Overall Study|Withdrawal by Subject|1
1436952|NCT00931385|4741843|P1|Overall Study|Withdrawal by Subject|0
1436953|NCT00931385|4741840|P4|Overall Study|Protocol Violation|0
1436954|NCT00931385|4741841|P3|Overall Study|Protocol Violation|1
1436955|NCT00931385|4741842|P2|Overall Study|Protocol Violation|0
1436956|NCT00931385|4741843|P1|Overall Study|Protocol Violation|0
1436957|NCT00931385|4741840|P4|Overall Study|Adverse Event|3
1436958|NCT00931385|4741841|P3|Overall Study|Adverse Event|0
1436959|NCT00931385|4741842|P2|Overall Study|Adverse Event|1
1436960|NCT00931385|4741843|P1|Overall Study|Adverse Event|2
1436961|NCT00931307|4741912|P1|Overall Study|Biomicroscopy|1
1436962|NCT00931307|4741912|P1|Overall Study|Lack of Efficacy|12
1436963|NCT00931268|4741916|P1|Overall Study|Lost to Follow-up|6
1436964|NCT00931255|4741928|P2|Overall Study|Follow up biopsy not done|3
1436965|NCT00931255|4741929|P1|Overall Study|Follow up biopsy not done|2
1436966|NCT00930982|4741966|P2|Overall Study|Withdrawal by Subject|1
1436967|NCT00930982|4741967|P1|Overall Study|Withdrawal by Subject|1
1436968|NCT00930982|4741966|P2|Overall Study|Protocol Violation|5
1436969|NCT00930982|4741967|P1|Overall Study|Protocol Violation|1
1436970|NCT00930982|4741966|P2|Overall Study|Adverse Event|23
1436971|NCT00930982|4741967|P1|Overall Study|Adverse Event|19
1436972|NCT00930969|4742001|P1|Overall Study|Withdrawal by Subject|19
1436973|NCT00930969|4742001|P1|Overall Study|Physician Decision|13
1436974|NCT00930969|4742001|P1|Overall Study|Lost to Follow-up|1
1436975|NCT00930969|4742001|P1|Overall Study|Death|5
1436976|NCT00930930|4742011|P2|Overall Study|patients not compliant|1
1436977|NCT00930930|4742012|P1|Overall Study|patients not compliant|1
1436978|NCT00930930|4742011|P2|Overall Study|excessive lapse btw txs, not eligible|1
1436979|NCT00930930|4742012|P1|Overall Study|excessive lapse btw txs, not eligible|0
1436980|NCT00930930|4742011|P2|Overall Study|Disease progression|3
1436981|NCT00930930|4742012|P1|Overall Study|Disease progression|2
1436982|NCT00930930|4742011|P2|Overall Study|Withdrawal by Subject|1
1436983|NCT00930930|4742012|P1|Overall Study|Withdrawal by Subject|3
1436984|NCT00930930|4742011|P2|Overall Study|Adverse Event|3
1436985|NCT00930930|4742012|P1|Overall Study|Adverse Event|13
1436986|NCT00930930|4742011|P2|Overall Study|Physician Decision|0
1436987|NCT00930930|4742012|P1|Overall Study|Physician Decision|1
1436988|NCT00930930|4742011|P2|Overall Study|Death|0
1436989|NCT00930930|4742012|P1|Overall Study|Death|1
1436990|NCT00930813|4742026|P2|Overall Study|Lost to Follow-up|4
1436991|NCT00930813|4742027|P1|Overall Study|Lost to Follow-up|2
1436992|NCT00930813|4742026|P2|Overall Study|Withdrawal by Subject|5
1436993|NCT00930813|4742027|P1|Overall Study|Withdrawal by Subject|2
1436994|NCT00930813|4742026|P2|Overall Study|Death|5
1436995|NCT00930813|4742027|P1|Overall Study|Death|4
1436996|NCT00930774|4742048|P4|Overall Study|Withdrawal by Subject|0
1436997|NCT00930774|4742049|P3|Overall Study|Withdrawal by Subject|2
1436998|NCT00930774|4742050|P2|Overall Study|Withdrawal by Subject|9
1436999|NCT00930774|4742051|P1|Overall Study|Withdrawal by Subject|1
1437000|NCT00930761|4742091|P2|Overall Study|less than 3 music therapy sessions|3
1437001|NCT00930761|4742092|P1|Overall Study|less than 3 music therapy sessions|0
1437002|NCT00930761|4742091|P2|Overall Study|3 newborns died; 1 mother quit the study|0
1437003|NCT00930761|4742092|P1|Overall Study|3 newborns died; 1 mother quit the study|4
1437004|NCT00930722|4742104|P1|Overall Study|Study terminated by sponsor|2
1437005|NCT00930722|4742104|P1|Overall Study|No longer willing to participate|9
1437006|NCT00930722|4742104|P1|Overall Study|Lost to Follow-up|16
1437007|NCT00930644|4742119|P1|Overall Study|Adverse Event|16
1437008|NCT00930644|4742119|P1|Overall Study|Death|1
1437009|NCT00930644|4742119|P1|Overall Study|Physician Decision|2
1437010|NCT00930644|4742119|P1|Overall Study|Withdrawal by Subject|4
1437011|NCT00930553|4742132|P1|Overall Study|Other than specified above|28
1437012|NCT00930553|4742132|P1|Overall Study|Study terminated by sponsor|24
1437013|NCT00930553|4742132|P1|Overall Study|Death|9
1437014|NCT00930553|4742132|P1|Overall Study|Lost to Follow-up|25
1437015|NCT00930553|4742132|P1|Overall Study|Withdrawal by Subject|88
1437016|NCT00930553|4742132|P1|Overall Study|Pregnancy|1
1437017|NCT00930553|4742132|P1|Overall Study|Protocol Violation|1
1437018|NCT00930553|4742132|P1|Overall Study|Physician Decision|39
1437019|NCT00930553|4742132|P1|Overall Study|Lack of Efficacy|7
1437020|NCT00930553|4742132|P1|Overall Study|Adverse Event|1
1437021|NCT00930176|4742209|P1|Overall Study|Death|1
1437022|NCT00929864|4742226|P2|Overall Study|Non-specified|7
1437023|NCT00929864|4742227|P1|Overall Study|Non-specified|2
1437024|NCT00929864|4742226|P2|Overall Study|Administrative reason by Sponsor|1
1437025|NCT00929864|4742227|P1|Overall Study|Administrative reason by Sponsor|1
1437026|NCT00929864|4742226|P2|Overall Study|Pregnancy|3
1437027|NCT00929864|4742227|P1|Overall Study|Pregnancy|0
1437028|NCT00929864|4742226|P2|Overall Study|Poor or non-compliance|3
1437029|NCT00929864|4742227|P1|Overall Study|Poor or non-compliance|3
1437030|NCT00929864|4742226|P2|Overall Study|No longer met criteria|1
1437031|NCT00929864|4742227|P1|Overall Study|No longer met criteria|2
1437032|NCT00929864|4742226|P2|Overall Study|Withdrawal by Subject|9
1437033|NCT00929864|4742227|P1|Overall Study|Withdrawal by Subject|20
1437034|NCT00929864|4742226|P2|Overall Study|Lost to Follow-up|12
1437035|NCT00929864|4742227|P1|Overall Study|Lost to Follow-up|7
1437036|NCT00929864|4742226|P2|Overall Study|Lack of Efficacy|16
1437037|NCT00929864|4742227|P1|Overall Study|Lack of Efficacy|19
1437038|NCT00929864|4742226|P2|Overall Study|Adverse Event|30
1437039|NCT00929864|4742227|P1|Overall Study|Adverse Event|11
1437040|NCT00929864|4742226|P2|Overall Study|Death|1
1437041|NCT00929864|4742227|P1|Overall Study|Death|1
1437042|NCT00929734|4742266|P2|Overall Study|Withdrawal by Subject|2
1437043|NCT00929734|4742267|P1|Overall Study|Withdrawal by Subject|0
1437044|NCT00929734|4742266|P2|Overall Study|Lost to Follow-up|1
1437045|NCT00929734|4742267|P1|Overall Study|Lost to Follow-up|2
1437046|NCT00929708|4742284|P5|Overall Study|Lost to Follow-up|0
1437047|NCT00929708|4742285|P4|Overall Study|Lost to Follow-up|1
1437048|NCT00929708|4742286|P3|Overall Study|Lost to Follow-up|0
1437049|NCT00929708|4742287|P2|Overall Study|Lost to Follow-up|0
1437050|NCT00929708|4742288|P1|Overall Study|Lost to Follow-up|0
1437051|NCT00929708|4742284|P5|Overall Study|Physician Decision|1
1437052|NCT00929708|4742285|P4|Overall Study|Physician Decision|2
1437053|NCT00929708|4742286|P3|Overall Study|Physician Decision|2
1437054|NCT00929708|4742287|P2|Overall Study|Physician Decision|2
1437055|NCT00929708|4742288|P1|Overall Study|Physician Decision|0
1437056|NCT00929708|4742284|P5|Overall Study|Adverse Event|3
1437057|NCT00929708|4742285|P4|Overall Study|Adverse Event|0
1437058|NCT00929708|4742286|P3|Overall Study|Adverse Event|0
1437059|NCT00929708|4742287|P2|Overall Study|Adverse Event|0
1437060|NCT00929708|4742288|P1|Overall Study|Adverse Event|0
1437061|NCT00929708|4742284|P5|Overall Study|Withdrawal by Subject|1
1437062|NCT00929708|4742285|P4|Overall Study|Withdrawal by Subject|2
1437063|NCT00929708|4742286|P3|Overall Study|Withdrawal by Subject|0
1437064|NCT00929708|4742287|P2|Overall Study|Withdrawal by Subject|0
1437065|NCT00929708|4742288|P1|Overall Study|Withdrawal by Subject|2
1437066|NCT00929708|4742284|P5|Overall Study|Protocol Violation|1
1437067|NCT00929708|4742285|P4|Overall Study|Protocol Violation|1
1437068|NCT00929708|4742286|P3|Overall Study|Protocol Violation|1
1437069|NCT00929708|4742287|P2|Overall Study|Protocol Violation|1
1437070|NCT00929708|4742288|P1|Overall Study|Protocol Violation|2
1437071|NCT00929695|4742342|P2|Overall Study|incorrect stratification|0
1437072|NCT00929695|4742343|P1|Overall Study|incorrect stratification|2
1437073|NCT00929695|4742342|P2|Overall Study|discharge home|3
1437074|NCT00929695|4742343|P1|Overall Study|discharge home|4
1437075|NCT00929695|4742342|P2|Overall Study|Withdrawal by Subject|2
1437076|NCT00929695|4742343|P1|Overall Study|Withdrawal by Subject|0
1437077|NCT00929695|4742342|P2|Overall Study|Death|1
1437078|NCT00929695|4742343|P1|Overall Study|Death|2
1437079|NCT00929669|4742373|P1|Overall Study|elevated glucose levels|1
1437080|NCT00929656|4742380|P2|Overall Study|Lost to Follow-up|1
1437081|NCT00929656|4742381|P1|Overall Study|Lost to Follow-up|0
1437082|NCT00929643|4742395|P1|Overall Study|Protocol Violation|2
1437083|NCT00929526|4742417|P2|Overall Study|Other|6
1437084|NCT00929526|4742418|P1|Overall Study|Other|8
1437085|NCT00929526|4742417|P2|Overall Study|Lost to Follow-up|12
1437086|NCT00929526|4742418|P1|Overall Study|Lost to Follow-up|8
1437087|NCT00929526|4742417|P2|Overall Study|Withdrawal by Subject|11
1437088|NCT00929526|4742418|P1|Overall Study|Withdrawal by Subject|1
1437089|NCT00929240|4742572|P3|Maintenance Phase|Participant not treated|0
1437090|NCT00929240|4742573|P2|Maintenance Phase|Participant not treated|2
1437091|NCT00929240|4742574|P1|Maintenance Phase|Participant not treated|0
1437092|NCT00929240|4742572|P3|Maintenance Phase|Treatment ongoing at study closure|10
1437093|NCT00929240|4742573|P2|Maintenance Phase|Treatment ongoing at study closure|0
1437094|NCT00929240|4742574|P1|Maintenance Phase|Treatment ongoing at study closure|0
1437095|NCT00929240|4742572|P3|Maintenance Phase|Change of treatment|0
1437096|NCT00929240|4742573|P2|Maintenance Phase|Change of treatment|4
1437097|NCT00929240|4742574|P1|Maintenance Phase|Change of treatment|0
1437098|NCT00929240|4742572|P3|Maintenance Phase|Physician Decision|1
1437099|NCT00929240|4742573|P2|Maintenance Phase|Physician Decision|2
1437100|NCT00929240|4742574|P1|Maintenance Phase|Physician Decision|0
1437101|NCT00929240|4742572|P3|Maintenance Phase|Health authority/Study termination|2
1437102|NCT00929240|4742573|P2|Maintenance Phase|Health authority/Study termination|1
1437103|NCT00929240|4742574|P1|Maintenance Phase|Health authority/Study termination|0
1437104|NCT00929240|4742572|P3|Maintenance Phase|Protocol Violation|0
1437105|NCT00929240|4742573|P2|Maintenance Phase|Protocol Violation|1
1437106|NCT00929240|4742574|P1|Maintenance Phase|Protocol Violation|0
1437107|NCT00929240|4742572|P3|Maintenance Phase|Withdrawal by Subject|6
1437108|NCT00929240|4742573|P2|Maintenance Phase|Withdrawal by Subject|2
1437109|NCT00929240|4742574|P1|Maintenance Phase|Withdrawal by Subject|0
1437110|NCT00929240|4742572|P3|Maintenance Phase|Adverse Event|12
1437111|NCT00929240|4742573|P2|Maintenance Phase|Adverse Event|9
1437112|NCT00929240|4742574|P1|Maintenance Phase|Adverse Event|0
1437113|NCT00929240|4742572|P3|Maintenance Phase|Disease progression|60
1437114|NCT00929240|4742573|P2|Maintenance Phase|Disease progression|73
1437115|NCT00929240|4742574|P1|Maintenance Phase|Disease progression|0
1437116|NCT00929240|4742572|P3|Initial Treatment Phase|Physician Decision|0
1437117|NCT00929240|4742573|P2|Initial Treatment Phase|Physician Decision|0
1437118|NCT00929240|4742574|P1|Initial Treatment Phase|Physician Decision|4
1437119|NCT00929240|4742572|P3|Initial Treatment Phase|Health authority/Study termination|0
1437120|NCT00929240|4742573|P2|Initial Treatment Phase|Health authority/Study termination|0
1437121|NCT00929240|4742574|P1|Initial Treatment Phase|Health authority/Study termination|3
1437122|NCT00929240|4742572|P3|Initial Treatment Phase|Death|0
1437123|NCT00929240|4742573|P2|Initial Treatment Phase|Death|0
1437124|NCT00929240|4742574|P1|Initial Treatment Phase|Death|2
1437125|NCT00929240|4742572|P3|Initial Treatment Phase|Protocol Violation|0
1437126|NCT00929240|4742573|P2|Initial Treatment Phase|Protocol Violation|0
1437127|NCT00929240|4742574|P1|Initial Treatment Phase|Protocol Violation|5
1437128|NCT00929240|4742572|P3|Initial Treatment Phase|Withdrawal by Subject|0
1437129|NCT00929240|4742573|P2|Initial Treatment Phase|Withdrawal by Subject|0
1437130|NCT00929240|4742574|P1|Initial Treatment Phase|Withdrawal by Subject|13
1437131|NCT00929240|4742572|P3|Initial Treatment Phase|Disease progression|0
1437132|NCT00929240|4742573|P2|Initial Treatment Phase|Disease progression|0
1437133|NCT00929240|4742574|P1|Initial Treatment Phase|Disease progression|41
1437134|NCT00929240|4742572|P3|Initial Treatment Phase|Adverse Event|0
1437135|NCT00929240|4742573|P2|Initial Treatment Phase|Adverse Event|0
1437136|NCT00929240|4742574|P1|Initial Treatment Phase|Adverse Event|31
1437137|NCT00929201|4742601|P2|Period 1|Withdrawal by Subject|1
1437138|NCT00929201|4742602|P1|Period 1|Withdrawal by Subject|0
1437139|NCT00929162|4742612|P2|Overall Study|Other termination reason|6
1437140|NCT00929162|4742613|P1|Overall Study|Other termination reason|5
1437141|NCT00929162|4742612|P2|Overall Study|Protocol Violation|30
1437142|NCT00929162|4742613|P1|Overall Study|Protocol Violation|32
1437143|NCT00929162|4742612|P2|Overall Study|Withdrawal by Subject|1
1437144|NCT00929162|4742613|P1|Overall Study|Withdrawal by Subject|3
1437145|NCT00929162|4742612|P2|Overall Study|Adverse Event|5
1437146|NCT00929162|4742613|P1|Overall Study|Adverse Event|8
1437147|NCT00929110|4742626|P3|Overall Study|Patient inability to use the device|0
1437148|NCT00929110|4742627|P2|Overall Study|Patient inability to use the device|1
1437149|NCT00929110|4742628|P1|Overall Study|Patient inability to use the device|0
1437150|NCT00929110|4742626|P3|Overall Study|Abnormal test procedure result(s)|1
1437151|NCT00929110|4742627|P2|Overall Study|Abnormal test procedure result(s)|1
1437152|NCT00929110|4742628|P1|Overall Study|Abnormal test procedure result(s)|0
1437153|NCT00929110|4742626|P3|Overall Study|Abnormal laboratory value(s)|0
1437154|NCT00929110|4742627|P2|Overall Study|Abnormal laboratory value(s)|1
1437155|NCT00929110|4742628|P1|Overall Study|Abnormal laboratory value(s)|0
1437156|NCT00929110|4742626|P3|Overall Study|Death|2
1437157|NCT00929110|4742627|P2|Overall Study|Death|2
1437158|NCT00929110|4742628|P1|Overall Study|Death|2
1437159|NCT00929110|4742626|P3|Overall Study|Administrative problems|2
1437160|NCT00929110|4742627|P2|Overall Study|Administrative problems|1
1437161|NCT00929110|4742628|P1|Overall Study|Administrative problems|4
1437162|NCT00929110|4742626|P3|Overall Study|Protocol deviation|4
1437163|NCT00929110|4742627|P2|Overall Study|Protocol deviation|2
1437164|NCT00929110|4742628|P1|Overall Study|Protocol deviation|5
1437165|NCT00929110|4742626|P3|Overall Study|Lost to Follow-up|3
1437166|NCT00929110|4742627|P2|Overall Study|Lost to Follow-up|7
1437167|NCT00929110|4742628|P1|Overall Study|Lost to Follow-up|7
1437168|NCT00929110|4742626|P3|Overall Study|Unsatisfactory therapeutic effect|6
1437169|NCT00929110|4742627|P2|Overall Study|Unsatisfactory therapeutic effect|9
1437170|NCT00929110|4742628|P1|Overall Study|Unsatisfactory therapeutic effect|20
1437171|NCT00929110|4742626|P3|Overall Study|Subject withdrew consent|26
1437172|NCT00929110|4742627|P2|Overall Study|Subject withdrew consent|23
1437173|NCT00929110|4742628|P1|Overall Study|Subject withdrew consent|40
1437174|NCT00929110|4742626|P3|Overall Study|Adverse Event|18
1437175|NCT00929110|4742627|P2|Overall Study|Adverse Event|29
1437176|NCT00929110|4742628|P1|Overall Study|Adverse Event|40
1437177|NCT00928889|4742711|P2|Overall Study|Other|0
1437178|NCT00928889|4742712|P1|Overall Study|Other|1
1437179|NCT00928889|4742711|P2|Overall Study|Adverse Event|0
1437180|NCT00928889|4742712|P1|Overall Study|Adverse Event|1
1437181|NCT00928889|4742711|P2|Overall Study|Protocol Violation|1
1437182|NCT00928889|4742712|P1|Overall Study|Protocol Violation|0
1437183|NCT00928889|4742711|P2|Overall Study|Lost to Follow-up|1
1437184|NCT00928889|4742712|P1|Overall Study|Lost to Follow-up|3
1437185|NCT00928746|4742758|P1|Overall Study|Other|2
1437186|NCT00928746|4742758|P1|Overall Study|Withdrawal by Subject|1
1437187|NCT00928746|4742758|P1|Overall Study|Protocol Violation|1
1437188|NCT00928746|4742758|P1|Overall Study|Adverse Event|2
1437189|NCT00928668|4742815|P5|Overall Study|Other reasons not listed above|0
1437190|NCT00928668|4742816|P4|Overall Study|Other reasons not listed above|1
1437191|NCT00928668|4742817|P3|Overall Study|Other reasons not listed above|0
1437192|NCT00928668|4742818|P2|Overall Study|Other reasons not listed above|0
1437193|NCT00928668|4742819|P1|Overall Study|Other reasons not listed above|0
1437194|NCT00928668|4742815|P5|Overall Study|Withdrawal by Subject|0
1437195|NCT00928668|4742816|P4|Overall Study|Withdrawal by Subject|0
1437196|NCT00928668|4742817|P3|Overall Study|Withdrawal by Subject|1
1437197|NCT00928668|4742818|P2|Overall Study|Withdrawal by Subject|1
1437198|NCT00928668|4742819|P1|Overall Study|Withdrawal by Subject|0
1437199|NCT00928668|4742815|P5|Overall Study|Protocol Violation|1
1437200|NCT00928668|4742816|P4|Overall Study|Protocol Violation|0
1437201|NCT00928668|4742817|P3|Overall Study|Protocol Violation|0
1437202|NCT00928668|4742818|P2|Overall Study|Protocol Violation|0
1437203|NCT00928668|4742819|P1|Overall Study|Protocol Violation|0
1437204|NCT00928668|4742815|P5|Overall Study|Adverse Event|0
1437205|NCT00928668|4742816|P4|Overall Study|Adverse Event|0
1437206|NCT00928668|4742817|P3|Overall Study|Adverse Event|0
1437207|NCT00928668|4742818|P2|Overall Study|Adverse Event|0
1437208|NCT00928668|4742819|P1|Overall Study|Adverse Event|1
1437209|NCT00928512|4742875|P5|Overall Study|Administrative Problems|0
1437210|NCT00928512|4742876|P4|Overall Study|Administrative Problems|0
1437211|NCT00928512|4742877|P3|Overall Study|Administrative Problems|0
1437212|NCT00928512|4742878|P2|Overall Study|Administrative Problems|1
1437213|NCT00928512|4742879|P1|Overall Study|Administrative Problems|0
1437214|NCT00928512|4742875|P5|Overall Study|Lost to Follow-up|3
1437215|NCT00928512|4742876|P4|Overall Study|Lost to Follow-up|1
1437216|NCT00928512|4742877|P3|Overall Study|Lost to Follow-up|2
1437217|NCT00928512|4742878|P2|Overall Study|Lost to Follow-up|1
1437218|NCT00928512|4742879|P1|Overall Study|Lost to Follow-up|1
1437219|NCT00928512|4742875|P5|Overall Study|Withdrawal by Subject|0
1437220|NCT00928512|4742876|P4|Overall Study|Withdrawal by Subject|4
1437221|NCT00928512|4742877|P3|Overall Study|Withdrawal by Subject|3
1437222|NCT00928512|4742878|P2|Overall Study|Withdrawal by Subject|0
1437223|NCT00928512|4742879|P1|Overall Study|Withdrawal by Subject|3
1437224|NCT00928512|4742875|P5|Overall Study|Protocol Violation|3
1437225|NCT00928512|4742876|P4|Overall Study|Protocol Violation|1
1437226|NCT00928512|4742877|P3|Overall Study|Protocol Violation|0
1437227|NCT00928512|4742878|P2|Overall Study|Protocol Violation|1
1437228|NCT00928512|4742879|P1|Overall Study|Protocol Violation|0
1437229|NCT00928512|4742875|P5|Overall Study|Lack of Efficacy|3
1437230|NCT00928512|4742876|P4|Overall Study|Lack of Efficacy|7
1437231|NCT00928512|4742877|P3|Overall Study|Lack of Efficacy|4
1437232|NCT00928512|4742878|P2|Overall Study|Lack of Efficacy|0
1437233|NCT00928512|4742879|P1|Overall Study|Lack of Efficacy|2
1437234|NCT00928512|4742875|P5|Overall Study|Adverse Event|6
1437235|NCT00928512|4742876|P4|Overall Study|Adverse Event|8
1437236|NCT00928512|4742877|P3|Overall Study|Adverse Event|2
1437237|NCT00928512|4742878|P2|Overall Study|Adverse Event|3
1437238|NCT00928512|4742879|P1|Overall Study|Adverse Event|4
1437239|NCT00928486|4742980|P1|Overall Study|Withdrawal by Subject|1
1437240|NCT00928486|4742980|P1|Overall Study|Disease Progression|7
1437241|NCT00928486|4742980|P1|Overall Study|Adverse Event|2
1437242|NCT00928434|4742989|P3|Overall Study|Other (not meeting above criteria)|2
1437243|NCT00928434|4742990|P2|Overall Study|Other (not meeting above criteria)|1
1437244|NCT00928434|4742991|P1|Overall Study|Other (not meeting above criteria)|5
1437245|NCT00928434|4742989|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
1437246|NCT00928434|4742990|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
1437247|NCT00928434|4742991|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
1437248|NCT00928434|4742989|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
1437249|NCT00928434|4742990|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
1437250|NCT00928434|4742991|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
1437251|NCT00928434|4742989|P3|Overall Study|Withdrawal by Subject|2
1437252|NCT00928434|4742990|P2|Overall Study|Withdrawal by Subject|3
1437253|NCT00928434|4742991|P1|Overall Study|Withdrawal by Subject|5
1437254|NCT00928434|4742989|P3|Overall Study|Lost to Follow-up|3
1437255|NCT00928434|4742990|P2|Overall Study|Lost to Follow-up|0
1437256|NCT00928434|4742991|P1|Overall Study|Lost to Follow-up|1
1437257|NCT00928434|4742989|P3|Overall Study|Physician Decision|3
1437258|NCT00928434|4742990|P2|Overall Study|Physician Decision|0
1437259|NCT00928434|4742991|P1|Overall Study|Physician Decision|2
1437260|NCT00928434|4742989|P3|Overall Study|Protocol Violation|8
1437261|NCT00928434|4742990|P2|Overall Study|Protocol Violation|0
1437262|NCT00928434|4742991|P1|Overall Study|Protocol Violation|5
1437263|NCT00928434|4742989|P3|Overall Study|Adverse Event|18
1437264|NCT00928434|4742990|P2|Overall Study|Adverse Event|5
1437265|NCT00928434|4742991|P1|Overall Study|Adverse Event|14
1437266|NCT00928408|4743067|P1|Overall Study|Lost to Follow-up|12
1437267|NCT00928408|4743067|P1|Overall Study|Death|5
1437268|NCT00928408|4743067|P1|Overall Study|Withdrawal by Subject|4
1437269|NCT00928408|4743067|P1|Overall Study|Other|2
1437270|NCT00928252|4743113|P1|Overall Study|Physician Decision|3
1437271|NCT00928187|4743122|P3|Overall Study|Protocol Violation|0
1437272|NCT00928187|4743123|P2|Overall Study|Protocol Violation|1
1437273|NCT00928187|4743124|P1|Overall Study|Protocol Violation|0
1437274|NCT00928187|4743122|P3|Overall Study|Withdrawal by Subject|1
1437275|NCT00928187|4743123|P2|Overall Study|Withdrawal by Subject|1
1437276|NCT00928187|4743124|P1|Overall Study|Withdrawal by Subject|0
1437277|NCT00928187|4743122|P3|Overall Study|Lost to Follow-up|1
1437278|NCT00928187|4743123|P2|Overall Study|Lost to Follow-up|2
1437279|NCT00928187|4743124|P1|Overall Study|Lost to Follow-up|1
1437280|NCT00928187|4743122|P3|Overall Study|Death|3
1437281|NCT00928187|4743123|P2|Overall Study|Death|2
1437282|NCT00928187|4743124|P1|Overall Study|Death|1
1437283|NCT00928070|4743294|P2|Overall Study|Other|5
1437284|NCT00928070|4743295|P1|Overall Study|Other|5
1437285|NCT00928070|4743294|P2|Overall Study|Randomized but not treated|2
1437286|NCT00928070|4743295|P1|Overall Study|Randomized but not treated|2
1437287|NCT00928070|4743294|P2|Overall Study|Protocol Violation|5
1437288|NCT00928070|4743295|P1|Overall Study|Protocol Violation|6
1437289|NCT00928070|4743294|P2|Overall Study|Did not meet entrance criteria|9
1437290|NCT00928070|4743295|P1|Overall Study|Did not meet entrance criteria|16
1437291|NCT00928070|4743294|P2|Overall Study|Lack of Efficacy|5
1437292|NCT00928070|4743295|P1|Overall Study|Lack of Efficacy|9
1437293|NCT00928070|4743294|P2|Overall Study|Adverse Event|26
1437294|NCT00928070|4743295|P1|Overall Study|Adverse Event|14
1437295|NCT00928070|4743294|P2|Overall Study|Withdrawal by Subject|3
1437296|NCT00928070|4743295|P1|Overall Study|Withdrawal by Subject|10
1437297|NCT00928070|4743294|P2|Overall Study|Lost to Follow-up|2
1437298|NCT00928070|4743295|P1|Overall Study|Lost to Follow-up|1
1437299|NCT00928057|4743353|P2|Overall Study|Protocol Violation|1
1437300|NCT00928057|4743354|P1|Overall Study|Protocol Violation|0
1437301|NCT00928057|4743353|P2|Overall Study|Lost to Follow-up|1
1437302|NCT00928057|4743354|P1|Overall Study|Lost to Follow-up|0
1437303|NCT00928057|4743353|P2|Overall Study|Withdrawal by Subject|0
1437304|NCT00928057|4743354|P1|Overall Study|Withdrawal by Subject|1
1437305|NCT00928057|4743353|P2|Overall Study|Adverse Event|2
1437306|NCT00928057|4743354|P1|Overall Study|Adverse Event|1
1437307|NCT00928018|4743379|P2|Overall Study|Withdrawal by Subject|0
1437308|NCT00928018|4743380|P1|Overall Study|Withdrawal by Subject|1
1437309|NCT00927953|4743410|P2|Overall Study|Death|1
1437310|NCT00927953|4743411|P1|Overall Study|Death|2
1437311|NCT00927940|4743425|P1|Overall Study|Death|1
1437312|NCT00927927|4743445|P15|Overall Study|Withdrawal by Subject|0
1437313|NCT00927927|4743446|P14|Overall Study|Withdrawal by Subject|0
1437314|NCT00927927|4743447|P13|Overall Study|Withdrawal by Subject|0
1437315|NCT00927927|4743448|P12|Overall Study|Withdrawal by Subject|2
1437316|NCT00927927|4743449|P11|Overall Study|Withdrawal by Subject|0
1437317|NCT00927927|4743450|P10|Overall Study|Withdrawal by Subject|0
1437318|NCT00927927|4743451|P9|Overall Study|Withdrawal by Subject|0
1437319|NCT00927927|4743452|P8|Overall Study|Withdrawal by Subject|2
1437320|NCT00927927|4743453|P7|Overall Study|Withdrawal by Subject|0
1437321|NCT00927927|4743454|P6|Overall Study|Withdrawal by Subject|0
1437322|NCT00927927|4743455|P5|Overall Study|Withdrawal by Subject|0
1437323|NCT00927927|4743456|P4|Overall Study|Withdrawal by Subject|0
1437324|NCT00927927|4743457|P3|Overall Study|Withdrawal by Subject|0
1437325|NCT00927927|4743458|P2|Overall Study|Withdrawal by Subject|0
1437326|NCT00927927|4743459|P1|Overall Study|Withdrawal by Subject|0
1437327|NCT00927901|4743506|P4|Treatment Period 4|Subject withdrew consent|0
1437328|NCT00927901|4743507|P3|Treatment Period 4|Subject withdrew consent|1
1437329|NCT00927901|4743508|P2|Treatment Period 4|Subject withdrew consent|0
1437330|NCT00927901|4743509|P1|Treatment Period 4|Subject withdrew consent|0
1437331|NCT00927901|4743506|P4|Treatment Period 4|Adverse Event|1
1437332|NCT00927901|4743507|P3|Treatment Period 4|Adverse Event|0
1437333|NCT00927901|4743508|P2|Treatment Period 4|Adverse Event|0
1437334|NCT00927901|4743509|P1|Treatment Period 4|Adverse Event|0
1437335|NCT00927901|4743506|P4|Treatment Period 1|Subject withdrew consent|0
1437336|NCT00927901|4743507|P3|Treatment Period 1|Subject withdrew consent|1
1437337|NCT00927901|4743508|P2|Treatment Period 1|Subject withdrew consent|0
1437338|NCT00927901|4743509|P1|Treatment Period 1|Subject withdrew consent|0
1437339|NCT00927862|4743550|P2|Overall Study|Missing data needed for endpt analyses|45
1437340|NCT00927862|4743551|P1|Overall Study|Missing data needed for endpt analyses|27
1437341|NCT00927823|4743586|P4|Continuous Dosing Period|Other|3
1437342|NCT00927823|4743587|P3|Continuous Dosing Period|Other|9
1437343|NCT00927823|4743588|P2|Continuous Dosing Period|Other|2
1437344|NCT00927823|4743589|P1|Continuous Dosing Period|Other|1
1437345|NCT00927823|4743586|P4|Continuous Dosing Period|Withdrawal by Subject|2
1437346|NCT00927823|4743587|P3|Continuous Dosing Period|Withdrawal by Subject|2
1437347|NCT00927823|4743588|P2|Continuous Dosing Period|Withdrawal by Subject|0
1437348|NCT00927823|4743589|P1|Continuous Dosing Period|Withdrawal by Subject|1
1437349|NCT00927823|4743586|P4|Continuous Dosing Period|Lost to Follow-up|0
1437350|NCT00927823|4743587|P3|Continuous Dosing Period|Lost to Follow-up|9
1437351|NCT00927823|4743588|P2|Continuous Dosing Period|Lost to Follow-up|1
1437352|NCT00927823|4743589|P1|Continuous Dosing Period|Lost to Follow-up|1
1437353|NCT00927823|4743586|P4|Continuous Dosing Period|Death|0
1437354|NCT00927823|4743587|P3|Continuous Dosing Period|Death|6
1437355|NCT00927823|4743588|P2|Continuous Dosing Period|Death|0
1437356|NCT00927823|4743589|P1|Continuous Dosing Period|Death|0
1437357|NCT00927758|4743653|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
1437358|NCT00927758|4743654|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
1437359|NCT00927758|4743655|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
1437360|NCT00927758|4743656|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
1437361|NCT00927758|4743657|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
1437362|NCT00927758|4743658|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
1437363|NCT00927758|4743653|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
1437364|NCT00927758|4743654|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
1437365|NCT00927758|4743655|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
1437366|NCT00927758|4743656|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
1437367|NCT00927758|4743657|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
1437368|NCT00927758|4743658|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
1437369|NCT00927589|4743666|P1|Overall Study|Non-compliance|1
1437370|NCT00927589|4743666|P1|Overall Study|Disease Progression|8
1437371|NCT00927589|4743666|P1|Overall Study|Adverse Event|2
1437372|NCT00927589|4743666|P1|Overall Study|Withdrawal by Subject|3
1437373|NCT00927589|4743666|P1|Overall Study|Physician Decision|1
1437374|NCT00927589|4743666|P1|Overall Study|Death|1
1437375|NCT00927563|4743696|P1|Overall Study|Withdrawal by Subject|1
1437376|NCT00927563|4743696|P1|Overall Study|Lost to Follow-up|1
1437377|NCT00927472|4743704|P2|Overall Study|Post treatment Assessment out of window|4
1437378|NCT00927472|4743705|P1|Overall Study|Post treatment Assessment out of window|0
1437379|NCT00927472|4743704|P2|Overall Study|Protocol Violation|1
1437380|NCT00927472|4743705|P1|Overall Study|Protocol Violation|0
1437381|NCT00927472|4743704|P2|Overall Study|Lost to Follow-up|6
1437382|NCT00927472|4743705|P1|Overall Study|Lost to Follow-up|1
1437383|NCT00927472|4743704|P2|Overall Study|Withdrawal by Subject|11
1437384|NCT00927472|4743705|P1|Overall Study|Withdrawal by Subject|10
1437385|NCT00927394|4743731|P2|Overall Study|Randomized in error|1
1437386|NCT00927394|4743732|P1|Overall Study|Randomized in error|0
1437387|NCT00927394|4743731|P2|Overall Study|Protocol deviation|13
1437388|NCT00927394|4743732|P1|Overall Study|Protocol deviation|16
1437389|NCT00927394|4743731|P2|Overall Study|Death|1
1437390|NCT00927394|4743732|P1|Overall Study|Death|1
1437391|NCT00927394|4743731|P2|Overall Study|Administrative Problem|0
1437392|NCT00927394|4743732|P1|Overall Study|Administrative Problem|1
1437393|NCT00927394|4743731|P2|Overall Study|Lost to Follow-up|14
1437394|NCT00927394|4743732|P1|Overall Study|Lost to Follow-up|8
1437395|NCT00927394|4743731|P2|Overall Study|Withdrawal by Subject|24
1437396|NCT00927394|4743732|P1|Overall Study|Withdrawal by Subject|20
1437397|NCT00927394|4743731|P2|Overall Study|Unsatisfactory therapeutic effect|23
1437398|NCT00927394|4743732|P1|Overall Study|Unsatisfactory therapeutic effect|17
1437399|NCT00927394|4743731|P2|Overall Study|Adverse Event|9
1437400|NCT00927394|4743732|P1|Overall Study|Adverse Event|14
1437401|NCT00927368|4743763|P3|Overall Study|cancellation of surgery|2
1437402|NCT00927368|4743764|P2|Overall Study|cancellation of surgery|1
1437403|NCT00927368|4743765|P1|Overall Study|cancellation of surgery|0
1437404|NCT00927368|4743763|P3|Overall Study|ineligible post randomization|1
1437405|NCT00927368|4743764|P2|Overall Study|ineligible post randomization|3
1437406|NCT00927368|4743765|P1|Overall Study|ineligible post randomization|0
1437407|NCT00927368|4743763|P3|Overall Study|equipment failure|0
1437408|NCT00927368|4743764|P2|Overall Study|equipment failure|0
1437409|NCT00927368|4743765|P1|Overall Study|equipment failure|1
1437410|NCT00927368|4743763|P3|Overall Study|Lost to Follow-up|0
1437411|NCT00927368|4743764|P2|Overall Study|Lost to Follow-up|0
1437412|NCT00927368|4743765|P1|Overall Study|Lost to Follow-up|4
1437413|NCT00927368|4743763|P3|Overall Study|enrollment in another study|2
1437414|NCT00927368|4743764|P2|Overall Study|enrollment in another study|1
1437415|NCT00927368|4743765|P1|Overall Study|enrollment in another study|1
1437416|NCT00927355|4743784|P2|Overall Study|Adverse Event|1
1437417|NCT00927355|4743785|P1|Overall Study|Adverse Event|1
1437418|NCT00927251|4743820|P1|Overall Study|Patients not implanted with 4296 lead|8
1437419|NCT00927186|4743826|P2|12 Months Primary Study|Withdrawal by Subject|1
1437420|NCT00927186|4743827|P1|12 Months Primary Study|Withdrawal by Subject|1
1437421|NCT00927186|4743826|P2|12 Months Primary Study|Protocol Violation|1
1437422|NCT00927186|4743827|P1|12 Months Primary Study|Protocol Violation|0
1437423|NCT00927186|4743826|P2|12 Months Primary Study|Lost to Follow-up|0
1437424|NCT00927186|4743827|P1|12 Months Primary Study|Lost to Follow-up|1
1437425|NCT00927186|4743826|P2|12 Months Primary Study|Adverse Event|2
1437426|NCT00927186|4743827|P1|12 Months Primary Study|Adverse Event|5
1437427|NCT00927095|4743957|P3|Overall Study|Physician Decision|1
1437428|NCT00927095|4743958|P2|Overall Study|Physician Decision|2
1437429|NCT00927095|4743959|P1|Overall Study|Physician Decision|1
1437430|NCT00927095|4743957|P3|Overall Study|Withdrawal by Subject|1
1437431|NCT00927095|4743958|P2|Overall Study|Withdrawal by Subject|1
1437432|NCT00927095|4743959|P1|Overall Study|Withdrawal by Subject|2
1437433|NCT00927095|4743957|P3|Overall Study|Adverse Event|0
1437434|NCT00927095|4743958|P2|Overall Study|Adverse Event|1
1437435|NCT00927095|4743959|P1|Overall Study|Adverse Event|3
1437436|NCT00927082|4743971|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
1437437|NCT00927082|4743972|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
1437438|NCT00927082|4743973|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
1437439|NCT00927082|4743974|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
1437440|NCT00927082|4743971|P4|Overall Study|Death|0
1437441|NCT00927082|4743972|P3|Overall Study|Death|1
1437442|NCT00927082|4743973|P2|Overall Study|Death|0
1437443|NCT00927082|4743974|P1|Overall Study|Death|0
1437444|NCT00927082|4743971|P4|Overall Study|Withdrawal by Subject|2
1437445|NCT00927082|4743972|P3|Overall Study|Withdrawal by Subject|7
1437446|NCT00927082|4743973|P2|Overall Study|Withdrawal by Subject|2
1437447|NCT00927082|4743974|P1|Overall Study|Withdrawal by Subject|3
1437448|NCT00927082|4743971|P4|Overall Study|Lost to Follow-up|16
1437449|NCT00927082|4743972|P3|Overall Study|Lost to Follow-up|12
1437450|NCT00927082|4743973|P2|Overall Study|Lost to Follow-up|8
1437451|NCT00927082|4743974|P1|Overall Study|Lost to Follow-up|9
1437452|NCT00927069|4744038|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
1437453|NCT00927069|4744039|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
1437454|NCT00927069|4744040|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
1437455|NCT00927069|4744041|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
1437456|NCT00927069|4744038|P4|Week 12 to Week 24|Withdrawal by Subject|0
1437457|NCT00927069|4744039|P3|Week 12 to Week 24|Withdrawal by Subject|0
1437458|NCT00927069|4744040|P2|Week 12 to Week 24|Withdrawal by Subject|0
1437459|NCT00927069|4744041|P1|Week 12 to Week 24|Withdrawal by Subject|1
1437460|NCT00927069|4744038|P4|Week 12 to Week 24|Lost to Follow-up|0
1437461|NCT00927069|4744039|P3|Week 12 to Week 24|Lost to Follow-up|1
1437462|NCT00927069|4744040|P2|Week 12 to Week 24|Lost to Follow-up|0
1437463|NCT00927069|4744041|P1|Week 12 to Week 24|Lost to Follow-up|0
1437464|NCT00927069|4744038|P4|Week 12 to Week 24|Lack of Efficacy|3
1437465|NCT00927069|4744039|P3|Week 12 to Week 24|Lack of Efficacy|2
1437466|NCT00927069|4744040|P2|Week 12 to Week 24|Lack of Efficacy|0
1437467|NCT00927069|4744041|P1|Week 12 to Week 24|Lack of Efficacy|0
1437468|NCT00927069|4744038|P4|Week 0 to Week 12|Worsening of psoriasis|0
1437469|NCT00927069|4744039|P3|Week 0 to Week 12|Worsening of psoriasis|0
1437470|NCT00927069|4744040|P2|Week 0 to Week 12|Worsening of psoriasis|1
1437471|NCT00927069|4744041|P1|Week 0 to Week 12|Worsening of psoriasis|1
1437472|NCT00926796|4744097|P2|Overall Study|Withdrawal by Subject|0
1437473|NCT00926796|4744098|P1|Overall Study|Withdrawal by Subject|1
1437474|NCT00926796|4744097|P2|Overall Study|Protocol Violation|11
1437475|NCT00926796|4744098|P1|Overall Study|Protocol Violation|15
1437476|NCT00926796|4744097|P2|Overall Study|Lost to Follow-up|13
1437477|NCT00926796|4744098|P1|Overall Study|Lost to Follow-up|22
1437478|NCT00926796|4744097|P2|Overall Study|Adverse Event|14
1437479|NCT00926796|4744098|P1|Overall Study|Adverse Event|7
1437480|NCT00926796|4744097|P2|Overall Study|Ineligible, but positive for gonorrhea|1
1437481|NCT00926796|4744098|P1|Overall Study|Ineligible, but positive for gonorrhea|1
1437482|NCT00926796|4744097|P2|Overall Study|Ineligible, negative for gonorrhea|60
1437483|NCT00926796|4744098|P1|Overall Study|Ineligible, negative for gonorrhea|57
1437484|NCT00926796|4744097|P2|Overall Study|Did not receive randomized treatment|7
1437485|NCT00926796|4744098|P1|Overall Study|Did not receive randomized treatment|4
1437486|NCT00926783|4744119|P2|Overall Study|Incomplete CFAE Procedures|3
1437487|NCT00926783|4744120|P1|Overall Study|Incomplete CFAE Procedures|3
1437488|NCT00926575|4744147|P2|Overall Study|Withdrawal by Subject|9
1437489|NCT00926575|4744148|P1|Overall Study|Withdrawal by Subject|8
1437490|NCT00926575|4744147|P2|Overall Study|Protocol Violation|0
1437491|NCT00926575|4744148|P1|Overall Study|Protocol Violation|1
1437492|NCT00926575|4744147|P2|Overall Study|Physician Decision|2
1437493|NCT00926575|4744148|P1|Overall Study|Physician Decision|1
1437494|NCT00926575|4744147|P2|Overall Study|Lost to Follow-up|1
1437495|NCT00926575|4744148|P1|Overall Study|Lost to Follow-up|1
1437496|NCT00926575|4744147|P2|Overall Study|Death|4
1437497|NCT00926575|4744148|P1|Overall Study|Death|4
1437498|NCT00926575|4744147|P2|Overall Study|Adverse Event|1
1437499|NCT00926575|4744148|P1|Overall Study|Adverse Event|1
1437500|NCT00926536|4744160|P2|Overall Study|Physician Decision|2
1437501|NCT00926536|4744161|P1|Overall Study|Physician Decision|1
1437502|NCT00926393|4744182|P2|Overall Study|Adverse Event|1
1437503|NCT00926393|4744183|P1|Overall Study|Adverse Event|1
1437504|NCT00926393|4744182|P2|Overall Study|Withdrawal by Subject|2
1437505|NCT00926393|4744183|P1|Overall Study|Withdrawal by Subject|1
1437506|NCT00926367|4744228|P2|Overall Study|Skin Irritation|2
1437507|NCT00926367|4744229|P1|Overall Study|Skin Irritation|1
1437508|NCT00926367|4744228|P2|Overall Study|Lost to Follow-up|0
1437509|NCT00926367|4744229|P1|Overall Study|Lost to Follow-up|1
1437510|NCT00926367|4744228|P2|Overall Study|Withdrawal by Subject|1
1437511|NCT00926367|4744229|P1|Overall Study|Withdrawal by Subject|0
1437512|NCT00926328|4744271|P2|Overall Study|Lost to Follow-up|14
1437513|NCT00926328|4744272|P1|Overall Study|Lost to Follow-up|12
1437514|NCT00926289|4744282|P2|Overall Study|not specified|3
1437515|NCT00926289|4744283|P1|Overall Study|not specified|1
1437516|NCT00926289|4744282|P2|Overall Study|Withdrawal by Subject|4
1437517|NCT00926289|4744283|P1|Overall Study|Withdrawal by Subject|4
1437518|NCT00926289|4744282|P2|Overall Study|Lost to Follow-up|6
1437519|NCT00926289|4744283|P1|Overall Study|Lost to Follow-up|3
1437520|NCT00926289|4744282|P2|Overall Study|Protocol Violation|12
1437521|NCT00926289|4744283|P1|Overall Study|Protocol Violation|8
1437522|NCT00926289|4744282|P2|Overall Study|Adverse Event|11
1437523|NCT00926289|4744283|P1|Overall Study|Adverse Event|9
1437524|NCT00926211|4744351|P1|Overall Study|Lost to Follow-up|1
1437525|NCT00926029|4744382|P3|Overall Study|Lost to Follow-up|1
1437526|NCT00926029|4744383|P2|Overall Study|Lost to Follow-up|1
1437527|NCT00926029|4744384|P1|Overall Study|Lost to Follow-up|2
1437528|NCT00925990|4744397|P2|Overall Study|moved out of state, missed medication|2
1437529|NCT00925990|4744398|P1|Overall Study|moved out of state, missed medication|0
1437530|NCT00925990|4744397|P2|Overall Study|Physician Decision|1
1437531|NCT00925990|4744398|P1|Overall Study|Physician Decision|1
1437532|NCT00925990|4744397|P2|Overall Study|Lost to Follow-up|3
1437533|NCT00925990|4744398|P1|Overall Study|Lost to Follow-up|1
1437534|NCT00925990|4744397|P2|Overall Study|Withdrawal by Subject|2
1437535|NCT00925990|4744398|P1|Overall Study|Withdrawal by Subject|2
1437536|NCT00925990|4744397|P2|Overall Study|Adverse Event|3
1437537|NCT00925990|4744398|P1|Overall Study|Adverse Event|1
1437538|NCT00925899|4744433|P2|Part 1|Withdrawal by Subject|9
1437539|NCT00925899|4744434|P1|Part 1|Withdrawal by Subject|10
1437540|NCT00925899|4744433|P2|Part 1|Death|2
1437541|NCT00925899|4744434|P1|Part 1|Death|1
1437542|NCT00925769|4744462|P6|Overall Study|Adverse Event|0
1437543|NCT00925769|4744463|P5|Overall Study|Adverse Event|1
1437544|NCT00925769|4744464|P4|Overall Study|Adverse Event|0
1437545|NCT00925769|4744465|P3|Overall Study|Adverse Event|0
1437546|NCT00925769|4744466|P2|Overall Study|Adverse Event|0
1437547|NCT00925769|4744467|P1|Overall Study|Adverse Event|0
1437548|NCT00925769|4744462|P6|Overall Study|Participant is unable to swallow drug|0
1437549|NCT00925769|4744463|P5|Overall Study|Participant is unable to swallow drug|0
1437550|NCT00925769|4744464|P4|Overall Study|Participant is unable to swallow drug|1
1437551|NCT00925769|4744465|P3|Overall Study|Participant is unable to swallow drug|0
1437552|NCT00925769|4744466|P2|Overall Study|Participant is unable to swallow drug|0
1437553|NCT00925769|4744467|P1|Overall Study|Participant is unable to swallow drug|0
1437554|NCT00925769|4744462|P6|Overall Study|End of study visit not done|0
1437555|NCT00925769|4744463|P5|Overall Study|End of study visit not done|0
1437556|NCT00925769|4744464|P4|Overall Study|End of study visit not done|0
1437557|NCT00925769|4744465|P3|Overall Study|End of study visit not done|1
1437558|NCT00925769|4744466|P2|Overall Study|End of study visit not done|0
1437559|NCT00925769|4744467|P1|Overall Study|End of study visit not done|0
1437560|NCT00925769|4744462|P6|Overall Study|Missing documentation|0
1437561|NCT00925769|4744463|P5|Overall Study|Missing documentation|0
1437562|NCT00925769|4744464|P4|Overall Study|Missing documentation|0
1437563|NCT00925769|4744465|P3|Overall Study|Missing documentation|0
1437564|NCT00925769|4744466|P2|Overall Study|Missing documentation|1
1437565|NCT00925769|4744467|P1|Overall Study|Missing documentation|0
1437566|NCT00925769|4744462|P6|Overall Study|Physician Decision|0
1437567|NCT00925769|4744463|P5|Overall Study|Physician Decision|0
1437568|NCT00925769|4744464|P4|Overall Study|Physician Decision|0
1437569|NCT00925769|4744465|P3|Overall Study|Physician Decision|0
1437570|NCT00925769|4744466|P2|Overall Study|Physician Decision|0
1437571|NCT00925769|4744467|P1|Overall Study|Physician Decision|1
1437572|NCT00925769|4744462|P6|Overall Study|Death|0
1437573|NCT00925769|4744463|P5|Overall Study|Death|0
1437574|NCT00925769|4744464|P4|Overall Study|Death|0
1437575|NCT00925769|4744465|P3|Overall Study|Death|1
1437576|NCT00925769|4744466|P2|Overall Study|Death|0
1437577|NCT00925769|4744467|P1|Overall Study|Death|0
1437578|NCT00925769|4744462|P6|Overall Study|Disease progression|3
1437579|NCT00925769|4744463|P5|Overall Study|Disease progression|2
1437580|NCT00925769|4744464|P4|Overall Study|Disease progression|4
1437581|NCT00925769|4744465|P3|Overall Study|Disease progression|3
1437582|NCT00925769|4744466|P2|Overall Study|Disease progression|5
1437583|NCT00925769|4744467|P1|Overall Study|Disease progression|4
1437584|NCT00925769|4744462|P6|Overall Study|Major toxicity|0
1437585|NCT00925769|4744463|P5|Overall Study|Major toxicity|0
1437586|NCT00925769|4744464|P4|Overall Study|Major toxicity|1
1437587|NCT00925769|4744465|P3|Overall Study|Major toxicity|1
1437588|NCT00925769|4744466|P2|Overall Study|Major toxicity|0
1437589|NCT00925769|4744467|P1|Overall Study|Major toxicity|1
1437590|NCT00925704|4744535|P6|Third Intervention|Withdrew consent|1
1437591|NCT00925704|4744536|P5|Third Intervention|Withdrew consent|0
1437592|NCT00925704|4744537|P4|Third Intervention|Withdrew consent|0
1437593|NCT00925704|4744538|P3|Third Intervention|Withdrew consent|0
1437594|NCT00925704|4744539|P2|Third Intervention|Withdrew consent|0
1437595|NCT00925704|4744540|P1|Third Intervention|Withdrew consent|0
1437596|NCT00925704|4744535|P6|Second Intervention|Withdrawal by Subject|0
1437597|NCT00925704|4744536|P5|Second Intervention|Withdrawal by Subject|1
1437598|NCT00925704|4744537|P4|Second Intervention|Withdrawal by Subject|0
1437599|NCT00925704|4744538|P3|Second Intervention|Withdrawal by Subject|0
1437600|NCT00925704|4744539|P2|Second Intervention|Withdrawal by Subject|0
1437601|NCT00925704|4744540|P1|Second Intervention|Withdrawal by Subject|1
1437602|NCT00925704|4744535|P6|First Intervention|Withdrew consent|0
1437603|NCT00925704|4744536|P5|First Intervention|Withdrew consent|1
1437604|NCT00925704|4744537|P4|First Intervention|Withdrew consent|1
1437605|NCT00925704|4744538|P3|First Intervention|Withdrew consent|0
1437606|NCT00925704|4744539|P2|First Intervention|Withdrew consent|0
1437607|NCT00925704|4744540|P1|First Intervention|Withdrew consent|0
1437608|NCT00925600|4744553|P2|Overall Study|Adverse Event|2
1437609|NCT00925600|4744554|P1|Overall Study|Adverse Event|1
1437610|NCT00925600|4744553|P2|Overall Study|Other|1
1437611|NCT00925600|4744554|P1|Overall Study|Other|3
1437612|NCT00925600|4744553|P2|Overall Study|Requirement for Alternative Therapy|1
1437613|NCT00925600|4744554|P1|Overall Study|Requirement for Alternative Therapy|0
1437614|NCT00925600|4744553|P2|Overall Study|Protocol Deviation|1
1437615|NCT00925600|4744554|P1|Overall Study|Protocol Deviation|0
1437616|NCT00925600|4744553|P2|Overall Study|Ineligibility Determined|0
1437617|NCT00925600|4744554|P1|Overall Study|Ineligibility Determined|2
1437618|NCT00925600|4744553|P2|Overall Study|Noncompliance|0
1437619|NCT00925600|4744554|P1|Overall Study|Noncompliance|2
1437620|NCT00925600|4744553|P2|Overall Study|Administrative Decision|1
1437621|NCT00925600|4744554|P1|Overall Study|Administrative Decision|1
1437622|NCT00925600|4744553|P2|Overall Study|Disease Progression|3
1437623|NCT00925600|4744554|P1|Overall Study|Disease Progression|1
1437624|NCT00925600|4744553|P2|Overall Study|Lost to Follow-up|2
1437625|NCT00925600|4744554|P1|Overall Study|Lost to Follow-up|2
1437626|NCT00925600|4744553|P2|Overall Study|Death|3
1437627|NCT00925600|4744554|P1|Overall Study|Death|4
1437628|NCT00925600|4744553|P2|Overall Study|Withdrawal by Subject|14
1437629|NCT00925600|4744554|P1|Overall Study|Withdrawal by Subject|16
1437630|NCT00925587|4744576|P2|Overall Study|Lost to Follow-up|1
1437631|NCT00925587|4744577|P1|Overall Study|Lost to Follow-up|0
1437632|NCT00925587|4744576|P2|Overall Study|Adverse Event|2
1437633|NCT00925587|4744577|P1|Overall Study|Adverse Event|6
1437634|NCT00925587|4744576|P2|Overall Study|Death|5
1437635|NCT00925587|4744577|P1|Overall Study|Death|5
1437636|NCT00925587|4744576|P2|Overall Study|Withdrawal by Subject|6
1437637|NCT00925587|4744577|P1|Overall Study|Withdrawal by Subject|9
1437638|NCT00925587|4744576|P2|Overall Study|Protocol Violation|4
1437639|NCT00925587|4744577|P1|Overall Study|Protocol Violation|6
1437640|NCT00925587|4744576|P2|Overall Study|Physician Decision|1
1437641|NCT00925587|4744577|P1|Overall Study|Physician Decision|4
1437642|NCT00925587|4744576|P2|Overall Study|Protocol Specified Criteria|6
1437643|NCT00925587|4744577|P1|Overall Study|Protocol Specified Criteria|6
1437644|NCT00925548|4744691|P2|Overall Study|Discontinuation of trial by sponsor|5
1437645|NCT00925548|4744692|P1|Overall Study|Discontinuation of trial by sponsor|10
1437646|NCT00925353|4744722|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
1437647|NCT00925288|4744728|P2|Overall Study|Lost to Follow-up|7
1437648|NCT00925288|4744729|P1|Overall Study|Lost to Follow-up|9
1437649|NCT00925132|4744741|P5|Overall Study|Removed due to disease progression|4
1437650|NCT00925132|4744742|P4|Overall Study|Removed due to disease progression|0
1437651|NCT00925132|4744743|P3|Overall Study|Removed due to disease progression|0
1437652|NCT00925132|4744744|P2|Overall Study|Removed due to disease progression|0
1437653|NCT00925132|4744745|P1|Overall Study|Removed due to disease progression|0
1437654|NCT00925132|4744741|P5|Overall Study|Withdrawal by Subject|1
1437655|NCT00925132|4744742|P4|Overall Study|Withdrawal by Subject|0
1437656|NCT00925132|4744743|P3|Overall Study|Withdrawal by Subject|0
1437657|NCT00925132|4744744|P2|Overall Study|Withdrawal by Subject|0
1437658|NCT00925132|4744745|P1|Overall Study|Withdrawal by Subject|2
1437659|NCT00925015|4744764|P3|Overall Study|Withdrawal by Subject|1
1437660|NCT00925015|4744765|P2|Overall Study|Withdrawal by Subject|0
1437661|NCT00925015|4744766|P1|Overall Study|Withdrawal by Subject|0
1437662|NCT00925015|4744764|P3|Overall Study|Progressive Disease|4
1437663|NCT00925015|4744765|P2|Overall Study|Progressive Disease|3
1437664|NCT00925015|4744766|P1|Overall Study|Progressive Disease|7
1437665|NCT00925015|4744764|P3|Overall Study|Physician Decision|0
1437666|NCT00925015|4744765|P2|Overall Study|Physician Decision|1
1437667|NCT00925015|4744766|P1|Overall Study|Physician Decision|0
1437668|NCT00925015|4744764|P3|Overall Study|Adverse Event|1
1437669|NCT00925015|4744765|P2|Overall Study|Adverse Event|2
1437670|NCT00925015|4744766|P1|Overall Study|Adverse Event|1
1437671|NCT00924950|4744822|P1|Overall Study|Lost to Follow-up|2
1437672|NCT00924898|4744827|P1|Overall Study|Withdrawal by Subject|2
1437673|NCT00924781|4744863|P2|Overall Study|Study terminated by sponsor|10
1437674|NCT00924781|4744864|P1|Overall Study|Study terminated by sponsor|12
1437675|NCT00924729|4744898|P2|Overall Study|Protocol Violation|0
1437676|NCT00924729|4744899|P1|Overall Study|Protocol Violation|1
1437677|NCT00924729|4744898|P2|Overall Study|insufficient volume for analysis|0
1437678|NCT00924729|4744899|P1|Overall Study|insufficient volume for analysis|1
1437679|NCT00924651|4744909|P2|Overall Study|Incomplete Form|1
1437680|NCT00924651|4744910|P1|Overall Study|Incomplete Form|2
1437681|NCT00924651|4744909|P2|Overall Study|Changed Mind|1
1437682|NCT00924651|4744910|P1|Overall Study|Changed Mind|10
1437683|NCT00924651|4744909|P2|Overall Study|Medical|3
1437684|NCT00924651|4744910|P1|Overall Study|Medical|1
1437685|NCT00924651|4744909|P2|Overall Study|Noncompliant|4
1437686|NCT00924651|4744910|P1|Overall Study|Noncompliant|1
1437687|NCT00924651|4744909|P2|Overall Study|Overwhelmed|6
1437688|NCT00924651|4744910|P1|Overall Study|Overwhelmed|6
1437689|NCT00924651|4744909|P2|Overall Study|No Reason|7
1437690|NCT00924651|4744910|P1|Overall Study|No Reason|3
1437691|NCT00924651|4744909|P2|Overall Study|Chemo started too soon|3
1437692|NCT00924651|4744910|P1|Overall Study|Chemo started too soon|2
1437693|NCT00924638|4744918|P2|Overall Study|Physician Decision|3
1437694|NCT00924638|4744919|P1|Overall Study|Physician Decision|3
1437695|NCT00924638|4744918|P2|Overall Study|Withdrawal by Subject|7
1437696|NCT00924638|4744919|P1|Overall Study|Withdrawal by Subject|5
1437697|NCT00924638|4744918|P2|Overall Study|Lost to Follow-up|1
1437698|NCT00924638|4744919|P1|Overall Study|Lost to Follow-up|1
1437699|NCT00924638|4744918|P2|Overall Study|Death|2
1437700|NCT00924638|4744919|P1|Overall Study|Death|3
1437701|NCT00924560|4744941|P3|Overall Study|Miscellaneous Reasons|10
1437702|NCT00924560|4744942|P2|Overall Study|Miscellaneous Reasons|10
1437703|NCT00924560|4744943|P1|Overall Study|Miscellaneous Reasons|13
1437704|NCT00924560|4744941|P3|Overall Study|Lost to Follow-up|45
1437705|NCT00924560|4744942|P2|Overall Study|Lost to Follow-up|94
1437706|NCT00924560|4744943|P1|Overall Study|Lost to Follow-up|78
1437707|NCT00924560|4744941|P3|Overall Study|Pregnancy|1
1437708|NCT00924560|4744942|P2|Overall Study|Pregnancy|7
1437709|NCT00924560|4744943|P1|Overall Study|Pregnancy|5
1437710|NCT00924560|4744941|P3|Overall Study|Adverse Event|0
1437711|NCT00924560|4744942|P2|Overall Study|Adverse Event|33
1437712|NCT00924560|4744943|P1|Overall Study|Adverse Event|39
1437713|NCT00924560|4744941|P3|Overall Study|Withdrawal by Subject|18
1437714|NCT00924560|4744942|P2|Overall Study|Withdrawal by Subject|44
1437715|NCT00924560|4744943|P1|Overall Study|Withdrawal by Subject|50
1437716|NCT00924560|4744941|P3|Overall Study|Physician Decision|4
1437717|NCT00924560|4744942|P2|Overall Study|Physician Decision|3
1437718|NCT00924560|4744943|P1|Overall Study|Physician Decision|2
1437719|NCT00924560|4744941|P3|Overall Study|Non Compliance with the Protocol|4
1437720|NCT00924560|4744942|P2|Overall Study|Non Compliance with the Protocol|15
1437721|NCT00924560|4744943|P1|Overall Study|Non Compliance with the Protocol|20
1437722|NCT00924560|4744941|P3|Overall Study|Did Not Meet Protocol Requirements|1
1437723|NCT00924560|4744942|P2|Overall Study|Did Not Meet Protocol Requirements|2
1437724|NCT00924560|4744943|P1|Overall Study|Did Not Meet Protocol Requirements|4
1437725|NCT00924508|4744987|P1|Overall Study|Withdrawal by Subject|3
1437726|NCT00924469|4745001|P2|Overall Study|Lost to Follow-up|1
1437727|NCT00924469|4745002|P1|Overall Study|Lost to Follow-up|0
1437728|NCT00924469|4745001|P2|Overall Study|Withdrawal by Subject|1
1437729|NCT00924469|4745002|P1|Overall Study|Withdrawal by Subject|0
1437730|NCT00924469|4745001|P2|Overall Study|Adverse Event|0
1437731|NCT00924469|4745002|P1|Overall Study|Adverse Event|2
1437732|NCT00924443|4745024|P1|Overall Study|Protocol Violation|1
1437733|NCT00924443|4745024|P1|Overall Study|Physician Decision|2
1437734|NCT00924404|4745034|P2|Overall Study|Lost to Follow-up|4
1437735|NCT00924404|4745035|P1|Overall Study|Lost to Follow-up|6
1437736|NCT00924313|4745057|P1|Overall Study|not imaged due to failed tracer imaging|1
1437737|NCT00924287|4745069|P1|Overall Study|Death|1
1437738|NCT00924170|4745082|P2|Overall Study|Death|0
1437739|NCT00924170|4745083|P1|Overall Study|Death|1
1437740|NCT00924170|4745082|P2|Overall Study|Stopped due to neutralizing antibodies|0
1437741|NCT00924170|4745083|P1|Overall Study|Stopped due to neutralizing antibodies|3
1437742|NCT00924170|4745082|P2|Overall Study|Progressive disease|6
1437743|NCT00924170|4745083|P1|Overall Study|Progressive disease|3
1437744|NCT00924170|4745082|P2|Overall Study|Physician Decision|1
1437745|NCT00924170|4745083|P1|Overall Study|Physician Decision|0
1437746|NCT00924170|4745082|P2|Overall Study|Refused further treatment|1
1437747|NCT00924170|4745083|P1|Overall Study|Refused further treatment|0
1437748|NCT00923975|4745208|P1|Overall Study|Did not meet inclusion criteria|1
1437749|NCT00923936|4745227|P2|Overall Study|Continuing in follow up period|1
1437750|NCT00923936|4745228|P1|Overall Study|Continuing in follow up period|2
1437751|NCT00923936|4745227|P2|Overall Study|Lost to follow up|0
1437752|NCT00923936|4745228|P1|Overall Study|Lost to follow up|2
1437753|NCT00923936|4745227|P2|Overall Study|Adverse Event|1
1437754|NCT00923936|4745228|P1|Overall Study|Adverse Event|2
1437755|NCT00923936|4745227|P2|Overall Study|progressive disease on study|1
1437756|NCT00923936|4745228|P1|Overall Study|progressive disease on study|2
1437757|NCT00923845|4745257|P2|Induction Therapy|Poor performance status|2
1437758|NCT00923845|4745258|P1|Induction Therapy|Poor performance status|0
1437759|NCT00923364|4745284|P2|Overall Study|Did not go to transplant|0
1437760|NCT00923364|4745285|P1|Overall Study|Did not go to transplant|1
1437761|NCT00923364|4745284|P2|Overall Study|Death|0
1437762|NCT00923364|4745285|P1|Overall Study|Death|3
1437763|NCT00923351|4745297|P3|Overall Study|no apheresis/adequate tumor sample|12
1437764|NCT00923351|4745298|P2|Overall Study|no apheresis/adequate tumor sample|0
1437765|NCT00923351|4745299|P1|Overall Study|no apheresis/adequate tumor sample|0
1437766|NCT00923273|4745314|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
1437767|NCT00923273|4745315|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
1437768|NCT00923273|4745316|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
1437769|NCT00923273|4745317|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
1437770|NCT00923273|4745318|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
1437771|NCT00923273|4745314|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
1437772|NCT00923273|4745315|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
1437773|NCT00923273|4745316|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
1437774|NCT00923273|4745317|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
1437775|NCT00923273|4745318|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
1437776|NCT00923260|4745343|P2|Overall Study|Lost to Follow-up|1
1437777|NCT00923260|4745344|P1|Overall Study|Lost to Follow-up|1
1437778|NCT00923195|4745507|P2|Overall Study|Death|1
1437779|NCT00923195|4745508|P1|Overall Study|Death|0
1437780|NCT00923156|4745519|P3|Overall Study|Lack of Efficacy|1
1437781|NCT00923156|4745520|P2|Overall Study|Lack of Efficacy|0
1437782|NCT00923156|4745521|P1|Overall Study|Lack of Efficacy|0
1437783|NCT00923156|4745519|P3|Overall Study|Death|0
1437784|NCT00923156|4745520|P2|Overall Study|Death|1
1437785|NCT00923156|4745521|P1|Overall Study|Death|0
1437786|NCT00923156|4745519|P3|Overall Study|Withdrawal by Subject|0
1437787|NCT00923156|4745520|P2|Overall Study|Withdrawal by Subject|1
1437788|NCT00923156|4745521|P1|Overall Study|Withdrawal by Subject|0
1437789|NCT00923156|4745519|P3|Overall Study|Abnormal laboratory values|1
1437790|NCT00923156|4745520|P2|Overall Study|Abnormal laboratory values|0
1437791|NCT00923156|4745521|P1|Overall Study|Abnormal laboratory values|0
1437792|NCT00923156|4745519|P3|Overall Study|Adverse Event|1
1437793|NCT00923156|4745520|P2|Overall Study|Adverse Event|2
1437794|NCT00923156|4745521|P1|Overall Study|Adverse Event|0
1437795|NCT00923130|4745547|P1|Overall Study|Refused further treatment|2
1437796|NCT00923130|4745547|P1|Overall Study|Switched to alternative treatment|2
1437797|NCT00923130|4745547|P1|Overall Study|Discontinued treatment due to toxicities|3
1437798|NCT00923130|4745547|P1|Overall Study|Death|1
1437799|NCT00923130|4745547|P1|Overall Study|Stopped treatment due to progression|17
1437800|NCT00923091|4745582|P13|Period VI (Open-Label)|Other Reason|0
1437801|NCT00923091|4745583|P12|Period VI (Open-Label)|Other Reason|0
1437802|NCT00923091|4745584|P11|Period VI (Open-Label)|Other Reason|0
1437803|NCT00923091|4745585|P10|Period VI (Open-Label)|Other Reason|0
1437804|NCT00923091|4745586|P9|Period VI (Open-Label)|Other Reason|0
1437805|NCT00923091|4745587|P8|Period VI (Open-Label)|Other Reason|0
1437806|NCT00923091|4745588|P7|Period VI (Open-Label)|Other Reason|0
1437807|NCT00923091|4745589|P6|Period VI (Open-Label)|Other Reason|0
1437808|NCT00923091|4745590|P5|Period VI (Open-Label)|Other Reason|1
1437809|NCT00923091|4745591|P4|Period VI (Open-Label)|Other Reason|1
1437810|NCT00923091|4745592|P3|Period VI (Open-Label)|Other Reason|0
1437811|NCT00923091|4745593|P2|Period VI (Open-Label)|Other Reason|0
1437812|NCT00923091|4745594|P1|Period VI (Open-Label)|Other Reason|0
1437813|NCT00923091|4745582|P13|Period VI (Open-Label)|Lost to Follow-up|0
1437814|NCT00923091|4745583|P12|Period VI (Open-Label)|Lost to Follow-up|0
1437815|NCT00923091|4745584|P11|Period VI (Open-Label)|Lost to Follow-up|0
1437816|NCT00923091|4745585|P10|Period VI (Open-Label)|Lost to Follow-up|0
1437817|NCT00923091|4745586|P9|Period VI (Open-Label)|Lost to Follow-up|0
1437818|NCT00923091|4745587|P8|Period VI (Open-Label)|Lost to Follow-up|0
1437819|NCT00923091|4745588|P7|Period VI (Open-Label)|Lost to Follow-up|0
1437820|NCT00923091|4745589|P6|Period VI (Open-Label)|Lost to Follow-up|0
1437821|NCT00923091|4745590|P5|Period VI (Open-Label)|Lost to Follow-up|0
1437822|NCT00923091|4745591|P4|Period VI (Open-Label)|Lost to Follow-up|0
1437823|NCT00923091|4745592|P3|Period VI (Open-Label)|Lost to Follow-up|1
1437824|NCT00923091|4745593|P2|Period VI (Open-Label)|Lost to Follow-up|0
1437825|NCT00923091|4745594|P1|Period VI (Open-Label)|Lost to Follow-up|1
1437826|NCT00923091|4745582|P13|Period VI (Open-Label)|Protocol Violation|0
1437827|NCT00923091|4745583|P12|Period VI (Open-Label)|Protocol Violation|0
1437828|NCT00923091|4745584|P11|Period VI (Open-Label)|Protocol Violation|0
1437829|NCT00923091|4745585|P10|Period VI (Open-Label)|Protocol Violation|0
1437830|NCT00923091|4745586|P9|Period VI (Open-Label)|Protocol Violation|0
1437831|NCT00923091|4745587|P8|Period VI (Open-Label)|Protocol Violation|0
1437832|NCT00923091|4745588|P7|Period VI (Open-Label)|Protocol Violation|0
1437833|NCT00923091|4745589|P6|Period VI (Open-Label)|Protocol Violation|0
1437834|NCT00923091|4745590|P5|Period VI (Open-Label)|Protocol Violation|4
1437835|NCT00923091|4745591|P4|Period VI (Open-Label)|Protocol Violation|1
1437836|NCT00923091|4745592|P3|Period VI (Open-Label)|Protocol Violation|3
1437837|NCT00923091|4745593|P2|Period VI (Open-Label)|Protocol Violation|1
1437838|NCT00923091|4745594|P1|Period VI (Open-Label)|Protocol Violation|6
1437839|NCT00923091|4745582|P13|Period VI (Open-Label)|Withdrawal by Subject|0
1437840|NCT00923091|4745583|P12|Period VI (Open-Label)|Withdrawal by Subject|0
1437841|NCT00923091|4745584|P11|Period VI (Open-Label)|Withdrawal by Subject|0
1437842|NCT00923091|4745585|P10|Period VI (Open-Label)|Withdrawal by Subject|0
1437843|NCT00923091|4745586|P9|Period VI (Open-Label)|Withdrawal by Subject|0
1437844|NCT00923091|4745587|P8|Period VI (Open-Label)|Withdrawal by Subject|0
1437845|NCT00923091|4745588|P7|Period VI (Open-Label)|Withdrawal by Subject|0
1437846|NCT00923091|4745589|P6|Period VI (Open-Label)|Withdrawal by Subject|0
1437847|NCT00923091|4745590|P5|Period VI (Open-Label)|Withdrawal by Subject|1
1437848|NCT00923091|4745591|P4|Period VI (Open-Label)|Withdrawal by Subject|0
1437849|NCT00923091|4745592|P3|Period VI (Open-Label)|Withdrawal by Subject|5
1437850|NCT00923091|4745593|P2|Period VI (Open-Label)|Withdrawal by Subject|7
1437851|NCT00923091|4745594|P1|Period VI (Open-Label)|Withdrawal by Subject|15
1437852|NCT00923091|4745582|P13|Period VI (Open-Label)|Adverse Event|0
1437853|NCT00923091|4745583|P12|Period VI (Open-Label)|Adverse Event|0
1437854|NCT00923091|4745584|P11|Period VI (Open-Label)|Adverse Event|0
1437855|NCT00923091|4745585|P10|Period VI (Open-Label)|Adverse Event|0
1437856|NCT00923091|4745586|P9|Period VI (Open-Label)|Adverse Event|0
1437857|NCT00923091|4745587|P8|Period VI (Open-Label)|Adverse Event|0
1437858|NCT00923091|4745588|P7|Period VI (Open-Label)|Adverse Event|0
1437859|NCT00923091|4745589|P6|Period VI (Open-Label)|Adverse Event|0
1437860|NCT00923091|4745590|P5|Period VI (Open-Label)|Adverse Event|1
1437861|NCT00923091|4745591|P4|Period VI (Open-Label)|Adverse Event|1
1437862|NCT00923091|4745592|P3|Period VI (Open-Label)|Adverse Event|4
1437863|NCT00923091|4745593|P2|Period VI (Open-Label)|Adverse Event|0
1437864|NCT00923091|4745594|P1|Period VI (Open-Label)|Adverse Event|17
1437865|NCT00923091|4745582|P13|Period V (Double -Blind)|Lost to Follow-up|0
1437866|NCT00923091|4745583|P12|Period V (Double -Blind)|Lost to Follow-up|0
1437867|NCT00923091|4745584|P11|Period V (Double -Blind)|Lost to Follow-up|1
1437868|NCT00923091|4745585|P10|Period V (Double -Blind)|Lost to Follow-up|0
1437869|NCT00923091|4745586|P9|Period V (Double -Blind)|Lost to Follow-up|0
1437870|NCT00923091|4745587|P8|Period V (Double -Blind)|Lost to Follow-up|0
1437871|NCT00923091|4745588|P7|Period V (Double -Blind)|Lost to Follow-up|0
1437872|NCT00923091|4745589|P6|Period V (Double -Blind)|Lost to Follow-up|0
1437873|NCT00923091|4745590|P5|Period V (Double -Blind)|Lost to Follow-up|0
1437874|NCT00923091|4745591|P4|Period V (Double -Blind)|Lost to Follow-up|0
1437875|NCT00923091|4745592|P3|Period V (Double -Blind)|Lost to Follow-up|0
1437876|NCT00923091|4745593|P2|Period V (Double -Blind)|Lost to Follow-up|0
1437877|NCT00923091|4745594|P1|Period V (Double -Blind)|Lost to Follow-up|0
1437878|NCT00923091|4745582|P13|Period V (Double -Blind)|Protocol Violation|1
1437879|NCT00923091|4745583|P12|Period V (Double -Blind)|Protocol Violation|0
1437880|NCT00923091|4745584|P11|Period V (Double -Blind)|Protocol Violation|0
1437881|NCT00923091|4745585|P10|Period V (Double -Blind)|Protocol Violation|0
1437882|NCT00923091|4745586|P9|Period V (Double -Blind)|Protocol Violation|0
1437883|NCT00923091|4745587|P8|Period V (Double -Blind)|Protocol Violation|0
1437884|NCT00923091|4745588|P7|Period V (Double -Blind)|Protocol Violation|0
1437885|NCT00923091|4745589|P6|Period V (Double -Blind)|Protocol Violation|0
1437886|NCT00923091|4745590|P5|Period V (Double -Blind)|Protocol Violation|0
1437887|NCT00923091|4745591|P4|Period V (Double -Blind)|Protocol Violation|0
1437888|NCT00923091|4745592|P3|Period V (Double -Blind)|Protocol Violation|0
1437889|NCT00923091|4745593|P2|Period V (Double -Blind)|Protocol Violation|0
1437890|NCT00923091|4745594|P1|Period V (Double -Blind)|Protocol Violation|0
1437891|NCT00923091|4745582|P13|Period V (Double -Blind)|Withdrawal by Subject|1
1437892|NCT00923091|4745583|P12|Period V (Double -Blind)|Withdrawal by Subject|0
1437893|NCT00923091|4745584|P11|Period V (Double -Blind)|Withdrawal by Subject|0
1437894|NCT00923091|4745585|P10|Period V (Double -Blind)|Withdrawal by Subject|0
1437895|NCT00923091|4745586|P9|Period V (Double -Blind)|Withdrawal by Subject|1
1437896|NCT00923091|4745587|P8|Period V (Double -Blind)|Withdrawal by Subject|0
1437897|NCT00923091|4745588|P7|Period V (Double -Blind)|Withdrawal by Subject|0
1437898|NCT00923091|4745589|P6|Period V (Double -Blind)|Withdrawal by Subject|0
1437899|NCT00923091|4745590|P5|Period V (Double -Blind)|Withdrawal by Subject|0
1437900|NCT00923091|4745591|P4|Period V (Double -Blind)|Withdrawal by Subject|0
1437901|NCT00923091|4745592|P3|Period V (Double -Blind)|Withdrawal by Subject|0
1437902|NCT00923091|4745593|P2|Period V (Double -Blind)|Withdrawal by Subject|0
1437903|NCT00923091|4745594|P1|Period V (Double -Blind)|Withdrawal by Subject|0
1437904|NCT00923091|4745582|P13|Period IV (Double-Blind)|Protocol Violation|0
1437905|NCT00923091|4745583|P12|Period IV (Double-Blind)|Protocol Violation|0
1437906|NCT00923091|4745584|P11|Period IV (Double-Blind)|Protocol Violation|0
1437907|NCT00923091|4745585|P10|Period IV (Double-Blind)|Protocol Violation|0
1437908|NCT00923091|4745586|P9|Period IV (Double-Blind)|Protocol Violation|0
1437909|NCT00923091|4745587|P8|Period IV (Double-Blind)|Protocol Violation|0
1437910|NCT00923091|4745588|P7|Period IV (Double-Blind)|Protocol Violation|0
1437911|NCT00923091|4745589|P6|Period IV (Double-Blind)|Protocol Violation|0
1437912|NCT00923091|4745590|P5|Period IV (Double-Blind)|Protocol Violation|0
1437913|NCT00923091|4745591|P4|Period IV (Double-Blind)|Protocol Violation|0
1437914|NCT00923091|4745592|P3|Period IV (Double-Blind)|Protocol Violation|0
1437915|NCT00923091|4745593|P2|Period IV (Double-Blind)|Protocol Violation|1
1437916|NCT00923091|4745594|P1|Period IV (Double-Blind)|Protocol Violation|0
1437917|NCT00923091|4745582|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
1437918|NCT00923091|4745583|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
1437919|NCT00923091|4745584|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
1437920|NCT00923091|4745585|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
1437921|NCT00923091|4745586|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
1437922|NCT00923091|4745587|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
1437923|NCT00923091|4745588|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
1437924|NCT00923091|4745589|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
1437925|NCT00923091|4745590|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
1437926|NCT00923091|4745591|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
1437927|NCT00923091|4745592|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
1437928|NCT00923091|4745593|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
1437929|NCT00923091|4745594|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
1437930|NCT00923091|4745582|P13|Period IV (Double-Blind)|Adverse Event|0
1437931|NCT00923091|4745583|P12|Period IV (Double-Blind)|Adverse Event|0
1437932|NCT00923091|4745584|P11|Period IV (Double-Blind)|Adverse Event|0
1437933|NCT00923091|4745585|P10|Period IV (Double-Blind)|Adverse Event|0
1437934|NCT00923091|4745586|P9|Period IV (Double-Blind)|Adverse Event|0
1437935|NCT00923091|4745587|P8|Period IV (Double-Blind)|Adverse Event|0
1437936|NCT00923091|4745588|P7|Period IV (Double-Blind)|Adverse Event|0
1437937|NCT00923091|4745589|P6|Period IV (Double-Blind)|Adverse Event|0
1437938|NCT00923091|4745590|P5|Period IV (Double-Blind)|Adverse Event|0
1437939|NCT00923091|4745591|P4|Period IV (Double-Blind)|Adverse Event|0
1437940|NCT00923091|4745592|P3|Period IV (Double-Blind)|Adverse Event|0
1437941|NCT00923091|4745593|P2|Period IV (Double-Blind)|Adverse Event|0
1437942|NCT00923091|4745594|P1|Period IV (Double-Blind)|Adverse Event|2
1437943|NCT00923091|4745582|P13|Period III (Single-Blind)|Lost to Follow-up|0
1437944|NCT00923091|4745583|P12|Period III (Single-Blind)|Lost to Follow-up|0
1437945|NCT00923091|4745584|P11|Period III (Single-Blind)|Lost to Follow-up|0
1437946|NCT00923091|4745585|P10|Period III (Single-Blind)|Lost to Follow-up|0
1437947|NCT00923091|4745586|P9|Period III (Single-Blind)|Lost to Follow-up|0
1437948|NCT00923091|4745587|P8|Period III (Single-Blind)|Lost to Follow-up|0
1437949|NCT00923091|4745588|P7|Period III (Single-Blind)|Lost to Follow-up|0
1437950|NCT00923091|4745589|P6|Period III (Single-Blind)|Lost to Follow-up|0
1437951|NCT00923091|4745590|P5|Period III (Single-Blind)|Lost to Follow-up|0
1437952|NCT00923091|4745591|P4|Period III (Single-Blind)|Lost to Follow-up|0
1437953|NCT00923091|4745592|P3|Period III (Single-Blind)|Lost to Follow-up|0
1437954|NCT00923091|4745593|P2|Period III (Single-Blind)|Lost to Follow-up|0
1437955|NCT00923091|4745594|P1|Period III (Single-Blind)|Lost to Follow-up|2
1437956|NCT00923091|4745582|P13|Period III (Single-Blind)|Protocol Violation|0
1437957|NCT00923091|4745583|P12|Period III (Single-Blind)|Protocol Violation|0
1437958|NCT00923091|4745584|P11|Period III (Single-Blind)|Protocol Violation|0
1437959|NCT00923091|4745585|P10|Period III (Single-Blind)|Protocol Violation|0
1437960|NCT00923091|4745586|P9|Period III (Single-Blind)|Protocol Violation|0
1437961|NCT00923091|4745587|P8|Period III (Single-Blind)|Protocol Violation|0
1437962|NCT00923091|4745588|P7|Period III (Single-Blind)|Protocol Violation|0
1437963|NCT00923091|4745589|P6|Period III (Single-Blind)|Protocol Violation|0
1437964|NCT00923091|4745590|P5|Period III (Single-Blind)|Protocol Violation|0
1437965|NCT00923091|4745591|P4|Period III (Single-Blind)|Protocol Violation|0
1437966|NCT00923091|4745592|P3|Period III (Single-Blind)|Protocol Violation|0
1437967|NCT00923091|4745593|P2|Period III (Single-Blind)|Protocol Violation|0
1437968|NCT00923091|4745594|P1|Period III (Single-Blind)|Protocol Violation|3
1437969|NCT00923091|4745582|P13|Period III (Single-Blind)|Withdrawal by Subject|0
1437970|NCT00923091|4745583|P12|Period III (Single-Blind)|Withdrawal by Subject|0
1437971|NCT00923091|4745584|P11|Period III (Single-Blind)|Withdrawal by Subject|0
1437972|NCT00923091|4745585|P10|Period III (Single-Blind)|Withdrawal by Subject|0
1437973|NCT00923091|4745586|P9|Period III (Single-Blind)|Withdrawal by Subject|0
1437974|NCT00923091|4745587|P8|Period III (Single-Blind)|Withdrawal by Subject|0
1437975|NCT00923091|4745588|P7|Period III (Single-Blind)|Withdrawal by Subject|0
1437976|NCT00923091|4745589|P6|Period III (Single-Blind)|Withdrawal by Subject|0
1437977|NCT00923091|4745590|P5|Period III (Single-Blind)|Withdrawal by Subject|0
1437978|NCT00923091|4745591|P4|Period III (Single-Blind)|Withdrawal by Subject|0
1437979|NCT00923091|4745592|P3|Period III (Single-Blind)|Withdrawal by Subject|0
1437980|NCT00923091|4745593|P2|Period III (Single-Blind)|Withdrawal by Subject|0
1437981|NCT00923091|4745594|P1|Period III (Single-Blind)|Withdrawal by Subject|10
1437982|NCT00923091|4745582|P13|Period III (Single-Blind)|Adverse Event|0
1437983|NCT00923091|4745583|P12|Period III (Single-Blind)|Adverse Event|0
1437984|NCT00923091|4745584|P11|Period III (Single-Blind)|Adverse Event|0
1437985|NCT00923091|4745585|P10|Period III (Single-Blind)|Adverse Event|0
1437986|NCT00923091|4745586|P9|Period III (Single-Blind)|Adverse Event|0
1437987|NCT00923091|4745587|P8|Period III (Single-Blind)|Adverse Event|0
1437988|NCT00923091|4745588|P7|Period III (Single-Blind)|Adverse Event|0
1437989|NCT00923091|4745589|P6|Period III (Single-Blind)|Adverse Event|0
1437990|NCT00923091|4745590|P5|Period III (Single-Blind)|Adverse Event|0
1437991|NCT00923091|4745591|P4|Period III (Single-Blind)|Adverse Event|0
1437992|NCT00923091|4745592|P3|Period III (Single-Blind)|Adverse Event|0
1437993|NCT00923091|4745593|P2|Period III (Single-Blind)|Adverse Event|0
1437994|NCT00923091|4745594|P1|Period III (Single-Blind)|Adverse Event|5
1437995|NCT00923091|4745582|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1437996|NCT00923091|4745583|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1437997|NCT00923091|4745584|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1437998|NCT00923091|4745585|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1437999|NCT00923091|4745586|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1438000|NCT00923091|4745587|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1438001|NCT00923091|4745588|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1438002|NCT00923091|4745589|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
1438003|NCT00923091|4745590|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1438004|NCT00923091|4745591|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
1438005|NCT00923091|4745592|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1438006|NCT00923091|4745593|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
1438007|NCT00923091|4745594|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1438008|NCT00923091|4745582|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1438009|NCT00923091|4745583|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1438010|NCT00923091|4745584|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1438011|NCT00923091|4745585|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1438012|NCT00923091|4745586|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1438013|NCT00923091|4745587|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1438014|NCT00923091|4745588|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1438015|NCT00923091|4745589|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
1438016|NCT00923091|4745590|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1438017|NCT00923091|4745591|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1438018|NCT00923091|4745592|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1438019|NCT00923091|4745593|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1438020|NCT00923091|4745594|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1438021|NCT00923091|4745582|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
1438022|NCT00923091|4745583|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
1438023|NCT00923091|4745584|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
1438024|NCT00923091|4745585|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
1438025|NCT00923091|4745586|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
1438026|NCT00923091|4745587|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
1438027|NCT00923091|4745588|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
1438028|NCT00923091|4745589|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
1438029|NCT00923091|4745590|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
1438030|NCT00923091|4745591|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
1438031|NCT00923091|4745592|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
1438032|NCT00923091|4745593|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
1438033|NCT00923091|4745594|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
1438034|NCT00923091|4745582|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
1438035|NCT00923091|4745583|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
1438036|NCT00923091|4745584|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
1438037|NCT00923091|4745585|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
1438038|NCT00923091|4745586|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
1438039|NCT00923091|4745587|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
1438040|NCT00923091|4745588|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
1438041|NCT00923091|4745589|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
1438042|NCT00923091|4745590|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
1438043|NCT00923091|4745591|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
1438044|NCT00923091|4745592|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
1438045|NCT00923091|4745593|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
1438046|NCT00923091|4745594|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
1438047|NCT00923091|4745582|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
1438048|NCT00923091|4745583|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
1438049|NCT00923091|4745584|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
1438050|NCT00923091|4745585|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
1438051|NCT00923091|4745586|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
1438052|NCT00923091|4745587|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
1438053|NCT00923091|4745588|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
1438054|NCT00923091|4745589|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
1438055|NCT00923091|4745590|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
1438056|NCT00923091|4745591|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
1438057|NCT00923091|4745592|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
1438058|NCT00923091|4745593|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
1438059|NCT00923091|4745594|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
1438060|NCT00923078|4745644|P3|First Intervention (Weeks 1-4)|No intervention per protocol|20
1438061|NCT00923078|4745645|P2|First Intervention (Weeks 1-4)|No intervention per protocol|0
1438062|NCT00923078|4745646|P1|First Intervention (Weeks 1-4)|No intervention per protocol|0
1438063|NCT00923078|4745644|P3|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
1438064|NCT00923078|4745645|P2|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
1438065|NCT00923078|4745646|P1|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
1438066|NCT00922987|4745665|P1|Overall Study|Adverse Event|1
1438067|NCT00922987|4745665|P1|Overall Study|Protocol Violation|2
1438068|NCT00922987|4745665|P1|Overall Study|Insufficient clinical response|1
1438069|NCT00922935|4745680|P3|Overall Study|Lost to Follow-up|0
1438070|NCT00922935|4745681|P2|Overall Study|Lost to Follow-up|1
1438071|NCT00922935|4745682|P1|Overall Study|Lost to Follow-up|0
1438072|NCT00922935|4745680|P3|Overall Study|Physician Decision|0
1438073|NCT00922935|4745681|P2|Overall Study|Physician Decision|1
1438074|NCT00922935|4745682|P1|Overall Study|Physician Decision|1
1438075|NCT00922935|4745680|P3|Overall Study|Protocol Violation|0
1438076|NCT00922935|4745681|P2|Overall Study|Protocol Violation|3
1438077|NCT00922935|4745682|P1|Overall Study|Protocol Violation|0
1438078|NCT00922779|4745694|P1|Overall Study|Missing|1874
1438079|NCT00922779|4745694|P1|Overall Study|Other|27
1438080|NCT00922779|4745694|P1|Overall Study|Lost to Follow-up|44
1438081|NCT00922779|4745694|P1|Overall Study|Withdrawal by Subject|308
1438082|NCT00922779|4745694|P1|Overall Study|Pregnancy|7
1438083|NCT00922779|4745694|P1|Overall Study|Adverse Event|67
1438084|NCT00922766|4745701|P1|Overall Study|Adverse Event|1
1438085|NCT00922766|4745701|P1|Overall Study|Other|1
1438086|NCT00922766|4745701|P1|Overall Study|Withdrawal by Subject|2
1438087|NCT00922766|4745701|P1|Overall Study|Death|3
1438088|NCT00922636|4745719|P5|Overall Study|Lost to Follow-up|4
1438089|NCT00922636|4745720|P4|Overall Study|Lost to Follow-up|2
1438090|NCT00922636|4745721|P3|Overall Study|Lost to Follow-up|2
1438091|NCT00922636|4745722|P2|Overall Study|Lost to Follow-up|2
1438092|NCT00922636|4745723|P1|Overall Study|Lost to Follow-up|1
1438093|NCT00922636|4745719|P5|Overall Study|Parent/Caregiver Decision|2
1438094|NCT00922636|4745720|P4|Overall Study|Parent/Caregiver Decision|5
1438095|NCT00922636|4745721|P3|Overall Study|Parent/Caregiver Decision|3
1438096|NCT00922636|4745722|P2|Overall Study|Parent/Caregiver Decision|4
1438097|NCT00922636|4745723|P1|Overall Study|Parent/Caregiver Decision|2
1438098|NCT00922636|4745719|P5|Overall Study|Entry Criteria Not Met|0
1438099|NCT00922636|4745720|P4|Overall Study|Entry Criteria Not Met|1
1438100|NCT00922636|4745721|P3|Overall Study|Entry Criteria Not Met|1
1438101|NCT00922636|4745722|P2|Overall Study|Entry Criteria Not Met|0
1438102|NCT00922636|4745723|P1|Overall Study|Entry Criteria Not Met|0
1438103|NCT00922636|4745719|P5|Overall Study|Protocol Violation|0
1438104|NCT00922636|4745720|P4|Overall Study|Protocol Violation|2
1438105|NCT00922636|4745721|P3|Overall Study|Protocol Violation|2
1438106|NCT00922636|4745722|P2|Overall Study|Protocol Violation|0
1438107|NCT00922636|4745723|P1|Overall Study|Protocol Violation|0
1438108|NCT00922636|4745719|P5|Overall Study|Withdrawal by Subject|4
1438109|NCT00922636|4745720|P4|Overall Study|Withdrawal by Subject|2
1438110|NCT00922636|4745721|P3|Overall Study|Withdrawal by Subject|5
1438111|NCT00922636|4745722|P2|Overall Study|Withdrawal by Subject|0
1438112|NCT00922636|4745723|P1|Overall Study|Withdrawal by Subject|0
1438113|NCT00922636|4745719|P5|Overall Study|Sponsor Decision|0
1438114|NCT00922636|4745720|P4|Overall Study|Sponsor Decision|0
1438115|NCT00922636|4745721|P3|Overall Study|Sponsor Decision|2
1438116|NCT00922636|4745722|P2|Overall Study|Sponsor Decision|0
1438117|NCT00922636|4745723|P1|Overall Study|Sponsor Decision|0
1438118|NCT00922636|4745719|P5|Overall Study|Lack of Efficacy|4
1438119|NCT00922636|4745720|P4|Overall Study|Lack of Efficacy|2
1438120|NCT00922636|4745721|P3|Overall Study|Lack of Efficacy|3
1438121|NCT00922636|4745722|P2|Overall Study|Lack of Efficacy|7
1438122|NCT00922636|4745723|P1|Overall Study|Lack of Efficacy|1
1438123|NCT00922636|4745719|P5|Overall Study|Adverse Event|2
1438124|NCT00922636|4745720|P4|Overall Study|Adverse Event|3
1438125|NCT00922636|4745721|P3|Overall Study|Adverse Event|2
1438126|NCT00922636|4745722|P2|Overall Study|Adverse Event|3
1438127|NCT00922636|4745723|P1|Overall Study|Adverse Event|3
1438128|NCT00922623|4745870|P1|Overall Study|Lost to Follow-up|1
1438129|NCT00922623|4745870|P1|Overall Study|Other|4
1438130|NCT00922480|4745878|P2|Extension Study|Others|1
1438131|NCT00922480|4745879|P1|Extension Study|Others|0
1438132|NCT00922480|4745878|P2|Extension Study|Withdrawal by Subject|1
1438133|NCT00922480|4745879|P1|Extension Study|Withdrawal by Subject|1
1438134|NCT00922480|4745878|P2|Extension Study|Adverse Event|1
1438135|NCT00922480|4745879|P1|Extension Study|Adverse Event|1
1438136|NCT00922480|4745878|P2|Extension Study|Protocol Violation|0
1438137|NCT00922480|4745879|P1|Extension Study|Protocol Violation|3
1438138|NCT00922480|4745878|P2|Main Study|Physician Decision|1
1438139|NCT00922480|4745879|P1|Main Study|Physician Decision|0
1438140|NCT00922480|4745878|P2|Main Study|Lost to Follow-up|0
1438141|NCT00922480|4745879|P1|Main Study|Lost to Follow-up|5
1438142|NCT00922480|4745878|P2|Main Study|Withdrawal by Subject|15
1438143|NCT00922480|4745879|P1|Main Study|Withdrawal by Subject|20
1438144|NCT00922480|4745878|P2|Main Study|Lack of Efficacy|0
1438145|NCT00922480|4745879|P1|Main Study|Lack of Efficacy|3
1438146|NCT00922480|4745878|P2|Main Study|Adverse Event|7
1438147|NCT00922480|4745879|P1|Main Study|Adverse Event|6
1438148|NCT00922480|4745878|P2|Main Study|Protocol Violation|6
1438149|NCT00922480|4745879|P1|Main Study|Protocol Violation|3
1438150|NCT00922441|4745890|P3|Overall Study|Withdrawal by Subject|1
1438151|NCT00922441|4745891|P2|Overall Study|Withdrawal by Subject|0
1438152|NCT00922441|4745892|P1|Overall Study|Withdrawal by Subject|0
1438153|NCT00922441|4745890|P3|Overall Study|Protocol Violation|2
1438154|NCT00922441|4745891|P2|Overall Study|Protocol Violation|0
1438155|NCT00922441|4745892|P1|Overall Study|Protocol Violation|0
1438156|NCT00922428|4745900|P1|Overall Study|no medication use or questionable use|13
1438157|NCT00922428|4745900|P1|Overall Study|retrospective/extremely implausible data|2
1438158|NCT00922272|4745929|P2|Double-blind Phase|Positive urine drug screen|1
1438159|NCT00922272|4745930|P1|Double-blind Phase|Positive urine drug screen|1
1438160|NCT00922272|4745929|P2|Double-blind Phase|Noncompliance|1
1438161|NCT00922272|4745930|P1|Double-blind Phase|Noncompliance|1
1438162|NCT00922272|4745929|P2|Double-blind Phase|Withdrawal criteria met|1
1438163|NCT00922272|4745930|P1|Double-blind Phase|Withdrawal criteria met|1
1438164|NCT00922272|4745929|P2|Double-blind Phase|Lost to Follow-up|1
1438165|NCT00922272|4745930|P1|Double-blind Phase|Lost to Follow-up|2
1438166|NCT00922272|4745929|P2|Double-blind Phase|Withdrawal by Subject|1
1438167|NCT00922272|4745930|P1|Double-blind Phase|Withdrawal by Subject|1
1438168|NCT00922272|4745929|P2|Double-blind Phase|Adverse Event|1
1438169|NCT00922272|4745930|P1|Double-blind Phase|Adverse Event|1
1438170|NCT00922272|4745929|P2|Open-label Phase|Withdrawal criteria met|0
1438171|NCT00922272|4745930|P1|Open-label Phase|Withdrawal criteria met|5
1438172|NCT00922272|4745929|P2|Open-label Phase|Failure to meet randomization criteria|0
1438173|NCT00922272|4745930|P1|Open-label Phase|Failure to meet randomization criteria|1
1438174|NCT00922272|4745929|P2|Open-label Phase|Withdrawal by Subject|0
1438175|NCT00922272|4745930|P1|Open-label Phase|Withdrawal by Subject|11
1438176|NCT00922272|4745929|P2|Open-label Phase|Protocol Violation|0
1438177|NCT00922272|4745930|P1|Open-label Phase|Protocol Violation|1
1438178|NCT00922272|4745929|P2|Open-label Phase|Adverse Event|0
1438179|NCT00922272|4745930|P1|Open-label Phase|Adverse Event|5
1438180|NCT00922207|4745995|P3|Overall Study|Abnormality of Laboratory Test|1
1438181|NCT00922207|4745996|P2|Overall Study|Abnormality of Laboratory Test|1
1438182|NCT00922207|4745997|P1|Overall Study|Abnormality of Laboratory Test|0
1438183|NCT00922207|4745995|P3|Overall Study|Withdrew Consent|2
1438184|NCT00922207|4745996|P2|Overall Study|Withdrew Consent|5
1438185|NCT00922207|4745997|P1|Overall Study|Withdrew Consent|2
1438186|NCT00922207|4745995|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
1438187|NCT00922207|4745996|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
1438188|NCT00922207|4745997|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
1438189|NCT00922207|4745995|P3|Overall Study|Violation of Selection Criteria at Entry|0
1438190|NCT00922207|4745996|P2|Overall Study|Violation of Selection Criteria at Entry|1
1438191|NCT00922207|4745997|P1|Overall Study|Violation of Selection Criteria at Entry|0
1438192|NCT00922207|4745995|P3|Overall Study|Insufficient Therapeutic Response|1
1438193|NCT00922207|4745996|P2|Overall Study|Insufficient Therapeutic Response|0
1438194|NCT00922207|4745997|P1|Overall Study|Insufficient Therapeutic Response|0
1438195|NCT00922207|4745995|P3|Overall Study|Adverse Event/Intercurrent Illness|0
1438196|NCT00922207|4745996|P2|Overall Study|Adverse Event/Intercurrent Illness|0
1438197|NCT00922207|4745997|P1|Overall Study|Adverse Event/Intercurrent Illness|3
1438198|NCT00922116|4746033|P1|Overall Study|Other|5
1438199|NCT00922116|4746033|P1|Overall Study|Withdrawal by Subject|4
1438200|NCT00922116|4746033|P1|Overall Study|Lost to Follow-up|1
1438201|NCT00922116|4746033|P1|Overall Study|Death|1
1438202|NCT00922116|4746033|P1|Overall Study|Adverse Event|4
1438203|NCT00921557|4746078|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
1438204|NCT00921557|4746079|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
1438205|NCT00921557|4746080|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
1438206|NCT00921557|4746078|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
1438207|NCT00921557|4746079|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
1438208|NCT00921557|4746080|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
1438209|NCT00921557|4746078|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
1438210|NCT00921557|4746079|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
1438211|NCT00921557|4746080|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
1438212|NCT00921557|4746078|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
1438213|NCT00921557|4746079|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
1438214|NCT00921557|4746080|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
1438215|NCT00921557|4746078|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
1438216|NCT00921557|4746079|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
1438217|NCT00921557|4746080|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
1438218|NCT00921024|4746182|P2|Overall Study|Withdrawal by Subject|3
1438219|NCT00921024|4746183|P1|Overall Study|Withdrawal by Subject|0
1438220|NCT00921024|4746182|P2|Overall Study|Received concomittant therapy|0
1438221|NCT00921024|4746183|P1|Overall Study|Received concomittant therapy|2
1438222|NCT00921024|4746182|P2|Overall Study|Lost to Follow-up|0
1438223|NCT00921024|4746183|P1|Overall Study|Lost to Follow-up|2
1438224|NCT00920907|4746193|P2|Maintenance Period|Adverse Event|1
1438225|NCT00920907|4746194|P1|Maintenance Period|Adverse Event|0
1438226|NCT00920907|4746193|P2|Maintenance Period|Withdrawal by Subject|0
1438227|NCT00920907|4746194|P1|Maintenance Period|Withdrawal by Subject|1
1438228|NCT00920907|4746193|P2|Maintenance Period|Death|1
1438229|NCT00920907|4746194|P1|Maintenance Period|Death|1
1438230|NCT00920907|4746193|P2|Maintenance Period|Study Drug Toxicity|2
1438231|NCT00920907|4746194|P1|Maintenance Period|Study Drug Toxicity|0
1438232|NCT00920907|4746193|P2|Maintenance Period|Administrative (study closure)|2
1438233|NCT00920907|4746194|P1|Maintenance Period|Administrative (study closure)|7
1438234|NCT00920907|4746193|P2|Maintenance Period|Disease Progression|7
1438235|NCT00920907|4746194|P1|Maintenance Period|Disease Progression|3
1438236|NCT00920907|4746193|P2|Induction Period|Withdrawal by Subject|1
1438237|NCT00920907|4746194|P1|Induction Period|Withdrawal by Subject|1
1438238|NCT00920907|4746193|P2|Induction Period|No longer meets study criteria|1
1438239|NCT00920907|4746194|P1|Induction Period|No longer meets study criteria|0
1438240|NCT00920907|4746193|P2|Induction Period|Study Drug Toxicity|6
1438241|NCT00920907|4746194|P1|Induction Period|Study Drug Toxicity|8
1438242|NCT00920907|4746193|P2|Induction Period|Disease Progression|11
1438243|NCT00920907|4746194|P1|Induction Period|Disease Progression|12
1438244|NCT00920907|4746193|P2|Induction Period|Death|1
1438245|NCT00920907|4746194|P1|Induction Period|Death|1
1438246|NCT00920907|4746193|P2|Induction Period|Adverse Event|2
1438247|NCT00920907|4746194|P1|Induction Period|Adverse Event|0
1438248|NCT00920855|4746235|P3|Overall Study|Response plateau; started maintenance|1
1438249|NCT00920855|4746236|P2|Overall Study|Response plateau; started maintenance|0
1438250|NCT00920855|4746237|P1|Overall Study|Response plateau; started maintenance|0
1438251|NCT00920855|4746235|P3|Overall Study|Noncompliance to study medication|1
1438252|NCT00920855|4746236|P2|Overall Study|Noncompliance to study medication|0
1438253|NCT00920855|4746237|P1|Overall Study|Noncompliance to study medication|0
1438254|NCT00920855|4746235|P3|Overall Study|Disease progression|10
1438255|NCT00920855|4746236|P2|Overall Study|Disease progression|1
1438256|NCT00920855|4746237|P1|Overall Study|Disease progression|2
1438257|NCT00920855|4746235|P3|Overall Study|Withdrawal by Subject|6
1438258|NCT00920855|4746236|P2|Overall Study|Withdrawal by Subject|1
1438259|NCT00920855|4746237|P1|Overall Study|Withdrawal by Subject|2
1438260|NCT00920855|4746235|P3|Overall Study|Adverse Event|4
1438261|NCT00920855|4746236|P2|Overall Study|Adverse Event|1
1438262|NCT00920855|4746237|P1|Overall Study|Adverse Event|1
1438263|NCT00920829|4746263|P4|Available for Analysis|Required more treatment|1
1438264|NCT00920829|4746264|P3|Available for Analysis|Required more treatment|0
1438265|NCT00920829|4746265|P2|Available for Analysis|Required more treatment|2
1438266|NCT00920829|4746266|P1|Available for Analysis|Required more treatment|0
1438267|NCT00920829|4746263|P4|Available for Analysis|Protocol Violation|0
1438268|NCT00920829|4746264|P3|Available for Analysis|Protocol Violation|1
1438269|NCT00920829|4746265|P2|Available for Analysis|Protocol Violation|0
1438270|NCT00920829|4746266|P1|Available for Analysis|Protocol Violation|0
1438271|NCT00920829|4746263|P4|Available for Analysis|Death|0
1438272|NCT00920829|4746264|P3|Available for Analysis|Death|0
1438273|NCT00920829|4746265|P2|Available for Analysis|Death|0
1438274|NCT00920829|4746266|P1|Available for Analysis|Death|1
1438275|NCT00920829|4746263|P4|Available for Analysis|Adverse Event|0
1438276|NCT00920829|4746264|P3|Available for Analysis|Adverse Event|1
1438277|NCT00920829|4746265|P2|Available for Analysis|Adverse Event|2
1438278|NCT00920829|4746266|P1|Available for Analysis|Adverse Event|1
1438279|NCT00920829|4746263|P4|Available for Analysis|Required Medical Treatment|0
1438280|NCT00920829|4746264|P3|Available for Analysis|Required Medical Treatment|2
1438281|NCT00920829|4746265|P2|Available for Analysis|Required Medical Treatment|1
1438282|NCT00920829|4746266|P1|Available for Analysis|Required Medical Treatment|0
1438283|NCT00920829|4746263|P4|Available for Analysis|Withdrawal by Subject|10
1438284|NCT00920829|4746264|P3|Available for Analysis|Withdrawal by Subject|6
1438285|NCT00920829|4746265|P2|Available for Analysis|Withdrawal by Subject|6
1438286|NCT00920829|4746266|P1|Available for Analysis|Withdrawal by Subject|6
1438287|NCT00920829|4746263|P4|Allocation|No post randomization data|2
1438288|NCT00920829|4746264|P3|Allocation|No post randomization data|0
1438289|NCT00920829|4746265|P2|Allocation|No post randomization data|1
1438290|NCT00920829|4746266|P1|Allocation|No post randomization data|3
1438291|NCT00920816|4746280|P4|Overall Study|Ongoing|36
1438292|NCT00920816|4746281|P3|Overall Study|Ongoing|70
1438293|NCT00920816|4746282|P2|Overall Study|Ongoing|56
1438294|NCT00920816|4746283|P1|Overall Study|Ongoing|106
1438295|NCT00920816|4746280|P4|Overall Study|Withdrawal by Subject|1
1438296|NCT00920816|4746281|P3|Overall Study|Withdrawal by Subject|1
1438297|NCT00920816|4746282|P2|Overall Study|Withdrawal by Subject|2
1438298|NCT00920816|4746283|P1|Overall Study|Withdrawal by Subject|7
1438299|NCT00920816|4746280|P4|Overall Study|Objective progression or relapse|0
1438300|NCT00920816|4746281|P3|Overall Study|Objective progression or relapse|2
1438301|NCT00920816|4746282|P2|Overall Study|Objective progression or relapse|0
1438302|NCT00920816|4746283|P1|Overall Study|Objective progression or relapse|0
1438303|NCT00920816|4746280|P4|Overall Study|Lost to Follow-up|4
1438304|NCT00920816|4746281|P3|Overall Study|Lost to Follow-up|3
1438305|NCT00920816|4746282|P2|Overall Study|Lost to Follow-up|2
1438306|NCT00920816|4746283|P1|Overall Study|Lost to Follow-up|1
1438307|NCT00920816|4746280|P4|Overall Study|Adverse Event|0
1438308|NCT00920816|4746281|P3|Overall Study|Adverse Event|1
1438309|NCT00920816|4746282|P2|Overall Study|Adverse Event|0
1438310|NCT00920816|4746283|P1|Overall Study|Adverse Event|1
1438311|NCT00920816|4746280|P4|Overall Study|Death|28
1438312|NCT00920816|4746281|P3|Overall Study|Death|58
1438313|NCT00920816|4746282|P2|Overall Study|Death|36
1438314|NCT00920816|4746283|P1|Overall Study|Death|77
1438315|NCT00920790|4746321|P1|Overall Study|aggravation of general condition|14
1438316|NCT00920699|4746333|P3|Overall Study|Lost to Follow-up|2
1438317|NCT00920699|4746334|P2|Overall Study|Lost to Follow-up|0
1438318|NCT00920699|4746335|P1|Overall Study|Lost to Follow-up|0
1438319|NCT00920699|4746333|P3|Overall Study|no longer met eligibility|0
1438320|NCT00920699|4746334|P2|Overall Study|no longer met eligibility|1
1438321|NCT00920699|4746335|P1|Overall Study|no longer met eligibility|0
1438322|NCT00920699|4746333|P3|Overall Study|Withdrawal by Subject|2
1438323|NCT00920699|4746334|P2|Overall Study|Withdrawal by Subject|0
1438324|NCT00920699|4746335|P1|Overall Study|Withdrawal by Subject|2
1438325|NCT00920686|4746352|P3|Overall Study|Study drug dosing criteria not met|12
1438326|NCT00920686|4746353|P2|Overall Study|Study drug dosing criteria not met|19
1438327|NCT00920686|4746354|P1|Overall Study|Study drug dosing criteria not met|17
1438328|NCT00920686|4746352|P3|Overall Study|Lost to Follow-up|1
1438329|NCT00920686|4746353|P2|Overall Study|Lost to Follow-up|3
1438330|NCT00920686|4746354|P1|Overall Study|Lost to Follow-up|2
1438331|NCT00920621|4746433|P4|Overall Study|Blood sample not collected|0
1438332|NCT00920621|4746434|P3|Overall Study|Blood sample not collected|0
1438333|NCT00920621|4746435|P2|Overall Study|Blood sample not collected|14
1438334|NCT00920621|4746436|P1|Overall Study|Blood sample not collected|22
1438335|NCT00920621|4746433|P4|Overall Study|Fetal/neonatal deaths|14
1438336|NCT00920621|4746434|P3|Overall Study|Fetal/neonatal deaths|16
1438337|NCT00920621|4746435|P2|Overall Study|Fetal/neonatal deaths|14
1438338|NCT00920621|4746436|P1|Overall Study|Fetal/neonatal deaths|16
1438339|NCT00920621|4746433|P4|Overall Study|Lost to Follow-up|21
1438340|NCT00920621|4746434|P3|Overall Study|Lost to Follow-up|19
1438341|NCT00920621|4746435|P2|Overall Study|Lost to Follow-up|17
1438342|NCT00920621|4746436|P1|Overall Study|Lost to Follow-up|16
1438343|NCT00920426|4746470|P4|ITZ111451|Adverse Event|0
1438344|NCT00920426|4746471|P3|ITZ111451|Adverse Event|0
1438345|NCT00920426|4746472|P2|ITZ111451|Adverse Event|0
1438346|NCT00920426|4746473|P1|ITZ111451|Adverse Event|1
1438347|NCT00920218|4746593|P4|Overall Study|Not specified|0
1438348|NCT00920218|4746594|P3|Overall Study|Not specified|1
1438349|NCT00920218|4746595|P2|Overall Study|Not specified|0
1438350|NCT00920218|4746596|P1|Overall Study|Not specified|0
1438351|NCT00920218|4746593|P4|Overall Study|Transplant failed/malignancy recurrence|3
1438352|NCT00920218|4746594|P3|Overall Study|Transplant failed/malignancy recurrence|2
1438353|NCT00920218|4746595|P2|Overall Study|Transplant failed/malignancy recurrence|1
1438354|NCT00920218|4746596|P1|Overall Study|Transplant failed/malignancy recurrence|0
1438355|NCT00920218|4746593|P4|Overall Study|Lost to Follow-up|3
1438356|NCT00920218|4746594|P3|Overall Study|Lost to Follow-up|0
1438357|NCT00920218|4746595|P2|Overall Study|Lost to Follow-up|1
1438358|NCT00920218|4746596|P1|Overall Study|Lost to Follow-up|0
1438359|NCT00920218|4746593|P4|Overall Study|Migrated/moved from study area|0
1438360|NCT00920218|4746594|P3|Overall Study|Migrated/moved from study area|1
1438361|NCT00920218|4746595|P2|Overall Study|Migrated/moved from study area|0
1438362|NCT00920218|4746596|P1|Overall Study|Migrated/moved from study area|0
1438363|NCT00920218|4746593|P4|Overall Study|Withdrawal by Subject|0
1438364|NCT00920218|4746594|P3|Overall Study|Withdrawal by Subject|2
1438365|NCT00920218|4746595|P2|Overall Study|Withdrawal by Subject|3
1438366|NCT00920218|4746596|P1|Overall Study|Withdrawal by Subject|0
1438367|NCT00920218|4746593|P4|Overall Study|Serious Adverse Event|1
1438368|NCT00920218|4746594|P3|Overall Study|Serious Adverse Event|2
1438369|NCT00920218|4746595|P2|Overall Study|Serious Adverse Event|0
1438370|NCT00920218|4746596|P1|Overall Study|Serious Adverse Event|2
1438371|NCT00920140|4746699|P5|Phase 2|Withdrawal by Subject|1
1438372|NCT00920140|4746700|P4|Phase 2|Withdrawal by Subject|2
1438373|NCT00920140|4746701|P3|Phase 2|Withdrawal by Subject|4
1438374|NCT00920140|4746702|P2|Phase 2|Withdrawal by Subject|0
1438375|NCT00920140|4746703|P1|Phase 2|Withdrawal by Subject|0
1438376|NCT00920140|4746699|P5|Phase 2|Physician Decision|2
1438377|NCT00920140|4746700|P4|Phase 2|Physician Decision|3
1438378|NCT00920140|4746701|P3|Phase 2|Physician Decision|3
1438379|NCT00920140|4746702|P2|Phase 2|Physician Decision|0
1438380|NCT00920140|4746703|P1|Phase 2|Physician Decision|0
1438381|NCT00920140|4746699|P5|Phase 2|Lost to Follow-up|0
1438382|NCT00920140|4746700|P4|Phase 2|Lost to Follow-up|1
1438383|NCT00920140|4746701|P3|Phase 2|Lost to Follow-up|0
1438384|NCT00920140|4746702|P2|Phase 2|Lost to Follow-up|0
1438385|NCT00920140|4746703|P1|Phase 2|Lost to Follow-up|0
1438386|NCT00920140|4746699|P5|Phase 2|Lack of Efficacy|5
1438387|NCT00920140|4746700|P4|Phase 2|Lack of Efficacy|14
1438388|NCT00920140|4746701|P3|Phase 2|Lack of Efficacy|29
1438389|NCT00920140|4746702|P2|Phase 2|Lack of Efficacy|0
1438390|NCT00920140|4746703|P1|Phase 2|Lack of Efficacy|0
1438391|NCT00920140|4746699|P5|Phase 2|Adverse Event|3
1438392|NCT00920140|4746700|P4|Phase 2|Adverse Event|2
1438393|NCT00920140|4746701|P3|Phase 2|Adverse Event|14
1438394|NCT00920140|4746702|P2|Phase 2|Adverse Event|0
1438395|NCT00920140|4746703|P1|Phase 2|Adverse Event|0
1438396|NCT00920140|4746699|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
1438397|NCT00920140|4746700|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
1438398|NCT00920140|4746701|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
1438399|NCT00920140|4746702|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
1438400|NCT00920140|4746703|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
1438401|NCT00920140|4746699|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
1438402|NCT00920140|4746700|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
1438403|NCT00920140|4746701|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
1438404|NCT00920140|4746702|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
1438405|NCT00920140|4746703|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
1438406|NCT00920140|4746699|P5|Phase 1 (Dose Escalation)|Adverse Event|0
1438407|NCT00920140|4746700|P4|Phase 1 (Dose Escalation)|Adverse Event|0
1438408|NCT00920140|4746701|P3|Phase 1 (Dose Escalation)|Adverse Event|0
1438409|NCT00920140|4746702|P2|Phase 1 (Dose Escalation)|Adverse Event|3
1438410|NCT00920140|4746703|P1|Phase 1 (Dose Escalation)|Adverse Event|3
1438411|NCT00919893|4746765|P2|Overall Study|Protocol Violation|9
1438412|NCT00919893|4746766|P1|Overall Study|Protocol Violation|19
1438413|NCT00919867|4746778|P6|First Intervention|Physician Decision|1
1438414|NCT00919867|4746779|P5|First Intervention|Physician Decision|0
1438415|NCT00919867|4746780|P4|First Intervention|Physician Decision|0
1438416|NCT00919867|4746781|P3|First Intervention|Physician Decision|0
1438417|NCT00919867|4746782|P2|First Intervention|Physician Decision|0
1438418|NCT00919867|4746783|P1|First Intervention|Physician Decision|0
1438419|NCT00919867|4746778|P6|First Intervention|Withdrawal by Subject|0
1438420|NCT00919867|4746779|P5|First Intervention|Withdrawal by Subject|0
1438421|NCT00919867|4746780|P4|First Intervention|Withdrawal by Subject|0
1438422|NCT00919867|4746781|P3|First Intervention|Withdrawal by Subject|1
1438423|NCT00919867|4746782|P2|First Intervention|Withdrawal by Subject|0
1438424|NCT00919867|4746783|P1|First Intervention|Withdrawal by Subject|0
1438425|NCT00919854|4746804|P1|Overall Study|Adverse Event|1
1438426|NCT00919711|4746842|P2|Overall Study|Noncompliance|0
1438427|NCT00919711|4746843|P1|Overall Study|Noncompliance|1
1438428|NCT00919711|4746842|P2|Overall Study|Death|0
1438429|NCT00919711|4746843|P1|Overall Study|Death|1
1438430|NCT00919711|4746842|P2|Overall Study|Lost to Follow-up|0
1438431|NCT00919711|4746843|P1|Overall Study|Lost to Follow-up|2
1438432|NCT00919711|4746842|P2|Overall Study|Administrative Decision|1
1438433|NCT00919711|4746843|P1|Overall Study|Administrative Decision|0
1438434|NCT00919711|4746842|P2|Overall Study|Other|2
1438435|NCT00919711|4746843|P1|Overall Study|Other|1
1438436|NCT00919711|4746842|P2|Overall Study|Adverse Event|3
1438437|NCT00919711|4746843|P1|Overall Study|Adverse Event|13
1438438|NCT00919711|4746842|P2|Overall Study|Withdrawal by Subject|7
1438439|NCT00919711|4746843|P1|Overall Study|Withdrawal by Subject|15
1438440|NCT00919633|4746859|P4|Overall Study|Viral rebound outside protocol timepoint|0
1438441|NCT00919633|4746860|P3|Overall Study|Viral rebound outside protocol timepoint|1
1438442|NCT00919633|4746861|P2|Overall Study|Viral rebound outside protocol timepoint|0
1438443|NCT00919633|4746862|P1|Overall Study|Viral rebound outside protocol timepoint|0
1438444|NCT00919633|4746859|P4|Overall Study|Request of withdrawal w/o future contact|0
1438445|NCT00919633|4746860|P3|Overall Study|Request of withdrawal w/o future contact|1
1438446|NCT00919633|4746861|P2|Overall Study|Request of withdrawal w/o future contact|0
1438447|NCT00919633|4746862|P1|Overall Study|Request of withdrawal w/o future contact|0
1438448|NCT00919633|4746859|P4|Overall Study|Physician Decision|1
1438449|NCT00919633|4746860|P3|Overall Study|Physician Decision|0
1438450|NCT00919633|4746861|P2|Overall Study|Physician Decision|0
1438451|NCT00919633|4746862|P1|Overall Study|Physician Decision|0
1438452|NCT00919633|4746859|P4|Overall Study|Protocol Violation|1
1438453|NCT00919633|4746860|P3|Overall Study|Protocol Violation|0
1438454|NCT00919633|4746861|P2|Overall Study|Protocol Violation|0
1438455|NCT00919633|4746862|P1|Overall Study|Protocol Violation|0
1438456|NCT00919633|4746859|P4|Overall Study|Withdraw consent post transition to SOC|1
1438457|NCT00919633|4746860|P3|Overall Study|Withdraw consent post transition to SOC|1
1438458|NCT00919633|4746861|P2|Overall Study|Withdraw consent post transition to SOC|0
1438459|NCT00919633|4746862|P1|Overall Study|Withdraw consent post transition to SOC|0
1438460|NCT00919633|4746859|P4|Overall Study|Lost to Follow-up|2
1438461|NCT00919633|4746860|P3|Overall Study|Lost to Follow-up|0
1438462|NCT00919633|4746861|P2|Overall Study|Lost to Follow-up|1
1438463|NCT00919633|4746862|P1|Overall Study|Lost to Follow-up|3
1438464|NCT00919633|4746859|P4|Overall Study|Withdrawal by Subject|3
1438465|NCT00919633|4746860|P3|Overall Study|Withdrawal by Subject|4
1438466|NCT00919633|4746861|P2|Overall Study|Withdrawal by Subject|2
1438467|NCT00919633|4746862|P1|Overall Study|Withdrawal by Subject|1
1438468|NCT00919633|4746859|P4|Overall Study|Lack of Efficacy|3
1438469|NCT00919633|4746860|P3|Overall Study|Lack of Efficacy|2
1438470|NCT00919633|4746861|P2|Overall Study|Lack of Efficacy|3
1438471|NCT00919633|4746862|P1|Overall Study|Lack of Efficacy|17
1438472|NCT00919633|4746859|P4|Overall Study|Death|0
1438473|NCT00919633|4746860|P3|Overall Study|Death|2
1438474|NCT00919633|4746861|P2|Overall Study|Death|0
1438475|NCT00919633|4746862|P1|Overall Study|Death|0
1438476|NCT00919633|4746859|P4|Overall Study|Adverse Event|10
1438477|NCT00919633|4746860|P3|Overall Study|Adverse Event|12
1438478|NCT00919633|4746861|P2|Overall Study|Adverse Event|9
1438479|NCT00919633|4746862|P1|Overall Study|Adverse Event|1
1438480|NCT00919061|4746947|P1|Overall Study|Withdrawal by Subject|1
1438481|NCT00919061|4746947|P1|Overall Study|Adverse Event|1
1438482|NCT00918957|4746960|P2|Overall Study|Withdrawal by Subject|0
1438483|NCT00918957|4746961|P1|Overall Study|Withdrawal by Subject|1
1438484|NCT00918957|4746960|P2|Overall Study|Adverse Event|0
1438485|NCT00918957|4746961|P1|Overall Study|Adverse Event|2
1438486|NCT00918879|4746994|P2|Overall Study|Severe non-compliance to protocol|1
1438487|NCT00918879|4746995|P1|Overall Study|Severe non-compliance to protocol|1
1438488|NCT00918879|4746994|P2|Overall Study|Lost to Follow-up|1
1438489|NCT00918879|4746995|P1|Overall Study|Lost to Follow-up|1
1438490|NCT00918879|4746994|P2|Overall Study|Withdrawal by Subject|4
1438491|NCT00918879|4746995|P1|Overall Study|Withdrawal by Subject|4
1438492|NCT00918749|4747027|P3|Overall Study|No Study Medication Taken|0
1438493|NCT00918749|4747028|P2|Overall Study|No Study Medication Taken|0
1438494|NCT00918749|4747029|P1|Overall Study|No Study Medication Taken|1
1438495|NCT00918749|4747027|P3|Overall Study|Withdrawal by Subject|5
1438496|NCT00918749|4747028|P2|Overall Study|Withdrawal by Subject|3
1438497|NCT00918749|4747029|P1|Overall Study|Withdrawal by Subject|5
1438498|NCT00918749|4747027|P3|Overall Study|Lost to Follow-up|1
1438499|NCT00918749|4747028|P2|Overall Study|Lost to Follow-up|0
1438500|NCT00918749|4747029|P1|Overall Study|Lost to Follow-up|0
1438501|NCT00918749|4747027|P3|Overall Study|Adverse Event|1
1438502|NCT00918749|4747028|P2|Overall Study|Adverse Event|0
1438503|NCT00918749|4747029|P1|Overall Study|Adverse Event|1
1438504|NCT00918736|4747061|P1|Overall Study|Withdrawal by Subject|4
1438505|NCT00918684|4747074|P1|Treatment Phase|Withdrawal by Subject|8
1438506|NCT00918684|4747074|P1|Treatment Phase|Protocol Violation|1
1438507|NCT00918684|4747074|P1|Treatment Phase|Physician Decision|8
1438508|NCT00918684|4747074|P1|Treatment Phase|Lost to Follow-up|2
1438509|NCT00918684|4747074|P1|Treatment Phase|Lack of Efficacy|6
1438510|NCT00918684|4747074|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
1438511|NCT00918645|4747085|P1|Overall Study|Withdrawal by Subject|1
1438512|NCT00918580|4747091|P1|After 6-month FU to 1-year FU|Failed to Return|2
1438513|NCT00918580|4747091|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
1438514|NCT00918580|4747091|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
1438515|NCT00918580|4747091|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
1438516|NCT00918580|4747091|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
1438517|NCT00918580|4747091|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
1438518|NCT00918580|4747091|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
1438519|NCT00918463|4747109|P1|Overall Study|Lack of Efficacy|1
1438520|NCT00918463|4747109|P1|Overall Study|Death|1
1438521|NCT00918385|4747117|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
1438522|NCT00918385|4747118|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
1438523|NCT00918385|4747117|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
1438524|NCT00918385|4747118|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
1438525|NCT00918385|4747117|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
1438526|NCT00918385|4747118|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
1438527|NCT00918385|4747117|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
1438528|NCT00918385|4747118|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
1438529|NCT00918385|4747117|P2|Monotherapy|Complicating illness|0
1438530|NCT00918385|4747118|P1|Monotherapy|Complicating illness|1
1438531|NCT00918385|4747117|P2|Monotherapy|Adverse Event|6
1438532|NCT00918385|4747118|P1|Monotherapy|Adverse Event|1
1438533|NCT00918346|4747127|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
1438534|NCT00918346|4747128|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
1438535|NCT00918333|4747144|P2|Overall Study|Withdrawal by Subject|1
1438536|NCT00918333|4747145|P1|Overall Study|Withdrawal by Subject|0
1438537|NCT00918333|4747144|P2|Overall Study|Ineligible|0
1438538|NCT00918333|4747145|P1|Overall Study|Ineligible|1
1438539|NCT00918333|4747144|P2|Overall Study|Inadequate amount of drugs provided|4
1438540|NCT00918333|4747145|P1|Overall Study|Inadequate amount of drugs provided|1
1438541|NCT00918333|4747144|P2|Overall Study|Drug not taken per protocol|0
1438542|NCT00918333|4747145|P1|Overall Study|Drug not taken per protocol|1
1438543|NCT00918281|4747165|P1|Overall Study|Physician Decision|29
1438544|NCT00918255|4747175|P3|Overall Study|Investigator discretion|0
1438545|NCT00918255|4747176|P2|Overall Study|Investigator discretion|0
1438546|NCT00918255|4747177|P1|Overall Study|Investigator discretion|1
1438547|NCT00918255|4747175|P3|Overall Study|Non-compliance|0
1438548|NCT00918255|4747176|P2|Overall Study|Non-compliance|0
1438549|NCT00918255|4747177|P1|Overall Study|Non-compliance|1
1438550|NCT00918255|4747175|P3|Overall Study|Exceeded allowed number of interventions|1
1438551|NCT00918255|4747176|P2|Overall Study|Exceeded allowed number of interventions|0
1438552|NCT00918255|4747177|P1|Overall Study|Exceeded allowed number of interventions|0
1438553|NCT00918255|4747175|P3|Overall Study|Lost to Follow-up|2
1438554|NCT00918255|4747176|P2|Overall Study|Lost to Follow-up|0
1438555|NCT00918255|4747177|P1|Overall Study|Lost to Follow-up|1
1438556|NCT00918255|4747175|P3|Overall Study|Lack of Efficacy|0
1438557|NCT00918255|4747176|P2|Overall Study|Lack of Efficacy|0
1438558|NCT00918255|4747177|P1|Overall Study|Lack of Efficacy|1
1438559|NCT00918255|4747175|P3|Overall Study|Withdrawal by Subject|2
1438560|NCT00918255|4747176|P2|Overall Study|Withdrawal by Subject|0
1438561|NCT00918255|4747177|P1|Overall Study|Withdrawal by Subject|1
1438562|NCT00918255|4747175|P3|Overall Study|Adverse Event|0
1438563|NCT00918255|4747176|P2|Overall Study|Adverse Event|0
1438564|NCT00918255|4747177|P1|Overall Study|Adverse Event|1
1438565|NCT00918203|4747205|P3|Crossover to Olaratumab Monotherapy|Other Therapy Started|1
1438566|NCT00918203|4747206|P2|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
1438567|NCT00918203|4747207|P1|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
1438568|NCT00918203|4747205|P3|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|2
1438569|NCT00918203|4747206|P2|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
1438570|NCT00918203|4747207|P1|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
1438571|NCT00918203|4747205|P3|Treatment With or Without Olaratumab|On Treatment|0
1438572|NCT00918203|4747206|P2|Treatment With or Without Olaratumab|On Treatment|0
1438573|NCT00918203|4747207|P1|Treatment With or Without Olaratumab|On Treatment|1
1438574|NCT00918203|4747205|P3|Treatment With or Without Olaratumab|Physician Decision|0
1438575|NCT00918203|4747206|P2|Treatment With or Without Olaratumab|Physician Decision|1
1438576|NCT00918203|4747207|P1|Treatment With or Without Olaratumab|Physician Decision|0
1438577|NCT00918203|4747205|P3|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
1438578|NCT00918203|4747206|P2|Treatment With or Without Olaratumab|Off Study Treatment/Alive|1
1438579|NCT00918203|4747207|P1|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
1438580|NCT00918203|4747205|P3|Treatment With or Without Olaratumab|Never Treated|0
1438581|NCT00918203|4747206|P2|Treatment With or Without Olaratumab|Never Treated|1
1438582|NCT00918203|4747207|P1|Treatment With or Without Olaratumab|Never Treated|2
1438583|NCT00918203|4747205|P3|Treatment With or Without Olaratumab|Adverse Event|0
1438584|NCT00918203|4747206|P2|Treatment With or Without Olaratumab|Adverse Event|1
1438585|NCT00918203|4747207|P1|Treatment With or Without Olaratumab|Adverse Event|1
1438586|NCT00918203|4747205|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
1438587|NCT00918203|4747206|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
1438588|NCT00918203|4747207|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
1438589|NCT00918203|4747205|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
1438590|NCT00918203|4747206|P2|Treatment With or Without Olaratumab|Lost to Follow-up|0
1438591|NCT00918203|4747207|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
1438592|NCT00918203|4747205|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
1438593|NCT00918203|4747206|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|9
1438594|NCT00918203|4747207|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|0
1438595|NCT00918138|4747238|P2|Overall Study|Death|0
1438596|NCT00918138|4747239|P1|Overall Study|Death|1
1438597|NCT00918138|4747238|P2|Overall Study|Subject withdrew consent|1
1438598|NCT00918138|4747239|P1|Overall Study|Subject withdrew consent|1
1438599|NCT00917852|4747278|P1|Overall Study|Death|6
1438600|NCT00917644|4747296|P2|Period 2: Second Intervention|family emergency|0
1438601|NCT00917644|4747297|P1|Period 2: Second Intervention|family emergency|1
1438602|NCT00917644|4747296|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
1438603|NCT00917644|4747297|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
1438604|NCT00917644|4747296|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
1438605|NCT00917644|4747297|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
1438606|NCT00917579|4747311|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
1438607|NCT00917579|4747312|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
1438608|NCT00917579|4747311|P2|Washout >= 2 Weeks|Adverse Event|0
1438609|NCT00917579|4747312|P1|Washout >= 2 Weeks|Adverse Event|1
1438610|NCT00917501|4747328|P2|Overall Study|trouble swollowing capsules|1
1438611|NCT00917501|4747329|P1|Overall Study|trouble swollowing capsules|0
1438612|NCT00917501|4747328|P2|Overall Study|Lack of Efficacy|2
1438613|NCT00917501|4747329|P1|Overall Study|Lack of Efficacy|1
1438614|NCT00917501|4747328|P2|Overall Study|Withdrawal by Subject|1
1438615|NCT00917501|4747329|P1|Overall Study|Withdrawal by Subject|3
1438616|NCT00917501|4747328|P2|Overall Study|Lost to Follow-up|1
1438617|NCT00917501|4747329|P1|Overall Study|Lost to Follow-up|4
1438618|NCT00917384|4747337|P2|Overall Study|Withdrawal by Subject|2
1438619|NCT00917384|4747338|P1|Overall Study|Withdrawal by Subject|10
1438620|NCT00917384|4747337|P2|Overall Study|Lost to Follow-up|2
1438621|NCT00917384|4747338|P1|Overall Study|Lost to Follow-up|4
1438622|NCT00917267|4747362|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
1438623|NCT00917267|4747363|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
1438624|NCT00917267|4747362|P2|Overall Study|Sponsor Decision|5
1438625|NCT00917267|4747363|P1|Overall Study|Sponsor Decision|5
1438626|NCT00917267|4747362|P2|Overall Study|Entry Criteria Not Met|0
1438627|NCT00917267|4747363|P1|Overall Study|Entry Criteria Not Met|1
1438628|NCT00917267|4747362|P2|Overall Study|Lost to follow up|2
1438629|NCT00917267|4747363|P1|Overall Study|Lost to follow up|0
1438630|NCT00917267|4747362|P2|Overall Study|Withdrawal by Subject|12
1438631|NCT00917267|4747363|P1|Overall Study|Withdrawal by Subject|5
1438632|NCT00917267|4747362|P2|Overall Study|Protocol Violation|18
1438633|NCT00917267|4747363|P1|Overall Study|Protocol Violation|9
1438634|NCT00917267|4747362|P2|Overall Study|Physician Decision|4
1438635|NCT00917267|4747363|P1|Overall Study|Physician Decision|2
1438636|NCT00917267|4747362|P2|Overall Study|Adverse Event|36
1438637|NCT00917267|4747363|P1|Overall Study|Adverse Event|15
1438638|NCT00917124|4747391|P2|Overall Study|Protocol Violation|6
1438639|NCT00917124|4747392|P1|Overall Study|Protocol Violation|4
1438640|NCT00916929|4747402|P2|Overall Study|Device unable to process impedance data|7
1438641|NCT00916929|4747403|P1|Overall Study|Device unable to process impedance data|0
1438642|NCT00916929|4747402|P2|Overall Study|Moved to another state|1
1438643|NCT00916929|4747403|P1|Overall Study|Moved to another state|0
1438644|NCT00916929|4747402|P2|Overall Study|System explant|0
1438645|NCT00916929|4747403|P1|Overall Study|System explant|1
1438646|NCT00916929|4747402|P2|Overall Study|Transferred to hospice care|1
1438647|NCT00916929|4747403|P1|Overall Study|Transferred to hospice care|1
1438648|NCT00916929|4747402|P2|Overall Study|Left ventricular epicardial lead|2
1438649|NCT00916929|4747403|P1|Overall Study|Left ventricular epicardial lead|1
1438650|NCT00916929|4747402|P2|Overall Study|Withdrawal by Subject|5
1438651|NCT00916929|4747403|P1|Overall Study|Withdrawal by Subject|1
1438652|NCT00916929|4747402|P2|Overall Study|Death|10
1438653|NCT00916929|4747403|P1|Overall Study|Death|5
1438654|NCT00916929|4747402|P2|Overall Study|Lost to Follow-up|3
1438655|NCT00916929|4747403|P1|Overall Study|Lost to Follow-up|1
1438656|NCT00916721|4747413|P2|Overall Study|Protocol Violation|4
1438657|NCT00916721|4747414|P1|Overall Study|Protocol Violation|2
1438658|NCT00916721|4747413|P2|Overall Study|Withdrawal by Subject|2
1438659|NCT00916721|4747414|P1|Overall Study|Withdrawal by Subject|2
1438660|NCT00916721|4747413|P2|Overall Study|Adverse Event|3
1438661|NCT00916721|4747414|P1|Overall Study|Adverse Event|6
1438662|NCT00916721|4747413|P2|Overall Study|Lost to Follow-up|1
1438663|NCT00916721|4747414|P1|Overall Study|Lost to Follow-up|0
1438664|NCT00916617|4747437|P4|Overall Study|Not specified|2
1438665|NCT00916617|4747438|P3|Overall Study|Not specified|0
1438666|NCT00916617|4747439|P2|Overall Study|Not specified|0
1438667|NCT00916617|4747440|P1|Overall Study|Not specified|2
1438668|NCT00916617|4747437|P4|Overall Study|Lack of Efficacy|0
1438669|NCT00916617|4747438|P3|Overall Study|Lack of Efficacy|0
1438670|NCT00916617|4747439|P2|Overall Study|Lack of Efficacy|0
1438671|NCT00916617|4747440|P1|Overall Study|Lack of Efficacy|1
1438672|NCT00916617|4747437|P4|Overall Study|Lost to Follow-up|0
1438673|NCT00916617|4747438|P3|Overall Study|Lost to Follow-up|0
1438674|NCT00916617|4747439|P2|Overall Study|Lost to Follow-up|1
1438675|NCT00916617|4747440|P1|Overall Study|Lost to Follow-up|2
1438676|NCT00916617|4747437|P4|Overall Study|Discontinuation of Study by Sponsor|1
1438677|NCT00916617|4747438|P3|Overall Study|Discontinuation of Study by Sponsor|3
1438678|NCT00916617|4747439|P2|Overall Study|Discontinuation of Study by Sponsor|13
1438679|NCT00916617|4747440|P1|Overall Study|Discontinuation of Study by Sponsor|8
1438680|NCT00916617|4747437|P4|Overall Study|Physician Decision|0
1438681|NCT00916617|4747438|P3|Overall Study|Physician Decision|0
1438682|NCT00916617|4747439|P2|Overall Study|Physician Decision|1
1438683|NCT00916617|4747440|P1|Overall Study|Physician Decision|1
1438684|NCT00916617|4747437|P4|Overall Study|Caregiver Request|0
1438685|NCT00916617|4747438|P3|Overall Study|Caregiver Request|1
1438686|NCT00916617|4747439|P2|Overall Study|Caregiver Request|2
1438687|NCT00916617|4747440|P1|Overall Study|Caregiver Request|3
1438688|NCT00916617|4747437|P4|Overall Study|Withdrawal by Subject|1
1438689|NCT00916617|4747438|P3|Overall Study|Withdrawal by Subject|0
1438690|NCT00916617|4747439|P2|Overall Study|Withdrawal by Subject|2
1438691|NCT00916617|4747440|P1|Overall Study|Withdrawal by Subject|3
1438692|NCT00916617|4747437|P4|Overall Study|Adverse Event|3
1438693|NCT00916617|4747438|P3|Overall Study|Adverse Event|6
1438694|NCT00916617|4747439|P2|Overall Study|Adverse Event|2
1438695|NCT00916617|4747440|P1|Overall Study|Adverse Event|3
1438696|NCT00916578|4747454|P1|Overall Study|Insurance Denial|2
1438697|NCT00916578|4747454|P1|Overall Study|Withdrawal by Subject|3
1438698|NCT00916578|4747454|P1|Overall Study|Physician Decision|2
1438699|NCT00916383|4747483|P1|Overall Study|Protocol Violation|1
1438700|NCT00916383|4747483|P1|Overall Study|Death|1
1438701|NCT00916383|4747483|P1|Overall Study|Adverse Event|1
1438702|NCT00916370|4747511|P2|Overall Study|Physician Decision|1
1438703|NCT00916370|4747512|P1|Overall Study|Physician Decision|0
1438704|NCT00916370|4747511|P2|Overall Study|Withdrawal by Subject|0
1438705|NCT00916370|4747512|P1|Overall Study|Withdrawal by Subject|2
1438706|NCT00916370|4747511|P2|Overall Study|Death|1
1438707|NCT00916370|4747512|P1|Overall Study|Death|3
1438708|NCT00916357|4747686|P6|Period 2|Weight loss > 3 kilograms (kg)|0
1438709|NCT00916357|4747687|P5|Period 2|Weight loss > 3 kilograms (kg)|0
1438710|NCT00916357|4747688|P4|Period 2|Weight loss > 3 kilograms (kg)|1
1438711|NCT00916357|4747689|P3|Period 2|Weight loss > 3 kilograms (kg)|0
1438712|NCT00916357|4747690|P2|Period 2|Weight loss > 3 kilograms (kg)|0
1438713|NCT00916357|4747691|P1|Period 2|Weight loss > 3 kilograms (kg)|0
1438714|NCT00916357|4747686|P6|Period 1|Withdrawal by Subject|0
1438715|NCT00916357|4747687|P5|Period 1|Withdrawal by Subject|0
1438716|NCT00916357|4747688|P4|Period 1|Withdrawal by Subject|0
1438717|NCT00916357|4747689|P3|Period 1|Withdrawal by Subject|0
1438718|NCT00916357|4747690|P2|Period 1|Withdrawal by Subject|0
1438719|NCT00916357|4747691|P1|Period 1|Withdrawal by Subject|1
1438720|NCT00916344|4747729|P1|Overall Study|Drop-out|5
1438721|NCT00916344|4747729|P1|Overall Study|ICD upgrade|1
1438722|NCT00916344|4747729|P1|Overall Study|Death|2
1438723|NCT00916305|4747736|P2|Overall Study|Withdrawal by Subject|1
1438724|NCT00916305|4747737|P1|Overall Study|Withdrawal by Subject|0
1438725|NCT00916305|4747736|P2|Overall Study|Lost to Follow-up|27
1438726|NCT00916305|4747737|P1|Overall Study|Lost to Follow-up|21
1438727|NCT00916279|4747745|P1|Overall Study|Lost to Follow-up|2
1438728|NCT00916279|4747745|P1|Overall Study|Death|2
1438729|NCT00916149|4747756|P3|Overall Study|Unable to place scalp EEG leads|0
1438730|NCT00916149|4747757|P2|Overall Study|Unable to place scalp EEG leads|0
1438731|NCT00916149|4747758|P1|Overall Study|Unable to place scalp EEG leads|1
1438732|NCT00916149|4747756|P3|Overall Study|Lost to Follow-up|0
1438733|NCT00916149|4747757|P2|Overall Study|Lost to Follow-up|2
1438734|NCT00916149|4747758|P1|Overall Study|Lost to Follow-up|3
1438735|NCT00916006|4747881|P2|Overall Study|Protocol Violation|1
1438736|NCT00916006|4747882|P1|Overall Study|Protocol Violation|0
1438737|NCT00916006|4747881|P2|Overall Study|Withdrawal by Subject|5
1438738|NCT00916006|4747882|P1|Overall Study|Withdrawal by Subject|2
1438739|NCT00916006|4747881|P2|Overall Study|Adverse Event|1
1438740|NCT00916006|4747882|P1|Overall Study|Adverse Event|1
1438741|NCT00915876|4747903|P2|Overall Study|Adverse Event|1
1438742|NCT00915876|4747904|P1|Overall Study|Adverse Event|0
1438743|NCT00915772|4747940|P3|Overall Study|Any other reason|7
1438744|NCT00915772|4747941|P2|Overall Study|Any other reason|7
1438745|NCT00915772|4747942|P1|Overall Study|Any other reason|4
1438746|NCT00915772|4747940|P3|Overall Study|Refused to continue trial medication|4
1438747|NCT00915772|4747941|P2|Overall Study|Refused to continue trial medication|8
1438748|NCT00915772|4747942|P1|Overall Study|Refused to continue trial medication|6
1438749|NCT00915772|4747940|P3|Overall Study|Lack of Efficacy|3
1438750|NCT00915772|4747941|P2|Overall Study|Lack of Efficacy|15
1438751|NCT00915772|4747942|P1|Overall Study|Lack of Efficacy|9
1438752|NCT00915772|4747940|P3|Overall Study|Lost to Follow-up|2
1438753|NCT00915772|4747941|P2|Overall Study|Lost to Follow-up|2
1438754|NCT00915772|4747942|P1|Overall Study|Lost to Follow-up|1
1438755|NCT00915772|4747940|P3|Overall Study|Protocol Violation|2
1438756|NCT00915772|4747941|P2|Overall Study|Protocol Violation|1
1438757|NCT00915772|4747942|P1|Overall Study|Protocol Violation|4
1438758|NCT00915772|4747940|P3|Overall Study|Adverse Event|11
1438759|NCT00915772|4747941|P2|Overall Study|Adverse Event|13
1438760|NCT00915772|4747942|P1|Overall Study|Adverse Event|12
1438761|NCT00915551|4748041|P2|Overall Study|Withdrawal by Subject|1
1438762|NCT00915551|4748042|P1|Overall Study|Withdrawal by Subject|0
1438763|NCT00915525|4748052|P2|Overall Study|Patient Moved|9
1438764|NCT00915525|4748053|P1|Overall Study|Patient Moved|15
1438765|NCT00915525|4748052|P2|Overall Study|Non-Compliance|1
1438766|NCT00915525|4748053|P1|Overall Study|Non-Compliance|3
1438767|NCT00915525|4748052|P2|Overall Study|Study Burden|12
1438768|NCT00915525|4748053|P1|Overall Study|Study Burden|28
1438769|NCT00915525|4748052|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
1438770|NCT00915525|4748053|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
1438771|NCT00915525|4748052|P2|Overall Study|Site Closed|9
1438772|NCT00915525|4748053|P1|Overall Study|Site Closed|27
1438773|NCT00915525|4748052|P2|Overall Study|Other Reason|12
1438774|NCT00915525|4748053|P1|Overall Study|Other Reason|35
1438775|NCT00915525|4748052|P2|Overall Study|Missing|1
1438776|NCT00915525|4748053|P1|Overall Study|Missing|12
1438777|NCT00915525|4748052|P2|Overall Study|Adverse Event|13
1438778|NCT00915525|4748053|P1|Overall Study|Adverse Event|29
1438779|NCT00915525|4748052|P2|Overall Study|Lack of Efficacy|32
1438780|NCT00915525|4748053|P1|Overall Study|Lack of Efficacy|15
1438781|NCT00915525|4748052|P2|Overall Study|Pregnancy|0
1438782|NCT00915525|4748053|P1|Overall Study|Pregnancy|2
1438783|NCT00915525|4748052|P2|Overall Study|Lost to Follow-up|16
1438784|NCT00915525|4748053|P1|Overall Study|Lost to Follow-up|27
1438785|NCT00915525|4748052|P2|Overall Study|Withdrawal by Subject|21
1438786|NCT00915525|4748053|P1|Overall Study|Withdrawal by Subject|59
1438787|NCT00915525|4748052|P2|Overall Study|Protocol Violation|4
1438788|NCT00915525|4748053|P1|Overall Study|Protocol Violation|9
1438789|NCT00915473|4748167|P2|4-week Follow Up|Lost to Follow-up|5
1438790|NCT00915473|4748168|P1|4-week Follow Up|Lost to Follow-up|1
1438791|NCT00915473|4748167|P2|Screening|Withdrawal by Subject|0
1438792|NCT00915473|4748168|P1|Screening|Withdrawal by Subject|1
1438793|NCT00915356|4748185|P5|Overall Study|Withdrawal by Subject|0
1438794|NCT00915356|4748186|P4|Overall Study|Withdrawal by Subject|0
1438795|NCT00915356|4748187|P3|Overall Study|Withdrawal by Subject|0
1438796|NCT00915356|4748188|P2|Overall Study|Withdrawal by Subject|0
1438797|NCT00915356|4748189|P1|Overall Study|Withdrawal by Subject|1
1438798|NCT00915343|4748251|P3|Part B - Open Label Period|Did not attend the last visit|1
1438799|NCT00915343|4748252|P2|Part B - Open Label Period|Did not attend the last visit|0
1438800|NCT00915343|4748253|P1|Part B - Open Label Period|Did not attend the last visit|0
1438801|NCT00915343|4748251|P3|Part B - Open Label Period|Treatment switch|1
1438802|NCT00915343|4748252|P2|Part B - Open Label Period|Treatment switch|0
1438803|NCT00915343|4748253|P1|Part B - Open Label Period|Treatment switch|0
1438804|NCT00915278|4748338|P6|Overall Study|Admission to hospice|0
1438805|NCT00915278|4748339|P5|Overall Study|Admission to hospice|0
1438806|NCT00915278|4748340|P4|Overall Study|Admission to hospice|0
1438807|NCT00915278|4748341|P3|Overall Study|Admission to hospice|1
1438808|NCT00915278|4748342|P2|Overall Study|Admission to hospice|0
1438809|NCT00915278|4748343|P1|Overall Study|Admission to hospice|0
1438810|NCT00915278|4748338|P6|Overall Study|Infusion related AEs|2
1438811|NCT00915278|4748339|P5|Overall Study|Infusion related AEs|0
1438812|NCT00915278|4748340|P4|Overall Study|Infusion related AEs|0
1438813|NCT00915278|4748341|P3|Overall Study|Infusion related AEs|0
1438814|NCT00915278|4748342|P2|Overall Study|Infusion related AEs|0
1438815|NCT00915278|4748343|P1|Overall Study|Infusion related AEs|0
1438816|NCT00915278|4748338|P6|Overall Study|Progressive disease/clinical progression|2
1438817|NCT00915278|4748339|P5|Overall Study|Progressive disease/clinical progression|1
1438818|NCT00915278|4748340|P4|Overall Study|Progressive disease/clinical progression|3
1438819|NCT00915278|4748341|P3|Overall Study|Progressive disease/clinical progression|0
1438820|NCT00915278|4748342|P2|Overall Study|Progressive disease/clinical progression|0
1438821|NCT00915278|4748343|P1|Overall Study|Progressive disease/clinical progression|0
1438822|NCT00915278|4748338|P6|Overall Study|Adverse Event|0
1438823|NCT00915278|4748339|P5|Overall Study|Adverse Event|0
1438824|NCT00915278|4748340|P4|Overall Study|Adverse Event|0
1438825|NCT00915278|4748341|P3|Overall Study|Adverse Event|0
1438826|NCT00915278|4748342|P2|Overall Study|Adverse Event|1
1438827|NCT00915278|4748343|P1|Overall Study|Adverse Event|4
1438828|NCT00915278|4748338|P6|Overall Study|Withdrawal by Subject|4
1438829|NCT00915278|4748339|P5|Overall Study|Withdrawal by Subject|1
1438830|NCT00915278|4748340|P4|Overall Study|Withdrawal by Subject|0
1438831|NCT00915278|4748341|P3|Overall Study|Withdrawal by Subject|0
1438832|NCT00915278|4748342|P2|Overall Study|Withdrawal by Subject|1
1438833|NCT00915278|4748343|P1|Overall Study|Withdrawal by Subject|0
1438834|NCT00915278|4748338|P6|Overall Study|Lost to Follow-up|0
1438835|NCT00915278|4748339|P5|Overall Study|Lost to Follow-up|0
1438836|NCT00915278|4748340|P4|Overall Study|Lost to Follow-up|0
1438837|NCT00915278|4748341|P3|Overall Study|Lost to Follow-up|0
1438838|NCT00915278|4748342|P2|Overall Study|Lost to Follow-up|1
1438839|NCT00915278|4748343|P1|Overall Study|Lost to Follow-up|0
1438840|NCT00915278|4748338|P6|Overall Study|Death|0
1438841|NCT00915278|4748339|P5|Overall Study|Death|0
1438842|NCT00915278|4748340|P4|Overall Study|Death|0
1438843|NCT00915278|4748341|P3|Overall Study|Death|0
1438844|NCT00915278|4748342|P2|Overall Study|Death|0
1438845|NCT00915278|4748343|P1|Overall Study|Death|1
1438846|NCT00915018|4748496|P2|Overall Study|By Sponsor due to Protocol Amendment|105
1438847|NCT00915018|4748497|P1|Overall Study|By Sponsor due to Protocol Amendment|92
1438848|NCT00915018|4748496|P2|Overall Study|Withdrawal by Subject|27
1438849|NCT00915018|4748497|P1|Overall Study|Withdrawal by Subject|38
1438850|NCT00915018|4748496|P2|Overall Study|Lost to Follow-up|5
1438851|NCT00915018|4748497|P1|Overall Study|Lost to Follow-up|10
1438852|NCT00915018|4748496|P2|Overall Study|Death|70
1438853|NCT00915018|4748497|P1|Overall Study|Death|75
1438854|NCT00914966|4748511|P1|Step 2: 2000 Units|Withdrawal by Subject|1
1438855|NCT00914966|4748511|P1|Step 1: 1500 Units|Physician Decision|1
1438856|NCT00914966|4748511|P1|Step 1: 1500 Units|Withdrawal by Subject|1
1438857|NCT00914927|4748530|P7|Overall Study|Administrative/Other|0
1438858|NCT00914927|4748531|P6|Overall Study|Administrative/Other|0
1438859|NCT00914927|4748532|P5|Overall Study|Administrative/Other|1
1438860|NCT00914927|4748533|P4|Overall Study|Administrative/Other|0
1438861|NCT00914927|4748534|P3|Overall Study|Administrative/Other|0
1438862|NCT00914927|4748535|P2|Overall Study|Administrative/Other|1
1438863|NCT00914927|4748536|P1|Overall Study|Administrative/Other|2
1438864|NCT00914927|4748530|P7|Overall Study|Lost to Follow-up|0
1438865|NCT00914927|4748531|P6|Overall Study|Lost to Follow-up|0
1438866|NCT00914927|4748532|P5|Overall Study|Lost to Follow-up|0
1438867|NCT00914927|4748533|P4|Overall Study|Lost to Follow-up|1
1438868|NCT00914927|4748534|P3|Overall Study|Lost to Follow-up|0
1438869|NCT00914927|4748535|P2|Overall Study|Lost to Follow-up|0
1438870|NCT00914927|4748536|P1|Overall Study|Lost to Follow-up|0
1438871|NCT00914927|4748530|P7|Overall Study|Withdrawal by Subject|0
1438872|NCT00914927|4748531|P6|Overall Study|Withdrawal by Subject|0
1438873|NCT00914927|4748532|P5|Overall Study|Withdrawal by Subject|0
1438874|NCT00914927|4748533|P4|Overall Study|Withdrawal by Subject|1
1438875|NCT00914927|4748534|P3|Overall Study|Withdrawal by Subject|0
1438876|NCT00914927|4748535|P2|Overall Study|Withdrawal by Subject|1
1438877|NCT00914927|4748536|P1|Overall Study|Withdrawal by Subject|0
1438878|NCT00914927|4748530|P7|Overall Study|Adverse Event|0
1438879|NCT00914927|4748531|P6|Overall Study|Adverse Event|0
1438880|NCT00914927|4748532|P5|Overall Study|Adverse Event|1
1438881|NCT00914927|4748533|P4|Overall Study|Adverse Event|0
1438882|NCT00914927|4748534|P3|Overall Study|Adverse Event|0
1438883|NCT00914927|4748535|P2|Overall Study|Adverse Event|0
1438884|NCT00914927|4748536|P1|Overall Study|Adverse Event|0
1438885|NCT00914849|4748663|P2|Overall Study|Not eligible|1
1438886|NCT00914849|4748664|P1|Overall Study|Not eligible|0
1438887|NCT00914849|4748663|P2|Overall Study|Withdrawal by Subject|0
1438888|NCT00914849|4748664|P1|Overall Study|Withdrawal by Subject|1
1438889|NCT00914810|4748698|P2|Overall Study|Hospitalized and unable to follow up.|1
1438890|NCT00914810|4748699|P1|Overall Study|Hospitalized and unable to follow up.|0
1438891|NCT00914810|4748698|P2|Overall Study|Relocated out of state|0
1438892|NCT00914810|4748699|P1|Overall Study|Relocated out of state|1
1438893|NCT00914810|4748698|P2|Overall Study|Withdrawal by Subject|0
1438894|NCT00914810|4748699|P1|Overall Study|Withdrawal by Subject|1
1438895|NCT00914589|4748710|P3|Overall Study|Death|1
1438896|NCT00914589|4748711|P2|Overall Study|Death|1
1438897|NCT00914589|4748712|P1|Overall Study|Death|0
1438898|NCT00914589|4748710|P3|Overall Study|unclassified|7
1438899|NCT00914589|4748711|P2|Overall Study|unclassified|9
1438900|NCT00914589|4748712|P1|Overall Study|unclassified|16
1438901|NCT00914589|4748710|P3|Overall Study|Protocol Violation|3
1438902|NCT00914589|4748711|P2|Overall Study|Protocol Violation|6
1438903|NCT00914589|4748712|P1|Overall Study|Protocol Violation|8
1438904|NCT00914589|4748710|P3|Overall Study|Adverse Event|1
1438905|NCT00914589|4748711|P2|Overall Study|Adverse Event|0
1438906|NCT00914589|4748712|P1|Overall Study|Adverse Event|1
1438907|NCT00914459|4748738|P2|Overall Study|Parent/Legal guardian request|0
1438908|NCT00914459|4748739|P1|Overall Study|Parent/Legal guardian request|1
1438909|NCT00914459|4748738|P2|Overall Study|Protocol Violation|1
1438910|NCT00914459|4748739|P1|Overall Study|Protocol Violation|0
1438911|NCT00914316|4748769|P4|Phase 2|Withdrawal by Subject|0
1438912|NCT00914316|4748770|P3|Phase 2|Withdrawal by Subject|1
1438913|NCT00914316|4748771|P2|Phase 2|Withdrawal by Subject|0
1438914|NCT00914316|4748772|P1|Phase 2|Withdrawal by Subject|1
1438915|NCT00914316|4748769|P4|Phase 1|Adverse Event|0
1438916|NCT00914316|4748770|P3|Phase 1|Adverse Event|0
1438917|NCT00914316|4748771|P2|Phase 1|Adverse Event|0
1438918|NCT00914316|4748772|P1|Phase 1|Adverse Event|1
1438919|NCT00914316|4748769|P4|Phase 1|Withdrawal by Subject|0
1438920|NCT00914316|4748770|P3|Phase 1|Withdrawal by Subject|4
1438921|NCT00914316|4748771|P2|Phase 1|Withdrawal by Subject|2
1438922|NCT00914316|4748772|P1|Phase 1|Withdrawal by Subject|0
1438923|NCT00914316|4748769|P4|Phase 1|Physician Decision|2
1438924|NCT00914316|4748770|P3|Phase 1|Physician Decision|1
1438925|NCT00914316|4748771|P2|Phase 1|Physician Decision|0
1438926|NCT00914316|4748772|P1|Phase 1|Physician Decision|4
1438927|NCT00913835|4748851|P2|Lip Dox: Olaratumab Monotherapy|Not Specified|3
1438928|NCT00913835|4748852|P1|Lip Dox: Olaratumab Monotherapy|Not Specified|0
1438929|NCT00913835|4748851|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
1438930|NCT00913835|4748852|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
1438931|NCT00913835|4748851|P2|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|3
1438932|NCT00913835|4748852|P1|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|4
1438933|NCT00913835|4748851|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
1438934|NCT00913835|4748852|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
1438935|NCT00913835|4748851|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
1438936|NCT00913835|4748852|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
1438937|NCT00913770|4748891|P3|Overall Study|Refused|8
1438938|NCT00913770|4748892|P2|Overall Study|Refused|10
1438939|NCT00913770|4748893|P1|Overall Study|Refused|11
1438940|NCT00913770|4748891|P3|Overall Study|Unable to contact|13
1438941|NCT00913770|4748892|P2|Overall Study|Unable to contact|19
1438942|NCT00913770|4748893|P1|Overall Study|Unable to contact|24
1438943|NCT00913744|4748906|P2|Overall Study|Death|0
1438944|NCT00913744|4748907|P1|Overall Study|Death|1
1438945|NCT00913744|4748906|P2|Overall Study|Withdrawal by Subject|1
1438946|NCT00913744|4748907|P1|Overall Study|Withdrawal by Subject|2
1438947|NCT00913744|4748906|P2|Overall Study|Adverse Event|0
1438948|NCT00913744|4748907|P1|Overall Study|Adverse Event|2
1438949|NCT00913692|4748913|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
1438950|NCT00913692|4748913|P1|Screening (4 Months)|Not eligible after screening phase.|6
1438951|NCT00913692|4748913|P1|Screening (4 Months)|Physician Decision|3
1438952|NCT00913523|4749007|P3|Overall Study|Inadequate Number of Tampons Used|3
1438953|NCT00913523|4749008|P2|Overall Study|Inadequate Number of Tampons Used|2
1438954|NCT00913523|4749009|P1|Overall Study|Inadequate Number of Tampons Used|7
1438955|NCT00913523|4749007|P3|Overall Study|Pregnancy|0
1438956|NCT00913523|4749008|P2|Overall Study|Pregnancy|3
1438957|NCT00913523|4749009|P1|Overall Study|Pregnancy|1
1438958|NCT00913523|4749007|P3|Overall Study|Protocol Violation|8
1438959|NCT00913523|4749008|P2|Overall Study|Protocol Violation|8
1438960|NCT00913523|4749009|P1|Overall Study|Protocol Violation|5
1438961|NCT00913523|4749007|P3|Overall Study|Adverse Event|0
1438962|NCT00913523|4749008|P2|Overall Study|Adverse Event|0
1438963|NCT00913523|4749009|P1|Overall Study|Adverse Event|1
1438964|NCT00913523|4749007|P3|Overall Study|Lost to Follow-up|1
1438965|NCT00913523|4749008|P2|Overall Study|Lost to Follow-up|1
1438966|NCT00913523|4749009|P1|Overall Study|Lost to Follow-up|1
1438967|NCT00913523|4749007|P3|Overall Study|Withdrawal by Subject|2
1438968|NCT00913523|4749008|P2|Overall Study|Withdrawal by Subject|2
1438969|NCT00913523|4749009|P1|Overall Study|Withdrawal by Subject|3
1438970|NCT00913458|4749041|P7|Phase 3|Unsatisfactory Response per Investigator|4
1438971|NCT00913458|4749042|P6|Phase 3|Unsatisfactory Response per Investigator|11
1438972|NCT00913458|4749043|P5|Phase 3|Unsatisfactory Response per Investigator|14
1438973|NCT00913458|4749044|P4|Phase 3|Unsatisfactory Response per Investigator|0
1438974|NCT00913458|4749045|P3|Phase 3|Unsatisfactory Response per Investigator|0
1438975|NCT00913458|4749046|P2|Phase 3|Unsatisfactory Response per Investigator|0
1438976|NCT00913458|4749047|P1|Phase 3|Unsatisfactory Response per Investigator|0
1438977|NCT00913458|4749041|P7|Phase 3|Withdrawal by Subject|0
1438978|NCT00913458|4749042|P6|Phase 3|Withdrawal by Subject|2
1438979|NCT00913458|4749043|P5|Phase 3|Withdrawal by Subject|1
1438980|NCT00913458|4749044|P4|Phase 3|Withdrawal by Subject|0
1438981|NCT00913458|4749045|P3|Phase 3|Withdrawal by Subject|0
1438982|NCT00913458|4749046|P2|Phase 3|Withdrawal by Subject|0
1438983|NCT00913458|4749047|P1|Phase 3|Withdrawal by Subject|0
1438984|NCT00913458|4749041|P7|Phase 3|Non-Responder|3
1438985|NCT00913458|4749042|P6|Phase 3|Non-Responder|1
1438986|NCT00913458|4749043|P5|Phase 3|Non-Responder|0
1438987|NCT00913458|4749044|P4|Phase 3|Non-Responder|0
1438988|NCT00913458|4749045|P3|Phase 3|Non-Responder|0
1438989|NCT00913458|4749046|P2|Phase 3|Non-Responder|0
1438990|NCT00913458|4749047|P1|Phase 3|Non-Responder|0
1438991|NCT00913458|4749041|P7|Phase 3|Lost to Follow-up|0
1438992|NCT00913458|4749042|P6|Phase 3|Lost to Follow-up|0
1438993|NCT00913458|4749043|P5|Phase 3|Lost to Follow-up|2
1438994|NCT00913458|4749044|P4|Phase 3|Lost to Follow-up|0
1438995|NCT00913458|4749045|P3|Phase 3|Lost to Follow-up|0
1438996|NCT00913458|4749046|P2|Phase 3|Lost to Follow-up|0
1438997|NCT00913458|4749047|P1|Phase 3|Lost to Follow-up|0
1438998|NCT00913458|4749041|P7|Phase 3|Adverse Event|1
1438999|NCT00913458|4749042|P6|Phase 3|Adverse Event|4
1439000|NCT00913458|4749043|P5|Phase 3|Adverse Event|5
1439001|NCT00913458|4749044|P4|Phase 3|Adverse Event|0
1439002|NCT00913458|4749045|P3|Phase 3|Adverse Event|0
1439003|NCT00913458|4749046|P2|Phase 3|Adverse Event|0
1439004|NCT00913458|4749047|P1|Phase 3|Adverse Event|0
1439005|NCT00913458|4749041|P7|Phase 2|Unsatisfactory Response per Investigator|0
1439006|NCT00913458|4749042|P6|Phase 2|Unsatisfactory Response per Investigator|0
1439007|NCT00913458|4749043|P5|Phase 2|Unsatisfactory Response per Investigator|0
1439008|NCT00913458|4749044|P4|Phase 2|Unsatisfactory Response per Investigator|17
1439009|NCT00913458|4749045|P3|Phase 2|Unsatisfactory Response per Investigator|11
1439010|NCT00913458|4749046|P2|Phase 2|Unsatisfactory Response per Investigator|0
1439011|NCT00913458|4749047|P1|Phase 2|Unsatisfactory Response per Investigator|0
1439012|NCT00913458|4749041|P7|Phase 2|Protocol Violation|0
1439013|NCT00913458|4749042|P6|Phase 2|Protocol Violation|0
1439014|NCT00913458|4749043|P5|Phase 2|Protocol Violation|0
1439015|NCT00913458|4749044|P4|Phase 2|Protocol Violation|0
1439016|NCT00913458|4749045|P3|Phase 2|Protocol Violation|0
1439017|NCT00913458|4749046|P2|Phase 2|Protocol Violation|2
1439018|NCT00913458|4749047|P1|Phase 2|Protocol Violation|0
1439019|NCT00913458|4749041|P7|Phase 2|Lost to Follow-up|0
1439020|NCT00913458|4749042|P6|Phase 2|Lost to Follow-up|0
1439021|NCT00913458|4749043|P5|Phase 2|Lost to Follow-up|0
1439022|NCT00913458|4749044|P4|Phase 2|Lost to Follow-up|1
1439023|NCT00913458|4749045|P3|Phase 2|Lost to Follow-up|0
1439024|NCT00913458|4749046|P2|Phase 2|Lost to Follow-up|0
1439025|NCT00913458|4749047|P1|Phase 2|Lost to Follow-up|0
1439026|NCT00913458|4749041|P7|Phase 2|Adverse Event|0
1439027|NCT00913458|4749042|P6|Phase 2|Adverse Event|0
1439028|NCT00913458|4749043|P5|Phase 2|Adverse Event|0
1439029|NCT00913458|4749044|P4|Phase 2|Adverse Event|1
1439030|NCT00913458|4749045|P3|Phase 2|Adverse Event|0
1439031|NCT00913458|4749046|P2|Phase 2|Adverse Event|3
1439032|NCT00913458|4749047|P1|Phase 2|Adverse Event|0
1439033|NCT00913458|4749041|P7|Phase 2|Subject Request|0
1439034|NCT00913458|4749042|P6|Phase 2|Subject Request|0
1439035|NCT00913458|4749043|P5|Phase 2|Subject Request|0
1439036|NCT00913458|4749044|P4|Phase 2|Subject Request|2
1439037|NCT00913458|4749045|P3|Phase 2|Subject Request|1
1439038|NCT00913458|4749046|P2|Phase 2|Subject Request|0
1439039|NCT00913458|4749047|P1|Phase 2|Subject Request|0
1439040|NCT00913458|4749041|P7|Phase 2|Non-Responder|0
1439041|NCT00913458|4749042|P6|Phase 2|Non-Responder|0
1439042|NCT00913458|4749043|P5|Phase 2|Non-Responder|0
1439043|NCT00913458|4749044|P4|Phase 2|Non-Responder|12
1439044|NCT00913458|4749045|P3|Phase 2|Non-Responder|7
1439045|NCT00913458|4749046|P2|Phase 2|Non-Responder|5
1439046|NCT00913458|4749047|P1|Phase 2|Non-Responder|0
1439047|NCT00913458|4749041|P7|Phase 1|Unsatisfactory Response per Investigator|0
1439048|NCT00913458|4749042|P6|Phase 1|Unsatisfactory Response per Investigator|0
1439049|NCT00913458|4749043|P5|Phase 1|Unsatisfactory Response per Investigator|0
1439050|NCT00913458|4749044|P4|Phase 1|Unsatisfactory Response per Investigator|0
1439051|NCT00913458|4749045|P3|Phase 1|Unsatisfactory Response per Investigator|0
1439052|NCT00913458|4749046|P2|Phase 1|Unsatisfactory Response per Investigator|0
1439053|NCT00913458|4749047|P1|Phase 1|Unsatisfactory Response per Investigator|7
1439054|NCT00913458|4749041|P7|Phase 1|Sponsor|0
1439055|NCT00913458|4749042|P6|Phase 1|Sponsor|0
1439056|NCT00913458|4749043|P5|Phase 1|Sponsor|0
1439057|NCT00913458|4749044|P4|Phase 1|Sponsor|0
1439058|NCT00913458|4749045|P3|Phase 1|Sponsor|0
1439059|NCT00913458|4749046|P2|Phase 1|Sponsor|0
1439060|NCT00913458|4749047|P1|Phase 1|Sponsor|2
1439061|NCT00913458|4749041|P7|Phase 1|Protocol Violation|0
1439062|NCT00913458|4749042|P6|Phase 1|Protocol Violation|0
1439063|NCT00913458|4749043|P5|Phase 1|Protocol Violation|0
1439064|NCT00913458|4749044|P4|Phase 1|Protocol Violation|0
1439065|NCT00913458|4749045|P3|Phase 1|Protocol Violation|0
1439066|NCT00913458|4749046|P2|Phase 1|Protocol Violation|0
1439067|NCT00913458|4749047|P1|Phase 1|Protocol Violation|10
1439068|NCT00913458|4749041|P7|Phase 1|Lost to Follow-up|0
1439069|NCT00913458|4749042|P6|Phase 1|Lost to Follow-up|0
1439070|NCT00913458|4749043|P5|Phase 1|Lost to Follow-up|0
1439071|NCT00913458|4749044|P4|Phase 1|Lost to Follow-up|0
1439072|NCT00913458|4749045|P3|Phase 1|Lost to Follow-up|0
1439073|NCT00913458|4749046|P2|Phase 1|Lost to Follow-up|0
1439074|NCT00913458|4749047|P1|Phase 1|Lost to Follow-up|2
1439075|NCT00913458|4749041|P7|Phase 1|Adverse Event|0
1439076|NCT00913458|4749042|P6|Phase 1|Adverse Event|0
1439077|NCT00913458|4749043|P5|Phase 1|Adverse Event|0
1439078|NCT00913458|4749044|P4|Phase 1|Adverse Event|0
1439079|NCT00913458|4749045|P3|Phase 1|Adverse Event|0
1439080|NCT00913458|4749046|P2|Phase 1|Adverse Event|0
1439081|NCT00913458|4749047|P1|Phase 1|Adverse Event|20
1439082|NCT00913458|4749041|P7|Phase 1|Subject Request|0
1439083|NCT00913458|4749042|P6|Phase 1|Subject Request|0
1439084|NCT00913458|4749043|P5|Phase 1|Subject Request|0
1439085|NCT00913458|4749044|P4|Phase 1|Subject Request|0
1439086|NCT00913458|4749045|P3|Phase 1|Subject Request|0
1439087|NCT00913458|4749046|P2|Phase 1|Subject Request|0
1439088|NCT00913458|4749047|P1|Phase 1|Subject Request|17
1439089|NCT00913458|4749041|P7|Phase 1|Non-Responder|0
1439090|NCT00913458|4749042|P6|Phase 1|Non-Responder|0
1439091|NCT00913458|4749043|P5|Phase 1|Non-Responder|0
1439092|NCT00913458|4749044|P4|Phase 1|Non-Responder|0
1439093|NCT00913458|4749045|P3|Phase 1|Non-Responder|0
1439094|NCT00913458|4749046|P2|Phase 1|Non-Responder|0
1439095|NCT00913458|4749047|P1|Phase 1|Non-Responder|54
1439096|NCT00913380|4749140|P2|Clinical Outcomes|Lost to Follow-up|6
1439097|NCT00913380|4749141|P1|Clinical Outcomes|Lost to Follow-up|6
1439098|NCT00912964|4749207|P3|Overall Study|Randomized but never received study drug|0
1439099|NCT00912964|4749208|P2|Overall Study|Randomized but never received study drug|1
1439100|NCT00912964|4749209|P1|Overall Study|Randomized but never received study drug|0
1439101|NCT00912964|4749207|P3|Overall Study|Violation of exclusion criterion|2
1439102|NCT00912964|4749208|P2|Overall Study|Violation of exclusion criterion|0
1439103|NCT00912964|4749209|P1|Overall Study|Violation of exclusion criterion|0
1439104|NCT00912964|4749207|P3|Overall Study|Non-compliance with study procedures|0
1439105|NCT00912964|4749208|P2|Overall Study|Non-compliance with study procedures|0
1439106|NCT00912964|4749209|P1|Overall Study|Non-compliance with study procedures|2
1439107|NCT00912964|4749207|P3|Overall Study|Medical History|0
1439108|NCT00912964|4749208|P2|Overall Study|Medical History|0
1439109|NCT00912964|4749209|P1|Overall Study|Medical History|1
1439110|NCT00912964|4749207|P3|Overall Study|Taking exclusionary medications|8
1439111|NCT00912964|4749208|P2|Overall Study|Taking exclusionary medications|4
1439112|NCT00912964|4749209|P1|Overall Study|Taking exclusionary medications|7
1439113|NCT00912964|4749207|P3|Overall Study|Protocol Violation|8
1439114|NCT00912964|4749208|P2|Overall Study|Protocol Violation|3
1439115|NCT00912964|4749209|P1|Overall Study|Protocol Violation|5
1439116|NCT00912964|4749207|P3|Overall Study|Lost to Follow-up|3
1439117|NCT00912964|4749208|P2|Overall Study|Lost to Follow-up|3
1439118|NCT00912964|4749209|P1|Overall Study|Lost to Follow-up|4
1439119|NCT00912964|4749207|P3|Overall Study|Withdrawal by Subject|18
1439120|NCT00912964|4749208|P2|Overall Study|Withdrawal by Subject|12
1439121|NCT00912964|4749209|P1|Overall Study|Withdrawal by Subject|20
1439122|NCT00912964|4749207|P3|Overall Study|Lack of Efficacy|3
1439123|NCT00912964|4749208|P2|Overall Study|Lack of Efficacy|4
1439124|NCT00912964|4749209|P1|Overall Study|Lack of Efficacy|11
1439125|NCT00912964|4749207|P3|Overall Study|Adverse Event|12
1439126|NCT00912964|4749208|P2|Overall Study|Adverse Event|18
1439127|NCT00912964|4749209|P1|Overall Study|Adverse Event|15
1439128|NCT00912964|4749207|P3|Overall Study|Eligibility criterion not met|0
1439129|NCT00912964|4749208|P2|Overall Study|Eligibility criterion not met|1
1439130|NCT00912964|4749209|P1|Overall Study|Eligibility criterion not met|1
1439131|NCT00912912|4749352|P1|Overall Study|Disease Progression|3
1439132|NCT00912912|4749352|P1|Overall Study|Withdrawal by Subject|1
1439133|NCT00912808|4749358|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|0
1439134|NCT00912808|4749359|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|1
1439135|NCT00912808|4749358|P2|Second Intervention (6 Weeks)|Adverse Event|1
1439136|NCT00912808|4749359|P1|Second Intervention (6 Weeks)|Adverse Event|0
1439137|NCT00912808|4749358|P2|Washout|Withdrawal by Subject|1
1439138|NCT00912808|4749359|P1|Washout|Withdrawal by Subject|0
1439139|NCT00912808|4749358|P2|First Intervention (6 Weeks)|Adverse Event|1
1439140|NCT00912808|4749359|P1|First Intervention (6 Weeks)|Adverse Event|2
1439141|NCT00912782|4749384|P2|Overall Study|Relocated before study completion|1
1439142|NCT00912782|4749385|P1|Overall Study|Relocated before study completion|0
1439143|NCT00912782|4749384|P2|Overall Study|Did not receive vascular access type|2
1439144|NCT00912782|4749385|P1|Overall Study|Did not receive vascular access type|1
1439145|NCT00912782|4749384|P2|Overall Study|Lost to Follow-up|1
1439146|NCT00912782|4749385|P1|Overall Study|Lost to Follow-up|0
1439147|NCT00912782|4749384|P2|Overall Study|Death|1
1439148|NCT00912782|4749385|P1|Overall Study|Death|2
1439149|NCT00912743|4749395|P2|Overall Study|End of treatment form was not collected|0
1439150|NCT00912743|4749396|P1|Overall Study|End of treatment form was not collected|1
1439151|NCT00912743|4749395|P2|Overall Study|Toxicity|1
1439152|NCT00912743|4749396|P1|Overall Study|Toxicity|0
1439153|NCT00912743|4749395|P2|Overall Study|Lack of Efficacy|18
1439154|NCT00912743|4749396|P1|Overall Study|Lack of Efficacy|9
1439155|NCT00912743|4749395|P2|Overall Study|Adverse Event|1
1439156|NCT00912743|4749396|P1|Overall Study|Adverse Event|3
1439157|NCT00912509|4749408|P2|Overall Study|Lack of Efficacy|3
1439158|NCT00912509|4749409|P1|Overall Study|Lack of Efficacy|4
1439159|NCT00912509|4749408|P2|Overall Study|Lost to Follow-up|0
1439160|NCT00912509|4749409|P1|Overall Study|Lost to Follow-up|1
1439161|NCT00912405|4749417|P1|Overall Study|Lost to Follow-up|5
1439162|NCT00912288|4749451|P2|Overall Study|Other|0
1439163|NCT00912288|4749452|P1|Overall Study|Other|1
1439164|NCT00912288|4749451|P2|Overall Study|Study terminated by sponsor|35
1439165|NCT00912288|4749452|P1|Overall Study|Study terminated by sponsor|34
1439166|NCT00912288|4749451|P2|Overall Study|Withdrawal by Subject|3
1439167|NCT00912288|4749452|P1|Overall Study|Withdrawal by Subject|3
1439168|NCT00912288|4749451|P2|Overall Study|Protocol Violation|0
1439169|NCT00912288|4749452|P1|Overall Study|Protocol Violation|1
1439170|NCT00912288|4749451|P2|Overall Study|Lost to Follow-up|0
1439171|NCT00912288|4749452|P1|Overall Study|Lost to Follow-up|1
1439172|NCT00912288|4749451|P2|Overall Study|Adverse Event|1
1439173|NCT00912288|4749452|P1|Overall Study|Adverse Event|1
1439174|NCT00912288|4749451|P2|Overall Study|Death|1
1439175|NCT00912288|4749452|P1|Overall Study|Death|0
1439176|NCT00912223|4749474|P1|Overall Study|Transformed disease|1
1439177|NCT00912223|4749474|P1|Overall Study|Not transplanted|1
1439178|NCT00912223|4749474|P1|Overall Study|Withdrawal by Subject|1
1439179|NCT00912093|4749505|P5|The Controlled Phase|Lost to Follow-up|1
1439180|NCT00912093|4749506|P4|The Controlled Phase|Lost to Follow-up|0
1439181|NCT00912093|4749507|P3|The Controlled Phase|Lost to Follow-up|0
1439182|NCT00912093|4749508|P2|The Controlled Phase|Lost to Follow-up|0
1439183|NCT00912093|4749509|P1|The Controlled Phase|Lost to Follow-up|0
1439184|NCT00912093|4749505|P5|The Controlled Phase|Medical Condition|0
1439185|NCT00912093|4749506|P4|The Controlled Phase|Medical Condition|0
1439186|NCT00912093|4749507|P3|The Controlled Phase|Medical Condition|0
1439187|NCT00912093|4749508|P2|The Controlled Phase|Medical Condition|1
1439188|NCT00912093|4749509|P1|The Controlled Phase|Medical Condition|0
1439189|NCT00912093|4749505|P5|The Controlled Phase|Death|0
1439190|NCT00912093|4749506|P4|The Controlled Phase|Death|0
1439191|NCT00912093|4749507|P3|The Controlled Phase|Death|0
1439192|NCT00912093|4749508|P2|The Controlled Phase|Death|1
1439193|NCT00912093|4749509|P1|The Controlled Phase|Death|0
1439194|NCT00912028|4749528|P5|Overall Study|Withdrawal by Subject|0
1439195|NCT00912028|4749529|P4|Overall Study|Withdrawal by Subject|0
1439196|NCT00912028|4749530|P3|Overall Study|Withdrawal by Subject|0
1439197|NCT00912028|4749531|P2|Overall Study|Withdrawal by Subject|0
1439198|NCT00912028|4749532|P1|Overall Study|Withdrawal by Subject|3
1439199|NCT00912028|4749528|P5|Overall Study|Lost to Follow-up|3
1439200|NCT00912028|4749529|P4|Overall Study|Lost to Follow-up|1
1439201|NCT00912028|4749530|P3|Overall Study|Lost to Follow-up|0
1439202|NCT00912028|4749531|P2|Overall Study|Lost to Follow-up|3
1439203|NCT00912028|4749532|P1|Overall Study|Lost to Follow-up|2
1439204|NCT00912015|4749561|P4|Overall Study|Adverse Event|1
1439205|NCT00912015|4749562|P3|Overall Study|Adverse Event|0
1439206|NCT00912015|4749563|P2|Overall Study|Adverse Event|0
1439207|NCT00912015|4749564|P1|Overall Study|Adverse Event|6
1439208|NCT00912015|4749561|P4|Overall Study|Protocol Violation|1
1439209|NCT00912015|4749562|P3|Overall Study|Protocol Violation|0
1439210|NCT00912015|4749563|P2|Overall Study|Protocol Violation|0
1439211|NCT00912015|4749564|P1|Overall Study|Protocol Violation|1
1439212|NCT00912015|4749561|P4|Overall Study|Withdrawal by Subject|0
1439213|NCT00912015|4749562|P3|Overall Study|Withdrawal by Subject|3
1439214|NCT00912015|4749563|P2|Overall Study|Withdrawal by Subject|8
1439215|NCT00912015|4749564|P1|Overall Study|Withdrawal by Subject|8
1439216|NCT00912015|4749561|P4|Overall Study|Lack of Efficacy|0
1439217|NCT00912015|4749562|P3|Overall Study|Lack of Efficacy|0
1439218|NCT00912015|4749563|P2|Overall Study|Lack of Efficacy|0
1439219|NCT00912015|4749564|P1|Overall Study|Lack of Efficacy|1
1439220|NCT00911989|4749580|P1|Overall Study|Adverse Event|1
1439221|NCT00911937|4749586|P2|Overall Study|Other|5
1439222|NCT00911937|4749587|P1|Overall Study|Other|9
1439223|NCT00911937|4749586|P2|Overall Study|Randomized but not treated|13
1439224|NCT00911937|4749587|P1|Overall Study|Randomized but not treated|13
1439225|NCT00911937|4749586|P2|Overall Study|Protocol Violation|23
1439226|NCT00911937|4749587|P1|Overall Study|Protocol Violation|14
1439227|NCT00911937|4749586|P2|Overall Study|Did not meet inclusion criteria|11
1439228|NCT00911937|4749587|P1|Overall Study|Did not meet inclusion criteria|9
1439229|NCT00911937|4749586|P2|Overall Study|Lack of Efficacy|6
1439230|NCT00911937|4749587|P1|Overall Study|Lack of Efficacy|11
1439231|NCT00911937|4749586|P2|Overall Study|Adverse Event|25
1439232|NCT00911937|4749587|P1|Overall Study|Adverse Event|11
1439233|NCT00911937|4749586|P2|Overall Study|Withdrawn due to pregnancy|0
1439234|NCT00911937|4749587|P1|Overall Study|Withdrawn due to pregnancy|1
1439235|NCT00911937|4749586|P2|Overall Study|Withdrawal by Subject|7
1439236|NCT00911937|4749587|P1|Overall Study|Withdrawal by Subject|10
1439237|NCT00911937|4749586|P2|Overall Study|Lost to Follow-up|5
1439238|NCT00911937|4749587|P1|Overall Study|Lost to Follow-up|8
1439239|NCT00911937|4749586|P2|Overall Study|Death|0
1439240|NCT00911937|4749587|P1|Overall Study|Death|1
1439241|NCT00911859|4749654|P3|Follow-up Period|Study terminated by sponsor|27
1439242|NCT00911859|4749655|P2|Follow-up Period|Study terminated by sponsor|33
1439243|NCT00911859|4749656|P1|Follow-up Period|Study terminated by sponsor|5
1439244|NCT00911859|4749654|P3|Follow-up Period|Withdrawal by Subject|4
1439245|NCT00911859|4749655|P2|Follow-up Period|Withdrawal by Subject|4
1439246|NCT00911859|4749656|P1|Follow-up Period|Withdrawal by Subject|0
1439247|NCT00911859|4749654|P3|Follow-up Period|Lost to Follow-up|0
1439248|NCT00911859|4749655|P2|Follow-up Period|Lost to Follow-up|1
1439249|NCT00911859|4749656|P1|Follow-up Period|Lost to Follow-up|1
1439250|NCT00911859|4749654|P3|Follow-up Period|Death|10
1439251|NCT00911859|4749655|P2|Follow-up Period|Death|8
1439252|NCT00911859|4749656|P1|Follow-up Period|Death|5
1439253|NCT00911859|4749654|P3|Maintainance Period|Withdrawal by Subject|3
1439254|NCT00911859|4749655|P2|Maintainance Period|Withdrawal by Subject|0
1439255|NCT00911859|4749656|P1|Maintainance Period|Withdrawal by Subject|0
1439256|NCT00911859|4749654|P3|Maintainance Period|Physician Decision|9
1439257|NCT00911859|4749655|P2|Maintainance Period|Physician Decision|0
1439258|NCT00911859|4749656|P1|Maintainance Period|Physician Decision|0
1439259|NCT00911859|4749654|P3|Maintainance Period|Lack of Efficacy|9
1439260|NCT00911859|4749655|P2|Maintainance Period|Lack of Efficacy|0
1439261|NCT00911859|4749656|P1|Maintainance Period|Lack of Efficacy|0
1439262|NCT00911859|4749654|P3|Treatment Period|Did not receive study treatment|0
1439263|NCT00911859|4749655|P2|Treatment Period|Did not receive study treatment|1
1439264|NCT00911859|4749656|P1|Treatment Period|Did not receive study treatment|0
1439265|NCT00911859|4749654|P3|Treatment Period|Withdrawal by Subject|5
1439266|NCT00911859|4749655|P2|Treatment Period|Withdrawal by Subject|4
1439267|NCT00911859|4749656|P1|Treatment Period|Withdrawal by Subject|0
1439268|NCT00911859|4749654|P3|Treatment Period|Physician Decision|3
1439269|NCT00911859|4749655|P2|Treatment Period|Physician Decision|3
1439270|NCT00911859|4749656|P1|Treatment Period|Physician Decision|3
1439271|NCT00911859|4749654|P3|Treatment Period|Lack of Efficacy|5
1439272|NCT00911859|4749655|P2|Treatment Period|Lack of Efficacy|7
1439273|NCT00911859|4749656|P1|Treatment Period|Lack of Efficacy|1
1439274|NCT00911859|4749654|P3|Treatment Period|Death|5
1439275|NCT00911859|4749655|P2|Treatment Period|Death|3
1439276|NCT00911859|4749656|P1|Treatment Period|Death|1
1439277|NCT00911859|4749654|P3|Treatment Period|Adverse Event|7
1439278|NCT00911859|4749655|P2|Treatment Period|Adverse Event|3
1439279|NCT00911859|4749656|P1|Treatment Period|Adverse Event|3
1439280|NCT00911820|4749682|P2|Overall Study|Withdraw before Receive Treatment|2
1439281|NCT00911820|4749683|P1|Overall Study|Withdraw before Receive Treatment|0
1439282|NCT00911820|4749682|P2|Overall Study|Pathology Not Confirmed|0
1439283|NCT00911820|4749683|P1|Overall Study|Pathology Not Confirmed|1
1439284|NCT00911820|4749682|P2|Overall Study|Still on Therapy|2
1439285|NCT00911820|4749683|P1|Overall Study|Still on Therapy|2
1439286|NCT00911820|4749682|P2|Overall Study|Pursue Radiation|0
1439287|NCT00911820|4749683|P1|Overall Study|Pursue Radiation|1
1439288|NCT00911820|4749682|P2|Overall Study|Pursue surgery|1
1439289|NCT00911820|4749683|P1|Overall Study|Pursue surgery|1
1439290|NCT00911820|4749682|P2|Overall Study|Death|2
1439291|NCT00911820|4749683|P1|Overall Study|Death|1
1439292|NCT00911820|4749682|P2|Overall Study|Withdrawal by Subject|4
1439293|NCT00911820|4749683|P1|Overall Study|Withdrawal by Subject|3
1439294|NCT00911820|4749682|P2|Overall Study|Decline in Performance Status|2
1439295|NCT00911820|4749683|P1|Overall Study|Decline in Performance Status|4
1439296|NCT00911820|4749682|P2|Overall Study|Physician Decision|9
1439297|NCT00911820|4749683|P1|Overall Study|Physician Decision|5
1439298|NCT00911820|4749682|P2|Overall Study|Clinical Progression|5
1439299|NCT00911820|4749683|P1|Overall Study|Clinical Progression|7
1439300|NCT00911820|4749682|P2|Overall Study|Adverse Event|8
1439301|NCT00911820|4749683|P1|Overall Study|Adverse Event|8
1439302|NCT00911820|4749682|P2|Overall Study|RECIST progression|8
1439303|NCT00911820|4749683|P1|Overall Study|RECIST progression|12
1439304|NCT00911807|4749700|P3|Overall Study|Organizational reasons|1
1439305|NCT00911807|4749701|P2|Overall Study|Organizational reasons|3
1439306|NCT00911807|4749702|P1|Overall Study|Organizational reasons|1
1439307|NCT00911807|4749700|P3|Overall Study|Withdrawal by Subject|7
1439308|NCT00911807|4749701|P2|Overall Study|Withdrawal by Subject|10
1439309|NCT00911807|4749702|P1|Overall Study|Withdrawal by Subject|8
1439310|NCT00911807|4749700|P3|Overall Study|Protocol Violation|9
1439311|NCT00911807|4749701|P2|Overall Study|Protocol Violation|4
1439312|NCT00911807|4749702|P1|Overall Study|Protocol Violation|6
1439313|NCT00911807|4749700|P3|Overall Study|Death|1
1439314|NCT00911807|4749701|P2|Overall Study|Death|0
1439315|NCT00911807|4749702|P1|Overall Study|Death|0
1439316|NCT00911807|4749700|P3|Overall Study|Adverse Event|5
1439317|NCT00911807|4749701|P2|Overall Study|Adverse Event|1
1439318|NCT00911807|4749702|P1|Overall Study|Adverse Event|2
1439319|NCT00911768|4749712|P2|Overall Study|Withdrawal by Subject|0
1439320|NCT00911768|4749713|P1|Overall Study|Withdrawal by Subject|1
1439321|NCT00911768|4749712|P2|Overall Study|Protocol Violation|4
1439322|NCT00911768|4749713|P1|Overall Study|Protocol Violation|5
1439323|NCT00911625|4749742|P2|Overall Study|Lost to Follow-up|0
1439324|NCT00911625|4749743|P1|Overall Study|Lost to Follow-up|7
1439325|NCT00911547|4749772|P4|Overall Study|Withdrawal by Subject|8
1439326|NCT00911547|4749773|P3|Overall Study|Withdrawal by Subject|4
1439327|NCT00911547|4749774|P2|Overall Study|Withdrawal by Subject|10
1439328|NCT00911547|4749775|P1|Overall Study|Withdrawal by Subject|3
1439329|NCT00911547|4749772|P4|Overall Study|Protocol Violation|1
1439330|NCT00911547|4749773|P3|Overall Study|Protocol Violation|5
1439331|NCT00911547|4749774|P2|Overall Study|Protocol Violation|5
1439332|NCT00911547|4749775|P1|Overall Study|Protocol Violation|0
1439333|NCT00911547|4749772|P4|Overall Study|Lost to Follow-up|1
1439334|NCT00911547|4749773|P3|Overall Study|Lost to Follow-up|2
1439335|NCT00911547|4749774|P2|Overall Study|Lost to Follow-up|0
1439336|NCT00911547|4749775|P1|Overall Study|Lost to Follow-up|0
1439337|NCT00911547|4749772|P4|Overall Study|Adverse Event|6
1439338|NCT00911547|4749773|P3|Overall Study|Adverse Event|11
1439339|NCT00911547|4749774|P2|Overall Study|Adverse Event|27
1439340|NCT00911547|4749775|P1|Overall Study|Adverse Event|8
1439341|NCT00911534|4749803|P2|Overall Study|Not specified|2
1439342|NCT00911534|4749804|P1|Overall Study|Not specified|2
1439343|NCT00911534|4749803|P2|Overall Study|Withdrawal of consent|4
1439344|NCT00911534|4749804|P1|Overall Study|Withdrawal of consent|1
1439345|NCT00911534|4749803|P2|Overall Study|Lack of Efficacy|1
1439346|NCT00911534|4749804|P1|Overall Study|Lack of Efficacy|4
1439347|NCT00911534|4749803|P2|Overall Study|Withdrawal by Subject|1
1439348|NCT00911534|4749804|P1|Overall Study|Withdrawal by Subject|2
1439349|NCT00911534|4749803|P2|Overall Study|Lost to Follow-up|4
1439350|NCT00911534|4749804|P1|Overall Study|Lost to Follow-up|2
1439351|NCT00911534|4749803|P2|Overall Study|Adverse Event|4
1439352|NCT00911534|4749804|P1|Overall Study|Adverse Event|4
1439353|NCT00911300|4749859|P2|Overall Study|Randomized; No Study Medication Received|2
1439354|NCT00911300|4749860|P1|Overall Study|Randomized; No Study Medication Received|0
1439355|NCT00911300|4749859|P2|Overall Study|Treatment Stopped by Mistake|1
1439356|NCT00911300|4749860|P1|Overall Study|Treatment Stopped by Mistake|0
1439357|NCT00911300|4749859|P2|Overall Study|Physician Decision|1
1439358|NCT00911300|4749860|P1|Overall Study|Physician Decision|0
1439359|NCT00911300|4749859|P2|Overall Study|Underlying Disease (Myocarditis)|1
1439360|NCT00911300|4749860|P1|Overall Study|Underlying Disease (Myocarditis)|0
1439361|NCT00911300|4749859|P2|Overall Study|Participant Refused Hospital Consulation|1
1439362|NCT00911300|4749860|P1|Overall Study|Participant Refused Hospital Consulation|0
1439363|NCT00911300|4749859|P2|Overall Study|International Normalized Ratio Too High|1
1439364|NCT00911300|4749860|P1|Overall Study|International Normalized Ratio Too High|0
1439365|NCT00911300|4749859|P2|Overall Study|Investigator's Decision; New AF Episode|1
1439366|NCT00911300|4749860|P1|Overall Study|Investigator's Decision; New AF Episode|0
1439367|NCT00911300|4749859|P2|Overall Study|Participant Could Not Stay in Hospital|1
1439368|NCT00911300|4749860|P1|Overall Study|Participant Could Not Stay in Hospital|0
1439369|NCT00911300|4749859|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
1439370|NCT00911300|4749860|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
1439371|NCT00911300|4749859|P2|Overall Study|Nurse Unavailable in Participant's City|0
1439372|NCT00911300|4749860|P1|Overall Study|Nurse Unavailable in Participant's City|1
1439373|NCT00911300|4749859|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
1439374|NCT00911300|4749860|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
1439375|NCT00911300|4749859|P2|Overall Study|Recurrent Tachyarrhythmia|1
1439376|NCT00911300|4749860|P1|Overall Study|Recurrent Tachyarrhythmia|1
1439377|NCT00911300|4749859|P2|Overall Study|Received Commercial Treatment|0
1439378|NCT00911300|4749860|P1|Overall Study|Received Commercial Treatment|1
1439379|NCT00911300|4749859|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
1439380|NCT00911300|4749860|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
1439381|NCT00911300|4749859|P2|Overall Study|Coronary Angiography Performed|0
1439382|NCT00911300|4749860|P1|Overall Study|Coronary Angiography Performed|1
1439383|NCT00911300|4749859|P2|Overall Study|Consent Withdrawn|12
1439384|NCT00911300|4749860|P1|Overall Study|Consent Withdrawn|4
1439385|NCT00911300|4749859|P2|Overall Study|Protocol Violation|2
1439386|NCT00911300|4749860|P1|Overall Study|Protocol Violation|3
1439387|NCT00911300|4749859|P2|Overall Study|Adverse Event|6
1439388|NCT00911300|4749860|P1|Overall Study|Adverse Event|14
1439389|NCT00911300|4749859|P2|Overall Study|Thrombus Persistant in Second TEE|7
1439390|NCT00911300|4749860|P1|Overall Study|Thrombus Persistant in Second TEE|3
1439391|NCT00911300|4749859|P2|Overall Study|Death|0
1439392|NCT00911300|4749860|P1|Overall Study|Death|1
1439393|NCT00911300|4749859|P2|Overall Study|Primary Endpoint Component Occurred|2
1439394|NCT00911300|4749860|P1|Overall Study|Primary Endpoint Component Occurred|1
1439395|NCT00911170|4749897|P2|Long Term Follow-Up|Death|121
1439396|NCT00911170|4749898|P1|Long Term Follow-Up|Death|116
1439397|NCT00911170|4749897|P2|Long Term Follow-Up|Lost to Follow-up|7
1439398|NCT00911170|4749898|P1|Long Term Follow-Up|Lost to Follow-up|8
1439399|NCT00911170|4749897|P2|Long Term Follow-Up|Physician Decision|4
1439400|NCT00911170|4749898|P1|Long Term Follow-Up|Physician Decision|5
1439401|NCT00911170|4749897|P2|Long Term Follow-Up|Withdrawal by Subject|21
1439402|NCT00911170|4749898|P1|Long Term Follow-Up|Withdrawal by Subject|20
1439403|NCT00911170|4749897|P2|Long Term Follow-Up|Continuing in study|269
1439404|NCT00911170|4749898|P1|Long Term Follow-Up|Continuing in study|274
1439405|NCT00911170|4749897|P2|Treatment Period|Death|9
1439406|NCT00911170|4749898|P1|Treatment Period|Death|6
1439407|NCT00911170|4749897|P2|Treatment Period|Lost to Follow-up|1
1439408|NCT00911170|4749898|P1|Treatment Period|Lost to Follow-up|0
1439409|NCT00911170|4749897|P2|Treatment Period|Physician Decision|5
1439410|NCT00911170|4749898|P1|Treatment Period|Physician Decision|5
1439411|NCT00911170|4749897|P2|Treatment Period|Disease progression|2
1439412|NCT00911170|4749898|P1|Treatment Period|Disease progression|0
1439413|NCT00911170|4749897|P2|Treatment Period|Withdrawal by Subject|4
1439414|NCT00911170|4749898|P1|Treatment Period|Withdrawal by Subject|4
1439415|NCT00911170|4749897|P2|Treatment Period|Adverse Event|10
1439416|NCT00911170|4749898|P1|Treatment Period|Adverse Event|9
1439417|NCT00911170|4749897|P2|Treatment Period|Protocol deviation|2
1439418|NCT00911170|4749898|P1|Treatment Period|Protocol deviation|1
1439419|NCT00911170|4749897|P2|Treatment Period|Ineligibility determined|3
1439420|NCT00911170|4749898|P1|Treatment Period|Ineligibility determined|1
1439421|NCT00911170|4749897|P2|Treatment Period|Randomized in error|1
1439422|NCT00911170|4749898|P1|Treatment Period|Randomized in error|1
1439423|NCT00911157|4749922|P2|Overall Study|Need to treat for lung cancer|0
1439424|NCT00911157|4749923|P1|Overall Study|Need to treat for lung cancer|1
1439425|NCT00911157|4749922|P2|Overall Study|Need for prohibited drug (heparin)|0
1439426|NCT00911157|4749923|P1|Overall Study|Need for prohibited drug (heparin)|1
1439427|NCT00911157|4749922|P2|Overall Study|Withdrawal by Subject|1
1439428|NCT00911157|4749923|P1|Overall Study|Withdrawal by Subject|1
1439429|NCT00911157|4749922|P2|Overall Study|Adverse Event|1
1439430|NCT00911157|4749923|P1|Overall Study|Adverse Event|4
1439431|NCT00911144|4749939|P2|Overall Study|Withdrawal by Subject|5
1439432|NCT00911144|4749940|P1|Overall Study|Withdrawal by Subject|16
1439433|NCT00910988|4749968|P4|Overall Study|Lost to Follow-up|0
1439434|NCT00910988|4749969|P3|Overall Study|Lost to Follow-up|3
1439435|NCT00910988|4749970|P2|Overall Study|Lost to Follow-up|4
1439436|NCT00910988|4749971|P1|Overall Study|Lost to Follow-up|2
1439437|NCT00910962|4750016|P3|Overall Study|Reached defined stopping criteria|17
1439438|NCT00910962|4750017|P2|Overall Study|Reached defined stopping criteria|14
1439439|NCT00910962|4750018|P1|Overall Study|Reached defined stopping criteria|12
1439440|NCT00910962|4750016|P3|Overall Study|Withdrawal by Subject|32
1439441|NCT00910962|4750017|P2|Overall Study|Withdrawal by Subject|32
1439442|NCT00910962|4750018|P1|Overall Study|Withdrawal by Subject|25
1439443|NCT00910962|4750016|P3|Overall Study|Physician Decision|6
1439444|NCT00910962|4750017|P2|Overall Study|Physician Decision|6
1439445|NCT00910962|4750018|P1|Overall Study|Physician Decision|0
1439446|NCT00910962|4750016|P3|Overall Study|Lost to Follow-up|1
1439447|NCT00910962|4750017|P2|Overall Study|Lost to Follow-up|3
1439448|NCT00910962|4750018|P1|Overall Study|Lost to Follow-up|0
1439449|NCT00910962|4750016|P3|Overall Study|Protocol Violation|3
1439450|NCT00910962|4750017|P2|Overall Study|Protocol Violation|3
1439451|NCT00910962|4750018|P1|Overall Study|Protocol Violation|1
1439452|NCT00910962|4750016|P3|Overall Study|Adverse Event|17
1439453|NCT00910962|4750017|P2|Overall Study|Adverse Event|20
1439454|NCT00910962|4750018|P1|Overall Study|Adverse Event|5
1439455|NCT00910910|4750110|P2|Overall Study|Untreated before cycle 1|2
1439456|NCT00910910|4750111|P1|Overall Study|Untreated before cycle 1|1
1439457|NCT00910910|4750110|P2|Overall Study|Other|32
1439458|NCT00910910|4750111|P1|Overall Study|Other|114
1439459|NCT00910910|4750110|P2|Overall Study|Completed 13 cycles of treatment|118
1439460|NCT00910910|4750111|P1|Overall Study|Completed 13 cycles of treatment|0
1439461|NCT00910910|4750110|P2|Overall Study|Protocol Violation|2
1439462|NCT00910910|4750111|P1|Overall Study|Protocol Violation|2
1439463|NCT00910910|4750110|P2|Overall Study|Death|3
1439464|NCT00910910|4750111|P1|Overall Study|Death|9
1439465|NCT00910910|4750110|P2|Overall Study|Lost to Follow-up|2
1439466|NCT00910910|4750111|P1|Overall Study|Lost to Follow-up|2
1439467|NCT00910910|4750110|P2|Overall Study|Withdrawal by Subject|5
1439468|NCT00910910|4750111|P1|Overall Study|Withdrawal by Subject|7
1439469|NCT00910910|4750110|P2|Overall Study|PD with histologic change|2
1439470|NCT00910910|4750111|P1|Overall Study|PD with histologic change|0
1439471|NCT00910910|4750110|P2|Overall Study|PD without histologic change|23
1439472|NCT00910910|4750111|P1|Overall Study|PD without histologic change|27
1439473|NCT00910910|4750110|P2|Overall Study|Adverse Event|35
1439474|NCT00910910|4750111|P1|Overall Study|Adverse Event|63
1439475|NCT00910871|4750145|P1|Overall Study|Undefined|1
1439476|NCT00910871|4750145|P1|Overall Study|Subject didn’t meet eligibility criteria|5
1439477|NCT00910871|4750145|P1|Overall Study|Withdrawal by Subject|12
1439478|NCT00910871|4750145|P1|Overall Study|Protocol Violation|11
1439479|NCT00910871|4750145|P1|Overall Study|Lost to Follow-up|8
1439480|NCT00910871|4750145|P1|Overall Study|Death|12
1439481|NCT00910871|4750145|P1|Overall Study|Adverse Event|5
1439482|NCT00910858|4750153|P3|Combined Treatment Phase|Other|1
1439483|NCT00910858|4750154|P2|Combined Treatment Phase|Other|2
1439484|NCT00910858|4750155|P1|Combined Treatment Phase|Other|0
1439485|NCT00910858|4750153|P3|Combined Treatment Phase|Protocol Violation|0
1439486|NCT00910858|4750154|P2|Combined Treatment Phase|Protocol Violation|0
1439487|NCT00910858|4750155|P1|Combined Treatment Phase|Protocol Violation|1
1439488|NCT00910858|4750153|P3|Combined Treatment Phase|Withdrawal by Subject|0
1439489|NCT00910858|4750154|P2|Combined Treatment Phase|Withdrawal by Subject|2
1439490|NCT00910858|4750155|P1|Combined Treatment Phase|Withdrawal by Subject|0
1439491|NCT00910858|4750153|P3|Combined Treatment Phase|Lack of therapeutic effect|3
1439492|NCT00910858|4750154|P2|Combined Treatment Phase|Lack of therapeutic effect|6
1439493|NCT00910858|4750155|P1|Combined Treatment Phase|Lack of therapeutic effect|8
1439494|NCT00910858|4750153|P3|Monotherapy Phase|Other|2
1439495|NCT00910858|4750154|P2|Monotherapy Phase|Other|4
1439496|NCT00910858|4750155|P1|Monotherapy Phase|Other|3
1439497|NCT00910858|4750153|P3|Monotherapy Phase|Protocol Violation|0
1439498|NCT00910858|4750154|P2|Monotherapy Phase|Protocol Violation|0
1439499|NCT00910858|4750155|P1|Monotherapy Phase|Protocol Violation|1
1439500|NCT00910858|4750153|P3|Monotherapy Phase|Withdrawal by Subject|1
1439501|NCT00910858|4750154|P2|Monotherapy Phase|Withdrawal by Subject|3
1439502|NCT00910858|4750155|P1|Monotherapy Phase|Withdrawal by Subject|1
1439503|NCT00910858|4750153|P3|Monotherapy Phase|Lack of therapeutic effect|4
1439504|NCT00910858|4750154|P2|Monotherapy Phase|Lack of therapeutic effect|6
1439505|NCT00910858|4750155|P1|Monotherapy Phase|Lack of therapeutic effect|9
1439506|NCT00910858|4750153|P3|Monotherapy Phase|Adverse Event|0
1439507|NCT00910858|4750154|P2|Monotherapy Phase|Adverse Event|2
1439508|NCT00910858|4750155|P1|Monotherapy Phase|Adverse Event|3
1439509|NCT00910858|4750153|P3|Pharmacokinetic Phase|Adverse Event|0
1439510|NCT00910858|4750154|P2|Pharmacokinetic Phase|Adverse Event|0
1439511|NCT00910858|4750155|P1|Pharmacokinetic Phase|Adverse Event|1
1439512|NCT00910728|4750200|P9|Overall Study|Adverse Event|1
1439513|NCT00910728|4750201|P8|Overall Study|Adverse Event|1
1439514|NCT00910728|4750202|P7|Overall Study|Adverse Event|2
1439515|NCT00910728|4750203|P6|Overall Study|Adverse Event|0
1439516|NCT00910728|4750204|P5|Overall Study|Adverse Event|0
1439517|NCT00910728|4750205|P4|Overall Study|Adverse Event|1
1439518|NCT00910728|4750206|P3|Overall Study|Adverse Event|1
1439519|NCT00910728|4750207|P2|Overall Study|Adverse Event|0
1439520|NCT00910728|4750208|P1|Overall Study|Adverse Event|2
1439521|NCT00910728|4750200|P9|Overall Study|(not specified)|0
1439522|NCT00910728|4750201|P8|Overall Study|(not specified)|0
1439523|NCT00910728|4750202|P7|Overall Study|(not specified)|0
1439524|NCT00910728|4750203|P6|Overall Study|(not specified)|0
1439525|NCT00910728|4750204|P5|Overall Study|(not specified)|1
1439526|NCT00910728|4750205|P4|Overall Study|(not specified)|0
1439527|NCT00910728|4750206|P3|Overall Study|(not specified)|1
1439528|NCT00910728|4750207|P2|Overall Study|(not specified)|0
1439529|NCT00910728|4750208|P1|Overall Study|(not specified)|2
1439530|NCT00910728|4750200|P9|Overall Study|Withdrawal by Subject|0
1439531|NCT00910728|4750201|P8|Overall Study|Withdrawal by Subject|0
1439532|NCT00910728|4750202|P7|Overall Study|Withdrawal by Subject|2
1439533|NCT00910728|4750203|P6|Overall Study|Withdrawal by Subject|1
1439534|NCT00910728|4750204|P5|Overall Study|Withdrawal by Subject|3
1439535|NCT00910728|4750205|P4|Overall Study|Withdrawal by Subject|0
1439536|NCT00910728|4750206|P3|Overall Study|Withdrawal by Subject|0
1439537|NCT00910728|4750207|P2|Overall Study|Withdrawal by Subject|0
1439538|NCT00910728|4750208|P1|Overall Study|Withdrawal by Subject|0
1439539|NCT00910728|4750200|P9|Overall Study|Lack of Efficacy|2
1439540|NCT00910728|4750201|P8|Overall Study|Lack of Efficacy|2
1439541|NCT00910728|4750202|P7|Overall Study|Lack of Efficacy|2
1439542|NCT00910728|4750203|P6|Overall Study|Lack of Efficacy|0
1439543|NCT00910728|4750204|P5|Overall Study|Lack of Efficacy|1
1439544|NCT00910728|4750205|P4|Overall Study|Lack of Efficacy|2
1439545|NCT00910728|4750206|P3|Overall Study|Lack of Efficacy|1
1439546|NCT00910728|4750207|P2|Overall Study|Lack of Efficacy|3
1439547|NCT00910728|4750208|P1|Overall Study|Lack of Efficacy|2
1439548|NCT00910715|4750330|P3|Overall Study|Lost to Follow-up|0
1439549|NCT00910715|4750331|P2|Overall Study|Lost to Follow-up|26
1439550|NCT00910715|4750332|P1|Overall Study|Lost to Follow-up|22
1439551|NCT00910689|4750346|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
1439552|NCT00910689|4750347|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
1439553|NCT00910689|4750348|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
1439554|NCT00910689|4750349|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
1439555|NCT00910689|4750346|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
1439556|NCT00910689|4750347|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
1439557|NCT00910689|4750348|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
1439558|NCT00910689|4750349|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
1439559|NCT00910689|4750346|P4|Months 11- 16: Evaluation Period II|Time Demands|0
1439560|NCT00910689|4750347|P3|Months 11- 16: Evaluation Period II|Time Demands|0
1439561|NCT00910689|4750348|P2|Months 11- 16: Evaluation Period II|Time Demands|1
1439562|NCT00910689|4750349|P1|Months 11- 16: Evaluation Period II|Time Demands|2
1439563|NCT00910689|4750346|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
1439564|NCT00910689|4750347|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
1439565|NCT00910689|4750348|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
1439566|NCT00910689|4750349|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
1439567|NCT00910689|4750346|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
1439568|NCT00910689|4750347|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
1439569|NCT00910689|4750348|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
1439570|NCT00910689|4750349|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
1439571|NCT00910689|4750346|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
1439572|NCT00910689|4750347|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
1439735|NCT00909870|4750581|P2|Overall Study|Withdrawal by Subject|8
1439573|NCT00910689|4750348|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
1439574|NCT00910689|4750349|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
1439575|NCT00910689|4750346|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
1439576|NCT00910689|4750347|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
1439577|NCT00910689|4750348|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
1439578|NCT00910689|4750349|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
1439579|NCT00910689|4750346|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
1439580|NCT00910689|4750347|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
1439581|NCT00910689|4750348|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
1439582|NCT00910689|4750349|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
1439583|NCT00910689|4750346|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
1439584|NCT00910689|4750347|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
1439585|NCT00910689|4750348|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
1439586|NCT00910689|4750349|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
1439587|NCT00910689|4750346|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
1439588|NCT00910689|4750347|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
1439589|NCT00910689|4750348|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
1439590|NCT00910689|4750349|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
1439591|NCT00910689|4750346|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
1439592|NCT00910689|4750347|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
1439593|NCT00910689|4750348|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
1439594|NCT00910689|4750349|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
1439595|NCT00910689|4750346|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
1439596|NCT00910689|4750347|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
1439597|NCT00910689|4750348|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
1439598|NCT00910689|4750349|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
1439599|NCT00910689|4750346|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
1439600|NCT00910689|4750347|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
1439601|NCT00910689|4750348|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
1439602|NCT00910689|4750349|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
1439603|NCT00910689|4750346|P4|Month 2- 4: Treatment Period|Protocol Violation|0
1439604|NCT00910689|4750347|P3|Month 2- 4: Treatment Period|Protocol Violation|0
1439605|NCT00910689|4750348|P2|Month 2- 4: Treatment Period|Protocol Violation|0
1439606|NCT00910689|4750349|P1|Month 2- 4: Treatment Period|Protocol Violation|1
1439607|NCT00910689|4750346|P4|Month 2- 4: Treatment Period|Pregnancy|0
1439608|NCT00910689|4750347|P3|Month 2- 4: Treatment Period|Pregnancy|0
1439609|NCT00910689|4750348|P2|Month 2- 4: Treatment Period|Pregnancy|2
1439610|NCT00910689|4750349|P1|Month 2- 4: Treatment Period|Pregnancy|0
1439611|NCT00910689|4750346|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
1439612|NCT00910689|4750347|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
1439613|NCT00910689|4750348|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
1439614|NCT00910689|4750349|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
1439615|NCT00910689|4750346|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
1439616|NCT00910689|4750347|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
1439617|NCT00910689|4750348|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
1439618|NCT00910689|4750349|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
1439619|NCT00910689|4750346|P4|Month 2- 4: Treatment Period|Time Demands|8
1439620|NCT00910689|4750347|P3|Month 2- 4: Treatment Period|Time Demands|4
1439621|NCT00910689|4750348|P2|Month 2- 4: Treatment Period|Time Demands|0
1439622|NCT00910689|4750349|P1|Month 2- 4: Treatment Period|Time Demands|1
1439623|NCT00910689|4750346|P4|Month 2- 4: Treatment Period|Adverse Event|0
1439624|NCT00910689|4750347|P3|Month 2- 4: Treatment Period|Adverse Event|2
1439625|NCT00910689|4750348|P2|Month 2- 4: Treatment Period|Adverse Event|3
1439626|NCT00910689|4750349|P1|Month 2- 4: Treatment Period|Adverse Event|2
1439627|NCT00910689|4750346|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
1439628|NCT00910689|4750347|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
1439629|NCT00910689|4750348|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
1439630|NCT00910689|4750349|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
1439631|NCT00910689|4750346|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
1439632|NCT00910689|4750347|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
1439633|NCT00910689|4750348|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
1439634|NCT00910689|4750349|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
1439635|NCT00910663|4750381|P2|Period 1|Withdrawal by Subject|1
1439636|NCT00910663|4750382|P1|Period 1|Withdrawal by Subject|0
1439637|NCT00910624|4750396|P4|Follow-Up Phase|Administrative|0
1439638|NCT00910624|4750397|P3|Follow-Up Phase|Administrative|1
1439639|NCT00910624|4750398|P2|Follow-Up Phase|Administrative|1
1439640|NCT00910624|4750399|P1|Follow-Up Phase|Administrative|0
1439641|NCT00910624|4750396|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
1439642|NCT00910624|4750397|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
1439643|NCT00910624|4750398|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
1439644|NCT00910624|4750399|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
1439645|NCT00910624|4750396|P4|Follow-Up Phase|Withdrawal by Subject|0
1439646|NCT00910624|4750397|P3|Follow-Up Phase|Withdrawal by Subject|0
1439647|NCT00910624|4750398|P2|Follow-Up Phase|Withdrawal by Subject|0
1439648|NCT00910624|4750399|P1|Follow-Up Phase|Withdrawal by Subject|1
1439649|NCT00910624|4750396|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
1439650|NCT00910624|4750397|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
1439651|NCT00910624|4750398|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
1439652|NCT00910624|4750399|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
1439653|NCT00910624|4750396|P4|Follow-Up Phase|Lost to Follow-up|0
1439654|NCT00910624|4750397|P3|Follow-Up Phase|Lost to Follow-up|2
1439655|NCT00910624|4750398|P2|Follow-Up Phase|Lost to Follow-up|1
1439656|NCT00910624|4750399|P1|Follow-Up Phase|Lost to Follow-up|3
1439657|NCT00910624|4750396|P4|Follow-Up Phase|Adverse Event|0
1439658|NCT00910624|4750397|P3|Follow-Up Phase|Adverse Event|1
1439659|NCT00910624|4750398|P2|Follow-Up Phase|Adverse Event|0
1439660|NCT00910624|4750399|P1|Follow-Up Phase|Adverse Event|0
1439661|NCT00910624|4750396|P4|Treatment Phase|Non-Compliance With Protocol|0
1439662|NCT00910624|4750397|P3|Treatment Phase|Non-Compliance With Protocol|1
1439663|NCT00910624|4750398|P2|Treatment Phase|Non-Compliance With Protocol|1
1439664|NCT00910624|4750399|P1|Treatment Phase|Non-Compliance With Protocol|0
1439665|NCT00910624|4750396|P4|Treatment Phase|Withdrawal by Subject|0
1439666|NCT00910624|4750397|P3|Treatment Phase|Withdrawal by Subject|0
1439667|NCT00910624|4750398|P2|Treatment Phase|Withdrawal by Subject|1
1439668|NCT00910624|4750399|P1|Treatment Phase|Withdrawal by Subject|2
1439669|NCT00910624|4750396|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
1439670|NCT00910624|4750397|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
1439671|NCT00910624|4750398|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
1439672|NCT00910624|4750399|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
1439673|NCT00910624|4750396|P4|Treatment Phase|Lost to Follow-up|0
1439674|NCT00910624|4750397|P3|Treatment Phase|Lost to Follow-up|1
1439675|NCT00910624|4750398|P2|Treatment Phase|Lost to Follow-up|0
1439676|NCT00910624|4750399|P1|Treatment Phase|Lost to Follow-up|0
1439677|NCT00910624|4750396|P4|Treatment Phase|Treatment Failure|0
1439678|NCT00910624|4750397|P3|Treatment Phase|Treatment Failure|0
1439679|NCT00910624|4750398|P2|Treatment Phase|Treatment Failure|10
1439680|NCT00910624|4750399|P1|Treatment Phase|Treatment Failure|23
1439681|NCT00910624|4750396|P4|Treatment Phase|Adverse Event|0
1439682|NCT00910624|4750397|P3|Treatment Phase|Adverse Event|6
1439683|NCT00910624|4750398|P2|Treatment Phase|Adverse Event|6
1439684|NCT00910624|4750399|P1|Treatment Phase|Adverse Event|2
1439685|NCT00910299|4750426|P2|Overall Study|Didn't receive any study drug|1
1439686|NCT00910299|4750427|P1|Overall Study|Didn't receive any study drug|2
1439687|NCT00910299|4750426|P2|Overall Study|Sponsor Decision|60
1439688|NCT00910299|4750427|P1|Overall Study|Sponsor Decision|58
1439689|NCT00910299|4750426|P2|Overall Study|Withdrawal by Subject|13
1439690|NCT00910299|4750427|P1|Overall Study|Withdrawal by Subject|16
1439691|NCT00910273|4750439|P2|Overall Study|Lost to Follow-up|1
1439692|NCT00910273|4750440|P1|Overall Study|Lost to Follow-up|1
1439693|NCT00910273|4750439|P2|Overall Study|Protocol Violation|0
1439694|NCT00910273|4750440|P1|Overall Study|Protocol Violation|1
1439695|NCT00910273|4750439|P2|Overall Study|Discontinuation of study by sponsor|2
1439696|NCT00910273|4750440|P1|Overall Study|Discontinuation of study by sponsor|8
1439697|NCT00910273|4750439|P2|Overall Study|Withdrawal by Subject|0
1439698|NCT00910273|4750440|P1|Overall Study|Withdrawal by Subject|1
1439699|NCT00910273|4750439|P2|Overall Study|Adverse Event|1
1439700|NCT00910273|4750440|P1|Overall Study|Adverse Event|1
1439701|NCT00910273|4750439|P2|Overall Study|Lack of Efficacy|9
1439702|NCT00910273|4750440|P1|Overall Study|Lack of Efficacy|6
1439703|NCT00910247|4750490|P1|Overall Study|Not collected|4
1439704|NCT00910247|4750490|P1|Overall Study|Withdrawal by Subject|25
1439705|NCT00910247|4750490|P1|Overall Study|Protocol Violation|10
1439706|NCT00910247|4750490|P1|Overall Study|Physician Decision|3
1439707|NCT00910247|4750490|P1|Overall Study|Lost to Follow-up|10
1439708|NCT00910247|4750490|P1|Overall Study|Death|2
1439709|NCT00910247|4750490|P1|Overall Study|Adverse Event|15
1439710|NCT00910091|4750512|P2|Treatment and Survival|Adverse Event|0
1439711|NCT00910091|4750513|P1|Treatment and Survival|Adverse Event|1
1439712|NCT00910091|4750512|P2|Treatment and Survival|Withdrawal by Subject|4
1439713|NCT00910091|4750513|P1|Treatment and Survival|Withdrawal by Subject|3
1439714|NCT00910091|4750512|P2|Pre-assignment|Withdrawal by Subject|2
1439715|NCT00910091|4750513|P1|Pre-assignment|Withdrawal by Subject|0
1439716|NCT00910039|4750541|P1|Overall Study|Physician Decision|1
1439717|NCT00910000|4750558|P6|Overall Study|Withdrawal by Subject|0
1439718|NCT00910000|4750559|P5|Overall Study|Withdrawal by Subject|1
1439719|NCT00910000|4750560|P4|Overall Study|Withdrawal by Subject|0
1439720|NCT00910000|4750561|P3|Overall Study|Withdrawal by Subject|1
1439721|NCT00910000|4750562|P2|Overall Study|Withdrawal by Subject|0
1439722|NCT00910000|4750563|P1|Overall Study|Withdrawal by Subject|0
1439723|NCT00910000|4750558|P6|Overall Study|Adverse Event|1
1439724|NCT00910000|4750559|P5|Overall Study|Adverse Event|0
1439725|NCT00910000|4750560|P4|Overall Study|Adverse Event|2
1439726|NCT00910000|4750561|P3|Overall Study|Adverse Event|2
1439727|NCT00910000|4750562|P2|Overall Study|Adverse Event|3
1439728|NCT00910000|4750563|P1|Overall Study|Adverse Event|0
1439729|NCT00909870|4750581|P2|Overall Study|Other|5
1439730|NCT00909870|4750582|P1|Overall Study|Other|1
1439731|NCT00909870|4750581|P2|Overall Study|Physician Decision|2
1439732|NCT00909870|4750582|P1|Overall Study|Physician Decision|0
1439733|NCT00909870|4750581|P2|Overall Study|Lost to Follow-up|3
1439734|NCT00909870|4750582|P1|Overall Study|Lost to Follow-up|3
1439736|NCT00909870|4750582|P1|Overall Study|Withdrawal by Subject|5
1439737|NCT00909870|4750581|P2|Overall Study|Protocol Violation|2
1439738|NCT00909870|4750582|P1|Overall Study|Protocol Violation|1
1439739|NCT00909870|4750581|P2|Overall Study|Adverse Event|7
1439740|NCT00909870|4750582|P1|Overall Study|Adverse Event|13
1439741|NCT00909857|4750594|P2|Overall Study|Did not receive study medication|24
1439742|NCT00909857|4750595|P1|Overall Study|Did not receive study medication|19
1439743|NCT00909857|4750594|P2|Overall Study|Other|0
1439744|NCT00909857|4750595|P1|Overall Study|Other|1
1439745|NCT00909857|4750594|P2|Overall Study|Pregnancy|0
1439746|NCT00909857|4750595|P1|Overall Study|Pregnancy|1
1439747|NCT00909857|4750594|P2|Overall Study|Protocol Violation|1
1439748|NCT00909857|4750595|P1|Overall Study|Protocol Violation|2
1439749|NCT00909857|4750594|P2|Overall Study|Lost to Follow-up|5
1439750|NCT00909857|4750595|P1|Overall Study|Lost to Follow-up|2
1439751|NCT00909857|4750594|P2|Overall Study|Adverse Event|5
1439752|NCT00909857|4750595|P1|Overall Study|Adverse Event|5
1439753|NCT00909857|4750594|P2|Overall Study|Withdrawal by Subject|10
1439754|NCT00909857|4750595|P1|Overall Study|Withdrawal by Subject|6
1439755|NCT00909844|4750735|P1|Overall Study|Lost to Follow-up|2
1439756|NCT00909844|4750735|P1|Overall Study|Withdrawal by Subject|1
1439757|NCT00909844|4750735|P1|Overall Study|Adverse Event|1
1439758|NCT00909792|4750753|P2|Period 2|Lost to Follow-up|1
1439759|NCT00909792|4750754|P1|Period 2|Lost to Follow-up|0
1439760|NCT00909792|4750753|P2|Period 2|Biomicroscopy|0
1439761|NCT00909792|4750754|P1|Period 2|Biomicroscopy|1
1439762|NCT00909792|4750753|P2|Period 1|Did not meet inclusion criteria|1
1439763|NCT00909792|4750754|P1|Period 1|Did not meet inclusion criteria|0
1439764|NCT00909779|4750762|P2|Overall Study|Randomized in error|1
1439765|NCT00909779|4750763|P1|Overall Study|Randomized in error|1
1439766|NCT00909779|4750762|P2|Overall Study|Noncompliance|1
1439767|NCT00909779|4750763|P1|Overall Study|Noncompliance|1
1439768|NCT00909779|4750762|P2|Overall Study|Medical Monitor Decision|0
1439769|NCT00909779|4750763|P1|Overall Study|Medical Monitor Decision|1
1439770|NCT00909779|4750762|P2|Overall Study|Site Ceasing Operation|2
1439771|NCT00909779|4750763|P1|Overall Study|Site Ceasing Operation|2
1439772|NCT00909779|4750762|P2|Overall Study|Withdrawal by Subject|80
1439773|NCT00909779|4750763|P1|Overall Study|Withdrawal by Subject|116
1439774|NCT00909779|4750762|P2|Overall Study|Protocol Violation|5
1439775|NCT00909779|4750763|P1|Overall Study|Protocol Violation|2
1439776|NCT00909779|4750762|P2|Overall Study|Physician Decision|2
1439777|NCT00909779|4750763|P1|Overall Study|Physician Decision|8
1439778|NCT00909779|4750762|P2|Overall Study|Lost to Follow-up|15
1439779|NCT00909779|4750763|P1|Overall Study|Lost to Follow-up|19
1439780|NCT00909779|4750762|P2|Overall Study|Lack of Efficacy|4
1439781|NCT00909779|4750763|P1|Overall Study|Lack of Efficacy|7
1439782|NCT00909779|4750762|P2|Overall Study|Adverse Event|55
1439783|NCT00909779|4750763|P1|Overall Study|Adverse Event|53
1439784|NCT00909753|4750787|P2|Period: Second Intervention|Protocol Violation|0
1439785|NCT00909753|4750788|P1|Period: Second Intervention|Protocol Violation|1
1439786|NCT00909753|4750787|P2|Period: Washout of 28 Days|Protocol Violation|3
1439787|NCT00909753|4750788|P1|Period: Washout of 28 Days|Protocol Violation|2
1439788|NCT00909727|4750808|P2|Overall Study|Prohibited Medication|0
1439789|NCT00909727|4750809|P1|Overall Study|Prohibited Medication|1
1439790|NCT00909727|4750808|P2|Overall Study|Withdrawal of Consent|0
1439791|NCT00909727|4750809|P1|Overall Study|Withdrawal of Consent|1
1439792|NCT00909727|4750808|P2|Overall Study|Wrong Genotype|0
1439793|NCT00909727|4750809|P1|Overall Study|Wrong Genotype|1
1439794|NCT00909727|4750808|P2|Overall Study|Adverse Event|0
1439795|NCT00909727|4750809|P1|Overall Study|Adverse Event|1
1439796|NCT00909610|4750832|P2|Period: Second Intervention|Adverse Event|0
1439797|NCT00909610|4750833|P1|Period: Second Intervention|Adverse Event|1
1439798|NCT00909610|4750832|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
1439799|NCT00909610|4750833|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
1439800|NCT00909610|4750832|P2|Period: First Intervention|Adverse Event|1
1439801|NCT00909610|4750833|P1|Period: First Intervention|Adverse Event|0
1439802|NCT00909532|4750994|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
1439803|NCT00909532|4750995|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
1439804|NCT00909532|4750994|P2|Overall Study|Wrong Genotype|0
1439805|NCT00909532|4750995|P1|Overall Study|Wrong Genotype|1
1439806|NCT00909532|4750994|P2|Overall Study|Physician Decision|0
1439807|NCT00909532|4750995|P1|Overall Study|Physician Decision|1
1439808|NCT00909532|4750994|P2|Overall Study|Noncompliance with Study Requirements|2
1439809|NCT00909532|4750995|P1|Overall Study|Noncompliance with Study Requirements|0
1439810|NCT00909532|4750994|P2|Overall Study|Withdrawal of Consent|1
1439811|NCT00909532|4750995|P1|Overall Study|Withdrawal of Consent|1
1439812|NCT00909532|4750994|P2|Overall Study|Prohibited Medication|1
1439813|NCT00909532|4750995|P1|Overall Study|Prohibited Medication|2
1439814|NCT00909532|4750994|P2|Overall Study|Pregnancy|1
1439815|NCT00909532|4750995|P1|Overall Study|Pregnancy|0
1439816|NCT00909532|4750994|P2|Overall Study|Adverse Event|1
1439817|NCT00909532|4750995|P1|Overall Study|Adverse Event|4
1439818|NCT00909480|4751013|P2|Overall Study|Unclassified|19
1439819|NCT00909480|4751014|P1|Overall Study|Unclassified|18
1439820|NCT00909480|4751013|P2|Overall Study|Withdrawal criteria|11
1439821|NCT00909480|4751014|P1|Overall Study|Withdrawal criteria|9
1439822|NCT00909480|4751013|P2|Overall Study|Protocol Violation|8
1439823|NCT00909480|4751014|P1|Overall Study|Protocol Violation|6
1439824|NCT00909480|4751013|P2|Overall Study|Adverse Event|3
1439825|NCT00909480|4751014|P1|Overall Study|Adverse Event|5
1439826|NCT00909428|4751049|P3|Overall Study|Lost to Follow-up|9
1439827|NCT00909428|4751050|P2|Overall Study|Lost to Follow-up|10
1439828|NCT00909428|4751051|P1|Overall Study|Lost to Follow-up|13
1439829|NCT00909389|4751058|P1|Overall Study|No Information|103
1439830|NCT00909389|4751058|P1|Overall Study|Lost to Follow-up|4
1439831|NCT00909389|4751058|P1|Overall Study|Poor Compliance|16
1439832|NCT00909389|4751058|P1|Overall Study|Death|4
1439833|NCT00909389|4751058|P1|Overall Study|Adverse Event|6
1439834|NCT00909181|4751092|P3|Overall Study|Lost to Follow-up|33
1439835|NCT00909181|4751093|P2|Overall Study|Lost to Follow-up|18
1439836|NCT00909181|4751094|P1|Overall Study|Lost to Follow-up|39
1439837|NCT00909038|4751124|P1|Overall Study|Non-evaluable Subjects|230
1439838|NCT00909038|4751124|P1|Overall Study|Protocol Violation|187
1439839|NCT00908960|4751136|P3|Overall Study|Presence VTE dx or Absent VTE eval|2
1439840|NCT00908960|4751137|P2|Overall Study|Presence VTE dx or Absent VTE eval|1
1439841|NCT00908960|4751138|P1|Overall Study|Presence VTE dx or Absent VTE eval|1
1439842|NCT00908895|4751160|P2|Overall Study|Adverse Event|1
1439843|NCT00908895|4751161|P1|Overall Study|Adverse Event|1
1439844|NCT00908895|4751160|P2|Overall Study|algodystrophy|2
1439845|NCT00908895|4751161|P1|Overall Study|algodystrophy|2
1439846|NCT00908895|4751160|P2|Overall Study|Lost to Follow-up|3
1439847|NCT00908895|4751161|P1|Overall Study|Lost to Follow-up|1
1439848|NCT00908596|4751245|P4|Overall Study|Withdrawal by Subject|1
1439849|NCT00908596|4751246|P3|Overall Study|Withdrawal by Subject|3
1439850|NCT00908596|4751247|P2|Overall Study|Withdrawal by Subject|1
1439851|NCT00908596|4751248|P1|Overall Study|Withdrawal by Subject|0
1439852|NCT00908596|4751245|P4|Overall Study|Protocol Violation|0
1439853|NCT00908596|4751246|P3|Overall Study|Protocol Violation|0
1439854|NCT00908596|4751247|P2|Overall Study|Protocol Violation|0
1439855|NCT00908596|4751248|P1|Overall Study|Protocol Violation|1
1439856|NCT00908596|4751245|P4|Overall Study|Death|32
1439857|NCT00908596|4751246|P3|Overall Study|Death|57
1439858|NCT00908596|4751247|P2|Overall Study|Death|5
1439859|NCT00908596|4751248|P1|Overall Study|Death|0
1439860|NCT00908596|4751245|P4|Overall Study|Lost to Follow-up|4
1439861|NCT00908596|4751246|P3|Overall Study|Lost to Follow-up|12
1439862|NCT00908596|4751247|P2|Overall Study|Lost to Follow-up|1
1439863|NCT00908596|4751248|P1|Overall Study|Lost to Follow-up|0
1439864|NCT00908596|4751245|P4|Overall Study|Other reasons|0
1439865|NCT00908596|4751246|P3|Overall Study|Other reasons|2
1439866|NCT00908596|4751247|P2|Overall Study|Other reasons|6
1439867|NCT00908596|4751248|P1|Overall Study|Other reasons|46
1439868|NCT00908583|4751278|P1|Phase 5|Adverse Event|3
1439869|NCT00908583|4751278|P1|Phase 4|Physician Decision|1
1439870|NCT00908583|4751278|P1|Phase 4|Adverse Event|1
1439871|NCT00908583|4751278|P1|Phase 3|Adverse Event|2
1439872|NCT00908583|4751278|P1|Phase 2|Adverse Event|1
1439873|NCT00908583|4751278|P1|Phase 2|Physician Decision|1
1439874|NCT00908583|4751278|P1|Phase 1|Adverse Event|4
1439875|NCT00908583|4751278|P1|Phase 1|Withdrawal by Subject|1
1439876|NCT00908375|4751315|P2|Overall Study|Lost to Follow-up|6
1439877|NCT00908375|4751316|P1|Overall Study|Lost to Follow-up|8
1439878|NCT00908375|4751315|P2|Overall Study|Withdrawal by Subject|4
1439879|NCT00908375|4751316|P1|Overall Study|Withdrawal by Subject|2
1439880|NCT00908349|4751326|P1|Overall Study|Various|6
1439881|NCT00908349|4751326|P1|Overall Study|Lost to Follow-up|5
1439882|NCT00908349|4751326|P1|Overall Study|Physician Decision|5
1439883|NCT00908349|4751326|P1|Overall Study|Withdrawal by Subject|9
1439884|NCT00908349|4751326|P1|Overall Study|Adverse Event|10
1439885|NCT00908310|4751330|P1|Overall Study|Other reasons|4
1439886|NCT00908310|4751330|P1|Overall Study|Screening failure|5
1439887|NCT00908310|4751330|P1|Overall Study|Lost to Follow-up|7
1439888|NCT00908310|4751330|P1|Overall Study|Withdrawal by Subject|7
1439889|NCT00908310|4751330|P1|Overall Study|Death|37
1439890|NCT00908232|4751334|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
1439891|NCT00908232|4751335|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
1439892|NCT00908232|4751336|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
1439893|NCT00908232|4751337|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
1439894|NCT00908232|4751334|P4|Randomization (Cycle 5) to Cycle 8|Other|0
1439895|NCT00908232|4751335|P3|Randomization (Cycle 5) to Cycle 8|Other|0
1439896|NCT00908232|4751336|P2|Randomization (Cycle 5) to Cycle 8|Other|1
1439897|NCT00908232|4751337|P1|Randomization (Cycle 5) to Cycle 8|Other|3
1439898|NCT00908232|4751334|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
1439899|NCT00908232|4751335|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
1439900|NCT00908232|4751336|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
1439901|NCT00908232|4751337|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
1439902|NCT00908232|4751334|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
1439903|NCT00908232|4751335|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
1439904|NCT00908232|4751336|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
1439905|NCT00908232|4751337|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
1439906|NCT00908232|4751334|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
1439907|NCT00908232|4751335|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
1439908|NCT00908232|4751336|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
1439909|NCT00908232|4751337|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
1439910|NCT00908232|4751334|P4|Randomization (Cycle 5) to Cycle 8|Death|0
1439911|NCT00908232|4751335|P3|Randomization (Cycle 5) to Cycle 8|Death|0
1439912|NCT00908232|4751336|P2|Randomization (Cycle 5) to Cycle 8|Death|0
1439913|NCT00908232|4751337|P1|Randomization (Cycle 5) to Cycle 8|Death|2
1439914|NCT00908232|4751334|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
1439915|NCT00908232|4751335|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
1439916|NCT00908232|4751336|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
1439917|NCT00908232|4751337|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
1439918|NCT00908232|4751334|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
1439919|NCT00908232|4751335|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
1439920|NCT00908232|4751336|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
1439921|NCT00908232|4751337|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
1439922|NCT00908232|4751334|P4|Cycle 1 to 4|not specified|0
1439923|NCT00908232|4751335|P3|Cycle 1 to 4|not specified|0
1439924|NCT00908232|4751336|P2|Cycle 1 to 4|not specified|0
1439925|NCT00908232|4751337|P1|Cycle 1 to 4|not specified|1
1439926|NCT00908232|4751334|P4|Cycle 1 to 4|Adverse Event|0
1439927|NCT00908232|4751335|P3|Cycle 1 to 4|Adverse Event|0
1439928|NCT00908232|4751336|P2|Cycle 1 to 4|Adverse Event|0
1439929|NCT00908232|4751337|P1|Cycle 1 to 4|Adverse Event|12
1439930|NCT00908232|4751334|P4|Cycle 1 to 4|Progressive Disease|0
1439931|NCT00908232|4751335|P3|Cycle 1 to 4|Progressive Disease|0
1439932|NCT00908232|4751336|P2|Cycle 1 to 4|Progressive Disease|0
1439933|NCT00908232|4751337|P1|Cycle 1 to 4|Progressive Disease|6
1439934|NCT00908232|4751334|P4|Cycle 1 to 4|Withdrawal by Subject|0
1439935|NCT00908232|4751335|P3|Cycle 1 to 4|Withdrawal by Subject|0
1439936|NCT00908232|4751336|P2|Cycle 1 to 4|Withdrawal by Subject|0
1439937|NCT00908232|4751337|P1|Cycle 1 to 4|Withdrawal by Subject|4
1439938|NCT00908232|4751334|P4|Cycle 1 to 4|Death|0
1439939|NCT00908232|4751335|P3|Cycle 1 to 4|Death|0
1439940|NCT00908232|4751336|P2|Cycle 1 to 4|Death|0
1439941|NCT00908232|4751337|P1|Cycle 1 to 4|Death|5
1439942|NCT00908141|4751355|P2|Overall Study|Withdrawal by Subject|1
1439943|NCT00908141|4751356|P1|Overall Study|Withdrawal by Subject|0
1439944|NCT00908115|4751373|P1|Overall Study|Other|14
1439945|NCT00908076|4751381|P2|Overall Study|Lack of Efficacy|1
1439946|NCT00908076|4751382|P1|Overall Study|Lack of Efficacy|1
1439947|NCT00908037|4751395|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1439948|NCT00908037|4751396|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
1439949|NCT00908037|4751397|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1439950|NCT00908037|4751398|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1439951|NCT00908037|4751399|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1439952|NCT00908037|4751400|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1439953|NCT00908037|4751401|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1439954|NCT00908037|4751402|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1439955|NCT00908037|4751403|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1439956|NCT00908037|4751404|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1439957|NCT00908037|4751405|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1439958|NCT00908037|4751406|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1439959|NCT00908037|4751395|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1439960|NCT00908037|4751396|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1439961|NCT00908037|4751397|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
1439962|NCT00908037|4751398|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1439963|NCT00908037|4751399|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1439964|NCT00908037|4751400|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1439965|NCT00908037|4751401|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1439966|NCT00908037|4751402|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1439967|NCT00908037|4751403|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1439968|NCT00908037|4751404|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1439969|NCT00908037|4751405|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1439970|NCT00908037|4751406|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1439971|NCT00908037|4751395|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1439972|NCT00908037|4751396|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
1439973|NCT00908037|4751397|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1439974|NCT00908037|4751398|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1439975|NCT00908037|4751399|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1439976|NCT00908037|4751400|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1439977|NCT00908037|4751401|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1439978|NCT00908037|4751402|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1439979|NCT00908037|4751403|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1439980|NCT00908037|4751404|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1439981|NCT00908037|4751405|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1439982|NCT00908037|4751406|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1439983|NCT00908037|4751395|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1439984|NCT00908037|4751396|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1439985|NCT00908037|4751397|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
1439986|NCT00908037|4751398|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1439987|NCT00908037|4751399|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1439988|NCT00908037|4751400|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1439989|NCT00908037|4751401|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1439990|NCT00908037|4751402|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1439991|NCT00908037|4751403|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1439992|NCT00908037|4751404|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1439993|NCT00908037|4751405|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1439994|NCT00908037|4751406|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1439995|NCT00908037|4751395|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
1439996|NCT00908037|4751396|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1439997|NCT00908037|4751397|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
1439998|NCT00908037|4751398|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1439999|NCT00908037|4751399|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1440000|NCT00908037|4751400|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1440001|NCT00908037|4751401|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1440002|NCT00908037|4751402|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1440003|NCT00908037|4751403|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1440004|NCT00908037|4751404|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1440005|NCT00908037|4751405|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1440006|NCT00908037|4751406|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1440007|NCT00908037|4751395|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
1440008|NCT00908037|4751396|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1440009|NCT00908037|4751397|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1440010|NCT00908037|4751398|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1440011|NCT00908037|4751399|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1440012|NCT00908037|4751400|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1440013|NCT00908037|4751401|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1440014|NCT00908037|4751402|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1440015|NCT00908037|4751403|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1440016|NCT00908037|4751404|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1440017|NCT00908037|4751405|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1440018|NCT00908037|4751406|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1440019|NCT00908037|4751395|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1440020|NCT00908037|4751396|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1440021|NCT00908037|4751397|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1440022|NCT00908037|4751398|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1440023|NCT00908037|4751399|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1440024|NCT00908037|4751400|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
1440025|NCT00908037|4751401|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1440026|NCT00908037|4751402|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1440027|NCT00908037|4751403|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
1440028|NCT00908037|4751404|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1440029|NCT00908037|4751405|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1440030|NCT00908037|4751406|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1440031|NCT00908037|4751395|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1440032|NCT00908037|4751396|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1440033|NCT00908037|4751397|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1440034|NCT00908037|4751398|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
1440035|NCT00908037|4751399|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1440036|NCT00908037|4751400|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1440037|NCT00908037|4751401|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1440038|NCT00908037|4751402|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
1440039|NCT00908037|4751403|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1440040|NCT00908037|4751404|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1440041|NCT00908037|4751405|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1440042|NCT00908037|4751406|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1440043|NCT00908037|4751395|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1440044|NCT00908037|4751396|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1440045|NCT00908037|4751397|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1440046|NCT00908037|4751398|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
1440047|NCT00908037|4751399|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1440048|NCT00908037|4751400|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
1440049|NCT00908037|4751401|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1440050|NCT00908037|4751402|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
1440051|NCT00908037|4751403|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1440052|NCT00908037|4751404|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1440053|NCT00908037|4751405|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1440054|NCT00908037|4751406|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1440055|NCT00908011|4751555|P2|Overall Study|Withdrawal by Subject|2
1440056|NCT00908011|4751556|P1|Overall Study|Withdrawal by Subject|2
1440057|NCT00907881|4751573|P1|Overall Study|Missing discontinuation information|15
1440058|NCT00907881|4751573|P1|Overall Study|Protocol Violation|1
1440059|NCT00907881|4751573|P1|Overall Study|Withdrawal by Subject|5
1440060|NCT00907881|4751573|P1|Overall Study|Noncompliance|5
1440061|NCT00907881|4751573|P1|Overall Study|Lost to Follow-up|59
1440062|NCT00907803|4751583|P3|Overall Study|Protocol Violation|0
1440063|NCT00907803|4751584|P2|Overall Study|Protocol Violation|1
1440064|NCT00907803|4751585|P1|Overall Study|Protocol Violation|0
1440065|NCT00907803|4751583|P3|Overall Study|Lost to Follow-up|0
1440066|NCT00907803|4751584|P2|Overall Study|Lost to Follow-up|1
1440067|NCT00907803|4751585|P1|Overall Study|Lost to Follow-up|0
1440068|NCT00907803|4751583|P3|Overall Study|Withdrawal by Subject|0
1440069|NCT00907803|4751584|P2|Overall Study|Withdrawal by Subject|1
1440070|NCT00907803|4751585|P1|Overall Study|Withdrawal by Subject|0
1440071|NCT00907803|4751583|P3|Overall Study|Adverse Event|0
1440072|NCT00907803|4751584|P2|Overall Study|Adverse Event|0
1440073|NCT00907803|4751585|P1|Overall Study|Adverse Event|2
1440074|NCT00907803|4751583|P3|Overall Study|Withdrawal of consent - long commute|0
1440075|NCT00907803|4751584|P2|Overall Study|Withdrawal of consent - long commute|0
1440076|NCT00907803|4751585|P1|Overall Study|Withdrawal of consent - long commute|1
1440077|NCT00907777|4751616|P2|Overall Study|Withdrawal by Subject|1
1440078|NCT00907777|4751617|P1|Overall Study|Withdrawal by Subject|0
1440079|NCT00907738|4751644|P5|Overall Study|Disease progression|2
1440080|NCT00907738|4751645|P4|Overall Study|Disease progression|4
1440081|NCT00907738|4751646|P3|Overall Study|Disease progression|6
1440082|NCT00907738|4751647|P2|Overall Study|Disease progression|1
1440083|NCT00907738|4751648|P1|Overall Study|Disease progression|8
1440084|NCT00907738|4751644|P5|Overall Study|not specified or withdrew consent|0
1440085|NCT00907738|4751645|P4|Overall Study|not specified or withdrew consent|0
1440086|NCT00907738|4751646|P3|Overall Study|not specified or withdrew consent|0
1440087|NCT00907738|4751647|P2|Overall Study|not specified or withdrew consent|0
1440088|NCT00907738|4751648|P1|Overall Study|not specified or withdrew consent|3
1440089|NCT00907738|4751644|P5|Overall Study|Adverse Event|0
1440090|NCT00907738|4751645|P4|Overall Study|Adverse Event|0
1440091|NCT00907738|4751646|P3|Overall Study|Adverse Event|1
1440092|NCT00907738|4751647|P2|Overall Study|Adverse Event|0
1440093|NCT00907738|4751648|P1|Overall Study|Adverse Event|2
1440094|NCT00907621|4751666|P2|Overall Study|intercurrent febrile illness|1
1440095|NCT00907621|4751667|P1|Overall Study|intercurrent febrile illness|1
1440096|NCT00907621|4751666|P2|Overall Study|Lost to Follow-up|3
1440097|NCT00907621|4751667|P1|Overall Study|Lost to Follow-up|6
1440098|NCT00907517|4751680|P5|Overall Study|Symptomatic Deterioration|1
1440099|NCT00907517|4751681|P4|Overall Study|Symptomatic Deterioration|0
1440100|NCT00907517|4751682|P3|Overall Study|Symptomatic Deterioration|0
1440101|NCT00907517|4751683|P2|Overall Study|Symptomatic Deterioration|0
1440102|NCT00907517|4751684|P1|Overall Study|Symptomatic Deterioration|0
1440103|NCT00907517|4751680|P5|Overall Study|Progressive Disease|4
1440104|NCT00907517|4751681|P4|Overall Study|Progressive Disease|4
1440105|NCT00907517|4751682|P3|Overall Study|Progressive Disease|4
1440106|NCT00907517|4751683|P2|Overall Study|Progressive Disease|3
1440107|NCT00907517|4751684|P1|Overall Study|Progressive Disease|3
1440108|NCT00907478|4751709|P3|Overall Study|Other|1
1440109|NCT00907478|4751710|P2|Overall Study|Other|0
1440110|NCT00907478|4751711|P1|Overall Study|Other|3
1440111|NCT00907478|4751709|P3|Overall Study|Lost to Follow-up|0
1440112|NCT00907478|4751710|P2|Overall Study|Lost to Follow-up|0
1440113|NCT00907478|4751711|P1|Overall Study|Lost to Follow-up|1
1440114|NCT00907478|4751709|P3|Overall Study|Pregnancy|1
1440115|NCT00907478|4751710|P2|Overall Study|Pregnancy|1
1440116|NCT00907478|4751711|P1|Overall Study|Pregnancy|0
1440117|NCT00907478|4751709|P3|Overall Study|Protocol-specified criteria|3
1440118|NCT00907478|4751710|P2|Overall Study|Protocol-specified criteria|2
1440119|NCT00907478|4751711|P1|Overall Study|Protocol-specified criteria|5
1440120|NCT00907478|4751709|P3|Overall Study|Death|1
1440121|NCT00907478|4751710|P2|Overall Study|Death|2
1440122|NCT00907478|4751711|P1|Overall Study|Death|4
1440123|NCT00907478|4751709|P3|Overall Study|Physician Decision|3
1440124|NCT00907478|4751710|P2|Overall Study|Physician Decision|0
1440125|NCT00907478|4751711|P1|Overall Study|Physician Decision|2
1440126|NCT00907478|4751709|P3|Overall Study|Requirement for alternative therapy|3
1440127|NCT00907478|4751710|P2|Overall Study|Requirement for alternative therapy|2
1440128|NCT00907478|4751711|P1|Overall Study|Requirement for alternative therapy|1
1440129|NCT00907478|4751709|P3|Overall Study|Withdrawal by Subject|6
1440130|NCT00907478|4751710|P2|Overall Study|Withdrawal by Subject|9
1440131|NCT00907478|4751711|P1|Overall Study|Withdrawal by Subject|8
1440132|NCT00907478|4751709|P3|Overall Study|Adverse Event|2
1440133|NCT00907478|4751710|P2|Overall Study|Adverse Event|1
1440134|NCT00907478|4751711|P1|Overall Study|Adverse Event|3
1440135|NCT00907478|4751709|P3|Overall Study|Noncompliance|1
1440136|NCT00907478|4751710|P2|Overall Study|Noncompliance|0
1440137|NCT00907478|4751711|P1|Overall Study|Noncompliance|0
1440138|NCT00907478|4751709|P3|Overall Study|Ineligibility determined|1
1440139|NCT00907478|4751710|P2|Overall Study|Ineligibility determined|0
1440140|NCT00907478|4751711|P1|Overall Study|Ineligibility determined|0
1440141|NCT00907374|4751761|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
1440142|NCT00907374|4751762|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
1440143|NCT00907335|4751776|P2|Overall Study|Lost to Follow-up|0
1440144|NCT00907335|4751777|P1|Overall Study|Lost to Follow-up|2
1440145|NCT00907335|4751776|P2|Overall Study|Adverse Event|1
1440146|NCT00907335|4751777|P1|Overall Study|Adverse Event|4
1440147|NCT00907335|4751776|P2|Overall Study|Withdrawal by Subject|0
1440148|NCT00907335|4751777|P1|Overall Study|Withdrawal by Subject|2
1440149|NCT00907257|4751795|P2|Overall Study|Personal Reasons|1
1440150|NCT00907257|4751796|P1|Overall Study|Personal Reasons|6
1440151|NCT00907257|4751795|P2|Overall Study|Moved|0
1440152|NCT00907257|4751796|P1|Overall Study|Moved|1
1440153|NCT00907257|4751795|P2|Overall Study|Per IRB-Subject became vulnerable|0
1440154|NCT00907257|4751796|P1|Overall Study|Per IRB-Subject became vulnerable|1
1440155|NCT00907257|4751795|P2|Overall Study|Withdrawal by Subject|2
1440156|NCT00907257|4751796|P1|Overall Study|Withdrawal by Subject|1
1440157|NCT00907257|4751795|P2|Overall Study|Lost to Follow-up|3
1440158|NCT00907257|4751796|P1|Overall Study|Lost to Follow-up|3
1440159|NCT00907257|4751795|P2|Overall Study|Protocol Violation|2
1440160|NCT00907257|4751796|P1|Overall Study|Protocol Violation|1
1440161|NCT00907257|4751795|P2|Overall Study|Adverse Event|4
1440162|NCT00907257|4751796|P1|Overall Study|Adverse Event|0
1440163|NCT00907153|4751818|P2|Overall Study|Withdrawal by Subject|3
1440164|NCT00907153|4751819|P1|Overall Study|Withdrawal by Subject|1
1440165|NCT00907153|4751818|P2|Overall Study|Lost to Follow-up|1
1440166|NCT00907153|4751819|P1|Overall Study|Lost to Follow-up|1
1440167|NCT00906971|4751880|P2|Overall Study|Lost to Follow-up|1
1440168|NCT00906971|4751881|P1|Overall Study|Lost to Follow-up|0
1440169|NCT00906971|4751880|P2|Overall Study|Withdrawal by Subject|2
1440170|NCT00906971|4751881|P1|Overall Study|Withdrawal by Subject|8
1440171|NCT00906945|4751894|P6|Overall Study|Physician Decision|1
1440172|NCT00906945|4751895|P5|Overall Study|Physician Decision|0
1440173|NCT00906945|4751896|P4|Overall Study|Physician Decision|0
1440174|NCT00906945|4751897|P3|Overall Study|Physician Decision|0
1440175|NCT00906945|4751898|P2|Overall Study|Physician Decision|0
1440176|NCT00906945|4751899|P1|Overall Study|Physician Decision|0
1440177|NCT00906945|4751894|P6|Overall Study|Found to be not eligible|1
1440178|NCT00906945|4751895|P5|Overall Study|Found to be not eligible|1
1440179|NCT00906945|4751896|P4|Overall Study|Found to be not eligible|1
1440180|NCT00906945|4751897|P3|Overall Study|Found to be not eligible|0
1440181|NCT00906945|4751898|P2|Overall Study|Found to be not eligible|0
1440182|NCT00906945|4751899|P1|Overall Study|Found to be not eligible|0
1440183|NCT00906698|4751959|P6|Overall Study|incl. non compliance, lost to follow-up|0
1440184|NCT00906698|4751960|P5|Overall Study|incl. non compliance, lost to follow-up|0
1440185|NCT00906698|4751961|P4|Overall Study|incl. non compliance, lost to follow-up|0
1440186|NCT00906698|4751962|P3|Overall Study|incl. non compliance, lost to follow-up|0
1440187|NCT00906698|4751963|P2|Overall Study|incl. non compliance, lost to follow-up|1
1440188|NCT00906698|4751964|P1|Overall Study|incl. non compliance, lost to follow-up|0
1440189|NCT00906698|4751959|P6|Overall Study|Withdrawal by Subject|0
1440190|NCT00906698|4751960|P5|Overall Study|Withdrawal by Subject|1
1440191|NCT00906698|4751961|P4|Overall Study|Withdrawal by Subject|0
1440192|NCT00906698|4751962|P3|Overall Study|Withdrawal by Subject|0
1440193|NCT00906698|4751963|P2|Overall Study|Withdrawal by Subject|0
1440194|NCT00906698|4751964|P1|Overall Study|Withdrawal by Subject|0
1440195|NCT00906698|4751959|P6|Overall Study|Disease progression|4
1440196|NCT00906698|4751960|P5|Overall Study|Disease progression|12
1440197|NCT00906698|4751961|P4|Overall Study|Disease progression|4
1440198|NCT00906698|4751962|P3|Overall Study|Disease progression|4
1440199|NCT00906698|4751963|P2|Overall Study|Disease progression|12
1440200|NCT00906698|4751964|P1|Overall Study|Disease progression|3
1440201|NCT00906698|4751959|P6|Overall Study|Adverse Event|1
1440202|NCT00906698|4751960|P5|Overall Study|Adverse Event|4
1440203|NCT00906698|4751961|P4|Overall Study|Adverse Event|0
1440204|NCT00906698|4751962|P3|Overall Study|Adverse Event|2
1440205|NCT00906698|4751963|P2|Overall Study|Adverse Event|0
1440206|NCT00906698|4751964|P1|Overall Study|Adverse Event|0
1440207|NCT00906698|4751959|P6|Overall Study|Dose-limiting toxicity (DLT)|0
1440208|NCT00906698|4751960|P5|Overall Study|Dose-limiting toxicity (DLT)|1
1440209|NCT00906698|4751961|P4|Overall Study|Dose-limiting toxicity (DLT)|0
1440210|NCT00906698|4751962|P3|Overall Study|Dose-limiting toxicity (DLT)|0
1440211|NCT00906698|4751963|P2|Overall Study|Dose-limiting toxicity (DLT)|6
1440212|NCT00906698|4751964|P1|Overall Study|Dose-limiting toxicity (DLT)|0
1440213|NCT00906399|4752066|P7|Year 2|Not specified|0
1440214|NCT00906399|4752067|P6|Year 2|Not specified|1
1440215|NCT00906399|4752068|P5|Year 2|Not specified|3
1440216|NCT00906399|4752069|P4|Year 2|Not specified|2
1440217|NCT00906399|4752070|P3|Year 2|Not specified|0
1440218|NCT00906399|4752071|P2|Year 2|Not specified|0
1440219|NCT00906399|4752072|P1|Year 2|Not specified|0
1440220|NCT00906399|4752066|P7|Year 2|Death|3
1440221|NCT00906399|4752067|P6|Year 2|Death|0
1440222|NCT00906399|4752068|P5|Year 2|Death|0
1440223|NCT00906399|4752069|P4|Year 2|Death|1
1440224|NCT00906399|4752070|P3|Year 2|Death|0
1440225|NCT00906399|4752071|P2|Year 2|Death|0
1440226|NCT00906399|4752072|P1|Year 2|Death|0
1440227|NCT00906399|4752066|P7|Year 2|Physician Decision|3
1440228|NCT00906399|4752067|P6|Year 2|Physician Decision|6
1440229|NCT00906399|4752068|P5|Year 2|Physician Decision|2
1440230|NCT00906399|4752069|P4|Year 2|Physician Decision|0
1440231|NCT00906399|4752070|P3|Year 2|Physician Decision|0
1440232|NCT00906399|4752071|P2|Year 2|Physician Decision|0
1440233|NCT00906399|4752072|P1|Year 2|Physician Decision|0
1440234|NCT00906399|4752066|P7|Year 2|Withdrawal by Subject|13
1440235|NCT00906399|4752067|P6|Year 2|Withdrawal by Subject|27
1440236|NCT00906399|4752068|P5|Year 2|Withdrawal by Subject|18
1440237|NCT00906399|4752069|P4|Year 2|Withdrawal by Subject|17
1440238|NCT00906399|4752070|P3|Year 2|Withdrawal by Subject|0
1440239|NCT00906399|4752071|P2|Year 2|Withdrawal by Subject|0
1440240|NCT00906399|4752072|P1|Year 2|Withdrawal by Subject|0
1440241|NCT00906399|4752066|P7|Year 2|Lost to Follow-up|4
1440242|NCT00906399|4752067|P6|Year 2|Lost to Follow-up|2
1440243|NCT00906399|4752068|P5|Year 2|Lost to Follow-up|4
1440244|NCT00906399|4752069|P4|Year 2|Lost to Follow-up|1
1440245|NCT00906399|4752070|P3|Year 2|Lost to Follow-up|0
1440246|NCT00906399|4752071|P2|Year 2|Lost to Follow-up|0
1440247|NCT00906399|4752072|P1|Year 2|Lost to Follow-up|0
1440248|NCT00906399|4752066|P7|Year 2|Adverse Event|6
1440249|NCT00906399|4752067|P6|Year 2|Adverse Event|11
1440250|NCT00906399|4752068|P5|Year 2|Adverse Event|8
1440251|NCT00906399|4752069|P4|Year 2|Adverse Event|9
1440252|NCT00906399|4752070|P3|Year 2|Adverse Event|0
1440253|NCT00906399|4752071|P2|Year 2|Adverse Event|0
1440254|NCT00906399|4752072|P1|Year 2|Adverse Event|0
1440255|NCT00906399|4752066|P7|Year 1|Not specified|0
1440256|NCT00906399|4752067|P6|Year 1|Not specified|0
1440257|NCT00906399|4752068|P5|Year 1|Not specified|0
1440258|NCT00906399|4752069|P4|Year 1|Not specified|0
1440259|NCT00906399|4752070|P3|Year 1|Not specified|7
1440260|NCT00906399|4752071|P2|Year 1|Not specified|2
1440261|NCT00906399|4752072|P1|Year 1|Not specified|4
1440262|NCT00906399|4752066|P7|Year 1|Death|0
1440263|NCT00906399|4752067|P6|Year 1|Death|0
1440264|NCT00906399|4752068|P5|Year 1|Death|0
1440265|NCT00906399|4752069|P4|Year 1|Death|0
1440266|NCT00906399|4752070|P3|Year 1|Death|1
1440267|NCT00906399|4752071|P2|Year 1|Death|1
1440268|NCT00906399|4752072|P1|Year 1|Death|2
1440269|NCT00906399|4752066|P7|Year 1|Physician Decision|0
1440270|NCT00906399|4752067|P6|Year 1|Physician Decision|0
1440271|NCT00906399|4752068|P5|Year 1|Physician Decision|0
1440272|NCT00906399|4752069|P4|Year 1|Physician Decision|0
1440273|NCT00906399|4752070|P3|Year 1|Physician Decision|3
1440274|NCT00906399|4752071|P2|Year 1|Physician Decision|1
1440275|NCT00906399|4752072|P1|Year 1|Physician Decision|0
1440276|NCT00906399|4752066|P7|Year 1|Withdrawal by Subject|0
1440277|NCT00906399|4752067|P6|Year 1|Withdrawal by Subject|0
1440278|NCT00906399|4752068|P5|Year 1|Withdrawal by Subject|0
1440279|NCT00906399|4752069|P4|Year 1|Withdrawal by Subject|0
1440280|NCT00906399|4752070|P3|Year 1|Withdrawal by Subject|36
1440281|NCT00906399|4752071|P2|Year 1|Withdrawal by Subject|32
1440282|NCT00906399|4752072|P1|Year 1|Withdrawal by Subject|30
1440283|NCT00906399|4752066|P7|Year 1|Lost to Follow-up|0
1440284|NCT00906399|4752067|P6|Year 1|Lost to Follow-up|0
1440285|NCT00906399|4752068|P5|Year 1|Lost to Follow-up|0
1440286|NCT00906399|4752069|P4|Year 1|Lost to Follow-up|0
1440287|NCT00906399|4752070|P3|Year 1|Lost to Follow-up|2
1440288|NCT00906399|4752071|P2|Year 1|Lost to Follow-up|4
1440289|NCT00906399|4752072|P1|Year 1|Lost to Follow-up|4
1440290|NCT00906399|4752066|P7|Year 1|Adverse Event|0
1440291|NCT00906399|4752067|P6|Year 1|Adverse Event|0
1440292|NCT00906399|4752068|P5|Year 1|Adverse Event|0
1440293|NCT00906399|4752069|P4|Year 1|Adverse Event|0
1440294|NCT00906399|4752070|P3|Year 1|Adverse Event|24
1440295|NCT00906399|4752071|P2|Year 1|Adverse Event|22
1440296|NCT00906399|4752072|P1|Year 1|Adverse Event|4
1440297|NCT00906399|4752066|P7|Year 1|Randomized But Not Treated|0
1440298|NCT00906399|4752067|P6|Year 1|Randomized But Not Treated|0
1440299|NCT00906399|4752068|P5|Year 1|Randomized But Not Treated|0
1440300|NCT00906399|4752069|P4|Year 1|Randomized But Not Treated|0
1440301|NCT00906399|4752070|P3|Year 1|Randomized But Not Treated|3
1440302|NCT00906399|4752071|P2|Year 1|Randomized But Not Treated|1
1440303|NCT00906399|4752072|P1|Year 1|Randomized But Not Treated|0
1440304|NCT00906373|4752095|P2|Overall Study|Still on treatment at cutoff date|2
1440305|NCT00906373|4752096|P1|Overall Study|Still on treatment at cutoff date|0
1440306|NCT00906373|4752095|P2|Overall Study|Other|1
1440307|NCT00906373|4752096|P1|Overall Study|Other|0
1440308|NCT00906373|4752095|P2|Overall Study|Withdrawal by Subject|5
1440309|NCT00906373|4752096|P1|Overall Study|Withdrawal by Subject|0
1440310|NCT00906347|4752135|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
1440311|NCT00906347|4752136|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
1440312|NCT00906347|4752135|P2|Received Study Drug|Refused study drug|0
1440313|NCT00906347|4752136|P1|Received Study Drug|Refused study drug|1
1440314|NCT00906347|4752135|P2|Received Study Drug|Nonreassuring fetal heart rate|1
1440315|NCT00906347|4752136|P1|Received Study Drug|Nonreassuring fetal heart rate|13
1440316|NCT00906347|4752135|P2|Received Study Drug|8 cm prior to initiation of study drug|30
1440317|NCT00906347|4752136|P1|Received Study Drug|8 cm prior to initiation of study drug|18
1440318|NCT00906282|4752156|P1|Preoperative Chemotherapy|Toxicity|1
1440319|NCT00906282|4752156|P1|Preoperative Chemotherapy|Progressive disease|6
1440320|NCT00906282|4752156|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
1440321|NCT00906282|4752156|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
1440322|NCT00906204|4752170|P2|Secondary Endpoints (Long-term Safety)|Death|1
1440323|NCT00906204|4752171|P1|Secondary Endpoints (Long-term Safety)|Death|0
1440324|NCT00906204|4752170|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
1440325|NCT00906204|4752171|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
1440326|NCT00906204|4752170|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
1440327|NCT00906204|4752171|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
1440328|NCT00906204|4752170|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
1440329|NCT00906204|4752171|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
1440330|NCT00906204|4752170|P2|Primary Endpoint (Early Safety)|Physician Decision|0
1440331|NCT00906204|4752171|P1|Primary Endpoint (Early Safety)|Physician Decision|1
1440332|NCT00906087|4752202|P1|Initial Washout|Physician Decision|1
1440333|NCT00906087|4752202|P1|Initial Washout|Withdrawal by Subject|1
1440334|NCT00906035|4752239|P3|Overall Study|Withdrawal by Subject|0
1440335|NCT00906035|4752240|P2|Overall Study|Withdrawal by Subject|3
1440336|NCT00906035|4752241|P1|Overall Study|Withdrawal by Subject|2
1440337|NCT00905840|4752255|P1|Overall Study|Adverse Event|1
1440338|NCT00905840|4752255|P1|Overall Study|Withdrawal by Subject|1
1440339|NCT00905840|4752255|P1|Overall Study|Death|3
1440340|NCT00905840|4752255|P1|Overall Study|Lost to Follow-up|11
1440341|NCT00905632|4752286|P7|Overall Study|Adverse Event|4
1440342|NCT00905632|4752287|P6|Overall Study|Adverse Event|1
1440343|NCT00905632|4752288|P5|Overall Study|Adverse Event|0
1440344|NCT00905632|4752289|P4|Overall Study|Adverse Event|0
1440345|NCT00905632|4752290|P3|Overall Study|Adverse Event|0
1440346|NCT00905632|4752291|P2|Overall Study|Adverse Event|0
1440347|NCT00905632|4752292|P1|Overall Study|Adverse Event|0
1440348|NCT00905606|4752430|P2|Washout|Withdrawal by Subject|0
1440349|NCT00905606|4752431|P1|Washout|Withdrawal by Subject|1
1440350|NCT00905606|4752430|P2|Period 1|Adverse Event|1
1440351|NCT00905606|4752431|P1|Period 1|Adverse Event|0
1440352|NCT00905567|4752456|P2|Washout|Withdrawal by Subject|1
1440353|NCT00905567|4752457|P1|Washout|Withdrawal by Subject|0
1440354|NCT00905489|4752489|P1|Optional Extension Phase (OEP)|Adverse Event|1
1440355|NCT00905489|4752489|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
1440356|NCT00905489|4752489|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
1440357|NCT00905437|4752538|P2|Overall Study|Other|6
1440358|NCT00905437|4752539|P1|Overall Study|Other|5
1440359|NCT00905437|4752538|P2|Overall Study|Withdrawal by Subject|1
1440360|NCT00905437|4752539|P1|Overall Study|Withdrawal by Subject|0
1440361|NCT00905437|4752538|P2|Overall Study|Lost to Follow-up|1
1440362|NCT00905437|4752539|P1|Overall Study|Lost to Follow-up|0
1440363|NCT00905437|4752538|P2|Overall Study|Adverse Event|2
1440364|NCT00905437|4752539|P1|Overall Study|Adverse Event|3
1440365|NCT00905424|4752559|P2|Overall Study|Non-adherence to visit schedule|1
1440366|NCT00905424|4752560|P1|Overall Study|Non-adherence to visit schedule|0
1440367|NCT00905424|4752559|P2|Overall Study|Positive urine drug screen|1
1440368|NCT00905424|4752560|P1|Overall Study|Positive urine drug screen|0
1440369|NCT00905424|4752559|P2|Overall Study|Sponsor decision|0
1440370|NCT00905424|4752560|P1|Overall Study|Sponsor decision|1
1440371|NCT00905424|4752559|P2|Overall Study|Non-compliance with study medication|0
1440372|NCT00905424|4752560|P1|Overall Study|Non-compliance with study medication|2
1440373|NCT00905424|4752559|P2|Overall Study|Adverse Event|2
1440374|NCT00905424|4752560|P1|Overall Study|Adverse Event|4
1440375|NCT00905424|4752559|P2|Overall Study|Withdrawal by Subject|2
1440376|NCT00905424|4752560|P1|Overall Study|Withdrawal by Subject|1
1440377|NCT00905424|4752559|P2|Overall Study|Lost to Follow-up|3
1440378|NCT00905424|4752560|P1|Overall Study|Lost to Follow-up|3
1440379|NCT00905359|4752602|P2|Overall Study|Withdrawal consent|6
1440380|NCT00905359|4752603|P1|Overall Study|Withdrawal consent|5
1440381|NCT00905359|4752602|P2|Overall Study|Death|0
1440382|NCT00905359|4752603|P1|Overall Study|Death|2
1440383|NCT00905359|4752602|P2|Overall Study|Lost to Follow-up|10
1440384|NCT00905359|4752603|P1|Overall Study|Lost to Follow-up|17
1440385|NCT00905346|4752639|P2|Period 1|Withdrawal by Subject|0
1440386|NCT00905346|4752640|P1|Period 1|Withdrawal by Subject|1
1440387|NCT00905307|4752654|P6|Overall Study|Lack of Efficacy|8
1440388|NCT00905307|4752655|P5|Overall Study|Lack of Efficacy|4
1440389|NCT00905307|4752656|P4|Overall Study|Lack of Efficacy|4
1440390|NCT00905307|4752657|P3|Overall Study|Lack of Efficacy|5
1440391|NCT00905307|4752658|P2|Overall Study|Lack of Efficacy|3
1440392|NCT00905307|4752659|P1|Overall Study|Lack of Efficacy|6
1440393|NCT00905307|4752654|P6|Overall Study|Protocol Violation|0
1440394|NCT00905307|4752655|P5|Overall Study|Protocol Violation|0
1440395|NCT00905307|4752656|P4|Overall Study|Protocol Violation|0
1440396|NCT00905307|4752657|P3|Overall Study|Protocol Violation|1
1440397|NCT00905307|4752658|P2|Overall Study|Protocol Violation|0
1440398|NCT00905307|4752659|P1|Overall Study|Protocol Violation|1
1440399|NCT00905307|4752654|P6|Overall Study|Withdrawal by Subject|13
1440400|NCT00905307|4752655|P5|Overall Study|Withdrawal by Subject|4
1440401|NCT00905307|4752656|P4|Overall Study|Withdrawal by Subject|11
1440402|NCT00905307|4752657|P3|Overall Study|Withdrawal by Subject|15
1440403|NCT00905307|4752658|P2|Overall Study|Withdrawal by Subject|13
1440404|NCT00905307|4752659|P1|Overall Study|Withdrawal by Subject|5
1440405|NCT00905307|4752654|P6|Overall Study|Adverse Event|5
1440406|NCT00905307|4752655|P5|Overall Study|Adverse Event|3
1440407|NCT00905307|4752656|P4|Overall Study|Adverse Event|11
1440408|NCT00905307|4752657|P3|Overall Study|Adverse Event|5
1440409|NCT00905307|4752658|P2|Overall Study|Adverse Event|4
1440410|NCT00905307|4752659|P1|Overall Study|Adverse Event|3
1440411|NCT00905307|4752654|P6|Overall Study|Lost to Follow-up|1
1440412|NCT00905307|4752655|P5|Overall Study|Lost to Follow-up|1
1440413|NCT00905307|4752656|P4|Overall Study|Lost to Follow-up|0
1440414|NCT00905307|4752657|P3|Overall Study|Lost to Follow-up|0
1440415|NCT00905307|4752658|P2|Overall Study|Lost to Follow-up|0
1440416|NCT00905307|4752659|P1|Overall Study|Lost to Follow-up|0
1440417|NCT00905307|4752654|P6|Overall Study|Switched to Open Label Rescue|15
1440418|NCT00905307|4752655|P5|Overall Study|Switched to Open Label Rescue|4
1440419|NCT00905307|4752656|P4|Overall Study|Switched to Open Label Rescue|11
1440420|NCT00905307|4752657|P3|Overall Study|Switched to Open Label Rescue|11
1440421|NCT00905307|4752658|P2|Overall Study|Switched to Open Label Rescue|17
1440422|NCT00905307|4752659|P1|Overall Study|Switched to Open Label Rescue|7
1440423|NCT00905255|4752754|P2|Overall Study|Familial and Personal Reasons|0
1440424|NCT00905255|4752755|P1|Overall Study|Familial and Personal Reasons|1
1440425|NCT00905255|4752754|P2|Overall Study|Withdrawal by Subject|4
1440426|NCT00905255|4752755|P1|Overall Study|Withdrawal by Subject|5
1440427|NCT00905255|4752754|P2|Overall Study|Adverse Event|5
1440428|NCT00905255|4752755|P1|Overall Study|Adverse Event|7
1440429|NCT00905164|4752773|P2|Period 1|Protocol Violation|1
1440430|NCT00905164|4752774|P1|Period 1|Protocol Violation|0
1440431|NCT00905034|4752821|P1|Overall Study|Withdrawal by Subject|1
1440432|NCT00905021|4752825|P1|Overall Study|Adverse Event|2
1440433|NCT00904982|4752843|P4|Overall Study|Withdrawal by Subject|0
1440434|NCT00904982|4752844|P3|Overall Study|Withdrawal by Subject|0
1440435|NCT00904982|4752845|P2|Overall Study|Withdrawal by Subject|0
1440436|NCT00904982|4752846|P1|Overall Study|Withdrawal by Subject|2
1440437|NCT00904969|4752856|P1|Overall Study|Case Aborted; Subject Exited|1
1440438|NCT00904969|4752856|P1|Overall Study|Additional Treatments|11
1440439|NCT00904969|4752856|P1|Overall Study|Withdrawal by Subject|3
1440440|NCT00904969|4752856|P1|Overall Study|Lost to Follow-up|4
1440441|NCT00904917|4752921|P4|Overall Study|Lost to Follow-up|2
1440442|NCT00904917|4752922|P3|Overall Study|Lost to Follow-up|2
1440443|NCT00904917|4752923|P2|Overall Study|Lost to Follow-up|2
1440444|NCT00904917|4752924|P1|Overall Study|Lost to Follow-up|2
1440445|NCT00904839|4752942|P3|Overall Study|Other than above|7
1440446|NCT00904839|4752943|P2|Overall Study|Other than above|9
1440447|NCT00904839|4752944|P1|Overall Study|Other than above|0
1440448|NCT00904839|4752942|P3|Overall Study|Not treated|1
1440449|NCT00904839|4752943|P2|Overall Study|Not treated|0
1440450|NCT00904839|4752944|P1|Overall Study|Not treated|1
1440451|NCT00904839|4752942|P3|Overall Study|Withdrawal by Subject|0
1440452|NCT00904839|4752943|P2|Overall Study|Withdrawal by Subject|2
1440453|NCT00904839|4752944|P1|Overall Study|Withdrawal by Subject|0
1440454|NCT00904839|4752942|P3|Overall Study|Lost to Follow-up|2
1440455|NCT00904839|4752943|P2|Overall Study|Lost to Follow-up|1
1440456|NCT00904839|4752944|P1|Overall Study|Lost to Follow-up|0
1440457|NCT00904839|4752942|P3|Overall Study|Protocol Violation|1
1440458|NCT00904839|4752943|P2|Overall Study|Protocol Violation|1
1440459|NCT00904839|4752944|P1|Overall Study|Protocol Violation|0
1440460|NCT00904839|4752942|P3|Overall Study|Adverse Event|4
1440461|NCT00904839|4752943|P2|Overall Study|Adverse Event|5
1440462|NCT00904839|4752944|P1|Overall Study|Adverse Event|0
1440463|NCT00904748|4752990|P6|Overall Study|Adverse Event|0
1440464|NCT00904748|4752991|P5|Overall Study|Adverse Event|1
1440465|NCT00904748|4752992|P4|Overall Study|Adverse Event|0
1440466|NCT00904748|4752993|P3|Overall Study|Adverse Event|0
1440467|NCT00904748|4752994|P2|Overall Study|Adverse Event|0
1440468|NCT00904748|4752995|P1|Overall Study|Adverse Event|0
1440469|NCT00904748|4752990|P6|Overall Study|Withdrawal by Subject|0
1440470|NCT00904748|4752991|P5|Overall Study|Withdrawal by Subject|0
1440471|NCT00904748|4752992|P4|Overall Study|Withdrawal by Subject|2
1440472|NCT00904748|4752993|P3|Overall Study|Withdrawal by Subject|1
1440473|NCT00904748|4752994|P2|Overall Study|Withdrawal by Subject|1
1440474|NCT00904748|4752995|P1|Overall Study|Withdrawal by Subject|1
1440475|NCT00904722|4753019|P1|Overall Study|Physician Decision|1
1440476|NCT00904670|4753024|P2|Open Label Phase|Lost to Follow-up|0
1440477|NCT00904670|4753025|P1|Open Label Phase|Lost to Follow-up|1
1440478|NCT00904670|4753024|P2|Open Label Phase|Lack of Efficacy|0
1440479|NCT00904670|4753025|P1|Open Label Phase|Lack of Efficacy|1
1440480|NCT00904670|4753024|P2|Open Label Phase|Adverse Event|0
1440481|NCT00904670|4753025|P1|Open Label Phase|Adverse Event|2
1440482|NCT00904670|4753024|P2|Open Label Phase|Withdrawal by Subject|0
1440483|NCT00904670|4753025|P1|Open Label Phase|Withdrawal by Subject|2
1440484|NCT00904371|4753095|P1|Overall Study|Continued with Tritace|1
1440485|NCT00904371|4753095|P1|Overall Study|Discontinued at target blood pressure|2
1440486|NCT00904371|4753095|P1|Overall Study|Lost to Follow-up|4
1440487|NCT00904371|4753095|P1|Overall Study|Adverse Event|2
1440488|NCT00904215|4753109|P1|Overall Study|Other|28
1440489|NCT00904215|4753109|P1|Overall Study|Withdrawal by Subject|9
1440490|NCT00904215|4753109|P1|Overall Study|Lost to Follow-up|63
1440491|NCT00904215|4753109|P1|Overall Study|Protocol Violation|10
1440492|NCT00904215|4753109|P1|Overall Study|Adverse Event|25
1440493|NCT00904150|4753123|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
1440494|NCT00904150|4753124|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
1440495|NCT00904150|4753123|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
1440496|NCT00904150|4753124|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
1440497|NCT00903968|4753153|P8|Overall Study|Lack of Efficacy|3
1440498|NCT00903968|4753154|P7|Overall Study|Lack of Efficacy|0
1440499|NCT00903968|4753155|P6|Overall Study|Lack of Efficacy|0
1440500|NCT00903968|4753156|P5|Overall Study|Lack of Efficacy|0
1440501|NCT00903968|4753157|P4|Overall Study|Lack of Efficacy|0
1440502|NCT00903968|4753158|P3|Overall Study|Lack of Efficacy|0
1440503|NCT00903968|4753159|P2|Overall Study|Lack of Efficacy|0
1440504|NCT00903968|4753160|P1|Overall Study|Lack of Efficacy|0
1440505|NCT00903968|4753153|P8|Overall Study|Progressive Disease|18
1440506|NCT00903968|4753154|P7|Overall Study|Progressive Disease|0
1440507|NCT00903968|4753155|P6|Overall Study|Progressive Disease|3
1440508|NCT00903968|4753156|P5|Overall Study|Progressive Disease|3
1440509|NCT00903968|4753157|P4|Overall Study|Progressive Disease|3
1440510|NCT00903968|4753158|P3|Overall Study|Progressive Disease|2
1440511|NCT00903968|4753159|P2|Overall Study|Progressive Disease|3
1440512|NCT00903968|4753160|P1|Overall Study|Progressive Disease|2
1440513|NCT00903968|4753153|P8|Overall Study|Physician Decision|0
1440514|NCT00903968|4753154|P7|Overall Study|Physician Decision|0
1440515|NCT00903968|4753155|P6|Overall Study|Physician Decision|1
1440516|NCT00903968|4753156|P5|Overall Study|Physician Decision|0
1440517|NCT00903968|4753157|P4|Overall Study|Physician Decision|0
1440518|NCT00903968|4753158|P3|Overall Study|Physician Decision|0
1440519|NCT00903968|4753159|P2|Overall Study|Physician Decision|0
1440520|NCT00903968|4753160|P1|Overall Study|Physician Decision|0
1440521|NCT00903968|4753153|P8|Overall Study|Non-Compliance|0
1440522|NCT00903968|4753154|P7|Overall Study|Non-Compliance|0
1440523|NCT00903968|4753155|P6|Overall Study|Non-Compliance|1
1440524|NCT00903968|4753156|P5|Overall Study|Non-Compliance|0
1440525|NCT00903968|4753157|P4|Overall Study|Non-Compliance|0
1440526|NCT00903968|4753158|P3|Overall Study|Non-Compliance|0
1440527|NCT00903968|4753159|P2|Overall Study|Non-Compliance|0
1440528|NCT00903968|4753160|P1|Overall Study|Non-Compliance|0
1440529|NCT00903968|4753153|P8|Overall Study|Withdrawal by Subject|4
1440530|NCT00903968|4753154|P7|Overall Study|Withdrawal by Subject|0
1440531|NCT00903968|4753155|P6|Overall Study|Withdrawal by Subject|1
1440532|NCT00903968|4753156|P5|Overall Study|Withdrawal by Subject|1
1440533|NCT00903968|4753157|P4|Overall Study|Withdrawal by Subject|0
1440534|NCT00903968|4753158|P3|Overall Study|Withdrawal by Subject|1
1440535|NCT00903968|4753159|P2|Overall Study|Withdrawal by Subject|0
1440536|NCT00903968|4753160|P1|Overall Study|Withdrawal by Subject|1
1440537|NCT00903968|4753153|P8|Overall Study|DLT|0
1440538|NCT00903968|4753154|P7|Overall Study|DLT|2
1440539|NCT00903968|4753155|P6|Overall Study|DLT|0
1440540|NCT00903968|4753156|P5|Overall Study|DLT|0
1440541|NCT00903968|4753157|P4|Overall Study|DLT|0
1440542|NCT00903968|4753158|P3|Overall Study|DLT|0
1440543|NCT00903968|4753159|P2|Overall Study|DLT|0
1440544|NCT00903968|4753160|P1|Overall Study|DLT|0
1440545|NCT00903968|4753153|P8|Overall Study|Adverse Event|8
1440546|NCT00903968|4753154|P7|Overall Study|Adverse Event|1
1440547|NCT00903968|4753155|P6|Overall Study|Adverse Event|0
1440548|NCT00903968|4753156|P5|Overall Study|Adverse Event|0
1440549|NCT00903968|4753157|P4|Overall Study|Adverse Event|0
1440550|NCT00903968|4753158|P3|Overall Study|Adverse Event|0
1440551|NCT00903968|4753159|P2|Overall Study|Adverse Event|0
1440552|NCT00903968|4753160|P1|Overall Study|Adverse Event|0
1440553|NCT00903929|4753190|P4|Overall Study|Adverse Event|1
1440554|NCT00903929|4753191|P3|Overall Study|Adverse Event|0
1440555|NCT00903929|4753192|P2|Overall Study|Adverse Event|0
1440556|NCT00903929|4753193|P1|Overall Study|Adverse Event|0
1440557|NCT00903929|4753190|P4|Overall Study|Withdrawal by Subject|2
1440558|NCT00903929|4753191|P3|Overall Study|Withdrawal by Subject|1
1440559|NCT00903929|4753192|P2|Overall Study|Withdrawal by Subject|0
1440560|NCT00903929|4753193|P1|Overall Study|Withdrawal by Subject|0
1440561|NCT00903877|4753199|P1|Overall Study|Participation put on hold|4
1440562|NCT00903877|4753199|P1|Overall Study|Lost to Follow-up|1
1440563|NCT00903877|4753199|P1|Overall Study|Adverse Event|2
1440564|NCT00903877|4753199|P1|Overall Study|Withdrawal by Subject|3
1440565|NCT00903877|4753199|P1|Overall Study|Did not meet study criteria|33
1440566|NCT00903786|4753203|P1|Overall Study|Reason other than lack of efficacy|4
1440567|NCT00903786|4753203|P1|Overall Study|Lack of Efficacy|5
1440568|NCT00903786|4753203|P1|Overall Study|Physician Decision|6
1440569|NCT00903695|4753213|P2|Overall Study|lung cancer|0
1440570|NCT00903695|4753214|P1|Overall Study|lung cancer|1
1440571|NCT00903695|4753213|P2|Overall Study|medical exclusion after 1st testing|0
1440572|NCT00903695|4753214|P1|Overall Study|medical exclusion after 1st testing|1
1440573|NCT00903682|4753236|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
1440574|NCT00903682|4753237|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
1440575|NCT00903682|4753236|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
1440576|NCT00903682|4753237|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
1440577|NCT00903682|4753236|P2|Overall Study|Subject Non-Compliant|0
1440578|NCT00903682|4753237|P1|Overall Study|Subject Non-Compliant|1
1440579|NCT00903682|4753236|P2|Overall Study|Subject Reached A Virologic Endpoint|1
1440580|NCT00903682|4753237|P1|Overall Study|Subject Reached A Virologic Endpoint|1
1440581|NCT00903682|4753236|P2|Overall Study|Pregnancy|1
1440582|NCT00903682|4753237|P1|Overall Study|Pregnancy|0
1440583|NCT00903682|4753236|P2|Overall Study|Withdrawal by Subject|0
1440584|NCT00903682|4753237|P1|Overall Study|Withdrawal by Subject|5
1440585|NCT00903682|4753236|P2|Overall Study|Lost to Follow-up|0
1440586|NCT00903682|4753237|P1|Overall Study|Lost to Follow-up|1
1440587|NCT00903682|4753236|P2|Overall Study|Adverse Event|13
1440588|NCT00903682|4753237|P1|Overall Study|Adverse Event|6
1440589|NCT00903630|4753258|P3|Phase 2|Adverse Event|1
1440590|NCT00903630|4753259|P2|Phase 2|Adverse Event|0
1440591|NCT00903630|4753260|P1|Phase 2|Adverse Event|0
1440592|NCT00903617|4753278|P4|Overall Study|Withdrawal by Subject|0
1440593|NCT00903617|4753279|P3|Overall Study|Withdrawal by Subject|3
1440594|NCT00903617|4753280|P2|Overall Study|Withdrawal by Subject|2
1440595|NCT00903617|4753281|P1|Overall Study|Withdrawal by Subject|1
1440596|NCT00903617|4753278|P4|Overall Study|Lost to Follow-up|1
1440597|NCT00903617|4753279|P3|Overall Study|Lost to Follow-up|1
1440598|NCT00903617|4753280|P2|Overall Study|Lost to Follow-up|0
1440599|NCT00903617|4753281|P1|Overall Study|Lost to Follow-up|2
1440600|NCT00903617|4753278|P4|Overall Study|Protocol-defined stopping criteria|0
1440601|NCT00903617|4753279|P3|Overall Study|Protocol-defined stopping criteria|0
1440602|NCT00903617|4753280|P2|Overall Study|Protocol-defined stopping criteria|2
1440603|NCT00903617|4753281|P1|Overall Study|Protocol-defined stopping criteria|0
1440604|NCT00903617|4753278|P4|Overall Study|Adverse Event|0
1440605|NCT00903617|4753279|P3|Overall Study|Adverse Event|1
1440606|NCT00903617|4753280|P2|Overall Study|Adverse Event|1
1440607|NCT00903617|4753281|P1|Overall Study|Adverse Event|0
1440608|NCT00903409|4753384|P2|Overall Study|Lost to Follow-up|6
1440609|NCT00903409|4753385|P1|Overall Study|Lost to Follow-up|2
1440610|NCT00903409|4753384|P2|Overall Study|Not specified|3
1440611|NCT00903409|4753385|P1|Overall Study|Not specified|2
1440612|NCT00903409|4753384|P2|Overall Study|Withdrawal by Subject|8
1440613|NCT00903409|4753385|P1|Overall Study|Withdrawal by Subject|8
1440614|NCT00903409|4753384|P2|Overall Study|Laboratory Abnormality|0
1440615|NCT00903409|4753385|P1|Overall Study|Laboratory Abnormality|2
1440616|NCT00903409|4753384|P2|Overall Study|Non-compliance with Protocol|1
1440617|NCT00903409|4753385|P1|Overall Study|Non-compliance with Protocol|1
1440618|NCT00903409|4753384|P2|Overall Study|Adverse Event|9
1440619|NCT00903409|4753385|P1|Overall Study|Adverse Event|11
1440620|NCT00903383|4753436|P4|Overall Study|Patient Decision|1
1440621|NCT00903383|4753437|P3|Overall Study|Patient Decision|0
1440622|NCT00903383|4753438|P2|Overall Study|Patient Decision|0
1440623|NCT00903383|4753439|P1|Overall Study|Patient Decision|0
1440624|NCT00903383|4753436|P4|Overall Study|Patient Decision - Lack of Efficacy|0
1440625|NCT00903383|4753437|P3|Overall Study|Patient Decision - Lack of Efficacy|0
1440626|NCT00903383|4753438|P2|Overall Study|Patient Decision - Lack of Efficacy|1
1440627|NCT00903383|4753439|P1|Overall Study|Patient Decision - Lack of Efficacy|0
1440628|NCT00903383|4753436|P4|Overall Study|Withdrawal by Subject|2
1440629|NCT00903383|4753437|P3|Overall Study|Withdrawal by Subject|0
1440630|NCT00903383|4753438|P2|Overall Study|Withdrawal by Subject|1
1440631|NCT00903383|4753439|P1|Overall Study|Withdrawal by Subject|4
1440632|NCT00903383|4753436|P4|Overall Study|Decision of Sponsor|0
1440633|NCT00903383|4753437|P3|Overall Study|Decision of Sponsor|0
1440634|NCT00903383|4753438|P2|Overall Study|Decision of Sponsor|0
1440635|NCT00903383|4753439|P1|Overall Study|Decision of Sponsor|1
1440636|NCT00903383|4753436|P4|Overall Study|Lost to Follow-up|1
1440637|NCT00903383|4753437|P3|Overall Study|Lost to Follow-up|0
1440638|NCT00903383|4753438|P2|Overall Study|Lost to Follow-up|0
1440639|NCT00903383|4753439|P1|Overall Study|Lost to Follow-up|0
1440640|NCT00903383|4753436|P4|Overall Study|Physician Decision|0
1440641|NCT00903383|4753437|P3|Overall Study|Physician Decision|0
1440642|NCT00903383|4753438|P2|Overall Study|Physician Decision|2
1440643|NCT00903383|4753439|P1|Overall Study|Physician Decision|1
1440644|NCT00903383|4753436|P4|Overall Study|Adverse Event|1
1440645|NCT00903383|4753437|P3|Overall Study|Adverse Event|3
1440646|NCT00903383|4753438|P2|Overall Study|Adverse Event|2
1440647|NCT00903383|4753439|P1|Overall Study|Adverse Event|1
1440648|NCT00903370|4753471|P2|Overall Study|Lost to Follow-up|8
1440649|NCT00903370|4753472|P1|Overall Study|Lost to Follow-up|6
1440650|NCT00903370|4753471|P2|Overall Study|Withdrawal by Subject|6
1440651|NCT00903370|4753472|P1|Overall Study|Withdrawal by Subject|9
1440652|NCT00903370|4753471|P2|Overall Study|Death|10
1440653|NCT00903370|4753472|P1|Overall Study|Death|13
1440654|NCT00903357|4753480|P2|Second Intervention|Lost to Follow-up|0
1440655|NCT00903357|4753481|P1|Second Intervention|Lost to Follow-up|1
1440656|NCT00903357|4753480|P2|Wash Out Period of 2 Weeks|Flu|1
1440657|NCT00903357|4753481|P1|Wash Out Period of 2 Weeks|Flu|0
1440658|NCT00903357|4753480|P2|First Intervention|Flu|1
1440659|NCT00903357|4753481|P1|First Intervention|Flu|0
1440660|NCT00903357|4753480|P2|First Intervention|Withdrawal by Subject|3
1440661|NCT00903357|4753481|P1|First Intervention|Withdrawal by Subject|5
1440662|NCT00903344|4753493|P2|Overall Study|Lost to Follow-up|0
1440663|NCT00903344|4753494|P1|Overall Study|Lost to Follow-up|3
1440664|NCT00903344|4753493|P2|Overall Study|Pregnancy|3
1440665|NCT00903344|4753494|P1|Overall Study|Pregnancy|2
1440666|NCT00903331|4753512|P2|Overall Study|Lung transplant|2
1440667|NCT00903331|4753513|P1|Overall Study|Lung transplant|0
1440668|NCT00903331|4753512|P2|Overall Study|Withdrawal of consent|8
1440669|NCT00903331|4753513|P1|Overall Study|Withdrawal of consent|1
1440670|NCT00903331|4753512|P2|Overall Study|Death|8
1440671|NCT00903331|4753513|P1|Overall Study|Death|4
1440672|NCT00903201|4753524|P3|Overall Study|Withdrawal by Subject|1
1440673|NCT00903201|4753525|P2|Overall Study|Withdrawal by Subject|0
1440674|NCT00903201|4753526|P1|Overall Study|Withdrawal by Subject|1
1440675|NCT00903201|4753524|P3|Overall Study|Physician Decision|1
1440676|NCT00903201|4753525|P2|Overall Study|Physician Decision|0
1440677|NCT00903201|4753526|P1|Overall Study|Physician Decision|1
1440678|NCT00903201|4753524|P3|Overall Study|Lost to Follow-up|0
1440679|NCT00903201|4753525|P2|Overall Study|Lost to Follow-up|1
1440680|NCT00903201|4753526|P1|Overall Study|Lost to Follow-up|0
1440681|NCT00903201|4753524|P3|Overall Study|Protocol Violation|0
1440682|NCT00903201|4753525|P2|Overall Study|Protocol Violation|1
1440683|NCT00903201|4753526|P1|Overall Study|Protocol Violation|2
1440684|NCT00903201|4753524|P3|Overall Study|Adverse Event|0
1440685|NCT00903201|4753525|P2|Overall Study|Adverse Event|4
1440686|NCT00903201|4753526|P1|Overall Study|Adverse Event|1
1440687|NCT00903175|4753584|P2|Period 2 - Second Line|Death|2
1440688|NCT00903175|4753585|P1|Period 2 - Second Line|Death|5
1440689|NCT00903175|4753584|P2|Period 2 - Second Line|Administrative problems|9
1440690|NCT00903175|4753585|P1|Period 2 - Second Line|Administrative problems|19
1440691|NCT00903175|4753584|P2|Period 2 - Second Line|Lost to Follow-up|0
1440692|NCT00903175|4753585|P1|Period 2 - Second Line|Lost to Follow-up|1
1440693|NCT00903175|4753584|P2|Period 2 - Second Line|Withdrawal by Subject|5
1440694|NCT00903175|4753585|P1|Period 2 - Second Line|Withdrawal by Subject|7
1440695|NCT00903175|4753584|P2|Period 2 - Second Line|Adverse Event|20
1440696|NCT00903175|4753585|P1|Period 2 - Second Line|Adverse Event|16
1440697|NCT00903175|4753584|P2|Period 2 - Second Line|Missing|0
1440698|NCT00903175|4753585|P1|Period 2 - Second Line|Missing|1
1440699|NCT00903175|4753584|P2|Period 1 - First Line|Death|10
1440700|NCT00903175|4753585|P1|Period 1 - First Line|Death|17
1440701|NCT00903175|4753584|P2|Period 1 - First Line|Administrative problems|13
1440702|NCT00903175|4753585|P1|Period 1 - First Line|Administrative problems|12
1440703|NCT00903175|4753584|P2|Period 1 - First Line|Withdrawal by Subject|12
1440704|NCT00903175|4753585|P1|Period 1 - First Line|Withdrawal by Subject|8
1440705|NCT00903175|4753584|P2|Period 1 - First Line|Protocol Violation|3
1440706|NCT00903175|4753585|P1|Period 1 - First Line|Protocol Violation|3
1440707|NCT00903175|4753584|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
1440708|NCT00903175|4753585|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
1440709|NCT00903175|4753584|P2|Period 1 - First Line|Abnormal lab value(s)|1
1440710|NCT00903175|4753585|P1|Period 1 - First Line|Abnormal lab value(s)|0
1440711|NCT00903175|4753584|P2|Period 1 - First Line|Adverse Event|50
1440712|NCT00903175|4753585|P1|Period 1 - First Line|Adverse Event|36
1440713|NCT00903032|4753623|P2|Overall Study|Lost to Follow-up|2
1440714|NCT00903032|4753624|P1|Overall Study|Lost to Follow-up|2
1440715|NCT00903032|4753623|P2|Overall Study|Withdrawal by Subject|3
1440716|NCT00903032|4753624|P1|Overall Study|Withdrawal by Subject|5
1440717|NCT00903006|4753634|P4|Overall Study|Progressive Disease|0
1440718|NCT00903006|4753635|P3|Overall Study|Progressive Disease|1
1440719|NCT00903006|4753636|P2|Overall Study|Progressive Disease|3
1440720|NCT00903006|4753637|P1|Overall Study|Progressive Disease|0
1440721|NCT00903006|4753634|P4|Overall Study|Withdrawal by Subject|0
1440722|NCT00903006|4753635|P3|Overall Study|Withdrawal by Subject|0
1440723|NCT00903006|4753636|P2|Overall Study|Withdrawal by Subject|0
1440724|NCT00903006|4753637|P1|Overall Study|Withdrawal by Subject|2
1440725|NCT00902850|4753649|P2|Overall Study|Physician Decision|2
1440726|NCT00902850|4753650|P1|Overall Study|Physician Decision|2
1440727|NCT00902746|4753656|P1|Overall Study|Physician Decision|2
1440728|NCT00902746|4753656|P1|Overall Study|Lost to Follow-up|3
1440729|NCT00902746|4753656|P1|Overall Study|Adverse Event|8
1440730|NCT00902746|4753656|P1|Overall Study|Withdrawal by Subject|16
1440731|NCT00902746|4753656|P1|Overall Study|Protocol Violation|7
1440732|NCT00902668|4753661|P1|Overall Study|Protocol stopped due to slow accrual.|3
1440733|NCT00902564|4753665|P1|Overall Study|Withdrawal by Subject|2
1440734|NCT00902538|4753680|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
1440735|NCT00902538|4753681|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
1440736|NCT00902538|4753682|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
1440737|NCT00902538|4753683|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
1440738|NCT00902538|4753684|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
1440739|NCT00902538|4753685|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
1440740|NCT00902538|4753680|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
1440741|NCT00902538|4753681|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
1440742|NCT00902538|4753682|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
1440743|NCT00902538|4753683|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
1440744|NCT00902538|4753684|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
1440745|NCT00902538|4753685|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
1440746|NCT00902538|4753680|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
1440747|NCT00902538|4753681|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
1440748|NCT00902538|4753682|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
1440749|NCT00902538|4753683|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
1440750|NCT00902538|4753684|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
1440751|NCT00902538|4753685|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
1440752|NCT00902538|4753680|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
1440753|NCT00902538|4753681|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
1440754|NCT00902538|4753682|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
1440755|NCT00902538|4753683|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
1440756|NCT00902538|4753684|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
1440757|NCT00902538|4753685|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
1440758|NCT00902538|4753680|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
1440759|NCT00902538|4753681|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
1440760|NCT00902538|4753682|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
1440761|NCT00902538|4753683|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
1440762|NCT00902538|4753684|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
1440763|NCT00902538|4753685|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
1440764|NCT00902538|4753680|P6|3-Single-blind, Single Treatment|Protocol Violation|0
1440765|NCT00902538|4753681|P5|3-Single-blind, Single Treatment|Protocol Violation|0
1440766|NCT00902538|4753682|P4|3-Single-blind, Single Treatment|Protocol Violation|0
1440767|NCT00902538|4753683|P3|3-Single-blind, Single Treatment|Protocol Violation|0
1440768|NCT00902538|4753684|P2|3-Single-blind, Single Treatment|Protocol Violation|5
1440769|NCT00902538|4753685|P1|3-Single-blind, Single Treatment|Protocol Violation|0
1440770|NCT00902538|4753680|P6|3-Single-blind, Single Treatment|Adverse Event|0
1440771|NCT00902538|4753681|P5|3-Single-blind, Single Treatment|Adverse Event|0
1440772|NCT00902538|4753682|P4|3-Single-blind, Single Treatment|Adverse Event|0
1440773|NCT00902538|4753683|P3|3-Single-blind, Single Treatment|Adverse Event|0
1440774|NCT00902538|4753684|P2|3-Single-blind, Single Treatment|Adverse Event|5
1440775|NCT00902538|4753685|P1|3-Single-blind, Single Treatment|Adverse Event|0
1440776|NCT00902538|4753680|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
1440777|NCT00902538|4753681|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
1440778|NCT00902538|4753682|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
1440779|NCT00902538|4753683|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
1440780|NCT00902538|4753684|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
1440781|NCT00902538|4753685|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
1440782|NCT00902538|4753680|P6|2-Randomized Double-blind 3 Treatments|Other|0
1440783|NCT00902538|4753681|P5|2-Randomized Double-blind 3 Treatments|Other|0
1440784|NCT00902538|4753682|P4|2-Randomized Double-blind 3 Treatments|Other|0
1440785|NCT00902538|4753683|P3|2-Randomized Double-blind 3 Treatments|Other|0
1440786|NCT00902538|4753684|P2|2-Randomized Double-blind 3 Treatments|Other|1
1440787|NCT00902538|4753685|P1|2-Randomized Double-blind 3 Treatments|Other|2
1440788|NCT00902538|4753680|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
1440789|NCT00902538|4753681|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
1440790|NCT00902538|4753682|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
1440791|NCT00902538|4753683|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
1440792|NCT00902538|4753684|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
1440793|NCT00902538|4753685|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
1440794|NCT00902538|4753680|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
1440795|NCT00902538|4753681|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
1440796|NCT00902538|4753682|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
1440797|NCT00902538|4753683|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
1440798|NCT00902538|4753684|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
1440799|NCT00902538|4753685|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
1440800|NCT00902538|4753680|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
1440801|NCT00902538|4753681|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
1440802|NCT00902538|4753682|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
1440803|NCT00902538|4753683|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
1440804|NCT00902538|4753684|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
1440805|NCT00902538|4753685|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
1440806|NCT00902538|4753680|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
1440807|NCT00902538|4753681|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
1440808|NCT00902538|4753682|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
1440809|NCT00902538|4753683|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
1440810|NCT00902538|4753684|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
1440811|NCT00902538|4753685|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
1440812|NCT00902538|4753680|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
1440813|NCT00902538|4753681|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
1440814|NCT00902538|4753682|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
1440815|NCT00902538|4753683|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
1440816|NCT00902538|4753684|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
1440817|NCT00902538|4753685|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
1440818|NCT00902538|4753680|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
1440819|NCT00902538|4753681|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
1440820|NCT00902538|4753682|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
1440821|NCT00902538|4753683|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
1440822|NCT00902538|4753684|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
1440823|NCT00902538|4753685|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
1440824|NCT00902538|4753680|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
1440825|NCT00902538|4753681|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
1440826|NCT00902538|4753682|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
1440827|NCT00902538|4753683|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
1440828|NCT00902538|4753684|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
1440829|NCT00902538|4753685|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
1440830|NCT00902538|4753680|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
1440831|NCT00902538|4753681|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
1440832|NCT00902538|4753682|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
1440833|NCT00902538|4753683|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
1440834|NCT00902538|4753684|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
1440835|NCT00902538|4753685|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
1440836|NCT00902330|4753717|P2|Overall Study|No post baseline data|0
1440837|NCT00902330|4753718|P1|Overall Study|No post baseline data|1
1440838|NCT00902330|4753717|P2|Overall Study|Adverse Event|0
1440839|NCT00902330|4753718|P1|Overall Study|Adverse Event|1
1440840|NCT00902330|4753717|P2|Overall Study|Too overwhelmed by treatment|5
1440841|NCT00902330|4753718|P1|Overall Study|Too overwhelmed by treatment|2
1440842|NCT00902304|4753755|P3|Overall Study|includes pregnancy|2
1440843|NCT00902304|4753756|P2|Overall Study|includes pregnancy|9
1440844|NCT00902304|4753757|P1|Overall Study|includes pregnancy|3
1440845|NCT00902304|4753755|P3|Overall Study|Withdrawal by Subject|43
1440846|NCT00902304|4753756|P2|Overall Study|Withdrawal by Subject|22
1440847|NCT00902304|4753757|P1|Overall Study|Withdrawal by Subject|32
1440848|NCT00902304|4753755|P3|Overall Study|Protocol Violation|20
1440849|NCT00902304|4753756|P2|Overall Study|Protocol Violation|18
1440850|NCT00902304|4753757|P1|Overall Study|Protocol Violation|9
1440851|NCT00902304|4753755|P3|Overall Study|Lost to Follow-up|7
1440852|NCT00902304|4753756|P2|Overall Study|Lost to Follow-up|7
1440853|NCT00902304|4753757|P1|Overall Study|Lost to Follow-up|7
1440854|NCT00902304|4753755|P3|Overall Study|Investigator discretion|13
1440855|NCT00902304|4753756|P2|Overall Study|Investigator discretion|5
1440856|NCT00902304|4753757|P1|Overall Study|Investigator discretion|3
1440857|NCT00902304|4753755|P3|Overall Study|Adverse Event|25
1440858|NCT00902304|4753756|P2|Overall Study|Adverse Event|10
1440859|NCT00902304|4753757|P1|Overall Study|Adverse Event|4
1440860|NCT00902278|4753807|P5|Overall Study|Lost to Follow-up|1
1440861|NCT00902278|4753808|P4|Overall Study|Lost to Follow-up|0
1440862|NCT00902278|4753809|P3|Overall Study|Lost to Follow-up|3
1440863|NCT00902278|4753810|P2|Overall Study|Lost to Follow-up|2
1440864|NCT00902278|4753811|P1|Overall Study|Lost to Follow-up|3
1440865|NCT00902278|4753807|P5|Overall Study|Physician Decision|1
1440866|NCT00902278|4753808|P4|Overall Study|Physician Decision|0
1440867|NCT00902278|4753809|P3|Overall Study|Physician Decision|2
1440868|NCT00902278|4753810|P2|Overall Study|Physician Decision|0
1440869|NCT00902278|4753811|P1|Overall Study|Physician Decision|1
1440870|NCT00902265|4753828|P1|Overall Study|Protocol Violation|1
1440871|NCT00902265|4753828|P1|Overall Study|Lack of Efficacy|2
1440872|NCT00902265|4753828|P1|Overall Study|Adverse Event|2
1440873|NCT00902265|4753828|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
1440874|NCT00902174|4753852|P2|Overall Study|Administration problem|1
1440875|NCT00902174|4753853|P1|Overall Study|Administration problem|0
1440876|NCT00902174|4753852|P2|Overall Study|Protocol Violation|1
1440877|NCT00902174|4753853|P1|Overall Study|Protocol Violation|1
1440878|NCT00902174|4753852|P2|Overall Study|Abnormal labs|1
1440879|NCT00902174|4753853|P1|Overall Study|Abnormal labs|1
1440880|NCT00902174|4753852|P2|Overall Study|Withdrawal by Subject|1
1440881|NCT00902174|4753853|P1|Overall Study|Withdrawal by Subject|2
1440882|NCT00902174|4753852|P2|Overall Study|Death|2
1440883|NCT00902174|4753853|P1|Overall Study|Death|2
1440884|NCT00902174|4753852|P2|Overall Study|Lack of Efficacy|5
1440885|NCT00902174|4753853|P1|Overall Study|Lack of Efficacy|1
1440886|NCT00902174|4753852|P2|Overall Study|Adverse Event|7
1440887|NCT00902174|4753853|P1|Overall Study|Adverse Event|27
1440888|NCT00901901|4753910|P2|Follow-up Period|Lost to Follow-up|8
1440889|NCT00901901|4753911|P1|Follow-up Period|Lost to Follow-up|12
1440890|NCT00901901|4753910|P2|Follow-up Period|Withdrawal by Subject|9
1440891|NCT00901901|4753911|P1|Follow-up Period|Withdrawal by Subject|6
1440892|NCT00901901|4753910|P2|Follow-up Period|Protocol driven decision point|35
1440893|NCT00901901|4753911|P1|Follow-up Period|Protocol driven decision point|47
1440894|NCT00901901|4753910|P2|Follow-up Period|Death|207
1440895|NCT00901901|4753911|P1|Follow-up Period|Death|181
1440896|NCT00901901|4753910|P2|Treatment Period|Never treated|3
1440897|NCT00901901|4753911|P1|Treatment Period|Never treated|0
1440898|NCT00901901|4753910|P2|Treatment Period|Missing|1
1440899|NCT00901901|4753911|P1|Treatment Period|Missing|1
1440900|NCT00901901|4753910|P2|Treatment Period|Protocol Violation|9
1440901|NCT00901901|4753911|P1|Treatment Period|Protocol Violation|4
1440902|NCT00901901|4753910|P2|Treatment Period|Noncompliance with study medication|1
1440903|NCT00901901|4753911|P1|Treatment Period|Noncompliance with study medication|4
1440904|NCT00901901|4753910|P2|Treatment Period|Lost to Follow-up|5
1440905|NCT00901901|4753911|P1|Treatment Period|Lost to Follow-up|3
1440906|NCT00901901|4753910|P2|Treatment Period|Physician Decision|2
1440907|NCT00901901|4753911|P1|Treatment Period|Physician Decision|2
1440908|NCT00901901|4753910|P2|Treatment Period|Withdrawal by Subject|24
1440909|NCT00901901|4753911|P1|Treatment Period|Withdrawal by Subject|26
1440910|NCT00901901|4753910|P2|Treatment Period|Adverse Event|123
1440911|NCT00901901|4753911|P1|Treatment Period|Adverse Event|117
1440912|NCT00901628|4753933|P2|Overall Study|peroneal nerve palsy|1
1440913|NCT00901628|4753934|P1|Overall Study|peroneal nerve palsy|0
1440914|NCT00901628|4753933|P2|Overall Study|disconnection of drain|1
1440915|NCT00901628|4753934|P1|Overall Study|disconnection of drain|0
1440916|NCT00901628|4753933|P2|Overall Study|disconnection of catheter|8
1440917|NCT00901628|4753934|P1|Overall Study|disconnection of catheter|4
1440918|NCT00901576|4753956|P6|Second Intervention|Physician Decision|0
1440919|NCT00901576|4753957|P5|Second Intervention|Physician Decision|0
1440920|NCT00901576|4753958|P4|Second Intervention|Physician Decision|0
1440921|NCT00901576|4753959|P3|Second Intervention|Physician Decision|0
1440922|NCT00901576|4753960|P2|Second Intervention|Physician Decision|0
1440923|NCT00901576|4753961|P1|Second Intervention|Physician Decision|1
1440924|NCT00901576|4753956|P6|Second Intervention|Withdrawal by Subject|1
1440925|NCT00901576|4753957|P5|Second Intervention|Withdrawal by Subject|0
1440926|NCT00901576|4753958|P4|Second Intervention|Withdrawal by Subject|1
1440927|NCT00901576|4753959|P3|Second Intervention|Withdrawal by Subject|0
1440928|NCT00901576|4753960|P2|Second Intervention|Withdrawal by Subject|0
1440929|NCT00901576|4753961|P1|Second Intervention|Withdrawal by Subject|0
1440930|NCT00901459|4753982|P1|Overall Study|Withdrawal by Subject|6
1440931|NCT00901342|4753993|P1|Overall Study|Withdrawal by Subject|9
1440932|NCT00901342|4753993|P1|Overall Study|Disease progression|1
1440933|NCT00901342|4753993|P1|Overall Study|Death|4
1440934|NCT00901342|4753993|P1|Overall Study|Adverse Event|1
1440935|NCT00901186|4754026|P2|Overall Study|Protocol deviations|4
1440936|NCT00901186|4754027|P1|Overall Study|Protocol deviations|5
1440937|NCT00901186|4754026|P2|Overall Study|Administration problems|1
1440938|NCT00901186|4754027|P1|Overall Study|Administration problems|0
1440939|NCT00901186|4754026|P2|Overall Study|Adverse Event|4
1440940|NCT00901186|4754027|P1|Overall Study|Adverse Event|2
1440941|NCT00901186|4754026|P2|Overall Study|Lost to Follow-up|0
1440942|NCT00901186|4754027|P1|Overall Study|Lost to Follow-up|2
1440943|NCT00901186|4754026|P2|Overall Study|Abnormal laboratory values|1
1440944|NCT00901186|4754027|P1|Overall Study|Abnormal laboratory values|0
1440945|NCT00901186|4754026|P2|Overall Study|Lack of Efficacy|1
1440946|NCT00901186|4754027|P1|Overall Study|Lack of Efficacy|0
1440947|NCT00900796|4754067|P1|Phase 2|Lost to Follow-up|5
1440948|NCT00900796|4754067|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
1440949|NCT00900796|4754067|P1|Phase 1|Missing information at Week 16|7
1440950|NCT00900796|4754067|P1|Phase 1|Lacked sufficient information|4
1440951|NCT00900757|4754077|P1|Overall Study|screen failure|19
1440952|NCT00900731|4754087|P2|Overall Study|Death|2
1440953|NCT00900731|4754088|P1|Overall Study|Death|0
1440954|NCT00900731|4754087|P2|Overall Study|Lack of Efficacy|3
1440955|NCT00900731|4754088|P1|Overall Study|Lack of Efficacy|1
1440956|NCT00900731|4754087|P2|Overall Study|Lost to Follow-up|3
1440957|NCT00900731|4754088|P1|Overall Study|Lost to Follow-up|2
1440958|NCT00900731|4754087|P2|Overall Study|Abnormal Laboratory Value(s)|4
1440959|NCT00900731|4754088|P1|Overall Study|Abnormal Laboratory Value(s)|2
1440960|NCT00900731|4754087|P2|Overall Study|Abnormal Test Procedure Result(s)|0
1440961|NCT00900731|4754088|P1|Overall Study|Abnormal Test Procedure Result(s)|3
1440962|NCT00900731|4754087|P2|Overall Study|Administrative Problems|4
1440963|NCT00900731|4754088|P1|Overall Study|Administrative Problems|5
1440964|NCT00900731|4754087|P2|Overall Study|Protocol Deviation|11
1440965|NCT00900731|4754088|P1|Overall Study|Protocol Deviation|8
1440966|NCT00900731|4754087|P2|Overall Study|Withdrawal by Subject|7
1440967|NCT00900731|4754088|P1|Overall Study|Withdrawal by Subject|8
1440968|NCT00900731|4754087|P2|Overall Study|Adverse Event|27
1440969|NCT00900731|4754088|P1|Overall Study|Adverse Event|31
1440970|NCT00900627|4754125|P6|Overall Study|Death|24
1440971|NCT00900627|4754126|P5|Overall Study|Death|28
1440972|NCT00900627|4754127|P4|Overall Study|Death|0
1440973|NCT00900627|4754128|P3|Overall Study|Death|0
1440974|NCT00900627|4754129|P2|Overall Study|Death|0
1440975|NCT00900627|4754130|P1|Overall Study|Death|0
1440976|NCT00900627|4754125|P6|Overall Study|Adverse Event|0
1440977|NCT00900627|4754126|P5|Overall Study|Adverse Event|0
1440978|NCT00900627|4754127|P4|Overall Study|Adverse Event|3
1440979|NCT00900627|4754128|P3|Overall Study|Adverse Event|0
1440980|NCT00900627|4754129|P2|Overall Study|Adverse Event|2
1440981|NCT00900627|4754130|P1|Overall Study|Adverse Event|1
1440982|NCT00900627|4754125|P6|Overall Study|Withdrawal by Subject|2
1440983|NCT00900627|4754126|P5|Overall Study|Withdrawal by Subject|1
1440984|NCT00900627|4754127|P4|Overall Study|Withdrawal by Subject|0
1440985|NCT00900627|4754128|P3|Overall Study|Withdrawal by Subject|1
1440986|NCT00900627|4754129|P2|Overall Study|Withdrawal by Subject|0
1440987|NCT00900627|4754130|P1|Overall Study|Withdrawal by Subject|1
1440988|NCT00900627|4754125|P6|Overall Study|Condition under investigation worsened|0
1440989|NCT00900627|4754126|P5|Overall Study|Condition under investigation worsened|0
1440990|NCT00900627|4754127|P4|Overall Study|Condition under investigation worsened|3
1440991|NCT00900627|4754128|P3|Overall Study|Condition under investigation worsened|5
1440992|NCT00900627|4754129|P2|Overall Study|Condition under investigation worsened|0
1440993|NCT00900627|4754130|P1|Overall Study|Condition under investigation worsened|4
1440994|NCT00900601|4754148|P1|Overall Study|Physician Decision|1
1440995|NCT00900159|4754167|P2|Second Intervention|disempanelled for inappropriate behavior|0
1440996|NCT00900159|4754168|P1|Second Intervention|disempanelled for inappropriate behavior|1
1440997|NCT00900146|4754187|P5|Intermediate: Period III|Administrative problems|163
1440998|NCT00900146|4754188|P4|Intermediate: Period III|Administrative problems|90
1440999|NCT00900146|4754189|P3|Intermediate: Period III|Administrative problems|84
1441000|NCT00900146|4754190|P2|Intermediate: Period III|Administrative problems|92
1441001|NCT00900146|4754191|P1|Intermediate: Period III|Administrative problems|85
1441002|NCT00900146|4754187|P5|Intermediate: Period III|Lost to Follow-up|1
1441003|NCT00900146|4754188|P4|Intermediate: Period III|Lost to Follow-up|0
1441004|NCT00900146|4754189|P3|Intermediate: Period III|Lost to Follow-up|0
1441005|NCT00900146|4754190|P2|Intermediate: Period III|Lost to Follow-up|0
1441006|NCT00900146|4754191|P1|Intermediate: Period III|Lost to Follow-up|2
1441007|NCT00900146|4754187|P5|Intermediate: Period III|Withdrawal by Subject|3
1441008|NCT00900146|4754188|P4|Intermediate: Period III|Withdrawal by Subject|0
1441009|NCT00900146|4754189|P3|Intermediate: Period III|Withdrawal by Subject|0
1441010|NCT00900146|4754190|P2|Intermediate: Period III|Withdrawal by Subject|1
1441011|NCT00900146|4754191|P1|Intermediate: Period III|Withdrawal by Subject|0
1441012|NCT00900146|4754187|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
1441013|NCT00900146|4754188|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
1441014|NCT00900146|4754189|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
1441015|NCT00900146|4754190|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
1441016|NCT00900146|4754191|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
1441017|NCT00900146|4754187|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
1441018|NCT00900146|4754188|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
1441019|NCT00900146|4754189|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
1441020|NCT00900146|4754190|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
1441021|NCT00900146|4754191|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
1441022|NCT00900146|4754187|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
1441023|NCT00900146|4754188|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
1441024|NCT00900146|4754189|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
1441025|NCT00900146|4754190|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
1441026|NCT00900146|4754191|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
1441027|NCT00900029|4754308|P5|Overall Study|Death|0
1441028|NCT00900029|4754309|P4|Overall Study|Death|1
1441029|NCT00900029|4754310|P3|Overall Study|Death|0
1441030|NCT00900029|4754311|P2|Overall Study|Death|0
1441031|NCT00900029|4754312|P1|Overall Study|Death|1
1441032|NCT00900029|4754308|P5|Overall Study|Adverse Event|1
1441033|NCT00900029|4754309|P4|Overall Study|Adverse Event|1
1441034|NCT00900029|4754310|P3|Overall Study|Adverse Event|1
1441035|NCT00900029|4754311|P2|Overall Study|Adverse Event|0
1441036|NCT00900029|4754312|P1|Overall Study|Adverse Event|0
1441037|NCT00900029|4754308|P5|Overall Study|Withdrawal by Subject|1
1441038|NCT00900029|4754309|P4|Overall Study|Withdrawal by Subject|1
1441039|NCT00900029|4754310|P3|Overall Study|Withdrawal by Subject|1
1441040|NCT00900029|4754311|P2|Overall Study|Withdrawal by Subject|2
1441041|NCT00900029|4754312|P1|Overall Study|Withdrawal by Subject|2
1441042|NCT00900029|4754308|P5|Overall Study|Lost to Follow-up|4
1441043|NCT00900029|4754309|P4|Overall Study|Lost to Follow-up|4
1441044|NCT00900029|4754310|P3|Overall Study|Lost to Follow-up|1
1441045|NCT00900029|4754311|P2|Overall Study|Lost to Follow-up|2
1441046|NCT00900029|4754312|P1|Overall Study|Lost to Follow-up|0
1441047|NCT00899847|4754329|P1|Overall Study|Lack of suitable allogeneic donor|2
1441048|NCT00899678|4754360|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
1441049|NCT00899678|4754361|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
1441050|NCT00899678|4754362|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
1441051|NCT00899678|4754360|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
1441052|NCT00899678|4754361|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
1441053|NCT00899678|4754362|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
1441054|NCT00899678|4754360|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
1441055|NCT00899678|4754361|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
1441056|NCT00899678|4754362|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
1441057|NCT00899678|4754360|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
1441058|NCT00899678|4754361|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
1441059|NCT00899678|4754362|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
1441060|NCT00899678|4754360|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
1441061|NCT00899678|4754361|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
1441062|NCT00899678|4754362|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
1441063|NCT00899678|4754360|P3|Induction Period (Weeks 0 to 6)|Other reason|0
1441064|NCT00899678|4754361|P2|Induction Period (Weeks 0 to 6)|Other reason|0
1441065|NCT00899678|4754362|P1|Induction Period (Weeks 0 to 6)|Other reason|1
1441066|NCT00899678|4754360|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
1441067|NCT00899678|4754361|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
1441068|NCT00899678|4754362|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
1441069|NCT00899678|4754360|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
1441070|NCT00899678|4754361|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
1441071|NCT00899678|4754362|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
1441072|NCT00899678|4754360|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
1441073|NCT00899678|4754361|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
1441074|NCT00899678|4754362|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
1441075|NCT00899392|4754485|P2|Overall Study|Subject didn't finish/partial pilot data|24
1441076|NCT00899392|4754486|P1|Overall Study|Subject didn't finish/partial pilot data|21
1441077|NCT00899379|4754503|P5|Overall Study|Inc/Exc Criteria Not Met|0
1441078|NCT00899379|4754504|P4|Overall Study|Inc/Exc Criteria Not Met|0
1441079|NCT00899379|4754505|P3|Overall Study|Inc/Exc Criteria Not Met|1
1441080|NCT00899379|4754506|P2|Overall Study|Inc/Exc Criteria Not Met|0
1441081|NCT00899379|4754507|P1|Overall Study|Inc/Exc Criteria Not Met|0
1441082|NCT00899379|4754503|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
1441083|NCT00899379|4754504|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
1441084|NCT00899379|4754505|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
1441085|NCT00899379|4754506|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
1441086|NCT00899379|4754507|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
1441087|NCT00899379|4754503|P5|Overall Study|No Attack Pretreatment|4
1441088|NCT00899379|4754504|P4|Overall Study|No Attack Pretreatment|6
1441089|NCT00899379|4754505|P3|Overall Study|No Attack Pretreatment|5
1441090|NCT00899379|4754506|P2|Overall Study|No Attack Pretreatment|5
1441091|NCT00899379|4754507|P1|Overall Study|No Attack Pretreatment|3
1441092|NCT00899379|4754503|P5|Overall Study|Abnormal Baseline ECG|0
1441093|NCT00899379|4754504|P4|Overall Study|Abnormal Baseline ECG|1
1441094|NCT00899379|4754505|P3|Overall Study|Abnormal Baseline ECG|1
1441095|NCT00899379|4754506|P2|Overall Study|Abnormal Baseline ECG|0
1441096|NCT00899379|4754507|P1|Overall Study|Abnormal Baseline ECG|0
1441097|NCT00899379|4754503|P5|Overall Study|Abnormal Prestudy Labs|2
1441098|NCT00899379|4754504|P4|Overall Study|Abnormal Prestudy Labs|0
1441099|NCT00899379|4754505|P3|Overall Study|Abnormal Prestudy Labs|0
1441100|NCT00899379|4754506|P2|Overall Study|Abnormal Prestudy Labs|0
1441101|NCT00899379|4754507|P1|Overall Study|Abnormal Prestudy Labs|0
1441102|NCT00899379|4754503|P5|Overall Study|Patient Uncooperative|0
1441103|NCT00899379|4754504|P4|Overall Study|Patient Uncooperative|1
1441104|NCT00899379|4754505|P3|Overall Study|Patient Uncooperative|0
1441105|NCT00899379|4754506|P2|Overall Study|Patient Uncooperative|0
1441106|NCT00899379|4754507|P1|Overall Study|Patient Uncooperative|0
1441107|NCT00899379|4754503|P5|Overall Study|Pregnancy|0
1441108|NCT00899379|4754504|P4|Overall Study|Pregnancy|0
1441109|NCT00899379|4754505|P3|Overall Study|Pregnancy|0
1441110|NCT00899379|4754506|P2|Overall Study|Pregnancy|0
1441111|NCT00899379|4754507|P1|Overall Study|Pregnancy|1
1441112|NCT00899379|4754503|P5|Overall Study|Withdrawal by Subject|2
1441113|NCT00899379|4754504|P4|Overall Study|Withdrawal by Subject|7
1441114|NCT00899379|4754505|P3|Overall Study|Withdrawal by Subject|4
1441115|NCT00899379|4754506|P2|Overall Study|Withdrawal by Subject|7
1441116|NCT00899379|4754507|P1|Overall Study|Withdrawal by Subject|4
1441117|NCT00899379|4754503|P5|Overall Study|Lost to Follow-up|5
1441118|NCT00899379|4754504|P4|Overall Study|Lost to Follow-up|2
1441119|NCT00899379|4754505|P3|Overall Study|Lost to Follow-up|0
1441120|NCT00899379|4754506|P2|Overall Study|Lost to Follow-up|1
1441121|NCT00899379|4754507|P1|Overall Study|Lost to Follow-up|3
1441122|NCT00899379|4754503|P5|Overall Study|Study Terminated|1
1441123|NCT00899379|4754504|P4|Overall Study|Study Terminated|3
1441124|NCT00899379|4754505|P3|Overall Study|Study Terminated|3
1441125|NCT00899379|4754506|P2|Overall Study|Study Terminated|0
1441126|NCT00899379|4754507|P1|Overall Study|Study Terminated|3
1441127|NCT00899379|4754503|P5|Overall Study|Not Completed/Entered Extn|3
1441128|NCT00899379|4754504|P4|Overall Study|Not Completed/Entered Extn|4
1441129|NCT00899379|4754505|P3|Overall Study|Not Completed/Entered Extn|6
1441130|NCT00899379|4754506|P2|Overall Study|Not Completed/Entered Extn|1
1441131|NCT00899379|4754507|P1|Overall Study|Not Completed/Entered Extn|5
1441132|NCT00899379|4754503|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
1441133|NCT00899379|4754504|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
1441134|NCT00899379|4754505|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
1441135|NCT00899379|4754506|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
1441136|NCT00899379|4754507|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
1441137|NCT00899379|4754503|P5|Overall Study|Abnormal Baseline ECG|0
1441138|NCT00899379|4754504|P4|Overall Study|Abnormal Baseline ECG|1
1441139|NCT00899379|4754505|P3|Overall Study|Abnormal Baseline ECG|0
1441140|NCT00899379|4754506|P2|Overall Study|Abnormal Baseline ECG|0
1441141|NCT00899379|4754507|P1|Overall Study|Abnormal Baseline ECG|0
1441142|NCT00899379|4754503|P5|Overall Study|Patient Uncooperative|2
1441143|NCT00899379|4754504|P4|Overall Study|Patient Uncooperative|1
1441144|NCT00899379|4754505|P3|Overall Study|Patient Uncooperative|0
1441145|NCT00899379|4754506|P2|Overall Study|Patient Uncooperative|1
1441146|NCT00899379|4754507|P1|Overall Study|Patient Uncooperative|0
1441147|NCT00899379|4754503|P5|Overall Study|Pregnancy|1
1441148|NCT00899379|4754504|P4|Overall Study|Pregnancy|0
1441149|NCT00899379|4754505|P3|Overall Study|Pregnancy|1
1441150|NCT00899379|4754506|P2|Overall Study|Pregnancy|0
1441151|NCT00899379|4754507|P1|Overall Study|Pregnancy|0
1441152|NCT00899379|4754503|P5|Overall Study|Withdrawal by Subject|6
1441153|NCT00899379|4754504|P4|Overall Study|Withdrawal by Subject|3
1441154|NCT00899379|4754505|P3|Overall Study|Withdrawal by Subject|2
1441155|NCT00899379|4754506|P2|Overall Study|Withdrawal by Subject|4
1441156|NCT00899379|4754507|P1|Overall Study|Withdrawal by Subject|2
1441157|NCT00899379|4754503|P5|Overall Study|Protocol Violation|0
1441158|NCT00899379|4754504|P4|Overall Study|Protocol Violation|1
1441159|NCT00899379|4754505|P3|Overall Study|Protocol Violation|1
1441160|NCT00899379|4754506|P2|Overall Study|Protocol Violation|0
1441161|NCT00899379|4754507|P1|Overall Study|Protocol Violation|0
1441162|NCT00899379|4754503|P5|Overall Study|Lost to Follow-up|2
1441163|NCT00899379|4754504|P4|Overall Study|Lost to Follow-up|6
1441164|NCT00899379|4754505|P3|Overall Study|Lost to Follow-up|0
1441165|NCT00899379|4754506|P2|Overall Study|Lost to Follow-up|3
1441166|NCT00899379|4754507|P1|Overall Study|Lost to Follow-up|9
1441167|NCT00899379|4754503|P5|Overall Study|Lack of Efficacy|1
1441168|NCT00899379|4754504|P4|Overall Study|Lack of Efficacy|0
1441169|NCT00899379|4754505|P3|Overall Study|Lack of Efficacy|3
1441170|NCT00899379|4754506|P2|Overall Study|Lack of Efficacy|4
1441171|NCT00899379|4754507|P1|Overall Study|Lack of Efficacy|0
1441172|NCT00899379|4754503|P5|Overall Study|Adverse Event|2
1441173|NCT00899379|4754504|P4|Overall Study|Adverse Event|1
1441174|NCT00899379|4754505|P3|Overall Study|Adverse Event|1
1441175|NCT00899379|4754506|P2|Overall Study|Adverse Event|2
1441176|NCT00899379|4754507|P1|Overall Study|Adverse Event|2
1441177|NCT00899353|4754519|P1|Overall Study|Withdrawal by Subject|2
1441178|NCT00899353|4754519|P1|Overall Study|Lost to Follow-up|1
1441179|NCT00899353|4754519|P1|Overall Study|Adverse Event|2
1441180|NCT00898807|4754555|P2|Overall Study|Death|1
1441181|NCT00898807|4754556|P1|Overall Study|Death|0
1441182|NCT00898807|4754555|P2|Overall Study|Lost to Follow-up|3
1441183|NCT00898807|4754556|P1|Overall Study|Lost to Follow-up|1
1441184|NCT00898807|4754555|P2|Overall Study|Family pressure to discontinue|2
1441185|NCT00898807|4754556|P1|Overall Study|Family pressure to discontinue|2
1441186|NCT00898807|4754555|P2|Overall Study|Withdrawal by Subject|3
1441187|NCT00898807|4754556|P1|Overall Study|Withdrawal by Subject|5
1441188|NCT00898677|4754572|P4|Overall Study|Not Treated: Other (Not Specified)|0
1441189|NCT00898677|4754573|P3|Overall Study|Not Treated: Other (Not Specified)|2
1441190|NCT00898677|4754574|P2|Overall Study|Not Treated: Other (Not Specified)|0
1441191|NCT00898677|4754575|P1|Overall Study|Not Treated: Other (Not Specified)|0
1441192|NCT00898677|4754572|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
1441193|NCT00898677|4754573|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
1441194|NCT00898677|4754574|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
1441195|NCT00898677|4754575|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
1441196|NCT00898677|4754572|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
1441197|NCT00898677|4754573|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
1441198|NCT00898677|4754574|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
1441199|NCT00898677|4754575|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
1441200|NCT00898677|4754572|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
1441201|NCT00898677|4754573|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
1441202|NCT00898677|4754574|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
1441203|NCT00898677|4754575|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
1441204|NCT00898677|4754572|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
1441205|NCT00898677|4754573|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
1441206|NCT00898677|4754574|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
1441207|NCT00898677|4754575|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
1441208|NCT00898677|4754572|P4|Overall Study|Not Treated: Patient uncooperative|0
1441209|NCT00898677|4754573|P3|Overall Study|Not Treated: Patient uncooperative|1
1441210|NCT00898677|4754574|P2|Overall Study|Not Treated: Patient uncooperative|3
1441211|NCT00898677|4754575|P1|Overall Study|Not Treated: Patient uncooperative|2
1441212|NCT00898677|4754572|P4|Overall Study|Not Treated: Withdraw by Subject|3
1441213|NCT00898677|4754573|P3|Overall Study|Not Treated: Withdraw by Subject|11
1441214|NCT00898677|4754574|P2|Overall Study|Not Treated: Withdraw by Subject|16
1441215|NCT00898677|4754575|P1|Overall Study|Not Treated: Withdraw by Subject|2
1441216|NCT00898677|4754572|P4|Overall Study|Not Treated: Protocol Violation|0
1441217|NCT00898677|4754573|P3|Overall Study|Not Treated: Protocol Violation|2
1441218|NCT00898677|4754574|P2|Overall Study|Not Treated: Protocol Violation|0
1441219|NCT00898677|4754575|P1|Overall Study|Not Treated: Protocol Violation|2
1441220|NCT00898677|4754572|P4|Overall Study|Not Treated: Pregnancy|0
1441221|NCT00898677|4754573|P3|Overall Study|Not Treated: Pregnancy|1
1441222|NCT00898677|4754574|P2|Overall Study|Not Treated: Pregnancy|0
1441223|NCT00898677|4754575|P1|Overall Study|Not Treated: Pregnancy|0
1441224|NCT00898677|4754572|P4|Overall Study|Not Treated: Lost to Follow-Up|2
1441225|NCT00898677|4754573|P3|Overall Study|Not Treated: Lost to Follow-Up|5
1441226|NCT00898677|4754574|P2|Overall Study|Not Treated: Lost to Follow-Up|5
1441227|NCT00898677|4754575|P1|Overall Study|Not Treated: Lost to Follow-Up|0
1441228|NCT00898677|4754572|P4|Overall Study|Not Treated: Adverse Event|0
1441229|NCT00898677|4754573|P3|Overall Study|Not Treated: Adverse Event|1
1441230|NCT00898677|4754574|P2|Overall Study|Not Treated: Adverse Event|2
1441231|NCT00898677|4754575|P1|Overall Study|Not Treated: Adverse Event|0
1441232|NCT00898677|4754572|P4|Overall Study|Withdrawal by Subject|1
1441233|NCT00898677|4754573|P3|Overall Study|Withdrawal by Subject|0
1441234|NCT00898677|4754574|P2|Overall Study|Withdrawal by Subject|0
1441235|NCT00898677|4754575|P1|Overall Study|Withdrawal by Subject|0
1441236|NCT00898677|4754572|P4|Overall Study|Protocol Violation|0
1441237|NCT00898677|4754573|P3|Overall Study|Protocol Violation|2
1441238|NCT00898677|4754574|P2|Overall Study|Protocol Violation|1
1441239|NCT00898677|4754575|P1|Overall Study|Protocol Violation|1
1441240|NCT00898677|4754572|P4|Overall Study|Lost to Follow-up|0
1441241|NCT00898677|4754573|P3|Overall Study|Lost to Follow-up|2
1441242|NCT00898677|4754574|P2|Overall Study|Lost to Follow-up|0
1441243|NCT00898677|4754575|P1|Overall Study|Lost to Follow-up|0
1441244|NCT00898677|4754572|P4|Overall Study|Adverse Event|0
1441245|NCT00898677|4754573|P3|Overall Study|Adverse Event|1
1441246|NCT00898677|4754574|P2|Overall Study|Adverse Event|0
1441247|NCT00898677|4754575|P1|Overall Study|Adverse Event|0
1441248|NCT00898443|4754613|P2|Overall Study|Withdrawal by Subject|0
1441249|NCT00898443|4754614|P1|Overall Study|Withdrawal by Subject|1
1441250|NCT00897949|4754629|P3|Overall Study|Did not take study drug|4
1441251|NCT00897949|4754630|P2|Overall Study|Did not take study drug|3
1441252|NCT00897949|4754631|P1|Overall Study|Did not take study drug|9
1441253|NCT00897949|4754629|P3|Overall Study|Lack of Migraine Attack|19
1441254|NCT00897949|4754630|P2|Overall Study|Lack of Migraine Attack|30
1441255|NCT00897949|4754631|P1|Overall Study|Lack of Migraine Attack|29
1441256|NCT00897949|4754629|P3|Overall Study|Need for Concom. Med.|1
1441257|NCT00897949|4754630|P2|Overall Study|Need for Concom. Med.|1
1441258|NCT00897949|4754631|P1|Overall Study|Need for Concom. Med.|0
1441259|NCT00897949|4754629|P3|Overall Study|Abnormal Baseline ECG|4
1441260|NCT00897949|4754630|P2|Overall Study|Abnormal Baseline ECG|2
1441261|NCT00897949|4754631|P1|Overall Study|Abnormal Baseline ECG|2
1441262|NCT00897949|4754629|P3|Overall Study|Abnormal Prestudy Labs|4
1441263|NCT00897949|4754630|P2|Overall Study|Abnormal Prestudy Labs|3
1441264|NCT00897949|4754631|P1|Overall Study|Abnormal Prestudy Labs|2
1441265|NCT00897949|4754629|P3|Overall Study|Withdrawal by Subject|17
1441266|NCT00897949|4754630|P2|Overall Study|Withdrawal by Subject|31
1441267|NCT00897949|4754631|P1|Overall Study|Withdrawal by Subject|24
1441268|NCT00897949|4754629|P3|Overall Study|Lost to Follow-up|17
1441269|NCT00897949|4754630|P2|Overall Study|Lost to Follow-up|23
1441270|NCT00897949|4754631|P1|Overall Study|Lost to Follow-up|30
1441271|NCT00897949|4754629|P3|Overall Study|Patient Uncoorperative|1
1441272|NCT00897949|4754630|P2|Overall Study|Patient Uncoorperative|2
1441273|NCT00897949|4754631|P1|Overall Study|Patient Uncoorperative|0
1441274|NCT00897949|4754629|P3|Overall Study|Withdrawal by Subject|0
1441275|NCT00897949|4754630|P2|Overall Study|Withdrawal by Subject|2
1441276|NCT00897949|4754631|P1|Overall Study|Withdrawal by Subject|1
1441277|NCT00897949|4754629|P3|Overall Study|Protocol Violation|1
1441278|NCT00897949|4754630|P2|Overall Study|Protocol Violation|3
1441279|NCT00897949|4754631|P1|Overall Study|Protocol Violation|6
1441280|NCT00897949|4754629|P3|Overall Study|Lost to Follow-up|1
1441281|NCT00897949|4754630|P2|Overall Study|Lost to Follow-up|2
1441282|NCT00897949|4754631|P1|Overall Study|Lost to Follow-up|0
1441283|NCT00897949|4754629|P3|Overall Study|Adverse Event|0
1441284|NCT00897949|4754630|P2|Overall Study|Adverse Event|1
1441285|NCT00897949|4754631|P1|Overall Study|Adverse Event|1
1441286|NCT00897715|4754665|P2|Overall Study|increased risk of infection|0
1441287|NCT00897715|4754666|P1|Overall Study|increased risk of infection|1
1441288|NCT00897715|4754665|P2|Overall Study|Physician Decision|0
1441289|NCT00897715|4754666|P1|Overall Study|Physician Decision|1
1441290|NCT00897715|4754665|P2|Overall Study|Lost to Follow-up|1
1441291|NCT00897715|4754666|P1|Overall Study|Lost to Follow-up|0
1441292|NCT00897390|4754691|P1|Overall Study|Did not Return for the Clinic Visit|2
1441293|NCT00897390|4754691|P1|Overall Study|Personal Reasons|1
1441294|NCT00897390|4754691|P1|Overall Study|No Longer Met Study Criteria|1
1441295|NCT00897390|4754691|P1|Overall Study|Adverse Event|2
1441296|NCT00897104|4754781|P3|Overall Study|Withdrawal by Subject|1
1441297|NCT00897104|4754782|P2|Overall Study|Withdrawal by Subject|0
1441298|NCT00897104|4754783|P1|Overall Study|Withdrawal by Subject|0
1441299|NCT00897104|4754781|P3|Overall Study|Protocol Violation|0
1441300|NCT00897104|4754782|P2|Overall Study|Protocol Violation|0
1441301|NCT00897104|4754783|P1|Overall Study|Protocol Violation|1
1441302|NCT00897104|4754781|P3|Overall Study|Not Specified|0
1441303|NCT00897104|4754782|P2|Overall Study|Not Specified|0
1441304|NCT00897104|4754783|P1|Overall Study|Not Specified|3
1441305|NCT00897104|4754781|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
1441306|NCT00897104|4754782|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
1441307|NCT00897104|4754783|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
1441308|NCT00897104|4754781|P3|Overall Study|Lack of Migraine Attack|1
1441309|NCT00897104|4754782|P2|Overall Study|Lack of Migraine Attack|22
1441310|NCT00897104|4754783|P1|Overall Study|Lack of Migraine Attack|20
1441311|NCT00897104|4754781|P3|Overall Study|Need for Concom. Med.|1
1441312|NCT00897104|4754782|P2|Overall Study|Need for Concom. Med.|1
1441313|NCT00897104|4754783|P1|Overall Study|Need for Concom. Med.|0
1441314|NCT00897104|4754781|P3|Overall Study|Abnormal Baseline ECG|0
1441315|NCT00897104|4754782|P2|Overall Study|Abnormal Baseline ECG|2
1441316|NCT00897104|4754783|P1|Overall Study|Abnormal Baseline ECG|2
1441317|NCT00897104|4754781|P3|Overall Study|Abnormal Prestudy Labs|0
1441318|NCT00897104|4754782|P2|Overall Study|Abnormal Prestudy Labs|0
1441319|NCT00897104|4754783|P1|Overall Study|Abnormal Prestudy Labs|2
1441320|NCT00897104|4754781|P3|Overall Study|Withdrawal by Subject|3
1441321|NCT00897104|4754782|P2|Overall Study|Withdrawal by Subject|27
1441322|NCT00897104|4754783|P1|Overall Study|Withdrawal by Subject|23
1441323|NCT00897104|4754781|P3|Overall Study|Protocol Violation|0
1441324|NCT00897104|4754782|P2|Overall Study|Protocol Violation|1
1441325|NCT00897104|4754783|P1|Overall Study|Protocol Violation|0
1441326|NCT00897104|4754781|P3|Overall Study|Pregnancy|0
1441327|NCT00897104|4754782|P2|Overall Study|Pregnancy|1
1441328|NCT00897104|4754783|P1|Overall Study|Pregnancy|0
1441329|NCT00897104|4754781|P3|Overall Study|Lost to Follow-up|2
1441330|NCT00897104|4754782|P2|Overall Study|Lost to Follow-up|17
1441331|NCT00897104|4754783|P1|Overall Study|Lost to Follow-up|12
1441332|NCT00896649|4754818|P1|Overall Study|technical difficulties|2
1441333|NCT00896649|4754818|P1|Overall Study|missing documentation|1
1441334|NCT00896649|4754818|P1|Overall Study|Pregnancy|1
1441335|NCT00896649|4754818|P1|Overall Study|Physician Decision|1
1441336|NCT00896454|4754823|P1|Overall Study|Withdrawal by Subject|1
1441337|NCT00896454|4754823|P1|Overall Study|Ongoing in study|2
1441338|NCT00896454|4754823|P1|Overall Study|Requirement for alternative therapy|3
1441339|NCT00896454|4754823|P1|Overall Study|Other|4
1441340|NCT00896454|4754823|P1|Overall Study|Disease Progression|5
1441341|NCT00896454|4754823|P1|Overall Study|Adverse Event|8
1441342|NCT00896454|4754823|P1|Overall Study|Death|10
1441343|NCT00896363|4754862|P3|Overall Study|Withdrawal by Subject|5
1441344|NCT00896363|4754863|P2|Overall Study|Withdrawal by Subject|5
1441345|NCT00896363|4754864|P1|Overall Study|Withdrawal by Subject|3
1441346|NCT00896363|4754862|P3|Overall Study|Lack of Efficacy|1
1441347|NCT00896363|4754863|P2|Overall Study|Lack of Efficacy|2
1441348|NCT00896363|4754864|P1|Overall Study|Lack of Efficacy|0
1441349|NCT00896363|4754862|P3|Overall Study|Adverse Event|2
1441350|NCT00896363|4754863|P2|Overall Study|Adverse Event|4
1441351|NCT00896363|4754864|P1|Overall Study|Adverse Event|3
1441352|NCT00896337|4754916|P1|Overall Study|Lost to Follow-up|11
1441353|NCT00896337|4754916|P1|Overall Study|Withdrawal by Subject|7
1441354|NCT00896337|4754916|P1|Overall Study|Death|7
1441355|NCT00896233|4754983|P1|Overall Study|Claustrophobia during MRI|1
1441356|NCT00896168|4754996|P2|Overall Study|Other|1
1441357|NCT00896168|4754997|P1|Overall Study|Other|1
1441358|NCT00896168|4754996|P2|Overall Study|Lost to Follow-up|1
1441359|NCT00896168|4754997|P1|Overall Study|Lost to Follow-up|1
1441360|NCT00896168|4754996|P2|Overall Study|Treatment failure|10
1441361|NCT00896168|4754997|P1|Overall Study|Treatment failure|8
1441362|NCT00896168|4754996|P2|Overall Study|Adverse Event|7
1441363|NCT00896168|4754997|P1|Overall Study|Adverse Event|4
1441364|NCT00896051|4755058|P2|Overall Study|Not specified|1
1441365|NCT00896051|4755059|P1|Overall Study|Not specified|1
1441366|NCT00896051|4755058|P2|Overall Study|Subject noncompliant|3
1441367|NCT00896051|4755059|P1|Overall Study|Subject noncompliant|1
1441368|NCT00896051|4755058|P2|Overall Study|Withdrawal by Subject|2
1441369|NCT00896051|4755059|P1|Overall Study|Withdrawal by Subject|3
1441370|NCT00896051|4755058|P2|Overall Study|Lost to Follow-up|2
1441371|NCT00896051|4755059|P1|Overall Study|Lost to Follow-up|3
1441372|NCT00896051|4755058|P2|Overall Study|Adverse Event|1
1441373|NCT00896051|4755059|P1|Overall Study|Adverse Event|2
1441374|NCT00895947|4755146|P2|Overall Study|Withdrawal by Subject|0
1441375|NCT00895947|4755147|P1|Overall Study|Withdrawal by Subject|2
1441376|NCT00895947|4755146|P2|Overall Study|Protocol Violation|2
1441377|NCT00895947|4755147|P1|Overall Study|Protocol Violation|4
1441378|NCT00895947|4755146|P2|Overall Study|Lost to Follow-up|4
1441379|NCT00895947|4755147|P1|Overall Study|Lost to Follow-up|3
1441380|NCT00895947|4755146|P2|Overall Study|Adverse Event|4
1441381|NCT00895947|4755147|P1|Overall Study|Adverse Event|3
1441382|NCT00895934|4755165|P2|Overall Study|ineligible|0
1441383|NCT00895934|4755166|P1|Overall Study|ineligible|1
1441384|NCT00895934|4755165|P2|Overall Study|Death|1
1441385|NCT00895934|4755166|P1|Overall Study|Death|0
1441386|NCT00895934|4755165|P2|Overall Study|Lack of Efficacy|24
1441387|NCT00895934|4755166|P1|Overall Study|Lack of Efficacy|5
1441388|NCT00895895|4755177|P5|Period 2|unsatisfactory response-efficacy|0
1441389|NCT00895895|4755178|P4|Period 2|unsatisfactory response-efficacy|0
1441390|NCT00895895|4755179|P3|Period 2|unsatisfactory response-efficacy|0
1441391|NCT00895895|4755180|P2|Period 2|unsatisfactory response-efficacy|1
1441392|NCT00895895|4755181|P1|Period 2|unsatisfactory response-efficacy|2
1441393|NCT00895895|4755177|P5|Period 2|Withdrawal by Subject|5
1441394|NCT00895895|4755178|P4|Period 2|Withdrawal by Subject|3
1441395|NCT00895895|4755179|P3|Period 2|Withdrawal by Subject|0
1441396|NCT00895895|4755180|P2|Period 2|Withdrawal by Subject|2
1441397|NCT00895895|4755181|P1|Period 2|Withdrawal by Subject|0
1441398|NCT00895895|4755177|P5|Period 2|Protocol Violation|1
1441399|NCT00895895|4755178|P4|Period 2|Protocol Violation|1
1441400|NCT00895895|4755179|P3|Period 2|Protocol Violation|1
1441401|NCT00895895|4755180|P2|Period 2|Protocol Violation|0
1441402|NCT00895895|4755181|P1|Period 2|Protocol Violation|1
1441403|NCT00895895|4755177|P5|Period 2|Other|1
1441404|NCT00895895|4755178|P4|Period 2|Other|1
1441405|NCT00895895|4755179|P3|Period 2|Other|3
1441406|NCT00895895|4755180|P2|Period 2|Other|1
1441407|NCT00895895|4755181|P1|Period 2|Other|1
1441408|NCT00895895|4755177|P5|Period 2|Lost to Follow-up|0
1441409|NCT00895895|4755178|P4|Period 2|Lost to Follow-up|1
1441410|NCT00895895|4755179|P3|Period 2|Lost to Follow-up|1
1441411|NCT00895895|4755180|P2|Period 2|Lost to Follow-up|2
1441412|NCT00895895|4755181|P1|Period 2|Lost to Follow-up|1
1441413|NCT00895895|4755177|P5|Period 2|investigator request|0
1441414|NCT00895895|4755178|P4|Period 2|investigator request|0
1441415|NCT00895895|4755179|P3|Period 2|investigator request|0
1441416|NCT00895895|4755180|P2|Period 2|investigator request|0
1441417|NCT00895895|4755181|P1|Period 2|investigator request|2
1441418|NCT00895895|4755177|P5|Period 2|failed to return|0
1441419|NCT00895895|4755178|P4|Period 2|failed to return|0
1441420|NCT00895895|4755179|P3|Period 2|failed to return|0
1441421|NCT00895895|4755180|P2|Period 2|failed to return|0
1441422|NCT00895895|4755181|P1|Period 2|failed to return|2
1441423|NCT00895895|4755177|P5|Period 2|discontinued by sponsor|37
1441424|NCT00895895|4755178|P4|Period 2|discontinued by sponsor|46
1441425|NCT00895895|4755179|P3|Period 2|discontinued by sponsor|38
1441426|NCT00895895|4755180|P2|Period 2|discontinued by sponsor|44
1441427|NCT00895895|4755181|P1|Period 2|discontinued by sponsor|44
1441428|NCT00895895|4755177|P5|Period 2|Death|0
1441429|NCT00895895|4755178|P4|Period 2|Death|0
1441430|NCT00895895|4755179|P3|Period 2|Death|1
1441431|NCT00895895|4755180|P2|Period 2|Death|0
1441432|NCT00895895|4755181|P1|Period 2|Death|0
1441433|NCT00895895|4755177|P5|Period 2|Adverse Event|5
1441434|NCT00895895|4755178|P4|Period 2|Adverse Event|2
1441435|NCT00895895|4755179|P3|Period 2|Adverse Event|5
1441436|NCT00895895|4755180|P2|Period 2|Adverse Event|3
1441437|NCT00895895|4755181|P1|Period 2|Adverse Event|3
1441438|NCT00895895|4755177|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
1441439|NCT00895895|4755178|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
1441440|NCT00895895|4755179|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
1441441|NCT00895895|4755180|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
1441442|NCT00895895|4755181|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
1441443|NCT00895895|4755177|P5|After Period 1, Prior to Period 2|Protocol Violation|1
1441444|NCT00895895|4755178|P4|After Period 1, Prior to Period 2|Protocol Violation|0
1441445|NCT00895895|4755179|P3|After Period 1, Prior to Period 2|Protocol Violation|0
1441446|NCT00895895|4755180|P2|After Period 1, Prior to Period 2|Protocol Violation|0
1441447|NCT00895895|4755181|P1|After Period 1, Prior to Period 2|Protocol Violation|0
1441448|NCT00895895|4755177|P5|After Period 1, Prior to Period 2|Other|0
1441449|NCT00895895|4755178|P4|After Period 1, Prior to Period 2|Other|0
1441450|NCT00895895|4755179|P3|After Period 1, Prior to Period 2|Other|1
1441451|NCT00895895|4755180|P2|After Period 1, Prior to Period 2|Other|0
1441452|NCT00895895|4755181|P1|After Period 1, Prior to Period 2|Other|0
1441453|NCT00895895|4755177|P5|After Period 1, Prior to Period 2|Adverse Event|0
1441454|NCT00895895|4755178|P4|After Period 1, Prior to Period 2|Adverse Event|0
1441455|NCT00895895|4755179|P3|After Period 1, Prior to Period 2|Adverse Event|1
1441456|NCT00895895|4755180|P2|After Period 1, Prior to Period 2|Adverse Event|0
1441457|NCT00895895|4755181|P1|After Period 1, Prior to Period 2|Adverse Event|0
1441458|NCT00895895|4755177|P5|Period 1|randomized and not treated|2
1441459|NCT00895895|4755178|P4|Period 1|randomized and not treated|1
1441460|NCT00895895|4755179|P3|Period 1|randomized and not treated|1
1441461|NCT00895895|4755180|P2|Period 1|randomized and not treated|3
1441462|NCT00895895|4755181|P1|Period 1|randomized and not treated|1
1441463|NCT00895895|4755177|P5|Period 1|unsatisfactory response-efficacy|0
1441464|NCT00895895|4755178|P4|Period 1|unsatisfactory response-efficacy|0
1441465|NCT00895895|4755179|P3|Period 1|unsatisfactory response-efficacy|0
1441466|NCT00895895|4755180|P2|Period 1|unsatisfactory response-efficacy|0
1441467|NCT00895895|4755181|P1|Period 1|unsatisfactory response-efficacy|2
1441468|NCT00895895|4755177|P5|Period 1|Withdrawal by Subject|4
1441469|NCT00895895|4755178|P4|Period 1|Withdrawal by Subject|2
1441470|NCT00895895|4755179|P3|Period 1|Withdrawal by Subject|8
1441471|NCT00895895|4755180|P2|Period 1|Withdrawal by Subject|6
1441472|NCT00895895|4755181|P1|Period 1|Withdrawal by Subject|6
1441473|NCT00895895|4755177|P5|Period 1|Protocol Violation|0
1441474|NCT00895895|4755178|P4|Period 1|Protocol Violation|0
1441475|NCT00895895|4755179|P3|Period 1|Protocol Violation|0
1441476|NCT00895895|4755180|P2|Period 1|Protocol Violation|1
1441477|NCT00895895|4755181|P1|Period 1|Protocol Violation|0
1441478|NCT00895895|4755177|P5|Period 1|Other|1
1441479|NCT00895895|4755178|P4|Period 1|Other|1
1441480|NCT00895895|4755179|P3|Period 1|Other|1
1441481|NCT00895895|4755180|P2|Period 1|Other|2
1441482|NCT00895895|4755181|P1|Period 1|Other|1
1441483|NCT00895895|4755177|P5|Period 1|Lost to Follow-up|3
1441484|NCT00895895|4755178|P4|Period 1|Lost to Follow-up|2
1441485|NCT00895895|4755179|P3|Period 1|Lost to Follow-up|3
1441486|NCT00895895|4755180|P2|Period 1|Lost to Follow-up|1
1441487|NCT00895895|4755181|P1|Period 1|Lost to Follow-up|2
1441488|NCT00895895|4755177|P5|Period 1|investigator request|0
1441489|NCT00895895|4755178|P4|Period 1|investigator request|0
1441490|NCT00895895|4755179|P3|Period 1|investigator request|0
1441491|NCT00895895|4755180|P2|Period 1|investigator request|1
1441492|NCT00895895|4755181|P1|Period 1|investigator request|0
1441493|NCT00895895|4755177|P5|Period 1|failed to return|1
1441494|NCT00895895|4755178|P4|Period 1|failed to return|0
1441495|NCT00895895|4755179|P3|Period 1|failed to return|1
1441496|NCT00895895|4755180|P2|Period 1|failed to return|0
1441497|NCT00895895|4755181|P1|Period 1|failed to return|0
1441498|NCT00895895|4755177|P5|Period 1|discontinued by sponsor|1
1441499|NCT00895895|4755178|P4|Period 1|discontinued by sponsor|1
1441500|NCT00895895|4755179|P3|Period 1|discontinued by sponsor|2
1441501|NCT00895895|4755180|P2|Period 1|discontinued by sponsor|1
1441502|NCT00895895|4755181|P1|Period 1|discontinued by sponsor|2
1441503|NCT00895895|4755177|P5|Period 1|Death|1
1441504|NCT00895895|4755178|P4|Period 1|Death|0
1441505|NCT00895895|4755179|P3|Period 1|Death|0
1441506|NCT00895895|4755180|P2|Period 1|Death|0
1441507|NCT00895895|4755181|P1|Period 1|Death|0
1441508|NCT00895895|4755177|P5|Period 1|Adverse Event|7
1441509|NCT00895895|4755178|P4|Period 1|Adverse Event|6
1441510|NCT00895895|4755179|P3|Period 1|Adverse Event|4
1441511|NCT00895895|4755180|P2|Period 1|Adverse Event|6
1441512|NCT00895895|4755181|P1|Period 1|Adverse Event|7
1441513|NCT00895843|4755295|P2|Overall Study|Protocol Violation|12
1441514|NCT00895843|4755296|P1|Overall Study|Protocol Violation|12
1441515|NCT00895661|4755343|P1|Overall Study|reason unknown|2
1441516|NCT00895661|4755343|P1|Overall Study|Death|1
1441517|NCT00895622|4755353|P3|Overall Study|Protocol Violation|4
1441518|NCT00895622|4755354|P2|Overall Study|Protocol Violation|4
1441519|NCT00895622|4755355|P1|Overall Study|Protocol Violation|5
1441520|NCT00895583|4755378|P2|Overall Study|Not specified|1
1441521|NCT00895583|4755379|P1|Overall Study|Not specified|0
1441522|NCT00895583|4755378|P2|Overall Study|Lack of Efficacy|0
1441523|NCT00895583|4755379|P1|Overall Study|Lack of Efficacy|5
1441524|NCT00895583|4755378|P2|Overall Study|Withdrawal by Subject|2
1441525|NCT00895583|4755379|P1|Overall Study|Withdrawal by Subject|4
1441526|NCT00895583|4755378|P2|Overall Study|Protocol Violation|0
1441527|NCT00895583|4755379|P1|Overall Study|Protocol Violation|1
1441528|NCT00895583|4755378|P2|Overall Study|Lost to Follow-up|3
1441529|NCT00895583|4755379|P1|Overall Study|Lost to Follow-up|1
1441530|NCT00895583|4755378|P2|Overall Study|Physician Decision|1
1441531|NCT00895583|4755379|P1|Overall Study|Physician Decision|3
1441532|NCT00895583|4755378|P2|Overall Study|Death|1
1441533|NCT00895583|4755379|P1|Overall Study|Death|2
1441534|NCT00895583|4755378|P2|Overall Study|Adverse Event|4
1441535|NCT00895583|4755379|P1|Overall Study|Adverse Event|28
1441536|NCT00895453|4755469|P3|Overall Study|Lost to Follow-up|23
1441537|NCT00895453|4755470|P2|Overall Study|Lost to Follow-up|25
1441538|NCT00895453|4755471|P1|Overall Study|Lost to Follow-up|25
1441539|NCT00895310|4755479|P1|Overall Study|Withdrawal by Subject|1
1441540|NCT00895245|4755495|P1|Overall Study|Lack of Efficacy|6
1441541|NCT00895037|4755574|P3|Overall Study|Death|1
1441542|NCT00895037|4755575|P2|Overall Study|Death|2
1441543|NCT00895037|4755576|P1|Overall Study|Death|0
1441544|NCT00895011|4755607|P3|Overall Study|schedule conflict|0
1441545|NCT00895011|4755608|P2|Overall Study|schedule conflict|0
1441546|NCT00895011|4755609|P1|Overall Study|schedule conflict|1
1441547|NCT00895011|4755607|P3|Overall Study|Adverse Event|2
1441548|NCT00895011|4755608|P2|Overall Study|Adverse Event|2
1441549|NCT00895011|4755609|P1|Overall Study|Adverse Event|1
1441550|NCT00895011|4755607|P3|Overall Study|Protocol Violation|3
1441551|NCT00895011|4755608|P2|Overall Study|Protocol Violation|1
1441552|NCT00895011|4755609|P1|Overall Study|Protocol Violation|3
1441553|NCT00895011|4755607|P3|Overall Study|Lost to Follow-up|1
1441554|NCT00895011|4755608|P2|Overall Study|Lost to Follow-up|4
1441555|NCT00895011|4755609|P1|Overall Study|Lost to Follow-up|5
1441556|NCT00895011|4755607|P3|Overall Study|Withdrawal by Subject|2
1441557|NCT00895011|4755608|P2|Overall Study|Withdrawal by Subject|7
1441558|NCT00895011|4755609|P1|Overall Study|Withdrawal by Subject|14
1441559|NCT00894933|4755623|P1|Overall Study|Did not meeting incl/excl criteria|1
1441560|NCT00894933|4755623|P1|Overall Study|Cancelled Procedure|1
1441561|NCT00894933|4755623|P1|Overall Study|Lost to Follow-up|2
1441562|NCT00894803|4755641|P2|Overall Study|Lost to Follow-up|1
1441563|NCT00894803|4755642|P1|Overall Study|Lost to Follow-up|0
1441564|NCT00894803|4755641|P2|Overall Study|Death|4
1441565|NCT00894803|4755642|P1|Overall Study|Death|20
1441566|NCT00894790|4755678|P2|Overall Study|Did not meet entrance criteria|0
1441567|NCT00894790|4755679|P1|Overall Study|Did not meet entrance criteria|1
1441568|NCT00894790|4755678|P2|Overall Study|Lost to Follow-up|1
1441569|NCT00894790|4755679|P1|Overall Study|Lost to Follow-up|0
1441570|NCT00894790|4755678|P2|Overall Study|Protocol Violation|1
1441571|NCT00894790|4755679|P1|Overall Study|Protocol Violation|0
1441572|NCT00894647|4755712|P2|Overall Study|Other, not due to AE|2
1441573|NCT00894647|4755713|P1|Overall Study|Other, not due to AE|1
1441574|NCT00894647|4755712|P2|Overall Study|Non-compliance with study procedures|2
1441575|NCT00894647|4755713|P1|Overall Study|Non-compliance with study procedures|0
1441576|NCT00894647|4755712|P2|Overall Study|Lost to Follow-up|2
1441577|NCT00894647|4755713|P1|Overall Study|Lost to Follow-up|0
1441578|NCT00894647|4755712|P2|Overall Study|Withdrawal by Subject|4
1441579|NCT00894647|4755713|P1|Overall Study|Withdrawal by Subject|4
1441580|NCT00894647|4755712|P2|Overall Study|Adverse Event|4
1441581|NCT00894647|4755713|P1|Overall Study|Adverse Event|5
1441582|NCT00894556|4755726|P4|Treatment Phase|Lack of Qualifying Event|0
1441583|NCT00894556|4755727|P3|Treatment Phase|Lack of Qualifying Event|0
1441584|NCT00894556|4755728|P2|Treatment Phase|Lack of Qualifying Event|1
1441585|NCT00894556|4755729|P1|Treatment Phase|Lack of Qualifying Event|2
1441586|NCT00894556|4755726|P4|Treatment Phase|Lost to Follow-up|0
1441587|NCT00894556|4755727|P3|Treatment Phase|Lost to Follow-up|1
1441588|NCT00894556|4755728|P2|Treatment Phase|Lost to Follow-up|3
1441589|NCT00894556|4755729|P1|Treatment Phase|Lost to Follow-up|2
1441590|NCT00894556|4755726|P4|Baseline Phase|Did not meet Randomization Criteria|85
1441591|NCT00894556|4755727|P3|Baseline Phase|Did not meet Randomization Criteria|0
1441592|NCT00894556|4755728|P2|Baseline Phase|Did not meet Randomization Criteria|0
1441593|NCT00894556|4755729|P1|Baseline Phase|Did not meet Randomization Criteria|0
1441594|NCT00894543|4755740|P2|Week 4 to Week 8|No diary or lost or withdrew|2
1441595|NCT00894543|4755741|P1|Week 4 to Week 8|No diary or lost or withdrew|4
1441596|NCT00894543|4755740|P2|Baseline to Week 4|No diary or lost or withdrew|2
1441597|NCT00894543|4755741|P1|Baseline to Week 4|No diary or lost or withdrew|3
1441598|NCT00894387|4755807|P2|Overall Study|GCP non-compliance|2
1441599|NCT00894387|4755808|P1|Overall Study|GCP non-compliance|0
1441600|NCT00894387|4755807|P2|Overall Study|Mis-randomized|9
1441601|NCT00894387|4755808|P1|Overall Study|Mis-randomized|13
1441602|NCT00894387|4755807|P2|Overall Study|Other (Missing)|3
1441603|NCT00894387|4755808|P1|Overall Study|Other (Missing)|5
1441604|NCT00894387|4755807|P2|Overall Study|Patient's request|30
1441605|NCT00894387|4755808|P1|Overall Study|Patient's request|25
1441606|NCT00894387|4755807|P2|Overall Study|Protocol Deviation|0
1441607|NCT00894387|4755808|P1|Overall Study|Protocol Deviation|4
1441608|NCT00894387|4755807|P2|Overall Study|Death|76
1441609|NCT00894387|4755808|P1|Overall Study|Death|77
1441610|NCT00894387|4755807|P2|Overall Study|Administrative problems|2
1441611|NCT00894387|4755808|P1|Overall Study|Administrative problems|2
1441612|NCT00894387|4755807|P2|Overall Study|Lost to Follow-up|5
1441613|NCT00894387|4755808|P1|Overall Study|Lost to Follow-up|3
1441614|NCT00894387|4755807|P2|Overall Study|Unsatisfactory therapeutic effect|1
1441615|NCT00894387|4755808|P1|Overall Study|Unsatisfactory therapeutic effect|0
1441616|NCT00894387|4755807|P2|Overall Study|Abnormal Laboratory values|2
1441617|NCT00894387|4755808|P1|Overall Study|Abnormal Laboratory values|2
1441618|NCT00894387|4755807|P2|Overall Study|Adverse Event|45
1441619|NCT00894387|4755808|P1|Overall Study|Adverse Event|44
1441620|NCT00894361|4755828|P2|Overall Study|deaths and less than 2 yr followup|64
1441621|NCT00894361|4755829|P1|Overall Study|deaths and less than 2 yr followup|24
1441622|NCT00894322|4755838|P3|Overall Study|Withdrawal by Subject|0
1441623|NCT00894322|4755839|P2|Overall Study|Withdrawal by Subject|0
1441624|NCT00894322|4755840|P1|Overall Study|Withdrawal by Subject|1
1441625|NCT00894166|4755891|P8|Overall Study|Death|0
1441626|NCT00894166|4755892|P7|Overall Study|Death|0
1441627|NCT00894166|4755893|P6|Overall Study|Death|0
1441628|NCT00894166|4755894|P5|Overall Study|Death|0
1441629|NCT00894166|4755895|P4|Overall Study|Death|1
1441630|NCT00894166|4755896|P3|Overall Study|Death|0
1441631|NCT00894166|4755897|P2|Overall Study|Death|0
1441632|NCT00894166|4755898|P1|Overall Study|Death|0
1441633|NCT00894166|4755891|P8|Overall Study|Withdrew or Lost to Follow-Up|34
1441634|NCT00894166|4755892|P7|Overall Study|Withdrew or Lost to Follow-Up|16
1441635|NCT00894166|4755893|P6|Overall Study|Withdrew or Lost to Follow-Up|16
1441636|NCT00894166|4755894|P5|Overall Study|Withdrew or Lost to Follow-Up|24
1441637|NCT00894166|4755895|P4|Overall Study|Withdrew or Lost to Follow-Up|68
1441638|NCT00894166|4755896|P3|Overall Study|Withdrew or Lost to Follow-Up|62
1441639|NCT00894166|4755897|P2|Overall Study|Withdrew or Lost to Follow-Up|63
1441640|NCT00894166|4755898|P1|Overall Study|Withdrew or Lost to Follow-Up|61
1441641|NCT00893971|4755937|P1|Overall Study|Physician Decision|3
1441642|NCT00893789|4756055|P4|Overall Study|Lost to Follow-up|1
1441643|NCT00893789|4756056|P3|Overall Study|Lost to Follow-up|0
1441644|NCT00893789|4756057|P2|Overall Study|Lost to Follow-up|0
1441645|NCT00893789|4756058|P1|Overall Study|Lost to Follow-up|0
1441646|NCT00893789|4756055|P4|Overall Study|Protocol Violation|4
1441647|NCT00893789|4756056|P3|Overall Study|Protocol Violation|1
1441648|NCT00893789|4756057|P2|Overall Study|Protocol Violation|1
1441649|NCT00893789|4756058|P1|Overall Study|Protocol Violation|0
1441650|NCT00893789|4756055|P4|Overall Study|Adverse Event|5
1441651|NCT00893789|4756056|P3|Overall Study|Adverse Event|1
1441652|NCT00893789|4756057|P2|Overall Study|Adverse Event|2
1441653|NCT00893789|4756058|P1|Overall Study|Adverse Event|0
1441654|NCT00893789|4756055|P4|Overall Study|Taking Excluded Concomitant Medication|0
1441655|NCT00893789|4756056|P3|Overall Study|Taking Excluded Concomitant Medication|1
1441656|NCT00893789|4756057|P2|Overall Study|Taking Excluded Concomitant Medication|0
1441657|NCT00893789|4756058|P1|Overall Study|Taking Excluded Concomitant Medication|1
1441658|NCT00893789|4756055|P4|Overall Study|Noncompliance With Study Procedures|0
1441659|NCT00893789|4756056|P3|Overall Study|Noncompliance With Study Procedures|0
1441660|NCT00893789|4756057|P2|Overall Study|Noncompliance With Study Procedures|0
1441661|NCT00893789|4756058|P1|Overall Study|Noncompliance With Study Procedures|1
1441662|NCT00893789|4756055|P4|Overall Study|Noncompliance With Study Drug|2
1441663|NCT00893789|4756056|P3|Overall Study|Noncompliance With Study Drug|1
1441664|NCT00893789|4756057|P2|Overall Study|Noncompliance With Study Drug|0
1441665|NCT00893789|4756058|P1|Overall Study|Noncompliance With Study Drug|1
1441666|NCT00893789|4756055|P4|Overall Study|Withdrawal by Subject|1
1441667|NCT00893789|4756056|P3|Overall Study|Withdrawal by Subject|3
1441668|NCT00893789|4756057|P2|Overall Study|Withdrawal by Subject|1
1441669|NCT00893789|4756058|P1|Overall Study|Withdrawal by Subject|3
1441670|NCT00893763|4756142|P2|Overall Study|extubated|110
1441671|NCT00893763|4756143|P1|Overall Study|extubated|110
1441672|NCT00893737|4756151|P1|Overall Study|Lost to Follow-up|6
1441673|NCT00893737|4756151|P1|Overall Study|Withdrawal by Subject|2
1441674|NCT00893737|4756151|P1|Overall Study|Adverse Event|4
1441675|NCT00893464|4756165|P8|Overall Study|Did not complete therapy/experience PD|2
1441676|NCT00893464|4756166|P7|Overall Study|Did not complete therapy/experience PD|2
1441677|NCT00893464|4756167|P6|Overall Study|Did not complete therapy/experience PD|0
1441678|NCT00893464|4756168|P5|Overall Study|Did not complete therapy/experience PD|0
1441679|NCT00893464|4756169|P4|Overall Study|Did not complete therapy/experience PD|0
1441680|NCT00893464|4756170|P3|Overall Study|Did not complete therapy/experience PD|0
1441681|NCT00893464|4756171|P2|Overall Study|Did not complete therapy/experience PD|0
1441682|NCT00893464|4756172|P1|Overall Study|Did not complete therapy/experience PD|0
1441683|NCT00893113|4756299|P2|Overall Study|Withdrew Consent|7
1441684|NCT00893113|4756300|P1|Overall Study|Withdrew Consent|8
1441685|NCT00893113|4756299|P2|Overall Study|Early Termination|1
1441686|NCT00893113|4756300|P1|Overall Study|Early Termination|1
1441687|NCT00893113|4756299|P2|Overall Study|Lost to Follow-up|8
1441688|NCT00893113|4756300|P1|Overall Study|Lost to Follow-up|4
1441689|NCT00892957|4756330|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
1441690|NCT00892957|4756331|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
1441691|NCT00892957|4756330|P2|Between Postoperative Day 1 and Day 14|Death|2
1441692|NCT00892957|4756331|P1|Between Postoperative Day 1 and Day 14|Death|0
1441693|NCT00892775|4756419|P2|Overall Study|Lost to Follow-up|0
1441694|NCT00892775|4756420|P1|Overall Study|Lost to Follow-up|1
1441695|NCT00892775|4756419|P2|Overall Study|Withdrawal by Subject|1
1441696|NCT00892775|4756420|P1|Overall Study|Withdrawal by Subject|0
1441697|NCT00892775|4756419|P2|Overall Study|Migrated/ moved from study area|0
1441698|NCT00892775|4756420|P1|Overall Study|Migrated/ moved from study area|1
1441699|NCT00892775|4756419|P2|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
1441700|NCT00892775|4756420|P1|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
1441701|NCT00892775|4756419|P2|Overall Study|Subject difficulties with blood drawing|0
1441702|NCT00892775|4756420|P1|Overall Study|Subject difficulties with blood drawing|1
1441703|NCT00892775|4756419|P2|Overall Study|Protocol Violation|0
1441704|NCT00892775|4756420|P1|Overall Study|Protocol Violation|1
1441705|NCT00892723|4756447|P3|Overall Study|Withdrawal by Subject|1
1441706|NCT00892723|4756448|P2|Overall Study|Withdrawal by Subject|1
1441707|NCT00892723|4756449|P1|Overall Study|Withdrawal by Subject|1
1441708|NCT00892723|4756447|P3|Overall Study|Lost to Follow-up|1
1441709|NCT00892723|4756448|P2|Overall Study|Lost to Follow-up|3
1441710|NCT00892723|4756449|P1|Overall Study|Lost to Follow-up|1
1441711|NCT00892437|4756538|P2|Open-Label Extension Phase|Withdrew Consent|1
1441712|NCT00892437|4756539|P1|Open-Label Extension Phase|Withdrew Consent|3
1441713|NCT00892437|4756538|P2|Open-Label Extension Phase|Investigator's Discretion|0
1441714|NCT00892437|4756539|P1|Open-Label Extension Phase|Investigator's Discretion|1
1441715|NCT00892437|4756538|P2|Open-Label Extension Phase|Lost to Follow-up|1
1441716|NCT00892437|4756539|P1|Open-Label Extension Phase|Lost to Follow-up|3
1441717|NCT00892437|4756538|P2|Open-Label Extension Phase|Lack of Efficacy|0
1441718|NCT00892437|4756539|P1|Open-Label Extension Phase|Lack of Efficacy|1
1441719|NCT00892437|4756538|P2|Open-Label Extension Phase|Adverse Event|2
1441720|NCT00892437|4756539|P1|Open-Label Extension Phase|Adverse Event|4
1441721|NCT00892437|4756538|P2|Randomized Phase|Withdrew Consent|0
1441722|NCT00892437|4756539|P1|Randomized Phase|Withdrew Consent|1
1441723|NCT00892437|4756538|P2|Randomized Phase|Investigator’s Discretion|0
1441724|NCT00892437|4756539|P1|Randomized Phase|Investigator’s Discretion|1
1441725|NCT00892437|4756538|P2|Randomized Phase|Lost to Follow-up|3
1441726|NCT00892437|4756539|P1|Randomized Phase|Lost to Follow-up|1
1441727|NCT00892437|4756538|P2|Randomized Phase|Adverse Event|2
1441728|NCT00892437|4756539|P1|Randomized Phase|Adverse Event|2
1441729|NCT00892437|4756538|P2|Randomized Phase|Randomized but not treated|0
1441730|NCT00892437|4756539|P1|Randomized Phase|Randomized but not treated|6
1441731|NCT00892281|4756558|P2|Overall Study|Visit 4 date out of window|0
1441732|NCT00892281|4756559|P1|Overall Study|Visit 4 date out of window|1
1441733|NCT00892281|4756558|P2|Overall Study|Rash on hand|0
1441734|NCT00892281|4756559|P1|Overall Study|Rash on hand|1
1441735|NCT00892281|4756558|P2|Overall Study|Subject had history of drug abuse|0
1441736|NCT00892281|4756559|P1|Overall Study|Subject had history of drug abuse|1
1441737|NCT00892281|4756558|P2|Overall Study|Non-compliant with visits as scheduled|0
1441738|NCT00892281|4756559|P1|Overall Study|Non-compliant with visits as scheduled|1
1441739|NCT00892281|4756558|P2|Overall Study|Missed visits rescheduled out of window|0
1441740|NCT00892281|4756559|P1|Overall Study|Missed visits rescheduled out of window|1
1441741|NCT00892281|4756558|P2|Overall Study|Missed multiple visits|0
1441742|NCT00892281|4756559|P1|Overall Study|Missed multiple visits|1
1441743|NCT00892281|4756558|P2|Overall Study|No show Visit 2; prescription not filled|0
1441744|NCT00892281|4756559|P1|Overall Study|No show Visit 2; prescription not filled|1
1441745|NCT00892281|4756558|P2|Overall Study|Subject not seen by PI at final visit|0
1441746|NCT00892281|4756559|P1|Overall Study|Subject not seen by PI at final visit|1
1441747|NCT00892281|4756558|P2|Overall Study|Lack of efficacy of study product|0
1441748|NCT00892281|4756559|P1|Overall Study|Lack of efficacy of study product|2
1441749|NCT00892281|4756558|P2|Overall Study|Death in family|0
1441750|NCT00892281|4756559|P1|Overall Study|Death in family|1
1441751|NCT00892281|4756558|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
1441752|NCT00892281|4756559|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
1441753|NCT00892281|4756558|P2|Overall Study|Subject lost interest in program|1
1441754|NCT00892281|4756559|P1|Overall Study|Subject lost interest in program|0
1441755|NCT00892281|4756558|P2|Overall Study|PI complained of inadequate compensation|0
1441756|NCT00892281|4756559|P1|Overall Study|PI complained of inadequate compensation|3
1441757|NCT00892281|4756558|P2|Overall Study|Scheduled for knee replacement|1
1441758|NCT00892281|4756559|P1|Overall Study|Scheduled for knee replacement|0
1441759|NCT00892281|4756558|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
1441760|NCT00892281|4756559|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
1441761|NCT00892281|4756558|P2|Overall Study|Subject missed several visits/lost meds|0
1441762|NCT00892281|4756559|P1|Overall Study|Subject missed several visits/lost meds|1
1441763|NCT00892281|4756558|P2|Overall Study|Subject did not return for any visits|0
1441764|NCT00892281|4756559|P1|Overall Study|Subject did not return for any visits|1
1441765|NCT00892281|4756558|P2|Overall Study|Subject not good candidate for study|0
1441766|NCT00892281|4756559|P1|Overall Study|Subject not good candidate for study|1
1441767|NCT00892281|4756558|P2|Overall Study|Unable to redeem the drug voucher|0
1441768|NCT00892281|4756559|P1|Overall Study|Unable to redeem the drug voucher|1
1441769|NCT00892281|4756558|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
1441770|NCT00892281|4756559|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
1441771|NCT00892281|4756558|P2|Overall Study|Did not meet incl/excl criteria|0
1441772|NCT00892281|4756559|P1|Overall Study|Did not meet incl/excl criteria|1
1441773|NCT00892281|4756558|P2|Overall Study|Last visit not done - death in family|0
1441774|NCT00892281|4756559|P1|Overall Study|Last visit not done - death in family|1
1441775|NCT00892281|4756558|P2|Overall Study|Family emergency|0
1441776|NCT00892281|4756559|P1|Overall Study|Family emergency|1
1441777|NCT00892281|4756558|P2|Overall Study|Subject completed day after study closed|0
1441778|NCT00892281|4756559|P1|Overall Study|Subject completed day after study closed|1
1441779|NCT00892281|4756558|P2|Overall Study|Final visit completed 4 weeks late|1
1441780|NCT00892281|4756559|P1|Overall Study|Final visit completed 4 weeks late|0
1441781|NCT00892281|4756558|P2|Overall Study|Subject unable to keep follow-up visits|0
1441782|NCT00892281|4756559|P1|Overall Study|Subject unable to keep follow-up visits|1
1441783|NCT00892281|4756558|P2|Overall Study|Subject failed to return for final visit|0
1441784|NCT00892281|4756559|P1|Overall Study|Subject failed to return for final visit|2
1441785|NCT00892281|4756558|P2|Overall Study|Withdrawal by Subject|14
1441786|NCT00892281|4756559|P1|Overall Study|Withdrawal by Subject|86
1441787|NCT00892281|4756558|P2|Overall Study|Protocol Violation|2
1441788|NCT00892281|4756559|P1|Overall Study|Protocol Violation|7
1441789|NCT00892281|4756558|P2|Overall Study|Pregnancy|0
1441790|NCT00892281|4756559|P1|Overall Study|Pregnancy|1
1441791|NCT00892281|4756558|P2|Overall Study|Lost to Follow-up|8
1441792|NCT00892281|4756559|P1|Overall Study|Lost to Follow-up|81
1441793|NCT00892281|4756558|P2|Overall Study|Adverse Event|8
1441794|NCT00892281|4756559|P1|Overall Study|Adverse Event|65
1441795|NCT00892177|4756572|P6|Phase II|Withdrawal by Subject|1
1441796|NCT00892177|4756573|P5|Phase II|Withdrawal by Subject|4
1441797|NCT00892177|4756574|P4|Phase II|Withdrawal by Subject|0
1441798|NCT00892177|4756575|P3|Phase II|Withdrawal by Subject|0
1441799|NCT00892177|4756576|P2|Phase II|Withdrawal by Subject|0
1441800|NCT00892177|4756577|P1|Phase II|Withdrawal by Subject|0
1441801|NCT00892177|4756572|P6|Phase II|Ineligible|1
1441802|NCT00892177|4756573|P5|Phase II|Ineligible|1
1441803|NCT00892177|4756574|P4|Phase II|Ineligible|0
1441804|NCT00892177|4756575|P3|Phase II|Ineligible|0
1441805|NCT00892177|4756576|P2|Phase II|Ineligible|0
1441806|NCT00892177|4756577|P1|Phase II|Ineligible|0
1441807|NCT00892151|4756602|P1|Overall Study|Protocol Violation|1
1441808|NCT00892099|4756611|P3|Overall Study|Lost to Follow-up|1
1441809|NCT00892099|4756612|P2|Overall Study|Lost to Follow-up|0
1441810|NCT00892099|4756613|P1|Overall Study|Lost to Follow-up|0
1441811|NCT00892099|4756611|P3|Overall Study|investigator decision|1
1441812|NCT00892099|4756612|P2|Overall Study|investigator decision|0
1441813|NCT00892099|4756613|P1|Overall Study|investigator decision|0
1441814|NCT00892099|4756611|P3|Overall Study|kidney function recovered|0
1441815|NCT00892099|4756612|P2|Overall Study|kidney function recovered|1
1441816|NCT00892099|4756613|P1|Overall Study|kidney function recovered|0
1441817|NCT00892099|4756611|P3|Overall Study|no further details|1
1441818|NCT00892099|4756612|P2|Overall Study|no further details|0
1441819|NCT00892099|4756613|P1|Overall Study|no further details|1
1441820|NCT00892099|4756611|P3|Overall Study|Prolonged hospitalization|1
1441821|NCT00892099|4756612|P2|Overall Study|Prolonged hospitalization|0
1441822|NCT00892099|4756613|P1|Overall Study|Prolonged hospitalization|1
1441823|NCT00892099|4756611|P3|Overall Study|replocated|2
1441824|NCT00892099|4756612|P2|Overall Study|replocated|0
1441825|NCT00892099|4756613|P1|Overall Study|replocated|1
1441826|NCT00892099|4756611|P3|Overall Study|Adverse Event|0
1441827|NCT00892099|4756612|P2|Overall Study|Adverse Event|0
1441828|NCT00892099|4756613|P1|Overall Study|Adverse Event|1
1441829|NCT00892099|4756611|P3|Overall Study|Death|1
1441830|NCT00892099|4756612|P2|Overall Study|Death|0
1441831|NCT00892099|4756613|P1|Overall Study|Death|1
1441832|NCT00892047|4756638|P2|Overall Study|Lack of Efficacy|2
1441833|NCT00892047|4756639|P1|Overall Study|Lack of Efficacy|0
1441834|NCT00892047|4756638|P2|Overall Study|subject burden|3
1441835|NCT00892047|4756639|P1|Overall Study|subject burden|2
1441836|NCT00892047|4756638|P2|Overall Study|Adverse Event|2
1441837|NCT00892047|4756639|P1|Overall Study|Adverse Event|2
1441838|NCT00892008|4756655|P1|Overall Study|Adverse Event|37
1441839|NCT00892008|4756655|P1|Overall Study|Other|378
1441840|NCT00892008|4756655|P1|Overall Study|Lost to Follow-up|142
1441841|NCT00892008|4756655|P1|Overall Study|Lack of Efficacy|3
1441842|NCT00892008|4756655|P1|Overall Study|Death|5
1441843|NCT00891930|4756741|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
1441844|NCT00891930|4756741|P1|Part 2: Panitumumab + Ganitumab|Death|30
1441845|NCT00891930|4756741|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
1441846|NCT00891930|4756741|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
1441847|NCT00891930|4756741|P1|Part 1: Panitumumab +Irinotecan|Death|38
1441848|NCT00891904|4756762|P1|Overall Study|Adverse Event|1
1441849|NCT00891904|4756762|P1|Overall Study|Death|1
1441850|NCT00891839|4756788|P1|Overall Study|Disease progression|3
1441851|NCT00891839|4756788|P1|Overall Study|Withdrawal by Subject|2
1441852|NCT00891839|4756788|P1|Overall Study|Adverse Event|2
1441853|NCT00891813|4756797|P1|Overall Study|Protocol Violation|2
1441854|NCT00891813|4756797|P1|Overall Study|Patient Noncompliance|6
1441855|NCT00891813|4756797|P1|Overall Study|Withdrawal by Subject|1
1441856|NCT00891813|4756797|P1|Overall Study|Adverse Event|3
1441857|NCT00891774|4756803|P1|Overall Study|Protocol Violation|4
1441858|NCT00891774|4756803|P1|Overall Study|Withdrawal by Subject|2
1441859|NCT00891774|4756803|P1|Overall Study|Illness (Self/Mother)|3
1441860|NCT00891774|4756803|P1|Overall Study|Lost to Follow-up|5
1441861|NCT00891735|4756811|P4|Overall Study|Patient's decision to withdraw|8
1441862|NCT00891735|4756812|P3|Overall Study|Patient's decision to withdraw|4
1441863|NCT00891735|4756813|P2|Overall Study|Patient's decision to withdraw|9
1441864|NCT00891735|4756814|P1|Overall Study|Patient's decision to withdraw|4
1441865|NCT00891735|4756811|P4|Overall Study|Physician's decision to withdraw patient|0
1441866|NCT00891735|4756812|P3|Overall Study|Physician's decision to withdraw patient|0
1441867|NCT00891735|4756813|P2|Overall Study|Physician's decision to withdraw patient|0
1441868|NCT00891735|4756814|P1|Overall Study|Physician's decision to withdraw patient|1
1441869|NCT00891735|4756811|P4|Overall Study|Lost to Follow-up|2
1441870|NCT00891735|4756812|P3|Overall Study|Lost to Follow-up|2
1441871|NCT00891735|4756813|P2|Overall Study|Lost to Follow-up|2
1441872|NCT00891735|4756814|P1|Overall Study|Lost to Follow-up|2
1441873|NCT00891735|4756811|P4|Overall Study|Death|5
1441874|NCT00891735|4756812|P3|Overall Study|Death|4
1441875|NCT00891735|4756813|P2|Overall Study|Death|5
1441876|NCT00891735|4756814|P1|Overall Study|Death|8
1441877|NCT00891735|4756811|P4|Overall Study|Adverse Event|0
1441878|NCT00891735|4756812|P3|Overall Study|Adverse Event|2
1441879|NCT00891735|4756813|P2|Overall Study|Adverse Event|0
1441880|NCT00891735|4756814|P1|Overall Study|Adverse Event|2
1441881|NCT00891657|4756854|P2|Overall Study|Withdrawal by Subject|1
1441882|NCT00891657|4756855|P1|Overall Study|Withdrawal by Subject|1
1441883|NCT00891618|4756867|P1|Overall Study|Withdrawal by Subject|1
1441884|NCT00891527|4756871|P1|Overall Study|Withdrawal by Subject|2
1441885|NCT00891462|4756880|P3|Overall Study|Lost to Follow-up|0
1441886|NCT00891462|4756881|P2|Overall Study|Lost to Follow-up|2
1441887|NCT00891462|4756882|P1|Overall Study|Lost to Follow-up|0
1441888|NCT00891462|4756880|P3|Overall Study|Inclusion/exclusion criteria|2
1441889|NCT00891462|4756881|P2|Overall Study|Inclusion/exclusion criteria|2
1441890|NCT00891462|4756882|P1|Overall Study|Inclusion/exclusion criteria|0
1441891|NCT00891462|4756880|P3|Overall Study|Protocol Violation|3
1441892|NCT00891462|4756881|P2|Overall Study|Protocol Violation|1
1441893|NCT00891462|4756882|P1|Overall Study|Protocol Violation|2
1441894|NCT00891462|4756880|P3|Overall Study|Other Reason|3
1441895|NCT00891462|4756881|P2|Overall Study|Other Reason|5
1441896|NCT00891462|4756882|P1|Overall Study|Other Reason|2
1441897|NCT00891462|4756880|P3|Overall Study|COPD exacerbation|1
1441898|NCT00891462|4756881|P2|Overall Study|COPD exacerbation|4
1441899|NCT00891462|4756882|P1|Overall Study|COPD exacerbation|7
1441900|NCT00891462|4756880|P3|Overall Study|Lack of Efficacy|1
1441901|NCT00891462|4756881|P2|Overall Study|Lack of Efficacy|5
1441902|NCT00891462|4756882|P1|Overall Study|Lack of Efficacy|10
1441903|NCT00891462|4756880|P3|Overall Study|Adverse Event|7
1441904|NCT00891462|4756881|P2|Overall Study|Adverse Event|8
1441905|NCT00891462|4756882|P1|Overall Study|Adverse Event|7
1441906|NCT00891462|4756880|P3|Overall Study|Withdrawal by Subject|7
1441907|NCT00891462|4756881|P2|Overall Study|Withdrawal by Subject|6
1441908|NCT00891462|4756882|P1|Overall Study|Withdrawal by Subject|9
1441909|NCT00891371|4756904|P1|Treatment|Lost to Follow-up|1
1441910|NCT00891371|4756904|P1|Treatment|Death|1
1441911|NCT00891371|4756904|P1|Treatment|Adverse Event|2
1441912|NCT00891371|4756904|P1|Treatment|Lack of Efficacy|5
1441913|NCT00891371|4756904|P1|Pre-assignment|Consent withdrawal|1
1441914|NCT00891371|4756904|P1|Pre-assignment|Inclusion/exclusion|5
1441915|NCT00891293|4756926|P1|Overall Study|Sponsor termination|62
1441916|NCT00891293|4756926|P1|Overall Study|Subject withdrew consent|7
1441917|NCT00891293|4756926|P1|Overall Study|Lost to Follow-up|7
1441918|NCT00891293|4756926|P1|Overall Study|Laboratory abnormality|4
1441919|NCT00891293|4756926|P1|Overall Study|Protocol Violation|2
1441920|NCT00891293|4756926|P1|Overall Study|Adverse Event|2
1441921|NCT00891228|4756941|P3|Overall Study|Pregnancy|0
1441922|NCT00891228|4756942|P2|Overall Study|Pregnancy|1
1441923|NCT00891228|4756943|P1|Overall Study|Pregnancy|0
1441924|NCT00891228|4756941|P3|Overall Study|Lost to Follow-up|5
1441925|NCT00891228|4756942|P2|Overall Study|Lost to Follow-up|4
1441926|NCT00891228|4756943|P1|Overall Study|Lost to Follow-up|4
1441927|NCT00891228|4756941|P3|Overall Study|Physician Decision|0
1441928|NCT00891228|4756942|P2|Overall Study|Physician Decision|1
1441929|NCT00891228|4756943|P1|Overall Study|Physician Decision|2
1441930|NCT00891228|4756941|P3|Overall Study|Protocol Violation|2
1441931|NCT00891228|4756942|P2|Overall Study|Protocol Violation|1
1441932|NCT00891228|4756943|P1|Overall Study|Protocol Violation|3
1441933|NCT00891228|4756941|P3|Overall Study|Withdrawal by Subject|5
1441934|NCT00891228|4756942|P2|Overall Study|Withdrawal by Subject|4
1441935|NCT00891228|4756943|P1|Overall Study|Withdrawal by Subject|2
1441936|NCT00891228|4756941|P3|Overall Study|Adverse Event|3
1441937|NCT00891228|4756942|P2|Overall Study|Adverse Event|2
1441938|NCT00891228|4756943|P1|Overall Study|Adverse Event|0
1441939|NCT00891202|4756965|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
1441940|NCT00891202|4756966|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
1441941|NCT00891202|4756967|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
1441942|NCT00891202|4756968|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
1441943|NCT00891202|4756965|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
1441944|NCT00891202|4756966|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
1441945|NCT00891202|4756967|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
1441946|NCT00891202|4756968|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
1441947|NCT00891202|4756965|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
1441948|NCT00891202|4756966|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
1441949|NCT00891202|4756967|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
1441950|NCT00891202|4756968|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
1441951|NCT00891202|4756965|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
1441952|NCT00891202|4756966|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
1441953|NCT00891202|4756967|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
1441954|NCT00891202|4756968|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
1441955|NCT00891046|4757144|P5|Overall Study|Lost to Follow-up|1
1441956|NCT00891046|4757145|P4|Overall Study|Lost to Follow-up|0
1441957|NCT00891046|4757146|P3|Overall Study|Lost to Follow-up|0
1441958|NCT00891046|4757147|P2|Overall Study|Lost to Follow-up|0
1441959|NCT00891046|4757148|P1|Overall Study|Lost to Follow-up|0
1441960|NCT00891046|4757144|P5|Overall Study|Withdrawal by Subject|1
1441961|NCT00891046|4757145|P4|Overall Study|Withdrawal by Subject|1
1441962|NCT00891046|4757146|P3|Overall Study|Withdrawal by Subject|2
1441963|NCT00891046|4757147|P2|Overall Study|Withdrawal by Subject|1
1441964|NCT00891046|4757148|P1|Overall Study|Withdrawal by Subject|2
1441965|NCT00891046|4757144|P5|Overall Study|Adverse Event|14
1441966|NCT00891046|4757145|P4|Overall Study|Adverse Event|0
1441967|NCT00891046|4757146|P3|Overall Study|Adverse Event|2
1441968|NCT00891046|4757147|P2|Overall Study|Adverse Event|3
1441969|NCT00891046|4757148|P1|Overall Study|Adverse Event|4
1441970|NCT00891046|4757144|P5|Overall Study|Participant no longer required drug|1
1441971|NCT00891046|4757145|P4|Overall Study|Participant no longer required drug|0
1441972|NCT00891046|4757146|P3|Overall Study|Participant no longer required drug|0
1441973|NCT00891046|4757147|P2|Overall Study|Participant no longer required drug|2
1441974|NCT00891046|4757148|P1|Overall Study|Participant no longer required drug|0
1441975|NCT00891046|4757144|P5|Overall Study|Administrative problems|1
1441976|NCT00891046|4757145|P4|Overall Study|Administrative problems|0
1441977|NCT00891046|4757146|P3|Overall Study|Administrative problems|0
1441978|NCT00891046|4757147|P2|Overall Study|Administrative problems|0
1441979|NCT00891046|4757148|P1|Overall Study|Administrative problems|0
1441980|NCT00891046|4757144|P5|Overall Study|Unsatisfactory therapeutic effect|20
1441981|NCT00891046|4757145|P4|Overall Study|Unsatisfactory therapeutic effect|2
1441982|NCT00891046|4757146|P3|Overall Study|Unsatisfactory therapeutic effect|19
1441983|NCT00891046|4757147|P2|Overall Study|Unsatisfactory therapeutic effect|2
1441984|NCT00891046|4757148|P1|Overall Study|Unsatisfactory therapeutic effect|5
1441985|NCT00891046|4757144|P5|Overall Study|Protocol Violation|1
1441986|NCT00891046|4757145|P4|Overall Study|Protocol Violation|0
1441987|NCT00891046|4757146|P3|Overall Study|Protocol Violation|0
1441988|NCT00891046|4757147|P2|Overall Study|Protocol Violation|1
1441989|NCT00891046|4757148|P1|Overall Study|Protocol Violation|1
1441990|NCT00891020|4757224|P3|Long-term Extension Period|Administrative|2
1441991|NCT00891020|4757225|P2|Long-term Extension Period|Administrative|2
1441992|NCT00891020|4757226|P1|Long-term Extension Period|Administrative|1
1441993|NCT00891020|4757224|P3|Long-term Extension Period|Failure to return|3
1441994|NCT00891020|4757225|P2|Long-term Extension Period|Failure to return|2
1441995|NCT00891020|4757226|P1|Long-term Extension Period|Failure to return|0
1441996|NCT00891020|4757224|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
1441997|NCT00891020|4757225|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
1441998|NCT00891020|4757226|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
1441999|NCT00891020|4757224|P3|Long-term Extension Period|Protocol Violation|1
1442000|NCT00891020|4757225|P2|Long-term Extension Period|Protocol Violation|1
1442001|NCT00891020|4757226|P1|Long-term Extension Period|Protocol Violation|0
1442002|NCT00891020|4757224|P3|Long-term Extension Period|Insufficient therapeutic response|2
1442003|NCT00891020|4757225|P2|Long-term Extension Period|Insufficient therapeutic response|2
1442004|NCT00891020|4757226|P1|Long-term Extension Period|Insufficient therapeutic response|3
1442005|NCT00891020|4757224|P3|Long-term Extension Period|Death|1
1442006|NCT00891020|4757225|P2|Long-term Extension Period|Death|0
1442007|NCT00891020|4757226|P1|Long-term Extension Period|Death|0
1442008|NCT00891020|4757224|P3|Long-term Extension Period|Adverse Event|10
1442009|NCT00891020|4757225|P2|Long-term Extension Period|Adverse Event|11
1442010|NCT00891020|4757226|P1|Long-term Extension Period|Adverse Event|1
1442011|NCT00891020|4757224|P3|24 Week Treatment Period|Administrative/Other|1
1442012|NCT00891020|4757225|P2|24 Week Treatment Period|Administrative/Other|6
1442013|NCT00891020|4757226|P1|24 Week Treatment Period|Administrative/Other|5
1442014|NCT00891020|4757224|P3|24 Week Treatment Period|Withdrew consent|15
1442015|NCT00891020|4757225|P2|24 Week Treatment Period|Withdrew consent|3
1442016|NCT00891020|4757226|P1|24 Week Treatment Period|Withdrew consent|6
1442017|NCT00891020|4757224|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
1442018|NCT00891020|4757225|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
1442019|NCT00891020|4757226|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
1442020|NCT00891020|4757224|P3|24 Week Treatment Period|Other protocol violation|2
1442021|NCT00891020|4757225|P2|24 Week Treatment Period|Other protocol violation|1
1442022|NCT00891020|4757226|P1|24 Week Treatment Period|Other protocol violation|1
1442023|NCT00891020|4757224|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
1442024|NCT00891020|4757225|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
1442025|NCT00891020|4757226|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
1442026|NCT00891020|4757224|P3|24 Week Treatment Period|Failure to return|5
1442027|NCT00891020|4757225|P2|24 Week Treatment Period|Failure to return|5
1442028|NCT00891020|4757226|P1|24 Week Treatment Period|Failure to return|4
1442029|NCT00891020|4757224|P3|24 Week Treatment Period|Insufficient therapeutic response|15
1442030|NCT00891020|4757225|P2|24 Week Treatment Period|Insufficient therapeutic response|9
1442031|NCT00891020|4757226|P1|24 Week Treatment Period|Insufficient therapeutic response|6
1442032|NCT00891020|4757224|P3|24 Week Treatment Period|Death|0
1442033|NCT00891020|4757225|P2|24 Week Treatment Period|Death|2
1442034|NCT00891020|4757226|P1|24 Week Treatment Period|Death|0
1442035|NCT00891020|4757224|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
1442036|NCT00891020|4757225|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
1442037|NCT00891020|4757226|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
1442038|NCT00890929|4757290|P1|Overall Study|Physician Decision|1
1442039|NCT00890929|4757290|P1|Overall Study|Withdrawal by Subject|3
1442040|NCT00890929|4757290|P1|Overall Study|Death before treatment|2
1442041|NCT00890825|4757308|P2|Overall Study|Alive at data cut off (DCO)|14
1442042|NCT00890825|4757309|P1|Overall Study|Alive at data cut off (DCO)|13
1442043|NCT00890825|4757308|P2|Overall Study|Withdrawal by Subject|0
1442044|NCT00890825|4757309|P1|Overall Study|Withdrawal by Subject|1
1442045|NCT00890695|4757338|P2|Overall Study|Protocol Violation|0
1442046|NCT00890695|4757339|P1|Overall Study|Protocol Violation|1
1442047|NCT00890591|4757368|P1|Overall Study|Lack of Efficacy|20
1442048|NCT00890552|4757374|P1|On-treatment|Early prog disease/ death|10
1442049|NCT00890552|4757374|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
1442050|NCT00890409|4757383|P2|Overall Study|Lost to Follow-up|21
1442051|NCT00890409|4757384|P1|Overall Study|Lost to Follow-up|20
1442052|NCT00890201|4757394|P2|Overall Study|Protocol Violation|56
1442053|NCT00890201|4757395|P1|Overall Study|Protocol Violation|5
1442054|NCT00890097|4757404|P3|Overall Study|Protocol Deviation|1
1442055|NCT00890097|4757405|P2|Overall Study|Protocol Deviation|1
1442056|NCT00890097|4757406|P1|Overall Study|Protocol Deviation|1
1442057|NCT00890097|4757404|P3|Overall Study|Subject Moved|0
1442058|NCT00890097|4757405|P2|Overall Study|Subject Moved|4
1442059|NCT00890097|4757406|P1|Overall Study|Subject Moved|0
1442060|NCT00890097|4757404|P3|Overall Study|Transportation|0
1442061|NCT00890097|4757405|P2|Overall Study|Transportation|2
1442062|NCT00890097|4757406|P1|Overall Study|Transportation|0
1442063|NCT00890097|4757404|P3|Overall Study|Failed inclusion criteria|0
1442064|NCT00890097|4757405|P2|Overall Study|Failed inclusion criteria|4
1442065|NCT00890097|4757406|P1|Overall Study|Failed inclusion criteria|3
1442066|NCT00890097|4757404|P3|Overall Study|Randomization Error|0
1442067|NCT00890097|4757405|P2|Overall Study|Randomization Error|0
1442068|NCT00890097|4757406|P1|Overall Study|Randomization Error|2
1442069|NCT00890097|4757404|P3|Overall Study|Subject Decision|6
1442070|NCT00890097|4757405|P2|Overall Study|Subject Decision|2
1442071|NCT00890097|4757406|P1|Overall Study|Subject Decision|3
1442072|NCT00890097|4757404|P3|Overall Study|Did not attend final visit|0
1442073|NCT00890097|4757405|P2|Overall Study|Did not attend final visit|3
1442074|NCT00890097|4757406|P1|Overall Study|Did not attend final visit|2
1442075|NCT00890097|4757404|P3|Overall Study|Sponsor Decision|7
1442076|NCT00890097|4757405|P2|Overall Study|Sponsor Decision|11
1442077|NCT00890097|4757406|P1|Overall Study|Sponsor Decision|7
1442078|NCT00890097|4757404|P3|Overall Study|Noncompliance|4
1442079|NCT00890097|4757405|P2|Overall Study|Noncompliance|4
1442080|NCT00890097|4757406|P1|Overall Study|Noncompliance|0
1442081|NCT00890097|4757404|P3|Overall Study|Lost to Follow-up|5
1442082|NCT00890097|4757405|P2|Overall Study|Lost to Follow-up|5
1442083|NCT00890097|4757406|P1|Overall Study|Lost to Follow-up|5
1442084|NCT00890097|4757404|P3|Overall Study|Withdrew Consent|9
1442085|NCT00890097|4757405|P2|Overall Study|Withdrew Consent|6
1442086|NCT00890097|4757406|P1|Overall Study|Withdrew Consent|9
1442087|NCT00890097|4757404|P3|Overall Study|Decision Unrelated to an Adverse Event|17
1442088|NCT00890097|4757405|P2|Overall Study|Decision Unrelated to an Adverse Event|12
1442089|NCT00890097|4757406|P1|Overall Study|Decision Unrelated to an Adverse Event|15
1442090|NCT00890097|4757404|P3|Overall Study|Adverse Event|28
1442091|NCT00890097|4757405|P2|Overall Study|Adverse Event|32
1442092|NCT00890097|4757406|P1|Overall Study|Adverse Event|21
1442093|NCT00890084|4757414|P1|Overall Study|Lost to Follow-up|126
1442094|NCT00890084|4757414|P1|Overall Study|Adverse Event|16
1442095|NCT00889863|4757454|P2|Part II: Randomized Double Blind|Protocol deviation|1
1442096|NCT00889863|4757455|P1|Part II: Randomized Double Blind|Protocol deviation|0
1442097|NCT00889863|4757454|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
1442098|NCT00889863|4757455|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
1442099|NCT00889863|4757454|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
1442100|NCT00889863|4757455|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
1442101|NCT00889863|4757454|P2|Part II: Randomized Double Blind|Adverse Event|4
1442102|NCT00889863|4757455|P1|Part II: Randomized Double Blind|Adverse Event|0
1442103|NCT00889863|4757454|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
1442104|NCT00889863|4757455|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
1442105|NCT00889863|4757454|P2|Part I: Open Label|Adverse Event|0
1442106|NCT00889863|4757455|P1|Part I: Open Label|Adverse Event|4
1442107|NCT00889863|4757454|P2|Part I: Open Label|Death|0
1442108|NCT00889863|4757455|P1|Part I: Open Label|Death|1
1442109|NCT00889720|4757481|P1|Overall Study|Other|4
1442110|NCT00889720|4757481|P1|Overall Study|Withdrawal by Subject|4
1442111|NCT00889707|4757508|P2|Overall Study|Lack of Efficacy|5
1442112|NCT00889707|4757509|P1|Overall Study|Lack of Efficacy|2
1442113|NCT00889707|4757508|P2|Overall Study|Lost to Follow-up|2
1442114|NCT00889707|4757509|P1|Overall Study|Lost to Follow-up|0
1442115|NCT00889707|4757508|P2|Overall Study|Withdrawal by Subject|3
1442116|NCT00889707|4757509|P1|Overall Study|Withdrawal by Subject|4
1442117|NCT00889707|4757508|P2|Overall Study|Adverse Event|0
1442118|NCT00889707|4757509|P1|Overall Study|Adverse Event|1
1442119|NCT00889681|4757517|P1|Overall Study|Insurance disapproval|1
1442120|NCT00889681|4757517|P1|Overall Study|Not meeting qualification Criteria|2
1442121|NCT00889603|4757524|P1|Overall Study|Not Specified|4
1442122|NCT00889603|4757524|P1|Overall Study|No longer willing to participant in stud|4
1442123|NCT00889603|4757524|P1|Overall Study|Lost to Follow-up|19
1442124|NCT00889603|4757524|P1|Overall Study|Death|3
1442125|NCT00889603|4757524|P1|Overall Study|Adverse Event|7
1442126|NCT00889421|4757546|P1|Overall Study|Lack of Efficacy|3
1442127|NCT00889265|4757587|P1|Overall Study|Protocol Violation|1
1442128|NCT00889265|4757587|P1|Overall Study|Lost to Follow-up|5
1442129|NCT00889265|4757587|P1|Overall Study|Adverse Event|1
1442130|NCT00889252|4757594|P2|Overall Study|Protocol Violation|0
1442131|NCT00889252|4757595|P1|Overall Study|Protocol Violation|2
1442132|NCT00889252|4757594|P2|Overall Study|Withdrawal by Subject|0
1442133|NCT00889252|4757595|P1|Overall Study|Withdrawal by Subject|3
1442134|NCT00889252|4757594|P2|Overall Study|Adverse Event|4
1442135|NCT00889252|4757595|P1|Overall Study|Adverse Event|2
1442136|NCT00888940|4757667|P2|Overall Study|Randomized Not Treated|13
1442137|NCT00888940|4757668|P1|Overall Study|Randomized Not Treated|11
1442138|NCT00888940|4757667|P2|Overall Study|Lost to Follow-up|5
1442139|NCT00888940|4757668|P1|Overall Study|Lost to Follow-up|5
1442140|NCT00888940|4757667|P2|Overall Study|Adverse Event|3
1442141|NCT00888940|4757668|P1|Overall Study|Adverse Event|12
1442142|NCT00888849|4757678|P2|Overall Study|Lost to Follow-up|2
1442143|NCT00888849|4757679|P1|Overall Study|Lost to Follow-up|1
1442144|NCT00888849|4757678|P2|Overall Study|Death|7
1442145|NCT00888849|4757679|P1|Overall Study|Death|4
1442146|NCT00888654|4757689|P1|Overall Study|Stopped meds due to headaches|1
1442147|NCT00888654|4757689|P1|Overall Study|Change in surg date|1
1442148|NCT00888654|4757689|P1|Overall Study|Inelig. due to contraindication of med|1
1442149|NCT00888654|4757689|P1|Overall Study|Withdrawal by Subject|1
1442150|NCT00888654|4757689|P1|Overall Study|Surgery aborted|2
1442151|NCT00888654|4757689|P1|Overall Study|Not enough oral meds before surgery|3
1442152|NCT00888654|4757689|P1|Overall Study|Problems swallowing oral meds.|1
1442153|NCT00888433|4757718|P2|Overall Study|Missed Visit|1
1442154|NCT00888433|4757719|P1|Overall Study|Missed Visit|2
1442155|NCT00888433|4757718|P2|Overall Study|Withdrawal by Subject|2
1442156|NCT00888433|4757719|P1|Overall Study|Withdrawal by Subject|1
1442157|NCT00888381|4757727|P2|Overall Study|Lost to Follow-up|1
1442158|NCT00888381|4757728|P1|Overall Study|Lost to Follow-up|0
1442159|NCT00888355|4757748|P4|Overall Study|Withdrawal by Subject|3
1442160|NCT00888355|4757749|P3|Overall Study|Withdrawal by Subject|1
1442161|NCT00888355|4757750|P2|Overall Study|Withdrawal by Subject|3
1442162|NCT00888355|4757751|P1|Overall Study|Withdrawal by Subject|0
1442163|NCT00888355|4757748|P4|Overall Study|Protocol Violation|2
1442164|NCT00888355|4757749|P3|Overall Study|Protocol Violation|1
1442165|NCT00888355|4757750|P2|Overall Study|Protocol Violation|2
1442166|NCT00888355|4757751|P1|Overall Study|Protocol Violation|3
1442167|NCT00888355|4757748|P4|Overall Study|Lost to Follow-up|0
1442168|NCT00888355|4757749|P3|Overall Study|Lost to Follow-up|2
1442169|NCT00888355|4757750|P2|Overall Study|Lost to Follow-up|2
1442170|NCT00888355|4757751|P1|Overall Study|Lost to Follow-up|0
1442171|NCT00888355|4757748|P4|Overall Study|Lack of Efficacy|2
1442172|NCT00888355|4757749|P3|Overall Study|Lack of Efficacy|5
1442173|NCT00888355|4757750|P2|Overall Study|Lack of Efficacy|2
1442174|NCT00888355|4757751|P1|Overall Study|Lack of Efficacy|9
1442175|NCT00888355|4757748|P4|Overall Study|Adverse Event|3
1442176|NCT00888355|4757749|P3|Overall Study|Adverse Event|3
1442177|NCT00888355|4757750|P2|Overall Study|Adverse Event|0
1442178|NCT00888355|4757751|P1|Overall Study|Adverse Event|10
1442179|NCT00888329|4757807|P2|Overall Study|Physician Decision|9
1442180|NCT00888329|4757808|P1|Overall Study|Physician Decision|6
1442181|NCT00888238|4757814|P3|Washout Period After Period 2|Adverse Event|1
1442182|NCT00888238|4757815|P2|Washout Period After Period 2|Adverse Event|0
1442183|NCT00888238|4757816|P1|Washout Period After Period 2|Adverse Event|0
1442184|NCT00888173|4757824|P1|Overall Study|Ineligible: required test not done|1
1442185|NCT00888173|4757824|P1|Overall Study|Wrong Primary|1
1442186|NCT00888134|4757832|P1|Follow-up|being followed for long-term survival|1
1442187|NCT00888134|4757832|P1|Treatment With Study Drug|Withdrawal by Subject|1
1442188|NCT00887978|4757842|P2|Overall Study|Lost to Follow-up|1
1442189|NCT00887978|4757843|P1|Overall Study|Lost to Follow-up|0
1442190|NCT00887978|4757842|P2|Overall Study|Withdrawal by Subject|2
1442191|NCT00887978|4757843|P1|Overall Study|Withdrawal by Subject|1
1442192|NCT00887978|4757842|P2|Overall Study|Death|3
1442193|NCT00887978|4757843|P1|Overall Study|Death|2
1442194|NCT00887978|4757842|P2|Overall Study|Clinical Worsening|4
1442195|NCT00887978|4757843|P1|Overall Study|Clinical Worsening|4
1442196|NCT00887978|4757842|P2|Overall Study|Adverse Event|5
1442197|NCT00887978|4757843|P1|Overall Study|Adverse Event|18
1442198|NCT00887913|4757909|P1|Overall Study|Withdrawal by Subject|6
1442199|NCT00887822|4757917|P2|Overall Study|Randomized but not treated|1
1442200|NCT00887822|4757918|P1|Overall Study|Randomized but not treated|0
1442201|NCT00887822|4757917|P2|Overall Study|Protocol Violation|1
1442202|NCT00887822|4757918|P1|Overall Study|Protocol Violation|0
1442203|NCT00887822|4757917|P2|Overall Study|Death|3
1442204|NCT00887822|4757918|P1|Overall Study|Death|2
1442205|NCT00887822|4757917|P2|Overall Study|Administrative/Other than specified|4
1442206|NCT00887822|4757918|P1|Overall Study|Administrative/Other than specified|5
1442207|NCT00887822|4757917|P2|Overall Study|Refused treatment/Did not cooperate|10
1442208|NCT00887822|4757918|P1|Overall Study|Refused treatment/Did not cooperate|12
1442209|NCT00887822|4757917|P2|Overall Study|Failure to return|11
1442210|NCT00887822|4757918|P1|Overall Study|Failure to return|11
1442211|NCT00887822|4757917|P2|Overall Study|Adverse Event|17
1442212|NCT00887822|4757918|P1|Overall Study|Adverse Event|14
1442213|NCT00887822|4757917|P2|Overall Study|Insufficient therapeutic response|55
1442214|NCT00887822|4757918|P1|Overall Study|Insufficient therapeutic response|53
1442215|NCT00887809|4757950|P2|Overall Study|Death|0
1442216|NCT00887809|4757951|P1|Overall Study|Death|1
1442217|NCT00887809|4757950|P2|Overall Study|Patient Not Treated|0
1442218|NCT00887809|4757951|P1|Overall Study|Patient Not Treated|3
1442219|NCT00887744|4757957|P1|Overall Study|Various reasons|9
1442220|NCT00887744|4757957|P1|Overall Study|Withdrawal by Subject|18
1442221|NCT00887744|4757957|P1|Overall Study|Lost to Follow-up|3
1442222|NCT00887744|4757957|P1|Overall Study|Death|1
1442223|NCT00887744|4757957|P1|Overall Study|Adverse Event|3
1442224|NCT00887679|4757966|P1|Overall Study|Physician Decision|5
1442225|NCT00887679|4757966|P1|Overall Study|Lost to Follow-up|4
1442226|NCT00887679|4757966|P1|Overall Study|Withdrawal by Subject|1
1442227|NCT00887588|4757996|P2|Extension Period|Lost to Follow-up|0
1442228|NCT00887588|4757997|P1|Extension Period|Lost to Follow-up|1
1442229|NCT00887588|4757996|P2|Extension Period|Protocol deviation|0
1442230|NCT00887588|4757997|P1|Extension Period|Protocol deviation|1
1442231|NCT00887588|4757996|P2|Extension Period|Death|1
1442232|NCT00887588|4757997|P1|Extension Period|Death|0
1442233|NCT00887588|4757996|P2|Extension Period|Adverse Event|4
1442234|NCT00887588|4757997|P1|Extension Period|Adverse Event|4
1442235|NCT00887588|4757996|P2|Core Period|Adverse Event|11
1442236|NCT00887588|4757997|P1|Core Period|Adverse Event|9
1442237|NCT00887588|4757996|P2|Core Period|Withdrawal by Subject|8
1442238|NCT00887588|4757997|P1|Core Period|Withdrawal by Subject|6
1442239|NCT00887588|4757996|P2|Core Period|Lost to Follow-up|1
1442240|NCT00887588|4757997|P1|Core Period|Lost to Follow-up|3
1442241|NCT00887588|4757996|P2|Core Period|Death|1
1442242|NCT00887588|4757997|P1|Core Period|Death|1
1442243|NCT00887549|4758078|P1|Maintenance Therapy|Death due to adverse event|1
1442244|NCT00887549|4758078|P1|Maintenance Therapy|Progressive Disease|25
1442245|NCT00887549|4758078|P1|Maintenance Therapy|Physician Decision|1
1442246|NCT00887549|4758078|P1|Maintenance Therapy|Adverse Event|16
1442247|NCT00887549|4758078|P1|Induction Therapy|Death due to Study Drug Toxicity|1
1442248|NCT00887549|4758078|P1|Induction Therapy|Death due to Study Disease|4
1442249|NCT00887549|4758078|P1|Induction Therapy|Progressive Disease|13
1442250|NCT00887549|4758078|P1|Induction Therapy|Physician Decision|1
1442251|NCT00887549|4758078|P1|Induction Therapy|Adverse Event|8
1442252|NCT00887484|4758096|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
1442253|NCT00887484|4758096|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
1442254|NCT00887484|4758096|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
1442255|NCT00887354|4758184|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
1442256|NCT00887354|4758185|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
1442257|NCT00887354|4758184|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
1442258|NCT00887354|4758185|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
1442259|NCT00887354|4758184|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
1442260|NCT00887354|4758185|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
1442261|NCT00887354|4758184|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
1442262|NCT00887354|4758185|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
1442263|NCT00887354|4758184|P2|Open Label Phase (Week 26 to Week 78)|Death|2
1442264|NCT00887354|4758185|P1|Open Label Phase (Week 26 to Week 78)|Death|0
1442265|NCT00887354|4758184|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
1442266|NCT00887354|4758185|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
1442267|NCT00887354|4758184|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
1442268|NCT00887354|4758185|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
1442269|NCT00887354|4758184|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
1442270|NCT00887354|4758185|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
1442271|NCT00887354|4758184|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
1442272|NCT00887354|4758185|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
1442273|NCT00887354|4758184|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
1442274|NCT00887354|4758185|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
1442275|NCT00887354|4758184|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
1442276|NCT00887354|4758185|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
1442277|NCT00887354|4758184|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
1442278|NCT00887354|4758185|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
1442279|NCT00887354|4758184|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
1442280|NCT00887354|4758185|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
1442281|NCT00887354|4758184|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
1442282|NCT00887354|4758185|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
1442283|NCT00887354|4758184|P2|Treatment Phase (Week 0 to Week 26)|Death|1
1442284|NCT00887354|4758185|P1|Treatment Phase (Week 0 to Week 26)|Death|0
1442285|NCT00887341|4758205|P2|Overall Study|Lost to Follow-up|1
1442286|NCT00887341|4758206|P1|Overall Study|Lost to Follow-up|0
1442287|NCT00887341|4758205|P2|Overall Study|Adverse Event|1
1442288|NCT00887341|4758206|P1|Overall Study|Adverse Event|0
1442289|NCT00887341|4758205|P2|Overall Study|Withdrawal by Subject|1
1442290|NCT00887341|4758206|P1|Overall Study|Withdrawal by Subject|1
1442291|NCT00887341|4758205|P2|Overall Study|Refused treatment|0
1442292|NCT00887341|4758206|P1|Overall Study|Refused treatment|1
1442293|NCT00887315|4758242|P2|Overall Study|Study termination|4
1442294|NCT00887315|4758243|P1|Overall Study|Study termination|7
1442295|NCT00887289|4758251|P1|Overall Study|not specified|20
1442296|NCT00887289|4758251|P1|Overall Study|Lost to Follow-up|8
1442297|NCT00887289|4758251|P1|Overall Study|Withdrawal by Subject|26
1442298|NCT00887289|4758251|P1|Overall Study|Adverse Event|27
1442299|NCT00887289|4758251|P1|Overall Study|Lack of Efficacy|14
1442300|NCT00887250|4758263|P3|Overall Study|Patient uncooperative|1
1442301|NCT00887250|4758264|P2|Overall Study|Patient uncooperative|0
1442302|NCT00887250|4758265|P1|Overall Study|Patient uncooperative|0
1442303|NCT00887250|4758263|P3|Overall Study|Withdrawal by Subject|2
1442304|NCT00887250|4758264|P2|Overall Study|Withdrawal by Subject|1
1442305|NCT00887250|4758265|P1|Overall Study|Withdrawal by Subject|2
1442306|NCT00887250|4758263|P3|Overall Study|Protocol Violation|1
1442307|NCT00887250|4758264|P2|Overall Study|Protocol Violation|2
1442308|NCT00887250|4758265|P1|Overall Study|Protocol Violation|2
1442309|NCT00887250|4758263|P3|Overall Study|Lost to Follow-up|1
1442310|NCT00887250|4758264|P2|Overall Study|Lost to Follow-up|3
1442311|NCT00887250|4758265|P1|Overall Study|Lost to Follow-up|2
1442312|NCT00887250|4758263|P3|Overall Study|Lack of Efficacy|1
1442313|NCT00887250|4758264|P2|Overall Study|Lack of Efficacy|6
1442314|NCT00887250|4758265|P1|Overall Study|Lack of Efficacy|9
1442315|NCT00887250|4758263|P3|Overall Study|Adverse Event|7
1442316|NCT00887250|4758264|P2|Overall Study|Adverse Event|0
1442317|NCT00887250|4758265|P1|Overall Study|Adverse Event|3
1442318|NCT00887224|4758288|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
1442319|NCT00887224|4758289|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
1442320|NCT00887224|4758290|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
1442321|NCT00887224|4758288|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
1442322|NCT00887224|4758289|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
1442323|NCT00887224|4758290|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
1442324|NCT00887224|4758288|P3|DB Taper Phase / Post Study Follow Up|Other|12
1442325|NCT00887224|4758289|P2|DB Taper Phase / Post Study Follow Up|Other|11
1442326|NCT00887224|4758290|P1|DB Taper Phase / Post Study Follow Up|Other|0
1442327|NCT00887224|4758288|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
1442328|NCT00887224|4758289|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
1442329|NCT00887224|4758290|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
1442330|NCT00887224|4758288|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
1442331|NCT00887224|4758289|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
1442332|NCT00887224|4758290|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
1442333|NCT00887224|4758288|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
1442334|NCT00887224|4758289|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
1442335|NCT00887224|4758290|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
1442336|NCT00887224|4758288|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
1442337|NCT00887224|4758289|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
1442338|NCT00887224|4758290|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
1442339|NCT00887224|4758288|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
1442340|NCT00887224|4758289|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
1442341|NCT00887224|4758290|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
1442342|NCT00887224|4758288|P3|Double-blind (DB) Phase|Protocol Violation|5
1442343|NCT00887224|4758289|P2|Double-blind (DB) Phase|Protocol Violation|8
1442344|NCT00887224|4758290|P1|Double-blind (DB) Phase|Protocol Violation|0
1442345|NCT00887224|4758288|P3|Double-blind (DB) Phase|Other|0
1442346|NCT00887224|4758289|P2|Double-blind (DB) Phase|Other|2
1442347|NCT00887224|4758290|P1|Double-blind (DB) Phase|Other|0
1442348|NCT00887224|4758288|P3|Double-blind (DB) Phase|Lost to Follow-up|8
1442349|NCT00887224|4758289|P2|Double-blind (DB) Phase|Lost to Follow-up|8
1442350|NCT00887224|4758290|P1|Double-blind (DB) Phase|Lost to Follow-up|0
1442351|NCT00887224|4758288|P3|Double-blind (DB) Phase|Lack of Efficacy|33
1442352|NCT00887224|4758289|P2|Double-blind (DB) Phase|Lack of Efficacy|67
1442353|NCT00887224|4758290|P1|Double-blind (DB) Phase|Lack of Efficacy|0
1442354|NCT00887224|4758288|P3|Double-blind (DB) Phase|Failed to return|2
1442355|NCT00887224|4758289|P2|Double-blind (DB) Phase|Failed to return|2
1442356|NCT00887224|4758290|P1|Double-blind (DB) Phase|Failed to return|0
1442357|NCT00887224|4758288|P3|Double-blind (DB) Phase|Adverse Event|2
1442358|NCT00887224|4758289|P2|Double-blind (DB) Phase|Adverse Event|7
1442359|NCT00887224|4758290|P1|Double-blind (DB) Phase|Adverse Event|0
1442360|NCT00887224|4758288|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
1442361|NCT00887224|4758289|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
1442362|NCT00887224|4758290|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
1442363|NCT00887224|4758288|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
1442364|NCT00887224|4758289|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
1442365|NCT00887224|4758290|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
1442366|NCT00887224|4758288|P3|OL Taper Phase / OL Follow Up|Other|0
1442367|NCT00887224|4758289|P2|OL Taper Phase / OL Follow Up|Other|0
1442368|NCT00887224|4758290|P1|OL Taper Phase / OL Follow Up|Other|30
1442369|NCT00887224|4758288|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
1442370|NCT00887224|4758289|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
1442371|NCT00887224|4758290|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
1442372|NCT00887224|4758288|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
1442373|NCT00887224|4758289|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
1442374|NCT00887224|4758290|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
1442375|NCT00887224|4758288|P3|OL Taper Phase / OL Follow Up|Failed to return|0
1442376|NCT00887224|4758289|P2|OL Taper Phase / OL Follow Up|Failed to return|0
1442377|NCT00887224|4758290|P1|OL Taper Phase / OL Follow Up|Failed to return|17
1442378|NCT00887224|4758288|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
1442379|NCT00887224|4758289|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
1442380|NCT00887224|4758290|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
1442381|NCT00887224|4758288|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
1442382|NCT00887224|4758289|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
1442383|NCT00887224|4758290|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
1442384|NCT00887224|4758288|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
1442385|NCT00887224|4758289|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
1442386|NCT00887224|4758290|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
1442387|NCT00887224|4758288|P3|Open-label Stability (OLS) Phase|Other|0
1442388|NCT00887224|4758289|P2|Open-label Stability (OLS) Phase|Other|0
1442389|NCT00887224|4758290|P1|Open-label Stability (OLS) Phase|Other|1
1442390|NCT00887224|4758288|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
1442391|NCT00887224|4758289|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
1442392|NCT00887224|4758290|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
1442393|NCT00887224|4758288|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
1442394|NCT00887224|4758289|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
1442395|NCT00887224|4758290|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
1442396|NCT00887224|4758288|P3|Open-label Stability (OLS) Phase|Failed to return|0
1442397|NCT00887224|4758289|P2|Open-label Stability (OLS) Phase|Failed to return|0
1442398|NCT00887224|4758290|P1|Open-label Stability (OLS) Phase|Failed to return|3
1442399|NCT00887224|4758288|P3|Open-label Stability (OLS) Phase|Adverse Event|0
1442400|NCT00887224|4758289|P2|Open-label Stability (OLS) Phase|Adverse Event|0
1442401|NCT00887224|4758290|P1|Open-label Stability (OLS) Phase|Adverse Event|22
1442402|NCT00887224|4758288|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
1442403|NCT00887224|4758289|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
1442404|NCT00887224|4758290|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
1442405|NCT00887224|4758288|P3|Open-label Response (OLR) Phase|Protocol Violation|0
1442406|NCT00887224|4758289|P2|Open-label Response (OLR) Phase|Protocol Violation|0
1442407|NCT00887224|4758290|P1|Open-label Response (OLR) Phase|Protocol Violation|12
1442408|NCT00887224|4758288|P3|Open-label Response (OLR) Phase|Other|0
1442409|NCT00887224|4758289|P2|Open-label Response (OLR) Phase|Other|0
1442410|NCT00887224|4758290|P1|Open-label Response (OLR) Phase|Other|1
1442411|NCT00887224|4758288|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
1442412|NCT00887224|4758289|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
1442413|NCT00887224|4758290|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
1442414|NCT00887224|4758288|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
1442415|NCT00887224|4758289|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
1442416|NCT00887224|4758290|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
1442417|NCT00887224|4758288|P3|Open-label Response (OLR) Phase|Failed to return|0
1442418|NCT00887224|4758289|P2|Open-label Response (OLR) Phase|Failed to return|0
1442419|NCT00887224|4758290|P1|Open-label Response (OLR) Phase|Failed to return|6
1442420|NCT00887224|4758288|P3|Open-label Response (OLR) Phase|Adverse Event|0
1442421|NCT00887224|4758289|P2|Open-label Response (OLR) Phase|Adverse Event|0
1442422|NCT00887224|4758290|P1|Open-label Response (OLR) Phase|Adverse Event|46
1442423|NCT00887198|4758317|P3|Cross Over (Placebo to AA)|Other|19
1442424|NCT00887198|4758318|P2|Cross Over (Placebo to AA)|Other|0
1442425|NCT00887198|4758319|P1|Cross Over (Placebo to AA)|Other|0
1442426|NCT00887198|4758317|P3|Cross Over (Placebo to AA)|Progressive disease|20
1442427|NCT00887198|4758318|P2|Cross Over (Placebo to AA)|Progressive disease|0
1442428|NCT00887198|4758319|P1|Cross Over (Placebo to AA)|Progressive disease|0
1442429|NCT00887198|4758317|P3|Cross Over (Placebo to AA)|Withdrawal by Subject|2
1442430|NCT00887198|4758318|P2|Cross Over (Placebo to AA)|Withdrawal by Subject|0
1442431|NCT00887198|4758319|P1|Cross Over (Placebo to AA)|Withdrawal by Subject|0
1442432|NCT00887198|4758317|P3|Cross Over (Placebo to AA)|Adverse Event|9
1442433|NCT00887198|4758318|P2|Cross Over (Placebo to AA)|Adverse Event|0
1442434|NCT00887198|4758319|P1|Cross Over (Placebo to AA)|Adverse Event|0
1442435|NCT00887198|4758317|P3|Cross Over (Placebo to AA)|Ongoing|35
1442436|NCT00887198|4758318|P2|Cross Over (Placebo to AA)|Ongoing|0
1442437|NCT00887198|4758319|P1|Cross Over (Placebo to AA)|Ongoing|0
1442438|NCT00887198|4758317|P3|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
1442439|NCT00887198|4758318|P2|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
1442440|NCT00887198|4758319|P1|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
1442441|NCT00887198|4758317|P3|Randomized Period|Randomized, Not treated|0
1442442|NCT00887198|4758318|P2|Randomized Period|Randomized, Not treated|2
1442443|NCT00887198|4758319|P1|Randomized Period|Randomized, Not treated|4
1442444|NCT00887198|4758317|P3|Randomized Period|Other|0
1442445|NCT00887198|4758318|P2|Randomized Period|Other|30
1442446|NCT00887198|4758319|P1|Randomized Period|Other|42
1442447|NCT00887198|4758317|P3|Randomized Period|Progressive disease|0
1442448|NCT00887198|4758318|P2|Randomized Period|Progressive disease|370
1442449|NCT00887198|4758319|P1|Randomized Period|Progressive disease|366
1442450|NCT00887198|4758317|P3|Randomized Period|Withdrawal by Subject|0
1442451|NCT00887198|4758318|P2|Randomized Period|Withdrawal by Subject|56
1442452|NCT00887198|4758319|P1|Randomized Period|Withdrawal by Subject|41
1442453|NCT00887198|4758317|P3|Randomized Period|Cross-over to AA (under amendment 3)|0
1442454|NCT00887198|4758318|P2|Randomized Period|Cross-over to AA (under amendment 3)|51
1442455|NCT00887198|4758319|P1|Randomized Period|Cross-over to AA (under amendment 3)|0
1442456|NCT00887198|4758317|P3|Randomized Period|Lost to Follow-up|0
1442457|NCT00887198|4758318|P2|Randomized Period|Lost to Follow-up|0
1442458|NCT00887198|4758319|P1|Randomized Period|Lost to Follow-up|1
1442459|NCT00887198|4758317|P3|Randomized Period|Adverse Event|0
1442460|NCT00887198|4758318|P2|Randomized Period|Adverse Event|33
1442461|NCT00887198|4758319|P1|Randomized Period|Adverse Event|50
1442462|NCT00887198|4758317|P3|Randomized Period|Ongoing|0
1442463|NCT00887198|4758318|P2|Randomized Period|Ongoing|0
1442464|NCT00887198|4758319|P1|Randomized Period|Ongoing|42
1442465|NCT00887159|4758350|P3|Overall Study|Never started assigned therapy|4
1442466|NCT00887159|4758351|P2|Overall Study|Never started assigned therapy|3
1442467|NCT00887159|4758352|P1|Overall Study|Never started assigned therapy|3
1442468|NCT00887159|4758350|P3|Overall Study|Ineligible|0
1442469|NCT00887159|4758351|P2|Overall Study|Ineligible|1
1442470|NCT00887159|4758352|P1|Overall Study|Ineligible|5
1442471|NCT00887159|4758350|P3|Overall Study|Received more tx instead of observation|0
1442472|NCT00887159|4758351|P2|Overall Study|Received more tx instead of observation|0
1442473|NCT00887159|4758352|P1|Overall Study|Received more tx instead of observation|1
1442474|NCT00887159|4758350|P3|Overall Study|Pt had PD but was SD when re-measured|0
1442475|NCT00887159|4758351|P2|Overall Study|Pt had PD but was SD when re-measured|1
1442476|NCT00887159|4758352|P1|Overall Study|Pt had PD but was SD when re-measured|0
1442477|NCT00887159|4758350|P3|Overall Study|Treatment delayed|0
1442478|NCT00887159|4758351|P2|Overall Study|Treatment delayed|1
1442479|NCT00887159|4758352|P1|Overall Study|Treatment delayed|1
1442480|NCT00887159|4758350|P3|Overall Study|Sympomatic deterioration|0
1442481|NCT00887159|4758351|P2|Overall Study|Sympomatic deterioration|0
1442482|NCT00887159|4758352|P1|Overall Study|Sympomatic deterioration|1
1442483|NCT00887159|4758350|P3|Overall Study|Physician Decision|0
1442484|NCT00887159|4758351|P2|Overall Study|Physician Decision|1
1442485|NCT00887159|4758352|P1|Overall Study|Physician Decision|1
1442486|NCT00887159|4758350|P3|Overall Study|Alternative therapy|0
1442487|NCT00887159|4758351|P2|Overall Study|Alternative therapy|0
1442488|NCT00887159|4758352|P1|Overall Study|Alternative therapy|2
1442489|NCT00887159|4758350|P3|Overall Study|Withdrawal by Subject|2
1442490|NCT00887159|4758351|P2|Overall Study|Withdrawal by Subject|4
1442491|NCT00887159|4758352|P1|Overall Study|Withdrawal by Subject|4
1442492|NCT00887159|4758350|P3|Overall Study|Death|0
1442493|NCT00887159|4758351|P2|Overall Study|Death|2
1442494|NCT00887159|4758352|P1|Overall Study|Death|2
1442495|NCT00887159|4758350|P3|Overall Study|Adverse Event|17
1442496|NCT00887159|4758351|P2|Overall Study|Adverse Event|4
1442497|NCT00887159|4758352|P1|Overall Study|Adverse Event|3
1442498|NCT00887159|4758350|P3|Overall Study|Disease progression|33
1442499|NCT00887159|4758351|P2|Overall Study|Disease progression|39
1442500|NCT00887159|4758352|P1|Overall Study|Disease progression|6
1442501|NCT00886938|4758368|P1|Overall Study|Withdrawal by Subject|1
1442502|NCT00886938|4758368|P1|Overall Study|Adverse Event|1
1442503|NCT00886834|4758381|P2|Overall Study|Protocol Violation|3
1442504|NCT00886834|4758382|P1|Overall Study|Protocol Violation|0
1442505|NCT00886821|4758404|P14|Stage 2|Lost to Follow-up|1
1442506|NCT00886821|4758405|P13|Stage 2|Lost to Follow-up|2
1442507|NCT00886821|4758406|P12|Stage 2|Lost to Follow-up|0
1442508|NCT00886821|4758407|P11|Stage 2|Lost to Follow-up|0
1442509|NCT00886821|4758408|P10|Stage 2|Lost to Follow-up|0
1442510|NCT00886821|4758409|P9|Stage 2|Lost to Follow-up|0
1442511|NCT00886821|4758410|P8|Stage 2|Lost to Follow-up|0
1442512|NCT00886821|4758411|P7|Stage 2|Lost to Follow-up|0
1442513|NCT00886821|4758412|P6|Stage 2|Lost to Follow-up|0
1442514|NCT00886821|4758413|P5|Stage 2|Lost to Follow-up|0
1442515|NCT00886821|4758414|P4|Stage 2|Lost to Follow-up|0
1442516|NCT00886821|4758415|P3|Stage 2|Lost to Follow-up|0
1442517|NCT00886821|4758416|P2|Stage 2|Lost to Follow-up|0
1442518|NCT00886821|4758417|P1|Stage 2|Lost to Follow-up|0
1442519|NCT00886821|4758404|P14|Stage 2|Adverse Event|0
1442520|NCT00886821|4758405|P13|Stage 2|Adverse Event|3
1442521|NCT00886821|4758406|P12|Stage 2|Adverse Event|1
1442522|NCT00886821|4758407|P11|Stage 2|Adverse Event|0
1442523|NCT00886821|4758408|P10|Stage 2|Adverse Event|0
1442524|NCT00886821|4758409|P9|Stage 2|Adverse Event|0
1442525|NCT00886821|4758410|P8|Stage 2|Adverse Event|0
1442526|NCT00886821|4758411|P7|Stage 2|Adverse Event|0
1442527|NCT00886821|4758412|P6|Stage 2|Adverse Event|0
1442528|NCT00886821|4758413|P5|Stage 2|Adverse Event|0
1442529|NCT00886821|4758414|P4|Stage 2|Adverse Event|0
1442530|NCT00886821|4758415|P3|Stage 2|Adverse Event|0
1442531|NCT00886821|4758416|P2|Stage 2|Adverse Event|0
1442532|NCT00886821|4758417|P1|Stage 2|Adverse Event|0
1442533|NCT00886795|4758642|P1|Overall Study|Lack of Efficacy|1
1442534|NCT00886769|4758649|P2|Overall Study|Unsatisfactory therapeutic effect|37
1442535|NCT00886769|4758650|P1|Overall Study|Unsatisfactory therapeutic effect|6
1442536|NCT00886743|4758674|P1|Overall Study|Other|1
1442537|NCT00886743|4758674|P1|Overall Study|Adverse Event|3
1442538|NCT00886639|4758712|P1|Overall Study|non-compliance|2
1442539|NCT00886639|4758712|P1|Overall Study|acute exacerbation|14
1442540|NCT00886613|4758726|P3|Overall Study|Subject withdrew consent (Part A)|2
1442541|NCT00886613|4758727|P2|Overall Study|Subject withdrew consent (Part A)|0
1442542|NCT00886613|4758728|P1|Overall Study|Subject withdrew consent (Part A)|0
1442543|NCT00886613|4758726|P3|Overall Study|Lost to follow-up (Part B)|1
1442544|NCT00886613|4758727|P2|Overall Study|Lost to follow-up (Part B)|0
1442545|NCT00886613|4758728|P1|Overall Study|Lost to follow-up (Part B)|1
1442546|NCT00886613|4758726|P3|Overall Study|Protocol deviation (Part B)|0
1442547|NCT00886613|4758727|P2|Overall Study|Protocol deviation (Part B)|0
1442548|NCT00886613|4758728|P1|Overall Study|Protocol deviation (Part B)|1
1442549|NCT00886600|4758750|P4|Combination Therapy Period|Protocol Violation|0
1442550|NCT00886600|4758751|P3|Combination Therapy Period|Protocol Violation|1
1442551|NCT00886600|4758752|P2|Combination Therapy Period|Protocol Violation|0
1442552|NCT00886600|4758753|P1|Combination Therapy Period|Protocol Violation|0
1442553|NCT00886600|4758750|P4|Combination Therapy Period|Adverse Event|0
1442554|NCT00886600|4758751|P3|Combination Therapy Period|Adverse Event|1
1442555|NCT00886600|4758752|P2|Combination Therapy Period|Adverse Event|0
1442556|NCT00886600|4758753|P1|Combination Therapy Period|Adverse Event|0
1442557|NCT00886600|4758750|P4|Double-blind Monotherapy|Withdrawal by Subject|0
1442558|NCT00886600|4758751|P3|Double-blind Monotherapy|Withdrawal by Subject|0
1442559|NCT00886600|4758752|P2|Double-blind Monotherapy|Withdrawal by Subject|0
1442560|NCT00886600|4758753|P1|Double-blind Monotherapy|Withdrawal by Subject|1
1442561|NCT00886600|4758750|P4|Double-blind Monotherapy|Protocol Violation|1
1442562|NCT00886600|4758751|P3|Double-blind Monotherapy|Protocol Violation|0
1442563|NCT00886600|4758752|P2|Double-blind Monotherapy|Protocol Violation|0
1442564|NCT00886600|4758753|P1|Double-blind Monotherapy|Protocol Violation|0
1442565|NCT00886600|4758750|P4|Double-blind Monotherapy|Adverse Event|1
1442566|NCT00886600|4758751|P3|Double-blind Monotherapy|Adverse Event|1
1442567|NCT00886600|4758752|P2|Double-blind Monotherapy|Adverse Event|1
1442568|NCT00886600|4758753|P1|Double-blind Monotherapy|Adverse Event|1
1442569|NCT00886587|4758777|P2|Overall Study|Withdrawal by Subject|1
1442570|NCT00886587|4758778|P1|Overall Study|Withdrawal by Subject|0
1442571|NCT00886587|4758777|P2|Overall Study|Protocol Violation|0
1442572|NCT00886587|4758778|P1|Overall Study|Protocol Violation|2
1442573|NCT00886587|4758777|P2|Overall Study|Adverse Event|1
1442574|NCT00886587|4758778|P1|Overall Study|Adverse Event|2
1442575|NCT00886483|4758792|P2|Overall Study|Distance to center, poor grades|0
1442576|NCT00886483|4758793|P1|Overall Study|Distance to center, poor grades|1
1442577|NCT00886483|4758792|P2|Overall Study|Pursue medications|2
1442578|NCT00886483|4758793|P1|Overall Study|Pursue medications|1
1442579|NCT00886483|4758792|P2|Overall Study|Lost to Follow-up|1
1442580|NCT00886483|4758793|P1|Overall Study|Lost to Follow-up|0
1442581|NCT00886340|4758811|P2|Overall Study|Withdrawal by Subject|7
1442582|NCT00886340|4758812|P1|Overall Study|Withdrawal by Subject|0
1442583|NCT00886288|4758820|P2|Overall Study|Lost to Follow-up|0
1442584|NCT00886288|4758821|P1|Overall Study|Lost to Follow-up|86
1442585|NCT00886288|4758820|P2|Overall Study|no respect of the 12 weeks period|227
1442586|NCT00886288|4758821|P1|Overall Study|no respect of the 12 weeks period|657
1442587|NCT00886119|4758843|P2|Period 1|Did not meet inclusion criteria|0
1442588|NCT00886119|4758844|P1|Period 1|Did not meet inclusion criteria|1
1442589|NCT00886015|4758852|P2|Overall Study|Death|2
1442590|NCT00886015|4758853|P1|Overall Study|Death|0
1442591|NCT00885846|4758872|P3|Overall Study|Withdrawal by Subject|2
1442592|NCT00885846|4758873|P2|Overall Study|Withdrawal by Subject|5
1442593|NCT00885846|4758874|P1|Overall Study|Withdrawal by Subject|2
1442594|NCT00885755|4758889|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
1442595|NCT00885755|4758890|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
1442596|NCT00885755|4758891|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
1442597|NCT00885755|4758889|P3|Part I: Trastuzumab+Taxane|Death|1
1442598|NCT00885755|4758890|P2|Part I: Trastuzumab+Taxane|Death|0
1442599|NCT00885755|4758891|P1|Part I: Trastuzumab+Taxane|Death|0
1442600|NCT00885755|4758889|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
1442601|NCT00885755|4758890|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
1442602|NCT00885755|4758891|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
1442603|NCT00885755|4758889|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
1442604|NCT00885755|4758890|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
1442605|NCT00885755|4758891|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
1442606|NCT00885755|4758889|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
1442607|NCT00885755|4758890|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
1442608|NCT00885755|4758891|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
1442609|NCT00885703|4758934|P7|Overall Study|Ineligible (no CM)|1
1442610|NCT00885703|4758935|P6|Overall Study|Ineligible (no CM)|3
1442611|NCT00885703|4758936|P5|Overall Study|Ineligible (no CM)|2
1442612|NCT00885703|4758937|P4|Overall Study|Ineligible (no CM)|1
1442613|NCT00885703|4758938|P3|Overall Study|Ineligible (no CM)|2
1442614|NCT00885703|4758939|P2|Overall Study|Ineligible (no CM)|3
1442615|NCT00885703|4758940|P1|Overall Study|Ineligible (no CM)|1
1442616|NCT00885703|4758934|P7|Overall Study|Withdrawal by Subject|1
1442617|NCT00885703|4758935|P6|Overall Study|Withdrawal by Subject|1
1442618|NCT00885703|4758936|P5|Overall Study|Withdrawal by Subject|3
1442619|NCT00885703|4758937|P4|Overall Study|Withdrawal by Subject|1
1442620|NCT00885703|4758938|P3|Overall Study|Withdrawal by Subject|0
1442621|NCT00885703|4758939|P2|Overall Study|Withdrawal by Subject|0
1442622|NCT00885703|4758940|P1|Overall Study|Withdrawal by Subject|0
1442623|NCT00885703|4758934|P7|Overall Study|Lost to Follow-up|0
1442624|NCT00885703|4758935|P6|Overall Study|Lost to Follow-up|1
1442625|NCT00885703|4758936|P5|Overall Study|Lost to Follow-up|0
1442626|NCT00885703|4758937|P4|Overall Study|Lost to Follow-up|0
1442627|NCT00885703|4758938|P3|Overall Study|Lost to Follow-up|1
1442628|NCT00885703|4758939|P2|Overall Study|Lost to Follow-up|0
1442629|NCT00885703|4758940|P1|Overall Study|Lost to Follow-up|0
1442630|NCT00885703|4758934|P7|Overall Study|Death|4
1442631|NCT00885703|4758935|P6|Overall Study|Death|8
1442632|NCT00885703|4758936|P5|Overall Study|Death|7
1442633|NCT00885703|4758937|P4|Overall Study|Death|7
1442634|NCT00885703|4758938|P3|Overall Study|Death|8
1442635|NCT00885703|4758939|P2|Overall Study|Death|7
1442636|NCT00885703|4758940|P1|Overall Study|Death|9
1442637|NCT00885677|4758998|P2|Overall Study|Inclusion/exclusion not met|27
1442638|NCT00885677|4758999|P1|Overall Study|Inclusion/exclusion not met|25
1442639|NCT00885677|4758998|P2|Overall Study|Heart transplantation|0
1442640|NCT00885677|4758999|P1|Overall Study|Heart transplantation|1
1442641|NCT00885677|4758998|P2|Overall Study|device/lead revision or replacement|6
1442642|NCT00885677|4758999|P1|Overall Study|device/lead revision or replacement|7
1442643|NCT00885677|4758998|P2|Overall Study|premature study closure|44
1442644|NCT00885677|4758999|P1|Overall Study|premature study closure|41
1442645|NCT00885677|4758998|P2|Overall Study|Protocol Violation|54
1442646|NCT00885677|4758999|P1|Overall Study|Protocol Violation|54
1442647|NCT00885677|4758998|P2|Overall Study|Lost to Follow-up|13
1442648|NCT00885677|4758999|P1|Overall Study|Lost to Follow-up|15
1442649|NCT00885677|4758998|P2|Overall Study|Death|34
1442650|NCT00885677|4758999|P1|Overall Study|Death|40
1442651|NCT00885534|4759015|P1|Overall Study|Patient deemed ineligible|1
1442652|NCT00885482|4759019|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
1442653|NCT00885482|4759019|P1|Overall Study|Death|1
1442654|NCT00885482|4759019|P1|Overall Study|Lack of Efficacy|1
1442655|NCT00885482|4759019|P1|Overall Study|Pregnancy|1
1442656|NCT00885378|4759025|P2|Overall Study|Protocol Violation|0
1442657|NCT00885378|4759026|P1|Overall Study|Protocol Violation|2
1442658|NCT00885378|4759025|P2|Overall Study|Poor/Noncompliance|2
1442659|NCT00885378|4759026|P1|Overall Study|Poor/Noncompliance|2
1442660|NCT00885378|4759025|P2|Overall Study|Lost to Follow-up|2
1442661|NCT00885378|4759026|P1|Overall Study|Lost to Follow-up|1
1442662|NCT00885378|4759025|P2|Overall Study|Withdrawal by Subject|2
1442663|NCT00885378|4759026|P1|Overall Study|Withdrawal by Subject|1
1442664|NCT00885378|4759025|P2|Overall Study|Lack of Efficacy|2
1442665|NCT00885378|4759026|P1|Overall Study|Lack of Efficacy|2
1442666|NCT00885365|4759056|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
1442667|NCT00885365|4759057|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
1442668|NCT00885365|4759056|P2|4 Weeks ON Treatment|Protocol Violation|2
1442669|NCT00885365|4759057|P1|4 Weeks ON Treatment|Protocol Violation|1
1442670|NCT00885365|4759056|P2|4 Weeks ON Treatment|Adverse Event|4
1442671|NCT00885365|4759057|P1|4 Weeks ON Treatment|Adverse Event|2
1442672|NCT00885352|4759093|P2|Overall Study|Lab abnormalities|1
1442673|NCT00885352|4759094|P1|Overall Study|Lab abnormalities|1
1442674|NCT00885352|4759093|P2|Overall Study|Excluded medication|2
1442675|NCT00885352|4759094|P1|Overall Study|Excluded medication|2
1442676|NCT00885352|4759093|P2|Overall Study|Contradiction to study medication|2
1442677|NCT00885352|4759094|P1|Overall Study|Contradiction to study medication|0
1442678|NCT00885352|4759093|P2|Overall Study|Withdrawal by Subject|5
1442679|NCT00885352|4759094|P1|Overall Study|Withdrawal by Subject|1
1442680|NCT00885352|4759093|P2|Overall Study|Protocol Violation|2
1442681|NCT00885352|4759094|P1|Overall Study|Protocol Violation|0
1442682|NCT00885352|4759093|P2|Overall Study|Physician Decision|3
1442683|NCT00885352|4759094|P1|Overall Study|Physician Decision|0
1442684|NCT00885352|4759093|P2|Overall Study|Lost to Follow-up|2
1442685|NCT00885352|4759094|P1|Overall Study|Lost to Follow-up|2
1442686|NCT00885352|4759093|P2|Overall Study|Adverse Event|3
1442687|NCT00885352|4759094|P1|Overall Study|Adverse Event|2
1442688|NCT00885170|4759106|P2|Overall Study|Withdrawal by Subject|13
1442689|NCT00885170|4759107|P1|Overall Study|Withdrawal by Subject|13
1442690|NCT00885170|4759106|P2|Overall Study|Protocol Violation|1
1442691|NCT00885170|4759107|P1|Overall Study|Protocol Violation|3
1442692|NCT00885170|4759106|P2|Overall Study|Physician Decision|1
1442693|NCT00885170|4759107|P1|Overall Study|Physician Decision|2
1442694|NCT00885170|4759106|P2|Overall Study|Lost to Follow-up|1
1442695|NCT00885170|4759107|P1|Overall Study|Lost to Follow-up|2
1442696|NCT00885170|4759106|P2|Overall Study|Excessive bone loss|3
1442697|NCT00885170|4759107|P1|Overall Study|Excessive bone loss|6
1442698|NCT00885170|4759106|P2|Overall Study|Adverse Event|4
1442699|NCT00885170|4759107|P1|Overall Study|Adverse Event|12
1442700|NCT00885118|4759166|P5|Overall Study|Other reason not defined above|0
1442701|NCT00885118|4759167|P4|Overall Study|Other reason not defined above|0
1442702|NCT00885118|4759168|P3|Overall Study|Other reason not defined above|1
1442703|NCT00885118|4759169|P2|Overall Study|Other reason not defined above|0
1442704|NCT00885118|4759170|P1|Overall Study|Other reason not defined above|0
1442705|NCT00885118|4759166|P5|Overall Study|Withdrawal by Subject|1
1442706|NCT00885118|4759167|P4|Overall Study|Withdrawal by Subject|0
1442707|NCT00885118|4759168|P3|Overall Study|Withdrawal by Subject|0
1442708|NCT00885118|4759169|P2|Overall Study|Withdrawal by Subject|0
1442709|NCT00885118|4759170|P1|Overall Study|Withdrawal by Subject|0
1442710|NCT00885118|4759166|P5|Overall Study|Adverse Event|0
1442711|NCT00885118|4759167|P4|Overall Study|Adverse Event|0
1442712|NCT00885118|4759168|P3|Overall Study|Adverse Event|0
1442713|NCT00885118|4759169|P2|Overall Study|Adverse Event|0
1442714|NCT00885118|4759170|P1|Overall Study|Adverse Event|1
1442715|NCT00885105|4759309|P2|Overall Study|Protocol Violation|2
1442716|NCT00885105|4759310|P1|Overall Study|Protocol Violation|0
1442717|NCT00885105|4759309|P2|Overall Study|Adverse Event|0
1442718|NCT00885105|4759310|P1|Overall Study|Adverse Event|1
1442719|NCT00885105|4759309|P2|Overall Study|Withdrawal by Subject|8
1442720|NCT00885105|4759310|P1|Overall Study|Withdrawal by Subject|0
1442721|NCT00884949|4759350|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
1442722|NCT00884949|4759350|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
1442723|NCT00884832|4759385|P2|Overall Study|Withdrawal by Subject|1
1442724|NCT00884832|4759386|P1|Overall Study|Withdrawal by Subject|0
1442725|NCT00884793|4759421|P1|Overall Study|Withdrawal by Subject|1
1442726|NCT00884741|4759440|P4|Randomization|Protocol Violation|8
1442727|NCT00884741|4759441|P3|Randomization|Protocol Violation|8
1442728|NCT00884741|4759442|P2|Randomization|Protocol Violation|0
1442729|NCT00884741|4759443|P1|Randomization|Protocol Violation|0
1442730|NCT00884741|4759440|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
1442731|NCT00884741|4759441|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
1442732|NCT00884741|4759442|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
1442733|NCT00884741|4759443|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
1442734|NCT00884741|4759440|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
1442735|NCT00884741|4759441|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
1442736|NCT00884741|4759442|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
1442737|NCT00884741|4759443|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
1442738|NCT00884741|4759440|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
1442739|NCT00884741|4759441|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
1442740|NCT00884741|4759442|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
1442741|NCT00884741|4759443|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
1442742|NCT00884741|4759440|P4|Step 2 Registration: Tissue Analysis|Death|0
1442743|NCT00884741|4759441|P3|Step 2 Registration: Tissue Analysis|Death|0
1442744|NCT00884741|4759442|P2|Step 2 Registration: Tissue Analysis|Death|1
1442745|NCT00884741|4759443|P1|Step 2 Registration: Tissue Analysis|Death|0
1442746|NCT00884741|4759440|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
1442747|NCT00884741|4759441|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
1442748|NCT00884741|4759442|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
1442749|NCT00884741|4759443|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
1442750|NCT00884741|4759440|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
1442751|NCT00884741|4759441|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
1442752|NCT00884741|4759442|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
1442753|NCT00884741|4759443|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
1442754|NCT00884741|4759440|P4|Step 1 Registration: Tissue Screening|Disease progression|0
1442755|NCT00884741|4759441|P3|Step 1 Registration: Tissue Screening|Disease progression|0
1442756|NCT00884741|4759442|P2|Step 1 Registration: Tissue Screening|Disease progression|0
1442757|NCT00884741|4759443|P1|Step 1 Registration: Tissue Screening|Disease progression|12
1442758|NCT00884741|4759440|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
1442759|NCT00884741|4759441|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
1442760|NCT00884741|4759442|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
1442761|NCT00884741|4759443|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
1442762|NCT00884741|4759440|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
1442763|NCT00884741|4759441|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
1442764|NCT00884741|4759442|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
1442765|NCT00884741|4759443|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
1442766|NCT00884741|4759440|P4|Step 1 Registration: Tissue Screening|Death|0
1442767|NCT00884741|4759441|P3|Step 1 Registration: Tissue Screening|Death|0
1442768|NCT00884741|4759442|P2|Step 1 Registration: Tissue Screening|Death|0
1442769|NCT00884741|4759443|P1|Step 1 Registration: Tissue Screening|Death|3
1442770|NCT00884741|4759440|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
1442771|NCT00884741|4759441|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
1442772|NCT00884741|4759442|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
1442773|NCT00884741|4759443|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
1442774|NCT00884390|4759493|P2|Overall Study|Not specified|1
1442775|NCT00884390|4759494|P1|Overall Study|Not specified|11
1442776|NCT00884390|4759493|P2|Overall Study|Discontinuation of Study by Sponsor|2
1442777|NCT00884390|4759494|P1|Overall Study|Discontinuation of Study by Sponsor|2
1442778|NCT00884390|4759493|P2|Overall Study|Withdrawal by Subject|1
1442779|NCT00884390|4759494|P1|Overall Study|Withdrawal by Subject|4
1442780|NCT00884390|4759493|P2|Overall Study|Protocol Violation|1
1442781|NCT00884390|4759494|P1|Overall Study|Protocol Violation|4
1442782|NCT00884390|4759493|P2|Overall Study|Physician Decision|1
1442783|NCT00884390|4759494|P1|Overall Study|Physician Decision|2
1442784|NCT00884390|4759493|P2|Overall Study|Lost to Follow-up|1
1442785|NCT00884390|4759494|P1|Overall Study|Lost to Follow-up|0
1442786|NCT00884390|4759493|P2|Overall Study|Adverse Event|1
1442787|NCT00884390|4759494|P1|Overall Study|Adverse Event|0
1442788|NCT00884377|4759512|P2|Overall Study|Physician Decision|1
1442789|NCT00884377|4759513|P1|Overall Study|Physician Decision|0
1442790|NCT00884377|4759512|P2|Overall Study|Could not confirm diagnosis|0
1442791|NCT00884377|4759513|P1|Overall Study|Could not confirm diagnosis|1
1442792|NCT00884377|4759512|P2|Overall Study|Withdrawal by Subject|0
1442793|NCT00884377|4759513|P1|Overall Study|Withdrawal by Subject|1
1442794|NCT00884325|4759535|P2|Overall Study|Not provided|0
1442795|NCT00884325|4759536|P1|Overall Study|Not provided|1
1442796|NCT00884325|4759535|P2|Overall Study|Withdrawal by Subject|1
1442797|NCT00884325|4759536|P1|Overall Study|Withdrawal by Subject|1
1442798|NCT00884325|4759535|P2|Overall Study|Lack of Efficacy|1
1442799|NCT00884325|4759536|P1|Overall Study|Lack of Efficacy|0
1442800|NCT00884325|4759535|P2|Overall Study|Lost to Follow-up|2
1442801|NCT00884325|4759536|P1|Overall Study|Lost to Follow-up|1
1442802|NCT00884312|4759546|P2|Overall Study|Did Not Receive Study Drug|1
1442803|NCT00884312|4759547|P1|Overall Study|Did Not Receive Study Drug|0
1442804|NCT00884312|4759546|P2|Overall Study|Other|4
1442805|NCT00884312|4759547|P1|Overall Study|Other|0
1442806|NCT00884312|4759546|P2|Overall Study|Physician Decision|1
1442807|NCT00884312|4759547|P1|Overall Study|Physician Decision|0
1442808|NCT00884312|4759546|P2|Overall Study|Withdrawal by Subject|6
1442809|NCT00884312|4759547|P1|Overall Study|Withdrawal by Subject|0
1442810|NCT00884312|4759546|P2|Overall Study|Fatal Adverse Event|4
1442811|NCT00884312|4759547|P1|Overall Study|Fatal Adverse Event|1
1442812|NCT00884312|4759546|P2|Overall Study|Non-fatal Adverse Event|0
1442813|NCT00884312|4759547|P1|Overall Study|Non-fatal Adverse Event|1
1442814|NCT00884312|4759546|P2|Overall Study|Fatal Progressive Disease|1
1442815|NCT00884312|4759547|P1|Overall Study|Fatal Progressive Disease|0
1442816|NCT00884312|4759546|P2|Overall Study|Non-fatal Progressive Disease|8
1442817|NCT00884312|4759547|P1|Overall Study|Non-fatal Progressive Disease|0
1442818|NCT00884286|4759563|P2|Overall Study|Comprised lung carcinoma|1
1442819|NCT00884286|4759564|P1|Overall Study|Comprised lung carcinoma|0
1442820|NCT00884286|4759563|P2|Overall Study|Not treated|1
1442821|NCT00884286|4759564|P1|Overall Study|Not treated|2
1442822|NCT00884286|4759563|P2|Overall Study|Thrombus in right auricle|0
1442823|NCT00884286|4759564|P1|Overall Study|Thrombus in right auricle|1
1442824|NCT00884286|4759563|P2|Overall Study|Septic shock|0
1442825|NCT00884286|4759564|P1|Overall Study|Septic shock|1
1442826|NCT00884286|4759563|P2|Overall Study|Physician Decision|0
1442827|NCT00884286|4759564|P1|Overall Study|Physician Decision|1
1442828|NCT00884286|4759563|P2|Overall Study|Death|2
1442829|NCT00884286|4759564|P1|Overall Study|Death|2
1442830|NCT00884286|4759563|P2|Overall Study|Toxicity|1
1442831|NCT00884286|4759564|P1|Overall Study|Toxicity|4
1442832|NCT00884286|4759563|P2|Overall Study|Progressive disease|28
1442833|NCT00884286|4759564|P1|Overall Study|Progressive disease|21
1442834|NCT00884273|4759578|P2|Overall Study|Practical reasons|0
1442835|NCT00884273|4759579|P1|Overall Study|Practical reasons|1
1442836|NCT00884273|4759578|P2|Overall Study|Protocol Violation|3
1442837|NCT00884273|4759579|P1|Overall Study|Protocol Violation|1
1442838|NCT00884273|4759578|P2|Overall Study|Adverse Event|2
1442839|NCT00884273|4759579|P1|Overall Study|Adverse Event|0
1442840|NCT00884221|4759605|P2|Overall Study|Cancellation of Cycle and Other Reason|13
1442841|NCT00884221|4759606|P1|Overall Study|Cancellation of Cycle and Other Reason|12
1442842|NCT00884221|4759605|P2|Overall Study|Protocol Violation|13
1442843|NCT00884221|4759606|P1|Overall Study|Protocol Violation|16
1442844|NCT00884221|4759605|P2|Overall Study|Adverse Event|3
1442845|NCT00884221|4759606|P1|Overall Study|Adverse Event|6
1442846|NCT00884221|4759605|P2|Overall Study|Withdrawal by Subject|3
1442847|NCT00884221|4759606|P1|Overall Study|Withdrawal by Subject|0
1442848|NCT00884117|4759642|P1|Overall Study|Not Specified|12
1442849|NCT00884117|4759642|P1|Overall Study|Lost to Follow-up|143
1442850|NCT00884117|4759642|P1|Overall Study|Death|3
1442851|NCT00884117|4759642|P1|Overall Study|Withdrawal by Subject|89
1442852|NCT00884117|4759642|P1|Overall Study|Adverse Event|2
1442853|NCT00884039|4759705|P2|Overall Study|Lack of Efficacy|0
1442854|NCT00884039|4759706|P1|Overall Study|Lack of Efficacy|2
1442855|NCT00884039|4759705|P2|Overall Study|Withdrawal by Subject|1
1442856|NCT00884039|4759706|P1|Overall Study|Withdrawal by Subject|0
1442857|NCT00883779|4759714|P2|Off-study Phase|Other|21
1442858|NCT00883779|4759715|P1|Off-study Phase|Other|18
1442859|NCT00883779|4759714|P2|Off-study Phase|Failure to return|6
1442860|NCT00883779|4759715|P1|Off-study Phase|Failure to return|5
1442861|NCT00883779|4759714|P2|Off-study Phase|Refused treatment|1
1442862|NCT00883779|4759715|P1|Off-study Phase|Refused treatment|1
1442863|NCT00883779|4759714|P2|Off-study Phase|Death|174
1442864|NCT00883779|4759715|P1|Off-study Phase|Death|185
1442865|NCT00883779|4759714|P2|Post-Study Treatment Phase|Ongoing in the study|6
1442866|NCT00883779|4759715|P1|Post-Study Treatment Phase|Ongoing in the study|0
1442867|NCT00883779|4759714|P2|Post-Study Treatment Phase|Other|0
1442868|NCT00883779|4759715|P1|Post-Study Treatment Phase|Other|3
1442869|NCT00883779|4759714|P2|Post-Study Treatment Phase|Disease progression|122
1442870|NCT00883779|4759715|P1|Post-Study Treatment Phase|Disease progression|103
1442871|NCT00883779|4759714|P2|Post-Study Treatment Phase|Refused Treatment|0
1442872|NCT00883779|4759715|P1|Post-Study Treatment Phase|Refused Treatment|3
1442873|NCT00883779|4759714|P2|Post-Study Treatment Phase|Protocol Violation|1
1442874|NCT00883779|4759715|P1|Post-Study Treatment Phase|Protocol Violation|0
1442875|NCT00883779|4759714|P2|Post-Study Treatment Phase|Death|3
1442876|NCT00883779|4759715|P1|Post-Study Treatment Phase|Death|1
1442877|NCT00883779|4759714|P2|Post-Study Treatment Phase|Adverse Event|3
1442878|NCT00883779|4759715|P1|Post-Study Treatment Phase|Adverse Event|2
1442879|NCT00883779|4759714|P2|Primary Study Treatment Phase|Other|0
1442880|NCT00883779|4759715|P1|Primary Study Treatment Phase|Other|3
1442881|NCT00883779|4759714|P2|Primary Study Treatment Phase|Refused Treatment|4
1442882|NCT00883779|4759715|P1|Primary Study Treatment Phase|Refused Treatment|5
1442883|NCT00883779|4759714|P2|Primary Study Treatment Phase|Death|3
1442884|NCT00883779|4759715|P1|Primary Study Treatment Phase|Death|2
1442885|NCT00883779|4759714|P2|Primary Study Treatment Phase|Adverse Event|16
1442886|NCT00883779|4759715|P1|Primary Study Treatment Phase|Adverse Event|16
1442887|NCT00883779|4759714|P2|Primary Study Treatment Phase|Disease progression|59
1442888|NCT00883779|4759715|P1|Primary Study Treatment Phase|Disease progression|75
1442889|NCT00883779|4759714|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
1442890|NCT00883779|4759715|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
1442891|NCT00883753|4759751|P1|Overall Study|Administrative/Other|8
1442892|NCT00883753|4759751|P1|Overall Study|Investigator's decision|17
1442893|NCT00883753|4759751|P1|Overall Study|Withdrew consent|10
1442894|NCT00883753|4759751|P1|Overall Study|Refused treatment|4
1442895|NCT00883753|4759751|P1|Overall Study|Protocol Violation|2
1442896|NCT00883753|4759751|P1|Overall Study|Violation of selection criteria at entry|7
1442897|NCT00883753|4759751|P1|Overall Study|Lost to Follow-up|4
1442898|NCT00883753|4759751|P1|Overall Study|Insufficient therapeutic response|16
1442899|NCT00883753|4759751|P1|Overall Study|Death|2
1442900|NCT00883753|4759751|P1|Overall Study|Adverse Event|37
1442901|NCT00883740|4759791|P2|Second Intervention|No longer willing to participate|1
1442902|NCT00883740|4759792|P1|Second Intervention|No longer willing to participate|0
1442903|NCT00883740|4759791|P2|Second Intervention|Protocol Violation|0
1442904|NCT00883740|4759792|P1|Second Intervention|Protocol Violation|1
1442905|NCT00883740|4759791|P2|First Intervention|Adverse Event|2
1442906|NCT00883740|4759792|P1|First Intervention|Adverse Event|1
1442907|NCT00883740|4759791|P2|First Intervention|Protocol Violation|6
1442908|NCT00883740|4759792|P1|First Intervention|Protocol Violation|3
1442909|NCT00883740|4759791|P2|First Intervention|No longer willing to participate|0
1442910|NCT00883740|4759792|P1|First Intervention|No longer willing to participate|2
1442911|NCT00883740|4759791|P2|First Intervention|Lost to Follow-up|0
1442912|NCT00883740|4759792|P1|First Intervention|Lost to Follow-up|1
1442913|NCT00883558|4759836|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
1442914|NCT00883558|4759837|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
1442915|NCT00883558|4759838|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
1442916|NCT00883558|4759836|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
1442917|NCT00883558|4759837|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
1442918|NCT00883558|4759838|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
1442919|NCT00883558|4759836|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
1442920|NCT00883558|4759837|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
1442921|NCT00883558|4759838|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
1442922|NCT00883558|4759836|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
1442923|NCT00883558|4759837|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
1442924|NCT00883558|4759838|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
1442925|NCT00883558|4759836|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
1442926|NCT00883558|4759837|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
1442927|NCT00883558|4759838|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
1442928|NCT00883493|4759850|P2|Overall Study|Not specified|3
1442929|NCT00883493|4759851|P1|Overall Study|Not specified|5
1442930|NCT00883493|4759850|P2|Overall Study|Study specific disc. criteria|0
1442931|NCT00883493|4759851|P1|Overall Study|Study specific disc. criteria|2
1442932|NCT00883493|4759850|P2|Overall Study|Eligibility Criteria not fullfilled|6
1442933|NCT00883493|4759851|P1|Overall Study|Eligibility Criteria not fullfilled|6
1442934|NCT00883493|4759850|P2|Overall Study|Withdrawal by Subject|20
1442935|NCT00883493|4759851|P1|Overall Study|Withdrawal by Subject|11
1442936|NCT00883493|4759850|P2|Overall Study|Lost to Follow-up|6
1442937|NCT00883493|4759851|P1|Overall Study|Lost to Follow-up|7
1442938|NCT00883493|4759850|P2|Overall Study|Lack of Efficacy|3
1442939|NCT00883493|4759851|P1|Overall Study|Lack of Efficacy|4
1442940|NCT00883493|4759850|P2|Overall Study|Adverse Event|12
1442941|NCT00883493|4759851|P1|Overall Study|Adverse Event|11
1442942|NCT00883337|4759882|P3|Extension Treatment Period|Other than above|5
1442943|NCT00883337|4759883|P2|Extension Treatment Period|Other than above|9
1442944|NCT00883337|4759884|P1|Extension Treatment Period|Other than above|10
1442945|NCT00883337|4759882|P3|Extension Treatment Period|Lost to Follow-up|0
1442946|NCT00883337|4759883|P2|Extension Treatment Period|Lost to Follow-up|0
1442947|NCT00883337|4759884|P1|Extension Treatment Period|Lost to Follow-up|1
1442948|NCT00883337|4759882|P3|Extension Treatment Period|Poor compliance to protocol|1
1442949|NCT00883337|4759883|P2|Extension Treatment Period|Poor compliance to protocol|1
1443035|NCT00882908|4760261|P4|Overall Study|Withdrawal by Subject|5
1442950|NCT00883337|4759884|P1|Extension Treatment Period|Poor compliance to protocol|1
1442951|NCT00883337|4759882|P3|Extension Treatment Period|Lack of Efficacy|8
1442952|NCT00883337|4759883|P2|Extension Treatment Period|Lack of Efficacy|8
1442953|NCT00883337|4759884|P1|Extension Treatment Period|Lack of Efficacy|8
1442954|NCT00883337|4759882|P3|Extension Treatment Period|Adverse Event|5
1442955|NCT00883337|4759883|P2|Extension Treatment Period|Adverse Event|5
1442956|NCT00883337|4759884|P1|Extension Treatment Period|Adverse Event|8
1442957|NCT00883337|4759882|P3|Core Treatment Period|Other than above|1
1442958|NCT00883337|4759883|P2|Core Treatment Period|Other than above|1
1442959|NCT00883337|4759884|P1|Core Treatment Period|Other than above|0
1442960|NCT00883337|4759882|P3|Core Treatment Period|Poor compliance to protocol|1
1442961|NCT00883337|4759883|P2|Core Treatment Period|Poor compliance to protocol|0
1442962|NCT00883337|4759884|P1|Core Treatment Period|Poor compliance to protocol|0
1442963|NCT00883337|4759882|P3|Core Treatment Period|Wish to be pregnant|1
1442964|NCT00883337|4759883|P2|Core Treatment Period|Wish to be pregnant|2
1442965|NCT00883337|4759884|P1|Core Treatment Period|Wish to be pregnant|1
1442966|NCT00883337|4759882|P3|Core Treatment Period|Withdrawal by Subject|6
1442967|NCT00883337|4759883|P2|Core Treatment Period|Withdrawal by Subject|2
1442968|NCT00883337|4759884|P1|Core Treatment Period|Withdrawal by Subject|2
1442969|NCT00883337|4759882|P3|Core Treatment Period|Lost to Follow-up|0
1442970|NCT00883337|4759883|P2|Core Treatment Period|Lost to Follow-up|1
1442971|NCT00883337|4759884|P1|Core Treatment Period|Lost to Follow-up|1
1442972|NCT00883337|4759882|P3|Core Treatment Period|Lack of Efficacy|2
1442973|NCT00883337|4759883|P2|Core Treatment Period|Lack of Efficacy|4
1442974|NCT00883337|4759884|P1|Core Treatment Period|Lack of Efficacy|7
1442975|NCT00883337|4759882|P3|Core Treatment Period|Adverse Event|22
1442976|NCT00883337|4759883|P2|Core Treatment Period|Adverse Event|12
1442977|NCT00883337|4759884|P1|Core Treatment Period|Adverse Event|9
1442978|NCT00883181|4759951|P1|Overall Study|Noncompliance|3
1442979|NCT00883181|4759951|P1|Overall Study|Protocol Deviation|3
1442980|NCT00883181|4759951|P1|Overall Study|Other|38
1442981|NCT00883181|4759951|P1|Overall Study|Death|31
1442982|NCT00883181|4759951|P1|Overall Study|Withdrawal by Subject|4
1442983|NCT00883181|4759951|P1|Overall Study|Administrative Reason|24
1442984|NCT00883181|4759951|P1|Overall Study|Disease Progression|94
1442985|NCT00883181|4759951|P1|Overall Study|Non-hematological Adverse Event|55
1442986|NCT00883181|4759951|P1|Overall Study|Hematological Adverse Event|26
1442987|NCT00883129|4760187|P2|Overall Study|Defined Treatment Failure|2
1442988|NCT00883129|4760188|P1|Overall Study|Defined Treatment Failure|0
1442989|NCT00883129|4760187|P2|Overall Study|Death|2
1442990|NCT00883129|4760188|P1|Overall Study|Death|1
1442991|NCT00883129|4760187|P2|Overall Study|Lost to Follow-up|2
1442992|NCT00883129|4760188|P1|Overall Study|Lost to Follow-up|1
1442993|NCT00883129|4760187|P2|Overall Study|Non-compliance|6
1442994|NCT00883129|4760188|P1|Overall Study|Non-compliance|3
1442995|NCT00883129|4760187|P2|Overall Study|Withdrawal by Subject|9
1442996|NCT00883129|4760188|P1|Overall Study|Withdrawal by Subject|8
1442997|NCT00883129|4760187|P2|Overall Study|Adverse Event|15
1442998|NCT00883129|4760188|P1|Overall Study|Adverse Event|7
1442999|NCT00883116|4760212|P2|Overall Study|No longer meets study criteria|2
1443000|NCT00883116|4760213|P1|Overall Study|No longer meets study criteria|2
1443001|NCT00883116|4760212|P2|Overall Study|Withdrawal by Subject|8
1443002|NCT00883116|4760213|P1|Overall Study|Withdrawal by Subject|14
1443003|NCT00883116|4760212|P2|Overall Study|Study drug toxicity|16
1443004|NCT00883116|4760213|P1|Overall Study|Study drug toxicity|36
1443005|NCT00883116|4760212|P2|Overall Study|Not identified|6
1443006|NCT00883116|4760213|P1|Overall Study|Not identified|3
1443007|NCT00883116|4760212|P2|Overall Study|Maximum clinical benefit|46
1443008|NCT00883116|4760213|P1|Overall Study|Maximum clinical benefit|13
1443009|NCT00883116|4760212|P2|Overall Study|Lost to Follow-up|1
1443010|NCT00883116|4760213|P1|Overall Study|Lost to Follow-up|0
1443011|NCT00883116|4760212|P2|Overall Study|Disease progression|128
1443012|NCT00883116|4760213|P1|Overall Study|Disease progression|130
1443013|NCT00883116|4760212|P2|Overall Study|Death|2
1443014|NCT00883116|4760213|P1|Overall Study|Death|6
1443015|NCT00883116|4760212|P2|Overall Study|Adverse event unrelated to study drug|10
1443016|NCT00883116|4760213|P1|Overall Study|Adverse event unrelated to study drug|5
1443017|NCT00883090|4760235|P1|Overall Study|Withdrawal by Subject|1
1443018|NCT00883090|4760235|P1|Overall Study|Sponsor's decision|1
1443019|NCT00882921|4760250|P1|Overall Study|Withdrawal Of Consent|1
1443020|NCT00882921|4760250|P1|Overall Study|Termination By Investigator|3
1443021|NCT00882921|4760250|P1|Overall Study|Lost to Follow-up|2
1443022|NCT00882921|4760250|P1|Overall Study|Not specified|3
1443023|NCT00882921|4760250|P1|Overall Study|Death|2
1443024|NCT00882908|4760260|P5|Overall Study|Study terminated in error|0
1443025|NCT00882908|4760261|P4|Overall Study|Study terminated in error|1
1443026|NCT00882908|4760262|P3|Overall Study|Study terminated in error|0
1443027|NCT00882908|4760263|P2|Overall Study|Study terminated in error|0
1443028|NCT00882908|4760264|P1|Overall Study|Study terminated in error|0
1443029|NCT00882908|4760260|P5|Overall Study|Subject reached a virologic endpoint|1
1443030|NCT00882908|4760261|P4|Overall Study|Subject reached a virologic endpoint|0
1443031|NCT00882908|4760262|P3|Overall Study|Subject reached a virologic endpoint|0
1443032|NCT00882908|4760263|P2|Overall Study|Subject reached a virologic endpoint|0
1443033|NCT00882908|4760264|P1|Overall Study|Subject reached a virologic endpoint|0
1443034|NCT00882908|4760260|P5|Overall Study|Withdrawal by Subject|2
1443036|NCT00882908|4760262|P3|Overall Study|Withdrawal by Subject|3
1443037|NCT00882908|4760263|P2|Overall Study|Withdrawal by Subject|0
1443038|NCT00882908|4760264|P1|Overall Study|Withdrawal by Subject|0
1443039|NCT00882908|4760260|P5|Overall Study|Protocol Violation|0
1443040|NCT00882908|4760261|P4|Overall Study|Protocol Violation|0
1443041|NCT00882908|4760262|P3|Overall Study|Protocol Violation|0
1443042|NCT00882908|4760263|P2|Overall Study|Protocol Violation|1
1443043|NCT00882908|4760264|P1|Overall Study|Protocol Violation|0
1443044|NCT00882908|4760260|P5|Overall Study|Lost to Follow-up|2
1443045|NCT00882908|4760261|P4|Overall Study|Lost to Follow-up|1
1443046|NCT00882908|4760262|P3|Overall Study|Lost to Follow-up|3
1443047|NCT00882908|4760263|P2|Overall Study|Lost to Follow-up|5
1443048|NCT00882908|4760264|P1|Overall Study|Lost to Follow-up|3
1443049|NCT00882908|4760260|P5|Overall Study|Adverse Event|1
1443050|NCT00882908|4760261|P4|Overall Study|Adverse Event|0
1443051|NCT00882908|4760262|P3|Overall Study|Adverse Event|1
1443052|NCT00882908|4760263|P2|Overall Study|Adverse Event|0
1443053|NCT00882908|4760264|P1|Overall Study|Adverse Event|0
1443054|NCT00882713|4760370|P1|Overall Study|Other - Reasons|2
1443055|NCT00882713|4760370|P1|Overall Study|Failure to return|2
1443056|NCT00882713|4760370|P1|Overall Study|Insufficient therapeutic response|3
1443057|NCT00882713|4760370|P1|Overall Study|Blood transfusion|2
1443058|NCT00882713|4760370|P1|Overall Study|refused treatment/withdrew consent|4
1443059|NCT00882713|4760370|P1|Overall Study|Administrative reasons|4
1443060|NCT00882713|4760370|P1|Overall Study|Death|3
1443061|NCT00882713|4760370|P1|Overall Study|Adverse Event|2
1443062|NCT00882583|4760463|P2|Overall Study|Adverse Event|1
1443063|NCT00882583|4760464|P1|Overall Study|Adverse Event|0
1443064|NCT00882583|4760463|P2|Overall Study|Physician Decision|0
1443065|NCT00882583|4760464|P1|Overall Study|Physician Decision|1
1443066|NCT00882557|4760472|P2|Overall Study|Randomized Not Treated|1
1443067|NCT00882557|4760473|P1|Overall Study|Randomized Not Treated|0
1443068|NCT00882557|4760472|P2|Overall Study|Trouble with Vein Access|0
1443069|NCT00882557|4760473|P1|Overall Study|Trouble with Vein Access|1
1443070|NCT00882557|4760472|P2|Overall Study|Withdrawal by Subject|0
1443071|NCT00882557|4760473|P1|Overall Study|Withdrawal by Subject|1
1443072|NCT00882518|4760493|P2|Overall Study|Allocating random number by mistake|1
1443073|NCT00882518|4760494|P1|Overall Study|Allocating random number by mistake|0
1443074|NCT00882518|4760493|P2|Overall Study|Central lab closure for National day|0
1443075|NCT00882518|4760494|P1|Overall Study|Central lab closure for National day|1
1443076|NCT00882518|4760493|P2|Overall Study|Incorrect enrolment|2
1443077|NCT00882518|4760494|P1|Overall Study|Incorrect enrolment|4
1443078|NCT00882518|4760493|P2|Overall Study|Severe non-compliance to protocol|1
1443079|NCT00882518|4760494|P1|Overall Study|Severe non-compliance to protocol|3
1443080|NCT00882518|4760493|P2|Overall Study|Lack of Efficacy|9
1443081|NCT00882518|4760494|P1|Overall Study|Lack of Efficacy|12
1443082|NCT00882518|4760493|P2|Overall Study|Withdrawal by Subject|13
1443083|NCT00882518|4760494|P1|Overall Study|Withdrawal by Subject|9
1443084|NCT00882518|4760493|P2|Overall Study|Adverse Event|18
1443085|NCT00882518|4760494|P1|Overall Study|Adverse Event|9
1443086|NCT00882440|4760523|P7|Overall Study|Patient Uncooperative|0
1443087|NCT00882440|4760524|P6|Overall Study|Patient Uncooperative|0
1443088|NCT00882440|4760525|P5|Overall Study|Patient Uncooperative|1
1443089|NCT00882440|4760526|P4|Overall Study|Patient Uncooperative|0
1443090|NCT00882440|4760527|P3|Overall Study|Patient Uncooperative|0
1443091|NCT00882440|4760528|P2|Overall Study|Patient Uncooperative|0
1443092|NCT00882440|4760529|P1|Overall Study|Patient Uncooperative|2
1443093|NCT00882440|4760523|P7|Overall Study|Withdrawal by Subject|1
1443094|NCT00882440|4760524|P6|Overall Study|Withdrawal by Subject|0
1443095|NCT00882440|4760525|P5|Overall Study|Withdrawal by Subject|6
1443096|NCT00882440|4760526|P4|Overall Study|Withdrawal by Subject|0
1443097|NCT00882440|4760527|P3|Overall Study|Withdrawal by Subject|1
1443098|NCT00882440|4760528|P2|Overall Study|Withdrawal by Subject|1
1443099|NCT00882440|4760529|P1|Overall Study|Withdrawal by Subject|2
1443100|NCT00882440|4760523|P7|Overall Study|Protocol Violation|0
1443101|NCT00882440|4760524|P6|Overall Study|Protocol Violation|0
1443102|NCT00882440|4760525|P5|Overall Study|Protocol Violation|1
1443103|NCT00882440|4760526|P4|Overall Study|Protocol Violation|1
1443104|NCT00882440|4760527|P3|Overall Study|Protocol Violation|1
1443105|NCT00882440|4760528|P2|Overall Study|Protocol Violation|0
1443106|NCT00882440|4760529|P1|Overall Study|Protocol Violation|0
1443107|NCT00882440|4760523|P7|Overall Study|Lost to Follow-up|1
1443108|NCT00882440|4760524|P6|Overall Study|Lost to Follow-up|0
1443109|NCT00882440|4760525|P5|Overall Study|Lost to Follow-up|1
1443110|NCT00882440|4760526|P4|Overall Study|Lost to Follow-up|1
1443111|NCT00882440|4760527|P3|Overall Study|Lost to Follow-up|1
1443112|NCT00882440|4760528|P2|Overall Study|Lost to Follow-up|0
1443113|NCT00882440|4760529|P1|Overall Study|Lost to Follow-up|2
1443114|NCT00882440|4760523|P7|Overall Study|Lack of Efficacy|0
1443115|NCT00882440|4760524|P6|Overall Study|Lack of Efficacy|3
1443116|NCT00882440|4760525|P5|Overall Study|Lack of Efficacy|0
1443117|NCT00882440|4760526|P4|Overall Study|Lack of Efficacy|0
1443118|NCT00882440|4760527|P3|Overall Study|Lack of Efficacy|2
1443119|NCT00882440|4760528|P2|Overall Study|Lack of Efficacy|5
1443120|NCT00882440|4760529|P1|Overall Study|Lack of Efficacy|3
1443121|NCT00882440|4760523|P7|Overall Study|Adverse Event|2
1443122|NCT00882440|4760524|P6|Overall Study|Adverse Event|4
1443123|NCT00882440|4760525|P5|Overall Study|Adverse Event|1
1443124|NCT00882440|4760526|P4|Overall Study|Adverse Event|1
1443125|NCT00882440|4760527|P3|Overall Study|Adverse Event|2
1443126|NCT00882440|4760528|P2|Overall Study|Adverse Event|2
1443127|NCT00882440|4760529|P1|Overall Study|Adverse Event|2
1443128|NCT00882362|4760554|P2|Overall Study|change of residence or other commitments|0
1443129|NCT00882362|4760555|P1|Overall Study|change of residence or other commitments|5
1443130|NCT00882362|4760554|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
1443131|NCT00882362|4760555|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
1443132|NCT00882362|4760554|P2|Overall Study|Physician Decision|1
1443133|NCT00882362|4760555|P1|Overall Study|Physician Decision|5
1443134|NCT00882362|4760554|P2|Overall Study|Pregnancy|0
1443135|NCT00882362|4760555|P1|Overall Study|Pregnancy|1
1443136|NCT00882362|4760554|P2|Overall Study|Protocol Violation|2
1443137|NCT00882362|4760555|P1|Overall Study|Protocol Violation|7
1443138|NCT00882362|4760554|P2|Overall Study|Lack of Efficacy|0
1443139|NCT00882362|4760555|P1|Overall Study|Lack of Efficacy|3
1443140|NCT00882362|4760554|P2|Overall Study|Withdrawal by Subject|10
1443141|NCT00882362|4760555|P1|Overall Study|Withdrawal by Subject|13
1443142|NCT00882362|4760554|P2|Overall Study|Adverse Event|10
1443143|NCT00882362|4760555|P1|Overall Study|Adverse Event|13
1443144|NCT00882310|4760561|P1|Overall Study|Adverse Event|1
1443145|NCT00882310|4760561|P1|Overall Study|Progression of disease|4
1443146|NCT00882310|4760561|P1|Overall Study|Death|6
1443147|NCT00882310|4760561|P1|Overall Study|Never received treatment|1
1443148|NCT00882310|4760561|P1|Overall Study|Screen Failure|10
1443149|NCT00881959|4760580|P2|Overall Study|Lost to Follow-up|4
1443150|NCT00881959|4760581|P1|Overall Study|Lost to Follow-up|2
1443151|NCT00881894|4760589|P2|Overall Study|Other reasons for premature termination|2
1443152|NCT00881894|4760590|P1|Overall Study|Other reasons for premature termination|1
1443153|NCT00881894|4760589|P2|Overall Study|Consent withdrawn|1
1443154|NCT00881894|4760590|P1|Overall Study|Consent withdrawn|0
1443155|NCT00881868|4760622|P2|Overall Study|Protocol Violation|0
1443156|NCT00881868|4760623|P1|Overall Study|Protocol Violation|2
1443157|NCT00881868|4760622|P2|Overall Study|Physician Decision|0
1443158|NCT00881868|4760623|P1|Overall Study|Physician Decision|4
1443159|NCT00881868|4760622|P2|Overall Study|Lost to Follow-up|1
1443160|NCT00881868|4760623|P1|Overall Study|Lost to Follow-up|2
1443161|NCT00881868|4760622|P2|Overall Study|Adverse Event|1
1443162|NCT00881868|4760623|P1|Overall Study|Adverse Event|0
1443163|NCT00881751|4760637|P2|Overall Study|Withdrawal by Subject|2
1443164|NCT00881751|4760638|P1|Overall Study|Withdrawal by Subject|0
1443165|NCT00881751|4760637|P2|Overall Study|Adverse Event|2
1443166|NCT00881751|4760638|P1|Overall Study|Adverse Event|0
1443167|NCT00881751|4760637|P2|Overall Study|Physician Decision|1
1443168|NCT00881751|4760638|P1|Overall Study|Physician Decision|0
1443169|NCT00881712|4760653|P3|Overall Study|Withdrawal by Subject|0
1443170|NCT00881712|4760654|P2|Overall Study|Withdrawal by Subject|0
1443171|NCT00881712|4760655|P1|Overall Study|Withdrawal by Subject|1
1443172|NCT00881712|4760653|P3|Overall Study|Death|0
1443173|NCT00881712|4760654|P2|Overall Study|Death|0
1443174|NCT00881712|4760655|P1|Overall Study|Death|1
1443175|NCT00881621|4760688|P1|Overall Study|Physician Decision|34
1443176|NCT00881608|4760700|P1|Overall Study|Study prematurely terminated|11
1443177|NCT00881530|4760723|P6|Overall Study|Other reason not defined above|2
1443178|NCT00881530|4760724|P5|Overall Study|Other reason not defined above|0
1443179|NCT00881530|4760725|P4|Overall Study|Other reason not defined above|0
1443180|NCT00881530|4760726|P3|Overall Study|Other reason not defined above|2
1443181|NCT00881530|4760727|P2|Overall Study|Other reason not defined above|1
1443182|NCT00881530|4760728|P1|Overall Study|Other reason not defined above|1
1443183|NCT00881530|4760723|P6|Overall Study|Refused to continue medication|0
1443184|NCT00881530|4760724|P5|Overall Study|Refused to continue medication|0
1443185|NCT00881530|4760725|P4|Overall Study|Refused to continue medication|2
1443186|NCT00881530|4760726|P3|Overall Study|Refused to continue medication|1
1443187|NCT00881530|4760727|P2|Overall Study|Refused to continue medication|2
1443188|NCT00881530|4760728|P1|Overall Study|Refused to continue medication|7
1443189|NCT00881530|4760723|P6|Overall Study|Lost to Follow-up|0
1443190|NCT00881530|4760724|P5|Overall Study|Lost to Follow-up|1
1443191|NCT00881530|4760725|P4|Overall Study|Lost to Follow-up|3
1443192|NCT00881530|4760726|P3|Overall Study|Lost to Follow-up|1
1443193|NCT00881530|4760727|P2|Overall Study|Lost to Follow-up|1
1443194|NCT00881530|4760728|P1|Overall Study|Lost to Follow-up|0
1443195|NCT00881530|4760723|P6|Overall Study|Not compliant with the protocol|0
1443196|NCT00881530|4760724|P5|Overall Study|Not compliant with the protocol|2
1443197|NCT00881530|4760725|P4|Overall Study|Not compliant with the protocol|0
1443198|NCT00881530|4760726|P3|Overall Study|Not compliant with the protocol|0
1443199|NCT00881530|4760727|P2|Overall Study|Not compliant with the protocol|0
1443200|NCT00881530|4760728|P1|Overall Study|Not compliant with the protocol|0
1443201|NCT00881530|4760723|P6|Overall Study|Lack of Efficacy|1
1443202|NCT00881530|4760724|P5|Overall Study|Lack of Efficacy|1
1443203|NCT00881530|4760725|P4|Overall Study|Lack of Efficacy|0
1443204|NCT00881530|4760726|P3|Overall Study|Lack of Efficacy|0
1443205|NCT00881530|4760727|P2|Overall Study|Lack of Efficacy|0
1443206|NCT00881530|4760728|P1|Overall Study|Lack of Efficacy|1
1443207|NCT00881530|4760723|P6|Overall Study|Adverse Event|2
1443208|NCT00881530|4760724|P5|Overall Study|Adverse Event|10
1443209|NCT00881530|4760725|P4|Overall Study|Adverse Event|4
1443210|NCT00881530|4760726|P3|Overall Study|Adverse Event|1
1443211|NCT00881530|4760727|P2|Overall Study|Adverse Event|1
1443212|NCT00881530|4760728|P1|Overall Study|Adverse Event|5
1443213|NCT00881504|4760784|P1|Overall Study|Withdrawal by Subject|1
1443214|NCT00881335|4760804|P2|Overall Study|Lost to Follow-up|2
1443215|NCT00881335|4760805|P1|Overall Study|Lost to Follow-up|3
1443216|NCT00881205|4760825|P2|Overall Study|Condition no longer requires drug|0
1443217|NCT00881205|4760826|P1|Overall Study|Condition no longer requires drug|1
1443218|NCT00881205|4760825|P2|Overall Study|Administrative problems|1
1443219|NCT00881205|4760826|P1|Overall Study|Administrative problems|1
1443220|NCT00881205|4760825|P2|Overall Study|Lost to Follow-up|1
1443221|NCT00881205|4760826|P1|Overall Study|Lost to Follow-up|0
1443222|NCT00881205|4760825|P2|Overall Study|Withdrawal by Subject|2
1443223|NCT00881205|4760826|P1|Overall Study|Withdrawal by Subject|1
1443224|NCT00881205|4760825|P2|Overall Study|Adverse Event|3
1443225|NCT00881205|4760826|P1|Overall Study|Adverse Event|8
1443226|NCT00880906|4760872|P2|Overall Study|Did not meet criteria following patholog|6
1443227|NCT00880906|4760873|P1|Overall Study|Did not meet criteria following patholog|12
1443228|NCT00880906|4760872|P2|Overall Study|Lost to Follow-up|1
1443229|NCT00880906|4760873|P1|Overall Study|Lost to Follow-up|0
1443230|NCT00880763|4760885|P4|Extension Period (Part 2)|Lack of Efficacy|1
1443231|NCT00880763|4760886|P3|Extension Period (Part 2)|Lack of Efficacy|0
1443232|NCT00880763|4760887|P2|Extension Period (Part 2)|Lack of Efficacy|0
1443233|NCT00880763|4760888|P1|Extension Period (Part 2)|Lack of Efficacy|0
1443234|NCT00880763|4760885|P4|Extension Period (Part 2)|Physician Decision|0
1443235|NCT00880763|4760886|P3|Extension Period (Part 2)|Physician Decision|1
1443236|NCT00880763|4760887|P2|Extension Period (Part 2)|Physician Decision|1
1443237|NCT00880763|4760888|P1|Extension Period (Part 2)|Physician Decision|0
1443238|NCT00880763|4760885|P4|Extension Period (Part 2)|Withdrawal by Subject|1
1443239|NCT00880763|4760886|P3|Extension Period (Part 2)|Withdrawal by Subject|1
1443240|NCT00880763|4760887|P2|Extension Period (Part 2)|Withdrawal by Subject|2
1443241|NCT00880763|4760888|P1|Extension Period (Part 2)|Withdrawal by Subject|0
1443242|NCT00880763|4760885|P4|Extension Period (Part 2)|Adverse Event|1
1443243|NCT00880763|4760886|P3|Extension Period (Part 2)|Adverse Event|1
1443244|NCT00880763|4760887|P2|Extension Period (Part 2)|Adverse Event|0
1443245|NCT00880763|4760888|P1|Extension Period (Part 2)|Adverse Event|0
1443246|NCT00880750|4760920|P2|Second Intervention|Unable to collect urine|0
1443247|NCT00880750|4760921|P1|Second Intervention|Unable to collect urine|1
1443248|NCT00880750|4760920|P2|Second Intervention|Protocol Violation|0
1443249|NCT00880750|4760921|P1|Second Intervention|Protocol Violation|1
1443250|NCT00880750|4760920|P2|Second Intervention|Withdrawal by Subject|2
1443251|NCT00880750|4760921|P1|Second Intervention|Withdrawal by Subject|2
1443252|NCT00880750|4760920|P2|First Intervention|Lost to Follow-up|0
1443253|NCT00880750|4760921|P1|First Intervention|Lost to Follow-up|2
1443254|NCT00880750|4760920|P2|First Intervention|Withdrawal by Subject|0
1443255|NCT00880750|4760921|P1|First Intervention|Withdrawal by Subject|2
1443256|NCT00880750|4760920|P2|First Intervention|Non-compliance with meals|1
1443257|NCT00880750|4760921|P1|First Intervention|Non-compliance with meals|0
1443258|NCT00880750|4760920|P2|First Intervention|Unable to collect urine|0
1443259|NCT00880750|4760921|P1|First Intervention|Unable to collect urine|4
1443260|NCT00880750|4760920|P2|First Intervention|Adverse Event|0
1443261|NCT00880750|4760921|P1|First Intervention|Adverse Event|1
1443262|NCT00880698|4760939|P4|Overall Study|Lost to Follow-up|1
1443263|NCT00880698|4760940|P3|Overall Study|Lost to Follow-up|0
1443264|NCT00880698|4760941|P2|Overall Study|Lost to Follow-up|3
1443265|NCT00880698|4760942|P1|Overall Study|Lost to Follow-up|1
1443266|NCT00880698|4760939|P4|Overall Study|Death|2
1443267|NCT00880698|4760940|P3|Overall Study|Death|1
1443268|NCT00880698|4760941|P2|Overall Study|Death|0
1443269|NCT00880698|4760942|P1|Overall Study|Death|0
1443270|NCT00880685|4760968|P1|Memantine 20mg|Withdrawal by Subject|1
1443271|NCT00880685|4760968|P1|Memantine 10mg|Lost to Follow-up|2
1443272|NCT00880620|4760980|P4|Overall Study|Not specified|2
1443273|NCT00880620|4760981|P3|Overall Study|Not specified|2
1443274|NCT00880620|4760982|P2|Overall Study|Not specified|1
1443275|NCT00880620|4760983|P1|Overall Study|Not specified|1
1443276|NCT00880620|4760980|P4|Overall Study|Noncompliance|1
1443277|NCT00880620|4760981|P3|Overall Study|Noncompliance|1
1443278|NCT00880620|4760982|P2|Overall Study|Noncompliance|0
1443279|NCT00880620|4760983|P1|Overall Study|Noncompliance|0
1443280|NCT00880620|4760980|P4|Overall Study|Withdrawal by Subject|3
1443281|NCT00880620|4760981|P3|Overall Study|Withdrawal by Subject|1
1443282|NCT00880620|4760982|P2|Overall Study|Withdrawal by Subject|3
1443283|NCT00880620|4760983|P1|Overall Study|Withdrawal by Subject|4
1443284|NCT00880620|4760980|P4|Overall Study|Protocol Violation|2
1443285|NCT00880620|4760981|P3|Overall Study|Protocol Violation|0
1443286|NCT00880620|4760982|P2|Overall Study|Protocol Violation|1
1443287|NCT00880620|4760983|P1|Overall Study|Protocol Violation|0
1443288|NCT00880620|4760980|P4|Overall Study|Lost to Follow-up|0
1443289|NCT00880620|4760981|P3|Overall Study|Lost to Follow-up|1
1443290|NCT00880620|4760982|P2|Overall Study|Lost to Follow-up|1
1443291|NCT00880620|4760983|P1|Overall Study|Lost to Follow-up|0
1443292|NCT00880620|4760980|P4|Overall Study|Lack of Efficacy|1
1443293|NCT00880620|4760981|P3|Overall Study|Lack of Efficacy|0
1443294|NCT00880620|4760982|P2|Overall Study|Lack of Efficacy|4
1443295|NCT00880620|4760983|P1|Overall Study|Lack of Efficacy|12
1443296|NCT00880620|4760980|P4|Overall Study|Death|0
1443297|NCT00880620|4760981|P3|Overall Study|Death|1
1443298|NCT00880620|4760982|P2|Overall Study|Death|0
1443299|NCT00880620|4760983|P1|Overall Study|Death|0
1443300|NCT00880620|4760980|P4|Overall Study|Adverse Event|15
1443301|NCT00880620|4760981|P3|Overall Study|Adverse Event|15
1443302|NCT00880620|4760982|P2|Overall Study|Adverse Event|5
1443303|NCT00880620|4760983|P1|Overall Study|Adverse Event|4
1443304|NCT00880568|4761011|P9|Overall Study|Withdrawal by Subject|0
1443305|NCT00880568|4761012|P8|Overall Study|Withdrawal by Subject|1
1443306|NCT00880568|4761013|P7|Overall Study|Withdrawal by Subject|0
1443307|NCT00880568|4761014|P6|Overall Study|Withdrawal by Subject|0
1443308|NCT00880568|4761015|P5|Overall Study|Withdrawal by Subject|0
1443309|NCT00880568|4761016|P4|Overall Study|Withdrawal by Subject|0
1443310|NCT00880568|4761017|P3|Overall Study|Withdrawal by Subject|0
1443311|NCT00880568|4761018|P2|Overall Study|Withdrawal by Subject|0
1443312|NCT00880568|4761019|P1|Overall Study|Withdrawal by Subject|0
1443313|NCT00880568|4761011|P9|Overall Study|Adverse Event|0
1443314|NCT00880568|4761012|P8|Overall Study|Adverse Event|1
1443315|NCT00880568|4761013|P7|Overall Study|Adverse Event|1
1443316|NCT00880568|4761014|P6|Overall Study|Adverse Event|0
1443317|NCT00880568|4761015|P5|Overall Study|Adverse Event|0
1443318|NCT00880568|4761016|P4|Overall Study|Adverse Event|0
1443319|NCT00880568|4761017|P3|Overall Study|Adverse Event|0
1443320|NCT00880568|4761018|P2|Overall Study|Adverse Event|0
1443321|NCT00880568|4761019|P1|Overall Study|Adverse Event|0
1443322|NCT00880568|4761011|P9|Overall Study|Disease progression|3
1443323|NCT00880568|4761012|P8|Overall Study|Disease progression|0
1443324|NCT00880568|4761013|P7|Overall Study|Disease progression|5
1443325|NCT00880568|4761014|P6|Overall Study|Disease progression|3
1443326|NCT00880568|4761015|P5|Overall Study|Disease progression|3
1443327|NCT00880568|4761016|P4|Overall Study|Disease progression|1
1443328|NCT00880568|4761017|P3|Overall Study|Disease progression|3
1443329|NCT00880568|4761018|P2|Overall Study|Disease progression|3
1443330|NCT00880568|4761019|P1|Overall Study|Disease progression|3
1443331|NCT00880555|4761065|P6|Overall Study|Lost to Follow-up|0
1443332|NCT00880555|4761066|P5|Overall Study|Lost to Follow-up|0
1443333|NCT00880555|4761067|P4|Overall Study|Lost to Follow-up|0
1443334|NCT00880555|4761068|P3|Overall Study|Lost to Follow-up|0
1443335|NCT00880555|4761069|P2|Overall Study|Lost to Follow-up|1
1443336|NCT00880555|4761070|P1|Overall Study|Lost to Follow-up|0
1443337|NCT00880555|4761065|P6|Overall Study|Death|1
1443338|NCT00880555|4761066|P5|Overall Study|Death|0
1443339|NCT00880555|4761067|P4|Overall Study|Death|0
1443340|NCT00880555|4761068|P3|Overall Study|Death|0
1443341|NCT00880555|4761069|P2|Overall Study|Death|0
1443342|NCT00880555|4761070|P1|Overall Study|Death|0
1443343|NCT00880555|4761065|P6|Overall Study|Lack of resources (hired rater)|0
1443344|NCT00880555|4761066|P5|Overall Study|Lack of resources (hired rater)|0
1443345|NCT00880555|4761067|P4|Overall Study|Lack of resources (hired rater)|0
1443346|NCT00880555|4761068|P3|Overall Study|Lack of resources (hired rater)|5
1443347|NCT00880555|4761069|P2|Overall Study|Lack of resources (hired rater)|7
1443348|NCT00880555|4761070|P1|Overall Study|Lack of resources (hired rater)|9
1443349|NCT00880555|4761065|P6|Overall Study|Withdrawal by Subject|0
1443350|NCT00880555|4761066|P5|Overall Study|Withdrawal by Subject|0
1443351|NCT00880555|4761067|P4|Overall Study|Withdrawal by Subject|0
1443352|NCT00880555|4761068|P3|Overall Study|Withdrawal by Subject|0
1443353|NCT00880555|4761069|P2|Overall Study|Withdrawal by Subject|1
1443354|NCT00880555|4761070|P1|Overall Study|Withdrawal by Subject|1
1443355|NCT00880555|4761065|P6|Overall Study|Physician Decision|0
1443356|NCT00880555|4761066|P5|Overall Study|Physician Decision|1
1443357|NCT00880555|4761067|P4|Overall Study|Physician Decision|2
1443358|NCT00880555|4761068|P3|Overall Study|Physician Decision|0
1443359|NCT00880555|4761069|P2|Overall Study|Physician Decision|8
1443360|NCT00880555|4761070|P1|Overall Study|Physician Decision|0
1443361|NCT00880542|4761081|P1|REP: Surgical Resection|progressive disease|1
1443362|NCT00880542|4761081|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
1443363|NCT00880542|4761081|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
1443364|NCT00880399|4761098|P3|Overall Study|Withdrawal by Subject|3
1443365|NCT00880399|4761099|P2|Overall Study|Withdrawal by Subject|3
1443366|NCT00880399|4761100|P1|Overall Study|Withdrawal by Subject|6
1443367|NCT00880399|4761098|P3|Overall Study|Physician Decision|3
1443368|NCT00880399|4761099|P2|Overall Study|Physician Decision|0
1443369|NCT00880399|4761100|P1|Overall Study|Physician Decision|5
1443370|NCT00880399|4761098|P3|Overall Study|Lost to Follow-up|3
1443371|NCT00880399|4761099|P2|Overall Study|Lost to Follow-up|5
1443372|NCT00880399|4761100|P1|Overall Study|Lost to Follow-up|8
1443373|NCT00880399|4761098|P3|Overall Study|Study closed/terminated|4
1443374|NCT00880399|4761099|P2|Overall Study|Study closed/terminated|7
1443375|NCT00880399|4761100|P1|Overall Study|Study closed/terminated|3
1443376|NCT00880399|4761098|P3|Overall Study|Protocol Violation|6
1443377|NCT00880399|4761099|P2|Overall Study|Protocol Violation|4
1443378|NCT00880399|4761100|P1|Overall Study|Protocol Violation|4
1443379|NCT00880399|4761098|P3|Overall Study|Lack of Efficacy|2
1443380|NCT00880399|4761099|P2|Overall Study|Lack of Efficacy|4
1443381|NCT00880399|4761100|P1|Overall Study|Lack of Efficacy|1
1443382|NCT00880399|4761098|P3|Overall Study|Adverse Event|5
1443383|NCT00880399|4761099|P2|Overall Study|Adverse Event|6
1443384|NCT00880399|4761100|P1|Overall Study|Adverse Event|4
1443385|NCT00880334|4761163|P2|Randomized Phase|Crossover Participants|37
1443386|NCT00880334|4761164|P1|Randomized Phase|Crossover Participants|0
1443387|NCT00880334|4761163|P2|Randomized Phase|Brain Metastasis|1
1443388|NCT00880334|4761164|P1|Randomized Phase|Brain Metastasis|0
1443389|NCT00880334|4761163|P2|Randomized Phase|Inadequate Labs|1
1443390|NCT00880334|4761164|P1|Randomized Phase|Inadequate Labs|1
1443391|NCT00880334|4761163|P2|Randomized Phase|Withdrawal by Subject|1
1443392|NCT00880334|4761164|P1|Randomized Phase|Withdrawal by Subject|2
1443393|NCT00880334|4761163|P2|Randomized Phase|Physician Decision|0
1443394|NCT00880334|4761164|P1|Randomized Phase|Physician Decision|1
1443395|NCT00880269|4761181|P2|Overall Study|Adverse Event|9
1443396|NCT00880269|4761182|P1|Overall Study|Adverse Event|10
1443397|NCT00880269|4761181|P2|Overall Study|Withdrawal by Subject|4
1443398|NCT00880269|4761182|P1|Overall Study|Withdrawal by Subject|3
1443399|NCT00880269|4761181|P2|Overall Study|Lost to Follow-up|1
1443400|NCT00880269|4761182|P1|Overall Study|Lost to Follow-up|0
1443401|NCT00880269|4761181|P2|Overall Study|Death|2
1443402|NCT00880269|4761182|P1|Overall Study|Death|4
1443403|NCT00880269|4761181|P2|Overall Study|New Cancer Therapy|0
1443404|NCT00880269|4761182|P1|Overall Study|New Cancer Therapy|1
1443405|NCT00880269|4761181|P2|Overall Study|Disease Progression|11
1443406|NCT00880269|4761182|P1|Overall Study|Disease Progression|13
1443407|NCT00880269|4761181|P2|Overall Study|Protocol Violation|0
1443408|NCT00880269|4761182|P1|Overall Study|Protocol Violation|1
1443409|NCT00880256|4761198|P1|Overall Study|Lost to Follow-up|28
1443410|NCT00880191|4761225|P2|Overall Study|Hospitalization/efficacy|1
1443411|NCT00880191|4761226|P1|Overall Study|Hospitalization/efficacy|1
1443412|NCT00880191|4761225|P2|Overall Study|Adverse Event|6
1443413|NCT00880191|4761226|P1|Overall Study|Adverse Event|8
1443414|NCT00880191|4761225|P2|Overall Study|Refused further treatment|1
1443415|NCT00880191|4761226|P1|Overall Study|Refused further treatment|4
1443416|NCT00880165|4761246|P2|Overall Study|Lost to follow|15
1443417|NCT00880165|4761247|P1|Overall Study|Lost to follow|9
1443418|NCT00880165|4761246|P2|Overall Study|Required BIPAP or oxygen treatment|4
1443419|NCT00880165|4761247|P1|Overall Study|Required BIPAP or oxygen treatment|12
1443420|NCT00880165|4761246|P2|Overall Study|Not diagnosed with OSA|8
1443421|NCT00880165|4761247|P1|Overall Study|Not diagnosed with OSA|14
1443422|NCT00880165|4761246|P2|Overall Study|Withdrawal by Subject|23
1443423|NCT00880165|4761247|P1|Overall Study|Withdrawal by Subject|27
1443424|NCT00880100|4761257|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
1443425|NCT00880100|4761257|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
1443426|NCT00880100|4761257|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
1443427|NCT00880087|4761270|P2|Overall Study|Lost to Follow-up|2
1443428|NCT00880087|4761271|P1|Overall Study|Lost to Follow-up|0
1443429|NCT00880048|4761286|P3|Overall Study|Study closed/terminated|6
1443430|NCT00880048|4761287|P2|Overall Study|Study closed/terminated|7
1443431|NCT00880048|4761288|P1|Overall Study|Study closed/terminated|9
1443432|NCT00880048|4761286|P3|Overall Study|Withdrawal by Subject|5
1443433|NCT00880048|4761287|P2|Overall Study|Withdrawal by Subject|8
1443434|NCT00880048|4761288|P1|Overall Study|Withdrawal by Subject|5
1443435|NCT00880048|4761286|P3|Overall Study|Physician Decision|7
1443436|NCT00880048|4761287|P2|Overall Study|Physician Decision|1
1443437|NCT00880048|4761288|P1|Overall Study|Physician Decision|1
1443438|NCT00880048|4761286|P3|Overall Study|Lost to Follow-up|5
1443439|NCT00880048|4761287|P2|Overall Study|Lost to Follow-up|6
1443440|NCT00880048|4761288|P1|Overall Study|Lost to Follow-up|6
1443441|NCT00880048|4761286|P3|Overall Study|Protocol Violation|5
1443442|NCT00880048|4761287|P2|Overall Study|Protocol Violation|6
1443443|NCT00880048|4761288|P1|Overall Study|Protocol Violation|4
1443444|NCT00880048|4761286|P3|Overall Study|Lack of Efficacy|2
1443445|NCT00880048|4761287|P2|Overall Study|Lack of Efficacy|2
1443446|NCT00880048|4761288|P1|Overall Study|Lack of Efficacy|1
1443447|NCT00880048|4761286|P3|Overall Study|Adverse Event|5
1443448|NCT00880048|4761287|P2|Overall Study|Adverse Event|3
1443449|NCT00880048|4761288|P1|Overall Study|Adverse Event|2
1443450|NCT00880009|4761355|P1|Overall Study|Protocol Violation|1
1443451|NCT00880009|4761355|P1|Overall Study|Withdrawal by Subject|1
1443452|NCT00880009|4761355|P1|Overall Study|Study terminated by sponsor|14
1443453|NCT00879996|4761379|P2|Overall Study|put on parole|0
1443454|NCT00879996|4761380|P1|Overall Study|put on parole|1
1443455|NCT00879996|4761379|P2|Overall Study|psychiatric problem|1
1443456|NCT00879996|4761380|P1|Overall Study|psychiatric problem|0
1443457|NCT00879996|4761379|P2|Overall Study|Physician Decision|2
1443458|NCT00879996|4761380|P1|Overall Study|Physician Decision|1
1443459|NCT00879996|4761379|P2|Overall Study|non-compliance|4
1443460|NCT00879996|4761380|P1|Overall Study|non-compliance|6
1443461|NCT00879996|4761379|P2|Overall Study|Lost to Follow-up|6
1443462|NCT00879996|4761380|P1|Overall Study|Lost to Follow-up|7
1443463|NCT00879970|4761395|P5|Period 2 Vitamin D Randomization|Death|0
1443464|NCT00879970|4761396|P4|Period 2 Vitamin D Randomization|Death|2
1443465|NCT00879970|4761397|P3|Period 2 Vitamin D Randomization|Death|0
1443466|NCT00879970|4761398|P2|Period 2 Vitamin D Randomization|Death|0
1443467|NCT00879970|4761399|P1|Period 2 Vitamin D Randomization|Death|0
1443468|NCT00879970|4761395|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
1443469|NCT00879970|4761396|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
1443470|NCT00879970|4761397|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
1443471|NCT00879970|4761398|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
1443472|NCT00879970|4761399|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
1443473|NCT00879970|4761395|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
1443474|NCT00879970|4761396|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
1443475|NCT00879970|4761397|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
1443476|NCT00879970|4761398|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
1443477|NCT00879970|4761399|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
1443478|NCT00879970|4761395|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
1443479|NCT00879970|4761396|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
1443480|NCT00879970|4761397|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
1443481|NCT00879970|4761398|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
1443482|NCT00879970|4761399|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
1443483|NCT00879970|4761395|P5|Period 1 TZD Randomization|Death|0
1443484|NCT00879970|4761396|P4|Period 1 TZD Randomization|Death|0
1443485|NCT00879970|4761397|P3|Period 1 TZD Randomization|Death|0
1443486|NCT00879970|4761398|P2|Period 1 TZD Randomization|Death|1
1443487|NCT00879970|4761399|P1|Period 1 TZD Randomization|Death|2
1443488|NCT00879970|4761395|P5|Period 1 TZD Randomization|Lost to Follow-up|0
1443489|NCT00879970|4761396|P4|Period 1 TZD Randomization|Lost to Follow-up|0
1443490|NCT00879970|4761397|P3|Period 1 TZD Randomization|Lost to Follow-up|1
1443491|NCT00879970|4761398|P2|Period 1 TZD Randomization|Lost to Follow-up|0
1443492|NCT00879970|4761399|P1|Period 1 TZD Randomization|Lost to Follow-up|1
1443493|NCT00879970|4761395|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
1443494|NCT00879970|4761396|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
1443495|NCT00879970|4761397|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
1443496|NCT00879970|4761398|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
1443497|NCT00879970|4761399|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
1443498|NCT00879879|4761481|P1|Overall Study|Physician Decision|1
1443499|NCT00879879|4761481|P1|Overall Study|Withdrawal by Subject|1
1443500|NCT00879879|4761481|P1|Overall Study|Death|1
1443501|NCT00879814|4761489|P4|Overall Study|Other|0
1443502|NCT00879814|4761490|P3|Overall Study|Other|1
1443503|NCT00879814|4761491|P2|Overall Study|Other|0
1443504|NCT00879814|4761492|P1|Overall Study|Other|0
1443505|NCT00879814|4761489|P4|Overall Study|Physician Decision|0
1443506|NCT00879814|4761490|P3|Overall Study|Physician Decision|1
1443507|NCT00879814|4761491|P2|Overall Study|Physician Decision|0
1443508|NCT00879814|4761492|P1|Overall Study|Physician Decision|0
1443509|NCT00879814|4761489|P4|Overall Study|Withdrawal by Subject|2
1443510|NCT00879814|4761490|P3|Overall Study|Withdrawal by Subject|1
1443511|NCT00879814|4761491|P2|Overall Study|Withdrawal by Subject|1
1443512|NCT00879814|4761492|P1|Overall Study|Withdrawal by Subject|3
1443513|NCT00879814|4761489|P4|Overall Study|Participant Failed to Return|1
1443514|NCT00879814|4761490|P3|Overall Study|Participant Failed to Return|0
1443515|NCT00879814|4761491|P2|Overall Study|Participant Failed to Return|0
1443516|NCT00879814|4761492|P1|Overall Study|Participant Failed to Return|0
1443517|NCT00879814|4761489|P4|Overall Study|Lost to Follow-up|2
1443518|NCT00879814|4761490|P3|Overall Study|Lost to Follow-up|0
1443519|NCT00879814|4761491|P2|Overall Study|Lost to Follow-up|0
1443520|NCT00879814|4761492|P1|Overall Study|Lost to Follow-up|1
1443521|NCT00879814|4761489|P4|Overall Study|Adverse Event|0
1443522|NCT00879814|4761490|P3|Overall Study|Adverse Event|0
1443523|NCT00879814|4761491|P2|Overall Study|Adverse Event|1
1443524|NCT00879814|4761492|P1|Overall Study|Adverse Event|0
1443525|NCT00879775|4761600|P2|Overall Study|Lost to Follow-up|1
1443526|NCT00879775|4761601|P1|Overall Study|Lost to Follow-up|2
1443527|NCT00879710|4761617|P4|Phase 1 - 6 Weeks|Adverse Event|0
1443528|NCT00879710|4761618|P3|Phase 1 - 6 Weeks|Adverse Event|1
1443529|NCT00879710|4761619|P2|Phase 1 - 6 Weeks|Adverse Event|0
1443530|NCT00879710|4761620|P1|Phase 1 - 6 Weeks|Adverse Event|0
1443531|NCT00879710|4761617|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
1443532|NCT00879710|4761618|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
1443533|NCT00879710|4761619|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
1443534|NCT00879710|4761620|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
1443535|NCT00879697|4761630|P2|Overall Study|Physician Decision|2
1443536|NCT00879697|4761631|P1|Overall Study|Physician Decision|2
1443537|NCT00879684|4761637|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
1443538|NCT00879684|4761638|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
1443539|NCT00879684|4761639|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
1443540|NCT00879684|4761640|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
1443541|NCT00879684|4761641|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
1443542|NCT00879684|4761642|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
1443543|NCT00879684|4761643|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
1443544|NCT00879684|4761637|P7|Stage 2: Expanded Cohort|Progressive Disease|11
1443545|NCT00879684|4761638|P6|Stage 2: Expanded Cohort|Progressive Disease|0
1443546|NCT00879684|4761639|P5|Stage 2: Expanded Cohort|Progressive Disease|0
1443547|NCT00879684|4761640|P4|Stage 2: Expanded Cohort|Progressive Disease|0
1443548|NCT00879684|4761641|P3|Stage 2: Expanded Cohort|Progressive Disease|0
1443549|NCT00879684|4761642|P2|Stage 2: Expanded Cohort|Progressive Disease|0
1443550|NCT00879684|4761643|P1|Stage 2: Expanded Cohort|Progressive Disease|0
1443551|NCT00879684|4761637|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
1443552|NCT00879684|4761638|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
1443553|NCT00879684|4761639|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
1443554|NCT00879684|4761640|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
1443555|NCT00879684|4761641|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
1443556|NCT00879684|4761642|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
1443557|NCT00879684|4761643|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
1443558|NCT00879684|4761637|P7|Stage 1: Dose Escalation|Death|0
1443559|NCT00879684|4761638|P6|Stage 1: Dose Escalation|Death|0
1443560|NCT00879684|4761639|P5|Stage 1: Dose Escalation|Death|0
1443561|NCT00879684|4761640|P4|Stage 1: Dose Escalation|Death|0
1443562|NCT00879684|4761641|P3|Stage 1: Dose Escalation|Death|1
1443563|NCT00879684|4761642|P2|Stage 1: Dose Escalation|Death|0
1443564|NCT00879684|4761643|P1|Stage 1: Dose Escalation|Death|0
1443565|NCT00879684|4761637|P7|Stage 1: Dose Escalation|Investigator declined participation|0
1443566|NCT00879684|4761638|P6|Stage 1: Dose Escalation|Investigator declined participation|0
1443567|NCT00879684|4761639|P5|Stage 1: Dose Escalation|Investigator declined participation|0
1443568|NCT00879684|4761640|P4|Stage 1: Dose Escalation|Investigator declined participation|2
1443569|NCT00879684|4761641|P3|Stage 1: Dose Escalation|Investigator declined participation|2
1443570|NCT00879684|4761642|P2|Stage 1: Dose Escalation|Investigator declined participation|0
1443571|NCT00879684|4761643|P1|Stage 1: Dose Escalation|Investigator declined participation|0
1443572|NCT00879684|4761637|P7|Stage 1: Dose Escalation|Progressive Disease|0
1443573|NCT00879684|4761638|P6|Stage 1: Dose Escalation|Progressive Disease|3
1443574|NCT00879684|4761639|P5|Stage 1: Dose Escalation|Progressive Disease|3
1443575|NCT00879684|4761640|P4|Stage 1: Dose Escalation|Progressive Disease|4
1443576|NCT00879684|4761641|P3|Stage 1: Dose Escalation|Progressive Disease|0
1443577|NCT00879684|4761642|P2|Stage 1: Dose Escalation|Progressive Disease|3
1443578|NCT00879684|4761643|P1|Stage 1: Dose Escalation|Progressive Disease|2
1443579|NCT00879684|4761637|P7|Stage 1: Dose Escalation|Adverse Event|0
1443580|NCT00879684|4761638|P6|Stage 1: Dose Escalation|Adverse Event|0
1443581|NCT00879684|4761639|P5|Stage 1: Dose Escalation|Adverse Event|0
1443582|NCT00879684|4761640|P4|Stage 1: Dose Escalation|Adverse Event|0
1443583|NCT00879684|4761641|P3|Stage 1: Dose Escalation|Adverse Event|0
1443584|NCT00879684|4761642|P2|Stage 1: Dose Escalation|Adverse Event|0
1443585|NCT00879684|4761643|P1|Stage 1: Dose Escalation|Adverse Event|1
1443586|NCT00879645|4761709|P4|Overall Study|Adverse Event|0
1443587|NCT00879645|4761710|P3|Overall Study|Adverse Event|0
1443588|NCT00879645|4761711|P2|Overall Study|Adverse Event|0
1443589|NCT00879645|4761712|P1|Overall Study|Adverse Event|1
1443590|NCT00879411|4761739|P1|Overall Study|lost to follow-up (non-AE)|162
1443591|NCT00879398|4761745|P1|Overall Study|Other Reasons|171
1443592|NCT00879398|4761745|P1|Overall Study|Adverse Event|41
1443593|NCT00879398|4761745|P1|Overall Study|Lack of Efficacy|64
1443594|NCT00879398|4761745|P1|Overall Study|Visit Stop|399
1443595|NCT00879333|4761763|P2|Overall Study|Protocol Violation|1
1443596|NCT00879333|4761764|P1|Overall Study|Protocol Violation|1
1443597|NCT00879333|4761763|P2|Overall Study|Disease Progression|169
1443598|NCT00879333|4761764|P1|Overall Study|Disease Progression|292
1443599|NCT00879333|4761763|P2|Overall Study|Death|5
1443600|NCT00879333|4761764|P1|Overall Study|Death|16
1443601|NCT00879333|4761763|P2|Overall Study|Administrative Problems|0
1443602|NCT00879333|4761764|P1|Overall Study|Administrative Problems|2
1443603|NCT00879333|4761763|P2|Overall Study|Lost to Follow-up|1
1443604|NCT00879333|4761764|P1|Overall Study|Lost to Follow-up|2
1443605|NCT00879333|4761763|P2|Overall Study|Withdrawal by Subject|7
1443606|NCT00879333|4761764|P1|Overall Study|Withdrawal by Subject|20
1443607|NCT00879333|4761763|P2|Overall Study|Abnormal Laboratory Value|0
1443608|NCT00879333|4761764|P1|Overall Study|Abnormal Laboratory Value|1
1443609|NCT00879333|4761763|P2|Overall Study|Adverse Event|34
1443610|NCT00879333|4761764|P1|Overall Study|Adverse Event|94
1443611|NCT00879229|4761797|P2|Overall Study|Other|0
1443612|NCT00879229|4761798|P1|Overall Study|Other|1
1443613|NCT00879229|4761797|P2|Overall Study|Clinical status did not improve|0
1443614|NCT00879229|4761798|P1|Overall Study|Clinical status did not improve|1
1443615|NCT00879229|4761797|P2|Overall Study|Withdrawal by Subject|0
1443616|NCT00879229|4761798|P1|Overall Study|Withdrawal by Subject|1
1443617|NCT00879229|4761797|P2|Overall Study|Adverse Event|0
1443618|NCT00879229|4761798|P1|Overall Study|Adverse Event|2
1443619|NCT00879229|4761797|P2|Overall Study|Death|2
1443620|NCT00879229|4761798|P1|Overall Study|Death|4
1443621|NCT00879229|4761797|P2|Overall Study|Study terminated by Sponsor|12
1443622|NCT00879229|4761798|P1|Overall Study|Study terminated by Sponsor|13
1443623|NCT00878995|4761846|P2|Baseline Study - Midpoint Study|Withdrawal by Subject|2
1443624|NCT00878995|4761847|P1|Baseline Study - Midpoint Study|Withdrawal by Subject|0
1443625|NCT00878969|4761948|P3|Overall Study|Pregnancy|0
1443626|NCT00878969|4761949|P2|Overall Study|Pregnancy|1
1443627|NCT00878969|4761950|P1|Overall Study|Pregnancy|0
1443628|NCT00878969|4761948|P3|Overall Study|Death|2
1443629|NCT00878969|4761949|P2|Overall Study|Death|0
1443630|NCT00878969|4761950|P1|Overall Study|Death|0
1443631|NCT00878969|4761948|P3|Overall Study|Protocol Violation|0
1443632|NCT00878969|4761949|P2|Overall Study|Protocol Violation|0
1443633|NCT00878969|4761950|P1|Overall Study|Protocol Violation|2
1443634|NCT00878969|4761948|P3|Overall Study|Lost to Follow-up|0
1443635|NCT00878969|4761949|P2|Overall Study|Lost to Follow-up|1
1443636|NCT00878969|4761950|P1|Overall Study|Lost to Follow-up|2
1443637|NCT00878969|4761948|P3|Overall Study|Adverse Event|2
1443638|NCT00878969|4761949|P2|Overall Study|Adverse Event|1
1443639|NCT00878969|4761950|P1|Overall Study|Adverse Event|3
1443640|NCT00878969|4761948|P3|Overall Study|kidney transplant|2
1443641|NCT00878969|4761949|P2|Overall Study|kidney transplant|3
1443642|NCT00878969|4761950|P1|Overall Study|kidney transplant|2
1443643|NCT00878969|4761948|P3|Overall Study|Withdrawal by Subject|3
1443644|NCT00878969|4761949|P2|Overall Study|Withdrawal by Subject|6
1443645|NCT00878969|4761950|P1|Overall Study|Withdrawal by Subject|1
1443646|NCT00878969|4761948|P3|Overall Study|Physician Decision|2
1443647|NCT00878969|4761949|P2|Overall Study|Physician Decision|3
1443648|NCT00878969|4761950|P1|Overall Study|Physician Decision|5
1443649|NCT00878800|4761998|P5|Overall Study|Other|1
1443650|NCT00878800|4761999|P4|Overall Study|Other|0
1443651|NCT00878800|4762000|P3|Overall Study|Other|0
1443652|NCT00878800|4762001|P2|Overall Study|Other|1
1443653|NCT00878800|4762002|P1|Overall Study|Other|1
1443654|NCT00878800|4761998|P5|Overall Study|Death|0
1443655|NCT00878800|4761999|P4|Overall Study|Death|0
1443656|NCT00878800|4762000|P3|Overall Study|Death|1
1443657|NCT00878800|4762001|P2|Overall Study|Death|0
1443658|NCT00878800|4762002|P1|Overall Study|Death|0
1443659|NCT00878800|4761998|P5|Overall Study|Withdrew consent|1
1443660|NCT00878800|4761999|P4|Overall Study|Withdrew consent|1
1443661|NCT00878800|4762000|P3|Overall Study|Withdrew consent|0
1443662|NCT00878800|4762001|P2|Overall Study|Withdrew consent|1
1443663|NCT00878800|4762002|P1|Overall Study|Withdrew consent|1
1443664|NCT00878800|4761998|P5|Overall Study|Progressive disease|13
1443665|NCT00878800|4761999|P4|Overall Study|Progressive disease|5
1443666|NCT00878800|4762000|P3|Overall Study|Progressive disease|6
1443667|NCT00878800|4762001|P2|Overall Study|Progressive disease|5
1443668|NCT00878800|4762002|P1|Overall Study|Progressive disease|1
1443669|NCT00878800|4761998|P5|Overall Study|Adverse Event|1
1443670|NCT00878800|4761999|P4|Overall Study|Adverse Event|0
1443671|NCT00878800|4762000|P3|Overall Study|Adverse Event|2
1443672|NCT00878800|4762001|P2|Overall Study|Adverse Event|0
1443673|NCT00878800|4762002|P1|Overall Study|Adverse Event|0
1443674|NCT00878722|4762037|P8|Overall Study|Relapse|0
1443675|NCT00878722|4762038|P7|Overall Study|Relapse|0
1443676|NCT00878722|4762039|P6|Overall Study|Relapse|0
1443677|NCT00878722|4762040|P5|Overall Study|Relapse|0
1443678|NCT00878722|4762041|P4|Overall Study|Relapse|1
1443679|NCT00878722|4762042|P3|Overall Study|Relapse|0
1443680|NCT00878722|4762043|P2|Overall Study|Relapse|0
1443681|NCT00878722|4762044|P1|Overall Study|Relapse|0
1443682|NCT00878722|4762037|P8|Overall Study|Withdrawal by Subject|2
1443683|NCT00878722|4762038|P7|Overall Study|Withdrawal by Subject|0
1443684|NCT00878722|4762039|P6|Overall Study|Withdrawal by Subject|0
1443685|NCT00878722|4762040|P5|Overall Study|Withdrawal by Subject|0
1443686|NCT00878722|4762041|P4|Overall Study|Withdrawal by Subject|0
1443687|NCT00878722|4762042|P3|Overall Study|Withdrawal by Subject|0
1443688|NCT00878722|4762043|P2|Overall Study|Withdrawal by Subject|0
1443689|NCT00878722|4762044|P1|Overall Study|Withdrawal by Subject|0
1443690|NCT00878722|4762037|P8|Overall Study|Adverse Event|0
1443691|NCT00878722|4762038|P7|Overall Study|Adverse Event|2
1443692|NCT00878722|4762039|P6|Overall Study|Adverse Event|0
1443693|NCT00878722|4762040|P5|Overall Study|Adverse Event|0
1443694|NCT00878722|4762041|P4|Overall Study|Adverse Event|0
1443695|NCT00878722|4762042|P3|Overall Study|Adverse Event|0
1443696|NCT00878722|4762043|P2|Overall Study|Adverse Event|0
1443697|NCT00878722|4762044|P1|Overall Study|Adverse Event|0
1443698|NCT00878722|4762037|P8|Overall Study|Death|2
1443699|NCT00878722|4762038|P7|Overall Study|Death|0
1443700|NCT00878722|4762039|P6|Overall Study|Death|1
1443701|NCT00878722|4762040|P5|Overall Study|Death|0
1443702|NCT00878722|4762041|P4|Overall Study|Death|1
1443703|NCT00878722|4762042|P3|Overall Study|Death|0
1443704|NCT00878722|4762043|P2|Overall Study|Death|0
1443705|NCT00878722|4762044|P1|Overall Study|Death|0
1443706|NCT00878722|4762037|P8|Overall Study|Progressive disease|3
1443707|NCT00878722|4762038|P7|Overall Study|Progressive disease|4
1443708|NCT00878722|4762039|P6|Overall Study|Progressive disease|1
1443709|NCT00878722|4762040|P5|Overall Study|Progressive disease|7
1443710|NCT00878722|4762041|P4|Overall Study|Progressive disease|7
1443711|NCT00878722|4762042|P3|Overall Study|Progressive disease|3
1443712|NCT00878722|4762043|P2|Overall Study|Progressive disease|3
1443713|NCT00878722|4762044|P1|Overall Study|Progressive disease|3
1443714|NCT00878709|4762129|P2|Overall Study|Other Reasons|84
1443715|NCT00878709|4762130|P1|Overall Study|Other Reasons|93
1443716|NCT00878709|4762129|P2|Overall Study|Lost to Follow-up|33
1443717|NCT00878709|4762130|P1|Overall Study|Lost to Follow-up|35
1443718|NCT00878709|4762129|P2|Overall Study|Withdrawal by Subject|120
1443719|NCT00878709|4762130|P1|Overall Study|Withdrawal by Subject|197
1443720|NCT00878553|4762190|P5|PK Study|Withdrawal by Subject|0
1443721|NCT00878553|4762191|P4|PK Study|Withdrawal by Subject|1
1443722|NCT00878553|4762192|P3|PK Study|Withdrawal by Subject|0
1443723|NCT00878553|4762193|P2|PK Study|Withdrawal by Subject|0
1443724|NCT00878553|4762194|P1|PK Study|Withdrawal by Subject|0
1443725|NCT00878553|4762190|P5|Sleep Study|family emergency|0
1443726|NCT00878553|4762191|P4|Sleep Study|family emergency|0
1443727|NCT00878553|4762192|P3|Sleep Study|family emergency|0
1443728|NCT00878553|4762193|P2|Sleep Study|family emergency|0
1443729|NCT00878553|4762194|P1|Sleep Study|family emergency|1
1443730|NCT00878553|4762190|P5|Sleep Study|car accident|0
1443731|NCT00878553|4762191|P4|Sleep Study|car accident|0
1443732|NCT00878553|4762192|P3|Sleep Study|car accident|0
1443733|NCT00878553|4762193|P2|Sleep Study|car accident|0
1443734|NCT00878553|4762194|P1|Sleep Study|car accident|1
1443735|NCT00878553|4762190|P5|Sleep Study|Lost to Follow-up|0
1443736|NCT00878553|4762191|P4|Sleep Study|Lost to Follow-up|0
1443737|NCT00878553|4762192|P3|Sleep Study|Lost to Follow-up|0
1443738|NCT00878553|4762193|P2|Sleep Study|Lost to Follow-up|0
1443739|NCT00878553|4762194|P1|Sleep Study|Lost to Follow-up|1
1443740|NCT00878553|4762190|P5|Sleep Study|Withdrawal by Subject|0
1443741|NCT00878553|4762191|P4|Sleep Study|Withdrawal by Subject|0
1443742|NCT00878553|4762192|P3|Sleep Study|Withdrawal by Subject|0
1443743|NCT00878553|4762193|P2|Sleep Study|Withdrawal by Subject|0
1443744|NCT00878553|4762194|P1|Sleep Study|Withdrawal by Subject|2
1443745|NCT00878501|4762253|P3|Overall Study|Administrative|1
1443746|NCT00878501|4762254|P2|Overall Study|Administrative|0
1443747|NCT00878501|4762255|P1|Overall Study|Administrative|0
1443748|NCT00878501|4762253|P3|Overall Study|Mis-randomisation of patient|0
1443749|NCT00878501|4762254|P2|Overall Study|Mis-randomisation of patient|0
1443750|NCT00878501|4762255|P1|Overall Study|Mis-randomisation of patient|1
1443751|NCT00878501|4762253|P3|Overall Study|Intake of prohibited concom. medication|1
1443752|NCT00878501|4762254|P2|Overall Study|Intake of prohibited concom. medication|0
1443753|NCT00878501|4762255|P1|Overall Study|Intake of prohibited concom. medication|0
1443754|NCT00878501|4762253|P3|Overall Study|Incorrect enrolment|0
1443755|NCT00878501|4762254|P2|Overall Study|Incorrect enrolment|2
1443756|NCT00878501|4762255|P1|Overall Study|Incorrect enrolment|1
1443757|NCT00878501|4762253|P3|Overall Study|Protocol Violation|1
1443758|NCT00878501|4762254|P2|Overall Study|Protocol Violation|0
1443759|NCT00878501|4762255|P1|Overall Study|Protocol Violation|0
1443760|NCT00878501|4762253|P3|Overall Study|Withdrawal by Subject|2
1443761|NCT00878501|4762254|P2|Overall Study|Withdrawal by Subject|1
1443762|NCT00878501|4762255|P1|Overall Study|Withdrawal by Subject|2
1443763|NCT00878501|4762253|P3|Overall Study|Lack of Efficacy|0
1443764|NCT00878501|4762254|P2|Overall Study|Lack of Efficacy|1
1443765|NCT00878501|4762255|P1|Overall Study|Lack of Efficacy|2
1443766|NCT00878501|4762253|P3|Overall Study|Adverse Event|3
1443767|NCT00878501|4762254|P2|Overall Study|Adverse Event|3
1443768|NCT00878501|4762255|P1|Overall Study|Adverse Event|11
1443769|NCT00878215|4762304|P4|Overall Study|Determined to be ineligible|0
1443770|NCT00878215|4762305|P3|Overall Study|Determined to be ineligible|0
1443771|NCT00878215|4762306|P2|Overall Study|Determined to be ineligible|10
1443772|NCT00878215|4762307|P1|Overall Study|Determined to be ineligible|0
1443773|NCT00877929|4762319|P2|Overall Study|Other reason (not specified)|6
1443774|NCT00877929|4762320|P1|Overall Study|Other reason (not specified)|2
1443775|NCT00877929|4762319|P2|Overall Study|Lack of Efficacy|1
1443776|NCT00877929|4762320|P1|Overall Study|Lack of Efficacy|0
1443777|NCT00877929|4762319|P2|Overall Study|Withdrawal by Subject|4
1443778|NCT00877929|4762320|P1|Overall Study|Withdrawal by Subject|4
1443779|NCT00877929|4762319|P2|Overall Study|Lost to Follow-up|1
1443780|NCT00877929|4762320|P1|Overall Study|Lost to Follow-up|0
1443781|NCT00877929|4762319|P2|Overall Study|Protocol Violation|3
1443782|NCT00877929|4762320|P1|Overall Study|Protocol Violation|3
1443783|NCT00877929|4762319|P2|Overall Study|Adverse Event|20
1443784|NCT00877929|4762320|P1|Overall Study|Adverse Event|11
1443785|NCT00877890|4762408|P2|Overall Study|Loss of Glucose Control|4
1443786|NCT00877890|4762409|P1|Overall Study|Loss of Glucose Control|3
1443787|NCT00877890|4762408|P2|Overall Study|Investigator Decision|2
1443788|NCT00877890|4762409|P1|Overall Study|Investigator Decision|0
1443789|NCT00877890|4762408|P2|Overall Study|Withdrawal of Consent|12
1443790|NCT00877890|4762409|P1|Overall Study|Withdrawal of Consent|6
1443791|NCT00877890|4762408|P2|Overall Study|Protocol Violation|1
1443792|NCT00877890|4762409|P1|Overall Study|Protocol Violation|0
1443793|NCT00877890|4762408|P2|Overall Study|Lost to Follow-up|5
1443794|NCT00877890|4762409|P1|Overall Study|Lost to Follow-up|5
1443795|NCT00877890|4762408|P2|Overall Study|Adverse Event|6
1443796|NCT00877890|4762409|P1|Overall Study|Adverse Event|6
1443797|NCT00877799|4762474|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
1443798|NCT00877799|4762475|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
1443799|NCT00877799|4762476|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
1443800|NCT00877799|4762477|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
1443801|NCT00877799|4762478|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
1443802|NCT00877799|4762474|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
1443803|NCT00877799|4762475|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
1443804|NCT00877799|4762476|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
1443805|NCT00877799|4762477|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
1443806|NCT00877799|4762478|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
1443807|NCT00877799|4762474|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
1443808|NCT00877799|4762475|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
1443809|NCT00877799|4762476|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
1443810|NCT00877799|4762477|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
1443811|NCT00877799|4762478|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
1443812|NCT00877799|4762474|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
1443813|NCT00877799|4762475|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
1443814|NCT00877799|4762476|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
1443815|NCT00877799|4762477|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
1443816|NCT00877799|4762478|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
1443817|NCT00877799|4762474|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
1443818|NCT00877799|4762475|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
1443819|NCT00877799|4762476|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
1443820|NCT00877799|4762477|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
1443821|NCT00877799|4762478|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
1443822|NCT00877773|4762493|P1|Overall Study|Disease Progression|44
1443823|NCT00877487|4762506|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
1443824|NCT00877487|4762507|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
1443825|NCT00877487|4762506|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
1443826|NCT00877487|4762507|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
1443827|NCT00877487|4762506|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
1443828|NCT00877487|4762507|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
1443829|NCT00877487|4762506|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
1443830|NCT00877487|4762507|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
1443831|NCT00877487|4762506|P2|Open-label Treatment Phase|Out of country for business|0
1443832|NCT00877487|4762507|P1|Open-label Treatment Phase|Out of country for business|1
1443833|NCT00877487|4762506|P2|Open-label Treatment Phase|Lost to Follow-up|0
1443834|NCT00877487|4762507|P1|Open-label Treatment Phase|Lost to Follow-up|1
1443835|NCT00877487|4762506|P2|Open-label Treatment Phase|Withdrawal by Subject|0
1443836|NCT00877487|4762507|P1|Open-label Treatment Phase|Withdrawal by Subject|1
1443837|NCT00877487|4762506|P2|Open-label Treatment Phase|Protocol Violation|0
1443838|NCT00877487|4762507|P1|Open-label Treatment Phase|Protocol Violation|3
1443839|NCT00877487|4762506|P2|Open-label Treatment Phase|Adverse Event|0
1443840|NCT00877487|4762507|P1|Open-label Treatment Phase|Adverse Event|1
1443841|NCT00877383|4762555|P2|Overall Study|Death|2
1443842|NCT00877383|4762556|P1|Overall Study|Death|1
1443843|NCT00877383|4762555|P2|Overall Study|Unsatisfactory therapeutic effect|0
1443844|NCT00877383|4762556|P1|Overall Study|Unsatisfactory therapeutic effect|1
1443845|NCT00877383|4762555|P2|Overall Study|Protocol deviation|6
1443846|NCT00877383|4762556|P1|Overall Study|Protocol deviation|2
1443847|NCT00877383|4762555|P2|Overall Study|Administrative problems|0
1443848|NCT00877383|4762556|P1|Overall Study|Administrative problems|2
1443849|NCT00877383|4762555|P2|Overall Study|Subject no longer requires study drug|0
1443850|NCT00877383|4762556|P1|Overall Study|Subject no longer requires study drug|2
1443851|NCT00877383|4762555|P2|Overall Study|Subject withdrew consent|12
1443852|NCT00877383|4762556|P1|Overall Study|Subject withdrew consent|3
1443853|NCT00877383|4762555|P2|Overall Study|Lost to Follow-up|3
1443854|NCT00877383|4762556|P1|Overall Study|Lost to Follow-up|5
1443855|NCT00877383|4762555|P2|Overall Study|Adverse Event|14
1443856|NCT00877383|4762556|P1|Overall Study|Adverse Event|13
1443857|NCT00877071|4762576|P1|Overall Study|disease progression|2
1443858|NCT00877032|4762609|P7|Overall Study|Did not meet entrance criteria|2
1443859|NCT00877032|4762610|P6|Overall Study|Did not meet entrance criteria|0
1443860|NCT00877032|4762611|P5|Overall Study|Did not meet entrance criteria|0
1443861|NCT00877032|4762612|P4|Overall Study|Did not meet entrance criteria|1
1443862|NCT00877032|4762613|P3|Overall Study|Did not meet entrance criteria|0
1443863|NCT00877032|4762614|P2|Overall Study|Did not meet entrance criteria|0
1443864|NCT00877032|4762615|P1|Overall Study|Did not meet entrance criteria|0
1443865|NCT00877006|4762716|P2|Long-Term Follow-up Period|Not specified|9
1443866|NCT00877006|4762717|P1|Long-Term Follow-up Period|Not specified|7
1443867|NCT00877006|4762716|P2|Long-Term Follow-up Period|Death|18
1443868|NCT00877006|4762717|P1|Long-Term Follow-up Period|Death|26
1443869|NCT00877006|4762716|P2|Long-Term Follow-up Period|Lost to Follow-up|9
1443870|NCT00877006|4762717|P1|Long-Term Follow-up Period|Lost to Follow-up|8
1443871|NCT00877006|4762716|P2|Long-Term Follow-up Period|Withdrawal by Subject|19
1443872|NCT00877006|4762717|P1|Long-Term Follow-up Period|Withdrawal by Subject|12
1443873|NCT00877006|4762716|P2|Treatment Period|Randomized but Not Treated|8
1443874|NCT00877006|4762717|P1|Treatment Period|Randomized but Not Treated|3
1443875|NCT00877006|4762716|P2|Treatment Period|Not Specified|4
1443876|NCT00877006|4762717|P1|Treatment Period|Not Specified|4
1443877|NCT00877006|4762716|P2|Treatment Period|Started New Treatment Regimen|5
1443878|NCT00877006|4762717|P1|Treatment Period|Started New Treatment Regimen|2
1443879|NCT00877006|4762716|P2|Treatment Period|Disease Progression|2
1443880|NCT00877006|4762717|P1|Treatment Period|Disease Progression|1
1443881|NCT00877006|4762716|P2|Treatment Period|Lost to Follow-up|1
1443882|NCT00877006|4762717|P1|Treatment Period|Lost to Follow-up|0
1443883|NCT00877006|4762716|P2|Treatment Period|Protocol Violation|0
1443884|NCT00877006|4762717|P1|Treatment Period|Protocol Violation|1
1443885|NCT00877006|4762716|P2|Treatment Period|Withdrawal by Subject|3
1443886|NCT00877006|4762717|P1|Treatment Period|Withdrawal by Subject|2
1443887|NCT00877006|4762716|P2|Treatment Period|Adverse Event|3
1443888|NCT00877006|4762717|P1|Treatment Period|Adverse Event|10
1443889|NCT00877006|4762716|P2|Treatment Period|Death|1
1443890|NCT00877006|4762717|P1|Treatment Period|Death|2
1443891|NCT00876928|4762757|P2|Overall Study|Hypokalemia-affects insulin secretion|0
1443892|NCT00876928|4762758|P1|Overall Study|Hypokalemia-affects insulin secretion|1
1443893|NCT00876928|4762757|P2|Overall Study|Lost to Follow-up|5
1443894|NCT00876928|4762758|P1|Overall Study|Lost to Follow-up|2
1443895|NCT00876733|4762795|P4|Overall Study|Data not available|1
1443896|NCT00876733|4762796|P3|Overall Study|Data not available|7
1443897|NCT00876733|4762797|P2|Overall Study|Data not available|3
1443898|NCT00876733|4762798|P1|Overall Study|Data not available|14
1443899|NCT00876733|4762795|P4|Overall Study|Lost to Follow-up|2
1443900|NCT00876733|4762796|P3|Overall Study|Lost to Follow-up|3
1443901|NCT00876733|4762797|P2|Overall Study|Lost to Follow-up|10
1443902|NCT00876733|4762798|P1|Overall Study|Lost to Follow-up|26
1443903|NCT00876733|4762795|P4|Overall Study|Lack of Efficacy|1
1443904|NCT00876733|4762796|P3|Overall Study|Lack of Efficacy|10
1443905|NCT00876733|4762797|P2|Overall Study|Lack of Efficacy|9
1443906|NCT00876733|4762798|P1|Overall Study|Lack of Efficacy|17
1443907|NCT00876733|4762795|P4|Overall Study|Adverse Event|3
1443908|NCT00876733|4762796|P3|Overall Study|Adverse Event|10
1443909|NCT00876733|4762797|P2|Overall Study|Adverse Event|20
1443910|NCT00876733|4762798|P1|Overall Study|Adverse Event|34
1443911|NCT00876694|4762906|P2|Overall Study|Death|0
1443912|NCT00876694|4762907|P1|Overall Study|Death|1
1443913|NCT00876694|4762906|P2|Overall Study|Administrative problems|1
1443914|NCT00876694|4762907|P1|Overall Study|Administrative problems|1
1443915|NCT00876694|4762906|P2|Overall Study|Abnormal test procedure result(s)|0
1443916|NCT00876694|4762907|P1|Overall Study|Abnormal test procedure result(s)|1
1443917|NCT00876694|4762906|P2|Overall Study|Unsatisfactory therapeutic effect|0
1443918|NCT00876694|4762907|P1|Overall Study|Unsatisfactory therapeutic effect|2
1443919|NCT00876694|4762906|P2|Overall Study|Subject withdrew consent|4
1443920|NCT00876694|4762907|P1|Overall Study|Subject withdrew consent|6
1443921|NCT00876694|4762906|P2|Overall Study|Adverse Event|7
1443922|NCT00876694|4762907|P1|Overall Study|Adverse Event|10
1443923|NCT00876460|4762933|P8|Mono Therapy Phase|Adverse Event|0
1443924|NCT00876460|4762934|P7|Mono Therapy Phase|Adverse Event|0
1443925|NCT00876460|4762935|P6|Mono Therapy Phase|Adverse Event|0
1443926|NCT00876460|4762936|P5|Mono Therapy Phase|Adverse Event|0
1443927|NCT00876460|4762937|P4|Mono Therapy Phase|Adverse Event|1
1443928|NCT00876460|4762938|P3|Mono Therapy Phase|Adverse Event|0
1443929|NCT00876460|4762939|P2|Mono Therapy Phase|Adverse Event|0
1443930|NCT00876460|4762940|P1|Mono Therapy Phase|Adverse Event|0
1443931|NCT00876460|4762933|P8|Mono Therapy Phase|Withdrawal by Subject|0
1443932|NCT00876460|4762934|P7|Mono Therapy Phase|Withdrawal by Subject|0
1443933|NCT00876460|4762935|P6|Mono Therapy Phase|Withdrawal by Subject|0
1443934|NCT00876460|4762936|P5|Mono Therapy Phase|Withdrawal by Subject|0
1443935|NCT00876460|4762937|P4|Mono Therapy Phase|Withdrawal by Subject|0
1443936|NCT00876460|4762938|P3|Mono Therapy Phase|Withdrawal by Subject|0
1443937|NCT00876460|4762939|P2|Mono Therapy Phase|Withdrawal by Subject|1
1443938|NCT00876460|4762940|P1|Mono Therapy Phase|Withdrawal by Subject|0
1443939|NCT00876460|4762933|P8|Mono Therapy Phase|Progressive disease|3
1443940|NCT00876460|4762934|P7|Mono Therapy Phase|Progressive disease|1
1443941|NCT00876460|4762935|P6|Mono Therapy Phase|Progressive disease|0
1443942|NCT00876460|4762936|P5|Mono Therapy Phase|Progressive disease|2
1443943|NCT00876460|4762937|P4|Mono Therapy Phase|Progressive disease|0
1443944|NCT00876460|4762938|P3|Mono Therapy Phase|Progressive disease|0
1443945|NCT00876460|4762939|P2|Mono Therapy Phase|Progressive disease|0
1443946|NCT00876460|4762940|P1|Mono Therapy Phase|Progressive disease|0
1443947|NCT00876460|4762933|P8|Combination Therapy Phase|Not treated|0
1443948|NCT00876460|4762934|P7|Combination Therapy Phase|Not treated|1
1443949|NCT00876460|4762935|P6|Combination Therapy Phase|Not treated|0
1443950|NCT00876460|4762936|P5|Combination Therapy Phase|Not treated|0
1443951|NCT00876460|4762937|P4|Combination Therapy Phase|Not treated|0
1443952|NCT00876460|4762938|P3|Combination Therapy Phase|Not treated|0
1443953|NCT00876460|4762939|P2|Combination Therapy Phase|Not treated|0
1443954|NCT00876460|4762940|P1|Combination Therapy Phase|Not treated|0
1443955|NCT00876460|4762933|P8|Combination Therapy Phase|Other reason not defined above|2
1443956|NCT00876460|4762934|P7|Combination Therapy Phase|Other reason not defined above|1
1443957|NCT00876460|4762935|P6|Combination Therapy Phase|Other reason not defined above|0
1443958|NCT00876460|4762936|P5|Combination Therapy Phase|Other reason not defined above|0
1443959|NCT00876460|4762937|P4|Combination Therapy Phase|Other reason not defined above|0
1443960|NCT00876460|4762938|P3|Combination Therapy Phase|Other reason not defined above|0
1443961|NCT00876460|4762939|P2|Combination Therapy Phase|Other reason not defined above|0
1443962|NCT00876460|4762940|P1|Combination Therapy Phase|Other reason not defined above|0
1443963|NCT00876460|4762933|P8|Combination Therapy Phase|Withdrawal by Subject|0
1443964|NCT00876460|4762934|P7|Combination Therapy Phase|Withdrawal by Subject|0
1443965|NCT00876460|4762935|P6|Combination Therapy Phase|Withdrawal by Subject|0
1443966|NCT00876460|4762936|P5|Combination Therapy Phase|Withdrawal by Subject|1
1443967|NCT00876460|4762937|P4|Combination Therapy Phase|Withdrawal by Subject|0
1443968|NCT00876460|4762938|P3|Combination Therapy Phase|Withdrawal by Subject|0
1443969|NCT00876460|4762939|P2|Combination Therapy Phase|Withdrawal by Subject|1
1443970|NCT00876460|4762940|P1|Combination Therapy Phase|Withdrawal by Subject|1
1443971|NCT00876460|4762933|P8|Combination Therapy Phase|Adverse Event|2
1443972|NCT00876460|4762934|P7|Combination Therapy Phase|Adverse Event|3
1443973|NCT00876460|4762935|P6|Combination Therapy Phase|Adverse Event|0
1443974|NCT00876460|4762936|P5|Combination Therapy Phase|Adverse Event|2
1443975|NCT00876460|4762937|P4|Combination Therapy Phase|Adverse Event|2
1443976|NCT00876460|4762938|P3|Combination Therapy Phase|Adverse Event|0
1443977|NCT00876460|4762939|P2|Combination Therapy Phase|Adverse Event|2
1443978|NCT00876460|4762940|P1|Combination Therapy Phase|Adverse Event|0
1443979|NCT00876460|4762933|P8|Combination Therapy Phase|Dose limiting toxicity|1
1443980|NCT00876460|4762934|P7|Combination Therapy Phase|Dose limiting toxicity|2
1443981|NCT00876460|4762935|P6|Combination Therapy Phase|Dose limiting toxicity|2
1443982|NCT00876460|4762936|P5|Combination Therapy Phase|Dose limiting toxicity|1
1443983|NCT00876460|4762937|P4|Combination Therapy Phase|Dose limiting toxicity|1
1443984|NCT00876460|4762938|P3|Combination Therapy Phase|Dose limiting toxicity|0
1443985|NCT00876460|4762939|P2|Combination Therapy Phase|Dose limiting toxicity|1
1443986|NCT00876460|4762940|P1|Combination Therapy Phase|Dose limiting toxicity|0
1443987|NCT00876460|4762933|P8|Combination Therapy Phase|Progressive disease|1
1443988|NCT00876460|4762934|P7|Combination Therapy Phase|Progressive disease|1
1443989|NCT00876460|4762935|P6|Combination Therapy Phase|Progressive disease|1
1443990|NCT00876460|4762936|P5|Combination Therapy Phase|Progressive disease|3
1443991|NCT00876460|4762937|P4|Combination Therapy Phase|Progressive disease|3
1443992|NCT00876460|4762938|P3|Combination Therapy Phase|Progressive disease|3
1443993|NCT00876460|4762939|P2|Combination Therapy Phase|Progressive disease|3
1443994|NCT00876460|4762940|P1|Combination Therapy Phase|Progressive disease|2
1443995|NCT00876447|4763012|P2|Overall Study|Adverse Event|8
1443996|NCT00876447|4763013|P1|Overall Study|Adverse Event|4
1443997|NCT00876447|4763012|P2|Overall Study|Lack of Efficacy|3
1443998|NCT00876447|4763013|P1|Overall Study|Lack of Efficacy|5
1443999|NCT00876447|4763012|P2|Overall Study|Pregnancy|2
1444000|NCT00876447|4763013|P1|Overall Study|Pregnancy|4
1444001|NCT00876447|4763012|P2|Overall Study|Lost to Follow-up|15
1444002|NCT00876447|4763013|P1|Overall Study|Lost to Follow-up|6
1444003|NCT00876447|4763012|P2|Overall Study|Personal reasons|28
1444004|NCT00876447|4763013|P1|Overall Study|Personal reasons|30
1444005|NCT00876447|4763012|P2|Overall Study|Protocol Violation|3
1444006|NCT00876447|4763013|P1|Overall Study|Protocol Violation|9
1444007|NCT00876447|4763012|P2|Overall Study|Site closure|14
1444008|NCT00876447|4763013|P1|Overall Study|Site closure|19
1444009|NCT00876447|4763012|P2|Overall Study|Other miscellaneous reasons|8
1444010|NCT00876447|4763013|P1|Overall Study|Other miscellaneous reasons|3
1444011|NCT00876343|4763074|P3|Overall Study|Change of residence or other commitments|3
1444012|NCT00876343|4763075|P2|Overall Study|Change of residence or other commitments|2
1444013|NCT00876343|4763076|P1|Overall Study|Change of residence or other commitments|2
1444014|NCT00876343|4763074|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
1444015|NCT00876343|4763075|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
1444016|NCT00876343|4763076|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
1444017|NCT00876343|4763074|P3|Overall Study|Physician Decision|1
1444018|NCT00876343|4763075|P2|Overall Study|Physician Decision|1
1444019|NCT00876343|4763076|P1|Overall Study|Physician Decision|0
1444020|NCT00876343|4763074|P3|Overall Study|Protocol Violation|1
1444021|NCT00876343|4763075|P2|Overall Study|Protocol Violation|1
1444022|NCT00876343|4763076|P1|Overall Study|Protocol Violation|4
1444023|NCT00876343|4763074|P3|Overall Study|Lack of Efficacy|1
1444024|NCT00876343|4763075|P2|Overall Study|Lack of Efficacy|0
1444025|NCT00876343|4763076|P1|Overall Study|Lack of Efficacy|0
1444026|NCT00876343|4763074|P3|Overall Study|Withdrawal by Subject|3
1444027|NCT00876343|4763075|P2|Overall Study|Withdrawal by Subject|4
1444028|NCT00876343|4763076|P1|Overall Study|Withdrawal by Subject|4
1444029|NCT00876343|4763074|P3|Overall Study|Adverse Event|2
1444030|NCT00876343|4763075|P2|Overall Study|Adverse Event|8
1444031|NCT00876343|4763076|P1|Overall Study|Adverse Event|7
1444032|NCT00876265|4763090|P1|Overall Study|Withdrawal by Subject|2
1444033|NCT00876265|4763090|P1|Overall Study|Lost to Follow-up|6
1444034|NCT00876265|4763090|P1|Overall Study|Miscellaneous reasons|4
1444035|NCT00876018|4763099|P3|Overall Study|Withdrew Consent due to Adverse Event|2
1444036|NCT00876018|4763100|P2|Overall Study|Withdrew Consent due to Adverse Event|4
1444037|NCT00876018|4763101|P1|Overall Study|Withdrew Consent due to Adverse Event|5
1444038|NCT00876018|4763099|P3|Overall Study|Lost to Follow-up|1
1444039|NCT00876018|4763100|P2|Overall Study|Lost to Follow-up|1
1444040|NCT00876018|4763101|P1|Overall Study|Lost to Follow-up|0
1444041|NCT00875979|4763156|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
1444042|NCT00875979|4763157|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
1444043|NCT00875979|4763156|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
1444044|NCT00875979|4763157|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
1444045|NCT00875979|4763156|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
1444046|NCT00875979|4763157|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
1444047|NCT00875979|4763156|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
1444048|NCT00875979|4763157|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
1444049|NCT00875979|4763156|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
1444050|NCT00875979|4763157|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
1444051|NCT00875979|4763156|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
1444052|NCT00875979|4763157|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
1444053|NCT00875979|4763156|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
1444054|NCT00875979|4763157|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
1444055|NCT00875979|4763156|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
1444056|NCT00875979|4763157|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
1444057|NCT00875979|4763156|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
1444058|NCT00875979|4763157|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
1444059|NCT00875810|4763180|P1|Overall Study|Device explanted|1
1444060|NCT00875810|4763180|P1|Overall Study|Patient enroled but not implanted|2
1444061|NCT00875810|4763180|P1|Overall Study|Lost to Follow-up|39
1444062|NCT00875810|4763180|P1|Overall Study|Physician Decision|3
1444063|NCT00875810|4763180|P1|Overall Study|Withdrawal by Subject|1
1444064|NCT00875797|4763189|P2|Overall Study|Protocol Violation|3
1444065|NCT00875797|4763190|P1|Overall Study|Protocol Violation|6
1444066|NCT00875706|4763203|P3|Overall Study|Withdrawal by Subject|0
1444067|NCT00875706|4763204|P2|Overall Study|Withdrawal by Subject|0
1444068|NCT00875706|4763205|P1|Overall Study|Withdrawal by Subject|1
1444069|NCT00875615|4763222|P1|Overall Study|Withdrawal by Subject|1
1444070|NCT00875563|4763236|P1|Overall Study|Still be eligible for follow-up|7
1444071|NCT00875563|4763236|P1|Overall Study|No long-term (3-5 year) consent|6
1444072|NCT00875563|4763236|P1|Overall Study|Withdrawal by Subject|7
1444073|NCT00875563|4763236|P1|Overall Study|Death|4
1444074|NCT00875485|4763261|P2|Challenge Dose Epoch|Pregnancy|0
1444075|NCT00875485|4763262|P1|Challenge Dose Epoch|Pregnancy|1
1444076|NCT00875433|4763302|P1|Overall Study|Not specified|3
1444077|NCT00875433|4763302|P1|Overall Study|Withdrawal by Subject|2
1444078|NCT00875433|4763302|P1|Overall Study|Other Adverse Event|14
1444079|NCT00875433|4763302|P1|Overall Study|Progressive disease|41
1444080|NCT00875420|4763332|P5|Overall Study|Withdrawal by Subject|0
1444081|NCT00875420|4763333|P4|Overall Study|Withdrawal by Subject|0
1444082|NCT00875420|4763334|P3|Overall Study|Withdrawal by Subject|1
1444083|NCT00875420|4763335|P2|Overall Study|Withdrawal by Subject|0
1444084|NCT00875420|4763336|P1|Overall Study|Withdrawal by Subject|0
1444085|NCT00875420|4763332|P5|Overall Study|Sponsor decision|0
1444086|NCT00875420|4763333|P4|Overall Study|Sponsor decision|0
1444087|NCT00875420|4763334|P3|Overall Study|Sponsor decision|0
1444088|NCT00875420|4763335|P2|Overall Study|Sponsor decision|1
1444089|NCT00875420|4763336|P1|Overall Study|Sponsor decision|0
1444090|NCT00875420|4763332|P5|Overall Study|Prohibited medication|0
1444091|NCT00875420|4763333|P4|Overall Study|Prohibited medication|1
1444092|NCT00875420|4763334|P3|Overall Study|Prohibited medication|0
1444093|NCT00875420|4763335|P2|Overall Study|Prohibited medication|0
1444094|NCT00875420|4763336|P1|Overall Study|Prohibited medication|0
1444095|NCT00875420|4763332|P5|Overall Study|Personal reason|1
1444096|NCT00875420|4763333|P4|Overall Study|Personal reason|0
1444097|NCT00875420|4763334|P3|Overall Study|Personal reason|0
1444098|NCT00875420|4763335|P2|Overall Study|Personal reason|0
1444099|NCT00875420|4763336|P1|Overall Study|Personal reason|0
1444100|NCT00875420|4763332|P5|Overall Study|Lost to Follow-up|0
1444101|NCT00875420|4763333|P4|Overall Study|Lost to Follow-up|0
1444102|NCT00875420|4763334|P3|Overall Study|Lost to Follow-up|0
1444103|NCT00875420|4763335|P2|Overall Study|Lost to Follow-up|0
1444104|NCT00875420|4763336|P1|Overall Study|Lost to Follow-up|1
1444105|NCT00875420|4763332|P5|Overall Study|Inability to complete study procedures|1
1444106|NCT00875420|4763333|P4|Overall Study|Inability to complete study procedures|1
1444107|NCT00875420|4763334|P3|Overall Study|Inability to complete study procedures|1
1444108|NCT00875420|4763335|P2|Overall Study|Inability to complete study procedures|0
1444109|NCT00875420|4763336|P1|Overall Study|Inability to complete study procedures|1
1444110|NCT00875420|4763332|P5|Overall Study|Adverse Event|0
1444111|NCT00875420|4763333|P4|Overall Study|Adverse Event|0
1444112|NCT00875420|4763334|P3|Overall Study|Adverse Event|1
1444113|NCT00875420|4763335|P2|Overall Study|Adverse Event|1
1444114|NCT00875420|4763336|P1|Overall Study|Adverse Event|0
1444115|NCT00875017|4763397|P6|Fourth Intervention|Inability to comply with fasting|1
1444116|NCT00875017|4763398|P5|Fourth Intervention|Inability to comply with fasting|0
1444117|NCT00875017|4763399|P4|Fourth Intervention|Inability to comply with fasting|0
1444118|NCT00875017|4763400|P3|Fourth Intervention|Inability to comply with fasting|0
1444119|NCT00875017|4763401|P2|Fourth Intervention|Inability to comply with fasting|0
1444120|NCT00875017|4763402|P1|Fourth Intervention|Inability to comply with fasting|0
1444121|NCT00875017|4763397|P6|Washout|Withdrawal by Subject|0
1444122|NCT00875017|4763398|P5|Washout|Withdrawal by Subject|1
1444123|NCT00875017|4763399|P4|Washout|Withdrawal by Subject|0
1444124|NCT00875017|4763400|P3|Washout|Withdrawal by Subject|0
1444125|NCT00875017|4763401|P2|Washout|Withdrawal by Subject|0
1444126|NCT00875017|4763402|P1|Washout|Withdrawal by Subject|0
1444127|NCT00875017|4763397|P6|Third Intervention|Adverse Event|0
1444128|NCT00875017|4763398|P5|Third Intervention|Adverse Event|0
1444129|NCT00875017|4763399|P4|Third Intervention|Adverse Event|0
1444130|NCT00875017|4763400|P3|Third Intervention|Adverse Event|1
1444131|NCT00875017|4763401|P2|Third Intervention|Adverse Event|1
1444132|NCT00875017|4763402|P1|Third Intervention|Adverse Event|0
1444133|NCT00875017|4763397|P6|Washout|Problems collecting rectal effluent|0
1444134|NCT00875017|4763398|P5|Washout|Problems collecting rectal effluent|0
1444135|NCT00875017|4763399|P4|Washout|Problems collecting rectal effluent|0
1444136|NCT00875017|4763400|P3|Washout|Problems collecting rectal effluent|0
1444137|NCT00875017|4763401|P2|Washout|Problems collecting rectal effluent|1
1444138|NCT00875017|4763402|P1|Washout|Problems collecting rectal effluent|0
1444139|NCT00875017|4763397|P6|Second Intervention|Adverse Event|0
1444140|NCT00875017|4763398|P5|Second Intervention|Adverse Event|0
1444141|NCT00875017|4763399|P4|Second Intervention|Adverse Event|1
1444142|NCT00875017|4763400|P3|Second Intervention|Adverse Event|0
1444143|NCT00875017|4763401|P2|Second Intervention|Adverse Event|0
1444144|NCT00875017|4763402|P1|Second Intervention|Adverse Event|0
1444145|NCT00875017|4763397|P6|Washout|Problem collecting rectal effluent|0
1444146|NCT00875017|4763398|P5|Washout|Problem collecting rectal effluent|0
1444147|NCT00875017|4763399|P4|Washout|Problem collecting rectal effluent|0
1444148|NCT00875017|4763400|P3|Washout|Problem collecting rectal effluent|1
1444149|NCT00875017|4763401|P2|Washout|Problem collecting rectal effluent|0
1444150|NCT00875017|4763402|P1|Washout|Problem collecting rectal effluent|0
1444151|NCT00875017|4763397|P6|First Intervention|Intolerance to nasogastric tube|0
1444152|NCT00875017|4763398|P5|First Intervention|Intolerance to nasogastric tube|1
1444153|NCT00875017|4763399|P4|First Intervention|Intolerance to nasogastric tube|0
1444154|NCT00875017|4763400|P3|First Intervention|Intolerance to nasogastric tube|0
1444155|NCT00875017|4763401|P2|First Intervention|Intolerance to nasogastric tube|0
1444156|NCT00875017|4763402|P1|First Intervention|Intolerance to nasogastric tube|0
1444157|NCT00875017|4763397|P6|First Intervention|Problems collecting rectal effluent|0
1444158|NCT00875017|4763398|P5|First Intervention|Problems collecting rectal effluent|0
1444159|NCT00875017|4763399|P4|First Intervention|Problems collecting rectal effluent|0
1444160|NCT00875017|4763400|P3|First Intervention|Problems collecting rectal effluent|0
1444161|NCT00875017|4763401|P2|First Intervention|Problems collecting rectal effluent|0
1444162|NCT00875017|4763402|P1|First Intervention|Problems collecting rectal effluent|1
1444163|NCT00875017|4763397|P6|First Intervention|Adverse Event|0
1444164|NCT00875017|4763398|P5|First Intervention|Adverse Event|0
1444165|NCT00875017|4763399|P4|First Intervention|Adverse Event|1
1444166|NCT00875017|4763400|P3|First Intervention|Adverse Event|0
1444167|NCT00875017|4763401|P2|First Intervention|Adverse Event|0
1444168|NCT00875017|4763402|P1|First Intervention|Adverse Event|0
1444169|NCT00875017|4763397|P6|First Intervention|Withdrawal by Subject|0
1444170|NCT00875017|4763398|P5|First Intervention|Withdrawal by Subject|0
1444171|NCT00875017|4763399|P4|First Intervention|Withdrawal by Subject|0
1444172|NCT00875017|4763400|P3|First Intervention|Withdrawal by Subject|1
1444173|NCT00875017|4763401|P2|First Intervention|Withdrawal by Subject|0
1444174|NCT00875017|4763402|P1|First Intervention|Withdrawal by Subject|1
1444175|NCT00874939|4763416|P1|Overall Study|Study terminated|4
1444176|NCT00874848|4763449|P2|Overall Study|Physician Decision|2
1444177|NCT00874848|4763450|P1|Overall Study|Physician Decision|0
1444178|NCT00874848|4763449|P2|Overall Study|Failure to comply with protocol|1
1444179|NCT00874848|4763450|P1|Overall Study|Failure to comply with protocol|0
1444180|NCT00874848|4763449|P2|Overall Study|Noncompliance|1
1444181|NCT00874848|4763450|P1|Overall Study|Noncompliance|1
1444182|NCT00874848|4763449|P2|Overall Study|Withdrawal by Subject|4
1444183|NCT00874848|4763450|P1|Overall Study|Withdrawal by Subject|7
1444184|NCT00874848|4763449|P2|Overall Study|Progressive neoplastic disease|18
1444185|NCT00874848|4763450|P1|Overall Study|Progressive neoplastic disease|38
1444186|NCT00874848|4763449|P2|Overall Study|Adverse Event|2
1444187|NCT00874848|4763450|P1|Overall Study|Adverse Event|13
1444188|NCT00874822|4763466|P1|Overall Study|excluded by criteria|8
1444189|NCT00874770|4763474|P4|Overall Study|Subject no Longer Meets Study Criteria|0
1444190|NCT00874770|4763475|P3|Overall Study|Subject no Longer Meets Study Criteria|0
1444191|NCT00874770|4763476|P2|Overall Study|Subject no Longer Meets Study Criteria|0
1444192|NCT00874770|4763477|P1|Overall Study|Subject no Longer Meets Study Criteria|1
1444193|NCT00874770|4763474|P4|Overall Study|Lost to Follow-up|1
1444194|NCT00874770|4763475|P3|Overall Study|Lost to Follow-up|0
1444195|NCT00874770|4763476|P2|Overall Study|Lost to Follow-up|0
1444196|NCT00874770|4763477|P1|Overall Study|Lost to Follow-up|1
1444197|NCT00874770|4763474|P4|Overall Study|Adverse Event|2
1444198|NCT00874770|4763475|P3|Overall Study|Adverse Event|4
1444199|NCT00874770|4763476|P2|Overall Study|Adverse Event|1
1444200|NCT00874770|4763477|P1|Overall Study|Adverse Event|1
1444201|NCT00874770|4763474|P4|Overall Study|Lack of Efficacy|2
1444202|NCT00874770|4763475|P3|Overall Study|Lack of Efficacy|0
1444203|NCT00874770|4763476|P2|Overall Study|Lack of Efficacy|0
1444204|NCT00874770|4763477|P1|Overall Study|Lack of Efficacy|2
1444205|NCT00874549|4763515|P4|Overall Study|Withdrawal by Subject|1
1444206|NCT00874549|4763516|P3|Overall Study|Withdrawal by Subject|0
1444207|NCT00874549|4763517|P2|Overall Study|Withdrawal by Subject|1
1444208|NCT00874549|4763518|P1|Overall Study|Withdrawal by Subject|0
1444209|NCT00874549|4763515|P4|Overall Study|Lost to Follow-up|0
1444210|NCT00874549|4763516|P3|Overall Study|Lost to Follow-up|1
1444211|NCT00874549|4763517|P2|Overall Study|Lost to Follow-up|0
1444212|NCT00874549|4763518|P1|Overall Study|Lost to Follow-up|0
1444213|NCT00874549|4763515|P4|Overall Study|Protocol Violation|1
1444214|NCT00874549|4763516|P3|Overall Study|Protocol Violation|2
1444215|NCT00874549|4763517|P2|Overall Study|Protocol Violation|0
1444216|NCT00874549|4763518|P1|Overall Study|Protocol Violation|1
1444217|NCT00874549|4763515|P4|Overall Study|Adverse Event|0
1444218|NCT00874549|4763516|P3|Overall Study|Adverse Event|1
1444219|NCT00874549|4763517|P2|Overall Study|Adverse Event|0
1444220|NCT00874549|4763518|P1|Overall Study|Adverse Event|0
1444221|NCT00874497|4763595|P2|Overall Study|Withdrawal by Subject|4
1444222|NCT00874497|4763596|P1|Overall Study|Withdrawal by Subject|5
1444223|NCT00874497|4763595|P2|Overall Study|Physician Decision|1
1444224|NCT00874497|4763596|P1|Overall Study|Physician Decision|1
1444225|NCT00874497|4763595|P2|Overall Study|Met Withdrawal Criteria|2
1444226|NCT00874497|4763596|P1|Overall Study|Met Withdrawal Criteria|4
1444227|NCT00874497|4763595|P2|Overall Study|Sponsor Discontinued Trial|3
1444228|NCT00874497|4763596|P1|Overall Study|Sponsor Discontinued Trial|7
1444229|NCT00874497|4763595|P2|Overall Study|Adverse Event|4
1444230|NCT00874497|4763596|P1|Overall Study|Adverse Event|9
1444231|NCT00874497|4763595|P2|Overall Study|Lost to Follow-up|4
1444232|NCT00874497|4763596|P1|Overall Study|Lost to Follow-up|2
1444233|NCT00874276|4763636|P2|Overall Study|Withdrawal by Subject|1
1444234|NCT00874276|4763637|P1|Overall Study|Withdrawal by Subject|1
1444235|NCT00874120|4763659|P2|Second Intervention|Protocol Violation|0
1444236|NCT00874120|4763660|P1|Second Intervention|Protocol Violation|1
1444237|NCT00874120|4763659|P2|Second Intervention|Withdrawal by Subject|0
1444238|NCT00874120|4763660|P1|Second Intervention|Withdrawal by Subject|1
1444239|NCT00874120|4763659|P2|First Intervention|positive drug test|0
1444240|NCT00874120|4763660|P1|First Intervention|positive drug test|1
1444241|NCT00874120|4763659|P2|First Intervention|Protocol Violation|0
1444242|NCT00874120|4763660|P1|First Intervention|Protocol Violation|3
1444243|NCT00874120|4763659|P2|First Intervention|Lost to Follow-up|1
1444244|NCT00874120|4763660|P1|First Intervention|Lost to Follow-up|0
1444245|NCT00874120|4763659|P2|First Intervention|Withdrawal by Subject|0
1444246|NCT00874120|4763660|P1|First Intervention|Withdrawal by Subject|2
1444247|NCT00874120|4763659|P2|First Intervention|Adverse Event|1
1444248|NCT00874120|4763660|P1|First Intervention|Adverse Event|0
1444249|NCT00874029|4763673|P1|Overall Study|Lost to Follow-up|5
1444250|NCT00874029|4763673|P1|Overall Study|Adverse Event|1
1444251|NCT00874029|4763673|P1|Overall Study|Physician Decision|1
1444252|NCT00874029|4763673|P1|Overall Study|Pregnancy|4
1444253|NCT00874029|4763673|P1|Overall Study|Withdrawal by Subject|10
1444254|NCT00873912|4763689|P2|Overall Study|Lost to Follow-up|0
1444255|NCT00873912|4763690|P1|Overall Study|Lost to Follow-up|2
1444256|NCT00873912|4763689|P2|Overall Study|Withdrawal by Subject|0
1444257|NCT00873912|4763690|P1|Overall Study|Withdrawal by Subject|1
1444258|NCT00873860|4763729|P4|Overall Study|Other|0
1444259|NCT00873860|4763730|P3|Overall Study|Other|1
1444260|NCT00873860|4763731|P2|Overall Study|Other|0
1444261|NCT00873860|4763732|P1|Overall Study|Other|1
1444262|NCT00873860|4763729|P4|Overall Study|Death|0
1444263|NCT00873860|4763730|P3|Overall Study|Death|0
1444264|NCT00873860|4763731|P2|Overall Study|Death|0
1444265|NCT00873860|4763732|P1|Overall Study|Death|1
1444266|NCT00873860|4763729|P4|Overall Study|Withdrawal by Subject|0
1444267|NCT00873860|4763730|P3|Overall Study|Withdrawal by Subject|2
1444268|NCT00873860|4763731|P2|Overall Study|Withdrawal by Subject|0
1444269|NCT00873860|4763732|P1|Overall Study|Withdrawal by Subject|1
1444270|NCT00873860|4763729|P4|Overall Study|Lost to Follow-up|1
1444271|NCT00873860|4763730|P3|Overall Study|Lost to Follow-up|0
1444272|NCT00873860|4763731|P2|Overall Study|Lost to Follow-up|0
1444273|NCT00873860|4763732|P1|Overall Study|Lost to Follow-up|1
1444274|NCT00873730|4763820|P2|Overall Study|Sponsor decision|0
1444275|NCT00873730|4763821|P1|Overall Study|Sponsor decision|1
1444276|NCT00873730|4763820|P2|Overall Study|Withdrawal by Subject|1
1444277|NCT00873730|4763821|P1|Overall Study|Withdrawal by Subject|0
1444278|NCT00873730|4763820|P2|Overall Study|Adverse Event|2
1444279|NCT00873730|4763821|P1|Overall Study|Adverse Event|0
1444280|NCT00873730|4763820|P2|Overall Study|Protocol Deviation|2
1444281|NCT00873730|4763821|P1|Overall Study|Protocol Deviation|5
1444282|NCT00873366|4763864|P1|Overall Study|Refused to continue DM-BT testing|3
1444283|NCT00873366|4763864|P1|Overall Study|Off tamoxifen due to side effects|2
1444284|NCT00873366|4763864|P1|Overall Study|Off tamoxifen for reconstructive surgery|1
1444285|NCT00873119|4763889|P2|Overall Study|Not treated|0
1444286|NCT00873119|4763890|P1|Overall Study|Not treated|2
1444287|NCT00873119|4763889|P2|Overall Study|Other|5
1444288|NCT00873119|4763890|P1|Overall Study|Other|2
1444289|NCT00873119|4763889|P2|Overall Study|Death|1
1444290|NCT00873119|4763890|P1|Overall Study|Death|2
1444291|NCT00873119|4763889|P2|Overall Study|Progressive disease|18
1444292|NCT00873119|4763890|P1|Overall Study|Progressive disease|26
1444293|NCT00873119|4763889|P2|Overall Study|Adverse Event|0
1444294|NCT00873119|4763890|P1|Overall Study|Adverse Event|8
1444295|NCT00873119|4763889|P2|Overall Study|Patient request|2
1444296|NCT00873119|4763890|P1|Overall Study|Patient request|4
1444297|NCT00873093|4763911|P5|Overall Study|Ineligible|0
1444298|NCT00873093|4763912|P4|Overall Study|Ineligible|1
1444299|NCT00873093|4763913|P3|Overall Study|Ineligible|0
1444300|NCT00873093|4763914|P2|Overall Study|Ineligible|1
1444301|NCT00873093|4763915|P1|Overall Study|Ineligible|0
1444302|NCT00873093|4763911|P5|Overall Study|Withdrawal by Subject|0
1444303|NCT00873093|4763912|P4|Overall Study|Withdrawal by Subject|0
1444304|NCT00873093|4763913|P3|Overall Study|Withdrawal by Subject|4
1444305|NCT00873093|4763914|P2|Overall Study|Withdrawal by Subject|4
1444306|NCT00873093|4763915|P1|Overall Study|Withdrawal by Subject|1
1444307|NCT00873093|4763911|P5|Overall Study|Physician Decision|2
1444308|NCT00873093|4763912|P4|Overall Study|Physician Decision|10
1444309|NCT00873093|4763913|P3|Overall Study|Physician Decision|10
1444310|NCT00873093|4763914|P2|Overall Study|Physician Decision|17
1444311|NCT00873093|4763915|P1|Overall Study|Physician Decision|0
1444312|NCT00873093|4763911|P5|Overall Study|Death|0
1444313|NCT00873093|4763912|P4|Overall Study|Death|0
1444314|NCT00873093|4763913|P3|Overall Study|Death|2
1444315|NCT00873093|4763914|P2|Overall Study|Death|3
1444316|NCT00873093|4763915|P1|Overall Study|Death|0
1444317|NCT00873093|4763911|P5|Overall Study|Adverse Event|0
1444318|NCT00873093|4763912|P4|Overall Study|Adverse Event|0
1444319|NCT00873093|4763913|P3|Overall Study|Adverse Event|0
1444320|NCT00873093|4763914|P2|Overall Study|Adverse Event|2
1444321|NCT00873093|4763915|P1|Overall Study|Adverse Event|0
1444322|NCT00873041|4763972|P3|Extension Study|Administrative reasons|1
1444323|NCT00873041|4763973|P2|Extension Study|Administrative reasons|0
1444324|NCT00873041|4763974|P1|Extension Study|Administrative reasons|0
1444325|NCT00873041|4763972|P3|Extension Study|Adverse Event|1
1444326|NCT00873041|4763973|P2|Extension Study|Adverse Event|0
1444327|NCT00873041|4763974|P1|Extension Study|Adverse Event|1
1444328|NCT00873041|4763972|P3|Core Study|Protocol deviation|1
1444329|NCT00873041|4763973|P2|Core Study|Protocol deviation|0
1444330|NCT00873041|4763974|P1|Core Study|Protocol deviation|1
1444331|NCT00873041|4763972|P3|Core Study|Abnormal laboratory value|1
1444332|NCT00873041|4763973|P2|Core Study|Abnormal laboratory value|0
1444333|NCT00873041|4763974|P1|Core Study|Abnormal laboratory value|0
1444334|NCT00873041|4763972|P3|Core Study|Lost to Follow-up|0
1444335|NCT00873041|4763973|P2|Core Study|Lost to Follow-up|1
1444336|NCT00873041|4763974|P1|Core Study|Lost to Follow-up|3
1444337|NCT00873041|4763972|P3|Core Study|Withdrawal by Subject|2
1444338|NCT00873041|4763973|P2|Core Study|Withdrawal by Subject|2
1444339|NCT00873041|4763974|P1|Core Study|Withdrawal by Subject|1
1444340|NCT00873041|4763972|P3|Core Study|Adverse Event|1
1444341|NCT00873041|4763973|P2|Core Study|Adverse Event|3
1444342|NCT00873041|4763974|P1|Core Study|Adverse Event|2
1444343|NCT00873015|4764032|P4|Overall Study|Withdrawal by Subject|0
1444344|NCT00873015|4764033|P3|Overall Study|Withdrawal by Subject|0
1444345|NCT00873015|4764034|P2|Overall Study|Withdrawal by Subject|1
1444346|NCT00873015|4764035|P1|Overall Study|Withdrawal by Subject|0
1444347|NCT00872989|4764044|P2|Overall Study|Not protocol specified|8
1444348|NCT00872989|4764045|P1|Overall Study|Not protocol specified|3
1444349|NCT00872989|4764044|P2|Overall Study|Progression/relapse|35
1444350|NCT00872989|4764045|P1|Overall Study|Progression/relapse|47
1444351|NCT00872989|4764044|P2|Overall Study|Withdrawal by Subject|5
1444352|NCT00872989|4764045|P1|Overall Study|Withdrawal by Subject|8
1444353|NCT00872989|4764044|P2|Overall Study|Adverse Event|15
1444354|NCT00872989|4764045|P1|Overall Study|Adverse Event|7
1444355|NCT00872898|4764064|P2|Part Two - Double Blind|Other reasons|0
1444356|NCT00872898|4764065|P1|Part Two - Double Blind|Other reasons|2
1444357|NCT00872898|4764064|P2|Part Two - Double Blind|Lost to Follow-up|2
1444358|NCT00872898|4764065|P1|Part Two - Double Blind|Lost to Follow-up|0
1444359|NCT00872898|4764064|P2|Part Two - Double Blind|Withdrawal by Subject|1
1444360|NCT00872898|4764065|P1|Part Two - Double Blind|Withdrawal by Subject|3
1444361|NCT00872898|4764064|P2|Part Two - Double Blind|Protocol Violation|0
1444362|NCT00872898|4764065|P1|Part Two - Double Blind|Protocol Violation|1
1444363|NCT00872898|4764064|P2|Part Two - Double Blind|Lack of Efficacy|0
1444364|NCT00872898|4764065|P1|Part Two - Double Blind|Lack of Efficacy|1
1444365|NCT00872898|4764064|P2|Part Two - Double Blind|Adverse Event|3
1444366|NCT00872898|4764065|P1|Part Two - Double Blind|Adverse Event|4
1444367|NCT00872599|4764139|P2|Second Washout Period|Adverse Event|1
1444368|NCT00872599|4764140|P1|Second Washout Period|Adverse Event|1
1444369|NCT00872521|4764160|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
1444370|NCT00872521|4764161|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
1444371|NCT00872521|4764162|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
1444372|NCT00872521|4764160|P3|Completed 3-month Follow up|Physician Decision|0
1444373|NCT00872521|4764161|P2|Completed 3-month Follow up|Physician Decision|1
1444374|NCT00872521|4764162|P1|Completed 3-month Follow up|Physician Decision|0
1444375|NCT00872521|4764160|P3|Completed 3-month Follow up|Not specified|0
1444376|NCT00872521|4764161|P2|Completed 3-month Follow up|Not specified|2
1444377|NCT00872521|4764162|P1|Completed 3-month Follow up|Not specified|0
1444378|NCT00872521|4764160|P3|Primary Endpoint Analysis|Patient response missing|1
1444379|NCT00872521|4764161|P2|Primary Endpoint Analysis|Patient response missing|0
1444380|NCT00872521|4764162|P1|Primary Endpoint Analysis|Patient response missing|0
1444381|NCT00872521|4764160|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
1444382|NCT00872521|4764161|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
1444383|NCT00872521|4764162|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
1444384|NCT00872521|4764160|P3|Primary Endpoint Analysis|Patient choice|0
1444385|NCT00872521|4764161|P2|Primary Endpoint Analysis|Patient choice|1
1444386|NCT00872521|4764162|P1|Primary Endpoint Analysis|Patient choice|0
1444387|NCT00872521|4764160|P3|Primary Endpoint Analysis|Not specified|0
1444388|NCT00872521|4764161|P2|Primary Endpoint Analysis|Not specified|2
1444389|NCT00872521|4764162|P1|Primary Endpoint Analysis|Not specified|1
1444390|NCT00872521|4764160|P3|Completed PAD Induction|Death|0
1444391|NCT00872521|4764161|P2|Completed PAD Induction|Death|1
1444392|NCT00872521|4764162|P1|Completed PAD Induction|Death|1
1444393|NCT00872521|4764160|P3|Completed PAD Induction|Adverse Event|0
1444394|NCT00872521|4764161|P2|Completed PAD Induction|Adverse Event|0
1444395|NCT00872521|4764162|P1|Completed PAD Induction|Adverse Event|4
1444396|NCT00872521|4764160|P3|Completed PAD Induction|Disease progression|0
1444397|NCT00872521|4764161|P2|Completed PAD Induction|Disease progression|2
1444398|NCT00872521|4764162|P1|Completed PAD Induction|Disease progression|0
1444399|NCT00872521|4764160|P3|Completed PAD Induction|Patient choice|0
1444400|NCT00872521|4764161|P2|Completed PAD Induction|Patient choice|1
1444401|NCT00872521|4764162|P1|Completed PAD Induction|Patient choice|0
1444402|NCT00872170|4764233|P2|Overall Study|Adverse Event|0
1444403|NCT00872170|4764234|P1|Overall Study|Adverse Event|1
1444404|NCT00872001|4764264|P2|Overall Study|Administrative|15
1444405|NCT00872001|4764265|P1|Overall Study|Administrative|23
1444406|NCT00872001|4764264|P2|Overall Study|Did Not Meet Protocol Eligibility|36
1444407|NCT00872001|4764265|P1|Overall Study|Did Not Meet Protocol Eligibility|38
1444408|NCT00872001|4764264|P2|Overall Study|Protocol Violation|8
1444409|NCT00872001|4764265|P1|Overall Study|Protocol Violation|5
1444410|NCT00872001|4764264|P2|Overall Study|Withdrawal by Subject|30
1444411|NCT00872001|4764265|P1|Overall Study|Withdrawal by Subject|18
1444412|NCT00872001|4764264|P2|Overall Study|Lost to Follow-up|12
1444413|NCT00872001|4764265|P1|Overall Study|Lost to Follow-up|13
1444414|NCT00872001|4764264|P2|Overall Study|Protocol Defined Clinical Event|7
1444415|NCT00872001|4764265|P1|Overall Study|Protocol Defined Clinical Event|5
1444416|NCT00872001|4764264|P2|Overall Study|Adverse Event|23
1444417|NCT00872001|4764265|P1|Overall Study|Adverse Event|34
1444418|NCT00871975|4764273|P1|Overall Study|Motion artifact, tracing uninterpretable|5
1444419|NCT00871975|4764273|P1|Overall Study|Patient unable to void/insufficient vol|13
1444420|NCT00871975|4764273|P1|Overall Study|Catheters could not be inserted|1
1444421|NCT00871975|4764273|P1|Overall Study|Technical difficulty w155-1ith equipment|3
1444422|NCT00871871|4764279|P4|Part II|Protocol Violation|1
1444423|NCT00871871|4764280|P3|Part II|Protocol Violation|0
1444424|NCT00871871|4764281|P2|Part II|Protocol Violation|0
1444425|NCT00871871|4764282|P1|Part II|Protocol Violation|0
1444426|NCT00871871|4764279|P4|Part II|Adverse Event|2
1444427|NCT00871871|4764280|P3|Part II|Adverse Event|1
1444428|NCT00871871|4764281|P2|Part II|Adverse Event|0
1444429|NCT00871871|4764282|P1|Part II|Adverse Event|0
1444430|NCT00871871|4764279|P4|Part II|Withdrawal by Subject|1
1444431|NCT00871871|4764280|P3|Part II|Withdrawal by Subject|2
1444432|NCT00871871|4764281|P2|Part II|Withdrawal by Subject|0
1444433|NCT00871871|4764282|P1|Part II|Withdrawal by Subject|0
1444434|NCT00871871|4764279|P4|Part II|Lack of Efficacy|0
1444435|NCT00871871|4764280|P3|Part II|Lack of Efficacy|1
1444436|NCT00871871|4764281|P2|Part II|Lack of Efficacy|0
1444437|NCT00871871|4764282|P1|Part II|Lack of Efficacy|0
1444438|NCT00871871|4764279|P4|Part I|Laboratory abnormality|0
1444439|NCT00871871|4764280|P3|Part I|Laboratory abnormality|0
1444440|NCT00871871|4764281|P2|Part I|Laboratory abnormality|1
1444441|NCT00871871|4764282|P1|Part I|Laboratory abnormality|0
1444442|NCT00871871|4764279|P4|Part I|Withdrawal by Subject|0
1444443|NCT00871871|4764280|P3|Part I|Withdrawal by Subject|0
1444444|NCT00871871|4764281|P2|Part I|Withdrawal by Subject|0
1444445|NCT00871871|4764282|P1|Part I|Withdrawal by Subject|3
1444446|NCT00871871|4764279|P4|Part I|Adverse Event|0
1444447|NCT00871871|4764280|P3|Part I|Adverse Event|0
1444448|NCT00871871|4764281|P2|Part I|Adverse Event|2
1444449|NCT00871871|4764282|P1|Part I|Adverse Event|0
1444450|NCT00871780|4764306|P1|Overall Study|Physician Decision|1
1444451|NCT00871780|4764306|P1|Overall Study|Death|1
1444452|NCT00871780|4764306|P1|Overall Study|Voluntary Discontinuation|4
1444453|NCT00871780|4764306|P1|Overall Study|Adverse Event|6
1444454|NCT00871780|4764306|P1|Overall Study|Withdrawal by Subject|9
1444455|NCT00871780|4764306|P1|Overall Study|Enrolled But Not Treated|6
1444456|NCT00871741|4764326|P2|Overall Study|Premature study termination|7
1444457|NCT00871741|4764327|P1|Overall Study|Premature study termination|9
1444458|NCT00871728|4764341|P1|Overall Study|Withdrawal of Informed Consent|5
1444459|NCT00871728|4764341|P1|Overall Study|Participant Non-compliance|1
1444460|NCT00871728|4764341|P1|Overall Study|Failed to Visit Hospital|4
1444461|NCT00871728|4764341|P1|Overall Study|Lost to Follow-up|2
1444462|NCT00871728|4764341|P1|Overall Study|Protocol Violation|7
1444463|NCT00871728|4764341|P1|Overall Study|Adverse Event|1
1444464|NCT00871715|4764354|P3|Overall Study|Lost to Follow-up|9
1444465|NCT00871715|4764355|P2|Overall Study|Lost to Follow-up|6
1444466|NCT00871715|4764356|P1|Overall Study|Lost to Follow-up|3
1444467|NCT00871715|4764354|P3|Overall Study|Physician Decision|2
1444468|NCT00871715|4764355|P2|Overall Study|Physician Decision|0
1444469|NCT00871715|4764356|P1|Overall Study|Physician Decision|6
1444470|NCT00871715|4764354|P3|Overall Study|Withdrawal by Subject|15
1444471|NCT00871715|4764355|P2|Overall Study|Withdrawal by Subject|10
1444472|NCT00871715|4764356|P1|Overall Study|Withdrawal by Subject|6
1444473|NCT00871572|4764400|P4|Overall Study|Withdrawal by Subject|1
1444474|NCT00871572|4764401|P3|Overall Study|Withdrawal by Subject|3
1444475|NCT00871572|4764402|P2|Overall Study|Withdrawal by Subject|2
1444476|NCT00871572|4764403|P1|Overall Study|Withdrawal by Subject|1
1444477|NCT00871572|4764400|P4|Overall Study|Sponsor Decision|0
1444478|NCT00871572|4764401|P3|Overall Study|Sponsor Decision|0
1444479|NCT00871572|4764402|P2|Overall Study|Sponsor Decision|0
1444480|NCT00871572|4764403|P1|Overall Study|Sponsor Decision|1
1444481|NCT00871572|4764400|P4|Overall Study|Protocol Violation|1
1444482|NCT00871572|4764401|P3|Overall Study|Protocol Violation|1
1444483|NCT00871572|4764402|P2|Overall Study|Protocol Violation|0
1444484|NCT00871572|4764403|P1|Overall Study|Protocol Violation|0
1444485|NCT00871572|4764400|P4|Overall Study|Lost to Follow-up|1
1444486|NCT00871572|4764401|P3|Overall Study|Lost to Follow-up|0
1444487|NCT00871572|4764402|P2|Overall Study|Lost to Follow-up|1
1444488|NCT00871572|4764403|P1|Overall Study|Lost to Follow-up|0
1444489|NCT00871572|4764400|P4|Overall Study|Investigator Decision|1
1444490|NCT00871572|4764401|P3|Overall Study|Investigator Decision|0
1444491|NCT00871572|4764402|P2|Overall Study|Investigator Decision|1
1444492|NCT00871572|4764403|P1|Overall Study|Investigator Decision|0
1444493|NCT00871572|4764400|P4|Overall Study|Adverse Event|3
1444494|NCT00871572|4764401|P3|Overall Study|Adverse Event|0
1444495|NCT00871572|4764402|P2|Overall Study|Adverse Event|2
1444496|NCT00871572|4764403|P1|Overall Study|Adverse Event|0
1444497|NCT00871494|4764473|P1|Overall Study|Lost to Follow-up|1
1444498|NCT00871494|4764473|P1|Overall Study|Adverse Event|4
1444499|NCT00871494|4764473|P1|Overall Study|Lack of Efficacy|4
1444500|NCT00871494|4764473|P1|Overall Study|Protocol Violation|5
1444501|NCT00871429|4764480|P1|Overall Study|Questionnaire not completed|1
1444502|NCT00871429|4764480|P1|Overall Study|Withdrawal by Subject|17
1444503|NCT00871429|4764480|P1|Overall Study|Lost to Follow-up|6
1444504|NCT00871403|4764491|P3|Monotherapy Treatment Phase|Adverse Event|0
1444505|NCT00871403|4764492|P2|Monotherapy Treatment Phase|Adverse Event|4
1444506|NCT00871403|4764493|P1|Monotherapy Treatment Phase|Adverse Event|0
1444507|NCT00871403|4764491|P3|Monotherapy Treatment Phase|Disease Progression|1
1444508|NCT00871403|4764492|P2|Monotherapy Treatment Phase|Disease Progression|9
1444509|NCT00871403|4764493|P1|Monotherapy Treatment Phase|Disease Progression|0
1444510|NCT00871403|4764491|P3|Combination Treatment Phase|Physician Decision|3
1444511|NCT00871403|4764492|P2|Combination Treatment Phase|Physician Decision|1
1444512|NCT00871403|4764493|P1|Combination Treatment Phase|Physician Decision|0
1444513|NCT00871403|4764491|P3|Combination Treatment Phase|Withdrawal by Subject|1
1444514|NCT00871403|4764492|P2|Combination Treatment Phase|Withdrawal by Subject|3
1444515|NCT00871403|4764493|P1|Combination Treatment Phase|Withdrawal by Subject|0
1444516|NCT00871403|4764491|P3|Combination Treatment Phase|Disease Progression|5
1444517|NCT00871403|4764492|P2|Combination Treatment Phase|Disease Progression|8
1444518|NCT00871403|4764493|P1|Combination Treatment Phase|Disease Progression|0
1444519|NCT00871403|4764491|P3|Combination Treatment Phase|Adverse Event|2
1444520|NCT00871403|4764492|P2|Combination Treatment Phase|Adverse Event|17
1444521|NCT00871403|4764493|P1|Combination Treatment Phase|Adverse Event|0
1444522|NCT00871403|4764491|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
1444523|NCT00871403|4764492|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
1444524|NCT00871403|4764493|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
1444525|NCT00871403|4764491|P3|Combination Treatment Phase|Randomized but Not Treated|1
1444526|NCT00871403|4764492|P2|Combination Treatment Phase|Randomized but Not Treated|1
1444527|NCT00871403|4764493|P1|Combination Treatment Phase|Randomized but Not Treated|1
1444528|NCT00871377|4764506|P6|Third Intervention (10 Weeks)|Death|0
1444529|NCT00871377|4764507|P5|Third Intervention (10 Weeks)|Death|0
1444530|NCT00871377|4764508|P4|Third Intervention (10 Weeks)|Death|1
1444531|NCT00871377|4764509|P3|Third Intervention (10 Weeks)|Death|0
1444532|NCT00871377|4764510|P2|Third Intervention (10 Weeks)|Death|0
1444533|NCT00871377|4764511|P1|Third Intervention (10 Weeks)|Death|0
1444534|NCT00871377|4764506|P6|Washout (6 Weeks)|Withdrawal by Subject|1
1444535|NCT00871377|4764507|P5|Washout (6 Weeks)|Withdrawal by Subject|0
1444536|NCT00871377|4764508|P4|Washout (6 Weeks)|Withdrawal by Subject|0
1444537|NCT00871377|4764509|P3|Washout (6 Weeks)|Withdrawal by Subject|0
1444538|NCT00871377|4764510|P2|Washout (6 Weeks)|Withdrawal by Subject|0
1444539|NCT00871377|4764511|P1|Washout (6 Weeks)|Withdrawal by Subject|0
1444540|NCT00871377|4764506|P6|Washout (6 Weeks)|Withdrawal by Subject|0
1444541|NCT00871377|4764507|P5|Washout (6 Weeks)|Withdrawal by Subject|0
1444542|NCT00871377|4764508|P4|Washout (6 Weeks)|Withdrawal by Subject|0
1444543|NCT00871377|4764509|P3|Washout (6 Weeks)|Withdrawal by Subject|0
1444544|NCT00871377|4764510|P2|Washout (6 Weeks)|Withdrawal by Subject|0
1444545|NCT00871377|4764511|P1|Washout (6 Weeks)|Withdrawal by Subject|1
1444546|NCT00871377|4764506|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
1444547|NCT00871377|4764507|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
1444548|NCT00871377|4764508|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
1444549|NCT00871377|4764509|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
1444550|NCT00871377|4764510|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
1444551|NCT00871377|4764511|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
1444552|NCT00871377|4764506|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
1444553|NCT00871377|4764507|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
1444554|NCT00871377|4764508|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
1444555|NCT00871377|4764509|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
1444556|NCT00871377|4764510|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
1444557|NCT00871377|4764511|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
1444558|NCT00871351|4764522|P3|Overall Study|Adverse Event|0
1444559|NCT00871351|4764523|P2|Overall Study|Adverse Event|1
1444560|NCT00871351|4764524|P1|Overall Study|Adverse Event|3
1444561|NCT00871351|4764522|P3|Overall Study|Withdrawal by Subject|0
1444562|NCT00871351|4764523|P2|Overall Study|Withdrawal by Subject|0
1444563|NCT00871351|4764524|P1|Overall Study|Withdrawal by Subject|1
1444564|NCT00871338|4764546|P2|Prior to Booster|Lost to Follow-up|0
1444565|NCT00871338|4764547|P1|Prior to Booster|Lost to Follow-up|1
1444566|NCT00871338|4764546|P2|Prior to Booster|Withdrawal by Subject|3
1444567|NCT00871338|4764547|P1|Prior to Booster|Withdrawal by Subject|1
1444568|NCT00871234|4764636|P1|Overall Study|Lost to Follow-up|3
1444569|NCT00871234|4764636|P1|Overall Study|Adverse Event|2
1444570|NCT00871169|4764640|P1|Overall Study|Patient did not receive study treatment|2
1444571|NCT00871169|4764640|P1|Overall Study|Protocol Violation|1
1444572|NCT00871117|4764668|P2|Overall Study|Other|4
1444573|NCT00871117|4764669|P1|Overall Study|Other|0
1444574|NCT00871117|4764668|P2|Overall Study|Lost to Follow-up|6
1444575|NCT00871117|4764669|P1|Overall Study|Lost to Follow-up|5
1444576|NCT00871000|4764703|P2|Overall Study|Withdrawal by Subject|0
1444577|NCT00871000|4764704|P1|Overall Study|Withdrawal by Subject|1
1444578|NCT00870870|4764756|P4|Overall Study|Adverse Event|2
1444579|NCT00870870|4764757|P3|Overall Study|Adverse Event|2
1444580|NCT00870870|4764758|P2|Overall Study|Adverse Event|0
1444581|NCT00870870|4764759|P1|Overall Study|Adverse Event|0
1444582|NCT00870870|4764756|P4|Overall Study|Withdrawal by Subject|3
1444583|NCT00870870|4764757|P3|Overall Study|Withdrawal by Subject|1
1444584|NCT00870870|4764758|P2|Overall Study|Withdrawal by Subject|1
1444585|NCT00870870|4764759|P1|Overall Study|Withdrawal by Subject|0
1444586|NCT00870740|4764803|P6|Overall Study|Not Specified|5
1444587|NCT00870740|4764804|P5|Overall Study|Not Specified|3
1444588|NCT00870740|4764805|P4|Overall Study|Not Specified|4
1444589|NCT00870740|4764806|P3|Overall Study|Not Specified|2
1444590|NCT00870740|4764807|P2|Overall Study|Not Specified|5
1444591|NCT00870740|4764808|P1|Overall Study|Not Specified|2
1444592|NCT00870740|4764803|P6|Overall Study|Death|0
1444593|NCT00870740|4764804|P5|Overall Study|Death|1
1444594|NCT00870740|4764805|P4|Overall Study|Death|0
1444595|NCT00870740|4764806|P3|Overall Study|Death|0
1444596|NCT00870740|4764807|P2|Overall Study|Death|0
1444597|NCT00870740|4764808|P1|Overall Study|Death|0
1444598|NCT00870740|4764803|P6|Overall Study|Subject Non-compliance|1
1444599|NCT00870740|4764804|P5|Overall Study|Subject Non-compliance|0
1444600|NCT00870740|4764805|P4|Overall Study|Subject Non-compliance|0
1444601|NCT00870740|4764806|P3|Overall Study|Subject Non-compliance|0
1444602|NCT00870740|4764807|P2|Overall Study|Subject Non-compliance|0
1444603|NCT00870740|4764808|P1|Overall Study|Subject Non-compliance|0
1444604|NCT00870740|4764803|P6|Overall Study|Investigator Decision|0
1444605|NCT00870740|4764804|P5|Overall Study|Investigator Decision|0
1444606|NCT00870740|4764805|P4|Overall Study|Investigator Decision|0
1444607|NCT00870740|4764806|P3|Overall Study|Investigator Decision|1
1444608|NCT00870740|4764807|P2|Overall Study|Investigator Decision|0
1444609|NCT00870740|4764808|P1|Overall Study|Investigator Decision|2
1444610|NCT00870740|4764803|P6|Overall Study|Consent Withdrawn|5
1444611|NCT00870740|4764804|P5|Overall Study|Consent Withdrawn|6
1444612|NCT00870740|4764805|P4|Overall Study|Consent Withdrawn|6
1444613|NCT00870740|4764806|P3|Overall Study|Consent Withdrawn|4
1444614|NCT00870740|4764807|P2|Overall Study|Consent Withdrawn|3
1444615|NCT00870740|4764808|P1|Overall Study|Consent Withdrawn|6
1444616|NCT00870740|4764803|P6|Overall Study|Adverse Event|6
1444617|NCT00870740|4764804|P5|Overall Study|Adverse Event|1
1444618|NCT00870740|4764805|P4|Overall Study|Adverse Event|2
1444619|NCT00870740|4764806|P3|Overall Study|Adverse Event|3
1444620|NCT00870740|4764807|P2|Overall Study|Adverse Event|1
1444621|NCT00870740|4764808|P1|Overall Study|Adverse Event|2
1444622|NCT00870688|4764882|P1|Overall Study|Granules in the Stools|1
1444623|NCT00870688|4764882|P1|Overall Study|Death, Unrelated|1
1444624|NCT00870688|4764882|P1|Overall Study|Lost to Follow-up|2
1444625|NCT00870584|4764887|P2|Overall Study|Protocol Deviation|2
1444626|NCT00870584|4764888|P1|Overall Study|Protocol Deviation|2
1444627|NCT00870584|4764887|P2|Overall Study|Lost to Follow-up|1
1444628|NCT00870584|4764888|P1|Overall Study|Lost to Follow-up|5
1444629|NCT00870584|4764887|P2|Overall Study|Withdrawal by Subject|7
1444630|NCT00870584|4764888|P1|Overall Study|Withdrawal by Subject|6
1444631|NCT00870584|4764887|P2|Overall Study|Adverse Event|3
1444632|NCT00870584|4764888|P1|Overall Study|Adverse Event|3
1444633|NCT00870233|4764997|P1|Overall Study|Death|1
1444634|NCT00870233|4764997|P1|Overall Study|Incompatible internet browser|2
1444635|NCT00870233|4764997|P1|Overall Study|Did not undergo laparotomy|3
1444636|NCT00870233|4764997|P1|Overall Study|Withdrawal by Subject|18
1444637|NCT00870194|4765006|P2|Overall Study|Subject Decision|2
1444638|NCT00870194|4765007|P1|Overall Study|Subject Decision|7
1444639|NCT00870194|4765006|P2|Overall Study|Entry Criteria Not Met|2
1444640|NCT00870194|4765007|P1|Overall Study|Entry Criteria Not Met|1
1444641|NCT00870194|4765006|P2|Overall Study|Protocol Violation|3
1444642|NCT00870194|4765007|P1|Overall Study|Protocol Violation|3
1444643|NCT00870194|4765006|P2|Overall Study|Physician Decision|1
1444644|NCT00870194|4765007|P1|Overall Study|Physician Decision|3
1444645|NCT00870194|4765006|P2|Overall Study|Lost to Follow-up|0
1444646|NCT00870194|4765007|P1|Overall Study|Lost to Follow-up|2
1444647|NCT00870194|4765006|P2|Overall Study|Lack of Efficacy|1
1444648|NCT00870194|4765007|P1|Overall Study|Lack of Efficacy|0
1444649|NCT00870194|4765006|P2|Overall Study|Adverse Event|5
1444650|NCT00870194|4765007|P1|Overall Study|Adverse Event|10
1444651|NCT00870103|4765045|P1|Overall Study|Lost to Follow-up|2
1444652|NCT00870103|4765045|P1|Overall Study|Physician Decision|2
1444653|NCT00869999|4765050|P1|Overall Study|removed prior to starting therapy|1
1444654|NCT00869999|4765050|P1|Overall Study|Withdrawal by Subject|1
1444655|NCT00869960|4765056|P1|Overall Study|Lost to Follow-up|2
1444656|NCT00869778|4765105|P3|Overall Study|Unblinding|0
1444657|NCT00869778|4765106|P2|Overall Study|Unblinding|0
1444658|NCT00869778|4765107|P1|Overall Study|Unblinding|1
1444659|NCT00869778|4765105|P3|Overall Study|Protocol Violation|5
1444660|NCT00869778|4765106|P2|Overall Study|Protocol Violation|3
1444661|NCT00869778|4765107|P1|Overall Study|Protocol Violation|5
1444662|NCT00869778|4765105|P3|Overall Study|Pregnancy|0
1444663|NCT00869778|4765106|P2|Overall Study|Pregnancy|0
1444664|NCT00869778|4765107|P1|Overall Study|Pregnancy|1
1444665|NCT00869778|4765105|P3|Overall Study|Withdrawal by Subject|5
1444666|NCT00869778|4765106|P2|Overall Study|Withdrawal by Subject|4
1444667|NCT00869778|4765107|P1|Overall Study|Withdrawal by Subject|3
1444668|NCT00869778|4765105|P3|Overall Study|Adverse Event|0
1444669|NCT00869778|4765106|P2|Overall Study|Adverse Event|0
1444670|NCT00869778|4765107|P1|Overall Study|Adverse Event|2
1444671|NCT00869557|4765182|P2|Extension Phase|Withdrew Consent|0
1444672|NCT00869557|4765183|P1|Extension Phase|Withdrew Consent|2
1444673|NCT00869557|4765182|P2|Extension Phase|Investigator's Discretion|0
1444674|NCT00869557|4765183|P1|Extension Phase|Investigator's Discretion|2
1444675|NCT00869557|4765182|P2|Extension Phase|Lost to Follow-up|1
1444676|NCT00869557|4765183|P1|Extension Phase|Lost to Follow-up|3
1444677|NCT00869557|4765182|P2|Extension Phase|Lack of Efficacy|0
1444678|NCT00869557|4765183|P1|Extension Phase|Lack of Efficacy|1
1444679|NCT00869557|4765182|P2|Extension Phase|Adverse Event|2
1444680|NCT00869557|4765183|P1|Extension Phase|Adverse Event|2
1444681|NCT00869557|4765182|P2|Randomized Phase|Withdrew Consent|1
1444682|NCT00869557|4765183|P1|Randomized Phase|Withdrew Consent|0
1444683|NCT00869557|4765182|P2|Randomized Phase|Investigator's Discretion|0
1444684|NCT00869557|4765183|P1|Randomized Phase|Investigator's Discretion|1
1444685|NCT00869557|4765182|P2|Randomized Phase|Lost to Follow-up|1
1444686|NCT00869557|4765183|P1|Randomized Phase|Lost to Follow-up|2
1444687|NCT00869518|4765202|P2|Overall Study|Lost to Follow-up|1
1444688|NCT00869518|4765203|P1|Overall Study|Lost to Follow-up|1
1444689|NCT00869401|4765231|P5|Overall Study|Withdrawal by Subject|3
1444690|NCT00869401|4765232|P4|Overall Study|Withdrawal by Subject|5
1444691|NCT00869401|4765233|P3|Overall Study|Withdrawal by Subject|0
1444692|NCT00869401|4765234|P2|Overall Study|Withdrawal by Subject|0
1444693|NCT00869401|4765235|P1|Overall Study|Withdrawal by Subject|0
1444694|NCT00869362|4765264|P2|Overall Study|Lost to Follow-up|3
1444695|NCT00869362|4765265|P1|Overall Study|Lost to Follow-up|1
1444696|NCT00869362|4765264|P2|Overall Study|Death|2
1444697|NCT00869362|4765265|P1|Overall Study|Death|0
1444698|NCT00869323|4765286|P1|Maintenance Therapy|concurrent illness|1
1444699|NCT00869258|4765294|P1|Overall Study|Physician Decision|1
1444700|NCT00869128|4765328|P2|Overall Study|lack of Compliance|6
1444701|NCT00869128|4765329|P1|Overall Study|lack of Compliance|6
1444702|NCT00869089|4765333|P1|Overall Study|Screen Fail|1
1444703|NCT00869089|4765333|P1|Overall Study|Withdrawal by Subject|1
1444704|NCT00869089|4765333|P1|Overall Study|Lost to Follow-up|1
1444705|NCT00869050|4765337|P1|Overall Study|Screen Failure|3
1444706|NCT00868998|4765342|P1|Overall Study|Death|1
1444707|NCT00868998|4765342|P1|Overall Study|Progression of disease|2
1444708|NCT00868998|4765342|P1|Overall Study|Withdrawal by Subject|1
1444709|NCT00868998|4765342|P1|Overall Study|Screen Failure|1
1444710|NCT00868790|4765353|P14|Post-study|Excluded Medication|0
1444711|NCT00868790|4765354|P13|Post-study|Excluded Medication|0
1444712|NCT00868790|4765355|P12|Post-study|Excluded Medication|0
1444713|NCT00868790|4765356|P11|Post-study|Excluded Medication|0
1444714|NCT00868790|4765357|P10|Post-study|Excluded Medication|1
1444715|NCT00868790|4765358|P9|Post-study|Excluded Medication|0
1444716|NCT00868790|4765359|P8|Post-study|Excluded Medication|2
1444717|NCT00868790|4765360|P7|Post-study|Excluded Medication|0
1444718|NCT00868790|4765361|P6|Post-study|Excluded Medication|0
1444719|NCT00868790|4765362|P5|Post-study|Excluded Medication|0
1444720|NCT00868790|4765363|P4|Post-study|Excluded Medication|0
1444721|NCT00868790|4765364|P3|Post-study|Excluded Medication|0
1444722|NCT00868790|4765365|P2|Post-study|Excluded Medication|0
1444723|NCT00868790|4765366|P1|Post-study|Excluded Medication|0
1444724|NCT00868790|4765353|P14|Post-study|Withdrawal by Subject|0
1444725|NCT00868790|4765354|P13|Post-study|Withdrawal by Subject|0
1444726|NCT00868790|4765355|P12|Post-study|Withdrawal by Subject|0
1444727|NCT00868790|4765356|P11|Post-study|Withdrawal by Subject|0
1444728|NCT00868790|4765357|P10|Post-study|Withdrawal by Subject|0
1444729|NCT00868790|4765358|P9|Post-study|Withdrawal by Subject|0
1444730|NCT00868790|4765359|P8|Post-study|Withdrawal by Subject|0
1444731|NCT00868790|4765360|P7|Post-study|Withdrawal by Subject|0
1444732|NCT00868790|4765361|P6|Post-study|Withdrawal by Subject|0
1444733|NCT00868790|4765362|P5|Post-study|Withdrawal by Subject|1
1444734|NCT00868790|4765363|P4|Post-study|Withdrawal by Subject|0
1444735|NCT00868790|4765364|P3|Post-study|Withdrawal by Subject|0
1444736|NCT00868790|4765365|P2|Post-study|Withdrawal by Subject|0
1444737|NCT00868790|4765366|P1|Post-study|Withdrawal by Subject|0
1444738|NCT00868790|4765353|P14|Period 4|Abnormal ALT/AST|0
1444739|NCT00868790|4765354|P13|Period 4|Abnormal ALT/AST|0
1444740|NCT00868790|4765355|P12|Period 4|Abnormal ALT/AST|0
1444741|NCT00868790|4765356|P11|Period 4|Abnormal ALT/AST|0
1444742|NCT00868790|4765357|P10|Period 4|Abnormal ALT/AST|0
1444743|NCT00868790|4765358|P9|Period 4|Abnormal ALT/AST|0
1444744|NCT00868790|4765359|P8|Period 4|Abnormal ALT/AST|0
1444745|NCT00868790|4765360|P7|Period 4|Abnormal ALT/AST|0
1444746|NCT00868790|4765361|P6|Period 4|Abnormal ALT/AST|0
1444747|NCT00868790|4765362|P5|Period 4|Abnormal ALT/AST|0
1444748|NCT00868790|4765363|P4|Period 4|Abnormal ALT/AST|0
1444749|NCT00868790|4765364|P3|Period 4|Abnormal ALT/AST|1
1444750|NCT00868790|4765365|P2|Period 4|Abnormal ALT/AST|0
1444751|NCT00868790|4765366|P1|Period 4|Abnormal ALT/AST|0
1444752|NCT00868790|4765353|P14|Period 4|Study Terminated by Sponsor|1
1444753|NCT00868790|4765354|P13|Period 4|Study Terminated by Sponsor|0
1444754|NCT00868790|4765355|P12|Period 4|Study Terminated by Sponsor|1
1444755|NCT00868790|4765356|P11|Period 4|Study Terminated by Sponsor|2
1444756|NCT00868790|4765357|P10|Period 4|Study Terminated by Sponsor|0
1444757|NCT00868790|4765358|P9|Period 4|Study Terminated by Sponsor|2
1444758|NCT00868790|4765359|P8|Period 4|Study Terminated by Sponsor|1
1444759|NCT00868790|4765360|P7|Period 4|Study Terminated by Sponsor|0
1444760|NCT00868790|4765361|P6|Period 4|Study Terminated by Sponsor|0
1444761|NCT00868790|4765362|P5|Period 4|Study Terminated by Sponsor|0
1444762|NCT00868790|4765363|P4|Period 4|Study Terminated by Sponsor|0
1444763|NCT00868790|4765364|P3|Period 4|Study Terminated by Sponsor|0
1444764|NCT00868790|4765365|P2|Period 4|Study Terminated by Sponsor|0
1444765|NCT00868790|4765366|P1|Period 4|Study Terminated by Sponsor|2
1444766|NCT00868790|4765353|P14|Period 4|Lost to Follow-up|0
1444767|NCT00868790|4765354|P13|Period 4|Lost to Follow-up|0
1444768|NCT00868790|4765355|P12|Period 4|Lost to Follow-up|0
1444769|NCT00868790|4765356|P11|Period 4|Lost to Follow-up|0
1444770|NCT00868790|4765357|P10|Period 4|Lost to Follow-up|0
1444771|NCT00868790|4765358|P9|Period 4|Lost to Follow-up|0
1444772|NCT00868790|4765359|P8|Period 4|Lost to Follow-up|1
1444773|NCT00868790|4765360|P7|Period 4|Lost to Follow-up|0
1444774|NCT00868790|4765361|P6|Period 4|Lost to Follow-up|0
1444775|NCT00868790|4765362|P5|Period 4|Lost to Follow-up|0
1444776|NCT00868790|4765363|P4|Period 4|Lost to Follow-up|0
1444777|NCT00868790|4765364|P3|Period 4|Lost to Follow-up|0
1444778|NCT00868790|4765365|P2|Period 4|Lost to Follow-up|0
1444779|NCT00868790|4765366|P1|Period 4|Lost to Follow-up|0
1444780|NCT00868790|4765353|P14|Period 4|Adverse Event|0
1444781|NCT00868790|4765354|P13|Period 4|Adverse Event|1
1444782|NCT00868790|4765355|P12|Period 4|Adverse Event|0
1444783|NCT00868790|4765356|P11|Period 4|Adverse Event|1
1444784|NCT00868790|4765357|P10|Period 4|Adverse Event|0
1444785|NCT00868790|4765358|P9|Period 4|Adverse Event|0
1444786|NCT00868790|4765359|P8|Period 4|Adverse Event|1
1444787|NCT00868790|4765360|P7|Period 4|Adverse Event|0
1444788|NCT00868790|4765361|P6|Period 4|Adverse Event|0
1444789|NCT00868790|4765362|P5|Period 4|Adverse Event|0
1444790|NCT00868790|4765363|P4|Period 4|Adverse Event|0
1444791|NCT00868790|4765364|P3|Period 4|Adverse Event|0
1444792|NCT00868790|4765365|P2|Period 4|Adverse Event|0
1444793|NCT00868790|4765366|P1|Period 4|Adverse Event|0
1444794|NCT00868790|4765353|P14|Period 3|Study Terminated by Sponsor|0
1444795|NCT00868790|4765354|P13|Period 3|Study Terminated by Sponsor|0
1444796|NCT00868790|4765355|P12|Period 3|Study Terminated by Sponsor|0
1444797|NCT00868790|4765356|P11|Period 3|Study Terminated by Sponsor|0
1444798|NCT00868790|4765357|P10|Period 3|Study Terminated by Sponsor|0
1444799|NCT00868790|4765358|P9|Period 3|Study Terminated by Sponsor|0
1444800|NCT00868790|4765359|P8|Period 3|Study Terminated by Sponsor|0
1444801|NCT00868790|4765360|P7|Period 3|Study Terminated by Sponsor|0
1444802|NCT00868790|4765361|P6|Period 3|Study Terminated by Sponsor|0
1444803|NCT00868790|4765362|P5|Period 3|Study Terminated by Sponsor|0
1444804|NCT00868790|4765363|P4|Period 3|Study Terminated by Sponsor|1
1444805|NCT00868790|4765364|P3|Period 3|Study Terminated by Sponsor|0
1444806|NCT00868790|4765365|P2|Period 3|Study Terminated by Sponsor|0
1444807|NCT00868790|4765366|P1|Period 3|Study Terminated by Sponsor|0
1444808|NCT00868790|4765353|P14|Period 3|Protocol Violation|0
1444809|NCT00868790|4765354|P13|Period 3|Protocol Violation|0
1444810|NCT00868790|4765355|P12|Period 3|Protocol Violation|0
1444811|NCT00868790|4765356|P11|Period 3|Protocol Violation|1
1444812|NCT00868790|4765357|P10|Period 3|Protocol Violation|0
1444813|NCT00868790|4765358|P9|Period 3|Protocol Violation|0
1444814|NCT00868790|4765359|P8|Period 3|Protocol Violation|0
1444815|NCT00868790|4765360|P7|Period 3|Protocol Violation|0
1444816|NCT00868790|4765361|P6|Period 3|Protocol Violation|0
1444817|NCT00868790|4765362|P5|Period 3|Protocol Violation|0
1444818|NCT00868790|4765363|P4|Period 3|Protocol Violation|0
1444819|NCT00868790|4765364|P3|Period 3|Protocol Violation|0
1444820|NCT00868790|4765365|P2|Period 3|Protocol Violation|0
1444821|NCT00868790|4765366|P1|Period 3|Protocol Violation|0
1444822|NCT00868790|4765353|P14|Period 3|Adverse Event|0
1444823|NCT00868790|4765354|P13|Period 3|Adverse Event|0
1444824|NCT00868790|4765355|P12|Period 3|Adverse Event|0
1444825|NCT00868790|4765356|P11|Period 3|Adverse Event|0
1444826|NCT00868790|4765357|P10|Period 3|Adverse Event|1
1444827|NCT00868790|4765358|P9|Period 3|Adverse Event|0
1444828|NCT00868790|4765359|P8|Period 3|Adverse Event|0
1444829|NCT00868790|4765360|P7|Period 3|Adverse Event|0
1444830|NCT00868790|4765361|P6|Period 3|Adverse Event|0
1444831|NCT00868790|4765362|P5|Period 3|Adverse Event|0
1444832|NCT00868790|4765363|P4|Period 3|Adverse Event|0
1444833|NCT00868790|4765364|P3|Period 3|Adverse Event|0
1444834|NCT00868790|4765365|P2|Period 3|Adverse Event|0
1444835|NCT00868790|4765366|P1|Period 3|Adverse Event|0
1444836|NCT00868790|4765353|P14|Period 2|Withdrawal by Subject|1
1444837|NCT00868790|4765354|P13|Period 2|Withdrawal by Subject|0
1444838|NCT00868790|4765355|P12|Period 2|Withdrawal by Subject|0
1444839|NCT00868790|4765356|P11|Period 2|Withdrawal by Subject|0
1444840|NCT00868790|4765357|P10|Period 2|Withdrawal by Subject|0
1444841|NCT00868790|4765358|P9|Period 2|Withdrawal by Subject|1
1444842|NCT00868790|4765359|P8|Period 2|Withdrawal by Subject|0
1444843|NCT00868790|4765360|P7|Period 2|Withdrawal by Subject|0
1444844|NCT00868790|4765361|P6|Period 2|Withdrawal by Subject|0
1444845|NCT00868790|4765362|P5|Period 2|Withdrawal by Subject|0
1444846|NCT00868790|4765363|P4|Period 2|Withdrawal by Subject|0
1444847|NCT00868790|4765364|P3|Period 2|Withdrawal by Subject|0
1444848|NCT00868790|4765365|P2|Period 2|Withdrawal by Subject|0
1444849|NCT00868790|4765366|P1|Period 2|Withdrawal by Subject|0
1444850|NCT00868790|4765353|P14|Period 2|Lost to Follow-up|0
1444851|NCT00868790|4765354|P13|Period 2|Lost to Follow-up|0
1444852|NCT00868790|4765355|P12|Period 2|Lost to Follow-up|0
1444853|NCT00868790|4765356|P11|Period 2|Lost to Follow-up|0
1444854|NCT00868790|4765357|P10|Period 2|Lost to Follow-up|0
1444855|NCT00868790|4765358|P9|Period 2|Lost to Follow-up|0
1444856|NCT00868790|4765359|P8|Period 2|Lost to Follow-up|0
1444857|NCT00868790|4765360|P7|Period 2|Lost to Follow-up|0
1444858|NCT00868790|4765361|P6|Period 2|Lost to Follow-up|1
1444859|NCT00868790|4765362|P5|Period 2|Lost to Follow-up|0
1444860|NCT00868790|4765363|P4|Period 2|Lost to Follow-up|0
1444861|NCT00868790|4765364|P3|Period 2|Lost to Follow-up|0
1444862|NCT00868790|4765365|P2|Period 2|Lost to Follow-up|1
1444863|NCT00868790|4765366|P1|Period 2|Lost to Follow-up|0
1444864|NCT00868790|4765353|P14|Period 2|Adverse Event|0
1444865|NCT00868790|4765354|P13|Period 2|Adverse Event|0
1444866|NCT00868790|4765355|P12|Period 2|Adverse Event|0
1444867|NCT00868790|4765356|P11|Period 2|Adverse Event|0
1444868|NCT00868790|4765357|P10|Period 2|Adverse Event|0
1444869|NCT00868790|4765358|P9|Period 2|Adverse Event|1
1444870|NCT00868790|4765359|P8|Period 2|Adverse Event|0
1444871|NCT00868790|4765360|P7|Period 2|Adverse Event|0
1444872|NCT00868790|4765361|P6|Period 2|Adverse Event|0
1444873|NCT00868790|4765362|P5|Period 2|Adverse Event|0
1444874|NCT00868790|4765363|P4|Period 2|Adverse Event|0
1444875|NCT00868790|4765364|P3|Period 2|Adverse Event|0
1444876|NCT00868790|4765365|P2|Period 2|Adverse Event|0
1444877|NCT00868790|4765366|P1|Period 2|Adverse Event|0
1444878|NCT00868790|4765353|P14|Period 1|Lost to Follow-up|0
1444879|NCT00868790|4765354|P13|Period 1|Lost to Follow-up|0
1444880|NCT00868790|4765355|P12|Period 1|Lost to Follow-up|0
1444881|NCT00868790|4765356|P11|Period 1|Lost to Follow-up|0
1444882|NCT00868790|4765357|P10|Period 1|Lost to Follow-up|0
1444883|NCT00868790|4765358|P9|Period 1|Lost to Follow-up|0
1444884|NCT00868790|4765359|P8|Period 1|Lost to Follow-up|0
1444885|NCT00868790|4765360|P7|Period 1|Lost to Follow-up|0
1444886|NCT00868790|4765361|P6|Period 1|Lost to Follow-up|1
1444887|NCT00868790|4765362|P5|Period 1|Lost to Follow-up|0
1444888|NCT00868790|4765363|P4|Period 1|Lost to Follow-up|0
1444889|NCT00868790|4765364|P3|Period 1|Lost to Follow-up|0
1444890|NCT00868790|4765365|P2|Period 1|Lost to Follow-up|0
1444891|NCT00868790|4765366|P1|Period 1|Lost to Follow-up|0
1444892|NCT00868790|4765353|P14|Period 1|Abnormal Triglycerides|0
1444893|NCT00868790|4765354|P13|Period 1|Abnormal Triglycerides|0
1444894|NCT00868790|4765355|P12|Period 1|Abnormal Triglycerides|0
1444895|NCT00868790|4765356|P11|Period 1|Abnormal Triglycerides|0
1444896|NCT00868790|4765357|P10|Period 1|Abnormal Triglycerides|0
1444897|NCT00868790|4765358|P9|Period 1|Abnormal Triglycerides|0
1444898|NCT00868790|4765359|P8|Period 1|Abnormal Triglycerides|0
1444899|NCT00868790|4765360|P7|Period 1|Abnormal Triglycerides|0
1444900|NCT00868790|4765361|P6|Period 1|Abnormal Triglycerides|0
1444901|NCT00868790|4765362|P5|Period 1|Abnormal Triglycerides|1
1444902|NCT00868790|4765363|P4|Period 1|Abnormal Triglycerides|0
1444903|NCT00868790|4765364|P3|Period 1|Abnormal Triglycerides|0
1444904|NCT00868790|4765365|P2|Period 1|Abnormal Triglycerides|0
1444905|NCT00868790|4765366|P1|Period 1|Abnormal Triglycerides|0
1444906|NCT00868790|4765353|P14|Period 1|Withdrawal by Subject|1
1444907|NCT00868790|4765354|P13|Period 1|Withdrawal by Subject|0
1444908|NCT00868790|4765355|P12|Period 1|Withdrawal by Subject|0
1444909|NCT00868790|4765356|P11|Period 1|Withdrawal by Subject|0
1444910|NCT00868790|4765357|P10|Period 1|Withdrawal by Subject|0
1444911|NCT00868790|4765358|P9|Period 1|Withdrawal by Subject|0
1444912|NCT00868790|4765359|P8|Period 1|Withdrawal by Subject|0
1444913|NCT00868790|4765360|P7|Period 1|Withdrawal by Subject|0
1444914|NCT00868790|4765361|P6|Period 1|Withdrawal by Subject|0
1444915|NCT00868790|4765362|P5|Period 1|Withdrawal by Subject|0
1444916|NCT00868790|4765363|P4|Period 1|Withdrawal by Subject|0
1444917|NCT00868790|4765364|P3|Period 1|Withdrawal by Subject|0
1444918|NCT00868790|4765365|P2|Period 1|Withdrawal by Subject|1
1444919|NCT00868790|4765366|P1|Period 1|Withdrawal by Subject|0
1444920|NCT00868790|4765353|P14|Period 1|Protocol Violation|0
1444921|NCT00868790|4765354|P13|Period 1|Protocol Violation|0
1444922|NCT00868790|4765355|P12|Period 1|Protocol Violation|0
1444923|NCT00868790|4765356|P11|Period 1|Protocol Violation|0
1444924|NCT00868790|4765357|P10|Period 1|Protocol Violation|0
1444925|NCT00868790|4765358|P9|Period 1|Protocol Violation|0
1444926|NCT00868790|4765359|P8|Period 1|Protocol Violation|0
1444927|NCT00868790|4765360|P7|Period 1|Protocol Violation|0
1444928|NCT00868790|4765361|P6|Period 1|Protocol Violation|0
1444929|NCT00868790|4765362|P5|Period 1|Protocol Violation|0
1444930|NCT00868790|4765363|P4|Period 1|Protocol Violation|0
1444931|NCT00868790|4765364|P3|Period 1|Protocol Violation|0
1444932|NCT00868790|4765365|P2|Period 1|Protocol Violation|0
1444933|NCT00868790|4765366|P1|Period 1|Protocol Violation|1
1444934|NCT00868790|4765353|P14|Period 1|Adverse Event|1
1444935|NCT00868790|4765354|P13|Period 1|Adverse Event|0
1444936|NCT00868790|4765355|P12|Period 1|Adverse Event|0
1444937|NCT00868790|4765356|P11|Period 1|Adverse Event|0
1444938|NCT00868790|4765357|P10|Period 1|Adverse Event|0
1444939|NCT00868790|4765358|P9|Period 1|Adverse Event|1
1444940|NCT00868790|4765359|P8|Period 1|Adverse Event|3
1444941|NCT00868790|4765360|P7|Period 1|Adverse Event|0
1444942|NCT00868790|4765361|P6|Period 1|Adverse Event|0
1444943|NCT00868790|4765362|P5|Period 1|Adverse Event|0
1444944|NCT00868790|4765363|P4|Period 1|Adverse Event|0
1444945|NCT00868790|4765364|P3|Period 1|Adverse Event|0
1444946|NCT00868790|4765365|P2|Period 1|Adverse Event|0
1444947|NCT00868790|4765366|P1|Period 1|Adverse Event|1
1444948|NCT00868608|4765449|P3|Overall Study|Other - Unspecified|0
1444949|NCT00868608|4765450|P2|Overall Study|Other - Unspecified|0
1444950|NCT00868608|4765451|P1|Overall Study|Other - Unspecified|1
1444951|NCT00868608|4765449|P3|Overall Study|Death|4
1444952|NCT00868608|4765450|P2|Overall Study|Death|2
1444953|NCT00868608|4765451|P1|Overall Study|Death|16
1444954|NCT00868608|4765449|P3|Overall Study|Lost to Follow-up|1
1444955|NCT00868608|4765450|P2|Overall Study|Lost to Follow-up|0
1444956|NCT00868608|4765451|P1|Overall Study|Lost to Follow-up|3
1444957|NCT00868608|4765449|P3|Overall Study|Withdrawal by Subject|0
1444958|NCT00868608|4765450|P2|Overall Study|Withdrawal by Subject|1
1444959|NCT00868608|4765451|P1|Overall Study|Withdrawal by Subject|3
1444960|NCT00868530|4765475|P1|Overall Study|Lost to Follow-up|1
1444961|NCT00868530|4765475|P1|Overall Study|Adverse Event|3
1444962|NCT00868517|4765490|P3|Overall Study|Protocol Violation|0
1444963|NCT00868517|4765491|P2|Overall Study|Protocol Violation|1
1444964|NCT00868517|4765492|P1|Overall Study|Protocol Violation|1
1444965|NCT00868517|4765490|P3|Overall Study|Withdrawal by Subject|2
1444966|NCT00868517|4765491|P2|Overall Study|Withdrawal by Subject|3
1444967|NCT00868517|4765492|P1|Overall Study|Withdrawal by Subject|3
1444968|NCT00868439|4765530|P2|Overall Study|Withdrawal by Subject|1
1444969|NCT00868439|4765531|P1|Overall Study|Withdrawal by Subject|0
1444970|NCT00868439|4765530|P2|Overall Study|Physician Decision|0
1444971|NCT00868439|4765531|P1|Overall Study|Physician Decision|1
1444972|NCT00868439|4765530|P2|Overall Study|Protocol Violation|1
1444973|NCT00868439|4765531|P1|Overall Study|Protocol Violation|1
1444974|NCT00868439|4765530|P2|Overall Study|Death|1
1444975|NCT00868439|4765531|P1|Overall Study|Death|0
1444976|NCT00868439|4765530|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
1444977|NCT00868439|4765531|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
1444978|NCT00868439|4765530|P2|Overall Study|Adverse Event|3
1444979|NCT00868439|4765531|P1|Overall Study|Adverse Event|4
1444980|NCT00868296|4765588|P2|Overall Study|Withdrawal by Subject|1
1444981|NCT00868296|4765589|P1|Overall Study|Withdrawal by Subject|0
1444982|NCT00868296|4765588|P2|Overall Study|Adverse Event|2
1444983|NCT00868296|4765589|P1|Overall Study|Adverse Event|0
1444984|NCT00868231|4765597|P6|Treatment Period 3|Adverse Event|0
1444985|NCT00868231|4765598|P5|Treatment Period 3|Adverse Event|0
1444986|NCT00868231|4765599|P4|Treatment Period 3|Adverse Event|0
1444987|NCT00868231|4765600|P3|Treatment Period 3|Adverse Event|1
1444988|NCT00868231|4765601|P2|Treatment Period 3|Adverse Event|0
1444989|NCT00868231|4765602|P1|Treatment Period 3|Adverse Event|0
1444990|NCT00868231|4765597|P6|Treatment Period 2|Adverse Event|0
1444991|NCT00868231|4765598|P5|Treatment Period 2|Adverse Event|0
1444992|NCT00868231|4765599|P4|Treatment Period 2|Adverse Event|0
1444993|NCT00868231|4765600|P3|Treatment Period 2|Adverse Event|0
1444994|NCT00868231|4765601|P2|Treatment Period 2|Adverse Event|0
1444995|NCT00868231|4765602|P1|Treatment Period 2|Adverse Event|1
1444996|NCT00868231|4765597|P6|Treatment Period 1|Adverse Event|0
1444997|NCT00868231|4765598|P5|Treatment Period 1|Adverse Event|1
1444998|NCT00868231|4765599|P4|Treatment Period 1|Adverse Event|0
1444999|NCT00868231|4765600|P3|Treatment Period 1|Adverse Event|0
1445000|NCT00868231|4765601|P2|Treatment Period 1|Adverse Event|0
1445001|NCT00868231|4765602|P1|Treatment Period 1|Adverse Event|0
1445002|NCT00868192|4765668|P1|Overall Study|Ineligible|4
1445003|NCT00867568|4765722|P1|Overall Study|Withdrawal by Subject|1
1445004|NCT00867568|4765722|P1|Overall Study|Adverse Event|4
1445005|NCT00867568|4765722|P1|Overall Study|Lack of Efficacy|10
1445006|NCT00867503|4765739|P1|Overall Study|Withdrawal by Subject|1
1445007|NCT00867490|4765745|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
1445008|NCT00867490|4765745|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
1445009|NCT00867490|4765745|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
1445010|NCT00867490|4765745|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
1445011|NCT00867490|4765745|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
1445012|NCT00867360|4765787|P2|Overall Study|Physician Decision|1
1445013|NCT00867360|4765788|P1|Overall Study|Physician Decision|0
1445014|NCT00867360|4765787|P2|Overall Study|Withdrawal by Subject|0
1445015|NCT00867360|4765788|P1|Overall Study|Withdrawal by Subject|1
1445016|NCT00867165|4765835|P2|Overall Study|Withdrawal by Subject|0
1445017|NCT00867165|4765836|P1|Overall Study|Withdrawal by Subject|1
1445018|NCT00867165|4765835|P2|Overall Study|Adverse Event|0
1445019|NCT00867165|4765836|P1|Overall Study|Adverse Event|3
1445020|NCT00867113|4765984|P1|Post Treatment After Survival Follow-up|Administrative problems|4
1445021|NCT00867113|4765984|P1|Post Treatment After Survival Follow-up|Lost to Follow-up|5
1445022|NCT00867113|4765984|P1|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
1445023|NCT00867113|4765984|P1|Post Treatment After Survival Follow-up|Death|1
1445024|NCT00867113|4765984|P1|Treatment Period|Protocol Violation|4
1445025|NCT00867113|4765984|P1|Treatment Period|Disease progression/relapse|1
1445026|NCT00867113|4765984|P1|Treatment Period|Administrative problems|1
1445027|NCT00867113|4765984|P1|Treatment Period|Lost to Follow-up|3
1445028|NCT00867113|4765984|P1|Treatment Period|Withdrawal by Subject|19
1445029|NCT00867113|4765984|P1|Treatment Period|Death|2
1445030|NCT00867113|4765984|P1|Treatment Period|Adverse Event|15
1445031|NCT00867087|4765991|P1|Overall Study|Death|37
1445032|NCT00867087|4765991|P1|Overall Study|Withdrawal by Subject|4
1445033|NCT00867087|4765991|P1|Overall Study|Other|1
1445034|NCT00867035|4766007|P2|Baseline to 1 Week|Withdrawal by Subject|0
1445035|NCT00867035|4766008|P1|Baseline to 1 Week|Withdrawal by Subject|1
1445036|NCT00867035|4766007|P2|Baseline to 1 Hour|Withdrawal by Subject|1
1445037|NCT00867035|4766008|P1|Baseline to 1 Hour|Withdrawal by Subject|1
1445038|NCT00867009|4766034|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
1445039|NCT00867009|4766034|P1|Induction Period|Progressive Disease (PD)|25
1445040|NCT00867009|4766034|P1|Induction Period|Physician Decision|3
1445041|NCT00867009|4766034|P1|Induction Period|Withdrawal by Subject|8
1445042|NCT00867009|4766034|P1|Induction Period|Protocol Violation|1
1445043|NCT00867009|4766034|P1|Induction Period|Death due to Study Disease|4
1445044|NCT00867009|4766034|P1|Induction Period|Death due to serious adverse event|6
1445045|NCT00867009|4766034|P1|Induction Period|Serious Adverse Event|10
1445046|NCT00867009|4766034|P1|Induction Period|Nonserious Adverse Event|5
1445047|NCT00866918|4766043|P2|Overall Study|Secondary malignancy|0
1445048|NCT00866918|4766044|P1|Overall Study|Secondary malignancy|1
1445049|NCT00866918|4766043|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
1445050|NCT00866918|4766044|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
1445051|NCT00866918|4766043|P2|Overall Study|Ineligible|4
1445052|NCT00866918|4766044|P1|Overall Study|Ineligible|2
1445053|NCT00866918|4766043|P2|Overall Study|Physician Decision|2
1445054|NCT00866918|4766044|P1|Overall Study|Physician Decision|10
1445055|NCT00866918|4766043|P2|Overall Study|Lack of Efficacy|1
1445056|NCT00866918|4766044|P1|Overall Study|Lack of Efficacy|1
1445057|NCT00866918|4766043|P2|Overall Study|Death|5
1445058|NCT00866918|4766044|P1|Overall Study|Death|1
1445059|NCT00866814|4766061|P1|Overall Study|Moved to area without study site|1
1445060|NCT00866814|4766061|P1|Overall Study|Unable to meet follow-up requirements|2
1445061|NCT00866814|4766061|P1|Overall Study|No longer wished to participate|1
1445062|NCT00866814|4766061|P1|Overall Study|Death|1
1445063|NCT00866814|4766061|P1|Overall Study|Physician Decision|1
1445064|NCT00866814|4766061|P1|Overall Study|Adverse Event|2
1445065|NCT00866814|4766061|P1|Overall Study|Lost to Follow-up|12
1445066|NCT00866788|4766074|P4|Overall Study|Physician Decision|1
1445067|NCT00866788|4766075|P3|Overall Study|Physician Decision|1
1445068|NCT00866788|4766076|P2|Overall Study|Physician Decision|0
1445069|NCT00866788|4766077|P1|Overall Study|Physician Decision|0
1445070|NCT00866788|4766074|P4|Overall Study|Disease progression|0
1445071|NCT00866788|4766075|P3|Overall Study|Disease progression|1
1445072|NCT00866788|4766076|P2|Overall Study|Disease progression|1
1445073|NCT00866788|4766077|P1|Overall Study|Disease progression|3
1445074|NCT00866788|4766074|P4|Overall Study|Pregnancy|0
1445075|NCT00866788|4766075|P3|Overall Study|Pregnancy|0
1445076|NCT00866788|4766076|P2|Overall Study|Pregnancy|1
1445077|NCT00866788|4766077|P1|Overall Study|Pregnancy|0
1445078|NCT00866788|4766074|P4|Overall Study|Withdrawal by Subject|1
1445079|NCT00866788|4766075|P3|Overall Study|Withdrawal by Subject|0
1445080|NCT00866788|4766076|P2|Overall Study|Withdrawal by Subject|1
1445081|NCT00866788|4766077|P1|Overall Study|Withdrawal by Subject|2
1445082|NCT00866788|4766074|P4|Overall Study|Lost to Follow-up|2
1445083|NCT00866788|4766075|P3|Overall Study|Lost to Follow-up|0
1445084|NCT00866788|4766076|P2|Overall Study|Lost to Follow-up|1
1445085|NCT00866788|4766077|P1|Overall Study|Lost to Follow-up|1
1445086|NCT00866788|4766074|P4|Overall Study|Adverse Event|1
1445087|NCT00866788|4766075|P3|Overall Study|Adverse Event|0
1445088|NCT00866788|4766076|P2|Overall Study|Adverse Event|2
1445089|NCT00866788|4766077|P1|Overall Study|Adverse Event|0
1445090|NCT00866775|4766125|P2|Overall Study|discontinued due to communication error|1
1445091|NCT00866775|4766126|P1|Overall Study|discontinued due to communication error|0
1445092|NCT00866775|4766125|P2|Overall Study|met exit criteria|17
1445093|NCT00866775|4766126|P1|Overall Study|met exit criteria|23
1445094|NCT00866775|4766125|P2|Overall Study|Withdrawal by Subject|4
1445095|NCT00866775|4766126|P1|Overall Study|Withdrawal by Subject|4
1445096|NCT00866775|4766125|P2|Overall Study|Protocol Violation|4
1445097|NCT00866775|4766126|P1|Overall Study|Protocol Violation|3
1445098|NCT00866775|4766125|P2|Overall Study|Physician Decision|3
1445099|NCT00866775|4766126|P1|Overall Study|Physician Decision|0
1445100|NCT00866775|4766125|P2|Overall Study|Lost to Follow-up|4
1445101|NCT00866775|4766126|P1|Overall Study|Lost to Follow-up|0
1445102|NCT00866775|4766125|P2|Overall Study|Death|0
1445103|NCT00866775|4766126|P1|Overall Study|Death|1
1445104|NCT00866775|4766125|P2|Overall Study|Adverse Event|19
1445105|NCT00866775|4766126|P1|Overall Study|Adverse Event|5
1445106|NCT00866723|4766162|P1|Overall Study|Disease Progression|4
1445107|NCT00866723|4766162|P1|Overall Study|Withdrawal by Subject|1
1445108|NCT00866697|4766169|P2|Overall Study|Ongoing|312
1445109|NCT00866697|4766170|P1|Overall Study|Ongoing|335
1445110|NCT00866697|4766169|P2|Overall Study|Withdrawal by Subject|53
1445111|NCT00866697|4766170|P1|Overall Study|Withdrawal by Subject|28
1445112|NCT00866697|4766169|P2|Overall Study|Physician Decision|4
1445113|NCT00866697|4766170|P1|Overall Study|Physician Decision|3
1445114|NCT00866697|4766169|P2|Overall Study|Lost to Follow-up|8
1445115|NCT00866697|4766170|P1|Overall Study|Lost to Follow-up|7
1445116|NCT00866658|4766214|P2|Overall Study|Familial and Personal Reasons|5
1445117|NCT00866658|4766215|P1|Overall Study|Familial and Personal Reasons|4
1445118|NCT00866658|4766214|P2|Overall Study|Protocol Violation|1
1445119|NCT00866658|4766215|P1|Overall Study|Protocol Violation|1
1445120|NCT00866658|4766214|P2|Overall Study|Withdrawal by Subject|0
1445121|NCT00866658|4766215|P1|Overall Study|Withdrawal by Subject|1
1445122|NCT00866658|4766214|P2|Overall Study|Lack of Efficacy|1
1445123|NCT00866658|4766215|P1|Overall Study|Lack of Efficacy|2
1445124|NCT00866658|4766214|P2|Overall Study|Adverse Event|14
1445125|NCT00866658|4766215|P1|Overall Study|Adverse Event|5
1445126|NCT00866606|4766243|P1|Overall Study|Adverse Event|1
1445127|NCT00866606|4766243|P1|Overall Study|Lost to Follow-up|3
1445128|NCT00866359|4766257|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
1445129|NCT00866359|4766258|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
1445130|NCT00866359|4766259|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
1445131|NCT00866359|4766260|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
1445132|NCT00866359|4766257|P4|Treatment Phase (Days 1 to 85)|Other|0
1445133|NCT00866359|4766258|P3|Treatment Phase (Days 1 to 85)|Other|0
1445134|NCT00866359|4766259|P2|Treatment Phase (Days 1 to 85)|Other|0
1445135|NCT00866359|4766260|P1|Treatment Phase (Days 1 to 85)|Other|1
1445136|NCT00866359|4766257|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
1445137|NCT00866359|4766258|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
1445138|NCT00866359|4766259|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
1445139|NCT00866359|4766260|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
1445140|NCT00866359|4766257|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
1445141|NCT00866359|4766258|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
1445142|NCT00866359|4766259|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
1445143|NCT00866359|4766260|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
1445144|NCT00866359|4766257|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
1445145|NCT00866359|4766258|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
1445146|NCT00866359|4766259|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
1445147|NCT00866359|4766260|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
1445148|NCT00866359|4766257|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
1445149|NCT00866359|4766258|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
1445150|NCT00866359|4766259|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
1445151|NCT00866359|4766260|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
1445152|NCT00866320|4766313|P1|Overall Study|Death|2
1445153|NCT00866320|4766313|P1|Overall Study|Withdrawal by Subject|4
1445154|NCT00866307|4766320|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
1445155|NCT00866307|4766321|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
1445156|NCT00866307|4766322|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
1445157|NCT00866307|4766320|P3|Consolidation/Maintenance|Non-compliance|1
1445158|NCT00866307|4766321|P2|Consolidation/Maintenance|Non-compliance|0
1445159|NCT00866307|4766322|P1|Consolidation/Maintenance|Non-compliance|0
1445160|NCT00866307|4766320|P3|Consolidation/Maintenance|Therapy error|0
1445161|NCT00866307|4766321|P2|Consolidation/Maintenance|Therapy error|1
1445162|NCT00866307|4766322|P1|Consolidation/Maintenance|Therapy error|0
1445163|NCT00866307|4766320|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
1445164|NCT00866307|4766321|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
1445165|NCT00866307|4766322|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
1445166|NCT00866307|4766320|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
1445167|NCT00866307|4766321|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
1445168|NCT00866307|4766322|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
1445169|NCT00866307|4766320|P3|Consolidation/Maintenance|Withdrawal by Subject|1
1445170|NCT00866307|4766321|P2|Consolidation/Maintenance|Withdrawal by Subject|1
1445171|NCT00866307|4766322|P1|Consolidation/Maintenance|Withdrawal by Subject|0
1445172|NCT00866307|4766320|P3|Consolidation/Maintenance|Physician Decision|2
1445173|NCT00866307|4766321|P2|Consolidation/Maintenance|Physician Decision|3
1445174|NCT00866307|4766322|P1|Consolidation/Maintenance|Physician Decision|0
1445175|NCT00866307|4766320|P3|Consolidation/Maintenance|Death|1
1445176|NCT00866307|4766321|P2|Consolidation/Maintenance|Death|0
1445177|NCT00866307|4766322|P1|Consolidation/Maintenance|Death|0
1445178|NCT00866307|4766320|P3|Consolidation/Maintenance|Adverse Event|8
1445179|NCT00866307|4766321|P2|Consolidation/Maintenance|Adverse Event|0
1445180|NCT00866307|4766322|P1|Consolidation/Maintenance|Adverse Event|0
1445181|NCT00866307|4766320|P3|Induction|Study was closed at the time|0
1445182|NCT00866307|4766321|P2|Induction|Study was closed at the time|0
1445183|NCT00866307|4766322|P1|Induction|Study was closed at the time|1
1445184|NCT00866307|4766320|P3|Induction|Improper post-induction consent|0
1445185|NCT00866307|4766321|P2|Induction|Improper post-induction consent|0
1445186|NCT00866307|4766322|P1|Induction|Improper post-induction consent|2
1445187|NCT00866307|4766320|P3|Induction|Inadequate cytognetic samples th|0
1445188|NCT00866307|4766321|P2|Induction|Inadequate cytognetic samples th|0
1445189|NCT00866307|4766322|P1|Induction|Inadequate cytognetic samples th|1
1445190|NCT00866307|4766320|P3|Induction|Identification of Patients with Day 29 M|0
1445191|NCT00866307|4766321|P2|Induction|Identification of Patients with Day 29 M|0
1445192|NCT00866307|4766322|P1|Induction|Identification of Patients with Day 29 M|3
1445193|NCT00866307|4766320|P3|Induction|Progressive Disease|0
1445194|NCT00866307|4766321|P2|Induction|Progressive Disease|0
1445195|NCT00866307|4766322|P1|Induction|Progressive Disease|1
1445196|NCT00866307|4766320|P3|Induction|Physician Decision|0
1445197|NCT00866307|4766321|P2|Induction|Physician Decision|0
1445198|NCT00866307|4766322|P1|Induction|Physician Decision|5
1445199|NCT00866307|4766320|P3|Induction|Death|0
1445200|NCT00866307|4766321|P2|Induction|Death|0
1445201|NCT00866307|4766322|P1|Induction|Death|2
1445202|NCT00866307|4766320|P3|Induction|Adverse Event|0
1445203|NCT00866307|4766321|P2|Induction|Adverse Event|0
1445204|NCT00866307|4766322|P1|Induction|Adverse Event|5
1445205|NCT00866294|4766332|P3|Overall Study|Physician Decision|1
1445206|NCT00866294|4766333|P2|Overall Study|Physician Decision|2
1445207|NCT00866294|4766334|P1|Overall Study|Physician Decision|6
1445208|NCT00866294|4766332|P3|Overall Study|Lost to Follow-up|0
1445209|NCT00866294|4766333|P2|Overall Study|Lost to Follow-up|3
1445210|NCT00866294|4766334|P1|Overall Study|Lost to Follow-up|1
1445211|NCT00866294|4766332|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
1445212|NCT00866294|4766333|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
1445213|NCT00866294|4766334|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
1445214|NCT00866294|4766332|P3|Overall Study|Protocol Violation|0
1445215|NCT00866294|4766333|P2|Overall Study|Protocol Violation|0
1445216|NCT00866294|4766334|P1|Overall Study|Protocol Violation|2
1445217|NCT00866294|4766332|P3|Overall Study|Lack of Efficacy|0
1445218|NCT00866294|4766333|P2|Overall Study|Lack of Efficacy|1
1445219|NCT00866294|4766334|P1|Overall Study|Lack of Efficacy|7
1445220|NCT00866294|4766332|P3|Overall Study|Adverse Event|9
1445221|NCT00866294|4766333|P2|Overall Study|Adverse Event|13
1445222|NCT00866294|4766334|P1|Overall Study|Adverse Event|12
1445223|NCT00866281|4766363|P2|Overall Study|New cancer therapy|4
1445224|NCT00866281|4766364|P1|Overall Study|New cancer therapy|0
1445225|NCT00866281|4766363|P2|Overall Study|Disease progression|11
1445226|NCT00866281|4766364|P1|Overall Study|Disease progression|3
1445227|NCT00866281|4766363|P2|Overall Study|Withdrawal by participants|0
1445228|NCT00866281|4766364|P1|Overall Study|Withdrawal by participants|3
1445229|NCT00866281|4766363|P2|Overall Study|Adverse Event|0
1445230|NCT00866281|4766364|P1|Overall Study|Adverse Event|1
1445231|NCT00866177|4766380|P1|Overall Study|Not Treated|151
1445232|NCT00866177|4766380|P1|Overall Study|Withdrawal by Subject|1
1445233|NCT00866047|4766384|P1|Follow-up Period|Lost to Follow-up|5
1445234|NCT00866047|4766384|P1|Treatment Period|Withdrawal by Subject|5
1445235|NCT00866047|4766384|P1|Treatment Period|Physician Decision|14
1445236|NCT00866047|4766384|P1|Treatment Period|Adverse Event|16
1445237|NCT00866047|4766384|P1|Treatment Period|Progressive disease|13
1445238|NCT00865904|4766416|P5|Overall Study|Randomized but not Treated|1
1445239|NCT00865904|4766417|P4|Overall Study|Randomized but not Treated|1
1445240|NCT00865904|4766418|P3|Overall Study|Randomized but not Treated|0
1445241|NCT00865904|4766419|P2|Overall Study|Randomized but not Treated|0
1445242|NCT00865904|4766420|P1|Overall Study|Randomized but not Treated|2
1445243|NCT00865709|4766477|P2|Treatment|Surgery|3
1445244|NCT00865709|4766478|P1|Treatment|Surgery|8
1445245|NCT00865709|4766477|P2|Treatment|Physician Decision|2
1445246|NCT00865709|4766478|P1|Treatment|Physician Decision|3
1445247|NCT00865709|4766477|P2|Treatment|Withdrawal by Subject|7
1445248|NCT00865709|4766478|P1|Treatment|Withdrawal by Subject|10
1445249|NCT00865709|4766477|P2|Treatment|Adverse Event|6
1445250|NCT00865709|4766478|P1|Treatment|Adverse Event|9
1445251|NCT00865514|4766494|P1|Overall Study|Infusion cost exceeded funding|2
1445252|NCT00865345|4766499|P1|Overall Study|Withdrawal by Subject|2
1445253|NCT00865306|4766506|P2|Controlled Trial|Withdrawal by Subject|1
1445254|NCT00865306|4766507|P1|Controlled Trial|Withdrawal by Subject|0
1445255|NCT00865306|4766506|P2|Controlled Trial|Sought treatment for conduct disorder|0
1445256|NCT00865306|4766507|P1|Controlled Trial|Sought treatment for conduct disorder|1
1445257|NCT00865306|4766506|P2|Controlled Trial|Improved btw baseline and first session|0
1445258|NCT00865306|4766507|P1|Controlled Trial|Improved btw baseline and first session|1
1445259|NCT00865306|4766506|P2|Controlled Trial|Difficulty commuting|0
1445260|NCT00865306|4766507|P1|Controlled Trial|Difficulty commuting|2
1445261|NCT00865306|4766506|P2|Controlled Trial|Lost to Follow-up|1
1445262|NCT00865306|4766507|P1|Controlled Trial|Lost to Follow-up|1
1445263|NCT00865189|4766536|P2|Overall Study|Withdrawal by Subject|0
1445264|NCT00865189|4766537|P1|Overall Study|Withdrawal by Subject|1
1445265|NCT00865189|4766536|P2|Overall Study|Lost to Follow-up|6
1445266|NCT00865189|4766537|P1|Overall Study|Lost to Follow-up|6
1445267|NCT00865189|4766536|P2|Overall Study|Death|11
1445268|NCT00865189|4766537|P1|Overall Study|Death|4
1445269|NCT00865189|4766536|P2|Overall Study|Other|2
1445270|NCT00865189|4766537|P1|Overall Study|Other|1
1445271|NCT00865124|4766565|P3|Overall Study|Withdrawn consent|0
1445272|NCT00865124|4766566|P2|Overall Study|Withdrawn consent|0
1445273|NCT00865124|4766567|P1|Overall Study|Withdrawn consent|2
1445274|NCT00865124|4766565|P3|Overall Study|Physician Decision|0
1445275|NCT00865124|4766566|P2|Overall Study|Physician Decision|1
1445276|NCT00865124|4766567|P1|Overall Study|Physician Decision|2
1445277|NCT00865098|4766584|P1|Overall Study|Progressive disease|1
1445278|NCT00865046|4766596|P3|Overall Study|Withdrawal by Subject|0
1445279|NCT00865046|4766597|P2|Overall Study|Withdrawal by Subject|0
1445280|NCT00865046|4766598|P1|Overall Study|Withdrawal by Subject|5
1445281|NCT00865046|4766596|P3|Overall Study|Death|1
1445282|NCT00865046|4766597|P2|Overall Study|Death|1
1445283|NCT00865046|4766598|P1|Overall Study|Death|0
1445284|NCT00865046|4766596|P3|Overall Study|Lost to Follow-up|0
1445285|NCT00865046|4766597|P2|Overall Study|Lost to Follow-up|4
1445286|NCT00865046|4766598|P1|Overall Study|Lost to Follow-up|1
1445287|NCT00865020|4766608|P2|Overall Study|Randomized but discontinued|4
1445288|NCT00865020|4766609|P1|Overall Study|Randomized but discontinued|2
1445289|NCT00865020|4766608|P2|Overall Study|Death|1
1445290|NCT00865020|4766609|P1|Overall Study|Death|0
1445291|NCT00865020|4766608|P2|Overall Study|Abnormal laboratory value(s)|1
1445292|NCT00865020|4766609|P1|Overall Study|Abnormal laboratory value(s)|0
1445293|NCT00865020|4766608|P2|Overall Study|Administrative problems|2
1445294|NCT00865020|4766609|P1|Overall Study|Administrative problems|0
1445295|NCT00865020|4766608|P2|Overall Study|Protocol deviation|1
1445296|NCT00865020|4766609|P1|Overall Study|Protocol deviation|4
1445297|NCT00865020|4766608|P2|Overall Study|Lost to Follow-up|4
1445298|NCT00865020|4766609|P1|Overall Study|Lost to Follow-up|6
1445299|NCT00865020|4766608|P2|Overall Study|Abnormal test procedure result(s)|8
1445300|NCT00865020|4766609|P1|Overall Study|Abnormal test procedure result(s)|6
1445301|NCT00865020|4766608|P2|Overall Study|Adverse Event|14
1445302|NCT00865020|4766609|P1|Overall Study|Adverse Event|9
1445303|NCT00865020|4766608|P2|Overall Study|Withdrawal by Subject|16
1445304|NCT00865020|4766609|P1|Overall Study|Withdrawal by Subject|22
1445305|NCT00864916|4766625|P2|Overall Study|Withdrawal by Subject|0
1445306|NCT00864916|4766626|P1|Overall Study|Withdrawal by Subject|1
1445307|NCT00864916|4766625|P2|Overall Study|Protocol Violation|0
1445308|NCT00864916|4766626|P1|Overall Study|Protocol Violation|1
1445309|NCT00864916|4766625|P2|Overall Study|Lost to Follow-up|4
1445310|NCT00864916|4766626|P1|Overall Study|Lost to Follow-up|4
1445311|NCT00864851|4766635|P3|Overall Study|Patient uncooperative|0
1445312|NCT00864851|4766636|P2|Overall Study|Patient uncooperative|0
1445313|NCT00864851|4766637|P1|Overall Study|Patient uncooperative|1
1445314|NCT00864851|4766635|P3|Overall Study|Death|0
1445315|NCT00864851|4766636|P2|Overall Study|Death|0
1445316|NCT00864851|4766637|P1|Overall Study|Death|1
1445317|NCT00864851|4766635|P3|Overall Study|Physician Decision|0
1445318|NCT00864851|4766636|P2|Overall Study|Physician Decision|0
1445319|NCT00864851|4766637|P1|Overall Study|Physician Decision|1
1445320|NCT00864851|4766635|P3|Overall Study|Withdrawal by Subject|0
1445321|NCT00864851|4766636|P2|Overall Study|Withdrawal by Subject|1
1445322|NCT00864851|4766637|P1|Overall Study|Withdrawal by Subject|0
1445323|NCT00864682|4766683|P3|Overall Study|Protocol Violation|2
1445324|NCT00864682|4766684|P2|Overall Study|Protocol Violation|1
1445325|NCT00864682|4766685|P1|Overall Study|Protocol Violation|2
1445326|NCT00864513|4766724|P1|Overall Study|Withdrawal by Subject|3
1445327|NCT00864253|4766770|P2|Overall Study|Untreated|7
1445328|NCT00864253|4766771|P1|Overall Study|Untreated|7
1445329|NCT00864253|4766770|P2|Overall Study|Ongoing|3
1445330|NCT00864253|4766771|P1|Overall Study|Ongoing|2
1445331|NCT00864253|4766770|P2|Overall Study|Death|0
1445332|NCT00864253|4766771|P1|Overall Study|Death|1
1445333|NCT00864253|4766770|P2|Overall Study|Withdrawal by Subject|18
1445334|NCT00864253|4766771|P1|Overall Study|Withdrawal by Subject|18
1445335|NCT00864253|4766770|P2|Overall Study|Lost to Follow-up|1
1445336|NCT00864253|4766771|P1|Overall Study|Lost to Follow-up|1
1445337|NCT00864253|4766770|P2|Overall Study|Protocol Violation|2
1445338|NCT00864253|4766771|P1|Overall Study|Protocol Violation|0
1445339|NCT00864253|4766770|P2|Overall Study|Physician Decision|15
1445340|NCT00864253|4766771|P1|Overall Study|Physician Decision|11
1445341|NCT00864253|4766770|P2|Overall Study|Unrelated Adverse Event|1
1445342|NCT00864253|4766771|P1|Overall Study|Unrelated Adverse Event|3
1445343|NCT00864253|4766770|P2|Overall Study|Adverse Event|11
1445344|NCT00864253|4766771|P1|Overall Study|Adverse Event|56
1445345|NCT00864227|4766801|P1|Overall Study|Disease Relapse/Progression|3
1445346|NCT00864227|4766801|P1|Overall Study|Withdrawal by Subject|1
1445347|NCT00863798|4766863|P3|Overall Study|Randomized not treated|3
1445348|NCT00863798|4766864|P2|Overall Study|Randomized not treated|2
1445349|NCT00863798|4766865|P1|Overall Study|Randomized not treated|4
1445350|NCT00863798|4766863|P3|Overall Study|Withdrawal by Subject|4
1445351|NCT00863798|4766864|P2|Overall Study|Withdrawal by Subject|7
1445352|NCT00863798|4766865|P1|Overall Study|Withdrawal by Subject|8
1445353|NCT00863798|4766863|P3|Overall Study|Protocol Violation|1
1445354|NCT00863798|4766864|P2|Overall Study|Protocol Violation|1
1445355|NCT00863798|4766865|P1|Overall Study|Protocol Violation|0
1445356|NCT00863798|4766863|P3|Overall Study|Other|1
1445357|NCT00863798|4766864|P2|Overall Study|Other|3
1445358|NCT00863798|4766865|P1|Overall Study|Other|2
1445359|NCT00863798|4766863|P3|Overall Study|Lost to Follow-up|5
1445360|NCT00863798|4766864|P2|Overall Study|Lost to Follow-up|9
1445361|NCT00863798|4766865|P1|Overall Study|Lost to Follow-up|6
1445362|NCT00863798|4766863|P3|Overall Study|Lack of Efficacy|6
1445363|NCT00863798|4766864|P2|Overall Study|Lack of Efficacy|3
1445364|NCT00863798|4766865|P1|Overall Study|Lack of Efficacy|4
1445365|NCT00863798|4766863|P3|Overall Study|Investigator request|1
1445366|NCT00863798|4766864|P2|Overall Study|Investigator request|2
1445367|NCT00863798|4766865|P1|Overall Study|Investigator request|1
1445368|NCT00863798|4766863|P3|Overall Study|Participant failed to return|0
1445369|NCT00863798|4766864|P2|Overall Study|Participant failed to return|1
1445370|NCT00863798|4766865|P1|Overall Study|Participant failed to return|2
1445371|NCT00863798|4766863|P3|Overall Study|Adverse Event|4
1445372|NCT00863798|4766864|P2|Overall Study|Adverse Event|2
1445373|NCT00863798|4766865|P1|Overall Study|Adverse Event|5
1445374|NCT00863746|4766917|P2|Survival Follow up|Consent Withdrawn|8
1445375|NCT00863746|4766918|P1|Survival Follow up|Consent Withdrawn|7
1445376|NCT00863746|4766917|P2|Survival Follow up|Lost to Follow-up|1
1445377|NCT00863746|4766918|P1|Survival Follow up|Lost to Follow-up|2
1445378|NCT00863746|4766917|P2|Survival Follow up|Death|271
1445379|NCT00863746|4766918|P1|Survival Follow up|Death|244
1445380|NCT00863746|4766917|P2|Treatment|not available|0
1445381|NCT00863746|4766918|P1|Treatment|not available|1
1445382|NCT00863746|4766917|P2|Treatment|Protocol Violation|3
1445383|NCT00863746|4766918|P1|Treatment|Protocol Violation|5
1445384|NCT00863746|4766917|P2|Treatment|Lost to Follow-up|0
1445385|NCT00863746|4766918|P1|Treatment|Lost to Follow-up|1
1445386|NCT00863746|4766917|P2|Treatment|Consent withdrawn|14
1445387|NCT00863746|4766918|P1|Treatment|Consent withdrawn|15
1445388|NCT00863746|4766917|P2|Treatment|non-compliant with study medication|0
1445389|NCT00863746|4766918|P1|Treatment|non-compliant with study medication|4
1445390|NCT00863746|4766917|P2|Treatment|Adverse Event|16
1445391|NCT00863746|4766918|P1|Treatment|Adverse Event|41
1445392|NCT00863746|4766917|P2|Treatment|Not treated|2
1445393|NCT00863746|4766918|P1|Treatment|Not treated|4
1445394|NCT00863707|4766944|P2|Overall Study|Randomized, but drug not received|3
1445395|NCT00863707|4766945|P1|Overall Study|Randomized, but drug not received|4
1445396|NCT00863655|4766953|P2|Overall Study|Treatment completed as per protocol|1
1445397|NCT00863655|4766954|P1|Overall Study|Treatment completed as per protocol|5
1445398|NCT00863655|4766953|P2|Overall Study|Disease progression|221
1445399|NCT00863655|4766954|P1|Overall Study|Disease progression|364
1445400|NCT00863655|4766953|P2|Overall Study|New cancer therapy|1
1445401|NCT00863655|4766954|P1|Overall Study|New cancer therapy|5
1445402|NCT00863655|4766953|P2|Overall Study|Death|1
1445403|NCT00863655|4766954|P1|Overall Study|Death|7
1445404|NCT00863655|4766953|P2|Overall Study|Administrative problems|0
1445405|NCT00863655|4766954|P1|Overall Study|Administrative problems|1
1445406|NCT00863655|4766953|P2|Overall Study|Withdrawal by Subject|7
1445407|NCT00863655|4766954|P1|Overall Study|Withdrawal by Subject|47
1445408|NCT00863655|4766953|P2|Overall Study|Adverse Event|8
1445409|NCT00863655|4766954|P1|Overall Study|Adverse Event|52
1445410|NCT00863655|4766953|P2|Overall Study|Protocol Violation|0
1445411|NCT00863655|4766954|P1|Overall Study|Protocol Violation|4
1445412|NCT00863512|4766991|P2|Overall Study|Physician Decision|0
1445413|NCT00863512|4766992|P1|Overall Study|Physician Decision|1
1445414|NCT00863512|4766991|P2|Overall Study|Withdrawal by Subject|0
1445415|NCT00863512|4766992|P1|Overall Study|Withdrawal by Subject|11
1445416|NCT00863512|4766991|P2|Overall Study|Adverse Event|0
1445417|NCT00863512|4766992|P1|Overall Study|Adverse Event|2
1445418|NCT00863330|4767023|P1|Overall Study|study terminated early due to administra|6
1445419|NCT00863317|4767029|P2|Overall Study|Lost to Follow-up|9
1445420|NCT00863317|4767030|P1|Overall Study|Lost to Follow-up|8
1445421|NCT00863057|4767072|P4|Period 2 (Weeks 6-10)|Physician Decision|1
1445422|NCT00863057|4767073|P3|Period 2 (Weeks 6-10)|Physician Decision|0
1445423|NCT00863057|4767074|P2|Period 2 (Weeks 6-10)|Physician Decision|0
1445424|NCT00863057|4767075|P1|Period 2 (Weeks 6-10)|Physician Decision|0
1445425|NCT00863057|4767072|P4|Period 2 (Weeks 6-10)|Adverse Event|0
1445426|NCT00863057|4767073|P3|Period 2 (Weeks 6-10)|Adverse Event|1
1445427|NCT00863057|4767074|P2|Period 2 (Weeks 6-10)|Adverse Event|1
1445428|NCT00863057|4767075|P1|Period 2 (Weeks 6-10)|Adverse Event|0
1445429|NCT00863057|4767072|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
1445430|NCT00863057|4767073|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
1445431|NCT00863057|4767074|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
1445432|NCT00863057|4767075|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
1445433|NCT00863057|4767072|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
1445434|NCT00863057|4767073|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
1445435|NCT00863057|4767074|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
1445436|NCT00863057|4767075|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
1445437|NCT00862979|4767125|P2|Overall Study|Death|1
1445438|NCT00862979|4767126|P1|Overall Study|Death|0
1445439|NCT00862979|4767125|P2|Overall Study|Administrative problems|1
1445440|NCT00862979|4767126|P1|Overall Study|Administrative problems|0
1445441|NCT00862979|4767125|P2|Overall Study|Patient withdrew consent|1
1445442|NCT00862979|4767126|P1|Overall Study|Patient withdrew consent|2
1445443|NCT00862979|4767125|P2|Overall Study|Protocol Violation|1
1445444|NCT00862979|4767126|P1|Overall Study|Protocol Violation|0
1445445|NCT00862979|4767125|P2|Overall Study|Adverse Event|3
1445446|NCT00862979|4767126|P1|Overall Study|Adverse Event|6
1445447|NCT00862940|4767144|P2|Overall Study|Administrative or other reason(s)|3
1445448|NCT00862940|4767145|P1|Overall Study|Administrative or other reason(s)|4
1445449|NCT00862940|4767144|P2|Overall Study|Lost to Follow-up|1
1445450|NCT00862940|4767145|P1|Overall Study|Lost to Follow-up|0
1445451|NCT00862940|4767144|P2|Overall Study|Non-compliance|0
1445452|NCT00862940|4767145|P1|Overall Study|Non-compliance|4
1445453|NCT00862940|4767144|P2|Overall Study|Withdrawal by Subject|6
1445454|NCT00862940|4767145|P1|Overall Study|Withdrawal by Subject|4
1445455|NCT00862940|4767144|P2|Overall Study|Protocol Violation|5
1445456|NCT00862940|4767145|P1|Overall Study|Protocol Violation|2
1445457|NCT00862940|4767144|P2|Overall Study|Lack of Efficacy|3
1445458|NCT00862940|4767145|P1|Overall Study|Lack of Efficacy|1
1445459|NCT00862940|4767144|P2|Overall Study|Adverse Event|12
1445460|NCT00862940|4767145|P1|Overall Study|Adverse Event|15
1445461|NCT00862849|4767157|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
1445462|NCT00862849|4767158|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
1445463|NCT00862849|4767159|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
1445464|NCT00862849|4767160|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
1445465|NCT00862849|4767161|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
1445466|NCT00862849|4767162|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
1445467|NCT00862849|4767157|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
1445468|NCT00862849|4767158|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
1445469|NCT00862849|4767159|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
1445470|NCT00862849|4767160|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
1445471|NCT00862849|4767161|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
1445472|NCT00862849|4767162|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
1445473|NCT00862836|4767185|P1|Overall Study|Withdrawal by Subject|1
1445474|NCT00862823|4767196|P2|First Intervention|Withdrawal by Subject|1
1445475|NCT00862823|4767197|P1|First Intervention|Withdrawal by Subject|1
1445476|NCT00862719|4767246|P4|Overall Study|Veno-Occlusive Disease|0
1445477|NCT00862719|4767247|P3|Overall Study|Veno-Occlusive Disease|1
1445478|NCT00862719|4767248|P2|Overall Study|Veno-Occlusive Disease|0
1445479|NCT00862719|4767249|P1|Overall Study|Veno-Occlusive Disease|0
1445480|NCT00862719|4767246|P4|Overall Study|Engraftment failure|0
1445481|NCT00862719|4767247|P3|Overall Study|Engraftment failure|1
1445482|NCT00862719|4767248|P2|Overall Study|Engraftment failure|0
1445483|NCT00862719|4767249|P1|Overall Study|Engraftment failure|0
1445484|NCT00862719|4767246|P4|Overall Study|Death|1
1445485|NCT00862719|4767247|P3|Overall Study|Death|1
1445486|NCT00862719|4767248|P2|Overall Study|Death|6
1445487|NCT00862719|4767249|P1|Overall Study|Death|5
1445488|NCT00862719|4767246|P4|Overall Study|Disease Progression|0
1445489|NCT00862719|4767247|P3|Overall Study|Disease Progression|1
1445490|NCT00862719|4767248|P2|Overall Study|Disease Progression|0
1445491|NCT00862719|4767249|P1|Overall Study|Disease Progression|5
1445492|NCT00862654|4767272|P4|Overall Study|Included after end of inclusions|0
1445493|NCT00862654|4767273|P3|Overall Study|Included after end of inclusions|1
1445494|NCT00862654|4767274|P2|Overall Study|Included after end of inclusions|0
1445495|NCT00862654|4767275|P1|Overall Study|Included after end of inclusions|0
1445496|NCT00862654|4767272|P4|Overall Study|Never used study drugs|0
1445497|NCT00862654|4767273|P3|Overall Study|Never used study drugs|0
1445498|NCT00862654|4767274|P2|Overall Study|Never used study drugs|0
1445499|NCT00862654|4767275|P1|Overall Study|Never used study drugs|1
1445500|NCT00862654|4767272|P4|Overall Study|Familly constraint|0
1445501|NCT00862654|4767273|P3|Overall Study|Familly constraint|0
1445502|NCT00862654|4767274|P2|Overall Study|Familly constraint|1
1445503|NCT00862654|4767275|P1|Overall Study|Familly constraint|0
1445504|NCT00862654|4767272|P4|Overall Study|Subject mistake|0
1445505|NCT00862654|4767273|P3|Overall Study|Subject mistake|0
1445506|NCT00862654|4767274|P2|Overall Study|Subject mistake|1
1445507|NCT00862654|4767275|P1|Overall Study|Subject mistake|0
1445508|NCT00862654|4767272|P4|Overall Study|Withdrawal by Subject|3
1445509|NCT00862654|4767273|P3|Overall Study|Withdrawal by Subject|2
1445510|NCT00862654|4767274|P2|Overall Study|Withdrawal by Subject|2
1445511|NCT00862654|4767275|P1|Overall Study|Withdrawal by Subject|2
1445512|NCT00862654|4767272|P4|Overall Study|Pregnancy|0
1445513|NCT00862654|4767273|P3|Overall Study|Pregnancy|0
1445514|NCT00862654|4767274|P2|Overall Study|Pregnancy|1
1445515|NCT00862654|4767275|P1|Overall Study|Pregnancy|1
1445516|NCT00862654|4767272|P4|Overall Study|Adverse Event|0
1445517|NCT00862654|4767273|P3|Overall Study|Adverse Event|1
1445518|NCT00862654|4767274|P2|Overall Study|Adverse Event|1
1445519|NCT00862654|4767275|P1|Overall Study|Adverse Event|0
1445520|NCT00862654|4767272|P4|Overall Study|Lost to Follow-up|3
1445521|NCT00862654|4767273|P3|Overall Study|Lost to Follow-up|1
1445522|NCT00862654|4767274|P2|Overall Study|Lost to Follow-up|2
1445523|NCT00862654|4767275|P1|Overall Study|Lost to Follow-up|1
1445524|NCT00862654|4767272|P4|Overall Study|Lack of Efficacy|0
1445525|NCT00862654|4767273|P3|Overall Study|Lack of Efficacy|1
1445526|NCT00862654|4767274|P2|Overall Study|Lack of Efficacy|0
1445527|NCT00862654|4767275|P1|Overall Study|Lack of Efficacy|1
1445528|NCT00862641|4767289|P4|Overall Study|Randomized, but drug not received|4
1445529|NCT00862641|4767290|P3|Overall Study|Randomized, but drug not received|1
1445530|NCT00862641|4767291|P2|Overall Study|Randomized, but drug not received|4
1445531|NCT00862641|4767292|P1|Overall Study|Randomized, but drug not received|1
1445532|NCT00862459|4767386|P3|Overall Study|Administrative problems|0
1445533|NCT00862459|4767387|P2|Overall Study|Administrative problems|1
1445534|NCT00862459|4767388|P1|Overall Study|Administrative problems|0
1445535|NCT00862459|4767386|P3|Overall Study|Inclusion/exclusion criteria not met|0
1445536|NCT00862459|4767387|P2|Overall Study|Inclusion/exclusion criteria not met|1
1445537|NCT00862459|4767388|P1|Overall Study|Inclusion/exclusion criteria not met|0
1445538|NCT00862459|4767386|P3|Overall Study|Unable to hold still for imaging|0
1445539|NCT00862459|4767387|P2|Overall Study|Unable to hold still for imaging|1
1445540|NCT00862459|4767388|P1|Overall Study|Unable to hold still for imaging|0
1445541|NCT00862459|4767386|P3|Overall Study|Intravenous (IV) site problems|1
1445542|NCT00862459|4767387|P2|Overall Study|Intravenous (IV) site problems|0
1445543|NCT00862459|4767388|P1|Overall Study|Intravenous (IV) site problems|1
1445544|NCT00862459|4767386|P3|Overall Study|Operation|0
1445545|NCT00862459|4767387|P2|Overall Study|Operation|1
1445546|NCT00862459|4767388|P1|Overall Study|Operation|1
1445547|NCT00862459|4767386|P3|Overall Study|Personal reasons|0
1445548|NCT00862459|4767387|P2|Overall Study|Personal reasons|0
1445549|NCT00862459|4767388|P1|Overall Study|Personal reasons|1
1445550|NCT00862459|4767386|P3|Overall Study|Adverse Event|0
1445551|NCT00862459|4767387|P2|Overall Study|Adverse Event|1
1445552|NCT00862459|4767388|P1|Overall Study|Adverse Event|0
1445553|NCT00862459|4767386|P3|Overall Study|Withdrawal by Subject|3
1445554|NCT00862459|4767387|P2|Overall Study|Withdrawal by Subject|1
1445555|NCT00862459|4767388|P1|Overall Study|Withdrawal by Subject|1
1445556|NCT00862459|4767386|P3|Overall Study|Protocol Violation|0
1445557|NCT00862459|4767387|P2|Overall Study|Protocol Violation|0
1445558|NCT00862459|4767388|P1|Overall Study|Protocol Violation|1
1445559|NCT00862459|4767386|P3|Overall Study|Lost to Follow-up|2
1445560|NCT00862459|4767387|P2|Overall Study|Lost to Follow-up|2
1445561|NCT00862459|4767388|P1|Overall Study|Lost to Follow-up|1
1445562|NCT00862277|4767535|P3|Overall Study|Protocol Violation|5
1445563|NCT00862277|4767536|P2|Overall Study|Protocol Violation|2
1445564|NCT00862277|4767537|P1|Overall Study|Protocol Violation|1
1445565|NCT00862251|4767551|P3|Overall Study|Withdrawal by Subject|6
1445566|NCT00862251|4767552|P2|Overall Study|Withdrawal by Subject|2
1445567|NCT00862251|4767553|P1|Overall Study|Withdrawal by Subject|9
1445568|NCT00862251|4767551|P3|Overall Study|Protocol Violation|1
1445569|NCT00862251|4767552|P2|Overall Study|Protocol Violation|0
1445570|NCT00862251|4767553|P1|Overall Study|Protocol Violation|2
1445571|NCT00862251|4767551|P3|Overall Study|Lost to Follow-up|1
1445572|NCT00862251|4767552|P2|Overall Study|Lost to Follow-up|0
1445573|NCT00862251|4767553|P1|Overall Study|Lost to Follow-up|0
1445574|NCT00862251|4767551|P3|Overall Study|Adverse Event|1
1445575|NCT00862251|4767552|P2|Overall Study|Adverse Event|3
1445576|NCT00862251|4767553|P1|Overall Study|Adverse Event|8
1445577|NCT00862134|4767613|P2|Overall Study|Withdrew prior to dosing|0
1445578|NCT00862134|4767614|P1|Overall Study|Withdrew prior to dosing|2
1445579|NCT00862134|4767613|P2|Overall Study|Adverse Event|2
1445580|NCT00862134|4767614|P1|Overall Study|Adverse Event|2
1445581|NCT00862134|4767613|P2|Overall Study|Sponsor terminated study|7
1445582|NCT00862134|4767614|P1|Overall Study|Sponsor terminated study|5
1445583|NCT00862134|4767613|P2|Overall Study|Withdrawal by Subject|2
1445584|NCT00862134|4767614|P1|Overall Study|Withdrawal by Subject|1
1445585|NCT00862134|4767613|P2|Overall Study|Physician Decision|1
1445586|NCT00862134|4767614|P1|Overall Study|Physician Decision|0
1445587|NCT00862134|4767613|P2|Overall Study|Death|0
1445588|NCT00862134|4767614|P1|Overall Study|Death|1
1445589|NCT00862121|4767626|P2|Overall Study|Incorrect randomisation|1
1445590|NCT00862121|4767627|P1|Overall Study|Incorrect randomisation|0
1445591|NCT00862121|4767626|P2|Overall Study|Exclusion criterion violation|1
1445592|NCT00862121|4767627|P1|Overall Study|Exclusion criterion violation|0
1445593|NCT00862121|4767626|P2|Overall Study|Protocol Violation|1
1445594|NCT00862121|4767627|P1|Overall Study|Protocol Violation|0
1445595|NCT00862121|4767626|P2|Overall Study|Lack of Efficacy|3
1445596|NCT00862121|4767627|P1|Overall Study|Lack of Efficacy|0
1445597|NCT00862121|4767626|P2|Overall Study|Adverse Event|2
1445598|NCT00862121|4767627|P1|Overall Study|Adverse Event|1
1445599|NCT00862082|4767645|P2|Overall Study|Withdrawal by Subject|1
1445600|NCT00862082|4767646|P1|Overall Study|Withdrawal by Subject|0
1445601|NCT00862082|4767645|P2|Overall Study|Sponsor decision to terminate the study|0
1445602|NCT00862082|4767646|P1|Overall Study|Sponsor decision to terminate the study|5
1445603|NCT00861757|4767701|P4|Overall Study|Withdrawal by Subject|2
1445604|NCT00861757|4767702|P3|Overall Study|Withdrawal by Subject|5
1445605|NCT00861757|4767703|P2|Overall Study|Withdrawal by Subject|5
1445606|NCT00861757|4767704|P1|Overall Study|Withdrawal by Subject|1
1445607|NCT00861757|4767701|P4|Overall Study|Protocol Violation|1
1445608|NCT00861757|4767702|P3|Overall Study|Protocol Violation|4
1445609|NCT00861757|4767703|P2|Overall Study|Protocol Violation|2
1445610|NCT00861757|4767704|P1|Overall Study|Protocol Violation|2
1445611|NCT00861757|4767701|P4|Overall Study|Physician Decision|1
1445612|NCT00861757|4767702|P3|Overall Study|Physician Decision|0
1445613|NCT00861757|4767703|P2|Overall Study|Physician Decision|0
1445614|NCT00861757|4767704|P1|Overall Study|Physician Decision|0
1445615|NCT00861757|4767701|P4|Overall Study|Lost to Follow-up|1
1445616|NCT00861757|4767702|P3|Overall Study|Lost to Follow-up|1
1445617|NCT00861757|4767703|P2|Overall Study|Lost to Follow-up|0
1445618|NCT00861757|4767704|P1|Overall Study|Lost to Follow-up|1
1445619|NCT00861757|4767701|P4|Overall Study|Lack of Efficacy|1
1445620|NCT00861757|4767702|P3|Overall Study|Lack of Efficacy|0
1445621|NCT00861757|4767703|P2|Overall Study|Lack of Efficacy|1
1445622|NCT00861757|4767704|P1|Overall Study|Lack of Efficacy|3
1445623|NCT00861757|4767701|P4|Overall Study|Entry Criteria Not Met|1
1445624|NCT00861757|4767702|P3|Overall Study|Entry Criteria Not Met|1
1445625|NCT00861757|4767703|P2|Overall Study|Entry Criteria Not Met|2
1445626|NCT00861757|4767704|P1|Overall Study|Entry Criteria Not Met|1
1445627|NCT00861757|4767701|P4|Overall Study|Adverse Event|2
1445628|NCT00861757|4767702|P3|Overall Study|Adverse Event|7
1445629|NCT00861757|4767703|P2|Overall Study|Adverse Event|5
1445630|NCT00861757|4767704|P1|Overall Study|Adverse Event|1
1445631|NCT00861744|4767762|P4|Overall Study|Blood draws|1
1445632|NCT00861744|4767763|P3|Overall Study|Blood draws|0
1445633|NCT00861744|4767764|P2|Overall Study|Blood draws|0
1445634|NCT00861744|4767765|P1|Overall Study|Blood draws|0
1445635|NCT00861744|4767762|P4|Overall Study|Migration from study area|0
1445636|NCT00861744|4767763|P3|Overall Study|Migration from study area|1
1445637|NCT00861744|4767764|P2|Overall Study|Migration from study area|3
1445638|NCT00861744|4767765|P1|Overall Study|Migration from study area|0
1445639|NCT00861744|4767762|P4|Overall Study|Protocol Violation|0
1445640|NCT00861744|4767763|P3|Overall Study|Protocol Violation|0
1445641|NCT00861744|4767764|P2|Overall Study|Protocol Violation|1
1445642|NCT00861744|4767765|P1|Overall Study|Protocol Violation|0
1445643|NCT00861744|4767762|P4|Overall Study|Withdrawal by Subject|19
1445644|NCT00861744|4767763|P3|Overall Study|Withdrawal by Subject|6
1445645|NCT00861744|4767764|P2|Overall Study|Withdrawal by Subject|6
1445646|NCT00861744|4767765|P1|Overall Study|Withdrawal by Subject|10
1445647|NCT00861744|4767762|P4|Overall Study|Lost to Follow-up|12
1445648|NCT00861744|4767763|P3|Overall Study|Lost to Follow-up|17
1445649|NCT00861744|4767764|P2|Overall Study|Lost to Follow-up|19
1445650|NCT00861744|4767765|P1|Overall Study|Lost to Follow-up|7
1445651|NCT00861744|4767762|P4|Overall Study|Adverse Event|1
1445652|NCT00861744|4767763|P3|Overall Study|Adverse Event|0
1445653|NCT00861744|4767764|P2|Overall Study|Adverse Event|0
1445654|NCT00861744|4767765|P1|Overall Study|Adverse Event|0
1445655|NCT00861705|4767947|P4|Overall Study|Never Began Treatment|1
1445656|NCT00861705|4767948|P3|Overall Study|Never Began Treatment|0
1445657|NCT00861705|4767949|P2|Overall Study|Never Began Treatment|3
1445658|NCT00861705|4767950|P1|Overall Study|Never Began Treatment|7
1445659|NCT00861692|4767966|P1|Overall Study|Death|6
1445660|NCT00861614|4767978|P2|Overall Study|Other|22
1445661|NCT00861614|4767979|P1|Overall Study|Other|17
1445662|NCT00861614|4767978|P2|Overall Study|Withdrawal by Subject|35
1445663|NCT00861614|4767979|P1|Overall Study|Withdrawal by Subject|34
1445664|NCT00861614|4767978|P2|Overall Study|Adverse Event|23
1445665|NCT00861614|4767979|P1|Overall Study|Adverse Event|27
1445666|NCT00861614|4767978|P2|Overall Study|Death|19
1445667|NCT00861614|4767979|P1|Overall Study|Death|32
1445668|NCT00861614|4767978|P2|Overall Study|Study Drug Toxicity|6
1445669|NCT00861614|4767979|P1|Overall Study|Study Drug Toxicity|79
1445670|NCT00861614|4767978|P2|Overall Study|Disease Progression|263
1445671|NCT00861614|4767979|P1|Overall Study|Disease Progression|182
1445672|NCT00861471|4768064|P1|Overall Study|Physician Decision|2
1445673|NCT00861471|4768064|P1|Overall Study|treatment for lumbar laminectomy|1
1445674|NCT00861471|4768064|P1|Overall Study|Lack of Efficacy|3
1445675|NCT00861471|4768064|P1|Overall Study|Adverse Event|2
1445676|NCT00861471|4768064|P1|Overall Study|Withdrawal by Subject|1
1445677|NCT00861341|4768072|P1|Overall Study|Withdrawal by Subject|2
1445678|NCT00861198|4768081|P1|Overall Study|SpyGlass Failed|5
1445679|NCT00860951|4768098|P1|Overall Study|Lost to Follow-up|5
1445680|NCT00860951|4768098|P1|Overall Study|Withdrawal by Subject|2
1445681|NCT00860743|4768140|P2|Overall Study|Withdrawal by Subject|0
1445682|NCT00860743|4768141|P1|Overall Study|Withdrawal by Subject|3
1445683|NCT00860470|4768154|P2|Overall Study|Lost to Follow-up|39
1445684|NCT00860470|4768155|P1|Overall Study|Lost to Follow-up|34
1445685|NCT00860470|4768154|P2|Overall Study|Moved away|10
1445686|NCT00860470|4768155|P1|Overall Study|Moved away|8
1445687|NCT00860470|4768154|P2|Overall Study|Death|10
1445688|NCT00860470|4768155|P1|Overall Study|Death|6
1445689|NCT00860405|4768185|P2|Overall Study|Main reason: Follow-up data not complete|4
1445690|NCT00860405|4768186|P1|Overall Study|Main reason: Follow-up data not complete|5
1445691|NCT00860262|4768226|P3|Overall Study|Not Specified|1
1445692|NCT00860262|4768227|P2|Overall Study|Not Specified|3
1445693|NCT00860262|4768228|P1|Overall Study|Not Specified|5
1445694|NCT00860262|4768226|P3|Overall Study|Lack of Efficacy|3
1445695|NCT00860262|4768227|P2|Overall Study|Lack of Efficacy|4
1445696|NCT00860262|4768228|P1|Overall Study|Lack of Efficacy|0
1445697|NCT00860262|4768226|P3|Overall Study|Withdrawal by Subject|6
1445698|NCT00860262|4768227|P2|Overall Study|Withdrawal by Subject|8
1445699|NCT00860262|4768228|P1|Overall Study|Withdrawal by Subject|4
1445700|NCT00860262|4768226|P3|Overall Study|Lost to Follow-up|1
1445701|NCT00860262|4768227|P2|Overall Study|Lost to Follow-up|0
1445702|NCT00860262|4768228|P1|Overall Study|Lost to Follow-up|2
1445703|NCT00860262|4768226|P3|Overall Study|Protocol Violation|0
1445704|NCT00860262|4768227|P2|Overall Study|Protocol Violation|1
1445705|NCT00860262|4768228|P1|Overall Study|Protocol Violation|0
1445706|NCT00860262|4768226|P3|Overall Study|Adverse Event|7
1445707|NCT00860262|4768227|P2|Overall Study|Adverse Event|6
1445708|NCT00860262|4768228|P1|Overall Study|Adverse Event|9
1445709|NCT00860249|4768341|P3|Overall Study|trial was terminated prior to completion|21
1445710|NCT00860249|4768342|P2|Overall Study|trial was terminated prior to completion|18
1445711|NCT00860249|4768343|P1|Overall Study|trial was terminated prior to completion|21
1445712|NCT00860158|4768361|P1|Overall Study|Study Terminated|1
1445713|NCT00860067|4768373|P3|Overall Study|Pregnancy|0
1445714|NCT00860067|4768374|P2|Overall Study|Pregnancy|0
1445715|NCT00860067|4768375|P1|Overall Study|Pregnancy|1
1445716|NCT00860067|4768373|P3|Overall Study|Withdrawal by Subject|0
1445717|NCT00860067|4768374|P2|Overall Study|Withdrawal by Subject|0
1445718|NCT00860067|4768375|P1|Overall Study|Withdrawal by Subject|4
1445719|NCT00860067|4768373|P3|Overall Study|Lost to Follow-up|9
1445720|NCT00860067|4768374|P2|Overall Study|Lost to Follow-up|9
1445721|NCT00860067|4768375|P1|Overall Study|Lost to Follow-up|46
1445722|NCT00860028|4768435|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
1445723|NCT00860028|4768436|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
1445724|NCT00859937|4768457|P2|Overall Study|Protocol Violation|0
1445725|NCT00859937|4768458|P1|Overall Study|Protocol Violation|1
1445726|NCT00859898|4768473|P3|Overall Study|non-specified|1
1445727|NCT00859898|4768474|P2|Overall Study|non-specified|1
1445728|NCT00859898|4768475|P1|Overall Study|non-specified|1
1445729|NCT00859898|4768473|P3|Overall Study|No longer meets criteria|0
1445730|NCT00859898|4768474|P2|Overall Study|No longer meets criteria|1
1445731|NCT00859898|4768475|P1|Overall Study|No longer meets criteria|0
1445732|NCT00859898|4768473|P3|Overall Study|poor/non-compliance|0
1445733|NCT00859898|4768474|P2|Overall Study|poor/non-compliance|0
1445734|NCT00859898|4768475|P1|Overall Study|poor/non-compliance|2
1445735|NCT00859898|4768473|P3|Overall Study|Lost to Follow-up|5
1445736|NCT00859898|4768474|P2|Overall Study|Lost to Follow-up|11
1445737|NCT00859898|4768475|P1|Overall Study|Lost to Follow-up|10
1445738|NCT00859898|4768473|P3|Overall Study|Death|1
1445739|NCT00859898|4768474|P2|Overall Study|Death|0
1445740|NCT00859898|4768475|P1|Overall Study|Death|0
1445741|NCT00859898|4768473|P3|Overall Study|Withdrawal by Subject|11
1445742|NCT00859898|4768474|P2|Overall Study|Withdrawal by Subject|8
1445743|NCT00859898|4768475|P1|Overall Study|Withdrawal by Subject|11
1445744|NCT00859898|4768473|P3|Overall Study|Adverse Event|8
1445745|NCT00859898|4768474|P2|Overall Study|Adverse Event|9
1445746|NCT00859898|4768475|P1|Overall Study|Adverse Event|4
1445747|NCT00859898|4768473|P3|Overall Study|Lack of Efficacy|1
1445748|NCT00859898|4768474|P2|Overall Study|Lack of Efficacy|1
1445749|NCT00859898|4768475|P1|Overall Study|Lack of Efficacy|0
1445750|NCT00859638|4768534|P2|Overall Study|Ill health|1
1445751|NCT00859638|4768535|P1|Overall Study|Ill health|1
1445752|NCT00859638|4768534|P2|Overall Study|Withdrawal by Subject|2
1445753|NCT00859638|4768535|P1|Overall Study|Withdrawal by Subject|3
1445754|NCT00859638|4768534|P2|Overall Study|Lost to Follow-up|1
1445755|NCT00859638|4768535|P1|Overall Study|Lost to Follow-up|6
1445756|NCT00859586|4768541|P1|Overall Study|Donors|4
1445757|NCT00859573|4768547|P2|Overall Study|Physician Decision|1
1445758|NCT00859573|4768548|P1|Overall Study|Physician Decision|1
1445759|NCT00859573|4768547|P2|Overall Study|Withdrawal by Subject|1
1445760|NCT00859573|4768548|P1|Overall Study|Withdrawal by Subject|4
1445761|NCT00859547|4768554|P1|Overall Study|Parent withdrew consent|1
1445762|NCT00859547|4768554|P1|Overall Study|Lost to Follow-up|1
1445763|NCT00859521|4768567|P2|Washout|Withdrawal by Subject|1
1445764|NCT00859521|4768568|P1|Washout|Withdrawal by Subject|0
1445765|NCT00859469|4768585|P1|Overall Study|Death|16
1445766|NCT00859469|4768585|P1|Overall Study|Withdrawal by Subject|1
1445767|NCT00859469|4768585|P1|Overall Study|Lack of Efficacy|9
1445768|NCT00859469|4768585|P1|Overall Study|Adverse Event|2
1445769|NCT00859430|4768593|P2|First Intervention|Withdrawal by Subject|1
1445770|NCT00859430|4768594|P1|First Intervention|Withdrawal by Subject|0
1445771|NCT00859313|4768610|P1|Overall Study|staff error|1
1445772|NCT00859313|4768610|P1|Overall Study|Adverse Event|1
1445773|NCT00859313|4768610|P1|Overall Study|Lack of Efficacy|2
1445774|NCT00859222|4768617|P5|Overall Study|DLT|0
1445775|NCT00859222|4768618|P4|Overall Study|DLT|0
1445776|NCT00859222|4768619|P3|Overall Study|DLT|0
1445777|NCT00859222|4768620|P2|Overall Study|DLT|0
1445778|NCT00859222|4768621|P1|Overall Study|DLT|1
1445779|NCT00859222|4768617|P5|Overall Study|Adverse Event|15
1445780|NCT00859222|4768618|P4|Overall Study|Adverse Event|24
1445781|NCT00859222|4768619|P3|Overall Study|Adverse Event|6
1445782|NCT00859222|4768620|P2|Overall Study|Adverse Event|3
1445783|NCT00859222|4768621|P1|Overall Study|Adverse Event|2
1445784|NCT00859014|4768743|P1|Overall Study|Lost to Follow-up|1
1445785|NCT00859014|4768743|P1|Overall Study|Death|4
1445786|NCT00858845|4768758|P2|Overall Study|Patient underwent heart transplant.|1
1445787|NCT00858845|4768759|P1|Overall Study|Patient underwent heart transplant.|0
1445788|NCT00858832|4768771|P2|Overall Study|Adverse Event|1
1445789|NCT00858832|4768772|P1|Overall Study|Adverse Event|0
1445790|NCT00858832|4768771|P2|Overall Study|became ineligible: delivered vaginally|0
1445791|NCT00858832|4768772|P1|Overall Study|became ineligible: delivered vaginally|1
1445792|NCT00858780|4768778|P5|OL Re-Treatment (Failure to Week 48)|Other|1
1445793|NCT00858780|4768779|P4|OL Re-Treatment (Failure to Week 48)|Other|0
1445794|NCT00858780|4768780|P3|OL Re-Treatment (Failure to Week 48)|Other|0
1445795|NCT00858780|4768781|P2|OL Re-Treatment (Failure to Week 48)|Other|0
1445796|NCT00858780|4768782|P1|OL Re-Treatment (Failure to Week 48)|Other|0
1445797|NCT00858780|4768778|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
1445798|NCT00858780|4768779|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
1445799|NCT00858780|4768780|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
1445800|NCT00858780|4768781|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
1445801|NCT00858780|4768782|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
1445802|NCT00858780|4768778|P5|Double-Blind (Week 0 to Failure/Week 48)|Other|0
1445803|NCT00858780|4768779|P4|Double-Blind (Week 0 to Failure/Week 48)|Other|0
1445804|NCT00858780|4768780|P3|Double-Blind (Week 0 to Failure/Week 48)|Other|0
1445805|NCT00858780|4768781|P2|Double-Blind (Week 0 to Failure/Week 48)|Other|1
1445806|NCT00858780|4768782|P1|Double-Blind (Week 0 to Failure/Week 48)|Other|0
1445807|NCT00858780|4768778|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
1445808|NCT00858780|4768779|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
1445809|NCT00858780|4768780|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
1445810|NCT00858780|4768781|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
1445811|NCT00858780|4768782|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
1445812|NCT00858780|4768778|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
1445813|NCT00858780|4768779|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
1445814|NCT00858780|4768780|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
1445815|NCT00858780|4768781|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
1445816|NCT00858780|4768782|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
1445817|NCT00858780|4768778|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
1445818|NCT00858780|4768779|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
1445819|NCT00858780|4768780|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
1445820|NCT00858780|4768781|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
1445821|NCT00858780|4768782|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
1445822|NCT00858702|4768857|P2|Overall Study|Withdrawal by Subject|0
1445823|NCT00858702|4768858|P1|Overall Study|Withdrawal by Subject|1
1445824|NCT00858702|4768857|P2|Overall Study|Other|1
1445825|NCT00858702|4768858|P1|Overall Study|Other|2
1445826|NCT00858702|4768857|P2|Overall Study|Protocol Violation|1
1445827|NCT00858702|4768858|P1|Overall Study|Protocol Violation|1
1445828|NCT00858702|4768857|P2|Overall Study|Lack of Efficacy|0
1445829|NCT00858702|4768858|P1|Overall Study|Lack of Efficacy|1
1445830|NCT00858637|4768873|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
1445831|NCT00858637|4768874|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
1445832|NCT00858637|4768875|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
1445833|NCT00858637|4768876|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
1445834|NCT00858637|4768877|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
1445835|NCT00858637|4768878|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
1445836|NCT00858637|4768873|P6|Placebo-controlled Withdrawal Phase|Death|0
1445837|NCT00858637|4768874|P5|Placebo-controlled Withdrawal Phase|Death|1
1445838|NCT00858637|4768875|P4|Placebo-controlled Withdrawal Phase|Death|0
1445839|NCT00858637|4768876|P3|Placebo-controlled Withdrawal Phase|Death|1
1445840|NCT00858637|4768877|P2|Placebo-controlled Withdrawal Phase|Death|0
1445841|NCT00858637|4768878|P1|Placebo-controlled Withdrawal Phase|Death|0
1445842|NCT00858637|4768873|P6|Active Comparison Phase|Other Reasons|0
1445843|NCT00858637|4768874|P5|Active Comparison Phase|Other Reasons|0
1445844|NCT00858637|4768875|P4|Active Comparison Phase|Other Reasons|1
1445845|NCT00858637|4768876|P3|Active Comparison Phase|Other Reasons|0
1445846|NCT00858637|4768877|P2|Active Comparison Phase|Other Reasons|0
1445847|NCT00858637|4768878|P1|Active Comparison Phase|Other Reasons|1
1445848|NCT00858637|4768873|P6|Active Comparison Phase|Withdrawal by Subject|0
1445849|NCT00858637|4768874|P5|Active Comparison Phase|Withdrawal by Subject|0
1445850|NCT00858637|4768875|P4|Active Comparison Phase|Withdrawal by Subject|6
1445851|NCT00858637|4768876|P3|Active Comparison Phase|Withdrawal by Subject|0
1445852|NCT00858637|4768877|P2|Active Comparison Phase|Withdrawal by Subject|0
1445853|NCT00858637|4768878|P1|Active Comparison Phase|Withdrawal by Subject|7
1445854|NCT00858637|4768873|P6|Active Comparison Phase|Physician Decision|0
1445855|NCT00858637|4768874|P5|Active Comparison Phase|Physician Decision|0
1445856|NCT00858637|4768875|P4|Active Comparison Phase|Physician Decision|1
1445857|NCT00858637|4768876|P3|Active Comparison Phase|Physician Decision|0
1445858|NCT00858637|4768877|P2|Active Comparison Phase|Physician Decision|0
1445859|NCT00858637|4768878|P1|Active Comparison Phase|Physician Decision|1
1445860|NCT00858637|4768873|P6|Active Comparison Phase|Death|0
1445861|NCT00858637|4768874|P5|Active Comparison Phase|Death|0
1445862|NCT00858637|4768875|P4|Active Comparison Phase|Death|1
1445863|NCT00858637|4768876|P3|Active Comparison Phase|Death|0
1445864|NCT00858637|4768877|P2|Active Comparison Phase|Death|0
1445865|NCT00858637|4768878|P1|Active Comparison Phase|Death|1
1445866|NCT00858637|4768873|P6|Active Comparison Phase|Adverse Event|0
1445867|NCT00858637|4768874|P5|Active Comparison Phase|Adverse Event|0
1445868|NCT00858637|4768875|P4|Active Comparison Phase|Adverse Event|9
1445869|NCT00858637|4768876|P3|Active Comparison Phase|Adverse Event|0
1445870|NCT00858637|4768877|P2|Active Comparison Phase|Adverse Event|0
1445871|NCT00858637|4768878|P1|Active Comparison Phase|Adverse Event|14
1445872|NCT00858442|4768919|P2|Compression:Start to Finish|Lost to Follow-up|3
1445873|NCT00858442|4768920|P1|Compression:Start to Finish|Lost to Follow-up|1
1445874|NCT00858403|4768930|P1|Overall Study|Disease Progression|1
1445875|NCT00858403|4768930|P1|Overall Study|Death|3
1445876|NCT00858403|4768930|P1|Overall Study|Withdrawal by Subject|1
1445877|NCT00858364|4768951|P2|Overall Study|Still on-study|247
1445878|NCT00858364|4768952|P1|Overall Study|Still on-study|114
1445879|NCT00858364|4768951|P2|Overall Study|Missing|1
1445880|NCT00858364|4768952|P1|Overall Study|Missing|1
1445881|NCT00858364|4768951|P2|Overall Study|Other|17
1445882|NCT00858364|4768952|P1|Overall Study|Other|9
1445883|NCT00858364|4768951|P2|Overall Study|Protocol Deviation|2
1445884|NCT00858364|4768952|P1|Overall Study|Protocol Deviation|0
1445885|NCT00858364|4768951|P2|Overall Study|Noncompliance|4
1445886|NCT00858364|4768952|P1|Overall Study|Noncompliance|3
1445887|NCT00858364|4768951|P2|Overall Study|Lost to Follow-up|54
1445888|NCT00858364|4768952|P1|Overall Study|Lost to Follow-up|24
1445889|NCT00858364|4768951|P2|Overall Study|Ineligibility Determined|10
1445890|NCT00858364|4768952|P1|Overall Study|Ineligibility Determined|1
1445891|NCT00858364|4768951|P2|Overall Study|Withdrawal by Subject|118
1445892|NCT00858364|4768952|P1|Overall Study|Withdrawal by Subject|44
1445893|NCT00858364|4768951|P2|Overall Study|Adverse Event|2
1445894|NCT00858364|4768952|P1|Overall Study|Adverse Event|5
1445895|NCT00858364|4768951|P2|Overall Study|Administrative Decision|2
1445896|NCT00858364|4768952|P1|Overall Study|Administrative Decision|3
1445897|NCT00858247|4768974|P2|Week 12 Follow-up|Withdrawal by Subject|1
1445898|NCT00858247|4768975|P1|Week 12 Follow-up|Withdrawal by Subject|0
1445899|NCT00858247|4768974|P2|Baseline Assessment|Protocol Violation|1
1445900|NCT00858247|4768975|P1|Baseline Assessment|Protocol Violation|0
1445901|NCT00858247|4768974|P2|Baseline Assessment|Poor IV access|0
1445902|NCT00858247|4768975|P1|Baseline Assessment|Poor IV access|1
1445903|NCT00858247|4768974|P2|Baseline Assessment|Withdrawal by Subject|1
1445904|NCT00858247|4768975|P1|Baseline Assessment|Withdrawal by Subject|1
1445905|NCT00858208|4768991|P1|Overall Study|Other|10
1445906|NCT00858208|4768991|P1|Overall Study|Participant refused|40
1445907|NCT00858208|4768991|P1|Overall Study|Lost to Follow-up|26
1445908|NCT00858208|4768991|P1|Overall Study|Adverse Event|3
1445909|NCT00858143|4769008|P1|Overall Study|Other|23
1445910|NCT00858143|4769008|P1|Overall Study|Death|7
1445911|NCT00858143|4769008|P1|Overall Study|Lack of Efficacy|4
1445912|NCT00858143|4769008|P1|Overall Study|Adverse Event|16
1445913|NCT00857948|4769120|P4|Overall Study|Protocol Violation|0
1445914|NCT00857948|4769121|P3|Overall Study|Protocol Violation|1
1445915|NCT00857948|4769122|P2|Overall Study|Protocol Violation|0
1445916|NCT00857948|4769123|P1|Overall Study|Protocol Violation|1
1445917|NCT00857948|4769120|P4|Overall Study|Withdrawal by Subject|0
1445918|NCT00857948|4769121|P3|Overall Study|Withdrawal by Subject|0
1445919|NCT00857948|4769122|P2|Overall Study|Withdrawal by Subject|0
1445920|NCT00857948|4769123|P1|Overall Study|Withdrawal by Subject|2
1445921|NCT00857896|4769145|P1|Baseline to Week 4|Withdrawal by Subject|1
1445922|NCT00857818|4769301|P2|Overall Study|Investigator decision|0
1445923|NCT00857818|4769302|P1|Overall Study|Investigator decision|1
1445924|NCT00857818|4769301|P2|Overall Study|Sponsor terminated study|4
1445925|NCT00857818|4769302|P1|Overall Study|Sponsor terminated study|6
1445926|NCT00857818|4769301|P2|Overall Study|Withdrawal by Subject|4
1445927|NCT00857818|4769302|P1|Overall Study|Withdrawal by Subject|0
1445928|NCT00857818|4769301|P2|Overall Study|Adverse Event|0
1445929|NCT00857818|4769302|P1|Overall Study|Adverse Event|3
1445930|NCT00857818|4769301|P2|Overall Study|Lack of Efficacy|0
1445931|NCT00857818|4769302|P1|Overall Study|Lack of Efficacy|1
1445932|NCT00857792|4769330|P1|Overall Study|inadequate image quality for analysis|12
1445933|NCT00857766|4769336|P2|Overall Study|Participant Withdrew Consent|4
1445934|NCT00857766|4769337|P1|Overall Study|Participant Withdrew Consent|4
1445935|NCT00857766|4769336|P2|Overall Study|Investigator Discretion|3
1445936|NCT00857766|4769337|P1|Overall Study|Investigator Discretion|2
1445937|NCT00857766|4769336|P2|Overall Study|Lost to Follow-up|0
1445938|NCT00857766|4769337|P1|Overall Study|Lost to Follow-up|1
1445939|NCT00857766|4769336|P2|Overall Study|Protocol Violation|11
1445940|NCT00857766|4769337|P1|Overall Study|Protocol Violation|11
1445941|NCT00857766|4769336|P2|Overall Study|Adverse Event|12
1445942|NCT00857766|4769337|P1|Overall Study|Adverse Event|13
1445943|NCT00857649|4769354|P2|Overall Study|Other Reasons|3
1445944|NCT00857649|4769355|P1|Overall Study|Other Reasons|1
1445945|NCT00857649|4769354|P2|Overall Study|Nursing Home Placement|9
1445946|NCT00857649|4769355|P1|Overall Study|Nursing Home Placement|2
1445947|NCT00857649|4769354|P2|Overall Study|Withdrawal of Consent|7
1445948|NCT00857649|4769355|P1|Overall Study|Withdrawal of Consent|10
1445949|NCT00857649|4769354|P2|Overall Study|Protocol Violation|2
1445950|NCT00857649|4769355|P1|Overall Study|Protocol Violation|2
1445951|NCT00857649|4769354|P2|Overall Study|Non-compliance|1
1445952|NCT00857649|4769355|P1|Overall Study|Non-compliance|1
1445953|NCT00857649|4769354|P2|Overall Study|Adverse Event|10
1445954|NCT00857649|4769355|P1|Overall Study|Adverse Event|15
1445955|NCT00857623|4769371|P2|Overall Study|Positive for HEP C|1
1445956|NCT00857623|4769372|P1|Overall Study|Positive for HEP C|0
1445957|NCT00857623|4769371|P2|Overall Study|Intake of prohibited medication|1
1445958|NCT00857623|4769372|P1|Overall Study|Intake of prohibited medication|0
1445959|NCT00857623|4769371|P2|Overall Study|Severe non-compliance to protocol|1
1445960|NCT00857623|4769372|P1|Overall Study|Severe non-compliance to protocol|1
1445961|NCT00857623|4769371|P2|Overall Study|Lack of Efficacy|1
1445962|NCT00857623|4769372|P1|Overall Study|Lack of Efficacy|1
1445963|NCT00857623|4769371|P2|Overall Study|Withdrawal by Subject|1
1445964|NCT00857623|4769372|P1|Overall Study|Withdrawal by Subject|2
1445965|NCT00857623|4769371|P2|Overall Study|Study-specific discontinuation criteria|3
1445966|NCT00857623|4769372|P1|Overall Study|Study-specific discontinuation criteria|5
1445967|NCT00857623|4769371|P2|Overall Study|Adverse Event|2
1445968|NCT00857623|4769372|P1|Overall Study|Adverse Event|5
1445969|NCT00857584|4769396|P2|Overall Study|Physician Decision|1
1445970|NCT00857584|4769397|P1|Overall Study|Physician Decision|1
1445971|NCT00857584|4769396|P2|Overall Study|Adverse Event|2
1445972|NCT00857584|4769397|P1|Overall Study|Adverse Event|2
1445973|NCT00857584|4769396|P2|Overall Study|Lack of Efficacy|2
1445974|NCT00857584|4769397|P1|Overall Study|Lack of Efficacy|1
1445975|NCT00857454|4769489|P1|Overall Study|MTE09 enrollment criteria not met|6
1445976|NCT00857454|4769489|P1|Overall Study|Total Testosterone <300 ng/dL|8
1445977|NCT00857454|4769489|P1|Overall Study|Total Testosterone >1050 ng/dL|1
1445978|NCT00857454|4769489|P1|Overall Study|Adverse Event|2
1445979|NCT00857454|4769489|P1|Overall Study|Lost to Follow-up|1
1445980|NCT00857454|4769489|P1|Overall Study|Withdrawal by Subject|2
1445981|NCT00857415|4769502|P2|Overall Study|Deceased with no autopsy|0
1445982|NCT00857415|4769503|P1|Overall Study|Deceased with no autopsy|2
1445983|NCT00857415|4769502|P2|Overall Study|Subject still living at end of study|0
1445984|NCT00857415|4769503|P1|Overall Study|Subject still living at end of study|110
1445985|NCT00857415|4769502|P2|Overall Study|Invalid image or not imaged|0
1445986|NCT00857415|4769503|P1|Overall Study|Invalid image or not imaged|3
1445987|NCT00857415|4769502|P2|Overall Study|Image acquisition failure|0
1445988|NCT00857415|4769503|P1|Overall Study|Image acquisition failure|2
1445989|NCT00857311|4769514|P4|Overall Study|Lost to Follow-up|0
1445990|NCT00857311|4769515|P3|Overall Study|Lost to Follow-up|0
1445991|NCT00857311|4769516|P2|Overall Study|Lost to Follow-up|0
1445992|NCT00857311|4769517|P1|Overall Study|Lost to Follow-up|1
1445993|NCT00857285|4769529|P2|Overall Study|Randomization criteria not met|1
1445994|NCT00857285|4769530|P1|Overall Study|Randomization criteria not met|1
1445995|NCT00857285|4769529|P2|Overall Study|Withdrawal by Subject|0
1445996|NCT00857285|4769530|P1|Overall Study|Withdrawal by Subject|4
1445997|NCT00857285|4769529|P2|Overall Study|Protocol Violation|1
1445998|NCT00857285|4769530|P1|Overall Study|Protocol Violation|3
1445999|NCT00857285|4769529|P2|Overall Study|Lack of Efficacy|2
1446000|NCT00857285|4769530|P1|Overall Study|Lack of Efficacy|0
1446001|NCT00857285|4769529|P2|Overall Study|Adverse Event|2
1446002|NCT00857285|4769530|P1|Overall Study|Adverse Event|4
1446003|NCT00857259|4769546|P3|Overall Study|Protocol Violation|1
1446004|NCT00857259|4769547|P2|Overall Study|Protocol Violation|0
1446005|NCT00857259|4769548|P1|Overall Study|Protocol Violation|1
1446006|NCT00857246|4769558|P1|ChemoRT|Adverse Event|2
1446007|NCT00857246|4769558|P1|ChemoRT|Withdrawal by Subject|1
1446008|NCT00857246|4769558|P1|Surgery (Curative)|disease progression|6
1446009|NCT00857246|4769558|P1|Induction Regimen|Withdrawal by Subject|1
1446010|NCT00857246|4769558|P1|Induction Regimen|disease-related complications|1
1446011|NCT00857246|4769558|P1|Induction Regimen|Adverse Event|1
1446012|NCT00857233|4769568|P1|Overall Study|Other Reasons|2
1446013|NCT00857233|4769568|P1|Overall Study|Nursing Home Placement|14
1446014|NCT00857233|4769568|P1|Overall Study|Lost to Follow-up|4
1446015|NCT00857233|4769568|P1|Overall Study|Withdrawal of Consent|9
1446016|NCT00857233|4769568|P1|Overall Study|Non-compliance|1
1446017|NCT00857233|4769568|P1|Overall Study|Lack of Efficacy|1
1446018|NCT00857233|4769568|P1|Overall Study|Adverse Event|24
1446019|NCT00857220|4769577|P1|Overall Study|Miscellaneous|8
1446020|NCT00857220|4769577|P1|Overall Study|Site Closed|5
1446021|NCT00857220|4769577|P1|Overall Study|Clinical Hold|6
1446022|NCT00857220|4769577|P1|Overall Study|Withdrawal by Subject|67
1446023|NCT00857220|4769577|P1|Overall Study|Protocol Violation|16
1446024|NCT00857220|4769577|P1|Overall Study|Physician Decision|4
1446025|NCT00857220|4769577|P1|Overall Study|Lost to Follow-up|30
1446026|NCT00857220|4769577|P1|Overall Study|Lack of Efficacy|11
1446027|NCT00857220|4769577|P1|Overall Study|Death|1
1446028|NCT00857220|4769577|P1|Overall Study|Adverse Event|35
1446029|NCT00856986|4769599|P5|Extension Period, Weeks 26-52|Unclassified|0
1446030|NCT00856986|4769600|P4|Extension Period, Weeks 26-52|Unclassified|0
1446031|NCT00856986|4769601|P3|Extension Period, Weeks 26-52|Unclassified|11
1446032|NCT00856986|4769602|P2|Extension Period, Weeks 26-52|Unclassified|2
1446033|NCT00856986|4769603|P1|Extension Period, Weeks 26-52|Unclassified|4
1446034|NCT00856986|4769599|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
1446035|NCT00856986|4769600|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
1446036|NCT00856986|4769601|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
1446037|NCT00856986|4769602|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
1446038|NCT00856986|4769603|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
1446039|NCT00856986|4769599|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
1446040|NCT00856986|4769600|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
1446041|NCT00856986|4769601|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
1446042|NCT00856986|4769602|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
1446043|NCT00856986|4769603|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
1446044|NCT00856986|4769599|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
1446045|NCT00856986|4769600|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
1446046|NCT00856986|4769601|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
1446047|NCT00856986|4769602|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
1446048|NCT00856986|4769603|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
1446049|NCT00856986|4769599|P5|Extension Period, Weeks 26-52|Protocol Violation|0
1446050|NCT00856986|4769600|P4|Extension Period, Weeks 26-52|Protocol Violation|0
1446051|NCT00856986|4769601|P3|Extension Period, Weeks 26-52|Protocol Violation|5
1446052|NCT00856986|4769602|P2|Extension Period, Weeks 26-52|Protocol Violation|2
1446053|NCT00856986|4769603|P1|Extension Period, Weeks 26-52|Protocol Violation|6
1446054|NCT00856986|4769599|P5|Extension Period, Weeks 26-52|Adverse Event|0
1446055|NCT00856986|4769600|P4|Extension Period, Weeks 26-52|Adverse Event|0
1446056|NCT00856986|4769601|P3|Extension Period, Weeks 26-52|Adverse Event|10
1446057|NCT00856986|4769602|P2|Extension Period, Weeks 26-52|Adverse Event|3
1446058|NCT00856986|4769603|P1|Extension Period, Weeks 26-52|Adverse Event|3
1446059|NCT00856986|4769599|P5|Main Period, Weeks 0-26|Unclassified|0
1446060|NCT00856986|4769600|P4|Main Period, Weeks 0-26|Unclassified|0
1446061|NCT00856986|4769601|P3|Main Period, Weeks 0-26|Unclassified|7
1446062|NCT00856986|4769602|P2|Main Period, Weeks 0-26|Unclassified|6
1446063|NCT00856986|4769603|P1|Main Period, Weeks 0-26|Unclassified|7
1446064|NCT00856986|4769599|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
1446065|NCT00856986|4769600|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
1446066|NCT00856986|4769601|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
1446067|NCT00856986|4769602|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
1446068|NCT00856986|4769603|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
1446069|NCT00856986|4769599|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
1446070|NCT00856986|4769600|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
1446071|NCT00856986|4769601|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
1446072|NCT00856986|4769602|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
1446073|NCT00856986|4769603|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
1446074|NCT00856986|4769599|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
1446075|NCT00856986|4769600|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
1446076|NCT00856986|4769601|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
1446077|NCT00856986|4769602|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
1446078|NCT00856986|4769603|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
1446079|NCT00856986|4769599|P5|Main Period, Weeks 0-26|Protocol Violation|0
1446080|NCT00856986|4769600|P4|Main Period, Weeks 0-26|Protocol Violation|0
1446081|NCT00856986|4769601|P3|Main Period, Weeks 0-26|Protocol Violation|7
1446082|NCT00856986|4769602|P2|Main Period, Weeks 0-26|Protocol Violation|5
1446083|NCT00856986|4769603|P1|Main Period, Weeks 0-26|Protocol Violation|4
1446084|NCT00856986|4769599|P5|Main Period, Weeks 0-26|Adverse Event|0
1446085|NCT00856986|4769600|P4|Main Period, Weeks 0-26|Adverse Event|0
1446086|NCT00856986|4769601|P3|Main Period, Weeks 0-26|Adverse Event|9
1446087|NCT00856986|4769602|P2|Main Period, Weeks 0-26|Adverse Event|4
1446088|NCT00856986|4769603|P1|Main Period, Weeks 0-26|Adverse Event|6
1446089|NCT00856986|4769599|P5|Run-in Period, Weeks -12-0|Unclassified|0
1446090|NCT00856986|4769600|P4|Run-in Period, Weeks -12-0|Unclassified|24
1446091|NCT00856986|4769601|P3|Run-in Period, Weeks -12-0|Unclassified|0
1446092|NCT00856986|4769602|P2|Run-in Period, Weeks -12-0|Unclassified|0
1446093|NCT00856986|4769603|P1|Run-in Period, Weeks -12-0|Unclassified|0
1446094|NCT00856986|4769599|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
1446095|NCT00856986|4769600|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
1446096|NCT00856986|4769601|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
1446097|NCT00856986|4769602|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
1446098|NCT00856986|4769603|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
1446099|NCT00856986|4769599|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
1446100|NCT00856986|4769600|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
1446101|NCT00856986|4769601|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
1446102|NCT00856986|4769602|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
1446103|NCT00856986|4769603|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
1446104|NCT00856986|4769599|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
1446105|NCT00856986|4769600|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
1446106|NCT00856986|4769601|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
1446107|NCT00856986|4769602|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
1446108|NCT00856986|4769603|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
1446109|NCT00856986|4769599|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
1446110|NCT00856986|4769600|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
1446111|NCT00856986|4769601|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
1446112|NCT00856986|4769602|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
1446113|NCT00856986|4769603|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
1446114|NCT00856986|4769599|P5|Run-in Period, Weeks -12-0|Adverse Event|0
1446115|NCT00856986|4769600|P4|Run-in Period, Weeks -12-0|Adverse Event|92
1446116|NCT00856986|4769601|P3|Run-in Period, Weeks -12-0|Adverse Event|0
1446117|NCT00856986|4769602|P2|Run-in Period, Weeks -12-0|Adverse Event|0
1446118|NCT00856986|4769603|P1|Run-in Period, Weeks -12-0|Adverse Event|0
1446119|NCT00856973|4769773|P3|Overall Study|Other|13
1446120|NCT00856973|4769774|P2|Overall Study|Other|12
1446121|NCT00856973|4769775|P1|Overall Study|Other|11
1446122|NCT00856973|4769773|P3|Overall Study|Withdrawal by Subject|15
1446123|NCT00856973|4769774|P2|Overall Study|Withdrawal by Subject|16
1446124|NCT00856973|4769775|P1|Overall Study|Withdrawal by Subject|13
1446125|NCT00856973|4769773|P3|Overall Study|Protocol Violation|1
1446126|NCT00856973|4769774|P2|Overall Study|Protocol Violation|2
1446127|NCT00856973|4769775|P1|Overall Study|Protocol Violation|1
1446128|NCT00856973|4769773|P3|Overall Study|Physician Decision|1
1446129|NCT00856973|4769774|P2|Overall Study|Physician Decision|3
1446130|NCT00856973|4769775|P1|Overall Study|Physician Decision|0
1446131|NCT00856973|4769773|P3|Overall Study|Lost to Follow-up|5
1446132|NCT00856973|4769774|P2|Overall Study|Lost to Follow-up|3
1446133|NCT00856973|4769775|P1|Overall Study|Lost to Follow-up|6
1446134|NCT00856973|4769773|P3|Overall Study|Adverse Event|3
1446135|NCT00856973|4769774|P2|Overall Study|Adverse Event|5
1446136|NCT00856973|4769775|P1|Overall Study|Adverse Event|5
1446137|NCT00856908|4769855|P2|Overall Study|Lost to Follow-up|0
1446138|NCT00856908|4769856|P1|Overall Study|Lost to Follow-up|1
1446139|NCT00856843|4769883|P2|Overall Study|Lack of Efficacy|0
1446140|NCT00856843|4769884|P1|Overall Study|Lack of Efficacy|1
1446141|NCT00856843|4769883|P2|Overall Study|Withdrawal by Subject|5
1446142|NCT00856843|4769884|P1|Overall Study|Withdrawal by Subject|1
1446143|NCT00856830|4769920|P4|Irinotecan & Bendamustine|Physician Decision|1
1446144|NCT00856830|4769921|P3|Irinotecan & Bendamustine|Physician Decision|0
1446145|NCT00856830|4769922|P2|Irinotecan & Bendamustine|Physician Decision|0
1446146|NCT00856830|4769923|P1|Irinotecan & Bendamustine|Physician Decision|0
1446147|NCT00856830|4769920|P4|Irinotecan & Bendamustine|Death|2
1446148|NCT00856830|4769921|P3|Irinotecan & Bendamustine|Death|0
1446149|NCT00856830|4769922|P2|Irinotecan & Bendamustine|Death|0
1446150|NCT00856830|4769923|P1|Irinotecan & Bendamustine|Death|0
1446151|NCT00856778|4769934|P1|Overall Study|Lost to Follow-up|5
1446152|NCT00856778|4769934|P1|Overall Study|Study deviation|2
1446153|NCT00856778|4769934|P1|Overall Study|Withdrawal by Subject|10
1446154|NCT00856778|4769934|P1|Overall Study|Adverse Event|7
1446155|NCT00856661|4769977|P2|Overall Study|Physician Judgement|5
1446156|NCT00856661|4769978|P1|Overall Study|Physician Judgement|8
1446157|NCT00856661|4769977|P2|Overall Study|Lost to Follow-up|3
1446158|NCT00856661|4769978|P1|Overall Study|Lost to Follow-up|1
1446159|NCT00856661|4769977|P2|Overall Study|Withdrawal by Subject|2
1446160|NCT00856661|4769978|P1|Overall Study|Withdrawal by Subject|1
1446161|NCT00856661|4769977|P2|Overall Study|Protocol Violation|1
1446162|NCT00856661|4769978|P1|Overall Study|Protocol Violation|2
1446163|NCT00856661|4769977|P2|Overall Study|Death|18
1446164|NCT00856661|4769978|P1|Overall Study|Death|15
1446165|NCT00856635|4769992|P2|Overall Study|Discontinued at Randomization|2
1446166|NCT00856635|4769993|P1|Overall Study|Discontinued at Randomization|2
1446167|NCT00856635|4769992|P2|Overall Study|Other|0
1446168|NCT00856635|4769993|P1|Overall Study|Other|1
1446169|NCT00856635|4769992|P2|Overall Study|Serious Adverse Event|0
1446170|NCT00856635|4769993|P1|Overall Study|Serious Adverse Event|1
1446171|NCT00856635|4769992|P2|Overall Study|Withdrawal by Subject|1
1446172|NCT00856635|4769993|P1|Overall Study|Withdrawal by Subject|3
1446173|NCT00856635|4769992|P2|Overall Study|Pregnancy|0
1446174|NCT00856635|4769993|P1|Overall Study|Pregnancy|1
1446175|NCT00856635|4769992|P2|Overall Study|Lost to Follow-up|5
1446176|NCT00856635|4769993|P1|Overall Study|Lost to Follow-up|2
1446177|NCT00856609|4770003|P2|Overall Study|Adverse Event|0
1446178|NCT00856609|4770004|P1|Overall Study|Adverse Event|1
1446179|NCT00856583|4770016|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
1446180|NCT00856583|4770017|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
1446181|NCT00856583|4770016|P2|Overall Study|Other|104
1446182|NCT00856583|4770017|P1|Overall Study|Other|92
1446183|NCT00856583|4770016|P2|Overall Study|Pregnancy|5
1446184|NCT00856583|4770017|P1|Overall Study|Pregnancy|14
1446185|NCT00856583|4770016|P2|Overall Study|Physician Decision|82
1446186|NCT00856583|4770017|P1|Overall Study|Physician Decision|59
1446187|NCT00856583|4770016|P2|Overall Study|Withdrawal by Subject|919
1446188|NCT00856583|4770017|P1|Overall Study|Withdrawal by Subject|1092
1446189|NCT00856583|4770016|P2|Overall Study|Non-compliance|262
1446190|NCT00856583|4770017|P1|Overall Study|Non-compliance|305
1446191|NCT00856583|4770016|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
1446192|NCT00856583|4770017|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
1446193|NCT00856583|4770016|P2|Overall Study|Serious Adverse Event (SAE)|65
1446194|NCT00856583|4770017|P1|Overall Study|Serious Adverse Event (SAE)|99
1446195|NCT00856583|4770016|P2|Overall Study|Lack of Efficacy|377
1446196|NCT00856583|4770017|P1|Overall Study|Lack of Efficacy|389
1446197|NCT00856557|4770047|P2|Overall Study|No patients with contextual flags|16
1446198|NCT00856557|4770048|P1|Overall Study|No patients with contextual flags|12
1446199|NCT00856544|4770062|P4|Overall Study|Withdrawal by Subject|1
1446200|NCT00856544|4770063|P3|Overall Study|Withdrawal by Subject|0
1446201|NCT00856544|4770064|P2|Overall Study|Withdrawal by Subject|5
1446202|NCT00856544|4770065|P1|Overall Study|Withdrawal by Subject|8
1446203|NCT00856544|4770062|P4|Overall Study|Lost to Follow-up|0
1446204|NCT00856544|4770063|P3|Overall Study|Lost to Follow-up|2
1446205|NCT00856544|4770064|P2|Overall Study|Lost to Follow-up|2
1446206|NCT00856544|4770065|P1|Overall Study|Lost to Follow-up|1
1446207|NCT00856544|4770062|P4|Overall Study|Other|6
1446208|NCT00856544|4770063|P3|Overall Study|Other|1
1446209|NCT00856544|4770064|P2|Overall Study|Other|16
1446210|NCT00856544|4770065|P1|Overall Study|Other|9
1446211|NCT00856544|4770062|P4|Overall Study|Lack of Efficacy|3
1446212|NCT00856544|4770063|P3|Overall Study|Lack of Efficacy|3
1446213|NCT00856544|4770064|P2|Overall Study|Lack of Efficacy|12
1446214|NCT00856544|4770065|P1|Overall Study|Lack of Efficacy|16
1446215|NCT00856544|4770062|P4|Overall Study|Adverse Event|3
1446216|NCT00856544|4770063|P3|Overall Study|Adverse Event|2
1446217|NCT00856544|4770064|P2|Overall Study|Adverse Event|29
1446218|NCT00856544|4770065|P1|Overall Study|Adverse Event|20
1446219|NCT00856544|4770062|P4|Overall Study|Death|0
1446220|NCT00856544|4770063|P3|Overall Study|Death|0
1446221|NCT00856544|4770064|P2|Overall Study|Death|2
1446222|NCT00856544|4770065|P1|Overall Study|Death|0
1446223|NCT00856544|4770062|P4|Overall Study|Randomized but not treated|0
1446224|NCT00856544|4770063|P3|Overall Study|Randomized but not treated|0
1446225|NCT00856544|4770064|P2|Overall Study|Randomized but not treated|0
1446226|NCT00856544|4770065|P1|Overall Study|Randomized but not treated|3
1446227|NCT00856518|4770244|P2|Overall Study|Lost to Follow-up|2
1446228|NCT00856518|4770245|P1|Overall Study|Lost to Follow-up|4
1446229|NCT00856492|4770258|P3|Overall Study|Ineligible or withdrew consent|2
1446230|NCT00856492|4770259|P2|Overall Study|Ineligible or withdrew consent|1
1446231|NCT00856492|4770260|P1|Overall Study|Ineligible or withdrew consent|1
1446232|NCT00856388|4770282|P1|Overall Study|Not Specified|1
1446233|NCT00856349|4770293|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
1446234|NCT00856349|4770293|P1|Overall Study|Site closure|78
1446235|NCT00856349|4770293|P1|Overall Study|Device explant|33
1446236|NCT00856349|4770293|P1|Overall Study|Subject relocation|104
1446237|NCT00856349|4770293|P1|Overall Study|Physician Decision|13
1446238|NCT00856349|4770293|P1|Overall Study|Protocol Violation|38
1446239|NCT00856349|4770293|P1|Overall Study|Lost to Follow-up|91
1446240|NCT00856349|4770293|P1|Overall Study|Withdrawal by Subject|116
1446241|NCT00856349|4770293|P1|Overall Study|Death|418
1446242|NCT00856323|4770302|P1|Overall Study|Withdrawal by Subject|2
1446243|NCT00856297|4770314|P5|Overall Study|Unable to classify|0
1446244|NCT00856297|4770315|P4|Overall Study|Unable to classify|0
1446245|NCT00856297|4770316|P3|Overall Study|Unable to classify|0
1446246|NCT00856297|4770317|P2|Overall Study|Unable to classify|0
1446247|NCT00856297|4770318|P1|Overall Study|Unable to classify|2
1446248|NCT00856284|4770351|P3|Overall Study|Randomized in error|1
1446249|NCT00856284|4770352|P2|Overall Study|Randomized in error|0
1446250|NCT00856284|4770353|P1|Overall Study|Randomized in error|0
1446251|NCT00856284|4770351|P3|Overall Study|Other|14
1446252|NCT00856284|4770352|P2|Overall Study|Other|17
1446253|NCT00856284|4770353|P1|Overall Study|Other|15
1446254|NCT00856284|4770351|P3|Overall Study|Investigator discretion|10
1446255|NCT00856284|4770352|P2|Overall Study|Investigator discretion|8
1446256|NCT00856284|4770353|P1|Overall Study|Investigator discretion|9
1446257|NCT00856284|4770351|P3|Overall Study|Pregnancy|0
1446258|NCT00856284|4770352|P2|Overall Study|Pregnancy|2
1446259|NCT00856284|4770353|P1|Overall Study|Pregnancy|1
1446260|NCT00856284|4770351|P3|Overall Study|Voluntary withdrawal|62
1446261|NCT00856284|4770352|P2|Overall Study|Voluntary withdrawal|52
1446262|NCT00856284|4770353|P1|Overall Study|Voluntary withdrawal|48
1446263|NCT00856284|4770351|P3|Overall Study|Lost to Follow-up|28
1446264|NCT00856284|4770352|P2|Overall Study|Lost to Follow-up|22
1446265|NCT00856284|4770353|P1|Overall Study|Lost to Follow-up|20
1446266|NCT00856284|4770351|P3|Overall Study|Major protocol deviation|15
1446267|NCT00856284|4770352|P2|Overall Study|Major protocol deviation|16
1446268|NCT00856284|4770353|P1|Overall Study|Major protocol deviation|24
1446269|NCT00856284|4770351|P3|Overall Study|Adverse Event|82
1446270|NCT00856284|4770352|P2|Overall Study|Adverse Event|74
1446271|NCT00856284|4770353|P1|Overall Study|Adverse Event|60
1446272|NCT00856284|4770351|P3|Overall Study|Hyperglycemic rescue|235
1446273|NCT00856284|4770352|P2|Overall Study|Hyperglycemic rescue|201
1446274|NCT00856284|4770353|P1|Overall Study|Hyperglycemic rescue|231
1446275|NCT00856245|4770379|P1|Overall Study|Was not transplanted|5
1446276|NCT00856206|4770402|P2|Overall Study|Other than specified above|10
1446277|NCT00856206|4770403|P1|Overall Study|Other than specified above|3
1446278|NCT00856206|4770402|P2|Overall Study|Decision by the Sponsor|8
1446279|NCT00856206|4770403|P1|Overall Study|Decision by the Sponsor|4
1446280|NCT00856206|4770402|P2|Overall Study|Death|2
1446281|NCT00856206|4770403|P1|Overall Study|Death|2
1446282|NCT00856206|4770402|P2|Overall Study|Lost to Follow-up|39
1446283|NCT00856206|4770403|P1|Overall Study|Lost to Follow-up|13
1446284|NCT00856206|4770402|P2|Overall Study|Withdrawal by Subject|36
1446285|NCT00856206|4770403|P1|Overall Study|Withdrawal by Subject|15
1446286|NCT00856206|4770402|P2|Overall Study|Lack of Efficacy|2
1446287|NCT00856206|4770403|P1|Overall Study|Lack of Efficacy|1
1446288|NCT00856206|4770402|P2|Overall Study|Adverse Event|46
1446289|NCT00856206|4770403|P1|Overall Study|Adverse Event|10
1446290|NCT00856206|4770402|P2|Overall Study|Protocol Violation|18
1446291|NCT00856206|4770403|P1|Overall Study|Protocol Violation|6
1446292|NCT00856193|4770417|P2|Period 2|Lost to Follow-up|1
1446293|NCT00856193|4770418|P1|Period 2|Lost to Follow-up|0
1446294|NCT00856193|4770417|P2|Period 2|Abnormal test procedure results|1
1446295|NCT00856193|4770418|P1|Period 2|Abnormal test procedure results|0
1446296|NCT00856180|4770430|P1|Overall Study|Progressive Disease|16
1446297|NCT00856180|4770430|P1|Overall Study|Adverse Event|4
1446298|NCT00855959|4770455|P1|Overall Study|Incorrect enrolment|1
1446299|NCT00855959|4770455|P1|Overall Study|Pregnancy|1
1446300|NCT00855959|4770455|P1|Overall Study|Withdrawal by Subject|3
1446301|NCT00855959|4770455|P1|Overall Study|Lost to Follow-up|2
1446302|NCT00855959|4770455|P1|Overall Study|Adverse Event|2
1446303|NCT00855933|4770472|P2|Overall Study|Withdrawal by Subject|1
1446304|NCT00855933|4770473|P1|Overall Study|Withdrawal by Subject|0
1446305|NCT00855920|4770482|P3|Overall Study|Other than specified above|1
1446306|NCT00855920|4770483|P2|Overall Study|Other than specified above|1
1446307|NCT00855920|4770484|P1|Overall Study|Other than specified above|1
1446308|NCT00855920|4770482|P3|Overall Study|Decision by the sponsor|1
1446309|NCT00855920|4770483|P2|Overall Study|Decision by the sponsor|1
1446310|NCT00855920|4770484|P1|Overall Study|Decision by the sponsor|0
1446311|NCT00855920|4770482|P3|Overall Study|Death|0
1446312|NCT00855920|4770483|P2|Overall Study|Death|1
1446313|NCT00855920|4770484|P1|Overall Study|Death|0
1446314|NCT00855920|4770482|P3|Overall Study|Lost to Follow-up|2
1446315|NCT00855920|4770483|P2|Overall Study|Lost to Follow-up|0
1446316|NCT00855920|4770484|P1|Overall Study|Lost to Follow-up|1
1446317|NCT00855920|4770482|P3|Overall Study|Withdrawal by Subject|2
1446318|NCT00855920|4770483|P2|Overall Study|Withdrawal by Subject|3
1446319|NCT00855920|4770484|P1|Overall Study|Withdrawal by Subject|2
1446320|NCT00855920|4770482|P3|Overall Study|Lack of Efficacy|2
1446321|NCT00855920|4770483|P2|Overall Study|Lack of Efficacy|2
1446322|NCT00855920|4770484|P1|Overall Study|Lack of Efficacy|2
1446323|NCT00855920|4770482|P3|Overall Study|Adverse Event|1
1446324|NCT00855920|4770483|P2|Overall Study|Adverse Event|1
1446325|NCT00855920|4770484|P1|Overall Study|Adverse Event|2
1446326|NCT00855920|4770482|P3|Overall Study|Protocol Violation|2
1446327|NCT00855920|4770483|P2|Overall Study|Protocol Violation|0
1446328|NCT00855920|4770484|P1|Overall Study|Protocol Violation|0
1446329|NCT00855894|4770501|P1|Overall Study|Disease progression|1
1446330|NCT00855894|4770501|P1|Overall Study|Patient's decision|1
1446331|NCT00855894|4770501|P1|Overall Study|Death|31
1446332|NCT00855816|4770524|P2|Overall Study|Became ineligible|1
1446333|NCT00855816|4770525|P1|Overall Study|Became ineligible|0
1446334|NCT00855816|4770524|P2|Overall Study|Death|0
1446335|NCT00855816|4770525|P1|Overall Study|Death|1
1446336|NCT00855816|4770524|P2|Overall Study|Lost to Follow-up|5
1446337|NCT00855816|4770525|P1|Overall Study|Lost to Follow-up|3
1446338|NCT00855816|4770524|P2|Overall Study|Withdrawal by Subject|15
1446339|NCT00855816|4770525|P1|Overall Study|Withdrawal by Subject|22
1446340|NCT00855738|4770531|P1|Overall Study|Death|1
1446341|NCT00855738|4770531|P1|Overall Study|Subject Defaulted|1
1446342|NCT00855738|4770531|P1|Overall Study|Adverse Event|1
1446343|NCT00855738|4770531|P1|Overall Study|Lost to Follow-up|2
1446344|NCT00855595|4770559|P2|Overall Study|patient left country|1
1446345|NCT00855595|4770560|P1|Overall Study|patient left country|0
1446346|NCT00855595|4770559|P2|Overall Study|patient moved out of state|0
1446347|NCT00855595|4770560|P1|Overall Study|patient moved out of state|1
1446348|NCT00855595|4770559|P2|Overall Study|Adverse Event|1
1446349|NCT00855595|4770560|P1|Overall Study|Adverse Event|1
1446350|NCT00855595|4770559|P2|Overall Study|Lost to Follow-up|3
1446351|NCT00855595|4770560|P1|Overall Study|Lost to Follow-up|3
1446352|NCT00855595|4770559|P2|Overall Study|Withdrawal by Subject|2
1446353|NCT00855595|4770560|P1|Overall Study|Withdrawal by Subject|1
1446354|NCT00855582|4770599|P3|Overall Study|Withdrawal by Subject|8
1446355|NCT00855582|4770600|P2|Overall Study|Withdrawal by Subject|4
1446356|NCT00855582|4770601|P1|Overall Study|Withdrawal by Subject|7
1446357|NCT00855582|4770599|P3|Overall Study|Entry Criteria Not Met|3
1446358|NCT00855582|4770600|P2|Overall Study|Entry Criteria Not Met|6
1446359|NCT00855582|4770601|P1|Overall Study|Entry Criteria Not Met|8
1446360|NCT00855582|4770599|P3|Overall Study|Protocol Violation|6
1446361|NCT00855582|4770600|P2|Overall Study|Protocol Violation|2
1446362|NCT00855582|4770601|P1|Overall Study|Protocol Violation|6
1446363|NCT00855582|4770599|P3|Overall Study|Physician Decision|1
1446364|NCT00855582|4770600|P2|Overall Study|Physician Decision|0
1446365|NCT00855582|4770601|P1|Overall Study|Physician Decision|0
1446366|NCT00855582|4770599|P3|Overall Study|Lost to Follow-up|1
1446367|NCT00855582|4770600|P2|Overall Study|Lost to Follow-up|3
1446368|NCT00855582|4770601|P1|Overall Study|Lost to Follow-up|1
1446369|NCT00855582|4770599|P3|Overall Study|Lack of Efficacy|8
1446370|NCT00855582|4770600|P2|Overall Study|Lack of Efficacy|3
1446371|NCT00855582|4770601|P1|Overall Study|Lack of Efficacy|1
1446372|NCT00855582|4770599|P3|Overall Study|Death|0
1446373|NCT00855582|4770600|P2|Overall Study|Death|0
1446374|NCT00855582|4770601|P1|Overall Study|Death|1
1446375|NCT00855582|4770599|P3|Overall Study|Adverse Event|3
1446376|NCT00855582|4770600|P2|Overall Study|Adverse Event|6
1446377|NCT00855582|4770601|P1|Overall Study|Adverse Event|2
1446378|NCT00855465|4770690|P2|Follow-up Period (FUP)|Missing|0
1446379|NCT00855465|4770691|P1|Follow-up Period (FUP)|Missing|1
1446380|NCT00855465|4770690|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
1446381|NCT00855465|4770691|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
1446382|NCT00855465|4770690|P2|Follow-up Period (FUP)|Lost to Follow-up|0
1446383|NCT00855465|4770691|P1|Follow-up Period (FUP)|Lost to Follow-up|3
1446384|NCT00855465|4770690|P2|Follow-up Period (FUP)|Death|1
1446385|NCT00855465|4770691|P1|Follow-up Period (FUP)|Death|0
1446386|NCT00855465|4770690|P2|Follow-up Period (FUP)|Adverse Event|1
1446387|NCT00855465|4770691|P1|Follow-up Period (FUP)|Adverse Event|0
1446388|NCT00855465|4770690|P2|Treatment Period|Not treated|0
1446389|NCT00855465|4770691|P1|Treatment Period|Not treated|1
1446390|NCT00855465|4770690|P2|Treatment Period|Withdrawal by Subject|0
1446391|NCT00855465|4770691|P1|Treatment Period|Withdrawal by Subject|2
1446392|NCT00855465|4770690|P2|Treatment Period|Protocol Violation|0
1446393|NCT00855465|4770691|P1|Treatment Period|Protocol Violation|2
1446394|NCT00855465|4770690|P2|Treatment Period|Non-compliance|0
1446395|NCT00855465|4770691|P1|Treatment Period|Non-compliance|1
1446396|NCT00855465|4770690|P2|Treatment Period|Lack of Efficacy|1
1446397|NCT00855465|4770691|P1|Treatment Period|Lack of Efficacy|2
1446398|NCT00855465|4770690|P2|Treatment Period|Death|2
1446399|NCT00855465|4770691|P1|Treatment Period|Death|2
1446400|NCT00855465|4770690|P2|Treatment Period|Adverse Event|2
1446401|NCT00855465|4770691|P1|Treatment Period|Adverse Event|4
1446402|NCT00855439|4770781|P2|Overall Study|Pregnancy|0
1446403|NCT00855439|4770782|P1|Overall Study|Pregnancy|1
1446404|NCT00855439|4770781|P2|Overall Study|Withdrawal by Subject|0
1446405|NCT00855439|4770782|P1|Overall Study|Withdrawal by Subject|2
1446406|NCT00855335|4770840|P5|Overall Study|Other|1
1446407|NCT00855335|4770841|P4|Overall Study|Other|5
1446408|NCT00855335|4770842|P3|Overall Study|Other|2
1446409|NCT00855335|4770843|P2|Overall Study|Other|1
1446410|NCT00855335|4770844|P1|Overall Study|Other|2
1446411|NCT00855335|4770840|P5|Overall Study|Physician Decision|0
1446412|NCT00855335|4770841|P4|Overall Study|Physician Decision|0
1446413|NCT00855335|4770842|P3|Overall Study|Physician Decision|0
1446414|NCT00855335|4770843|P2|Overall Study|Physician Decision|1
1446415|NCT00855335|4770844|P1|Overall Study|Physician Decision|1
1446416|NCT00855335|4770840|P5|Overall Study|Adverse Event|0
1446417|NCT00855335|4770841|P4|Overall Study|Adverse Event|0
1446418|NCT00855335|4770842|P3|Overall Study|Adverse Event|0
1446419|NCT00855335|4770843|P2|Overall Study|Adverse Event|0
1446420|NCT00855335|4770844|P1|Overall Study|Adverse Event|2
1446421|NCT00855335|4770840|P5|Overall Study|Withdrawal by Subject|0
1446422|NCT00855335|4770841|P4|Overall Study|Withdrawal by Subject|1
1446423|NCT00855335|4770842|P3|Overall Study|Withdrawal by Subject|0
1446424|NCT00855335|4770843|P2|Overall Study|Withdrawal by Subject|0
1446425|NCT00855335|4770844|P1|Overall Study|Withdrawal by Subject|0
1446426|NCT00855335|4770840|P5|Overall Study|Lost to Follow-up|0
1446427|NCT00855335|4770841|P4|Overall Study|Lost to Follow-up|1
1446428|NCT00855335|4770842|P3|Overall Study|Lost to Follow-up|3
1446429|NCT00855335|4770843|P2|Overall Study|Lost to Follow-up|0
1446430|NCT00855335|4770844|P1|Overall Study|Lost to Follow-up|0
1446431|NCT00855309|4770931|P2|Overall Study|patient never recieved drug|0
1446432|NCT00855309|4770932|P1|Overall Study|patient never recieved drug|1
1446433|NCT00855218|4770940|P2|Overall Study|Clinical endpoint reached|13
1446434|NCT00855218|4770941|P1|Overall Study|Clinical endpoint reached|10
1446435|NCT00855218|4770940|P2|Overall Study|Progression measurement proven|15
1446436|NCT00855218|4770941|P1|Overall Study|Progression measurement proven|7
1446437|NCT00855218|4770940|P2|Overall Study|Second malignancy|1
1446438|NCT00855218|4770941|P1|Overall Study|Second malignancy|0
1446439|NCT00855218|4770940|P2|Overall Study|Untreatable disease progression|67
1446440|NCT00855218|4770941|P1|Overall Study|Untreatable disease progression|54
1446441|NCT00855218|4770940|P2|Overall Study|Still treated with study medication|1
1446442|NCT00855218|4770941|P1|Overall Study|Still treated with study medication|0
1446443|NCT00855218|4770940|P2|Overall Study|technical problems|1
1446444|NCT00855218|4770941|P1|Overall Study|technical problems|2
1446445|NCT00855218|4770940|P2|Overall Study|patient convenience|0
1446446|NCT00855218|4770941|P1|Overall Study|patient convenience|2
1446447|NCT00855218|4770940|P2|Overall Study|non-compliant with study drug|1
1446448|NCT00855218|4770941|P1|Overall Study|non-compliant with study drug|3
1446449|NCT00855218|4770940|P2|Overall Study|Protocol Violation|9
1446450|NCT00855218|4770941|P1|Overall Study|Protocol Violation|5
1446451|NCT00855218|4770940|P2|Overall Study|Lost to Follow-up|1
1446452|NCT00855218|4770941|P1|Overall Study|Lost to Follow-up|0
1446453|NCT00855218|4770940|P2|Overall Study|Physician Decision|11
1446454|NCT00855218|4770941|P1|Overall Study|Physician Decision|18
1446455|NCT00855218|4770940|P2|Overall Study|Withdrawal by Subject|6
1446456|NCT00855218|4770941|P1|Overall Study|Withdrawal by Subject|10
1446457|NCT00855218|4770940|P2|Overall Study|Adverse Event|27
1446458|NCT00855218|4770941|P1|Overall Study|Adverse Event|43
1446459|NCT00855166|4770959|P2|Overall Study|Subject no longer meets study criteria|1
1446460|NCT00855166|4770960|P1|Overall Study|Subject no longer meets study criteria|1
1446461|NCT00855166|4770959|P2|Overall Study|Administrative reasons by sponsor|0
1446462|NCT00855166|4770960|P1|Overall Study|Administrative reasons by sponsor|1
1446463|NCT00855166|4770959|P2|Overall Study|Poor/non-compliance|0
1446464|NCT00855166|4770960|P1|Overall Study|Poor/non-compliance|2
1446465|NCT00855166|4770959|P2|Overall Study|Withdrawal by Subject|4
1446466|NCT00855166|4770960|P1|Overall Study|Withdrawal by Subject|1
1446467|NCT00855166|4770959|P2|Overall Study|Death|1
1446468|NCT00855166|4770960|P1|Overall Study|Death|0
1446469|NCT00855166|4770959|P2|Overall Study|Adverse Event|2
1446470|NCT00855166|4770960|P1|Overall Study|Adverse Event|0
1446471|NCT00855062|4770980|P2|Step2|Initiation of antiretroviral therapy/ART|1
1446472|NCT00855062|4770981|P1|Step2|Initiation of antiretroviral therapy/ART|0
1446473|NCT00855062|4770980|P2|Step2|Adverse Event|3
1446474|NCT00855062|4770981|P1|Step2|Adverse Event|0
1446475|NCT00855062|4770980|P2|Step2|Early Study Closure|2
1446476|NCT00855062|4770981|P1|Step2|Early Study Closure|6
1446477|NCT00855062|4770980|P2|Step1|Withdrawal by Subject|3
1446478|NCT00855062|4770981|P1|Step1|Withdrawal by Subject|2
1446479|NCT00855062|4770980|P2|Step1|Pregnancy|0
1446480|NCT00855062|4770981|P1|Step1|Pregnancy|1
1446481|NCT00855062|4770980|P2|Step1|Protocol Violation|0
1446482|NCT00855062|4770981|P1|Step1|Protocol Violation|1
1446483|NCT00855062|4770980|P2|Step1|Adverse Event|1
1446484|NCT00855062|4770981|P1|Step1|Adverse Event|1
1446485|NCT00855062|4770980|P2|Step1|Early Study Closure|7
1446486|NCT00855062|4770981|P1|Step1|Early Study Closure|5
1446487|NCT00854906|4771030|P1|Overall Study|One person had no ocular history|1
1446488|NCT00854724|4771039|P2|Second Intervention|Physician Decision|1
1446489|NCT00854724|4771040|P1|Second Intervention|Physician Decision|0
1446490|NCT00854724|4771039|P2|Second Intervention|Protocol Violation|0
1446491|NCT00854724|4771040|P1|Second Intervention|Protocol Violation|1
1446492|NCT00854724|4771039|P2|Washout|Withdrawal by Subject|1
1446493|NCT00854724|4771040|P1|Washout|Withdrawal by Subject|0
1446494|NCT00854724|4771039|P2|Washout|Protocol Violation|0
1446495|NCT00854724|4771040|P1|Washout|Protocol Violation|1
1446496|NCT00854724|4771039|P2|First Intervention|Withdrawal by Subject|1
1446497|NCT00854724|4771040|P1|First Intervention|Withdrawal by Subject|1
1446498|NCT00854620|4771046|P1|Overall Study|Adverse Event|1
1446499|NCT00854607|4771050|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
1446500|NCT00854581|4771098|P1|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
1446501|NCT00854581|4771098|P1|Induction (Up to Day 21)|Physician Decision|1
1446502|NCT00854581|4771098|P1|Induction (Up to Day 21)|Death|1
1446503|NCT00854581|4771098|P1|Induction (Up to Day 21)|Lack of Efficacy|4
1446504|NCT00854373|4771113|P2|Overall Study|Forgot to take study drug|1
1446505|NCT00854373|4771114|P1|Overall Study|Forgot to take study drug|1
1446506|NCT00854373|4771113|P2|Overall Study|Withdrawal by Subject|3
1446507|NCT00854373|4771114|P1|Overall Study|Withdrawal by Subject|1
1446508|NCT00854360|4771128|P4|Overall Study|Other|3
1446509|NCT00854360|4771129|P3|Overall Study|Other|0
1446510|NCT00854360|4771130|P2|Overall Study|Other|0
1446511|NCT00854360|4771131|P1|Overall Study|Other|0
1446512|NCT00854360|4771128|P4|Overall Study|Lack of Efficacy|0
1446513|NCT00854360|4771129|P3|Overall Study|Lack of Efficacy|0
1446514|NCT00854360|4771130|P2|Overall Study|Lack of Efficacy|1
1446515|NCT00854360|4771131|P1|Overall Study|Lack of Efficacy|2
1446516|NCT00854360|4771128|P4|Overall Study|Pregnancy|0
1446517|NCT00854360|4771129|P3|Overall Study|Pregnancy|0
1446518|NCT00854360|4771130|P2|Overall Study|Pregnancy|1
1446519|NCT00854360|4771131|P1|Overall Study|Pregnancy|0
1446520|NCT00854360|4771128|P4|Overall Study|Withdrawal by Subject|1
1446521|NCT00854360|4771129|P3|Overall Study|Withdrawal by Subject|0
1446522|NCT00854360|4771130|P2|Overall Study|Withdrawal by Subject|0
1446523|NCT00854360|4771131|P1|Overall Study|Withdrawal by Subject|0
1446524|NCT00854360|4771128|P4|Overall Study|Adverse Event|6
1446525|NCT00854360|4771129|P3|Overall Study|Adverse Event|2
1446526|NCT00854360|4771130|P2|Overall Study|Adverse Event|1
1446527|NCT00854360|4771131|P1|Overall Study|Adverse Event|0
1446528|NCT00854308|4771163|P2|Overall Study|Sponsor's decision to terminate study|1
1446529|NCT00854308|4771164|P1|Overall Study|Sponsor's decision to terminate study|0
1446530|NCT00854308|4771163|P2|Overall Study|Withdrawal by Subject|2
1446531|NCT00854308|4771164|P1|Overall Study|Withdrawal by Subject|4
1446532|NCT00854308|4771163|P2|Overall Study|Physician Decision|6
1446533|NCT00854308|4771164|P1|Overall Study|Physician Decision|6
1446534|NCT00854308|4771163|P2|Overall Study|Death|5
1446535|NCT00854308|4771164|P1|Overall Study|Death|2
1446536|NCT00854308|4771163|P2|Overall Study|Adverse Event|3
1446537|NCT00854308|4771164|P1|Overall Study|Adverse Event|8
1446538|NCT00854308|4771163|P2|Overall Study|Disease progression|50
1446539|NCT00854308|4771164|P1|Overall Study|Disease progression|42
1446540|NCT00854113|4771189|P11|Overall Study|Withdrawal by Subject|0
1446541|NCT00854113|4771190|P10|Overall Study|Withdrawal by Subject|0
1446542|NCT00854113|4771191|P9|Overall Study|Withdrawal by Subject|1
1446543|NCT00854113|4771192|P8|Overall Study|Withdrawal by Subject|1
1446544|NCT00854113|4771193|P7|Overall Study|Withdrawal by Subject|0
1446545|NCT00854113|4771194|P6|Overall Study|Withdrawal by Subject|0
1446546|NCT00854113|4771195|P5|Overall Study|Withdrawal by Subject|0
1446547|NCT00854113|4771196|P4|Overall Study|Withdrawal by Subject|0
1446548|NCT00854113|4771197|P3|Overall Study|Withdrawal by Subject|0
1446549|NCT00854113|4771198|P2|Overall Study|Withdrawal by Subject|0
1446550|NCT00854113|4771199|P1|Overall Study|Withdrawal by Subject|0
1446551|NCT00854113|4771189|P11|Overall Study|Adverse Event|0
1446552|NCT00854113|4771190|P10|Overall Study|Adverse Event|0
1446553|NCT00854113|4771191|P9|Overall Study|Adverse Event|0
1446554|NCT00854113|4771192|P8|Overall Study|Adverse Event|2
1446555|NCT00854113|4771193|P7|Overall Study|Adverse Event|0
1446556|NCT00854113|4771194|P6|Overall Study|Adverse Event|0
1446557|NCT00854113|4771195|P5|Overall Study|Adverse Event|0
1446558|NCT00854113|4771196|P4|Overall Study|Adverse Event|0
1446559|NCT00854113|4771197|P3|Overall Study|Adverse Event|0
1446560|NCT00854113|4771198|P2|Overall Study|Adverse Event|0
1446561|NCT00854113|4771199|P1|Overall Study|Adverse Event|0
1446562|NCT00853970|4771321|P2|Overall Study|Cancelled surgery|2
1446563|NCT00853970|4771322|P1|Overall Study|Cancelled surgery|4
1446564|NCT00853970|4771321|P2|Overall Study|Withdrawal by Subject|1
1446565|NCT00853970|4771322|P1|Overall Study|Withdrawal by Subject|2
1446566|NCT00853957|4771332|P2|Overall Study|Protocol deviation|3
1446567|NCT00853957|4771333|P1|Overall Study|Protocol deviation|0
1446568|NCT00853957|4771332|P2|Overall Study|Lost to Follow-up|6
1446569|NCT00853957|4771333|P1|Overall Study|Lost to Follow-up|1
1446570|NCT00853957|4771332|P2|Overall Study|Subject withdrew consent|5
1446571|NCT00853957|4771333|P1|Overall Study|Subject withdrew consent|4
1446572|NCT00853957|4771332|P2|Overall Study|Unsatisfactory therapeutic effect|2
1446573|NCT00853957|4771333|P1|Overall Study|Unsatisfactory therapeutic effect|0
1446574|NCT00853957|4771332|P2|Overall Study|Adverse Event|3
1446575|NCT00853957|4771333|P1|Overall Study|Adverse Event|9
1446576|NCT00853905|4771351|P2|Overall Study|never had surgery|0
1446577|NCT00853905|4771352|P1|Overall Study|never had surgery|1
1446578|NCT00853905|4771351|P2|Overall Study|Withdrawal by Subject|1
1446579|NCT00853905|4771352|P1|Overall Study|Withdrawal by Subject|0
1446580|NCT00853905|4771351|P2|Overall Study|Lost to Follow-up|3
1446581|NCT00853905|4771352|P1|Overall Study|Lost to Follow-up|1
1446582|NCT00853827|4771384|P2|Double Blind Period (103 Weeks)|Death|6
1446583|NCT00853827|4771385|P1|Double Blind Period (103 Weeks)|Death|1
1446584|NCT00853827|4771384|P2|Double Blind Period (103 Weeks)|Administrative problems|56
1446585|NCT00853827|4771385|P1|Double Blind Period (103 Weeks)|Administrative problems|45
1446586|NCT00853827|4771384|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
1446587|NCT00853827|4771385|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
1446588|NCT00853827|4771384|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
1446589|NCT00853827|4771385|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
1446590|NCT00853827|4771384|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
1446591|NCT00853827|4771385|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
1446592|NCT00853827|4771384|P2|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|1
1446593|NCT00853827|4771385|P1|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|3
1446594|NCT00853827|4771384|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
1446595|NCT00853827|4771385|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
1446596|NCT00853827|4771384|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
1446597|NCT00853827|4771385|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
1446598|NCT00853827|4771384|P2|Double Blind Period (103 Weeks)|Adverse Event|14
1446599|NCT00853827|4771385|P1|Double Blind Period (103 Weeks)|Adverse Event|25
1446600|NCT00853827|4771384|P2|Single Blind Period (1 Week)|Protocol Violation|0
1446601|NCT00853827|4771385|P1|Single Blind Period (1 Week)|Protocol Violation|12
1446602|NCT00853827|4771384|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
1446603|NCT00853827|4771385|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
1446604|NCT00853827|4771384|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
1446605|NCT00853827|4771385|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
1446606|NCT00853827|4771384|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
1446607|NCT00853827|4771385|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
1446608|NCT00853827|4771384|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
1446609|NCT00853827|4771385|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
1446610|NCT00853827|4771384|P2|Single Blind Period (1 Week)|Adverse Event|0
1446611|NCT00853827|4771385|P1|Single Blind Period (1 Week)|Adverse Event|9
1446612|NCT00853827|4771384|P2|Single Blind Period (1 Week)|Other|0
1446613|NCT00853827|4771385|P1|Single Blind Period (1 Week)|Other|4
1446614|NCT00853762|4771401|P4|Overall Study|Randomised but not Treated|0
1446615|NCT00853762|4771402|P3|Overall Study|Randomised but not Treated|2
1446616|NCT00853762|4771403|P2|Overall Study|Randomised but not Treated|2
1446617|NCT00853762|4771404|P1|Overall Study|Randomised but not Treated|0
1446618|NCT00853762|4771401|P4|Overall Study|Other|0
1446619|NCT00853762|4771402|P3|Overall Study|Other|0
1446620|NCT00853762|4771403|P2|Overall Study|Other|2
1446621|NCT00853762|4771404|P1|Overall Study|Other|0
1446622|NCT00853762|4771401|P4|Overall Study|Withdrawal by Subject|0
1446623|NCT00853762|4771402|P3|Overall Study|Withdrawal by Subject|1
1446624|NCT00853762|4771403|P2|Overall Study|Withdrawal by Subject|0
1446625|NCT00853762|4771404|P1|Overall Study|Withdrawal by Subject|0
1446626|NCT00853762|4771401|P4|Overall Study|Protocol Violation|1
1446627|NCT00853762|4771402|P3|Overall Study|Protocol Violation|0
1446628|NCT00853762|4771403|P2|Overall Study|Protocol Violation|0
1446629|NCT00853762|4771404|P1|Overall Study|Protocol Violation|0
1446630|NCT00853762|4771401|P4|Overall Study|Premature Termination|21
1446631|NCT00853762|4771402|P3|Overall Study|Premature Termination|14
1446632|NCT00853762|4771403|P2|Overall Study|Premature Termination|15
1446633|NCT00853762|4771404|P1|Overall Study|Premature Termination|16
1446634|NCT00853749|4771472|P2|Overall Study|Lost to Follow-up|1
1446635|NCT00853749|4771473|P1|Overall Study|Lost to Follow-up|0
1446636|NCT00853723|4771494|P3|Overall Study|Protocol Violation|1
1446637|NCT00853723|4771495|P2|Overall Study|Protocol Violation|2
1446638|NCT00853723|4771496|P1|Overall Study|Protocol Violation|1
1446639|NCT00853723|4771494|P3|Overall Study|Withdrawal by Subject|0
1446640|NCT00853723|4771495|P2|Overall Study|Withdrawal by Subject|1
1446641|NCT00853723|4771496|P1|Overall Study|Withdrawal by Subject|2
1446642|NCT00853723|4771494|P3|Overall Study|Adverse Event|1
1446643|NCT00853723|4771495|P2|Overall Study|Adverse Event|4
1446644|NCT00853723|4771496|P1|Overall Study|Adverse Event|3
1446645|NCT00853658|4771543|P3|Overall Study|Missing study completion information|6
1446646|NCT00853658|4771544|P2|Overall Study|Missing study completion information|4
1446647|NCT00853658|4771545|P1|Overall Study|Missing study completion information|5
1446648|NCT00853658|4771543|P3|Overall Study|Patient's request|11
1446649|NCT00853658|4771544|P2|Overall Study|Patient's request|17
1446650|NCT00853658|4771545|P1|Overall Study|Patient's request|21
1446651|NCT00853658|4771543|P3|Overall Study|Vital Status at study end N/A|10
1446652|NCT00853658|4771544|P2|Overall Study|Vital Status at study end N/A|10
1446653|NCT00853658|4771545|P1|Overall Study|Vital Status at study end N/A|8
1446654|NCT00853658|4771543|P3|Overall Study|Vital Status unknown at study end|0
1446655|NCT00853658|4771544|P2|Overall Study|Vital Status unknown at study end|1
1446656|NCT00853658|4771545|P1|Overall Study|Vital Status unknown at study end|1
1446657|NCT00853658|4771543|P3|Overall Study|Vital Status known (alive) at study end|3
1446658|NCT00853658|4771544|P2|Overall Study|Vital Status known (alive) at study end|3
1446659|NCT00853658|4771545|P1|Overall Study|Vital Status known (alive) at study end|2
1446660|NCT00853658|4771543|P3|Overall Study|IRB request|2
1446661|NCT00853658|4771544|P2|Overall Study|IRB request|0
1446662|NCT00853658|4771545|P1|Overall Study|IRB request|0
1446663|NCT00853658|4771543|P3|Overall Study|H.A. Request|19
1446664|NCT00853658|4771544|P2|Overall Study|H.A. Request|23
1446665|NCT00853658|4771545|P1|Overall Study|H.A. Request|26
1446666|NCT00853658|4771543|P3|Overall Study|Lost to Follow-up|11
1446667|NCT00853658|4771544|P2|Overall Study|Lost to Follow-up|6
1446668|NCT00853658|4771545|P1|Overall Study|Lost to Follow-up|11
1446669|NCT00853658|4771543|P3|Overall Study|Death|753
1446670|NCT00853658|4771544|P2|Overall Study|Death|768
1446671|NCT00853658|4771545|P1|Overall Study|Death|713
1446672|NCT00853593|4771565|P1|Overall Study|Implant not attempted|4
1446673|NCT00853593|4771565|P1|Overall Study|Model 4396 lead not attempted|29
1446674|NCT00853593|4771565|P1|Overall Study|Subjects did not receive a 4396 lead|12
1446675|NCT00853580|4771592|P2|Overall Study|Commenced contraindicated therapy|2
1446676|NCT00853580|4771593|P1|Overall Study|Commenced contraindicated therapy|0
1446677|NCT00853580|4771592|P2|Overall Study|Withdrawal by Subject|8
1446678|NCT00853580|4771593|P1|Overall Study|Withdrawal by Subject|2
1446679|NCT00853580|4771592|P2|Overall Study|Protocol Violation|1
1446680|NCT00853580|4771593|P1|Overall Study|Protocol Violation|2
1446681|NCT00853580|4771592|P2|Overall Study|Lost to Follow-up|5
1446682|NCT00853580|4771593|P1|Overall Study|Lost to Follow-up|3
1446683|NCT00853567|4771640|P1|Overall Study|Study prematurely terminated|71
1446684|NCT00853489|4771650|P2|Overall Study|Lost to Follow-up|2
1446685|NCT00853489|4771651|P1|Overall Study|Lost to Follow-up|5
1446686|NCT00853385|4771666|P5|Overall Study|Other|12
1446687|NCT00853385|4771667|P4|Overall Study|Other|4
1446688|NCT00853385|4771668|P3|Overall Study|Other|4
1446689|NCT00853385|4771669|P2|Overall Study|Other|9
1446690|NCT00853385|4771670|P1|Overall Study|Other|18
1446691|NCT00853385|4771666|P5|Overall Study|Withdrawal by Subject|1
1446692|NCT00853385|4771667|P4|Overall Study|Withdrawal by Subject|1
1446693|NCT00853385|4771668|P3|Overall Study|Withdrawal by Subject|0
1446694|NCT00853385|4771669|P2|Overall Study|Withdrawal by Subject|2
1446695|NCT00853385|4771670|P1|Overall Study|Withdrawal by Subject|4
1446696|NCT00853385|4771666|P5|Overall Study|Lost to Follow-up|0
1446697|NCT00853385|4771667|P4|Overall Study|Lost to Follow-up|0
1446698|NCT00853385|4771668|P3|Overall Study|Lost to Follow-up|0
1446699|NCT00853385|4771669|P2|Overall Study|Lost to Follow-up|1
1446700|NCT00853385|4771670|P1|Overall Study|Lost to Follow-up|2
1446701|NCT00853385|4771666|P5|Overall Study|Lack of Efficacy|6
1446702|NCT00853385|4771667|P4|Overall Study|Lack of Efficacy|3
1446703|NCT00853385|4771668|P3|Overall Study|Lack of Efficacy|3
1446704|NCT00853385|4771669|P2|Overall Study|Lack of Efficacy|7
1446705|NCT00853385|4771670|P1|Overall Study|Lack of Efficacy|6
1446706|NCT00853385|4771666|P5|Overall Study|Adverse Event|22
1446707|NCT00853385|4771667|P4|Overall Study|Adverse Event|5
1446708|NCT00853385|4771668|P3|Overall Study|Adverse Event|2
1446709|NCT00853385|4771669|P2|Overall Study|Adverse Event|24
1446710|NCT00853385|4771670|P1|Overall Study|Adverse Event|24
1446711|NCT00853385|4771666|P5|Overall Study|Death|1
1446712|NCT00853385|4771667|P4|Overall Study|Death|0
1446713|NCT00853385|4771668|P3|Overall Study|Death|0
1446714|NCT00853385|4771669|P2|Overall Study|Death|0
1446715|NCT00853385|4771670|P1|Overall Study|Death|0
1446716|NCT00853307|4771898|P2|Overall Study|Reason Not Specified|1
1446717|NCT00853307|4771899|P1|Overall Study|Reason Not Specified|0
1446718|NCT00853307|4771898|P2|Overall Study|Withdrawal by Subject|2
1446719|NCT00853307|4771899|P1|Overall Study|Withdrawal by Subject|1
1446720|NCT00853307|4771898|P2|Overall Study|Adverse Event|2
1446721|NCT00853307|4771899|P1|Overall Study|Adverse Event|1
1446722|NCT00853242|4771926|P7|Overall Study|Other|2
1446723|NCT00853242|4771927|P6|Overall Study|Other|1
1446724|NCT00853242|4771928|P5|Overall Study|Other|0
1446725|NCT00853242|4771929|P4|Overall Study|Other|0
1446726|NCT00853242|4771930|P3|Overall Study|Other|2
1446727|NCT00853242|4771931|P2|Overall Study|Other|0
1446728|NCT00853242|4771932|P1|Overall Study|Other|2
1446729|NCT00853242|4771926|P7|Overall Study|Withdrawal by Subject|2
1446730|NCT00853242|4771927|P6|Overall Study|Withdrawal by Subject|0
1446731|NCT00853242|4771928|P5|Overall Study|Withdrawal by Subject|0
1446732|NCT00853242|4771929|P4|Overall Study|Withdrawal by Subject|4
1446733|NCT00853242|4771930|P3|Overall Study|Withdrawal by Subject|0
1446734|NCT00853242|4771931|P2|Overall Study|Withdrawal by Subject|2
1446735|NCT00853242|4771932|P1|Overall Study|Withdrawal by Subject|1
1446736|NCT00853242|4771926|P7|Overall Study|Noncompliant|0
1446737|NCT00853242|4771927|P6|Overall Study|Noncompliant|0
1446738|NCT00853242|4771928|P5|Overall Study|Noncompliant|1
1446739|NCT00853242|4771929|P4|Overall Study|Noncompliant|0
1446740|NCT00853242|4771930|P3|Overall Study|Noncompliant|0
1446741|NCT00853242|4771931|P2|Overall Study|Noncompliant|0
1446742|NCT00853242|4771932|P1|Overall Study|Noncompliant|0
1446743|NCT00853242|4771926|P7|Overall Study|Adverse Event|1
1446744|NCT00853242|4771927|P6|Overall Study|Adverse Event|1
1446745|NCT00853242|4771928|P5|Overall Study|Adverse Event|3
1446746|NCT00853242|4771929|P4|Overall Study|Adverse Event|0
1446747|NCT00853242|4771930|P3|Overall Study|Adverse Event|1
1446748|NCT00853242|4771931|P2|Overall Study|Adverse Event|1
1446749|NCT00853242|4771932|P1|Overall Study|Adverse Event|0
1446750|NCT00853229|4771974|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
1446751|NCT00853229|4771975|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
1446752|NCT00853151|4771985|P4|Overall Study|Sponsor Decision|0
1446753|NCT00853151|4771986|P3|Overall Study|Sponsor Decision|0
1446754|NCT00853151|4771987|P2|Overall Study|Sponsor Decision|3
1446755|NCT00853151|4771988|P1|Overall Study|Sponsor Decision|0
1446756|NCT00853151|4771985|P4|Overall Study|Physician Decision|0
1446757|NCT00853151|4771986|P3|Overall Study|Physician Decision|1
1446758|NCT00853151|4771987|P2|Overall Study|Physician Decision|2
1446759|NCT00853151|4771988|P1|Overall Study|Physician Decision|0
1446760|NCT00853151|4771985|P4|Overall Study|Withdrawal by Subject|1
1446761|NCT00853151|4771986|P3|Overall Study|Withdrawal by Subject|2
1446762|NCT00853151|4771987|P2|Overall Study|Withdrawal by Subject|4
1446763|NCT00853151|4771988|P1|Overall Study|Withdrawal by Subject|5
1446764|NCT00853151|4771985|P4|Overall Study|Protocol Violation|1
1446765|NCT00853151|4771986|P3|Overall Study|Protocol Violation|0
1446766|NCT00853151|4771987|P2|Overall Study|Protocol Violation|0
1446767|NCT00853151|4771988|P1|Overall Study|Protocol Violation|0
1446768|NCT00853151|4771985|P4|Overall Study|Death|1
1446769|NCT00853151|4771986|P3|Overall Study|Death|0
1446770|NCT00853151|4771987|P2|Overall Study|Death|0
1446771|NCT00853151|4771988|P1|Overall Study|Death|1
1446772|NCT00853151|4771985|P4|Overall Study|Lost to Follow-up|0
1446773|NCT00853151|4771986|P3|Overall Study|Lost to Follow-up|3
1446774|NCT00853151|4771987|P2|Overall Study|Lost to Follow-up|0
1446775|NCT00853151|4771988|P1|Overall Study|Lost to Follow-up|2
1446776|NCT00853151|4771985|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1446777|NCT00853151|4771986|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1446778|NCT00853151|4771987|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1446779|NCT00853151|4771988|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
1446780|NCT00853151|4771985|P4|Overall Study|Adverse Event|0
1446781|NCT00853151|4771986|P3|Overall Study|Adverse Event|2
1446782|NCT00853151|4771987|P2|Overall Study|Adverse Event|4
1446783|NCT00853151|4771988|P1|Overall Study|Adverse Event|1
1446784|NCT00853112|4772137|P7|Overall Study|Randomized but not treated|1
1446785|NCT00853112|4772138|P6|Overall Study|Randomized but not treated|0
1446786|NCT00853112|4772139|P5|Overall Study|Randomized but not treated|0
1446787|NCT00853112|4772140|P4|Overall Study|Randomized but not treated|2
1446788|NCT00853112|4772141|P3|Overall Study|Randomized but not treated|0
1446789|NCT00853112|4772142|P2|Overall Study|Randomized but not treated|1
1446790|NCT00853112|4772143|P1|Overall Study|Randomized but not treated|0
1446791|NCT00853099|4772253|P4|Double-blind + Open-label Periods|Not Specified|6
1446792|NCT00853099|4772254|P3|Double-blind + Open-label Periods|Not Specified|0
1446793|NCT00853099|4772255|P2|Double-blind + Open-label Periods|Not Specified|0
1446794|NCT00853099|4772256|P1|Double-blind + Open-label Periods|Not Specified|0
1446795|NCT00853099|4772253|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
1446796|NCT00853099|4772254|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
1446797|NCT00853099|4772255|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
1446798|NCT00853099|4772256|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
1446799|NCT00853099|4772253|P4|Double-blind + Open-label Periods|Adverse Event|47
1446800|NCT00853099|4772254|P3|Double-blind + Open-label Periods|Adverse Event|0
1446801|NCT00853099|4772255|P2|Double-blind + Open-label Periods|Adverse Event|0
1446802|NCT00853099|4772256|P1|Double-blind + Open-label Periods|Adverse Event|0
1446803|NCT00853099|4772253|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
1446804|NCT00853099|4772254|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
1446805|NCT00853099|4772255|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
1446806|NCT00853099|4772256|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
1446807|NCT00853099|4772253|P4|Double-blind Period|Mistreated with rescue study drug|0
1446808|NCT00853099|4772254|P3|Double-blind Period|Mistreated with rescue study drug|1
1446809|NCT00853099|4772255|P2|Double-blind Period|Mistreated with rescue study drug|0
1446810|NCT00853099|4772256|P1|Double-blind Period|Mistreated with rescue study drug|0
1446811|NCT00853099|4772253|P4|Double-blind Period|Not Specified|0
1446812|NCT00853099|4772254|P3|Double-blind Period|Not Specified|1
1446813|NCT00853099|4772255|P2|Double-blind Period|Not Specified|0
1446814|NCT00853099|4772256|P1|Double-blind Period|Not Specified|0
1446815|NCT00853099|4772253|P4|Double-blind Period|Lack of Efficacy|0
1446816|NCT00853099|4772254|P3|Double-blind Period|Lack of Efficacy|16
1446817|NCT00853099|4772255|P2|Double-blind Period|Lack of Efficacy|17
1446818|NCT00853099|4772256|P1|Double-blind Period|Lack of Efficacy|14
1446819|NCT00853099|4772253|P4|Double-blind Period|Withdrawal by Subject|0
1446820|NCT00853099|4772254|P3|Double-blind Period|Withdrawal by Subject|0
1446821|NCT00853099|4772255|P2|Double-blind Period|Withdrawal by Subject|3
1446822|NCT00853099|4772256|P1|Double-blind Period|Withdrawal by Subject|2
1446823|NCT00853099|4772253|P4|Double-blind Period|Adverse Event|0
1446824|NCT00853099|4772254|P3|Double-blind Period|Adverse Event|13
1446825|NCT00853099|4772255|P2|Double-blind Period|Adverse Event|9
1446826|NCT00853099|4772256|P1|Double-blind Period|Adverse Event|7
1446827|NCT00853073|4772298|P2|Overall Study|Withdrawal by Subject|2
1446828|NCT00853073|4772299|P1|Overall Study|Withdrawal by Subject|3
1446829|NCT00853021|4772307|P1|Overall Study|Death|1
1446830|NCT00853021|4772307|P1|Overall Study|Withdrawal by Subject|2
1446831|NCT00853021|4772307|P1|Overall Study|Adverse Event|2
1446832|NCT00852995|4772319|P5|Overall Study|Moved Out of Area|0
1446833|NCT00852995|4772320|P4|Overall Study|Moved Out of Area|0
1446834|NCT00852995|4772321|P3|Overall Study|Moved Out of Area|0
1446835|NCT00852995|4772322|P2|Overall Study|Moved Out of Area|0
1446836|NCT00852995|4772323|P1|Overall Study|Moved Out of Area|1
1446837|NCT00852995|4772319|P5|Overall Study|Protocol Violation|1
1446838|NCT00852995|4772320|P4|Overall Study|Protocol Violation|0
1446839|NCT00852995|4772321|P3|Overall Study|Protocol Violation|0
1446840|NCT00852995|4772322|P2|Overall Study|Protocol Violation|0
1446841|NCT00852995|4772323|P1|Overall Study|Protocol Violation|0
1446842|NCT00852995|4772319|P5|Overall Study|Physician Decision|0
1446843|NCT00852995|4772320|P4|Overall Study|Physician Decision|0
1446844|NCT00852995|4772321|P3|Overall Study|Physician Decision|0
1446845|NCT00852995|4772322|P2|Overall Study|Physician Decision|0
1446846|NCT00852995|4772323|P1|Overall Study|Physician Decision|1
1446847|NCT00852995|4772319|P5|Overall Study|Progressive Disease|1
1446848|NCT00852995|4772320|P4|Overall Study|Progressive Disease|2
1446849|NCT00852995|4772321|P3|Overall Study|Progressive Disease|0
1446850|NCT00852995|4772322|P2|Overall Study|Progressive Disease|0
1446851|NCT00852995|4772323|P1|Overall Study|Progressive Disease|1
1446852|NCT00852995|4772319|P5|Overall Study|Non-Compliance|0
1446853|NCT00852995|4772320|P4|Overall Study|Non-Compliance|2
1446854|NCT00852995|4772321|P3|Overall Study|Non-Compliance|0
1446855|NCT00852995|4772322|P2|Overall Study|Non-Compliance|0
1446856|NCT00852995|4772323|P1|Overall Study|Non-Compliance|0
1446857|NCT00852995|4772319|P5|Overall Study|Withdrawal by Subject|2
1446858|NCT00852995|4772320|P4|Overall Study|Withdrawal by Subject|1
1446859|NCT00852995|4772321|P3|Overall Study|Withdrawal by Subject|0
1446860|NCT00852995|4772322|P2|Overall Study|Withdrawal by Subject|0
1446861|NCT00852995|4772323|P1|Overall Study|Withdrawal by Subject|4
1446862|NCT00852995|4772319|P5|Overall Study|Lost to Follow-up|0
1446863|NCT00852995|4772320|P4|Overall Study|Lost to Follow-up|0
1446864|NCT00852995|4772321|P3|Overall Study|Lost to Follow-up|1
1446865|NCT00852995|4772322|P2|Overall Study|Lost to Follow-up|1
1446866|NCT00852995|4772323|P1|Overall Study|Lost to Follow-up|0
1446867|NCT00852995|4772319|P5|Overall Study|Adverse Event|0
1446868|NCT00852995|4772320|P4|Overall Study|Adverse Event|0
1446869|NCT00852995|4772321|P3|Overall Study|Adverse Event|4
1446870|NCT00852995|4772322|P2|Overall Study|Adverse Event|0
1446871|NCT00852995|4772323|P1|Overall Study|Adverse Event|1
1446872|NCT00852969|4772367|P2|Overall Study|Lost to Follow-up|1
1446873|NCT00852969|4772368|P1|Overall Study|Lost to Follow-up|0
1446874|NCT00852969|4772367|P2|Overall Study|Adverse Event|1
1446875|NCT00852969|4772368|P1|Overall Study|Adverse Event|0
1446876|NCT00852930|4772379|P3|Overall Study|Physician Decision|1
1446877|NCT00852930|4772380|P2|Overall Study|Physician Decision|0
1446878|NCT00852930|4772381|P1|Overall Study|Physician Decision|0
1446879|NCT00852930|4772379|P3|Overall Study|Withdrawal by Subject|1
1446880|NCT00852930|4772380|P2|Overall Study|Withdrawal by Subject|1
1446881|NCT00852930|4772381|P1|Overall Study|Withdrawal by Subject|1
1446882|NCT00852917|4772402|P4|Overall Study|Death|1
1446883|NCT00852917|4772403|P3|Overall Study|Death|0
1446884|NCT00852917|4772404|P2|Overall Study|Death|0
1446885|NCT00852917|4772405|P1|Overall Study|Death|0
1446886|NCT00852917|4772402|P4|Overall Study|Physician Decision|19
1446887|NCT00852917|4772403|P3|Overall Study|Physician Decision|2
1446888|NCT00852917|4772404|P2|Overall Study|Physician Decision|7
1446889|NCT00852917|4772405|P1|Overall Study|Physician Decision|6
1446890|NCT00852917|4772402|P4|Overall Study|Withdrawal by Subject|9
1446891|NCT00852917|4772403|P3|Overall Study|Withdrawal by Subject|10
1446892|NCT00852917|4772404|P2|Overall Study|Withdrawal by Subject|8
1446893|NCT00852917|4772405|P1|Overall Study|Withdrawal by Subject|4
1446894|NCT00852917|4772402|P4|Overall Study|Lack of Efficacy|47
1446895|NCT00852917|4772403|P3|Overall Study|Lack of Efficacy|11
1446896|NCT00852917|4772404|P2|Overall Study|Lack of Efficacy|11
1446897|NCT00852917|4772405|P1|Overall Study|Lack of Efficacy|21
1446898|NCT00852917|4772402|P4|Overall Study|Adverse Event|17
1446899|NCT00852917|4772403|P3|Overall Study|Adverse Event|35
1446900|NCT00852917|4772404|P2|Overall Study|Adverse Event|20
1446901|NCT00852917|4772405|P1|Overall Study|Adverse Event|13
1446902|NCT00852540|4772533|P2|Overall Study|Did Not Receive Study Drug|3
1446903|NCT00852540|4772534|P1|Overall Study|Did Not Receive Study Drug|3
1446904|NCT00852540|4772533|P2|Overall Study|Withdrawal by Subject|1
1446905|NCT00852540|4772534|P1|Overall Study|Withdrawal by Subject|3
1446906|NCT00852540|4772533|P2|Overall Study|Investigator Discretion|3
1446907|NCT00852540|4772534|P1|Overall Study|Investigator Discretion|2
1446908|NCT00852540|4772533|P2|Overall Study|Lost to Follow-up|3
1446909|NCT00852540|4772534|P1|Overall Study|Lost to Follow-up|2
1446910|NCT00852540|4772533|P2|Overall Study|Protocol Violation|2
1446911|NCT00852540|4772534|P1|Overall Study|Protocol Violation|1
1446912|NCT00852540|4772533|P2|Overall Study|Lack of Efficacy|3
1446913|NCT00852540|4772534|P1|Overall Study|Lack of Efficacy|15
1446914|NCT00852540|4772533|P2|Overall Study|Adverse Event|3
1446915|NCT00852540|4772534|P1|Overall Study|Adverse Event|10
1446916|NCT00852475|4772568|P2|Overall Study|Lost to Follow-up|4
1446917|NCT00852475|4772569|P1|Overall Study|Lost to Follow-up|3
1446918|NCT00852397|4772580|P3|Overall Study|Protocol Violation|1
1446919|NCT00852397|4772581|P2|Overall Study|Protocol Violation|0
1446920|NCT00852397|4772582|P1|Overall Study|Protocol Violation|0
1446921|NCT00852397|4772580|P3|Overall Study|Difficulty in study site visit|0
1446922|NCT00852397|4772581|P2|Overall Study|Difficulty in study site visit|0
1446923|NCT00852397|4772582|P1|Overall Study|Difficulty in study site visit|1
1446924|NCT00852397|4772580|P3|Overall Study|Study terminated by sponsor|6
1446925|NCT00852397|4772581|P2|Overall Study|Study terminated by sponsor|1
1446926|NCT00852397|4772582|P1|Overall Study|Study terminated by sponsor|2
1446927|NCT00852397|4772580|P3|Overall Study|Withdrawal by Subject|2
1446928|NCT00852397|4772581|P2|Overall Study|Withdrawal by Subject|1
1446929|NCT00852397|4772582|P1|Overall Study|Withdrawal by Subject|4
1446930|NCT00852397|4772580|P3|Overall Study|Death|1
1446931|NCT00852397|4772581|P2|Overall Study|Death|0
1446932|NCT00852397|4772582|P1|Overall Study|Death|0
1446933|NCT00852397|4772580|P3|Overall Study|Adverse Event|4
1446934|NCT00852397|4772581|P2|Overall Study|Adverse Event|6
1446935|NCT00852397|4772582|P1|Overall Study|Adverse Event|4
1446936|NCT00852241|4772611|P1|Overall Study|Physician Decision|18
1446937|NCT00852202|4772618|P3|Overall Study|pregnancy,moving away and surgery|2
1446938|NCT00852202|4772619|P2|Overall Study|pregnancy,moving away and surgery|0
1446939|NCT00852202|4772620|P1|Overall Study|pregnancy,moving away and surgery|1
1446940|NCT00852202|4772618|P3|Overall Study|Lost to Follow-up|6
1446941|NCT00852202|4772619|P2|Overall Study|Lost to Follow-up|5
1446942|NCT00852202|4772620|P1|Overall Study|Lost to Follow-up|5
1446943|NCT00852202|4772618|P3|Overall Study|Withdrawal by Subject|2
1446944|NCT00852202|4772619|P2|Overall Study|Withdrawal by Subject|1
1446945|NCT00852202|4772620|P1|Overall Study|Withdrawal by Subject|3
1446946|NCT00852202|4772618|P3|Overall Study|Protocol Violation|7
1446947|NCT00852202|4772619|P2|Overall Study|Protocol Violation|2
1446948|NCT00852202|4772620|P1|Overall Study|Protocol Violation|2
1446949|NCT00852202|4772618|P3|Overall Study|Lack of Efficacy|2
1446950|NCT00852202|4772619|P2|Overall Study|Lack of Efficacy|1
1446951|NCT00852202|4772620|P1|Overall Study|Lack of Efficacy|4
1446952|NCT00852202|4772618|P3|Overall Study|Adverse Event|7
1446953|NCT00852202|4772619|P2|Overall Study|Adverse Event|3
1446954|NCT00852202|4772620|P1|Overall Study|Adverse Event|2
1446955|NCT00851903|4772662|P1|Overall Study|Withdrawal by Subject|2
1446956|NCT00851890|4772676|P4|Overall Study|Lost to Follow-up|1
1446957|NCT00851890|4772677|P3|Overall Study|Lost to Follow-up|0
1446958|NCT00851890|4772678|P2|Overall Study|Lost to Follow-up|1
1446959|NCT00851890|4772679|P1|Overall Study|Lost to Follow-up|0
1446960|NCT00851877|4772736|P3|Phase II|Withdrawal by Subject|3
1446961|NCT00851877|4772737|P2|Phase II|Withdrawal by Subject|0
1446962|NCT00851877|4772738|P1|Phase II|Withdrawal by Subject|0
1446963|NCT00851877|4772736|P3|Phase I-1|Death|0
1446964|NCT00851877|4772737|P2|Phase I-1|Death|0
1446965|NCT00851877|4772738|P1|Phase I-1|Death|1
1446966|NCT00851799|4772748|P3|Overall Study|Completed protocol due to pregnancy|1
1446967|NCT00851799|4772749|P2|Overall Study|Completed protocol due to pregnancy|0
1446968|NCT00851799|4772750|P1|Overall Study|Completed protocol due to pregnancy|0
1446969|NCT00851799|4772748|P3|Overall Study|Severe Debilitation|0
1446970|NCT00851799|4772749|P2|Overall Study|Severe Debilitation|1
1446971|NCT00851799|4772750|P1|Overall Study|Severe Debilitation|0
1446972|NCT00851799|4772748|P3|Overall Study|Withdrew consent prior study completion|1
1446973|NCT00851799|4772749|P2|Overall Study|Withdrew consent prior study completion|2
1446974|NCT00851799|4772750|P1|Overall Study|Withdrew consent prior study completion|1
1446975|NCT00851799|4772748|P3|Overall Study|Not willing to adhere to requirements|2
1446976|NCT00851799|4772749|P2|Overall Study|Not willing to adhere to requirements|2
1446977|NCT00851799|4772750|P1|Overall Study|Not willing to adhere to requirements|1
1446978|NCT00851799|4772748|P3|Overall Study|Not able to get to clinic|9
1446979|NCT00851799|4772749|P2|Overall Study|Not able to get to clinic|5
1446980|NCT00851799|4772750|P1|Overall Study|Not able to get to clinic|8
1446981|NCT00851799|4772748|P3|Overall Study|Lost to Follow-up|10
1446982|NCT00851799|4772749|P2|Overall Study|Lost to Follow-up|3
1446983|NCT00851799|4772750|P1|Overall Study|Lost to Follow-up|5
1446984|NCT00851799|4772748|P3|Overall Study|Death|1
1446985|NCT00851799|4772749|P2|Overall Study|Death|0
1446986|NCT00851799|4772750|P1|Overall Study|Death|1
1446987|NCT00851786|4772838|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
1446988|NCT00851786|4772839|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
1446989|NCT00851786|4772838|P2|Overall Study|Site Closure|0
1446990|NCT00851786|4772839|P1|Overall Study|Site Closure|1
1446991|NCT00851786|4772838|P2|Overall Study|Incarceration|0
1446992|NCT00851786|4772839|P1|Overall Study|Incarceration|1
1446993|NCT00851786|4772838|P2|Overall Study|Lost to Follow-up|0
1446994|NCT00851786|4772839|P1|Overall Study|Lost to Follow-up|1
1446995|NCT00851786|4772838|P2|Overall Study|Protocol Violation|1
1446996|NCT00851786|4772839|P1|Overall Study|Protocol Violation|0
1446997|NCT00851786|4772838|P2|Overall Study|Withdrawal by Subject|1
1446998|NCT00851786|4772839|P1|Overall Study|Withdrawal by Subject|0
1446999|NCT00851747|4772852|P3|Overall Study|Physician Decision|6
1447000|NCT00851747|4772853|P2|Overall Study|Physician Decision|6
1447001|NCT00851747|4772854|P1|Overall Study|Physician Decision|6
1447002|NCT00851721|4772863|P2|Overall Study|Adverse Event|1
1447003|NCT00851721|4772864|P1|Overall Study|Adverse Event|0
1447004|NCT00851721|4772863|P2|Overall Study|Death|0
1447005|NCT00851721|4772864|P1|Overall Study|Death|1
1447006|NCT00851721|4772863|P2|Overall Study|planned surgery|0
1447007|NCT00851721|4772864|P1|Overall Study|planned surgery|1
1447008|NCT00851682|4772954|P2|Overall Study|screen failure|0
1447009|NCT00851682|4772955|P1|Overall Study|screen failure|5
1447010|NCT00851643|4772969|P6|Extension Study (Up to 36 Months)|Moved|1
1447011|NCT00851643|4772970|P5|Extension Study (Up to 36 Months)|Moved|0
1447012|NCT00851643|4772971|P4|Extension Study (Up to 36 Months)|Moved|1
1447013|NCT00851643|4772972|P3|Extension Study (Up to 36 Months)|Moved|1
1447014|NCT00851643|4772973|P2|Extension Study (Up to 36 Months)|Moved|2
1447015|NCT00851643|4772974|P1|Extension Study (Up to 36 Months)|Moved|0
1447016|NCT00851643|4772969|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
1447017|NCT00851643|4772970|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
1447018|NCT00851643|4772971|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
1447019|NCT00851643|4772972|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
1447020|NCT00851643|4772973|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
1447021|NCT00851643|4772974|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
1447022|NCT00851643|4772969|P6|Base Study (Up to 12 Months)|Other|1
1447023|NCT00851643|4772970|P5|Base Study (Up to 12 Months)|Other|0
1447024|NCT00851643|4772971|P4|Base Study (Up to 12 Months)|Other|0
1447025|NCT00851643|4772972|P3|Base Study (Up to 12 Months)|Other|0
1447026|NCT00851643|4772973|P2|Base Study (Up to 12 Months)|Other|0
1447027|NCT00851643|4772974|P1|Base Study (Up to 12 Months)|Other|0
1447028|NCT00851643|4772969|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
1447029|NCT00851643|4772970|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
1447030|NCT00851643|4772971|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
1447031|NCT00851643|4772972|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
1447032|NCT00851643|4772973|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
1447033|NCT00851643|4772974|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
1447034|NCT00851630|4772995|P2|Overall Study|Clinical failure|1
1447035|NCT00851630|4772996|P1|Overall Study|Clinical failure|0
1447036|NCT00851630|4772995|P2|Overall Study|Death|1
1447037|NCT00851630|4772996|P1|Overall Study|Death|2
1447038|NCT00851591|4773010|P2|Overall Study|Withdrawal by Subject|0
1447039|NCT00851591|4773011|P1|Overall Study|Withdrawal by Subject|2
1447040|NCT00851552|4773017|P1|Overall Study|Disease Progression|4
1447041|NCT00851552|4773017|P1|Overall Study|Adverse Event|1
1447042|NCT00851552|4773017|P1|Overall Study|Death|2
1447043|NCT00851318|4773031|P4|Overall Study|Physician Decision|1
1447044|NCT00851318|4773032|P3|Overall Study|Physician Decision|1
1447045|NCT00851318|4773033|P2|Overall Study|Physician Decision|0
1447046|NCT00851318|4773034|P1|Overall Study|Physician Decision|0
1447047|NCT00851318|4773031|P4|Overall Study|Non-compliance with Study Procedures|0
1447048|NCT00851318|4773032|P3|Overall Study|Non-compliance with Study Procedures|1
1447049|NCT00851318|4773033|P2|Overall Study|Non-compliance with Study Procedures|0
1447050|NCT00851318|4773034|P1|Overall Study|Non-compliance with Study Procedures|2
1447051|NCT00851318|4773031|P4|Overall Study|Lack of Efficacy|2
1447052|NCT00851318|4773032|P3|Overall Study|Lack of Efficacy|4
1447053|NCT00851318|4773033|P2|Overall Study|Lack of Efficacy|2
1447054|NCT00851318|4773034|P1|Overall Study|Lack of Efficacy|8
1447055|NCT00851318|4773031|P4|Overall Study|Pregnancy|1
1447056|NCT00851318|4773032|P3|Overall Study|Pregnancy|1
1447057|NCT00851318|4773033|P2|Overall Study|Pregnancy|0
1447058|NCT00851318|4773034|P1|Overall Study|Pregnancy|0
1447059|NCT00851318|4773031|P4|Overall Study|Adverse Event|12
1447060|NCT00851318|4773032|P3|Overall Study|Adverse Event|9
1447061|NCT00851318|4773033|P2|Overall Study|Adverse Event|2
1447062|NCT00851318|4773034|P1|Overall Study|Adverse Event|13
1447063|NCT00851318|4773031|P4|Overall Study|Withdrawal by Subject|3
1447064|NCT00851318|4773032|P3|Overall Study|Withdrawal by Subject|5
1447065|NCT00851318|4773033|P2|Overall Study|Withdrawal by Subject|1
1447066|NCT00851318|4773034|P1|Overall Study|Withdrawal by Subject|7
1447067|NCT00851253|4773070|P2|Overall Study|Disease Progression|0
1447068|NCT00851253|4773071|P1|Overall Study|Disease Progression|1
1447069|NCT00851084|4773081|P2|Overall Study|Not specified|1
1447070|NCT00851084|4773082|P1|Overall Study|Not specified|7
1447071|NCT00851084|4773081|P2|Overall Study|Metastatic surgery|6
1447072|NCT00851084|4773082|P1|Overall Study|Metastatic surgery|6
1447073|NCT00851084|4773081|P2|Overall Study|Withdrawal by Subject|12
1447074|NCT00851084|4773082|P1|Overall Study|Withdrawal by Subject|11
1447075|NCT00851084|4773081|P2|Overall Study|Consent withdrawn|2
1447076|NCT00851084|4773082|P1|Overall Study|Consent withdrawn|0
1447077|NCT00851084|4773081|P2|Overall Study|Physician Decision|14
1447078|NCT00851084|4773082|P1|Overall Study|Physician Decision|13
1447079|NCT00851084|4773081|P2|Overall Study|Poor compliance to protocol|1
1447080|NCT00851084|4773082|P1|Overall Study|Poor compliance to protocol|1
1447081|NCT00851084|4773081|P2|Overall Study|Disease progression|47
1447082|NCT00851084|4773082|P1|Overall Study|Disease progression|52
1447083|NCT00851084|4773081|P2|Overall Study|Adverse Event|36
1447084|NCT00851084|4773082|P1|Overall Study|Adverse Event|26
1447085|NCT00851084|4773081|P2|Overall Study|Randomized but not treated|0
1447086|NCT00851084|4773082|P1|Overall Study|Randomized but not treated|1
1447087|NCT00850759|4773142|P4|Overall Study|Lost to Follow-up|3
1447088|NCT00850759|4773143|P3|Overall Study|Lost to Follow-up|5
1447089|NCT00850759|4773144|P2|Overall Study|Lost to Follow-up|5
1447090|NCT00850759|4773145|P1|Overall Study|Lost to Follow-up|7
1447091|NCT00850564|4773226|P1|Overall Study|Withdrawal by Subject|2
1447092|NCT00850538|4773231|P1|Overall Study|Protocol Violation|2
1447093|NCT00850538|4773231|P1|Overall Study|radiology error|2
1447094|NCT00850538|4773231|P1|Overall Study|Withdrawal by Subject|3
1447095|NCT00850538|4773231|P1|Overall Study|specimen unusable|7
1447096|NCT00850538|4773231|P1|Overall Study|specimen missed due to scheduling error|14
1447097|NCT00850538|4773231|P1|Overall Study|unable/unwilling to complete MRI|13
1447098|NCT00850499|4773237|P2|Overall Study|Lack of Efficacy|1
1447099|NCT00850499|4773238|P1|Overall Study|Lack of Efficacy|0
1447100|NCT00850499|4773237|P2|Overall Study|Adverse Event|1
1447101|NCT00850499|4773238|P1|Overall Study|Adverse Event|3
1447102|NCT00850460|4773252|P2|Overall Study|Lost to Follow-up|4
1447103|NCT00850460|4773253|P1|Overall Study|Lost to Follow-up|4
1447104|NCT00850395|4773267|P1|Overall Study|Other|5
1447105|NCT00850395|4773267|P1|Overall Study|Insufficient clinical response|3
1447106|NCT00850395|4773267|P1|Overall Study|Adverse Event|1
1447107|NCT00850395|4773267|P1|Overall Study|Death|1
1447108|NCT00850343|4773287|P4|Overall Study|Physician Decision|1
1447109|NCT00850343|4773288|P3|Overall Study|Physician Decision|1
1447110|NCT00850343|4773289|P2|Overall Study|Physician Decision|1
1447111|NCT00850343|4773290|P1|Overall Study|Physician Decision|2
1447112|NCT00850343|4773287|P4|Overall Study|Non-compliance with Study Procedures|1
1447113|NCT00850343|4773288|P3|Overall Study|Non-compliance with Study Procedures|1
1447114|NCT00850343|4773289|P2|Overall Study|Non-compliance with Study Procedures|0
1447115|NCT00850343|4773290|P1|Overall Study|Non-compliance with Study Procedures|1
1447116|NCT00850343|4773287|P4|Overall Study|Lack of Efficacy|2
1447117|NCT00850343|4773288|P3|Overall Study|Lack of Efficacy|3
1447118|NCT00850343|4773289|P2|Overall Study|Lack of Efficacy|0
1447119|NCT00850343|4773290|P1|Overall Study|Lack of Efficacy|17
1447120|NCT00850343|4773287|P4|Overall Study|Pregnancy|1
1447121|NCT00850343|4773288|P3|Overall Study|Pregnancy|0
1447122|NCT00850343|4773289|P2|Overall Study|Pregnancy|0
1447123|NCT00850343|4773290|P1|Overall Study|Pregnancy|0
1447124|NCT00850343|4773287|P4|Overall Study|Adverse Event|6
1447125|NCT00850343|4773288|P3|Overall Study|Adverse Event|6
1447126|NCT00850343|4773289|P2|Overall Study|Adverse Event|2
1447127|NCT00850343|4773290|P1|Overall Study|Adverse Event|15
1447128|NCT00850343|4773287|P4|Overall Study|Withdrawal by Subject|2
1447129|NCT00850343|4773288|P3|Overall Study|Withdrawal by Subject|3
1447130|NCT00850343|4773289|P2|Overall Study|Withdrawal by Subject|0
1447131|NCT00850343|4773290|P1|Overall Study|Withdrawal by Subject|11
1447132|NCT00850200|4773320|P1|Overall Study|Withdrawal by Subject|1
1447133|NCT00850174|4773328|P2|Second Intervention|Withdrawal by Subject|0
1447134|NCT00850174|4773329|P1|Second Intervention|Withdrawal by Subject|1
1447135|NCT00850174|4773328|P2|Washout: One Week|Withdrawal by Subject|2
1447136|NCT00850174|4773329|P1|Washout: One Week|Withdrawal by Subject|0
1447137|NCT00850135|4773343|P1|Overall Study|Physician Decision|1
1447138|NCT00850070|4773362|P2|Overall Study|Adverse Event|0
1447139|NCT00850070|4773363|P1|Overall Study|Adverse Event|2
1447140|NCT00850070|4773362|P2|Overall Study|Lack of Efficacy|1
1447141|NCT00850070|4773363|P1|Overall Study|Lack of Efficacy|1
1447142|NCT00849940|4773392|P1|Overall Study|Physician Decision|4
1447143|NCT00849901|4773403|P3|Extension Phase|Lack of Efficacy|1
1447144|NCT00849901|4773404|P2|Extension Phase|Lack of Efficacy|4
1447145|NCT00849901|4773405|P1|Extension Phase|Lack of Efficacy|2
1447146|NCT00849901|4773403|P3|Extension Phase|Physician Decision|0
1447147|NCT00849901|4773404|P2|Extension Phase|Physician Decision|2
1447148|NCT00849901|4773405|P1|Extension Phase|Physician Decision|1
1447149|NCT00849901|4773403|P3|Extension Phase|Parent or Caregiver Decision|4
1447150|NCT00849901|4773404|P2|Extension Phase|Parent or Caregiver Decision|4
1447151|NCT00849901|4773405|P1|Extension Phase|Parent or Caregiver Decision|10
1447152|NCT00849901|4773403|P3|Extension Phase|Withdrawal by Subject|3
1447153|NCT00849901|4773404|P2|Extension Phase|Withdrawal by Subject|6
1447154|NCT00849901|4773405|P1|Extension Phase|Withdrawal by Subject|7
1447155|NCT00849901|4773403|P3|Extension Phase|Protocol Violation|4
1447156|NCT00849901|4773404|P2|Extension Phase|Protocol Violation|2
1447157|NCT00849901|4773405|P1|Extension Phase|Protocol Violation|2
1447158|NCT00849901|4773403|P3|Extension Phase|Lost to Follow-up|1
1447159|NCT00849901|4773404|P2|Extension Phase|Lost to Follow-up|0
1447160|NCT00849901|4773405|P1|Extension Phase|Lost to Follow-up|3
1447161|NCT00849901|4773403|P3|Extension Phase|Adverse Event|4
1447162|NCT00849901|4773404|P2|Extension Phase|Adverse Event|8
1447163|NCT00849901|4773405|P1|Extension Phase|Adverse Event|2
1447164|NCT00849901|4773403|P3|Acute Treatment Phase|Lack of Efficacy|2
1447165|NCT00849901|4773404|P2|Acute Treatment Phase|Lack of Efficacy|3
1447166|NCT00849901|4773405|P1|Acute Treatment Phase|Lack of Efficacy|2
1447167|NCT00849901|4773403|P3|Acute Treatment Phase|Sponsor Decision|0
1447168|NCT00849901|4773404|P2|Acute Treatment Phase|Sponsor Decision|0
1447169|NCT00849901|4773405|P1|Acute Treatment Phase|Sponsor Decision|1
1447170|NCT00849901|4773403|P3|Acute Treatment Phase|Physician Decision|1
1447171|NCT00849901|4773404|P2|Acute Treatment Phase|Physician Decision|1
1447172|NCT00849901|4773405|P1|Acute Treatment Phase|Physician Decision|1
1447173|NCT00849901|4773403|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
1447174|NCT00849901|4773404|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
1447175|NCT00849901|4773405|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
1447176|NCT00849901|4773403|P3|Acute Treatment Phase|Withdrawal by Subject|4
1447177|NCT00849901|4773404|P2|Acute Treatment Phase|Withdrawal by Subject|10
1447178|NCT00849901|4773405|P1|Acute Treatment Phase|Withdrawal by Subject|4
1447179|NCT00849901|4773403|P3|Acute Treatment Phase|Protocol Violation|1
1447180|NCT00849901|4773404|P2|Acute Treatment Phase|Protocol Violation|2
1447181|NCT00849901|4773405|P1|Acute Treatment Phase|Protocol Violation|0
1447182|NCT00849901|4773403|P3|Acute Treatment Phase|Lost to Follow-up|1
1447183|NCT00849901|4773404|P2|Acute Treatment Phase|Lost to Follow-up|4
1447184|NCT00849901|4773405|P1|Acute Treatment Phase|Lost to Follow-up|2
1447185|NCT00849901|4773403|P3|Acute Treatment Phase|Adverse Event|3
1447186|NCT00849901|4773404|P2|Acute Treatment Phase|Adverse Event|1
1447187|NCT00849901|4773405|P1|Acute Treatment Phase|Adverse Event|9
1447188|NCT00849875|4773452|P1|Overall Study|Lost to Follow-up|2
1447189|NCT00849875|4773452|P1|Overall Study|Others|6
1447190|NCT00849875|4773452|P1|Overall Study|Ongoing (unknown completion status)|11
1447191|NCT00849875|4773452|P1|Overall Study|Death|28
1447192|NCT00849797|4773549|P2|Washout: One Week|Withdrawal by Subject|2
1447193|NCT00849797|4773550|P1|Washout: One Week|Withdrawal by Subject|0
1447194|NCT00849797|4773549|P2|First Intervention|Adverse Event|1
1447195|NCT00849797|4773550|P1|First Intervention|Adverse Event|0
1447196|NCT00849797|4773549|P2|First Intervention|bad veins|0
1447197|NCT00849797|4773550|P1|First Intervention|bad veins|1
1447198|NCT00849693|4773568|P4|Extension Phase|Lack of Efficacy|1
1447199|NCT00849693|4773569|P3|Extension Phase|Lack of Efficacy|2
1447200|NCT00849693|4773570|P2|Extension Phase|Lack of Efficacy|2
1447201|NCT00849693|4773571|P1|Extension Phase|Lack of Efficacy|2
1447202|NCT00849693|4773568|P4|Extension Phase|Sponsor decision|1
1447203|NCT00849693|4773569|P3|Extension Phase|Sponsor decision|0
1447204|NCT00849693|4773570|P2|Extension Phase|Sponsor decision|0
1447205|NCT00849693|4773571|P1|Extension Phase|Sponsor decision|1
1447206|NCT00849693|4773568|P4|Extension Phase|Physician Decision|0
1447207|NCT00849693|4773569|P3|Extension Phase|Physician Decision|2
1447208|NCT00849693|4773570|P2|Extension Phase|Physician Decision|1
1447209|NCT00849693|4773571|P1|Extension Phase|Physician Decision|1
1447210|NCT00849693|4773568|P4|Extension Phase|Parent or caregiver decision|5
1447211|NCT00849693|4773569|P3|Extension Phase|Parent or caregiver decision|10
1447212|NCT00849693|4773570|P2|Extension Phase|Parent or caregiver decision|4
1447213|NCT00849693|4773571|P1|Extension Phase|Parent or caregiver decision|9
1447214|NCT00849693|4773568|P4|Extension Phase|Withdrawal by Subject|15
1447215|NCT00849693|4773569|P3|Extension Phase|Withdrawal by Subject|10
1447216|NCT00849693|4773570|P2|Extension Phase|Withdrawal by Subject|9
1447217|NCT00849693|4773571|P1|Extension Phase|Withdrawal by Subject|6
1447218|NCT00849693|4773568|P4|Extension Phase|Protocol Violation|3
1447219|NCT00849693|4773569|P3|Extension Phase|Protocol Violation|2
1447220|NCT00849693|4773570|P2|Extension Phase|Protocol Violation|3
1447221|NCT00849693|4773571|P1|Extension Phase|Protocol Violation|0
1447222|NCT00849693|4773568|P4|Extension Phase|Lost to Follow-up|6
1447223|NCT00849693|4773569|P3|Extension Phase|Lost to Follow-up|6
1447224|NCT00849693|4773570|P2|Extension Phase|Lost to Follow-up|5
1447225|NCT00849693|4773571|P1|Extension Phase|Lost to Follow-up|7
1447226|NCT00849693|4773568|P4|Extension Phase|Adverse Event|7
1447227|NCT00849693|4773569|P3|Extension Phase|Adverse Event|3
1447228|NCT00849693|4773570|P2|Extension Phase|Adverse Event|6
1447229|NCT00849693|4773571|P1|Extension Phase|Adverse Event|4
1447230|NCT00849693|4773568|P4|Acute Treatment Phase|Lack of Efficacy|2
1447231|NCT00849693|4773569|P3|Acute Treatment Phase|Lack of Efficacy|1
1447232|NCT00849693|4773570|P2|Acute Treatment Phase|Lack of Efficacy|3
1447233|NCT00849693|4773571|P1|Acute Treatment Phase|Lack of Efficacy|1
1447234|NCT00849693|4773568|P4|Acute Treatment Phase|Sponsor decision|0
1447235|NCT00849693|4773569|P3|Acute Treatment Phase|Sponsor decision|1
1447236|NCT00849693|4773570|P2|Acute Treatment Phase|Sponsor decision|0
1447237|NCT00849693|4773571|P1|Acute Treatment Phase|Sponsor decision|0
1447238|NCT00849693|4773568|P4|Acute Treatment Phase|Physician Decision|1
1447239|NCT00849693|4773569|P3|Acute Treatment Phase|Physician Decision|2
1447240|NCT00849693|4773570|P2|Acute Treatment Phase|Physician Decision|1
1447241|NCT00849693|4773571|P1|Acute Treatment Phase|Physician Decision|2
1447242|NCT00849693|4773568|P4|Acute Treatment Phase|Parent or caregiver decision|7
1447243|NCT00849693|4773569|P3|Acute Treatment Phase|Parent or caregiver decision|7
1447244|NCT00849693|4773570|P2|Acute Treatment Phase|Parent or caregiver decision|6
1447245|NCT00849693|4773571|P1|Acute Treatment Phase|Parent or caregiver decision|7
1447246|NCT00849693|4773568|P4|Acute Treatment Phase|Withdrawal by Subject|8
1447247|NCT00849693|4773569|P3|Acute Treatment Phase|Withdrawal by Subject|3
1447248|NCT00849693|4773570|P2|Acute Treatment Phase|Withdrawal by Subject|5
1447249|NCT00849693|4773571|P1|Acute Treatment Phase|Withdrawal by Subject|5
1447250|NCT00849693|4773568|P4|Acute Treatment Phase|Protocol Violation|6
1447251|NCT00849693|4773569|P3|Acute Treatment Phase|Protocol Violation|2
1447252|NCT00849693|4773570|P2|Acute Treatment Phase|Protocol Violation|5
1447253|NCT00849693|4773571|P1|Acute Treatment Phase|Protocol Violation|1
1447254|NCT00849693|4773568|P4|Acute Treatment Phase|Lost to Follow-up|9
1447255|NCT00849693|4773569|P3|Acute Treatment Phase|Lost to Follow-up|11
1447256|NCT00849693|4773570|P2|Acute Treatment Phase|Lost to Follow-up|8
1447257|NCT00849693|4773571|P1|Acute Treatment Phase|Lost to Follow-up|5
1447258|NCT00849693|4773568|P4|Acute Treatment Phase|Adverse Event|4
1447259|NCT00849693|4773569|P3|Acute Treatment Phase|Adverse Event|6
1447260|NCT00849693|4773570|P2|Acute Treatment Phase|Adverse Event|7
1447261|NCT00849693|4773571|P1|Acute Treatment Phase|Adverse Event|12
1447262|NCT00849680|4773638|P8|Overall Study|Subject unable to comply with protocol|0
1447263|NCT00849680|4773639|P7|Overall Study|Subject unable to comply with protocol|0
1447264|NCT00849680|4773640|P6|Overall Study|Subject unable to comply with protocol|0
1447265|NCT00849680|4773641|P5|Overall Study|Subject unable to comply with protocol|0
1447266|NCT00849680|4773642|P4|Overall Study|Subject unable to comply with protocol|0
1447267|NCT00849680|4773643|P3|Overall Study|Subject unable to comply with protocol|0
1447268|NCT00849680|4773644|P2|Overall Study|Subject unable to comply with protocol|0
1447269|NCT00849680|4773645|P1|Overall Study|Subject unable to comply with protocol|1
1447270|NCT00849680|4773638|P8|Overall Study|Withdrawal by Subject|1
1447271|NCT00849680|4773639|P7|Overall Study|Withdrawal by Subject|1
1447272|NCT00849680|4773640|P6|Overall Study|Withdrawal by Subject|2
1447273|NCT00849680|4773641|P5|Overall Study|Withdrawal by Subject|2
1447274|NCT00849680|4773642|P4|Overall Study|Withdrawal by Subject|2
1447275|NCT00849680|4773643|P3|Overall Study|Withdrawal by Subject|0
1447276|NCT00849680|4773644|P2|Overall Study|Withdrawal by Subject|0
1447277|NCT00849680|4773645|P1|Overall Study|Withdrawal by Subject|2
1447278|NCT00849680|4773638|P8|Overall Study|Subject moved|2
1447279|NCT00849680|4773639|P7|Overall Study|Subject moved|2
1447280|NCT00849680|4773640|P6|Overall Study|Subject moved|2
1447281|NCT00849680|4773641|P5|Overall Study|Subject moved|0
1447282|NCT00849680|4773642|P4|Overall Study|Subject moved|1
1447283|NCT00849680|4773643|P3|Overall Study|Subject moved|3
1447284|NCT00849680|4773644|P2|Overall Study|Subject moved|0
1447285|NCT00849680|4773645|P1|Overall Study|Subject moved|1
1447286|NCT00849680|4773638|P8|Overall Study|Lost to Follow-up|5
1447287|NCT00849680|4773639|P7|Overall Study|Lost to Follow-up|12
1447288|NCT00849680|4773640|P6|Overall Study|Lost to Follow-up|11
1447289|NCT00849680|4773641|P5|Overall Study|Lost to Follow-up|8
1447290|NCT00849680|4773642|P4|Overall Study|Lost to Follow-up|11
1447291|NCT00849680|4773643|P3|Overall Study|Lost to Follow-up|12
1447292|NCT00849680|4773644|P2|Overall Study|Lost to Follow-up|3
1447293|NCT00849680|4773645|P1|Overall Study|Lost to Follow-up|7
1447294|NCT00849680|4773638|P8|Overall Study|Adverse Event|0
1447295|NCT00849680|4773639|P7|Overall Study|Adverse Event|2
1447296|NCT00849680|4773640|P6|Overall Study|Adverse Event|0
1447297|NCT00849680|4773641|P5|Overall Study|Adverse Event|0
1447298|NCT00849680|4773642|P4|Overall Study|Adverse Event|0
1447299|NCT00849680|4773643|P3|Overall Study|Adverse Event|0
1447300|NCT00849680|4773644|P2|Overall Study|Adverse Event|0
1447301|NCT00849680|4773645|P1|Overall Study|Adverse Event|0
1447302|NCT00849524|4773687|P1|Overall Study|Lack of Efficacy|3
1447303|NCT00849472|4773704|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
1447304|NCT00849472|4773704|P1|Pazopanib Postsurgery Treatment|Moved|1
1447305|NCT00849472|4773704|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
1447306|NCT00849472|4773704|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
1447307|NCT00849472|4773704|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
1447308|NCT00849472|4773704|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
1447309|NCT00849472|4773704|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
1447310|NCT00849472|4773704|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
1447311|NCT00849472|4773704|P1|Weekly Paclitaxel|Physician Decision|3
1447312|NCT00849472|4773704|P1|Weekly Paclitaxel|Withdrawal by Subject|1
1447313|NCT00849472|4773704|P1|Weekly Paclitaxel|Adverse Event|11
1447314|NCT00849472|4773704|P1|Weekly Paclitaxel|Disease Progression|1
1447315|NCT00849472|4773704|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
1447316|NCT00849472|4773704|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
1447317|NCT00849472|4773704|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
1447318|NCT00849472|4773704|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
1447319|NCT00849472|4773704|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
1447320|NCT00849381|4773718|P1|Overall Study|Other|4
1447321|NCT00849381|4773718|P1|Overall Study|Withdrawal by Subject|6
1447322|NCT00849381|4773718|P1|Overall Study|Protocol Violation|5
1447323|NCT00849381|4773718|P1|Overall Study|Lost to Follow-up|129
1447324|NCT00849381|4773718|P1|Overall Study|Adverse Event|1
1447325|NCT00849290|4773724|P1|Overall Study|Disease Progression|20
1447326|NCT00849290|4773724|P1|Overall Study|Protocol Violation|5
1447327|NCT00849290|4773724|P1|Overall Study|Lost to Follow-up|2
1447328|NCT00849290|4773724|P1|Overall Study|Withdrawal by Subject|11
1447329|NCT00849290|4773724|P1|Overall Study|Death|14
1447330|NCT00849290|4773724|P1|Overall Study|Adverse Event|3
1447331|NCT00849212|4773735|P1|Overall Study|Miscellaneous|1
1447332|NCT00849212|4773735|P1|Overall Study|Adverse Event|2
1447333|NCT00849212|4773735|P1|Overall Study|Withdrawal by Subject|3
1447334|NCT00849212|4773735|P1|Overall Study|Lack of Efficacy|1
1447335|NCT00849186|4773740|P1|Overall Study|Other|1
1447336|NCT00849186|4773740|P1|Overall Study|not treated|6
1447337|NCT00849186|4773740|P1|Overall Study|Withdrawal by Subject|1
1447338|NCT00849186|4773740|P1|Overall Study|Adverse Event|2
1447339|NCT00849147|4773746|P1|Overall Study|Disease Relapse/Progression|2
1447340|NCT00849147|4773746|P1|Overall Study|Protocol Violation|2
1447341|NCT00849147|4773746|P1|Overall Study|Withdrawal by Subject|1
1447342|NCT00849108|4773779|P2|Cohort 2 Efficacy|Not specified|9
1447343|NCT00849108|4773780|P1|Cohort 2 Efficacy|Not specified|0
1447344|NCT00849108|4773779|P2|Cohort 2 Efficacy|Adverse Event|1
1447345|NCT00849108|4773780|P1|Cohort 2 Efficacy|Adverse Event|0
1447346|NCT00849108|4773779|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
1447347|NCT00849108|4773780|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
1447348|NCT00849056|4773790|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
1447349|NCT00849056|4773791|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
1447350|NCT00849056|4773790|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
1447351|NCT00849056|4773791|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
1447352|NCT00849056|4773790|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
1447353|NCT00849056|4773791|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
1447354|NCT00849056|4773790|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
1447355|NCT00849056|4773791|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
1447356|NCT00849056|4773790|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
1447357|NCT00849056|4773791|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
1447358|NCT00849056|4773790|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
1447359|NCT00849056|4773791|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
1447360|NCT00849056|4773790|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
1447361|NCT00849056|4773791|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
1447362|NCT00849056|4773790|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
1447363|NCT00849056|4773791|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
1447364|NCT00849056|4773790|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
1447365|NCT00849056|4773791|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
1447366|NCT00849056|4773790|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
1447367|NCT00849056|4773791|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
1447368|NCT00849056|4773790|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
1447369|NCT00849056|4773791|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
1447370|NCT00849056|4773790|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
1447371|NCT00849056|4773791|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
1447372|NCT00849056|4773790|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
1447373|NCT00849056|4773791|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
1447374|NCT00849056|4773790|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
1447375|NCT00849056|4773791|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
1447376|NCT00849056|4773790|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
1447377|NCT00849056|4773791|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
1447378|NCT00849056|4773790|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
1447379|NCT00849056|4773791|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
1447380|NCT00849017|4773816|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
1447381|NCT00849017|4773817|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
1447382|NCT00849017|4773818|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
1447383|NCT00849017|4773816|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
1447384|NCT00849017|4773817|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
1447385|NCT00849017|4773818|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
1447386|NCT00849017|4773816|P3|Follow-up Period (8 Weeks)|Physician Decision|1
1447387|NCT00849017|4773817|P2|Follow-up Period (8 Weeks)|Physician Decision|1
1447388|NCT00849017|4773818|P1|Follow-up Period (8 Weeks)|Physician Decision|0
1447389|NCT00849017|4773816|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
1447390|NCT00849017|4773817|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
1447391|NCT00849017|4773818|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
1447392|NCT00849017|4773816|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
1447393|NCT00849017|4773817|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
1447394|NCT00849017|4773818|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
1447395|NCT00849017|4773816|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
1447396|NCT00849017|4773817|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
1447397|NCT00849017|4773818|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
1447398|NCT00849017|4773816|P3|Follow-up Period (8 Weeks)|Noncompliance|0
1447399|NCT00849017|4773817|P2|Follow-up Period (8 Weeks)|Noncompliance|1
1447400|NCT00849017|4773818|P1|Follow-up Period (8 Weeks)|Noncompliance|2
1447401|NCT00849017|4773816|P3|Follow-up Period (8 Weeks)|Adverse Event|0
1447402|NCT00849017|4773817|P2|Follow-up Period (8 Weeks)|Adverse Event|0
1447403|NCT00849017|4773818|P1|Follow-up Period (8 Weeks)|Adverse Event|1
1447404|NCT00849017|4773816|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
1447405|NCT00849017|4773817|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
1447406|NCT00849017|4773818|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
1447407|NCT00849017|4773816|P3|Treatment Period (156 Weeks)|Pregnancy|1
1447408|NCT00849017|4773817|P2|Treatment Period (156 Weeks)|Pregnancy|0
1447409|NCT00849017|4773818|P1|Treatment Period (156 Weeks)|Pregnancy|1
1447410|NCT00849017|4773816|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
1447411|NCT00849017|4773817|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
1447412|NCT00849017|4773818|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
1447413|NCT00849017|4773816|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
1447414|NCT00849017|4773817|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
1447415|NCT00849017|4773818|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
1447416|NCT00849017|4773816|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
1447417|NCT00849017|4773817|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
1447418|NCT00849017|4773818|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
1447419|NCT00849017|4773816|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
1447420|NCT00849017|4773817|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
1447421|NCT00849017|4773818|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
1447422|NCT00849017|4773816|P3|Treatment Period (156 Weeks)|Physician Decision|1
1447423|NCT00849017|4773817|P2|Treatment Period (156 Weeks)|Physician Decision|2
1447424|NCT00849017|4773818|P1|Treatment Period (156 Weeks)|Physician Decision|0
1447425|NCT00849017|4773816|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
1447426|NCT00849017|4773817|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
1447427|NCT00849017|4773818|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
1447428|NCT00849017|4773816|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
1447429|NCT00849017|4773817|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
1447430|NCT00849017|4773818|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
1447431|NCT00849017|4773816|P3|Treatment Period (156 Weeks)|Noncompliance|4
1447432|NCT00849017|4773817|P2|Treatment Period (156 Weeks)|Noncompliance|3
1447433|NCT00849017|4773818|P1|Treatment Period (156 Weeks)|Noncompliance|3
1447434|NCT00849017|4773816|P3|Treatment Period (156 Weeks)|Adverse Event|15
1447435|NCT00849017|4773817|P2|Treatment Period (156 Weeks)|Adverse Event|6
1447436|NCT00849017|4773818|P1|Treatment Period (156 Weeks)|Adverse Event|5
1447437|NCT00848965|4773861|P1|Overall Study|Withdrawal by Subject|1
1447438|NCT00848965|4773861|P1|Overall Study|Adverse Event|1
1447439|NCT00848926|4773903|P1|Follow-up Period|Not specified|2
1447440|NCT00848926|4773903|P1|Follow-up Period|Withdrawal by Subject|3
1447441|NCT00848926|4773903|P1|Follow-up Period|Lost to Follow-up|7
1447442|NCT00848926|4773903|P1|Treatment Period|Withdrawal by Subject|7
1447443|NCT00848926|4773903|P1|Treatment Period|Physician Decision|12
1447444|NCT00848926|4773903|P1|Treatment Period|Adverse Event|20
1447445|NCT00848926|4773903|P1|Treatment Period|Progressive disease|45
1447446|NCT00848549|4773942|P2|E2090-E044-314 (Extension Study)|Not Specified|6
1447447|NCT00848549|4773943|P1|E2090-E044-314 (Extension Study)|Not Specified|5
1447448|NCT00848549|4773942|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
1447449|NCT00848549|4773943|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
1447450|NCT00848549|4773942|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
1447451|NCT00848549|4773943|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
1447452|NCT00848549|4773942|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
1447453|NCT00848549|4773943|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
1447454|NCT00848549|4773942|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
1447455|NCT00848549|4773943|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
1447456|NCT00848549|4773942|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
1447457|NCT00848549|4773943|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
1447458|NCT00848549|4773942|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
1447459|NCT00848549|4773943|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
1447460|NCT00848549|4773942|P2|E2090-E044-310 (Base Study) Disposition|Not Specified|3
1447461|NCT00848549|4773943|P1|E2090-E044-310 (Base Study) Disposition|Not Specified|4
1447462|NCT00848549|4773942|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
1447463|NCT00848549|4773943|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
1447464|NCT00848549|4773942|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
1447465|NCT00848549|4773943|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
1447466|NCT00848549|4773942|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
1447467|NCT00848549|4773943|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
1447468|NCT00848549|4773942|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
1447469|NCT00848549|4773943|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
1447470|NCT00848549|4773942|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
1447471|NCT00848549|4773943|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
1447472|NCT00848549|4773942|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
1447473|NCT00848549|4773943|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
1447474|NCT00848536|4773961|P2|Overall Study|Patient Moved|2
1447475|NCT00848536|4773962|P1|Overall Study|Patient Moved|0
1447476|NCT00848536|4773961|P2|Overall Study|Inadequate Control of IOP|1
1447477|NCT00848536|4773962|P1|Overall Study|Inadequate Control of IOP|1
1447478|NCT00848536|4773961|P2|Overall Study|Noncompliance|0
1447479|NCT00848536|4773962|P1|Overall Study|Noncompliance|1
1447480|NCT00848536|4773961|P2|Overall Study|Protocol Violation|1
1447481|NCT00848536|4773962|P1|Overall Study|Protocol Violation|0
1447482|NCT00848536|4773961|P2|Overall Study|Withdrawal by Subject|1
1447483|NCT00848536|4773962|P1|Overall Study|Withdrawal by Subject|0
1447484|NCT00848536|4773961|P2|Overall Study|Adverse Event|2
1447485|NCT00848536|4773962|P1|Overall Study|Adverse Event|2
1447486|NCT00848497|4774027|P2|Overall Study|Withdrawal by Subject|1
1447487|NCT00848497|4774028|P1|Overall Study|Withdrawal by Subject|0
1447488|NCT00848497|4774027|P2|Overall Study|Screen failure|0
1447489|NCT00848497|4774028|P1|Overall Study|Screen failure|2
1447490|NCT00848484|4774042|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
1447491|NCT00848484|4774043|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
1447492|NCT00848484|4774042|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
1447493|NCT00848484|4774043|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
1447494|NCT00848484|4774042|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
1447495|NCT00848484|4774043|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
1447496|NCT00848484|4774042|P2|First Intervention (Treatment Period 1)|Physician Decision|1
1447497|NCT00848484|4774043|P1|First Intervention (Treatment Period 1)|Physician Decision|0
1447498|NCT00848484|4774042|P2|First Intervention (Treatment Period 1)|Adverse Event|1
1447499|NCT00848484|4774043|P1|First Intervention (Treatment Period 1)|Adverse Event|2
1447500|NCT00848393|4774062|P3|Overall Study|surgical complications unrelated to stud|2
1447501|NCT00848393|4774063|P2|Overall Study|surgical complications unrelated to stud|0
1447502|NCT00848393|4774064|P1|Overall Study|surgical complications unrelated to stud|0
1447503|NCT00848393|4774062|P3|Overall Study|Protocol Violation|1
1447504|NCT00848393|4774063|P2|Overall Study|Protocol Violation|0
1447505|NCT00848393|4774064|P1|Overall Study|Protocol Violation|0
1447506|NCT00848354|4774103|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
1447507|NCT00848354|4774104|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
1447508|NCT00848354|4774103|P2|Phase 2 Year 2|Subject Request|1
1447509|NCT00848354|4774104|P1|Phase 2 Year 2|Subject Request|1
1447510|NCT00848354|4774103|P2|Phase 2 Year 2|Protocol Violation|1
1447511|NCT00848354|4774104|P1|Phase 2 Year 2|Protocol Violation|1
1447512|NCT00848354|4774103|P2|Phase 2 Year 2|Unspecified Reason|0
1447513|NCT00848354|4774104|P1|Phase 2 Year 2|Unspecified Reason|1
1447514|NCT00848354|4774103|P2|Phase 2 Year 2|Lost to Follow-up|3
1447515|NCT00848354|4774104|P1|Phase 2 Year 2|Lost to Follow-up|1
1447516|NCT00848354|4774103|P2|Phase 2 Year 2|Failed to return|0
1447517|NCT00848354|4774104|P1|Phase 2 Year 2|Failed to return|3
1447518|NCT00848354|4774103|P2|Phase 2 Year 2|Death|0
1447519|NCT00848354|4774104|P1|Phase 2 Year 2|Death|2
1447520|NCT00848354|4774103|P2|Phase 2 Year 2|Adverse Event|2
1447521|NCT00848354|4774104|P1|Phase 2 Year 2|Adverse Event|12
1447522|NCT00848354|4774103|P2|Phase 2 Year 1|Subject Request|2
1447523|NCT00848354|4774104|P1|Phase 2 Year 1|Subject Request|1
1447524|NCT00848354|4774103|P2|Phase 2 Year 1|Protocol Violation|1
1447525|NCT00848354|4774104|P1|Phase 2 Year 1|Protocol Violation|4
1447526|NCT00848354|4774103|P2|Phase 2 Year 1|Unspecified Reason|0
1447527|NCT00848354|4774104|P1|Phase 2 Year 1|Unspecified Reason|3
1447528|NCT00848354|4774103|P2|Phase 2 Year 1|Lost to Follow-up|0
1447529|NCT00848354|4774104|P1|Phase 2 Year 1|Lost to Follow-up|1
1447530|NCT00848354|4774103|P2|Phase 2 Year 1|Failed to Return|1
1447531|NCT00848354|4774104|P1|Phase 2 Year 1|Failed to Return|1
1447532|NCT00848354|4774103|P2|Phase 2 Year 1|Death|0
1447533|NCT00848354|4774104|P1|Phase 2 Year 1|Death|1
1447534|NCT00848354|4774103|P2|Phase 2 Year 1|Adverse Event|2
1447535|NCT00848354|4774104|P1|Phase 2 Year 1|Adverse Event|7
1447536|NCT00848354|4774103|P2|Phase 1|Lack of Efficacy|1
1447537|NCT00848354|4774104|P1|Phase 1|Lack of Efficacy|0
1447538|NCT00848354|4774103|P2|Phase 1|Withdrawal by Subject|4
1447539|NCT00848354|4774104|P1|Phase 1|Withdrawal by Subject|2
1447540|NCT00848354|4774103|P2|Phase 1|Protocol Violation|1
1447541|NCT00848354|4774104|P1|Phase 1|Protocol Violation|1
1447542|NCT00848354|4774103|P2|Phase 1|Unspecified Reason|1
1447543|NCT00848354|4774104|P1|Phase 1|Unspecified Reason|1
1447544|NCT00848354|4774103|P2|Phase 1|Lost to Follow-up|1
1447545|NCT00848354|4774104|P1|Phase 1|Lost to Follow-up|1
1447546|NCT00848354|4774103|P2|Phase 1|Failed to return|1
1447547|NCT00848354|4774104|P1|Phase 1|Failed to return|0
1447548|NCT00848354|4774103|P2|Phase 1|Discontinuation of study by sponsor|1
1447549|NCT00848354|4774104|P1|Phase 1|Discontinuation of study by sponsor|2
1447550|NCT00848354|4774103|P2|Phase 1|Adverse Event|4
1447551|NCT00848354|4774104|P1|Phase 1|Adverse Event|5
1447552|NCT00848250|4774256|P2|Overall Study|surgery was completed without cardiopulm|1
1447553|NCT00848250|4774257|P1|Overall Study|surgery was completed without cardiopulm|0
1447554|NCT00848211|4774288|P4|Overall Study|Adverse Event|0
1447555|NCT00848211|4774289|P3|Overall Study|Adverse Event|0
1447556|NCT00848211|4774290|P2|Overall Study|Adverse Event|0
1447557|NCT00848211|4774291|P1|Overall Study|Adverse Event|0
1447558|NCT00848211|4774288|P4|Overall Study|Protocol Violation|0
1447559|NCT00848211|4774289|P3|Overall Study|Protocol Violation|1
1447560|NCT00848211|4774290|P2|Overall Study|Protocol Violation|1
1447561|NCT00848211|4774291|P1|Overall Study|Protocol Violation|0
1447562|NCT00848198|4774309|P1|Overall Study|Incomplete Case Report Forms|15
1447563|NCT00848120|4774374|P1|Overall Study|Adverse Event|1
1447564|NCT00848107|4774386|P1|Overall Study|Pregnancy|1
1447565|NCT00848107|4774386|P1|Overall Study|Death|1
1447566|NCT00848107|4774386|P1|Overall Study|Adverse Event|9
1447567|NCT00848107|4774386|P1|Overall Study|Withdrawal by Subject|8
1447568|NCT00848107|4774386|P1|Overall Study|Lost to Follow-up|2
1447569|NCT00848081|4774396|P2|Overall Study|Withdrawal by Subject|3
1447570|NCT00848081|4774397|P1|Overall Study|Withdrawal by Subject|5
1447571|NCT00848081|4774396|P2|Overall Study|Physician Decision|3
1447572|NCT00848081|4774397|P1|Overall Study|Physician Decision|0
1447573|NCT00848081|4774396|P2|Overall Study|Lost to Follow-up|0
1447574|NCT00848081|4774397|P1|Overall Study|Lost to Follow-up|1
1447575|NCT00848081|4774396|P2|Overall Study|Protocol Violation|5
1447576|NCT00848081|4774397|P1|Overall Study|Protocol Violation|8
1447577|NCT00848081|4774396|P2|Overall Study|Adverse Event|7
1447578|NCT00848081|4774397|P1|Overall Study|Adverse Event|6
1447579|NCT00848042|4774414|P3|Overall Study|Other Therapy|0
1447580|NCT00848042|4774415|P2|Overall Study|Other Therapy|0
1447581|NCT00848042|4774416|P1|Overall Study|Other Therapy|3
1447582|NCT00848042|4774414|P3|Overall Study|Death|0
1447583|NCT00848042|4774415|P2|Overall Study|Death|2
1447584|NCT00848042|4774416|P1|Overall Study|Death|1
1447585|NCT00847912|4774435|P2|Overall Study|Withdrawal by Subject|6
1447586|NCT00847912|4774436|P1|Overall Study|Withdrawal by Subject|3
1447587|NCT00847912|4774435|P2|Overall Study|Protocol Violation|7
1447588|NCT00847912|4774436|P1|Overall Study|Protocol Violation|6
1447589|NCT00847886|4774446|P2|Overall Study|Adverse Event|1
1447590|NCT00847886|4774447|P1|Overall Study|Adverse Event|0
1447591|NCT00847808|4774473|P1|Overall Study|Participant Took Excluded Medication|1
1447592|NCT00847808|4774473|P1|Overall Study|Participant Reported Lack of Efficacy|1
1447593|NCT00847808|4774473|P1|Overall Study|Withdrawal by Subject|4
1447594|NCT00847808|4774473|P1|Overall Study|Lost to Follow-up|1
1447595|NCT00847808|4774473|P1|Overall Study|Protocol Violation|1
1447596|NCT00847808|4774473|P1|Overall Study|Adverse Event|7
1447597|NCT00847704|4774490|P1|Overall Study|Withdrawal by Subject|1
1447598|NCT00847665|4774501|P2|Overall Study|Withdrawal by Subject|0
1447599|NCT00847665|4774502|P1|Overall Study|Withdrawal by Subject|1
1447600|NCT00847626|4774525|P11|Overall Study|Other|3
1447601|NCT00847626|4774526|P10|Overall Study|Other|1
1447602|NCT00847626|4774527|P9|Overall Study|Other|1
1447603|NCT00847626|4774528|P8|Overall Study|Other|3
1447604|NCT00847626|4774529|P7|Overall Study|Other|2
1447605|NCT00847626|4774530|P6|Overall Study|Other|2
1447606|NCT00847626|4774531|P5|Overall Study|Other|2
1447607|NCT00847626|4774532|P4|Overall Study|Other|1
1447608|NCT00847626|4774533|P3|Overall Study|Other|4
1447609|NCT00847626|4774534|P2|Overall Study|Other|5
1447610|NCT00847626|4774535|P1|Overall Study|Other|1
1447611|NCT00847626|4774525|P11|Overall Study|Lack of Efficacy|7
1447612|NCT00847626|4774526|P10|Overall Study|Lack of Efficacy|1
1447613|NCT00847626|4774527|P9|Overall Study|Lack of Efficacy|5
1447614|NCT00847626|4774528|P8|Overall Study|Lack of Efficacy|2
1447615|NCT00847626|4774529|P7|Overall Study|Lack of Efficacy|6
1447616|NCT00847626|4774530|P6|Overall Study|Lack of Efficacy|0
1447617|NCT00847626|4774531|P5|Overall Study|Lack of Efficacy|2
1447618|NCT00847626|4774532|P4|Overall Study|Lack of Efficacy|1
1447619|NCT00847626|4774533|P3|Overall Study|Lack of Efficacy|0
1447620|NCT00847626|4774534|P2|Overall Study|Lack of Efficacy|1
1447621|NCT00847626|4774535|P1|Overall Study|Lack of Efficacy|3
1447622|NCT00847626|4774525|P11|Overall Study|Withdrawal by Subject|2
1447623|NCT00847626|4774526|P10|Overall Study|Withdrawal by Subject|5
1447624|NCT00847626|4774527|P9|Overall Study|Withdrawal by Subject|4
1447625|NCT00847626|4774528|P8|Overall Study|Withdrawal by Subject|4
1447626|NCT00847626|4774529|P7|Overall Study|Withdrawal by Subject|8
1447627|NCT00847626|4774530|P6|Overall Study|Withdrawal by Subject|9
1447628|NCT00847626|4774531|P5|Overall Study|Withdrawal by Subject|12
1447629|NCT00847626|4774532|P4|Overall Study|Withdrawal by Subject|8
1447630|NCT00847626|4774533|P3|Overall Study|Withdrawal by Subject|3
1447631|NCT00847626|4774534|P2|Overall Study|Withdrawal by Subject|5
1447632|NCT00847626|4774535|P1|Overall Study|Withdrawal by Subject|5
1447633|NCT00847626|4774525|P11|Overall Study|Lost to Follow-up|1
1447634|NCT00847626|4774526|P10|Overall Study|Lost to Follow-up|0
1447635|NCT00847626|4774527|P9|Overall Study|Lost to Follow-up|1
1447636|NCT00847626|4774528|P8|Overall Study|Lost to Follow-up|3
1447637|NCT00847626|4774529|P7|Overall Study|Lost to Follow-up|1
1447638|NCT00847626|4774530|P6|Overall Study|Lost to Follow-up|3
1447639|NCT00847626|4774531|P5|Overall Study|Lost to Follow-up|0
1447640|NCT00847626|4774532|P4|Overall Study|Lost to Follow-up|1
1447641|NCT00847626|4774533|P3|Overall Study|Lost to Follow-up|1
1447642|NCT00847626|4774534|P2|Overall Study|Lost to Follow-up|1
1447643|NCT00847626|4774535|P1|Overall Study|Lost to Follow-up|0
1447644|NCT00847626|4774525|P11|Overall Study|Protocol Violation|1
1447645|NCT00847626|4774526|P10|Overall Study|Protocol Violation|1
1447646|NCT00847626|4774527|P9|Overall Study|Protocol Violation|0
1447647|NCT00847626|4774528|P8|Overall Study|Protocol Violation|1
1447648|NCT00847626|4774529|P7|Overall Study|Protocol Violation|1
1447649|NCT00847626|4774530|P6|Overall Study|Protocol Violation|1
1447650|NCT00847626|4774531|P5|Overall Study|Protocol Violation|1
1447651|NCT00847626|4774532|P4|Overall Study|Protocol Violation|1
1447652|NCT00847626|4774533|P3|Overall Study|Protocol Violation|2
1447653|NCT00847626|4774534|P2|Overall Study|Protocol Violation|1
1447654|NCT00847626|4774535|P1|Overall Study|Protocol Violation|2
1447655|NCT00847626|4774525|P11|Overall Study|Adverse Event|6
1447656|NCT00847626|4774526|P10|Overall Study|Adverse Event|6
1447657|NCT00847626|4774527|P9|Overall Study|Adverse Event|3
1447658|NCT00847626|4774528|P8|Overall Study|Adverse Event|6
1447659|NCT00847626|4774529|P7|Overall Study|Adverse Event|4
1447660|NCT00847626|4774530|P6|Overall Study|Adverse Event|22
1447661|NCT00847626|4774531|P5|Overall Study|Adverse Event|11
1447662|NCT00847626|4774532|P4|Overall Study|Adverse Event|19
1447663|NCT00847626|4774533|P3|Overall Study|Adverse Event|6
1447664|NCT00847626|4774534|P2|Overall Study|Adverse Event|10
1447665|NCT00847626|4774535|P1|Overall Study|Adverse Event|10
1447666|NCT00847613|4774734|P4|Overall Study|Other|0
1447667|NCT00847613|4774735|P3|Overall Study|Other|2
1447668|NCT00847613|4774736|P2|Overall Study|Other|1
1447669|NCT00847613|4774737|P1|Overall Study|Other|1
1447670|NCT00847613|4774734|P4|Overall Study|Randomized, but not treated|0
1447671|NCT00847613|4774735|P3|Overall Study|Randomized, but not treated|0
1447672|NCT00847613|4774736|P2|Overall Study|Randomized, but not treated|3
1447673|NCT00847613|4774737|P1|Overall Study|Randomized, but not treated|0
1447674|NCT00847613|4774734|P4|Overall Study|Sponsor request|0
1447675|NCT00847613|4774735|P3|Overall Study|Sponsor request|0
1447676|NCT00847613|4774736|P2|Overall Study|Sponsor request|1
1447677|NCT00847613|4774737|P1|Overall Study|Sponsor request|0
1447678|NCT00847613|4774734|P4|Overall Study|Participant moved|0
1447679|NCT00847613|4774735|P3|Overall Study|Participant moved|0
1447680|NCT00847613|4774736|P2|Overall Study|Participant moved|1
1447681|NCT00847613|4774737|P1|Overall Study|Participant moved|4
1447682|NCT00847613|4774734|P4|Overall Study|Withdrawal by Subject|2
1447683|NCT00847613|4774735|P3|Overall Study|Withdrawal by Subject|2
1447684|NCT00847613|4774736|P2|Overall Study|Withdrawal by Subject|11
1447685|NCT00847613|4774737|P1|Overall Study|Withdrawal by Subject|8
1447686|NCT00847613|4774734|P4|Overall Study|Site closure|1
1447687|NCT00847613|4774735|P3|Overall Study|Site closure|0
1447688|NCT00847613|4774736|P2|Overall Study|Site closure|0
1447689|NCT00847613|4774737|P1|Overall Study|Site closure|1
1447690|NCT00847613|4774734|P4|Overall Study|Pregnancy|0
1447691|NCT00847613|4774735|P3|Overall Study|Pregnancy|0
1447692|NCT00847613|4774736|P2|Overall Study|Pregnancy|1
1447693|NCT00847613|4774737|P1|Overall Study|Pregnancy|1
1447694|NCT00847613|4774734|P4|Overall Study|Protocol Violation|1
1447695|NCT00847613|4774735|P3|Overall Study|Protocol Violation|3
1447696|NCT00847613|4774736|P2|Overall Study|Protocol Violation|6
1447697|NCT00847613|4774737|P1|Overall Study|Protocol Violation|6
1447698|NCT00847613|4774734|P4|Overall Study|Lost to Follow-up|3
1447699|NCT00847613|4774735|P3|Overall Study|Lost to Follow-up|0
1447700|NCT00847613|4774736|P2|Overall Study|Lost to Follow-up|0
1447701|NCT00847613|4774737|P1|Overall Study|Lost to Follow-up|5
1447702|NCT00847613|4774734|P4|Overall Study|Study terminated by Sponsor|1
1447703|NCT00847613|4774735|P3|Overall Study|Study terminated by Sponsor|2
1447704|NCT00847613|4774736|P2|Overall Study|Study terminated by Sponsor|0
1447705|NCT00847613|4774737|P1|Overall Study|Study terminated by Sponsor|1
1447706|NCT00847613|4774734|P4|Overall Study|Lack of Efficacy|1
1447707|NCT00847613|4774735|P3|Overall Study|Lack of Efficacy|3
1447708|NCT00847613|4774736|P2|Overall Study|Lack of Efficacy|3
1447709|NCT00847613|4774737|P1|Overall Study|Lack of Efficacy|7
1447710|NCT00847613|4774734|P4|Overall Study|Adverse Event|6
1447711|NCT00847613|4774735|P3|Overall Study|Adverse Event|5
1447712|NCT00847613|4774736|P2|Overall Study|Adverse Event|26
1447713|NCT00847613|4774737|P1|Overall Study|Adverse Event|36
1447714|NCT00847613|4774734|P4|Overall Study|Death|0
1447715|NCT00847613|4774735|P3|Overall Study|Death|0
1447716|NCT00847613|4774736|P2|Overall Study|Death|1
1447717|NCT00847613|4774737|P1|Overall Study|Death|1
1447718|NCT00847613|4774734|P4|Overall Study|Ongoing at cut-off date|64
1447719|NCT00847613|4774735|P3|Overall Study|Ongoing at cut-off date|64
1447720|NCT00847613|4774736|P2|Overall Study|Ongoing at cut-off date|265
1447721|NCT00847613|4774737|P1|Overall Study|Ongoing at cut-off date|250
1447722|NCT00847561|4774988|P2|Overall Study|Unable to schedule|1
1447723|NCT00847561|4774989|P1|Overall Study|Unable to schedule|9
1447724|NCT00847561|4774988|P2|Overall Study|Withdrawal by Subject|3
1447725|NCT00847561|4774989|P1|Overall Study|Withdrawal by Subject|4
1447726|NCT00847535|4774995|P3|Overall Study|Lost to Follow-up|0
1447727|NCT00847535|4774996|P2|Overall Study|Lost to Follow-up|1
1447728|NCT00847535|4774997|P1|Overall Study|Lost to Follow-up|0
1447729|NCT00847535|4774995|P3|Overall Study|Withdrawal by Subject|1
1447730|NCT00847535|4774996|P2|Overall Study|Withdrawal by Subject|1
1447731|NCT00847535|4774997|P1|Overall Study|Withdrawal by Subject|2
1447732|NCT00847405|4775016|P2|Washout of 7 Days|Withdrawal by Subject|0
1447733|NCT00847405|4775017|P1|Washout of 7 Days|Withdrawal by Subject|1
1447734|NCT00847405|4775016|P2|First Intervention|Adverse Event|1
1447735|NCT00847405|4775017|P1|First Intervention|Adverse Event|0
1447736|NCT00847301|4775025|P1|Overall Study|Other reason not defined above|1
1447737|NCT00847301|4775025|P1|Overall Study|No prescription after hospital discharge|1
1447738|NCT00847301|4775025|P1|Overall Study|Lost to Follow-up|1
1447739|NCT00847301|4775025|P1|Overall Study|Switch to other anticoagulants|16
1447740|NCT00847301|4775025|P1|Overall Study|Adverse Event|35
1447741|NCT00847197|4775073|P2|Overall Study|Withdrawal by Subject|1
1447742|NCT00847197|4775074|P1|Overall Study|Withdrawal by Subject|3
1447743|NCT00847197|4775073|P2|Overall Study|Protocol Violation|1
1447744|NCT00847197|4775074|P1|Overall Study|Protocol Violation|0
1447745|NCT00847197|4775073|P2|Overall Study|Adverse Event|3
1447746|NCT00847197|4775074|P1|Overall Study|Adverse Event|21
1447747|NCT00847145|4775092|P8|Overall Study|Protocol Violation|1
1447748|NCT00847145|4775093|P7|Overall Study|Protocol Violation|0
1447749|NCT00847145|4775094|P6|Overall Study|Protocol Violation|0
1447750|NCT00847145|4775095|P5|Overall Study|Protocol Violation|1
1447751|NCT00847145|4775096|P4|Overall Study|Protocol Violation|0
1447752|NCT00847145|4775097|P3|Overall Study|Protocol Violation|3
1447753|NCT00847145|4775098|P2|Overall Study|Protocol Violation|0
1447754|NCT00847145|4775099|P1|Overall Study|Protocol Violation|0
1447755|NCT00847145|4775092|P8|Overall Study|Inappropriate enrollment|0
1447756|NCT00847145|4775093|P7|Overall Study|Inappropriate enrollment|0
1447757|NCT00847145|4775094|P6|Overall Study|Inappropriate enrollment|0
1447758|NCT00847145|4775095|P5|Overall Study|Inappropriate enrollment|1
1447759|NCT00847145|4775096|P4|Overall Study|Inappropriate enrollment|0
1447760|NCT00847145|4775097|P3|Overall Study|Inappropriate enrollment|0
1447761|NCT00847145|4775098|P2|Overall Study|Inappropriate enrollment|0
1447762|NCT00847145|4775099|P1|Overall Study|Inappropriate enrollment|0
1447763|NCT00847145|4775092|P8|Overall Study|Lost to Follow-up|2
1447764|NCT00847145|4775093|P7|Overall Study|Lost to Follow-up|8
1447765|NCT00847145|4775094|P6|Overall Study|Lost to Follow-up|4
1447766|NCT00847145|4775095|P5|Overall Study|Lost to Follow-up|4
1447767|NCT00847145|4775096|P4|Overall Study|Lost to Follow-up|0
1447768|NCT00847145|4775097|P3|Overall Study|Lost to Follow-up|1
1447769|NCT00847145|4775098|P2|Overall Study|Lost to Follow-up|1
1447770|NCT00847145|4775099|P1|Overall Study|Lost to Follow-up|3
1447771|NCT00847145|4775092|P8|Overall Study|Withdrawal by Subject|1
1447772|NCT00847145|4775093|P7|Overall Study|Withdrawal by Subject|1
1447773|NCT00847145|4775094|P6|Overall Study|Withdrawal by Subject|0
1447774|NCT00847145|4775095|P5|Overall Study|Withdrawal by Subject|0
1447775|NCT00847145|4775096|P4|Overall Study|Withdrawal by Subject|1
1447776|NCT00847145|4775097|P3|Overall Study|Withdrawal by Subject|6
1447777|NCT00847145|4775098|P2|Overall Study|Withdrawal by Subject|4
1447778|NCT00847145|4775099|P1|Overall Study|Withdrawal by Subject|3
1447779|NCT00847145|4775092|P8|Overall Study|AE or Death|0
1447780|NCT00847145|4775093|P7|Overall Study|AE or Death|0
1447781|NCT00847145|4775094|P6|Overall Study|AE or Death|0
1447782|NCT00847145|4775095|P5|Overall Study|AE or Death|0
1447783|NCT00847145|4775096|P4|Overall Study|AE or Death|0
1447784|NCT00847145|4775097|P3|Overall Study|AE or Death|1
1447785|NCT00847145|4775098|P2|Overall Study|AE or Death|1
1447786|NCT00847145|4775099|P1|Overall Study|AE or Death|0
1447787|NCT00847132|4775149|P2|Overall Study|Death|1
1447788|NCT00847132|4775150|P1|Overall Study|Death|1
1447789|NCT00847015|4775158|P1|Overall Study|partial cystectomy vs radical cystectomy|1
1447790|NCT00847015|4775158|P1|Overall Study|declined any surgery|1
1447791|NCT00847015|4775158|P1|Overall Study|Withdrawal by Subject|1
1447792|NCT00846846|4775186|P1|Overall Study|Withdrawal by Subject|19
1447793|NCT00846846|4775186|P1|Overall Study|Death|56
1447794|NCT00846807|4775191|P1|Overall Study|Other|60
1447795|NCT00846807|4775191|P1|Overall Study|No prescription after hospital discharge|56
1447796|NCT00846807|4775191|P1|Overall Study|Switch to other anticoagulants|89
1447797|NCT00846807|4775191|P1|Overall Study|Non compliant with European label|7
1447798|NCT00846807|4775191|P1|Overall Study|Withdrawal by Subject|56
1447799|NCT00846807|4775191|P1|Overall Study|Lost to Follow-up|94
1447800|NCT00846807|4775191|P1|Overall Study|Adverse Event|270
1447801|NCT00846768|4775199|P4|Overall Study|Adverse Event|0
1447802|NCT00846768|4775200|P3|Overall Study|Adverse Event|0
1447803|NCT00846768|4775201|P2|Overall Study|Adverse Event|1
1447804|NCT00846768|4775202|P1|Overall Study|Adverse Event|0
1447805|NCT00846586|4775293|P2|Overall Study|Unsatisfactory therapeutic effect|1
1447806|NCT00846586|4775294|P1|Overall Study|Unsatisfactory therapeutic effect|0
1447807|NCT00846586|4775293|P2|Overall Study|Lost to Follow-up|4
1447808|NCT00846586|4775294|P1|Overall Study|Lost to Follow-up|1
1447809|NCT00846586|4775293|P2|Overall Study|Abnormal test procedure result(s)|0
1447810|NCT00846586|4775294|P1|Overall Study|Abnormal test procedure result(s)|1
1447811|NCT00846586|4775293|P2|Overall Study|Protocol deviation|6
1447812|NCT00846586|4775294|P1|Overall Study|Protocol deviation|2
1447813|NCT00846586|4775293|P2|Overall Study|Death|0
1447814|NCT00846586|4775294|P1|Overall Study|Death|2
1447815|NCT00846586|4775293|P2|Overall Study|Administrative problems|4
1447816|NCT00846586|4775294|P1|Overall Study|Administrative problems|5
1447817|NCT00846586|4775293|P2|Overall Study|Subject withdrew consent|10
1447818|NCT00846586|4775294|P1|Overall Study|Subject withdrew consent|8
1447819|NCT00846586|4775293|P2|Overall Study|Adverse Event|10
1447820|NCT00846586|4775294|P1|Overall Study|Adverse Event|20
1447821|NCT00846521|4775328|P1|Overall Study|Protocol Violation|1
1447822|NCT00846521|4775328|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
1447823|NCT00846521|4775328|P1|Overall Study|Withdrawal by Subject|5
1447824|NCT00846495|4775335|P2|Overall Study|Physician Decision|0
1447825|NCT00846495|4775336|P1|Overall Study|Physician Decision|1
1447826|NCT00846495|4775335|P2|Overall Study|Lack of Efficacy|2
1447827|NCT00846495|4775336|P1|Overall Study|Lack of Efficacy|1
1447828|NCT00846495|4775335|P2|Overall Study|Adverse Event|1
1447829|NCT00846495|4775336|P1|Overall Study|Adverse Event|5
1447830|NCT00846495|4775335|P2|Overall Study|Lost to Follow-up|0
1447831|NCT00846495|4775336|P1|Overall Study|Lost to Follow-up|1
1447832|NCT00846391|4775359|P3|Overall Study|Study Terminated by Sponsor|2
1447833|NCT00846391|4775360|P2|Overall Study|Study Terminated by Sponsor|2
1447834|NCT00846391|4775361|P1|Overall Study|Study Terminated by Sponsor|1
1447835|NCT00846391|4775359|P3|Overall Study|Physician Decision|1
1447836|NCT00846391|4775360|P2|Overall Study|Physician Decision|0
1447837|NCT00846391|4775361|P1|Overall Study|Physician Decision|0
1447838|NCT00846365|4775372|P3|Overall Study|Other|6
1447839|NCT00846365|4775373|P2|Overall Study|Other|1
1447840|NCT00846365|4775374|P1|Overall Study|Other|9
1447841|NCT00846365|4775372|P3|Overall Study|Lack of Efficacy|2
1447842|NCT00846365|4775373|P2|Overall Study|Lack of Efficacy|1
1447843|NCT00846365|4775374|P1|Overall Study|Lack of Efficacy|1
1447844|NCT00846365|4775372|P3|Overall Study|Pregnancy|0
1447845|NCT00846365|4775373|P2|Overall Study|Pregnancy|0
1447846|NCT00846365|4775374|P1|Overall Study|Pregnancy|1
1447847|NCT00846365|4775372|P3|Overall Study|Withdrawal by Subject|9
1447848|NCT00846365|4775373|P2|Overall Study|Withdrawal by Subject|11
1447849|NCT00846365|4775374|P1|Overall Study|Withdrawal by Subject|11
1447850|NCT00846365|4775372|P3|Overall Study|Lost to Follow-up|5
1447851|NCT00846365|4775373|P2|Overall Study|Lost to Follow-up|2
1447852|NCT00846365|4775374|P1|Overall Study|Lost to Follow-up|8
1447853|NCT00846365|4775372|P3|Overall Study|Protocol Violation|0
1447854|NCT00846365|4775373|P2|Overall Study|Protocol Violation|4
1447855|NCT00846365|4775374|P1|Overall Study|Protocol Violation|5
1447856|NCT00846365|4775372|P3|Overall Study|Adverse Event|11
1447857|NCT00846365|4775373|P2|Overall Study|Adverse Event|30
1447858|NCT00846365|4775374|P1|Overall Study|Adverse Event|20
1447859|NCT00846053|4775455|P2|Overall Study|Physician Decision|0
1447860|NCT00846053|4775456|P1|Overall Study|Physician Decision|3
1447861|NCT00846027|4775464|P1|Overall Study|Subject Not Treated|7
1447862|NCT00846027|4775464|P1|Overall Study|Protocol Violation|2
1447863|NCT00846027|4775464|P1|Overall Study|Investigator Discretion|29
1447864|NCT00846027|4775464|P1|Overall Study|Patient Decision|7
1447865|NCT00846027|4775464|P1|Overall Study|Toxicity|12
1447866|NCT00846027|4775464|P1|Overall Study|Disease Progression|30
1447867|NCT00846027|4775464|P1|Overall Study|Death|3
1447868|NCT00845897|4775487|P3|Overall Study|Too ill to participate|0
1447869|NCT00845897|4775488|P2|Overall Study|Too ill to participate|1
1447870|NCT00845897|4775489|P1|Overall Study|Too ill to participate|0
1447871|NCT00845897|4775487|P3|Overall Study|Ulcer did not heal|1
1447872|NCT00845897|4775488|P2|Overall Study|Ulcer did not heal|0
1447873|NCT00845897|4775489|P1|Overall Study|Ulcer did not heal|1
1447874|NCT00845897|4775487|P3|Overall Study|Withdrawal by Subject|2
1447875|NCT00845897|4775488|P2|Overall Study|Withdrawal by Subject|3
1447876|NCT00845897|4775489|P1|Overall Study|Withdrawal by Subject|0
1447877|NCT00845897|4775487|P3|Overall Study|Lost to Follow-up|0
1447878|NCT00845897|4775488|P2|Overall Study|Lost to Follow-up|1
1447879|NCT00845897|4775489|P1|Overall Study|Lost to Follow-up|1
1447880|NCT00845858|4775503|P3|Overall Study|not eligible|2
1447881|NCT00845858|4775504|P2|Overall Study|not eligible|3
1447882|NCT00845858|4775505|P1|Overall Study|not eligible|0
1447883|NCT00845858|4775503|P3|Overall Study|Protocol Violation|1
1447884|NCT00845858|4775504|P2|Overall Study|Protocol Violation|0
1447885|NCT00845858|4775505|P1|Overall Study|Protocol Violation|0
1447886|NCT00845858|4775503|P3|Overall Study|Adverse Event|4
1447887|NCT00845858|4775504|P2|Overall Study|Adverse Event|8
1447888|NCT00845858|4775505|P1|Overall Study|Adverse Event|3
1447889|NCT00845858|4775503|P3|Overall Study|Withdrawal by Subject|1
1447890|NCT00845858|4775504|P2|Overall Study|Withdrawal by Subject|1
1447891|NCT00845858|4775505|P1|Overall Study|Withdrawal by Subject|5
1447892|NCT00845845|4775518|P2|Overall Study|Lost to Follow-up|4
1447893|NCT00845845|4775519|P1|Overall Study|Lost to Follow-up|0
1447894|NCT00845832|4775530|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
1447895|NCT00845832|4775531|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
1447896|NCT00845832|4775532|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
1447897|NCT00845832|4775530|P3|Safety Follow-Up|Withdrawal by Subject|0
1447898|NCT00845832|4775531|P2|Safety Follow-Up|Withdrawal by Subject|0
1447899|NCT00845832|4775532|P1|Safety Follow-Up|Withdrawal by Subject|1
1447900|NCT00845832|4775530|P3|Treatment Period|Protocol Violation|0
1447901|NCT00845832|4775531|P2|Treatment Period|Protocol Violation|1
1447902|NCT00845832|4775532|P1|Treatment Period|Protocol Violation|1
1447903|NCT00845832|4775530|P3|Treatment Period|Adverse Event|0
1447904|NCT00845832|4775531|P2|Treatment Period|Adverse Event|2
1447905|NCT00845832|4775532|P1|Treatment Period|Adverse Event|0
1447906|NCT00845728|4775578|P2|Overall Study|Withdrawal by Subject|108
1447907|NCT00845728|4775579|P1|Overall Study|Withdrawal by Subject|105
1447908|NCT00845728|4775578|P2|Overall Study|Adverse Event|96
1447909|NCT00845728|4775579|P1|Overall Study|Adverse Event|101
1447910|NCT00845728|4775578|P2|Overall Study|Lack of Efficacy|39
1447911|NCT00845728|4775579|P1|Overall Study|Lack of Efficacy|51
1447912|NCT00845728|4775578|P2|Overall Study|Protocol Violation|24
1447913|NCT00845728|4775579|P1|Overall Study|Protocol Violation|36
1447914|NCT00845728|4775578|P2|Overall Study|Administrative Problems|26
1447915|NCT00845728|4775579|P1|Overall Study|Administrative Problems|34
1447916|NCT00845728|4775578|P2|Overall Study|Death|26
1447917|NCT00845728|4775579|P1|Overall Study|Death|24
1447918|NCT00845728|4775578|P2|Overall Study|Lost to Follow-up|13
1447919|NCT00845728|4775579|P1|Overall Study|Lost to Follow-up|22
1447920|NCT00845728|4775578|P2|Overall Study|Abnormal test procedure result (s)|2
1447921|NCT00845728|4775579|P1|Overall Study|Abnormal test procedure result (s)|7
1447922|NCT00845728|4775578|P2|Overall Study|Patient's inability to use the device|6
1447923|NCT00845728|4775579|P1|Overall Study|Patient's inability to use the device|4
1447924|NCT00845728|4775578|P2|Overall Study|Abnormal laboratory value (s)|2
1447925|NCT00845728|4775579|P1|Overall Study|Abnormal laboratory value (s)|2
1447926|NCT00845676|4775593|P1|Overall Study|Adverse Event|1
1447927|NCT00845676|4775593|P1|Overall Study|Virologic breakthrough at week 20|1
1447928|NCT00845650|4775654|P6|Overall Study|Unable to access IV line|0
1447929|NCT00845650|4775655|P5|Overall Study|Unable to access IV line|0
1447930|NCT00845650|4775656|P4|Overall Study|Unable to access IV line|0
1447931|NCT00845650|4775657|P3|Overall Study|Unable to access IV line|0
1447932|NCT00845650|4775658|P2|Overall Study|Unable to access IV line|0
1447933|NCT00845650|4775659|P1|Overall Study|Unable to access IV line|1
1447934|NCT00845650|4775654|P6|Overall Study|Sponsor hold on dosing|1
1447935|NCT00845650|4775655|P5|Overall Study|Sponsor hold on dosing|1
1447936|NCT00845650|4775656|P4|Overall Study|Sponsor hold on dosing|0
1447937|NCT00845650|4775657|P3|Overall Study|Sponsor hold on dosing|0
1447938|NCT00845650|4775658|P2|Overall Study|Sponsor hold on dosing|0
1447939|NCT00845650|4775659|P1|Overall Study|Sponsor hold on dosing|0
1447940|NCT00845650|4775654|P6|Overall Study|Lost to Follow-up|1
1447941|NCT00845650|4775655|P5|Overall Study|Lost to Follow-up|0
1447942|NCT00845650|4775656|P4|Overall Study|Lost to Follow-up|1
1447943|NCT00845650|4775657|P3|Overall Study|Lost to Follow-up|3
1447944|NCT00845650|4775658|P2|Overall Study|Lost to Follow-up|0
1447945|NCT00845650|4775659|P1|Overall Study|Lost to Follow-up|0
1447946|NCT00845650|4775654|P6|Overall Study|Withdrawal by Subject|0
1447947|NCT00845650|4775655|P5|Overall Study|Withdrawal by Subject|2
1447948|NCT00845650|4775656|P4|Overall Study|Withdrawal by Subject|0
1447949|NCT00845650|4775657|P3|Overall Study|Withdrawal by Subject|0
1447950|NCT00845650|4775658|P2|Overall Study|Withdrawal by Subject|0
1447951|NCT00845650|4775659|P1|Overall Study|Withdrawal by Subject|0
1447952|NCT00845520|4775697|P3|Overall Study|Adverse Event|1
1447953|NCT00845520|4775698|P2|Overall Study|Adverse Event|0
1447954|NCT00845520|4775699|P1|Overall Study|Adverse Event|0
1447955|NCT00845520|4775697|P3|Overall Study|Lost to Follow-up|0
1447956|NCT00845520|4775698|P2|Overall Study|Lost to Follow-up|0
1447957|NCT00845520|4775699|P1|Overall Study|Lost to Follow-up|1
1447958|NCT00845520|4775697|P3|Overall Study|Death|0
1447959|NCT00845520|4775698|P2|Overall Study|Death|2
1447960|NCT00845520|4775699|P1|Overall Study|Death|1
1447961|NCT00845429|4775736|P3|Overall Study|Serious adverse event|1
1447962|NCT00845429|4775737|P2|Overall Study|Serious adverse event|0
1447963|NCT00845429|4775738|P1|Overall Study|Serious adverse event|0
1447964|NCT00845429|4775736|P3|Overall Study|Withdrawal by Subject|2
1447965|NCT00845429|4775737|P2|Overall Study|Withdrawal by Subject|2
1447966|NCT00845429|4775738|P1|Overall Study|Withdrawal by Subject|2
1447967|NCT00845429|4775736|P3|Overall Study|Lost to Follow-up|10
1447968|NCT00845429|4775737|P2|Overall Study|Lost to Follow-up|9
1447969|NCT00845429|4775738|P1|Overall Study|Lost to Follow-up|7
1447970|NCT00845429|4775736|P3|Overall Study|Protocol Violation|7
1447971|NCT00845429|4775737|P2|Overall Study|Protocol Violation|4
1447972|NCT00845429|4775738|P1|Overall Study|Protocol Violation|5
1447973|NCT00845182|4775773|P3|Overall Study|Physician Decision|1
1447974|NCT00845182|4775774|P2|Overall Study|Physician Decision|0
1447975|NCT00845182|4775775|P1|Overall Study|Physician Decision|0
1447976|NCT00845182|4775773|P3|Overall Study|Adverse Event|1
1447977|NCT00845182|4775774|P2|Overall Study|Adverse Event|1
1447978|NCT00845182|4775775|P1|Overall Study|Adverse Event|0
1447979|NCT00845182|4775773|P3|Overall Study|Lost to Follow-up|4
1447980|NCT00845182|4775774|P2|Overall Study|Lost to Follow-up|3
1447981|NCT00845182|4775775|P1|Overall Study|Lost to Follow-up|3
1447982|NCT00845065|4775800|P2|Overall Study|Non-Medical Reasons|11
1447983|NCT00845065|4775801|P1|Overall Study|Non-Medical Reasons|1
1447984|NCT00845065|4775800|P2|Overall Study|Lack of Efficacy|21
1447985|NCT00845065|4775801|P1|Overall Study|Lack of Efficacy|43
1447986|NCT00845065|4775800|P2|Overall Study|Adverse Event|23
1447987|NCT00845065|4775801|P1|Overall Study|Adverse Event|3
1447988|NCT00844896|4775869|P2|Overall Study|Parents did not have time to complete|1
1447989|NCT00844896|4775870|P1|Overall Study|Parents did not have time to complete|0
1447990|NCT00844896|4775869|P2|Overall Study|Lost to Follow-up|16
1447991|NCT00844896|4775870|P1|Overall Study|Lost to Follow-up|12
1447992|NCT00844883|4775892|P1|Overall Study|Bridged to resection|1
1447993|NCT00844883|4775892|P1|Overall Study|Bridged to liver transplant|3
1447994|NCT00844857|4775904|P2|Overall Study|Good Clinical Practice Violations|11
1447995|NCT00844857|4775905|P1|Overall Study|Good Clinical Practice Violations|21
1447996|NCT00844857|4775904|P2|Overall Study|Did Not Take Study Drug|1
1447997|NCT00844857|4775905|P1|Overall Study|Did Not Take Study Drug|3
1447998|NCT00844857|4775904|P2|Overall Study|Lost to Follow-up|3
1447999|NCT00844857|4775905|P1|Overall Study|Lost to Follow-up|2
1448000|NCT00844857|4775904|P2|Overall Study|Entry Criteria Not Met|1
1448001|NCT00844857|4775905|P1|Overall Study|Entry Criteria Not Met|0
1448002|NCT00844857|4775904|P2|Overall Study|Clinical Relapse|1
1448003|NCT00844857|4775905|P1|Overall Study|Clinical Relapse|0
1448004|NCT00844857|4775904|P2|Overall Study|Lack of Efficacy|5
1448005|NCT00844857|4775905|P1|Overall Study|Lack of Efficacy|5
1448006|NCT00844857|4775904|P2|Overall Study|Protocol Violation|0
1448007|NCT00844857|4775905|P1|Overall Study|Protocol Violation|6
1448008|NCT00844857|4775904|P2|Overall Study|Withdrawal by Subject|7
1448009|NCT00844857|4775905|P1|Overall Study|Withdrawal by Subject|8
1448010|NCT00844857|4775904|P2|Overall Study|Parent/Caregiver Decision|2
1448011|NCT00844857|4775905|P1|Overall Study|Parent/Caregiver Decision|6
1448012|NCT00844857|4775904|P2|Overall Study|Physician Decision|0
1448013|NCT00844857|4775905|P1|Overall Study|Physician Decision|2
1448014|NCT00844857|4775904|P2|Overall Study|Sponsor Decision|1
1448015|NCT00844857|4775905|P1|Overall Study|Sponsor Decision|1
1448016|NCT00844857|4775904|P2|Overall Study|Adverse Event|5
1448017|NCT00844857|4775905|P1|Overall Study|Adverse Event|24
1448018|NCT00844844|4775949|P1|Post Treatment Period|Withdrawal by Subject|1
1448019|NCT00844844|4775949|P1|Extension Treatment Period|Adverse Event|2
1448020|NCT00844844|4775949|P1|Treatment Period (26 Weeks)|Protocol Violation|1
1448021|NCT00844844|4775949|P1|Treatment Period (26 Weeks)|Adverse Event|1
1448022|NCT00844831|4775963|P1|Overall Study|Physician Decision|1
1448023|NCT00844831|4775963|P1|Overall Study|Adverse Event|1
1448024|NCT00844831|4775963|P1|Overall Study|Withdrawal by Subject|4
1448025|NCT00844805|4775973|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
1448026|NCT00844805|4775974|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
1448027|NCT00844805|4775975|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
1448028|NCT00844805|4775976|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
1448029|NCT00844805|4775973|P4|Follow-Up Phase|Relapse/Recurrence|4
1448030|NCT00844805|4775974|P3|Follow-Up Phase|Relapse/Recurrence|2
1448031|NCT00844805|4775975|P2|Follow-Up Phase|Relapse/Recurrence|0
1448032|NCT00844805|4775976|P1|Follow-Up Phase|Relapse/Recurrence|0
1448033|NCT00844805|4775973|P4|Follow-Up Phase|Noncompliance With Protocol|1
1448034|NCT00844805|4775974|P3|Follow-Up Phase|Noncompliance With Protocol|0
1448035|NCT00844805|4775975|P2|Follow-Up Phase|Noncompliance With Protocol|0
1448036|NCT00844805|4775976|P1|Follow-Up Phase|Noncompliance With Protocol|0
1448037|NCT00844805|4775973|P4|Follow-Up Phase|Withdrawal by Subject|3
1448038|NCT00844805|4775974|P3|Follow-Up Phase|Withdrawal by Subject|6
1448039|NCT00844805|4775975|P2|Follow-Up Phase|Withdrawal by Subject|0
1448040|NCT00844805|4775976|P1|Follow-Up Phase|Withdrawal by Subject|0
1448041|NCT00844805|4775973|P4|Follow-Up Phase|Adverse Event|0
1448042|NCT00844805|4775974|P3|Follow-Up Phase|Adverse Event|1
1448043|NCT00844805|4775975|P2|Follow-Up Phase|Adverse Event|0
1448044|NCT00844805|4775976|P1|Follow-Up Phase|Adverse Event|0
1448045|NCT00844805|4775973|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
1448046|NCT00844805|4775974|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
1448047|NCT00844805|4775975|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
1448048|NCT00844805|4775976|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
1448049|NCT00844805|4775973|P4|Treatment Phase|Noncompliance With Protocol|0
1448050|NCT00844805|4775974|P3|Treatment Phase|Noncompliance With Protocol|0
1448051|NCT00844805|4775975|P2|Treatment Phase|Noncompliance With Protocol|0
1448052|NCT00844805|4775976|P1|Treatment Phase|Noncompliance With Protocol|1
1448053|NCT00844805|4775973|P4|Treatment Phase|Withdrawal by Subject|0
1448054|NCT00844805|4775974|P3|Treatment Phase|Withdrawal by Subject|0
1448055|NCT00844805|4775975|P2|Treatment Phase|Withdrawal by Subject|4
1448056|NCT00844805|4775976|P1|Treatment Phase|Withdrawal by Subject|3
1448057|NCT00844805|4775973|P4|Treatment Phase|Adverse Event|0
1448058|NCT00844805|4775974|P3|Treatment Phase|Adverse Event|0
1448059|NCT00844805|4775975|P2|Treatment Phase|Adverse Event|1
1448060|NCT00844805|4775976|P1|Treatment Phase|Adverse Event|5
1448061|NCT00844753|4776020|P4|Overall Study|Withdrawal by Subject|3
1448062|NCT00844753|4776021|P3|Overall Study|Withdrawal by Subject|0
1448063|NCT00844753|4776022|P2|Overall Study|Withdrawal by Subject|0
1448064|NCT00844753|4776023|P1|Overall Study|Withdrawal by Subject|1
1448065|NCT00844753|4776020|P4|Overall Study|could not swallow medication|0
1448066|NCT00844753|4776021|P3|Overall Study|could not swallow medication|0
1448067|NCT00844753|4776022|P2|Overall Study|could not swallow medication|0
1448068|NCT00844753|4776023|P1|Overall Study|could not swallow medication|2
1448069|NCT00844753|4776020|P4|Overall Study|Lost to Follow-up|1
1448070|NCT00844753|4776021|P3|Overall Study|Lost to Follow-up|0
1448071|NCT00844753|4776022|P2|Overall Study|Lost to Follow-up|1
1448072|NCT00844753|4776023|P1|Overall Study|Lost to Follow-up|1
1448073|NCT00844753|4776020|P4|Overall Study|Adverse Event|5
1448074|NCT00844753|4776021|P3|Overall Study|Adverse Event|5
1448075|NCT00844753|4776022|P2|Overall Study|Adverse Event|2
1448076|NCT00844753|4776023|P1|Overall Study|Adverse Event|3
1448077|NCT00844753|4776020|P4|Overall Study|Lack of Efficacy|2
1448078|NCT00844753|4776021|P3|Overall Study|Lack of Efficacy|2
1448079|NCT00844753|4776022|P2|Overall Study|Lack of Efficacy|0
1448080|NCT00844753|4776023|P1|Overall Study|Lack of Efficacy|1
1448081|NCT00844649|4776041|P2|Overall Study|Withdrew prior to starting treatment|27
1448082|NCT00844649|4776042|P1|Overall Study|Withdrew prior to starting treatment|11
1448083|NCT00844649|4776041|P2|Overall Study|Other|10
1448084|NCT00844649|4776042|P1|Overall Study|Other|7
1448085|NCT00844649|4776041|P2|Overall Study|Withdrawal by Subject|39
1448086|NCT00844649|4776042|P1|Overall Study|Withdrawal by Subject|28
1448087|NCT00844649|4776041|P2|Overall Study|Protocol Violation|6
1448088|NCT00844649|4776042|P1|Overall Study|Protocol Violation|10
1448089|NCT00844649|4776041|P2|Overall Study|Physician Decision|18
1448090|NCT00844649|4776042|P1|Overall Study|Physician Decision|25
1448091|NCT00844649|4776041|P2|Overall Study|Adverse Event|73
1448092|NCT00844649|4776042|P1|Overall Study|Adverse Event|128
1448093|NCT00844649|4776041|P2|Overall Study|Progressive Disease|245
1448094|NCT00844649|4776042|P1|Overall Study|Progressive Disease|196
1448095|NCT00844597|4776066|P6|Overall Study|Adverse Event|0
1448096|NCT00844597|4776067|P5|Overall Study|Adverse Event|0
1448097|NCT00844597|4776068|P4|Overall Study|Adverse Event|1
1448098|NCT00844597|4776069|P3|Overall Study|Adverse Event|0
1448099|NCT00844597|4776070|P2|Overall Study|Adverse Event|0
1448100|NCT00844597|4776071|P1|Overall Study|Adverse Event|0
1448101|NCT00844558|4776091|P2|Overall Study|Physician Decision|0
1448102|NCT00844558|4776092|P1|Overall Study|Physician Decision|1
1448103|NCT00844558|4776091|P2|Overall Study|Lost to Follow-up|1
1448104|NCT00844558|4776092|P1|Overall Study|Lost to Follow-up|0
1448105|NCT00844558|4776091|P2|Overall Study|Protocol Violation|1
1448106|NCT00844558|4776092|P1|Overall Study|Protocol Violation|1
1448107|NCT00844558|4776091|P2|Overall Study|Death|0
1448108|NCT00844558|4776092|P1|Overall Study|Death|1
1448109|NCT00844558|4776091|P2|Overall Study|Withdrawal by Subject|2
1448110|NCT00844558|4776092|P1|Overall Study|Withdrawal by Subject|9
1448111|NCT00844545|4776108|P1|Post Treatment Period|Withdrawal by Subject|1
1448112|NCT00844545|4776108|P1|Extension Treatment Period|Adverse Event|2
1448113|NCT00844545|4776108|P1|Treatment Period (26 Weeks)|Protocol Violation|1
1448114|NCT00844545|4776108|P1|Treatment Period (26 Weeks)|Adverse Event|1
1448115|NCT00844532|4776122|P1|Overall Study|Lost to Follow-up|7
1448116|NCT00844532|4776122|P1|Overall Study|Withdrawal by Subject|16
1448117|NCT00844532|4776122|P1|Overall Study|Death|16
1448118|NCT00844519|4776208|P2|Overall Study|Adverse Event|0
1448119|NCT00844519|4776209|P1|Overall Study|Adverse Event|1
1448120|NCT00844519|4776208|P2|Overall Study|Withdrawal by Subject|1
1448121|NCT00844519|4776209|P1|Overall Study|Withdrawal by Subject|1
1448122|NCT00844480|4776217|P2|Overall Study|Withdrawal by Subject|3
1448123|NCT00844480|4776218|P1|Overall Study|Withdrawal by Subject|2
1448124|NCT00844428|4776226|P1|Post Treatment Period (Patients Who Disc|Death|1
1448125|NCT00844428|4776226|P1|Extension Treatment Period|Death|1
1448126|NCT00844428|4776226|P1|Screening Period|Screen Failure|3
1448127|NCT00844415|4776242|P1|Overall Study|Withdrawal by Subject|1
1448128|NCT00844376|4776256|P2|Period 1: First Intervention|Withdrawal by Subject|0
1448129|NCT00844376|4776257|P1|Period 1: First Intervention|Withdrawal by Subject|1
1448130|NCT00844194|4776281|P2|Overall Study|Other reason (not specified)|0
1448131|NCT00844194|4776282|P1|Overall Study|Other reason (not specified)|1
1448132|NCT00844194|4776281|P2|Overall Study|Lack of Efficacy|0
1448133|NCT00844194|4776282|P1|Overall Study|Lack of Efficacy|3
1448134|NCT00844194|4776281|P2|Overall Study|Withdrawal by Subject|1
1448135|NCT00844194|4776282|P1|Overall Study|Withdrawal by Subject|2
1448136|NCT00844194|4776281|P2|Overall Study|Lost to Follow-up|1
1448137|NCT00844194|4776282|P1|Overall Study|Lost to Follow-up|1
1448138|NCT00844194|4776281|P2|Overall Study|Protocol Violation|1
1448139|NCT00844194|4776282|P1|Overall Study|Protocol Violation|1
1448140|NCT00844194|4776281|P2|Overall Study|Adverse Event|5
1448141|NCT00844194|4776282|P1|Overall Study|Adverse Event|17
1448142|NCT00843843|4776537|P2|Overall Study|Protocol Violation|1
1448143|NCT00843843|4776538|P1|Overall Study|Protocol Violation|1
1448144|NCT00843843|4776537|P2|Overall Study|Physician Decision|1
1448145|NCT00843843|4776538|P1|Overall Study|Physician Decision|1
1448146|NCT00843778|4776551|P1|Overall Study|Withdrawal by Subject|4
1448147|NCT00843778|4776551|P1|Overall Study|Loss of efficacy|2
1448148|NCT00843778|4776551|P1|Overall Study|Lack of Efficacy|14
1448149|NCT00843778|4776551|P1|Overall Study|Adverse Event|15
1448150|NCT00843635|4776596|P3|Overall Study|Adverse Event|0
1448151|NCT00843635|4776597|P2|Overall Study|Adverse Event|2
1448152|NCT00843635|4776598|P1|Overall Study|Adverse Event|2
1448153|NCT00843518|4776627|P2|Period 2 (Double-blind Treatment)|Caregiver decision|7
1448154|NCT00843518|4776628|P1|Period 2 (Double-blind Treatment)|Caregiver decision|7
1448155|NCT00843518|4776627|P2|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
1448156|NCT00843518|4776628|P1|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
1448157|NCT00843518|4776627|P2|Period 2 (Double-blind Treatment)|Protocol Violation|5
1448158|NCT00843518|4776628|P1|Period 2 (Double-blind Treatment)|Protocol Violation|2
1448159|NCT00843518|4776627|P2|Period 2 (Double-blind Treatment)|Physician Decision|1
1448160|NCT00843518|4776628|P1|Period 2 (Double-blind Treatment)|Physician Decision|2
1448161|NCT00843518|4776627|P2|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
1448162|NCT00843518|4776628|P1|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
1448163|NCT00843518|4776627|P2|Period 2 (Double-blind Treatment)|Death|1
1448164|NCT00843518|4776628|P1|Period 2 (Double-blind Treatment)|Death|0
1448165|NCT00843518|4776627|P2|Period 2 (Double-blind Treatment)|Adverse Event|3
1448166|NCT00843518|4776628|P1|Period 2 (Double-blind Treatment)|Adverse Event|5
1448167|NCT00843492|4776658|P2|Overall Study|Deep-vein Thrombosis|0
1448168|NCT00843492|4776659|P1|Overall Study|Deep-vein Thrombosis|1
1448169|NCT00843492|4776658|P2|Overall Study|Visit Not Performed|0
1448170|NCT00843492|4776659|P1|Overall Study|Visit Not Performed|1
1448171|NCT00843492|4776658|P2|Overall Study|Orthopedic Surgery|2
1448172|NCT00843492|4776659|P1|Overall Study|Orthopedic Surgery|0
1448173|NCT00843492|4776658|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
1448174|NCT00843492|4776659|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
1448175|NCT00843492|4776658|P2|Overall Study|Immobilization Stopped|0
1448176|NCT00843492|4776659|P1|Overall Study|Immobilization Stopped|1
1448177|NCT00843492|4776658|P2|Overall Study|Withdrawal by Subject|4
1448178|NCT00843492|4776659|P1|Overall Study|Withdrawal by Subject|0
1448179|NCT00843492|4776658|P2|Overall Study|Lost to Follow-up|4
1448180|NCT00843492|4776659|P1|Overall Study|Lost to Follow-up|4
1448181|NCT00843492|4776658|P2|Overall Study|Adverse Event|3
1448182|NCT00843492|4776659|P1|Overall Study|Adverse Event|0
1448183|NCT00843284|4776730|P1|Overall Study|Death|3
1448184|NCT00843284|4776730|P1|Overall Study|Withdrawal by Subject|4
1448185|NCT00843284|4776730|P1|Overall Study|Other|10
1448186|NCT00843284|4776730|P1|Overall Study|Lost to Follow-up|11
1448187|NCT00843284|4776730|P1|Overall Study|Lack of Efficacy|5
1448188|NCT00843284|4776730|P1|Overall Study|Adverse Event|39
1448189|NCT00843193|4776740|P2|Overall Study|Withdrawal by Subject|3
1448190|NCT00843193|4776741|P1|Overall Study|Withdrawal by Subject|3
1448191|NCT00843193|4776740|P2|Overall Study|Physician Decision|1
1448192|NCT00843193|4776741|P1|Overall Study|Physician Decision|0
1448193|NCT00843193|4776740|P2|Overall Study|Lost to Follow-up|0
1448194|NCT00843193|4776741|P1|Overall Study|Lost to Follow-up|1
1448195|NCT00843193|4776740|P2|Overall Study|Protocol Violation|2
1448196|NCT00843193|4776741|P1|Overall Study|Protocol Violation|1
1448197|NCT00843193|4776740|P2|Overall Study|Lack of Efficacy|1
1448198|NCT00843193|4776741|P1|Overall Study|Lack of Efficacy|1
1448199|NCT00843193|4776740|P2|Overall Study|Adverse Event|4
1448200|NCT00843193|4776741|P1|Overall Study|Adverse Event|2
1448201|NCT00843167|4776792|P2|Treatment Period|Withdrawal by Subject|3
1448202|NCT00843167|4776793|P1|Treatment Period|Withdrawal by Subject|2
1448203|NCT00843167|4776792|P2|Treatment Period|Adverse Event|5
1448204|NCT00843167|4776793|P1|Treatment Period|Adverse Event|1
1448205|NCT00843115|4776806|P1|Overall Study|Syndrome De Glissement|1
1448206|NCT00843115|4776806|P1|Overall Study|week 12 not done|1
1448207|NCT00843115|4776806|P1|Overall Study|hospitalized due to deterioration|1
1448208|NCT00843115|4776806|P1|Overall Study|patient never took the medication|1
1448209|NCT00843115|4776806|P1|Overall Study|patient took for 2 days then stopped|1
1448210|NCT00843115|4776806|P1|Overall Study|Family discontinued meds|1
1448211|NCT00843115|4776806|P1|Overall Study|Physician Decision|1
1448212|NCT00843115|4776806|P1|Overall Study|Does not meet entrance criteria|1
1448213|NCT00843115|4776806|P1|Overall Study|Patient forgot to take meds|1
1448214|NCT00843115|4776806|P1|Overall Study|Family does not want continuation|1
1448215|NCT00843115|4776806|P1|Overall Study|Family wanted meds stopped|1
1448216|NCT00843115|4776806|P1|Overall Study|Withdrawal by Subject|17
1448217|NCT00843115|4776806|P1|Overall Study|Lost to Follow-up|4
1448218|NCT00843115|4776806|P1|Overall Study|Adverse Event|30
1448219|NCT00843115|4776806|P1|Overall Study|Death|4
1448220|NCT00843024|4776862|P6|Double-blind Treatment Phase|Lack of Efficacy|0
1448221|NCT00843024|4776863|P5|Double-blind Treatment Phase|Lack of Efficacy|1
1448222|NCT00843024|4776864|P4|Double-blind Treatment Phase|Lack of Efficacy|0
1448223|NCT00843024|4776865|P3|Double-blind Treatment Phase|Lack of Efficacy|0
1448224|NCT00843024|4776866|P2|Double-blind Treatment Phase|Lack of Efficacy|0
1448225|NCT00843024|4776867|P1|Double-blind Treatment Phase|Lack of Efficacy|0
1448226|NCT00843024|4776862|P6|Double-blind Treatment Phase|Adverse Event|1
1448227|NCT00843024|4776863|P5|Double-blind Treatment Phase|Adverse Event|1
1448228|NCT00843024|4776864|P4|Double-blind Treatment Phase|Adverse Event|0
1448229|NCT00843024|4776865|P3|Double-blind Treatment Phase|Adverse Event|0
1448230|NCT00843024|4776866|P2|Double-blind Treatment Phase|Adverse Event|0
1448231|NCT00843024|4776867|P1|Double-blind Treatment Phase|Adverse Event|0
1448232|NCT00843024|4776862|P6|Double-blind Treatment Phase|Physician Decision|1
1448233|NCT00843024|4776863|P5|Double-blind Treatment Phase|Physician Decision|1
1448234|NCT00843024|4776864|P4|Double-blind Treatment Phase|Physician Decision|3
1448235|NCT00843024|4776865|P3|Double-blind Treatment Phase|Physician Decision|0
1448236|NCT00843024|4776866|P2|Double-blind Treatment Phase|Physician Decision|0
1448237|NCT00843024|4776867|P1|Double-blind Treatment Phase|Physician Decision|0
1448238|NCT00843024|4776862|P6|Double-blind Treatment Phase|Protocol Violation|3
1448239|NCT00843024|4776863|P5|Double-blind Treatment Phase|Protocol Violation|0
1448240|NCT00843024|4776864|P4|Double-blind Treatment Phase|Protocol Violation|0
1448241|NCT00843024|4776865|P3|Double-blind Treatment Phase|Protocol Violation|3
1448242|NCT00843024|4776866|P2|Double-blind Treatment Phase|Protocol Violation|0
1448243|NCT00843024|4776867|P1|Double-blind Treatment Phase|Protocol Violation|0
1448244|NCT00843024|4776862|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
1448245|NCT00843024|4776863|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
1448246|NCT00843024|4776864|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
1448247|NCT00843024|4776865|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
1448248|NCT00843024|4776866|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
1448249|NCT00843024|4776867|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
1448250|NCT00843024|4776862|P6|Double-blind Treatment Phase|Lost to Follow-up|4
1448251|NCT00843024|4776863|P5|Double-blind Treatment Phase|Lost to Follow-up|4
1448252|NCT00843024|4776864|P4|Double-blind Treatment Phase|Lost to Follow-up|4
1448253|NCT00843024|4776865|P3|Double-blind Treatment Phase|Lost to Follow-up|8
1448254|NCT00843024|4776866|P2|Double-blind Treatment Phase|Lost to Follow-up|0
1448255|NCT00843024|4776867|P1|Double-blind Treatment Phase|Lost to Follow-up|0
1448256|NCT00843024|4776862|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
1448257|NCT00843024|4776863|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
1448258|NCT00843024|4776864|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
1448259|NCT00843024|4776865|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
1448260|NCT00843024|4776866|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
1448261|NCT00843024|4776867|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
1448262|NCT00843024|4776862|P6|Single-blind Placebo Run-In Phase|Other|0
1448263|NCT00843024|4776863|P5|Single-blind Placebo Run-In Phase|Other|0
1448264|NCT00843024|4776864|P4|Single-blind Placebo Run-In Phase|Other|0
1448265|NCT00843024|4776865|P3|Single-blind Placebo Run-In Phase|Other|0
1448266|NCT00843024|4776866|P2|Single-blind Placebo Run-In Phase|Other|1
1448267|NCT00843024|4776867|P1|Single-blind Placebo Run-In Phase|Other|0
1448268|NCT00843024|4776862|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
1448269|NCT00843024|4776863|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
1448270|NCT00843024|4776864|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
1448271|NCT00843024|4776865|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
1448272|NCT00843024|4776866|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
1448273|NCT00843024|4776867|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
1448274|NCT00843024|4776862|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
1448275|NCT00843024|4776863|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
1448276|NCT00843024|4776864|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
1448277|NCT00843024|4776865|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
1448278|NCT00843024|4776866|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
1448279|NCT00843024|4776867|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
1448280|NCT00843024|4776862|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
1448281|NCT00843024|4776863|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
1448282|NCT00843024|4776864|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
1448283|NCT00843024|4776865|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
1448284|NCT00843024|4776866|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
1448285|NCT00843024|4776867|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
1448286|NCT00843024|4776862|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
1448287|NCT00843024|4776863|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
1448288|NCT00843024|4776864|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
1448289|NCT00843024|4776865|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
1448290|NCT00843024|4776866|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
1448291|NCT00843024|4776867|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
1448292|NCT00843024|4776862|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
1448293|NCT00843024|4776863|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
1448294|NCT00843024|4776864|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
1448295|NCT00843024|4776865|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
1448296|NCT00843024|4776866|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
1448297|NCT00843024|4776867|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
1448298|NCT00843024|4776862|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
1448299|NCT00843024|4776863|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
1448300|NCT00843024|4776864|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
1448301|NCT00843024|4776865|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
1448302|NCT00843024|4776866|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
1448303|NCT00843024|4776867|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
1448304|NCT00842985|4776932|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
1448305|NCT00842985|4776932|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
1448306|NCT00842985|4776932|P1|First Intervention|Protocol Violation|3
1448307|NCT00842985|4776932|P1|First Intervention|Withdrawal by Subject|3
1448308|NCT00842985|4776932|P1|Screening|Did not meet entrance requirements|27
1448309|NCT00842829|4776950|P3|Continuation Period|Non-compliance to study drug|1
1448310|NCT00842829|4776951|P2|Continuation Period|Non-compliance to study drug|0
1448311|NCT00842829|4776952|P1|Continuation Period|Non-compliance to study drug|0
1448312|NCT00842829|4776950|P3|Continuation Period|Non-compliance to study procedures|2
1448313|NCT00842829|4776951|P2|Continuation Period|Non-compliance to study procedures|0
1448314|NCT00842829|4776952|P1|Continuation Period|Non-compliance to study procedures|0
1448315|NCT00842829|4776950|P3|Continuation Period|Not specified|7
1448316|NCT00842829|4776951|P2|Continuation Period|Not specified|0
1448317|NCT00842829|4776952|P1|Continuation Period|Not specified|0
1448318|NCT00842829|4776950|P3|Continuation Period|Withdrawal by Subject|10
1448319|NCT00842829|4776951|P2|Continuation Period|Withdrawal by Subject|0
1448320|NCT00842829|4776952|P1|Continuation Period|Withdrawal by Subject|0
1448321|NCT00842829|4776950|P3|Continuation Period|Unstable persistent cancer pain|3
1448322|NCT00842829|4776951|P2|Continuation Period|Unstable persistent cancer pain|0
1448323|NCT00842829|4776952|P1|Continuation Period|Unstable persistent cancer pain|0
1448324|NCT00842829|4776950|P3|Continuation Period|Lack of Efficacy|6
1448325|NCT00842829|4776951|P2|Continuation Period|Lack of Efficacy|0
1448326|NCT00842829|4776952|P1|Continuation Period|Lack of Efficacy|0
1448327|NCT00842829|4776950|P3|Continuation Period|Adverse Event|32
1448328|NCT00842829|4776951|P2|Continuation Period|Adverse Event|0
1448329|NCT00842829|4776952|P1|Continuation Period|Adverse Event|0
1448330|NCT00842829|4776950|P3|Treatment Period|Unclear completion status|1
1448331|NCT00842829|4776951|P2|Treatment Period|Unclear completion status|0
1448332|NCT00842829|4776952|P1|Treatment Period|Unclear completion status|0
1448333|NCT00842829|4776950|P3|Treatment Period|Non-compliance to study procedures|4
1448334|NCT00842829|4776951|P2|Treatment Period|Non-compliance to study procedures|0
1448335|NCT00842829|4776952|P1|Treatment Period|Non-compliance to study procedures|0
1448336|NCT00842829|4776950|P3|Treatment Period|Not specified|18
1448337|NCT00842829|4776951|P2|Treatment Period|Not specified|0
1448338|NCT00842829|4776952|P1|Treatment Period|Not specified|0
1448339|NCT00842829|4776950|P3|Treatment Period|Protocol Violation|2
1448340|NCT00842829|4776951|P2|Treatment Period|Protocol Violation|0
1448341|NCT00842829|4776952|P1|Treatment Period|Protocol Violation|0
1448342|NCT00842829|4776950|P3|Treatment Period|Consistently >4 BTP episodes daily|1
1448343|NCT00842829|4776951|P2|Treatment Period|Consistently >4 BTP episodes daily|0
1448344|NCT00842829|4776952|P1|Treatment Period|Consistently >4 BTP episodes daily|0
1448345|NCT00842829|4776950|P3|Treatment Period|Withdrawal by Subject|11
1448346|NCT00842829|4776951|P2|Treatment Period|Withdrawal by Subject|0
1448347|NCT00842829|4776952|P1|Treatment Period|Withdrawal by Subject|0
1448348|NCT00842829|4776950|P3|Treatment Period|Unstable persistent cancer pain|5
1448349|NCT00842829|4776951|P2|Treatment Period|Unstable persistent cancer pain|0
1448350|NCT00842829|4776952|P1|Treatment Period|Unstable persistent cancer pain|0
1448351|NCT00842829|4776950|P3|Treatment Period|Lack of Efficacy|6
1448352|NCT00842829|4776951|P2|Treatment Period|Lack of Efficacy|0
1448353|NCT00842829|4776952|P1|Treatment Period|Lack of Efficacy|0
1448354|NCT00842829|4776950|P3|Treatment Period|Adverse Event|15
1448355|NCT00842829|4776951|P2|Treatment Period|Adverse Event|0
1448356|NCT00842829|4776952|P1|Treatment Period|Adverse Event|0
1448357|NCT00842829|4776950|P3|Dose Titration Period|Non-compliance to study drug|0
1448358|NCT00842829|4776951|P2|Dose Titration Period|Non-compliance to study drug|1
1448359|NCT00842829|4776952|P1|Dose Titration Period|Non-compliance to study drug|2
1448360|NCT00842829|4776950|P3|Dose Titration Period|Non-compliance to study procedures|0
1448361|NCT00842829|4776951|P2|Dose Titration Period|Non-compliance to study procedures|1
1448362|NCT00842829|4776952|P1|Dose Titration Period|Non-compliance to study procedures|1
1448363|NCT00842829|4776950|P3|Dose Titration Period|Not specified|0
1448364|NCT00842829|4776951|P2|Dose Titration Period|Not specified|4
1448365|NCT00842829|4776952|P1|Dose Titration Period|Not specified|5
1448366|NCT00842829|4776950|P3|Dose Titration Period|Withdrawal by Subject|0
1448367|NCT00842829|4776951|P2|Dose Titration Period|Withdrawal by Subject|6
1448368|NCT00842829|4776952|P1|Dose Titration Period|Withdrawal by Subject|2
1448369|NCT00842829|4776950|P3|Dose Titration Period|Unstable persistent cancer pain|0
1448370|NCT00842829|4776951|P2|Dose Titration Period|Unstable persistent cancer pain|0
1448371|NCT00842829|4776952|P1|Dose Titration Period|Unstable persistent cancer pain|1
1448372|NCT00842829|4776950|P3|Dose Titration Period|Lack of Efficacy|0
1448373|NCT00842829|4776951|P2|Dose Titration Period|Lack of Efficacy|1
1448374|NCT00842829|4776952|P1|Dose Titration Period|Lack of Efficacy|4
1448375|NCT00842829|4776950|P3|Dose Titration Period|Adverse Event|0
1448376|NCT00842829|4776951|P2|Dose Titration Period|Adverse Event|10
1448377|NCT00842829|4776952|P1|Dose Titration Period|Adverse Event|11
1448378|NCT00842712|4777007|P7|Randomized Part|Ongoing at cut-off date|2
1448379|NCT00842712|4777008|P6|Randomized Part|Ongoing at cut-off date|0
1448380|NCT00842712|4777009|P5|Randomized Part|Ongoing at cut-off date|0
1448381|NCT00842712|4777010|P4|Randomized Part|Ongoing at cut-off date|0
1448382|NCT00842712|4777011|P3|Randomized Part|Ongoing at cut-off date|0
1448383|NCT00842712|4777012|P2|Randomized Part|Ongoing at cut-off date|0
1448384|NCT00842712|4777013|P1|Randomized Part|Ongoing at cut-off date|0
1448385|NCT00842712|4777007|P7|Randomized Part|Randomized but not treated|4
1448386|NCT00842712|4777008|P6|Randomized Part|Randomized but not treated|1
1448387|NCT00842712|4777009|P5|Randomized Part|Randomized but not treated|0
1448388|NCT00842712|4777010|P4|Randomized Part|Randomized but not treated|0
1448389|NCT00842712|4777011|P3|Randomized Part|Randomized but not treated|0
1448390|NCT00842712|4777012|P2|Randomized Part|Randomized but not treated|0
1448391|NCT00842712|4777013|P1|Randomized Part|Randomized but not treated|0
1448392|NCT00842712|4777007|P7|Safety Run-in Part|Progressive disease|0
1448393|NCT00842712|4777008|P6|Safety Run-in Part|Progressive disease|0
1448394|NCT00842712|4777009|P5|Safety Run-in Part|Progressive disease|0
1448395|NCT00842712|4777010|P4|Safety Run-in Part|Progressive disease|1
1448396|NCT00842712|4777011|P3|Safety Run-in Part|Progressive disease|0
1448397|NCT00842712|4777012|P2|Safety Run-in Part|Progressive disease|1
1448398|NCT00842712|4777013|P1|Safety Run-in Part|Progressive disease|3
1448399|NCT00842712|4777007|P7|Safety Run-in Part|Adverse Event|0
1448400|NCT00842712|4777008|P6|Safety Run-in Part|Adverse Event|0
1448401|NCT00842712|4777009|P5|Safety Run-in Part|Adverse Event|0
1448402|NCT00842712|4777010|P4|Safety Run-in Part|Adverse Event|0
1448403|NCT00842712|4777011|P3|Safety Run-in Part|Adverse Event|0
1448404|NCT00842712|4777012|P2|Safety Run-in Part|Adverse Event|1
1448405|NCT00842712|4777013|P1|Safety Run-in Part|Adverse Event|0
1448406|NCT00842543|4777070|P4|Overall Study|Withdrawal by Subject|4
1448407|NCT00842543|4777071|P3|Overall Study|Withdrawal by Subject|3
1448408|NCT00842543|4777072|P2|Overall Study|Withdrawal by Subject|0
1448409|NCT00842543|4777073|P1|Overall Study|Withdrawal by Subject|2
1448410|NCT00842361|4777087|P2|Overall Study|Unclassified|2
1448411|NCT00842361|4777088|P1|Overall Study|Unclassified|0
1448412|NCT00842361|4777087|P2|Overall Study|Protocol Violation|0
1448413|NCT00842361|4777088|P1|Overall Study|Protocol Violation|1
1448414|NCT00842348|4777108|P2|Study 729|Surgical resection|0
1448415|NCT00842348|4777109|P1|Study 729|Surgical resection|1
1448416|NCT00842348|4777108|P2|Study 729|Sponsor's decision|0
1448417|NCT00842348|4777109|P1|Study 729|Sponsor's decision|1
1448418|NCT00842348|4777108|P2|Study 729|Due to non-availability of IP|1
1448419|NCT00842348|4777109|P1|Study 729|Due to non-availability of IP|0
1448420|NCT00842348|4777108|P2|Study 729|Due to Sponsor stopping the study|1
1448421|NCT00842348|4777109|P1|Study 729|Due to Sponsor stopping the study|1
1448422|NCT00842348|4777108|P2|Study 729|Withdrawal by Subject|4
1448423|NCT00842348|4777109|P1|Study 729|Withdrawal by Subject|2
1448424|NCT00842348|4777108|P2|Study 729|Protocol Violation|1
1448425|NCT00842348|4777109|P1|Study 729|Protocol Violation|1
1448426|NCT00842348|4777108|P2|Study 729|Adverse Event|1
1448427|NCT00842348|4777109|P1|Study 729|Adverse Event|1
1448428|NCT00842348|4777108|P2|Study 729|Disease progression/death|30
1448429|NCT00842348|4777109|P1|Study 729|Disease progression/death|19
1448430|NCT00842348|4777108|P2|Patients Randomised in Study 726|Did not enter Study 729|56
1448431|NCT00842348|4777109|P1|Patients Randomised in Study 726|Did not enter Study 729|59
1448432|NCT00842257|4777152|P1|Overall Study|Adverse Event|1
1448433|NCT00842244|4777159|P1|Overall Study|Other|17
1448434|NCT00842244|4777159|P1|Overall Study|Withdrawal by Subject|1
1448435|NCT00842244|4777159|P1|Overall Study|Death|3
1448436|NCT00842153|4777186|P2|Overall Study|Lost to Follow-up|2
1448437|NCT00842153|4777187|P1|Overall Study|Lost to Follow-up|1
1448438|NCT00842153|4777186|P2|Overall Study|Adverse Event|1
1448439|NCT00842153|4777187|P1|Overall Study|Adverse Event|0
1448440|NCT00841906|4777262|P2|Overall Study|Withdrawal by Subject|0
1448441|NCT00841906|4777263|P1|Overall Study|Withdrawal by Subject|2
1448442|NCT00841815|4777277|P2|Washout|Withdrawal by Subject|1
1448443|NCT00841815|4777278|P1|Washout|Withdrawal by Subject|0
1448444|NCT00841776|4777288|P2|Overall Study|Withdrawal by Subject|1
1448445|NCT00841776|4777289|P1|Overall Study|Withdrawal by Subject|0
1448446|NCT00841776|4777288|P2|Overall Study|Lost to Follow-up|1
1448447|NCT00841776|4777289|P1|Overall Study|Lost to Follow-up|2
1448448|NCT00841776|4777288|P2|Overall Study|Lack of Efficacy|1
1448449|NCT00841776|4777289|P1|Overall Study|Lack of Efficacy|0
1448450|NCT00841763|4777307|P4|Overall Study|Unable to Classify|0
1448451|NCT00841763|4777308|P3|Overall Study|Unable to Classify|0
1448452|NCT00841763|4777309|P2|Overall Study|Unable to Classify|1
1448453|NCT00841763|4777310|P1|Overall Study|Unable to Classify|7
1448454|NCT00841763|4777307|P4|Overall Study|Administrative Reasons|0
1448455|NCT00841763|4777308|P3|Overall Study|Administrative Reasons|0
1448456|NCT00841763|4777309|P2|Overall Study|Administrative Reasons|1
1448457|NCT00841763|4777310|P1|Overall Study|Administrative Reasons|3
1448458|NCT00841763|4777307|P4|Overall Study|Protocol Violation|0
1448459|NCT00841763|4777308|P3|Overall Study|Protocol Violation|1
1448460|NCT00841763|4777309|P2|Overall Study|Protocol Violation|3
1448461|NCT00841763|4777310|P1|Overall Study|Protocol Violation|20
1448462|NCT00841763|4777307|P4|Overall Study|Lost to Follow-up|0
1448463|NCT00841763|4777308|P3|Overall Study|Lost to Follow-up|0
1448464|NCT00841763|4777309|P2|Overall Study|Lost to Follow-up|25
1448465|NCT00841763|4777310|P1|Overall Study|Lost to Follow-up|63
1448466|NCT00841763|4777307|P4|Overall Study|Adverse Event|2
1448467|NCT00841763|4777308|P3|Overall Study|Adverse Event|3
1448468|NCT00841763|4777309|P2|Overall Study|Adverse Event|10
1448469|NCT00841763|4777310|P1|Overall Study|Adverse Event|9
1448470|NCT00841763|4777307|P4|Overall Study|Withdrawal by Subject|1
1448471|NCT00841763|4777308|P3|Overall Study|Withdrawal by Subject|4
1448472|NCT00841763|4777309|P2|Overall Study|Withdrawal by Subject|17
1448473|NCT00841763|4777310|P1|Overall Study|Withdrawal by Subject|60
1448474|NCT00841698|4777372|P2|First Intervention|Withdrawal by Subject|0
1448475|NCT00841698|4777373|P1|First Intervention|Withdrawal by Subject|1
1448476|NCT00841672|4777383|P2|Overall Study|Protocol Deviation|1
1448477|NCT00841672|4777384|P1|Overall Study|Protocol Deviation|0
1448478|NCT00841672|4777383|P2|Overall Study|Misrandomized|0
1448479|NCT00841672|4777384|P1|Overall Study|Misrandomized|1
1448480|NCT00841672|4777383|P2|Overall Study|Administrative problems|9
1448481|NCT00841672|4777384|P1|Overall Study|Administrative problems|9
1448482|NCT00841672|4777383|P2|Overall Study|Lost to Follow-up|1
1448483|NCT00841672|4777384|P1|Overall Study|Lost to Follow-up|1
1448484|NCT00841672|4777383|P2|Overall Study|Subject withdrew consent|4
1448485|NCT00841672|4777384|P1|Overall Study|Subject withdrew consent|2
1448486|NCT00841672|4777383|P2|Overall Study|Abnormal test procedure result(s)|1
1448487|NCT00841672|4777384|P1|Overall Study|Abnormal test procedure result(s)|0
1448488|NCT00841672|4777383|P2|Overall Study|Adverse Event|16
1448489|NCT00841672|4777384|P1|Overall Study|Adverse Event|7
1448490|NCT00841659|4777400|P2|Washout: 2 Weeks|Protocol Violation|0
1448491|NCT00841659|4777401|P1|Washout: 2 Weeks|Protocol Violation|1
1448492|NCT00841568|4777409|P1|Overall Study|Creatinine over the withdrawal criteria|1
1448493|NCT00841568|4777409|P1|Overall Study|Withdrawal by Subject|2
1448494|NCT00841568|4777409|P1|Overall Study|Death|1
1448495|NCT00841568|4777409|P1|Overall Study|Adverse Event|1
1448496|NCT00841542|4777437|P2|Period 1|Adverse Event|0
1448497|NCT00841542|4777438|P1|Period 1|Adverse Event|1
1448498|NCT00841321|4777453|P2|Overall Study|Adverse Event|2
1448499|NCT00841321|4777454|P1|Overall Study|Adverse Event|0
1448500|NCT00841321|4777453|P2|Overall Study|Lost to Follow-up|1
1448501|NCT00841321|4777454|P1|Overall Study|Lost to Follow-up|1
1448502|NCT00841035|4777522|P1|Phase 1 Overall Study|Physician Decision|13
1448503|NCT00840996|4777529|P2|Overall Study|Withdrawal by Subject|0
1448504|NCT00840996|4777530|P1|Overall Study|Withdrawal by Subject|1
1448505|NCT00840879|4777550|P2|Second Intervention|Withdrawal by Subject|0
1448506|NCT00840879|4777551|P1|Second Intervention|Withdrawal by Subject|1
1448507|NCT00840658|4777591|P4|Overall Study|Lost to Follow-up|1
1448508|NCT00840658|4777592|P3|Overall Study|Lost to Follow-up|2
1448509|NCT00840658|4777593|P2|Overall Study|Lost to Follow-up|1
1448510|NCT00840658|4777594|P1|Overall Study|Lost to Follow-up|3
1448511|NCT00840658|4777591|P4|Overall Study|Death|3
1448512|NCT00840658|4777592|P3|Overall Study|Death|3
1448513|NCT00840658|4777593|P2|Overall Study|Death|2
1448514|NCT00840658|4777594|P1|Overall Study|Death|2
1448515|NCT00840632|4777606|P2|Washout|Withdrawal by Subject|1
1448516|NCT00840632|4777607|P1|Washout|Withdrawal by Subject|1
1448517|NCT00840632|4777606|P2|First Intervention|Withdrawal by Subject|1
1448518|NCT00840632|4777607|P1|First Intervention|Withdrawal by Subject|0
1448519|NCT00840450|4777632|P1|Overall Study|Lack of Efficacy|2
1448520|NCT00840450|4777632|P1|Overall Study|Adverse Event|1
1448521|NCT00840411|4777640|P2|Washout|Withdrawal by Subject|0
1448522|NCT00840411|4777641|P1|Washout|Withdrawal by Subject|1
1448523|NCT00840411|4777640|P2|First Intervention|Adverse Event|0
1448524|NCT00840411|4777641|P1|First Intervention|Adverse Event|1
1448525|NCT00840294|4777655|P2|Overall Study|Illness|1
1448526|NCT00840294|4777656|P1|Overall Study|Illness|0
1448527|NCT00840294|4777655|P2|Overall Study|Protocol Violation|3
1448528|NCT00840294|4777656|P1|Overall Study|Protocol Violation|1
1448529|NCT00840294|4777655|P2|Overall Study|Withdrawal by Subject|1
1448530|NCT00840294|4777656|P1|Overall Study|Withdrawal by Subject|2
1448531|NCT00840216|4777677|P2|Washout: 7 Days|Withdrawal by Subject|0
1448532|NCT00840216|4777678|P1|Washout: 7 Days|Withdrawal by Subject|1
1448533|NCT00840203|4777688|P2|Washout|Protocol Violation|0
1448534|NCT00840203|4777689|P1|Washout|Protocol Violation|1
1448535|NCT00840203|4777688|P2|First Intervention|Protocol Violation|1
1448536|NCT00840203|4777689|P1|First Intervention|Protocol Violation|1
1448537|NCT00840086|4777720|P1|Overall Study|Lost to Follow-up|1
1448538|NCT00840086|4777720|P1|Overall Study|Protocol Violation|2
1448539|NCT00840086|4777720|P1|Overall Study|Adverse Event|1
1448540|NCT00840073|4777729|P2|Second Intervention|Missed 72 hour blood draw|1
1448541|NCT00840073|4777730|P1|Second Intervention|Missed 72 hour blood draw|1
1448542|NCT00840060|4777744|P2|Overall Study|Change in emotional/behavioral status|1
1448543|NCT00840060|4777745|P1|Overall Study|Change in emotional/behavioral status|0
1448544|NCT00840060|4777744|P2|Overall Study|Withdrawal by Subject|0
1448545|NCT00840060|4777745|P1|Overall Study|Withdrawal by Subject|1
1448546|NCT00840034|4777755|P2|Taper Phase|Withdrawal by Subject|1
1448547|NCT00840034|4777756|P1|Taper Phase|Withdrawal by Subject|1
1448548|NCT00840034|4777755|P2|Taper Phase|Lost to Follow-up|1
1448549|NCT00840034|4777756|P1|Taper Phase|Lost to Follow-up|1
1448550|NCT00840034|4777755|P2|Taper Phase|Adverse Event|0
1448551|NCT00840034|4777756|P1|Taper Phase|Adverse Event|1
1448552|NCT00840034|4777755|P2|Acute Treatment Phase|Withdrawal by Subject|11
1448553|NCT00840034|4777756|P1|Acute Treatment Phase|Withdrawal by Subject|6
1448554|NCT00840034|4777755|P2|Acute Treatment Phase|Protocol Violation|4
1448555|NCT00840034|4777756|P1|Acute Treatment Phase|Protocol Violation|2
1448556|NCT00840034|4777755|P2|Acute Treatment Phase|Physician Decision|1
1448557|NCT00840034|4777756|P1|Acute Treatment Phase|Physician Decision|0
1448558|NCT00840034|4777755|P2|Acute Treatment Phase|Lost to Follow-up|12
1448559|NCT00840034|4777756|P1|Acute Treatment Phase|Lost to Follow-up|5
1448560|NCT00840034|4777755|P2|Acute Treatment Phase|Lack of Efficacy|0
1448561|NCT00840034|4777756|P1|Acute Treatment Phase|Lack of Efficacy|2
1448562|NCT00840034|4777755|P2|Acute Treatment Phase|Adverse Event|8
1448563|NCT00840034|4777756|P1|Acute Treatment Phase|Adverse Event|6
1448564|NCT00839956|4777809|P1|Overall Study|Withdrawal by Subject|3
1448565|NCT00839956|4777809|P1|Overall Study|Physician Decision|1
1448566|NCT00839956|4777809|P1|Overall Study|Lack of Efficacy|6
1448567|NCT00839956|4777809|P1|Overall Study|Adverse Event|2
1448568|NCT00839917|4777829|P2|Overall Study|Did not receive vaccine|1
1448569|NCT00839917|4777830|P1|Overall Study|Did not receive vaccine|0
1448570|NCT00839917|4777829|P2|Overall Study|Lost to Follow-up|0
1448571|NCT00839917|4777830|P1|Overall Study|Lost to Follow-up|1
1448572|NCT00839800|4777868|P2|Overall Study|Severe Non-Compliance to Protocol|7
1448573|NCT00839800|4777869|P1|Overall Study|Severe Non-Compliance to Protocol|7
1448574|NCT00839800|4777868|P2|Overall Study|Not Specified|14
1448575|NCT00839800|4777869|P1|Overall Study|Not Specified|8
1448576|NCT00839800|4777868|P2|Overall Study|Safety Reasons|1
1448577|NCT00839800|4777869|P1|Overall Study|Safety Reasons|2
1448578|NCT00839800|4777868|P2|Overall Study|Study-Specific Discontinuation Criteria|13
1448579|NCT00839800|4777869|P1|Overall Study|Study-Specific Discontinuation Criteria|6
1448580|NCT00839800|4777868|P2|Overall Study|Incorrect Enrolment|3
1448581|NCT00839800|4777869|P1|Overall Study|Incorrect Enrolment|3
1448582|NCT00839800|4777868|P2|Overall Study|Withdrawal by Subject|34
1448583|NCT00839800|4777869|P1|Overall Study|Withdrawal by Subject|28
1448584|NCT00839800|4777868|P2|Overall Study|Lost to Follow-up|26
1448585|NCT00839800|4777869|P1|Overall Study|Lost to Follow-up|31
1448586|NCT00839800|4777868|P2|Overall Study|Adverse Event|12
1448587|NCT00839800|4777869|P1|Overall Study|Adverse Event|8
1448588|NCT00839527|4777915|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
1448589|NCT00839527|4777916|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
1448590|NCT00839527|4777917|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
1448591|NCT00839527|4777915|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
1448592|NCT00839527|4777916|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
1448593|NCT00839527|4777917|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
1448594|NCT00839527|4777915|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
1448595|NCT00839527|4777916|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
1448596|NCT00839527|4777917|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
1448597|NCT00839527|4777915|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
1448598|NCT00839527|4777916|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
1448599|NCT00839527|4777917|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
1448600|NCT00839527|4777915|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
1448601|NCT00839527|4777916|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
1448602|NCT00839527|4777917|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
1448603|NCT00839527|4777915|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
1448604|NCT00839527|4777916|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
1448605|NCT00839527|4777917|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
1448606|NCT00839527|4777915|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
1448607|NCT00839527|4777916|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
1448608|NCT00839527|4777917|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
1448609|NCT00839527|4777915|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
1448610|NCT00839527|4777916|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
1448611|NCT00839527|4777917|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
1448612|NCT00839527|4777915|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
1448613|NCT00839527|4777916|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
1448614|NCT00839527|4777917|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
1448615|NCT00839527|4777915|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
1448616|NCT00839527|4777916|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
1448617|NCT00839527|4777917|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
1448618|NCT00839527|4777915|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
1448619|NCT00839527|4777916|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
1448620|NCT00839527|4777917|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
1448621|NCT00839527|4777915|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
1448622|NCT00839527|4777916|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
1448623|NCT00839527|4777917|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
1448624|NCT00839527|4777915|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
1448625|NCT00839527|4777916|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
1448626|NCT00839527|4777917|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
1448627|NCT00839527|4777915|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
1448628|NCT00839527|4777916|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
1448629|NCT00839527|4777917|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
1448630|NCT00839527|4777915|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
1448631|NCT00839527|4777916|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
1448632|NCT00839527|4777917|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
1448633|NCT00839527|4777915|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
1448634|NCT00839527|4777916|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
1448635|NCT00839527|4777917|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
1448636|NCT00839527|4777915|P3|Treatment Period (TP) (156 Weeks)|Missing|0
1448637|NCT00839527|4777916|P2|Treatment Period (TP) (156 Weeks)|Missing|1
1448638|NCT00839527|4777917|P1|Treatment Period (TP) (156 Weeks)|Missing|0
1448639|NCT00839527|4777915|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
1448640|NCT00839527|4777916|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
1448641|NCT00839527|4777917|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
1448642|NCT00839527|4777915|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
1448643|NCT00839527|4777916|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
1448644|NCT00839527|4777917|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
1448645|NCT00839527|4777915|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
1448646|NCT00839527|4777916|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
1448647|NCT00839527|4777917|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
1448648|NCT00839527|4777915|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
1448649|NCT00839527|4777916|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
1448650|NCT00839527|4777917|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
1448651|NCT00839527|4777915|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
1448652|NCT00839527|4777916|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
1448653|NCT00839527|4777917|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
1448654|NCT00839527|4777915|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
1448655|NCT00839527|4777916|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
1448656|NCT00839527|4777917|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
1448657|NCT00839527|4777915|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
1448658|NCT00839527|4777916|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
1448659|NCT00839527|4777917|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
1448660|NCT00839436|4777952|P3|Overall Study|Study drug no longer available|1
1448661|NCT00839436|4777953|P2|Overall Study|Study drug no longer available|0
1448662|NCT00839436|4777954|P1|Overall Study|Study drug no longer available|0
1448663|NCT00839436|4777952|P3|Overall Study|Withdrawal by Subject|0
1448664|NCT00839436|4777953|P2|Overall Study|Withdrawal by Subject|1
1448665|NCT00839436|4777954|P1|Overall Study|Withdrawal by Subject|0
1448666|NCT00839436|4777952|P3|Overall Study|Developed exclusionary condition|0
1448667|NCT00839436|4777953|P2|Overall Study|Developed exclusionary condition|0
1448668|NCT00839436|4777954|P1|Overall Study|Developed exclusionary condition|1
1448669|NCT00839423|4777966|P4|Overall Study|Administrative or other reasons|0
1448670|NCT00839423|4777967|P3|Overall Study|Administrative or other reasons|1
1448671|NCT00839423|4777968|P2|Overall Study|Administrative or other reasons|0
1448672|NCT00839423|4777969|P1|Overall Study|Administrative or other reasons|3
1448673|NCT00839423|4777966|P4|Overall Study|Lost to Follow-up|0
1448674|NCT00839423|4777967|P3|Overall Study|Lost to Follow-up|1
1448675|NCT00839423|4777968|P2|Overall Study|Lost to Follow-up|0
1448676|NCT00839423|4777969|P1|Overall Study|Lost to Follow-up|1
1448677|NCT00839423|4777966|P4|Overall Study|Withdrawal of consent|1
1448678|NCT00839423|4777967|P3|Overall Study|Withdrawal of consent|4
1448679|NCT00839423|4777968|P2|Overall Study|Withdrawal of consent|0
1448680|NCT00839423|4777969|P1|Overall Study|Withdrawal of consent|4
1448681|NCT00839423|4777966|P4|Overall Study|Protocol Violation|0
1448682|NCT00839423|4777967|P3|Overall Study|Protocol Violation|2
1448683|NCT00839423|4777968|P2|Overall Study|Protocol Violation|1
1448684|NCT00839423|4777969|P1|Overall Study|Protocol Violation|0
1448685|NCT00839423|4777966|P4|Overall Study|Non-compliance|1
1448686|NCT00839423|4777967|P3|Overall Study|Non-compliance|0
1448687|NCT00839423|4777968|P2|Overall Study|Non-compliance|0
1448688|NCT00839423|4777969|P1|Overall Study|Non-compliance|0
1448689|NCT00839423|4777966|P4|Overall Study|Lack of Efficacy|2
1448690|NCT00839423|4777967|P3|Overall Study|Lack of Efficacy|3
1448691|NCT00839423|4777968|P2|Overall Study|Lack of Efficacy|6
1448692|NCT00839423|4777969|P1|Overall Study|Lack of Efficacy|6
1448693|NCT00839423|4777966|P4|Overall Study|Adverse Event|16
1448694|NCT00839423|4777967|P3|Overall Study|Adverse Event|7
1448695|NCT00839423|4777968|P2|Overall Study|Adverse Event|3
1448696|NCT00839423|4777969|P1|Overall Study|Adverse Event|4
1448697|NCT00839332|4778010|P3|Phase 2|Lost to Follow-up|1
1448698|NCT00839332|4778011|P2|Phase 2|Lost to Follow-up|0
1448699|NCT00839332|4778012|P1|Phase 2|Lost to Follow-up|0
1448700|NCT00839332|4778010|P3|Phase 2|Physician Decision|1
1448701|NCT00839332|4778011|P2|Phase 2|Physician Decision|4
1448702|NCT00839332|4778012|P1|Phase 2|Physician Decision|0
1448703|NCT00839332|4778010|P3|Phase 2|Withdrawal by Subject|8
1448704|NCT00839332|4778011|P2|Phase 2|Withdrawal by Subject|5
1448705|NCT00839332|4778012|P1|Phase 2|Withdrawal by Subject|0
1448706|NCT00839332|4778010|P3|Phase 2|Death|2
1448707|NCT00839332|4778011|P2|Phase 2|Death|4
1448708|NCT00839332|4778012|P1|Phase 2|Death|0
1448709|NCT00839332|4778010|P3|Phase 2|Adverse Event|6
1448710|NCT00839332|4778011|P2|Phase 2|Adverse Event|8
1448711|NCT00839332|4778012|P1|Phase 2|Adverse Event|0
1448712|NCT00839332|4778010|P3|Phase 2|Disease Progression|21
1448713|NCT00839332|4778011|P2|Phase 2|Disease Progression|46
1448714|NCT00839332|4778012|P1|Phase 2|Disease Progression|0
1448715|NCT00839332|4778010|P3|Phase 2|Protocol Violation|0
1448716|NCT00839332|4778011|P2|Phase 2|Protocol Violation|1
1448717|NCT00839332|4778012|P1|Phase 2|Protocol Violation|0
1448718|NCT00839332|4778010|P3|Phase 1|Physician Decision|0
1448719|NCT00839332|4778011|P2|Phase 1|Physician Decision|0
1448720|NCT00839332|4778012|P1|Phase 1|Physician Decision|2
1448721|NCT00839332|4778010|P3|Phase 1|Withdrawal by Subject|0
1448722|NCT00839332|4778011|P2|Phase 1|Withdrawal by Subject|0
1448723|NCT00839332|4778012|P1|Phase 1|Withdrawal by Subject|4
1448724|NCT00839332|4778010|P3|Phase 1|Adverse Event|0
1448725|NCT00839332|4778011|P2|Phase 1|Adverse Event|0
1448726|NCT00839332|4778012|P1|Phase 1|Adverse Event|6
1448727|NCT00839332|4778010|P3|Phase 1|Disease Progression|0
1448728|NCT00839332|4778011|P2|Phase 1|Disease Progression|0
1448729|NCT00839332|4778012|P1|Phase 1|Disease Progression|38
1448730|NCT00839306|4778073|P2|Overall Study|Not specified|18
1448731|NCT00839306|4778074|P1|Overall Study|Not specified|6
1448732|NCT00839306|4778073|P2|Overall Study|Lack of Efficacy|4
1448733|NCT00839306|4778074|P1|Overall Study|Lack of Efficacy|5
1448734|NCT00839306|4778073|P2|Overall Study|Withdrawal by Subject|7
1448735|NCT00839306|4778074|P1|Overall Study|Withdrawal by Subject|5
1448736|NCT00839306|4778073|P2|Overall Study|Lost to Follow-up|9
1448737|NCT00839306|4778074|P1|Overall Study|Lost to Follow-up|6
1448738|NCT00839306|4778073|P2|Overall Study|Adverse Event|5
1448739|NCT00839306|4778074|P1|Overall Study|Adverse Event|3
1448740|NCT00839098|4778172|P3|Overall Study|Withdrawal by Subject|7
1448741|NCT00839098|4778173|P2|Overall Study|Withdrawal by Subject|1
1448742|NCT00839098|4778174|P1|Overall Study|Withdrawal by Subject|2
1448743|NCT00839072|4778200|P2|Second Intervention Period|Withdrawal by Subject|0
1448744|NCT00839072|4778201|P1|Second Intervention Period|Withdrawal by Subject|1
1448745|NCT00839072|4778200|P2|First Intervention Period|Adverse Event|1
1448746|NCT00839072|4778201|P1|First Intervention Period|Adverse Event|1
1448747|NCT00839072|4778200|P2|First Intervention Period|Withdrawal by Subject|0
1448748|NCT00839072|4778201|P1|First Intervention Period|Withdrawal by Subject|1
1448749|NCT00838929|4778245|P3|Overall Study|Disease progression|1
1448750|NCT00838929|4778246|P2|Overall Study|Disease progression|2
1448751|NCT00838929|4778247|P1|Overall Study|Disease progression|0
1448752|NCT00838929|4778245|P3|Overall Study|Protocol Violation|0
1448753|NCT00838929|4778246|P2|Overall Study|Protocol Violation|1
1448754|NCT00838929|4778247|P1|Overall Study|Protocol Violation|0
1448755|NCT00838916|4778255|P2|Follow-up Period (8 Weeks)|Missing|0
1448756|NCT00838916|4778256|P1|Follow-up Period (8 Weeks)|Missing|3
1448757|NCT00838916|4778255|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
1448758|NCT00838916|4778256|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
1448759|NCT00838916|4778255|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
1448760|NCT00838916|4778256|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
1448761|NCT00838916|4778255|P2|Follow-up Period (8 Weeks)|Physician Decision|0
1448762|NCT00838916|4778256|P1|Follow-up Period (8 Weeks)|Physician Decision|2
1448763|NCT00838916|4778255|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
1448764|NCT00838916|4778256|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
1448765|NCT00838916|4778255|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
1448766|NCT00838916|4778256|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
1448767|NCT00838916|4778255|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
1448768|NCT00838916|4778256|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
1448769|NCT00838916|4778255|P2|Follow-up Period (8 Weeks)|Noncompliance|5
1448770|NCT00838916|4778256|P1|Follow-up Period (8 Weeks)|Noncompliance|6
1448771|NCT00838916|4778255|P2|Follow-up Period (8 Weeks)|Adverse Event|5
1448772|NCT00838916|4778256|P1|Follow-up Period (8 Weeks)|Adverse Event|10
1448773|NCT00838916|4778255|P2|Treatment Period (156 Weeks)|Pregnancy|0
1448774|NCT00838916|4778256|P1|Treatment Period (156 Weeks)|Pregnancy|2
1448775|NCT00838916|4778255|P2|Treatment Period (156 Weeks)|Missing|1
1448776|NCT00838916|4778256|P1|Treatment Period (156 Weeks)|Missing|3
1448777|NCT00838916|4778255|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
1448778|NCT00838916|4778256|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
1448779|NCT00838916|4778255|P2|Treatment Period (156 Weeks)|Physician Decision|1
1448780|NCT00838916|4778256|P1|Treatment Period (156 Weeks)|Physician Decision|6
1448781|NCT00838916|4778255|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
1448782|NCT00838916|4778256|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
1448783|NCT00838916|4778255|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
1448784|NCT00838916|4778256|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
1448785|NCT00838916|4778255|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
1448786|NCT00838916|4778256|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
1448787|NCT00838916|4778255|P2|Treatment Period (156 Weeks)|Noncompliance|14
1448788|NCT00838916|4778256|P1|Treatment Period (156 Weeks)|Noncompliance|21
1448789|NCT00838916|4778255|P2|Treatment Period (156 Weeks)|Protocol Violation|3
1448790|NCT00838916|4778256|P1|Treatment Period (156 Weeks)|Protocol Violation|12
1448791|NCT00838916|4778255|P2|Treatment Period (156 Weeks)|Adverse Event|11
1448792|NCT00838916|4778256|P1|Treatment Period (156 Weeks)|Adverse Event|50
1448793|NCT00838903|4778285|P4|Follow-up Period (8 Weeks)|Missing|1
1448794|NCT00838903|4778286|P3|Follow-up Period (8 Weeks)|Missing|1
1448795|NCT00838903|4778287|P2|Follow-up Period (8 Weeks)|Missing|2
1448796|NCT00838903|4778288|P1|Follow-up Period (8 Weeks)|Missing|1
1448797|NCT00838903|4778285|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
1448798|NCT00838903|4778286|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
1448799|NCT00838903|4778287|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
1448800|NCT00838903|4778288|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
1448801|NCT00838903|4778285|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
1448802|NCT00838903|4778286|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
1448803|NCT00838903|4778287|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
1448804|NCT00838903|4778288|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
1448805|NCT00838903|4778285|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
1448806|NCT00838903|4778286|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
1448807|NCT00838903|4778287|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
1448808|NCT00838903|4778288|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
1448809|NCT00838903|4778285|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
1448810|NCT00838903|4778286|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
1448811|NCT00838903|4778287|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
1448812|NCT00838903|4778288|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
1448813|NCT00838903|4778285|P4|Follow-up Period (8 Weeks)|Physician Decision|1
1448814|NCT00838903|4778286|P3|Follow-up Period (8 Weeks)|Physician Decision|1
1448815|NCT00838903|4778287|P2|Follow-up Period (8 Weeks)|Physician Decision|1
1448816|NCT00838903|4778288|P1|Follow-up Period (8 Weeks)|Physician Decision|1
1448817|NCT00838903|4778285|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
1448818|NCT00838903|4778286|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
1448819|NCT00838903|4778287|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
1448820|NCT00838903|4778288|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
1448821|NCT00838903|4778285|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
1448822|NCT00838903|4778286|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
1448823|NCT00838903|4778287|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
1448824|NCT00838903|4778288|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
1448825|NCT00838903|4778285|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
1448826|NCT00838903|4778286|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
1448827|NCT00838903|4778287|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
1448828|NCT00838903|4778288|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
1448829|NCT00838903|4778285|P4|Follow-up Period (8 Weeks)|Noncompliance|5
1448830|NCT00838903|4778286|P3|Follow-up Period (8 Weeks)|Noncompliance|5
1448831|NCT00838903|4778287|P2|Follow-up Period (8 Weeks)|Noncompliance|8
1448832|NCT00838903|4778288|P1|Follow-up Period (8 Weeks)|Noncompliance|2
1448833|NCT00838903|4778285|P4|Follow-up Period (8 Weeks)|Adverse Event|1
1448834|NCT00838903|4778286|P3|Follow-up Period (8 Weeks)|Adverse Event|3
1448835|NCT00838903|4778287|P2|Follow-up Period (8 Weeks)|Adverse Event|0
1448836|NCT00838903|4778288|P1|Follow-up Period (8 Weeks)|Adverse Event|0
1448837|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
1448838|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
1448839|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
1448840|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
1448841|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
1448842|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
1448843|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
1448844|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
1448845|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
1448846|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
1448847|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
1448848|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
1448849|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Site closed|0
1448850|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Site closed|1
1448851|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Site closed|0
1448852|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Site closed|0
1448853|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
1448854|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
1448855|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
1448856|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
1448857|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Pregnancy|0
1448858|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Pregnancy|1
1448859|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Pregnancy|0
1448860|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Pregnancy|0
1448861|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
1448862|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
1448863|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
1448864|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
1448865|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
1448866|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
1448867|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
1448868|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
1448869|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
1448870|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
1448871|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
1448952|NCT00838539|4778390|P2|Overall Study|Physician Decision|0
1448872|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
1448873|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
1448874|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
1448875|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
1448876|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
1448877|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Physician Decision|2
1448878|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Physician Decision|1
1448879|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Physician Decision|2
1448880|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Physician Decision|1
1448881|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
1448882|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
1448883|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
1448884|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
1448885|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
1448886|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
1448887|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
1448888|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
1448889|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
1448890|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
1448891|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
1448892|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
1448893|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Noncompliance|6
1448894|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Noncompliance|12
1448895|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Noncompliance|13
1448896|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Noncompliance|9
1448897|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Protocol Violation|5
1448898|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Protocol Violation|6
1448899|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Protocol Violation|6
1448900|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Protocol Violation|1
1448901|NCT00838903|4778285|P4|Treatment Period (156 Weeks)|Adverse Event|25
1448902|NCT00838903|4778286|P3|Treatment Period (156 Weeks)|Adverse Event|17
1448903|NCT00838903|4778287|P2|Treatment Period (156 Weeks)|Adverse Event|13
1448904|NCT00838903|4778288|P1|Treatment Period (156 Weeks)|Adverse Event|5
1448905|NCT00838682|4778332|P2|Overall Study|Withdrawal by Subject|1
1448906|NCT00838682|4778333|P1|Overall Study|Withdrawal by Subject|0
1448907|NCT00838682|4778332|P2|Overall Study|Protocol Violation|1
1448908|NCT00838682|4778333|P1|Overall Study|Protocol Violation|0
1448909|NCT00838682|4778332|P2|Overall Study|detection of exclusion criteria|3
1448910|NCT00838682|4778333|P1|Overall Study|detection of exclusion criteria|4
1448911|NCT00838682|4778332|P2|Overall Study|Lost to Follow-up|14
1448912|NCT00838682|4778333|P1|Overall Study|Lost to Follow-up|21
1448913|NCT00838630|4778351|P2|Washout: 7 Days|Protocol Violation|0
1448914|NCT00838630|4778352|P1|Washout: 7 Days|Protocol Violation|1
1448915|NCT00838630|4778351|P2|First Intervention|Adverse Event|0
1448916|NCT00838630|4778352|P1|First Intervention|Adverse Event|1
1448917|NCT00838578|4778360|P1|Overall Study|Protocol Violation|2
1448918|NCT00838539|4778380|P12|Overall Study|Symptomatic Deterioration|0
1448919|NCT00838539|4778381|P11|Overall Study|Symptomatic Deterioration|0
1448920|NCT00838539|4778382|P10|Overall Study|Symptomatic Deterioration|1
1448921|NCT00838539|4778383|P9|Overall Study|Symptomatic Deterioration|0
1448922|NCT00838539|4778384|P8|Overall Study|Symptomatic Deterioration|0
1448923|NCT00838539|4778385|P7|Overall Study|Symptomatic Deterioration|0
1448924|NCT00838539|4778386|P6|Overall Study|Symptomatic Deterioration|1
1448925|NCT00838539|4778387|P5|Overall Study|Symptomatic Deterioration|0
1448926|NCT00838539|4778388|P4|Overall Study|Symptomatic Deterioration|1
1448927|NCT00838539|4778389|P3|Overall Study|Symptomatic Deterioration|1
1448928|NCT00838539|4778390|P2|Overall Study|Symptomatic Deterioration|0
1448929|NCT00838539|4778391|P1|Overall Study|Symptomatic Deterioration|0
1448930|NCT00838539|4778380|P12|Overall Study|Clinical Progression|0
1448931|NCT00838539|4778381|P11|Overall Study|Clinical Progression|0
1448932|NCT00838539|4778382|P10|Overall Study|Clinical Progression|0
1448933|NCT00838539|4778383|P9|Overall Study|Clinical Progression|0
1448934|NCT00838539|4778384|P8|Overall Study|Clinical Progression|0
1448935|NCT00838539|4778385|P7|Overall Study|Clinical Progression|1
1448936|NCT00838539|4778386|P6|Overall Study|Clinical Progression|0
1448937|NCT00838539|4778387|P5|Overall Study|Clinical Progression|0
1448938|NCT00838539|4778388|P4|Overall Study|Clinical Progression|0
1448939|NCT00838539|4778389|P3|Overall Study|Clinical Progression|0
1448940|NCT00838539|4778390|P2|Overall Study|Clinical Progression|0
1448941|NCT00838539|4778391|P1|Overall Study|Clinical Progression|0
1448942|NCT00838539|4778380|P12|Overall Study|Physician Decision|0
1448943|NCT00838539|4778381|P11|Overall Study|Physician Decision|0
1448944|NCT00838539|4778382|P10|Overall Study|Physician Decision|0
1448945|NCT00838539|4778383|P9|Overall Study|Physician Decision|1
1448946|NCT00838539|4778384|P8|Overall Study|Physician Decision|0
1448947|NCT00838539|4778385|P7|Overall Study|Physician Decision|0
1448948|NCT00838539|4778386|P6|Overall Study|Physician Decision|0
1448949|NCT00838539|4778387|P5|Overall Study|Physician Decision|0
1448950|NCT00838539|4778388|P4|Overall Study|Physician Decision|0
1448951|NCT00838539|4778389|P3|Overall Study|Physician Decision|0
1448953|NCT00838539|4778391|P1|Overall Study|Physician Decision|0
1448954|NCT00838539|4778380|P12|Overall Study|Death|0
1448955|NCT00838539|4778381|P11|Overall Study|Death|0
1448956|NCT00838539|4778382|P10|Overall Study|Death|0
1448957|NCT00838539|4778383|P9|Overall Study|Death|0
1448958|NCT00838539|4778384|P8|Overall Study|Death|0
1448959|NCT00838539|4778385|P7|Overall Study|Death|1
1448960|NCT00838539|4778386|P6|Overall Study|Death|0
1448961|NCT00838539|4778387|P5|Overall Study|Death|0
1448962|NCT00838539|4778388|P4|Overall Study|Death|0
1448963|NCT00838539|4778389|P3|Overall Study|Death|0
1448964|NCT00838539|4778390|P2|Overall Study|Death|0
1448965|NCT00838539|4778391|P1|Overall Study|Death|0
1448966|NCT00838539|4778380|P12|Overall Study|Withdrawal by Subject|0
1448967|NCT00838539|4778381|P11|Overall Study|Withdrawal by Subject|2
1448968|NCT00838539|4778382|P10|Overall Study|Withdrawal by Subject|1
1448969|NCT00838539|4778383|P9|Overall Study|Withdrawal by Subject|0
1448970|NCT00838539|4778384|P8|Overall Study|Withdrawal by Subject|0
1448971|NCT00838539|4778385|P7|Overall Study|Withdrawal by Subject|0
1448972|NCT00838539|4778386|P6|Overall Study|Withdrawal by Subject|0
1448973|NCT00838539|4778387|P5|Overall Study|Withdrawal by Subject|0
1448974|NCT00838539|4778388|P4|Overall Study|Withdrawal by Subject|0
1448975|NCT00838539|4778389|P3|Overall Study|Withdrawal by Subject|0
1448976|NCT00838539|4778390|P2|Overall Study|Withdrawal by Subject|1
1448977|NCT00838539|4778391|P1|Overall Study|Withdrawal by Subject|0
1448978|NCT00838539|4778380|P12|Overall Study|Adverse Event|0
1448979|NCT00838539|4778381|P11|Overall Study|Adverse Event|2
1448980|NCT00838539|4778382|P10|Overall Study|Adverse Event|1
1448981|NCT00838539|4778383|P9|Overall Study|Adverse Event|0
1448982|NCT00838539|4778384|P8|Overall Study|Adverse Event|2
1448983|NCT00838539|4778385|P7|Overall Study|Adverse Event|0
1448984|NCT00838539|4778386|P6|Overall Study|Adverse Event|1
1448985|NCT00838539|4778387|P5|Overall Study|Adverse Event|2
1448986|NCT00838539|4778388|P4|Overall Study|Adverse Event|1
1448987|NCT00838539|4778389|P3|Overall Study|Adverse Event|1
1448988|NCT00838539|4778390|P2|Overall Study|Adverse Event|1
1448989|NCT00838539|4778391|P1|Overall Study|Adverse Event|1
1448990|NCT00838539|4778380|P12|Overall Study|Disease Progression|4
1448991|NCT00838539|4778381|P11|Overall Study|Disease Progression|1
1448992|NCT00838539|4778382|P10|Overall Study|Disease Progression|5
1448993|NCT00838539|4778383|P9|Overall Study|Disease Progression|4
1448994|NCT00838539|4778384|P8|Overall Study|Disease Progression|4
1448995|NCT00838539|4778385|P7|Overall Study|Disease Progression|3
1448996|NCT00838539|4778386|P6|Overall Study|Disease Progression|2
1448997|NCT00838539|4778387|P5|Overall Study|Disease Progression|4
1448998|NCT00838539|4778388|P4|Overall Study|Disease Progression|2
1448999|NCT00838539|4778389|P3|Overall Study|Disease Progression|3
1449000|NCT00838539|4778390|P2|Overall Study|Disease Progression|4
1449001|NCT00838539|4778391|P1|Overall Study|Disease Progression|2
1449002|NCT00838526|4778429|P2|Overall Study|Not specified|7
1449003|NCT00838526|4778430|P1|Overall Study|Not specified|11
1449004|NCT00838526|4778429|P2|Overall Study|Lack of Efficacy|3
1449005|NCT00838526|4778430|P1|Overall Study|Lack of Efficacy|2
1449006|NCT00838526|4778429|P2|Overall Study|Withdrawal by Subject|5
1449007|NCT00838526|4778430|P1|Overall Study|Withdrawal by Subject|4
1449008|NCT00838526|4778429|P2|Overall Study|Lost to Follow-up|12
1449009|NCT00838526|4778430|P1|Overall Study|Lost to Follow-up|4
1449010|NCT00838526|4778429|P2|Overall Study|Adverse Event|12
1449011|NCT00838526|4778430|P1|Overall Study|Adverse Event|3
1449012|NCT00838513|4778438|P1|Post Treatment Period (Patients Who Disc|Death|1
1449013|NCT00838513|4778438|P1|Extension Treatment Period|Death|1
1449014|NCT00838513|4778438|P1|Screening Period|Screen Failure|3
1449015|NCT00838331|4778454|P1|Aged Blood Transfusion|Withdrawal by Subject|9
1449016|NCT00838279|4778460|P2|Washout|Withdrawal by Subject|1
1449017|NCT00838279|4778461|P1|Washout|Withdrawal by Subject|0
1449018|NCT00838279|4778460|P2|Washout|Protocol Violation|0
1449019|NCT00838279|4778461|P1|Washout|Protocol Violation|1
1449020|NCT00838201|4778471|P2|Overall Study|Death|13
1449021|NCT00838201|4778472|P1|Overall Study|Death|11
1449022|NCT00838201|4778471|P2|Overall Study|Adverse Event|9
1449023|NCT00838201|4778472|P1|Overall Study|Adverse Event|5
1449024|NCT00838201|4778471|P2|Overall Study|Lost to Follow-up|3
1449025|NCT00838201|4778472|P1|Overall Study|Lost to Follow-up|4
1449026|NCT00838201|4778471|P2|Overall Study|Consetn withdrawn|19
1449027|NCT00838201|4778472|P1|Overall Study|Consetn withdrawn|16
1449028|NCT00838201|4778471|P2|Overall Study|Disease progression|3
1449029|NCT00838201|4778472|P1|Overall Study|Disease progression|3
1449030|NCT00838201|4778471|P2|Overall Study|Administrative decision|2
1449031|NCT00838201|4778472|P1|Overall Study|Administrative decision|1
1449032|NCT00838201|4778471|P2|Overall Study|Noncompliance|1
1449033|NCT00838201|4778472|P1|Overall Study|Noncompliance|0
1449034|NCT00838201|4778471|P2|Overall Study|Investigator decision, or other reasons|3
1449035|NCT00838201|4778472|P1|Overall Study|Investigator decision, or other reasons|2
1449036|NCT00838110|4778540|P4|Overall Study|Randomized but not treated|0
1449037|NCT00838110|4778541|P3|Overall Study|Randomized but not treated|0
1449038|NCT00838110|4778542|P2|Overall Study|Randomized but not treated|1
1449039|NCT00838110|4778543|P1|Overall Study|Randomized but not treated|0
1449040|NCT00838110|4778540|P4|Overall Study|Did not meet eligibility criteria|2
1449041|NCT00838110|4778541|P3|Overall Study|Did not meet eligibility criteria|1
1449042|NCT00838110|4778542|P2|Overall Study|Did not meet eligibility criteria|0
1449043|NCT00838110|4778543|P1|Overall Study|Did not meet eligibility criteria|0
1449044|NCT00838110|4778540|P4|Overall Study|Lost to Follow-up|0
1449045|NCT00838110|4778541|P3|Overall Study|Lost to Follow-up|0
1449046|NCT00838110|4778542|P2|Overall Study|Lost to Follow-up|0
1449047|NCT00838110|4778543|P1|Overall Study|Lost to Follow-up|3
1449048|NCT00838110|4778540|P4|Overall Study|Protocol Violation|1
1449049|NCT00838110|4778541|P3|Overall Study|Protocol Violation|1
1449050|NCT00838110|4778542|P2|Overall Study|Protocol Violation|2
1449051|NCT00838110|4778543|P1|Overall Study|Protocol Violation|0
1449052|NCT00838110|4778540|P4|Overall Study|Other|2
1449053|NCT00838110|4778541|P3|Overall Study|Other|3
1449054|NCT00838110|4778542|P2|Overall Study|Other|3
1449055|NCT00838110|4778543|P1|Overall Study|Other|3
1449056|NCT00838110|4778540|P4|Overall Study|Withdrawal by Subject|4
1449057|NCT00838110|4778541|P3|Overall Study|Withdrawal by Subject|3
1449058|NCT00838110|4778542|P2|Overall Study|Withdrawal by Subject|6
1449059|NCT00838110|4778543|P1|Overall Study|Withdrawal by Subject|5
1449060|NCT00838110|4778540|P4|Overall Study|Adverse Event|7
1449061|NCT00838110|4778541|P3|Overall Study|Adverse Event|8
1449062|NCT00838110|4778542|P2|Overall Study|Adverse Event|10
1449063|NCT00838110|4778543|P1|Overall Study|Adverse Event|11
1449064|NCT00838110|4778540|P4|Overall Study|Death|2
1449065|NCT00838110|4778541|P3|Overall Study|Death|1
1449066|NCT00838110|4778542|P2|Overall Study|Death|0
1449067|NCT00838110|4778543|P1|Overall Study|Death|0
1449068|NCT00838097|4778563|P1|Overall Study|Protocol-specified criteria|142
1449069|NCT00838097|4778563|P1|Overall Study|Death|6
1449070|NCT00838097|4778563|P1|Overall Study|Lost to Follow-up|11
1449071|NCT00838097|4778563|P1|Overall Study|Physician Decision|4
1449072|NCT00838097|4778563|P1|Overall Study|Requirement for alternative therapy|2
1449073|NCT00838097|4778563|P1|Overall Study|Withdrawal by Subject|3
1449074|NCT00838097|4778563|P1|Overall Study|Adverse Event|2
1449075|NCT00838097|4778563|P1|Overall Study|Ineligibility determined|6
1449076|NCT00837967|4778571|P2|Washout Period of 7 - 14 Days|Adverse Event|0
1449077|NCT00837967|4778572|P1|Washout Period of 7 - 14 Days|Adverse Event|2
1449078|NCT00837876|4778588|P1|Overall Study|disease progression|24
1449079|NCT00837876|4778588|P1|Overall Study|Withdrawal by Subject|3
1449080|NCT00837876|4778588|P1|Overall Study|Physician Decision|1
1449081|NCT00837876|4778588|P1|Overall Study|Adverse Event|7
1449082|NCT00837876|4778588|P1|Overall Study|Death|2
1449083|NCT00837811|4778610|P3|Overall Study|Sponsor Decision|0
1449084|NCT00837811|4778611|P2|Overall Study|Sponsor Decision|2
1449085|NCT00837811|4778612|P1|Overall Study|Sponsor Decision|0
1449086|NCT00837811|4778610|P3|Overall Study|Withdrawal by Subject|0
1449087|NCT00837811|4778611|P2|Overall Study|Withdrawal by Subject|9
1449088|NCT00837811|4778612|P1|Overall Study|Withdrawal by Subject|1
1449089|NCT00837811|4778610|P3|Overall Study|Physician Decision|1
1449090|NCT00837811|4778611|P2|Overall Study|Physician Decision|2
1449091|NCT00837811|4778612|P1|Overall Study|Physician Decision|0
1449092|NCT00837811|4778610|P3|Overall Study|Lost to Follow-up|0
1449093|NCT00837811|4778611|P2|Overall Study|Lost to Follow-up|3
1449094|NCT00837811|4778612|P1|Overall Study|Lost to Follow-up|1
1449095|NCT00837811|4778610|P3|Overall Study|Lack of Efficacy|0
1449096|NCT00837811|4778611|P2|Overall Study|Lack of Efficacy|11
1449097|NCT00837811|4778612|P1|Overall Study|Lack of Efficacy|0
1449098|NCT00837811|4778610|P3|Overall Study|Death|0
1449099|NCT00837811|4778611|P2|Overall Study|Death|1
1449100|NCT00837811|4778612|P1|Overall Study|Death|1
1449101|NCT00837811|4778610|P3|Overall Study|Adverse Event|0
1449102|NCT00837811|4778611|P2|Overall Study|Adverse Event|6
1449103|NCT00837811|4778612|P1|Overall Study|Adverse Event|4
1449104|NCT00837759|4778697|P1|Overall Study|Lost to Follow-up|1
1449105|NCT00837759|4778697|P1|Overall Study|Protocol Violation|3
1449106|NCT00837616|4778708|P2|Overall Study|Withdrawal by Subject|1
1449107|NCT00837616|4778709|P1|Overall Study|Withdrawal by Subject|0
1449108|NCT00837577|4778735|P2|Open-label Period|Other Reason|1
1449109|NCT00837577|4778736|P1|Open-label Period|Other Reason|1
1449110|NCT00837577|4778735|P2|Open-label Period|Withdrawal by Subject|2
1449111|NCT00837577|4778736|P1|Open-label Period|Withdrawal by Subject|1
1449112|NCT00837577|4778735|P2|Open-label Period|Lack of Efficacy|3
1449113|NCT00837577|4778736|P1|Open-label Period|Lack of Efficacy|4
1449114|NCT00837577|4778735|P2|Open-label Period|Laboratory Adverse Event|1
1449115|NCT00837577|4778736|P1|Open-label Period|Laboratory Adverse Event|0
1449116|NCT00837577|4778735|P2|Open-label Period|Clinical Adverse Event|2
1449117|NCT00837577|4778736|P1|Open-label Period|Clinical Adverse Event|2
1449118|NCT00837577|4778735|P2|Double-blind Period|Withdrawal by Subject|0
1449119|NCT00837577|4778736|P1|Double-blind Period|Withdrawal by Subject|1
1449120|NCT00837577|4778735|P2|Double-blind Period|Clinical Adverse Event|0
1449121|NCT00837577|4778736|P1|Double-blind Period|Clinical Adverse Event|1
1449122|NCT00837486|4778756|P2|Long-term Follow-up Phase - Open Label|Death|0
1449123|NCT00837486|4778757|P1|Long-term Follow-up Phase - Open Label|Death|1
1449124|NCT00837486|4778756|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
1449125|NCT00837486|4778757|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
1449126|NCT00837486|4778756|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
1449127|NCT00837486|4778757|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
1449128|NCT00837486|4778756|P2|Blinded-treatment Phase|Physician Decision|0
1449129|NCT00837486|4778757|P1|Blinded-treatment Phase|Physician Decision|1
1449130|NCT00837473|4778769|P1|Overall Study|Withdrawal by Subject|2
1449131|NCT00837473|4778769|P1|Overall Study|Lost to Follow-up|1
1449132|NCT00837434|4778789|P2|Overall Study|Unable to obtain study drug|0
1449133|NCT00837434|4778790|P1|Overall Study|Unable to obtain study drug|1
1449134|NCT00837434|4778789|P2|Overall Study|Baseline assessments not done in time|0
1449135|NCT00837434|4778790|P1|Overall Study|Baseline assessments not done in time|1
1449136|NCT00837434|4778789|P2|Overall Study|Noncompliant|0
1449137|NCT00837434|4778790|P1|Overall Study|Noncompliant|2
1449138|NCT00837434|4778789|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
1449139|NCT00837434|4778790|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
1449140|NCT00837434|4778789|P2|Overall Study|Lost to Follow-up|1
1449141|NCT00837434|4778790|P1|Overall Study|Lost to Follow-up|1
1449142|NCT00837434|4778789|P2|Overall Study|Physician Decision|0
1449143|NCT00837434|4778790|P1|Overall Study|Physician Decision|3
1449144|NCT00837330|4778810|P2|Overall Study|Lost to Follow-up|3
1449145|NCT00837330|4778811|P1|Overall Study|Lost to Follow-up|1
1449146|NCT00837213|4778834|P2|Overall Study|not stated|1
1449147|NCT00837213|4778835|P1|Overall Study|not stated|1
1449148|NCT00837213|4778834|P2|Overall Study|Withdrawal by Subject|2
1449149|NCT00837213|4778835|P1|Overall Study|Withdrawal by Subject|2
1449150|NCT00837213|4778834|P2|Overall Study|Lost to Follow-up|2
1449151|NCT00837213|4778835|P1|Overall Study|Lost to Follow-up|3
1449152|NCT00837161|4778861|P1|Overall Study|refused hysterectomy|2
1449153|NCT00837148|4778869|P1|Overall Study|Death|1
1449154|NCT00837148|4778869|P1|Overall Study|Adverse Event|1
1449155|NCT00836953|4778879|P1|Overall Study|Lost to Follow-up|1
1449156|NCT00836953|4778879|P1|Overall Study|Withdrawal by Subject|1
1449157|NCT00836927|4778890|P5|Overall Study|Withdrawal by Subject|0
1449158|NCT00836927|4778891|P4|Overall Study|Withdrawal by Subject|0
1449159|NCT00836927|4778892|P3|Overall Study|Withdrawal by Subject|0
1449160|NCT00836927|4778893|P2|Overall Study|Withdrawal by Subject|0
1449161|NCT00836927|4778894|P1|Overall Study|Withdrawal by Subject|1
1449162|NCT00836927|4778890|P5|Overall Study|Study drug terminated by sponsor|0
1449163|NCT00836927|4778891|P4|Overall Study|Study drug terminated by sponsor|0
1449164|NCT00836927|4778892|P3|Overall Study|Study drug terminated by sponsor|1
1449165|NCT00836927|4778893|P2|Overall Study|Study drug terminated by sponsor|1
1449166|NCT00836927|4778894|P1|Overall Study|Study drug terminated by sponsor|0
1449167|NCT00836927|4778890|P5|Overall Study|Progressive disease|1
1449168|NCT00836927|4778891|P4|Overall Study|Progressive disease|1
1449169|NCT00836927|4778892|P3|Overall Study|Progressive disease|0
1449170|NCT00836927|4778893|P2|Overall Study|Progressive disease|0
1449171|NCT00836927|4778894|P1|Overall Study|Progressive disease|2
1449172|NCT00836901|4778928|P2|First Intervention|Withdrawal by Subject|0
1449173|NCT00836901|4778929|P1|First Intervention|Withdrawal by Subject|1
1449174|NCT00836875|4778945|P2|Overall Study|Withdrawal by Subject|1
1449175|NCT00836875|4778946|P1|Overall Study|Withdrawal by Subject|0
1449176|NCT00836875|4778945|P2|Overall Study|Death|2
1449177|NCT00836875|4778946|P1|Overall Study|Death|3
1449178|NCT00836810|4778962|P2|Overall Study|New diagnosis|0
1449179|NCT00836810|4778963|P1|Overall Study|New diagnosis|1
1449180|NCT00836745|4778979|P1|Overall Study|Other|2
1449181|NCT00836745|4778979|P1|Overall Study|Objective progression or relapse|4
1449182|NCT00836745|4778979|P1|Overall Study|Adverse Event|3
1449183|NCT00836745|4778979|P1|Overall Study|Lost to Follow-up|10
1449184|NCT00836745|4778979|P1|Overall Study|Death|2
1449185|NCT00836706|4778993|P2|Washout: 7 Days|Withdrawal by Subject|1
1449186|NCT00836706|4778994|P1|Washout: 7 Days|Withdrawal by Subject|0
1449187|NCT00836693|4779004|P2|Overall Study|Lost to Follow-up|0
1449188|NCT00836693|4779005|P1|Overall Study|Lost to Follow-up|1
1449189|NCT00836693|4779004|P2|Overall Study|Protocol Violation|0
1449190|NCT00836693|4779005|P1|Overall Study|Protocol Violation|1
1449191|NCT00836693|4779004|P2|Overall Study|Withdrawal by Subject|4
1449192|NCT00836693|4779005|P1|Overall Study|Withdrawal by Subject|9
1449193|NCT00836693|4779004|P2|Overall Study|Physician Decision|0
1449194|NCT00836693|4779005|P1|Overall Study|Physician Decision|2
1449195|NCT00836693|4779004|P2|Overall Study|Sponsor Decision|1
1449196|NCT00836693|4779005|P1|Overall Study|Sponsor Decision|0
1449197|NCT00836693|4779004|P2|Overall Study|Adverse Event|1
1449198|NCT00836693|4779005|P1|Overall Study|Adverse Event|4
1449199|NCT00836498|4779057|P2|Overall Study|Withdrawal by Subject|1
1449200|NCT00836498|4779058|P1|Overall Study|Withdrawal by Subject|2
1449201|NCT00836498|4779057|P2|Overall Study|Lost to Follow-up|0
1449202|NCT00836498|4779058|P1|Overall Study|Lost to Follow-up|1
1449203|NCT00836498|4779057|P2|Overall Study|Adverse Event|0
1449204|NCT00836498|4779058|P1|Overall Study|Adverse Event|1
1449205|NCT00836472|4779090|P2|Washout|Withdrawal by Subject|1
1449206|NCT00836472|4779091|P1|Washout|Withdrawal by Subject|1
1449207|NCT00836472|4779090|P2|Washout|Adverse Event|2
1449208|NCT00836472|4779091|P1|Washout|Adverse Event|1
1449209|NCT00836277|4779168|P1|Overall Study|Not evaluable for response|6
1449210|NCT00836095|4779178|P2|Overall Study|Physician Decision|3
1449211|NCT00836095|4779179|P1|Overall Study|Physician Decision|0
1449212|NCT00836056|4779189|P2|First Intervention|Adverse Event|0
1449213|NCT00836056|4779190|P1|First Intervention|Adverse Event|1
1449214|NCT00835991|4779219|P2|Washout|Withdrawal by Subject|1
1449215|NCT00835991|4779220|P1|Washout|Withdrawal by Subject|3
1449216|NCT00835991|4779219|P2|Washout|Protocol Violation|2
1449217|NCT00835991|4779220|P1|Washout|Protocol Violation|0
1449218|NCT00835991|4779219|P2|First Intervention|Adverse Event|1
1449219|NCT00835991|4779220|P1|First Intervention|Adverse Event|0
1449220|NCT00835978|4779238|P4|Overall Study|Study terminated by sponsor|0
1449221|NCT00835978|4779239|P3|Overall Study|Study terminated by sponsor|30
1449222|NCT00835978|4779240|P2|Overall Study|Study terminated by sponsor|8
1449223|NCT00835978|4779241|P1|Overall Study|Study terminated by sponsor|12
1449224|NCT00835978|4779238|P4|Overall Study|Withdrawal by Subject|5
1449225|NCT00835978|4779239|P3|Overall Study|Withdrawal by Subject|0
1449226|NCT00835978|4779240|P2|Overall Study|Withdrawal by Subject|3
1449227|NCT00835978|4779241|P1|Overall Study|Withdrawal by Subject|0
1449228|NCT00835978|4779238|P4|Overall Study|Adverse Event|0
1449229|NCT00835978|4779239|P3|Overall Study|Adverse Event|1
1449230|NCT00835978|4779240|P2|Overall Study|Adverse Event|0
1449231|NCT00835978|4779241|P1|Overall Study|Adverse Event|1
1449232|NCT00835978|4779238|P4|Overall Study|Objective progression or relapse|0
1449233|NCT00835978|4779239|P3|Overall Study|Objective progression or relapse|1
1449234|NCT00835978|4779240|P2|Overall Study|Objective progression or relapse|0
1449235|NCT00835978|4779241|P1|Overall Study|Objective progression or relapse|2
1449236|NCT00835978|4779238|P4|Overall Study|Not Specified|0
1449237|NCT00835978|4779239|P3|Overall Study|Not Specified|8
1449238|NCT00835978|4779240|P2|Overall Study|Not Specified|1
1449239|NCT00835978|4779241|P1|Overall Study|Not Specified|5
1449240|NCT00835978|4779238|P4|Overall Study|Lost to Follow-up|1
1449241|NCT00835978|4779239|P3|Overall Study|Lost to Follow-up|2
1449242|NCT00835978|4779240|P2|Overall Study|Lost to Follow-up|4
1449243|NCT00835978|4779241|P1|Overall Study|Lost to Follow-up|3
1449244|NCT00835978|4779238|P4|Overall Study|Death|4
1449245|NCT00835978|4779239|P3|Overall Study|Death|49
1449246|NCT00835978|4779240|P2|Overall Study|Death|40
1449247|NCT00835978|4779241|P1|Overall Study|Death|33
1449248|NCT00835796|4779352|P2|First Intervention|Withdrawal by Subject|1
1449249|NCT00835796|4779353|P1|First Intervention|Withdrawal by Subject|0
1449250|NCT00835731|4779363|P2|Overall Study|Physician Decision|1
1449251|NCT00835731|4779364|P1|Overall Study|Physician Decision|1
1449252|NCT00835731|4779363|P2|Overall Study|Withdrawal by Subject|0
1449253|NCT00835731|4779364|P1|Overall Study|Withdrawal by Subject|1
1449254|NCT00835705|4779384|P2|Second Intervention|Difficulty with vein|0
1449255|NCT00835705|4779385|P1|Second Intervention|Difficulty with vein|1
1449256|NCT00835705|4779384|P2|First Intervention|Difficulty with vein|0
1449257|NCT00835705|4779385|P1|First Intervention|Difficulty with vein|1
1449258|NCT00835692|4779401|P2|First Intervention|Withdrawal by Subject|0
1449259|NCT00835692|4779402|P1|First Intervention|Withdrawal by Subject|1
1449260|NCT00835679|4779414|P4|Overall Study|Withdrawal by Subject|0
1449261|NCT00835679|4779415|P3|Overall Study|Withdrawal by Subject|0
1449262|NCT00835679|4779416|P2|Overall Study|Withdrawal by Subject|0
1449263|NCT00835679|4779417|P1|Overall Study|Withdrawal by Subject|1
1449264|NCT00835666|4779441|P2|Washout|Withdrawal by Subject|0
1449265|NCT00835666|4779442|P1|Washout|Withdrawal by Subject|1
1449266|NCT00835666|4779441|P2|Washout|Protocol Violation|0
1449267|NCT00835666|4779442|P1|Washout|Protocol Violation|1
1449268|NCT00835640|4779452|P2|Second Intervention|Protocol Violation|0
1449269|NCT00835640|4779453|P1|Second Intervention|Protocol Violation|1
1449270|NCT00835575|4779485|P2|Washout of 14 Days|Withdrawal by Subject|0
1449271|NCT00835575|4779486|P1|Washout of 14 Days|Withdrawal by Subject|1
1449272|NCT00835549|4779496|P2|Washout of 7 Days|Withdrawal by Subject|0
1449273|NCT00835549|4779497|P1|Washout of 7 Days|Withdrawal by Subject|2
1449274|NCT00835536|4779507|P2|Washout of 5 Weeks|Withdrawal by Subject|0
1449275|NCT00835536|4779508|P1|Washout of 5 Weeks|Withdrawal by Subject|1
1449276|NCT00835406|4779569|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
1449277|NCT00835406|4779570|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
1449278|NCT00835406|4779569|P2|Period: First Intervention|Withdrawal by Subject|0
1449279|NCT00835406|4779570|P1|Period: First Intervention|Withdrawal by Subject|2
1449280|NCT00835406|4779569|P2|Period: First Intervention|Adverse Event|1
1449281|NCT00835406|4779570|P1|Period: First Intervention|Adverse Event|0
1449282|NCT00835380|4779576|P1|Overall Study|Withdrawal by Subject|2
1449283|NCT00835367|4779583|P2|Second Intervention|Adverse Event|1
1449284|NCT00835367|4779584|P1|Second Intervention|Adverse Event|1
1449285|NCT00835367|4779583|P2|Washout|Withdrawal by Subject|0
1449286|NCT00835367|4779584|P1|Washout|Withdrawal by Subject|1
1449287|NCT00835367|4779583|P2|Washout|Adverse Event|0
1449288|NCT00835367|4779584|P1|Washout|Adverse Event|2
1449289|NCT00835354|4779606|P2|First Intervention|Adverse Event|1
1449290|NCT00835354|4779607|P1|First Intervention|Adverse Event|0
1449291|NCT00835341|4779617|P2|Overall Study|Lost to Follow-up|12
1449292|NCT00835341|4779618|P1|Overall Study|Lost to Follow-up|3
1449293|NCT00835263|4779637|P2|Second Intervention|Adverse Event|0
1449294|NCT00835263|4779638|P1|Second Intervention|Adverse Event|1
1449295|NCT00835237|4779648|P2|Overall Study|Withdrawal by Subject|0
1449296|NCT00835237|4779649|P1|Overall Study|Withdrawal by Subject|2
1449297|NCT00835237|4779648|P2|Overall Study|Lost to Follow-up|0
1449298|NCT00835237|4779649|P1|Overall Study|Lost to Follow-up|4
1449299|NCT00835211|4779689|P2|Washout: 7 Days|Withdrawal by Subject|0
1449300|NCT00835211|4779690|P1|Washout: 7 Days|Withdrawal by Subject|1
1449301|NCT00835211|4779689|P2|Washout: 7 Days|Adverse Event|1
1449302|NCT00835211|4779690|P1|Washout: 7 Days|Adverse Event|2
1449303|NCT00835211|4779689|P2|First Intervention|Withdrawal by Subject|1
1449304|NCT00835211|4779690|P1|First Intervention|Withdrawal by Subject|0
1449305|NCT00835172|4779736|P2|Washout|Protocol Violation|1
1449306|NCT00835172|4779737|P1|Washout|Protocol Violation|0
1449307|NCT00835120|4779763|P1|Overall Study|Withdrawal by Subject|2
1449308|NCT00835120|4779763|P1|Overall Study|Adverse Event|2
1449309|NCT00835120|4779763|P1|Overall Study|Lost to Follow-up|3
1449310|NCT00835120|4779763|P1|Overall Study|Lack of Efficacy|1
1449311|NCT00835081|4779773|P2|Washout of 7 Days|Withdrawal by Subject|0
1449312|NCT00835081|4779774|P1|Washout of 7 Days|Withdrawal by Subject|1
1449313|NCT00835068|4779784|P2|Overall Study|Withdrawal by Subject|0
1449314|NCT00835068|4779785|P1|Overall Study|Withdrawal by Subject|1
1449315|NCT00835068|4779784|P2|Overall Study|Other|0
1449316|NCT00835068|4779785|P1|Overall Study|Other|8
1449317|NCT00835068|4779784|P2|Overall Study|Adverse Event|1
1449318|NCT00835068|4779785|P1|Overall Study|Adverse Event|0
1449319|NCT00835068|4779784|P2|Overall Study|Death|0
1449320|NCT00835068|4779785|P1|Overall Study|Death|1
1449321|NCT00835042|4779805|P2|Washout of 21 Days|Withdrawal by Subject|2
1449322|NCT00835042|4779806|P1|Washout of 21 Days|Withdrawal by Subject|0
1449323|NCT00835042|4779805|P2|First Intervention|Adverse Event|2
1449324|NCT00835042|4779806|P1|First Intervention|Adverse Event|1
1449325|NCT00835042|4779805|P2|First Intervention|Withdrawal by Subject|0
1449326|NCT00835042|4779806|P1|First Intervention|Withdrawal by Subject|3
1449327|NCT00834912|4779892|P6|Treatment Period 2|Withdrawal by Subject|0
1449328|NCT00834912|4779893|P5|Treatment Period 2|Withdrawal by Subject|1
1449329|NCT00834912|4779894|P4|Treatment Period 2|Withdrawal by Subject|0
1449330|NCT00834912|4779895|P3|Treatment Period 2|Withdrawal by Subject|1
1449331|NCT00834912|4779896|P2|Treatment Period 2|Withdrawal by Subject|0
1449332|NCT00834912|4779897|P1|Treatment Period 2|Withdrawal by Subject|0
1449333|NCT00834912|4779892|P6|Treatment Period 1|Adverse Event|0
1449334|NCT00834912|4779893|P5|Treatment Period 1|Adverse Event|0
1449335|NCT00834912|4779894|P4|Treatment Period 1|Adverse Event|1
1449336|NCT00834912|4779895|P3|Treatment Period 1|Adverse Event|0
1449337|NCT00834912|4779896|P2|Treatment Period 1|Adverse Event|1
1449338|NCT00834912|4779897|P1|Treatment Period 1|Adverse Event|0
1449339|NCT00834899|4779919|P2|Overall Study|Withdrawal by Subject|1
1449340|NCT00834899|4779920|P1|Overall Study|Withdrawal by Subject|1
1449341|NCT00834873|4779959|P2|First Intervention|Adverse Event|1
1449342|NCT00834873|4779960|P1|First Intervention|Adverse Event|0
1449343|NCT00834834|4779970|P2|Overall Study|Withdrawal by Subject|3
1449344|NCT00834834|4779971|P1|Overall Study|Withdrawal by Subject|4
1449345|NCT00834795|4780006|P2|Second Intervention|Adverse Event|0
1449346|NCT00834795|4780007|P1|Second Intervention|Adverse Event|1
1449347|NCT00834795|4780006|P2|Washout: 7 Days|Withdrawal by Subject|1
1449348|NCT00834795|4780007|P1|Washout: 7 Days|Withdrawal by Subject|0
1449349|NCT00834756|4780017|P2|Washout: 21 Days|Withdrawal by Subject|0
1449350|NCT00834756|4780018|P1|Washout: 21 Days|Withdrawal by Subject|1
1449351|NCT00834756|4780017|P2|First Intervention|Adverse Event|0
1449352|NCT00834756|4780018|P1|First Intervention|Adverse Event|1
1449353|NCT00834743|4780028|P2|Second Intervention|Withdrawal by Subject|0
1449354|NCT00834743|4780029|P1|Second Intervention|Withdrawal by Subject|1
1449355|NCT00834717|4780039|P2|First Intervention|Withdrawal by Subject|1
1449356|NCT00834717|4780040|P1|First Intervention|Withdrawal by Subject|0
1449357|NCT00834717|4780039|P2|First Intervention|Adverse Event|0
1449358|NCT00834717|4780040|P1|First Intervention|Adverse Event|1
1449359|NCT00834639|4780071|P2|Second Intervention|Physician Decision|2
1449360|NCT00834639|4780072|P1|Second Intervention|Physician Decision|0
1449361|NCT00834613|4780089|P2|First Intervention|Protocol Violation|0
1449362|NCT00834613|4780090|P1|First Intervention|Protocol Violation|1
1449363|NCT00834587|4780100|P2|Washout: 7 Days|Withdrawal by Subject|0
1449364|NCT00834587|4780101|P1|Washout: 7 Days|Withdrawal by Subject|1
1449365|NCT00834522|4780150|P2|Washout|Withdrawal by Subject|1
1449366|NCT00834522|4780151|P1|Washout|Withdrawal by Subject|2
1449367|NCT00834522|4780150|P2|Washout|Adverse Event|0
1449368|NCT00834522|4780151|P1|Washout|Adverse Event|1
1449369|NCT00834444|4780174|P2|Second Intervention|Adverse Event|0
1449370|NCT00834444|4780175|P1|Second Intervention|Adverse Event|1
1449371|NCT00834444|4780174|P2|Washout of 7 Days|Withdrawal by Subject|1
1449372|NCT00834444|4780175|P1|Washout of 7 Days|Withdrawal by Subject|0
1449373|NCT00834444|4780174|P2|First Intervention|Intolerance to Venopuncture|1
1449374|NCT00834444|4780175|P1|First Intervention|Intolerance to Venopuncture|0
1449375|NCT00834444|4780174|P2|First Intervention|Adverse Event|0
1449376|NCT00834444|4780175|P1|First Intervention|Adverse Event|1
1449377|NCT00834431|4780185|P2|Washout of 7 Days|Withdrawal by Subject|1
1449378|NCT00834431|4780186|P1|Washout of 7 Days|Withdrawal by Subject|0
1449379|NCT00834431|4780185|P2|First Intervention|Adverse Event|1
1449380|NCT00834431|4780186|P1|First Intervention|Adverse Event|0
1449381|NCT00834418|4780196|P2|Overall Study|Adverse Event|2
1449382|NCT00834418|4780197|P1|Overall Study|Adverse Event|0
1449383|NCT00834366|4780214|P2|Treatment Period 1|Adverse Event|1
1449384|NCT00834366|4780215|P1|Treatment Period 1|Adverse Event|1
1449385|NCT00834340|4780231|P2|Washout|Withdrawal by Subject|0
1449386|NCT00834340|4780232|P1|Washout|Withdrawal by Subject|1
1449387|NCT00834340|4780231|P2|Washout|Adverse Event|0
1449388|NCT00834340|4780232|P1|Washout|Adverse Event|1
1449389|NCT00834249|4780276|P2|Second Intervention|Adverse Event|0
1449390|NCT00834249|4780277|P1|Second Intervention|Adverse Event|1
1449391|NCT00834249|4780276|P2|Washout: 7 Days|Withdrawal by Subject|1
1449392|NCT00834249|4780277|P1|Washout: 7 Days|Withdrawal by Subject|1
1449393|NCT00834080|4780373|P1|Overall Study|Subject Relocated|1
1449394|NCT00834080|4780373|P1|Overall Study|Physician Decision|1
1449395|NCT00834080|4780373|P1|Overall Study|Other - False positive tests of the UDS|1
1449396|NCT00834080|4780373|P1|Overall Study|Other - Pregnancy|1
1449397|NCT00834080|4780373|P1|Overall Study|Withdrawal by Subject|5
1449398|NCT00834080|4780373|P1|Overall Study|Lost to Follow-up|7
1449399|NCT00834080|4780373|P1|Overall Study|Adverse Event|7
1449400|NCT00834067|4780379|P2|Washout of 21 Days|Protocol Violation|1
1449401|NCT00834067|4780380|P1|Washout of 21 Days|Protocol Violation|0
1449402|NCT00834041|4780402|P2|Overall Study|Lost to Follow-up|1
1449403|NCT00834041|4780403|P1|Overall Study|Lost to Follow-up|0
1449404|NCT00834041|4780402|P2|Overall Study|Withdrawal by Subject|0
1449405|NCT00834041|4780403|P1|Overall Study|Withdrawal by Subject|1
1449406|NCT00833989|4780421|P4|Overall Study|Withdrawal by Subject|1
1449407|NCT00833989|4780422|P3|Overall Study|Withdrawal by Subject|1
1449408|NCT00833989|4780423|P2|Overall Study|Withdrawal by Subject|0
1449409|NCT00833989|4780424|P1|Overall Study|Withdrawal by Subject|3
1449410|NCT00833989|4780421|P4|Overall Study|Physician Decision|1
1449411|NCT00833989|4780422|P3|Overall Study|Physician Decision|0
1449412|NCT00833989|4780423|P2|Overall Study|Physician Decision|0
1449413|NCT00833989|4780424|P1|Overall Study|Physician Decision|0
1449414|NCT00833976|4780528|P1|Overall Study|Physician Decision|1
1449415|NCT00833976|4780528|P1|Overall Study|Did not meet eligibility criteria|41
1449416|NCT00833976|4780528|P1|Overall Study|Lost to Follow-up|4
1449417|NCT00833976|4780528|P1|Overall Study|Withdrawal by Subject|5
1449418|NCT00833937|4780536|P2|Washout|Withdrawal by Subject|0
1449419|NCT00833937|4780537|P1|Washout|Withdrawal by Subject|1
1449420|NCT00833924|4780545|P1|Overall Study|In study follow-up|71
1449421|NCT00833924|4780545|P1|Overall Study|Withdrawal by Subject|13
1449422|NCT00833924|4780545|P1|Overall Study|Lost to Follow-up|2
1449423|NCT00833924|4780545|P1|Overall Study|Conversion|2
1449424|NCT00833924|4780545|P1|Overall Study|Death|21
1449425|NCT00833911|4780550|P1|Maintenance Phase II|Lack of Efficacy|1
1449426|NCT00833911|4780550|P1|Maintenance Phase II|Withdrawal by Subject|1
1449427|NCT00833911|4780550|P1|Maintenance Phase II|Physician Decision|2
1449428|NCT00833911|4780550|P1|Maintenance Phase II|Adverse Event|6
1449429|NCT00833911|4780550|P1|Maintenance Phase I|Lack of Efficacy|4
1449430|NCT00833911|4780550|P1|Maintenance Phase I|Physician Decision|10
1449431|NCT00833911|4780550|P1|Maintenance Phase I|Withdrawal by Subject|11
1449432|NCT00833911|4780550|P1|Maintenance Phase I|Adverse Event|73
1449433|NCT00833911|4780550|P1|Titration|Withdrawal by Subject|3
1449434|NCT00833911|4780550|P1|Titration|Adverse Event|18
1449435|NCT00833898|4780560|P2|Overall Study|Patient did not receive transplant|2
1449436|NCT00833898|4780561|P1|Overall Study|Patient did not receive transplant|0
1449437|NCT00833898|4780560|P2|Overall Study|Lost to Follow-up|7
1449438|NCT00833898|4780561|P1|Overall Study|Lost to Follow-up|7
1449439|NCT00833898|4780560|P2|Overall Study|Withdrawal by Subject|27
1449440|NCT00833898|4780561|P1|Overall Study|Withdrawal by Subject|33
1449441|NCT00833833|4780620|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
1449442|NCT00833833|4780621|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
1449443|NCT00833833|4780622|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
1449444|NCT00833833|4780623|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
1449445|NCT00833833|4780624|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
1449446|NCT00833833|4780625|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
1449447|NCT00833833|4780620|P6|Phase 2 (as of 01 April 2011)|Other|3
1449448|NCT00833833|4780621|P5|Phase 2 (as of 01 April 2011)|Other|4
1449449|NCT00833833|4780622|P4|Phase 2 (as of 01 April 2011)|Other|0
1449450|NCT00833833|4780623|P3|Phase 2 (as of 01 April 2011)|Other|0
1449451|NCT00833833|4780624|P2|Phase 2 (as of 01 April 2011)|Other|0
1449452|NCT00833833|4780625|P1|Phase 2 (as of 01 April 2011)|Other|0
1449453|NCT00833833|4780620|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
1449454|NCT00833833|4780621|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
1449455|NCT00833833|4780622|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
1449456|NCT00833833|4780623|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
1449457|NCT00833833|4780624|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
1449458|NCT00833833|4780625|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
1449459|NCT00833833|4780620|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
1449460|NCT00833833|4780621|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
1449461|NCT00833833|4780622|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
1449462|NCT00833833|4780623|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
1449463|NCT00833833|4780624|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
1449464|NCT00833833|4780625|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
1449465|NCT00833833|4780620|P6|Phase 2 (as of 01 April 2011)|Death|9
1449466|NCT00833833|4780621|P5|Phase 2 (as of 01 April 2011)|Death|8
1449467|NCT00833833|4780622|P4|Phase 2 (as of 01 April 2011)|Death|0
1449468|NCT00833833|4780623|P3|Phase 2 (as of 01 April 2011)|Death|0
1449469|NCT00833833|4780624|P2|Phase 2 (as of 01 April 2011)|Death|0
1449470|NCT00833833|4780625|P1|Phase 2 (as of 01 April 2011)|Death|0
1449471|NCT00833833|4780620|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
1449472|NCT00833833|4780621|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
1449473|NCT00833833|4780622|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
1449474|NCT00833833|4780623|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
1449475|NCT00833833|4780624|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
1449476|NCT00833833|4780625|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
1449477|NCT00833833|4780620|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
1449478|NCT00833833|4780621|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
1449479|NCT00833833|4780622|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
1449480|NCT00833833|4780623|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
1449481|NCT00833833|4780624|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
1449482|NCT00833833|4780625|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
1449483|NCT00833833|4780620|P6|Phase 1 (as of 01 April 2011)|Other|0
1449484|NCT00833833|4780621|P5|Phase 1 (as of 01 April 2011)|Other|0
1449485|NCT00833833|4780622|P4|Phase 1 (as of 01 April 2011)|Other|1
1449486|NCT00833833|4780623|P3|Phase 1 (as of 01 April 2011)|Other|0
1449487|NCT00833833|4780624|P2|Phase 1 (as of 01 April 2011)|Other|3
1449488|NCT00833833|4780625|P1|Phase 1 (as of 01 April 2011)|Other|1
1449489|NCT00833833|4780620|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
1449490|NCT00833833|4780621|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
1449491|NCT00833833|4780622|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
1449492|NCT00833833|4780623|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
1449493|NCT00833833|4780624|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
1449494|NCT00833833|4780625|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
1449495|NCT00833833|4780620|P6|Phase 1 (as of 01 April 2011)|Death|0
1449496|NCT00833833|4780621|P5|Phase 1 (as of 01 April 2011)|Death|0
1449497|NCT00833833|4780622|P4|Phase 1 (as of 01 April 2011)|Death|0
1449498|NCT00833833|4780623|P3|Phase 1 (as of 01 April 2011)|Death|2
1449499|NCT00833833|4780624|P2|Phase 1 (as of 01 April 2011)|Death|1
1449500|NCT00833833|4780625|P1|Phase 1 (as of 01 April 2011)|Death|0
1449501|NCT00833833|4780620|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
1449502|NCT00833833|4780621|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
1449503|NCT00833833|4780622|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
1449504|NCT00833833|4780623|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
1449505|NCT00833833|4780624|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
1449506|NCT00833833|4780625|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
1449507|NCT00833833|4780620|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
1449508|NCT00833833|4780621|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
1449509|NCT00833833|4780622|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
1449510|NCT00833833|4780623|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
1449511|NCT00833833|4780624|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
1449512|NCT00833833|4780625|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
1449513|NCT00833833|4780620|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
1449514|NCT00833833|4780621|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
1449515|NCT00833833|4780622|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
1449516|NCT00833833|4780623|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
1449517|NCT00833833|4780624|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
1449518|NCT00833833|4780625|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
1449519|NCT00833794|4780665|P2|Double-blind Phase|Administrative reason|3
1449520|NCT00833794|4780666|P1|Double-blind Phase|Administrative reason|1
1449521|NCT00833794|4780665|P2|Double-blind Phase|Physician Decision|7
1449522|NCT00833794|4780666|P1|Double-blind Phase|Physician Decision|4
1449523|NCT00833794|4780665|P2|Double-blind Phase|Withdrawal by Subject|6
1449524|NCT00833794|4780666|P1|Double-blind Phase|Withdrawal by Subject|23
1449525|NCT00833794|4780665|P2|Double-blind Phase|Lack of Efficacy|22
1449526|NCT00833794|4780666|P1|Double-blind Phase|Lack of Efficacy|34
1449527|NCT00833794|4780665|P2|Double-blind Phase|Adverse Event|11
1449528|NCT00833794|4780666|P1|Double-blind Phase|Adverse Event|44
1449529|NCT00833794|4780665|P2|Open-label Phase|enrolled in error (immediately D/C)|0
1449530|NCT00833794|4780666|P1|Open-label Phase|enrolled in error (immediately D/C)|1
1449531|NCT00833794|4780665|P2|Open-label Phase|Did not complete wash-out period|0
1449532|NCT00833794|4780666|P1|Open-label Phase|Did not complete wash-out period|12
1449533|NCT00833794|4780665|P2|Open-label Phase|Protocol Violation|0
1449534|NCT00833794|4780666|P1|Open-label Phase|Protocol Violation|47
1449535|NCT00833794|4780665|P2|Open-label Phase|Administrative reason|0
1449536|NCT00833794|4780666|P1|Open-label Phase|Administrative reason|1
1449537|NCT00833794|4780665|P2|Open-label Phase|Physician Decision|0
1449538|NCT00833794|4780666|P1|Open-label Phase|Physician Decision|20
1449539|NCT00833794|4780665|P2|Open-label Phase|Withdrawal by Subject|0
1449540|NCT00833794|4780666|P1|Open-label Phase|Withdrawal by Subject|48
1449541|NCT00833794|4780665|P2|Open-label Phase|Lack of Efficacy|0
1449542|NCT00833794|4780666|P1|Open-label Phase|Lack of Efficacy|28
1449543|NCT00833794|4780665|P2|Open-label Phase|Adverse Event|0
1449544|NCT00833794|4780666|P1|Open-label Phase|Adverse Event|225
1449545|NCT00833755|4780710|P4|Overall Study|Subject had scheduling issues|0
1449546|NCT00833755|4780711|P3|Overall Study|Subject had scheduling issues|0
1449547|NCT00833755|4780712|P2|Overall Study|Subject had scheduling issues|1
1449548|NCT00833755|4780713|P1|Overall Study|Subject had scheduling issues|0
1449549|NCT00833755|4780710|P4|Overall Study|Physician Decision|6
1449550|NCT00833755|4780711|P3|Overall Study|Physician Decision|2
1449551|NCT00833755|4780712|P2|Overall Study|Physician Decision|4
1449552|NCT00833755|4780713|P1|Overall Study|Physician Decision|4
1449553|NCT00833703|4780733|P2|Overall Study|Parent(s)/guardian(s)'s request|1
1449554|NCT00833703|4780734|P1|Overall Study|Parent(s)/guardian(s)'s request|0
1449555|NCT00833690|4780747|P3|Overall Study|Discontinued study drug|0
1449556|NCT00833690|4780748|P2|Overall Study|Discontinued study drug|2
1449557|NCT00833690|4780749|P1|Overall Study|Discontinued study drug|3
1449558|NCT00833690|4780747|P3|Overall Study|Withdrawal by Subject|0
1449559|NCT00833690|4780748|P2|Overall Study|Withdrawal by Subject|0
1449560|NCT00833690|4780749|P1|Overall Study|Withdrawal by Subject|1
1449561|NCT00833638|4780885|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
1449562|NCT00833638|4780886|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
1449563|NCT00833638|4780887|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
1449564|NCT00833638|4780885|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
1449565|NCT00833638|4780886|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
1449566|NCT00833638|4780887|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
1449567|NCT00833638|4780885|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
1449568|NCT00833638|4780886|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
1449569|NCT00833638|4780887|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
1449570|NCT00833638|4780885|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
1449571|NCT00833638|4780886|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
1449572|NCT00833638|4780887|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
1449573|NCT00833638|4780885|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
1449574|NCT00833638|4780886|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
1449575|NCT00833638|4780887|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
1449576|NCT00833638|4780885|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
1449577|NCT00833638|4780886|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
1449578|NCT00833638|4780887|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
1449579|NCT00833638|4780885|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
1449580|NCT00833638|4780886|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
1449581|NCT00833638|4780887|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
1449582|NCT00833638|4780885|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
1449583|NCT00833638|4780886|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
1449584|NCT00833638|4780887|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
1449585|NCT00833638|4780885|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
1449586|NCT00833638|4780886|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
1449587|NCT00833638|4780887|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
1449588|NCT00833560|4780938|P1|Overall Study|Not specified|5
1449589|NCT00833560|4780938|P1|Overall Study|Pregression of other disease|1
1449590|NCT00833560|4780938|P1|Overall Study|Death|2
1449591|NCT00833560|4780938|P1|Overall Study|Lack of Efficacy|4
1449592|NCT00833560|4780938|P1|Overall Study|Protocol Violation|6
1449593|NCT00833560|4780938|P1|Overall Study|Adverse Event|11
1449594|NCT00833560|4780938|P1|Overall Study|Toxicity|13
1449595|NCT00833547|4780947|P2|Overall Study|Withdrawal by Subject|2
1449596|NCT00833547|4780948|P1|Overall Study|Withdrawal by Subject|2
1449597|NCT00833482|4780969|P6|Days 21-30|Withdrawal by Subject|0
1449598|NCT00833482|4780970|P5|Days 21-30|Withdrawal by Subject|1
1449599|NCT00833482|4780971|P4|Days 21-30|Withdrawal by Subject|0
1449600|NCT00833482|4780972|P3|Days 21-30|Withdrawal by Subject|0
1449601|NCT00833482|4780973|P2|Days 21-30|Withdrawal by Subject|0
1449602|NCT00833482|4780974|P1|Days 21-30|Withdrawal by Subject|0
1449603|NCT00833482|4780969|P6|Days 21-30|Adverse Event|0
1449604|NCT00833482|4780970|P5|Days 21-30|Adverse Event|0
1449605|NCT00833482|4780971|P4|Days 21-30|Adverse Event|0
1449606|NCT00833482|4780972|P3|Days 21-30|Adverse Event|1
1449607|NCT00833482|4780973|P2|Days 21-30|Adverse Event|0
1449608|NCT00833482|4780974|P1|Days 21-30|Adverse Event|0
1449609|NCT00833482|4780969|P6|Days 11-20|Withdrawal by Subject|0
1449610|NCT00833482|4780970|P5|Days 11-20|Withdrawal by Subject|0
1449611|NCT00833482|4780971|P4|Days 11-20|Withdrawal by Subject|0
1449612|NCT00833482|4780972|P3|Days 11-20|Withdrawal by Subject|0
1449613|NCT00833482|4780973|P2|Days 11-20|Withdrawal by Subject|1
1449614|NCT00833482|4780974|P1|Days 11-20|Withdrawal by Subject|0
1449615|NCT00833482|4780969|P6|Days 11-20|Adverse Event|0
1449616|NCT00833482|4780970|P5|Days 11-20|Adverse Event|0
1449617|NCT00833482|4780971|P4|Days 11-20|Adverse Event|0
1449618|NCT00833482|4780972|P3|Days 11-20|Adverse Event|0
1449619|NCT00833482|4780973|P2|Days 11-20|Adverse Event|2
1449620|NCT00833482|4780974|P1|Days 11-20|Adverse Event|0
1449621|NCT00833469|4781030|P1|Overall Study|Lost to Follow-up|1
1449622|NCT00833469|4781030|P1|Overall Study|Withdrawal by Subject|1
1449623|NCT00833417|4781053|P2|Overall Study|Reason Not Specified|1
1449624|NCT00833417|4781054|P1|Overall Study|Reason Not Specified|0
1449625|NCT00833417|4781053|P2|Overall Study|Disease Progression|17
1449626|NCT00833417|4781054|P1|Overall Study|Disease Progression|18
1449627|NCT00833417|4781053|P2|Overall Study|Sponsor Decision to Terminate Study|2
1449628|NCT00833417|4781054|P1|Overall Study|Sponsor Decision to Terminate Study|1
1449629|NCT00833417|4781053|P2|Overall Study|Patient Decision to Withdraw|23
1449630|NCT00833417|4781054|P1|Overall Study|Patient Decision to Withdraw|4
1449631|NCT00833417|4781053|P2|Overall Study|Physician Decision to Withdraw Patient|7
1449632|NCT00833417|4781054|P1|Overall Study|Physician Decision to Withdraw Patient|3
1449633|NCT00833417|4781053|P2|Overall Study|Lost to Follow-up|2
1449634|NCT00833417|4781054|P1|Overall Study|Lost to Follow-up|1
1449635|NCT00833417|4781053|P2|Overall Study|Death|3
1449636|NCT00833417|4781054|P1|Overall Study|Death|1
1449637|NCT00833417|4781053|P2|Overall Study|Adverse Event|16
1449638|NCT00833417|4781054|P1|Overall Study|Adverse Event|5
1449639|NCT00833248|4781080|P2|Overall Study|Withdrawal by Subject|1
1449640|NCT00833248|4781081|P1|Overall Study|Withdrawal by Subject|0
1449641|NCT00833248|4781080|P2|Overall Study|Protocol Violation|2
1449642|NCT00833248|4781081|P1|Overall Study|Protocol Violation|1
1449643|NCT00833248|4781080|P2|Overall Study|Adverse Event|0
1449644|NCT00833248|4781081|P1|Overall Study|Adverse Event|3
1449645|NCT00833092|4781105|P2|Overall Study|constipation|1
1449646|NCT00833092|4781106|P1|Overall Study|constipation|0
1449647|NCT00833092|4781105|P2|Overall Study|Diarrhea|2
1449648|NCT00833092|4781106|P1|Overall Study|Diarrhea|0
1449649|NCT00833092|4781105|P2|Overall Study|Protocol Violation|1
1449650|NCT00833092|4781106|P1|Overall Study|Protocol Violation|2
1449651|NCT00833092|4781105|P2|Overall Study|Withdrawal by Subject|3
1449652|NCT00833092|4781106|P1|Overall Study|Withdrawal by Subject|2
1449653|NCT00833053|4781114|P2|Overall Study|Protocol Violation|1
1449654|NCT00833053|4781115|P1|Overall Study|Protocol Violation|2
1449655|NCT00833053|4781114|P2|Overall Study|Withdrawal by Subject|1
1449656|NCT00833053|4781115|P1|Overall Study|Withdrawal by Subject|0
1449657|NCT00833053|4781114|P2|Overall Study|Treatment Failure|1
1449658|NCT00833053|4781115|P1|Overall Study|Treatment Failure|3
1449659|NCT00833053|4781114|P2|Overall Study|Adverse Event|0
1449660|NCT00833053|4781115|P1|Overall Study|Adverse Event|4
1449661|NCT00833040|4781133|P6|Overall Study|Adverse Event|1
1449662|NCT00833040|4781134|P5|Overall Study|Adverse Event|0
1449663|NCT00833040|4781135|P4|Overall Study|Adverse Event|0
1449664|NCT00833040|4781136|P3|Overall Study|Adverse Event|0
1449665|NCT00833040|4781137|P2|Overall Study|Adverse Event|0
1449666|NCT00833040|4781138|P1|Overall Study|Adverse Event|0
1449667|NCT00833027|4781143|P1|Overall Study|Missing|10
1449668|NCT00833027|4781143|P1|Overall Study|Withdrawal by Subject|16
1449669|NCT00833027|4781143|P1|Overall Study|Protocol Violation|115
1449670|NCT00833027|4781143|P1|Overall Study|Lost to Follow-up|24
1449671|NCT00833027|4781143|P1|Overall Study|Lack of Efficacy|12
1449672|NCT00833027|4781143|P1|Overall Study|Death|1
1449673|NCT00833027|4781143|P1|Overall Study|Adverse Event|33
1449674|NCT00832975|4781148|P1|Overall Study|Other reasons|14
1449675|NCT00832975|4781148|P1|Overall Study|Withdrawal by Subject|3
1449676|NCT00832975|4781148|P1|Overall Study|Physician Decision|4
1449677|NCT00832975|4781148|P1|Overall Study|Death|5
1449678|NCT00832975|4781148|P1|Overall Study|Protocol Violation|6
1449679|NCT00832975|4781148|P1|Overall Study|Lost to Follow-up|7
1449680|NCT00832819|4781162|P3|Overall Study|Protocol Violation|1
1449681|NCT00832819|4781163|P2|Overall Study|Protocol Violation|0
1449682|NCT00832819|4781164|P1|Overall Study|Protocol Violation|0
1449683|NCT00832819|4781162|P3|Overall Study|Adverse Event|0
1449684|NCT00832819|4781163|P2|Overall Study|Adverse Event|1
1449685|NCT00832819|4781164|P1|Overall Study|Adverse Event|0
1449686|NCT00832780|4781170|P1|Overall Study|Physician Decision|1
1449687|NCT00832780|4781170|P1|Overall Study|other complicating condition|2
1449688|NCT00832780|4781170|P1|Overall Study|no reason given|2
1449689|NCT00832780|4781170|P1|Overall Study|Lost to Follow-up|4
1449690|NCT00832780|4781170|P1|Overall Study|Death|16
1449691|NCT00832650|4781212|P3|Overall Study|Randomized but not treated|1
1449692|NCT00832650|4781213|P2|Overall Study|Randomized but not treated|0
1449693|NCT00832650|4781214|P1|Overall Study|Randomized but not treated|0
1449694|NCT00832624|4781254|P1|Overall Study|Study Terminated|10
1449695|NCT00832585|4781264|P1|Overall Study|Lost to Follow-up|1
1449696|NCT00832585|4781264|P1|Overall Study|Withdrawal by Subject|1
1449697|NCT00832455|4781289|P1|Overall Study|Patient moved|1
1449698|NCT00832455|4781289|P1|Overall Study|No improvement|3
1449699|NCT00832455|4781289|P1|Overall Study|Parent dissatisfied|1
1449700|NCT00832455|4781289|P1|Overall Study|Parent misunderstood study|1
1449701|NCT00832455|4781289|P1|Overall Study|Stopped Medication|4
1449702|NCT00832455|4781289|P1|Overall Study|Screening Failure|2
1449703|NCT00832455|4781289|P1|Overall Study|Withdrawal by Subject|17
1449704|NCT00832455|4781289|P1|Overall Study|Protocol Violation|4
1449705|NCT00832455|4781289|P1|Overall Study|Lost to Follow-up|26
1449706|NCT00832455|4781289|P1|Overall Study|Adverse Event|13
1449707|NCT00832416|4781313|P4|Overall Study|Death|0
1449708|NCT00832416|4781314|P3|Overall Study|Death|0
1449709|NCT00832416|4781315|P2|Overall Study|Death|0
1449710|NCT00832416|4781316|P1|Overall Study|Death|1
1449711|NCT00832416|4781313|P4|Overall Study|Adverse Event|10
1449712|NCT00832416|4781314|P3|Overall Study|Adverse Event|41
1449713|NCT00832416|4781315|P2|Overall Study|Adverse Event|19
1449714|NCT00832416|4781316|P1|Overall Study|Adverse Event|21
1449715|NCT00832416|4781313|P4|Overall Study|Administrative|1
1449716|NCT00832416|4781314|P3|Overall Study|Administrative|0
1449717|NCT00832416|4781315|P2|Overall Study|Administrative|0
1449718|NCT00832416|4781316|P1|Overall Study|Administrative|0
1449719|NCT00832416|4781313|P4|Overall Study|Physician Decision|10
1449720|NCT00832416|4781314|P3|Overall Study|Physician Decision|5
1449721|NCT00832416|4781315|P2|Overall Study|Physician Decision|12
1449722|NCT00832416|4781316|P1|Overall Study|Physician Decision|2
1449723|NCT00832416|4781313|P4|Overall Study|Withdrawal by Subject|10
1449724|NCT00832416|4781314|P3|Overall Study|Withdrawal by Subject|2
1449725|NCT00832416|4781315|P2|Overall Study|Withdrawal by Subject|7
1449726|NCT00832416|4781316|P1|Overall Study|Withdrawal by Subject|5
1449727|NCT00832416|4781313|P4|Overall Study|Lack of Efficacy|52
1449728|NCT00832416|4781314|P3|Overall Study|Lack of Efficacy|13
1449729|NCT00832416|4781315|P2|Overall Study|Lack of Efficacy|15
1449730|NCT00832416|4781316|P1|Overall Study|Lack of Efficacy|17
1449731|NCT00832377|4781367|P1|Overall Study|Protocol Violation|1
1449732|NCT00832117|4781413|P1|Overall Study|Disease Progression|11
1449733|NCT00832117|4781413|P1|Overall Study|Death|1
1449734|NCT00832091|4781432|P2|Overall Study|Prohibited Medication|0
1449735|NCT00832091|4781433|P1|Overall Study|Prohibited Medication|1
1449736|NCT00832091|4781432|P2|Overall Study|Withdrawal by Subject|1
1449737|NCT00832091|4781433|P1|Overall Study|Withdrawal by Subject|2
1449738|NCT00832091|4781432|P2|Overall Study|Protocol Violation|0
1449739|NCT00832091|4781433|P1|Overall Study|Protocol Violation|1
1449740|NCT00832091|4781432|P2|Overall Study|Adverse Event|1
1449741|NCT00832091|4781433|P1|Overall Study|Adverse Event|1
1449742|NCT00832078|4781441|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
1449743|NCT00832078|4781442|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
1449744|NCT00832078|4781441|P2|Test Day 1-2 Period|Lack of Efficacy|2
1449745|NCT00832078|4781442|P1|Test Day 1-2 Period|Lack of Efficacy|0
1449746|NCT00832000|4781448|P2|Overall Study|No calls to IVR in period 2|0
1449747|NCT00832000|4781449|P1|Overall Study|No calls to IVR in period 2|2
1449748|NCT00832000|4781448|P2|Overall Study|No calls to IVR in either period|1
1449749|NCT00832000|4781449|P1|Overall Study|No calls to IVR in either period|1
1449750|NCT00832000|4781448|P2|Overall Study|Withdrawal by Subject|0
1449751|NCT00832000|4781449|P1|Overall Study|Withdrawal by Subject|1
1449752|NCT00832000|4781448|P2|Overall Study|Adverse Event|0
1449753|NCT00832000|4781449|P1|Overall Study|Adverse Event|2
1449754|NCT00831844|4781510|P10|Overall Study|Ineligible|0
1449755|NCT00831844|4781511|P9|Overall Study|Ineligible|0
1449756|NCT00831844|4781512|P8|Overall Study|Ineligible|0
1449757|NCT00831844|4781513|P7|Overall Study|Ineligible|0
1449758|NCT00831844|4781514|P6|Overall Study|Ineligible|0
1449759|NCT00831844|4781515|P5|Overall Study|Ineligible|1
1449760|NCT00831844|4781516|P4|Overall Study|Ineligible|0
1449761|NCT00831844|4781517|P3|Overall Study|Ineligible|1
1449762|NCT00831844|4781518|P2|Overall Study|Ineligible|1
1449763|NCT00831844|4781519|P1|Overall Study|Ineligible|0
1449764|NCT00831844|4781510|P10|Overall Study|Withdrawal by Subject|0
1449765|NCT00831844|4781511|P9|Overall Study|Withdrawal by Subject|1
1449766|NCT00831844|4781512|P8|Overall Study|Withdrawal by Subject|1
1449767|NCT00831844|4781513|P7|Overall Study|Withdrawal by Subject|0
1449768|NCT00831844|4781514|P6|Overall Study|Withdrawal by Subject|0
1449769|NCT00831844|4781515|P5|Overall Study|Withdrawal by Subject|0
1449770|NCT00831844|4781516|P4|Overall Study|Withdrawal by Subject|0
1449771|NCT00831844|4781517|P3|Overall Study|Withdrawal by Subject|1
1449772|NCT00831844|4781518|P2|Overall Study|Withdrawal by Subject|0
1449773|NCT00831844|4781519|P1|Overall Study|Withdrawal by Subject|0
1449774|NCT00831844|4781510|P10|Overall Study|Physician Decision|0
1449775|NCT00831844|4781511|P9|Overall Study|Physician Decision|1
1449776|NCT00831844|4781512|P8|Overall Study|Physician Decision|0
1449777|NCT00831844|4781513|P7|Overall Study|Physician Decision|0
1449778|NCT00831844|4781514|P6|Overall Study|Physician Decision|1
1449779|NCT00831844|4781515|P5|Overall Study|Physician Decision|1
1449780|NCT00831844|4781516|P4|Overall Study|Physician Decision|1
1449781|NCT00831844|4781517|P3|Overall Study|Physician Decision|3
1449782|NCT00831844|4781518|P2|Overall Study|Physician Decision|1
1449783|NCT00831844|4781519|P1|Overall Study|Physician Decision|0
1449784|NCT00831844|4781510|P10|Overall Study|Lack of Efficacy|0
1449785|NCT00831844|4781511|P9|Overall Study|Lack of Efficacy|7
1449786|NCT00831844|4781512|P8|Overall Study|Lack of Efficacy|9
1449787|NCT00831844|4781513|P7|Overall Study|Lack of Efficacy|8
1449788|NCT00831844|4781514|P6|Overall Study|Lack of Efficacy|17
1449789|NCT00831844|4781515|P5|Overall Study|Lack of Efficacy|11
1449790|NCT00831844|4781516|P4|Overall Study|Lack of Efficacy|8
1449791|NCT00831844|4781517|P3|Overall Study|Lack of Efficacy|15
1449792|NCT00831844|4781518|P2|Overall Study|Lack of Efficacy|10
1449793|NCT00831844|4781519|P1|Overall Study|Lack of Efficacy|8
1449794|NCT00831844|4781510|P10|Overall Study|Death|0
1449795|NCT00831844|4781511|P9|Overall Study|Death|0
1449796|NCT00831844|4781512|P8|Overall Study|Death|0
1449797|NCT00831844|4781513|P7|Overall Study|Death|0
1449798|NCT00831844|4781514|P6|Overall Study|Death|0
1449799|NCT00831844|4781515|P5|Overall Study|Death|0
1449800|NCT00831844|4781516|P4|Overall Study|Death|1
1449801|NCT00831844|4781517|P3|Overall Study|Death|0
1449802|NCT00831844|4781518|P2|Overall Study|Death|0
1449803|NCT00831844|4781519|P1|Overall Study|Death|0
1449804|NCT00831844|4781510|P10|Overall Study|Adverse Event|0
1449805|NCT00831844|4781511|P9|Overall Study|Adverse Event|0
1449806|NCT00831844|4781512|P8|Overall Study|Adverse Event|0
1449807|NCT00831844|4781513|P7|Overall Study|Adverse Event|2
1449808|NCT00831844|4781514|P6|Overall Study|Adverse Event|1
1449809|NCT00831844|4781515|P5|Overall Study|Adverse Event|1
1449810|NCT00831844|4781516|P4|Overall Study|Adverse Event|0
1449811|NCT00831844|4781517|P3|Overall Study|Adverse Event|0
1449812|NCT00831844|4781518|P2|Overall Study|Adverse Event|0
1449813|NCT00831844|4781519|P1|Overall Study|Adverse Event|2
1449814|NCT00831779|4781543|P2|Overall Study|No longer met criteria|1
1449815|NCT00831779|4781544|P1|Overall Study|No longer met criteria|0
1449816|NCT00831779|4781543|P2|Overall Study|Lost to Follow-up|0
1449817|NCT00831779|4781544|P1|Overall Study|Lost to Follow-up|1
1449818|NCT00831701|4781581|P2|Overall Study|Lost to Follow-up|3
1449819|NCT00831701|4781582|P1|Overall Study|Lost to Follow-up|1
1449820|NCT00831701|4781581|P2|Overall Study|Stone expulsion before first medication|2
1449821|NCT00831701|4781582|P1|Overall Study|Stone expulsion before first medication|2
1449822|NCT00831701|4781581|P2|Overall Study|Withdrawal by Subject|0
1449823|NCT00831701|4781582|P1|Overall Study|Withdrawal by Subject|2
1449824|NCT00831493|4781611|P1|Overall Study|Intractable nausea and vomiting|1
1449825|NCT00831441|4781621|P2|Follow Up (30 Days)|missing end of study status|1
1449826|NCT00831441|4781622|P1|Follow Up (30 Days)|missing end of study status|0
1449827|NCT00831441|4781621|P2|Follow Up (30 Days)|non-specified|26
1449828|NCT00831441|4781622|P1|Follow Up (30 Days)|non-specified|16
1449829|NCT00831441|4781621|P2|Follow Up (30 Days)|Death|86
1449830|NCT00831441|4781622|P1|Follow Up (30 Days)|Death|63
1449831|NCT00831441|4781621|P2|Follow Up (30 Days)|Lost to Follow-up|27
1449832|NCT00831441|4781622|P1|Follow Up (30 Days)|Lost to Follow-up|13
1449833|NCT00831441|4781621|P2|Follow Up (30 Days)|Withdrawal by Subject|34
1449834|NCT00831441|4781622|P1|Follow Up (30 Days)|Withdrawal by Subject|41
1449835|NCT00831441|4781621|P2|Randomized|non-specified|266
1449836|NCT00831441|4781622|P1|Randomized|non-specified|276
1449837|NCT00831441|4781621|P2|Randomized|poor/non-compliance|38
1449838|NCT00831441|4781622|P1|Randomized|poor/non-compliance|30
1449839|NCT00831441|4781621|P2|Randomized|Administrative reason by sponsor|2671
1449840|NCT00831441|4781622|P1|Randomized|Administrative reason by sponsor|2780
1449841|NCT00831441|4781621|P2|Randomized|Lost to Follow-up|35
1449842|NCT00831441|4781622|P1|Randomized|Lost to Follow-up|26
1449843|NCT00831441|4781621|P2|Randomized|Withdrawal by Subject|212
1449844|NCT00831441|4781622|P1|Randomized|Withdrawal by Subject|178
1449845|NCT00831441|4781621|P2|Randomized|No longer met criteria|19
1449846|NCT00831441|4781622|P1|Randomized|No longer met criteria|13
1449847|NCT00831441|4781621|P2|Randomized|Physician Decision|35
1449848|NCT00831441|4781622|P1|Randomized|Physician Decision|26
1449849|NCT00831441|4781621|P2|Randomized|Elective procedure|25
1449850|NCT00831441|4781622|P1|Randomized|Elective procedure|26
1449851|NCT00831441|4781621|P2|Randomized|Emergency procedure|2
1449852|NCT00831441|4781622|P1|Randomized|Emergency procedure|2
1449853|NCT00831441|4781621|P2|Randomized|Adverse Event|321
1449854|NCT00831441|4781622|P1|Randomized|Adverse Event|248
1449855|NCT00831441|4781621|P2|Randomized|Death|81
1449856|NCT00831441|4781622|P1|Randomized|Death|82
1449857|NCT00831415|4781654|P1|Overall Study|Death|1
1449858|NCT00831415|4781654|P1|Overall Study|Unsatisfactory response - Efficacy|4
1449859|NCT00831415|4781654|P1|Overall Study|Withdrawal by Subject|35
1449860|NCT00831415|4781654|P1|Overall Study|Protocol Violation|3
1449861|NCT00831415|4781654|P1|Overall Study|Lost to Follow-up|9
1449862|NCT00831415|4781654|P1|Overall Study|Physician Decision|6
1449863|NCT00831415|4781654|P1|Overall Study|Failed to return|3
1449864|NCT00831415|4781654|P1|Overall Study|Adverse Event|14
1449865|NCT00831389|4781663|P2|Overall Study|Withdrawal by Subject|1
1449866|NCT00831389|4781664|P1|Overall Study|Withdrawal by Subject|0
1449867|NCT00831311|4781690|P2|Overall Study|Withdrawal by Subject|4
1449868|NCT00831311|4781691|P1|Overall Study|Withdrawal by Subject|6
1449869|NCT00831311|4781690|P2|Overall Study|Physician Decision|1
1449870|NCT00831311|4781691|P1|Overall Study|Physician Decision|0
1449871|NCT00831311|4781690|P2|Overall Study|Lost to Follow-up|0
1449872|NCT00831311|4781691|P1|Overall Study|Lost to Follow-up|3
1449873|NCT00831311|4781690|P2|Overall Study|Definitive Contraindication|3
1449874|NCT00831311|4781691|P1|Overall Study|Definitive Contraindication|3
1449875|NCT00831233|4781728|P2|Overall Study|Selection Criteria Not Met|0
1449876|NCT00831233|4781729|P1|Overall Study|Selection Criteria Not Met|2
1449877|NCT00831233|4781728|P2|Overall Study|Protocol Violation|0
1449878|NCT00831233|4781729|P1|Overall Study|Protocol Violation|1
1449879|NCT00831233|4781728|P2|Overall Study|Adverse Event|1
1449880|NCT00831233|4781729|P1|Overall Study|Adverse Event|0
1449881|NCT00831181|4781753|P1|Overall Study|Adverse Event|12
1449882|NCT00831129|4781766|P2|Overall Study|9 lost to follow-up reasons uknown|9
1449883|NCT00831129|4781767|P1|Overall Study|9 lost to follow-up reasons uknown|0
1449884|NCT00831129|4781766|P2|Overall Study|Adverse Event|1
1449885|NCT00831129|4781767|P1|Overall Study|Adverse Event|0
1449886|NCT00830960|4781809|P6|Overall Study|No study drug received|7
1449887|NCT00830960|4781810|P5|Overall Study|No study drug received|5
1449888|NCT00830960|4781811|P4|Overall Study|No study drug received|3
1449889|NCT00830960|4781812|P3|Overall Study|No study drug received|4
1449890|NCT00830960|4781813|P2|Overall Study|No study drug received|2
1449891|NCT00830960|4781814|P1|Overall Study|No study drug received|7
1449892|NCT00830960|4781809|P6|Overall Study|Sponsor Decision|7
1449893|NCT00830960|4781810|P5|Overall Study|Sponsor Decision|5
1449894|NCT00830960|4781811|P4|Overall Study|Sponsor Decision|4
1449895|NCT00830960|4781812|P3|Overall Study|Sponsor Decision|3
1449896|NCT00830960|4781813|P2|Overall Study|Sponsor Decision|2
1449897|NCT00830960|4781814|P1|Overall Study|Sponsor Decision|1
1449898|NCT00830960|4781809|P6|Overall Study|Withdrawal by Subject|21
1449899|NCT00830960|4781810|P5|Overall Study|Withdrawal by Subject|16
1449900|NCT00830960|4781811|P4|Overall Study|Withdrawal by Subject|23
1449901|NCT00830960|4781812|P3|Overall Study|Withdrawal by Subject|18
1449902|NCT00830960|4781813|P2|Overall Study|Withdrawal by Subject|19
1449903|NCT00830960|4781814|P1|Overall Study|Withdrawal by Subject|19
1449904|NCT00830960|4781809|P6|Overall Study|Lost to Follow-up|1
1449905|NCT00830960|4781810|P5|Overall Study|Lost to Follow-up|0
1449906|NCT00830960|4781811|P4|Overall Study|Lost to Follow-up|0
1449907|NCT00830960|4781812|P3|Overall Study|Lost to Follow-up|1
1449908|NCT00830960|4781813|P2|Overall Study|Lost to Follow-up|1
1449909|NCT00830960|4781814|P1|Overall Study|Lost to Follow-up|1
1449910|NCT00830960|4781809|P6|Overall Study|Death|1
1449911|NCT00830960|4781810|P5|Overall Study|Death|6
1449912|NCT00830960|4781811|P4|Overall Study|Death|2
1449913|NCT00830960|4781812|P3|Overall Study|Death|3
1449914|NCT00830960|4781813|P2|Overall Study|Death|4
1449915|NCT00830960|4781814|P1|Overall Study|Death|5
1449916|NCT00830947|4781930|P2|Overall Study|Lost to Follow-up|4
1449917|NCT00830947|4781931|P1|Overall Study|Lost to Follow-up|4
1449918|NCT00830804|4781937|P1|Overall Study|Unwilling to adhere to study requirement|1
1449919|NCT00830804|4781937|P1|Overall Study|Consent withdrawn|2
1449920|NCT00830804|4781937|P1|Overall Study|Unable to get to clinic|7
1449921|NCT00830804|4781937|P1|Overall Study|Death|1
1449922|NCT00830804|4781937|P1|Overall Study|Lost to Follow-up|4
1449923|NCT00830765|4782017|P2|Overall Study|Protocol Violation|2
1449924|NCT00830765|4782018|P1|Overall Study|Protocol Violation|3
1449925|NCT00830518|4782051|P2|Overall Study|Reason not Specified|1
1449926|NCT00830518|4782052|P1|Overall Study|Reason not Specified|8
1449927|NCT00830518|4782051|P2|Overall Study|Withdrawal by Patient|0
1449928|NCT00830518|4782052|P1|Overall Study|Withdrawal by Patient|2
1449929|NCT00830518|4782051|P2|Overall Study|Adverse Event|1
1449930|NCT00830518|4782052|P1|Overall Study|Adverse Event|14
1449931|NCT00830518|4782051|P2|Overall Study|Symptomatic Deterioration|1
1449932|NCT00830518|4782052|P1|Overall Study|Symptomatic Deterioration|4
1449933|NCT00830518|4782051|P2|Overall Study|Progressive Disease|8
1449934|NCT00830518|4782052|P1|Overall Study|Progressive Disease|18
1449935|NCT00830440|4782071|P2|Overall Study|Adverse Event|0
1449936|NCT00830440|4782072|P1|Overall Study|Adverse Event|2
1449937|NCT00830440|4782071|P2|Overall Study|unsuccessful procedure|0
1449938|NCT00830440|4782072|P1|Overall Study|unsuccessful procedure|4
1449939|NCT00830440|4782071|P2|Overall Study|Withdrawal by Subject|0
1449940|NCT00830440|4782072|P1|Overall Study|Withdrawal by Subject|1
1449941|NCT00830440|4782071|P2|Overall Study|Protocol Violation|0
1449942|NCT00830440|4782072|P1|Overall Study|Protocol Violation|1
1449943|NCT00830375|4782087|P1|Overall Study|Lost to Follow-up|1
1449944|NCT00830336|4782102|P2|Washout: 21 Days|Withdrawal by Subject|0
1449945|NCT00830336|4782103|P1|Washout: 21 Days|Withdrawal by Subject|1
1449946|NCT00830258|4782130|P2|Washout: 7 Days|Protocol Violation|0
1449947|NCT00830258|4782131|P1|Washout: 7 Days|Protocol Violation|1
1449948|NCT00830258|4782130|P2|First Intervention|Adverse Event|0
1449949|NCT00830258|4782131|P1|First Intervention|Adverse Event|1
1449950|NCT00830219|4782150|P2|Washout of 7 Days|Withdrawal by Subject|1
1449951|NCT00830219|4782151|P1|Washout of 7 Days|Withdrawal by Subject|1
1449952|NCT00830206|4782161|P2|Washout: 21 Days|Withdrawal by Subject|1
1449953|NCT00830206|4782162|P1|Washout: 21 Days|Withdrawal by Subject|1
1449954|NCT00830167|4782172|P2|Overall Study|Other|2
1449955|NCT00830167|4782173|P1|Overall Study|Other|2
1449956|NCT00830167|4782172|P2|Overall Study|Protocol Violation|1
1449957|NCT00830167|4782173|P1|Overall Study|Protocol Violation|0
1449958|NCT00830167|4782172|P2|Overall Study|Lost to Follow-up|1
1449959|NCT00830167|4782173|P1|Overall Study|Lost to Follow-up|0
1449960|NCT00830167|4782172|P2|Overall Study|Withdrawal by Subject|0
1449961|NCT00830167|4782173|P1|Overall Study|Withdrawal by Subject|2
1449962|NCT00830167|4782172|P2|Overall Study|Not meeting entrance criteria|5
1449963|NCT00830167|4782173|P1|Overall Study|Not meeting entrance criteria|2
1449964|NCT00830167|4782172|P2|Overall Study|Adverse Event|24
1449965|NCT00830167|4782173|P1|Overall Study|Adverse Event|8
1449966|NCT00830167|4782172|P2|Overall Study|Lack of Efficacy|10
1449967|NCT00830167|4782173|P1|Overall Study|Lack of Efficacy|26
1449968|NCT00830128|4782243|P1|Overall Study|Operating a vehicle|1
1449969|NCT00830128|4782243|P1|Overall Study|Work obligation|1
1449970|NCT00830128|4782243|P1|Overall Study|Relocation|1
1449971|NCT00830128|4782243|P1|Overall Study|Family obligation|1
1449972|NCT00830128|4782243|P1|Overall Study|Withdrawal by Subject|2
1449973|NCT00830128|4782243|P1|Overall Study|Protocol Violation|1
1449974|NCT00830128|4782243|P1|Overall Study|Lack of Efficacy|7
1449975|NCT00830128|4782243|P1|Overall Study|Adverse Event|5
1449976|NCT00830115|4782258|P1|Overall Study|Improvement/recovery|1
1449977|NCT00830115|4782258|P1|Overall Study|Adverse Event|2
1449978|NCT00830037|4782285|P2|Overall Study|Active when terminated by DSMB|14
1449979|NCT00830037|4782286|P1|Overall Study|Active when terminated by DSMB|15
1449980|NCT00830037|4782285|P2|Overall Study|Lost to Follow-up|2
1449981|NCT00830037|4782286|P1|Overall Study|Lost to Follow-up|1
1449982|NCT00830037|4782285|P2|Overall Study|Withdrawal by Subject|3
1449983|NCT00830037|4782286|P1|Overall Study|Withdrawal by Subject|2
1449984|NCT00830024|4782296|P2|Washout: 7 Days|Withdrawal by Subject|0
1449985|NCT00830024|4782297|P1|Washout: 7 Days|Withdrawal by Subject|1
1449986|NCT00829998|4782307|P2|Washout|Adverse Event|1
1449987|NCT00829998|4782308|P1|Washout|Adverse Event|0
1449988|NCT00829933|4782337|P4|Overall Study|withdrew before treatment started|9
1449989|NCT00829933|4782338|P3|Overall Study|withdrew before treatment started|2
1449990|NCT00829933|4782339|P2|Overall Study|withdrew before treatment started|1
1449991|NCT00829933|4782340|P1|Overall Study|withdrew before treatment started|5
1449992|NCT00829933|4782337|P4|Overall Study|Protocol Violation|0
1449993|NCT00829933|4782338|P3|Overall Study|Protocol Violation|0
1449994|NCT00829933|4782339|P2|Overall Study|Protocol Violation|1
1449995|NCT00829933|4782340|P1|Overall Study|Protocol Violation|2
1449996|NCT00829933|4782337|P4|Overall Study|Pregnancy|2
1449997|NCT00829933|4782338|P3|Overall Study|Pregnancy|0
1449998|NCT00829933|4782339|P2|Overall Study|Pregnancy|0
1449999|NCT00829933|4782340|P1|Overall Study|Pregnancy|0
1450000|NCT00829933|4782337|P4|Overall Study|Physician Decision|1
1450001|NCT00829933|4782338|P3|Overall Study|Physician Decision|8
1450002|NCT00829933|4782339|P2|Overall Study|Physician Decision|7
1450003|NCT00829933|4782340|P1|Overall Study|Physician Decision|5
1450004|NCT00829933|4782337|P4|Overall Study|Lack of Efficacy|0
1450005|NCT00829933|4782338|P3|Overall Study|Lack of Efficacy|0
1450006|NCT00829933|4782339|P2|Overall Study|Lack of Efficacy|1
1450007|NCT00829933|4782340|P1|Overall Study|Lack of Efficacy|0
1450008|NCT00829933|4782337|P4|Overall Study|Death|1
1450009|NCT00829933|4782338|P3|Overall Study|Death|1
1450010|NCT00829933|4782339|P2|Overall Study|Death|0
1450011|NCT00829933|4782340|P1|Overall Study|Death|0
1450012|NCT00829933|4782337|P4|Overall Study|Adverse Event|1
1450013|NCT00829933|4782338|P3|Overall Study|Adverse Event|2
1450014|NCT00829933|4782339|P2|Overall Study|Adverse Event|3
1450015|NCT00829933|4782340|P1|Overall Study|Adverse Event|2
1450016|NCT00829868|4782352|P2|Washout|Physician Decision|0
1450017|NCT00829868|4782353|P1|Washout|Physician Decision|1
1450018|NCT00829829|4782364|P3|Overall Study|Other than specified above|1
1450019|NCT00829829|4782365|P2|Overall Study|Other than specified above|2
1450020|NCT00829829|4782366|P1|Overall Study|Other than specified above|2
1450021|NCT00829829|4782364|P3|Overall Study|Lost to Follow-up|3
1450022|NCT00829829|4782365|P2|Overall Study|Lost to Follow-up|3
1450023|NCT00829829|4782366|P1|Overall Study|Lost to Follow-up|7
1450024|NCT00829829|4782364|P3|Overall Study|Decision by the Sponsor|2
1450025|NCT00829829|4782365|P2|Overall Study|Decision by the Sponsor|0
1450026|NCT00829829|4782366|P1|Overall Study|Decision by the Sponsor|1
1450027|NCT00829829|4782364|P3|Overall Study|Withdrawal by Subject|2
1450028|NCT00829829|4782365|P2|Overall Study|Withdrawal by Subject|4
1450029|NCT00829829|4782366|P1|Overall Study|Withdrawal by Subject|8
1450030|NCT00829829|4782364|P3|Overall Study|Adverse Event|3
1450031|NCT00829829|4782365|P2|Overall Study|Adverse Event|4
1450032|NCT00829829|4782366|P1|Overall Study|Adverse Event|4
1450033|NCT00829829|4782364|P3|Overall Study|Protocol Violation|0
1450034|NCT00829829|4782365|P2|Overall Study|Protocol Violation|3
1450035|NCT00829829|4782366|P1|Overall Study|Protocol Violation|0
1450036|NCT00829790|4782391|P2|Washout of 14 Days|Withdrawal by Subject|1
1450037|NCT00829790|4782392|P1|Washout of 14 Days|Withdrawal by Subject|0
1450038|NCT00829764|4782402|P2|First Intervention|Withdrawal by Subject|1
1450039|NCT00829764|4782403|P1|First Intervention|Withdrawal by Subject|1
1450040|NCT00829764|4782402|P2|First Intervention|Adverse Event|0
1450041|NCT00829764|4782403|P1|First Intervention|Adverse Event|1
1450042|NCT00829712|4782429|P2|Washout of 7 Days|Withdrawal by Subject|1
1450043|NCT00829712|4782430|P1|Washout of 7 Days|Withdrawal by Subject|0
1450044|NCT00829673|4782449|P2|Washout of 7 Days|Withdrawal by Subject|0
1450045|NCT00829673|4782450|P1|Washout of 7 Days|Withdrawal by Subject|1
1450046|NCT00829621|4782460|P2|Overall Study|Lost to Follow-up|4
1450047|NCT00829621|4782461|P1|Overall Study|Lost to Follow-up|3
1450048|NCT00829621|4782460|P2|Overall Study|Death|0
1450049|NCT00829621|4782461|P1|Overall Study|Death|1
1450050|NCT00829530|4782469|P2|Second Intervention|Intolerance to Venopuncture|0
1450051|NCT00829530|4782470|P1|Second Intervention|Intolerance to Venopuncture|1
1450052|NCT00829530|4782469|P2|First Intervention|Intolerance to Venopuncture|1
1450053|NCT00829530|4782470|P1|First Intervention|Intolerance to Venopuncture|0
1450054|NCT00829530|4782469|P2|First Intervention|Adverse Event|1
1450055|NCT00829530|4782470|P1|First Intervention|Adverse Event|0
1450056|NCT00829504|4782484|P2|Second Intervention|Physician Decision|0
1450057|NCT00829504|4782485|P1|Second Intervention|Physician Decision|1
1450058|NCT00829504|4782484|P2|Washout of 7 Days|Withdrawal by Subject|0
1450059|NCT00829504|4782485|P1|Washout of 7 Days|Withdrawal by Subject|1
1450060|NCT00829504|4782484|P2|First Intervention|Adverse Event|0
1450061|NCT00829504|4782485|P1|First Intervention|Adverse Event|1
1450062|NCT00829452|4782495|P2|Second Intervention|Physician Decision|1
1450063|NCT00829452|4782496|P1|Second Intervention|Physician Decision|0
1450064|NCT00829452|4782495|P2|Washout of 42 Days|Withdrawal by Subject|1
1450065|NCT00829452|4782496|P1|Washout of 42 Days|Withdrawal by Subject|0
1450066|NCT00829452|4782495|P2|First Intervention|Withdrawal by Subject|1
1450067|NCT00829452|4782496|P1|First Intervention|Withdrawal by Subject|0
1450068|NCT00829439|4782508|P4|Overall Study|Adverse Event|0
1450069|NCT00829439|4782509|P3|Overall Study|Adverse Event|1
1450070|NCT00829439|4782510|P2|Overall Study|Adverse Event|0
1450071|NCT00829439|4782511|P1|Overall Study|Adverse Event|0
1450072|NCT00829426|4782517|P2|Washout: 7 Days|Withdrawal by Subject|0
1450073|NCT00829426|4782518|P1|Washout: 7 Days|Withdrawal by Subject|1
1450074|NCT00829413|4782526|P1|Overall Study|Indeterminate diagnosis from truth stand|3
1450075|NCT00829413|4782526|P1|Overall Study|Technically inadequate truth standard|2
1450076|NCT00829413|4782526|P1|Overall Study|No truth standard procedure available|9
1450077|NCT00829413|4782526|P1|Overall Study|Training Patients|67
1450078|NCT00829413|4782526|P1|Overall Study|No study drug admimnistered|13
1450079|NCT00829387|4782575|P2|Overall Study|Disqualified by PI|0
1450080|NCT00829387|4782576|P1|Overall Study|Disqualified by PI|1
1450081|NCT00829387|4782575|P2|Overall Study|Withdrawal by Subject|3
1450082|NCT00829387|4782576|P1|Overall Study|Withdrawal by Subject|2
1450083|NCT00829309|4782594|P2|Washout: 7 Days|Protocol Violation|0
1450084|NCT00829309|4782595|P1|Washout: 7 Days|Protocol Violation|1
1450085|NCT00829296|4782605|P2|Overall Study|Adverse Event|4
1450086|NCT00829296|4782606|P1|Overall Study|Adverse Event|5
1450087|NCT00829283|4782620|P2|Overall Study|Lost to Follow-up|25
1450088|NCT00829283|4782621|P1|Overall Study|Lost to Follow-up|7
1450089|NCT00829244|4782631|P2|Overall Study|No embryo cleavage|2
1450090|NCT00829244|4782632|P1|Overall Study|No embryo cleavage|0
1450091|NCT00829244|4782631|P2|Overall Study|All embryos discarded|3
1450092|NCT00829244|4782632|P1|Overall Study|All embryos discarded|0
1450093|NCT00829244|4782631|P2|Overall Study|No fertilization|2
1450094|NCT00829244|4782632|P1|Overall Study|No fertilization|2
1450095|NCT00829244|4782631|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
1450096|NCT00829244|4782632|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
1450097|NCT00829244|4782631|P2|Overall Study|Lack of ovarian response to stimulation|5
1450098|NCT00829244|4782632|P1|Overall Study|Lack of ovarian response to stimulation|9
1450099|NCT00829244|4782631|P2|Overall Study|Protocol Violation|0
1450100|NCT00829244|4782632|P1|Overall Study|Protocol Violation|1
1450101|NCT00829244|4782631|P2|Overall Study|Adverse Event|3
1450102|NCT00829244|4782632|P1|Overall Study|Adverse Event|1
1450103|NCT00829179|4782662|P1|Overall Study|Withdrawal by Subject|1
1450104|NCT00829166|4782668|P2|Overall Study|Reason Not Specified|3
1450105|NCT00829166|4782669|P1|Overall Study|Reason Not Specified|3
1450106|NCT00829166|4782668|P2|Overall Study|Sponsor’s Decision|98
1450107|NCT00829166|4782669|P1|Overall Study|Sponsor’s Decision|137
1450108|NCT00829166|4782668|P2|Overall Study|Subject's Decision|55
1450109|NCT00829166|4782669|P1|Overall Study|Subject's Decision|41
1450110|NCT00829166|4782668|P2|Overall Study|Physician's Decision|3
1450111|NCT00829166|4782669|P1|Overall Study|Physician's Decision|4
1450112|NCT00829166|4782668|P2|Overall Study|Lost to Follow-up|4
1450113|NCT00829166|4782669|P1|Overall Study|Lost to Follow-up|5
1450114|NCT00829166|4782668|P2|Overall Study|Death|333
1450115|NCT00829166|4782669|P1|Overall Study|Death|305
1450116|NCT00829010|4782732|P5|Overall Study|Migrated/Moved from study area|0
1450117|NCT00829010|4782733|P4|Overall Study|Migrated/Moved from study area|5
1450118|NCT00829010|4782734|P3|Overall Study|Migrated/Moved from study area|0
1450119|NCT00829010|4782735|P2|Overall Study|Migrated/Moved from study area|4
1450120|NCT00829010|4782736|P1|Overall Study|Migrated/Moved from study area|3
1450121|NCT00829010|4782732|P5|Overall Study|Fatality|0
1450122|NCT00829010|4782733|P4|Overall Study|Fatality|3
1450123|NCT00829010|4782734|P3|Overall Study|Fatality|0
1450124|NCT00829010|4782735|P2|Overall Study|Fatality|4
1450125|NCT00829010|4782736|P1|Overall Study|Fatality|5
1450126|NCT00829010|4782732|P5|Overall Study|Lost to Follow-up|0
1450127|NCT00829010|4782733|P4|Overall Study|Lost to Follow-up|0
1450128|NCT00829010|4782734|P3|Overall Study|Lost to Follow-up|2
1450129|NCT00829010|4782735|P2|Overall Study|Lost to Follow-up|0
1450130|NCT00829010|4782736|P1|Overall Study|Lost to Follow-up|1
1450131|NCT00829010|4782732|P5|Overall Study|Withdrawal by Subject|2
1450132|NCT00829010|4782733|P4|Overall Study|Withdrawal by Subject|0
1450133|NCT00829010|4782734|P3|Overall Study|Withdrawal by Subject|1
1450134|NCT00829010|4782735|P2|Overall Study|Withdrawal by Subject|1
1450135|NCT00829010|4782736|P1|Overall Study|Withdrawal by Subject|0
1450136|NCT00829010|4782732|P5|Overall Study|Adverse Event|0
1450137|NCT00829010|4782733|P4|Overall Study|Adverse Event|0
1450138|NCT00829010|4782734|P3|Overall Study|Adverse Event|0
1450139|NCT00829010|4782735|P2|Overall Study|Adverse Event|0
1450140|NCT00829010|4782736|P1|Overall Study|Adverse Event|1
1450141|NCT00828984|4782901|P3|Overall Study|ConMed|1
1450142|NCT00828984|4782902|P2|Overall Study|ConMed|1
1450143|NCT00828984|4782903|P1|Overall Study|ConMed|1
1450144|NCT00828984|4782901|P3|Overall Study|Noncompliant|3
1450145|NCT00828984|4782902|P2|Overall Study|Noncompliant|2
1450146|NCT00828984|4782903|P1|Overall Study|Noncompliant|1
1450147|NCT00828984|4782901|P3|Overall Study|Medical Contraindication|0
1450148|NCT00828984|4782902|P2|Overall Study|Medical Contraindication|1
1450149|NCT00828984|4782903|P1|Overall Study|Medical Contraindication|0
1450150|NCT00828984|4782901|P3|Overall Study|Ineligable|0
1450151|NCT00828984|4782902|P2|Overall Study|Ineligable|2
1450152|NCT00828984|4782903|P1|Overall Study|Ineligable|1
1450153|NCT00828984|4782901|P3|Overall Study|Withdrawal by Subject|4
1450154|NCT00828984|4782902|P2|Overall Study|Withdrawal by Subject|4
1450155|NCT00828984|4782903|P1|Overall Study|Withdrawal by Subject|4
1450156|NCT00828984|4782901|P3|Overall Study|Lost to Follow-up|1
1450157|NCT00828984|4782902|P2|Overall Study|Lost to Follow-up|3
1450158|NCT00828984|4782903|P1|Overall Study|Lost to Follow-up|5
1450159|NCT00828984|4782901|P3|Overall Study|Adverse Event|0
1450160|NCT00828984|4782902|P2|Overall Study|Adverse Event|3
1450161|NCT00828984|4782903|P1|Overall Study|Adverse Event|2
1450162|NCT00828945|4782926|P1|Overall Study|Other|36
1450163|NCT00828945|4782926|P1|Overall Study|Participant was missing|1
1450164|NCT00828945|4782926|P1|Overall Study|Death|4
1450165|NCT00828750|4782958|P1|Overall Study|Normal PC Remained While No Treatment|1
1450166|NCT00828750|4782958|P1|Overall Study|Lack of Efficacy|3
1450167|NCT00828711|4782972|P3|Overall Study|Lost to Follow-up|0
1450168|NCT00828711|4782973|P2|Overall Study|Lost to Follow-up|0
1450169|NCT00828711|4782974|P1|Overall Study|Lost to Follow-up|1
1450170|NCT00828568|4783006|P3|Treated - Received at Least One Dose|Protocol Violation|3
1450171|NCT00828568|4783007|P2|Treated - Received at Least One Dose|Protocol Violation|5
1450172|NCT00828568|4783008|P1|Treated - Received at Least One Dose|Protocol Violation|9
1450173|NCT00828568|4783006|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
1450174|NCT00828568|4783007|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
1450175|NCT00828568|4783008|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
1450176|NCT00828568|4783006|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
1450177|NCT00828568|4783007|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
1450178|NCT00828568|4783008|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
1450179|NCT00828568|4783006|P3|Treated - Received at Least One Dose|Adverse Event|1
1450180|NCT00828568|4783007|P2|Treated - Received at Least One Dose|Adverse Event|8
1450181|NCT00828568|4783008|P1|Treated - Received at Least One Dose|Adverse Event|11
1450182|NCT00828568|4783006|P3|Randomized|Withdrawal by Subject|2
1450183|NCT00828568|4783007|P2|Randomized|Withdrawal by Subject|0
1450184|NCT00828568|4783008|P1|Randomized|Withdrawal by Subject|1
1450185|NCT00828516|4783030|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
1450186|NCT00828464|4783035|P1|Overall Study|Withdrawal by Subject|1
1450187|NCT00828451|4783052|P1|Overall Study|Deterioration in clinical status|1
1450188|NCT00828451|4783052|P1|Overall Study|Withdrawal by Subject|1
1450189|NCT00828451|4783052|P1|Overall Study|Lack of intravenous line|7
1450190|NCT00828451|4783052|P1|Overall Study|Death|2
1450191|NCT00828321|4783078|P2|Second Intervention|Protocol Violation|1
1450192|NCT00828321|4783079|P1|Second Intervention|Protocol Violation|0
1450193|NCT00828321|4783078|P2|Washout of 42 Days|Withdrawal by Subject|0
1450194|NCT00828321|4783079|P1|Washout of 42 Days|Withdrawal by Subject|2
1450195|NCT00828204|4783108|P2|Extension Study|Physician Decision|2
1450196|NCT00828204|4783109|P1|Extension Study|Physician Decision|0
1450197|NCT00828204|4783108|P2|Extension Study|Lost to Follow-up|1
1450198|NCT00828204|4783109|P1|Extension Study|Lost to Follow-up|0
1450199|NCT00828204|4783108|P2|Main Study: After Study Restart|Noncompliance|1
1450200|NCT00828204|4783109|P1|Main Study: After Study Restart|Noncompliance|0
1450201|NCT00828204|4783108|P2|Main Study: After Study Restart|Adverse Event|2
1450202|NCT00828204|4783109|P1|Main Study: After Study Restart|Adverse Event|0
1450203|NCT00828204|4783108|P2|Main Study: Prior to Study Suspension|Study Suspension|0
1450204|NCT00828204|4783109|P1|Main Study: Prior to Study Suspension|Study Suspension|11
1450205|NCT00828204|4783108|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
1450206|NCT00828204|4783109|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
1450207|NCT00828204|4783108|P2|Main Study: Prior to Study Suspension|Adverse Event|0
1450208|NCT00828204|4783109|P1|Main Study: Prior to Study Suspension|Adverse Event|1
1450209|NCT00828139|4783156|P4|Overall Study|Not specified|2
1450210|NCT00828139|4783157|P3|Overall Study|Not specified|5
1450211|NCT00828139|4783158|P2|Overall Study|Not specified|2
1450212|NCT00828139|4783159|P1|Overall Study|Not specified|4
1450213|NCT00828139|4783156|P4|Overall Study|Disease Progression|39
1450214|NCT00828139|4783157|P3|Overall Study|Disease Progression|35
1450215|NCT00828139|4783158|P2|Overall Study|Disease Progression|33
1450216|NCT00828139|4783159|P1|Overall Study|Disease Progression|24
1450217|NCT00828139|4783156|P4|Overall Study|Refusal unrelated to toxicity|3
1450218|NCT00828139|4783157|P3|Overall Study|Refusal unrelated to toxicity|5
1450219|NCT00828139|4783158|P2|Overall Study|Refusal unrelated to toxicity|4
1450220|NCT00828139|4783159|P1|Overall Study|Refusal unrelated to toxicity|3
1450221|NCT00828139|4783156|P4|Overall Study|Death|2
1450222|NCT00828139|4783157|P3|Overall Study|Death|0
1450223|NCT00828139|4783158|P2|Overall Study|Death|1
1450224|NCT00828139|4783159|P1|Overall Study|Death|2
1450225|NCT00828139|4783156|P4|Overall Study|Adverse Event|5
1450226|NCT00828139|4783157|P3|Overall Study|Adverse Event|10
1450227|NCT00828139|4783158|P2|Overall Study|Adverse Event|1
1450228|NCT00828139|4783159|P1|Overall Study|Adverse Event|8
1450229|NCT00828113|4783179|P2|Overall Study|Lost to Follow-up|5
1450230|NCT00828113|4783180|P1|Overall Study|Lost to Follow-up|3
1450231|NCT00828113|4783179|P2|Overall Study|Withdrawal by Subject|26
1450232|NCT00828113|4783180|P1|Overall Study|Withdrawal by Subject|27
1450233|NCT00827931|4783254|P2|Overall Study|Other|0
1450234|NCT00827931|4783255|P1|Overall Study|Other|1
1450235|NCT00827931|4783254|P2|Overall Study|Withdrawal by Subject|1
1450236|NCT00827931|4783255|P1|Overall Study|Withdrawal by Subject|0
1450237|NCT00827931|4783254|P2|Overall Study|Lost to Follow-up|0
1450238|NCT00827931|4783255|P1|Overall Study|Lost to Follow-up|1
1450239|NCT00827931|4783254|P2|Overall Study|Adverse Event|0
1450240|NCT00827931|4783255|P1|Overall Study|Adverse Event|1
1450241|NCT00827931|4783254|P2|Overall Study|Death|5
1450242|NCT00827931|4783255|P1|Overall Study|Death|3
1450243|NCT00827918|4783276|P3|Overall Study|Withdrawal by Subject|6
1450244|NCT00827918|4783277|P2|Overall Study|Withdrawal by Subject|2
1450245|NCT00827918|4783278|P1|Overall Study|Withdrawal by Subject|6
1450246|NCT00827918|4783276|P3|Overall Study|Protocol Violation|0
1450247|NCT00827918|4783277|P2|Overall Study|Protocol Violation|1
1450248|NCT00827918|4783278|P1|Overall Study|Protocol Violation|0
1450249|NCT00827918|4783276|P3|Overall Study|Progressive Disease|0
1450250|NCT00827918|4783277|P2|Overall Study|Progressive Disease|1
1450251|NCT00827918|4783278|P1|Overall Study|Progressive Disease|1
1450252|NCT00827918|4783276|P3|Overall Study|Pregnancy|0
1450253|NCT00827918|4783277|P2|Overall Study|Pregnancy|1
1450254|NCT00827918|4783278|P1|Overall Study|Pregnancy|0
1450255|NCT00827918|4783276|P3|Overall Study|Physician Decision|0
1450256|NCT00827918|4783277|P2|Overall Study|Physician Decision|0
1450257|NCT00827918|4783278|P1|Overall Study|Physician Decision|1
1450258|NCT00827918|4783276|P3|Overall Study|Lack of Efficacy|15
1450259|NCT00827918|4783277|P2|Overall Study|Lack of Efficacy|4
1450260|NCT00827918|4783278|P1|Overall Study|Lack of Efficacy|16
1450261|NCT00827918|4783276|P3|Overall Study|Adverse Event|0
1450262|NCT00827918|4783277|P2|Overall Study|Adverse Event|0
1450263|NCT00827918|4783278|P1|Overall Study|Adverse Event|4
1450264|NCT00827827|4783306|P2|Overall Study|Burned with water at home|0
1450265|NCT00827827|4783307|P1|Overall Study|Burned with water at home|1
1450266|NCT00827827|4783306|P2|Overall Study|Transportation issues|0
1450267|NCT00827827|4783307|P1|Overall Study|Transportation issues|1
1450268|NCT00827827|4783306|P2|Overall Study|Gout|0
1450269|NCT00827827|4783307|P1|Overall Study|Gout|1
1450270|NCT00827827|4783306|P2|Overall Study|Another cerebrovascular accident (CVA)|0
1450271|NCT00827827|4783307|P1|Overall Study|Another cerebrovascular accident (CVA)|1
1450272|NCT00827827|4783306|P2|Overall Study|Fall at home- hospitalization|0
1450273|NCT00827827|4783307|P1|Overall Study|Fall at home- hospitalization|1
1450274|NCT00827827|4783306|P2|Overall Study|Lost to Follow-up|0
1450275|NCT00827827|4783307|P1|Overall Study|Lost to Follow-up|3
1450276|NCT00827632|4783351|P2|Overall Study|Early withdrawal|11
1450277|NCT00827632|4783352|P1|Overall Study|Early withdrawal|14
1450278|NCT00827632|4783351|P2|Overall Study|Lost to Follow-up|12
1450279|NCT00827632|4783352|P1|Overall Study|Lost to Follow-up|8
1450280|NCT00827606|4783360|P2|Overall Study|Adverse Event|2
1450281|NCT00827606|4783361|P1|Overall Study|Adverse Event|4
1450282|NCT00827606|4783360|P2|Overall Study|LDL below 2.59 mmol/L|12
1450283|NCT00827606|4783361|P1|Overall Study|LDL below 2.59 mmol/L|4
1450284|NCT00827606|4783360|P2|Overall Study|Not specified|13
1450285|NCT00827606|4783361|P1|Overall Study|Not specified|5
1450286|NCT00827606|4783360|P2|Overall Study|Pregnancy|1
1450287|NCT00827606|4783361|P1|Overall Study|Pregnancy|0
1450288|NCT00827606|4783360|P2|Overall Study|Withdrawal by Subject|6
1450289|NCT00827606|4783361|P1|Overall Study|Withdrawal by Subject|7
1450290|NCT00827606|4783360|P2|Overall Study|Lost to Follow-up|1
1450291|NCT00827606|4783361|P1|Overall Study|Lost to Follow-up|3
1450292|NCT00827606|4783360|P2|Overall Study|Protocol Violation|3
1450293|NCT00827606|4783361|P1|Overall Study|Protocol Violation|4
1450294|NCT00827567|4783422|P1|Overall Study|Progression of Disease/Screen Failure|4
1450295|NCT00827541|4783428|P2|Overall Study|Lack of effectiveness|0
1450296|NCT00827541|4783429|P1|Overall Study|Lack of effectiveness|1
1450297|NCT00827541|4783428|P2|Overall Study|Pathogen not susceptible|0
1450298|NCT00827541|4783429|P1|Overall Study|Pathogen not susceptible|1
1450299|NCT00827541|4783428|P2|Overall Study|Other|3
1450300|NCT00827541|4783429|P1|Overall Study|Other|1
1450301|NCT00827541|4783428|P2|Overall Study|Exitus|8
1450302|NCT00827541|4783429|P1|Overall Study|Exitus|1
1450303|NCT00827502|4783441|P1|Overall Study|Withdrawal by Subject|5
1450304|NCT00827502|4783441|P1|Overall Study|Lost to Follow-up|4
1450305|NCT00827502|4783441|P1|Overall Study|Adverse Event|1
1450306|NCT00827502|4783441|P1|Overall Study|randomized but not treated|11
1450307|NCT00827372|4783447|P1|Overall Study|Lack of Efficacy|3
1450308|NCT00827372|4783447|P1|Overall Study|Adverse Event|5
1450309|NCT00827242|4783462|P2|Overall Study|Lack of Efficacy|0
1450310|NCT00827242|4783463|P1|Overall Study|Lack of Efficacy|1
1450311|NCT00827242|4783462|P2|Overall Study|Death|0
1450312|NCT00827242|4783463|P1|Overall Study|Death|1
1450313|NCT00827242|4783462|P2|Overall Study|Physician Decision|0
1450314|NCT00827242|4783463|P1|Overall Study|Physician Decision|2
1450315|NCT00827242|4783462|P2|Overall Study|Entry Criteria Not Met|1
1450316|NCT00827242|4783463|P1|Overall Study|Entry Criteria Not Met|4
1450317|NCT00827242|4783462|P2|Overall Study|Adverse Event Excluding Death|1
1450318|NCT00827242|4783463|P1|Overall Study|Adverse Event Excluding Death|2
1450319|NCT00827242|4783462|P2|Overall Study|Lost to Follow-up|3
1450320|NCT00827242|4783463|P1|Overall Study|Lost to Follow-up|0
1450321|NCT00827242|4783462|P2|Overall Study|Protocol Violation|3
1450322|NCT00827242|4783463|P1|Overall Study|Protocol Violation|1
1450323|NCT00827242|4783462|P2|Overall Study|Withdrawal by Subject|4
1450324|NCT00827242|4783463|P1|Overall Study|Withdrawal by Subject|2
1450325|NCT00827112|4783501|P2|Overall Study|Other|3
1450326|NCT00827112|4783502|P1|Overall Study|Other|1
1450327|NCT00827112|4783501|P2|Overall Study|Randomized but not treated|3
1450328|NCT00827112|4783502|P1|Overall Study|Randomized but not treated|5
1450329|NCT00827112|4783501|P2|Overall Study|Withdrawal by Subject|1
1450330|NCT00827112|4783502|P1|Overall Study|Withdrawal by Subject|2
1450331|NCT00827112|4783501|P2|Overall Study|Protocol Violation|2
1450332|NCT00827112|4783502|P1|Overall Study|Protocol Violation|0
1450333|NCT00827112|4783501|P2|Overall Study|Pregnancy|1
1450334|NCT00827112|4783502|P1|Overall Study|Pregnancy|0
1450335|NCT00827112|4783501|P2|Overall Study|Lost to Follow-up|2
1450336|NCT00827112|4783502|P1|Overall Study|Lost to Follow-up|3
1450337|NCT00827112|4783501|P2|Overall Study|Lack of Efficacy|0
1450338|NCT00827112|4783502|P1|Overall Study|Lack of Efficacy|2
1450339|NCT00827112|4783501|P2|Overall Study|Adverse Event|0
1450340|NCT00827112|4783502|P1|Overall Study|Adverse Event|2
1450341|NCT00826943|4783555|P6|Overall Study|Withdrawal by Subject|0
1450342|NCT00826943|4783556|P5|Overall Study|Withdrawal by Subject|1
1450343|NCT00826943|4783557|P4|Overall Study|Withdrawal by Subject|0
1450344|NCT00826943|4783558|P3|Overall Study|Withdrawal by Subject|0
1450345|NCT00826943|4783559|P2|Overall Study|Withdrawal by Subject|0
1450346|NCT00826943|4783560|P1|Overall Study|Withdrawal by Subject|0
1450347|NCT00826748|4783581|P3|Overall Study|Samples Did Not pass QC|1
1450348|NCT00826748|4783582|P2|Overall Study|Samples Did Not pass QC|0
1450349|NCT00826748|4783583|P1|Overall Study|Samples Did Not pass QC|0
1450350|NCT00826748|4783581|P3|Overall Study|Physician Decision|1
1450351|NCT00826748|4783582|P2|Overall Study|Physician Decision|0
1450352|NCT00826748|4783583|P1|Overall Study|Physician Decision|0
1450353|NCT00826748|4783581|P3|Overall Study|Withdrawal by Subject|2
1450354|NCT00826748|4783582|P2|Overall Study|Withdrawal by Subject|0
1450355|NCT00826748|4783583|P1|Overall Study|Withdrawal by Subject|0
1450356|NCT00826618|4783591|P1|Overall Study|Withdrawal by Subject|1
1450357|NCT00826540|4783595|P1|Overall Study|Withdrawal by Subject|1
1450358|NCT00826540|4783595|P1|Overall Study|ineligible|3
1450359|NCT00826449|4783601|P1|Overall Study|Withdrawal by Subject|1
1450360|NCT00826449|4783601|P1|Overall Study|Disease Progression|4
1450361|NCT00826280|4783610|P3|Overall Study|One or more non-interpretable scan|1
1450362|NCT00826280|4783611|P2|Overall Study|One or more non-interpretable scan|1
1450363|NCT00826280|4783612|P1|Overall Study|One or more non-interpretable scan|0
1450364|NCT00826280|4783610|P3|Overall Study|Machine Failure|0
1450365|NCT00826280|4783611|P2|Overall Study|Machine Failure|1
1450366|NCT00826280|4783612|P1|Overall Study|Machine Failure|1
1450367|NCT00826280|4783610|P3|Overall Study|Interpretation Failure|0
1450368|NCT00826280|4783611|P2|Overall Study|Interpretation Failure|0
1450369|NCT00826280|4783612|P1|Overall Study|Interpretation Failure|1
1450370|NCT00826280|4783610|P3|Overall Study|Reversible ischemic defect not present|44
1450371|NCT00826280|4783611|P2|Overall Study|Reversible ischemic defect not present|40
1450372|NCT00826280|4783612|P1|Overall Study|Reversible ischemic defect not present|43
1450373|NCT00826280|4783610|P3|Overall Study|Sponsor discontinued subject or study|0
1450374|NCT00826280|4783611|P2|Overall Study|Sponsor discontinued subject or study|0
1450375|NCT00826280|4783612|P1|Overall Study|Sponsor discontinued subject or study|1
1450376|NCT00826280|4783610|P3|Overall Study|Lost to Follow-up|0
1450377|NCT00826280|4783611|P2|Overall Study|Lost to Follow-up|1
1450378|NCT00826280|4783612|P1|Overall Study|Lost to Follow-up|0
1450379|NCT00826280|4783610|P3|Overall Study|Adverse Event|0
1450380|NCT00826280|4783611|P2|Overall Study|Adverse Event|3
1450381|NCT00826280|4783612|P1|Overall Study|Adverse Event|1
1450382|NCT00826280|4783610|P3|Overall Study|Randomized but drug not received|1
1450383|NCT00826280|4783611|P2|Overall Study|Randomized but drug not received|0
1450384|NCT00826280|4783612|P1|Overall Study|Randomized but drug not received|1
1450385|NCT00826267|4783641|P3|Overall Study|Other Adverse Event|0
1450386|NCT00826267|4783642|P2|Overall Study|Other Adverse Event|0
1450387|NCT00826267|4783643|P1|Overall Study|Other Adverse Event|1
1450388|NCT00826228|4783661|P1|Overall Study|Withdrawal by Subject|1
1450389|NCT00826176|4783683|P2|Overall Study|Administrative|0
1450390|NCT00826176|4783684|P1|Overall Study|Administrative|9
1450391|NCT00826176|4783683|P2|Overall Study|Subject Withdrew Consent|0
1450392|NCT00826176|4783684|P1|Overall Study|Subject Withdrew Consent|3
1450393|NCT00826176|4783683|P2|Overall Study|Lost to Follow-up|0
1450394|NCT00826176|4783684|P1|Overall Study|Lost to Follow-up|1
1450395|NCT00826111|4783696|P2|Overall Study|Physician Decision|1
1450396|NCT00826111|4783697|P1|Overall Study|Physician Decision|1
1450397|NCT00826111|4783696|P2|Overall Study|Withdrawal by Subject|0
1450398|NCT00826111|4783697|P1|Overall Study|Withdrawal by Subject|5
1450399|NCT00826111|4783696|P2|Overall Study|Protocol Violation|0
1450400|NCT00826111|4783697|P1|Overall Study|Protocol Violation|1
1450401|NCT00826111|4783696|P2|Overall Study|Lost to Follow-up|1
1450402|NCT00826111|4783697|P1|Overall Study|Lost to Follow-up|0
1450403|NCT00825994|4783727|P1|Overall Study|Placebo Responder at V2|1
1450404|NCT00825994|4783727|P1|Overall Study|Protocol Violation|1
1450405|NCT00825994|4783727|P1|Overall Study|Lost to Follow-up|1
1450406|NCT00825994|4783727|P1|Overall Study|Withdrawal by Subject|2
1450407|NCT00825916|4783735|P3|Overall Study|Lost to Follow-up|1
1450408|NCT00825916|4783736|P2|Overall Study|Lost to Follow-up|2
1450409|NCT00825916|4783737|P1|Overall Study|Lost to Follow-up|4
1450410|NCT00825825|4783778|P6|Third Medication Period (14 Days)|poor data quality|0
1450411|NCT00825825|4783779|P5|Third Medication Period (14 Days)|poor data quality|0
1450412|NCT00825825|4783780|P4|Third Medication Period (14 Days)|poor data quality|0
1450413|NCT00825825|4783781|P3|Third Medication Period (14 Days)|poor data quality|0
1450414|NCT00825825|4783782|P2|Third Medication Period (14 Days)|poor data quality|1
1450415|NCT00825825|4783783|P1|Third Medication Period (14 Days)|poor data quality|0
1450416|NCT00825825|4783778|P6|Third Medication Period (14 Days)|Protocol Violation|2
1450417|NCT00825825|4783779|P5|Third Medication Period (14 Days)|Protocol Violation|0
1450418|NCT00825825|4783780|P4|Third Medication Period (14 Days)|Protocol Violation|0
1450419|NCT00825825|4783781|P3|Third Medication Period (14 Days)|Protocol Violation|0
1450420|NCT00825825|4783782|P2|Third Medication Period (14 Days)|Protocol Violation|0
1450421|NCT00825825|4783783|P1|Third Medication Period (14 Days)|Protocol Violation|0
1450422|NCT00825825|4783778|P6|Third Medication Period (14 Days)|Adverse Event|0
1450423|NCT00825825|4783779|P5|Third Medication Period (14 Days)|Adverse Event|0
1450424|NCT00825825|4783780|P4|Third Medication Period (14 Days)|Adverse Event|0
1450425|NCT00825825|4783781|P3|Third Medication Period (14 Days)|Adverse Event|0
1450426|NCT00825825|4783782|P2|Third Medication Period (14 Days)|Adverse Event|1
1450427|NCT00825825|4783783|P1|Third Medication Period (14 Days)|Adverse Event|0
1450428|NCT00825825|4783778|P6|Second Medication Period (14 Days)|Protocol Violation|0
1450429|NCT00825825|4783779|P5|Second Medication Period (14 Days)|Protocol Violation|1
1450430|NCT00825825|4783780|P4|Second Medication Period (14 Days)|Protocol Violation|0
1450431|NCT00825825|4783781|P3|Second Medication Period (14 Days)|Protocol Violation|0
1450432|NCT00825825|4783782|P2|Second Medication Period (14 Days)|Protocol Violation|0
1450433|NCT00825825|4783783|P1|Second Medication Period (14 Days)|Protocol Violation|1
1450434|NCT00825825|4783778|P6|Second Medication Period (14 Days)|Physician Decision|0
1450435|NCT00825825|4783779|P5|Second Medication Period (14 Days)|Physician Decision|0
1450436|NCT00825825|4783780|P4|Second Medication Period (14 Days)|Physician Decision|2
1450437|NCT00825825|4783781|P3|Second Medication Period (14 Days)|Physician Decision|0
1450438|NCT00825825|4783782|P2|Second Medication Period (14 Days)|Physician Decision|0
1450439|NCT00825825|4783783|P1|Second Medication Period (14 Days)|Physician Decision|1
1450440|NCT00825825|4783778|P6|First Medication Period (14 Days)|Physician Decision|1
1450441|NCT00825825|4783779|P5|First Medication Period (14 Days)|Physician Decision|0
1450442|NCT00825825|4783780|P4|First Medication Period (14 Days)|Physician Decision|0
1450443|NCT00825825|4783781|P3|First Medication Period (14 Days)|Physician Decision|1
1450444|NCT00825825|4783782|P2|First Medication Period (14 Days)|Physician Decision|0
1450445|NCT00825825|4783783|P1|First Medication Period (14 Days)|Physician Decision|2
1450446|NCT00825825|4783778|P6|First Medication Period (14 Days)|Adverse Event|1
1450447|NCT00825825|4783779|P5|First Medication Period (14 Days)|Adverse Event|0
1450448|NCT00825825|4783780|P4|First Medication Period (14 Days)|Adverse Event|0
1450449|NCT00825825|4783781|P3|First Medication Period (14 Days)|Adverse Event|0
1450450|NCT00825825|4783782|P2|First Medication Period (14 Days)|Adverse Event|0
1450451|NCT00825825|4783783|P1|First Medication Period (14 Days)|Adverse Event|1
1450452|NCT00825812|4783799|P4|Overall Study|Administrative|5
1450453|NCT00825812|4783800|P3|Overall Study|Administrative|3
1450454|NCT00825812|4783801|P2|Overall Study|Administrative|1
1450455|NCT00825812|4783802|P1|Overall Study|Administrative|0
1450456|NCT00825812|4783799|P4|Overall Study|Non-compliance with protocol|1
1450457|NCT00825812|4783800|P3|Overall Study|Non-compliance with protocol|0
1450458|NCT00825812|4783801|P2|Overall Study|Non-compliance with protocol|0
1450459|NCT00825812|4783802|P1|Overall Study|Non-compliance with protocol|0
1450460|NCT00825812|4783799|P4|Overall Study|Subject withdrew consent|2
1450461|NCT00825812|4783800|P3|Overall Study|Subject withdrew consent|3
1450462|NCT00825812|4783801|P2|Overall Study|Subject withdrew consent|0
1450463|NCT00825812|4783802|P1|Overall Study|Subject withdrew consent|0
1450464|NCT00825812|4783799|P4|Overall Study|Adverse Event|1
1450465|NCT00825812|4783800|P3|Overall Study|Adverse Event|0
1450466|NCT00825812|4783801|P2|Overall Study|Adverse Event|0
1450467|NCT00825812|4783802|P1|Overall Study|Adverse Event|0
1450468|NCT00825812|4783799|P4|Overall Study|Never entered follow up|1
1450469|NCT00825812|4783800|P3|Overall Study|Never entered follow up|0
1450470|NCT00825812|4783801|P2|Overall Study|Never entered follow up|0
1450471|NCT00825812|4783802|P1|Overall Study|Never entered follow up|0
1450472|NCT00825682|4783849|P2|Overall Study|personal reasons/ inconvenience|5
1450473|NCT00825682|4783850|P1|Overall Study|personal reasons/ inconvenience|13
1450474|NCT00825305|4783941|P2|Overall Study|Can not be classified|1
1450475|NCT00825305|4783942|P1|Overall Study|Can not be classified|0
1450476|NCT00825305|4783941|P2|Overall Study|Protocol Violation|9
1450477|NCT00825305|4783942|P1|Overall Study|Protocol Violation|9
1450478|NCT00825305|4783941|P2|Overall Study|Inappropriate inclusion|0
1450479|NCT00825305|4783942|P1|Overall Study|Inappropriate inclusion|1
1450480|NCT00825305|4783941|P2|Overall Study|Withdrawal by Subject|12
1450481|NCT00825305|4783942|P1|Overall Study|Withdrawal by Subject|6
1450482|NCT00825305|4783941|P2|Overall Study|Adverse Event|1
1450483|NCT00825305|4783942|P1|Overall Study|Adverse Event|1
1450484|NCT00825175|4783982|P2|Overall Study|Withdrawal by Subject|5
1450485|NCT00825175|4783983|P1|Overall Study|Withdrawal by Subject|0
1450486|NCT00825162|4783992|P3|Overall Study|Unable to attend the study visit|0
1450487|NCT00825162|4783993|P2|Overall Study|Unable to attend the study visit|2
1450488|NCT00825162|4783994|P1|Overall Study|Unable to attend the study visit|5
1450489|NCT00825162|4783992|P3|Overall Study|Move away from the study area|0
1450490|NCT00825162|4783993|P2|Overall Study|Move away from the study area|0
1450491|NCT00825162|4783994|P1|Overall Study|Move away from the study area|1
1450492|NCT00825162|4783992|P3|Overall Study|Physician Decision|0
1450493|NCT00825162|4783993|P2|Overall Study|Physician Decision|0
1450494|NCT00825162|4783994|P1|Overall Study|Physician Decision|2
1450495|NCT00825162|4783992|P3|Overall Study|Lost to Follow-up|3
1450496|NCT00825162|4783993|P2|Overall Study|Lost to Follow-up|6
1450497|NCT00825162|4783994|P1|Overall Study|Lost to Follow-up|9
1450498|NCT00825162|4783992|P3|Overall Study|Withdrawal by Subject|3
1450499|NCT00825162|4783993|P2|Overall Study|Withdrawal by Subject|13
1450500|NCT00825162|4783994|P1|Overall Study|Withdrawal by Subject|11
1450501|NCT00824993|4784020|P2|Overall Study|Death|3
1450502|NCT00824993|4784021|P1|Overall Study|Death|0
1450503|NCT00824993|4784020|P2|Overall Study|Insurance Issue|1
1450504|NCT00824993|4784021|P1|Overall Study|Insurance Issue|2
1450505|NCT00824993|4784020|P2|Overall Study|Non-Compliant|1
1450506|NCT00824993|4784021|P1|Overall Study|Non-Compliant|2
1450507|NCT00824993|4784020|P2|Overall Study|Rapid Bone Loss|1
1450508|NCT00824993|4784021|P1|Overall Study|Rapid Bone Loss|0
1450509|NCT00824993|4784020|P2|Overall Study|Malignancy Relapse|10
1450510|NCT00824993|4784021|P1|Overall Study|Malignancy Relapse|9
1450511|NCT00824993|4784020|P2|Overall Study|Withdrawal by Subject|1
1450512|NCT00824993|4784021|P1|Overall Study|Withdrawal by Subject|1
1450513|NCT00824850|4784029|P2|Overall Study|Withdrawal by Subject|1
1450514|NCT00824850|4784030|P1|Overall Study|Withdrawal by Subject|0
1450515|NCT00824772|4784083|P1|Overall Study|Withdrawal by Subject|8
1450516|NCT00824720|4784103|P3|Overall Study|Protocol Violation|1
1450517|NCT00824720|4784104|P2|Overall Study|Protocol Violation|0
1450518|NCT00824720|4784105|P1|Overall Study|Protocol Violation|0
1450519|NCT00824720|4784103|P3|Overall Study|failed plug insertion|0
1450520|NCT00824720|4784104|P2|Overall Study|failed plug insertion|1
1450521|NCT00824720|4784105|P1|Overall Study|failed plug insertion|3
1450522|NCT00824655|4784121|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
1450523|NCT00824655|4784122|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
1450524|NCT00824655|4784121|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
1450525|NCT00824655|4784122|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
1450526|NCT00824616|4784142|P2|Overall Study|Withdrawal by Subject|1
1450527|NCT00824616|4784143|P1|Overall Study|Withdrawal by Subject|1
1450528|NCT00824616|4784142|P2|Overall Study|Lost to Follow-up|1
1450529|NCT00824616|4784143|P1|Overall Study|Lost to Follow-up|0
1450530|NCT00824616|4784142|P2|Overall Study|Lack of Efficacy|1
1450531|NCT00824616|4784143|P1|Overall Study|Lack of Efficacy|2
1450532|NCT00824616|4784142|P2|Overall Study|Hyperglycemia|1
1450533|NCT00824616|4784143|P1|Overall Study|Hyperglycemia|1
1450534|NCT00824616|4784142|P2|Overall Study|Creatinine/Creatinine Clearance|2
1450535|NCT00824616|4784143|P1|Overall Study|Creatinine/Creatinine Clearance|0
1450536|NCT00824616|4784142|P2|Overall Study|Adverse Event|1
1450537|NCT00824616|4784143|P1|Overall Study|Adverse Event|2
1450538|NCT00824564|4784153|P2|Overall Study|Randomized, but not treated|0
1450539|NCT00824564|4784154|P1|Overall Study|Randomized, but not treated|1
1450540|NCT00824564|4784153|P2|Overall Study|Other|2
1450541|NCT00824564|4784154|P1|Overall Study|Other|1
1450542|NCT00824564|4784153|P2|Overall Study|Withdrawal by Subject|1
1450543|NCT00824564|4784154|P1|Overall Study|Withdrawal by Subject|1
1450544|NCT00824564|4784153|P2|Overall Study|Lost to Follow-up|7
1450545|NCT00824564|4784154|P1|Overall Study|Lost to Follow-up|5
1450546|NCT00824473|4784233|P2|Overall Study|Other|1
1450547|NCT00824473|4784234|P1|Overall Study|Other|1
1450548|NCT00824473|4784233|P2|Overall Study|Withdrawal by Subject|3
1450549|NCT00824473|4784234|P1|Overall Study|Withdrawal by Subject|2
1450550|NCT00824473|4784233|P2|Overall Study|Non-Compliance|2
1450551|NCT00824473|4784234|P1|Overall Study|Non-Compliance|4
1450552|NCT00824473|4784233|P2|Overall Study|Protocol Violation|0
1450553|NCT00824473|4784234|P1|Overall Study|Protocol Violation|2
1450554|NCT00824473|4784233|P2|Overall Study|Lack of Efficacy|2
1450555|NCT00824473|4784234|P1|Overall Study|Lack of Efficacy|2
1450556|NCT00824473|4784233|P2|Overall Study|Adverse Event|5
1450557|NCT00824473|4784234|P1|Overall Study|Adverse Event|4
1450558|NCT00824421|4784315|P3|Overall Study|Other|0
1450559|NCT00824421|4784316|P2|Overall Study|Other|1
1450560|NCT00824421|4784317|P1|Overall Study|Other|0
1450561|NCT00824421|4784315|P3|Overall Study|Randomized but not Treated|0
1450562|NCT00824421|4784316|P2|Overall Study|Randomized but not Treated|1
1450563|NCT00824421|4784317|P1|Overall Study|Randomized but not Treated|1
1450564|NCT00824421|4784315|P3|Overall Study|Withdrawal by Subject|3
1450565|NCT00824421|4784316|P2|Overall Study|Withdrawal by Subject|3
1450566|NCT00824421|4784317|P1|Overall Study|Withdrawal by Subject|2
1450567|NCT00824421|4784315|P3|Overall Study|Pregnancy|1
1450568|NCT00824421|4784316|P2|Overall Study|Pregnancy|0
1450569|NCT00824421|4784317|P1|Overall Study|Pregnancy|1
1450570|NCT00824421|4784315|P3|Overall Study|Lost to Follow-up|0
1450571|NCT00824421|4784316|P2|Overall Study|Lost to Follow-up|3
1450572|NCT00824421|4784317|P1|Overall Study|Lost to Follow-up|2
1450573|NCT00824421|4784315|P3|Overall Study|Lack of Efficacy|4
1450574|NCT00824421|4784316|P2|Overall Study|Lack of Efficacy|7
1450575|NCT00824421|4784317|P1|Overall Study|Lack of Efficacy|5
1450576|NCT00824421|4784315|P3|Overall Study|Death|0
1450577|NCT00824421|4784316|P2|Overall Study|Death|1
1450578|NCT00824421|4784317|P1|Overall Study|Death|0
1450579|NCT00824421|4784315|P3|Overall Study|Adverse Event|6
1450580|NCT00824421|4784316|P2|Overall Study|Adverse Event|6
1450581|NCT00824421|4784317|P1|Overall Study|Adverse Event|6
1450582|NCT00824408|4784368|P5|Randomized Phase|Other reason not defined above|4
1450583|NCT00824408|4784369|P4|Randomized Phase|Other reason not defined above|2
1450584|NCT00824408|4784370|P3|Randomized Phase|Other reason not defined above|4
1450585|NCT00824408|4784371|P2|Randomized Phase|Other reason not defined above|0
1450586|NCT00824408|4784372|P1|Randomized Phase|Other reason not defined above|0
1450587|NCT00824408|4784368|P5|Randomized Phase|Refused to continue medication|2
1450588|NCT00824408|4784369|P4|Randomized Phase|Refused to continue medication|2
1450589|NCT00824408|4784370|P3|Randomized Phase|Refused to continue medication|2
1450590|NCT00824408|4784371|P2|Randomized Phase|Refused to continue medication|0
1450591|NCT00824408|4784372|P1|Randomized Phase|Refused to continue medication|0
1450592|NCT00824408|4784368|P5|Randomized Phase|Adverse Event|5
1450593|NCT00824408|4784369|P4|Randomized Phase|Adverse Event|5
1450594|NCT00824408|4784370|P3|Randomized Phase|Adverse Event|4
1450595|NCT00824408|4784371|P2|Randomized Phase|Adverse Event|0
1450596|NCT00824408|4784372|P1|Randomized Phase|Adverse Event|0
1450597|NCT00824408|4784368|P5|Randomized Phase|Progressive disease|34
1450598|NCT00824408|4784369|P4|Randomized Phase|Progressive disease|36
1450599|NCT00824408|4784370|P3|Randomized Phase|Progressive disease|25
1450600|NCT00824408|4784371|P2|Randomized Phase|Progressive disease|0
1450601|NCT00824408|4784372|P1|Randomized Phase|Progressive disease|0
1450602|NCT00824408|4784368|P5|Randomized Phase|Not treated|1
1450603|NCT00824408|4784369|P4|Randomized Phase|Not treated|1
1450604|NCT00824408|4784370|P3|Randomized Phase|Not treated|1
1450605|NCT00824408|4784371|P2|Randomized Phase|Not treated|0
1450606|NCT00824408|4784372|P1|Randomized Phase|Not treated|0
1450607|NCT00824408|4784368|P5|Run-in Phase|Other reason not defined above|0
1450608|NCT00824408|4784369|P4|Run-in Phase|Other reason not defined above|0
1450609|NCT00824408|4784370|P3|Run-in Phase|Other reason not defined above|0
1450610|NCT00824408|4784371|P2|Run-in Phase|Other reason not defined above|1
1450611|NCT00824408|4784372|P1|Run-in Phase|Other reason not defined above|0
1450612|NCT00824408|4784368|P5|Run-in Phase|Refused to continue medication|0
1450613|NCT00824408|4784369|P4|Run-in Phase|Refused to continue medication|0
1450614|NCT00824408|4784370|P3|Run-in Phase|Refused to continue medication|0
1450615|NCT00824408|4784371|P2|Run-in Phase|Refused to continue medication|0
1450616|NCT00824408|4784372|P1|Run-in Phase|Refused to continue medication|1
1450617|NCT00824408|4784368|P5|Run-in Phase|Adverse Event|0
1450618|NCT00824408|4784369|P4|Run-in Phase|Adverse Event|0
1450619|NCT00824408|4784370|P3|Run-in Phase|Adverse Event|0
1450620|NCT00824408|4784371|P2|Run-in Phase|Adverse Event|1
1450621|NCT00824408|4784372|P1|Run-in Phase|Adverse Event|1
1450622|NCT00824408|4784368|P5|Run-in Phase|Progressive disease|0
1450623|NCT00824408|4784369|P4|Run-in Phase|Progressive disease|0
1450624|NCT00824408|4784370|P3|Run-in Phase|Progressive disease|0
1450625|NCT00824408|4784371|P2|Run-in Phase|Progressive disease|4
1450626|NCT00824408|4784372|P1|Run-in Phase|Progressive disease|4
1450627|NCT00824382|4784424|P4|Overall Study|Investigator's decision|0
1450628|NCT00824382|4784425|P3|Overall Study|Investigator's decision|2
1450629|NCT00824382|4784426|P2|Overall Study|Investigator's decision|1
1450630|NCT00824382|4784427|P1|Overall Study|Investigator's decision|0
1450631|NCT00824382|4784424|P4|Overall Study|Protocol Violation|1
1450632|NCT00824382|4784425|P3|Overall Study|Protocol Violation|0
1450633|NCT00824382|4784426|P2|Overall Study|Protocol Violation|0
1450634|NCT00824382|4784427|P1|Overall Study|Protocol Violation|1
1450635|NCT00824382|4784424|P4|Overall Study|Adverse Event|4
1450636|NCT00824382|4784425|P3|Overall Study|Adverse Event|1
1450637|NCT00824382|4784426|P2|Overall Study|Adverse Event|1
1450638|NCT00824382|4784427|P1|Overall Study|Adverse Event|4
1450639|NCT00824369|4784503|P6|Overall Study|Lost to Follow-up|0
1450640|NCT00824369|4784504|P5|Overall Study|Lost to Follow-up|1
1450641|NCT00824369|4784505|P4|Overall Study|Lost to Follow-up|0
1450642|NCT00824369|4784506|P3|Overall Study|Lost to Follow-up|0
1450643|NCT00824369|4784507|P2|Overall Study|Lost to Follow-up|0
1450644|NCT00824369|4784508|P1|Overall Study|Lost to Follow-up|0
1450645|NCT00824369|4784503|P6|Overall Study|Nolonger willing to participate in study|1
1450646|NCT00824369|4784504|P5|Overall Study|Nolonger willing to participate in study|0
1450647|NCT00824369|4784505|P4|Overall Study|Nolonger willing to participate in study|2
1450648|NCT00824369|4784506|P3|Overall Study|Nolonger willing to participate in study|1
1450649|NCT00824369|4784507|P2|Overall Study|Nolonger willing to participate in study|0
1450650|NCT00824369|4784508|P1|Overall Study|Nolonger willing to participate in study|1
1450651|NCT00824291|4784548|P2|Overall Study|Participant on prohibited medication|0
1450652|NCT00824291|4784549|P1|Overall Study|Participant on prohibited medication|1
1450653|NCT00824291|4784548|P2|Overall Study|Lack of Efficacy|8
1450654|NCT00824291|4784549|P1|Overall Study|Lack of Efficacy|7
1450655|NCT00824291|4784548|P2|Overall Study|Withdrawal by Subject|8
1450656|NCT00824291|4784549|P1|Overall Study|Withdrawal by Subject|14
1450657|NCT00824291|4784548|P2|Overall Study|Protocol Violation|1
1450658|NCT00824291|4784549|P1|Overall Study|Protocol Violation|4
1450659|NCT00824291|4784548|P2|Overall Study|Non-compliance|1
1450660|NCT00824291|4784549|P1|Overall Study|Non-compliance|1
1450661|NCT00824291|4784548|P2|Overall Study|Lost to Follow-up|9
1450662|NCT00824291|4784549|P1|Overall Study|Lost to Follow-up|11
1450663|NCT00824291|4784548|P2|Overall Study|Discontinuation of Study by Sponsor|2
1450664|NCT00824291|4784549|P1|Overall Study|Discontinuation of Study by Sponsor|1
1450665|NCT00824291|4784548|P2|Overall Study|Adverse Event|6
1450666|NCT00824291|4784549|P1|Overall Study|Adverse Event|15
1450667|NCT00824265|4784571|P2|Overall Study|Withdrawal by Subject|15
1450668|NCT00824265|4784572|P1|Overall Study|Withdrawal by Subject|6
1450669|NCT00824265|4784571|P2|Overall Study|Physician Decision|12
1450670|NCT00824265|4784572|P1|Overall Study|Physician Decision|6
1450671|NCT00824265|4784571|P2|Overall Study|Lost to Follow-up|1
1450672|NCT00824265|4784572|P1|Overall Study|Lost to Follow-up|1
1450673|NCT00824265|4784571|P2|Overall Study|Protocol Violation|0
1450674|NCT00824265|4784572|P1|Overall Study|Protocol Violation|1
1450675|NCT00824265|4784571|P2|Overall Study|Adverse Event,non-fatal|52
1450676|NCT00824265|4784572|P1|Overall Study|Adverse Event,non-fatal|50
1450677|NCT00824161|4784631|P1|Overall Study|Screen Failure|1
1450678|NCT00824161|4784631|P1|Overall Study|Withdrawal by Subject|1
1450679|NCT00824005|4784697|P2|Overall Study|Lost to Follow-up|1
1450680|NCT00824005|4784698|P1|Overall Study|Lost to Follow-up|0
1450681|NCT00824005|4784697|P2|Overall Study|Death|1
1450682|NCT00824005|4784698|P1|Overall Study|Death|0
1450683|NCT00823979|4784733|P3|Overall Study|Study Terminated by Sponsor|7
1450684|NCT00823979|4784734|P2|Overall Study|Study Terminated by Sponsor|5
1450685|NCT00823979|4784735|P1|Overall Study|Study Terminated by Sponsor|5
1450686|NCT00823979|4784733|P3|Overall Study|Randomized but not Treated|1
1450687|NCT00823979|4784734|P2|Overall Study|Randomized but not Treated|3
1450688|NCT00823979|4784735|P1|Overall Study|Randomized but not Treated|4
1450689|NCT00823979|4784733|P3|Overall Study|Other|1
1450690|NCT00823979|4784734|P2|Overall Study|Other|0
1450691|NCT00823979|4784735|P1|Overall Study|Other|2
1450692|NCT00823979|4784733|P3|Overall Study|Adverse Event|4
1450693|NCT00823979|4784734|P2|Overall Study|Adverse Event|2
1450694|NCT00823979|4784735|P1|Overall Study|Adverse Event|0
1450695|NCT00823979|4784733|P3|Overall Study|Pregnancy|0
1450696|NCT00823979|4784734|P2|Overall Study|Pregnancy|1
1450697|NCT00823979|4784735|P1|Overall Study|Pregnancy|0
1450698|NCT00823979|4784733|P3|Overall Study|Protocol Violation|0
1450699|NCT00823979|4784734|P2|Overall Study|Protocol Violation|1
1450700|NCT00823979|4784735|P1|Overall Study|Protocol Violation|1
1450701|NCT00823979|4784733|P3|Overall Study|Withdrawal by Subject|2
1450702|NCT00823979|4784734|P2|Overall Study|Withdrawal by Subject|3
1450703|NCT00823979|4784735|P1|Overall Study|Withdrawal by Subject|2
1450704|NCT00823979|4784733|P3|Overall Study|Lost to Follow-up|0
1450705|NCT00823979|4784734|P2|Overall Study|Lost to Follow-up|1
1450706|NCT00823979|4784735|P1|Overall Study|Lost to Follow-up|2
1450707|NCT00823979|4784733|P3|Overall Study|Lack of Efficacy|9
1450708|NCT00823979|4784734|P2|Overall Study|Lack of Efficacy|16
1450709|NCT00823979|4784735|P1|Overall Study|Lack of Efficacy|13
1450710|NCT00823901|4784780|P2|Overall Study|Lost to Follow-up|1
1450711|NCT00823901|4784781|P1|Overall Study|Lost to Follow-up|2
1450712|NCT00823901|4784780|P2|Overall Study|Lack of Efficacy|0
1450713|NCT00823901|4784781|P1|Overall Study|Lack of Efficacy|1
1450714|NCT00823901|4784780|P2|Overall Study|Adverse Event|1
1450715|NCT00823901|4784781|P1|Overall Study|Adverse Event|1
1450716|NCT00823836|4784789|P2|Long-term Phase|Withdrawal by Subject|1
1450717|NCT00823836|4784790|P1|Long-term Phase|Withdrawal by Subject|1
1450718|NCT00823836|4784789|P2|Long-term Phase|Physician Decision|2
1450719|NCT00823836|4784790|P1|Long-term Phase|Physician Decision|1
1450720|NCT00823836|4784789|P2|Long-term Phase|Adverse Event|2
1450721|NCT00823836|4784790|P1|Long-term Phase|Adverse Event|3
1450722|NCT00823836|4784789|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
1450723|NCT00823836|4784790|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
1450724|NCT00823836|4784789|P2|NV and PR/XR Switching Phases|Physician Decision|2
1450725|NCT00823836|4784790|P1|NV and PR/XR Switching Phases|Physician Decision|5
1450726|NCT00823836|4784789|P2|NV and PR/XR Switching Phases|Protocol Violation|1
1450727|NCT00823836|4784790|P1|NV and PR/XR Switching Phases|Protocol Violation|1
1450728|NCT00823836|4784789|P2|NV and PR/XR Switching Phases|Adverse Event|21
1450729|NCT00823836|4784790|P1|NV and PR/XR Switching Phases|Adverse Event|22
1450730|NCT00823823|4784896|P2|Overall Study|Protocol Violation|5
1450731|NCT00823823|4784897|P1|Overall Study|Protocol Violation|5
1450732|NCT00823823|4784896|P2|Overall Study|Lost to Follow-up|1
1450733|NCT00823823|4784897|P1|Overall Study|Lost to Follow-up|3
1450734|NCT00823719|4784921|P2|Overall Study|Disease Progression|4
1450735|NCT00823719|4784922|P1|Overall Study|Disease Progression|4
1450736|NCT00823719|4784921|P2|Overall Study|Withdrawal by Subject|1
1450737|NCT00823719|4784922|P1|Overall Study|Withdrawal by Subject|0
1450738|NCT00823719|4784921|P2|Overall Study|Physician Decision|4
1450739|NCT00823719|4784922|P1|Overall Study|Physician Decision|1
1450740|NCT00823719|4784921|P2|Overall Study|Adverse Event|2
1450741|NCT00823719|4784922|P1|Overall Study|Adverse Event|1
1450742|NCT00823615|4784975|P2|Period 2|Time/Job Conflict|2
1450743|NCT00823615|4784976|P1|Period 2|Time/Job Conflict|1
1450744|NCT00823615|4784975|P2|Period 2|Lost to Follow-up|0
1450745|NCT00823615|4784976|P1|Period 2|Lost to Follow-up|2
1450746|NCT00823472|4784986|P2|Overall Study|Physician Decision|28
1450747|NCT00823472|4784987|P1|Overall Study|Physician Decision|24
1450748|NCT00823264|4785006|P2|Overall Study|Protocol Violation|0
1450749|NCT00823264|4785007|P1|Overall Study|Protocol Violation|2
1450750|NCT00823212|4785015|P2|Overall Study|Missed 12-month visit|21
1450751|NCT00823212|4785016|P1|Overall Study|Missed 12-month visit|21
1450752|NCT00823212|4785015|P2|Overall Study|Incarcerated|1
1450753|NCT00823212|4785016|P1|Overall Study|Incarcerated|0
1450754|NCT00823212|4785015|P2|Overall Study|Withdrawal by Subject|1
1450755|NCT00823212|4785016|P1|Overall Study|Withdrawal by Subject|6
1450756|NCT00823212|4785015|P2|Overall Study|Death|10
1450757|NCT00823212|4785016|P1|Overall Study|Death|8
1450758|NCT00823199|4785098|P1|Overall Study|Withdrawal by Subject|2
1450759|NCT00822926|4785167|P2|Second Injection Visit|Withdrawal by Subject|1
1450760|NCT00822926|4785168|P1|Second Injection Visit|Withdrawal by Subject|0
1450761|NCT00822926|4785167|P2|Second Injection Visit|Lost to Follow-up|0
1450762|NCT00822926|4785168|P1|Second Injection Visit|Lost to Follow-up|1
1450763|NCT00822900|4785182|P2|Overall Study|Became a ward of the state|1
1450764|NCT00822900|4785183|P1|Overall Study|Became a ward of the state|2
1450765|NCT00822900|4785182|P2|Overall Study|Death|69
1450766|NCT00822900|4785183|P1|Overall Study|Death|83
1450767|NCT00822900|4785182|P2|Overall Study|Lost to Follow-up|9
1450768|NCT00822900|4785183|P1|Overall Study|Lost to Follow-up|9
1450769|NCT00822900|4785182|P2|Overall Study|Withdrawal by Subject|14
1450770|NCT00822900|4785183|P1|Overall Study|Withdrawal by Subject|14
1450771|NCT00822692|4785230|P2|Overall Study|Lost to Follow-up|25
1450772|NCT00822692|4785231|P1|Overall Study|Lost to Follow-up|17
1450773|NCT00822237|4785369|P2|Dose 2 Vaccination|Lost to Follow-up|9
1450774|NCT00822237|4785370|P1|Dose 2 Vaccination|Lost to Follow-up|2
1450775|NCT00822237|4785369|P2|Dose 2 Vaccination|Withdrawal by Subject|2
1450776|NCT00822237|4785370|P1|Dose 2 Vaccination|Withdrawal by Subject|2
1450777|NCT00822237|4785369|P2|Dose 1 Vaccination|Lost to Follow-up|12
1450778|NCT00822237|4785370|P1|Dose 1 Vaccination|Lost to Follow-up|9
1450779|NCT00822237|4785369|P2|Dose 1 Vaccination|Withdrawal by Subject|14
1450780|NCT00822237|4785370|P1|Dose 1 Vaccination|Withdrawal by Subject|13
1450781|NCT00822237|4785369|P2|Dose 1 Vaccination|Not vaccinated|0
1450782|NCT00822237|4785370|P1|Dose 1 Vaccination|Not vaccinated|3
1450783|NCT00822172|4785451|P2|Overall Study|Other|1
1450784|NCT00822172|4785452|P1|Overall Study|Other|0
1450785|NCT00822172|4785451|P2|Overall Study|site closed|1
1450786|NCT00822172|4785452|P1|Overall Study|site closed|0
1450787|NCT00822172|4785451|P2|Overall Study|Withdrawal by Subject|4
1450788|NCT00822172|4785452|P1|Overall Study|Withdrawal by Subject|1
1450789|NCT00822172|4785451|P2|Overall Study|Lost to Follow-up|1
1450790|NCT00822172|4785452|P1|Overall Study|Lost to Follow-up|3
1450791|NCT00822172|4785451|P2|Overall Study|Death|0
1450792|NCT00822172|4785452|P1|Overall Study|Death|1
1450793|NCT00822172|4785451|P2|Overall Study|Adverse Event|12
1450794|NCT00822172|4785452|P1|Overall Study|Adverse Event|10
1450795|NCT00822120|4785460|P6|PET-directed Therapy|Protocol Violation|0
1450796|NCT00822120|4785461|P5|PET-directed Therapy|Protocol Violation|0
1450797|NCT00822120|4785462|P4|PET-directed Therapy|Protocol Violation|6
1450798|NCT00822120|4785463|P3|PET-directed Therapy|Protocol Violation|0
1450799|NCT00822120|4785464|P2|PET-directed Therapy|Protocol Violation|0
1450800|NCT00822120|4785465|P1|PET-directed Therapy|Protocol Violation|0
1450801|NCT00822120|4785460|P6|PET-directed Therapy|Death|0
1450802|NCT00822120|4785461|P5|PET-directed Therapy|Death|0
1450803|NCT00822120|4785462|P4|PET-directed Therapy|Death|2
1450804|NCT00822120|4785463|P3|PET-directed Therapy|Death|0
1450805|NCT00822120|4785464|P2|PET-directed Therapy|Death|0
1450806|NCT00822120|4785465|P1|PET-directed Therapy|Death|0
1450807|NCT00822120|4785460|P6|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1450808|NCT00822120|4785461|P5|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1450809|NCT00822120|4785462|P4|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
1450810|NCT00822120|4785463|P3|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1450811|NCT00822120|4785464|P2|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1450812|NCT00822120|4785465|P1|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1450813|NCT00822120|4785460|P6|PET-directed Therapy|Adverse Event|0
1450814|NCT00822120|4785461|P5|PET-directed Therapy|Adverse Event|0
1450815|NCT00822120|4785462|P4|PET-directed Therapy|Adverse Event|1
1450816|NCT00822120|4785463|P3|PET-directed Therapy|Adverse Event|0
1450817|NCT00822120|4785464|P2|PET-directed Therapy|Adverse Event|0
1450818|NCT00822120|4785465|P1|PET-directed Therapy|Adverse Event|0
1450819|NCT00822120|4785460|P6|Initial Registration|Ineligible|0
1450820|NCT00822120|4785461|P5|Initial Registration|Ineligible|0
1450821|NCT00822120|4785462|P4|Initial Registration|Ineligible|0
1450822|NCT00822120|4785463|P3|Initial Registration|Ineligible|0
1450823|NCT00822120|4785464|P2|Initial Registration|Ineligible|1
1450824|NCT00822120|4785465|P1|Initial Registration|Ineligible|22
1450825|NCT00822120|4785460|P6|Initial Registration|Reasons not Protocol Specified|0
1450826|NCT00822120|4785461|P5|Initial Registration|Reasons not Protocol Specified|0
1450827|NCT00822120|4785462|P4|Initial Registration|Reasons not Protocol Specified|0
1450828|NCT00822120|4785463|P3|Initial Registration|Reasons not Protocol Specified|0
1450829|NCT00822120|4785464|P2|Initial Registration|Reasons not Protocol Specified|0
1450830|NCT00822120|4785465|P1|Initial Registration|Reasons not Protocol Specified|2
1450831|NCT00822120|4785460|P6|Initial Registration|Refusal Unrelated to Adverse Event|0
1450832|NCT00822120|4785461|P5|Initial Registration|Refusal Unrelated to Adverse Event|0
1450833|NCT00822120|4785462|P4|Initial Registration|Refusal Unrelated to Adverse Event|0
1450834|NCT00822120|4785463|P3|Initial Registration|Refusal Unrelated to Adverse Event|0
1450835|NCT00822120|4785464|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
1450836|NCT00822120|4785465|P1|Initial Registration|Refusal Unrelated to Adverse Event|1
1450837|NCT00822120|4785460|P6|Initial Registration|Adverse Event|0
1450838|NCT00822120|4785461|P5|Initial Registration|Adverse Event|0
1450839|NCT00822120|4785462|P4|Initial Registration|Adverse Event|0
1450840|NCT00822120|4785463|P3|Initial Registration|Adverse Event|0
1450841|NCT00822120|4785464|P2|Initial Registration|Adverse Event|0
1450842|NCT00822120|4785465|P1|Initial Registration|Adverse Event|1
1450843|NCT00821873|4785527|P1|Overall Study|Lost to Follow-up|4
1450844|NCT00821678|4785548|P2|Overall Study|Death|2
1450845|NCT00821678|4785549|P1|Overall Study|Death|0
1450846|NCT00821678|4785548|P2|Overall Study|Lost to Follow-up|12
1450847|NCT00821678|4785549|P1|Overall Study|Lost to Follow-up|13
1450848|NCT00821678|4785548|P2|Overall Study|Withdrawal by Subject|0
1450849|NCT00821678|4785549|P1|Overall Study|Withdrawal by Subject|8
1450850|NCT00821587|4785567|P2|Overall Study|Physician Decision|1
1450851|NCT00821587|4785568|P1|Overall Study|Physician Decision|0
1450852|NCT00821509|4785577|P3|Overall Study|Withdrawal by Subject|34
1450853|NCT00821509|4785578|P2|Overall Study|Withdrawal by Subject|11
1450854|NCT00821509|4785579|P1|Overall Study|Withdrawal by Subject|12
1450855|NCT00821431|4785592|P2|Overall Study|Physician Decision|1
1450856|NCT00821431|4785593|P1|Overall Study|Physician Decision|0
1450857|NCT00821431|4785592|P2|Overall Study|Protocol Violation|1
1450858|NCT00821431|4785593|P1|Overall Study|Protocol Violation|3
1450859|NCT00821431|4785592|P2|Overall Study|Lost to Follow-up|0
1450860|NCT00821431|4785593|P1|Overall Study|Lost to Follow-up|1
1450861|NCT00821431|4785592|P2|Overall Study|Withdrawal by Subject|0
1450862|NCT00821431|4785593|P1|Overall Study|Withdrawal by Subject|5
1450863|NCT00821431|4785592|P2|Overall Study|Adverse Event|3
1450864|NCT00821431|4785593|P1|Overall Study|Adverse Event|6
1450865|NCT00821327|4785601|P1|Overall Study|Other/Unknown|5
1450866|NCT00821327|4785601|P1|Overall Study|Disease Progression|13
1450867|NCT00821327|4785601|P1|Overall Study|Sponsor Request|1
1450868|NCT00821327|4785601|P1|Overall Study|Investigator Request|2
1450869|NCT00821327|4785601|P1|Overall Study|Patient Request|1
1450870|NCT00821327|4785601|P1|Overall Study|Adverse Event|13
1450871|NCT00821236|4785610|P1|Overall Study|Lost to Follow-up|3
1450872|NCT00821093|4785650|P2|Overall Study|Administrative problems|2
1450873|NCT00821093|4785651|P1|Overall Study|Administrative problems|1
1450874|NCT00821093|4785650|P2|Overall Study|Abnormal test procedure result(s)|1
1450875|NCT00821093|4785651|P1|Overall Study|Abnormal test procedure result(s)|1
1450876|NCT00821093|4785650|P2|Overall Study|Death|1
1450877|NCT00821093|4785651|P1|Overall Study|Death|2
1450878|NCT00821093|4785650|P2|Overall Study|Lack of Efficacy|2
1450879|NCT00821093|4785651|P1|Overall Study|Lack of Efficacy|2
1450880|NCT00821093|4785650|P2|Overall Study|Abnormal laboratory value(s)|0
1450881|NCT00821093|4785651|P1|Overall Study|Abnormal laboratory value(s)|2
1450882|NCT00821093|4785650|P2|Overall Study|Protocol deviation|6
1450883|NCT00821093|4785651|P1|Overall Study|Protocol deviation|3
1450884|NCT00821093|4785650|P2|Overall Study|Lost to Follow-up|3
1450885|NCT00821093|4785651|P1|Overall Study|Lost to Follow-up|9
1450886|NCT00821093|4785650|P2|Overall Study|Withdrawal by Subject|13
1450887|NCT00821093|4785651|P1|Overall Study|Withdrawal by Subject|9
1450888|NCT00821093|4785650|P2|Overall Study|Adverse Event|12
1450889|NCT00821093|4785651|P1|Overall Study|Adverse Event|20
1450890|NCT00820898|4785670|P1|Overall Study|Inelgible - wrong primary site|1
1450891|NCT00820755|4785684|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
1450892|NCT00820755|4785685|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
1450893|NCT00820755|4785686|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
1450894|NCT00820755|4785684|P3|Period 1: Combination Therapy Phase|Other|0
1450895|NCT00820755|4785685|P2|Period 1: Combination Therapy Phase|Other|0
1450896|NCT00820755|4785686|P1|Period 1: Combination Therapy Phase|Other|11
1450897|NCT00820755|4785684|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
1450898|NCT00820755|4785685|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
1450899|NCT00820755|4785686|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
1450900|NCT00820755|4785684|P3|Period 1: Combination Therapy Phase|Progressive disease|0
1450901|NCT00820755|4785685|P2|Period 1: Combination Therapy Phase|Progressive disease|0
1450902|NCT00820755|4785686|P1|Period 1: Combination Therapy Phase|Progressive disease|114
1450903|NCT00820755|4785684|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
1450904|NCT00820755|4785685|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
1450905|NCT00820755|4785686|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
1450906|NCT00820755|4785684|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
1450907|NCT00820755|4785685|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
1450908|NCT00820755|4785686|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
1450909|NCT00820755|4785684|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
1450910|NCT00820755|4785685|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
1450911|NCT00820755|4785686|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
1450912|NCT00820755|4785684|P3|Period 1: Combination Therapy Phase|Death|0
1450913|NCT00820755|4785685|P2|Period 1: Combination Therapy Phase|Death|0
1450914|NCT00820755|4785686|P1|Period 1: Combination Therapy Phase|Death|28
1450915|NCT00820755|4785684|P3|Period 1: Combination Therapy Phase|Adverse Event|0
1450916|NCT00820755|4785685|P2|Period 1: Combination Therapy Phase|Adverse Event|0
1450917|NCT00820755|4785686|P1|Period 1: Combination Therapy Phase|Adverse Event|77
1450918|NCT00820248|4785779|P2|Overall Study|No treated|1
1450919|NCT00820248|4785780|P1|Overall Study|No treated|4
1450920|NCT00820222|4785790|P2|Overall Study|Ongoing|191
1450921|NCT00820222|4785791|P1|Overall Study|Ongoing|185
1450922|NCT00820222|4785790|P2|Overall Study|Sponsor Terminated Study|1
1450923|NCT00820222|4785791|P1|Overall Study|Sponsor Terminated Study|0
1450924|NCT00820222|4785790|P2|Overall Study|Physician Decision|6
1450925|NCT00820222|4785791|P1|Overall Study|Physician Decision|4
1450926|NCT00820222|4785790|P2|Overall Study|Withdrawal by Subject|9
1450927|NCT00820222|4785791|P1|Overall Study|Withdrawal by Subject|8
1450928|NCT00820222|4785790|P2|Overall Study|Lost to Follow-up|4
1450929|NCT00820222|4785791|P1|Overall Study|Lost to Follow-up|4
1450930|NCT00819910|4785821|P4|Overall Study|Lost to Follow-up|0
1450931|NCT00819910|4785822|P3|Overall Study|Lost to Follow-up|0
1450932|NCT00819910|4785823|P2|Overall Study|Lost to Follow-up|0
1450933|NCT00819910|4785824|P1|Overall Study|Lost to Follow-up|1
1450934|NCT00819910|4785821|P4|Overall Study|Withdrawal by Subject|0
1450935|NCT00819910|4785822|P3|Overall Study|Withdrawal by Subject|1
1450936|NCT00819910|4785823|P2|Overall Study|Withdrawal by Subject|1
1450937|NCT00819910|4785824|P1|Overall Study|Withdrawal by Subject|1
1450938|NCT00819910|4785821|P4|Overall Study|Adverse Event|1
1450939|NCT00819910|4785822|P3|Overall Study|Adverse Event|2
1450940|NCT00819910|4785823|P2|Overall Study|Adverse Event|0
1450941|NCT00819910|4785824|P1|Overall Study|Adverse Event|0
1450942|NCT00819832|4785856|P6|Overall Study|Sponsor Termination of Study|0
1450943|NCT00819832|4785857|P5|Overall Study|Sponsor Termination of Study|0
1450944|NCT00819832|4785858|P4|Overall Study|Sponsor Termination of Study|0
1450945|NCT00819832|4785859|P3|Overall Study|Sponsor Termination of Study|0
1450946|NCT00819832|4785860|P2|Overall Study|Sponsor Termination of Study|0
1450947|NCT00819832|4785861|P1|Overall Study|Sponsor Termination of Study|3
1450948|NCT00819780|4785877|P2|Overall Study|Still in treatment|17
1450949|NCT00819780|4785878|P1|Overall Study|Still in treatment|25
1450950|NCT00819780|4785877|P2|Overall Study|Did not receive study drug|4
1450951|NCT00819780|4785878|P1|Overall Study|Did not receive study drug|3
1450952|NCT00819767|4785912|P2|Overall Study|Unsatisfactory therapeutic effect|2
1450953|NCT00819767|4785913|P1|Overall Study|Unsatisfactory therapeutic effect|1
1450954|NCT00819741|4785925|P2|Overall Study|Reasons unknown|3
1450955|NCT00819741|4785926|P1|Overall Study|Reasons unknown|3
1450956|NCT00819741|4785925|P2|Overall Study|Unclassified|0
1450957|NCT00819741|4785926|P1|Overall Study|Unclassified|6
1450958|NCT00819741|4785925|P2|Overall Study|Withdrawal by Subject|2
1450959|NCT00819741|4785926|P1|Overall Study|Withdrawal by Subject|2
1450960|NCT00819741|4785925|P2|Overall Study|Protocol Violation|4
1450961|NCT00819741|4785926|P1|Overall Study|Protocol Violation|3
1450962|NCT00819741|4785925|P2|Overall Study|Lost to Follow-up|1
1450963|NCT00819741|4785926|P1|Overall Study|Lost to Follow-up|3
1450964|NCT00819741|4785925|P2|Overall Study|Lack of Efficacy|2
1450965|NCT00819741|4785926|P1|Overall Study|Lack of Efficacy|0
1450966|NCT00819741|4785925|P2|Overall Study|Adverse Event|2
1450967|NCT00819741|4785926|P1|Overall Study|Adverse Event|5
1450968|NCT00819585|4785980|P11|Extension Study|Death|0
1450969|NCT00819585|4785981|P10|Extension Study|Death|0
1450970|NCT00819585|4785982|P9|Extension Study|Death|2
1450971|NCT00819585|4785983|P8|Extension Study|Death|0
1450972|NCT00819585|4785984|P7|Extension Study|Death|0
1450973|NCT00819585|4785985|P6|Extension Study|Death|0
1450974|NCT00819585|4785986|P5|Extension Study|Death|0
1450975|NCT00819585|4785987|P4|Extension Study|Death|0
1450976|NCT00819585|4785988|P3|Extension Study|Death|0
1450977|NCT00819585|4785989|P2|Extension Study|Death|0
1450978|NCT00819585|4785990|P1|Extension Study|Death|0
1450979|NCT00819585|4785980|P11|Extension Study|Lost to Follow-up|1
1450980|NCT00819585|4785981|P10|Extension Study|Lost to Follow-up|1
1450981|NCT00819585|4785982|P9|Extension Study|Lost to Follow-up|2
1450982|NCT00819585|4785983|P8|Extension Study|Lost to Follow-up|0
1450983|NCT00819585|4785984|P7|Extension Study|Lost to Follow-up|0
1450984|NCT00819585|4785985|P6|Extension Study|Lost to Follow-up|0
1450985|NCT00819585|4785986|P5|Extension Study|Lost to Follow-up|0
1450986|NCT00819585|4785987|P4|Extension Study|Lost to Follow-up|0
1450987|NCT00819585|4785988|P3|Extension Study|Lost to Follow-up|0
1450988|NCT00819585|4785989|P2|Extension Study|Lost to Follow-up|0
1450989|NCT00819585|4785990|P1|Extension Study|Lost to Follow-up|0
1450990|NCT00819585|4785980|P11|Extension Study|Subject Withdrew Consent|1
1450991|NCT00819585|4785981|P10|Extension Study|Subject Withdrew Consent|0
1450992|NCT00819585|4785982|P9|Extension Study|Subject Withdrew Consent|3
1450993|NCT00819585|4785983|P8|Extension Study|Subject Withdrew Consent|0
1450994|NCT00819585|4785984|P7|Extension Study|Subject Withdrew Consent|0
1450995|NCT00819585|4785985|P6|Extension Study|Subject Withdrew Consent|0
1450996|NCT00819585|4785986|P5|Extension Study|Subject Withdrew Consent|0
1450997|NCT00819585|4785987|P4|Extension Study|Subject Withdrew Consent|0
1450998|NCT00819585|4785988|P3|Extension Study|Subject Withdrew Consent|0
1450999|NCT00819585|4785989|P2|Extension Study|Subject Withdrew Consent|0
1451000|NCT00819585|4785990|P1|Extension Study|Subject Withdrew Consent|0
1451001|NCT00819585|4785980|P11|Extension Study|Abnormal Laboratory Value(s)|0
1451002|NCT00819585|4785981|P10|Extension Study|Abnormal Laboratory Value(s)|0
1451003|NCT00819585|4785982|P9|Extension Study|Abnormal Laboratory Value(s)|1
1451004|NCT00819585|4785983|P8|Extension Study|Abnormal Laboratory Value(s)|0
1451005|NCT00819585|4785984|P7|Extension Study|Abnormal Laboratory Value(s)|0
1451006|NCT00819585|4785985|P6|Extension Study|Abnormal Laboratory Value(s)|0
1451007|NCT00819585|4785986|P5|Extension Study|Abnormal Laboratory Value(s)|0
1451008|NCT00819585|4785987|P4|Extension Study|Abnormal Laboratory Value(s)|0
1451009|NCT00819585|4785988|P3|Extension Study|Abnormal Laboratory Value(s)|0
1451010|NCT00819585|4785989|P2|Extension Study|Abnormal Laboratory Value(s)|0
1451011|NCT00819585|4785990|P1|Extension Study|Abnormal Laboratory Value(s)|0
1451012|NCT00819585|4785980|P11|Core Study|Protocol Violation|0
1451013|NCT00819585|4785981|P10|Core Study|Protocol Violation|0
1451014|NCT00819585|4785982|P9|Core Study|Protocol Violation|0
1451015|NCT00819585|4785983|P8|Core Study|Protocol Violation|0
1451016|NCT00819585|4785984|P7|Core Study|Protocol Violation|3
1451017|NCT00819585|4785985|P6|Core Study|Protocol Violation|1
1451018|NCT00819585|4785986|P5|Core Study|Protocol Violation|0
1451019|NCT00819585|4785987|P4|Core Study|Protocol Violation|0
1451020|NCT00819585|4785988|P3|Core Study|Protocol Violation|1
1451021|NCT00819585|4785989|P2|Core Study|Protocol Violation|0
1451022|NCT00819585|4785990|P1|Core Study|Protocol Violation|0
1451023|NCT00819585|4785980|P11|Core Study|Death|0
1451024|NCT00819585|4785981|P10|Core Study|Death|0
1451025|NCT00819585|4785982|P9|Core Study|Death|0
1451026|NCT00819585|4785983|P8|Core Study|Death|0
1451027|NCT00819585|4785984|P7|Core Study|Death|1
1451028|NCT00819585|4785985|P6|Core Study|Death|0
1451029|NCT00819585|4785986|P5|Core Study|Death|0
1451030|NCT00819585|4785987|P4|Core Study|Death|0
1451031|NCT00819585|4785988|P3|Core Study|Death|0
1451032|NCT00819585|4785989|P2|Core Study|Death|0
1451033|NCT00819585|4785990|P1|Core Study|Death|0
1451034|NCT00819585|4785980|P11|Core Study|Administrative Problems|0
1451035|NCT00819585|4785981|P10|Core Study|Administrative Problems|0
1451036|NCT00819585|4785982|P9|Core Study|Administrative Problems|0
1451037|NCT00819585|4785983|P8|Core Study|Administrative Problems|0
1451038|NCT00819585|4785984|P7|Core Study|Administrative Problems|2
1451039|NCT00819585|4785985|P6|Core Study|Administrative Problems|0
1451040|NCT00819585|4785986|P5|Core Study|Administrative Problems|0
1451041|NCT00819585|4785987|P4|Core Study|Administrative Problems|0
1451042|NCT00819585|4785988|P3|Core Study|Administrative Problems|0
1451043|NCT00819585|4785989|P2|Core Study|Administrative Problems|0
1451044|NCT00819585|4785990|P1|Core Study|Administrative Problems|0
1451045|NCT00819585|4785980|P11|Core Study|Lost to Follow-up|0
1451046|NCT00819585|4785981|P10|Core Study|Lost to Follow-up|0
1451047|NCT00819585|4785982|P9|Core Study|Lost to Follow-up|0
1451048|NCT00819585|4785983|P8|Core Study|Lost to Follow-up|0
1451049|NCT00819585|4785984|P7|Core Study|Lost to Follow-up|1
1451050|NCT00819585|4785985|P6|Core Study|Lost to Follow-up|1
1451051|NCT00819585|4785986|P5|Core Study|Lost to Follow-up|1
1451052|NCT00819585|4785987|P4|Core Study|Lost to Follow-up|0
1451053|NCT00819585|4785988|P3|Core Study|Lost to Follow-up|2
1451054|NCT00819585|4785989|P2|Core Study|Lost to Follow-up|1
1451055|NCT00819585|4785990|P1|Core Study|Lost to Follow-up|2
1451056|NCT00819585|4785980|P11|Core Study|Subject Withdrew Consent|0
1451057|NCT00819585|4785981|P10|Core Study|Subject Withdrew Consent|0
1451058|NCT00819585|4785982|P9|Core Study|Subject Withdrew Consent|0
1451059|NCT00819585|4785983|P8|Core Study|Subject Withdrew Consent|0
1451060|NCT00819585|4785984|P7|Core Study|Subject Withdrew Consent|3
1451061|NCT00819585|4785985|P6|Core Study|Subject Withdrew Consent|0
1451062|NCT00819585|4785986|P5|Core Study|Subject Withdrew Consent|0
1451063|NCT00819585|4785987|P4|Core Study|Subject Withdrew Consent|1
1451064|NCT00819585|4785988|P3|Core Study|Subject Withdrew Consent|2
1451065|NCT00819585|4785989|P2|Core Study|Subject Withdrew Consent|3
1451066|NCT00819585|4785990|P1|Core Study|Subject Withdrew Consent|0
1451067|NCT00819585|4785980|P11|Core Study|Subject No Longer Requires Study Drug|0
1451068|NCT00819585|4785981|P10|Core Study|Subject No Longer Requires Study Drug|0
1451069|NCT00819585|4785982|P9|Core Study|Subject No Longer Requires Study Drug|0
1451070|NCT00819585|4785983|P8|Core Study|Subject No Longer Requires Study Drug|0
1451071|NCT00819585|4785984|P7|Core Study|Subject No Longer Requires Study Drug|0
1451072|NCT00819585|4785985|P6|Core Study|Subject No Longer Requires Study Drug|0
1451073|NCT00819585|4785986|P5|Core Study|Subject No Longer Requires Study Drug|1
1451074|NCT00819585|4785987|P4|Core Study|Subject No Longer Requires Study Drug|0
1451075|NCT00819585|4785988|P3|Core Study|Subject No Longer Requires Study Drug|0
1451076|NCT00819585|4785989|P2|Core Study|Subject No Longer Requires Study Drug|0
1451077|NCT00819585|4785990|P1|Core Study|Subject No Longer Requires Study Drug|0
1451078|NCT00819585|4785980|P11|Core Study|Unsatisfactory Therapeutic Effect|0
1451079|NCT00819585|4785981|P10|Core Study|Unsatisfactory Therapeutic Effect|0
1451080|NCT00819585|4785982|P9|Core Study|Unsatisfactory Therapeutic Effect|0
1451081|NCT00819585|4785983|P8|Core Study|Unsatisfactory Therapeutic Effect|0
1451082|NCT00819585|4785984|P7|Core Study|Unsatisfactory Therapeutic Effect|1
1451083|NCT00819585|4785985|P6|Core Study|Unsatisfactory Therapeutic Effect|0
1451084|NCT00819585|4785986|P5|Core Study|Unsatisfactory Therapeutic Effect|0
1451085|NCT00819585|4785987|P4|Core Study|Unsatisfactory Therapeutic Effect|0
1451086|NCT00819585|4785988|P3|Core Study|Unsatisfactory Therapeutic Effect|0
1451087|NCT00819585|4785989|P2|Core Study|Unsatisfactory Therapeutic Effect|1
1451088|NCT00819585|4785990|P1|Core Study|Unsatisfactory Therapeutic Effect|0
1451089|NCT00819585|4785980|P11|Core Study|Abnormal Laboratory Value(s)|0
1451090|NCT00819585|4785981|P10|Core Study|Abnormal Laboratory Value(s)|0
1451091|NCT00819585|4785982|P9|Core Study|Abnormal Laboratory Value(s)|0
1451092|NCT00819585|4785983|P8|Core Study|Abnormal Laboratory Value(s)|0
1451093|NCT00819585|4785984|P7|Core Study|Abnormal Laboratory Value(s)|0
1451094|NCT00819585|4785985|P6|Core Study|Abnormal Laboratory Value(s)|0
1451095|NCT00819585|4785986|P5|Core Study|Abnormal Laboratory Value(s)|0
1451096|NCT00819585|4785987|P4|Core Study|Abnormal Laboratory Value(s)|0
1451097|NCT00819585|4785988|P3|Core Study|Abnormal Laboratory Value(s)|0
1451098|NCT00819585|4785989|P2|Core Study|Abnormal Laboratory Value(s)|0
1451099|NCT00819585|4785990|P1|Core Study|Abnormal Laboratory Value(s)|2
1451100|NCT00819585|4785980|P11|Core Study|Adverse Event|0
1451101|NCT00819585|4785981|P10|Core Study|Adverse Event|0
1451102|NCT00819585|4785982|P9|Core Study|Adverse Event|0
1451103|NCT00819585|4785983|P8|Core Study|Adverse Event|0
1451104|NCT00819585|4785984|P7|Core Study|Adverse Event|2
1451105|NCT00819585|4785985|P6|Core Study|Adverse Event|0
1451106|NCT00819585|4785986|P5|Core Study|Adverse Event|1
1451107|NCT00819585|4785987|P4|Core Study|Adverse Event|4
1451108|NCT00819585|4785988|P3|Core Study|Adverse Event|1
1451109|NCT00819585|4785989|P2|Core Study|Adverse Event|1
1451110|NCT00819585|4785990|P1|Core Study|Adverse Event|2
1451111|NCT00819390|4786081|P4|Overall Study|Adverse Event|0
1451112|NCT00819390|4786082|P3|Overall Study|Adverse Event|1
1451113|NCT00819390|4786083|P2|Overall Study|Adverse Event|0
1451114|NCT00819390|4786084|P1|Overall Study|Adverse Event|0
1451115|NCT00819390|4786081|P4|Overall Study|Withdrawal by Subject|0
1451116|NCT00819390|4786082|P3|Overall Study|Withdrawal by Subject|0
1451117|NCT00819390|4786083|P2|Overall Study|Withdrawal by Subject|0
1451118|NCT00819390|4786084|P1|Overall Study|Withdrawal by Subject|2
1451119|NCT00819390|4786081|P4|Overall Study|Lost to Follow-up|0
1451120|NCT00819390|4786082|P3|Overall Study|Lost to Follow-up|0
1451121|NCT00819390|4786083|P2|Overall Study|Lost to Follow-up|1
1451122|NCT00819390|4786084|P1|Overall Study|Lost to Follow-up|1
1451123|NCT00819247|4786220|P3|Overall Study|not specified|0
1451124|NCT00819247|4786221|P2|Overall Study|not specified|0
1451125|NCT00819247|4786222|P1|Overall Study|not specified|1
1451126|NCT00819247|4786220|P3|Overall Study|Bad prostate-specific antigen response|0
1451127|NCT00819247|4786221|P2|Overall Study|Bad prostate-specific antigen response|2
1451128|NCT00819247|4786222|P1|Overall Study|Bad prostate-specific antigen response|3
1451129|NCT00819247|4786220|P3|Overall Study|Mistakenly withdrawn|0
1451130|NCT00819247|4786221|P2|Overall Study|Mistakenly withdrawn|1
1451131|NCT00819247|4786222|P1|Overall Study|Mistakenly withdrawn|0
1451132|NCT00819247|4786220|P3|Overall Study|Protocol Violation|1
1451133|NCT00819247|4786221|P2|Overall Study|Protocol Violation|0
1451134|NCT00819247|4786222|P1|Overall Study|Protocol Violation|1
1451135|NCT00819247|4786220|P3|Overall Study|Withdrawal by Subject|0
1451136|NCT00819247|4786221|P2|Overall Study|Withdrawal by Subject|0
1451137|NCT00819247|4786222|P1|Overall Study|Withdrawal by Subject|1
1451138|NCT00819247|4786220|P3|Overall Study|Insufficient testosterone response|10
1451139|NCT00819247|4786221|P2|Overall Study|Insufficient testosterone response|8
1451140|NCT00819247|4786222|P1|Overall Study|Insufficient testosterone response|5
1451141|NCT00819247|4786220|P3|Overall Study|Adverse Event|3
1451142|NCT00819247|4786221|P2|Overall Study|Adverse Event|5
1451143|NCT00819247|4786222|P1|Overall Study|Adverse Event|0
1451144|NCT00819234|4786248|P10|Overall Study|Lost to Follow-up|2
1451145|NCT00819234|4786249|P9|Overall Study|Lost to Follow-up|1
1451146|NCT00819234|4786250|P8|Overall Study|Lost to Follow-up|1
1451147|NCT00819234|4786251|P7|Overall Study|Lost to Follow-up|1
1451148|NCT00819234|4786252|P6|Overall Study|Lost to Follow-up|1
1451149|NCT00819234|4786253|P5|Overall Study|Lost to Follow-up|1
1451150|NCT00819234|4786254|P4|Overall Study|Lost to Follow-up|2
1451151|NCT00819234|4786255|P3|Overall Study|Lost to Follow-up|0
1451152|NCT00819234|4786256|P2|Overall Study|Lost to Follow-up|2
1451153|NCT00819234|4786257|P1|Overall Study|Lost to Follow-up|2
1451154|NCT00819234|4786248|P10|Overall Study|Protocol Violation|0
1451155|NCT00819234|4786249|P9|Overall Study|Protocol Violation|0
1451156|NCT00819234|4786250|P8|Overall Study|Protocol Violation|0
1451157|NCT00819234|4786251|P7|Overall Study|Protocol Violation|0
1451158|NCT00819234|4786252|P6|Overall Study|Protocol Violation|0
1451159|NCT00819234|4786253|P5|Overall Study|Protocol Violation|0
1451160|NCT00819234|4786254|P4|Overall Study|Protocol Violation|0
1451161|NCT00819234|4786255|P3|Overall Study|Protocol Violation|1
1451162|NCT00819234|4786256|P2|Overall Study|Protocol Violation|0
1451163|NCT00819234|4786257|P1|Overall Study|Protocol Violation|0
1451164|NCT00819234|4786248|P10|Overall Study|Physician Decision|2
1451165|NCT00819234|4786249|P9|Overall Study|Physician Decision|0
1451166|NCT00819234|4786250|P8|Overall Study|Physician Decision|0
1451167|NCT00819234|4786251|P7|Overall Study|Physician Decision|0
1451168|NCT00819234|4786252|P6|Overall Study|Physician Decision|0
1451169|NCT00819234|4786253|P5|Overall Study|Physician Decision|0
1451170|NCT00819234|4786254|P4|Overall Study|Physician Decision|1
1451171|NCT00819234|4786255|P3|Overall Study|Physician Decision|0
1451172|NCT00819234|4786256|P2|Overall Study|Physician Decision|0
1451173|NCT00819234|4786257|P1|Overall Study|Physician Decision|0
1451174|NCT00819234|4786248|P10|Overall Study|Adverse Event|0
1451175|NCT00819234|4786249|P9|Overall Study|Adverse Event|0
1451176|NCT00819234|4786250|P8|Overall Study|Adverse Event|0
1451177|NCT00819234|4786251|P7|Overall Study|Adverse Event|0
1451178|NCT00819234|4786252|P6|Overall Study|Adverse Event|2
1451179|NCT00819234|4786253|P5|Overall Study|Adverse Event|0
1451180|NCT00819234|4786254|P4|Overall Study|Adverse Event|0
1451181|NCT00819234|4786255|P3|Overall Study|Adverse Event|1
1451182|NCT00819234|4786256|P2|Overall Study|Adverse Event|0
1451183|NCT00819234|4786257|P1|Overall Study|Adverse Event|0
1451184|NCT00819234|4786248|P10|Overall Study|Withdrawal by Subject|3
1451185|NCT00819234|4786249|P9|Overall Study|Withdrawal by Subject|5
1451186|NCT00819234|4786250|P8|Overall Study|Withdrawal by Subject|8
1451187|NCT00819234|4786251|P7|Overall Study|Withdrawal by Subject|4
1451188|NCT00819234|4786252|P6|Overall Study|Withdrawal by Subject|4
1451189|NCT00819234|4786253|P5|Overall Study|Withdrawal by Subject|0
1451190|NCT00819234|4786254|P4|Overall Study|Withdrawal by Subject|3
1451191|NCT00819234|4786255|P3|Overall Study|Withdrawal by Subject|6
1451192|NCT00819234|4786256|P2|Overall Study|Withdrawal by Subject|13
1451193|NCT00819234|4786257|P1|Overall Study|Withdrawal by Subject|8
1451194|NCT00819156|4786456|P6|Overall Study|Prostate-specific antigen progression|0
1451195|NCT00819156|4786457|P5|Overall Study|Prostate-specific antigen progression|1
1451196|NCT00819156|4786458|P4|Overall Study|Prostate-specific antigen progression|0
1451197|NCT00819156|4786459|P3|Overall Study|Prostate-specific antigen progression|0
1451198|NCT00819156|4786460|P2|Overall Study|Prostate-specific antigen progression|0
1451199|NCT00819156|4786461|P1|Overall Study|Prostate-specific antigen progression|0
1451200|NCT00819156|4786456|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
1451201|NCT00819156|4786457|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
1451202|NCT00819156|4786458|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
1451203|NCT00819156|4786459|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
1451204|NCT00819156|4786460|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
1451205|NCT00819156|4786461|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
1451206|NCT00819156|4786456|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
1451207|NCT00819156|4786457|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
1451208|NCT00819156|4786458|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
1451209|NCT00819156|4786459|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
1451210|NCT00819156|4786460|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
1451211|NCT00819156|4786461|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
1451212|NCT00819156|4786456|P6|Overall Study|Lost to Follow-up|2
1451213|NCT00819156|4786457|P5|Overall Study|Lost to Follow-up|0
1451214|NCT00819156|4786458|P4|Overall Study|Lost to Follow-up|0
1451215|NCT00819156|4786459|P3|Overall Study|Lost to Follow-up|0
1451216|NCT00819156|4786460|P2|Overall Study|Lost to Follow-up|1
1451217|NCT00819156|4786461|P1|Overall Study|Lost to Follow-up|0
1451218|NCT00819156|4786456|P6|Overall Study|Protocol Violation|1
1451219|NCT00819156|4786457|P5|Overall Study|Protocol Violation|0
1451220|NCT00819156|4786458|P4|Overall Study|Protocol Violation|0
1451221|NCT00819156|4786459|P3|Overall Study|Protocol Violation|1
1451222|NCT00819156|4786460|P2|Overall Study|Protocol Violation|0
1451223|NCT00819156|4786461|P1|Overall Study|Protocol Violation|1
1451224|NCT00819156|4786456|P6|Overall Study|Withdrawal by Subject|0
1451225|NCT00819156|4786457|P5|Overall Study|Withdrawal by Subject|1
1451226|NCT00819156|4786458|P4|Overall Study|Withdrawal by Subject|0
1451227|NCT00819156|4786459|P3|Overall Study|Withdrawal by Subject|2
1451228|NCT00819156|4786460|P2|Overall Study|Withdrawal by Subject|3
1451229|NCT00819156|4786461|P1|Overall Study|Withdrawal by Subject|0
1451230|NCT00819156|4786456|P6|Overall Study|Adverse Event|3
1451231|NCT00819156|4786457|P5|Overall Study|Adverse Event|2
1451232|NCT00819156|4786458|P4|Overall Study|Adverse Event|1
1451233|NCT00819156|4786459|P3|Overall Study|Adverse Event|2
1451234|NCT00819156|4786460|P2|Overall Study|Adverse Event|4
1451235|NCT00819156|4786461|P1|Overall Study|Adverse Event|1
1451236|NCT00819091|4786551|P2|Overall Study|Not Specified|2
1451237|NCT00819091|4786552|P1|Overall Study|Not Specified|1
1451238|NCT00819091|4786551|P2|Overall Study|Withdrawal by Subject|2
1451239|NCT00819091|4786552|P1|Overall Study|Withdrawal by Subject|1
1451240|NCT00819091|4786551|P2|Overall Study|Lost to Follow-up|0
1451241|NCT00819091|4786552|P1|Overall Study|Lost to Follow-up|2
1451242|NCT00819091|4786551|P2|Overall Study|Protocol Violation|1
1451243|NCT00819091|4786552|P1|Overall Study|Protocol Violation|0
1451244|NCT00819091|4786551|P2|Overall Study|Adverse Event|5
1451245|NCT00819091|4786552|P1|Overall Study|Adverse Event|3
1451246|NCT00819052|4786578|P2|Overall Study|Death or events leading to death|0
1451247|NCT00819052|4786579|P1|Overall Study|Death or events leading to death|1
1451248|NCT00819052|4786578|P2|Overall Study|Pregnancy|2
1451249|NCT00819052|4786579|P1|Overall Study|Pregnancy|1
1451250|NCT00819052|4786578|P2|Overall Study|Lack of Efficacy|1
1451251|NCT00819052|4786579|P1|Overall Study|Lack of Efficacy|1
1451252|NCT00819052|4786578|P2|Overall Study|Withdrawal by Subject|2
1451253|NCT00819052|4786579|P1|Overall Study|Withdrawal by Subject|1
1451254|NCT00819052|4786578|P2|Overall Study|Lost to Follow-up|2
1451255|NCT00819052|4786579|P1|Overall Study|Lost to Follow-up|1
1451256|NCT00819052|4786578|P2|Overall Study|Protocol Violation|2
1451257|NCT00819052|4786579|P1|Overall Study|Protocol Violation|1
1451258|NCT00819052|4786578|P2|Overall Study|Adverse Event|5
1451259|NCT00819052|4786579|P1|Overall Study|Adverse Event|0
1451260|NCT00819039|4786694|P3|Overall Study|Protocol Violation|0
1451261|NCT00819039|4786695|P2|Overall Study|Protocol Violation|0
1451262|NCT00819039|4786696|P1|Overall Study|Protocol Violation|1
1451263|NCT00819039|4786694|P3|Overall Study|Physician Decision|1
1451264|NCT00819039|4786695|P2|Overall Study|Physician Decision|0
1451265|NCT00819039|4786696|P1|Overall Study|Physician Decision|1
1451266|NCT00819013|4786726|P4|Overall Study|Death|1
1451267|NCT00819013|4786727|P3|Overall Study|Death|0
1451268|NCT00819013|4786728|P2|Overall Study|Death|0
1451269|NCT00819013|4786729|P1|Overall Study|Death|0
1451270|NCT00819013|4786726|P4|Overall Study|Lost to Follow-up|2
1451271|NCT00819013|4786727|P3|Overall Study|Lost to Follow-up|1
1451272|NCT00819013|4786728|P2|Overall Study|Lost to Follow-up|0
1451273|NCT00819013|4786729|P1|Overall Study|Lost to Follow-up|0
1451274|NCT00819013|4786726|P4|Overall Study|Withdrawal by Subject|0
1451275|NCT00819013|4786727|P3|Overall Study|Withdrawal by Subject|1
1451276|NCT00819013|4786728|P2|Overall Study|Withdrawal by Subject|0
1451277|NCT00819013|4786729|P1|Overall Study|Withdrawal by Subject|1
1451278|NCT00819013|4786726|P4|Overall Study|Adverse Event|0
1451279|NCT00819013|4786727|P3|Overall Study|Adverse Event|1
1451280|NCT00819013|4786728|P2|Overall Study|Adverse Event|0
1451281|NCT00819013|4786729|P1|Overall Study|Adverse Event|0
1451282|NCT00819013|4786726|P4|Overall Study|Not meeting continuing study eligibility|1
1451283|NCT00819013|4786727|P3|Overall Study|Not meeting continuing study eligibility|2
1451284|NCT00819013|4786728|P2|Overall Study|Not meeting continuing study eligibility|1
1451285|NCT00819013|4786729|P1|Overall Study|Not meeting continuing study eligibility|2
1451286|NCT00818883|4786795|P2|Overall Study|Other|7
1451287|NCT00818883|4786796|P1|Overall Study|Other|2
1451288|NCT00818883|4786795|P2|Overall Study|Lack of Efficacy|2
1451289|NCT00818883|4786796|P1|Overall Study|Lack of Efficacy|0
1451290|NCT00818883|4786795|P2|Overall Study|Withdrawal by Subject|14
1451291|NCT00818883|4786796|P1|Overall Study|Withdrawal by Subject|16
1451292|NCT00818883|4786795|P2|Overall Study|Lost to Follow-up|2
1451293|NCT00818883|4786796|P1|Overall Study|Lost to Follow-up|3
1451294|NCT00818883|4786795|P2|Overall Study|Protocol Violation|2
1451295|NCT00818883|4786796|P1|Overall Study|Protocol Violation|2
1451296|NCT00818883|4786795|P2|Overall Study|Adverse Event|19
1451297|NCT00818883|4786796|P1|Overall Study|Adverse Event|28
1451298|NCT00818779|4786843|P2|Overall Study|Adverse Event|1
1451299|NCT00818779|4786844|P1|Overall Study|Adverse Event|4
1451300|NCT00818779|4786843|P2|Overall Study|Lost to Follow-up|0
1451301|NCT00818779|4786844|P1|Overall Study|Lost to Follow-up|1
1451302|NCT00818779|4786843|P2|Overall Study|Protocol Violation|0
1451303|NCT00818779|4786844|P1|Overall Study|Protocol Violation|1
1451304|NCT00818766|4786860|P2|Overall Study|Did not Receive Allocated Intervention|0
1451305|NCT00818766|4786861|P1|Overall Study|Did not Receive Allocated Intervention|3
1451306|NCT00818766|4786860|P2|Overall Study|Death|0
1451307|NCT00818766|4786861|P1|Overall Study|Death|1
1451308|NCT00818766|4786860|P2|Overall Study|Could not be Contacted on Day 28|10
1451309|NCT00818766|4786861|P1|Overall Study|Could not be Contacted on Day 28|11
1451310|NCT00818753|4786890|P3|Overall Study|Randomised and not treated|0
1451311|NCT00818753|4786891|P2|Overall Study|Randomised and not treated|0
1451312|NCT00818753|4786892|P1|Overall Study|Randomised and not treated|2
1451313|NCT00818753|4786890|P3|Overall Study|Other reason (not specified)|1
1451314|NCT00818753|4786891|P2|Overall Study|Other reason (not specified)|0
1451315|NCT00818753|4786892|P1|Overall Study|Other reason (not specified)|0
1451316|NCT00818753|4786890|P3|Overall Study|Protocol Violation|0
1451317|NCT00818753|4786891|P2|Overall Study|Protocol Violation|0
1451318|NCT00818753|4786892|P1|Overall Study|Protocol Violation|1
1451319|NCT00818662|4786916|P4|Overall Study|Admitted to long term nursing care|0
1451320|NCT00818662|4786917|P3|Overall Study|Admitted to long term nursing care|0
1451321|NCT00818662|4786918|P2|Overall Study|Admitted to long term nursing care|1
1451322|NCT00818662|4786919|P1|Overall Study|Admitted to long term nursing care|0
1451323|NCT00818662|4786916|P4|Overall Study|Study partner decision|1
1451324|NCT00818662|4786917|P3|Overall Study|Study partner decision|0
1451325|NCT00818662|4786918|P2|Overall Study|Study partner decision|0
1451326|NCT00818662|4786919|P1|Overall Study|Study partner decision|0
1451327|NCT00818662|4786916|P4|Overall Study|Change in living situation|1
1451328|NCT00818662|4786917|P3|Overall Study|Change in living situation|0
1451329|NCT00818662|4786918|P2|Overall Study|Change in living situation|0
1451330|NCT00818662|4786919|P1|Overall Study|Change in living situation|0
1451331|NCT00818662|4786916|P4|Overall Study|Declined move to another study site|0
1451332|NCT00818662|4786917|P3|Overall Study|Declined move to another study site|0
1451333|NCT00818662|4786918|P2|Overall Study|Declined move to another study site|0
1451334|NCT00818662|4786919|P1|Overall Study|Declined move to another study site|1
1451335|NCT00818662|4786916|P4|Overall Study|Moving out of state|1
1451336|NCT00818662|4786917|P3|Overall Study|Moving out of state|0
1451337|NCT00818662|4786918|P2|Overall Study|Moving out of state|0
1451338|NCT00818662|4786919|P1|Overall Study|Moving out of state|0
1451339|NCT00818662|4786916|P4|Overall Study|Caregiver to pursue other treatment|0
1451340|NCT00818662|4786917|P3|Overall Study|Caregiver to pursue other treatment|0
1451341|NCT00818662|4786918|P2|Overall Study|Caregiver to pursue other treatment|1
1451342|NCT00818662|4786919|P1|Overall Study|Caregiver to pursue other treatment|0
1451343|NCT00818662|4786916|P4|Overall Study|Participant's health declined|1
1451344|NCT00818662|4786917|P3|Overall Study|Participant's health declined|0
1451345|NCT00818662|4786918|P2|Overall Study|Participant's health declined|0
1451346|NCT00818662|4786919|P1|Overall Study|Participant's health declined|0
1451347|NCT00818662|4786916|P4|Overall Study|Study Partner Unwilling or Unable|1
1451348|NCT00818662|4786917|P3|Overall Study|Study Partner Unwilling or Unable|1
1451349|NCT00818662|4786918|P2|Overall Study|Study Partner Unwilling or Unable|2
1451350|NCT00818662|4786919|P1|Overall Study|Study Partner Unwilling or Unable|3
1451351|NCT00818662|4786916|P4|Overall Study|Safety Risk|1
1451352|NCT00818662|4786917|P3|Overall Study|Safety Risk|0
1451353|NCT00818662|4786918|P2|Overall Study|Safety Risk|1
1451354|NCT00818662|4786919|P1|Overall Study|Safety Risk|1
1451355|NCT00818662|4786916|P4|Overall Study|Requires a Prohibited Medication|0
1451356|NCT00818662|4786917|P3|Overall Study|Requires a Prohibited Medication|0
1451357|NCT00818662|4786918|P2|Overall Study|Requires a Prohibited Medication|0
1451358|NCT00818662|4786919|P1|Overall Study|Requires a Prohibited Medication|1
1451359|NCT00818662|4786916|P4|Overall Study|Protocol Violation|0
1451360|NCT00818662|4786917|P3|Overall Study|Protocol Violation|0
1451361|NCT00818662|4786918|P2|Overall Study|Protocol Violation|1
1451362|NCT00818662|4786919|P1|Overall Study|Protocol Violation|1
1451363|NCT00818662|4786916|P4|Overall Study|Unwilling or Unable to Participate|4
1451364|NCT00818662|4786917|P3|Overall Study|Unwilling or Unable to Participate|2
1451365|NCT00818662|4786918|P2|Overall Study|Unwilling or Unable to Participate|6
1451366|NCT00818662|4786919|P1|Overall Study|Unwilling or Unable to Participate|4
1451367|NCT00818662|4786916|P4|Overall Study|Lost to Follow-up|1
1451368|NCT00818662|4786917|P3|Overall Study|Lost to Follow-up|0
1451369|NCT00818662|4786918|P2|Overall Study|Lost to Follow-up|0
1451370|NCT00818662|4786919|P1|Overall Study|Lost to Follow-up|0
1451371|NCT00818662|4786916|P4|Overall Study|Physician Decision|0
1451372|NCT00818662|4786917|P3|Overall Study|Physician Decision|0
1451373|NCT00818662|4786918|P2|Overall Study|Physician Decision|0
1451374|NCT00818662|4786919|P1|Overall Study|Physician Decision|1
1451375|NCT00818662|4786916|P4|Overall Study|Death|0
1451376|NCT00818662|4786917|P3|Overall Study|Death|0
1451377|NCT00818662|4786918|P2|Overall Study|Death|3
1451378|NCT00818662|4786919|P1|Overall Study|Death|1
1451379|NCT00818662|4786916|P4|Overall Study|Withdrawal by Subject|2
1451380|NCT00818662|4786917|P3|Overall Study|Withdrawal by Subject|2
1451381|NCT00818662|4786918|P2|Overall Study|Withdrawal by Subject|4
1451382|NCT00818662|4786919|P1|Overall Study|Withdrawal by Subject|5
1451383|NCT00818662|4786916|P4|Overall Study|Adverse Event|3
1451384|NCT00818662|4786917|P3|Overall Study|Adverse Event|4
1451385|NCT00818662|4786918|P2|Overall Study|Adverse Event|14
1451386|NCT00818662|4786919|P1|Overall Study|Adverse Event|5
1451387|NCT00818649|4787005|P1|Overall Study|Adverse Event|1
1451388|NCT00818649|4787005|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
1451389|NCT00818649|4787005|P1|Overall Study|Declining performance status|2
1451390|NCT00818623|4787019|P8|Overall Study|Disease progression|0
1451391|NCT00818623|4787020|P7|Overall Study|Disease progression|1
1451392|NCT00818623|4787021|P6|Overall Study|Disease progression|0
1451393|NCT00818623|4787022|P5|Overall Study|Disease progression|0
1451394|NCT00818623|4787023|P4|Overall Study|Disease progression|0
1451395|NCT00818623|4787024|P3|Overall Study|Disease progression|0
1451396|NCT00818623|4787025|P2|Overall Study|Disease progression|0
1451397|NCT00818623|4787026|P1|Overall Study|Disease progression|0
1451398|NCT00818623|4787019|P8|Overall Study|Lack of trial drug at site|0
1451399|NCT00818623|4787020|P7|Overall Study|Lack of trial drug at site|1
1451400|NCT00818623|4787021|P6|Overall Study|Lack of trial drug at site|0
1451401|NCT00818623|4787022|P5|Overall Study|Lack of trial drug at site|2
1451402|NCT00818623|4787023|P4|Overall Study|Lack of trial drug at site|0
1451403|NCT00818623|4787024|P3|Overall Study|Lack of trial drug at site|0
1451404|NCT00818623|4787025|P2|Overall Study|Lack of trial drug at site|0
1451405|NCT00818623|4787026|P1|Overall Study|Lack of trial drug at site|0
1451406|NCT00818623|4787019|P8|Overall Study|Need of additional treatment|0
1451407|NCT00818623|4787020|P7|Overall Study|Need of additional treatment|0
1451408|NCT00818623|4787021|P6|Overall Study|Need of additional treatment|0
1451409|NCT00818623|4787022|P5|Overall Study|Need of additional treatment|1
1451410|NCT00818623|4787023|P4|Overall Study|Need of additional treatment|0
1451411|NCT00818623|4787024|P3|Overall Study|Need of additional treatment|0
1451412|NCT00818623|4787025|P2|Overall Study|Need of additional treatment|0
1451413|NCT00818623|4787026|P1|Overall Study|Need of additional treatment|0
1451414|NCT00818623|4787019|P8|Overall Study|Protocol Violation|0
1451415|NCT00818623|4787020|P7|Overall Study|Protocol Violation|1
1451416|NCT00818623|4787021|P6|Overall Study|Protocol Violation|0
1451417|NCT00818623|4787022|P5|Overall Study|Protocol Violation|1
1451418|NCT00818623|4787023|P4|Overall Study|Protocol Violation|0
1451419|NCT00818623|4787024|P3|Overall Study|Protocol Violation|0
1451420|NCT00818623|4787025|P2|Overall Study|Protocol Violation|0
1451421|NCT00818623|4787026|P1|Overall Study|Protocol Violation|1
1451422|NCT00818623|4787019|P8|Overall Study|Withdrawal by Subject|1
1451423|NCT00818623|4787020|P7|Overall Study|Withdrawal by Subject|1
1451424|NCT00818623|4787021|P6|Overall Study|Withdrawal by Subject|1
1451425|NCT00818623|4787022|P5|Overall Study|Withdrawal by Subject|0
1451426|NCT00818623|4787023|P4|Overall Study|Withdrawal by Subject|0
1451427|NCT00818623|4787024|P3|Overall Study|Withdrawal by Subject|1
1451428|NCT00818623|4787025|P2|Overall Study|Withdrawal by Subject|1
1451429|NCT00818623|4787026|P1|Overall Study|Withdrawal by Subject|0
1451430|NCT00818623|4787019|P8|Overall Study|Bad prostate specific antigen response|0
1451431|NCT00818623|4787020|P7|Overall Study|Bad prostate specific antigen response|0
1451432|NCT00818623|4787021|P6|Overall Study|Bad prostate specific antigen response|1
1451433|NCT00818623|4787022|P5|Overall Study|Bad prostate specific antigen response|0
1451434|NCT00818623|4787023|P4|Overall Study|Bad prostate specific antigen response|5
1451435|NCT00818623|4787024|P3|Overall Study|Bad prostate specific antigen response|2
1451436|NCT00818623|4787025|P2|Overall Study|Bad prostate specific antigen response|3
1451437|NCT00818623|4787026|P1|Overall Study|Bad prostate specific antigen response|0
1451438|NCT00818623|4787019|P8|Overall Study|Adverse Event|0
1451439|NCT00818623|4787020|P7|Overall Study|Adverse Event|0
1451440|NCT00818623|4787021|P6|Overall Study|Adverse Event|1
1451441|NCT00818623|4787022|P5|Overall Study|Adverse Event|0
1451442|NCT00818623|4787023|P4|Overall Study|Adverse Event|0
1451443|NCT00818623|4787024|P3|Overall Study|Adverse Event|1
1451444|NCT00818623|4787025|P2|Overall Study|Adverse Event|0
1451445|NCT00818623|4787026|P1|Overall Study|Adverse Event|1
1451446|NCT00818519|4787102|P2|Overall Study|participant will leave for long tme|0
1451447|NCT00818519|4787103|P1|Overall Study|participant will leave for long tme|1
1451448|NCT00818519|4787102|P2|Overall Study|participant recovered completely|0
1451449|NCT00818519|4787103|P1|Overall Study|participant recovered completely|1
1451450|NCT00818519|4787102|P2|Overall Study|Withdrawal by Subject|9
1451451|NCT00818519|4787103|P1|Overall Study|Withdrawal by Subject|4
1451452|NCT00818519|4787102|P2|Overall Study|Pregnancy|1
1451453|NCT00818519|4787103|P1|Overall Study|Pregnancy|0
1451454|NCT00818519|4787102|P2|Overall Study|Protocol Violation|1
1451455|NCT00818519|4787103|P1|Overall Study|Protocol Violation|2
1451456|NCT00818519|4787102|P2|Overall Study|Lost to Follow-up|6
1451457|NCT00818519|4787103|P1|Overall Study|Lost to Follow-up|4
1451458|NCT00818519|4787102|P2|Overall Study|Adverse Event|2
1451459|NCT00818519|4787103|P1|Overall Study|Adverse Event|2
1451460|NCT00818454|4787133|P4|Treatment Period 3|Adverse Event|1
1451461|NCT00818454|4787134|P3|Treatment Period 3|Adverse Event|0
1451462|NCT00818454|4787135|P2|Treatment Period 3|Adverse Event|0
1451463|NCT00818454|4787136|P1|Treatment Period 3|Adverse Event|0
1451464|NCT00818454|4787133|P4|Treatment Period 2|not specified|0
1451465|NCT00818454|4787134|P3|Treatment Period 2|not specified|0
1451466|NCT00818454|4787135|P2|Treatment Period 2|not specified|1
1451467|NCT00818454|4787136|P1|Treatment Period 2|not specified|2
1451468|NCT00818454|4787133|P4|Washout Period of 1 Week|not specified|0
1451469|NCT00818454|4787134|P3|Washout Period of 1 Week|not specified|0
1451470|NCT00818454|4787135|P2|Washout Period of 1 Week|not specified|2
1451471|NCT00818454|4787136|P1|Washout Period of 1 Week|not specified|1
1451472|NCT00818454|4787133|P4|Washout Period of 1 Week|Protocol Violation|0
1451473|NCT00818454|4787134|P3|Washout Period of 1 Week|Protocol Violation|0
1451474|NCT00818454|4787135|P2|Washout Period of 1 Week|Protocol Violation|0
1451475|NCT00818454|4787136|P1|Washout Period of 1 Week|Protocol Violation|2
1451476|NCT00818454|4787133|P4|Washout Period of 1 Week|Adverse Event|0
1451477|NCT00818454|4787134|P3|Washout Period of 1 Week|Adverse Event|0
1451478|NCT00818454|4787135|P2|Washout Period of 1 Week|Adverse Event|1
1451479|NCT00818454|4787136|P1|Washout Period of 1 Week|Adverse Event|1
1451480|NCT00818454|4787133|P4|Treatment Period 1|not specified|0
1451481|NCT00818454|4787134|P3|Treatment Period 1|not specified|0
1451482|NCT00818454|4787135|P2|Treatment Period 1|not specified|0
1451483|NCT00818454|4787136|P1|Treatment Period 1|not specified|3
1451484|NCT00818454|4787133|P4|Treatment Period 1|Adverse Event|0
1451485|NCT00818454|4787134|P3|Treatment Period 1|Adverse Event|0
1451486|NCT00818454|4787135|P2|Treatment Period 1|Adverse Event|1
1451487|NCT00818454|4787136|P1|Treatment Period 1|Adverse Event|0
1451488|NCT00818441|4787164|P2|Overall Study|Study terminated by sponsor|2
1451489|NCT00818441|4787165|P1|Overall Study|Study terminated by sponsor|11
1451490|NCT00818441|4787164|P2|Overall Study|Adverse Event|1
1451491|NCT00818441|4787165|P1|Overall Study|Adverse Event|0
1451492|NCT00818441|4787164|P2|Overall Study|Withdrawal by Subject|0
1451493|NCT00818441|4787165|P1|Overall Study|Withdrawal by Subject|2
1451494|NCT00818441|4787164|P2|Overall Study|Lost to Follow-up|1
1451495|NCT00818441|4787165|P1|Overall Study|Lost to Follow-up|2
1451496|NCT00818441|4787164|P2|Overall Study|Other|0
1451497|NCT00818441|4787165|P1|Overall Study|Other|5
1451498|NCT00818441|4787164|P2|Overall Study|Death|26
1451499|NCT00818441|4787165|P1|Overall Study|Death|69
1451500|NCT00818389|4787187|P2|Overall Study|Adverse Event|1
1451501|NCT00818389|4787188|P1|Overall Study|Adverse Event|0
1451502|NCT00818389|4787187|P2|Overall Study|Withdrawal by Subject|2
1451503|NCT00818389|4787188|P1|Overall Study|Withdrawal by Subject|2
1451504|NCT00818389|4787187|P2|Overall Study|ALS Disease Progression|0
1451505|NCT00818389|4787188|P1|Overall Study|ALS Disease Progression|1
1451506|NCT00818389|4787187|P2|Overall Study|Death|3
1451507|NCT00818389|4787188|P1|Overall Study|Death|1
1451508|NCT00818259|4787223|P9|Part V|Adverse Event|0
1451509|NCT00818259|4787224|P8|Part V|Adverse Event|1
1451510|NCT00818259|4787225|P7|Part V|Adverse Event|0
1451511|NCT00818259|4787226|P6|Part V|Adverse Event|0
1451512|NCT00818259|4787227|P5|Part V|Adverse Event|0
1451513|NCT00818259|4787228|P4|Part V|Adverse Event|0
1451514|NCT00818259|4787229|P3|Part V|Adverse Event|0
1451515|NCT00818259|4787230|P2|Part V|Adverse Event|0
1451516|NCT00818259|4787231|P1|Part V|Adverse Event|0
1451517|NCT00818259|4787223|P9|Part IV|Physician Decision|0
1451518|NCT00818259|4787224|P8|Part IV|Physician Decision|0
1451519|NCT00818259|4787225|P7|Part IV|Physician Decision|0
1451520|NCT00818259|4787226|P6|Part IV|Physician Decision|1
1451521|NCT00818259|4787227|P5|Part IV|Physician Decision|0
1451522|NCT00818259|4787228|P4|Part IV|Physician Decision|0
1451523|NCT00818259|4787229|P3|Part IV|Physician Decision|0
1451524|NCT00818259|4787230|P2|Part IV|Physician Decision|0
1451525|NCT00818259|4787231|P1|Part IV|Physician Decision|0
1451526|NCT00818259|4787223|P9|Part II|Not Treated|0
1451527|NCT00818259|4787224|P8|Part II|Not Treated|0
1451528|NCT00818259|4787225|P7|Part II|Not Treated|0
1451529|NCT00818259|4787226|P6|Part II|Not Treated|0
1451530|NCT00818259|4787227|P5|Part II|Not Treated|0
1451531|NCT00818259|4787228|P4|Part II|Not Treated|1
1451532|NCT00818259|4787229|P3|Part II|Not Treated|0
1451533|NCT00818259|4787230|P2|Part II|Not Treated|0
1451534|NCT00818259|4787231|P1|Part II|Not Treated|0
1451535|NCT00818259|4787223|P9|Part II|Lack of Efficacy|0
1451536|NCT00818259|4787224|P8|Part II|Lack of Efficacy|0
1451537|NCT00818259|4787225|P7|Part II|Lack of Efficacy|0
1451538|NCT00818259|4787226|P6|Part II|Lack of Efficacy|0
1451539|NCT00818259|4787227|P5|Part II|Lack of Efficacy|0
1451540|NCT00818259|4787228|P4|Part II|Lack of Efficacy|1
1451541|NCT00818259|4787229|P3|Part II|Lack of Efficacy|0
1451542|NCT00818259|4787230|P2|Part II|Lack of Efficacy|0
1451543|NCT00818259|4787231|P1|Part II|Lack of Efficacy|0
1451544|NCT00818259|4787223|P9|Part II|Physician Decision|0
1451545|NCT00818259|4787224|P8|Part II|Physician Decision|0
1451546|NCT00818259|4787225|P7|Part II|Physician Decision|0
1451547|NCT00818259|4787226|P6|Part II|Physician Decision|0
1451548|NCT00818259|4787227|P5|Part II|Physician Decision|0
1451549|NCT00818259|4787228|P4|Part II|Physician Decision|0
1451550|NCT00818259|4787229|P3|Part II|Physician Decision|1
1451551|NCT00818259|4787230|P2|Part II|Physician Decision|0
1451552|NCT00818259|4787231|P1|Part II|Physician Decision|0
1451553|NCT00818259|4787223|P9|Part I|Withdrawal by Subject|0
1451554|NCT00818259|4787224|P8|Part I|Withdrawal by Subject|0
1451555|NCT00818259|4787225|P7|Part I|Withdrawal by Subject|0
1451556|NCT00818259|4787226|P6|Part I|Withdrawal by Subject|0
1451557|NCT00818259|4787227|P5|Part I|Withdrawal by Subject|0
1451558|NCT00818259|4787228|P4|Part I|Withdrawal by Subject|0
1451559|NCT00818259|4787229|P3|Part I|Withdrawal by Subject|0
1451560|NCT00818259|4787230|P2|Part I|Withdrawal by Subject|0
1451561|NCT00818259|4787231|P1|Part I|Withdrawal by Subject|1
1451562|NCT00818246|4787303|P1|Overall Study|Impossible to match pictures|5
1451563|NCT00818207|4787312|P2|Overall Study|Death|5
1451564|NCT00818207|4787313|P1|Overall Study|Death|3
1451565|NCT00818207|4787312|P2|Overall Study|Withdrawal by Subject|104
1451566|NCT00818207|4787313|P1|Overall Study|Withdrawal by Subject|42
1451567|NCT00818207|4787312|P2|Overall Study|Multiple reasons|12
1451568|NCT00818207|4787313|P1|Overall Study|Multiple reasons|11
1451569|NCT00818207|4787312|P2|Overall Study|Lost to Follow-up|146
1451570|NCT00818207|4787313|P1|Overall Study|Lost to Follow-up|160
1451571|NCT00818207|4787312|P2|Overall Study|Adverse Event|0
1451572|NCT00818207|4787313|P1|Overall Study|Adverse Event|6
1451573|NCT00818168|4787327|P1|Overall Study|Participant Moved|2
1451574|NCT00818168|4787327|P1|Overall Study|Reason for Non-completion Not reported|6
1451575|NCT00818168|4787327|P1|Overall Study|Adverse Event|19
1451576|NCT00818168|4787327|P1|Overall Study|Lost to Follow-up|7
1451577|NCT00818168|4787327|P1|Overall Study|Withdrawal by Subject|16
1451578|NCT00818168|4787327|P1|Overall Study|Pregnancy|2
1451579|NCT00818168|4787327|P1|Overall Study|Lack of Efficacy|18
1451580|NCT00817778|4787367|P2|Overall Study|Poor venous access|0
1451581|NCT00817778|4787368|P1|Overall Study|Poor venous access|1
1451582|NCT00817778|4787367|P2|Overall Study|Study-specific discontinuation criteria|1
1451583|NCT00817778|4787368|P1|Overall Study|Study-specific discontinuation criteria|0
1451584|NCT00817778|4787367|P2|Overall Study|Protocol Violation|1
1451585|NCT00817778|4787368|P1|Overall Study|Protocol Violation|0
1451586|NCT00817778|4787367|P2|Overall Study|Withdrawal by Subject|1
1451587|NCT00817778|4787368|P1|Overall Study|Withdrawal by Subject|1
1451588|NCT00817778|4787367|P2|Overall Study|Adverse Event|0
1451589|NCT00817778|4787368|P1|Overall Study|Adverse Event|1
1451590|NCT00817531|4787397|P1|Overall Study|Lack of Efficacy|1
1451591|NCT00817531|4787397|P1|Overall Study|Adverse Event|1
1451592|NCT00817479|4787403|P2|Overall Study|Physician Decision|1
1451593|NCT00817479|4787404|P1|Overall Study|Physician Decision|1
1451594|NCT00817336|4787414|P2|Overall Study|Withdrawal by Subject|1
1451595|NCT00817336|4787415|P1|Overall Study|Withdrawal by Subject|1
1451596|NCT00817206|4787441|P2|Overall Study|Physician Decision|0
1451597|NCT00817206|4787442|P1|Overall Study|Physician Decision|2
1451598|NCT00817206|4787441|P2|Overall Study|Withdrawal by Subject|3
1451599|NCT00817206|4787442|P1|Overall Study|Withdrawal by Subject|7
1451600|NCT00817206|4787441|P2|Overall Study|Death|0
1451601|NCT00817206|4787442|P1|Overall Study|Death|2
1451602|NCT00817206|4787441|P2|Overall Study|Lost to Follow-up|1
1451603|NCT00817206|4787442|P1|Overall Study|Lost to Follow-up|0
1451604|NCT00817206|4787441|P2|Overall Study|Protocol Violation|2
1451605|NCT00817206|4787442|P1|Overall Study|Protocol Violation|0
1451606|NCT00817206|4787441|P2|Overall Study|Adverse Event|3
1451607|NCT00817206|4787442|P1|Overall Study|Adverse Event|10
1451608|NCT00817063|4787450|P2|Overall Study|Abnormality of Laboratory Test|1
1451609|NCT00817063|4787451|P1|Overall Study|Abnormality of Laboratory Test|2
1451610|NCT00817063|4787450|P2|Overall Study|Administrative|4
1451611|NCT00817063|4787451|P1|Overall Study|Administrative|10
1451612|NCT00817063|4787450|P2|Overall Study|Early Improvement|4
1451613|NCT00817063|4787451|P1|Overall Study|Early Improvement|19
1451614|NCT00817063|4787450|P2|Overall Study|Withdrawal by Subject|37
1451615|NCT00817063|4787451|P1|Overall Study|Withdrawal by Subject|17
1451616|NCT00817063|4787450|P2|Overall Study|Protocol Violation|8
1451617|NCT00817063|4787451|P1|Overall Study|Protocol Violation|3
1451618|NCT00817063|4787450|P2|Overall Study|Violation of Selection at Entry|4
1451619|NCT00817063|4787451|P1|Overall Study|Violation of Selection at Entry|7
1451620|NCT00817063|4787450|P2|Overall Study|Failure to Return|12
1451621|NCT00817063|4787451|P1|Overall Study|Failure to Return|13
1451622|NCT00817063|4787450|P2|Overall Study|Lack of Efficacy|86
1451623|NCT00817063|4787451|P1|Overall Study|Lack of Efficacy|33
1451624|NCT00817063|4787450|P2|Overall Study|Death|1
1451625|NCT00817063|4787451|P1|Overall Study|Death|1
1451626|NCT00817063|4787450|P2|Overall Study|Adverse Event|13
1451627|NCT00817063|4787451|P1|Overall Study|Adverse Event|32
1451628|NCT00816595|4787554|P2|Overall Study|Withdrawal by Subject|0
1451629|NCT00816595|4787555|P1|Overall Study|Withdrawal by Subject|2
1451630|NCT00816556|4787568|P3|Overall Study|Lost to Follow-up|1
1451631|NCT00816556|4787569|P2|Overall Study|Lost to Follow-up|0
1451632|NCT00816556|4787570|P1|Overall Study|Lost to Follow-up|0
1451633|NCT00816556|4787568|P3|Overall Study|Withdrawal by Subject|1
1451634|NCT00816556|4787569|P2|Overall Study|Withdrawal by Subject|1
1451635|NCT00816556|4787570|P1|Overall Study|Withdrawal by Subject|1
1451636|NCT00816556|4787568|P3|Overall Study|Adverse Event|1
1451637|NCT00816556|4787569|P2|Overall Study|Adverse Event|1
1451638|NCT00816556|4787570|P1|Overall Study|Adverse Event|1
1451639|NCT00816400|4787593|P9|Overall Study|In hospice care at the end of the study|0
1451640|NCT00816400|4787594|P8|Overall Study|In hospice care at the end of the study|0
1451641|NCT00816400|4787595|P7|Overall Study|In hospice care at the end of the study|0
1451642|NCT00816400|4787596|P6|Overall Study|In hospice care at the end of the study|0
1451643|NCT00816400|4787597|P5|Overall Study|In hospice care at the end of the study|0
1451644|NCT00816400|4787598|P4|Overall Study|In hospice care at the end of the study|0
1451645|NCT00816400|4787599|P3|Overall Study|In hospice care at the end of the study|2
1451646|NCT00816400|4787600|P2|Overall Study|In hospice care at the end of the study|0
1451647|NCT00816400|4787601|P1|Overall Study|In hospice care at the end of the study|0
1451648|NCT00816400|4787593|P9|Overall Study|Death|6
1451649|NCT00816400|4787594|P8|Overall Study|Death|5
1451650|NCT00816400|4787595|P7|Overall Study|Death|2
1451651|NCT00816400|4787596|P6|Overall Study|Death|3
1451652|NCT00816400|4787597|P5|Overall Study|Death|2
1451653|NCT00816400|4787598|P4|Overall Study|Death|3
1451654|NCT00816400|4787599|P3|Overall Study|Death|3
1451655|NCT00816400|4787600|P2|Overall Study|Death|3
1451656|NCT00816400|4787601|P1|Overall Study|Death|2
1451657|NCT00816166|4787791|P2|Overall Study|Death|2
1451658|NCT00816166|4787792|P1|Overall Study|Death|4
1451659|NCT00816166|4787791|P2|Overall Study|Lost to Follow-up|10
1451660|NCT00816166|4787792|P1|Overall Study|Lost to Follow-up|6
1451661|NCT00816036|4787824|P2|Overall Study|Withdrawal by Subject|23
1451662|NCT00816036|4787825|P1|Overall Study|Withdrawal by Subject|54
1451663|NCT00816036|4787824|P2|Overall Study|Lost to Follow-up|57
1451664|NCT00816036|4787825|P1|Overall Study|Lost to Follow-up|75
1451665|NCT00816036|4787824|P2|Overall Study|Death|28
1451666|NCT00816036|4787825|P1|Overall Study|Death|47
1451667|NCT00816023|4787839|P4|Overall Study|Randomized Not Treated|11
1451668|NCT00816023|4787840|P3|Overall Study|Randomized Not Treated|6
1451669|NCT00816023|4787841|P2|Overall Study|Randomized Not Treated|4
1451670|NCT00816023|4787842|P1|Overall Study|Randomized Not Treated|6
1451671|NCT00816023|4787839|P4|Overall Study|assessments complete prior to window|1
1451672|NCT00816023|4787840|P3|Overall Study|assessments complete prior to window|2
1451673|NCT00816023|4787841|P2|Overall Study|assessments complete prior to window|1
1451674|NCT00816023|4787842|P1|Overall Study|assessments complete prior to window|1
1451675|NCT00816023|4787839|P4|Overall Study|Physician Decision|0
1451676|NCT00816023|4787840|P3|Overall Study|Physician Decision|1
1451677|NCT00816023|4787841|P2|Overall Study|Physician Decision|0
1451678|NCT00816023|4787842|P1|Overall Study|Physician Decision|0
1451679|NCT00816023|4787839|P4|Overall Study|Withdrawal by Subject|0
1451680|NCT00816023|4787840|P3|Overall Study|Withdrawal by Subject|0
1451681|NCT00816023|4787841|P2|Overall Study|Withdrawal by Subject|0
1451682|NCT00816023|4787842|P1|Overall Study|Withdrawal by Subject|1
1451683|NCT00816023|4787839|P4|Overall Study|Lost to Follow-up|0
1451684|NCT00816023|4787840|P3|Overall Study|Lost to Follow-up|0
1451685|NCT00816023|4787841|P2|Overall Study|Lost to Follow-up|1
1451686|NCT00816023|4787842|P1|Overall Study|Lost to Follow-up|1
1451687|NCT00815919|4787856|P1|Overall Study|Lack of Efficacy|2
1451688|NCT00815919|4787856|P1|Overall Study|AML Relapse|1
1451689|NCT00815919|4787856|P1|Overall Study|Unrelated Fungal Infection|1
1451690|NCT00815659|4787899|P1|Overall Study|Protocol Violation|1
1451691|NCT00815659|4787899|P1|Overall Study|Lost to Follow-up|4
1451692|NCT00815659|4787899|P1|Overall Study|Withdrawal by Subject|9
1451693|NCT00815659|4787899|P1|Overall Study|Adverse Event|9
1451694|NCT00815633|4787942|P1|Overall Study|study terminated|1
1451695|NCT00815516|4787949|P2|Overall Study|Physician Decision|0
1451696|NCT00815516|4787950|P1|Overall Study|Physician Decision|1
1451697|NCT00815516|4787949|P2|Overall Study|Death|1
1451698|NCT00815516|4787950|P1|Overall Study|Death|3
1451699|NCT00815308|4788015|P1|Overall Study|Protocol Violation|6
1451700|NCT00815308|4788015|P1|Overall Study|Withdrawal by Subject|0
1451701|NCT00815308|4788015|P1|Overall Study|Adverse Event|4
1451702|NCT00815295|4788024|P3|Overall Study|Cetuximab hypersensitivity reaction|3
1451703|NCT00815295|4788025|P2|Overall Study|Cetuximab hypersensitivity reaction|1
1451704|NCT00815295|4788026|P1|Overall Study|Cetuximab hypersensitivity reaction|0
1451705|NCT00815191|4788038|P2|Overall Study|Protocol Violation|1
1451706|NCT00815191|4788039|P1|Overall Study|Protocol Violation|1
1451707|NCT00814983|4788076|P2|Overall Study|Graft failure|0
1451708|NCT00814983|4788077|P1|Overall Study|Graft failure|1
1451709|NCT00814983|4788076|P2|Overall Study|Withdrawal by Subject|0
1451710|NCT00814983|4788077|P1|Overall Study|Withdrawal by Subject|1
1451711|NCT00814983|4788076|P2|Overall Study|Screen failure|0
1451712|NCT00814983|4788077|P1|Overall Study|Screen failure|1
1451713|NCT00814892|4788108|P1|Overall Study|Study Termination|1
1451714|NCT00814892|4788108|P1|Overall Study|Disease Progression|1
1451715|NCT00814879|4788120|P2|By Week 48|Death|1
1451716|NCT00814879|4788121|P1|By Week 48|Death|0
1451717|NCT00814879|4788120|P2|By Week 48|Lost to Follow-up|2
1451718|NCT00814879|4788121|P1|By Week 48|Lost to Follow-up|2
1451719|NCT00814879|4788120|P2|By Week 24|Incarceration|1
1451720|NCT00814879|4788121|P1|By Week 24|Incarceration|0
1451721|NCT00814879|4788120|P2|By Week 24|Cancer Diagnosis|0
1451722|NCT00814879|4788121|P1|By Week 24|Cancer Diagnosis|1
1451723|NCT00814801|4788140|P3|Overall Study|Not specified|4
1451724|NCT00814801|4788141|P2|Overall Study|Not specified|6
1451725|NCT00814801|4788142|P1|Overall Study|Not specified|2
1451726|NCT00814801|4788140|P3|Overall Study|Non-compliance|1
1451727|NCT00814801|4788141|P2|Overall Study|Non-compliance|1
1451728|NCT00814801|4788142|P1|Overall Study|Non-compliance|0
1451729|NCT00814801|4788140|P3|Overall Study|Missing or change of caregiver|4
1451730|NCT00814801|4788141|P2|Overall Study|Missing or change of caregiver|2
1451731|NCT00814801|4788142|P1|Overall Study|Missing or change of caregiver|6
1451732|NCT00814801|4788140|P3|Overall Study|Change of patients for CIBIC plus-J|0
1451733|NCT00814801|4788141|P2|Overall Study|Change of patients for CIBIC plus-J|1
1451734|NCT00814801|4788142|P1|Overall Study|Change of patients for CIBIC plus-J|1
1451735|NCT00814801|4788140|P3|Overall Study|Inappropriate as a subject|1
1451736|NCT00814801|4788141|P2|Overall Study|Inappropriate as a subject|1
1451737|NCT00814801|4788142|P1|Overall Study|Inappropriate as a subject|1
1451738|NCT00814801|4788140|P3|Overall Study|Withdrawal by Subject|14
1451739|NCT00814801|4788141|P2|Overall Study|Withdrawal by Subject|11
1451740|NCT00814801|4788142|P1|Overall Study|Withdrawal by Subject|9
1451741|NCT00814801|4788140|P3|Overall Study|Adverse Event|19
1451742|NCT00814801|4788141|P2|Overall Study|Adverse Event|16
1451743|NCT00814801|4788142|P1|Overall Study|Adverse Event|15
1451744|NCT00814710|4788181|P2|Overall Study|Lost to Follow-up|3
1451745|NCT00814710|4788182|P1|Overall Study|Lost to Follow-up|7
1451746|NCT00814710|4788181|P2|Overall Study|Adverse Event|0
1451747|NCT00814710|4788182|P1|Overall Study|Adverse Event|1
1451748|NCT00814658|4788250|P2|Overall Study|Adverse Event|3
1451749|NCT00814658|4788251|P1|Overall Study|Adverse Event|3
1451750|NCT00814658|4788250|P2|Overall Study|Physician Decision|0
1451751|NCT00814658|4788251|P1|Overall Study|Physician Decision|1
1451752|NCT00814658|4788250|P2|Overall Study|Lost to Follow-up|1
1451753|NCT00814658|4788251|P1|Overall Study|Lost to Follow-up|0
1451754|NCT00814632|4788317|P1|Overall Study|Lack of Efficacy|2
1451755|NCT00814580|4788323|P2|Overall Study|Did Not Take Drug|2
1451756|NCT00814580|4788324|P1|Overall Study|Did Not Take Drug|2
1451757|NCT00814580|4788323|P2|Overall Study|Other|3
1451758|NCT00814580|4788324|P1|Overall Study|Other|1
1451759|NCT00814580|4788323|P2|Overall Study|Withdrawal by Subject|2
1451760|NCT00814580|4788324|P1|Overall Study|Withdrawal by Subject|2
1451761|NCT00814580|4788323|P2|Overall Study|Protocol Violation|0
1451762|NCT00814580|4788324|P1|Overall Study|Protocol Violation|2
1451763|NCT00814580|4788323|P2|Overall Study|Lack of Efficacy|25
1451764|NCT00814580|4788324|P1|Overall Study|Lack of Efficacy|18
1451765|NCT00814580|4788323|P2|Overall Study|Adverse Event|15
1451766|NCT00814580|4788324|P1|Overall Study|Adverse Event|6
1451767|NCT00814502|4788454|P2|Overall Study|Withdrawal by Subject|2
1451768|NCT00814502|4788455|P1|Overall Study|Withdrawal by Subject|0
1451769|NCT00814502|4788454|P2|Overall Study|Adverse Event|0
1451770|NCT00814502|4788455|P1|Overall Study|Adverse Event|1
1451771|NCT00814489|4788468|P3|Overall Study|Other|1
1451772|NCT00814489|4788469|P2|Overall Study|Other|0
1451773|NCT00814489|4788470|P1|Overall Study|Other|2
1451774|NCT00814463|4788502|P1|Overall Study|Lost to Follow-up|1
1451775|NCT00814346|4788508|P2|Open Phase (17 Months)|Not otherwise specified|0
1451776|NCT00814346|4788509|P1|Open Phase (17 Months)|Not otherwise specified|1
1451777|NCT00814346|4788508|P2|Open Phase (17 Months)|Lost to Follow-up|0
1451778|NCT00814346|4788509|P1|Open Phase (17 Months)|Lost to Follow-up|2
1451779|NCT00814346|4788508|P2|Open Phase (17 Months)|Consent|0
1451780|NCT00814346|4788509|P1|Open Phase (17 Months)|Consent|2
1451781|NCT00814346|4788508|P2|Open Phase (17 Months)|Adverse Event|0
1451782|NCT00814346|4788509|P1|Open Phase (17 Months)|Adverse Event|5
1451783|NCT00814346|4788508|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
1451784|NCT00814346|4788509|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
1451785|NCT00814346|4788508|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
1451786|NCT00814346|4788509|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
1451787|NCT00814333|4788575|P2|Enrollment|Lost to Follow-up|0
1451788|NCT00814333|4788576|P1|Enrollment|Lost to Follow-up|1
1451789|NCT00814320|4788584|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
1451790|NCT00814320|4788585|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
1451791|NCT00814320|4788584|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
1451792|NCT00814320|4788585|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
1451793|NCT00814320|4788584|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
1451794|NCT00814320|4788585|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
1451795|NCT00814320|4788584|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
1451796|NCT00814320|4788585|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
1451797|NCT00814320|4788584|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
1451798|NCT00814320|4788585|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
1451799|NCT00814320|4788584|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
1451800|NCT00814320|4788585|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
1451801|NCT00814320|4788584|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
1451802|NCT00814320|4788585|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
1451803|NCT00814320|4788584|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
1451804|NCT00814320|4788585|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
1451805|NCT00814320|4788584|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
1451806|NCT00814320|4788585|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
1451807|NCT00814320|4788584|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
1451808|NCT00814320|4788585|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
1451809|NCT00814307|4788717|P4|Overall Study|Death|0
1451810|NCT00814307|4788718|P3|Overall Study|Death|0
1451811|NCT00814307|4788719|P2|Overall Study|Death|1
1451812|NCT00814307|4788720|P1|Overall Study|Death|0
1451813|NCT00814307|4788717|P4|Overall Study|Withdrawal by Subject|2
1451814|NCT00814307|4788718|P3|Overall Study|Withdrawal by Subject|0
1451815|NCT00814307|4788719|P2|Overall Study|Withdrawal by Subject|6
1451816|NCT00814307|4788720|P1|Overall Study|Withdrawal by Subject|4
1451817|NCT00814307|4788717|P4|Overall Study|Protocol Violation|1
1451818|NCT00814307|4788718|P3|Overall Study|Protocol Violation|1
1451819|NCT00814307|4788719|P2|Overall Study|Protocol Violation|8
1451820|NCT00814307|4788720|P1|Overall Study|Protocol Violation|2
1451821|NCT00814307|4788717|P4|Overall Study|Other|1
1451822|NCT00814307|4788718|P3|Overall Study|Other|0
1451823|NCT00814307|4788719|P2|Overall Study|Other|2
1451824|NCT00814307|4788720|P1|Overall Study|Other|1
1451825|NCT00814307|4788717|P4|Overall Study|Lack of Efficacy|4
1451826|NCT00814307|4788718|P3|Overall Study|Lack of Efficacy|3
1451827|NCT00814307|4788719|P2|Overall Study|Lack of Efficacy|1
1451828|NCT00814307|4788720|P1|Overall Study|Lack of Efficacy|1
1451829|NCT00814307|4788717|P4|Overall Study|Adverse Event|2
1451830|NCT00814307|4788718|P3|Overall Study|Adverse Event|3
1451831|NCT00814307|4788719|P2|Overall Study|Adverse Event|9
1451832|NCT00814307|4788720|P1|Overall Study|Adverse Event|3
1451833|NCT00814307|4788717|P4|Overall Study|Randomized but not treated|0
1451834|NCT00814307|4788718|P3|Overall Study|Randomized but not treated|0
1451835|NCT00814307|4788719|P2|Overall Study|Randomized but not treated|0
1451836|NCT00814307|4788720|P1|Overall Study|Randomized but not treated|1
1451837|NCT00814164|4788916|P1|Overall Study|Death|5
1451838|NCT00814164|4788916|P1|Overall Study|not stated|7
1451839|NCT00814164|4788916|P1|Overall Study|Progression|7
1451840|NCT00813995|4788950|P2|Overall Study|Withdrawal by Subject|5
1451841|NCT00813995|4788951|P1|Overall Study|Withdrawal by Subject|0
1451842|NCT00813995|4788950|P2|Overall Study|Subject moved|0
1451843|NCT00813995|4788951|P1|Overall Study|Subject moved|4
1451844|NCT00813995|4788950|P2|Overall Study|Protocol Violation|2
1451845|NCT00813995|4788951|P1|Overall Study|Protocol Violation|3
1451846|NCT00813995|4788950|P2|Overall Study|Other reason|2
1451847|NCT00813995|4788951|P1|Overall Study|Other reason|2
1451848|NCT00813995|4788950|P2|Overall Study|Lost to Follow-up|2
1451849|NCT00813995|4788951|P1|Overall Study|Lost to Follow-up|4
1451850|NCT00813995|4788950|P2|Overall Study|Lack of Efficacy|0
1451851|NCT00813995|4788951|P1|Overall Study|Lack of Efficacy|1
1451852|NCT00813995|4788950|P2|Overall Study|Laboratory adverse event|2
1451853|NCT00813995|4788951|P1|Overall Study|Laboratory adverse event|0
1451854|NCT00813995|4788950|P2|Overall Study|Clinical adverse event|3
1451855|NCT00813995|4788951|P1|Overall Study|Clinical adverse event|9
1451856|NCT00813943|4788974|P3|Overall Study|Ongoing at cut-off date|3
1451857|NCT00813943|4788975|P2|Overall Study|Ongoing at cut-off date|5
1451858|NCT00813943|4788976|P1|Overall Study|Ongoing at cut-off date|5
1451859|NCT00813917|4789006|P2|Overall Study|Lost to Follow-up|1
1451860|NCT00813917|4789007|P1|Overall Study|Lost to Follow-up|3
1451861|NCT00813917|4789006|P2|Overall Study|Withdrawal by Subject|4
1451862|NCT00813917|4789007|P1|Overall Study|Withdrawal by Subject|3
1451863|NCT00813917|4789006|P2|Overall Study|Adverse Event|1
1451864|NCT00813917|4789007|P1|Overall Study|Adverse Event|0
1451865|NCT00813904|4789013|P1|Overall Study|Death|1
1451866|NCT00813865|4789019|P1|Overall Study|Withdrawal by Subject|1
1451867|NCT00813865|4789019|P1|Overall Study|Lost to Follow-up|3
1451868|NCT00813865|4789019|P1|Overall Study|Failure to Respond|3
1451869|NCT00813813|4789027|P2|Overall Study|Other|1
1451870|NCT00813813|4789028|P1|Overall Study|Other|0
1451871|NCT00813813|4789027|P2|Overall Study|Lost to Follow-up|7
1451872|NCT00813813|4789028|P1|Overall Study|Lost to Follow-up|2
1451873|NCT00813813|4789027|P2|Overall Study|Withdrawal by Subject|1
1451874|NCT00813813|4789028|P1|Overall Study|Withdrawal by Subject|1
1451875|NCT00813800|4789044|P1|Overall Study|Physician Decision|1
1451876|NCT00813800|4789044|P1|Overall Study|Worsening of depression|2
1451877|NCT00813800|4789044|P1|Overall Study|Adverse Event|1
1451878|NCT00813800|4789044|P1|Overall Study|Screen Failure after Consent|2
1451879|NCT00813761|4789052|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
1451880|NCT00813761|4789053|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
1451881|NCT00813761|4789054|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
1451882|NCT00813761|4789055|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
1451883|NCT00813761|4789052|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
1451884|NCT00813761|4789053|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
1451885|NCT00813761|4789054|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
1451886|NCT00813761|4789055|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
1451887|NCT00813761|4789052|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
1451888|NCT00813761|4789053|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
1451889|NCT00813761|4789054|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
1451890|NCT00813761|4789055|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
1451891|NCT00813761|4789052|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
1451892|NCT00813761|4789053|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
1451893|NCT00813761|4789054|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
1451894|NCT00813761|4789055|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
1451895|NCT00813761|4789052|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
1451896|NCT00813761|4789053|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
1451897|NCT00813761|4789054|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
1451898|NCT00813761|4789055|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
1451899|NCT00813761|4789052|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
1451900|NCT00813761|4789053|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
1451901|NCT00813761|4789054|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
1451902|NCT00813761|4789055|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
1451903|NCT00813761|4789052|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
1451904|NCT00813761|4789053|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
1451905|NCT00813761|4789054|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
1451906|NCT00813761|4789055|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
1451907|NCT00813761|4789052|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
1451908|NCT00813761|4789053|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
1451909|NCT00813761|4789054|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
1451910|NCT00813761|4789055|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
1451911|NCT00813761|4789052|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
1451912|NCT00813761|4789053|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
1451913|NCT00813761|4789054|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
1451914|NCT00813761|4789055|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
1451915|NCT00813761|4789052|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
1451916|NCT00813761|4789053|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
1451917|NCT00813761|4789054|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
1451918|NCT00813761|4789055|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
1451919|NCT00813761|4789052|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
1451920|NCT00813761|4789053|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
1451921|NCT00813761|4789054|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
1451922|NCT00813761|4789055|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
1451923|NCT00813761|4789052|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
1451924|NCT00813761|4789053|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
1451925|NCT00813761|4789054|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
1451926|NCT00813761|4789055|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
1451927|NCT00813748|4789105|P2|Skin Test Substudy|Physician Decision|1
1451928|NCT00813748|4789106|P1|Skin Test Substudy|Physician Decision|0
1451929|NCT00813709|4789135|P6|Open Label Period|Other|6
1451930|NCT00813709|4789136|P5|Open Label Period|Other|5
1451931|NCT00813709|4789137|P4|Open Label Period|Other|11
1451932|NCT00813709|4789138|P3|Open Label Period|Other|0
1451933|NCT00813709|4789139|P2|Open Label Period|Other|0
1451934|NCT00813709|4789140|P1|Open Label Period|Other|0
1451935|NCT00813709|4789135|P6|Open Label Period|Randomized but not treated|1
1451936|NCT00813709|4789136|P5|Open Label Period|Randomized but not treated|0
1451937|NCT00813709|4789137|P4|Open Label Period|Randomized but not treated|1
1451938|NCT00813709|4789138|P3|Open Label Period|Randomized but not treated|0
1451939|NCT00813709|4789139|P2|Open Label Period|Randomized but not treated|0
1451940|NCT00813709|4789140|P1|Open Label Period|Randomized but not treated|0
1451941|NCT00813709|4789135|P6|Open Label Period|Lack of Efficacy|1
1451942|NCT00813709|4789136|P5|Open Label Period|Lack of Efficacy|1
1451943|NCT00813709|4789137|P4|Open Label Period|Lack of Efficacy|3
1451944|NCT00813709|4789138|P3|Open Label Period|Lack of Efficacy|0
1451945|NCT00813709|4789139|P2|Open Label Period|Lack of Efficacy|0
1451946|NCT00813709|4789140|P1|Open Label Period|Lack of Efficacy|0
1451947|NCT00813709|4789135|P6|Open Label Period|Adverse Event|3
1451948|NCT00813709|4789136|P5|Open Label Period|Adverse Event|4
1451949|NCT00813709|4789137|P4|Open Label Period|Adverse Event|5
1451950|NCT00813709|4789138|P3|Open Label Period|Adverse Event|0
1451951|NCT00813709|4789139|P2|Open Label Period|Adverse Event|0
1451952|NCT00813709|4789140|P1|Open Label Period|Adverse Event|0
1451953|NCT00813709|4789135|P6|Double Blind Period|Other|0
1451954|NCT00813709|4789136|P5|Double Blind Period|Other|0
1451955|NCT00813709|4789137|P4|Double Blind Period|Other|0
1451956|NCT00813709|4789138|P3|Double Blind Period|Other|6
1451957|NCT00813709|4789139|P2|Double Blind Period|Other|9
1451958|NCT00813709|4789140|P1|Double Blind Period|Other|14
1451959|NCT00813709|4789135|P6|Double Blind Period|Randomized but not treated|0
1451960|NCT00813709|4789136|P5|Double Blind Period|Randomized but not treated|0
1451961|NCT00813709|4789137|P4|Double Blind Period|Randomized but not treated|0
1451962|NCT00813709|4789138|P3|Double Blind Period|Randomized but not treated|1
1451963|NCT00813709|4789139|P2|Double Blind Period|Randomized but not treated|3
1451964|NCT00813709|4789140|P1|Double Blind Period|Randomized but not treated|1
1451965|NCT00813709|4789135|P6|Double Blind Period|Switched to open label phase|0
1451966|NCT00813709|4789136|P5|Double Blind Period|Switched to open label phase|0
1451967|NCT00813709|4789137|P4|Double Blind Period|Switched to open label phase|0
1451968|NCT00813709|4789138|P3|Double Blind Period|Switched to open label phase|18
1451969|NCT00813709|4789139|P2|Double Blind Period|Switched to open label phase|26
1451970|NCT00813709|4789140|P1|Double Blind Period|Switched to open label phase|9
1451971|NCT00813709|4789135|P6|Double Blind Period|Lost to Follow-up|0
1451972|NCT00813709|4789136|P5|Double Blind Period|Lost to Follow-up|0
1451973|NCT00813709|4789137|P4|Double Blind Period|Lost to Follow-up|0
1451974|NCT00813709|4789138|P3|Double Blind Period|Lost to Follow-up|2
1451975|NCT00813709|4789139|P2|Double Blind Period|Lost to Follow-up|2
1451976|NCT00813709|4789140|P1|Double Blind Period|Lost to Follow-up|3
1451977|NCT00813709|4789135|P6|Double Blind Period|Adverse Event|0
1451978|NCT00813709|4789136|P5|Double Blind Period|Adverse Event|0
1451979|NCT00813709|4789137|P4|Double Blind Period|Adverse Event|0
1451980|NCT00813709|4789138|P3|Double Blind Period|Adverse Event|4
1451981|NCT00813709|4789139|P2|Double Blind Period|Adverse Event|1
1451982|NCT00813709|4789140|P1|Double Blind Period|Adverse Event|4
1451983|NCT00813592|4789220|P1|Overall Study|Disease assessment was not completed per|2
1451984|NCT00813488|4789229|P2|Open-label Extension|Not specified|0
1451985|NCT00813488|4789230|P1|Open-label Extension|Not specified|1
1451986|NCT00813488|4789229|P2|Open-label Extension|Non-compliance study procedures|1
1451987|NCT00813488|4789230|P1|Open-label Extension|Non-compliance study procedures|2
1451988|NCT00813488|4789229|P2|Open-label Extension|Non-compliance study medication|0
1451989|NCT00813488|4789230|P1|Open-label Extension|Non-compliance study medication|4
1451990|NCT00813488|4789229|P2|Open-label Extension|Protocol Violation|2
1451991|NCT00813488|4789230|P1|Open-label Extension|Protocol Violation|1
1451992|NCT00813488|4789229|P2|Open-label Extension|Withdrawal by Subject|2
1451993|NCT00813488|4789230|P1|Open-label Extension|Withdrawal by Subject|0
1451994|NCT00813488|4789229|P2|Open-label Extension|Lack of Efficacy|0
1451995|NCT00813488|4789230|P1|Open-label Extension|Lack of Efficacy|3
1451996|NCT00813488|4789229|P2|Open-label Extension|Adverse Event|2
1451997|NCT00813488|4789230|P1|Open-label Extension|Adverse Event|1
1451998|NCT00813488|4789229|P2|Double-blind Treatment Period 2|Not Specified|0
1451999|NCT00813488|4789230|P1|Double-blind Treatment Period 2|Not Specified|1
1452000|NCT00813488|4789229|P2|Double-blind Treatment Period 2|Protocol Violation|0
1452001|NCT00813488|4789230|P1|Double-blind Treatment Period 2|Protocol Violation|2
1452002|NCT00813488|4789229|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
1452003|NCT00813488|4789230|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
1452004|NCT00813488|4789229|P2|Double-blind Treatment Period 2|Adverse Event|0
1452005|NCT00813488|4789230|P1|Double-blind Treatment Period 2|Adverse Event|1
1452006|NCT00813488|4789229|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
1452007|NCT00813488|4789230|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
1452008|NCT00813488|4789229|P2|Double-blind Treatment Period 1|Protocol Violation|2
1452009|NCT00813488|4789230|P1|Double-blind Treatment Period 1|Protocol Violation|0
1452010|NCT00813488|4789229|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
1452011|NCT00813488|4789230|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
1452012|NCT00813488|4789229|P2|Double-blind Treatment Period 1|Adverse Event|1
1452013|NCT00813488|4789230|P1|Double-blind Treatment Period 1|Adverse Event|1
1452014|NCT00813488|4789229|P2|Titration Period 2|Non-compliance with study procedures|1
1452015|NCT00813488|4789230|P1|Titration Period 2|Non-compliance with study procedures|2
1452016|NCT00813488|4789229|P2|Titration Period 2|Lost to Follow-up|0
1452017|NCT00813488|4789230|P1|Titration Period 2|Lost to Follow-up|1
1452018|NCT00813488|4789229|P2|Titration Period 2|Protocol Violation|2
1452019|NCT00813488|4789230|P1|Titration Period 2|Protocol Violation|3
1452020|NCT00813488|4789229|P2|Titration Period 2|Lack of Efficacy|4
1452021|NCT00813488|4789230|P1|Titration Period 2|Lack of Efficacy|8
1452022|NCT00813488|4789229|P2|Titration Period 2|Adverse Event|3
1452023|NCT00813488|4789230|P1|Titration Period 2|Adverse Event|2
1452024|NCT00813488|4789229|P2|Titration Period 1|Technical Difficulties|1
1452025|NCT00813488|4789230|P1|Titration Period 1|Technical Difficulties|0
1452026|NCT00813488|4789229|P2|Titration Period 1|Non-compliance to study procedures|2
1452027|NCT00813488|4789230|P1|Titration Period 1|Non-compliance to study procedures|2
1452028|NCT00813488|4789229|P2|Titration Period 1|Non-compliance to study medication|1
1452029|NCT00813488|4789230|P1|Titration Period 1|Non-compliance to study medication|4
1452030|NCT00813488|4789229|P2|Titration Period 1|Protocol Violation|3
1452031|NCT00813488|4789230|P1|Titration Period 1|Protocol Violation|4
1452032|NCT00813488|4789229|P2|Titration Period 1|Withdrawal by Subject|2
1452033|NCT00813488|4789230|P1|Titration Period 1|Withdrawal by Subject|2
1452034|NCT00813488|4789229|P2|Titration Period 1|Lack of Efficacy|7
1452035|NCT00813488|4789230|P1|Titration Period 1|Lack of Efficacy|9
1452036|NCT00813488|4789229|P2|Titration Period 1|Adverse Event|1
1452037|NCT00813488|4789230|P1|Titration Period 1|Adverse Event|6
1452038|NCT00813150|4789360|P2|Long Term Follow-up|Progression/Relapse|24
1452039|NCT00813150|4789361|P1|Long Term Follow-up|Progression/Relapse|22
1452040|NCT00813150|4789360|P2|Long Term Follow-up|Lost to Follow-up|0
1452041|NCT00813150|4789361|P1|Long Term Follow-up|Lost to Follow-up|2
1452042|NCT00813150|4789360|P2|Long Term Follow-up|Not specified|3
1452043|NCT00813150|4789361|P1|Long Term Follow-up|Not specified|0
1452044|NCT00813150|4789360|P2|Long Term Follow-up|Death|4
1452045|NCT00813150|4789361|P1|Long Term Follow-up|Death|0
1452046|NCT00813150|4789360|P2|Treatment Period|Data not available|2
1452047|NCT00813150|4789361|P1|Treatment Period|Data not available|1
1452048|NCT00813150|4789360|P2|Treatment Period|Reason not specified|4
1452049|NCT00813150|4789361|P1|Treatment Period|Reason not specified|3
1452050|NCT00813150|4789360|P2|Treatment Period|Non compliance|1
1452051|NCT00813150|4789361|P1|Treatment Period|Non compliance|0
1452052|NCT00813150|4789360|P2|Treatment Period|Withdrawal by Subject|3
1452053|NCT00813150|4789361|P1|Treatment Period|Withdrawal by Subject|5
1452054|NCT00813150|4789360|P2|Treatment Period|Protocol Violation|4
1452055|NCT00813150|4789361|P1|Treatment Period|Protocol Violation|3
1452056|NCT00813150|4789360|P2|Treatment Period|Stable disease|2
1452057|NCT00813150|4789361|P1|Treatment Period|Stable disease|1
1452058|NCT00813150|4789360|P2|Treatment Period|Complete response|1
1452059|NCT00813150|4789361|P1|Treatment Period|Complete response|0
1452060|NCT00813150|4789360|P2|Treatment Period|Progressive disease|0
1452061|NCT00813150|4789361|P1|Treatment Period|Progressive disease|1
1452062|NCT00813150|4789360|P2|Treatment Period|Death|0
1452063|NCT00813150|4789361|P1|Treatment Period|Death|2
1452064|NCT00813150|4789360|P2|Treatment Period|Adverse Event|15
1452065|NCT00813150|4789361|P1|Treatment Period|Adverse Event|16
1452066|NCT00813098|4789385|P3|Overall Study|Withdrew Consent|0
1452067|NCT00813098|4789386|P2|Overall Study|Withdrew Consent|1
1452068|NCT00813098|4789387|P1|Overall Study|Withdrew Consent|0
1452069|NCT00813098|4789385|P3|Overall Study|Principal Investigator decision|0
1452070|NCT00813098|4789386|P2|Overall Study|Principal Investigator decision|1
1452071|NCT00813098|4789387|P1|Overall Study|Principal Investigator decision|0
1452072|NCT00813098|4789385|P3|Overall Study|Protocol Violation|1
1452073|NCT00813098|4789386|P2|Overall Study|Protocol Violation|0
1452074|NCT00813098|4789387|P1|Overall Study|Protocol Violation|0
1452075|NCT00813098|4789385|P3|Overall Study|Lost to Follow-up|0
1452076|NCT00813098|4789386|P2|Overall Study|Lost to Follow-up|1
1452077|NCT00813098|4789387|P1|Overall Study|Lost to Follow-up|0
1452078|NCT00813098|4789385|P3|Overall Study|Inability to complete study procedures|0
1452079|NCT00813098|4789386|P2|Overall Study|Inability to complete study procedures|0
1452080|NCT00813098|4789387|P1|Overall Study|Inability to complete study procedures|1
1452081|NCT00813098|4789385|P3|Overall Study|Withdrawal by Subject|0
1452082|NCT00813098|4789386|P2|Overall Study|Withdrawal by Subject|1
1452083|NCT00813098|4789387|P1|Overall Study|Withdrawal by Subject|0
1452084|NCT00813098|4789385|P3|Overall Study|Adverse Event|1
1452085|NCT00813098|4789386|P2|Overall Study|Adverse Event|4
1452086|NCT00813098|4789387|P1|Overall Study|Adverse Event|2
1452087|NCT00812981|4789412|P2|Overall Study|Other|1
1452088|NCT00812981|4789413|P1|Overall Study|Other|0
1452089|NCT00812968|4789451|P1|Overall Study|Study closed due to marketing approval|3
1452090|NCT00812968|4789451|P1|Overall Study|No further treatment required|1
1452091|NCT00812968|4789451|P1|Overall Study|Disease progression|1
1452092|NCT00812968|4789451|P1|Overall Study|Relapse after erythroid response|6
1452093|NCT00812955|4789486|P4|Overall Study|randomized in error|0
1452094|NCT00812955|4789487|P3|Overall Study|randomized in error|1
1452095|NCT00812955|4789488|P2|Overall Study|randomized in error|0
1452096|NCT00812955|4789489|P1|Overall Study|randomized in error|0
1452097|NCT00812955|4789486|P4|Overall Study|Withdrawal by Subject|2
1452098|NCT00812955|4789487|P3|Overall Study|Withdrawal by Subject|1
1452099|NCT00812955|4789488|P2|Overall Study|Withdrawal by Subject|0
1452100|NCT00812955|4789489|P1|Overall Study|Withdrawal by Subject|1
1452101|NCT00812955|4789486|P4|Overall Study|Lost to Follow-up|2
1452102|NCT00812955|4789487|P3|Overall Study|Lost to Follow-up|1
1452103|NCT00812955|4789488|P2|Overall Study|Lost to Follow-up|1
1452104|NCT00812955|4789489|P1|Overall Study|Lost to Follow-up|2
1452105|NCT00812955|4789486|P4|Overall Study|Adverse Event|4
1452106|NCT00812955|4789487|P3|Overall Study|Adverse Event|3
1452107|NCT00812955|4789488|P2|Overall Study|Adverse Event|6
1452108|NCT00812955|4789489|P1|Overall Study|Adverse Event|7
1452109|NCT00812929|4789509|P10|Washout Period 3 (7 Days)|Adverse Event|0
1452110|NCT00812929|4789510|P9|Washout Period 3 (7 Days)|Adverse Event|0
1452111|NCT00812929|4789511|P8|Washout Period 3 (7 Days)|Adverse Event|0
1452112|NCT00812929|4789512|P7|Washout Period 3 (7 Days)|Adverse Event|0
1452113|NCT00812929|4789513|P6|Washout Period 3 (7 Days)|Adverse Event|1
1452114|NCT00812929|4789514|P5|Washout Period 3 (7 Days)|Adverse Event|0
1452115|NCT00812929|4789515|P4|Washout Period 3 (7 Days)|Adverse Event|0
1452116|NCT00812929|4789516|P3|Washout Period 3 (7 Days)|Adverse Event|0
1452117|NCT00812929|4789517|P2|Washout Period 3 (7 Days)|Adverse Event|0
1452118|NCT00812929|4789518|P1|Washout Period 3 (7 Days)|Adverse Event|0
1452119|NCT00812929|4789509|P10|Washout Period 2 (7 Days)|Physician Decision|1
1452120|NCT00812929|4789510|P9|Washout Period 2 (7 Days)|Physician Decision|0
1452121|NCT00812929|4789511|P8|Washout Period 2 (7 Days)|Physician Decision|0
1452122|NCT00812929|4789512|P7|Washout Period 2 (7 Days)|Physician Decision|0
1452123|NCT00812929|4789513|P6|Washout Period 2 (7 Days)|Physician Decision|0
1452124|NCT00812929|4789514|P5|Washout Period 2 (7 Days)|Physician Decision|0
1452125|NCT00812929|4789515|P4|Washout Period 2 (7 Days)|Physician Decision|0
1452126|NCT00812929|4789516|P3|Washout Period 2 (7 Days)|Physician Decision|0
1452127|NCT00812929|4789517|P2|Washout Period 2 (7 Days)|Physician Decision|0
1452128|NCT00812929|4789518|P1|Washout Period 2 (7 Days)|Physician Decision|0
1452129|NCT00812929|4789509|P10|Washout Period 1 (7 Days)|Physician Decision|0
1452130|NCT00812929|4789510|P9|Washout Period 1 (7 Days)|Physician Decision|0
1452131|NCT00812929|4789511|P8|Washout Period 1 (7 Days)|Physician Decision|0
1452132|NCT00812929|4789512|P7|Washout Period 1 (7 Days)|Physician Decision|0
1452133|NCT00812929|4789513|P6|Washout Period 1 (7 Days)|Physician Decision|0
1452134|NCT00812929|4789514|P5|Washout Period 1 (7 Days)|Physician Decision|0
1452135|NCT00812929|4789515|P4|Washout Period 1 (7 Days)|Physician Decision|0
1452136|NCT00812929|4789516|P3|Washout Period 1 (7 Days)|Physician Decision|1
1452137|NCT00812929|4789517|P2|Washout Period 1 (7 Days)|Physician Decision|0
1452138|NCT00812929|4789518|P1|Washout Period 1 (7 Days)|Physician Decision|0
1452139|NCT00812812|4789656|P2|Overall Study|Withdrawal by Subject|2
1452140|NCT00812812|4789657|P1|Overall Study|Withdrawal by Subject|0
1452141|NCT00812812|4789656|P2|Overall Study|Lost to Follow-up|1
1452142|NCT00812812|4789657|P1|Overall Study|Lost to Follow-up|0
1452143|NCT00812812|4789656|P2|Overall Study|Lack of Efficacy|0
1452144|NCT00812812|4789657|P1|Overall Study|Lack of Efficacy|1
1452145|NCT00812812|4789656|P2|Overall Study|Adverse Event|1
1452146|NCT00812812|4789657|P1|Overall Study|Adverse Event|2
1452147|NCT00812708|4789670|P1|Overall Study|Signed consent but later withdrew|3
1452148|NCT00812708|4789670|P1|Overall Study|Surgery cancelled due to uveitis|1
1452149|NCT00812708|4789670|P1|Overall Study|Switched to another study|1
1452150|NCT00812708|4789670|P1|Overall Study|Lack of medical insurance|1
1452151|NCT00812708|4789670|P1|Overall Study|Device could not be implanted|2
1452152|NCT00812565|4789698|P8|Overall Study|Reason Not Specified|0
1452153|NCT00812565|4789699|P7|Overall Study|Reason Not Specified|0
1452154|NCT00812565|4789700|P6|Overall Study|Reason Not Specified|1
1452155|NCT00812565|4789701|P5|Overall Study|Reason Not Specified|0
1452156|NCT00812565|4789702|P4|Overall Study|Reason Not Specified|0
1452157|NCT00812565|4789703|P3|Overall Study|Reason Not Specified|0
1452158|NCT00812565|4789704|P2|Overall Study|Reason Not Specified|0
1452159|NCT00812565|4789705|P1|Overall Study|Reason Not Specified|0
1452160|NCT00812565|4789698|P8|Overall Study|Withdrawal of Consent|0
1452161|NCT00812565|4789699|P7|Overall Study|Withdrawal of Consent|0
1452162|NCT00812565|4789700|P6|Overall Study|Withdrawal of Consent|0
1452163|NCT00812565|4789701|P5|Overall Study|Withdrawal of Consent|1
1452164|NCT00812565|4789702|P4|Overall Study|Withdrawal of Consent|0
1452165|NCT00812565|4789703|P3|Overall Study|Withdrawal of Consent|0
1452166|NCT00812565|4789704|P2|Overall Study|Withdrawal of Consent|0
1452167|NCT00812565|4789705|P1|Overall Study|Withdrawal of Consent|1
1452168|NCT00812565|4789698|P8|Overall Study|Did Not Come to Study Visit|0
1452169|NCT00812565|4789699|P7|Overall Study|Did Not Come to Study Visit|0
1452170|NCT00812565|4789700|P6|Overall Study|Did Not Come to Study Visit|0
1452171|NCT00812565|4789701|P5|Overall Study|Did Not Come to Study Visit|0
1452172|NCT00812565|4789702|P4|Overall Study|Did Not Come to Study Visit|0
1452173|NCT00812565|4789703|P3|Overall Study|Did Not Come to Study Visit|0
1452174|NCT00812565|4789704|P2|Overall Study|Did Not Come to Study Visit|0
1452175|NCT00812565|4789705|P1|Overall Study|Did Not Come to Study Visit|1
1452176|NCT00812565|4789698|P8|Overall Study|Adverse Event|1
1452177|NCT00812565|4789699|P7|Overall Study|Adverse Event|0
1452178|NCT00812565|4789700|P6|Overall Study|Adverse Event|0
1452179|NCT00812565|4789701|P5|Overall Study|Adverse Event|0
1452180|NCT00812565|4789702|P4|Overall Study|Adverse Event|2
1452181|NCT00812565|4789703|P3|Overall Study|Adverse Event|0
1452182|NCT00812565|4789704|P2|Overall Study|Adverse Event|0
1452183|NCT00812565|4789705|P1|Overall Study|Adverse Event|0
1452184|NCT00812565|4789698|P8|Overall Study|Did Not Receive Study Medication|0
1452185|NCT00812565|4789699|P7|Overall Study|Did Not Receive Study Medication|0
1452186|NCT00812565|4789700|P6|Overall Study|Did Not Receive Study Medication|0
1452187|NCT00812565|4789701|P5|Overall Study|Did Not Receive Study Medication|0
1452188|NCT00812565|4789702|P4|Overall Study|Did Not Receive Study Medication|0
1452189|NCT00812565|4789703|P3|Overall Study|Did Not Receive Study Medication|0
1452190|NCT00812565|4789704|P2|Overall Study|Did Not Receive Study Medication|1
1452191|NCT00812565|4789705|P1|Overall Study|Did Not Receive Study Medication|1
1452192|NCT00812487|4789829|P2|Overall Study|Protocol Violation|1
1452193|NCT00812487|4789830|P1|Overall Study|Protocol Violation|0
1452194|NCT00812487|4789829|P2|Overall Study|Transfer to ICU prior to intervention|0
1452195|NCT00812487|4789830|P1|Overall Study|Transfer to ICU prior to intervention|1
1452196|NCT00812487|4789829|P2|Overall Study|Withdrawal by Subject|2
1452197|NCT00812487|4789830|P1|Overall Study|Withdrawal by Subject|3
1452198|NCT00812487|4789829|P2|Overall Study|Lost to Follow-up|0
1452199|NCT00812487|4789830|P1|Overall Study|Lost to Follow-up|2
1452200|NCT00812461|4789856|P2|All Treated Patients|Other Reason|21
1452201|NCT00812461|4789857|P1|All Treated Patients|Other Reason|13
1452202|NCT00812461|4789856|P2|All Treated Patients|Lost to Follow-up|14
1452203|NCT00812461|4789857|P1|All Treated Patients|Lost to Follow-up|11
1452204|NCT00812461|4789856|P2|All Treated Patients|Withdrawal by Subject|54
1452205|NCT00812461|4789857|P1|All Treated Patients|Withdrawal by Subject|45
1452206|NCT00812461|4789856|P2|All Treated Patients|Protocol Violation|27
1452207|NCT00812461|4789857|P1|All Treated Patients|Protocol Violation|36
1452208|NCT00812461|4789856|P2|All Treated Patients|Non-compliance|9
1452209|NCT00812461|4789857|P1|All Treated Patients|Non-compliance|6
1452210|NCT00812461|4789856|P2|All Treated Patients|Lack of Efficacy|7
1452211|NCT00812461|4789857|P1|All Treated Patients|Lack of Efficacy|13
1452212|NCT00812461|4789856|P2|All Treated Patients|Adverse Event|15
1452213|NCT00812461|4789857|P1|All Treated Patients|Adverse Event|8
1452214|NCT00812461|4789856|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
1452215|NCT00812461|4789857|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
1452216|NCT00812331|4789880|P5|Overall Study|Adverse Event|0
1452217|NCT00812331|4789881|P4|Overall Study|Adverse Event|0
1452218|NCT00812331|4789882|P3|Overall Study|Adverse Event|0
1452219|NCT00812331|4789883|P2|Overall Study|Adverse Event|0
1452220|NCT00812331|4789884|P1|Overall Study|Adverse Event|1
1452221|NCT00812253|4789959|P2|Overall Study|Lost to Follow-up|0
1452222|NCT00812253|4789960|P1|Overall Study|Lost to Follow-up|2
1452223|NCT00812253|4789959|P2|Overall Study|Protocol Violation|1
1452224|NCT00812253|4789960|P1|Overall Study|Protocol Violation|1
1452225|NCT00812253|4789959|P2|Overall Study|Withdrawal by Subject|2
1452226|NCT00812253|4789960|P1|Overall Study|Withdrawal by Subject|3
1452227|NCT00812097|4789985|P4|Overall Study|Unknown reasons and patient/doctor moves|5
1452228|NCT00812097|4789986|P3|Overall Study|Unknown reasons and patient/doctor moves|15
1452229|NCT00812097|4789987|P2|Overall Study|Unknown reasons and patient/doctor moves|24
1452230|NCT00812097|4789988|P1|Overall Study|Unknown reasons and patient/doctor moves|111
1452231|NCT00812097|4789985|P4|Overall Study|Explantation of study device(s)|20
1452232|NCT00812097|4789986|P3|Overall Study|Explantation of study device(s)|14
1452233|NCT00812097|4789987|P2|Overall Study|Explantation of study device(s)|29
1452234|NCT00812097|4789988|P1|Overall Study|Explantation of study device(s)|27
1452235|NCT00812097|4789985|P4|Overall Study|Lost to Follow-up|5
1452236|NCT00812097|4789986|P3|Overall Study|Lost to Follow-up|17
1452237|NCT00812097|4789987|P2|Overall Study|Lost to Follow-up|14
1452238|NCT00812097|4789988|P1|Overall Study|Lost to Follow-up|90
1452239|NCT00812097|4789985|P4|Overall Study|Withdrawal by Subject|2
1452240|NCT00812097|4789986|P3|Overall Study|Withdrawal by Subject|8
1452241|NCT00812097|4789987|P2|Overall Study|Withdrawal by Subject|12
1452242|NCT00812097|4789988|P1|Overall Study|Withdrawal by Subject|14
1452243|NCT00812097|4789985|P4|Overall Study|Death|3
1452244|NCT00812097|4789986|P3|Overall Study|Death|3
1452245|NCT00812097|4789987|P2|Overall Study|Death|10
1452246|NCT00812097|4789988|P1|Overall Study|Death|3
1452247|NCT00812006|4790017|P3|Overall Study|Lack of Qualifying Event|2
1452248|NCT00812006|4790018|P2|Overall Study|Lack of Qualifying Event|2
1452249|NCT00812006|4790019|P1|Overall Study|Lack of Qualifying Event|4
1452250|NCT00812006|4790017|P3|Overall Study|Withdrawal by Subject|1
1452251|NCT00812006|4790018|P2|Overall Study|Withdrawal by Subject|1
1452252|NCT00812006|4790019|P1|Overall Study|Withdrawal by Subject|2
1452253|NCT00812006|4790017|P3|Overall Study|Physician Decision|1
1452254|NCT00812006|4790018|P2|Overall Study|Physician Decision|0
1452255|NCT00812006|4790019|P1|Overall Study|Physician Decision|0
1452256|NCT00812006|4790017|P3|Overall Study|Lost to Follow-up|2
1452257|NCT00812006|4790018|P2|Overall Study|Lost to Follow-up|0
1452258|NCT00812006|4790019|P1|Overall Study|Lost to Follow-up|0
1452259|NCT00811954|4790036|P3|Overall Study|Complete Protocol: No follow-up|1
1452260|NCT00811954|4790037|P2|Overall Study|Complete Protocol: No follow-up|0
1452261|NCT00811954|4790038|P1|Overall Study|Complete Protocol: No follow-up|0
1452262|NCT00811954|4790036|P3|Overall Study|Severe Debilitation|1
1452263|NCT00811954|4790037|P2|Overall Study|Severe Debilitation|0
1452264|NCT00811954|4790038|P1|Overall Study|Severe Debilitation|2
1452265|NCT00811954|4790036|P3|Overall Study|Site Closure|1
1452266|NCT00811954|4790037|P2|Overall Study|Site Closure|0
1452267|NCT00811954|4790038|P1|Overall Study|Site Closure|4
1452268|NCT00811954|4790036|P3|Overall Study|Withdraw consent prior study completion|5
1452269|NCT00811954|4790037|P2|Overall Study|Withdraw consent prior study completion|6
1452270|NCT00811954|4790038|P1|Overall Study|Withdraw consent prior study completion|4
1452271|NCT00811954|4790036|P3|Overall Study|Not willing to adhere to requirements|16
1452272|NCT00811954|4790037|P2|Overall Study|Not willing to adhere to requirements|2
1452273|NCT00811954|4790038|P1|Overall Study|Not willing to adhere to requirements|12
1452274|NCT00811954|4790036|P3|Overall Study|Not able to get to clinic|30
1452275|NCT00811954|4790037|P2|Overall Study|Not able to get to clinic|35
1452276|NCT00811954|4790038|P1|Overall Study|Not able to get to clinic|28
1452277|NCT00811954|4790036|P3|Overall Study|Lost to Follow-up|34
1452278|NCT00811954|4790037|P2|Overall Study|Lost to Follow-up|23
1452279|NCT00811954|4790038|P1|Overall Study|Lost to Follow-up|29
1452280|NCT00811954|4790036|P3|Overall Study|Death|13
1452281|NCT00811954|4790037|P2|Overall Study|Death|6
1452282|NCT00811954|4790038|P1|Overall Study|Death|10
1452283|NCT00811941|4790102|P2|All Treated Patients|Other Reason|14
1452284|NCT00811941|4790103|P1|All Treated Patients|Other Reason|4
1452285|NCT00811941|4790102|P2|All Treated Patients|Lost to Follow-up|12
1452286|NCT00811941|4790103|P1|All Treated Patients|Lost to Follow-up|3
1452287|NCT00811941|4790102|P2|All Treated Patients|Withdrawal by Subject|94
1452288|NCT00811941|4790103|P1|All Treated Patients|Withdrawal by Subject|35
1452289|NCT00811941|4790102|P2|All Treated Patients|Protocol Violation|17
1452290|NCT00811941|4790103|P1|All Treated Patients|Protocol Violation|5
1452291|NCT00811941|4790102|P2|All Treated Patients|Non-compliance|8
1452292|NCT00811941|4790103|P1|All Treated Patients|Non-compliance|1
1452293|NCT00811941|4790102|P2|All Treated Patients|Lack of Efficacy|3
1452294|NCT00811941|4790103|P1|All Treated Patients|Lack of Efficacy|2
1452295|NCT00811941|4790102|P2|All Treated Patients|Adverse Event|43
1452296|NCT00811941|4790103|P1|All Treated Patients|Adverse Event|2
1452297|NCT00811941|4790102|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
1452298|NCT00811941|4790103|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
1452299|NCT00811928|4790141|P2|Overall Study|Poor Compliance|5
1452300|NCT00811928|4790142|P1|Overall Study|Poor Compliance|2
1452301|NCT00811928|4790141|P2|Overall Study|Investigator Decision|1
1452302|NCT00811928|4790142|P1|Overall Study|Investigator Decision|2
1452303|NCT00811928|4790141|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
1452304|NCT00811928|4790142|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
1452305|NCT00811928|4790141|P2|Overall Study|Did Not Take Study Drug|0
1452306|NCT00811928|4790142|P1|Overall Study|Did Not Take Study Drug|3
1452307|NCT00811928|4790141|P2|Overall Study|Withdrawal by Subject|12
1452308|NCT00811928|4790142|P1|Overall Study|Withdrawal by Subject|18
1452309|NCT00811928|4790141|P2|Overall Study|AEs and SAEs Including Death|11
1452310|NCT00811928|4790142|P1|Overall Study|AEs and SAEs Including Death|7
1452311|NCT00811733|4790186|P2|Overall Study|Withdrawal by Subject|2
1452312|NCT00811733|4790187|P1|Overall Study|Withdrawal by Subject|1
1452313|NCT00811733|4790186|P2|Overall Study|Investigator Discretion|8
1452314|NCT00811733|4790187|P1|Overall Study|Investigator Discretion|10
1452315|NCT00811720|4790235|P2|All Treated Patients|Other Reason|4
1452316|NCT00811720|4790236|P1|All Treated Patients|Other Reason|7
1452317|NCT00811720|4790235|P2|All Treated Patients|Lost to Follow-up|16
1452318|NCT00811720|4790236|P1|All Treated Patients|Lost to Follow-up|10
1452319|NCT00811720|4790235|P2|All Treated Patients|Withdrawal by Subject|34
1452320|NCT00811720|4790236|P1|All Treated Patients|Withdrawal by Subject|28
1452321|NCT00811720|4790235|P2|All Treated Patients|Protocol Violation|16
1452322|NCT00811720|4790236|P1|All Treated Patients|Protocol Violation|9
1452323|NCT00811720|4790235|P2|All Treated Patients|Non-compliance|14
1452324|NCT00811720|4790236|P1|All Treated Patients|Non-compliance|0
1452325|NCT00811720|4790235|P2|All Treated Patients|Lack of Efficacy|18
1452326|NCT00811720|4790236|P1|All Treated Patients|Lack of Efficacy|22
1452327|NCT00811720|4790235|P2|All Treated Patients|Adverse Event|62
1452328|NCT00811720|4790236|P1|All Treated Patients|Adverse Event|20
1452329|NCT00811720|4790235|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
1452330|NCT00811720|4790236|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
1452331|NCT00811655|4790254|P1|Overall Study|Physician Decision|1
1452332|NCT00811642|4790266|P1|Overall Study|Cumulative use of antifungal agent|2
1452333|NCT00811642|4790266|P1|Overall Study|Withdrawal by Subject|7
1452334|NCT00811642|4790266|P1|Overall Study|Death|2
1452335|NCT00811642|4790266|P1|Overall Study|Protocol Violation|1
1452336|NCT00811642|4790266|P1|Overall Study|Adverse Event|3
1452337|NCT00811577|4790282|P2|Overall Study|Withdrawal by Subject|0
1452338|NCT00811577|4790283|P1|Overall Study|Withdrawal by Subject|3
1452339|NCT00811577|4790282|P2|Overall Study|Lost to Follow-up|1
1452340|NCT00811577|4790283|P1|Overall Study|Lost to Follow-up|7
1452341|NCT00811473|4790343|P2|Overall Study|Safety Reasons|0
1452342|NCT00811473|4790344|P1|Overall Study|Safety Reasons|1
1452343|NCT00811473|4790343|P2|Overall Study|Incorrect Enrollment|0
1452344|NCT00811473|4790344|P1|Overall Study|Incorrect Enrollment|1
1452345|NCT00811473|4790343|P2|Overall Study|Other 2|1
1452346|NCT00811473|4790344|P1|Overall Study|Other 2|4
1452347|NCT00811473|4790343|P2|Overall Study|Condition under investigation worsened|3
1452348|NCT00811473|4790344|P1|Overall Study|Condition under investigation worsened|1
1452349|NCT00811473|4790343|P2|Overall Study|Lack of therapeutic response|1
1452350|NCT00811473|4790344|P1|Overall Study|Lack of therapeutic response|4
1452351|NCT00811473|4790343|P2|Overall Study|Severe non-compliance to protocol|4
1452352|NCT00811473|4790344|P1|Overall Study|Severe non-compliance to protocol|2
1452353|NCT00811473|4790343|P2|Overall Study|Withdrawal by Subject|4
1452354|NCT00811473|4790344|P1|Overall Study|Withdrawal by Subject|2
1452355|NCT00811473|4790343|P2|Overall Study|Lost to Follow-up|1
1452356|NCT00811473|4790344|P1|Overall Study|Lost to Follow-up|5
1452357|NCT00811473|4790343|P2|Overall Study|Adverse Event|12
1452358|NCT00811473|4790344|P1|Overall Study|Adverse Event|3
1452359|NCT00811395|4790375|P6|Extension Treatment|Other than above|0
1452360|NCT00811395|4790376|P5|Extension Treatment|Other than above|0
1452361|NCT00811395|4790377|P4|Extension Treatment|Other than above|0
1452362|NCT00811395|4790378|P3|Extension Treatment|Other than above|1
1452363|NCT00811395|4790379|P2|Extension Treatment|Other than above|0
1452364|NCT00811395|4790380|P1|Extension Treatment|Other than above|0
1452365|NCT00811395|4790375|P6|Extension Treatment|Participant did not wish to continue|1
1452366|NCT00811395|4790376|P5|Extension Treatment|Participant did not wish to continue|0
1452367|NCT00811395|4790377|P4|Extension Treatment|Participant did not wish to continue|1
1452368|NCT00811395|4790378|P3|Extension Treatment|Participant did not wish to continue|0
1452369|NCT00811395|4790379|P2|Extension Treatment|Participant did not wish to continue|3
1452370|NCT00811395|4790380|P1|Extension Treatment|Participant did not wish to continue|0
1452371|NCT00811395|4790375|P6|Extension Treatment|Progressive disease|0
1452372|NCT00811395|4790376|P5|Extension Treatment|Progressive disease|0
1452373|NCT00811395|4790377|P4|Extension Treatment|Progressive disease|0
1452374|NCT00811395|4790378|P3|Extension Treatment|Progressive disease|0
1452375|NCT00811395|4790379|P2|Extension Treatment|Progressive disease|1
1452376|NCT00811395|4790380|P1|Extension Treatment|Progressive disease|1
1452377|NCT00811395|4790375|P6|Extension Treatment|Adverse Event|1
1452378|NCT00811395|4790376|P5|Extension Treatment|Adverse Event|0
1452379|NCT00811395|4790377|P4|Extension Treatment|Adverse Event|2
1452380|NCT00811395|4790378|P3|Extension Treatment|Adverse Event|2
1452381|NCT00811395|4790379|P2|Extension Treatment|Adverse Event|2
1452382|NCT00811395|4790380|P1|Extension Treatment|Adverse Event|1
1452383|NCT00811252|4790486|P3|Overall Study|Administrative or Other Reasons|2
1452384|NCT00811252|4790487|P2|Overall Study|Administrative or Other Reasons|3
1452385|NCT00811252|4790488|P1|Overall Study|Administrative or Other Reasons|0
1452386|NCT00811252|4790486|P3|Overall Study|Lost to Follow-up|2
1452387|NCT00811252|4790487|P2|Overall Study|Lost to Follow-up|0
1452388|NCT00811252|4790488|P1|Overall Study|Lost to Follow-up|0
1452389|NCT00811252|4790486|P3|Overall Study|Withdrawal of Consent|2
1452390|NCT00811252|4790487|P2|Overall Study|Withdrawal of Consent|2
1452391|NCT00811252|4790488|P1|Overall Study|Withdrawal of Consent|1
1452392|NCT00811252|4790486|P3|Overall Study|Protocol Violation|2
1452393|NCT00811252|4790487|P2|Overall Study|Protocol Violation|3
1452394|NCT00811252|4790488|P1|Overall Study|Protocol Violation|3
1452395|NCT00811252|4790486|P3|Overall Study|Lack of Efficacy|0
1452396|NCT00811252|4790487|P2|Overall Study|Lack of Efficacy|2
1452397|NCT00811252|4790488|P1|Overall Study|Lack of Efficacy|7
1452398|NCT00811252|4790486|P3|Overall Study|Adverse Event|15
1452399|NCT00811252|4790487|P2|Overall Study|Adverse Event|10
1452400|NCT00811252|4790488|P1|Overall Study|Adverse Event|6
1452401|NCT00811174|4790532|P1|Overall Study|Sponsors Decision|1
1452402|NCT00811174|4790532|P1|Overall Study|Protocol Violation|2
1452403|NCT00811135|4790543|P1|Overall Study|Ongoing|59
1452404|NCT00811135|4790543|P1|Overall Study|Administrative/Other Unspecified|11
1452405|NCT00811135|4790543|P1|Overall Study|Withdrawal by Subject|3
1452406|NCT00811135|4790543|P1|Overall Study|Refused Treatment|1
1452407|NCT00811135|4790543|P1|Overall Study|Violation of Selection Criteria|1
1452408|NCT00811135|4790543|P1|Overall Study|Protocol Violation|2
1452409|NCT00811135|4790543|P1|Overall Study|Death|3
1452410|NCT00811135|4790543|P1|Overall Study|Adverse Event/Intercurrent Illness|8
1452411|NCT00811070|4790561|P6|Overall Study|Physician Decision|1
1452412|NCT00811070|4790562|P5|Overall Study|Physician Decision|0
1452413|NCT00811070|4790563|P4|Overall Study|Physician Decision|0
1452414|NCT00811070|4790564|P3|Overall Study|Physician Decision|0
1452415|NCT00811070|4790565|P2|Overall Study|Physician Decision|0
1452416|NCT00811070|4790566|P1|Overall Study|Physician Decision|0
1452417|NCT00811070|4790561|P6|Overall Study|Withdrawal by Subject|0
1452418|NCT00811070|4790562|P5|Overall Study|Withdrawal by Subject|0
1452419|NCT00811070|4790563|P4|Overall Study|Withdrawal by Subject|0
1452420|NCT00811070|4790564|P3|Overall Study|Withdrawal by Subject|0
1452421|NCT00811070|4790565|P2|Overall Study|Withdrawal by Subject|1
1452422|NCT00811070|4790566|P1|Overall Study|Withdrawal by Subject|0
1452423|NCT00811070|4790561|P6|Overall Study|Other|0
1452424|NCT00811070|4790562|P5|Overall Study|Other|0
1452425|NCT00811070|4790563|P4|Overall Study|Other|0
1452426|NCT00811070|4790564|P3|Overall Study|Other|0
1452427|NCT00811070|4790565|P2|Overall Study|Other|0
1452428|NCT00811070|4790566|P1|Overall Study|Other|1
1452429|NCT00811070|4790561|P6|Overall Study|Death|0
1452430|NCT00811070|4790562|P5|Overall Study|Death|5
1452431|NCT00811070|4790563|P4|Overall Study|Death|2
1452432|NCT00811070|4790564|P3|Overall Study|Death|0
1452433|NCT00811070|4790565|P2|Overall Study|Death|0
1452434|NCT00811070|4790566|P1|Overall Study|Death|0
1452435|NCT00811057|4790626|P3|Overall Study|Protocol Violation|10
1452436|NCT00811057|4790627|P2|Overall Study|Protocol Violation|10
1452437|NCT00811057|4790628|P1|Overall Study|Protocol Violation|5
1452438|NCT00811018|4790639|P1|Overall Study|Other|26
1452439|NCT00811018|4790639|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
1452440|NCT00811018|4790639|P1|Overall Study|Withdrawal by Subject|70
1452441|NCT00811018|4790639|P1|Overall Study|Sponsor Decision|450
1452442|NCT00811018|4790639|P1|Overall Study|Pregnancy|6
1452443|NCT00811018|4790639|P1|Overall Study|Lost to Follow-up|19
1452444|NCT00811018|4790639|P1|Overall Study|Investigator Decision|57
1452445|NCT00811018|4790639|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
1452446|NCT00811018|4790639|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
1452447|NCT00811018|4790639|P1|Overall Study|Death|147
1452448|NCT00811018|4790639|P1|Overall Study|Adverse Event|79
1452449|NCT00811018|4790639|P1|Overall Study|Additional Chronic Treatment|31
1452450|NCT00810901|4790657|P2|Overall Study|Lost to Follow-up|58
1452451|NCT00810901|4790658|P1|Overall Study|Lost to Follow-up|88
1452452|NCT00810810|4790704|P4|Overall Study|Physician Decision|5
1452453|NCT00810810|4790705|P3|Overall Study|Physician Decision|1
1452454|NCT00810810|4790706|P2|Overall Study|Physician Decision|3
1452455|NCT00810810|4790707|P1|Overall Study|Physician Decision|0
1452456|NCT00810810|4790704|P4|Overall Study|Withdrawal by Subject|8
1452457|NCT00810810|4790705|P3|Overall Study|Withdrawal by Subject|10
1452458|NCT00810810|4790706|P2|Overall Study|Withdrawal by Subject|8
1452459|NCT00810810|4790707|P1|Overall Study|Withdrawal by Subject|0
1452460|NCT00810693|4790755|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
1452461|NCT00810693|4790756|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
1452462|NCT00810693|4790757|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
1452463|NCT00810693|4790755|P3|Follow-up Period (FUP)|Protocol Violation|0
1452464|NCT00810693|4790756|P2|Follow-up Period (FUP)|Protocol Violation|1
1452465|NCT00810693|4790757|P1|Follow-up Period (FUP)|Protocol Violation|0
1452466|NCT00810693|4790755|P3|Follow-up Period (FUP)|Lost to Follow-up|2
1452467|NCT00810693|4790756|P2|Follow-up Period (FUP)|Lost to Follow-up|0
1452468|NCT00810693|4790757|P1|Follow-up Period (FUP)|Lost to Follow-up|1
1452469|NCT00810693|4790755|P3|Follow-up Period (FUP)|Death|1
1452470|NCT00810693|4790756|P2|Follow-up Period (FUP)|Death|0
1452471|NCT00810693|4790757|P1|Follow-up Period (FUP)|Death|2
1452472|NCT00810693|4790755|P3|Follow-up Period (FUP)|Adverse Event|1
1452473|NCT00810693|4790756|P2|Follow-up Period (FUP)|Adverse Event|1
1452474|NCT00810693|4790757|P1|Follow-up Period (FUP)|Adverse Event|3
1452475|NCT00810693|4790755|P3|Treatment Period|Not treated|1
1452476|NCT00810693|4790756|P2|Treatment Period|Not treated|1
1452477|NCT00810693|4790757|P1|Treatment Period|Not treated|0
1452478|NCT00810693|4790755|P3|Treatment Period|Withdrawal by Subject|3
1452479|NCT00810693|4790756|P2|Treatment Period|Withdrawal by Subject|2
1452480|NCT00810693|4790757|P1|Treatment Period|Withdrawal by Subject|6
1452481|NCT00810693|4790755|P3|Treatment Period|Protocol Violation|2
1452482|NCT00810693|4790756|P2|Treatment Period|Protocol Violation|2
1452483|NCT00810693|4790757|P1|Treatment Period|Protocol Violation|1
1452484|NCT00810693|4790755|P3|Treatment Period|Non-compliance|0
1452485|NCT00810693|4790756|P2|Treatment Period|Non-compliance|0
1452486|NCT00810693|4790757|P1|Treatment Period|Non-compliance|1
1452487|NCT00810693|4790755|P3|Treatment Period|Lost to Follow-up|0
1452488|NCT00810693|4790756|P2|Treatment Period|Lost to Follow-up|0
1452489|NCT00810693|4790757|P1|Treatment Period|Lost to Follow-up|1
1452490|NCT00810693|4790755|P3|Treatment Period|Lack of Efficacy|1
1452491|NCT00810693|4790756|P2|Treatment Period|Lack of Efficacy|0
1452492|NCT00810693|4790757|P1|Treatment Period|Lack of Efficacy|0
1452493|NCT00810693|4790755|P3|Treatment Period|Death|2
1452494|NCT00810693|4790756|P2|Treatment Period|Death|1
1452495|NCT00810693|4790757|P1|Treatment Period|Death|0
1452496|NCT00810693|4790755|P3|Treatment Period|Adverse Event|7
1452497|NCT00810693|4790756|P2|Treatment Period|Adverse Event|1
1452498|NCT00810693|4790757|P1|Treatment Period|Adverse Event|8
1452499|NCT00810641|4790789|P3|Overall Study|Withdrawal by Subject|2
1452500|NCT00810641|4790790|P2|Overall Study|Withdrawal by Subject|1
1452501|NCT00810641|4790791|P1|Overall Study|Withdrawal by Subject|0
1452502|NCT00810615|4790801|P2|Overall Study|Withdrawal by Subject|1
1452503|NCT00810615|4790802|P1|Overall Study|Withdrawal by Subject|1
1452504|NCT00810602|4790852|P2|Overall Study|Withdrawal by Subject|3
1452505|NCT00810602|4790853|P1|Overall Study|Withdrawal by Subject|8
1452506|NCT00810511|4790866|P2|Overall Study|deposits on contact lens|1
1452507|NCT00810511|4790867|P1|Overall Study|deposits on contact lens|0
1452508|NCT00810511|4790866|P2|Overall Study|Lost to Follow-up|0
1452509|NCT00810511|4790867|P1|Overall Study|Lost to Follow-up|1
1452510|NCT00810511|4790866|P2|Overall Study|death in the family|1
1452511|NCT00810511|4790867|P1|Overall Study|death in the family|0
1452512|NCT00810511|4790866|P2|Overall Study|Lack of Efficacy|1
1452513|NCT00810511|4790867|P1|Overall Study|Lack of Efficacy|9
1452514|NCT00810511|4790866|P2|Overall Study|Protocol Violation|1
1452515|NCT00810511|4790867|P1|Overall Study|Protocol Violation|0
1452516|NCT00810394|4790873|P1|Overall Study|Withdrawal by Subject|3
1452517|NCT00810368|4790881|P2|Overall Study|Lack of Efficacy|0
1452518|NCT00810368|4790882|P1|Overall Study|Lack of Efficacy|2
1452519|NCT00810368|4790881|P2|Overall Study|Lost to Follow-up|2
1452520|NCT00810368|4790882|P1|Overall Study|Lost to Follow-up|4
1452521|NCT00810355|4790903|P3|Overall Study|Withdrawal by Subject|0
1452522|NCT00810355|4790904|P2|Overall Study|Withdrawal by Subject|0
1452523|NCT00810355|4790905|P1|Overall Study|Withdrawal by Subject|1
1452524|NCT00810355|4790903|P3|Overall Study|Lost to Follow-up|11
1452525|NCT00810355|4790904|P2|Overall Study|Lost to Follow-up|17
1452526|NCT00810355|4790905|P1|Overall Study|Lost to Follow-up|13
1452527|NCT00810342|4790921|P2|12-month Followup|Lost to Follow-up|1
1452528|NCT00810342|4790922|P1|12-month Followup|Lost to Follow-up|3
1452529|NCT00810342|4790921|P2|12-month Followup|Pregnancy|10
1452530|NCT00810342|4790922|P1|12-month Followup|Pregnancy|9
1452531|NCT00810342|4790921|P2|6-month Follow-up|Pregnancy|2
1452532|NCT00810342|4790922|P1|6-month Follow-up|Pregnancy|6
1452533|NCT00810342|4790921|P2|6-month Follow-up|Lost to Follow-up|6
1452534|NCT00810342|4790922|P1|6-month Follow-up|Lost to Follow-up|18
1452535|NCT00810342|4790921|P2|Month 1 Follow-up|Pregnancy|0
1452536|NCT00810342|4790922|P1|Month 1 Follow-up|Pregnancy|1
1452537|NCT00810342|4790921|P2|Month 1 Follow-up|Lost to Follow-up|2
1452538|NCT00810342|4790922|P1|Month 1 Follow-up|Lost to Follow-up|4
1452539|NCT00810277|4790955|P1|Overall Study|Adverse Event|1
1452540|NCT00810199|4790970|P2|Overall Study|Did not receive study drug|1
1452541|NCT00810199|4790971|P1|Overall Study|Did not receive study drug|2
1452542|NCT00810199|4790970|P2|Overall Study|Failure to return|4
1452543|NCT00810199|4790971|P1|Overall Study|Failure to return|1
1452544|NCT00810199|4790970|P2|Overall Study|Protocol Violation|6
1452545|NCT00810199|4790971|P1|Overall Study|Protocol Violation|2
1452546|NCT00810199|4790970|P2|Overall Study|Administrative/Other|6
1452547|NCT00810199|4790971|P1|Overall Study|Administrative/Other|5
1452548|NCT00810199|4790970|P2|Overall Study|Refused treatment/Did not cooperate|7
1452549|NCT00810199|4790971|P1|Overall Study|Refused treatment/Did not cooperate|7
1452550|NCT00810199|4790970|P2|Overall Study|Insufficient therapeutic response|14
1452551|NCT00810199|4790971|P1|Overall Study|Insufficient therapeutic response|5
1452552|NCT00810199|4790970|P2|Overall Study|Withdrew consent|12
1452553|NCT00810199|4790971|P1|Overall Study|Withdrew consent|9
1452554|NCT00810199|4790970|P2|Overall Study|Death|6
1452555|NCT00810199|4790971|P1|Overall Study|Death|4
1452556|NCT00810199|4790970|P2|Overall Study|Adverse Event|26
1452557|NCT00810199|4790971|P1|Overall Study|Adverse Event|24
1452558|NCT00810108|4791049|P2|Overall Study|Withdrawal by Subject|0
1452559|NCT00810108|4791050|P1|Overall Study|Withdrawal by Subject|1
1452560|NCT00810082|4791064|P2|Overall Study|Lost to Follow-up|4
1452561|NCT00810082|4791065|P1|Overall Study|Lost to Follow-up|0
1452562|NCT00810069|4791073|P3|Double-Blind Period II|Protocol Violation|6
1452563|NCT00810069|4791074|P2|Double-Blind Period II|Protocol Violation|7
1452564|NCT00810069|4791075|P1|Double-Blind Period II|Protocol Violation|0
1452565|NCT00810069|4791073|P3|Double-Blind Period II|Clinical relapse|0
1452566|NCT00810069|4791074|P2|Double-Blind Period II|Clinical relapse|3
1452567|NCT00810069|4791075|P1|Double-Blind Period II|Clinical relapse|0
1452568|NCT00810069|4791073|P3|Double-Blind Period II|Protocol entry criterion not met|1
1452569|NCT00810069|4791074|P2|Double-Blind Period II|Protocol entry criterion not met|0
1452570|NCT00810069|4791075|P1|Double-Blind Period II|Protocol entry criterion not met|0
1452571|NCT00810069|4791073|P3|Double-Blind Period II|Withdrawal by Subject|35
1452572|NCT00810069|4791074|P2|Double-Blind Period II|Withdrawal by Subject|21
1452573|NCT00810069|4791075|P1|Double-Blind Period II|Withdrawal by Subject|0
1452574|NCT00810069|4791073|P3|Double-Blind Period II|Physician Decision|1
1452575|NCT00810069|4791074|P2|Double-Blind Period II|Physician Decision|0
1452576|NCT00810069|4791075|P1|Double-Blind Period II|Physician Decision|0
1452577|NCT00810069|4791073|P3|Double-Blind Period II|Lost to Follow-up|9
1452578|NCT00810069|4791074|P2|Double-Blind Period II|Lost to Follow-up|9
1452579|NCT00810069|4791075|P1|Double-Blind Period II|Lost to Follow-up|0
1452580|NCT00810069|4791073|P3|Double-Blind Period II|Lack of Efficacy|12
1452581|NCT00810069|4791074|P2|Double-Blind Period II|Lack of Efficacy|7
1452582|NCT00810069|4791075|P1|Double-Blind Period II|Lack of Efficacy|0
1452583|NCT00810069|4791073|P3|Double-Blind Period II|Adverse Event|8
1452584|NCT00810069|4791074|P2|Double-Blind Period II|Adverse Event|9
1452585|NCT00810069|4791075|P1|Double-Blind Period II|Adverse Event|0
1452586|NCT00810069|4791073|P3|Lead-in Period I|Randomization criteria not met|0
1452587|NCT00810069|4791074|P2|Lead-in Period I|Randomization criteria not met|0
1452588|NCT00810069|4791075|P1|Lead-in Period I|Randomization criteria not met|158
1452589|NCT00810069|4791073|P3|Lead-in Period I|Protocol entry criterion not met|0
1452590|NCT00810069|4791074|P2|Lead-in Period I|Protocol entry criterion not met|0
1452591|NCT00810069|4791075|P1|Lead-in Period I|Protocol entry criterion not met|5
1452592|NCT00810069|4791073|P3|Lead-in Period I|Withdrawal by Subject|0
1452593|NCT00810069|4791074|P2|Lead-in Period I|Withdrawal by Subject|0
1452594|NCT00810069|4791075|P1|Lead-in Period I|Withdrawal by Subject|46
1452595|NCT00810069|4791073|P3|Lead-in Period I|Protocol Violation|0
1452596|NCT00810069|4791074|P2|Lead-in Period I|Protocol Violation|0
1452597|NCT00810069|4791075|P1|Lead-in Period I|Protocol Violation|1
1452598|NCT00810069|4791073|P3|Lead-in Period I|Physician Decision|0
1452599|NCT00810069|4791074|P2|Lead-in Period I|Physician Decision|0
1452600|NCT00810069|4791075|P1|Lead-in Period I|Physician Decision|1
1452601|NCT00810069|4791073|P3|Lead-in Period I|Lost to Follow-up|0
1452602|NCT00810069|4791074|P2|Lead-in Period I|Lost to Follow-up|0
1452603|NCT00810069|4791075|P1|Lead-in Period I|Lost to Follow-up|19
1452604|NCT00810069|4791073|P3|Lead-in Period I|Lack of Efficacy|0
1452605|NCT00810069|4791074|P2|Lead-in Period I|Lack of Efficacy|0
1452606|NCT00810069|4791075|P1|Lead-in Period I|Lack of Efficacy|1
1452607|NCT00810069|4791073|P3|Lead-in Period I|Adverse Event|0
1452608|NCT00810069|4791074|P2|Lead-in Period I|Adverse Event|0
1452609|NCT00810069|4791075|P1|Lead-in Period I|Adverse Event|43
1452610|NCT00810043|4791120|P3|Overall Study|No longer met enrollment criteria|3
1452611|NCT00810043|4791121|P2|Overall Study|No longer met enrollment criteria|0
1452612|NCT00810043|4791122|P1|Overall Study|No longer met enrollment criteria|0
1452613|NCT00810043|4791120|P3|Overall Study|Non-medical problem|1
1452614|NCT00810043|4791121|P2|Overall Study|Non-medical problem|0
1452615|NCT00810043|4791122|P1|Overall Study|Non-medical problem|0
1452616|NCT00810043|4791120|P3|Overall Study|Unrelated medical problem|0
1452617|NCT00810043|4791121|P2|Overall Study|Unrelated medical problem|1
1452618|NCT00810043|4791122|P1|Overall Study|Unrelated medical problem|0
1452619|NCT00810043|4791120|P3|Overall Study|Death|0
1452620|NCT00810043|4791121|P2|Overall Study|Death|0
1452621|NCT00810043|4791122|P1|Overall Study|Death|2
1452622|NCT00810043|4791120|P3|Overall Study|Physician Decision|2
1452623|NCT00810043|4791121|P2|Overall Study|Physician Decision|0
1452624|NCT00810043|4791122|P1|Overall Study|Physician Decision|0
1452625|NCT00810043|4791120|P3|Overall Study|Lost to Follow-up|0
1452626|NCT00810043|4791121|P2|Overall Study|Lost to Follow-up|0
1452627|NCT00810043|4791122|P1|Overall Study|Lost to Follow-up|1
1452628|NCT00810043|4791120|P3|Overall Study|Withdrawal by Subject|2
1452629|NCT00810043|4791121|P2|Overall Study|Withdrawal by Subject|0
1452630|NCT00810043|4791122|P1|Overall Study|Withdrawal by Subject|1
1452631|NCT00809965|4791144|P3|Overall Study|Other Reason|189
1452632|NCT00809965|4791145|P2|Overall Study|Other Reason|170
1452633|NCT00809965|4791146|P1|Overall Study|Other Reason|167
1452634|NCT00809965|4791144|P3|Overall Study|Withdrawal by Subject|441
1452635|NCT00809965|4791145|P2|Overall Study|Withdrawal by Subject|448
1452636|NCT00809965|4791146|P1|Overall Study|Withdrawal by Subject|405
1452637|NCT00809965|4791144|P3|Overall Study|Lost to Follow-up|18
1452638|NCT00809965|4791145|P2|Overall Study|Lost to Follow-up|10
1452639|NCT00809965|4791146|P1|Overall Study|Lost to Follow-up|17
1452640|NCT00809965|4791144|P3|Overall Study|Death|196
1452641|NCT00809965|4791145|P2|Overall Study|Death|147
1452642|NCT00809965|4791146|P1|Overall Study|Death|194
1452643|NCT00809926|4791168|P2|Overall Study|Protocol deviation|2
1452644|NCT00809926|4791169|P1|Overall Study|Protocol deviation|0
1452645|NCT00809926|4791168|P2|Overall Study|Administrative Problems|1
1452646|NCT00809926|4791169|P1|Overall Study|Administrative Problems|0
1452647|NCT00809926|4791168|P2|Overall Study|Lost to Follow-up|1
1452648|NCT00809926|4791169|P1|Overall Study|Lost to Follow-up|2
1452649|NCT00809926|4791168|P2|Overall Study|Patient withdrew consent|6
1452650|NCT00809926|4791169|P1|Overall Study|Patient withdrew consent|8
1452651|NCT00809926|4791168|P2|Overall Study|Unsatisfactory therapeutic effect|3
1452652|NCT00809926|4791169|P1|Overall Study|Unsatisfactory therapeutic effect|3
1452653|NCT00809926|4791168|P2|Overall Study|Adverse Event|10
1452654|NCT00809926|4791169|P1|Overall Study|Adverse Event|18
1452655|NCT00809835|4791223|P4|Overall Study|Withdrawal by Subject|0
1452656|NCT00809835|4791224|P3|Overall Study|Withdrawal by Subject|1
1452657|NCT00809835|4791225|P2|Overall Study|Withdrawal by Subject|1
1452658|NCT00809835|4791226|P1|Overall Study|Withdrawal by Subject|1
1452659|NCT00809835|4791223|P4|Overall Study|Lost to Follow-up|2
1452660|NCT00809835|4791224|P3|Overall Study|Lost to Follow-up|10
1452661|NCT00809835|4791225|P2|Overall Study|Lost to Follow-up|6
1452662|NCT00809835|4791226|P1|Overall Study|Lost to Follow-up|7
1452663|NCT00809757|4791256|P3|Overall Study|Noncompliance with Medication|1
1452664|NCT00809757|4791257|P2|Overall Study|Noncompliance with Medication|0
1452665|NCT00809757|4791258|P1|Overall Study|Noncompliance with Medication|0
1452666|NCT00809757|4791256|P3|Overall Study|Subject Uncooperative|2
1452667|NCT00809757|4791257|P2|Overall Study|Subject Uncooperative|0
1452668|NCT00809757|4791258|P1|Overall Study|Subject Uncooperative|1
1452669|NCT00809757|4791256|P3|Overall Study|Withdrawal by Subject|3
1452670|NCT00809757|4791257|P2|Overall Study|Withdrawal by Subject|1
1452671|NCT00809757|4791258|P1|Overall Study|Withdrawal by Subject|2
1452672|NCT00809757|4791256|P3|Overall Study|Protocol Violation|1
1452673|NCT00809757|4791257|P2|Overall Study|Protocol Violation|1
1452674|NCT00809757|4791258|P1|Overall Study|Protocol Violation|1
1452675|NCT00809757|4791256|P3|Overall Study|Lost to Follow-up|1
1452676|NCT00809757|4791257|P2|Overall Study|Lost to Follow-up|0
1452677|NCT00809757|4791258|P1|Overall Study|Lost to Follow-up|0
1452678|NCT00809757|4791256|P3|Overall Study|Adverse Event|3
1452679|NCT00809757|4791257|P2|Overall Study|Adverse Event|3
1452680|NCT00809757|4791258|P1|Overall Study|Adverse Event|2
1452681|NCT00809614|4791343|P2|Overall Study|Withdrawal by Subject|1
1452682|NCT00809614|4791344|P1|Overall Study|Withdrawal by Subject|1
1452683|NCT00809614|4791343|P2|Overall Study|Lack of Efficacy|3
1452684|NCT00809614|4791344|P1|Overall Study|Lack of Efficacy|2
1452685|NCT00809471|4791388|P3|Overall Study|Requirement for restricted medication|0
1452686|NCT00809471|4791389|P2|Overall Study|Requirement for restricted medication|1
1452687|NCT00809471|4791390|P1|Overall Study|Requirement for restricted medication|1
1452688|NCT00809471|4791388|P3|Overall Study|Adverse Event|2
1452689|NCT00809471|4791389|P2|Overall Study|Adverse Event|2
1452690|NCT00809471|4791390|P1|Overall Study|Adverse Event|0
1452691|NCT00809471|4791388|P3|Overall Study|Lost to Follow-up|9
1452692|NCT00809471|4791389|P2|Overall Study|Lost to Follow-up|2
1452693|NCT00809471|4791390|P1|Overall Study|Lost to Follow-up|4
1452694|NCT00809471|4791388|P3|Overall Study|Protocol non-compliance|6
1452695|NCT00809471|4791389|P2|Overall Study|Protocol non-compliance|15
1452696|NCT00809471|4791390|P1|Overall Study|Protocol non-compliance|15
1452697|NCT00809445|4791420|P3|6 Month Follow-up|Withdrew consent|1
1452698|NCT00809445|4791421|P2|6 Month Follow-up|Withdrew consent|0
1452699|NCT00809445|4791422|P1|6 Month Follow-up|Withdrew consent|0
1452700|NCT00809445|4791420|P3|6 Month Follow-up|Incarcerated|8
1452701|NCT00809445|4791421|P2|6 Month Follow-up|Incarcerated|8
1452702|NCT00809445|4791422|P1|6 Month Follow-up|Incarcerated|6
1452703|NCT00809445|4791420|P3|6 Month Follow-up|Death|1
1452704|NCT00809445|4791421|P2|6 Month Follow-up|Death|1
1452705|NCT00809445|4791422|P1|6 Month Follow-up|Death|2
1452706|NCT00809445|4791420|P3|6 Month Follow-up|Lost contact|14
1452707|NCT00809445|4791421|P2|6 Month Follow-up|Lost contact|14
1452708|NCT00809445|4791422|P1|6 Month Follow-up|Lost contact|16
1452709|NCT00809445|4791420|P3|1 Month Follow-up|Incarcerated|1
1452710|NCT00809445|4791421|P2|1 Month Follow-up|Incarcerated|0
1452711|NCT00809445|4791422|P1|1 Month Follow-up|Incarcerated|0
1452712|NCT00809445|4791420|P3|1 Month Follow-up|Death|1
1452713|NCT00809445|4791421|P2|1 Month Follow-up|Death|1
1452714|NCT00809445|4791422|P1|1 Month Follow-up|Death|0
1452715|NCT00809445|4791420|P3|1 Month Follow-up|Withdrew consent|1
1452716|NCT00809445|4791421|P2|1 Month Follow-up|Withdrew consent|1
1452717|NCT00809445|4791422|P1|1 Month Follow-up|Withdrew consent|1
1452718|NCT00809445|4791420|P3|1 Month Follow-up|Lost contact|1
1452719|NCT00809445|4791421|P2|1 Month Follow-up|Lost contact|2
1452720|NCT00809445|4791422|P1|1 Month Follow-up|Lost contact|1
1452721|NCT00809328|4791439|P1|Overall Study|Withdrawal by Subject|2
1452722|NCT00809328|4791439|P1|Overall Study|Protocol Violation|3
1452723|NCT00809328|4791439|P1|Overall Study|Adverse Event|6
1452724|NCT00809328|4791439|P1|Overall Study|Lack of Efficacy|18
1452725|NCT00809159|4791459|P6|Part 1 and 2|Withdrawal by Subject|1
1452726|NCT00809159|4791460|P5|Part 1 and 2|Withdrawal by Subject|0
1452727|NCT00809159|4791461|P4|Part 1 and 2|Withdrawal by Subject|0
1452728|NCT00809159|4791462|P3|Part 1 and 2|Withdrawal by Subject|4
1452729|NCT00809159|4791463|P2|Part 1 and 2|Withdrawal by Subject|0
1452730|NCT00809159|4791464|P1|Part 1 and 2|Withdrawal by Subject|0
1452731|NCT00809159|4791459|P6|Part 1 and 2|Lost to Follow-up|0
1452732|NCT00809159|4791460|P5|Part 1 and 2|Lost to Follow-up|0
1452733|NCT00809159|4791461|P4|Part 1 and 2|Lost to Follow-up|1
1452734|NCT00809159|4791462|P3|Part 1 and 2|Lost to Follow-up|1
1452735|NCT00809159|4791463|P2|Part 1 and 2|Lost to Follow-up|0
1452736|NCT00809159|4791464|P1|Part 1 and 2|Lost to Follow-up|0
1452737|NCT00809159|4791459|P6|Part 1 and 2|Adverse Event|1
1452738|NCT00809159|4791460|P5|Part 1 and 2|Adverse Event|1
1452739|NCT00809159|4791461|P4|Part 1 and 2|Adverse Event|0
1452740|NCT00809159|4791462|P3|Part 1 and 2|Adverse Event|1
1452741|NCT00809159|4791463|P2|Part 1 and 2|Adverse Event|0
1452742|NCT00809159|4791464|P1|Part 1 and 2|Adverse Event|0
1452743|NCT00809159|4791459|P6|Part 1 and 2|Administrative problems|0
1452744|NCT00809159|4791460|P5|Part 1 and 2|Administrative problems|0
1452745|NCT00809159|4791461|P4|Part 1 and 2|Administrative problems|1
1452746|NCT00809159|4791462|P3|Part 1 and 2|Administrative problems|0
1452747|NCT00809159|4791463|P2|Part 1 and 2|Administrative problems|0
1452748|NCT00809159|4791464|P1|Part 1 and 2|Administrative problems|0
1452749|NCT00809159|4791459|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
1452750|NCT00809159|4791460|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
1452751|NCT00809159|4791461|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
1452752|NCT00809159|4791462|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
1452753|NCT00809159|4791463|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
1452754|NCT00809159|4791464|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
1452755|NCT00809159|4791459|P6|Part 1|Unsatisfactory therapeutic effect|0
1452756|NCT00809159|4791460|P5|Part 1|Unsatisfactory therapeutic effect|0
1452757|NCT00809159|4791461|P4|Part 1|Unsatisfactory therapeutic effect|0
1452758|NCT00809159|4791462|P3|Part 1|Unsatisfactory therapeutic effect|0
1452759|NCT00809159|4791463|P2|Part 1|Unsatisfactory therapeutic effect|1
1452760|NCT00809159|4791464|P1|Part 1|Unsatisfactory therapeutic effect|3
1452761|NCT00809159|4791459|P6|Part 1|Withdrawal by Subject|0
1452762|NCT00809159|4791460|P5|Part 1|Withdrawal by Subject|0
1452763|NCT00809159|4791461|P4|Part 1|Withdrawal by Subject|0
1452764|NCT00809159|4791462|P3|Part 1|Withdrawal by Subject|0
1452765|NCT00809159|4791463|P2|Part 1|Withdrawal by Subject|1
1452766|NCT00809159|4791464|P1|Part 1|Withdrawal by Subject|3
1452767|NCT00809159|4791459|P6|Part 1|Lost to Follow-up|0
1452768|NCT00809159|4791460|P5|Part 1|Lost to Follow-up|0
1452769|NCT00809159|4791461|P4|Part 1|Lost to Follow-up|0
1452770|NCT00809159|4791462|P3|Part 1|Lost to Follow-up|0
1452771|NCT00809159|4791463|P2|Part 1|Lost to Follow-up|0
1452772|NCT00809159|4791464|P1|Part 1|Lost to Follow-up|1
1452773|NCT00809159|4791459|P6|Part 1|Adverse Event|0
1452774|NCT00809159|4791460|P5|Part 1|Adverse Event|0
1452775|NCT00809159|4791461|P4|Part 1|Adverse Event|0
1452776|NCT00809159|4791462|P3|Part 1|Adverse Event|0
1452777|NCT00809159|4791463|P2|Part 1|Adverse Event|1
1452778|NCT00809159|4791464|P1|Part 1|Adverse Event|1
1452779|NCT00809133|4791569|P14|Overall Study|Other not mentioned above|0
1452780|NCT00809133|4791570|P13|Overall Study|Other not mentioned above|0
1452781|NCT00809133|4791571|P12|Overall Study|Other not mentioned above|0
1452782|NCT00809133|4791572|P11|Overall Study|Other not mentioned above|0
1452783|NCT00809133|4791573|P10|Overall Study|Other not mentioned above|0
1452784|NCT00809133|4791574|P9|Overall Study|Other not mentioned above|0
1452785|NCT00809133|4791575|P8|Overall Study|Other not mentioned above|0
1452786|NCT00809133|4791576|P7|Overall Study|Other not mentioned above|0
1452787|NCT00809133|4791577|P6|Overall Study|Other not mentioned above|1
1452788|NCT00809133|4791578|P5|Overall Study|Other not mentioned above|0
1452789|NCT00809133|4791579|P4|Overall Study|Other not mentioned above|0
1452790|NCT00809133|4791580|P3|Overall Study|Other not mentioned above|0
1452791|NCT00809133|4791581|P2|Overall Study|Other not mentioned above|1
1452792|NCT00809133|4791582|P1|Overall Study|Other not mentioned above|0
1452793|NCT00809133|4791569|P14|Overall Study|Consent withdrawn|0
1452794|NCT00809133|4791570|P13|Overall Study|Consent withdrawn|0
1452795|NCT00809133|4791571|P12|Overall Study|Consent withdrawn|0
1452796|NCT00809133|4791572|P11|Overall Study|Consent withdrawn|0
1452797|NCT00809133|4791573|P10|Overall Study|Consent withdrawn|0
1452798|NCT00809133|4791574|P9|Overall Study|Consent withdrawn|0
1452799|NCT00809133|4791575|P8|Overall Study|Consent withdrawn|0
1452800|NCT00809133|4791576|P7|Overall Study|Consent withdrawn|0
1452801|NCT00809133|4791577|P6|Overall Study|Consent withdrawn|0
1452802|NCT00809133|4791578|P5|Overall Study|Consent withdrawn|1
1452803|NCT00809133|4791579|P4|Overall Study|Consent withdrawn|0
1452804|NCT00809133|4791580|P3|Overall Study|Consent withdrawn|0
1452805|NCT00809133|4791581|P2|Overall Study|Consent withdrawn|0
1452806|NCT00809133|4791582|P1|Overall Study|Consent withdrawn|0
1452807|NCT00809133|4791569|P14|Overall Study|Lost to Follow-up|0
1452808|NCT00809133|4791570|P13|Overall Study|Lost to Follow-up|0
1452809|NCT00809133|4791571|P12|Overall Study|Lost to Follow-up|0
1452810|NCT00809133|4791572|P11|Overall Study|Lost to Follow-up|0
1452811|NCT00809133|4791573|P10|Overall Study|Lost to Follow-up|0
1452812|NCT00809133|4791574|P9|Overall Study|Lost to Follow-up|0
1452813|NCT00809133|4791575|P8|Overall Study|Lost to Follow-up|0
1452814|NCT00809133|4791576|P7|Overall Study|Lost to Follow-up|0
1452815|NCT00809133|4791577|P6|Overall Study|Lost to Follow-up|1
1452816|NCT00809133|4791578|P5|Overall Study|Lost to Follow-up|0
1452817|NCT00809133|4791579|P4|Overall Study|Lost to Follow-up|0
1452818|NCT00809133|4791580|P3|Overall Study|Lost to Follow-up|0
1452819|NCT00809133|4791581|P2|Overall Study|Lost to Follow-up|0
1452820|NCT00809133|4791582|P1|Overall Study|Lost to Follow-up|0
1452821|NCT00809133|4791569|P14|Overall Study|Other adverse event|1
1452822|NCT00809133|4791570|P13|Overall Study|Other adverse event|0
1452823|NCT00809133|4791571|P12|Overall Study|Other adverse event|1
1452824|NCT00809133|4791572|P11|Overall Study|Other adverse event|1
1452825|NCT00809133|4791573|P10|Overall Study|Other adverse event|0
1452826|NCT00809133|4791574|P9|Overall Study|Other adverse event|0
1452827|NCT00809133|4791575|P8|Overall Study|Other adverse event|4
1452828|NCT00809133|4791576|P7|Overall Study|Other adverse event|2
1452829|NCT00809133|4791577|P6|Overall Study|Other adverse event|3
1452830|NCT00809133|4791578|P5|Overall Study|Other adverse event|0
1452831|NCT00809133|4791579|P4|Overall Study|Other adverse event|0
1452832|NCT00809133|4791580|P3|Overall Study|Other adverse event|1
1452833|NCT00809133|4791581|P2|Overall Study|Other adverse event|1
1452834|NCT00809133|4791582|P1|Overall Study|Other adverse event|1
1452835|NCT00809133|4791569|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
1452836|NCT00809133|4791570|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
1452837|NCT00809133|4791571|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
1452838|NCT00809133|4791572|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
1452839|NCT00809133|4791573|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
1452840|NCT00809133|4791574|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
1452841|NCT00809133|4791575|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
1452842|NCT00809133|4791576|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
1452843|NCT00809133|4791577|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
1452844|NCT00809133|4791578|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
1452845|NCT00809133|4791579|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
1452846|NCT00809133|4791580|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
1452847|NCT00809133|4791581|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
1452848|NCT00809133|4791582|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
1452849|NCT00809133|4791569|P14|Overall Study|Progressive disease|4
1452850|NCT00809133|4791570|P13|Overall Study|Progressive disease|5
1452851|NCT00809133|4791571|P12|Overall Study|Progressive disease|7
1452852|NCT00809133|4791572|P11|Overall Study|Progressive disease|5
1452853|NCT00809133|4791573|P10|Overall Study|Progressive disease|9
1452854|NCT00809133|4791574|P9|Overall Study|Progressive disease|3
1452855|NCT00809133|4791575|P8|Overall Study|Progressive disease|3
1452856|NCT00809133|4791576|P7|Overall Study|Progressive disease|3
1452857|NCT00809133|4791577|P6|Overall Study|Progressive disease|1
1452858|NCT00809133|4791578|P5|Overall Study|Progressive disease|4
1452859|NCT00809133|4791579|P4|Overall Study|Progressive disease|3
1452860|NCT00809133|4791580|P3|Overall Study|Progressive disease|5
1452861|NCT00809133|4791581|P2|Overall Study|Progressive disease|5
1452862|NCT00809133|4791582|P1|Overall Study|Progressive disease|2
1452863|NCT00809094|4791736|P2|Overall Study|Lost to Follow-up|1
1452864|NCT00809094|4791737|P1|Overall Study|Lost to Follow-up|0
1452865|NCT00808899|4791782|P1|Overall Study|Physician Decision|3
1452866|NCT00808899|4791782|P1|Overall Study|Death|1
1452867|NCT00808808|4791796|P3|Overall Study|Employee was not vaccinated.|2255
1452868|NCT00808808|4791797|P2|Overall Study|Employee was not vaccinated.|2268
1452869|NCT00808808|4791798|P1|Overall Study|Employee was not vaccinated.|2686
1452870|NCT00808808|4791796|P3|Overall Study|Vaccinated; survey not completed|302
1452871|NCT00808808|4791797|P2|Overall Study|Vaccinated; survey not completed|169
1452872|NCT00808808|4791798|P1|Overall Study|Vaccinated; survey not completed|131
1452873|NCT00808665|4791833|P2|Overall Study|Medication stopped by resident|1
1452874|NCT00808665|4791834|P1|Overall Study|Medication stopped by resident|0
1452875|NCT00808665|4791833|P2|Overall Study|Physician Decision|1
1452876|NCT00808665|4791834|P1|Overall Study|Physician Decision|3
1452877|NCT00808665|4791833|P2|Overall Study|required an additional procedure|1
1452878|NCT00808665|4791834|P1|Overall Study|required an additional procedure|0
1452879|NCT00808665|4791833|P2|Overall Study|surgery cancelled|0
1452880|NCT00808665|4791834|P1|Overall Study|surgery cancelled|1
1452881|NCT00808665|4791833|P2|Overall Study|only required minimally invasive surgery|0
1452882|NCT00808665|4791834|P1|Overall Study|only required minimally invasive surgery|1
1452883|NCT00808665|4791833|P2|Overall Study|Withdrawal by Subject|0
1452884|NCT00808665|4791834|P1|Overall Study|Withdrawal by Subject|1
1452885|NCT00808639|4791840|P1|Overall Study|Disease progression before surgery.|1
1452886|NCT00808509|4791848|P2|Randomized Phase|Patient refused rescue therapy|3
1452887|NCT00808509|4791849|P1|Randomized Phase|Patient refused rescue therapy|0
1452888|NCT00808509|4791848|P2|Randomized Phase|Reduced methotrexate dose|2
1452889|NCT00808509|4791849|P1|Randomized Phase|Reduced methotrexate dose|1
1452890|NCT00808509|4791848|P2|Randomized Phase|Did not meet eligibility criteria|0
1452891|NCT00808509|4791849|P1|Randomized Phase|Did not meet eligibility criteria|1
1452892|NCT00808483|4791947|P2|From 5 Months to 12 Months|Lack of Efficacy|0
1452893|NCT00808483|4791948|P1|From 5 Months to 12 Months|Lack of Efficacy|1
1452894|NCT00808483|4791947|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
1452895|NCT00808483|4791948|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
1452896|NCT00808483|4791947|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
1452897|NCT00808483|4791948|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
1452898|NCT00808444|4791985|P2|Overall Study|Lost to Follow-up|1
1452899|NCT00808444|4791986|P1|Overall Study|Lost to Follow-up|0
1452900|NCT00808444|4791985|P2|Overall Study|Withdrawal by Subject|0
1452901|NCT00808444|4791986|P1|Overall Study|Withdrawal by Subject|1
1452902|NCT00808249|4792061|P4|Overall Study|All other reasons|1
1452903|NCT00808249|4792062|P3|Overall Study|All other reasons|3
1452904|NCT00808249|4792063|P2|Overall Study|All other reasons|1
1452905|NCT00808249|4792064|P1|Overall Study|All other reasons|2
1452906|NCT00808249|4792061|P4|Overall Study|study specific discontinuation criteria|0
1452907|NCT00808249|4792062|P3|Overall Study|study specific discontinuation criteria|1
1452908|NCT00808249|4792063|P2|Overall Study|study specific discontinuation criteria|0
1452909|NCT00808249|4792064|P1|Overall Study|study specific discontinuation criteria|1
1452910|NCT00808249|4792061|P4|Overall Study|Lack of Efficacy|0
1452911|NCT00808249|4792062|P3|Overall Study|Lack of Efficacy|0
1452912|NCT00808249|4792063|P2|Overall Study|Lack of Efficacy|1
1452913|NCT00808249|4792064|P1|Overall Study|Lack of Efficacy|1
1452914|NCT00808249|4792061|P4|Overall Study|Protocol Violation|0
1452915|NCT00808249|4792062|P3|Overall Study|Protocol Violation|3
1452916|NCT00808249|4792063|P2|Overall Study|Protocol Violation|3
1452917|NCT00808249|4792064|P1|Overall Study|Protocol Violation|3
1452918|NCT00808249|4792061|P4|Overall Study|Withdrawal by Subject|4
1452919|NCT00808249|4792062|P3|Overall Study|Withdrawal by Subject|2
1452920|NCT00808249|4792063|P2|Overall Study|Withdrawal by Subject|0
1452921|NCT00808249|4792064|P1|Overall Study|Withdrawal by Subject|4
1452922|NCT00808249|4792061|P4|Overall Study|Lost to Follow-up|5
1452923|NCT00808249|4792062|P3|Overall Study|Lost to Follow-up|3
1452924|NCT00808249|4792063|P2|Overall Study|Lost to Follow-up|3
1452925|NCT00808249|4792064|P1|Overall Study|Lost to Follow-up|2
1452926|NCT00808249|4792061|P4|Overall Study|Adverse Event|6
1452927|NCT00808249|4792062|P3|Overall Study|Adverse Event|10
1452928|NCT00808249|4792063|P2|Overall Study|Adverse Event|7
1452929|NCT00808249|4792064|P1|Overall Study|Adverse Event|4
1452930|NCT00808236|4792092|P2|Overall Study|Death|30
1452931|NCT00808236|4792093|P1|Overall Study|Death|18
1452932|NCT00808236|4792092|P2|Overall Study|Physician Decision|1
1452933|NCT00808236|4792093|P1|Overall Study|Physician Decision|0
1452934|NCT00808236|4792092|P2|Overall Study|Lost to Follow-up|1
1452935|NCT00808236|4792093|P1|Overall Study|Lost to Follow-up|1
1452936|NCT00808236|4792092|P2|Overall Study|Pre-defined exclusion|3
1452937|NCT00808236|4792093|P1|Overall Study|Pre-defined exclusion|13
1452938|NCT00808236|4792092|P2|Overall Study|Was not resuscitated|56
1452939|NCT00808236|4792093|P1|Overall Study|Was not resuscitated|50
1452940|NCT00808132|4792126|P5|Overall Study|Unsatisfactory response|12
1452941|NCT00808132|4792127|P4|Overall Study|Unsatisfactory response|4
1452942|NCT00808132|4792128|P3|Overall Study|Unsatisfactory response|6
1452943|NCT00808132|4792129|P2|Overall Study|Unsatisfactory response|6
1452944|NCT00808132|4792130|P1|Overall Study|Unsatisfactory response|5
1452945|NCT00808132|4792126|P5|Overall Study|Randomized, but not treated|9
1452946|NCT00808132|4792127|P4|Overall Study|Randomized, but not treated|8
1452947|NCT00808132|4792128|P3|Overall Study|Randomized, but not treated|9
1452948|NCT00808132|4792129|P2|Overall Study|Randomized, but not treated|7
1452949|NCT00808132|4792130|P1|Overall Study|Randomized, but not treated|10
1452950|NCT00808132|4792126|P5|Overall Study|Other|15
1452951|NCT00808132|4792127|P4|Overall Study|Other|2
1452952|NCT00808132|4792128|P3|Overall Study|Other|6
1452953|NCT00808132|4792129|P2|Overall Study|Other|4
1452954|NCT00808132|4792130|P1|Overall Study|Other|6
1452955|NCT00808132|4792126|P5|Overall Study|Withdrawal by Subject|16
1452956|NCT00808132|4792127|P4|Overall Study|Withdrawal by Subject|7
1452957|NCT00808132|4792128|P3|Overall Study|Withdrawal by Subject|2
1452958|NCT00808132|4792129|P2|Overall Study|Withdrawal by Subject|18
1452959|NCT00808132|4792130|P1|Overall Study|Withdrawal by Subject|27
1452960|NCT00808132|4792126|P5|Overall Study|Protocol Violation|5
1452961|NCT00808132|4792127|P4|Overall Study|Protocol Violation|9
1452962|NCT00808132|4792128|P3|Overall Study|Protocol Violation|4
1452963|NCT00808132|4792129|P2|Overall Study|Protocol Violation|9
1452964|NCT00808132|4792130|P1|Overall Study|Protocol Violation|8
1452965|NCT00808132|4792126|P5|Overall Study|Lost to Follow-up|9
1452966|NCT00808132|4792127|P4|Overall Study|Lost to Follow-up|8
1452967|NCT00808132|4792128|P3|Overall Study|Lost to Follow-up|11
1452968|NCT00808132|4792129|P2|Overall Study|Lost to Follow-up|10
1452969|NCT00808132|4792130|P1|Overall Study|Lost to Follow-up|8
1452970|NCT00808132|4792126|P5|Overall Study|Physician Decision|0
1452971|NCT00808132|4792127|P4|Overall Study|Physician Decision|0
1452972|NCT00808132|4792128|P3|Overall Study|Physician Decision|0
1452973|NCT00808132|4792129|P2|Overall Study|Physician Decision|1
1452974|NCT00808132|4792130|P1|Overall Study|Physician Decision|0
1452975|NCT00808132|4792126|P5|Overall Study|Death|1
1452976|NCT00808132|4792127|P4|Overall Study|Death|0
1452977|NCT00808132|4792128|P3|Overall Study|Death|0
1452978|NCT00808132|4792129|P2|Overall Study|Death|0
1452979|NCT00808132|4792130|P1|Overall Study|Death|0
1452980|NCT00808132|4792126|P5|Overall Study|Adverse Event|33
1452981|NCT00808132|4792127|P4|Overall Study|Adverse Event|31
1452982|NCT00808132|4792128|P3|Overall Study|Adverse Event|16
1452983|NCT00808132|4792129|P2|Overall Study|Adverse Event|33
1452984|NCT00808132|4792130|P1|Overall Study|Adverse Event|34
1452985|NCT00808080|4792202|P1|Overall Study|Patients Became Ineligible for infusion|6
1452986|NCT00808067|4792208|P2|Overall Study|Excluded from analysis|19
1452987|NCT00808067|4792209|P1|Overall Study|Excluded from analysis|13
1452988|NCT00808067|4792208|P2|Overall Study|Other reason not defined above|5
1452989|NCT00808067|4792209|P1|Overall Study|Other reason not defined above|5
1452990|NCT00808067|4792208|P2|Overall Study|Site closed for cause|19
1452991|NCT00808067|4792209|P1|Overall Study|Site closed for cause|19
1452992|NCT00808067|4792208|P2|Overall Study|Patient elected|9
1452993|NCT00808067|4792209|P1|Overall Study|Patient elected|7
1452994|NCT00808067|4792208|P2|Overall Study|Protocol Violation|11
1452995|NCT00808067|4792209|P1|Overall Study|Protocol Violation|3
1452996|NCT00808067|4792208|P2|Overall Study|Physician Decision|38
1452997|NCT00808067|4792209|P1|Overall Study|Physician Decision|47
1452998|NCT00808067|4792208|P2|Overall Study|Site closed|3
1452999|NCT00808067|4792209|P1|Overall Study|Site closed|4
1453000|NCT00808067|4792208|P2|Overall Study|Withdrawal by Subject|25
1453001|NCT00808067|4792209|P1|Overall Study|Withdrawal by Subject|21
1453002|NCT00808067|4792208|P2|Overall Study|Procedure|7
1453003|NCT00808067|4792209|P1|Overall Study|Procedure|6
1453004|NCT00808067|4792208|P2|Overall Study|Death|1
1453005|NCT00808067|4792209|P1|Overall Study|Death|1
1453006|NCT00808067|4792208|P2|Overall Study|Missing|0
1453007|NCT00808067|4792209|P1|Overall Study|Missing|1
1453008|NCT00808067|4792208|P2|Overall Study|Patient refused to take study medication|76
1453009|NCT00808067|4792209|P1|Overall Study|Patient refused to take study medication|65
1453010|NCT00808067|4792208|P2|Overall Study|Elevated LFT results|3
1453011|NCT00808067|4792209|P1|Overall Study|Elevated LFT results|7
1453012|NCT00808067|4792208|P2|Overall Study|Reduced creatinine clearance|55
1453013|NCT00808067|4792209|P1|Overall Study|Reduced creatinine clearance|53
1453014|NCT00808067|4792208|P2|Overall Study|Hospitalization due to surgery|40
1453015|NCT00808067|4792209|P1|Overall Study|Hospitalization due to surgery|37
1453016|NCT00808067|4792208|P2|Overall Study|Hospitalization (not including surgery)|17
1453017|NCT00808067|4792209|P1|Overall Study|Hospitalization (not including surgery)|18
1453018|NCT00808067|4792208|P2|Overall Study|Adverse Event|121
1453019|NCT00808067|4792209|P1|Overall Study|Adverse Event|111
1453020|NCT00808067|4792208|P2|Overall Study|Outcome event - other|25
1453021|NCT00808067|4792209|P1|Overall Study|Outcome event - other|33
1453022|NCT00808067|4792208|P2|Overall Study|Major/minor bleed|44
1453023|NCT00808067|4792209|P1|Overall Study|Major/minor bleed|30
1453024|NCT00808028|4792245|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
1453025|NCT00808028|4792246|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
1453026|NCT00808028|4792247|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
1453027|NCT00808028|4792248|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
1453028|NCT00808028|4792245|P4|Stage 2 (Followed up to 48 Months )|Death|0
1453029|NCT00808028|4792246|P3|Stage 2 (Followed up to 48 Months )|Death|1
1453030|NCT00808028|4792247|P2|Stage 2 (Followed up to 48 Months )|Death|0
1453031|NCT00808028|4792248|P1|Stage 2 (Followed up to 48 Months )|Death|0
1453032|NCT00808028|4792245|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
1453033|NCT00808028|4792246|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
1453034|NCT00808028|4792247|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
1453035|NCT00808028|4792248|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
1453036|NCT00808028|4792245|P4|Stage 2 (Followed up to 48 Months )|Other|1
1453037|NCT00808028|4792246|P3|Stage 2 (Followed up to 48 Months )|Other|1
1453038|NCT00808028|4792247|P2|Stage 2 (Followed up to 48 Months )|Other|0
1453039|NCT00808028|4792248|P1|Stage 2 (Followed up to 48 Months )|Other|0
1453040|NCT00808028|4792245|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
1453041|NCT00808028|4792246|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
1453042|NCT00808028|4792247|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
1453043|NCT00808028|4792248|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
1453044|NCT00808028|4792245|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
1453045|NCT00808028|4792246|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
1453046|NCT00808028|4792247|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
1453047|NCT00808028|4792248|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
1453048|NCT00808028|4792245|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
1453049|NCT00808028|4792246|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
1453050|NCT00808028|4792247|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
1453051|NCT00808028|4792248|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
1453052|NCT00808028|4792245|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
1453053|NCT00808028|4792246|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
1453054|NCT00808028|4792247|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
1453055|NCT00808028|4792248|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
1453056|NCT00808028|4792245|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
1453057|NCT00808028|4792246|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
1453058|NCT00808028|4792247|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
1453059|NCT00808028|4792248|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
1453060|NCT00808028|4792245|P4|Stage 1 (6 Months)|Protocol Violation|1
1453061|NCT00808028|4792246|P3|Stage 1 (6 Months)|Protocol Violation|0
1453062|NCT00808028|4792247|P2|Stage 1 (6 Months)|Protocol Violation|0
1453063|NCT00808028|4792248|P1|Stage 1 (6 Months)|Protocol Violation|0
1453064|NCT00808028|4792245|P4|Stage 1 (6 Months)|Lost to Follow-up|0
1453065|NCT00808028|4792246|P3|Stage 1 (6 Months)|Lost to Follow-up|1
1453066|NCT00808028|4792247|P2|Stage 1 (6 Months)|Lost to Follow-up|0
1453067|NCT00808028|4792248|P1|Stage 1 (6 Months)|Lost to Follow-up|1
1453068|NCT00808028|4792245|P4|Stage 1 (6 Months)|Adverse Event|2
1453069|NCT00808028|4792246|P3|Stage 1 (6 Months)|Adverse Event|1
1453070|NCT00808028|4792247|P2|Stage 1 (6 Months)|Adverse Event|0
1453071|NCT00808028|4792248|P1|Stage 1 (6 Months)|Adverse Event|0
1453072|NCT00808028|4792245|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
1453073|NCT00808028|4792246|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
1453074|NCT00808028|4792247|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
1453075|NCT00808028|4792248|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
1453076|NCT00808028|4792245|P4|Stage 1 (6 Months)|Other|4
1453077|NCT00808028|4792246|P3|Stage 1 (6 Months)|Other|2
1453078|NCT00808028|4792247|P2|Stage 1 (6 Months)|Other|0
1453079|NCT00808028|4792248|P1|Stage 1 (6 Months)|Other|1
1453080|NCT00808028|4792245|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
1453081|NCT00808028|4792246|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
1453082|NCT00808028|4792247|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
1453083|NCT00808028|4792248|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
1453084|NCT00808015|4792284|P1|Overall Study|Enrolled but not treated|4
1453085|NCT00808015|4792284|P1|Overall Study|Other|25
1453086|NCT00808015|4792284|P1|Overall Study|Adverse Event|22
1453087|NCT00808015|4792284|P1|Overall Study|Participants not willing to participate|158
1453088|NCT00808015|4792284|P1|Overall Study|Lost to Follow-up|76
1453089|NCT00808015|4792284|P1|Overall Study|Lack of Efficacy|58
1453090|NCT00808015|4792284|P1|Overall Study|Death|1
1453091|NCT00807937|4792313|P4|Overall Study|All other reasons (not provided)|1
1453092|NCT00807937|4792314|P3|Overall Study|All other reasons (not provided)|0
1453093|NCT00807937|4792315|P2|Overall Study|All other reasons (not provided)|4
1453094|NCT00807937|4792316|P1|Overall Study|All other reasons (not provided)|2
1453095|NCT00807937|4792313|P4|Overall Study|Intake of prohibited medicine|0
1453096|NCT00807937|4792314|P3|Overall Study|Intake of prohibited medicine|2
1453097|NCT00807937|4792315|P2|Overall Study|Intake of prohibited medicine|0
1453098|NCT00807937|4792316|P1|Overall Study|Intake of prohibited medicine|0
1453099|NCT00807937|4792313|P4|Overall Study|Lack of Efficacy|2
1453100|NCT00807937|4792314|P3|Overall Study|Lack of Efficacy|1
1453101|NCT00807937|4792315|P2|Overall Study|Lack of Efficacy|0
1453102|NCT00807937|4792316|P1|Overall Study|Lack of Efficacy|0
1453103|NCT00807937|4792313|P4|Overall Study|Lost to Follow-up|1
1453104|NCT00807937|4792314|P3|Overall Study|Lost to Follow-up|2
1453105|NCT00807937|4792315|P2|Overall Study|Lost to Follow-up|0
1453106|NCT00807937|4792316|P1|Overall Study|Lost to Follow-up|4
1453107|NCT00807937|4792313|P4|Overall Study|Withdrawal by Subject|4
1453108|NCT00807937|4792314|P3|Overall Study|Withdrawal by Subject|1
1453109|NCT00807937|4792315|P2|Overall Study|Withdrawal by Subject|4
1453110|NCT00807937|4792316|P1|Overall Study|Withdrawal by Subject|5
1453111|NCT00807937|4792313|P4|Overall Study|Protocol Violation|3
1453112|NCT00807937|4792314|P3|Overall Study|Protocol Violation|3
1453113|NCT00807937|4792315|P2|Overall Study|Protocol Violation|5
1453114|NCT00807937|4792316|P1|Overall Study|Protocol Violation|4
1453115|NCT00807937|4792313|P4|Overall Study|Adverse Event|4
1453116|NCT00807937|4792314|P3|Overall Study|Adverse Event|5
1453117|NCT00807937|4792315|P2|Overall Study|Adverse Event|12
1453118|NCT00807937|4792316|P1|Overall Study|Adverse Event|12
1453119|NCT00807885|4792351|P9|Overall Study|Lost to Follow-up|0
1453120|NCT00807885|4792352|P8|Overall Study|Lost to Follow-up|0
1453121|NCT00807885|4792353|P7|Overall Study|Lost to Follow-up|0
1453122|NCT00807885|4792354|P6|Overall Study|Lost to Follow-up|1
1453123|NCT00807885|4792355|P5|Overall Study|Lost to Follow-up|0
1453124|NCT00807885|4792356|P4|Overall Study|Lost to Follow-up|0
1453125|NCT00807885|4792357|P3|Overall Study|Lost to Follow-up|0
1453126|NCT00807885|4792358|P2|Overall Study|Lost to Follow-up|0
1453127|NCT00807885|4792359|P1|Overall Study|Lost to Follow-up|0
1453128|NCT00807846|4792408|P2|Overall Study|Not Specified|2
1453129|NCT00807846|4792409|P1|Overall Study|Not Specified|1
1453130|NCT00807846|4792408|P2|Overall Study|Withdrawal by Subject|1
1453131|NCT00807846|4792409|P1|Overall Study|Withdrawal by Subject|2
1453132|NCT00807846|4792408|P2|Overall Study|Protocol Violation|1
1453133|NCT00807846|4792409|P1|Overall Study|Protocol Violation|2
1453134|NCT00807846|4792408|P2|Overall Study|Lack of Efficacy|0
1453135|NCT00807846|4792409|P1|Overall Study|Lack of Efficacy|2
1453136|NCT00807846|4792408|P2|Overall Study|Adverse Event|0
1453137|NCT00807846|4792409|P1|Overall Study|Adverse Event|5
1453138|NCT00807573|4792473|P1|Overall Study|Adverse Event|1
1453139|NCT00807573|4792473|P1|Overall Study|Withdrawal by Subject|1
1453140|NCT00807495|4792519|P5|Overall Study|Reason Not Specified|3
1453141|NCT00807495|4792520|P4|Overall Study|Reason Not Specified|0
1453142|NCT00807495|4792521|P3|Overall Study|Reason Not Specified|2
1453143|NCT00807495|4792522|P2|Overall Study|Reason Not Specified|3
1453144|NCT00807495|4792523|P1|Overall Study|Reason Not Specified|0
1453145|NCT00807495|4792519|P5|Overall Study|Withdrawal by Patient|0
1453146|NCT00807495|4792520|P4|Overall Study|Withdrawal by Patient|0
1453147|NCT00807495|4792521|P3|Overall Study|Withdrawal by Patient|1
1453148|NCT00807495|4792522|P2|Overall Study|Withdrawal by Patient|0
1453149|NCT00807495|4792523|P1|Overall Study|Withdrawal by Patient|2
1453150|NCT00807495|4792519|P5|Overall Study|Adverse Event|2
1453151|NCT00807495|4792520|P4|Overall Study|Adverse Event|1
1453152|NCT00807495|4792521|P3|Overall Study|Adverse Event|1
1453153|NCT00807495|4792522|P2|Overall Study|Adverse Event|3
1453154|NCT00807495|4792523|P1|Overall Study|Adverse Event|6
1453155|NCT00807365|4792569|P1|Overall Study|Study Terminated|5
1453156|NCT00807248|4792577|P4|Overall Study|Other Reason|0
1453157|NCT00807248|4792578|P3|Overall Study|Other Reason|2
1453158|NCT00807248|4792579|P2|Overall Study|Other Reason|0
1453159|NCT00807248|4792580|P1|Overall Study|Other Reason|0
1453160|NCT00807248|4792577|P4|Overall Study|Lost to Follow-up|0
1453161|NCT00807248|4792578|P3|Overall Study|Lost to Follow-up|0
1453162|NCT00807248|4792579|P2|Overall Study|Lost to Follow-up|0
1453163|NCT00807248|4792580|P1|Overall Study|Lost to Follow-up|1
1453164|NCT00807248|4792577|P4|Overall Study|Withdrawal of Consent|5
1453165|NCT00807248|4792578|P3|Overall Study|Withdrawal of Consent|5
1453166|NCT00807248|4792579|P2|Overall Study|Withdrawal of Consent|5
1453167|NCT00807248|4792580|P1|Overall Study|Withdrawal of Consent|5
1453168|NCT00807248|4792577|P4|Overall Study|Protocol Violation|0
1453169|NCT00807248|4792578|P3|Overall Study|Protocol Violation|1
1453170|NCT00807248|4792579|P2|Overall Study|Protocol Violation|1
1453171|NCT00807248|4792580|P1|Overall Study|Protocol Violation|0
1453172|NCT00807248|4792577|P4|Overall Study|Lack of Efficacy|3
1453173|NCT00807248|4792578|P3|Overall Study|Lack of Efficacy|8
1453174|NCT00807248|4792579|P2|Overall Study|Lack of Efficacy|4
1453175|NCT00807248|4792580|P1|Overall Study|Lack of Efficacy|14
1453176|NCT00807248|4792577|P4|Overall Study|Adverse Event|6
1453177|NCT00807248|4792578|P3|Overall Study|Adverse Event|2
1453178|NCT00807248|4792579|P2|Overall Study|Adverse Event|2
1453179|NCT00807248|4792580|P1|Overall Study|Adverse Event|1
1453180|NCT00807235|4792624|P2|Overall Study|Adverse Event|0
1453181|NCT00807235|4792625|P1|Overall Study|Adverse Event|1
1453182|NCT00807092|4792670|P2|Overall Study|CGMS data collection failed|1
1453183|NCT00807092|4792671|P1|Overall Study|CGMS data collection failed|0
1453184|NCT00807092|4792670|P2|Overall Study|Withdrawal by Subject|0
1453185|NCT00807092|4792671|P1|Overall Study|Withdrawal by Subject|1
1453186|NCT00807092|4792670|P2|Overall Study|Protocol Violation|2
1453187|NCT00807092|4792671|P1|Overall Study|Protocol Violation|0
1453188|NCT00807092|4792670|P2|Overall Study|Adverse Event|1
1453189|NCT00807092|4792671|P1|Overall Study|Adverse Event|0
1453190|NCT00807040|4792701|P2|Overall Study|Lost to Follow-up|6
1453191|NCT00807040|4792702|P1|Overall Study|Lost to Follow-up|4
1453192|NCT00807040|4792701|P2|Overall Study|Withdrawal by Subject|6
1453193|NCT00807040|4792702|P1|Overall Study|Withdrawal by Subject|8
1453194|NCT00807040|4792701|P2|Overall Study|Death|29
1453195|NCT00807040|4792702|P1|Overall Study|Death|24
1453196|NCT00807014|4792712|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
1453197|NCT00807014|4792713|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
1453198|NCT00807014|4792712|P2|Overall Study|Recovery|0
1453199|NCT00807014|4792713|P1|Overall Study|Recovery|1
1453200|NCT00807014|4792712|P2|Overall Study|Lost to Follow-up|7
1453201|NCT00807014|4792713|P1|Overall Study|Lost to Follow-up|9
1453202|NCT00807014|4792712|P2|Overall Study|Adverse Event|2
1453203|NCT00807014|4792713|P1|Overall Study|Adverse Event|0
1453204|NCT00807014|4792712|P2|Overall Study|Protocol Violation|8
1453205|NCT00807014|4792713|P1|Overall Study|Protocol Violation|2
1453206|NCT00807014|4792712|P2|Overall Study|Participant Considered Disease Not Cured|7
1453207|NCT00807014|4792713|P1|Overall Study|Participant Considered Disease Not Cured|2
1453208|NCT00807014|4792712|P2|Overall Study|Participant Considered Disease Cured|2
1453209|NCT00807014|4792713|P1|Overall Study|Participant Considered Disease Cured|13
1453210|NCT00807001|4792744|P5|Overall Study|Non-compliance|0
1453211|NCT00807001|4792745|P4|Overall Study|Non-compliance|0
1453212|NCT00807001|4792746|P3|Overall Study|Non-compliance|0
1453213|NCT00807001|4792747|P2|Overall Study|Non-compliance|1
1453214|NCT00807001|4792748|P1|Overall Study|Non-compliance|0
1453215|NCT00806988|4792767|P2|Overall Study|Lost to Follow-up|19
1453216|NCT00806988|4792768|P1|Overall Study|Lost to Follow-up|4
1453217|NCT00806988|4792767|P2|Overall Study|Withdrawal by Subject|8
1453218|NCT00806988|4792768|P1|Overall Study|Withdrawal by Subject|8
1453219|NCT00806988|4792767|P2|Overall Study|Death|16
1453220|NCT00806988|4792768|P1|Overall Study|Death|15
1453221|NCT00806819|4792778|P2|Overall Study|Reasons other than stated above|41
1453222|NCT00806819|4792779|P1|Overall Study|Reasons other than stated above|25
1453223|NCT00806819|4792778|P2|Overall Study|Not treated|3
1453224|NCT00806819|4792779|P1|Overall Study|Not treated|6
1453225|NCT00806819|4792778|P2|Overall Study|Withdrawal by Subject|29
1453226|NCT00806819|4792779|P1|Overall Study|Withdrawal by Subject|32
1453227|NCT00806819|4792778|P2|Overall Study|Lost to Follow-up|0
1453228|NCT00806819|4792779|P1|Overall Study|Lost to Follow-up|1
1453229|NCT00806819|4792778|P2|Overall Study|Protocol Violation|4
1453230|NCT00806819|4792779|P1|Overall Study|Protocol Violation|9
1453231|NCT00806819|4792778|P2|Overall Study|Other AE|40
1453232|NCT00806819|4792779|P1|Overall Study|Other AE|38
1453233|NCT00806819|4792778|P2|Overall Study|Worsening or AE of underlying disease|25
1453234|NCT00806819|4792779|P1|Overall Study|Worsening or AE of underlying disease|18
1453235|NCT00806819|4792778|P2|Overall Study|progressive disease (modified RECIST )|216
1453236|NCT00806819|4792779|P1|Overall Study|progressive disease (modified RECIST )|217
1453237|NCT00806624|4792848|P3|Overall Study|discontinued before start of treatment|1
1453238|NCT00806624|4792849|P2|Overall Study|discontinued before start of treatment|0
1453239|NCT00806624|4792850|P1|Overall Study|discontinued before start of treatment|0
1453240|NCT00806624|4792848|P3|Overall Study|Withdrawal by Subject|3
1453241|NCT00806624|4792849|P2|Overall Study|Withdrawal by Subject|3
1453242|NCT00806624|4792850|P1|Overall Study|Withdrawal by Subject|6
1453243|NCT00806624|4792848|P3|Overall Study|Lost to Follow-up|1
1453244|NCT00806624|4792849|P2|Overall Study|Lost to Follow-up|0
1453245|NCT00806624|4792850|P1|Overall Study|Lost to Follow-up|1
1453246|NCT00806624|4792848|P3|Overall Study|Death|1
1453247|NCT00806624|4792849|P2|Overall Study|Death|1
1453248|NCT00806624|4792850|P1|Overall Study|Death|0
1453249|NCT00806624|4792848|P3|Overall Study|Adverse Event|0
1453250|NCT00806624|4792849|P2|Overall Study|Adverse Event|8
1453251|NCT00806624|4792850|P1|Overall Study|Adverse Event|2
1453252|NCT00806585|4792867|P5|Overall Study|Completion status unknown|12
1453253|NCT00806585|4792868|P4|Overall Study|Completion status unknown|4
1453254|NCT00806585|4792869|P3|Overall Study|Completion status unknown|12
1453255|NCT00806585|4792870|P2|Overall Study|Completion status unknown|14
1453256|NCT00806585|4792871|P1|Overall Study|Completion status unknown|15
1453257|NCT00806585|4792867|P5|Overall Study|Withdrawal by Subject|11
1453258|NCT00806585|4792868|P4|Overall Study|Withdrawal by Subject|3
1453259|NCT00806585|4792869|P3|Overall Study|Withdrawal by Subject|9
1453260|NCT00806585|4792870|P2|Overall Study|Withdrawal by Subject|8
1453261|NCT00806585|4792871|P1|Overall Study|Withdrawal by Subject|10
1453262|NCT00806585|4792867|P5|Overall Study|Adverse Event|2
1453263|NCT00806585|4792868|P4|Overall Study|Adverse Event|4
1453264|NCT00806585|4792869|P3|Overall Study|Adverse Event|3
1453265|NCT00806585|4792870|P2|Overall Study|Adverse Event|5
1453266|NCT00806585|4792871|P1|Overall Study|Adverse Event|1
1453267|NCT00806585|4792867|P5|Overall Study|Lack of Efficacy|0
1453268|NCT00806585|4792868|P4|Overall Study|Lack of Efficacy|0
1453269|NCT00806585|4792869|P3|Overall Study|Lack of Efficacy|0
1453270|NCT00806585|4792870|P2|Overall Study|Lack of Efficacy|0
1453271|NCT00806585|4792871|P1|Overall Study|Lack of Efficacy|1
1453272|NCT00806585|4792867|P5|Overall Study|Lost to Follow-up|5
1453273|NCT00806585|4792868|P4|Overall Study|Lost to Follow-up|2
1453274|NCT00806585|4792869|P3|Overall Study|Lost to Follow-up|2
1453275|NCT00806585|4792870|P2|Overall Study|Lost to Follow-up|1
1453276|NCT00806585|4792871|P1|Overall Study|Lost to Follow-up|2
1453277|NCT00806585|4792867|P5|Overall Study|Physician Decision|1
1453278|NCT00806585|4792868|P4|Overall Study|Physician Decision|0
1453279|NCT00806585|4792869|P3|Overall Study|Physician Decision|3
1453280|NCT00806585|4792870|P2|Overall Study|Physician Decision|2
1453281|NCT00806585|4792871|P1|Overall Study|Physician Decision|0
1453282|NCT00806585|4792867|P5|Overall Study|Protocol Violation|0
1453283|NCT00806585|4792868|P4|Overall Study|Protocol Violation|0
1453284|NCT00806585|4792869|P3|Overall Study|Protocol Violation|2
1453285|NCT00806585|4792870|P2|Overall Study|Protocol Violation|1
1453286|NCT00806585|4792871|P1|Overall Study|Protocol Violation|3
1453287|NCT00806585|4792867|P5|Overall Study|Study terminated by Sponsor|0
1453288|NCT00806585|4792868|P4|Overall Study|Study terminated by Sponsor|2
1453289|NCT00806585|4792869|P3|Overall Study|Study terminated by Sponsor|1
1453290|NCT00806585|4792870|P2|Overall Study|Study terminated by Sponsor|0
1453291|NCT00806585|4792871|P1|Overall Study|Study terminated by Sponsor|0
1453292|NCT00806546|4792903|P1|Overall Study|Various|42
1453293|NCT00806546|4792903|P1|Overall Study|Protocol Violation|49
1453294|NCT00806546|4792903|P1|Overall Study|Withdrawal by Subject|75
1453295|NCT00806546|4792903|P1|Overall Study|Adverse Event|74
1453296|NCT00806546|4792903|P1|Overall Study|Lost to Follow-up|32
1453297|NCT00806546|4792903|P1|Overall Study|Enrolled, not treated|35
1453298|NCT00806494|4792907|P1|Overall Study|Withdrawal by Subject|5
1453299|NCT00806494|4792907|P1|Overall Study|Other|30
1453300|NCT00806494|4792907|P1|Overall Study|Lost to Follow-up|10
1453301|NCT00806494|4792907|P1|Overall Study|Lack of Efficacy|6
1453302|NCT00806494|4792907|P1|Overall Study|Adverse Event|29
1453303|NCT00806442|4792931|P2|Overall Study|Withdrawal by Subject|5
1453304|NCT00806442|4792932|P1|Overall Study|Withdrawal by Subject|1
1453305|NCT00806442|4792931|P2|Overall Study|Lost to Follow-up|2
1453306|NCT00806442|4792932|P1|Overall Study|Lost to Follow-up|3
1453307|NCT00806416|4792954|P4|Period 1 - Part II|Withdrawal by Subject|2
1453308|NCT00806416|4792955|P3|Period 1 - Part II|Withdrawal by Subject|0
1453309|NCT00806416|4792956|P2|Period 1 - Part II|Withdrawal by Subject|0
1453310|NCT00806416|4792957|P1|Period 1 - Part II|Withdrawal by Subject|0
1453311|NCT00806416|4792954|P4|Period 1 - Part I|Withdrawal by Subject|0
1453312|NCT00806416|4792955|P3|Period 1 - Part I|Withdrawal by Subject|0
1453313|NCT00806416|4792956|P2|Period 1 - Part I|Withdrawal by Subject|1
1453314|NCT00806416|4792957|P1|Period 1 - Part I|Withdrawal by Subject|3
1453315|NCT00806416|4792954|P4|Period 1 - Part I|Lost to Follow-up|0
1453316|NCT00806416|4792955|P3|Period 1 - Part I|Lost to Follow-up|0
1453317|NCT00806416|4792956|P2|Period 1 - Part I|Lost to Follow-up|2
1453318|NCT00806416|4792957|P1|Period 1 - Part I|Lost to Follow-up|0
1453319|NCT00806416|4792954|P4|Period 1 - Part I|Adverse Event|0
1453320|NCT00806416|4792955|P3|Period 1 - Part I|Adverse Event|0
1453321|NCT00806416|4792956|P2|Period 1 - Part I|Adverse Event|1
1453322|NCT00806416|4792957|P1|Period 1 - Part I|Adverse Event|0
1453323|NCT00806403|4792970|P2|Overall Study|Death|3
1453324|NCT00806403|4792971|P1|Overall Study|Death|4
1453325|NCT00806351|4792994|P2|Overall Study|Death|4
1453326|NCT00806351|4792995|P1|Overall Study|Death|5
1453327|NCT00806260|4793032|P6|Period 3|Pregnancy|0
1453328|NCT00806260|4793033|P5|Period 3|Pregnancy|0
1453329|NCT00806260|4793034|P4|Period 3|Pregnancy|0
1453330|NCT00806260|4793035|P3|Period 3|Pregnancy|0
1453331|NCT00806260|4793036|P2|Period 3|Pregnancy|0
1453332|NCT00806260|4793037|P1|Period 3|Pregnancy|1
1453333|NCT00806260|4793032|P6|Period 3|Protocol Violation|0
1453334|NCT00806260|4793033|P5|Period 3|Protocol Violation|0
1453335|NCT00806260|4793034|P4|Period 3|Protocol Violation|0
1453336|NCT00806260|4793035|P3|Period 3|Protocol Violation|1
1453337|NCT00806260|4793036|P2|Period 3|Protocol Violation|1
1453338|NCT00806260|4793037|P1|Period 3|Protocol Violation|0
1453339|NCT00806260|4793032|P6|Period 2|sponsor request|0
1453340|NCT00806260|4793033|P5|Period 2|sponsor request|0
1453341|NCT00806260|4793034|P4|Period 2|sponsor request|1
1453342|NCT00806260|4793035|P3|Period 2|sponsor request|1
1453343|NCT00806260|4793036|P2|Period 2|sponsor request|0
1453344|NCT00806260|4793037|P1|Period 2|sponsor request|0
1453345|NCT00806260|4793032|P6|Period 2|Need to take concomitant medication|0
1453346|NCT00806260|4793033|P5|Period 2|Need to take concomitant medication|0
1453347|NCT00806260|4793034|P4|Period 2|Need to take concomitant medication|0
1453348|NCT00806260|4793035|P3|Period 2|Need to take concomitant medication|0
1453349|NCT00806260|4793036|P2|Period 2|Need to take concomitant medication|0
1453350|NCT00806260|4793037|P1|Period 2|Need to take concomitant medication|1
1453351|NCT00806260|4793032|P6|Period 2|Protocol Violation|0
1453352|NCT00806260|4793033|P5|Period 2|Protocol Violation|0
1453353|NCT00806260|4793034|P4|Period 2|Protocol Violation|0
1453354|NCT00806260|4793035|P3|Period 2|Protocol Violation|1
1453355|NCT00806260|4793036|P2|Period 2|Protocol Violation|0
1453356|NCT00806260|4793037|P1|Period 2|Protocol Violation|1
1453357|NCT00806260|4793032|P6|Period 2|Adverse Event|0
1453358|NCT00806260|4793033|P5|Period 2|Adverse Event|0
1453359|NCT00806260|4793034|P4|Period 2|Adverse Event|1
1453360|NCT00806260|4793035|P3|Period 2|Adverse Event|0
1453361|NCT00806260|4793036|P2|Period 2|Adverse Event|0
1453362|NCT00806260|4793037|P1|Period 2|Adverse Event|0
1453363|NCT00806260|4793032|P6|Period 1 (1 Day)|Adverse Event|0
1453364|NCT00806260|4793033|P5|Period 1 (1 Day)|Adverse Event|3
1453365|NCT00806260|4793034|P4|Period 1 (1 Day)|Adverse Event|0
1453366|NCT00806260|4793035|P3|Period 1 (1 Day)|Adverse Event|0
1453367|NCT00806260|4793036|P2|Period 1 (1 Day)|Adverse Event|0
1453368|NCT00806260|4793037|P1|Period 1 (1 Day)|Adverse Event|0
1453369|NCT00806195|4793082|P4|Overall Study|Protocol Violation|9
1453370|NCT00806195|4793083|P3|Overall Study|Protocol Violation|26
1453371|NCT00806195|4793084|P2|Overall Study|Protocol Violation|24
1453372|NCT00806195|4793085|P1|Overall Study|Protocol Violation|34
1453373|NCT00806195|4793082|P4|Overall Study|Administrative Reason|26
1453374|NCT00806195|4793083|P3|Overall Study|Administrative Reason|66
1453375|NCT00806195|4793084|P2|Overall Study|Administrative Reason|35
1453376|NCT00806195|4793085|P1|Overall Study|Administrative Reason|113
1453377|NCT00806195|4793082|P4|Overall Study|Inappropriate Enrollment|0
1453378|NCT00806195|4793083|P3|Overall Study|Inappropriate Enrollment|0
1453379|NCT00806195|4793084|P2|Overall Study|Inappropriate Enrollment|1
1453380|NCT00806195|4793085|P1|Overall Study|Inappropriate Enrollment|0
1453381|NCT00806195|4793082|P4|Overall Study|Lost to Follow-up|34
1453382|NCT00806195|4793083|P3|Overall Study|Lost to Follow-up|90
1453383|NCT00806195|4793084|P2|Overall Study|Lost to Follow-up|66
1453384|NCT00806195|4793085|P1|Overall Study|Lost to Follow-up|217
1453385|NCT00806195|4793082|P4|Overall Study|Withdrawal by Subject|35
1453386|NCT00806195|4793083|P3|Overall Study|Withdrawal by Subject|76
1453387|NCT00806195|4793084|P2|Overall Study|Withdrawal by Subject|31
1453388|NCT00806195|4793085|P1|Overall Study|Withdrawal by Subject|119
1453389|NCT00806195|4793082|P4|Overall Study|Adverse Event|2
1453390|NCT00806195|4793083|P3|Overall Study|Adverse Event|11
1453391|NCT00806195|4793084|P2|Overall Study|Adverse Event|5
1453392|NCT00806195|4793085|P1|Overall Study|Adverse Event|25
1453393|NCT00806195|4793082|P4|Overall Study|Death|0
1453394|NCT00806195|4793083|P3|Overall Study|Death|1
1453395|NCT00806195|4793084|P2|Overall Study|Death|0
1453396|NCT00806195|4793085|P1|Overall Study|Death|6
1453397|NCT00806026|4793116|P6|Overall Study|Adverse Event|9
1453398|NCT00806026|4793117|P5|Overall Study|Adverse Event|9
1453399|NCT00806026|4793118|P4|Overall Study|Adverse Event|17
1453400|NCT00806026|4793119|P3|Overall Study|Adverse Event|44
1453401|NCT00806026|4793120|P2|Overall Study|Adverse Event|35
1453402|NCT00806026|4793121|P1|Overall Study|Adverse Event|52
1453403|NCT00806026|4793116|P6|Overall Study|Protocol Violation|3
1453404|NCT00806026|4793117|P5|Overall Study|Protocol Violation|2
1453405|NCT00806026|4793118|P4|Overall Study|Protocol Violation|0
1453406|NCT00806026|4793119|P3|Overall Study|Protocol Violation|9
1453407|NCT00806026|4793120|P2|Overall Study|Protocol Violation|9
1453408|NCT00806026|4793121|P1|Overall Study|Protocol Violation|6
1453409|NCT00806026|4793116|P6|Overall Study|Other|4
1453410|NCT00806026|4793117|P5|Overall Study|Other|0
1453411|NCT00806026|4793118|P4|Overall Study|Other|2
1453412|NCT00806026|4793119|P3|Overall Study|Other|8
1453413|NCT00806026|4793120|P2|Overall Study|Other|6
1453414|NCT00806026|4793121|P1|Overall Study|Other|3
1453415|NCT00806026|4793116|P6|Overall Study|Withdrawal by Subject|3
1453416|NCT00806026|4793117|P5|Overall Study|Withdrawal by Subject|5
1453417|NCT00806026|4793118|P4|Overall Study|Withdrawal by Subject|2
1453418|NCT00806026|4793119|P3|Overall Study|Withdrawal by Subject|9
1453419|NCT00806026|4793120|P2|Overall Study|Withdrawal by Subject|17
1453420|NCT00806026|4793121|P1|Overall Study|Withdrawal by Subject|14
1453421|NCT00806026|4793116|P6|Overall Study|Lost to Follow-up|6
1453422|NCT00806026|4793117|P5|Overall Study|Lost to Follow-up|6
1453423|NCT00806026|4793118|P4|Overall Study|Lost to Follow-up|2
1453424|NCT00806026|4793119|P3|Overall Study|Lost to Follow-up|8
1453425|NCT00806026|4793120|P2|Overall Study|Lost to Follow-up|15
1453426|NCT00806026|4793121|P1|Overall Study|Lost to Follow-up|8
1453427|NCT00806026|4793116|P6|Overall Study|Lack of Efficacy|7
1453428|NCT00806026|4793117|P5|Overall Study|Lack of Efficacy|8
1453429|NCT00806026|4793118|P4|Overall Study|Lack of Efficacy|4
1453430|NCT00806026|4793119|P3|Overall Study|Lack of Efficacy|13
1453431|NCT00806026|4793120|P2|Overall Study|Lack of Efficacy|18
1453432|NCT00806026|4793121|P1|Overall Study|Lack of Efficacy|5
1453433|NCT00806026|4793116|P6|Overall Study|Did not meet entrance criteria|0
1453434|NCT00806026|4793117|P5|Overall Study|Did not meet entrance criteria|0
1453435|NCT00806026|4793118|P4|Overall Study|Did not meet entrance criteria|1
1453436|NCT00806026|4793119|P3|Overall Study|Did not meet entrance criteria|2
1453437|NCT00806026|4793120|P2|Overall Study|Did not meet entrance criteria|1
1453438|NCT00806026|4793121|P1|Overall Study|Did not meet entrance criteria|4
1453439|NCT00806026|4793116|P6|Overall Study|Death|0
1453440|NCT00806026|4793117|P5|Overall Study|Death|0
1453441|NCT00806026|4793118|P4|Overall Study|Death|1
1453442|NCT00806026|4793119|P3|Overall Study|Death|0
1453443|NCT00806026|4793120|P2|Overall Study|Death|0
1453444|NCT00806026|4793121|P1|Overall Study|Death|0
1453445|NCT00805961|4793216|P1|Maintenance Treatment|Withdrawn Consent|1
1453446|NCT00805961|4793216|P1|Maintenance Treatment|Symptomatic Deterioration|2
1453447|NCT00805961|4793216|P1|Maintenance Treatment|Withdrawal by Subject|5
1453448|NCT00805961|4793216|P1|Maintenance Treatment|Adverse Event|6
1453449|NCT00805961|4793216|P1|Maintenance Treatment|Intercurrent Illness|7
1453450|NCT00805961|4793216|P1|Maintenance Treatment|Lack of Efficacy|13
1453451|NCT00805961|4793216|P1|Treatment-Free Interval|Lack of Efficacy|1
1453452|NCT00805961|4793216|P1|Treatment-Free Interval|Physician Decision|1
1453453|NCT00805961|4793216|P1|Treatment-Free Interval|Intercurrent Illness|2
1453454|NCT00805961|4793216|P1|Treatment-Free Interval|Adverse Event|3
1453455|NCT00805961|4793216|P1|Modality Therapy|Disease Progression|2
1453456|NCT00805961|4793216|P1|Modality Therapy|Adverse Event|1
1453457|NCT00805961|4793216|P1|Modality Therapy|Withdrawal by Subject|1
1453458|NCT00805935|4793226|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
1453459|NCT00805935|4793227|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
1453546|NCT00805467|4793442|P1|Overall Study|Not reported|0
1453460|NCT00805935|4793228|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
1453461|NCT00805935|4793229|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
1453462|NCT00805935|4793226|P4|Overall Study|Ectopic pregnancy|0
1453463|NCT00805935|4793227|P3|Overall Study|Ectopic pregnancy|1
1453464|NCT00805935|4793228|P2|Overall Study|Ectopic pregnancy|0
1453465|NCT00805935|4793229|P1|Overall Study|Ectopic pregnancy|0
1453466|NCT00805935|4793226|P4|Overall Study|Chemical pregnancy|2
1453467|NCT00805935|4793227|P3|Overall Study|Chemical pregnancy|3
1453468|NCT00805935|4793228|P2|Overall Study|Chemical pregnancy|5
1453469|NCT00805935|4793229|P1|Overall Study|Chemical pregnancy|0
1453470|NCT00805935|4793226|P4|Overall Study|Biochemical pregnancy|0
1453471|NCT00805935|4793227|P3|Overall Study|Biochemical pregnancy|0
1453472|NCT00805935|4793228|P2|Overall Study|Biochemical pregnancy|1
1453473|NCT00805935|4793229|P1|Overall Study|Biochemical pregnancy|0
1453474|NCT00805935|4793226|P4|Overall Study|Pregnancy loss/miscarriage|0
1453475|NCT00805935|4793227|P3|Overall Study|Pregnancy loss/miscarriage|0
1453476|NCT00805935|4793228|P2|Overall Study|Pregnancy loss/miscarriage|0
1453477|NCT00805935|4793229|P1|Overall Study|Pregnancy loss/miscarriage|2
1453478|NCT00805935|4793226|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
1453479|NCT00805935|4793227|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
1453480|NCT00805935|4793228|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
1453481|NCT00805935|4793229|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
1453482|NCT00805935|4793226|P4|Overall Study|No positive serum pregnancy|5
1453483|NCT00805935|4793227|P3|Overall Study|No positive serum pregnancy|6
1453484|NCT00805935|4793228|P2|Overall Study|No positive serum pregnancy|7
1453485|NCT00805935|4793229|P1|Overall Study|No positive serum pregnancy|8
1453486|NCT00805935|4793226|P4|Overall Study|Lost to Follow-up|0
1453487|NCT00805935|4793227|P3|Overall Study|Lost to Follow-up|0
1453488|NCT00805935|4793228|P2|Overall Study|Lost to Follow-up|0
1453489|NCT00805935|4793229|P1|Overall Study|Lost to Follow-up|1
1453490|NCT00805935|4793226|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
1453491|NCT00805935|4793227|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
1453492|NCT00805935|4793228|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
1453493|NCT00805935|4793229|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
1453494|NCT00805935|4793226|P4|Overall Study|Cycle cancellation for risk of OHSS|0
1453495|NCT00805935|4793227|P3|Overall Study|Cycle cancellation for risk of OHSS|1
1453496|NCT00805935|4793228|P2|Overall Study|Cycle cancellation for risk of OHSS|0
1453497|NCT00805935|4793229|P1|Overall Study|Cycle cancellation for risk of OHSS|1
1453498|NCT00805935|4793226|P4|Overall Study|Cycle cancelled|0
1453499|NCT00805935|4793227|P3|Overall Study|Cycle cancelled|2
1453500|NCT00805935|4793228|P2|Overall Study|Cycle cancelled|0
1453501|NCT00805935|4793229|P1|Overall Study|Cycle cancelled|0
1453502|NCT00805935|4793226|P4|Overall Study|Stimulation Failure|2
1453503|NCT00805935|4793227|P3|Overall Study|Stimulation Failure|2
1453504|NCT00805935|4793228|P2|Overall Study|Stimulation Failure|5
1453505|NCT00805935|4793229|P1|Overall Study|Stimulation Failure|1
1453506|NCT00805792|4793296|P1|Overall Study|Lost to Follow-up|2
1453507|NCT00805792|4793296|P1|Overall Study|Death|3
1453508|NCT00805766|4793304|P1|Increased Dose Period|Withdrawal by Subject|1
1453509|NCT00805766|4793304|P1|Increased Dose Period|Pregnancy|1
1453510|NCT00805766|4793304|P1|Increased Dose Period|Lack of Efficacy|7
1453511|NCT00805766|4793304|P1|Increased Dose Period|Adverse Event|4
1453512|NCT00805766|4793304|P1|Screening Period|Responder|2
1453513|NCT00805766|4793304|P1|Screening Period|Pregnancy|1
1453514|NCT00805766|4793304|P1|Screening Period|Lack of Efficacy|2
1453515|NCT00805766|4793304|P1|Screening Period|Adverse Event|1
1453516|NCT00805740|4793318|P2|Overall Study|Randomized, but not treated|0
1453517|NCT00805740|4793319|P1|Overall Study|Randomized, but not treated|2
1453518|NCT00805740|4793318|P2|Overall Study|Lost to Follow-up|0
1453519|NCT00805740|4793319|P1|Overall Study|Lost to Follow-up|1
1453520|NCT00805740|4793318|P2|Overall Study|Withdrawal by Subject|0
1453521|NCT00805740|4793319|P1|Overall Study|Withdrawal by Subject|1
1453522|NCT00805740|4793318|P2|Overall Study|Death|4
1453523|NCT00805740|4793319|P1|Overall Study|Death|7
1453524|NCT00805675|4793344|P3|Overall Study|Adverse Event|1
1453525|NCT00805675|4793345|P2|Overall Study|Adverse Event|0
1453526|NCT00805675|4793346|P1|Overall Study|Adverse Event|0
1453527|NCT00805545|4793380|P2|Overall Study|Protocol Violation|1
1453528|NCT00805545|4793381|P1|Overall Study|Protocol Violation|3
1453529|NCT00805545|4793380|P2|Overall Study|Protocol Violation|2
1453530|NCT00805545|4793381|P1|Overall Study|Protocol Violation|3
1453531|NCT00805480|4793407|P4|Overall Study|Adverse Event|0
1453532|NCT00805480|4793408|P3|Overall Study|Adverse Event|1
1453533|NCT00805480|4793409|P2|Overall Study|Adverse Event|0
1453534|NCT00805480|4793410|P1|Overall Study|Adverse Event|0
1453535|NCT00805480|4793407|P4|Overall Study|Lost to Follow-up|0
1453536|NCT00805480|4793408|P3|Overall Study|Lost to Follow-up|0
1453537|NCT00805480|4793409|P2|Overall Study|Lost to Follow-up|2
1453538|NCT00805480|4793410|P1|Overall Study|Lost to Follow-up|1
1453539|NCT00805480|4793407|P4|Overall Study|Withdrawal by Subject|5
1453540|NCT00805480|4793408|P3|Overall Study|Withdrawal by Subject|11
1453541|NCT00805480|4793409|P2|Overall Study|Withdrawal by Subject|5
1453542|NCT00805480|4793410|P1|Overall Study|Withdrawal by Subject|13
1453543|NCT00805467|4793439|P4|Overall Study|Not reported|7
1453544|NCT00805467|4793440|P3|Overall Study|Not reported|3
1453545|NCT00805467|4793441|P2|Overall Study|Not reported|0
1453547|NCT00805467|4793439|P4|Overall Study|Physician Decision|6
1453548|NCT00805467|4793440|P3|Overall Study|Physician Decision|2
1453549|NCT00805467|4793441|P2|Overall Study|Physician Decision|1
1453550|NCT00805467|4793442|P1|Overall Study|Physician Decision|0
1453551|NCT00805467|4793439|P4|Overall Study|Death|5
1453552|NCT00805467|4793440|P3|Overall Study|Death|7
1453553|NCT00805467|4793441|P2|Overall Study|Death|2
1453554|NCT00805467|4793442|P1|Overall Study|Death|0
1453555|NCT00805467|4793439|P4|Overall Study|Adverse Event|57
1453556|NCT00805467|4793440|P3|Overall Study|Adverse Event|26
1453557|NCT00805467|4793441|P2|Overall Study|Adverse Event|13
1453558|NCT00805467|4793442|P1|Overall Study|Adverse Event|0
1453559|NCT00805467|4793439|P4|Overall Study|Protocol Violation|5
1453560|NCT00805467|4793440|P3|Overall Study|Protocol Violation|0
1453561|NCT00805467|4793441|P2|Overall Study|Protocol Violation|3
1453562|NCT00805467|4793442|P1|Overall Study|Protocol Violation|0
1453563|NCT00805467|4793439|P4|Overall Study|Withdrawal by Subject|50
1453564|NCT00805467|4793440|P3|Overall Study|Withdrawal by Subject|45
1453565|NCT00805467|4793441|P2|Overall Study|Withdrawal by Subject|6
1453566|NCT00805467|4793442|P1|Overall Study|Withdrawal by Subject|0
1453567|NCT00805467|4793439|P4|Overall Study|Lost to Follow-up|21
1453568|NCT00805467|4793440|P3|Overall Study|Lost to Follow-up|7
1453569|NCT00805467|4793441|P2|Overall Study|Lost to Follow-up|1
1453570|NCT00805467|4793442|P1|Overall Study|Lost to Follow-up|0
1453571|NCT00805467|4793439|P4|Overall Study|Lack of Efficacy|86
1453572|NCT00805467|4793440|P3|Overall Study|Lack of Efficacy|13
1453573|NCT00805467|4793441|P2|Overall Study|Lack of Efficacy|8
1453574|NCT00805467|4793442|P1|Overall Study|Lack of Efficacy|0
1453575|NCT00805441|4793462|P2|Overall Study|Acute Alcohol Withdrawal|1
1453576|NCT00805441|4793463|P1|Overall Study|Acute Alcohol Withdrawal|0
1453577|NCT00805441|4793462|P2|Overall Study|Physician Decision|1
1453578|NCT00805441|4793463|P1|Overall Study|Physician Decision|0
1453579|NCT00805441|4793462|P2|Overall Study|Withdrawal by Subject|9
1453580|NCT00805441|4793463|P1|Overall Study|Withdrawal by Subject|15
1453581|NCT00805441|4793462|P2|Overall Study|Lost to Follow-up|13
1453582|NCT00805441|4793463|P1|Overall Study|Lost to Follow-up|10
1453583|NCT00805441|4793462|P2|Overall Study|Protocol Violation|8
1453584|NCT00805441|4793463|P1|Overall Study|Protocol Violation|4
1453585|NCT00805441|4793462|P2|Overall Study|Lack of Efficacy|2
1453586|NCT00805441|4793463|P1|Overall Study|Lack of Efficacy|0
1453587|NCT00805441|4793462|P2|Overall Study|Adverse Event|2
1453588|NCT00805441|4793463|P1|Overall Study|Adverse Event|5
1453589|NCT00805389|4793498|P5|Overall Study|Withdrawal by Subject|4
1453590|NCT00805389|4793499|P4|Overall Study|Withdrawal by Subject|5
1453591|NCT00805389|4793500|P3|Overall Study|Withdrawal by Subject|4
1453592|NCT00805389|4793501|P2|Overall Study|Withdrawal by Subject|2
1453593|NCT00805389|4793502|P1|Overall Study|Withdrawal by Subject|3
1453594|NCT00805389|4793498|P5|Overall Study|Protocol Violation|0
1453595|NCT00805389|4793499|P4|Overall Study|Protocol Violation|0
1453596|NCT00805389|4793500|P3|Overall Study|Protocol Violation|1
1453597|NCT00805389|4793501|P2|Overall Study|Protocol Violation|0
1453598|NCT00805389|4793502|P1|Overall Study|Protocol Violation|0
1453599|NCT00805389|4793498|P5|Overall Study|Lost to Follow-up|9
1453600|NCT00805389|4793499|P4|Overall Study|Lost to Follow-up|10
1453601|NCT00805389|4793500|P3|Overall Study|Lost to Follow-up|6
1453602|NCT00805389|4793501|P2|Overall Study|Lost to Follow-up|3
1453603|NCT00805389|4793502|P1|Overall Study|Lost to Follow-up|4
1453604|NCT00805389|4793498|P5|Overall Study|Adverse Event|0
1453605|NCT00805389|4793499|P4|Overall Study|Adverse Event|2
1453606|NCT00805389|4793500|P3|Overall Study|Adverse Event|1
1453607|NCT00805389|4793501|P2|Overall Study|Adverse Event|0
1453608|NCT00805389|4793502|P1|Overall Study|Adverse Event|0
1453609|NCT00805285|4793749|P1|Overall Study|Lack of Efficacy|1
1453610|NCT00805207|4793766|P9|Overall Study|Withdrawal by Subject|0
1453611|NCT00805207|4793767|P8|Overall Study|Withdrawal by Subject|0
1453612|NCT00805207|4793768|P7|Overall Study|Withdrawal by Subject|0
1453613|NCT00805207|4793769|P6|Overall Study|Withdrawal by Subject|2
1453614|NCT00805207|4793770|P5|Overall Study|Withdrawal by Subject|1
1453615|NCT00805207|4793771|P4|Overall Study|Withdrawal by Subject|0
1453616|NCT00805207|4793772|P3|Overall Study|Withdrawal by Subject|0
1453617|NCT00805207|4793773|P2|Overall Study|Withdrawal by Subject|1
1453618|NCT00805207|4793774|P1|Overall Study|Withdrawal by Subject|0
1453619|NCT00805207|4793766|P9|Overall Study|Physician Decision|0
1453620|NCT00805207|4793767|P8|Overall Study|Physician Decision|0
1453621|NCT00805207|4793768|P7|Overall Study|Physician Decision|0
1453622|NCT00805207|4793769|P6|Overall Study|Physician Decision|1
1453623|NCT00805207|4793770|P5|Overall Study|Physician Decision|0
1453624|NCT00805207|4793771|P4|Overall Study|Physician Decision|0
1453625|NCT00805207|4793772|P3|Overall Study|Physician Decision|0
1453626|NCT00805207|4793773|P2|Overall Study|Physician Decision|1
1453627|NCT00805207|4793774|P1|Overall Study|Physician Decision|0
1453628|NCT00805207|4793766|P9|Overall Study|Protocol Violation|0
1453629|NCT00805207|4793767|P8|Overall Study|Protocol Violation|0
1453630|NCT00805207|4793768|P7|Overall Study|Protocol Violation|0
1453631|NCT00805207|4793769|P6|Overall Study|Protocol Violation|0
1453632|NCT00805207|4793770|P5|Overall Study|Protocol Violation|0
1453633|NCT00805207|4793771|P4|Overall Study|Protocol Violation|0
1453634|NCT00805207|4793772|P3|Overall Study|Protocol Violation|1
1453635|NCT00805207|4793773|P2|Overall Study|Protocol Violation|0
1453636|NCT00805207|4793774|P1|Overall Study|Protocol Violation|0
1453637|NCT00805194|4793832|P2|Overall Study|Reasons other than stated above|16
1453638|NCT00805194|4793833|P1|Overall Study|Reasons other than stated above|20
1453639|NCT00805194|4793832|P2|Overall Study|Not treated|4
1453640|NCT00805194|4793833|P1|Overall Study|Not treated|3
1453641|NCT00805194|4793832|P2|Overall Study|Withdrawal by Subject|42
1453642|NCT00805194|4793833|P1|Overall Study|Withdrawal by Subject|60
1453643|NCT00805194|4793832|P2|Overall Study|Lost to Follow-up|5
1453644|NCT00805194|4793833|P1|Overall Study|Lost to Follow-up|5
1453645|NCT00805194|4793832|P2|Overall Study|Protocol Violation|9
1453646|NCT00805194|4793833|P1|Overall Study|Protocol Violation|9
1453647|NCT00805194|4793832|P2|Overall Study|Other AE|73
1453648|NCT00805194|4793833|P1|Overall Study|Other AE|84
1453649|NCT00805194|4793832|P2|Overall Study|Worsening or AE of underlying disease|70
1453650|NCT00805194|4793833|P1|Overall Study|Worsening or AE of underlying disease|64
1453651|NCT00805194|4793832|P2|Overall Study|Progressive disease (modified RECIST)|435
1453652|NCT00805194|4793833|P1|Overall Study|Progressive disease (modified RECIST)|404
1453653|NCT00805142|4793867|P2|Maintenance Period|Other|1
1453654|NCT00805142|4793868|P1|Maintenance Period|Other|0
1453655|NCT00805142|4793867|P2|Maintenance Period|Adverse Event|1
1453656|NCT00805142|4793868|P1|Maintenance Period|Adverse Event|0
1453657|NCT00805142|4793867|P2|Titration Period|Other|3
1453658|NCT00805142|4793868|P1|Titration Period|Other|0
1453659|NCT00805142|4793867|P2|Titration Period|Withdrawal of consent|1
1453660|NCT00805142|4793868|P1|Titration Period|Withdrawal of consent|0
1453661|NCT00805142|4793867|P2|Titration Period|Disease Progression|1
1453662|NCT00805142|4793868|P1|Titration Period|Disease Progression|2
1453663|NCT00805142|4793867|P2|Titration Period|Lost to Follow-up|1
1453664|NCT00805142|4793868|P1|Titration Period|Lost to Follow-up|0
1453665|NCT00805142|4793867|P2|Titration Period|Lack of Efficacy|1
1453666|NCT00805142|4793868|P1|Titration Period|Lack of Efficacy|1
1453667|NCT00805142|4793867|P2|Titration Period|Adverse Event|3
1453668|NCT00805142|4793868|P1|Titration Period|Adverse Event|3
1453669|NCT00805025|4793901|P1|Overall Study|Physician Decision|1
1453670|NCT00805025|4793901|P1|Overall Study|Withdrawal by Subject|2
1453671|NCT00805025|4793901|P1|Overall Study|Adverse Event|4
1453672|NCT00805025|4793901|P1|Overall Study|Screened but not enrolled/treated|42
1453673|NCT00804986|4793930|P6|Overall Study|Physician Decision|0
1453674|NCT00804986|4793931|P5|Overall Study|Physician Decision|0
1453675|NCT00804986|4793932|P4|Overall Study|Physician Decision|0
1453676|NCT00804986|4793933|P3|Overall Study|Physician Decision|0
1453677|NCT00804986|4793934|P2|Overall Study|Physician Decision|0
1453678|NCT00804986|4793935|P1|Overall Study|Physician Decision|1
1453679|NCT00804986|4793930|P6|Overall Study|Sponsor Decision|0
1453680|NCT00804986|4793931|P5|Overall Study|Sponsor Decision|0
1453681|NCT00804986|4793932|P4|Overall Study|Sponsor Decision|0
1453682|NCT00804986|4793933|P3|Overall Study|Sponsor Decision|0
1453683|NCT00804986|4793934|P2|Overall Study|Sponsor Decision|1
1453684|NCT00804986|4793935|P1|Overall Study|Sponsor Decision|0
1453685|NCT00804986|4793930|P6|Overall Study|Inclusion/Exclusion criteria not met|1
1453686|NCT00804986|4793931|P5|Overall Study|Inclusion/Exclusion criteria not met|0
1453687|NCT00804986|4793932|P4|Overall Study|Inclusion/Exclusion criteria not met|1
1453688|NCT00804986|4793933|P3|Overall Study|Inclusion/Exclusion criteria not met|0
1453689|NCT00804986|4793934|P2|Overall Study|Inclusion/Exclusion criteria not met|2
1453690|NCT00804986|4793935|P1|Overall Study|Inclusion/Exclusion criteria not met|0
1453691|NCT00804986|4793930|P6|Overall Study|Withdrawal by Subject|3
1453692|NCT00804986|4793931|P5|Overall Study|Withdrawal by Subject|5
1453693|NCT00804986|4793932|P4|Overall Study|Withdrawal by Subject|3
1453694|NCT00804986|4793933|P3|Overall Study|Withdrawal by Subject|0
1453695|NCT00804986|4793934|P2|Overall Study|Withdrawal by Subject|3
1453696|NCT00804986|4793935|P1|Overall Study|Withdrawal by Subject|0
1453697|NCT00804986|4793930|P6|Overall Study|Protocol Violation|0
1453698|NCT00804986|4793931|P5|Overall Study|Protocol Violation|0
1453699|NCT00804986|4793932|P4|Overall Study|Protocol Violation|1
1453700|NCT00804986|4793933|P3|Overall Study|Protocol Violation|0
1453701|NCT00804986|4793934|P2|Overall Study|Protocol Violation|1
1453702|NCT00804986|4793935|P1|Overall Study|Protocol Violation|0
1453703|NCT00804986|4793930|P6|Overall Study|Lost to Follow-up|3
1453704|NCT00804986|4793931|P5|Overall Study|Lost to Follow-up|1
1453705|NCT00804986|4793932|P4|Overall Study|Lost to Follow-up|1
1453706|NCT00804986|4793933|P3|Overall Study|Lost to Follow-up|0
1453707|NCT00804986|4793934|P2|Overall Study|Lost to Follow-up|0
1453708|NCT00804986|4793935|P1|Overall Study|Lost to Follow-up|0
1453709|NCT00804986|4793930|P6|Overall Study|Lack of Efficacy|3
1453710|NCT00804986|4793931|P5|Overall Study|Lack of Efficacy|0
1453711|NCT00804986|4793932|P4|Overall Study|Lack of Efficacy|1
1453712|NCT00804986|4793933|P3|Overall Study|Lack of Efficacy|0
1453713|NCT00804986|4793934|P2|Overall Study|Lack of Efficacy|0
1453714|NCT00804986|4793935|P1|Overall Study|Lack of Efficacy|0
1453715|NCT00804986|4793930|P6|Overall Study|Adverse Event|0
1453716|NCT00804986|4793931|P5|Overall Study|Adverse Event|3
1453717|NCT00804986|4793932|P4|Overall Study|Adverse Event|1
1453718|NCT00804986|4793933|P3|Overall Study|Adverse Event|2
1453719|NCT00804986|4793934|P2|Overall Study|Adverse Event|1
1453720|NCT00804986|4793935|P1|Overall Study|Adverse Event|0
1453721|NCT00804908|4794030|P3|Overall Study|Not specified|114
1453722|NCT00804908|4794031|P2|Overall Study|Not specified|116
1453723|NCT00804908|4794032|P1|Overall Study|Not specified|115
1453724|NCT00804843|4794063|P2|Overall Study|Withdrawal by Subject|2
1453725|NCT00804843|4794064|P1|Overall Study|Withdrawal by Subject|1
1453726|NCT00804843|4794063|P2|Overall Study|Adverse Event|5
1453727|NCT00804843|4794064|P1|Overall Study|Adverse Event|8
1453728|NCT00804843|4794063|P2|Overall Study|Protocol Violation|0
1453729|NCT00804843|4794064|P1|Overall Study|Protocol Violation|1
1453730|NCT00804687|4794082|P6|Period 5: Treatment Period|Positive drug test|0
1453731|NCT00804687|4794083|P5|Period 5: Treatment Period|Positive drug test|0
1453732|NCT00804687|4794084|P4|Period 5: Treatment Period|Positive drug test|0
1453733|NCT00804687|4794085|P3|Period 5: Treatment Period|Positive drug test|0
1453734|NCT00804687|4794086|P2|Period 5: Treatment Period|Positive drug test|0
1453735|NCT00804687|4794087|P1|Period 5: Treatment Period|Positive drug test|1
1453736|NCT00804687|4794082|P6|Period 5: Treatment Period|Positive drugs of abuse|0
1453737|NCT00804687|4794083|P5|Period 5: Treatment Period|Positive drugs of abuse|0
1453738|NCT00804687|4794084|P4|Period 5: Treatment Period|Positive drugs of abuse|0
1453739|NCT00804687|4794085|P3|Period 5: Treatment Period|Positive drugs of abuse|1
1453740|NCT00804687|4794086|P2|Period 5: Treatment Period|Positive drugs of abuse|0
1453741|NCT00804687|4794087|P1|Period 5: Treatment Period|Positive drugs of abuse|0
1453742|NCT00804687|4794082|P6|Period 5: Treatment Period|Withdrawal by Subject|0
1453743|NCT00804687|4794083|P5|Period 5: Treatment Period|Withdrawal by Subject|1
1453744|NCT00804687|4794084|P4|Period 5: Treatment Period|Withdrawal by Subject|0
1453745|NCT00804687|4794085|P3|Period 5: Treatment Period|Withdrawal by Subject|0
1453746|NCT00804687|4794086|P2|Period 5: Treatment Period|Withdrawal by Subject|0
1453747|NCT00804687|4794087|P1|Period 5: Treatment Period|Withdrawal by Subject|0
1453748|NCT00804687|4794082|P6|Period 3: Treatment Period|Positive Drug screen|0
1453749|NCT00804687|4794083|P5|Period 3: Treatment Period|Positive Drug screen|0
1453750|NCT00804687|4794084|P4|Period 3: Treatment Period|Positive Drug screen|1
1453751|NCT00804687|4794085|P3|Period 3: Treatment Period|Positive Drug screen|0
1453752|NCT00804687|4794086|P2|Period 3: Treatment Period|Positive Drug screen|0
1453753|NCT00804687|4794087|P1|Period 3: Treatment Period|Positive Drug screen|0
1453754|NCT00804570|4794166|P2|Overall Study|Withdrawal by Subject|38
1453755|NCT00804570|4794167|P1|Overall Study|Withdrawal by Subject|21
1453756|NCT00804570|4794166|P2|Overall Study|Sponsor decision|4
1453757|NCT00804570|4794167|P1|Overall Study|Sponsor decision|1
1453758|NCT00804570|4794166|P2|Overall Study|Physician Decision|2
1453759|NCT00804570|4794167|P1|Overall Study|Physician Decision|1
1453760|NCT00804570|4794166|P2|Overall Study|Protocol Violation|16
1453761|NCT00804570|4794167|P1|Overall Study|Protocol Violation|12
1453762|NCT00804570|4794166|P2|Overall Study|Entry criteria not met|5
1453763|NCT00804570|4794167|P1|Overall Study|Entry criteria not met|5
1453764|NCT00804570|4794166|P2|Overall Study|Lost to Follow-up|21
1453765|NCT00804570|4794167|P1|Overall Study|Lost to Follow-up|18
1453766|NCT00804570|4794166|P2|Overall Study|Lack of Efficacy|1
1453767|NCT00804570|4794167|P1|Overall Study|Lack of Efficacy|0
1453768|NCT00804570|4794166|P2|Overall Study|Adverse Event|7
1453769|NCT00804570|4794167|P1|Overall Study|Adverse Event|14
1453770|NCT00804193|4794226|P3|Overall Study|Withdrawal by Subject|2
1453771|NCT00804193|4794227|P2|Overall Study|Withdrawal by Subject|1
1453772|NCT00804193|4794228|P1|Overall Study|Withdrawal by Subject|3
1453773|NCT00804193|4794226|P3|Overall Study|Lost to Follow-up|4
1453774|NCT00804193|4794227|P2|Overall Study|Lost to Follow-up|3
1453775|NCT00804193|4794228|P1|Overall Study|Lost to Follow-up|3
1453776|NCT00804193|4794226|P3|Overall Study|Protocol Violation|2
1453777|NCT00804193|4794227|P2|Overall Study|Protocol Violation|8
1453778|NCT00804193|4794228|P1|Overall Study|Protocol Violation|0
1453779|NCT00804193|4794226|P3|Overall Study|Lack of Efficacy|3
1453780|NCT00804193|4794227|P2|Overall Study|Lack of Efficacy|1
1453781|NCT00804193|4794228|P1|Overall Study|Lack of Efficacy|1
1453782|NCT00804193|4794226|P3|Overall Study|Adverse Event|2
1453783|NCT00804193|4794227|P2|Overall Study|Adverse Event|0
1453784|NCT00804193|4794228|P1|Overall Study|Adverse Event|0
1453785|NCT00804193|4794226|P3|Overall Study|Lack of baseline fungus|19
1453786|NCT00804193|4794227|P2|Overall Study|Lack of baseline fungus|31
1453787|NCT00804193|4794228|P1|Overall Study|Lack of baseline fungus|32
1453788|NCT00803790|4794277|P4|Period 2|Positive Drug Screen or Personal Reasons|0
1453789|NCT00803790|4794278|P3|Period 2|Positive Drug Screen or Personal Reasons|0
1453790|NCT00803790|4794279|P2|Period 2|Positive Drug Screen or Personal Reasons|0
1453791|NCT00803790|4794280|P1|Period 2|Positive Drug Screen or Personal Reasons|1
1453792|NCT00803790|4794277|P4|Period 2|Withdrawal by Subject|0
1453793|NCT00803790|4794278|P3|Period 2|Withdrawal by Subject|0
1453794|NCT00803790|4794279|P2|Period 2|Withdrawal by Subject|0
1453795|NCT00803790|4794280|P1|Period 2|Withdrawal by Subject|1
1453796|NCT00803790|4794277|P4|Period 2|Adverse Event|1
1453797|NCT00803790|4794278|P3|Period 2|Adverse Event|1
1453798|NCT00803790|4794279|P2|Period 2|Adverse Event|0
1453799|NCT00803790|4794280|P1|Period 2|Adverse Event|0
1453800|NCT00803790|4794277|P4|Period 1|Protocol Violation|0
1453801|NCT00803790|4794278|P3|Period 1|Protocol Violation|1
1453802|NCT00803790|4794279|P2|Period 1|Protocol Violation|0
1453803|NCT00803790|4794280|P1|Period 1|Protocol Violation|0
1453804|NCT00803790|4794277|P4|Period 1|positive drug screen or personal reasons|4
1453805|NCT00803790|4794278|P3|Period 1|positive drug screen or personal reasons|0
1453806|NCT00803790|4794279|P2|Period 1|positive drug screen or personal reasons|3
1453807|NCT00803790|4794280|P1|Period 1|positive drug screen or personal reasons|0
1453808|NCT00803790|4794277|P4|Period 1|Withdrawal by Subject|0
1453809|NCT00803790|4794278|P3|Period 1|Withdrawal by Subject|0
1453810|NCT00803790|4794279|P2|Period 1|Withdrawal by Subject|6
1453811|NCT00803790|4794280|P1|Period 1|Withdrawal by Subject|8
1453812|NCT00803790|4794277|P4|Period 1|Lost to Follow-up|0
1453813|NCT00803790|4794278|P3|Period 1|Lost to Follow-up|0
1453814|NCT00803790|4794279|P2|Period 1|Lost to Follow-up|2
1453815|NCT00803790|4794280|P1|Period 1|Lost to Follow-up|1
1453816|NCT00803790|4794277|P4|Period 1|Adverse Event|0
1453817|NCT00803790|4794278|P3|Period 1|Adverse Event|0
1453818|NCT00803790|4794279|P2|Period 1|Adverse Event|1
1453819|NCT00803790|4794280|P1|Period 1|Adverse Event|0
1453820|NCT00803738|4794320|P2|Overall Study|Positive Results for STD or abnormal PAP|8
1453821|NCT00803738|4794321|P1|Overall Study|Positive Results for STD or abnormal PAP|2
1453822|NCT00803738|4794320|P2|Overall Study|Negative Baseline Culture of Candida|63
1453823|NCT00803738|4794321|P1|Overall Study|Negative Baseline Culture of Candida|56
1453824|NCT00803738|4794320|P2|Overall Study|Lack of Efficacy|16
1453825|NCT00803738|4794321|P1|Overall Study|Lack of Efficacy|10
1453826|NCT00803738|4794320|P2|Overall Study|Withdrawal by Subject|4
1453827|NCT00803738|4794321|P1|Overall Study|Withdrawal by Subject|1
1453828|NCT00803738|4794320|P2|Overall Study|Protocol Violation|10
1453829|NCT00803738|4794321|P1|Overall Study|Protocol Violation|18
1453830|NCT00803738|4794320|P2|Overall Study|Lost to Follow-up|4
1453831|NCT00803738|4794321|P1|Overall Study|Lost to Follow-up|4
1453832|NCT00803738|4794320|P2|Overall Study|Adverse Event|5
1453833|NCT00803738|4794321|P1|Overall Study|Adverse Event|3
1453834|NCT00803712|4794333|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
1453835|NCT00803712|4794334|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
1453836|NCT00803712|4794333|P2|Overall Study|Administrative decision|3
1453837|NCT00803712|4794334|P1|Overall Study|Administrative decision|2
1453838|NCT00803712|4794333|P2|Overall Study|Protocol criteria (renal transplant)|8
1453839|NCT00803712|4794334|P1|Overall Study|Protocol criteria (renal transplant)|12
1453840|NCT00803712|4794333|P2|Overall Study|Protocol criteria (other)|2
1453841|NCT00803712|4794334|P1|Overall Study|Protocol criteria (other)|0
1453842|NCT00803712|4794333|P2|Overall Study|"Other in electronic Case Report Form"|1
1453843|NCT00803712|4794334|P1|Overall Study|"Other in electronic Case Report Form"|0
1453844|NCT00803712|4794333|P2|Overall Study|Withdrawal by Subject|4
1453845|NCT00803712|4794334|P1|Overall Study|Withdrawal by Subject|2
1453846|NCT00803712|4794333|P2|Overall Study|Lost to Follow-up|1
1453847|NCT00803712|4794334|P1|Overall Study|Lost to Follow-up|3
1453848|NCT00803712|4794333|P2|Overall Study|Death|7
1453849|NCT00803712|4794334|P1|Overall Study|Death|8
1453850|NCT00803712|4794333|P2|Overall Study|Adverse Event|0
1453851|NCT00803712|4794334|P1|Overall Study|Adverse Event|5
1453852|NCT00803712|4794333|P2|Overall Study|Noncompliance|0
1453853|NCT00803712|4794334|P1|Overall Study|Noncompliance|3
1453854|NCT00803634|4794433|P2|Overall Study|Death|2
1453855|NCT00803634|4794434|P1|Overall Study|Death|3
1453856|NCT00803634|4794433|P2|Overall Study|Lost to Follow-up|3
1453857|NCT00803634|4794434|P1|Overall Study|Lost to Follow-up|2
1453858|NCT00803634|4794433|P2|Overall Study|Withdrew Consent|0
1453859|NCT00803634|4794434|P1|Overall Study|Withdrew Consent|1
1453860|NCT00803595|4794463|P3|Overall Study|Withdrawal by Subject|3
1453861|NCT00803595|4794464|P2|Overall Study|Withdrawal by Subject|2
1453862|NCT00803595|4794465|P1|Overall Study|Withdrawal by Subject|5
1453863|NCT00803595|4794463|P3|Overall Study|Protocol Violation|12
1453864|NCT00803595|4794464|P2|Overall Study|Protocol Violation|2
1453865|NCT00803595|4794465|P1|Overall Study|Protocol Violation|7
1453866|NCT00803595|4794463|P3|Overall Study|Adverse Event|1
1453867|NCT00803595|4794464|P2|Overall Study|Adverse Event|4
1453868|NCT00803595|4794465|P1|Overall Study|Adverse Event|3
1453869|NCT00803452|4794502|P2|Overall Study|Lost to Follow-up|3
1453870|NCT00803452|4794503|P1|Overall Study|Lost to Follow-up|0
1453871|NCT00803452|4794502|P2|Overall Study|Adverse Event|2
1453872|NCT00803452|4794503|P1|Overall Study|Adverse Event|0
1453873|NCT00803361|4794541|P2|Overall Study|Withdrawal by Subject|6
1453874|NCT00803361|4794542|P1|Overall Study|Withdrawal by Subject|5
1453875|NCT00803361|4794541|P2|Overall Study|Protocol Violation|4
1453876|NCT00803361|4794542|P1|Overall Study|Protocol Violation|2
1453877|NCT00803361|4794541|P2|Overall Study|Physician Decision|0
1453878|NCT00803361|4794542|P1|Overall Study|Physician Decision|1
1453879|NCT00803361|4794541|P2|Overall Study|Lost to Follow-up|2
1453880|NCT00803361|4794542|P1|Overall Study|Lost to Follow-up|1
1453881|NCT00803361|4794541|P2|Overall Study|Lack of Efficacy|13
1453882|NCT00803361|4794542|P1|Overall Study|Lack of Efficacy|4
1453883|NCT00803361|4794541|P2|Overall Study|Adverse Event|3
1453884|NCT00803361|4794542|P1|Overall Study|Adverse Event|13
1453885|NCT00803270|4794589|P2|Overall Study|Lost to Follow-up|2
1453886|NCT00803270|4794590|P1|Overall Study|Lost to Follow-up|1
1453887|NCT00803244|4794600|P2|Overall Study|Any other reason not above-mentioned|10
1453888|NCT00803244|4794601|P1|Overall Study|Any other reason not above-mentioned|4
1453889|NCT00803244|4794600|P2|Overall Study|Withdrawal by Subject|3
1453890|NCT00803244|4794601|P1|Overall Study|Withdrawal by Subject|2
1453891|NCT00803244|4794600|P2|Overall Study|Adverse Event|2
1453892|NCT00803244|4794601|P1|Overall Study|Adverse Event|1
1453893|NCT00803179|4794609|P1|Overall Study|Lost to Follow-up|3
1453894|NCT00803101|4794628|P2|Overall Study|Patient did not have surgery|1
1453895|NCT00803101|4794629|P1|Overall Study|Patient did not have surgery|1
1453896|NCT00803101|4794628|P2|Overall Study|Patient did not attend scheduled visit|1
1453897|NCT00803101|4794629|P1|Overall Study|Patient did not attend scheduled visit|2
1453898|NCT00803101|4794628|P2|Overall Study|Patient died outside SAE report period|0
1453899|NCT00803101|4794629|P1|Overall Study|Patient died outside SAE report period|1
1453900|NCT00803101|4794628|P2|Overall Study|Surgery finished outside protocol window|1
1453901|NCT00803101|4794629|P1|Overall Study|Surgery finished outside protocol window|1
1453902|NCT00803101|4794628|P2|Overall Study|Protocol Violation|7
1453903|NCT00803101|4794629|P1|Overall Study|Protocol Violation|1
1453904|NCT00803101|4794628|P2|Overall Study|Lost to Follow-up|2
1453905|NCT00803101|4794629|P1|Overall Study|Lost to Follow-up|2
1453906|NCT00803101|4794628|P2|Overall Study|Withdrawal by Subject|4
1453907|NCT00803101|4794629|P1|Overall Study|Withdrawal by Subject|6
1453908|NCT00803101|4794628|P2|Overall Study|Death / Serious Adverse Event|6
1453909|NCT00803101|4794629|P1|Overall Study|Death / Serious Adverse Event|4
1453910|NCT00803049|4794680|P4|Overall Study|Other than Specified Above|5
1453911|NCT00803049|4794681|P3|Overall Study|Other than Specified Above|2
1453912|NCT00803049|4794682|P2|Overall Study|Other than Specified Above|9
1453913|NCT00803049|4794683|P1|Overall Study|Other than Specified Above|3
1453914|NCT00803049|4794680|P4|Overall Study|Randomized and Not Treated|2
1453915|NCT00803049|4794681|P3|Overall Study|Randomized and Not Treated|0
1453916|NCT00803049|4794682|P2|Overall Study|Randomized and Not Treated|0
1453917|NCT00803049|4794683|P1|Overall Study|Randomized and Not Treated|0
1453918|NCT00803049|4794680|P4|Overall Study|Protocol Violation|0
1453919|NCT00803049|4794681|P3|Overall Study|Protocol Violation|1
1453920|NCT00803049|4794682|P2|Overall Study|Protocol Violation|1
1453921|NCT00803049|4794683|P1|Overall Study|Protocol Violation|0
1453922|NCT00803049|4794680|P4|Overall Study|Withdrawal by Subject|44
1453923|NCT00803049|4794681|P3|Overall Study|Withdrawal by Subject|16
1453924|NCT00803049|4794682|P2|Overall Study|Withdrawal by Subject|43
1453925|NCT00803049|4794683|P1|Overall Study|Withdrawal by Subject|19
1453926|NCT00803049|4794680|P4|Overall Study|Progressive Disease|6
1453927|NCT00803049|4794681|P3|Overall Study|Progressive Disease|6
1453928|NCT00803049|4794682|P2|Overall Study|Progressive Disease|10
1453929|NCT00803049|4794683|P1|Overall Study|Progressive Disease|6
1453930|NCT00803049|4794680|P4|Overall Study|Death|2
1453931|NCT00803049|4794681|P3|Overall Study|Death|0
1453932|NCT00803049|4794682|P2|Overall Study|Death|1
1453933|NCT00803049|4794683|P1|Overall Study|Death|2
1453934|NCT00803049|4794680|P4|Overall Study|Lost to Follow-up|3
1453935|NCT00803049|4794681|P3|Overall Study|Lost to Follow-up|0
1453936|NCT00803049|4794682|P2|Overall Study|Lost to Follow-up|2
1453937|NCT00803049|4794683|P1|Overall Study|Lost to Follow-up|0
1453938|NCT00803049|4794680|P4|Overall Study|Lack of Efficacy|13
1453939|NCT00803049|4794681|P3|Overall Study|Lack of Efficacy|6
1453940|NCT00803049|4794682|P2|Overall Study|Lack of Efficacy|19
1453941|NCT00803049|4794683|P1|Overall Study|Lack of Efficacy|10
1453942|NCT00803049|4794680|P4|Overall Study|Adverse Event|27
1453943|NCT00803049|4794681|P3|Overall Study|Adverse Event|13
1453944|NCT00803049|4794682|P2|Overall Study|Adverse Event|33
1453945|NCT00803049|4794683|P1|Overall Study|Adverse Event|21
1453946|NCT00803023|4794717|P4|Overall Study|Lack of Efficacy|1
1453947|NCT00803023|4794718|P3|Overall Study|Lack of Efficacy|1
1453948|NCT00803023|4794719|P2|Overall Study|Lack of Efficacy|1
1453949|NCT00803023|4794720|P1|Overall Study|Lack of Efficacy|0
1453950|NCT00803023|4794717|P4|Overall Study|Lost to Follow-up|1
1453951|NCT00803023|4794718|P3|Overall Study|Lost to Follow-up|2
1453952|NCT00803023|4794719|P2|Overall Study|Lost to Follow-up|1
1453953|NCT00803023|4794720|P1|Overall Study|Lost to Follow-up|0
1453954|NCT00803023|4794717|P4|Overall Study|Withdrawal by Subject|0
1453955|NCT00803023|4794718|P3|Overall Study|Withdrawal by Subject|0
1453956|NCT00803023|4794719|P2|Overall Study|Withdrawal by Subject|2
1453957|NCT00803023|4794720|P1|Overall Study|Withdrawal by Subject|0
1453958|NCT00803023|4794717|P4|Overall Study|Adverse Event|6
1453959|NCT00803023|4794718|P3|Overall Study|Adverse Event|8
1453960|NCT00803023|4794719|P2|Overall Study|Adverse Event|4
1453961|NCT00803023|4794720|P1|Overall Study|Adverse Event|5
1453962|NCT00802945|4794758|P2|Overall Study|Terminated by sponsor|12
1453963|NCT00802945|4794759|P1|Overall Study|Terminated by sponsor|8
1453964|NCT00802945|4794758|P2|Overall Study|Death|23
1453965|NCT00802945|4794759|P1|Overall Study|Death|27
1453966|NCT00802893|4794790|P1|Overall Study|study terminated|3
1453967|NCT00802867|4794814|P1|Overall Study|Withdrawal by Subject|1
1453968|NCT00802867|4794814|P1|Overall Study|Protocol Violation|6
1453969|NCT00802867|4794814|P1|Overall Study|Lost to Follow-up|6
1453970|NCT00802841|4794837|P2|Overall Study|Treatment duration completed|76
1453971|NCT00802841|4794838|P1|Overall Study|Treatment duration completed|66
1453972|NCT00802841|4794837|P2|Overall Study|Protocol deviation|6
1453973|NCT00802841|4794838|P1|Overall Study|Protocol deviation|2
1453974|NCT00802841|4794837|P2|Overall Study|Withdrawal by Subject|5
1453975|NCT00802841|4794838|P1|Overall Study|Withdrawal by Subject|9
1453976|NCT00802841|4794837|P2|Overall Study|Disease progression|3
1453977|NCT00802841|4794838|P1|Overall Study|Disease progression|7
1453978|NCT00802841|4794837|P2|Overall Study|Adverse Event|2
1453979|NCT00802841|4794838|P1|Overall Study|Adverse Event|8
1453980|NCT00802841|4794837|P2|Overall Study|Death|2
1453981|NCT00802841|4794838|P1|Overall Study|Death|1
1453982|NCT00802841|4794837|P2|Overall Study|Lost to Follow-up|1
1453983|NCT00802841|4794838|P1|Overall Study|Lost to Follow-up|2
1453984|NCT00802841|4794837|P2|Overall Study|Administrative problems|0
1453985|NCT00802841|4794838|P1|Overall Study|Administrative problems|1
1453986|NCT00802737|4794863|P3|Overall Study|Participant too Unwell|0
1453987|NCT00802737|4794864|P2|Overall Study|Participant too Unwell|2
1453988|NCT00802737|4794865|P1|Overall Study|Participant too Unwell|0
1453989|NCT00802737|4794863|P3|Overall Study|Ongoing CLL-Treatment|0
1453990|NCT00802737|4794864|P2|Overall Study|Ongoing CLL-Treatment|1
1453991|NCT00802737|4794865|P1|Overall Study|Ongoing CLL-Treatment|0
1453992|NCT00802737|4794863|P3|Overall Study|Received Prohibited Therapy|0
1453993|NCT00802737|4794864|P2|Overall Study|Received Prohibited Therapy|0
1453994|NCT00802737|4794865|P1|Overall Study|Received Prohibited Therapy|1
1453995|NCT00802737|4794863|P3|Overall Study|Adverse Event|0
1453996|NCT00802737|4794864|P2|Overall Study|Adverse Event|0
1453997|NCT00802737|4794865|P1|Overall Study|Adverse Event|1
1453998|NCT00802737|4794863|P3|Overall Study|Death|1
1453999|NCT00802737|4794864|P2|Overall Study|Death|5
1454000|NCT00802737|4794865|P1|Overall Study|Death|6
1454001|NCT00802737|4794863|P3|Overall Study|Withdrawn due to Disease Progression|0
1454002|NCT00802737|4794864|P2|Overall Study|Withdrawn due to Disease Progression|3
1454003|NCT00802737|4794865|P1|Overall Study|Withdrawn due to Disease Progression|9
1454004|NCT00802672|4794925|P3|Overall Study|other|2
1454005|NCT00802672|4794926|P2|Overall Study|other|1
1454006|NCT00802672|4794927|P1|Overall Study|other|3
1454007|NCT00802672|4794925|P3|Overall Study|Withdrawal by Subject|2
1454008|NCT00802672|4794926|P2|Overall Study|Withdrawal by Subject|1
1454009|NCT00802672|4794927|P1|Overall Study|Withdrawal by Subject|1
1454010|NCT00802672|4794925|P3|Overall Study|Lost to Follow-up|3
1454011|NCT00802672|4794926|P2|Overall Study|Lost to Follow-up|5
1454012|NCT00802672|4794927|P1|Overall Study|Lost to Follow-up|5
1454013|NCT00802672|4794925|P3|Overall Study|Protocol Violation|1
1454014|NCT00802672|4794926|P2|Overall Study|Protocol Violation|1
1454015|NCT00802672|4794927|P1|Overall Study|Protocol Violation|2
1454016|NCT00802672|4794925|P3|Overall Study|Adverse Event|1
1454017|NCT00802672|4794926|P2|Overall Study|Adverse Event|1
1454018|NCT00802672|4794927|P1|Overall Study|Adverse Event|1
1454019|NCT00802672|4794925|P3|Overall Study|Lack of fungal pathogen at baseline|25
1454020|NCT00802672|4794926|P2|Overall Study|Lack of fungal pathogen at baseline|43
1454021|NCT00802672|4794927|P1|Overall Study|Lack of fungal pathogen at baseline|56
1454022|NCT00802659|4794945|P4|Overall Study|Physician Decision|0
1454023|NCT00802659|4794946|P3|Overall Study|Physician Decision|0
1454024|NCT00802659|4794947|P2|Overall Study|Physician Decision|1
1454025|NCT00802659|4794948|P1|Overall Study|Physician Decision|0
1454026|NCT00802529|4794987|P2|Overall Study|Lost to Follow-up|1
1454027|NCT00802529|4794988|P1|Overall Study|Lost to Follow-up|0
1454028|NCT00802464|4795027|P4|Month 8 - Month 14|Lost to Follow-up|0
1454029|NCT00802464|4795028|P3|Month 8 - Month 14|Lost to Follow-up|1
1454030|NCT00802464|4795029|P2|Month 8 - Month 14|Lost to Follow-up|0
1454031|NCT00802464|4795030|P1|Month 8 - Month 14|Lost to Follow-up|0
1454032|NCT00802464|4795027|P4|Month 8 - Month 14|Withdrawal by Subject|0
1454033|NCT00802464|4795028|P3|Month 8 - Month 14|Withdrawal by Subject|0
1454034|NCT00802464|4795029|P2|Month 8 - Month 14|Withdrawal by Subject|1
1454035|NCT00802464|4795030|P1|Month 8 - Month 14|Withdrawal by Subject|1
1454036|NCT00802464|4795027|P4|Month 8 - Month 14|Adverse Event|0
1454037|NCT00802464|4795028|P3|Month 8 - Month 14|Adverse Event|0
1454038|NCT00802464|4795029|P2|Month 8 - Month 14|Adverse Event|1
1454039|NCT00802464|4795030|P1|Month 8 - Month 14|Adverse Event|0
1454040|NCT00802464|4795027|P4|Month 0 - Month 8|Not specified|0
1454041|NCT00802464|4795028|P3|Month 0 - Month 8|Not specified|1
1454042|NCT00802464|4795029|P2|Month 0 - Month 8|Not specified|0
1454043|NCT00802464|4795030|P1|Month 0 - Month 8|Not specified|0
1454044|NCT00802464|4795027|P4|Month 0 - Month 8|Lost to Follow-up|2
1454045|NCT00802464|4795028|P3|Month 0 - Month 8|Lost to Follow-up|2
1454046|NCT00802464|4795029|P2|Month 0 - Month 8|Lost to Follow-up|1
1454047|NCT00802464|4795030|P1|Month 0 - Month 8|Lost to Follow-up|0
1454048|NCT00802464|4795027|P4|Month 0 - Month 8|Withdrawal by Subject|5
1454049|NCT00802464|4795028|P3|Month 0 - Month 8|Withdrawal by Subject|2
1454050|NCT00802464|4795029|P2|Month 0 - Month 8|Withdrawal by Subject|1
1454051|NCT00802464|4795030|P1|Month 0 - Month 8|Withdrawal by Subject|0
1454052|NCT00802464|4795027|P4|Month 0 - Month 8|Protocol Violation|0
1454053|NCT00802464|4795028|P3|Month 0 - Month 8|Protocol Violation|1
1454054|NCT00802464|4795029|P2|Month 0 - Month 8|Protocol Violation|0
1454055|NCT00802464|4795030|P1|Month 0 - Month 8|Protocol Violation|0
1454056|NCT00802464|4795027|P4|Month 0 - Month 8|Adverse Event|2
1454057|NCT00802464|4795028|P3|Month 0 - Month 8|Adverse Event|1
1454058|NCT00802464|4795029|P2|Month 0 - Month 8|Adverse Event|1
1454059|NCT00802464|4795030|P1|Month 0 - Month 8|Adverse Event|0
1454060|NCT00802438|4795116|P1|Overall Study|Physician Decision|1
1454061|NCT00802438|4795116|P1|Overall Study|Withdrawal by Subject|7
1454062|NCT00802438|4795116|P1|Overall Study|Screen Failure|20
1454063|NCT00802360|4795136|P4|Overall Study|Other|3
1454064|NCT00802360|4795137|P3|Overall Study|Other|6
1454065|NCT00802360|4795138|P2|Overall Study|Other|3
1454066|NCT00802360|4795139|P1|Overall Study|Other|2
1454067|NCT00802360|4795136|P4|Overall Study|Pregnancy loss/miscarriage|3
1454068|NCT00802360|4795137|P3|Overall Study|Pregnancy loss/miscarriage|0
1454069|NCT00802360|4795138|P2|Overall Study|Pregnancy loss/miscarriage|2
1454070|NCT00802360|4795139|P1|Overall Study|Pregnancy loss/miscarriage|0
1454071|NCT00802360|4795136|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
1454072|NCT00802360|4795137|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
1454073|NCT00802360|4795138|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
1454074|NCT00802360|4795139|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
1454075|NCT00802360|4795136|P4|Overall Study|No positive serum pregnancy|10
1454076|NCT00802360|4795137|P3|Overall Study|No positive serum pregnancy|14
1454077|NCT00802360|4795138|P2|Overall Study|No positive serum pregnancy|20
1454078|NCT00802360|4795139|P1|Overall Study|No positive serum pregnancy|17
1454079|NCT00802360|4795136|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
1454080|NCT00802360|4795137|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
1454081|NCT00802360|4795138|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
1454082|NCT00802360|4795139|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
1454083|NCT00802360|4795136|P4|Overall Study|Cycle cancelled|1
1454084|NCT00802360|4795137|P3|Overall Study|Cycle cancelled|1
1454085|NCT00802360|4795138|P2|Overall Study|Cycle cancelled|1
1454086|NCT00802360|4795139|P1|Overall Study|Cycle cancelled|0
1454087|NCT00802360|4795136|P4|Overall Study|Inadequate number of oocytes retrieved|1
1454088|NCT00802360|4795137|P3|Overall Study|Inadequate number of oocytes retrieved|0
1454089|NCT00802360|4795138|P2|Overall Study|Inadequate number of oocytes retrieved|0
1454090|NCT00802360|4795139|P1|Overall Study|Inadequate number of oocytes retrieved|0
1454091|NCT00802360|4795136|P4|Overall Study|Stimulation failure|3
1454092|NCT00802360|4795137|P3|Overall Study|Stimulation failure|3
1454093|NCT00802360|4795138|P2|Overall Study|Stimulation failure|0
1454094|NCT00802360|4795139|P1|Overall Study|Stimulation failure|4
1454095|NCT00802178|4795206|P1|Overall Study|Patients wish and other reason|1
1454096|NCT00802178|4795206|P1|Overall Study|IT and patient wish|8
1454097|NCT00802178|4795206|P1|Overall Study|Lack of efficacy and patient wish|1
1454098|NCT00802178|4795206|P1|Overall Study|Other|32
1454099|NCT00802178|4795206|P1|Overall Study|Withdrawal by Subject|18
1454100|NCT00802178|4795206|P1|Overall Study|Insufficient tolerability (IT)|17
1454101|NCT00802178|4795206|P1|Overall Study|Lack of Efficacy|36
1454102|NCT00802074|4795233|P6|Overall Study|Withdrawal by Subject|0
1454103|NCT00802074|4795234|P5|Overall Study|Withdrawal by Subject|0
1454104|NCT00802074|4795235|P4|Overall Study|Withdrawal by Subject|0
1454105|NCT00802074|4795236|P3|Overall Study|Withdrawal by Subject|0
1454106|NCT00802074|4795237|P2|Overall Study|Withdrawal by Subject|0
1454107|NCT00802074|4795238|P1|Overall Study|Withdrawal by Subject|1
1454108|NCT00802074|4795233|P6|Overall Study|Adverse Event|0
1454109|NCT00802074|4795234|P5|Overall Study|Adverse Event|0
1454110|NCT00802074|4795235|P4|Overall Study|Adverse Event|0
1454111|NCT00802074|4795236|P3|Overall Study|Adverse Event|1
1454112|NCT00802074|4795237|P2|Overall Study|Adverse Event|1
1454113|NCT00802074|4795238|P1|Overall Study|Adverse Event|1
1454114|NCT00801983|4795272|P2|Period 2|Withdrawal by Subject|1
1454115|NCT00801983|4795273|P1|Period 2|Withdrawal by Subject|2
1454116|NCT00801983|4795272|P2|Period 1|Withdrawal by Subject|8
1454117|NCT00801983|4795273|P1|Period 1|Withdrawal by Subject|2
1454118|NCT00801983|4795272|P2|Period 1|Lost to Follow-up|0
1454119|NCT00801983|4795273|P1|Period 1|Lost to Follow-up|2
1454120|NCT00801892|4795281|P2|Sham Crossover Period|Lost to Follow-up|2
1454121|NCT00801892|4795282|P1|Sham Crossover Period|Lost to Follow-up|0
1454122|NCT00801892|4795281|P2|Main Study Period|Withdrawal by Subject|1
1454123|NCT00801892|4795282|P1|Main Study Period|Withdrawal by Subject|0
1454124|NCT00801632|4795329|P1|Overall Study|Re-transplant|1
1454125|NCT00801242|4795340|P1|Overall Study|Miscellaneous reasons|20
1454126|NCT00801242|4795340|P1|Overall Study|Lost to Follow-up|1
1454127|NCT00801242|4795340|P1|Overall Study|Physician Decision|3
1454128|NCT00801242|4795340|P1|Overall Study|Protocol Violation|5
1454129|NCT00801242|4795340|P1|Overall Study|Withdrawal by Subject|13
1454130|NCT00801242|4795340|P1|Overall Study|Adverse Event|10
1454131|NCT00801229|4795353|P2|Received Study Drug/Placebo|Adverse Event|1
1454132|NCT00801229|4795354|P1|Received Study Drug/Placebo|Adverse Event|1
1454133|NCT00801229|4795353|P2|Received Study Drug/Placebo|Lost to Follow-up|1
1454134|NCT00801229|4795354|P1|Received Study Drug/Placebo|Lost to Follow-up|0
1454135|NCT00801229|4795353|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
1454136|NCT00801229|4795354|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
1454137|NCT00801229|4795353|P2|Received Study Drug/Placebo|Simulator sickness|1
1454138|NCT00801229|4795354|P1|Received Study Drug/Placebo|Simulator sickness|1
1454139|NCT00801229|4795353|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
1454140|NCT00801229|4795354|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
1454141|NCT00801229|4795353|P2|Received Study Drug/Placebo|Elevated SGOT level|0
1454142|NCT00801229|4795354|P1|Received Study Drug/Placebo|Elevated SGOT level|1
1454143|NCT00801229|4795353|P2|Signed Consent|Found Ineligible|1
1454144|NCT00801229|4795354|P1|Signed Consent|Found Ineligible|1
1454145|NCT00801229|4795353|P2|Signed Consent|Withdrawal by Subject|2
1454146|NCT00801229|4795354|P1|Signed Consent|Withdrawal by Subject|2
1454147|NCT00801099|4795389|P1|Overall Study|Lost to Follow-up|101
1454148|NCT00800982|4795395|P2|Overall Study|Patient moved out of state|0
1454149|NCT00800982|4795396|P1|Overall Study|Patient moved out of state|1
1454150|NCT00800982|4795395|P2|Overall Study|Withdrawal by Subject|1
1454151|NCT00800982|4795396|P1|Overall Study|Withdrawal by Subject|0
1454152|NCT00800982|4795395|P2|Overall Study|Lost to Follow-up|2
1454153|NCT00800982|4795396|P1|Overall Study|Lost to Follow-up|1
1454154|NCT00800735|4795422|P1|Overall Study|Withdrew Consent|3
1454155|NCT00800735|4795422|P1|Overall Study|Violation of Selection Criteria at Entry|7
1454156|NCT00800735|4795422|P1|Overall Study|Insufficient Therapeutic Response|2
1454157|NCT00800735|4795422|P1|Overall Study|Administrative/Other|2
1454158|NCT00800683|4795428|P2|Overall Study|Not specified|2
1454159|NCT00800683|4795429|P1|Overall Study|Not specified|1
1454160|NCT00800683|4795428|P2|Overall Study|Lack of Efficacy|1
1454161|NCT00800683|4795429|P1|Overall Study|Lack of Efficacy|1
1454162|NCT00800683|4795428|P2|Overall Study|Withdrawal by Subject|7
1454163|NCT00800683|4795429|P1|Overall Study|Withdrawal by Subject|1
1454164|NCT00800683|4795428|P2|Overall Study|Lost to Follow-up|1
1454165|NCT00800683|4795429|P1|Overall Study|Lost to Follow-up|3
1454166|NCT00800683|4795428|P2|Overall Study|Adverse Event|8
1454167|NCT00800683|4795429|P1|Overall Study|Adverse Event|11
1454168|NCT00800540|4795475|P2|Period 2: 6 Weeks|Adverse Event|1
1454169|NCT00800540|4795476|P1|Period 2: 6 Weeks|Adverse Event|0
1454170|NCT00800540|4795475|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
1454171|NCT00800540|4795476|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
1454172|NCT00800540|4795475|P2|Period One: 6 Weeks|Noncompliance|0
1454173|NCT00800540|4795476|P1|Period One: 6 Weeks|Noncompliance|1
1454174|NCT00800436|4795511|P7|Overall Study|Withdrawal by Subject|0
1454175|NCT00800436|4795512|P6|Overall Study|Withdrawal by Subject|0
1454176|NCT00800436|4795513|P5|Overall Study|Withdrawal by Subject|0
1454177|NCT00800436|4795514|P4|Overall Study|Withdrawal by Subject|1
1454178|NCT00800436|4795515|P3|Overall Study|Withdrawal by Subject|1
1454179|NCT00800436|4795516|P2|Overall Study|Withdrawal by Subject|0
1454180|NCT00800436|4795517|P1|Overall Study|Withdrawal by Subject|0
1454181|NCT00800384|4795563|P2|Overall Study|Lost to Follow-up|26
1454182|NCT00800384|4795564|P1|Overall Study|Lost to Follow-up|17
1454183|NCT00800384|4795563|P2|Overall Study|Withdrawal by Subject|17
1454184|NCT00800384|4795564|P1|Overall Study|Withdrawal by Subject|24
1454185|NCT00800202|4795602|P2|Overall Study|Disease Progression|18
1454186|NCT00800202|4795603|P1|Overall Study|Disease Progression|54
1454187|NCT00800202|4795602|P2|Overall Study|Other|0
1454188|NCT00800202|4795603|P1|Overall Study|Other|5
1454189|NCT00800202|4795602|P2|Overall Study|Death|0
1454190|NCT00800202|4795603|P1|Overall Study|Death|1
1454191|NCT00800202|4795602|P2|Overall Study|Adverse Event|6
1454192|NCT00800202|4795603|P1|Overall Study|Adverse Event|7
1454193|NCT00799903|4795623|P2|Overall Study|Lost to Follow-up|80
1454194|NCT00799903|4795624|P1|Overall Study|Lost to Follow-up|69
1454195|NCT00799903|4795623|P2|Overall Study|Withdrawal by Subject|175
1454196|NCT00799903|4795624|P1|Overall Study|Withdrawal by Subject|179
1454197|NCT00799903|4795623|P2|Overall Study|Investigator Site Closed|23
1454198|NCT00799903|4795624|P1|Overall Study|Investigator Site Closed|25
1454199|NCT00799825|4795644|P1|Overall Study|Pregnancy|3
1454200|NCT00799825|4795644|P1|Overall Study|Lost to Follow-up|38
1454201|NCT00799825|4795644|P1|Overall Study|Withdrawal by Subject|6
1454202|NCT00799825|4795644|P1|Overall Study|Adverse Event|1
1454203|NCT00799708|4795684|P3|Overall Study|non-compliance|0
1454204|NCT00799708|4795685|P2|Overall Study|non-compliance|0
1454205|NCT00799708|4795686|P1|Overall Study|non-compliance|1
1454206|NCT00799617|4795709|P2|Anemia Trial|Withdrawal by Subject|3
1454207|NCT00799617|4795710|P1|Anemia Trial|Withdrawal by Subject|3
1454208|NCT00799617|4795709|P2|Cognitive Function Trial|Lost to Follow-up|1
1454209|NCT00799617|4795710|P1|Cognitive Function Trial|Lost to Follow-up|0
1454210|NCT00799617|4795709|P2|Bone Trial|Month 12 scan not available|16
1454211|NCT00799617|4795710|P1|Bone Trial|Month 12 scan not available|6
1454212|NCT00799617|4795709|P2|Cardiovascular Trial|Baseline scan not analyzable|2
1454213|NCT00799617|4795710|P1|Cardiovascular Trial|Baseline scan not analyzable|0
1454214|NCT00799617|4795709|P2|Cardiovascular Trial|Month 12 scan not available|15
1454215|NCT00799617|4795710|P1|Cardiovascular Trial|Month 12 scan not available|15
1454216|NCT00799617|4795709|P2|Vitality Trial|Lost to Follow-up|22
1454217|NCT00799617|4795710|P1|Vitality Trial|Lost to Follow-up|7
1454218|NCT00799617|4795709|P2|Physical Function Trial|Lost to Follow-up|11
1454219|NCT00799617|4795710|P1|Physical Function Trial|Lost to Follow-up|6
1454220|NCT00799617|4795709|P2|Sexual Funtion Trial|No Baseline Data|7
1454221|NCT00799617|4795710|P1|Sexual Funtion Trial|No Baseline Data|4
1454222|NCT00799617|4795709|P2|Sexual Funtion Trial|Lost to Follow-up|14
1454223|NCT00799617|4795710|P1|Sexual Funtion Trial|Lost to Follow-up|12
1454224|NCT00799617|4795709|P2|Main Testosterone Trial|Lost to Follow-up|20
1454225|NCT00799617|4795710|P1|Main Testosterone Trial|Lost to Follow-up|18
1454226|NCT00799617|4795709|P2|Main Testosterone Trial|Randomized in error|1
1454227|NCT00799617|4795710|P1|Main Testosterone Trial|Randomized in error|1
1454228|NCT00799591|4795817|P1|Overall Study|Infectious origin not probable|1
1454229|NCT00799591|4795817|P1|Overall Study|Antibiotic changed, no apparent reason|1
1454230|NCT00799591|4795817|P1|Overall Study|Persistance of fever undetermined origin|1
1454231|NCT00799591|4795817|P1|Overall Study|Resistance germ and technical failure|2
1454232|NCT00799591|4795817|P1|Overall Study|New infection|4
1454233|NCT00799591|4795817|P1|Overall Study|Resistant germ|11
1454234|NCT00799591|4795817|P1|Overall Study|Technical failure|12
1454235|NCT00799591|4795817|P1|Overall Study|Death|14
1454236|NCT00799591|4795817|P1|Overall Study|De-escalation of doses|20
1454237|NCT00799487|4795835|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
1454238|NCT00799487|4795836|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
1454239|NCT00799487|4795837|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
1454240|NCT00799487|4795835|P3|Double-Blind Assessment Period|Subject was out of the state|1
1454241|NCT00799487|4795836|P2|Double-Blind Assessment Period|Subject was out of the state|0
1454242|NCT00799487|4795837|P1|Double-Blind Assessment Period|Subject was out of the state|0
1454243|NCT00799487|4795835|P3|Double-Blind Assessment Period|Lost to Follow-up|1
1454244|NCT00799487|4795836|P2|Double-Blind Assessment Period|Lost to Follow-up|0
1454245|NCT00799487|4795837|P1|Double-Blind Assessment Period|Lost to Follow-up|0
1454246|NCT00799487|4795835|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
1454247|NCT00799487|4795836|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
1454248|NCT00799487|4795837|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
1454249|NCT00799487|4795835|P3|Dose Adjustment Period|Missed laboratory day 1|0
1454250|NCT00799487|4795836|P2|Dose Adjustment Period|Missed laboratory day 1|0
1454251|NCT00799487|4795837|P1|Dose Adjustment Period|Missed laboratory day 1|1
1454252|NCT00799487|4795835|P3|Dose Adjustment Period|Child too young (exclusion)|0
1454253|NCT00799487|4795836|P2|Dose Adjustment Period|Child too young (exclusion)|0
1454254|NCT00799487|4795837|P1|Dose Adjustment Period|Child too young (exclusion)|1
1454255|NCT00799487|4795835|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
1454256|NCT00799487|4795836|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
1454257|NCT00799487|4795837|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
1454258|NCT00799487|4795835|P3|Dose Adjustment Period|Withdrawal by Subject|0
1454259|NCT00799487|4795836|P2|Dose Adjustment Period|Withdrawal by Subject|0
1454260|NCT00799487|4795837|P1|Dose Adjustment Period|Withdrawal by Subject|3
1454261|NCT00799487|4795835|P3|Dose Adjustment Period|Investigator Discretion|0
1454262|NCT00799487|4795836|P2|Dose Adjustment Period|Investigator Discretion|0
1454263|NCT00799487|4795837|P1|Dose Adjustment Period|Investigator Discretion|2
1454264|NCT00799487|4795835|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
1454265|NCT00799487|4795836|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
1454266|NCT00799487|4795837|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
1454267|NCT00799487|4795835|P3|Dose Adjustment Period|Adverse Event|0
1454268|NCT00799487|4795836|P2|Dose Adjustment Period|Adverse Event|0
1454269|NCT00799487|4795837|P1|Dose Adjustment Period|Adverse Event|2
1454270|NCT00799487|4795835|P3|Dose Adjustment Period|Lost to Follow-up|0
1454271|NCT00799487|4795836|P2|Dose Adjustment Period|Lost to Follow-up|0
1454272|NCT00799487|4795837|P1|Dose Adjustment Period|Lost to Follow-up|1
1454273|NCT00799422|4795932|P6|First Week of Wear|Adverse Event|0
1454274|NCT00799422|4795933|P5|First Week of Wear|Adverse Event|0
1454275|NCT00799422|4795934|P4|First Week of Wear|Adverse Event|1
1454276|NCT00799422|4795935|P3|First Week of Wear|Adverse Event|0
1454277|NCT00799422|4795936|P2|First Week of Wear|Adverse Event|0
1454278|NCT00799422|4795937|P1|First Week of Wear|Adverse Event|0
1454279|NCT00799422|4795932|P6|First Week of Wear|Lost to Follow-up|0
1454280|NCT00799422|4795933|P5|First Week of Wear|Lost to Follow-up|0
1454281|NCT00799422|4795934|P4|First Week of Wear|Lost to Follow-up|0
1454282|NCT00799422|4795935|P3|First Week of Wear|Lost to Follow-up|1
1454283|NCT00799422|4795936|P2|First Week of Wear|Lost to Follow-up|0
1454284|NCT00799422|4795937|P1|First Week of Wear|Lost to Follow-up|0
1454285|NCT00799409|4795954|P3|Overall Study|medication compliance|0
1454286|NCT00799409|4795955|P2|Overall Study|medication compliance|0
1454287|NCT00799409|4795956|P1|Overall Study|medication compliance|1
1454288|NCT00799409|4795954|P3|Overall Study|Did not attend lab school day 1|0
1454289|NCT00799409|4795955|P2|Overall Study|Did not attend lab school day 1|0
1454290|NCT00799409|4795956|P1|Overall Study|Did not attend lab school day 1|1
1454291|NCT00799409|4795954|P3|Overall Study|Failure to follow study protocol)|0
1454292|NCT00799409|4795955|P2|Overall Study|Failure to follow study protocol)|0
1454293|NCT00799409|4795956|P1|Overall Study|Failure to follow study protocol)|1
1454294|NCT00799409|4795954|P3|Overall Study|Optimal Dose Not Achieved|0
1454295|NCT00799409|4795955|P2|Overall Study|Optimal Dose Not Achieved|0
1454296|NCT00799409|4795956|P1|Overall Study|Optimal Dose Not Achieved|2
1454297|NCT00799409|4795954|P3|Overall Study|Lost to Follow-up|0
1454298|NCT00799409|4795955|P2|Overall Study|Lost to Follow-up|0
1454299|NCT00799409|4795956|P1|Overall Study|Lost to Follow-up|1
1454300|NCT00799409|4795954|P3|Overall Study|Withdrawal by Subject|0
1454301|NCT00799409|4795955|P2|Overall Study|Withdrawal by Subject|0
1454302|NCT00799409|4795956|P1|Overall Study|Withdrawal by Subject|1
1454303|NCT00799396|4796036|P1|Clopidogrel Plus Aspirin|Physician Decision|4
1454304|NCT00799396|4796036|P1|Clopidogrel Plus Aspirin|Adverse Event|2
1454305|NCT00799396|4796036|P1|Clopidogrel Treatment|Withdrawal by Subject|2
1454306|NCT00799396|4796036|P1|Clopidogrel Treatment|Physician Decision|5
1454307|NCT00799396|4796036|P1|Clopidogrel Treatment|Adverse Event|6
1454308|NCT00799383|4796043|P2|Overall Study|Withdrawal by Subject|1
1454309|NCT00799383|4796044|P1|Overall Study|Withdrawal by Subject|0
1454310|NCT00799383|4796043|P2|Overall Study|Urinary Calcium/Creatinine > 0.2|1
1454311|NCT00799383|4796044|P1|Overall Study|Urinary Calcium/Creatinine > 0.2|1
1454312|NCT00799383|4796043|P2|Overall Study|Lost to Follow-up|2
1454313|NCT00799383|4796044|P1|Overall Study|Lost to Follow-up|1
1454314|NCT00799383|4796043|P2|Overall Study|Adverse Event|1
1454315|NCT00799383|4796044|P1|Overall Study|Adverse Event|0
1454316|NCT00799383|4796043|P2|Overall Study|Protocol Violation|1
1454317|NCT00799383|4796044|P1|Overall Study|Protocol Violation|1
1454318|NCT00798967|4796080|P2|Overall Study|Randomized in error by site|0
1454319|NCT00798967|4796081|P1|Overall Study|Randomized in error by site|1
1454320|NCT00798967|4796080|P2|Overall Study|Physician Decision|0
1454321|NCT00798967|4796081|P1|Overall Study|Physician Decision|1
1454322|NCT00798967|4796080|P2|Overall Study|Withdrawal by Subject|1
1454323|NCT00798967|4796081|P1|Overall Study|Withdrawal by Subject|0
1454324|NCT00798967|4796080|P2|Overall Study|Adverse Event|3
1454325|NCT00798967|4796081|P1|Overall Study|Adverse Event|2
1454326|NCT00798889|4796089|P1|Overall Study|Enrolled, Not treated|3
1454327|NCT00798889|4796089|P1|Overall Study|Decision of Sponsor|11
1454328|NCT00798889|4796089|P1|Overall Study|Lack of Efficacy|213
1454329|NCT00798889|4796089|P1|Overall Study|Lost to Follow-up|1
1454330|NCT00798889|4796089|P1|Overall Study|Withdrawal by Subject|31
1454331|NCT00798889|4796089|P1|Overall Study|Protocol Violation|2
1454332|NCT00798889|4796089|P1|Overall Study|Adverse Event|53
1454333|NCT00798759|4796095|P2|Overall Study|Not specified|1
1454334|NCT00798759|4796096|P1|Overall Study|Not specified|0
1454335|NCT00798759|4796095|P2|Overall Study|Protocol Violation|8
1454336|NCT00798759|4796096|P1|Overall Study|Protocol Violation|4
1454337|NCT00798759|4796095|P2|Overall Study|Lost to Follow-up|1
1454338|NCT00798759|4796096|P1|Overall Study|Lost to Follow-up|1
1454339|NCT00798759|4796095|P2|Overall Study|Adverse Event|3
1454340|NCT00798759|4796096|P1|Overall Study|Adverse Event|3
1454341|NCT00798707|4796114|P3|Overall Study|Randomized not treated|1
1454342|NCT00798707|4796115|P2|Overall Study|Randomized not treated|5
1454343|NCT00798707|4796116|P1|Overall Study|Randomized not treated|4
1454344|NCT00798707|4796114|P3|Overall Study|Withdrawal by Subject|2
1454345|NCT00798707|4796115|P2|Overall Study|Withdrawal by Subject|8
1454346|NCT00798707|4796116|P1|Overall Study|Withdrawal by Subject|3
1454347|NCT00798707|4796114|P3|Overall Study|Protocol Violation|2
1454348|NCT00798707|4796115|P2|Overall Study|Protocol Violation|0
1454349|NCT00798707|4796116|P1|Overall Study|Protocol Violation|4
1454350|NCT00798707|4796114|P3|Overall Study|Other|0
1454351|NCT00798707|4796115|P2|Overall Study|Other|1
1454352|NCT00798707|4796116|P1|Overall Study|Other|0
1454353|NCT00798707|4796114|P3|Overall Study|Lost to Follow-up|6
1454354|NCT00798707|4796115|P2|Overall Study|Lost to Follow-up|6
1454355|NCT00798707|4796116|P1|Overall Study|Lost to Follow-up|5
1454356|NCT00798707|4796114|P3|Overall Study|Lack of Efficacy|1
1454357|NCT00798707|4796115|P2|Overall Study|Lack of Efficacy|2
1454358|NCT00798707|4796116|P1|Overall Study|Lack of Efficacy|2
1454359|NCT00798707|4796114|P3|Overall Study|Investigator|2
1454360|NCT00798707|4796115|P2|Overall Study|Investigator|1
1454361|NCT00798707|4796116|P1|Overall Study|Investigator|0
1454362|NCT00798707|4796114|P3|Overall Study|Failed to return|0
1454363|NCT00798707|4796115|P2|Overall Study|Failed to return|2
1454364|NCT00798707|4796116|P1|Overall Study|Failed to return|2
1454365|NCT00798707|4796114|P3|Overall Study|Adverse Event|8
1454366|NCT00798707|4796115|P2|Overall Study|Adverse Event|8
1454367|NCT00798707|4796116|P1|Overall Study|Adverse Event|6
1454368|NCT00798694|4796168|P2|Overall Study|Physician Decision|0
1454369|NCT00798694|4796169|P1|Overall Study|Physician Decision|1
1454370|NCT00798694|4796168|P2|Overall Study|Lost to Follow-up|1
1454371|NCT00798694|4796169|P1|Overall Study|Lost to Follow-up|1
1454372|NCT00798655|4796193|P1|Overall Study|Did not receive at least one dose of pan|2
1454373|NCT00798603|4796198|P1|Overall Study|Lack of insurance coverage|1
1454374|NCT00798603|4796198|P1|Overall Study|Physician Decision|1
1454375|NCT00798603|4796198|P1|Overall Study|Adverse Event|22
1454376|NCT00798603|4796198|P1|Overall Study|Withdrawal by Subject|10
1454377|NCT00798603|4796198|P1|Overall Study|Still on treatment as of 11/6/2012|1
1454378|NCT00798590|4796220|P2|Overall Study|P.I, Left institution. Study terminated|8
1454379|NCT00798590|4796221|P1|Overall Study|P.I, Left institution. Study terminated|11
1454380|NCT00798434|4796255|P2|Open-Label|Not Treated|1
1454381|NCT00798434|4796256|P1|Open-Label|Not Treated|0
1454382|NCT00798434|4796255|P2|Open-Label|Not Specified|2
1454383|NCT00798434|4796256|P1|Open-Label|Not Specified|1
1454384|NCT00798434|4796255|P2|Open-Label|Protocol Violation|0
1454385|NCT00798434|4796256|P1|Open-Label|Protocol Violation|1
1454386|NCT00798434|4796255|P2|Open-Label|Withdrawal by Subject|7
1454387|NCT00798434|4796256|P1|Open-Label|Withdrawal by Subject|2
1454388|NCT00798434|4796255|P2|Open-Label|Lack of Efficacy|11
1454389|NCT00798434|4796256|P1|Open-Label|Lack of Efficacy|5
1454390|NCT00798434|4796255|P2|Open-Label|Adverse Event|11
1454391|NCT00798434|4796256|P1|Open-Label|Adverse Event|33
1454392|NCT00798434|4796255|P2|Double-Blind|Not Treated|6
1454393|NCT00798434|4796256|P1|Double-Blind|Not Treated|3
1454394|NCT00798434|4796255|P2|Double-Blind|Not Specified|0
1454395|NCT00798434|4796256|P1|Double-Blind|Not Specified|1
1454396|NCT00798434|4796255|P2|Double-Blind|Did Not Meet Entrance Criteria|1
1454397|NCT00798434|4796256|P1|Double-Blind|Did Not Meet Entrance Criteria|2
1454398|NCT00798434|4796255|P2|Double-Blind|Protocol Violation|4
1454399|NCT00798434|4796256|P1|Double-Blind|Protocol Violation|1
1454400|NCT00798434|4796255|P2|Double-Blind|Withdrawal by Subject|14
1454401|NCT00798434|4796256|P1|Double-Blind|Withdrawal by Subject|17
1454402|NCT00798434|4796255|P2|Double-Blind|Lack of Efficacy|12
1454403|NCT00798434|4796256|P1|Double-Blind|Lack of Efficacy|8
1454404|NCT00798434|4796255|P2|Double-Blind|Lost to Follow-up|0
1454405|NCT00798434|4796256|P1|Double-Blind|Lost to Follow-up|1
1454406|NCT00798434|4796255|P2|Double-Blind|Death|1
1454407|NCT00798434|4796256|P1|Double-Blind|Death|0
1454408|NCT00798434|4796255|P2|Double-Blind|Adverse Event|46
1454409|NCT00798434|4796256|P1|Double-Blind|Adverse Event|22
1454410|NCT00798369|4796342|P6|Overall Study|Adminstrative problems|1
1454411|NCT00798369|4796343|P5|Overall Study|Adminstrative problems|0
1454412|NCT00798369|4796344|P4|Overall Study|Adminstrative problems|0
1454413|NCT00798369|4796345|P3|Overall Study|Adminstrative problems|0
1454414|NCT00798369|4796346|P2|Overall Study|Adminstrative problems|0
1454415|NCT00798369|4796347|P1|Overall Study|Adminstrative problems|0
1454416|NCT00798369|4796342|P6|Overall Study|Lost to Follow-up|0
1454417|NCT00798369|4796343|P5|Overall Study|Lost to Follow-up|1
1454418|NCT00798369|4796344|P4|Overall Study|Lost to Follow-up|0
1454419|NCT00798369|4796345|P3|Overall Study|Lost to Follow-up|1
1454420|NCT00798369|4796346|P2|Overall Study|Lost to Follow-up|1
1454421|NCT00798369|4796347|P1|Overall Study|Lost to Follow-up|1
1454422|NCT00798369|4796342|P6|Overall Study|Subject withdrew consent|2
1454423|NCT00798369|4796343|P5|Overall Study|Subject withdrew consent|0
1454424|NCT00798369|4796344|P4|Overall Study|Subject withdrew consent|1
1454425|NCT00798369|4796345|P3|Overall Study|Subject withdrew consent|1
1454426|NCT00798369|4796346|P2|Overall Study|Subject withdrew consent|0
1454427|NCT00798369|4796347|P1|Overall Study|Subject withdrew consent|0
1454428|NCT00798317|4796394|P2|Overall Study|Death|0
1454429|NCT00798317|4796395|P1|Overall Study|Death|1
1454430|NCT00798317|4796394|P2|Overall Study|Adverse Event|0
1454431|NCT00798317|4796395|P1|Overall Study|Adverse Event|2
1454432|NCT00798317|4796394|P2|Overall Study|Lost to Follow-up|2
1454433|NCT00798317|4796395|P1|Overall Study|Lost to Follow-up|2
1454434|NCT00798317|4796394|P2|Overall Study|Withdrawal by Subject|4
1454435|NCT00798317|4796395|P1|Overall Study|Withdrawal by Subject|5
1454436|NCT00798317|4796394|P2|Overall Study|Physician Decision|1
1454437|NCT00798317|4796395|P1|Overall Study|Physician Decision|0
1454438|NCT00798304|4796406|P3|Overall Study|Discontinuation by Sponsor|9
1454439|NCT00798304|4796407|P2|Overall Study|Discontinuation by Sponsor|21
1454440|NCT00798304|4796408|P1|Overall Study|Discontinuation by Sponsor|14
1454441|NCT00798304|4796406|P3|Overall Study|Adverse Event|1
1454442|NCT00798304|4796407|P2|Overall Study|Adverse Event|1
1454443|NCT00798304|4796408|P1|Overall Study|Adverse Event|0
1454444|NCT00798161|4796441|P7|Overall Study|Other reason (incl. lack of efficacy)|5
1454445|NCT00798161|4796442|P6|Overall Study|Other reason (incl. lack of efficacy)|4
1454446|NCT00798161|4796443|P5|Overall Study|Other reason (incl. lack of efficacy)|2
1454447|NCT00798161|4796444|P4|Overall Study|Other reason (incl. lack of efficacy)|5
1454448|NCT00798161|4796445|P3|Overall Study|Other reason (incl. lack of efficacy)|3
1454449|NCT00798161|4796446|P2|Overall Study|Other reason (incl. lack of efficacy)|5
1454450|NCT00798161|4796447|P1|Overall Study|Other reason (incl. lack of efficacy)|7
1454451|NCT00798161|4796441|P7|Overall Study|Withdrawal by Subject|1
1454452|NCT00798161|4796442|P6|Overall Study|Withdrawal by Subject|3
1454453|NCT00798161|4796443|P5|Overall Study|Withdrawal by Subject|2
1454454|NCT00798161|4796444|P4|Overall Study|Withdrawal by Subject|4
1454455|NCT00798161|4796445|P3|Overall Study|Withdrawal by Subject|5
1454456|NCT00798161|4796446|P2|Overall Study|Withdrawal by Subject|4
1454457|NCT00798161|4796447|P1|Overall Study|Withdrawal by Subject|5
1454458|NCT00798161|4796441|P7|Overall Study|Lost to Follow-up|0
1454459|NCT00798161|4796442|P6|Overall Study|Lost to Follow-up|0
1454460|NCT00798161|4796443|P5|Overall Study|Lost to Follow-up|4
1454461|NCT00798161|4796444|P4|Overall Study|Lost to Follow-up|3
1454462|NCT00798161|4796445|P3|Overall Study|Lost to Follow-up|4
1454463|NCT00798161|4796446|P2|Overall Study|Lost to Follow-up|3
1454464|NCT00798161|4796447|P1|Overall Study|Lost to Follow-up|1
1454465|NCT00798161|4796441|P7|Overall Study|Protocol Violation|0
1454466|NCT00798161|4796442|P6|Overall Study|Protocol Violation|2
1454467|NCT00798161|4796443|P5|Overall Study|Protocol Violation|3
1454468|NCT00798161|4796444|P4|Overall Study|Protocol Violation|3
1454469|NCT00798161|4796445|P3|Overall Study|Protocol Violation|3
1454470|NCT00798161|4796446|P2|Overall Study|Protocol Violation|1
1454471|NCT00798161|4796447|P1|Overall Study|Protocol Violation|2
1454472|NCT00798161|4796441|P7|Overall Study|Adverse Event|4
1454473|NCT00798161|4796442|P6|Overall Study|Adverse Event|2
1454474|NCT00798161|4796443|P5|Overall Study|Adverse Event|5
1454475|NCT00798161|4796444|P4|Overall Study|Adverse Event|6
1454476|NCT00798161|4796445|P3|Overall Study|Adverse Event|6
1454477|NCT00798161|4796446|P2|Overall Study|Adverse Event|4
1454478|NCT00798161|4796447|P1|Overall Study|Adverse Event|3
1454479|NCT00798135|4796554|P1|Overall Study|Physician Decision|1
1454480|NCT00798135|4796554|P1|Overall Study|Disease progression, refractory|1
1454481|NCT00798135|4796554|P1|Overall Study|Disease progression, relapse|11
1454482|NCT00798096|4796560|P1|Overall Study|Ongoing|2
1454483|NCT00797966|4796588|P6|Phase A+|Protocol deviation|4
1454484|NCT00797966|4796589|P5|Phase A+|Protocol deviation|0
1454485|NCT00797966|4796590|P4|Phase A+|Protocol deviation|0
1454486|NCT00797966|4796591|P3|Phase A+|Protocol deviation|0
1454487|NCT00797966|4796592|P2|Phase A+|Protocol deviation|0
1454488|NCT00797966|4796593|P1|Phase A+|Protocol deviation|0
1454489|NCT00797966|4796588|P6|Phase A+|Adverse Event|4
1454490|NCT00797966|4796589|P5|Phase A+|Adverse Event|0
1454491|NCT00797966|4796590|P4|Phase A+|Adverse Event|0
1454492|NCT00797966|4796591|P3|Phase A+|Adverse Event|0
1454493|NCT00797966|4796592|P2|Phase A+|Adverse Event|0
1454494|NCT00797966|4796593|P1|Phase A+|Adverse Event|0
1454495|NCT00797966|4796588|P6|Phase A+|Withdrawal by Subject|6
1454496|NCT00797966|4796589|P5|Phase A+|Withdrawal by Subject|0
1454497|NCT00797966|4796590|P4|Phase A+|Withdrawal by Subject|0
1454498|NCT00797966|4796591|P3|Phase A+|Withdrawal by Subject|0
1454499|NCT00797966|4796592|P2|Phase A+|Withdrawal by Subject|0
1454500|NCT00797966|4796593|P1|Phase A+|Withdrawal by Subject|0
1454501|NCT00797966|4796588|P6|Phase A+|Met withdrawal criteria|5
1454502|NCT00797966|4796589|P5|Phase A+|Met withdrawal criteria|0
1454503|NCT00797966|4796590|P4|Phase A+|Met withdrawal criteria|0
1454504|NCT00797966|4796591|P3|Phase A+|Met withdrawal criteria|0
1454505|NCT00797966|4796592|P2|Phase A+|Met withdrawal criteria|0
1454506|NCT00797966|4796593|P1|Phase A+|Met withdrawal criteria|0
1454507|NCT00797966|4796588|P6|Phase A+|Lost to Follow-up|9
1454508|NCT00797966|4796589|P5|Phase A+|Lost to Follow-up|0
1454509|NCT00797966|4796590|P4|Phase A+|Lost to Follow-up|0
1454510|NCT00797966|4796591|P3|Phase A+|Lost to Follow-up|0
1454511|NCT00797966|4796592|P2|Phase A+|Lost to Follow-up|0
1454512|NCT00797966|4796593|P1|Phase A+|Lost to Follow-up|0
1454513|NCT00797966|4796588|P6|Phase B|Lack of Efficacy|0
1454514|NCT00797966|4796589|P5|Phase B|Lack of Efficacy|0
1454515|NCT00797966|4796590|P4|Phase B|Lack of Efficacy|4
1454516|NCT00797966|4796591|P3|Phase B|Lack of Efficacy|1
1454517|NCT00797966|4796592|P2|Phase B|Lack of Efficacy|1
1454518|NCT00797966|4796593|P1|Phase B|Lack of Efficacy|0
1454519|NCT00797966|4796588|P6|Phase B|Protocol Deviation|0
1454520|NCT00797966|4796589|P5|Phase B|Protocol Deviation|0
1454521|NCT00797966|4796590|P4|Phase B|Protocol Deviation|6
1454522|NCT00797966|4796591|P3|Phase B|Protocol Deviation|2
1454523|NCT00797966|4796592|P2|Phase B|Protocol Deviation|8
1454524|NCT00797966|4796593|P1|Phase B|Protocol Deviation|4
1454525|NCT00797966|4796588|P6|Phase B|Withdrawal by Subject|0
1454526|NCT00797966|4796589|P5|Phase B|Withdrawal by Subject|0
1454527|NCT00797966|4796590|P4|Phase B|Withdrawal by Subject|3
1454528|NCT00797966|4796591|P3|Phase B|Withdrawal by Subject|3
1454529|NCT00797966|4796592|P2|Phase B|Withdrawal by Subject|4
1454530|NCT00797966|4796593|P1|Phase B|Withdrawal by Subject|1
1454531|NCT00797966|4796588|P6|Phase B|Physician Decision|0
1454532|NCT00797966|4796589|P5|Phase B|Physician Decision|0
1454533|NCT00797966|4796590|P4|Phase B|Physician Decision|1
1454534|NCT00797966|4796591|P3|Phase B|Physician Decision|3
1454535|NCT00797966|4796592|P2|Phase B|Physician Decision|0
1454536|NCT00797966|4796593|P1|Phase B|Physician Decision|1
1454537|NCT00797966|4796588|P6|Phase B|Met Withdrawal Criteria|0
1454538|NCT00797966|4796589|P5|Phase B|Met Withdrawal Criteria|0
1454539|NCT00797966|4796590|P4|Phase B|Met Withdrawal Criteria|1
1454540|NCT00797966|4796591|P3|Phase B|Met Withdrawal Criteria|6
1454541|NCT00797966|4796592|P2|Phase B|Met Withdrawal Criteria|3
1454542|NCT00797966|4796593|P1|Phase B|Met Withdrawal Criteria|3
1454543|NCT00797966|4796588|P6|Phase B|Adverse Event|0
1454544|NCT00797966|4796589|P5|Phase B|Adverse Event|0
1454545|NCT00797966|4796590|P4|Phase B|Adverse Event|1
1454546|NCT00797966|4796591|P3|Phase B|Adverse Event|3
1454547|NCT00797966|4796592|P2|Phase B|Adverse Event|1
1454548|NCT00797966|4796593|P1|Phase B|Adverse Event|2
1454549|NCT00797966|4796588|P6|Phase B|Lost to Follow-up|0
1454550|NCT00797966|4796589|P5|Phase B|Lost to Follow-up|0
1454551|NCT00797966|4796590|P4|Phase B|Lost to Follow-up|0
1454552|NCT00797966|4796591|P3|Phase B|Lost to Follow-up|3
1454553|NCT00797966|4796592|P2|Phase B|Lost to Follow-up|1
1454554|NCT00797966|4796593|P1|Phase B|Lost to Follow-up|0
1454555|NCT00797966|4796588|P6|Phase A|Protocol deviation|0
1454556|NCT00797966|4796589|P5|Phase A|Protocol deviation|56
1454557|NCT00797966|4796590|P4|Phase A|Protocol deviation|0
1454558|NCT00797966|4796591|P3|Phase A|Protocol deviation|0
1454559|NCT00797966|4796592|P2|Phase A|Protocol deviation|0
1454560|NCT00797966|4796593|P1|Phase A|Protocol deviation|0
1454561|NCT00797966|4796588|P6|Phase A|Withdrawal by Subject|0
1454562|NCT00797966|4796589|P5|Phase A|Withdrawal by Subject|33
1454563|NCT00797966|4796590|P4|Phase A|Withdrawal by Subject|0
1454564|NCT00797966|4796591|P3|Phase A|Withdrawal by Subject|0
1454565|NCT00797966|4796592|P2|Phase A|Withdrawal by Subject|0
1454566|NCT00797966|4796593|P1|Phase A|Withdrawal by Subject|0
1454567|NCT00797966|4796588|P6|Phase A|Physician Decision|0
1454568|NCT00797966|4796589|P5|Phase A|Physician Decision|13
1454569|NCT00797966|4796590|P4|Phase A|Physician Decision|0
1454570|NCT00797966|4796591|P3|Phase A|Physician Decision|0
1454571|NCT00797966|4796592|P2|Phase A|Physician Decision|0
1454572|NCT00797966|4796593|P1|Phase A|Physician Decision|0
1454573|NCT00797966|4796588|P6|Phase A|Met withdrawal criteria|0
1454574|NCT00797966|4796589|P5|Phase A|Met withdrawal criteria|4
1454575|NCT00797966|4796590|P4|Phase A|Met withdrawal criteria|0
1454576|NCT00797966|4796591|P3|Phase A|Met withdrawal criteria|0
1454577|NCT00797966|4796592|P2|Phase A|Met withdrawal criteria|0
1454578|NCT00797966|4796593|P1|Phase A|Met withdrawal criteria|0
1454579|NCT00797966|4796588|P6|Phase A|Adverse Event|0
1454580|NCT00797966|4796589|P5|Phase A|Adverse Event|46
1454581|NCT00797966|4796590|P4|Phase A|Adverse Event|0
1454582|NCT00797966|4796591|P3|Phase A|Adverse Event|0
1454583|NCT00797966|4796592|P2|Phase A|Adverse Event|0
1454584|NCT00797966|4796593|P1|Phase A|Adverse Event|0
1454585|NCT00797966|4796588|P6|Phase A|Lost to Follow-up|0
1454586|NCT00797966|4796589|P5|Phase A|Lost to Follow-up|33
1454587|NCT00797966|4796590|P4|Phase A|Lost to Follow-up|0
1454588|NCT00797966|4796591|P3|Phase A|Lost to Follow-up|0
1454589|NCT00797966|4796592|P2|Phase A|Lost to Follow-up|0
1454590|NCT00797966|4796593|P1|Phase A|Lost to Follow-up|0
1454591|NCT00797862|4796658|P3|Overall Study|Mis-randomized|1
1454592|NCT00797862|4796659|P2|Overall Study|Mis-randomized|3
1454593|NCT00797862|4796660|P1|Overall Study|Mis-randomized|3
1454594|NCT00797862|4796658|P3|Overall Study|Protocol Violation|8
1454595|NCT00797862|4796659|P2|Overall Study|Protocol Violation|6
1454596|NCT00797862|4796660|P1|Overall Study|Protocol Violation|4
1454597|NCT00797862|4796658|P3|Overall Study|Administrative Problem|0
1454598|NCT00797862|4796659|P2|Overall Study|Administrative Problem|0
1454599|NCT00797862|4796660|P1|Overall Study|Administrative Problem|4
1454600|NCT00797862|4796658|P3|Overall Study|Lost to Follow-up|5
1454601|NCT00797862|4796659|P2|Overall Study|Lost to Follow-up|0
1454602|NCT00797862|4796660|P1|Overall Study|Lost to Follow-up|11
1454603|NCT00797862|4796658|P3|Overall Study|Withdrawal by Subject|7
1454604|NCT00797862|4796659|P2|Overall Study|Withdrawal by Subject|7
1454605|NCT00797862|4796660|P1|Overall Study|Withdrawal by Subject|14
1454606|NCT00797862|4796658|P3|Overall Study|No longer required study medication|0
1454607|NCT00797862|4796659|P2|Overall Study|No longer required study medication|0
1454608|NCT00797862|4796660|P1|Overall Study|No longer required study medication|1
1454609|NCT00797862|4796658|P3|Overall Study|Lack of Efficacy|6
1454610|NCT00797862|4796659|P2|Overall Study|Lack of Efficacy|7
1454611|NCT00797862|4796660|P1|Overall Study|Lack of Efficacy|1
1454612|NCT00797862|4796658|P3|Overall Study|Abnormal Test Procedure Result|1
1454613|NCT00797862|4796659|P2|Overall Study|Abnormal Test Procedure Result|1
1454614|NCT00797862|4796660|P1|Overall Study|Abnormal Test Procedure Result|0
1454615|NCT00797862|4796658|P3|Overall Study|Adverse Event|58
1454616|NCT00797862|4796659|P2|Overall Study|Adverse Event|44
1454617|NCT00797862|4796660|P1|Overall Study|Adverse Event|86
1454618|NCT00797823|4796689|P3|First Period (Initial Randomization)|Physician Decision|0
1454619|NCT00797823|4796690|P2|First Period (Initial Randomization)|Physician Decision|0
1454620|NCT00797823|4796691|P1|First Period (Initial Randomization)|Physician Decision|1
1454621|NCT00797732|4796713|P3|Overall Study|Refused to Participate|123
1454622|NCT00797732|4796714|P2|Overall Study|Refused to Participate|0
1454623|NCT00797732|4796715|P1|Overall Study|Refused to Participate|0
1454624|NCT00797732|4796713|P3|Overall Study|Excluded due to time constraints|24
1454625|NCT00797732|4796714|P2|Overall Study|Excluded due to time constraints|0
1454626|NCT00797732|4796715|P1|Overall Study|Excluded due to time constraints|0
1454627|NCT00797732|4796713|P3|Overall Study|Not meet inclusion criteria|7
1454628|NCT00797732|4796714|P2|Overall Study|Not meet inclusion criteria|0
1454629|NCT00797732|4796715|P1|Overall Study|Not meet inclusion criteria|0
1454630|NCT00797732|4796713|P3|Overall Study|Death|0
1454631|NCT00797732|4796714|P2|Overall Study|Death|0
1454632|NCT00797732|4796715|P1|Overall Study|Death|1
1454633|NCT00797732|4796713|P3|Overall Study|Lost to Follow-up|0
1454634|NCT00797732|4796714|P2|Overall Study|Lost to Follow-up|0
1454635|NCT00797732|4796715|P1|Overall Study|Lost to Follow-up|1
1454636|NCT00797732|4796713|P3|Overall Study|Withdrawal by Subject|0
1454637|NCT00797732|4796714|P2|Overall Study|Withdrawal by Subject|3
1454638|NCT00797732|4796715|P1|Overall Study|Withdrawal by Subject|3
1454639|NCT00797667|4796730|P3|Overall Study|Adverse Event|8
1454640|NCT00797667|4796731|P2|Overall Study|Adverse Event|8
1454641|NCT00797667|4796732|P1|Overall Study|Adverse Event|19
1454642|NCT00797667|4796730|P3|Overall Study|Withdrawal by Subject|2
1454643|NCT00797667|4796731|P2|Overall Study|Withdrawal by Subject|14
1454644|NCT00797667|4796732|P1|Overall Study|Withdrawal by Subject|9
1454645|NCT00797667|4796730|P3|Overall Study|Study Terminated by Sponsor|115
1454646|NCT00797667|4796731|P2|Overall Study|Study Terminated by Sponsor|216
1454647|NCT00797667|4796732|P1|Overall Study|Study Terminated by Sponsor|217
1454648|NCT00797667|4796730|P3|Overall Study|Protocol Violation|0
1454649|NCT00797667|4796731|P2|Overall Study|Protocol Violation|7
1454650|NCT00797667|4796732|P1|Overall Study|Protocol Violation|2
1454651|NCT00797667|4796730|P3|Overall Study|Pregnancy|0
1454652|NCT00797667|4796731|P2|Overall Study|Pregnancy|0
1454653|NCT00797667|4796732|P1|Overall Study|Pregnancy|2
1454654|NCT00797667|4796730|P3|Overall Study|Physician Decision|0
1454655|NCT00797667|4796731|P2|Overall Study|Physician Decision|1
1454656|NCT00797667|4796732|P1|Overall Study|Physician Decision|3
1454657|NCT00797667|4796730|P3|Overall Study|Lost to Follow-up|2
1454658|NCT00797667|4796731|P2|Overall Study|Lost to Follow-up|12
1454659|NCT00797667|4796732|P1|Overall Study|Lost to Follow-up|8
1454660|NCT00797667|4796730|P3|Overall Study|Lack of Efficacy|0
1454661|NCT00797667|4796731|P2|Overall Study|Lack of Efficacy|1
1454662|NCT00797667|4796732|P1|Overall Study|Lack of Efficacy|0
1454663|NCT00797563|4796758|P1|Overall Study|Adverse Event|1
1454664|NCT00797511|4796764|P1|Overall Study|Withdrawal by Subject|1
1454665|NCT00797316|4796782|P2|Overall Study|Unsatisfactory therapeutic effect|13
1454666|NCT00797316|4796783|P1|Overall Study|Unsatisfactory therapeutic effect|0
1454667|NCT00797316|4796782|P2|Overall Study|Patient withdrew consent|6
1454668|NCT00797316|4796783|P1|Overall Study|Patient withdrew consent|12
1454669|NCT00797316|4796782|P2|Overall Study|Protocol Deviation|2
1454670|NCT00797316|4796783|P1|Overall Study|Protocol Deviation|1
1454671|NCT00797316|4796782|P2|Overall Study|Lost to Follow-up|8
1454672|NCT00797316|4796783|P1|Overall Study|Lost to Follow-up|4
1454673|NCT00797316|4796782|P2|Overall Study|Adverse Event|3
1454674|NCT00797316|4796783|P1|Overall Study|Adverse Event|5
1454675|NCT00797316|4796782|P2|Overall Study|Administrative problems|0
1454676|NCT00797316|4796783|P1|Overall Study|Administrative problems|1
1454677|NCT00797108|4796817|P3|Overall Study|Randomized but not Treated|0
1454678|NCT00797108|4796818|P2|Overall Study|Randomized but not Treated|0
1454679|NCT00797108|4796819|P1|Overall Study|Randomized but not Treated|2
1454680|NCT00797108|4796817|P3|Overall Study|Other|2
1454681|NCT00797108|4796818|P2|Overall Study|Other|0
1454682|NCT00797108|4796819|P1|Overall Study|Other|0
1454683|NCT00797108|4796817|P3|Overall Study|Lack of Efficacy|1
1454684|NCT00797108|4796818|P2|Overall Study|Lack of Efficacy|0
1454685|NCT00797108|4796819|P1|Overall Study|Lack of Efficacy|1
1454686|NCT00797108|4796817|P3|Overall Study|Global Deterioration of Health Status|0
1454687|NCT00797108|4796818|P2|Overall Study|Global Deterioration of Health Status|1
1454688|NCT00797108|4796819|P1|Overall Study|Global Deterioration of Health Status|0
1454689|NCT00797108|4796817|P3|Overall Study|Did Not Meet Entrance Criteria|0
1454690|NCT00797108|4796818|P2|Overall Study|Did Not Meet Entrance Criteria|1
1454691|NCT00797108|4796819|P1|Overall Study|Did Not Meet Entrance Criteria|0
1454692|NCT00797108|4796817|P3|Overall Study|Adverse Event|3
1454693|NCT00797108|4796818|P2|Overall Study|Adverse Event|0
1454694|NCT00797108|4796819|P1|Overall Study|Adverse Event|1
1454695|NCT00796991|4796854|P3|Overall Study|Withdrawal by Subject|1
1454696|NCT00796991|4796855|P2|Overall Study|Withdrawal by Subject|0
1454697|NCT00796991|4796856|P1|Overall Study|Withdrawal by Subject|0
1454698|NCT00796991|4796854|P3|Overall Study|Study Drug Toxicity|5
1454699|NCT00796991|4796855|P2|Overall Study|Study Drug Toxicity|3
1454700|NCT00796991|4796856|P1|Overall Study|Study Drug Toxicity|3
1454701|NCT00796991|4796854|P3|Overall Study|Disease Progression|7
1454702|NCT00796991|4796855|P2|Overall Study|Disease Progression|9
1454703|NCT00796991|4796856|P1|Overall Study|Disease Progression|10
1454704|NCT00796991|4796854|P3|Overall Study|Death|0
1454705|NCT00796991|4796855|P2|Overall Study|Death|0
1454706|NCT00796991|4796856|P1|Overall Study|Death|2
1454707|NCT00796991|4796854|P3|Overall Study|Adverse Event|1
1454708|NCT00796991|4796855|P2|Overall Study|Adverse Event|0
1454709|NCT00796991|4796856|P1|Overall Study|Adverse Event|0
1454710|NCT00796861|4796963|P1|Overall Study|Death|2
1454711|NCT00796861|4796963|P1|Overall Study|Withdrawal by Subject|2
1454712|NCT00796822|4796969|P2|Overall Study|Adverse Event|0
1454713|NCT00796822|4796970|P1|Overall Study|Adverse Event|1
1454714|NCT00796822|4796969|P2|Overall Study|Lost to Follow-up|0
1454715|NCT00796822|4796970|P1|Overall Study|Lost to Follow-up|2
1454716|NCT00796757|4796978|P1|Overall Study|Not specified|7
1454717|NCT00796757|4796978|P1|Overall Study|Investigator's decision|2
1454718|NCT00796757|4796978|P1|Overall Study|Participant noncompliance|1
1454719|NCT00796757|4796978|P1|Overall Study|Protocol Violation|1
1454720|NCT00796757|4796978|P1|Overall Study|Death|61
1454721|NCT00796757|4796978|P1|Overall Study|Withdrawal by Subject|14
1454722|NCT00796718|4797012|P1|Overall Study|Withdrawal by Informed Consent|1
1454723|NCT00796718|4797012|P1|Overall Study|Lost to Follow-up|5
1454724|NCT00796718|4797012|P1|Overall Study|Exclusion Criteria|1
1454725|NCT00796718|4797012|P1|Overall Study|Adverse Event|2
1454726|NCT00796666|4797064|P2|Overall Study|Randomized and not treated|0
1454727|NCT00796666|4797065|P1|Overall Study|Randomized and not treated|1
1454728|NCT00796666|4797064|P2|Overall Study|Terminated by sponsor|55
1454729|NCT00796666|4797065|P1|Overall Study|Terminated by sponsor|53
1454730|NCT00796666|4797064|P2|Overall Study|Other|0
1454731|NCT00796666|4797065|P1|Overall Study|Other|1
1454732|NCT00796666|4797064|P2|Overall Study|Protocol Violation|0
1454733|NCT00796666|4797065|P1|Overall Study|Protocol Violation|1
1454734|NCT00796666|4797064|P2|Overall Study|Adverse Event|5
1454735|NCT00796666|4797065|P1|Overall Study|Adverse Event|7
1454736|NCT00796666|4797064|P2|Overall Study|Withdrawal by Subject|0
1454737|NCT00796666|4797065|P1|Overall Study|Withdrawal by Subject|2
1454738|NCT00796666|4797064|P2|Overall Study|Death|4
1454739|NCT00796666|4797065|P1|Overall Study|Death|2
1454740|NCT00796653|4797099|P4|Overall Study|Other reason not described above|4
1454741|NCT00796653|4797100|P3|Overall Study|Other reason not described above|7
1454742|NCT00796653|4797101|P2|Overall Study|Other reason not described above|9
1454743|NCT00796653|4797102|P1|Overall Study|Other reason not described above|4
1454744|NCT00796653|4797099|P4|Overall Study|Non compliance with protocol|2
1454745|NCT00796653|4797100|P3|Overall Study|Non compliance with protocol|0
1454746|NCT00796653|4797101|P2|Overall Study|Non compliance with protocol|2
1454747|NCT00796653|4797102|P1|Overall Study|Non compliance with protocol|2
1454748|NCT00796653|4797099|P4|Overall Study|Lack of Efficacy|2
1454749|NCT00796653|4797100|P3|Overall Study|Lack of Efficacy|3
1454750|NCT00796653|4797101|P2|Overall Study|Lack of Efficacy|1
1454751|NCT00796653|4797102|P1|Overall Study|Lack of Efficacy|8
1454752|NCT00796653|4797099|P4|Overall Study|Withdrawal by Subject|13
1454753|NCT00796653|4797100|P3|Overall Study|Withdrawal by Subject|8
1454754|NCT00796653|4797101|P2|Overall Study|Withdrawal by Subject|8
1454755|NCT00796653|4797102|P1|Overall Study|Withdrawal by Subject|16
1454756|NCT00796653|4797099|P4|Overall Study|Lost to Follow-up|3
1454757|NCT00796653|4797100|P3|Overall Study|Lost to Follow-up|2
1454758|NCT00796653|4797101|P2|Overall Study|Lost to Follow-up|1
1454759|NCT00796653|4797102|P1|Overall Study|Lost to Follow-up|2
1454760|NCT00796653|4797099|P4|Overall Study|Adverse Event|16
1454761|NCT00796653|4797100|P3|Overall Study|Adverse Event|16
1454762|NCT00796653|4797101|P2|Overall Study|Adverse Event|16
1454763|NCT00796653|4797102|P1|Overall Study|Adverse Event|19
1454764|NCT00796614|4797387|P4|Overall Study|Other than stated|0
1454765|NCT00796614|4797388|P3|Overall Study|Other than stated|0
1454766|NCT00796614|4797389|P2|Overall Study|Other than stated|0
1454767|NCT00796614|4797390|P1|Overall Study|Other than stated|1
1454768|NCT00796614|4797387|P4|Overall Study|Withdrawal by Subject|1
1454769|NCT00796614|4797388|P3|Overall Study|Withdrawal by Subject|0
1454770|NCT00796614|4797389|P2|Overall Study|Withdrawal by Subject|0
1454771|NCT00796614|4797390|P1|Overall Study|Withdrawal by Subject|1
1454772|NCT00796614|4797387|P4|Overall Study|Lost to Follow-up|0
1454773|NCT00796614|4797388|P3|Overall Study|Lost to Follow-up|1
1454774|NCT00796614|4797389|P2|Overall Study|Lost to Follow-up|2
1454775|NCT00796614|4797390|P1|Overall Study|Lost to Follow-up|2
1454776|NCT00796614|4797387|P4|Overall Study|Protocol Violation|0
1454777|NCT00796614|4797388|P3|Overall Study|Protocol Violation|2
1454778|NCT00796614|4797389|P2|Overall Study|Protocol Violation|0
1454779|NCT00796614|4797390|P1|Overall Study|Protocol Violation|0
1454780|NCT00796614|4797387|P4|Overall Study|Adverse Event|0
1454781|NCT00796614|4797388|P3|Overall Study|Adverse Event|0
1454782|NCT00796614|4797389|P2|Overall Study|Adverse Event|2
1454783|NCT00796614|4797390|P1|Overall Study|Adverse Event|1
1454784|NCT00796549|4797432|P1|Overall Study|Progressive disease|56
1454785|NCT00796549|4797432|P1|Overall Study|Other|2
1454786|NCT00796549|4797432|P1|Overall Study|not entered|149
1454787|NCT00796549|4797432|P1|Overall Study|Adverse Event|11
1454788|NCT00796523|4797449|P2|Overall Study|Lost to Follow-up|7
1454789|NCT00796523|4797450|P1|Overall Study|Lost to Follow-up|9
1454790|NCT00796510|4797460|P2|Overall Study|Study Terminated|0
1454791|NCT00796510|4797461|P1|Overall Study|Study Terminated|2
1454792|NCT00796510|4797460|P2|Overall Study|Death|0
1454793|NCT00796510|4797461|P1|Overall Study|Death|1
1454794|NCT00796419|4797473|P2|Overall Study|Death|1
1454795|NCT00796419|4797474|P1|Overall Study|Death|0
1454796|NCT00796367|4797487|P3|Overall Study|other|3
1454797|NCT00796367|4797488|P2|Overall Study|other|4
1454798|NCT00796367|4797489|P1|Overall Study|other|2
1454799|NCT00796367|4797487|P3|Overall Study|Requirement for restricted medication|2
1454800|NCT00796367|4797488|P2|Overall Study|Requirement for restricted medication|0
1454801|NCT00796367|4797489|P1|Overall Study|Requirement for restricted medication|2
1454802|NCT00796367|4797487|P3|Overall Study|Pregnancy|1
1454803|NCT00796367|4797488|P2|Overall Study|Pregnancy|0
1454804|NCT00796367|4797489|P1|Overall Study|Pregnancy|1
1454805|NCT00796367|4797487|P3|Overall Study|non compliance|1
1454806|NCT00796367|4797488|P2|Overall Study|non compliance|1
1454807|NCT00796367|4797489|P1|Overall Study|non compliance|3
1454808|NCT00796367|4797487|P3|Overall Study|Lack of Efficacy|0
1454809|NCT00796367|4797488|P2|Overall Study|Lack of Efficacy|1
1454810|NCT00796367|4797489|P1|Overall Study|Lack of Efficacy|2
1454811|NCT00796367|4797487|P3|Overall Study|Withdrawal by Subject|12
1454812|NCT00796367|4797488|P2|Overall Study|Withdrawal by Subject|11
1454813|NCT00796367|4797489|P1|Overall Study|Withdrawal by Subject|9
1454814|NCT00796367|4797487|P3|Overall Study|Lost to Follow-up|21
1454815|NCT00796367|4797488|P2|Overall Study|Lost to Follow-up|4
1454816|NCT00796367|4797489|P1|Overall Study|Lost to Follow-up|5
1454817|NCT00796367|4797487|P3|Overall Study|Adverse Event|7
1454818|NCT00796367|4797488|P2|Overall Study|Adverse Event|4
1454819|NCT00796367|4797489|P1|Overall Study|Adverse Event|6
1454820|NCT00796328|4797500|P1|Overall Study|experienced hypotension requiring tx|6
1454821|NCT00796315|4797504|P3|Overall Study|Protocol Violation|0
1454822|NCT00796315|4797505|P2|Overall Study|Protocol Violation|1
1454823|NCT00796315|4797506|P1|Overall Study|Protocol Violation|0
1454824|NCT00796224|4797534|P2|Overall Study|Protocol Violation|1
1454825|NCT00796224|4797535|P1|Overall Study|Protocol Violation|0
1454826|NCT00796224|4797534|P2|Overall Study|Adverse Event|0
1454827|NCT00796224|4797535|P1|Overall Study|Adverse Event|1
1454828|NCT00796120|4797555|P2|Overall Study|Randomized but not treated|3
1454829|NCT00796120|4797556|P1|Overall Study|Randomized but not treated|0
1454830|NCT00796120|4797555|P2|Overall Study|Physician Decision|17
1454831|NCT00796120|4797556|P1|Overall Study|Physician Decision|16
1454832|NCT00796120|4797555|P2|Overall Study|Other|17
1454833|NCT00796120|4797556|P1|Overall Study|Other|6
1454834|NCT00796120|4797555|P2|Overall Study|Participant refusal|4
1454835|NCT00796120|4797556|P1|Overall Study|Participant refusal|3
1454836|NCT00796120|4797555|P2|Overall Study|Progressive disease|13
1454837|NCT00796120|4797556|P1|Overall Study|Progressive disease|22
1454838|NCT00796120|4797555|P2|Overall Study|Adverse Event|6
1454839|NCT00796120|4797556|P1|Overall Study|Adverse Event|11
1454840|NCT00796120|4797555|P2|Overall Study|Death|0
1454841|NCT00796120|4797556|P1|Overall Study|Death|3
1454842|NCT00796003|4797572|P2|Overall Study|Participants Not treated|2
1454843|NCT00796003|4797573|P1|Overall Study|Participants Not treated|0
1454844|NCT00796003|4797572|P2|Overall Study|Other|1
1454845|NCT00796003|4797573|P1|Overall Study|Other|0
1454846|NCT00796003|4797572|P2|Overall Study|Withdrawal by Subject|1
1454847|NCT00796003|4797573|P1|Overall Study|Withdrawal by Subject|0
1454848|NCT00796003|4797572|P2|Overall Study|Physician Decision|4
1454849|NCT00796003|4797573|P1|Overall Study|Physician Decision|0
1454850|NCT00796003|4797572|P2|Overall Study|Specified organ function not met|1
1454851|NCT00796003|4797573|P1|Overall Study|Specified organ function not met|0
1454852|NCT00796003|4797572|P2|Overall Study|Adverse Event|7
1454853|NCT00796003|4797573|P1|Overall Study|Adverse Event|1
1454854|NCT00796003|4797572|P2|Overall Study|Disease Progression|13
1454855|NCT00796003|4797573|P1|Overall Study|Disease Progression|2
1454856|NCT00795951|4797594|P1|Overall Study|Withdrawal by Subject|1
1454857|NCT00795951|4797594|P1|Overall Study|Lost to Follow-up|1
1454858|NCT00795886|4797631|P1|Overall Study|Death|10
1454859|NCT00795821|4797639|P2|Taper Phase|Withdrawal by Subject|0
1454860|NCT00795821|4797640|P1|Taper Phase|Withdrawal by Subject|4
1454861|NCT00795821|4797639|P2|Taper Phase|Physician Decision|0
1454862|NCT00795821|4797640|P1|Taper Phase|Physician Decision|2
1454863|NCT00795821|4797639|P2|Taper Phase|Lost to Follow-up|0
1454864|NCT00795821|4797640|P1|Taper Phase|Lost to Follow-up|1
1454865|NCT00795821|4797639|P2|Taper Phase|Adverse Event|0
1454866|NCT00795821|4797640|P1|Taper Phase|Adverse Event|2
1454867|NCT00795821|4797639|P2|Long-term Extension Phase|Withdrawal by Subject|25
1454868|NCT00795821|4797640|P1|Long-term Extension Phase|Withdrawal by Subject|25
1454869|NCT00795821|4797639|P2|Long-term Extension Phase|Protocol Violation|5
1454870|NCT00795821|4797640|P1|Long-term Extension Phase|Protocol Violation|3
1454871|NCT00795821|4797639|P2|Long-term Extension Phase|Physician Decision|2
1454872|NCT00795821|4797640|P1|Long-term Extension Phase|Physician Decision|1
1454873|NCT00795821|4797639|P2|Long-term Extension Phase|Lost to Follow-up|16
1454874|NCT00795821|4797640|P1|Long-term Extension Phase|Lost to Follow-up|20
1454875|NCT00795821|4797639|P2|Long-term Extension Phase|Lack of Efficacy|12
1454876|NCT00795821|4797640|P1|Long-term Extension Phase|Lack of Efficacy|16
1454877|NCT00795821|4797639|P2|Long-term Extension Phase|Adverse Event|32
1454878|NCT00795821|4797640|P1|Long-term Extension Phase|Adverse Event|25
1454879|NCT00795821|4797639|P2|Acute Treatment Phase|Withdrawal by Subject|10
1454880|NCT00795821|4797640|P1|Acute Treatment Phase|Withdrawal by Subject|16
1454881|NCT00795821|4797639|P2|Acute Treatment Phase|Protocol Violation|2
1454882|NCT00795821|4797640|P1|Acute Treatment Phase|Protocol Violation|1
1454883|NCT00795821|4797639|P2|Acute Treatment Phase|Physician Decision|1
1454884|NCT00795821|4797640|P1|Acute Treatment Phase|Physician Decision|1
1454885|NCT00795821|4797639|P2|Acute Treatment Phase|Lost to Follow-up|12
1454886|NCT00795821|4797640|P1|Acute Treatment Phase|Lost to Follow-up|9
1454887|NCT00795821|4797639|P2|Acute Treatment Phase|Lack of Efficacy|2
1454888|NCT00795821|4797640|P1|Acute Treatment Phase|Lack of Efficacy|5
1454889|NCT00795821|4797639|P2|Acute Treatment Phase|Death|0
1454890|NCT00795821|4797640|P1|Acute Treatment Phase|Death|1
1454891|NCT00795821|4797639|P2|Acute Treatment Phase|Adverse Event|4
1454892|NCT00795821|4797640|P1|Acute Treatment Phase|Adverse Event|23
1454893|NCT00795717|4797715|P2|Phase II|too busy|1
1454894|NCT00795717|4797716|P1|Phase II|too busy|0
1454895|NCT00795717|4797715|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
1454896|NCT00795717|4797716|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
1454897|NCT00795717|4797715|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
1454898|NCT00795717|4797716|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
1454899|NCT00795717|4797715|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
1454900|NCT00795717|4797716|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
1454901|NCT00795704|4797728|P2|Overall Study|Adverse Event|1
1454902|NCT00795704|4797729|P1|Overall Study|Adverse Event|1
1454903|NCT00795704|4797728|P2|Overall Study|Withdrawal by Subject|2
1454904|NCT00795704|4797729|P1|Overall Study|Withdrawal by Subject|3
1454905|NCT00795639|4797741|P2|Overall Study|Randomized and not treated|1
1454906|NCT00795639|4797742|P1|Overall Study|Randomized and not treated|0
1454907|NCT00795639|4797741|P2|Overall Study|Terminated by sponsor|12
1454908|NCT00795639|4797742|P1|Overall Study|Terminated by sponsor|13
1454909|NCT00795639|4797741|P2|Overall Study|Other|2
1454910|NCT00795639|4797742|P1|Overall Study|Other|0
1454911|NCT00795639|4797741|P2|Overall Study|Adverse Event|2
1454912|NCT00795639|4797742|P1|Overall Study|Adverse Event|5
1454913|NCT00795639|4797741|P2|Overall Study|Pregnancy|0
1454914|NCT00795639|4797742|P1|Overall Study|Pregnancy|1
1454915|NCT00795639|4797741|P2|Overall Study|Withdrawal by Subject|3
1454916|NCT00795639|4797742|P1|Overall Study|Withdrawal by Subject|1
1454917|NCT00795639|4797741|P2|Overall Study|Death|6
1454918|NCT00795639|4797742|P1|Overall Study|Death|1
1454919|NCT00795600|4797754|P2|Overall Study|Unclassified|1
1454920|NCT00795600|4797755|P1|Overall Study|Unclassified|1
1454921|NCT00795600|4797754|P2|Overall Study|Withdrawal by Subject|0
1454922|NCT00795600|4797755|P1|Overall Study|Withdrawal by Subject|1
1454923|NCT00795600|4797754|P2|Overall Study|Protocol Violation|2
1454924|NCT00795600|4797755|P1|Overall Study|Protocol Violation|1
1454925|NCT00795600|4797754|P2|Overall Study|Adverse Event|1
1454926|NCT00795600|4797755|P1|Overall Study|Adverse Event|1
1454927|NCT00795535|4797875|P1|Overall Study|incomplete data and technical problems|20
1454928|NCT00795509|4797882|P1|Overall Study|Protocol Violation|31
1454929|NCT00795184|4797938|P2|Overall Study|Tissue sampling incomplete/conclusive|13
1454930|NCT00795184|4797939|P1|Overall Study|Tissue sampling incomplete/conclusive|8
1454931|NCT00795132|4798000|P1|Overall Study|Relapse|2
1454932|NCT00795132|4798000|P1|Overall Study|Death|1
1454933|NCT00794963|4798027|P2|Overall Study|Withdrawal by Subject|4
1454934|NCT00794963|4798028|P1|Overall Study|Withdrawal by Subject|1
1454935|NCT00794924|4798036|P2|Overall Study|Adverse Event|2
1454936|NCT00794924|4798037|P1|Overall Study|Adverse Event|6
1454937|NCT00794924|4798036|P2|Overall Study|Withdrawal by Subject|60
1454938|NCT00794924|4798037|P1|Overall Study|Withdrawal by Subject|48
1454939|NCT00794924|4798036|P2|Overall Study|Lost to Follow-up|8
1454940|NCT00794924|4798037|P1|Overall Study|Lost to Follow-up|6
1454941|NCT00794820|4798041|P1|Overall Study|Ineligible/Screen Failure|1
1454942|NCT00794820|4798041|P1|Overall Study|Resistant Disease|2
1454943|NCT00794820|4798041|P1|Overall Study|Secondary Malignancies|2
1454944|NCT00794820|4798041|P1|Overall Study|Adverse Event|11
1454945|NCT00794677|4798049|P2|First Intervention|Withdrawal by Subject|0
1454946|NCT00794677|4798050|P1|First Intervention|Withdrawal by Subject|2
1454947|NCT00794664|4798072|P2|Follow-up Period|Protocol non-compliance|1
1454948|NCT00794664|4798073|P1|Follow-up Period|Protocol non-compliance|0
1454949|NCT00794664|4798072|P2|Follow-up Period|Withdrawal by Subject|2
1454950|NCT00794664|4798073|P1|Follow-up Period|Withdrawal by Subject|0
1454951|NCT00794664|4798072|P2|Follow-up Period|Not specified|2
1454952|NCT00794664|4798073|P1|Follow-up Period|Not specified|1
1454953|NCT00794664|4798072|P2|Treatment Period|Adverse Event|8
1454954|NCT00794664|4798073|P1|Treatment Period|Adverse Event|1
1454955|NCT00794664|4798072|P2|Treatment Period|Not specified|1
1454956|NCT00794664|4798073|P1|Treatment Period|Not specified|0
1454957|NCT00794664|4798072|P2|Treatment Period|Protocol non-compliance|1
1454958|NCT00794664|4798073|P1|Treatment Period|Protocol non-compliance|0
1454959|NCT00794664|4798072|P2|Treatment Period|Withdrawal by Subject|2
1454960|NCT00794664|4798073|P1|Treatment Period|Withdrawal by Subject|0
1454961|NCT00794365|4798158|P1|Overall Study|Lack of Efficacy|3
1454962|NCT00794365|4798158|P1|Overall Study|Adverse Event|10
1454963|NCT00794365|4798158|P1|Overall Study|Poor Compliance|11
1454964|NCT00794365|4798158|P1|Overall Study|Other|17
1454965|NCT00794365|4798158|P1|Overall Study|Lost to Follow-up|38
1454966|NCT00794196|4798179|P2|Overall Study|Lost to Follow-up|23
1454967|NCT00794196|4798180|P1|Overall Study|Lost to Follow-up|5
1454968|NCT00794157|4798200|P3|Overall Study|Protocol deviation|1
1454969|NCT00794157|4798201|P2|Overall Study|Protocol deviation|1
1454970|NCT00794157|4798202|P1|Overall Study|Protocol deviation|0
1454971|NCT00794157|4798200|P3|Overall Study|Abnormal test procedure result(s)|0
1454972|NCT00794157|4798201|P2|Overall Study|Abnormal test procedure result(s)|1
1454973|NCT00794157|4798202|P1|Overall Study|Abnormal test procedure result(s)|0
1454974|NCT00794157|4798200|P3|Overall Study|Administrative problems|4
1454975|NCT00794157|4798201|P2|Overall Study|Administrative problems|7
1454976|NCT00794157|4798202|P1|Overall Study|Administrative problems|1
1454977|NCT00794157|4798200|P3|Overall Study|Unsatisfactory therapeutic effect|2
1454978|NCT00794157|4798201|P2|Overall Study|Unsatisfactory therapeutic effect|0
1454979|NCT00794157|4798202|P1|Overall Study|Unsatisfactory therapeutic effect|1
1454980|NCT00794157|4798200|P3|Overall Study|Lost to Follow-up|1
1454981|NCT00794157|4798201|P2|Overall Study|Lost to Follow-up|0
1454982|NCT00794157|4798202|P1|Overall Study|Lost to Follow-up|2
1454983|NCT00794157|4798200|P3|Overall Study|Subject withdrew consent|3
1454984|NCT00794157|4798201|P2|Overall Study|Subject withdrew consent|0
1454985|NCT00794157|4798202|P1|Overall Study|Subject withdrew consent|2
1454986|NCT00794157|4798200|P3|Overall Study|Adverse Event|8
1454987|NCT00794157|4798201|P2|Overall Study|Adverse Event|1
1454988|NCT00794157|4798202|P1|Overall Study|Adverse Event|4
1454989|NCT00794118|4798231|P1|Overall Study|Changed hospital center|2
1454990|NCT00794118|4798231|P1|Overall Study|Withdrawal by Subject|9
1454991|NCT00794118|4798231|P1|Overall Study|Lost to Follow-up|16
1454992|NCT00793910|4798289|P2|Overall Study|Withdrawal by Subject|1
1454993|NCT00793910|4798290|P1|Overall Study|Withdrawal by Subject|0
1454994|NCT00793910|4798289|P2|Overall Study|decided to undergo LASIK instead of PRK|1
1454995|NCT00793910|4798290|P1|Overall Study|decided to undergo LASIK instead of PRK|2
1454996|NCT00793910|4798289|P2|Overall Study|ineligible based on entry criteria|3
1454997|NCT00793910|4798290|P1|Overall Study|ineligible based on entry criteria|2
1454998|NCT00793910|4798289|P2|Overall Study|did not pick up medications|1
1454999|NCT00793910|4798290|P1|Overall Study|did not pick up medications|1
1455000|NCT00793910|4798289|P2|Overall Study|discarded study pills|1
1455001|NCT00793910|4798290|P1|Overall Study|discarded study pills|0
1455002|NCT00793871|4798304|P1|Overall Study|Study terminated by the Sponsor|7
1455003|NCT00793871|4798304|P1|Overall Study|Lost to Follow-up|3
1455004|NCT00793871|4798304|P1|Overall Study|Death|50
1455005|NCT00793819|4798318|P2|Overall Study|Lost to Follow-up|1
1455006|NCT00793819|4798319|P1|Overall Study|Lost to Follow-up|1
1455007|NCT00793819|4798318|P2|Overall Study|Withdrawal by Subject|3
1455008|NCT00793819|4798319|P1|Overall Study|Withdrawal by Subject|4
1455009|NCT00793819|4798318|P2|Overall Study|Lack of Efficacy|1
1455010|NCT00793819|4798319|P1|Overall Study|Lack of Efficacy|1
1455011|NCT00793819|4798318|P2|Overall Study|Adverse Event|4
1455012|NCT00793819|4798319|P1|Overall Study|Adverse Event|8
1455013|NCT00793793|4798337|P12|Overall Study|reason not specified|4
1455014|NCT00793793|4798338|P11|Overall Study|reason not specified|2
1455015|NCT00793793|4798339|P10|Overall Study|reason not specified|6
1455016|NCT00793793|4798340|P9|Overall Study|reason not specified|7
1455017|NCT00793793|4798341|P8|Overall Study|reason not specified|0
1455018|NCT00793793|4798342|P7|Overall Study|reason not specified|2
1455019|NCT00793793|4798343|P6|Overall Study|reason not specified|1
1455020|NCT00793793|4798344|P5|Overall Study|reason not specified|1
1455021|NCT00793793|4798345|P4|Overall Study|reason not specified|1
1455022|NCT00793793|4798346|P3|Overall Study|reason not specified|0
1455023|NCT00793793|4798347|P2|Overall Study|reason not specified|1
1455024|NCT00793793|4798348|P1|Overall Study|reason not specified|0
1455025|NCT00793793|4798337|P12|Overall Study|Withdrawal by Subject|0
1455026|NCT00793793|4798338|P11|Overall Study|Withdrawal by Subject|0
1455027|NCT00793793|4798339|P10|Overall Study|Withdrawal by Subject|0
1455028|NCT00793793|4798340|P9|Overall Study|Withdrawal by Subject|1
1455029|NCT00793793|4798341|P8|Overall Study|Withdrawal by Subject|0
1455030|NCT00793793|4798342|P7|Overall Study|Withdrawal by Subject|0
1455031|NCT00793793|4798343|P6|Overall Study|Withdrawal by Subject|0
1455032|NCT00793793|4798344|P5|Overall Study|Withdrawal by Subject|1
1455033|NCT00793793|4798345|P4|Overall Study|Withdrawal by Subject|0
1455034|NCT00793793|4798346|P3|Overall Study|Withdrawal by Subject|0
1455035|NCT00793793|4798347|P2|Overall Study|Withdrawal by Subject|0
1455036|NCT00793793|4798348|P1|Overall Study|Withdrawal by Subject|0
1455037|NCT00793793|4798337|P12|Overall Study|Lost to Follow-up|0
1455038|NCT00793793|4798338|P11|Overall Study|Lost to Follow-up|1
1455039|NCT00793793|4798339|P10|Overall Study|Lost to Follow-up|3
1455040|NCT00793793|4798340|P9|Overall Study|Lost to Follow-up|1
1455041|NCT00793793|4798341|P8|Overall Study|Lost to Follow-up|0
1455042|NCT00793793|4798342|P7|Overall Study|Lost to Follow-up|0
1455043|NCT00793793|4798343|P6|Overall Study|Lost to Follow-up|0
1455044|NCT00793793|4798344|P5|Overall Study|Lost to Follow-up|0
1455045|NCT00793793|4798345|P4|Overall Study|Lost to Follow-up|0
1455046|NCT00793793|4798346|P3|Overall Study|Lost to Follow-up|1
1455047|NCT00793793|4798347|P2|Overall Study|Lost to Follow-up|0
1455048|NCT00793793|4798348|P1|Overall Study|Lost to Follow-up|0
1455049|NCT00793793|4798337|P12|Overall Study|Protocol Violation|0
1455050|NCT00793793|4798338|P11|Overall Study|Protocol Violation|0
1455051|NCT00793793|4798339|P10|Overall Study|Protocol Violation|0
1455052|NCT00793793|4798340|P9|Overall Study|Protocol Violation|0
1455053|NCT00793793|4798341|P8|Overall Study|Protocol Violation|0
1455054|NCT00793793|4798342|P7|Overall Study|Protocol Violation|0
1455055|NCT00793793|4798343|P6|Overall Study|Protocol Violation|0
1455056|NCT00793793|4798344|P5|Overall Study|Protocol Violation|0
1455057|NCT00793793|4798345|P4|Overall Study|Protocol Violation|1
1455058|NCT00793793|4798346|P3|Overall Study|Protocol Violation|0
1455059|NCT00793793|4798347|P2|Overall Study|Protocol Violation|0
1455060|NCT00793793|4798348|P1|Overall Study|Protocol Violation|0
1455061|NCT00793793|4798337|P12|Overall Study|Adverse Event|2
1455062|NCT00793793|4798338|P11|Overall Study|Adverse Event|0
1455063|NCT00793793|4798339|P10|Overall Study|Adverse Event|0
1455064|NCT00793793|4798340|P9|Overall Study|Adverse Event|0
1455065|NCT00793793|4798341|P8|Overall Study|Adverse Event|0
1455066|NCT00793793|4798342|P7|Overall Study|Adverse Event|2
1455067|NCT00793793|4798343|P6|Overall Study|Adverse Event|1
1455068|NCT00793793|4798344|P5|Overall Study|Adverse Event|0
1455069|NCT00793793|4798345|P4|Overall Study|Adverse Event|1
1455070|NCT00793793|4798346|P3|Overall Study|Adverse Event|1
1455071|NCT00793793|4798347|P2|Overall Study|Adverse Event|0
1455072|NCT00793793|4798348|P1|Overall Study|Adverse Event|0
1455073|NCT00793780|4798723|P2|Overall Study|Withdrawal by Subject|1
1455074|NCT00793780|4798724|P1|Overall Study|Withdrawal by Subject|2
1455075|NCT00793624|4798755|P4|Overall Study|Other reason not described above|3
1455076|NCT00793624|4798756|P3|Overall Study|Other reason not described above|6
1455077|NCT00793624|4798757|P2|Overall Study|Other reason not described above|4
1455078|NCT00793624|4798758|P1|Overall Study|Other reason not described above|6
1455079|NCT00793624|4798755|P4|Overall Study|Non compliance with protocol|3
1455080|NCT00793624|4798756|P3|Overall Study|Non compliance with protocol|2
1455081|NCT00793624|4798757|P2|Overall Study|Non compliance with protocol|3
1455082|NCT00793624|4798758|P1|Overall Study|Non compliance with protocol|2
1455083|NCT00793624|4798755|P4|Overall Study|Lack of Efficacy|3
1455084|NCT00793624|4798756|P3|Overall Study|Lack of Efficacy|1
1455085|NCT00793624|4798757|P2|Overall Study|Lack of Efficacy|2
1455086|NCT00793624|4798758|P1|Overall Study|Lack of Efficacy|9
1455087|NCT00793624|4798755|P4|Overall Study|Withdrawal by Subject|14
1455088|NCT00793624|4798756|P3|Overall Study|Withdrawal by Subject|11
1455089|NCT00793624|4798757|P2|Overall Study|Withdrawal by Subject|9
1455090|NCT00793624|4798758|P1|Overall Study|Withdrawal by Subject|20
1455091|NCT00793624|4798755|P4|Overall Study|Lost to Follow-up|0
1455092|NCT00793624|4798756|P3|Overall Study|Lost to Follow-up|4
1455093|NCT00793624|4798757|P2|Overall Study|Lost to Follow-up|2
1455094|NCT00793624|4798758|P1|Overall Study|Lost to Follow-up|2
1455095|NCT00793624|4798755|P4|Overall Study|Adverse Event|20
1455096|NCT00793624|4798756|P3|Overall Study|Adverse Event|15
1455097|NCT00793624|4798757|P2|Overall Study|Adverse Event|16
1455098|NCT00793624|4798758|P1|Overall Study|Adverse Event|18
1455099|NCT00793585|4799039|P2|Overall Study|Protocol Violation|2
1455100|NCT00793585|4799040|P1|Overall Study|Protocol Violation|1
1455101|NCT00793585|4799039|P2|Overall Study|Adverse Event|1
1455102|NCT00793585|4799040|P1|Overall Study|Adverse Event|1
1455103|NCT00793546|4799059|P2|Overall Study|Other|0
1455104|NCT00793546|4799060|P1|Overall Study|Other|1
1455105|NCT00793546|4799059|P2|Overall Study|Study Terminated by Sponsor|27
1455106|NCT00793546|4799060|P1|Overall Study|Study Terminated by Sponsor|8
1455107|NCT00793546|4799059|P2|Overall Study|Withdrawal by Subject|1
1455108|NCT00793546|4799060|P1|Overall Study|Withdrawal by Subject|1
1455109|NCT00793546|4799059|P2|Overall Study|Lost to Follow-up|0
1455110|NCT00793546|4799060|P1|Overall Study|Lost to Follow-up|1
1455111|NCT00793546|4799059|P2|Overall Study|Death|0
1455112|NCT00793546|4799060|P1|Overall Study|Death|3
1455113|NCT00793403|4799110|P1|Overall Study|Other|73
1455114|NCT00793325|4799157|P1|Overall Study|Lost to Follow-up|1
1455115|NCT00793325|4799157|P1|Overall Study|Protocol Violation|18
1455116|NCT00793104|4799189|P1|Overall Study|Lost to Follow-up|1
1455117|NCT00792948|4799197|P1|Overall Study|Protocol Violation|1
1455118|NCT00792948|4799197|P1|Overall Study|Physician Decision|11
1455119|NCT00792948|4799197|P1|Overall Study|Insurance denial - not treated|1
1455120|NCT00792948|4799197|P1|Overall Study|Ineligible|2
1455121|NCT00792948|4799197|P1|Overall Study|Withdrawal by Subject|3
1455122|NCT00792948|4799197|P1|Overall Study|Death|4
1455123|NCT00792948|4799197|P1|Overall Study|Adverse Event|6
1455124|NCT00792935|4799208|P2|Overall Study|Withdrawal by Subject|1
1455125|NCT00792935|4799209|P1|Overall Study|Withdrawal by Subject|0
1455126|NCT00792935|4799208|P2|Overall Study|Protocol Violation|0
1455127|NCT00792935|4799209|P1|Overall Study|Protocol Violation|2
1455128|NCT00792935|4799208|P2|Overall Study|Lost to Follow-up|1
1455129|NCT00792935|4799209|P1|Overall Study|Lost to Follow-up|0
1455130|NCT00792935|4799208|P2|Overall Study|Adverse Event|1
1455131|NCT00792935|4799209|P1|Overall Study|Adverse Event|2
1455132|NCT00792909|4799241|P3|Overall Study|Withdrawal by Subject|0
1455133|NCT00792909|4799242|P2|Overall Study|Withdrawal by Subject|1
1455134|NCT00792909|4799243|P1|Overall Study|Withdrawal by Subject|0
1455135|NCT00792805|4799299|P3|Overall Study|Protocol deviation|1
1455136|NCT00792805|4799300|P2|Overall Study|Protocol deviation|1
1455137|NCT00792805|4799301|P1|Overall Study|Protocol deviation|0
1455138|NCT00792805|4799299|P3|Overall Study|Abnormal laboratory value(s)|1
1455139|NCT00792805|4799300|P2|Overall Study|Abnormal laboratory value(s)|0
1455140|NCT00792805|4799301|P1|Overall Study|Abnormal laboratory value(s)|0
1455141|NCT00792805|4799299|P3|Overall Study|Lost to Follow-up|6
1455142|NCT00792805|4799300|P2|Overall Study|Lost to Follow-up|1
1455143|NCT00792805|4799301|P1|Overall Study|Lost to Follow-up|1
1455144|NCT00792805|4799299|P3|Overall Study|Unsatisfactory therapeutic effect|6
1455145|NCT00792805|4799300|P2|Overall Study|Unsatisfactory therapeutic effect|6
1455146|NCT00792805|4799301|P1|Overall Study|Unsatisfactory therapeutic effect|1
1455147|NCT00792805|4799299|P3|Overall Study|Abnormal test procedure result(s)|0
1455148|NCT00792805|4799300|P2|Overall Study|Abnormal test procedure result(s)|2
1455149|NCT00792805|4799301|P1|Overall Study|Abnormal test procedure result(s)|1
1455150|NCT00792805|4799299|P3|Overall Study|Administrative problems|4
1455151|NCT00792805|4799300|P2|Overall Study|Administrative problems|0
1455152|NCT00792805|4799301|P1|Overall Study|Administrative problems|2
1455153|NCT00792805|4799299|P3|Overall Study|Subject withdrew consent|5
1455154|NCT00792805|4799300|P2|Overall Study|Subject withdrew consent|6
1455155|NCT00792805|4799301|P1|Overall Study|Subject withdrew consent|5
1455156|NCT00792805|4799299|P3|Overall Study|Adverse Event|10
1455157|NCT00792805|4799300|P2|Overall Study|Adverse Event|10
1455158|NCT00792805|4799301|P1|Overall Study|Adverse Event|12
1455159|NCT00792701|4799311|P2|Overall Study|Not protocol specified|0
1455160|NCT00792701|4799312|P1|Overall Study|Not protocol specified|17
1455161|NCT00792701|4799311|P2|Overall Study|Withdrawal by Subject|19
1455162|NCT00792701|4799312|P1|Overall Study|Withdrawal by Subject|1
1455163|NCT00792701|4799311|P2|Overall Study|Ineligible|3
1455164|NCT00792701|4799312|P1|Overall Study|Ineligible|1
1455165|NCT00792701|4799311|P2|Overall Study|Adverse Event|22
1455166|NCT00792701|4799312|P1|Overall Study|Adverse Event|0
1455167|NCT00792636|4799342|P3|Overall Study|Investigator Discretion|2
1455168|NCT00792636|4799343|P2|Overall Study|Investigator Discretion|0
1455169|NCT00792636|4799344|P1|Overall Study|Investigator Discretion|2
1455170|NCT00792636|4799342|P3|Overall Study|Adverse Event|3
1455171|NCT00792636|4799343|P2|Overall Study|Adverse Event|2
1455172|NCT00792636|4799344|P1|Overall Study|Adverse Event|4
1455173|NCT00792636|4799342|P3|Overall Study|Lack of Efficacy|13
1455174|NCT00792636|4799343|P2|Overall Study|Lack of Efficacy|4
1455175|NCT00792636|4799344|P1|Overall Study|Lack of Efficacy|3
1455176|NCT00792636|4799342|P3|Overall Study|Withdrew Consent|9
1455177|NCT00792636|4799343|P2|Overall Study|Withdrew Consent|13
1455178|NCT00792636|4799344|P1|Overall Study|Withdrew Consent|10
1455179|NCT00792636|4799342|P3|Overall Study|Lost to Follow-up|14
1455180|NCT00792636|4799343|P2|Overall Study|Lost to Follow-up|19
1455181|NCT00792636|4799344|P1|Overall Study|Lost to Follow-up|13
1455182|NCT00792636|4799342|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
1455183|NCT00792636|4799343|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
1455184|NCT00792636|4799344|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
1455185|NCT00792636|4799342|P3|Overall Study|Protocol Violation|20
1455186|NCT00792636|4799343|P2|Overall Study|Protocol Violation|23
1455187|NCT00792636|4799344|P1|Overall Study|Protocol Violation|17
1455188|NCT00792623|4799381|P1|Overall Study|Withdrawal by Subject|5
1455189|NCT00792623|4799381|P1|Overall Study|Adverse Event|2
1455190|NCT00792298|4799409|P8|Treatment Period 2|Withdrawal by Subject|2
1455191|NCT00792298|4799410|P7|Treatment Period 2|Withdrawal by Subject|0
1455192|NCT00792298|4799411|P6|Treatment Period 2|Withdrawal by Subject|0
1455193|NCT00792298|4799412|P5|Treatment Period 2|Withdrawal by Subject|1
1455194|NCT00792298|4799413|P4|Treatment Period 2|Withdrawal by Subject|2
1455195|NCT00792298|4799414|P3|Treatment Period 2|Withdrawal by Subject|0
1455196|NCT00792298|4799415|P2|Treatment Period 2|Withdrawal by Subject|1
1455197|NCT00792298|4799416|P1|Treatment Period 2|Withdrawal by Subject|1
1455198|NCT00792298|4799409|P8|Treatment Period 2|Pregnancy|0
1455199|NCT00792298|4799410|P7|Treatment Period 2|Pregnancy|0
1455200|NCT00792298|4799411|P6|Treatment Period 2|Pregnancy|0
1455201|NCT00792298|4799412|P5|Treatment Period 2|Pregnancy|0
1455202|NCT00792298|4799413|P4|Treatment Period 2|Pregnancy|0
1455203|NCT00792298|4799414|P3|Treatment Period 2|Pregnancy|1
1455204|NCT00792298|4799415|P2|Treatment Period 2|Pregnancy|0
1455205|NCT00792298|4799416|P1|Treatment Period 2|Pregnancy|0
1455206|NCT00792298|4799409|P8|Treatment Period 2|Physician Decision|0
1455207|NCT00792298|4799410|P7|Treatment Period 2|Physician Decision|1
1455208|NCT00792298|4799411|P6|Treatment Period 2|Physician Decision|0
1455209|NCT00792298|4799412|P5|Treatment Period 2|Physician Decision|0
1455210|NCT00792298|4799413|P4|Treatment Period 2|Physician Decision|0
1455211|NCT00792298|4799414|P3|Treatment Period 2|Physician Decision|0
1455212|NCT00792298|4799415|P2|Treatment Period 2|Physician Decision|0
1455213|NCT00792298|4799416|P1|Treatment Period 2|Physician Decision|0
1455214|NCT00792298|4799409|P8|Treatment Period 2|Lack of Efficacy|0
1455215|NCT00792298|4799410|P7|Treatment Period 2|Lack of Efficacy|0
1455216|NCT00792298|4799411|P6|Treatment Period 2|Lack of Efficacy|0
1455217|NCT00792298|4799412|P5|Treatment Period 2|Lack of Efficacy|1
1455218|NCT00792298|4799413|P4|Treatment Period 2|Lack of Efficacy|0
1455219|NCT00792298|4799414|P3|Treatment Period 2|Lack of Efficacy|0
1455220|NCT00792298|4799415|P2|Treatment Period 2|Lack of Efficacy|0
1455221|NCT00792298|4799416|P1|Treatment Period 2|Lack of Efficacy|0
1455222|NCT00792298|4799409|P8|Washout|Withdrawal by Subject|0
1455223|NCT00792298|4799410|P7|Washout|Withdrawal by Subject|0
1455224|NCT00792298|4799411|P6|Washout|Withdrawal by Subject|1
1455225|NCT00792298|4799412|P5|Washout|Withdrawal by Subject|0
1455226|NCT00792298|4799413|P4|Washout|Withdrawal by Subject|0
1455227|NCT00792298|4799414|P3|Washout|Withdrawal by Subject|1
1455228|NCT00792298|4799415|P2|Washout|Withdrawal by Subject|0
1455229|NCT00792298|4799416|P1|Washout|Withdrawal by Subject|0
1455230|NCT00792298|4799409|P8|Washout|Adverse Event|0
1455231|NCT00792298|4799410|P7|Washout|Adverse Event|0
1455232|NCT00792298|4799411|P6|Washout|Adverse Event|1
1455233|NCT00792298|4799412|P5|Washout|Adverse Event|0
1455234|NCT00792298|4799413|P4|Washout|Adverse Event|0
1455235|NCT00792298|4799414|P3|Washout|Adverse Event|0
1455236|NCT00792298|4799415|P2|Washout|Adverse Event|0
1455237|NCT00792298|4799416|P1|Washout|Adverse Event|0
1455238|NCT00792298|4799409|P8|Treatment Period 1|Protocol Violation|1
1455239|NCT00792298|4799410|P7|Treatment Period 1|Protocol Violation|0
1455240|NCT00792298|4799411|P6|Treatment Period 1|Protocol Violation|0
1455241|NCT00792298|4799412|P5|Treatment Period 1|Protocol Violation|0
1455242|NCT00792298|4799413|P4|Treatment Period 1|Protocol Violation|0
1455243|NCT00792298|4799414|P3|Treatment Period 1|Protocol Violation|0
1455244|NCT00792298|4799415|P2|Treatment Period 1|Protocol Violation|0
1455245|NCT00792298|4799416|P1|Treatment Period 1|Protocol Violation|0
1455246|NCT00792298|4799409|P8|Treatment Period 1|Physician Decision|0
1455247|NCT00792298|4799410|P7|Treatment Period 1|Physician Decision|1
1455248|NCT00792298|4799411|P6|Treatment Period 1|Physician Decision|0
1455249|NCT00792298|4799412|P5|Treatment Period 1|Physician Decision|0
1455250|NCT00792298|4799413|P4|Treatment Period 1|Physician Decision|1
1455251|NCT00792298|4799414|P3|Treatment Period 1|Physician Decision|0
1455252|NCT00792298|4799415|P2|Treatment Period 1|Physician Decision|0
1455253|NCT00792298|4799416|P1|Treatment Period 1|Physician Decision|0
1455254|NCT00792298|4799409|P8|Treatment Period 1|Lost to Follow-up|0
1455255|NCT00792298|4799410|P7|Treatment Period 1|Lost to Follow-up|1
1455256|NCT00792298|4799411|P6|Treatment Period 1|Lost to Follow-up|0
1455257|NCT00792298|4799412|P5|Treatment Period 1|Lost to Follow-up|0
1455258|NCT00792298|4799413|P4|Treatment Period 1|Lost to Follow-up|0
1455259|NCT00792298|4799414|P3|Treatment Period 1|Lost to Follow-up|0
1455260|NCT00792298|4799415|P2|Treatment Period 1|Lost to Follow-up|0
1455261|NCT00792298|4799416|P1|Treatment Period 1|Lost to Follow-up|0
1455262|NCT00792298|4799409|P8|Treatment Period 1|Withdrawal by Subject|0
1455263|NCT00792298|4799410|P7|Treatment Period 1|Withdrawal by Subject|1
1455264|NCT00792298|4799411|P6|Treatment Period 1|Withdrawal by Subject|2
1455265|NCT00792298|4799412|P5|Treatment Period 1|Withdrawal by Subject|0
1455266|NCT00792298|4799413|P4|Treatment Period 1|Withdrawal by Subject|2
1455267|NCT00792298|4799414|P3|Treatment Period 1|Withdrawal by Subject|1
1455268|NCT00792298|4799415|P2|Treatment Period 1|Withdrawal by Subject|0
1455269|NCT00792298|4799416|P1|Treatment Period 1|Withdrawal by Subject|1
1455270|NCT00792298|4799409|P8|Treatment Period 1|Lack of Efficacy|0
1455271|NCT00792298|4799410|P7|Treatment Period 1|Lack of Efficacy|0
1455272|NCT00792298|4799411|P6|Treatment Period 1|Lack of Efficacy|0
1455273|NCT00792298|4799412|P5|Treatment Period 1|Lack of Efficacy|0
1455274|NCT00792298|4799413|P4|Treatment Period 1|Lack of Efficacy|0
1455275|NCT00792298|4799414|P3|Treatment Period 1|Lack of Efficacy|1
1455276|NCT00792298|4799415|P2|Treatment Period 1|Lack of Efficacy|0
1455277|NCT00792298|4799416|P1|Treatment Period 1|Lack of Efficacy|0
1455278|NCT00792298|4799409|P8|Treatment Period 1|Adverse Event|0
1455279|NCT00792298|4799410|P7|Treatment Period 1|Adverse Event|1
1455280|NCT00792298|4799411|P6|Treatment Period 1|Adverse Event|1
1455281|NCT00792298|4799412|P5|Treatment Period 1|Adverse Event|0
1455282|NCT00792298|4799413|P4|Treatment Period 1|Adverse Event|1
1455283|NCT00792298|4799414|P3|Treatment Period 1|Adverse Event|0
1455284|NCT00792298|4799415|P2|Treatment Period 1|Adverse Event|1
1455285|NCT00792298|4799416|P1|Treatment Period 1|Adverse Event|0
1455286|NCT00792259|4799446|P3|Overall Study|Poor Quality Scans|0
1455287|NCT00792259|4799447|P2|Overall Study|Poor Quality Scans|0
1455288|NCT00792259|4799448|P1|Overall Study|Poor Quality Scans|1
1455289|NCT00792116|4799458|P2|Overall Study|Discontnued intervention|0
1455290|NCT00792116|4799459|P1|Overall Study|Discontnued intervention|1
1455291|NCT00792116|4799458|P2|Overall Study|Lost to Follow-up|1
1455292|NCT00792116|4799459|P1|Overall Study|Lost to Follow-up|0
1455293|NCT00792103|4799469|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
1455294|NCT00792103|4799469|P1|Overall Study|Protocol Violation|10
1455295|NCT00792103|4799469|P1|Overall Study|Withdrawal by Subject|52
1455296|NCT00792103|4799469|P1|Overall Study|Adverse Event|25
1455297|NCT00792103|4799469|P1|Overall Study|Lost to Follow-up|17
1455298|NCT00792103|4799469|P1|Overall Study|Enrolled, not treated|15
1455299|NCT00791999|4799481|P4|Overall Study|Reason other than those above|0
1455300|NCT00791999|4799482|P3|Overall Study|Reason other than those above|1
1455301|NCT00791999|4799483|P2|Overall Study|Reason other than those above|0
1455302|NCT00791999|4799484|P1|Overall Study|Reason other than those above|1
1455303|NCT00791999|4799481|P4|Overall Study|Lack of Efficacy|2
1455304|NCT00791999|4799482|P3|Overall Study|Lack of Efficacy|0
1455305|NCT00791999|4799483|P2|Overall Study|Lack of Efficacy|1
1455306|NCT00791999|4799484|P1|Overall Study|Lack of Efficacy|0
1455307|NCT00791999|4799481|P4|Overall Study|Adverse Event|3
1455308|NCT00791999|4799482|P3|Overall Study|Adverse Event|7
1455309|NCT00791999|4799483|P2|Overall Study|Adverse Event|3
1455310|NCT00791999|4799484|P1|Overall Study|Adverse Event|3
1455311|NCT00791999|4799481|P4|Overall Study|Protocol Violation|0
1455312|NCT00791999|4799482|P3|Overall Study|Protocol Violation|1
1455313|NCT00791999|4799483|P2|Overall Study|Protocol Violation|0
1455314|NCT00791999|4799484|P1|Overall Study|Protocol Violation|3
1455315|NCT00791999|4799481|P4|Overall Study|Withdrawal by Subject|2
1455316|NCT00791999|4799482|P3|Overall Study|Withdrawal by Subject|0
1455317|NCT00791999|4799483|P2|Overall Study|Withdrawal by Subject|1
1455318|NCT00791999|4799484|P1|Overall Study|Withdrawal by Subject|0
1455319|NCT00791999|4799481|P4|Overall Study|Protocol planed withdrawal|45
1455320|NCT00791999|4799482|P3|Overall Study|Protocol planed withdrawal|11
1455321|NCT00791999|4799483|P2|Overall Study|Protocol planed withdrawal|11
1455322|NCT00791999|4799484|P1|Overall Study|Protocol planed withdrawal|14
1455323|NCT00791934|4799509|P1|Overall Study|Did not consent for extended follow-up|13
1455324|NCT00791934|4799509|P1|Overall Study|Withdrawal by Subject|2
1455325|NCT00791921|4799519|P2|Overall Study|Reason other than those above|1
1455326|NCT00791921|4799520|P1|Overall Study|Reason other than those above|0
1455327|NCT00791921|4799519|P2|Overall Study|Lack of study drug administration|1
1455328|NCT00791921|4799520|P1|Overall Study|Lack of study drug administration|1
1455329|NCT00791921|4799519|P2|Overall Study|Lack of Efficacy|2
1455330|NCT00791921|4799520|P1|Overall Study|Lack of Efficacy|0
1455331|NCT00791921|4799519|P2|Overall Study|Adverse Event|2
1455332|NCT00791921|4799520|P1|Overall Study|Adverse Event|8
1455333|NCT00791921|4799519|P2|Overall Study|Withdrawal by Subject|2
1455334|NCT00791921|4799520|P1|Overall Study|Withdrawal by Subject|1
1455335|NCT00791921|4799519|P2|Overall Study|Protocol planed|88
1455336|NCT00791921|4799520|P1|Overall Study|Protocol planed|24
1455337|NCT00791778|4799547|P2|Follow-up|Lost to Follow-up|1
1455338|NCT00791778|4799548|P1|Follow-up|Lost to Follow-up|2
1455339|NCT00791778|4799547|P2|Follow-up|Withdrawal by Subject|0
1455340|NCT00791778|4799548|P1|Follow-up|Withdrawal by Subject|3
1455341|NCT00791778|4799547|P2|Double-blind Treatment|Non-compliant with study medication|0
1455342|NCT00791778|4799548|P1|Double-blind Treatment|Non-compliant with study medication|2
1455343|NCT00791778|4799547|P2|Double-blind Treatment|Withdrawal by Subject|9
1455344|NCT00791778|4799548|P1|Double-blind Treatment|Withdrawal by Subject|20
1455345|NCT00791778|4799547|P2|Double-blind Treatment|Protocol Violation|4
1455346|NCT00791778|4799548|P1|Double-blind Treatment|Protocol Violation|0
1455347|NCT00791778|4799547|P2|Double-blind Treatment|Physician Decision|26
1455348|NCT00791778|4799548|P1|Double-blind Treatment|Physician Decision|6
1455349|NCT00791778|4799547|P2|Double-blind Treatment|Adverse Event|9
1455350|NCT00791778|4799548|P1|Double-blind Treatment|Adverse Event|49
1455351|NCT00791765|4799602|P2|Weeks 13 to 24|Other|1
1455352|NCT00791765|4799603|P1|Weeks 13 to 24|Other|0
1455353|NCT00791765|4799602|P2|Weeks 13 to 24|Lost to Follow-up|2
1455354|NCT00791765|4799603|P1|Weeks 13 to 24|Lost to Follow-up|1
1455355|NCT00791765|4799602|P2|Weeks 13 to 24|Disease progression|1
1455356|NCT00791765|4799603|P1|Weeks 13 to 24|Disease progression|0
1455357|NCT00791765|4799602|P2|Weeks 13 to 24|Withdrawal by Subject|1
1455358|NCT00791765|4799603|P1|Weeks 13 to 24|Withdrawal by Subject|2
1455359|NCT00791765|4799602|P2|Weeks 13 to 24|Adverse Event|3
1455360|NCT00791765|4799603|P1|Weeks 13 to 24|Adverse Event|0
1455361|NCT00791765|4799602|P2|Weeks 13 to 24|Protocol deviation|0
1455362|NCT00791765|4799603|P1|Weeks 13 to 24|Protocol deviation|2
1455363|NCT00791765|4799602|P2|Weeks 1 to 12|Ineligibility determined|3
1455364|NCT00791765|4799603|P1|Weeks 1 to 12|Ineligibility determined|0
1455365|NCT00791765|4799602|P2|Weeks 1 to 12|Disease progression|0
1455366|NCT00791765|4799603|P1|Weeks 1 to 12|Disease progression|3
1455367|NCT00791765|4799602|P2|Weeks 1 to 12|Physician Decision|0
1455368|NCT00791765|4799603|P1|Weeks 1 to 12|Physician Decision|1
1455369|NCT00791765|4799602|P2|Weeks 1 to 12|Withdrawal by Subject|0
1455370|NCT00791765|4799603|P1|Weeks 1 to 12|Withdrawal by Subject|3
1455371|NCT00791765|4799602|P2|Weeks 1 to 12|Lost to Follow-up|0
1455372|NCT00791765|4799603|P1|Weeks 1 to 12|Lost to Follow-up|1
1455373|NCT00791765|4799602|P2|Weeks 1 to 12|Adverse Event|1
1455374|NCT00791765|4799603|P1|Weeks 1 to 12|Adverse Event|0
1455375|NCT00791700|4799618|P4|Overall Study|Blood sampling not done before Stage 1|1
1455376|NCT00791700|4799619|P3|Overall Study|Blood sampling not done before Stage 1|0
1455377|NCT00791700|4799620|P2|Overall Study|Blood sampling not done before Stage 1|0
1455378|NCT00791700|4799621|P1|Overall Study|Blood sampling not done before Stage 1|0
1455379|NCT00791700|4799618|P4|Overall Study|Non-compliance with study treatment|2
1455380|NCT00791700|4799619|P3|Overall Study|Non-compliance with study treatment|0
1455381|NCT00791700|4799620|P2|Overall Study|Non-compliance with study treatment|0
1455382|NCT00791700|4799621|P1|Overall Study|Non-compliance with study treatment|1
1455383|NCT00791700|4799618|P4|Overall Study|No longer willing to participate|1
1455384|NCT00791700|4799619|P3|Overall Study|No longer willing to participate|0
1455385|NCT00791700|4799620|P2|Overall Study|No longer willing to participate|1
1455386|NCT00791700|4799621|P1|Overall Study|No longer willing to participate|0
1455387|NCT00791700|4799618|P4|Overall Study|Adverse Event|1
1455388|NCT00791700|4799619|P3|Overall Study|Adverse Event|1
1455389|NCT00791700|4799620|P2|Overall Study|Adverse Event|0
1455390|NCT00791700|4799621|P1|Overall Study|Adverse Event|0
1455391|NCT00791700|4799618|P4|Overall Study|Insufficient clinical response|13
1455392|NCT00791700|4799619|P3|Overall Study|Insufficient clinical response|3
1455393|NCT00791700|4799620|P2|Overall Study|Insufficient clinical response|4
1455394|NCT00791700|4799621|P1|Overall Study|Insufficient clinical response|3
1455395|NCT00791661|4799709|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
1455396|NCT00791661|4799710|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
1455397|NCT00791661|4799711|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
1455398|NCT00791661|4799709|P3|7 Day Wash-out|Adverse Event|1
1455399|NCT00791661|4799710|P2|7 Day Wash-out|Adverse Event|0
1455400|NCT00791661|4799711|P1|7 Day Wash-out|Adverse Event|0
1455401|NCT00791648|4799804|P2|Overall Study|Withdrawal by Subject|1
1455402|NCT00791648|4799805|P1|Overall Study|Withdrawal by Subject|0
1455403|NCT00791648|4799804|P2|Overall Study|Physician Decision|1
1455404|NCT00791648|4799805|P1|Overall Study|Physician Decision|0
1455405|NCT00791557|4799821|P1|Overall Study|Adverse Event|1
1455406|NCT00791518|4799825|P1|Overall Study|Protocol Violation|93
1455407|NCT00791492|4799853|P2|Overall Study|Liver transplantation|1
1455408|NCT00791492|4799854|P1|Overall Study|Liver transplantation|5
1455409|NCT00791492|4799853|P2|Overall Study|Withdrawal by Subject|2
1455410|NCT00791492|4799854|P1|Overall Study|Withdrawal by Subject|1
1455411|NCT00791479|4799902|P6|Overall Study|Withdrawal by Subject|1
1455412|NCT00791479|4799903|P5|Overall Study|Withdrawal by Subject|0
1455413|NCT00791479|4799904|P4|Overall Study|Withdrawal by Subject|1
1455414|NCT00791479|4799905|P3|Overall Study|Withdrawal by Subject|0
1455415|NCT00791479|4799906|P2|Overall Study|Withdrawal by Subject|0
1455416|NCT00791479|4799907|P1|Overall Study|Withdrawal by Subject|0
1455417|NCT00791479|4799902|P6|Overall Study|Protocol Violation|0
1455418|NCT00791479|4799903|P5|Overall Study|Protocol Violation|0
1455419|NCT00791479|4799904|P4|Overall Study|Protocol Violation|1
1455420|NCT00791479|4799905|P3|Overall Study|Protocol Violation|0
1455421|NCT00791479|4799906|P2|Overall Study|Protocol Violation|1
1455422|NCT00791479|4799907|P1|Overall Study|Protocol Violation|2
1455423|NCT00791479|4799902|P6|Overall Study|Lost to Follow-up|1
1455424|NCT00791479|4799903|P5|Overall Study|Lost to Follow-up|0
1455425|NCT00791479|4799904|P4|Overall Study|Lost to Follow-up|0
1455426|NCT00791479|4799905|P3|Overall Study|Lost to Follow-up|0
1455427|NCT00791479|4799906|P2|Overall Study|Lost to Follow-up|1
1455428|NCT00791479|4799907|P1|Overall Study|Lost to Follow-up|0
1455429|NCT00791479|4799902|P6|Overall Study|Adverse Event|1
1455430|NCT00791479|4799903|P5|Overall Study|Adverse Event|0
1455431|NCT00791479|4799904|P4|Overall Study|Adverse Event|2
1455432|NCT00791479|4799905|P3|Overall Study|Adverse Event|0
1455433|NCT00791479|4799906|P2|Overall Study|Adverse Event|1
1455434|NCT00791479|4799907|P1|Overall Study|Adverse Event|0
1455435|NCT00791479|4799902|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
1455436|NCT00791479|4799903|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
1455437|NCT00791479|4799904|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
1455438|NCT00791479|4799905|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
1455439|NCT00791479|4799906|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
1455440|NCT00791479|4799907|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
1455441|NCT00791388|4800006|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
1455442|NCT00791388|4800007|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
1455443|NCT00791388|4800008|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
1455444|NCT00791388|4800009|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
1455445|NCT00791388|4800010|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
1455446|NCT00791388|4800006|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
1455447|NCT00791388|4800007|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
1455448|NCT00791388|4800008|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
1455449|NCT00791388|4800009|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
1455450|NCT00791388|4800010|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
1455451|NCT00791388|4800006|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
1455452|NCT00791388|4800007|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
1455453|NCT00791388|4800008|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
1455454|NCT00791388|4800009|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
1455455|NCT00791388|4800010|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
1455456|NCT00791258|4800052|P1|Overall Study|Lack of Efficacy|1
1455457|NCT00791258|4800052|P1|Overall Study|Subject required restricted medication|1
1455458|NCT00791258|4800052|P1|Overall Study|Subject incarcerated|1
1455459|NCT00791258|4800052|P1|Overall Study|non-compliance|3
1455460|NCT00791258|4800052|P1|Overall Study|subject left area|2
1455461|NCT00791258|4800052|P1|Overall Study|Did not take medication for >3 days|1
1455462|NCT00791258|4800052|P1|Overall Study|Withdrawal by Subject|40
1455463|NCT00791258|4800052|P1|Overall Study|Protocol Violation|109
1455464|NCT00791258|4800052|P1|Overall Study|Lost to Follow-up|18
1455465|NCT00791258|4800052|P1|Overall Study|Adverse Event|87
1455466|NCT00791128|4800114|P1|Overall Study|abdominal tumor, unrelated to device|1
1455467|NCT00791128|4800114|P1|Overall Study|non-compliance by subject|2
1455468|NCT00791128|4800114|P1|Overall Study|Device migration|2
1455469|NCT00791128|4800114|P1|Overall Study|Adverse Event|4
1455470|NCT00791076|4800145|P1|Overall Study|Study was terminated,PI left institution|8
1455471|NCT00790907|4800163|P3|Overall Study|Did Not Receive Study Drug|0
1455472|NCT00790907|4800164|P2|Overall Study|Did Not Receive Study Drug|0
1455473|NCT00790907|4800165|P1|Overall Study|Did Not Receive Study Drug|10
1455474|NCT00790907|4800163|P3|Overall Study|Verbatim Reason on the Case Report Form|29
1455475|NCT00790907|4800164|P2|Overall Study|Verbatim Reason on the Case Report Form|20
1455476|NCT00790907|4800165|P1|Overall Study|Verbatim Reason on the Case Report Form|74
1455477|NCT00790907|4800163|P3|Overall Study|Qualifying Condition Not Present|16
1455478|NCT00790907|4800164|P2|Overall Study|Qualifying Condition Not Present|14
1455479|NCT00790907|4800165|P1|Overall Study|Qualifying Condition Not Present|29
1455480|NCT00790907|4800163|P3|Overall Study|Required Protocol-prohibited Therapy|7
1455481|NCT00790907|4800164|P2|Overall Study|Required Protocol-prohibited Therapy|5
1455482|NCT00790907|4800165|P1|Overall Study|Required Protocol-prohibited Therapy|17
1455483|NCT00790907|4800163|P3|Overall Study|Bleeding Event|21
1455484|NCT00790907|4800164|P2|Overall Study|Bleeding Event|16
1455485|NCT00790907|4800165|P1|Overall Study|Bleeding Event|11
1455486|NCT00790907|4800163|P3|Overall Study|Withdrawal by Subject|5
1455487|NCT00790907|4800164|P2|Overall Study|Withdrawal by Subject|7
1455488|NCT00790907|4800165|P1|Overall Study|Withdrawal by Subject|1
1455489|NCT00790907|4800163|P3|Overall Study|Physician Decision|255
1455490|NCT00790907|4800164|P2|Overall Study|Physician Decision|271
1455491|NCT00790907|4800165|P1|Overall Study|Physician Decision|304
1455492|NCT00790907|4800163|P3|Overall Study|Adverse Event|6
1455493|NCT00790907|4800164|P2|Overall Study|Adverse Event|7
1455494|NCT00790907|4800165|P1|Overall Study|Adverse Event|9
1455495|NCT00790868|4800188|P2|Overall Study|Lost to Follow-up|12
1455496|NCT00790868|4800189|P1|Overall Study|Lost to Follow-up|2
1455497|NCT00790868|4800188|P2|Overall Study|Withdrawal by Subject|5
1455498|NCT00790868|4800189|P1|Overall Study|Withdrawal by Subject|4
1455499|NCT00790790|4800219|P3|Study Period 2: Therapy Phase|Physician Decision|0
1455500|NCT00790790|4800220|P2|Study Period 2: Therapy Phase|Physician Decision|1
1455501|NCT00790790|4800221|P1|Study Period 2: Therapy Phase|Physician Decision|0
1455502|NCT00790790|4800219|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
1455503|NCT00790790|4800220|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
1455504|NCT00790790|4800221|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
1455505|NCT00790790|4800219|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
1455506|NCT00790790|4800220|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
1455507|NCT00790790|4800221|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
1455508|NCT00790790|4800219|P3|Study Period 2: Therapy Phase|Protocol Violation|0
1455509|NCT00790790|4800220|P2|Study Period 2: Therapy Phase|Protocol Violation|1
1455510|NCT00790790|4800221|P1|Study Period 2: Therapy Phase|Protocol Violation|1
1455511|NCT00790790|4800219|P3|Study Period 2: Therapy Phase|Adverse Event|16
1455512|NCT00790790|4800220|P2|Study Period 2: Therapy Phase|Adverse Event|16
1455513|NCT00790790|4800221|P1|Study Period 2: Therapy Phase|Adverse Event|3
1455514|NCT00790751|4800298|P4|Overall Study|Physician Decision|1
1455515|NCT00790751|4800299|P3|Overall Study|Physician Decision|0
1455516|NCT00790751|4800300|P2|Overall Study|Physician Decision|0
1455517|NCT00790751|4800301|P1|Overall Study|Physician Decision|0
1455518|NCT00790751|4800298|P4|Overall Study|Death|0
1455519|NCT00790751|4800299|P3|Overall Study|Death|1
1455520|NCT00790751|4800300|P2|Overall Study|Death|0
1455521|NCT00790751|4800301|P1|Overall Study|Death|0
1455522|NCT00790751|4800298|P4|Overall Study|Requirement for restricted medication|0
1455523|NCT00790751|4800299|P3|Overall Study|Requirement for restricted medication|0
1455524|NCT00790751|4800300|P2|Overall Study|Requirement for restricted medication|2
1455525|NCT00790751|4800301|P1|Overall Study|Requirement for restricted medication|0
1455526|NCT00790751|4800298|P4|Overall Study|Adverse Event|4
1455527|NCT00790751|4800299|P3|Overall Study|Adverse Event|5
1455528|NCT00790751|4800300|P2|Overall Study|Adverse Event|3
1455529|NCT00790751|4800301|P1|Overall Study|Adverse Event|5
1455530|NCT00790751|4800298|P4|Overall Study|Lost to Follow-up|5
1455531|NCT00790751|4800299|P3|Overall Study|Lost to Follow-up|4
1455532|NCT00790751|4800300|P2|Overall Study|Lost to Follow-up|9
1455533|NCT00790751|4800301|P1|Overall Study|Lost to Follow-up|4
1455534|NCT00790751|4800298|P4|Overall Study|Protocol non-compliance|11
1455535|NCT00790751|4800299|P3|Overall Study|Protocol non-compliance|10
1455536|NCT00790751|4800300|P2|Overall Study|Protocol non-compliance|16
1455537|NCT00790751|4800301|P1|Overall Study|Protocol non-compliance|16
1455538|NCT00790647|4800349|P1|Overall Study|Adverse Event|1
1455539|NCT00790569|4800359|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
1455540|NCT00790569|4800360|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
1455541|NCT00790569|4800361|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
1455542|NCT00790569|4800359|P3|End of Treatment (6 Month Interview)|Incarcerated|3
1455543|NCT00790569|4800360|P2|End of Treatment (6 Month Interview)|Incarcerated|0
1455544|NCT00790569|4800361|P1|End of Treatment (6 Month Interview)|Incarcerated|0
1455545|NCT00790569|4800359|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
1455546|NCT00790569|4800360|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
1455547|NCT00790569|4800361|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
1455548|NCT00790569|4800359|P3|End of Treatment (6 Month Interview)|Hospitalized|0
1455549|NCT00790569|4800360|P2|End of Treatment (6 Month Interview)|Hospitalized|0
1455550|NCT00790569|4800361|P1|End of Treatment (6 Month Interview)|Hospitalized|2
1455551|NCT00790569|4800359|P3|End of Treatment (6 Month Interview)|Death|1
1455552|NCT00790569|4800360|P2|End of Treatment (6 Month Interview)|Death|2
1455553|NCT00790569|4800361|P1|End of Treatment (6 Month Interview)|Death|0
1455554|NCT00790569|4800359|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
1455555|NCT00790569|4800360|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
1455556|NCT00790569|4800361|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
1455557|NCT00790556|4800402|P2|Treatment Period 1|Withdrawal by Subject|0
1455558|NCT00790556|4800403|P1|Treatment Period 1|Withdrawal by Subject|1
1455559|NCT00790556|4800402|P2|Treatment Period 1|Physician Decision|0
1455560|NCT00790556|4800403|P1|Treatment Period 1|Physician Decision|1
1455561|NCT00790452|4800415|P2|Overall Study|Drug supply issue|0
1455562|NCT00790452|4800416|P1|Overall Study|Drug supply issue|1
1455563|NCT00790400|4800424|P2|Everolimus Period (Core or Extension)|New treatment|0
1455564|NCT00790400|4800425|P1|Everolimus Period (Core or Extension)|New treatment|2
1455565|NCT00790400|4800424|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
1455566|NCT00790400|4800425|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
1455567|NCT00790400|4800424|P2|Everolimus Period (Core or Extension)|Disease progression|0
1455568|NCT00790400|4800425|P1|Everolimus Period (Core or Extension)|Disease progression|5
1455569|NCT00790400|4800424|P2|Everolimus Period (Core or Extension)|Death|0
1455570|NCT00790400|4800425|P1|Everolimus Period (Core or Extension)|Death|1
1455571|NCT00790400|4800424|P2|Everolimus Period (Core or Extension)|Administrative problems|0
1455572|NCT00790400|4800425|P1|Everolimus Period (Core or Extension)|Administrative problems|2
1455573|NCT00790400|4800424|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
1455574|NCT00790400|4800425|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
1455575|NCT00790400|4800424|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
1455576|NCT00790400|4800425|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
1455577|NCT00790400|4800424|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
1455578|NCT00790400|4800425|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
1455579|NCT00790400|4800424|P2|Everolimus Period (Core or Extension)|Adverse Event|0
1455580|NCT00790400|4800425|P1|Everolimus Period (Core or Extension)|Adverse Event|9
1455581|NCT00790400|4800424|P2|Double-blind Period (Core Phase)|Death|0
1455582|NCT00790400|4800425|P1|Double-blind Period (Core Phase)|Death|1
1455583|NCT00790400|4800424|P2|Double-blind Period (Core Phase)|Administrative problems|0
1455584|NCT00790400|4800425|P1|Double-blind Period (Core Phase)|Administrative problems|1
1455585|NCT00790400|4800424|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
1455586|NCT00790400|4800425|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
1455587|NCT00790400|4800424|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
1455588|NCT00790400|4800425|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
1455589|NCT00790400|4800424|P2|Double-blind Period (Core Phase)|Adverse Event|4
1455590|NCT00790400|4800425|P1|Double-blind Period (Core Phase)|Adverse Event|2
1455591|NCT00790400|4800424|P2|Double-blind Period (Core Phase)|Progressive disease|9
1455592|NCT00790400|4800425|P1|Double-blind Period (Core Phase)|Progressive disease|0
1455593|NCT00790400|4800424|P2|Double-blind Period (Core Phase)|Protocol Violation|0
1455594|NCT00790400|4800425|P1|Double-blind Period (Core Phase)|Protocol Violation|1
1455595|NCT00790296|4800515|P2|Overall Study|Adverse Event|1
1455596|NCT00790296|4800516|P1|Overall Study|Adverse Event|0
1455597|NCT00790296|4800515|P2|Overall Study|Did not meet study eligibility criteria|1
1455598|NCT00790296|4800516|P1|Overall Study|Did not meet study eligibility criteria|1
1455599|NCT00790218|4800538|P3|Overall Study|Death|0
1455600|NCT00790218|4800539|P2|Overall Study|Death|0
1455601|NCT00790218|4800540|P1|Overall Study|Death|1
1455602|NCT00790205|4800550|P2|Overall Study|Withdrawal by Subject|363
1455603|NCT00790205|4800551|P1|Overall Study|Withdrawal by Subject|299
1455604|NCT00790205|4800550|P2|Overall Study|Lost to Follow-up|71
1455605|NCT00790205|4800551|P1|Overall Study|Lost to Follow-up|61
1455606|NCT00790036|4800648|P2|Overall Study|Subject/guardian decision|7
1455607|NCT00790036|4800649|P1|Overall Study|Subject/guardian decision|20
1455608|NCT00790036|4800648|P2|Overall Study|Withdrawal by Subject|7
1455609|NCT00790036|4800649|P1|Overall Study|Withdrawal by Subject|18
1455610|NCT00790036|4800648|P2|Overall Study|Protocol Violation|2
1455611|NCT00790036|4800649|P1|Overall Study|Protocol Violation|10
1455612|NCT00790036|4800648|P2|Overall Study|Lost to Follow-up|2
1455613|NCT00790036|4800649|P1|Overall Study|Lost to Follow-up|1
1455614|NCT00790036|4800648|P2|Overall Study|Disease progression|48
1455615|NCT00790036|4800649|P1|Overall Study|Disease progression|24
1455616|NCT00790036|4800648|P2|Overall Study|Death|0
1455617|NCT00790036|4800649|P1|Overall Study|Death|1
1455618|NCT00790036|4800648|P2|Overall Study|Adverse Event|44
1455619|NCT00790036|4800649|P1|Overall Study|Adverse Event|113
1455620|NCT00790036|4800648|P2|Overall Study|Administrative problems|9
1455621|NCT00790036|4800649|P1|Overall Study|Administrative problems|5
1455622|NCT00790036|4800648|P2|Overall Study|Abnormal lab values|2
1455623|NCT00790036|4800649|P1|Overall Study|Abnormal lab values|3
1455624|NCT00790023|4800663|P3|Overall Study|Not specified|8
1455625|NCT00790023|4800664|P2|Overall Study|Not specified|5
1455626|NCT00790023|4800665|P1|Overall Study|Not specified|5
1455627|NCT00790023|4800663|P3|Overall Study|Lost to Follow-up|1
1455628|NCT00790023|4800664|P2|Overall Study|Lost to Follow-up|0
1455629|NCT00790023|4800665|P1|Overall Study|Lost to Follow-up|0
1455630|NCT00790023|4800663|P3|Overall Study|Withdrawal by Subject|6
1455631|NCT00790023|4800664|P2|Overall Study|Withdrawal by Subject|0
1455632|NCT00790023|4800665|P1|Overall Study|Withdrawal by Subject|2
1455633|NCT00790023|4800663|P3|Overall Study|Protocol Violation|2
1455634|NCT00790023|4800664|P2|Overall Study|Protocol Violation|4
1455635|NCT00790023|4800665|P1|Overall Study|Protocol Violation|2
1455636|NCT00790023|4800663|P3|Overall Study|Adverse Event|4
1455637|NCT00790023|4800664|P2|Overall Study|Adverse Event|1
1455638|NCT00790023|4800665|P1|Overall Study|Adverse Event|2
1455639|NCT00789958|4800764|P1|Overall Study|Not eligible/not analyzable|26
1455640|NCT00789958|4800764|P1|Overall Study|not protocol specified|1
1455641|NCT00789958|4800764|P1|Overall Study|Progression|3
1455642|NCT00789958|4800764|P1|Overall Study|Withdrawal by Subject|4
1455643|NCT00789958|4800764|P1|Overall Study|Adverse Event|3
1455644|NCT00789880|4800783|P6|Overall Study|Withdrawal by Subject|0
1455645|NCT00789880|4800784|P5|Overall Study|Withdrawal by Subject|2
1455646|NCT00789880|4800785|P4|Overall Study|Withdrawal by Subject|0
1455647|NCT00789880|4800786|P3|Overall Study|Withdrawal by Subject|0
1455648|NCT00789880|4800787|P2|Overall Study|Withdrawal by Subject|0
1455649|NCT00789880|4800788|P1|Overall Study|Withdrawal by Subject|1
1455650|NCT00789880|4800783|P6|Overall Study|Protocol Violation|0
1455651|NCT00789880|4800784|P5|Overall Study|Protocol Violation|0
1455652|NCT00789880|4800785|P4|Overall Study|Protocol Violation|1
1455653|NCT00789880|4800786|P3|Overall Study|Protocol Violation|0
1455654|NCT00789880|4800787|P2|Overall Study|Protocol Violation|1
1455655|NCT00789880|4800788|P1|Overall Study|Protocol Violation|0
1455656|NCT00789880|4800783|P6|Overall Study|Adverse Event|0
1455657|NCT00789880|4800784|P5|Overall Study|Adverse Event|1
1455658|NCT00789880|4800785|P4|Overall Study|Adverse Event|0
1455659|NCT00789880|4800786|P3|Overall Study|Adverse Event|0
1455660|NCT00789880|4800787|P2|Overall Study|Adverse Event|0
1455661|NCT00789880|4800788|P1|Overall Study|Adverse Event|0
1455662|NCT00789854|4800817|P3|Overall Study|Other|5
1455663|NCT00789854|4800818|P2|Overall Study|Other|0
1455664|NCT00789854|4800819|P1|Overall Study|Other|6
1455665|NCT00789854|4800817|P3|Overall Study|Safety reasons|2
1455666|NCT00789854|4800818|P2|Overall Study|Safety reasons|0
1455667|NCT00789854|4800819|P1|Overall Study|Safety reasons|0
1455668|NCT00789854|4800817|P3|Overall Study|Severe non-compliance to the protocol|0
1455669|NCT00789854|4800818|P2|Overall Study|Severe non-compliance to the protocol|0
1455670|NCT00789854|4800819|P1|Overall Study|Severe non-compliance to the protocol|3
1455671|NCT00789854|4800817|P3|Overall Study|Eligibility criteria not fulfilled|1
1455672|NCT00789854|4800818|P2|Overall Study|Eligibility criteria not fulfilled|5
1455673|NCT00789854|4800819|P1|Overall Study|Eligibility criteria not fulfilled|2
1455674|NCT00789854|4800817|P3|Overall Study|Withdrawal by Subject|17
1455675|NCT00789854|4800818|P2|Overall Study|Withdrawal by Subject|6
1455676|NCT00789854|4800819|P1|Overall Study|Withdrawal by Subject|9
1455677|NCT00789854|4800817|P3|Overall Study|Lost to Follow-up|4
1455678|NCT00789854|4800818|P2|Overall Study|Lost to Follow-up|1
1455679|NCT00789854|4800819|P1|Overall Study|Lost to Follow-up|1
1455680|NCT00789854|4800817|P3|Overall Study|Adverse Event|18
1455681|NCT00789854|4800818|P2|Overall Study|Adverse Event|23
1455682|NCT00789854|4800819|P1|Overall Study|Adverse Event|28
1455683|NCT00789828|4800916|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
1455684|NCT00789828|4800917|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
1455685|NCT00789828|4800916|P2|Open-label Extension Period (4 Years)|Disease progression|0
1455686|NCT00789828|4800917|P1|Open-label Extension Period (4 Years)|Disease progression|1
1455687|NCT00789828|4800916|P2|Open-label Extension Period (4 Years)|Death|0
1455688|NCT00789828|4800917|P1|Open-label Extension Period (4 Years)|Death|1
1455689|NCT00789828|4800916|P2|Open-label Extension Period (4 Years)|Administrative problems|0
1455690|NCT00789828|4800917|P1|Open-label Extension Period (4 Years)|Administrative problems|7
1455691|NCT00789828|4800916|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
1455692|NCT00789828|4800917|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
1455693|NCT00789828|4800916|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
1455694|NCT00789828|4800917|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
1455695|NCT00789828|4800916|P2|Open-label Extension Period (4 Years)|Adverse Event|0
1455696|NCT00789828|4800917|P1|Open-label Extension Period (4 Years)|Adverse Event|10
1455697|NCT00789828|4800916|P2|Core Period (48 Weeks)|Lost to Follow-up|1
1455698|NCT00789828|4800917|P1|Core Period (48 Weeks)|Lost to Follow-up|0
1455699|NCT00789828|4800916|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
1455700|NCT00789828|4800917|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
1455701|NCT00789828|4800916|P2|Core Period (48 Weeks)|Administrative problems|1
1455702|NCT00789828|4800917|P1|Core Period (48 Weeks)|Administrative problems|0
1455703|NCT00789815|4800951|P2|Overall Study|Intubation due to massive bleeding|0
1455704|NCT00789815|4800952|P1|Overall Study|Intubation due to massive bleeding|1
1455705|NCT00789815|4800951|P2|Overall Study|Protocol Violation|1
1455706|NCT00789815|4800952|P1|Overall Study|Protocol Violation|6
1455707|NCT00789737|4801062|P2|Overall Study|not specified|7
1455708|NCT00789737|4801063|P1|Overall Study|not specified|11
1455709|NCT00789737|4801062|P2|Overall Study|hyperglycemia that met protocol-specifie|4
1455710|NCT00789737|4801063|P1|Overall Study|hyperglycemia that met protocol-specifie|0
1455711|NCT00789737|4801062|P2|Overall Study|Lack of Efficacy|0
1455712|NCT00789737|4801063|P1|Overall Study|Lack of Efficacy|3
1455713|NCT00789737|4801062|P2|Overall Study|Protocol Violation|0
1455714|NCT00789737|4801063|P1|Overall Study|Protocol Violation|3
1455715|NCT00789737|4801062|P2|Overall Study|Adverse Event|8
1455716|NCT00789737|4801063|P1|Overall Study|Adverse Event|8
1455717|NCT00789737|4801062|P2|Overall Study|Lost to Follow-up|14
1455718|NCT00789737|4801063|P1|Overall Study|Lost to Follow-up|10
1455719|NCT00789737|4801062|P2|Overall Study|Withdrawal by Subject|22
1455720|NCT00789737|4801063|P1|Overall Study|Withdrawal by Subject|13
1455721|NCT00789698|4801106|P4|Overall Study|Administrative|1
1455722|NCT00789698|4801107|P3|Overall Study|Administrative|3
1455723|NCT00789698|4801108|P2|Overall Study|Administrative|3
1455724|NCT00789698|4801109|P1|Overall Study|Administrative|0
1455725|NCT00789698|4801106|P4|Overall Study|Withdrawal by Subject|19
1455726|NCT00789698|4801107|P3|Overall Study|Withdrawal by Subject|12
1455727|NCT00789698|4801108|P2|Overall Study|Withdrawal by Subject|15
1455728|NCT00789698|4801109|P1|Overall Study|Withdrawal by Subject|14
1455729|NCT00789698|4801106|P4|Overall Study|Protocol Violation|1
1455730|NCT00789698|4801107|P3|Overall Study|Protocol Violation|2
1455731|NCT00789698|4801108|P2|Overall Study|Protocol Violation|1
1455732|NCT00789698|4801109|P1|Overall Study|Protocol Violation|6
1455733|NCT00789698|4801106|P4|Overall Study|Lost to Follow-up|9
1455734|NCT00789698|4801107|P3|Overall Study|Lost to Follow-up|2
1455735|NCT00789698|4801108|P2|Overall Study|Lost to Follow-up|5
1455736|NCT00789698|4801109|P1|Overall Study|Lost to Follow-up|5
1455737|NCT00789698|4801106|P4|Overall Study|Adverse Event|4
1455738|NCT00789698|4801107|P3|Overall Study|Adverse Event|3
1455739|NCT00789698|4801108|P2|Overall Study|Adverse Event|5
1455740|NCT00789698|4801109|P1|Overall Study|Adverse Event|5
1455741|NCT00789698|4801106|P4|Overall Study|Lack of Efficacy|18
1455742|NCT00789698|4801107|P3|Overall Study|Lack of Efficacy|5
1455743|NCT00789698|4801108|P2|Overall Study|Lack of Efficacy|4
1455744|NCT00789698|4801109|P1|Overall Study|Lack of Efficacy|10
1455745|NCT00789581|4801164|P2|Adjuvant Therapy|Not Specified|1
1455746|NCT00789581|4801165|P1|Adjuvant Therapy|Not Specified|0
1455747|NCT00789581|4801164|P2|Adjuvant Therapy|Protocol Violation|1
1455748|NCT00789581|4801165|P1|Adjuvant Therapy|Protocol Violation|1
1455749|NCT00789581|4801164|P2|Adjuvant Therapy|Intercurrent Illness|3
1455750|NCT00789581|4801165|P1|Adjuvant Therapy|Intercurrent Illness|1
1455751|NCT00789581|4801164|P2|Adjuvant Therapy|Disease recurrence|1
1455752|NCT00789581|4801165|P1|Adjuvant Therapy|Disease recurrence|2
1455753|NCT00789581|4801164|P2|Adjuvant Therapy|Withdrawal by Subject|5
1455754|NCT00789581|4801165|P1|Adjuvant Therapy|Withdrawal by Subject|14
1455755|NCT00789581|4801164|P2|Adjuvant Therapy|Adverse Event|44
1455756|NCT00789581|4801165|P1|Adjuvant Therapy|Adverse Event|20
1455757|NCT00789581|4801164|P2|Adjuvant Therapy|Never treated|2
1455758|NCT00789581|4801165|P1|Adjuvant Therapy|Never treated|2
1455759|NCT00789581|4801164|P2|AC Therapy|Not specified|2
1455760|NCT00789581|4801165|P1|AC Therapy|Not specified|0
1455761|NCT00789581|4801164|P2|AC Therapy|Never Treated|4
1455762|NCT00789581|4801165|P1|AC Therapy|Never Treated|1
1455763|NCT00789581|4801164|P2|AC Therapy|Intercurrent Illness|0
1455764|NCT00789581|4801165|P1|AC Therapy|Intercurrent Illness|1
1455765|NCT00789581|4801164|P2|AC Therapy|Disease recurrence|1
1455766|NCT00789581|4801165|P1|AC Therapy|Disease recurrence|3
1455767|NCT00789581|4801164|P2|AC Therapy|Withdrawal by Subject|7
1455768|NCT00789581|4801165|P1|AC Therapy|Withdrawal by Subject|4
1455769|NCT00789581|4801164|P2|AC Therapy|Adverse Event|3
1455770|NCT00789581|4801165|P1|AC Therapy|Adverse Event|2
1455771|NCT00789555|4801176|P3|Overall Study|Protocol Violation|13
1455772|NCT00789555|4801177|P2|Overall Study|Protocol Violation|9
1455773|NCT00789555|4801178|P1|Overall Study|Protocol Violation|6
1455774|NCT00789555|4801176|P3|Overall Study|Treatment failure|12
1455775|NCT00789555|4801177|P2|Overall Study|Treatment failure|8
1455776|NCT00789555|4801178|P1|Overall Study|Treatment failure|11
1455777|NCT00789555|4801176|P3|Overall Study|Patient decision unnrelated to adv event|26
1455778|NCT00789555|4801177|P2|Overall Study|Patient decision unnrelated to adv event|29
1455779|NCT00789555|4801178|P1|Overall Study|Patient decision unnrelated to adv event|38
1455780|NCT00789555|4801176|P3|Overall Study|Lost to Follow-up|18
1455781|NCT00789555|4801177|P2|Overall Study|Lost to Follow-up|10
1455782|NCT00789555|4801178|P1|Overall Study|Lost to Follow-up|9
1455783|NCT00789555|4801176|P3|Overall Study|Adverse Event|10
1455784|NCT00789555|4801177|P2|Overall Study|Adverse Event|7
1455785|NCT00789555|4801178|P1|Overall Study|Adverse Event|17
1455786|NCT00789555|4801176|P3|Overall Study|Protocol Amendment|80
1455787|NCT00789555|4801177|P2|Overall Study|Protocol Amendment|76
1455788|NCT00789555|4801178|P1|Overall Study|Protocol Amendment|78
1455789|NCT00789529|4801203|P2|Overall Study|Other Reason|0
1455790|NCT00789529|4801204|P1|Overall Study|Other Reason|1
1455791|NCT00789529|4801203|P2|Overall Study|Withdrawal by Subject|1
1455792|NCT00789529|4801204|P1|Overall Study|Withdrawal by Subject|0
1455793|NCT00789477|4801217|P5|Overall Study|Other|0
1455794|NCT00789477|4801218|P4|Overall Study|Other|3
1455795|NCT00789477|4801219|P3|Overall Study|Other|1
1455796|NCT00789477|4801220|P2|Overall Study|Other|0
1455797|NCT00789477|4801221|P1|Overall Study|Other|2
1455798|NCT00789477|4801217|P5|Overall Study|Lack of Efficacy|0
1455799|NCT00789477|4801218|P4|Overall Study|Lack of Efficacy|0
1455800|NCT00789477|4801219|P3|Overall Study|Lack of Efficacy|0
1455801|NCT00789477|4801220|P2|Overall Study|Lack of Efficacy|0
1455802|NCT00789477|4801221|P1|Overall Study|Lack of Efficacy|2
1455803|NCT00789477|4801217|P5|Overall Study|Lost to Follow-up|4
1455804|NCT00789477|4801218|P4|Overall Study|Lost to Follow-up|2
1455805|NCT00789477|4801219|P3|Overall Study|Lost to Follow-up|4
1455806|NCT00789477|4801220|P2|Overall Study|Lost to Follow-up|1
1455807|NCT00789477|4801221|P1|Overall Study|Lost to Follow-up|0
1455808|NCT00789477|4801217|P5|Overall Study|Death|0
1455809|NCT00789477|4801218|P4|Overall Study|Death|2
1455810|NCT00789477|4801219|P3|Overall Study|Death|2
1455811|NCT00789477|4801220|P2|Overall Study|Death|1
1455812|NCT00789477|4801221|P1|Overall Study|Death|1
1455813|NCT00789477|4801217|P5|Overall Study|Adverse Event|0
1455814|NCT00789477|4801218|P4|Overall Study|Adverse Event|0
1455815|NCT00789477|4801219|P3|Overall Study|Adverse Event|1
1455816|NCT00789477|4801220|P2|Overall Study|Adverse Event|3
1455817|NCT00789477|4801221|P1|Overall Study|Adverse Event|3
1455818|NCT00789477|4801217|P5|Overall Study|Protocol Violation|0
1455819|NCT00789477|4801218|P4|Overall Study|Protocol Violation|1
1455820|NCT00789477|4801219|P3|Overall Study|Protocol Violation|0
1455821|NCT00789477|4801220|P2|Overall Study|Protocol Violation|0
1455822|NCT00789477|4801221|P1|Overall Study|Protocol Violation|1
1455823|NCT00789477|4801217|P5|Overall Study|Withdrawal by Subject|3
1455824|NCT00789477|4801218|P4|Overall Study|Withdrawal by Subject|2
1455825|NCT00789477|4801219|P3|Overall Study|Withdrawal by Subject|3
1455826|NCT00789477|4801220|P2|Overall Study|Withdrawal by Subject|1
1455827|NCT00789477|4801221|P1|Overall Study|Withdrawal by Subject|2
1455828|NCT00789373|4801266|P3|Maintenance|Participants On-Going at Data Cut-Off|0
1455829|NCT00789373|4801267|P2|Maintenance|Participants On-Going at Data Cut-Off|4
1455830|NCT00789373|4801268|P1|Maintenance|Participants On-Going at Data Cut-Off|0
1455831|NCT00789373|4801266|P3|Maintenance|Sponsor Decision|2
1455832|NCT00789373|4801267|P2|Maintenance|Sponsor Decision|0
1455833|NCT00789373|4801268|P1|Maintenance|Sponsor Decision|0
1455834|NCT00789373|4801266|P3|Maintenance|Withdrawal by Subject|8
1455835|NCT00789373|4801267|P2|Maintenance|Withdrawal by Subject|21
1455836|NCT00789373|4801268|P1|Maintenance|Withdrawal by Subject|0
1455837|NCT00789373|4801266|P3|Maintenance|Progressive Disease|152
1455838|NCT00789373|4801267|P2|Maintenance|Progressive Disease|253
1455839|NCT00789373|4801268|P1|Maintenance|Progressive Disease|0
1455840|NCT00789373|4801266|P3|Maintenance|Lost to Follow-up|0
1455841|NCT00789373|4801267|P2|Maintenance|Lost to Follow-up|2
1455842|NCT00789373|4801268|P1|Maintenance|Lost to Follow-up|0
1455843|NCT00789373|4801266|P3|Maintenance|Protocol entry criteria not met|0
1455844|NCT00789373|4801267|P2|Maintenance|Protocol entry criteria not met|2
1455845|NCT00789373|4801268|P1|Maintenance|Protocol entry criteria not met|0
1455846|NCT00789373|4801266|P3|Maintenance|Investigator Decision|2
1455847|NCT00789373|4801267|P2|Maintenance|Investigator Decision|4
1455848|NCT00789373|4801268|P1|Maintenance|Investigator Decision|0
1455849|NCT00789373|4801266|P3|Maintenance|Death due to toxicity|2
1455850|NCT00789373|4801267|P2|Maintenance|Death due to toxicity|1
1455851|NCT00789373|4801268|P1|Maintenance|Death due to toxicity|0
1455852|NCT00789373|4801266|P3|Maintenance|Death due to adverse event|1
1455853|NCT00789373|4801267|P2|Maintenance|Death due to adverse event|4
1455854|NCT00789373|4801268|P1|Maintenance|Death due to adverse event|0
1455855|NCT00789373|4801266|P3|Maintenance|Death due to study disease|1
1455856|NCT00789373|4801267|P2|Maintenance|Death due to study disease|3
1455857|NCT00789373|4801268|P1|Maintenance|Death due to study disease|0
1455858|NCT00789373|4801266|P3|Maintenance|Adverse Event|12
1455859|NCT00789373|4801267|P2|Maintenance|Adverse Event|65
1455860|NCT00789373|4801268|P1|Maintenance|Adverse Event|0
1455861|NCT00789373|4801266|P3|Induction|Withdrawal by Subject|0
1455862|NCT00789373|4801267|P2|Induction|Withdrawal by Subject|0
1455863|NCT00789373|4801268|P1|Induction|Withdrawal by Subject|37
1455864|NCT00789373|4801266|P3|Induction|Progressive Disease|0
1455865|NCT00789373|4801267|P2|Induction|Progressive Disease|0
1455866|NCT00789373|4801268|P1|Induction|Progressive Disease|220
1455867|NCT00789373|4801266|P3|Induction|Protocol Violation|0
1455868|NCT00789373|4801267|P2|Induction|Protocol Violation|0
1455869|NCT00789373|4801268|P1|Induction|Protocol Violation|1
1455870|NCT00789373|4801266|P3|Induction|Lost to Follow-up|0
1455871|NCT00789373|4801267|P2|Induction|Lost to Follow-up|0
1455872|NCT00789373|4801268|P1|Induction|Lost to Follow-up|6
1455873|NCT00789373|4801266|P3|Induction|Protocol entry criteria not met|0
1455874|NCT00789373|4801267|P2|Induction|Protocol entry criteria not met|0
1455875|NCT00789373|4801268|P1|Induction|Protocol entry criteria not met|9
1455876|NCT00789373|4801266|P3|Induction|Investigator decision|0
1455877|NCT00789373|4801267|P2|Induction|Investigator decision|0
1455878|NCT00789373|4801268|P1|Induction|Investigator decision|7
1455879|NCT00789373|4801266|P3|Induction|Death due to procedure|0
1455880|NCT00789373|4801267|P2|Induction|Death due to procedure|0
1455881|NCT00789373|4801268|P1|Induction|Death due to procedure|1
1455882|NCT00789373|4801266|P3|Induction|Death due to toxicity|0
1455883|NCT00789373|4801267|P2|Induction|Death due to toxicity|0
1455884|NCT00789373|4801268|P1|Induction|Death due to toxicity|11
1455885|NCT00789373|4801266|P3|Induction|Death due to adverse event|0
1455886|NCT00789373|4801267|P2|Induction|Death due to adverse event|0
1455887|NCT00789373|4801268|P1|Induction|Death due to adverse event|19
1455888|NCT00789373|4801266|P3|Induction|Death Due to study disease|0
1455889|NCT00789373|4801267|P2|Induction|Death Due to study disease|0
1455890|NCT00789373|4801268|P1|Induction|Death Due to study disease|24
1455891|NCT00789373|4801266|P3|Induction|Adverse Event|0
1455892|NCT00789373|4801267|P2|Induction|Adverse Event|0
1455893|NCT00789373|4801268|P1|Induction|Adverse Event|64
1455894|NCT00789321|4801295|P2|Overall Study|Adverse Event|1
1455895|NCT00789321|4801296|P1|Overall Study|Adverse Event|0
1455896|NCT00789191|4801315|P2|Overall Study|Unclassified|3
1455897|NCT00789191|4801316|P1|Overall Study|Unclassified|5
1455898|NCT00789191|4801315|P2|Overall Study|Withdrawal Criteria|4
1455899|NCT00789191|4801316|P1|Overall Study|Withdrawal Criteria|2
1455900|NCT00789191|4801315|P2|Overall Study|Protocol Violation|3
1455901|NCT00789191|4801316|P1|Overall Study|Protocol Violation|5
1455902|NCT00789191|4801315|P2|Overall Study|Lack of Efficacy|5
1455903|NCT00789191|4801316|P1|Overall Study|Lack of Efficacy|0
1455904|NCT00789191|4801315|P2|Overall Study|Adverse Event|4
1455905|NCT00789191|4801316|P1|Overall Study|Adverse Event|2
1455906|NCT00789035|4801373|P5|Overall Study|Other reason not defined above|1
1455907|NCT00789035|4801374|P4|Overall Study|Other reason not defined above|0
1455908|NCT00789035|4801375|P3|Overall Study|Other reason not defined above|1
1455909|NCT00789035|4801376|P2|Overall Study|Other reason not defined above|3
1455910|NCT00789035|4801377|P1|Overall Study|Other reason not defined above|2
1455911|NCT00789035|4801373|P5|Overall Study|Withdrawal by Subject|0
1455912|NCT00789035|4801374|P4|Overall Study|Withdrawal by Subject|0
1455913|NCT00789035|4801375|P3|Overall Study|Withdrawal by Subject|0
1455914|NCT00789035|4801376|P2|Overall Study|Withdrawal by Subject|2
1455915|NCT00789035|4801377|P1|Overall Study|Withdrawal by Subject|0
1455916|NCT00789035|4801373|P5|Overall Study|Protocol Violation|0
1455917|NCT00789035|4801374|P4|Overall Study|Protocol Violation|0
1455918|NCT00789035|4801375|P3|Overall Study|Protocol Violation|0
1455919|NCT00789035|4801376|P2|Overall Study|Protocol Violation|0
1455920|NCT00789035|4801377|P1|Overall Study|Protocol Violation|1
1455921|NCT00789035|4801373|P5|Overall Study|Lack of Efficacy|2
1455922|NCT00789035|4801374|P4|Overall Study|Lack of Efficacy|0
1455923|NCT00789035|4801375|P3|Overall Study|Lack of Efficacy|0
1455924|NCT00789035|4801376|P2|Overall Study|Lack of Efficacy|0
1455925|NCT00789035|4801377|P1|Overall Study|Lack of Efficacy|3
1455926|NCT00789035|4801373|P5|Overall Study|Adverse Event|3
1455927|NCT00789035|4801374|P4|Overall Study|Adverse Event|1
1455928|NCT00789035|4801375|P3|Overall Study|Adverse Event|0
1455929|NCT00789035|4801376|P2|Overall Study|Adverse Event|2
1455930|NCT00789035|4801377|P1|Overall Study|Adverse Event|0
1455931|NCT00788957|4801436|P6|Part 3|On-study at time of data cut-off|0
1455932|NCT00788957|4801437|P5|Part 3|On-study at time of data cut-off|1
1455933|NCT00788957|4801438|P4|Part 3|On-study at time of data cut-off|0
1455934|NCT00788957|4801439|P3|Part 3|On-study at time of data cut-off|0
1455935|NCT00788957|4801440|P2|Part 3|On-study at time of data cut-off|0
1455936|NCT00788957|4801441|P1|Part 3|On-study at time of data cut-off|0
1455937|NCT00788957|4801436|P6|Part 3|Death|9
1455938|NCT00788957|4801437|P5|Part 3|Death|8
1455939|NCT00788957|4801438|P4|Part 3|Death|0
1455940|NCT00788957|4801439|P3|Part 3|Death|0
1455941|NCT00788957|4801440|P2|Part 3|Death|0
1455942|NCT00788957|4801441|P1|Part 3|Death|0
1455943|NCT00788957|4801436|P6|Part 3|Withdrawal by Subject|2
1455944|NCT00788957|4801437|P5|Part 3|Withdrawal by Subject|0
1455945|NCT00788957|4801438|P4|Part 3|Withdrawal by Subject|0
1455946|NCT00788957|4801439|P3|Part 3|Withdrawal by Subject|0
1455947|NCT00788957|4801440|P2|Part 3|Withdrawal by Subject|0
1455948|NCT00788957|4801441|P1|Part 3|Withdrawal by Subject|0
1455949|NCT00788957|4801436|P6|Part 2|On-study at time of data cut-off|0
1455950|NCT00788957|4801437|P5|Part 2|On-study at time of data cut-off|0
1455951|NCT00788957|4801438|P4|Part 2|On-study at time of data cut-off|1
1455952|NCT00788957|4801439|P3|Part 2|On-study at time of data cut-off|1
1455953|NCT00788957|4801440|P2|Part 2|On-study at time of data cut-off|1
1455954|NCT00788957|4801441|P1|Part 2|On-study at time of data cut-off|0
1455955|NCT00788957|4801436|P6|Part 2|Lost to Follow-up|0
1455956|NCT00788957|4801437|P5|Part 2|Lost to Follow-up|0
1455957|NCT00788957|4801438|P4|Part 2|Lost to Follow-up|0
1455958|NCT00788957|4801439|P3|Part 2|Lost to Follow-up|3
1455959|NCT00788957|4801440|P2|Part 2|Lost to Follow-up|0
1455960|NCT00788957|4801441|P1|Part 2|Lost to Follow-up|0
1455961|NCT00788957|4801436|P6|Part 2|Death|0
1455962|NCT00788957|4801437|P5|Part 2|Death|0
1455963|NCT00788957|4801438|P4|Part 2|Death|37
1455964|NCT00788957|4801439|P3|Part 2|Death|35
1455965|NCT00788957|4801440|P2|Part 2|Death|32
1455966|NCT00788957|4801441|P1|Part 2|Death|0
1455967|NCT00788957|4801436|P6|Part 2|Withdrawal by Subject|0
1455968|NCT00788957|4801437|P5|Part 2|Withdrawal by Subject|0
1455969|NCT00788957|4801438|P4|Part 2|Withdrawal by Subject|3
1455970|NCT00788957|4801439|P3|Part 2|Withdrawal by Subject|5
1455971|NCT00788957|4801440|P2|Part 2|Withdrawal by Subject|9
1455972|NCT00788957|4801441|P1|Part 2|Withdrawal by Subject|0
1455973|NCT00788957|4801436|P6|Part 1|Lost to Follow-up|0
1455974|NCT00788957|4801437|P5|Part 1|Lost to Follow-up|0
1455975|NCT00788957|4801438|P4|Part 1|Lost to Follow-up|0
1455976|NCT00788957|4801439|P3|Part 1|Lost to Follow-up|0
1455977|NCT00788957|4801440|P2|Part 1|Lost to Follow-up|0
1455978|NCT00788957|4801441|P1|Part 1|Lost to Follow-up|1
1455979|NCT00788957|4801436|P6|Part 1|Death|0
1455980|NCT00788957|4801437|P5|Part 1|Death|0
1455981|NCT00788957|4801438|P4|Part 1|Death|0
1455982|NCT00788957|4801439|P3|Part 1|Death|0
1455983|NCT00788957|4801440|P2|Part 1|Death|0
1455984|NCT00788957|4801441|P1|Part 1|Death|8
1455985|NCT00788775|4801516|P2|Overall Study|Patient's measurable disease resected.|0
1455986|NCT00788775|4801517|P1|Overall Study|Patient's measurable disease resected.|1
1455987|NCT00788775|4801516|P2|Overall Study|Patient Non-Compliance|0
1455988|NCT00788775|4801517|P1|Overall Study|Patient Non-Compliance|1
1455989|NCT00788775|4801516|P2|Overall Study|Withdrawal by Subject|2
1455990|NCT00788775|4801517|P1|Overall Study|Withdrawal by Subject|0
1455991|NCT00788775|4801516|P2|Overall Study|Progressive Disease|6
1455992|NCT00788775|4801517|P1|Overall Study|Progressive Disease|8
1455993|NCT00788710|4801532|P3|Overall Study|Withdrawal by Subject|0
1455994|NCT00788710|4801533|P2|Overall Study|Withdrawal by Subject|2
1455995|NCT00788710|4801534|P1|Overall Study|Withdrawal by Subject|2
1455996|NCT00788710|4801532|P3|Overall Study|Protocol Violation|1
1455997|NCT00788710|4801533|P2|Overall Study|Protocol Violation|1
1455998|NCT00788710|4801534|P1|Overall Study|Protocol Violation|0
1455999|NCT00788710|4801532|P3|Overall Study|Physician Decision|0
1456000|NCT00788710|4801533|P2|Overall Study|Physician Decision|1
1456001|NCT00788710|4801534|P1|Overall Study|Physician Decision|2
1456002|NCT00788710|4801532|P3|Overall Study|Lost to Follow-up|0
1456003|NCT00788710|4801533|P2|Overall Study|Lost to Follow-up|1
1456004|NCT00788710|4801534|P1|Overall Study|Lost to Follow-up|0
1456005|NCT00788710|4801532|P3|Overall Study|Lack of Efficacy|1
1456006|NCT00788710|4801533|P2|Overall Study|Lack of Efficacy|0
1456007|NCT00788710|4801534|P1|Overall Study|Lack of Efficacy|0
1456008|NCT00788710|4801532|P3|Overall Study|Adverse Event|4
1456009|NCT00788710|4801533|P2|Overall Study|Adverse Event|3
1456010|NCT00788710|4801534|P1|Overall Study|Adverse Event|1
1456011|NCT00788697|4801548|P1|Overall Study|Indeterminate diagnosis from truth stand|17
1456012|NCT00788697|4801548|P1|Overall Study|Technically inadequate truth standard|1
1456013|NCT00788697|4801548|P1|Overall Study|no truth standard procedure available|5
1456014|NCT00788697|4801548|P1|Overall Study|Training Patients|74
1456015|NCT00788697|4801548|P1|Overall Study|No study drug administered|12
1456016|NCT00788593|4801595|P3|Second Intervention Period|Other|1
1456017|NCT00788593|4801596|P2|Second Intervention Period|Other|0
1456018|NCT00788593|4801597|P1|Second Intervention Period|Other|0
1456019|NCT00788593|4801595|P3|Second Intervention Period|Lost to Follow-up|0
1456020|NCT00788593|4801596|P2|Second Intervention Period|Lost to Follow-up|1
1456021|NCT00788593|4801597|P1|Second Intervention Period|Lost to Follow-up|0
1456022|NCT00788593|4801595|P3|First Intervention Period|Adverse Event|0
1456023|NCT00788593|4801596|P2|First Intervention Period|Adverse Event|1
1456024|NCT00788593|4801597|P1|First Intervention Period|Adverse Event|0
1456025|NCT00788593|4801595|P3|Placebo Run-in Phase|Protocol Violation|0
1456026|NCT00788593|4801596|P2|Placebo Run-in Phase|Protocol Violation|0
1456027|NCT00788593|4801597|P1|Placebo Run-in Phase|Protocol Violation|2
1456028|NCT00788593|4801595|P3|Placebo Run-in Phase|Withdrawal by Subject|0
1456029|NCT00788593|4801596|P2|Placebo Run-in Phase|Withdrawal by Subject|0
1456030|NCT00788593|4801597|P1|Placebo Run-in Phase|Withdrawal by Subject|2
1456031|NCT00788593|4801595|P3|Placebo Run-in Phase|Adverse Event|0
1456032|NCT00788593|4801596|P2|Placebo Run-in Phase|Adverse Event|0
1456033|NCT00788593|4801597|P1|Placebo Run-in Phase|Adverse Event|2
1456034|NCT00788372|4801614|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
1456035|NCT00788372|4801614|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
1456036|NCT00788372|4801614|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
1456037|NCT00788372|4801614|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
1456038|NCT00788372|4801614|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
1456039|NCT00788372|4801614|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
1456040|NCT00788372|4801614|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
1456041|NCT00788073|4801643|P2|Placebo Then STX209|Protocol Violation|1
1456042|NCT00788073|4801644|P1|Placebo Then STX209|Protocol Violation|0
1456043|NCT00788073|4801643|P2|Placebo Then STX209|Adverse Event|0
1456044|NCT00788073|4801644|P1|Placebo Then STX209|Adverse Event|2
1456045|NCT00788073|4801643|P2|STX209 Then Placebo|unable to return due to travel|1
1456046|NCT00788073|4801644|P1|STX209 Then Placebo|unable to return due to travel|0
1456047|NCT00788073|4801643|P2|STX209 Then Placebo|Withdrawal by Subject|1
1456048|NCT00788073|4801644|P1|STX209 Then Placebo|Withdrawal by Subject|0
1456049|NCT00788073|4801643|P2|STX209 Then Placebo|Lost to Follow-up|1
1456050|NCT00788073|4801644|P1|STX209 Then Placebo|Lost to Follow-up|0
1456051|NCT00788073|4801643|P2|STX209 Then Placebo|Adverse Event|0
1456052|NCT00788073|4801644|P1|STX209 Then Placebo|Adverse Event|1
1456053|NCT00787930|4801669|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
1456054|NCT00787917|4801684|P2|Open Label|Administrative problems|0
1456055|NCT00787917|4801685|P1|Open Label|Administrative problems|3
1456056|NCT00787917|4801684|P2|Open Label|Unsatisfactory therapeutic effect|0
1456057|NCT00787917|4801685|P1|Open Label|Unsatisfactory therapeutic effect|1
1456058|NCT00787917|4801684|P2|Blinded Treatment|Administrative problems|2
1456059|NCT00787917|4801685|P1|Blinded Treatment|Administrative problems|3
1456060|NCT00787917|4801684|P2|Blinded Treatment|Lack of Efficacy|0
1456061|NCT00787917|4801685|P1|Blinded Treatment|Lack of Efficacy|1
1456062|NCT00787917|4801684|P2|Blinded Treatment|Adverse Event|0
1456063|NCT00787917|4801685|P1|Blinded Treatment|Adverse Event|1
1456064|NCT00787891|4801715|P2|Maintenance Double-blind Phase (Part 2)|Not specified|2
1456065|NCT00787891|4801716|P1|Maintenance Double-blind Phase (Part 2)|Not specified|5
1456066|NCT00787891|4801715|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
1456067|NCT00787891|4801716|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
1456068|NCT00787891|4801715|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
1456069|NCT00787891|4801716|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
1456070|NCT00787891|4801715|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
1456071|NCT00787891|4801716|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
1456072|NCT00787891|4801715|P2|Short-term Double-blind Phase (Part 1)|Not specified|2
1456073|NCT00787891|4801716|P1|Short-term Double-blind Phase (Part 1)|Not specified|0
1456074|NCT00787891|4801715|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
1456075|NCT00787891|4801716|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
1456076|NCT00787891|4801715|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
1456077|NCT00787891|4801716|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
1456078|NCT00787891|4801715|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
1456079|NCT00787891|4801716|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
1456080|NCT00787891|4801715|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
1456081|NCT00787891|4801716|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
1456082|NCT00787891|4801715|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
1456083|NCT00787891|4801716|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
1456084|NCT00787839|4801743|P1|Overall Study|Failure to have the OGTT was most common|404
1456085|NCT00787800|4801766|P2|Overall Study|Death|2
1456086|NCT00787800|4801767|P1|Overall Study|Death|0
1456087|NCT00787800|4801766|P2|Overall Study|Withdrawal by Subject|5
1456088|NCT00787800|4801767|P1|Overall Study|Withdrawal by Subject|3
1456089|NCT00787787|4801783|P1|Overall Study|Adverse Event|3
1456090|NCT00787787|4801783|P1|Overall Study|Lack of Efficacy|4
1456091|NCT00787644|4801802|P2|Overall Study|Withdrawal by Subject|1
1456092|NCT00787644|4801803|P1|Overall Study|Withdrawal by Subject|1
1456093|NCT00787644|4801802|P2|Overall Study|Lost to Follow-up|1
1456094|NCT00787644|4801803|P1|Overall Study|Lost to Follow-up|1
1456095|NCT00787605|4801824|P2|Overall Study|Lack of Efficacy|9
1456096|NCT00787605|4801825|P1|Overall Study|Lack of Efficacy|13
1456097|NCT00787605|4801824|P2|Overall Study|Withdrawal by Subject|13
1456098|NCT00787605|4801825|P1|Overall Study|Withdrawal by Subject|6
1456099|NCT00787605|4801824|P2|Overall Study|Protocol Violation|3
1456100|NCT00787605|4801825|P1|Overall Study|Protocol Violation|7
1456101|NCT00787605|4801824|P2|Overall Study|Lost to Follow-up|6
1456102|NCT00787605|4801825|P1|Overall Study|Lost to Follow-up|3
1456103|NCT00787605|4801824|P2|Overall Study|Adverse Event|25
1456104|NCT00787605|4801825|P1|Overall Study|Adverse Event|14
1456105|NCT00787605|4801824|P2|Overall Study|Administrative Problems|0
1456106|NCT00787605|4801825|P1|Overall Study|Administrative Problems|3
1456107|NCT00787566|4801844|P3|Overall Study|AE related to chemotherapy|0
1456108|NCT00787566|4801845|P2|Overall Study|AE related to chemotherapy|1
1456109|NCT00787566|4801846|P1|Overall Study|AE related to chemotherapy|0
1456110|NCT00787527|4801854|P1|Overall Study|Toxicity|3
1456111|NCT00787319|4801871|P1|Overall Study|Inactive disease|5
1456112|NCT00787319|4801871|P1|Overall Study|Stabilized disease findings|3
1456113|NCT00787319|4801871|P1|Overall Study|No health insurance reimbursement|2
1456114|NCT00787319|4801871|P1|Overall Study|Unresponsiveness to visit invitation|1
1456115|NCT00787319|4801871|P1|Overall Study|Budget exhausted/exceeded|1
1456116|NCT00787319|4801871|P1|Overall Study|Lack of Efficacy|1
1456117|NCT00787319|4801871|P1|Overall Study|Objective progression or relapse|30
1456118|NCT00787319|4801871|P1|Overall Study|Adverse Event|3
1456119|NCT00787319|4801871|P1|Overall Study|Withdrawal by Subject|15
1456120|NCT00787319|4801871|P1|Overall Study|Lost to Follow-up|2
1456121|NCT00787267|4801883|P1|Overall Study|Withdrawal by Subject|1
1456122|NCT00787267|4801883|P1|Overall Study|No Reason Provided|1
1456123|NCT00787267|4801883|P1|Overall Study|Screen failure/Ineligible|10
1456124|NCT00787254|4801893|P2|Overall Study|Physician Decision|8
1456125|NCT00787254|4801894|P1|Overall Study|Physician Decision|4
1456126|NCT00787254|4801893|P2|Overall Study|Institution closed|0
1456127|NCT00787254|4801894|P1|Overall Study|Institution closed|1
1456128|NCT00787254|4801893|P2|Overall Study|NSAIDs discontinuation|2
1456129|NCT00787254|4801894|P1|Overall Study|NSAIDs discontinuation|1
1456130|NCT00787254|4801893|P2|Overall Study|Lack of Efficacy|15
1456131|NCT00787254|4801894|P1|Overall Study|Lack of Efficacy|4
1456132|NCT00787254|4801893|P2|Overall Study|Withdrawal by Subject|11
1456133|NCT00787254|4801894|P1|Overall Study|Withdrawal by Subject|16
1456134|NCT00787254|4801893|P2|Overall Study|Protocol Violation|23
1456135|NCT00787254|4801894|P1|Overall Study|Protocol Violation|26
1456136|NCT00787254|4801893|P2|Overall Study|Adverse Event|23
1456137|NCT00787254|4801894|P1|Overall Study|Adverse Event|24
1456138|NCT00787202|4802018|P5|Overall Study|Randomized, not treated|0
1456139|NCT00787202|4802019|P4|Overall Study|Randomized, not treated|0
1456140|NCT00787202|4802020|P3|Overall Study|Randomized, not treated|0
1456141|NCT00787202|4802021|P2|Overall Study|Randomized, not treated|0
1456142|NCT00787202|4802022|P1|Overall Study|Randomized, not treated|1
1456143|NCT00787202|4802018|P5|Overall Study|Protocol Violation|1
1456144|NCT00787202|4802019|P4|Overall Study|Protocol Violation|0
1456145|NCT00787202|4802020|P3|Overall Study|Protocol Violation|0
1456146|NCT00787202|4802021|P2|Overall Study|Protocol Violation|1
1456147|NCT00787202|4802022|P1|Overall Study|Protocol Violation|2
1456148|NCT00787202|4802018|P5|Overall Study|Withdrawal by Subject|0
1456149|NCT00787202|4802019|P4|Overall Study|Withdrawal by Subject|0
1456150|NCT00787202|4802020|P3|Overall Study|Withdrawal by Subject|2
1456151|NCT00787202|4802021|P2|Overall Study|Withdrawal by Subject|2
1456152|NCT00787202|4802022|P1|Overall Study|Withdrawal by Subject|2
1456153|NCT00787202|4802018|P5|Overall Study|Lost to Follow-up|0
1456154|NCT00787202|4802019|P4|Overall Study|Lost to Follow-up|0
1456155|NCT00787202|4802020|P3|Overall Study|Lost to Follow-up|0
1456156|NCT00787202|4802021|P2|Overall Study|Lost to Follow-up|0
1456157|NCT00787202|4802022|P1|Overall Study|Lost to Follow-up|1
1456158|NCT00787202|4802018|P5|Overall Study|Lack of Efficacy|1
1456159|NCT00787202|4802019|P4|Overall Study|Lack of Efficacy|2
1456160|NCT00787202|4802020|P3|Overall Study|Lack of Efficacy|5
1456161|NCT00787202|4802021|P2|Overall Study|Lack of Efficacy|6
1456162|NCT00787202|4802022|P1|Overall Study|Lack of Efficacy|5
1456163|NCT00787202|4802018|P5|Overall Study|Adverse Event|2
1456164|NCT00787202|4802019|P4|Overall Study|Adverse Event|0
1456165|NCT00787202|4802020|P3|Overall Study|Adverse Event|0
1456166|NCT00787202|4802021|P2|Overall Study|Adverse Event|2
1456167|NCT00787202|4802022|P1|Overall Study|Adverse Event|3
1456168|NCT00787189|4802075|P2|Overall Study|Lost to Follow-up|2
1456169|NCT00787189|4802076|P1|Overall Study|Lost to Follow-up|2
1456170|NCT00787150|4802085|P3|Overall Study|Dosing incorrect study durg|0
1456171|NCT00787150|4802086|P2|Overall Study|Dosing incorrect study durg|0
1456172|NCT00787150|4802087|P1|Overall Study|Dosing incorrect study durg|2
1456173|NCT00787150|4802085|P3|Overall Study|Withdrawal by Subject|0
1456174|NCT00787150|4802086|P2|Overall Study|Withdrawal by Subject|1
1456175|NCT00787150|4802087|P1|Overall Study|Withdrawal by Subject|2
1456176|NCT00787150|4802085|P3|Overall Study|Physician Decision|1
1456177|NCT00787150|4802086|P2|Overall Study|Physician Decision|2
1456178|NCT00787150|4802087|P1|Overall Study|Physician Decision|1
1456179|NCT00787150|4802085|P3|Overall Study|Adverse Event|4
1456180|NCT00787150|4802086|P2|Overall Study|Adverse Event|4
1456181|NCT00787150|4802087|P1|Overall Study|Adverse Event|4
1456182|NCT00787137|4802132|P3|Overall Study|Study Termination|1
1456183|NCT00787137|4802133|P2|Overall Study|Study Termination|0
1456184|NCT00787137|4802134|P1|Overall Study|Study Termination|0
1456185|NCT00786864|4802209|P2|Overall Study|Sustained serious back injury|0
1456186|NCT00786864|4802210|P1|Overall Study|Sustained serious back injury|1
1456187|NCT00786864|4802209|P2|Overall Study|Lost to Follow-up|1
1456188|NCT00786864|4802210|P1|Overall Study|Lost to Follow-up|0
1456189|NCT00786838|4802222|P1|Overall Study|Withdrawal by Subject|4
1456190|NCT00786838|4802222|P1|Overall Study|Progressive disease|31
1456191|NCT00786838|4802222|P1|Overall Study|Adverse Event|6
1456192|NCT00786838|4802222|P1|Overall Study|Death|4
1456193|NCT00786838|4802222|P1|Overall Study|Physician Decision|4
1456194|NCT00786799|4802249|P2|Overall Study|Lost to Follow-up|1
1456195|NCT00786799|4802250|P1|Overall Study|Lost to Follow-up|1
1456196|NCT00786565|4802280|P1|Post Surgery|Adapt AO implanted posterior side up|1
1456197|NCT00786565|4802280|P1|Post Surgery|Abnormal macular pucker|1
1456198|NCT00786565|4802280|P1|Enrollment Prior to Surgery|Protocol Violation|3
1456199|NCT00786565|4802280|P1|Enrollment Prior to Surgery|Site Closed|3
1456200|NCT00786474|4802337|P2|Overall Study|Not Specified|4
1456201|NCT00786474|4802338|P1|Overall Study|Not Specified|4
1456202|NCT00786474|4802337|P2|Overall Study|Physician Decision|1
1456203|NCT00786474|4802338|P1|Overall Study|Physician Decision|2
1456204|NCT00786474|4802337|P2|Overall Study|Lost to Follow-up|3
1456205|NCT00786474|4802338|P1|Overall Study|Lost to Follow-up|3
1456206|NCT00786474|4802337|P2|Overall Study|Withdrawal by Subject|31
1456207|NCT00786474|4802338|P1|Overall Study|Withdrawal by Subject|23
1456208|NCT00786474|4802337|P2|Overall Study|Death|4
1456209|NCT00786474|4802338|P1|Overall Study|Death|5
1456210|NCT00786422|4802350|P1|Follow-up Period|End-of-study done up to 4 days early|2
1456211|NCT00786422|4802350|P1|Follow-up Period|Death|1
1456212|NCT00786422|4802350|P1|Rivaroxaban Treatment|Adverse Event|2
1456213|NCT00786422|4802350|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
1456214|NCT00786422|4802350|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
1456215|NCT00786422|4802350|P1|Rivaroxaban Treatment|Physician Decision|1
1456216|NCT00786422|4802350|P1|Rivaroxaban Treatment|Lack of Efficacy|1
1456217|NCT00786422|4802350|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
1456218|NCT00786422|4802350|P1|Rivaroxaban Treatment|Death|2
1456219|NCT00786409|4802366|P1|Overall Study|Lost to Follow-up|1
1456220|NCT00786409|4802366|P1|Overall Study|Pregnancy|2
1456221|NCT00786409|4802366|P1|Overall Study|Adverse Event|2
1456222|NCT00786409|4802366|P1|Overall Study|Withdrawal by Subject|2
1456223|NCT00786188|4802383|P2|Overall Study|Withdrawal by Subject|0
1456224|NCT00786188|4802384|P1|Overall Study|Withdrawal by Subject|2
1456225|NCT00786188|4802383|P2|Overall Study|Adverse Event|1
1456226|NCT00786188|4802384|P1|Overall Study|Adverse Event|3
1456227|NCT00786032|4802410|P1|Overall Study|Did not complete in the timeframe|6
1456228|NCT00786032|4802410|P1|Overall Study|Withdrawal by Subject|14
1456229|NCT00786032|4802410|P1|Overall Study|Death|4
1456230|NCT00785980|4802420|P1|7 Day Washout Period|Protocol Violation|3
1456231|NCT00785928|4802438|P7|Treatment Phase|Withdrawal by Subject|0
1456232|NCT00785928|4802439|P6|Treatment Phase|Withdrawal by Subject|0
1456233|NCT00785928|4802440|P5|Treatment Phase|Withdrawal by Subject|1
1456234|NCT00785928|4802441|P4|Treatment Phase|Withdrawal by Subject|0
1456235|NCT00785928|4802442|P3|Treatment Phase|Withdrawal by Subject|0
1456236|NCT00785928|4802443|P2|Treatment Phase|Withdrawal by Subject|2
1456237|NCT00785928|4802444|P1|Treatment Phase|Withdrawal by Subject|1
1456238|NCT00785928|4802438|P7|Treatment Phase|Sponsor Decision|1
1456239|NCT00785928|4802439|P6|Treatment Phase|Sponsor Decision|0
1456240|NCT00785928|4802440|P5|Treatment Phase|Sponsor Decision|0
1456241|NCT00785928|4802441|P4|Treatment Phase|Sponsor Decision|0
1456242|NCT00785928|4802442|P3|Treatment Phase|Sponsor Decision|0
1456243|NCT00785928|4802443|P2|Treatment Phase|Sponsor Decision|0
1456244|NCT00785928|4802444|P1|Treatment Phase|Sponsor Decision|1
1456245|NCT00785928|4802438|P7|Treatment Phase|Physician Decision|0
1456246|NCT00785928|4802439|P6|Treatment Phase|Physician Decision|0
1456247|NCT00785928|4802440|P5|Treatment Phase|Physician Decision|1
1456248|NCT00785928|4802441|P4|Treatment Phase|Physician Decision|0
1456249|NCT00785928|4802442|P3|Treatment Phase|Physician Decision|0
1456250|NCT00785928|4802443|P2|Treatment Phase|Physician Decision|0
1456251|NCT00785928|4802444|P1|Treatment Phase|Physician Decision|0
1456252|NCT00785928|4802438|P7|Treatment Phase|Lack of Efficacy|0
1456253|NCT00785928|4802439|P6|Treatment Phase|Lack of Efficacy|0
1456254|NCT00785928|4802440|P5|Treatment Phase|Lack of Efficacy|0
1456255|NCT00785928|4802441|P4|Treatment Phase|Lack of Efficacy|0
1456256|NCT00785928|4802442|P3|Treatment Phase|Lack of Efficacy|1
1456257|NCT00785928|4802443|P2|Treatment Phase|Lack of Efficacy|1
1456258|NCT00785928|4802444|P1|Treatment Phase|Lack of Efficacy|0
1456259|NCT00785928|4802438|P7|Treatment Phase|Inadequate Response|0
1456260|NCT00785928|4802439|P6|Treatment Phase|Inadequate Response|0
1456261|NCT00785928|4802440|P5|Treatment Phase|Inadequate Response|0
1456262|NCT00785928|4802441|P4|Treatment Phase|Inadequate Response|0
1456263|NCT00785928|4802442|P3|Treatment Phase|Inadequate Response|0
1456264|NCT00785928|4802443|P2|Treatment Phase|Inadequate Response|1
1456265|NCT00785928|4802444|P1|Treatment Phase|Inadequate Response|0
1456266|NCT00785928|4802438|P7|Treatment Phase|Adverse Event|2
1456267|NCT00785928|4802439|P6|Treatment Phase|Adverse Event|0
1456268|NCT00785928|4802440|P5|Treatment Phase|Adverse Event|0
1456269|NCT00785928|4802441|P4|Treatment Phase|Adverse Event|0
1456270|NCT00785928|4802442|P3|Treatment Phase|Adverse Event|2
1456271|NCT00785928|4802443|P2|Treatment Phase|Adverse Event|1
1456272|NCT00785928|4802444|P1|Treatment Phase|Adverse Event|1
1456273|NCT00785785|4802591|P2|Optional Extension Phase|Study terminated by sponsor|37
1456274|NCT00785785|4802592|P1|Optional Extension Phase|Study terminated by sponsor|3
1456275|NCT00785785|4802591|P2|Optional Extension Phase|Protocol deviation|2
1456276|NCT00785785|4802592|P1|Optional Extension Phase|Protocol deviation|0
1456277|NCT00785785|4802591|P2|Optional Extension Phase|Disease progression|70
1456278|NCT00785785|4802592|P1|Optional Extension Phase|Disease progression|22
1456279|NCT00785785|4802591|P2|Optional Extension Phase|Death|5
1456280|NCT00785785|4802592|P1|Optional Extension Phase|Death|1
1456281|NCT00785785|4802591|P2|Optional Extension Phase|Administrative problems|0
1456282|NCT00785785|4802592|P1|Optional Extension Phase|Administrative problems|2
1456283|NCT00785785|4802591|P2|Optional Extension Phase|Lost to Follow-up|0
1456284|NCT00785785|4802592|P1|Optional Extension Phase|Lost to Follow-up|1
1456285|NCT00785785|4802591|P2|Optional Extension Phase|Withdrawal by Subject|6
1456286|NCT00785785|4802592|P1|Optional Extension Phase|Withdrawal by Subject|6
1456287|NCT00785785|4802591|P2|Optional Extension Phase|Adverse Event|5
1456288|NCT00785785|4802592|P1|Optional Extension Phase|Adverse Event|4
1456289|NCT00785785|4802591|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
1456290|NCT00785785|4802592|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
1456291|NCT00785785|4802591|P2|Core Phase up to 36 Months|Protocol deviation|6
1456292|NCT00785785|4802592|P1|Core Phase up to 36 Months|Protocol deviation|5
1456293|NCT00785785|4802591|P2|Core Phase up to 36 Months|Disease progression|119
1456294|NCT00785785|4802592|P1|Core Phase up to 36 Months|Disease progression|139
1456295|NCT00785785|4802591|P2|Core Phase up to 36 Months|Death|8
1456296|NCT00785785|4802592|P1|Core Phase up to 36 Months|Death|5
1456297|NCT00785785|4802591|P2|Core Phase up to 36 Months|Administrative problems|3
1456298|NCT00785785|4802592|P1|Core Phase up to 36 Months|Administrative problems|3
1456299|NCT00785785|4802591|P2|Core Phase up to 36 Months|Lost to Follow-up|7
1456300|NCT00785785|4802592|P1|Core Phase up to 36 Months|Lost to Follow-up|3
1456301|NCT00785785|4802591|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
1456302|NCT00785785|4802592|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
1456303|NCT00785785|4802591|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
1456304|NCT00785785|4802592|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
1456305|NCT00785785|4802591|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
1456306|NCT00785785|4802592|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
1456307|NCT00785785|4802591|P2|Core Phase up to 36 Months|Adverse Event|21
1456308|NCT00785785|4802592|P1|Core Phase up to 36 Months|Adverse Event|31
1456309|NCT00785785|4802591|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
1456310|NCT00785785|4802592|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
1456311|NCT00785707|4802606|P1|Overall Study|Lost to Follow-up|7
1456312|NCT00785629|4802615|P4|Overall Study|Withdrawal by Subject|2
1456313|NCT00785629|4802616|P3|Overall Study|Withdrawal by Subject|2
1456314|NCT00785629|4802617|P2|Overall Study|Withdrawal by Subject|1
1456315|NCT00785629|4802618|P1|Overall Study|Withdrawal by Subject|0
1456316|NCT00785629|4802615|P4|Overall Study|administrative decision|4
1456317|NCT00785629|4802616|P3|Overall Study|administrative decision|3
1456318|NCT00785629|4802617|P2|Overall Study|administrative decision|1
1456319|NCT00785629|4802618|P1|Overall Study|administrative decision|5
1456320|NCT00785629|4802615|P4|Overall Study|Protocol Violation|5
1456321|NCT00785629|4802616|P3|Overall Study|Protocol Violation|4
1456322|NCT00785629|4802617|P2|Overall Study|Protocol Violation|2
1456323|NCT00785629|4802618|P1|Overall Study|Protocol Violation|1
1456324|NCT00785629|4802615|P4|Overall Study|Adverse Event|5
1456325|NCT00785629|4802616|P3|Overall Study|Adverse Event|1
1456326|NCT00785629|4802617|P2|Overall Study|Adverse Event|1
1456327|NCT00785629|4802618|P1|Overall Study|Adverse Event|2
1456328|NCT00785577|4802631|P5|Study Period 3: 1-Week Washout Phase|Death|1
1456329|NCT00785577|4802632|P4|Study Period 3: 1-Week Washout Phase|Death|0
1456330|NCT00785577|4802633|P3|Study Period 3: 1-Week Washout Phase|Death|0
1456331|NCT00785577|4802634|P2|Study Period 3: 1-Week Washout Phase|Death|0
1456332|NCT00785577|4802635|P1|Study Period 3: 1-Week Washout Phase|Death|0
1456333|NCT00785577|4802631|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
1456334|NCT00785577|4802632|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
1456335|NCT00785577|4802633|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
1456336|NCT00785577|4802634|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
1456337|NCT00785577|4802635|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
1456338|NCT00785577|4802631|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
1456339|NCT00785577|4802632|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
1456340|NCT00785577|4802633|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
1456341|NCT00785577|4802634|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
1456342|NCT00785577|4802635|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
1456343|NCT00785577|4802631|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
1456344|NCT00785577|4802632|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
1456345|NCT00785577|4802633|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
1456346|NCT00785577|4802634|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
1456347|NCT00785577|4802635|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
1456348|NCT00785577|4802631|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
1456349|NCT00785577|4802632|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
1456350|NCT00785577|4802633|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
1456351|NCT00785577|4802634|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
1456352|NCT00785577|4802635|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
1456353|NCT00785577|4802631|P5|Study Period 2: Therapy Phase|Protocol Violation|1
1456354|NCT00785577|4802632|P4|Study Period 2: Therapy Phase|Protocol Violation|0
1456355|NCT00785577|4802633|P3|Study Period 2: Therapy Phase|Protocol Violation|1
1456356|NCT00785577|4802634|P2|Study Period 2: Therapy Phase|Protocol Violation|1
1456357|NCT00785577|4802635|P1|Study Period 2: Therapy Phase|Protocol Violation|1
1456358|NCT00785577|4802631|P5|Study Period 2: Therapy Phase|Physician Decision|0
1456359|NCT00785577|4802632|P4|Study Period 2: Therapy Phase|Physician Decision|0
1456360|NCT00785577|4802633|P3|Study Period 2: Therapy Phase|Physician Decision|0
1456361|NCT00785577|4802634|P2|Study Period 2: Therapy Phase|Physician Decision|0
1456362|NCT00785577|4802635|P1|Study Period 2: Therapy Phase|Physician Decision|1
1456363|NCT00785577|4802631|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
1456364|NCT00785577|4802632|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
1456365|NCT00785577|4802633|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
1456366|NCT00785577|4802634|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
1456367|NCT00785577|4802635|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
1456368|NCT00785577|4802631|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
1456369|NCT00785577|4802632|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
1456370|NCT00785577|4802633|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
1456371|NCT00785577|4802634|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
1456372|NCT00785577|4802635|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
1456373|NCT00785577|4802631|P5|Study Period 2: Therapy Phase|Adverse Event|17
1456374|NCT00785577|4802632|P4|Study Period 2: Therapy Phase|Adverse Event|10
1456375|NCT00785577|4802633|P3|Study Period 2: Therapy Phase|Adverse Event|14
1456376|NCT00785577|4802634|P2|Study Period 2: Therapy Phase|Adverse Event|7
1456377|NCT00785577|4802635|P1|Study Period 2: Therapy Phase|Adverse Event|5
1456378|NCT00785512|4802773|P2|Overall Study|Lack of compliance|1
1456379|NCT00785512|4802774|P1|Overall Study|Lack of compliance|0
1456380|NCT00785512|4802773|P2|Overall Study|Physician Decision|0
1456381|NCT00785512|4802774|P1|Overall Study|Physician Decision|0
1456382|NCT00785512|4802773|P2|Overall Study|IVRS Programing Error|0
1456383|NCT00785512|4802774|P1|Overall Study|IVRS Programing Error|0
1456384|NCT00785512|4802773|P2|Overall Study|Precedure Refused|0
1456385|NCT00785512|4802774|P1|Overall Study|Precedure Refused|0
1456386|NCT00785512|4802773|P2|Overall Study|Lost to Follow-up|0
1456387|NCT00785512|4802774|P1|Overall Study|Lost to Follow-up|3
1456388|NCT00785512|4802773|P2|Overall Study|Withdrawal by Subject|1
1456389|NCT00785512|4802774|P1|Overall Study|Withdrawal by Subject|0
1456390|NCT00785512|4802773|P2|Overall Study|Lack of Efficacy|2
1456391|NCT00785512|4802774|P1|Overall Study|Lack of Efficacy|0
1456392|NCT00785512|4802773|P2|Overall Study|Adverse Event|0
1456393|NCT00785512|4802774|P1|Overall Study|Adverse Event|0
1456394|NCT00785512|4802773|P2|Overall Study|Inclusion/Exclusion not meet|0
1456395|NCT00785512|4802774|P1|Overall Study|Inclusion/Exclusion not meet|0
1456396|NCT00785486|4802783|P1|Midazolam Alone|Withdrawal by Subject|1
1456397|NCT00785356|4802807|P1|Overall Study|Study prematurely terminated|8
1456398|NCT00785291|4802818|P3|Overall Study|Other Medical Reasons|15
1456399|NCT00785291|4802819|P2|Overall Study|Other Medical Reasons|25
1456400|NCT00785291|4802820|P1|Overall Study|Other Medical Reasons|29
1456401|NCT00785291|4802818|P3|Overall Study|Complicating illness|4
1456402|NCT00785291|4802819|P2|Overall Study|Complicating illness|4
1456403|NCT00785291|4802820|P1|Overall Study|Complicating illness|6
1456404|NCT00785291|4802818|P3|Overall Study|Alternative Therapy|7
1456405|NCT00785291|4802819|P2|Overall Study|Alternative Therapy|6
1456406|NCT00785291|4802820|P1|Overall Study|Alternative Therapy|12
1456407|NCT00785291|4802818|P3|Overall Study|Withdrawal by Subject|17
1456408|NCT00785291|4802819|P2|Overall Study|Withdrawal by Subject|36
1456409|NCT00785291|4802820|P1|Overall Study|Withdrawal by Subject|35
1456410|NCT00785291|4802818|P3|Overall Study|Death|3
1456411|NCT00785291|4802819|P2|Overall Study|Death|4
1456412|NCT00785291|4802820|P1|Overall Study|Death|7
1456413|NCT00785291|4802818|P3|Overall Study|Adverse Event|56
1456414|NCT00785291|4802819|P2|Overall Study|Adverse Event|70
1456415|NCT00785291|4802820|P1|Overall Study|Adverse Event|39
1456416|NCT00785291|4802818|P3|Overall Study|Never began treatment|4
1456417|NCT00785291|4802819|P2|Overall Study|Never began treatment|4
1456418|NCT00785291|4802820|P1|Overall Study|Never began treatment|8
1456419|NCT00785213|4802840|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
1456420|NCT00785213|4802840|P1|Quinine Sulfate Alone|Adverse Event|4
1456421|NCT00785044|4802851|P1|Overall Study|Withdrawal by Subject|1
1456422|NCT00785044|4802851|P1|Overall Study|Lost to Follow-up|266
1456423|NCT00785044|4802851|P1|Overall Study|Death|77
1456424|NCT00785044|4802851|P1|Overall Study|Dosed at non-participating sites|152
1456425|NCT00784979|4802856|P1|Overall Study|incomplete data|6
1456426|NCT00784927|4802860|P1|Overall Study|Ineligible|1
1456427|NCT00784927|4802860|P1|Overall Study|Protocol Violation|1
1456428|NCT00784927|4802860|P1|Overall Study|Cancel Prior to Initiating Treatment|1
1456429|NCT00784875|4802872|P4|Period D|Lost to Follow-up|1
1456430|NCT00784875|4802873|P3|Period D|Lost to Follow-up|1
1456431|NCT00784875|4802874|P2|Period D|Lost to Follow-up|0
1456432|NCT00784875|4802875|P1|Period D|Lost to Follow-up|1
1456433|NCT00784875|4802872|P4|Period D|Sponsor Decision|0
1456434|NCT00784875|4802873|P3|Period D|Sponsor Decision|1
1456435|NCT00784875|4802874|P2|Period D|Sponsor Decision|1
1456436|NCT00784875|4802875|P1|Period D|Sponsor Decision|1
1456437|NCT00784875|4802872|P4|Period D|Physician Decision|0
1456438|NCT00784875|4802873|P3|Period D|Physician Decision|0
1456439|NCT00784875|4802874|P2|Period D|Physician Decision|1
1456440|NCT00784875|4802875|P1|Period D|Physician Decision|0
1456441|NCT00784875|4802872|P4|Period D|Withdrawal by Subject|0
1456442|NCT00784875|4802873|P3|Period D|Withdrawal by Subject|2
1456443|NCT00784875|4802874|P2|Period D|Withdrawal by Subject|0
1456444|NCT00784875|4802875|P1|Period D|Withdrawal by Subject|2
1456445|NCT00784875|4802872|P4|Period D|Protocol Violation|0
1456446|NCT00784875|4802873|P3|Period D|Protocol Violation|0
1456447|NCT00784875|4802874|P2|Period D|Protocol Violation|0
1456448|NCT00784875|4802875|P1|Period D|Protocol Violation|1
1456449|NCT00784875|4802872|P4|Period D|Adverse Event|0
1456450|NCT00784875|4802873|P3|Period D|Adverse Event|2
1456451|NCT00784875|4802874|P2|Period D|Adverse Event|2
1456452|NCT00784875|4802875|P1|Period D|Adverse Event|0
1456453|NCT00784875|4802872|P4|Period C|Sponsor Decision|2
1456454|NCT00784875|4802873|P3|Period C|Sponsor Decision|4
1456455|NCT00784875|4802874|P2|Period C|Sponsor Decision|5
1456456|NCT00784875|4802875|P1|Period C|Sponsor Decision|5
1456457|NCT00784875|4802872|P4|Period C|Physician Decision|1
1456458|NCT00784875|4802873|P3|Period C|Physician Decision|1
1456459|NCT00784875|4802874|P2|Period C|Physician Decision|0
1456460|NCT00784875|4802875|P1|Period C|Physician Decision|0
1456461|NCT00784875|4802872|P4|Period C|Withdrawal by Subject|0
1456462|NCT00784875|4802873|P3|Period C|Withdrawal by Subject|2
1456463|NCT00784875|4802874|P2|Period C|Withdrawal by Subject|1
1456464|NCT00784875|4802875|P1|Period C|Withdrawal by Subject|1
1456465|NCT00784875|4802872|P4|Period C|Lack of Efficacy|0
1456466|NCT00784875|4802873|P3|Period C|Lack of Efficacy|1
1456467|NCT00784875|4802874|P2|Period C|Lack of Efficacy|0
1456468|NCT00784875|4802875|P1|Period C|Lack of Efficacy|0
1456469|NCT00784875|4802872|P4|Period C|Protocol Violation|2
1456470|NCT00784875|4802873|P3|Period C|Protocol Violation|1
1456471|NCT00784875|4802874|P2|Period C|Protocol Violation|0
1456472|NCT00784875|4802875|P1|Period C|Protocol Violation|0
1456473|NCT00784875|4802872|P4|Period C|Adverse Event|2
1456474|NCT00784875|4802873|P3|Period C|Adverse Event|4
1456475|NCT00784875|4802874|P2|Period C|Adverse Event|0
1456476|NCT00784875|4802875|P1|Period C|Adverse Event|1
1456477|NCT00784875|4802872|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
1456478|NCT00784875|4802873|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
1456479|NCT00784875|4802874|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
1456480|NCT00784875|4802875|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
1456481|NCT00784875|4802872|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
1456482|NCT00784875|4802873|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
1456483|NCT00784875|4802874|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
1456484|NCT00784875|4802875|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
1456485|NCT00784875|4802872|P4|Period B - Efficacy Endpoint|Physician Decision|0
1456486|NCT00784875|4802873|P3|Period B - Efficacy Endpoint|Physician Decision|1
1456487|NCT00784875|4802874|P2|Period B - Efficacy Endpoint|Physician Decision|0
1456488|NCT00784875|4802875|P1|Period B - Efficacy Endpoint|Physician Decision|0
1456489|NCT00784875|4802872|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
1456490|NCT00784875|4802873|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
1456491|NCT00784875|4802874|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
1456492|NCT00784875|4802875|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
1456493|NCT00784875|4802872|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
1456494|NCT00784875|4802873|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
1456495|NCT00784875|4802874|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
1456496|NCT00784875|4802875|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
1456497|NCT00784875|4802872|P4|Period B - Efficacy Endpoint|Protocol Violation|3
1456498|NCT00784875|4802873|P3|Period B - Efficacy Endpoint|Protocol Violation|2
1456499|NCT00784875|4802874|P2|Period B - Efficacy Endpoint|Protocol Violation|1
1456500|NCT00784875|4802875|P1|Period B - Efficacy Endpoint|Protocol Violation|1
1456501|NCT00784875|4802872|P4|Period B - Efficacy Endpoint|Adverse Event|1
1456502|NCT00784875|4802873|P3|Period B - Efficacy Endpoint|Adverse Event|2
1456503|NCT00784875|4802874|P2|Period B - Efficacy Endpoint|Adverse Event|3
1456504|NCT00784875|4802875|P1|Period B - Efficacy Endpoint|Adverse Event|0
1456505|NCT00784875|4802872|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
1456506|NCT00784875|4802873|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
1456507|NCT00784875|4802874|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
1456508|NCT00784875|4802875|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
1456509|NCT00784875|4802872|P4|Period A - Baseline|Lost to Follow-up|2
1456510|NCT00784875|4802873|P3|Period A - Baseline|Lost to Follow-up|0
1456511|NCT00784875|4802874|P2|Period A - Baseline|Lost to Follow-up|0
1456512|NCT00784875|4802875|P1|Period A - Baseline|Lost to Follow-up|0
1456513|NCT00784875|4802872|P4|Period A - Baseline|Sponsor Decision|113
1456514|NCT00784875|4802873|P3|Period A - Baseline|Sponsor Decision|0
1456515|NCT00784875|4802874|P2|Period A - Baseline|Sponsor Decision|0
1456516|NCT00784875|4802875|P1|Period A - Baseline|Sponsor Decision|0
1456517|NCT00784875|4802872|P4|Period A - Baseline|Physician Decision|2
1456518|NCT00784875|4802873|P3|Period A - Baseline|Physician Decision|0
1456519|NCT00784875|4802874|P2|Period A - Baseline|Physician Decision|0
1456520|NCT00784875|4802875|P1|Period A - Baseline|Physician Decision|0
1456521|NCT00784875|4802872|P4|Period A - Baseline|Withdrawal by Subject|27
1456522|NCT00784875|4802873|P3|Period A - Baseline|Withdrawal by Subject|0
1456523|NCT00784875|4802874|P2|Period A - Baseline|Withdrawal by Subject|0
1456524|NCT00784875|4802875|P1|Period A - Baseline|Withdrawal by Subject|0
1456525|NCT00784875|4802872|P4|Period A - Baseline|Protocol Violation|25
1456526|NCT00784875|4802873|P3|Period A - Baseline|Protocol Violation|0
1456527|NCT00784875|4802874|P2|Period A - Baseline|Protocol Violation|0
1456528|NCT00784875|4802875|P1|Period A - Baseline|Protocol Violation|0
1456529|NCT00784875|4802872|P4|Period A - Baseline|Adverse Event|8
1456530|NCT00784875|4802873|P3|Period A - Baseline|Adverse Event|0
1456531|NCT00784875|4802874|P2|Period A - Baseline|Adverse Event|0
1456532|NCT00784875|4802875|P1|Period A - Baseline|Adverse Event|0
1456533|NCT00784875|4802872|P4|Period A - Baseline|Entry Criteria Not Met|5
1456534|NCT00784875|4802873|P3|Period A - Baseline|Entry Criteria Not Met|0
1456535|NCT00784875|4802874|P2|Period A - Baseline|Entry Criteria Not Met|0
1456536|NCT00784875|4802875|P1|Period A - Baseline|Entry Criteria Not Met|0
1456537|NCT00784836|4802995|P1|Overall Study|Early Study Termination|3
1456538|NCT00784810|4803002|P2|Overall Study|Lost to Follow-up|1
1456539|NCT00784810|4803003|P1|Overall Study|Lost to Follow-up|1
1456540|NCT00784810|4803002|P2|Overall Study|Administrative|8
1456541|NCT00784810|4803003|P1|Overall Study|Administrative|5
1456542|NCT00784810|4803002|P2|Overall Study|Withdrawal by Subject|9
1456543|NCT00784810|4803003|P1|Overall Study|Withdrawal by Subject|11
1456544|NCT00784810|4803002|P2|Overall Study|Lack of Efficacy|11
1456545|NCT00784810|4803003|P1|Overall Study|Lack of Efficacy|14
1456546|NCT00784810|4803002|P2|Overall Study|Adverse Event|20
1456547|NCT00784810|4803003|P1|Overall Study|Adverse Event|32
1456548|NCT00784784|4803013|P2|Overall Study|Withdrawal by Subject|2
1456549|NCT00784784|4803014|P1|Overall Study|Withdrawal by Subject|2
1456550|NCT00784719|4803029|P7|Overall Study|Withdrawal by Subject|1
1456551|NCT00784719|4803030|P6|Overall Study|Withdrawal by Subject|0
1456552|NCT00784719|4803031|P5|Overall Study|Withdrawal by Subject|2
1456553|NCT00784719|4803032|P4|Overall Study|Withdrawal by Subject|0
1456554|NCT00784719|4803033|P3|Overall Study|Withdrawal by Subject|0
1456555|NCT00784719|4803034|P2|Overall Study|Withdrawal by Subject|0
1456556|NCT00784719|4803035|P1|Overall Study|Withdrawal by Subject|1
1456557|NCT00784719|4803029|P7|Overall Study|Other|3
1456558|NCT00784719|4803030|P6|Overall Study|Other|1
1456559|NCT00784719|4803031|P5|Overall Study|Other|2
1456560|NCT00784719|4803032|P4|Overall Study|Other|0
1456561|NCT00784719|4803033|P3|Overall Study|Other|1
1456562|NCT00784719|4803034|P2|Overall Study|Other|1
1456563|NCT00784719|4803035|P1|Overall Study|Other|2
1456564|NCT00784719|4803029|P7|Overall Study|Lost to Follow-up|0
1456565|NCT00784719|4803030|P6|Overall Study|Lost to Follow-up|1
1456566|NCT00784719|4803031|P5|Overall Study|Lost to Follow-up|1
1456567|NCT00784719|4803032|P4|Overall Study|Lost to Follow-up|0
1456568|NCT00784719|4803033|P3|Overall Study|Lost to Follow-up|0
1456569|NCT00784719|4803034|P2|Overall Study|Lost to Follow-up|0
1456570|NCT00784719|4803035|P1|Overall Study|Lost to Follow-up|0
1456571|NCT00784719|4803029|P7|Overall Study|Adverse Event|1
1456572|NCT00784719|4803030|P6|Overall Study|Adverse Event|1
1456573|NCT00784719|4803031|P5|Overall Study|Adverse Event|1
1456574|NCT00784719|4803032|P4|Overall Study|Adverse Event|0
1456575|NCT00784719|4803033|P3|Overall Study|Adverse Event|0
1456576|NCT00784719|4803034|P2|Overall Study|Adverse Event|2
1456577|NCT00784719|4803035|P1|Overall Study|Adverse Event|0
1456578|NCT00784654|4803205|P3|Randomized Withdrawal Period|Family reasons|1
1456579|NCT00784654|4803206|P2|Randomized Withdrawal Period|Family reasons|0
1456580|NCT00784654|4803207|P1|Randomized Withdrawal Period|Family reasons|0
1456581|NCT00784654|4803205|P3|Randomized Withdrawal Period|Did not complete a visit|0
1456582|NCT00784654|4803206|P2|Randomized Withdrawal Period|Did not complete a visit|1
1456583|NCT00784654|4803207|P1|Randomized Withdrawal Period|Did not complete a visit|0
1456584|NCT00784654|4803205|P3|Randomized Withdrawal Period|Adverse Event|1
1456585|NCT00784654|4803206|P2|Randomized Withdrawal Period|Adverse Event|1
1456586|NCT00784654|4803207|P1|Randomized Withdrawal Period|Adverse Event|0
1456587|NCT00784654|4803205|P3|Randomized Withdrawal Period|Protocol Violation|1
1456588|NCT00784654|4803206|P2|Randomized Withdrawal Period|Protocol Violation|2
1456589|NCT00784654|4803207|P1|Randomized Withdrawal Period|Protocol Violation|0
1456590|NCT00784654|4803205|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
1456591|NCT00784654|4803206|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
1456592|NCT00784654|4803207|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
1456593|NCT00784654|4803205|P3|Randomized Withdrawal Period|Lack of Efficacy|18
1456594|NCT00784654|4803206|P2|Randomized Withdrawal Period|Lack of Efficacy|5
1456595|NCT00784654|4803207|P1|Randomized Withdrawal Period|Lack of Efficacy|0
1456596|NCT00784654|4803205|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
1456597|NCT00784654|4803206|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
1456598|NCT00784654|4803207|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
1456599|NCT00784654|4803205|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
1456600|NCT00784654|4803206|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
1456601|NCT00784654|4803207|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
1456602|NCT00784654|4803205|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
1456603|NCT00784654|4803206|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
1456604|NCT00784654|4803207|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
1456605|NCT00784654|4803205|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
1456606|NCT00784654|4803206|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
1456607|NCT00784654|4803207|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
1456608|NCT00784654|4803205|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
1456609|NCT00784654|4803206|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
1456610|NCT00784654|4803207|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
1456611|NCT00784654|4803205|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
1456612|NCT00784654|4803206|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
1456613|NCT00784654|4803207|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
1456614|NCT00784654|4803205|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
1456615|NCT00784654|4803206|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
1456616|NCT00784654|4803207|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
1456617|NCT00784654|4803205|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
1456618|NCT00784654|4803206|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
1456619|NCT00784654|4803207|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
1456620|NCT00784654|4803205|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
1456621|NCT00784654|4803206|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
1456622|NCT00784654|4803207|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
1456623|NCT00784654|4803205|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
1456624|NCT00784654|4803206|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
1456625|NCT00784654|4803207|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
1456626|NCT00784654|4803205|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
1456627|NCT00784654|4803206|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
1456628|NCT00784654|4803207|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
1456629|NCT00784654|4803205|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
1456630|NCT00784654|4803206|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
1456631|NCT00784654|4803207|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
1456632|NCT00784563|4803242|P3|Year 3|Adverse Event|1
1456633|NCT00784563|4803243|P2|Year 3|Adverse Event|0
1456634|NCT00784563|4803244|P1|Year 3|Adverse Event|0
1456635|NCT00784563|4803242|P3|Year 3|Withdrawal by Subject|2
1456636|NCT00784563|4803243|P2|Year 3|Withdrawal by Subject|0
1456637|NCT00784563|4803244|P1|Year 3|Withdrawal by Subject|0
1456638|NCT00784563|4803242|P3|Years 1 & 2|Adverse Event|0
1456639|NCT00784563|4803243|P2|Years 1 & 2|Adverse Event|3
1456640|NCT00784563|4803244|P1|Years 1 & 2|Adverse Event|0
1456641|NCT00784563|4803242|P3|Years 1 & 2|Withdrawal by Subject|0
1456642|NCT00784563|4803243|P2|Years 1 & 2|Withdrawal by Subject|2
1456643|NCT00784563|4803244|P1|Years 1 & 2|Withdrawal by Subject|3
1456644|NCT00784550|4803262|P2|Overall Study|Withdrawal by Subject|13
1456645|NCT00784550|4803263|P1|Overall Study|Withdrawal by Subject|4
1456646|NCT00784550|4803262|P2|Overall Study|Physician Decision|3
1456647|NCT00784550|4803263|P1|Overall Study|Physician Decision|2
1456648|NCT00784550|4803262|P2|Overall Study|Lost to Follow-up|5
1456649|NCT00784550|4803263|P1|Overall Study|Lost to Follow-up|8
1456650|NCT00784550|4803262|P2|Overall Study|Protocol Violation|10
1456651|NCT00784550|4803263|P1|Overall Study|Protocol Violation|10
1456652|NCT00784550|4803262|P2|Overall Study|Lack of Efficacy|1
1456653|NCT00784550|4803263|P1|Overall Study|Lack of Efficacy|0
1456654|NCT00784550|4803262|P2|Overall Study|Adverse Event|10
1456655|NCT00784550|4803263|P1|Overall Study|Adverse Event|12
1456656|NCT00784459|4803281|P2|Overall Study|Adverse Event|2
1456657|NCT00784459|4803282|P1|Overall Study|Adverse Event|0
1456658|NCT00784368|4803293|P3|Overall Study|Withdrawal of informed consent|0
1456659|NCT00784368|4803294|P2|Overall Study|Withdrawal of informed consent|1
1456660|NCT00784368|4803295|P1|Overall Study|Withdrawal of informed consent|0
1456661|NCT00784368|4803293|P3|Overall Study|Worsening of symptoms|0
1456662|NCT00784368|4803294|P2|Overall Study|Worsening of symptoms|1
1456663|NCT00784368|4803295|P1|Overall Study|Worsening of symptoms|0
1456664|NCT00784368|4803293|P3|Overall Study|Worsening of complications|1
1456665|NCT00784368|4803294|P2|Overall Study|Worsening of complications|0
1456666|NCT00784368|4803295|P1|Overall Study|Worsening of complications|0
1456667|NCT00784368|4803293|P3|Overall Study|Diagnosis of fever|1
1456668|NCT00784368|4803294|P2|Overall Study|Diagnosis of fever|0
1456669|NCT00784368|4803295|P1|Overall Study|Diagnosis of fever|0
1456670|NCT00784368|4803293|P3|Overall Study|Adverse Event|2
1456671|NCT00784368|4803294|P2|Overall Study|Adverse Event|9
1456672|NCT00784368|4803295|P1|Overall Study|Adverse Event|6
1456673|NCT00784368|4803293|P3|Overall Study|Lack of Efficacy|1
1456674|NCT00784368|4803294|P2|Overall Study|Lack of Efficacy|0
1456675|NCT00784368|4803295|P1|Overall Study|Lack of Efficacy|2
1456676|NCT00784368|4803293|P3|Overall Study|Physician Decision|6
1456677|NCT00784368|4803294|P2|Overall Study|Physician Decision|0
1456678|NCT00784368|4803295|P1|Overall Study|Physician Decision|0
1456679|NCT00784277|4803333|P7|ER Treatment|Other|2
1456680|NCT00784277|4803334|P6|ER Treatment|Other|3
1456681|NCT00784277|4803335|P5|ER Treatment|Other|1
1456682|NCT00784277|4803336|P4|ER Treatment|Other|0
1456683|NCT00784277|4803337|P3|ER Treatment|Other|0
1456684|NCT00784277|4803338|P2|ER Treatment|Other|0
1456685|NCT00784277|4803339|P1|ER Treatment|Other|0
1456686|NCT00784277|4803333|P7|ER Treatment|Study Medication Non-Compliant|3
1456687|NCT00784277|4803334|P6|ER Treatment|Study Medication Non-Compliant|3
1456688|NCT00784277|4803335|P5|ER Treatment|Study Medication Non-Compliant|2
1456689|NCT00784277|4803336|P4|ER Treatment|Study Medication Non-Compliant|0
1456690|NCT00784277|4803337|P3|ER Treatment|Study Medication Non-Compliant|0
1456691|NCT00784277|4803338|P2|ER Treatment|Study Medication Non-Compliant|0
1456692|NCT00784277|4803339|P1|ER Treatment|Study Medication Non-Compliant|0
1456693|NCT00784277|4803333|P7|ER Treatment|Withdrawal by Subject|3
1456694|NCT00784277|4803334|P6|ER Treatment|Withdrawal by Subject|5
1456695|NCT00784277|4803335|P5|ER Treatment|Withdrawal by Subject|2
1456696|NCT00784277|4803336|P4|ER Treatment|Withdrawal by Subject|0
1456697|NCT00784277|4803337|P3|ER Treatment|Withdrawal by Subject|0
1456698|NCT00784277|4803338|P2|ER Treatment|Withdrawal by Subject|0
1456699|NCT00784277|4803339|P1|ER Treatment|Withdrawal by Subject|0
1456700|NCT00784277|4803333|P7|ER Treatment|Lost to Follow-up|0
1456701|NCT00784277|4803334|P6|ER Treatment|Lost to Follow-up|2
1456702|NCT00784277|4803335|P5|ER Treatment|Lost to Follow-up|0
1456703|NCT00784277|4803336|P4|ER Treatment|Lost to Follow-up|0
1456704|NCT00784277|4803337|P3|ER Treatment|Lost to Follow-up|0
1456705|NCT00784277|4803338|P2|ER Treatment|Lost to Follow-up|0
1456706|NCT00784277|4803339|P1|ER Treatment|Lost to Follow-up|0
1456707|NCT00784277|4803333|P7|ER Treatment|Lack of Efficacy|0
1456708|NCT00784277|4803334|P6|ER Treatment|Lack of Efficacy|4
1456709|NCT00784277|4803335|P5|ER Treatment|Lack of Efficacy|3
1456710|NCT00784277|4803336|P4|ER Treatment|Lack of Efficacy|0
1456711|NCT00784277|4803337|P3|ER Treatment|Lack of Efficacy|0
1456712|NCT00784277|4803338|P2|ER Treatment|Lack of Efficacy|0
1456713|NCT00784277|4803339|P1|ER Treatment|Lack of Efficacy|0
1456714|NCT00784277|4803333|P7|ER Treatment|Adverse Event|7
1456715|NCT00784277|4803334|P6|ER Treatment|Adverse Event|7
1456716|NCT00784277|4803335|P5|ER Treatment|Adverse Event|1
1456717|NCT00784277|4803336|P4|ER Treatment|Adverse Event|0
1456718|NCT00784277|4803337|P3|ER Treatment|Adverse Event|0
1456719|NCT00784277|4803338|P2|ER Treatment|Adverse Event|0
1456720|NCT00784277|4803339|P1|ER Treatment|Adverse Event|0
1456721|NCT00784277|4803333|P7|IR Treatment|Other|0
1456722|NCT00784277|4803334|P6|IR Treatment|Other|0
1456723|NCT00784277|4803335|P5|IR Treatment|Other|0
1456724|NCT00784277|4803336|P4|IR Treatment|Other|2
1456725|NCT00784277|4803337|P3|IR Treatment|Other|3
1456726|NCT00784277|4803338|P2|IR Treatment|Other|3
1456727|NCT00784277|4803339|P1|IR Treatment|Other|2
1456728|NCT00784277|4803333|P7|IR Treatment|Resolution Of Pain|0
1456729|NCT00784277|4803334|P6|IR Treatment|Resolution Of Pain|0
1456730|NCT00784277|4803335|P5|IR Treatment|Resolution Of Pain|0
1456731|NCT00784277|4803336|P4|IR Treatment|Resolution Of Pain|0
1456732|NCT00784277|4803337|P3|IR Treatment|Resolution Of Pain|0
1456733|NCT00784277|4803338|P2|IR Treatment|Resolution Of Pain|1
1456734|NCT00784277|4803339|P1|IR Treatment|Resolution Of Pain|0
1456735|NCT00784277|4803333|P7|IR Treatment|Withdrawal by Subject|0
1456736|NCT00784277|4803334|P6|IR Treatment|Withdrawal by Subject|0
1456737|NCT00784277|4803335|P5|IR Treatment|Withdrawal by Subject|0
1456738|NCT00784277|4803336|P4|IR Treatment|Withdrawal by Subject|6
1456739|NCT00784277|4803337|P3|IR Treatment|Withdrawal by Subject|4
1456740|NCT00784277|4803338|P2|IR Treatment|Withdrawal by Subject|1
1456741|NCT00784277|4803339|P1|IR Treatment|Withdrawal by Subject|5
1456742|NCT00784277|4803333|P7|IR Treatment|Lost to Follow-up|0
1456743|NCT00784277|4803334|P6|IR Treatment|Lost to Follow-up|0
1456744|NCT00784277|4803335|P5|IR Treatment|Lost to Follow-up|0
1456745|NCT00784277|4803336|P4|IR Treatment|Lost to Follow-up|0
1456746|NCT00784277|4803337|P3|IR Treatment|Lost to Follow-up|1
1456747|NCT00784277|4803338|P2|IR Treatment|Lost to Follow-up|0
1456748|NCT00784277|4803339|P1|IR Treatment|Lost to Follow-up|1
1456749|NCT00784277|4803333|P7|IR Treatment|Lack of Efficacy|0
1456750|NCT00784277|4803334|P6|IR Treatment|Lack of Efficacy|0
1456751|NCT00784277|4803335|P5|IR Treatment|Lack of Efficacy|0
1456752|NCT00784277|4803336|P4|IR Treatment|Lack of Efficacy|0
1456753|NCT00784277|4803337|P3|IR Treatment|Lack of Efficacy|1
1456754|NCT00784277|4803338|P2|IR Treatment|Lack of Efficacy|4
1456755|NCT00784277|4803339|P1|IR Treatment|Lack of Efficacy|4
1456756|NCT00784277|4803333|P7|IR Treatment|Adverse Event|0
1456757|NCT00784277|4803334|P6|IR Treatment|Adverse Event|0
1456758|NCT00784277|4803335|P5|IR Treatment|Adverse Event|0
1456759|NCT00784277|4803336|P4|IR Treatment|Adverse Event|35
1456760|NCT00784277|4803337|P3|IR Treatment|Adverse Event|19
1456761|NCT00784277|4803338|P2|IR Treatment|Adverse Event|8
1456762|NCT00784277|4803339|P1|IR Treatment|Adverse Event|4
1456763|NCT00784238|4803356|P1|Overall Study|Other|14
1456764|NCT00784238|4803356|P1|Overall Study|Withdrawal by Subject|26
1456765|NCT00784238|4803356|P1|Overall Study|Pregnancy|1
1456766|NCT00784238|4803356|P1|Overall Study|Lost to Follow-up|29
1456767|NCT00784238|4803356|P1|Overall Study|Lack of Efficacy|33
1456768|NCT00784238|4803356|P1|Overall Study|Death|2
1456769|NCT00784238|4803356|P1|Overall Study|Adverse Event|14
1456770|NCT00784147|4803399|P2|Overall Study|Death|0
1456771|NCT00784147|4803400|P1|Overall Study|Death|2
1456772|NCT00784147|4803399|P2|Overall Study|Protocol Violation|1
1456773|NCT00784147|4803400|P1|Overall Study|Protocol Violation|1
1456774|NCT00784147|4803399|P2|Overall Study|Physician Decision|1
1456775|NCT00784147|4803400|P1|Overall Study|Physician Decision|2
1456776|NCT00784147|4803399|P2|Overall Study|Withdrawal by Subject|3
1456777|NCT00784147|4803400|P1|Overall Study|Withdrawal by Subject|1
1456778|NCT00784147|4803399|P2|Overall Study|Lost to Follow-up|4
1456779|NCT00784147|4803400|P1|Overall Study|Lost to Follow-up|2
1456780|NCT00784134|4803420|P2|Overall Study|Lost to Follow-up|6
1456781|NCT00784134|4803421|P1|Overall Study|Lost to Follow-up|3
1456782|NCT00784043|4803544|P2|Overall Study|Protocol Terminated|1
1456783|NCT00784043|4803545|P1|Overall Study|Protocol Terminated|23
1456784|NCT00784043|4803544|P2|Overall Study|Withdrawal by Subject|5
1456785|NCT00784043|4803545|P1|Overall Study|Withdrawal by Subject|8
1456786|NCT00783835|4803580|P1|Overall Study|Participant not Adherent|3
1456787|NCT00783835|4803580|P1|Overall Study|Lost to Follow-up|1
1456788|NCT00783835|4803580|P1|Overall Study|Withdrawal by Subject|2
1456789|NCT00783835|4803580|P1|Overall Study|Medical Criteria|1
1456790|NCT00783835|4803580|P1|Overall Study|Adverse Event|3
1456791|NCT00783796|4803592|P1|Overall Study|Received commercial XIENCE V stent|1
1456792|NCT00783796|4803592|P1|Overall Study|Received non-XIENCE V stent|1
1456793|NCT00783796|4803592|P1|Overall Study|Did not receive any stent|4
1456794|NCT00783718|4803697|P7|Maintenance Phase|Lost to Follow-up|2
1456795|NCT00783718|4803698|P6|Maintenance Phase|Lost to Follow-up|0
1456796|NCT00783718|4803699|P5|Maintenance Phase|Lost to Follow-up|2
1456797|NCT00783718|4803700|P4|Maintenance Phase|Lost to Follow-up|0
1456798|NCT00783718|4803701|P3|Maintenance Phase|Lost to Follow-up|0
1456799|NCT00783718|4803702|P2|Maintenance Phase|Lost to Follow-up|0
1456800|NCT00783718|4803703|P1|Maintenance Phase|Lost to Follow-up|3
1456801|NCT00783718|4803697|P7|Maintenance Phase|Withdrawal by Subject|20
1456802|NCT00783718|4803698|P6|Maintenance Phase|Withdrawal by Subject|2
1456803|NCT00783718|4803699|P5|Maintenance Phase|Withdrawal by Subject|5
1456804|NCT00783718|4803700|P4|Maintenance Phase|Withdrawal by Subject|2
1456805|NCT00783718|4803701|P3|Maintenance Phase|Withdrawal by Subject|0
1456806|NCT00783718|4803702|P2|Maintenance Phase|Withdrawal by Subject|0
1456807|NCT00783718|4803703|P1|Maintenance Phase|Withdrawal by Subject|6
1456808|NCT00783718|4803697|P7|Maintenance Phase|Lack of Efficacy|155
1456809|NCT00783718|4803698|P6|Maintenance Phase|Lack of Efficacy|33
1456810|NCT00783718|4803699|P5|Maintenance Phase|Lack of Efficacy|31
1456811|NCT00783718|4803700|P4|Maintenance Phase|Lack of Efficacy|61
1456812|NCT00783718|4803701|P3|Maintenance Phase|Lack of Efficacy|0
1456813|NCT00783718|4803702|P2|Maintenance Phase|Lack of Efficacy|0
1456814|NCT00783718|4803703|P1|Maintenance Phase|Lack of Efficacy|83
1456815|NCT00783718|4803697|P7|Maintenance Phase|Protocol Violation|2
1456816|NCT00783718|4803698|P6|Maintenance Phase|Protocol Violation|0
1456817|NCT00783718|4803699|P5|Maintenance Phase|Protocol Violation|0
1456818|NCT00783718|4803700|P4|Maintenance Phase|Protocol Violation|0
1456819|NCT00783718|4803701|P3|Maintenance Phase|Protocol Violation|0
1456820|NCT00783718|4803702|P2|Maintenance Phase|Protocol Violation|0
1456821|NCT00783718|4803703|P1|Maintenance Phase|Protocol Violation|1
1456822|NCT00783718|4803697|P7|Maintenance Phase|Adverse Event|16
1456823|NCT00783718|4803698|P6|Maintenance Phase|Adverse Event|6
1456824|NCT00783718|4803699|P5|Maintenance Phase|Adverse Event|7
1456825|NCT00783718|4803700|P4|Maintenance Phase|Adverse Event|15
1456826|NCT00783718|4803701|P3|Maintenance Phase|Adverse Event|0
1456827|NCT00783718|4803702|P2|Maintenance Phase|Adverse Event|0
1456828|NCT00783718|4803703|P1|Maintenance Phase|Adverse Event|12
1456829|NCT00783718|4803697|P7|Induction Phase|Lost to Follow-up|0
1456830|NCT00783718|4803698|P6|Induction Phase|Lost to Follow-up|0
1456831|NCT00783718|4803699|P5|Induction Phase|Lost to Follow-up|0
1456832|NCT00783718|4803700|P4|Induction Phase|Lost to Follow-up|0
1456833|NCT00783718|4803701|P3|Induction Phase|Lost to Follow-up|1
1456834|NCT00783718|4803702|P2|Induction Phase|Lost to Follow-up|0
1456835|NCT00783718|4803703|P1|Induction Phase|Lost to Follow-up|1
1456836|NCT00783718|4803697|P7|Induction Phase|Withdrawal by Subject|0
1456837|NCT00783718|4803698|P6|Induction Phase|Withdrawal by Subject|0
1456838|NCT00783718|4803699|P5|Induction Phase|Withdrawal by Subject|0
1456839|NCT00783718|4803700|P4|Induction Phase|Withdrawal by Subject|0
1456840|NCT00783718|4803701|P3|Induction Phase|Withdrawal by Subject|8
1456841|NCT00783718|4803702|P2|Induction Phase|Withdrawal by Subject|4
1456842|NCT00783718|4803703|P1|Induction Phase|Withdrawal by Subject|3
1456843|NCT00783718|4803697|P7|Induction Phase|Lack of Efficacy|0
1456844|NCT00783718|4803698|P6|Induction Phase|Lack of Efficacy|0
1456845|NCT00783718|4803699|P5|Induction Phase|Lack of Efficacy|0
1456846|NCT00783718|4803700|P4|Induction Phase|Lack of Efficacy|0
1456847|NCT00783718|4803701|P3|Induction Phase|Lack of Efficacy|14
1456848|NCT00783718|4803702|P2|Induction Phase|Lack of Efficacy|2
1456849|NCT00783718|4803703|P1|Induction Phase|Lack of Efficacy|5
1456850|NCT00783718|4803697|P7|Induction Phase|Protocol Violation|0
1456851|NCT00783718|4803698|P6|Induction Phase|Protocol Violation|0
1456852|NCT00783718|4803699|P5|Induction Phase|Protocol Violation|0
1456853|NCT00783718|4803700|P4|Induction Phase|Protocol Violation|0
1456854|NCT00783718|4803701|P3|Induction Phase|Protocol Violation|6
1456855|NCT00783718|4803702|P2|Induction Phase|Protocol Violation|1
1456856|NCT00783718|4803703|P1|Induction Phase|Protocol Violation|1
1456857|NCT00783718|4803697|P7|Induction Phase|Adverse Event|0
1456858|NCT00783718|4803698|P6|Induction Phase|Adverse Event|0
1456859|NCT00783718|4803699|P5|Induction Phase|Adverse Event|0
1456860|NCT00783718|4803700|P4|Induction Phase|Adverse Event|0
1456861|NCT00783718|4803701|P3|Induction Phase|Adverse Event|7
1456862|NCT00783718|4803702|P2|Induction Phase|Adverse Event|0
1456863|NCT00783718|4803703|P1|Induction Phase|Adverse Event|4
1456864|NCT00783705|4803731|P2|Overall Study|Lost to Follow-up|3
1456865|NCT00783705|4803732|P1|Overall Study|Lost to Follow-up|1
1456866|NCT00783705|4803731|P2|Overall Study|Withdrawal by Subject|2
1456867|NCT00783705|4803732|P1|Overall Study|Withdrawal by Subject|3
1456868|NCT00783705|4803731|P2|Overall Study|Adverse Event|0
1456869|NCT00783705|4803732|P1|Overall Study|Adverse Event|2
1456870|NCT00783692|4803779|P7|Maintenance Phase|Other|1
1456871|NCT00783692|4803780|P6|Maintenance Phase|Other|1
1456872|NCT00783692|4803781|P5|Maintenance Phase|Other|0
1456873|NCT00783692|4803782|P4|Maintenance Phase|Other|1
1456874|NCT00783692|4803783|P3|Maintenance Phase|Other|0
1456875|NCT00783692|4803784|P2|Maintenance Phase|Other|0
1456876|NCT00783692|4803785|P1|Maintenance Phase|Other|0
1456877|NCT00783692|4803779|P7|Maintenance Phase|Lost to Follow-up|5
1456878|NCT00783692|4803780|P6|Maintenance Phase|Lost to Follow-up|2
1456879|NCT00783692|4803781|P5|Maintenance Phase|Lost to Follow-up|3
1456880|NCT00783692|4803782|P4|Maintenance Phase|Lost to Follow-up|1
1456881|NCT00783692|4803783|P3|Maintenance Phase|Lost to Follow-up|0
1456882|NCT00783692|4803784|P2|Maintenance Phase|Lost to Follow-up|0
1456883|NCT00783692|4803785|P1|Maintenance Phase|Lost to Follow-up|2
1456884|NCT00783692|4803779|P7|Maintenance Phase|Withdrawal by Subject|24
1456885|NCT00783692|4803780|P6|Maintenance Phase|Withdrawal by Subject|9
1456886|NCT00783692|4803781|P5|Maintenance Phase|Withdrawal by Subject|6
1456887|NCT00783692|4803782|P4|Maintenance Phase|Withdrawal by Subject|7
1456888|NCT00783692|4803783|P3|Maintenance Phase|Withdrawal by Subject|0
1456889|NCT00783692|4803784|P2|Maintenance Phase|Withdrawal by Subject|0
1456890|NCT00783692|4803785|P1|Maintenance Phase|Withdrawal by Subject|7
1456891|NCT00783692|4803779|P7|Maintenance Phase|Lack of Efficacy|177
1456892|NCT00783692|4803780|P6|Maintenance Phase|Lack of Efficacy|48
1456893|NCT00783692|4803781|P5|Maintenance Phase|Lack of Efficacy|58
1456894|NCT00783692|4803782|P4|Maintenance Phase|Lack of Efficacy|64
1456895|NCT00783692|4803783|P3|Maintenance Phase|Lack of Efficacy|0
1456896|NCT00783692|4803784|P2|Maintenance Phase|Lack of Efficacy|0
1456897|NCT00783692|4803785|P1|Maintenance Phase|Lack of Efficacy|79
1456898|NCT00783692|4803779|P7|Maintenance Phase|Protocol Violation|4
1456899|NCT00783692|4803780|P6|Maintenance Phase|Protocol Violation|3
1456900|NCT00783692|4803781|P5|Maintenance Phase|Protocol Violation|2
1456901|NCT00783692|4803782|P4|Maintenance Phase|Protocol Violation|1
1456902|NCT00783692|4803783|P3|Maintenance Phase|Protocol Violation|0
1456903|NCT00783692|4803784|P2|Maintenance Phase|Protocol Violation|0
1456904|NCT00783692|4803785|P1|Maintenance Phase|Protocol Violation|0
1456905|NCT00783692|4803779|P7|Maintenance Phase|Adverse Event|38
1456906|NCT00783692|4803780|P6|Maintenance Phase|Adverse Event|9
1456907|NCT00783692|4803781|P5|Maintenance Phase|Adverse Event|12
1456908|NCT00783692|4803782|P4|Maintenance Phase|Adverse Event|15
1456909|NCT00783692|4803783|P3|Maintenance Phase|Adverse Event|0
1456910|NCT00783692|4803784|P2|Maintenance Phase|Adverse Event|0
1456911|NCT00783692|4803785|P1|Maintenance Phase|Adverse Event|7
1456912|NCT00783692|4803779|P7|Induction Phase|Other|0
1456913|NCT00783692|4803780|P6|Induction Phase|Other|0
1456914|NCT00783692|4803781|P5|Induction Phase|Other|0
1456915|NCT00783692|4803782|P4|Induction Phase|Other|0
1456916|NCT00783692|4803783|P3|Induction Phase|Other|2
1456917|NCT00783692|4803784|P2|Induction Phase|Other|0
1456918|NCT00783692|4803785|P1|Induction Phase|Other|0
1456919|NCT00783692|4803779|P7|Induction Phase|Lost to Follow-up|0
1456920|NCT00783692|4803780|P6|Induction Phase|Lost to Follow-up|0
1456921|NCT00783692|4803781|P5|Induction Phase|Lost to Follow-up|0
1456922|NCT00783692|4803782|P4|Induction Phase|Lost to Follow-up|0
1456923|NCT00783692|4803783|P3|Induction Phase|Lost to Follow-up|3
1456924|NCT00783692|4803784|P2|Induction Phase|Lost to Follow-up|0
1456925|NCT00783692|4803785|P1|Induction Phase|Lost to Follow-up|0
1456926|NCT00783692|4803779|P7|Induction Phase|Withdrawal by Subject|0
1456927|NCT00783692|4803780|P6|Induction Phase|Withdrawal by Subject|0
1456928|NCT00783692|4803781|P5|Induction Phase|Withdrawal by Subject|0
1456929|NCT00783692|4803782|P4|Induction Phase|Withdrawal by Subject|0
1456930|NCT00783692|4803783|P3|Induction Phase|Withdrawal by Subject|16
1456931|NCT00783692|4803784|P2|Induction Phase|Withdrawal by Subject|9
1456932|NCT00783692|4803785|P1|Induction Phase|Withdrawal by Subject|3
1456933|NCT00783692|4803779|P7|Induction Phase|Lack of Efficacy|0
1456934|NCT00783692|4803780|P6|Induction Phase|Lack of Efficacy|0
1456935|NCT00783692|4803781|P5|Induction Phase|Lack of Efficacy|0
1456936|NCT00783692|4803782|P4|Induction Phase|Lack of Efficacy|0
1456937|NCT00783692|4803783|P3|Induction Phase|Lack of Efficacy|28
1456938|NCT00783692|4803784|P2|Induction Phase|Lack of Efficacy|3
1456939|NCT00783692|4803785|P1|Induction Phase|Lack of Efficacy|1
1456940|NCT00783692|4803779|P7|Induction Phase|Protocol Violation|0
1456941|NCT00783692|4803780|P6|Induction Phase|Protocol Violation|0
1456942|NCT00783692|4803781|P5|Induction Phase|Protocol Violation|0
1456943|NCT00783692|4803782|P4|Induction Phase|Protocol Violation|0
1456944|NCT00783692|4803783|P3|Induction Phase|Protocol Violation|1
1456945|NCT00783692|4803784|P2|Induction Phase|Protocol Violation|0
1456946|NCT00783692|4803785|P1|Induction Phase|Protocol Violation|0
1456947|NCT00783692|4803779|P7|Induction Phase|Adverse Event|0
1456948|NCT00783692|4803780|P6|Induction Phase|Adverse Event|0
1456949|NCT00783692|4803781|P5|Induction Phase|Adverse Event|0
1456950|NCT00783692|4803782|P4|Induction Phase|Adverse Event|0
1456951|NCT00783692|4803783|P3|Induction Phase|Adverse Event|24
1456952|NCT00783692|4803784|P2|Induction Phase|Adverse Event|9
1456953|NCT00783692|4803785|P1|Induction Phase|Adverse Event|7
1456954|NCT00783432|4803831|P2|Overall Study|Protocol Violation|9
1456955|NCT00783432|4803832|P1|Overall Study|Protocol Violation|6
1456956|NCT00783432|4803831|P2|Overall Study|subject moved|5
1456957|NCT00783432|4803832|P1|Overall Study|subject moved|3
1456958|NCT00783432|4803831|P2|Overall Study|Withdrawal by Subject|20
1456959|NCT00783432|4803832|P1|Overall Study|Withdrawal by Subject|23
1456960|NCT00783432|4803831|P2|Overall Study|Lost to Follow-up|6
1456961|NCT00783432|4803832|P1|Overall Study|Lost to Follow-up|11
1456962|NCT00783432|4803831|P2|Overall Study|Lack of Efficacy|21
1456963|NCT00783432|4803832|P1|Overall Study|Lack of Efficacy|20
1456964|NCT00783432|4803831|P2|Overall Study|Adverse Event|17
1456965|NCT00783432|4803832|P1|Overall Study|Adverse Event|22
1456966|NCT00783302|4803842|P1|Overall Study|Withdrawal by Subject|3
1456967|NCT00783302|4803842|P1|Overall Study|Physician Decision|1
1456968|NCT00783302|4803842|P1|Overall Study|Protocol Violation|3
1456969|NCT00783302|4803842|P1|Overall Study|Technical Problems|11
1456970|NCT00783302|4803842|P1|Overall Study|Lost to Follow-up|17
1456971|NCT00783263|4803864|P4|Overall Study|Withdrawal by Subject|2
1456972|NCT00783263|4803865|P3|Overall Study|Withdrawal by Subject|1
1456973|NCT00783263|4803866|P2|Overall Study|Withdrawal by Subject|1
1456974|NCT00783263|4803867|P1|Overall Study|Withdrawal by Subject|0
1456975|NCT00783263|4803864|P4|Overall Study|Lost to Follow-up|0
1456976|NCT00783263|4803865|P3|Overall Study|Lost to Follow-up|0
1456977|NCT00783263|4803866|P2|Overall Study|Lost to Follow-up|1
1456978|NCT00783263|4803867|P1|Overall Study|Lost to Follow-up|1
1456979|NCT00783263|4803864|P4|Overall Study|Adverse Event|1
1456980|NCT00783263|4803865|P3|Overall Study|Adverse Event|2
1456981|NCT00783263|4803866|P2|Overall Study|Adverse Event|0
1456982|NCT00783263|4803867|P1|Overall Study|Adverse Event|3
1456983|NCT00783224|4803897|P4|Overall Study|Inappropriate as a study subject|1
1456984|NCT00783224|4803898|P3|Overall Study|Inappropriate as a study subject|0
1456985|NCT00783224|4803899|P2|Overall Study|Inappropriate as a study subject|0
1456986|NCT00783224|4803900|P1|Overall Study|Inappropriate as a study subject|0
1456987|NCT00783224|4803897|P4|Overall Study|Discarded the Investigational Drug Used|1
1456988|NCT00783224|4803898|P3|Overall Study|Discarded the Investigational Drug Used|0
1456989|NCT00783224|4803899|P2|Overall Study|Discarded the Investigational Drug Used|0
1456990|NCT00783224|4803900|P1|Overall Study|Discarded the Investigational Drug Used|0
1456991|NCT00783224|4803897|P4|Overall Study|Adverse Event|0
1456992|NCT00783224|4803898|P3|Overall Study|Adverse Event|1
1456993|NCT00783224|4803899|P2|Overall Study|Adverse Event|0
1456994|NCT00783224|4803900|P1|Overall Study|Adverse Event|0
1456995|NCT00783198|4803912|P3|Overall Study|Administrative|2
1456996|NCT00783198|4803913|P2|Overall Study|Administrative|1
1456997|NCT00783198|4803914|P1|Overall Study|Administrative|2
1456998|NCT00783198|4803912|P3|Overall Study|Did not meet protocol eligibility|0
1456999|NCT00783198|4803913|P2|Overall Study|Did not meet protocol eligibility|1
1457000|NCT00783198|4803914|P1|Overall Study|Did not meet protocol eligibility|0
1457001|NCT00783198|4803912|P3|Overall Study|Noncompliance with protocol|10
1457002|NCT00783198|4803913|P2|Overall Study|Noncompliance with protocol|7
1457003|NCT00783198|4803914|P1|Overall Study|Noncompliance with protocol|7
1457004|NCT00783198|4803912|P3|Overall Study|Withdrawal by Subject|20
1457005|NCT00783198|4803913|P2|Overall Study|Withdrawal by Subject|14
1457006|NCT00783198|4803914|P1|Overall Study|Withdrawal by Subject|22
1457007|NCT00783198|4803912|P3|Overall Study|Lost to Follow-up|7
1457008|NCT00783198|4803913|P2|Overall Study|Lost to Follow-up|1
1457009|NCT00783198|4803914|P1|Overall Study|Lost to Follow-up|11
1457010|NCT00783198|4803912|P3|Overall Study|Adverse Event|3
1457011|NCT00783198|4803913|P2|Overall Study|Adverse Event|19
1457012|NCT00783198|4803914|P1|Overall Study|Adverse Event|15
1457013|NCT00783094|4803937|P3|Open-Label Extension Period|Lack of Efficacy|0
1457014|NCT00783094|4803938|P2|Open-Label Extension Period|Lack of Efficacy|4
1457015|NCT00783094|4803939|P1|Open-Label Extension Period|Lack of Efficacy|1
1457016|NCT00783094|4803937|P3|Open-Label Extension Period|Physician Decision|3
1457017|NCT00783094|4803938|P2|Open-Label Extension Period|Physician Decision|2
1457018|NCT00783094|4803939|P1|Open-Label Extension Period|Physician Decision|4
1457019|NCT00783094|4803937|P3|Open-Label Extension Period|Withdrawal by Subject|3
1457020|NCT00783094|4803938|P2|Open-Label Extension Period|Withdrawal by Subject|1
1457021|NCT00783094|4803939|P1|Open-Label Extension Period|Withdrawal by Subject|1
1457022|NCT00783094|4803937|P3|Open-Label Extension Period|Protocol Violation|7
1457023|NCT00783094|4803938|P2|Open-Label Extension Period|Protocol Violation|5
1457024|NCT00783094|4803939|P1|Open-Label Extension Period|Protocol Violation|4
1457025|NCT00783094|4803937|P3|Open-Label Extension Period|Death|1
1457026|NCT00783094|4803938|P2|Open-Label Extension Period|Death|0
1457027|NCT00783094|4803939|P1|Open-Label Extension Period|Death|0
1457028|NCT00783094|4803937|P3|Open-Label Extension Period|Adverse Event|16
1457029|NCT00783094|4803938|P2|Open-Label Extension Period|Adverse Event|7
1457030|NCT00783094|4803939|P1|Open-Label Extension Period|Adverse Event|12
1457031|NCT00783094|4803937|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
1457032|NCT00783094|4803938|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
1457033|NCT00783094|4803939|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
1457034|NCT00783094|4803937|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
1457035|NCT00783094|4803938|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
1457036|NCT00783094|4803939|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
1457037|NCT00783094|4803937|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
1457038|NCT00783094|4803938|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
1457039|NCT00783094|4803939|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
1457040|NCT00783094|4803937|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
1457041|NCT00783094|4803938|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
1457042|NCT00783094|4803939|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
1457043|NCT00783094|4803937|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
1457044|NCT00783094|4803938|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
1457045|NCT00783094|4803939|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
1457046|NCT00782834|4804015|P1|Treatment Phase|fibrous tumor not GIST|1
1457047|NCT00782795|4804055|P2|Overall Study|Withdrawal by Subject|2
1457048|NCT00782795|4804056|P1|Overall Study|Withdrawal by Subject|1
1457049|NCT00782717|4804096|P2|Overall Study|Exited in error|2
1457050|NCT00782717|4804097|P1|Overall Study|Exited in error|0
1457051|NCT00782717|4804096|P2|Overall Study|Did not meet entrance criteria|3
1457052|NCT00782717|4804097|P1|Overall Study|Did not meet entrance criteria|1
1457053|NCT00782717|4804096|P2|Overall Study|Enrollment close prior to surgery|0
1457054|NCT00782717|4804097|P1|Overall Study|Enrollment close prior to surgery|1
1457055|NCT00782717|4804096|P2|Overall Study|Treatment failure|14
1457056|NCT00782717|4804097|P1|Overall Study|Treatment failure|3
1457057|NCT00782717|4804096|P2|Overall Study|Noncompliance|1
1457058|NCT00782717|4804097|P1|Overall Study|Noncompliance|2
1457059|NCT00782717|4804096|P2|Overall Study|Patient decision unrelated to AE|3
1457060|NCT00782717|4804097|P1|Overall Study|Patient decision unrelated to AE|6
1457061|NCT00782717|4804096|P2|Overall Study|Adverse Event|5
1457062|NCT00782717|4804097|P1|Overall Study|Adverse Event|2
1457063|NCT00782626|4804124|P1|Overall Study|Other Complicating Disease|1
1457064|NCT00782626|4804124|P1|Overall Study|Progressive Disease|5
1457065|NCT00782626|4804124|P1|Overall Study|Adverse Event|1
1457066|NCT00782509|4804131|P3|Overall Study|Lack of Efficacy|2
1457067|NCT00782509|4804132|P2|Overall Study|Lack of Efficacy|5
1457068|NCT00782509|4804133|P1|Overall Study|Lack of Efficacy|10
1457069|NCT00782509|4804131|P3|Overall Study|Other reasons not stated above|3
1457070|NCT00782509|4804132|P2|Overall Study|Other reasons not stated above|2
1457071|NCT00782509|4804133|P1|Overall Study|Other reasons not stated above|5
1457072|NCT00782509|4804131|P3|Overall Study|Non compliance with protocol|0
1457073|NCT00782509|4804132|P2|Overall Study|Non compliance with protocol|0
1457074|NCT00782509|4804133|P1|Overall Study|Non compliance with protocol|2
1457075|NCT00782509|4804131|P3|Overall Study|Withdrawal by Subject|8
1457076|NCT00782509|4804132|P2|Overall Study|Withdrawal by Subject|5
1457077|NCT00782509|4804133|P1|Overall Study|Withdrawal by Subject|3
1457078|NCT00782509|4804131|P3|Overall Study|Lost to Follow-up|3
1457079|NCT00782509|4804132|P2|Overall Study|Lost to Follow-up|2
1457080|NCT00782509|4804133|P1|Overall Study|Lost to Follow-up|1
1457081|NCT00782509|4804131|P3|Overall Study|Adverse Event|20
1457082|NCT00782509|4804132|P2|Overall Study|Adverse Event|10
1457083|NCT00782509|4804133|P1|Overall Study|Adverse Event|20
1457084|NCT00782496|4804326|P2|Overall Study|Lost to Follow-up|15
1457085|NCT00782496|4804327|P1|Overall Study|Lost to Follow-up|14
1457086|NCT00782483|4804334|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
1457087|NCT00782418|4804338|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
1457088|NCT00782418|4804339|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
1457089|NCT00782418|4804340|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
1457090|NCT00782418|4804341|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
1457091|NCT00782418|4804342|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
1457092|NCT00782418|4804343|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
1457093|NCT00782418|4804344|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
1457094|NCT00782418|4804338|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
1457095|NCT00782418|4804339|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
1457096|NCT00782418|4804340|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
1457097|NCT00782418|4804341|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
1457098|NCT00782418|4804342|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
1457099|NCT00782418|4804343|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
1457100|NCT00782418|4804344|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
1457101|NCT00782340|4804381|P3|Open Label Titration|Randomized in error|0
1457102|NCT00782340|4804382|P2|Open Label Titration|Randomized in error|0
1457103|NCT00782340|4804383|P1|Open Label Titration|Randomized in error|6
1457104|NCT00782340|4804381|P3|Open Label Titration|Lost to Follow-up|0
1457105|NCT00782340|4804382|P2|Open Label Titration|Lost to Follow-up|0
1457106|NCT00782340|4804383|P1|Open Label Titration|Lost to Follow-up|5
1457107|NCT00782340|4804381|P3|Open Label Titration|Did not meet responder criteria|0
1457108|NCT00782340|4804382|P2|Open Label Titration|Did not meet responder criteria|0
1457109|NCT00782340|4804383|P1|Open Label Titration|Did not meet responder criteria|2
1457110|NCT00782340|4804381|P3|Open Label Titration|Enrollment capped|0
1457111|NCT00782340|4804382|P2|Open Label Titration|Enrollment capped|0
1457112|NCT00782340|4804383|P1|Open Label Titration|Enrollment capped|16
1457113|NCT00782340|4804381|P3|Open Label Titration|Withdrawal by Subject|0
1457114|NCT00782340|4804382|P2|Open Label Titration|Withdrawal by Subject|0
1457115|NCT00782340|4804383|P1|Open Label Titration|Withdrawal by Subject|5
1457116|NCT00782340|4804381|P3|Open Label Titration|Protocol Violation|0
1457117|NCT00782340|4804382|P2|Open Label Titration|Protocol Violation|0
1457118|NCT00782340|4804383|P1|Open Label Titration|Protocol Violation|5
1457119|NCT00782340|4804381|P3|Open Label Titration|Treatment failure|0
1457120|NCT00782340|4804382|P2|Open Label Titration|Treatment failure|0
1457121|NCT00782340|4804383|P1|Open Label Titration|Treatment failure|50
1457122|NCT00782340|4804381|P3|Open Label Titration|Adverse Event|0
1457123|NCT00782340|4804382|P2|Open Label Titration|Adverse Event|0
1457124|NCT00782340|4804383|P1|Open Label Titration|Adverse Event|12
1457125|NCT00782275|4804453|P1|Overall Study|Other|3
1457126|NCT00782275|4804453|P1|Overall Study|Not started treatment|1
1457127|NCT00782275|4804453|P1|Overall Study|Physician Decision|4
1457128|NCT00782275|4804453|P1|Overall Study|Progressive Disease|21
1457129|NCT00782275|4804453|P1|Overall Study|Withdrawal by Subject|1
1457130|NCT00782275|4804453|P1|Overall Study|Adverse Event|11
1457131|NCT00782210|4804462|P3|Overall Study|Other reason not described above|3
1457132|NCT00782210|4804463|P2|Overall Study|Other reason not described above|2
1457133|NCT00782210|4804464|P1|Overall Study|Other reason not described above|3
1457134|NCT00782210|4804462|P3|Overall Study|Lack of Efficacy|1
1457135|NCT00782210|4804463|P2|Overall Study|Lack of Efficacy|4
1457136|NCT00782210|4804464|P1|Overall Study|Lack of Efficacy|13
1457137|NCT00782210|4804462|P3|Overall Study|Non compliance with protocol|2
1457138|NCT00782210|4804463|P2|Overall Study|Non compliance with protocol|3
1457139|NCT00782210|4804464|P1|Overall Study|Non compliance with protocol|0
1457140|NCT00782210|4804462|P3|Overall Study|Withdrawal by Subject|11
1457141|NCT00782210|4804463|P2|Overall Study|Withdrawal by Subject|8
1457142|NCT00782210|4804464|P1|Overall Study|Withdrawal by Subject|11
1457143|NCT00782210|4804462|P3|Overall Study|Lost to Follow-up|2
1457144|NCT00782210|4804463|P2|Overall Study|Lost to Follow-up|1
1457145|NCT00782210|4804464|P1|Overall Study|Lost to Follow-up|2
1457146|NCT00782210|4804462|P3|Overall Study|Adverse Event|16
1457147|NCT00782210|4804463|P2|Overall Study|Adverse Event|17
1457148|NCT00782210|4804464|P1|Overall Study|Adverse Event|21
1457149|NCT00782184|4804657|P2|Overall Study|Withdrawal by Subject|2
1457150|NCT00782184|4804658|P1|Overall Study|Withdrawal by Subject|3
1457151|NCT00782184|4804657|P2|Overall Study|Protocol Violation|1
1457152|NCT00782184|4804658|P1|Overall Study|Protocol Violation|0
1457153|NCT00782184|4804657|P2|Overall Study|Adverse Event|2
1457154|NCT00782184|4804658|P1|Overall Study|Adverse Event|1
1457155|NCT00782171|4804695|P2|Overall Study|not eligible|6
1457156|NCT00782171|4804696|P1|Overall Study|not eligible|8
1457157|NCT00782171|4804695|P2|Overall Study|others|9
1457158|NCT00782171|4804696|P1|Overall Study|others|7
1457159|NCT00782171|4804695|P2|Overall Study|complications|1
1457160|NCT00782171|4804696|P1|Overall Study|complications|3
1457161|NCT00782171|4804695|P2|Overall Study|Withdrawal by Subject|1
1457162|NCT00782171|4804696|P1|Overall Study|Withdrawal by Subject|2
1457163|NCT00782171|4804695|P2|Overall Study|Lost to Follow-up|2
1457164|NCT00782171|4804696|P1|Overall Study|Lost to Follow-up|2
1457165|NCT00782067|4804728|P1|Overall Study|Disease progression|44
1457166|NCT00782067|4804728|P1|Overall Study|Withdrawal by Subject|10
1457167|NCT00782067|4804728|P1|Overall Study|Adverse Event|28
1457168|NCT00782067|4804728|P1|Overall Study|Death|8
1457169|NCT00782067|4804728|P1|Overall Study|Protocol deviation|2
1457170|NCT00782067|4804728|P1|Overall Study|Lost to Follow-up|1
1457171|NCT00782067|4804728|P1|Overall Study|Administrative problems|1
1457172|NCT00782067|4804728|P1|Overall Study|Abnormal procedure results|1
1457173|NCT00781963|4804738|P3|Overall Study|Refused follow-up|0
1457174|NCT00781963|4804739|P2|Overall Study|Refused follow-up|5
1457175|NCT00781963|4804740|P1|Overall Study|Refused follow-up|4
1457176|NCT00781963|4804738|P3|Overall Study|Withdrawal by Subject|1
1457177|NCT00781963|4804739|P2|Overall Study|Withdrawal by Subject|3
1457178|NCT00781963|4804740|P1|Overall Study|Withdrawal by Subject|0
1457179|NCT00781963|4804738|P3|Overall Study|Lost to Follow-up|1
1457180|NCT00781963|4804739|P2|Overall Study|Lost to Follow-up|1
1457181|NCT00781963|4804740|P1|Overall Study|Lost to Follow-up|1
1457182|NCT00781963|4804738|P3|Overall Study|Death|0
1457183|NCT00781963|4804739|P2|Overall Study|Death|0
1457184|NCT00781963|4804740|P1|Overall Study|Death|3
1457185|NCT00781937|4804761|P2|Follow up Period (Week 56-68)|Unclassified|4
1457186|NCT00781937|4804762|P1|Follow up Period (Week 56-68)|Unclassified|5
1457187|NCT00781937|4804761|P2|Follow up Period (Week 56-68)|Protocol Violation|1
1457188|NCT00781937|4804762|P1|Follow up Period (Week 56-68)|Protocol Violation|1
1457189|NCT00781937|4804761|P2|Main Trial Period Through Week 56|Unclassified|15
1457190|NCT00781937|4804762|P1|Main Trial Period Through Week 56|Unclassified|10
1457191|NCT00781937|4804761|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
1457192|NCT00781937|4804762|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
1457193|NCT00781937|4804761|P2|Main Trial Period Through Week 56|Protocol Violation|5
1457194|NCT00781937|4804762|P1|Main Trial Period Through Week 56|Protocol Violation|8
1457195|NCT00781937|4804761|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
1457196|NCT00781937|4804762|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
1457197|NCT00781937|4804761|P2|Main Trial Period Through Week 56|Adverse Event|18
1457198|NCT00781937|4804762|P1|Main Trial Period Through Week 56|Adverse Event|18
1457199|NCT00781911|4804820|P2|Overall Study|Sponsor Decision|0
1457200|NCT00781911|4804821|P1|Overall Study|Sponsor Decision|1
1457201|NCT00781911|4804820|P2|Overall Study|Physician Decision|2
1457202|NCT00781911|4804821|P1|Overall Study|Physician Decision|0
1457203|NCT00781911|4804820|P2|Overall Study|Withdrawal by Subject|2
1457204|NCT00781911|4804821|P1|Overall Study|Withdrawal by Subject|1
1457205|NCT00781911|4804820|P2|Overall Study|Adverse Event|4
1457206|NCT00781911|4804821|P1|Overall Study|Adverse Event|4
1457207|NCT00781859|4804858|P2|Overall Study|Death|0
1457208|NCT00781859|4804859|P1|Overall Study|Death|3
1457209|NCT00781859|4804858|P2|Overall Study|Lost to Follow-up|3
1457210|NCT00781859|4804859|P1|Overall Study|Lost to Follow-up|6
1457211|NCT00781859|4804858|P2|Overall Study|Withdrawal by Subject|4
1457212|NCT00781859|4804859|P1|Overall Study|Withdrawal by Subject|8
1457213|NCT00781859|4804858|P2|Overall Study|Adverse Event|2
1457214|NCT00781859|4804859|P1|Overall Study|Adverse Event|2
1457215|NCT00781768|4804869|P2|Overall Study|Not transplanted.|2
1457216|NCT00781768|4804870|P1|Overall Study|Not transplanted.|0
1457217|NCT00781599|4804878|P2|Overall Study|Lost to Follow-up|4
1457218|NCT00781599|4804879|P1|Overall Study|Lost to Follow-up|7
1457219|NCT00781456|4804904|P2|Overall Study|Other Reason, Unknown|1
1457220|NCT00781456|4804905|P1|Overall Study|Other Reason, Unknown|0
1457221|NCT00781456|4804904|P2|Overall Study|Lost to Follow-up|5
1457222|NCT00781456|4804905|P1|Overall Study|Lost to Follow-up|10
1457223|NCT00781456|4804904|P2|Overall Study|Noncompliance With Protocol|1
1457224|NCT00781456|4804905|P1|Overall Study|Noncompliance With Protocol|1
1457225|NCT00781456|4804904|P2|Overall Study|Protocol Violation|1
1457226|NCT00781456|4804905|P1|Overall Study|Protocol Violation|4
1457227|NCT00781456|4804904|P2|Overall Study|Withdrawal by Subject|5
1457228|NCT00781456|4804905|P1|Overall Study|Withdrawal by Subject|3
1457229|NCT00781456|4804904|P2|Overall Study|Adverse Event|3
1457230|NCT00781456|4804905|P1|Overall Study|Adverse Event|3
1457231|NCT00781391|4804928|P3|Overall Study|Lost to Follow-up|1
1457232|NCT00781391|4804929|P2|Overall Study|Lost to Follow-up|0
1457233|NCT00781391|4804930|P1|Overall Study|Lost to Follow-up|0
1457234|NCT00781391|4804928|P3|Overall Study|Withdrawal by Subject|25
1457235|NCT00781391|4804929|P2|Overall Study|Withdrawal by Subject|37
1457236|NCT00781391|4804930|P1|Overall Study|Withdrawal by Subject|47
1457237|NCT00781391|4804928|P3|Overall Study|Death|706
1457238|NCT00781391|4804929|P2|Overall Study|Death|730
1457239|NCT00781391|4804930|P1|Overall Study|Death|789
1457240|NCT00781391|4804928|P3|Overall Study|Protocol Violation|20
1457241|NCT00781391|4804929|P2|Overall Study|Protocol Violation|17
1457242|NCT00781391|4804930|P1|Overall Study|Protocol Violation|19
1457243|NCT00781391|4804928|P3|Overall Study|never received study drug|32
1457244|NCT00781391|4804929|P2|Overall Study|never received study drug|23
1457245|NCT00781391|4804930|P1|Overall Study|never received study drug|24
1457246|NCT00781365|4804964|P2|Overall Study|Language barrier|0
1457247|NCT00781365|4804965|P1|Overall Study|Language barrier|1
1457248|NCT00781365|4804964|P2|Overall Study|Did Not Attend Visit|28
1457249|NCT00781365|4804965|P1|Overall Study|Did Not Attend Visit|20
1457250|NCT00781365|4804964|P2|Overall Study|Withdrawal by Subject|8
1457251|NCT00781365|4804965|P1|Overall Study|Withdrawal by Subject|13
1457252|NCT00781326|4804975|P1|Phase I|Physician Decision|2
1457253|NCT00781326|4804975|P1|Phase I|Withdrawal by Subject|1
1457254|NCT00781326|4804975|P1|Phase I|Adverse Event|1
1457255|NCT00781274|4804979|P1|Overall Study|Withdrawal by Subject|2
1457256|NCT00780910|4805003|P1|Overall Study|Adverse Event|2
1457257|NCT00780416|4805108|P2|Overall Study|Withdrawal by Subject|6
1457258|NCT00780416|4805109|P1|Overall Study|Withdrawal by Subject|8
1457259|NCT00780416|4805108|P2|Overall Study|Protocol Violation|0
1457260|NCT00780416|4805109|P1|Overall Study|Protocol Violation|1
1457261|NCT00780416|4805108|P2|Overall Study|Physician Decision|3
1457262|NCT00780416|4805109|P1|Overall Study|Physician Decision|3
1457263|NCT00780273|4805154|P1|Overall Study|Lost to Follow-up|1
1457264|NCT00780273|4805154|P1|Overall Study|Death|1
1457265|NCT00779909|4805193|P4|Overall Study|Withdrawal by Subject|0
1457266|NCT00779909|4805194|P3|Overall Study|Withdrawal by Subject|0
1457267|NCT00779909|4805195|P2|Overall Study|Withdrawal by Subject|1
1457268|NCT00779909|4805196|P1|Overall Study|Withdrawal by Subject|0
1457269|NCT00779909|4805193|P4|Overall Study|Lost to Follow-up|1
1457270|NCT00779909|4805194|P3|Overall Study|Lost to Follow-up|0
1457271|NCT00779909|4805195|P2|Overall Study|Lost to Follow-up|0
1457272|NCT00779909|4805196|P1|Overall Study|Lost to Follow-up|1
1457273|NCT00779857|4805238|P1|Overall Study|Missed Visit|2
1457274|NCT00779857|4805238|P1|Overall Study|Withdrawal by Subject|3
1457275|NCT00779857|4805238|P1|Overall Study|Death|1
1457276|NCT00779779|4805243|P1|Overall Study|Lost to Follow-up|5
1457277|NCT00779779|4805243|P1|Overall Study|Withdrawal by Subject|4
1457278|NCT00779779|4805243|P1|Overall Study|Protocol Violation|14
1457279|NCT00779779|4805243|P1|Overall Study|Adverse Event|1
1457280|NCT00779766|4805252|P2|Overall Study|Withdrawal by Subject|67
1457281|NCT00779766|4805253|P1|Overall Study|Withdrawal by Subject|84
1457282|NCT00779766|4805252|P2|Overall Study|Protocol Violation|1
1457283|NCT00779766|4805253|P1|Overall Study|Protocol Violation|1
1457284|NCT00779675|4805335|P1|Extended Treatment Period|Lost to Follow-up|6
1457285|NCT00779675|4805335|P1|Extended Treatment Period|Protocol defined clinical event|1
1457286|NCT00779675|4805335|P1|Extended Treatment Period|Treatment Failure|11
1457287|NCT00779675|4805335|P1|Extended Treatment Period|Adverse Event|6
1457288|NCT00779675|4805335|P1|Extended Treatment Period|Protocol Violation|13
1457289|NCT00779675|4805335|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
1457290|NCT00779675|4805335|P1|Treatment Period|Administrative|3
1457291|NCT00779675|4805335|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
1457292|NCT00779675|4805335|P1|Treatment Period|Protocol Violation|54
1457293|NCT00779675|4805335|P1|Treatment Period|Withdrawal by Subject|46
1457294|NCT00779675|4805335|P1|Treatment Period|Lost to Follow-up|23
1457295|NCT00779675|4805335|P1|Treatment Period|Transferred to Another Study|38
1457296|NCT00779675|4805335|P1|Treatment Period|Treatment Failure|80
1457297|NCT00779675|4805335|P1|Treatment Period|Adverse Event|87
1457298|NCT00779584|4805363|P9|Overall Study|Ongoing in Study|0
1457299|NCT00779584|4805364|P8|Overall Study|Ongoing in Study|0
1457300|NCT00779584|4805365|P7|Overall Study|Ongoing in Study|0
1457301|NCT00779584|4805366|P6|Overall Study|Ongoing in Study|1
1457302|NCT00779584|4805367|P5|Overall Study|Ongoing in Study|1
1457303|NCT00779584|4805368|P4|Overall Study|Ongoing in Study|0
1457304|NCT00779584|4805369|P3|Overall Study|Ongoing in Study|0
1457305|NCT00779584|4805370|P2|Overall Study|Ongoing in Study|0
1457306|NCT00779584|4805371|P1|Overall Study|Ongoing in Study|0
1457307|NCT00779584|4805363|P9|Overall Study|Symptomatic Deterioration|0
1457308|NCT00779584|4805364|P8|Overall Study|Symptomatic Deterioration|0
1457309|NCT00779584|4805365|P7|Overall Study|Symptomatic Deterioration|1
1457310|NCT00779584|4805366|P6|Overall Study|Symptomatic Deterioration|1
1457311|NCT00779584|4805367|P5|Overall Study|Symptomatic Deterioration|0
1457312|NCT00779584|4805368|P4|Overall Study|Symptomatic Deterioration|0
1457313|NCT00779584|4805369|P3|Overall Study|Symptomatic Deterioration|1
1457314|NCT00779584|4805370|P2|Overall Study|Symptomatic Deterioration|1
1457315|NCT00779584|4805371|P1|Overall Study|Symptomatic Deterioration|1
1457316|NCT00779584|4805363|P9|Overall Study|Adverse Event|1
1457317|NCT00779584|4805364|P8|Overall Study|Adverse Event|1
1457318|NCT00779584|4805365|P7|Overall Study|Adverse Event|2
1457319|NCT00779584|4805366|P6|Overall Study|Adverse Event|0
1457320|NCT00779584|4805367|P5|Overall Study|Adverse Event|0
1457321|NCT00779584|4805368|P4|Overall Study|Adverse Event|0
1457322|NCT00779584|4805369|P3|Overall Study|Adverse Event|2
1457323|NCT00779584|4805370|P2|Overall Study|Adverse Event|0
1457324|NCT00779584|4805371|P1|Overall Study|Adverse Event|1
1457325|NCT00779584|4805363|P9|Overall Study|Progression of Disease|1
1457326|NCT00779584|4805364|P8|Overall Study|Progression of Disease|2
1457327|NCT00779584|4805365|P7|Overall Study|Progression of Disease|4
1457328|NCT00779584|4805366|P6|Overall Study|Progression of Disease|1
1457329|NCT00779584|4805367|P5|Overall Study|Progression of Disease|5
1457330|NCT00779584|4805368|P4|Overall Study|Progression of Disease|6
1457331|NCT00779584|4805369|P3|Overall Study|Progression of Disease|2
1457332|NCT00779584|4805370|P2|Overall Study|Progression of Disease|1
1457333|NCT00779584|4805371|P1|Overall Study|Progression of Disease|0
1457334|NCT00779584|4805363|P9|Overall Study|Lost to Follow-up|0
1457335|NCT00779584|4805364|P8|Overall Study|Lost to Follow-up|0
1457336|NCT00779584|4805365|P7|Overall Study|Lost to Follow-up|0
1457337|NCT00779584|4805366|P6|Overall Study|Lost to Follow-up|0
1457338|NCT00779584|4805367|P5|Overall Study|Lost to Follow-up|1
1457339|NCT00779584|4805368|P4|Overall Study|Lost to Follow-up|0
1457340|NCT00779584|4805369|P3|Overall Study|Lost to Follow-up|0
1457341|NCT00779584|4805370|P2|Overall Study|Lost to Follow-up|0
1457342|NCT00779584|4805371|P1|Overall Study|Lost to Follow-up|0
1457343|NCT00779584|4805363|P9|Overall Study|Withdrawal by Subject|0
1457344|NCT00779584|4805364|P8|Overall Study|Withdrawal by Subject|0
1457345|NCT00779584|4805365|P7|Overall Study|Withdrawal by Subject|1
1457346|NCT00779584|4805366|P6|Overall Study|Withdrawal by Subject|2
1457347|NCT00779584|4805367|P5|Overall Study|Withdrawal by Subject|0
1457348|NCT00779584|4805368|P4|Overall Study|Withdrawal by Subject|0
1457349|NCT00779584|4805369|P3|Overall Study|Withdrawal by Subject|2
1457350|NCT00779584|4805370|P2|Overall Study|Withdrawal by Subject|1
1457351|NCT00779584|4805371|P1|Overall Study|Withdrawal by Subject|1
1457352|NCT00779584|4805363|P9|Overall Study|Protocol Violation|0
1457353|NCT00779584|4805364|P8|Overall Study|Protocol Violation|0
1457354|NCT00779584|4805365|P7|Overall Study|Protocol Violation|0
1457355|NCT00779584|4805366|P6|Overall Study|Protocol Violation|1
1457356|NCT00779584|4805367|P5|Overall Study|Protocol Violation|0
1457357|NCT00779584|4805368|P4|Overall Study|Protocol Violation|0
1457358|NCT00779584|4805369|P3|Overall Study|Protocol Violation|0
1457359|NCT00779584|4805370|P2|Overall Study|Protocol Violation|0
1457360|NCT00779584|4805371|P1|Overall Study|Protocol Violation|0
1457361|NCT00779506|4805462|P1|Overall Study|Lost to Follow-up|1
1457362|NCT00779506|4805462|P1|Overall Study|Withdrawal by Subject|6
1457363|NCT00779506|4805462|P1|Overall Study|Protocol Violation|5
1457364|NCT00779506|4805462|P1|Overall Study|Lack of Efficacy|11
1457365|NCT00779506|4805462|P1|Overall Study|Adverse Event|4
1457366|NCT00779506|4805462|P1|Overall Study|Screening Failed|2
1457367|NCT00779467|4805476|P4|Overall Study|unavailable research staff|1
1457368|NCT00779467|4805477|P3|Overall Study|unavailable research staff|0
1457369|NCT00779467|4805478|P2|Overall Study|unavailable research staff|0
1457370|NCT00779467|4805479|P1|Overall Study|unavailable research staff|0
1457371|NCT00779467|4805476|P4|Overall Study|technical issue|1
1457372|NCT00779467|4805477|P3|Overall Study|technical issue|2
1457373|NCT00779467|4805478|P2|Overall Study|technical issue|0
1457374|NCT00779467|4805479|P1|Overall Study|technical issue|0
1457375|NCT00779467|4805476|P4|Overall Study|missing data|4
1457376|NCT00779467|4805477|P3|Overall Study|missing data|1
1457377|NCT00779467|4805478|P2|Overall Study|missing data|0
1457378|NCT00779467|4805479|P1|Overall Study|missing data|1
1457379|NCT00779467|4805476|P4|Overall Study|failed inclusion criteria|2
1457380|NCT00779467|4805477|P3|Overall Study|failed inclusion criteria|1
1457381|NCT00779467|4805478|P2|Overall Study|failed inclusion criteria|3
1457382|NCT00779467|4805479|P1|Overall Study|failed inclusion criteria|3
1457383|NCT00779467|4805476|P4|Overall Study|Lack of Efficacy|11
1457384|NCT00779467|4805477|P3|Overall Study|Lack of Efficacy|6
1457385|NCT00779467|4805478|P2|Overall Study|Lack of Efficacy|2
1457386|NCT00779467|4805479|P1|Overall Study|Lack of Efficacy|11
1457387|NCT00779402|4805519|P2|Long-term Follow-up|Completed Protocol Visits|2
1457388|NCT00779402|4805520|P1|Long-term Follow-up|Completed Protocol Visits|6
1457389|NCT00779402|4805519|P2|Long-term Follow-up|Closure of Study|4
1457390|NCT00779402|4805520|P1|Long-term Follow-up|Closure of Study|8
1457391|NCT00779402|4805519|P2|Long-term Follow-up|Not specified|0
1457392|NCT00779402|4805520|P1|Long-term Follow-up|Not specified|5
1457393|NCT00779402|4805519|P2|Long-term Follow-up|Patient refused to continue|0
1457394|NCT00779402|4805520|P1|Long-term Follow-up|Patient refused to continue|2
1457395|NCT00779402|4805519|P2|Surveillance Phase|Completed Protocol Visits|2
1457396|NCT00779402|4805520|P1|Surveillance Phase|Completed Protocol Visits|3
1457397|NCT00779402|4805519|P2|Surveillance Phase|Closure of study|6
1457398|NCT00779402|4805520|P1|Surveillance Phase|Closure of study|5
1457399|NCT00779402|4805519|P2|Surveillance Phase|Withdrawal by Subject|1
1457400|NCT00779402|4805520|P1|Surveillance Phase|Withdrawal by Subject|4
1457401|NCT00779402|4805519|P2|Surveillance Phase|Not specified|5
1457402|NCT00779402|4805520|P1|Surveillance Phase|Not specified|5
1457403|NCT00779402|4805519|P2|Surveillance Phase|Intercurrent Illness|0
1457404|NCT00779402|4805520|P1|Surveillance Phase|Intercurrent Illness|2
1457405|NCT00779402|4805519|P2|Surveillance Phase|Death|1
1457406|NCT00779402|4805520|P1|Surveillance Phase|Death|0
1457407|NCT00779402|4805519|P2|Surveillance Phase|Lost to Follow-up|1
1457408|NCT00779402|4805520|P1|Surveillance Phase|Lost to Follow-up|2
1457409|NCT00779402|4805519|P2|Surveillance Phase|Patient refused to continue|14
1457410|NCT00779402|4805520|P1|Surveillance Phase|Patient refused to continue|22
1457411|NCT00779402|4805519|P2|Surveillance Phase|Protocol Violation|1
1457412|NCT00779402|4805520|P1|Surveillance Phase|Protocol Violation|0
1457413|NCT00779402|4805519|P2|Treatment Phase 1|Completed Protocol Visits|6
1457414|NCT00779402|4805520|P1|Treatment Phase 1|Completed Protocol Visits|3
1457415|NCT00779402|4805519|P2|Treatment Phase 1|Closure of Study|2
1457416|NCT00779402|4805520|P1|Treatment Phase 1|Closure of Study|3
1457417|NCT00779402|4805519|P2|Treatment Phase 1|Not Specified|2
1457418|NCT00779402|4805520|P1|Treatment Phase 1|Not Specified|4
1457419|NCT00779402|4805519|P2|Treatment Phase 1|Withdrawal by Subject|0
1457420|NCT00779402|4805520|P1|Treatment Phase 1|Withdrawal by Subject|1
1457421|NCT00779402|4805519|P2|Treatment Phase 1|Intercurrent Illness|1
1457422|NCT00779402|4805520|P1|Treatment Phase 1|Intercurrent Illness|1
1457423|NCT00779402|4805519|P2|Treatment Phase 1|Death|1
1457424|NCT00779402|4805520|P1|Treatment Phase 1|Death|0
1457425|NCT00779402|4805519|P2|Treatment Phase 1|Lost to Follow-up|1
1457426|NCT00779402|4805520|P1|Treatment Phase 1|Lost to Follow-up|0
1457427|NCT00779402|4805519|P2|Treatment Phase 1|Patient Refused to Continue|2
1457428|NCT00779402|4805520|P1|Treatment Phase 1|Patient Refused to Continue|17
1457429|NCT00779402|4805519|P2|Treatment Phase 1|Protocol Violation|0
1457430|NCT00779402|4805520|P1|Treatment Phase 1|Protocol Violation|1
1457431|NCT00779402|4805519|P2|Treatment Phase 1|Adverse Event|0
1457432|NCT00779402|4805520|P1|Treatment Phase 1|Adverse Event|2
1457433|NCT00779402|4805519|P2|Treatment Phase 1|Disease Progression|0
1457434|NCT00779402|4805520|P1|Treatment Phase 1|Disease Progression|1
1457435|NCT00779259|4805563|P1|Quinine Alone|Adverse Event|2
1457436|NCT00779246|4805584|P2|Overall Study|Missing sufficient data for analysis|53
1457437|NCT00779246|4805585|P1|Overall Study|Missing sufficient data for analysis|33
1457438|NCT00779142|4805604|P1|Overall Study|Screen Failures|3
1457439|NCT00779038|4805618|P1|Overall Study|Study Prematurely Terminated|13
1457440|NCT00779025|4805627|P1|Overall Study|Withdrawal by Subject|1
1457441|NCT00778999|4805638|P2|Overall Study|Did not receive recFSH|20
1457442|NCT00778999|4805639|P1|Overall Study|Did not receive recFSH|14
1457443|NCT00778999|4805638|P2|Overall Study|Discontinuation: no embryo transfer|14
1457444|NCT00778999|4805639|P1|Overall Study|Discontinuation: no embryo transfer|14
1457445|NCT00778921|4805648|P3|Overall Study|Not treated|2
1457446|NCT00778921|4805649|P2|Overall Study|Not treated|2
1457447|NCT00778921|4805650|P1|Overall Study|Not treated|0
1457448|NCT00778921|4805648|P3|Overall Study|Protocol Violation|2
1457449|NCT00778921|4805649|P2|Overall Study|Protocol Violation|0
1457450|NCT00778921|4805650|P1|Overall Study|Protocol Violation|3
1457451|NCT00778921|4805648|P3|Overall Study|Administrative Problems|0
1457452|NCT00778921|4805649|P2|Overall Study|Administrative Problems|2
1457453|NCT00778921|4805650|P1|Overall Study|Administrative Problems|1
1457454|NCT00778921|4805648|P3|Overall Study|Lost to Follow-up|1
1457455|NCT00778921|4805649|P2|Overall Study|Lost to Follow-up|2
1457456|NCT00778921|4805650|P1|Overall Study|Lost to Follow-up|0
1457457|NCT00778921|4805648|P3|Overall Study|Patient withdrew request|6
1457458|NCT00778921|4805649|P2|Overall Study|Patient withdrew request|1
1457459|NCT00778921|4805650|P1|Overall Study|Patient withdrew request|3
1457460|NCT00778921|4805648|P3|Overall Study|Patient No Longer Requires Study Drug|0
1457461|NCT00778921|4805649|P2|Overall Study|Patient No Longer Requires Study Drug|1
1457462|NCT00778921|4805650|P1|Overall Study|Patient No Longer Requires Study Drug|0
1457463|NCT00778921|4805648|P3|Overall Study|Unsatisfactory therapeutic response|1
1457464|NCT00778921|4805649|P2|Overall Study|Unsatisfactory therapeutic response|1
1457465|NCT00778921|4805650|P1|Overall Study|Unsatisfactory therapeutic response|1
1457466|NCT00778921|4805648|P3|Overall Study|Abnormal Test Procedure Result(s)|2
1457467|NCT00778921|4805649|P2|Overall Study|Abnormal Test Procedure Result(s)|0
1457468|NCT00778921|4805650|P1|Overall Study|Abnormal Test Procedure Result(s)|0
1457469|NCT00778921|4805648|P3|Overall Study|Abnormal Laboratory Value(s)|0
1457470|NCT00778921|4805649|P2|Overall Study|Abnormal Laboratory Value(s)|0
1457471|NCT00778921|4805650|P1|Overall Study|Abnormal Laboratory Value(s)|1
1457472|NCT00778921|4805648|P3|Overall Study|Adverse Event|14
1457473|NCT00778921|4805649|P2|Overall Study|Adverse Event|10
1457474|NCT00778921|4805650|P1|Overall Study|Adverse Event|9
1457475|NCT00778895|4805667|P3|ESFU Phase|Other|0
1457476|NCT00778895|4805668|P2|ESFU Phase|Other|0
1457477|NCT00778895|4805669|P1|ESFU Phase|Other|2
1457478|NCT00778895|4805667|P3|ESFU Phase|Lost to Follow-up|2
1457479|NCT00778895|4805668|P2|ESFU Phase|Lost to Follow-up|7
1457480|NCT00778895|4805669|P1|ESFU Phase|Lost to Follow-up|6
1457481|NCT00778895|4805667|P3|ESFU Phase|Withdrawal by Subject|0
1457482|NCT00778895|4805668|P2|ESFU Phase|Withdrawal by Subject|4
1457483|NCT00778895|4805669|P1|ESFU Phase|Withdrawal by Subject|1
1457484|NCT00778895|4805667|P3|ESFU Phase|Adverse Event|0
1457485|NCT00778895|4805668|P2|ESFU Phase|Adverse Event|1
1457486|NCT00778895|4805669|P1|ESFU Phase|Adverse Event|2
1457487|NCT00778895|4805667|P3|Active Phase|Other|0
1457488|NCT00778895|4805668|P2|Active Phase|Other|0
1457489|NCT00778895|4805669|P1|Active Phase|Other|2
1457490|NCT00778895|4805667|P3|Active Phase|Lost to Follow-up|0
1457491|NCT00778895|4805668|P2|Active Phase|Lost to Follow-up|1
1457492|NCT00778895|4805669|P1|Active Phase|Lost to Follow-up|1
1457493|NCT00778895|4805667|P3|Active Phase|Withdrawal by Subject|0
1457494|NCT00778895|4805668|P2|Active Phase|Withdrawal by Subject|4
1457495|NCT00778895|4805669|P1|Active Phase|Withdrawal by Subject|1
1457496|NCT00778895|4805667|P3|Active Phase|Adverse Event|0
1457497|NCT00778895|4805668|P2|Active Phase|Adverse Event|1
1457498|NCT00778895|4805669|P1|Active Phase|Adverse Event|3
1457499|NCT00778830|4805713|P2|Overall Study|Ongoing at data cut-off|1
1457500|NCT00778830|4805714|P1|Overall Study|Ongoing at data cut-off|0
1457501|NCT00778817|4805726|P1|Overall Study|Withdrawal by Subject|2
1457502|NCT00778817|4805726|P1|Overall Study|Adverse Event|2
1457503|NCT00778622|4805753|P3|Overall Study|Other|1
1457504|NCT00778622|4805754|P2|Overall Study|Other|0
1457505|NCT00778622|4805755|P1|Overall Study|Other|1
1457506|NCT00778622|4805753|P3|Overall Study|immigration|0
1457507|NCT00778622|4805754|P2|Overall Study|immigration|0
1457508|NCT00778622|4805755|P1|Overall Study|immigration|1
1457509|NCT00778622|4805753|P3|Overall Study|Lack of Efficacy|0
1457510|NCT00778622|4805754|P2|Overall Study|Lack of Efficacy|0
1457511|NCT00778622|4805755|P1|Overall Study|Lack of Efficacy|2
1457512|NCT00778622|4805753|P3|Overall Study|Protocol Violation|0
1457513|NCT00778622|4805754|P2|Overall Study|Protocol Violation|3
1457514|NCT00778622|4805755|P1|Overall Study|Protocol Violation|0
1457515|NCT00778622|4805753|P3|Overall Study|Lost to Follow-up|2
1457516|NCT00778622|4805754|P2|Overall Study|Lost to Follow-up|3
1457517|NCT00778622|4805755|P1|Overall Study|Lost to Follow-up|3
1457518|NCT00778622|4805753|P3|Overall Study|Withdrawal by Subject|5
1457519|NCT00778622|4805754|P2|Overall Study|Withdrawal by Subject|5
1457520|NCT00778622|4805755|P1|Overall Study|Withdrawal by Subject|4
1457521|NCT00778622|4805753|P3|Overall Study|Adverse Event|7
1457522|NCT00778622|4805754|P2|Overall Study|Adverse Event|4
1457523|NCT00778622|4805755|P1|Overall Study|Adverse Event|5
1457524|NCT00778375|4805808|P1|Overall Study|Ineligible|3
1457525|NCT00778336|4805822|P4|3 Month Follow Up|Death|0
1457526|NCT00778336|4805823|P3|3 Month Follow Up|Death|2
1457527|NCT00778336|4805824|P2|3 Month Follow Up|Death|3
1457528|NCT00778336|4805825|P1|3 Month Follow Up|Death|8
1457529|NCT00778336|4805822|P4|3 Month Follow Up|Lost to Follow-up|0
1457530|NCT00778336|4805823|P3|3 Month Follow Up|Lost to Follow-up|3
1457531|NCT00778336|4805824|P2|3 Month Follow Up|Lost to Follow-up|20
1457532|NCT00778336|4805825|P1|3 Month Follow Up|Lost to Follow-up|15
1457533|NCT00778336|4805822|P4|Index Procedure-Discharge|Death|0
1457534|NCT00778336|4805823|P3|Index Procedure-Discharge|Death|2
1457535|NCT00778336|4805824|P2|Index Procedure-Discharge|Death|3
1457536|NCT00778336|4805825|P1|Index Procedure-Discharge|Death|6
1457537|NCT00778258|4805863|P9|Overall Study|Other|0
1457538|NCT00778258|4805864|P8|Overall Study|Other|0
1457539|NCT00778258|4805865|P7|Overall Study|Other|1
1457540|NCT00778258|4805866|P6|Overall Study|Other|0
1457541|NCT00778258|4805867|P5|Overall Study|Other|0
1457542|NCT00778258|4805868|P4|Overall Study|Other|0
1457543|NCT00778258|4805869|P3|Overall Study|Other|0
1457544|NCT00778258|4805870|P2|Overall Study|Other|0
1457545|NCT00778258|4805871|P1|Overall Study|Other|0
1457546|NCT00778258|4805863|P9|Overall Study|Non-compliance|0
1457547|NCT00778258|4805864|P8|Overall Study|Non-compliance|0
1457548|NCT00778258|4805865|P7|Overall Study|Non-compliance|0
1457549|NCT00778258|4805866|P6|Overall Study|Non-compliance|0
1457550|NCT00778258|4805867|P5|Overall Study|Non-compliance|0
1457551|NCT00778258|4805868|P4|Overall Study|Non-compliance|1
1457552|NCT00778258|4805869|P3|Overall Study|Non-compliance|0
1457553|NCT00778258|4805870|P2|Overall Study|Non-compliance|0
1457554|NCT00778258|4805871|P1|Overall Study|Non-compliance|0
1457555|NCT00778258|4805863|P9|Overall Study|New Contraindication|0
1457556|NCT00778258|4805864|P8|Overall Study|New Contraindication|1
1457557|NCT00778258|4805865|P7|Overall Study|New Contraindication|0
1457558|NCT00778258|4805866|P6|Overall Study|New Contraindication|0
1457559|NCT00778258|4805867|P5|Overall Study|New Contraindication|0
1457560|NCT00778258|4805868|P4|Overall Study|New Contraindication|0
1457561|NCT00778258|4805869|P3|Overall Study|New Contraindication|0
1457562|NCT00778258|4805870|P2|Overall Study|New Contraindication|0
1457563|NCT00778258|4805871|P1|Overall Study|New Contraindication|0
1457564|NCT00778258|4805863|P9|Overall Study|Withdrawal by Subject|4
1457565|NCT00778258|4805864|P8|Overall Study|Withdrawal by Subject|12
1457566|NCT00778258|4805865|P7|Overall Study|Withdrawal by Subject|12
1457567|NCT00778258|4805866|P6|Overall Study|Withdrawal by Subject|6
1457568|NCT00778258|4805867|P5|Overall Study|Withdrawal by Subject|0
1457569|NCT00778258|4805868|P4|Overall Study|Withdrawal by Subject|2
1457570|NCT00778258|4805869|P3|Overall Study|Withdrawal by Subject|8
1457571|NCT00778258|4805870|P2|Overall Study|Withdrawal by Subject|2
1457572|NCT00778258|4805871|P1|Overall Study|Withdrawal by Subject|6
1457573|NCT00778258|4805863|P9|Overall Study|Lost to Follow-up|0
1457574|NCT00778258|4805864|P8|Overall Study|Lost to Follow-up|2
1457575|NCT00778258|4805865|P7|Overall Study|Lost to Follow-up|2
1457576|NCT00778258|4805866|P6|Overall Study|Lost to Follow-up|3
1457577|NCT00778258|4805867|P5|Overall Study|Lost to Follow-up|0
1457578|NCT00778258|4805868|P4|Overall Study|Lost to Follow-up|0
1457579|NCT00778258|4805869|P3|Overall Study|Lost to Follow-up|2
1457580|NCT00778258|4805870|P2|Overall Study|Lost to Follow-up|0
1457581|NCT00778258|4805871|P1|Overall Study|Lost to Follow-up|0
1457582|NCT00778258|4805863|P9|Overall Study|Adverse Event|0
1457583|NCT00778258|4805864|P8|Overall Study|Adverse Event|0
1457584|NCT00778258|4805865|P7|Overall Study|Adverse Event|0
1457585|NCT00778258|4805866|P6|Overall Study|Adverse Event|1
1457586|NCT00778258|4805867|P5|Overall Study|Adverse Event|0
1457587|NCT00778258|4805868|P4|Overall Study|Adverse Event|0
1457588|NCT00778258|4805869|P3|Overall Study|Adverse Event|0
1457589|NCT00778258|4805870|P2|Overall Study|Adverse Event|0
1457590|NCT00778258|4805871|P1|Overall Study|Adverse Event|1
1457591|NCT00778102|4805938|P2|Overall Study|Administrative Reason|10
1457592|NCT00778102|4805939|P1|Overall Study|Administrative Reason|7
1457593|NCT00778102|4805938|P2|Overall Study|Withdrawal by Subject|1
1457594|NCT00778102|4805939|P1|Overall Study|Withdrawal by Subject|1
1457595|NCT00778102|4805938|P2|Overall Study|Refused Treatment|3
1457596|NCT00778102|4805939|P1|Overall Study|Refused Treatment|2
1457597|NCT00778102|4805938|P2|Overall Study|Protocol Violation|1
1457598|NCT00778102|4805939|P1|Overall Study|Protocol Violation|0
1457599|NCT00778102|4805938|P2|Overall Study|Violation of Selection Criteria|1
1457600|NCT00778102|4805939|P1|Overall Study|Violation of Selection Criteria|1
1457601|NCT00778102|4805938|P2|Overall Study|Lost to Follow-up|0
1457602|NCT00778102|4805939|P1|Overall Study|Lost to Follow-up|1
1457603|NCT00778102|4805938|P2|Overall Study|Death|1
1457604|NCT00778102|4805939|P1|Overall Study|Death|1
1457605|NCT00778102|4805938|P2|Overall Study|Adverse Event|5
1457606|NCT00778102|4805939|P1|Overall Study|Adverse Event|8
1457607|NCT00777946|4805974|P3|Overall Study|Randomized in error|0
1457608|NCT00777946|4805975|P2|Overall Study|Randomized in error|1
1457609|NCT00777946|4805976|P1|Overall Study|Randomized in error|1
1457610|NCT00777946|4805974|P3|Overall Study|Protocol deviation|1
1457611|NCT00777946|4805975|P2|Overall Study|Protocol deviation|1
1457612|NCT00777946|4805976|P1|Overall Study|Protocol deviation|2
1457613|NCT00777946|4805974|P3|Overall Study|Lost to Follow-up|0
1457614|NCT00777946|4805975|P2|Overall Study|Lost to Follow-up|1
1457615|NCT00777946|4805976|P1|Overall Study|Lost to Follow-up|3
1457616|NCT00777946|4805974|P3|Overall Study|Patient withdrew consent|3
1457617|NCT00777946|4805975|P2|Overall Study|Patient withdrew consent|2
1457618|NCT00777946|4805976|P1|Overall Study|Patient withdrew consent|3
1457619|NCT00777946|4805974|P3|Overall Study|Condition no longer required study drug|0
1457620|NCT00777946|4805975|P2|Overall Study|Condition no longer required study drug|0
1457621|NCT00777946|4805976|P1|Overall Study|Condition no longer required study drug|1
1457622|NCT00777946|4805974|P3|Overall Study|Lack of Efficacy|9
1457623|NCT00777946|4805975|P2|Overall Study|Lack of Efficacy|0
1457624|NCT00777946|4805976|P1|Overall Study|Lack of Efficacy|0
1457625|NCT00777946|4805974|P3|Overall Study|Adverse Event|3
1457626|NCT00777946|4805975|P2|Overall Study|Adverse Event|1
1457627|NCT00777946|4805976|P1|Overall Study|Adverse Event|11
1457628|NCT00777803|4806011|P2|Overall Study|Non-compliance|2
1457629|NCT00777803|4806012|P1|Overall Study|Non-compliance|2
1457630|NCT00777803|4806011|P2|Overall Study|Adverse Event|0
1457631|NCT00777803|4806012|P1|Overall Study|Adverse Event|1
1457632|NCT00777803|4806011|P2|Overall Study|Lost to Follow-up|5
1457633|NCT00777803|4806012|P1|Overall Study|Lost to Follow-up|12
1457634|NCT00777608|4806091|P2|Overall Study|Investigator Decision|2
1457635|NCT00777608|4806092|P1|Overall Study|Investigator Decision|1
1457636|NCT00777608|4806091|P2|Overall Study|Protocol Violation|0
1457637|NCT00777608|4806092|P1|Overall Study|Protocol Violation|1
1457638|NCT00777608|4806091|P2|Overall Study|Withdrawal by Subject|3
1457639|NCT00777608|4806092|P1|Overall Study|Withdrawal by Subject|1
1457640|NCT00777608|4806091|P2|Overall Study|Lost to Follow-up|1
1457641|NCT00777608|4806092|P1|Overall Study|Lost to Follow-up|1
1457642|NCT00777556|4806102|P1|Overall Study|Did not complete all 3 follow-up visits|20
1457643|NCT00777556|4806102|P1|Overall Study|Dispensed but did not use product|12
1457644|NCT00777556|4806102|P1|Overall Study|Inappropriate self-selection|34
1457645|NCT00777257|4806123|P3|Overall Study|Withdrawal by Subject|5
1457646|NCT00777257|4806124|P2|Overall Study|Withdrawal by Subject|6
1457647|NCT00777257|4806125|P1|Overall Study|Withdrawal by Subject|3
1457648|NCT00777257|4806123|P3|Overall Study|Protocol Violation|2
1457649|NCT00777257|4806124|P2|Overall Study|Protocol Violation|2
1457650|NCT00777257|4806125|P1|Overall Study|Protocol Violation|2
1457651|NCT00777257|4806123|P3|Overall Study|Lost to Follow-up|2
1457652|NCT00777257|4806124|P2|Overall Study|Lost to Follow-up|3
1457653|NCT00777257|4806125|P1|Overall Study|Lost to Follow-up|3
1457654|NCT00777257|4806123|P3|Overall Study|Adverse Event|0
1457655|NCT00777257|4806124|P2|Overall Study|Adverse Event|1
1457656|NCT00777257|4806125|P1|Overall Study|Adverse Event|3
1457657|NCT00777205|4806144|P2|Overall Study|Protocol Violation|56
1457658|NCT00777205|4806145|P1|Overall Study|Protocol Violation|0
1457659|NCT00777205|4806144|P2|Overall Study|Death|2
1457660|NCT00777205|4806145|P1|Overall Study|Death|0
1457661|NCT00777205|4806144|P2|Overall Study|Withdrawal by Subject|4
1457662|NCT00777205|4806145|P1|Overall Study|Withdrawal by Subject|6
1457663|NCT00777205|4806144|P2|Overall Study|Lost to Follow-up|9
1457664|NCT00777205|4806145|P1|Overall Study|Lost to Follow-up|25
1457665|NCT00777153|4806179|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
1457666|NCT00777153|4806180|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
1457667|NCT00777153|4806181|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
1457668|NCT00777153|4806179|P3|Overall Study|Withdrawal by Subject|3
1457669|NCT00777153|4806180|P2|Overall Study|Withdrawal by Subject|4
1457670|NCT00777153|4806181|P1|Overall Study|Withdrawal by Subject|3
1457671|NCT00777153|4806179|P3|Overall Study|Death|33
1457672|NCT00777153|4806180|P2|Overall Study|Death|73
1457673|NCT00777153|4806181|P1|Overall Study|Death|85
1457674|NCT00777153|4806179|P3|Overall Study|Lost to Follow-up|0
1457675|NCT00777153|4806180|P2|Overall Study|Lost to Follow-up|1
1457676|NCT00777153|4806181|P1|Overall Study|Lost to Follow-up|1
1457677|NCT00777101|4806206|P2|Overall Study|Failed to Return|1
1457678|NCT00777101|4806207|P1|Overall Study|Failed to Return|0
1457679|NCT00777101|4806206|P2|Overall Study|Discontinuation of Study by Sponsor|0
1457680|NCT00777101|4806207|P1|Overall Study|Discontinuation of Study by Sponsor|1
1457681|NCT00777101|4806206|P2|Overall Study|Lost to Follow-up|1
1457682|NCT00777101|4806207|P1|Overall Study|Lost to Follow-up|2
1457683|NCT00777101|4806206|P2|Overall Study|Withdrawal by Subject|6
1457684|NCT00777101|4806207|P1|Overall Study|Withdrawal by Subject|11
1457685|NCT00777101|4806206|P2|Overall Study|Death|43
1457686|NCT00777101|4806207|P1|Overall Study|Death|48
1457687|NCT00777049|4806238|P2|Overall Study|No treatment (elevated liver enzymes)|1
1457688|NCT00777049|4806239|P1|Overall Study|No treatment (elevated liver enzymes)|0
1457689|NCT00777049|4806238|P2|Overall Study|Withdrawal by Subject|0
1457690|NCT00777049|4806239|P1|Overall Study|Withdrawal by Subject|1
1457691|NCT00777036|4806248|P3|Follow-Up|Death|0
1457692|NCT00777036|4806249|P2|Follow-Up|Death|8
1457693|NCT00777036|4806250|P1|Follow-Up|Death|1
1457694|NCT00777036|4806248|P3|Follow-Up|Withdrawal by Subject|4
1457695|NCT00777036|4806249|P2|Follow-Up|Withdrawal by Subject|0
1457696|NCT00777036|4806250|P1|Follow-Up|Withdrawal by Subject|1
1457697|NCT00777036|4806248|P3|Follow-Up|Reason Not Specified|0
1457698|NCT00777036|4806249|P2|Follow-Up|Reason Not Specified|0
1457699|NCT00777036|4806250|P1|Follow-Up|Reason Not Specified|2
1457700|NCT00777036|4806248|P3|Follow-Up|Lost to Follow-up|0
1457701|NCT00777036|4806249|P2|Follow-Up|Lost to Follow-up|0
1457702|NCT00777036|4806250|P1|Follow-Up|Lost to Follow-up|1
1457703|NCT00777036|4806248|P3|On Treatment|Progressive Disease|6
1457704|NCT00777036|4806249|P2|On Treatment|Progressive Disease|4
1457705|NCT00777036|4806250|P1|On Treatment|Progressive Disease|5
1457706|NCT00777036|4806248|P3|On Treatment|Study Drug Toxicity|1
1457707|NCT00777036|4806249|P2|On Treatment|Study Drug Toxicity|0
1457708|NCT00777036|4806250|P1|On Treatment|Study Drug Toxicity|0
1457709|NCT00777036|4806248|P3|On Treatment|Death|0
1457710|NCT00777036|4806249|P2|On Treatment|Death|2
1457711|NCT00777036|4806250|P1|On Treatment|Death|0
1457712|NCT00777036|4806248|P3|On Treatment|Withdrawal by Subject|3
1457713|NCT00777036|4806249|P2|On Treatment|Withdrawal by Subject|2
1457714|NCT00777036|4806250|P1|On Treatment|Withdrawal by Subject|3
1457715|NCT00777036|4806248|P3|On Treatment|Maximum Clinical Benefit|1
1457716|NCT00777036|4806249|P2|On Treatment|Maximum Clinical Benefit|0
1457717|NCT00777036|4806250|P1|On Treatment|Maximum Clinical Benefit|2
1457718|NCT00777036|4806248|P3|On Treatment|Non-compliance with Study Drug|0
1457719|NCT00777036|4806249|P2|On Treatment|Non-compliance with Study Drug|0
1457720|NCT00777036|4806250|P1|On Treatment|Non-compliance with Study Drug|1
1457721|NCT00777036|4806248|P3|On Treatment|Failure to Meet Study Criteria|0
1457722|NCT00777036|4806249|P2|On Treatment|Failure to Meet Study Criteria|1
1457723|NCT00777036|4806250|P1|On Treatment|Failure to Meet Study Criteria|0
1457724|NCT00777036|4806248|P3|On Treatment|Reason Not Specified|12
1457725|NCT00777036|4806249|P2|On Treatment|Reason Not Specified|7
1457726|NCT00777036|4806250|P1|On Treatment|Reason Not Specified|4
1457727|NCT00777023|4806346|P3|Overall Study|Last dose date unknown|1
1457728|NCT00777023|4806347|P2|Overall Study|Last dose date unknown|3
1457729|NCT00777023|4806348|P1|Overall Study|Last dose date unknown|3
1457730|NCT00777023|4806346|P3|Overall Study|Reasons not specified|2
1457731|NCT00777023|4806347|P2|Overall Study|Reasons not specified|4
1457732|NCT00777023|4806348|P1|Overall Study|Reasons not specified|4
1457733|NCT00777023|4806346|P3|Overall Study|Missing data|0
1457734|NCT00777023|4806347|P2|Overall Study|Missing data|1
1457735|NCT00777023|4806348|P1|Overall Study|Missing data|1
1457736|NCT00777023|4806346|P3|Overall Study|Withdrawal by Subject|8
1457737|NCT00777023|4806347|P2|Overall Study|Withdrawal by Subject|7
1457738|NCT00777023|4806348|P1|Overall Study|Withdrawal by Subject|7
1457739|NCT00777023|4806346|P3|Overall Study|Death|0
1457740|NCT00777023|4806347|P2|Overall Study|Death|1
1457741|NCT00777023|4806348|P1|Overall Study|Death|0
1457742|NCT00777023|4806346|P3|Overall Study|Lost to Follow-up|3
1457743|NCT00777023|4806347|P2|Overall Study|Lost to Follow-up|3
1457744|NCT00777023|4806348|P1|Overall Study|Lost to Follow-up|2
1457745|NCT00777023|4806346|P3|Overall Study|Protocol Violation|1
1457746|NCT00777023|4806347|P2|Overall Study|Protocol Violation|1
1457747|NCT00777023|4806348|P1|Overall Study|Protocol Violation|2
1457748|NCT00777023|4806346|P3|Overall Study|Lack of Efficacy|14
1457749|NCT00777023|4806347|P2|Overall Study|Lack of Efficacy|0
1457750|NCT00777023|4806348|P1|Overall Study|Lack of Efficacy|1
1457751|NCT00777023|4806346|P3|Overall Study|Adverse Event|8
1457752|NCT00777023|4806347|P2|Overall Study|Adverse Event|21
1457753|NCT00777023|4806348|P1|Overall Study|Adverse Event|15
1457754|NCT00776997|4806365|P1|Overall Study|Adverse Event|2
1457755|NCT00776984|4806374|P2|Overall Study|Other|9
1457756|NCT00776984|4806375|P1|Overall Study|Other|5
1457757|NCT00776984|4806374|P2|Overall Study|Lack of Efficacy|1
1457758|NCT00776984|4806375|P1|Overall Study|Lack of Efficacy|0
1457759|NCT00776984|4806374|P2|Overall Study|Withdrawal by Subject|7
1457760|NCT00776984|4806375|P1|Overall Study|Withdrawal by Subject|12
1457761|NCT00776984|4806374|P2|Overall Study|Lost to Follow-up|0
1457762|NCT00776984|4806375|P1|Overall Study|Lost to Follow-up|2
1457763|NCT00776984|4806374|P2|Overall Study|Protocol Violation|2
1457764|NCT00776984|4806375|P1|Overall Study|Protocol Violation|4
1457765|NCT00776984|4806374|P2|Overall Study|Adverse Event|2
1457766|NCT00776984|4806375|P1|Overall Study|Adverse Event|8
1457767|NCT00776919|4806449|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
1457768|NCT00776919|4806450|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
1457769|NCT00776919|4806451|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
1457770|NCT00776919|4806452|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
1457771|NCT00776919|4806449|P4|Overall Study|Protocol Violation|1
1457772|NCT00776919|4806450|P3|Overall Study|Protocol Violation|0
1457773|NCT00776919|4806451|P2|Overall Study|Protocol Violation|2
1457774|NCT00776919|4806452|P1|Overall Study|Protocol Violation|1
1457775|NCT00776919|4806449|P4|Overall Study|Adverse Event|2
1457776|NCT00776919|4806450|P3|Overall Study|Adverse Event|2
1457777|NCT00776919|4806451|P2|Overall Study|Adverse Event|0
1457778|NCT00776919|4806452|P1|Overall Study|Adverse Event|1
1457779|NCT00776919|4806449|P4|Overall Study|Lost to Follow-up|8
1457780|NCT00776919|4806450|P3|Overall Study|Lost to Follow-up|11
1457781|NCT00776919|4806451|P2|Overall Study|Lost to Follow-up|12
1457782|NCT00776919|4806452|P1|Overall Study|Lost to Follow-up|8
1457783|NCT00776919|4806449|P4|Overall Study|Withdrawal by Subject|26
1457784|NCT00776919|4806450|P3|Overall Study|Withdrawal by Subject|15
1457785|NCT00776919|4806451|P2|Overall Study|Withdrawal by Subject|14
1457786|NCT00776919|4806452|P1|Overall Study|Withdrawal by Subject|16
1457787|NCT00776789|4806516|P2|Overall Study|Poor quality video|1
1457788|NCT00776789|4806517|P1|Overall Study|Poor quality video|1
1457789|NCT00776789|4806516|P2|Overall Study|Consent refusal|2
1457790|NCT00776789|4806517|P1|Overall Study|Consent refusal|2
1457791|NCT00776659|4806529|P1|Overall Study|Study Terminated by Sponsor|1
1457792|NCT00776659|4806529|P1|Overall Study|Withdrawal by Subject|10
1457793|NCT00776659|4806529|P1|Overall Study|Lost to Follow-up|15
1457794|NCT00776555|4806556|P2|Overall Study|Study terminated|0
1457795|NCT00776555|4806557|P1|Overall Study|Study terminated|3
1457796|NCT00776230|4806575|P3|Overall Study|Subject missed Visit 4|0
1457797|NCT00776230|4806576|P2|Overall Study|Subject missed Visit 4|1
1457798|NCT00776230|4806577|P1|Overall Study|Subject missed Visit 4|0
1457799|NCT00776230|4806575|P3|Overall Study|Withdrawal by Subject|0
1457800|NCT00776230|4806576|P2|Overall Study|Withdrawal by Subject|1
1457801|NCT00776230|4806577|P1|Overall Study|Withdrawal by Subject|0
1457802|NCT00776230|4806575|P3|Overall Study|Not vaccinated at Day 0|0
1457803|NCT00776230|4806576|P2|Overall Study|Not vaccinated at Day 0|0
1457804|NCT00776230|4806577|P1|Overall Study|Not vaccinated at Day 0|1
1457805|NCT00776230|4806575|P3|Overall Study|Lost to Follow-up|5
1457806|NCT00776230|4806576|P2|Overall Study|Lost to Follow-up|1
1457807|NCT00776230|4806577|P1|Overall Study|Lost to Follow-up|2
1457808|NCT00776100|4806587|P2|Overall Study|Disease Progression|0
1457809|NCT00776100|4806588|P1|Overall Study|Disease Progression|1
1457810|NCT00776009|4806610|P6|Period 3: Third Intervention|Withdrawal by Subject|0
1457811|NCT00776009|4806611|P5|Period 3: Third Intervention|Withdrawal by Subject|0
1457812|NCT00776009|4806612|P4|Period 3: Third Intervention|Withdrawal by Subject|0
1457813|NCT00776009|4806613|P3|Period 3: Third Intervention|Withdrawal by Subject|0
1457814|NCT00776009|4806614|P2|Period 3: Third Intervention|Withdrawal by Subject|0
1457815|NCT00776009|4806615|P1|Period 3: Third Intervention|Withdrawal by Subject|1
1457816|NCT00776009|4806610|P6|Period 2: Second Intervention|Protocol Violation|0
1457817|NCT00776009|4806611|P5|Period 2: Second Intervention|Protocol Violation|0
1457818|NCT00776009|4806612|P4|Period 2: Second Intervention|Protocol Violation|0
1457819|NCT00776009|4806613|P3|Period 2: Second Intervention|Protocol Violation|1
1457820|NCT00776009|4806614|P2|Period 2: Second Intervention|Protocol Violation|0
1457821|NCT00776009|4806615|P1|Period 2: Second Intervention|Protocol Violation|1
1457822|NCT00776009|4806610|P6|Period 2: Second Intervention|Withdrawal by Subject|1
1457823|NCT00776009|4806611|P5|Period 2: Second Intervention|Withdrawal by Subject|0
1457824|NCT00776009|4806612|P4|Period 2: Second Intervention|Withdrawal by Subject|0
1457825|NCT00776009|4806613|P3|Period 2: Second Intervention|Withdrawal by Subject|0
1457826|NCT00776009|4806614|P2|Period 2: Second Intervention|Withdrawal by Subject|0
1457827|NCT00776009|4806615|P1|Period 2: Second Intervention|Withdrawal by Subject|0
1457828|NCT00776009|4806610|P6|Period 1: First Intervention|Protocol Violation|0
1457829|NCT00776009|4806611|P5|Period 1: First Intervention|Protocol Violation|1
1457830|NCT00776009|4806612|P4|Period 1: First Intervention|Protocol Violation|0
1457831|NCT00776009|4806613|P3|Period 1: First Intervention|Protocol Violation|0
1457832|NCT00776009|4806614|P2|Period 1: First Intervention|Protocol Violation|1
1457833|NCT00776009|4806615|P1|Period 1: First Intervention|Protocol Violation|0
1457834|NCT00776009|4806610|P6|Period 1: First Intervention|Withdrawal by Subject|0
1457835|NCT00776009|4806611|P5|Period 1: First Intervention|Withdrawal by Subject|1
1457836|NCT00776009|4806612|P4|Period 1: First Intervention|Withdrawal by Subject|0
1457837|NCT00776009|4806613|P3|Period 1: First Intervention|Withdrawal by Subject|1
1457838|NCT00776009|4806614|P2|Period 1: First Intervention|Withdrawal by Subject|0
1457839|NCT00776009|4806615|P1|Period 1: First Intervention|Withdrawal by Subject|0
1457840|NCT00775983|4806637|P2|Overall Study|Protocol Violation|2
1457841|NCT00775983|4806638|P1|Overall Study|Protocol Violation|1
1457842|NCT00775606|4806749|P2|Overall Study|Study sponsor terminated funding|0
1457843|NCT00775606|4806750|P1|Overall Study|Study sponsor terminated funding|3
1457844|NCT00775593|4806760|P1|Overall Study|Death|1
1457845|NCT00775593|4806760|P1|Overall Study|Unmet eligibility criteria|6
1457846|NCT00775528|4806767|P1|Overall Study|Protocol Violation|1
1457847|NCT00775463|4806776|P2|Overall Study|Lack of Efficacy|1
1457848|NCT00775463|4806777|P1|Overall Study|Lack of Efficacy|1
1457849|NCT00775463|4806776|P2|Overall Study|Lost to Follow-up|0
1457850|NCT00775463|4806777|P1|Overall Study|Lost to Follow-up|1
1457851|NCT00775463|4806776|P2|Overall Study|Protocol Violation|2
1457852|NCT00775463|4806777|P1|Overall Study|Protocol Violation|2
1457853|NCT00775463|4806776|P2|Overall Study|Adverse Event|9
1457854|NCT00775463|4806777|P1|Overall Study|Adverse Event|7
1457855|NCT00775463|4806776|P2|Overall Study|Withdrawal by Subject|1
1457856|NCT00775463|4806777|P1|Overall Study|Withdrawal by Subject|0
1457857|NCT00775450|4806814|P5|Overall Study|Withdrawal by Subject|1
1457858|NCT00775450|4806815|P4|Overall Study|Withdrawal by Subject|0
1457859|NCT00775450|4806816|P3|Overall Study|Withdrawal by Subject|0
1457860|NCT00775450|4806817|P2|Overall Study|Withdrawal by Subject|0
1457861|NCT00775450|4806818|P1|Overall Study|Withdrawal by Subject|1
1457862|NCT00775450|4806814|P5|Overall Study|Protocol Violation|1
1457863|NCT00775450|4806815|P4|Overall Study|Protocol Violation|0
1457864|NCT00775450|4806816|P3|Overall Study|Protocol Violation|0
1457865|NCT00775450|4806817|P2|Overall Study|Protocol Violation|0
1457866|NCT00775450|4806818|P1|Overall Study|Protocol Violation|0
1457867|NCT00775450|4806814|P5|Overall Study|Serious Adverse Event|0
1457868|NCT00775450|4806815|P4|Overall Study|Serious Adverse Event|0
1457869|NCT00775450|4806816|P3|Overall Study|Serious Adverse Event|0
1457870|NCT00775450|4806817|P2|Overall Study|Serious Adverse Event|0
1457871|NCT00775450|4806818|P1|Overall Study|Serious Adverse Event|2
1457872|NCT00775437|4806845|P1|Overall Study|Lost to Follow-up|1
1457873|NCT00775437|4806845|P1|Overall Study|Withdrawal by Subject|3
1457874|NCT00775437|4806845|P1|Overall Study|Loss of efficacy|2
1457875|NCT00775203|4806920|P2|Overall Study|Physician Decision|1
1457876|NCT00775203|4806921|P1|Overall Study|Physician Decision|0
1457877|NCT00775203|4806920|P2|Overall Study|Entered other study|0
1457878|NCT00775203|4806921|P1|Overall Study|Entered other study|1
1457879|NCT00775203|4806920|P2|Overall Study|Protocol Violation|1
1457880|NCT00775203|4806921|P1|Overall Study|Protocol Violation|0
1457881|NCT00775203|4806920|P2|Overall Study|Noncompliance|2
1457882|NCT00775203|4806921|P1|Overall Study|Noncompliance|4
1457883|NCT00775203|4806920|P2|Overall Study|Administrative reason|0
1457884|NCT00775203|4806921|P1|Overall Study|Administrative reason|2
1457885|NCT00775203|4806920|P2|Overall Study|Lost to Follow-up|15
1457886|NCT00775203|4806921|P1|Overall Study|Lost to Follow-up|11
1457887|NCT00775203|4806920|P2|Overall Study|Withdrawal by Subject|9
1457888|NCT00775203|4806921|P1|Overall Study|Withdrawal by Subject|11
1457889|NCT00775203|4806920|P2|Overall Study|Lack of Efficacy|9
1457890|NCT00775203|4806921|P1|Overall Study|Lack of Efficacy|8
1457891|NCT00775203|4806920|P2|Overall Study|Adverse Event|6
1457892|NCT00775203|4806921|P1|Overall Study|Adverse Event|25
1457893|NCT00775190|4806955|P2|Overall Study|Protocol Violation|0
1457894|NCT00775190|4806956|P1|Overall Study|Protocol Violation|1
1457895|NCT00775190|4806955|P2|Overall Study|Withdrawal by Subject|2
1457896|NCT00775190|4806956|P1|Overall Study|Withdrawal by Subject|1
1457897|NCT00775190|4806955|P2|Overall Study|Lost to Follow-up|3
1457898|NCT00775190|4806956|P1|Overall Study|Lost to Follow-up|2
1457899|NCT00775021|4806978|P2|Second Intervention|Adverse Event|1
1457900|NCT00775021|4806979|P1|Second Intervention|Adverse Event|0
1457901|NCT00775021|4806978|P2|First Intervention|Lost to Follow-up|0
1457902|NCT00775021|4806979|P1|First Intervention|Lost to Follow-up|1
1457903|NCT00774995|4806997|P4|Overall Study|Protocol Violation|0
1457904|NCT00774995|4806998|P3|Overall Study|Protocol Violation|1
1457905|NCT00774995|4806999|P2|Overall Study|Protocol Violation|0
1457906|NCT00774995|4807000|P1|Overall Study|Protocol Violation|0
1457907|NCT00774930|4807040|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
1457908|NCT00774930|4807041|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
1457909|NCT00774930|4807040|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
1457910|NCT00774930|4807041|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
1457911|NCT00774930|4807040|P2|LTOLE Phase|Disease Progression|5
1457912|NCT00774930|4807041|P1|LTOLE Phase|Disease Progression|2
1457913|NCT00774930|4807040|P2|LTOLE Phase|Sponsor decision|1
1457914|NCT00774930|4807041|P1|LTOLE Phase|Sponsor decision|2
1457915|NCT00774930|4807040|P2|LTOLE Phase|Physician Decision|1
1457916|NCT00774930|4807041|P1|LTOLE Phase|Physician Decision|4
1457917|NCT00774930|4807040|P2|LTOLE Phase|Subject decision|5
1457918|NCT00774930|4807041|P1|LTOLE Phase|Subject decision|0
1457919|NCT00774930|4807040|P2|LTOLE Phase|Adverse Event|3
1457920|NCT00774930|4807041|P1|LTOLE Phase|Adverse Event|7
1457921|NCT00774930|4807040|P2|IOL Phase|Brain radiation|1
1457922|NCT00774930|4807041|P1|IOL Phase|Brain radiation|0
1457923|NCT00774930|4807040|P2|IOL Phase|Other|0
1457924|NCT00774930|4807041|P1|IOL Phase|Other|1
1457925|NCT00774930|4807040|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
1457926|NCT00774930|4807041|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
1457927|NCT00774930|4807040|P2|IOL Phase|Subject Consumed Prohibited Medication|0
1457928|NCT00774930|4807041|P1|IOL Phase|Subject Consumed Prohibited Medication|1
1457929|NCT00774930|4807040|P2|IOL Phase|Disease Progression|1
1457930|NCT00774930|4807041|P1|IOL Phase|Disease Progression|2
1457931|NCT00774930|4807040|P2|IOL Phase|Sponsor Decision|0
1457932|NCT00774930|4807041|P1|IOL Phase|Sponsor Decision|1
1457933|NCT00774930|4807040|P2|IOL Phase|Physician Decision|2
1457934|NCT00774930|4807041|P1|IOL Phase|Physician Decision|3
1457935|NCT00774930|4807040|P2|IOL Phase|Subject Decision|3
1457936|NCT00774930|4807041|P1|IOL Phase|Subject Decision|4
1457937|NCT00774930|4807040|P2|IOL Phase|Adverse Event|1
1457938|NCT00774930|4807041|P1|IOL Phase|Adverse Event|1
1457939|NCT00774930|4807040|P2|DB Phase|Started Nonprotocol Radiation therapy|1
1457940|NCT00774930|4807041|P1|DB Phase|Started Nonprotocol Radiation therapy|0
1457941|NCT00774930|4807040|P2|DB Phase|Disease Progression|1
1457942|NCT00774930|4807041|P1|DB Phase|Disease Progression|1
1457943|NCT00774930|4807040|P2|DB Phase|Sponsor Decision|1
1457944|NCT00774930|4807041|P1|DB Phase|Sponsor Decision|0
1457945|NCT00774930|4807040|P2|DB Phase|Subject Decision|5
1457946|NCT00774930|4807041|P1|DB Phase|Subject Decision|1
1457947|NCT00774930|4807040|P2|DB Phase|Adverse Event|2
1457948|NCT00774930|4807041|P1|DB Phase|Adverse Event|1
1457949|NCT00774930|4807040|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
1457950|NCT00774930|4807041|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
1457951|NCT00774852|4807069|P2|Overall Study|Subject received prohibited medication|0
1457952|NCT00774852|4807070|P1|Overall Study|Subject received prohibited medication|1
1457953|NCT00774852|4807069|P2|Overall Study|Protocol Violation|0
1457954|NCT00774852|4807070|P1|Overall Study|Protocol Violation|1
1457955|NCT00774852|4807069|P2|Overall Study|Subject non-compliance|1
1457956|NCT00774852|4807070|P1|Overall Study|Subject non-compliance|0
1457957|NCT00774852|4807069|P2|Overall Study|Non-responder|11
1457958|NCT00774852|4807070|P1|Overall Study|Non-responder|15
1457959|NCT00774852|4807069|P2|Overall Study|Withdrawal by Subject|2
1457960|NCT00774852|4807070|P1|Overall Study|Withdrawal by Subject|2
1457961|NCT00774852|4807069|P2|Overall Study|Pregnancy|2
1457962|NCT00774852|4807070|P1|Overall Study|Pregnancy|1
1457963|NCT00774852|4807069|P2|Overall Study|Physician Decision|6
1457964|NCT00774852|4807070|P1|Overall Study|Physician Decision|2
1457965|NCT00774852|4807069|P2|Overall Study|Lost to Follow-up|5
1457966|NCT00774852|4807070|P1|Overall Study|Lost to Follow-up|9
1457967|NCT00774852|4807069|P2|Overall Study|Lack of Efficacy|7
1457968|NCT00774852|4807070|P1|Overall Study|Lack of Efficacy|3
1457969|NCT00774852|4807069|P2|Overall Study|Death|1
1457970|NCT00774852|4807070|P1|Overall Study|Death|2
1457971|NCT00774852|4807069|P2|Overall Study|Adverse Event|6
1457972|NCT00774852|4807070|P1|Overall Study|Adverse Event|9
1457973|NCT00774800|4807118|P1|Intervention 4|Withdrawal by Subject|1
1457974|NCT00774787|4807140|P1|Overall Study|Lost to Follow-up|1
1457975|NCT00774748|4807147|P1|Overall Study|Lost to Follow-up|3
1457976|NCT00774397|4807162|P7|Overall Study|Other than those stated above|1
1457977|NCT00774397|4807163|P6|Overall Study|Other than those stated above|0
1457978|NCT00774397|4807164|P5|Overall Study|Other than those stated above|2
1457979|NCT00774397|4807165|P4|Overall Study|Other than those stated above|2
1457980|NCT00774397|4807166|P3|Overall Study|Other than those stated above|3
1457981|NCT00774397|4807167|P2|Overall Study|Other than those stated above|1
1457982|NCT00774397|4807168|P1|Overall Study|Other than those stated above|1
1457983|NCT00774397|4807162|P7|Overall Study|Not treated|1
1457984|NCT00774397|4807163|P6|Overall Study|Not treated|0
1457985|NCT00774397|4807164|P5|Overall Study|Not treated|1
1457986|NCT00774397|4807165|P4|Overall Study|Not treated|0
1457987|NCT00774397|4807166|P3|Overall Study|Not treated|0
1457988|NCT00774397|4807167|P2|Overall Study|Not treated|0
1457989|NCT00774397|4807168|P1|Overall Study|Not treated|0
1457990|NCT00774397|4807162|P7|Overall Study|Refused to continue trial medication|3
1457991|NCT00774397|4807163|P6|Overall Study|Refused to continue trial medication|2
1457992|NCT00774397|4807164|P5|Overall Study|Refused to continue trial medication|6
1457993|NCT00774397|4807165|P4|Overall Study|Refused to continue trial medication|2
1457994|NCT00774397|4807166|P3|Overall Study|Refused to continue trial medication|2
1457995|NCT00774397|4807167|P2|Overall Study|Refused to continue trial medication|3
1457996|NCT00774397|4807168|P1|Overall Study|Refused to continue trial medication|1
1457997|NCT00774397|4807162|P7|Overall Study|Lost to Follow-up|0
1457998|NCT00774397|4807163|P6|Overall Study|Lost to Follow-up|1
1457999|NCT00774397|4807164|P5|Overall Study|Lost to Follow-up|0
1458000|NCT00774397|4807165|P4|Overall Study|Lost to Follow-up|1
1458001|NCT00774397|4807166|P3|Overall Study|Lost to Follow-up|1
1458002|NCT00774397|4807167|P2|Overall Study|Lost to Follow-up|1
1458003|NCT00774397|4807168|P1|Overall Study|Lost to Follow-up|0
1458004|NCT00774397|4807162|P7|Overall Study|Protocol Violation|0
1458005|NCT00774397|4807163|P6|Overall Study|Protocol Violation|1
1458006|NCT00774397|4807164|P5|Overall Study|Protocol Violation|2
1458007|NCT00774397|4807165|P4|Overall Study|Protocol Violation|1
1458008|NCT00774397|4807166|P3|Overall Study|Protocol Violation|3
1458009|NCT00774397|4807167|P2|Overall Study|Protocol Violation|1
1458010|NCT00774397|4807168|P1|Overall Study|Protocol Violation|0
1458011|NCT00774397|4807162|P7|Overall Study|Lack of Efficacy|9
1458012|NCT00774397|4807163|P6|Overall Study|Lack of Efficacy|15
1458013|NCT00774397|4807164|P5|Overall Study|Lack of Efficacy|27
1458014|NCT00774397|4807165|P4|Overall Study|Lack of Efficacy|3
1458015|NCT00774397|4807166|P3|Overall Study|Lack of Efficacy|5
1458016|NCT00774397|4807167|P2|Overall Study|Lack of Efficacy|4
1458017|NCT00774397|4807168|P1|Overall Study|Lack of Efficacy|11
1458018|NCT00774397|4807162|P7|Overall Study|Adverse Event|16
1458019|NCT00774397|4807163|P6|Overall Study|Adverse Event|3
1458020|NCT00774397|4807164|P5|Overall Study|Adverse Event|8
1458021|NCT00774397|4807165|P4|Overall Study|Adverse Event|8
1458022|NCT00774397|4807166|P3|Overall Study|Adverse Event|16
1458023|NCT00774397|4807167|P2|Overall Study|Adverse Event|3
1458024|NCT00774397|4807168|P1|Overall Study|Adverse Event|1
1458025|NCT00774306|4807404|P4|Overall Study|Death|0
1458026|NCT00774306|4807405|P3|Overall Study|Death|0
1458027|NCT00774306|4807406|P2|Overall Study|Death|1
1458028|NCT00774306|4807407|P1|Overall Study|Death|1
1458029|NCT00774306|4807404|P4|Overall Study|Lost to Follow-up|5
1458030|NCT00774306|4807405|P3|Overall Study|Lost to Follow-up|4
1458031|NCT00774306|4807406|P2|Overall Study|Lost to Follow-up|0
1458032|NCT00774306|4807407|P1|Overall Study|Lost to Follow-up|6
1458033|NCT00774306|4807404|P4|Overall Study|Withdrawal by Subject|0
1458034|NCT00774306|4807405|P3|Overall Study|Withdrawal by Subject|1
1458035|NCT00774306|4807406|P2|Overall Study|Withdrawal by Subject|1
1458036|NCT00774306|4807407|P1|Overall Study|Withdrawal by Subject|6
1458037|NCT00774306|4807404|P4|Overall Study|Protocol Violation|0
1458038|NCT00774306|4807405|P3|Overall Study|Protocol Violation|3
1458039|NCT00774306|4807406|P2|Overall Study|Protocol Violation|0
1458040|NCT00774306|4807407|P1|Overall Study|Protocol Violation|2
1458041|NCT00774306|4807404|P4|Overall Study|Adverse Event|0
1458042|NCT00774306|4807405|P3|Overall Study|Adverse Event|0
1458043|NCT00774306|4807406|P2|Overall Study|Adverse Event|0
1458044|NCT00774306|4807407|P1|Overall Study|Adverse Event|3
1458045|NCT00774046|4807475|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
1458046|NCT00774046|4807475|P1|Enrollment|Desired other therapy/refused|28
1458047|NCT00774046|4807475|P1|Screening|Not eligible|56
1458048|NCT00773968|4807485|P1|Overall Study|Other|8
1458049|NCT00773968|4807485|P1|Overall Study|Screen Failure|17
1458050|NCT00773968|4807485|P1|Overall Study|Withdrawal by Subject|11
1458051|NCT00773968|4807485|P1|Overall Study|Protocol Violation|1
1458052|NCT00773968|4807485|P1|Overall Study|Lack of Efficacy|3
1458053|NCT00773968|4807485|P1|Overall Study|Failure to Return|2
1458054|NCT00773968|4807485|P1|Overall Study|Death|1
1458055|NCT00773968|4807485|P1|Overall Study|Adverse Event|2
1458056|NCT00773734|4807516|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
1458057|NCT00773734|4807517|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
1458058|NCT00773734|4807518|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
1458059|NCT00773734|4807519|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
1458060|NCT00773734|4807520|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
1458061|NCT00773734|4807521|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
1458062|NCT00773734|4807516|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
1458063|NCT00773734|4807517|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
1458064|NCT00773734|4807518|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
1458065|NCT00773734|4807519|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
1458066|NCT00773734|4807520|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
1458067|NCT00773734|4807521|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
1458068|NCT00773734|4807516|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
1458069|NCT00773734|4807517|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
1458070|NCT00773734|4807518|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
1458071|NCT00773734|4807519|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
1458072|NCT00773734|4807520|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
1458073|NCT00773734|4807521|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
1458074|NCT00773734|4807516|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
1458075|NCT00773734|4807517|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
1458076|NCT00773734|4807518|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
1458077|NCT00773734|4807519|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
1458078|NCT00773734|4807520|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
1458079|NCT00773734|4807521|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
1458080|NCT00773734|4807516|P6|Extension: Active Treatment Week 24-52|Other|1
1458081|NCT00773734|4807517|P5|Extension: Active Treatment Week 24-52|Other|0
1458082|NCT00773734|4807518|P4|Extension: Active Treatment Week 24-52|Other|2
1458083|NCT00773734|4807519|P3|Extension: Active Treatment Week 24-52|Other|1
1458084|NCT00773734|4807520|P2|Extension: Active Treatment Week 24-52|Other|0
1458085|NCT00773734|4807521|P1|Extension: Active Treatment Week 24-52|Other|0
1458086|NCT00773734|4807516|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
1458087|NCT00773734|4807517|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
1458088|NCT00773734|4807518|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
1458089|NCT00773734|4807519|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
1458090|NCT00773734|4807520|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
1458091|NCT00773734|4807521|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
1458092|NCT00773734|4807516|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
1458093|NCT00773734|4807517|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
1458094|NCT00773734|4807518|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
1458095|NCT00773734|4807519|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
1458096|NCT00773734|4807520|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
1458097|NCT00773734|4807521|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
1458098|NCT00773734|4807516|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
1458099|NCT00773734|4807517|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
1458100|NCT00773734|4807518|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
1458101|NCT00773734|4807519|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
1458102|NCT00773734|4807520|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
1458103|NCT00773734|4807521|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
1458104|NCT00773734|4807516|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
1458105|NCT00773734|4807517|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
1458106|NCT00773734|4807518|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
1458107|NCT00773734|4807519|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
1458108|NCT00773734|4807520|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
1458109|NCT00773734|4807521|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
1458110|NCT00773734|4807516|P6|Core: Active Treatment Phase Week 16-24|Other|0
1458111|NCT00773734|4807517|P5|Core: Active Treatment Phase Week 16-24|Other|0
1458112|NCT00773734|4807518|P4|Core: Active Treatment Phase Week 16-24|Other|0
1458113|NCT00773734|4807519|P3|Core: Active Treatment Phase Week 16-24|Other|0
1458114|NCT00773734|4807520|P2|Core: Active Treatment Phase Week 16-24|Other|1
1458115|NCT00773734|4807521|P1|Core: Active Treatment Phase Week 16-24|Other|0
1458116|NCT00773734|4807516|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
1458117|NCT00773734|4807517|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
1458118|NCT00773734|4807518|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
1458119|NCT00773734|4807519|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
1458120|NCT00773734|4807520|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
1458121|NCT00773734|4807521|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
1458122|NCT00773734|4807516|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
1458123|NCT00773734|4807517|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
1458124|NCT00773734|4807518|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
1458125|NCT00773734|4807519|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
1458126|NCT00773734|4807520|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
1458127|NCT00773734|4807521|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
1458128|NCT00773734|4807516|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
1458129|NCT00773734|4807517|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
1458130|NCT00773734|4807518|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
1458131|NCT00773734|4807519|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
1458132|NCT00773734|4807520|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
1458133|NCT00773734|4807521|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
1458134|NCT00773734|4807516|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
1458135|NCT00773734|4807517|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
1458136|NCT00773734|4807518|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
1458137|NCT00773734|4807519|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
1458138|NCT00773734|4807520|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
1458139|NCT00773734|4807521|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
1458140|NCT00773734|4807516|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
1458141|NCT00773734|4807517|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
1458142|NCT00773734|4807518|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
1458143|NCT00773734|4807519|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
1458144|NCT00773734|4807520|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
1458145|NCT00773734|4807521|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
1458146|NCT00773734|4807516|P6|Core: Placebo Controlled Phase Week 0-16|Other|0
1458147|NCT00773734|4807517|P5|Core: Placebo Controlled Phase Week 0-16|Other|0
1458148|NCT00773734|4807518|P4|Core: Placebo Controlled Phase Week 0-16|Other|1
1458149|NCT00773734|4807519|P3|Core: Placebo Controlled Phase Week 0-16|Other|1
1458150|NCT00773734|4807520|P2|Core: Placebo Controlled Phase Week 0-16|Other|1
1458151|NCT00773734|4807521|P1|Core: Placebo Controlled Phase Week 0-16|Other|1
1458152|NCT00773734|4807516|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
1458153|NCT00773734|4807517|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
1458154|NCT00773734|4807518|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
1458155|NCT00773734|4807519|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
1458156|NCT00773734|4807520|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
1458157|NCT00773734|4807521|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
1458158|NCT00773734|4807516|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
1458159|NCT00773734|4807517|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
1458160|NCT00773734|4807518|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
1458161|NCT00773734|4807519|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
1458162|NCT00773734|4807520|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
1458163|NCT00773734|4807521|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
1458164|NCT00773734|4807516|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
1458165|NCT00773734|4807517|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
1458166|NCT00773734|4807518|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
1458167|NCT00773734|4807519|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
1458168|NCT00773734|4807520|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
1458169|NCT00773734|4807521|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
1458170|NCT00773734|4807516|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
1458171|NCT00773734|4807517|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
1458172|NCT00773734|4807518|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
1458173|NCT00773734|4807519|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
1458174|NCT00773734|4807520|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
1458175|NCT00773734|4807521|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
1458176|NCT00773734|4807516|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
1458177|NCT00773734|4807517|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
1458178|NCT00773734|4807518|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
1458179|NCT00773734|4807519|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
1458180|NCT00773734|4807520|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
1458181|NCT00773734|4807521|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
1458182|NCT00773734|4807516|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
1458183|NCT00773734|4807517|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
1458184|NCT00773734|4807518|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
1458185|NCT00773734|4807519|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
1458186|NCT00773734|4807520|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
1458187|NCT00773734|4807521|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
1458188|NCT00773513|4808085|P2|Overall Study|Death|545
1458189|NCT00773513|4808086|P1|Overall Study|Death|531
1458190|NCT00773513|4808085|P2|Overall Study|Reason Not Specified|126
1458191|NCT00773513|4808086|P1|Overall Study|Reason Not Specified|159
1458192|NCT00773513|4808085|P2|Overall Study|Insufficient Therapeutic Response|18
1458193|NCT00773513|4808086|P1|Overall Study|Insufficient Therapeutic Response|1
1458194|NCT00773513|4808085|P2|Overall Study|Failure to Return|8
1458195|NCT00773513|4808086|P1|Overall Study|Failure to Return|22
1458196|NCT00773513|4808085|P2|Overall Study|Refused Treatment / Did not Cooperate|32
1458197|NCT00773513|4808086|P1|Overall Study|Refused Treatment / Did not Cooperate|26
1458198|NCT00773513|4808085|P2|Overall Study|Withdrew Consent|69
1458199|NCT00773513|4808086|P1|Overall Study|Withdrew Consent|68
1458200|NCT00773513|4808085|P2|Overall Study|Adverse Event / Intercurrent Illness|48
1458201|NCT00773513|4808086|P1|Overall Study|Adverse Event / Intercurrent Illness|40
1458202|NCT00773513|4808085|P2|Overall Study|Renal Transplant|263
1458203|NCT00773513|4808086|P1|Overall Study|Renal Transplant|254
1458204|NCT00773461|4808115|P2|Overall Study|Withdrawal by Subject|1
1458205|NCT00773461|4808116|P1|Overall Study|Withdrawal by Subject|4
1458206|NCT00773461|4808115|P2|Overall Study|Adverse Event|3
1458207|NCT00773461|4808116|P1|Overall Study|Adverse Event|1
1458208|NCT00773383|4808170|P1|Overall Study|No study dose received|1
1458209|NCT00773383|4808170|P1|Overall Study|not specified|2
1458210|NCT00773383|4808170|P1|Overall Study|Progression of Disease|23
1458211|NCT00773383|4808170|P1|Overall Study|Death|1
1458212|NCT00773383|4808170|P1|Overall Study|Adverse Event|4
1458213|NCT00773279|4808205|P2|Period 2|Unclassified|2
1458214|NCT00773279|4808206|P1|Period 2|Unclassified|2
1458215|NCT00773279|4808205|P2|Period 2|Protocol Violation|3
1458216|NCT00773279|4808206|P1|Period 2|Protocol Violation|0
1458217|NCT00773279|4808205|P2|Period 2|Lack of Efficacy|0
1458218|NCT00773279|4808206|P1|Period 2|Lack of Efficacy|1
1458219|NCT00773279|4808205|P2|Period 2|Adverse Event|1
1458220|NCT00773279|4808206|P1|Period 2|Adverse Event|0
1458221|NCT00773279|4808205|P2|Period 1|Unclassified|1
1458222|NCT00773279|4808206|P1|Period 1|Unclassified|5
1458223|NCT00773279|4808205|P2|Period 1|Lack of Efficacy|2
1458224|NCT00773279|4808206|P1|Period 1|Lack of Efficacy|0
1458225|NCT00773279|4808205|P2|Period 1|Adverse Event|1
1458226|NCT00773279|4808206|P1|Period 1|Adverse Event|2
1458227|NCT00773253|4808227|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
1458228|NCT00773253|4808228|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
1458229|NCT00773136|4808234|P1|Overall Study|Physician Decision|2
1458230|NCT00773097|4808239|P1|Overall Study|Physician Decision|6
1458231|NCT00773097|4808239|P1|Overall Study|Withdrawal by Subject|1
1458232|NCT00772967|4808245|P6|Crossover Treatment 3|Adverse Event|0
1458233|NCT00772967|4808246|P5|Crossover Treatment 3|Adverse Event|1
1458234|NCT00772967|4808247|P4|Crossover Treatment 3|Adverse Event|0
1458235|NCT00772967|4808248|P3|Crossover Treatment 3|Adverse Event|0
1458236|NCT00772967|4808249|P2|Crossover Treatment 3|Adverse Event|0
1458237|NCT00772967|4808250|P1|Crossover Treatment 3|Adverse Event|0
1458238|NCT00772967|4808245|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
1458239|NCT00772967|4808246|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
1458240|NCT00772967|4808247|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
1458241|NCT00772967|4808248|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
1458242|NCT00772967|4808249|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
1458243|NCT00772967|4808250|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
1458244|NCT00772967|4808245|P6|Crossover Treatment 1|Adverse Event (Pain)|0
1458245|NCT00772967|4808246|P5|Crossover Treatment 1|Adverse Event (Pain)|0
1458246|NCT00772967|4808247|P4|Crossover Treatment 1|Adverse Event (Pain)|1
1458247|NCT00772967|4808248|P3|Crossover Treatment 1|Adverse Event (Pain)|0
1458248|NCT00772967|4808249|P2|Crossover Treatment 1|Adverse Event (Pain)|0
1458249|NCT00772967|4808250|P1|Crossover Treatment 1|Adverse Event (Pain)|0
1458250|NCT00772954|4808270|P3|Overall Study|Adverse Event|1
1458251|NCT00772954|4808271|P2|Overall Study|Adverse Event|0
1458252|NCT00772954|4808272|P1|Overall Study|Adverse Event|0
1458253|NCT00772941|4808280|P1|Overall Study|GPSP Violation|90
1458254|NCT00772941|4808280|P1|Overall Study|Poor Compliance|7
1458255|NCT00772941|4808280|P1|Overall Study|Missed Visits|374
1458256|NCT00772941|4808280|P1|Overall Study|Study not completed|16
1458257|NCT00772941|4808280|P1|Overall Study|CRFs not available|195
1458258|NCT00772928|4808311|P2|Overall Study|Did not receive vaccine|1
1458259|NCT00772928|4808312|P1|Overall Study|Did not receive vaccine|0
1458260|NCT00772928|4808311|P2|Overall Study|Withdrawal by Subject|22
1458261|NCT00772928|4808312|P1|Overall Study|Withdrawal by Subject|25
1458262|NCT00772928|4808311|P2|Overall Study|Protocol Violation|12
1458263|NCT00772928|4808312|P1|Overall Study|Protocol Violation|10
1458264|NCT00772928|4808311|P2|Overall Study|Lost to Follow-up|6
1458265|NCT00772928|4808312|P1|Overall Study|Lost to Follow-up|9
1458266|NCT00772889|4808329|P3|Overall Study|Lost to Follow-up|7
1458267|NCT00772889|4808330|P2|Overall Study|Lost to Follow-up|6
1458268|NCT00772889|4808331|P1|Overall Study|Lost to Follow-up|6
1458269|NCT00772889|4808329|P3|Overall Study|Withdrawal by Subject|9
1458270|NCT00772889|4808330|P2|Overall Study|Withdrawal by Subject|8
1458271|NCT00772889|4808331|P1|Overall Study|Withdrawal by Subject|9
1458272|NCT00772889|4808329|P3|Overall Study|Adverse Event|0
1458273|NCT00772889|4808330|P2|Overall Study|Adverse Event|4
1458274|NCT00772889|4808331|P1|Overall Study|Adverse Event|7
1458275|NCT00772707|4808389|P1|Overall Study|Withdrawn|3
1458276|NCT00772668|4808394|P1|Overall Study|Physician Decision|3
1458277|NCT00772629|4808403|P2|Overall Study|Subject was not vaccinated|0
1458278|NCT00772629|4808404|P1|Overall Study|Subject was not vaccinated|1
1458279|NCT00772603|4808413|P3|Overall Study|Other|2
1458280|NCT00772603|4808414|P2|Overall Study|Other|0
1458281|NCT00772603|4808415|P1|Overall Study|Other|2
1458282|NCT00772603|4808413|P3|Overall Study|Physician Decision|1
1458283|NCT00772603|4808414|P2|Overall Study|Physician Decision|0
1458284|NCT00772603|4808415|P1|Overall Study|Physician Decision|0
1458285|NCT00772603|4808413|P3|Overall Study|Lost to Follow-up|2
1458286|NCT00772603|4808414|P2|Overall Study|Lost to Follow-up|5
1458287|NCT00772603|4808415|P1|Overall Study|Lost to Follow-up|1
1458288|NCT00772603|4808413|P3|Overall Study|Protocol Violation|1
1458289|NCT00772603|4808414|P2|Overall Study|Protocol Violation|1
1458290|NCT00772603|4808415|P1|Overall Study|Protocol Violation|0
1458291|NCT00772603|4808413|P3|Overall Study|Subject Non-compliance|4
1458292|NCT00772603|4808414|P2|Overall Study|Subject Non-compliance|6
1458293|NCT00772603|4808415|P1|Overall Study|Subject Non-compliance|1
1458294|NCT00772603|4808413|P3|Overall Study|Adverse Event|10
1458295|NCT00772603|4808414|P2|Overall Study|Adverse Event|18
1458296|NCT00772603|4808415|P1|Overall Study|Adverse Event|37
1458297|NCT00772603|4808413|P3|Overall Study|Withdrawal by Subject|6
1458298|NCT00772603|4808414|P2|Overall Study|Withdrawal by Subject|10
1458299|NCT00772603|4808415|P1|Overall Study|Withdrawal by Subject|11
1458300|NCT00772577|4808454|P2|Overall Study|Protocol Deviation|2
1458301|NCT00772577|4808455|P1|Overall Study|Protocol Deviation|3
1458302|NCT00772577|4808454|P2|Overall Study|Administrative problems|1
1458303|NCT00772577|4808455|P1|Overall Study|Administrative problems|2
1458304|NCT00772577|4808454|P2|Overall Study|Lost to Follow-up|3
1458305|NCT00772577|4808455|P1|Overall Study|Lost to Follow-up|4
1458306|NCT00772577|4808454|P2|Overall Study|Patient withdrew consent|5
1458307|NCT00772577|4808455|P1|Overall Study|Patient withdrew consent|8
1458308|NCT00772577|4808454|P2|Overall Study|Unsatisfactory therapeutic effect|8
1458309|NCT00772577|4808455|P1|Overall Study|Unsatisfactory therapeutic effect|0
1458310|NCT00772577|4808454|P2|Overall Study|Abnormal laboratory values|1
1458311|NCT00772577|4808455|P1|Overall Study|Abnormal laboratory values|0
1458312|NCT00772577|4808454|P2|Overall Study|Adverse Event|3
1458313|NCT00772577|4808455|P1|Overall Study|Adverse Event|6
1458314|NCT00772538|4808471|P2|Overall Study|Other|7
1458315|NCT00772538|4808472|P1|Overall Study|Other|7
1458316|NCT00772538|4808471|P2|Overall Study|Lack of Efficacy|1
1458317|NCT00772538|4808472|P1|Overall Study|Lack of Efficacy|0
1458318|NCT00772538|4808471|P2|Overall Study|Withdrawal by Subject|8
1458319|NCT00772538|4808472|P1|Overall Study|Withdrawal by Subject|3
1458320|NCT00772538|4808471|P2|Overall Study|Lost to Follow-up|1
1458321|NCT00772538|4808472|P1|Overall Study|Lost to Follow-up|1
1458322|NCT00772538|4808471|P2|Overall Study|Protocol Violation|3
1458323|NCT00772538|4808472|P1|Overall Study|Protocol Violation|3
1458324|NCT00772538|4808471|P2|Overall Study|Adverse Event|6
1458325|NCT00772538|4808472|P1|Overall Study|Adverse Event|6
1458326|NCT00772447|4808544|P2|Overall Study|all others|2
1458327|NCT00772447|4808545|P1|Overall Study|all others|2
1458328|NCT00772447|4808544|P2|Overall Study|Protocol Violation|1
1458329|NCT00772447|4808545|P1|Overall Study|Protocol Violation|0
1458330|NCT00772447|4808544|P2|Overall Study|incorrect enrolment|4
1458331|NCT00772447|4808545|P1|Overall Study|incorrect enrolment|3
1458332|NCT00772447|4808544|P2|Overall Study|Lost to Follow-up|4
1458333|NCT00772447|4808545|P1|Overall Study|Lost to Follow-up|2
1458334|NCT00772447|4808544|P2|Overall Study|Physician Decision|8
1458335|NCT00772447|4808545|P1|Overall Study|Physician Decision|4
1458336|NCT00772447|4808544|P2|Overall Study|Withdrawal by Subject|5
1458337|NCT00772447|4808545|P1|Overall Study|Withdrawal by Subject|9
1458338|NCT00772382|4808573|P1|Overall Study|Other Reasons|10
1458339|NCT00772382|4808573|P1|Overall Study|Withdrawal by Subject|10
1458340|NCT00772382|4808573|P1|Overall Study|Protocol Violation|1
1458341|NCT00772382|4808573|P1|Overall Study|Physician Decision|5
1458342|NCT00772382|4808573|P1|Overall Study|Lack of Efficacy|4
1458343|NCT00772382|4808573|P1|Overall Study|Death|6
1458344|NCT00772382|4808573|P1|Overall Study|Adverse Event|19
1458345|NCT00772369|4808578|P1|Overall Study|Did not return record release form|1
1458346|NCT00772148|4808589|P2|Maintenance Phase (Week 52)|Administrative/other|2
1458347|NCT00772148|4808590|P1|Maintenance Phase (Week 52)|Administrative/other|1
1458348|NCT00772148|4808589|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
1458349|NCT00772148|4808590|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
1458350|NCT00772148|4808589|P2|Maintenance Phase (Week 52)|Adverse Event|0
1458351|NCT00772148|4808590|P1|Maintenance Phase (Week 52)|Adverse Event|1
1458352|NCT00772148|4808589|P2|Maintenance Phase (Week 52)|Death|2
1458353|NCT00772148|4808590|P1|Maintenance Phase (Week 52)|Death|2
1458354|NCT00772148|4808589|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
1458355|NCT00772148|4808590|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
1458356|NCT00772148|4808589|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
1458357|NCT00772148|4808590|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
1458358|NCT00772148|4808589|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
1458359|NCT00772148|4808590|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
1458360|NCT00772109|4808610|P4|Overall Study|Withdrawal by Subject|16
1458361|NCT00772109|4808611|P3|Overall Study|Withdrawal by Subject|6
1458362|NCT00772109|4808612|P2|Overall Study|Withdrawal by Subject|8
1458363|NCT00772109|4808613|P1|Overall Study|Withdrawal by Subject|8
1458364|NCT00772109|4808610|P4|Overall Study|Lost to Follow-up|9
1458365|NCT00772109|4808611|P3|Overall Study|Lost to Follow-up|5
1458366|NCT00772109|4808612|P2|Overall Study|Lost to Follow-up|3
1458367|NCT00772109|4808613|P1|Overall Study|Lost to Follow-up|7
1458368|NCT00772109|4808610|P4|Overall Study|Protocol Violation|6
1458369|NCT00772109|4808611|P3|Overall Study|Protocol Violation|7
1458370|NCT00772109|4808612|P2|Overall Study|Protocol Violation|8
1458371|NCT00772109|4808613|P1|Overall Study|Protocol Violation|5
1458372|NCT00772109|4808610|P4|Overall Study|Serious adverse event|0
1458373|NCT00772109|4808611|P3|Overall Study|Serious adverse event|1
1458374|NCT00772109|4808612|P2|Overall Study|Serious adverse event|0
1458375|NCT00772109|4808613|P1|Overall Study|Serious adverse event|1
1458376|NCT00772070|4808637|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
1458377|NCT00772070|4808638|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
1458378|NCT00772070|4808637|P2|Overall Study|Withdrawal by Subject|2
1458379|NCT00772070|4808638|P1|Overall Study|Withdrawal by Subject|0
1458380|NCT00772070|4808637|P2|Overall Study|Lost to Follow-up|8
1458381|NCT00772070|4808638|P1|Overall Study|Lost to Follow-up|0
1458382|NCT00772031|4808650|P2|Overall Study|Lost to Follow-up|33
1458383|NCT00772031|4808651|P1|Overall Study|Lost to Follow-up|20
1458384|NCT00772031|4808650|P2|Overall Study|Early termination of trial|10
1458385|NCT00772031|4808651|P1|Overall Study|Early termination of trial|12
1458386|NCT00772005|4808677|P4|Overall Study|Non-compliance with drug administration|1
1458387|NCT00772005|4808678|P3|Overall Study|Non-compliance with drug administration|1
1458388|NCT00772005|4808679|P2|Overall Study|Non-compliance with drug administration|0
1458389|NCT00772005|4808680|P1|Overall Study|Non-compliance with drug administration|3
1458390|NCT00772005|4808677|P4|Overall Study|Non-compliance with study procedures|1
1458391|NCT00772005|4808678|P3|Overall Study|Non-compliance with study procedures|0
1458392|NCT00772005|4808679|P2|Overall Study|Non-compliance with study procedures|1
1458393|NCT00772005|4808680|P1|Overall Study|Non-compliance with study procedures|1
1458394|NCT00772005|4808677|P4|Overall Study|Lost to Follow-up|3
1458395|NCT00772005|4808678|P3|Overall Study|Lost to Follow-up|6
1458396|NCT00772005|4808679|P2|Overall Study|Lost to Follow-up|3
1458397|NCT00772005|4808680|P1|Overall Study|Lost to Follow-up|7
1458398|NCT00772005|4808677|P4|Overall Study|Protocol Violation|6
1458399|NCT00772005|4808678|P3|Overall Study|Protocol Violation|1
1458400|NCT00772005|4808679|P2|Overall Study|Protocol Violation|4
1458401|NCT00772005|4808680|P1|Overall Study|Protocol Violation|2
1458402|NCT00772005|4808677|P4|Overall Study|Withdrawal by Subject|2
1458403|NCT00772005|4808678|P3|Overall Study|Withdrawal by Subject|10
1458404|NCT00772005|4808679|P2|Overall Study|Withdrawal by Subject|7
1458405|NCT00772005|4808680|P1|Overall Study|Withdrawal by Subject|3
1458406|NCT00772005|4808677|P4|Overall Study|Lack of Efficacy|0
1458407|NCT00772005|4808678|P3|Overall Study|Lack of Efficacy|0
1458408|NCT00772005|4808679|P2|Overall Study|Lack of Efficacy|1
1458409|NCT00772005|4808680|P1|Overall Study|Lack of Efficacy|0
1458410|NCT00772005|4808677|P4|Overall Study|Adverse Event|13
1458411|NCT00772005|4808678|P3|Overall Study|Adverse Event|10
1458412|NCT00772005|4808679|P2|Overall Study|Adverse Event|14
1458413|NCT00772005|4808680|P1|Overall Study|Adverse Event|9
1458414|NCT00771953|4809368|P2|Overall Study|Withdrawal by Subject|3
1458415|NCT00771953|4809369|P1|Overall Study|Withdrawal by Subject|0
1458416|NCT00771953|4809368|P2|Overall Study|Other complicating disease|0
1458417|NCT00771953|4809369|P1|Overall Study|Other complicating disease|1
1458418|NCT00771953|4809368|P2|Overall Study|Sponsor decision|0
1458419|NCT00771953|4809369|P1|Overall Study|Sponsor decision|1
1458420|NCT00771953|4809368|P2|Overall Study|Progression before active Tx|2
1458421|NCT00771953|4809369|P1|Overall Study|Progression before active Tx|1
1458422|NCT00771953|4809368|P2|Overall Study|Death|2
1458423|NCT00771953|4809369|P1|Overall Study|Death|2
1458424|NCT00771953|4809368|P2|Overall Study|Adverse Event|3
1458425|NCT00771953|4809369|P1|Overall Study|Adverse Event|5
1458426|NCT00771927|4809379|P2|Overall Study|Other reason|27
1458427|NCT00771927|4809380|P1|Overall Study|Other reason|23
1458428|NCT00771927|4809379|P2|Overall Study|Withdrawal by Subject|17
1458429|NCT00771927|4809380|P1|Overall Study|Withdrawal by Subject|16
1458430|NCT00771927|4809379|P2|Overall Study|Lost to Follow-up|46
1458431|NCT00771927|4809380|P1|Overall Study|Lost to Follow-up|46
1458432|NCT00771927|4809379|P2|Overall Study|Lack of Efficacy|42
1458433|NCT00771927|4809380|P1|Overall Study|Lack of Efficacy|70
1458434|NCT00771927|4809379|P2|Overall Study|Adverse Event|105
1458435|NCT00771927|4809380|P1|Overall Study|Adverse Event|100
1458436|NCT00771914|4809392|P4|Overall Study|Lost to Follow-up|1
1458437|NCT00771914|4809393|P3|Overall Study|Lost to Follow-up|0
1458438|NCT00771914|4809394|P2|Overall Study|Lost to Follow-up|0
1458439|NCT00771914|4809395|P1|Overall Study|Lost to Follow-up|0
1458440|NCT00771914|4809392|P4|Overall Study|Physician Decision|1
1458441|NCT00771914|4809393|P3|Overall Study|Physician Decision|0
1458442|NCT00771914|4809394|P2|Overall Study|Physician Decision|0
1458443|NCT00771914|4809395|P1|Overall Study|Physician Decision|0
1458444|NCT00771901|4809408|P3|Overall Study|Dissat w/# of study medication (40/day)|4
1458445|NCT00771901|4809409|P2|Overall Study|Dissat w/# of study medication (40/day)|0
1458446|NCT00771901|4809410|P1|Overall Study|Dissat w/# of study medication (40/day)|0
1458447|NCT00771849|4809457|P2|Overall Study|Not vaccinated|1
1458448|NCT00771849|4809458|P1|Overall Study|Not vaccinated|0
1458449|NCT00771849|4809457|P2|Overall Study|Withdrawal by Subject|1
1458450|NCT00771849|4809458|P1|Overall Study|Withdrawal by Subject|1
1458451|NCT00771849|4809457|P2|Overall Study|Lost to Follow-up|2
1458452|NCT00771849|4809458|P1|Overall Study|Lost to Follow-up|1
1458453|NCT00771810|4809469|P3|Overall Study|Other|1
1458454|NCT00771810|4809470|P2|Overall Study|Other|0
1458455|NCT00771810|4809471|P1|Overall Study|Other|0
1458456|NCT00771810|4809469|P3|Overall Study|Withdrawal by Subject|0
1458457|NCT00771810|4809470|P2|Overall Study|Withdrawal by Subject|2
1458458|NCT00771810|4809471|P1|Overall Study|Withdrawal by Subject|1
1458459|NCT00771810|4809469|P3|Overall Study|Protocol Violation|1
1458460|NCT00771810|4809470|P2|Overall Study|Protocol Violation|1
1458461|NCT00771810|4809471|P1|Overall Study|Protocol Violation|0
1458462|NCT00771810|4809469|P3|Overall Study|Physician Decision|2
1458463|NCT00771810|4809470|P2|Overall Study|Physician Decision|2
1458464|NCT00771810|4809471|P1|Overall Study|Physician Decision|1
1458465|NCT00771810|4809469|P3|Overall Study|Lost to Follow-up|1
1458466|NCT00771810|4809470|P2|Overall Study|Lost to Follow-up|0
1458467|NCT00771810|4809471|P1|Overall Study|Lost to Follow-up|0
1458468|NCT00771810|4809469|P3|Overall Study|Adverse Event|2
1458469|NCT00771810|4809470|P2|Overall Study|Adverse Event|0
1458470|NCT00771810|4809471|P1|Overall Study|Adverse Event|3
1458471|NCT00771758|4809509|P3|Overall Study|Other|0
1458472|NCT00771758|4809510|P2|Overall Study|Other|2
1458473|NCT00771758|4809511|P1|Overall Study|Other|3
1458474|NCT00771758|4809509|P3|Overall Study|Withdrawal by Subject|0
1458475|NCT00771758|4809510|P2|Overall Study|Withdrawal by Subject|0
1458476|NCT00771758|4809511|P1|Overall Study|Withdrawal by Subject|1
1458477|NCT00771758|4809509|P3|Overall Study|Protocol Violation|0
1458478|NCT00771758|4809510|P2|Overall Study|Protocol Violation|0
1458479|NCT00771758|4809511|P1|Overall Study|Protocol Violation|1
1458480|NCT00771758|4809509|P3|Overall Study|Lost to Follow-up|0
1458481|NCT00771758|4809510|P2|Overall Study|Lost to Follow-up|0
1458482|NCT00771758|4809511|P1|Overall Study|Lost to Follow-up|1
1458483|NCT00771758|4809509|P3|Overall Study|Lack of Efficacy|1
1458484|NCT00771758|4809510|P2|Overall Study|Lack of Efficacy|2
1458485|NCT00771758|4809511|P1|Overall Study|Lack of Efficacy|0
1458486|NCT00771758|4809509|P3|Overall Study|Adverse Event|1
1458487|NCT00771758|4809510|P2|Overall Study|Adverse Event|8
1458488|NCT00771758|4809511|P1|Overall Study|Adverse Event|2
1458489|NCT00771667|4809672|P10|Maintenance Phase|Other|3
1458490|NCT00771667|4809673|P9|Maintenance Phase|Other|3
1458491|NCT00771667|4809674|P8|Maintenance Phase|Other|2
1458492|NCT00771667|4809675|P7|Maintenance Phase|Other|2
1458493|NCT00771667|4809676|P6|Maintenance Phase|Other|1
1458494|NCT00771667|4809677|P5|Maintenance Phase|Other|0
1458495|NCT00771667|4809678|P4|Maintenance Phase|Other|0
1458496|NCT00771667|4809679|P3|Maintenance Phase|Other|0
1458497|NCT00771667|4809680|P2|Maintenance Phase|Other|0
1458498|NCT00771667|4809681|P1|Maintenance Phase|Other|0
1458499|NCT00771667|4809672|P10|Maintenance Phase|Lack of Efficacy|7
1458500|NCT00771667|4809673|P9|Maintenance Phase|Lack of Efficacy|11
1458501|NCT00771667|4809674|P8|Maintenance Phase|Lack of Efficacy|2
1458502|NCT00771667|4809675|P7|Maintenance Phase|Lack of Efficacy|3
1458503|NCT00771667|4809676|P6|Maintenance Phase|Lack of Efficacy|3
1458504|NCT00771667|4809677|P5|Maintenance Phase|Lack of Efficacy|1
1458505|NCT00771667|4809678|P4|Maintenance Phase|Lack of Efficacy|0
1458506|NCT00771667|4809679|P3|Maintenance Phase|Lack of Efficacy|0
1458507|NCT00771667|4809680|P2|Maintenance Phase|Lack of Efficacy|0
1458508|NCT00771667|4809681|P1|Maintenance Phase|Lack of Efficacy|0
1458509|NCT00771667|4809672|P10|Maintenance Phase|Adverse Event|7
1458510|NCT00771667|4809673|P9|Maintenance Phase|Adverse Event|8
1458511|NCT00771667|4809674|P8|Maintenance Phase|Adverse Event|1
1458512|NCT00771667|4809675|P7|Maintenance Phase|Adverse Event|5
1458513|NCT00771667|4809676|P6|Maintenance Phase|Adverse Event|3
1458514|NCT00771667|4809677|P5|Maintenance Phase|Adverse Event|1
1458515|NCT00771667|4809678|P4|Maintenance Phase|Adverse Event|0
1458516|NCT00771667|4809679|P3|Maintenance Phase|Adverse Event|0
1458517|NCT00771667|4809680|P2|Maintenance Phase|Adverse Event|0
1458518|NCT00771667|4809681|P1|Maintenance Phase|Adverse Event|0
1458519|NCT00771667|4809672|P10|Induction Phase|Other|0
1458520|NCT00771667|4809673|P9|Induction Phase|Other|0
1458521|NCT00771667|4809674|P8|Induction Phase|Other|0
1458522|NCT00771667|4809675|P7|Induction Phase|Other|0
1458523|NCT00771667|4809676|P6|Induction Phase|Other|0
1458524|NCT00771667|4809677|P5|Induction Phase|Other|0
1458525|NCT00771667|4809678|P4|Induction Phase|Other|4
1458526|NCT00771667|4809679|P3|Induction Phase|Other|3
1458527|NCT00771667|4809680|P2|Induction Phase|Other|6
1458528|NCT00771667|4809681|P1|Induction Phase|Other|4
1458529|NCT00771667|4809672|P10|Induction Phase|Lost to Follow-up|0
1458530|NCT00771667|4809673|P9|Induction Phase|Lost to Follow-up|0
1458531|NCT00771667|4809674|P8|Induction Phase|Lost to Follow-up|0
1458532|NCT00771667|4809675|P7|Induction Phase|Lost to Follow-up|0
1458533|NCT00771667|4809676|P6|Induction Phase|Lost to Follow-up|0
1458534|NCT00771667|4809677|P5|Induction Phase|Lost to Follow-up|0
1458535|NCT00771667|4809678|P4|Induction Phase|Lost to Follow-up|0
1458536|NCT00771667|4809679|P3|Induction Phase|Lost to Follow-up|1
1458537|NCT00771667|4809680|P2|Induction Phase|Lost to Follow-up|0
1458538|NCT00771667|4809681|P1|Induction Phase|Lost to Follow-up|1
1458539|NCT00771667|4809672|P10|Induction Phase|Lack of Efficacy|0
1458540|NCT00771667|4809673|P9|Induction Phase|Lack of Efficacy|0
1458541|NCT00771667|4809674|P8|Induction Phase|Lack of Efficacy|0
1458542|NCT00771667|4809675|P7|Induction Phase|Lack of Efficacy|0
1458543|NCT00771667|4809676|P6|Induction Phase|Lack of Efficacy|0
1458544|NCT00771667|4809677|P5|Induction Phase|Lack of Efficacy|0
1458545|NCT00771667|4809678|P4|Induction Phase|Lack of Efficacy|3
1458546|NCT00771667|4809679|P3|Induction Phase|Lack of Efficacy|4
1458547|NCT00771667|4809680|P2|Induction Phase|Lack of Efficacy|2
1458548|NCT00771667|4809681|P1|Induction Phase|Lack of Efficacy|9
1458549|NCT00771667|4809672|P10|Induction Phase|Adverse Event|0
1458550|NCT00771667|4809673|P9|Induction Phase|Adverse Event|0
1458551|NCT00771667|4809674|P8|Induction Phase|Adverse Event|0
1458552|NCT00771667|4809675|P7|Induction Phase|Adverse Event|0
1458553|NCT00771667|4809676|P6|Induction Phase|Adverse Event|0
1458554|NCT00771667|4809677|P5|Induction Phase|Adverse Event|0
1458555|NCT00771667|4809678|P4|Induction Phase|Adverse Event|1
1458556|NCT00771667|4809679|P3|Induction Phase|Adverse Event|4
1458557|NCT00771667|4809680|P2|Induction Phase|Adverse Event|2
1458558|NCT00771667|4809681|P1|Induction Phase|Adverse Event|5
1458559|NCT00771615|4809726|P9|Overall Study|Lost to Follow-up|0
1458560|NCT00771615|4809727|P8|Overall Study|Lost to Follow-up|0
1458561|NCT00771615|4809728|P7|Overall Study|Lost to Follow-up|1
1458562|NCT00771615|4809729|P6|Overall Study|Lost to Follow-up|1
1458563|NCT00771615|4809730|P5|Overall Study|Lost to Follow-up|0
1458564|NCT00771615|4809731|P4|Overall Study|Lost to Follow-up|1
1458565|NCT00771615|4809732|P3|Overall Study|Lost to Follow-up|1
1458566|NCT00771615|4809733|P2|Overall Study|Lost to Follow-up|1
1458567|NCT00771615|4809734|P1|Overall Study|Lost to Follow-up|1
1458568|NCT00771615|4809726|P9|Overall Study|Withdrawal by Subject|0
1458569|NCT00771615|4809727|P8|Overall Study|Withdrawal by Subject|1
1458570|NCT00771615|4809728|P7|Overall Study|Withdrawal by Subject|0
1458571|NCT00771615|4809729|P6|Overall Study|Withdrawal by Subject|0
1458572|NCT00771615|4809730|P5|Overall Study|Withdrawal by Subject|0
1458573|NCT00771615|4809731|P4|Overall Study|Withdrawal by Subject|0
1458574|NCT00771615|4809732|P3|Overall Study|Withdrawal by Subject|0
1458575|NCT00771615|4809733|P2|Overall Study|Withdrawal by Subject|1
1458576|NCT00771615|4809734|P1|Overall Study|Withdrawal by Subject|0
1458577|NCT00771472|4809995|P2|Overall Study|Protocol Violation|0
1458578|NCT00771472|4809996|P1|Overall Study|Protocol Violation|1
1458579|NCT00771472|4809995|P2|Overall Study|Progressive Disease|1
1458580|NCT00771472|4809996|P1|Overall Study|Progressive Disease|3
1458581|NCT00771472|4809995|P2|Overall Study|Physician Decision|3
1458582|NCT00771472|4809996|P1|Overall Study|Physician Decision|2
1458583|NCT00771316|4810016|P2|Overall Study|Discontinued due to early termination|0
1458584|NCT00771316|4810017|P1|Overall Study|Discontinued due to early termination|1
1458585|NCT00771316|4810016|P2|Overall Study|Patient withdrew consent|0
1458586|NCT00771316|4810017|P1|Overall Study|Patient withdrew consent|1
1458587|NCT00771316|4810016|P2|Overall Study|Adverse Event|1
1458588|NCT00771316|4810017|P1|Overall Study|Adverse Event|0
1458589|NCT00770991|4810069|P2|Overall Study|Pregnancy|0
1458590|NCT00770991|4810070|P1|Overall Study|Pregnancy|1
1458591|NCT00770991|4810069|P2|Overall Study|Adverse Event|5
1458592|NCT00770991|4810070|P1|Overall Study|Adverse Event|1
1458593|NCT00770991|4810069|P2|Overall Study|Withdrawal by Subject|0
1458594|NCT00770991|4810070|P1|Overall Study|Withdrawal by Subject|1
1458595|NCT00770991|4810069|P2|Overall Study|Physician Decision|0
1458596|NCT00770991|4810070|P1|Overall Study|Physician Decision|2
1458597|NCT00770965|4810086|P4|Excluded Set|Withdrawal by Subject|3
1458598|NCT00770965|4810087|P3|Excluded Set|Withdrawal by Subject|2
1458599|NCT00770965|4810088|P2|Excluded Set|Withdrawal by Subject|1
1458600|NCT00770965|4810089|P1|Excluded Set|Withdrawal by Subject|1
1458601|NCT00770965|4810086|P4|Excluded Set|Administrative problems|10
1458602|NCT00770965|4810087|P3|Excluded Set|Administrative problems|12
1458603|NCT00770965|4810088|P2|Excluded Set|Administrative problems|12
1458604|NCT00770965|4810089|P1|Excluded Set|Administrative problems|14
1458605|NCT00770965|4810086|P4|Safety Set|Protocol deviation|0
1458606|NCT00770965|4810087|P3|Safety Set|Protocol deviation|1
1458607|NCT00770965|4810088|P2|Safety Set|Protocol deviation|0
1458608|NCT00770965|4810089|P1|Safety Set|Protocol deviation|0
1458609|NCT00770965|4810086|P4|Safety Set|Withdrawal by Subject|1
1458610|NCT00770965|4810087|P3|Safety Set|Withdrawal by Subject|0
1458611|NCT00770965|4810088|P2|Safety Set|Withdrawal by Subject|0
1458612|NCT00770965|4810089|P1|Safety Set|Withdrawal by Subject|0
1458613|NCT00770913|4810110|P3|Overall Study|Incorrect drug was allocated|0
1458614|NCT00770913|4810111|P2|Overall Study|Incorrect drug was allocated|0
1458615|NCT00770913|4810112|P1|Overall Study|Incorrect drug was allocated|1
1458616|NCT00770913|4810110|P3|Overall Study|Protocol Violation|1
1458617|NCT00770913|4810111|P2|Overall Study|Protocol Violation|0
1458618|NCT00770913|4810112|P1|Overall Study|Protocol Violation|3
1458619|NCT00770913|4810110|P3|Overall Study|Physician Decision|1
1458620|NCT00770913|4810111|P2|Overall Study|Physician Decision|1
1458621|NCT00770913|4810112|P1|Overall Study|Physician Decision|0
1458622|NCT00770913|4810110|P3|Overall Study|Refusal to continue participation|5
1458623|NCT00770913|4810111|P2|Overall Study|Refusal to continue participation|4
1458624|NCT00770913|4810112|P1|Overall Study|Refusal to continue participation|6
1458625|NCT00770913|4810110|P3|Overall Study|Adverse Event|6
1458626|NCT00770913|4810111|P2|Overall Study|Adverse Event|3
1458627|NCT00770913|4810112|P1|Overall Study|Adverse Event|1
1458628|NCT00770809|4810134|P3|Overall Study|Other Medical Reasons|3
1458629|NCT00770809|4810135|P2|Overall Study|Other Medical Reasons|4
1458630|NCT00770809|4810136|P1|Overall Study|Other Medical Reasons|2
1458631|NCT00770809|4810134|P3|Overall Study|Complicating illness|1
1458632|NCT00770809|4810135|P2|Overall Study|Complicating illness|0
1458633|NCT00770809|4810136|P1|Overall Study|Complicating illness|0
1458634|NCT00770809|4810134|P3|Overall Study|Progression|0
1458635|NCT00770809|4810135|P2|Overall Study|Progression|2
1458636|NCT00770809|4810136|P1|Overall Study|Progression|2
1458637|NCT00770809|4810134|P3|Overall Study|Withdrawal by Subject|7
1458638|NCT00770809|4810135|P2|Overall Study|Withdrawal by Subject|3
1458639|NCT00770809|4810136|P1|Overall Study|Withdrawal by Subject|3
1458640|NCT00770809|4810134|P3|Overall Study|Death|0
1458641|NCT00770809|4810135|P2|Overall Study|Death|0
1458642|NCT00770809|4810136|P1|Overall Study|Death|1
1458643|NCT00770809|4810134|P3|Overall Study|Adverse Event|12
1458644|NCT00770809|4810135|P2|Overall Study|Adverse Event|1
1458645|NCT00770809|4810136|P1|Overall Study|Adverse Event|9
1458646|NCT00770770|4810146|P2|Overall Study|Study Terminated|0
1458647|NCT00770770|4810147|P1|Overall Study|Study Terminated|8
1458648|NCT00770770|4810146|P2|Overall Study|Death|1
1458649|NCT00770770|4810147|P1|Overall Study|Death|0
1458650|NCT00770770|4810146|P2|Overall Study|Withdrawal by Subject|0
1458651|NCT00770770|4810147|P1|Overall Study|Withdrawal by Subject|1
1458652|NCT00770770|4810146|P2|Overall Study|Lost to Follow-up|0
1458653|NCT00770770|4810147|P1|Overall Study|Lost to Follow-up|1
1458654|NCT00770692|4810165|P4|Overall Study|Investigator judgment|1
1458655|NCT00770692|4810166|P3|Overall Study|Investigator judgment|1
1458656|NCT00770692|4810167|P2|Overall Study|Investigator judgment|0
1458657|NCT00770692|4810168|P1|Overall Study|Investigator judgment|2
1458658|NCT00770692|4810165|P4|Overall Study|Adverse Event|4
1458659|NCT00770692|4810166|P3|Overall Study|Adverse Event|4
1458660|NCT00770692|4810167|P2|Overall Study|Adverse Event|0
1458661|NCT00770692|4810168|P1|Overall Study|Adverse Event|3
1458662|NCT00770692|4810165|P4|Overall Study|Withdrawal by Subject|6
1458663|NCT00770692|4810166|P3|Overall Study|Withdrawal by Subject|9
1458664|NCT00770692|4810167|P2|Overall Study|Withdrawal by Subject|9
1458665|NCT00770692|4810168|P1|Overall Study|Withdrawal by Subject|7
1458666|NCT00770679|4810194|P1|Overall Study|Follow-up LDL measurement not collected|3
1458667|NCT00770679|4810194|P1|Overall Study|Lost to Follow-up|3
1458668|NCT00770653|4810202|P2|Overall Study|Physician Decision|0
1458669|NCT00770653|4810203|P1|Overall Study|Physician Decision|1
1458670|NCT00770653|4810202|P2|Overall Study|Lost to Follow-up|2
1458671|NCT00770653|4810203|P1|Overall Study|Lost to Follow-up|1
1458672|NCT00770653|4810202|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
1458673|NCT00770653|4810203|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
1458674|NCT00770653|4810202|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
1458675|NCT00770653|4810203|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
1458676|NCT00770653|4810202|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
1458677|NCT00770653|4810203|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
1458678|NCT00770653|4810202|P2|Overall Study|Lack of Compliance|4
1458679|NCT00770653|4810203|P1|Overall Study|Lack of Compliance|1
1458680|NCT00770653|4810202|P2|Overall Study|Withdrawal by Subject|7
1458681|NCT00770653|4810203|P1|Overall Study|Withdrawal by Subject|4
1458682|NCT00770653|4810202|P2|Overall Study|Protocol Violation|6
1458683|NCT00770653|4810203|P1|Overall Study|Protocol Violation|8
1458684|NCT00770653|4810202|P2|Overall Study|Adverse Event|5
1458685|NCT00770653|4810203|P1|Overall Study|Adverse Event|13
1458686|NCT00770588|4810273|P2|Overall Study|Withdrawal by Subject|1
1458687|NCT00770588|4810274|P1|Overall Study|Withdrawal by Subject|1
1458688|NCT00770588|4810273|P2|Overall Study|Lost to Follow-up|1
1458689|NCT00770588|4810274|P1|Overall Study|Lost to Follow-up|1
1458690|NCT00770588|4810273|P2|Overall Study|Death caused by progression of disease|91
1458691|NCT00770588|4810274|P1|Overall Study|Death caused by progression of disease|70
1458692|NCT00770588|4810273|P2|Overall Study|Adverse Event|2
1458693|NCT00770588|4810274|P1|Overall Study|Adverse Event|9
1458694|NCT00770562|4810290|P2|Overall Study|Did not take treatment|1
1458695|NCT00770562|4810291|P1|Overall Study|Did not take treatment|1
1458696|NCT00770510|4810302|P1|Overall Study|Withdrawal by Subject|2
1458697|NCT00770510|4810302|P1|Overall Study|Pregnancy|1
1458698|NCT00770510|4810302|P1|Overall Study|Lost to Follow-up|2
1458699|NCT00770484|4810341|P2|Overall Study|Withdrawal by Subject|0
1458700|NCT00770484|4810342|P1|Overall Study|Withdrawal by Subject|1
1458701|NCT00770432|4810350|P2|Overall Study|Non-compliance|1
1458702|NCT00770432|4810351|P1|Overall Study|Non-compliance|0
1458703|NCT00770432|4810350|P2|Overall Study|Not specified|6
1458704|NCT00770432|4810351|P1|Overall Study|Not specified|4
1458705|NCT00770367|4810359|P2|Second Intervention|Lost to Follow-up|0
1458706|NCT00770367|4810360|P1|Second Intervention|Lost to Follow-up|2
1458707|NCT00770367|4810359|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
1458708|NCT00770367|4810360|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
1458709|NCT00770367|4810359|P2|First Intervention|Withdrawal by Subject|2
1458710|NCT00770367|4810360|P1|First Intervention|Withdrawal by Subject|0
1458711|NCT00770341|4810371|P3|Overall Study|Not treated|0
1458712|NCT00770341|4810372|P2|Overall Study|Not treated|0
1458713|NCT00770341|4810373|P1|Overall Study|Not treated|1
1458714|NCT00770341|4810371|P3|Overall Study|Not specified|0
1458715|NCT00770341|4810372|P2|Overall Study|Not specified|0
1458716|NCT00770341|4810373|P1|Overall Study|Not specified|1
1458717|NCT00770341|4810371|P3|Overall Study|Lack of Efficacy|1
1458718|NCT00770341|4810372|P2|Overall Study|Lack of Efficacy|0
1458719|NCT00770341|4810373|P1|Overall Study|Lack of Efficacy|3
1458720|NCT00770341|4810371|P3|Overall Study|Laboratory adverse event|0
1458721|NCT00770341|4810372|P2|Overall Study|Laboratory adverse event|3
1458722|NCT00770341|4810373|P1|Overall Study|Laboratory adverse event|3
1458723|NCT00770341|4810371|P3|Overall Study|Clinical Adverse Event|2
1458724|NCT00770341|4810372|P2|Overall Study|Clinical Adverse Event|1
1458725|NCT00770341|4810373|P1|Overall Study|Clinical Adverse Event|3
1458726|NCT00770341|4810371|P3|Overall Study|Withdrawal by Subject|0
1458727|NCT00770341|4810372|P2|Overall Study|Withdrawal by Subject|1
1458728|NCT00770341|4810373|P1|Overall Study|Withdrawal by Subject|0
1458729|NCT00770341|4810371|P3|Overall Study|Did not meet eligibility criteria|0
1458730|NCT00770341|4810372|P2|Overall Study|Did not meet eligibility criteria|0
1458731|NCT00770341|4810373|P1|Overall Study|Did not meet eligibility criteria|1
1458732|NCT00770328|4810399|P2|Overall Study|Lost to Follow-up|2
1458733|NCT00770328|4810400|P1|Overall Study|Lost to Follow-up|2
1458734|NCT00770328|4810399|P2|Overall Study|Adverse Event|2
1458735|NCT00770328|4810400|P1|Overall Study|Adverse Event|11
1458736|NCT00770315|4810416|P4|Overall Study|Noncompliance with Protocol|9
1458737|NCT00770315|4810417|P3|Overall Study|Noncompliance with Protocol|7
1458738|NCT00770315|4810418|P2|Overall Study|Noncompliance with Protocol|4
1458739|NCT00770315|4810419|P1|Overall Study|Noncompliance with Protocol|7
1458740|NCT00770315|4810416|P4|Overall Study|Withdrawal by Subject|20
1458741|NCT00770315|4810417|P3|Overall Study|Withdrawal by Subject|24
1458742|NCT00770315|4810418|P2|Overall Study|Withdrawal by Subject|17
1458743|NCT00770315|4810419|P1|Overall Study|Withdrawal by Subject|13
1458744|NCT00770315|4810416|P4|Overall Study|Lost to Follow-up|3
1458745|NCT00770315|4810417|P3|Overall Study|Lost to Follow-up|10
1458746|NCT00770315|4810418|P2|Overall Study|Lost to Follow-up|5
1458747|NCT00770315|4810419|P1|Overall Study|Lost to Follow-up|9
1458748|NCT00770315|4810416|P4|Overall Study|Adverse Event|6
1458749|NCT00770315|4810417|P3|Overall Study|Adverse Event|16
1458750|NCT00770315|4810418|P2|Overall Study|Adverse Event|17
1458751|NCT00770315|4810419|P1|Overall Study|Adverse Event|11
1458752|NCT00770289|4810445|P1|Overall Study|Other|6
1458753|NCT00770211|4810456|P2|Overall Study|Withdrawal by Subject|2
1458754|NCT00770211|4810457|P1|Overall Study|Withdrawal by Subject|0
1458755|NCT00770211|4810456|P2|Overall Study|Lost to Follow-up|0
1458756|NCT00770211|4810457|P1|Overall Study|Lost to Follow-up|1
1458757|NCT00770146|4810473|P2|Follow-up Period|Other|5
1458758|NCT00770146|4810474|P1|Follow-up Period|Other|4
1458759|NCT00770146|4810473|P2|Follow-up Period|Adverse Event|2
1458760|NCT00770146|4810474|P1|Follow-up Period|Adverse Event|0
1458761|NCT00770146|4810473|P2|Follow-up Period|Withdrawal by Subject|13
1458762|NCT00770146|4810474|P1|Follow-up Period|Withdrawal by Subject|7
1458763|NCT00770146|4810473|P2|Treatment Period|Protocol non-compliance|1
1458764|NCT00770146|4810474|P1|Treatment Period|Protocol non-compliance|0
1458765|NCT00770146|4810473|P2|Treatment Period|Other|5
1458766|NCT00770146|4810474|P1|Treatment Period|Other|1
1458767|NCT00770146|4810473|P2|Treatment Period|Adverse Event|26
1458768|NCT00770146|4810474|P1|Treatment Period|Adverse Event|2
1458769|NCT00770146|4810473|P2|Treatment Period|Withdrawal by Subject|13
1458770|NCT00770146|4810474|P1|Treatment Period|Withdrawal by Subject|6
1458771|NCT00770120|4810518|P1|Overall Study|Reason under Review|1
1458772|NCT00770120|4810518|P1|Overall Study|Never Received Treatment/Not Analyzable|1
1458773|NCT00770120|4810518|P1|Overall Study|Ineligible|1
1458774|NCT00770120|4810518|P1|Overall Study|Withdrawal by Subject|2
1458775|NCT00770120|4810518|P1|Overall Study|Death|3
1458776|NCT00770120|4810518|P1|Overall Study|Not Protocol Specified|11
1458777|NCT00770120|4810518|P1|Overall Study|Adverse Event|11
1458778|NCT00770120|4810518|P1|Overall Study|Progression|31
1458779|NCT00770029|4810527|P2|Overall Study|Adverse Event|0
1458780|NCT00770029|4810528|P1|Overall Study|Adverse Event|1
1458781|NCT00770029|4810527|P2|Overall Study|Withdrawal by Subject|3
1458782|NCT00770029|4810528|P1|Overall Study|Withdrawal by Subject|3
1458783|NCT00770029|4810527|P2|Overall Study|Lost to Follow-up|0
1458784|NCT00770029|4810528|P1|Overall Study|Lost to Follow-up|2
1458785|NCT00769860|4810544|P2|Overall Study|Withdrawal by Subject|0
1458786|NCT00769860|4810545|P1|Overall Study|Withdrawal by Subject|2
1458787|NCT00769704|4810573|P2|Overall Study|Other|2
1458788|NCT00769704|4810574|P1|Overall Study|Other|1
1458789|NCT00769704|4810573|P2|Overall Study|Withdrawal by Subject|5
1458790|NCT00769704|4810574|P1|Overall Study|Withdrawal by Subject|12
1458791|NCT00769704|4810573|P2|Overall Study|Death|190
1458792|NCT00769704|4810574|P1|Overall Study|Death|95
1458793|NCT00769704|4810573|P2|Overall Study|Lost to Follow-up|2
1458794|NCT00769704|4810574|P1|Overall Study|Lost to Follow-up|3
1458795|NCT00769561|4810607|P2|Overall Study|Lost to Follow-up|3
1458796|NCT00769561|4810608|P1|Overall Study|Lost to Follow-up|1
1458797|NCT00769561|4810607|P2|Overall Study|Withdrawal by Subject|2
1458798|NCT00769561|4810608|P1|Overall Study|Withdrawal by Subject|2
1458799|NCT00769184|4810657|P2|No Treatment (6 Weeks)|Adverse Event|1
1458800|NCT00769184|4810658|P1|No Treatment (6 Weeks)|Adverse Event|1
1458801|NCT00769184|4810657|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
1458802|NCT00769184|4810658|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
1458803|NCT00769184|4810657|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
1458804|NCT00769184|4810658|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
1458805|NCT00769132|4810666|P4|Period 4|Withdrawal by Subject|0
1458806|NCT00769132|4810667|P3|Period 4|Withdrawal by Subject|0
1458807|NCT00769132|4810668|P2|Period 4|Withdrawal by Subject|1
1458808|NCT00769132|4810669|P1|Period 4|Withdrawal by Subject|0
1458809|NCT00769132|4810666|P4|Period 3|Withdrawal by Subject|0
1458810|NCT00769132|4810667|P3|Period 3|Withdrawal by Subject|0
1458811|NCT00769132|4810668|P2|Period 3|Withdrawal by Subject|0
1458812|NCT00769132|4810669|P1|Period 3|Withdrawal by Subject|1
1458813|NCT00769132|4810666|P4|Period 2|Withdrawal by Subject|1
1458814|NCT00769132|4810667|P3|Period 2|Withdrawal by Subject|0
1458815|NCT00769132|4810668|P2|Period 2|Withdrawal by Subject|0
1458816|NCT00769132|4810669|P1|Period 2|Withdrawal by Subject|0
1458817|NCT00769132|4810666|P4|Period 1|Adverse Event|1
1458818|NCT00769132|4810667|P3|Period 1|Adverse Event|0
1458819|NCT00769132|4810668|P2|Period 1|Adverse Event|0
1458820|NCT00769132|4810669|P1|Period 1|Adverse Event|1
1458821|NCT00769119|4810685|P2|Overall Study|Disallowed medication|0
1458822|NCT00769119|4810686|P1|Overall Study|Disallowed medication|1
1458823|NCT00769119|4810685|P2|Overall Study|Adverse Event|1
1458824|NCT00769119|4810686|P1|Overall Study|Adverse Event|1
1458825|NCT00769119|4810685|P2|Overall Study|Voluntary discontinuation|2
1458826|NCT00769119|4810686|P1|Overall Study|Voluntary discontinuation|0
1458827|NCT00769067|4810732|P2|Overall Study|Withdrawal by Subject|1
1458828|NCT00769067|4810733|P1|Overall Study|Withdrawal by Subject|0
1458829|NCT00769067|4810732|P2|Overall Study|Other|3
1458830|NCT00769067|4810733|P1|Overall Study|Other|1
1458831|NCT00769067|4810732|P2|Overall Study|Study terminated by sponsor|3
1458832|NCT00769067|4810733|P1|Overall Study|Study terminated by sponsor|1
1458833|NCT00769067|4810732|P2|Overall Study|Lost to Follow-up|1
1458834|NCT00769067|4810733|P1|Overall Study|Lost to Follow-up|3
1458835|NCT00769067|4810732|P2|Overall Study|Death|86
1458836|NCT00769067|4810733|P1|Overall Study|Death|89
1458837|NCT00768989|4810781|P2|On or After Week 36|Sponsor Termination|26
1458838|NCT00768989|4810782|P1|On or After Week 36|Sponsor Termination|45
1458839|NCT00768989|4810781|P2|On or After Week 36|Did not attend termination visit|0
1458840|NCT00768989|4810782|P1|On or After Week 36|Did not attend termination visit|2
1458841|NCT00768989|4810781|P2|On or After Week 36|Protocol Violation|0
1458842|NCT00768989|4810782|P1|On or After Week 36|Protocol Violation|1
1458843|NCT00768989|4810781|P2|On or After Week 36|Poor Compliance|0
1458844|NCT00768989|4810782|P1|On or After Week 36|Poor Compliance|1
1458845|NCT00768989|4810781|P2|On or After Week 36|Lost to Follow-up|0
1458846|NCT00768989|4810782|P1|On or After Week 36|Lost to Follow-up|1
1458847|NCT00768989|4810781|P2|On or After Week 36|Adverse Event|1
1458848|NCT00768989|4810782|P1|On or After Week 36|Adverse Event|0
1458849|NCT00768989|4810781|P2|On or After Week 36|Lack of Efficacy|0
1458850|NCT00768989|4810782|P1|On or After Week 36|Lack of Efficacy|1
1458851|NCT00768989|4810781|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
1458852|NCT00768989|4810782|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
1458853|NCT00768989|4810781|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
1458854|NCT00768989|4810782|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
1458855|NCT00768989|4810781|P2|Week 24 to Prior to Week 36|Adverse Event|0
1458856|NCT00768989|4810782|P1|Week 24 to Prior to Week 36|Adverse Event|1
1458857|NCT00768989|4810781|P2|Prior to Week 24|Protocol Violation|2
1458858|NCT00768989|4810782|P1|Prior to Week 24|Protocol Violation|0
1458859|NCT00768989|4810781|P2|Prior to Week 24|Lost to Follow-up|1
1458860|NCT00768989|4810782|P1|Prior to Week 24|Lost to Follow-up|0
1458861|NCT00768989|4810781|P2|Prior to Week 24|Adverse Event|0
1458862|NCT00768989|4810782|P1|Prior to Week 24|Adverse Event|3
1458863|NCT00768989|4810781|P2|Prior to Week 24|Withdrawal by Subject|0
1458864|NCT00768989|4810782|P1|Prior to Week 24|Withdrawal by Subject|1
1458865|NCT00768898|4810830|P1|Overall Study|Headache|1
1458866|NCT00768898|4810830|P1|Overall Study|Unrelated injury|1
1458867|NCT00768755|4810854|P4|Phase 2|Randomized but not treated|2
1458868|NCT00768755|4810855|P3|Phase 2|Randomized but not treated|0
1458869|NCT00768755|4810856|P2|Phase 2|Randomized but not treated|0
1458870|NCT00768755|4810857|P1|Phase 2|Randomized but not treated|0
1458871|NCT00768755|4810854|P4|Phase 2|Study Terminated by Sponsor|14
1458872|NCT00768755|4810855|P3|Phase 2|Study Terminated by Sponsor|7
1458873|NCT00768755|4810856|P2|Phase 2|Study Terminated by Sponsor|13
1458874|NCT00768755|4810857|P1|Phase 2|Study Terminated by Sponsor|0
1458875|NCT00768755|4810854|P4|Phase 2|Other|4
1458876|NCT00768755|4810855|P3|Phase 2|Other|2
1458877|NCT00768755|4810856|P2|Phase 2|Other|1
1458878|NCT00768755|4810857|P1|Phase 2|Other|0
1458879|NCT00768755|4810854|P4|Phase 2|Withdrawal by Subject|1
1458880|NCT00768755|4810855|P3|Phase 2|Withdrawal by Subject|0
1458881|NCT00768755|4810856|P2|Phase 2|Withdrawal by Subject|1
1458882|NCT00768755|4810857|P1|Phase 2|Withdrawal by Subject|0
1458883|NCT00768755|4810854|P4|Phase 2|Lost to Follow-up|4
1458884|NCT00768755|4810855|P3|Phase 2|Lost to Follow-up|1
1458885|NCT00768755|4810856|P2|Phase 2|Lost to Follow-up|1
1458886|NCT00768755|4810857|P1|Phase 2|Lost to Follow-up|0
1458887|NCT00768755|4810854|P4|Phase 2|Protocol Violation|1
1458888|NCT00768755|4810855|P3|Phase 2|Protocol Violation|0
1458889|NCT00768755|4810856|P2|Phase 2|Protocol Violation|2
1458890|NCT00768755|4810857|P1|Phase 2|Protocol Violation|0
1458891|NCT00768755|4810854|P4|Phase 2|Death|31
1458892|NCT00768755|4810855|P3|Phase 2|Death|48
1458893|NCT00768755|4810856|P2|Phase 2|Death|37
1458894|NCT00768755|4810857|P1|Phase 2|Death|0
1458895|NCT00768755|4810854|P4|Phase 1|Other|0
1458896|NCT00768755|4810855|P3|Phase 1|Other|0
1458897|NCT00768755|4810856|P2|Phase 1|Other|0
1458898|NCT00768755|4810857|P1|Phase 1|Other|4
1458899|NCT00768755|4810854|P4|Phase 1|Death|0
1458900|NCT00768755|4810855|P3|Phase 1|Death|0
1458901|NCT00768755|4810856|P2|Phase 1|Death|0
1458902|NCT00768755|4810857|P1|Phase 1|Death|6
1458903|NCT00768651|4810881|P1|Overall Study|Withdrawal by Subject|1
1458904|NCT00768560|4810920|P6|Intervention Set 1|Adverse Event|0
1458905|NCT00768560|4810921|P5|Intervention Set 1|Adverse Event|0
1458906|NCT00768560|4810922|P4|Intervention Set 1|Adverse Event|0
1458907|NCT00768560|4810923|P3|Intervention Set 1|Adverse Event|0
1458908|NCT00768560|4810924|P2|Intervention Set 1|Adverse Event|1
1458909|NCT00768560|4810925|P1|Intervention Set 1|Adverse Event|0
1458910|NCT00768430|4810962|P2|7 Day Endpoint|Withdrawal by Subject|3
1458911|NCT00768430|4810963|P1|7 Day Endpoint|Withdrawal by Subject|2
1458912|NCT00768300|4810971|P2|Overall Study|Missing data|0
1458913|NCT00768300|4810972|P1|Overall Study|Missing data|1
1458914|NCT00768300|4810971|P2|Overall Study|Treated but never dosed with Study drug|0
1458915|NCT00768300|4810972|P1|Overall Study|Treated but never dosed with Study drug|1
1458916|NCT00768300|4810971|P2|Overall Study|Began prohibited concomitant medication|1
1458917|NCT00768300|4810972|P1|Overall Study|Began prohibited concomitant medication|0
1458918|NCT00768300|4810971|P2|Overall Study|Lost to Follow-up|1
1458919|NCT00768300|4810972|P1|Overall Study|Lost to Follow-up|0
1458920|NCT00768300|4810971|P2|Overall Study|Received lung transplant|1
1458921|NCT00768300|4810972|P1|Overall Study|Received lung transplant|1
1458922|NCT00768300|4810971|P2|Overall Study|Screen failure following randomization|0
1458923|NCT00768300|4810972|P1|Overall Study|Screen failure following randomization|1
1458924|NCT00768300|4810971|P2|Overall Study|Subject moved to pursue lung transplant|1
1458925|NCT00768300|4810972|P1|Overall Study|Subject moved to pursue lung transplant|1
1458926|NCT00768300|4810971|P2|Overall Study|Death|5
1458927|NCT00768300|4810972|P1|Overall Study|Death|21
1458928|NCT00768300|4810971|P2|Overall Study|Study discontinued by Sponsor|140
1458929|NCT00768300|4810972|P1|Overall Study|Study discontinued by Sponsor|271
1458930|NCT00768300|4810971|P2|Overall Study|Physician Decision|3
1458931|NCT00768300|4810972|P1|Overall Study|Physician Decision|2
1458932|NCT00768300|4810971|P2|Overall Study|Withdrawal by Subject|7
1458933|NCT00768300|4810972|P1|Overall Study|Withdrawal by Subject|13
1458934|NCT00768300|4810971|P2|Overall Study|Protocol Violation|1
1458935|NCT00768300|4810972|P1|Overall Study|Protocol Violation|6
1458936|NCT00768300|4810971|P2|Overall Study|Adverse Event|2
1458937|NCT00768300|4810972|P1|Overall Study|Adverse Event|10
1458938|NCT00768300|4810971|P2|Overall Study|Randomized but not treated|1
1458939|NCT00768300|4810972|P1|Overall Study|Randomized but not treated|1
1458940|NCT00768222|4810996|P2|Overall Study|Protocol Violation|2
1458941|NCT00768222|4810997|P1|Overall Study|Protocol Violation|0
1458942|NCT00768222|4810996|P2|Overall Study|Withdrawal by Subject|1
1458943|NCT00768222|4810997|P1|Overall Study|Withdrawal by Subject|3
1458944|NCT00768222|4810996|P2|Overall Study|Lost to Follow-up|1
1458945|NCT00768222|4810997|P1|Overall Study|Lost to Follow-up|1
1458946|NCT00768144|4811019|P1|Overall Study|Pt Withdrew Consent|1
1458947|NCT00768144|4811019|P1|Overall Study|Patient or MD Decision to End Treatment|1
1458948|NCT00768144|4811019|P1|Overall Study|Progressive Disease|21
1458949|NCT00768144|4811019|P1|Overall Study|Adverse Event|13
1458950|NCT00768066|4811032|P3|Overall Study|Did not receive study product injection.|0
1458951|NCT00768066|4811033|P2|Overall Study|Did not receive study product injection.|3
1458952|NCT00768066|4811034|P1|Overall Study|Did not receive study product injection.|3
1458953|NCT00768053|4811066|P1|Overall Study|Lost to Follow-up|1
1458954|NCT00768053|4811066|P1|Overall Study|Adverse Event|10
1458955|NCT00768040|4811097|P2|Overall Study|Abnormal laboratory value|1
1458956|NCT00768040|4811098|P1|Overall Study|Abnormal laboratory value|1
1458957|NCT00768040|4811097|P2|Overall Study|Adverse Event|2
1458958|NCT00768040|4811098|P1|Overall Study|Adverse Event|3
1458959|NCT00767806|4811106|P2|Overall Study|Sponsor Decision|1
1458960|NCT00767806|4811107|P1|Overall Study|Sponsor Decision|0
1458961|NCT00767806|4811106|P2|Overall Study|Entry Criteria Not Met|1
1458962|NCT00767806|4811107|P1|Overall Study|Entry Criteria Not Met|1
1458963|NCT00767806|4811106|P2|Overall Study|Lost to Follow-up|4
1458964|NCT00767806|4811107|P1|Overall Study|Lost to Follow-up|1
1458965|NCT00767806|4811106|P2|Overall Study|Physician Decision|3
1458966|NCT00767806|4811107|P1|Overall Study|Physician Decision|4
1458967|NCT00767806|4811106|P2|Overall Study|Lack of Efficacy|9
1458968|NCT00767806|4811107|P1|Overall Study|Lack of Efficacy|1
1458969|NCT00767806|4811106|P2|Overall Study|Protocol Violation|5
1458970|NCT00767806|4811107|P1|Overall Study|Protocol Violation|6
1458971|NCT00767806|4811106|P2|Overall Study|Withdrawal by Subject|13
1458972|NCT00767806|4811107|P1|Overall Study|Withdrawal by Subject|8
1458973|NCT00767806|4811106|P2|Overall Study|Adverse Event|11
1458974|NCT00767806|4811107|P1|Overall Study|Adverse Event|30
1458975|NCT00767676|4811184|P1|Overall Study|Investigator error|54
1458976|NCT00767520|4811207|P2|Overall Study|Randomized in error and Never treated|2
1458977|NCT00767520|4811208|P1|Overall Study|Randomized in error and Never treated|0
1458978|NCT00767520|4811207|P2|Overall Study|Participants still on treatment|15
1458979|NCT00767520|4811208|P1|Overall Study|Participants still on treatment|11
1458980|NCT00767455|4811261|P1|Overall Study|Investigator error|19
1458981|NCT00767325|4811295|P1|Overall Study|Missed visit due to family reasons|1
1458982|NCT00767325|4811295|P1|Overall Study|No longer met study criteria|2
1458983|NCT00767325|4811295|P1|Overall Study|Lost to Follow-up|3
1458984|NCT00767325|4811295|P1|Overall Study|Adverse Event|7
1458985|NCT00767325|4811295|P1|Overall Study|Lack of Efficacy|2
1458986|NCT00767104|4811306|P2|Overall Study|Lost to Follow-up|2
1458987|NCT00767104|4811307|P1|Overall Study|Lost to Follow-up|1
1458988|NCT00767039|4811317|P2|Overall Study|Death|2
1458989|NCT00767039|4811318|P1|Overall Study|Death|5
1458990|NCT00767000|4811349|P5|Optional 104-week Extension|Study terminated by sponsor|4
1458991|NCT00767000|4811350|P4|Optional 104-week Extension|Study terminated by sponsor|2
1458992|NCT00767000|4811351|P3|Optional 104-week Extension|Study terminated by sponsor|7
1458993|NCT00767000|4811352|P2|Optional 104-week Extension|Study terminated by sponsor|3
1458994|NCT00767000|4811353|P1|Optional 104-week Extension|Study terminated by sponsor|7
1458995|NCT00767000|4811349|P5|54-week Study|Reason not reported|0
1458996|NCT00767000|4811350|P4|54-week Study|Reason not reported|1
1458997|NCT00767000|4811351|P3|54-week Study|Reason not reported|0
1458998|NCT00767000|4811352|P2|54-week Study|Reason not reported|0
1458999|NCT00767000|4811353|P1|54-week Study|Reason not reported|0
1459000|NCT00767000|4811349|P5|54-week Study|Study terminated by sponsor|194
1459001|NCT00767000|4811350|P4|54-week Study|Study terminated by sponsor|196
1459002|NCT00767000|4811351|P3|54-week Study|Study terminated by sponsor|89
1459003|NCT00767000|4811352|P2|54-week Study|Study terminated by sponsor|102
1459004|NCT00767000|4811353|P1|54-week Study|Study terminated by sponsor|90
1459005|NCT00767000|4811349|P5|54-week Study|Withdrawal by Subject|13
1459006|NCT00767000|4811350|P4|54-week Study|Withdrawal by Subject|11
1459007|NCT00767000|4811351|P3|54-week Study|Withdrawal by Subject|5
1459008|NCT00767000|4811352|P2|54-week Study|Withdrawal by Subject|3
1459009|NCT00767000|4811353|P1|54-week Study|Withdrawal by Subject|2
1459010|NCT00767000|4811349|P5|54-week Study|Protocol Violation|0
1459011|NCT00767000|4811350|P4|54-week Study|Protocol Violation|2
1459012|NCT00767000|4811351|P3|54-week Study|Protocol Violation|1
1459013|NCT00767000|4811352|P2|54-week Study|Protocol Violation|0
1459014|NCT00767000|4811353|P1|54-week Study|Protocol Violation|0
1459015|NCT00767000|4811349|P5|54-week Study|Progressive disease|0
1459016|NCT00767000|4811350|P4|54-week Study|Progressive disease|0
1459017|NCT00767000|4811351|P3|54-week Study|Progressive disease|1
1459018|NCT00767000|4811352|P2|54-week Study|Progressive disease|0
1459019|NCT00767000|4811353|P1|54-week Study|Progressive disease|0
1459020|NCT00767000|4811349|P5|54-week Study|Physician Decision|1
1459021|NCT00767000|4811350|P4|54-week Study|Physician Decision|1
1459022|NCT00767000|4811351|P3|54-week Study|Physician Decision|1
1459023|NCT00767000|4811352|P2|54-week Study|Physician Decision|0
1459024|NCT00767000|4811353|P1|54-week Study|Physician Decision|4
1459025|NCT00767000|4811349|P5|54-week Study|Lost to Follow-up|2
1459026|NCT00767000|4811350|P4|54-week Study|Lost to Follow-up|4
1459027|NCT00767000|4811351|P3|54-week Study|Lost to Follow-up|1
1459028|NCT00767000|4811352|P2|54-week Study|Lost to Follow-up|0
1459029|NCT00767000|4811353|P1|54-week Study|Lost to Follow-up|4
1459030|NCT00767000|4811349|P5|54-week Study|Lack of Efficacy|5
1459031|NCT00767000|4811350|P4|54-week Study|Lack of Efficacy|0
1459032|NCT00767000|4811351|P3|54-week Study|Lack of Efficacy|1
1459033|NCT00767000|4811352|P2|54-week Study|Lack of Efficacy|0
1459034|NCT00767000|4811353|P1|54-week Study|Lack of Efficacy|2
1459035|NCT00767000|4811349|P5|54-week Study|Interruption of study medication|0
1459036|NCT00767000|4811350|P4|54-week Study|Interruption of study medication|0
1459037|NCT00767000|4811351|P3|54-week Study|Interruption of study medication|1
1459038|NCT00767000|4811352|P2|54-week Study|Interruption of study medication|0
1459039|NCT00767000|4811353|P1|54-week Study|Interruption of study medication|0
1459040|NCT00767000|4811349|P5|54-week Study|Hypoglycemia|0
1459041|NCT00767000|4811350|P4|54-week Study|Hypoglycemia|0
1459042|NCT00767000|4811351|P3|54-week Study|Hypoglycemia|0
1459043|NCT00767000|4811352|P2|54-week Study|Hypoglycemia|1
1459044|NCT00767000|4811353|P1|54-week Study|Hypoglycemia|0
1459045|NCT00767000|4811349|P5|54-week Study|Hyperglycemia|1
1459046|NCT00767000|4811350|P4|54-week Study|Hyperglycemia|0
1459047|NCT00767000|4811351|P3|54-week Study|Hyperglycemia|1
1459048|NCT00767000|4811352|P2|54-week Study|Hyperglycemia|0
1459049|NCT00767000|4811353|P1|54-week Study|Hyperglycemia|0
1459050|NCT00767000|4811349|P5|54-week Study|Creaninine/creatinine clearance|4
1459051|NCT00767000|4811350|P4|54-week Study|Creaninine/creatinine clearance|2
1459052|NCT00767000|4811351|P3|54-week Study|Creaninine/creatinine clearance|2
1459053|NCT00767000|4811352|P2|54-week Study|Creaninine/creatinine clearance|1
1459054|NCT00767000|4811353|P1|54-week Study|Creaninine/creatinine clearance|2
1459055|NCT00767000|4811349|P5|54-week Study|Adverse Event|4
1459056|NCT00767000|4811350|P4|54-week Study|Adverse Event|8
1459057|NCT00767000|4811351|P3|54-week Study|Adverse Event|6
1459058|NCT00767000|4811352|P2|54-week Study|Adverse Event|6
1459059|NCT00767000|4811353|P1|54-week Study|Adverse Event|4
1459060|NCT00766831|4811395|P1|Overall Study|Not specified|28
1459061|NCT00766831|4811395|P1|Overall Study|Non cooperation by participants|14
1459062|NCT00766831|4811395|P1|Overall Study|Withdrawal of consent|26
1459063|NCT00766831|4811395|P1|Overall Study|Physician Decision|5
1459064|NCT00766831|4811395|P1|Overall Study|Protocol Violation|15
1459065|NCT00766831|4811395|P1|Overall Study|Adverse Event|20
1459066|NCT00766831|4811395|P1|Overall Study|Lost to Follow-up|3
1459067|NCT00766831|4811395|P1|Overall Study|Withdrawal by Subject|4
1459068|NCT00766675|4811425|P1|Overall Study|Insufficient therapy|1
1459069|NCT00766675|4811425|P1|Overall Study|Receive other anti-neoplastic treatment|1
1459070|NCT00766675|4811425|P1|Overall Study|Participant took prohibited medication|1
1459071|NCT00766675|4811425|P1|Overall Study|Protocol Violation|8
1459072|NCT00766675|4811425|P1|Overall Study|Withdrawal by Subject|11
1459073|NCT00766675|4811425|P1|Overall Study|Lost to Follow-up|2
1459074|NCT00766675|4811425|P1|Overall Study|Adverse Event|16
1459075|NCT00766636|4811452|P2|Overall Study|Disease Progression|0
1459076|NCT00766636|4811453|P1|Overall Study|Disease Progression|1
1459077|NCT00766636|4811452|P2|Overall Study|Adverse Event|0
1459078|NCT00766636|4811453|P1|Overall Study|Adverse Event|1
1459079|NCT00766636|4811452|P2|Overall Study|Incomplete Treatment|1
1459080|NCT00766636|4811453|P1|Overall Study|Incomplete Treatment|0
1459081|NCT00766636|4811452|P2|Overall Study|Withdrawal by Subject|1
1459082|NCT00766636|4811453|P1|Overall Study|Withdrawal by Subject|1
1459083|NCT00766597|4811459|P1|Overall Study|Without CCR5-tropic virus|5
1459084|NCT00766597|4811459|P1|Overall Study|Unexpected closure of study|4
1459085|NCT00766532|4811471|P1|Overall Study|Protocol Violation|2
1459086|NCT00766506|4811477|P2|Overall Study|Other|2
1459087|NCT00766506|4811478|P1|Overall Study|Other|2
1459088|NCT00766506|4811477|P2|Overall Study|Use rescue medication after 3 hours|0
1459089|NCT00766506|4811478|P1|Overall Study|Use rescue medication after 3 hours|3
1459090|NCT00766493|4811502|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
1459091|NCT00766493|4811502|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
1459092|NCT00766493|4811502|P1|30 Days Post-Procedure|Discontinued|7
1459093|NCT00766467|4811512|P2|Overall Study|Physician Decision|0
1459094|NCT00766467|4811513|P1|Overall Study|Physician Decision|1
1459095|NCT00766467|4811512|P2|Overall Study|Tumor Progression on Study|1
1459096|NCT00766467|4811513|P1|Overall Study|Tumor Progression on Study|0
1459097|NCT00766467|4811512|P2|Overall Study|Protocol Violation|4
1459098|NCT00766467|4811513|P1|Overall Study|Protocol Violation|2
1459099|NCT00766467|4811512|P2|Overall Study|Adverse Event|1
1459100|NCT00766467|4811513|P1|Overall Study|Adverse Event|1
1459101|NCT00766467|4811512|P2|Overall Study|Withdrawal by Subject|2
1459102|NCT00766467|4811513|P1|Overall Study|Withdrawal by Subject|7
1459103|NCT00766415|4811525|P2|Overall Study|Withdrawal by Subject|1
1459104|NCT00766415|4811526|P1|Overall Study|Withdrawal by Subject|0
1459105|NCT00766376|4811574|P1|Overall Study|Withdrawal by Subject|27
1459106|NCT00766363|4811583|P4|Overall Study|Adverse Event Prior to Randomization|0
1459107|NCT00766363|4811584|P3|Overall Study|Adverse Event Prior to Randomization|0
1459108|NCT00766363|4811585|P2|Overall Study|Adverse Event Prior to Randomization|1
1459109|NCT00766363|4811586|P1|Overall Study|Adverse Event Prior to Randomization|0
1459110|NCT00766363|4811583|P4|Overall Study|Withdrawal by Subject|0
1459111|NCT00766363|4811584|P3|Overall Study|Withdrawal by Subject|0
1459112|NCT00766363|4811585|P2|Overall Study|Withdrawal by Subject|0
1459113|NCT00766363|4811586|P1|Overall Study|Withdrawal by Subject|1
1459114|NCT00766090|4811625|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1459115|NCT00766090|4811626|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1459116|NCT00766090|4811627|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1459117|NCT00766090|4811628|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1459118|NCT00766090|4811629|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1459119|NCT00766090|4811630|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1459120|NCT00766090|4811631|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1459121|NCT00766090|4811632|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
1459122|NCT00766090|4811633|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1459123|NCT00766090|4811634|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1459124|NCT00766090|4811635|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1459125|NCT00766090|4811636|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1459126|NCT00766090|4811625|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
1459127|NCT00766090|4811626|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1459128|NCT00766090|4811627|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1459129|NCT00766090|4811628|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1459130|NCT00766090|4811629|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1459131|NCT00766090|4811630|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1459132|NCT00766090|4811631|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1459133|NCT00766090|4811632|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1459134|NCT00766090|4811633|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
1459135|NCT00766090|4811634|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1459136|NCT00766090|4811635|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
1459137|NCT00766090|4811636|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1459138|NCT00766090|4811625|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
1459139|NCT00766090|4811626|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
1459140|NCT00766090|4811627|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
1459141|NCT00766090|4811628|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
1459142|NCT00766090|4811629|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
1459143|NCT00766090|4811630|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
1459144|NCT00766090|4811631|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
1459145|NCT00766090|4811632|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
1459146|NCT00766090|4811633|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
1459147|NCT00766090|4811634|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
1459148|NCT00766090|4811635|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
1459149|NCT00766090|4811636|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
1459150|NCT00766090|4811625|P12|Washout Period 2 (14 Days)|Physician Decision|0
1459151|NCT00766090|4811626|P11|Washout Period 2 (14 Days)|Physician Decision|0
1459152|NCT00766090|4811627|P10|Washout Period 2 (14 Days)|Physician Decision|0
1459153|NCT00766090|4811628|P9|Washout Period 2 (14 Days)|Physician Decision|0
1459154|NCT00766090|4811629|P8|Washout Period 2 (14 Days)|Physician Decision|0
1459155|NCT00766090|4811630|P7|Washout Period 2 (14 Days)|Physician Decision|0
1459156|NCT00766090|4811631|P6|Washout Period 2 (14 Days)|Physician Decision|0
1459157|NCT00766090|4811632|P5|Washout Period 2 (14 Days)|Physician Decision|0
1459158|NCT00766090|4811633|P4|Washout Period 2 (14 Days)|Physician Decision|0
1459159|NCT00766090|4811634|P3|Washout Period 2 (14 Days)|Physician Decision|1
1459160|NCT00766090|4811635|P2|Washout Period 2 (14 Days)|Physician Decision|0
1459161|NCT00766090|4811636|P1|Washout Period 2 (14 Days)|Physician Decision|0
1459162|NCT00766090|4811625|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1459163|NCT00766090|4811626|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1459164|NCT00766090|4811627|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1459165|NCT00766090|4811628|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1459166|NCT00766090|4811629|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1459167|NCT00766090|4811630|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1459168|NCT00766090|4811631|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1459169|NCT00766090|4811632|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1459170|NCT00766090|4811633|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1459171|NCT00766090|4811634|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
1459172|NCT00766090|4811635|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1459173|NCT00766090|4811636|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1459174|NCT00766090|4811625|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1459175|NCT00766090|4811626|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1459176|NCT00766090|4811627|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1459177|NCT00766090|4811628|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1459178|NCT00766090|4811629|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1459179|NCT00766090|4811630|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1459180|NCT00766090|4811631|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1459181|NCT00766090|4811632|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
1459182|NCT00766090|4811633|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1459183|NCT00766090|4811634|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1459184|NCT00766090|4811635|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1459185|NCT00766090|4811636|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1459186|NCT00766090|4811625|P12|Washout Period 1 (14 Days)|Protocol Violation|0
1459187|NCT00766090|4811626|P11|Washout Period 1 (14 Days)|Protocol Violation|0
1459188|NCT00766090|4811627|P10|Washout Period 1 (14 Days)|Protocol Violation|0
1459189|NCT00766090|4811628|P9|Washout Period 1 (14 Days)|Protocol Violation|0
1459190|NCT00766090|4811629|P8|Washout Period 1 (14 Days)|Protocol Violation|0
1459191|NCT00766090|4811630|P7|Washout Period 1 (14 Days)|Protocol Violation|0
1459192|NCT00766090|4811631|P6|Washout Period 1 (14 Days)|Protocol Violation|0
1459193|NCT00766090|4811632|P5|Washout Period 1 (14 Days)|Protocol Violation|0
1459194|NCT00766090|4811633|P4|Washout Period 1 (14 Days)|Protocol Violation|0
1459195|NCT00766090|4811634|P3|Washout Period 1 (14 Days)|Protocol Violation|1
1459196|NCT00766090|4811635|P2|Washout Period 1 (14 Days)|Protocol Violation|0
1459197|NCT00766090|4811636|P1|Washout Period 1 (14 Days)|Protocol Violation|0
1459198|NCT00766090|4811625|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1459199|NCT00766090|4811626|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1459200|NCT00766090|4811627|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1459201|NCT00766090|4811628|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1459202|NCT00766090|4811629|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1459203|NCT00766090|4811630|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1459204|NCT00766090|4811631|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1459205|NCT00766090|4811632|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1459206|NCT00766090|4811633|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1459207|NCT00766090|4811634|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1459208|NCT00766090|4811635|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1459209|NCT00766090|4811636|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1459210|NCT00766090|4811625|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1459211|NCT00766090|4811626|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1459212|NCT00766090|4811627|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1459213|NCT00766090|4811628|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1459214|NCT00766090|4811629|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1459215|NCT00766090|4811630|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1459216|NCT00766090|4811631|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1459217|NCT00766090|4811632|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1459218|NCT00766090|4811633|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1459219|NCT00766090|4811634|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1459220|NCT00766090|4811635|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1459221|NCT00766090|4811636|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
1459222|NCT00766090|4811625|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1459223|NCT00766090|4811626|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1459224|NCT00766090|4811627|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1459225|NCT00766090|4811628|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
1459226|NCT00766090|4811629|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1459227|NCT00766090|4811630|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1459228|NCT00766090|4811631|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1459229|NCT00766090|4811632|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1459230|NCT00766090|4811633|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1459231|NCT00766090|4811634|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1459232|NCT00766090|4811635|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1459233|NCT00766090|4811636|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1459234|NCT00766051|4811677|P2|Overall Study|Withdrawal by Subject|0
1459235|NCT00766051|4811678|P1|Overall Study|Withdrawal by Subject|2
1459236|NCT00765882|4811709|P3|Overall Study|Other Reason|2
1459237|NCT00765882|4811710|P2|Overall Study|Other Reason|1
1459238|NCT00765882|4811711|P1|Overall Study|Other Reason|3
1459239|NCT00765882|4811709|P3|Overall Study|Lost to Follow-up|6
1459240|NCT00765882|4811710|P2|Overall Study|Lost to Follow-up|9
1459241|NCT00765882|4811711|P1|Overall Study|Lost to Follow-up|1
1459242|NCT00765882|4811709|P3|Overall Study|Withdrawal by Subject|6
1459243|NCT00765882|4811710|P2|Overall Study|Withdrawal by Subject|6
1459244|NCT00765882|4811711|P1|Overall Study|Withdrawal by Subject|2
1459245|NCT00765882|4811709|P3|Overall Study|Protocol Violation|1
1459246|NCT00765882|4811710|P2|Overall Study|Protocol Violation|3
1459247|NCT00765882|4811711|P1|Overall Study|Protocol Violation|4
1459248|NCT00765882|4811709|P3|Overall Study|Lack of Efficacy|1
1459249|NCT00765882|4811710|P2|Overall Study|Lack of Efficacy|0
1459250|NCT00765882|4811711|P1|Overall Study|Lack of Efficacy|4
1459251|NCT00765882|4811709|P3|Overall Study|Adverse Event|20
1459252|NCT00765882|4811710|P2|Overall Study|Adverse Event|21
1459253|NCT00765882|4811711|P1|Overall Study|Adverse Event|10
1459254|NCT00765843|4811743|P3|Overall Study|Adverse Event|1
1459255|NCT00765843|4811744|P2|Overall Study|Adverse Event|0
1459256|NCT00765843|4811745|P1|Overall Study|Adverse Event|0
1459257|NCT00765843|4811743|P3|Overall Study|did not return to receive intervention|0
1459258|NCT00765843|4811744|P2|Overall Study|did not return to receive intervention|1
1459259|NCT00765843|4811745|P1|Overall Study|did not return to receive intervention|0
1459260|NCT00765843|4811743|P3|Overall Study|Lost to Follow-up|2
1459261|NCT00765843|4811744|P2|Overall Study|Lost to Follow-up|3
1459262|NCT00765843|4811745|P1|Overall Study|Lost to Follow-up|1
1459263|NCT00765817|4811755|P2|Overall Study|Subject decision|11
1459264|NCT00765817|4811756|P1|Overall Study|Subject decision|7
1459265|NCT00765817|4811755|P2|Overall Study|Protocol Violation|1
1459266|NCT00765817|4811756|P1|Overall Study|Protocol Violation|1
1459267|NCT00765817|4811755|P2|Overall Study|Physician Decision|1
1459268|NCT00765817|4811756|P1|Overall Study|Physician Decision|2
1459269|NCT00765817|4811755|P2|Overall Study|Lost to Follow-up|3
1459270|NCT00765817|4811756|P1|Overall Study|Lost to Follow-up|1
1459271|NCT00765817|4811755|P2|Overall Study|Loss of glucose control|2
1459272|NCT00765817|4811756|P1|Overall Study|Loss of glucose control|0
1459273|NCT00765817|4811755|P2|Overall Study|Entry criteria not met|2
1459274|NCT00765817|4811756|P1|Overall Study|Entry criteria not met|2
1459275|NCT00765817|4811755|P2|Overall Study|Death|1
1459276|NCT00765817|4811756|P1|Overall Study|Death|0
1459277|NCT00765817|4811755|P2|Overall Study|Adverse Event|1
1459278|NCT00765817|4811756|P1|Overall Study|Adverse Event|13
1459279|NCT00765726|4811804|P1|Overall Study|Discontinuation of study by sponsor|8
1459280|NCT00765726|4811804|P1|Overall Study|Withdrawal by Subject|1
1459281|NCT00765674|4811812|P4|Overall Study|Randomized in Error - No Study Drug|1
1459282|NCT00765674|4811813|P3|Overall Study|Randomized in Error - No Study Drug|0
1459283|NCT00765674|4811814|P2|Overall Study|Randomized in Error - No Study Drug|1
1459284|NCT00765674|4811815|P1|Overall Study|Randomized in Error - No Study Drug|0
1459285|NCT00765674|4811812|P4|Overall Study|Lost to Follow-up|1
1459286|NCT00765674|4811813|P3|Overall Study|Lost to Follow-up|2
1459287|NCT00765674|4811814|P2|Overall Study|Lost to Follow-up|6
1459288|NCT00765674|4811815|P1|Overall Study|Lost to Follow-up|4
1459289|NCT00765674|4811812|P4|Overall Study|Withdrawal by Subject|8
1459290|NCT00765674|4811813|P3|Overall Study|Withdrawal by Subject|3
1459291|NCT00765674|4811814|P2|Overall Study|Withdrawal by Subject|7
1459292|NCT00765674|4811815|P1|Overall Study|Withdrawal by Subject|5
1459293|NCT00765674|4811812|P4|Overall Study|Protocol Violation|0
1459294|NCT00765674|4811813|P3|Overall Study|Protocol Violation|1
1459295|NCT00765674|4811814|P2|Overall Study|Protocol Violation|0
1459296|NCT00765674|4811815|P1|Overall Study|Protocol Violation|2
1459297|NCT00765674|4811812|P4|Overall Study|Lack of Efficacy|2
1459298|NCT00765674|4811813|P3|Overall Study|Lack of Efficacy|1
1459299|NCT00765674|4811814|P2|Overall Study|Lack of Efficacy|3
1459300|NCT00765674|4811815|P1|Overall Study|Lack of Efficacy|2
1459301|NCT00765674|4811812|P4|Overall Study|Abnormal Test Procedure Result(s)|2
1459302|NCT00765674|4811813|P3|Overall Study|Abnormal Test Procedure Result(s)|1
1459303|NCT00765674|4811814|P2|Overall Study|Abnormal Test Procedure Result(s)|3
1459304|NCT00765674|4811815|P1|Overall Study|Abnormal Test Procedure Result(s)|1
1459305|NCT00765674|4811812|P4|Overall Study|Abnormal Laboratory Value(s)|0
1459306|NCT00765674|4811813|P3|Overall Study|Abnormal Laboratory Value(s)|1
1459307|NCT00765674|4811814|P2|Overall Study|Abnormal Laboratory Value(s)|0
1459308|NCT00765674|4811815|P1|Overall Study|Abnormal Laboratory Value(s)|0
1459309|NCT00765674|4811812|P4|Overall Study|Adverse Event|11
1459310|NCT00765674|4811813|P3|Overall Study|Adverse Event|8
1459311|NCT00765674|4811814|P2|Overall Study|Adverse Event|2
1459312|NCT00765674|4811815|P1|Overall Study|Adverse Event|7
1459313|NCT00765388|4811882|P2|Period 1|Hip operation|1
1459314|NCT00765388|4811883|P1|Period 1|Hip operation|0
1459315|NCT00765388|4811882|P2|Period 1|Herpes Zoster|1
1459316|NCT00765388|4811883|P1|Period 1|Herpes Zoster|0
1459317|NCT00765388|4811882|P2|Period 1|Lost to Follow-up|1
1459318|NCT00765388|4811883|P1|Period 1|Lost to Follow-up|0
1459319|NCT00765388|4811882|P2|Period 1|Lack of Efficacy|2
1459320|NCT00765388|4811883|P1|Period 1|Lack of Efficacy|1
1459321|NCT00765362|4811917|P1|Overall Study|Lost to Follow-up|95
1459322|NCT00765362|4811917|P1|Overall Study|Withdrawal by Subject|13
1459323|NCT00765362|4811917|P1|Overall Study|Protocol Violation|18
1459324|NCT00765362|4811917|P1|Overall Study|Adverse Event|2
1459325|NCT00765362|4811917|P1|Overall Study|Death|9
1459326|NCT00765336|4811925|P2|Overall Study|Adverse Event|1
1459327|NCT00765336|4811926|P1|Overall Study|Adverse Event|2
1459328|NCT00765336|4811925|P2|Overall Study|Lost to Follow-up|9
1459329|NCT00765336|4811926|P1|Overall Study|Lost to Follow-up|7
1459330|NCT00765336|4811925|P2|Overall Study|Withdrawal by Subject|4
1459331|NCT00765336|4811926|P1|Overall Study|Withdrawal by Subject|6
1459332|NCT00765336|4811925|P2|Overall Study|Protocol Violation|2
1459333|NCT00765336|4811926|P1|Overall Study|Protocol Violation|4
1459334|NCT00765245|4811934|P2|Overall Study|Death|0
1459335|NCT00765245|4811935|P1|Overall Study|Death|1
1459336|NCT00765245|4811934|P2|Overall Study|Physician Decision|0
1459337|NCT00765245|4811935|P1|Overall Study|Physician Decision|1
1459338|NCT00765245|4811934|P2|Overall Study|Adverse Event|0
1459339|NCT00765245|4811935|P1|Overall Study|Adverse Event|5
1459340|NCT00765245|4811934|P2|Overall Study|Withdrawal by Subject|0
1459341|NCT00765245|4811935|P1|Overall Study|Withdrawal by Subject|3
1459342|NCT00765245|4811934|P2|Overall Study|disease progression|2
1459343|NCT00765245|4811935|P1|Overall Study|disease progression|3
1459344|NCT00765102|4811981|P1|Overall Study|Protocol Violation|1
1459345|NCT00765102|4811981|P1|Overall Study|Withdrawal by Subject|2
1459346|NCT00765102|4811981|P1|Overall Study|Physician Decision|4
1459347|NCT00765102|4811981|P1|Overall Study|Adverse Event|6
1459348|NCT00765102|4811981|P1|Overall Study|Progressive disease|18
1459349|NCT00765076|4812006|P3|Overall Study|Withdrawal by Subject|1
1459350|NCT00765076|4812007|P2|Overall Study|Withdrawal by Subject|0
1459351|NCT00765076|4812008|P1|Overall Study|Withdrawal by Subject|0
1459352|NCT00765076|4812006|P3|Overall Study|Adverse Event|0
1459353|NCT00765076|4812007|P2|Overall Study|Adverse Event|0
1459354|NCT00765076|4812008|P1|Overall Study|Adverse Event|1
1459355|NCT00765063|4812061|P1|Overall Study|Adverse Event|4
1459356|NCT00765063|4812061|P1|Overall Study|Protocol Violation|6
1459357|NCT00765063|4812061|P1|Overall Study|Other|16
1459358|NCT00765063|4812061|P1|Overall Study|Withdrawal by Subject|1
1459359|NCT00765063|4812061|P1|Overall Study|Lack of Efficacy|5
1459360|NCT00765037|4812077|P1|Overall Study|Adverse Event|1
1459361|NCT00765037|4812077|P1|Overall Study|Lost to Follow-up|5
1459362|NCT00764946|4812084|P3|Overall Study|Never Treated|1
1459363|NCT00764946|4812085|P2|Overall Study|Never Treated|1
1459364|NCT00764946|4812086|P1|Overall Study|Never Treated|1
1459365|NCT00764946|4812084|P3|Overall Study|Withdrawal by Subject|2
1459366|NCT00764946|4812085|P2|Overall Study|Withdrawal by Subject|6
1459367|NCT00764946|4812086|P1|Overall Study|Withdrawal by Subject|3
1459368|NCT00764946|4812084|P3|Overall Study|Adverse Event|1
1459369|NCT00764946|4812085|P2|Overall Study|Adverse Event|2
1459370|NCT00764946|4812086|P1|Overall Study|Adverse Event|3
1459371|NCT00764946|4812084|P3|Overall Study|Physician Decision|0
1459372|NCT00764946|4812085|P2|Overall Study|Physician Decision|4
1459373|NCT00764946|4812086|P1|Overall Study|Physician Decision|2
1459374|NCT00764946|4812084|P3|Overall Study|Lost to Follow-up|0
1459375|NCT00764946|4812085|P2|Overall Study|Lost to Follow-up|4
1459376|NCT00764946|4812086|P1|Overall Study|Lost to Follow-up|3
1459377|NCT00764946|4812084|P3|Overall Study|Lack of Efficacy|0
1459378|NCT00764946|4812085|P2|Overall Study|Lack of Efficacy|0
1459379|NCT00764946|4812086|P1|Overall Study|Lack of Efficacy|1
1459380|NCT00764881|4812114|P2|Overall Study|no treatment or no observation|2
1459381|NCT00764881|4812115|P1|Overall Study|no treatment or no observation|2
1459382|NCT00764881|4812114|P2|Overall Study|Possibly noncompliant (study drug)|2
1459383|NCT00764881|4812115|P1|Overall Study|Possibly noncompliant (study drug)|0
1459384|NCT00764881|4812114|P2|Overall Study|Carcinoma detected|0
1459385|NCT00764881|4812115|P1|Overall Study|Carcinoma detected|1
1459386|NCT00764881|4812114|P2|Overall Study|Wished to become pregnant|0
1459387|NCT00764881|4812115|P1|Overall Study|Wished to become pregnant|1
1459388|NCT00764881|4812114|P2|Overall Study|Accidentally discontinued study drug|0
1459389|NCT00764881|4812115|P1|Overall Study|Accidentally discontinued study drug|1
1459390|NCT00764881|4812114|P2|Overall Study|Noncompliant|0
1459391|NCT00764881|4812115|P1|Overall Study|Noncompliant|1
1459392|NCT00764881|4812114|P2|Overall Study|Lost to Follow-up|0
1459393|NCT00764881|4812115|P1|Overall Study|Lost to Follow-up|2
1459394|NCT00764881|4812114|P2|Overall Study|Protocol Violation|2
1459395|NCT00764881|4812115|P1|Overall Study|Protocol Violation|2
1459396|NCT00764881|4812114|P2|Overall Study|Withdrawal by Subject|3
1459397|NCT00764881|4812115|P1|Overall Study|Withdrawal by Subject|1
1459398|NCT00764881|4812114|P2|Overall Study|Adverse Event|1
1459399|NCT00764881|4812115|P1|Overall Study|Adverse Event|5
1459400|NCT00764868|4812339|P1|Overall Study|Sponsor requested withdrawal|1
1459401|NCT00764868|4812339|P1|Overall Study|Positive drug screen|2
1459402|NCT00764868|4812339|P1|Overall Study|Met an exclusion criteria|1
1459403|NCT00764868|4812339|P1|Overall Study|Subject sent to boarding school|1
1459404|NCT00764868|4812339|P1|Overall Study|Misuse and compliance of study drug|1
1459405|NCT00764868|4812339|P1|Overall Study|Out of town|1
1459406|NCT00764868|4812339|P1|Overall Study|Prohibited medication|1
1459407|NCT00764868|4812339|P1|Overall Study|Pregnancy|3
1459408|NCT00764868|4812339|P1|Overall Study|Subject moved|7
1459409|NCT00764868|4812339|P1|Overall Study|Lack of Efficacy|5
1459410|NCT00764868|4812339|P1|Overall Study|Lost to Follow-up|25
1459411|NCT00764868|4812339|P1|Overall Study|Non-compliance|16
1459412|NCT00764868|4812339|P1|Overall Study|Withdrawal by Subject|31
1459413|NCT00764868|4812339|P1|Overall Study|Adverse Event|18
1459414|NCT00764790|4812348|P3|Overall Study|Lost to Follow-up|23
1459415|NCT00764790|4812349|P2|Overall Study|Lost to Follow-up|29
1459416|NCT00764790|4812350|P1|Overall Study|Lost to Follow-up|28
1459417|NCT00764790|4812348|P3|Overall Study|Withdrawal by Subject|6
1459418|NCT00764790|4812349|P2|Overall Study|Withdrawal by Subject|12
1459419|NCT00764790|4812350|P1|Overall Study|Withdrawal by Subject|10
1459420|NCT00764790|4812348|P3|Overall Study|Protocol Violation|1
1459421|NCT00764790|4812349|P2|Overall Study|Protocol Violation|0
1459422|NCT00764790|4812350|P1|Overall Study|Protocol Violation|0
1459423|NCT00764699|4812382|P1|Overall Study|PI left and study terminated|3
1459424|NCT00764673|4812386|P1|Overall Study|Revision of Device|2
1459425|NCT00764673|4812386|P1|Overall Study|Withdrawal by Subject|6
1459426|NCT00764673|4812386|P1|Overall Study|Lost to Follow-up|3
1459427|NCT00764673|4812386|P1|Overall Study|Death|1
1459428|NCT00764660|4812396|P2|Overall Study|Did Not Meet Protocol Eligibility|0
1459429|NCT00764660|4812397|P1|Overall Study|Did Not Meet Protocol Eligibility|1
1459430|NCT00764660|4812396|P2|Overall Study|Noncompliance With Protocol|1
1459431|NCT00764660|4812397|P1|Overall Study|Noncompliance With Protocol|5
1459432|NCT00764660|4812396|P2|Overall Study|Withdrawal by Subject|3
1459433|NCT00764660|4812397|P1|Overall Study|Withdrawal by Subject|7
1459434|NCT00764660|4812396|P2|Overall Study|Lost to Follow-up|4
1459435|NCT00764660|4812397|P1|Overall Study|Lost to Follow-up|3
1459436|NCT00764660|4812396|P2|Overall Study|Adverse Event|3
1459437|NCT00764660|4812397|P1|Overall Study|Adverse Event|6
1459438|NCT00764517|4812431|P2|Overall Study|Physician Decision|0
1459439|NCT00764517|4812432|P1|Overall Study|Physician Decision|3
1459440|NCT00764517|4812431|P2|Overall Study|Death|11
1459441|NCT00764517|4812432|P1|Overall Study|Death|3
1459442|NCT00764517|4812431|P2|Overall Study|Adverse Event|3
1459443|NCT00764517|4812432|P1|Overall Study|Adverse Event|9
1459444|NCT00764504|4812453|P3|Overall Study|Lost to Follow-up|72
1459445|NCT00764504|4812454|P2|Overall Study|Lost to Follow-up|34
1459446|NCT00764504|4812455|P1|Overall Study|Lost to Follow-up|40
1459447|NCT00764504|4812453|P3|Overall Study|Withdrawal by Subject|4
1459448|NCT00764504|4812454|P2|Overall Study|Withdrawal by Subject|7
1459449|NCT00764504|4812455|P1|Overall Study|Withdrawal by Subject|1
1459450|NCT00764504|4812453|P3|Overall Study|Physician Decision|0
1459451|NCT00764504|4812454|P2|Overall Study|Physician Decision|0
1459452|NCT00764504|4812455|P1|Overall Study|Physician Decision|1
1459453|NCT00764504|4812453|P3|Overall Study|Revision of Device|14
1459454|NCT00764504|4812454|P2|Overall Study|Revision of Device|23
1459455|NCT00764504|4812455|P1|Overall Study|Revision of Device|12
1459456|NCT00764504|4812453|P3|Overall Study|Death|13
1459457|NCT00764504|4812454|P2|Overall Study|Death|6
1459458|NCT00764504|4812455|P1|Overall Study|Death|12
1459459|NCT00764478|4812484|P3|Overall Study|Protocol Violation|1
1459460|NCT00764478|4812485|P2|Overall Study|Protocol Violation|1
1459461|NCT00764478|4812486|P1|Overall Study|Protocol Violation|0
1459462|NCT00764478|4812484|P3|Overall Study|Lost to Follow-up|5
1459463|NCT00764478|4812485|P2|Overall Study|Lost to Follow-up|8
1459464|NCT00764478|4812486|P1|Overall Study|Lost to Follow-up|7
1459465|NCT00764478|4812484|P3|Overall Study|Withdrawal by Subject|1
1459466|NCT00764478|4812485|P2|Overall Study|Withdrawal by Subject|12
1459467|NCT00764478|4812486|P1|Overall Study|Withdrawal by Subject|7
1459468|NCT00764478|4812484|P3|Overall Study|Adverse Event|1
1459469|NCT00764478|4812485|P2|Overall Study|Adverse Event|1
1459470|NCT00764478|4812486|P1|Overall Study|Adverse Event|1
1459471|NCT00764465|4812566|P6|Overall Study|Withdrawal by Subject|0
1459472|NCT00764465|4812567|P5|Overall Study|Withdrawal by Subject|0
1459473|NCT00764465|4812568|P4|Overall Study|Withdrawal by Subject|0
1459474|NCT00764465|4812569|P3|Overall Study|Withdrawal by Subject|1
1459475|NCT00764465|4812570|P2|Overall Study|Withdrawal by Subject|1
1459476|NCT00764465|4812571|P1|Overall Study|Withdrawal by Subject|0
1459477|NCT00764465|4812566|P6|Overall Study|Adverse Event|1
1459478|NCT00764465|4812567|P5|Overall Study|Adverse Event|1
1459479|NCT00764465|4812568|P4|Overall Study|Adverse Event|1
1459480|NCT00764465|4812569|P3|Overall Study|Adverse Event|0
1459481|NCT00764465|4812570|P2|Overall Study|Adverse Event|0
1459482|NCT00764465|4812571|P1|Overall Study|Adverse Event|2
1459483|NCT00764361|4812599|P2|Overall Study|Adverse Event|1
1459484|NCT00764361|4812600|P1|Overall Study|Adverse Event|0
1459485|NCT00764361|4812599|P2|Overall Study|Withdrawal by Subject|3
1459486|NCT00764361|4812600|P1|Overall Study|Withdrawal by Subject|2
1459487|NCT00764322|4812608|P1|Overall Study|No CYP2D6 genotyping|9
1459488|NCT00764322|4812608|P1|Overall Study|Withdrawal by Subject|11
1459489|NCT00763971|4812635|P3|Overall Study|Participation in 489-326 required|0
1459490|NCT00763971|4812636|P2|Overall Study|Participation in 489-326 required|0
1459491|NCT00763971|4812637|P1|Overall Study|Participation in 489-326 required|1
1459492|NCT00763971|4812635|P3|Overall Study|Performed final visit on phone|0
1459493|NCT00763971|4812636|P2|Overall Study|Performed final visit on phone|1
1459494|NCT00763971|4812637|P1|Overall Study|Performed final visit on phone|0
1459495|NCT00763971|4812635|P3|Overall Study|Lack of availability|0
1459496|NCT00763971|4812636|P2|Overall Study|Lack of availability|1
1459497|NCT00763971|4812637|P1|Overall Study|Lack of availability|0
1459498|NCT00763971|4812635|P3|Overall Study|Subject wanted dose reduction|0
1459499|NCT00763971|4812636|P2|Overall Study|Subject wanted dose reduction|1
1459500|NCT00763971|4812637|P1|Overall Study|Subject wanted dose reduction|0
1459501|NCT00763971|4812635|P3|Overall Study|Moved to another country|0
1459502|NCT00763971|4812636|P2|Overall Study|Moved to another country|1
1459503|NCT00763971|4812637|P1|Overall Study|Moved to another country|0
1459504|NCT00763971|4812635|P3|Overall Study|Medical monitor decision|1
1459505|NCT00763971|4812636|P2|Overall Study|Medical monitor decision|0
1459506|NCT00763971|4812637|P1|Overall Study|Medical monitor decision|0
1459507|NCT00763971|4812635|P3|Overall Study|Randomization error|1
1459508|NCT00763971|4812636|P2|Overall Study|Randomization error|0
1459509|NCT00763971|4812637|P1|Overall Study|Randomization error|0
1459510|NCT00763971|4812635|P3|Overall Study|Due to holiday season|1
1459511|NCT00763971|4812636|P2|Overall Study|Due to holiday season|0
1459512|NCT00763971|4812637|P1|Overall Study|Due to holiday season|2
1459513|NCT00763971|4812635|P3|Overall Study|Sponsor decision|0
1459514|NCT00763971|4812636|P2|Overall Study|Sponsor decision|0
1459515|NCT00763971|4812637|P1|Overall Study|Sponsor decision|1
1459516|NCT00763971|4812635|P3|Overall Study|Exclusion criteria met|0
1459517|NCT00763971|4812636|P2|Overall Study|Exclusion criteria met|0
1459518|NCT00763971|4812637|P1|Overall Study|Exclusion criteria met|1
1459519|NCT00763971|4812635|P3|Overall Study|Personal reason|0
1459520|NCT00763971|4812636|P2|Overall Study|Personal reason|0
1459521|NCT00763971|4812637|P1|Overall Study|Personal reason|3
1459522|NCT00763971|4812635|P3|Overall Study|Unable to swallow capsule|1
1459523|NCT00763971|4812636|P2|Overall Study|Unable to swallow capsule|1
1459524|NCT00763971|4812637|P1|Overall Study|Unable to swallow capsule|2
1459525|NCT00763971|4812635|P3|Overall Study|Lack of Efficacy|54
1459526|NCT00763971|4812636|P2|Overall Study|Lack of Efficacy|22
1459527|NCT00763971|4812637|P1|Overall Study|Lack of Efficacy|11
1459528|NCT00763971|4812635|P3|Overall Study|Lost to Follow-up|0
1459529|NCT00763971|4812636|P2|Overall Study|Lost to Follow-up|1
1459530|NCT00763971|4812637|P1|Overall Study|Lost to Follow-up|0
1459531|NCT00763971|4812635|P3|Overall Study|Withdrawal by Subject|5
1459532|NCT00763971|4812636|P2|Overall Study|Withdrawal by Subject|5
1459533|NCT00763971|4812637|P1|Overall Study|Withdrawal by Subject|4
1459534|NCT00763971|4812635|P3|Overall Study|Protocol Violation|2
1459535|NCT00763971|4812636|P2|Overall Study|Protocol Violation|3
1459536|NCT00763971|4812637|P1|Overall Study|Protocol Violation|3
1459537|NCT00763971|4812635|P3|Overall Study|Adverse Event|4
1459538|NCT00763971|4812636|P2|Overall Study|Adverse Event|2
1459539|NCT00763971|4812637|P1|Overall Study|Adverse Event|5
1459540|NCT00763958|4812668|P2|Overall Study|Believed they were receiving placebo|5
1459541|NCT00763958|4812669|P1|Overall Study|Believed they were receiving placebo|0
1459542|NCT00763958|4812668|P2|Overall Study|Lost to Follow-up|2
1459543|NCT00763958|4812669|P1|Overall Study|Lost to Follow-up|10
1459544|NCT00763958|4812668|P2|Overall Study|did not meet final criteria|4
1459545|NCT00763958|4812669|P1|Overall Study|did not meet final criteria|4
1459546|NCT00763815|4812804|P2|Overall Study|Sponsor's Decision|1
1459547|NCT00763815|4812805|P1|Overall Study|Sponsor's Decision|0
1459548|NCT00763815|4812804|P2|Overall Study|Protocol Violation|5
1459549|NCT00763815|4812805|P1|Overall Study|Protocol Violation|2
1459550|NCT00763815|4812804|P2|Overall Study|Withdrawal by Subject|12
1459551|NCT00763815|4812805|P1|Overall Study|Withdrawal by Subject|7
1459552|NCT00763815|4812804|P2|Overall Study|Physician Decision|0
1459553|NCT00763815|4812805|P1|Overall Study|Physician Decision|1
1459554|NCT00763815|4812804|P2|Overall Study|Familial and Personal Reasons|16
1459555|NCT00763815|4812805|P1|Overall Study|Familial and Personal Reasons|9
1459556|NCT00763815|4812804|P2|Overall Study|Early Termination|0
1459557|NCT00763815|4812805|P1|Overall Study|Early Termination|1
1459558|NCT00763815|4812804|P2|Overall Study|Lost to Follow-up|4
1459559|NCT00763815|4812805|P1|Overall Study|Lost to Follow-up|2
1459560|NCT00763815|4812804|P2|Overall Study|Poor Compliance to Protocol|6
1459561|NCT00763815|4812805|P1|Overall Study|Poor Compliance to Protocol|6
1459562|NCT00763815|4812804|P2|Overall Study|Lack of Efficacy|11
1459563|NCT00763815|4812805|P1|Overall Study|Lack of Efficacy|10
1459564|NCT00763815|4812804|P2|Overall Study|Adverse Event|29
1459565|NCT00763815|4812805|P1|Overall Study|Adverse Event|14
1459566|NCT00763698|4812833|P1|Overall Study|Withdrawal by Subject|1
1459567|NCT00763698|4812833|P1|Overall Study|Death|4
1459568|NCT00763698|4812833|P1|Overall Study|Unsuccessful Implant|5
1459569|NCT00763451|4812850|P4|Overall Study|Study Site Reason|1
1459570|NCT00763451|4812851|P3|Overall Study|Study Site Reason|1
1459571|NCT00763451|4812852|P2|Overall Study|Study Site Reason|1
1459572|NCT00763451|4812853|P1|Overall Study|Study Site Reason|0
1459573|NCT00763451|4812850|P4|Overall Study|Randomized but not Treated|0
1459574|NCT00763451|4812851|P3|Overall Study|Randomized but not Treated|0
1459575|NCT00763451|4812852|P2|Overall Study|Randomized but not Treated|1
1459576|NCT00763451|4812853|P1|Overall Study|Randomized but not Treated|1
1459577|NCT00763451|4812850|P4|Overall Study|Familial and Personal Reasons|4
1459578|NCT00763451|4812851|P3|Overall Study|Familial and Personal Reasons|5
1459579|NCT00763451|4812852|P2|Overall Study|Familial and Personal Reasons|3
1459580|NCT00763451|4812853|P1|Overall Study|Familial and Personal Reasons|5
1459581|NCT00763451|4812850|P4|Overall Study|Poor Compliance to Protocol|2
1459582|NCT00763451|4812851|P3|Overall Study|Poor Compliance to Protocol|2
1459583|NCT00763451|4812852|P2|Overall Study|Poor Compliance to Protocol|1
1459584|NCT00763451|4812853|P1|Overall Study|Poor Compliance to Protocol|1
1459585|NCT00763451|4812850|P4|Overall Study|Protocol Violation|0
1459586|NCT00763451|4812851|P3|Overall Study|Protocol Violation|1
1459587|NCT00763451|4812852|P2|Overall Study|Protocol Violation|0
1459588|NCT00763451|4812853|P1|Overall Study|Protocol Violation|0
1459589|NCT00763451|4812850|P4|Overall Study|Withdrawal by Subject|7
1459590|NCT00763451|4812851|P3|Overall Study|Withdrawal by Subject|9
1459591|NCT00763451|4812852|P2|Overall Study|Withdrawal by Subject|6
1459592|NCT00763451|4812853|P1|Overall Study|Withdrawal by Subject|1
1459593|NCT00763451|4812850|P4|Overall Study|Lack of Efficacy|2
1459594|NCT00763451|4812851|P3|Overall Study|Lack of Efficacy|3
1459595|NCT00763451|4812852|P2|Overall Study|Lack of Efficacy|4
1459596|NCT00763451|4812853|P1|Overall Study|Lack of Efficacy|1
1459597|NCT00763451|4812850|P4|Overall Study|Adverse Event|14
1459598|NCT00763451|4812851|P3|Overall Study|Adverse Event|19
1459599|NCT00763451|4812852|P2|Overall Study|Adverse Event|6
1459600|NCT00763451|4812853|P1|Overall Study|Adverse Event|4
1459601|NCT00763386|4812912|P2|Overall Study|Study Prosthesis Removed|0
1459602|NCT00763386|4812913|P1|Overall Study|Study Prosthesis Removed|1
1459603|NCT00763386|4812912|P2|Overall Study|CRF missing|1
1459604|NCT00763386|4812913|P1|Overall Study|CRF missing|0
1459605|NCT00763386|4812912|P2|Overall Study|Withdrawal by Subject|1
1459606|NCT00763386|4812913|P1|Overall Study|Withdrawal by Subject|0
1459607|NCT00763386|4812912|P2|Overall Study|Lost to Follow-up|3
1459608|NCT00763386|4812913|P1|Overall Study|Lost to Follow-up|3
1459609|NCT00763386|4812912|P2|Overall Study|Death|2
1459610|NCT00763386|4812913|P1|Overall Study|Death|1
1459611|NCT00763386|4812912|P2|Overall Study|Adverse Event|33
1459612|NCT00763386|4812913|P1|Overall Study|Adverse Event|43
1459613|NCT00763321|4812946|P3|Double-blind Period|Not specified|3
1459614|NCT00763321|4812947|P2|Double-blind Period|Not specified|2
1459615|NCT00763321|4812948|P1|Double-blind Period|Not specified|0
1459616|NCT00763321|4812946|P3|Double-blind Period|Withdrawal by Subject|3
1459617|NCT00763321|4812947|P2|Double-blind Period|Withdrawal by Subject|2
1459618|NCT00763321|4812948|P1|Double-blind Period|Withdrawal by Subject|0
1459619|NCT00763321|4812946|P3|Double-blind Period|Lost to Follow-up|2
1459620|NCT00763321|4812947|P2|Double-blind Period|Lost to Follow-up|4
1459621|NCT00763321|4812948|P1|Double-blind Period|Lost to Follow-up|0
1459622|NCT00763321|4812946|P3|Double-blind Period|Adverse Event|4
1459623|NCT00763321|4812947|P2|Double-blind Period|Adverse Event|4
1459624|NCT00763321|4812948|P1|Double-blind Period|Adverse Event|0
1459625|NCT00763321|4812946|P3|Double-blind Period|Lack of Efficacy|17
1459626|NCT00763321|4812947|P2|Double-blind Period|Lack of Efficacy|9
1459627|NCT00763321|4812948|P1|Double-blind Period|Lack of Efficacy|0
1459628|NCT00763321|4812946|P3|Open-label Period|Not specified|0
1459629|NCT00763321|4812947|P2|Open-label Period|Not specified|0
1459630|NCT00763321|4812948|P1|Open-label Period|Not specified|4
1459631|NCT00763321|4812946|P3|Open-label Period|Lack of Efficacy|0
1459632|NCT00763321|4812947|P2|Open-label Period|Lack of Efficacy|0
1459633|NCT00763321|4812948|P1|Open-label Period|Lack of Efficacy|2
1459634|NCT00763321|4812946|P3|Open-label Period|Did not meet DB randomization criteria|0
1459635|NCT00763321|4812947|P2|Open-label Period|Did not meet DB randomization criteria|0
1459636|NCT00763321|4812948|P1|Open-label Period|Did not meet DB randomization criteria|5
1459637|NCT00763321|4812946|P3|Open-label Period|Subject noncompliant|0
1459638|NCT00763321|4812947|P2|Open-label Period|Subject noncompliant|0
1459639|NCT00763321|4812948|P1|Open-label Period|Subject noncompliant|7
1459640|NCT00763321|4812946|P3|Open-label Period|Withdrawal by Subject|0
1459641|NCT00763321|4812947|P2|Open-label Period|Withdrawal by Subject|0
1459642|NCT00763321|4812948|P1|Open-label Period|Withdrawal by Subject|7
1459643|NCT00763321|4812946|P3|Open-label Period|Lost to Follow-up|0
1459644|NCT00763321|4812947|P2|Open-label Period|Lost to Follow-up|0
1459645|NCT00763321|4812948|P1|Open-label Period|Lost to Follow-up|14
1459646|NCT00763321|4812946|P3|Open-label Period|Adverse Event|0
1459647|NCT00763321|4812947|P2|Open-label Period|Adverse Event|0
1459648|NCT00763321|4812948|P1|Open-label Period|Adverse Event|24
1459649|NCT00763282|4812959|P2|Overall Study|Lost to Follow-up|26
1459650|NCT00763282|4812960|P1|Overall Study|Lost to Follow-up|22
1459651|NCT00763282|4812959|P2|Overall Study|Death|3
1459652|NCT00763282|4812960|P1|Overall Study|Death|4
1459653|NCT00763282|4812959|P2|Overall Study|Withdrawal by Subject|5
1459654|NCT00763282|4812960|P1|Overall Study|Withdrawal by Subject|6
1459655|NCT00763269|4812976|P2|Overall Study|Lost to Follow-up|13
1459656|NCT00763269|4812977|P1|Overall Study|Lost to Follow-up|12
1459657|NCT00763256|4812991|P2|Overall Study|Didn't return for appointments|10
1459658|NCT00763256|4812992|P1|Overall Study|Didn't return for appointments|7
1459659|NCT00763139|4813028|P2|Overall Study|med change not allowed by protocol|0
1459660|NCT00763139|4813029|P1|Overall Study|med change not allowed by protocol|1
1459661|NCT00763139|4813028|P2|Overall Study|Withdrawal by Subject|1
1459662|NCT00763139|4813029|P1|Overall Study|Withdrawal by Subject|0
1459663|NCT00763139|4813028|P2|Overall Study|Adverse Event|2
1459664|NCT00763139|4813029|P1|Overall Study|Adverse Event|4
1459665|NCT00763009|4813091|P1|Overall Study|Coronary Anatomy unsuitable|1
1459666|NCT00762996|4813096|P4|Period One|Withdrawal by Subject|0
1459667|NCT00762996|4813097|P3|Period One|Withdrawal by Subject|1
1459668|NCT00762996|4813098|P2|Period One|Withdrawal by Subject|0
1459669|NCT00762996|4813099|P1|Period One|Withdrawal by Subject|0
1459670|NCT00762996|4813096|P4|Period One|Adverse Event|0
1459671|NCT00762996|4813097|P3|Period One|Adverse Event|1
1459672|NCT00762996|4813098|P2|Period One|Adverse Event|0
1459673|NCT00762996|4813099|P1|Period One|Adverse Event|0
1459674|NCT00762996|4813096|P4|Period One|ineligible|1
1459675|NCT00762996|4813097|P3|Period One|ineligible|1
1459676|NCT00762996|4813098|P2|Period One|ineligible|0
1459677|NCT00762996|4813099|P1|Period One|ineligible|0
1459678|NCT00762996|4813096|P4|Period One|Protocol Violation|0
1459679|NCT00762996|4813097|P3|Period One|Protocol Violation|1
1459680|NCT00762996|4813098|P2|Period One|Protocol Violation|0
1459681|NCT00762996|4813099|P1|Period One|Protocol Violation|0
1459682|NCT00762970|4813112|P3|Overall Study|Difficulty of handling lens|0
1459683|NCT00762970|4813113|P2|Overall Study|Difficulty of handling lens|2
1459684|NCT00762970|4813114|P1|Overall Study|Difficulty of handling lens|1
1459685|NCT00762970|4813112|P3|Overall Study|Lost to Follow-up|0
1459686|NCT00762970|4813113|P2|Overall Study|Lost to Follow-up|2
1459687|NCT00762970|4813114|P1|Overall Study|Lost to Follow-up|1
1459688|NCT00762970|4813112|P3|Overall Study|Protocol Violation|1
1459689|NCT00762970|4813113|P2|Overall Study|Protocol Violation|1
1459690|NCT00762970|4813114|P1|Overall Study|Protocol Violation|3
1459691|NCT00762970|4813112|P3|Overall Study|Withdrawal by Subject|0
1459692|NCT00762970|4813113|P2|Overall Study|Withdrawal by Subject|4
1459693|NCT00762970|4813114|P1|Overall Study|Withdrawal by Subject|7
1459694|NCT00762892|4813132|P2|Overall Study|Incarceration|0
1459695|NCT00762892|4813133|P1|Overall Study|Incarceration|1
1459696|NCT00762892|4813132|P2|Overall Study|Pregnancy|0
1459697|NCT00762892|4813133|P1|Overall Study|Pregnancy|1
1459698|NCT00762892|4813132|P2|Overall Study|Death|0
1459699|NCT00762892|4813133|P1|Overall Study|Death|1
1459700|NCT00762892|4813132|P2|Overall Study|Withdrawal by Subject|1
1459701|NCT00762892|4813133|P1|Overall Study|Withdrawal by Subject|0
1459702|NCT00762892|4813132|P2|Overall Study|Lost to Follow-up|5
1459703|NCT00762892|4813133|P1|Overall Study|Lost to Follow-up|2
1459704|NCT00762788|4813162|P6|Overall Study|Lost to Follow-up|21
1459705|NCT00762788|4813163|P5|Overall Study|Lost to Follow-up|13
1459706|NCT00762788|4813164|P4|Overall Study|Lost to Follow-up|26
1459707|NCT00762788|4813165|P3|Overall Study|Lost to Follow-up|21
1459708|NCT00762788|4813166|P2|Overall Study|Lost to Follow-up|37
1459709|NCT00762788|4813167|P1|Overall Study|Lost to Follow-up|26
1459710|NCT00762762|4813189|P2|Overall Study|Did not report for appointments|10
1459711|NCT00762762|4813190|P1|Overall Study|Did not report for appointments|8
1459712|NCT00762723|4813207|P3|Overall Study|Study Terminated slow enrollement|3
1459713|NCT00762723|4813208|P2|Overall Study|Study Terminated slow enrollement|5
1459714|NCT00762723|4813209|P1|Overall Study|Study Terminated slow enrollement|5
1459715|NCT00762606|4813373|P2|Overall Study|Lost to Follow-up|13
1459716|NCT00762606|4813374|P1|Overall Study|Lost to Follow-up|18
1459717|NCT00762502|4813419|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
1459718|NCT00762502|4813420|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
1459719|NCT00762502|4813421|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
1459720|NCT00762502|4813419|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
1459721|NCT00762502|4813420|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
1459722|NCT00762502|4813421|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
1459723|NCT00762502|4813419|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
1459724|NCT00762502|4813420|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
1459725|NCT00762502|4813421|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
1459726|NCT00762476|4813435|P2|Overall Study|Seasonal allergies|0
1459727|NCT00762476|4813436|P1|Overall Study|Seasonal allergies|1
1459728|NCT00762476|4813435|P2|Overall Study|non-compliance with study visits|2
1459729|NCT00762476|4813436|P1|Overall Study|non-compliance with study visits|0
1459730|NCT00762476|4813435|P2|Overall Study|antibiotic use|1
1459731|NCT00762476|4813436|P1|Overall Study|antibiotic use|0
1459732|NCT00762476|4813435|P2|Overall Study|Withdrawal by Subject|12
1459733|NCT00762476|4813436|P1|Overall Study|Withdrawal by Subject|6
1459734|NCT00762476|4813435|P2|Overall Study|Physician Decision|14
1459735|NCT00762476|4813436|P1|Overall Study|Physician Decision|2
1459736|NCT00762476|4813435|P2|Overall Study|Protocol Violation|6
1459737|NCT00762476|4813436|P1|Overall Study|Protocol Violation|5
1459738|NCT00762476|4813435|P2|Overall Study|Lost to Follow-up|0
1459739|NCT00762476|4813436|P1|Overall Study|Lost to Follow-up|2
1459740|NCT00762476|4813435|P2|Overall Study|Adverse Event|1
1459741|NCT00762476|4813436|P1|Overall Study|Adverse Event|7
1459742|NCT00762463|4813448|P4|Extension Phase (Week 6 to Week 12)|Not specified|1
1459743|NCT00762463|4813449|P3|Extension Phase (Week 6 to Week 12)|Not specified|0
1459744|NCT00762463|4813450|P2|Extension Phase (Week 6 to Week 12)|Not specified|0
1459745|NCT00762463|4813451|P1|Extension Phase (Week 6 to Week 12)|Not specified|0
1459746|NCT00762463|4813448|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
1459747|NCT00762463|4813449|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
1459748|NCT00762463|4813450|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
1459749|NCT00762463|4813451|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
1459750|NCT00762463|4813448|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
1459751|NCT00762463|4813449|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
1459752|NCT00762463|4813450|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
1459753|NCT00762463|4813451|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
1459754|NCT00762463|4813448|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
1459755|NCT00762463|4813449|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
1459756|NCT00762463|4813450|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
1459757|NCT00762463|4813451|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
1459758|NCT00762463|4813448|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
1459759|NCT00762463|4813449|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
1459760|NCT00762463|4813450|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
1459761|NCT00762463|4813451|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
1459762|NCT00762463|4813448|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
1459763|NCT00762463|4813449|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
1459764|NCT00762463|4813450|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
1459765|NCT00762463|4813451|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
1459766|NCT00762463|4813448|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
1459767|NCT00762463|4813449|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
1459768|NCT00762463|4813450|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
1459769|NCT00762463|4813451|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
1459770|NCT00762463|4813448|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
1459771|NCT00762463|4813449|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
1459772|NCT00762463|4813450|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
1459773|NCT00762463|4813451|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
1459774|NCT00762411|4813557|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
1459775|NCT00762411|4813558|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
1459776|NCT00762411|4813557|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
1459777|NCT00762411|4813558|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
1459778|NCT00762411|4813557|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
1459779|NCT00762411|4813558|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
1459780|NCT00762411|4813557|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
1459781|NCT00762411|4813558|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
1459782|NCT00762411|4813557|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
1459783|NCT00762411|4813558|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
1459784|NCT00762411|4813557|P2|Safety Follow Up (SFU)-Optional|Death|8
1459785|NCT00762411|4813558|P1|Safety Follow Up (SFU)-Optional|Death|1
1459786|NCT00762411|4813557|P2|Delayed Start|Caregiver Decision|1
1459787|NCT00762411|4813558|P1|Delayed Start|Caregiver Decision|1
1459788|NCT00762411|4813557|P2|Delayed Start|Sponsor Decision|20
1459789|NCT00762411|4813558|P1|Delayed Start|Sponsor Decision|16
1459790|NCT00762411|4813557|P2|Delayed Start|Protocol Violation|1
1459791|NCT00762411|4813558|P1|Delayed Start|Protocol Violation|0
1459792|NCT00762411|4813557|P2|Delayed Start|Adverse Event|4
1459793|NCT00762411|4813558|P1|Delayed Start|Adverse Event|0
1459794|NCT00762411|4813557|P2|Initial Treatment|Entry Criteria Exclusion|1
1459795|NCT00762411|4813558|P1|Initial Treatment|Entry Criteria Exclusion|0
1459796|NCT00762411|4813557|P2|Initial Treatment|Abnormal Lab/ECG Result|4
1459797|NCT00762411|4813558|P1|Initial Treatment|Abnormal Lab/ECG Result|6
1459798|NCT00762411|4813557|P2|Initial Treatment|Caregiver Decision|16
1459799|NCT00762411|4813558|P1|Initial Treatment|Caregiver Decision|21
1459800|NCT00762411|4813557|P2|Initial Treatment|Lost to Follow-up|0
1459801|NCT00762411|4813558|P1|Initial Treatment|Lost to Follow-up|5
1459802|NCT00762411|4813557|P2|Initial Treatment|Sponsor Decision|401
1459803|NCT00762411|4813558|P1|Initial Treatment|Sponsor Decision|293
1459804|NCT00762411|4813557|P2|Initial Treatment|Physician Decision|0
1459805|NCT00762411|4813558|P1|Initial Treatment|Physician Decision|1
1459806|NCT00762411|4813557|P2|Initial Treatment|Withdrawal by Subject|52
1459807|NCT00762411|4813558|P1|Initial Treatment|Withdrawal by Subject|65
1459808|NCT00762411|4813557|P2|Initial Treatment|Protocol Violation|1
1459809|NCT00762411|4813558|P1|Initial Treatment|Protocol Violation|4
1459810|NCT00762411|4813557|P2|Initial Treatment|Adverse Event|40
1459811|NCT00762411|4813558|P1|Initial Treatment|Adverse Event|132
1459812|NCT00762411|4813557|P2|Initial Treatment|Death|6
1459813|NCT00762411|4813558|P1|Initial Treatment|Death|7
1459814|NCT00762385|4813622|P2|Second Intervention|Protocol Violation|3
1459815|NCT00762385|4813623|P1|Second Intervention|Protocol Violation|3
1459816|NCT00762385|4813622|P2|First Intervention|Protocol Violation|1
1459817|NCT00762385|4813623|P1|First Intervention|Protocol Violation|0
1459818|NCT00762385|4813622|P2|First Intervention|Ineligible|0
1459819|NCT00762385|4813623|P1|First Intervention|Ineligible|1
1459820|NCT00762385|4813622|P2|First Intervention|Lost to Follow-up|2
1459821|NCT00762385|4813623|P1|First Intervention|Lost to Follow-up|0
1459822|NCT00762385|4813622|P2|First Intervention|Lens Issue|1
1459823|NCT00762385|4813623|P1|First Intervention|Lens Issue|1
1459824|NCT00762359|4813635|P2|Overall Study|Withdrew consent|0
1459825|NCT00762359|4813636|P1|Overall Study|Withdrew consent|1
1459826|NCT00762359|4813635|P2|Overall Study|Removal|1
1459827|NCT00762359|4813636|P1|Overall Study|Removal|0
1459828|NCT00762359|4813635|P2|Overall Study|Physician Decision|3
1459829|NCT00762359|4813636|P1|Overall Study|Physician Decision|2
1459830|NCT00762359|4813635|P2|Overall Study|Institution closed|3
1459831|NCT00762359|4813636|P1|Overall Study|Institution closed|2
1459832|NCT00762359|4813635|P2|Overall Study|Lack of Efficacy|4
1459833|NCT00762359|4813636|P1|Overall Study|Lack of Efficacy|0
1459834|NCT00762359|4813635|P2|Overall Study|Withdrawal by Subject|10
1459835|NCT00762359|4813636|P1|Overall Study|Withdrawal by Subject|13
1459836|NCT00762359|4813635|P2|Overall Study|Protocol Violation|13
1459837|NCT00762359|4813636|P1|Overall Study|Protocol Violation|21
1459838|NCT00762359|4813635|P2|Overall Study|Adverse Event|23
1459839|NCT00762359|4813636|P1|Overall Study|Adverse Event|20
1459840|NCT00762268|4813753|P2|Overall Study|Protocol Violation|2
1459841|NCT00762268|4813754|P1|Overall Study|Protocol Violation|1
1459842|NCT00762229|4813762|P2|Overall Study|did not recveive intervention|1
1459843|NCT00762229|4813763|P1|Overall Study|did not recveive intervention|0
1459844|NCT00762229|4813762|P2|Overall Study|Lost to Follow-up|1
1459845|NCT00762229|4813763|P1|Overall Study|Lost to Follow-up|1
1459846|NCT00762164|4813860|P2|Overall Study|Withdrawal by Subject|1
1459847|NCT00762164|4813861|P1|Overall Study|Withdrawal by Subject|0
1459848|NCT00762164|4813860|P2|Overall Study|Discontinued medication|0
1459849|NCT00762164|4813861|P1|Overall Study|Discontinued medication|2
1459850|NCT00762164|4813860|P2|Overall Study|Lost to Follow-up|1
1459851|NCT00762164|4813861|P1|Overall Study|Lost to Follow-up|1
1459852|NCT00762086|4813871|P2|Overall Study|Ineligible to participate in the study|0
1459853|NCT00762086|4813872|P1|Overall Study|Ineligible to participate in the study|1
1459854|NCT00762086|4813871|P2|Overall Study|Withdrawal by Subject|2
1459855|NCT00762086|4813872|P1|Overall Study|Withdrawal by Subject|2
1459856|NCT00762086|4813871|P2|Overall Study|Non compliance|0
1459857|NCT00762086|4813872|P1|Overall Study|Non compliance|1
1459858|NCT00762086|4813871|P2|Overall Study|Lost to Follow-up|2
1459859|NCT00762086|4813872|P1|Overall Study|Lost to Follow-up|0
1459860|NCT00762086|4813871|P2|Overall Study|Adverse Event|0
1459861|NCT00762086|4813872|P1|Overall Study|Adverse Event|2
1459862|NCT00762073|4813882|P4|Overall Study|Not on treatment for >/= 77 days|0
1459863|NCT00762073|4813883|P3|Overall Study|Not on treatment for >/= 77 days|0
1459864|NCT00762073|4813884|P2|Overall Study|Not on treatment for >/= 77 days|0
1459865|NCT00762073|4813885|P1|Overall Study|Not on treatment for >/= 77 days|1
1459866|NCT00762073|4813882|P4|Overall Study|Withdrawal by Subject|1
1459867|NCT00762073|4813883|P3|Overall Study|Withdrawal by Subject|1
1459868|NCT00762073|4813884|P2|Overall Study|Withdrawal by Subject|2
1459869|NCT00762073|4813885|P1|Overall Study|Withdrawal by Subject|1
1459870|NCT00762073|4813882|P4|Overall Study|Significant Subject Noncompliance|1
1459871|NCT00762073|4813883|P3|Overall Study|Significant Subject Noncompliance|0
1459872|NCT00762073|4813884|P2|Overall Study|Significant Subject Noncompliance|1
1459873|NCT00762073|4813885|P1|Overall Study|Significant Subject Noncompliance|0
1459874|NCT00762073|4813882|P4|Overall Study|Adverse Event|1
1459875|NCT00762073|4813883|P3|Overall Study|Adverse Event|1
1459876|NCT00762073|4813884|P2|Overall Study|Adverse Event|0
1459877|NCT00762073|4813885|P1|Overall Study|Adverse Event|1
1459878|NCT00762073|4813882|P4|Overall Study|Lack of Efficacy|0
1459879|NCT00762073|4813883|P3|Overall Study|Lack of Efficacy|0
1459880|NCT00762073|4813884|P2|Overall Study|Lack of Efficacy|1
1459881|NCT00762073|4813885|P1|Overall Study|Lack of Efficacy|1
1459882|NCT00762034|4813949|P2|Maintenance Period|Other|1
1459883|NCT00762034|4813950|P1|Maintenance Period|Other|1
1459884|NCT00762034|4813949|P2|Maintenance Period|Death due to study disease|3
1459885|NCT00762034|4813950|P1|Maintenance Period|Death due to study disease|3
1459886|NCT00762034|4813949|P2|Maintenance Period|Death not due to study disease|5
1459887|NCT00762034|4813950|P1|Maintenance Period|Death not due to study disease|2
1459888|NCT00762034|4813949|P2|Maintenance Period|Withdrawal by Subject|14
1459889|NCT00762034|4813950|P1|Maintenance Period|Withdrawal by Subject|34
1459890|NCT00762034|4813949|P2|Maintenance Period|Physician Decision|20
1459891|NCT00762034|4813950|P1|Maintenance Period|Physician Decision|25
1459892|NCT00762034|4813949|P2|Maintenance Period|Progressive Disease|224
1459893|NCT00762034|4813950|P1|Maintenance Period|Progressive Disease|186
1459894|NCT00762034|4813949|P2|Maintenance Period|Adverse Event|26
1459895|NCT00762034|4813950|P1|Maintenance Period|Adverse Event|42
1459896|NCT00762034|4813949|P2|Maintenance Period|Entry Criterion Not Met|2
1459897|NCT00762034|4813950|P1|Maintenance Period|Entry Criterion Not Met|0
1459898|NCT00762034|4813949|P2|Maintenance Period|Protocol Violation|3
1459899|NCT00762034|4813950|P1|Maintenance Period|Protocol Violation|1
1459900|NCT00762034|4813949|P2|Induction Period|Deaths Due to Study Disease|9
1459901|NCT00762034|4813950|P1|Induction Period|Deaths Due to Study Disease|9
1459902|NCT00762034|4813949|P2|Induction Period|Deaths Not Due to Study Disease|14
1459903|NCT00762034|4813950|P1|Induction Period|Deaths Not Due to Study Disease|19
1459904|NCT00762034|4813949|P2|Induction Period|Withdrawal by Subject|19
1459905|NCT00762034|4813950|P1|Induction Period|Withdrawal by Subject|15
1459906|NCT00762034|4813949|P2|Induction Period|Physician Decision|20
1459907|NCT00762034|4813950|P1|Induction Period|Physician Decision|21
1459908|NCT00762034|4813949|P2|Induction Period|Progressive Disease|55
1459909|NCT00762034|4813950|P1|Induction Period|Progressive Disease|73
1459910|NCT00762034|4813949|P2|Induction Period|Lost to Follow-up|1
1459911|NCT00762034|4813950|P1|Induction Period|Lost to Follow-up|1
1459912|NCT00762034|4813949|P2|Induction Period|Adverse Event|38
1459913|NCT00762034|4813950|P1|Induction Period|Adverse Event|27
1459914|NCT00762034|4813949|P2|Induction Period|Entry Criterion Not Met|11
1459915|NCT00762034|4813950|P1|Induction Period|Entry Criterion Not Met|12
1459916|NCT00762034|4813949|P2|Induction Period|Protocol Violation|2
1459917|NCT00762034|4813950|P1|Induction Period|Protocol Violation|1
1459918|NCT00761969|4814022|P2|Overall Study|Lost to Follow-up|93
1459919|NCT00761969|4814023|P1|Overall Study|Lost to Follow-up|88
1459920|NCT00761969|4814022|P2|Overall Study|Death|47
1459921|NCT00761969|4814023|P1|Overall Study|Death|112
1459922|NCT00761956|4814033|P2|Overall Study|Adverse Event|34
1459923|NCT00761956|4814034|P1|Overall Study|Adverse Event|26
1459924|NCT00761956|4814033|P2|Overall Study|Death|1
1459925|NCT00761956|4814034|P1|Overall Study|Death|0
1459926|NCT00761956|4814033|P2|Overall Study|Withdrawal by Subject|8
1459927|NCT00761956|4814034|P1|Overall Study|Withdrawal by Subject|3
1459928|NCT00761956|4814033|P2|Overall Study|Lost to Follow-up|11
1459929|NCT00761956|4814034|P1|Overall Study|Lost to Follow-up|6
1459930|NCT00761865|4814063|P2|Overall Study|Lost to Follow-up|7
1459931|NCT00761865|4814064|P1|Overall Study|Lost to Follow-up|8
1459932|NCT00761774|4814085|P1|Overall Study|IP stopped by hospital physician|1
1459933|NCT00761774|4814085|P1|Overall Study|Subject IP non-compliance|1
1459934|NCT00761774|4814085|P1|Overall Study|Coordinator leaving site|1
1459935|NCT00761774|4814085|P1|Overall Study|Patient moved out of study area|1
1459936|NCT00761774|4814085|P1|Overall Study|Investigator clinical judgement|1
1459937|NCT00761774|4814085|P1|Overall Study|Sponsor decision|1
1459938|NCT00761774|4814085|P1|Overall Study|Medical decision to read SUSAR reports|1
1459939|NCT00761774|4814085|P1|Overall Study|Reclassification of seizures|1
1459940|NCT00761774|4814085|P1|Overall Study|End of study|2
1459941|NCT00761774|4814085|P1|Overall Study|Non-compliance|4
1459942|NCT00761774|4814085|P1|Overall Study|Withdrawal by Subject|9
1459943|NCT00761774|4814085|P1|Overall Study|Lost to Follow-up|2
1459944|NCT00761774|4814085|P1|Overall Study|Lack of Efficacy|37
1459945|NCT00761774|4814085|P1|Overall Study|Adverse Event|17
1459946|NCT00761761|4814096|P2|Overall Study|Withdrawal by Subject|0
1459947|NCT00761761|4814097|P1|Overall Study|Withdrawal by Subject|3
1459948|NCT00761761|4814096|P2|Overall Study|Lost to Follow-up|1
1459949|NCT00761761|4814097|P1|Overall Study|Lost to Follow-up|3
1459950|NCT00761748|4814109|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
1459951|NCT00761748|4814110|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
1459952|NCT00761748|4814109|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
1459953|NCT00761748|4814110|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
1459954|NCT00761735|4814116|P1|Overall Study|Administrative|1
1459955|NCT00761735|4814116|P1|Overall Study|Non-compliance with protocol|1
1459956|NCT00761735|4814116|P1|Overall Study|Withdrawal by Subject|6
1459957|NCT00761735|4814116|P1|Overall Study|Lost to Follow-up|6
1459958|NCT00761631|4814132|P6|Overall Study|Other|1
1459959|NCT00761631|4814133|P5|Overall Study|Other|1
1459960|NCT00761631|4814134|P4|Overall Study|Other|0
1459961|NCT00761631|4814135|P3|Overall Study|Other|0
1459962|NCT00761631|4814136|P2|Overall Study|Other|0
1459963|NCT00761631|4814137|P1|Overall Study|Other|0
1459964|NCT00761631|4814132|P6|Overall Study|Physician Decision|0
1459965|NCT00761631|4814133|P5|Overall Study|Physician Decision|0
1459966|NCT00761631|4814134|P4|Overall Study|Physician Decision|0
1459967|NCT00761631|4814135|P3|Overall Study|Physician Decision|0
1459968|NCT00761631|4814136|P2|Overall Study|Physician Decision|0
1459969|NCT00761631|4814137|P1|Overall Study|Physician Decision|1
1459970|NCT00761631|4814132|P6|Overall Study|Failed to return|2
1459971|NCT00761631|4814133|P5|Overall Study|Failed to return|5
1459972|NCT00761631|4814134|P4|Overall Study|Failed to return|1
1459973|NCT00761631|4814135|P3|Overall Study|Failed to return|1
1459974|NCT00761631|4814136|P2|Overall Study|Failed to return|0
1459975|NCT00761631|4814137|P1|Overall Study|Failed to return|1
1459976|NCT00761631|4814132|P6|Overall Study|Randomized, not treated|0
1459977|NCT00761631|4814133|P5|Overall Study|Randomized, not treated|0
1459978|NCT00761631|4814134|P4|Overall Study|Randomized, not treated|0
1459979|NCT00761631|4814135|P3|Overall Study|Randomized, not treated|0
1459980|NCT00761631|4814136|P2|Overall Study|Randomized, not treated|0
1459981|NCT00761631|4814137|P1|Overall Study|Randomized, not treated|1
1459982|NCT00761631|4814132|P6|Overall Study|Protocol Violation|1
1459983|NCT00761631|4814133|P5|Overall Study|Protocol Violation|5
1459984|NCT00761631|4814134|P4|Overall Study|Protocol Violation|1
1459985|NCT00761631|4814135|P3|Overall Study|Protocol Violation|0
1459986|NCT00761631|4814136|P2|Overall Study|Protocol Violation|0
1459987|NCT00761631|4814137|P1|Overall Study|Protocol Violation|2
1459988|NCT00761631|4814132|P6|Overall Study|Lost to Follow-up|1
1459989|NCT00761631|4814133|P5|Overall Study|Lost to Follow-up|6
1459990|NCT00761631|4814134|P4|Overall Study|Lost to Follow-up|1
1459991|NCT00761631|4814135|P3|Overall Study|Lost to Follow-up|7
1459992|NCT00761631|4814136|P2|Overall Study|Lost to Follow-up|4
1459993|NCT00761631|4814137|P1|Overall Study|Lost to Follow-up|2
1459994|NCT00761631|4814132|P6|Overall Study|Parent/legal guardian request|0
1459995|NCT00761631|4814133|P5|Overall Study|Parent/legal guardian request|5
1459996|NCT00761631|4814134|P4|Overall Study|Parent/legal guardian request|0
1459997|NCT00761631|4814135|P3|Overall Study|Parent/legal guardian request|8
1459998|NCT00761631|4814136|P2|Overall Study|Parent/legal guardian request|3
1459999|NCT00761631|4814137|P1|Overall Study|Parent/legal guardian request|8
1460000|NCT00761605|4814172|P1|Overall Study|Other|21
1460001|NCT00761605|4814172|P1|Overall Study|Withdrawal by Subject|37
1460002|NCT00761605|4814172|P1|Overall Study|Lost to Follow-up|29
1460003|NCT00761605|4814172|P1|Overall Study|Lack of Efficacy|26
1460004|NCT00761605|4814172|P1|Overall Study|Death|2
1460005|NCT00761605|4814172|P1|Overall Study|Adverse Event|26
1460006|NCT00761579|4814216|P1|Overall Study|Intake of prohibited concomitant drug|1
1460007|NCT00761579|4814216|P1|Overall Study|Lost survey form|1
1460008|NCT00761579|4814216|P1|Overall Study|Aggravation of symptoms by changing drug|1
1460009|NCT00761579|4814216|P1|Overall Study|Aggravation of depression|1
1460010|NCT00761579|4814216|P1|Overall Study|Drug overdose|1
1460011|NCT00761579|4814216|P1|Overall Study|Protocol deviation|1
1460012|NCT00761579|4814216|P1|Overall Study|Lack of compliance|2
1460013|NCT00761579|4814216|P1|Overall Study|Withdrawal by Subject|34
1460014|NCT00761579|4814216|P1|Overall Study|Pregnancy|1
1460015|NCT00761579|4814216|P1|Overall Study|Lost to Follow-up|16
1460016|NCT00761579|4814216|P1|Overall Study|Lack of Efficacy|21
1460017|NCT00761579|4814216|P1|Overall Study|Death|2
1460018|NCT00761579|4814216|P1|Overall Study|Adverse Event|10
1460019|NCT00761527|4814249|P1|Overall Study|Unknown reason|2
1460020|NCT00761527|4814249|P1|Overall Study|Lost to Follow-up|9
1460021|NCT00761527|4814249|P1|Overall Study|Poor Compliance|8
1460022|NCT00761527|4814249|P1|Overall Study|Adverse Event|3
1460023|NCT00761514|4814256|P1|Overall Study|Unable to pay for medications|1
1460024|NCT00761514|4814256|P1|Overall Study|Problem complying with study visit|1
1460025|NCT00761514|4814256|P1|Overall Study|Health insurance didn't cover study drug|1
1460026|NCT00761514|4814256|P1|Overall Study|Lost to Follow-up|1
1460027|NCT00761514|4814256|P1|Overall Study|Withdrawal by Subject|2
1460028|NCT00761514|4814256|P1|Overall Study|Adverse Event|1
1460029|NCT00761462|4814263|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
1460030|NCT00761462|4814264|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
1460031|NCT00761462|4814263|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
1460032|NCT00761462|4814264|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
1460033|NCT00761462|4814263|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
1460034|NCT00761462|4814264|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
1460035|NCT00761462|4814263|P2|Treatment|Subjects never received study medication|12
1460036|NCT00761462|4814264|P1|Treatment|Subjects never received study medication|23
1460037|NCT00761319|4814278|P2|Overall Study|Missing|0
1460038|NCT00761319|4814279|P1|Overall Study|Missing|1
1460039|NCT00761319|4814278|P2|Overall Study|Nonspecified|2
1460040|NCT00761319|4814279|P1|Overall Study|Nonspecified|2
1460041|NCT00761319|4814278|P2|Overall Study|Lost to Follow-up|1
1460042|NCT00761319|4814279|P1|Overall Study|Lost to Follow-up|1
1460043|NCT00761319|4814278|P2|Overall Study|Noncompliance|3
1460044|NCT00761319|4814279|P1|Overall Study|Noncompliance|4
1460045|NCT00761319|4814278|P2|Overall Study|Withdrawal by Subject|7
1460046|NCT00761319|4814279|P1|Overall Study|Withdrawal by Subject|8
1460047|NCT00761319|4814278|P2|Overall Study|Adverse Event|7
1460048|NCT00761319|4814279|P1|Overall Study|Adverse Event|11
1460049|NCT00761319|4814278|P2|Overall Study|Protocol Violation|14
1460050|NCT00761319|4814279|P1|Overall Study|Protocol Violation|21
1460051|NCT00761306|4814287|P1|Overall Study|Administrative or Other Reasons|5
1460052|NCT00761306|4814287|P1|Overall Study|Lost to Follow-up|1
1460053|NCT00761306|4814287|P1|Overall Study|Withdrawal of Consent|3
1460054|NCT00761306|4814287|P1|Overall Study|Protocol Violation|2
1460055|NCT00761306|4814287|P1|Overall Study|Lack of Efficacy|4
1460056|NCT00761306|4814287|P1|Overall Study|Adverse Event|5
1460057|NCT00761280|4814298|P2|First Dose to End of Study|Lost to Follow-up|1
1460058|NCT00761280|4814299|P1|First Dose to End of Study|Lost to Follow-up|0
1460059|NCT00761280|4814298|P2|First Dose to End of Study|Death|0
1460060|NCT00761280|4814299|P1|First Dose to End of Study|Death|1
1460061|NCT00761280|4814298|P2|First Dose to End of Study|Sponsor decision|2
1460062|NCT00761280|4814299|P1|First Dose to End of Study|Sponsor decision|1
1460063|NCT00761280|4814298|P2|First Dose to End of Study|Progressive disease|3
1460064|NCT00761280|4814299|P1|First Dose to End of Study|Progressive disease|5
1460065|NCT00761280|4814298|P2|First Dose to End of Study|End of trial|5
1460066|NCT00761280|4814299|P1|First Dose to End of Study|End of trial|5
1460067|NCT00761280|4814298|P2|Randomization to First Dose|Other|0
1460068|NCT00761280|4814299|P1|Randomization to First Dose|Other|1
1460069|NCT00761280|4814298|P2|Randomization to First Dose|Sponsor decision|0
1460070|NCT00761280|4814299|P1|Randomization to First Dose|Sponsor decision|1
1460071|NCT00761280|4814298|P2|Randomization to First Dose|Withdrawal by Subject|2
1460072|NCT00761280|4814299|P1|Randomization to First Dose|Withdrawal by Subject|0
1460073|NCT00761215|4814330|P3|Overall Study|Bacteremia|0
1460074|NCT00761215|4814331|P2|Overall Study|Bacteremia|0
1460075|NCT00761215|4814332|P1|Overall Study|Bacteremia|1
1460076|NCT00761215|4814330|P3|Overall Study|Withdrawal by Subject|0
1460077|NCT00761215|4814331|P2|Overall Study|Withdrawal by Subject|0
1460078|NCT00761215|4814332|P1|Overall Study|Withdrawal by Subject|1
1460079|NCT00761215|4814330|P3|Overall Study|Lost to Follow-up|6
1460080|NCT00761215|4814331|P2|Overall Study|Lost to Follow-up|3
1460081|NCT00761215|4814332|P1|Overall Study|Lost to Follow-up|6
1460082|NCT00761215|4814330|P3|Overall Study|Randomized but didn't receive drug|2
1460083|NCT00761215|4814331|P2|Overall Study|Randomized but didn't receive drug|1
1460084|NCT00761215|4814332|P1|Overall Study|Randomized but didn't receive drug|1
1460085|NCT00761189|4814374|P1|Overall Study|Other|13
1460086|NCT00761189|4814374|P1|Overall Study|Withdrawal by Subject|49
1460087|NCT00761189|4814374|P1|Overall Study|Lost to Follow-up|36
1460088|NCT00761189|4814374|P1|Overall Study|Lack of Efficacy|45
1460089|NCT00761189|4814374|P1|Overall Study|Adverse Event|42
1460090|NCT00761176|4814391|P2|Overall Study|Withdrawal by Subject|1
1460091|NCT00761176|4814392|P1|Overall Study|Withdrawal by Subject|1
1460092|NCT00761176|4814391|P2|Overall Study|Death|0
1460093|NCT00761176|4814392|P1|Overall Study|Death|1
1460094|NCT00761150|4814401|P3|Double-blind Period|Not specified|3
1460095|NCT00761150|4814402|P2|Double-blind Period|Not specified|3
1460096|NCT00761150|4814403|P1|Double-blind Period|Not specified|0
1460097|NCT00761150|4814401|P3|Double-blind Period|Noncompliance|0
1460098|NCT00761150|4814402|P2|Double-blind Period|Noncompliance|1
1460099|NCT00761150|4814403|P1|Double-blind Period|Noncompliance|0
1460100|NCT00761150|4814401|P3|Double-blind Period|Did not meet DB randomization criteria|1
1460101|NCT00761150|4814402|P2|Double-blind Period|Did not meet DB randomization criteria|0
1460102|NCT00761150|4814403|P1|Double-blind Period|Did not meet DB randomization criteria|0
1460103|NCT00761150|4814401|P3|Double-blind Period|Lost to Follow-up|1
1460104|NCT00761150|4814402|P2|Double-blind Period|Lost to Follow-up|2
1460105|NCT00761150|4814403|P1|Double-blind Period|Lost to Follow-up|0
1460106|NCT00761150|4814401|P3|Double-blind Period|Withdrawal by Subject|2
1460107|NCT00761150|4814402|P2|Double-blind Period|Withdrawal by Subject|3
1460108|NCT00761150|4814403|P1|Double-blind Period|Withdrawal by Subject|0
1460109|NCT00761150|4814401|P3|Double-blind Period|Adverse Event|3
1460110|NCT00761150|4814402|P2|Double-blind Period|Adverse Event|3
1460111|NCT00761150|4814403|P1|Double-blind Period|Adverse Event|0
1460112|NCT00761150|4814401|P3|Double-blind Period|Lack of Efficacy|19
1460113|NCT00761150|4814402|P2|Double-blind Period|Lack of Efficacy|2
1460114|NCT00761150|4814403|P1|Double-blind Period|Lack of Efficacy|0
1460115|NCT00761150|4814401|P3|Open-label Period|Not specified|0
1460116|NCT00761150|4814402|P2|Open-label Period|Not specified|0
1460117|NCT00761150|4814403|P1|Open-label Period|Not specified|5
1460118|NCT00761150|4814401|P3|Open-label Period|Noncompliance|0
1460119|NCT00761150|4814402|P2|Open-label Period|Noncompliance|0
1460120|NCT00761150|4814403|P1|Open-label Period|Noncompliance|2
1460121|NCT00761150|4814401|P3|Open-label Period|Withdrawal by Subject|0
1460122|NCT00761150|4814402|P2|Open-label Period|Withdrawal by Subject|0
1460123|NCT00761150|4814403|P1|Open-label Period|Withdrawal by Subject|5
1460124|NCT00761150|4814401|P3|Open-label Period|Lack of Efficacy|0
1460125|NCT00761150|4814402|P2|Open-label Period|Lack of Efficacy|0
1460126|NCT00761150|4814403|P1|Open-label Period|Lack of Efficacy|4
1460127|NCT00761150|4814401|P3|Open-label Period|Lost to Follow-up|0
1460128|NCT00761150|4814402|P2|Open-label Period|Lost to Follow-up|0
1460129|NCT00761150|4814403|P1|Open-label Period|Lost to Follow-up|7
1460130|NCT00761150|4814401|P3|Open-label Period|Did not meet DB randomization criteria|0
1460131|NCT00761150|4814402|P2|Open-label Period|Did not meet DB randomization criteria|0
1460132|NCT00761150|4814403|P1|Open-label Period|Did not meet DB randomization criteria|11
1460133|NCT00761150|4814401|P3|Open-label Period|Adverse Event|0
1460134|NCT00761150|4814402|P2|Open-label Period|Adverse Event|0
1460135|NCT00761150|4814403|P1|Open-label Period|Adverse Event|36
1460136|NCT00760877|4814454|P2|Overall Study|Treatment failure|0
1460137|NCT00760877|4814455|P1|Overall Study|Treatment failure|1
1460138|NCT00760877|4814454|P2|Overall Study|Participants transferred to AMN107A2408|1
1460139|NCT00760877|4814455|P1|Overall Study|Participants transferred to AMN107A2408|11
1460140|NCT00760877|4814454|P2|Overall Study|Physician Decision|2
1460141|NCT00760877|4814455|P1|Overall Study|Physician Decision|1
1460142|NCT00760877|4814454|P2|Overall Study|Participant not eligible to cross-over|1
1460143|NCT00760877|4814455|P1|Overall Study|Participant not eligible to cross-over|0
1460144|NCT00760877|4814454|P2|Overall Study|Participant diagnosed with AML|1
1460145|NCT00760877|4814455|P1|Overall Study|Participant diagnosed with AML|0
1460146|NCT00760877|4814454|P2|Overall Study|Adverse Event|12
1460147|NCT00760877|4814455|P1|Overall Study|Adverse Event|19
1460148|NCT00760877|4814454|P2|Overall Study|Withdrawal by Subject|3
1460149|NCT00760877|4814455|P1|Overall Study|Withdrawal by Subject|7
1460150|NCT00760877|4814454|P2|Overall Study|Death|1
1460151|NCT00760877|4814455|P1|Overall Study|Death|2
1460152|NCT00760877|4814454|P2|Overall Study|Pregnancy|4
1460153|NCT00760877|4814455|P1|Overall Study|Pregnancy|1
1460154|NCT00760877|4814454|P2|Overall Study|Non-compliance with protocol treatment|1
1460155|NCT00760877|4814455|P1|Overall Study|Non-compliance with protocol treatment|2
1460156|NCT00760877|4814454|P2|Overall Study|Protocol Violation|0
1460157|NCT00760877|4814455|P1|Overall Study|Protocol Violation|1
1460158|NCT00760838|4814473|P2|Overall Study|Withdrawal by Subject|1
1460159|NCT00760838|4814474|P1|Overall Study|Withdrawal by Subject|1
1460160|NCT00760838|4814473|P2|Overall Study|Lost to Follow-up|0
1460161|NCT00760838|4814474|P1|Overall Study|Lost to Follow-up|2
1460162|NCT00760838|4814473|P2|Overall Study|Lack of Efficacy|0
1460163|NCT00760838|4814474|P1|Overall Study|Lack of Efficacy|1
1460164|NCT00760838|4814473|P2|Overall Study|Adverse Event|1
1460165|NCT00760838|4814474|P1|Overall Study|Adverse Event|1
1460166|NCT00760747|4814492|P2|Study Period III|Physician Decision|1
1460167|NCT00760747|4814493|P1|Study Period III|Physician Decision|0
1460168|NCT00760747|4814492|P2|Study Period III|Protocol Violation|1
1460169|NCT00760747|4814493|P1|Study Period III|Protocol Violation|1
1460170|NCT00760747|4814492|P2|Study Period III|Parent/Caregiver Decision|1
1460171|NCT00760747|4814493|P1|Study Period III|Parent/Caregiver Decision|0
1460172|NCT00760747|4814492|P2|Study Period III|Lack of Efficacy|0
1460173|NCT00760747|4814493|P1|Study Period III|Lack of Efficacy|1
1460174|NCT00760747|4814492|P2|Study Period III|Adverse Event|0
1460175|NCT00760747|4814493|P1|Study Period III|Adverse Event|1
1460176|NCT00760747|4814492|P2|Study Period II|No drug administered|1
1460177|NCT00760747|4814493|P1|Study Period II|No drug administered|0
1460178|NCT00760747|4814492|P2|Study Period II|Withdrawal by Subject|0
1460179|NCT00760747|4814493|P1|Study Period II|Withdrawal by Subject|1
1460180|NCT00760747|4814492|P2|Study Period II|Protocol Violation|3
1460181|NCT00760747|4814493|P1|Study Period II|Protocol Violation|6
1460182|NCT00760747|4814492|P2|Study Period II|Parent/Caregiver Decision|0
1460183|NCT00760747|4814493|P1|Study Period II|Parent/Caregiver Decision|3
1460184|NCT00760747|4814492|P2|Study Period II|Lack of Efficacy|6
1460185|NCT00760747|4814493|P1|Study Period II|Lack of Efficacy|0
1460186|NCT00760747|4814492|P2|Study Period II|Adverse Event|4
1460187|NCT00760747|4814493|P1|Study Period II|Adverse Event|3
1460188|NCT00760669|4814521|P1|Overall Study|Took drug before entering in contract|5
1460189|NCT00760669|4814521|P1|Overall Study|Participants with overlapping cases|1
1460190|NCT00760669|4814521|P1|Overall Study|Participants missing efficacy assessment|6
1460191|NCT00760669|4814521|P1|Overall Study|Not assessed for overall improvement|18
1460192|NCT00760617|4814538|P3|Overall Study|Lost to Follow-up|5
1460193|NCT00760617|4814539|P2|Overall Study|Lost to Follow-up|0
1460194|NCT00760617|4814540|P1|Overall Study|Lost to Follow-up|0
1460195|NCT00760617|4814538|P3|Overall Study|Adverse Event|0
1460196|NCT00760617|4814539|P2|Overall Study|Adverse Event|2
1460197|NCT00760617|4814540|P1|Overall Study|Adverse Event|5
1460198|NCT00760552|4814654|P2|Overall Study|Lost to Follow-up|10
1460199|NCT00760552|4814655|P1|Overall Study|Lost to Follow-up|11
1460200|NCT00760552|4814654|P2|Overall Study|Death|0
1460201|NCT00760552|4814655|P1|Overall Study|Death|2
1460202|NCT00760487|4814689|P1|Overall Study|Unilateral implantation|3
1460203|NCT00760474|4814695|P2|Period 2 (P2)|Adverse Event|1
1460204|NCT00760474|4814696|P1|Period 2 (P2)|Adverse Event|0
1460205|NCT00760474|4814695|P2|Period 2 (P2)|Lost to Follow-up|0
1460206|NCT00760474|4814696|P1|Period 2 (P2)|Lost to Follow-up|1
1460207|NCT00760474|4814695|P2|Placebo Washout Period|Other|1
1460208|NCT00760474|4814696|P1|Placebo Washout Period|Other|0
1460209|NCT00760474|4814695|P2|Period 1 (P1)|Discontinued then re-entered|1
1460210|NCT00760474|4814696|P1|Period 1 (P1)|Discontinued then re-entered|1
1460211|NCT00760383|4814753|P2|Overall Study|moved away; withdrew; medical reasons|7
1460212|NCT00760383|4814754|P1|Overall Study|moved away; withdrew; medical reasons|5
1460213|NCT00760266|4814766|P2|Overall Study|Administrative Problems|1
1460214|NCT00760266|4814767|P1|Overall Study|Administrative Problems|0
1460215|NCT00760266|4814766|P2|Overall Study|Lost to Follow-up|1
1460216|NCT00760266|4814767|P1|Overall Study|Lost to Follow-up|2
1460217|NCT00760266|4814766|P2|Overall Study|Patient withdrew consent|3
1460218|NCT00760266|4814767|P1|Overall Study|Patient withdrew consent|3
1460219|NCT00760266|4814766|P2|Overall Study|Protocol deviation|4
1460220|NCT00760266|4814767|P1|Overall Study|Protocol deviation|2
1460221|NCT00760266|4814766|P2|Overall Study|Lack of Efficacy|2
1460222|NCT00760266|4814767|P1|Overall Study|Lack of Efficacy|2
1460223|NCT00760266|4814766|P2|Overall Study|Abnormal test procedure result(s)|0
1460224|NCT00760266|4814767|P1|Overall Study|Abnormal test procedure result(s)|1
1460225|NCT00760266|4814766|P2|Overall Study|Abnormal laboratory value(s)|0
1460226|NCT00760266|4814767|P1|Overall Study|Abnormal laboratory value(s)|1
1460227|NCT00760266|4814766|P2|Overall Study|Adverse Event|7
1460228|NCT00760266|4814767|P1|Overall Study|Adverse Event|13
1460229|NCT00760214|4814784|P3|Overall Study|Other|6
1460230|NCT00760214|4814785|P2|Overall Study|Other|4
1460231|NCT00760214|4814786|P1|Overall Study|Other|3
1460232|NCT00760214|4814784|P3|Overall Study|Physician Decision|1
1460233|NCT00760214|4814785|P2|Overall Study|Physician Decision|1
1460234|NCT00760214|4814786|P1|Overall Study|Physician Decision|1
1460235|NCT00760214|4814784|P3|Overall Study|Pregnancy|1
1460236|NCT00760214|4814785|P2|Overall Study|Pregnancy|0
1460237|NCT00760214|4814786|P1|Overall Study|Pregnancy|0
1460238|NCT00760214|4814784|P3|Overall Study|Lack of Efficacy|4
1460239|NCT00760214|4814785|P2|Overall Study|Lack of Efficacy|2
1460240|NCT00760214|4814786|P1|Overall Study|Lack of Efficacy|3
1460241|NCT00760214|4814784|P3|Overall Study|Withdrawal by Subject|13
1460242|NCT00760214|4814785|P2|Overall Study|Withdrawal by Subject|14
1460243|NCT00760214|4814786|P1|Overall Study|Withdrawal by Subject|12
1460244|NCT00760214|4814784|P3|Overall Study|Lost to Follow-up|1
1460245|NCT00760214|4814785|P2|Overall Study|Lost to Follow-up|0
1460246|NCT00760214|4814786|P1|Overall Study|Lost to Follow-up|0
1460247|NCT00760214|4814784|P3|Overall Study|Protocol Violation|3
1460248|NCT00760214|4814785|P2|Overall Study|Protocol Violation|0
1460249|NCT00760214|4814786|P1|Overall Study|Protocol Violation|3
1460250|NCT00760214|4814784|P3|Overall Study|Adverse Event|12
1460251|NCT00760214|4814785|P2|Overall Study|Adverse Event|9
1460252|NCT00760214|4814786|P1|Overall Study|Adverse Event|8
1460253|NCT00760084|4814827|P1|Overall Study|Progressive Disease|3
1460254|NCT00760084|4814827|P1|Overall Study|Withdrawal by Subject|2
1460255|NCT00760084|4814827|P1|Overall Study|Physician Decision|5
1460256|NCT00759954|4814870|P2|Overall Study|Adverse Event|2
1460257|NCT00759954|4814871|P1|Overall Study|Adverse Event|1
1460258|NCT00759954|4814870|P2|Overall Study|Personal reason|0
1460259|NCT00759954|4814871|P1|Overall Study|Personal reason|1
1460260|NCT00759941|4814885|P2|Overall Study|Exited in error by site|1
1460261|NCT00759941|4814886|P1|Overall Study|Exited in error by site|1
1460262|NCT00759941|4814885|P2|Overall Study|Adverse Event|0
1460263|NCT00759941|4814886|P1|Overall Study|Adverse Event|1
1460264|NCT00759941|4814885|P2|Overall Study|Use of medication|0
1460265|NCT00759941|4814886|P1|Overall Study|Use of medication|1
1460266|NCT00759915|4814900|P2|Overall Study|Adverse Event|1
1460267|NCT00759915|4814901|P1|Overall Study|Adverse Event|0
1460268|NCT00759915|4814900|P2|Overall Study|Withdrawal by Subject|0
1460269|NCT00759915|4814901|P1|Overall Study|Withdrawal by Subject|1
1460270|NCT00759902|4814915|P2|Overall Study|Adverse Event|1
1460271|NCT00759902|4814916|P1|Overall Study|Adverse Event|0
1460272|NCT00759863|4814930|P2|Overall Study|Death, moved, or lost contact|18
1460273|NCT00759863|4814931|P1|Overall Study|Death, moved, or lost contact|20
1460274|NCT00759785|4814952|P2|Overall Study|Withdrawal by Subject|1
1460275|NCT00759785|4814953|P1|Overall Study|Withdrawal by Subject|0
1460276|NCT00759785|4814952|P2|Overall Study|Physician Decision|1
1460277|NCT00759785|4814953|P1|Overall Study|Physician Decision|0
1460278|NCT00759785|4814952|P2|Overall Study|Protocol Violation|0
1460279|NCT00759785|4814953|P1|Overall Study|Protocol Violation|1
1460280|NCT00759785|4814952|P2|Overall Study|Participant sample lost|1
1460281|NCT00759785|4814953|P1|Overall Study|Participant sample lost|0
1460282|NCT00759785|4814952|P2|Overall Study|Participant sample not evaluable|2
1460283|NCT00759785|4814953|P1|Overall Study|Participant sample not evaluable|11
1460284|NCT00759759|4814976|P2|Overall Study|Withdrawal by Subject|1
1460285|NCT00759759|4814977|P1|Overall Study|Withdrawal by Subject|2
1460286|NCT00759759|4814976|P2|Overall Study|Didn't receive drug in period 2|0
1460287|NCT00759759|4814977|P1|Overall Study|Didn't receive drug in period 2|1
1460288|NCT00759759|4814976|P2|Overall Study|didn't return for period 2|0
1460289|NCT00759759|4814977|P1|Overall Study|didn't return for period 2|1
1460290|NCT00759681|4814995|P2|Overall Study|Lost to Follow-up|5
1460291|NCT00759681|4814996|P1|Overall Study|Lost to Follow-up|8
1460292|NCT00759681|4814995|P2|Overall Study|Death|5
1460293|NCT00759681|4814996|P1|Overall Study|Death|2
1460294|NCT00759655|4815023|P1|Overall Study|Termination of the study by sponsor|1
1460295|NCT00759564|4815051|P5|Washout Period (at Least 14 Days)|Adverse Event|1
1460296|NCT00759564|4815052|P4|Washout Period (at Least 14 Days)|Adverse Event|0
1460297|NCT00759564|4815053|P3|Washout Period (at Least 14 Days)|Adverse Event|0
1460298|NCT00759564|4815054|P2|Washout Period (at Least 14 Days)|Adverse Event|0
1460299|NCT00759564|4815055|P1|Washout Period (at Least 14 Days)|Adverse Event|0
1460300|NCT00759395|4815225|P2|Overall Study|Lack of Efficacy|2
1460301|NCT00759395|4815226|P1|Overall Study|Lack of Efficacy|0
1460302|NCT00759395|4815225|P2|Overall Study|Withdrawal by Subject|0
1460303|NCT00759395|4815226|P1|Overall Study|Withdrawal by Subject|1
1460304|NCT00759395|4815225|P2|Overall Study|Adverse Event|0
1460305|NCT00759395|4815226|P1|Overall Study|Adverse Event|1
1460306|NCT00759356|4815242|P2|Overall Study|Subject was unable to return|0
1460307|NCT00759356|4815243|P1|Overall Study|Subject was unable to return|1
1460308|NCT00759356|4815242|P2|Overall Study|Withdrawal by Subject|2
1460309|NCT00759356|4815243|P1|Overall Study|Withdrawal by Subject|0
1460310|NCT00759356|4815242|P2|Overall Study|Adverse Event|1
1460311|NCT00759356|4815243|P1|Overall Study|Adverse Event|0
1460312|NCT00759174|4815323|P2|Overall Study|Other|2
1460313|NCT00759174|4815324|P1|Overall Study|Other|0
1460314|NCT00759148|4815348|P2|Overall Study|Reason not given|0
1460315|NCT00759148|4815349|P1|Overall Study|Reason not given|1
1460316|NCT00759148|4815348|P2|Overall Study|Treatment Failure|10
1460317|NCT00759148|4815349|P1|Overall Study|Treatment Failure|6
1460318|NCT00759148|4815348|P2|Overall Study|Lost to Follow-up|9
1460319|NCT00759148|4815349|P1|Overall Study|Lost to Follow-up|3
1460320|NCT00759148|4815348|P2|Overall Study|Withdrawal by Subject|7
1460321|NCT00759148|4815349|P1|Overall Study|Withdrawal by Subject|3
1460322|NCT00759148|4815348|P2|Overall Study|Adverse Event|6
1460323|NCT00759148|4815349|P1|Overall Study|Adverse Event|1
1460324|NCT00759109|4815359|P2|Overall Study|Lost during study|0
1460325|NCT00759109|4815360|P1|Overall Study|Lost during study|1
1460326|NCT00759109|4815359|P2|Overall Study|Participant had a liver transplant|1
1460327|NCT00759109|4815360|P1|Overall Study|Participant had a liver transplant|0
1460328|NCT00759109|4815359|P2|Overall Study|Participant moved to a different city|1
1460329|NCT00759109|4815360|P1|Overall Study|Participant moved to a different city|0
1460330|NCT00759109|4815359|P2|Overall Study|HCV RNA negative|0
1460331|NCT00759109|4815360|P1|Overall Study|HCV RNA negative|1
1460332|NCT00759109|4815359|P2|Overall Study|Started new therapy|6
1460333|NCT00759109|4815360|P1|Overall Study|Started new therapy|2
1460334|NCT00759109|4815359|P2|Overall Study|Lost to Follow-up|6
1460335|NCT00759109|4815360|P1|Overall Study|Lost to Follow-up|4
1460336|NCT00759109|4815359|P2|Overall Study|Death|3
1460337|NCT00759109|4815360|P1|Overall Study|Death|4
1460338|NCT00759109|4815359|P2|Overall Study|Withdrawal by Subject|5
1460339|NCT00759109|4815360|P1|Overall Study|Withdrawal by Subject|9
1460340|NCT00759109|4815359|P2|Overall Study|Inability to comply|1
1460341|NCT00759109|4815360|P1|Overall Study|Inability to comply|1
1460342|NCT00759109|4815359|P2|Overall Study|Adverse Event|12
1460343|NCT00759109|4815360|P1|Overall Study|Adverse Event|17
1460344|NCT00759031|4815382|P2|First Intervention (1 Day)|Screening failure|0
1460345|NCT00759031|4815383|P1|First Intervention (1 Day)|Screening failure|1
1460346|NCT00759031|4815382|P2|First Intervention (1 Day)|Withdrawal by Subject|1
1460347|NCT00759031|4815383|P1|First Intervention (1 Day)|Withdrawal by Subject|0
1460348|NCT00759031|4815382|P2|First Intervention (1 Day)|Physician Decision|0
1460349|NCT00759031|4815383|P1|First Intervention (1 Day)|Physician Decision|1
1460350|NCT00758771|4815436|P2|Overall Study|Did not meet eligibility criteria|4
1460351|NCT00758771|4815437|P1|Overall Study|Did not meet eligibility criteria|2
1460352|NCT00758771|4815436|P2|Overall Study|Withdrawal by Subject|1
1460353|NCT00758771|4815437|P1|Overall Study|Withdrawal by Subject|1
1460354|NCT00758706|4815495|P2|Overall Study|Adverse Event|4
1460355|NCT00758706|4815496|P1|Overall Study|Adverse Event|4
1460356|NCT00758680|4815532|P10|Overall Study|Withdrawal by Subject|0
1460357|NCT00758680|4815533|P9|Overall Study|Withdrawal by Subject|1
1460358|NCT00758680|4815534|P8|Overall Study|Withdrawal by Subject|0
1460359|NCT00758680|4815535|P7|Overall Study|Withdrawal by Subject|1
1460360|NCT00758680|4815536|P6|Overall Study|Withdrawal by Subject|0
1460361|NCT00758680|4815537|P5|Overall Study|Withdrawal by Subject|0
1460362|NCT00758680|4815538|P4|Overall Study|Withdrawal by Subject|0
1460363|NCT00758680|4815539|P3|Overall Study|Withdrawal by Subject|0
1460364|NCT00758680|4815540|P2|Overall Study|Withdrawal by Subject|0
1460365|NCT00758680|4815541|P1|Overall Study|Withdrawal by Subject|0
1460366|NCT00758680|4815532|P10|Overall Study|Laboratory Adverse Event|0
1460367|NCT00758680|4815533|P9|Overall Study|Laboratory Adverse Event|1
1460368|NCT00758680|4815534|P8|Overall Study|Laboratory Adverse Event|0
1460369|NCT00758680|4815535|P7|Overall Study|Laboratory Adverse Event|0
1460370|NCT00758680|4815536|P6|Overall Study|Laboratory Adverse Event|0
1460371|NCT00758680|4815537|P5|Overall Study|Laboratory Adverse Event|0
1460372|NCT00758680|4815538|P4|Overall Study|Laboratory Adverse Event|0
1460373|NCT00758680|4815539|P3|Overall Study|Laboratory Adverse Event|0
1460374|NCT00758680|4815540|P2|Overall Study|Laboratory Adverse Event|0
1460375|NCT00758680|4815541|P1|Overall Study|Laboratory Adverse Event|0
1460376|NCT00758680|4815532|P10|Overall Study|Adverse Event|1
1460377|NCT00758680|4815533|P9|Overall Study|Adverse Event|0
1460378|NCT00758680|4815534|P8|Overall Study|Adverse Event|1
1460379|NCT00758680|4815535|P7|Overall Study|Adverse Event|0
1460380|NCT00758680|4815536|P6|Overall Study|Adverse Event|0
1460381|NCT00758680|4815537|P5|Overall Study|Adverse Event|0
1460382|NCT00758680|4815538|P4|Overall Study|Adverse Event|0
1460383|NCT00758680|4815539|P3|Overall Study|Adverse Event|0
1460384|NCT00758680|4815540|P2|Overall Study|Adverse Event|0
1460385|NCT00758680|4815541|P1|Overall Study|Adverse Event|0
1460386|NCT00758602|4815594|P2|Overall Study|Reason not specified|3
1460387|NCT00758602|4815595|P1|Overall Study|Reason not specified|3
1460388|NCT00758602|4815594|P2|Overall Study|Death|1
1460389|NCT00758602|4815595|P1|Overall Study|Death|0
1460390|NCT00758602|4815594|P2|Overall Study|Protocol Violation|2
1460391|NCT00758602|4815595|P1|Overall Study|Protocol Violation|0
1460392|NCT00758602|4815594|P2|Overall Study|Withdrawal by Subject|3
1460393|NCT00758602|4815595|P1|Overall Study|Withdrawal by Subject|1
1460394|NCT00758602|4815594|P2|Overall Study|Lost to Follow-up|3
1460395|NCT00758602|4815595|P1|Overall Study|Lost to Follow-up|4
1460396|NCT00758602|4815594|P2|Overall Study|Adverse Event|10
1460397|NCT00758602|4815595|P1|Overall Study|Adverse Event|11
1460398|NCT00758589|4815621|P4|Overall Study|Palm stopped to work|1
1460399|NCT00758589|4815622|P3|Overall Study|Palm stopped to work|0
1460400|NCT00758589|4815623|P2|Overall Study|Palm stopped to work|0
1460401|NCT00758589|4815624|P1|Overall Study|Palm stopped to work|0
1460402|NCT00758589|4815621|P4|Overall Study|Withdrawal by Subject|1
1460403|NCT00758589|4815622|P3|Overall Study|Withdrawal by Subject|1
1460404|NCT00758589|4815623|P2|Overall Study|Withdrawal by Subject|1
1460405|NCT00758589|4815624|P1|Overall Study|Withdrawal by Subject|0
1460406|NCT00758589|4815621|P4|Overall Study|Adverse Event|4
1460407|NCT00758589|4815622|P3|Overall Study|Adverse Event|5
1460408|NCT00758589|4815623|P2|Overall Study|Adverse Event|2
1460409|NCT00758589|4815624|P1|Overall Study|Adverse Event|3
1460410|NCT00758498|4815717|P3|Overall Study|Noncompliance to study procedures|1
1460411|NCT00758498|4815718|P2|Overall Study|Noncompliance to study procedures|0
1460412|NCT00758498|4815719|P1|Overall Study|Noncompliance to study procedures|0
1460413|NCT00758498|4815717|P3|Overall Study|Withdrawal by Subject|1
1460414|NCT00758498|4815718|P2|Overall Study|Withdrawal by Subject|0
1460415|NCT00758498|4815719|P1|Overall Study|Withdrawal by Subject|0
1460416|NCT00758498|4815717|P3|Overall Study|Subject legally detained out of state|0
1460417|NCT00758498|4815718|P2|Overall Study|Subject legally detained out of state|0
1460418|NCT00758498|4815719|P1|Overall Study|Subject legally detained out of state|1
1460419|NCT00758498|4815717|P3|Overall Study|Adverse Event|3
1460420|NCT00758498|4815718|P2|Overall Study|Adverse Event|2
1460421|NCT00758498|4815719|P1|Overall Study|Adverse Event|2
1460422|NCT00758485|4815804|P2|Overall Study|Not Treated|2
1460423|NCT00758485|4815805|P1|Overall Study|Not Treated|1
1460424|NCT00758485|4815804|P2|Overall Study|Lost to Follow-up|1
1460425|NCT00758485|4815805|P1|Overall Study|Lost to Follow-up|0
1460426|NCT00758459|4815817|P2|Overall Study|Withdrawal by Subject|1
1460427|NCT00758459|4815818|P1|Overall Study|Withdrawal by Subject|0
1460428|NCT00758459|4815817|P2|Overall Study|Protocol Violation|1
1460429|NCT00758459|4815818|P1|Overall Study|Protocol Violation|0
1460430|NCT00758459|4815817|P2|Overall Study|Adverse Event|2
1460431|NCT00758459|4815818|P1|Overall Study|Adverse Event|3
1460432|NCT00758394|4815863|P4|3rd Intervention|Lost to Follow-up|1
1460433|NCT00758394|4815864|P3|3rd Intervention|Lost to Follow-up|0
1460434|NCT00758394|4815865|P2|3rd Intervention|Lost to Follow-up|0
1460435|NCT00758394|4815866|P1|3rd Intervention|Lost to Follow-up|1
1460436|NCT00758394|4815863|P4|2nd Intervention Order|Lost to Follow-up|0
1460437|NCT00758394|4815864|P3|2nd Intervention Order|Lost to Follow-up|0
1460438|NCT00758394|4815865|P2|2nd Intervention Order|Lost to Follow-up|1
1460439|NCT00758394|4815866|P1|2nd Intervention Order|Lost to Follow-up|0
1460440|NCT00758264|4815895|P3|Active Phase|Not specified|4
1460441|NCT00758264|4815896|P2|Active Phase|Not specified|0
1460442|NCT00758264|4815897|P1|Active Phase|Not specified|0
1460443|NCT00758264|4815895|P3|Active Phase|Lost to Follow-up|0
1460444|NCT00758264|4815896|P2|Active Phase|Lost to Follow-up|0
1460445|NCT00758264|4815897|P1|Active Phase|Lost to Follow-up|1
1460446|NCT00758264|4815895|P3|Active Phase|Withdrawal by Subject|1
1460447|NCT00758264|4815896|P2|Active Phase|Withdrawal by Subject|0
1460448|NCT00758264|4815897|P1|Active Phase|Withdrawal by Subject|0
1460449|NCT00758160|4815956|P1|Overall Study|Withdrawal by Subject|8
1460450|NCT00758160|4815956|P1|Overall Study|Protocol Violation|12
1460451|NCT00758160|4815956|P1|Overall Study|Lost to Follow-up|14
1460452|NCT00758160|4815956|P1|Overall Study|Lack of Efficacy|10
1460453|NCT00758160|4815956|P1|Overall Study|Adverse Event|15
1460454|NCT00758160|4815956|P1|Overall Study|Administration Problems|3
1460455|NCT00758160|4815956|P1|Overall Study|No Longer Requires Study Medication|4
1460456|NCT00758069|4815977|P3|Overall Study|Incorrect Study Drug|0
1460457|NCT00758069|4815978|P2|Overall Study|Incorrect Study Drug|0
1460458|NCT00758069|4815979|P1|Overall Study|Incorrect Study Drug|1
1460459|NCT00758069|4815977|P3|Overall Study|Lack of Efficacy|1
1460460|NCT00758069|4815978|P2|Overall Study|Lack of Efficacy|0
1460461|NCT00758069|4815979|P1|Overall Study|Lack of Efficacy|0
1460462|NCT00758043|4815994|P4|Overall Study|Other Reasons|5
1460463|NCT00758043|4815995|P3|Overall Study|Other Reasons|0
1460464|NCT00758043|4815996|P2|Overall Study|Other Reasons|1
1460465|NCT00758043|4815997|P1|Overall Study|Other Reasons|0
1460466|NCT00758043|4815994|P4|Overall Study|Non-Compliant With study Drug|1
1460467|NCT00758043|4815995|P3|Overall Study|Non-Compliant With study Drug|0
1460468|NCT00758043|4815996|P2|Overall Study|Non-Compliant With study Drug|0
1460469|NCT00758043|4815997|P1|Overall Study|Non-Compliant With study Drug|0
1460470|NCT00758043|4815994|P4|Overall Study|Required Prohibited Medication|3
1460471|NCT00758043|4815995|P3|Overall Study|Required Prohibited Medication|1
1460472|NCT00758043|4815996|P2|Overall Study|Required Prohibited Medication|0
1460473|NCT00758043|4815997|P1|Overall Study|Required Prohibited Medication|0
1460474|NCT00758043|4815994|P4|Overall Study|Withdrawal by Subject|4
1460475|NCT00758043|4815995|P3|Overall Study|Withdrawal by Subject|1
1460476|NCT00758043|4815996|P2|Overall Study|Withdrawal by Subject|1
1460477|NCT00758043|4815997|P1|Overall Study|Withdrawal by Subject|0
1460478|NCT00758043|4815994|P4|Overall Study|Lost to Follow-up|5
1460479|NCT00758043|4815995|P3|Overall Study|Lost to Follow-up|2
1460480|NCT00758043|4815996|P2|Overall Study|Lost to Follow-up|2
1460481|NCT00758043|4815997|P1|Overall Study|Lost to Follow-up|0
1460482|NCT00758043|4815994|P4|Overall Study|Refused Further Treatment|8
1460483|NCT00758043|4815995|P3|Overall Study|Refused Further Treatment|5
1460484|NCT00758043|4815996|P2|Overall Study|Refused Further Treatment|11
1460485|NCT00758043|4815997|P1|Overall Study|Refused Further Treatment|0
1460486|NCT00758043|4815994|P4|Overall Study|Lack of Efficacy|12
1460487|NCT00758043|4815995|P3|Overall Study|Lack of Efficacy|18
1460488|NCT00758043|4815996|P2|Overall Study|Lack of Efficacy|6
1460489|NCT00758043|4815997|P1|Overall Study|Lack of Efficacy|0
1460490|NCT00758043|4815994|P4|Overall Study|Adverse Event|62
1460491|NCT00758043|4815995|P3|Overall Study|Adverse Event|12
1460492|NCT00758043|4815996|P2|Overall Study|Adverse Event|20
1460493|NCT00758043|4815997|P1|Overall Study|Adverse Event|1
1460494|NCT00757848|4816025|P2|Overall Study|Incorrect enrolment|0
1460495|NCT00757848|4816026|P1|Overall Study|Incorrect enrolment|1
1460496|NCT00757848|4816025|P2|Overall Study|Adverse Event|2
1460497|NCT00757848|4816026|P1|Overall Study|Adverse Event|1
1460498|NCT00757848|4816025|P2|Overall Study|Voluntary discontinuation|0
1460499|NCT00757848|4816026|P1|Overall Study|Voluntary discontinuation|1
1460500|NCT00757783|4816095|P2|Overall Study|Other|2
1460501|NCT00757783|4816096|P1|Overall Study|Other|1
1460502|NCT00757783|4816095|P2|Overall Study|Withdrawal by Subject|1
1460503|NCT00757783|4816096|P1|Overall Study|Withdrawal by Subject|2
1460504|NCT00757783|4816095|P2|Overall Study|Protocol Violation|0
1460505|NCT00757783|4816096|P1|Overall Study|Protocol Violation|1
1460506|NCT00757783|4816095|P2|Overall Study|Lost to Follow-up|1
1460507|NCT00757783|4816096|P1|Overall Study|Lost to Follow-up|1
1460508|NCT00757783|4816095|P2|Overall Study|Adverse Event|2
1460509|NCT00757783|4816096|P1|Overall Study|Adverse Event|0
1460510|NCT00757705|4816132|P1|Overall Study|Other|18
1460511|NCT00757705|4816132|P1|Overall Study|Non-compliant|9
1460512|NCT00757705|4816132|P1|Overall Study|Ineligible to continue|8
1460513|NCT00757705|4816132|P1|Overall Study|Insufficient Response|26
1460514|NCT00757705|4816132|P1|Overall Study|Withdrawal by Subject|25
1460515|NCT00757705|4816132|P1|Overall Study|Lost to Follow-up|16
1460516|NCT00757705|4816132|P1|Overall Study|Adverse Event|19
1460517|NCT00757627|4816161|P1|Overall Study|Other|1
1460518|NCT00757627|4816161|P1|Overall Study|Withdrawal by Subject|27
1460519|NCT00757627|4816161|P1|Overall Study|Lost to Follow-up|28
1460520|NCT00757627|4816161|P1|Overall Study|Lack of Efficacy|10
1460521|NCT00757627|4816161|P1|Overall Study|Adverse Event|15
1460522|NCT00757588|4816296|P2|Period 2: Long-term (52-week) Phase|Not specified|0
1460523|NCT00757588|4816297|P1|Period 2: Long-term (52-week) Phase|Not specified|1
1460524|NCT00757588|4816296|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
1460525|NCT00757588|4816297|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
1460526|NCT00757588|4816296|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
1460527|NCT00757588|4816297|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
1460528|NCT00757588|4816296|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
1460529|NCT00757588|4816297|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
1460530|NCT00757588|4816296|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
1460531|NCT00757588|4816297|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
1460532|NCT00757588|4816296|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
1460533|NCT00757588|4816297|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
1460534|NCT00757588|4816296|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
1460535|NCT00757588|4816297|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
1460536|NCT00757588|4816296|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
1460537|NCT00757588|4816297|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
1460538|NCT00757588|4816296|P2|Period 1: Short-term (24-week) Phase|Not specified|1
1460539|NCT00757588|4816297|P1|Period 1: Short-term (24-week) Phase|Not specified|0
1460540|NCT00757588|4816296|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
1460541|NCT00757588|4816297|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
1460542|NCT00757588|4816296|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
1460543|NCT00757588|4816297|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
1460544|NCT00757588|4816296|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
1460545|NCT00757588|4816297|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
1460546|NCT00757588|4816296|P2|Period 1: Short-term (24-week) Phase|Death|0
1460547|NCT00757588|4816297|P1|Period 1: Short-term (24-week) Phase|Death|1
1460548|NCT00757588|4816296|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
1460549|NCT00757588|4816297|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
1460550|NCT00757588|4816296|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
1460551|NCT00757588|4816297|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
1460552|NCT00757588|4816296|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
1460553|NCT00757588|4816297|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
1460554|NCT00757237|4816338|P2|Overall Study|Other|2
1460555|NCT00757237|4816339|P1|Overall Study|Other|0
1460556|NCT00757237|4816338|P2|Overall Study|Safety or Tolerability|5
1460557|NCT00757237|4816339|P1|Overall Study|Safety or Tolerability|3
1460558|NCT00757237|4816338|P2|Overall Study|Withdrawal by Subject|12
1460559|NCT00757237|4816339|P1|Overall Study|Withdrawal by Subject|8
1460560|NCT00757237|4816338|P2|Overall Study|Physician Decision|3
1460561|NCT00757237|4816339|P1|Overall Study|Physician Decision|2
1460562|NCT00757237|4816338|P2|Overall Study|Protocol Violation|2
1460563|NCT00757237|4816339|P1|Overall Study|Protocol Violation|0
1460564|NCT00757237|4816338|P2|Overall Study|Lost to Follow-up|1
1460565|NCT00757237|4816339|P1|Overall Study|Lost to Follow-up|0
1460566|NCT00757172|4816367|P1|Overall Study|Progression|4
1460567|NCT00757172|4816367|P1|Overall Study|Physician Decision|3
1460568|NCT00757172|4816367|P1|Overall Study|Withdrawal by Subject|4
1460569|NCT00757003|4816375|P1|Overall Study|Not implanted|1
1460570|NCT00757003|4816375|P1|Overall Study|Surgically explanted|2
1460571|NCT00757003|4816375|P1|Overall Study|Withdrawal by Subject|4
1460572|NCT00757003|4816375|P1|Overall Study|Lost to Follow-up|9
1460573|NCT00757003|4816375|P1|Overall Study|Death|33
1460574|NCT00756938|4816422|P4|Optional Extension|Adverse Event|1
1460575|NCT00756938|4816423|P3|Optional Extension|Adverse Event|0
1460576|NCT00756938|4816424|P2|Optional Extension|Adverse Event|0
1460577|NCT00756938|4816425|P1|Optional Extension|Adverse Event|0
1460578|NCT00756938|4816422|P4|Optional Extension|Withdrawal by Subject|10
1460579|NCT00756938|4816423|P3|Optional Extension|Withdrawal by Subject|0
1460580|NCT00756938|4816424|P2|Optional Extension|Withdrawal by Subject|0
1460581|NCT00756938|4816425|P1|Optional Extension|Withdrawal by Subject|0
1460582|NCT00756938|4816422|P4|Optional Extension|Protocol Violation|1
1460583|NCT00756938|4816423|P3|Optional Extension|Protocol Violation|0
1460584|NCT00756938|4816424|P2|Optional Extension|Protocol Violation|0
1460585|NCT00756938|4816425|P1|Optional Extension|Protocol Violation|0
1460586|NCT00756938|4816422|P4|Optional Extension|Lost to Follow-up|1
1460587|NCT00756938|4816423|P3|Optional Extension|Lost to Follow-up|0
1460588|NCT00756938|4816424|P2|Optional Extension|Lost to Follow-up|0
1460589|NCT00756938|4816425|P1|Optional Extension|Lost to Follow-up|0
1460590|NCT00756938|4816422|P4|Optional Extension|Physician Decision|3
1460591|NCT00756938|4816423|P3|Optional Extension|Physician Decision|0
1460592|NCT00756938|4816424|P2|Optional Extension|Physician Decision|0
1460593|NCT00756938|4816425|P1|Optional Extension|Physician Decision|0
1460594|NCT00756938|4816422|P4|Optional Extension|Protocol-specific criteria met|9
1460595|NCT00756938|4816423|P3|Optional Extension|Protocol-specific criteria met|0
1460596|NCT00756938|4816424|P2|Optional Extension|Protocol-specific criteria met|0
1460597|NCT00756938|4816425|P1|Optional Extension|Protocol-specific criteria met|0
1460598|NCT00756938|4816422|P4|Optional Extension|End of Study|11
1460599|NCT00756938|4816423|P3|Optional Extension|End of Study|0
1460600|NCT00756938|4816424|P2|Optional Extension|End of Study|0
1460601|NCT00756938|4816425|P1|Optional Extension|End of Study|0
1460602|NCT00756938|4816422|P4|Optional Extension|Lack of Efficacy|1
1460603|NCT00756938|4816423|P3|Optional Extension|Lack of Efficacy|0
1460604|NCT00756938|4816424|P2|Optional Extension|Lack of Efficacy|0
1460605|NCT00756938|4816425|P1|Optional Extension|Lack of Efficacy|0
1460606|NCT00756938|4816422|P4|12-week Base Study|Lost to Follow-up|0
1460607|NCT00756938|4816423|P3|12-week Base Study|Lost to Follow-up|0
1460608|NCT00756938|4816424|P2|12-week Base Study|Lost to Follow-up|0
1460609|NCT00756938|4816425|P1|12-week Base Study|Lost to Follow-up|1
1460610|NCT00756938|4816422|P4|12-week Base Study|Protocol Violation|0
1460611|NCT00756938|4816423|P3|12-week Base Study|Protocol Violation|1
1460612|NCT00756938|4816424|P2|12-week Base Study|Protocol Violation|0
1460613|NCT00756938|4816425|P1|12-week Base Study|Protocol Violation|0
1460614|NCT00756938|4816422|P4|12-week Base Study|Protocol-specific Criteria Met|0
1460615|NCT00756938|4816423|P3|12-week Base Study|Protocol-specific Criteria Met|1
1460616|NCT00756938|4816424|P2|12-week Base Study|Protocol-specific Criteria Met|0
1460617|NCT00756938|4816425|P1|12-week Base Study|Protocol-specific Criteria Met|1
1460618|NCT00756886|4816453|P2|Overall Study|Ineligible|4
1460619|NCT00756886|4816454|P1|Overall Study|Ineligible|9
1460620|NCT00756886|4816453|P2|Overall Study|Lack of Efficacy|0
1460621|NCT00756886|4816454|P1|Overall Study|Lack of Efficacy|1
1460622|NCT00756886|4816453|P2|Overall Study|Adverse Event|3
1460623|NCT00756886|4816454|P1|Overall Study|Adverse Event|0
1460624|NCT00756886|4816453|P2|Overall Study|Lost to Follow-up|0
1460625|NCT00756886|4816454|P1|Overall Study|Lost to Follow-up|1
1460626|NCT00756730|4816462|P2|Overall Study|persistent low-level viremmia|1
1460627|NCT00756730|4816463|P1|Overall Study|persistent low-level viremmia|0
1460628|NCT00756730|4816462|P2|Overall Study|discontinued due to rash prior to week 4|1
1460629|NCT00756730|4816463|P1|Overall Study|discontinued due to rash prior to week 4|0
1460630|NCT00756574|4816496|P2|Overall Study|Lost to Follow-up|4
1460631|NCT00756574|4816497|P1|Overall Study|Lost to Follow-up|4
1460632|NCT00756574|4816496|P2|Overall Study|Withdrawal by Subject|7
1460633|NCT00756574|4816497|P1|Overall Study|Withdrawal by Subject|9
1460634|NCT00756470|4816541|P1|Overall Study|Adverse Event|4
1460635|NCT00756470|4816541|P1|Overall Study|Withdrawal by Subject|1
1460636|NCT00756457|4816548|P2|Overall Study|Lost to Follow-up|2
1460637|NCT00756457|4816549|P1|Overall Study|Lost to Follow-up|1
1460638|NCT00756444|4816579|P2|Overall Study|Ineligibility Determined|0
1460639|NCT00756444|4816580|P1|Overall Study|Ineligibility Determined|1
1460640|NCT00756444|4816579|P2|Overall Study|Disease Progression|7
1460641|NCT00756444|4816580|P1|Overall Study|Disease Progression|2
1460642|NCT00756444|4816579|P2|Overall Study|Death|4
1460643|NCT00756444|4816580|P1|Overall Study|Death|5
1460644|NCT00756444|4816579|P2|Overall Study|Lost to Follow-up|1
1460645|NCT00756444|4816580|P1|Overall Study|Lost to Follow-up|0
1460646|NCT00756444|4816579|P2|Overall Study|Withdrawal by Subject|8
1460647|NCT00756444|4816580|P1|Overall Study|Withdrawal by Subject|6
1460648|NCT00756444|4816579|P2|Overall Study|Adverse Event|1
1460649|NCT00756444|4816580|P1|Overall Study|Adverse Event|1
1460650|NCT00756314|4816591|P2|Overall Study|Lost to Follow-up|59
1460651|NCT00756314|4816592|P1|Overall Study|Lost to Follow-up|2
1460652|NCT00756275|4816608|P2|Overall Study|Withdrawal by Subject|7
1460653|NCT00756275|4816609|P1|Overall Study|Withdrawal by Subject|4
1460654|NCT00756275|4816608|P2|Overall Study|Lost to Follow-up|21
1460655|NCT00756275|4816609|P1|Overall Study|Lost to Follow-up|25
1460656|NCT00756002|4816661|P2|Double-Blind Treatment Period|Not Specified|2
1460657|NCT00756002|4816662|P1|Double-Blind Treatment Period|Not Specified|2
1460658|NCT00756002|4816661|P2|Double-Blind Treatment Period|Protocol Violation|5
1460659|NCT00756002|4816662|P1|Double-Blind Treatment Period|Protocol Violation|6
1460660|NCT00756002|4816661|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
1460661|NCT00756002|4816662|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
1460662|NCT00756002|4816661|P2|Double-Blind Treatment Period|Lost to Follow-up|1
1460663|NCT00756002|4816662|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1460664|NCT00756002|4816661|P2|Double-Blind Treatment Period|Lack of Efficacy|1
1460665|NCT00756002|4816662|P1|Double-Blind Treatment Period|Lack of Efficacy|1
1460666|NCT00755937|4816756|P1|Observational Follow-up|Lost to Follow-up|148
1460667|NCT00755937|4816756|P1|Recruitment|Unknown if infliximab received|164
1460668|NCT00755846|4816783|P6|Overall Study|Participant Non-compliance|0
1460669|NCT00755846|4816784|P5|Overall Study|Participant Non-compliance|1
1460670|NCT00755846|4816785|P4|Overall Study|Participant Non-compliance|0
1460671|NCT00755846|4816786|P3|Overall Study|Participant Non-compliance|0
1460672|NCT00755846|4816787|P2|Overall Study|Participant Non-compliance|0
1460673|NCT00755846|4816788|P1|Overall Study|Participant Non-compliance|0
1460674|NCT00755846|4816783|P6|Overall Study|Administrative Error|0
1460675|NCT00755846|4816784|P5|Overall Study|Administrative Error|0
1460676|NCT00755846|4816785|P4|Overall Study|Administrative Error|0
1460677|NCT00755846|4816786|P3|Overall Study|Administrative Error|0
1460678|NCT00755846|4816787|P2|Overall Study|Administrative Error|1
1460679|NCT00755846|4816788|P1|Overall Study|Administrative Error|0
1460680|NCT00755846|4816783|P6|Overall Study|Physician Decision|1
1460681|NCT00755846|4816784|P5|Overall Study|Physician Decision|0
1460682|NCT00755846|4816785|P4|Overall Study|Physician Decision|1
1460683|NCT00755846|4816786|P3|Overall Study|Physician Decision|0
1460684|NCT00755846|4816787|P2|Overall Study|Physician Decision|3
1460685|NCT00755846|4816788|P1|Overall Study|Physician Decision|1
1460686|NCT00755846|4816783|P6|Overall Study|Hyperglycemic Rescue|7
1460687|NCT00755846|4816784|P5|Overall Study|Hyperglycemic Rescue|8
1460688|NCT00755846|4816785|P4|Overall Study|Hyperglycemic Rescue|8
1460689|NCT00755846|4816786|P3|Overall Study|Hyperglycemic Rescue|5
1460690|NCT00755846|4816787|P2|Overall Study|Hyperglycemic Rescue|7
1460691|NCT00755846|4816788|P1|Overall Study|Hyperglycemic Rescue|21
1460692|NCT00755846|4816783|P6|Overall Study|Withdrawal by Subject|1
1460693|NCT00755846|4816784|P5|Overall Study|Withdrawal by Subject|0
1460694|NCT00755846|4816785|P4|Overall Study|Withdrawal by Subject|2
1460695|NCT00755846|4816786|P3|Overall Study|Withdrawal by Subject|5
1460696|NCT00755846|4816787|P2|Overall Study|Withdrawal by Subject|3
1460697|NCT00755846|4816788|P1|Overall Study|Withdrawal by Subject|2
1460698|NCT00755846|4816783|P6|Overall Study|Lost to Follow-up|2
1460699|NCT00755846|4816784|P5|Overall Study|Lost to Follow-up|4
1460700|NCT00755846|4816785|P4|Overall Study|Lost to Follow-up|0
1460701|NCT00755846|4816786|P3|Overall Study|Lost to Follow-up|1
1460702|NCT00755846|4816787|P2|Overall Study|Lost to Follow-up|2
1460703|NCT00755846|4816788|P1|Overall Study|Lost to Follow-up|0
1460704|NCT00755846|4816783|P6|Overall Study|Protocol Violation|1
1460705|NCT00755846|4816784|P5|Overall Study|Protocol Violation|1
1460706|NCT00755846|4816785|P4|Overall Study|Protocol Violation|1
1460707|NCT00755846|4816786|P3|Overall Study|Protocol Violation|1
1460708|NCT00755846|4816787|P2|Overall Study|Protocol Violation|1
1460709|NCT00755846|4816788|P1|Overall Study|Protocol Violation|1
1460710|NCT00755846|4816783|P6|Overall Study|Adverse Event|2
1460711|NCT00755846|4816784|P5|Overall Study|Adverse Event|3
1460712|NCT00755846|4816785|P4|Overall Study|Adverse Event|1
1460713|NCT00755846|4816786|P3|Overall Study|Adverse Event|0
1460714|NCT00755846|4816787|P2|Overall Study|Adverse Event|0
1460715|NCT00755846|4816788|P1|Overall Study|Adverse Event|0
1460716|NCT00755807|4816888|P2|Open-label Extension Phase|Sponsor Decision|1
1460717|NCT00755807|4816889|P1|Open-label Extension Phase|Sponsor Decision|0
1460718|NCT00755807|4816888|P2|Open-label Extension Phase|Lost to Follow-up|0
1460719|NCT00755807|4816889|P1|Open-label Extension Phase|Lost to Follow-up|2
1460720|NCT00755807|4816888|P2|Open-label Extension Phase|Withdrawal by Subject|3
1460721|NCT00755807|4816889|P1|Open-label Extension Phase|Withdrawal by Subject|1
1460722|NCT00755807|4816888|P2|Open-label Extension Phase|Lack of Efficacy|3
1460723|NCT00755807|4816889|P1|Open-label Extension Phase|Lack of Efficacy|3
1460724|NCT00755807|4816888|P2|Open-label Extension Phase|Protocol Violation|2
1460725|NCT00755807|4816889|P1|Open-label Extension Phase|Protocol Violation|5
1460726|NCT00755807|4816888|P2|Open-label Extension Phase|Adverse Event|7
1460727|NCT00755807|4816889|P1|Open-label Extension Phase|Adverse Event|7
1460728|NCT00755807|4816888|P2|Acute Phase|Physician Decision|1
1460729|NCT00755807|4816889|P1|Acute Phase|Physician Decision|0
1460730|NCT00755807|4816888|P2|Acute Phase|Lack of Efficacy|1
1460731|NCT00755807|4816889|P1|Acute Phase|Lack of Efficacy|0
1460732|NCT00755807|4816888|P2|Acute Phase|Withdrawal by Subject|2
1460733|NCT00755807|4816889|P1|Acute Phase|Withdrawal by Subject|1
1460734|NCT00755807|4816888|P2|Acute Phase|Protocol Violation|3
1460735|NCT00755807|4816889|P1|Acute Phase|Protocol Violation|1
1460736|NCT00755807|4816888|P2|Acute Phase|Adverse Event|5
1460737|NCT00755807|4816889|P1|Acute Phase|Adverse Event|16
1460738|NCT00755716|4816969|P3|Overall Study|work schedule issues|1
1460739|NCT00755716|4816970|P2|Overall Study|work schedule issues|1
1460740|NCT00755716|4816971|P1|Overall Study|work schedule issues|0
1460741|NCT00755716|4816969|P3|Overall Study|Lost to Follow-up|1
1460742|NCT00755716|4816970|P2|Overall Study|Lost to Follow-up|3
1460743|NCT00755716|4816971|P1|Overall Study|Lost to Follow-up|5
1460744|NCT00755716|4816969|P3|Overall Study|Lack of Efficacy|0
1460745|NCT00755716|4816970|P2|Overall Study|Lack of Efficacy|0
1460746|NCT00755716|4816971|P1|Overall Study|Lack of Efficacy|2
1460747|NCT00755716|4816969|P3|Overall Study|Adverse Event|1
1460748|NCT00755716|4816970|P2|Overall Study|Adverse Event|4
1460749|NCT00755716|4816971|P1|Overall Study|Adverse Event|1
1460750|NCT00755417|4816985|P3|Overall Study|Not specified or missing data|12
1460751|NCT00755417|4816986|P2|Overall Study|Not specified or missing data|18
1460752|NCT00755417|4816987|P1|Overall Study|Not specified or missing data|9
1460753|NCT00755417|4816985|P3|Overall Study|Withdrawal by Subject|12
1460754|NCT00755417|4816986|P2|Overall Study|Withdrawal by Subject|12
1460755|NCT00755417|4816987|P1|Overall Study|Withdrawal by Subject|12
1460756|NCT00755417|4816985|P3|Overall Study|Lost to Follow-up|1
1460757|NCT00755417|4816986|P2|Overall Study|Lost to Follow-up|0
1460758|NCT00755417|4816987|P1|Overall Study|Lost to Follow-up|3
1460759|NCT00755417|4816985|P3|Overall Study|Protocol Violation|1
1460760|NCT00755417|4816986|P2|Overall Study|Protocol Violation|1
1460761|NCT00755417|4816987|P1|Overall Study|Protocol Violation|2
1460762|NCT00755417|4816985|P3|Overall Study|Lack of Efficacy|9
1460763|NCT00755417|4816986|P2|Overall Study|Lack of Efficacy|4
1460764|NCT00755417|4816987|P1|Overall Study|Lack of Efficacy|8
1460765|NCT00755417|4816985|P3|Overall Study|Adverse Event|7
1460766|NCT00755417|4816986|P2|Overall Study|Adverse Event|20
1460767|NCT00755417|4816987|P1|Overall Study|Adverse Event|28
1460768|NCT00755222|4817044|P2|Overall Study|Protocol Violation|0
1460769|NCT00755222|4817045|P1|Overall Study|Protocol Violation|2
1460770|NCT00755222|4817044|P2|Overall Study|Adverse Event|0
1460771|NCT00755222|4817045|P1|Overall Study|Adverse Event|2
1460772|NCT00755222|4817044|P2|Overall Study|Withdrawal by Subject|2
1460773|NCT00755222|4817045|P1|Overall Study|Withdrawal by Subject|4
1460774|NCT00755196|4817059|P1|Overall Study|Lack of Efficiency|1
1460775|NCT00755196|4817059|P1|Overall Study|Lost to Follow-up|1
1460776|NCT00755105|4817080|P3|Overall Study|Withdrawal by Subject|4
1460777|NCT00755105|4817081|P2|Overall Study|Withdrawal by Subject|11
1460778|NCT00755105|4817082|P1|Overall Study|Withdrawal by Subject|9
1460779|NCT00755079|4817092|P2|Overall Study|Withdrawal by Subject|2
1460780|NCT00755079|4817093|P1|Overall Study|Withdrawal by Subject|0
1460781|NCT00755079|4817092|P2|Overall Study|Adverse Event|1
1460782|NCT00755079|4817093|P1|Overall Study|Adverse Event|0
1460783|NCT00755079|4817092|P2|Overall Study|Lost to Follow-up|3
1460784|NCT00755079|4817093|P1|Overall Study|Lost to Follow-up|1
1460785|NCT00754793|4817130|P2|Overall Study|voluntary withdrawn from study|1
1460786|NCT00754793|4817131|P1|Overall Study|voluntary withdrawn from study|0
1460787|NCT00754741|4817149|P3|Overall Study|Died or disenrolled|54
1460788|NCT00754741|4817150|P2|Overall Study|Died or disenrolled|69
1460789|NCT00754741|4817151|P1|Overall Study|Died or disenrolled|57
1460790|NCT00754650|4817198|P1|Overall Study|Disease Progression|2
1460791|NCT00754624|4817203|P1|Overall Study|Lost to Follow-up|3
1460792|NCT00754624|4817203|P1|Overall Study|Various|12
1460793|NCT00754624|4817203|P1|Overall Study|Withdrawal by Subject|28
1460794|NCT00754624|4817203|P1|Overall Study|Protocol Violation|1
1460795|NCT00754624|4817203|P1|Overall Study|Physician Decision|8
1460796|NCT00754624|4817203|P1|Overall Study|Death|1
1460797|NCT00754624|4817203|P1|Overall Study|Adverse Event|16
1460798|NCT00754572|4817213|P1|Overall Study|Lost to Follow-up|1
1460799|NCT00754572|4817213|P1|Overall Study|Administrative Reason|3
1460800|NCT00754572|4817213|P1|Overall Study|Death|1
1460801|NCT00754572|4817213|P1|Overall Study|Lack of Efficacy|2
1460802|NCT00754572|4817213|P1|Overall Study|Withdrawal by Subject|3
1460803|NCT00754572|4817213|P1|Overall Study|Protocol Violation|3
1460804|NCT00754572|4817213|P1|Overall Study|Other|39
1460805|NCT00754572|4817213|P1|Overall Study|Adverse Event|19
1460806|NCT00754559|4817240|P1|Overall Study|Withdrawal by Subject|3
1460807|NCT00754559|4817240|P1|Overall Study|Other|5
1460808|NCT00754559|4817240|P1|Overall Study|Administrative reason|1
1460809|NCT00754559|4817240|P1|Overall Study|Lost to Follow-up|2
1460810|NCT00754559|4817240|P1|Overall Study|Lack of Efficacy|10
1460811|NCT00754559|4817240|P1|Overall Study|Protocol Violation|11
1460812|NCT00754559|4817240|P1|Overall Study|Adverse Event|15
1460813|NCT00754442|4817340|P2|Overall Study|Withdrawal by Subject|3
1460814|NCT00754442|4817341|P1|Overall Study|Withdrawal by Subject|5
1460815|NCT00754390|4817348|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
1460816|NCT00754390|4817348|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
1460817|NCT00754390|4817348|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
1460818|NCT00754390|4817348|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
1460819|NCT00754338|4817370|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
1460820|NCT00754338|4817371|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
1460821|NCT00754338|4817372|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
1460822|NCT00754338|4817373|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
1460823|NCT00754338|4817370|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
1460824|NCT00754338|4817371|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
1460825|NCT00754338|4817372|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
1460826|NCT00754338|4817373|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
1460827|NCT00754325|4817405|P2|Initial Treatment|Disease Progression|35
1460828|NCT00754325|4817406|P1|Initial Treatment|Disease Progression|35
1460829|NCT00754325|4817405|P2|Initial Treatment|Sponsor Request|1
1460830|NCT00754325|4817406|P1|Initial Treatment|Sponsor Request|0
1460831|NCT00754325|4817405|P2|Initial Treatment|Physician Decision|0
1460832|NCT00754325|4817406|P1|Initial Treatment|Physician Decision|2
1460833|NCT00754325|4817405|P2|Initial Treatment|Withdrawal by Subject|2
1460834|NCT00754325|4817406|P1|Initial Treatment|Withdrawal by Subject|2
1460835|NCT00754325|4817405|P2|Initial Treatment|Adverse Event|6
1460836|NCT00754325|4817406|P1|Initial Treatment|Adverse Event|7
1460837|NCT00754325|4817405|P2|Initial Treatment|Continuing Active Treatment|5
1460838|NCT00754325|4817406|P1|Initial Treatment|Continuing Active Treatment|4
1460839|NCT00754234|4817425|P1|Overall Study|Withdrawal by Subject|3
1460840|NCT00754065|4817511|P2|Overall Study|Reason not specified or unknown, etc.|27
1460841|NCT00754065|4817512|P1|Overall Study|Reason not specified or unknown, etc.|21
1460842|NCT00754065|4817511|P2|Overall Study|Pregnancy|0
1460843|NCT00754065|4817512|P1|Overall Study|Pregnancy|6
1460844|NCT00754065|4817511|P2|Overall Study|Withdrawal by Subject|5
1460845|NCT00754065|4817512|P1|Overall Study|Withdrawal by Subject|4
1460846|NCT00754065|4817511|P2|Overall Study|Protocol Violation|10
1460847|NCT00754065|4817512|P1|Overall Study|Protocol Violation|12
1460848|NCT00754065|4817511|P2|Overall Study|Lost to Follow-up|11
1460849|NCT00754065|4817512|P1|Overall Study|Lost to Follow-up|7
1460850|NCT00754065|4817511|P2|Overall Study|Adverse Event|25
1460851|NCT00754065|4817512|P1|Overall Study|Adverse Event|19
1460852|NCT00754065|4817511|P2|Overall Study|Never received treatment|2
1460853|NCT00754065|4817512|P1|Overall Study|Never received treatment|12
1460854|NCT00754052|4817752|P2|Overall Study|Study terminated by Sponsor|3
1460855|NCT00754052|4817753|P1|Overall Study|Study terminated by Sponsor|5
1460856|NCT00754013|4817767|P2|Overall Study|didn't return after study termed|4
1460857|NCT00754013|4817768|P1|Overall Study|didn't return after study termed|3
1460858|NCT00754013|4817767|P2|Overall Study|Lost to Follow-up|1
1460859|NCT00754013|4817768|P1|Overall Study|Lost to Follow-up|1
1460860|NCT00753922|4817802|P4|Overall Study|Discontinuation Due to Explantation|4
1460861|NCT00753922|4817803|P3|Overall Study|Discontinuation Due to Explantation|14
1460862|NCT00753922|4817804|P2|Overall Study|Discontinuation Due to Explantation|14
1460863|NCT00753922|4817805|P1|Overall Study|Discontinuation Due to Explantation|14
1460864|NCT00753922|4817802|P4|Overall Study|Death|1
1460865|NCT00753922|4817803|P3|Overall Study|Death|2
1460866|NCT00753922|4817804|P2|Overall Study|Death|23
1460867|NCT00753922|4817805|P1|Overall Study|Death|2
1460868|NCT00753922|4817802|P4|Overall Study|Patients Not Completing Visit|0
1460869|NCT00753922|4817803|P3|Overall Study|Patients Not Completing Visit|1
1460870|NCT00753922|4817804|P2|Overall Study|Patients Not Completing Visit|0
1460871|NCT00753922|4817805|P1|Overall Study|Patients Not Completing Visit|11
1460872|NCT00753922|4817802|P4|Overall Study|Patient Non-compliance|11
1460873|NCT00753922|4817803|P3|Overall Study|Patient Non-compliance|14
1460874|NCT00753922|4817804|P2|Overall Study|Patient Non-compliance|22
1460875|NCT00753922|4817805|P1|Overall Study|Patient Non-compliance|55
1460876|NCT00753922|4817802|P4|Overall Study|Withdrawal by Subject|2
1460877|NCT00753922|4817803|P3|Overall Study|Withdrawal by Subject|4
1460878|NCT00753922|4817804|P2|Overall Study|Withdrawal by Subject|11
1460879|NCT00753922|4817805|P1|Overall Study|Withdrawal by Subject|9
1460880|NCT00753922|4817802|P4|Overall Study|Lost to Follow-up|5
1460881|NCT00753922|4817803|P3|Overall Study|Lost to Follow-up|28
1460882|NCT00753922|4817804|P2|Overall Study|Lost to Follow-up|24
1460883|NCT00753922|4817805|P1|Overall Study|Lost to Follow-up|155
1460884|NCT00753896|4817835|P1|Overall Study|Entry Criteria Not Met|4
1460885|NCT00753896|4817835|P1|Overall Study|Withdrawal by Subject|4
1460886|NCT00753896|4817835|P1|Overall Study|Protocol Violation|1
1460887|NCT00753896|4817835|P1|Overall Study|Lost to Follow-up|2
1460888|NCT00753896|4817835|P1|Overall Study|Death|1
1460889|NCT00753896|4817835|P1|Overall Study|Adverse Event|4
1460890|NCT00753766|4817851|P2|Overall Study|Physician Decision|0
1460891|NCT00753766|4817852|P1|Overall Study|Physician Decision|1
1460892|NCT00753714|4817862|P2|Overall Study|not specified|5
1460893|NCT00753714|4817863|P1|Overall Study|not specified|7
1460894|NCT00753714|4817862|P2|Overall Study|Death|3
1460895|NCT00753714|4817863|P1|Overall Study|Death|3
1460896|NCT00753714|4817862|P2|Overall Study|Withdrawal by Subject|1
1460897|NCT00753714|4817863|P1|Overall Study|Withdrawal by Subject|2
1460898|NCT00753714|4817862|P2|Overall Study|Lost to Follow-up|1
1460899|NCT00753714|4817863|P1|Overall Study|Lost to Follow-up|0
1460900|NCT00753714|4817862|P2|Overall Study|Protocol Violation|0
1460901|NCT00753714|4817863|P1|Overall Study|Protocol Violation|1
1460902|NCT00753714|4817862|P2|Overall Study|Adverse Event|18
1460903|NCT00753714|4817863|P1|Overall Study|Adverse Event|26
1460904|NCT00753714|4817862|P2|Overall Study|Lack of Efficacy|34
1460905|NCT00753714|4817863|P1|Overall Study|Lack of Efficacy|21
1460906|NCT00753688|4817879|P2|Overall Study|Adverse Event|1
1460907|NCT00753688|4817880|P1|Overall Study|Adverse Event|0
1460908|NCT00753688|4817879|P2|Overall Study|Ongoing - in Follow-up|31
1460909|NCT00753688|4817880|P1|Overall Study|Ongoing - in Follow-up|15
1460910|NCT00753688|4817879|P2|Overall Study|Participant Withdrew Consent|2
1460911|NCT00753688|4817880|P1|Overall Study|Participant Withdrew Consent|2
1460912|NCT00753688|4817879|P2|Overall Study|Missing|9
1460913|NCT00753688|4817880|P1|Overall Study|Missing|4
1460914|NCT00753688|4817879|P2|Overall Study|Death|203
1460915|NCT00753688|4817880|P1|Overall Study|Death|102
1460916|NCT00753675|4817909|P3|Overall Study|Lost to Follow-up|0
1460917|NCT00753675|4817910|P2|Overall Study|Lost to Follow-up|0
1460918|NCT00753675|4817911|P1|Overall Study|Lost to Follow-up|1
1460919|NCT00753675|4817909|P3|Overall Study|Withdrawal by Subject|0
1460920|NCT00753675|4817910|P2|Overall Study|Withdrawal by Subject|1
1460921|NCT00753675|4817911|P1|Overall Study|Withdrawal by Subject|0
1460922|NCT00753675|4817909|P3|Overall Study|Objective progression of disease|35
1460923|NCT00753675|4817910|P2|Overall Study|Objective progression of disease|35
1460924|NCT00753675|4817911|P1|Overall Study|Objective progression of disease|35
1460925|NCT00753675|4817909|P3|Overall Study|Adverse Event|4
1460926|NCT00753675|4817910|P2|Overall Study|Adverse Event|9
1460927|NCT00753675|4817911|P1|Overall Study|Adverse Event|11
1460928|NCT00753675|4817909|P3|Overall Study|Death|4
1460929|NCT00753675|4817910|P2|Overall Study|Death|2
1460930|NCT00753675|4817911|P1|Overall Study|Death|1
1460931|NCT00753675|4817909|P3|Overall Study|other reason|13
1460932|NCT00753675|4817910|P2|Overall Study|other reason|12
1460933|NCT00753675|4817911|P1|Overall Study|other reason|11
1460934|NCT00753649|4817933|P2|Overall Study|Protocol Violation|0
1460935|NCT00753649|4817934|P1|Overall Study|Protocol Violation|2
1460936|NCT00753649|4817933|P2|Overall Study|Lost to follow-up-complete vaccination|0
1460937|NCT00753649|4817934|P1|Overall Study|Lost to follow-up-complete vaccination|1
1460938|NCT00753649|4817933|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
1460939|NCT00753649|4817934|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
1460940|NCT00753649|4817933|P2|Overall Study|Migrated/moved from study area|0
1460941|NCT00753649|4817934|P1|Overall Study|Migrated/moved from study area|1
1460942|NCT00753623|4817966|P2|Phase II (14 Days)|Physician Decision|1
1460943|NCT00753623|4817967|P1|Phase II (14 Days)|Physician Decision|0
1460944|NCT00753623|4817966|P2|Washout (7 Days)|Physician Decision|0
1460945|NCT00753623|4817967|P1|Washout (7 Days)|Physician Decision|1
1460946|NCT00753623|4817966|P2|Phase I (14 Days)|Adverse Event|1
1460947|NCT00753623|4817967|P1|Phase I (14 Days)|Adverse Event|0
1460948|NCT00753623|4817966|P2|Phase I (14 Days)|Physician Decision|2
1460949|NCT00753623|4817967|P1|Phase I (14 Days)|Physician Decision|1
1460950|NCT00753623|4817966|P2|Phase I (14 Days)|Withdrawal by Subject|1
1460951|NCT00753623|4817967|P1|Phase I (14 Days)|Withdrawal by Subject|1
1460952|NCT00753545|4817975|P2|Overall Study|Voluntary Discontinuation of Patient|3
1460953|NCT00753545|4817976|P1|Overall Study|Voluntary Discontinuation of Patient|7
1460954|NCT00753545|4817975|P2|Overall Study|Protocol Violation|0
1460955|NCT00753545|4817976|P1|Overall Study|Protocol Violation|1
1460956|NCT00753545|4817975|P2|Overall Study|Lost to Follow-up|3
1460957|NCT00753545|4817976|P1|Overall Study|Lost to Follow-up|2
1460958|NCT00753545|4817975|P2|Overall Study|Death|112
1460959|NCT00753545|4817976|P1|Overall Study|Death|98
1460960|NCT00753519|4818014|P2|Overall Study|Withdrawal by Subject|2
1460961|NCT00753519|4818015|P1|Overall Study|Withdrawal by Subject|0
1460962|NCT00753506|4818037|P2|Overall Study|Other reason|1
1460963|NCT00753506|4818038|P1|Overall Study|Other reason|1
1460964|NCT00753506|4818037|P2|Overall Study|Lost to Follow-up|0
1460965|NCT00753506|4818038|P1|Overall Study|Lost to Follow-up|2
1460966|NCT00753506|4818037|P2|Overall Study|Withdrawal by Subject|1
1460967|NCT00753506|4818038|P1|Overall Study|Withdrawal by Subject|4
1460968|NCT00753454|4818044|P1|Overall Study|Investigator Decision|1
1460969|NCT00753454|4818044|P1|Overall Study|Withdrawal by Subject|5
1460970|NCT00753454|4818044|P1|Overall Study|Lost to Follow-up|3
1460971|NCT00753454|4818044|P1|Overall Study|Lack of Efficacy|1
1460972|NCT00753454|4818044|P1|Overall Study|Adverse Event|4
1460973|NCT00753415|4818078|P10|Part B|Disease progression|1
1460974|NCT00753415|4818079|P9|Part B|Disease progression|2
1460975|NCT00753415|4818080|P8|Part B|Disease progression|0
1460976|NCT00753415|4818081|P7|Part B|Disease progression|0
1460977|NCT00753415|4818082|P6|Part B|Disease progression|0
1460978|NCT00753415|4818083|P5|Part B|Disease progression|0
1460979|NCT00753415|4818084|P4|Part B|Disease progression|0
1460980|NCT00753415|4818085|P3|Part B|Disease progression|0
1460981|NCT00753415|4818086|P2|Part B|Disease progression|0
1460982|NCT00753415|4818087|P1|Part B|Disease progression|0
1460983|NCT00753415|4818078|P10|Part B|Lost to Follow-up|0
1460984|NCT00753415|4818079|P9|Part B|Lost to Follow-up|1
1460985|NCT00753415|4818080|P8|Part B|Lost to Follow-up|1
1460986|NCT00753415|4818081|P7|Part B|Lost to Follow-up|0
1460987|NCT00753415|4818082|P6|Part B|Lost to Follow-up|0
1460988|NCT00753415|4818083|P5|Part B|Lost to Follow-up|0
1460989|NCT00753415|4818084|P4|Part B|Lost to Follow-up|0
1460990|NCT00753415|4818085|P3|Part B|Lost to Follow-up|0
1460991|NCT00753415|4818086|P2|Part B|Lost to Follow-up|0
1460992|NCT00753415|4818087|P1|Part B|Lost to Follow-up|0
1460993|NCT00753415|4818078|P10|Part A|Withdrawal by Subject|0
1460994|NCT00753415|4818079|P9|Part A|Withdrawal by Subject|0
1460995|NCT00753415|4818080|P8|Part A|Withdrawal by Subject|0
1460996|NCT00753415|4818081|P7|Part A|Withdrawal by Subject|0
1460997|NCT00753415|4818082|P6|Part A|Withdrawal by Subject|0
1460998|NCT00753415|4818083|P5|Part A|Withdrawal by Subject|0
1460999|NCT00753415|4818084|P4|Part A|Withdrawal by Subject|0
1461000|NCT00753415|4818085|P3|Part A|Withdrawal by Subject|1
1461001|NCT00753415|4818086|P2|Part A|Withdrawal by Subject|0
1461002|NCT00753415|4818087|P1|Part A|Withdrawal by Subject|0
1461003|NCT00753415|4818078|P10|Part A|Disease progression|0
1461004|NCT00753415|4818079|P9|Part A|Disease progression|0
1461005|NCT00753415|4818080|P8|Part A|Disease progression|0
1461006|NCT00753415|4818081|P7|Part A|Disease progression|0
1461007|NCT00753415|4818082|P6|Part A|Disease progression|0
1461008|NCT00753415|4818083|P5|Part A|Disease progression|0
1461009|NCT00753415|4818084|P4|Part A|Disease progression|2
1461010|NCT00753415|4818085|P3|Part A|Disease progression|1
1461011|NCT00753415|4818086|P2|Part A|Disease progression|0
1461012|NCT00753415|4818087|P1|Part A|Disease progression|1
1461013|NCT00753272|4818177|P2|Overall Study|Other|1088
1461014|NCT00753272|4818178|P1|Overall Study|Other|1104
1461015|NCT00753272|4818177|P2|Overall Study|Lost to Follow-up|497
1461016|NCT00753272|4818178|P1|Overall Study|Lost to Follow-up|491
1461017|NCT00753272|4818177|P2|Overall Study|Withdrawal by Subject|2407
1461018|NCT00753272|4818178|P1|Overall Study|Withdrawal by Subject|2481
1461019|NCT00753272|4818177|P2|Overall Study|Protocol Violation|46
1461020|NCT00753272|4818178|P1|Overall Study|Protocol Violation|28
1461021|NCT00753272|4818177|P2|Overall Study|Adverse Event|869
1461022|NCT00753272|4818178|P1|Overall Study|Adverse Event|878
1461023|NCT00753012|4818259|P2|Overall Study|Confounded endpoint data|0
1461024|NCT00753012|4818260|P1|Overall Study|Confounded endpoint data|1
1461025|NCT00753012|4818259|P2|Overall Study|Lost to Follow-up|0
1461026|NCT00753012|4818260|P1|Overall Study|Lost to Follow-up|4
1461027|NCT00753012|4818259|P2|Overall Study|Withdrawal by Subject|1
1461028|NCT00753012|4818260|P1|Overall Study|Withdrawal by Subject|0
1461029|NCT00753012|4818259|P2|Overall Study|Adverse Event|0
1461030|NCT00753012|4818260|P1|Overall Study|Adverse Event|2
1461031|NCT00753012|4818259|P2|Overall Study|Ineligible, abnormal cardiac histo|0
1461032|NCT00753012|4818260|P1|Overall Study|Ineligible, abnormal cardiac histo|1
1461033|NCT00752986|4818273|P3|Overall Study|Protocol Violation|0
1461034|NCT00752986|4818274|P2|Overall Study|Protocol Violation|0
1461035|NCT00752986|4818275|P1|Overall Study|Protocol Violation|3
1461036|NCT00752986|4818273|P3|Overall Study|Withdrawal by Subject|2
1461037|NCT00752986|4818274|P2|Overall Study|Withdrawal by Subject|1
1461038|NCT00752986|4818275|P1|Overall Study|Withdrawal by Subject|2
1461039|NCT00752895|4818304|P2|Overall Study|Withdrawal by Subject|3
1461040|NCT00752895|4818305|P1|Overall Study|Withdrawal by Subject|8
1461041|NCT00752791|4818313|P1|Overall Study|Protocol deviation|1
1461042|NCT00752791|4818313|P1|Overall Study|Switched to hemodialysis|2
1461043|NCT00752791|4818313|P1|Overall Study|Renal transplant|3
1461044|NCT00752791|4818313|P1|Overall Study|Death|1
1461045|NCT00752791|4818313|P1|Overall Study|Physician Decision|1
1461046|NCT00752791|4818313|P1|Overall Study|Withdrawal by Subject|1
1461047|NCT00752791|4818313|P1|Overall Study|Adverse Event|7
1461048|NCT00752726|4818325|P2|Overall Study|Other Reason|2
1461049|NCT00752726|4818326|P1|Overall Study|Other Reason|1
1461050|NCT00752726|4818325|P2|Overall Study|Withdrawal by Subject|10
1461051|NCT00752726|4818326|P1|Overall Study|Withdrawal by Subject|5
1461052|NCT00752726|4818325|P2|Overall Study|Adverse Event|0
1461053|NCT00752726|4818326|P1|Overall Study|Adverse Event|3
1461054|NCT00752726|4818325|P2|Overall Study|Lost to Follow-up|1
1461055|NCT00752726|4818326|P1|Overall Study|Lost to Follow-up|2
1461056|NCT00752622|4818351|P1|Interventional Phase|Premature Study Termination|5
1461057|NCT00752622|4818351|P1|Interventional Phase|Physician Decision|1
1461058|NCT00752622|4818351|P1|Interventional Phase|Non-responder|2
1461059|NCT00752622|4818351|P1|Observational Phase|Other|2
1461060|NCT00752622|4818351|P1|Observational Phase|Adverse Event|1
1461061|NCT00752622|4818351|P1|Observational Phase|Withdrawal by Subject|2
1461062|NCT00752622|4818351|P1|Observational Phase|Non-responder|2
1461063|NCT00752622|4818351|P1|Observational Phase|Premature Study Termination|36
1461064|NCT00752622|4818351|P1|Induction Phase|Premature study termination|14
1461065|NCT00752622|4818351|P1|Induction Phase|Withdrawal by Subject|1
1461066|NCT00752622|4818351|P1|Induction Phase|Non-responder|14
1461067|NCT00752622|4818351|P1|Induction Phase|Other|3
1461068|NCT00752622|4818351|P1|Induction Phase|Adverse Event|3
1461069|NCT00752609|4818364|P2|Overall Study|Received Aranesp in error|0
1461070|NCT00752609|4818365|P1|Overall Study|Received Aranesp in error|1
1461071|NCT00752609|4818364|P2|Overall Study|Met exclusion criteria|0
1461072|NCT00752609|4818365|P1|Overall Study|Met exclusion criteria|1
1461073|NCT00752609|4818364|P2|Overall Study|Death|0
1461074|NCT00752609|4818365|P1|Overall Study|Death|1
1461075|NCT00752609|4818364|P2|Overall Study|Physician Decision|0
1461076|NCT00752609|4818365|P1|Overall Study|Physician Decision|1
1461077|NCT00752609|4818364|P2|Overall Study|Withdrawal by Subject|0
1461078|NCT00752609|4818365|P1|Overall Study|Withdrawal by Subject|3
1461079|NCT00752609|4818364|P2|Overall Study|Adverse Event|2
1461080|NCT00752609|4818365|P1|Overall Study|Adverse Event|2
1461081|NCT00752232|4818391|P7|Overall Study|Caregiver could not attend the subject|0
1461082|NCT00752232|4818392|P6|Overall Study|Caregiver could not attend the subject|0
1461083|NCT00752232|4818393|P5|Overall Study|Caregiver could not attend the subject|1
1461084|NCT00752232|4818394|P4|Overall Study|Caregiver could not attend the subject|0
1461085|NCT00752232|4818395|P3|Overall Study|Caregiver could not attend the subject|0
1461086|NCT00752232|4818396|P2|Overall Study|Caregiver could not attend the subject|0
1461087|NCT00752232|4818397|P1|Overall Study|Caregiver could not attend the subject|0
1461088|NCT00752232|4818391|P7|Overall Study|Group home admission|0
1461089|NCT00752232|4818392|P6|Overall Study|Group home admission|0
1461090|NCT00752232|4818393|P5|Overall Study|Group home admission|0
1461091|NCT00752232|4818394|P4|Overall Study|Group home admission|1
1461092|NCT00752232|4818395|P3|Overall Study|Group home admission|0
1461093|NCT00752232|4818396|P2|Overall Study|Group home admission|0
1461094|NCT00752232|4818397|P1|Overall Study|Group home admission|0
1461095|NCT00752232|4818391|P7|Overall Study|Subject request|0
1461096|NCT00752232|4818392|P6|Overall Study|Subject request|0
1461097|NCT00752232|4818393|P5|Overall Study|Subject request|0
1461098|NCT00752232|4818394|P4|Overall Study|Subject request|0
1461099|NCT00752232|4818395|P3|Overall Study|Subject request|1
1461100|NCT00752232|4818396|P2|Overall Study|Subject request|0
1461101|NCT00752232|4818397|P1|Overall Study|Subject request|0
1461102|NCT00752232|4818391|P7|Overall Study|Investigator request|0
1461103|NCT00752232|4818392|P6|Overall Study|Investigator request|0
1461104|NCT00752232|4818393|P5|Overall Study|Investigator request|1
1461105|NCT00752232|4818394|P4|Overall Study|Investigator request|0
1461106|NCT00752232|4818395|P3|Overall Study|Investigator request|0
1461107|NCT00752232|4818396|P2|Overall Study|Investigator request|0
1461108|NCT00752232|4818397|P1|Overall Study|Investigator request|0
1461109|NCT00752232|4818391|P7|Overall Study|Caregiver request|0
1461110|NCT00752232|4818392|P6|Overall Study|Caregiver request|0
1461111|NCT00752232|4818393|P5|Overall Study|Caregiver request|1
1461112|NCT00752232|4818394|P4|Overall Study|Caregiver request|0
1461113|NCT00752232|4818395|P3|Overall Study|Caregiver request|0
1461114|NCT00752232|4818396|P2|Overall Study|Caregiver request|0
1461115|NCT00752232|4818397|P1|Overall Study|Caregiver request|2
1461116|NCT00752232|4818391|P7|Overall Study|Protocol Violation|0
1461117|NCT00752232|4818392|P6|Overall Study|Protocol Violation|1
1461118|NCT00752232|4818393|P5|Overall Study|Protocol Violation|0
1461119|NCT00752232|4818394|P4|Overall Study|Protocol Violation|0
1461120|NCT00752232|4818395|P3|Overall Study|Protocol Violation|0
1461121|NCT00752232|4818396|P2|Overall Study|Protocol Violation|0
1461122|NCT00752232|4818397|P1|Overall Study|Protocol Violation|0
1461123|NCT00752219|4818471|P2|Overall Study|Other|0
1461124|NCT00752219|4818472|P1|Overall Study|Other|3
1461125|NCT00752219|4818471|P2|Overall Study|Randomized but not treated|0
1461126|NCT00752219|4818472|P1|Overall Study|Randomized but not treated|1
1461127|NCT00752219|4818471|P2|Overall Study|Lost to Follow-up|2
1461128|NCT00752219|4818472|P1|Overall Study|Lost to Follow-up|1
1461129|NCT00752219|4818471|P2|Overall Study|Protocol deviation|0
1461130|NCT00752219|4818472|P1|Overall Study|Protocol deviation|1
1461131|NCT00752219|4818471|P2|Overall Study|Adverse Event|3
1461132|NCT00752219|4818472|P1|Overall Study|Adverse Event|5
1461133|NCT00752219|4818471|P2|Overall Study|Clinical failure|1
1461134|NCT00752219|4818472|P1|Overall Study|Clinical failure|0
1461135|NCT00752128|4818496|P1|Overall Study|Withdrawal by Subject|4
1461136|NCT00752089|4818510|P1|Overall Study|Cannot continue the study|1
1461137|NCT00752089|4818510|P1|Overall Study|Not capable of wearing partial denture|1
1461138|NCT00752089|4818510|P1|Overall Study|Could not attend visit 9|1
1461139|NCT00752089|4818510|P1|Overall Study|Protocol Deviation|2
1461140|NCT00752089|4818510|P1|Overall Study|Adverse Event|1
1461141|NCT00751998|4818524|P1|Overall Study|Withdrawal by Subject|2
1461142|NCT00751998|4818524|P1|Overall Study|Death|11
1461143|NCT00751998|4818524|P1|Overall Study|Lost to Follow-up|7
1461144|NCT00751933|4818543|P4|Overall Study|Physician Decision|1
1461145|NCT00751933|4818544|P3|Overall Study|Physician Decision|1
1461146|NCT00751933|4818545|P2|Overall Study|Physician Decision|0
1461147|NCT00751933|4818546|P1|Overall Study|Physician Decision|0
1461148|NCT00751933|4818543|P4|Overall Study|Withdrawal by Subject|0
1461149|NCT00751933|4818544|P3|Overall Study|Withdrawal by Subject|0
1461150|NCT00751933|4818545|P2|Overall Study|Withdrawal by Subject|1
1461151|NCT00751933|4818546|P1|Overall Study|Withdrawal by Subject|0
1461152|NCT00751881|4818554|P3|Extension Study Period|Other than specified above|18
1461153|NCT00751881|4818555|P2|Extension Study Period|Other than specified above|30
1461154|NCT00751881|4818556|P1|Extension Study Period|Other than specified above|26
1461155|NCT00751881|4818554|P3|Extension Study Period|Poor Compliance to Protocol|1
1461156|NCT00751881|4818555|P2|Extension Study Period|Poor Compliance to Protocol|2
1461157|NCT00751881|4818556|P1|Extension Study Period|Poor Compliance to Protocol|3
1461158|NCT00751881|4818554|P3|Extension Study Period|Lost to Follow-up|6
1461159|NCT00751881|4818555|P2|Extension Study Period|Lost to Follow-up|9
1461160|NCT00751881|4818556|P1|Extension Study Period|Lost to Follow-up|4
1461161|NCT00751881|4818554|P3|Extension Study Period|Lack of Efficacy|20
1461162|NCT00751881|4818555|P2|Extension Study Period|Lack of Efficacy|10
1461163|NCT00751881|4818556|P1|Extension Study Period|Lack of Efficacy|14
1461164|NCT00751881|4818554|P3|Extension Study Period|Adverse Event|21
1461165|NCT00751881|4818555|P2|Extension Study Period|Adverse Event|20
1461166|NCT00751881|4818556|P1|Extension Study Period|Adverse Event|18
1461167|NCT00751881|4818554|P3|Core Treatment Period|Other:participant's decision/unspecified|16
1461168|NCT00751881|4818555|P2|Core Treatment Period|Other:participant's decision/unspecified|22
1461169|NCT00751881|4818556|P1|Core Treatment Period|Other:participant's decision/unspecified|19
1461170|NCT00751881|4818554|P3|Core Treatment Period|Other: tolerability complaints|0
1461171|NCT00751881|4818555|P2|Core Treatment Period|Other: tolerability complaints|0
1461172|NCT00751881|4818556|P1|Core Treatment Period|Other: tolerability complaints|2
1461173|NCT00751881|4818554|P3|Core Treatment Period|Other: MS treatment change|4
1461174|NCT00751881|4818555|P2|Core Treatment Period|Other: MS treatment change|4
1461175|NCT00751881|4818556|P1|Core Treatment Period|Other: MS treatment change|6
1461176|NCT00751881|4818554|P3|Core Treatment Period|Other: personal/family constraints|10
1461177|NCT00751881|4818555|P2|Core Treatment Period|Other: personal/family constraints|7
1461178|NCT00751881|4818556|P1|Core Treatment Period|Other: personal/family constraints|6
1461179|NCT00751881|4818554|P3|Core Treatment Period|Other: wish to parent|4
1461180|NCT00751881|4818555|P2|Core Treatment Period|Other: wish to parent|7
1461181|NCT00751881|4818556|P1|Core Treatment Period|Other: wish to parent|5
1461182|NCT00751881|4818554|P3|Core Treatment Period|Other: protocol deviation|7
1461183|NCT00751881|4818555|P2|Core Treatment Period|Other: protocol deviation|3
1461184|NCT00751881|4818556|P1|Core Treatment Period|Other: protocol deviation|3
1461185|NCT00751881|4818554|P3|Core Treatment Period|Lost to Follow-up|3
1461186|NCT00751881|4818555|P2|Core Treatment Period|Lost to Follow-up|4
1461187|NCT00751881|4818556|P1|Core Treatment Period|Lost to Follow-up|6
1461188|NCT00751881|4818554|P3|Core Treatment Period|Poor compliance to protocol|4
1461189|NCT00751881|4818555|P2|Core Treatment Period|Poor compliance to protocol|3
1461190|NCT00751881|4818556|P1|Core Treatment Period|Poor compliance to protocol|15
1461191|NCT00751881|4818554|P3|Core Treatment Period|Lack of Efficacy|20
1461192|NCT00751881|4818555|P2|Core Treatment Period|Lack of Efficacy|30
1461193|NCT00751881|4818556|P1|Core Treatment Period|Lack of Efficacy|37
1461194|NCT00751881|4818554|P3|Core Treatment Period|Adverse Event|58
1461195|NCT00751881|4818555|P2|Core Treatment Period|Adverse Event|54
1461196|NCT00751881|4818556|P1|Core Treatment Period|Adverse Event|26
1461197|NCT00751881|4818554|P3|Core Treatment Period|Not treated|2
1461198|NCT00751881|4818555|P2|Core Treatment Period|Not treated|1
1461199|NCT00751881|4818556|P1|Core Treatment Period|Not treated|1
1461200|NCT00751790|4818603|P1|Overall Study|Withdrawal by Subject|1
1461201|NCT00751790|4818603|P1|Overall Study|Death|3
1461202|NCT00751790|4818603|P1|Overall Study|Lost to Follow-up|1
1461203|NCT00751621|4818628|P1|Overall Study|Poor adherence to asthma treatment|1
1461204|NCT00751621|4818628|P1|Overall Study|Subject moved to another country|1
1461205|NCT00751621|4818628|P1|Overall Study|Withdrawal by Subject|1
1461206|NCT00751621|4818628|P1|Overall Study|Adverse Event|1
1461207|NCT00751400|4818662|P1|Overall Study|Lost to Follow-up|10
1461208|NCT00751348|4818677|P2|Overall Study|Migration from study area|0
1461209|NCT00751348|4818678|P1|Overall Study|Migration from study area|1
1461210|NCT00751348|4818677|P2|Overall Study|Withdrawal by Subject|2
1461211|NCT00751348|4818678|P1|Overall Study|Withdrawal by Subject|5
1461212|NCT00751296|4818700|P1|Overall Study|Adverse Event|2
1461213|NCT00751140|4818728|P1|Overall Study|benign angioma excluded from analysis|1
1461214|NCT00751114|4818738|P2|Overall Study|Move to another city|0
1461215|NCT00751114|4818739|P1|Overall Study|Move to another city|1
1461216|NCT00751114|4818738|P2|Overall Study|Out of country for 2 months|0
1461217|NCT00751114|4818739|P1|Overall Study|Out of country for 2 months|1
1461218|NCT00751114|4818738|P2|Overall Study|Not Treated|1
1461219|NCT00751114|4818739|P1|Overall Study|Not Treated|13
1461220|NCT00751114|4818738|P2|Overall Study|Lack of Efficacy|7
1461221|NCT00751114|4818739|P1|Overall Study|Lack of Efficacy|0
1461222|NCT00751114|4818738|P2|Overall Study|Lost to Follow-up|7
1461223|NCT00751114|4818739|P1|Overall Study|Lost to Follow-up|4
1461224|NCT00751114|4818738|P2|Overall Study|Withdrawal by Subject|4
1461225|NCT00751114|4818739|P1|Overall Study|Withdrawal by Subject|9
1461226|NCT00751114|4818738|P2|Overall Study|Protocol Violation|9
1461227|NCT00751114|4818739|P1|Overall Study|Protocol Violation|8
1461228|NCT00751114|4818738|P2|Overall Study|Adverse Event|4
1461229|NCT00751114|4818739|P1|Overall Study|Adverse Event|2
1461230|NCT00751036|4818764|P2|Overall Study|Missing end of Treatment Page|3
1461231|NCT00751036|4818765|P1|Overall Study|Missing end of Treatment Page|2
1461232|NCT00751036|4818764|P2|Overall Study|Protocol Violation|0
1461233|NCT00751036|4818765|P1|Overall Study|Protocol Violation|1
1461234|NCT00751036|4818764|P2|Overall Study|Lost to Follow-up|1
1461235|NCT00751036|4818765|P1|Overall Study|Lost to Follow-up|0
1461236|NCT00751036|4818764|P2|Overall Study|Death|3
1461237|NCT00751036|4818765|P1|Overall Study|Death|3
1461238|NCT00751036|4818764|P2|Overall Study|Withdrawal by Subject|2
1461239|NCT00751036|4818765|P1|Overall Study|Withdrawal by Subject|5
1461240|NCT00751036|4818764|P2|Overall Study|Administrative Problems|4
1461241|NCT00751036|4818765|P1|Overall Study|Administrative Problems|3
1461242|NCT00751036|4818764|P2|Overall Study|Adverse Event|4
1461243|NCT00751036|4818765|P1|Overall Study|Adverse Event|6
1461244|NCT00751036|4818764|P2|Overall Study|Disease Progression|29
1461245|NCT00751036|4818765|P1|Overall Study|Disease Progression|28
1461246|NCT00750919|4818777|P1|Overall Study|Other|36
1461247|NCT00750919|4818777|P1|Overall Study|Could not cooperate, unrelated to trial|4
1461248|NCT00750919|4818777|P1|Overall Study|Lack of Efficacy|8
1461249|NCT00750919|4818777|P1|Overall Study|Withdrawal by Subject|1
1461250|NCT00750919|4818777|P1|Overall Study|Adverse Event|9
1461251|NCT00750893|4818785|P1|Overall Study|Other|17
1461252|NCT00750893|4818785|P1|Overall Study|Lost to Follow-up|510
1461253|NCT00750893|4818785|P1|Overall Study|Withdrawal by Subject|10
1461254|NCT00750893|4818785|P1|Overall Study|Adverse Event|5
1461255|NCT00750880|4818800|P1|Overall Study|Administrative|11
1461256|NCT00750880|4818800|P1|Overall Study|Physician Decision|20
1461257|NCT00750880|4818800|P1|Overall Study|Withdrawal by Subject|33
1461258|NCT00750880|4818800|P1|Overall Study|Protocol Violation|15
1461259|NCT00750880|4818800|P1|Overall Study|Lost to Follow-up|10
1461260|NCT00750880|4818800|P1|Overall Study|Lack of Efficacy|46
1461261|NCT00750880|4818800|P1|Overall Study|Death|4
1461262|NCT00750880|4818800|P1|Overall Study|Adverse Event|76
1461263|NCT00750867|4818823|P1|Overall Study|Adverse Event|2
1461264|NCT00750737|4818844|P2|Overall Study|Withdrawal by Subject|3
1461265|NCT00750737|4818845|P1|Overall Study|Withdrawal by Subject|3
1461266|NCT00750308|4818905|P12|Third Treatment|Withdrawal by Subject|0
1461267|NCT00750308|4818906|P11|Third Treatment|Withdrawal by Subject|0
1461268|NCT00750308|4818907|P10|Third Treatment|Withdrawal by Subject|0
1461269|NCT00750308|4818908|P9|Third Treatment|Withdrawal by Subject|0
1461270|NCT00750308|4818909|P8|Third Treatment|Withdrawal by Subject|0
1461271|NCT00750308|4818910|P7|Third Treatment|Withdrawal by Subject|0
1461272|NCT00750308|4818911|P6|Third Treatment|Withdrawal by Subject|0
1461273|NCT00750308|4818912|P5|Third Treatment|Withdrawal by Subject|0
1461274|NCT00750308|4818913|P4|Third Treatment|Withdrawal by Subject|0
1461275|NCT00750308|4818914|P3|Third Treatment|Withdrawal by Subject|0
1461276|NCT00750308|4818915|P2|Third Treatment|Withdrawal by Subject|1
1461277|NCT00750308|4818916|P1|Third Treatment|Withdrawal by Subject|0
1461278|NCT00750308|4818905|P12|Second Treatment|Withdrawal by Subject|0
1461279|NCT00750308|4818906|P11|Second Treatment|Withdrawal by Subject|0
1461280|NCT00750308|4818907|P10|Second Treatment|Withdrawal by Subject|0
1461281|NCT00750308|4818908|P9|Second Treatment|Withdrawal by Subject|0
1461282|NCT00750308|4818909|P8|Second Treatment|Withdrawal by Subject|0
1461283|NCT00750308|4818910|P7|Second Treatment|Withdrawal by Subject|0
1461284|NCT00750308|4818911|P6|Second Treatment|Withdrawal by Subject|0
1461285|NCT00750308|4818912|P5|Second Treatment|Withdrawal by Subject|1
1461286|NCT00750308|4818913|P4|Second Treatment|Withdrawal by Subject|0
1461287|NCT00750308|4818914|P3|Second Treatment|Withdrawal by Subject|0
1461288|NCT00750308|4818915|P2|Second Treatment|Withdrawal by Subject|0
1461289|NCT00750308|4818916|P1|Second Treatment|Withdrawal by Subject|0
1461290|NCT00750308|4818905|P12|Second Treatment|Adverse Event|0
1461291|NCT00750308|4818906|P11|Second Treatment|Adverse Event|0
1461292|NCT00750308|4818907|P10|Second Treatment|Adverse Event|0
1461293|NCT00750308|4818908|P9|Second Treatment|Adverse Event|1
1461294|NCT00750308|4818909|P8|Second Treatment|Adverse Event|0
1461295|NCT00750308|4818910|P7|Second Treatment|Adverse Event|0
1461296|NCT00750308|4818911|P6|Second Treatment|Adverse Event|1
1461297|NCT00750308|4818912|P5|Second Treatment|Adverse Event|0
1461298|NCT00750308|4818913|P4|Second Treatment|Adverse Event|0
1461299|NCT00750308|4818914|P3|Second Treatment|Adverse Event|0
1461300|NCT00750308|4818915|P2|Second Treatment|Adverse Event|0
1461301|NCT00750308|4818916|P1|Second Treatment|Adverse Event|0
1461302|NCT00750308|4818905|P12|First Treatment|Withdrawal by Subject|0
1461303|NCT00750308|4818906|P11|First Treatment|Withdrawal by Subject|0
1461304|NCT00750308|4818907|P10|First Treatment|Withdrawal by Subject|0
1461305|NCT00750308|4818908|P9|First Treatment|Withdrawal by Subject|0
1461306|NCT00750308|4818909|P8|First Treatment|Withdrawal by Subject|1
1461307|NCT00750308|4818910|P7|First Treatment|Withdrawal by Subject|0
1461308|NCT00750308|4818911|P6|First Treatment|Withdrawal by Subject|0
1461309|NCT00750308|4818912|P5|First Treatment|Withdrawal by Subject|0
1461310|NCT00750308|4818913|P4|First Treatment|Withdrawal by Subject|1
1461311|NCT00750308|4818914|P3|First Treatment|Withdrawal by Subject|0
1461312|NCT00750308|4818915|P2|First Treatment|Withdrawal by Subject|0
1461313|NCT00750308|4818916|P1|First Treatment|Withdrawal by Subject|0
1461314|NCT00750308|4818905|P12|First Treatment|Adverse Event|1
1461315|NCT00750308|4818906|P11|First Treatment|Adverse Event|1
1461316|NCT00750308|4818907|P10|First Treatment|Adverse Event|0
1461317|NCT00750308|4818908|P9|First Treatment|Adverse Event|0
1461318|NCT00750308|4818909|P8|First Treatment|Adverse Event|0
1461319|NCT00750308|4818910|P7|First Treatment|Adverse Event|0
1461320|NCT00750308|4818911|P6|First Treatment|Adverse Event|0
1461321|NCT00750308|4818912|P5|First Treatment|Adverse Event|0
1461322|NCT00750308|4818913|P4|First Treatment|Adverse Event|0
1461323|NCT00750308|4818914|P3|First Treatment|Adverse Event|0
1461324|NCT00750308|4818915|P2|First Treatment|Adverse Event|1
1461325|NCT00750308|4818916|P1|First Treatment|Adverse Event|0
1461326|NCT00750269|4818966|P5|Overall Study|Fiducials could not be placed|1
1461327|NCT00750269|4818967|P4|Overall Study|Fiducials could not be placed|0
1461328|NCT00750269|4818968|P3|Overall Study|Fiducials could not be placed|0
1461329|NCT00750269|4818969|P2|Overall Study|Fiducials could not be placed|0
1461330|NCT00750269|4818970|P1|Overall Study|Fiducials could not be placed|0
1461331|NCT00750269|4818966|P5|Overall Study|SBRT plan could not be drawn|1
1461332|NCT00750269|4818967|P4|Overall Study|SBRT plan could not be drawn|0
1461333|NCT00750269|4818968|P3|Overall Study|SBRT plan could not be drawn|0
1461334|NCT00750269|4818969|P2|Overall Study|SBRT plan could not be drawn|0
1461335|NCT00750269|4818970|P1|Overall Study|SBRT plan could not be drawn|0
1461336|NCT00750269|4818966|P5|Overall Study|Site error|0
1461337|NCT00750269|4818967|P4|Overall Study|Site error|1
1461338|NCT00750269|4818968|P3|Overall Study|Site error|0
1461339|NCT00750269|4818969|P2|Overall Study|Site error|0
1461340|NCT00750269|4818970|P1|Overall Study|Site error|0
1461341|NCT00750269|4818966|P5|Overall Study|Patient too large for positioning|0
1461342|NCT00750269|4818967|P4|Overall Study|Patient too large for positioning|0
1461343|NCT00750269|4818968|P3|Overall Study|Patient too large for positioning|1
1461344|NCT00750269|4818969|P2|Overall Study|Patient too large for positioning|0
1461345|NCT00750269|4818970|P1|Overall Study|Patient too large for positioning|0
1461346|NCT00750269|4818966|P5|Overall Study|Physician Decision|2
1461347|NCT00750269|4818967|P4|Overall Study|Physician Decision|0
1461348|NCT00750269|4818968|P3|Overall Study|Physician Decision|0
1461349|NCT00750269|4818969|P2|Overall Study|Physician Decision|0
1461350|NCT00750269|4818970|P1|Overall Study|Physician Decision|0
1461351|NCT00750269|4818966|P5|Overall Study|Withdrawal by Subject|2
1461352|NCT00750269|4818967|P4|Overall Study|Withdrawal by Subject|2
1461353|NCT00750269|4818968|P3|Overall Study|Withdrawal by Subject|2
1461354|NCT00750269|4818969|P2|Overall Study|Withdrawal by Subject|0
1461355|NCT00750269|4818970|P1|Overall Study|Withdrawal by Subject|0
1461356|NCT00750269|4818966|P5|Overall Study|Protocol Violation|4
1461357|NCT00750269|4818967|P4|Overall Study|Protocol Violation|2
1461358|NCT00750269|4818968|P3|Overall Study|Protocol Violation|1
1461359|NCT00750269|4818969|P2|Overall Study|Protocol Violation|1
1461360|NCT00750269|4818970|P1|Overall Study|Protocol Violation|0
1461361|NCT00750204|4819017|P2|Overall Study|study halted prematurely|1
1461362|NCT00750204|4819018|P1|Overall Study|study halted prematurely|1
1461363|NCT00750152|4819041|P2|Overall Study|Not specified|8
1461364|NCT00750152|4819042|P1|Overall Study|Not specified|7
1461365|NCT00750152|4819041|P2|Overall Study|Termination by sponsor|0
1461366|NCT00750152|4819042|P1|Overall Study|Termination by sponsor|1
1461367|NCT00750152|4819041|P2|Overall Study|Non-compliance|1
1461368|NCT00750152|4819042|P1|Overall Study|Non-compliance|0
1461369|NCT00750152|4819041|P2|Overall Study|Physician Decision|1
1461370|NCT00750152|4819042|P1|Overall Study|Physician Decision|1
1461371|NCT00750152|4819041|P2|Overall Study|Withdrawal by Subject|3
1461372|NCT00750152|4819042|P1|Overall Study|Withdrawal by Subject|3
1461373|NCT00750152|4819041|P2|Overall Study|Lost to Follow-up|13
1461374|NCT00750152|4819042|P1|Overall Study|Lost to Follow-up|8
1461375|NCT00750152|4819041|P2|Overall Study|Adverse Event|1
1461376|NCT00750152|4819042|P1|Overall Study|Adverse Event|2
1461377|NCT00750139|4819054|P4|Overall Study|Non-specific|33
1461378|NCT00750139|4819055|P3|Overall Study|Non-specific|79
1461379|NCT00750139|4819056|P2|Overall Study|Non-specific|42
1461380|NCT00750139|4819057|P1|Overall Study|Non-specific|62
1461381|NCT00750139|4819054|P4|Overall Study|Termination by sponsor|1
1461382|NCT00750139|4819055|P3|Overall Study|Termination by sponsor|0
1461383|NCT00750139|4819056|P2|Overall Study|Termination by sponsor|0
1461384|NCT00750139|4819057|P1|Overall Study|Termination by sponsor|4
1461385|NCT00750139|4819054|P4|Overall Study|Non-compliance|3
1461386|NCT00750139|4819055|P3|Overall Study|Non-compliance|1
1461387|NCT00750139|4819056|P2|Overall Study|Non-compliance|0
1461388|NCT00750139|4819057|P1|Overall Study|Non-compliance|1
1461389|NCT00750139|4819054|P4|Overall Study|Physician Decision|0
1461390|NCT00750139|4819055|P3|Overall Study|Physician Decision|0
1461391|NCT00750139|4819056|P2|Overall Study|Physician Decision|1
1461392|NCT00750139|4819057|P1|Overall Study|Physician Decision|1
1461393|NCT00750139|4819054|P4|Overall Study|Withdrawal by Subject|2
1461394|NCT00750139|4819055|P3|Overall Study|Withdrawal by Subject|6
1461395|NCT00750139|4819056|P2|Overall Study|Withdrawal by Subject|2
1461396|NCT00750139|4819057|P1|Overall Study|Withdrawal by Subject|3
1461397|NCT00750139|4819054|P4|Overall Study|Lost to Follow-up|6
1461398|NCT00750139|4819055|P3|Overall Study|Lost to Follow-up|15
1461399|NCT00750139|4819056|P2|Overall Study|Lost to Follow-up|12
1461400|NCT00750139|4819057|P1|Overall Study|Lost to Follow-up|17
1461401|NCT00750139|4819054|P4|Overall Study|Adverse Event|1
1461402|NCT00750139|4819055|P3|Overall Study|Adverse Event|0
1461403|NCT00750139|4819056|P2|Overall Study|Adverse Event|2
1461404|NCT00750139|4819057|P1|Overall Study|Adverse Event|1
1461405|NCT00750061|4819073|P2|Overall Study|Physician Decision|1
1461406|NCT00750061|4819074|P1|Overall Study|Physician Decision|0
1461407|NCT00750061|4819073|P2|Overall Study|Withdrawal by Subject|1
1461408|NCT00750061|4819074|P1|Overall Study|Withdrawal by Subject|0
1461409|NCT00750061|4819073|P2|Overall Study|Adverse Event|0
1461410|NCT00750061|4819074|P1|Overall Study|Adverse Event|2
1461411|NCT00749996|4819084|P2|Overall Study|Death|0
1461412|NCT00749996|4819085|P1|Overall Study|Death|1
1461413|NCT00749996|4819084|P2|Overall Study|Adverse Event|0
1461414|NCT00749996|4819085|P1|Overall Study|Adverse Event|1
1461415|NCT00749996|4819084|P2|Overall Study|Pregnancy|2
1461416|NCT00749996|4819085|P1|Overall Study|Pregnancy|0
1461417|NCT00749996|4819084|P2|Overall Study|Physician Decision|0
1461418|NCT00749996|4819085|P1|Overall Study|Physician Decision|2
1461419|NCT00749996|4819084|P2|Overall Study|Protocol Violation|3
1461420|NCT00749996|4819085|P1|Overall Study|Protocol Violation|2
1461421|NCT00749996|4819084|P2|Overall Study|Withdrawal by Subject|4
1461422|NCT00749996|4819085|P1|Overall Study|Withdrawal by Subject|5
1461423|NCT00749996|4819084|P2|Overall Study|Lost to Follow-up|4
1461424|NCT00749996|4819085|P1|Overall Study|Lost to Follow-up|7
1461425|NCT00749944|4819108|P2|Overall Study|Withdrawal by Subject|0
1461426|NCT00749944|4819109|P1|Overall Study|Withdrawal by Subject|2
1461427|NCT00749944|4819108|P2|Overall Study|Not specified|0
1461428|NCT00749944|4819109|P1|Overall Study|Not specified|1
1461429|NCT00749944|4819108|P2|Overall Study|Lost to Follow-up|1
1461430|NCT00749944|4819109|P1|Overall Study|Lost to Follow-up|2
1461431|NCT00749775|4819188|P1|Overall Study|No drug administration|3
1461432|NCT00749775|4819188|P1|Overall Study|No visit after first day of treatment|44
1461433|NCT00749775|4819188|P1|Overall Study|Lost to Follow-up|36
1461434|NCT00749775|4819188|P1|Overall Study|Protocol Violation|24
1461435|NCT00749684|4819204|P1|Overall Study|Missing|9
1461436|NCT00749684|4819204|P1|Overall Study|AE+discontinuation on participants wish|1
1461437|NCT00749684|4819204|P1|Overall Study|Therapy according to protocol + AE|2
1461438|NCT00749684|4819204|P1|Overall Study|Progressive Desease|31
1461439|NCT00749684|4819204|P1|Overall Study|Not Documented|1
1461440|NCT00749684|4819204|P1|Overall Study|Participant's Wish|10
1461441|NCT00749684|4819204|P1|Overall Study|Adverse Event|27
1461442|NCT00749684|4819204|P1|Overall Study|Death|1
1461443|NCT00749580|4819243|P2|Overall Study|Adverse Event|1
1461444|NCT00749580|4819244|P1|Overall Study|Adverse Event|0
1461445|NCT00749580|4819243|P2|Overall Study|Lost to Follow-up|8
1461446|NCT00749580|4819244|P1|Overall Study|Lost to Follow-up|4
1461447|NCT00749463|4819259|P3|Overall Study|Withdrawal by Subject|0
1461448|NCT00749463|4819260|P2|Overall Study|Withdrawal by Subject|0
1461449|NCT00749463|4819261|P1|Overall Study|Withdrawal by Subject|1
1461450|NCT00749463|4819259|P3|Overall Study|Adverse Event|1
1461451|NCT00749463|4819260|P2|Overall Study|Adverse Event|4
1461452|NCT00749463|4819261|P1|Overall Study|Adverse Event|0
1461453|NCT00749398|4819287|P1|Overall Study|Unknown reason|1
1461454|NCT00749398|4819287|P1|Overall Study|Reason not specified|2
1461455|NCT00749398|4819287|P1|Overall Study|Lost to Follow-up|11
1461456|NCT00749398|4819287|P1|Overall Study|Withdrawal by Subject|17
1461457|NCT00749398|4819287|P1|Overall Study|Serious adverse event|11
1461458|NCT00749398|4819287|P1|Overall Study|Adverse Event|4
1461459|NCT00749398|4819287|P1|Overall Study|Lack of Efficacy|7
1461460|NCT00749203|4819330|P2|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
1461461|NCT00749203|4819331|P1|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
1461462|NCT00749203|4819330|P2|Second Infusion at 2 Weeks|Protocol Violation|1
1461463|NCT00749203|4819331|P1|Second Infusion at 2 Weeks|Protocol Violation|0
1461464|NCT00749203|4819330|P2|no Infusion at Week 1|low baseline PTSD symptoms level|1
1461465|NCT00749203|4819331|P1|no Infusion at Week 1|low baseline PTSD symptoms level|0
1461466|NCT00749203|4819330|P2|no Infusion at Week 1|delayed-onset sedation|1
1461467|NCT00749203|4819331|P1|no Infusion at Week 1|delayed-onset sedation|0
1461468|NCT00749203|4819330|P2|no Infusion at Week 1|Withdrawal by Subject|1
1461469|NCT00749203|4819331|P1|no Infusion at Week 1|Withdrawal by Subject|0
1461470|NCT00749203|4819330|P2|no Infusion at Week 1|Lost to Follow-up|1
1461471|NCT00749203|4819331|P1|no Infusion at Week 1|Lost to Follow-up|0
1461472|NCT00749190|4819352|P7|Overall Study|Other reason not defined above|0
1461473|NCT00749190|4819353|P6|Overall Study|Other reason not defined above|0
1461474|NCT00749190|4819354|P5|Overall Study|Other reason not defined above|0
1461475|NCT00749190|4819355|P4|Overall Study|Other reason not defined above|1
1461476|NCT00749190|4819356|P3|Overall Study|Other reason not defined above|0
1461477|NCT00749190|4819357|P2|Overall Study|Other reason not defined above|0
1461478|NCT00749190|4819358|P1|Overall Study|Other reason not defined above|0
1461479|NCT00749190|4819352|P7|Overall Study|Protocol Violation|1
1461480|NCT00749190|4819353|P6|Overall Study|Protocol Violation|0
1461481|NCT00749190|4819354|P5|Overall Study|Protocol Violation|0
1461482|NCT00749190|4819355|P4|Overall Study|Protocol Violation|0
1461483|NCT00749190|4819356|P3|Overall Study|Protocol Violation|0
1461484|NCT00749190|4819357|P2|Overall Study|Protocol Violation|1
1461485|NCT00749190|4819358|P1|Overall Study|Protocol Violation|0
1461486|NCT00749190|4819352|P7|Overall Study|Withdrawal by Subject|0
1461487|NCT00749190|4819353|P6|Overall Study|Withdrawal by Subject|1
1461488|NCT00749190|4819354|P5|Overall Study|Withdrawal by Subject|0
1461489|NCT00749190|4819355|P4|Overall Study|Withdrawal by Subject|0
1461490|NCT00749190|4819356|P3|Overall Study|Withdrawal by Subject|0
1461491|NCT00749190|4819357|P2|Overall Study|Withdrawal by Subject|1
1461492|NCT00749190|4819358|P1|Overall Study|Withdrawal by Subject|2
1461493|NCT00749190|4819352|P7|Overall Study|Lack of Efficacy|0
1461494|NCT00749190|4819353|P6|Overall Study|Lack of Efficacy|1
1461495|NCT00749190|4819354|P5|Overall Study|Lack of Efficacy|0
1461496|NCT00749190|4819355|P4|Overall Study|Lack of Efficacy|0
1461497|NCT00749190|4819356|P3|Overall Study|Lack of Efficacy|1
1461498|NCT00749190|4819357|P2|Overall Study|Lack of Efficacy|1
1461499|NCT00749190|4819358|P1|Overall Study|Lack of Efficacy|3
1461500|NCT00749190|4819352|P7|Overall Study|Adverse Event|0
1461501|NCT00749190|4819353|P6|Overall Study|Adverse Event|3
1461502|NCT00749190|4819354|P5|Overall Study|Adverse Event|0
1461503|NCT00749190|4819355|P4|Overall Study|Adverse Event|4
1461504|NCT00749190|4819356|P3|Overall Study|Adverse Event|0
1461505|NCT00749190|4819357|P2|Overall Study|Adverse Event|2
1461506|NCT00749190|4819358|P1|Overall Study|Adverse Event|0
1461507|NCT00748969|4819467|P2|Overall Study|Withdrawal by Subject|1
1461508|NCT00748969|4819468|P1|Overall Study|Withdrawal by Subject|0
1461509|NCT00748969|4819467|P2|Overall Study|Withdrawal by Subject|0
1461510|NCT00748969|4819468|P1|Overall Study|Withdrawal by Subject|1
1461511|NCT00748709|4819516|P1|Overall Study|Other Reasons|1
1461512|NCT00748709|4819516|P1|Overall Study|Withdrawal by Subject|1
1461513|NCT00748709|4819516|P1|Overall Study|Other Adverse Event|1
1461514|NCT00748709|4819516|P1|Overall Study|Drug reducing Toxity|2
1461515|NCT00748709|4819516|P1|Overall Study|Progressive disease|15
1461516|NCT00748566|4819549|P1|Overall Study|Other|9
1461517|NCT00748566|4819549|P1|Overall Study|Study terminated by sponsor|5
1461518|NCT00748566|4819549|P1|Overall Study|Withdrawal by Subject|22
1461519|NCT00748566|4819549|P1|Overall Study|Protocol Violation|13
1461520|NCT00748566|4819549|P1|Overall Study|Lost to Follow-up|1
1461521|NCT00748566|4819549|P1|Overall Study|Lack of Efficacy|12
1461522|NCT00748566|4819549|P1|Overall Study|Death|1
1461523|NCT00748566|4819549|P1|Overall Study|Adverse Event|49
1461524|NCT00748553|4819579|P2|Overall Study|noncompliance|0
1461525|NCT00748553|4819580|P1|Overall Study|noncompliance|1
1461526|NCT00748553|4819579|P2|Overall Study|disease progression|0
1461527|NCT00748553|4819580|P1|Overall Study|disease progression|2
1461528|NCT00748553|4819579|P2|Overall Study|Adverse Event|1
1461529|NCT00748553|4819580|P1|Overall Study|Adverse Event|0
1461530|NCT00748540|4819587|P1|Overall Study|Physician Decision|1
1461531|NCT00748241|4819613|P1|Overall Study|Death|2
1461532|NCT00748241|4819613|P1|Overall Study|Lost to Follow-up|5
1461533|NCT00748241|4819613|P1|Overall Study|Implant failure|1
1461534|NCT00748189|4819623|P2|Overall Study|Ongoing|162
1461535|NCT00748189|4819624|P1|Overall Study|Ongoing|155
1461536|NCT00748189|4819623|P2|Overall Study|Study terminated by Sponsor|1
1461537|NCT00748189|4819624|P1|Overall Study|Study terminated by Sponsor|0
1461538|NCT00748189|4819623|P2|Overall Study|Lost to Follow-up|4
1461539|NCT00748189|4819624|P1|Overall Study|Lost to Follow-up|2
1461540|NCT00748189|4819623|P2|Overall Study|Physician Decision|4
1461541|NCT00748189|4819624|P1|Overall Study|Physician Decision|13
1461542|NCT00748189|4819623|P2|Overall Study|Withdrawal by Subject|16
1461543|NCT00748189|4819624|P1|Overall Study|Withdrawal by Subject|15
1461544|NCT00748189|4819623|P2|Overall Study|Death|34
1461545|NCT00748189|4819624|P1|Overall Study|Death|40
1461546|NCT00748098|4819678|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
1461547|NCT00748098|4819679|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
1461548|NCT00748098|4819678|P2|Second Treatment Intervention Period|Lost to Follow-up|1
1461549|NCT00748098|4819679|P1|Second Treatment Intervention Period|Lost to Follow-up|1
1461550|NCT00748098|4819678|P2|Second Treatment Intervention Period|Adverse Event|1
1461551|NCT00748098|4819679|P1|Second Treatment Intervention Period|Adverse Event|4
1461552|NCT00748098|4819678|P2|1-Week Washout Period|Withdrawal by Subject|0
1461553|NCT00748098|4819679|P1|1-Week Washout Period|Withdrawal by Subject|2
1461554|NCT00748098|4819678|P2|1-Week Washout Period|Adverse Event|1
1461555|NCT00748098|4819679|P1|1-Week Washout Period|Adverse Event|0
1461556|NCT00748098|4819678|P2|First Taper Period|Protocol Stopping Criteria Met|1
1461557|NCT00748098|4819679|P1|First Taper Period|Protocol Stopping Criteria Met|0
1461558|NCT00748098|4819678|P2|First Taper Period|Withdrawal by Subject|0
1461559|NCT00748098|4819679|P1|First Taper Period|Withdrawal by Subject|2
1461560|NCT00748098|4819678|P2|First Taper Period|Protocol Violation|0
1461561|NCT00748098|4819679|P1|First Taper Period|Protocol Violation|1
1461562|NCT00748098|4819678|P2|First Treatment Intervention Period|Withdrawal by Subject|0
1461563|NCT00748098|4819679|P1|First Treatment Intervention Period|Withdrawal by Subject|2
1461564|NCT00748098|4819678|P2|First Treatment Intervention Period|Lost to Follow-up|0
1461565|NCT00748098|4819679|P1|First Treatment Intervention Period|Lost to Follow-up|1
1461566|NCT00748098|4819678|P2|First Treatment Intervention Period|Protocol Violation|0
1461567|NCT00748098|4819679|P1|First Treatment Intervention Period|Protocol Violation|1
1461568|NCT00748098|4819678|P2|First Treatment Intervention Period|Adverse Event|1
1461569|NCT00748098|4819679|P1|First Treatment Intervention Period|Adverse Event|1
1461570|NCT00747812|4819760|P2|Overall Study|Research Site Staff Relocation|3
1461571|NCT00747812|4819761|P1|Overall Study|Research Site Staff Relocation|5
1461572|NCT00747643|4819799|P2|Overall Study|Withdrawal by Subject|27
1461573|NCT00747643|4819800|P1|Overall Study|Withdrawal by Subject|36
1461574|NCT00747617|4819814|P2|Overall Study|Lost to Follow-up|1
1461575|NCT00747617|4819815|P1|Overall Study|Lost to Follow-up|3
1461576|NCT00747565|4819823|P2|Overall Study|Lost to Follow-up|1
1461577|NCT00747565|4819824|P1|Overall Study|Lost to Follow-up|4
1461578|NCT00747565|4819823|P2|Overall Study|Withdrawal by Subject|6
1461579|NCT00747565|4819824|P1|Overall Study|Withdrawal by Subject|10
1461580|NCT00747474|4819837|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1461581|NCT00747474|4819838|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1461582|NCT00747474|4819839|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1461583|NCT00747474|4819840|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1461584|NCT00747474|4819841|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
1461585|NCT00747474|4819842|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1461586|NCT00747474|4819843|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1461587|NCT00747474|4819844|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1461588|NCT00747474|4819845|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1461589|NCT00747474|4819846|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1461590|NCT00747474|4819847|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1461591|NCT00747474|4819848|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1461592|NCT00747461|4819874|P1|Overall Study|study terminated by sponsor|5
1461593|NCT00747435|4819879|P1|Overall Study|Still undergoing follow up|1
1461594|NCT00747435|4819879|P1|Overall Study|Withdrawal by Subject|3
1461595|NCT00747435|4819879|P1|Overall Study|Lost to Follow-up|2
1461596|NCT00747344|4819889|P4|After Controlled Period|Adverse Event|1
1461597|NCT00747344|4819890|P3|After Controlled Period|Adverse Event|0
1461598|NCT00747344|4819891|P2|After Controlled Period|Adverse Event|0
1461599|NCT00747344|4819892|P1|After Controlled Period|Adverse Event|0
1461600|NCT00747344|4819889|P4|Controlled Period|Other|0
1461601|NCT00747344|4819890|P3|Controlled Period|Other|0
1461602|NCT00747344|4819891|P2|Controlled Period|Other|3
1461603|NCT00747344|4819892|P1|Controlled Period|Other|0
1461604|NCT00747344|4819889|P4|Controlled Period|Lack of Efficacy|0
1461605|NCT00747344|4819890|P3|Controlled Period|Lack of Efficacy|0
1461606|NCT00747344|4819891|P2|Controlled Period|Lack of Efficacy|1
1461607|NCT00747344|4819892|P1|Controlled Period|Lack of Efficacy|2
1461608|NCT00747344|4819889|P4|Controlled Period|Adverse Event|0
1461609|NCT00747344|4819890|P3|Controlled Period|Adverse Event|0
1461610|NCT00747344|4819891|P2|Controlled Period|Adverse Event|0
1461611|NCT00747344|4819892|P1|Controlled Period|Adverse Event|3
1461612|NCT00747227|4819906|P2|Overall Study|Illness|1
1461613|NCT00747227|4819907|P1|Overall Study|Illness|1
1461614|NCT00747227|4819906|P2|Overall Study|Lost to Follow-up|2
1461615|NCT00747227|4819907|P1|Overall Study|Lost to Follow-up|1
1461616|NCT00747227|4819906|P2|Overall Study|Withdrawal by Subject|0
1461617|NCT00747227|4819907|P1|Overall Study|Withdrawal by Subject|1
1461618|NCT00747227|4819906|P2|Overall Study|Death|1
1461619|NCT00747227|4819907|P1|Overall Study|Death|3
1461620|NCT00747149|4819936|P2|Overall Study|Not reported|4
1461621|NCT00747149|4819937|P1|Overall Study|Not reported|1
1461622|NCT00747149|4819936|P2|Overall Study|Severe non-compliance to protocol|1
1461623|NCT00747149|4819937|P1|Overall Study|Severe non-compliance to protocol|0
1461624|NCT00747149|4819936|P2|Overall Study|Incorrect enrollment|6
1461625|NCT00747149|4819937|P1|Overall Study|Incorrect enrollment|0
1461626|NCT00747149|4819936|P2|Overall Study|Did not receive treatment|1
1461627|NCT00747149|4819937|P1|Overall Study|Did not receive treatment|0
1461628|NCT00747149|4819936|P2|Overall Study|Withdrawal by Subject|6
1461629|NCT00747149|4819937|P1|Overall Study|Withdrawal by Subject|0
1461630|NCT00747149|4819936|P2|Overall Study|Lost to Follow-up|10
1461631|NCT00747149|4819937|P1|Overall Study|Lost to Follow-up|0
1461632|NCT00747149|4819936|P2|Overall Study|Adverse Event|15
1461633|NCT00747149|4819937|P1|Overall Study|Adverse Event|0
1461634|NCT00747006|4819952|P3|Overall Study|Physician Decision|1
1461635|NCT00747006|4819953|P2|Overall Study|Physician Decision|0
1461636|NCT00747006|4819954|P1|Overall Study|Physician Decision|2
1461637|NCT00747006|4819952|P3|Overall Study|Lost to Follow-up|0
1461638|NCT00747006|4819953|P2|Overall Study|Lost to Follow-up|1
1461639|NCT00747006|4819954|P1|Overall Study|Lost to Follow-up|0
1461640|NCT00747006|4819952|P3|Overall Study|Adverse Event|0
1461641|NCT00747006|4819953|P2|Overall Study|Adverse Event|0
1461642|NCT00747006|4819954|P1|Overall Study|Adverse Event|1
1461643|NCT00746941|4820032|P4|Overall Study|Adverse Event|1
1461644|NCT00746941|4820033|P3|Overall Study|Adverse Event|0
1461645|NCT00746941|4820034|P2|Overall Study|Adverse Event|0
1461646|NCT00746941|4820035|P1|Overall Study|Adverse Event|0
1461647|NCT00746941|4820032|P4|Overall Study|Other, reason not provided|4
1461648|NCT00746941|4820033|P3|Overall Study|Other, reason not provided|0
1461649|NCT00746941|4820034|P2|Overall Study|Other, reason not provided|4
1461650|NCT00746941|4820035|P1|Overall Study|Other, reason not provided|2
1461651|NCT00746941|4820032|P4|Overall Study|Withdrawal by Subject|2
1461652|NCT00746941|4820033|P3|Overall Study|Withdrawal by Subject|0
1461653|NCT00746941|4820034|P2|Overall Study|Withdrawal by Subject|0
1461654|NCT00746941|4820035|P1|Overall Study|Withdrawal by Subject|3
1461655|NCT00746941|4820032|P4|Overall Study|Physician Decision|0
1461656|NCT00746941|4820033|P3|Overall Study|Physician Decision|2
1461657|NCT00746941|4820034|P2|Overall Study|Physician Decision|0
1461658|NCT00746941|4820035|P1|Overall Study|Physician Decision|0
1461659|NCT00746941|4820032|P4|Overall Study|Death|6
1461660|NCT00746941|4820033|P3|Overall Study|Death|0
1461661|NCT00746941|4820034|P2|Overall Study|Death|0
1461662|NCT00746941|4820035|P1|Overall Study|Death|2
1461663|NCT00746798|4820093|P4|Overall Study|Participant unable to return for visit|0
1461664|NCT00746798|4820094|P3|Overall Study|Participant unable to return for visit|0
1461665|NCT00746798|4820095|P2|Overall Study|Participant unable to return for visit|0
1461666|NCT00746798|4820096|P1|Overall Study|Participant unable to return for visit|1
1461667|NCT00746798|4820093|P4|Overall Study|Death|0
1461668|NCT00746798|4820094|P3|Overall Study|Death|2
1461669|NCT00746798|4820095|P2|Overall Study|Death|0
1461670|NCT00746798|4820096|P1|Overall Study|Death|0
1461671|NCT00746798|4820093|P4|Overall Study|Withdrawal by Subject|0
1461672|NCT00746798|4820094|P3|Overall Study|Withdrawal by Subject|1
1461673|NCT00746798|4820095|P2|Overall Study|Withdrawal by Subject|1
1461674|NCT00746798|4820096|P1|Overall Study|Withdrawal by Subject|0
1461675|NCT00746798|4820093|P4|Overall Study|Protocol Violation|0
1461676|NCT00746798|4820094|P3|Overall Study|Protocol Violation|0
1461677|NCT00746798|4820095|P2|Overall Study|Protocol Violation|1
1461678|NCT00746798|4820096|P1|Overall Study|Protocol Violation|0
1461679|NCT00746785|4820121|P3|Overall Study|Lost to Follow-up|27
1461680|NCT00746785|4820122|P2|Overall Study|Lost to Follow-up|25
1461681|NCT00746785|4820123|P1|Overall Study|Lost to Follow-up|29
1461682|NCT00746733|4820131|P2|Third Intervention|Withdrawal by Subject|1
1461683|NCT00746733|4820132|P1|Third Intervention|Withdrawal by Subject|1
1461684|NCT00746733|4820131|P2|Second Intervention|Adverse Event|0
1461685|NCT00746733|4820132|P1|Second Intervention|Adverse Event|1
1461686|NCT00746590|4820216|P1|Overall Study|Death|1
1461687|NCT00746564|4820220|P1|Overall Study|Required Pacemaker/ICD Implant|2
1461688|NCT00746551|4820235|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
1461689|NCT00746551|4820236|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
1461690|NCT00746551|4820235|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
1461691|NCT00746551|4820236|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
1461692|NCT00746551|4820235|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
1461693|NCT00746551|4820236|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
1461694|NCT00746356|4820287|P2|Overall Study|Patient relocated|0
1461695|NCT00746356|4820288|P1|Overall Study|Patient relocated|1
1461696|NCT00746356|4820287|P2|Overall Study|Removal of Device|1
1461697|NCT00746356|4820288|P1|Overall Study|Removal of Device|0
1461698|NCT00746356|4820287|P2|Overall Study|Lost to Follow-up|0
1461699|NCT00746356|4820288|P1|Overall Study|Lost to Follow-up|1
1461700|NCT00746356|4820287|P2|Overall Study|Death|3
1461701|NCT00746356|4820288|P1|Overall Study|Death|7
1461702|NCT00746356|4820287|P2|Overall Study|Withdrawal by Subject|3
1461703|NCT00746356|4820288|P1|Overall Study|Withdrawal by Subject|2
1461704|NCT00746330|4820300|P4|Period 1|Abnormal test procedure result|0
1461705|NCT00746330|4820301|P3|Period 1|Abnormal test procedure result|1
1461706|NCT00746330|4820302|P2|Period 1|Abnormal test procedure result|0
1461707|NCT00746330|4820303|P1|Period 1|Abnormal test procedure result|0
1461708|NCT00746252|4820333|P2|Overall Study|weight gain >7.5 %|2
1461709|NCT00746252|4820334|P1|Overall Study|weight gain >7.5 %|1
1461710|NCT00746096|4820356|P2|Overall Study|No study drug treatment|1
1461711|NCT00746096|4820357|P1|Overall Study|No study drug treatment|1
1461712|NCT00746096|4820356|P2|Overall Study|Protocol Violation|0
1461713|NCT00746096|4820357|P1|Overall Study|Protocol Violation|1
1461714|NCT00746096|4820356|P2|Overall Study|Lost to Follow-up|1
1461715|NCT00746096|4820357|P1|Overall Study|Lost to Follow-up|2
1461716|NCT00746096|4820356|P2|Overall Study|Withdrawal by Subject|1
1461717|NCT00746096|4820357|P1|Overall Study|Withdrawal by Subject|5
1461718|NCT00746096|4820356|P2|Overall Study|Adverse Event|0
1461719|NCT00746096|4820357|P1|Overall Study|Adverse Event|1
1461720|NCT00745901|4820388|P2|Overall Study|Patient didn't take any study medication|3
1461721|NCT00745901|4820389|P1|Overall Study|Patient didn't take any study medication|7
1461722|NCT00745901|4820388|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
1461723|NCT00745901|4820389|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
1461724|NCT00745901|4820388|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
1461725|NCT00745901|4820389|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
1461726|NCT00745901|4820388|P2|Overall Study|Patient's next menses did not start with|0
1461727|NCT00745901|4820389|P1|Overall Study|Patient's next menses did not start with|1
1461728|NCT00745901|4820388|P2|Overall Study|Lack of compliance|2
1461729|NCT00745901|4820389|P1|Overall Study|Lack of compliance|2
1461730|NCT00745901|4820388|P2|Overall Study|Pregnancy|4
1461731|NCT00745901|4820389|P1|Overall Study|Pregnancy|2
1461732|NCT00745901|4820388|P2|Overall Study|Lost to Follow-up|4
1461733|NCT00745901|4820389|P1|Overall Study|Lost to Follow-up|7
1461734|NCT00745901|4820388|P2|Overall Study|Withdrawal by Subject|0
1461735|NCT00745901|4820389|P1|Overall Study|Withdrawal by Subject|1
1461736|NCT00745901|4820388|P2|Overall Study|Protocol Violation|1
1461737|NCT00745901|4820389|P1|Overall Study|Protocol Violation|0
1461738|NCT00745901|4820388|P2|Overall Study|Adverse Event|4
1461739|NCT00745901|4820389|P1|Overall Study|Adverse Event|3
1461740|NCT00745875|4820435|P2|Overall Study|Continuing study treatment|4
1461741|NCT00745875|4820436|P1|Overall Study|Continuing study treatment|4
1461742|NCT00745823|4820446|P2|Overall Study|Study Terminated by Sponsor|349
1461743|NCT00745823|4820447|P1|Overall Study|Study Terminated by Sponsor|326
1461744|NCT00745823|4820446|P2|Overall Study|Withdrawal by Subject|8
1461745|NCT00745823|4820447|P1|Overall Study|Withdrawal by Subject|14
1461746|NCT00745823|4820446|P2|Overall Study|Pregnancy|4
1461747|NCT00745823|4820447|P1|Overall Study|Pregnancy|0
1461748|NCT00745823|4820446|P2|Overall Study|Physician Decision|5
1461749|NCT00745823|4820447|P1|Overall Study|Physician Decision|10
1461750|NCT00745823|4820446|P2|Overall Study|Lost to Follow-up|11
1461751|NCT00745823|4820447|P1|Overall Study|Lost to Follow-up|10
1461752|NCT00745823|4820446|P2|Overall Study|Lack of Efficacy|6
1461753|NCT00745823|4820447|P1|Overall Study|Lack of Efficacy|20
1461754|NCT00745823|4820446|P2|Overall Study|Adverse Event|3
1461755|NCT00745823|4820447|P1|Overall Study|Adverse Event|5
1461756|NCT00745498|4820474|P3|Overall Study|Edophthalmitis after preoperative IVB|0
1461757|NCT00745498|4820475|P2|Overall Study|Edophthalmitis after preoperative IVB|0
1461758|NCT00745498|4820476|P1|Overall Study|Edophthalmitis after preoperative IVB|1
1461759|NCT00745498|4820474|P3|Overall Study|Non-PDR related VH|1
1461760|NCT00745498|4820475|P2|Overall Study|Non-PDR related VH|1
1461761|NCT00745498|4820476|P1|Overall Study|Non-PDR related VH|0
1461762|NCT00745498|4820474|P3|Overall Study|Injection of intravitreal silicone oil o|4
1461763|NCT00745498|4820475|P2|Overall Study|Injection of intravitreal silicone oil o|4
1461764|NCT00745498|4820476|P1|Overall Study|Injection of intravitreal silicone oil o|3
1461765|NCT00745498|4820474|P3|Overall Study|Lost to Follow-up|3
1461766|NCT00745498|4820475|P2|Overall Study|Lost to Follow-up|1
1461767|NCT00745498|4820476|P1|Overall Study|Lost to Follow-up|1
1461768|NCT00745420|4820490|P1|Overall Study|Ineligible|1
1461769|NCT00745368|4820507|P1|Overall Study|Unable to provide sample|3
1461770|NCT00745251|4820529|P2|Overall Study|Withdrawal by Subject|1
1461771|NCT00745251|4820530|P1|Overall Study|Withdrawal by Subject|1
1461772|NCT00745251|4820529|P2|Overall Study|Adverse Event|2
1461773|NCT00745251|4820530|P1|Overall Study|Adverse Event|1
1461774|NCT00745095|4820544|P6|Overall Study|Ineligible due to GFR criteria|28
1461775|NCT00745095|4820545|P5|Overall Study|Ineligible due to GFR criteria|30
1461776|NCT00745095|4820546|P4|Overall Study|Ineligible due to GFR criteria|3
1461777|NCT00745095|4820547|P3|Overall Study|Ineligible due to GFR criteria|3
1461778|NCT00745095|4820548|P2|Overall Study|Ineligible due to GFR criteria|2
1461779|NCT00745095|4820549|P1|Overall Study|Ineligible due to GFR criteria|0
1461780|NCT00745095|4820544|P6|Overall Study|Declined to participate|95
1461781|NCT00745095|4820545|P5|Overall Study|Declined to participate|92
1461782|NCT00745095|4820546|P4|Overall Study|Declined to participate|0
1461783|NCT00745095|4820547|P3|Overall Study|Declined to participate|0
1461784|NCT00745095|4820548|P2|Overall Study|Declined to participate|0
1461785|NCT00745095|4820549|P1|Overall Study|Declined to participate|1
1461786|NCT00744978|4820580|P2|Period 2|Adverse Event|1
1461787|NCT00744978|4820581|P1|Period 2|Adverse Event|0
1461788|NCT00744978|4820580|P2|Period 1|Randomized but not Treated|1
1461789|NCT00744978|4820581|P1|Period 1|Randomized but not Treated|1
1461790|NCT00744978|4820580|P2|Period 1|Adverse Event|0
1461791|NCT00744978|4820581|P1|Period 1|Adverse Event|4
1461792|NCT00744978|4820580|P2|Period 1|Other|2
1461793|NCT00744978|4820581|P1|Period 1|Other|0
1461794|NCT00744978|4820580|P2|Period 1|Withdrawal by Subject|2
1461795|NCT00744978|4820581|P1|Period 1|Withdrawal by Subject|0
1461796|NCT00744978|4820580|P2|Period 1|Lost to Follow-up|0
1461797|NCT00744978|4820581|P1|Period 1|Lost to Follow-up|1
1461798|NCT00744939|4820633|P1|Overall Study|incorrect race|1
1461799|NCT00744939|4820633|P1|Overall Study|coma|1
1461800|NCT00744939|4820633|P1|Overall Study|Failed inclusion/exclusion criteria|19
1461801|NCT00744939|4820633|P1|Overall Study|Did not receive Magnevist|7
1461802|NCT00744939|4820633|P1|Overall Study|Medical history exclusionary|1
1461803|NCT00744939|4820633|P1|Overall Study|Lost to Follow-up|12
1461804|NCT00744939|4820633|P1|Overall Study|distance|4
1461805|NCT00744939|4820633|P1|Overall Study|Death|24
1461806|NCT00744939|4820633|P1|Overall Study|Protocol Violation|13
1461807|NCT00744939|4820633|P1|Overall Study|Withdrawal by Subject|9
1461808|NCT00744874|4820669|P1|Overall Study|Unable to accomodate schedule|1
1461809|NCT00744874|4820669|P1|Overall Study|Study Device not available at procedure|1
1461810|NCT00744874|4820669|P1|Overall Study|Withdrawal by Subject|1
1461811|NCT00744874|4820669|P1|Overall Study|Lost to Follow-up|1
1461812|NCT00744757|4820694|P1|Overall Study|Adverse Event|2
1461813|NCT00744757|4820694|P1|Overall Study|Death|6
1461814|NCT00744757|4820694|P1|Overall Study|Withdrawal by Subject|1
1461815|NCT00744757|4820694|P1|Overall Study|Physician Decision|5
1461816|NCT00744757|4820694|P1|Overall Study|Objective disease progression|7
1461817|NCT00744653|4820719|P1|Overall Study|Physician Decision|3
1461818|NCT00744653|4820719|P1|Overall Study|Lost to Follow-up|1
1461819|NCT00744653|4820719|P1|Overall Study|Death|1
1461820|NCT00744653|4820719|P1|Overall Study|antineoplastic treatment|11
1461821|NCT00744627|4820727|P2|Overall Study|Other|0
1461822|NCT00744627|4820728|P1|Overall Study|Other|1
1461823|NCT00744627|4820727|P2|Overall Study|Lost to Follow-up|1
1461824|NCT00744627|4820728|P1|Overall Study|Lost to Follow-up|2
1461825|NCT00744627|4820727|P2|Overall Study|Voluntary Withdrawal|6
1461826|NCT00744627|4820728|P1|Overall Study|Voluntary Withdrawal|9
1461827|NCT00744627|4820727|P2|Overall Study|Protocol Deviations|2
1461828|NCT00744627|4820728|P1|Overall Study|Protocol Deviations|0
1461829|NCT00744627|4820727|P2|Overall Study|Noncompliance|1
1461830|NCT00744627|4820728|P1|Overall Study|Noncompliance|0
1461831|NCT00744627|4820727|P2|Overall Study|Lack of Efficacy|3
1461832|NCT00744627|4820728|P1|Overall Study|Lack of Efficacy|7
1461833|NCT00744627|4820727|P2|Overall Study|Adverse Event|9
1461834|NCT00744627|4820728|P1|Overall Study|Adverse Event|6
1461835|NCT00744523|4820784|P2|30 Days After the Procedure|Insufficient follow-up|5
1461836|NCT00744523|4820785|P1|30 Days After the Procedure|Insufficient follow-up|0
1461837|NCT00744497|4820805|P2|Overall Study|Not defined|13
1461838|NCT00744497|4820806|P1|Overall Study|Not defined|19
1461839|NCT00744497|4820805|P2|Overall Study|Maximum clinical benefit|142
1461840|NCT00744497|4820806|P1|Overall Study|Maximum clinical benefit|141
1461841|NCT00744497|4820805|P2|Overall Study|Patient requested to stop study drug|80
1461842|NCT00744497|4820806|P1|Overall Study|Patient requested to stop study drug|65
1461843|NCT00744497|4820805|P2|Overall Study|Adverse event unrelated to study drug|122
1461844|NCT00744497|4820806|P1|Overall Study|Adverse event unrelated to study drug|78
1461845|NCT00744497|4820805|P2|Overall Study|Study drug toxicity|141
1461846|NCT00744497|4820806|P1|Overall Study|Study drug toxicity|68
1461847|NCT00744497|4820805|P2|Overall Study|Disease progression|219
1461848|NCT00744497|4820806|P1|Overall Study|Disease progression|312
1461849|NCT00744497|4820805|P2|Overall Study|Administrative Reason By Sponsor|8
1461850|NCT00744497|4820806|P1|Overall Study|Administrative Reason By Sponsor|25
1461851|NCT00744497|4820805|P2|Overall Study|No longer meets study criteria|3
1461852|NCT00744497|4820806|P1|Overall Study|No longer meets study criteria|7
1461853|NCT00744497|4820805|P2|Overall Study|Poor compliance/noncompliance|5
1461854|NCT00744497|4820806|P1|Overall Study|Poor compliance/noncompliance|9
1461855|NCT00744497|4820805|P2|Overall Study|Lost to Follow-up|2
1461856|NCT00744497|4820806|P1|Overall Study|Lost to Follow-up|4
1461857|NCT00744497|4820805|P2|Overall Study|Death|9
1461858|NCT00744497|4820806|P1|Overall Study|Death|11
1461859|NCT00744497|4820805|P2|Overall Study|Withdrawal by Subject|18
1461860|NCT00744497|4820806|P1|Overall Study|Withdrawal by Subject|21
1461861|NCT00744328|4820866|P3|Overall Study|Found ineligible after randomization|1
1461862|NCT00744328|4820867|P2|Overall Study|Found ineligible after randomization|0
1461863|NCT00744328|4820868|P1|Overall Study|Found ineligible after randomization|0
1461864|NCT00744328|4820866|P3|Overall Study|Withdrawal by Subject|4
1461865|NCT00744328|4820867|P2|Overall Study|Withdrawal by Subject|3
1461866|NCT00744328|4820868|P1|Overall Study|Withdrawal by Subject|5
1461867|NCT00744328|4820866|P3|Overall Study|Lost to Follow-up|3
1461868|NCT00744328|4820867|P2|Overall Study|Lost to Follow-up|5
1461869|NCT00744328|4820868|P1|Overall Study|Lost to Follow-up|2
1461870|NCT00744263|4820878|P2|Overall Study|Other|2
1461871|NCT00744263|4820879|P1|Overall Study|Other|2
1461872|NCT00744263|4820878|P2|Overall Study|Adverse Event|0
1461873|NCT00744263|4820879|P1|Overall Study|Adverse Event|1
1461874|NCT00744263|4820878|P2|Overall Study|Protocol Violation|5
1461875|NCT00744263|4820879|P1|Overall Study|Protocol Violation|3
1461876|NCT00744263|4820878|P2|Overall Study|Physician Decision|23
1461877|NCT00744263|4820879|P1|Overall Study|Physician Decision|20
1461878|NCT00744263|4820878|P2|Overall Study|Withdrawal by Subject|150
1461879|NCT00744263|4820879|P1|Overall Study|Withdrawal by Subject|166
1461880|NCT00744263|4820878|P2|Overall Study|Lost to Follow-up|2135
1461881|NCT00744263|4820879|P1|Overall Study|Lost to Follow-up|2038
1461882|NCT00744263|4820878|P2|Overall Study|Death|3005
1461883|NCT00744263|4820879|P1|Overall Study|Death|3006
1461884|NCT00744237|4820902|P3|Overall Study|Adverse Event|5
1461885|NCT00744237|4820903|P2|Overall Study|Adverse Event|13
1461886|NCT00744237|4820904|P1|Overall Study|Adverse Event|9
1461887|NCT00744237|4820902|P3|Overall Study|Administrative. Site Closed|1
1461888|NCT00744237|4820903|P2|Overall Study|Administrative. Site Closed|1
1461889|NCT00744237|4820904|P1|Overall Study|Administrative. Site Closed|1
1461890|NCT00744237|4820902|P3|Overall Study|Poor Compliance|0
1461891|NCT00744237|4820903|P2|Overall Study|Poor Compliance|2
1461892|NCT00744237|4820904|P1|Overall Study|Poor Compliance|0
1461893|NCT00744237|4820902|P3|Overall Study|Prohibited Concomitant Medication|1
1461894|NCT00744237|4820903|P2|Overall Study|Prohibited Concomitant Medication|0
1461895|NCT00744237|4820904|P1|Overall Study|Prohibited Concomitant Medication|0
1461896|NCT00744237|4820902|P3|Overall Study|Study Drug Error|0
1461897|NCT00744237|4820903|P2|Overall Study|Study Drug Error|0
1461898|NCT00744237|4820904|P1|Overall Study|Study Drug Error|1
1461899|NCT00744237|4820902|P3|Overall Study|Dosing Error|1
1461900|NCT00744237|4820903|P2|Overall Study|Dosing Error|0
1461901|NCT00744237|4820904|P1|Overall Study|Dosing Error|1
1461902|NCT00744237|4820902|P3|Overall Study|Inclusion/Exclusion criteria not met|0
1461903|NCT00744237|4820903|P2|Overall Study|Inclusion/Exclusion criteria not met|0
1461904|NCT00744237|4820904|P1|Overall Study|Inclusion/Exclusion criteria not met|1
1461905|NCT00744237|4820902|P3|Overall Study|Protocol Violation|3
1461906|NCT00744237|4820903|P2|Overall Study|Protocol Violation|4
1461907|NCT00744237|4820904|P1|Overall Study|Protocol Violation|3
1461908|NCT00744237|4820902|P3|Overall Study|Lost to Follow-up|1
1461909|NCT00744237|4820903|P2|Overall Study|Lost to Follow-up|1
1461910|NCT00744237|4820904|P1|Overall Study|Lost to Follow-up|1
1461911|NCT00744237|4820902|P3|Overall Study|Withdrawal by Subject|3
1461912|NCT00744237|4820903|P2|Overall Study|Withdrawal by Subject|5
1461913|NCT00744237|4820904|P1|Overall Study|Withdrawal by Subject|9
1461914|NCT00744237|4820902|P3|Overall Study|Lack of Efficacy|0
1461915|NCT00744237|4820903|P2|Overall Study|Lack of Efficacy|1
1461916|NCT00744237|4820904|P1|Overall Study|Lack of Efficacy|1
1461917|NCT00744055|4820938|P2|Overall Study|Lost to Follow-up|1
1461918|NCT00744055|4820939|P1|Overall Study|Lost to Follow-up|0
1461919|NCT00744055|4820938|P2|Overall Study|Protocol Violation|1
1461920|NCT00744055|4820939|P1|Overall Study|Protocol Violation|1
1461921|NCT00744055|4820938|P2|Overall Study|Physician Decision|2
1461922|NCT00744055|4820939|P1|Overall Study|Physician Decision|0
1461923|NCT00744055|4820938|P2|Overall Study|Lack of Efficacy|1
1461924|NCT00744055|4820939|P1|Overall Study|Lack of Efficacy|0
1461925|NCT00744055|4820938|P2|Overall Study|Withdrawal by Subject|9
1461926|NCT00744055|4820939|P1|Overall Study|Withdrawal by Subject|6
1461927|NCT00744042|4820947|P1|Overall Study|Withdrawal by Subject|1
1461928|NCT00743652|4820993|P5|Overall Study|Lost to Follow-up|0
1461929|NCT00743652|4820994|P4|Overall Study|Lost to Follow-up|0
1461930|NCT00743652|4820995|P3|Overall Study|Lost to Follow-up|0
1461931|NCT00743652|4820996|P2|Overall Study|Lost to Follow-up|0
1461932|NCT00743652|4820997|P1|Overall Study|Lost to Follow-up|1
1461933|NCT00743652|4820993|P5|Overall Study|Other|0
1461934|NCT00743652|4820994|P4|Overall Study|Other|0
1461935|NCT00743652|4820995|P3|Overall Study|Other|0
1461936|NCT00743652|4820996|P2|Overall Study|Other|1
1461937|NCT00743652|4820997|P1|Overall Study|Other|1
1461938|NCT00743652|4820993|P5|Overall Study|Investigator Request|0
1461939|NCT00743652|4820994|P4|Overall Study|Investigator Request|2
1461940|NCT00743652|4820995|P3|Overall Study|Investigator Request|0
1461941|NCT00743652|4820996|P2|Overall Study|Investigator Request|0
1461942|NCT00743652|4820997|P1|Overall Study|Investigator Request|0
1461943|NCT00743652|4820993|P5|Overall Study|Death|0
1461944|NCT00743652|4820994|P4|Overall Study|Death|0
1461945|NCT00743652|4820995|P3|Overall Study|Death|0
1461946|NCT00743652|4820996|P2|Overall Study|Death|0
1461947|NCT00743652|4820997|P1|Overall Study|Death|2
1461948|NCT00743652|4820993|P5|Overall Study|Adverse Event|0
1461949|NCT00743652|4820994|P4|Overall Study|Adverse Event|0
1461950|NCT00743652|4820995|P3|Overall Study|Adverse Event|0
1461951|NCT00743652|4820996|P2|Overall Study|Adverse Event|0
1461952|NCT00743652|4820997|P1|Overall Study|Adverse Event|3
1461953|NCT00743652|4820993|P5|Overall Study|Parent/Legal Guardian Request|0
1461954|NCT00743652|4820994|P4|Overall Study|Parent/Legal Guardian Request|2
1461955|NCT00743652|4820995|P3|Overall Study|Parent/Legal Guardian Request|2
1461956|NCT00743652|4820996|P2|Overall Study|Parent/Legal Guardian Request|2
1461957|NCT00743652|4820997|P1|Overall Study|Parent/Legal Guardian Request|3
1461958|NCT00743509|4821081|P1|Overall Study|Withdrawal by Subject|2
1461959|NCT00743483|4821086|P1|Treatment Period|Adverse Event|1
1461960|NCT00743483|4821086|P1|Baseline Period|Physician Decision|1
1461961|NCT00743444|4821090|P2|Washout Period|Adverse Event|1
1461962|NCT00743444|4821091|P1|Washout Period|Adverse Event|0
1461963|NCT00743444|4821090|P2|First Intervention|Catheter placement problems|1
1461964|NCT00743444|4821091|P1|First Intervention|Catheter placement problems|0
1461965|NCT00743431|4821100|P1|Overall Study|No documentation available|13
1461966|NCT00743431|4821100|P1|Overall Study|Reason for discontinuation not specified|29
1461967|NCT00743431|4821100|P1|Overall Study|Death|9
1461968|NCT00743431|4821100|P1|Overall Study|Withdrawal by Subject|13
1461969|NCT00743431|4821100|P1|Overall Study|Tumor progression|56
1461970|NCT00743431|4821100|P1|Overall Study|Toxicity|6
1461971|NCT00743366|4821104|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
1461972|NCT00743366|4821105|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
1461973|NCT00743340|4821111|P1|Overall Study|Participant Relocated|1
1461974|NCT00743340|4821111|P1|Overall Study|Rolled over to other Gilead Study|23
1461975|NCT00743340|4821111|P1|Overall Study|Pregnancy|1
1461976|NCT00743340|4821111|P1|Overall Study|Virologic failure|8
1461977|NCT00743340|4821111|P1|Overall Study|Protocol Violation|1
1461978|NCT00743340|4821111|P1|Overall Study|Withdrawal from the Study|5
1461979|NCT00743340|4821111|P1|Overall Study|Lost to Follow-up|1
1461980|NCT00743340|4821111|P1|Overall Study|Study medication non-compliance|1
1461981|NCT00743288|4821115|P7|Overall Study|Worsening of condition (Not PD)|0
1461982|NCT00743288|4821116|P6|Overall Study|Worsening of condition (Not PD)|0
1461983|NCT00743288|4821117|P5|Overall Study|Worsening of condition (Not PD)|0
1461984|NCT00743288|4821118|P4|Overall Study|Worsening of condition (Not PD)|1
1461985|NCT00743288|4821119|P3|Overall Study|Worsening of condition (Not PD)|1
1461986|NCT00743288|4821120|P2|Overall Study|Worsening of condition (Not PD)|2
1461987|NCT00743288|4821121|P1|Overall Study|Worsening of condition (Not PD)|0
1461988|NCT00743288|4821115|P7|Overall Study|Progressive disease (PD)|6
1461989|NCT00743288|4821116|P6|Overall Study|Progressive disease (PD)|3
1461990|NCT00743288|4821117|P5|Overall Study|Progressive disease (PD)|5
1461991|NCT00743288|4821118|P4|Overall Study|Progressive disease (PD)|4
1461992|NCT00743288|4821119|P3|Overall Study|Progressive disease (PD)|1
1461993|NCT00743288|4821120|P2|Overall Study|Progressive disease (PD)|0
1461994|NCT00743288|4821121|P1|Overall Study|Progressive disease (PD)|2
1461995|NCT00743288|4821115|P7|Overall Study|Withdrawal by Subject|1
1461996|NCT00743288|4821116|P6|Overall Study|Withdrawal by Subject|1
1461997|NCT00743288|4821117|P5|Overall Study|Withdrawal by Subject|0
1461998|NCT00743288|4821118|P4|Overall Study|Withdrawal by Subject|0
1461999|NCT00743288|4821119|P3|Overall Study|Withdrawal by Subject|1
1462000|NCT00743288|4821120|P2|Overall Study|Withdrawal by Subject|0
1462001|NCT00743288|4821121|P1|Overall Study|Withdrawal by Subject|0
1462002|NCT00743288|4821115|P7|Overall Study|Adverse Event|2
1462003|NCT00743288|4821116|P6|Overall Study|Adverse Event|1
1462004|NCT00743288|4821117|P5|Overall Study|Adverse Event|1
1462005|NCT00743288|4821118|P4|Overall Study|Adverse Event|2
1462006|NCT00743288|4821119|P3|Overall Study|Adverse Event|2
1462007|NCT00743288|4821120|P2|Overall Study|Adverse Event|1
1462008|NCT00743288|4821121|P1|Overall Study|Adverse Event|1
1462009|NCT00743275|4821135|P2|Overall Study|Protocol Violation|1
1462010|NCT00743275|4821136|P1|Overall Study|Protocol Violation|0
1462011|NCT00743249|4821156|P2|Overall Study|Unsuccessful insertion of stent|1
1462012|NCT00743249|4821157|P1|Overall Study|Unsuccessful insertion of stent|2
1462013|NCT00743249|4821156|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
1462014|NCT00743249|4821157|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
1462015|NCT00743249|4821156|P2|Overall Study|Adverse Event|4
1462016|NCT00743249|4821157|P1|Overall Study|Adverse Event|0
1462017|NCT00743197|4821167|P2|Overall Study|Study terminated due to departure of PI.|2
1462018|NCT00743197|4821168|P1|Overall Study|Study terminated due to departure of PI.|1
1462019|NCT00743119|4821174|P1|Overall Study|Withdrawal by Subject|1
1462020|NCT00743119|4821174|P1|Overall Study|unreliable|3
1462021|NCT00743106|4821188|P2|Overall Study|Met intraoperative exclusion criterion|5
1462022|NCT00743106|4821189|P1|Overall Study|Met intraoperative exclusion criterion|8
1462023|NCT00742924|4821216|P4|Overall Study|Withdrawal by Subject|0
1462024|NCT00742924|4821217|P3|Overall Study|Withdrawal by Subject|1
1462025|NCT00742924|4821218|P2|Overall Study|Withdrawal by Subject|1
1462026|NCT00742924|4821219|P1|Overall Study|Withdrawal by Subject|0
1462027|NCT00742924|4821216|P4|Overall Study|Physician Decision|1
1462028|NCT00742924|4821217|P3|Overall Study|Physician Decision|0
1462029|NCT00742924|4821218|P2|Overall Study|Physician Decision|0
1462030|NCT00742924|4821219|P1|Overall Study|Physician Decision|0
1462031|NCT00742924|4821216|P4|Overall Study|Lack of Efficacy|4
1462032|NCT00742924|4821217|P3|Overall Study|Lack of Efficacy|2
1462033|NCT00742924|4821218|P2|Overall Study|Lack of Efficacy|1
1462034|NCT00742924|4821219|P1|Overall Study|Lack of Efficacy|5
1462035|NCT00742924|4821216|P4|Overall Study|Adverse Event|1
1462036|NCT00742924|4821217|P3|Overall Study|Adverse Event|1
1462037|NCT00742924|4821218|P2|Overall Study|Adverse Event|0
1462038|NCT00742924|4821219|P1|Overall Study|Adverse Event|0
1462039|NCT00742885|4821231|P2|Overall Study|Lost to Follow-up|0
1462040|NCT00742885|4821232|P1|Overall Study|Lost to Follow-up|1
1462041|NCT00742859|4821291|P4|Overall Study|Site error|1
1462042|NCT00742859|4821292|P3|Overall Study|Site error|1
1462043|NCT00742859|4821293|P2|Overall Study|Site error|0
1462044|NCT00742859|4821294|P1|Overall Study|Site error|0
1462045|NCT00742859|4821291|P4|Overall Study|Sponsor request patient out of town|1
1462046|NCT00742859|4821292|P3|Overall Study|Sponsor request patient out of town|1
1462047|NCT00742859|4821293|P2|Overall Study|Sponsor request patient out of town|0
1462048|NCT00742859|4821294|P1|Overall Study|Sponsor request patient out of town|0
1462049|NCT00742859|4821291|P4|Overall Study|Sponsor req visit schedule noncompliance|1
1462050|NCT00742859|4821292|P3|Overall Study|Sponsor req visit schedule noncompliance|0
1462051|NCT00742859|4821293|P2|Overall Study|Sponsor req visit schedule noncompliance|0
1462052|NCT00742859|4821294|P1|Overall Study|Sponsor req visit schedule noncompliance|0
1462053|NCT00742859|4821291|P4|Overall Study|Amendment 2 patient off study drug >4wks|0
1462054|NCT00742859|4821292|P3|Overall Study|Amendment 2 patient off study drug >4wks|1
1462055|NCT00742859|4821293|P2|Overall Study|Amendment 2 patient off study drug >4wks|1
1462056|NCT00742859|4821294|P1|Overall Study|Amendment 2 patient off study drug >4wks|0
1462057|NCT00742859|4821291|P4|Overall Study|Endpoint|2
1462058|NCT00742859|4821292|P3|Overall Study|Endpoint|1
1462059|NCT00742859|4821293|P2|Overall Study|Endpoint|1
1462060|NCT00742859|4821294|P1|Overall Study|Endpoint|0
1462061|NCT00742859|4821291|P4|Overall Study|Withdrawal by Subject|1
1462062|NCT00742859|4821292|P3|Overall Study|Withdrawal by Subject|4
1462063|NCT00742859|4821293|P2|Overall Study|Withdrawal by Subject|2
1462064|NCT00742859|4821294|P1|Overall Study|Withdrawal by Subject|4
1462065|NCT00742859|4821291|P4|Overall Study|Physician Decision|0
1462066|NCT00742859|4821292|P3|Overall Study|Physician Decision|0
1462067|NCT00742859|4821293|P2|Overall Study|Physician Decision|2
1462068|NCT00742859|4821294|P1|Overall Study|Physician Decision|1
1462069|NCT00742859|4821291|P4|Overall Study|Death|1
1462070|NCT00742859|4821292|P3|Overall Study|Death|0
1462071|NCT00742859|4821293|P2|Overall Study|Death|0
1462072|NCT00742859|4821294|P1|Overall Study|Death|1
1462073|NCT00742859|4821291|P4|Overall Study|Adverse Event|1
1462074|NCT00742859|4821292|P3|Overall Study|Adverse Event|3
1462075|NCT00742859|4821293|P2|Overall Study|Adverse Event|6
1462076|NCT00742859|4821294|P1|Overall Study|Adverse Event|5
1462077|NCT00742781|4821308|P1|Overall Study|Withdrawal by Subject|3
1462078|NCT00742625|4821317|P1|Consolidation|Non protocol therapy|13
1462079|NCT00742625|4821317|P1|Consolidation|Refused|1
1462080|NCT00742625|4821317|P1|Consolidation|Death|1
1462081|NCT00742625|4821317|P1|Consolidation|Adverse Event|1
1462082|NCT00742625|4821317|P1|Consolidation|Progression|5
1462083|NCT00742625|4821317|P1|Remission Induction|Other, not specified|5
1462084|NCT00742625|4821317|P1|Remission Induction|Non protocol treatment|17
1462085|NCT00742625|4821317|P1|Remission Induction|Refusal|5
1462086|NCT00742625|4821317|P1|Remission Induction|Death|10
1462087|NCT00742625|4821317|P1|Remission Induction|Adverse Event|3
1462088|NCT00742625|4821317|P1|Remission Induction|Failed induction|8
1462089|NCT00742625|4821317|P1|Remission Induction|Progression|6
1462090|NCT00742560|4821331|P5|Overall Study|MIssing|1
1462091|NCT00742560|4821332|P4|Overall Study|MIssing|0
1462092|NCT00742560|4821333|P3|Overall Study|MIssing|0
1462093|NCT00742560|4821334|P2|Overall Study|MIssing|0
1462094|NCT00742560|4821335|P1|Overall Study|MIssing|0
1462095|NCT00742560|4821331|P5|Overall Study|Not Specified|9
1462096|NCT00742560|4821332|P4|Overall Study|Not Specified|9
1462097|NCT00742560|4821333|P3|Overall Study|Not Specified|8
1462098|NCT00742560|4821334|P2|Overall Study|Not Specified|1
1462099|NCT00742560|4821335|P1|Overall Study|Not Specified|0
1462100|NCT00742560|4821331|P5|Overall Study|New Multiple Myeloma Therapy|4
1462101|NCT00742560|4821332|P4|Overall Study|New Multiple Myeloma Therapy|3
1462102|NCT00742560|4821333|P3|Overall Study|New Multiple Myeloma Therapy|2
1462103|NCT00742560|4821334|P2|Overall Study|New Multiple Myeloma Therapy|0
1462104|NCT00742560|4821335|P1|Overall Study|New Multiple Myeloma Therapy|1
1462105|NCT00742560|4821331|P5|Overall Study|Disease Progression|16
1462106|NCT00742560|4821332|P4|Overall Study|Disease Progression|17
1462107|NCT00742560|4821333|P3|Overall Study|Disease Progression|5
1462108|NCT00742560|4821334|P2|Overall Study|Disease Progression|0
1462109|NCT00742560|4821335|P1|Overall Study|Disease Progression|1
1462110|NCT00742560|4821331|P5|Overall Study|Investigator's Decision|0
1462111|NCT00742560|4821332|P4|Overall Study|Investigator's Decision|1
1462112|NCT00742560|4821333|P3|Overall Study|Investigator's Decision|4
1462113|NCT00742560|4821334|P2|Overall Study|Investigator's Decision|0
1462114|NCT00742560|4821335|P1|Overall Study|Investigator's Decision|0
1462115|NCT00742560|4821331|P5|Overall Study|Subject's Decision|3
1462116|NCT00742560|4821332|P4|Overall Study|Subject's Decision|3
1462117|NCT00742560|4821333|P3|Overall Study|Subject's Decision|2
1462118|NCT00742560|4821334|P2|Overall Study|Subject's Decision|0
1462119|NCT00742560|4821335|P1|Overall Study|Subject's Decision|1
1462120|NCT00742560|4821331|P5|Overall Study|Death|3
1462121|NCT00742560|4821332|P4|Overall Study|Death|2
1462122|NCT00742560|4821333|P3|Overall Study|Death|0
1462123|NCT00742560|4821334|P2|Overall Study|Death|2
1462124|NCT00742560|4821335|P1|Overall Study|Death|0
1462125|NCT00742560|4821331|P5|Overall Study|Adverse Event|1
1462126|NCT00742560|4821332|P4|Overall Study|Adverse Event|1
1462127|NCT00742560|4821333|P3|Overall Study|Adverse Event|1
1462128|NCT00742560|4821334|P2|Overall Study|Adverse Event|0
1462129|NCT00742560|4821335|P1|Overall Study|Adverse Event|0
1462130|NCT00742508|4821409|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
1462131|NCT00742508|4821410|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
1462132|NCT00742508|4821409|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
1462133|NCT00742508|4821410|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
1462134|NCT00742508|4821409|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
1462135|NCT00742508|4821410|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
1462136|NCT00742508|4821409|P2|8-Week Primary Evaluation Period|Protocol Violation|0
1462137|NCT00742508|4821410|P1|8-Week Primary Evaluation Period|Protocol Violation|1
1462138|NCT00742508|4821409|P2|8-Week Primary Evaluation Period|Adverse Event|4
1462139|NCT00742508|4821410|P1|8-Week Primary Evaluation Period|Adverse Event|2
1462140|NCT00742417|4821474|P2|Intensive Period|Adverse Event|0
1462141|NCT00742417|4821475|P1|Intensive Period|Adverse Event|2
1462142|NCT00742417|4821474|P2|Intensive Period|Withdrawal by Subject|1
1462143|NCT00742417|4821475|P1|Intensive Period|Withdrawal by Subject|1
1462144|NCT00742417|4821474|P2|Randomized|Physician Decision|0
1462145|NCT00742417|4821475|P1|Randomized|Physician Decision|1
1462146|NCT00742417|4821474|P2|Randomized|Withdrawal by Subject|0
1462147|NCT00742417|4821475|P1|Randomized|Withdrawal by Subject|1
1462148|NCT00742417|4821474|P2|Randomized|Withdrawal by legal representative|1
1462149|NCT00742417|4821475|P1|Randomized|Withdrawal by legal representative|0
1462150|NCT00742391|4821499|P2|Overall Study|Protocol Violation|0
1462151|NCT00742391|4821500|P1|Overall Study|Protocol Violation|1
1462152|NCT00742391|4821499|P2|Overall Study|Lost to Follow-up|0
1462153|NCT00742391|4821500|P1|Overall Study|Lost to Follow-up|1
1462154|NCT00742391|4821499|P2|Overall Study|Adverse Event|1
1462155|NCT00742391|4821500|P1|Overall Study|Adverse Event|2
1462156|NCT00742326|4821510|P2|Overall Study|Physician Decision|1
1462157|NCT00742326|4821511|P1|Overall Study|Physician Decision|0
1462158|NCT00742274|4821530|P2|Overall Study|Removed for medical reasons|1
1462159|NCT00742274|4821531|P1|Overall Study|Removed for medical reasons|1
1462160|NCT00742274|4821530|P2|Overall Study|Withdrawal by Subject|2
1462161|NCT00742274|4821531|P1|Overall Study|Withdrawal by Subject|1
1462162|NCT00742274|4821530|P2|Overall Study|Death|0
1462163|NCT00742274|4821531|P1|Overall Study|Death|1
1462164|NCT00742235|4821539|P2|Overall Study|Lost to Follow-up|31
1462165|NCT00742235|4821540|P1|Overall Study|Lost to Follow-up|0
1462166|NCT00742209|4821553|P5|Overall Study|Investigator Discretion|1
1462167|NCT00742209|4821554|P4|Overall Study|Investigator Discretion|1
1462168|NCT00742209|4821555|P3|Overall Study|Investigator Discretion|5
1462169|NCT00742209|4821556|P2|Overall Study|Investigator Discretion|0
1462170|NCT00742209|4821557|P1|Overall Study|Investigator Discretion|0
1462171|NCT00742209|4821553|P5|Overall Study|Lack of Efficacy|1
1462172|NCT00742209|4821554|P4|Overall Study|Lack of Efficacy|3
1462173|NCT00742209|4821555|P3|Overall Study|Lack of Efficacy|1
1462174|NCT00742209|4821556|P2|Overall Study|Lack of Efficacy|1
1462175|NCT00742209|4821557|P1|Overall Study|Lack of Efficacy|6
1462176|NCT00742209|4821553|P5|Overall Study|Lost to Follow-up|3
1462177|NCT00742209|4821554|P4|Overall Study|Lost to Follow-up|5
1462178|NCT00742209|4821555|P3|Overall Study|Lost to Follow-up|5
1462179|NCT00742209|4821556|P2|Overall Study|Lost to Follow-up|4
1462180|NCT00742209|4821557|P1|Overall Study|Lost to Follow-up|3
1462181|NCT00742209|4821553|P5|Overall Study|Protocol Violation|3
1462182|NCT00742209|4821554|P4|Overall Study|Protocol Violation|5
1462183|NCT00742209|4821555|P3|Overall Study|Protocol Violation|4
1462184|NCT00742209|4821556|P2|Overall Study|Protocol Violation|5
1462185|NCT00742209|4821557|P1|Overall Study|Protocol Violation|6
1462186|NCT00742209|4821553|P5|Overall Study|Participant Withdrew Consent|4
1462187|NCT00742209|4821554|P4|Overall Study|Participant Withdrew Consent|7
1462188|NCT00742209|4821555|P3|Overall Study|Participant Withdrew Consent|14
1462189|NCT00742209|4821556|P2|Overall Study|Participant Withdrew Consent|4
1462190|NCT00742209|4821557|P1|Overall Study|Participant Withdrew Consent|8
1462191|NCT00742209|4821553|P5|Overall Study|Adverse Event|13
1462192|NCT00742209|4821554|P4|Overall Study|Adverse Event|16
1462193|NCT00742209|4821555|P3|Overall Study|Adverse Event|17
1462194|NCT00742209|4821556|P2|Overall Study|Adverse Event|4
1462195|NCT00742209|4821557|P1|Overall Study|Adverse Event|11
1462196|NCT00742183|4821660|P2|Overall Study|Lack of Efficacy|3
1462197|NCT00742183|4821661|P1|Overall Study|Lack of Efficacy|0
1462198|NCT00742183|4821660|P2|Overall Study|Withdrawal by Subject|0
1462199|NCT00742183|4821661|P1|Overall Study|Withdrawal by Subject|1
1462200|NCT00742183|4821660|P2|Overall Study|Required skin-graft|1
1462201|NCT00742183|4821661|P1|Overall Study|Required skin-graft|1
1462202|NCT00742183|4821660|P2|Overall Study|Lost to Follow-up|4
1462203|NCT00742183|4821661|P1|Overall Study|Lost to Follow-up|4
1462204|NCT00742183|4821660|P2|Overall Study|Physician Decision|2
1462205|NCT00742183|4821661|P1|Overall Study|Physician Decision|0
1462206|NCT00742183|4821660|P2|Overall Study|Death|0
1462207|NCT00742183|4821661|P1|Overall Study|Death|1
1462208|NCT00742183|4821660|P2|Overall Study|Adverse Event|2
1462209|NCT00742183|4821661|P1|Overall Study|Adverse Event|2
1462210|NCT00742079|4821680|P2|Overall Study|Lost to Follow-up|1
1462211|NCT00742079|4821681|P1|Overall Study|Lost to Follow-up|0
1462212|NCT00741988|4821701|P2|Overall Study|Lack of Efficacy|0
1462213|NCT00741988|4821702|P1|Overall Study|Lack of Efficacy|2
1462214|NCT00741988|4821701|P2|Overall Study|Adverse Event|4
1462215|NCT00741988|4821702|P1|Overall Study|Adverse Event|2
1462216|NCT00741936|4821714|P2|Overall Study|Low compliance|0
1462217|NCT00741936|4821715|P1|Overall Study|Low compliance|3
1462218|NCT00741936|4821714|P2|Overall Study|Lack of Efficacy|2
1462219|NCT00741936|4821715|P1|Overall Study|Lack of Efficacy|0
1462220|NCT00741936|4821714|P2|Overall Study|Protocol Violation|0
1462221|NCT00741936|4821715|P1|Overall Study|Protocol Violation|2
1462222|NCT00741936|4821714|P2|Overall Study|Pregnancy|1
1462223|NCT00741936|4821715|P1|Overall Study|Pregnancy|0
1462224|NCT00741936|4821714|P2|Overall Study|Adverse Event|4
1462225|NCT00741936|4821715|P1|Overall Study|Adverse Event|3
1462226|NCT00741936|4821714|P2|Overall Study|Lost to Follow-up|1
1462227|NCT00741936|4821715|P1|Overall Study|Lost to Follow-up|1
1462228|NCT00741819|4821750|P1|Overall Study|Disease progression|1
1462229|NCT00741819|4821750|P1|Overall Study|Death|1
1462230|NCT00741819|4821750|P1|Overall Study|Withdrawal by Subject|3
1462231|NCT00741819|4821750|P1|Overall Study|Adverse Event|3
1462232|NCT00741611|4821764|P3|Overall Study|Withdrawal by Subject|2
1462233|NCT00741611|4821765|P2|Overall Study|Withdrawal by Subject|2
1462234|NCT00741611|4821766|P1|Overall Study|Withdrawal by Subject|0
1462235|NCT00741611|4821764|P3|Overall Study|Death|1
1462236|NCT00741611|4821765|P2|Overall Study|Death|0
1462237|NCT00741611|4821766|P1|Overall Study|Death|0
1462238|NCT00741598|4821785|P2|Overall Study|Withdrawal by Subject|2
1462239|NCT00741598|4821786|P1|Overall Study|Withdrawal by Subject|3
1462240|NCT00741598|4821785|P2|Overall Study|Pregnancy|0
1462241|NCT00741598|4821786|P1|Overall Study|Pregnancy|1
1462242|NCT00741598|4821785|P2|Overall Study|Physician Decision|1
1462243|NCT00741598|4821786|P1|Overall Study|Physician Decision|1
1462244|NCT00741598|4821785|P2|Overall Study|Lack of Efficacy|2
1462245|NCT00741598|4821786|P1|Overall Study|Lack of Efficacy|1
1462246|NCT00741598|4821785|P2|Overall Study|Lost to Follow-up|4
1462247|NCT00741598|4821786|P1|Overall Study|Lost to Follow-up|3
1462248|NCT00741338|4821832|P2|Overall Study|Adverse Event|1
1462249|NCT00741338|4821833|P1|Overall Study|Adverse Event|0
1462250|NCT00741286|4821843|P2|Overall Study|Primary Outcome|1
1462251|NCT00741286|4821844|P1|Overall Study|Primary Outcome|1
1462252|NCT00741286|4821843|P2|Overall Study|Protocol Violation|2
1462253|NCT00741286|4821844|P1|Overall Study|Protocol Violation|3
1462254|NCT00741286|4821843|P2|Overall Study|Adverse Event|6
1462255|NCT00741286|4821844|P1|Overall Study|Adverse Event|1
1462256|NCT00741286|4821843|P2|Overall Study|Lost to Follow-up|10
1462257|NCT00741286|4821844|P1|Overall Study|Lost to Follow-up|15
1462258|NCT00741260|4821878|P7|Overall Study|Not Specified|1
1462259|NCT00741260|4821879|P6|Overall Study|Not Specified|3
1462260|NCT00741260|4821880|P5|Overall Study|Not Specified|1
1462261|NCT00741260|4821881|P4|Overall Study|Not Specified|2
1462262|NCT00741260|4821882|P3|Overall Study|Not Specified|1
1462263|NCT00741260|4821883|P2|Overall Study|Not Specified|1
1462264|NCT00741260|4821884|P1|Overall Study|Not Specified|2
1462265|NCT00741260|4821878|P7|Overall Study|Physician Decision|0
1462266|NCT00741260|4821879|P6|Overall Study|Physician Decision|0
1462267|NCT00741260|4821880|P5|Overall Study|Physician Decision|0
1462268|NCT00741260|4821881|P4|Overall Study|Physician Decision|0
1462269|NCT00741260|4821882|P3|Overall Study|Physician Decision|0
1462270|NCT00741260|4821883|P2|Overall Study|Physician Decision|1
1462271|NCT00741260|4821884|P1|Overall Study|Physician Decision|1
1462272|NCT00741260|4821878|P7|Overall Study|Withdrawal by Subject|1
1462273|NCT00741260|4821879|P6|Overall Study|Withdrawal by Subject|3
1462274|NCT00741260|4821880|P5|Overall Study|Withdrawal by Subject|1
1462275|NCT00741260|4821881|P4|Overall Study|Withdrawal by Subject|0
1462276|NCT00741260|4821882|P3|Overall Study|Withdrawal by Subject|0
1462277|NCT00741260|4821883|P2|Overall Study|Withdrawal by Subject|0
1462278|NCT00741260|4821884|P1|Overall Study|Withdrawal by Subject|0
1462279|NCT00741260|4821878|P7|Overall Study|Death|1
1462280|NCT00741260|4821879|P6|Overall Study|Death|2
1462281|NCT00741260|4821880|P5|Overall Study|Death|2
1462282|NCT00741260|4821881|P4|Overall Study|Death|1
1462283|NCT00741260|4821882|P3|Overall Study|Death|0
1462284|NCT00741260|4821883|P2|Overall Study|Death|1
1462285|NCT00741260|4821884|P1|Overall Study|Death|0
1462286|NCT00741260|4821878|P7|Overall Study|Disease Progression|4
1462287|NCT00741260|4821879|P6|Overall Study|Disease Progression|37
1462288|NCT00741260|4821880|P5|Overall Study|Disease Progression|5
1462289|NCT00741260|4821881|P4|Overall Study|Disease Progression|3
1462290|NCT00741260|4821882|P3|Overall Study|Disease Progression|3
1462291|NCT00741260|4821883|P2|Overall Study|Disease Progression|5
1462292|NCT00741260|4821884|P1|Overall Study|Disease Progression|3
1462293|NCT00741091|4821931|P1|Overall Study|Missed Visit|22
1462294|NCT00741091|4821931|P1|Overall Study|Withdrawal by Subject|6
1462295|NCT00741091|4821931|P1|Overall Study|Lost to Follow-up|16
1462296|NCT00741091|4821931|P1|Overall Study|Death|13
1462297|NCT00741039|4821941|P2|Overall Study|Patient non-compliance|0
1462298|NCT00741039|4821942|P1|Overall Study|Patient non-compliance|2
1462299|NCT00741013|4821979|P3|Overall Study|Discovered failed screen after enrolled|0
1462300|NCT00741013|4821980|P2|Overall Study|Discovered failed screen after enrolled|2
1462301|NCT00741013|4821981|P1|Overall Study|Discovered failed screen after enrolled|0
1462302|NCT00741013|4821979|P3|Overall Study|Withdrawal by Subject|1
1462303|NCT00741013|4821980|P2|Overall Study|Withdrawal by Subject|0
1462304|NCT00741013|4821981|P1|Overall Study|Withdrawal by Subject|0
1462305|NCT00741013|4821979|P3|Overall Study|Adverse Event|0
1462306|NCT00741013|4821980|P2|Overall Study|Adverse Event|0
1462307|NCT00741013|4821981|P1|Overall Study|Adverse Event|1
1462308|NCT00740870|4821992|P1|Overall Study|Further testing contraindicated implant|17
1462309|NCT00740870|4821992|P1|Overall Study|Not Catheterized|4
1462310|NCT00740857|4822007|P3|Overall Study|Withdrawal by Subject|0
1462311|NCT00740857|4822008|P2|Overall Study|Withdrawal by Subject|0
1462312|NCT00740857|4822009|P1|Overall Study|Withdrawal by Subject|1
1462313|NCT00740792|4822064|P4|Overall Study|administrative|2
1462314|NCT00740792|4822065|P3|Overall Study|administrative|8
1462315|NCT00740792|4822066|P2|Overall Study|administrative|3
1462316|NCT00740792|4822067|P1|Overall Study|administrative|3
1462317|NCT00740792|4822064|P4|Overall Study|Withdrawal by Subject|0
1462318|NCT00740792|4822065|P3|Overall Study|Withdrawal by Subject|0
1462319|NCT00740792|4822066|P2|Overall Study|Withdrawal by Subject|1
1462320|NCT00740792|4822067|P1|Overall Study|Withdrawal by Subject|1
1462321|NCT00740792|4822064|P4|Overall Study|Protocol Violation|2
1462322|NCT00740792|4822065|P3|Overall Study|Protocol Violation|0
1462323|NCT00740792|4822066|P2|Overall Study|Protocol Violation|1
1462324|NCT00740792|4822067|P1|Overall Study|Protocol Violation|0
1462325|NCT00740792|4822064|P4|Overall Study|Lost to Follow-up|0
1462326|NCT00740792|4822065|P3|Overall Study|Lost to Follow-up|0
1462327|NCT00740792|4822066|P2|Overall Study|Lost to Follow-up|1
1462328|NCT00740792|4822067|P1|Overall Study|Lost to Follow-up|2
1462329|NCT00740792|4822064|P4|Overall Study|Lack of Efficacy|3
1462330|NCT00740792|4822065|P3|Overall Study|Lack of Efficacy|0
1462331|NCT00740792|4822066|P2|Overall Study|Lack of Efficacy|1
1462332|NCT00740792|4822067|P1|Overall Study|Lack of Efficacy|1
1462333|NCT00740792|4822064|P4|Overall Study|Adverse Event|3
1462334|NCT00740792|4822065|P3|Overall Study|Adverse Event|1
1462335|NCT00740792|4822066|P2|Overall Study|Adverse Event|1
1462336|NCT00740792|4822067|P1|Overall Study|Adverse Event|3
1462337|NCT00740779|4822088|P3|Overall Study|Lost to Follow-up|5
1462338|NCT00740779|4822089|P2|Overall Study|Lost to Follow-up|3
1462339|NCT00740779|4822090|P1|Overall Study|Lost to Follow-up|2
1462340|NCT00740779|4822088|P3|Overall Study|Withdrawal by Subject|2
1462341|NCT00740779|4822089|P2|Overall Study|Withdrawal by Subject|4
1462342|NCT00740779|4822090|P1|Overall Study|Withdrawal by Subject|2
1462343|NCT00740779|4822088|P3|Overall Study|Lack of Efficacy|2
1462344|NCT00740779|4822089|P2|Overall Study|Lack of Efficacy|0
1462345|NCT00740779|4822090|P1|Overall Study|Lack of Efficacy|0
1462346|NCT00740779|4822088|P3|Overall Study|Protocol Violation|1
1462347|NCT00740779|4822089|P2|Overall Study|Protocol Violation|1
1462348|NCT00740779|4822090|P1|Overall Study|Protocol Violation|1
1462349|NCT00740779|4822088|P3|Overall Study|Adverse Event|3
1462350|NCT00740779|4822089|P2|Overall Study|Adverse Event|6
1462351|NCT00740779|4822090|P1|Overall Study|Adverse Event|4
1462352|NCT00740714|4822107|P3|Overall Study|Withdrawal by Subject|29
1462353|NCT00740714|4822108|P2|Overall Study|Withdrawal by Subject|19
1462354|NCT00740714|4822109|P1|Overall Study|Withdrawal by Subject|17
1462355|NCT00740636|4822185|P2|Overall Study|Death|0
1462356|NCT00740636|4822186|P1|Overall Study|Death|1
1462357|NCT00740636|4822185|P2|Overall Study|Progressive Disease|0
1462358|NCT00740636|4822186|P1|Overall Study|Progressive Disease|1
1462359|NCT00740636|4822185|P2|Overall Study|Patient Not Treated|1
1462360|NCT00740636|4822186|P1|Overall Study|Patient Not Treated|0
1462361|NCT00740636|4822185|P2|Overall Study|Patient Ineligible|1
1462362|NCT00740636|4822186|P1|Overall Study|Patient Ineligible|0
1462363|NCT00740636|4822185|P2|Overall Study|Adverse Event|2
1462364|NCT00740636|4822186|P1|Overall Study|Adverse Event|0
1462365|NCT00740597|4822192|P1|Overall Study|insurance would not cover treatment|1
1462366|NCT00740584|4822196|P1|Overall Study|Withdrawal by Subject|1
1462367|NCT00740480|4822200|P1|Overall Study|Physician Decision|1
1462368|NCT00740480|4822200|P1|Overall Study|Adverse Event|1
1462369|NCT00740220|4822204|P1|Overall Study|screen failures (non-COPD patients)|9
1462370|NCT00740051|4822229|P2|Overall Study|Other reason (not specified)|1
1462371|NCT00740051|4822230|P1|Overall Study|Other reason (not specified)|4
1462372|NCT00740051|4822229|P2|Overall Study|Withdrawal by Subject|8
1462373|NCT00740051|4822230|P1|Overall Study|Withdrawal by Subject|6
1462374|NCT00740051|4822229|P2|Overall Study|Lost to Follow-up|8
1462375|NCT00740051|4822230|P1|Overall Study|Lost to Follow-up|3
1462376|NCT00740051|4822229|P2|Overall Study|Protocol Violation|6
1462377|NCT00740051|4822230|P1|Overall Study|Protocol Violation|2
1462378|NCT00740051|4822229|P2|Overall Study|Adverse Event|4
1462379|NCT00740051|4822230|P1|Overall Study|Adverse Event|1
1462380|NCT00740051|4822229|P2|Overall Study|Lack of Efficacy|5
1462381|NCT00740051|4822230|P1|Overall Study|Lack of Efficacy|2
1462382|NCT00739973|4822333|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1462383|NCT00739973|4822334|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1462384|NCT00739973|4822335|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
1462385|NCT00739973|4822336|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1462386|NCT00739973|4822337|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1462387|NCT00739973|4822338|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1462388|NCT00739973|4822339|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1462389|NCT00739973|4822340|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
1462390|NCT00739973|4822341|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1462391|NCT00739973|4822333|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
1462392|NCT00739973|4822334|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
1462393|NCT00739973|4822335|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
1462394|NCT00739973|4822336|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
1462395|NCT00739973|4822337|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
1462396|NCT00739973|4822338|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
1462397|NCT00739973|4822339|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
1462398|NCT00739973|4822340|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
1462399|NCT00739973|4822341|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
1462400|NCT00739973|4822333|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1462401|NCT00739973|4822334|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1462402|NCT00739973|4822335|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
1462403|NCT00739973|4822336|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1462404|NCT00739973|4822337|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1462405|NCT00739973|4822338|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1462406|NCT00739973|4822339|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1462407|NCT00739973|4822340|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1462408|NCT00739973|4822341|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1462409|NCT00739973|4822333|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
1462410|NCT00739973|4822334|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
1462411|NCT00739973|4822335|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
1462412|NCT00739973|4822336|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
1462413|NCT00739973|4822337|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
1462414|NCT00739973|4822338|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
1462415|NCT00739973|4822339|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
1462416|NCT00739973|4822340|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
1462417|NCT00739973|4822341|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
1462418|NCT00739973|4822333|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
1462419|NCT00739973|4822334|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
1462420|NCT00739973|4822335|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
1462421|NCT00739973|4822336|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
1462422|NCT00739973|4822337|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
1462423|NCT00739973|4822338|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
1462424|NCT00739973|4822339|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
1462425|NCT00739973|4822340|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
1462426|NCT00739973|4822341|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
1462427|NCT00739973|4822333|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1462428|NCT00739973|4822334|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1462429|NCT00739973|4822335|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1462430|NCT00739973|4822336|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1462431|NCT00739973|4822337|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1462432|NCT00739973|4822338|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1462433|NCT00739973|4822339|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
1462434|NCT00739973|4822340|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1462435|NCT00739973|4822341|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1462436|NCT00739973|4822333|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
1462437|NCT00739973|4822334|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
1462438|NCT00739973|4822335|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
1462439|NCT00739973|4822336|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
1462440|NCT00739973|4822337|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
1462441|NCT00739973|4822338|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
1462442|NCT00739973|4822339|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
1462443|NCT00739973|4822340|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
1462444|NCT00739973|4822341|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
1462445|NCT00739973|4822333|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1462446|NCT00739973|4822334|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1462447|NCT00739973|4822335|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1462448|NCT00739973|4822336|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1462449|NCT00739973|4822337|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1462450|NCT00739973|4822338|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1462451|NCT00739973|4822339|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1462452|NCT00739973|4822340|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
1462453|NCT00739973|4822341|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
1462454|NCT00739973|4822333|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1462455|NCT00739973|4822334|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
1462456|NCT00739973|4822335|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1462457|NCT00739973|4822336|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1462458|NCT00739973|4822337|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
1462459|NCT00739973|4822338|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1462460|NCT00739973|4822339|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1462461|NCT00739973|4822340|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1462462|NCT00739973|4822341|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1462463|NCT00739973|4822333|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
1462464|NCT00739973|4822334|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
1462465|NCT00739973|4822335|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
1462466|NCT00739973|4822336|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
1462467|NCT00739973|4822337|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
1462468|NCT00739973|4822338|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
1462469|NCT00739973|4822339|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
1462470|NCT00739973|4822340|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
1462471|NCT00739973|4822341|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
1462472|NCT00739973|4822333|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1462473|NCT00739973|4822334|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1462474|NCT00739973|4822335|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1462475|NCT00739973|4822336|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1462476|NCT00739973|4822337|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1462477|NCT00739973|4822338|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1462478|NCT00739973|4822339|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1462479|NCT00739973|4822340|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1462480|NCT00739973|4822341|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
1462481|NCT00739973|4822333|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1462482|NCT00739973|4822334|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1462483|NCT00739973|4822335|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1462484|NCT00739973|4822336|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1462485|NCT00739973|4822337|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1462486|NCT00739973|4822338|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1462487|NCT00739973|4822339|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1462488|NCT00739973|4822340|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1462489|NCT00739973|4822341|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
1462490|NCT00739973|4822333|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1462491|NCT00739973|4822334|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1462492|NCT00739973|4822335|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1462493|NCT00739973|4822336|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1462494|NCT00739973|4822337|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1462495|NCT00739973|4822338|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1462496|NCT00739973|4822339|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1462497|NCT00739973|4822340|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1462498|NCT00739973|4822341|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
1462499|NCT00739973|4822333|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1462500|NCT00739973|4822334|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1462501|NCT00739973|4822335|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1462502|NCT00739973|4822336|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1462503|NCT00739973|4822337|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1462504|NCT00739973|4822338|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1462505|NCT00739973|4822339|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1462506|NCT00739973|4822340|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1462507|NCT00739973|4822341|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
1462508|NCT00739973|4822333|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1462509|NCT00739973|4822334|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1462510|NCT00739973|4822335|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1462511|NCT00739973|4822336|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1462512|NCT00739973|4822337|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1462513|NCT00739973|4822338|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1462514|NCT00739973|4822339|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1462515|NCT00739973|4822340|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1462516|NCT00739973|4822341|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
1462517|NCT00739973|4822333|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1462518|NCT00739973|4822334|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1462519|NCT00739973|4822335|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1462520|NCT00739973|4822336|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1462521|NCT00739973|4822337|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1462522|NCT00739973|4822338|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1462523|NCT00739973|4822339|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1462524|NCT00739973|4822340|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1462525|NCT00739973|4822341|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
1462526|NCT00739973|4822333|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1462527|NCT00739973|4822334|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1462528|NCT00739973|4822335|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1462529|NCT00739973|4822336|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1462530|NCT00739973|4822337|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1462531|NCT00739973|4822338|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1462532|NCT00739973|4822339|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1462533|NCT00739973|4822340|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1462534|NCT00739973|4822341|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
1462535|NCT00739934|4822427|P1|Voriconazole Oral|Other|3
1462536|NCT00739934|4822427|P1|Voriconazole IV|Adverse Event|6
1462537|NCT00739908|4822449|P2|Overall Study|Relocation|1
1462538|NCT00739908|4822450|P1|Overall Study|Relocation|0
1462539|NCT00739908|4822449|P2|Overall Study|Lack of Efficacy|1
1462540|NCT00739908|4822450|P1|Overall Study|Lack of Efficacy|0
1462541|NCT00739908|4822449|P2|Overall Study|Non-Compliance With Study Medication|3
1462542|NCT00739908|4822450|P1|Overall Study|Non-Compliance With Study Medication|0
1462543|NCT00739908|4822449|P2|Overall Study|Non-Compliance With Study Procedures|3
1462544|NCT00739908|4822450|P1|Overall Study|Non-Compliance With Study Procedures|2
1462545|NCT00739908|4822449|P2|Overall Study|Lost to Follow-up|9
1462546|NCT00739908|4822450|P1|Overall Study|Lost to Follow-up|14
1462547|NCT00739908|4822449|P2|Overall Study|Withdrawal by Subject|2
1462548|NCT00739908|4822450|P1|Overall Study|Withdrawal by Subject|4
1462549|NCT00739908|4822449|P2|Overall Study|Adverse Event|6
1462550|NCT00739908|4822450|P1|Overall Study|Adverse Event|5
1462551|NCT00739882|4822470|P2|Open-label Period|Other|5
1462552|NCT00739882|4822471|P1|Open-label Period|Other|9
1462553|NCT00739882|4822470|P2|Open-label Period|Adverse Event|0
1462554|NCT00739882|4822471|P1|Open-label Period|Adverse Event|1
1462555|NCT00739882|4822470|P2|Double-blind Period|Not specified|8
1462556|NCT00739882|4822471|P1|Double-blind Period|Not specified|16
1462557|NCT00739882|4822470|P2|Double-blind Period|Lack of Efficacy|1
1462558|NCT00739882|4822471|P1|Double-blind Period|Lack of Efficacy|1
1462559|NCT00739882|4822470|P2|Double-blind Period|Protocol Violation|0
1462560|NCT00739882|4822471|P1|Double-blind Period|Protocol Violation|1
1462561|NCT00739882|4822470|P2|Double-blind Period|Adverse Event|2
1462562|NCT00739882|4822471|P1|Double-blind Period|Adverse Event|1
1462563|NCT00739674|4822532|P2|Overall Study|Erectile dysfunction|1
1462564|NCT00739674|4822533|P1|Overall Study|Erectile dysfunction|0
1462565|NCT00739674|4822532|P2|Overall Study|Home monitoring off meds|0
1462566|NCT00739674|4822533|P1|Overall Study|Home monitoring off meds|1
1462567|NCT00739674|4822532|P2|Overall Study|Unable to attend visit|1
1462568|NCT00739674|4822533|P1|Overall Study|Unable to attend visit|3
1462569|NCT00739674|4822532|P2|Overall Study|Non compliant|0
1462570|NCT00739674|4822533|P1|Overall Study|Non compliant|4
1462571|NCT00739674|4822532|P2|Overall Study|Patient moved|2
1462572|NCT00739674|4822533|P1|Overall Study|Patient moved|3
1462573|NCT00739674|4822532|P2|Overall Study|Clinic closed|4
1462574|NCT00739674|4822533|P1|Overall Study|Clinic closed|6
1462575|NCT00739674|4822532|P2|Overall Study|Reason missing|0
1462576|NCT00739674|4822533|P1|Overall Study|Reason missing|2
1462577|NCT00739674|4822532|P2|Overall Study|Withdrawal by Subject|9
1462578|NCT00739674|4822533|P1|Overall Study|Withdrawal by Subject|9
1462579|NCT00739674|4822532|P2|Overall Study|Protocol Violation|5
1462580|NCT00739674|4822533|P1|Overall Study|Protocol Violation|5
1462581|NCT00739674|4822532|P2|Overall Study|Lost to Follow-up|30
1462582|NCT00739674|4822533|P1|Overall Study|Lost to Follow-up|52
1462583|NCT00739674|4822532|P2|Overall Study|Lack of Efficacy|0
1462584|NCT00739674|4822533|P1|Overall Study|Lack of Efficacy|1
1462585|NCT00739674|4822532|P2|Overall Study|Death|0
1462586|NCT00739674|4822533|P1|Overall Study|Death|1
1462587|NCT00739674|4822532|P2|Overall Study|Adverse Event|13
1462588|NCT00739674|4822533|P1|Overall Study|Adverse Event|22
1462589|NCT00739674|4822532|P2|Overall Study|Dietician consultation >30 days|9
1462590|NCT00739674|4822533|P1|Overall Study|Dietician consultation >30 days|1
1462591|NCT00739674|4822532|P2|Overall Study|No follow-up data|18
1462592|NCT00739674|4822533|P1|Overall Study|No follow-up data|33
1462593|NCT00739674|4822532|P2|Overall Study|Site 212 removal|13
1462594|NCT00739674|4822533|P1|Overall Study|Site 212 removal|19
1462595|NCT00739674|4822532|P2|Overall Study|Screening failures|17
1462596|NCT00739674|4822533|P1|Overall Study|Screening failures|19
1462597|NCT00739661|4822561|P2|Overall Study|Reason for discontinuation not available|1
1462598|NCT00739661|4822562|P1|Overall Study|Reason for discontinuation not available|1
1462599|NCT00739661|4822561|P2|Overall Study|Disease progression, radiographic|37
1462600|NCT00739661|4822562|P1|Overall Study|Disease progression, radiographic|33
1462601|NCT00739661|4822561|P2|Overall Study|Patient decision to withdraw|4
1462602|NCT00739661|4822562|P1|Overall Study|Patient decision to withdraw|9
1462603|NCT00739661|4822561|P2|Overall Study|Physician decision to withdraw patient|0
1462604|NCT00739661|4822562|P1|Overall Study|Physician decision to withdraw patient|1
1462605|NCT00739661|4822561|P2|Overall Study|Adverse Event|0
1462606|NCT00739661|4822562|P1|Overall Study|Adverse Event|2
1462607|NCT00739648|4822574|P2|Overall Study|Do not know|6
1462608|NCT00739648|4822575|P1|Overall Study|Do not know|4
1462609|NCT00739648|4822574|P2|Overall Study|Death|0
1462610|NCT00739648|4822575|P1|Overall Study|Death|2
1462611|NCT00739648|4822574|P2|Overall Study|Lost to Follow-up|7
1462612|NCT00739648|4822575|P1|Overall Study|Lost to Follow-up|4
1462613|NCT00739648|4822574|P2|Overall Study|Withdrawal by Subject|25
1462614|NCT00739648|4822575|P1|Overall Study|Withdrawal by Subject|13
1462615|NCT00739648|4822574|P2|Overall Study|Adverse Event|15
1462616|NCT00739648|4822575|P1|Overall Study|Adverse Event|3
1462617|NCT00739596|4822589|P2|Overall Study|Protocol Deviation|1
1462618|NCT00739596|4822590|P1|Overall Study|Protocol Deviation|1
1462619|NCT00739596|4822589|P2|Overall Study|Lost to Follow-up|2
1462620|NCT00739596|4822590|P1|Overall Study|Lost to Follow-up|0
1462621|NCT00739596|4822589|P2|Overall Study|Patient Withdrew Consent|8
1462622|NCT00739596|4822590|P1|Overall Study|Patient Withdrew Consent|8
1462623|NCT00739596|4822589|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
1462624|NCT00739596|4822590|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
1462625|NCT00739596|4822589|P2|Overall Study|Adverse Event|6
1462626|NCT00739596|4822590|P1|Overall Study|Adverse Event|12
1462627|NCT00739310|4822632|P1|Overall Study|Lost to Follow-up|2
1462628|NCT00739310|4822632|P1|Overall Study|Withdrawal by Subject|1
1462629|NCT00739310|4822632|P1|Overall Study|Poor adherance to prescribed therapy|4
1462630|NCT00739297|4822637|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
1462631|NCT00739297|4822638|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
1462632|NCT00739297|4822639|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
1462633|NCT00739297|4822640|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
1462634|NCT00739297|4822641|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
1462635|NCT00739297|4822642|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
1462636|NCT00739297|4822643|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
1462637|NCT00739297|4822637|P7|First Washout Period of 4-7 Days|Adverse Event|2
1462638|NCT00739297|4822638|P6|First Washout Period of 4-7 Days|Adverse Event|0
1462639|NCT00739297|4822639|P5|First Washout Period of 4-7 Days|Adverse Event|0
1462640|NCT00739297|4822640|P4|First Washout Period of 4-7 Days|Adverse Event|2
1462641|NCT00739297|4822641|P3|First Washout Period of 4-7 Days|Adverse Event|0
1462642|NCT00739297|4822642|P2|First Washout Period of 4-7 Days|Adverse Event|0
1462643|NCT00739297|4822643|P1|First Washout Period of 4-7 Days|Adverse Event|0
1462644|NCT00739102|4822671|P1|Overall Study|Withdrawal by Subject|10
1462645|NCT00739102|4822671|P1|Overall Study|Death|5
1462646|NCT00739063|4822687|P1|Overall Study|Screen failures|8
1462647|NCT00738894|4822732|P2|Overall Study|Death|0
1462648|NCT00738894|4822733|P1|Overall Study|Death|2
1462649|NCT00738894|4822732|P2|Overall Study|Physician Decision|5
1462650|NCT00738894|4822733|P1|Overall Study|Physician Decision|4
1462651|NCT00738894|4822732|P2|Overall Study|Withdrawal by Subject|15
1462652|NCT00738894|4822733|P1|Overall Study|Withdrawal by Subject|10
1462653|NCT00738894|4822732|P2|Overall Study|Lost to Follow-up|13
1462654|NCT00738894|4822733|P1|Overall Study|Lost to Follow-up|23
1462655|NCT00738881|4822746|P2|Overall Study|Withdrawal by Subject|2
1462656|NCT00738881|4822747|P1|Overall Study|Withdrawal by Subject|0
1462657|NCT00738699|4822761|P2|Overall Study|Not specified|0
1462658|NCT00738699|4822762|P1|Overall Study|Not specified|2
1462659|NCT00738699|4822761|P2|Overall Study|Discontinuation of study by Sponsor|72
1462660|NCT00738699|4822762|P1|Overall Study|Discontinuation of study by Sponsor|123
1462661|NCT00738699|4822761|P2|Overall Study|Death|68
1462662|NCT00738699|4822762|P1|Overall Study|Death|144
1462663|NCT00738699|4822761|P2|Overall Study|Lost to Follow-up|0
1462664|NCT00738699|4822762|P1|Overall Study|Lost to Follow-up|1
1462665|NCT00738699|4822761|P2|Overall Study|Withdrawal by Subject|0
1462666|NCT00738699|4822762|P1|Overall Study|Withdrawal by Subject|5
1462667|NCT00738673|4822780|P2|Overall Study|Withdrawal by Subject|1
1462668|NCT00738673|4822781|P1|Overall Study|Withdrawal by Subject|3
1462669|NCT00738673|4822780|P2|Overall Study|Protocol Violation|2
1462670|NCT00738673|4822781|P1|Overall Study|Protocol Violation|1
1462671|NCT00738673|4822780|P2|Overall Study|Lack of Efficacy|8
1462672|NCT00738673|4822781|P1|Overall Study|Lack of Efficacy|19
1462673|NCT00738673|4822780|P2|Overall Study|Adverse Event|0
1462674|NCT00738673|4822781|P1|Overall Study|Adverse Event|1
1462675|NCT00738530|4822819|P2|Overall Study|Withdrawal by Subject|8
1462676|NCT00738530|4822820|P1|Overall Study|Withdrawal by Subject|6
1462677|NCT00738530|4822819|P2|Overall Study|Lost to Follow-up|6
1462678|NCT00738530|4822820|P1|Overall Study|Lost to Follow-up|8
1462679|NCT00738530|4822819|P2|Overall Study|Death|224
1462680|NCT00738530|4822820|P1|Overall Study|Death|220
1462681|NCT00738400|4822855|P2|Overall Study|Non-compliant with study medication|1
1462682|NCT00738400|4822856|P1|Overall Study|Non-compliant with study medication|0
1462683|NCT00738400|4822855|P2|Overall Study|Protocol Violation|0
1462684|NCT00738400|4822856|P1|Overall Study|Protocol Violation|1
1462685|NCT00738400|4822855|P2|Overall Study|Lost to Follow-up|3
1462686|NCT00738400|4822856|P1|Overall Study|Lost to Follow-up|0
1462687|NCT00738400|4822855|P2|Overall Study|Lack of Efficacy|1
1462688|NCT00738400|4822856|P1|Overall Study|Lack of Efficacy|0
1462689|NCT00738400|4822855|P2|Overall Study|Withdrawal by Subject|1
1462690|NCT00738400|4822856|P1|Overall Study|Withdrawal by Subject|0
1462691|NCT00738400|4822855|P2|Overall Study|Adverse Event|1
1462692|NCT00738400|4822856|P1|Overall Study|Adverse Event|3
1462693|NCT00738374|4822877|P4|Maintenance Treatment/Observation Phase|Not Specified|0
1462694|NCT00738374|4822878|P3|Maintenance Treatment/Observation Phase|Not Specified|0
1462695|NCT00738374|4822879|P2|Maintenance Treatment/Observation Phase|Not Specified|1
1462696|NCT00738374|4822880|P1|Maintenance Treatment/Observation Phase|Not Specified|0
1462697|NCT00738374|4822877|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
1462698|NCT00738374|4822878|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
1462699|NCT00738374|4822879|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
1462700|NCT00738374|4822880|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
1462701|NCT00738374|4822877|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
1462702|NCT00738374|4822878|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
1462703|NCT00738374|4822879|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
1462704|NCT00738374|4822880|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
1462705|NCT00738374|4822877|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
1462706|NCT00738374|4822878|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
1462707|NCT00738374|4822879|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
1462708|NCT00738374|4822880|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
1462709|NCT00738374|4822877|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
1462710|NCT00738374|4822878|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
1462711|NCT00738374|4822879|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
1462712|NCT00738374|4822880|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
1462713|NCT00738374|4822877|P4|Induction Treatment Phase|Withdrawal by Subject|0
1462714|NCT00738374|4822878|P3|Induction Treatment Phase|Withdrawal by Subject|0
1462715|NCT00738374|4822879|P2|Induction Treatment Phase|Withdrawal by Subject|0
1462716|NCT00738374|4822880|P1|Induction Treatment Phase|Withdrawal by Subject|1
1462717|NCT00738374|4822877|P4|Induction Treatment Phase|Non-compliance|0
1462718|NCT00738374|4822878|P3|Induction Treatment Phase|Non-compliance|0
1462719|NCT00738374|4822879|P2|Induction Treatment Phase|Non-compliance|0
1462720|NCT00738374|4822880|P1|Induction Treatment Phase|Non-compliance|1
1462721|NCT00738374|4822877|P4|Induction Treatment Phase|Protocol Violation|0
1462722|NCT00738374|4822878|P3|Induction Treatment Phase|Protocol Violation|0
1462723|NCT00738374|4822879|P2|Induction Treatment Phase|Protocol Violation|0
1462724|NCT00738374|4822880|P1|Induction Treatment Phase|Protocol Violation|2
1462725|NCT00738374|4822877|P4|Induction Treatment Phase|Physician Decision|0
1462726|NCT00738374|4822878|P3|Induction Treatment Phase|Physician Decision|0
1462727|NCT00738374|4822879|P2|Induction Treatment Phase|Physician Decision|0
1462728|NCT00738374|4822880|P1|Induction Treatment Phase|Physician Decision|2
1462729|NCT00738374|4822877|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
1462730|NCT00738374|4822878|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
1462731|NCT00738374|4822879|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
1462732|NCT00738374|4822880|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
1462733|NCT00738374|4822877|P4|Induction Treatment Phase|Adverse Event|0
1462734|NCT00738374|4822878|P3|Induction Treatment Phase|Adverse Event|0
1462735|NCT00738374|4822879|P2|Induction Treatment Phase|Adverse Event|0
1462736|NCT00738374|4822880|P1|Induction Treatment Phase|Adverse Event|14
1462737|NCT00738283|4822918|P1|Overall Study|Discharge home prior to end of study|1
1462738|NCT00738283|4822918|P1|Overall Study|Transfer to another facility|2
1462739|NCT00738283|4822918|P1|Overall Study|Death|1
1462740|NCT00738062|4822925|P3|Open-Label Extension|Study Terminated|0
1462741|NCT00738062|4822926|P2|Open-Label Extension|Study Terminated|0
1462742|NCT00738062|4822927|P1|Open-Label Extension|Study Terminated|2
1462743|NCT00738062|4822925|P3|Open-Label Extension|Protocol Violation|0
1462744|NCT00738062|4822926|P2|Open-Label Extension|Protocol Violation|0
1462745|NCT00738062|4822927|P1|Open-Label Extension|Protocol Violation|1
1462746|NCT00738062|4822925|P3|Open-Label Extension|Withdrawal by Subject|0
1462747|NCT00738062|4822926|P2|Open-Label Extension|Withdrawal by Subject|0
1462748|NCT00738062|4822927|P1|Open-Label Extension|Withdrawal by Subject|6
1462749|NCT00738062|4822925|P3|Open-Label Extension|Lack of Efficacy|0
1462750|NCT00738062|4822926|P2|Open-Label Extension|Lack of Efficacy|0
1462751|NCT00738062|4822927|P1|Open-Label Extension|Lack of Efficacy|2
1462752|NCT00738062|4822925|P3|Open-Label Extension|Physician Decision|0
1462753|NCT00738062|4822926|P2|Open-Label Extension|Physician Decision|0
1462754|NCT00738062|4822927|P1|Open-Label Extension|Physician Decision|1
1462755|NCT00738062|4822925|P3|Open-Label Extension|Adverse Event|0
1462756|NCT00738062|4822926|P2|Open-Label Extension|Adverse Event|0
1462757|NCT00738062|4822927|P1|Open-Label Extension|Adverse Event|5
1462758|NCT00738062|4822925|P3|Open Label Treatment|Investigator Decision|0
1462759|NCT00738062|4822926|P2|Open Label Treatment|Investigator Decision|0
1462760|NCT00738062|4822927|P1|Open Label Treatment|Investigator Decision|1
1462761|NCT00738062|4822925|P3|Open Label Treatment|Withdrawal by Subject|0
1462762|NCT00738062|4822926|P2|Open Label Treatment|Withdrawal by Subject|0
1462763|NCT00738062|4822927|P1|Open Label Treatment|Withdrawal by Subject|9
1462764|NCT00738062|4822925|P3|Open Label Treatment|Protocol Violation|0
1462765|NCT00738062|4822926|P2|Open Label Treatment|Protocol Violation|0
1462766|NCT00738062|4822927|P1|Open Label Treatment|Protocol Violation|2
1462767|NCT00738062|4822925|P3|Open Label Treatment|Adverse Event|0
1462768|NCT00738062|4822926|P2|Open Label Treatment|Adverse Event|0
1462769|NCT00738062|4822927|P1|Open Label Treatment|Adverse Event|11
1462770|NCT00738062|4822925|P3|Open Label Treatment|Lack of Efficacy|0
1462771|NCT00738062|4822926|P2|Open Label Treatment|Lack of Efficacy|0
1462772|NCT00738062|4822927|P1|Open Label Treatment|Lack of Efficacy|5
1462773|NCT00737711|4822989|P1|Overall Study|Other|5
1462774|NCT00737711|4822989|P1|Overall Study|Blood transfusion|6
1462775|NCT00737711|4822989|P1|Overall Study|Withdrawal by Subject|5
1462776|NCT00737711|4822989|P1|Overall Study|Protocol Violation|1
1462777|NCT00737711|4822989|P1|Overall Study|Failure to return|4
1462778|NCT00737711|4822989|P1|Overall Study|Death|8
1462779|NCT00737711|4822989|P1|Overall Study|Adverse Event|2
1462780|NCT00737672|4823022|P2|Overall Study|Physician Decision|2
1462781|NCT00737672|4823023|P1|Overall Study|Physician Decision|0
1462782|NCT00737672|4823022|P2|Overall Study|Miscellaneous|1
1462783|NCT00737672|4823023|P1|Overall Study|Miscellaneous|7
1462784|NCT00737672|4823022|P2|Overall Study|Lost to Follow-up|0
1462785|NCT00737672|4823023|P1|Overall Study|Lost to Follow-up|1
1462786|NCT00737672|4823022|P2|Overall Study|Withdrawal by Subject|2
1462787|NCT00737672|4823023|P1|Overall Study|Withdrawal by Subject|1
1462788|NCT00737672|4823022|P2|Overall Study|Death|22
1462789|NCT00737672|4823023|P1|Overall Study|Death|23
1462790|NCT00737672|4823022|P2|Overall Study|Graft Abandonment|56
1462791|NCT00737672|4823023|P1|Overall Study|Graft Abandonment|48
1462792|NCT00737633|4823061|P2|Overall Study|protocol non-compliance|1
1462793|NCT00737633|4823062|P1|Overall Study|protocol non-compliance|0
1462794|NCT00737633|4823061|P2|Overall Study|Lost to Follow-up|1
1462795|NCT00737633|4823062|P1|Overall Study|Lost to Follow-up|0
1462796|NCT00737633|4823061|P2|Overall Study|Study terminated by sponsor|55
1462797|NCT00737633|4823062|P1|Overall Study|Study terminated by sponsor|44
1462798|NCT00737568|4823085|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
1462799|NCT00737568|4823086|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
1462800|NCT00737568|4823085|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
1462801|NCT00737568|4823086|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
1462802|NCT00737568|4823085|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
1462803|NCT00737568|4823086|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
1462804|NCT00737568|4823085|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
1462805|NCT00737568|4823086|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
1462806|NCT00737568|4823085|P2|Treatment Period Through Week 240|Protocol Violation|3
1462807|NCT00737568|4823086|P1|Treatment Period Through Week 240|Protocol Violation|2
1462808|NCT00737568|4823085|P2|Treatment Period Through Week 240|Lost to Follow-up|3
1462809|NCT00737568|4823086|P1|Treatment Period Through Week 240|Lost to Follow-up|3
1462810|NCT00737568|4823085|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
1462811|NCT00737568|4823086|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
1462812|NCT00737568|4823085|P2|Treatment Period Through Week 240|Withdrew Consent|6
1462813|NCT00737568|4823086|P1|Treatment Period Through Week 240|Withdrew Consent|5
1462814|NCT00737568|4823085|P2|Treatment Period Through Week 240|Investigator’s Discretion|5
1462815|NCT00737568|4823086|P1|Treatment Period Through Week 240|Investigator’s Discretion|6
1462816|NCT00737529|4823116|P1|Overall Study|Other|2
1462817|NCT00737529|4823116|P1|Overall Study|Protocol Violation|1
1462818|NCT00737529|4823116|P1|Overall Study|Death|3
1462819|NCT00737529|4823116|P1|Overall Study|Withdrawal by Subject|3
1462820|NCT00737529|4823116|P1|Overall Study|Adverse Event|23
1462821|NCT00737529|4823116|P1|Overall Study|Disease Progression|80
1462822|NCT00737477|4823130|P1|Overall Study|Not Specified|4
1462823|NCT00737477|4823130|P1|Overall Study|Renal Transplantation|10
1462824|NCT00737477|4823130|P1|Overall Study|Withdrawal by Subject|1
1462825|NCT00737477|4823130|P1|Overall Study|Treatment Refusal|1
1462826|NCT00737477|4823130|P1|Overall Study|Death|9
1462827|NCT00737477|4823130|P1|Overall Study|Adverse Event|9
1462828|NCT00737464|4823146|P1|Overall Study|Other reasons|4
1462829|NCT00737464|4823146|P1|Overall Study|Refused Treatment / Withdrew Consent|6
1462830|NCT00737464|4823146|P1|Overall Study|Other - Failure to Return|1
1462831|NCT00737464|4823146|P1|Overall Study|Death|6
1462832|NCT00737464|4823146|P1|Overall Study|Adverse Event|1
1462833|NCT00737438|4823167|P1|Overall Study|Patient ineligible|1
1462834|NCT00737438|4823167|P1|Overall Study|Withdrawal by Subject|2
1462835|NCT00737282|4823180|P1|Overall Study|Study prematurely terminated|175
1462836|NCT00737100|4823223|P3|Overall Study|Reason discontinued not explained above|1
1462837|NCT00737100|4823224|P2|Overall Study|Reason discontinued not explained above|1
1462838|NCT00737100|4823225|P1|Overall Study|Reason discontinued not explained above|1
1462839|NCT00737100|4823223|P3|Overall Study|Withdrawal by Subject|3
1462840|NCT00737100|4823224|P2|Overall Study|Withdrawal by Subject|0
1462841|NCT00737100|4823225|P1|Overall Study|Withdrawal by Subject|0
1462842|NCT00737100|4823223|P3|Overall Study|Lost to Follow-up|0
1462843|NCT00737100|4823224|P2|Overall Study|Lost to Follow-up|1
1462844|NCT00737100|4823225|P1|Overall Study|Lost to Follow-up|0
1462845|NCT00737100|4823223|P3|Overall Study|Adverse Event|3
1462846|NCT00737100|4823224|P2|Overall Study|Adverse Event|5
1462847|NCT00737100|4823225|P1|Overall Study|Adverse Event|6
1462848|NCT00737061|4823269|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
1462849|NCT00737061|4823269|P1|1 Year Wearing Period|Discontinued reilance|3
1462850|NCT00737061|4823269|P1|1 Year Wearing Period|Withdrawal by Subject|2
1462851|NCT00737061|4823269|P1|1 Year Wearing Period|Lost to Follow-up|11
1462852|NCT00737061|4823269|P1|Waiting Period|Elected surgical tubal ligation|5
1462853|NCT00737061|4823269|P1|Waiting Period|Alternative contraception failure|3
1462854|NCT00737061|4823269|P1|Waiting Period|Deemed patent following HSG|26
1462855|NCT00737061|4823269|P1|Waiting Period|Bilateral placement failure|34
1462856|NCT00737061|4823269|P1|Waiting Period|Withdrawal by Subject|1
1462857|NCT00737061|4823269|P1|Waiting Period|Lost to Follow-up|6
1462858|NCT00737048|4823286|P3|Overall Study|Worsening of the symptoms|3
1462859|NCT00737048|4823287|P2|Overall Study|Worsening of the symptoms|5
1462860|NCT00737048|4823288|P1|Overall Study|Worsening of the symptoms|3
1462861|NCT00737048|4823286|P3|Overall Study|Adverse Event|0
1462862|NCT00737048|4823287|P2|Overall Study|Adverse Event|1
1462863|NCT00737048|4823288|P1|Overall Study|Adverse Event|0
1462864|NCT00737048|4823286|P3|Overall Study|Physician Decision|1
1462865|NCT00737048|4823287|P2|Overall Study|Physician Decision|0
1462866|NCT00737048|4823288|P1|Overall Study|Physician Decision|0
1462867|NCT00736996|4823332|P3|Overall Study|Lost to Follow-up|2
1462868|NCT00736996|4823333|P2|Overall Study|Lost to Follow-up|9
1462869|NCT00736996|4823334|P1|Overall Study|Lost to Follow-up|1
1462870|NCT00736957|4823348|P1|Overall Study|Physician Decision|5
1462871|NCT00736957|4823348|P1|Overall Study|not eligible for Treatment Period I|22
1462872|NCT00736957|4823348|P1|Overall Study|did not attend hospital appointments|1
1462873|NCT00736957|4823348|P1|Overall Study|violation of eligibility criteria|2
1462874|NCT00736957|4823348|P1|Overall Study|Withdrawal by Subject|49
1462875|NCT00736957|4823348|P1|Overall Study|Adverse Event|43
1462876|NCT00736944|4823358|P1|Definitive Treatment|Physician Decision|1
1462877|NCT00736944|4823358|P1|Induction|Death|1
1462878|NCT00736879|4823389|P4|Follow up Period - No Drug Treatment|non-specified|0
1462879|NCT00736879|4823390|P3|Follow up Period - No Drug Treatment|non-specified|0
1462880|NCT00736879|4823391|P2|Follow up Period - No Drug Treatment|non-specified|2
1462881|NCT00736879|4823392|P1|Follow up Period - No Drug Treatment|non-specified|1
1462882|NCT00736879|4823389|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
1462883|NCT00736879|4823390|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
1462884|NCT00736879|4823391|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
1462885|NCT00736879|4823392|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
1462886|NCT00736879|4823389|P4|Double Blind Treatment Period|non-specified|0
1462887|NCT00736879|4823390|P3|Double Blind Treatment Period|non-specified|0
1462888|NCT00736879|4823391|P2|Double Blind Treatment Period|non-specified|1
1462889|NCT00736879|4823392|P1|Double Blind Treatment Period|non-specified|0
1462890|NCT00736879|4823389|P4|Double Blind Treatment Period|No longer met criteria|0
1462891|NCT00736879|4823390|P3|Double Blind Treatment Period|No longer met criteria|0
1462892|NCT00736879|4823391|P2|Double Blind Treatment Period|No longer met criteria|1
1462893|NCT00736879|4823392|P1|Double Blind Treatment Period|No longer met criteria|0
1462894|NCT00736879|4823389|P4|Double Blind Treatment Period|Poor non-compliance|1
1462895|NCT00736879|4823390|P3|Double Blind Treatment Period|Poor non-compliance|1
1462896|NCT00736879|4823391|P2|Double Blind Treatment Period|Poor non-compliance|0
1462897|NCT00736879|4823392|P1|Double Blind Treatment Period|Poor non-compliance|0
1462898|NCT00736879|4823389|P4|Double Blind Treatment Period|Lost to Follow-up|1
1462899|NCT00736879|4823390|P3|Double Blind Treatment Period|Lost to Follow-up|2
1462900|NCT00736879|4823391|P2|Double Blind Treatment Period|Lost to Follow-up|0
1462901|NCT00736879|4823392|P1|Double Blind Treatment Period|Lost to Follow-up|0
1462902|NCT00736879|4823389|P4|Double Blind Treatment Period|Withdrawal by Subject|3
1462903|NCT00736879|4823390|P3|Double Blind Treatment Period|Withdrawal by Subject|3
1462904|NCT00736879|4823391|P2|Double Blind Treatment Period|Withdrawal by Subject|1
1462905|NCT00736879|4823392|P1|Double Blind Treatment Period|Withdrawal by Subject|2
1462906|NCT00736879|4823389|P4|Double Blind Treatment Period|Adverse Event|0
1462907|NCT00736879|4823390|P3|Double Blind Treatment Period|Adverse Event|1
1462908|NCT00736879|4823391|P2|Double Blind Treatment Period|Adverse Event|1
1462909|NCT00736879|4823392|P1|Double Blind Treatment Period|Adverse Event|0
1462910|NCT00736879|4823389|P4|Double Blind Treatment Period|Lack of Efficacy|0
1462911|NCT00736879|4823390|P3|Double Blind Treatment Period|Lack of Efficacy|0
1462912|NCT00736879|4823391|P2|Double Blind Treatment Period|Lack of Efficacy|0
1462913|NCT00736879|4823392|P1|Double Blind Treatment Period|Lack of Efficacy|1
1462914|NCT00736853|4823446|P3|Double-Blind Period|Ineligible to participate the study|0
1462915|NCT00736853|4823447|P2|Double-Blind Period|Ineligible to participate the study|1
1462916|NCT00736853|4823448|P1|Double-Blind Period|Ineligible to participate the study|0
1462917|NCT00736853|4823446|P3|Double-Blind Period|Withdrawal by Subject|4
1462918|NCT00736853|4823447|P2|Double-Blind Period|Withdrawal by Subject|1
1462919|NCT00736853|4823448|P1|Double-Blind Period|Withdrawal by Subject|0
1462920|NCT00736853|4823446|P3|Double-Blind Period|Adverse Event|2
1462921|NCT00736853|4823447|P2|Double-Blind Period|Adverse Event|3
1462922|NCT00736853|4823448|P1|Double-Blind Period|Adverse Event|0
1462923|NCT00736853|4823446|P3|Double-Blind Period|Lack of Efficacy|42
1462924|NCT00736853|4823447|P2|Double-Blind Period|Lack of Efficacy|19
1462925|NCT00736853|4823448|P1|Double-Blind Period|Lack of Efficacy|0
1462926|NCT00736853|4823446|P3|Open-Label Period|Unable to attend hospital appointments|0
1462927|NCT00736853|4823447|P2|Open-Label Period|Unable to attend hospital appointments|0
1462928|NCT00736853|4823448|P1|Open-Label Period|Unable to attend hospital appointments|1
1462929|NCT00736853|4823446|P3|Open-Label Period|Failed to meet the transfer criteria|0
1462930|NCT00736853|4823447|P2|Open-Label Period|Failed to meet the transfer criteria|0
1462931|NCT00736853|4823448|P1|Open-Label Period|Failed to meet the transfer criteria|40
1462932|NCT00736853|4823446|P3|Open-Label Period|Started but not treated|0
1462933|NCT00736853|4823447|P2|Open-Label Period|Started but not treated|0
1462934|NCT00736853|4823448|P1|Open-Label Period|Started but not treated|42
1462935|NCT00736853|4823446|P3|Open-Label Period|Withdrawal by Subject|0
1462936|NCT00736853|4823447|P2|Open-Label Period|Withdrawal by Subject|0
1462937|NCT00736853|4823448|P1|Open-Label Period|Withdrawal by Subject|16
1462938|NCT00736853|4823446|P3|Open-Label Period|Adverse Event|0
1462939|NCT00736853|4823447|P2|Open-Label Period|Adverse Event|0
1462940|NCT00736853|4823448|P1|Open-Label Period|Adverse Event|31
1462941|NCT00736853|4823446|P3|Open-Label Period|Physician Decision|0
1462942|NCT00736853|4823447|P2|Open-Label Period|Physician Decision|0
1462943|NCT00736853|4823448|P1|Open-Label Period|Physician Decision|2
1462944|NCT00736840|4823488|P1|Overall Study|Lost to Follow-up|13
1462945|NCT00736723|4823495|P2|Overall Study|Withdrawal by Subject|3
1462946|NCT00736723|4823496|P1|Overall Study|Withdrawal by Subject|4
1462947|NCT00736645|4823506|P4|Overall Study|Adverse Event|0
1462948|NCT00736645|4823507|P3|Overall Study|Adverse Event|0
1462949|NCT00736645|4823508|P2|Overall Study|Adverse Event|2
1462950|NCT00736645|4823509|P1|Overall Study|Adverse Event|0
1462951|NCT00736502|4823532|P1|Overall Study|Lost to Follow-up|27
1462952|NCT00736502|4823532|P1|Overall Study|Lack of Efficacy|16
1462953|NCT00736502|4823532|P1|Overall Study|Adverse Event|22
1462954|NCT00736489|4823538|P6|Period 1|Withdrawal by Subject|1
1462955|NCT00736489|4823539|P5|Period 1|Withdrawal by Subject|0
1462956|NCT00736489|4823540|P4|Period 1|Withdrawal by Subject|0
1462957|NCT00736489|4823541|P3|Period 1|Withdrawal by Subject|0
1462958|NCT00736489|4823542|P2|Period 1|Withdrawal by Subject|0
1462959|NCT00736489|4823543|P1|Period 1|Withdrawal by Subject|0
1462960|NCT00736489|4823538|P6|Period 1|Lost to Follow-up|0
1462961|NCT00736489|4823539|P5|Period 1|Lost to Follow-up|0
1462962|NCT00736489|4823540|P4|Period 1|Lost to Follow-up|0
1462963|NCT00736489|4823541|P3|Period 1|Lost to Follow-up|0
1462964|NCT00736489|4823542|P2|Period 1|Lost to Follow-up|0
1462965|NCT00736489|4823543|P1|Period 1|Lost to Follow-up|1
1462966|NCT00736476|4823697|P2|Overall Study|Adverse Event|0
1462967|NCT00736476|4823698|P1|Overall Study|Adverse Event|1
1462968|NCT00736450|4823718|P1|Overall Study|Physician Decision|1
1462969|NCT00736450|4823718|P1|Overall Study|Withdrawal by Subject|5
1462970|NCT00736450|4823718|P1|Overall Study|Not ABC gene eligible|19
1462971|NCT00736385|4823726|P2|Overall Study|Adverse Event|1
1462972|NCT00736385|4823727|P1|Overall Study|Adverse Event|0
1462973|NCT00736385|4823726|P2|Overall Study|Withdrawal by Subject|2
1462974|NCT00736385|4823727|P1|Overall Study|Withdrawal by Subject|2
1462975|NCT00736333|4823739|P1|Overall Study|Not Specified|4
1462976|NCT00736333|4823739|P1|Overall Study|Death|7
1462977|NCT00736333|4823739|P1|Overall Study|Withdrawal by Subject|10
1462978|NCT00736333|4823739|P1|Overall Study|Toxicity|6
1462979|NCT00736333|4823739|P1|Overall Study|Tumor Progression|75
1462980|NCT00736333|4823739|P1|Overall Study|Data Missing|2
1462981|NCT00736333|4823739|P1|Overall Study|Did Not Receive Drug or Not Documented|7
1462982|NCT00736255|4823750|P2|Overall Study|Non-compliance|1
1462983|NCT00736255|4823751|P1|Overall Study|Non-compliance|1
1462984|NCT00736255|4823750|P2|Overall Study|Physician Decision|0
1462985|NCT00736255|4823751|P1|Overall Study|Physician Decision|1
1462986|NCT00736255|4823750|P2|Overall Study|Adverse Event|0
1462987|NCT00736255|4823751|P1|Overall Study|Adverse Event|1
1462988|NCT00736190|4823790|P1|Overall Study|Adverse Event|1
1462989|NCT00736190|4823790|P1|Overall Study|Withdrawal by Subject|1
1462990|NCT00736190|4823790|P1|Overall Study|Pregnancy|1
1462991|NCT00736099|4823816|P2|Overall Study|Other reason|10
1462992|NCT00736099|4823817|P1|Overall Study|Other reason|43
1462993|NCT00736099|4823816|P2|Overall Study|Lack of Efficacy|8
1462994|NCT00736099|4823817|P1|Overall Study|Lack of Efficacy|15
1462995|NCT00736099|4823816|P2|Overall Study|Withdrawal by Subject|13
1462996|NCT00736099|4823817|P1|Overall Study|Withdrawal by Subject|42
1462997|NCT00736099|4823816|P2|Overall Study|Lost to Follow-up|5
1462998|NCT00736099|4823817|P1|Overall Study|Lost to Follow-up|12
1462999|NCT00736099|4823816|P2|Overall Study|Protocol Violation|4
1463000|NCT00736099|4823817|P1|Overall Study|Protocol Violation|10
1463001|NCT00736099|4823816|P2|Overall Study|Adverse Event|18
1463002|NCT00736099|4823817|P1|Overall Study|Adverse Event|61
1463003|NCT00736034|4823926|P1|Overall Study|Adverse Event|2
1463004|NCT00735943|4823934|P1|Overall Study|Adverse Event|1
1463005|NCT00735943|4823934|P1|Overall Study|Lost to Follow-up|1
1463006|NCT00735904|4823959|P1|Overall Study|Other|8
1463007|NCT00735904|4823959|P1|Overall Study|Study Terminated by Sponsor|5
1463008|NCT00735904|4823959|P1|Overall Study|Withdrawal by Subject|1
1463009|NCT00735904|4823959|P1|Overall Study|Protocol Violation|1
1463010|NCT00735904|4823959|P1|Overall Study|Death|20
1463011|NCT00735904|4823959|P1|Overall Study|Adverse Event|3
1463012|NCT00735709|4824028|P4|Overall Study|Excluded medication|1
1463013|NCT00735709|4824029|P3|Overall Study|Excluded medication|0
1463014|NCT00735709|4824030|P2|Overall Study|Excluded medication|0
1463015|NCT00735709|4824031|P1|Overall Study|Excluded medication|1
1463016|NCT00735709|4824028|P4|Overall Study|Lost to Follow-up|1
1463017|NCT00735709|4824029|P3|Overall Study|Lost to Follow-up|1
1463018|NCT00735709|4824030|P2|Overall Study|Lost to Follow-up|1
1463019|NCT00735709|4824031|P1|Overall Study|Lost to Follow-up|0
1463020|NCT00735709|4824028|P4|Overall Study|Voluntary Withdrawal|7
1463021|NCT00735709|4824029|P3|Overall Study|Voluntary Withdrawal|5
1463022|NCT00735709|4824030|P2|Overall Study|Voluntary Withdrawal|3
1463023|NCT00735709|4824031|P1|Overall Study|Voluntary Withdrawal|1
1463024|NCT00735709|4824028|P4|Overall Study|Protocol deviations|1
1463025|NCT00735709|4824029|P3|Overall Study|Protocol deviations|1
1463026|NCT00735709|4824030|P2|Overall Study|Protocol deviations|2
1463027|NCT00735709|4824031|P1|Overall Study|Protocol deviations|1
1463028|NCT00735709|4824028|P4|Overall Study|Noncompliance|0
1463029|NCT00735709|4824029|P3|Overall Study|Noncompliance|1
1463030|NCT00735709|4824030|P2|Overall Study|Noncompliance|0
1463031|NCT00735709|4824031|P1|Overall Study|Noncompliance|0
1463032|NCT00735709|4824028|P4|Overall Study|Lack of Efficacy|3
1463033|NCT00735709|4824029|P3|Overall Study|Lack of Efficacy|2
1463034|NCT00735709|4824030|P2|Overall Study|Lack of Efficacy|4
1463035|NCT00735709|4824031|P1|Overall Study|Lack of Efficacy|8
1463036|NCT00735709|4824028|P4|Overall Study|Adverse Event|5
1463037|NCT00735709|4824029|P3|Overall Study|Adverse Event|1
1463038|NCT00735709|4824030|P2|Overall Study|Adverse Event|3
1463039|NCT00735709|4824031|P1|Overall Study|Adverse Event|2
1463040|NCT00735696|4824141|P1|Overall Study|Enrolled but never Treated|1
1463041|NCT00735696|4824141|P1|Overall Study|Withdrawal by Subject|1
1463042|NCT00735644|4824169|P5|Overall Study|Withdrawal by Subject|0
1463043|NCT00735644|4824170|P4|Overall Study|Withdrawal by Subject|1
1463044|NCT00735644|4824171|P3|Overall Study|Withdrawal by Subject|1
1463045|NCT00735644|4824172|P2|Overall Study|Withdrawal by Subject|1
1463046|NCT00735644|4824173|P1|Overall Study|Withdrawal by Subject|0
1463047|NCT00735644|4824169|P5|Overall Study|Did not receive study vaccine|0
1463048|NCT00735644|4824170|P4|Overall Study|Did not receive study vaccine|0
1463049|NCT00735644|4824171|P3|Overall Study|Did not receive study vaccine|0
1463050|NCT00735644|4824172|P2|Overall Study|Did not receive study vaccine|1
1463051|NCT00735644|4824173|P1|Overall Study|Did not receive study vaccine|0
1463052|NCT00735553|4824217|P1|Overall Study|Study prematurely terminated|77
1463053|NCT00735475|4824227|P2|Overall Study|Withdrawal by Subject|5
1463054|NCT00735475|4824228|P1|Overall Study|Withdrawal by Subject|4
1463055|NCT00735475|4824227|P2|Overall Study|Physician Decision|1
1463056|NCT00735475|4824228|P1|Overall Study|Physician Decision|0
1463057|NCT00735475|4824227|P2|Overall Study|Lost to Follow-up|3
1463058|NCT00735475|4824228|P1|Overall Study|Lost to Follow-up|3
1463059|NCT00735475|4824227|P2|Overall Study|Death|1
1463060|NCT00735475|4824228|P1|Overall Study|Death|1
1463061|NCT00735475|4824227|P2|Overall Study|Adverse Event|1
1463062|NCT00735475|4824228|P1|Overall Study|Adverse Event|0
1463063|NCT00735397|4824288|P1|Overall Study|Administrative/Other|502
1463064|NCT00735397|4824288|P1|Overall Study|Inadequate therapeutic effect|202
1463065|NCT00735397|4824288|P1|Overall Study|Participant choice|252
1463066|NCT00735397|4824288|P1|Overall Study|Lost to Follow-up|33
1463067|NCT00735397|4824288|P1|Overall Study|Adverse Event|194
1463068|NCT00735371|4824302|P4|Overall Study|Exclusion criteria|0
1463069|NCT00735371|4824303|P3|Overall Study|Exclusion criteria|0
1463070|NCT00735371|4824304|P2|Overall Study|Exclusion criteria|0
1463071|NCT00735371|4824305|P1|Overall Study|Exclusion criteria|1
1463072|NCT00735371|4824302|P4|Overall Study|Prior Vyvanse Exposure|0
1463073|NCT00735371|4824303|P3|Overall Study|Prior Vyvanse Exposure|0
1463074|NCT00735371|4824304|P2|Overall Study|Prior Vyvanse Exposure|1
1463075|NCT00735371|4824305|P1|Overall Study|Prior Vyvanse Exposure|1
1463076|NCT00735371|4824302|P4|Overall Study|Protocol Violation|0
1463077|NCT00735371|4824303|P3|Overall Study|Protocol Violation|2
1463078|NCT00735371|4824304|P2|Overall Study|Protocol Violation|1
1463079|NCT00735371|4824305|P1|Overall Study|Protocol Violation|0
1463080|NCT00735371|4824302|P4|Overall Study|Sponsor Decision|1
1463081|NCT00735371|4824303|P3|Overall Study|Sponsor Decision|0
1463082|NCT00735371|4824304|P2|Overall Study|Sponsor Decision|1
1463083|NCT00735371|4824305|P1|Overall Study|Sponsor Decision|3
1463084|NCT00735371|4824302|P4|Overall Study|Lack of Efficacy|4
1463085|NCT00735371|4824303|P3|Overall Study|Lack of Efficacy|0
1463086|NCT00735371|4824304|P2|Overall Study|Lack of Efficacy|2
1463087|NCT00735371|4824305|P1|Overall Study|Lack of Efficacy|4
1463088|NCT00735371|4824302|P4|Overall Study|Lost to Follow-up|1
1463089|NCT00735371|4824303|P3|Overall Study|Lost to Follow-up|3
1463090|NCT00735371|4824304|P2|Overall Study|Lost to Follow-up|1
1463091|NCT00735371|4824305|P1|Overall Study|Lost to Follow-up|1
1463092|NCT00735371|4824302|P4|Overall Study|Withdrawal by Subject|0
1463093|NCT00735371|4824303|P3|Overall Study|Withdrawal by Subject|2
1463094|NCT00735371|4824304|P2|Overall Study|Withdrawal by Subject|2
1463095|NCT00735371|4824305|P1|Overall Study|Withdrawal by Subject|0
1463096|NCT00735371|4824302|P4|Overall Study|Protocol Violation|3
1463097|NCT00735371|4824303|P3|Overall Study|Protocol Violation|0
1463098|NCT00735371|4824304|P2|Overall Study|Protocol Violation|2
1463099|NCT00735371|4824305|P1|Overall Study|Protocol Violation|2
1463100|NCT00735371|4824302|P4|Overall Study|Adverse Event|1
1463101|NCT00735371|4824303|P3|Overall Study|Adverse Event|4
1463102|NCT00735371|4824304|P2|Overall Study|Adverse Event|3
1463103|NCT00735371|4824305|P1|Overall Study|Adverse Event|3
1463104|NCT00735254|4824333|P4|Overall Study|Protocol Violation|0
1463105|NCT00735254|4824334|P3|Overall Study|Protocol Violation|1
1463106|NCT00735254|4824335|P2|Overall Study|Protocol Violation|1
1463107|NCT00735254|4824336|P1|Overall Study|Protocol Violation|1
1463108|NCT00735072|4824348|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
1463109|NCT00735072|4824349|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
1463110|NCT00735072|4824348|P2|Overall Study|interrupted study med during ARV change|0
1463111|NCT00735072|4824349|P1|Overall Study|interrupted study med during ARV change|1
1463112|NCT00735007|4824355|P1|Overall Study|Protocol Violation|1
1463113|NCT00735007|4824355|P1|Overall Study|Adverse Event|4
1463114|NCT00734994|4824380|P1|Overall Study|Withdrawal by Subject|1
1463115|NCT00734929|4824400|P2|Overall Study|No intervention/ screen fail|3
1463116|NCT00734929|4824401|P1|Overall Study|No intervention/ screen fail|5
1463117|NCT00734929|4824400|P2|Overall Study|Lost to Follow-up|2
1463118|NCT00734929|4824401|P1|Overall Study|Lost to Follow-up|1
1463119|NCT00734851|4824429|P1|Overall Study|Physician Decision|18
1463120|NCT00734851|4824429|P1|Overall Study|Lost to Follow-up|1
1463121|NCT00734851|4824429|P1|Overall Study|Withdrawal by Subject|2
1463122|NCT00734747|4824450|P1|6 Month Follow-up|Did not meet inclusion criteria|3
1463123|NCT00734747|4824450|P1|SRS Procedure|No staples placed|3
1463124|NCT00734656|4824464|P4|Lab Session 4|Withdrawal by Subject|1
1463125|NCT00734656|4824465|P3|Lab Session 4|Withdrawal by Subject|0
1463126|NCT00734656|4824466|P2|Lab Session 4|Withdrawal by Subject|0
1463127|NCT00734656|4824467|P1|Lab Session 4|Withdrawal by Subject|0
1463128|NCT00734656|4824464|P4|Washout 3|Withdrawal by Subject|1
1463129|NCT00734656|4824465|P3|Washout 3|Withdrawal by Subject|0
1463130|NCT00734656|4824466|P2|Washout 3|Withdrawal by Subject|0
1463131|NCT00734656|4824467|P1|Washout 3|Withdrawal by Subject|1
1463132|NCT00734656|4824464|P4|Washout 2|Withdrawal by Subject|0
1463133|NCT00734656|4824465|P3|Washout 2|Withdrawal by Subject|1
1463134|NCT00734656|4824466|P2|Washout 2|Withdrawal by Subject|1
1463135|NCT00734656|4824467|P1|Washout 2|Withdrawal by Subject|1
1463136|NCT00734656|4824464|P4|Lab Session 2|Withdrawal by Subject|1
1463137|NCT00734656|4824465|P3|Lab Session 2|Withdrawal by Subject|0
1463138|NCT00734656|4824466|P2|Lab Session 2|Withdrawal by Subject|0
1463139|NCT00734656|4824467|P1|Lab Session 2|Withdrawal by Subject|1
1463140|NCT00734656|4824464|P4|Washout 1|Withdrawal by Subject|3
1463141|NCT00734656|4824465|P3|Washout 1|Withdrawal by Subject|2
1463142|NCT00734656|4824466|P2|Washout 1|Withdrawal by Subject|5
1463143|NCT00734656|4824467|P1|Washout 1|Withdrawal by Subject|1
1463144|NCT00734656|4824464|P4|Lab Session 1|Withdrawal by Subject|0
1463145|NCT00734656|4824465|P3|Lab Session 1|Withdrawal by Subject|0
1463146|NCT00734656|4824466|P2|Lab Session 1|Withdrawal by Subject|0
1463147|NCT00734656|4824467|P1|Lab Session 1|Withdrawal by Subject|2
1463148|NCT00734630|4824491|P2|Overall Study|Poor Compliance|1
1463149|NCT00734630|4824492|P1|Overall Study|Poor Compliance|1
1463150|NCT00734630|4824491|P2|Overall Study|Tested Positive for Illegal Drug Use|1
1463151|NCT00734630|4824492|P1|Overall Study|Tested Positive for Illegal Drug Use|1
1463152|NCT00734630|4824491|P2|Overall Study|Randomized in Error|1
1463153|NCT00734630|4824492|P1|Overall Study|Randomized in Error|0
1463154|NCT00734630|4824491|P2|Overall Study|Adverse Event|6
1463155|NCT00734630|4824492|P1|Overall Study|Adverse Event|3
1463156|NCT00734630|4824491|P2|Overall Study|Inclusion/Exclusion criteria not met|1
1463157|NCT00734630|4824492|P1|Overall Study|Inclusion/Exclusion criteria not met|0
1463158|NCT00734630|4824491|P2|Overall Study|Protocol Violation|3
1463159|NCT00734630|4824492|P1|Overall Study|Protocol Violation|0
1463160|NCT00734630|4824491|P2|Overall Study|Lost to Follow-up|7
1463161|NCT00734630|4824492|P1|Overall Study|Lost to Follow-up|13
1463162|NCT00734630|4824491|P2|Overall Study|Withdrawal by Subject|9
1463163|NCT00734630|4824492|P1|Overall Study|Withdrawal by Subject|7
1463164|NCT00734630|4824491|P2|Overall Study|Lack of Efficacy|4
1463165|NCT00734630|4824492|P1|Overall Study|Lack of Efficacy|4
1463166|NCT00734617|4824502|P2|Overall Study|Withdrawal by Subject|95
1463167|NCT00734617|4824503|P1|Overall Study|Withdrawal by Subject|103
1463168|NCT00734617|4824502|P2|Overall Study|Adverse Event|7
1463169|NCT00734617|4824503|P1|Overall Study|Adverse Event|4
1463170|NCT00734604|4824515|P6|Overall Study|Lack of Efficacy|0
1463171|NCT00734604|4824516|P5|Overall Study|Lack of Efficacy|0
1463172|NCT00734604|4824517|P4|Overall Study|Lack of Efficacy|0
1463173|NCT00734604|4824518|P3|Overall Study|Lack of Efficacy|1
1463174|NCT00734604|4824519|P2|Overall Study|Lack of Efficacy|1
1463175|NCT00734604|4824520|P1|Overall Study|Lack of Efficacy|0
1463176|NCT00734604|4824515|P6|Overall Study|Withdrawal by Subject|1
1463177|NCT00734604|4824516|P5|Overall Study|Withdrawal by Subject|2
1463178|NCT00734604|4824517|P4|Overall Study|Withdrawal by Subject|1
1463179|NCT00734604|4824518|P3|Overall Study|Withdrawal by Subject|0
1463180|NCT00734604|4824519|P2|Overall Study|Withdrawal by Subject|2
1463181|NCT00734604|4824520|P1|Overall Study|Withdrawal by Subject|0
1463182|NCT00734604|4824515|P6|Overall Study|Sponsor Decision|0
1463183|NCT00734604|4824516|P5|Overall Study|Sponsor Decision|2
1463184|NCT00734604|4824517|P4|Overall Study|Sponsor Decision|0
1463185|NCT00734604|4824518|P3|Overall Study|Sponsor Decision|1
1463186|NCT00734604|4824519|P2|Overall Study|Sponsor Decision|2
1463187|NCT00734604|4824520|P1|Overall Study|Sponsor Decision|1
1463188|NCT00734604|4824515|P6|Overall Study|Protocol Violation|0
1463189|NCT00734604|4824516|P5|Overall Study|Protocol Violation|1
1463190|NCT00734604|4824517|P4|Overall Study|Protocol Violation|0
1463191|NCT00734604|4824518|P3|Overall Study|Protocol Violation|0
1463192|NCT00734604|4824519|P2|Overall Study|Protocol Violation|2
1463193|NCT00734604|4824520|P1|Overall Study|Protocol Violation|0
1463194|NCT00734604|4824515|P6|Overall Study|Physician Decision|0
1463195|NCT00734604|4824516|P5|Overall Study|Physician Decision|0
1463196|NCT00734604|4824517|P4|Overall Study|Physician Decision|0
1463197|NCT00734604|4824518|P3|Overall Study|Physician Decision|1
1463198|NCT00734604|4824519|P2|Overall Study|Physician Decision|1
1463199|NCT00734604|4824520|P1|Overall Study|Physician Decision|0
1463200|NCT00734604|4824515|P6|Overall Study|Lost to Follow-up|3
1463201|NCT00734604|4824516|P5|Overall Study|Lost to Follow-up|2
1463202|NCT00734604|4824517|P4|Overall Study|Lost to Follow-up|4
1463203|NCT00734604|4824518|P3|Overall Study|Lost to Follow-up|2
1463204|NCT00734604|4824519|P2|Overall Study|Lost to Follow-up|2
1463205|NCT00734604|4824520|P1|Overall Study|Lost to Follow-up|1
1463206|NCT00734604|4824515|P6|Overall Study|Serious Adverse Event|1
1463207|NCT00734604|4824516|P5|Overall Study|Serious Adverse Event|0
1463208|NCT00734604|4824517|P4|Overall Study|Serious Adverse Event|2
1463209|NCT00734604|4824518|P3|Overall Study|Serious Adverse Event|1
1463210|NCT00734604|4824519|P2|Overall Study|Serious Adverse Event|0
1463211|NCT00734604|4824520|P1|Overall Study|Serious Adverse Event|1
1463212|NCT00734604|4824515|P6|Overall Study|Adverse Event|1
1463213|NCT00734604|4824516|P5|Overall Study|Adverse Event|1
1463214|NCT00734604|4824517|P4|Overall Study|Adverse Event|2
1463215|NCT00734604|4824518|P3|Overall Study|Adverse Event|0
1463216|NCT00734604|4824519|P2|Overall Study|Adverse Event|2
1463217|NCT00734604|4824520|P1|Overall Study|Adverse Event|0
1463218|NCT00734591|4824570|P2|Prospective Period|Other|2
1463219|NCT00734591|4824571|P1|Prospective Period|Other|2
1463220|NCT00734591|4824570|P2|Prospective Period|Study Terminated|0
1463221|NCT00734591|4824571|P1|Prospective Period|Study Terminated|1
1463222|NCT00734591|4824570|P2|Prospective Period|Lost to Follow-up|33
1463223|NCT00734591|4824571|P1|Prospective Period|Lost to Follow-up|37
1463224|NCT00734591|4824570|P2|Prospective Period|Withdrawal by Subject|9
1463225|NCT00734591|4824571|P1|Prospective Period|Withdrawal by Subject|11
1463226|NCT00734591|4824570|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
1463227|NCT00734591|4824571|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
1463228|NCT00734591|4824570|P2|Screening for Prospective Period|Site did not participate|1488
1463229|NCT00734591|4824571|P1|Screening for Prospective Period|Site did not participate|1604
1463230|NCT00734578|4824586|P3|Overall Study|Exclusion criteria|0
1463231|NCT00734578|4824587|P2|Overall Study|Exclusion criteria|0
1463232|NCT00734578|4824588|P1|Overall Study|Exclusion criteria|1
1463233|NCT00734578|4824586|P3|Overall Study|Randomized in error|0
1463234|NCT00734578|4824587|P2|Overall Study|Randomized in error|0
1463235|NCT00734578|4824588|P1|Overall Study|Randomized in error|1
1463236|NCT00734578|4824586|P3|Overall Study|Lack of Efficacy|5
1463237|NCT00734578|4824587|P2|Overall Study|Lack of Efficacy|2
1463238|NCT00734578|4824588|P1|Overall Study|Lack of Efficacy|3
1463239|NCT00734578|4824586|P3|Overall Study|Lost to Follow-up|5
1463240|NCT00734578|4824587|P2|Overall Study|Lost to Follow-up|3
1463241|NCT00734578|4824588|P1|Overall Study|Lost to Follow-up|9
1463242|NCT00734578|4824586|P3|Overall Study|Withdrawal by Subject|11
1463243|NCT00734578|4824587|P2|Overall Study|Withdrawal by Subject|8
1463244|NCT00734578|4824588|P1|Overall Study|Withdrawal by Subject|7
1463245|NCT00734578|4824586|P3|Overall Study|Protocol Violation|3
1463246|NCT00734578|4824587|P2|Overall Study|Protocol Violation|6
1463247|NCT00734578|4824588|P1|Overall Study|Protocol Violation|8
1463248|NCT00734578|4824586|P3|Overall Study|Adverse Event|1
1463249|NCT00734578|4824587|P2|Overall Study|Adverse Event|6
1463250|NCT00734578|4824588|P1|Overall Study|Adverse Event|4
1463251|NCT00734539|4824622|P2|Main Study|Enrolled in error; ineligible|0
1463252|NCT00734539|4824623|P1|Main Study|Enrolled in error; ineligible|1
1463253|NCT00734539|4824622|P2|Main Study|Withdrawal by Subject|3
1463254|NCT00734539|4824623|P1|Main Study|Withdrawal by Subject|1
1463255|NCT00734539|4824622|P2|Main Study|Physician Decision|0
1463256|NCT00734539|4824623|P1|Main Study|Physician Decision|2
1463257|NCT00734539|4824622|P2|Main Study|Death|32
1463258|NCT00734539|4824623|P1|Main Study|Death|33
1463259|NCT00734474|4824665|P9|Overall Study|Lack of Efficacy|6
1463260|NCT00734474|4824666|P8|Overall Study|Lack of Efficacy|4
1463261|NCT00734474|4824667|P7|Overall Study|Lack of Efficacy|0
1463262|NCT00734474|4824668|P6|Overall Study|Lack of Efficacy|0
1463263|NCT00734474|4824669|P5|Overall Study|Lack of Efficacy|0
1463264|NCT00734474|4824670|P4|Overall Study|Lack of Efficacy|0
1463265|NCT00734474|4824671|P3|Overall Study|Lack of Efficacy|4
1463266|NCT00734474|4824672|P2|Overall Study|Lack of Efficacy|0
1463267|NCT00734474|4824673|P1|Overall Study|Lack of Efficacy|0
1463268|NCT00734474|4824665|P9|Overall Study|Death|1
1463269|NCT00734474|4824666|P8|Overall Study|Death|2
1463270|NCT00734474|4824667|P7|Overall Study|Death|0
1463271|NCT00734474|4824668|P6|Overall Study|Death|0
1463272|NCT00734474|4824669|P5|Overall Study|Death|0
1463273|NCT00734474|4824670|P4|Overall Study|Death|0
1463274|NCT00734474|4824671|P3|Overall Study|Death|1
1463275|NCT00734474|4824672|P2|Overall Study|Death|0
1463276|NCT00734474|4824673|P1|Overall Study|Death|0
1463277|NCT00734474|4824665|P9|Overall Study|Sponsor Decision|0
1463278|NCT00734474|4824666|P8|Overall Study|Sponsor Decision|0
1463279|NCT00734474|4824667|P7|Overall Study|Sponsor Decision|0
1463280|NCT00734474|4824668|P6|Overall Study|Sponsor Decision|0
1463281|NCT00734474|4824669|P5|Overall Study|Sponsor Decision|2
1463282|NCT00734474|4824670|P4|Overall Study|Sponsor Decision|0
1463283|NCT00734474|4824671|P3|Overall Study|Sponsor Decision|0
1463284|NCT00734474|4824672|P2|Overall Study|Sponsor Decision|0
1463285|NCT00734474|4824673|P1|Overall Study|Sponsor Decision|0
1463286|NCT00734474|4824665|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
1463287|NCT00734474|4824666|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
1463288|NCT00734474|4824667|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
1463289|NCT00734474|4824668|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
1463290|NCT00734474|4824669|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
1463291|NCT00734474|4824670|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
1463292|NCT00734474|4824671|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
1463293|NCT00734474|4824672|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
1463294|NCT00734474|4824673|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
1463295|NCT00734474|4824665|P9|Overall Study|Protocol Violation|1
1463296|NCT00734474|4824666|P8|Overall Study|Protocol Violation|3
1463297|NCT00734474|4824667|P7|Overall Study|Protocol Violation|0
1463298|NCT00734474|4824668|P6|Overall Study|Protocol Violation|0
1463299|NCT00734474|4824669|P5|Overall Study|Protocol Violation|3
1463300|NCT00734474|4824670|P4|Overall Study|Protocol Violation|0
1463301|NCT00734474|4824671|P3|Overall Study|Protocol Violation|4
1463302|NCT00734474|4824672|P2|Overall Study|Protocol Violation|0
1463303|NCT00734474|4824673|P1|Overall Study|Protocol Violation|0
1463304|NCT00734474|4824665|P9|Overall Study|Adverse Event|39
1463305|NCT00734474|4824666|P8|Overall Study|Adverse Event|65
1463306|NCT00734474|4824667|P7|Overall Study|Adverse Event|1
1463307|NCT00734474|4824668|P6|Overall Study|Adverse Event|0
1463308|NCT00734474|4824669|P5|Overall Study|Adverse Event|64
1463309|NCT00734474|4824670|P4|Overall Study|Adverse Event|1
1463310|NCT00734474|4824671|P3|Overall Study|Adverse Event|63
1463311|NCT00734474|4824672|P2|Overall Study|Adverse Event|4
1463312|NCT00734474|4824673|P1|Overall Study|Adverse Event|4
1463313|NCT00734474|4824665|P9|Overall Study|Physician Decision|9
1463314|NCT00734474|4824666|P8|Overall Study|Physician Decision|9
1463315|NCT00734474|4824667|P7|Overall Study|Physician Decision|0
1463316|NCT00734474|4824668|P6|Overall Study|Physician Decision|0
1463317|NCT00734474|4824669|P5|Overall Study|Physician Decision|11
1463318|NCT00734474|4824670|P4|Overall Study|Physician Decision|1
1463319|NCT00734474|4824671|P3|Overall Study|Physician Decision|4
1463320|NCT00734474|4824672|P2|Overall Study|Physician Decision|0
1463321|NCT00734474|4824673|P1|Overall Study|Physician Decision|0
1463322|NCT00734474|4824665|P9|Overall Study|Withdrawal by Subject|21
1463323|NCT00734474|4824666|P8|Overall Study|Withdrawal by Subject|36
1463324|NCT00734474|4824667|P7|Overall Study|Withdrawal by Subject|0
1463325|NCT00734474|4824668|P6|Overall Study|Withdrawal by Subject|2
1463326|NCT00734474|4824669|P5|Overall Study|Withdrawal by Subject|24
1463327|NCT00734474|4824670|P4|Overall Study|Withdrawal by Subject|0
1463328|NCT00734474|4824671|P3|Overall Study|Withdrawal by Subject|18
1463329|NCT00734474|4824672|P2|Overall Study|Withdrawal by Subject|1
1463330|NCT00734474|4824673|P1|Overall Study|Withdrawal by Subject|2
1463331|NCT00734474|4824665|P9|Overall Study|Lost to Follow-up|4
1463332|NCT00734474|4824666|P8|Overall Study|Lost to Follow-up|9
1463333|NCT00734474|4824667|P7|Overall Study|Lost to Follow-up|0
1463334|NCT00734474|4824668|P6|Overall Study|Lost to Follow-up|1
1463335|NCT00734474|4824669|P5|Overall Study|Lost to Follow-up|11
1463336|NCT00734474|4824670|P4|Overall Study|Lost to Follow-up|0
1463337|NCT00734474|4824671|P3|Overall Study|Lost to Follow-up|13
1463338|NCT00734474|4824672|P2|Overall Study|Lost to Follow-up|0
1463339|NCT00734474|4824673|P1|Overall Study|Lost to Follow-up|1
1463340|NCT00734474|4824665|P9|Overall Study|Entry Criteria Not Met|1
1463341|NCT00734474|4824666|P8|Overall Study|Entry Criteria Not Met|1
1463342|NCT00734474|4824667|P7|Overall Study|Entry Criteria Not Met|0
1463343|NCT00734474|4824668|P6|Overall Study|Entry Criteria Not Met|1
1463344|NCT00734474|4824669|P5|Overall Study|Entry Criteria Not Met|3
1463345|NCT00734474|4824670|P4|Overall Study|Entry Criteria Not Met|0
1463346|NCT00734474|4824671|P3|Overall Study|Entry Criteria Not Met|5
1463347|NCT00734474|4824672|P2|Overall Study|Entry Criteria Not Met|0
1463348|NCT00734474|4824673|P1|Overall Study|Entry Criteria Not Met|0
1463349|NCT00734214|4824963|P2|Overall Study|MD withdrawal|0
1463350|NCT00734214|4824964|P1|Overall Study|MD withdrawal|1
1463351|NCT00734214|4824963|P2|Overall Study|Withdrawal by Subject|4
1463352|NCT00734214|4824964|P1|Overall Study|Withdrawal by Subject|3
1463353|NCT00734162|4824974|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
1463354|NCT00734162|4824975|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
1463355|NCT00734162|4824976|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
1463356|NCT00734162|4824977|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
1463357|NCT00734162|4824974|P4|Open-Label Phase|Lost to Follow-up|1
1463358|NCT00734162|4824975|P3|Open-Label Phase|Lost to Follow-up|0
1463359|NCT00734162|4824976|P2|Open-Label Phase|Lost to Follow-up|2
1463360|NCT00734162|4824977|P1|Open-Label Phase|Lost to Follow-up|1
1463361|NCT00734162|4824974|P4|Open-Label Phase|Withdrew Consent|1
1463362|NCT00734162|4824975|P3|Open-Label Phase|Withdrew Consent|1
1463363|NCT00734162|4824976|P2|Open-Label Phase|Withdrew Consent|0
1463364|NCT00734162|4824977|P1|Open-Label Phase|Withdrew Consent|1
1463365|NCT00734162|4824974|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
1463366|NCT00734162|4824975|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
1463367|NCT00734162|4824976|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
1463368|NCT00734162|4824977|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
1463369|NCT00734162|4824974|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
1463370|NCT00734162|4824975|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
1463371|NCT00734162|4824976|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
1463372|NCT00734162|4824977|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
1463373|NCT00734162|4824974|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
1463374|NCT00734162|4824975|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
1463375|NCT00734162|4824976|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
1463376|NCT00734162|4824977|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
1463377|NCT00734149|4825201|P1|Overall Study|Withdrawal by Subject|1
1463378|NCT00734097|4825208|P1|Open Label|Protocol Violation|4
1463379|NCT00734097|4825208|P1|Open Label|Withdrawal by Subject|5
1463380|NCT00734097|4825208|P1|Open Label|Lost to Follow-up|7
1463381|NCT00734097|4825208|P1|Screening|Unconfirmed pregnancy|1
1463382|NCT00734097|4825208|P1|Screening|Lost to Follow-up|2
1463383|NCT00734097|4825208|P1|Screening|Withdrawal by Subject|5
1463384|NCT00734097|4825208|P1|Screening|Protocol Violation|12
1463385|NCT00734071|4825225|P2|Overall Study|Other|2
1463386|NCT00734071|4825226|P1|Overall Study|Other|1
1463387|NCT00734071|4825225|P2|Overall Study|Lost to Follow-up|8
1463388|NCT00734071|4825226|P1|Overall Study|Lost to Follow-up|16
1463389|NCT00734071|4825225|P2|Overall Study|Voluntary Withdrawal|7
1463390|NCT00734071|4825226|P1|Overall Study|Voluntary Withdrawal|9
1463391|NCT00734071|4825225|P2|Overall Study|Protocol Deviations|4
1463392|NCT00734071|4825226|P1|Overall Study|Protocol Deviations|3
1463393|NCT00734071|4825225|P2|Overall Study|Noncompliance|2
1463394|NCT00734071|4825226|P1|Overall Study|Noncompliance|2
1463395|NCT00734071|4825225|P2|Overall Study|Lack of Efficacy|1
1463396|NCT00734071|4825226|P1|Overall Study|Lack of Efficacy|3
1463397|NCT00734071|4825225|P2|Overall Study|Adverse Event|3
1463398|NCT00734071|4825226|P1|Overall Study|Adverse Event|4
1463399|NCT00734032|4825284|P4|Overall Study|Adverse Event|0
1463400|NCT00734032|4825285|P3|Overall Study|Adverse Event|0
1463401|NCT00734032|4825286|P2|Overall Study|Adverse Event|1
1463402|NCT00734032|4825287|P1|Overall Study|Adverse Event|0
1463403|NCT00733980|4825343|P2|Overall Study|Withdrawal by Subject|2
1463404|NCT00733980|4825344|P1|Overall Study|Withdrawal by Subject|6
1463405|NCT00733980|4825343|P2|Overall Study|Physician Decision|3
1463406|NCT00733980|4825344|P1|Overall Study|Physician Decision|2
1463407|NCT00733980|4825343|P2|Overall Study|Lost to Follow-up|11
1463408|NCT00733980|4825344|P1|Overall Study|Lost to Follow-up|6
1463409|NCT00733980|4825343|P2|Overall Study|Protocol defined stopping criteria reach|1
1463410|NCT00733980|4825344|P1|Overall Study|Protocol defined stopping criteria reach|1
1463411|NCT00733980|4825343|P2|Overall Study|Protocol Violation|1
1463412|NCT00733980|4825344|P1|Overall Study|Protocol Violation|2
1463413|NCT00733980|4825343|P2|Overall Study|Lack of Efficacy|1
1463414|NCT00733980|4825344|P1|Overall Study|Lack of Efficacy|0
1463415|NCT00733980|4825343|P2|Overall Study|Adverse Event|2
1463416|NCT00733980|4825344|P1|Overall Study|Adverse Event|5
1463417|NCT00733954|4825388|P2|Overall Study|Withdrawal by Subject|0
1463418|NCT00733954|4825389|P1|Overall Study|Withdrawal by Subject|2
1463419|NCT00733954|4825388|P2|Overall Study|Protocol Violation|0
1463420|NCT00733954|4825389|P1|Overall Study|Protocol Violation|1
1463421|NCT00733954|4825388|P2|Overall Study|Lost to Follow-up|2
1463422|NCT00733954|4825389|P1|Overall Study|Lost to Follow-up|5
1463423|NCT00733824|4825436|P5|Phase I|Withdrawal by Subject|0
1463424|NCT00733824|4825437|P4|Phase I|Withdrawal by Subject|0
1463425|NCT00733824|4825438|P3|Phase I|Withdrawal by Subject|0
1463426|NCT00733824|4825439|P2|Phase I|Withdrawal by Subject|0
1463427|NCT00733824|4825440|P1|Phase I|Withdrawal by Subject|1
1463428|NCT00733746|4825459|P1|Overall Study|Ineligible|5
1463429|NCT00733499|4825474|P2|24 Months Follow-up|Death|1
1463430|NCT00733499|4825475|P1|24 Months Follow-up|Death|0
1463431|NCT00733499|4825474|P2|12 Months Follow-up|Death|1
1463432|NCT00733499|4825475|P1|12 Months Follow-up|Death|2
1463433|NCT00733499|4825474|P2|6 Months Follow-up|Adverse Event|1
1463434|NCT00733499|4825475|P1|6 Months Follow-up|Adverse Event|0
1463435|NCT00733499|4825474|P2|6 Months Follow-up|Death|2
1463436|NCT00733499|4825475|P1|6 Months Follow-up|Death|0
1463437|NCT00733499|4825474|P2|3 Months Follow-up|Death|2
1463438|NCT00733499|4825475|P1|3 Months Follow-up|Death|1
1463439|NCT00733499|4825474|P2|Pre-operative|Protocol Violation|1
1463440|NCT00733499|4825475|P1|Pre-operative|Protocol Violation|0
1463441|NCT00733421|4825483|P2|Overall Study|Withdrawal by Subject|1
1463442|NCT00733421|4825484|P1|Overall Study|Withdrawal by Subject|1
1463443|NCT00733369|4825508|P2|Overall Study|Protocol Violation|4
1463444|NCT00733369|4825509|P1|Overall Study|Protocol Violation|4
1463445|NCT00733369|4825508|P2|Overall Study|Adverse Event|4
1463446|NCT00733369|4825509|P1|Overall Study|Adverse Event|4
1463447|NCT00733369|4825508|P2|Overall Study|Lost to Follow-up|1
1463448|NCT00733369|4825509|P1|Overall Study|Lost to Follow-up|2
1463449|NCT00733304|4825717|P3|Overall Study|Withdrawal by Subject|0
1463450|NCT00733304|4825718|P2|Overall Study|Withdrawal by Subject|1
1463451|NCT00733304|4825719|P1|Overall Study|Withdrawal by Subject|1
1463452|NCT00733304|4825717|P3|Overall Study|Physician Decision|3
1463453|NCT00733304|4825718|P2|Overall Study|Physician Decision|1
1463454|NCT00733304|4825719|P1|Overall Study|Physician Decision|3
1463455|NCT00733304|4825717|P3|Overall Study|Lost to Follow-up|0
1463456|NCT00733304|4825718|P2|Overall Study|Lost to Follow-up|1
1463457|NCT00733304|4825719|P1|Overall Study|Lost to Follow-up|0
1463458|NCT00733304|4825717|P3|Overall Study|Lack of Efficacy|2
1463459|NCT00733304|4825718|P2|Overall Study|Lack of Efficacy|0
1463460|NCT00733304|4825719|P1|Overall Study|Lack of Efficacy|0
1463461|NCT00733304|4825717|P3|Overall Study|Adverse Event|0
1463462|NCT00733304|4825718|P2|Overall Study|Adverse Event|0
1463463|NCT00733304|4825719|P1|Overall Study|Adverse Event|3
1463464|NCT00733291|4825801|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
1463465|NCT00733291|4825802|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
1463466|NCT00733291|4825803|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
1463467|NCT00733291|4825804|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
1463468|NCT00733226|4825833|P2|Overall Study|moved to another place|0
1463469|NCT00733226|4825834|P1|Overall Study|moved to another place|2
1463470|NCT00733226|4825833|P2|Overall Study|Lost to Follow-up|0
1463471|NCT00733226|4825834|P1|Overall Study|Lost to Follow-up|2
1463472|NCT00733226|4825833|P2|Overall Study|Withdrawal by Subject|0
1463473|NCT00733226|4825834|P1|Overall Study|Withdrawal by Subject|1
1463474|NCT00733005|4825883|P2|Overall Study|Protocol Violation|0
1463475|NCT00733005|4825884|P1|Overall Study|Protocol Violation|2
1463476|NCT00733005|4825883|P2|Overall Study|Withdrawal by Subject|1
1463477|NCT00733005|4825884|P1|Overall Study|Withdrawal by Subject|0
1463478|NCT00733005|4825883|P2|Overall Study|Treatment Failure|1
1463479|NCT00733005|4825884|P1|Overall Study|Treatment Failure|0
1463480|NCT00733005|4825883|P2|Overall Study|Adverse Event|1
1463481|NCT00733005|4825884|P1|Overall Study|Adverse Event|0
1463482|NCT00732992|4825894|P2|Overall Study|Withdrawal by Subject|0
1463483|NCT00732992|4825895|P1|Overall Study|Withdrawal by Subject|1
1463484|NCT00732992|4825894|P2|Overall Study|Global Deterioration of Health Status|0
1463485|NCT00732992|4825895|P1|Overall Study|Global Deterioration of Health Status|1
1463486|NCT00732992|4825894|P2|Overall Study|Objective Progression or Relapse|5
1463487|NCT00732992|4825895|P1|Overall Study|Objective Progression or Relapse|3
1463488|NCT00732992|4825894|P2|Overall Study|Adverse Event|1
1463489|NCT00732992|4825895|P1|Overall Study|Adverse Event|1
1463490|NCT00732940|4825914|P2|Overall Study|Lost to Follow-up|0
1463491|NCT00732940|4825915|P1|Overall Study|Lost to Follow-up|1
1463492|NCT00732940|4825914|P2|Overall Study|Adverse Event|1
1463493|NCT00732940|4825915|P1|Overall Study|Adverse Event|0
1463494|NCT00732940|4825914|P2|Overall Study|Withdrawal by Subject|2
1463495|NCT00732940|4825915|P1|Overall Study|Withdrawal by Subject|1
1463496|NCT00732875|4825996|P1|Overall Study|Lack of Efficacy|13
1463497|NCT00732875|4825996|P1|Overall Study|Withdrawal by Subject|6
1463498|NCT00732875|4825996|P1|Overall Study|Adverse Event|16
1463499|NCT00732758|4826004|P2|Overall Study|Lost to Follow-up|16
1463500|NCT00732758|4826005|P1|Overall Study|Lost to Follow-up|8
1463501|NCT00732641|4826045|P2|Overall Study|Not Specified|5
1463502|NCT00732641|4826046|P1|Overall Study|Not Specified|18
1463503|NCT00732641|4826045|P2|Overall Study|Unable to Complete|1
1463504|NCT00732641|4826046|P1|Overall Study|Unable to Complete|1
1463505|NCT00732641|4826045|P2|Overall Study|Withdrawal by Subject|2
1463506|NCT00732641|4826046|P1|Overall Study|Withdrawal by Subject|4
1463507|NCT00732641|4826045|P2|Overall Study|Physician Decision|0
1463508|NCT00732641|4826046|P1|Overall Study|Physician Decision|6
1463509|NCT00732641|4826045|P2|Overall Study|Serious Adverse Events|3
1463510|NCT00732641|4826046|P1|Overall Study|Serious Adverse Events|12
1463511|NCT00732641|4826045|P2|Overall Study|Relapse or Progressive Disease|101
1463512|NCT00732641|4826046|P1|Overall Study|Relapse or Progressive Disease|65
1463513|NCT00732615|4826066|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
1463514|NCT00732615|4826067|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
1463515|NCT00732615|4826066|P2|Overall Study|Physician Decision|0
1463516|NCT00732615|4826067|P1|Overall Study|Physician Decision|3
1463517|NCT00732615|4826066|P2|Overall Study|Adverse Event|2
1463518|NCT00732615|4826067|P1|Overall Study|Adverse Event|0
1463519|NCT00732615|4826066|P2|Overall Study|Lost to Follow-up|1
1463520|NCT00732615|4826067|P1|Overall Study|Lost to Follow-up|0
1463521|NCT00732615|4826066|P2|Overall Study|Withdrawal by Subject|1
1463522|NCT00732615|4826067|P1|Overall Study|Withdrawal by Subject|3
1463523|NCT00732472|4826083|P4|Overall Study|Withdrawal by Subject|1
1463524|NCT00732472|4826084|P3|Overall Study|Withdrawal by Subject|0
1463525|NCT00732472|4826085|P2|Overall Study|Withdrawal by Subject|2
1463526|NCT00732472|4826086|P1|Overall Study|Withdrawal by Subject|0
1463527|NCT00732472|4826083|P4|Overall Study|Protocol Violation|1
1463528|NCT00732472|4826084|P3|Overall Study|Protocol Violation|0
1463529|NCT00732472|4826085|P2|Overall Study|Protocol Violation|0
1463530|NCT00732472|4826086|P1|Overall Study|Protocol Violation|0
1463531|NCT00732472|4826083|P4|Overall Study|Adverse Event|1
1463532|NCT00732472|4826084|P3|Overall Study|Adverse Event|1
1463533|NCT00732472|4826085|P2|Overall Study|Adverse Event|1
1463534|NCT00732472|4826086|P1|Overall Study|Adverse Event|0
1463535|NCT00732381|4826186|P2|Overall Study|Treatment Failure|1
1463536|NCT00732381|4826187|P1|Overall Study|Treatment Failure|1
1463537|NCT00732381|4826186|P2|Overall Study|Adverse Event|0
1463538|NCT00732381|4826187|P1|Overall Study|Adverse Event|1
1463539|NCT00732303|4826195|P1|Overall Study|Study Terminated|2
1463540|NCT00732251|4826201|P1|Overall Study|Early Term due to Site Closure|1
1463541|NCT00732251|4826201|P1|Overall Study|Withdrawal by Subject|3
1463542|NCT00732251|4826201|P1|Overall Study|Lost to Follow-up|3
1463543|NCT00732238|4826207|P2|Overall Study|Asymptomatic bacteriuria|0
1463544|NCT00732238|4826208|P1|Overall Study|Asymptomatic bacteriuria|1
1463545|NCT00732238|4826207|P2|Overall Study|Bacteremia|1
1463546|NCT00732238|4826208|P1|Overall Study|Bacteremia|4
1463547|NCT00732199|4826309|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
1463548|NCT00732199|4826310|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
1463549|NCT00732199|4826309|P2|Overall Study|Withdrawal by Subject|18
1463550|NCT00732199|4826310|P1|Overall Study|Withdrawal by Subject|25
1463551|NCT00732160|4826325|P4|Overall Study|scheduling|1
1463552|NCT00732160|4826326|P3|Overall Study|scheduling|2
1463553|NCT00732160|4826327|P2|Overall Study|scheduling|4
1463554|NCT00732160|4826328|P1|Overall Study|scheduling|4
1463555|NCT00732160|4826325|P4|Overall Study|Adverse Event|1
1463556|NCT00732160|4826326|P3|Overall Study|Adverse Event|1
1463557|NCT00732160|4826327|P2|Overall Study|Adverse Event|0
1463558|NCT00732160|4826328|P1|Overall Study|Adverse Event|1
1463559|NCT00732069|4826342|P6|Washout After First Study Drug|Adverse Event|0
1463560|NCT00732069|4826343|P5|Washout After First Study Drug|Adverse Event|0
1463561|NCT00732069|4826344|P4|Washout After First Study Drug|Adverse Event|0
1463562|NCT00732069|4826345|P3|Washout After First Study Drug|Adverse Event|0
1463563|NCT00732069|4826346|P2|Washout After First Study Drug|Adverse Event|0
1463564|NCT00732069|4826347|P1|Washout After First Study Drug|Adverse Event|1
1463565|NCT00731939|4826365|P1|Overall Study|Did not meet enrollment criteria|2
1463566|NCT00731939|4826365|P1|Overall Study|Withdrawal by Subject|2
1463567|NCT00731939|4826365|P1|Overall Study|Not implanted with study device|9
1463568|NCT00731939|4826365|P1|Overall Study|Lost to Follow-up|15
1463569|NCT00731939|4826365|P1|Overall Study|Adverse Event|6
1463570|NCT00731822|4826426|P2|Overall Study|Lost to Follow-up|0
1463571|NCT00731822|4826427|P1|Overall Study|Lost to Follow-up|1
1463572|NCT00731822|4826426|P2|Overall Study|Protocol Violation|0
1463573|NCT00731822|4826427|P1|Overall Study|Protocol Violation|1
1463574|NCT00731822|4826426|P2|Overall Study|Adverse Event|1
1463575|NCT00731822|4826427|P1|Overall Study|Adverse Event|2
1463576|NCT00731783|4826441|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
1463577|NCT00731783|4826442|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
1463578|NCT00731783|4826441|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
1463579|NCT00731783|4826442|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
1463580|NCT00731783|4826441|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
1463581|NCT00731783|4826442|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
1463582|NCT00731783|4826441|P2|One Month Follow-Up Visit|Lost to Follow-up|22
1463583|NCT00731783|4826442|P1|One Month Follow-Up Visit|Lost to Follow-up|14
1463584|NCT00731731|4826465|P3|Overall Study|Cancel prior to treatment|2
1463585|NCT00731731|4826466|P2|Overall Study|Cancel prior to treatment|0
1463586|NCT00731731|4826467|P1|Overall Study|Cancel prior to treatment|0
1463587|NCT00731731|4826465|P3|Overall Study|Protocol Violation|1
1463588|NCT00731731|4826466|P2|Overall Study|Protocol Violation|0
1463589|NCT00731731|4826467|P1|Overall Study|Protocol Violation|0
1463590|NCT00731692|4826485|P3|Extension Phase|Adverse Event|15
1463591|NCT00731692|4826486|P2|Extension Phase|Adverse Event|1
1463592|NCT00731692|4826487|P1|Extension Phase|Adverse Event|1
1463593|NCT00731692|4826485|P3|Extension Phase|Withdrawal by Subject|3
1463594|NCT00731692|4826486|P2|Extension Phase|Withdrawal by Subject|5
1463595|NCT00731692|4826487|P1|Extension Phase|Withdrawal by Subject|4
1463596|NCT00731692|4826485|P3|Extension Phase|Lost to Follow-up|4
1463597|NCT00731692|4826486|P2|Extension Phase|Lost to Follow-up|1
1463598|NCT00731692|4826487|P1|Extension Phase|Lost to Follow-up|0
1463599|NCT00731692|4826485|P3|Extension Phase|Abnormal lab values|1
1463600|NCT00731692|4826486|P2|Extension Phase|Abnormal lab values|0
1463601|NCT00731692|4826487|P1|Extension Phase|Abnormal lab values|0
1463602|NCT00731692|4826485|P3|Extension Phase|Abnormal test procedure|1
1463603|NCT00731692|4826486|P2|Extension Phase|Abnormal test procedure|0
1463604|NCT00731692|4826487|P1|Extension Phase|Abnormal test procedure|0
1463605|NCT00731692|4826485|P3|Extension Phase|Admin Problems: Terminated # patients|277
1463606|NCT00731692|4826486|P2|Extension Phase|Admin Problems: Terminated # patients|189
1463607|NCT00731692|4826487|P1|Extension Phase|Admin Problems: Terminated # patients|69
1463608|NCT00731692|4826485|P3|Core Study (36 Months)|Withdrawal by Subject|46
1463609|NCT00731692|4826486|P2|Core Study (36 Months)|Withdrawal by Subject|32
1463610|NCT00731692|4826487|P1|Core Study (36 Months)|Withdrawal by Subject|12
1463611|NCT00731692|4826485|P3|Core Study (36 Months)|Adverse Event|29
1463612|NCT00731692|4826486|P2|Core Study (36 Months)|Adverse Event|28
1463613|NCT00731692|4826487|P1|Core Study (36 Months)|Adverse Event|25
1463614|NCT00731692|4826485|P3|Core Study (36 Months)|Abnormal Lab values|5
1463615|NCT00731692|4826486|P2|Core Study (36 Months)|Abnormal Lab values|19
1463616|NCT00731692|4826487|P1|Core Study (36 Months)|Abnormal Lab values|6
1463617|NCT00731692|4826485|P3|Core Study (36 Months)|Protocol Violation|8
1463618|NCT00731692|4826486|P2|Core Study (36 Months)|Protocol Violation|5
1463619|NCT00731692|4826487|P1|Core Study (36 Months)|Protocol Violation|4
1463620|NCT00731692|4826485|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
1463621|NCT00731692|4826486|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
1463622|NCT00731692|4826487|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
1463623|NCT00731692|4826485|P3|Core Study (36 Months)|Administrative|6
1463624|NCT00731692|4826486|P2|Core Study (36 Months)|Administrative|2
1463625|NCT00731692|4826487|P1|Core Study (36 Months)|Administrative|2
1463626|NCT00731692|4826485|P3|Core Study (36 Months)|Lost to Follow-up|3
1463627|NCT00731692|4826486|P2|Core Study (36 Months)|Lost to Follow-up|3
1463628|NCT00731692|4826487|P1|Core Study (36 Months)|Lost to Follow-up|1
1463629|NCT00731692|4826485|P3|Core Study (36 Months)|Death|2
1463630|NCT00731692|4826486|P2|Core Study (36 Months)|Death|1
1463631|NCT00731692|4826487|P1|Core Study (36 Months)|Death|2
1463632|NCT00731692|4826485|P3|Core Study (36 Months)|Physician Decision|2
1463633|NCT00731692|4826486|P2|Core Study (36 Months)|Physician Decision|0
1463634|NCT00731692|4826487|P1|Core Study (36 Months)|Physician Decision|1
1463635|NCT00731692|4826485|P3|Core Study (36 Months)|Lack of Efficacy|64
1463636|NCT00731692|4826486|P2|Core Study (36 Months)|Lack of Efficacy|23
1463637|NCT00731692|4826487|P1|Core Study (36 Months)|Lack of Efficacy|11
1463638|NCT00731679|4826533|P2|Overall Study|Pregnancy|1
1463639|NCT00731679|4826534|P1|Overall Study|Pregnancy|0
1463640|NCT00731679|4826533|P2|Overall Study|Noncompliance|1
1463641|NCT00731679|4826534|P1|Overall Study|Noncompliance|0
1463642|NCT00731679|4826533|P2|Overall Study|Lost to Follow-up|8
1463643|NCT00731679|4826534|P1|Overall Study|Lost to Follow-up|7
1463644|NCT00731679|4826533|P2|Overall Study|Withdrawal by Subject|8
1463645|NCT00731679|4826534|P1|Overall Study|Withdrawal by Subject|8
1463646|NCT00731679|4826533|P2|Overall Study|Adverse Event|8
1463647|NCT00731679|4826534|P1|Overall Study|Adverse Event|7
1463648|NCT00731666|4826542|P1|Overall Study|Withdrawal by Subject|2
1463649|NCT00731666|4826542|P1|Overall Study|Lost to Follow-up|8
1463650|NCT00731666|4826542|P1|Overall Study|Adverse Event|2
1463651|NCT00731549|4826576|P1|Overall Study|Lack of efficacy without AE|6
1463652|NCT00731549|4826576|P1|Overall Study|Lack of efficacy with AE|37
1463653|NCT00731549|4826576|P1|Overall Study|Adverse Event|31
1463654|NCT00731549|4826576|P1|Overall Study|Protocol deviation|1
1463655|NCT00731549|4826576|P1|Overall Study|Withdrawal by Subject|89
1463656|NCT00731549|4826576|P1|Overall Study|Physician Decision|16
1463657|NCT00731549|4826576|P1|Overall Study|Met withdrawal criteria|24
1463658|NCT00731549|4826576|P1|Overall Study|Lost to Follow-up|19
1463659|NCT00731133|4826616|P1|Overall Study|Withdrawal by Subject|10
1463660|NCT00731120|4826624|P3|Overall Study|Other|1
1463661|NCT00731120|4826625|P2|Overall Study|Other|0
1463662|NCT00731120|4826626|P1|Overall Study|Other|4
1463663|NCT00731120|4826624|P3|Overall Study|Lost to Follow-up|17
1463664|NCT00731120|4826625|P2|Overall Study|Lost to Follow-up|15
1463665|NCT00731120|4826626|P1|Overall Study|Lost to Follow-up|10
1463666|NCT00731120|4826624|P3|Overall Study|Withdrawal of Consent|4
1463667|NCT00731120|4826625|P2|Overall Study|Withdrawal of Consent|8
1463668|NCT00731120|4826626|P1|Overall Study|Withdrawal of Consent|13
1463669|NCT00731120|4826624|P3|Overall Study|Protocol Deviations|1
1463670|NCT00731120|4826625|P2|Overall Study|Protocol Deviations|6
1463671|NCT00731120|4826626|P1|Overall Study|Protocol Deviations|1
1463672|NCT00731120|4826624|P3|Overall Study|Noncompliance with Study Drug|1
1463673|NCT00731120|4826625|P2|Overall Study|Noncompliance with Study Drug|3
1463674|NCT00731120|4826626|P1|Overall Study|Noncompliance with Study Drug|3
1463675|NCT00731120|4826624|P3|Overall Study|Lack of Efficacy|4
1463676|NCT00731120|4826625|P2|Overall Study|Lack of Efficacy|5
1463677|NCT00731120|4826626|P1|Overall Study|Lack of Efficacy|4
1463678|NCT00731120|4826624|P3|Overall Study|Adverse Event|8
1463679|NCT00731120|4826625|P2|Overall Study|Adverse Event|6
1463680|NCT00731120|4826626|P1|Overall Study|Adverse Event|7
1463681|NCT00731042|4826743|P2|Second Intervention|Did not meet inclusion criteria|2
1463682|NCT00731042|4826744|P1|Second Intervention|Did not meet inclusion criteria|0
1463683|NCT00730925|4826755|P1|Overall Study|Other|1
1463684|NCT00730925|4826755|P1|Overall Study|Switch to combination therapy|8
1463685|NCT00730925|4826755|P1|Overall Study|Withdrawal by Subject|1
1463686|NCT00730925|4826755|P1|Overall Study|Protocol Violation|1
1463687|NCT00730925|4826755|P1|Overall Study|Other Averse Event|7
1463688|NCT00730925|4826755|P1|Overall Study|Dose reducing Event|2
1463689|NCT00730925|4826755|P1|Overall Study|Progressive Disease|21
1463690|NCT00730912|4826765|P3|Overall Study|Discontinued|1
1463691|NCT00730912|4826766|P2|Overall Study|Discontinued|0
1463692|NCT00730912|4826767|P1|Overall Study|Discontinued|0
1463693|NCT00730886|4826780|P2|Overall Study|Physician Decision|0
1463694|NCT00730886|4826781|P1|Overall Study|Physician Decision|1
1463695|NCT00730886|4826780|P2|Overall Study|Lost to Follow-up|0
1463696|NCT00730886|4826781|P1|Overall Study|Lost to Follow-up|1
1463697|NCT00730847|4826805|P1|Overall Study|Other|24
1463698|NCT00730847|4826805|P1|Overall Study|Unknown completion status|21
1463699|NCT00730847|4826805|P1|Overall Study|Lost to Follow-up|67
1463700|NCT00730847|4826805|P1|Overall Study|Withdrawal by Subject|16
1463701|NCT00730847|4826805|P1|Overall Study|Protocol Violation|2
1463702|NCT00730847|4826805|P1|Overall Study|Adverse Event|1
1463703|NCT00730756|4826814|P2|Overall Study|Withdrew Consent|1
1463704|NCT00730756|4826815|P1|Overall Study|Withdrew Consent|0
1463705|NCT00730756|4826814|P2|Overall Study|Lost to Follow-up|1
1463706|NCT00730756|4826815|P1|Overall Study|Lost to Follow-up|0
1463707|NCT00730756|4826814|P2|Overall Study|Protocol Deviation|2
1463708|NCT00730756|4826815|P1|Overall Study|Protocol Deviation|1
1463709|NCT00730756|4826814|P2|Overall Study|Lack of Efficacy|1
1463710|NCT00730756|4826815|P1|Overall Study|Lack of Efficacy|1
1463711|NCT00730756|4826814|P2|Overall Study|Adverse Event|0
1463712|NCT00730756|4826815|P1|Overall Study|Adverse Event|2
1463713|NCT00730691|4826849|P5|Overall Study|Other|2
1463714|NCT00730691|4826850|P4|Overall Study|Other|2
1463715|NCT00730691|4826851|P3|Overall Study|Other|1
1463716|NCT00730691|4826852|P2|Overall Study|Other|1
1463717|NCT00730691|4826853|P1|Overall Study|Other|1
1463718|NCT00730691|4826849|P5|Overall Study|Lost to Follow-up|13
1463719|NCT00730691|4826850|P4|Overall Study|Lost to Follow-up|15
1463720|NCT00730691|4826851|P3|Overall Study|Lost to Follow-up|13
1463721|NCT00730691|4826852|P2|Overall Study|Lost to Follow-up|8
1463722|NCT00730691|4826853|P1|Overall Study|Lost to Follow-up|11
1463723|NCT00730691|4826849|P5|Overall Study|Withdrawal of Consent|3
1463724|NCT00730691|4826850|P4|Overall Study|Withdrawal of Consent|6
1463725|NCT00730691|4826851|P3|Overall Study|Withdrawal of Consent|3
1463726|NCT00730691|4826852|P2|Overall Study|Withdrawal of Consent|9
1463727|NCT00730691|4826853|P1|Overall Study|Withdrawal of Consent|7
1463728|NCT00730691|4826849|P5|Overall Study|Protocol Deviations|5
1463729|NCT00730691|4826850|P4|Overall Study|Protocol Deviations|7
1463730|NCT00730691|4826851|P3|Overall Study|Protocol Deviations|3
1463731|NCT00730691|4826852|P2|Overall Study|Protocol Deviations|5
1463732|NCT00730691|4826853|P1|Overall Study|Protocol Deviations|3
1463733|NCT00730691|4826849|P5|Overall Study|Non-compliance with Study Drug|3
1463734|NCT00730691|4826850|P4|Overall Study|Non-compliance with Study Drug|3
1463735|NCT00730691|4826851|P3|Overall Study|Non-compliance with Study Drug|6
1463736|NCT00730691|4826852|P2|Overall Study|Non-compliance with Study Drug|1
1463737|NCT00730691|4826853|P1|Overall Study|Non-compliance with Study Drug|6
1463738|NCT00730691|4826849|P5|Overall Study|Lack of Efficacy|1
1463739|NCT00730691|4826850|P4|Overall Study|Lack of Efficacy|1
1463740|NCT00730691|4826851|P3|Overall Study|Lack of Efficacy|2
1463741|NCT00730691|4826852|P2|Overall Study|Lack of Efficacy|4
1463742|NCT00730691|4826853|P1|Overall Study|Lack of Efficacy|4
1463743|NCT00730691|4826849|P5|Overall Study|Adverse Event|23
1463744|NCT00730691|4826850|P4|Overall Study|Adverse Event|11
1463745|NCT00730691|4826851|P3|Overall Study|Adverse Event|11
1463746|NCT00730691|4826852|P2|Overall Study|Adverse Event|8
1463747|NCT00730691|4826853|P1|Overall Study|Adverse Event|4
1463748|NCT00730639|4826945|P5|Overall Study|Treatment on-going|4
1463749|NCT00730639|4826946|P4|Overall Study|Treatment on-going|4
1463750|NCT00730639|4826947|P3|Overall Study|Treatment on-going|5
1463751|NCT00730639|4826948|P2|Overall Study|Treatment on-going|5
1463752|NCT00730639|4826949|P1|Overall Study|Treatment on-going|2
1463753|NCT00730639|4826945|P5|Overall Study|Withdrawal by Subject|4
1463754|NCT00730639|4826946|P4|Overall Study|Withdrawal by Subject|3
1463755|NCT00730639|4826947|P3|Overall Study|Withdrawal by Subject|6
1463756|NCT00730639|4826948|P2|Overall Study|Withdrawal by Subject|0
1463757|NCT00730639|4826949|P1|Overall Study|Withdrawal by Subject|0
1463758|NCT00730639|4826945|P5|Overall Study|Protocol Violation|0
1463759|NCT00730639|4826946|P4|Overall Study|Protocol Violation|0
1463760|NCT00730639|4826947|P3|Overall Study|Protocol Violation|1
1463761|NCT00730639|4826948|P2|Overall Study|Protocol Violation|0
1463762|NCT00730639|4826949|P1|Overall Study|Protocol Violation|0
1463763|NCT00730639|4826945|P5|Overall Study|non-specified|3
1463764|NCT00730639|4826946|P4|Overall Study|non-specified|2
1463765|NCT00730639|4826947|P3|Overall Study|non-specified|4
1463766|NCT00730639|4826948|P2|Overall Study|non-specified|0
1463767|NCT00730639|4826949|P1|Overall Study|non-specified|0
1463768|NCT00730639|4826945|P5|Overall Study|Disease Progression|88
1463769|NCT00730639|4826946|P4|Overall Study|Disease Progression|32
1463770|NCT00730639|4826947|P3|Overall Study|Disease Progression|48
1463771|NCT00730639|4826948|P2|Overall Study|Disease Progression|13
1463772|NCT00730639|4826949|P1|Overall Study|Disease Progression|12
1463773|NCT00730639|4826945|P5|Overall Study|Death|2
1463774|NCT00730639|4826946|P4|Overall Study|Death|0
1463775|NCT00730639|4826947|P3|Overall Study|Death|0
1463776|NCT00730639|4826948|P2|Overall Study|Death|0
1463777|NCT00730639|4826949|P1|Overall Study|Death|0
1463778|NCT00730639|4826945|P5|Overall Study|Completed Maximum Cycles|6
1463779|NCT00730639|4826946|P4|Overall Study|Completed Maximum Cycles|3
1463780|NCT00730639|4826947|P3|Overall Study|Completed Maximum Cycles|11
1463781|NCT00730639|4826948|P2|Overall Study|Completed Maximum Cycles|0
1463782|NCT00730639|4826949|P1|Overall Study|Completed Maximum Cycles|0
1463783|NCT00730639|4826945|P5|Overall Study|Complete Response|1
1463784|NCT00730639|4826946|P4|Overall Study|Complete Response|2
1463785|NCT00730639|4826947|P3|Overall Study|Complete Response|2
1463786|NCT00730639|4826948|P2|Overall Study|Complete Response|0
1463787|NCT00730639|4826949|P1|Overall Study|Complete Response|0
1463788|NCT00730639|4826945|P5|Overall Study|Adverse Event|23
1463789|NCT00730639|4826946|P4|Overall Study|Adverse Event|8
1463790|NCT00730639|4826947|P3|Overall Study|Adverse Event|9
1463791|NCT00730639|4826948|P2|Overall Study|Adverse Event|0
1463792|NCT00730639|4826949|P1|Overall Study|Adverse Event|3
1463793|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Atrial fibrillation history|0
1463794|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Atrial fibrillation history|0
1463795|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Atrial fibrillation history|0
1463796|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Atrial fibrillation history|0
1463797|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Atrial fibrillation history|1
1463798|NCT00730405|4827026|P5|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
1463799|NCT00730405|4827027|P4|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
1463800|NCT00730405|4827028|P3|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
1463801|NCT00730405|4827029|P2|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
1463802|NCT00730405|4827030|P1|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
1463803|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Other Protocol violation|0
1463804|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Other Protocol violation|0
1463805|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Other Protocol violation|1
1463806|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Other Protocol violation|0
1463807|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Other Protocol violation|0
1463808|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Mis-randomized|0
1463809|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Mis-randomized|0
1463810|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Mis-randomized|0
1463811|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Mis-randomized|1
1463812|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Mis-randomized|0
1463813|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
1463814|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
1463815|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
1463816|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
1463817|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
1463818|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Use an exclusionary medication|1
1463819|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Use an exclusionary medication|0
1463820|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Use an exclusionary medication|0
1463821|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Use an exclusionary medication|0
1463822|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Use an exclusionary medication|0
1463823|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Missing|0
1463824|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Missing|0
1463825|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Missing|2
1463826|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Missing|0
1463827|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Missing|0
1463828|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Non-compliance|0
1463829|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Non-compliance|0
1463830|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Non-compliance|2
1463831|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Non-compliance|0
1463832|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Non-compliance|1
1463833|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Use of restricted medication|0
1463834|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Use of restricted medication|0
1463835|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Use of restricted medication|0
1463836|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Use of restricted medication|1
1463837|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Use of restricted medication|0
1463838|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Declined to continue with follow-up|0
1463839|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Declined to continue with follow-up|0
1463840|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Declined to continue with follow-up|0
1463841|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Declined to continue with follow-up|1
1463842|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Declined to continue with follow-up|1
1463843|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
1463844|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
1463845|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
1463846|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
1463989|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Adverse Event|8
1463847|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
1463848|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Refused follow-up due to AE|0
1463849|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Refused follow-up due to AE|1
1463850|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Refused follow-up due to AE|0
1463851|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Refused follow-up due to AE|0
1463852|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Refused follow-up due to AE|0
1463853|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Prohibited concomitant medication|0
1463854|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Prohibited concomitant medication|0
1463855|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Prohibited concomitant medication|0
1463856|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Prohibited concomitant medication|0
1463857|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Prohibited concomitant medication|1
1463858|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
1463859|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
1463860|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
1463861|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
1463862|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
1463863|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
1463864|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
1463865|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
1463866|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
1463867|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
1463868|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Non-compliance with study treatment|0
1463869|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Non-compliance with study treatment|0
1463870|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Non-compliance with study treatment|1
1463871|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Non-compliance with study treatment|0
1463872|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Non-compliance with study treatment|0
1463873|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Did not met eligibility|0
1463874|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Did not met eligibility|0
1463875|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Did not met eligibility|1
1463876|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Did not met eligibility|0
1463877|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Did not met eligibility|0
1463878|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Change of location|0
1463879|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Change of location|1
1463880|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Change of location|0
1463881|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Change of location|1
1463882|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Change of location|1
1463883|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Death|0
1463884|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Death|1
1463885|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Death|0
1463886|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Death|1
1463887|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Death|0
1463888|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Withdrawal by Subject|10
1463889|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Withdrawal by Subject|6
1463890|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Withdrawal by Subject|3
1463891|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Withdrawal by Subject|3
1463892|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Withdrawal by Subject|7
1463893|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Lost to Follow-up|6
1463894|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Lost to Follow-up|4
1463895|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Lost to Follow-up|8
1463896|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Lost to Follow-up|6
1463897|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Lost to Follow-up|7
1463898|NCT00730405|4827026|P5|Overall Study-follow-up Phase|Adverse Event|4
1463899|NCT00730405|4827027|P4|Overall Study-follow-up Phase|Adverse Event|3
1463900|NCT00730405|4827028|P3|Overall Study-follow-up Phase|Adverse Event|2
1463901|NCT00730405|4827029|P2|Overall Study-follow-up Phase|Adverse Event|6
1463902|NCT00730405|4827030|P1|Overall Study-follow-up Phase|Adverse Event|2
1463903|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Atrial fibrillation history|0
1463904|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Atrial fibrillation history|0
1463905|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Atrial fibrillation history|0
1463906|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Atrial fibrillation history|0
1463907|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Atrial fibrillation history|1
1463908|NCT00730405|4827026|P5|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
1463909|NCT00730405|4827027|P4|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
1463910|NCT00730405|4827028|P3|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
1463911|NCT00730405|4827029|P2|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
1463912|NCT00730405|4827030|P1|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
1463913|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Pregnancy|0
1463914|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Pregnancy|0
1463915|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Pregnancy|0
1463916|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Pregnancy|1
1463917|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Pregnancy|0
1463918|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Change of location|0
1463919|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Change of location|1
1463920|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Change of location|0
1463921|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Change of location|0
1463922|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Change of location|0
1463923|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
1463924|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
1463925|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
1463926|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
1463927|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
1463928|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
1463929|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
1463930|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
1463931|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
1463932|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
1463933|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Study drug interrupted|0
1463934|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Study drug interrupted|0
1463935|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Study drug interrupted|0
1463936|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Study drug interrupted|1
1463937|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Study drug interrupted|0
1463938|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Misrandomized|0
1463939|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Misrandomized|0
1463940|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Misrandomized|0
1463941|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Misrandomized|1
1463942|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Misrandomized|0
1463943|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
1463944|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
1463945|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
1463946|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
1463947|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
1463948|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Use of prohibited medication|2
1463949|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Use of prohibited medication|0
1463950|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Use of prohibited medication|0
1463951|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Use of prohibited medication|1
1463952|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Use of prohibited medication|0
1463953|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Withdrew from study treatment|0
1463954|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Withdrew from study treatment|0
1463955|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Withdrew from study treatment|0
1463956|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Withdrew from study treatment|1
1463957|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Withdrew from study treatment|0
1463958|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Prohibited concomitant medication|0
1463959|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Prohibited concomitant medication|0
1463960|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Prohibited concomitant medication|0
1463961|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Prohibited concomitant medication|0
1463962|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Prohibited concomitant medication|1
1463963|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Participant meets exclusion|0
1463964|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Participant meets exclusion|0
1463965|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Participant meets exclusion|1
1463966|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Participant meets exclusion|0
1463967|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Participant meets exclusion|0
1463968|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Did not met eligibility|0
1463969|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Did not met eligibility|0
1463970|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Did not met eligibility|1
1463971|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Did not met eligibility|0
1463972|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Did not met eligibility|0
1463973|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Withdrawal by Subject|8
1463974|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Withdrawal by Subject|5
1463975|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Withdrawal by Subject|2
1463976|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Withdrawal by Subject|1
1463977|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Withdrawal by Subject|7
1463978|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
1463979|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
1463980|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
1463981|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
1463982|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
1463983|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Lost to Follow-up|4
1463984|NCT00730405|4827027|P4|Overall Study-Treatment Phase|Lost to Follow-up|4
1463985|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Lost to Follow-up|6
1463986|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Lost to Follow-up|5
1463987|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Lost to Follow-up|4
1463988|NCT00730405|4827026|P5|Overall Study-Treatment Phase|Adverse Event|4
1463990|NCT00730405|4827028|P3|Overall Study-Treatment Phase|Adverse Event|4
1463991|NCT00730405|4827029|P2|Overall Study-Treatment Phase|Adverse Event|10
1463992|NCT00730405|4827030|P1|Overall Study-Treatment Phase|Adverse Event|5
1463993|NCT00730327|4827077|P2|Overall Study|Subject withdrew (reason not specified)|7
1463994|NCT00730327|4827078|P1|Overall Study|Subject withdrew (reason not specified)|2
1463995|NCT00730327|4827077|P2|Overall Study|Withdrawal by Subject|13
1463996|NCT00730327|4827078|P1|Overall Study|Withdrawal by Subject|3
1463997|NCT00730327|4827077|P2|Overall Study|Adverse Event|1
1463998|NCT00730327|4827078|P1|Overall Study|Adverse Event|8
1463999|NCT00730327|4827077|P2|Overall Study|Lost to Follow-up|16
1464000|NCT00730327|4827078|P1|Overall Study|Lost to Follow-up|14
1464001|NCT00730275|4827103|P4|Overall Study|Withdrawal by Subject|1
1464002|NCT00730275|4827104|P3|Overall Study|Withdrawal by Subject|0
1464003|NCT00730275|4827105|P2|Overall Study|Withdrawal by Subject|0
1464004|NCT00730275|4827106|P1|Overall Study|Withdrawal by Subject|0
1464005|NCT00730236|4827132|P1|Overall Study|Non-compliance|1
1464006|NCT00730236|4827132|P1|Overall Study|Withdrawal by Subject|1
1464007|NCT00730236|4827132|P1|Overall Study|Adverse Event|4
1464008|NCT00730171|4827147|P1|Overall Study|Not Specified|61
1464009|NCT00730171|4827147|P1|Overall Study|Insufficient Therapeutic Response|141
1464010|NCT00730171|4827147|P1|Overall Study|Lost to Follow-up|121
1464011|NCT00730171|4827147|P1|Overall Study|Withdrawal by Subject|202
1464012|NCT00730171|4827147|P1|Overall Study|Protocol Violation|48
1464013|NCT00730171|4827147|P1|Overall Study|Adverse Event|193
1464014|NCT00730171|4827147|P1|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
1464015|NCT00730132|4827155|P1|Overall Study|Death|1
1464016|NCT00730132|4827155|P1|Overall Study|Protocol Violation|154
1464017|NCT00730041|4827173|P2|Overall Study|Lost to Follow-up|2
1464018|NCT00730041|4827174|P1|Overall Study|Lost to Follow-up|0
1464019|NCT00730028|4827197|P5|Overall Study|Randomization Error|2
1464020|NCT00730028|4827198|P4|Overall Study|Randomization Error|0
1464021|NCT00730028|4827199|P3|Overall Study|Randomization Error|0
1464022|NCT00730028|4827200|P2|Overall Study|Randomization Error|0
1464023|NCT00730028|4827201|P1|Overall Study|Randomization Error|1
1464024|NCT00730028|4827197|P5|Overall Study|Treatment Failure|1
1464025|NCT00730028|4827198|P4|Overall Study|Treatment Failure|0
1464026|NCT00730028|4827199|P3|Overall Study|Treatment Failure|0
1464027|NCT00730028|4827200|P2|Overall Study|Treatment Failure|5
1464028|NCT00730028|4827201|P1|Overall Study|Treatment Failure|5
1464029|NCT00730028|4827197|P5|Overall Study|Physician Decision|2
1464030|NCT00730028|4827198|P4|Overall Study|Physician Decision|3
1464031|NCT00730028|4827199|P3|Overall Study|Physician Decision|2
1464032|NCT00730028|4827200|P2|Overall Study|Physician Decision|3
1464033|NCT00730028|4827201|P1|Overall Study|Physician Decision|3
1464034|NCT00730028|4827197|P5|Overall Study|Withdrawal by Subject|9
1464035|NCT00730028|4827198|P4|Overall Study|Withdrawal by Subject|5
1464036|NCT00730028|4827199|P3|Overall Study|Withdrawal by Subject|4
1464037|NCT00730028|4827200|P2|Overall Study|Withdrawal by Subject|5
1464038|NCT00730028|4827201|P1|Overall Study|Withdrawal by Subject|9
1464039|NCT00730028|4827197|P5|Overall Study|Protocol Violation|0
1464040|NCT00730028|4827198|P4|Overall Study|Protocol Violation|2
1464041|NCT00730028|4827199|P3|Overall Study|Protocol Violation|1
1464042|NCT00730028|4827200|P2|Overall Study|Protocol Violation|1
1464043|NCT00730028|4827201|P1|Overall Study|Protocol Violation|6
1464044|NCT00730028|4827197|P5|Overall Study|Lost to Follow-up|25
1464045|NCT00730028|4827198|P4|Overall Study|Lost to Follow-up|26
1464046|NCT00730028|4827199|P3|Overall Study|Lost to Follow-up|22
1464047|NCT00730028|4827200|P2|Overall Study|Lost to Follow-up|26
1464048|NCT00730028|4827201|P1|Overall Study|Lost to Follow-up|13
1464049|NCT00730028|4827197|P5|Overall Study|Adverse Event|43
1464050|NCT00730028|4827198|P4|Overall Study|Adverse Event|20
1464051|NCT00730028|4827199|P3|Overall Study|Adverse Event|16
1464052|NCT00730028|4827200|P2|Overall Study|Adverse Event|26
1464053|NCT00730028|4827201|P1|Overall Study|Adverse Event|23
1464054|NCT00730015|4827251|P3|Overall Study|Other Reason|1
1464055|NCT00730015|4827252|P2|Overall Study|Other Reason|0
1464056|NCT00730015|4827253|P1|Overall Study|Other Reason|1
1464057|NCT00730015|4827251|P3|Overall Study|Lack of Efficacy|8
1464058|NCT00730015|4827252|P2|Overall Study|Lack of Efficacy|2
1464059|NCT00730015|4827253|P1|Overall Study|Lack of Efficacy|1
1464060|NCT00730015|4827251|P3|Overall Study|Lost to Follow-up|3
1464061|NCT00730015|4827252|P2|Overall Study|Lost to Follow-up|10
1464062|NCT00730015|4827253|P1|Overall Study|Lost to Follow-up|4
1464063|NCT00730015|4827251|P3|Overall Study|Withdrawal by Subject|8
1464064|NCT00730015|4827252|P2|Overall Study|Withdrawal by Subject|12
1464065|NCT00730015|4827253|P1|Overall Study|Withdrawal by Subject|12
1464066|NCT00730015|4827251|P3|Overall Study|Protocol Violation|4
1464067|NCT00730015|4827252|P2|Overall Study|Protocol Violation|6
1464068|NCT00730015|4827253|P1|Overall Study|Protocol Violation|2
1464069|NCT00730015|4827251|P3|Overall Study|Adverse Event|8
1464070|NCT00730015|4827252|P2|Overall Study|Adverse Event|10
1464071|NCT00730015|4827253|P1|Overall Study|Adverse Event|11
1464072|NCT00729937|4827293|P6|Overall Study|Incarcerated|0
1464073|NCT00729937|4827294|P5|Overall Study|Incarcerated|0
1464074|NCT00729937|4827295|P4|Overall Study|Incarcerated|1
1464075|NCT00729937|4827296|P3|Overall Study|Incarcerated|1
1464076|NCT00729937|4827297|P2|Overall Study|Incarcerated|2
1464077|NCT00729937|4827298|P1|Overall Study|Incarcerated|0
1464078|NCT00729937|4827293|P6|Overall Study|Did not meet eligibility criteria|0
1464079|NCT00729937|4827294|P5|Overall Study|Did not meet eligibility criteria|0
1464080|NCT00729937|4827295|P4|Overall Study|Did not meet eligibility criteria|0
1464081|NCT00729937|4827296|P3|Overall Study|Did not meet eligibility criteria|0
1464082|NCT00729937|4827297|P2|Overall Study|Did not meet eligibility criteria|1
1464083|NCT00729937|4827298|P1|Overall Study|Did not meet eligibility criteria|2
1464084|NCT00729937|4827293|P6|Overall Study|Randomized but not treated|3
1464085|NCT00729937|4827294|P5|Overall Study|Randomized but not treated|1
1464086|NCT00729937|4827295|P4|Overall Study|Randomized but not treated|0
1464087|NCT00729937|4827296|P3|Overall Study|Randomized but not treated|1
1464088|NCT00729937|4827297|P2|Overall Study|Randomized but not treated|6
1464089|NCT00729937|4827298|P1|Overall Study|Randomized but not treated|12
1464090|NCT00729937|4827293|P6|Overall Study|Withdrawal by Subject|2
1464091|NCT00729937|4827294|P5|Overall Study|Withdrawal by Subject|4
1464092|NCT00729937|4827295|P4|Overall Study|Withdrawal by Subject|0
1464093|NCT00729937|4827296|P3|Overall Study|Withdrawal by Subject|6
1464094|NCT00729937|4827297|P2|Overall Study|Withdrawal by Subject|5
1464095|NCT00729937|4827298|P1|Overall Study|Withdrawal by Subject|3
1464096|NCT00729937|4827293|P6|Overall Study|Death|1
1464097|NCT00729937|4827294|P5|Overall Study|Death|0
1464098|NCT00729937|4827295|P4|Overall Study|Death|0
1464099|NCT00729937|4827296|P3|Overall Study|Death|1
1464100|NCT00729937|4827297|P2|Overall Study|Death|0
1464101|NCT00729937|4827298|P1|Overall Study|Death|1
1464102|NCT00729937|4827293|P6|Overall Study|Physician Decision|8
1464103|NCT00729937|4827294|P5|Overall Study|Physician Decision|5
1464104|NCT00729937|4827295|P4|Overall Study|Physician Decision|0
1464105|NCT00729937|4827296|P3|Overall Study|Physician Decision|2
1464106|NCT00729937|4827297|P2|Overall Study|Physician Decision|16
1464107|NCT00729937|4827298|P1|Overall Study|Physician Decision|7
1464108|NCT00729937|4827293|P6|Overall Study|Lost to Follow-up|23
1464109|NCT00729937|4827294|P5|Overall Study|Lost to Follow-up|18
1464110|NCT00729937|4827295|P4|Overall Study|Lost to Follow-up|33
1464111|NCT00729937|4827296|P3|Overall Study|Lost to Follow-up|18
1464112|NCT00729937|4827297|P2|Overall Study|Lost to Follow-up|58
1464113|NCT00729937|4827298|P1|Overall Study|Lost to Follow-up|49
1464114|NCT00729859|4827502|P3|Overall Study|Withdrawal by Subject|0
1464115|NCT00729859|4827503|P2|Overall Study|Withdrawal by Subject|1
1464116|NCT00729859|4827504|P1|Overall Study|Withdrawal by Subject|0
1464117|NCT00729859|4827502|P3|Overall Study|Adverse Event|0
1464118|NCT00729859|4827503|P2|Overall Study|Adverse Event|1
1464119|NCT00729859|4827504|P1|Overall Study|Adverse Event|0
1464120|NCT00729833|4827548|P4|Overall Study|Unspecified Reasons|1
1464121|NCT00729833|4827549|P3|Overall Study|Unspecified Reasons|5
1464122|NCT00729833|4827550|P2|Overall Study|Unspecified Reasons|5
1464123|NCT00729833|4827551|P1|Overall Study|Unspecified Reasons|11
1464124|NCT00729833|4827548|P4|Overall Study|Withdrawal by Subject|0
1464125|NCT00729833|4827549|P3|Overall Study|Withdrawal by Subject|3
1464126|NCT00729833|4827550|P2|Overall Study|Withdrawal by Subject|1
1464127|NCT00729833|4827551|P1|Overall Study|Withdrawal by Subject|3
1464128|NCT00729833|4827548|P4|Overall Study|Lost to Follow-up|0
1464129|NCT00729833|4827549|P3|Overall Study|Lost to Follow-up|0
1464130|NCT00729833|4827550|P2|Overall Study|Lost to Follow-up|0
1464131|NCT00729833|4827551|P1|Overall Study|Lost to Follow-up|1
1464132|NCT00729833|4827548|P4|Overall Study|Study Terminated by Sponsor|0
1464133|NCT00729833|4827549|P3|Overall Study|Study Terminated by Sponsor|1
1464134|NCT00729833|4827550|P2|Overall Study|Study Terminated by Sponsor|0
1464135|NCT00729833|4827551|P1|Overall Study|Study Terminated by Sponsor|0
1464136|NCT00729833|4827548|P4|Overall Study|Death|5
1464137|NCT00729833|4827549|P3|Overall Study|Death|3
1464138|NCT00729833|4827550|P2|Overall Study|Death|1
1464139|NCT00729833|4827551|P1|Overall Study|Death|5
1464140|NCT00729690|4827603|P3|Overall Study|IT Catheter Malfunction|2
1464141|NCT00729690|4827604|P2|Overall Study|IT Catheter Malfunction|2
1464142|NCT00729690|4827605|P1|Overall Study|IT Catheter Malfunction|0
1464143|NCT00729651|4827635|P2|Overall Study|Subject’s private reason|0
1464144|NCT00729651|4827636|P1|Overall Study|Subject’s private reason|2
1464145|NCT00729651|4827635|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
1464146|NCT00729651|4827636|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
1464147|NCT00729651|4827635|P2|Overall Study|Adverse Event|3
1464148|NCT00729651|4827636|P1|Overall Study|Adverse Event|7
1464149|NCT00729651|4827635|P2|Overall Study|Protocol Violation|1
1464150|NCT00729651|4827636|P1|Overall Study|Protocol Violation|0
1464151|NCT00729651|4827635|P2|Overall Study|Lost to Follow-up|4
1464152|NCT00729651|4827636|P1|Overall Study|Lost to Follow-up|5
1464153|NCT00729651|4827635|P2|Overall Study|Withdrawal by Subject|6
1464154|NCT00729651|4827636|P1|Overall Study|Withdrawal by Subject|5
1464155|NCT00729612|4827648|P1|Overall Study|Non evaluable for response|10
1464156|NCT00729586|4827657|P2|Overall Study|never treated|0
1464157|NCT00729586|4827658|P1|Overall Study|never treated|1
1464158|NCT00729586|4827657|P2|Overall Study|Ineligible|1
1464159|NCT00729586|4827658|P1|Overall Study|Ineligible|0
1464160|NCT00729560|4827671|P1|Overall Study|Withdrawal by Subject|3
1464161|NCT00729469|4827697|P2|Overall Study|Other-Not mentioned|4
1464162|NCT00729469|4827698|P1|Overall Study|Other-Not mentioned|9
1464163|NCT00729469|4827697|P2|Overall Study|Withdrawal by Subject|8
1464164|NCT00729469|4827698|P1|Overall Study|Withdrawal by Subject|19
1464165|NCT00729469|4827697|P2|Overall Study|Protocol Violation|1
1464166|NCT00729469|4827698|P1|Overall Study|Protocol Violation|2
1464167|NCT00729469|4827697|P2|Overall Study|Lost to Follow-up|9
1464168|NCT00729469|4827698|P1|Overall Study|Lost to Follow-up|9
1464169|NCT00729469|4827697|P2|Overall Study|Adverse Event|25
1464170|NCT00729469|4827698|P1|Overall Study|Adverse Event|14
1464171|NCT00729378|4827751|P2|36-months|Lost to Follow-up|6
1464172|NCT00729378|4827752|P1|36-months|Lost to Follow-up|15
1464173|NCT00729378|4827751|P2|24-months|Lost to Follow-up|51
1464174|NCT00729378|4827752|P1|24-months|Lost to Follow-up|72
1464175|NCT00729378|4827751|P2|12-months|Lost to Follow-up|65
1464176|NCT00729378|4827752|P1|12-months|Lost to Follow-up|100
1464177|NCT00729378|4827751|P2|Baseline|Withdrawal by Subject|59
1464178|NCT00729378|4827752|P1|Baseline|Withdrawal by Subject|66
1464179|NCT00729378|4827751|P2|Baseline|Did not complete study measurements|33
1464180|NCT00729378|4827752|P1|Baseline|Did not complete study measurements|72
1464181|NCT00729365|4827951|P3|Overall Study|Physician Decision|7
1464182|NCT00729365|4827952|P2|Overall Study|Physician Decision|6
1464183|NCT00729365|4827953|P1|Overall Study|Physician Decision|33
1464184|NCT00729326|4827966|P2|Overall Study|Sponsor Decision|2
1464185|NCT00729326|4827967|P1|Overall Study|Sponsor Decision|1
1464186|NCT00729326|4827966|P2|Overall Study|Subject Decision|4
1464187|NCT00729326|4827967|P1|Overall Study|Subject Decision|4
1464188|NCT00729326|4827966|P2|Overall Study|Protocol Violation|2
1464189|NCT00729326|4827967|P1|Overall Study|Protocol Violation|3
1464190|NCT00729326|4827966|P2|Overall Study|Physician Decision|1
1464191|NCT00729326|4827967|P1|Overall Study|Physician Decision|0
1464192|NCT00729326|4827966|P2|Overall Study|Lost to Follow-up|0
1464193|NCT00729326|4827967|P1|Overall Study|Lost to Follow-up|2
1464194|NCT00729248|4828009|P1|Overall Study|Physician Decision|2
1464195|NCT00729183|4828016|P2|Overall Study|Withdrawal by Subject|7
1464196|NCT00729183|4828017|P1|Overall Study|Withdrawal by Subject|9
1464197|NCT00729183|4828016|P2|Overall Study|Protocol Violation|0
1464198|NCT00729183|4828017|P1|Overall Study|Protocol Violation|1
1464199|NCT00729183|4828016|P2|Overall Study|Physician Decision|1
1464200|NCT00729183|4828017|P1|Overall Study|Physician Decision|1
1464201|NCT00729183|4828016|P2|Overall Study|Lost to Follow-up|1
1464202|NCT00729183|4828017|P1|Overall Study|Lost to Follow-up|3
1464203|NCT00729183|4828016|P2|Overall Study|Lack of Efficacy|1
1464204|NCT00729183|4828017|P1|Overall Study|Lack of Efficacy|0
1464205|NCT00729183|4828016|P2|Overall Study|Adverse Event|5
1464206|NCT00729183|4828017|P1|Overall Study|Adverse Event|11
1464207|NCT00729157|4828049|P1|Overall Study|Withdrawal by Subject|1
1464208|NCT00728988|4828092|P2|Overall Study|Withdrawal by Subject|6
1464209|NCT00728988|4828093|P1|Overall Study|Withdrawal by Subject|2
1464210|NCT00728988|4828092|P2|Overall Study|Other|77
1464211|NCT00728988|4828093|P1|Overall Study|Other|85
1464212|NCT00728988|4828092|P2|Overall Study|Adverse Event|2
1464213|NCT00728988|4828093|P1|Overall Study|Adverse Event|3
1464214|NCT00728988|4828092|P2|Overall Study|Death|1
1464215|NCT00728988|4828093|P1|Overall Study|Death|1
1464216|NCT00728988|4828092|P2|Overall Study|Not Treated|2
1464217|NCT00728988|4828093|P1|Overall Study|Not Treated|2
1464218|NCT00728962|4828111|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
1464219|NCT00728962|4828111|P1|Permanent Prosthesis Placement|Adverse Event|3
1464220|NCT00728962|4828111|P1|Implant Placement Surgery|Protocol Violation|1
1464221|NCT00728962|4828111|P1|Implant Placement Surgery|Lost to Follow-up|1
1464222|NCT00728962|4828111|P1|Implant Placement Surgery|Adverse Event|8
1464223|NCT00728949|4828117|P2|Overall Study|On treatment at cutoff date|0
1464224|NCT00728949|4828118|P1|Overall Study|On treatment at cutoff date|1
1464225|NCT00728949|4828117|P2|Overall Study|Abnormal Lab Results|2
1464226|NCT00728949|4828118|P1|Overall Study|Abnormal Lab Results|0
1464227|NCT00728949|4828117|P2|Overall Study|Withdrawal by Subject|2
1464228|NCT00728949|4828118|P1|Overall Study|Withdrawal by Subject|2
1464229|NCT00728949|4828117|P2|Overall Study|Adverse Event|0
1464230|NCT00728949|4828118|P1|Overall Study|Adverse Event|8
1464231|NCT00728884|4828153|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
1464232|NCT00728884|4828153|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
1464233|NCT00728754|4828189|P2|One Year Post Placement Follow-up|Adverse Event|0
1464234|NCT00728754|4828190|P1|One Year Post Placement Follow-up|Adverse Event|1
1464235|NCT00728754|4828189|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
1464236|NCT00728754|4828190|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
1464237|NCT00728754|4828189|P2|Permanent Prosthesis Placement|Adverse Event|1
1464238|NCT00728754|4828190|P1|Permanent Prosthesis Placement|Adverse Event|1
1464239|NCT00728689|4828219|P2|Washout Period (Days 4 - 10)|Death in family|0
1464240|NCT00728689|4828220|P1|Washout Period (Days 4 - 10)|Death in family|1
1464241|NCT00728494|4828249|P2|Overall Study|No data available|1
1464242|NCT00728494|4828250|P1|Overall Study|No data available|0
1464243|NCT00728494|4828249|P2|Overall Study|Lack of Efficacy|4
1464244|NCT00728494|4828250|P1|Overall Study|Lack of Efficacy|2
1464245|NCT00728494|4828249|P2|Overall Study|Withdrawal by Subject|2
1464246|NCT00728494|4828250|P1|Overall Study|Withdrawal by Subject|0
1464247|NCT00728494|4828249|P2|Overall Study|Adverse Event|0
1464248|NCT00728494|4828250|P1|Overall Study|Adverse Event|7
1464249|NCT00728481|4828268|P2|Overall Study|Incorrectly assigned to opposite arm|0
1464250|NCT00728481|4828269|P1|Overall Study|Incorrectly assigned to opposite arm|1
1464251|NCT00728481|4828268|P2|Overall Study|Study medication non-compliance|2
1464252|NCT00728481|4828269|P1|Overall Study|Study medication non-compliance|0
1464253|NCT00728481|4828268|P2|Overall Study|Adverse Event|1
1464254|NCT00728481|4828269|P1|Overall Study|Adverse Event|0
1464255|NCT00728481|4828268|P2|Overall Study|Withdrawal by Subject|1
1464256|NCT00728481|4828269|P1|Overall Study|Withdrawal by Subject|0
1464257|NCT00728468|4828285|P1|Overall Study|Study terminated by sponsor|1
1464258|NCT00728468|4828285|P1|Overall Study|Objective progression or relapse|9
1464259|NCT00728468|4828285|P1|Overall Study|Protocol Violation|4
1464260|NCT00728468|4828285|P1|Overall Study|Death|1
1464261|NCT00728468|4828285|P1|Overall Study|Enrolled but not treated|1
1464262|NCT00728416|4828309|P2|Overall Study|Withdrawal by Subject|0
1464263|NCT00728416|4828310|P1|Overall Study|Withdrawal by Subject|1
1464264|NCT00728416|4828309|P2|Overall Study|Treatment Failure|1
1464265|NCT00728416|4828310|P1|Overall Study|Treatment Failure|0
1464266|NCT00728416|4828309|P2|Overall Study|Adverse Event|1
1464267|NCT00728416|4828310|P1|Overall Study|Adverse Event|1
1464268|NCT00728182|4828326|P2|Overall Study|Protocol Noncompliance|1
1464269|NCT00728182|4828327|P1|Overall Study|Protocol Noncompliance|0
1464270|NCT00728182|4828326|P2|Overall Study|Death|2
1464271|NCT00728182|4828327|P1|Overall Study|Death|0
1464272|NCT00728182|4828326|P2|Overall Study|Lost to Follow-up|0
1464273|NCT00728182|4828327|P1|Overall Study|Lost to Follow-up|2
1464274|NCT00728182|4828326|P2|Overall Study|Adverse Event|0
1464275|NCT00728182|4828327|P1|Overall Study|Adverse Event|1
1464276|NCT00728130|4828355|P1|Overall Study|Physician Decision|1
1464277|NCT00728130|4828355|P1|Overall Study|Paperwork not completed in time|1
1464278|NCT00728130|4828355|P1|Overall Study|Withdrawal by Subject|1
1464279|NCT00727961|4828360|P1|Overall Study|Progression|30
1464280|NCT00727961|4828360|P1|Overall Study|Patient's refusal|2
1464281|NCT00727961|4828360|P1|Overall Study|Adverse Event|4
1464282|NCT00727961|4828360|P1|Overall Study|Lost to Follow-up|1
1464283|NCT00727909|4828370|P4|Overall Study|Death|0
1464284|NCT00727909|4828371|P3|Overall Study|Death|1
1464285|NCT00727909|4828372|P2|Overall Study|Death|0
1464286|NCT00727909|4828373|P1|Overall Study|Death|0
1464287|NCT00727909|4828370|P4|Overall Study|Withdrawal by Subject|5
1464288|NCT00727909|4828371|P3|Overall Study|Withdrawal by Subject|8
1464289|NCT00727909|4828372|P2|Overall Study|Withdrawal by Subject|11
1464290|NCT00727909|4828373|P1|Overall Study|Withdrawal by Subject|5
1464291|NCT00727844|4828470|P4|Initial Randomization|Physician Decision|0
1464292|NCT00727844|4828471|P3|Initial Randomization|Physician Decision|0
1464293|NCT00727844|4828472|P2|Initial Randomization|Physician Decision|0
1464294|NCT00727844|4828473|P1|Initial Randomization|Physician Decision|2
1464295|NCT00727714|4828487|P1|Overall Study|Lost to Follow-up|2
1464296|NCT00727649|4828497|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
1464297|NCT00727649|4828498|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
1464298|NCT00727649|4828497|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
1464299|NCT00727649|4828498|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
1464300|NCT00727649|4828497|P2|Second Intervention (4-weeks)|Death|0
1464301|NCT00727649|4828498|P1|Second Intervention (4-weeks)|Death|1
1464302|NCT00727649|4828497|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
1464303|NCT00727649|4828498|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
1464304|NCT00727649|4828497|P2|Wash-out (2-weeks)|Lost to Follow-up|1
1464305|NCT00727649|4828498|P1|Wash-out (2-weeks)|Lost to Follow-up|3
1464306|NCT00727649|4828497|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
1464307|NCT00727649|4828498|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
1464308|NCT00727649|4828497|P2|First Intervention (4-weeks)|Lost to Follow-up|2
1464309|NCT00727649|4828498|P1|First Intervention (4-weeks)|Lost to Follow-up|1
1464310|NCT00727571|4828540|P4|Overall Study|Other|0
1464311|NCT00727571|4828541|P3|Overall Study|Other|6
1464312|NCT00727571|4828542|P2|Overall Study|Other|4
1464313|NCT00727571|4828543|P1|Overall Study|Other|0
1464314|NCT00727571|4828540|P4|Overall Study|AE not leading to hospitalization|0
1464315|NCT00727571|4828541|P3|Overall Study|AE not leading to hospitalization|2
1464316|NCT00727571|4828542|P2|Overall Study|AE not leading to hospitalization|0
1464317|NCT00727571|4828543|P1|Overall Study|AE not leading to hospitalization|0
1464318|NCT00727571|4828540|P4|Overall Study|Hospitalization|1
1464319|NCT00727571|4828541|P3|Overall Study|Hospitalization|0
1464320|NCT00727571|4828542|P2|Overall Study|Hospitalization|1
1464321|NCT00727571|4828543|P1|Overall Study|Hospitalization|0
1464322|NCT00727571|4828540|P4|Overall Study|Dismissed from nursing home|0
1464323|NCT00727571|4828541|P3|Overall Study|Dismissed from nursing home|5
1464324|NCT00727571|4828542|P2|Overall Study|Dismissed from nursing home|9
1464325|NCT00727571|4828543|P1|Overall Study|Dismissed from nursing home|0
1464326|NCT00727571|4828540|P4|Overall Study|Subject Non Compliance|4
1464327|NCT00727571|4828541|P3|Overall Study|Subject Non Compliance|0
1464328|NCT00727571|4828542|P2|Overall Study|Subject Non Compliance|6
1464329|NCT00727571|4828543|P1|Overall Study|Subject Non Compliance|0
1464330|NCT00727571|4828540|P4|Overall Study|Withdrawal by Subject|0
1464331|NCT00727571|4828541|P3|Overall Study|Withdrawal by Subject|11
1464332|NCT00727571|4828542|P2|Overall Study|Withdrawal by Subject|10
1464333|NCT00727571|4828543|P1|Overall Study|Withdrawal by Subject|0
1464334|NCT00727571|4828540|P4|Overall Study|Physician Decision|0
1464335|NCT00727571|4828541|P3|Overall Study|Physician Decision|0
1464336|NCT00727571|4828542|P2|Overall Study|Physician Decision|5
1464337|NCT00727571|4828543|P1|Overall Study|Physician Decision|0
1464338|NCT00727571|4828540|P4|Overall Study|Death|1
1464339|NCT00727571|4828541|P3|Overall Study|Death|5
1464340|NCT00727571|4828542|P2|Overall Study|Death|19
1464341|NCT00727571|4828543|P1|Overall Study|Death|0
1464342|NCT00727571|4828540|P4|Overall Study|Ineligibility determined|0
1464343|NCT00727571|4828541|P3|Overall Study|Ineligibility determined|1
1464344|NCT00727571|4828542|P2|Overall Study|Ineligibility determined|1
1464345|NCT00727571|4828543|P1|Overall Study|Ineligibility determined|1
1464346|NCT00727558|4828570|P2|Overall Study|Lost to Follow-up|0
1464347|NCT00727558|4828571|P1|Overall Study|Lost to Follow-up|1
1464348|NCT00727558|4828570|P2|Overall Study|Subject unable to return for follow-up|1
1464349|NCT00727558|4828571|P1|Overall Study|Subject unable to return for follow-up|1
1464350|NCT00727558|4828570|P2|Overall Study|Adverse Event|1
1464351|NCT00727558|4828571|P1|Overall Study|Adverse Event|0
1464352|NCT00727558|4828570|P2|Overall Study|Lens issue|1
1464353|NCT00727558|4828571|P1|Overall Study|Lens issue|0
1464354|NCT00727506|4828595|P6|Overall Study|Other reason not described above|1
1464355|NCT00727506|4828596|P5|Overall Study|Other reason not described above|1
1464356|NCT00727506|4828597|P4|Overall Study|Other reason not described above|4
1464357|NCT00727506|4828598|P3|Overall Study|Other reason not described above|1
1464358|NCT00727506|4828599|P2|Overall Study|Other reason not described above|0
1464359|NCT00727506|4828600|P1|Overall Study|Other reason not described above|0
1464360|NCT00727506|4828595|P6|Overall Study|Refused to continue medication|2
1464361|NCT00727506|4828596|P5|Overall Study|Refused to continue medication|1
1464362|NCT00727506|4828597|P4|Overall Study|Refused to continue medication|3
1464363|NCT00727506|4828598|P3|Overall Study|Refused to continue medication|2
1464364|NCT00727506|4828599|P2|Overall Study|Refused to continue medication|1
1464365|NCT00727506|4828600|P1|Overall Study|Refused to continue medication|0
1464366|NCT00727506|4828595|P6|Overall Study|Progressive disease|28
1464367|NCT00727506|4828596|P5|Overall Study|Progressive disease|38
1464368|NCT00727506|4828597|P4|Overall Study|Progressive disease|28
1464369|NCT00727506|4828598|P3|Overall Study|Progressive disease|9
1464370|NCT00727506|4828599|P2|Overall Study|Progressive disease|7
1464371|NCT00727506|4828600|P1|Overall Study|Progressive disease|4
1464372|NCT00727506|4828595|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
1464373|NCT00727506|4828596|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
1464374|NCT00727506|4828597|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
1464375|NCT00727506|4828598|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
1464376|NCT00727506|4828599|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
1464377|NCT00727506|4828600|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
1464378|NCT00727506|4828595|P6|Overall Study|Adverse Event|8
1464379|NCT00727506|4828596|P5|Overall Study|Adverse Event|1
1464380|NCT00727506|4828597|P4|Overall Study|Adverse Event|4
1464381|NCT00727506|4828598|P3|Overall Study|Adverse Event|4
1464382|NCT00727506|4828599|P2|Overall Study|Adverse Event|0
1464383|NCT00727506|4828600|P1|Overall Study|Adverse Event|0
1464384|NCT00727402|4828693|P1|Overall Study|Physician Decision|116
1464385|NCT00727311|4828722|P1|Overall Study|Multiple reasons|39
1464386|NCT00727311|4828722|P1|Overall Study|not specified|97
1464387|NCT00727311|4828722|P1|Overall Study|Withdrawal by Subject|77
1464388|NCT00727311|4828722|P1|Overall Study|Lost to Follow-up|73
1464389|NCT00727311|4828722|P1|Overall Study|Lack of Efficacy|242
1464390|NCT00727311|4828722|P1|Overall Study|Adverse Event|58
1464391|NCT00727311|4828722|P1|Overall Study|Missing end of therapy data|205
1464392|NCT00727311|4828722|P1|Overall Study|Did not receive drug|316
1464393|NCT00727272|4828735|P3|Washout Period B|Withdrawal by Subject|1
1464394|NCT00727272|4828736|P2|Washout Period B|Withdrawal by Subject|0
1464395|NCT00727272|4828737|P1|Washout Period B|Withdrawal by Subject|0
1464396|NCT00727272|4828735|P3|Washout Period A|Adverse Event|1
1464397|NCT00727272|4828736|P2|Washout Period A|Adverse Event|0
1464398|NCT00727272|4828737|P1|Washout Period A|Adverse Event|0
1464399|NCT00727259|4828754|P1|Overall Study|Not all questionnaires completed|1055
1464400|NCT00727246|4828763|P4|Overall Study|withdrawn|0
1464401|NCT00727246|4828764|P3|Overall Study|withdrawn|1
1464402|NCT00727246|4828765|P2|Overall Study|withdrawn|0
1464403|NCT00727246|4828766|P1|Overall Study|withdrawn|0
1464404|NCT00727246|4828763|P4|Overall Study|incidental finding|1
1464405|NCT00727246|4828764|P3|Overall Study|incidental finding|0
1464406|NCT00727246|4828765|P2|Overall Study|incidental finding|0
1464407|NCT00727246|4828766|P1|Overall Study|incidental finding|0
1464408|NCT00727246|4828763|P4|Overall Study|could not complete MRI|1
1464409|NCT00727246|4828764|P3|Overall Study|could not complete MRI|0
1464410|NCT00727246|4828765|P2|Overall Study|could not complete MRI|1
1464411|NCT00727246|4828766|P1|Overall Study|could not complete MRI|0
1464412|NCT00727194|4828789|P3|Treatment Period 2|Lack of Efficacy|0
1464413|NCT00727194|4828790|P2|Treatment Period 2|Lack of Efficacy|1
1464414|NCT00727194|4828791|P1|Treatment Period 2|Lack of Efficacy|0
1464415|NCT00727194|4828789|P3|Screening Period|History of thymoma|1
1464416|NCT00727194|4828790|P2|Screening Period|History of thymoma|0
1464417|NCT00727194|4828791|P1|Screening Period|History of thymoma|0
1464418|NCT00727194|4828789|P3|Screening Period|Severe infections|2
1464419|NCT00727194|4828790|P2|Screening Period|Severe infections|0
1464420|NCT00727194|4828791|P1|Screening Period|Severe infections|0
1464421|NCT00727194|4828789|P3|Screening Period|Not stable on concomitant MG therapy|2
1464422|NCT00727194|4828790|P2|Screening Period|Not stable on concomitant MG therapy|0
1464423|NCT00727194|4828791|P1|Screening Period|Not stable on concomitant MG therapy|0
1464424|NCT00727194|4828789|P3|Screening Period|Lacked AChR antibodies|5
1464425|NCT00727194|4828790|P2|Screening Period|Lacked AChR antibodies|0
1464426|NCT00727194|4828791|P1|Screening Period|Lacked AChR antibodies|0
1464427|NCT00727194|4828789|P3|Screening Period|Low QMG scores|6
1464428|NCT00727194|4828790|P2|Screening Period|Low QMG scores|0
1464429|NCT00727194|4828791|P1|Screening Period|Low QMG scores|0
1464430|NCT00727025|4828863|P1|Overall Study|Physician Decision|23
1464431|NCT00726999|4828875|P2|Overall Study|Protocol Violation|0
1464432|NCT00726999|4828876|P1|Overall Study|Protocol Violation|1
1464433|NCT00726999|4828875|P2|Overall Study|Withdrawal by Subject|0
1464434|NCT00726999|4828876|P1|Overall Study|Withdrawal by Subject|2
1464435|NCT00726999|4828875|P2|Overall Study|Physician Decision|1
1464436|NCT00726999|4828876|P1|Overall Study|Physician Decision|0
1464437|NCT00726986|4828886|P1|Maintenance Phase|Lack of Efficacy|2
1464438|NCT00726986|4828886|P1|Maintenance Phase|Adverse Event|1
1464439|NCT00726986|4828886|P1|Induction Phase|Secondary Disease|2
1464440|NCT00726986|4828886|P1|Induction Phase|Lack of Efficacy|5
1464441|NCT00726986|4828886|P1|Induction Phase|Death|2
1464442|NCT00726986|4828886|P1|Induction Phase|Withdrawal by Subject|2
1464443|NCT00726986|4828886|P1|Induction Phase|Adverse Event|4
1464444|NCT00726895|4828893|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1464445|NCT00726895|4828894|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1464446|NCT00726882|4828907|P1|Overall Study|Not Specified|10
1464447|NCT00726882|4828907|P1|Overall Study|Lost to Follow-up|7
1464448|NCT00726882|4828907|P1|Overall Study|Withdrawal by Subject|5
1464449|NCT00726752|4828922|P1|Overall Study|Lack of Efficacy|6
1464450|NCT00726661|4828984|P2|Overall Study|Not specified|35
1464451|NCT00726661|4828985|P1|Overall Study|Not specified|47
1464452|NCT00726661|4828984|P2|Overall Study|Physician Decision|13
1464453|NCT00726661|4828985|P1|Overall Study|Physician Decision|25
1464454|NCT00726661|4828984|P2|Overall Study|Death|159
1464455|NCT00726661|4828985|P1|Overall Study|Death|475
1464456|NCT00726661|4828984|P2|Overall Study|Trial terminated by sponsor|187
1464457|NCT00726661|4828985|P1|Overall Study|Trial terminated by sponsor|214
1464458|NCT00726661|4828984|P2|Overall Study|Withdrawal by Subject|13
1464459|NCT00726661|4828985|P1|Overall Study|Withdrawal by Subject|17
1464460|NCT00726661|4828984|P2|Overall Study|Lost to Follow-up|11
1464461|NCT00726661|4828985|P1|Overall Study|Lost to Follow-up|36
1464462|NCT00726622|4829002|P2|Overall Study|Metastasis|0
1464463|NCT00726622|4829003|P1|Overall Study|Metastasis|2
1464464|NCT00726622|4829002|P2|Overall Study|Physician Decision|1
1464465|NCT00726622|4829003|P1|Overall Study|Physician Decision|0
1464466|NCT00726622|4829002|P2|Overall Study|Withdrawal by Subject|2
1464467|NCT00726622|4829003|P1|Overall Study|Withdrawal by Subject|16
1464468|NCT00726609|4829021|P1|Overall Study|Other|3
1464469|NCT00726609|4829021|P1|Overall Study|Missing|42
1464470|NCT00726609|4829021|P1|Overall Study|Not specified|16
1464471|NCT00726609|4829021|P1|Overall Study|Lack of Efficacy|25
1464472|NCT00726609|4829021|P1|Overall Study|Withdrawal by Subject|2
1464473|NCT00726609|4829021|P1|Overall Study|Adverse Event|10
1464474|NCT00726557|4829025|P1|Overall Study|Inclusion criteria not met|15
1464475|NCT00726557|4829025|P1|Overall Study|Treatment less than 3 months|17
1464476|NCT00726557|4829025|P1|Overall Study|No follow-up documentation available|55
1464477|NCT00726557|4829025|P1|Overall Study|No end of treatment documentation|37
1464478|NCT00726557|4829025|P1|Overall Study|Screening failure|4
1464479|NCT00726453|4829032|P2|38 mm Length Group|Death|3
1464480|NCT00726453|4829033|P1|38 mm Length Group|Death|0
1464481|NCT00726453|4829032|P2|Primary Enrollment Group|Withdrawal by Subject|0
1464482|NCT00726453|4829033|P1|Primary Enrollment Group|Withdrawal by Subject|13
1464483|NCT00726453|4829032|P2|Primary Enrollment Group|Death|0
1464484|NCT00726453|4829033|P1|Primary Enrollment Group|Death|18
1464485|NCT00726323|4829061|P2|Overall Study|Metastatic lesions inferred cyst|1
1464486|NCT00726323|4829062|P1|Overall Study|Metastatic lesions inferred cyst|0
1464487|NCT00726323|4829061|P2|Overall Study|Participant wished to discontinue|1
1464488|NCT00726323|4829062|P1|Overall Study|Participant wished to discontinue|0
1464489|NCT00726323|4829061|P2|Overall Study|Death|0
1464490|NCT00726323|4829062|P1|Overall Study|Death|1
1464491|NCT00726323|4829061|P2|Overall Study|Adverse Event|9
1464492|NCT00726323|4829062|P1|Overall Study|Adverse Event|9
1464493|NCT00726323|4829061|P2|Overall Study|Clinical progression|3
1464494|NCT00726323|4829062|P1|Overall Study|Clinical progression|0
1464495|NCT00726323|4829061|P2|Overall Study|Progressive disease|16
1464496|NCT00726323|4829062|P1|Overall Study|Progressive disease|23
1464497|NCT00726323|4829061|P2|Overall Study|Physician Decision|0
1464498|NCT00726323|4829062|P1|Overall Study|Physician Decision|1
1464499|NCT00726323|4829061|P2|Overall Study|Withdrawal by Subject|1
1464500|NCT00726323|4829062|P1|Overall Study|Withdrawal by Subject|3
1464501|NCT00726232|4829092|P6|Overall Study|No response|1
1464502|NCT00726232|4829093|P5|Overall Study|No response|3
1464503|NCT00726232|4829094|P4|Overall Study|No response|0
1464504|NCT00726232|4829095|P3|Overall Study|No response|0
1464505|NCT00726232|4829096|P2|Overall Study|No response|0
1464506|NCT00726232|4829097|P1|Overall Study|No response|1
1464507|NCT00726232|4829092|P6|Overall Study|Disease progression|0
1464508|NCT00726232|4829093|P5|Overall Study|Disease progression|0
1464509|NCT00726232|4829094|P4|Overall Study|Disease progression|0
1464510|NCT00726232|4829095|P3|Overall Study|Disease progression|0
1464511|NCT00726232|4829096|P2|Overall Study|Disease progression|0
1464512|NCT00726232|4829097|P1|Overall Study|Disease progression|1
1464513|NCT00726232|4829092|P6|Overall Study|Adverse Event|1
1464514|NCT00726232|4829093|P5|Overall Study|Adverse Event|2
1464515|NCT00726232|4829094|P4|Overall Study|Adverse Event|1
1464516|NCT00726232|4829095|P3|Overall Study|Adverse Event|0
1464517|NCT00726232|4829096|P2|Overall Study|Adverse Event|1
1464518|NCT00726232|4829097|P1|Overall Study|Adverse Event|1
1464519|NCT00726232|4829092|P6|Overall Study|Withdrawal by Subject|2
1464520|NCT00726232|4829093|P5|Overall Study|Withdrawal by Subject|0
1464521|NCT00726232|4829094|P4|Overall Study|Withdrawal by Subject|0
1464522|NCT00726232|4829095|P3|Overall Study|Withdrawal by Subject|0
1464523|NCT00726232|4829096|P2|Overall Study|Withdrawal by Subject|0
1464524|NCT00726232|4829097|P1|Overall Study|Withdrawal by Subject|2
1464525|NCT00726063|4829147|P2|Overall Study|Adverse Event|7
1464526|NCT00726063|4829148|P1|Overall Study|Adverse Event|9
1464527|NCT00725985|4829162|P12|LTFU (No Cladribine Treatment)|Other|14
1464528|NCT00725985|4829163|P11|LTFU (No Cladribine Treatment)|Other|36
1464529|NCT00725985|4829164|P10|LTFU (No Cladribine Treatment)|Other|34
1464530|NCT00725985|4829165|P9|LTFU (No Cladribine Treatment)|Other|0
1464531|NCT00725985|4829166|P8|LTFU (No Cladribine Treatment)|Other|0
1464532|NCT00725985|4829167|P7|LTFU (No Cladribine Treatment)|Other|0
1464533|NCT00725985|4829168|P6|LTFU (No Cladribine Treatment)|Other|0
1464534|NCT00725985|4829169|P5|LTFU (No Cladribine Treatment)|Other|0
1464535|NCT00725985|4829170|P4|LTFU (No Cladribine Treatment)|Other|0
1464536|NCT00725985|4829171|P3|LTFU (No Cladribine Treatment)|Other|0
1464537|NCT00725985|4829172|P2|LTFU (No Cladribine Treatment)|Other|0
1464538|NCT00725985|4829173|P1|LTFU (No Cladribine Treatment)|Other|0
1464539|NCT00725985|4829162|P12|LTFU (With Cladribine Treatment)|Other|0
1464540|NCT00725985|4829163|P11|LTFU (With Cladribine Treatment)|Other|0
1464541|NCT00725985|4829164|P10|LTFU (With Cladribine Treatment)|Other|0
1464542|NCT00725985|4829165|P9|LTFU (With Cladribine Treatment)|Other|16
1464543|NCT00725985|4829166|P8|LTFU (With Cladribine Treatment)|Other|8
1464544|NCT00725985|4829167|P7|LTFU (With Cladribine Treatment)|Other|9
1464545|NCT00725985|4829168|P6|LTFU (With Cladribine Treatment)|Other|0
1464546|NCT00725985|4829169|P5|LTFU (With Cladribine Treatment)|Other|0
1464547|NCT00725985|4829170|P4|LTFU (With Cladribine Treatment)|Other|0
1464548|NCT00725985|4829171|P3|LTFU (With Cladribine Treatment)|Other|0
1464549|NCT00725985|4829172|P2|LTFU (With Cladribine Treatment)|Other|0
1464550|NCT00725985|4829173|P1|LTFU (With Cladribine Treatment)|Other|0
1464551|NCT00725985|4829162|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1464552|NCT00725985|4829163|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1464553|NCT00725985|4829164|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1464554|NCT00725985|4829165|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
1464555|NCT00725985|4829166|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1464556|NCT00725985|4829167|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1464557|NCT00725985|4829168|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1464558|NCT00725985|4829169|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1464559|NCT00725985|4829170|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1464560|NCT00725985|4829171|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1464561|NCT00725985|4829172|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1464562|NCT00725985|4829173|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1464563|NCT00725985|4829162|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
1464564|NCT00725985|4829163|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
1464565|NCT00725985|4829164|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
1464566|NCT00725985|4829165|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
1464567|NCT00725985|4829166|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
1464568|NCT00725985|4829167|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
1464569|NCT00725985|4829168|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
1464570|NCT00725985|4829169|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
1464571|NCT00725985|4829170|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
1464572|NCT00725985|4829171|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
1464573|NCT00725985|4829172|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
1464574|NCT00725985|4829173|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
1464575|NCT00725985|4829162|P12|OLMP|Other|0
1464576|NCT00725985|4829163|P11|OLMP|Other|0
1464577|NCT00725985|4829164|P10|OLMP|Other|0
1464578|NCT00725985|4829165|P9|OLMP|Other|0
1464579|NCT00725985|4829166|P8|OLMP|Other|0
1464580|NCT00725985|4829167|P7|OLMP|Other|0
1464581|NCT00725985|4829168|P6|OLMP|Other|44
1464582|NCT00725985|4829169|P5|OLMP|Other|20
1464583|NCT00725985|4829170|P4|OLMP|Other|15
1464584|NCT00725985|4829171|P3|OLMP|Other|0
1464585|NCT00725985|4829172|P2|OLMP|Other|0
1464586|NCT00725985|4829173|P1|OLMP|Other|0
1464587|NCT00725985|4829162|P12|OLMP|Disease progression|0
1464588|NCT00725985|4829163|P11|OLMP|Disease progression|0
1464589|NCT00725985|4829164|P10|OLMP|Disease progression|0
1464590|NCT00725985|4829165|P9|OLMP|Disease progression|0
1464591|NCT00725985|4829166|P8|OLMP|Disease progression|0
1464592|NCT00725985|4829167|P7|OLMP|Disease progression|0
1464593|NCT00725985|4829168|P6|OLMP|Disease progression|4
1464594|NCT00725985|4829169|P5|OLMP|Disease progression|0
1464595|NCT00725985|4829170|P4|OLMP|Disease progression|0
1464596|NCT00725985|4829171|P3|OLMP|Disease progression|0
1464597|NCT00725985|4829172|P2|OLMP|Disease progression|0
1464598|NCT00725985|4829173|P1|OLMP|Disease progression|0
1464599|NCT00725985|4829162|P12|OLMP|Lost to Follow-up|0
1464600|NCT00725985|4829163|P11|OLMP|Lost to Follow-up|0
1464601|NCT00725985|4829164|P10|OLMP|Lost to Follow-up|0
1464602|NCT00725985|4829165|P9|OLMP|Lost to Follow-up|0
1464603|NCT00725985|4829166|P8|OLMP|Lost to Follow-up|0
1464604|NCT00725985|4829167|P7|OLMP|Lost to Follow-up|0
1464605|NCT00725985|4829168|P6|OLMP|Lost to Follow-up|0
1464606|NCT00725985|4829169|P5|OLMP|Lost to Follow-up|0
1464607|NCT00725985|4829170|P4|OLMP|Lost to Follow-up|1
1464608|NCT00725985|4829171|P3|OLMP|Lost to Follow-up|0
1464609|NCT00725985|4829172|P2|OLMP|Lost to Follow-up|0
1464610|NCT00725985|4829173|P1|OLMP|Lost to Follow-up|0
1464611|NCT00725985|4829162|P12|OLMP|Death|0
1464612|NCT00725985|4829163|P11|OLMP|Death|0
1464613|NCT00725985|4829164|P10|OLMP|Death|0
1464614|NCT00725985|4829165|P9|OLMP|Death|0
1464615|NCT00725985|4829166|P8|OLMP|Death|0
1464616|NCT00725985|4829167|P7|OLMP|Death|0
1464617|NCT00725985|4829168|P6|OLMP|Death|0
1464618|NCT00725985|4829169|P5|OLMP|Death|1
1464619|NCT00725985|4829170|P4|OLMP|Death|0
1464620|NCT00725985|4829171|P3|OLMP|Death|0
1464621|NCT00725985|4829172|P2|OLMP|Death|0
1464622|NCT00725985|4829173|P1|OLMP|Death|0
1464623|NCT00725985|4829162|P12|OLMP|Adverse Event|0
1464624|NCT00725985|4829163|P11|OLMP|Adverse Event|0
1464625|NCT00725985|4829164|P10|OLMP|Adverse Event|0
1464626|NCT00725985|4829165|P9|OLMP|Adverse Event|0
1464627|NCT00725985|4829166|P8|OLMP|Adverse Event|0
1464628|NCT00725985|4829167|P7|OLMP|Adverse Event|0
1464629|NCT00725985|4829168|P6|OLMP|Adverse Event|5
1464630|NCT00725985|4829169|P5|OLMP|Adverse Event|2
1464631|NCT00725985|4829170|P4|OLMP|Adverse Event|2
1464632|NCT00725985|4829171|P3|OLMP|Adverse Event|0
1464633|NCT00725985|4829172|P2|OLMP|Adverse Event|0
1464634|NCT00725985|4829173|P1|OLMP|Adverse Event|0
1464635|NCT00725985|4829162|P12|ITP (Up to 96 Weeks)|Other|0
1464636|NCT00725985|4829163|P11|ITP (Up to 96 Weeks)|Other|0
1464637|NCT00725985|4829164|P10|ITP (Up to 96 Weeks)|Other|0
1464638|NCT00725985|4829165|P9|ITP (Up to 96 Weeks)|Other|0
1464639|NCT00725985|4829166|P8|ITP (Up to 96 Weeks)|Other|0
1464640|NCT00725985|4829167|P7|ITP (Up to 96 Weeks)|Other|0
1464641|NCT00725985|4829168|P6|ITP (Up to 96 Weeks)|Other|0
1464642|NCT00725985|4829169|P5|ITP (Up to 96 Weeks)|Other|0
1464643|NCT00725985|4829170|P4|ITP (Up to 96 Weeks)|Other|0
1464644|NCT00725985|4829171|P3|ITP (Up to 96 Weeks)|Other|24
1464645|NCT00725985|4829172|P2|ITP (Up to 96 Weeks)|Other|38
1464646|NCT00725985|4829173|P1|ITP (Up to 96 Weeks)|Other|50
1464647|NCT00725985|4829162|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
1464648|NCT00725985|4829163|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
1464649|NCT00725985|4829164|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
1464650|NCT00725985|4829165|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
1464651|NCT00725985|4829166|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
1464652|NCT00725985|4829167|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
1464653|NCT00725985|4829168|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
1464654|NCT00725985|4829169|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
1464655|NCT00725985|4829170|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
1464656|NCT00725985|4829171|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
1464657|NCT00725985|4829172|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
1464658|NCT00725985|4829173|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
1464659|NCT00725985|4829162|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
1464660|NCT00725985|4829163|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
1464661|NCT00725985|4829164|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
1464662|NCT00725985|4829165|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
1464663|NCT00725985|4829166|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
1464664|NCT00725985|4829167|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
1464665|NCT00725985|4829168|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
1464666|NCT00725985|4829169|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
1464667|NCT00725985|4829170|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
1464668|NCT00725985|4829171|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
1464669|NCT00725985|4829172|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
1464670|NCT00725985|4829173|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
1464671|NCT00725985|4829162|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1464672|NCT00725985|4829163|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1464673|NCT00725985|4829164|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1464674|NCT00725985|4829165|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1464675|NCT00725985|4829166|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1464676|NCT00725985|4829167|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1464677|NCT00725985|4829168|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1464678|NCT00725985|4829169|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1464679|NCT00725985|4829170|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1464680|NCT00725985|4829171|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
1464681|NCT00725985|4829172|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1464682|NCT00725985|4829173|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1464683|NCT00725985|4829162|P12|ITP (Up to 96 Weeks)|Adverse Event|0
1464684|NCT00725985|4829163|P11|ITP (Up to 96 Weeks)|Adverse Event|0
1464685|NCT00725985|4829164|P10|ITP (Up to 96 Weeks)|Adverse Event|0
1464686|NCT00725985|4829165|P9|ITP (Up to 96 Weeks)|Adverse Event|0
1464687|NCT00725985|4829166|P8|ITP (Up to 96 Weeks)|Adverse Event|0
1464688|NCT00725985|4829167|P7|ITP (Up to 96 Weeks)|Adverse Event|0
1464689|NCT00725985|4829168|P6|ITP (Up to 96 Weeks)|Adverse Event|0
1464690|NCT00725985|4829169|P5|ITP (Up to 96 Weeks)|Adverse Event|0
1464691|NCT00725985|4829170|P4|ITP (Up to 96 Weeks)|Adverse Event|0
1464692|NCT00725985|4829171|P3|ITP (Up to 96 Weeks)|Adverse Event|5
1464693|NCT00725985|4829172|P2|ITP (Up to 96 Weeks)|Adverse Event|10
1464694|NCT00725985|4829173|P1|ITP (Up to 96 Weeks)|Adverse Event|20
1464695|NCT00725920|4829210|P2|Overall Study|Lack of Efficacy|6
1464696|NCT00725920|4829211|P1|Overall Study|Lack of Efficacy|3
1464697|NCT00725842|4829217|P1|Overall Study|No Visit 1 data|1
1464698|NCT00725842|4829217|P1|Overall Study|Inclusion criterion not met|1
1464699|NCT00725842|4829217|P1|Overall Study|Consent date prior to study start date|5
1464700|NCT00725842|4829217|P1|Overall Study|Positive HCV-RNA at Visit 2|13
1464701|NCT00725842|4829217|P1|Overall Study|Death|1
1464702|NCT00725842|4829217|P1|Overall Study|Lost to Follow-up|19
1464703|NCT00725764|4829224|P1|Overall Study|Decline in performance status|1
1464704|NCT00725764|4829224|P1|Overall Study|Participant non compliant with protocol|1
1464705|NCT00725764|4829224|P1|Overall Study|Death|1
1464706|NCT00725764|4829224|P1|Overall Study|Lost to Follow-up|1
1464707|NCT00725764|4829224|P1|Overall Study|Progressive Disease|7
1464708|NCT00725764|4829224|P1|Overall Study|Physician Decision|1
1464709|NCT00725764|4829224|P1|Overall Study|Withdrawal by Subject|2
1464710|NCT00725725|4829257|P3|Overall Study|Protocol Violation|0
1464711|NCT00725725|4829258|P2|Overall Study|Protocol Violation|1
1464712|NCT00725725|4829259|P1|Overall Study|Protocol Violation|0
1464713|NCT00725725|4829257|P3|Overall Study|Withdrawal by Subject|1
1464714|NCT00725725|4829258|P2|Overall Study|Withdrawal by Subject|0
1464715|NCT00725725|4829259|P1|Overall Study|Withdrawal by Subject|1
1464716|NCT00725725|4829257|P3|Overall Study|Lost to Follow-up|2
1464717|NCT00725725|4829258|P2|Overall Study|Lost to Follow-up|0
1464718|NCT00725725|4829259|P1|Overall Study|Lost to Follow-up|2
1464719|NCT00725725|4829257|P3|Overall Study|Adverse Event|2
1464720|NCT00725725|4829258|P2|Overall Study|Adverse Event|3
1464721|NCT00725725|4829259|P1|Overall Study|Adverse Event|1
1464722|NCT00725712|4829302|P2|Overall Study|Hospitalized, unable to continue|1
1464723|NCT00725712|4829303|P1|Overall Study|Hospitalized, unable to continue|0
1464724|NCT00725712|4829302|P2|Overall Study|Other: Death|0
1464725|NCT00725712|4829303|P1|Overall Study|Other: Death|1
1464726|NCT00725712|4829302|P2|Overall Study|Death|0
1464727|NCT00725712|4829303|P1|Overall Study|Death|2
1464728|NCT00725712|4829302|P2|Overall Study|Adverse Event|5
1464729|NCT00725712|4829303|P1|Overall Study|Adverse Event|5
1464730|NCT00725712|4829302|P2|Overall Study|Clinical progression not based on RECIST|3
1464731|NCT00725712|4829303|P1|Overall Study|Clinical progression not based on RECIST|0
1464732|NCT00725712|4829302|P2|Overall Study|Progressive disease|16
1464733|NCT00725712|4829303|P1|Overall Study|Progressive disease|37
1464734|NCT00725712|4829302|P2|Overall Study|Protocol Violation|0
1464735|NCT00725712|4829303|P1|Overall Study|Protocol Violation|1
1464736|NCT00725712|4829302|P2|Overall Study|Withdrawal by Subject|1
1464737|NCT00725712|4829303|P1|Overall Study|Withdrawal by Subject|2
1464738|NCT00725621|4829339|P1|Overall Study|Reason not specified|55
1464739|NCT00725621|4829339|P1|Overall Study|Prepared for elective surgery|1
1464740|NCT00725621|4829339|P1|Overall Study|Switched to other drug|1
1464741|NCT00725621|4829339|P1|Overall Study|Switched to other study|1
1464742|NCT00725621|4829339|P1|Overall Study|Continued treatment by other physician|6
1464743|NCT00725621|4829339|P1|Overall Study|Non-compliance|8
1464744|NCT00725621|4829339|P1|Overall Study|Lost to Follow-up|52
1464745|NCT00725621|4829339|P1|Overall Study|Physician Decision|19
1464746|NCT00725621|4829339|P1|Overall Study|Withdrawal by Subject|57
1464747|NCT00725621|4829339|P1|Overall Study|Lack of Efficacy|46
1464748|NCT00725621|4829339|P1|Overall Study|Adverse Event|25
1464749|NCT00725608|4829362|P1|Overall Study|Other|7
1464750|NCT00725608|4829362|P1|Overall Study|Individual reasons|86
1464751|NCT00725608|4829362|P1|Overall Study|Adverse Event|14
1464752|NCT00725608|4829362|P1|Overall Study|Lost to Follow-up|60
1464753|NCT00725543|4829368|P1|Overall Study|Not specified|119
1464754|NCT00725543|4829368|P1|Overall Study|Non-compliance|2
1464755|NCT00725543|4829368|P1|Overall Study|Lost to Follow-up|4
1464756|NCT00725543|4829368|P1|Overall Study|Physician Decision|5
1464757|NCT00725543|4829368|P1|Overall Study|Withdrawal by Subject|10
1464758|NCT00725543|4829368|P1|Overall Study|Lack of Efficacy|3
1464759|NCT00725543|4829368|P1|Overall Study|Adverse Event|10
1464760|NCT00725491|4829393|P2|Overall Study|No/too few embryos/ bad quality embryos|2
1464761|NCT00725491|4829394|P1|Overall Study|No/too few embryos/ bad quality embryos|3
1464762|NCT00725491|4829393|P2|Overall Study|Fertilization failure|1
1464763|NCT00725491|4829394|P1|Overall Study|Fertilization failure|0
1464764|NCT00725491|4829393|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
1464765|NCT00725491|4829394|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
1464766|NCT00725491|4829393|P2|Overall Study|Risk for hyperstimulation|9
1464767|NCT00725491|4829394|P1|Overall Study|Risk for hyperstimulation|2
1464768|NCT00725491|4829393|P2|Overall Study|Pregnancy|3
1464769|NCT00725491|4829394|P1|Overall Study|Pregnancy|0
1464770|NCT00725491|4829393|P2|Overall Study|Adverse Event|2
1464771|NCT00725491|4829394|P1|Overall Study|Adverse Event|3
1464772|NCT00725452|4829400|P1|Overall Study|Lost to Follow-up|1
1464773|NCT00725452|4829400|P1|Overall Study|Withdrawal by Subject|3
1464774|NCT00725452|4829400|P1|Overall Study|Physician Decision|1
1464775|NCT00725452|4829400|P1|Overall Study|Reason not specified|1
1464776|NCT00725452|4829400|P1|Overall Study|Lack of Efficacy|2
1464777|NCT00725452|4829400|P1|Overall Study|Adverse Event|3
1464778|NCT00725322|4829419|P2|Washout (28 Days)|Protocol Violation|1
1464779|NCT00725322|4829420|P1|Washout (28 Days)|Protocol Violation|0
1464780|NCT00725322|4829419|P2|Washout (28 Days)|Withdrawal by Subject|0
1464781|NCT00725322|4829420|P1|Washout (28 Days)|Withdrawal by Subject|2
1464782|NCT00725296|4829428|P1|Overall Study|Not Specified|38
1464783|NCT00725296|4829428|P1|Overall Study|Lost to Follow-up|1
1464784|NCT00725296|4829428|P1|Overall Study|Non-Compliance|2
1464785|NCT00725296|4829428|P1|Overall Study|Withdrawal by Subject|3
1464786|NCT00725296|4829428|P1|Overall Study|Lack of Efficacy|7
1464787|NCT00725296|4829428|P1|Overall Study|Adverse Event|11
1464788|NCT00725283|4829437|P1|Overall Study|Withdrawal by Subject|10
1464789|NCT00725283|4829437|P1|Overall Study|Not specified|6
1464790|NCT00725283|4829437|P1|Overall Study|Death|5
1464791|NCT00725283|4829437|P1|Overall Study|Missing Code|3
1464792|NCT00725205|4829458|P1|Overall Study|Treatment Failure|41
1464793|NCT00725205|4829458|P1|Overall Study|Protocol Defined Clinical Event|1
1464794|NCT00725205|4829458|P1|Overall Study|Other|8
1464795|NCT00725205|4829458|P1|Overall Study|Non-compliance With Protocol|14
1464796|NCT00725205|4829458|P1|Overall Study|Investigator Discontinued|1
1464797|NCT00725205|4829458|P1|Overall Study|Adverse Event|22
1464798|NCT00725101|4829471|P1|Overall Study|not specified/no reason given|11
1464799|NCT00725101|4829471|P1|Overall Study|Withdrawal by Subject|127
1464800|NCT00725101|4829471|P1|Overall Study|Protocol Violation|1
1464801|NCT00725101|4829471|P1|Overall Study|Lost to Follow-up|353
1464802|NCT00725101|4829471|P1|Overall Study|Death|3
1464803|NCT00725075|4829494|P3|Overall Study|Other|0
1464804|NCT00725075|4829495|P2|Overall Study|Other|0
1464805|NCT00725075|4829496|P1|Overall Study|Other|1
1464806|NCT00725075|4829494|P3|Overall Study|Inclusion/Exclusion Criteria|1
1464807|NCT00725075|4829495|P2|Overall Study|Inclusion/Exclusion Criteria|0
1464808|NCT00725075|4829496|P1|Overall Study|Inclusion/Exclusion Criteria|1
1464809|NCT00725075|4829494|P3|Overall Study|Worsening of Disease|2
1464810|NCT00725075|4829495|P2|Overall Study|Worsening of Disease|1
1464811|NCT00725075|4829496|P1|Overall Study|Worsening of Disease|2
1464812|NCT00725075|4829494|P3|Overall Study|Adverse Event|1
1464813|NCT00725075|4829495|P2|Overall Study|Adverse Event|1
1464814|NCT00725075|4829496|P1|Overall Study|Adverse Event|2
1464815|NCT00725075|4829494|P3|Overall Study|Withdrawal by Subject|4
1464816|NCT00725075|4829495|P2|Overall Study|Withdrawal by Subject|5
1464817|NCT00725075|4829496|P1|Overall Study|Withdrawal by Subject|4
1464818|NCT00725075|4829494|P3|Overall Study|Lost to Follow-up|0
1464819|NCT00725075|4829495|P2|Overall Study|Lost to Follow-up|0
1464820|NCT00725075|4829496|P1|Overall Study|Lost to Follow-up|1
1464821|NCT00725075|4829494|P3|Overall Study|Protocol Violation|1
1464822|NCT00725075|4829495|P2|Overall Study|Protocol Violation|0
1464823|NCT00725075|4829496|P1|Overall Study|Protocol Violation|0
1464824|NCT00725075|4829494|P3|Overall Study|Use of Excluded Medication|0
1464825|NCT00725075|4829495|P2|Overall Study|Use of Excluded Medication|1
1464826|NCT00725075|4829496|P1|Overall Study|Use of Excluded Medication|0
1464827|NCT00725010|4829549|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
1464828|NCT00725010|4829549|P1|Overall Study|No further documentation|1
1464829|NCT00725010|4829549|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
1464830|NCT00725010|4829549|P1|Overall Study|Hepatopathy probably not Temodal-related|1
1464831|NCT00725010|4829549|P1|Overall Study|Lost to Follow-up|1
1464832|NCT00725010|4829549|P1|Overall Study|Death|1
1464833|NCT00725010|4829549|P1|Overall Study|Withdrawal by Subject|2
1464834|NCT00725010|4829549|P1|Overall Study|Tumor Progression|7
1464835|NCT00725010|4829549|P1|Overall Study|Toxicity|9
1464836|NCT00724958|4829582|P1|Overall Study|No documentation for end of therapy|13
1464837|NCT00724958|4829582|P1|Overall Study|Other Reason|76
1464838|NCT00724958|4829582|P1|Overall Study|Remission|7
1464839|NCT00724958|4829582|P1|Overall Study|No Response|18
1464840|NCT00724958|4829582|P1|Overall Study|Loss of Response|40
1464841|NCT00724958|4829582|P1|Overall Study|Adverse Event|28
1464842|NCT00724945|4829591|P2|Period 2|lens physiology issue|0
1464843|NCT00724945|4829592|P1|Period 2|lens physiology issue|1
1464844|NCT00724945|4829591|P2|Period 2|lens comfort issue|0
1464845|NCT00724945|4829592|P1|Period 2|lens comfort issue|3
1464846|NCT00724945|4829591|P2|Period 1|Lost to Follow-up|0
1464847|NCT00724945|4829592|P1|Period 1|Lost to Follow-up|1
1464848|NCT00724945|4829591|P2|Period 1|Adverse Event|1
1464849|NCT00724945|4829592|P1|Period 1|Adverse Event|1
1464850|NCT00724945|4829591|P2|Period 1|non-compliance|0
1464851|NCT00724945|4829592|P1|Period 1|non-compliance|1
1464852|NCT00724932|4829604|P2|Overall Study|Not treated|3
1464853|NCT00724932|4829605|P1|Overall Study|Not treated|4
1464854|NCT00724932|4829604|P2|Overall Study|Lost to Follow-up|0
1464855|NCT00724932|4829605|P1|Overall Study|Lost to Follow-up|1
1464856|NCT00724893|4829676|P2|Overall Study|Unknown, missing data|1
1464857|NCT00724893|4829677|P1|Overall Study|Unknown, missing data|1
1464858|NCT00724893|4829676|P2|Overall Study|Lost to Follow-up|52
1464859|NCT00724893|4829677|P1|Overall Study|Lost to Follow-up|0
1464860|NCT00724893|4829676|P2|Overall Study|Assigned shorter treatment|2
1464861|NCT00724893|4829677|P1|Overall Study|Assigned shorter treatment|0
1464862|NCT00724893|4829676|P2|Overall Study|Financial reasons|2
1464863|NCT00724893|4829677|P1|Overall Study|Financial reasons|0
1464864|NCT00724893|4829676|P2|Overall Study|Substance abuse|3
1464865|NCT00724893|4829677|P1|Overall Study|Substance abuse|0
1464866|NCT00724893|4829676|P2|Overall Study|Incarceration|9
1464867|NCT00724893|4829677|P1|Overall Study|Incarceration|0
1464868|NCT00724893|4829676|P2|Overall Study|Geographic reasons|11
1464869|NCT00724893|4829677|P1|Overall Study|Geographic reasons|0
1464870|NCT00724893|4829676|P2|Overall Study|Patient choice|26
1464871|NCT00724893|4829677|P1|Overall Study|Patient choice|0
1464872|NCT00724893|4829676|P2|Overall Study|Reason not specified|7
1464873|NCT00724893|4829677|P1|Overall Study|Reason not specified|193
1464874|NCT00724893|4829676|P2|Overall Study|Lack of virologic response|202
1464875|NCT00724893|4829677|P1|Overall Study|Lack of virologic response|94
1464876|NCT00724893|4829676|P2|Overall Study|Withdrawal by Subject|1
1464877|NCT00724893|4829677|P1|Overall Study|Withdrawal by Subject|0
1464878|NCT00724893|4829676|P2|Overall Study|Adverse Event|142
1464879|NCT00724893|4829677|P1|Overall Study|Adverse Event|76
1464880|NCT00724867|4829745|P1|Overall Study|Elected to exit due to site closure|2
1464881|NCT00724867|4829745|P1|Overall Study|Subject moved out of state|1
1464882|NCT00724867|4829745|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
1464883|NCT00724867|4829745|P1|Overall Study|Subject incarcerated|1
1464884|NCT00724867|4829745|P1|Overall Study|Sponsor decision to end study|14
1464885|NCT00724867|4829745|P1|Overall Study|Withdrawal by Subject|31
1464886|NCT00724867|4829745|P1|Overall Study|Protocol Violation|1
1464887|NCT00724867|4829745|P1|Overall Study|Physician Decision|17
1464888|NCT00724867|4829745|P1|Overall Study|Non-compliance with study drug|6
1464889|NCT00724867|4829745|P1|Overall Study|Lost to Follow-up|12
1464890|NCT00724867|4829745|P1|Overall Study|Lack of Efficacy|14
1464891|NCT00724867|4829745|P1|Overall Study|Adverse Event|25
1464892|NCT00724854|4829785|P2|Overall Study|Adverse event + lack of efficacy|1
1464893|NCT00724854|4829786|P1|Overall Study|Adverse event + lack of efficacy|2
1464894|NCT00724854|4829785|P2|Overall Study|Withdrawal by Subject|0
1464895|NCT00724854|4829786|P1|Overall Study|Withdrawal by Subject|5
1464896|NCT00724854|4829785|P2|Overall Study|Change of treatment|0
1464897|NCT00724854|4829786|P1|Overall Study|Change of treatment|7
1464898|NCT00724854|4829785|P2|Overall Study|Death|0
1464899|NCT00724854|4829786|P1|Overall Study|Death|11
1464900|NCT00724854|4829785|P2|Overall Study|Not specified|3
1464901|NCT00724854|4829786|P1|Overall Study|Not specified|42
1464902|NCT00724854|4829785|P2|Overall Study|Adverse Event|4
1464903|NCT00724854|4829786|P1|Overall Study|Adverse Event|62
1464904|NCT00724854|4829785|P2|Overall Study|Lost to Follow-up|10
1464905|NCT00724854|4829786|P1|Overall Study|Lost to Follow-up|87
1464906|NCT00724854|4829785|P2|Overall Study|Lack of Efficacy|13
1464907|NCT00724854|4829786|P1|Overall Study|Lack of Efficacy|187
1464908|NCT00724815|4829803|P2|Overall Study|Other Various|5
1464909|NCT00724815|4829804|P1|Overall Study|Other Various|3
1464910|NCT00724815|4829803|P2|Overall Study|Lost to Follow-up|1
1464911|NCT00724815|4829804|P1|Overall Study|Lost to Follow-up|4
1464912|NCT00724815|4829803|P2|Overall Study|Adverse Event|3
1464913|NCT00724815|4829804|P1|Overall Study|Adverse Event|5
1464914|NCT00724815|4829803|P2|Overall Study|Randomized, not treated|30
1464915|NCT00724815|4829804|P1|Overall Study|Randomized, not treated|31
1464916|NCT00724711|4829837|P2|Overall Study|Protocol Violation|0
1464917|NCT00724711|4829838|P1|Overall Study|Protocol Violation|1
1464918|NCT00724711|4829837|P2|Overall Study|Lost to Follow-up|5
1464919|NCT00724711|4829838|P1|Overall Study|Lost to Follow-up|4
1464920|NCT00724711|4829837|P2|Overall Study|Withdrawal by Subject|4
1464921|NCT00724711|4829838|P1|Overall Study|Withdrawal by Subject|5
1464922|NCT00724711|4829837|P2|Overall Study|Physician Decision|3
1464923|NCT00724711|4829838|P1|Overall Study|Physician Decision|0
1464924|NCT00724711|4829837|P2|Overall Study|Lack of Efficacy|1
1464925|NCT00724711|4829838|P1|Overall Study|Lack of Efficacy|0
1464926|NCT00724711|4829837|P2|Overall Study|Pregnancy|1
1464927|NCT00724711|4829838|P1|Overall Study|Pregnancy|0
1464928|NCT00724711|4829837|P2|Overall Study|Adverse Event|3
1464929|NCT00724711|4829838|P1|Overall Study|Adverse Event|7
1464930|NCT00724698|4829870|P1|Overall Study|No Info|25
1464931|NCT00724698|4829870|P1|Overall Study|Lost to Follow-up|36
1464932|NCT00724698|4829870|P1|Overall Study|Poor Compliance|16
1464933|NCT00724698|4829870|P1|Overall Study|Failure of Therapy|4
1464934|NCT00724698|4829870|P1|Overall Study|Adverse Event|9
1464935|NCT00724451|4829925|P1|Overall Study|Investigator + Participant Decision|13
1464936|NCT00724451|4829925|P1|Overall Study|Withdrawal by Subject|45
1464937|NCT00724451|4829925|P1|Overall Study|Physician Decision|116
1464938|NCT00724451|4829925|P1|Overall Study|Unknown; No Data Sources Available|9
1464939|NCT00724451|4829925|P1|Overall Study|Never Started Treatment|89
1464940|NCT00724451|4829925|P1|Overall Study|Participant Refused Treatment|89
1464941|NCT00724451|4829925|P1|Overall Study|Not Eligible for Treatment|431
1464942|NCT00724451|4829925|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
1464943|NCT00724451|4829925|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
1464944|NCT00724373|4829931|P1|Overall Study|Tolerability|23
1464945|NCT00724373|4829931|P1|Overall Study|Drug Relapse|1
1464946|NCT00724373|4829931|P1|Overall Study|Acute HCV infection|1
1464947|NCT00724373|4829931|P1|Overall Study|Viral Relapse|1
1464948|NCT00724373|4829931|P1|Overall Study|Only to have 24 week regimen|1
1464949|NCT00724373|4829931|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
1464950|NCT00724373|4829931|P1|Overall Study|Participant moved away|1
1464951|NCT00724373|4829931|P1|Overall Study|HCV RNA negative after 4 weeks|9
1464952|NCT00724373|4829931|P1|Overall Study|Non-compliance|2
1464953|NCT00724373|4829931|P1|Overall Study|Lost to Follow-up|7
1464954|NCT00724373|4829931|P1|Overall Study|Lack of Efficacy|82
1464955|NCT00724373|4829931|P1|Overall Study|Adverse Event|41
1464956|NCT00724282|4829948|P1|Overall Study|Physician Decision|1
1464957|NCT00724282|4829948|P1|Overall Study|Withdrawal by Subject|3
1464958|NCT00724243|4829952|P1|Overall Study|Adverse Event|5
1464959|NCT00724243|4829952|P1|Overall Study|Lack of Efficacy|10
1464960|NCT00724152|4829962|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
1464961|NCT00724152|4829963|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
1464962|NCT00724152|4829964|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
1464963|NCT00724152|4829962|P3|Two-arm Study Period|Withdrawal by Subject|0
1464964|NCT00724152|4829963|P2|Two-arm Study Period|Withdrawal by Subject|2
1464965|NCT00724152|4829964|P1|Two-arm Study Period|Withdrawal by Subject|3
1464966|NCT00724126|4829981|P2|Overall Study|Subject had to leave vicinity of site|1
1464967|NCT00724126|4829982|P1|Overall Study|Subject had to leave vicinity of site|0
1464968|NCT00724126|4829981|P2|Overall Study|Subject randomized although ineligible|1
1464969|NCT00724126|4829982|P1|Overall Study|Subject randomized although ineligible|1
1464970|NCT00724126|4829981|P2|Overall Study|Noncompliance|1
1464971|NCT00724126|4829982|P1|Overall Study|Noncompliance|2
1464972|NCT00724126|4829981|P2|Overall Study|Lost to Follow-up|6
1464973|NCT00724126|4829982|P1|Overall Study|Lost to Follow-up|6
1464974|NCT00724126|4829981|P2|Overall Study|Withdrawal by Subject|6
1464975|NCT00724126|4829982|P1|Overall Study|Withdrawal by Subject|8
1464976|NCT00724126|4829981|P2|Overall Study|Adverse Event|0
1464977|NCT00724126|4829982|P1|Overall Study|Adverse Event|2
1464978|NCT00724061|4829990|P1|Dose Escalation Phase|Disease Progression|3
1464979|NCT00724061|4829990|P1|Dose Escalation Phase|Adverse Event|2
1464980|NCT00723957|4830007|P2|Overall Study|Never received treatment|3
1464981|NCT00723957|4830008|P1|Overall Study|Never received treatment|3
1464982|NCT00723957|4830007|P2|Overall Study|Reason not analyzed|0
1464983|NCT00723957|4830008|P1|Overall Study|Reason not analyzed|1
1464984|NCT00723957|4830007|P2|Overall Study|Withdrawal by Subject|5
1464985|NCT00723957|4830008|P1|Overall Study|Withdrawal by Subject|7
1464986|NCT00723957|4830007|P2|Overall Study|Study drug toxicity|6
1464987|NCT00723957|4830008|P1|Overall Study|Study drug toxicity|4
1464988|NCT00723957|4830007|P2|Overall Study|Investigator decision|1
1464989|NCT00723957|4830008|P1|Overall Study|Investigator decision|1
1464990|NCT00723957|4830007|P2|Overall Study|Maximum clinical benefit|5
1464991|NCT00723957|4830008|P1|Overall Study|Maximum clinical benefit|4
1464992|NCT00723957|4830007|P2|Overall Study|Disease progression|25
1464993|NCT00723957|4830008|P1|Overall Study|Disease progression|27
1464994|NCT00723957|4830007|P2|Overall Study|Death|4
1464995|NCT00723957|4830008|P1|Overall Study|Death|3
1464996|NCT00723957|4830007|P2|Overall Study|Adverse event unrelated to study drug|4
1464997|NCT00723957|4830008|P1|Overall Study|Adverse event unrelated to study drug|1
1464998|NCT00723944|4830032|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
1464999|NCT00723944|4830033|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
1465000|NCT00723944|4830032|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
1465001|NCT00723944|4830033|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
1465002|NCT00723944|4830032|P2|Permanent Prosthesis Placement|Adverse Event|7
1465003|NCT00723944|4830033|P1|Permanent Prosthesis Placement|Adverse Event|1
1465004|NCT00723892|4830046|P2|Overall Study|Drug addiction|0
1465005|NCT00723892|4830047|P1|Overall Study|Drug addiction|1
1465006|NCT00723892|4830046|P2|Overall Study|Intercurrent infection|0
1465007|NCT00723892|4830047|P1|Overall Study|Intercurrent infection|2
1465008|NCT00723892|4830046|P2|Overall Study|Alcohol abuse|1
1465009|NCT00723892|4830047|P1|Overall Study|Alcohol abuse|0
1465010|NCT00723892|4830046|P2|Overall Study|Weight loss|3
1465011|NCT00723892|4830047|P1|Overall Study|Weight loss|1
1465012|NCT00723892|4830046|P2|Overall Study|Study end|3
1465013|NCT00723892|4830047|P1|Overall Study|Study end|1
1465014|NCT00723892|4830046|P2|Overall Study|Not specified|3
1465015|NCT00723892|4830047|P1|Overall Study|Not specified|6
1465016|NCT00723892|4830046|P2|Overall Study|Multiple reasons|12
1465017|NCT00723892|4830047|P1|Overall Study|Multiple reasons|17
1465018|NCT00723892|4830046|P2|Overall Study|Bad tolerance|5
1465019|NCT00723892|4830047|P1|Overall Study|Bad tolerance|5
1465020|NCT00723892|4830046|P2|Overall Study|End planned|7
1465021|NCT00723892|4830047|P1|Overall Study|End planned|11
1465022|NCT00723892|4830046|P2|Overall Study|Withdrawal by Subject|9
1465023|NCT00723892|4830047|P1|Overall Study|Withdrawal by Subject|6
1465024|NCT00723892|4830046|P2|Overall Study|Virological criterion|9
1465025|NCT00723892|4830047|P1|Overall Study|Virological criterion|24
1465026|NCT00723892|4830046|P2|Overall Study|Participant not tracked|35
1465027|NCT00723892|4830047|P1|Overall Study|Participant not tracked|33
1465028|NCT00723840|4830054|P1|Overall Study|Unspecified reason|2
1465029|NCT00723840|4830054|P1|Overall Study|Other Medical Event|2
1465030|NCT00723840|4830054|P1|Overall Study|Serious Adverse Events|3
1465031|NCT00723840|4830054|P1|Overall Study|Withdrawal by Subject|55
1465032|NCT00723840|4830054|P1|Overall Study|Failure to return|18
1465033|NCT00723840|4830054|P1|Overall Study|Lost to Follow-up|2
1465034|NCT00723801|4830075|P2|Overall Study|Protocol Violation|1
1465035|NCT00723801|4830076|P1|Overall Study|Protocol Violation|2
1465036|NCT00723801|4830075|P2|Overall Study|Lost to Follow-up|2
1465037|NCT00723801|4830076|P1|Overall Study|Lost to Follow-up|1
1465038|NCT00723710|4830101|P1|Overall Study|Physician Decision|2
1465039|NCT00723710|4830101|P1|Overall Study|Withdrawal by Subject|36
1465040|NCT00723710|4830101|P1|Overall Study|Adverse Event|88
1465041|NCT00723710|4830101|P1|Overall Study|Disease progression|48
1465042|NCT00723697|4830105|P1|Overall Study|Other exclusion criteria applied|6
1465043|NCT00723697|4830105|P1|Overall Study|Missing Informed Consent Form|10
1465044|NCT00723697|4830105|P1|Overall Study|Physician questionnaires not received|2
1465045|NCT00723606|4830126|P2|Overall Study|Withdrawal by Subject|2
1465046|NCT00723606|4830127|P1|Overall Study|Withdrawal by Subject|0
1465047|NCT00723606|4830126|P2|Overall Study|Other|0
1465048|NCT00723606|4830127|P1|Overall Study|Other|2
1465049|NCT00723606|4830126|P2|Overall Study|Adverse Event|5
1465050|NCT00723606|4830127|P1|Overall Study|Adverse Event|2
1465051|NCT00723554|4830147|P1|Overall Study|Non-compliance|1
1465052|NCT00723554|4830147|P1|Overall Study|Lost to Follow-up|1
1465053|NCT00723554|4830147|P1|Overall Study|Not specified|3
1465054|NCT00723554|4830147|P1|Overall Study|Withdrawal of consent|3
1465055|NCT00723554|4830147|P1|Overall Study|Inhaled medication other than iloprost|4
1465056|NCT00723554|4830147|P1|Overall Study|Investigator's judgement|5
1465057|NCT00723554|4830147|P1|Overall Study|Adverse Event|12
1465058|NCT00723528|4830197|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
1465059|NCT00723528|4830198|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1465060|NCT00723528|4830199|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1465061|NCT00723528|4830200|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1465062|NCT00723528|4830201|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1465063|NCT00723528|4830202|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1465064|NCT00723528|4830203|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1465065|NCT00723528|4830197|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
1465066|NCT00723528|4830198|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1465067|NCT00723528|4830199|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1465068|NCT00723528|4830200|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1465069|NCT00723528|4830201|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1465070|NCT00723528|4830202|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1465071|NCT00723528|4830203|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1465072|NCT00723528|4830197|P7|Period 2: After Controlled Period|Adverse Event|1
1465073|NCT00723528|4830198|P6|Period 2: After Controlled Period|Adverse Event|0
1465074|NCT00723528|4830199|P5|Period 2: After Controlled Period|Adverse Event|1
1465075|NCT00723528|4830200|P4|Period 2: After Controlled Period|Adverse Event|0
1465076|NCT00723528|4830201|P3|Period 2: After Controlled Period|Adverse Event|0
1465077|NCT00723528|4830202|P2|Period 2: After Controlled Period|Adverse Event|0
1465078|NCT00723528|4830203|P1|Period 2: After Controlled Period|Adverse Event|0
1465079|NCT00723528|4830197|P7|Period 2: After Controlled Period|Other|0
1465080|NCT00723528|4830198|P6|Period 2: After Controlled Period|Other|4
1465081|NCT00723528|4830199|P5|Period 2: After Controlled Period|Other|1
1465082|NCT00723528|4830200|P4|Period 2: After Controlled Period|Other|0
1465083|NCT00723528|4830201|P3|Period 2: After Controlled Period|Other|0
1465084|NCT00723528|4830202|P2|Period 2: After Controlled Period|Other|0
1465085|NCT00723528|4830203|P1|Period 2: After Controlled Period|Other|0
1465086|NCT00723528|4830197|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1465087|NCT00723528|4830198|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
1465088|NCT00723528|4830199|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1465089|NCT00723528|4830200|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1465090|NCT00723528|4830201|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1465091|NCT00723528|4830202|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1465092|NCT00723528|4830203|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1465093|NCT00723528|4830197|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
1465094|NCT00723528|4830198|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
1465095|NCT00723528|4830199|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
1465096|NCT00723528|4830200|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
1465097|NCT00723528|4830201|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
1465098|NCT00723528|4830202|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
1465099|NCT00723528|4830203|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
1465100|NCT00723528|4830197|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
1465101|NCT00723528|4830198|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
1465102|NCT00723528|4830199|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
1465103|NCT00723528|4830200|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
1465104|NCT00723528|4830201|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
1465105|NCT00723528|4830202|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
1465106|NCT00723528|4830203|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
1465107|NCT00723528|4830197|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1465108|NCT00723528|4830198|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1465109|NCT00723528|4830199|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1465110|NCT00723528|4830200|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1465111|NCT00723528|4830201|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
1465112|NCT00723528|4830202|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1465113|NCT00723528|4830203|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1465114|NCT00723528|4830197|P7|Period 1: Controlled Period (CP)|Physician Decision|0
1465115|NCT00723528|4830198|P6|Period 1: Controlled Period (CP)|Physician Decision|0
1465116|NCT00723528|4830199|P5|Period 1: Controlled Period (CP)|Physician Decision|0
1465117|NCT00723528|4830200|P4|Period 1: Controlled Period (CP)|Physician Decision|0
1465118|NCT00723528|4830201|P3|Period 1: Controlled Period (CP)|Physician Decision|1
1465119|NCT00723528|4830202|P2|Period 1: Controlled Period (CP)|Physician Decision|0
1465120|NCT00723528|4830203|P1|Period 1: Controlled Period (CP)|Physician Decision|0
1465121|NCT00723528|4830197|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1465122|NCT00723528|4830198|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1465123|NCT00723528|4830199|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1465124|NCT00723528|4830200|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1465125|NCT00723528|4830201|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1465126|NCT00723528|4830202|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1465127|NCT00723528|4830203|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
1465128|NCT00723528|4830197|P7|Period 1: Controlled Period (CP)|Adverse Event|0
1465129|NCT00723528|4830198|P6|Period 1: Controlled Period (CP)|Adverse Event|0
1465130|NCT00723528|4830199|P5|Period 1: Controlled Period (CP)|Adverse Event|0
1465131|NCT00723528|4830200|P4|Period 1: Controlled Period (CP)|Adverse Event|0
1465132|NCT00723528|4830201|P3|Period 1: Controlled Period (CP)|Adverse Event|1
1465133|NCT00723528|4830202|P2|Period 1: Controlled Period (CP)|Adverse Event|0
1465134|NCT00723528|4830203|P1|Period 1: Controlled Period (CP)|Adverse Event|0
1465135|NCT00723489|4830265|P4|Overall Study|Samples Collected Out of Window|0
1465136|NCT00723489|4830266|P3|Overall Study|Samples Collected Out of Window|0
1465137|NCT00723489|4830267|P2|Overall Study|Samples Collected Out of Window|3
1465138|NCT00723489|4830268|P1|Overall Study|Samples Collected Out of Window|0
1465139|NCT00723489|4830265|P4|Overall Study|Prohibited Medication|1
1465140|NCT00723489|4830266|P3|Overall Study|Prohibited Medication|0
1465141|NCT00723489|4830267|P2|Overall Study|Prohibited Medication|0
1465142|NCT00723489|4830268|P1|Overall Study|Prohibited Medication|0
1465143|NCT00723489|4830265|P4|Overall Study|Seropositive at baseline|0
1465144|NCT00723489|4830266|P3|Overall Study|Seropositive at baseline|0
1465145|NCT00723489|4830267|P2|Overall Study|Seropositive at baseline|0
1465146|NCT00723489|4830268|P1|Overall Study|Seropositive at baseline|1
1465147|NCT00723489|4830265|P4|Overall Study|Withdrawal by Subject|1
1465148|NCT00723489|4830266|P3|Overall Study|Withdrawal by Subject|0
1465149|NCT00723489|4830267|P2|Overall Study|Withdrawal by Subject|0
1465150|NCT00723489|4830268|P1|Overall Study|Withdrawal by Subject|0
1465151|NCT00723489|4830265|P4|Overall Study|Pregnancy|1
1465152|NCT00723489|4830266|P3|Overall Study|Pregnancy|0
1465153|NCT00723489|4830267|P2|Overall Study|Pregnancy|0
1465154|NCT00723489|4830268|P1|Overall Study|Pregnancy|0
1465155|NCT00723489|4830265|P4|Overall Study|Physician Decision|0
1465156|NCT00723489|4830266|P3|Overall Study|Physician Decision|0
1465157|NCT00723489|4830267|P2|Overall Study|Physician Decision|1
1465158|NCT00723489|4830268|P1|Overall Study|Physician Decision|0
1465159|NCT00723450|4830296|P3|Randomized Phase|Withdrawal by Subject|22
1465160|NCT00723450|4830297|P2|Randomized Phase|Withdrawal by Subject|14
1465161|NCT00723450|4830298|P1|Randomized Phase|Withdrawal by Subject|0
1465162|NCT00723450|4830296|P3|Randomized Phase|Physician Decision|1
1465163|NCT00723450|4830297|P2|Randomized Phase|Physician Decision|3
1465164|NCT00723450|4830298|P1|Randomized Phase|Physician Decision|0
1465165|NCT00723450|4830296|P3|Randomized Phase|Lost to Follow-up|3
1465166|NCT00723450|4830297|P2|Randomized Phase|Lost to Follow-up|2
1465167|NCT00723450|4830298|P1|Randomized Phase|Lost to Follow-up|0
1465168|NCT00723450|4830296|P3|Randomized Phase|Protocol Violation|13
1465169|NCT00723450|4830297|P2|Randomized Phase|Protocol Violation|9
1465170|NCT00723450|4830298|P1|Randomized Phase|Protocol Violation|0
1465171|NCT00723450|4830296|P3|Randomized Phase|Lack of Efficacy|11
1465172|NCT00723450|4830297|P2|Randomized Phase|Lack of Efficacy|11
1465173|NCT00723450|4830298|P1|Randomized Phase|Lack of Efficacy|0
1465174|NCT00723450|4830296|P3|Randomized Phase|Adverse Event|17
1465175|NCT00723450|4830297|P2|Randomized Phase|Adverse Event|26
1465176|NCT00723450|4830298|P1|Randomized Phase|Adverse Event|0
1465177|NCT00723450|4830296|P3|Open-Label Phase|Withdrawal by Subject|0
1465178|NCT00723450|4830297|P2|Open-Label Phase|Withdrawal by Subject|0
1465179|NCT00723450|4830298|P1|Open-Label Phase|Withdrawal by Subject|37
1465180|NCT00723450|4830296|P3|Open-Label Phase|Physician Decision|0
1465181|NCT00723450|4830297|P2|Open-Label Phase|Physician Decision|0
1465182|NCT00723450|4830298|P1|Open-Label Phase|Physician Decision|2
1465183|NCT00723450|4830296|P3|Open-Label Phase|Lost to Follow-up|0
1465184|NCT00723450|4830297|P2|Open-Label Phase|Lost to Follow-up|0
1465185|NCT00723450|4830298|P1|Open-Label Phase|Lost to Follow-up|7
1465186|NCT00723450|4830296|P3|Open-Label Phase|Protocol Violation|0
1465187|NCT00723450|4830297|P2|Open-Label Phase|Protocol Violation|0
1465188|NCT00723450|4830298|P1|Open-Label Phase|Protocol Violation|35
1465189|NCT00723450|4830296|P3|Open-Label Phase|Lack of Efficacy|0
1465190|NCT00723450|4830297|P2|Open-Label Phase|Lack of Efficacy|0
1465191|NCT00723450|4830298|P1|Open-Label Phase|Lack of Efficacy|18
1465192|NCT00723450|4830296|P3|Open-Label Phase|Adverse Event|0
1465193|NCT00723450|4830297|P2|Open-Label Phase|Adverse Event|0
1465194|NCT00723450|4830298|P1|Open-Label Phase|Adverse Event|26
1465195|NCT00723294|4830339|P1|Overall Study|No treatment due to probe failure|1
1465196|NCT00723294|4830339|P1|Overall Study|Withdrawal by Subject|1
1465197|NCT00723294|4830339|P1|Overall Study|Benign lesion|1
1465198|NCT00723294|4830339|P1|Overall Study|Treated by non-credentialed surgeon|1
1465199|NCT00723294|4830339|P1|Overall Study|Treated prior to registration|1
1465200|NCT00723294|4830339|P1|Overall Study|Did not undergo surgery|1
1465201|NCT00723294|4830339|P1|Overall Study|No cryoabalation|2
1465202|NCT00723294|4830339|P1|Overall Study|1.0-Tesla MRI|1
1465203|NCT00723294|4830339|P1|Overall Study|No MRI tumor enhancement|1
1465204|NCT00723294|4830339|P1|Overall Study|>25% intraductal component|1
1465205|NCT00723294|4830339|P1|Overall Study|Lobular histology|2
1465206|NCT00723255|4830344|P1|Overall Study|Ineligible: Wrong Primary|2
1465207|NCT00723255|4830344|P1|Overall Study|Ineligible: Second primary|1
1465208|NCT00723255|4830344|P1|Overall Study|Ineligible: Inadequate pathology|1
1465209|NCT00723229|4830371|P2|First Intervention|Lost to Follow-up|3
1465210|NCT00723229|4830372|P1|First Intervention|Lost to Follow-up|7
1465211|NCT00723203|4830384|P1|Overall Study|Withdrawal by Subject|3
1465212|NCT00723190|4830388|P1|Overall Study|Other-Not included in safety population|2
1465213|NCT00723190|4830388|P1|Overall Study|Other-Premature Discontinuation|9
1465214|NCT00723190|4830388|P1|Overall Study|Protocol Violation|15
1465215|NCT00723190|4830388|P1|Overall Study|Lack of Efficacy|16
1465216|NCT00723190|4830388|P1|Overall Study|Adverse Event|18
1465217|NCT00723190|4830388|P1|Overall Study|Lost to Follow-up|37
1465218|NCT00723190|4830388|P1|Overall Study|Withdrawal by Subject|45
1465219|NCT00723125|4830421|P2|Overall Study|Adverse Event|0
1465220|NCT00723125|4830422|P1|Overall Study|Adverse Event|2
1465221|NCT00723125|4830421|P2|Overall Study|Withdrawal by Subject|6
1465222|NCT00723125|4830422|P1|Overall Study|Withdrawal by Subject|15
1465223|NCT00723125|4830421|P2|Overall Study|Met Dx|0
1465224|NCT00723125|4830422|P1|Overall Study|Met Dx|1
1465225|NCT00723021|4830459|P5|Intervention Period 4|Adverse Event|1
1465226|NCT00723021|4830460|P4|Intervention Period 4|Adverse Event|0
1465227|NCT00723021|4830461|P3|Intervention Period 4|Adverse Event|0
1465228|NCT00723021|4830462|P2|Intervention Period 4|Adverse Event|0
1465229|NCT00723021|4830463|P1|Intervention Period 4|Adverse Event|0
1465230|NCT00723008|4830517|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
1465231|NCT00723008|4830518|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
1465232|NCT00723008|4830517|P2|4-Week Unblinded Treatment|Adverse Event|0
1465233|NCT00723008|4830518|P1|4-Week Unblinded Treatment|Adverse Event|1
1465234|NCT00723008|4830517|P2|4-Week Double Blinded|Lost to Follow-up|3
1465235|NCT00723008|4830518|P1|4-Week Double Blinded|Lost to Follow-up|4
1465236|NCT00723008|4830517|P2|4-Week Double Blinded|Withdrawal by Subject|1
1465237|NCT00723008|4830518|P1|4-Week Double Blinded|Withdrawal by Subject|1
1465238|NCT00723008|4830517|P2|4-Week Double Blinded|Lack of Efficacy|1
1465239|NCT00723008|4830518|P1|4-Week Double Blinded|Lack of Efficacy|0
1465240|NCT00723008|4830517|P2|Enrollment|Lost to Follow-up|0
1465241|NCT00723008|4830518|P1|Enrollment|Lost to Follow-up|1
1465242|NCT00722800|4830550|P2|Overall Study|Physician Decision|0
1465243|NCT00722800|4830551|P1|Overall Study|Physician Decision|1
1465244|NCT00722800|4830550|P2|Overall Study|Withdrawal by Subject|0
1465245|NCT00722800|4830551|P1|Overall Study|Withdrawal by Subject|1
1465246|NCT00722761|4830563|P2|Overall Study|Withdrawal by Subject|2
1465247|NCT00722761|4830564|P1|Overall Study|Withdrawal by Subject|5
1465248|NCT00722761|4830563|P2|Overall Study|Lost to Follow-up|4
1465249|NCT00722761|4830564|P1|Overall Study|Lost to Follow-up|1
1465250|NCT00722423|4830621|P2|Overall Study|Protocol Violation|1
1465251|NCT00722423|4830622|P1|Overall Study|Protocol Violation|0
1465252|NCT00722371|4830637|P7|Overall Study|Withdrawal by Subject|26
1465253|NCT00722371|4830638|P6|Overall Study|Withdrawal by Subject|18
1465254|NCT00722371|4830639|P5|Overall Study|Withdrawal by Subject|19
1465255|NCT00722371|4830640|P4|Overall Study|Withdrawal by Subject|23
1465256|NCT00722371|4830641|P3|Overall Study|Withdrawal by Subject|19
1465257|NCT00722371|4830642|P2|Overall Study|Withdrawal by Subject|27
1465258|NCT00722371|4830643|P1|Overall Study|Withdrawal by Subject|18
1465259|NCT00722371|4830637|P7|Overall Study|Protocol Violation|1
1465260|NCT00722371|4830638|P6|Overall Study|Protocol Violation|2
1465261|NCT00722371|4830639|P5|Overall Study|Protocol Violation|4
1465262|NCT00722371|4830640|P4|Overall Study|Protocol Violation|1
1465263|NCT00722371|4830641|P3|Overall Study|Protocol Violation|0
1465264|NCT00722371|4830642|P2|Overall Study|Protocol Violation|1
1465265|NCT00722371|4830643|P1|Overall Study|Protocol Violation|6
1465266|NCT00722371|4830637|P7|Overall Study|Pregnancy|0
1465267|NCT00722371|4830638|P6|Overall Study|Pregnancy|1
1465268|NCT00722371|4830639|P5|Overall Study|Pregnancy|0
1465269|NCT00722371|4830640|P4|Overall Study|Pregnancy|0
1465270|NCT00722371|4830641|P3|Overall Study|Pregnancy|0
1465271|NCT00722371|4830642|P2|Overall Study|Pregnancy|1
1465272|NCT00722371|4830643|P1|Overall Study|Pregnancy|1
1465273|NCT00722371|4830637|P7|Overall Study|Physician Decision|4
1465274|NCT00722371|4830638|P6|Overall Study|Physician Decision|3
1465275|NCT00722371|4830639|P5|Overall Study|Physician Decision|2
1465276|NCT00722371|4830640|P4|Overall Study|Physician Decision|5
1465277|NCT00722371|4830641|P3|Overall Study|Physician Decision|2
1465278|NCT00722371|4830642|P2|Overall Study|Physician Decision|2
1465279|NCT00722371|4830643|P1|Overall Study|Physician Decision|5
1465280|NCT00722371|4830637|P7|Overall Study|Lost to Follow-up|13
1465281|NCT00722371|4830638|P6|Overall Study|Lost to Follow-up|16
1465282|NCT00722371|4830639|P5|Overall Study|Lost to Follow-up|8
1465283|NCT00722371|4830640|P4|Overall Study|Lost to Follow-up|13
1465284|NCT00722371|4830641|P3|Overall Study|Lost to Follow-up|21
1465285|NCT00722371|4830642|P2|Overall Study|Lost to Follow-up|14
1465286|NCT00722371|4830643|P1|Overall Study|Lost to Follow-up|11
1465287|NCT00722371|4830637|P7|Overall Study|Lack of Efficacy|0
1465288|NCT00722371|4830638|P6|Overall Study|Lack of Efficacy|3
1465289|NCT00722371|4830639|P5|Overall Study|Lack of Efficacy|2
1465290|NCT00722371|4830640|P4|Overall Study|Lack of Efficacy|6
1465291|NCT00722371|4830641|P3|Overall Study|Lack of Efficacy|6
1465292|NCT00722371|4830642|P2|Overall Study|Lack of Efficacy|6
1465293|NCT00722371|4830643|P1|Overall Study|Lack of Efficacy|4
1465294|NCT00722371|4830637|P7|Overall Study|Hypoglycemia|0
1465295|NCT00722371|4830638|P6|Overall Study|Hypoglycemia|0
1465296|NCT00722371|4830639|P5|Overall Study|Hypoglycemia|0
1465297|NCT00722371|4830640|P4|Overall Study|Hypoglycemia|0
1465298|NCT00722371|4830641|P3|Overall Study|Hypoglycemia|0
1465299|NCT00722371|4830642|P2|Overall Study|Hypoglycemia|0
1465300|NCT00722371|4830643|P1|Overall Study|Hypoglycemia|1
1465301|NCT00722371|4830637|P7|Overall Study|Hyperglycemia|1
1465302|NCT00722371|4830638|P6|Overall Study|Hyperglycemia|1
1465303|NCT00722371|4830639|P5|Overall Study|Hyperglycemia|5
1465304|NCT00722371|4830640|P4|Overall Study|Hyperglycemia|2
1465305|NCT00722371|4830641|P3|Overall Study|Hyperglycemia|4
1465306|NCT00722371|4830642|P2|Overall Study|Hyperglycemia|6
1465307|NCT00722371|4830643|P1|Overall Study|Hyperglycemia|2
1465308|NCT00722371|4830637|P7|Overall Study|Excluded medication|1
1465309|NCT00722371|4830638|P6|Overall Study|Excluded medication|0
1465310|NCT00722371|4830639|P5|Overall Study|Excluded medication|0
1465311|NCT00722371|4830640|P4|Overall Study|Excluded medication|0
1465312|NCT00722371|4830641|P3|Overall Study|Excluded medication|1
1465313|NCT00722371|4830642|P2|Overall Study|Excluded medication|1
1465314|NCT00722371|4830643|P1|Overall Study|Excluded medication|0
1465315|NCT00722371|4830637|P7|Overall Study|Creatinine / Creatinine clearance|1
1465316|NCT00722371|4830638|P6|Overall Study|Creatinine / Creatinine clearance|1
1465317|NCT00722371|4830639|P5|Overall Study|Creatinine / Creatinine clearance|2
1465318|NCT00722371|4830640|P4|Overall Study|Creatinine / Creatinine clearance|3
1465319|NCT00722371|4830641|P3|Overall Study|Creatinine / Creatinine clearance|2
1465320|NCT00722371|4830642|P2|Overall Study|Creatinine / Creatinine clearance|1
1465321|NCT00722371|4830643|P1|Overall Study|Creatinine / Creatinine clearance|2
1465322|NCT00722371|4830637|P7|Overall Study|Contraindication|0
1465323|NCT00722371|4830638|P6|Overall Study|Contraindication|0
1465324|NCT00722371|4830639|P5|Overall Study|Contraindication|0
1465325|NCT00722371|4830640|P4|Overall Study|Contraindication|0
1465326|NCT00722371|4830641|P3|Overall Study|Contraindication|1
1465327|NCT00722371|4830642|P2|Overall Study|Contraindication|0
1465328|NCT00722371|4830643|P1|Overall Study|Contraindication|0
1465329|NCT00722371|4830637|P7|Overall Study|Adverse Event|4
1465330|NCT00722371|4830638|P6|Overall Study|Adverse Event|8
1465331|NCT00722371|4830639|P5|Overall Study|Adverse Event|6
1465332|NCT00722371|4830640|P4|Overall Study|Adverse Event|10
1465333|NCT00722371|4830641|P3|Overall Study|Adverse Event|9
1465334|NCT00722371|4830642|P2|Overall Study|Adverse Event|13
1465335|NCT00722371|4830643|P1|Overall Study|Adverse Event|6
1465336|NCT00722137|4830696|P2|Overall Study|Randomized But Not Treated|3
1465337|NCT00722137|4830697|P1|Overall Study|Randomized But Not Treated|2
1465338|NCT00722137|4830696|P2|Overall Study|Other Reason Unknown|4
1465339|NCT00722137|4830697|P1|Overall Study|Other Reason Unknown|3
1465340|NCT00722137|4830696|P2|Overall Study|Withdrawal by Subject|9
1465341|NCT00722137|4830697|P1|Overall Study|Withdrawal by Subject|6
1465342|NCT00722137|4830696|P2|Overall Study|Death|7
1465343|NCT00722137|4830697|P1|Overall Study|Death|12
1465344|NCT00722137|4830696|P2|Overall Study|Adverse Event|21
1465345|NCT00722137|4830697|P1|Overall Study|Adverse Event|17
1465346|NCT00722137|4830696|P2|Overall Study|Overt Disease Progression|4
1465347|NCT00722137|4830697|P1|Overall Study|Overt Disease Progression|5
1465348|NCT00721968|4830767|P2|Overall Study|Lost to Follow-up|0
1465349|NCT00721968|4830768|P1|Overall Study|Lost to Follow-up|2
1465350|NCT00721955|4830779|P3|Overall Study|Adverse Event|2
1465351|NCT00721955|4830780|P2|Overall Study|Adverse Event|0
1465352|NCT00721955|4830781|P1|Overall Study|Adverse Event|0
1465353|NCT00721799|4830795|P1|Overall Study|withdraw by subject after scan 1|1
1465354|NCT00721799|4830795|P1|Overall Study|Withdrawal by Subject|7
1465355|NCT00721734|4830835|P5|Overall Study|Other|0
1465356|NCT00721734|4830836|P4|Overall Study|Other|1
1465357|NCT00721734|4830837|P3|Overall Study|Other|0
1465358|NCT00721734|4830838|P2|Overall Study|Other|0
1465359|NCT00721734|4830839|P1|Overall Study|Other|0
1465360|NCT00721734|4830835|P5|Overall Study|Withdrawal by Subject|1
1465361|NCT00721734|4830836|P4|Overall Study|Withdrawal by Subject|0
1465362|NCT00721734|4830837|P3|Overall Study|Withdrawal by Subject|0
1465363|NCT00721734|4830838|P2|Overall Study|Withdrawal by Subject|1
1465364|NCT00721734|4830839|P1|Overall Study|Withdrawal by Subject|2
1465365|NCT00721734|4830835|P5|Overall Study|Adverse Event|3
1465366|NCT00721734|4830836|P4|Overall Study|Adverse Event|0
1465367|NCT00721734|4830837|P3|Overall Study|Adverse Event|4
1465368|NCT00721734|4830838|P2|Overall Study|Adverse Event|1
1465369|NCT00721734|4830839|P1|Overall Study|Adverse Event|3
1465370|NCT00721734|4830835|P5|Overall Study|Progressive Disease|2
1465371|NCT00721734|4830836|P4|Overall Study|Progressive Disease|5
1465372|NCT00721734|4830837|P3|Overall Study|Progressive Disease|4
1465373|NCT00721734|4830838|P2|Overall Study|Progressive Disease|10
1465374|NCT00721734|4830839|P1|Overall Study|Progressive Disease|3
1465375|NCT00721630|4830951|P1|Overall Study|Participant found to be ineligible|1
1465376|NCT00721578|4830980|P2|Overall Study|Withdrawal by Subject|1
1465377|NCT00721578|4830981|P1|Overall Study|Withdrawal by Subject|1
1465378|NCT00721578|4830980|P2|Overall Study|Death|1
1465379|NCT00721578|4830981|P1|Overall Study|Death|1
1465380|NCT00721409|4831024|P3|Overall Study|Death|0
1465381|NCT00721409|4831025|P2|Overall Study|Death|1
1465382|NCT00721409|4831026|P1|Overall Study|Death|0
1465383|NCT00721409|4831024|P3|Overall Study|Adverse Event|2
1465384|NCT00721409|4831025|P2|Overall Study|Adverse Event|11
1465385|NCT00721409|4831026|P1|Overall Study|Adverse Event|0
1465386|NCT00721409|4831024|P3|Overall Study|Reason not specified|5
1465387|NCT00721409|4831025|P2|Overall Study|Reason not specified|1
1465388|NCT00721409|4831026|P1|Overall Study|Reason not specified|0
1465389|NCT00721409|4831024|P3|Overall Study|Withdrawal by Subject|6
1465390|NCT00721409|4831025|P2|Overall Study|Withdrawal by Subject|5
1465391|NCT00721409|4831026|P1|Overall Study|Withdrawal by Subject|1
1465392|NCT00721409|4831024|P3|Overall Study|Objective progression or relapse|57
1465393|NCT00721409|4831025|P2|Overall Study|Objective progression or relapse|42
1465394|NCT00721409|4831026|P1|Overall Study|Objective progression or relapse|7
1465395|NCT00721409|4831024|P3|Overall Study|Global deterioration of health status|3
1465396|NCT00721409|4831025|P2|Overall Study|Global deterioration of health status|5
1465397|NCT00721409|4831026|P1|Overall Study|Global deterioration of health status|2
1465398|NCT00721409|4831024|P3|Overall Study|Ongoing at date of cutoff|8
1465399|NCT00721409|4831025|P2|Overall Study|Ongoing at date of cutoff|19
1465400|NCT00721409|4831026|P1|Overall Study|Ongoing at date of cutoff|2
1465401|NCT00721396|4831153|P4|Overall Study|Administrative reason|0
1465402|NCT00721396|4831154|P3|Overall Study|Administrative reason|1
1465403|NCT00721396|4831155|P2|Overall Study|Administrative reason|0
1465404|NCT00721396|4831156|P1|Overall Study|Administrative reason|3
1465405|NCT00721396|4831153|P4|Overall Study|Inappropriate enrollment|0
1465406|NCT00721396|4831154|P3|Overall Study|Inappropriate enrollment|0
1465407|NCT00721396|4831155|P2|Overall Study|Inappropriate enrollment|2
1465408|NCT00721396|4831156|P1|Overall Study|Inappropriate enrollment|0
1465409|NCT00721396|4831153|P4|Overall Study|Protocol Violation|0
1465410|NCT00721396|4831154|P3|Overall Study|Protocol Violation|1
1465411|NCT00721396|4831155|P2|Overall Study|Protocol Violation|3
1465412|NCT00721396|4831156|P1|Overall Study|Protocol Violation|4
1465413|NCT00721396|4831153|P4|Overall Study|Lost to Follow-up|3
1465414|NCT00721396|4831154|P3|Overall Study|Lost to Follow-up|3
1465415|NCT00721396|4831155|P2|Overall Study|Lost to Follow-up|9
1465416|NCT00721396|4831156|P1|Overall Study|Lost to Follow-up|7
1465417|NCT00721396|4831153|P4|Overall Study|Withdrawal by Subject|7
1465418|NCT00721396|4831154|P3|Overall Study|Withdrawal by Subject|3
1465419|NCT00721396|4831155|P2|Overall Study|Withdrawal by Subject|15
1465420|NCT00721396|4831156|P1|Overall Study|Withdrawal by Subject|12
1465421|NCT00721396|4831153|P4|Overall Study|Adverse Event|0
1465422|NCT00721396|4831154|P3|Overall Study|Adverse Event|2
1465423|NCT00721396|4831155|P2|Overall Study|Adverse Event|7
1465424|NCT00721396|4831156|P1|Overall Study|Adverse Event|4
1465425|NCT00721279|4831203|P2|Overall Study|Other|16
1465426|NCT00721279|4831204|P1|Overall Study|Other|12
1465427|NCT00721279|4831203|P2|Overall Study|Withdrawal by Subject|3
1465428|NCT00721279|4831204|P1|Overall Study|Withdrawal by Subject|13
1465429|NCT00721279|4831203|P2|Overall Study|Tolerability insufficient|2
1465430|NCT00721279|4831204|P1|Overall Study|Tolerability insufficient|5
1465431|NCT00721279|4831203|P2|Overall Study|Lack of Efficacy|3
1465432|NCT00721279|4831204|P1|Overall Study|Lack of Efficacy|6
1465433|NCT00721227|4831232|P2|Overall Study|Noncompliance with scheduled visits.|0
1465434|NCT00721227|4831233|P1|Overall Study|Noncompliance with scheduled visits.|1
1465435|NCT00721227|4831232|P2|Overall Study|Lost to Follow-up|0
1465436|NCT00721227|4831233|P1|Overall Study|Lost to Follow-up|3
1465437|NCT00721214|4831243|P1|Overall Study|Death|3
1465438|NCT00721214|4831243|P1|Overall Study|Chose another center for transplant|1
1465439|NCT00721149|4831293|P1|Overall Study|Physician Decision|1
1465440|NCT00721123|4831327|P1|Overall Study|Withdrawal by Subject|5
1465441|NCT00721123|4831327|P1|Overall Study|Failure to Return|9
1465442|NCT00721123|4831327|P1|Overall Study|Refused Treatment|41
1465443|NCT00721123|4831327|P1|Overall Study|Protocol Violation|1
1465444|NCT00721123|4831327|P1|Overall Study|Insufficient Therapeutic Response|21
1465445|NCT00721123|4831327|P1|Overall Study|Death|10
1465446|NCT00721123|4831327|P1|Overall Study|Adverse Event|96
1465447|NCT00721110|4831405|P4|Overall Study|vertical incision|0
1465448|NCT00721110|4831406|P3|Overall Study|vertical incision|1
1465449|NCT00721110|4831407|P2|Overall Study|vertical incision|0
1465450|NCT00721110|4831408|P1|Overall Study|vertical incision|0
1465451|NCT00721110|4831405|P4|Overall Study|Ultram use|0
1465452|NCT00721110|4831406|P3|Overall Study|Ultram use|0
1465453|NCT00721110|4831407|P2|Overall Study|Ultram use|0
1465454|NCT00721110|4831408|P1|Overall Study|Ultram use|1
1465455|NCT00720941|4831436|P2|Overall Study|Ongoing|23
1465456|NCT00720941|4831437|P1|Overall Study|Ongoing|34
1465457|NCT00720941|4831436|P2|Overall Study|Withdrawal by Subject|35
1465458|NCT00720941|4831437|P1|Overall Study|Withdrawal by Subject|27
1465459|NCT00720941|4831436|P2|Overall Study|Physician Decision|5
1465460|NCT00720941|4831437|P1|Overall Study|Physician Decision|1
1465461|NCT00720941|4831436|P2|Overall Study|Lost to Follow-up|15
1465462|NCT00720941|4831437|P1|Overall Study|Lost to Follow-up|17
1465463|NCT00720941|4831436|P2|Overall Study|Protocol Violation|2
1465464|NCT00720941|4831437|P1|Overall Study|Protocol Violation|0
1465465|NCT00720941|4831436|P2|Overall Study|Death|335
1465466|NCT00720941|4831437|P1|Overall Study|Death|334
1465467|NCT00720876|4831477|P1|Overall Study|found to be ineligible after starting tx|2
1465468|NCT00720798|4831483|P1|Overall Study|Reason not Specified|83
1465469|NCT00720798|4831483|P1|Overall Study|Failure to Return|46
1465470|NCT00720798|4831483|P1|Overall Study|Refused Treatment|151
1465471|NCT00720798|4831483|P1|Overall Study|Protocol Violation|4
1465472|NCT00720798|4831483|P1|Overall Study|Insufficient Therapeutic Response|129
1465473|NCT00720798|4831483|P1|Overall Study|Death|39
1465474|NCT00720798|4831483|P1|Overall Study|Adverse Event|304
1465475|NCT00720759|4831506|P4|Overall Study|Lost to Follow-up|0
1465476|NCT00720759|4831507|P3|Overall Study|Lost to Follow-up|1
1465477|NCT00720759|4831508|P2|Overall Study|Lost to Follow-up|1
1465478|NCT00720759|4831509|P1|Overall Study|Lost to Follow-up|0
1465479|NCT00720499|4831529|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
1465480|NCT00720499|4831530|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
1465481|NCT00720499|4831529|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
1465482|NCT00720499|4831530|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
1465483|NCT00720499|4831529|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
1465484|NCT00720499|4831530|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
1465485|NCT00720434|4831623|P4|Open-Label Period (Week 5-72)|Other|2
1465486|NCT00720434|4831624|P3|Open-Label Period (Week 5-72)|Other|3
1465487|NCT00720434|4831625|P2|Open-Label Period (Week 5-72)|Other|3
1465488|NCT00720434|4831626|P1|Open-Label Period (Week 5-72)|Other|4
1465489|NCT00720434|4831623|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
1465490|NCT00720434|4831624|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
1465491|NCT00720434|4831625|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
1465492|NCT00720434|4831626|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
1465493|NCT00720434|4831623|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
1465494|NCT00720434|4831624|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
1465495|NCT00720434|4831625|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
1465496|NCT00720434|4831626|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
1465497|NCT00720434|4831623|P4|Open-Label Period (Week 5-72)|Adverse Event|2
1465498|NCT00720434|4831624|P3|Open-Label Period (Week 5-72)|Adverse Event|0
1465499|NCT00720434|4831625|P2|Open-Label Period (Week 5-72)|Adverse Event|0
1465500|NCT00720434|4831626|P1|Open-Label Period (Week 5-72)|Adverse Event|0
1465501|NCT00720434|4831623|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
1465502|NCT00720434|4831624|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
1465503|NCT00720434|4831625|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
1465504|NCT00720434|4831626|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
1465505|NCT00720382|4831650|P2|Overall Study|administrative|5
1465506|NCT00720382|4831651|P1|Overall Study|administrative|14
1465507|NCT00720382|4831650|P2|Overall Study|Lost to Follow-up|14
1465508|NCT00720382|4831651|P1|Overall Study|Lost to Follow-up|28
1465509|NCT00720382|4831650|P2|Overall Study|Withdrawal by Subject|11
1465510|NCT00720382|4831651|P1|Overall Study|Withdrawal by Subject|47
1465511|NCT00720382|4831650|P2|Overall Study|Non-Compliance|5
1465512|NCT00720382|4831651|P1|Overall Study|Non-Compliance|15
1465513|NCT00720382|4831650|P2|Overall Study|Lack of Efficacy|7
1465514|NCT00720382|4831651|P1|Overall Study|Lack of Efficacy|18
1465515|NCT00720382|4831650|P2|Overall Study|Adverse Event|17
1465516|NCT00720382|4831651|P1|Overall Study|Adverse Event|54
1465517|NCT00720343|4831670|P1|Overall Study|No data|3
1465518|NCT00720343|4831670|P1|Overall Study|Physician Decision|3
1465519|NCT00720278|4831704|P3|Overall Study|eligibility criteria violation|1
1465520|NCT00720278|4831705|P2|Overall Study|eligibility criteria violation|0
1465521|NCT00720278|4831706|P1|Overall Study|eligibility criteria violation|1
1465522|NCT00720278|4831704|P3|Overall Study|Non-compliance|0
1465523|NCT00720278|4831705|P2|Overall Study|Non-compliance|0
1465524|NCT00720278|4831706|P1|Overall Study|Non-compliance|1
1465525|NCT00720278|4831704|P3|Overall Study|Lost to Follow-up|1
1465526|NCT00720278|4831705|P2|Overall Study|Lost to Follow-up|0
1465527|NCT00720278|4831706|P1|Overall Study|Lost to Follow-up|0
1465528|NCT00720278|4831704|P3|Overall Study|Withdrawal by Subject|0
1465529|NCT00720278|4831705|P2|Overall Study|Withdrawal by Subject|1
1465530|NCT00720278|4831706|P1|Overall Study|Withdrawal by Subject|0
1465531|NCT00720278|4831704|P3|Overall Study|Adverse Event|4
1465532|NCT00720278|4831705|P2|Overall Study|Adverse Event|3
1465533|NCT00720278|4831706|P1|Overall Study|Adverse Event|5
1465534|NCT00720226|4831728|P2|Overall Study|Withdrawal by Subject|4
1465535|NCT00720226|4831729|P1|Overall Study|Withdrawal by Subject|7
1465536|NCT00720122|4831737|P1|Overall Study|Withdrawal by Subject|7
1465537|NCT00720122|4831737|P1|Overall Study|Physician Decision|1
1465538|NCT00720122|4831737|P1|Overall Study|Lost to Follow-up|1
1465539|NCT00720109|4831741|P3|Risk Stratification Period|Development of second malignant neoplasm|0
1465540|NCT00720109|4831742|P2|Risk Stratification Period|Development of second malignant neoplasm|1
1465541|NCT00720109|4831743|P1|Risk Stratification Period|Development of second malignant neoplasm|0
1465542|NCT00720109|4831741|P3|Risk Stratification Period|Disease progression or relapse|0
1465543|NCT00720109|4831742|P2|Risk Stratification Period|Disease progression or relapse|2
1465544|NCT00720109|4831743|P1|Risk Stratification Period|Disease progression or relapse|0
1465545|NCT00720109|4831741|P3|Risk Stratification Period|Bone marrow transplant|7
1465546|NCT00720109|4831742|P2|Risk Stratification Period|Bone marrow transplant|9
1465547|NCT00720109|4831743|P1|Risk Stratification Period|Bone marrow transplant|0
1465548|NCT00720109|4831741|P3|Risk Stratification Period|Physician Decision|1
1465549|NCT00720109|4831742|P2|Risk Stratification Period|Physician Decision|2
1465550|NCT00720109|4831743|P1|Risk Stratification Period|Physician Decision|0
1465551|NCT00720109|4831741|P3|Risk Stratification Period|Adverse Event|0
1465552|NCT00720109|4831742|P2|Risk Stratification Period|Adverse Event|1
1465553|NCT00720109|4831743|P1|Risk Stratification Period|Adverse Event|0
1465554|NCT00720109|4831741|P3|Induction Period|Physician Decision|0
1465555|NCT00720109|4831742|P2|Induction Period|Physician Decision|0
1465556|NCT00720109|4831743|P1|Induction Period|Physician Decision|1
1465557|NCT00720109|4831741|P3|Induction Period|Bone Marrow Transplant|0
1465558|NCT00720109|4831742|P2|Induction Period|Bone Marrow Transplant|0
1465559|NCT00720109|4831743|P1|Induction Period|Bone Marrow Transplant|2
1465560|NCT00720109|4831741|P3|Induction Period|Did not meet eligibility criteria|0
1465561|NCT00720109|4831742|P2|Induction Period|Did not meet eligibility criteria|0
1465562|NCT00720109|4831743|P1|Induction Period|Did not meet eligibility criteria|3
1465563|NCT00720096|4831763|P2|Overall Study|Withdrawal by Subject|2
1465564|NCT00720096|4831764|P1|Overall Study|Withdrawal by Subject|0
1465565|NCT00720083|4831776|P2|Overall Study|Ineligible|2
1465566|NCT00720083|4831777|P1|Overall Study|Ineligible|1
1465567|NCT00720057|4831785|P2|Overall Study|Withdrawal by Subject|1
1465568|NCT00720057|4831786|P1|Overall Study|Withdrawal by Subject|0
1465569|NCT00720057|4831785|P2|Overall Study|Protocol Violation|0
1465570|NCT00720057|4831786|P1|Overall Study|Protocol Violation|1
1465571|NCT00720057|4831785|P2|Overall Study|Lost to Follow-up|2
1465572|NCT00720057|4831786|P1|Overall Study|Lost to Follow-up|0
1465573|NCT00719953|4831802|P1|Overall Study|Adverse Event|4
1465574|NCT00719901|4831815|P1|Overall Study|Availability of Study Drug|1
1465575|NCT00719901|4831815|P1|Overall Study|Disease Progression|3
1465576|NCT00719901|4831815|P1|Overall Study|Alternate Treatment|1
1465577|NCT00719901|4831815|P1|Overall Study|Withdrawal by Subject|1
1465578|NCT00719901|4831815|P1|Overall Study|Adverse Event|5
1465579|NCT00719862|4831827|P2|Overall Study|Other|3
1465580|NCT00719862|4831828|P1|Overall Study|Other|2
1465581|NCT00719862|4831827|P2|Overall Study|Lost to Follow-up|1
1465582|NCT00719862|4831828|P1|Overall Study|Lost to Follow-up|0
1465583|NCT00719862|4831827|P2|Overall Study|Withdrawal by Subject|0
1465584|NCT00719862|4831828|P1|Overall Study|Withdrawal by Subject|1
1465585|NCT00719862|4831827|P2|Overall Study|Non-Compliance|0
1465586|NCT00719862|4831828|P1|Overall Study|Non-Compliance|1
1465587|NCT00719862|4831827|P2|Overall Study|Lack of Efficacy|0
1465588|NCT00719862|4831828|P1|Overall Study|Lack of Efficacy|3
1465589|NCT00719862|4831827|P2|Overall Study|Adverse Event|2
1465590|NCT00719862|4831828|P1|Overall Study|Adverse Event|1
1465591|NCT00719849|4831846|P2|Overall Study|Death|1
1465592|NCT00719849|4831847|P1|Overall Study|Death|0
1465593|NCT00719810|4831886|P3|Overall Study|Withdrawal by Subject|2
1465594|NCT00719810|4831887|P2|Overall Study|Withdrawal by Subject|1
1465595|NCT00719810|4831888|P1|Overall Study|Withdrawal by Subject|1
1465596|NCT00719810|4831886|P3|Overall Study|Physician Decision|0
1465597|NCT00719810|4831887|P2|Overall Study|Physician Decision|1
1465598|NCT00719810|4831888|P1|Overall Study|Physician Decision|0
1465599|NCT00719810|4831886|P3|Overall Study|Lost to Follow-up|3
1465600|NCT00719810|4831887|P2|Overall Study|Lost to Follow-up|0
1465601|NCT00719810|4831888|P1|Overall Study|Lost to Follow-up|2
1465602|NCT00719810|4831886|P3|Overall Study|Adverse Event|3
1465603|NCT00719810|4831887|P2|Overall Study|Adverse Event|2
1465604|NCT00719810|4831888|P1|Overall Study|Adverse Event|0
1465605|NCT00719732|4831899|P1|Overall Study|Illness not associated with device|1
1465606|NCT00719732|4831899|P1|Overall Study|Unilateral (not bilateral) implantation|1
1465607|NCT00719732|4831899|P1|Overall Study|Lost to Follow-up|20
1465608|NCT00719706|4831905|P2|Overall Study|Protocol Violation|0
1465609|NCT00719706|4831906|P1|Overall Study|Protocol Violation|3
1465610|NCT00719706|4831905|P2|Overall Study|Withdrawal by Subject|2
1465611|NCT00719706|4831906|P1|Overall Study|Withdrawal by Subject|1
1465612|NCT00719706|4831905|P2|Overall Study|Adverse Event|4
1465613|NCT00719706|4831906|P1|Overall Study|Adverse Event|5
1465614|NCT00719680|4831920|P1|Overall Study|Withdrawal by Subject|3
1465615|NCT00719680|4831920|P1|Overall Study|Lost to Follow-up|1
1465616|NCT00719680|4831920|P1|Overall Study|Adverse Event|1
1465617|NCT00719563|4831976|P2|Overall Study|Lost to Follow-up|3
1465618|NCT00719563|4831977|P1|Overall Study|Lost to Follow-up|5
1465619|NCT00719563|4831976|P2|Overall Study|Noncompliant|1
1465620|NCT00719563|4831977|P1|Overall Study|Noncompliant|1
1465621|NCT00719563|4831976|P2|Overall Study|Unknown reasons|6
1465622|NCT00719563|4831977|P1|Overall Study|Unknown reasons|4
1465623|NCT00719563|4831976|P2|Overall Study|Personal reasons|7
1465624|NCT00719563|4831977|P1|Overall Study|Personal reasons|6
1465625|NCT00719563|4831976|P2|Overall Study|Lack of Efficacy|7
1465626|NCT00719563|4831977|P1|Overall Study|Lack of Efficacy|3
1465627|NCT00719563|4831976|P2|Overall Study|Medical condition changed|5
1465628|NCT00719563|4831977|P1|Overall Study|Medical condition changed|3
1465629|NCT00719563|4831976|P2|Overall Study|Adverse Event|13
1465630|NCT00719563|4831977|P1|Overall Study|Adverse Event|16
1465631|NCT00719537|4832009|P2|Overall Study|Lost to Follow-up|1
1465632|NCT00719537|4832010|P1|Overall Study|Lost to Follow-up|0
1465633|NCT00719537|4832009|P2|Overall Study|Withdrawal by Subject|0
1465634|NCT00719537|4832010|P1|Overall Study|Withdrawal by Subject|1
1465635|NCT00719472|4832016|P1|Received Cycle 2 Treatment|Various Reasons|25
1465636|NCT00719472|4832016|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
1465637|NCT00719472|4832016|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
1465638|NCT00719472|4832016|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
1465639|NCT00719472|4832016|P1|Received Cycle 2 Treatment|Disease progression|3
1465640|NCT00719472|4832016|P1|Received Cycle 2 Treatment|Death|6
1465641|NCT00719472|4832016|P1|Received Cycle 2 Treatment|Adverse Event|12
1465642|NCT00719472|4832016|P1|Received Cycle 1 Treatment|Various Reasons|13
1465643|NCT00719472|4832016|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
1465644|NCT00719472|4832016|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
1465645|NCT00719472|4832016|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
1465646|NCT00719472|4832016|P1|Received Cycle 1 Treatment|Death|5
1465647|NCT00719472|4832016|P1|Received Cycle 1 Treatment|Adverse Event|8
1465648|NCT00719472|4832016|P1|Enrolled in Study|Various Reasons|17
1465649|NCT00719472|4832016|P1|Enrolled in Study|Subject decision to withdraw|8
1465650|NCT00719472|4832016|P1|Enrolled in Study|Physician decision to withdraw patient|1
1465651|NCT00719355|4832027|P2|Overall Study|Moved|1
1465652|NCT00719355|4832028|P1|Overall Study|Moved|0
1465653|NCT00719355|4832027|P2|Overall Study|Compliance|6
1465654|NCT00719355|4832028|P1|Overall Study|Compliance|4
1465655|NCT00719355|4832027|P2|Overall Study|Medical|5
1465656|NCT00719355|4832028|P1|Overall Study|Medical|14
1465657|NCT00719355|4832027|P2|Overall Study|Death|1
1465658|NCT00719355|4832028|P1|Overall Study|Death|0
1465659|NCT00719264|4832057|P2|Overall Study|Disease Progression|107
1465660|NCT00719264|4832058|P1|Overall Study|Disease Progression|104
1465661|NCT00719264|4832057|P2|Overall Study|New Cancer Therapy|2
1465662|NCT00719264|4832058|P1|Overall Study|New Cancer Therapy|4
1465663|NCT00719264|4832057|P2|Overall Study|Protocol Deviation|3
1465664|NCT00719264|4832058|P1|Overall Study|Protocol Deviation|1
1465665|NCT00719264|4832057|P2|Overall Study|Withdrawal by Subject|7
1465666|NCT00719264|4832058|P1|Overall Study|Withdrawal by Subject|12
1465667|NCT00719264|4832057|P2|Overall Study|Lost to Follow-up|1
1465668|NCT00719264|4832058|P1|Overall Study|Lost to Follow-up|1
1465669|NCT00719264|4832057|P2|Overall Study|Administrative Problems|4
1465670|NCT00719264|4832058|P1|Overall Study|Administrative Problems|6
1465671|NCT00719264|4832057|P2|Overall Study|Death|10
1465672|NCT00719264|4832058|P1|Overall Study|Death|13
1465673|NCT00719264|4832057|P2|Overall Study|Adverse Event|49
1465674|NCT00719264|4832058|P1|Overall Study|Adverse Event|41
1465675|NCT00719212|4832077|P1|Overall Study|Withdrawal by Subject|1
1465676|NCT00719212|4832077|P1|Overall Study|Lost to Follow-up|2
1465677|NCT00719212|4832077|P1|Overall Study|Death|41
1465678|NCT00719043|4832125|P7|Overall Study|Withdrawal by Subject|14
1465679|NCT00719043|4832126|P6|Overall Study|Withdrawal by Subject|18
1465680|NCT00719043|4832127|P5|Overall Study|Withdrawal by Subject|16
1465681|NCT00719043|4832128|P4|Overall Study|Withdrawal by Subject|10
1465682|NCT00719043|4832129|P3|Overall Study|Withdrawal by Subject|9
1465683|NCT00719043|4832130|P2|Overall Study|Withdrawal by Subject|14
1465684|NCT00719043|4832131|P1|Overall Study|Withdrawal by Subject|12
1465685|NCT00719043|4832125|P7|Overall Study|Other|1
1465686|NCT00719043|4832126|P6|Overall Study|Other|2
1465687|NCT00719043|4832127|P5|Overall Study|Other|0
1465688|NCT00719043|4832128|P4|Overall Study|Other|2
1465689|NCT00719043|4832129|P3|Overall Study|Other|1
1465690|NCT00719043|4832130|P2|Overall Study|Other|0
1465691|NCT00719043|4832131|P1|Overall Study|Other|1
1465692|NCT00719043|4832125|P7|Overall Study|Protocol Violation|0
1465693|NCT00719043|4832126|P6|Overall Study|Protocol Violation|1
1465694|NCT00719043|4832127|P5|Overall Study|Protocol Violation|0
1465695|NCT00719043|4832128|P4|Overall Study|Protocol Violation|0
1465696|NCT00719043|4832129|P3|Overall Study|Protocol Violation|0
1465697|NCT00719043|4832130|P2|Overall Study|Protocol Violation|0
1465698|NCT00719043|4832131|P1|Overall Study|Protocol Violation|0
1465699|NCT00719043|4832125|P7|Overall Study|Lost to Follow-up|9
1465700|NCT00719043|4832126|P6|Overall Study|Lost to Follow-up|9
1465701|NCT00719043|4832127|P5|Overall Study|Lost to Follow-up|10
1465702|NCT00719043|4832128|P4|Overall Study|Lost to Follow-up|9
1465703|NCT00719043|4832129|P3|Overall Study|Lost to Follow-up|8
1465704|NCT00719043|4832130|P2|Overall Study|Lost to Follow-up|10
1465705|NCT00719043|4832131|P1|Overall Study|Lost to Follow-up|14
1465706|NCT00719043|4832125|P7|Overall Study|Adverse Event|4
1465707|NCT00719043|4832126|P6|Overall Study|Adverse Event|4
1465708|NCT00719043|4832127|P5|Overall Study|Adverse Event|1
1465709|NCT00719043|4832128|P4|Overall Study|Adverse Event|2
1465710|NCT00719043|4832129|P3|Overall Study|Adverse Event|2
1465711|NCT00719043|4832130|P2|Overall Study|Adverse Event|1
1465712|NCT00719043|4832131|P1|Overall Study|Adverse Event|5
1465713|NCT00718887|4832255|P2|Overall Study|Not identified|7
1465714|NCT00718887|4832256|P1|Overall Study|Not identified|2
1465715|NCT00718887|4832255|P2|Overall Study|Withdrawal by Subject|2
1465716|NCT00718887|4832256|P1|Overall Study|Withdrawal by Subject|3
1465717|NCT00718861|4832280|P2|Overall Study|Death|5
1465718|NCT00718861|4832281|P1|Overall Study|Death|1
1465719|NCT00718861|4832280|P2|Overall Study|Administrative Problems|1
1465720|NCT00718861|4832281|P1|Overall Study|Administrative Problems|1
1465721|NCT00718861|4832280|P2|Overall Study|Lost to Follow-up|1
1465722|NCT00718861|4832281|P1|Overall Study|Lost to Follow-up|2
1465723|NCT00718861|4832280|P2|Overall Study|Adverse Event|1
1465724|NCT00718861|4832281|P1|Overall Study|Adverse Event|2
1465725|NCT00718861|4832280|P2|Overall Study|Withdrawal by Subject|10
1465726|NCT00718861|4832281|P1|Overall Study|Withdrawal by Subject|15
1465727|NCT00718809|4832309|P2|Overall Study|Noncompliance|0
1465728|NCT00718809|4832310|P1|Overall Study|Noncompliance|1
1465729|NCT00718809|4832309|P2|Overall Study|Lost to Follow-up|0
1465730|NCT00718809|4832310|P1|Overall Study|Lost to Follow-up|1
1465731|NCT00718809|4832309|P2|Overall Study|Withdrawal by Subject|1
1465732|NCT00718809|4832310|P1|Overall Study|Withdrawal by Subject|0
1465733|NCT00718809|4832309|P2|Overall Study|Adverse Event|1
1465734|NCT00718809|4832310|P1|Overall Study|Adverse Event|1
1465735|NCT00718809|4832309|P2|Overall Study|Disease progression|7
1465736|NCT00718809|4832310|P1|Overall Study|Disease progression|9
1465737|NCT00718770|4832324|P1|Overall Study|Adverse Event|1
1465738|NCT00718770|4832324|P1|Overall Study|Lack of Efficacy|1
1465739|NCT00718770|4832324|P1|Overall Study|Adverse Event|1
1465740|NCT00718770|4832324|P1|Overall Study|Lack of Efficacy|1
1465741|NCT00718770|4832324|P1|Overall Study|Adverse Event|1
1465742|NCT00718770|4832324|P1|Overall Study|Lack of Efficacy|1
1465743|NCT00718770|4832324|P1|Overall Study|Lack of Efficacy|1
1465744|NCT00718770|4832324|P1|Overall Study|Adverse Event|1
1465745|NCT00718718|4832335|P10|Week 12 to End of Study|Other|0
1465746|NCT00718718|4832336|P9|Week 12 to End of Study|Other|0
1465747|NCT00718718|4832337|P8|Week 12 to End of Study|Other|0
1465748|NCT00718718|4832338|P7|Week 12 to End of Study|Other|1
1465749|NCT00718718|4832339|P6|Week 12 to End of Study|Other|0
1465750|NCT00718718|4832340|P5|Week 12 to End of Study|Other|0
1465751|NCT00718718|4832341|P4|Week 12 to End of Study|Other|1
1465752|NCT00718718|4832342|P3|Week 12 to End of Study|Other|0
1465753|NCT00718718|4832343|P2|Week 12 to End of Study|Other|1
1465754|NCT00718718|4832344|P1|Week 12 to End of Study|Other|0
1465755|NCT00718718|4832335|P10|Week 12 to End of Study|Lost to Follow-up|0
1465756|NCT00718718|4832336|P9|Week 12 to End of Study|Lost to Follow-up|1
1465757|NCT00718718|4832337|P8|Week 12 to End of Study|Lost to Follow-up|0
1465758|NCT00718718|4832338|P7|Week 12 to End of Study|Lost to Follow-up|0
1465759|NCT00718718|4832339|P6|Week 12 to End of Study|Lost to Follow-up|0
1465760|NCT00718718|4832340|P5|Week 12 to End of Study|Lost to Follow-up|0
1465761|NCT00718718|4832341|P4|Week 12 to End of Study|Lost to Follow-up|0
1465762|NCT00718718|4832342|P3|Week 12 to End of Study|Lost to Follow-up|0
1465763|NCT00718718|4832343|P2|Week 12 to End of Study|Lost to Follow-up|0
1465764|NCT00718718|4832344|P1|Week 12 to End of Study|Lost to Follow-up|0
1465765|NCT00718718|4832335|P10|Week 12 to End of Study|Withdrawal by Subject|0
1465766|NCT00718718|4832336|P9|Week 12 to End of Study|Withdrawal by Subject|0
1465767|NCT00718718|4832337|P8|Week 12 to End of Study|Withdrawal by Subject|0
1465768|NCT00718718|4832338|P7|Week 12 to End of Study|Withdrawal by Subject|1
1465769|NCT00718718|4832339|P6|Week 12 to End of Study|Withdrawal by Subject|2
1465770|NCT00718718|4832340|P5|Week 12 to End of Study|Withdrawal by Subject|0
1465771|NCT00718718|4832341|P4|Week 12 to End of Study|Withdrawal by Subject|0
1465772|NCT00718718|4832342|P3|Week 12 to End of Study|Withdrawal by Subject|0
1465773|NCT00718718|4832343|P2|Week 12 to End of Study|Withdrawal by Subject|0
1465774|NCT00718718|4832344|P1|Week 12 to End of Study|Withdrawal by Subject|0
1465775|NCT00718718|4832335|P10|Week 12 to End of Study|Death|0
1465776|NCT00718718|4832336|P9|Week 12 to End of Study|Death|0
1465777|NCT00718718|4832337|P8|Week 12 to End of Study|Death|0
1465778|NCT00718718|4832338|P7|Week 12 to End of Study|Death|0
1465779|NCT00718718|4832339|P6|Week 12 to End of Study|Death|1
1465780|NCT00718718|4832340|P5|Week 12 to End of Study|Death|0
1465781|NCT00718718|4832341|P4|Week 12 to End of Study|Death|0
1465782|NCT00718718|4832342|P3|Week 12 to End of Study|Death|0
1465783|NCT00718718|4832343|P2|Week 12 to End of Study|Death|0
1465784|NCT00718718|4832344|P1|Week 12 to End of Study|Death|0
1465785|NCT00718718|4832335|P10|Week 12 to End of Study|Adverse Event|0
1465786|NCT00718718|4832336|P9|Week 12 to End of Study|Adverse Event|0
1465787|NCT00718718|4832337|P8|Week 12 to End of Study|Adverse Event|1
1465788|NCT00718718|4832338|P7|Week 12 to End of Study|Adverse Event|0
1465789|NCT00718718|4832339|P6|Week 12 to End of Study|Adverse Event|0
1465790|NCT00718718|4832340|P5|Week 12 to End of Study|Adverse Event|0
1465791|NCT00718718|4832341|P4|Week 12 to End of Study|Adverse Event|0
1465792|NCT00718718|4832342|P3|Week 12 to End of Study|Adverse Event|0
1465793|NCT00718718|4832343|P2|Week 12 to End of Study|Adverse Event|0
1465794|NCT00718718|4832344|P1|Week 12 to End of Study|Adverse Event|0
1465795|NCT00718718|4832335|P10|Prior to Week 12|Other|0
1465796|NCT00718718|4832336|P9|Prior to Week 12|Other|0
1465797|NCT00718718|4832337|P8|Prior to Week 12|Other|0
1465798|NCT00718718|4832338|P7|Prior to Week 12|Other|0
1465799|NCT00718718|4832339|P6|Prior to Week 12|Other|0
1465800|NCT00718718|4832340|P5|Prior to Week 12|Other|0
1465801|NCT00718718|4832341|P4|Prior to Week 12|Other|0
1465802|NCT00718718|4832342|P3|Prior to Week 12|Other|1
1465803|NCT00718718|4832343|P2|Prior to Week 12|Other|0
1465804|NCT00718718|4832344|P1|Prior to Week 12|Other|1
1465805|NCT00718718|4832335|P10|Prior to Week 12|Withdrawal by Subject|0
1465806|NCT00718718|4832336|P9|Prior to Week 12|Withdrawal by Subject|1
1465807|NCT00718718|4832337|P8|Prior to Week 12|Withdrawal by Subject|1
1465808|NCT00718718|4832338|P7|Prior to Week 12|Withdrawal by Subject|1
1465809|NCT00718718|4832339|P6|Prior to Week 12|Withdrawal by Subject|0
1465810|NCT00718718|4832340|P5|Prior to Week 12|Withdrawal by Subject|3
1465811|NCT00718718|4832341|P4|Prior to Week 12|Withdrawal by Subject|0
1465812|NCT00718718|4832342|P3|Prior to Week 12|Withdrawal by Subject|0
1465813|NCT00718718|4832343|P2|Prior to Week 12|Withdrawal by Subject|0
1465814|NCT00718718|4832344|P1|Prior to Week 12|Withdrawal by Subject|0
1465815|NCT00718718|4832335|P10|Prior to Week 12|Adverse Event|0
1465816|NCT00718718|4832336|P9|Prior to Week 12|Adverse Event|1
1465817|NCT00718718|4832337|P8|Prior to Week 12|Adverse Event|1
1465818|NCT00718718|4832338|P7|Prior to Week 12|Adverse Event|0
1465819|NCT00718718|4832339|P6|Prior to Week 12|Adverse Event|0
1465820|NCT00718718|4832340|P5|Prior to Week 12|Adverse Event|0
1465821|NCT00718718|4832341|P4|Prior to Week 12|Adverse Event|0
1465822|NCT00718718|4832342|P3|Prior to Week 12|Adverse Event|0
1465823|NCT00718718|4832343|P2|Prior to Week 12|Adverse Event|0
1465824|NCT00718718|4832344|P1|Prior to Week 12|Adverse Event|0
1465825|NCT00718666|4832387|P3|Booster Phase Year 5|Lost to Follow-up|4
1465826|NCT00718666|4832388|P2|Booster Phase Year 5|Lost to Follow-up|0
1465827|NCT00718666|4832389|P1|Booster Phase Year 5|Lost to Follow-up|1
1465828|NCT00718666|4832387|P3|Booster Phase Year 5|Withdrawal by Subject|1
1465829|NCT00718666|4832388|P2|Booster Phase Year 5|Withdrawal by Subject|0
1465830|NCT00718666|4832389|P1|Booster Phase Year 5|Withdrawal by Subject|0
1465831|NCT00718666|4832387|P3|Booster Phase Year 5|Declined v-4 serology|0
1465832|NCT00718666|4832388|P2|Booster Phase Year 5|Declined v-4 serology|0
1465833|NCT00718666|4832389|P1|Booster Phase Year 5|Declined v-4 serology|1
1465834|NCT00718666|4832387|P3|Booster Phase Year 5|No active participation request|1
1465835|NCT00718666|4832388|P2|Booster Phase Year 5|No active participation request|0
1465836|NCT00718666|4832389|P1|Booster Phase Year 5|No active participation request|0
1465837|NCT00718640|4832473|P1|Overall Study|Unresolved toxicity after 2 weeks|2
1465838|NCT00718640|4832473|P1|Overall Study|Death|1
1465839|NCT00718640|4832473|P1|Overall Study|Adverse Event|4
1465840|NCT00718549|4832485|P3|Maintenance/ Observation Phase|Relapse|2
1465841|NCT00718549|4832486|P2|Maintenance/ Observation Phase|Relapse|3
1465842|NCT00718549|4832487|P1|Maintenance/ Observation Phase|Relapse|0
1465843|NCT00718549|4832485|P3|Maintenance/ Observation Phase|Progression|14
1465844|NCT00718549|4832486|P2|Maintenance/ Observation Phase|Progression|5
1465845|NCT00718549|4832487|P1|Maintenance/ Observation Phase|Progression|0
1465846|NCT00718549|4832485|P3|Maintenance/ Observation Phase|Lost to Follow-up|4
1465847|NCT00718549|4832486|P2|Maintenance/ Observation Phase|Lost to Follow-up|4
1465848|NCT00718549|4832487|P1|Maintenance/ Observation Phase|Lost to Follow-up|0
1465849|NCT00718549|4832485|P3|Maintenance/ Observation Phase|Death|2
1465850|NCT00718549|4832486|P2|Maintenance/ Observation Phase|Death|1
1465851|NCT00718549|4832487|P1|Maintenance/ Observation Phase|Death|0
1465852|NCT00718549|4832485|P3|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
1465853|NCT00718549|4832486|P2|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
1465854|NCT00718549|4832487|P1|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
1465855|NCT00718549|4832485|P3|Induction Phase|Early Termination - No Additional Info|0
1465856|NCT00718549|4832486|P2|Induction Phase|Early Termination - No Additional Info|0
1465857|NCT00718549|4832487|P1|Induction Phase|Early Termination - No Additional Info|59
1465858|NCT00718549|4832485|P3|Induction Phase|Eligibility Criteria Violation|0
1465859|NCT00718549|4832486|P2|Induction Phase|Eligibility Criteria Violation|0
1465860|NCT00718549|4832487|P1|Induction Phase|Eligibility Criteria Violation|2
1465861|NCT00718549|4832485|P3|Induction Phase|Disease Progression|0
1465862|NCT00718549|4832486|P2|Induction Phase|Disease Progression|0
1465863|NCT00718549|4832487|P1|Induction Phase|Disease Progression|1
1465864|NCT00718523|4832512|P2|Overall Study|Death|17
1465865|NCT00718523|4832513|P1|Overall Study|Death|13
1465866|NCT00718523|4832512|P2|Overall Study|Withdrawal by Subject|7
1465867|NCT00718523|4832513|P1|Overall Study|Withdrawal by Subject|5
1465868|NCT00718510|4832525|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
1465869|NCT00718510|4832526|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
1465870|NCT00718510|4832525|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
1465871|NCT00718510|4832526|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
1465872|NCT00718328|4832538|P2|Overall Study|Lost to Follow-up|0
1465873|NCT00718328|4832539|P1|Overall Study|Lost to Follow-up|1
1465874|NCT00718315|4832548|P3|Overall Study|Use of ATB and Corticoids|2
1465875|NCT00718315|4832549|P2|Overall Study|Use of ATB and Corticoids|1
1465876|NCT00718315|4832550|P1|Overall Study|Use of ATB and Corticoids|0
1465877|NCT00718315|4832548|P3|Overall Study|Other|1
1465878|NCT00718315|4832549|P2|Overall Study|Other|0
1465879|NCT00718315|4832550|P1|Overall Study|Other|0
1465880|NCT00718315|4832548|P3|Overall Study|Disease progression|1
1465881|NCT00718315|4832549|P2|Overall Study|Disease progression|1
1465882|NCT00718315|4832550|P1|Overall Study|Disease progression|0
1465883|NCT00718315|4832548|P3|Overall Study|Use of Minocyclin|1
1465884|NCT00718315|4832549|P2|Overall Study|Use of Minocyclin|1
1465885|NCT00718315|4832550|P1|Overall Study|Use of Minocyclin|1
1465886|NCT00718315|4832548|P3|Overall Study|Erlotinib dose decreased|1
1465887|NCT00718315|4832549|P2|Overall Study|Erlotinib dose decreased|3
1465888|NCT00718315|4832550|P1|Overall Study|Erlotinib dose decreased|4
1465889|NCT00718315|4832548|P3|Overall Study|Protocol Violation|3
1465890|NCT00718315|4832549|P2|Overall Study|Protocol Violation|5
1465891|NCT00718315|4832550|P1|Overall Study|Protocol Violation|5
1465892|NCT00718315|4832548|P3|Overall Study|Lost to Follow-up|4
1465893|NCT00718315|4832549|P2|Overall Study|Lost to Follow-up|3
1465894|NCT00718315|4832550|P1|Overall Study|Lost to Follow-up|2
1465895|NCT00718315|4832548|P3|Overall Study|Death|5
1465896|NCT00718315|4832549|P2|Overall Study|Death|6
1465897|NCT00718315|4832550|P1|Overall Study|Death|6
1465898|NCT00718315|4832548|P3|Overall Study|Adverse Event|3
1465899|NCT00718315|4832549|P2|Overall Study|Adverse Event|2
1465900|NCT00718315|4832550|P1|Overall Study|Adverse Event|1
1465901|NCT00718237|4832601|P2|Overall Study|Withdrawal by Subject|10
1465902|NCT00718237|4832602|P1|Overall Study|Withdrawal by Subject|9
1465903|NCT00718237|4832601|P2|Overall Study|Physician Decision|0
1465904|NCT00718237|4832602|P1|Overall Study|Physician Decision|1
1465905|NCT00718237|4832601|P2|Overall Study|Lost to Follow-up|2
1465906|NCT00718237|4832602|P1|Overall Study|Lost to Follow-up|2
1465907|NCT00718237|4832601|P2|Overall Study|Adverse Event|3
1465908|NCT00718237|4832602|P1|Overall Study|Adverse Event|1
1465909|NCT00718081|4832645|P3|Overall Study|Lack of Efficacy|21
1465910|NCT00718081|4832646|P2|Overall Study|Lack of Efficacy|3
1465911|NCT00718081|4832647|P1|Overall Study|Lack of Efficacy|7
1465912|NCT00718081|4832645|P3|Overall Study|Adverse Event|0
1465913|NCT00718081|4832646|P2|Overall Study|Adverse Event|1
1465914|NCT00718081|4832647|P1|Overall Study|Adverse Event|0
1465915|NCT00718042|4832664|P6|Donor Follow-up|Lost to Follow-up|0
1465916|NCT00718042|4832665|P5|Donor Follow-up|Lost to Follow-up|19
1465917|NCT00718042|4832666|P4|Donor Follow-up|Lost to Follow-up|0
1465918|NCT00718042|4832667|P3|Donor Follow-up|Lost to Follow-up|0
1465919|NCT00718042|4832668|P2|Donor Follow-up|Lost to Follow-up|0
1465920|NCT00718042|4832669|P1|Donor Follow-up|Lost to Follow-up|13
1465921|NCT00718042|4832664|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
1465922|NCT00718042|4832665|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
1465923|NCT00718042|4832666|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
1465924|NCT00718042|4832667|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
1465925|NCT00718042|4832668|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
1465926|NCT00718042|4832669|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
1465927|NCT00718042|4832664|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
1465928|NCT00718042|4832665|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
1465929|NCT00718042|4832666|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
1465930|NCT00718042|4832667|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
1465931|NCT00718042|4832668|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
1465932|NCT00718042|4832669|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
1465933|NCT00718042|4832664|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
1465934|NCT00718042|4832665|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
1465935|NCT00718042|4832666|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
1465936|NCT00718042|4832667|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
1465937|NCT00718042|4832668|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
1465938|NCT00718042|4832669|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
1465939|NCT00718042|4832664|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
1465940|NCT00718042|4832665|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
1465941|NCT00718042|4832666|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
1465942|NCT00718042|4832667|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
1465943|NCT00718042|4832668|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
1465944|NCT00718042|4832669|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
1465945|NCT00717886|4832725|P1|Overall Study|Treatment Failure|1
1465946|NCT00717886|4832725|P1|Overall Study|Withdrawal by Subject|3
1465947|NCT00717860|4832740|P2|Overall Study|Withdrew consent|3
1465948|NCT00717860|4832741|P1|Overall Study|Withdrew consent|7
1465949|NCT00717860|4832740|P2|Overall Study|Discontinued for other reason|1
1465950|NCT00717860|4832741|P1|Overall Study|Discontinued for other reason|6
1465951|NCT00717860|4832740|P2|Overall Study|Lack of Efficacy|13
1465952|NCT00717860|4832741|P1|Overall Study|Lack of Efficacy|7
1465953|NCT00717860|4832740|P2|Overall Study|Laboratory adverse experience|2
1465954|NCT00717860|4832741|P1|Overall Study|Laboratory adverse experience|2
1465955|NCT00717860|4832740|P2|Overall Study|Clinical adverse experience|9
1465956|NCT00717860|4832741|P1|Overall Study|Clinical adverse experience|5
1465957|NCT00717756|4832751|P1|Overall Study|Withdrawal by Subject|1
1465958|NCT00717522|4832764|P1|Overall Study|Death|1
1465959|NCT00717522|4832764|P1|Overall Study|Adverse Event|1
1465960|NCT00717522|4832764|P1|Overall Study|Disease Progression|5
1465961|NCT00717366|4832800|P2|Extension Period (52 Weeks)|Withdrew consent|1
1465962|NCT00717366|4832801|P1|Extension Period (52 Weeks)|Withdrew consent|1
1465963|NCT00717366|4832800|P2|Extension Period (52 Weeks)|Admin/Other than specified|2
1465964|NCT00717366|4832801|P1|Extension Period (52 Weeks)|Admin/Other than specified|0
1465965|NCT00717366|4832800|P2|Extension Period (52 Weeks)|Renal transplant|13
1465966|NCT00717366|4832801|P1|Extension Period (52 Weeks)|Renal transplant|3
1465967|NCT00717366|4832800|P2|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
1465968|NCT00717366|4832801|P1|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
1465969|NCT00717366|4832800|P2|Core Study Period (20 Weeks)|Death|1
1465970|NCT00717366|4832801|P1|Core Study Period (20 Weeks)|Death|0
1465971|NCT00717366|4832800|P2|Core Study Period (20 Weeks)|Admin/Other than specified|2
1465972|NCT00717366|4832801|P1|Core Study Period (20 Weeks)|Admin/Other than specified|0
1465973|NCT00717366|4832800|P2|Core Study Period (20 Weeks)|Renal transplant|9
1465974|NCT00717366|4832801|P1|Core Study Period (20 Weeks)|Renal transplant|4
1465975|NCT00717314|4832825|P2|Overall Study|Withdrawal by Subject|3
1465976|NCT00717314|4832826|P1|Overall Study|Withdrawal by Subject|1
1465977|NCT00717314|4832825|P2|Overall Study|Lost to Follow-up|5
1465978|NCT00717314|4832826|P1|Overall Study|Lost to Follow-up|1
1465979|NCT00717314|4832825|P2|Overall Study|Protocol Violation|0
1465980|NCT00717314|4832826|P1|Overall Study|Protocol Violation|1
1465981|NCT00717314|4832825|P2|Overall Study|Adverse Event|2
1465982|NCT00717314|4832826|P1|Overall Study|Adverse Event|3
1465983|NCT00717275|4832863|P1|Overall Study|Premature study termination.|3
1465984|NCT00717249|4832869|P2|Overall Study|Headaches|0
1465985|NCT00717249|4832870|P1|Overall Study|Headaches|1
1465986|NCT00717249|4832869|P2|Overall Study|Subject relocated|0
1465987|NCT00717249|4832870|P1|Overall Study|Subject relocated|1
1465988|NCT00717249|4832869|P2|Overall Study|Diagnosed with Multiple Scletosis|0
1465989|NCT00717249|4832870|P1|Overall Study|Diagnosed with Multiple Scletosis|1
1465990|NCT00717249|4832869|P2|Overall Study|Diagnosed with Diabetes|0
1465991|NCT00717249|4832870|P1|Overall Study|Diagnosed with Diabetes|1
1465992|NCT00717249|4832869|P2|Overall Study|Gastric Surgery|1
1465993|NCT00717249|4832870|P1|Overall Study|Gastric Surgery|0
1465994|NCT00717249|4832869|P2|Overall Study|Unsatisfactory Physiological Response|1
1465995|NCT00717249|4832870|P1|Overall Study|Unsatisfactory Physiological Response|0
1465996|NCT00717249|4832869|P2|Overall Study|Subject became Ineligible|1
1465997|NCT00717249|4832870|P1|Overall Study|Subject became Ineligible|1
1465998|NCT00717249|4832869|P2|Overall Study|Protocol Violation|2
1465999|NCT00717249|4832870|P1|Overall Study|Protocol Violation|0
1466000|NCT00717249|4832869|P2|Overall Study|Pregnancy|3
1466001|NCT00717249|4832870|P1|Overall Study|Pregnancy|6
1466002|NCT00717249|4832869|P2|Overall Study|Withdrawal by Subject|2
1466003|NCT00717249|4832870|P1|Overall Study|Withdrawal by Subject|1
1466004|NCT00717249|4832869|P2|Overall Study|Lost to Follow-up|0
1466005|NCT00717249|4832870|P1|Overall Study|Lost to Follow-up|2
1466006|NCT00717249|4832869|P2|Overall Study|Adverse Event|2
1466007|NCT00717249|4832870|P1|Overall Study|Adverse Event|4
1466008|NCT00717249|4832869|P2|Overall Study|Unsatisfactory visual Response|2
1466009|NCT00717249|4832870|P1|Overall Study|Unsatisfactory visual Response|0
1466010|NCT00717249|4832869|P2|Overall Study|Lens Discomfort|1
1466011|NCT00717249|4832870|P1|Overall Study|Lens Discomfort|4
1466012|NCT00717236|4832884|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
1466013|NCT00717236|4832885|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
1466014|NCT00717236|4832884|P2|Open-Label Period|Other: Completion Accidently Performed|0
1466015|NCT00717236|4832885|P1|Open-Label Period|Other: Completion Accidently Performed|1
1466016|NCT00717236|4832884|P2|Open-Label Period|Other: Administration of Golimumab|0
1466017|NCT00717236|4832885|P1|Open-Label Period|Other: Administration of Golimumab|1
1466018|NCT00717236|4832884|P2|Open-Label Period|Other: Cataract Surgery|0
1466019|NCT00717236|4832885|P1|Open-Label Period|Other: Cataract Surgery|1
1466020|NCT00717236|4832884|P2|Open-Label Period|Other: Sponsor Request|0
1466021|NCT00717236|4832885|P1|Open-Label Period|Other: Sponsor Request|3
1466022|NCT00717236|4832884|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
1466023|NCT00717236|4832885|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
1466024|NCT00717236|4832884|P2|Open-Label Period|Other: Investigator Decision|0
1466025|NCT00717236|4832885|P1|Open-Label Period|Other: Investigator Decision|1
1466026|NCT00717236|4832884|P2|Open-Label Period|Other: Moved|0
1466027|NCT00717236|4832885|P1|Open-Label Period|Other: Moved|1
1466028|NCT00717236|4832884|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
1466029|NCT00717236|4832885|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
1466030|NCT00717236|4832884|P2|Open-Label Period|Other: Lack of Compliance|1
1466031|NCT00717236|4832885|P1|Open-Label Period|Other: Lack of Compliance|1
1466032|NCT00717236|4832884|P2|Open-Label Period|Other: Peripheral Neuropathy|1
1466033|NCT00717236|4832885|P1|Open-Label Period|Other: Peripheral Neuropathy|0
1466034|NCT00717236|4832884|P2|Open-Label Period|Loss of Efficacy|1
1466035|NCT00717236|4832885|P1|Open-Label Period|Loss of Efficacy|6
1466036|NCT00717236|4832884|P2|Open-Label Period|Withdrawal by Subject|2
1466037|NCT00717236|4832885|P1|Open-Label Period|Withdrawal by Subject|20
1466038|NCT00717236|4832884|P2|Open-Label Period|Lost to Follow-up|4
1466039|NCT00717236|4832885|P1|Open-Label Period|Lost to Follow-up|28
1466040|NCT00717236|4832884|P2|Open-Label Period|Lack of Efficacy|8
1466041|NCT00717236|4832885|P1|Open-Label Period|Lack of Efficacy|30
1466042|NCT00717236|4832884|P2|Open-Label Period|Adverse Event|4
1466043|NCT00717236|4832885|P1|Open-Label Period|Adverse Event|29
1466044|NCT00717236|4832884|P2|Double-Blind Period|Other: Investigator Decision|1
1466045|NCT00717236|4832885|P1|Double-Blind Period|Other: Investigator Decision|0
1466046|NCT00717236|4832884|P2|Double-Blind Period|Other: Transportation problems|1
1466047|NCT00717236|4832885|P1|Double-Blind Period|Other: Transportation problems|0
1466048|NCT00717236|4832884|P2|Double-Blind Period|Other: Prohibited medication taken|2
1466049|NCT00717236|4832885|P1|Double-Blind Period|Other: Prohibited medication taken|2
1466050|NCT00717236|4832884|P2|Double-Blind Period|Other: Stopped taking DMARD|0
1466051|NCT00717236|4832885|P1|Double-Blind Period|Other: Stopped taking DMARD|1
1466052|NCT00717236|4832884|P2|Double-Blind Period|Other: Subject moved|1
1466053|NCT00717236|4832885|P1|Double-Blind Period|Other: Subject moved|1
1466054|NCT00717236|4832884|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
1466055|NCT00717236|4832885|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
1466056|NCT00717236|4832884|P2|Double-Blind Period|Other: Inappropriate randomization|0
1466057|NCT00717236|4832885|P1|Double-Blind Period|Other: Inappropriate randomization|1
1466058|NCT00717236|4832884|P2|Double-Blind Period|Other: Sponsor request|0
1466059|NCT00717236|4832885|P1|Double-Blind Period|Other: Sponsor request|1
1466060|NCT00717236|4832884|P2|Double-Blind Period|Other: History of cancer|0
1466061|NCT00717236|4832885|P1|Double-Blind Period|Other: History of cancer|1
1466062|NCT00717236|4832884|P2|Double-Blind Period|Other: History of adenoid grown|0
1466063|NCT00717236|4832885|P1|Double-Blind Period|Other: History of adenoid grown|1
1466064|NCT00717236|4832884|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
1466065|NCT00717236|4832885|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
1466066|NCT00717236|4832884|P2|Double-Blind Period|Other: subject withdrew consent|1
1466067|NCT00717236|4832885|P1|Double-Blind Period|Other: subject withdrew consent|1
1466068|NCT00717236|4832884|P2|Double-Blind Period|Other: Screening failure|0
1466069|NCT00717236|4832885|P1|Double-Blind Period|Other: Screening failure|1
1466070|NCT00717236|4832884|P2|Double-Blind Period|Other: Site withdrew|0
1466071|NCT00717236|4832885|P1|Double-Blind Period|Other: Site withdrew|2
1466072|NCT00717236|4832884|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
1466073|NCT00717236|4832885|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
1466074|NCT00717236|4832884|P2|Double-Blind Period|Other: Protocol Violation|0
1466075|NCT00717236|4832885|P1|Double-Blind Period|Other: Protocol Violation|2
1466076|NCT00717236|4832884|P2|Double-Blind Period|Other: Pregnancy|0
1466077|NCT00717236|4832885|P1|Double-Blind Period|Other: Pregnancy|1
1466078|NCT00717236|4832884|P2|Double-Blind Period|Other: Death|0
1466079|NCT00717236|4832885|P1|Double-Blind Period|Other: Death|1
1466080|NCT00717236|4832884|P2|Double-Blind Period|Loss of efficacy|0
1466081|NCT00717236|4832885|P1|Double-Blind Period|Loss of efficacy|3
1466082|NCT00717236|4832884|P2|Double-Blind Period|Withdrawal by Subject|2
1466083|NCT00717236|4832885|P1|Double-Blind Period|Withdrawal by Subject|10
1466084|NCT00717236|4832884|P2|Double-Blind Period|Lost to Follow-up|5
1466085|NCT00717236|4832885|P1|Double-Blind Period|Lost to Follow-up|3
1466086|NCT00717236|4832884|P2|Double-Blind Period|Lack of Efficacy|6
1466087|NCT00717236|4832885|P1|Double-Blind Period|Lack of Efficacy|6
1466088|NCT00717236|4832884|P2|Double-Blind Period|Adverse Event|6
1466089|NCT00717236|4832885|P1|Double-Blind Period|Adverse Event|33
1466090|NCT00717197|4832954|P1|Overall Study|Physician Decision|1
1466091|NCT00717197|4832954|P1|Overall Study|Tumor Progression|1
1466092|NCT00717197|4832954|P1|Overall Study|Unable to purchase study drug|5
1466093|NCT00717093|4832960|P2|Overall Study|Randomized but not treated|0
1466094|NCT00717093|4832961|P1|Overall Study|Randomized but not treated|1
1466095|NCT00717093|4832960|P2|Overall Study|Other|1
1466096|NCT00717093|4832961|P1|Overall Study|Other|0
1466097|NCT00717093|4832960|P2|Overall Study|Withdrawal by Subject|19
1466098|NCT00717093|4832961|P1|Overall Study|Withdrawal by Subject|12
1466099|NCT00717093|4832960|P2|Overall Study|Lost to Follow-up|6
1466100|NCT00717093|4832961|P1|Overall Study|Lost to Follow-up|9
1466101|NCT00717093|4832960|P2|Overall Study|Lack of Efficacy|13
1466102|NCT00717093|4832961|P1|Overall Study|Lack of Efficacy|3
1466103|NCT00717093|4832960|P2|Overall Study|Adverse Event|9
1466104|NCT00717093|4832961|P1|Overall Study|Adverse Event|19
1466105|NCT00717067|4832978|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
1466106|NCT00717067|4832979|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
1466107|NCT00717067|4832980|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
1466108|NCT00717067|4832981|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
1466109|NCT00717067|4832982|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
1466110|NCT00716976|4833089|P2|Overall Study|Ineligibles|2
1466111|NCT00716976|4833090|P1|Overall Study|Ineligibles|4
1466112|NCT00716976|4833089|P2|Overall Study|Radiation during protocol|0
1466113|NCT00716976|4833090|P1|Overall Study|Radiation during protocol|1
1466114|NCT00716976|4833089|P2|Overall Study|Premature discontinuation cisplatin|4
1466115|NCT00716976|4833090|P1|Overall Study|Premature discontinuation cisplatin|5
1466116|NCT00716976|4833089|P2|Overall Study|Withdrawal by Subject|1
1466117|NCT00716976|4833090|P1|Overall Study|Withdrawal by Subject|5
1466118|NCT00716976|4833089|P2|Overall Study|Physician Decision|2
1466119|NCT00716976|4833090|P1|Overall Study|Physician Decision|2
1466120|NCT00716976|4833089|P2|Overall Study|Death|0
1466121|NCT00716976|4833090|P1|Overall Study|Death|1
1466122|NCT00716976|4833089|P2|Overall Study|Adverse Event|0
1466123|NCT00716976|4833090|P1|Overall Study|Adverse Event|2
1466124|NCT00716859|4833128|P2|Overall Study|Not treated|1
1466125|NCT00716859|4833129|P1|Overall Study|Not treated|1
1466126|NCT00716859|4833128|P2|Overall Study|Withdrawal by Subject|3
1466127|NCT00716859|4833129|P1|Overall Study|Withdrawal by Subject|1
1466128|NCT00716859|4833128|P2|Overall Study|Lack of Efficacy|0
1466129|NCT00716859|4833129|P1|Overall Study|Lack of Efficacy|3
1466130|NCT00716859|4833128|P2|Overall Study|Adverse Event|1
1466131|NCT00716859|4833129|P1|Overall Study|Adverse Event|4
1466132|NCT00716625|4833214|P1|Overall Study|Safety was not Assessable|1
1466133|NCT00716482|4833239|P1|Overall Study|inclusion/exclusion criteria not met|25
1466134|NCT00716482|4833239|P1|Overall Study|technical/machine error|28
1466135|NCT00716482|4833239|P1|Overall Study|no pathology obtained|10
1466136|NCT00716482|4833239|P1|Overall Study|Inadequate acquisition or analysis|50
1466137|NCT00716482|4833239|P1|Overall Study|Lost to Follow-up|6
1466138|NCT00716456|4833252|P3|Overall Study|Adverse Event|0
1466139|NCT00716456|4833253|P2|Overall Study|Adverse Event|2
1466140|NCT00716456|4833254|P1|Overall Study|Adverse Event|0
1466141|NCT00716417|4833305|P10|Overall Study|On patient request due to toxicities|0
1466142|NCT00716417|4833306|P9|Overall Study|On patient request due to toxicities|0
1466143|NCT00716417|4833307|P8|Overall Study|On patient request due to toxicities|1
1466144|NCT00716417|4833308|P7|Overall Study|On patient request due to toxicities|0
1466145|NCT00716417|4833309|P6|Overall Study|On patient request due to toxicities|0
1466146|NCT00716417|4833310|P5|Overall Study|On patient request due to toxicities|0
1466147|NCT00716417|4833311|P4|Overall Study|On patient request due to toxicities|0
1466148|NCT00716417|4833312|P3|Overall Study|On patient request due to toxicities|0
1466149|NCT00716417|4833313|P2|Overall Study|On patient request due to toxicities|0
1466150|NCT00716417|4833314|P1|Overall Study|On patient request due to toxicities|0
1466151|NCT00716417|4833305|P10|Overall Study|Dose limiting toxicity (DLT)|0
1466152|NCT00716417|4833306|P9|Overall Study|Dose limiting toxicity (DLT)|0
1466153|NCT00716417|4833307|P8|Overall Study|Dose limiting toxicity (DLT)|0
1466154|NCT00716417|4833308|P7|Overall Study|Dose limiting toxicity (DLT)|0
1466155|NCT00716417|4833309|P6|Overall Study|Dose limiting toxicity (DLT)|0
1466156|NCT00716417|4833310|P5|Overall Study|Dose limiting toxicity (DLT)|1
1466157|NCT00716417|4833311|P4|Overall Study|Dose limiting toxicity (DLT)|0
1466158|NCT00716417|4833312|P3|Overall Study|Dose limiting toxicity (DLT)|0
1466159|NCT00716417|4833313|P2|Overall Study|Dose limiting toxicity (DLT)|0
1466160|NCT00716417|4833314|P1|Overall Study|Dose limiting toxicity (DLT)|0
1466161|NCT00716417|4833305|P10|Overall Study|Progressive disease|0
1466162|NCT00716417|4833306|P9|Overall Study|Progressive disease|5
1466163|NCT00716417|4833307|P8|Overall Study|Progressive disease|1
1466164|NCT00716417|4833308|P7|Overall Study|Progressive disease|3
1466165|NCT00716417|4833309|P6|Overall Study|Progressive disease|3
1466166|NCT00716417|4833310|P5|Overall Study|Progressive disease|0
1466167|NCT00716417|4833311|P4|Overall Study|Progressive disease|8
1466168|NCT00716417|4833312|P3|Overall Study|Progressive disease|3
1466169|NCT00716417|4833313|P2|Overall Study|Progressive disease|5
1466170|NCT00716417|4833314|P1|Overall Study|Progressive disease|3
1466171|NCT00716417|4833305|P10|Overall Study|Withdrawal by Subject|0
1466172|NCT00716417|4833306|P9|Overall Study|Withdrawal by Subject|0
1466173|NCT00716417|4833307|P8|Overall Study|Withdrawal by Subject|0
1466174|NCT00716417|4833308|P7|Overall Study|Withdrawal by Subject|1
1466175|NCT00716417|4833309|P6|Overall Study|Withdrawal by Subject|0
1466176|NCT00716417|4833310|P5|Overall Study|Withdrawal by Subject|0
1466177|NCT00716417|4833311|P4|Overall Study|Withdrawal by Subject|2
1466178|NCT00716417|4833312|P3|Overall Study|Withdrawal by Subject|0
1466179|NCT00716417|4833313|P2|Overall Study|Withdrawal by Subject|1
1466180|NCT00716417|4833314|P1|Overall Study|Withdrawal by Subject|0
1466181|NCT00716417|4833305|P10|Overall Study|Adverse Event|3
1466182|NCT00716417|4833306|P9|Overall Study|Adverse Event|0
1466183|NCT00716417|4833307|P8|Overall Study|Adverse Event|1
1466184|NCT00716417|4833308|P7|Overall Study|Adverse Event|3
1466185|NCT00716417|4833309|P6|Overall Study|Adverse Event|0
1466186|NCT00716417|4833310|P5|Overall Study|Adverse Event|0
1466187|NCT00716417|4833311|P4|Overall Study|Adverse Event|1
1466188|NCT00716417|4833312|P3|Overall Study|Adverse Event|2
1466189|NCT00716417|4833313|P2|Overall Study|Adverse Event|0
1466190|NCT00716417|4833314|P1|Overall Study|Adverse Event|0
1466191|NCT00716274|4833361|P6|Study Period III (16-Weeks)|Adverse Event|0
1466192|NCT00716274|4833362|P5|Study Period III (16-Weeks)|Adverse Event|1
1466193|NCT00716274|4833363|P4|Study Period III (16-Weeks)|Adverse Event|0
1466194|NCT00716274|4833364|P3|Study Period III (16-Weeks)|Adverse Event|0
1466195|NCT00716274|4833365|P2|Study Period III (16-Weeks)|Adverse Event|0
1466196|NCT00716274|4833366|P1|Study Period III (16-Weeks)|Adverse Event|0
1466197|NCT00716274|4833361|P6|Study Period III (16-Weeks)|Parent Caregiver Decision|0
1466198|NCT00716274|4833362|P5|Study Period III (16-Weeks)|Parent Caregiver Decision|1
1466199|NCT00716274|4833363|P4|Study Period III (16-Weeks)|Parent Caregiver Decision|1
1466200|NCT00716274|4833364|P3|Study Period III (16-Weeks)|Parent Caregiver Decision|0
1466201|NCT00716274|4833365|P2|Study Period III (16-Weeks)|Parent Caregiver Decision|0
1466202|NCT00716274|4833366|P1|Study Period III (16-Weeks)|Parent Caregiver Decision|0
1466203|NCT00716274|4833361|P6|Study Period III (16-Weeks)|Physician Decision|0
1466204|NCT00716274|4833362|P5|Study Period III (16-Weeks)|Physician Decision|1
1466205|NCT00716274|4833363|P4|Study Period III (16-Weeks)|Physician Decision|0
1466206|NCT00716274|4833364|P3|Study Period III (16-Weeks)|Physician Decision|0
1466207|NCT00716274|4833365|P2|Study Period III (16-Weeks)|Physician Decision|0
1466208|NCT00716274|4833366|P1|Study Period III (16-Weeks)|Physician Decision|0
1466209|NCT00716274|4833361|P6|Study Period III (16-Weeks)|Withdrawal by Subject|0
1466210|NCT00716274|4833362|P5|Study Period III (16-Weeks)|Withdrawal by Subject|0
1466211|NCT00716274|4833363|P4|Study Period III (16-Weeks)|Withdrawal by Subject|0
1466212|NCT00716274|4833364|P3|Study Period III (16-Weeks)|Withdrawal by Subject|2
1466213|NCT00716274|4833365|P2|Study Period III (16-Weeks)|Withdrawal by Subject|0
1466214|NCT00716274|4833366|P1|Study Period III (16-Weeks)|Withdrawal by Subject|0
1466215|NCT00716274|4833361|P6|Study Period II (16-Weeks)|Lost to Follow-up|0
1466216|NCT00716274|4833362|P5|Study Period II (16-Weeks)|Lost to Follow-up|0
1466217|NCT00716274|4833363|P4|Study Period II (16-Weeks)|Lost to Follow-up|0
1466218|NCT00716274|4833364|P3|Study Period II (16-Weeks)|Lost to Follow-up|0
1466219|NCT00716274|4833365|P2|Study Period II (16-Weeks)|Lost to Follow-up|2
1466220|NCT00716274|4833366|P1|Study Period II (16-Weeks)|Lost to Follow-up|0
1466221|NCT00716274|4833361|P6|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
1466222|NCT00716274|4833362|P5|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
1466223|NCT00716274|4833363|P4|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
1466224|NCT00716274|4833364|P3|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
1466225|NCT00716274|4833365|P2|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
1466226|NCT00716274|4833366|P1|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
1466227|NCT00716274|4833361|P6|Study Period II (16-Weeks)|Physician Decision|1
1466228|NCT00716274|4833362|P5|Study Period II (16-Weeks)|Physician Decision|0
1466229|NCT00716274|4833363|P4|Study Period II (16-Weeks)|Physician Decision|0
1466230|NCT00716274|4833364|P3|Study Period II (16-Weeks)|Physician Decision|0
1466231|NCT00716274|4833365|P2|Study Period II (16-Weeks)|Physician Decision|1
1466232|NCT00716274|4833366|P1|Study Period II (16-Weeks)|Physician Decision|3
1466233|NCT00716274|4833361|P6|Study Period II (16-Weeks)|Withdrawal by Subject|0
1466234|NCT00716274|4833362|P5|Study Period II (16-Weeks)|Withdrawal by Subject|0
1466235|NCT00716274|4833363|P4|Study Period II (16-Weeks)|Withdrawal by Subject|0
1466236|NCT00716274|4833364|P3|Study Period II (16-Weeks)|Withdrawal by Subject|0
1466237|NCT00716274|4833365|P2|Study Period II (16-Weeks)|Withdrawal by Subject|0
1466238|NCT00716274|4833366|P1|Study Period II (16-Weeks)|Withdrawal by Subject|1
1466239|NCT00716274|4833361|P6|Study Period II (16-Weeks)|Protocol Violation|1
1466240|NCT00716274|4833362|P5|Study Period II (16-Weeks)|Protocol Violation|0
1466241|NCT00716274|4833363|P4|Study Period II (16-Weeks)|Protocol Violation|0
1466242|NCT00716274|4833364|P3|Study Period II (16-Weeks)|Protocol Violation|0
1466243|NCT00716274|4833365|P2|Study Period II (16-Weeks)|Protocol Violation|3
1466244|NCT00716274|4833366|P1|Study Period II (16-Weeks)|Protocol Violation|0
1466245|NCT00716274|4833361|P6|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1466246|NCT00716274|4833362|P5|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1466247|NCT00716274|4833363|P4|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1466248|NCT00716274|4833364|P3|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1466249|NCT00716274|4833365|P2|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1466250|NCT00716274|4833366|P1|Study Period II (16-Weeks)|Entry Criteria Not Met|2
1466251|NCT00716144|4833500|P4|Overall Study|Clinical Depression|0
1466252|NCT00716144|4833501|P3|Overall Study|Clinical Depression|0
1466253|NCT00716144|4833502|P2|Overall Study|Clinical Depression|1
1466254|NCT00716144|4833503|P1|Overall Study|Clinical Depression|0
1466255|NCT00716144|4833500|P4|Overall Study|Adverse event: left foot pain|0
1466256|NCT00716144|4833501|P3|Overall Study|Adverse event: left foot pain|0
1466257|NCT00716144|4833502|P2|Overall Study|Adverse event: left foot pain|1
1466258|NCT00716144|4833503|P1|Overall Study|Adverse event: left foot pain|0
1466259|NCT00716144|4833500|P4|Overall Study|Withdrew consent, allowed use of data|0
1466260|NCT00716144|4833501|P3|Overall Study|Withdrew consent, allowed use of data|1
1466261|NCT00716144|4833502|P2|Overall Study|Withdrew consent, allowed use of data|0
1466262|NCT00716144|4833503|P1|Overall Study|Withdrew consent, allowed use of data|0
1466263|NCT00716144|4833500|P4|Overall Study|Intercurrent illness|0
1466264|NCT00716144|4833501|P3|Overall Study|Intercurrent illness|1
1466265|NCT00716144|4833502|P2|Overall Study|Intercurrent illness|0
1466266|NCT00716144|4833503|P1|Overall Study|Intercurrent illness|0
1466267|NCT00716144|4833500|P4|Overall Study|Physician Decision|2
1466268|NCT00716144|4833501|P3|Overall Study|Physician Decision|2
1466269|NCT00716144|4833502|P2|Overall Study|Physician Decision|1
1466270|NCT00716144|4833503|P1|Overall Study|Physician Decision|0
1466271|NCT00716144|4833500|P4|Overall Study|Protocol Violation|0
1466272|NCT00716144|4833501|P3|Overall Study|Protocol Violation|1
1466273|NCT00716144|4833502|P2|Overall Study|Protocol Violation|0
1466274|NCT00716144|4833503|P1|Overall Study|Protocol Violation|2
1466275|NCT00716144|4833500|P4|Overall Study|Non-compliance|0
1466276|NCT00716144|4833501|P3|Overall Study|Non-compliance|0
1466277|NCT00716144|4833502|P2|Overall Study|Non-compliance|0
1466278|NCT00716144|4833503|P1|Overall Study|Non-compliance|1
1466279|NCT00716144|4833500|P4|Overall Study|Adverse Event|2
1466280|NCT00716144|4833501|P3|Overall Study|Adverse Event|0
1466281|NCT00716144|4833502|P2|Overall Study|Adverse Event|0
1466282|NCT00716144|4833503|P1|Overall Study|Adverse Event|0
1466283|NCT00716144|4833500|P4|Overall Study|Lost to Follow-up|2
1466284|NCT00716144|4833501|P3|Overall Study|Lost to Follow-up|1
1466285|NCT00716144|4833502|P2|Overall Study|Lost to Follow-up|2
1466286|NCT00716144|4833503|P1|Overall Study|Lost to Follow-up|2
1466287|NCT00716144|4833500|P4|Overall Study|Withdrawal by Subject|6
1466288|NCT00716144|4833501|P3|Overall Study|Withdrawal by Subject|6
1466289|NCT00716144|4833502|P2|Overall Study|Withdrawal by Subject|2
1466290|NCT00716144|4833503|P1|Overall Study|Withdrawal by Subject|4
1466291|NCT00716092|4833528|P3|Overall Study|Other incl. Lack of Efficacy|0
1466292|NCT00716092|4833529|P2|Overall Study|Other incl. Lack of Efficacy|1
1466293|NCT00716092|4833530|P1|Overall Study|Other incl. Lack of Efficacy|2
1466294|NCT00715949|4833583|P1|Overall Study|could not finish first test|4
1466295|NCT00715910|4833591|P6|Booster and ESFU Phase|Other|0
1466296|NCT00715910|4833592|P5|Booster and ESFU Phase|Other|1
1466297|NCT00715910|4833593|P4|Booster and ESFU Phase|Other|5
1466298|NCT00715910|4833594|P3|Booster and ESFU Phase|Other|0
1466299|NCT00715910|4833595|P2|Booster and ESFU Phase|Other|0
1466300|NCT00715910|4833596|P1|Booster and ESFU Phase|Other|0
1466301|NCT00715910|4833591|P6|Booster and ESFU Phase|Lost to Follow-up|13
1466302|NCT00715910|4833592|P5|Booster and ESFU Phase|Lost to Follow-up|1
1466303|NCT00715910|4833593|P4|Booster and ESFU Phase|Lost to Follow-up|6
1466304|NCT00715910|4833594|P3|Booster and ESFU Phase|Lost to Follow-up|0
1466305|NCT00715910|4833595|P2|Booster and ESFU Phase|Lost to Follow-up|0
1466306|NCT00715910|4833596|P1|Booster and ESFU Phase|Lost to Follow-up|0
1466307|NCT00715793|4833715|P2|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
1466308|NCT00715793|4833716|P1|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
1466309|NCT00715793|4833715|P2|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
1466310|NCT00715793|4833716|P1|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
1466311|NCT00715676|4833777|P3|Overall Study|Elevated Blood Glucose|0
1466312|NCT00715676|4833778|P2|Overall Study|Elevated Blood Glucose|1
1466313|NCT00715676|4833779|P1|Overall Study|Elevated Blood Glucose|0
1466314|NCT00715676|4833777|P3|Overall Study|Use of Exclusionary Medication|1
1466315|NCT00715676|4833778|P2|Overall Study|Use of Exclusionary Medication|0
1466316|NCT00715676|4833779|P1|Overall Study|Use of Exclusionary Medication|0
1466317|NCT00715676|4833777|P3|Overall Study|Did Not Meet Entry Criteria|1
1466318|NCT00715676|4833778|P2|Overall Study|Did Not Meet Entry Criteria|0
1466319|NCT00715676|4833779|P1|Overall Study|Did Not Meet Entry Criteria|0
1466320|NCT00715676|4833777|P3|Overall Study|Terminated by Sponsor|0
1466321|NCT00715676|4833778|P2|Overall Study|Terminated by Sponsor|0
1466322|NCT00715676|4833779|P1|Overall Study|Terminated by Sponsor|1
1466323|NCT00715676|4833777|P3|Overall Study|Lost to Follow-up|1
1466324|NCT00715676|4833778|P2|Overall Study|Lost to Follow-up|2
1466325|NCT00715676|4833779|P1|Overall Study|Lost to Follow-up|1
1466326|NCT00715676|4833777|P3|Overall Study|Withdrawal by Subject|8
1466327|NCT00715676|4833778|P2|Overall Study|Withdrawal by Subject|3
1466328|NCT00715676|4833779|P1|Overall Study|Withdrawal by Subject|1
1466329|NCT00715676|4833777|P3|Overall Study|Adverse Event|21
1466330|NCT00715676|4833778|P2|Overall Study|Adverse Event|5
1466331|NCT00715676|4833779|P1|Overall Study|Adverse Event|3
1466332|NCT00715624|4833822|P2|Overall Study|Other|1
1466333|NCT00715624|4833823|P1|Overall Study|Other|0
1466334|NCT00715624|4833822|P2|Overall Study|Incorrect randomization (not treated)|1
1466335|NCT00715624|4833823|P1|Overall Study|Incorrect randomization (not treated)|0
1466336|NCT00715624|4833822|P2|Overall Study|Sponsor decision|4
1466337|NCT00715624|4833823|P1|Overall Study|Sponsor decision|0
1466338|NCT00715624|4833822|P2|Overall Study|Poor compliance|13
1466339|NCT00715624|4833823|P1|Overall Study|Poor compliance|6
1466340|NCT00715624|4833822|P2|Overall Study|Familial and personal reasons|22
1466341|NCT00715624|4833823|P1|Overall Study|Familial and personal reasons|10
1466342|NCT00715624|4833822|P2|Overall Study|Withdrawal by Subject|25
1466343|NCT00715624|4833823|P1|Overall Study|Withdrawal by Subject|11
1466344|NCT00715624|4833822|P2|Overall Study|Protocol Violation|0
1466345|NCT00715624|4833823|P1|Overall Study|Protocol Violation|1
1466346|NCT00715624|4833822|P2|Overall Study|Lost to Follow-up|2
1466347|NCT00715624|4833823|P1|Overall Study|Lost to Follow-up|1
1466348|NCT00715624|4833822|P2|Overall Study|Lack of Efficacy|11
1466349|NCT00715624|4833823|P1|Overall Study|Lack of Efficacy|11
1466350|NCT00715624|4833822|P2|Overall Study|Adverse Event|37
1466351|NCT00715624|4833823|P1|Overall Study|Adverse Event|12
1466352|NCT00715559|4833851|P1|Overall Study|medication not tolerated - nausea|1
1466353|NCT00715520|4833861|P3|Overall Study|Withdrawal by Subject|1
1466354|NCT00715520|4833862|P2|Overall Study|Withdrawal by Subject|0
1466355|NCT00715520|4833863|P1|Overall Study|Withdrawal by Subject|2
1466356|NCT00715520|4833861|P3|Overall Study|Screen failure|1
1466357|NCT00715520|4833862|P2|Overall Study|Screen failure|1
1466358|NCT00715520|4833863|P1|Overall Study|Screen failure|8
1466359|NCT00715403|4833883|P7|Overall Study|Other reason not defined above|0
1466360|NCT00715403|4833884|P6|Overall Study|Other reason not defined above|1
1466361|NCT00715403|4833885|P5|Overall Study|Other reason not defined above|1
1466362|NCT00715403|4833886|P4|Overall Study|Other reason not defined above|0
1466363|NCT00715403|4833887|P3|Overall Study|Other reason not defined above|1
1466364|NCT00715403|4833888|P2|Overall Study|Other reason not defined above|0
1466365|NCT00715403|4833889|P1|Overall Study|Other reason not defined above|0
1466366|NCT00715403|4833883|P7|Overall Study|Protocol Violation|0
1466367|NCT00715403|4833884|P6|Overall Study|Protocol Violation|1
1466368|NCT00715403|4833885|P5|Overall Study|Protocol Violation|0
1466369|NCT00715403|4833886|P4|Overall Study|Protocol Violation|0
1466370|NCT00715403|4833887|P3|Overall Study|Protocol Violation|0
1466371|NCT00715403|4833888|P2|Overall Study|Protocol Violation|0
1466372|NCT00715403|4833889|P1|Overall Study|Protocol Violation|0
1466373|NCT00715403|4833883|P7|Overall Study|Other Adverse Event than DLT|0
1466374|NCT00715403|4833884|P6|Overall Study|Other Adverse Event than DLT|2
1466375|NCT00715403|4833885|P5|Overall Study|Other Adverse Event than DLT|0
1466376|NCT00715403|4833886|P4|Overall Study|Other Adverse Event than DLT|0
1466377|NCT00715403|4833887|P3|Overall Study|Other Adverse Event than DLT|0
1466378|NCT00715403|4833888|P2|Overall Study|Other Adverse Event than DLT|0
1466379|NCT00715403|4833889|P1|Overall Study|Other Adverse Event than DLT|1
1466380|NCT00715403|4833883|P7|Overall Study|Dose limiting Toxicity (DLT)|0
1466381|NCT00715403|4833884|P6|Overall Study|Dose limiting Toxicity (DLT)|1
1466382|NCT00715403|4833885|P5|Overall Study|Dose limiting Toxicity (DLT)|0
1466383|NCT00715403|4833886|P4|Overall Study|Dose limiting Toxicity (DLT)|0
1466384|NCT00715403|4833887|P3|Overall Study|Dose limiting Toxicity (DLT)|0
1466385|NCT00715403|4833888|P2|Overall Study|Dose limiting Toxicity (DLT)|0
1466386|NCT00715403|4833889|P1|Overall Study|Dose limiting Toxicity (DLT)|0
1466387|NCT00715403|4833883|P7|Overall Study|Progressive disease|1
1466388|NCT00715403|4833884|P6|Overall Study|Progressive disease|14
1466389|NCT00715403|4833885|P5|Overall Study|Progressive disease|5
1466390|NCT00715403|4833886|P4|Overall Study|Progressive disease|9
1466391|NCT00715403|4833887|P3|Overall Study|Progressive disease|3
1466392|NCT00715403|4833888|P2|Overall Study|Progressive disease|1
1466393|NCT00715403|4833889|P1|Overall Study|Progressive disease|0
1466394|NCT00715299|4834028|P1|Overall Study|failed the pre-screen exercise test|2
1466395|NCT00715299|4834028|P1|Overall Study|Adverse Event|3
1466396|NCT00715299|4834028|P1|Overall Study|Withdrawal by Subject|1
1466397|NCT00715208|4834034|P2|Overall Study|Lack of Efficacy|2
1466398|NCT00715208|4834035|P1|Overall Study|Lack of Efficacy|0
1466399|NCT00715208|4834034|P2|Overall Study|Adverse Event|6
1466400|NCT00715208|4834035|P1|Overall Study|Adverse Event|0
1466401|NCT00715208|4834034|P2|Overall Study|Withdrawal by Subject|1
1466402|NCT00715208|4834035|P1|Overall Study|Withdrawal by Subject|1
1466403|NCT00715117|4834051|P2|Overall Study|Crohn's flare and rescue with steroids|1
1466404|NCT00715117|4834052|P1|Overall Study|Crohn's flare and rescue with steroids|0
1466405|NCT00715078|4834120|P3|Overall Study|Unable to start due to disease prog.|1
1466406|NCT00715078|4834121|P2|Overall Study|Unable to start due to disease prog.|0
1466407|NCT00715078|4834122|P1|Overall Study|Unable to start due to disease prog.|0
1466408|NCT00715078|4834120|P3|Overall Study|Withdrawal by Subject|1
1466409|NCT00715078|4834121|P2|Overall Study|Withdrawal by Subject|0
1466410|NCT00715078|4834122|P1|Overall Study|Withdrawal by Subject|1
1466411|NCT00715078|4834120|P3|Overall Study|Death|36
1466412|NCT00715078|4834121|P2|Overall Study|Death|36
1466413|NCT00715078|4834122|P1|Overall Study|Death|29
1466414|NCT00715026|4834130|P1|Overall Study|Surgery done on non-study consented hip|1
1466415|NCT00715026|4834130|P1|Overall Study|Protocol Violation|1
1466416|NCT00715026|4834130|P1|Overall Study|Lost to Follow-up|3
1466417|NCT00715026|4834130|P1|Overall Study|Withdrawal by Subject|5
1466418|NCT00714948|4834135|P1|Overall Study|Adverse Event|2
1466419|NCT00714870|4834141|P2|Overall Study|did not attend minimum of 4 sessions|0
1466420|NCT00714870|4834142|P1|Overall Study|did not attend minimum of 4 sessions|4
1466421|NCT00714870|4834141|P2|Overall Study|patient unable to come b/c back pain|0
1466422|NCT00714870|4834142|P1|Overall Study|patient unable to come b/c back pain|1
1466423|NCT00714870|4834141|P2|Overall Study|Lost to Follow-up|5
1466424|NCT00714870|4834142|P1|Overall Study|Lost to Follow-up|22
1466425|NCT00714714|4834157|P1|Overall Study|Adverse Event|1
1466426|NCT00714688|4834166|P3|Overall Study|Other|5
1466427|NCT00714688|4834167|P2|Overall Study|Other|6
1466428|NCT00714688|4834168|P1|Overall Study|Other|1
1466429|NCT00714688|4834166|P3|Overall Study|Sponsor's Decision|0
1466430|NCT00714688|4834167|P2|Overall Study|Sponsor's Decision|2
1466431|NCT00714688|4834168|P1|Overall Study|Sponsor's Decision|0
1466432|NCT00714688|4834166|P3|Overall Study|Ineligible to Continue the Study|1
1466433|NCT00714688|4834167|P2|Overall Study|Ineligible to Continue the Study|1
1466434|NCT00714688|4834168|P1|Overall Study|Ineligible to Continue the Study|0
1466435|NCT00714688|4834166|P3|Overall Study|Subject Non-compliant|5
1466436|NCT00714688|4834167|P2|Overall Study|Subject Non-compliant|5
1466437|NCT00714688|4834168|P1|Overall Study|Subject Non-compliant|3
1466438|NCT00714688|4834166|P3|Overall Study|Adverse Event|19
1466439|NCT00714688|4834167|P2|Overall Study|Adverse Event|15
1466440|NCT00714688|4834168|P1|Overall Study|Adverse Event|2
1466441|NCT00714688|4834166|P3|Overall Study|Lost to Follow-up|0
1466442|NCT00714688|4834167|P2|Overall Study|Lost to Follow-up|2
1466443|NCT00714688|4834168|P1|Overall Study|Lost to Follow-up|5
1466444|NCT00714688|4834166|P3|Overall Study|Withdrawal by Subject|3
1466445|NCT00714688|4834167|P2|Overall Study|Withdrawal by Subject|3
1466446|NCT00714688|4834168|P1|Overall Study|Withdrawal by Subject|4
1466447|NCT00714688|4834166|P3|Overall Study|Lack of Efficacy|4
1466448|NCT00714688|4834167|P2|Overall Study|Lack of Efficacy|1
1466449|NCT00714688|4834168|P1|Overall Study|Lack of Efficacy|14
1466450|NCT00714493|4834210|P1|Overall Study|OTHER|2
1466451|NCT00714493|4834210|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
1466452|NCT00714493|4834210|P1|Overall Study|Protocol Violation|12
1466453|NCT00714493|4834210|P1|Overall Study|Lost to Follow-up|3
1466454|NCT00714493|4834210|P1|Overall Study|Lack of Efficacy|10
1466455|NCT00714493|4834210|P1|Overall Study|Death|3
1466456|NCT00714493|4834210|P1|Overall Study|Adverse Event|11
1466457|NCT00714285|4834238|P4|Overall Study|Migrated/moved from study area|0
1466458|NCT00714285|4834239|P3|Overall Study|Migrated/moved from study area|0
1466459|NCT00714285|4834240|P2|Overall Study|Migrated/moved from study area|1
1466460|NCT00714285|4834241|P1|Overall Study|Migrated/moved from study area|0
1466461|NCT00714285|4834238|P4|Overall Study|Lost to Follow-up|1
1466462|NCT00714285|4834239|P3|Overall Study|Lost to Follow-up|0
1466463|NCT00714285|4834240|P2|Overall Study|Lost to Follow-up|2
1466464|NCT00714285|4834241|P1|Overall Study|Lost to Follow-up|0
1466465|NCT00714259|4834291|P1|Overall Study|Death|2
1466466|NCT00714168|4834337|P2|Overall Study|Non-study medical condition|2
1466467|NCT00714168|4834338|P1|Overall Study|Non-study medical condition|3
1466468|NCT00714168|4834337|P2|Overall Study|Relocation|3
1466469|NCT00714168|4834338|P1|Overall Study|Relocation|4
1466470|NCT00714168|4834337|P2|Overall Study|Lost to Follow-up|50
1466471|NCT00714168|4834338|P1|Overall Study|Lost to Follow-up|32
1466472|NCT00714168|4834337|P2|Overall Study|Pregnancy|4
1466473|NCT00714168|4834338|P1|Overall Study|Pregnancy|5
1466474|NCT00714051|4834354|P2|Overall Study|Death|1
1466475|NCT00714051|4834355|P1|Overall Study|Death|0
1466476|NCT00714051|4834354|P2|Overall Study|Withdrawal by Subject|0
1466477|NCT00714051|4834355|P1|Overall Study|Withdrawal by Subject|1
1466478|NCT00713830|4834363|P2|Overall Study|Sponsor Decision|10
1466479|NCT00713830|4834364|P1|Overall Study|Sponsor Decision|4
1466480|NCT00713830|4834363|P2|Overall Study|Familial and Personal Reasons|34
1466481|NCT00713830|4834364|P1|Overall Study|Familial and Personal Reasons|9
1466482|NCT00713830|4834363|P2|Overall Study|Poor Compliance to Protocol|14
1466483|NCT00713830|4834364|P1|Overall Study|Poor Compliance to Protocol|7
1466484|NCT00713830|4834363|P2|Overall Study|Withdrawal by Subject|23
1466485|NCT00713830|4834364|P1|Overall Study|Withdrawal by Subject|13
1466486|NCT00713830|4834363|P2|Overall Study|Lost to Follow-up|9
1466487|NCT00713830|4834364|P1|Overall Study|Lost to Follow-up|2
1466488|NCT00713830|4834363|P2|Overall Study|Lack of Efficacy|16
1466489|NCT00713830|4834364|P1|Overall Study|Lack of Efficacy|24
1466490|NCT00713830|4834363|P2|Overall Study|Adverse Event|71
1466491|NCT00713830|4834364|P1|Overall Study|Adverse Event|23
1466492|NCT00713700|4834421|P1|Overall Study|Withdrawal by Subject|1
1466493|NCT00713700|4834421|P1|Overall Study|Lost to Follow-up|3
1466494|NCT00713648|4834447|P1|Overall Study|Development of antibodies|3
1466495|NCT00713648|4834447|P1|Overall Study|According to Protocol|2
1466496|NCT00713648|4834447|P1|Overall Study|Unclassified|2
1466497|NCT00713648|4834447|P1|Overall Study|Adverse Event|1
1466498|NCT00713609|4834460|P6|Overall Study|Protocol Violation|0
1466499|NCT00713609|4834461|P5|Overall Study|Protocol Violation|2
1466500|NCT00713609|4834462|P4|Overall Study|Protocol Violation|1
1466501|NCT00713609|4834463|P3|Overall Study|Protocol Violation|1
1466502|NCT00713609|4834464|P2|Overall Study|Protocol Violation|3
1466503|NCT00713609|4834465|P1|Overall Study|Protocol Violation|6
1466504|NCT00713609|4834460|P6|Overall Study|Withdrawal by Subject|7
1466505|NCT00713609|4834461|P5|Overall Study|Withdrawal by Subject|5
1466506|NCT00713609|4834462|P4|Overall Study|Withdrawal by Subject|1
1466507|NCT00713609|4834463|P3|Overall Study|Withdrawal by Subject|5
1466508|NCT00713609|4834464|P2|Overall Study|Withdrawal by Subject|1
1466509|NCT00713609|4834465|P1|Overall Study|Withdrawal by Subject|6
1466510|NCT00713609|4834460|P6|Overall Study|Non-Compliance with Study Treatment|0
1466511|NCT00713609|4834461|P5|Overall Study|Non-Compliance with Study Treatment|1
1466512|NCT00713609|4834462|P4|Overall Study|Non-Compliance with Study Treatment|0
1466513|NCT00713609|4834463|P3|Overall Study|Non-Compliance with Study Treatment|2
1466514|NCT00713609|4834464|P2|Overall Study|Non-Compliance with Study Treatment|1
1466515|NCT00713609|4834465|P1|Overall Study|Non-Compliance with Study Treatment|1
1466516|NCT00713609|4834460|P6|Overall Study|Lack of Efficacy|0
1466517|NCT00713609|4834461|P5|Overall Study|Lack of Efficacy|1
1466518|NCT00713609|4834462|P4|Overall Study|Lack of Efficacy|0
1466519|NCT00713609|4834463|P3|Overall Study|Lack of Efficacy|0
1466520|NCT00713609|4834464|P2|Overall Study|Lack of Efficacy|3
1466521|NCT00713609|4834465|P1|Overall Study|Lack of Efficacy|1
1466522|NCT00713609|4834460|P6|Overall Study|Lost to Follow-up|0
1466523|NCT00713609|4834461|P5|Overall Study|Lost to Follow-up|7
1466524|NCT00713609|4834462|P4|Overall Study|Lost to Follow-up|5
1466525|NCT00713609|4834463|P3|Overall Study|Lost to Follow-up|5
1466526|NCT00713609|4834464|P2|Overall Study|Lost to Follow-up|7
1466527|NCT00713609|4834465|P1|Overall Study|Lost to Follow-up|5
1466528|NCT00713609|4834460|P6|Overall Study|Adverse Event|1
1466529|NCT00713609|4834461|P5|Overall Study|Adverse Event|3
1466530|NCT00713609|4834462|P4|Overall Study|Adverse Event|2
1466531|NCT00713609|4834463|P3|Overall Study|Adverse Event|2
1466532|NCT00713609|4834464|P2|Overall Study|Adverse Event|0
1466533|NCT00713609|4834465|P1|Overall Study|Adverse Event|2
1466534|NCT00713596|4834500|P3|Overall Study|Study was terminated|2
1466535|NCT00713596|4834501|P2|Overall Study|Study was terminated|3
1466536|NCT00713596|4834502|P1|Overall Study|Study was terminated|2
1466537|NCT00713544|4834528|P6|Overall Study|Hepatotoxicity - not an AE|0
1466538|NCT00713544|4834529|P5|Overall Study|Hepatotoxicity - not an AE|1
1466539|NCT00713544|4834530|P4|Overall Study|Hepatotoxicity - not an AE|0
1466540|NCT00713544|4834531|P3|Overall Study|Hepatotoxicity - not an AE|0
1466541|NCT00713544|4834532|P2|Overall Study|Hepatotoxicity - not an AE|0
1466542|NCT00713544|4834533|P1|Overall Study|Hepatotoxicity - not an AE|0
1466543|NCT00713544|4834528|P6|Overall Study|Incorrect enrollment|0
1466544|NCT00713544|4834529|P5|Overall Study|Incorrect enrollment|0
1466545|NCT00713544|4834530|P4|Overall Study|Incorrect enrollment|0
1466546|NCT00713544|4834531|P3|Overall Study|Incorrect enrollment|0
1466547|NCT00713544|4834532|P2|Overall Study|Incorrect enrollment|1
1466548|NCT00713544|4834533|P1|Overall Study|Incorrect enrollment|0
1466549|NCT00713544|4834528|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
1466550|NCT00713544|4834529|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
1466551|NCT00713544|4834530|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
1466552|NCT00713544|4834531|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
1466553|NCT00713544|4834532|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
1466554|NCT00713544|4834533|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
1466555|NCT00713544|4834528|P6|Overall Study|Lost to Follow-up|0
1466556|NCT00713544|4834529|P5|Overall Study|Lost to Follow-up|0
1466557|NCT00713544|4834530|P4|Overall Study|Lost to Follow-up|0
1466558|NCT00713544|4834531|P3|Overall Study|Lost to Follow-up|1
1466559|NCT00713544|4834532|P2|Overall Study|Lost to Follow-up|0
1466560|NCT00713544|4834533|P1|Overall Study|Lost to Follow-up|0
1466561|NCT00713544|4834528|P6|Overall Study|Lack of Efficacy|0
1466562|NCT00713544|4834529|P5|Overall Study|Lack of Efficacy|1
1466563|NCT00713544|4834530|P4|Overall Study|Lack of Efficacy|1
1466564|NCT00713544|4834531|P3|Overall Study|Lack of Efficacy|0
1466565|NCT00713544|4834532|P2|Overall Study|Lack of Efficacy|1
1466566|NCT00713544|4834533|P1|Overall Study|Lack of Efficacy|0
1466567|NCT00713544|4834528|P6|Overall Study|Physician Decision|2
1466568|NCT00713544|4834529|P5|Overall Study|Physician Decision|0
1466569|NCT00713544|4834530|P4|Overall Study|Physician Decision|0
1466570|NCT00713544|4834531|P3|Overall Study|Physician Decision|0
1466571|NCT00713544|4834532|P2|Overall Study|Physician Decision|0
1466572|NCT00713544|4834533|P1|Overall Study|Physician Decision|0
1466573|NCT00713544|4834528|P6|Overall Study|Protocol Violation|1
1466574|NCT00713544|4834529|P5|Overall Study|Protocol Violation|0
1466575|NCT00713544|4834530|P4|Overall Study|Protocol Violation|0
1466576|NCT00713544|4834531|P3|Overall Study|Protocol Violation|0
1466577|NCT00713544|4834532|P2|Overall Study|Protocol Violation|0
1466578|NCT00713544|4834533|P1|Overall Study|Protocol Violation|0
1466579|NCT00713544|4834528|P6|Overall Study|Withdrawal by Subject|1
1466580|NCT00713544|4834529|P5|Overall Study|Withdrawal by Subject|3
1466581|NCT00713544|4834530|P4|Overall Study|Withdrawal by Subject|2
1466582|NCT00713544|4834531|P3|Overall Study|Withdrawal by Subject|3
1466583|NCT00713544|4834532|P2|Overall Study|Withdrawal by Subject|0
1466584|NCT00713544|4834533|P1|Overall Study|Withdrawal by Subject|2
1466585|NCT00713544|4834528|P6|Overall Study|Adverse Event|5
1466586|NCT00713544|4834529|P5|Overall Study|Adverse Event|3
1466587|NCT00713544|4834530|P4|Overall Study|Adverse Event|7
1466588|NCT00713544|4834531|P3|Overall Study|Adverse Event|7
1466589|NCT00713544|4834532|P2|Overall Study|Adverse Event|3
1466590|NCT00713544|4834533|P1|Overall Study|Adverse Event|5
1466591|NCT00713349|4834584|P1|Overall Study|Protocol Violation|1
1466592|NCT00713323|4834590|P1|Overall Study|Treatment that may interact with Sativex|1
1466593|NCT00713323|4834590|P1|Overall Study|Subject travelling to Dominica Republic|1
1466594|NCT00713323|4834590|P1|Overall Study|Subject travelling to USA|1
1466595|NCT00713323|4834590|P1|Overall Study|Pain resolved|1
1466596|NCT00713323|4834590|P1|Overall Study|Non-compliance|1
1466597|NCT00713323|4834590|P1|Overall Study|Pain free|1
1466598|NCT00713323|4834590|P1|Overall Study|Surgery cured allodynic pain|1
1466599|NCT00713323|4834590|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
1466600|NCT00713323|4834590|P1|Overall Study|Low creatine clearance at screening|1
1466601|NCT00713323|4834590|P1|Overall Study|Lack of Efficacy|36
1466602|NCT00713323|4834590|P1|Overall Study|Lost to Follow-up|11
1466603|NCT00713323|4834590|P1|Overall Study|Withdrawal by Subject|15
1466604|NCT00713323|4834590|P1|Overall Study|Adverse Event|75
1466605|NCT00713310|4834603|P2|Overall Study|Withdrawal by Subject|2
1466606|NCT00713310|4834604|P1|Overall Study|Withdrawal by Subject|0
1466607|NCT00713310|4834603|P2|Overall Study|Lack of Efficacy|2
1466608|NCT00713310|4834604|P1|Overall Study|Lack of Efficacy|0
1466609|NCT00713310|4834603|P2|Overall Study|Adverse Event|2
1466610|NCT00713310|4834604|P1|Overall Study|Adverse Event|5
1466611|NCT00713258|4834614|P2|Overall Study|Other|1
1466612|NCT00713258|4834615|P1|Overall Study|Other|1
1466613|NCT00713258|4834614|P2|Overall Study|Non-Compliance|1
1466614|NCT00713258|4834615|P1|Overall Study|Non-Compliance|2
1466615|NCT00713258|4834614|P2|Overall Study|Adverse Event|4
1466616|NCT00713258|4834615|P1|Overall Study|Adverse Event|2
1466617|NCT00713219|4834623|P1|Overall Study|Protocol Violation|1
1466618|NCT00713219|4834623|P1|Overall Study|Death|1
1466619|NCT00713206|4834629|P2|Overall Study|Adverse Event|1
1466620|NCT00713206|4834630|P1|Overall Study|Adverse Event|2
1466621|NCT00713206|4834629|P2|Overall Study|Lost to Follow-up|2
1466622|NCT00713206|4834630|P1|Overall Study|Lost to Follow-up|5
1466623|NCT00712985|4834636|P1|Overall Study|Lack of Efficacy|3
1466624|NCT00712985|4834636|P1|Overall Study|1 patient moved out of state|1
1466625|NCT00712985|4834636|P1|Overall Study|1 withdrew prior to start of drug|1
1466626|NCT00712959|4834642|P2|Overall Study|Withdrawal by Subject|0
1466627|NCT00712959|4834643|P1|Overall Study|Withdrawal by Subject|3
1466628|NCT00712959|4834642|P2|Overall Study|Lost to Follow-up|2
1466629|NCT00712959|4834643|P1|Overall Study|Lost to Follow-up|13
1466630|NCT00712959|4834642|P2|Overall Study|Protocol Violation|1
1466631|NCT00712959|4834643|P1|Overall Study|Protocol Violation|3
1466632|NCT00712933|4834661|P1|Overall Study|Withdrawal by Subject|151
1466633|NCT00712933|4834661|P1|Overall Study|Protocol Violation|4
1466634|NCT00712933|4834661|P1|Overall Study|Physician Decision|36
1466635|NCT00712933|4834661|P1|Overall Study|Participant received medication|1
1466636|NCT00712933|4834661|P1|Overall Study|Not committed to contraception|1
1466637|NCT00712933|4834661|P1|Overall Study|Other Physician decision|1
1466638|NCT00712933|4834661|P1|Overall Study|Death of patient|1
1466639|NCT00712933|4834661|P1|Overall Study|Participant travelled overseas|2
1466640|NCT00712933|4834661|P1|Overall Study|Participant hospitalized|1
1466641|NCT00712933|4834661|P1|Overall Study|Involved in Clinical research|3
1466642|NCT00712933|4834661|P1|Overall Study|Hip replacement surgery|1
1466643|NCT00712933|4834661|P1|Overall Study|Withdrew consent|4
1466644|NCT00712933|4834661|P1|Overall Study|Sponsor decision|14
1466645|NCT00712933|4834661|P1|Overall Study|Other Pregnancy|37
1466646|NCT00712933|4834661|P1|Overall Study|Non-compliance with study drug|13
1466647|NCT00712933|4834661|P1|Overall Study|Lost to Follow-up|22
1466648|NCT00712933|4834661|P1|Overall Study|Lack of Efficacy|6
1466649|NCT00712933|4834661|P1|Overall Study|Adverse Event|69
1466650|NCT00712920|4834691|P3|Overall Study|Non-compliance|0
1466651|NCT00712920|4834692|P2|Overall Study|Non-compliance|0
1466652|NCT00712920|4834693|P1|Overall Study|Non-compliance|3
1466653|NCT00712920|4834691|P3|Overall Study|Other|3
1466654|NCT00712920|4834692|P2|Overall Study|Other|7
1466655|NCT00712920|4834693|P1|Overall Study|Other|5
1466656|NCT00712920|4834691|P3|Overall Study|Lack of Efficacy|1
1466657|NCT00712920|4834692|P2|Overall Study|Lack of Efficacy|0
1466658|NCT00712920|4834693|P1|Overall Study|Lack of Efficacy|1
1466659|NCT00712920|4834691|P3|Overall Study|Lost to Follow-up|0
1466660|NCT00712920|4834692|P2|Overall Study|Lost to Follow-up|4
1466661|NCT00712920|4834693|P1|Overall Study|Lost to Follow-up|1
1466662|NCT00712920|4834691|P3|Overall Study|Withdrawal by Subject|1
1466663|NCT00712920|4834692|P2|Overall Study|Withdrawal by Subject|2
1466664|NCT00712920|4834693|P1|Overall Study|Withdrawal by Subject|4
1466665|NCT00712920|4834691|P3|Overall Study|Adverse Event|7
1466666|NCT00712920|4834692|P2|Overall Study|Adverse Event|4
1466667|NCT00712920|4834693|P1|Overall Study|Adverse Event|3
1466668|NCT00712725|4834721|P8|Overall Study|Protocol Specified Criteria|1
1466669|NCT00712725|4834722|P7|Overall Study|Protocol Specified Criteria|2
1466670|NCT00712725|4834723|P6|Overall Study|Protocol Specified Criteria|0
1466671|NCT00712725|4834724|P5|Overall Study|Protocol Specified Criteria|1
1466672|NCT00712725|4834725|P4|Overall Study|Protocol Specified Criteria|2
1466673|NCT00712725|4834726|P3|Overall Study|Protocol Specified Criteria|1
1466674|NCT00712725|4834727|P2|Overall Study|Protocol Specified Criteria|0
1466675|NCT00712725|4834728|P1|Overall Study|Protocol Specified Criteria|3
1466676|NCT00712725|4834721|P8|Overall Study|Lack of Qualifying Event|6
1466677|NCT00712725|4834722|P7|Overall Study|Lack of Qualifying Event|11
1466678|NCT00712725|4834723|P6|Overall Study|Lack of Qualifying Event|13
1466679|NCT00712725|4834724|P5|Overall Study|Lack of Qualifying Event|11
1466680|NCT00712725|4834725|P4|Overall Study|Lack of Qualifying Event|8
1466681|NCT00712725|4834726|P3|Overall Study|Lack of Qualifying Event|6
1466682|NCT00712725|4834727|P2|Overall Study|Lack of Qualifying Event|2
1466683|NCT00712725|4834728|P1|Overall Study|Lack of Qualifying Event|16
1466684|NCT00712725|4834721|P8|Overall Study|Withdrawal by Subject|2
1466685|NCT00712725|4834722|P7|Overall Study|Withdrawal by Subject|1
1466686|NCT00712725|4834723|P6|Overall Study|Withdrawal by Subject|1
1466687|NCT00712725|4834724|P5|Overall Study|Withdrawal by Subject|1
1466688|NCT00712725|4834725|P4|Overall Study|Withdrawal by Subject|2
1466689|NCT00712725|4834726|P3|Overall Study|Withdrawal by Subject|1
1466690|NCT00712725|4834727|P2|Overall Study|Withdrawal by Subject|1
1466691|NCT00712725|4834728|P1|Overall Study|Withdrawal by Subject|2
1466692|NCT00712725|4834721|P8|Overall Study|Protocol Violation|1
1466693|NCT00712725|4834722|P7|Overall Study|Protocol Violation|1
1466694|NCT00712725|4834723|P6|Overall Study|Protocol Violation|0
1466695|NCT00712725|4834724|P5|Overall Study|Protocol Violation|2
1466696|NCT00712725|4834725|P4|Overall Study|Protocol Violation|3
1466697|NCT00712725|4834726|P3|Overall Study|Protocol Violation|1
1466698|NCT00712725|4834727|P2|Overall Study|Protocol Violation|0
1466699|NCT00712725|4834728|P1|Overall Study|Protocol Violation|2
1466700|NCT00712725|4834721|P8|Overall Study|Pregnancy|0
1466701|NCT00712725|4834722|P7|Overall Study|Pregnancy|2
1466702|NCT00712725|4834723|P6|Overall Study|Pregnancy|0
1466703|NCT00712725|4834724|P5|Overall Study|Pregnancy|1
1466704|NCT00712725|4834725|P4|Overall Study|Pregnancy|0
1466705|NCT00712725|4834726|P3|Overall Study|Pregnancy|0
1466706|NCT00712725|4834727|P2|Overall Study|Pregnancy|1
1466707|NCT00712725|4834728|P1|Overall Study|Pregnancy|0
1466708|NCT00712725|4834721|P8|Overall Study|Physician Decision|0
1466709|NCT00712725|4834722|P7|Overall Study|Physician Decision|2
1466710|NCT00712725|4834723|P6|Overall Study|Physician Decision|0
1466711|NCT00712725|4834724|P5|Overall Study|Physician Decision|1
1466712|NCT00712725|4834725|P4|Overall Study|Physician Decision|0
1466713|NCT00712725|4834726|P3|Overall Study|Physician Decision|0
1466714|NCT00712725|4834727|P2|Overall Study|Physician Decision|0
1466715|NCT00712725|4834728|P1|Overall Study|Physician Decision|2
1466716|NCT00712725|4834721|P8|Overall Study|Lost to Follow-up|1
1466717|NCT00712725|4834722|P7|Overall Study|Lost to Follow-up|3
1466718|NCT00712725|4834723|P6|Overall Study|Lost to Follow-up|2
1466719|NCT00712725|4834724|P5|Overall Study|Lost to Follow-up|2
1466720|NCT00712725|4834725|P4|Overall Study|Lost to Follow-up|1
1466721|NCT00712725|4834726|P3|Overall Study|Lost to Follow-up|1
1466722|NCT00712725|4834727|P2|Overall Study|Lost to Follow-up|2
1466723|NCT00712725|4834728|P1|Overall Study|Lost to Follow-up|3
1466724|NCT00712725|4834721|P8|Overall Study|Adverse Event|0
1466725|NCT00712725|4834722|P7|Overall Study|Adverse Event|0
1466726|NCT00712725|4834723|P6|Overall Study|Adverse Event|0
1466727|NCT00712725|4834724|P5|Overall Study|Adverse Event|0
1466728|NCT00712725|4834725|P4|Overall Study|Adverse Event|1
1466729|NCT00712725|4834726|P3|Overall Study|Adverse Event|0
1466730|NCT00712725|4834727|P2|Overall Study|Adverse Event|0
1466731|NCT00712725|4834728|P1|Overall Study|Adverse Event|1
1466732|NCT00712673|4834789|P4|Overall Study|Protocol Violation|0
1466733|NCT00712673|4834790|P3|Overall Study|Protocol Violation|2
1466734|NCT00712673|4834791|P2|Overall Study|Protocol Violation|0
1466735|NCT00712673|4834792|P1|Overall Study|Protocol Violation|0
1466736|NCT00712673|4834789|P4|Overall Study|Investigator's Decision|0
1466737|NCT00712673|4834790|P3|Overall Study|Investigator's Decision|0
1466738|NCT00712673|4834791|P2|Overall Study|Investigator's Decision|0
1466739|NCT00712673|4834792|P1|Overall Study|Investigator's Decision|1
1466740|NCT00712673|4834789|P4|Overall Study|Familial and Personal Reasons|2
1466741|NCT00712673|4834790|P3|Overall Study|Familial and Personal Reasons|5
1466742|NCT00712673|4834791|P2|Overall Study|Familial and Personal Reasons|0
1466743|NCT00712673|4834792|P1|Overall Study|Familial and Personal Reasons|5
1466744|NCT00712673|4834789|P4|Overall Study|Withdrawal by Subject|20
1466745|NCT00712673|4834790|P3|Overall Study|Withdrawal by Subject|15
1466746|NCT00712673|4834791|P2|Overall Study|Withdrawal by Subject|7
1466747|NCT00712673|4834792|P1|Overall Study|Withdrawal by Subject|6
1466748|NCT00712673|4834789|P4|Overall Study|Lost to Follow-up|0
1466749|NCT00712673|4834790|P3|Overall Study|Lost to Follow-up|2
1466750|NCT00712673|4834791|P2|Overall Study|Lost to Follow-up|0
1466751|NCT00712673|4834792|P1|Overall Study|Lost to Follow-up|1
1466752|NCT00712673|4834789|P4|Overall Study|Poor Compliance to Protocol|16
1466753|NCT00712673|4834790|P3|Overall Study|Poor Compliance to Protocol|4
1466754|NCT00712673|4834791|P2|Overall Study|Poor Compliance to Protocol|3
1466755|NCT00712673|4834792|P1|Overall Study|Poor Compliance to Protocol|3
1466756|NCT00712673|4834789|P4|Overall Study|Lack of Efficacy|6
1466757|NCT00712673|4834790|P3|Overall Study|Lack of Efficacy|8
1466758|NCT00712673|4834791|P2|Overall Study|Lack of Efficacy|8
1466759|NCT00712673|4834792|P1|Overall Study|Lack of Efficacy|2
1466760|NCT00712673|4834789|P4|Overall Study|Adverse Event|26
1466761|NCT00712673|4834790|P3|Overall Study|Adverse Event|21
1466762|NCT00712673|4834791|P2|Overall Study|Adverse Event|3
1466763|NCT00712673|4834792|P1|Overall Study|Adverse Event|3
1466764|NCT00712543|4834856|P2|Day 8-14|Lost to Follow-up|2
1466765|NCT00712543|4834857|P1|Day 8-14|Lost to Follow-up|0
1466766|NCT00712348|4834891|P1|Overall Study|Withdrawal by Subject|1
1466767|NCT00712335|4834903|P5|Overall Study|Other Reason|0
1466768|NCT00712335|4834904|P4|Overall Study|Other Reason|0
1466769|NCT00712335|4834905|P3|Overall Study|Other Reason|1
1466770|NCT00712335|4834906|P2|Overall Study|Other Reason|3
1466771|NCT00712335|4834907|P1|Overall Study|Other Reason|0
1466772|NCT00712335|4834903|P5|Overall Study|Lack of Efficacy|0
1466773|NCT00712335|4834904|P4|Overall Study|Lack of Efficacy|1
1466774|NCT00712335|4834905|P3|Overall Study|Lack of Efficacy|1
1466775|NCT00712335|4834906|P2|Overall Study|Lack of Efficacy|0
1466776|NCT00712335|4834907|P1|Overall Study|Lack of Efficacy|0
1466777|NCT00712335|4834903|P5|Overall Study|Protocol Violation|0
1466778|NCT00712335|4834904|P4|Overall Study|Protocol Violation|0
1466779|NCT00712335|4834905|P3|Overall Study|Protocol Violation|1
1466780|NCT00712335|4834906|P2|Overall Study|Protocol Violation|2
1466781|NCT00712335|4834907|P1|Overall Study|Protocol Violation|1
1466782|NCT00712335|4834903|P5|Overall Study|Lost to Follow-up|0
1466783|NCT00712335|4834904|P4|Overall Study|Lost to Follow-up|1
1466784|NCT00712335|4834905|P3|Overall Study|Lost to Follow-up|0
1466785|NCT00712335|4834906|P2|Overall Study|Lost to Follow-up|5
1466786|NCT00712335|4834907|P1|Overall Study|Lost to Follow-up|2
1466787|NCT00712335|4834903|P5|Overall Study|Withdrawal by Subject|0
1466788|NCT00712335|4834904|P4|Overall Study|Withdrawal by Subject|3
1466789|NCT00712335|4834905|P3|Overall Study|Withdrawal by Subject|2
1466790|NCT00712335|4834906|P2|Overall Study|Withdrawal by Subject|7
1466791|NCT00712335|4834907|P1|Overall Study|Withdrawal by Subject|0
1466792|NCT00712166|4835004|P2|Overall Study|Noncompliance|1
1466793|NCT00712166|4835005|P1|Overall Study|Noncompliance|0
1466794|NCT00712010|4835048|P1|Washout (7 Days)|Withdrawal by Subject|1
1466795|NCT00711971|4835087|P3|Overall Study|Lost to Follow-up|1
1466796|NCT00711971|4835088|P2|Overall Study|Lost to Follow-up|4
1466797|NCT00711971|4835089|P1|Overall Study|Lost to Follow-up|3
1466798|NCT00711958|4835123|P2|Overall Study|Progression of disease|0
1466799|NCT00711958|4835124|P1|Overall Study|Progression of disease|1
1466800|NCT00711958|4835123|P2|Overall Study|Death|5
1466801|NCT00711958|4835124|P1|Overall Study|Death|10
1466802|NCT00711958|4835123|P2|Overall Study|Lost to Follow-up|2
1466803|NCT00711958|4835124|P1|Overall Study|Lost to Follow-up|2
1466804|NCT00711958|4835123|P2|Overall Study|Protocol Violation|0
1466805|NCT00711958|4835124|P1|Overall Study|Protocol Violation|1
1466806|NCT00711958|4835123|P2|Overall Study|Adverse Event|7
1466807|NCT00711958|4835124|P1|Overall Study|Adverse Event|9
1466808|NCT00711958|4835123|P2|Overall Study|Clinical deterioration|0
1466809|NCT00711958|4835124|P1|Overall Study|Clinical deterioration|1
1466810|NCT00711958|4835123|P2|Overall Study|Lack of Efficacy|1
1466811|NCT00711958|4835124|P1|Overall Study|Lack of Efficacy|3
1466812|NCT00711958|4835123|P2|Overall Study|Withdrawal by Subject|8
1466813|NCT00711958|4835124|P1|Overall Study|Withdrawal by Subject|6
1466814|NCT00711880|4835132|P2|Overall Study|Lack of Efficacy|5
1466815|NCT00711880|4835133|P1|Overall Study|Lack of Efficacy|1
1466816|NCT00711880|4835132|P2|Overall Study|Patient non-compliance|0
1466817|NCT00711880|4835133|P1|Overall Study|Patient non-compliance|1
1466818|NCT00711880|4835132|P2|Overall Study|Adverse Event|2
1466819|NCT00711880|4835133|P1|Overall Study|Adverse Event|11
1466820|NCT00711802|4835195|P8|Overall Study|Reason not reported|0
1466821|NCT00711802|4835196|P7|Overall Study|Reason not reported|1
1466822|NCT00711802|4835197|P6|Overall Study|Reason not reported|0
1466823|NCT00711802|4835198|P5|Overall Study|Reason not reported|1
1466824|NCT00711802|4835199|P4|Overall Study|Reason not reported|0
1466825|NCT00711802|4835200|P3|Overall Study|Reason not reported|1
1466826|NCT00711802|4835201|P2|Overall Study|Reason not reported|1
1466827|NCT00711802|4835202|P1|Overall Study|Reason not reported|0
1466828|NCT00711802|4835195|P8|Overall Study|Lost to Follow-up|2
1466829|NCT00711802|4835196|P7|Overall Study|Lost to Follow-up|4
1466830|NCT00711802|4835197|P6|Overall Study|Lost to Follow-up|6
1466831|NCT00711802|4835198|P5|Overall Study|Lost to Follow-up|10
1466832|NCT00711802|4835199|P4|Overall Study|Lost to Follow-up|1
1466833|NCT00711802|4835200|P3|Overall Study|Lost to Follow-up|3
1466834|NCT00711802|4835201|P2|Overall Study|Lost to Follow-up|0
1466835|NCT00711802|4835202|P1|Overall Study|Lost to Follow-up|0
1466836|NCT00711802|4835195|P8|Overall Study|Withdrawal by Subject|0
1466837|NCT00711802|4835196|P7|Overall Study|Withdrawal by Subject|0
1466838|NCT00711802|4835197|P6|Overall Study|Withdrawal by Subject|0
1466839|NCT00711802|4835198|P5|Overall Study|Withdrawal by Subject|0
1466840|NCT00711802|4835199|P4|Overall Study|Withdrawal by Subject|1
1466841|NCT00711802|4835200|P3|Overall Study|Withdrawal by Subject|0
1466842|NCT00711802|4835201|P2|Overall Study|Withdrawal by Subject|1
1466843|NCT00711802|4835202|P1|Overall Study|Withdrawal by Subject|0
1466844|NCT00711802|4835195|P8|Overall Study|Physician Decision|0
1466845|NCT00711802|4835196|P7|Overall Study|Physician Decision|0
1466846|NCT00711802|4835197|P6|Overall Study|Physician Decision|0
1466847|NCT00711802|4835198|P5|Overall Study|Physician Decision|0
1466848|NCT00711802|4835199|P4|Overall Study|Physician Decision|0
1466849|NCT00711802|4835200|P3|Overall Study|Physician Decision|0
1466850|NCT00711802|4835201|P2|Overall Study|Physician Decision|2
1466851|NCT00711802|4835202|P1|Overall Study|Physician Decision|0
1466852|NCT00711802|4835195|P8|Overall Study|Protocol Violation|0
1466853|NCT00711802|4835196|P7|Overall Study|Protocol Violation|0
1466854|NCT00711802|4835197|P6|Overall Study|Protocol Violation|0
1466855|NCT00711802|4835198|P5|Overall Study|Protocol Violation|0
1466856|NCT00711802|4835199|P4|Overall Study|Protocol Violation|1
1466857|NCT00711802|4835200|P3|Overall Study|Protocol Violation|0
1466858|NCT00711802|4835201|P2|Overall Study|Protocol Violation|0
1466859|NCT00711802|4835202|P1|Overall Study|Protocol Violation|0
1466860|NCT00711802|4835195|P8|Overall Study|Microbiological failure|0
1466861|NCT00711802|4835196|P7|Overall Study|Microbiological failure|0
1466862|NCT00711802|4835197|P6|Overall Study|Microbiological failure|1
1466863|NCT00711802|4835198|P5|Overall Study|Microbiological failure|0
1466864|NCT00711802|4835199|P4|Overall Study|Microbiological failure|0
1466865|NCT00711802|4835200|P3|Overall Study|Microbiological failure|0
1466866|NCT00711802|4835201|P2|Overall Study|Microbiological failure|1
1466867|NCT00711802|4835202|P1|Overall Study|Microbiological failure|0
1466868|NCT00711802|4835195|P8|Overall Study|Adverse Event|0
1466869|NCT00711802|4835196|P7|Overall Study|Adverse Event|0
1466870|NCT00711802|4835197|P6|Overall Study|Adverse Event|1
1466871|NCT00711802|4835198|P5|Overall Study|Adverse Event|1
1466872|NCT00711802|4835199|P4|Overall Study|Adverse Event|0
1466873|NCT00711802|4835200|P3|Overall Study|Adverse Event|0
1466874|NCT00711802|4835201|P2|Overall Study|Adverse Event|0
1466875|NCT00711802|4835202|P1|Overall Study|Adverse Event|0
1466876|NCT00711802|4835195|P8|Overall Study|Not treated (no further detail)|0
1466877|NCT00711802|4835196|P7|Overall Study|Not treated (no further detail)|0
1466878|NCT00711802|4835197|P6|Overall Study|Not treated (no further detail)|0
1466879|NCT00711802|4835198|P5|Overall Study|Not treated (no further detail)|2
1466880|NCT00711802|4835199|P4|Overall Study|Not treated (no further detail)|0
1466881|NCT00711802|4835200|P3|Overall Study|Not treated (no further detail)|2
1466882|NCT00711802|4835201|P2|Overall Study|Not treated (no further detail)|1
1466883|NCT00711802|4835202|P1|Overall Study|Not treated (no further detail)|2
1466884|NCT00711646|4835234|P2|Overall Study|patient non-compliance|0
1466885|NCT00711646|4835235|P1|Overall Study|patient non-compliance|1
1466886|NCT00711646|4835234|P2|Overall Study|administrative decision|1
1466887|NCT00711646|4835235|P1|Overall Study|administrative decision|0
1466888|NCT00711646|4835234|P2|Overall Study|Lost to Follow-up|0
1466889|NCT00711646|4835235|P1|Overall Study|Lost to Follow-up|1
1466890|NCT00711646|4835234|P2|Overall Study|Protocol Violation|1
1466891|NCT00711646|4835235|P1|Overall Study|Protocol Violation|0
1466892|NCT00711646|4835234|P2|Overall Study|Withdrawal by Subject|0
1466893|NCT00711646|4835235|P1|Overall Study|Withdrawal by Subject|4
1466894|NCT00711646|4835234|P2|Overall Study|Adverse Event|1
1466895|NCT00711646|4835235|P1|Overall Study|Adverse Event|6
1466896|NCT00711594|4835257|P4|Overall Study|Withdrawal by Subject|2
1466897|NCT00711594|4835258|P3|Overall Study|Withdrawal by Subject|0
1466898|NCT00711594|4835259|P2|Overall Study|Withdrawal by Subject|1
1466899|NCT00711594|4835260|P1|Overall Study|Withdrawal by Subject|0
1466900|NCT00711594|4835257|P4|Overall Study|Other Adverse Event|16
1466901|NCT00711594|4835258|P3|Overall Study|Other Adverse Event|0
1466902|NCT00711594|4835259|P2|Overall Study|Other Adverse Event|0
1466903|NCT00711594|4835260|P1|Overall Study|Other Adverse Event|1
1466904|NCT00711594|4835257|P4|Overall Study|Progressive disease|44
1466905|NCT00711594|4835258|P3|Overall Study|Progressive disease|6
1466906|NCT00711594|4835259|P2|Overall Study|Progressive disease|2
1466907|NCT00711594|4835260|P1|Overall Study|Progressive disease|2
1466908|NCT00711555|4835297|P1|Overall Study|Adverse Event|3
1466909|NCT00711529|4835306|P2|Overall Study|Withdrawal by Subject|6
1466910|NCT00711529|4835307|P1|Overall Study|Withdrawal by Subject|2
1466911|NCT00711529|4835306|P2|Overall Study|Protocol Violation|0
1466912|NCT00711529|4835307|P1|Overall Study|Protocol Violation|2
1466913|NCT00711516|4835331|P2|Overall Study|Protocol Violation|1
1466914|NCT00711516|4835332|P1|Overall Study|Protocol Violation|0
1466915|NCT00711516|4835331|P2|Overall Study|Withdrawal by Subject|1
1466916|NCT00711516|4835332|P1|Overall Study|Withdrawal by Subject|0
1466917|NCT00711516|4835331|P2|Overall Study|Adverse Event|1
1466918|NCT00711516|4835332|P1|Overall Study|Adverse Event|1
1466919|NCT00711477|4835439|P2|Overall Study|Noncompliance|1
1466920|NCT00711477|4835440|P1|Overall Study|Noncompliance|0
1466921|NCT00711477|4835439|P2|Overall Study|Lost to Follow-up|1
1466922|NCT00711477|4835440|P1|Overall Study|Lost to Follow-up|0
1466923|NCT00711477|4835439|P2|Overall Study|Adverse Event|1
1466924|NCT00711477|4835440|P1|Overall Study|Adverse Event|3
1466925|NCT00711425|4835486|P1|Overall Study|Lost to Follow-up|1
1466926|NCT00711425|4835486|P1|Overall Study|Death|2
1466927|NCT00711425|4835486|P1|Overall Study|Protocol Violation|1
1466928|NCT00711412|4835492|P1|Survival Follow up Until Death|Other|12
1466929|NCT00711412|4835492|P1|Evaluation for Response and Surgery|Death|1
1466930|NCT00711412|4835492|P1|Evaluation for Response and Surgery|Withdrawal by Subject|1
1466931|NCT00711412|4835492|P1|Evaluation for Response and Surgery|Too high risk for surgery|2
1466932|NCT00711412|4835492|P1|Evaluation for Response and Surgery|Progressive Disease|2
1466933|NCT00711412|4835492|P1|Combination Treatment|Progressive Disease|1
1466934|NCT00711412|4835492|P1|Evaluated for Combination Treatment|Progressive disease|2
1466935|NCT00711412|4835492|P1|Evaluated for Combination Treatment|Withdrawal by Subject|1
1466936|NCT00711412|4835492|P1|Evaluated for Combination Treatment|Death|1
1466937|NCT00711412|4835492|P1|Evaluated for Combination Treatment|Adverse Event|2
1466938|NCT00711412|4835492|P1|Induction Treatment|Other|1
1466939|NCT00711412|4835492|P1|Induction Treatment|Adverse Event|1
1466940|NCT00711412|4835492|P1|Induction Treatment|Death|2
1466941|NCT00711191|4835526|P3|Overall Study|Withdrawal by Subject|3
1466942|NCT00711191|4835527|P2|Overall Study|Withdrawal by Subject|1
1466943|NCT00711191|4835528|P1|Overall Study|Withdrawal by Subject|0
1466944|NCT00711191|4835526|P3|Overall Study|Objective progression or relapse|7
1466945|NCT00711191|4835527|P2|Overall Study|Objective progression or relapse|3
1466946|NCT00711191|4835528|P1|Overall Study|Objective progression or relapse|2
1466947|NCT00711191|4835526|P3|Overall Study|Adverse Event|2
1466948|NCT00711191|4835527|P2|Overall Study|Adverse Event|1
1466949|NCT00711191|4835528|P1|Overall Study|Adverse Event|1
1466950|NCT00711113|4835565|P1|Overall Study|Implant lost|2
1466951|NCT00711113|4835565|P1|Overall Study|Lost to Follow-up|9
1466952|NCT00711100|4835571|P1|Overall Study|Withdrawal by Subject|8
1466953|NCT00711100|4835571|P1|Overall Study|Lack of Efficacy|5
1466954|NCT00711087|4835589|P2|Overall Study|Lost to Follow-up|0
1466955|NCT00711087|4835590|P1|Overall Study|Lost to Follow-up|1
1466956|NCT00711009|4835602|P2|Overall Study|Dose adjustment|0
1466957|NCT00711009|4835603|P1|Overall Study|Dose adjustment|1
1466958|NCT00711009|4835602|P2|Overall Study|Site closing|1
1466959|NCT00711009|4835603|P1|Overall Study|Site closing|0
1466960|NCT00711009|4835602|P2|Overall Study|Pregnancy|0
1466961|NCT00711009|4835603|P1|Overall Study|Pregnancy|1
1466962|NCT00711009|4835602|P2|Overall Study|Virologic Failure|1
1466963|NCT00711009|4835603|P1|Overall Study|Virologic Failure|2
1466964|NCT00711009|4835602|P2|Overall Study|Participant Noncompliant|1
1466965|NCT00711009|4835603|P1|Overall Study|Participant Noncompliant|0
1466966|NCT00711009|4835602|P2|Overall Study|Lost to Follow-up|9
1466967|NCT00711009|4835603|P1|Overall Study|Lost to Follow-up|3
1466968|NCT00711009|4835602|P2|Overall Study|Withdrawal by Subject|2
1466969|NCT00711009|4835603|P1|Overall Study|Withdrawal by Subject|4
1466970|NCT00711009|4835602|P2|Overall Study|Adverse Event/HIV-Related Event|5
1466971|NCT00711009|4835603|P1|Overall Study|Adverse Event/HIV-Related Event|4
1466972|NCT00710970|4835784|P1|Overall Study|Never took drug|2
1466973|NCT00710970|4835784|P1|Overall Study|Lost to Follow-up|8
1466974|NCT00710879|4835811|P2|Overall Study|Protocol Violation|3
1466975|NCT00710879|4835812|P1|Overall Study|Protocol Violation|0
1466976|NCT00710879|4835811|P2|Overall Study|Lost to Follow-up|1
1466977|NCT00710879|4835812|P1|Overall Study|Lost to Follow-up|2
1466978|NCT00710866|4835824|P2|Overall Study|Failed to meet eligibility|1
1466979|NCT00710866|4835825|P1|Overall Study|Failed to meet eligibility|1
1466980|NCT00710866|4835824|P2|Overall Study|Lost to Follow-up|0
1466981|NCT00710866|4835825|P1|Overall Study|Lost to Follow-up|1
1466982|NCT00710866|4835824|P2|Overall Study|Withdrawal by Subject|1
1466983|NCT00710866|4835825|P1|Overall Study|Withdrawal by Subject|2
1466984|NCT00710866|4835824|P2|Overall Study|Protocol Violation|4
1466985|NCT00710866|4835825|P1|Overall Study|Protocol Violation|5
1466986|NCT00710762|4835871|P2|Overall Study|Reason other than listed above|2
1466987|NCT00710762|4835872|P1|Overall Study|Reason other than listed above|2
1466988|NCT00710762|4835871|P2|Overall Study|Lost to Follow-up|0
1466989|NCT00710762|4835872|P1|Overall Study|Lost to Follow-up|1
1466990|NCT00710762|4835871|P2|Overall Study|Other Adverse Event|7
1466991|NCT00710762|4835872|P1|Overall Study|Other Adverse Event|7
1466992|NCT00710762|4835871|P2|Overall Study|Adverse Event other disease worsening|1
1466993|NCT00710762|4835872|P1|Overall Study|Adverse Event other disease worsening|2
1466994|NCT00710762|4835871|P2|Overall Study|Progressive disease|30
1466995|NCT00710762|4835872|P1|Overall Study|Progressive disease|27
1466996|NCT00710749|4835888|P2|First Intervention|Withdrawal by Subject|0
1466997|NCT00710749|4835889|P1|First Intervention|Withdrawal by Subject|1
1466998|NCT00710684|4835900|P3|Overall Study|Did not continue after week 24|16
1466999|NCT00710684|4835901|P2|Overall Study|Did not continue after week 24|21
1467000|NCT00710684|4835902|P1|Overall Study|Did not continue after week 24|25
1467001|NCT00710684|4835900|P3|Overall Study|Missing|0
1467002|NCT00710684|4835901|P2|Overall Study|Missing|0
1467003|NCT00710684|4835902|P1|Overall Study|Missing|1
1467004|NCT00710684|4835900|P3|Overall Study|Withdrawal by Subject|11
1467005|NCT00710684|4835901|P2|Overall Study|Withdrawal by Subject|18
1467006|NCT00710684|4835902|P1|Overall Study|Withdrawal by Subject|24
1467007|NCT00710684|4835900|P3|Overall Study|Physician Decision|4
1467008|NCT00710684|4835901|P2|Overall Study|Physician Decision|2
1467009|NCT00710684|4835902|P1|Overall Study|Physician Decision|0
1467010|NCT00710684|4835900|P3|Overall Study|Lost to Follow-up|7
1467011|NCT00710684|4835901|P2|Overall Study|Lost to Follow-up|6
1467012|NCT00710684|4835902|P1|Overall Study|Lost to Follow-up|4
1467013|NCT00710684|4835900|P3|Overall Study|Protocol Violation|5
1467014|NCT00710684|4835901|P2|Overall Study|Protocol Violation|5
1467015|NCT00710684|4835902|P1|Overall Study|Protocol Violation|5
1467016|NCT00710684|4835900|P3|Overall Study|Lack of Efficacy|5
1467017|NCT00710684|4835901|P2|Overall Study|Lack of Efficacy|3
1467018|NCT00710684|4835902|P1|Overall Study|Lack of Efficacy|4
1467019|NCT00710684|4835900|P3|Overall Study|Adverse Event|16
1467020|NCT00710684|4835901|P2|Overall Study|Adverse Event|19
1467021|NCT00710684|4835902|P1|Overall Study|Adverse Event|11
1467022|NCT00710606|4835959|P2|Overall Study|Adverse Event|2
1467023|NCT00710606|4835960|P1|Overall Study|Adverse Event|0
1467024|NCT00710593|4835972|P2|Overall Study|Prem disc vaccine, completed all visits|2
1467025|NCT00710593|4835973|P1|Overall Study|Prem disc vaccine, completed all visits|6
1467026|NCT00710593|4835972|P2|Overall Study|Protocol Violation|1
1467027|NCT00710593|4835973|P1|Overall Study|Protocol Violation|1
1467028|NCT00710593|4835972|P2|Overall Study|Failure to adhere or complete study eval|1
1467029|NCT00710593|4835973|P1|Overall Study|Failure to adhere or complete study eval|1
1467030|NCT00710593|4835972|P2|Overall Study|Moved out of area|0
1467031|NCT00710593|4835973|P1|Overall Study|Moved out of area|1
1467032|NCT00710593|4835972|P2|Overall Study|Lost to Follow-up|1
1467033|NCT00710593|4835973|P1|Overall Study|Lost to Follow-up|3
1467034|NCT00710593|4835972|P2|Overall Study|Unable to complete Wk 48 within window|0
1467035|NCT00710593|4835973|P1|Overall Study|Unable to complete Wk 48 within window|2
1467036|NCT00710593|4835972|P2|Overall Study|Incarceration|0
1467037|NCT00710593|4835973|P1|Overall Study|Incarceration|1
1467038|NCT00710554|4836016|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
1467039|NCT00710554|4836017|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
1467040|NCT00710554|4836016|P2|Overall Study|Lack of Efficacy|12
1467041|NCT00710554|4836017|P1|Overall Study|Lack of Efficacy|11
1467042|NCT00710554|4836016|P2|Overall Study|Lost to Follow-up|1
1467043|NCT00710554|4836017|P1|Overall Study|Lost to Follow-up|7
1467044|NCT00710554|4836016|P2|Overall Study|Withdrawal by Subject|3
1467045|NCT00710554|4836017|P1|Overall Study|Withdrawal by Subject|7
1467046|NCT00710554|4836016|P2|Overall Study|Adverse Event|7
1467047|NCT00710554|4836017|P1|Overall Study|Adverse Event|24
1467048|NCT00710424|4836045|P2|Overall Study|Felt good so stopped treatment|1
1467049|NCT00710424|4836046|P1|Overall Study|Felt good so stopped treatment|0
1467050|NCT00710424|4836045|P2|Overall Study|Subject preferred paracetamol|1
1467051|NCT00710424|4836046|P1|Overall Study|Subject preferred paracetamol|0
1467052|NCT00710424|4836045|P2|Overall Study|Ceased treatment due to travel|0
1467053|NCT00710424|4836046|P1|Overall Study|Ceased treatment due to travel|1
1467054|NCT00710424|4836045|P2|Overall Study|Subject thought medication changed|0
1467055|NCT00710424|4836046|P1|Overall Study|Subject thought medication changed|1
1467056|NCT00710424|4836045|P2|Overall Study|Did not meet entry criteria at visit 1|0
1467057|NCT00710424|4836046|P1|Overall Study|Did not meet entry criteria at visit 1|1
1467058|NCT00710424|4836045|P2|Overall Study|Non-compliance with stable analgesia|0
1467059|NCT00710424|4836046|P1|Overall Study|Non-compliance with stable analgesia|1
1467060|NCT00710424|4836045|P2|Overall Study|Refused medication, no side effects|0
1467061|NCT00710424|4836046|P1|Overall Study|Refused medication, no side effects|1
1467062|NCT00710424|4836045|P2|Overall Study|Lost to Follow-up|1
1467063|NCT00710424|4836046|P1|Overall Study|Lost to Follow-up|0
1467064|NCT00710424|4836045|P2|Overall Study|Withdrawal by Subject|3
1467065|NCT00710424|4836046|P1|Overall Study|Withdrawal by Subject|5
1467066|NCT00710424|4836045|P2|Overall Study|Lack of Efficacy|5
1467067|NCT00710424|4836046|P1|Overall Study|Lack of Efficacy|4
1467068|NCT00710424|4836045|P2|Overall Study|Adverse Event|12
1467069|NCT00710424|4836046|P1|Overall Study|Adverse Event|30
1467070|NCT00710385|4836070|P1|Overall Study|Undisclosed excessive methadone use|1
1467071|NCT00710385|4836070|P1|Overall Study|Physician Decision|1
1467072|NCT00710385|4836070|P1|Overall Study|Undisclosed back pain|1
1467073|NCT00710385|4836070|P1|Overall Study|Withdrawal by Subject|1
1467074|NCT00710385|4836070|P1|Overall Study|Did not qualify|1
1467075|NCT00710034|4836115|P2|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
1467076|NCT00710034|4836116|P1|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
1467077|NCT00710034|4836115|P2|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
1467078|NCT00710034|4836116|P1|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
1467079|NCT00710034|4836115|P2|Completed 12 Weeks of Treatment|Lost to Follow-up|5
1467080|NCT00710034|4836116|P1|Completed 12 Weeks of Treatment|Lost to Follow-up|5
1467081|NCT00710034|4836115|P2|Completed 12 Weeks of Treatment|Lack of Efficacy|2
1467082|NCT00710034|4836116|P1|Completed 12 Weeks of Treatment|Lack of Efficacy|0
1467083|NCT00710034|4836115|P2|Completed 12 Weeks of Treatment|Adverse Event|1
1467084|NCT00710034|4836116|P1|Completed 12 Weeks of Treatment|Adverse Event|0
1467085|NCT00710034|4836115|P2|Completed 6 Weeks of Treatment|Physician Decision|0
1467086|NCT00710034|4836116|P1|Completed 6 Weeks of Treatment|Physician Decision|1
1467087|NCT00710034|4836115|P2|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
1467088|NCT00710034|4836116|P1|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
1467089|NCT00710034|4836115|P2|Completed 6 Weeks of Treatment|Product dissatisfaction|6
1467090|NCT00710034|4836116|P1|Completed 6 Weeks of Treatment|Product dissatisfaction|2
1467091|NCT00710034|4836115|P2|Completed 6 Weeks of Treatment|Lost to Follow-up|17
1467092|NCT00710034|4836116|P1|Completed 6 Weeks of Treatment|Lost to Follow-up|15
1467181|NCT00709098|4836626|P2|Double-blind Period|Administrative reason|3
1467093|NCT00710034|4836115|P2|Completed 6 Weeks of Treatment|Lack of Efficacy|8
1467094|NCT00710034|4836116|P1|Completed 6 Weeks of Treatment|Lack of Efficacy|12
1467095|NCT00710034|4836115|P2|Completed 6 Weeks of Treatment|Adverse Event|12
1467096|NCT00710034|4836116|P1|Completed 6 Weeks of Treatment|Adverse Event|5
1467097|NCT00710021|4836133|P3|Overall Study|Physician Decision|0
1467098|NCT00710021|4836134|P2|Overall Study|Physician Decision|1
1467099|NCT00710021|4836135|P1|Overall Study|Physician Decision|0
1467100|NCT00710021|4836133|P3|Overall Study|Subject misrandomized|1
1467101|NCT00710021|4836134|P2|Overall Study|Subject misrandomized|1
1467102|NCT00710021|4836135|P1|Overall Study|Subject misrandomized|0
1467103|NCT00710021|4836133|P3|Overall Study|Subject's Decision|0
1467104|NCT00710021|4836134|P2|Overall Study|Subject's Decision|1
1467105|NCT00710021|4836135|P1|Overall Study|Subject's Decision|0
1467106|NCT00710021|4836133|P3|Overall Study|Lost to Follow-up|0
1467107|NCT00710021|4836134|P2|Overall Study|Lost to Follow-up|0
1467108|NCT00710021|4836135|P1|Overall Study|Lost to Follow-up|1
1467109|NCT00709956|4836250|P2|Overall Study|Inclusion/exclusion criteria violation|3
1467110|NCT00709956|4836251|P1|Overall Study|Inclusion/exclusion criteria violation|2
1467111|NCT00709956|4836250|P2|Overall Study|Withdrawal by Subject|1
1467112|NCT00709956|4836251|P1|Overall Study|Withdrawal by Subject|1
1467113|NCT00709852|4836281|P2|Period 2|No 72-hour follow-up|0
1467114|NCT00709852|4836282|P1|Period 2|No 72-hour follow-up|3
1467115|NCT00709852|4836281|P2|Period 2|Lost to Follow-up|0
1467116|NCT00709852|4836282|P1|Period 2|Lost to Follow-up|1
1467117|NCT00709852|4836281|P2|Period 2|Adverse Event|1
1467118|NCT00709852|4836282|P1|Period 2|Adverse Event|1
1467119|NCT00709852|4836281|P2|Period 2|Protocol Violation|1
1467120|NCT00709852|4836282|P1|Period 2|Protocol Violation|4
1467121|NCT00709852|4836281|P2|Period 1|Lost to Follow-up|0
1467122|NCT00709852|4836282|P1|Period 1|Lost to Follow-up|1
1467123|NCT00709852|4836281|P2|Period 1|Defective scanner|1
1467124|NCT00709852|4836282|P1|Period 1|Defective scanner|0
1467125|NCT00709852|4836281|P2|Period 1|Protocol Violation|0
1467126|NCT00709852|4836282|P1|Period 1|Protocol Violation|1
1467127|NCT00709852|4836281|P2|Period 1|Withdrawal by Subject|2
1467128|NCT00709852|4836282|P1|Period 1|Withdrawal by Subject|4
1467129|NCT00709852|4836281|P2|Period 1|Adverse Event|0
1467130|NCT00709852|4836282|P1|Period 1|Adverse Event|2
1467131|NCT00709761|4836446|P1|Overall Study|Ongoing|40
1467132|NCT00709761|4836446|P1|Overall Study|Withdrawal by Subject|7
1467133|NCT00709735|4836457|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
1467134|NCT00709735|4836458|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
1467135|NCT00709735|4836457|P2|Overall Study|Relapse into Opioid Abuse|1
1467136|NCT00709735|4836458|P1|Overall Study|Relapse into Opioid Abuse|0
1467137|NCT00709735|4836457|P2|Overall Study|Lost to Follow-up|1
1467138|NCT00709735|4836458|P1|Overall Study|Lost to Follow-up|1
1467139|NCT00709722|4836466|P1|Overall Study|Adverse Event|1
1467140|NCT00709618|4836481|P1|Overall Study|Study Closed/Terminated|25
1467141|NCT00709618|4836481|P1|Overall Study|Lost to Follow-up|1
1467142|NCT00709618|4836481|P1|Overall Study|Withdrawal by Subject|4
1467143|NCT00709592|4836493|P2|Overall Study|Unable to proceed to transplant|1
1467144|NCT00709592|4836494|P1|Overall Study|Unable to proceed to transplant|0
1467145|NCT00709319|4836514|P1|Overall Study|Withdrawal by Subject|2
1467146|NCT00709319|4836514|P1|Overall Study|Death|4
1467147|NCT00709228|4836543|P1|Overall Study|Non-compliance|5
1467148|NCT00709228|4836543|P1|Overall Study|Lost to Follow-up|6
1467149|NCT00709228|4836543|P1|Overall Study|Disease progression|1
1467150|NCT00709228|4836543|P1|Overall Study|Discontinued follow-up|5
1467151|NCT00709228|4836543|P1|Overall Study|Did not enter follow-up|4
1467152|NCT00709228|4836543|P1|Overall Study|Discontinued treatment|14
1467153|NCT00709228|4836543|P1|Overall Study|Adverse events|2
1467154|NCT00709228|4836543|P1|Overall Study|Eligibility criteria not met|281
1467155|NCT00709228|4836543|P1|Overall Study|Not treated|14
1467156|NCT00709124|4836549|P2|Overall Study|encephalopathy; can't do assessment|0
1467157|NCT00709124|4836550|P1|Overall Study|encephalopathy; can't do assessment|1
1467158|NCT00709124|4836549|P2|Overall Study|Death|1
1467159|NCT00709124|4836550|P1|Overall Study|Death|3
1467160|NCT00709111|4836584|P1|Overall Study|Unable to attend clinic visits|1
1467161|NCT00709111|4836584|P1|Overall Study|Withdrawal by Subject|1
1467162|NCT00709098|4836625|P3|Open-label Period|Lost to Follow-up|1
1467163|NCT00709098|4836626|P2|Open-label Period|Lost to Follow-up|0
1467164|NCT00709098|4836627|P1|Open-label Period|Lost to Follow-up|0
1467165|NCT00709098|4836625|P3|Open-label Period|Death|1
1467166|NCT00709098|4836626|P2|Open-label Period|Death|0
1467167|NCT00709098|4836627|P1|Open-label Period|Death|0
1467168|NCT00709098|4836625|P3|Open-label Period|Administrative reason|5
1467169|NCT00709098|4836626|P2|Open-label Period|Administrative reason|0
1467170|NCT00709098|4836627|P1|Open-label Period|Administrative reason|0
1467171|NCT00709098|4836625|P3|Open-label Period|Withdrawal of consent|7
1467172|NCT00709098|4836626|P2|Open-label Period|Withdrawal of consent|0
1467173|NCT00709098|4836627|P1|Open-label Period|Withdrawal of consent|0
1467174|NCT00709098|4836625|P3|Double-blind Period|Lost to Follow-up|0
1467175|NCT00709098|4836626|P2|Double-blind Period|Lost to Follow-up|1
1467176|NCT00709098|4836627|P1|Double-blind Period|Lost to Follow-up|1
1467177|NCT00709098|4836625|P3|Double-blind Period|Death|0
1467178|NCT00709098|4836626|P2|Double-blind Period|Death|1
1467179|NCT00709098|4836627|P1|Double-blind Period|Death|1
1467180|NCT00709098|4836625|P3|Double-blind Period|Administrative reason|0
1467182|NCT00709098|4836627|P1|Double-blind Period|Administrative reason|1
1467183|NCT00709098|4836625|P3|Double-blind Period|Withdrawal of consent|0
1467184|NCT00709098|4836626|P2|Double-blind Period|Withdrawal of consent|3
1467185|NCT00709098|4836627|P1|Double-blind Period|Withdrawal of consent|3
1467186|NCT00709059|4836646|P1|Overall Study|Serious side effects|11
1467187|NCT00709059|4836646|P1|Overall Study|Side effects|20
1467188|NCT00709059|4836646|P1|Overall Study|Disease complication|3
1467189|NCT00709059|4836646|P1|Overall Study|Physician Decision|7
1467190|NCT00709059|4836646|P1|Overall Study|Withdrawal by Subject|19
1467191|NCT00709059|4836646|P1|Overall Study|Lost to Follow-up|34
1467192|NCT00708734|4836693|P1|Overall Study|leg fracture|1
1467193|NCT00708734|4836693|P1|Overall Study|vertigo|1
1467194|NCT00708734|4836693|P1|Overall Study|knee replacement|1
1467195|NCT00708734|4836693|P1|Overall Study|leg injury|1
1467196|NCT00708734|4836693|P1|Overall Study|moved|1
1467197|NCT00708734|4836693|P1|Overall Study|scheduling conflict|2
1467198|NCT00708708|4836713|P1|Overall Study|Missing values|392
1467199|NCT00708708|4836713|P1|Overall Study|Adverse Event|3
1467200|NCT00708708|4836713|P1|Overall Study|Pregnancy|3
1467201|NCT00708708|4836713|P1|Overall Study|Lack of compliance|3
1467202|NCT00708708|4836713|P1|Overall Study|Lack of effectiveness|4
1467203|NCT00708708|4836713|P1|Overall Study|Administrative reasons|7
1467204|NCT00708708|4836713|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
1467205|NCT00708708|4836713|P1|Overall Study|Good effectiveness|9
1467206|NCT00708708|4836713|P1|Overall Study|Other unspecified|11
1467207|NCT00708708|4836713|P1|Overall Study|Another therapy along with Enbrel|15
1467208|NCT00708708|4836713|P1|Overall Study|Intolerance|42
1467209|NCT00708708|4836713|P1|Overall Study|Withdrawal by Subject|51
1467210|NCT00708708|4836713|P1|Overall Study|Lost to Follow-up|52
1467211|NCT00708708|4836713|P1|Overall Study|Another therapy instead of Enbrel|141
1467212|NCT00708682|4836761|P1|Toddler Dose|Failed to Return|4
1467213|NCT00708682|4836761|P1|Toddler Dose|Lost to Follow-up|3
1467214|NCT00708682|4836761|P1|Toddler Dose|Parent/Legal Guardian Request|1
1467215|NCT00708682|4836761|P1|After Infant Series|Parent/Legal Guardian Request|1
1467216|NCT00708682|4836761|P1|Infant Series|Not Specified|19
1467217|NCT00708682|4836761|P1|Infant Series|Failed to return|2
1467218|NCT00708682|4836761|P1|Infant Series|Parent/legal guardian request|6
1467219|NCT00708682|4836761|P1|Infant Series|Protocol Violation|1
1467220|NCT00708682|4836761|P1|Infant Series|Lost to Follow-up|4
1467221|NCT00708682|4836761|P1|Infant Series|Adverse Event|1
1467222|NCT00708643|4836782|P2|Overall Study|Adverse Event|1
1467223|NCT00708643|4836783|P1|Overall Study|Adverse Event|0
1467224|NCT00708552|4836803|P4|Overall Study|Withdrawal by Subject|10
1467225|NCT00708552|4836804|P3|Overall Study|Withdrawal by Subject|8
1467226|NCT00708552|4836805|P2|Overall Study|Withdrawal by Subject|7
1467227|NCT00708552|4836806|P1|Overall Study|Withdrawal by Subject|12
1467228|NCT00708552|4836803|P4|Overall Study|Physician Decision|0
1467229|NCT00708552|4836804|P3|Overall Study|Physician Decision|0
1467230|NCT00708552|4836805|P2|Overall Study|Physician Decision|2
1467231|NCT00708552|4836806|P1|Overall Study|Physician Decision|1
1467232|NCT00708552|4836803|P4|Overall Study|Lost to Follow-up|1
1467233|NCT00708552|4836804|P3|Overall Study|Lost to Follow-up|0
1467234|NCT00708552|4836805|P2|Overall Study|Lost to Follow-up|2
1467235|NCT00708552|4836806|P1|Overall Study|Lost to Follow-up|4
1467236|NCT00708552|4836803|P4|Overall Study|Protocol Violation|4
1467237|NCT00708552|4836804|P3|Overall Study|Protocol Violation|2
1467238|NCT00708552|4836805|P2|Overall Study|Protocol Violation|0
1467239|NCT00708552|4836806|P1|Overall Study|Protocol Violation|0
1467240|NCT00708552|4836803|P4|Overall Study|Lack of Efficacy|0
1467241|NCT00708552|4836804|P3|Overall Study|Lack of Efficacy|1
1467242|NCT00708552|4836805|P2|Overall Study|Lack of Efficacy|4
1467243|NCT00708552|4836806|P1|Overall Study|Lack of Efficacy|0
1467244|NCT00708552|4836803|P4|Overall Study|Adverse Event|6
1467245|NCT00708552|4836804|P3|Overall Study|Adverse Event|4
1467246|NCT00708552|4836805|P2|Overall Study|Adverse Event|3
1467247|NCT00708552|4836806|P1|Overall Study|Adverse Event|10
1467248|NCT00708500|4836968|P3|FOLLOWUP|Non-compliance with protocol|1
1467249|NCT00708500|4836969|P2|FOLLOWUP|Non-compliance with protocol|0
1467250|NCT00708500|4836970|P1|FOLLOWUP|Non-compliance with protocol|5
1467251|NCT00708500|4836968|P3|FOLLOWUP|Subject withdrew consent|5
1467252|NCT00708500|4836969|P2|FOLLOWUP|Subject withdrew consent|4
1467253|NCT00708500|4836970|P1|FOLLOWUP|Subject withdrew consent|31
1467254|NCT00708500|4836968|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
1467255|NCT00708500|4836969|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
1467256|NCT00708500|4836970|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
1467257|NCT00708500|4836968|P3|FOLLOWUP|Lost to Follow-up|4
1467258|NCT00708500|4836969|P2|FOLLOWUP|Lost to Follow-up|6
1467259|NCT00708500|4836970|P1|FOLLOWUP|Lost to Follow-up|1
1467260|NCT00708500|4836968|P3|FOLLOWUP|Adverse Event|0
1467261|NCT00708500|4836969|P2|FOLLOWUP|Adverse Event|1
1467262|NCT00708500|4836970|P1|FOLLOWUP|Adverse Event|0
1467263|NCT00708500|4836968|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
1467264|NCT00708500|4836969|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
1467265|NCT00708500|4836970|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
1467266|NCT00708500|4836968|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
1467267|NCT00708500|4836969|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
1467268|NCT00708500|4836970|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
1467269|NCT00708500|4836968|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
1467270|NCT00708500|4836969|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
1467271|NCT00708500|4836970|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
1467272|NCT00708500|4836968|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
1467273|NCT00708500|4836969|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
1467274|NCT00708500|4836970|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
1467275|NCT00708500|4836968|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
1467276|NCT00708500|4836969|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
1467277|NCT00708500|4836970|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
1467278|NCT00708500|4836968|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
1467279|NCT00708500|4836969|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
1467280|NCT00708500|4836970|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
1467281|NCT00708500|4836968|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
1467282|NCT00708500|4836969|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
1467283|NCT00708500|4836970|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
1467284|NCT00708500|4836968|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
1467285|NCT00708500|4836969|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
1467286|NCT00708500|4836970|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
1467287|NCT00708500|4836968|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
1467288|NCT00708500|4836969|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
1467289|NCT00708500|4836970|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
1467290|NCT00708500|4836968|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
1467291|NCT00708500|4836969|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
1467292|NCT00708500|4836970|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
1467293|NCT00708500|4836968|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
1467294|NCT00708500|4836969|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
1467295|NCT00708500|4836970|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
1467296|NCT00708500|4836968|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
1467297|NCT00708500|4836969|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
1467298|NCT00708500|4836970|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
1467299|NCT00708500|4836968|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
1467300|NCT00708500|4836969|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
1467301|NCT00708500|4836970|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
1467302|NCT00708461|4836989|P2|Overall Study|left workforce|180
1467303|NCT00708461|4836990|P1|Overall Study|left workforce|115
1467304|NCT00708461|4836989|P2|Overall Study|Withdrawal by Subject|9
1467305|NCT00708461|4836990|P1|Overall Study|Withdrawal by Subject|8
1467306|NCT00708461|4836989|P2|Overall Study|Lost to Follow-up|11
1467307|NCT00708461|4836990|P1|Overall Study|Lost to Follow-up|18
1467308|NCT00708435|4836998|P2|Overall Study|Refused hospitalization|0
1467309|NCT00708435|4836999|P1|Overall Study|Refused hospitalization|1
1467310|NCT00708435|4836998|P2|Overall Study|Intervention by primary care physician|0
1467311|NCT00708435|4836999|P1|Overall Study|Intervention by primary care physician|1
1467312|NCT00708435|4836998|P2|Overall Study|Protocol Violation|1
1467313|NCT00708435|4836999|P1|Overall Study|Protocol Violation|0
1467314|NCT00708435|4836998|P2|Overall Study|Adverse Event|0
1467315|NCT00708435|4836999|P1|Overall Study|Adverse Event|1
1467316|NCT00708435|4836998|P2|Overall Study|Withdrawal by Subject|7
1467317|NCT00708435|4836999|P1|Overall Study|Withdrawal by Subject|3
1467318|NCT00708435|4836998|P2|Overall Study|Lost to Follow-up|4
1467319|NCT00708435|4836999|P1|Overall Study|Lost to Follow-up|9
1467320|NCT00708435|4836998|P2|Overall Study|Death / Serious Adverse Event|5
1467321|NCT00708435|4836999|P1|Overall Study|Death / Serious Adverse Event|10
1467322|NCT00708422|4837026|P2|Overall Study|Withdrawal by Subject|0
1467323|NCT00708422|4837027|P1|Overall Study|Withdrawal by Subject|1
1467324|NCT00708422|4837026|P2|Overall Study|Adverse Event|1
1467325|NCT00708422|4837027|P1|Overall Study|Adverse Event|3
1467326|NCT00708305|4837035|P4|Period 3|Other Reason|0
1467327|NCT00708305|4837036|P3|Period 3|Other Reason|0
1467328|NCT00708305|4837037|P2|Period 3|Other Reason|0
1467329|NCT00708305|4837038|P1|Period 3|Other Reason|1
1467330|NCT00708305|4837035|P4|Period 3|Protocol Violation|0
1467331|NCT00708305|4837036|P3|Period 3|Protocol Violation|0
1467332|NCT00708305|4837037|P2|Period 3|Protocol Violation|2
1467333|NCT00708305|4837038|P1|Period 3|Protocol Violation|0
1467334|NCT00708305|4837035|P4|Period 2|Other Reason|1
1467335|NCT00708305|4837036|P3|Period 2|Other Reason|0
1467336|NCT00708305|4837037|P2|Period 2|Other Reason|0
1467337|NCT00708305|4837038|P1|Period 2|Other Reason|1
1467338|NCT00708305|4837035|P4|Period 2|Protocol Violation|0
1467339|NCT00708305|4837036|P3|Period 2|Protocol Violation|0
1467340|NCT00708305|4837037|P2|Period 2|Protocol Violation|1
1467341|NCT00708305|4837038|P1|Period 2|Protocol Violation|0
1467342|NCT00708305|4837035|P4|Period 2|Lost to Follow-up|0
1467343|NCT00708305|4837036|P3|Period 2|Lost to Follow-up|0
1467344|NCT00708305|4837037|P2|Period 2|Lost to Follow-up|1
1467345|NCT00708305|4837038|P1|Period 2|Lost to Follow-up|0
1467346|NCT00708305|4837035|P4|Period 1|Other Reason|2
1467347|NCT00708305|4837036|P3|Period 1|Other Reason|0
1467348|NCT00708305|4837037|P2|Period 1|Other Reason|0
1467349|NCT00708305|4837038|P1|Period 1|Other Reason|0
1467350|NCT00708305|4837035|P4|Period 1|Protocol Violation|0
1467351|NCT00708305|4837036|P3|Period 1|Protocol Violation|1
1467352|NCT00708305|4837037|P2|Period 1|Protocol Violation|0
1467353|NCT00708305|4837038|P1|Period 1|Protocol Violation|1
1467354|NCT00708227|4837074|P4|Overall Study|Withdrawal by Subject|1
1467355|NCT00708227|4837075|P3|Overall Study|Withdrawal by Subject|0
1467356|NCT00708227|4837076|P2|Overall Study|Withdrawal by Subject|2
1467357|NCT00708227|4837077|P1|Overall Study|Withdrawal by Subject|1
1467358|NCT00708227|4837074|P4|Overall Study|Physician Decision|2
1467359|NCT00708227|4837075|P3|Overall Study|Physician Decision|1
1467360|NCT00708227|4837076|P2|Overall Study|Physician Decision|3
1467361|NCT00708227|4837077|P1|Overall Study|Physician Decision|0
1467362|NCT00708214|4837110|P3|Overall Study|Progressive Disease|5
1467363|NCT00708214|4837111|P2|Overall Study|Progressive Disease|6
1467364|NCT00708214|4837112|P1|Overall Study|Progressive Disease|4
1467365|NCT00708214|4837110|P3|Overall Study|Other|1
1467366|NCT00708214|4837111|P2|Overall Study|Other|1
1467367|NCT00708214|4837112|P1|Overall Study|Other|0
1467368|NCT00708214|4837110|P3|Overall Study|Other Adverse Event|2
1467369|NCT00708214|4837111|P2|Overall Study|Other Adverse Event|6
1467370|NCT00708214|4837112|P1|Overall Study|Other Adverse Event|3
1467371|NCT00708201|4837155|P2|Overall Study|Protocol Violation|1
1467372|NCT00708201|4837156|P1|Overall Study|Protocol Violation|0
1467373|NCT00708201|4837155|P2|Overall Study|Lost to Follow-up|0
1467374|NCT00708201|4837156|P1|Overall Study|Lost to Follow-up|2
1467375|NCT00708201|4837155|P2|Overall Study|Withdrawal by Subject|1
1467376|NCT00708201|4837156|P1|Overall Study|Withdrawal by Subject|1
1467377|NCT00708201|4837155|P2|Overall Study|Adverse Event|4
1467378|NCT00708201|4837156|P1|Overall Study|Adverse Event|4
1467379|NCT00708175|4837180|P2|Overall Study|BMD loss >7%|3
1467380|NCT00708175|4837181|P1|Overall Study|BMD loss >7%|2
1467381|NCT00708175|4837180|P2|Overall Study|Withdrawal by Subject|7
1467382|NCT00708175|4837181|P1|Overall Study|Withdrawal by Subject|5
1467383|NCT00708175|4837180|P2|Overall Study|Lost to Follow-up|3
1467384|NCT00708175|4837181|P1|Overall Study|Lost to Follow-up|5
1467385|NCT00708175|4837180|P2|Overall Study|Protocol Violation|3
1467386|NCT00708175|4837181|P1|Overall Study|Protocol Violation|2
1467387|NCT00708175|4837180|P2|Overall Study|Adverse Event|5
1467388|NCT00708175|4837181|P1|Overall Study|Adverse Event|4
1467389|NCT00708162|4837197|P2|Open-Label Phase|Other|0
1467390|NCT00708162|4837198|P1|Open-Label Phase|Other|1
1467391|NCT00708162|4837197|P2|Open-Label Phase|Adverse Event|2
1467392|NCT00708162|4837198|P1|Open-Label Phase|Adverse Event|1
1467393|NCT00708162|4837197|P2|Open-Label Phase|Death|1
1467394|NCT00708162|4837198|P1|Open-Label Phase|Death|3
1467395|NCT00708162|4837197|P2|Open-Label Phase|Investigator's Discretion|2
1467396|NCT00708162|4837198|P1|Open-Label Phase|Investigator's Discretion|3
1467397|NCT00708162|4837197|P2|Open-Label Phase|Lack of Efficacy|4
1467398|NCT00708162|4837198|P1|Open-Label Phase|Lack of Efficacy|7
1467399|NCT00708162|4837197|P2|Open-Label Phase|Participant Noncompliance|7
1467400|NCT00708162|4837198|P1|Open-Label Phase|Participant Noncompliance|7
1467401|NCT00708162|4837197|P2|Open-Label Phase|Withdrew Consent|6
1467402|NCT00708162|4837198|P1|Open-Label Phase|Withdrew Consent|12
1467403|NCT00708162|4837197|P2|Open-Label Phase|Lost to Follow-up|8
1467404|NCT00708162|4837198|P1|Open-Label Phase|Lost to Follow-up|10
1467405|NCT00708162|4837197|P2|Randomized Phase|Pregnancy|0
1467406|NCT00708162|4837198|P1|Randomized Phase|Pregnancy|3
1467407|NCT00708162|4837197|P2|Randomized Phase|Death|9
1467408|NCT00708162|4837198|P1|Randomized Phase|Death|2
1467409|NCT00708162|4837197|P2|Randomized Phase|Investigator’s Discretion|10
1467410|NCT00708162|4837198|P1|Randomized Phase|Investigator’s Discretion|7
1467411|NCT00708162|4837197|P2|Randomized Phase|Adverse Event|12
1467412|NCT00708162|4837198|P1|Randomized Phase|Adverse Event|8
1467413|NCT00708162|4837197|P2|Randomized Phase|Protocol Violation|11
1467414|NCT00708162|4837198|P1|Randomized Phase|Protocol Violation|10
1467415|NCT00708162|4837197|P2|Randomized Phase|Lack of Efficacy|19
1467416|NCT00708162|4837198|P1|Randomized Phase|Lack of Efficacy|14
1467417|NCT00708162|4837197|P2|Randomized Phase|Withdrew Consent|22
1467418|NCT00708162|4837198|P1|Randomized Phase|Withdrew Consent|31
1467419|NCT00708162|4837197|P2|Randomized Phase|Lost to Follow-up|34
1467420|NCT00708162|4837198|P1|Randomized Phase|Lost to Follow-up|34
1467421|NCT00708162|4837197|P2|Randomized Phase|Participant Noncompliance|32
1467422|NCT00708162|4837198|P1|Randomized Phase|Participant Noncompliance|40
1467423|NCT00708162|4837197|P2|Randomized Phase|Randomized but Not Treated|5
1467424|NCT00708162|4837198|P1|Randomized Phase|Randomized but Not Treated|7
1467425|NCT00708123|4837239|P5|Period 4|Protocol Violation|0
1467426|NCT00708123|4837240|P4|Period 4|Protocol Violation|0
1467427|NCT00708123|4837241|P3|Period 4|Protocol Violation|0
1467428|NCT00708123|4837242|P2|Period 4|Protocol Violation|1
1467429|NCT00708123|4837243|P1|Period 4|Protocol Violation|0
1467430|NCT00708123|4837239|P5|Period 3|Lost to Follow-up|0
1467431|NCT00708123|4837240|P4|Period 3|Lost to Follow-up|1
1467432|NCT00708123|4837241|P3|Period 3|Lost to Follow-up|1
1467433|NCT00708123|4837242|P2|Period 3|Lost to Follow-up|0
1467434|NCT00708123|4837243|P1|Period 3|Lost to Follow-up|0
1467435|NCT00708123|4837239|P5|Period 2|Other Reason|0
1467436|NCT00708123|4837240|P4|Period 2|Other Reason|0
1467437|NCT00708123|4837241|P3|Period 2|Other Reason|0
1467438|NCT00708123|4837242|P2|Period 2|Other Reason|0
1467439|NCT00708123|4837243|P1|Period 2|Other Reason|1
1467440|NCT00708123|4837239|P5|Period 2|Protocol Violation|0
1467441|NCT00708123|4837240|P4|Period 2|Protocol Violation|1
1467442|NCT00708123|4837241|P3|Period 2|Protocol Violation|0
1467443|NCT00708123|4837242|P2|Period 2|Protocol Violation|0
1467444|NCT00708123|4837243|P1|Period 2|Protocol Violation|0
1467445|NCT00708123|4837239|P5|Period 1|Adverse Event|0
1467446|NCT00708123|4837240|P4|Period 1|Adverse Event|0
1467447|NCT00708123|4837241|P3|Period 1|Adverse Event|1
1467448|NCT00708123|4837242|P2|Period 1|Adverse Event|0
1467449|NCT00708123|4837243|P1|Period 1|Adverse Event|0
1467450|NCT00708123|4837239|P5|Period 1|Protocol Violation|0
1467451|NCT00708123|4837240|P4|Period 1|Protocol Violation|1
1467452|NCT00708123|4837241|P3|Period 1|Protocol Violation|0
1467453|NCT00708123|4837242|P2|Period 1|Protocol Violation|1
1467454|NCT00708123|4837243|P1|Period 1|Protocol Violation|0
1467455|NCT00708097|4837376|P5|Period 2|Protocol Violation|0
1467456|NCT00708097|4837377|P4|Period 2|Protocol Violation|1
1467457|NCT00708097|4837378|P3|Period 2|Protocol Violation|1
1467458|NCT00708097|4837379|P2|Period 2|Protocol Violation|1
1467459|NCT00708097|4837380|P1|Period 2|Protocol Violation|0
1467460|NCT00708097|4837376|P5|Period 1|Other Reason|1
1467461|NCT00708097|4837377|P4|Period 1|Other Reason|0
1467462|NCT00708097|4837378|P3|Period 1|Other Reason|0
1467463|NCT00708097|4837379|P2|Period 1|Other Reason|0
1467464|NCT00708097|4837380|P1|Period 1|Other Reason|0
1467465|NCT00708097|4837376|P5|Period 1|Protocol Violation|0
1467466|NCT00708097|4837377|P4|Period 1|Protocol Violation|2
1467467|NCT00708097|4837378|P3|Period 1|Protocol Violation|0
1467468|NCT00708097|4837379|P2|Period 1|Protocol Violation|1
1467469|NCT00708097|4837380|P1|Period 1|Protocol Violation|0
1467470|NCT00708032|4837490|P2|Overall Study|Withdrawal by Subject|1
1467471|NCT00708032|4837491|P1|Overall Study|Withdrawal by Subject|0
1467472|NCT00708032|4837490|P2|Overall Study|Protocol Violation|1
1467473|NCT00708032|4837491|P1|Overall Study|Protocol Violation|4
1467474|NCT00708032|4837490|P2|Overall Study|Did not meet protocol criteria|2
1467475|NCT00708032|4837491|P1|Overall Study|Did not meet protocol criteria|1
1467476|NCT00708032|4837490|P2|Overall Study|Visit out of range at month 12|1
1467477|NCT00708032|4837491|P1|Overall Study|Visit out of range at month 12|4
1467478|NCT00708032|4837490|P2|Overall Study|Poor vision|6
1467479|NCT00708032|4837491|P1|Overall Study|Poor vision|0
1467480|NCT00708032|4837490|P2|Overall Study|Pregnancy|1
1467481|NCT00708032|4837491|P1|Overall Study|Pregnancy|0
1467482|NCT00708032|4837490|P2|Overall Study|Lost to Follow-up|2
1467483|NCT00708032|4837491|P1|Overall Study|Lost to Follow-up|1
1467484|NCT00708032|4837490|P2|Overall Study|Adverse Event|2
1467485|NCT00708032|4837491|P1|Overall Study|Adverse Event|0
1467486|NCT00707993|4837518|P2|Overall Study|Other|0
1467487|NCT00707993|4837519|P1|Overall Study|Other|2
1467488|NCT00707993|4837518|P2|Overall Study|Hyperglycemic Rescue|47
1467489|NCT00707993|4837519|P1|Overall Study|Hyperglycemic Rescue|55
1467490|NCT00707993|4837518|P2|Overall Study|Withdrawal by Subject|16
1467491|NCT00707993|4837519|P1|Overall Study|Withdrawal by Subject|12
1467492|NCT00707993|4837518|P2|Overall Study|Lost to Follow-up|4
1467493|NCT00707993|4837519|P1|Overall Study|Lost to Follow-up|0
1467494|NCT00707993|4837518|P2|Overall Study|Protocol Violation|7
1467495|NCT00707993|4837519|P1|Overall Study|Protocol Violation|4
1467496|NCT00707993|4837518|P2|Overall Study|Adverse Event|20
1467497|NCT00707993|4837519|P1|Overall Study|Adverse Event|16
1467498|NCT00707980|4837561|P1|Overall Study|Other|39
1467499|NCT00707980|4837561|P1|Overall Study|Lost to Follow-up|59
1467500|NCT00707980|4837561|P1|Overall Study|Withdrawal of Consent|81
1467501|NCT00707980|4837561|P1|Overall Study|Protocol Deviations|19
1467502|NCT00707980|4837561|P1|Overall Study|Non-Compliance with Study Drug|28
1467503|NCT00707980|4837561|P1|Overall Study|Lack of Efficacy|35
1467504|NCT00707980|4837561|P1|Overall Study|Adverse Event|49
1467505|NCT00707954|4837645|P5|Overall Study|Physician Decision|1
1467506|NCT00707954|4837646|P4|Overall Study|Physician Decision|0
1467507|NCT00707954|4837647|P3|Overall Study|Physician Decision|0
1467508|NCT00707954|4837648|P2|Overall Study|Physician Decision|0
1467509|NCT00707954|4837649|P1|Overall Study|Physician Decision|0
1467510|NCT00707746|4837690|P2|Treatment Period|Ineligibility|1
1467511|NCT00707746|4837691|P1|Treatment Period|Ineligibility|0
1467512|NCT00707746|4837690|P2|Treatment Period|Adverse Event|4
1467513|NCT00707746|4837691|P1|Treatment Period|Adverse Event|2
1467514|NCT00707577|4837752|P2|Overall Study|Pregnancy|1
1467515|NCT00707577|4837753|P1|Overall Study|Pregnancy|4
1467516|NCT00707577|4837752|P2|Overall Study|Left employment|10
1467517|NCT00707577|4837753|P1|Overall Study|Left employment|13
1467518|NCT00707577|4837752|P2|Overall Study|Lost to Follow-up|25
1467519|NCT00707577|4837753|P1|Overall Study|Lost to Follow-up|34
1467520|NCT00707577|4837752|P2|Overall Study|Withdrawal by Subject|2
1467521|NCT00707577|4837753|P1|Overall Study|Withdrawal by Subject|3
1467522|NCT00707486|4837759|P1|Overall Study|Withdrawal by Subject|1
1467523|NCT00707239|4837802|P3|Overall Study|Other|5
1467524|NCT00707239|4837803|P2|Overall Study|Other|3
1467525|NCT00707239|4837804|P1|Overall Study|Other|8
1467526|NCT00707239|4837802|P3|Overall Study|Randomized, but not treated|1
1467527|NCT00707239|4837803|P2|Overall Study|Randomized, but not treated|1
1467528|NCT00707239|4837804|P1|Overall Study|Randomized, but not treated|1
1467529|NCT00707239|4837802|P3|Overall Study|Lack of Efficacy|0
1467530|NCT00707239|4837803|P2|Overall Study|Lack of Efficacy|2
1467531|NCT00707239|4837804|P1|Overall Study|Lack of Efficacy|1
1467532|NCT00707239|4837802|P3|Overall Study|Protocol Violation|1
1467533|NCT00707239|4837803|P2|Overall Study|Protocol Violation|0
1467534|NCT00707239|4837804|P1|Overall Study|Protocol Violation|0
1467535|NCT00707239|4837802|P3|Overall Study|Physician Decision|2
1467536|NCT00707239|4837803|P2|Overall Study|Physician Decision|1
1467537|NCT00707239|4837804|P1|Overall Study|Physician Decision|1
1467538|NCT00707239|4837802|P3|Overall Study|Death|3
1467539|NCT00707239|4837803|P2|Overall Study|Death|1
1467540|NCT00707239|4837804|P1|Overall Study|Death|3
1467541|NCT00707239|4837802|P3|Overall Study|Adverse Event|2
1467542|NCT00707239|4837803|P2|Overall Study|Adverse Event|3
1467543|NCT00707239|4837804|P1|Overall Study|Adverse Event|5
1467544|NCT00707174|4837852|P2|Overall Study|Withdrawal by Subject|1
1467545|NCT00707174|4837853|P1|Overall Study|Withdrawal by Subject|4
1467546|NCT00707174|4837852|P2|Overall Study|Adverse Event|6
1467547|NCT00707174|4837853|P1|Overall Study|Adverse Event|1
1467548|NCT00707161|4837859|P1|Overall Study|Physician Decision|6
1467549|NCT00707057|4837865|P2|Overall Study|Dosed incorrectly|1
1467550|NCT00707057|4837866|P1|Overall Study|Dosed incorrectly|0
1467551|NCT00707057|4837865|P2|Overall Study|Withdrawal by Subject|3
1467552|NCT00707057|4837866|P1|Overall Study|Withdrawal by Subject|8
1467553|NCT00707031|4837900|P2|Overall Study|Sponsor Decision|8
1467554|NCT00707031|4837901|P1|Overall Study|Sponsor Decision|9
1467555|NCT00707031|4837900|P2|Overall Study|Serious Noncompliance|3
1467556|NCT00707031|4837901|P1|Overall Study|Serious Noncompliance|2
1467557|NCT00707031|4837900|P2|Overall Study|Familial or Personal Reasons|15
1467558|NCT00707031|4837901|P1|Overall Study|Familial or Personal Reasons|12
1467559|NCT00707031|4837900|P2|Overall Study|Poor Compliance to Protocol|13
1467560|NCT00707031|4837901|P1|Overall Study|Poor Compliance to Protocol|7
1467561|NCT00707031|4837900|P2|Overall Study|Withdrawal by Subject|8
1467562|NCT00707031|4837901|P1|Overall Study|Withdrawal by Subject|7
1467563|NCT00707031|4837900|P2|Overall Study|Protocol Violation|0
1467564|NCT00707031|4837901|P1|Overall Study|Protocol Violation|1
1467565|NCT00707031|4837900|P2|Overall Study|Lost to Follow-up|1
1467566|NCT00707031|4837901|P1|Overall Study|Lost to Follow-up|2
1467567|NCT00707031|4837900|P2|Overall Study|Lack of Efficacy|6
1467568|NCT00707031|4837901|P1|Overall Study|Lack of Efficacy|19
1467569|NCT00707031|4837900|P2|Overall Study|Adverse Event|45
1467570|NCT00707031|4837901|P1|Overall Study|Adverse Event|45
1467571|NCT00706992|4837930|P7|Overall Study|Disease progression before treatment|0
1467572|NCT00706992|4837931|P6|Overall Study|Disease progression before treatment|0
1467573|NCT00706992|4837932|P5|Overall Study|Disease progression before treatment|1
1467574|NCT00706992|4837933|P4|Overall Study|Disease progression before treatment|0
1467575|NCT00706992|4837934|P3|Overall Study|Disease progression before treatment|0
1467576|NCT00706992|4837935|P2|Overall Study|Disease progression before treatment|0
1467577|NCT00706992|4837936|P1|Overall Study|Disease progression before treatment|0
1467578|NCT00706992|4837930|P7|Overall Study|Study termination|3
1467579|NCT00706992|4837931|P6|Overall Study|Study termination|2
1467580|NCT00706992|4837932|P5|Overall Study|Study termination|3
1467581|NCT00706992|4837933|P4|Overall Study|Study termination|2
1467582|NCT00706992|4837934|P3|Overall Study|Study termination|6
1467583|NCT00706992|4837935|P2|Overall Study|Study termination|5
1467584|NCT00706992|4837936|P1|Overall Study|Study termination|5
1467585|NCT00706966|4837968|P1|Overall Study|Adverse Event|1
1467586|NCT00706914|4838004|P3|Overall Study|Protocol Violation|1
1467587|NCT00706914|4838005|P2|Overall Study|Protocol Violation|1
1467588|NCT00706914|4838006|P1|Overall Study|Protocol Violation|3
1467589|NCT00706914|4838004|P3|Overall Study|Adverse Event|0
1467590|NCT00706914|4838005|P2|Overall Study|Adverse Event|2
1467591|NCT00706914|4838006|P1|Overall Study|Adverse Event|2
1467592|NCT00706914|4838004|P3|Overall Study|Lost to Follow-up|0
1467593|NCT00706914|4838005|P2|Overall Study|Lost to Follow-up|0
1467594|NCT00706914|4838006|P1|Overall Study|Lost to Follow-up|1
1467595|NCT00706914|4838004|P3|Overall Study|Lack of Efficacy|0
1467596|NCT00706914|4838005|P2|Overall Study|Lack of Efficacy|1
1467597|NCT00706914|4838006|P1|Overall Study|Lack of Efficacy|0
1467598|NCT00706901|4838029|P3|Overall Study|Death|0
1467599|NCT00706901|4838030|P2|Overall Study|Death|0
1467600|NCT00706901|4838031|P1|Overall Study|Death|1
1467601|NCT00706901|4838029|P3|Overall Study|In Jail|1
1467602|NCT00706901|4838030|P2|Overall Study|In Jail|0
1467603|NCT00706901|4838031|P1|Overall Study|In Jail|1
1467604|NCT00706901|4838029|P3|Overall Study|Withdrawal by Subject|5
1467605|NCT00706901|4838030|P2|Overall Study|Withdrawal by Subject|2
1467606|NCT00706901|4838031|P1|Overall Study|Withdrawal by Subject|4
1467607|NCT00706901|4838029|P3|Overall Study|Lost to Follow-up|2
1467608|NCT00706901|4838030|P2|Overall Study|Lost to Follow-up|3
1467609|NCT00706901|4838031|P1|Overall Study|Lost to Follow-up|2
1467610|NCT00706849|4838056|P2|Follow-up Period|Protocol non-compliance|1
1467611|NCT00706849|4838057|P1|Follow-up Period|Protocol non-compliance|0
1467612|NCT00706849|4838056|P2|Follow-up Period|Withdrawal by Subject|2
1467613|NCT00706849|4838057|P1|Follow-up Period|Withdrawal by Subject|0
1467614|NCT00706849|4838056|P2|Treatment Period|Other|1
1467615|NCT00706849|4838057|P1|Treatment Period|Other|0
1467616|NCT00706849|4838056|P2|Treatment Period|Adverse Event|9
1467617|NCT00706849|4838057|P1|Treatment Period|Adverse Event|0
1467618|NCT00706797|4838135|P2|Overall Study|Other|0
1467619|NCT00706797|4838136|P1|Overall Study|Other|1
1467620|NCT00706797|4838135|P2|Overall Study|Lost to Follow-up|2
1467621|NCT00706797|4838136|P1|Overall Study|Lost to Follow-up|1
1467622|NCT00706797|4838135|P2|Overall Study|Protocol Violation|2
1467623|NCT00706797|4838136|P1|Overall Study|Protocol Violation|3
1467624|NCT00706797|4838135|P2|Overall Study|Discontinuation of study by sponsor|63
1467625|NCT00706797|4838136|P1|Overall Study|Discontinuation of study by sponsor|52
1467626|NCT00706797|4838135|P2|Overall Study|Death|0
1467627|NCT00706797|4838136|P1|Overall Study|Death|1
1467628|NCT00706797|4838135|P2|Overall Study|Withdrawal by Subject|1
1467629|NCT00706797|4838136|P1|Overall Study|Withdrawal by Subject|8
1467630|NCT00706797|4838135|P2|Overall Study|Adverse Event|3
1467631|NCT00706797|4838136|P1|Overall Study|Adverse Event|0
1467632|NCT00706797|4838135|P2|Overall Study|Lack of Efficacy|0
1467633|NCT00706797|4838136|P1|Overall Study|Lack of Efficacy|3
1467634|NCT00706706|4838205|P1|Overall Study|Study endpoint had reached|45
1467635|NCT00706706|4838205|P1|Overall Study|Lost to Follow-up|7
1467636|NCT00706706|4838205|P1|Overall Study|Death|53
1467637|NCT00706654|4838215|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
1467638|NCT00706654|4838216|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
1467639|NCT00706654|4838217|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
1467640|NCT00706654|4838218|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
1467641|NCT00706654|4838215|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
1467642|NCT00706654|4838216|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
1467643|NCT00706654|4838217|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
1467644|NCT00706654|4838218|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
1467645|NCT00706654|4838215|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
1467646|NCT00706654|4838216|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
1467647|NCT00706654|4838217|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
1467648|NCT00706654|4838218|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
1467649|NCT00706654|4838215|P4|Depot Maintenance Phase|Protocol Deviation|1
1467650|NCT00706654|4838216|P3|Depot Maintenance Phase|Protocol Deviation|3
1467651|NCT00706654|4838217|P2|Depot Maintenance Phase|Protocol Deviation|2
1467652|NCT00706654|4838218|P1|Depot Maintenance Phase|Protocol Deviation|0
1467653|NCT00706654|4838215|P4|Depot Maintenance Phase|Withdrew Consent|14
1467654|NCT00706654|4838216|P3|Depot Maintenance Phase|Withdrew Consent|29
1467655|NCT00706654|4838217|P2|Depot Maintenance Phase|Withdrew Consent|21
1467656|NCT00706654|4838218|P1|Depot Maintenance Phase|Withdrew Consent|0
1467657|NCT00706654|4838215|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
1467658|NCT00706654|4838216|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
1467659|NCT00706654|4838217|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
1467660|NCT00706654|4838218|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
1467661|NCT00706654|4838215|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
1467662|NCT00706654|4838216|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
1467663|NCT00706654|4838217|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
1467664|NCT00706654|4838218|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
1467665|NCT00706654|4838215|P4|Depot Maintenance Phase|Lost to Follow-up|6
1467666|NCT00706654|4838216|P3|Depot Maintenance Phase|Lost to Follow-up|10
1467667|NCT00706654|4838217|P2|Depot Maintenance Phase|Lost to Follow-up|4
1467668|NCT00706654|4838218|P1|Depot Maintenance Phase|Lost to Follow-up|0
1467669|NCT00706654|4838215|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
1467670|NCT00706654|4838216|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
1467671|NCT00706654|4838217|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
1467672|NCT00706654|4838218|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
1467673|NCT00706654|4838215|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
1467674|NCT00706654|4838216|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
1467675|NCT00706654|4838217|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
1467676|NCT00706654|4838218|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
1467677|NCT00706654|4838215|P4|Oral Stabilization Phase|Adverse Event|0
1467678|NCT00706654|4838216|P3|Oral Stabilization Phase|Adverse Event|0
1467679|NCT00706654|4838217|P2|Oral Stabilization Phase|Adverse Event|0
1467680|NCT00706654|4838218|P1|Oral Stabilization Phase|Adverse Event|21
1467681|NCT00706654|4838215|P4|Oral Stabilization Phase|Protocol Deviation|0
1467682|NCT00706654|4838216|P3|Oral Stabilization Phase|Protocol Deviation|0
1467683|NCT00706654|4838217|P2|Oral Stabilization Phase|Protocol Deviation|0
1467684|NCT00706654|4838218|P1|Oral Stabilization Phase|Protocol Deviation|2
1467685|NCT00706654|4838215|P4|Oral Stabilization Phase|Withdrew consent|0
1467686|NCT00706654|4838216|P3|Oral Stabilization Phase|Withdrew consent|0
1467687|NCT00706654|4838217|P2|Oral Stabilization Phase|Withdrew consent|0
1467688|NCT00706654|4838218|P1|Oral Stabilization Phase|Withdrew consent|55
1467689|NCT00706654|4838215|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
1467690|NCT00706654|4838216|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
1467691|NCT00706654|4838217|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
1467692|NCT00706654|4838218|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
1467693|NCT00706654|4838215|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
1467694|NCT00706654|4838216|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
1467695|NCT00706654|4838217|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
1467696|NCT00706654|4838218|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
1467697|NCT00706654|4838215|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
1467698|NCT00706654|4838216|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
1467699|NCT00706654|4838217|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
1467700|NCT00706654|4838218|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
1467701|NCT00706654|4838215|P4|Oral Stabilization Phase|Lost to Follow-up|0
1467702|NCT00706654|4838216|P3|Oral Stabilization Phase|Lost to Follow-up|0
1467703|NCT00706654|4838217|P2|Oral Stabilization Phase|Lost to Follow-up|0
1467704|NCT00706654|4838218|P1|Oral Stabilization Phase|Lost to Follow-up|17
1467705|NCT00706654|4838215|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
1467706|NCT00706654|4838216|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
1467707|NCT00706654|4838217|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
1467708|NCT00706654|4838218|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
1467709|NCT00706654|4838215|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
1467710|NCT00706654|4838216|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
1467711|NCT00706654|4838217|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
1467712|NCT00706654|4838218|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
1467713|NCT00706654|4838215|P4|Conversion Phase|Adverse Event|0
1467714|NCT00706654|4838216|P3|Conversion Phase|Adverse Event|0
1467715|NCT00706654|4838217|P2|Conversion Phase|Adverse Event|0
1467716|NCT00706654|4838218|P1|Conversion Phase|Adverse Event|18
1467717|NCT00706654|4838215|P4|Conversion Phase|Withdrew Consent|0
1467718|NCT00706654|4838216|P3|Conversion Phase|Withdrew Consent|0
1467719|NCT00706654|4838217|P2|Conversion Phase|Withdrew Consent|0
1467720|NCT00706654|4838218|P1|Conversion Phase|Withdrew Consent|38
1467721|NCT00706654|4838215|P4|Conversion Phase|Withdrawn by Investigator|0
1467722|NCT00706654|4838216|P3|Conversion Phase|Withdrawn by Investigator|0
1467723|NCT00706654|4838217|P2|Conversion Phase|Withdrawn by Investigator|0
1467724|NCT00706654|4838218|P1|Conversion Phase|Withdrawn by Investigator|14
1467725|NCT00706654|4838215|P4|Conversion Phase|Met Withdrawal Criteria|0
1467726|NCT00706654|4838216|P3|Conversion Phase|Met Withdrawal Criteria|0
1467727|NCT00706654|4838217|P2|Conversion Phase|Met Withdrawal Criteria|0
1467728|NCT00706654|4838218|P1|Conversion Phase|Met Withdrawal Criteria|2
1467729|NCT00706654|4838215|P4|Conversion Phase|Sponsor Discontinued Trial|0
1467730|NCT00706654|4838216|P3|Conversion Phase|Sponsor Discontinued Trial|0
1467731|NCT00706654|4838217|P2|Conversion Phase|Sponsor Discontinued Trial|0
1467732|NCT00706654|4838218|P1|Conversion Phase|Sponsor Discontinued Trial|8
1467733|NCT00706654|4838215|P4|Conversion Phase|Lost to Follow-up|0
1467734|NCT00706654|4838216|P3|Conversion Phase|Lost to Follow-up|0
1467735|NCT00706654|4838217|P2|Conversion Phase|Lost to Follow-up|0
1467736|NCT00706654|4838218|P1|Conversion Phase|Lost to Follow-up|4
1467737|NCT00706641|4838237|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
1467738|NCT00706641|4838237|P1|Dasatinib Administration|Ineligible after start of therapy|1
1467739|NCT00706641|4838237|P1|Dasatinib Administration|Withdrawal by Subject|1
1467740|NCT00706628|4838251|P4|Overall Study|Not treated|0
1467741|NCT00706628|4838252|P3|Overall Study|Not treated|0
1467742|NCT00706628|4838253|P2|Overall Study|Not treated|1
1467743|NCT00706628|4838254|P1|Overall Study|Not treated|1
1467744|NCT00706628|4838251|P4|Overall Study|Other than those stated above|0
1467745|NCT00706628|4838252|P3|Overall Study|Other than those stated above|0
1467746|NCT00706628|4838253|P2|Overall Study|Other than those stated above|0
1467747|NCT00706628|4838254|P1|Overall Study|Other than those stated above|4
1467748|NCT00706628|4838251|P4|Overall Study|Progressive disease|1
1467749|NCT00706628|4838252|P3|Overall Study|Progressive disease|8
1467750|NCT00706628|4838253|P2|Overall Study|Progressive disease|13
1467751|NCT00706628|4838254|P1|Overall Study|Progressive disease|20
1467752|NCT00706628|4838251|P4|Overall Study|Consent withdrawn|0
1467753|NCT00706628|4838252|P3|Overall Study|Consent withdrawn|3
1467754|NCT00706628|4838253|P2|Overall Study|Consent withdrawn|1
1467755|NCT00706628|4838254|P1|Overall Study|Consent withdrawn|6
1467756|NCT00706628|4838251|P4|Overall Study|Non compliant with protocol|0
1467757|NCT00706628|4838252|P3|Overall Study|Non compliant with protocol|0
1467758|NCT00706628|4838253|P2|Overall Study|Non compliant with protocol|1
1467759|NCT00706628|4838254|P1|Overall Study|Non compliant with protocol|0
1467760|NCT00706628|4838251|P4|Overall Study|Other Adverse Event|2
1467761|NCT00706628|4838252|P3|Overall Study|Other Adverse Event|5
1467762|NCT00706628|4838253|P2|Overall Study|Other Adverse Event|5
1467763|NCT00706628|4838254|P1|Overall Study|Other Adverse Event|16
1467764|NCT00706433|4838414|P4|Overall Study|new job|1
1467765|NCT00706433|4838415|P3|Overall Study|new job|0
1467766|NCT00706433|4838416|P2|Overall Study|new job|0
1467767|NCT00706433|4838417|P1|Overall Study|new job|0
1467768|NCT00706433|4838414|P4|Overall Study|Protocol Violation|0
1467769|NCT00706433|4838415|P3|Overall Study|Protocol Violation|0
1467770|NCT00706433|4838416|P2|Overall Study|Protocol Violation|0
1467771|NCT00706433|4838417|P1|Overall Study|Protocol Violation|1
1467772|NCT00706433|4838414|P4|Overall Study|Adverse Event|0
1467773|NCT00706433|4838415|P3|Overall Study|Adverse Event|1
1467774|NCT00706433|4838416|P2|Overall Study|Adverse Event|0
1467775|NCT00706433|4838417|P1|Overall Study|Adverse Event|0
1467776|NCT00706433|4838414|P4|Overall Study|Withdrawal by Subject|1
1467777|NCT00706433|4838415|P3|Overall Study|Withdrawal by Subject|3
1467778|NCT00706433|4838416|P2|Overall Study|Withdrawal by Subject|2
1467779|NCT00706433|4838417|P1|Overall Study|Withdrawal by Subject|1
1467780|NCT00706433|4838414|P4|Overall Study|Lost to Follow-up|0
1467781|NCT00706433|4838415|P3|Overall Study|Lost to Follow-up|6
1467782|NCT00706433|4838416|P2|Overall Study|Lost to Follow-up|1
1467783|NCT00706433|4838417|P1|Overall Study|Lost to Follow-up|3
1467784|NCT00706355|4838744|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
1467785|NCT00706355|4838745|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
1467786|NCT00706355|4838746|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
1467787|NCT00706355|4838747|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
1467788|NCT00706355|4838744|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
1467789|NCT00706355|4838745|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
1467790|NCT00706355|4838746|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
1467791|NCT00706355|4838747|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
1467792|NCT00706355|4838744|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
1467793|NCT00706355|4838745|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
1467794|NCT00706355|4838746|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
1467795|NCT00706355|4838747|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
1467796|NCT00706355|4838744|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
1467797|NCT00706355|4838745|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
1467798|NCT00706355|4838746|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
1467799|NCT00706355|4838747|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
1467800|NCT00706355|4838744|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
1467801|NCT00706355|4838745|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
1467802|NCT00706355|4838746|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
1467803|NCT00706355|4838747|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
1467804|NCT00706355|4838744|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
1467805|NCT00706355|4838745|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
1467806|NCT00706355|4838746|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
1467807|NCT00706355|4838747|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
1467808|NCT00706355|4838744|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
1467809|NCT00706355|4838745|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
1467810|NCT00706355|4838746|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
1467811|NCT00706355|4838747|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
1467812|NCT00706355|4838744|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
1467813|NCT00706355|4838745|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
1467814|NCT00706355|4838746|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
1467815|NCT00706355|4838747|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
1467816|NCT00706355|4838744|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
1467817|NCT00706355|4838745|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
1467818|NCT00706355|4838746|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
1467819|NCT00706355|4838747|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
1467820|NCT00706342|4838799|P1|Overall Study|WIthdrawal of consent|1
1467821|NCT00706342|4838799|P1|Overall Study|Ongoing|6
1467822|NCT00706342|4838799|P1|Overall Study|Non-responder Week 12|1
1467823|NCT00706342|4838799|P1|Overall Study|Investigator discretion|2
1467824|NCT00706342|4838799|P1|Overall Study|Withdrew from the study on his own.|1
1467825|NCT00706342|4838799|P1|Overall Study|Death|1
1467826|NCT00706342|4838799|P1|Overall Study|Withdrawn due to failure to respond|1
1467827|NCT00706342|4838799|P1|Overall Study|Not responding to treatment|2
1467828|NCT00706342|4838799|P1|Overall Study|Adverse Event|3
1467829|NCT00706134|4838816|P4|Overall Study|Did not meet study criteria|0
1467830|NCT00706134|4838817|P3|Overall Study|Did not meet study criteria|0
1467831|NCT00706134|4838818|P2|Overall Study|Did not meet study criteria|0
1467832|NCT00706134|4838819|P1|Overall Study|Did not meet study criteria|2
1467833|NCT00706134|4838816|P4|Overall Study|Unsatisfactory therapeutic effect|5
1467834|NCT00706134|4838817|P3|Overall Study|Unsatisfactory therapeutic effect|3
1467835|NCT00706134|4838818|P2|Overall Study|Unsatisfactory therapeutic effect|3
1467836|NCT00706134|4838819|P1|Overall Study|Unsatisfactory therapeutic effect|9
1467837|NCT00706134|4838816|P4|Overall Study|Withdrawal by Subject|0
1467838|NCT00706134|4838817|P3|Overall Study|Withdrawal by Subject|1
1467839|NCT00706134|4838818|P2|Overall Study|Withdrawal by Subject|2
1467840|NCT00706134|4838819|P1|Overall Study|Withdrawal by Subject|1
1467841|NCT00706134|4838816|P4|Overall Study|Protocol Violation|3
1467842|NCT00706134|4838817|P3|Overall Study|Protocol Violation|0
1467843|NCT00706134|4838818|P2|Overall Study|Protocol Violation|6
1467844|NCT00706134|4838819|P1|Overall Study|Protocol Violation|0
1467845|NCT00706134|4838816|P4|Overall Study|Lost to Follow-up|0
1467846|NCT00706134|4838817|P3|Overall Study|Lost to Follow-up|0
1467847|NCT00706134|4838818|P2|Overall Study|Lost to Follow-up|1
1467848|NCT00706134|4838819|P1|Overall Study|Lost to Follow-up|0
1467849|NCT00706134|4838816|P4|Overall Study|Adverse Event|3
1467850|NCT00706134|4838817|P3|Overall Study|Adverse Event|2
1467851|NCT00706134|4838818|P2|Overall Study|Adverse Event|7
1467852|NCT00706134|4838819|P1|Overall Study|Adverse Event|8
1467853|NCT00706095|4838885|P3|Overall Study|Withdrawal by Subject|0
1467854|NCT00706095|4838886|P2|Overall Study|Withdrawal by Subject|0
1467855|NCT00706095|4838887|P1|Overall Study|Withdrawal by Subject|1
1467856|NCT00706095|4838885|P3|Overall Study|Clinical Progression|2
1467857|NCT00706095|4838886|P2|Overall Study|Clinical Progression|2
1467858|NCT00706095|4838887|P1|Overall Study|Clinical Progression|1
1467859|NCT00706095|4838885|P3|Overall Study|Progressive Disease|3
1467860|NCT00706095|4838886|P2|Overall Study|Progressive Disease|5
1467861|NCT00706095|4838887|P1|Overall Study|Progressive Disease|4
1467862|NCT00706030|4838905|P4|Overall Study|Death|0
1467863|NCT00706030|4838906|P3|Overall Study|Death|1
1467864|NCT00706030|4838907|P2|Overall Study|Death|0
1467865|NCT00706030|4838908|P1|Overall Study|Death|0
1467866|NCT00706030|4838905|P4|Overall Study|No treatment received|1
1467867|NCT00706030|4838906|P3|Overall Study|No treatment received|0
1467868|NCT00706030|4838907|P2|Overall Study|No treatment received|0
1467869|NCT00706030|4838908|P1|Overall Study|No treatment received|0
1467870|NCT00706030|4838905|P4|Overall Study|Symptomatic Deterioration|0
1467871|NCT00706030|4838906|P3|Overall Study|Symptomatic Deterioration|1
1467872|NCT00706030|4838907|P2|Overall Study|Symptomatic Deterioration|0
1467873|NCT00706030|4838908|P1|Overall Study|Symptomatic Deterioration|0
1467874|NCT00706030|4838905|P4|Overall Study|Failed to return|0
1467875|NCT00706030|4838906|P3|Overall Study|Failed to return|1
1467876|NCT00706030|4838907|P2|Overall Study|Failed to return|0
1467877|NCT00706030|4838908|P1|Overall Study|Failed to return|0
1467878|NCT00706030|4838905|P4|Overall Study|Protocol Violation|1
1467879|NCT00706030|4838906|P3|Overall Study|Protocol Violation|1
1467880|NCT00706030|4838907|P2|Overall Study|Protocol Violation|0
1467881|NCT00706030|4838908|P1|Overall Study|Protocol Violation|0
1467882|NCT00706030|4838905|P4|Overall Study|Not recorded|0
1467883|NCT00706030|4838906|P3|Overall Study|Not recorded|2
1467884|NCT00706030|4838907|P2|Overall Study|Not recorded|0
1467885|NCT00706030|4838908|P1|Overall Study|Not recorded|0
1467886|NCT00706030|4838905|P4|Overall Study|Physician Decision|0
1467887|NCT00706030|4838906|P3|Overall Study|Physician Decision|2
1467888|NCT00706030|4838907|P2|Overall Study|Physician Decision|0
1467889|NCT00706030|4838908|P1|Overall Study|Physician Decision|0
1467890|NCT00706030|4838905|P4|Overall Study|Withdrawal by Subject|0
1467891|NCT00706030|4838906|P3|Overall Study|Withdrawal by Subject|2
1467892|NCT00706030|4838907|P2|Overall Study|Withdrawal by Subject|0
1467893|NCT00706030|4838908|P1|Overall Study|Withdrawal by Subject|1
1467894|NCT00706030|4838905|P4|Overall Study|Adverse Event|2
1467895|NCT00706030|4838906|P3|Overall Study|Adverse Event|4
1467896|NCT00706030|4838907|P2|Overall Study|Adverse Event|0
1467897|NCT00706030|4838908|P1|Overall Study|Adverse Event|1
1467898|NCT00706030|4838905|P4|Overall Study|Disease Progression|12
1467899|NCT00706030|4838906|P3|Overall Study|Disease Progression|46
1467900|NCT00706030|4838907|P2|Overall Study|Disease Progression|6
1467901|NCT00706030|4838908|P1|Overall Study|Disease Progression|4
1467902|NCT00706004|4838923|P1|Overall Study|Did not meet eligibility criteria|2
1467903|NCT00705939|4838951|P3|Overall Study|Physician Decision|0
1467904|NCT00705939|4838952|P2|Overall Study|Physician Decision|1
1467905|NCT00705939|4838953|P1|Overall Study|Physician Decision|0
1467906|NCT00705939|4838951|P3|Overall Study|Withdrawal by Subject|3
1467907|NCT00705939|4838952|P2|Overall Study|Withdrawal by Subject|1
1467908|NCT00705939|4838953|P1|Overall Study|Withdrawal by Subject|0
1467909|NCT00705939|4838951|P3|Overall Study|Protocol Violation|1
1467910|NCT00705939|4838952|P2|Overall Study|Protocol Violation|0
1467911|NCT00705939|4838953|P1|Overall Study|Protocol Violation|0
1467912|NCT00705783|4839007|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
1467913|NCT00705783|4839008|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
1467914|NCT00705783|4839009|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
1467915|NCT00705783|4839007|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
1467916|NCT00705783|4839008|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
1467917|NCT00705783|4839009|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
1467918|NCT00705783|4839007|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
1467919|NCT00705783|4839008|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
1467920|NCT00705783|4839009|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
1467921|NCT00705783|4839007|P3|Depot Maintenance Phase|Protocol Deviation|0
1467922|NCT00705783|4839008|P2|Depot Maintenance Phase|Protocol Deviation|2
1467923|NCT00705783|4839009|P1|Depot Maintenance Phase|Protocol Deviation|0
1467924|NCT00705783|4839007|P3|Depot Maintenance Phase|Withdrew Consent|4
1467925|NCT00705783|4839008|P2|Depot Maintenance Phase|Withdrew Consent|14
1467926|NCT00705783|4839009|P1|Depot Maintenance Phase|Withdrew Consent|0
1467927|NCT00705783|4839007|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
1467928|NCT00705783|4839008|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
1467929|NCT00705783|4839009|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
1467930|NCT00705783|4839007|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
1467931|NCT00705783|4839008|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
1467932|NCT00705783|4839009|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
1467933|NCT00705783|4839007|P3|Depot Maintenance Phase|Lost to Follow-up|3
1467934|NCT00705783|4839008|P2|Depot Maintenance Phase|Lost to Follow-up|5
1467935|NCT00705783|4839009|P1|Depot Maintenance Phase|Lost to Follow-up|0
1467936|NCT00705783|4839007|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
1467937|NCT00705783|4839008|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
1467938|NCT00705783|4839009|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
1467939|NCT00705783|4839007|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
1467940|NCT00705783|4839008|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
1467941|NCT00705783|4839009|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
1467942|NCT00705783|4839007|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
1467943|NCT00705783|4839008|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
1467944|NCT00705783|4839009|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
1467945|NCT00705783|4839007|P3|Depot Stabilization Phase|Adverse Event|0
1467946|NCT00705783|4839008|P2|Depot Stabilization Phase|Adverse Event|0
1467947|NCT00705783|4839009|P1|Depot Stabilization Phase|Adverse Event|17
1467948|NCT00705783|4839007|P3|Depot Stabilization Phase|Withdrew Consent|0
1467949|NCT00705783|4839008|P2|Depot Stabilization Phase|Withdrew Consent|0
1467950|NCT00705783|4839009|P1|Depot Stabilization Phase|Withdrew Consent|29
1467951|NCT00705783|4839007|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
1467952|NCT00705783|4839008|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
1467953|NCT00705783|4839009|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
1467954|NCT00705783|4839007|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
1467955|NCT00705783|4839008|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
1467956|NCT00705783|4839009|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
1467957|NCT00705783|4839007|P3|Depot Stabilization Phase|Lost to Follow-up|0
1467958|NCT00705783|4839008|P2|Depot Stabilization Phase|Lost to Follow-up|0
1467959|NCT00705783|4839009|P1|Depot Stabilization Phase|Lost to Follow-up|11
1467960|NCT00705783|4839007|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
1467961|NCT00705783|4839008|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
1467962|NCT00705783|4839009|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
1467963|NCT00705783|4839007|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
1467964|NCT00705783|4839008|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
1467965|NCT00705783|4839009|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
1467966|NCT00705783|4839007|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
1467967|NCT00705783|4839008|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
1467968|NCT00705783|4839009|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
1467969|NCT00705783|4839007|P3|Oral Stabilization Phase|Adverse Event|0
1467970|NCT00705783|4839008|P2|Oral Stabilization Phase|Adverse Event|0
1467971|NCT00705783|4839009|P1|Oral Stabilization Phase|Adverse Event|14
1467972|NCT00705783|4839007|P3|Oral Stabilization Phase|Withdrew Consent|0
1467973|NCT00705783|4839008|P2|Oral Stabilization Phase|Withdrew Consent|0
1467974|NCT00705783|4839009|P1|Oral Stabilization Phase|Withdrew Consent|29
1467975|NCT00705783|4839007|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
1467976|NCT00705783|4839008|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
1467977|NCT00705783|4839009|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
1467978|NCT00705783|4839007|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
1467979|NCT00705783|4839008|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
1467980|NCT00705783|4839009|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
1467981|NCT00705783|4839007|P3|Oral Stabilization Phase|Lost to Follow-up|0
1467982|NCT00705783|4839008|P2|Oral Stabilization Phase|Lost to Follow-up|0
1467983|NCT00705783|4839009|P1|Oral Stabilization Phase|Lost to Follow-up|7
1467984|NCT00705783|4839007|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
1467985|NCT00705783|4839008|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
1467986|NCT00705783|4839009|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
1467987|NCT00705783|4839007|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
1467988|NCT00705783|4839008|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
1467989|NCT00705783|4839009|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
1467990|NCT00705783|4839007|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
1467991|NCT00705783|4839008|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
1467992|NCT00705783|4839009|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
1467993|NCT00705783|4839007|P3|Conversion Phase|Adverse Event|0
1467994|NCT00705783|4839008|P2|Conversion Phase|Adverse Event|0
1467995|NCT00705783|4839009|P1|Conversion Phase|Adverse Event|11
1467996|NCT00705783|4839007|P3|Conversion Phase|Protocol Deviation|0
1467997|NCT00705783|4839008|P2|Conversion Phase|Protocol Deviation|0
1467998|NCT00705783|4839009|P1|Conversion Phase|Protocol Deviation|2
1467999|NCT00705783|4839007|P3|Conversion Phase|Withdrew Consent|0
1468000|NCT00705783|4839008|P2|Conversion Phase|Withdrew Consent|0
1468001|NCT00705783|4839009|P1|Conversion Phase|Withdrew Consent|24
1468002|NCT00705783|4839007|P3|Conversion Phase|Withdrawn by Investigator|0
1468003|NCT00705783|4839008|P2|Conversion Phase|Withdrawn by Investigator|0
1468004|NCT00705783|4839009|P1|Conversion Phase|Withdrawn by Investigator|4
1468005|NCT00705783|4839007|P3|Conversion Phase|Met Withdrawal Criteria|0
1468006|NCT00705783|4839008|P2|Conversion Phase|Met Withdrawal Criteria|0
1468007|NCT00705783|4839009|P1|Conversion Phase|Met Withdrawal Criteria|4
1468008|NCT00705783|4839007|P3|Conversion Phase|Lost to Follow-up|0
1468009|NCT00705783|4839008|P2|Conversion Phase|Lost to Follow-up|0
1468010|NCT00705783|4839009|P1|Conversion Phase|Lost to Follow-up|13
1468011|NCT00705783|4839007|P3|Conversion Phase|Sponsor Discontinued Study|0
1468012|NCT00705783|4839008|P2|Conversion Phase|Sponsor Discontinued Study|0
1468013|NCT00705783|4839009|P1|Conversion Phase|Sponsor Discontinued Study|54
1468014|NCT00705757|4839039|P3|Overall Study|Withdrawal by Subject|2
1468015|NCT00705757|4839040|P2|Overall Study|Withdrawal by Subject|1
1468016|NCT00705757|4839041|P1|Overall Study|Withdrawal by Subject|1
1468017|NCT00705757|4839039|P3|Overall Study|Lost to Follow-up|6
1468018|NCT00705757|4839040|P2|Overall Study|Lost to Follow-up|6
1468019|NCT00705757|4839041|P1|Overall Study|Lost to Follow-up|7
1468020|NCT00705757|4839039|P3|Overall Study|Lack of Efficacy|3
1468021|NCT00705757|4839040|P2|Overall Study|Lack of Efficacy|1
1468022|NCT00705757|4839041|P1|Overall Study|Lack of Efficacy|5
1468023|NCT00705718|4839051|P2|Overall Study|Follow up not done|4
1468024|NCT00705718|4839052|P1|Overall Study|Follow up not done|1
1468025|NCT00705718|4839051|P2|Overall Study|Not due for Visit|12
1468026|NCT00705718|4839052|P1|Overall Study|Not due for Visit|0
1468027|NCT00705718|4839051|P2|Overall Study|Death|6
1468028|NCT00705718|4839052|P1|Overall Study|Death|6
1468029|NCT00705679|4839073|P5|Overall Study|Withdrawal by Subject|33
1468030|NCT00705679|4839074|P4|Overall Study|Withdrawal by Subject|47
1468031|NCT00705679|4839075|P3|Overall Study|Withdrawal by Subject|68
1468032|NCT00705679|4839076|P2|Overall Study|Withdrawal by Subject|77
1468033|NCT00705679|4839077|P1|Overall Study|Withdrawal by Subject|32
1468034|NCT00705679|4839073|P5|Overall Study|Physician Decision|0
1468035|NCT00705679|4839074|P4|Overall Study|Physician Decision|1
1468036|NCT00705679|4839075|P3|Overall Study|Physician Decision|0
1468037|NCT00705679|4839076|P2|Overall Study|Physician Decision|1
1468038|NCT00705679|4839077|P1|Overall Study|Physician Decision|0
1468039|NCT00705679|4839073|P5|Overall Study|Lost to Follow-up|35
1468040|NCT00705679|4839074|P4|Overall Study|Lost to Follow-up|30
1468041|NCT00705679|4839075|P3|Overall Study|Lost to Follow-up|44
1468042|NCT00705679|4839076|P2|Overall Study|Lost to Follow-up|60
1468043|NCT00705679|4839077|P1|Overall Study|Lost to Follow-up|32
1468044|NCT00705679|4839073|P5|Overall Study|Death|1
1468045|NCT00705679|4839074|P4|Overall Study|Death|2
1468046|NCT00705679|4839075|P3|Overall Study|Death|3
1468047|NCT00705679|4839076|P2|Overall Study|Death|0
1468048|NCT00705679|4839077|P1|Overall Study|Death|0
1468049|NCT00705679|4839073|P5|Overall Study|Adverse Event|0
1468050|NCT00705679|4839074|P4|Overall Study|Adverse Event|0
1468051|NCT00705679|4839075|P3|Overall Study|Adverse Event|0
1468052|NCT00705679|4839076|P2|Overall Study|Adverse Event|1
1468053|NCT00705679|4839077|P1|Overall Study|Adverse Event|1
1468054|NCT00705666|4839112|P1|Overall Study|Untreated|5
1468055|NCT00705666|4839112|P1|Overall Study|Lack of data|3
1468056|NCT00705666|4839112|P1|Overall Study|Other|2
1468057|NCT00705666|4839112|P1|Overall Study|Not specified|12
1468058|NCT00705666|4839112|P1|Overall Study|Adverse Event|4
1468059|NCT00705666|4839112|P1|Overall Study|Death|1
1468060|NCT00705666|4839112|P1|Overall Study|Lost to Follow-up|5
1468061|NCT00705666|4839112|P1|Overall Study|Physician Decision|7
1468062|NCT00705666|4839112|P1|Overall Study|Withdrawal by Subject|21
1468063|NCT00705666|4839112|P1|Overall Study|No post-treatment questionnaire|279
1468064|NCT00705614|4839123|P2|Switch to Remicade|Administrative Reason|9
1468065|NCT00705614|4839124|P1|Switch to Remicade|Administrative Reason|0
1468066|NCT00705614|4839123|P2|Switch to Remicade|Withdrawal by Subject|12
1468067|NCT00705614|4839124|P1|Switch to Remicade|Withdrawal by Subject|0
1468068|NCT00705614|4839123|P2|Switch to Remicade|Lost to Follow-up|23
1468069|NCT00705614|4839124|P1|Switch to Remicade|Lost to Follow-up|0
1468070|NCT00705614|4839123|P2|Switch to Remicade|Adverse Event|5
1468071|NCT00705614|4839124|P1|Switch to Remicade|Adverse Event|0
1468072|NCT00705614|4839123|P2|Initial Intervention|Status completion unknown|0
1468073|NCT00705614|4839124|P1|Initial Intervention|Status completion unknown|3
1468074|NCT00705614|4839123|P2|Initial Intervention|Administrative Reason|38
1468075|NCT00705614|4839124|P1|Initial Intervention|Administrative Reason|51
1468076|NCT00705614|4839123|P2|Initial Intervention|Withdrawal by Subject|71
1468077|NCT00705614|4839124|P1|Initial Intervention|Withdrawal by Subject|114
1468078|NCT00705614|4839123|P2|Initial Intervention|Lost to Follow-up|191
1468079|NCT00705614|4839124|P1|Initial Intervention|Lost to Follow-up|310
1468080|NCT00705614|4839123|P2|Initial Intervention|Adverse Event|21
1468081|NCT00705614|4839124|P1|Initial Intervention|Adverse Event|40
1468082|NCT00705575|4839173|P2|Overall Study|Withdrawal by Subject|10
1468083|NCT00705575|4839174|P1|Overall Study|Withdrawal by Subject|5
1468084|NCT00705575|4839173|P2|Overall Study|Protocol Violation|2
1468085|NCT00705575|4839174|P1|Overall Study|Protocol Violation|2
1468086|NCT00705575|4839173|P2|Overall Study|Lost to Follow-up|4
1468087|NCT00705575|4839174|P1|Overall Study|Lost to Follow-up|3
1468088|NCT00705575|4839173|P2|Overall Study|Adverse Event|15
1468089|NCT00705575|4839174|P1|Overall Study|Adverse Event|11
1468090|NCT00705575|4839173|P2|Overall Study|Abnormal test procedure result(s)|12
1468091|NCT00705575|4839174|P1|Overall Study|Abnormal test procedure result(s)|2
1468092|NCT00705575|4839173|P2|Overall Study|Abnormal laboratory value(s)|3
1468093|NCT00705575|4839174|P1|Overall Study|Abnormal laboratory value(s)|0
1468094|NCT00705536|4839188|P4|Start Period 1|Withdrawal by Subject|1
1468095|NCT00705536|4839189|P3|Start Period 1|Withdrawal by Subject|0
1468096|NCT00705536|4839190|P2|Start Period 1|Withdrawal by Subject|0
1468097|NCT00705536|4839191|P1|Start Period 1|Withdrawal by Subject|0
1468098|NCT00705523|4839252|P2|Overall Study|Lost to Follow-up|3
1468099|NCT00705523|4839253|P1|Overall Study|Lost to Follow-up|2
1468100|NCT00705484|4839263|P2|Overall Study|Administrative|59
1468101|NCT00705484|4839264|P1|Overall Study|Administrative|89
1468102|NCT00705484|4839263|P2|Overall Study|Withdrawal by Subject|72
1468103|NCT00705484|4839264|P1|Overall Study|Withdrawal by Subject|96
1468104|NCT00705484|4839263|P2|Overall Study|Lost to Follow-up|250
1468105|NCT00705484|4839264|P1|Overall Study|Lost to Follow-up|169
1468106|NCT00705484|4839263|P2|Overall Study|Adverse Event|27
1468107|NCT00705484|4839264|P1|Overall Study|Adverse Event|28
1468108|NCT00705432|4839278|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
1468109|NCT00705432|4839279|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
1468110|NCT00705432|4839280|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
1468111|NCT00705432|4839281|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
1468112|NCT00705432|4839282|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
1468113|NCT00705432|4839283|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
1468114|NCT00705432|4839278|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
1468115|NCT00705432|4839279|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
1468116|NCT00705432|4839280|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
1468117|NCT00705432|4839281|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
1468118|NCT00705432|4839282|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
1468119|NCT00705432|4839283|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
1468120|NCT00705432|4839278|P6|Treatment Period|Non medical reason|7
1468121|NCT00705432|4839279|P5|Treatment Period|Non medical reason|7
1468122|NCT00705432|4839280|P4|Treatment Period|Non medical reason|4
1468123|NCT00705432|4839281|P3|Treatment Period|Non medical reason|37
1468124|NCT00705432|4839282|P2|Treatment Period|Non medical reason|32
1468125|NCT00705432|4839283|P1|Treatment Period|Non medical reason|26
1468126|NCT00705432|4839278|P6|Treatment Period|Treatment failure|14
1468127|NCT00705432|4839279|P5|Treatment Period|Treatment failure|13
1468128|NCT00705432|4839280|P4|Treatment Period|Treatment failure|25
1468129|NCT00705432|4839281|P3|Treatment Period|Treatment failure|33
1468130|NCT00705432|4839282|P2|Treatment Period|Treatment failure|42
1468131|NCT00705432|4839283|P1|Treatment Period|Treatment failure|92
1468132|NCT00705432|4839278|P6|Treatment Period|Adverse Event|9
1468133|NCT00705432|4839279|P5|Treatment Period|Adverse Event|8
1468134|NCT00705432|4839280|P4|Treatment Period|Adverse Event|12
1468135|NCT00705432|4839281|P3|Treatment Period|Adverse Event|51
1468136|NCT00705432|4839282|P2|Treatment Period|Adverse Event|37
1468137|NCT00705432|4839283|P1|Treatment Period|Adverse Event|45
1468138|NCT00705406|4839320|P2|Overall Study|Did not receive study drug|2
1468139|NCT00705406|4839321|P1|Overall Study|Did not receive study drug|1
1468140|NCT00705406|4839320|P2|Overall Study|Lost to Follow-up|3
1468141|NCT00705406|4839321|P1|Overall Study|Lost to Follow-up|3
1468142|NCT00705367|4839345|P2|Long-term Extension Period|Administrative reason by sponsor|0
1468143|NCT00705367|4839346|P1|Long-term Extension Period|Administrative reason by sponsor|3
1468144|NCT00705367|4839345|P2|Long-term Extension Period|No longer met study criteria|0
1468145|NCT00705367|4839346|P1|Long-term Extension Period|No longer met study criteria|1
1468146|NCT00705367|4839345|P2|Long-term Extension Period|Lack of Efficacy|0
1468147|NCT00705367|4839346|P1|Long-term Extension Period|Lack of Efficacy|1
1468148|NCT00705367|4839345|P2|Long-term Extension Period|Withdrawal by Subject|0
1468149|NCT00705367|4839346|P1|Long-term Extension Period|Withdrawal by Subject|2
1468150|NCT00705367|4839345|P2|Long-term Extension Period|Adverse Event|0
1468151|NCT00705367|4839346|P1|Long-term Extension Period|Adverse Event|2
1468152|NCT00705341|4839373|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
1468153|NCT00705341|4839374|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
1468154|NCT00705341|4839375|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
1468155|NCT00705341|4839376|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
1468156|NCT00705341|4839373|P4|Phase 2: Trial|Withdrawal by Subject|4
1468157|NCT00705341|4839374|P3|Phase 2: Trial|Withdrawal by Subject|6
1468158|NCT00705341|4839375|P2|Phase 2: Trial|Withdrawal by Subject|0
1468159|NCT00705341|4839376|P1|Phase 2: Trial|Withdrawal by Subject|0
1468160|NCT00705289|4839384|P1|Overall Study|Subject or treating physician's choice|131
1468161|NCT00705263|4839408|P1|Overall Study|Withdrawal by Subject|2
1468162|NCT00705250|4839412|P1|Overall Study|Patient died in car accident|1
1468163|NCT00705250|4839412|P1|Overall Study|Withdrawal by Subject|1
1468164|NCT00705224|4839416|P1|Overall Study|Lost to Follow-up|5
1468165|NCT00705224|4839416|P1|Overall Study|Withdrawal by Subject|3
1468166|NCT00705224|4839416|P1|Overall Study|Lack of Efficacy|2
1468167|NCT00705224|4839416|P1|Overall Study|Adverse Event|1
1468168|NCT00705159|4839432|P4|Overall Study|Screen Failure|1
1468169|NCT00705159|4839433|P3|Overall Study|Screen Failure|0
1468170|NCT00705159|4839434|P2|Overall Study|Screen Failure|0
1468171|NCT00705159|4839435|P1|Overall Study|Screen Failure|0
1468172|NCT00705159|4839432|P4|Overall Study|Lost to Follow-up|2
1468173|NCT00705159|4839433|P3|Overall Study|Lost to Follow-up|3
1468174|NCT00705159|4839434|P2|Overall Study|Lost to Follow-up|0
1468175|NCT00705159|4839435|P1|Overall Study|Lost to Follow-up|0
1468176|NCT00705159|4839432|P4|Overall Study|Adverse Event|0
1468177|NCT00705159|4839433|P3|Overall Study|Adverse Event|1
1468178|NCT00705159|4839434|P2|Overall Study|Adverse Event|0
1468179|NCT00705159|4839435|P1|Overall Study|Adverse Event|0
1468180|NCT00705159|4839432|P4|Overall Study|Protocol Violation|0
1468181|NCT00705159|4839433|P3|Overall Study|Protocol Violation|0
1468182|NCT00705159|4839434|P2|Overall Study|Protocol Violation|1
1468183|NCT00705159|4839435|P1|Overall Study|Protocol Violation|0
1468184|NCT00705159|4839432|P4|Overall Study|Withdrawal by Subject|1
1468185|NCT00705159|4839433|P3|Overall Study|Withdrawal by Subject|1
1468186|NCT00705159|4839434|P2|Overall Study|Withdrawal by Subject|1
1468187|NCT00705159|4839435|P1|Overall Study|Withdrawal by Subject|0
1468188|NCT00705146|4839455|P2|Overall Study|Lost to Follow-up|1
1468189|NCT00705146|4839456|P1|Overall Study|Lost to Follow-up|1
1468190|NCT00705016|4839485|P3|Overall Study|Other|6
1468191|NCT00705016|4839486|P2|Overall Study|Other|6
1468192|NCT00705016|4839487|P1|Overall Study|Other|9
1468193|NCT00705016|4839485|P3|Overall Study|Symptomatic Deterioration|1
1468194|NCT00705016|4839486|P2|Overall Study|Symptomatic Deterioration|1
1468195|NCT00705016|4839487|P1|Overall Study|Symptomatic Deterioration|3
1468196|NCT00705016|4839485|P3|Overall Study|Progressive Disease|33
1468197|NCT00705016|4839486|P2|Overall Study|Progressive Disease|29
1468198|NCT00705016|4839487|P1|Overall Study|Progressive Disease|33
1468199|NCT00705016|4839485|P3|Overall Study|Withdrawal by Subject|2
1468200|NCT00705016|4839486|P2|Overall Study|Withdrawal by Subject|3
1468201|NCT00705016|4839487|P1|Overall Study|Withdrawal by Subject|4
1468202|NCT00705016|4839485|P3|Overall Study|Protocol Violation|1
1468203|NCT00705016|4839486|P2|Overall Study|Protocol Violation|1
1468204|NCT00705016|4839487|P1|Overall Study|Protocol Violation|0
1468205|NCT00705016|4839485|P3|Overall Study|Death|5
1468206|NCT00705016|4839486|P2|Overall Study|Death|7
1468207|NCT00705016|4839487|P1|Overall Study|Death|5
1468208|NCT00705016|4839485|P3|Overall Study|Adverse Event|10
1468209|NCT00705016|4839486|P2|Overall Study|Adverse Event|11
1468210|NCT00705016|4839487|P1|Overall Study|Adverse Event|6
1468211|NCT00704964|4839538|P1|Overall Study|Not completed on time|328
1468212|NCT00704808|4839587|P1|Overall Study|Treatment change|1
1468213|NCT00704808|4839587|P1|Overall Study|Lost to Follow-up|1
1468214|NCT00704808|4839587|P1|Overall Study|Adverse Event|1
1468215|NCT00704808|4839587|P1|Overall Study|Early therapy discontinuation|16
1468216|NCT00704808|4839587|P1|Overall Study|Patient's decision|11
1468217|NCT00704808|4839587|P1|Overall Study|Tumor progression|80
1468218|NCT00704808|4839587|P1|Overall Study|Death|7
1468219|NCT00704808|4839587|P1|Overall Study|Discontinued prior to starting treatment|14
1468220|NCT00704730|4839598|P2|Overall Study|Withdrawal by Subject|13
1468221|NCT00704730|4839599|P1|Overall Study|Withdrawal by Subject|9
1468222|NCT00704730|4839598|P2|Overall Study|data unavailable|0
1468223|NCT00704730|4839599|P1|Overall Study|data unavailable|1
1468224|NCT00704730|4839598|P2|Overall Study|Disease progression per PI|67
1468225|NCT00704730|4839599|P1|Overall Study|Disease progression per PI|58
1468226|NCT00704730|4839598|P2|Overall Study|Did not receive drug|2
1468227|NCT00704730|4839599|P1|Overall Study|Did not receive drug|5
1468228|NCT00704730|4839598|P2|Overall Study|Physician Decision|0
1468229|NCT00704730|4839599|P1|Overall Study|Physician Decision|2
1468230|NCT00704730|4839598|P2|Overall Study|Death|5
1468231|NCT00704730|4839599|P1|Overall Study|Death|11
1468232|NCT00704730|4839598|P2|Overall Study|Adverse Event|9
1468233|NCT00704730|4839599|P1|Overall Study|Adverse Event|35
1468234|NCT00704535|4839619|P1|Overall Study|Completed status not on Case Report Form|124
1468235|NCT00704535|4839619|P1|Overall Study|Protocol Violation|10
1468236|NCT00704535|4839619|P1|Overall Study|Lost to Follow-up|8
1468237|NCT00704535|4839619|P1|Overall Study|Death|2
1468238|NCT00704535|4839619|P1|Overall Study|Adverse Event|2
1468239|NCT00704522|4839632|P2|Overall Study|No information on therapy end|2
1468240|NCT00704522|4839633|P1|Overall Study|No information on therapy end|27
1468241|NCT00704522|4839632|P2|Overall Study|Undefined causes|7
1468242|NCT00704522|4839633|P1|Overall Study|Undefined causes|9
1468243|NCT00704522|4839632|P2|Overall Study|Adverse Event|1
1468244|NCT00704522|4839633|P1|Overall Study|Adverse Event|9
1468245|NCT00704522|4839632|P2|Overall Study|Withdrawal by Subject|8
1468246|NCT00704522|4839633|P1|Overall Study|Withdrawal by Subject|17
1468247|NCT00704522|4839632|P2|Overall Study|Failure to appear again at hospital|10
1468248|NCT00704522|4839633|P1|Overall Study|Failure to appear again at hospital|56
1468249|NCT00704522|4839632|P2|Overall Study|Lack of Efficacy|17
1468250|NCT00704522|4839633|P1|Overall Study|Lack of Efficacy|65
1468251|NCT00704418|4839653|P2|Overall Study|Over-enrolled/surgery postponed|6
1468252|NCT00704418|4839654|P1|Overall Study|Over-enrolled/surgery postponed|3
1468253|NCT00704418|4839653|P2|Overall Study|Withdrawal by Subject|0
1468254|NCT00704418|4839654|P1|Overall Study|Withdrawal by Subject|2
1468255|NCT00704405|4839667|P5|Overall Study (C Population)|Lost to Follow-up|0
1468256|NCT00704405|4839668|P4|Overall Study (C Population)|Lost to Follow-up|0
1468257|NCT00704405|4839669|P3|Overall Study (C Population)|Lost to Follow-up|0
1468258|NCT00704405|4839670|P2|Overall Study (C Population)|Lost to Follow-up|2
1468259|NCT00704405|4839671|P1|Overall Study (C Population)|Lost to Follow-up|0
1468260|NCT00704405|4839667|P5|Overall Study (C Population)|Withdrawal by Subject|0
1468261|NCT00704405|4839668|P4|Overall Study (C Population)|Withdrawal by Subject|1
1468262|NCT00704405|4839669|P3|Overall Study (C Population)|Withdrawal by Subject|1
1468263|NCT00704405|4839670|P2|Overall Study (C Population)|Withdrawal by Subject|1
1468264|NCT00704405|4839671|P1|Overall Study (C Population)|Withdrawal by Subject|1
1468265|NCT00704405|4839667|P5|Overall Study (NC Population)|Other|1
1468266|NCT00704405|4839668|P4|Overall Study (NC Population)|Other|0
1468267|NCT00704405|4839669|P3|Overall Study (NC Population)|Other|0
1468268|NCT00704405|4839670|P2|Overall Study (NC Population)|Other|0
1468269|NCT00704405|4839671|P1|Overall Study (NC Population)|Other|0
1468270|NCT00704405|4839667|P5|Overall Study (NC Population)|Withdrawal by Subject|2
1468271|NCT00704405|4839668|P4|Overall Study (NC Population)|Withdrawal by Subject|2
1468272|NCT00704405|4839669|P3|Overall Study (NC Population)|Withdrawal by Subject|2
1468273|NCT00704405|4839670|P2|Overall Study (NC Population)|Withdrawal by Subject|3
1468274|NCT00704405|4839671|P1|Overall Study (NC Population)|Withdrawal by Subject|2
1468275|NCT00704405|4839667|P5|Overall Study (NC Population)|Lost to Follow-up|2
1468276|NCT00704405|4839668|P4|Overall Study (NC Population)|Lost to Follow-up|2
1468277|NCT00704405|4839669|P3|Overall Study (NC Population)|Lost to Follow-up|1
1468278|NCT00704405|4839670|P2|Overall Study (NC Population)|Lost to Follow-up|1
1468279|NCT00704405|4839671|P1|Overall Study (NC Population)|Lost to Follow-up|2
1468280|NCT00704405|4839667|P5|Overall Study (NC Population)|Adverse Event|0
1468281|NCT00704405|4839668|P4|Overall Study (NC Population)|Adverse Event|0
1468282|NCT00704405|4839669|P3|Overall Study (NC Population)|Adverse Event|0
1468283|NCT00704405|4839670|P2|Overall Study (NC Population)|Adverse Event|0
1468284|NCT00704405|4839671|P1|Overall Study (NC Population)|Adverse Event|1
1468285|NCT00704340|4839729|P2|Overall Study|Death|1
1468286|NCT00704340|4839730|P1|Overall Study|Death|0
1468287|NCT00704340|4839729|P2|Overall Study|Lost to Follow-up|1
1468288|NCT00704340|4839730|P1|Overall Study|Lost to Follow-up|2
1468289|NCT00704184|4839745|P5|Open-Label Treatment|Withdrawal by Subject|0
1468290|NCT00704184|4839746|P4|Open-Label Treatment|Withdrawal by Subject|3
1468291|NCT00704184|4839747|P3|Open-Label Treatment|Withdrawal by Subject|0
1468292|NCT00704184|4839748|P2|Open-Label Treatment|Withdrawal by Subject|0
1468293|NCT00704184|4839749|P1|Open-Label Treatment|Withdrawal by Subject|1
1468294|NCT00704184|4839745|P5|Open-Label Treatment|Physician Decision|1
1468295|NCT00704184|4839746|P4|Open-Label Treatment|Physician Decision|0
1468296|NCT00704184|4839747|P3|Open-Label Treatment|Physician Decision|0
1468297|NCT00704184|4839748|P2|Open-Label Treatment|Physician Decision|0
1468298|NCT00704184|4839749|P1|Open-Label Treatment|Physician Decision|0
1468299|NCT00704184|4839745|P5|Open-Label Treatment|Lack of Efficacy|1
1468300|NCT00704184|4839746|P4|Open-Label Treatment|Lack of Efficacy|2
1468301|NCT00704184|4839747|P3|Open-Label Treatment|Lack of Efficacy|2
1468302|NCT00704184|4839748|P2|Open-Label Treatment|Lack of Efficacy|2
1468303|NCT00704184|4839749|P1|Open-Label Treatment|Lack of Efficacy|0
1468304|NCT00704184|4839745|P5|Open-Label Treatment|Adverse Event|1
1468305|NCT00704184|4839746|P4|Open-Label Treatment|Adverse Event|0
1468306|NCT00704184|4839747|P3|Open-Label Treatment|Adverse Event|2
1468307|NCT00704184|4839748|P2|Open-Label Treatment|Adverse Event|0
1468308|NCT00704184|4839749|P1|Open-Label Treatment|Adverse Event|0
1468309|NCT00704184|4839745|P5|Double-Blind Treatment|Withdrawal by Subject|0
1468310|NCT00704184|4839746|P4|Double-Blind Treatment|Withdrawal by Subject|0
1468311|NCT00704184|4839747|P3|Double-Blind Treatment|Withdrawal by Subject|0
1468312|NCT00704184|4839748|P2|Double-Blind Treatment|Withdrawal by Subject|0
1468313|NCT00704184|4839749|P1|Double-Blind Treatment|Withdrawal by Subject|1
1468314|NCT00704171|4839788|P2|Overall Study|Withdrawal by Subject|0
1468315|NCT00704171|4839789|P1|Overall Study|Withdrawal by Subject|1
1468316|NCT00704132|4839807|P2|Overall Study|Withdrawal by Subject|1
1468317|NCT00704132|4839808|P1|Overall Study|Withdrawal by Subject|0
1468318|NCT00704132|4839807|P2|Overall Study|Lack of Efficacy|1
1468319|NCT00704132|4839808|P1|Overall Study|Lack of Efficacy|0
1468320|NCT00704132|4839807|P2|Overall Study|Clinical Adverse Experience|0
1468321|NCT00704132|4839808|P1|Overall Study|Clinical Adverse Experience|1
1468322|NCT00703963|4839836|P2|Overall Study|Physician Decision|1
1468323|NCT00703963|4839837|P1|Overall Study|Physician Decision|0
1468324|NCT00703963|4839836|P2|Overall Study|Withdrawal by Subject|13
1468325|NCT00703963|4839837|P1|Overall Study|Withdrawal by Subject|7
1468326|NCT00703924|4839858|P2|Overall Study|Withdrawal by Subject|1
1468327|NCT00703924|4839859|P1|Overall Study|Withdrawal by Subject|1
1468328|NCT00703911|4839875|P1|Overall Study|Withdrawal by Subject|2
1468329|NCT00703911|4839875|P1|Overall Study|Lost to Follow-up|1
1468330|NCT00703911|4839875|P1|Overall Study|Physician Decision|6
1468331|NCT00703911|4839875|P1|Overall Study|Death|1
1468332|NCT00703846|4839908|P1|Overall Study|Did Not Receive Study Drug|2
1468333|NCT00703846|4839908|P1|Overall Study|Other|14
1468334|NCT00703846|4839908|P1|Overall Study|Death|1
1468335|NCT00703846|4839908|P1|Overall Study|Withdrawal by Subject|40
1468336|NCT00703846|4839908|P1|Overall Study|Noncompliance with Study Treatment|2
1468337|NCT00703846|4839908|P1|Overall Study|Lack of Efficacy|15
1468338|NCT00703846|4839908|P1|Overall Study|Lost to Follow-up|55
1468339|NCT00703846|4839908|P1|Overall Study|Adverse Event|8
1468340|NCT00703820|4839924|P2|Overall Study|Withdrawal by Subject|1
1468341|NCT00703820|4839925|P1|Overall Study|Withdrawal by Subject|2
1468342|NCT00703820|4839924|P2|Overall Study|Physician Decision|5
1468343|NCT00703820|4839925|P1|Overall Study|Physician Decision|4
1468344|NCT00703820|4839924|P2|Overall Study|Received non-protocol therapy|0
1468345|NCT00703820|4839925|P1|Overall Study|Received non-protocol therapy|1
1468346|NCT00703820|4839924|P2|Overall Study|Lack of Efficacy|11
1468347|NCT00703820|4839925|P1|Overall Study|Lack of Efficacy|11
1468348|NCT00703820|4839924|P2|Overall Study|Death|0
1468349|NCT00703820|4839925|P1|Overall Study|Death|5
1468350|NCT00703820|4839924|P2|Overall Study|Adverse Event|17
1468351|NCT00703820|4839925|P1|Overall Study|Adverse Event|12
1468352|NCT00703781|4839934|P2|Overall Study|Cancelled surgery|0
1468353|NCT00703781|4839935|P1|Overall Study|Cancelled surgery|1
1468354|NCT00703781|4839934|P2|Overall Study|Withdrawal by Subject|2
1468355|NCT00703781|4839935|P1|Overall Study|Withdrawal by Subject|1
1468356|NCT00703677|4839980|P1|Overall Study|Dropout-withdrawal not related to drug|3
1468357|NCT00703534|4840020|P2|Overall Study|Severe Non Compliance|5
1468358|NCT00703534|4840021|P1|Overall Study|Severe Non Compliance|1
1468359|NCT00703534|4840020|P2|Overall Study|Lost to Follow-up|4
1468360|NCT00703534|4840021|P1|Overall Study|Lost to Follow-up|1
1468361|NCT00703534|4840020|P2|Overall Study|Incorrect Enrollment|6
1468362|NCT00703534|4840021|P1|Overall Study|Incorrect Enrollment|6
1468363|NCT00703534|4840020|P2|Overall Study|Withdrawal by Subject|7
1468364|NCT00703534|4840021|P1|Overall Study|Withdrawal by Subject|8
1468365|NCT00703534|4840020|P2|Overall Study|Adverse Event|3
1468366|NCT00703534|4840021|P1|Overall Study|Adverse Event|14
1468367|NCT00703326|4840093|P2|Overall Study|Withdrawal by Subject|20
1468368|NCT00703326|4840094|P1|Overall Study|Withdrawal by Subject|42
1468369|NCT00703326|4840093|P2|Overall Study|Lost to Follow-up|8
1468370|NCT00703326|4840094|P1|Overall Study|Lost to Follow-up|25
1468371|NCT00703326|4840093|P2|Overall Study|Still on study|197
1468372|NCT00703326|4840094|P1|Overall Study|Still on study|380
1468373|NCT00703157|4840126|P2|Overall Study|source data permanently lost/ other|1
1468374|NCT00703157|4840127|P1|Overall Study|source data permanently lost/ other|4
1468375|NCT00703157|4840126|P2|Overall Study|Lost to Follow-up|1
1468376|NCT00703157|4840127|P1|Overall Study|Lost to Follow-up|0
1468377|NCT00703118|4840161|P3|Overall Study|Not specified|1
1468378|NCT00703118|4840162|P2|Overall Study|Not specified|0
1468379|NCT00703118|4840163|P1|Overall Study|Not specified|0
1468380|NCT00703118|4840161|P3|Overall Study|Withdrawal by Subject|13
1468381|NCT00703118|4840162|P2|Overall Study|Withdrawal by Subject|7
1468382|NCT00703118|4840163|P1|Overall Study|Withdrawal by Subject|8
1468383|NCT00703118|4840161|P3|Overall Study|Lost to Follow-up|4
1468384|NCT00703118|4840162|P2|Overall Study|Lost to Follow-up|4
1468385|NCT00703118|4840163|P1|Overall Study|Lost to Follow-up|6
1468386|NCT00703118|4840161|P3|Overall Study|Subject Ineligible To Continue The Trial|2
1468387|NCT00703118|4840162|P2|Overall Study|Subject Ineligible To Continue The Trial|3
1468388|NCT00703118|4840163|P1|Overall Study|Subject Ineligible To Continue The Trial|6
1468389|NCT00703118|4840161|P3|Overall Study|Adverse Event|2
1468390|NCT00703118|4840162|P2|Overall Study|Adverse Event|2
1468391|NCT00703118|4840163|P1|Overall Study|Adverse Event|1
1468392|NCT00703092|4840194|P1|Overall Study|Withdrawal by Subject|2
1468393|NCT00703014|4840402|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
1468394|NCT00703014|4840403|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
1468395|NCT00703014|4840404|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
1468396|NCT00703014|4840405|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
1468397|NCT00703014|4840402|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
1468398|NCT00703014|4840403|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
1468399|NCT00703014|4840404|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
1468400|NCT00703014|4840405|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
1468401|NCT00702949|4840426|P3|Overall Study|Other Medical Reason/unknown|3
1468402|NCT00702949|4840427|P2|Overall Study|Other Medical Reason/unknown|1
1468403|NCT00702949|4840428|P1|Overall Study|Other Medical Reason/unknown|1
1468404|NCT00702949|4840426|P3|Overall Study|Adverse Event|3
1468405|NCT00702949|4840427|P2|Overall Study|Adverse Event|6
1468406|NCT00702949|4840428|P1|Overall Study|Adverse Event|1
1468407|NCT00702949|4840426|P3|Overall Study|Refusal|2
1468408|NCT00702949|4840427|P2|Overall Study|Refusal|2
1468409|NCT00702949|4840428|P1|Overall Study|Refusal|3
1468410|NCT00702923|4840453|P1|Overall Study|Adverse Event|1
1468411|NCT00702845|4840476|P2|Overall Study|Not randomized|1
1468412|NCT00702845|4840477|P1|Overall Study|Not randomized|0
1468413|NCT00702845|4840476|P2|Overall Study|Patient's decision|1
1468414|NCT00702845|4840477|P1|Overall Study|Patient's decision|2
1468415|NCT00702845|4840476|P2|Overall Study|No or abnormal fertilization|2
1468416|NCT00702845|4840477|P1|Overall Study|No or abnormal fertilization|4
1468417|NCT00702845|4840476|P2|Overall Study|No/too few/bad quality embryos retrieved|1
1468418|NCT00702845|4840477|P1|Overall Study|No/too few/bad quality embryos retrieved|7
1468419|NCT00702845|4840476|P2|Overall Study|Insufficient ovarian response|0
1468420|NCT00702845|4840477|P1|Overall Study|Insufficient ovarian response|1
1468421|NCT00702845|4840476|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
1468422|NCT00702845|4840477|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
1468423|NCT00702845|4840476|P2|Overall Study|Too high ovarian response|1
1468424|NCT00702845|4840477|P1|Overall Study|Too high ovarian response|5
1468425|NCT00702845|4840476|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
1468426|NCT00702845|4840477|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
1468427|NCT00702715|4840539|P2|Overall Study|Lost to Follow-up|0
1468428|NCT00702715|4840540|P1|Overall Study|Lost to Follow-up|1
1468429|NCT00702702|4840553|P1|Overall Study|Study prematurely terminated|56
1468430|NCT00702689|4840561|P1|Overall Study|Adverse Event|1
1468431|NCT00702689|4840561|P1|Overall Study|Recurrent malignancy|1
1468432|NCT00702689|4840561|P1|Overall Study|Withdrawal by Subject|4
1468433|NCT00702650|4840572|P1|Overall Study|Adverse Event|3
1468434|NCT00702650|4840572|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
1468435|NCT00702650|4840572|P1|Overall Study|Sponsor Request|1
1468436|NCT00702650|4840572|P1|Overall Study|Non-Compliance with Site Directives|1
1468437|NCT00702650|4840572|P1|Overall Study|Lost to Follow-up|2
1468438|NCT00702650|4840572|P1|Overall Study|Non-Compliance of Study Drug|3
1468439|NCT00702650|4840572|P1|Overall Study|Withdrawal by Subject|9
1468440|NCT00702520|4840634|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
1468441|NCT00702520|4840635|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
1468442|NCT00702520|4840636|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
1468443|NCT00702520|4840637|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
1468444|NCT00702520|4840634|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
1468445|NCT00702520|4840635|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
1468446|NCT00702520|4840636|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
1468447|NCT00702520|4840637|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
1468448|NCT00702520|4840634|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
1468449|NCT00702520|4840635|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
1468450|NCT00702520|4840636|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
1468451|NCT00702520|4840637|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
1468452|NCT00702507|4840653|P1|Follow-up Phase|Late Enrollment|1
1468453|NCT00702507|4840653|P1|Follow-up Phase|Lost to Follow-up|23
1468454|NCT00702507|4840653|P1|Follow-up Phase|Protocol Violation|2
1468455|NCT00702507|4840653|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
1468456|NCT00702507|4840653|P1|Initial Treatment Phase|Negative Candida Culture|34
1468457|NCT00702507|4840653|P1|Initial Treatment Phase|Lost to Follow-up|2
1468458|NCT00702507|4840653|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
1468459|NCT00702507|4840653|P1|Initial Treatment Phase|Adverse Event|2
1468460|NCT00702403|4840690|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
1468461|NCT00702403|4840690|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
1468462|NCT00702403|4840690|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
1468463|NCT00702403|4840690|P1|From Engraftment to Study Completion|Suicide|1
1468464|NCT00702403|4840690|P1|From Engraftment to Study Completion|Liver GVHD|1
1468465|NCT00702403|4840690|P1|From Engraftment to Study Completion|Adenocarcinoma|1
1468466|NCT00702403|4840690|P1|From Engraftment to Study Completion|Non-compliance|2
1468467|NCT00702403|4840690|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
1468468|NCT00702403|4840690|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
1468469|NCT00702403|4840690|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
1468470|NCT00702403|4840690|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
1468471|NCT00702403|4840690|P1|From Consent to Engraftment|Myocardial infarction|1
1468472|NCT00702403|4840690|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
1468473|NCT00702403|4840690|P1|From Consent to Engraftment|Critically ill|2
1468474|NCT00702403|4840690|P1|From Consent to Engraftment|Progressive leukemia|6
1468475|NCT00702325|4840744|P2|Overall Study|Incorrectly Discontinued|1
1468476|NCT00702325|4840745|P1|Overall Study|Incorrectly Discontinued|0
1468477|NCT00702325|4840744|P2|Overall Study|Withdrew consent|1
1468478|NCT00702325|4840745|P1|Overall Study|Withdrew consent|0
1468479|NCT00702325|4840744|P2|Overall Study|Didn't follow study medication dosage|2
1468480|NCT00702325|4840745|P1|Overall Study|Didn't follow study medication dosage|0
1468481|NCT00702325|4840744|P2|Overall Study|Termination due to lab results|0
1468482|NCT00702325|4840745|P1|Overall Study|Termination due to lab results|1
1468483|NCT00702325|4840744|P2|Overall Study|Severe noncompliance to protocol|3
1468484|NCT00702325|4840745|P1|Overall Study|Severe noncompliance to protocol|3
1468485|NCT00702325|4840744|P2|Overall Study|Developed study discontinuation criteria|28
1468486|NCT00702325|4840745|P1|Overall Study|Developed study discontinuation criteria|18
1468487|NCT00702325|4840744|P2|Overall Study|Incorrect enrollment|7
1468488|NCT00702325|4840745|P1|Overall Study|Incorrect enrollment|5
1468489|NCT00702325|4840744|P2|Overall Study|Lost to Follow-up|4
1468490|NCT00702325|4840745|P1|Overall Study|Lost to Follow-up|3
1468491|NCT00702325|4840744|P2|Overall Study|Withdrawal by Subject|7
1468492|NCT00702325|4840745|P1|Overall Study|Withdrawal by Subject|7
1468493|NCT00702325|4840744|P2|Overall Study|Adverse Event|0
1468494|NCT00702325|4840745|P1|Overall Study|Adverse Event|1
1468495|NCT00702221|4840841|P2|Overall Study|Adverse Event|3
1468496|NCT00702221|4840842|P1|Overall Study|Adverse Event|4
1468497|NCT00702208|4840848|P1|Overall Study|Unsatisfactory colposcopy|2
1468498|NCT00702208|4840848|P1|Overall Study|Did not self-lavage|1
1468499|NCT00702208|4840848|P1|Overall Study|Lost to Follow-up|28
1468500|NCT00702143|4840857|P3|Overall Study|Lost to Follow-up|1
1468501|NCT00702143|4840858|P2|Overall Study|Lost to Follow-up|0
1468502|NCT00702143|4840859|P1|Overall Study|Lost to Follow-up|0
1468503|NCT00701805|4840908|P4|Overall Study|Resumption criteria were not met|0
1468504|NCT00701805|4840909|P3|Overall Study|Resumption criteria were not met|0
1468505|NCT00701805|4840910|P2|Overall Study|Resumption criteria were not met|1
1468506|NCT00701805|4840911|P1|Overall Study|Resumption criteria were not met|0
1468507|NCT00701805|4840908|P4|Overall Study|Difficult to travel to dialysis site|0
1468508|NCT00701805|4840909|P3|Overall Study|Difficult to travel to dialysis site|1
1468509|NCT00701805|4840910|P2|Overall Study|Difficult to travel to dialysis site|0
1468510|NCT00701805|4840911|P1|Overall Study|Difficult to travel to dialysis site|0
1468511|NCT00701805|4840908|P4|Overall Study|Physician decision, change of therapy|1
1468512|NCT00701805|4840909|P3|Overall Study|Physician decision, change of therapy|0
1468513|NCT00701805|4840910|P2|Overall Study|Physician decision, change of therapy|0
1468514|NCT00701805|4840911|P1|Overall Study|Physician decision, change of therapy|0
1468515|NCT00701805|4840908|P4|Overall Study|Admitted to hospital for 2 weeks|0
1468516|NCT00701805|4840909|P3|Overall Study|Admitted to hospital for 2 weeks|1
1468517|NCT00701805|4840910|P2|Overall Study|Admitted to hospital for 2 weeks|0
1468518|NCT00701805|4840911|P1|Overall Study|Admitted to hospital for 2 weeks|0
1468519|NCT00701805|4840908|P4|Overall Study|Missed 7 consecutive doses|0
1468520|NCT00701805|4840909|P3|Overall Study|Missed 7 consecutive doses|0
1468521|NCT00701805|4840910|P2|Overall Study|Missed 7 consecutive doses|1
1468522|NCT00701805|4840911|P1|Overall Study|Missed 7 consecutive doses|0
1468523|NCT00701805|4840908|P4|Overall Study|Adverse Event|0
1468524|NCT00701805|4840909|P3|Overall Study|Adverse Event|1
1468525|NCT00701805|4840910|P2|Overall Study|Adverse Event|1
1468526|NCT00701805|4840911|P1|Overall Study|Adverse Event|0
1468527|NCT00701805|4840908|P4|Overall Study|Withdrawal by Subject|3
1468528|NCT00701805|4840909|P3|Overall Study|Withdrawal by Subject|4
1468529|NCT00701805|4840910|P2|Overall Study|Withdrawal by Subject|1
1468530|NCT00701805|4840911|P1|Overall Study|Withdrawal by Subject|3
1468531|NCT00701779|4840961|P1|Overall Study|Withdrawal by Subject|2
1468532|NCT00701779|4840961|P1|Overall Study|Lost to Follow-up|1
1468533|NCT00701779|4840961|P1|Overall Study|Adverse Event|6
1468534|NCT00701727|4840970|P2|Second Treatment Period|Withdrawal by Subject|0
1468535|NCT00701727|4840971|P1|Second Treatment Period|Withdrawal by Subject|2
1468536|NCT00701727|4840970|P2|First Treatment Period|Lost to Follow-up|1
1468537|NCT00701727|4840971|P1|First Treatment Period|Lost to Follow-up|0
1468538|NCT00701727|4840970|P2|First Treatment Period|sponsor decision|1
1468539|NCT00701727|4840971|P1|First Treatment Period|sponsor decision|0
1468540|NCT00701727|4840970|P2|First Treatment Period|Withdrawal by Subject|0
1468541|NCT00701727|4840971|P1|First Treatment Period|Withdrawal by Subject|1
1468542|NCT00701727|4840970|P2|First Treatment Period|Adverse Event|0
1468543|NCT00701727|4840971|P1|First Treatment Period|Adverse Event|0
1468544|NCT00701662|4841017|P1|Overall Study|Lack of Efficacy|1
1468545|NCT00701558|4841042|P1|Overall Study|Lost to Follow-up|8
1468546|NCT00701558|4841042|P1|Overall Study|Death|7
1468547|NCT00701441|4841050|P2|Overall Study|failure in cpap compliance|4
1468548|NCT00701441|4841051|P1|Overall Study|failure in cpap compliance|0
1468549|NCT00701415|4841063|P2|Overall Study|Social/family issues and needle phobia|0
1468550|NCT00701415|4841064|P1|Overall Study|Social/family issues and needle phobia|1
1468551|NCT00701415|4841063|P2|Overall Study|Adverse Event|1
1468552|NCT00701415|4841064|P1|Overall Study|Adverse Event|0
1468553|NCT00701363|4841099|P4|Treatment Phase 2|Withdrawal by Subject|0
1468554|NCT00701363|4841100|P3|Treatment Phase 2|Withdrawal by Subject|1
1468555|NCT00701363|4841101|P2|Treatment Phase 2|Withdrawal by Subject|0
1468556|NCT00701363|4841102|P1|Treatment Phase 2|Withdrawal by Subject|0
1468557|NCT00701363|4841099|P4|Treatment Phase 2|Adverse Event|0
1468558|NCT00701363|4841100|P3|Treatment Phase 2|Adverse Event|1
1468559|NCT00701363|4841101|P2|Treatment Phase 2|Adverse Event|0
1468560|NCT00701363|4841102|P1|Treatment Phase 2|Adverse Event|0
1468561|NCT00701363|4841099|P4|Treatment Phase 1|Lack of Efficacy|0
1468562|NCT00701363|4841100|P3|Treatment Phase 1|Lack of Efficacy|0
1468563|NCT00701363|4841101|P2|Treatment Phase 1|Lack of Efficacy|0
1468564|NCT00701363|4841102|P1|Treatment Phase 1|Lack of Efficacy|1
1468565|NCT00701363|4841099|P4|Treatment Phase 1|Withdrawal by Subject|0
1468566|NCT00701363|4841100|P3|Treatment Phase 1|Withdrawal by Subject|0
1468567|NCT00701363|4841101|P2|Treatment Phase 1|Withdrawal by Subject|0
1468568|NCT00701363|4841102|P1|Treatment Phase 1|Withdrawal by Subject|5
1468569|NCT00701363|4841099|P4|Treatment Phase 1|Protocol Violation|0
1468570|NCT00701363|4841100|P3|Treatment Phase 1|Protocol Violation|0
1468571|NCT00701363|4841101|P2|Treatment Phase 1|Protocol Violation|0
1468572|NCT00701363|4841102|P1|Treatment Phase 1|Protocol Violation|1
1468573|NCT00701363|4841099|P4|Treatment Phase 1|Adverse Event|0
1468574|NCT00701363|4841100|P3|Treatment Phase 1|Adverse Event|0
1468575|NCT00701363|4841101|P2|Treatment Phase 1|Adverse Event|0
1468576|NCT00701363|4841102|P1|Treatment Phase 1|Adverse Event|7
1468577|NCT00701363|4841099|P4|Treatment Phase 1|Does not meet entry Criteria|0
1468578|NCT00701363|4841100|P3|Treatment Phase 1|Does not meet entry Criteria|0
1468579|NCT00701363|4841101|P2|Treatment Phase 1|Does not meet entry Criteria|0
1468580|NCT00701363|4841102|P1|Treatment Phase 1|Does not meet entry Criteria|1
1468581|NCT00701363|4841099|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
1468582|NCT00701363|4841100|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
1468583|NCT00701363|4841101|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
1468584|NCT00701363|4841102|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
1468585|NCT00701311|4841142|P1|Overall Study|Withdrawal by Subject|2
1468586|NCT00701311|4841142|P1|Overall Study|Adverse Event|3
1468587|NCT00701311|4841142|P1|Overall Study|Lack of Efficacy|3
1468588|NCT00701129|4841146|P1|Overall Study|Death|2
1468589|NCT00701103|4841168|P11|Overall Study|Other|0
1468590|NCT00701103|4841169|P10|Overall Study|Other|1
1468591|NCT00701103|4841170|P9|Overall Study|Other|1
1468592|NCT00701103|4841171|P8|Overall Study|Other|0
1468593|NCT00701103|4841172|P7|Overall Study|Other|0
1468594|NCT00701103|4841173|P6|Overall Study|Other|0
1468595|NCT00701103|4841174|P5|Overall Study|Other|0
1468596|NCT00701103|4841175|P4|Overall Study|Other|0
1468597|NCT00701103|4841176|P3|Overall Study|Other|0
1468598|NCT00701103|4841177|P2|Overall Study|Other|0
1468599|NCT00701103|4841178|P1|Overall Study|Other|0
1468600|NCT00701103|4841168|P11|Overall Study|Withdrawal by Subject|0
1468601|NCT00701103|4841169|P10|Overall Study|Withdrawal by Subject|0
1468602|NCT00701103|4841170|P9|Overall Study|Withdrawal by Subject|0
1468603|NCT00701103|4841171|P8|Overall Study|Withdrawal by Subject|0
1468604|NCT00701103|4841172|P7|Overall Study|Withdrawal by Subject|0
1468605|NCT00701103|4841173|P6|Overall Study|Withdrawal by Subject|0
1468606|NCT00701103|4841174|P5|Overall Study|Withdrawal by Subject|0
1468607|NCT00701103|4841175|P4|Overall Study|Withdrawal by Subject|0
1468608|NCT00701103|4841176|P3|Overall Study|Withdrawal by Subject|1
1468609|NCT00701103|4841177|P2|Overall Study|Withdrawal by Subject|1
1468610|NCT00701103|4841178|P1|Overall Study|Withdrawal by Subject|0
1468611|NCT00701103|4841168|P11|Overall Study|Progressive Disease|11
1468612|NCT00701103|4841169|P10|Overall Study|Progressive Disease|8
1468613|NCT00701103|4841170|P9|Overall Study|Progressive Disease|8
1468614|NCT00701103|4841171|P8|Overall Study|Progressive Disease|7
1468615|NCT00701103|4841172|P7|Overall Study|Progressive Disease|7
1468616|NCT00701103|4841173|P6|Overall Study|Progressive Disease|5
1468617|NCT00701103|4841174|P5|Overall Study|Progressive Disease|6
1468618|NCT00701103|4841175|P4|Overall Study|Progressive Disease|5
1468619|NCT00701103|4841176|P3|Overall Study|Progressive Disease|6
1468620|NCT00701103|4841177|P2|Overall Study|Progressive Disease|2
1468621|NCT00701103|4841178|P1|Overall Study|Progressive Disease|5
1468622|NCT00701103|4841168|P11|Overall Study|Adverse Event|0
1468623|NCT00701103|4841169|P10|Overall Study|Adverse Event|2
1468624|NCT00701103|4841170|P9|Overall Study|Adverse Event|0
1468625|NCT00701103|4841171|P8|Overall Study|Adverse Event|0
1468626|NCT00701103|4841172|P7|Overall Study|Adverse Event|1
1468627|NCT00701103|4841173|P6|Overall Study|Adverse Event|1
1468628|NCT00701103|4841174|P5|Overall Study|Adverse Event|0
1468629|NCT00701103|4841175|P4|Overall Study|Adverse Event|1
1468630|NCT00701103|4841176|P3|Overall Study|Adverse Event|1
1468631|NCT00701103|4841177|P2|Overall Study|Adverse Event|0
1468632|NCT00701103|4841178|P1|Overall Study|Adverse Event|0
1468633|NCT00701090|4841284|P2|Overall Study|Other|12
1468634|NCT00701090|4841285|P1|Overall Study|Other|7
1468635|NCT00701090|4841284|P2|Overall Study|Withdrawal by Subject|16
1468636|NCT00701090|4841285|P1|Overall Study|Withdrawal by Subject|11
1468637|NCT00701090|4841284|P2|Overall Study|Protocol Violation|3
1468638|NCT00701090|4841285|P1|Overall Study|Protocol Violation|2
1468639|NCT00701090|4841284|P2|Overall Study|Physician Decision|4
1468640|NCT00701090|4841285|P1|Overall Study|Physician Decision|3
1468641|NCT00701090|4841284|P2|Overall Study|Lost to Follow-up|9
1468642|NCT00701090|4841285|P1|Overall Study|Lost to Follow-up|9
1468643|NCT00701090|4841284|P2|Overall Study|Lack of Efficacy|4
1468644|NCT00701090|4841285|P1|Overall Study|Lack of Efficacy|5
1468645|NCT00701090|4841284|P2|Overall Study|Death|1
1468646|NCT00701090|4841285|P1|Overall Study|Death|0
1468647|NCT00701090|4841284|P2|Overall Study|Adverse Event|2
1468648|NCT00701090|4841285|P1|Overall Study|Adverse Event|11
1468649|NCT00701064|4841303|P2|Overall Study|initiated other PTSD treatment|2
1468650|NCT00701064|4841304|P1|Overall Study|initiated other PTSD treatment|2
1468651|NCT00701064|4841303|P2|Overall Study|Withdrawal by Subject|1
1468652|NCT00701064|4841304|P1|Overall Study|Withdrawal by Subject|1
1468653|NCT00701064|4841303|P2|Overall Study|Protocol Violation|1
1468654|NCT00701064|4841304|P1|Overall Study|Protocol Violation|1
1468655|NCT00701051|4841312|P3|Exercise Intervention|time conflict; non-study related illness|3
1468656|NCT00701051|4841313|P2|Exercise Intervention|time conflict; non-study related illness|5
1468657|NCT00701051|4841314|P1|Exercise Intervention|time conflict; non-study related illness|0
1468658|NCT00701051|4841312|P3|Screening|Time conflicts|0
1468659|NCT00701051|4841313|P2|Screening|Time conflicts|0
1468660|NCT00701051|4841314|P1|Screening|Time conflicts|19
1468661|NCT00701051|4841312|P3|Screening|Failed Screening|0
1468662|NCT00701051|4841313|P2|Screening|Failed Screening|0
1468663|NCT00701051|4841314|P1|Screening|Failed Screening|40
1468664|NCT00701038|4841332|P2|Overall Study|study amended pilot group of patients|4
1468665|NCT00701038|4841333|P1|Overall Study|study amended pilot group of patients|4
1468666|NCT00700999|4841341|P2|Overall Study|Withdrawal by Subject|1
1468667|NCT00700999|4841342|P1|Overall Study|Withdrawal by Subject|8
1468668|NCT00700999|4841341|P2|Overall Study|Excluded - did not meet study criteria|1
1468669|NCT00700999|4841342|P1|Overall Study|Excluded - did not meet study criteria|0
1468670|NCT00700999|4841341|P2|Overall Study|Lost to Follow-up|7
1468671|NCT00700999|4841342|P1|Overall Study|Lost to Follow-up|7
1468672|NCT00700817|4841362|P5|Week 52-78 (Extension Period 2)|Unclassified|1
1468673|NCT00700817|4841363|P4|Week 52-78 (Extension Period 2)|Unclassified|0
1468674|NCT00700817|4841364|P3|Week 52-78 (Extension Period 2)|Unclassified|0
1468675|NCT00700817|4841365|P2|Week 52-78 (Extension Period 2)|Unclassified|4
1468676|NCT00700817|4841366|P1|Week 52-78 (Extension Period 2)|Unclassified|2
1468677|NCT00700817|4841362|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
1468678|NCT00700817|4841363|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
1468679|NCT00700817|4841364|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
1468680|NCT00700817|4841365|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
1468681|NCT00700817|4841366|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
1468682|NCT00700817|4841362|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
1468683|NCT00700817|4841363|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
1468684|NCT00700817|4841364|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
1468685|NCT00700817|4841365|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
1468686|NCT00700817|4841366|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
1468687|NCT00700817|4841362|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
1468688|NCT00700817|4841363|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
1468689|NCT00700817|4841364|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
1468690|NCT00700817|4841365|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
1468691|NCT00700817|4841366|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
1468692|NCT00700817|4841362|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
1468693|NCT00700817|4841363|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
1468694|NCT00700817|4841364|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
1468695|NCT00700817|4841365|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
1468696|NCT00700817|4841366|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
1468697|NCT00700817|4841362|P5|Week 26-52 (Extension Period 1)|Unclassified|0
1468698|NCT00700817|4841363|P4|Week 26-52 (Extension Period 1)|Unclassified|0
1468699|NCT00700817|4841364|P3|Week 26-52 (Extension Period 1)|Unclassified|1
1468700|NCT00700817|4841365|P2|Week 26-52 (Extension Period 1)|Unclassified|3
1468701|NCT00700817|4841366|P1|Week 26-52 (Extension Period 1)|Unclassified|4
1468702|NCT00700817|4841362|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
1468703|NCT00700817|4841363|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
1468704|NCT00700817|4841364|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
1468705|NCT00700817|4841365|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
1468706|NCT00700817|4841366|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
1468707|NCT00700817|4841362|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
1468708|NCT00700817|4841363|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
1468709|NCT00700817|4841364|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
1468710|NCT00700817|4841365|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
1468711|NCT00700817|4841366|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
1468712|NCT00700817|4841362|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
1468713|NCT00700817|4841363|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
1468714|NCT00700817|4841364|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
1468715|NCT00700817|4841365|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
1468716|NCT00700817|4841366|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
1468717|NCT00700817|4841362|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
1468718|NCT00700817|4841363|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
1468719|NCT00700817|4841364|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
1468720|NCT00700817|4841365|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
1468721|NCT00700817|4841366|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
1468722|NCT00700817|4841362|P5|Week 0-26 (Main Period)|Unclassified|0
1468723|NCT00700817|4841363|P4|Week 0-26 (Main Period)|Unclassified|0
1468724|NCT00700817|4841364|P3|Week 0-26 (Main Period)|Unclassified|8
1468725|NCT00700817|4841365|P2|Week 0-26 (Main Period)|Unclassified|4
1468726|NCT00700817|4841366|P1|Week 0-26 (Main Period)|Unclassified|14
1468727|NCT00700817|4841362|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
1468728|NCT00700817|4841363|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
1468729|NCT00700817|4841364|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
1468730|NCT00700817|4841365|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
1468731|NCT00700817|4841366|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
1468732|NCT00700817|4841362|P5|Week 0-26 (Main Period)|Protocol Violation|0
1468733|NCT00700817|4841363|P4|Week 0-26 (Main Period)|Protocol Violation|0
1468734|NCT00700817|4841364|P3|Week 0-26 (Main Period)|Protocol Violation|4
1468735|NCT00700817|4841365|P2|Week 0-26 (Main Period)|Protocol Violation|4
1468736|NCT00700817|4841366|P1|Week 0-26 (Main Period)|Protocol Violation|14
1468737|NCT00700817|4841362|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
1468738|NCT00700817|4841363|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
1468739|NCT00700817|4841364|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
1468740|NCT00700817|4841365|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
1468741|NCT00700817|4841366|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
1468742|NCT00700817|4841362|P5|Week 0-26 (Main Period)|Adverse Event|0
1468743|NCT00700817|4841363|P4|Week 0-26 (Main Period)|Adverse Event|0
1468744|NCT00700817|4841364|P3|Week 0-26 (Main Period)|Adverse Event|4
1468745|NCT00700817|4841365|P2|Week 0-26 (Main Period)|Adverse Event|15
1468746|NCT00700817|4841366|P1|Week 0-26 (Main Period)|Adverse Event|14
1468747|NCT00700804|4841748|P2|Overall Study|Loose Stools|1
1468748|NCT00700804|4841749|P1|Overall Study|Loose Stools|1
1468749|NCT00700804|4841748|P2|Overall Study|Protocol Violation|1
1468750|NCT00700804|4841749|P1|Overall Study|Protocol Violation|1
1468751|NCT00700804|4841748|P2|Overall Study|Withdrawal by Subject|2
1468752|NCT00700804|4841749|P1|Overall Study|Withdrawal by Subject|1
1468753|NCT00700752|4841757|P2|First Intervention|Withdrawal by Subject|2
1468754|NCT00700752|4841758|P1|First Intervention|Withdrawal by Subject|0
1468755|NCT00700739|4841766|P2|Overall Study|Lost to Follow-up|4
1468756|NCT00700739|4841767|P1|Overall Study|Lost to Follow-up|4
1468757|NCT00700713|4841806|P3|Overall Study|Withdrawal by Subject|1
1468758|NCT00700713|4841807|P2|Overall Study|Withdrawal by Subject|0
1468759|NCT00700713|4841808|P1|Overall Study|Withdrawal by Subject|0
1468760|NCT00700713|4841806|P3|Overall Study|Protocol Violation|1
1468761|NCT00700713|4841807|P2|Overall Study|Protocol Violation|0
1468762|NCT00700713|4841808|P1|Overall Study|Protocol Violation|1
1468763|NCT00700635|4841825|P3|Overall Study|Withdrawal by Subject|1
1468764|NCT00700635|4841826|P2|Overall Study|Withdrawal by Subject|3
1468765|NCT00700635|4841827|P1|Overall Study|Withdrawal by Subject|7
1468766|NCT00700635|4841825|P3|Overall Study|Protocol Violation|0
1468767|NCT00700635|4841826|P2|Overall Study|Protocol Violation|2
1468768|NCT00700635|4841827|P1|Overall Study|Protocol Violation|2
1468769|NCT00700635|4841825|P3|Overall Study|Lost to Follow-up|0
1468770|NCT00700635|4841826|P2|Overall Study|Lost to Follow-up|3
1468771|NCT00700635|4841827|P1|Overall Study|Lost to Follow-up|1
1468772|NCT00700635|4841825|P3|Overall Study|Adverse Event|0
1468773|NCT00700635|4841826|P2|Overall Study|Adverse Event|0
1468774|NCT00700635|4841827|P1|Overall Study|Adverse Event|1
1468775|NCT00700622|4841849|P2|Overall Study|Other|1
1468776|NCT00700622|4841850|P1|Overall Study|Other|3
1468777|NCT00700622|4841849|P2|Overall Study|Withdrawal by Subject|1
1468778|NCT00700622|4841850|P1|Overall Study|Withdrawal by Subject|4
1468779|NCT00700622|4841849|P2|Overall Study|Protocol Violation|1
1468780|NCT00700622|4841850|P1|Overall Study|Protocol Violation|0
1468781|NCT00700622|4841849|P2|Overall Study|Physician Decision|1
1468782|NCT00700622|4841850|P1|Overall Study|Physician Decision|2
1468783|NCT00700622|4841849|P2|Overall Study|Lost to Follow-up|1
1468784|NCT00700622|4841850|P1|Overall Study|Lost to Follow-up|0
1468785|NCT00700622|4841849|P2|Overall Study|Adverse Event|0
1468786|NCT00700622|4841850|P1|Overall Study|Adverse Event|4
1468787|NCT00700570|4841858|P2|Overall Study|Withdrawal by Subject|6
1468788|NCT00700570|4841859|P1|Overall Study|Withdrawal by Subject|1
1468789|NCT00700570|4841858|P2|Overall Study|Disease Progression|11
1468790|NCT00700570|4841859|P1|Overall Study|Disease Progression|8
1468791|NCT00700570|4841858|P2|Overall Study|Discretion of Investigator or Sponsor|3
1468792|NCT00700570|4841859|P1|Overall Study|Discretion of Investigator or Sponsor|0
1468793|NCT00700570|4841858|P2|Overall Study|Adverse Event|6
1468794|NCT00700570|4841859|P1|Overall Study|Adverse Event|2
1468795|NCT00700427|4841875|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
1468796|NCT00700427|4841876|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
1468797|NCT00700427|4841877|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
1468798|NCT00700427|4841878|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
1468799|NCT00700427|4841879|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
1468800|NCT00700427|4841875|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
1468801|NCT00700427|4841876|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
1468802|NCT00700427|4841877|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
1468803|NCT00700427|4841878|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
1468804|NCT00700427|4841879|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
1468805|NCT00700427|4841875|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
1468806|NCT00700427|4841876|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
1468807|NCT00700427|4841877|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
1468808|NCT00700427|4841878|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
1468809|NCT00700427|4841879|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
1468810|NCT00700427|4841875|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
1468811|NCT00700427|4841876|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
1468812|NCT00700427|4841877|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
1468813|NCT00700427|4841878|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
1468814|NCT00700427|4841879|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
1468815|NCT00700427|4841875|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
1468816|NCT00700427|4841876|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
1468817|NCT00700427|4841877|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
1468818|NCT00700427|4841878|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
1468819|NCT00700427|4841879|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
1468820|NCT00700427|4841875|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
1468821|NCT00700427|4841876|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
1468822|NCT00700427|4841877|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
1468823|NCT00700427|4841878|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
1468824|NCT00700427|4841879|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
1468825|NCT00700427|4841875|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
1468826|NCT00700427|4841876|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
1468827|NCT00700427|4841877|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
1468828|NCT00700427|4841878|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
1468829|NCT00700427|4841879|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
1468830|NCT00700427|4841875|P5|Study Period 4 (Open-Label Extension)|Death|1
1468831|NCT00700427|4841876|P4|Study Period 4 (Open-Label Extension)|Death|0
1468832|NCT00700427|4841877|P3|Study Period 4 (Open-Label Extension)|Death|0
1468833|NCT00700427|4841878|P2|Study Period 4 (Open-Label Extension)|Death|0
1468834|NCT00700427|4841879|P1|Study Period 4 (Open-Label Extension)|Death|0
1468835|NCT00700427|4841875|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
1468836|NCT00700427|4841876|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
1468837|NCT00700427|4841877|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
1468838|NCT00700427|4841878|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
1468839|NCT00700427|4841879|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
1468840|NCT00700427|4841875|P5|Study Period 3B (Randomized Withdrawal)|Death|0
1468841|NCT00700427|4841876|P4|Study Period 3B (Randomized Withdrawal)|Death|0
1468842|NCT00700427|4841877|P3|Study Period 3B (Randomized Withdrawal)|Death|1
1468843|NCT00700427|4841878|P2|Study Period 3B (Randomized Withdrawal)|Death|0
1468844|NCT00700427|4841879|P1|Study Period 3B (Randomized Withdrawal)|Death|0
1468845|NCT00700427|4841875|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
1468846|NCT00700427|4841876|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
1468847|NCT00700427|4841877|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
1468848|NCT00700427|4841878|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
1468849|NCT00700427|4841879|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
1468850|NCT00700427|4841875|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
1468851|NCT00700427|4841876|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
1468852|NCT00700427|4841877|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
1468853|NCT00700427|4841878|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
1468854|NCT00700427|4841879|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
1468855|NCT00700427|4841875|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
1468856|NCT00700427|4841876|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
1468857|NCT00700427|4841877|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
1468858|NCT00700427|4841878|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
1468859|NCT00700427|4841879|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
1468860|NCT00700427|4841875|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
1468861|NCT00700427|4841876|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
1468862|NCT00700427|4841877|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
1468863|NCT00700427|4841878|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
1468864|NCT00700427|4841879|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
1468865|NCT00700427|4841875|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
1468866|NCT00700427|4841876|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
1468867|NCT00700427|4841877|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
1468868|NCT00700427|4841878|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
1468869|NCT00700427|4841879|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
1468870|NCT00700427|4841875|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
1468871|NCT00700427|4841876|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
1468872|NCT00700427|4841877|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
1468873|NCT00700427|4841878|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
1468874|NCT00700427|4841879|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
1468875|NCT00700427|4841875|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
1468876|NCT00700427|4841876|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
1468877|NCT00700427|4841877|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
1468878|NCT00700427|4841878|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
1468879|NCT00700427|4841879|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
1468880|NCT00700427|4841875|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
1468881|NCT00700427|4841876|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
1468882|NCT00700427|4841877|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
1468883|NCT00700427|4841878|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
1468884|NCT00700427|4841879|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
1468885|NCT00700427|4841875|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
1468886|NCT00700427|4841876|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
1468887|NCT00700427|4841877|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
1468888|NCT00700427|4841878|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
1468889|NCT00700427|4841879|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
1468890|NCT00700427|4841875|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
1468891|NCT00700427|4841876|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
1468892|NCT00700427|4841877|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
1468893|NCT00700427|4841878|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
1468894|NCT00700427|4841879|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
1468895|NCT00700427|4841875|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
1468896|NCT00700427|4841876|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
1468897|NCT00700427|4841877|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
1468898|NCT00700427|4841878|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
1468899|NCT00700427|4841879|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
1468900|NCT00700427|4841875|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
1468901|NCT00700427|4841876|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
1468902|NCT00700427|4841877|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
1468903|NCT00700427|4841878|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
1468904|NCT00700427|4841879|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
1468905|NCT00700427|4841875|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
1468906|NCT00700427|4841876|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
1468907|NCT00700427|4841877|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
1468908|NCT00700427|4841878|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
1468909|NCT00700427|4841879|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
1468910|NCT00700427|4841875|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
1468911|NCT00700427|4841876|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
1468912|NCT00700427|4841877|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
1468913|NCT00700427|4841878|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
1468914|NCT00700427|4841879|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
1468915|NCT00700427|4841875|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
1468916|NCT00700427|4841876|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
1468917|NCT00700427|4841877|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
1468918|NCT00700427|4841878|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
1468919|NCT00700427|4841879|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
1468920|NCT00700427|4841875|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
1468921|NCT00700427|4841876|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
1468922|NCT00700427|4841877|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
1468923|NCT00700427|4841878|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
1468924|NCT00700427|4841879|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
1468925|NCT00700427|4841875|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
1468926|NCT00700427|4841876|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
1468927|NCT00700427|4841877|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
1468928|NCT00700427|4841878|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
1468929|NCT00700427|4841879|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
1468930|NCT00700427|4841875|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
1468931|NCT00700427|4841876|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
1468932|NCT00700427|4841877|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
1468933|NCT00700427|4841878|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
1468934|NCT00700427|4841879|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
1468935|NCT00700427|4841875|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
1468936|NCT00700427|4841876|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
1468937|NCT00700427|4841877|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
1468938|NCT00700427|4841878|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
1468939|NCT00700427|4841879|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
1468940|NCT00700427|4841875|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
1468941|NCT00700427|4841876|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
1468942|NCT00700427|4841877|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
1468943|NCT00700427|4841878|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
1468944|NCT00700427|4841879|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
1468945|NCT00700427|4841875|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
1468946|NCT00700427|4841876|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
1468947|NCT00700427|4841877|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
1468948|NCT00700427|4841878|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
1468949|NCT00700427|4841879|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
1468950|NCT00700427|4841875|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
1468951|NCT00700427|4841876|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
1468952|NCT00700427|4841877|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
1468953|NCT00700427|4841878|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
1468954|NCT00700427|4841879|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
1468955|NCT00700427|4841875|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
1468956|NCT00700427|4841876|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
1468957|NCT00700427|4841877|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
1468958|NCT00700427|4841878|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
1468959|NCT00700427|4841879|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
1468960|NCT00700427|4841875|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
1468961|NCT00700427|4841876|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
1468962|NCT00700427|4841877|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
1468963|NCT00700427|4841878|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
1468964|NCT00700427|4841879|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
1468965|NCT00700427|4841875|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
1468966|NCT00700427|4841876|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
1468967|NCT00700427|4841877|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
1468968|NCT00700427|4841878|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
1468969|NCT00700427|4841879|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
1468970|NCT00700427|4841875|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
1468971|NCT00700427|4841876|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
1468972|NCT00700427|4841877|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
1468973|NCT00700427|4841878|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
1468974|NCT00700427|4841879|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
1468975|NCT00700427|4841875|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
1468976|NCT00700427|4841876|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
1468977|NCT00700427|4841877|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
1468978|NCT00700427|4841878|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
1468979|NCT00700427|4841879|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
1468980|NCT00700427|4841875|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
1468981|NCT00700427|4841876|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
1468982|NCT00700427|4841877|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
1468983|NCT00700427|4841878|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
1468984|NCT00700427|4841879|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
1468985|NCT00700401|4841901|P1|Overall Study|Withdrawal by Subject|2
1468986|NCT00700401|4841901|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
1468987|NCT00700401|4841901|P1|Overall Study|Treatment never started|1
1468988|NCT00700401|4841901|P1|Overall Study|Lost to Follow-up|1
1468989|NCT00700401|4841901|P1|Overall Study|Refused Treatment|2
1468990|NCT00700401|4841901|P1|Overall Study|Adverse Event|5
1468991|NCT00700401|4841901|P1|Overall Study|Detectable HCV RNA after Week 4|82
1468992|NCT00700310|4841925|P4|Overall Study|Randomized, Not Treated|2
1468993|NCT00700310|4841926|P3|Overall Study|Randomized, Not Treated|2
1468994|NCT00700310|4841927|P2|Overall Study|Randomized, Not Treated|0
1468995|NCT00700310|4841928|P1|Overall Study|Randomized, Not Treated|2
1468996|NCT00700310|4841925|P4|Overall Study|Administrative/Other|3
1468997|NCT00700310|4841926|P3|Overall Study|Administrative/Other|1
1468998|NCT00700310|4841927|P2|Overall Study|Administrative/Other|3
1468999|NCT00700310|4841928|P1|Overall Study|Administrative/Other|1
1469000|NCT00700310|4841925|P4|Overall Study|Lack of Efficacy|1
1469001|NCT00700310|4841926|P3|Overall Study|Lack of Efficacy|0
1469002|NCT00700310|4841927|P2|Overall Study|Lack of Efficacy|3
1469003|NCT00700310|4841928|P1|Overall Study|Lack of Efficacy|0
1469004|NCT00700310|4841925|P4|Overall Study|Withdrawal by Subject|8
1469005|NCT00700310|4841926|P3|Overall Study|Withdrawal by Subject|8
1469006|NCT00700310|4841927|P2|Overall Study|Withdrawal by Subject|9
1469007|NCT00700310|4841928|P1|Overall Study|Withdrawal by Subject|8
1469008|NCT00700310|4841925|P4|Overall Study|Lost to Follow-up|1
1469009|NCT00700310|4841926|P3|Overall Study|Lost to Follow-up|0
1469010|NCT00700310|4841927|P2|Overall Study|Lost to Follow-up|1
1469011|NCT00700310|4841928|P1|Overall Study|Lost to Follow-up|4
1469012|NCT00700310|4841925|P4|Overall Study|Adverse Event|11
1469013|NCT00700310|4841926|P3|Overall Study|Adverse Event|5
1469014|NCT00700310|4841927|P2|Overall Study|Adverse Event|10
1469015|NCT00700310|4841928|P1|Overall Study|Adverse Event|6
1469016|NCT00700271|4841948|P2|Overall Study|Lost to Follow-up|2
1469017|NCT00700271|4841949|P1|Overall Study|Lost to Follow-up|2
1469018|NCT00700271|4841948|P2|Overall Study|Withdrawal by Subject|4
1469019|NCT00700271|4841949|P1|Overall Study|Withdrawal by Subject|6
1469020|NCT00700271|4841948|P2|Overall Study|Administrative Reasons|0
1469021|NCT00700271|4841949|P1|Overall Study|Administrative Reasons|1
1469022|NCT00700271|4841948|P2|Overall Study|Protocol Violation|0
1469023|NCT00700271|4841949|P1|Overall Study|Protocol Violation|1
1469024|NCT00700271|4841948|P2|Overall Study|Adverse Event|6
1469025|NCT00700271|4841949|P1|Overall Study|Adverse Event|4
1469026|NCT00700180|4841977|P2|Overall Study|Lost to Follow-up|5
1469027|NCT00700180|4841978|P1|Overall Study|Lost to Follow-up|4
1469028|NCT00700180|4841977|P2|Overall Study|Alive in follow-up|27
1469029|NCT00700180|4841978|P1|Overall Study|Alive in follow-up|46
1469030|NCT00700180|4841977|P2|Overall Study|Alive on treatment|3
1469031|NCT00700180|4841978|P1|Overall Study|Alive on treatment|5
1469032|NCT00700180|4841977|P2|Overall Study|Death|114
1469033|NCT00700180|4841978|P1|Overall Study|Death|99
1469034|NCT00700115|4842007|P2|Overall Study|Lost to Follow-up|1
1469035|NCT00700115|4842008|P1|Overall Study|Lost to Follow-up|0
1469036|NCT00700115|4842007|P2|Overall Study|Withdrawal by Subject|0
1469037|NCT00700115|4842008|P1|Overall Study|Withdrawal by Subject|1
1469038|NCT00700102|4842018|P2|Overall Study|Lost to Follow-up|10
1469039|NCT00700102|4842019|P1|Overall Study|Lost to Follow-up|8
1469040|NCT00700102|4842018|P2|Overall Study|Died|385
1469041|NCT00700102|4842019|P1|Overall Study|Died|394
1469042|NCT00700011|4842158|P2|Overall Study|Death|1
1469043|NCT00700011|4842159|P1|Overall Study|Death|0
1469044|NCT00699998|4842175|P4|Overall Study|Lost to Follow-up|1
1469045|NCT00699998|4842176|P3|Overall Study|Lost to Follow-up|3
1469046|NCT00699998|4842177|P2|Overall Study|Lost to Follow-up|1
1469047|NCT00699998|4842178|P1|Overall Study|Lost to Follow-up|2
1469048|NCT00699998|4842175|P4|Overall Study|Physician Decision|1
1469049|NCT00699998|4842176|P3|Overall Study|Physician Decision|1
1469050|NCT00699998|4842177|P2|Overall Study|Physician Decision|2
1469051|NCT00699998|4842178|P1|Overall Study|Physician Decision|3
1469052|NCT00699998|4842175|P4|Overall Study|Withdrawal by Subject|80
1469053|NCT00699998|4842176|P3|Overall Study|Withdrawal by Subject|202
1469054|NCT00699998|4842177|P2|Overall Study|Withdrawal by Subject|83
1469055|NCT00699998|4842178|P1|Overall Study|Withdrawal by Subject|194
1469056|NCT00699972|4842223|P3|Overall Study|Randomized, Not Treated|1
1469057|NCT00699972|4842224|P2|Overall Study|Randomized, Not Treated|0
1469058|NCT00699972|4842225|P1|Overall Study|Randomized, Not Treated|1
1469059|NCT00699972|4842223|P3|Overall Study|Administrative/Other|4
1469060|NCT00699972|4842224|P2|Overall Study|Administrative/Other|1
1469061|NCT00699972|4842225|P1|Overall Study|Administrative/Other|3
1469062|NCT00699972|4842223|P3|Overall Study|Lack of Efficacy|2
1469063|NCT00699972|4842224|P2|Overall Study|Lack of Efficacy|0
1469064|NCT00699972|4842225|P1|Overall Study|Lack of Efficacy|2
1469065|NCT00699972|4842223|P3|Overall Study|Withdrawal by Subject|4
1469066|NCT00699972|4842224|P2|Overall Study|Withdrawal by Subject|7
1469067|NCT00699972|4842225|P1|Overall Study|Withdrawal by Subject|3
1469068|NCT00699972|4842223|P3|Overall Study|Lost to Follow-up|0
1469069|NCT00699972|4842224|P2|Overall Study|Lost to Follow-up|2
1469070|NCT00699972|4842225|P1|Overall Study|Lost to Follow-up|0
1469071|NCT00699972|4842223|P3|Overall Study|Adverse Event|24
1469072|NCT00699972|4842224|P2|Overall Study|Adverse Event|9
1469073|NCT00699972|4842225|P1|Overall Study|Adverse Event|7
1469074|NCT00699907|4842242|P3|Overall Study|No usable sample|8
1469075|NCT00699907|4842243|P2|Overall Study|No usable sample|9
1469076|NCT00699907|4842244|P1|Overall Study|No usable sample|0
1469077|NCT00699907|4842242|P3|Overall Study|Withdrawal by Subject|0
1469078|NCT00699907|4842243|P2|Overall Study|Withdrawal by Subject|1
1469079|NCT00699907|4842244|P1|Overall Study|Withdrawal by Subject|2
1469080|NCT00699842|4842279|P3|Overall Study|Death|0
1469081|NCT00699842|4842280|P2|Overall Study|Death|1
1469082|NCT00699842|4842281|P1|Overall Study|Death|0
1469083|NCT00699816|4842294|P2|Overall Study|Protocol Violation|3
1469084|NCT00699816|4842295|P1|Overall Study|Protocol Violation|1
1469085|NCT00699751|4842313|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
1469086|NCT00699751|4842314|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
1469087|NCT00699751|4842313|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
1469088|NCT00699751|4842314|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
1469089|NCT00699751|4842313|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
1469090|NCT00699751|4842314|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
1469091|NCT00699751|4842313|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
1469092|NCT00699751|4842314|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
1469093|NCT00699751|4842313|P2|Period 1: Without/Before Drug Switch|Other|20
1469094|NCT00699751|4842314|P1|Period 1: Without/Before Drug Switch|Other|30
1469095|NCT00699751|4842313|P2|Period 1: Without/Before Drug Switch|Subject Request|23
1469096|NCT00699751|4842314|P1|Period 1: Without/Before Drug Switch|Subject Request|43
1469097|NCT00699751|4842313|P2|Period 1: Without/Before Drug Switch|Death|29
1469098|NCT00699751|4842314|P1|Period 1: Without/Before Drug Switch|Death|28
1469099|NCT00699751|4842313|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
1469100|NCT00699751|4842314|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
1469101|NCT00699699|4842399|P1|Overall Study|Individual different reasons|21
1469102|NCT00699699|4842399|P1|Overall Study|Adverse Event|36
1469103|NCT00699660|4842408|P2|Overall Study|missing reports and recording failures|6
1469104|NCT00699660|4842409|P1|Overall Study|missing reports and recording failures|10
1469105|NCT00699660|4842408|P2|Overall Study|Lost to Follow-up|2
1469106|NCT00699660|4842409|P1|Overall Study|Lost to Follow-up|4
1469107|NCT00699608|4842421|P6|Second Intervention|Withdrawal by Subject|0
1469108|NCT00699608|4842422|P5|Second Intervention|Withdrawal by Subject|0
1469109|NCT00699608|4842423|P4|Second Intervention|Withdrawal by Subject|1
1469110|NCT00699608|4842424|P3|Second Intervention|Withdrawal by Subject|0
1469111|NCT00699608|4842425|P2|Second Intervention|Withdrawal by Subject|0
1469112|NCT00699608|4842426|P1|Second Intervention|Withdrawal by Subject|0
1469113|NCT00699608|4842421|P6|Second Intervention|Adverse Event|0
1469114|NCT00699608|4842422|P5|Second Intervention|Adverse Event|0
1469115|NCT00699608|4842423|P4|Second Intervention|Adverse Event|0
1469116|NCT00699608|4842424|P3|Second Intervention|Adverse Event|1
1469117|NCT00699608|4842425|P2|Second Intervention|Adverse Event|0
1469118|NCT00699608|4842426|P1|Second Intervention|Adverse Event|0
1469119|NCT00699608|4842421|P6|First Intervention|Protocol Violation|0
1469120|NCT00699608|4842422|P5|First Intervention|Protocol Violation|1
1469121|NCT00699608|4842423|P4|First Intervention|Protocol Violation|0
1469122|NCT00699608|4842424|P3|First Intervention|Protocol Violation|0
1469123|NCT00699608|4842425|P2|First Intervention|Protocol Violation|0
1469124|NCT00699608|4842426|P1|First Intervention|Protocol Violation|0
1469125|NCT00699608|4842421|P6|First Intervention|Withdrawal by Subject|0
1469126|NCT00699608|4842422|P5|First Intervention|Withdrawal by Subject|0
1469127|NCT00699608|4842423|P4|First Intervention|Withdrawal by Subject|0
1469128|NCT00699608|4842424|P3|First Intervention|Withdrawal by Subject|1
1469129|NCT00699608|4842425|P2|First Intervention|Withdrawal by Subject|0
1469130|NCT00699608|4842426|P1|First Intervention|Withdrawal by Subject|0
1469131|NCT00699582|4842479|P3|Overall Study|Randomized, Not Treated|0
1469132|NCT00699582|4842480|P2|Overall Study|Randomized, Not Treated|1
1469133|NCT00699582|4842481|P1|Overall Study|Randomized, Not Treated|2
1469134|NCT00699582|4842479|P3|Overall Study|Administrative/Other|0
1469135|NCT00699582|4842480|P2|Overall Study|Administrative/Other|3
1469136|NCT00699582|4842481|P1|Overall Study|Administrative/Other|4
1469137|NCT00699582|4842479|P3|Overall Study|Progressive Disease|0
1469138|NCT00699582|4842480|P2|Overall Study|Progressive Disease|0
1469139|NCT00699582|4842481|P1|Overall Study|Progressive Disease|1
1469140|NCT00699582|4842479|P3|Overall Study|Lack of Efficacy|1
1469141|NCT00699582|4842480|P2|Overall Study|Lack of Efficacy|0
1469142|NCT00699582|4842481|P1|Overall Study|Lack of Efficacy|1
1469143|NCT00699582|4842479|P3|Overall Study|Withdrawal by Subject|4
1469144|NCT00699582|4842480|P2|Overall Study|Withdrawal by Subject|7
1469145|NCT00699582|4842481|P1|Overall Study|Withdrawal by Subject|6
1469146|NCT00699582|4842479|P3|Overall Study|Adverse Event|23
1469147|NCT00699582|4842480|P2|Overall Study|Adverse Event|11
1469148|NCT00699582|4842481|P1|Overall Study|Adverse Event|4
1469149|NCT00699374|4842585|P2|Overall Study|Died 28 days after last dose|9
1469150|NCT00699374|4842586|P1|Overall Study|Died 28 days after last dose|5
1469151|NCT00699374|4842585|P2|Overall Study|Randomized but not treated|2
1469152|NCT00699374|4842586|P1|Overall Study|Randomized but not treated|4
1469153|NCT00699374|4842585|P2|Overall Study|Study terminated by sponsor|28
1469154|NCT00699374|4842586|P1|Overall Study|Study terminated by sponsor|13
1469155|NCT00699374|4842585|P2|Overall Study|Protocol Violation|6
1469156|NCT00699374|4842586|P1|Overall Study|Protocol Violation|2
1469157|NCT00699374|4842585|P2|Overall Study|Other|15
1469158|NCT00699374|4842586|P1|Overall Study|Other|18
1469159|NCT00699374|4842585|P2|Overall Study|Objective progression or relapse|277
1469160|NCT00699374|4842586|P1|Overall Study|Objective progression or relapse|281
1469161|NCT00699374|4842585|P2|Overall Study|Withdrawal by Subject|44
1469162|NCT00699374|4842586|P1|Overall Study|Withdrawal by Subject|34
1469163|NCT00699374|4842585|P2|Overall Study|Lost to Follow-up|5
1469164|NCT00699374|4842586|P1|Overall Study|Lost to Follow-up|3
1469165|NCT00699374|4842585|P2|Overall Study|Global deterioration of health status|8
1469166|NCT00699374|4842586|P1|Overall Study|Global deterioration of health status|7
1469167|NCT00699374|4842585|P2|Overall Study|Adverse Event|67
1469168|NCT00699374|4842586|P1|Overall Study|Adverse Event|70
1469169|NCT00699374|4842585|P2|Overall Study|Death|83
1469170|NCT00699374|4842586|P1|Overall Study|Death|93
1469171|NCT00699348|4842598|P1|Overall Study|Other|5
1469172|NCT00699348|4842598|P1|Overall Study|Renal transplantation|10
1469173|NCT00699348|4842598|P1|Overall Study|Blood transfusion|24
1469174|NCT00699348|4842598|P1|Overall Study|Failure to return|1
1469175|NCT00699348|4842598|P1|Overall Study|Lack of Efficacy|8
1469176|NCT00699348|4842598|P1|Overall Study|Protocol Violation|10
1469177|NCT00699348|4842598|P1|Overall Study|Withdrawal by Subject|11
1469178|NCT00699348|4842598|P1|Overall Study|Adverse Event|15
1469179|NCT00699348|4842598|P1|Overall Study|Death|6
1469180|NCT00699335|4842607|P1|Overall Study|Missing data|52
1469181|NCT00699335|4842607|P1|Overall Study|Combination of multiple reasons|176
1469182|NCT00699283|4842640|P2|Overall Study|AE of unknown type|0
1469183|NCT00699283|4842641|P1|Overall Study|AE of unknown type|1
1469184|NCT00699283|4842640|P2|Overall Study|AE, non-serious non-fatal|1
1469185|NCT00699283|4842641|P1|Overall Study|AE, non-serious non-fatal|8
1469186|NCT00699283|4842640|P2|Overall Study|SAE, non-fatal|1
1469187|NCT00699283|4842641|P1|Overall Study|SAE, non-fatal|1
1469188|NCT00699283|4842640|P2|Overall Study|Other Reason|1
1469189|NCT00699283|4842641|P1|Overall Study|Other Reason|5
1469190|NCT00699283|4842640|P2|Overall Study|Withdrawal by Subject|0
1469191|NCT00699283|4842641|P1|Overall Study|Withdrawal by Subject|1
1469192|NCT00699283|4842640|P2|Overall Study|Lost to Follow-up|0
1469193|NCT00699283|4842641|P1|Overall Study|Lost to Follow-up|2
1469194|NCT00699283|4842640|P2|Overall Study|Lack of Efficacy|5
1469195|NCT00699283|4842641|P1|Overall Study|Lack of Efficacy|15
1469196|NCT00699192|4842654|P3|Overall Study|Protocol Violation|0
1469197|NCT00699192|4842655|P2|Overall Study|Protocol Violation|2
1469198|NCT00699192|4842656|P1|Overall Study|Protocol Violation|2
1469199|NCT00699192|4842654|P3|Overall Study|Administrative problems|1
1469200|NCT00699192|4842655|P2|Overall Study|Administrative problems|3
1469201|NCT00699192|4842656|P1|Overall Study|Administrative problems|1
1469202|NCT00699192|4842654|P3|Overall Study|Withdrawal by Subject|4
1469203|NCT00699192|4842655|P2|Overall Study|Withdrawal by Subject|2
1469204|NCT00699192|4842656|P1|Overall Study|Withdrawal by Subject|3
1469205|NCT00699192|4842654|P3|Overall Study|Lack of Efficacy|1
1469206|NCT00699192|4842655|P2|Overall Study|Lack of Efficacy|0
1469207|NCT00699192|4842656|P1|Overall Study|Lack of Efficacy|0
1469208|NCT00699192|4842654|P3|Overall Study|Abnormal test procedure result(s)|1
1469209|NCT00699192|4842655|P2|Overall Study|Abnormal test procedure result(s)|0
1469210|NCT00699192|4842656|P1|Overall Study|Abnormal test procedure result(s)|0
1469211|NCT00699192|4842654|P3|Overall Study|Adverse Event|3
1469212|NCT00699192|4842655|P2|Overall Study|Adverse Event|4
1469213|NCT00699192|4842656|P1|Overall Study|Adverse Event|9
1469214|NCT00699192|4842654|P3|Overall Study|Missing|1
1469215|NCT00699192|4842655|P2|Overall Study|Missing|1
1469216|NCT00699192|4842656|P1|Overall Study|Missing|1
1469217|NCT00699153|4842678|P2|Overall Study|Travel Problem|0
1469218|NCT00699153|4842679|P1|Overall Study|Travel Problem|1
1469219|NCT00699153|4842678|P2|Overall Study|Protocol Violation|0
1469220|NCT00699153|4842679|P1|Overall Study|Protocol Violation|1
1469221|NCT00699153|4842678|P2|Overall Study|Adverse Event|2
1469222|NCT00699153|4842679|P1|Overall Study|Adverse Event|0
1469223|NCT00699153|4842678|P2|Overall Study|Lost to Follow-up|0
1469224|NCT00699153|4842679|P1|Overall Study|Lost to Follow-up|1
1469225|NCT00698932|4842705|P2|Overall Study|Death|0
1469226|NCT00698932|4842706|P1|Overall Study|Death|1
1469227|NCT00698932|4842705|P2|Overall Study|Safety reasons|2
1469228|NCT00698932|4842706|P1|Overall Study|Safety reasons|0
1469229|NCT00698932|4842705|P2|Overall Study|Severe non-compliance to protocol|2
1469230|NCT00698932|4842706|P1|Overall Study|Severe non-compliance to protocol|1
1469231|NCT00698932|4842705|P2|Overall Study|Lost to Follow-up|1
1469232|NCT00698932|4842706|P1|Overall Study|Lost to Follow-up|6
1469233|NCT00698932|4842705|P2|Overall Study|Withdrawal by Subject|23
1469234|NCT00698932|4842706|P1|Overall Study|Withdrawal by Subject|11
1469235|NCT00698932|4842705|P2|Overall Study|Study specific discontinuation criteria|4
1469236|NCT00698932|4842706|P1|Overall Study|Study specific discontinuation criteria|3
1469237|NCT00698932|4842705|P2|Overall Study|Incorrect enrollment|2
1469238|NCT00698932|4842706|P1|Overall Study|Incorrect enrollment|0
1469239|NCT00698932|4842705|P2|Overall Study|Adverse Event|2
1469240|NCT00698932|4842706|P1|Overall Study|Adverse Event|0
1469241|NCT00698841|4842732|P1|Overall Study|Other|2
1469242|NCT00698841|4842732|P1|Overall Study|Study drug toxicity|2
1469243|NCT00698841|4842732|P1|Overall Study|Failure to meet eligibility criteria|2
1469244|NCT00698841|4842732|P1|Overall Study|Disease progression|7
1469245|NCT00698841|4842732|P1|Overall Study|Adverse Event|3
1469246|NCT00698841|4842732|P1|Overall Study|Withdrawal by Subject|2
1469247|NCT00698815|4842746|P3|Overall Study|Did not receive protocol treatment|2
1469248|NCT00698815|4842747|P2|Overall Study|Did not receive protocol treatment|2
1469249|NCT00698815|4842748|P1|Overall Study|Did not receive protocol treatment|1
1469250|NCT00698815|4842746|P3|Overall Study|MD discretion|2
1469251|NCT00698815|4842747|P2|Overall Study|MD discretion|7
1469252|NCT00698815|4842748|P1|Overall Study|MD discretion|2
1469253|NCT00698815|4842746|P3|Overall Study|Withdrawal by Subject|2
1469254|NCT00698815|4842747|P2|Overall Study|Withdrawal by Subject|3
1469255|NCT00698815|4842748|P1|Overall Study|Withdrawal by Subject|6
1469256|NCT00698815|4842746|P3|Overall Study|Death|4
1469257|NCT00698815|4842747|P2|Overall Study|Death|2
1469258|NCT00698815|4842748|P1|Overall Study|Death|1
1469259|NCT00698685|4842765|P1|Overall Study|Off study pre transplant by clinic MD|1
1469260|NCT00698685|4842765|P1|Overall Study|Sister withdrew as donor|1
1469261|NCT00698646|4842773|P3|Overall Study|Administrative problems|1
1469262|NCT00698646|4842774|P2|Overall Study|Administrative problems|0
1469263|NCT00698646|4842775|P1|Overall Study|Administrative problems|1
1469264|NCT00698646|4842773|P3|Overall Study|Lost to Follow-up|2
1469265|NCT00698646|4842774|P2|Overall Study|Lost to Follow-up|0
1469266|NCT00698646|4842775|P1|Overall Study|Lost to Follow-up|0
1469267|NCT00698646|4842773|P3|Overall Study|Withdrawal by Subject|8
1469268|NCT00698646|4842774|P2|Overall Study|Withdrawal by Subject|11
1469269|NCT00698646|4842775|P1|Overall Study|Withdrawal by Subject|10
1469270|NCT00698646|4842773|P3|Overall Study|Protocol Deviation|3
1469271|NCT00698646|4842774|P2|Overall Study|Protocol Deviation|2
1469272|NCT00698646|4842775|P1|Overall Study|Protocol Deviation|6
1469273|NCT00698646|4842773|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
1469274|NCT00698646|4842774|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
1469275|NCT00698646|4842775|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
1469276|NCT00698646|4842773|P3|Overall Study|Adverse Event|8
1469277|NCT00698646|4842774|P2|Overall Study|Adverse Event|7
1469278|NCT00698646|4842775|P1|Overall Study|Adverse Event|8
1469279|NCT00698581|4842800|P2|Overall Study|AE of unknown type|0
1469280|NCT00698581|4842801|P1|Overall Study|AE of unknown type|1
1469281|NCT00698581|4842800|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
1469282|NCT00698581|4842801|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1469283|NCT00698581|4842800|P2|Overall Study|AE, non-serious non-fatal|0
1469284|NCT00698581|4842801|P1|Overall Study|AE, non-serious non-fatal|4
1469285|NCT00698581|4842800|P2|Overall Study|SAE, non-fatal|0
1469286|NCT00698581|4842801|P1|Overall Study|SAE, non-fatal|1
1469287|NCT00698581|4842800|P2|Overall Study|Other reason|1
1469288|NCT00698581|4842801|P1|Overall Study|Other reason|9
1469289|NCT00698581|4842800|P2|Overall Study|Withdrawal by Subject|0
1469290|NCT00698581|4842801|P1|Overall Study|Withdrawal by Subject|6
1469291|NCT00698581|4842800|P2|Overall Study|Lack of Efficacy|11
1469292|NCT00698581|4842801|P1|Overall Study|Lack of Efficacy|23
1469293|NCT00698516|4842812|P1|Overall Study|Withdrawal by Subject|3
1469294|NCT00698516|4842812|P1|Overall Study|Study Termination|2
1469295|NCT00698451|4842830|P1|Overall Study|Disease progression|3
1469296|NCT00698451|4842830|P1|Overall Study|Withdrawal by Subject|6
1469297|NCT00698451|4842830|P1|Overall Study|Protocol Violation|6
1469298|NCT00698451|4842830|P1|Overall Study|Physician Decision|2
1469299|NCT00698451|4842830|P1|Overall Study|Adverse Event|22
1469300|NCT00698204|4842837|P2|Overall Study|Withdrawal by Subject|0
1469301|NCT00698204|4842838|P1|Overall Study|Withdrawal by Subject|1
1469302|NCT00698009|4842898|P1|Overall Study|Withdrawal by Subject|1
1469303|NCT00697827|4842904|P2|Overall Study|enrolled but not treated|1
1469304|NCT00697827|4842905|P1|Overall Study|enrolled but not treated|2
1469305|NCT00697788|4842932|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1469306|NCT00697788|4842933|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1469307|NCT00697788|4842934|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1469308|NCT00697788|4842935|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
1469309|NCT00697788|4842936|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1469310|NCT00697788|4842937|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1469311|NCT00697788|4842938|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1469312|NCT00697788|4842939|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1469313|NCT00697788|4842932|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1469314|NCT00697788|4842933|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1469315|NCT00697788|4842934|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1469316|NCT00697788|4842935|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1469317|NCT00697788|4842936|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1469318|NCT00697788|4842937|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1469319|NCT00697788|4842938|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
1469320|NCT00697788|4842939|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1469321|NCT00697619|4842994|P2|Overall Study|Adverse Event|6
1469322|NCT00697619|4842995|P1|Overall Study|Adverse Event|4
1469323|NCT00697619|4842994|P2|Overall Study|Lack of Efficacy|2
1469324|NCT00697619|4842995|P1|Overall Study|Lack of Efficacy|2
1469325|NCT00697593|4843001|P1|Overall Study|Suspension of the study by sponsor|12
1469326|NCT00697593|4843001|P1|Overall Study|Lack of Efficacy|3
1469327|NCT00697593|4843001|P1|Overall Study|Protocol Violation|1
1469328|NCT00697593|4843001|P1|Overall Study|Adverse Event|3
1469329|NCT00697515|4843045|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
1469330|NCT00697515|4843046|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
1469331|NCT00697515|4843045|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
1469332|NCT00697515|4843046|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
1469333|NCT00697515|4843045|P2|First Intervention (Crossover Period)|Adverse Event|2
1469334|NCT00697515|4843046|P1|First Intervention (Crossover Period)|Adverse Event|0
1469335|NCT00697515|4843045|P2|First Intervention (Crossover Period)|Natural disaster|9
1469336|NCT00697515|4843046|P1|First Intervention (Crossover Period)|Natural disaster|8
1469337|NCT00697515|4843045|P2|Dose Optimization Period|elevated QTc|0
1469338|NCT00697515|4843046|P1|Dose Optimization Period|elevated QTc|1
1469339|NCT00697515|4843045|P2|Dose Optimization Period|called to active duty|0
1469340|NCT00697515|4843046|P1|Dose Optimization Period|called to active duty|1
1469341|NCT00697515|4843045|P2|Dose Optimization Period|sponsor request|0
1469342|NCT00697515|4843046|P1|Dose Optimization Period|sponsor request|2
1469343|NCT00697515|4843045|P2|Dose Optimization Period|Lost to Follow-up|0
1469344|NCT00697515|4843046|P1|Dose Optimization Period|Lost to Follow-up|2
1469345|NCT00697515|4843045|P2|Dose Optimization Period|Withdrawal by Subject|0
1469346|NCT00697515|4843046|P1|Dose Optimization Period|Withdrawal by Subject|5
1469347|NCT00697515|4843045|P2|Dose Optimization Period|Adverse Event|0
1469348|NCT00697515|4843046|P1|Dose Optimization Period|Adverse Event|4
1469349|NCT00697463|4843074|P1|Overall Study|Withdrawal by Subject|1
1469350|NCT00697255|4843080|P2|Stage 1b|Insufficient ovarian response|1
1469351|NCT00697255|4843081|P1|Stage 1b|Insufficient ovarian response|0
1469352|NCT00697255|4843080|P2|Stage 1b|Not growing of dominant follicle|1
1469353|NCT00697255|4843081|P1|Stage 1b|Not growing of dominant follicle|0
1469354|NCT00697255|4843080|P2|Stage 1a|Not growing of dominant follicle|0
1469355|NCT00697255|4843081|P1|Stage 1a|Not growing of dominant follicle|1
1469356|NCT00697255|4843080|P2|Stage 1a|Multifollicular growth|0
1469357|NCT00697255|4843081|P1|Stage 1a|Multifollicular growth|1
1469358|NCT00697255|4843080|P2|Stage 1a|Insufficient ovarian response|0
1469359|NCT00697255|4843081|P1|Stage 1a|Insufficient ovarian response|1
1469360|NCT00697112|4843132|P1|Overall Study|Did not meet inclusion criteria|1
1469361|NCT00697112|4843132|P1|Overall Study|Lost to Follow-up|1
1469362|NCT00697112|4843132|P1|Overall Study|Adverse Event|8
1469363|NCT00697073|4843156|P1|Overall Study|non compliance and other|6
1469364|NCT00697073|4843156|P1|Overall Study|Pregnancy|1
1469365|NCT00697073|4843156|P1|Overall Study|Withdrawal by Subject|2
1469366|NCT00696878|4843160|P1|Overall Study|Other reason (not specified)|55
1469367|NCT00696878|4843160|P1|Overall Study|Trial stopped|32
1469368|NCT00696878|4843160|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
1469369|NCT00696878|4843160|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
1469370|NCT00696878|4843160|P1|Overall Study|Withdrawal by Subject|87
1469371|NCT00696878|4843160|P1|Overall Study|Adverse Event|8
1469372|NCT00696800|4843234|P2|Overall Study|Not treated|2
1469373|NCT00696800|4843235|P1|Overall Study|Not treated|1
1469374|NCT00696800|4843234|P2|Overall Study|Other Reasons|3
1469375|NCT00696800|4843235|P1|Overall Study|Other Reasons|5
1469376|NCT00696800|4843234|P2|Overall Study|No/too few/bad quality embryos|18
1469377|NCT00696800|4843235|P1|Overall Study|No/too few/bad quality embryos|24
1469378|NCT00696800|4843234|P2|Overall Study|No/abnormal fertilization|13
1469379|NCT00696800|4843235|P1|Overall Study|No/abnormal fertilization|11
1469380|NCT00696800|4843234|P2|Overall Study|No/too few/bad quality oocytes|3
1469381|NCT00696800|4843235|P1|Overall Study|No/too few/bad quality oocytes|4
1469382|NCT00696800|4843234|P2|Overall Study|Too high ovarian response|1
1469383|NCT00696800|4843235|P1|Overall Study|Too high ovarian response|6
1469384|NCT00696800|4843234|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
1469385|NCT00696800|4843235|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
1469386|NCT00696800|4843234|P2|Overall Study|Insufficient ovarian response|1
1469387|NCT00696800|4843235|P1|Overall Study|Insufficient ovarian response|4
1469388|NCT00696800|4843234|P2|Overall Study|Insufficient ovarian response on Day 8|1
1469389|NCT00696800|4843235|P1|Overall Study|Insufficient ovarian response on Day 8|4
1469390|NCT00696800|4843234|P2|Overall Study|Insufficient compliance with medication|1
1469391|NCT00696800|4843235|P1|Overall Study|Insufficient compliance with medication|2
1469392|NCT00696800|4843234|P2|Overall Study|Adverse Event|3
1469393|NCT00696800|4843235|P1|Overall Study|Adverse Event|16
1469394|NCT00696787|4843288|P3|Overall Study|Failed to return|1
1469395|NCT00696787|4843289|P2|Overall Study|Failed to return|3
1469396|NCT00696787|4843290|P1|Overall Study|Failed to return|1
1469397|NCT00696787|4843288|P3|Overall Study|Withdrawal by Subject|2
1469398|NCT00696787|4843289|P2|Overall Study|Withdrawal by Subject|3
1469399|NCT00696787|4843290|P1|Overall Study|Withdrawal by Subject|0
1469400|NCT00696787|4843288|P3|Overall Study|Lost to Follow-up|3
1469401|NCT00696787|4843289|P2|Overall Study|Lost to Follow-up|0
1469402|NCT00696787|4843290|P1|Overall Study|Lost to Follow-up|4
1469403|NCT00696787|4843288|P3|Overall Study|Lack of Efficacy|0
1469404|NCT00696787|4843289|P2|Overall Study|Lack of Efficacy|1
1469405|NCT00696787|4843290|P1|Overall Study|Lack of Efficacy|0
1469406|NCT00696787|4843288|P3|Overall Study|Discontinuation by Sponsor|14
1469407|NCT00696787|4843289|P2|Overall Study|Discontinuation by Sponsor|13
1469408|NCT00696787|4843290|P1|Overall Study|Discontinuation by Sponsor|9
1469409|NCT00696787|4843288|P3|Overall Study|Adverse Event|6
1469410|NCT00696787|4843289|P2|Overall Study|Adverse Event|0
1469411|NCT00696787|4843290|P1|Overall Study|Adverse Event|1
1469412|NCT00696774|4843304|P3|Period III|Lack of Efficacy|0
1469413|NCT00696774|4843305|P2|Period III|Lack of Efficacy|2
1469414|NCT00696774|4843306|P1|Period III|Lack of Efficacy|0
1469415|NCT00696774|4843304|P3|Period III|Sponsor Decision|0
1469416|NCT00696774|4843305|P2|Period III|Sponsor Decision|0
1469417|NCT00696774|4843306|P1|Period III|Sponsor Decision|2
1469418|NCT00696774|4843304|P3|Period III|Withdrawal by Subject|0
1469419|NCT00696774|4843305|P2|Period III|Withdrawal by Subject|2
1469420|NCT00696774|4843306|P1|Period III|Withdrawal by Subject|1
1469421|NCT00696774|4843304|P3|Period III|Protocol Violation|0
1469422|NCT00696774|4843305|P2|Period III|Protocol Violation|1
1469423|NCT00696774|4843306|P1|Period III|Protocol Violation|1
1469424|NCT00696774|4843304|P3|Period III|Lost to Follow-up|0
1469425|NCT00696774|4843305|P2|Period III|Lost to Follow-up|1
1469426|NCT00696774|4843306|P1|Period III|Lost to Follow-up|2
1469427|NCT00696774|4843304|P3|Period III|Adverse Event|0
1469428|NCT00696774|4843305|P2|Period III|Adverse Event|1
1469429|NCT00696774|4843306|P1|Period III|Adverse Event|1
1469430|NCT00696774|4843304|P3|Period II|Lack of Efficacy|2
1469431|NCT00696774|4843305|P2|Period II|Lack of Efficacy|0
1469432|NCT00696774|4843306|P1|Period II|Lack of Efficacy|0
1469433|NCT00696774|4843304|P3|Period II|Sponsor Decision|0
1469434|NCT00696774|4843305|P2|Period II|Sponsor Decision|0
1469435|NCT00696774|4843306|P1|Period II|Sponsor Decision|0
1469436|NCT00696774|4843304|P3|Period II|Withdrawal by Subject|4
1469437|NCT00696774|4843305|P2|Period II|Withdrawal by Subject|0
1469438|NCT00696774|4843306|P1|Period II|Withdrawal by Subject|0
1469439|NCT00696774|4843304|P3|Period II|Protocol Violation|11
1469440|NCT00696774|4843305|P2|Period II|Protocol Violation|0
1469441|NCT00696774|4843306|P1|Period II|Protocol Violation|0
1469442|NCT00696774|4843304|P3|Period II|Lost to Follow-up|4
1469443|NCT00696774|4843305|P2|Period II|Lost to Follow-up|0
1469444|NCT00696774|4843306|P1|Period II|Lost to Follow-up|0
1469445|NCT00696774|4843304|P3|Period II|Adverse Event|15
1469446|NCT00696774|4843305|P2|Period II|Adverse Event|0
1469447|NCT00696774|4843306|P1|Period II|Adverse Event|0
1469448|NCT00696696|4843361|P1|Overall Study|Death|3
1469449|NCT00696696|4843361|P1|Overall Study|Physician Decision|2
1469450|NCT00696696|4843361|P1|Overall Study|Withdrawal by Subject|8
1469451|NCT00696696|4843361|P1|Overall Study|Adverse Event|5
1469452|NCT00696436|4843412|P5|Overall Study|Missing|0
1469453|NCT00696436|4843413|P4|Overall Study|Missing|0
1469454|NCT00696436|4843414|P3|Overall Study|Missing|1
1469455|NCT00696436|4843415|P2|Overall Study|Missing|1
1469456|NCT00696436|4843416|P1|Overall Study|Missing|0
1469457|NCT00696436|4843412|P5|Overall Study|Administrative Decision|0
1469458|NCT00696436|4843413|P4|Overall Study|Administrative Decision|0
1469459|NCT00696436|4843414|P3|Overall Study|Administrative Decision|0
1469460|NCT00696436|4843415|P2|Overall Study|Administrative Decision|0
1469461|NCT00696436|4843416|P1|Overall Study|Administrative Decision|1
1469462|NCT00696436|4843412|P5|Overall Study|Participant Non-compliance|0
1469463|NCT00696436|4843413|P4|Overall Study|Participant Non-compliance|2
1469464|NCT00696436|4843414|P3|Overall Study|Participant Non-compliance|1
1469465|NCT00696436|4843415|P2|Overall Study|Participant Non-compliance|0
1469466|NCT00696436|4843416|P1|Overall Study|Participant Non-compliance|0
1469467|NCT00696436|4843412|P5|Overall Study|Administrative Error|0
1469468|NCT00696436|4843413|P4|Overall Study|Administrative Error|0
1469469|NCT00696436|4843414|P3|Overall Study|Administrative Error|2
1469470|NCT00696436|4843415|P2|Overall Study|Administrative Error|0
1469471|NCT00696436|4843416|P1|Overall Study|Administrative Error|2
1469472|NCT00696436|4843412|P5|Overall Study|Participant Unavailability|0
1469473|NCT00696436|4843413|P4|Overall Study|Participant Unavailability|1
1469474|NCT00696436|4843414|P3|Overall Study|Participant Unavailability|2
1469475|NCT00696436|4843415|P2|Overall Study|Participant Unavailability|0
1469476|NCT00696436|4843416|P1|Overall Study|Participant Unavailability|2
1469477|NCT00696436|4843412|P5|Overall Study|Lack of Efficacy|4
1469478|NCT00696436|4843413|P4|Overall Study|Lack of Efficacy|2
1469479|NCT00696436|4843414|P3|Overall Study|Lack of Efficacy|5
1469480|NCT00696436|4843415|P2|Overall Study|Lack of Efficacy|1
1469481|NCT00696436|4843416|P1|Overall Study|Lack of Efficacy|3
1469482|NCT00696436|4843412|P5|Overall Study|Withdrawal by Subject|1
1469483|NCT00696436|4843413|P4|Overall Study|Withdrawal by Subject|7
1469484|NCT00696436|4843414|P3|Overall Study|Withdrawal by Subject|5
1469485|NCT00696436|4843415|P2|Overall Study|Withdrawal by Subject|11
1469486|NCT00696436|4843416|P1|Overall Study|Withdrawal by Subject|4
1469487|NCT00696436|4843412|P5|Overall Study|Lost to Follow-up|3
1469488|NCT00696436|4843413|P4|Overall Study|Lost to Follow-up|4
1469489|NCT00696436|4843414|P3|Overall Study|Lost to Follow-up|2
1469490|NCT00696436|4843415|P2|Overall Study|Lost to Follow-up|6
1469491|NCT00696436|4843416|P1|Overall Study|Lost to Follow-up|1
1469492|NCT00696436|4843412|P5|Overall Study|Protocol Violation|1
1469493|NCT00696436|4843413|P4|Overall Study|Protocol Violation|0
1469494|NCT00696436|4843414|P3|Overall Study|Protocol Violation|2
1469495|NCT00696436|4843415|P2|Overall Study|Protocol Violation|2
1469496|NCT00696436|4843416|P1|Overall Study|Protocol Violation|3
1469497|NCT00696436|4843412|P5|Overall Study|Adverse Event|4
1469498|NCT00696436|4843413|P4|Overall Study|Adverse Event|6
1469499|NCT00696436|4843414|P3|Overall Study|Adverse Event|8
1469500|NCT00696436|4843415|P2|Overall Study|Adverse Event|9
1469501|NCT00696436|4843416|P1|Overall Study|Adverse Event|7
1469502|NCT00696423|4843500|P2|Overall Study|Lost to Follow-up|5
1469503|NCT00696423|4843501|P1|Overall Study|Lost to Follow-up|0
1469504|NCT00696410|4843533|P2|Overall Study|Physician Decision|0
1469505|NCT00696410|4843534|P1|Overall Study|Physician Decision|3
1469506|NCT00696410|4843533|P2|Overall Study|Withdrawal by Subject|0
1469507|NCT00696410|4843534|P1|Overall Study|Withdrawal by Subject|8
1469508|NCT00696410|4843533|P2|Overall Study|Lost to Follow-up|0
1469509|NCT00696410|4843534|P1|Overall Study|Lost to Follow-up|2
1469510|NCT00696384|4843548|P3|Double Blind Phase|Physician Decision|0
1469511|NCT00696384|4843549|P2|Double Blind Phase|Physician Decision|2
1469512|NCT00696384|4843550|P1|Double Blind Phase|Physician Decision|0
1469513|NCT00696384|4843548|P3|Double Blind Phase|Lack of Efficacy|0
1469514|NCT00696384|4843549|P2|Double Blind Phase|Lack of Efficacy|1
1469515|NCT00696384|4843550|P1|Double Blind Phase|Lack of Efficacy|0
1469516|NCT00696384|4843548|P3|Double Blind Phase|Withdrawal by Subject|3
1469517|NCT00696384|4843549|P2|Double Blind Phase|Withdrawal by Subject|4
1469518|NCT00696384|4843550|P1|Double Blind Phase|Withdrawal by Subject|0
1469519|NCT00696384|4843548|P3|Double Blind Phase|Lost to Follow-up|1
1469520|NCT00696384|4843549|P2|Double Blind Phase|Lost to Follow-up|2
1469521|NCT00696384|4843550|P1|Double Blind Phase|Lost to Follow-up|0
1469522|NCT00696384|4843548|P3|Double Blind Phase|Adverse Event|2
1469523|NCT00696384|4843549|P2|Double Blind Phase|Adverse Event|2
1469524|NCT00696384|4843550|P1|Double Blind Phase|Adverse Event|0
1469525|NCT00696384|4843548|P3|Open Label Phase|Physician Decision|0
1469526|NCT00696384|4843549|P2|Open Label Phase|Physician Decision|0
1469527|NCT00696384|4843550|P1|Open Label Phase|Physician Decision|4
1469528|NCT00696384|4843548|P3|Open Label Phase|Lack of Efficacy|0
1469529|NCT00696384|4843549|P2|Open Label Phase|Lack of Efficacy|0
1469530|NCT00696384|4843550|P1|Open Label Phase|Lack of Efficacy|3
1469531|NCT00696384|4843548|P3|Open Label Phase|Other|0
1469532|NCT00696384|4843549|P2|Open Label Phase|Other|0
1469533|NCT00696384|4843550|P1|Open Label Phase|Other|6
1469534|NCT00696384|4843548|P3|Open Label Phase|Withdrawal by Subject|0
1469535|NCT00696384|4843549|P2|Open Label Phase|Withdrawal by Subject|0
1469536|NCT00696384|4843550|P1|Open Label Phase|Withdrawal by Subject|37
1469537|NCT00696384|4843548|P3|Open Label Phase|Lost to Follow-up|0
1469538|NCT00696384|4843549|P2|Open Label Phase|Lost to Follow-up|0
1469539|NCT00696384|4843550|P1|Open Label Phase|Lost to Follow-up|24
1469540|NCT00696384|4843548|P3|Open Label Phase|Protocol Violation|0
1469541|NCT00696384|4843549|P2|Open Label Phase|Protocol Violation|0
1469542|NCT00696384|4843550|P1|Open Label Phase|Protocol Violation|18
1469543|NCT00696384|4843548|P3|Open Label Phase|Adverse Event|0
1469544|NCT00696384|4843549|P2|Open Label Phase|Adverse Event|0
1469545|NCT00696384|4843550|P1|Open Label Phase|Adverse Event|27
1469546|NCT00696241|4843574|P5|Overall Study|Other|1
1469547|NCT00696241|4843575|P4|Overall Study|Other|2
1469548|NCT00696241|4843576|P3|Overall Study|Other|5
1469549|NCT00696241|4843577|P2|Overall Study|Other|1
1469550|NCT00696241|4843578|P1|Overall Study|Other|6
1469551|NCT00696241|4843574|P5|Overall Study|Lack of Efficacy|3
1469552|NCT00696241|4843575|P4|Overall Study|Lack of Efficacy|5
1469553|NCT00696241|4843576|P3|Overall Study|Lack of Efficacy|4
1469554|NCT00696241|4843577|P2|Overall Study|Lack of Efficacy|5
1469555|NCT00696241|4843578|P1|Overall Study|Lack of Efficacy|1
1469556|NCT00696241|4843574|P5|Overall Study|Withdrawal by Subject|0
1469557|NCT00696241|4843575|P4|Overall Study|Withdrawal by Subject|1
1469558|NCT00696241|4843576|P3|Overall Study|Withdrawal by Subject|6
1469559|NCT00696241|4843577|P2|Overall Study|Withdrawal by Subject|8
1469560|NCT00696241|4843578|P1|Overall Study|Withdrawal by Subject|4
1469561|NCT00696241|4843574|P5|Overall Study|Lost to Follow-up|0
1469562|NCT00696241|4843575|P4|Overall Study|Lost to Follow-up|2
1469563|NCT00696241|4843576|P3|Overall Study|Lost to Follow-up|1
1469564|NCT00696241|4843577|P2|Overall Study|Lost to Follow-up|4
1469565|NCT00696241|4843578|P1|Overall Study|Lost to Follow-up|1
1469566|NCT00696241|4843574|P5|Overall Study|Protocol Violation|3
1469567|NCT00696241|4843575|P4|Overall Study|Protocol Violation|0
1469568|NCT00696241|4843576|P3|Overall Study|Protocol Violation|2
1469569|NCT00696241|4843577|P2|Overall Study|Protocol Violation|1
1469570|NCT00696241|4843578|P1|Overall Study|Protocol Violation|1
1469571|NCT00696241|4843574|P5|Overall Study|Adverse Event|5
1469572|NCT00696241|4843575|P4|Overall Study|Adverse Event|4
1469573|NCT00696241|4843576|P3|Overall Study|Adverse Event|6
1469574|NCT00696241|4843577|P2|Overall Study|Adverse Event|3
1469575|NCT00696241|4843578|P1|Overall Study|Adverse Event|11
1469576|NCT00696072|4843662|P2|Overall Study|Non-specified|2
1469577|NCT00696072|4843663|P1|Overall Study|Non-specified|1
1469578|NCT00696072|4843662|P2|Overall Study|Disease Progression|30
1469579|NCT00696072|4843663|P1|Overall Study|Disease Progression|32
1469580|NCT00696072|4843662|P2|Overall Study|Sponsor Request|1
1469581|NCT00696072|4843663|P1|Overall Study|Sponsor Request|0
1469582|NCT00696072|4843662|P2|Overall Study|Investigator Request|4
1469583|NCT00696072|4843663|P1|Overall Study|Investigator Request|1
1469584|NCT00696072|4843662|P2|Overall Study|Patient Request|7
1469585|NCT00696072|4843663|P1|Overall Study|Patient Request|3
1469586|NCT00696072|4843662|P2|Overall Study|Adverse Event|6
1469587|NCT00696072|4843663|P1|Overall Study|Adverse Event|10
1469588|NCT00696072|4843662|P2|Overall Study|continuing active treatment|13
1469589|NCT00696072|4843663|P1|Overall Study|continuing active treatment|10
1469590|NCT00696020|4843684|P4|Overall Study|Other not stated above|1
1469591|NCT00696020|4843685|P3|Overall Study|Other not stated above|1
1469592|NCT00696020|4843686|P2|Overall Study|Other not stated above|0
1469593|NCT00696020|4843687|P1|Overall Study|Other not stated above|0
1469594|NCT00696020|4843684|P4|Overall Study|Withdrawal by Subject|1
1469595|NCT00696020|4843685|P3|Overall Study|Withdrawal by Subject|0
1469596|NCT00696020|4843686|P2|Overall Study|Withdrawal by Subject|1
1469597|NCT00696020|4843687|P1|Overall Study|Withdrawal by Subject|0
1469598|NCT00696020|4843684|P4|Overall Study|Protocol Violation|1
1469599|NCT00696020|4843685|P3|Overall Study|Protocol Violation|0
1469600|NCT00696020|4843686|P2|Overall Study|Protocol Violation|0
1469601|NCT00696020|4843687|P1|Overall Study|Protocol Violation|0
1469602|NCT00696020|4843684|P4|Overall Study|Lack of Efficacy|0
1469603|NCT00696020|4843685|P3|Overall Study|Lack of Efficacy|0
1469604|NCT00696020|4843686|P2|Overall Study|Lack of Efficacy|0
1469605|NCT00696020|4843687|P1|Overall Study|Lack of Efficacy|1
1469606|NCT00696020|4843684|P4|Overall Study|Adverse Event|1
1469607|NCT00696020|4843685|P3|Overall Study|Adverse Event|2
1469608|NCT00696020|4843686|P2|Overall Study|Adverse Event|1
1469609|NCT00696020|4843687|P1|Overall Study|Adverse Event|3
1469610|NCT00695955|4843795|P1|Cohort 2|Other|5
1469611|NCT00695955|4843795|P1|Cohort 2|Lack of Efficacy|4
1469612|NCT00695955|4843795|P1|Cohort 2|Withdrawal by Subject|28
1469613|NCT00695955|4843795|P1|Cohort 2|Lost to Follow-up|38
1469614|NCT00695955|4843795|P1|Cohort 2|Protocol Violation|5
1469615|NCT00695955|4843795|P1|Cohort 2|Adverse Event|24
1469616|NCT00695955|4843795|P1|Cohort 1|Other|16
1469617|NCT00695955|4843795|P1|Cohort 1|Lack of Efficacy|3
1469618|NCT00695955|4843795|P1|Cohort 1|Withdrawal by Subject|25
1469619|NCT00695955|4843795|P1|Cohort 1|Lost to Follow-up|30
1469620|NCT00695955|4843795|P1|Cohort 1|Protocol Violation|2
1469621|NCT00695955|4843795|P1|Cohort 1|Adverse Event|26
1469622|NCT00695903|4843807|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
1469623|NCT00695903|4843808|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
1469624|NCT00695903|4843807|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
1469625|NCT00695903|4843808|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
1469626|NCT00695903|4843807|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
1469627|NCT00695903|4843808|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
1469628|NCT00695903|4843807|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
1469629|NCT00695903|4843808|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
1469630|NCT00695903|4843807|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
1469631|NCT00695903|4843808|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
1469632|NCT00695903|4843807|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
1469633|NCT00695903|4843808|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
1469634|NCT00695903|4843807|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
1469635|NCT00695903|4843808|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
1469636|NCT00695903|4843807|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
1469637|NCT00695903|4843808|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
1469638|NCT00695903|4843807|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
1469639|NCT00695903|4843808|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
1469640|NCT00695864|4843820|P1|Placebo|Physician Decision|4
1469641|NCT00695864|4843820|P1|Placebo|Withdrawal by Subject|1
1469642|NCT00695669|4843830|P4|Overall Study|Lost to Follow-up|4
1469643|NCT00695669|4843831|P3|Overall Study|Lost to Follow-up|1
1469644|NCT00695669|4843832|P2|Overall Study|Lost to Follow-up|4
1469645|NCT00695669|4843833|P1|Overall Study|Lost to Follow-up|4
1469646|NCT00695669|4843830|P4|Overall Study|Adverse Event|0
1469647|NCT00695669|4843831|P3|Overall Study|Adverse Event|2
1469648|NCT00695669|4843832|P2|Overall Study|Adverse Event|0
1469649|NCT00695669|4843833|P1|Overall Study|Adverse Event|0
1469650|NCT00695565|4843909|P2|Overall Study|Subject did not follow instructions|1
1469651|NCT00695565|4843910|P1|Overall Study|Subject did not follow instructions|1
1469652|NCT00695565|4843909|P2|Overall Study|Lack of Efficacy|1
1469653|NCT00695565|4843910|P1|Overall Study|Lack of Efficacy|1
1469654|NCT00695565|4843909|P2|Overall Study|Withdrawal by Subject|1
1469655|NCT00695565|4843910|P1|Overall Study|Withdrawal by Subject|1
1469656|NCT00695565|4843909|P2|Overall Study|Protocol Violation|1
1469657|NCT00695565|4843910|P1|Overall Study|Protocol Violation|3
1469658|NCT00695565|4843909|P2|Overall Study|Adverse Event|1
1469659|NCT00695565|4843910|P1|Overall Study|Adverse Event|3
1469660|NCT00695565|4843909|P2|Overall Study|Lost to Follow-up|4
1469661|NCT00695565|4843910|P1|Overall Study|Lost to Follow-up|4
1469662|NCT00695396|4843983|P3|Overall Study|Withdrawal by Subject|0
1469663|NCT00695396|4843984|P2|Overall Study|Withdrawal by Subject|2
1469664|NCT00695396|4843985|P1|Overall Study|Withdrawal by Subject|2
1469665|NCT00695396|4843983|P3|Overall Study|Study Closed Prematurely|8
1469666|NCT00695396|4843984|P2|Overall Study|Study Closed Prematurely|6
1469667|NCT00695396|4843985|P1|Overall Study|Study Closed Prematurely|5
1469668|NCT00695318|4844001|P2|Overall Study|Study Terminated|0
1469669|NCT00695318|4844002|P1|Overall Study|Study Terminated|1
1469670|NCT00695318|4844001|P2|Overall Study|Death|1
1469671|NCT00695318|4844002|P1|Overall Study|Death|1
1469672|NCT00695318|4844001|P2|Overall Study|Withdrawal by Subject|0
1469673|NCT00695318|4844002|P1|Overall Study|Withdrawal by Subject|2
1469674|NCT00695318|4844001|P2|Overall Study|Lost to Follow-up|0
1469675|NCT00695318|4844002|P1|Overall Study|Lost to Follow-up|1
1469676|NCT00695136|4844027|P1|Overall Study|unrelated adverse event|1
1469677|NCT00695136|4844027|P1|Overall Study|Withdrawal by Subject|1
1469678|NCT00695019|4844043|P3|Overall Study|Various|4
1469679|NCT00695019|4844044|P2|Overall Study|Various|5
1469680|NCT00695019|4844045|P1|Overall Study|Various|4
1469681|NCT00695019|4844043|P3|Overall Study|Lack of Efficacy|1
1469682|NCT00695019|4844044|P2|Overall Study|Lack of Efficacy|0
1469683|NCT00695019|4844045|P1|Overall Study|Lack of Efficacy|0
1469684|NCT00695019|4844043|P3|Overall Study|Protocol Violation|1
1469685|NCT00695019|4844044|P2|Overall Study|Protocol Violation|3
1469686|NCT00695019|4844045|P1|Overall Study|Protocol Violation|1
1469687|NCT00695019|4844043|P3|Overall Study|Withdrawal by Subject|4
1469688|NCT00695019|4844044|P2|Overall Study|Withdrawal by Subject|6
1469689|NCT00695019|4844045|P1|Overall Study|Withdrawal by Subject|8
1469690|NCT00694551|4844086|P3|Overall Study|Disease Progression|1
1469691|NCT00694551|4844087|P2|Overall Study|Disease Progression|0
1469692|NCT00694551|4844088|P1|Overall Study|Disease Progression|1
1469693|NCT00694369|4844117|P5|Overall Study|Withdrawal by Subject|2
1469694|NCT00694369|4844118|P4|Overall Study|Withdrawal by Subject|1
1469695|NCT00694369|4844119|P3|Overall Study|Withdrawal by Subject|1
1469696|NCT00694369|4844120|P2|Overall Study|Withdrawal by Subject|1
1469697|NCT00694369|4844121|P1|Overall Study|Withdrawal by Subject|1
1469698|NCT00694369|4844117|P5|Overall Study|Protocol Violation|0
1469699|NCT00694369|4844118|P4|Overall Study|Protocol Violation|0
1469700|NCT00694369|4844119|P3|Overall Study|Protocol Violation|0
1469701|NCT00694369|4844120|P2|Overall Study|Protocol Violation|1
1469702|NCT00694369|4844121|P1|Overall Study|Protocol Violation|0
1469703|NCT00694369|4844117|P5|Overall Study|Physician Decision|1
1469704|NCT00694369|4844118|P4|Overall Study|Physician Decision|0
1469705|NCT00694369|4844119|P3|Overall Study|Physician Decision|0
1469706|NCT00694369|4844120|P2|Overall Study|Physician Decision|0
1469707|NCT00694369|4844121|P1|Overall Study|Physician Decision|0
1469708|NCT00694369|4844117|P5|Overall Study|Lost to Follow-up|0
1469709|NCT00694369|4844118|P4|Overall Study|Lost to Follow-up|1
1469710|NCT00694369|4844119|P3|Overall Study|Lost to Follow-up|1
1469711|NCT00694369|4844120|P2|Overall Study|Lost to Follow-up|0
1469712|NCT00694369|4844121|P1|Overall Study|Lost to Follow-up|0
1469713|NCT00694369|4844117|P5|Overall Study|Adverse Event|3
1469714|NCT00694369|4844118|P4|Overall Study|Adverse Event|1
1469715|NCT00694369|4844119|P3|Overall Study|Adverse Event|0
1469716|NCT00694369|4844120|P2|Overall Study|Adverse Event|1
1469717|NCT00694369|4844121|P1|Overall Study|Adverse Event|0
1469718|NCT00694356|4844141|P3|Overall Study|Progressive Disease|6
1469719|NCT00694356|4844142|P2|Overall Study|Progressive Disease|6
1469720|NCT00694356|4844143|P1|Overall Study|Progressive Disease|2
1469721|NCT00694356|4844141|P3|Overall Study|Adverse Event|0
1469722|NCT00694356|4844142|P2|Overall Study|Adverse Event|0
1469723|NCT00694356|4844143|P1|Overall Study|Adverse Event|1
1469724|NCT00694304|4844178|P1|Overall Study|Administrative or Other Reasons|32
1469725|NCT00694304|4844178|P1|Overall Study|Lost to Follow-up|15
1469726|NCT00694304|4844178|P1|Overall Study|Withdrawal of Consent|61
1469727|NCT00694304|4844178|P1|Overall Study|Protocol Violation|6
1469728|NCT00694304|4844178|P1|Overall Study|Non-compliance With Study Product|16
1469729|NCT00694304|4844178|P1|Overall Study|Lack of Efficacy|35
1469730|NCT00694304|4844178|P1|Overall Study|Adverse Event|42
1469731|NCT00694161|4844191|P1|Part 2 (After Week 6 up to Month 12)|Death|1
1469732|NCT00694161|4844191|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
1469733|NCT00694161|4844191|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
1469734|NCT00694122|4844230|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
1469735|NCT00694122|4844231|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
1469736|NCT00694122|4844230|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
1469737|NCT00694122|4844231|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
1469738|NCT00694122|4844230|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
1469739|NCT00694122|4844231|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
1469740|NCT00694109|4844247|P1|Overall Study|Consented but no additional treatment|3
1469741|NCT00694109|4844247|P1|Overall Study|Other|2
1469742|NCT00694109|4844247|P1|Overall Study|Enrolled but not treated|1
1469743|NCT00694109|4844247|P1|Overall Study|Pregnancy|1
1469744|NCT00694109|4844247|P1|Overall Study|Withdrawal by Subject|13
1469745|NCT00694109|4844247|P1|Overall Study|Lack of Efficacy|2
1469746|NCT00694109|4844247|P1|Overall Study|Not consent of more 2 years of treatment|18
1469747|NCT00694109|4844247|P1|Overall Study|Adverse Event|74
1469748|NCT00694109|4844247|P1|Overall Study|Physician Decision|3
1469749|NCT00694096|4844271|P1|Overall Study|Withdrawal by Subject|5
1469750|NCT00693784|4844311|P1|Overall Study|Withdrawal by Subject|2
1469751|NCT00693784|4844311|P1|Overall Study|Lost to Follow-up|2
1469752|NCT00693706|4844324|P2|Overall Study|Protocol Violation|1
1469753|NCT00693706|4844325|P1|Overall Study|Protocol Violation|0
1469754|NCT00693693|4844352|P3|Overall Study|Lost to Follow-up|2
1469755|NCT00693693|4844353|P2|Overall Study|Lost to Follow-up|1
1469756|NCT00693693|4844354|P1|Overall Study|Lost to Follow-up|1
1469757|NCT00693472|4844413|P4|Part 2|Withdrew - reason unrelated to treatment|2
1469758|NCT00693472|4844414|P3|Part 2|Withdrew - reason unrelated to treatment|1
1469759|NCT00693472|4844415|P2|Part 2|Withdrew - reason unrelated to treatment|0
1469760|NCT00693472|4844416|P1|Part 2|Withdrew - reason unrelated to treatment|0
1469761|NCT00693472|4844413|P4|Part 2|Adverse Event|0
1469762|NCT00693472|4844414|P3|Part 2|Adverse Event|1
1469763|NCT00693472|4844415|P2|Part 2|Adverse Event|0
1469764|NCT00693472|4844416|P1|Part 2|Adverse Event|0
1469765|NCT00693472|4844413|P4|Part 1|Withdrew - reason unrelated to treatment|0
1469766|NCT00693472|4844414|P3|Part 1|Withdrew - reason unrelated to treatment|0
1469767|NCT00693472|4844415|P2|Part 1|Withdrew - reason unrelated to treatment|2
1469768|NCT00693472|4844416|P1|Part 1|Withdrew - reason unrelated to treatment|5
1469769|NCT00693472|4844413|P4|Part 1|Lost to Follow-up|0
1469770|NCT00693472|4844414|P3|Part 1|Lost to Follow-up|0
1469771|NCT00693472|4844415|P2|Part 1|Lost to Follow-up|1
1469772|NCT00693472|4844416|P1|Part 1|Lost to Follow-up|0
1469773|NCT00693472|4844413|P4|Part 1|Adverse Event|0
1469774|NCT00693472|4844414|P3|Part 1|Adverse Event|0
1469775|NCT00693472|4844415|P2|Part 1|Adverse Event|1
1469776|NCT00693472|4844416|P1|Part 1|Adverse Event|1
1469777|NCT00693420|4844436|P2|Overall Study|Personal Reasons|4
1469778|NCT00693420|4844437|P1|Overall Study|Personal Reasons|1
1469779|NCT00693420|4844436|P2|Overall Study|Sponsor Request - Conflict of Interest|2
1469780|NCT00693420|4844437|P1|Overall Study|Sponsor Request - Conflict of Interest|0
1469781|NCT00693420|4844436|P2|Overall Study|Protocol Violation|2
1469782|NCT00693420|4844437|P1|Overall Study|Protocol Violation|0
1469783|NCT00693420|4844436|P2|Overall Study|Withdrawal by Subject|0
1469784|NCT00693420|4844437|P1|Overall Study|Withdrawal by Subject|1
1469785|NCT00693420|4844436|P2|Overall Study|Lost to Follow-up|3
1469786|NCT00693420|4844437|P1|Overall Study|Lost to Follow-up|0
1469787|NCT00693420|4844436|P2|Overall Study|Adverse Event|4
1469788|NCT00693420|4844437|P1|Overall Study|Adverse Event|4
1469789|NCT00693225|4844476|P2|Overall Study|Adverse Event|3
1469790|NCT00693225|4844477|P1|Overall Study|Adverse Event|1
1469791|NCT00693225|4844476|P2|Overall Study|Lost to Follow-up|2
1469792|NCT00693225|4844477|P1|Overall Study|Lost to Follow-up|1
1469793|NCT00693017|4844500|P2|Overall Study|Death|1
1469794|NCT00693017|4844501|P1|Overall Study|Death|0
1469795|NCT00693017|4844500|P2|Overall Study|Sponsor Decision|1
1469796|NCT00693017|4844501|P1|Overall Study|Sponsor Decision|2
1469797|NCT00692913|4844511|P2|Overall Study|Withdrawal by Subject|20
1469798|NCT00692913|4844512|P1|Overall Study|Withdrawal by Subject|15
1469799|NCT00692913|4844511|P2|Overall Study|Protocol Violation|1
1469800|NCT00692913|4844512|P1|Overall Study|Protocol Violation|1
1469801|NCT00692913|4844511|P2|Overall Study|Physician Decision|0
1469802|NCT00692913|4844512|P1|Overall Study|Physician Decision|2
1469803|NCT00692913|4844511|P2|Overall Study|Lost to Follow-up|5
1469804|NCT00692913|4844512|P1|Overall Study|Lost to Follow-up|3
1469805|NCT00692913|4844511|P2|Overall Study|Adverse Event|4
1469806|NCT00692913|4844512|P1|Overall Study|Adverse Event|8
1469807|NCT00692770|4844534|P2|Overall Study|Randomized but not treated|4
1469808|NCT00692770|4844535|P1|Overall Study|Randomized but not treated|3
1469809|NCT00692770|4844534|P2|Overall Study|Study terminated by sponsor|2
1469810|NCT00692770|4844535|P1|Overall Study|Study terminated by sponsor|2
1469811|NCT00692770|4844534|P2|Overall Study|Clinical endpoint reached|43
1469812|NCT00692770|4844535|P1|Overall Study|Clinical endpoint reached|16
1469813|NCT00692770|4844534|P2|Overall Study|Radiological and clinical progression|8
1469814|NCT00692770|4844535|P1|Overall Study|Radiological and clinical progression|8
1469815|NCT00692770|4844534|P2|Overall Study|Completed all planned assessments|101
1469816|NCT00692770|4844535|P1|Overall Study|Completed all planned assessments|79
1469817|NCT00692770|4844534|P2|Overall Study|Protocol driven decision point|7
1469818|NCT00692770|4844535|P1|Overall Study|Protocol driven decision point|3
1469819|NCT00692770|4844534|P2|Overall Study|Disease progression, recurrence/relapse|279
1469820|NCT00692770|4844535|P1|Overall Study|Disease progression, recurrence/relapse|170
1469821|NCT00692770|4844534|P2|Overall Study|Physician decision not protocol driven|14
1469822|NCT00692770|4844535|P1|Overall Study|Physician decision not protocol driven|10
1469823|NCT00692770|4844534|P2|Overall Study|Progression by clinical judgment|3
1469824|NCT00692770|4844535|P1|Overall Study|Progression by clinical judgment|2
1469825|NCT00692770|4844534|P2|Overall Study|Non-compliant with study medication|5
1469826|NCT00692770|4844535|P1|Overall Study|Non-compliant with study medication|11
1469827|NCT00692770|4844534|P2|Overall Study|Lost to Follow-up|3
1469828|NCT00692770|4844535|P1|Overall Study|Lost to Follow-up|7
1469829|NCT00692770|4844534|P2|Overall Study|Death|5
1469830|NCT00692770|4844535|P1|Overall Study|Death|10
1469831|NCT00692770|4844534|P2|Overall Study|Adverse Event|41
1469832|NCT00692770|4844535|P1|Overall Study|Adverse Event|136
1469833|NCT00692770|4844534|P2|Overall Study|Withdrawal by Subject|36
1469834|NCT00692770|4844535|P1|Overall Study|Withdrawal by Subject|97
1469835|NCT00692770|4844534|P2|Overall Study|Protocol Violation|7
1469836|NCT00692770|4844535|P1|Overall Study|Protocol Violation|2
1469837|NCT00692406|4844581|P1|Overall Study|PI dropped, bad data|57
1469838|NCT00692237|4844643|P2|Overall Study|Adverse Event|1
1469839|NCT00692237|4844644|P1|Overall Study|Adverse Event|0
1469840|NCT00692237|4844643|P2|Overall Study|Withdrawal by Subject|3
1469841|NCT00692237|4844644|P1|Overall Study|Withdrawal by Subject|1
1469842|NCT00692003|4844708|P2|Overall Study|Sponsor Decision|1
1469843|NCT00692003|4844709|P1|Overall Study|Sponsor Decision|5
1469844|NCT00691938|4844724|P7|Overall Study|QTc prolongation|0
1469845|NCT00691938|4844725|P6|Overall Study|QTc prolongation|0
1469846|NCT00691938|4844726|P5|Overall Study|QTc prolongation|0
1469847|NCT00691938|4844727|P4|Overall Study|QTc prolongation|0
1469848|NCT00691938|4844728|P3|Overall Study|QTc prolongation|0
1469849|NCT00691938|4844729|P2|Overall Study|QTc prolongation|0
1469850|NCT00691938|4844730|P1|Overall Study|QTc prolongation|1
1469851|NCT00691704|4844797|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
1469852|NCT00691704|4844797|P1|Two Years of Maintenance Therapy|Physician Decision|4
1469853|NCT00691704|4844797|P1|Two Years of Maintenance Therapy|Disease Progression|8
1469854|NCT00691704|4844797|P1|Induction Therapy|Active Hepatitis|1
1469855|NCT00691704|4844797|P1|Induction Therapy|Disease Progression|1
1469856|NCT00691483|4844826|P2|Overall Study|Randomized by not treated|1
1469857|NCT00691483|4844827|P1|Overall Study|Randomized by not treated|7
1469858|NCT00691483|4844826|P2|Overall Study|Other known cause|1
1469859|NCT00691483|4844827|P1|Overall Study|Other known cause|6
1469860|NCT00691483|4844826|P2|Overall Study|Withdrawal by Subject|7
1469861|NCT00691483|4844827|P1|Overall Study|Withdrawal by Subject|24
1469862|NCT00691483|4844826|P2|Overall Study|Lost to Follow-up|10
1469863|NCT00691483|4844827|P1|Overall Study|Lost to Follow-up|17
1469864|NCT00691483|4844826|P2|Overall Study|Adverse Event|6
1469865|NCT00691483|4844827|P1|Overall Study|Adverse Event|14
1469866|NCT00691301|4844854|P1|Overall Study|Did not initiate study treatment|1
1469867|NCT00691301|4844854|P1|Overall Study|other reason|3
1469868|NCT00691301|4844854|P1|Overall Study|Concurrent illness|2
1469869|NCT00691301|4844854|P1|Overall Study|Withdrawal by Subject|4
1469870|NCT00691301|4844854|P1|Overall Study|Lack of Efficacy|32
1469871|NCT00691301|4844854|P1|Overall Study|Death|2
1469872|NCT00691301|4844854|P1|Overall Study|Adverse Event|10
1469873|NCT00691210|4844874|P8|Overall Study|Lack of Efficacy|0
1469874|NCT00691210|4844875|P7|Overall Study|Lack of Efficacy|0
1469875|NCT00691210|4844876|P6|Overall Study|Lack of Efficacy|1
1469876|NCT00691210|4844877|P5|Overall Study|Lack of Efficacy|0
1469877|NCT00691210|4844878|P4|Overall Study|Lack of Efficacy|1
1469878|NCT00691210|4844879|P3|Overall Study|Lack of Efficacy|0
1469879|NCT00691210|4844880|P2|Overall Study|Lack of Efficacy|0
1469880|NCT00691210|4844881|P1|Overall Study|Lack of Efficacy|0
1469881|NCT00691210|4844874|P8|Overall Study|Progression of Disease|0
1469882|NCT00691210|4844875|P7|Overall Study|Progression of Disease|0
1469883|NCT00691210|4844876|P6|Overall Study|Progression of Disease|0
1469884|NCT00691210|4844877|P5|Overall Study|Progression of Disease|0
1469885|NCT00691210|4844878|P4|Overall Study|Progression of Disease|2
1469886|NCT00691210|4844879|P3|Overall Study|Progression of Disease|0
1469887|NCT00691210|4844880|P2|Overall Study|Progression of Disease|0
1469888|NCT00691210|4844881|P1|Overall Study|Progression of Disease|0
1469889|NCT00691132|4844916|P2|Overall Study|Withdrawal by Subject|10
1469890|NCT00691132|4844917|P1|Overall Study|Withdrawal by Subject|10
1469891|NCT00691132|4844916|P2|Overall Study|Adverse Event|3
1469892|NCT00691132|4844917|P1|Overall Study|Adverse Event|2
1469893|NCT00691093|4844936|P1|Overall Study|Ongoing at Date of Cut-Off|4
1469894|NCT00691093|4844936|P1|Overall Study|Lack of Efficacy|1
1469895|NCT00691093|4844936|P1|Overall Study|Lost to Follow-up|1
1469896|NCT00691093|4844936|P1|Overall Study|Adverse Event|1
1469897|NCT00691054|4844970|P1|Overall Study|Withdrawal by Subject|1
1469898|NCT00691028|4844982|P4|Double-blind Period|not come to a hospital.|0
1469899|NCT00691028|4844983|P3|Double-blind Period|not come to a hospital.|0
1469900|NCT00691028|4844984|P2|Double-blind Period|not come to a hospital.|1
1469901|NCT00691028|4844985|P1|Double-blind Period|not come to a hospital.|0
1469902|NCT00691028|4844982|P4|Double-blind Period|Withdrawal by Subject|0
1469903|NCT00691028|4844983|P3|Double-blind Period|Withdrawal by Subject|1
1469904|NCT00691028|4844984|P2|Double-blind Period|Withdrawal by Subject|0
1469905|NCT00691028|4844985|P1|Double-blind Period|Withdrawal by Subject|1
1469906|NCT00691028|4844982|P4|Double-blind Period|Lack of Efficacy|0
1469907|NCT00691028|4844983|P3|Double-blind Period|Lack of Efficacy|2
1469908|NCT00691028|4844984|P2|Double-blind Period|Lack of Efficacy|3
1469909|NCT00691028|4844985|P1|Double-blind Period|Lack of Efficacy|4
1469910|NCT00691028|4844982|P4|Double-blind Period|Adverse Event|0
1469911|NCT00691028|4844983|P3|Double-blind Period|Adverse Event|6
1469912|NCT00691028|4844984|P2|Double-blind Period|Adverse Event|9
1469913|NCT00691028|4844985|P1|Double-blind Period|Adverse Event|8
1469914|NCT00691028|4844982|P4|Open-label Period|not come to a hospital|1
1469915|NCT00691028|4844983|P3|Open-label Period|not come to a hospital|0
1469916|NCT00691028|4844984|P2|Open-label Period|not come to a hospital|0
1469917|NCT00691028|4844985|P1|Open-label Period|not come to a hospital|0
1469918|NCT00691028|4844982|P4|Open-label Period|Withdrawal by Subject|3
1469919|NCT00691028|4844983|P3|Open-label Period|Withdrawal by Subject|0
1469920|NCT00691028|4844984|P2|Open-label Period|Withdrawal by Subject|0
1469921|NCT00691028|4844985|P1|Open-label Period|Withdrawal by Subject|0
1469922|NCT00691028|4844982|P4|Open-label Period|Adverse Event|16
1469923|NCT00691028|4844983|P3|Open-label Period|Adverse Event|0
1469924|NCT00691028|4844984|P2|Open-label Period|Adverse Event|0
1469925|NCT00691028|4844985|P1|Open-label Period|Adverse Event|0
1469926|NCT00691015|4845018|P1|Overall Study|Refused further treatment|1
1469927|NCT00690898|4845033|P1|TREATMENT|Other (not otherwise specified)|1
1469928|NCT00690898|4845033|P1|TREATMENT|Withdrawal by Subject|4
1469929|NCT00690898|4845033|P1|TREATMENT|Lack of Efficacy|18
1469930|NCT00690898|4845033|P1|TREATMENT|Adverse Event|3
1469931|NCT00690898|4845033|P1|SCREENING|Screen failure|18
1469932|NCT00690820|4845053|P2|Period 1|Withdrawal by Subject|1
1469933|NCT00690820|4845054|P1|Period 1|Withdrawal by Subject|0
1469934|NCT00690794|4845076|P2|Overall Study|Other not specified|3
1469935|NCT00690794|4845077|P1|Overall Study|Other not specified|1
1469936|NCT00690794|4845076|P2|Overall Study|Noncompliance|2
1469937|NCT00690794|4845077|P1|Overall Study|Noncompliance|1
1469938|NCT00690794|4845076|P2|Overall Study|Protocol Violation|7
1469939|NCT00690794|4845077|P1|Overall Study|Protocol Violation|6
1469940|NCT00690794|4845076|P2|Overall Study|Withdrawal by Subject|9
1469941|NCT00690794|4845077|P1|Overall Study|Withdrawal by Subject|0
1469942|NCT00690794|4845076|P2|Overall Study|Lost to Follow-up|4
1469943|NCT00690794|4845077|P1|Overall Study|Lost to Follow-up|1
1469944|NCT00690794|4845076|P2|Overall Study|Adverse Event|10
1469945|NCT00690794|4845077|P1|Overall Study|Adverse Event|12
1469946|NCT00690755|4845092|P7|Overall Study|Physician Decision|0
1469947|NCT00690755|4845093|P6|Overall Study|Physician Decision|4
1469948|NCT00690755|4845094|P5|Overall Study|Physician Decision|0
1469949|NCT00690755|4845095|P4|Overall Study|Physician Decision|5
1469950|NCT00690755|4845096|P3|Overall Study|Physician Decision|46
1469951|NCT00690755|4845097|P2|Overall Study|Physician Decision|0
1469952|NCT00690755|4845098|P1|Overall Study|Physician Decision|2
1469953|NCT00690612|4845114|P1|Overall Study|Withdrawal by Subject|2
1469954|NCT00690612|4845114|P1|Overall Study|Adverse Event|1
1469955|NCT00690573|4845119|P1|Overall Study|Withdrawal by Subject|1
1469956|NCT00690573|4845119|P1|Overall Study|Lack of Efficacy|8
1469957|NCT00690482|4845138|P2|Overall Study|withdrew consent at rand.day|1
1469958|NCT00690482|4845139|P1|Overall Study|withdrew consent at rand.day|0
1469959|NCT00690482|4845138|P2|Overall Study|Intake of prohibited medicine|0
1469960|NCT00690482|4845139|P1|Overall Study|Intake of prohibited medicine|1
1469961|NCT00690482|4845138|P2|Overall Study|Study-specific discontinuation criteria|0
1469962|NCT00690482|4845139|P1|Overall Study|Study-specific discontinuation criteria|1
1469963|NCT00690482|4845138|P2|Overall Study|Incorrect enrolment|1
1469964|NCT00690482|4845139|P1|Overall Study|Incorrect enrolment|0
1469965|NCT00690482|4845138|P2|Overall Study|Adverse Event|1
1469966|NCT00690482|4845139|P1|Overall Study|Adverse Event|2
1469967|NCT00690443|4845173|P2|Overall Study|Adverse Event|2
1469968|NCT00690443|4845174|P1|Overall Study|Adverse Event|1
1469969|NCT00690430|4845184|P3|Extension Phase|Early Termination|3
1469970|NCT00690430|4845185|P2|Extension Phase|Early Termination|1
1469971|NCT00690430|4845186|P1|Extension Phase|Early Termination|10
1469972|NCT00690430|4845184|P3|Extension Phase|Withdrawal by Subject|2
1469973|NCT00690430|4845185|P2|Extension Phase|Withdrawal by Subject|0
1469974|NCT00690430|4845186|P1|Extension Phase|Withdrawal by Subject|0
1469975|NCT00690430|4845184|P3|Extension Phase|Death|1
1469976|NCT00690430|4845185|P2|Extension Phase|Death|1
1469977|NCT00690430|4845186|P1|Extension Phase|Death|1
1469978|NCT00690430|4845184|P3|Extension Phase|Adverse Event|2
1469979|NCT00690430|4845185|P2|Extension Phase|Adverse Event|1
1469980|NCT00690430|4845186|P1|Extension Phase|Adverse Event|2
1469981|NCT00690430|4845184|P3|Extension Phase|Administrative Problems|1
1469982|NCT00690430|4845185|P2|Extension Phase|Administrative Problems|1
1469983|NCT00690430|4845186|P1|Extension Phase|Administrative Problems|0
1469984|NCT00690430|4845184|P3|Extension Phase|Abnormal test procedure results|0
1469985|NCT00690430|4845185|P2|Extension Phase|Abnormal test procedure results|0
1469986|NCT00690430|4845186|P1|Extension Phase|Abnormal test procedure results|1
1469987|NCT00690430|4845184|P3|Extension Phase|Abnormal Lab Values|0
1469988|NCT00690430|4845185|P2|Extension Phase|Abnormal Lab Values|0
1469989|NCT00690430|4845186|P1|Extension Phase|Abnormal Lab Values|1
1469990|NCT00690430|4845184|P3|Extension Phase|Lack of Efficacy|4
1469991|NCT00690430|4845185|P2|Extension Phase|Lack of Efficacy|1
1469992|NCT00690430|4845186|P1|Extension Phase|Lack of Efficacy|3
1469993|NCT00690430|4845184|P3|Core Phase|Early Termination|0
1469994|NCT00690430|4845185|P2|Core Phase|Early Termination|5
1469995|NCT00690430|4845186|P1|Core Phase|Early Termination|0
1469996|NCT00690430|4845184|P3|Core Phase|Administrative Problems|0
1469997|NCT00690430|4845185|P2|Core Phase|Administrative Problems|1
1469998|NCT00690430|4845186|P1|Core Phase|Administrative Problems|0
1469999|NCT00690430|4845184|P3|Core Phase|Lack of Efficacy|0
1470000|NCT00690430|4845185|P2|Core Phase|Lack of Efficacy|10
1470001|NCT00690430|4845186|P1|Core Phase|Lack of Efficacy|8
1470002|NCT00690430|4845184|P3|Core Phase|Subject no longer requires study drug|0
1470003|NCT00690430|4845185|P2|Core Phase|Subject no longer requires study drug|0
1470004|NCT00690430|4845186|P1|Core Phase|Subject no longer requires study drug|1
1470005|NCT00690430|4845184|P3|Core Phase|Withdrawal by Subject|0
1470006|NCT00690430|4845185|P2|Core Phase|Withdrawal by Subject|3
1470007|NCT00690430|4845186|P1|Core Phase|Withdrawal by Subject|3
1470008|NCT00690430|4845184|P3|Core Phase|Protocol Violation|0
1470009|NCT00690430|4845185|P2|Core Phase|Protocol Violation|0
1470010|NCT00690430|4845186|P1|Core Phase|Protocol Violation|1
1470011|NCT00690430|4845184|P3|Core Phase|Death|0
1470012|NCT00690430|4845185|P2|Core Phase|Death|2
1470013|NCT00690430|4845186|P1|Core Phase|Death|0
1470014|NCT00690430|4845184|P3|Core Phase|Adverse Event|0
1470015|NCT00690430|4845185|P2|Core Phase|Adverse Event|1
1470016|NCT00690430|4845186|P1|Core Phase|Adverse Event|5
1470017|NCT00690430|4845184|P3|Core Phase|Abnormal Laboratory value|0
1470018|NCT00690430|4845185|P2|Core Phase|Abnormal Laboratory value|1
1470019|NCT00690430|4845186|P1|Core Phase|Abnormal Laboratory value|0
1470020|NCT00690378|4845215|P2|Overall Study|Social problem|0
1470021|NCT00690378|4845216|P1|Overall Study|Social problem|1
1470022|NCT00690378|4845215|P2|Overall Study|Did not meet inc/exc criteria|11
1470023|NCT00690378|4845216|P1|Overall Study|Did not meet inc/exc criteria|13
1470024|NCT00690378|4845215|P2|Overall Study|Lost to Follow-up|3
1470025|NCT00690378|4845216|P1|Overall Study|Lost to Follow-up|2
1470026|NCT00690378|4845215|P2|Overall Study|Protocol Violation|0
1470027|NCT00690378|4845216|P1|Overall Study|Protocol Violation|1
1470028|NCT00690378|4845215|P2|Overall Study|Withdrawal by Subject|0
1470029|NCT00690378|4845216|P1|Overall Study|Withdrawal by Subject|2
1470030|NCT00690378|4845215|P2|Overall Study|Adverse Event|0
1470031|NCT00690378|4845216|P1|Overall Study|Adverse Event|1
1470032|NCT00689936|4845293|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
1470033|NCT00689936|4845294|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
1470034|NCT00689936|4845295|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
1470035|NCT00689936|4845293|P3|Active Treatment Phase|Miscellaneous|47
1470036|NCT00689936|4845294|P2|Active Treatment Phase|Miscellaneous|34
1470037|NCT00689936|4845295|P1|Active Treatment Phase|Miscellaneous|52
1470038|NCT00689936|4845293|P3|Active Treatment Phase|Study Close Out|21
1470039|NCT00689936|4845294|P2|Active Treatment Phase|Study Close Out|26
1470040|NCT00689936|4845295|P1|Active Treatment Phase|Study Close Out|64
1470041|NCT00689936|4845293|P3|Active Treatment Phase|Protocol Violation|4
1470042|NCT00689936|4845294|P2|Active Treatment Phase|Protocol Violation|2
1470043|NCT00689936|4845295|P1|Active Treatment Phase|Protocol Violation|2
1470044|NCT00689936|4845293|P3|Active Treatment Phase|Lost to Follow-up|2
1470045|NCT00689936|4845294|P2|Active Treatment Phase|Lost to Follow-up|2
1470046|NCT00689936|4845295|P1|Active Treatment Phase|Lost to Follow-up|0
1470047|NCT00689936|4845293|P3|Active Treatment Phase|Death|37
1470048|NCT00689936|4845294|P2|Active Treatment Phase|Death|28
1470049|NCT00689936|4845295|P1|Active Treatment Phase|Death|60
1470050|NCT00689936|4845293|P3|Active Treatment Phase|Withdrawal by Subject|21
1470051|NCT00689936|4845294|P2|Active Treatment Phase|Withdrawal by Subject|16
1470052|NCT00689936|4845295|P1|Active Treatment Phase|Withdrawal by Subject|16
1470053|NCT00689936|4845293|P3|Active Treatment Phase|Disease Progression|339
1470054|NCT00689936|4845294|P2|Active Treatment Phase|Disease Progression|362
1470055|NCT00689936|4845295|P1|Active Treatment Phase|Disease Progression|273
1470056|NCT00689936|4845293|P3|Active Treatment Phase|Adverse Event|76
1470057|NCT00689936|4845294|P2|Active Treatment Phase|Adverse Event|71
1470058|NCT00689936|4845295|P1|Active Treatment Phase|Adverse Event|68
1470059|NCT00689871|4845444|P4|Overall Study|Physician Decision|0
1470060|NCT00689871|4845445|P3|Overall Study|Physician Decision|1
1470061|NCT00689871|4845446|P2|Overall Study|Physician Decision|1
1470062|NCT00689871|4845447|P1|Overall Study|Physician Decision|2
1470063|NCT00689871|4845444|P4|Overall Study|Death|2
1470064|NCT00689871|4845445|P3|Overall Study|Death|2
1470065|NCT00689871|4845446|P2|Overall Study|Death|10
1470066|NCT00689871|4845447|P1|Overall Study|Death|1
1470067|NCT00689871|4845444|P4|Overall Study|Withdrawal by Subject|1
1470068|NCT00689871|4845445|P3|Overall Study|Withdrawal by Subject|4
1470069|NCT00689871|4845446|P2|Overall Study|Withdrawal by Subject|3
1470070|NCT00689871|4845447|P1|Overall Study|Withdrawal by Subject|13
1470071|NCT00689871|4845444|P4|Overall Study|Explanted of All Study Devices|3
1470072|NCT00689871|4845445|P3|Overall Study|Explanted of All Study Devices|29
1470073|NCT00689871|4845446|P2|Overall Study|Explanted of All Study Devices|25
1470074|NCT00689871|4845447|P1|Overall Study|Explanted of All Study Devices|36
1470075|NCT00689871|4845444|P4|Overall Study|Lost to Follow-up|1
1470076|NCT00689871|4845445|P3|Overall Study|Lost to Follow-up|37
1470077|NCT00689871|4845446|P2|Overall Study|Lost to Follow-up|13
1470078|NCT00689871|4845447|P1|Overall Study|Lost to Follow-up|123
1470079|NCT00689793|4845474|P2|Overall Study|Lost to Follow-up|5
1470080|NCT00689793|4845475|P1|Overall Study|Lost to Follow-up|4
1470081|NCT00689611|4845493|P2|Overall Study|Lost to Follow-up|28
1470082|NCT00689611|4845494|P1|Overall Study|Lost to Follow-up|27
1470083|NCT00689611|4845493|P2|Overall Study|Withdrawal by Subject|9
1470084|NCT00689611|4845494|P1|Overall Study|Withdrawal by Subject|8
1470085|NCT00689611|4845493|P2|Overall Study|Death|9
1470086|NCT00689611|4845494|P1|Overall Study|Death|6
1470087|NCT00689481|4845504|P2|Overall Study|Subject early term, left on vacation|1
1470088|NCT00689481|4845505|P1|Overall Study|Subject early term, left on vacation|0
1470089|NCT00689481|4845504|P2|Overall Study|Excluded medication started during study|1
1470090|NCT00689481|4845505|P1|Overall Study|Excluded medication started during study|0
1470091|NCT00689481|4845504|P2|Overall Study|Withdrawal by Subject|4
1470092|NCT00689481|4845505|P1|Overall Study|Withdrawal by Subject|8
1470093|NCT00689481|4845504|P2|Overall Study|Non-compliance with study treatment|1
1470094|NCT00689481|4845505|P1|Overall Study|Non-compliance with study treatment|1
1470095|NCT00689481|4845504|P2|Overall Study|Lack of Efficacy|3
1470096|NCT00689481|4845505|P1|Overall Study|Lack of Efficacy|4
1470097|NCT00689481|4845504|P2|Overall Study|Lost to Follow-up|3
1470098|NCT00689481|4845505|P1|Overall Study|Lost to Follow-up|4
1470099|NCT00689481|4845504|P2|Overall Study|Adverse Event|1
1470100|NCT00689481|4845505|P1|Overall Study|Adverse Event|7
1470101|NCT00689390|4845523|P2|Overall Study|Administrative|0
1470102|NCT00689390|4845524|P1|Overall Study|Administrative|37
1470103|NCT00689390|4845523|P2|Overall Study|Did Not Meet Protocol Eligibility|0
1470104|NCT00689390|4845524|P1|Overall Study|Did Not Meet Protocol Eligibility|1
1470105|NCT00689390|4845523|P2|Overall Study|Non-Compliance With Protocol|0
1470106|NCT00689390|4845524|P1|Overall Study|Non-Compliance With Protocol|21
1470107|NCT00689390|4845523|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
1470108|NCT00689390|4845524|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
1470109|NCT00689390|4845523|P2|Overall Study|Withdrawal by Subject|3
1470110|NCT00689390|4845524|P1|Overall Study|Withdrawal by Subject|117
1470111|NCT00689390|4845523|P2|Overall Study|Lost to Follow-up|7
1470112|NCT00689390|4845524|P1|Overall Study|Lost to Follow-up|179
1470113|NCT00689390|4845523|P2|Overall Study|Adverse Event|0
1470114|NCT00689390|4845524|P1|Overall Study|Adverse Event|19
1470115|NCT00689351|4845542|P2|After Infant Series|Parent/legal guardian request|0
1470116|NCT00689351|4845543|P1|After Infant Series|Parent/legal guardian request|1
1470117|NCT00689351|4845542|P2|Infant Series of Dosing|Lost to Follow-up|1
1470118|NCT00689351|4845543|P1|Infant Series of Dosing|Lost to Follow-up|0
1470119|NCT00689351|4845542|P2|Infant Series of Dosing|Adverse Event|0
1470120|NCT00689351|4845543|P1|Infant Series of Dosing|Adverse Event|1
1470121|NCT00689351|4845542|P2|Infant Series of Dosing|Parent/legal guardian request|0
1470122|NCT00689351|4845543|P1|Infant Series of Dosing|Parent/legal guardian request|5
1470123|NCT00689338|4845575|P1|Overall Study|Protocol Violation|15
1470124|NCT00689338|4845575|P1|Overall Study|Withdrawal by Subject|3
1470125|NCT00689338|4845575|P1|Overall Study|Lost to Follow-up|5
1470126|NCT00689338|4845575|P1|Overall Study|Did not Meet Entrance Criteria|27
1470127|NCT00689338|4845575|P1|Overall Study|Other|8
1470128|NCT00689338|4845575|P1|Overall Study|Lack of Efficacy|6
1470129|NCT00689338|4845575|P1|Overall Study|Insufficient Clinical Response|1
1470130|NCT00689338|4845575|P1|Overall Study|Adverse Event|13
1470131|NCT00689338|4845575|P1|Overall Study|Death|65
1470132|NCT00689299|4845588|P3|Overall Study|Protocol Violation|0
1470133|NCT00689299|4845589|P2|Overall Study|Protocol Violation|0
1470134|NCT00689299|4845590|P1|Overall Study|Protocol Violation|1
1470135|NCT00689299|4845588|P3|Overall Study|Withdrawal by Subject|3
1470136|NCT00689299|4845589|P2|Overall Study|Withdrawal by Subject|1
1470137|NCT00689299|4845590|P1|Overall Study|Withdrawal by Subject|4
1470138|NCT00689299|4845588|P3|Overall Study|Lost to Follow-up|1
1470139|NCT00689299|4845589|P2|Overall Study|Lost to Follow-up|1
1470140|NCT00689299|4845590|P1|Overall Study|Lost to Follow-up|0
1470141|NCT00689299|4845588|P3|Overall Study|Adverse Event|1
1470142|NCT00689299|4845589|P2|Overall Study|Adverse Event|1
1470143|NCT00689299|4845590|P1|Overall Study|Adverse Event|2
1470144|NCT00689221|4845619|P2|Overall Study|Ongoing at cut-off date|36
1470145|NCT00689221|4845620|P1|Overall Study|Ongoing at cut-off date|39
1470146|NCT00689117|4845649|P4|Overall Study|Dispensing Error|0
1470147|NCT00689117|4845650|P3|Overall Study|Dispensing Error|0
1470148|NCT00689117|4845651|P2|Overall Study|Dispensing Error|1
1470149|NCT00689117|4845652|P1|Overall Study|Dispensing Error|0
1470150|NCT00689117|4845649|P4|Overall Study|Personal Reason|0
1470151|NCT00689117|4845650|P3|Overall Study|Personal Reason|0
1470152|NCT00689117|4845651|P2|Overall Study|Personal Reason|1
1470153|NCT00689117|4845652|P1|Overall Study|Personal Reason|0
1470154|NCT00689117|4845649|P4|Overall Study|Patient Withdrew from Study|1
1470155|NCT00689117|4845650|P3|Overall Study|Patient Withdrew from Study|0
1470156|NCT00689117|4845651|P2|Overall Study|Patient Withdrew from Study|0
1470157|NCT00689117|4845652|P1|Overall Study|Patient Withdrew from Study|0
1470158|NCT00689117|4845649|P4|Overall Study|Transportation|0
1470159|NCT00689117|4845650|P3|Overall Study|Transportation|0
1470160|NCT00689117|4845651|P2|Overall Study|Transportation|0
1470161|NCT00689117|4845652|P1|Overall Study|Transportation|1
1470162|NCT00689117|4845649|P4|Overall Study|Fear of Birth Defects|0
1470163|NCT00689117|4845650|P3|Overall Study|Fear of Birth Defects|1
1470164|NCT00689117|4845651|P2|Overall Study|Fear of Birth Defects|0
1470165|NCT00689117|4845652|P1|Overall Study|Fear of Birth Defects|0
1470166|NCT00689117|4845649|P4|Overall Study|Incarceration|0
1470167|NCT00689117|4845650|P3|Overall Study|Incarceration|0
1470168|NCT00689117|4845651|P2|Overall Study|Incarceration|0
1470169|NCT00689117|4845652|P1|Overall Study|Incarceration|2
1470170|NCT00689117|4845649|P4|Overall Study|Pregnancy|2
1470171|NCT00689117|4845650|P3|Overall Study|Pregnancy|0
1470172|NCT00689117|4845651|P2|Overall Study|Pregnancy|2
1470173|NCT00689117|4845652|P1|Overall Study|Pregnancy|0
1470174|NCT00689117|4845649|P4|Overall Study|Use of Prohibitive Medication|0
1470175|NCT00689117|4845650|P3|Overall Study|Use of Prohibitive Medication|3
1470176|NCT00689117|4845651|P2|Overall Study|Use of Prohibitive Medication|1
1470177|NCT00689117|4845652|P1|Overall Study|Use of Prohibitive Medication|2
1470178|NCT00689117|4845649|P4|Overall Study|Change/Discontinuation of Birth Control|0
1470179|NCT00689117|4845650|P3|Overall Study|Change/Discontinuation of Birth Control|1
1470180|NCT00689117|4845651|P2|Overall Study|Change/Discontinuation of Birth Control|1
1470181|NCT00689117|4845652|P1|Overall Study|Change/Discontinuation of Birth Control|1
1470182|NCT00689117|4845649|P4|Overall Study|Non-compliance with Treatment Regimen|0
1470183|NCT00689117|4845650|P3|Overall Study|Non-compliance with Treatment Regimen|0
1470184|NCT00689117|4845651|P2|Overall Study|Non-compliance with Treatment Regimen|1
1470185|NCT00689117|4845652|P1|Overall Study|Non-compliance with Treatment Regimen|0
1470186|NCT00689117|4845649|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1470187|NCT00689117|4845650|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1470188|NCT00689117|4845651|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
1470189|NCT00689117|4845652|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
1470190|NCT00689117|4845649|P4|Overall Study|Unable to Comply with Visit Schedule|1
1470191|NCT00689117|4845650|P3|Overall Study|Unable to Comply with Visit Schedule|1
1470192|NCT00689117|4845651|P2|Overall Study|Unable to Comply with Visit Schedule|0
1470193|NCT00689117|4845652|P1|Overall Study|Unable to Comply with Visit Schedule|0
1470194|NCT00689117|4845649|P4|Overall Study|Withdrawal by Subject|13
1470195|NCT00689117|4845650|P3|Overall Study|Withdrawal by Subject|26
1470196|NCT00689117|4845651|P2|Overall Study|Withdrawal by Subject|18
1470197|NCT00689117|4845652|P1|Overall Study|Withdrawal by Subject|19
1470198|NCT00689117|4845649|P4|Overall Study|Non-Compliance with Study Treatment|1
1470199|NCT00689117|4845650|P3|Overall Study|Non-Compliance with Study Treatment|3
1470200|NCT00689117|4845651|P2|Overall Study|Non-Compliance with Study Treatment|3
1470201|NCT00689117|4845652|P1|Overall Study|Non-Compliance with Study Treatment|3
1470202|NCT00689117|4845649|P4|Overall Study|Lack of Efficacy|2
1470203|NCT00689117|4845650|P3|Overall Study|Lack of Efficacy|2
1470204|NCT00689117|4845651|P2|Overall Study|Lack of Efficacy|2
1470205|NCT00689117|4845652|P1|Overall Study|Lack of Efficacy|1
1470206|NCT00689117|4845649|P4|Overall Study|Lost to Follow-up|11
1470207|NCT00689117|4845650|P3|Overall Study|Lost to Follow-up|17
1470208|NCT00689117|4845651|P2|Overall Study|Lost to Follow-up|19
1470209|NCT00689117|4845652|P1|Overall Study|Lost to Follow-up|26
1470210|NCT00689117|4845649|P4|Overall Study|Adverse Event|0
1470211|NCT00689117|4845650|P3|Overall Study|Adverse Event|5
1470212|NCT00689117|4845651|P2|Overall Study|Adverse Event|0
1470213|NCT00689117|4845652|P1|Overall Study|Adverse Event|6
1470214|NCT00689104|4845682|P4|Overall Study|Non-compliance with study procedures|0
1470215|NCT00689104|4845683|P3|Overall Study|Non-compliance with study procedures|1
1470216|NCT00689104|4845684|P2|Overall Study|Non-compliance with study procedures|0
1470217|NCT00689104|4845685|P1|Overall Study|Non-compliance with study procedures|0
1470218|NCT00689104|4845682|P4|Overall Study|Physician Decision|0
1470219|NCT00689104|4845683|P3|Overall Study|Physician Decision|0
1470220|NCT00689104|4845684|P2|Overall Study|Physician Decision|0
1470221|NCT00689104|4845685|P1|Overall Study|Physician Decision|1
1470222|NCT00689104|4845682|P4|Overall Study|Randomized but never received study drug|0
1470223|NCT00689104|4845683|P3|Overall Study|Randomized but never received study drug|1
1470224|NCT00689104|4845684|P2|Overall Study|Randomized but never received study drug|1
1470225|NCT00689104|4845685|P1|Overall Study|Randomized but never received study drug|2
1470226|NCT00689104|4845682|P4|Overall Study|Protocol Violation|3
1470227|NCT00689104|4845683|P3|Overall Study|Protocol Violation|5
1470228|NCT00689104|4845684|P2|Overall Study|Protocol Violation|3
1470229|NCT00689104|4845685|P1|Overall Study|Protocol Violation|2
1470230|NCT00689104|4845682|P4|Overall Study|Lost to Follow-up|5
1470231|NCT00689104|4845683|P3|Overall Study|Lost to Follow-up|2
1470232|NCT00689104|4845684|P2|Overall Study|Lost to Follow-up|3
1470233|NCT00689104|4845685|P1|Overall Study|Lost to Follow-up|4
1470234|NCT00689104|4845682|P4|Overall Study|Withdrawal by Subject|11
1470235|NCT00689104|4845683|P3|Overall Study|Withdrawal by Subject|18
1470236|NCT00689104|4845684|P2|Overall Study|Withdrawal by Subject|11
1470237|NCT00689104|4845685|P1|Overall Study|Withdrawal by Subject|12
1470238|NCT00689104|4845682|P4|Overall Study|Lack of Efficacy|3
1470239|NCT00689104|4845683|P3|Overall Study|Lack of Efficacy|2
1470240|NCT00689104|4845684|P2|Overall Study|Lack of Efficacy|6
1470241|NCT00689104|4845685|P1|Overall Study|Lack of Efficacy|5
1470242|NCT00689104|4845682|P4|Overall Study|Adverse Event|24
1470243|NCT00689104|4845683|P3|Overall Study|Adverse Event|16
1470244|NCT00689104|4845684|P2|Overall Study|Adverse Event|25
1470245|NCT00689104|4845685|P1|Overall Study|Adverse Event|13
1470246|NCT00689104|4845682|P4|Overall Study|Eligibility criterion not met|4
1470247|NCT00689104|4845683|P3|Overall Study|Eligibility criterion not met|0
1470248|NCT00689104|4845684|P2|Overall Study|Eligibility criterion not met|8
1470249|NCT00689104|4845685|P1|Overall Study|Eligibility criterion not met|5
1470250|NCT00689052|4845838|P2|Overall Study|Early termination of the trial|24
1470251|NCT00689052|4845839|P1|Overall Study|Early termination of the trial|22
1470252|NCT00689052|4845838|P2|Overall Study|Withdrawal by Subject|0
1470253|NCT00689052|4845839|P1|Overall Study|Withdrawal by Subject|2
1470254|NCT00689052|4845838|P2|Overall Study|Lost to Follow-up|0
1470255|NCT00689052|4845839|P1|Overall Study|Lost to Follow-up|2
1470256|NCT00689052|4845838|P2|Overall Study|Protocol Violation|0
1470257|NCT00689052|4845839|P1|Overall Study|Protocol Violation|1
1470258|NCT00689052|4845838|P2|Overall Study|Adverse Event|6
1470259|NCT00689052|4845839|P1|Overall Study|Adverse Event|4
1470260|NCT00689026|4845871|P2|Overall Study|Withdrawal by Subject|6
1470261|NCT00689026|4845872|P1|Overall Study|Withdrawal by Subject|13
1470262|NCT00688870|4845880|P2|Infant Series|Parent or legal guardian request|0
1470263|NCT00688870|4845881|P1|Infant Series|Parent or legal guardian request|4
1470264|NCT00688844|4845913|P1|Overall Study|Lost to Follow-up|10
1470265|NCT00688753|4845923|P1|Overall Study|Lost to Follow-up|3
1470266|NCT00688753|4845923|P1|Overall Study|Protocol Violation|1
1470267|NCT00688753|4845923|P1|Overall Study|Adverse Event|20
1470268|NCT00688753|4845923|P1|Overall Study|Withdrawal by Subject|3
1470269|NCT00688753|4845923|P1|Overall Study|Death|9
1470270|NCT00688753|4845923|P1|Overall Study|Missing|1
1470271|NCT00688753|4845923|P1|Overall Study|Disease progression|55
1470272|NCT00688740|4845934|P2|Overall Study|Violation of Inclusion Criteria|3
1470273|NCT00688740|4845935|P1|Overall Study|Violation of Inclusion Criteria|1
1470274|NCT00688740|4845934|P2|Overall Study|Breast Cancer Relapse|4
1470275|NCT00688740|4845935|P1|Overall Study|Breast Cancer Relapse|1
1470276|NCT00688740|4845934|P2|Overall Study|Consent Withdrawn|17
1470277|NCT00688740|4845935|P1|Overall Study|Consent Withdrawn|17
1470278|NCT00688740|4845934|P2|Overall Study|Lost to Follow-up|1
1470279|NCT00688740|4845935|P1|Overall Study|Lost to Follow-up|0
1470280|NCT00688740|4845934|P2|Overall Study|Death|2
1470281|NCT00688740|4845935|P1|Overall Study|Death|2
1470282|NCT00688740|4845934|P2|Overall Study|Adverse Event|8
1470283|NCT00688740|4845935|P1|Overall Study|Adverse Event|45
1470284|NCT00688701|4845948|P4|Overall Study|Poor compliance to protocol|0
1470285|NCT00688701|4845949|P3|Overall Study|Poor compliance to protocol|1
1470286|NCT00688701|4845950|P2|Overall Study|Poor compliance to protocol|1
1470287|NCT00688701|4845951|P1|Overall Study|Poor compliance to protocol|0
1470288|NCT00688701|4845948|P4|Overall Study|Withdrawal by Subject|8
1470289|NCT00688701|4845949|P3|Overall Study|Withdrawal by Subject|4
1470290|NCT00688701|4845950|P2|Overall Study|Withdrawal by Subject|3
1470291|NCT00688701|4845951|P1|Overall Study|Withdrawal by Subject|3
1470292|NCT00688701|4845948|P4|Overall Study|Lack of Efficacy|0
1470293|NCT00688701|4845949|P3|Overall Study|Lack of Efficacy|0
1470294|NCT00688701|4845950|P2|Overall Study|Lack of Efficacy|1
1470295|NCT00688701|4845951|P1|Overall Study|Lack of Efficacy|0
1470296|NCT00688701|4845948|P4|Overall Study|Adverse Event|3
1470297|NCT00688701|4845949|P3|Overall Study|Adverse Event|5
1470298|NCT00688701|4845950|P2|Overall Study|Adverse Event|0
1470299|NCT00688701|4845951|P1|Overall Study|Adverse Event|1
1470300|NCT00688688|4845992|P3|Overall Study|Violation of exclusion criterion|0
1470301|NCT00688688|4845993|P2|Overall Study|Violation of exclusion criterion|1
1470302|NCT00688688|4845994|P1|Overall Study|Violation of exclusion criterion|0
1470303|NCT00688688|4845992|P3|Overall Study|Site closure|0
1470304|NCT00688688|4845993|P2|Overall Study|Site closure|1
1470305|NCT00688688|4845994|P1|Overall Study|Site closure|0
1470306|NCT00688688|4845992|P3|Overall Study|Taking exclusionary medications|0
1470307|NCT00688688|4845993|P2|Overall Study|Taking exclusionary medications|0
1470308|NCT00688688|4845994|P1|Overall Study|Taking exclusionary medications|1
1470309|NCT00688688|4845992|P3|Overall Study|Non-compliance with study procedures|4
1470310|NCT00688688|4845993|P2|Overall Study|Non-compliance with study procedures|3
1470311|NCT00688688|4845994|P1|Overall Study|Non-compliance with study procedures|5
1470312|NCT00688688|4845992|P3|Overall Study|Randomized but never received study drug|0
1470313|NCT00688688|4845993|P2|Overall Study|Randomized but never received study drug|0
1470314|NCT00688688|4845994|P1|Overall Study|Randomized but never received study drug|1
1470315|NCT00688688|4845992|P3|Overall Study|Protocol Violation|11
1470316|NCT00688688|4845993|P2|Overall Study|Protocol Violation|9
1470317|NCT00688688|4845994|P1|Overall Study|Protocol Violation|6
1470318|NCT00688688|4845992|P3|Overall Study|Lost to Follow-up|7
1470319|NCT00688688|4845993|P2|Overall Study|Lost to Follow-up|7
1470320|NCT00688688|4845994|P1|Overall Study|Lost to Follow-up|14
1470321|NCT00688688|4845992|P3|Overall Study|Withdrawal by Subject|65
1470322|NCT00688688|4845993|P2|Overall Study|Withdrawal by Subject|75
1470323|NCT00688688|4845994|P1|Overall Study|Withdrawal by Subject|66
1470324|NCT00688688|4845992|P3|Overall Study|Lack of Efficacy|45
1470325|NCT00688688|4845993|P2|Overall Study|Lack of Efficacy|25
1470326|NCT00688688|4845994|P1|Overall Study|Lack of Efficacy|34
1470327|NCT00688688|4845992|P3|Overall Study|Adverse Event|50
1470328|NCT00688688|4845993|P2|Overall Study|Adverse Event|51
1470329|NCT00688688|4845994|P1|Overall Study|Adverse Event|52
1470330|NCT00688688|4845992|P3|Overall Study|Eligibility criterion not met|10
1470331|NCT00688688|4845993|P2|Overall Study|Eligibility criterion not met|7
1470332|NCT00688688|4845994|P1|Overall Study|Eligibility criterion not met|7
1470333|NCT00688636|4846096|P2|Overall Study|Adverse Event|1
1470334|NCT00688636|4846097|P1|Overall Study|Adverse Event|2
1470335|NCT00688597|4846114|P3|Overall Study|Physician Decision|0
1470336|NCT00688597|4846115|P2|Overall Study|Physician Decision|0
1470337|NCT00688597|4846116|P1|Overall Study|Physician Decision|1
1470338|NCT00688597|4846114|P3|Overall Study|Adverse Event|0
1470339|NCT00688597|4846115|P2|Overall Study|Adverse Event|0
1470340|NCT00688597|4846116|P1|Overall Study|Adverse Event|2
1470341|NCT00688545|4846129|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
1470342|NCT00688545|4846130|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
1470343|NCT00688545|4846129|P2|Overall Study|Withdrawal by Subject|3
1470344|NCT00688545|4846130|P1|Overall Study|Withdrawal by Subject|2
1470345|NCT00688545|4846129|P2|Overall Study|Insurance/cost of drug|1
1470346|NCT00688545|4846130|P1|Overall Study|Insurance/cost of drug|0
1470347|NCT00688545|4846129|P2|Overall Study|Lost to Follow-up|4
1470348|NCT00688545|4846130|P1|Overall Study|Lost to Follow-up|1
1470349|NCT00688519|4846140|P2|Overall Study|Pregnancy|1
1470350|NCT00688519|4846141|P1|Overall Study|Pregnancy|0
1470351|NCT00688519|4846140|P2|Overall Study|Subject moved out of area|0
1470352|NCT00688519|4846141|P1|Overall Study|Subject moved out of area|1
1470353|NCT00688519|4846140|P2|Overall Study|Investigator decision|0
1470354|NCT00688519|4846141|P1|Overall Study|Investigator decision|1
1470355|NCT00688519|4846140|P2|Overall Study|Subject moved out of state|0
1470356|NCT00688519|4846141|P1|Overall Study|Subject moved out of state|1
1470357|NCT00688519|4846140|P2|Overall Study|Non-compliance|1
1470358|NCT00688519|4846141|P1|Overall Study|Non-compliance|0
1470359|NCT00688519|4846140|P2|Overall Study|Prohibited medication|0
1470360|NCT00688519|4846141|P1|Overall Study|Prohibited medication|1
1470361|NCT00688519|4846140|P2|Overall Study|Withdrawal by Subject|6
1470362|NCT00688519|4846141|P1|Overall Study|Withdrawal by Subject|7
1470363|NCT00688519|4846140|P2|Overall Study|Lack of Efficacy|1
1470364|NCT00688519|4846141|P1|Overall Study|Lack of Efficacy|3
1470365|NCT00688519|4846140|P2|Overall Study|Lost to Follow-up|3
1470366|NCT00688519|4846141|P1|Overall Study|Lost to Follow-up|3
1470367|NCT00688519|4846140|P2|Overall Study|Adverse Event|3
1470368|NCT00688519|4846141|P1|Overall Study|Adverse Event|2
1470369|NCT00688467|4846159|P2|Treatment Period 2|Adverse Event|1
1470370|NCT00688467|4846160|P1|Treatment Period 2|Adverse Event|0
1470371|NCT00688467|4846159|P2|Treatment Period 2|Protocol Violation|1
1470372|NCT00688467|4846160|P1|Treatment Period 2|Protocol Violation|0
1470373|NCT00688467|4846159|P2|Treatment Period 1|Did not meet protocol eligibility|1
1470374|NCT00688467|4846160|P1|Treatment Period 1|Did not meet protocol eligibility|0
1470375|NCT00688467|4846159|P2|Treatment Period 1|Adverse Event|1
1470376|NCT00688467|4846160|P1|Treatment Period 1|Adverse Event|2
1470377|NCT00688324|4846190|P1|Overall Study|Lost to Follow-up|1
1470378|NCT00688324|4846190|P1|Overall Study|Physician Decision|5
1470379|NCT00688324|4846190|P1|Overall Study|Withdrawal by Subject|2
1470380|NCT00688259|4846235|P2|Overall Study|Hospitalized at Follow-up|1
1470381|NCT00688259|4846236|P1|Overall Study|Hospitalized at Follow-up|0
1470382|NCT00688259|4846235|P2|Overall Study|Declined Interview|3
1470383|NCT00688259|4846236|P1|Overall Study|Declined Interview|2
1470384|NCT00688259|4846235|P2|Overall Study|Withdrawal by Subject|0
1470385|NCT00688259|4846236|P1|Overall Study|Withdrawal by Subject|2
1470386|NCT00688259|4846235|P2|Overall Study|Physician Decision|0
1470387|NCT00688259|4846236|P1|Overall Study|Physician Decision|1
1470388|NCT00688259|4846235|P2|Overall Study|Lost to Follow-up|4
1470389|NCT00688259|4846236|P1|Overall Study|Lost to Follow-up|2
1470390|NCT00688155|4846256|P4|Overall Study|Withdrawal by Subject|1
1470391|NCT00688155|4846257|P3|Overall Study|Withdrawal by Subject|1
1470392|NCT00688155|4846258|P2|Overall Study|Withdrawal by Subject|2
1470393|NCT00688155|4846259|P1|Overall Study|Withdrawal by Subject|2
1470394|NCT00688103|4846279|P2|Overall Study|complex reasons|9
1470395|NCT00688103|4846280|P1|Overall Study|complex reasons|11
1470396|NCT00688103|4846279|P2|Overall Study|Withdrawal by Subject|2
1470397|NCT00688103|4846280|P1|Overall Study|Withdrawal by Subject|4
1470398|NCT00688103|4846279|P2|Overall Study|Lack of Efficacy|1
1470399|NCT00688103|4846280|P1|Overall Study|Lack of Efficacy|11
1470400|NCT00688103|4846279|P2|Overall Study|Adverse Event|1
1470401|NCT00688103|4846280|P1|Overall Study|Adverse Event|4
1470402|NCT00688064|4846292|P2|Overall Study|Any other reasons|3
1470403|NCT00688064|4846293|P1|Overall Study|Any other reasons|1
1470404|NCT00688064|4846292|P2|Overall Study|Pregnancy|0
1470405|NCT00688064|4846293|P1|Overall Study|Pregnancy|1
1470406|NCT00688064|4846292|P2|Overall Study|Lack of Efficacy|1
1470407|NCT00688064|4846293|P1|Overall Study|Lack of Efficacy|0
1470408|NCT00688064|4846292|P2|Overall Study|Lost to Follow-up|10
1470409|NCT00688064|4846293|P1|Overall Study|Lost to Follow-up|10
1470410|NCT00688064|4846292|P2|Overall Study|Withdrawal by Subject|7
1470411|NCT00688064|4846293|P1|Overall Study|Withdrawal by Subject|7
1470412|NCT00688064|4846292|P2|Overall Study|Adverse Event|4
1470413|NCT00688064|4846293|P1|Overall Study|Adverse Event|2
1470414|NCT00688064|4846292|P2|Overall Study|Protocol Violation|1
1470415|NCT00688064|4846293|P1|Overall Study|Protocol Violation|0
1470416|NCT00687973|4846309|P2|Overall Study|Withdrawal by Subject|3
1470417|NCT00687973|4846310|P1|Overall Study|Withdrawal by Subject|3
1470418|NCT00687973|4846309|P2|Overall Study|Administrative Reasons|2
1470419|NCT00687973|4846310|P1|Overall Study|Administrative Reasons|0
1470420|NCT00687973|4846309|P2|Overall Study|Protocol Violation|2
1470421|NCT00687973|4846310|P1|Overall Study|Protocol Violation|1
1470422|NCT00687973|4846309|P2|Overall Study|Lack of Efficacy|3
1470423|NCT00687973|4846310|P1|Overall Study|Lack of Efficacy|2
1470424|NCT00687973|4846309|P2|Overall Study|Adverse Event|28
1470425|NCT00687973|4846310|P1|Overall Study|Adverse Event|18
1470426|NCT00687804|4846372|P3|Open-Label Extension Study|Death|3
1470427|NCT00687804|4846373|P2|Open-Label Extension Study|Death|3
1470428|NCT00687804|4846374|P1|Open-Label Extension Study|Death|2
1470429|NCT00687804|4846372|P3|Open-Label Extension Study|Administrative problems|0
1470430|NCT00687804|4846373|P2|Open-Label Extension Study|Administrative problems|1
1470431|NCT00687804|4846374|P1|Open-Label Extension Study|Administrative problems|1
1470432|NCT00687804|4846372|P3|Open-Label Extension Study|Lost to Follow-up|2
1470433|NCT00687804|4846373|P2|Open-Label Extension Study|Lost to Follow-up|1
1470434|NCT00687804|4846374|P1|Open-Label Extension Study|Lost to Follow-up|2
1470435|NCT00687804|4846372|P3|Open-Label Extension Study|Subject withdrew consent|4
1470436|NCT00687804|4846373|P2|Open-Label Extension Study|Subject withdrew consent|4
1470437|NCT00687804|4846374|P1|Open-Label Extension Study|Subject withdrew consent|3
1470438|NCT00687804|4846372|P3|Open-Label Extension Study|Adverse Event|2
1470439|NCT00687804|4846373|P2|Open-Label Extension Study|Adverse Event|2
1470440|NCT00687804|4846374|P1|Open-Label Extension Study|Adverse Event|2
1470441|NCT00687804|4846372|P3|Core Study|Protocol Violation|0
1470442|NCT00687804|4846373|P2|Core Study|Protocol Violation|1
1470443|NCT00687804|4846374|P1|Core Study|Protocol Violation|1
1470444|NCT00687804|4846372|P3|Core Study|Death|2
1470445|NCT00687804|4846373|P2|Core Study|Death|2
1470446|NCT00687804|4846374|P1|Core Study|Death|2
1470447|NCT00687804|4846372|P3|Core Study|Lost to Follow-up|0
1470448|NCT00687804|4846373|P2|Core Study|Lost to Follow-up|1
1470449|NCT00687804|4846374|P1|Core Study|Lost to Follow-up|0
1470450|NCT00687804|4846372|P3|Core Study|Withdrawal by Subject|7
1470451|NCT00687804|4846373|P2|Core Study|Withdrawal by Subject|7
1470452|NCT00687804|4846374|P1|Core Study|Withdrawal by Subject|4
1470453|NCT00687804|4846372|P3|Core Study|Lack of Efficacy|1
1470454|NCT00687804|4846373|P2|Core Study|Lack of Efficacy|1
1470455|NCT00687804|4846374|P1|Core Study|Lack of Efficacy|1
1470456|NCT00687804|4846372|P3|Core Study|Abnormal laboratory value(s)|0
1470457|NCT00687804|4846373|P2|Core Study|Abnormal laboratory value(s)|0
1470458|NCT00687804|4846374|P1|Core Study|Abnormal laboratory value(s)|1
1470459|NCT00687804|4846372|P3|Core Study|Adverse Event|3
1470460|NCT00687804|4846373|P2|Core Study|Adverse Event|3
1470461|NCT00687804|4846374|P1|Core Study|Adverse Event|5
1470462|NCT00687609|4846435|P1|Overall Study|Withdrawal by Subject|2
1470463|NCT00687609|4846435|P1|Overall Study|Physician Decision|1
1470464|NCT00687531|4846458|P1|Overall Study|Lost to Follow-up|26
1470465|NCT00687531|4846458|P1|Overall Study|Adverse Event|5
1470466|NCT00687531|4846458|P1|Overall Study|Did not meet protocol eligibility|104
1470467|NCT00687440|4846481|P1|Overall Study|Missing|1
1470468|NCT00687440|4846481|P1|Overall Study|Not specified|1
1470469|NCT00687440|4846481|P1|Overall Study|Death|2
1470470|NCT00687440|4846481|P1|Overall Study|Lack of Efficacy|2
1470471|NCT00687440|4846481|P1|Overall Study|Lost to Follow-up|3
1470472|NCT00687440|4846481|P1|Overall Study|Adverse Event|3
1470473|NCT00687401|4846485|P1|Overall Study|For reasons different from those above|4
1470474|NCT00687401|4846485|P1|Overall Study|Did not return for visit|3
1470475|NCT00687401|4846485|P1|Overall Study|Withdrawal by Subject|4
1470476|NCT00687401|4846485|P1|Overall Study|Lack of Efficacy|6
1470477|NCT00687401|4846485|P1|Overall Study|Adverse Event|6
1470478|NCT00687401|4846485|P1|Overall Study|Protocol Violation|7
1470479|NCT00687362|4846490|P1|Overall Study|Withdrawal by Subject|1
1470480|NCT00687362|4846490|P1|Overall Study|Protocol Violation|2
1470481|NCT00687323|4846494|P1|Overall Study|Screen failure|148
1470482|NCT00687323|4846494|P1|Overall Study|Excluded from efficacy evaluations|6
1470483|NCT00687323|4846494|P1|Overall Study|Withdrawal by Subject|1
1470484|NCT00687323|4846494|P1|Overall Study|Death|25
1470485|NCT00687297|4846510|P2|Induction|Other|1
1470486|NCT00687297|4846511|P1|Induction|Other|0
1470487|NCT00687297|4846510|P2|Induction|Physician Decision|2
1470488|NCT00687297|4846511|P1|Induction|Physician Decision|0
1470489|NCT00687297|4846510|P2|Induction|Patient Noncompliance|0
1470490|NCT00687297|4846511|P1|Induction|Patient Noncompliance|1
1470491|NCT00687297|4846510|P2|Induction|Ineligible|1
1470492|NCT00687297|4846511|P1|Induction|Ineligible|0
1470493|NCT00687297|4846510|P2|Induction|Lack of Efficacy|21
1470494|NCT00687297|4846511|P1|Induction|Lack of Efficacy|17
1470495|NCT00687297|4846510|P2|Induction|Death|11
1470496|NCT00687297|4846511|P1|Induction|Death|7
1470497|NCT00687297|4846510|P2|Induction|Adverse Event|15
1470498|NCT00687297|4846511|P1|Induction|Adverse Event|16
1470499|NCT00687297|4846510|P2|Induction|Withdrawal by Subject|4
1470500|NCT00687297|4846511|P1|Induction|Withdrawal by Subject|4
1470501|NCT00687297|4846510|P2|Randomization|Withdrew before treatment, ineligible|1
1470502|NCT00687297|4846511|P1|Randomization|Withdrew before treatment, ineligible|1
1470503|NCT00687297|4846510|P2|Randomization|Withdrawal by Subject|0
1470504|NCT00687297|4846511|P1|Randomization|Withdrawal by Subject|2
1470505|NCT00687219|4846521|P1|Overall Study|Lack of Efficacy|1
1470506|NCT00687219|4846521|P1|Overall Study|Withdrawal by Subject|1
1470507|NCT00687219|4846521|P1|Overall Study|HCV-RNA positive conversion|34
1470508|NCT00687219|4846521|P1|Overall Study|Discontinuance criteria met|7
1470509|NCT00687219|4846521|P1|Overall Study|Adverse Event|8
1470510|NCT00687193|4846533|P6|Overall Study|Protocol Violation|0
1470511|NCT00687193|4846534|P5|Overall Study|Protocol Violation|2
1470512|NCT00687193|4846535|P4|Overall Study|Protocol Violation|1
1470513|NCT00687193|4846536|P3|Overall Study|Protocol Violation|0
1470514|NCT00687193|4846537|P2|Overall Study|Protocol Violation|2
1470515|NCT00687193|4846538|P1|Overall Study|Protocol Violation|1
1470516|NCT00687193|4846533|P6|Overall Study|Lack of Efficacy|2
1470517|NCT00687193|4846534|P5|Overall Study|Lack of Efficacy|0
1470518|NCT00687193|4846535|P4|Overall Study|Lack of Efficacy|0
1470519|NCT00687193|4846536|P3|Overall Study|Lack of Efficacy|0
1470520|NCT00687193|4846537|P2|Overall Study|Lack of Efficacy|1
1470521|NCT00687193|4846538|P1|Overall Study|Lack of Efficacy|1
1470522|NCT00687193|4846533|P6|Overall Study|Adverse Event|2
1470523|NCT00687193|4846534|P5|Overall Study|Adverse Event|0
1470524|NCT00687193|4846535|P4|Overall Study|Adverse Event|3
1470525|NCT00687193|4846536|P3|Overall Study|Adverse Event|2
1470526|NCT00687193|4846537|P2|Overall Study|Adverse Event|1
1470527|NCT00687193|4846538|P1|Overall Study|Adverse Event|0
1470528|NCT00686998|4846748|P3|Overall Study|Safety Reasons|0
1470529|NCT00686998|4846749|P2|Overall Study|Safety Reasons|0
1470530|NCT00686998|4846750|P1|Overall Study|Safety Reasons|1
1470531|NCT00686998|4846748|P3|Overall Study|Not specified|1
1470532|NCT00686998|4846749|P2|Overall Study|Not specified|0
1470533|NCT00686998|4846750|P1|Overall Study|Not specified|0
1470534|NCT00686998|4846748|P3|Overall Study|Lack of Efficacy|0
1470535|NCT00686998|4846749|P2|Overall Study|Lack of Efficacy|5
1470536|NCT00686998|4846750|P1|Overall Study|Lack of Efficacy|7
1470537|NCT00686998|4846748|P3|Overall Study|Withdrawal by Subject|2
1470538|NCT00686998|4846749|P2|Overall Study|Withdrawal by Subject|1
1470539|NCT00686998|4846750|P1|Overall Study|Withdrawal by Subject|2
1470540|NCT00686998|4846748|P3|Overall Study|Adverse Event|1
1470541|NCT00686998|4846749|P2|Overall Study|Adverse Event|2
1470542|NCT00686998|4846750|P1|Overall Study|Adverse Event|3
1470543|NCT00686972|4846758|P1|Overall Study|P.I, Left institution. Study terminated|51
1470544|NCT00686959|4846764|P2|Overall Study|Participants censored (no death events)|117
1470545|NCT00686959|4846765|P1|Overall Study|Participants censored (no death events)|124
1470546|NCT00686894|4846783|P1|Overall Study|Protocol Violation|4
1470547|NCT00686894|4846783|P1|Overall Study|Relapse|2
1470548|NCT00686881|4846789|P2|Overall Study|Never received study drug|6
1470549|NCT00686881|4846790|P1|Overall Study|Never received study drug|2
1470550|NCT00686881|4846789|P2|Overall Study|Study discontinuation|32
1470551|NCT00686881|4846790|P1|Overall Study|Study discontinuation|35
1470552|NCT00686881|4846789|P2|Overall Study|Irregular visits|0
1470553|NCT00686881|4846790|P1|Overall Study|Irregular visits|1
1470554|NCT00686881|4846789|P2|Overall Study|Did not meet protocol eligibility|0
1470555|NCT00686881|4846790|P1|Overall Study|Did not meet protocol eligibility|1
1470556|NCT00686881|4846789|P2|Overall Study|Circumstances of site|1
1470557|NCT00686881|4846790|P1|Overall Study|Circumstances of site|1
1470558|NCT00686881|4846789|P2|Overall Study|Physician Decision|0
1470559|NCT00686881|4846790|P1|Overall Study|Physician Decision|1
1470560|NCT00686881|4846789|P2|Overall Study|Lack of Efficacy|3
1470561|NCT00686881|4846790|P1|Overall Study|Lack of Efficacy|4
1470562|NCT00686881|4846789|P2|Overall Study|Onset of malignant tumor|11
1470563|NCT00686881|4846790|P1|Overall Study|Onset of malignant tumor|11
1470564|NCT00686881|4846789|P2|Overall Study|Met discontinuation criteria|0
1470565|NCT00686881|4846790|P1|Overall Study|Met discontinuation criteria|5
1470566|NCT00686881|4846789|P2|Overall Study|Treatment-related adverse event|9
1470567|NCT00686881|4846790|P1|Overall Study|Treatment-related adverse event|10
1470568|NCT00686881|4846789|P2|Overall Study|Lost to Follow-up|1
1470569|NCT00686881|4846790|P1|Overall Study|Lost to Follow-up|0
1470570|NCT00686881|4846789|P2|Overall Study|Withdrawal by Subject|18
1470571|NCT00686881|4846790|P1|Overall Study|Withdrawal by Subject|11
1470572|NCT00686855|4846802|P2|Overall Study|Progressive GVHD|1
1470573|NCT00686855|4846803|P1|Overall Study|Progressive GVHD|0
1470574|NCT00686855|4846802|P2|Overall Study|Lost to Follow-up|0
1470575|NCT00686855|4846803|P1|Overall Study|Lost to Follow-up|1
1470576|NCT00686790|4846829|P1|Overall Study|Lost to Follow-up|12
1470577|NCT00686790|4846829|P1|Overall Study|Death|1
1470578|NCT00686790|4846829|P1|Overall Study|Withdrawal by Subject|1
1470579|NCT00686790|4846829|P1|Overall Study|Adverse Event|2
1470580|NCT00686777|4846837|P1|Overall Study|No Visit|1
1470581|NCT00686777|4846837|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
1470582|NCT00686777|4846837|P1|Overall Study|Withdrawal by Subject|2
1470583|NCT00686777|4846837|P1|Overall Study|Pregnancy|1
1470584|NCT00686777|4846837|P1|Overall Study|Adverse Event|2
1470585|NCT00686725|4846845|P2|Overall Study|Not Specified|3
1470586|NCT00686725|4846846|P1|Overall Study|Not Specified|1
1470587|NCT00686725|4846845|P2|Overall Study|Protocol Violation|3
1470588|NCT00686725|4846846|P1|Overall Study|Protocol Violation|1
1470589|NCT00686725|4846845|P2|Overall Study|Withdrawal by Subject|4
1470590|NCT00686725|4846846|P1|Overall Study|Withdrawal by Subject|13
1470591|NCT00686725|4846845|P2|Overall Study|Death|3
1470592|NCT00686725|4846846|P1|Overall Study|Death|6
1470593|NCT00686725|4846845|P2|Overall Study|Lost to Follow-up|5
1470594|NCT00686725|4846846|P1|Overall Study|Lost to Follow-up|7
1470595|NCT00686725|4846845|P2|Overall Study|Progressive Disease|23
1470596|NCT00686725|4846846|P1|Overall Study|Progressive Disease|17
1470597|NCT00686725|4846845|P2|Overall Study|Adverse Event|1
1470598|NCT00686725|4846846|P1|Overall Study|Adverse Event|1
1470599|NCT00686712|4846871|P3|Overall Study|Adverse Event|0
1470600|NCT00686712|4846872|P2|Overall Study|Adverse Event|1
1470601|NCT00686712|4846873|P1|Overall Study|Adverse Event|1
1470602|NCT00686712|4846871|P3|Overall Study|Lost to Follow-up|3
1470603|NCT00686712|4846872|P2|Overall Study|Lost to Follow-up|2
1470604|NCT00686712|4846873|P1|Overall Study|Lost to Follow-up|1
1470605|NCT00686712|4846871|P3|Overall Study|Protocol Violation|10
1470606|NCT00686712|4846872|P2|Overall Study|Protocol Violation|8
1470607|NCT00686712|4846873|P1|Overall Study|Protocol Violation|8
1470608|NCT00686699|4846901|P2|Treatment Period 1|Adverse Event|2
1470609|NCT00686699|4846902|P1|Treatment Period 1|Adverse Event|0
1470610|NCT00686686|4846926|P1|Overall Study|Lost to Follow-up|3
1470611|NCT00686686|4846926|P1|Overall Study|Adverse Event|2
1470612|NCT00686686|4846926|P1|Overall Study|Non-compliance|1
1470613|NCT00686647|4846934|P1|Overall Study|Death|1
1470614|NCT00686647|4846934|P1|Overall Study|Lost to Follow-up|1
1470615|NCT00686634|4846940|P1|Overall Study|Protocol Violation|6
1470616|NCT00686595|4846947|P1|Overall Study|Poor Compliance|1
1470617|NCT00686595|4846947|P1|Overall Study|Lack of Efficacy|1
1470618|NCT00686595|4846947|P1|Overall Study|Lost to Follow-up|1
1470619|NCT00686595|4846947|P1|Overall Study|Protocol Violation|1
1470620|NCT00686595|4846947|P1|Overall Study|Adverse Event|3
1470621|NCT00686543|4846976|P4|Overall Study|Protocol Violation|1
1470622|NCT00686543|4846977|P3|Overall Study|Protocol Violation|2
1470623|NCT00686543|4846978|P2|Overall Study|Protocol Violation|0
1470624|NCT00686543|4846979|P1|Overall Study|Protocol Violation|3
1470625|NCT00686543|4846976|P4|Overall Study|Withdrawal by Subject|0
1470626|NCT00686543|4846977|P3|Overall Study|Withdrawal by Subject|0
1470627|NCT00686543|4846978|P2|Overall Study|Withdrawal by Subject|0
1470628|NCT00686543|4846979|P1|Overall Study|Withdrawal by Subject|2
1470629|NCT00686543|4846976|P4|Overall Study|Adverse Event|2
1470630|NCT00686543|4846977|P3|Overall Study|Adverse Event|3
1470631|NCT00686543|4846978|P2|Overall Study|Adverse Event|1
1470632|NCT00686543|4846979|P1|Overall Study|Adverse Event|9
1470633|NCT00686517|4847000|P3|Treatment|Protocol Violation|0
1470634|NCT00686517|4847001|P2|Treatment|Protocol Violation|1
1470635|NCT00686517|4847002|P1|Treatment|Protocol Violation|2
1470636|NCT00686517|4847000|P3|Treatment|Poor Protocol Compliance|0
1470637|NCT00686517|4847001|P2|Treatment|Poor Protocol Compliance|0
1470638|NCT00686517|4847002|P1|Treatment|Poor Protocol Compliance|1
1470639|NCT00686517|4847000|P3|Treatment|Adverse Event|0
1470640|NCT00686517|4847001|P2|Treatment|Adverse Event|0
1470641|NCT00686517|4847002|P1|Treatment|Adverse Event|2
1470642|NCT00686517|4847000|P3|Treatment|Serious Adverse Event|1
1470643|NCT00686517|4847001|P2|Treatment|Serious Adverse Event|2
1470644|NCT00686517|4847002|P1|Treatment|Serious Adverse Event|1
1470645|NCT00686374|4847025|P1|Overall Study|Other, not specified|4
1470646|NCT00686374|4847025|P1|Overall Study|Missing reason|33
1470647|NCT00686374|4847025|P1|Overall Study|Lost to Follow-up|1
1470648|NCT00686374|4847025|P1|Overall Study|Withdrew consent|5
1470649|NCT00686374|4847025|P1|Overall Study|Adverse Event|8
1470650|NCT00686374|4847025|P1|Overall Study|Lack of Efficacy|10
1470651|NCT00686335|4847036|P1|Run-in Period|violation of inclusion/exclusion criteri|3
1470652|NCT00686335|4847036|P1|Run-in Period|asthma exacerbation|1
1470653|NCT00686335|4847036|P1|Run-in Period|Adverse Event|1
1470654|NCT00686205|4847080|P2|Overall Study|Specimens not confirmed HIV positive|981
1470655|NCT00686205|4847081|P1|Overall Study|Specimens not confirmed HIV positive|0
1470656|NCT00686205|4847080|P2|Overall Study|Specimen handling procedure altered|0
1470657|NCT00686205|4847081|P1|Overall Study|Specimen handling procedure altered|5878
1470658|NCT00686205|4847080|P2|Overall Study|Withdrawal by Subject|0
1470659|NCT00686205|4847081|P1|Overall Study|Withdrawal by Subject|2
1470660|NCT00686205|4847080|P2|Overall Study|Protocol Violation|0
1470661|NCT00686205|4847081|P1|Overall Study|Protocol Violation|127
1470662|NCT00686166|4847087|P1|Overall Study|Did not begin protocol therapy|4
1470663|NCT00686166|4847087|P1|Overall Study|Ineligible|5
1470664|NCT00686166|4847087|P1|Overall Study|Not Protocol Specified|1
1470665|NCT00686166|4847087|P1|Overall Study|Death|1
1470666|NCT00686166|4847087|P1|Overall Study|Progression/Relapse|1
1470667|NCT00686166|4847087|P1|Overall Study|Withdrawal by Subject|1
1470668|NCT00686166|4847087|P1|Overall Study|Adverse Event|7
1470669|NCT00686127|4847099|P2|Overall Study|Withdrawal by Subject|6
1470670|NCT00686127|4847100|P1|Overall Study|Withdrawal by Subject|14
1470671|NCT00686075|4847116|P10|Overall Study|Other|1
1470672|NCT00686075|4847117|P9|Overall Study|Other|0
1470673|NCT00686075|4847118|P8|Overall Study|Other|0
1470674|NCT00686075|4847119|P7|Overall Study|Other|0
1470675|NCT00686075|4847120|P6|Overall Study|Other|0
1470676|NCT00686075|4847121|P5|Overall Study|Other|0
1470677|NCT00686075|4847122|P4|Overall Study|Other|0
1470678|NCT00686075|4847123|P3|Overall Study|Other|0
1470679|NCT00686075|4847124|P2|Overall Study|Other|1
1470680|NCT00686075|4847125|P1|Overall Study|Other|1
1470681|NCT00686075|4847116|P10|Overall Study|Lost to Follow-up|3
1470682|NCT00686075|4847117|P9|Overall Study|Lost to Follow-up|2
1470683|NCT00686075|4847118|P8|Overall Study|Lost to Follow-up|0
1470684|NCT00686075|4847119|P7|Overall Study|Lost to Follow-up|0
1470685|NCT00686075|4847120|P6|Overall Study|Lost to Follow-up|3
1470686|NCT00686075|4847121|P5|Overall Study|Lost to Follow-up|3
1470687|NCT00686075|4847122|P4|Overall Study|Lost to Follow-up|2
1470688|NCT00686075|4847123|P3|Overall Study|Lost to Follow-up|3
1470689|NCT00686075|4847124|P2|Overall Study|Lost to Follow-up|6
1470690|NCT00686075|4847125|P1|Overall Study|Lost to Follow-up|3
1470691|NCT00686075|4847116|P10|Overall Study|Withdrawal by Subject|6
1470692|NCT00686075|4847117|P9|Overall Study|Withdrawal by Subject|4
1470693|NCT00686075|4847118|P8|Overall Study|Withdrawal by Subject|2
1470694|NCT00686075|4847119|P7|Overall Study|Withdrawal by Subject|0
1470695|NCT00686075|4847120|P6|Overall Study|Withdrawal by Subject|0
1470696|NCT00686075|4847121|P5|Overall Study|Withdrawal by Subject|1
1470697|NCT00686075|4847122|P4|Overall Study|Withdrawal by Subject|7
1470698|NCT00686075|4847123|P3|Overall Study|Withdrawal by Subject|3
1470699|NCT00686075|4847124|P2|Overall Study|Withdrawal by Subject|3
1470700|NCT00686075|4847125|P1|Overall Study|Withdrawal by Subject|4
1470701|NCT00686036|4847319|P2|Overall Study|Other reasons not identified|4
1470702|NCT00686036|4847320|P1|Overall Study|Other reasons not identified|0
1470703|NCT00686036|4847319|P2|Overall Study|PSA ≥ 10ng/mL|0
1470704|NCT00686036|4847320|P1|Overall Study|PSA ≥ 10ng/mL|1
1470705|NCT00686036|4847319|P2|Overall Study|Study terminated by AstraZeneca|1
1470706|NCT00686036|4847320|P1|Overall Study|Study terminated by AstraZeneca|2
1470707|NCT00686036|4847319|P2|Overall Study|Withdrawal by Subject|1
1470708|NCT00686036|4847320|P1|Overall Study|Withdrawal by Subject|3
1470709|NCT00686036|4847319|P2|Overall Study|Adverse Event|0
1470710|NCT00686036|4847320|P1|Overall Study|Adverse Event|3
1470711|NCT00685945|4847332|P1|L-NMMA + Bradykinin|Physician Decision|1
1470712|NCT00685802|4847367|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1470713|NCT00685802|4847368|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1470714|NCT00685802|4847367|P2|Washout Period of 7 Days|Protocol Violation|0
1470715|NCT00685802|4847368|P1|Washout Period of 7 Days|Protocol Violation|2
1470716|NCT00685763|4847378|P1|Overall Study|Protocol Violation|1
1470717|NCT00685763|4847378|P1|Overall Study|Intercurrent death-incomplete treatment|1
1470718|NCT00685698|4847382|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
1470719|NCT00685698|4847382|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
1470720|NCT00685698|4847382|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
1470721|NCT00685698|4847382|P1|Overall Study|Adverse Event|3
1470722|NCT00685698|4847382|P1|Overall Study|Protocol Violation|6
1470723|NCT00685698|4847382|P1|Overall Study|Withdrawal by Subject|1
1470724|NCT00685685|4847417|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1470725|NCT00685685|4847418|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1470726|NCT00685685|4847417|P2|Washout Period of 7 Days|Adverse Event|0
1470727|NCT00685685|4847418|P1|Washout Period of 7 Days|Adverse Event|2
1470728|NCT00685399|4847571|P8|Extension|Adverse Event|0
1470729|NCT00685399|4847572|P7|Extension|Adverse Event|0
1470730|NCT00685399|4847573|P6|Extension|Adverse Event|0
1470731|NCT00685399|4847574|P5|Extension|Adverse Event|0
1470732|NCT00685399|4847575|P4|Extension|Adverse Event|2
1470733|NCT00685399|4847576|P3|Extension|Adverse Event|0
1470734|NCT00685399|4847577|P2|Extension|Adverse Event|0
1470735|NCT00685399|4847578|P1|Extension|Adverse Event|0
1470736|NCT00685399|4847571|P8|Extension|Lack of Efficacy|0
1470737|NCT00685399|4847572|P7|Extension|Lack of Efficacy|0
1470738|NCT00685399|4847573|P6|Extension|Lack of Efficacy|0
1470739|NCT00685399|4847574|P5|Extension|Lack of Efficacy|0
1470740|NCT00685399|4847575|P4|Extension|Lack of Efficacy|2
1470741|NCT00685399|4847576|P3|Extension|Lack of Efficacy|0
1470742|NCT00685399|4847577|P2|Extension|Lack of Efficacy|0
1470743|NCT00685399|4847578|P1|Extension|Lack of Efficacy|0
1470744|NCT00685399|4847571|P8|Extension|Protocol Violation|0
1470745|NCT00685399|4847572|P7|Extension|Protocol Violation|0
1470746|NCT00685399|4847573|P6|Extension|Protocol Violation|0
1470747|NCT00685399|4847574|P5|Extension|Protocol Violation|0
1470748|NCT00685399|4847575|P4|Extension|Protocol Violation|1
1470749|NCT00685399|4847576|P3|Extension|Protocol Violation|0
1470750|NCT00685399|4847577|P2|Extension|Protocol Violation|0
1470751|NCT00685399|4847578|P1|Extension|Protocol Violation|0
1470752|NCT00685399|4847571|P8|Extension|Withdrawal by Subject|0
1470753|NCT00685399|4847572|P7|Extension|Withdrawal by Subject|0
1470754|NCT00685399|4847573|P6|Extension|Withdrawal by Subject|0
1470755|NCT00685399|4847574|P5|Extension|Withdrawal by Subject|0
1470756|NCT00685399|4847575|P4|Extension|Withdrawal by Subject|1
1470757|NCT00685399|4847576|P3|Extension|Withdrawal by Subject|0
1470758|NCT00685399|4847577|P2|Extension|Withdrawal by Subject|0
1470759|NCT00685399|4847578|P1|Extension|Withdrawal by Subject|0
1470760|NCT00685399|4847571|P8|Extension|Administrative Issues|0
1470761|NCT00685399|4847572|P7|Extension|Administrative Issues|0
1470762|NCT00685399|4847573|P6|Extension|Administrative Issues|0
1470763|NCT00685399|4847574|P5|Extension|Administrative Issues|0
1470764|NCT00685399|4847575|P4|Extension|Administrative Issues|1
1470765|NCT00685399|4847576|P3|Extension|Administrative Issues|0
1470766|NCT00685399|4847577|P2|Extension|Administrative Issues|0
1470767|NCT00685399|4847578|P1|Extension|Administrative Issues|0
1470768|NCT00685399|4847571|P8|Treatment Period 2|Lack of Efficacy|0
1470769|NCT00685399|4847572|P7|Treatment Period 2|Lack of Efficacy|0
1470770|NCT00685399|4847573|P6|Treatment Period 2|Lack of Efficacy|1
1470771|NCT00685399|4847574|P5|Treatment Period 2|Lack of Efficacy|0
1470772|NCT00685399|4847575|P4|Treatment Period 2|Lack of Efficacy|0
1470773|NCT00685399|4847576|P3|Treatment Period 2|Lack of Efficacy|2
1470774|NCT00685399|4847577|P2|Treatment Period 2|Lack of Efficacy|10
1470775|NCT00685399|4847578|P1|Treatment Period 2|Lack of Efficacy|0
1470776|NCT00685399|4847571|P8|Treatment Period 2|Adverse Event|0
1470777|NCT00685399|4847572|P7|Treatment Period 2|Adverse Event|0
1470778|NCT00685399|4847573|P6|Treatment Period 2|Adverse Event|1
1470779|NCT00685399|4847574|P5|Treatment Period 2|Adverse Event|0
1470780|NCT00685399|4847575|P4|Treatment Period 2|Adverse Event|0
1470781|NCT00685399|4847576|P3|Treatment Period 2|Adverse Event|0
1470782|NCT00685399|4847577|P2|Treatment Period 2|Adverse Event|0
1470783|NCT00685399|4847578|P1|Treatment Period 2|Adverse Event|0
1470784|NCT00685399|4847571|P8|Treatment Period 2|Withdrawal by Subject|2
1470785|NCT00685399|4847572|P7|Treatment Period 2|Withdrawal by Subject|0
1470786|NCT00685399|4847573|P6|Treatment Period 2|Withdrawal by Subject|0
1470787|NCT00685399|4847574|P5|Treatment Period 2|Withdrawal by Subject|0
1470788|NCT00685399|4847575|P4|Treatment Period 2|Withdrawal by Subject|0
1470789|NCT00685399|4847576|P3|Treatment Period 2|Withdrawal by Subject|0
1470790|NCT00685399|4847577|P2|Treatment Period 2|Withdrawal by Subject|0
1470791|NCT00685399|4847578|P1|Treatment Period 2|Withdrawal by Subject|0
1470792|NCT00685399|4847571|P8|Treatment Period 2|Administrative Problems|0
1470793|NCT00685399|4847572|P7|Treatment Period 2|Administrative Problems|0
1470794|NCT00685399|4847573|P6|Treatment Period 2|Administrative Problems|0
1470795|NCT00685399|4847574|P5|Treatment Period 2|Administrative Problems|0
1470796|NCT00685399|4847575|P4|Treatment Period 2|Administrative Problems|0
1470797|NCT00685399|4847576|P3|Treatment Period 2|Administrative Problems|1
1470798|NCT00685399|4847577|P2|Treatment Period 2|Administrative Problems|2
1470799|NCT00685399|4847578|P1|Treatment Period 2|Administrative Problems|0
1470800|NCT00685399|4847571|P8|Treatment Period 1|Lack of Efficacy|0
1470801|NCT00685399|4847572|P7|Treatment Period 1|Lack of Efficacy|0
1470802|NCT00685399|4847573|P6|Treatment Period 1|Lack of Efficacy|0
1470803|NCT00685399|4847574|P5|Treatment Period 1|Lack of Efficacy|0
1470804|NCT00685399|4847575|P4|Treatment Period 1|Lack of Efficacy|0
1470805|NCT00685399|4847576|P3|Treatment Period 1|Lack of Efficacy|0
1470806|NCT00685399|4847577|P2|Treatment Period 1|Lack of Efficacy|0
1470807|NCT00685399|4847578|P1|Treatment Period 1|Lack of Efficacy|1
1470808|NCT00685399|4847571|P8|Treatment Period 1|Administrative|0
1470809|NCT00685399|4847572|P7|Treatment Period 1|Administrative|0
1470810|NCT00685399|4847573|P6|Treatment Period 1|Administrative|0
1470811|NCT00685399|4847574|P5|Treatment Period 1|Administrative|0
1470812|NCT00685399|4847575|P4|Treatment Period 1|Administrative|0
1470813|NCT00685399|4847576|P3|Treatment Period 1|Administrative|0
1470814|NCT00685399|4847577|P2|Treatment Period 1|Administrative|0
1470815|NCT00685399|4847578|P1|Treatment Period 1|Administrative|2
1470816|NCT00685399|4847571|P8|Treatment Period 1|Protocol Violation|0
1470817|NCT00685399|4847572|P7|Treatment Period 1|Protocol Violation|0
1470818|NCT00685399|4847573|P6|Treatment Period 1|Protocol Violation|0
1470819|NCT00685399|4847574|P5|Treatment Period 1|Protocol Violation|0
1470820|NCT00685399|4847575|P4|Treatment Period 1|Protocol Violation|0
1470821|NCT00685399|4847576|P3|Treatment Period 1|Protocol Violation|0
1470822|NCT00685399|4847577|P2|Treatment Period 1|Protocol Violation|0
1470823|NCT00685399|4847578|P1|Treatment Period 1|Protocol Violation|1
1470824|NCT00685399|4847571|P8|Treatment Period 1|Withdrawal by Subject|0
1470825|NCT00685399|4847572|P7|Treatment Period 1|Withdrawal by Subject|0
1470826|NCT00685399|4847573|P6|Treatment Period 1|Withdrawal by Subject|0
1470827|NCT00685399|4847574|P5|Treatment Period 1|Withdrawal by Subject|0
1470828|NCT00685399|4847575|P4|Treatment Period 1|Withdrawal by Subject|0
1470829|NCT00685399|4847576|P3|Treatment Period 1|Withdrawal by Subject|0
1470830|NCT00685399|4847577|P2|Treatment Period 1|Withdrawal by Subject|0
1470831|NCT00685399|4847578|P1|Treatment Period 1|Withdrawal by Subject|2
1470832|NCT00685373|4847611|P1|Overall Study|Protocol Violation|1
1470833|NCT00685373|4847611|P1|Overall Study|Lost to Follow-up|2
1470834|NCT00685373|4847611|P1|Overall Study|Condition no longer requires study drug|1
1470835|NCT00685373|4847611|P1|Overall Study|Lack of Efficacy|3
1470836|NCT00685373|4847611|P1|Overall Study|Withdrawal by Subject|5
1470837|NCT00685373|4847611|P1|Overall Study|Adverse Event|3
1470838|NCT00685334|4847620|P2|Overall Study|Chose to enter hospital|1
1470839|NCT00685334|4847621|P1|Overall Study|Chose to enter hospital|1
1470840|NCT00685334|4847620|P2|Overall Study|Lost to Follow-up|0
1470841|NCT00685334|4847621|P1|Overall Study|Lost to Follow-up|4
1470842|NCT00685334|4847620|P2|Overall Study|Withdrawal by Subject|6
1470843|NCT00685334|4847621|P1|Overall Study|Withdrawal by Subject|5
1470844|NCT00685178|4847646|P4|Overall Study|Pregnancy|1
1470845|NCT00685178|4847647|P3|Overall Study|Pregnancy|0
1470846|NCT00685178|4847648|P2|Overall Study|Pregnancy|0
1470847|NCT00685178|4847649|P1|Overall Study|Pregnancy|0
1470848|NCT00685178|4847646|P4|Overall Study|administrative (disciplinary) discharge|2
1470849|NCT00685178|4847647|P3|Overall Study|administrative (disciplinary) discharge|0
1470850|NCT00685178|4847648|P2|Overall Study|administrative (disciplinary) discharge|1
1470851|NCT00685178|4847649|P1|Overall Study|administrative (disciplinary) discharge|0
1470852|NCT00685178|4847646|P4|Overall Study|incarcerated|0
1470853|NCT00685178|4847647|P3|Overall Study|incarcerated|7
1470854|NCT00685178|4847648|P2|Overall Study|incarcerated|3
1470855|NCT00685178|4847649|P1|Overall Study|incarcerated|1
1470856|NCT00685178|4847646|P4|Overall Study|voluntary study discharge|1
1470857|NCT00685178|4847647|P3|Overall Study|voluntary study discharge|1
1470858|NCT00685178|4847648|P2|Overall Study|voluntary study discharge|5
1470859|NCT00685178|4847649|P1|Overall Study|voluntary study discharge|4
1470860|NCT00685178|4847646|P4|Overall Study|missed 3 consecutive methadone clin days|6
1470861|NCT00685178|4847647|P3|Overall Study|missed 3 consecutive methadone clin days|2
1470862|NCT00685178|4847648|P2|Overall Study|missed 3 consecutive methadone clin days|5
1470863|NCT00685178|4847649|P1|Overall Study|missed 3 consecutive methadone clin days|7
1470864|NCT00685178|4847646|P4|Overall Study|Adverse Event|4
1470865|NCT00685178|4847647|P3|Overall Study|Adverse Event|2
1470866|NCT00685178|4847648|P2|Overall Study|Adverse Event|5
1470867|NCT00685178|4847649|P1|Overall Study|Adverse Event|1
1470868|NCT00685165|4847663|P2|Washout Period of 14 Days|Adverse Event|0
1470869|NCT00685165|4847664|P1|Washout Period of 14 Days|Adverse Event|1
1470870|NCT00685035|4847683|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
1470871|NCT00685035|4847684|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
1470872|NCT00684996|4847708|P1|Overall Study|Other reasons not protocol specified|1
1470873|NCT00684996|4847708|P1|Overall Study|Progression/relapse|2
1470874|NCT00684996|4847708|P1|Overall Study|Refusal unrelated to adverse event|1
1470875|NCT00684996|4847708|P1|Overall Study|Adverse Event|1
1470876|NCT00684814|4847740|P2|Second Intervention|Adverse Event|0
1470877|NCT00684814|4847741|P1|Second Intervention|Adverse Event|1
1470878|NCT00684814|4847740|P2|Washout Period of 7 Days|Withdrawal by Subject|2
1470879|NCT00684814|4847741|P1|Washout Period of 7 Days|Withdrawal by Subject|1
1470880|NCT00684814|4847740|P2|Washout Period of 7 Days|Adverse Event|2
1470881|NCT00684814|4847741|P1|Washout Period of 7 Days|Adverse Event|1
1470882|NCT00684762|4847793|P2|Washout Period of 7 Days|Withdrawal by Subject|2
1470883|NCT00684762|4847794|P1|Washout Period of 7 Days|Withdrawal by Subject|2
1470884|NCT00684671|4847822|P3|Overall Study|Alcoholic dependance|0
1470885|NCT00684671|4847823|P2|Overall Study|Alcoholic dependance|0
1470886|NCT00684671|4847824|P1|Overall Study|Alcoholic dependance|1
1470887|NCT00684671|4847822|P3|Overall Study|Lost to Follow-up|0
1470888|NCT00684671|4847823|P2|Overall Study|Lost to Follow-up|0
1470889|NCT00684671|4847824|P1|Overall Study|Lost to Follow-up|1
1470890|NCT00684671|4847822|P3|Overall Study|Adverse Event|0
1470891|NCT00684671|4847823|P2|Overall Study|Adverse Event|0
1470892|NCT00684671|4847824|P1|Overall Study|Adverse Event|1
1470893|NCT00684645|4847853|P1|Overall Study|Not specified|15
1470894|NCT00684645|4847853|P1|Overall Study|Lost to Follow-up|3
1470895|NCT00684645|4847853|P1|Overall Study|Adverse Event|27
1470896|NCT00684645|4847853|P1|Overall Study|Progressive disease|67
1470897|NCT00684645|4847853|P1|Overall Study|Death|2
1470898|NCT00684593|4847873|P2|Overall Study|Adverse Event|2
1470899|NCT00684593|4847874|P1|Overall Study|Adverse Event|0
1470900|NCT00684567|4847886|P1|Monotherapy Period|Progression of primary disease|11
1470901|NCT00684567|4847886|P1|Monotherapy Period|Death|1
1470902|NCT00684567|4847886|P1|Monotherapy Period|Adverse Event|2
1470903|NCT00684567|4847886|P1|Concomitant Radiotherapy Period|Adverse Event|2
1470904|NCT00684515|4847919|P3|Overall Study|Protocol-Defined Clinical Event|0
1470905|NCT00684515|4847920|P2|Overall Study|Protocol-Defined Clinical Event|0
1470906|NCT00684515|4847921|P1|Overall Study|Protocol-Defined Clinical Event|1
1470907|NCT00684515|4847919|P3|Overall Study|Adverse Event|1
1470908|NCT00684515|4847920|P2|Overall Study|Adverse Event|3
1470909|NCT00684515|4847921|P1|Overall Study|Adverse Event|3
1470910|NCT00684424|4847944|P1|Overall Study|Not Specified|2
1470911|NCT00684424|4847944|P1|Overall Study|Lost to Follow-up|2
1470912|NCT00684424|4847944|P1|Overall Study|Adverse Event|1
1470913|NCT00684411|4847959|P1|Overall Study|Adverse Event|1
1470914|NCT00684411|4847959|P1|Overall Study|Disease Progression|10
1470915|NCT00684411|4847959|P1|Overall Study|New Primary Cancer|1
1470916|NCT00684307|4847981|P5|Overall Study|Criteria from the CSR|3
1470917|NCT00684307|4847982|P4|Overall Study|Criteria from the CSR|3
1470918|NCT00684307|4847983|P3|Overall Study|Criteria from the CSR|1
1470919|NCT00684307|4847984|P2|Overall Study|Criteria from the CSR|0
1470920|NCT00684307|4847985|P1|Overall Study|Criteria from the CSR|0
1470921|NCT00684307|4847981|P5|Overall Study|Participant not willing to continue|8
1470922|NCT00684307|4847982|P4|Overall Study|Participant not willing to continue|5
1470923|NCT00684307|4847983|P3|Overall Study|Participant not willing to continue|11
1470924|NCT00684307|4847984|P2|Overall Study|Participant not willing to continue|10
1470925|NCT00684307|4847985|P1|Overall Study|Participant not willing to continue|7
1470926|NCT00684307|4847981|P5|Overall Study|Severe non compliance to protocol|2
1470927|NCT00684307|4847982|P4|Overall Study|Severe non compliance to protocol|1
1470928|NCT00684307|4847983|P3|Overall Study|Severe non compliance to protocol|0
1470929|NCT00684307|4847984|P2|Overall Study|Severe non compliance to protocol|0
1470930|NCT00684307|4847985|P1|Overall Study|Severe non compliance to protocol|1
1470931|NCT00684307|4847981|P5|Overall Study|Interupted IP for more than 7 days|3
1470932|NCT00684307|4847982|P4|Overall Study|Interupted IP for more than 7 days|3
1470933|NCT00684307|4847983|P3|Overall Study|Interupted IP for more than 7 days|1
1470934|NCT00684307|4847984|P2|Overall Study|Interupted IP for more than 7 days|4
1470935|NCT00684307|4847985|P1|Overall Study|Interupted IP for more than 7 days|0
1470936|NCT00684307|4847981|P5|Overall Study|Incorrect enrolment or randomization|0
1470937|NCT00684307|4847982|P4|Overall Study|Incorrect enrolment or randomization|0
1470938|NCT00684307|4847983|P3|Overall Study|Incorrect enrolment or randomization|0
1470939|NCT00684307|4847984|P2|Overall Study|Incorrect enrolment or randomization|0
1470940|NCT00684307|4847985|P1|Overall Study|Incorrect enrolment or randomization|4
1470941|NCT00684307|4847981|P5|Overall Study|Fullfillment of exclusion criteria|1
1470942|NCT00684307|4847982|P4|Overall Study|Fullfillment of exclusion criteria|3
1470943|NCT00684307|4847983|P3|Overall Study|Fullfillment of exclusion criteria|0
1470944|NCT00684307|4847984|P2|Overall Study|Fullfillment of exclusion criteria|0
1470945|NCT00684307|4847985|P1|Overall Study|Fullfillment of exclusion criteria|1
1470946|NCT00684307|4847981|P5|Overall Study|Development of increasing Liver Function|0
1470947|NCT00684307|4847982|P4|Overall Study|Development of increasing Liver Function|1
1470948|NCT00684307|4847983|P3|Overall Study|Development of increasing Liver Function|0
1470949|NCT00684307|4847984|P2|Overall Study|Development of increasing Liver Function|2
1470950|NCT00684307|4847985|P1|Overall Study|Development of increasing Liver Function|0
1470951|NCT00684307|4847981|P5|Overall Study|Adverse Event|8
1470952|NCT00684307|4847982|P4|Overall Study|Adverse Event|16
1470953|NCT00684307|4847983|P3|Overall Study|Adverse Event|15
1470954|NCT00684307|4847984|P2|Overall Study|Adverse Event|6
1470955|NCT00684307|4847985|P1|Overall Study|Adverse Event|11
1470956|NCT00684203|4848067|P6|Overall Study|Did not meet protocol eligibility|0
1470957|NCT00684203|4848068|P5|Overall Study|Did not meet protocol eligibility|0
1470958|NCT00684203|4848069|P4|Overall Study|Did not meet protocol eligibility|0
1470959|NCT00684203|4848070|P3|Overall Study|Did not meet protocol eligibility|0
1470960|NCT00684203|4848071|P2|Overall Study|Did not meet protocol eligibility|1
1470961|NCT00684203|4848072|P1|Overall Study|Did not meet protocol eligibility|0
1470962|NCT00684203|4848067|P6|Overall Study|Withdrawal by Subject|0
1470963|NCT00684203|4848068|P5|Overall Study|Withdrawal by Subject|0
1470964|NCT00684203|4848069|P4|Overall Study|Withdrawal by Subject|0
1470965|NCT00684203|4848070|P3|Overall Study|Withdrawal by Subject|1
1470966|NCT00684203|4848071|P2|Overall Study|Withdrawal by Subject|2
1470967|NCT00684203|4848072|P1|Overall Study|Withdrawal by Subject|0
1470968|NCT00684203|4848067|P6|Overall Study|Protocol-defined clinical event|0
1470969|NCT00684203|4848068|P5|Overall Study|Protocol-defined clinical event|0
1470970|NCT00684203|4848069|P4|Overall Study|Protocol-defined clinical event|0
1470971|NCT00684203|4848070|P3|Overall Study|Protocol-defined clinical event|0
1470972|NCT00684203|4848071|P2|Overall Study|Protocol-defined clinical event|1
1470973|NCT00684203|4848072|P1|Overall Study|Protocol-defined clinical event|3
1470974|NCT00684203|4848067|P6|Overall Study|Adverse Event|0
1470975|NCT00684203|4848068|P5|Overall Study|Adverse Event|0
1470976|NCT00684203|4848069|P4|Overall Study|Adverse Event|0
1470977|NCT00684203|4848070|P3|Overall Study|Adverse Event|8
1470978|NCT00684203|4848071|P2|Overall Study|Adverse Event|4
1470979|NCT00684203|4848072|P1|Overall Study|Adverse Event|6
1470980|NCT00684177|4848133|P2|Overall Study|Other|2
1470981|NCT00684177|4848134|P1|Overall Study|Other|1
1470982|NCT00684177|4848133|P2|Overall Study|Withdrawal by Subject|2
1470983|NCT00684177|4848134|P1|Overall Study|Withdrawal by Subject|1
1470984|NCT00684177|4848133|P2|Overall Study|Physician Decision|0
1470985|NCT00684177|4848134|P1|Overall Study|Physician Decision|2
1470986|NCT00684177|4848133|P2|Overall Study|Lost to Follow-up|1
1470987|NCT00684177|4848134|P1|Overall Study|Lost to Follow-up|2
1470988|NCT00684177|4848133|P2|Overall Study|Protocol Violation|0
1470989|NCT00684177|4848134|P1|Overall Study|Protocol Violation|1
1470990|NCT00684177|4848133|P2|Overall Study|Lack of Efficacy|15
1470991|NCT00684177|4848134|P1|Overall Study|Lack of Efficacy|10
1470992|NCT00684177|4848133|P2|Overall Study|Adverse Event|3
1470993|NCT00684177|4848134|P1|Overall Study|Adverse Event|4
1470994|NCT00684073|4848169|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
1470995|NCT00684073|4848169|P1|Selection|request of the sponsor|1
1470996|NCT00684073|4848169|P1|Selection|Lost to Follow-up|1
1470997|NCT00684073|4848169|P1|Selection|noncompliance|1
1470998|NCT00684073|4848169|P1|Selection|Death|1
1470999|NCT00684073|4848169|P1|Selection|Selection/non-selection criteria|3
1471000|NCT00684060|4848179|P2|Overall Study|Death|1
1471001|NCT00684060|4848180|P1|Overall Study|Death|0
1471002|NCT00684060|4848179|P2|Overall Study|Unable to collect MRI|2
1471003|NCT00684060|4848180|P1|Overall Study|Unable to collect MRI|1
1471004|NCT00684060|4848179|P2|Overall Study|New stenosis identified|0
1471005|NCT00684060|4848180|P1|Overall Study|New stenosis identified|1
1471006|NCT00684060|4848179|P2|Overall Study|Lost to Follow-up|0
1471007|NCT00684060|4848180|P1|Overall Study|Lost to Follow-up|1
1471008|NCT00684021|4848219|P4|Overall Study|Death|0
1471009|NCT00684021|4848220|P3|Overall Study|Death|0
1471010|NCT00684021|4848221|P2|Overall Study|Death|0
1471011|NCT00684021|4848222|P1|Overall Study|Death|1
1471012|NCT00684021|4848219|P4|Overall Study|MRI not performed|2
1471013|NCT00684021|4848220|P3|Overall Study|MRI not performed|1
1471014|NCT00684021|4848221|P2|Overall Study|MRI not performed|1
1471015|NCT00684021|4848222|P1|Overall Study|MRI not performed|0
1471016|NCT00684021|4848219|P4|Overall Study|MRI Contraindicated|0
1471017|NCT00684021|4848220|P3|Overall Study|MRI Contraindicated|1
1471018|NCT00684021|4848221|P2|Overall Study|MRI Contraindicated|1
1471019|NCT00684021|4848222|P1|Overall Study|MRI Contraindicated|1
1471020|NCT00683917|4848283|P1|Overall Study|Study prematurely terminated|10
1471021|NCT00683904|4848293|P2|Dose Level 2|Adverse Event|2
1471022|NCT00683904|4848294|P1|Dose Level 2|Adverse Event|0
1471023|NCT00683904|4848293|P2|Dose Level 1|Adverse Event|0
1471024|NCT00683904|4848294|P1|Dose Level 1|Adverse Event|1
1471025|NCT00683904|4848293|P2|Dose Level 1|Disease progression|0
1471026|NCT00683904|4848294|P1|Dose Level 1|Disease progression|2
1471027|NCT00683878|4848330|P3|Overall Study|Non-compliance, not met criteria etc.|0
1471028|NCT00683878|4848331|P2|Overall Study|Non-compliance, not met criteria etc.|2
1471029|NCT00683878|4848332|P1|Overall Study|Non-compliance, not met criteria etc.|3
1471030|NCT00683878|4848330|P3|Overall Study|Lost to Follow-up|4
1471031|NCT00683878|4848331|P2|Overall Study|Lost to Follow-up|2
1471032|NCT00683878|4848332|P1|Overall Study|Lost to Follow-up|4
1471033|NCT00683878|4848330|P3|Overall Study|Death|0
1471034|NCT00683878|4848331|P2|Overall Study|Death|1
1471035|NCT00683878|4848332|P1|Overall Study|Death|0
1471036|NCT00683878|4848330|P3|Overall Study|Withdrawal by Subject|6
1471037|NCT00683878|4848331|P2|Overall Study|Withdrawal by Subject|8
1471038|NCT00683878|4848332|P1|Overall Study|Withdrawal by Subject|9
1471039|NCT00683878|4848330|P3|Overall Study|Adverse Event|3
1471040|NCT00683878|4848331|P2|Overall Study|Adverse Event|3
1471041|NCT00683878|4848332|P1|Overall Study|Adverse Event|4
1471042|NCT00683878|4848330|P3|Overall Study|Lack of Efficacy|1
1471043|NCT00683878|4848331|P2|Overall Study|Lack of Efficacy|0
1471044|NCT00683878|4848332|P1|Overall Study|Lack of Efficacy|3
1471045|NCT00683800|4848406|P2|Overall Study|Randomized, not treated|33
1471046|NCT00683800|4848407|P1|Overall Study|Randomized, not treated|35
1471047|NCT00683800|4848406|P2|Overall Study|Lack of Efficacy|104
1471048|NCT00683800|4848407|P1|Overall Study|Lack of Efficacy|61
1471049|NCT00683800|4848406|P2|Overall Study|Withdrawal by Subject|64
1471050|NCT00683800|4848407|P1|Overall Study|Withdrawal by Subject|66
1471051|NCT00683800|4848406|P2|Overall Study|Protocol Violation|16
1471052|NCT00683800|4848407|P1|Overall Study|Protocol Violation|13
1471053|NCT00683800|4848406|P2|Overall Study|Other|2
1471054|NCT00683800|4848407|P1|Overall Study|Other|5
1471055|NCT00683800|4848406|P2|Overall Study|Lost to Follow-up|44
1471056|NCT00683800|4848407|P1|Overall Study|Lost to Follow-up|57
1471057|NCT00683800|4848406|P2|Overall Study|Death|1
1471058|NCT00683800|4848407|P1|Overall Study|Death|0
1471059|NCT00683800|4848406|P2|Overall Study|Adverse Event|102
1471060|NCT00683800|4848407|P1|Overall Study|Adverse Event|195
1471061|NCT00683787|4848474|P3|Overall Study|Adverse Event|2
1471062|NCT00683787|4848475|P2|Overall Study|Adverse Event|0
1471063|NCT00683787|4848476|P1|Overall Study|Adverse Event|0
1471064|NCT00683787|4848474|P3|Overall Study|Progression|0
1471065|NCT00683787|4848475|P2|Overall Study|Progression|3
1471066|NCT00683787|4848476|P1|Overall Study|Progression|3
1471067|NCT00683774|4848495|P2|Overall Study|Physician Decision|0
1471068|NCT00683774|4848496|P1|Overall Study|Physician Decision|3
1471069|NCT00683774|4848495|P2|Overall Study|Withdrawal by Subject|1
1471070|NCT00683774|4848496|P1|Overall Study|Withdrawal by Subject|0
1471071|NCT00683696|4848506|P2|Overall Study|Death|30
1471072|NCT00683696|4848507|P1|Overall Study|Death|46
1471073|NCT00683696|4848506|P2|Overall Study|Vital status follow-up only|3
1471074|NCT00683696|4848507|P1|Overall Study|Vital status follow-up only|3
1471075|NCT00683696|4848506|P2|Overall Study|Lost to Follow-up|6
1471076|NCT00683696|4848507|P1|Overall Study|Lost to Follow-up|5
1471077|NCT00683696|4848506|P2|Overall Study|Withdrawn prior to study closure|28
1471078|NCT00683696|4848507|P1|Overall Study|Withdrawn prior to study closure|13
1471079|NCT00683696|4848506|P2|Overall Study|Withdrawn due to study closure|338
1471080|NCT00683696|4848507|P1|Overall Study|Withdrawn due to study closure|337
1471081|NCT00683657|4848526|P2|Overall Study|Subject Withdrew Consent|0
1471082|NCT00683657|4848527|P1|Overall Study|Subject Withdrew Consent|1
1471083|NCT00683657|4848526|P2|Overall Study|Adverse Event|1
1471084|NCT00683657|4848527|P1|Overall Study|Adverse Event|0
1471085|NCT00683644|4848543|P2|Overall Study|Low copper, other health problems,|6
1471086|NCT00683644|4848544|P1|Overall Study|Low copper, other health problems,|7
1471087|NCT00683644|4848543|P2|Overall Study|Adverse Event|2
1471088|NCT00683644|4848544|P1|Overall Study|Adverse Event|1
1471089|NCT00683644|4848543|P2|Overall Study|Lost to Follow-up|4
1471090|NCT00683644|4848544|P1|Overall Study|Lost to Follow-up|1
1471091|NCT00683644|4848543|P2|Overall Study|Withdrawal by Subject|2
1471092|NCT00683644|4848544|P1|Overall Study|Withdrawal by Subject|4
1471093|NCT00683618|4848557|P3|Extension Treatment Period|Protocol Violation|0
1471094|NCT00683618|4848558|P2|Extension Treatment Period|Protocol Violation|0
1471095|NCT00683618|4848559|P1|Extension Treatment Period|Protocol Violation|1
1471096|NCT00683618|4848557|P3|Extension Treatment Period|Adverse Event|0
1471097|NCT00683618|4848558|P2|Extension Treatment Period|Adverse Event|0
1471098|NCT00683618|4848559|P1|Extension Treatment Period|Adverse Event|1
1471099|NCT00683618|4848557|P3|Extension Treatment Period|Withdrawal by Subject|0
1471100|NCT00683618|4848558|P2|Extension Treatment Period|Withdrawal by Subject|0
1471101|NCT00683618|4848559|P1|Extension Treatment Period|Withdrawal by Subject|1
1471102|NCT00683618|4848557|P3|Randomised Treatment Period|Reason not provided|2
1471103|NCT00683618|4848558|P2|Randomised Treatment Period|Reason not provided|0
1471104|NCT00683618|4848559|P1|Randomised Treatment Period|Reason not provided|0
1471105|NCT00683618|4848557|P3|Randomised Treatment Period|Adverse Event|2
1471106|NCT00683618|4848558|P2|Randomised Treatment Period|Adverse Event|0
1471107|NCT00683618|4848559|P1|Randomised Treatment Period|Adverse Event|2
1471108|NCT00683618|4848557|P3|Randomised Treatment Period|Protocol Violation|0
1471109|NCT00683618|4848558|P2|Randomised Treatment Period|Protocol Violation|1
1471110|NCT00683618|4848559|P1|Randomised Treatment Period|Protocol Violation|0
1471111|NCT00683618|4848557|P3|Randomised Treatment Period|Withdrawal by Subject|2
1471112|NCT00683618|4848558|P2|Randomised Treatment Period|Withdrawal by Subject|1
1471113|NCT00683618|4848559|P1|Randomised Treatment Period|Withdrawal by Subject|4
1471114|NCT00683592|4848609|P2|Overall Study|Other|1
1471115|NCT00683592|4848610|P1|Overall Study|Other|1
1471116|NCT00683592|4848609|P2|Overall Study|Non-compliance|5
1471117|NCT00683592|4848610|P1|Overall Study|Non-compliance|3
1471118|NCT00683592|4848609|P2|Overall Study|Physician Decision|1
1471119|NCT00683592|4848610|P1|Overall Study|Physician Decision|0
1471120|NCT00683592|4848609|P2|Overall Study|Lack of Efficacy|7
1471121|NCT00683592|4848610|P1|Overall Study|Lack of Efficacy|3
1471122|NCT00683592|4848609|P2|Overall Study|Lost to Follow-up|17
1471123|NCT00683592|4848610|P1|Overall Study|Lost to Follow-up|17
1471124|NCT00683592|4848609|P2|Overall Study|Withdrawal by Subject|11
1471125|NCT00683592|4848610|P1|Overall Study|Withdrawal by Subject|11
1471126|NCT00683592|4848609|P2|Overall Study|Adverse Event|4
1471127|NCT00683592|4848610|P1|Overall Study|Adverse Event|12
1471128|NCT00683475|4848628|P2|Overall Study|Never Treated: Progressive Disease|0
1471129|NCT00683475|4848629|P1|Overall Study|Never Treated: Progressive Disease|1
1471130|NCT00683475|4848628|P2|Overall Study|Never Treated: Adverse Event|3
1471131|NCT00683475|4848629|P1|Overall Study|Never Treated: Adverse Event|2
1471132|NCT00683475|4848628|P2|Overall Study|Withdrawal by Subject|0
1471133|NCT00683475|4848629|P1|Overall Study|Withdrawal by Subject|1
1471134|NCT00683449|4848664|P5|Overall Study|Lost to Follow-up|0
1471135|NCT00683449|4848665|P4|Overall Study|Lost to Follow-up|0
1471136|NCT00683449|4848666|P3|Overall Study|Lost to Follow-up|0
1471137|NCT00683449|4848667|P2|Overall Study|Lost to Follow-up|1
1471138|NCT00683449|4848668|P1|Overall Study|Lost to Follow-up|0
1471139|NCT00683384|4848694|P1|Overall Study|Adverse Event|1
1471140|NCT00683384|4848694|P1|Overall Study|Death|1
1471141|NCT00683293|4848704|P2|Overall Study|Withdrawal by Subject|3
1471142|NCT00683293|4848705|P1|Overall Study|Withdrawal by Subject|2
1471143|NCT00682929|4848768|P3|Overall Study|lag in DEA renewal|0
1471144|NCT00682929|4848769|P2|Overall Study|lag in DEA renewal|0
1471145|NCT00682929|4848770|P1|Overall Study|lag in DEA renewal|1
1471146|NCT00682929|4848768|P3|Overall Study|dosing compliance < 80%|0
1471147|NCT00682929|4848769|P2|Overall Study|dosing compliance < 80%|2
1471148|NCT00682929|4848770|P1|Overall Study|dosing compliance < 80%|0
1471149|NCT00682929|4848768|P3|Overall Study|Withdrawal by Subject|1
1471150|NCT00682929|4848769|P2|Overall Study|Withdrawal by Subject|2
1471151|NCT00682929|4848770|P1|Overall Study|Withdrawal by Subject|1
1471152|NCT00682929|4848768|P3|Overall Study|Adverse Event|1
1471153|NCT00682929|4848769|P2|Overall Study|Adverse Event|1
1471154|NCT00682929|4848770|P1|Overall Study|Adverse Event|4
1471155|NCT00682890|4848939|P2|Overall Study|heavy menstrual bleeding|0
1471156|NCT00682890|4848940|P1|Overall Study|heavy menstrual bleeding|1
1471157|NCT00682890|4848939|P2|Overall Study|subject moved away|1
1471158|NCT00682890|4848940|P1|Overall Study|subject moved away|0
1471159|NCT00682890|4848939|P2|Overall Study|Lost to Follow-up|1
1471160|NCT00682890|4848940|P1|Overall Study|Lost to Follow-up|1
1471161|NCT00682786|4848982|P2|Overall Study|Did not receive irinotecan|1
1471162|NCT00682786|4848983|P1|Overall Study|Did not receive irinotecan|0
1471163|NCT00682786|4848982|P2|Overall Study|Withdrawal by Subject|2
1471164|NCT00682786|4848983|P1|Overall Study|Withdrawal by Subject|2
1471165|NCT00682643|4849032|P2|Overall Study|Did Not Receive Study Drug|1
1471166|NCT00682643|4849033|P1|Overall Study|Did Not Receive Study Drug|1
1471167|NCT00682643|4849032|P2|Overall Study|Withdrawal by Subject|53
1471168|NCT00682643|4849033|P1|Overall Study|Withdrawal by Subject|19
1471169|NCT00682643|4849032|P2|Overall Study|Physician Decision|6
1471170|NCT00682643|4849033|P1|Overall Study|Physician Decision|2
1471171|NCT00682643|4849032|P2|Overall Study|Lost to Follow-up|6
1471172|NCT00682643|4849033|P1|Overall Study|Lost to Follow-up|1
1471173|NCT00682643|4849032|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
1471174|NCT00682643|4849033|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
1471175|NCT00682643|4849032|P2|Overall Study|Protocol Violation|76
1471176|NCT00682643|4849033|P1|Overall Study|Protocol Violation|38
1471177|NCT00682643|4849032|P2|Overall Study|Lack of Efficacy|0
1471178|NCT00682643|4849033|P1|Overall Study|Lack of Efficacy|2
1471179|NCT00682643|4849032|P2|Overall Study|Adverse Event|23
1471180|NCT00682643|4849033|P1|Overall Study|Adverse Event|12
1471181|NCT00682539|4849094|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
1471182|NCT00682539|4849095|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
1471183|NCT00682539|4849096|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
1471184|NCT00682539|4849094|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
1471185|NCT00682539|4849095|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
1471186|NCT00682539|4849096|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
1471187|NCT00682461|4849109|P2|Overall Study|Withdrawal by Subject|19
1471188|NCT00682461|4849110|P1|Overall Study|Withdrawal by Subject|12
1471189|NCT00682461|4849109|P2|Overall Study|Lost to Follow-up|5
1471190|NCT00682461|4849110|P1|Overall Study|Lost to Follow-up|8
1471191|NCT00682461|4849109|P2|Overall Study|Adverse Event|7
1471192|NCT00682461|4849110|P1|Overall Study|Adverse Event|5
1471193|NCT00682435|4849124|P1|Overall Study|Erroneously enrolled twice|2
1471194|NCT00682435|4849124|P1|Overall Study|Insufficient data|5
1471195|NCT00681863|4849157|P1|Overall Study|not specified|18
1471196|NCT00681863|4849157|P1|Overall Study|Lack of Efficacy|2
1471197|NCT00681863|4849157|P1|Overall Study|Lost to Follow-up|2
1471198|NCT00681863|4849157|P1|Overall Study|Adverse Event|1
1471199|NCT00681824|4849205|P3|Overall Study|Death|0
1471200|NCT00681824|4849206|P2|Overall Study|Death|1
1471201|NCT00681824|4849207|P1|Overall Study|Death|0
1471202|NCT00681824|4849205|P3|Overall Study|scheduling conflict|0
1471203|NCT00681824|4849206|P2|Overall Study|scheduling conflict|0
1471204|NCT00681824|4849207|P1|Overall Study|scheduling conflict|1
1471205|NCT00681824|4849205|P3|Overall Study|withdrawn by investigator|1
1471206|NCT00681824|4849206|P2|Overall Study|withdrawn by investigator|0
1471207|NCT00681824|4849207|P1|Overall Study|withdrawn by investigator|0
1471208|NCT00681811|4849225|P2|Overall Study|Non-compliance|1
1471209|NCT00681811|4849226|P1|Overall Study|Non-compliance|0
1471210|NCT00681811|4849225|P2|Overall Study|Withdrawal by Subject|2
1471211|NCT00681811|4849226|P1|Overall Study|Withdrawal by Subject|2
1471212|NCT00681811|4849225|P2|Overall Study|Adverse Event|1
1471213|NCT00681811|4849226|P1|Overall Study|Adverse Event|1
1471214|NCT00681668|4849254|P1|Overall Study|Withdrawal by Subject|1
1471215|NCT00681668|4849254|P1|Overall Study|Protocol Violation|1
1471216|NCT00681629|4849263|P2|Overall Study|Adverse Event|0
1471217|NCT00681629|4849264|P1|Overall Study|Adverse Event|1
1471218|NCT00681629|4849263|P2|Overall Study|Study termination|2
1471219|NCT00681629|4849264|P1|Overall Study|Study termination|4
1471220|NCT00681590|4849310|P2|Overall Study|Withdrawal by Subject|12
1471221|NCT00681590|4849311|P1|Overall Study|Withdrawal by Subject|2
1471222|NCT00681564|4849321|P2|Overall Study|Death|1
1471223|NCT00681564|4849322|P1|Overall Study|Death|0
1471224|NCT00681564|4849321|P2|Overall Study|Withdrawal by Subject|1
1471225|NCT00681564|4849322|P1|Overall Study|Withdrawal by Subject|0
1471226|NCT00681564|4849321|P2|Overall Study|Lost to Follow-up|6
1471227|NCT00681564|4849322|P1|Overall Study|Lost to Follow-up|6
1471228|NCT00681187|4849414|P2|Overall Study|Adverse Event|1
1471229|NCT00681187|4849415|P1|Overall Study|Adverse Event|0
1471230|NCT00681187|4849414|P2|Overall Study|Death|1
1471231|NCT00681187|4849415|P1|Overall Study|Death|0
1471232|NCT00681187|4849414|P2|Overall Study|Withdrawal by Subject|0
1471233|NCT00681187|4849415|P1|Overall Study|Withdrawal by Subject|1
1471234|NCT00681109|4849450|P3|Overall Study|Lost to Follow-up|0
1471235|NCT00681109|4849451|P2|Overall Study|Lost to Follow-up|6
1471236|NCT00681109|4849452|P1|Overall Study|Lost to Follow-up|2
1471237|NCT00680914|4849502|P2|Overall Study|serious adverse event (SAE)|1
1471238|NCT00680914|4849503|P1|Overall Study|serious adverse event (SAE)|0
1471239|NCT00680914|4849502|P2|Overall Study|Lost to Follow-up|0
1471240|NCT00680914|4849503|P1|Overall Study|Lost to Follow-up|4
1471241|NCT00680914|4849502|P2|Overall Study|Consent withdrawal|3
1471242|NCT00680914|4849503|P1|Overall Study|Consent withdrawal|6
1471243|NCT00680901|4849537|P2|Overall Study|Ongoing: In Follow Up|41
1471244|NCT00680901|4849538|P1|Overall Study|Ongoing: In Follow Up|45
1471245|NCT00680901|4849537|P2|Overall Study|Ongoing: On Study Treatment|13
1471246|NCT00680901|4849538|P1|Overall Study|Ongoing: On Study Treatment|16
1471247|NCT00680901|4849537|P2|Overall Study|Physician Decision|1
1471248|NCT00680901|4849538|P1|Overall Study|Physician Decision|0
1471249|NCT00680901|4849537|P2|Overall Study|Withdrawal by Subject|13
1471250|NCT00680901|4849538|P1|Overall Study|Withdrawal by Subject|4
1471251|NCT00680901|4849537|P2|Overall Study|Lost to Follow-up|8
1471252|NCT00680901|4849538|P1|Overall Study|Lost to Follow-up|8
1471253|NCT00680836|4849576|P2|Overall Study|Physician Decision|1
1471254|NCT00680836|4849577|P1|Overall Study|Physician Decision|2
1471255|NCT00680836|4849576|P2|Overall Study|Lost to Follow-up|1
1471256|NCT00680836|4849577|P1|Overall Study|Lost to Follow-up|3
1471257|NCT00680836|4849576|P2|Overall Study|Withdrawal by Subject|0
1471258|NCT00680836|4849577|P1|Overall Study|Withdrawal by Subject|3
1471259|NCT00680771|4849631|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
1471260|NCT00680771|4849632|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
1471261|NCT00680771|4849631|P2|Overall Study|Sleep Apnea suspected after PSG|0
1471262|NCT00680771|4849632|P1|Overall Study|Sleep Apnea suspected after PSG|1
1471263|NCT00680771|4849631|P2|Overall Study|Withdrawal by Subject|0
1471264|NCT00680771|4849632|P1|Overall Study|Withdrawal by Subject|1
1471265|NCT00680745|4849642|P4|Overall Study|False Treatment|0
1471266|NCT00680745|4849643|P3|Overall Study|False Treatment|3
1471267|NCT00680745|4849644|P2|Overall Study|False Treatment|1
1471268|NCT00680745|4849645|P1|Overall Study|False Treatment|0
1471269|NCT00680745|4849642|P4|Overall Study|Subject No Longer Meets Study Criteria|2
1471270|NCT00680745|4849643|P3|Overall Study|Subject No Longer Meets Study Criteria|0
1471271|NCT00680745|4849644|P2|Overall Study|Subject No Longer Meets Study Criteria|2
1471272|NCT00680745|4849645|P1|Overall Study|Subject No Longer Meets Study Criteria|0
1471273|NCT00680745|4849642|P4|Overall Study|Poor/Non-compliance|0
1471274|NCT00680745|4849643|P3|Overall Study|Poor/Non-compliance|0
1471275|NCT00680745|4849644|P2|Overall Study|Poor/Non-compliance|3
1471276|NCT00680745|4849645|P1|Overall Study|Poor/Non-compliance|0
1471277|NCT00680745|4849642|P4|Overall Study|Adverse Event|3
1471278|NCT00680745|4849643|P3|Overall Study|Adverse Event|3
1471279|NCT00680745|4849644|P2|Overall Study|Adverse Event|3
1471280|NCT00680745|4849645|P1|Overall Study|Adverse Event|5
1471281|NCT00680745|4849642|P4|Overall Study|Death|0
1471282|NCT00680745|4849643|P3|Overall Study|Death|1
1471283|NCT00680745|4849644|P2|Overall Study|Death|0
1471284|NCT00680745|4849645|P1|Overall Study|Death|1
1471285|NCT00680745|4849642|P4|Overall Study|Lost to Follow-up|0
1471286|NCT00680745|4849643|P3|Overall Study|Lost to Follow-up|1
1471287|NCT00680745|4849644|P2|Overall Study|Lost to Follow-up|1
1471288|NCT00680745|4849645|P1|Overall Study|Lost to Follow-up|0
1471289|NCT00680745|4849642|P4|Overall Study|Withdrawal by Subject|8
1471290|NCT00680745|4849643|P3|Overall Study|Withdrawal by Subject|2
1471291|NCT00680745|4849644|P2|Overall Study|Withdrawal by Subject|3
1471292|NCT00680745|4849645|P1|Overall Study|Withdrawal by Subject|8
1471293|NCT00680407|4849719|P3|Overall Study|Withdrawal by Subject|2
1471294|NCT00680407|4849720|P2|Overall Study|Withdrawal by Subject|2
1471295|NCT00680407|4849721|P1|Overall Study|Withdrawal by Subject|5
1471296|NCT00680407|4849719|P3|Overall Study|Lost to Follow-up|1
1471297|NCT00680407|4849720|P2|Overall Study|Lost to Follow-up|3
1471298|NCT00680407|4849721|P1|Overall Study|Lost to Follow-up|3
1471299|NCT00680368|4849735|P1|Overall Study|not supervised, not eligible|15
1471300|NCT00680186|4849763|P2|Overall Study|Other|1
1471301|NCT00680186|4849764|P1|Overall Study|Other|4
1471302|NCT00680186|4849763|P2|Overall Study|Withdrawal by Subject|39
1471303|NCT00680186|4849764|P1|Overall Study|Withdrawal by Subject|32
1471304|NCT00680186|4849763|P2|Overall Study|Lost to Follow-up|6
1471305|NCT00680186|4849764|P1|Overall Study|Lost to Follow-up|11
1471306|NCT00680186|4849763|P2|Overall Study|Protocol Violation|26
1471307|NCT00680186|4849764|P1|Overall Study|Protocol Violation|31
1471308|NCT00680186|4849763|P2|Overall Study|Adverse Event|44
1471309|NCT00680186|4849764|P1|Overall Study|Adverse Event|47
1471310|NCT00680121|4849790|P2|Overall Study|Lost to Follow-up|23
1471311|NCT00680121|4849791|P1|Overall Study|Lost to Follow-up|27
1471312|NCT00680056|4849805|P2|Second Intervention|Protocol Violation|1
1471313|NCT00680056|4849806|P1|Second Intervention|Protocol Violation|3
1471314|NCT00680056|4849805|P2|First Intervention|Mainly Exacerbation of COPD|2
1471315|NCT00680056|4849806|P1|First Intervention|Mainly Exacerbation of COPD|1
1471316|NCT00680043|4849817|P3|Overall Study|Renal Transplant|4
1471317|NCT00680043|4849818|P2|Overall Study|Renal Transplant|0
1471318|NCT00680043|4849819|P1|Overall Study|Renal Transplant|1
1471319|NCT00680043|4849817|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
1471320|NCT00680043|4849818|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
1471321|NCT00680043|4849819|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
1471322|NCT00680043|4849817|P3|Overall Study|Withdrawal by Subject|0
1471323|NCT00680043|4849818|P2|Overall Study|Withdrawal by Subject|0
1471324|NCT00680043|4849819|P1|Overall Study|Withdrawal by Subject|1
1471325|NCT00680017|4849835|P2|Overall Study|Lost to Follow-up|0
1471326|NCT00680017|4849836|P1|Overall Study|Lost to Follow-up|2
1471327|NCT00680017|4849835|P2|Overall Study|Withdrawal by Subject|5
1471328|NCT00680017|4849836|P1|Overall Study|Withdrawal by Subject|2
1471329|NCT00680017|4849835|P2|Overall Study|Adverse Event|7
1471330|NCT00680017|4849836|P1|Overall Study|Adverse Event|13
1471331|NCT00679939|4849855|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
1471332|NCT00679939|4849856|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
1471333|NCT00679939|4849855|P2|24-Week Open-Label (OL) Period|Physician Decision|0
1471334|NCT00679939|4849856|P1|24-Week Open-Label (OL) Period|Physician Decision|1
1471335|NCT00679939|4849855|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
1471336|NCT00679939|4849856|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
1471337|NCT00679939|4849855|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
1471338|NCT00679939|4849856|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
1471339|NCT00679939|4849855|P2|24-Week Open-Label (OL) Period|Adverse Event|1
1471340|NCT00679939|4849856|P1|24-Week Open-Label (OL) Period|Adverse Event|0
1471341|NCT00679939|4849855|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
1471342|NCT00679939|4849856|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
1471343|NCT00679939|4849855|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
1471344|NCT00679939|4849856|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
1471345|NCT00679939|4849855|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
1471346|NCT00679939|4849856|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
1471347|NCT00679939|4849855|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
1471348|NCT00679939|4849856|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
1471349|NCT00679939|4849855|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
1471350|NCT00679939|4849856|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
1471351|NCT00679913|4850007|P2|Overall Study|Protocol Violation|13
1471352|NCT00679913|4850008|P1|Overall Study|Protocol Violation|18
1471353|NCT00679783|4850023|P7|Overall Study|Ongoing at data cut-off|0
1471354|NCT00679783|4850024|P6|Overall Study|Ongoing at data cut-off|0
1471355|NCT00679783|4850025|P5|Overall Study|Ongoing at data cut-off|1
1471356|NCT00679783|4850026|P4|Overall Study|Ongoing at data cut-off|9
1471357|NCT00679783|4850027|P3|Overall Study|Ongoing at data cut-off|0
1471358|NCT00679783|4850028|P2|Overall Study|Ongoing at data cut-off|2
1471359|NCT00679783|4850029|P1|Overall Study|Ongoing at data cut-off|2
1471360|NCT00679783|4850023|P7|Overall Study|Not Captured|0
1471361|NCT00679783|4850024|P6|Overall Study|Not Captured|0
1471362|NCT00679783|4850025|P5|Overall Study|Not Captured|0
1471363|NCT00679783|4850026|P4|Overall Study|Not Captured|5
1471364|NCT00679783|4850027|P3|Overall Study|Not Captured|0
1471365|NCT00679783|4850028|P2|Overall Study|Not Captured|0
1471366|NCT00679783|4850029|P1|Overall Study|Not Captured|0
1471367|NCT00679783|4850023|P7|Overall Study|Withdrawal by Subject|0
1471368|NCT00679783|4850024|P6|Overall Study|Withdrawal by Subject|0
1471369|NCT00679783|4850025|P5|Overall Study|Withdrawal by Subject|0
1471370|NCT00679783|4850026|P4|Overall Study|Withdrawal by Subject|1
1471371|NCT00679783|4850027|P3|Overall Study|Withdrawal by Subject|1
1471372|NCT00679783|4850028|P2|Overall Study|Withdrawal by Subject|0
1471373|NCT00679783|4850029|P1|Overall Study|Withdrawal by Subject|0
1471374|NCT00679783|4850023|P7|Overall Study|Lack of Efficacy|0
1471375|NCT00679783|4850024|P6|Overall Study|Lack of Efficacy|0
1471376|NCT00679783|4850025|P5|Overall Study|Lack of Efficacy|0
1471377|NCT00679783|4850026|P4|Overall Study|Lack of Efficacy|2
1471378|NCT00679783|4850027|P3|Overall Study|Lack of Efficacy|0
1471379|NCT00679783|4850028|P2|Overall Study|Lack of Efficacy|1
1471380|NCT00679783|4850029|P1|Overall Study|Lack of Efficacy|0
1471381|NCT00679783|4850023|P7|Overall Study|Adverse Event|1
1471382|NCT00679783|4850024|P6|Overall Study|Adverse Event|0
1471383|NCT00679783|4850025|P5|Overall Study|Adverse Event|0
1471384|NCT00679783|4850026|P4|Overall Study|Adverse Event|3
1471385|NCT00679783|4850027|P3|Overall Study|Adverse Event|0
1471386|NCT00679783|4850028|P2|Overall Study|Adverse Event|0
1471387|NCT00679783|4850029|P1|Overall Study|Adverse Event|0
1471388|NCT00679627|4850082|P2|Overall Study|Early Study Closure|405
1471389|NCT00679627|4850083|P1|Overall Study|Early Study Closure|425
1471390|NCT00679627|4850082|P2|Overall Study|Lost to Follow-up|26
1471391|NCT00679627|4850083|P1|Overall Study|Lost to Follow-up|22
1471392|NCT00679627|4850082|P2|Overall Study|Withdrawal by Subject|172
1471393|NCT00679627|4850083|P1|Overall Study|Withdrawal by Subject|168
1471394|NCT00679627|4850082|P2|Overall Study|Adverse Event|53
1471395|NCT00679627|4850083|P1|Overall Study|Adverse Event|43
1471396|NCT00679627|4850082|P2|Overall Study|Death|29
1471397|NCT00679627|4850083|P1|Overall Study|Death|41
1471398|NCT00679432|4850109|P4|Overall Study|Randomization error, return to prior Rx|0
1471399|NCT00679432|4850110|P3|Overall Study|Randomization error, return to prior Rx|3
1471400|NCT00679432|4850111|P2|Overall Study|Randomization error, return to prior Rx|0
1471401|NCT00679432|4850112|P1|Overall Study|Randomization error, return to prior Rx|0
1471402|NCT00679432|4850109|P4|Overall Study|Infectious colitis, normal histology|3
1471403|NCT00679432|4850110|P3|Overall Study|Infectious colitis, normal histology|8
1471404|NCT00679432|4850111|P2|Overall Study|Infectious colitis, normal histology|4
1471405|NCT00679432|4850112|P1|Overall Study|Infectious colitis, normal histology|5
1471406|NCT00679432|4850109|P4|Overall Study|Lack of Efficacy|8
1471407|NCT00679432|4850110|P3|Overall Study|Lack of Efficacy|14
1471408|NCT00679432|4850111|P2|Overall Study|Lack of Efficacy|9
1471409|NCT00679432|4850112|P1|Overall Study|Lack of Efficacy|13
1471410|NCT00679432|4850109|P4|Overall Study|Sponsor decision|0
1471411|NCT00679432|4850110|P3|Overall Study|Sponsor decision|0
1471412|NCT00679432|4850111|P2|Overall Study|Sponsor decision|0
1471413|NCT00679432|4850112|P1|Overall Study|Sponsor decision|1
1471414|NCT00679432|4850109|P4|Overall Study|Physician Decision|2
1471415|NCT00679432|4850110|P3|Overall Study|Physician Decision|2
1471416|NCT00679432|4850111|P2|Overall Study|Physician Decision|2
1471417|NCT00679432|4850112|P1|Overall Study|Physician Decision|3
1471418|NCT00679432|4850109|P4|Overall Study|Lost to Follow-up|2
1471419|NCT00679432|4850110|P3|Overall Study|Lost to Follow-up|4
1471420|NCT00679432|4850111|P2|Overall Study|Lost to Follow-up|5
1471421|NCT00679432|4850112|P1|Overall Study|Lost to Follow-up|1
1471422|NCT00679432|4850109|P4|Overall Study|Withdrawal by Subject|9
1471423|NCT00679432|4850110|P3|Overall Study|Withdrawal by Subject|10
1471424|NCT00679432|4850111|P2|Overall Study|Withdrawal by Subject|11
1471425|NCT00679432|4850112|P1|Overall Study|Withdrawal by Subject|8
1471426|NCT00679432|4850109|P4|Overall Study|Protocol Violation|1
1471427|NCT00679432|4850110|P3|Overall Study|Protocol Violation|2
1471428|NCT00679432|4850111|P2|Overall Study|Protocol Violation|1
1471429|NCT00679432|4850112|P1|Overall Study|Protocol Violation|1
1471430|NCT00679432|4850109|P4|Overall Study|Adverse Event|7
1471431|NCT00679432|4850110|P3|Overall Study|Adverse Event|10
1471432|NCT00679432|4850111|P2|Overall Study|Adverse Event|6
1471433|NCT00679432|4850112|P1|Overall Study|Adverse Event|5
1471434|NCT00679367|4850155|P1|Overall Study|Withdrawal by Subject|1
1471435|NCT00679367|4850155|P1|Overall Study|Lack of Efficacy|3
1471436|NCT00679367|4850155|P1|Overall Study|inability to swallow oral drugs|1
1471437|NCT00679367|4850155|P1|Overall Study|Adverse Event|7
1471438|NCT00679354|4850161|P1|Overall Study|Ineligible|1
1471439|NCT00679354|4850161|P1|Overall Study|Physician Decision|4
1471440|NCT00679354|4850161|P1|Overall Study|Lack of Efficacy|22
1471441|NCT00679354|4850161|P1|Overall Study|Death|3
1471442|NCT00679341|4850179|P2|Overall Study|Physician/patient decision to withdraw|6
1471443|NCT00679341|4850180|P1|Overall Study|Physician/patient decision to withdraw|0
1471444|NCT00679341|4850179|P2|Overall Study|Not treated|2
1471445|NCT00679341|4850180|P1|Overall Study|Not treated|0
1471446|NCT00679341|4850179|P2|Overall Study|Physician Decision|0
1471447|NCT00679341|4850180|P1|Overall Study|Physician Decision|1
1471448|NCT00679341|4850179|P2|Overall Study|Not specified|0
1471449|NCT00679341|4850180|P1|Overall Study|Not specified|1
1471450|NCT00679341|4850179|P2|Overall Study|Death|1
1471451|NCT00679341|4850180|P1|Overall Study|Death|1
1471452|NCT00679341|4850179|P2|Overall Study|Subject/guardian decision to discontinue|0
1471453|NCT00679341|4850180|P1|Overall Study|Subject/guardian decision to discontinue|3
1471454|NCT00679341|4850179|P2|Overall Study|Adverse Event|6
1471455|NCT00679341|4850180|P1|Overall Study|Adverse Event|5
1471456|NCT00679341|4850179|P2|Overall Study|Disease progression|36
1471457|NCT00679341|4850180|P1|Overall Study|Disease progression|42
1471458|NCT00679302|4850200|P2|Overall Study|Lost to Follow-up|4
1471459|NCT00679302|4850201|P1|Overall Study|Lost to Follow-up|8
1471460|NCT00679289|4850212|P3|Overall Study|Physician Decision|1
1471461|NCT00679289|4850213|P2|Overall Study|Physician Decision|0
1471462|NCT00679289|4850214|P1|Overall Study|Physician Decision|1
1471463|NCT00679289|4850212|P3|Overall Study|Adverse Event|3
1471464|NCT00679289|4850213|P2|Overall Study|Adverse Event|0
1471465|NCT00679289|4850214|P1|Overall Study|Adverse Event|0
1471466|NCT00679289|4850212|P3|Overall Study|Withdrawal by Subject|1
1471467|NCT00679289|4850213|P2|Overall Study|Withdrawal by Subject|1
1471468|NCT00679289|4850214|P1|Overall Study|Withdrawal by Subject|0
1471469|NCT00679289|4850212|P3|Overall Study|Progressive disease|18
1471470|NCT00679289|4850213|P2|Overall Study|Progressive disease|5
1471471|NCT00679289|4850214|P1|Overall Study|Progressive disease|4
1471472|NCT00679263|4850236|P3|Visit 2/Dose 1|subject not compliance|0
1471473|NCT00679263|4850237|P2|Visit 2/Dose 1|subject not compliance|1
1471474|NCT00679263|4850238|P1|Visit 2/Dose 1|subject not compliance|1
1471475|NCT00679263|4850236|P3|Visit 2/Dose 1|Adverse Event|0
1471476|NCT00679263|4850237|P2|Visit 2/Dose 1|Adverse Event|0
1471477|NCT00679263|4850238|P1|Visit 2/Dose 1|Adverse Event|1
1471478|NCT00679211|4850249|P1|Overall Study|Other|1
1471479|NCT00679211|4850249|P1|Overall Study|Transferred to extension study TDM4529g|12
1471480|NCT00679211|4850249|P1|Overall Study|Refused to undergo protocol procedures|1
1471481|NCT00679211|4850249|P1|Overall Study|Physician Decision|5
1471482|NCT00679211|4850249|P1|Overall Study|Withdrawal by Subject|2
1471483|NCT00679211|4850249|P1|Overall Study|Adverse Event|7
1471484|NCT00679211|4850249|P1|Overall Study|Progressive disease|82
1471485|NCT00679172|4850266|P5|Overall Study|Other not specified|0
1471486|NCT00679172|4850267|P4|Overall Study|Other not specified|0
1471487|NCT00679172|4850268|P3|Overall Study|Other not specified|1
1471488|NCT00679172|4850269|P2|Overall Study|Other not specified|0
1471489|NCT00679172|4850270|P1|Overall Study|Other not specified|0
1471490|NCT00679172|4850266|P5|Overall Study|Non-compliance|0
1471491|NCT00679172|4850267|P4|Overall Study|Non-compliance|1
1471492|NCT00679172|4850268|P3|Overall Study|Non-compliance|0
1471493|NCT00679172|4850269|P2|Overall Study|Non-compliance|1
1471494|NCT00679172|4850270|P1|Overall Study|Non-compliance|1
1471495|NCT00679081|4850333|P1|Overall Study|Lost to Follow-up|1
1471496|NCT00679055|4850343|P2|Overall Study|Study Terminated|1
1471497|NCT00679055|4850344|P1|Overall Study|Study Terminated|2
1471498|NCT00679055|4850343|P2|Overall Study|Other|3
1471499|NCT00679055|4850344|P1|Overall Study|Other|0
1471500|NCT00679055|4850343|P2|Overall Study|Adverse Event|1
1471501|NCT00679055|4850344|P1|Overall Study|Adverse Event|0
1471502|NCT00678899|4850354|P1|Overall Study|Adverse Event|1
1471503|NCT00678886|4850363|P4|Overall Study|Other|0
1471504|NCT00678886|4850364|P3|Overall Study|Other|1
1471505|NCT00678886|4850365|P2|Overall Study|Other|0
1471506|NCT00678886|4850366|P1|Overall Study|Other|0
1471507|NCT00678886|4850363|P4|Overall Study|Lost to Follow-up|2
1471508|NCT00678886|4850364|P3|Overall Study|Lost to Follow-up|3
1471509|NCT00678886|4850365|P2|Overall Study|Lost to Follow-up|0
1471510|NCT00678886|4850366|P1|Overall Study|Lost to Follow-up|0
1471511|NCT00678886|4850363|P4|Overall Study|Physician Decision|1
1471512|NCT00678886|4850364|P3|Overall Study|Physician Decision|1
1471513|NCT00678886|4850365|P2|Overall Study|Physician Decision|0
1471514|NCT00678886|4850366|P1|Overall Study|Physician Decision|0
1471515|NCT00678886|4850363|P4|Overall Study|Withdrawal by Subject|6
1471516|NCT00678886|4850364|P3|Overall Study|Withdrawal by Subject|4
1471517|NCT00678886|4850365|P2|Overall Study|Withdrawal by Subject|0
1471518|NCT00678886|4850366|P1|Overall Study|Withdrawal by Subject|0
1471519|NCT00678795|4850435|P2|Overall Study|Lack of Efficacy|1
1471520|NCT00678795|4850436|P1|Overall Study|Lack of Efficacy|1
1471521|NCT00678795|4850435|P2|Overall Study|Lost to Follow-up|1
1471522|NCT00678795|4850436|P1|Overall Study|Lost to Follow-up|0
1471523|NCT00678795|4850435|P2|Overall Study|Protocol Violation|1
1471524|NCT00678795|4850436|P1|Overall Study|Protocol Violation|0
1471525|NCT00678795|4850435|P2|Overall Study|Withdrawal by Subject|0
1471526|NCT00678795|4850436|P1|Overall Study|Withdrawal by Subject|3
1471527|NCT00678795|4850435|P2|Overall Study|Adverse Event|3
1471528|NCT00678795|4850436|P1|Overall Study|Adverse Event|7
1471529|NCT00678691|4850458|P2|Overall Study|Adverse Event|4
1471530|NCT00678691|4850459|P1|Overall Study|Adverse Event|6
1471531|NCT00678652|4850469|P4|Overall Study|Relocation|0
1471532|NCT00678652|4850470|P3|Overall Study|Relocation|0
1471533|NCT00678652|4850471|P2|Overall Study|Relocation|0
1471534|NCT00678652|4850472|P1|Overall Study|Relocation|1
1471535|NCT00678652|4850469|P4|Overall Study|Pregnancy|0
1471536|NCT00678652|4850470|P3|Overall Study|Pregnancy|1
1471537|NCT00678652|4850471|P2|Overall Study|Pregnancy|0
1471538|NCT00678652|4850472|P1|Overall Study|Pregnancy|0
1471539|NCT00678652|4850469|P4|Overall Study|Protocol Violation|0
1471540|NCT00678652|4850470|P3|Overall Study|Protocol Violation|0
1471541|NCT00678652|4850471|P2|Overall Study|Protocol Violation|0
1471542|NCT00678652|4850472|P1|Overall Study|Protocol Violation|2
1471543|NCT00678639|4850496|P2|Overall Study|Lost to Follow-up at 30 days|0
1471544|NCT00678639|4850497|P1|Overall Study|Lost to Follow-up at 30 days|2
1471545|NCT00678587|4850512|P2|Overall Study|Withdrew Consent|3
1471546|NCT00678587|4850513|P1|Overall Study|Withdrew Consent|8
1471547|NCT00678587|4850512|P2|Overall Study|Investigator Discretion|6
1471548|NCT00678587|4850513|P1|Overall Study|Investigator Discretion|2
1471549|NCT00678587|4850512|P2|Overall Study|Lost to Follow-up|5
1471550|NCT00678587|4850513|P1|Overall Study|Lost to Follow-up|3
1471551|NCT00678587|4850512|P2|Overall Study|Study Closed/Terminated|0
1471552|NCT00678587|4850513|P1|Overall Study|Study Closed/Terminated|1
1471553|NCT00678587|4850512|P2|Overall Study|Protocol Violation|1
1471554|NCT00678587|4850513|P1|Overall Study|Protocol Violation|2
1471555|NCT00678587|4850512|P2|Overall Study|Lack of Efficacy|0
1471556|NCT00678587|4850513|P1|Overall Study|Lack of Efficacy|1
1471557|NCT00678587|4850512|P2|Overall Study|Adverse Event|3
1471558|NCT00678587|4850513|P1|Overall Study|Adverse Event|3
1471559|NCT00678392|4850607|P2|Overall Study|Other|53
1471560|NCT00678392|4850608|P1|Overall Study|Other|56
1471561|NCT00678392|4850607|P2|Overall Study|Randomized But Not Treated|7
1471562|NCT00678392|4850608|P1|Overall Study|Randomized But Not Treated|2
1471563|NCT00678392|4850607|P2|Overall Study|Withdrawal by Subject|4
1471564|NCT00678392|4850608|P1|Overall Study|Withdrawal by Subject|4
1471565|NCT00678392|4850607|P2|Overall Study|Sponsor's Decision|2
1471566|NCT00678392|4850608|P1|Overall Study|Sponsor's Decision|1
1471567|NCT00678392|4850607|P2|Overall Study|Objective Progression or Relapse|8
1471568|NCT00678392|4850608|P1|Overall Study|Objective Progression or Relapse|3
1471569|NCT00678392|4850607|P2|Overall Study|Lost to Follow-up|13
1471570|NCT00678392|4850608|P1|Overall Study|Lost to Follow-up|15
1471571|NCT00678392|4850607|P2|Overall Study|Death|269
1471572|NCT00678392|4850608|P1|Overall Study|Death|280
1471573|NCT00678392|4850607|P2|Overall Study|Adverse Event|6
1471574|NCT00678392|4850608|P1|Overall Study|Adverse Event|0
1471575|NCT00678379|4850643|P3|Overall Study|Incomplete Data|3
1471576|NCT00678379|4850644|P2|Overall Study|Incomplete Data|3
1471577|NCT00678379|4850645|P1|Overall Study|Incomplete Data|4
1471578|NCT00678379|4850643|P3|Overall Study|Injection performed after tonsillectomy|1
1471579|NCT00678379|4850644|P2|Overall Study|Injection performed after tonsillectomy|0
1471580|NCT00678379|4850645|P1|Overall Study|Injection performed after tonsillectomy|2
1471581|NCT00678301|4850673|P2|Overall Study|Lost to Follow-up|1
1471582|NCT00678301|4850674|P1|Overall Study|Lost to Follow-up|3
1471583|NCT00678301|4850673|P2|Overall Study|Withdrawal by Subject|0
1471584|NCT00678301|4850674|P1|Overall Study|Withdrawal by Subject|4
1471585|NCT00678301|4850673|P2|Overall Study|Adverse Event|0
1471586|NCT00678301|4850674|P1|Overall Study|Adverse Event|1
1471587|NCT00678301|4850673|P2|Overall Study|Non-compliance with study procedures|1
1471588|NCT00678301|4850674|P1|Overall Study|Non-compliance with study procedures|0
1471589|NCT00678288|4850732|P2|Overall Study|Disease progression/recurrence/relapse|1
1471590|NCT00678288|4850733|P1|Overall Study|Disease progression/recurrence/relapse|6
1471591|NCT00678288|4850732|P2|Overall Study|Reason not reported|0
1471592|NCT00678288|4850733|P1|Overall Study|Reason not reported|1
1471593|NCT00678288|4850732|P2|Overall Study|Switch to commercial drug|1
1471594|NCT00678288|4850733|P1|Overall Study|Switch to commercial drug|0
1471595|NCT00678288|4850732|P2|Overall Study|Not compliant with study medication|1
1471596|NCT00678288|4850733|P1|Overall Study|Not compliant with study medication|0
1471597|NCT00678288|4850732|P2|Overall Study|Study terminated by the sponsor|0
1471598|NCT00678288|4850733|P1|Overall Study|Study terminated by the sponsor|2
1471599|NCT00678288|4850732|P2|Overall Study|Withdrawal by Subject|1
1471600|NCT00678288|4850733|P1|Overall Study|Withdrawal by Subject|1
1471601|NCT00678288|4850732|P2|Overall Study|Adverse Event|2
1471602|NCT00678288|4850733|P1|Overall Study|Adverse Event|0
1471603|NCT00678210|4850788|P4|Overall Study|Other|0
1471604|NCT00678210|4850789|P3|Overall Study|Other|1
1471605|NCT00678210|4850790|P2|Overall Study|Other|0
1471606|NCT00678210|4850791|P1|Overall Study|Other|1
1471607|NCT00678210|4850788|P4|Overall Study|Withdrawal by Subject|7
1471608|NCT00678210|4850789|P3|Overall Study|Withdrawal by Subject|1
1471609|NCT00678210|4850790|P2|Overall Study|Withdrawal by Subject|4
1471610|NCT00678210|4850791|P1|Overall Study|Withdrawal by Subject|3
1471611|NCT00678210|4850788|P4|Overall Study|Lost to Follow-up|1
1471612|NCT00678210|4850789|P3|Overall Study|Lost to Follow-up|0
1471613|NCT00678210|4850790|P2|Overall Study|Lost to Follow-up|2
1471614|NCT00678210|4850791|P1|Overall Study|Lost to Follow-up|4
1471615|NCT00678210|4850788|P4|Overall Study|Lack of Efficacy|9
1471616|NCT00678210|4850789|P3|Overall Study|Lack of Efficacy|1
1471617|NCT00678210|4850790|P2|Overall Study|Lack of Efficacy|3
1471618|NCT00678210|4850791|P1|Overall Study|Lack of Efficacy|2
1471619|NCT00678210|4850788|P4|Overall Study|Adverse Event|3
1471620|NCT00678210|4850789|P3|Overall Study|Adverse Event|3
1471621|NCT00678210|4850790|P2|Overall Study|Adverse Event|2
1471622|NCT00678210|4850791|P1|Overall Study|Adverse Event|1
1471623|NCT00678041|4850827|P2|Overall Study|Physician Decision|5
1471624|NCT00678041|4850828|P1|Overall Study|Physician Decision|5
1471625|NCT00677833|4850881|P4|Overall Study|Lost to Follow-up|0
1471626|NCT00677833|4850882|P3|Overall Study|Lost to Follow-up|1
1471627|NCT00677833|4850883|P2|Overall Study|Lost to Follow-up|0
1471628|NCT00677833|4850884|P1|Overall Study|Lost to Follow-up|0
1471629|NCT00677833|4850881|P4|Overall Study|Withdrawal by Subject|3
1471630|NCT00677833|4850882|P3|Overall Study|Withdrawal by Subject|1
1471631|NCT00677833|4850883|P2|Overall Study|Withdrawal by Subject|0
1471632|NCT00677833|4850884|P1|Overall Study|Withdrawal by Subject|4
1471633|NCT00677820|4850934|P2|Overall Study|Lost to Follow-up|0
1471634|NCT00677820|4850935|P1|Overall Study|Lost to Follow-up|1
1471635|NCT00677807|4850956|P3|Overall Study|Protocol Deviation|0
1471636|NCT00677807|4850957|P2|Overall Study|Protocol Deviation|3
1471637|NCT00677807|4850958|P1|Overall Study|Protocol Deviation|1
1471638|NCT00677807|4850956|P3|Overall Study|Death|1
1471639|NCT00677807|4850957|P2|Overall Study|Death|1
1471640|NCT00677807|4850958|P1|Overall Study|Death|0
1471641|NCT00677807|4850956|P3|Overall Study|Administrative problems|2
1471642|NCT00677807|4850957|P2|Overall Study|Administrative problems|1
1471643|NCT00677807|4850958|P1|Overall Study|Administrative problems|1
1471644|NCT00677807|4850956|P3|Overall Study|Lost to Follow-up|2
1471645|NCT00677807|4850957|P2|Overall Study|Lost to Follow-up|2
1471646|NCT00677807|4850958|P1|Overall Study|Lost to Follow-up|2
1471647|NCT00677807|4850956|P3|Overall Study|Withdrawal by Subject|6
1471648|NCT00677807|4850957|P2|Overall Study|Withdrawal by Subject|3
1471649|NCT00677807|4850958|P1|Overall Study|Withdrawal by Subject|10
1471650|NCT00677807|4850956|P3|Overall Study|Participant no longer needs study drug|1
1471651|NCT00677807|4850957|P2|Overall Study|Participant no longer needs study drug|0
1471652|NCT00677807|4850958|P1|Overall Study|Participant no longer needs study drug|0
1471653|NCT00677807|4850956|P3|Overall Study|Lack of Efficacy|2
1471654|NCT00677807|4850957|P2|Overall Study|Lack of Efficacy|0
1471655|NCT00677807|4850958|P1|Overall Study|Lack of Efficacy|0
1471656|NCT00677807|4850956|P3|Overall Study|Adverse Event|6
1471657|NCT00677807|4850957|P2|Overall Study|Adverse Event|1
1471658|NCT00677807|4850958|P1|Overall Study|Adverse Event|4
1471659|NCT00677534|4851004|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
1471660|NCT00677534|4851004|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
1471661|NCT00677534|4851004|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
1471662|NCT00677365|4851012|P4|Overall Study|Other reason|1
1471663|NCT00677365|4851013|P3|Overall Study|Other reason|0
1471664|NCT00677365|4851014|P2|Overall Study|Other reason|0
1471665|NCT00677365|4851015|P1|Overall Study|Other reason|0
1471666|NCT00677365|4851012|P4|Overall Study|Withdrawal by Subject|0
1471667|NCT00677365|4851013|P3|Overall Study|Withdrawal by Subject|1
1471668|NCT00677365|4851014|P2|Overall Study|Withdrawal by Subject|0
1471669|NCT00677365|4851015|P1|Overall Study|Withdrawal by Subject|0
1471670|NCT00677365|4851012|P4|Overall Study|Adverse Event|2
1471671|NCT00677365|4851013|P3|Overall Study|Adverse Event|1
1471672|NCT00677365|4851014|P2|Overall Study|Adverse Event|1
1471673|NCT00677365|4851015|P1|Overall Study|Adverse Event|2
1471674|NCT00677352|4851047|P2|Tapering Phase|Job transfer|1
1471675|NCT00677352|4851048|P1|Tapering Phase|Job transfer|0
1471676|NCT00677352|4851047|P2|Tapering Phase|Pregnancy|1
1471677|NCT00677352|4851048|P1|Tapering Phase|Pregnancy|0
1471678|NCT00677352|4851047|P2|Tapering Phase|Withdrawal by Subject|3
1471679|NCT00677352|4851048|P1|Tapering Phase|Withdrawal by Subject|5
1471680|NCT00677352|4851047|P2|Tapering Phase|Adverse Event|5
1471681|NCT00677352|4851048|P1|Tapering Phase|Adverse Event|1
1471682|NCT00677352|4851047|P2|Treatment Phase|Not treated|2
1471683|NCT00677352|4851048|P1|Treatment Phase|Not treated|0
1471684|NCT00677352|4851047|P2|Treatment Phase|Transference or work related matter|5
1471685|NCT00677352|4851048|P1|Treatment Phase|Transference or work related matter|0
1471686|NCT00677352|4851047|P2|Treatment Phase|Protocol Violation|1
1471687|NCT00677352|4851048|P1|Treatment Phase|Protocol Violation|1
1471688|NCT00677352|4851047|P2|Treatment Phase|Pregnancy|1
1471689|NCT00677352|4851048|P1|Treatment Phase|Pregnancy|0
1471690|NCT00677352|4851047|P2|Treatment Phase|Physician Decision|0
1471691|NCT00677352|4851048|P1|Treatment Phase|Physician Decision|1
1471692|NCT00677352|4851047|P2|Treatment Phase|Withdrawal by Subject|7
1471693|NCT00677352|4851048|P1|Treatment Phase|Withdrawal by Subject|7
1471694|NCT00677352|4851047|P2|Treatment Phase|Lost to Follow-up|1
1471695|NCT00677352|4851048|P1|Treatment Phase|Lost to Follow-up|0
1471696|NCT00677352|4851047|P2|Treatment Phase|Lack of Efficacy|3
1471697|NCT00677352|4851048|P1|Treatment Phase|Lack of Efficacy|2
1471698|NCT00677352|4851047|P2|Treatment Phase|Adverse Event|22
1471699|NCT00677352|4851048|P1|Treatment Phase|Adverse Event|14
1471700|NCT00677235|4851068|P2|Overall Study|Adverse Experience|0
1471701|NCT00677235|4851069|P1|Overall Study|Adverse Experience|1
1471702|NCT00677235|4851068|P2|Overall Study|Death|36
1471703|NCT00677235|4851069|P1|Overall Study|Death|37
1471704|NCT00677235|4851068|P2|Overall Study|Lost to Follow-up|1
1471705|NCT00677235|4851069|P1|Overall Study|Lost to Follow-up|2
1471706|NCT00677235|4851068|P2|Overall Study|Withdrawal by Subject|1
1471707|NCT00677235|4851069|P1|Overall Study|Withdrawal by Subject|1
1471708|NCT00677092|4851109|P1|Overall Study|Death Prior to Receiving Treatment|1
1471709|NCT00677092|4851109|P1|Overall Study|Withdrawal by Subject|3
1471710|NCT00677092|4851109|P1|Overall Study|Lost to Follow-up|1
1471711|NCT00677092|4851109|P1|Overall Study|Adverse Event|1
1471712|NCT00677014|4851126|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
1471713|NCT00677014|4851127|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
1471714|NCT00677014|4851128|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
1471715|NCT00677014|4851126|P3|Overall Study|Death|7
1471716|NCT00677014|4851127|P2|Overall Study|Death|15
1471717|NCT00677014|4851128|P1|Overall Study|Death|6
1471718|NCT00677014|4851126|P3|Overall Study|Lost to Follow-up|24
1471719|NCT00677014|4851127|P2|Overall Study|Lost to Follow-up|12
1471720|NCT00677014|4851128|P1|Overall Study|Lost to Follow-up|20
1471721|NCT00676715|4851181|P4|Overall Study|Participants Ongoing|24
1471722|NCT00676715|4851182|P3|Overall Study|Participants Ongoing|17
1471723|NCT00676715|4851183|P2|Overall Study|Participants Ongoing|29
1471724|NCT00676715|4851184|P1|Overall Study|Participants Ongoing|29
1471725|NCT00676715|4851181|P4|Overall Study|Adverse Event|0
1471726|NCT00676715|4851182|P3|Overall Study|Adverse Event|2
1471727|NCT00676715|4851183|P2|Overall Study|Adverse Event|1
1471728|NCT00676715|4851184|P1|Overall Study|Adverse Event|0
1471729|NCT00676715|4851181|P4|Overall Study|Death|0
1471730|NCT00676715|4851182|P3|Overall Study|Death|1
1471731|NCT00676715|4851183|P2|Overall Study|Death|1
1471732|NCT00676715|4851184|P1|Overall Study|Death|1
1471733|NCT00676715|4851181|P4|Overall Study|Lost to Follow-up|3
1471734|NCT00676715|4851182|P3|Overall Study|Lost to Follow-up|7
1471735|NCT00676715|4851183|P2|Overall Study|Lost to Follow-up|1
1471736|NCT00676715|4851184|P1|Overall Study|Lost to Follow-up|1
1471737|NCT00676715|4851181|P4|Overall Study|Other|3
1471738|NCT00676715|4851182|P3|Overall Study|Other|4
1471739|NCT00676715|4851183|P2|Overall Study|Other|6
1471740|NCT00676715|4851184|P1|Overall Study|Other|2
1471741|NCT00676715|4851181|P4|Overall Study|Withdrawal by Subject|10
1471742|NCT00676715|4851182|P3|Overall Study|Withdrawal by Subject|10
1471743|NCT00676715|4851183|P2|Overall Study|Withdrawal by Subject|9
1471744|NCT00676715|4851184|P1|Overall Study|Withdrawal by Subject|7
1471745|NCT00676689|4851214|P1|Overall Study|Continuing FU|49
1471746|NCT00676689|4851214|P1|Overall Study|Withdrawal by Subject|3
1471747|NCT00676689|4851214|P1|Overall Study|Physician Decision|1
1471748|NCT00676689|4851214|P1|Overall Study|Lost to Follow-up|4
1471749|NCT00676689|4851214|P1|Overall Study|Death|2
1471750|NCT00676689|4851214|P1|Overall Study|Screen Failure|2
1471751|NCT00676650|4851226|P2|Overall Study|Randomized but not treated|4
1471752|NCT00676650|4851227|P1|Overall Study|Randomized but not treated|3
1471753|NCT00676650|4851226|P2|Overall Study|Withdrawal by Subject|24
1471754|NCT00676650|4851227|P1|Overall Study|Withdrawal by Subject|48
1471755|NCT00676650|4851226|P2|Overall Study|Study terminated by sponsor|43
1471756|NCT00676650|4851227|P1|Overall Study|Study terminated by sponsor|57
1471757|NCT00676650|4851226|P2|Overall Study|Protocol Violation|1
1471758|NCT00676650|4851227|P1|Overall Study|Protocol Violation|3
1471759|NCT00676650|4851226|P2|Overall Study|Other|10
1471760|NCT00676650|4851227|P1|Overall Study|Other|14
1471761|NCT00676650|4851226|P2|Overall Study|Objective progression or relapse|140
1471762|NCT00676650|4851227|P1|Overall Study|Objective progression or relapse|189
1471763|NCT00676650|4851226|P2|Overall Study|Lost to Follow-up|1
1471764|NCT00676650|4851227|P1|Overall Study|Lost to Follow-up|0
1471765|NCT00676650|4851226|P2|Overall Study|Global deterioration of health status|31
1471766|NCT00676650|4851227|P1|Overall Study|Global deterioration of health status|66
1471767|NCT00676650|4851226|P2|Overall Study|Adverse Event|21
1471768|NCT00676650|4851227|P1|Overall Study|Adverse Event|159
1471769|NCT00676650|4851226|P2|Overall Study|Death|14
1471770|NCT00676650|4851227|P1|Overall Study|Death|45
1471771|NCT00676520|4851258|P1|Overall Study|Other Reason|18
1471772|NCT00676520|4851258|P1|Overall Study|Ineligible for Randomization to DAPT|209
1471773|NCT00676520|4851258|P1|Overall Study|Physician Decision|20
1471774|NCT00676520|4851258|P1|Overall Study|Death|159
1471775|NCT00676520|4851258|P1|Overall Study|Lost to Follow-up|162
1471776|NCT00676520|4851258|P1|Overall Study|Withdrawal by Subject|163
1471777|NCT00676494|4851315|P1|Overall Study|Withdrawal by Subject|6
1471778|NCT00676494|4851315|P1|Overall Study|Missed Visit|8
1471779|NCT00676403|4851332|P6|Overall Study|Withdrawal by Subject|1
1471780|NCT00676403|4851333|P5|Overall Study|Withdrawal by Subject|0
1471781|NCT00676403|4851334|P4|Overall Study|Withdrawal by Subject|0
1471782|NCT00676403|4851335|P3|Overall Study|Withdrawal by Subject|0
1471783|NCT00676403|4851336|P2|Overall Study|Withdrawal by Subject|0
1471784|NCT00676403|4851337|P1|Overall Study|Withdrawal by Subject|0
1471785|NCT00676403|4851332|P6|Overall Study|Reason Unspecified|1
1471786|NCT00676403|4851333|P5|Overall Study|Reason Unspecified|0
1471787|NCT00676403|4851334|P4|Overall Study|Reason Unspecified|0
1471788|NCT00676403|4851335|P3|Overall Study|Reason Unspecified|1
1471789|NCT00676403|4851336|P2|Overall Study|Reason Unspecified|0
1471790|NCT00676403|4851337|P1|Overall Study|Reason Unspecified|1
1471791|NCT00676403|4851332|P6|Overall Study|Lost to Follow-up|1
1471792|NCT00676403|4851333|P5|Overall Study|Lost to Follow-up|0
1471793|NCT00676403|4851334|P4|Overall Study|Lost to Follow-up|0
1471794|NCT00676403|4851335|P3|Overall Study|Lost to Follow-up|0
1471795|NCT00676403|4851336|P2|Overall Study|Lost to Follow-up|0
1471796|NCT00676403|4851337|P1|Overall Study|Lost to Follow-up|0
1471797|NCT00676403|4851332|P6|Overall Study|Adverse Event|2
1471798|NCT00676403|4851333|P5|Overall Study|Adverse Event|1
1471799|NCT00676403|4851334|P4|Overall Study|Adverse Event|5
1471800|NCT00676403|4851335|P3|Overall Study|Adverse Event|0
1471801|NCT00676403|4851336|P2|Overall Study|Adverse Event|2
1471802|NCT00676403|4851337|P1|Overall Study|Adverse Event|1
1471803|NCT00676338|4851480|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
1471804|NCT00676338|4851481|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
1471805|NCT00676338|4851482|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
1471806|NCT00676338|4851483|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
1471807|NCT00676338|4851480|P4|Overall Study|Entry Criteria Not Met|1
1471808|NCT00676338|4851481|P3|Overall Study|Entry Criteria Not Met|1
1471809|NCT00676338|4851482|P2|Overall Study|Entry Criteria Not Met|2
1471810|NCT00676338|4851483|P1|Overall Study|Entry Criteria Not Met|0
1471811|NCT00676338|4851480|P4|Overall Study|Withdrawal by Subject|6
1471812|NCT00676338|4851481|P3|Overall Study|Withdrawal by Subject|12
1471813|NCT00676338|4851482|P2|Overall Study|Withdrawal by Subject|9
1471814|NCT00676338|4851483|P1|Overall Study|Withdrawal by Subject|17
1471815|NCT00676338|4851480|P4|Overall Study|Protocol Violation|5
1471816|NCT00676338|4851481|P3|Overall Study|Protocol Violation|2
1471817|NCT00676338|4851482|P2|Overall Study|Protocol Violation|9
1471818|NCT00676338|4851483|P1|Overall Study|Protocol Violation|5
1471819|NCT00676338|4851480|P4|Overall Study|Physician Decision|3
1471820|NCT00676338|4851481|P3|Overall Study|Physician Decision|2
1471821|NCT00676338|4851482|P2|Overall Study|Physician Decision|3
1471822|NCT00676338|4851483|P1|Overall Study|Physician Decision|3
1471823|NCT00676338|4851480|P4|Overall Study|Lost to Follow-up|4
1471824|NCT00676338|4851481|P3|Overall Study|Lost to Follow-up|3
1471825|NCT00676338|4851482|P2|Overall Study|Lost to Follow-up|1
1471826|NCT00676338|4851483|P1|Overall Study|Lost to Follow-up|4
1471827|NCT00676338|4851480|P4|Overall Study|Adverse Event|1
1471828|NCT00676338|4851481|P3|Overall Study|Adverse Event|5
1471829|NCT00676338|4851482|P2|Overall Study|Adverse Event|6
1471830|NCT00676338|4851483|P1|Overall Study|Adverse Event|6
1471831|NCT00676208|4851535|P2|Overall Study|Incomplete data|4
1471832|NCT00676208|4851536|P1|Overall Study|Incomplete data|2
1471833|NCT00676208|4851535|P2|Overall Study|Lost to Follow-up|2
1471834|NCT00676208|4851536|P1|Overall Study|Lost to Follow-up|0
1471835|NCT00676195|4851544|P1|Overall Study|Physician Decision|1
1471836|NCT00676195|4851544|P1|Overall Study|Adverse Event|1
1471837|NCT00676195|4851544|P1|Overall Study|Lost to Follow-up|1
1471838|NCT00676143|4851569|P2|Overall Study|Vasogenic edema recurrence|3
1471839|NCT00676143|4851570|P1|Overall Study|Vasogenic edema recurrence|1
1471840|NCT00676143|4851569|P2|Overall Study|Participant participation unknown|4
1471841|NCT00676143|4851570|P1|Overall Study|Participant participation unknown|1
1471842|NCT00676143|4851569|P2|Overall Study|Not specified|20
1471843|NCT00676143|4851570|P1|Overall Study|Not specified|11
1471844|NCT00676143|4851569|P2|Overall Study|Loss of caregiver|3
1471845|NCT00676143|4851570|P1|Overall Study|Loss of caregiver|5
1471846|NCT00676143|4851569|P2|Overall Study|Failed to return|1
1471847|NCT00676143|4851570|P1|Overall Study|Failed to return|2
1471848|NCT00676143|4851569|P2|Overall Study|Discontinuation of study by sponsor|88
1471849|NCT00676143|4851570|P1|Overall Study|Discontinuation of study by sponsor|65
1471850|NCT00676143|4851569|P2|Overall Study|Withdrawal by Subject|42
1471851|NCT00676143|4851570|P1|Overall Study|Withdrawal by Subject|24
1471852|NCT00676143|4851569|P2|Overall Study|Protocol Violation|8
1471853|NCT00676143|4851570|P1|Overall Study|Protocol Violation|4
1471854|NCT00676143|4851569|P2|Overall Study|Physician Decision|8
1471855|NCT00676143|4851570|P1|Overall Study|Physician Decision|5
1471856|NCT00676143|4851569|P2|Overall Study|Lost to Follow-up|13
1471857|NCT00676143|4851570|P1|Overall Study|Lost to Follow-up|0
1471858|NCT00676143|4851569|P2|Overall Study|Lack of Efficacy|6
1471859|NCT00676143|4851570|P1|Overall Study|Lack of Efficacy|0
1471860|NCT00676143|4851569|P2|Overall Study|Death|4
1471861|NCT00676143|4851570|P1|Overall Study|Death|4
1471862|NCT00676143|4851569|P2|Overall Study|Adverse Event|60
1471863|NCT00676143|4851570|P1|Overall Study|Adverse Event|34
1471864|NCT00676130|4851610|P2|Overall Study|Withdrawal by Subject|1
1471865|NCT00676130|4851611|P1|Overall Study|Withdrawal by Subject|0
1471866|NCT00676130|4851610|P2|Overall Study|Found ineligible|2
1471867|NCT00676130|4851611|P1|Overall Study|Found ineligible|3
1471868|NCT00676130|4851610|P2|Overall Study|Lost to Follow-up|1
1471869|NCT00676130|4851611|P1|Overall Study|Lost to Follow-up|0
1471870|NCT00676091|4851621|P2|Toddler Dose|Parent or legal guardian request|0
1471871|NCT00676091|4851622|P1|Toddler Dose|Parent or legal guardian request|1
1471872|NCT00676091|4851621|P2|Toddler Dose|Failed to return|0
1471873|NCT00676091|4851622|P1|Toddler Dose|Failed to return|2
1471874|NCT00676091|4851621|P2|After Infant Series|Failed to return|1
1471875|NCT00676091|4851622|P1|After Infant Series|Failed to return|1
1471876|NCT00676091|4851621|P2|After Infant Series|Protocol Violation|1
1471877|NCT00676091|4851622|P1|After Infant Series|Protocol Violation|0
1471878|NCT00676091|4851621|P2|After Infant Series|Adverse Event|1
1471879|NCT00676091|4851622|P1|After Infant Series|Adverse Event|0
1471880|NCT00676091|4851621|P2|Infant Series|Died prior to receiving 7vPnC|1
1471881|NCT00676091|4851622|P1|Infant Series|Died prior to receiving 7vPnC|0
1471882|NCT00676091|4851621|P2|Infant Series|Lost to Follow-up|0
1471883|NCT00676091|4851622|P1|Infant Series|Lost to Follow-up|1
1471884|NCT00676091|4851621|P2|Infant Series|Failed to return|3
1471885|NCT00676091|4851622|P1|Infant Series|Failed to return|1
1471886|NCT00676091|4851621|P2|Infant Series|Adverse Event|3
1471887|NCT00676091|4851622|P1|Infant Series|Adverse Event|2
1471888|NCT00676091|4851621|P2|Infant Series|Protocol Violation|3
1471889|NCT00676091|4851622|P1|Infant Series|Protocol Violation|6
1471890|NCT00676091|4851621|P2|Infant Series|Parent or legal guardian request|8
1471891|NCT00676091|4851622|P1|Infant Series|Parent or legal guardian request|10
1471892|NCT00676052|4851679|P6|Overall Study|Withdrawal by Subject|0
1471893|NCT00676052|4851680|P5|Overall Study|Withdrawal by Subject|0
1471894|NCT00676052|4851681|P4|Overall Study|Withdrawal by Subject|0
1471895|NCT00676052|4851682|P3|Overall Study|Withdrawal by Subject|1
1471896|NCT00676052|4851683|P2|Overall Study|Withdrawal by Subject|0
1471897|NCT00676052|4851684|P1|Overall Study|Withdrawal by Subject|1
1471898|NCT00676052|4851679|P6|Overall Study|Physician Decision|1
1471899|NCT00676052|4851680|P5|Overall Study|Physician Decision|0
1471900|NCT00676052|4851681|P4|Overall Study|Physician Decision|0
1471901|NCT00676052|4851682|P3|Overall Study|Physician Decision|1
1471902|NCT00676052|4851683|P2|Overall Study|Physician Decision|1
1471903|NCT00676052|4851684|P1|Overall Study|Physician Decision|1
1471904|NCT00676052|4851679|P6|Overall Study|Lost to Follow-up|0
1471905|NCT00676052|4851680|P5|Overall Study|Lost to Follow-up|1
1471906|NCT00676052|4851681|P4|Overall Study|Lost to Follow-up|0
1471907|NCT00676052|4851682|P3|Overall Study|Lost to Follow-up|0
1471908|NCT00676052|4851683|P2|Overall Study|Lost to Follow-up|0
1471909|NCT00676052|4851684|P1|Overall Study|Lost to Follow-up|0
1471910|NCT00676052|4851679|P6|Overall Study|Protocol Violation|2
1471911|NCT00676052|4851680|P5|Overall Study|Protocol Violation|1
1471912|NCT00676052|4851681|P4|Overall Study|Protocol Violation|2
1471913|NCT00676052|4851682|P3|Overall Study|Protocol Violation|2
1471914|NCT00676052|4851683|P2|Overall Study|Protocol Violation|3
1471915|NCT00676052|4851684|P1|Overall Study|Protocol Violation|5
1471916|NCT00676052|4851679|P6|Overall Study|Lack of Efficacy|1
1471917|NCT00676052|4851680|P5|Overall Study|Lack of Efficacy|2
1471918|NCT00676052|4851681|P4|Overall Study|Lack of Efficacy|1
1471919|NCT00676052|4851682|P3|Overall Study|Lack of Efficacy|1
1471920|NCT00676052|4851683|P2|Overall Study|Lack of Efficacy|2
1471921|NCT00676052|4851684|P1|Overall Study|Lack of Efficacy|2
1471922|NCT00676052|4851679|P6|Overall Study|Adverse Event|2
1471923|NCT00676052|4851680|P5|Overall Study|Adverse Event|2
1471924|NCT00676052|4851681|P4|Overall Study|Adverse Event|2
1471925|NCT00676052|4851682|P3|Overall Study|Adverse Event|1
1471926|NCT00676052|4851683|P2|Overall Study|Adverse Event|1
1471927|NCT00676052|4851684|P1|Overall Study|Adverse Event|0
1471928|NCT00675948|4851733|P2|Overall Study|Patient feels unable to take medication|1
1471929|NCT00675948|4851734|P1|Overall Study|Patient feels unable to take medication|0
1471930|NCT00675948|4851733|P2|Overall Study|Patient unable to comply with diaries|0
1471931|NCT00675948|4851734|P1|Overall Study|Patient unable to comply with diaries|1
1471932|NCT00675948|4851733|P2|Overall Study|Patient died|0
1471933|NCT00675948|4851734|P1|Overall Study|Patient died|1
1471934|NCT00675948|4851733|P2|Overall Study|Sponsor decision|1
1471935|NCT00675948|4851734|P1|Overall Study|Sponsor decision|0
1471936|NCT00675948|4851733|P2|Overall Study|Pain under control|0
1471937|NCT00675948|4851734|P1|Overall Study|Pain under control|1
1471938|NCT00675948|4851733|P2|Overall Study|Protocol Violation|0
1471939|NCT00675948|4851734|P1|Overall Study|Protocol Violation|1
1471940|NCT00675948|4851733|P2|Overall Study|Lost to Follow-up|0
1471941|NCT00675948|4851734|P1|Overall Study|Lost to Follow-up|2
1471942|NCT00675948|4851733|P2|Overall Study|Withdrawal by Subject|0
1471943|NCT00675948|4851734|P1|Overall Study|Withdrawal by Subject|7
1471944|NCT00675948|4851733|P2|Overall Study|Lack of Efficacy|0
1471945|NCT00675948|4851734|P1|Overall Study|Lack of Efficacy|3
1471946|NCT00675948|4851733|P2|Overall Study|Adverse Event|1
1471947|NCT00675948|4851734|P1|Overall Study|Adverse Event|23
1471948|NCT00675766|4851785|P4|Overall Study|Lost to Follow-up|26
1471949|NCT00675766|4851786|P3|Overall Study|Lost to Follow-up|21
1471950|NCT00675766|4851787|P2|Overall Study|Lost to Follow-up|5
1471951|NCT00675766|4851788|P1|Overall Study|Lost to Follow-up|6
1471952|NCT00675597|4851798|P1|Overall Study|Withdrawal by Subject|3
1471953|NCT00675506|4851852|P2|Overall Study|Schedule conflict|1
1471954|NCT00675506|4851853|P1|Overall Study|Schedule conflict|0
1471955|NCT00675506|4851852|P2|Overall Study|Declined participation|0
1471956|NCT00675506|4851853|P1|Overall Study|Declined participation|1
1471957|NCT00675506|4851852|P2|Overall Study|Disclosed history of cancer|0
1471958|NCT00675506|4851853|P1|Overall Study|Disclosed history of cancer|1
1471959|NCT00675506|4851852|P2|Overall Study|Hypersensitivity Reaction|0
1471960|NCT00675506|4851853|P1|Overall Study|Hypersensitivity Reaction|1
1471961|NCT00675506|4851852|P2|Overall Study|Elevated IGF-1|0
1471962|NCT00675506|4851853|P1|Overall Study|Elevated IGF-1|2
1471963|NCT00675506|4851852|P2|Overall Study|Elevated IGF-1 prior to treatment|0
1471964|NCT00675506|4851853|P1|Overall Study|Elevated IGF-1 prior to treatment|1
1471965|NCT00675506|4851852|P2|Overall Study|Elevated fasting glucose|1
1471966|NCT00675506|4851853|P1|Overall Study|Elevated fasting glucose|2
1471967|NCT00675506|4851852|P2|Overall Study|Lost interest|5
1471968|NCT00675506|4851853|P1|Overall Study|Lost interest|3
1471969|NCT00675506|4851852|P2|Overall Study|Lost to Follow-up|5
1471970|NCT00675506|4851853|P1|Overall Study|Lost to Follow-up|1
1471971|NCT00675441|4851869|P1|Overall Study|Death|1
1471972|NCT00675441|4851869|P1|Overall Study|Withdrawal by Subject|2
1471973|NCT00675428|4851875|P2|Overall Study|Physician Decision|0
1471974|NCT00675428|4851876|P1|Overall Study|Physician Decision|1
1471975|NCT00675428|4851875|P2|Overall Study|No Disease Response After Cycle 6|1
1471976|NCT00675428|4851876|P1|Overall Study|No Disease Response After Cycle 6|0
1471977|NCT00675428|4851875|P2|Overall Study|Disease Progression|2
1471978|NCT00675428|4851876|P1|Overall Study|Disease Progression|2
1471979|NCT00675103|4851918|P1|Overall Study|Adverse Event|1
1471980|NCT00675103|4851918|P1|Overall Study|Lack of Efficacy|2
1471981|NCT00674986|4851925|P2|Overall Study|Other reasons|8
1471982|NCT00674986|4851926|P1|Overall Study|Other reasons|4
1471983|NCT00674986|4851925|P2|Overall Study|Lost to Follow-up|53
1471984|NCT00674986|4851926|P1|Overall Study|Lost to Follow-up|25
1471985|NCT00674986|4851925|P2|Overall Study|Subject withdrew consent|19
1471986|NCT00674986|4851926|P1|Overall Study|Subject withdrew consent|12
1471987|NCT00674986|4851925|P2|Overall Study|Adverse Event|1
1471988|NCT00674986|4851926|P1|Overall Study|Adverse Event|2
1471989|NCT00674973|4851947|P2|Overall Study|Protocol Violation|1
1471990|NCT00674973|4851948|P1|Overall Study|Protocol Violation|0
1471991|NCT00674973|4851947|P2|Overall Study|Death|15
1471992|NCT00674973|4851948|P1|Overall Study|Death|19
1471993|NCT00674973|4851947|P2|Overall Study|Adverse Event|9
1471994|NCT00674973|4851948|P1|Overall Study|Adverse Event|2
1471995|NCT00674973|4851947|P2|Overall Study|Failure to Return|0
1471996|NCT00674973|4851948|P1|Overall Study|Failure to Return|1
1471997|NCT00674973|4851947|P2|Overall Study|Refused Treatment|5
1471998|NCT00674973|4851948|P1|Overall Study|Refused Treatment|1
1471999|NCT00674973|4851947|P2|Overall Study|Insufficient Therapeutic Response|72
1472000|NCT00674973|4851948|P1|Overall Study|Insufficient Therapeutic Response|77
1472001|NCT00674817|4851962|P1|Period 4|Adverse Event|1
1472002|NCT00674817|4851962|P1|Period 3|Protocol Violation|1
1472003|NCT00674817|4851962|P1|Period 3|Adverse Event|1
1472004|NCT00674817|4851962|P1|Period 1|Protocol Violation|1
1472005|NCT00674817|4851962|P1|Period 1|Withdrawal by Subject|2
1472006|NCT00674700|4852139|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
1472007|NCT00674700|4852140|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
1472008|NCT00674700|4852141|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
1472009|NCT00674700|4852139|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
1472010|NCT00674700|4852140|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
1472011|NCT00674700|4852141|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
1472012|NCT00674700|4852139|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
1472013|NCT00674700|4852140|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
1472014|NCT00674700|4852141|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
1472015|NCT00674700|4852139|P3|Year 1|Any other reason not above-mentioned|6
1472016|NCT00674700|4852140|P2|Year 1|Any other reason not above-mentioned|7
1472017|NCT00674700|4852141|P1|Year 1|Any other reason not above-mentioned|7
1472018|NCT00674700|4852139|P3|Year 1|Withdrawal by Subject|6
1472019|NCT00674700|4852140|P2|Year 1|Withdrawal by Subject|7
1472020|NCT00674700|4852141|P1|Year 1|Withdrawal by Subject|7
1472021|NCT00674700|4852139|P3|Year 1|Adverse Event|5
1472022|NCT00674700|4852140|P2|Year 1|Adverse Event|20
1472023|NCT00674700|4852141|P1|Year 1|Adverse Event|17
1472024|NCT00674661|4852154|P2|Overall Study|Withdrawal by Subject|5
1472025|NCT00674661|4852155|P1|Overall Study|Withdrawal by Subject|0
1472026|NCT00674661|4852154|P2|Overall Study|Lost to Follow-up|3
1472027|NCT00674661|4852155|P1|Overall Study|Lost to Follow-up|6
1472028|NCT00674661|4852154|P2|Overall Study|not specified|7
1472029|NCT00674661|4852155|P1|Overall Study|not specified|5
1472030|NCT00674362|4852275|P2|Open Label|Other: Subject moved to extension study|0
1472031|NCT00674362|4852276|P1|Open Label|Other: Subject moved to extension study|1
1472032|NCT00674362|4852275|P2|Open Label|Adverse Event|0
1472033|NCT00674362|4852276|P1|Open Label|Adverse Event|1
1472034|NCT00674362|4852275|P2|Double Blind|Other: Surgery|1
1472035|NCT00674362|4852276|P1|Double Blind|Other: Surgery|0
1472036|NCT00674362|4852275|P2|Double Blind|Other: Loss of Patient Compliance|1
1472037|NCT00674362|4852276|P1|Double Blind|Other: Loss of Patient Compliance|0
1472038|NCT00674362|4852275|P2|Double Blind|Withdrawal by Subject|3
1472039|NCT00674362|4852276|P1|Double Blind|Withdrawal by Subject|4
1472040|NCT00674362|4852275|P2|Double Blind|Loss of efficacy|1
1472041|NCT00674362|4852276|P1|Double Blind|Loss of efficacy|0
1472042|NCT00674362|4852275|P2|Double Blind|Lack of Efficacy|6
1472043|NCT00674362|4852276|P1|Double Blind|Lack of Efficacy|2
1472044|NCT00674362|4852275|P2|Double Blind|Adverse Event|6
1472045|NCT00674362|4852276|P1|Double Blind|Adverse Event|6
1472046|NCT00674323|4852344|P3|Overall Study|Protocol Violation|0
1472047|NCT00674323|4852345|P2|Overall Study|Protocol Violation|0
1472048|NCT00674323|4852346|P1|Overall Study|Protocol Violation|1
1472049|NCT00674323|4852344|P3|Overall Study|Adverse Event|0
1472050|NCT00674323|4852345|P2|Overall Study|Adverse Event|1
1472051|NCT00674323|4852346|P1|Overall Study|Adverse Event|0
1472052|NCT00674154|4852388|P2|Overall Study|Did not want parathyroidectomy|2
1472053|NCT00674154|4852389|P1|Overall Study|Did not want parathyroidectomy|0
1472054|NCT00674154|4852388|P2|Overall Study|Withdrawal by Subject|1
1472055|NCT00674154|4852389|P1|Overall Study|Withdrawal by Subject|3
1472056|NCT00674128|4852397|P2|Overall Study|Withdrawal by Subject|23
1472057|NCT00674128|4852398|P1|Overall Study|Withdrawal by Subject|25
1472058|NCT00673933|4852423|P1|Overall Study|Lost to Follow-up|1
1472059|NCT00673933|4852423|P1|Overall Study|Withdrawal by Subject|2
1472060|NCT00673881|4852439|P1|Overall Study|Withdrawal by Subject|1
1472061|NCT00673816|4852453|P1|Overall Study|Withdrawal by Subject|1
1472062|NCT00673816|4852453|P1|Overall Study|Adverse Event|1
1472063|NCT00673673|4852488|P1|Overall Study|Investigators' discretion|2
1472064|NCT00673673|4852488|P1|Overall Study|Withdrawal by Subject|3
1472065|NCT00673673|4852488|P1|Overall Study|Adverse Event|4
1472066|NCT00673673|4852488|P1|Overall Study|Progressive disease|27
1472067|NCT00673660|4852494|P1|Overall Study|Lost to Follow-up|107
1472068|NCT00673465|4852516|P12|Part 1/Period 2 (United States)|Protocol Violation|0
1472069|NCT00673465|4852517|P11|Part 1/Period 2 (United States)|Protocol Violation|0
1472070|NCT00673465|4852518|P10|Part 1/Period 2 (United States)|Protocol Violation|0
1472071|NCT00673465|4852519|P9|Part 1/Period 2 (United States)|Protocol Violation|0
1472072|NCT00673465|4852520|P8|Part 1/Period 2 (United States)|Protocol Violation|0
1472073|NCT00673465|4852521|P7|Part 1/Period 2 (United States)|Protocol Violation|0
1472074|NCT00673465|4852522|P6|Part 1/Period 2 (United States)|Protocol Violation|0
1472075|NCT00673465|4852523|P5|Part 1/Period 2 (United States)|Protocol Violation|1
1472076|NCT00673465|4852524|P4|Part 1/Period 2 (United States)|Protocol Violation|0
1472077|NCT00673465|4852525|P3|Part 1/Period 2 (United States)|Protocol Violation|0
1472078|NCT00673465|4852526|P2|Part 1/Period 2 (United States)|Protocol Violation|0
1472079|NCT00673465|4852527|P1|Part 1/Period 2 (United States)|Protocol Violation|0
1472080|NCT00673465|4852516|P12|Part 1/Period 1 (United States)|Protocol Violation|0
1472081|NCT00673465|4852517|P11|Part 1/Period 1 (United States)|Protocol Violation|0
1472082|NCT00673465|4852518|P10|Part 1/Period 1 (United States)|Protocol Violation|0
1472083|NCT00673465|4852519|P9|Part 1/Period 1 (United States)|Protocol Violation|0
1472084|NCT00673465|4852520|P8|Part 1/Period 1 (United States)|Protocol Violation|0
1472085|NCT00673465|4852521|P7|Part 1/Period 1 (United States)|Protocol Violation|0
1472086|NCT00673465|4852522|P6|Part 1/Period 1 (United States)|Protocol Violation|1
1472087|NCT00673465|4852523|P5|Part 1/Period 1 (United States)|Protocol Violation|1
1472088|NCT00673465|4852524|P4|Part 1/Period 1 (United States)|Protocol Violation|0
1472089|NCT00673465|4852525|P3|Part 1/Period 1 (United States)|Protocol Violation|0
1472090|NCT00673465|4852526|P2|Part 1/Period 1 (United States)|Protocol Violation|0
1472091|NCT00673465|4852527|P1|Part 1/Period 1 (United States)|Protocol Violation|0
1472092|NCT00673452|4852576|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
1472093|NCT00673452|4852577|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
1472094|NCT00673452|4852576|P2|Continuation Double-Blind Phase|Physician Decision|0
1472095|NCT00673452|4852577|P1|Continuation Double-Blind Phase|Physician Decision|2
1472096|NCT00673452|4852576|P2|Continuation Double-Blind Phase|Sponsor Decision|3
1472097|NCT00673452|4852577|P1|Continuation Double-Blind Phase|Sponsor Decision|0
1472098|NCT00673452|4852576|P2|Continuation Double-Blind Phase|Protocol Violation|3
1472099|NCT00673452|4852577|P1|Continuation Double-Blind Phase|Protocol Violation|2
1472100|NCT00673452|4852576|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
1472101|NCT00673452|4852577|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
1472102|NCT00673452|4852576|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
1472103|NCT00673452|4852577|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
1472104|NCT00673452|4852576|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
1472105|NCT00673452|4852577|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
1472106|NCT00673452|4852576|P2|Continuation Double-Blind Phase|Adverse Event|13
1472107|NCT00673452|4852577|P1|Continuation Double-Blind Phase|Adverse Event|5
1472108|NCT00673452|4852576|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
1472109|NCT00673452|4852577|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
1472110|NCT00673452|4852576|P2|Acute Double-Blind Phase|Sponsor Decision|1
1472111|NCT00673452|4852577|P1|Acute Double-Blind Phase|Sponsor Decision|0
1472112|NCT00673452|4852576|P2|Acute Double-Blind Phase|Protocol Violation|3
1472113|NCT00673452|4852577|P1|Acute Double-Blind Phase|Protocol Violation|5
1472114|NCT00673452|4852576|P2|Acute Double-Blind Phase|Physician Decision|6
1472115|NCT00673452|4852577|P1|Acute Double-Blind Phase|Physician Decision|0
1472116|NCT00673452|4852576|P2|Acute Double-Blind Phase|Lost to Follow-up|19
1472117|NCT00673452|4852577|P1|Acute Double-Blind Phase|Lost to Follow-up|16
1472118|NCT00673452|4852576|P2|Acute Double-Blind Phase|Lack of Efficacy|14
1472119|NCT00673452|4852577|P1|Acute Double-Blind Phase|Lack of Efficacy|9
1472120|NCT00673452|4852576|P2|Acute Double-Blind Phase|Adverse Event|24
1472121|NCT00673452|4852577|P1|Acute Double-Blind Phase|Adverse Event|41
1472122|NCT00673387|4852640|P8|Overall Study|Lost to Follow-up|5
1472123|NCT00673387|4852641|P7|Overall Study|Lost to Follow-up|8
1472124|NCT00673387|4852642|P6|Overall Study|Lost to Follow-up|5
1472125|NCT00673387|4852643|P5|Overall Study|Lost to Follow-up|6
1472126|NCT00673387|4852644|P4|Overall Study|Lost to Follow-up|6
1472127|NCT00673387|4852645|P3|Overall Study|Lost to Follow-up|5
1472128|NCT00673387|4852646|P2|Overall Study|Lost to Follow-up|6
1472129|NCT00673387|4852647|P1|Overall Study|Lost to Follow-up|8
1472130|NCT00673387|4852640|P8|Overall Study|Protocol Violation|3
1472131|NCT00673387|4852641|P7|Overall Study|Protocol Violation|1
1472132|NCT00673387|4852642|P6|Overall Study|Protocol Violation|1
1472133|NCT00673387|4852643|P5|Overall Study|Protocol Violation|0
1472134|NCT00673387|4852644|P4|Overall Study|Protocol Violation|2
1472135|NCT00673387|4852645|P3|Overall Study|Protocol Violation|1
1472136|NCT00673387|4852646|P2|Overall Study|Protocol Violation|0
1472137|NCT00673387|4852647|P1|Overall Study|Protocol Violation|3
1472138|NCT00673387|4852640|P8|Overall Study|Physician Decision|1
1472139|NCT00673387|4852641|P7|Overall Study|Physician Decision|1
1472140|NCT00673387|4852642|P6|Overall Study|Physician Decision|5
1472141|NCT00673387|4852643|P5|Overall Study|Physician Decision|0
1472142|NCT00673387|4852644|P4|Overall Study|Physician Decision|0
1472143|NCT00673387|4852645|P3|Overall Study|Physician Decision|0
1472144|NCT00673387|4852646|P2|Overall Study|Physician Decision|0
1472145|NCT00673387|4852647|P1|Overall Study|Physician Decision|0
1472146|NCT00673387|4852640|P8|Overall Study|Adverse Event|5
1472147|NCT00673387|4852641|P7|Overall Study|Adverse Event|5
1472148|NCT00673387|4852642|P6|Overall Study|Adverse Event|2
1472149|NCT00673387|4852643|P5|Overall Study|Adverse Event|6
1472150|NCT00673387|4852644|P4|Overall Study|Adverse Event|2
1472151|NCT00673387|4852645|P3|Overall Study|Adverse Event|5
1472152|NCT00673387|4852646|P2|Overall Study|Adverse Event|1
1472153|NCT00673387|4852647|P1|Overall Study|Adverse Event|3
1472154|NCT00673387|4852640|P8|Overall Study|Withdrawal by Subject|21
1472155|NCT00673387|4852641|P7|Overall Study|Withdrawal by Subject|15
1472156|NCT00673387|4852642|P6|Overall Study|Withdrawal by Subject|21
1472157|NCT00673387|4852643|P5|Overall Study|Withdrawal by Subject|18
1472158|NCT00673387|4852644|P4|Overall Study|Withdrawal by Subject|16
1472159|NCT00673387|4852645|P3|Overall Study|Withdrawal by Subject|20
1472160|NCT00673387|4852646|P2|Overall Study|Withdrawal by Subject|16
1472161|NCT00673387|4852647|P1|Overall Study|Withdrawal by Subject|15
1472162|NCT00673361|4852863|P1|Overall Study|Screen Failure|2
1472163|NCT00673257|4852867|P1|Overall Study|Unable to obtain specimen|1
1472164|NCT00673257|4852867|P1|Overall Study|Withdrawal by Subject|4
1472165|NCT00673231|4852876|P4|Overall Study|Study criteria,compliance,safety, other|4
1472166|NCT00673231|4852877|P3|Overall Study|Study criteria,compliance,safety, other|7
1472167|NCT00673231|4852878|P2|Overall Study|Study criteria,compliance,safety, other|5
1472168|NCT00673231|4852879|P1|Overall Study|Study criteria,compliance,safety, other|8
1472169|NCT00673231|4852876|P4|Overall Study|Death|0
1472170|NCT00673231|4852877|P3|Overall Study|Death|1
1472171|NCT00673231|4852878|P2|Overall Study|Death|0
1472172|NCT00673231|4852879|P1|Overall Study|Death|0
1472173|NCT00673231|4852876|P4|Overall Study|Lost to Follow-up|2
1472174|NCT00673231|4852877|P3|Overall Study|Lost to Follow-up|1
1472175|NCT00673231|4852878|P2|Overall Study|Lost to Follow-up|2
1472176|NCT00673231|4852879|P1|Overall Study|Lost to Follow-up|1
1472177|NCT00673231|4852876|P4|Overall Study|Adverse Event|6
1472178|NCT00673231|4852877|P3|Overall Study|Adverse Event|9
1472179|NCT00673231|4852878|P2|Overall Study|Adverse Event|5
1472180|NCT00673231|4852879|P1|Overall Study|Adverse Event|6
1472181|NCT00673231|4852876|P4|Overall Study|Withdrawal by Subject|6
1472182|NCT00673231|4852877|P3|Overall Study|Withdrawal by Subject|8
1472183|NCT00673231|4852878|P2|Overall Study|Withdrawal by Subject|10
1472184|NCT00673231|4852879|P1|Overall Study|Withdrawal by Subject|14
1472185|NCT00673179|4852911|P2|Overall Study|Toxicity/Complications|0
1472186|NCT00673179|4852912|P1|Overall Study|Toxicity/Complications|3
1472187|NCT00673049|4852961|P4|After Progression on Erlotinib|study terminated by sponsor|4
1472188|NCT00673049|4852962|P3|After Progression on Erlotinib|study terminated by sponsor|0
1472189|NCT00673049|4852963|P2|After Progression on Erlotinib|study terminated by sponsor|0
1472190|NCT00673049|4852964|P1|After Progression on Erlotinib|study terminated by sponsor|0
1472191|NCT00673049|4852961|P4|After Progression on Erlotinib|Withdrawal by Subject|5
1472192|NCT00673049|4852962|P3|After Progression on Erlotinib|Withdrawal by Subject|0
1472193|NCT00673049|4852963|P2|After Progression on Erlotinib|Withdrawal by Subject|0
1472194|NCT00673049|4852964|P1|After Progression on Erlotinib|Withdrawal by Subject|0
1472195|NCT00673049|4852961|P4|After Progression on Erlotinib|Lost to Follow-up|3
1472196|NCT00673049|4852962|P3|After Progression on Erlotinib|Lost to Follow-up|0
1472197|NCT00673049|4852963|P2|After Progression on Erlotinib|Lost to Follow-up|0
1472198|NCT00673049|4852964|P1|After Progression on Erlotinib|Lost to Follow-up|0
1472199|NCT00673049|4852961|P4|After Progression on Erlotinib|Death|71
1472200|NCT00673049|4852962|P3|After Progression on Erlotinib|Death|0
1472201|NCT00673049|4852963|P2|After Progression on Erlotinib|Death|0
1472202|NCT00673049|4852964|P1|After Progression on Erlotinib|Death|0
1472203|NCT00673049|4852961|P4|Before Progression on Erlotinib|Switched to figitumumab|0
1472204|NCT00673049|4852962|P3|Before Progression on Erlotinib|Switched to figitumumab|0
1472205|NCT00673049|4852963|P2|Before Progression on Erlotinib|Switched to figitumumab|83
1472206|NCT00673049|4852964|P1|Before Progression on Erlotinib|Switched to figitumumab|0
1472207|NCT00673049|4852961|P4|Before Progression on Erlotinib|study terminated by sponsor|0
1472208|NCT00673049|4852962|P3|Before Progression on Erlotinib|study terminated by sponsor|0
1472209|NCT00673049|4852963|P2|Before Progression on Erlotinib|study terminated by sponsor|14
1472210|NCT00673049|4852964|P1|Before Progression on Erlotinib|study terminated by sponsor|18
1472211|NCT00673049|4852961|P4|Before Progression on Erlotinib|Other|0
1472212|NCT00673049|4852962|P3|Before Progression on Erlotinib|Other|0
1472213|NCT00673049|4852963|P2|Before Progression on Erlotinib|Other|2
1472214|NCT00673049|4852964|P1|Before Progression on Erlotinib|Other|1
1472215|NCT00673049|4852961|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
1472216|NCT00673049|4852962|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
1472217|NCT00673049|4852963|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
1472218|NCT00673049|4852964|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
1472219|NCT00673049|4852961|P4|Before Progression on Erlotinib|Lost to Follow-up|0
1472220|NCT00673049|4852962|P3|Before Progression on Erlotinib|Lost to Follow-up|0
1472221|NCT00673049|4852963|P2|Before Progression on Erlotinib|Lost to Follow-up|5
1472222|NCT00673049|4852964|P1|Before Progression on Erlotinib|Lost to Follow-up|9
1472223|NCT00673049|4852961|P4|Before Progression on Erlotinib|Death|0
1472224|NCT00673049|4852962|P3|Before Progression on Erlotinib|Death|1
1472225|NCT00673049|4852963|P2|Before Progression on Erlotinib|Death|167
1472226|NCT00673049|4852964|P1|Before Progression on Erlotinib|Death|235
1472227|NCT00673049|4852961|P4|Before Progression on Erlotinib|Randomized but not treated|0
1472228|NCT00673049|4852962|P3|Before Progression on Erlotinib|Randomized but not treated|0
1472229|NCT00673049|4852963|P2|Before Progression on Erlotinib|Randomized but not treated|1
1472230|NCT00673049|4852964|P1|Before Progression on Erlotinib|Randomized but not treated|3
1472231|NCT00672984|4852988|P3|Third Intervention|Adverse Event|1
1472232|NCT00672984|4852989|P2|Third Intervention|Adverse Event|0
1472233|NCT00672984|4852990|P1|Third Intervention|Adverse Event|1
1472234|NCT00672984|4852988|P3|Second Intervention|Protocol Violation|1
1472235|NCT00672984|4852989|P2|Second Intervention|Protocol Violation|1
1472236|NCT00672984|4852990|P1|Second Intervention|Protocol Violation|0
1472237|NCT00672984|4852988|P3|Second Intervention|Withdrawal by Subject|0
1472238|NCT00672984|4852989|P2|Second Intervention|Withdrawal by Subject|3
1472239|NCT00672984|4852990|P1|Second Intervention|Withdrawal by Subject|0
1472240|NCT00672984|4852988|P3|Second Intervention|Non-compliance with facility policies|0
1472241|NCT00672984|4852989|P2|Second Intervention|Non-compliance with facility policies|2
1472242|NCT00672984|4852990|P1|Second Intervention|Non-compliance with facility policies|0
1472243|NCT00672984|4852988|P3|First Intervention|Sponsor decision|0
1472244|NCT00672984|4852989|P2|First Intervention|Sponsor decision|0
1472245|NCT00672984|4852990|P1|First Intervention|Sponsor decision|3
1472246|NCT00672984|4852988|P3|First Intervention|Withdrawal by Subject|2
1472247|NCT00672984|4852989|P2|First Intervention|Withdrawal by Subject|2
1472248|NCT00672984|4852990|P1|First Intervention|Withdrawal by Subject|1
1472249|NCT00672984|4852988|P3|First Intervention|Adverse Event|0
1472250|NCT00672984|4852989|P2|First Intervention|Adverse Event|0
1472251|NCT00672984|4852990|P1|First Intervention|Adverse Event|5
1472252|NCT00672958|4853041|P2|Overall Study|Reason not specified|3
1472253|NCT00672958|4853042|P1|Overall Study|Reason not specified|0
1472254|NCT00672958|4853041|P2|Overall Study|Lost to Follow-up|17
1472255|NCT00672958|4853042|P1|Overall Study|Lost to Follow-up|22
1472256|NCT00672958|4853041|P2|Overall Study|Voluntary withdrawal|8
1472257|NCT00672958|4853042|P1|Overall Study|Voluntary withdrawal|12
1472258|NCT00672958|4853041|P2|Overall Study|Protocol deviations|5
1472259|NCT00672958|4853042|P1|Overall Study|Protocol deviations|11
1472260|NCT00672958|4853041|P2|Overall Study|Non-compliance with study drug|3
1472261|NCT00672958|4853042|P1|Overall Study|Non-compliance with study drug|2
1472262|NCT00672958|4853041|P2|Overall Study|Lack of Efficacy|11
1472263|NCT00672958|4853042|P1|Overall Study|Lack of Efficacy|6
1472264|NCT00672958|4853041|P2|Overall Study|Adverse Event|9
1472265|NCT00672958|4853042|P1|Overall Study|Adverse Event|11
1472266|NCT00672841|4853094|P2|Overall Study|Pregnancy|1
1472267|NCT00672841|4853095|P1|Overall Study|Pregnancy|0
1472268|NCT00672841|4853094|P2|Overall Study|Adverse Event|3
1472269|NCT00672841|4853095|P1|Overall Study|Adverse Event|0
1472270|NCT00672841|4853094|P2|Overall Study|Antifungal therapy, negative glucan|4
1472271|NCT00672841|4853095|P1|Overall Study|Antifungal therapy, negative glucan|0
1472272|NCT00672841|4853094|P2|Overall Study|icteric specimens|3
1472273|NCT00672841|4853095|P1|Overall Study|icteric specimens|0
1472274|NCT00672841|4853094|P2|Overall Study|Comfort care|4
1472275|NCT00672841|4853095|P1|Overall Study|Comfort care|1
1472276|NCT00672646|4853117|P3|Overall Study|Withdrawal by Subject|1
1472277|NCT00672646|4853118|P2|Overall Study|Withdrawal by Subject|0
1472278|NCT00672646|4853119|P1|Overall Study|Withdrawal by Subject|0
1472279|NCT00672646|4853117|P3|Overall Study|Lost to Follow-up|2
1472280|NCT00672646|4853118|P2|Overall Study|Lost to Follow-up|1
1472281|NCT00672646|4853119|P1|Overall Study|Lost to Follow-up|0
1472282|NCT00672633|4853144|P2|Overall Study|Withdrawal by Subject|1
1472283|NCT00672633|4853145|P1|Overall Study|Withdrawal by Subject|0
1472284|NCT00672620|4853159|P4|Overall Study|Reason not Specified|1
1472285|NCT00672620|4853160|P3|Overall Study|Reason not Specified|2
1472286|NCT00672620|4853161|P2|Overall Study|Reason not Specified|3
1472287|NCT00672620|4853162|P1|Overall Study|Reason not Specified|3
1472288|NCT00672620|4853159|P4|Overall Study|Lost to Follow-up|11
1472289|NCT00672620|4853160|P3|Overall Study|Lost to Follow-up|8
1472290|NCT00672620|4853161|P2|Overall Study|Lost to Follow-up|19
1472291|NCT00672620|4853162|P1|Overall Study|Lost to Follow-up|8
1472292|NCT00672620|4853159|P4|Overall Study|Withdrawal of Consent|6
1472293|NCT00672620|4853160|P3|Overall Study|Withdrawal of Consent|5
1472294|NCT00672620|4853161|P2|Overall Study|Withdrawal of Consent|12
1472295|NCT00672620|4853162|P1|Overall Study|Withdrawal of Consent|6
1472296|NCT00672620|4853159|P4|Overall Study|Protocol Deviations|5
1472297|NCT00672620|4853160|P3|Overall Study|Protocol Deviations|2
1472298|NCT00672620|4853161|P2|Overall Study|Protocol Deviations|7
1472299|NCT00672620|4853162|P1|Overall Study|Protocol Deviations|5
1472300|NCT00672620|4853159|P4|Overall Study|Noncompliance with Study Drug|2
1472301|NCT00672620|4853160|P3|Overall Study|Noncompliance with Study Drug|0
1472302|NCT00672620|4853161|P2|Overall Study|Noncompliance with Study Drug|4
1472303|NCT00672620|4853162|P1|Overall Study|Noncompliance with Study Drug|3
1472304|NCT00672620|4853159|P4|Overall Study|Lack of Efficacy|0
1472305|NCT00672620|4853160|P3|Overall Study|Lack of Efficacy|2
1472306|NCT00672620|4853161|P2|Overall Study|Lack of Efficacy|2
1472307|NCT00672620|4853162|P1|Overall Study|Lack of Efficacy|1
1472308|NCT00672620|4853159|P4|Overall Study|Adverse Event|17
1472309|NCT00672620|4853160|P3|Overall Study|Adverse Event|12
1472310|NCT00672620|4853161|P2|Overall Study|Adverse Event|7
1472311|NCT00672620|4853162|P1|Overall Study|Adverse Event|7
1472312|NCT00672555|4853227|P1|Overall Study|Did not want to answer questionnaire|2
1472313|NCT00672555|4853227|P1|Overall Study|Lost to Follow-up|4
1472314|NCT00672490|4853238|P2|Overall Study|No reason was provided|2
1472315|NCT00672490|4853239|P1|Overall Study|No reason was provided|6
1472316|NCT00672490|4853238|P2|Overall Study|Lost to Follow-up|5
1472317|NCT00672490|4853239|P1|Overall Study|Lost to Follow-up|1
1472318|NCT00672490|4853238|P2|Overall Study|Intolerance|2
1472319|NCT00672490|4853239|P1|Overall Study|Intolerance|0
1472320|NCT00672490|4853238|P2|Overall Study|Violation of Concomitant Medicine|0
1472321|NCT00672490|4853239|P1|Overall Study|Violation of Concomitant Medicine|1
1472322|NCT00672490|4853238|P2|Overall Study|Adverse Event|8
1472323|NCT00672490|4853239|P1|Overall Study|Adverse Event|5
1472324|NCT00672490|4853238|P2|Overall Study|Mismatch Include/Exclude Criteria|0
1472325|NCT00672490|4853239|P1|Overall Study|Mismatch Include/Exclude Criteria|1
1472326|NCT00672490|4853238|P2|Overall Study|Lack of Compliance|7
1472327|NCT00672490|4853239|P1|Overall Study|Lack of Compliance|2
1472328|NCT00672490|4853238|P2|Overall Study|Withdrawal by Subject|8
1472329|NCT00672490|4853239|P1|Overall Study|Withdrawal by Subject|8
1472330|NCT00672477|4853263|P2|Overall Study|no study drug for low GFR, health cond.|3
1472331|NCT00672477|4853264|P1|Overall Study|no study drug for low GFR, health cond.|1
1472332|NCT00672477|4853263|P2|Overall Study|Lack of Efficacy|1
1472333|NCT00672477|4853264|P1|Overall Study|Lack of Efficacy|1
1472334|NCT00672477|4853263|P2|Overall Study|Withdrawal by Subject|3
1472335|NCT00672477|4853264|P1|Overall Study|Withdrawal by Subject|5
1472336|NCT00672477|4853263|P2|Overall Study|Protocol Violation|1
1472337|NCT00672477|4853264|P1|Overall Study|Protocol Violation|1
1472338|NCT00672477|4853263|P2|Overall Study|Physician Decision|0
1472339|NCT00672477|4853264|P1|Overall Study|Physician Decision|2
1472340|NCT00672477|4853263|P2|Overall Study|Death|11
1472341|NCT00672477|4853264|P1|Overall Study|Death|7
1472342|NCT00672477|4853263|P2|Overall Study|Adverse Event|7
1472343|NCT00672477|4853264|P1|Overall Study|Adverse Event|10
1472344|NCT00672256|4853306|P1|Overall Study|PI dropped, bad data|44
1472345|NCT00672139|4853331|P2|Overall Study|hospice discharge, caregiver requests|2
1472346|NCT00672139|4853332|P1|Overall Study|hospice discharge, caregiver requests|3
1472347|NCT00672139|4853331|P2|Overall Study|Protocol Violation|1
1472348|NCT00672139|4853332|P1|Overall Study|Protocol Violation|1
1472349|NCT00672139|4853331|P2|Overall Study|Lack of Efficacy|1
1472350|NCT00672139|4853332|P1|Overall Study|Lack of Efficacy|4
1472351|NCT00672139|4853331|P2|Overall Study|Physician Decision|0
1472352|NCT00672139|4853332|P1|Overall Study|Physician Decision|2
1472353|NCT00672139|4853331|P2|Overall Study|Adverse Event|7
1472354|NCT00672139|4853332|P1|Overall Study|Adverse Event|4
1472355|NCT00672139|4853331|P2|Overall Study|Withdrawal by Subject|11
1472356|NCT00672139|4853332|P1|Overall Study|Withdrawal by Subject|2
1472357|NCT00672139|4853331|P2|Overall Study|Death|23
1472358|NCT00672139|4853332|P1|Overall Study|Death|14
1472359|NCT00671931|4853389|P5|Overall Study|Physician Decision|1
1472360|NCT00671931|4853390|P4|Overall Study|Physician Decision|2
1472361|NCT00671931|4853391|P3|Overall Study|Physician Decision|0
1472362|NCT00671931|4853392|P2|Overall Study|Physician Decision|0
1472363|NCT00671931|4853393|P1|Overall Study|Physician Decision|1
1472364|NCT00671879|4853413|P3|Overall Study|Withdrawal by Subject|6
1472365|NCT00671879|4853414|P2|Overall Study|Withdrawal by Subject|4
1472366|NCT00671879|4853415|P1|Overall Study|Withdrawal by Subject|0
1472367|NCT00671853|4853428|P2|Overall Study|Non-adherence with study procedures|4
1472368|NCT00671853|4853429|P1|Overall Study|Non-adherence with study procedures|1
1472369|NCT00671853|4853428|P2|Overall Study|Physician Decision|2
1472370|NCT00671853|4853429|P1|Overall Study|Physician Decision|0
1472371|NCT00671853|4853428|P2|Overall Study|Lost to Follow-up|8
1472372|NCT00671853|4853429|P1|Overall Study|Lost to Follow-up|8
1472373|NCT00671853|4853428|P2|Overall Study|Withdrawal by Subject|5
1472374|NCT00671853|4853429|P1|Overall Study|Withdrawal by Subject|1
1472375|NCT00671853|4853428|P2|Overall Study|Adverse Event|1
1472376|NCT00671853|4853429|P1|Overall Study|Adverse Event|7
1472377|NCT00671853|4853428|P2|Overall Study|Lack of Efficacy|7
1472378|NCT00671853|4853429|P1|Overall Study|Lack of Efficacy|3
1472379|NCT00671788|4853445|P1|Overall Study|Other|1
1472380|NCT00671788|4853445|P1|Overall Study|MD Decision|1
1472381|NCT00671788|4853445|P1|Overall Study|Ineligible|1
1472382|NCT00671788|4853445|P1|Overall Study|Refused further treatment|3
1472383|NCT00671788|4853445|P1|Overall Study|Adverse Event|8
1472384|NCT00671749|4853452|P1|Overall Study|Lost to Follow-up|1
1472385|NCT00671749|4853452|P1|Overall Study|Protocol Violation|1
1472386|NCT00671749|4853452|P1|Overall Study|Withdrawal by Subject|4
1472387|NCT00671749|4853452|P1|Overall Study|Adverse Event|2
1472388|NCT00671554|4853511|P1|Overall Study|Disease progression|3
1472389|NCT00671437|4853550|P1|Overall Study|Ineligible post-hoc|1
1472390|NCT00671437|4853550|P1|Overall Study|Adverse Event|3
1472391|NCT00671437|4853550|P1|Overall Study|Cutaneous SCC of head and neck|3
1472392|NCT00671437|4853550|P1|Overall Study|Progressive disease before C1 week 8|8
1472393|NCT00671060|4853584|P2|Overall Study|Physician Decision|1
1472394|NCT00671060|4853585|P1|Overall Study|Physician Decision|0
1472395|NCT00671060|4853584|P2|Overall Study|Protocol Violation|0
1472396|NCT00671060|4853585|P1|Overall Study|Protocol Violation|1
1472397|NCT00670930|4853611|P2|Overall Study|Lost to Follow-up|0
1472398|NCT00670930|4853612|P1|Overall Study|Lost to Follow-up|1
1472399|NCT00670930|4853611|P2|Overall Study|Adminstrative Problem|1
1472400|NCT00670930|4853612|P1|Overall Study|Adminstrative Problem|0
1472401|NCT00670800|4853628|P2|Overall Study|2 controls were insulin resistant|2
1472402|NCT00670800|4853629|P1|Overall Study|2 controls were insulin resistant|0
1472403|NCT00670748|4853660|P4|Overall Study|Not off study|1
1472404|NCT00670748|4853661|P3|Overall Study|Not off study|1
1472405|NCT00670748|4853662|P2|Overall Study|Not off study|1
1472406|NCT00670748|4853663|P1|Overall Study|Not off study|2
1472407|NCT00670748|4853660|P4|Overall Study|Death during treatment|0
1472408|NCT00670748|4853661|P3|Overall Study|Death during treatment|1
1472409|NCT00670748|4853662|P2|Overall Study|Death during treatment|1
1472410|NCT00670748|4853663|P1|Overall Study|Death during treatment|1
1472411|NCT00670540|4853698|P1|Overall Study|missing information inclusion criteria|1
1472412|NCT00670540|4853698|P1|Overall Study|controls randomised for no follow up|2770
1472413|NCT00670540|4853698|P1|Overall Study|refused to participate|189
1472414|NCT00670540|4853698|P1|Overall Study|not living in France|348
1472415|NCT00670540|4853698|P1|Overall Study|ineligible|17
1472416|NCT00670449|4853743|P4|Overall Study|Abnormal Laboratory Value(s)|0
1472417|NCT00670449|4853744|P3|Overall Study|Abnormal Laboratory Value(s)|0
1472418|NCT00670449|4853745|P2|Overall Study|Abnormal Laboratory Value(s)|2
1472419|NCT00670449|4853746|P1|Overall Study|Abnormal Laboratory Value(s)|0
1472420|NCT00670449|4853743|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
1472421|NCT00670449|4853744|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
1472422|NCT00670449|4853745|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
1472423|NCT00670449|4853746|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
1472424|NCT00670449|4853743|P4|Overall Study|Subject Withdrew Consent|1
1472425|NCT00670449|4853744|P3|Overall Study|Subject Withdrew Consent|0
1472426|NCT00670449|4853745|P2|Overall Study|Subject Withdrew Consent|2
1472427|NCT00670449|4853746|P1|Overall Study|Subject Withdrew Consent|0
1472428|NCT00670449|4853743|P4|Overall Study|Administrative Problems|1
1472429|NCT00670449|4853744|P3|Overall Study|Administrative Problems|0
1472430|NCT00670449|4853745|P2|Overall Study|Administrative Problems|2
1472431|NCT00670449|4853746|P1|Overall Study|Administrative Problems|0
1472432|NCT00670449|4853743|P4|Overall Study|Protocol Deviation|1
1472433|NCT00670449|4853744|P3|Overall Study|Protocol Deviation|0
1472434|NCT00670449|4853745|P2|Overall Study|Protocol Deviation|2
1472435|NCT00670449|4853746|P1|Overall Study|Protocol Deviation|1
1472436|NCT00670449|4853743|P4|Overall Study|Adverse Event|5
1472437|NCT00670449|4853744|P3|Overall Study|Adverse Event|8
1472438|NCT00670449|4853745|P2|Overall Study|Adverse Event|2
1472439|NCT00670449|4853746|P1|Overall Study|Adverse Event|6
1472440|NCT00670306|4853770|P1|Overall Study|incl/excl criterias did not meet|19
1472441|NCT00670306|4853770|P1|Overall Study|Lost to Follow-up|8
1472442|NCT00670306|4853770|P1|Overall Study|Physician Decision|1
1472443|NCT00670306|4853770|P1|Overall Study|Withdrawal by Subject|9
1472444|NCT00670306|4853770|P1|Overall Study|Lack of Efficacy|10
1472445|NCT00670306|4853770|P1|Overall Study|Adverse Event|8
1472446|NCT00670228|4853809|P2|Overall Study|Not meeting the selection criteria|0
1472447|NCT00670228|4853810|P1|Overall Study|Not meeting the selection criteria|2
1472448|NCT00670228|4853809|P2|Overall Study|Not treated|2
1472449|NCT00670228|4853810|P1|Overall Study|Not treated|2
1472450|NCT00670228|4853809|P2|Overall Study|Death or MACE|1
1472451|NCT00670228|4853810|P1|Overall Study|Death or MACE|0
1472452|NCT00670228|4853809|P2|Overall Study|Adverse Event|0
1472453|NCT00670228|4853810|P1|Overall Study|Adverse Event|1
1472454|NCT00670111|4853834|P3|Enrollment to One Month|Physician Decision|0
1472455|NCT00670111|4853835|P2|Enrollment to One Month|Physician Decision|0
1472456|NCT00670111|4853836|P1|Enrollment to One Month|Physician Decision|1
1472457|NCT00670111|4853834|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
1472458|NCT00670111|4853835|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
1472459|NCT00670111|4853836|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
1472460|NCT00670111|4853834|P3|Enrollment to One Month|Testing Failure|13
1472461|NCT00670111|4853835|P2|Enrollment to One Month|Testing Failure|0
1472462|NCT00670111|4853836|P1|Enrollment to One Month|Testing Failure|0
1472463|NCT00670007|4853844|P1|Overall Study|Withdrawal by Subject|4
1472464|NCT00670007|4853844|P1|Overall Study|Adverse Event|1
1472465|NCT00670007|4853844|P1|Overall Study|Adverse event, serious fatal|1
1472466|NCT00670007|4853844|P1|Overall Study|Travel/Vacation|1
1472467|NCT00670007|4853844|P1|Overall Study|Lung transplant|1
1472468|NCT00670007|4853844|P1|Overall Study|Drug abuse|1
1472469|NCT00669955|4853871|P2|Overall Study|not compliant with study drug/visit|3
1472470|NCT00669955|4853872|P1|Overall Study|not compliant with study drug/visit|2
1472471|NCT00669955|4853871|P2|Overall Study|Investigator Sponsor Judgement|1
1472472|NCT00669955|4853872|P1|Overall Study|Investigator Sponsor Judgement|0
1472473|NCT00669955|4853871|P2|Overall Study|Protocol Violation|7
1472474|NCT00669955|4853872|P1|Overall Study|Protocol Violation|2
1472475|NCT00669955|4853871|P2|Overall Study|Lost to Follow-up|7
1472476|NCT00669955|4853872|P1|Overall Study|Lost to Follow-up|5
1472477|NCT00669955|4853871|P2|Overall Study|Withdrawal by Subject|3
1472478|NCT00669955|4853872|P1|Overall Study|Withdrawal by Subject|2
1472479|NCT00669955|4853871|P2|Overall Study|Death|1
1472480|NCT00669955|4853872|P1|Overall Study|Death|0
1472481|NCT00669955|4853871|P2|Overall Study|Adverse Event|5
1472482|NCT00669955|4853872|P1|Overall Study|Adverse Event|3
1472483|NCT00669942|4853902|P12|Parts 2 and 3|Protocol Violation|0
1472484|NCT00669942|4853903|P11|Parts 2 and 3|Protocol Violation|0
1472485|NCT00669942|4853904|P10|Parts 2 and 3|Protocol Violation|0
1472486|NCT00669942|4853905|P9|Parts 2 and 3|Protocol Violation|0
1472487|NCT00669942|4853906|P8|Parts 2 and 3|Protocol Violation|0
1472488|NCT00669942|4853907|P7|Parts 2 and 3|Protocol Violation|0
1472489|NCT00669942|4853908|P6|Parts 2 and 3|Protocol Violation|1
1472490|NCT00669942|4853909|P5|Parts 2 and 3|Protocol Violation|0
1472491|NCT00669942|4853910|P4|Parts 2 and 3|Protocol Violation|0
1472492|NCT00669942|4853911|P3|Parts 2 and 3|Protocol Violation|0
1472493|NCT00669942|4853912|P2|Parts 2 and 3|Protocol Violation|0
1472494|NCT00669942|4853913|P1|Parts 2 and 3|Protocol Violation|0
1472495|NCT00669942|4853902|P12|Parts 2 and 3|Withdrawal by Subject|0
1472496|NCT00669942|4853903|P11|Parts 2 and 3|Withdrawal by Subject|0
1472497|NCT00669942|4853904|P10|Parts 2 and 3|Withdrawal by Subject|0
1472498|NCT00669942|4853905|P9|Parts 2 and 3|Withdrawal by Subject|2
1472499|NCT00669942|4853906|P8|Parts 2 and 3|Withdrawal by Subject|0
1472500|NCT00669942|4853907|P7|Parts 2 and 3|Withdrawal by Subject|0
1472501|NCT00669942|4853908|P6|Parts 2 and 3|Withdrawal by Subject|1
1472502|NCT00669942|4853909|P5|Parts 2 and 3|Withdrawal by Subject|0
1472503|NCT00669942|4853910|P4|Parts 2 and 3|Withdrawal by Subject|0
1472504|NCT00669942|4853911|P3|Parts 2 and 3|Withdrawal by Subject|0
1472505|NCT00669942|4853912|P2|Parts 2 and 3|Withdrawal by Subject|0
1472506|NCT00669942|4853913|P1|Parts 2 and 3|Withdrawal by Subject|0
1472507|NCT00669942|4853902|P12|Parts 2 and 3|Adverse Event|0
1472508|NCT00669942|4853903|P11|Parts 2 and 3|Adverse Event|0
1472509|NCT00669942|4853904|P10|Parts 2 and 3|Adverse Event|0
1472510|NCT00669942|4853905|P9|Parts 2 and 3|Adverse Event|1
1472511|NCT00669942|4853906|P8|Parts 2 and 3|Adverse Event|2
1472512|NCT00669942|4853907|P7|Parts 2 and 3|Adverse Event|0
1472513|NCT00669942|4853908|P6|Parts 2 and 3|Adverse Event|0
1472514|NCT00669942|4853909|P5|Parts 2 and 3|Adverse Event|0
1472515|NCT00669942|4853910|P4|Parts 2 and 3|Adverse Event|0
1472516|NCT00669942|4853911|P3|Parts 2 and 3|Adverse Event|0
1472517|NCT00669942|4853912|P2|Parts 2 and 3|Adverse Event|0
1472518|NCT00669942|4853913|P1|Parts 2 and 3|Adverse Event|0
1472519|NCT00669903|4853996|P4|Overall Study|Protocol Violation|0
1472520|NCT00669903|4853997|P3|Overall Study|Protocol Violation|0
1472521|NCT00669903|4853998|P2|Overall Study|Protocol Violation|1
1472522|NCT00669903|4853999|P1|Overall Study|Protocol Violation|0
1472523|NCT00669903|4853996|P4|Overall Study|Lost to Follow-up|1
1472524|NCT00669903|4853997|P3|Overall Study|Lost to Follow-up|0
1472525|NCT00669903|4853998|P2|Overall Study|Lost to Follow-up|1
1472526|NCT00669903|4853999|P1|Overall Study|Lost to Follow-up|1
1472527|NCT00669903|4853996|P4|Overall Study|Withdrawal by Subject|2
1472528|NCT00669903|4853997|P3|Overall Study|Withdrawal by Subject|2
1472529|NCT00669903|4853998|P2|Overall Study|Withdrawal by Subject|2
1472530|NCT00669903|4853999|P1|Overall Study|Withdrawal by Subject|0
1472531|NCT00669903|4853996|P4|Overall Study|Adverse Event|1
1472532|NCT00669903|4853997|P3|Overall Study|Adverse Event|3
1472533|NCT00669903|4853998|P2|Overall Study|Adverse Event|1
1472534|NCT00669903|4853999|P1|Overall Study|Adverse Event|0
1472535|NCT00669877|4854029|P1|Overall Study|Disease Progression/Death|4
1472536|NCT00669864|4854034|P1|Overall Study|Other|2
1472537|NCT00669864|4854034|P1|Overall Study|Withdrawal by Subject|3
1472538|NCT00669864|4854034|P1|Overall Study|Protocol Violation|2
1472539|NCT00669864|4854034|P1|Overall Study|Lost to Follow-up|2
1472540|NCT00669617|4854048|P5|Period 3|Lost to Follow-up|0
1472541|NCT00669617|4854049|P4|Period 3|Lost to Follow-up|0
1472542|NCT00669617|4854050|P3|Period 3|Lost to Follow-up|0
1472543|NCT00669617|4854051|P2|Period 3|Lost to Follow-up|0
1472544|NCT00669617|4854052|P1|Period 3|Lost to Follow-up|1
1472545|NCT00669617|4854048|P5|Period 1|Protocol Deviation|1
1472546|NCT00669617|4854049|P4|Period 1|Protocol Deviation|0
1472547|NCT00669617|4854050|P3|Period 1|Protocol Deviation|0
1472548|NCT00669617|4854051|P2|Period 1|Protocol Deviation|0
1472549|NCT00669617|4854052|P1|Period 1|Protocol Deviation|0
1472550|NCT00669617|4854048|P5|Period 1|Withdrawal by Subject|0
1472551|NCT00669617|4854049|P4|Period 1|Withdrawal by Subject|0
1472552|NCT00669617|4854050|P3|Period 1|Withdrawal by Subject|1
1472553|NCT00669617|4854051|P2|Period 1|Withdrawal by Subject|0
1472554|NCT00669617|4854052|P1|Period 1|Withdrawal by Subject|0
1472555|NCT00669396|4854100|P2|Overall Study|Lost to Follow-up|12
1472556|NCT00669396|4854101|P1|Overall Study|Lost to Follow-up|10
1472557|NCT00669331|4854115|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
1472558|NCT00669331|4854116|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
1472559|NCT00669331|4854115|P2|Blinded Treatment Period|Physician Decision|3
1472560|NCT00669331|4854116|P1|Blinded Treatment Period|Physician Decision|3
1472561|NCT00669331|4854115|P2|Blinded Treatment Period|Death|2
1472562|NCT00669331|4854116|P1|Blinded Treatment Period|Death|0
1472563|NCT00669331|4854115|P2|Blinded Treatment Period|Lost to Follow-up|2
1472564|NCT00669331|4854116|P1|Blinded Treatment Period|Lost to Follow-up|3
1472565|NCT00669331|4854115|P2|Blinded Treatment Period|Withdrawal by Subject|19
1472566|NCT00669331|4854116|P1|Blinded Treatment Period|Withdrawal by Subject|17
1472567|NCT00669331|4854115|P2|Blinded Treatment Period|Protocol Violation|1
1472568|NCT00669331|4854116|P1|Blinded Treatment Period|Protocol Violation|1
1472569|NCT00669331|4854115|P2|Blinded Treatment Period|Adverse Event|10
1472570|NCT00669331|4854116|P1|Blinded Treatment Period|Adverse Event|16
1472571|NCT00669331|4854115|P2|Randomisation to First Dose|Randomised in error|10
1472572|NCT00669331|4854116|P1|Randomisation to First Dose|Randomised in error|3
1472573|NCT00669331|4854115|P2|Randomisation to First Dose|Sponsor decision|1
1472574|NCT00669331|4854116|P1|Randomisation to First Dose|Sponsor decision|0
1472575|NCT00669331|4854115|P2|Randomisation to First Dose|Death|0
1472576|NCT00669331|4854116|P1|Randomisation to First Dose|Death|1
1472577|NCT00669331|4854115|P2|Randomisation to First Dose|Lost to Follow-up|0
1472578|NCT00669331|4854116|P1|Randomisation to First Dose|Lost to Follow-up|2
1472579|NCT00669331|4854115|P2|Randomisation to First Dose|Withdrawal by Subject|2
1472580|NCT00669331|4854116|P1|Randomisation to First Dose|Withdrawal by Subject|3
1472581|NCT00669331|4854115|P2|Randomisation to First Dose|Protocol Violation|0
1472582|NCT00669331|4854116|P1|Randomisation to First Dose|Protocol Violation|1
1472583|NCT00669331|4854115|P2|Randomisation to First Dose|Adverse Event|0
1472584|NCT00669331|4854116|P1|Randomisation to First Dose|Adverse Event|1
1472585|NCT00669318|4854158|P1|Overall Study|Withdrawal by Subject|2
1472586|NCT00669240|4854175|P1|Overall Study|Enrolled but no dosing record|1
1472587|NCT00669240|4854175|P1|Overall Study|Enrolled but not treated|15
1472588|NCT00669240|4854175|P1|Overall Study|Other|19
1472589|NCT00669240|4854175|P1|Overall Study|Adverse Event|21
1472590|NCT00669240|4854175|P1|Overall Study|Lost to Follow-up|34
1472591|NCT00669240|4854175|P1|Overall Study|Withdrawal by Subject|42
1472592|NCT00669240|4854175|P1|Overall Study|Lack of Efficacy|33
1472593|NCT00669110|4854226|P2|Overall Study|Withdrawal by Subject|2
1472594|NCT00669110|4854227|P1|Overall Study|Withdrawal by Subject|0
1472595|NCT00669110|4854226|P2|Overall Study|Protocol Violation|5
1472596|NCT00669110|4854227|P1|Overall Study|Protocol Violation|0
1472597|NCT00669110|4854226|P2|Overall Study|Lost to Follow-up|0
1472598|NCT00669110|4854227|P1|Overall Study|Lost to Follow-up|1
1472599|NCT00669110|4854226|P2|Overall Study|Physician Decision|1
1472600|NCT00669110|4854227|P1|Overall Study|Physician Decision|0
1472601|NCT00669110|4854226|P2|Overall Study|Caregiver request|2
1472602|NCT00669110|4854227|P1|Overall Study|Caregiver request|3
1472603|NCT00669110|4854226|P2|Overall Study|Adverse Event|3
1472604|NCT00669110|4854227|P1|Overall Study|Adverse Event|4
1472605|NCT00669071|4854263|P1|Overall Study|Final visit 40 days out of window|1
1472606|NCT00669071|4854263|P1|Overall Study|Lost to Follow-up|3
1472607|NCT00669032|4854284|P2|Overall Study|No fulfilment of the selection criteria|5
1472608|NCT00669032|4854285|P1|Overall Study|No fulfilment of the selection criteria|5
1472609|NCT00669032|4854284|P2|Overall Study|Physician Decision|1
1472610|NCT00669032|4854285|P1|Overall Study|Physician Decision|1
1472611|NCT00669032|4854284|P2|Overall Study|Adverse Event|16
1472612|NCT00669032|4854285|P1|Overall Study|Adverse Event|12
1472613|NCT00669032|4854284|P2|Overall Study|Withdrawal by Subject|13
1472614|NCT00669032|4854285|P1|Overall Study|Withdrawal by Subject|12
1472615|NCT00669032|4854284|P2|Overall Study|Lack of Efficacy|19
1472616|NCT00669032|4854285|P1|Overall Study|Lack of Efficacy|8
1472617|NCT00669032|4854284|P2|Overall Study|Lost to Follow-up|5
1472618|NCT00669032|4854285|P1|Overall Study|Lost to Follow-up|6
1472619|NCT00668863|4854331|P1|Overall Study|Physician Decision|1
1472620|NCT00668863|4854331|P1|Overall Study|Subject’s work scheduling problem|1
1472621|NCT00668863|4854331|P1|Overall Study|Surgery|1
1472622|NCT00668863|4854331|P1|Overall Study|Withdrawal by Subject|1
1472623|NCT00668863|4854331|P1|Overall Study|Global Deterioration of Health Status|4
1472624|NCT00668863|4854331|P1|Overall Study|Study Terminated by Sponsor|8
1472625|NCT00668863|4854331|P1|Overall Study|Adverse Event|13
1472626|NCT00668863|4854331|P1|Overall Study|Objective Progression or Relapse|42
1472627|NCT00668746|4854361|P2|Overall Study|Lost to Follow-up|1
1472628|NCT00668746|4854362|P1|Overall Study|Lost to Follow-up|2
1472629|NCT00668733|4854382|P2|Overall Study|Withdrawal by Subject|4
1472630|NCT00668733|4854383|P1|Overall Study|Withdrawal by Subject|0
1472631|NCT00668733|4854382|P2|Overall Study|Lost to Follow-up|3
1472632|NCT00668733|4854383|P1|Overall Study|Lost to Follow-up|2
1472633|NCT00668395|4854428|P3|Overall Study|Physician Decision|0
1472634|NCT00668395|4854429|P2|Overall Study|Physician Decision|1
1472635|NCT00668395|4854430|P1|Overall Study|Physician Decision|1
1472636|NCT00668395|4854428|P3|Overall Study|Adverse Event|0
1472637|NCT00668395|4854429|P2|Overall Study|Adverse Event|1
1472638|NCT00668395|4854430|P1|Overall Study|Adverse Event|1
1472639|NCT00668395|4854428|P3|Overall Study|Withdrawal by Subject|1
1472640|NCT00668395|4854429|P2|Overall Study|Withdrawal by Subject|4
1472641|NCT00668395|4854430|P1|Overall Study|Withdrawal by Subject|4
1472642|NCT00668317|4854442|P1|Overall Study|Adverse Event|2
1472643|NCT00668200|4854457|P1|Overall Study|Lost to Follow-up|1
1472644|NCT00668200|4854457|P1|Overall Study|Withdrawal by Subject|2
1472645|NCT00668148|4854463|P1|Overall Study|Withdrawal of Consent|2
1472646|NCT00668148|4854463|P1|Overall Study|Progressive Disease Before Treatment|2
1472647|NCT00668148|4854463|P1|Overall Study|Subject Non-compliance|1
1472648|NCT00668148|4854463|P1|Overall Study|Adverse Event|5
1472649|NCT00667992|4854502|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
1472650|NCT00667992|4854503|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
1472651|NCT00667992|4854502|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
1472652|NCT00667992|4854503|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
1472653|NCT00667992|4854502|P2|Wash-out|Withdrawal by Subject|0
1472654|NCT00667992|4854503|P1|Wash-out|Withdrawal by Subject|1
1472655|NCT00667992|4854502|P2|Wash-out|Failure to wash-out|2
1472656|NCT00667992|4854503|P1|Wash-out|Failure to wash-out|2
1472657|NCT00667992|4854502|P2|Wash-out|Not within one doubling dilution|3
1472658|NCT00667992|4854503|P1|Wash-out|Not within one doubling dilution|4
1472659|NCT00667992|4854502|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
1472660|NCT00667992|4854503|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
1472661|NCT00667992|4854502|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
1472662|NCT00667992|4854503|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
1472663|NCT00667992|4854502|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
1472664|NCT00667992|4854503|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
1472665|NCT00667992|4854502|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
1472666|NCT00667992|4854503|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
1472667|NCT00667992|4854502|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
1472668|NCT00667992|4854503|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
1472669|NCT00667992|4854502|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
1472670|NCT00667992|4854503|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
1472671|NCT00667992|4854502|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
1472672|NCT00667992|4854503|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
1472673|NCT00667992|4854502|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
1472674|NCT00667992|4854503|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
1472675|NCT00667875|4854560|P3|Overall Study|Withdrawal by Subject|7
1472676|NCT00667875|4854561|P2|Overall Study|Withdrawal by Subject|9
1472677|NCT00667875|4854562|P1|Overall Study|Withdrawal by Subject|10
1472678|NCT00667875|4854560|P3|Overall Study|Adverse Event|6
1472679|NCT00667875|4854561|P2|Overall Study|Adverse Event|2
1472680|NCT00667875|4854562|P1|Overall Study|Adverse Event|0
1472681|NCT00667810|4854596|P4|Overall Study|Not specified|0
1472682|NCT00667810|4854597|P3|Overall Study|Not specified|5
1472683|NCT00667810|4854598|P2|Overall Study|Not specified|6
1472684|NCT00667810|4854599|P1|Overall Study|Not specified|6
1472685|NCT00667810|4854596|P4|Overall Study|Vasogenic Edema Recurrence|0
1472686|NCT00667810|4854597|P3|Overall Study|Vasogenic Edema Recurrence|0
1472687|NCT00667810|4854598|P2|Overall Study|Vasogenic Edema Recurrence|3
1472688|NCT00667810|4854599|P1|Overall Study|Vasogenic Edema Recurrence|0
1472689|NCT00667810|4854596|P4|Overall Study|Loss of Caregiver|0
1472690|NCT00667810|4854597|P3|Overall Study|Loss of Caregiver|3
1472691|NCT00667810|4854598|P2|Overall Study|Loss of Caregiver|1
1472692|NCT00667810|4854599|P1|Overall Study|Loss of Caregiver|0
1472693|NCT00667810|4854596|P4|Overall Study|Failed to Return|0
1472694|NCT00667810|4854597|P3|Overall Study|Failed to Return|2
1472695|NCT00667810|4854598|P2|Overall Study|Failed to Return|0
1472696|NCT00667810|4854599|P1|Overall Study|Failed to Return|0
1472697|NCT00667810|4854596|P4|Overall Study|Discontinuation of Study by Sponsor|0
1472698|NCT00667810|4854597|P3|Overall Study|Discontinuation of Study by Sponsor|155
1472699|NCT00667810|4854598|P2|Overall Study|Discontinuation of Study by Sponsor|118
1472700|NCT00667810|4854599|P1|Overall Study|Discontinuation of Study by Sponsor|130
1472701|NCT00667810|4854596|P4|Overall Study|Withdrawal by Subject|1
1472702|NCT00667810|4854597|P3|Overall Study|Withdrawal by Subject|29
1472703|NCT00667810|4854598|P2|Overall Study|Withdrawal by Subject|20
1472704|NCT00667810|4854599|P1|Overall Study|Withdrawal by Subject|14
1472705|NCT00667810|4854596|P4|Overall Study|Protocol Violation|0
1472706|NCT00667810|4854597|P3|Overall Study|Protocol Violation|0
1472707|NCT00667810|4854598|P2|Overall Study|Protocol Violation|2
1472708|NCT00667810|4854599|P1|Overall Study|Protocol Violation|0
1472709|NCT00667810|4854596|P4|Overall Study|Physician Decision|0
1472710|NCT00667810|4854597|P3|Overall Study|Physician Decision|2
1472711|NCT00667810|4854598|P2|Overall Study|Physician Decision|1
1472712|NCT00667810|4854599|P1|Overall Study|Physician Decision|1
1472713|NCT00667810|4854596|P4|Overall Study|Lost to Follow-up|0
1472714|NCT00667810|4854597|P3|Overall Study|Lost to Follow-up|2
1472715|NCT00667810|4854598|P2|Overall Study|Lost to Follow-up|4
1472716|NCT00667810|4854599|P1|Overall Study|Lost to Follow-up|1
1472717|NCT00667810|4854596|P4|Overall Study|Lack of Efficacy|0
1472718|NCT00667810|4854597|P3|Overall Study|Lack of Efficacy|2
1472719|NCT00667810|4854598|P2|Overall Study|Lack of Efficacy|0
1472720|NCT00667810|4854599|P1|Overall Study|Lack of Efficacy|1
1472721|NCT00667810|4854596|P4|Overall Study|Death|0
1472722|NCT00667810|4854597|P3|Overall Study|Death|3
1472723|NCT00667810|4854598|P2|Overall Study|Death|1
1472724|NCT00667810|4854599|P1|Overall Study|Death|1
1472725|NCT00667810|4854596|P4|Overall Study|Adverse Event|1
1472726|NCT00667810|4854597|P3|Overall Study|Adverse Event|19
1472727|NCT00667810|4854598|P2|Overall Study|Adverse Event|14
1472728|NCT00667810|4854599|P1|Overall Study|Adverse Event|13
1472729|NCT00667732|4854675|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
1472730|NCT00667732|4854676|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
1472731|NCT00667732|4854677|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
1472732|NCT00667732|4854675|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
1472733|NCT00667732|4854676|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
1472734|NCT00667732|4854677|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
1472735|NCT00667732|4854675|P3|Run -In (8 Weeks)|Adverse Event|0
1472736|NCT00667732|4854676|P2|Run -In (8 Weeks)|Adverse Event|0
1472737|NCT00667732|4854677|P1|Run -In (8 Weeks)|Adverse Event|4
1472738|NCT00667602|4854713|P3|Overall Study|Protocol Violation|0
1472739|NCT00667602|4854714|P2|Overall Study|Protocol Violation|1
1472740|NCT00667602|4854715|P1|Overall Study|Protocol Violation|0
1472741|NCT00667602|4854713|P3|Overall Study|Administrative reason|2
1472742|NCT00667602|4854714|P2|Overall Study|Administrative reason|0
1472743|NCT00667602|4854715|P1|Overall Study|Administrative reason|0
1472744|NCT00667602|4854713|P3|Overall Study|Lost to Follow-up|6
1472745|NCT00667602|4854714|P2|Overall Study|Lost to Follow-up|5
1472746|NCT00667602|4854715|P1|Overall Study|Lost to Follow-up|4
1472747|NCT00667602|4854713|P3|Overall Study|Withdrawal by Subject|10
1472748|NCT00667602|4854714|P2|Overall Study|Withdrawal by Subject|9
1472749|NCT00667602|4854715|P1|Overall Study|Withdrawal by Subject|4
1472750|NCT00667576|4854783|P5|Overall Study|Missed Visit|0
1472751|NCT00667576|4854784|P4|Overall Study|Missed Visit|1
1472752|NCT00667576|4854785|P3|Overall Study|Missed Visit|0
1472753|NCT00667576|4854786|P2|Overall Study|Missed Visit|0
1472754|NCT00667576|4854787|P1|Overall Study|Missed Visit|0
1472755|NCT00667576|4854783|P5|Overall Study|Physician Decision|0
1472756|NCT00667576|4854784|P4|Overall Study|Physician Decision|1
1472757|NCT00667576|4854785|P3|Overall Study|Physician Decision|0
1472758|NCT00667576|4854786|P2|Overall Study|Physician Decision|0
1472759|NCT00667576|4854787|P1|Overall Study|Physician Decision|0
1472760|NCT00667576|4854783|P5|Overall Study|Protocol Violation|0
1472761|NCT00667576|4854784|P4|Overall Study|Protocol Violation|1
1472762|NCT00667576|4854785|P3|Overall Study|Protocol Violation|0
1472763|NCT00667576|4854786|P2|Overall Study|Protocol Violation|0
1472764|NCT00667576|4854787|P1|Overall Study|Protocol Violation|0
1472765|NCT00667576|4854783|P5|Overall Study|Lost to Follow-up|0
1472766|NCT00667576|4854784|P4|Overall Study|Lost to Follow-up|0
1472767|NCT00667576|4854785|P3|Overall Study|Lost to Follow-up|1
1472768|NCT00667576|4854786|P2|Overall Study|Lost to Follow-up|0
1472769|NCT00667576|4854787|P1|Overall Study|Lost to Follow-up|0
1472770|NCT00667576|4854783|P5|Overall Study|Adverse Event|0
1472771|NCT00667576|4854784|P4|Overall Study|Adverse Event|0
1472772|NCT00667576|4854785|P3|Overall Study|Adverse Event|0
1472773|NCT00667576|4854786|P2|Overall Study|Adverse Event|1
1472774|NCT00667576|4854787|P1|Overall Study|Adverse Event|1
1472775|NCT00667576|4854783|P5|Overall Study|Withdrawal by Subject|1
1472776|NCT00667576|4854784|P4|Overall Study|Withdrawal by Subject|1
1472777|NCT00667576|4854785|P3|Overall Study|Withdrawal by Subject|1
1472778|NCT00667576|4854786|P2|Overall Study|Withdrawal by Subject|0
1472779|NCT00667576|4854787|P1|Overall Study|Withdrawal by Subject|1
1472780|NCT00667563|4854834|P1|Overall Study|Protocol Violation|24
1472781|NCT00667459|4854854|P2|Overall Study|Lost to Follow-up|43
1472782|NCT00667459|4854855|P1|Overall Study|Lost to Follow-up|8
1472783|NCT00667459|4854854|P2|Overall Study|Death|2
1472784|NCT00667459|4854855|P1|Overall Study|Death|0
1472785|NCT00667446|4854897|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
1472786|NCT00667446|4854898|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
1472787|NCT00667446|4854897|P2|Treatment Period (36 Months)|Therapeutic Failure|1
1472788|NCT00667446|4854898|P1|Treatment Period (36 Months)|Therapeutic Failure|1
1472789|NCT00667446|4854897|P2|Treatment Period (36 Months)|Protocol Violation|1
1472790|NCT00667446|4854898|P1|Treatment Period (36 Months)|Protocol Violation|1
1472791|NCT00667446|4854897|P2|Treatment Period (36 Months)|Lost to Follow-up|0
1472792|NCT00667446|4854898|P1|Treatment Period (36 Months)|Lost to Follow-up|1
1472793|NCT00667446|4854897|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
1472794|NCT00667446|4854898|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
1472795|NCT00667446|4854897|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
1472796|NCT00667446|4854898|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
1472797|NCT00667446|4854897|P2|Treatment Period (36 Months)|Personal reasons|2
1472798|NCT00667446|4854898|P1|Treatment Period (36 Months)|Personal reasons|2
1472799|NCT00667446|4854897|P2|Treatment Period (36 Months)|Other|2
1472800|NCT00667446|4854898|P1|Treatment Period (36 Months)|Other|2
1472801|NCT00667446|4854897|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
1472802|NCT00667446|4854898|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
1472803|NCT00667420|4854920|P1|Overall Study|Withdrawal by Subject|2
1472804|NCT00667420|4854920|P1|Overall Study|Physician Decision|1
1472805|NCT00667420|4854920|P1|Overall Study|Lack of Efficacy|5
1472806|NCT00667420|4854920|P1|Overall Study|Adverse Event|2
1472807|NCT00667394|4854930|P2|Overall Study|Progressive disease|0
1472808|NCT00667394|4854931|P1|Overall Study|Progressive disease|1
1472809|NCT00667394|4854930|P2|Overall Study|Adverse Event|0
1472810|NCT00667394|4854931|P1|Overall Study|Adverse Event|3
1472811|NCT00667368|4854958|P2|Overall Study|Discontinued early|17
1472812|NCT00667368|4854959|P1|Overall Study|Discontinued early|24
1472813|NCT00667368|4854958|P2|Overall Study|Lost to Follow-up|155
1472814|NCT00667368|4854959|P1|Overall Study|Lost to Follow-up|176
1472815|NCT00667355|4854967|P1|Overall Study|Other reason was not specified|5
1472816|NCT00667355|4854967|P1|Overall Study|Lost to Follow-up|1
1472817|NCT00667355|4854967|P1|Overall Study|Adverse Event|5
1472818|NCT00667342|4854992|P3|Overall Study|Ineligible|1
1472819|NCT00667342|4854993|P2|Overall Study|Ineligible|0
1472820|NCT00667342|4854994|P1|Overall Study|Ineligible|0
1472821|NCT00667342|4854992|P3|Overall Study|Adverse Event|1
1472822|NCT00667342|4854993|P2|Overall Study|Adverse Event|0
1472823|NCT00667342|4854994|P1|Overall Study|Adverse Event|0
1472824|NCT00667342|4854992|P3|Overall Study|Relapse or tumor progression|7
1472825|NCT00667342|4854993|P2|Overall Study|Relapse or tumor progression|0
1472826|NCT00667342|4854994|P1|Overall Study|Relapse or tumor progression|9
1472827|NCT00667342|4854992|P3|Overall Study|Physician Decision|0
1472828|NCT00667342|4854993|P2|Overall Study|Physician Decision|0
1472829|NCT00667342|4854994|P1|Overall Study|Physician Decision|3
1472830|NCT00667342|4854992|P3|Overall Study|Withdrawal by Subject|0
1472831|NCT00667342|4854993|P2|Overall Study|Withdrawal by Subject|0
1472832|NCT00667342|4854994|P1|Overall Study|Withdrawal by Subject|1
1472833|NCT00667342|4854992|P3|Overall Study|Protocol Violation|0
1472834|NCT00667342|4854993|P2|Overall Study|Protocol Violation|0
1472835|NCT00667342|4854994|P1|Overall Study|Protocol Violation|1
1472836|NCT00667277|4855032|P1|Overall Study|Withdrawal by Subject|2
1472837|NCT00667251|4855039|P2|Overall Study|Symptomatic progression|2
1472838|NCT00667251|4855040|P1|Overall Study|Symptomatic progression|1
1472839|NCT00667251|4855039|P2|Overall Study|Intercurrent Illness|3
1472840|NCT00667251|4855040|P1|Overall Study|Intercurrent Illness|4
1472841|NCT00667251|4855039|P2|Overall Study|Other/missing|84
1472842|NCT00667251|4855040|P1|Overall Study|Other/missing|46
1472843|NCT00667251|4855039|P2|Overall Study|Withdrawal by Subject|2
1472844|NCT00667251|4855040|P1|Overall Study|Withdrawal by Subject|6
1472845|NCT00667251|4855039|P2|Overall Study|Adverse Event|4
1472846|NCT00667251|4855040|P1|Overall Study|Adverse Event|13
1472847|NCT00667225|4855066|P2|Overall Study|Lost to Follow-up|1
1472848|NCT00667225|4855067|P1|Overall Study|Lost to Follow-up|0
1472849|NCT00667225|4855066|P2|Overall Study|Subject had no more lesions to treat.|0
1472850|NCT00667225|4855067|P1|Overall Study|Subject had no more lesions to treat.|1
1472851|NCT00667095|4855088|P2|Overall Study|Withdrawal by Subject|1
1472852|NCT00667095|4855089|P1|Overall Study|Withdrawal by Subject|0
1472853|NCT00666965|4855121|P4|Overall Study|Withdrawal by Subject|2
1472854|NCT00666965|4855122|P3|Overall Study|Withdrawal by Subject|0
1472855|NCT00666965|4855123|P2|Overall Study|Withdrawal by Subject|0
1472856|NCT00666965|4855124|P1|Overall Study|Withdrawal by Subject|0
1472857|NCT00666965|4855121|P4|Overall Study|Discontinuation criteria|2
1472858|NCT00666965|4855122|P3|Overall Study|Discontinuation criteria|1
1472859|NCT00666965|4855123|P2|Overall Study|Discontinuation criteria|1
1472860|NCT00666965|4855124|P1|Overall Study|Discontinuation criteria|2
1472861|NCT00666965|4855121|P4|Overall Study|Protocol Violation|2
1472862|NCT00666965|4855122|P3|Overall Study|Protocol Violation|0
1472863|NCT00666965|4855123|P2|Overall Study|Protocol Violation|0
1472864|NCT00666965|4855124|P1|Overall Study|Protocol Violation|0
1472865|NCT00666965|4855121|P4|Overall Study|Lack of Efficacy|0
1472866|NCT00666965|4855122|P3|Overall Study|Lack of Efficacy|0
1472867|NCT00666965|4855123|P2|Overall Study|Lack of Efficacy|1
1472868|NCT00666965|4855124|P1|Overall Study|Lack of Efficacy|1
1472869|NCT00666965|4855121|P4|Overall Study|Adverse Event|9
1472870|NCT00666965|4855122|P3|Overall Study|Adverse Event|1
1472871|NCT00666965|4855123|P2|Overall Study|Adverse Event|2
1472872|NCT00666965|4855124|P1|Overall Study|Adverse Event|0
1472873|NCT00666926|4855154|P16|Overall Study|Death|0
1472874|NCT00666926|4855155|P15|Overall Study|Death|0
1472875|NCT00666926|4855156|P14|Overall Study|Death|0
1472876|NCT00666926|4855157|P13|Overall Study|Death|0
1472877|NCT00666926|4855158|P12|Overall Study|Death|1
1472878|NCT00666926|4855159|P11|Overall Study|Death|0
1472879|NCT00666926|4855160|P10|Overall Study|Death|0
1472880|NCT00666926|4855161|P9|Overall Study|Death|0
1472881|NCT00666926|4855162|P8|Overall Study|Death|0
1472882|NCT00666926|4855163|P7|Overall Study|Death|0
1472883|NCT00666926|4855164|P6|Overall Study|Death|0
1472884|NCT00666926|4855165|P5|Overall Study|Death|0
1472885|NCT00666926|4855166|P4|Overall Study|Death|0
1472886|NCT00666926|4855167|P3|Overall Study|Death|0
1472887|NCT00666926|4855168|P2|Overall Study|Death|0
1472888|NCT00666926|4855169|P1|Overall Study|Death|0
1472889|NCT00666926|4855154|P16|Overall Study|Withdrawal by Subject|3
1472890|NCT00666926|4855155|P15|Overall Study|Withdrawal by Subject|3
1472891|NCT00666926|4855156|P14|Overall Study|Withdrawal by Subject|1
1472892|NCT00666926|4855157|P13|Overall Study|Withdrawal by Subject|0
1472893|NCT00666926|4855158|P12|Overall Study|Withdrawal by Subject|3
1472894|NCT00666926|4855159|P11|Overall Study|Withdrawal by Subject|0
1472895|NCT00666926|4855160|P10|Overall Study|Withdrawal by Subject|3
1472896|NCT00666926|4855161|P9|Overall Study|Withdrawal by Subject|0
1472897|NCT00666926|4855162|P8|Overall Study|Withdrawal by Subject|1
1472898|NCT00666926|4855163|P7|Overall Study|Withdrawal by Subject|0
1472899|NCT00666926|4855164|P6|Overall Study|Withdrawal by Subject|0
1472900|NCT00666926|4855165|P5|Overall Study|Withdrawal by Subject|0
1472901|NCT00666926|4855166|P4|Overall Study|Withdrawal by Subject|0
1472902|NCT00666926|4855167|P3|Overall Study|Withdrawal by Subject|0
1472903|NCT00666926|4855168|P2|Overall Study|Withdrawal by Subject|0
1472904|NCT00666926|4855169|P1|Overall Study|Withdrawal by Subject|0
1472905|NCT00666926|4855154|P16|Overall Study|Other|4
1472906|NCT00666926|4855155|P15|Overall Study|Other|4
1472907|NCT00666926|4855156|P14|Overall Study|Other|2
1472908|NCT00666926|4855157|P13|Overall Study|Other|3
1472909|NCT00666926|4855158|P12|Overall Study|Other|26
1472910|NCT00666926|4855159|P11|Overall Study|Other|3
1472911|NCT00666926|4855160|P10|Overall Study|Other|5
1472912|NCT00666926|4855161|P9|Overall Study|Other|3
1472913|NCT00666926|4855162|P8|Overall Study|Other|0
1472914|NCT00666926|4855163|P7|Overall Study|Other|4
1472915|NCT00666926|4855164|P6|Overall Study|Other|3
1472916|NCT00666926|4855165|P5|Overall Study|Other|3
1472917|NCT00666926|4855166|P4|Overall Study|Other|3
1472918|NCT00666926|4855167|P3|Overall Study|Other|3
1472919|NCT00666926|4855168|P2|Overall Study|Other|4
1472920|NCT00666926|4855169|P1|Overall Study|Other|2
1472921|NCT00666926|4855154|P16|Overall Study|Lost to Follow-up|0
1472922|NCT00666926|4855155|P15|Overall Study|Lost to Follow-up|0
1472923|NCT00666926|4855156|P14|Overall Study|Lost to Follow-up|0
1472924|NCT00666926|4855157|P13|Overall Study|Lost to Follow-up|0
1472925|NCT00666926|4855158|P12|Overall Study|Lost to Follow-up|0
1472926|NCT00666926|4855159|P11|Overall Study|Lost to Follow-up|0
1472927|NCT00666926|4855160|P10|Overall Study|Lost to Follow-up|0
1472928|NCT00666926|4855161|P9|Overall Study|Lost to Follow-up|0
1472929|NCT00666926|4855162|P8|Overall Study|Lost to Follow-up|0
1472930|NCT00666926|4855163|P7|Overall Study|Lost to Follow-up|0
1472931|NCT00666926|4855164|P6|Overall Study|Lost to Follow-up|0
1472932|NCT00666926|4855165|P5|Overall Study|Lost to Follow-up|0
1472933|NCT00666926|4855166|P4|Overall Study|Lost to Follow-up|1
1472934|NCT00666926|4855167|P3|Overall Study|Lost to Follow-up|0
1472935|NCT00666926|4855168|P2|Overall Study|Lost to Follow-up|0
1472936|NCT00666926|4855169|P1|Overall Study|Lost to Follow-up|0
1472937|NCT00666926|4855154|P16|Overall Study|Lack of Efficacy|0
1472938|NCT00666926|4855155|P15|Overall Study|Lack of Efficacy|0
1472939|NCT00666926|4855156|P14|Overall Study|Lack of Efficacy|0
1472940|NCT00666926|4855157|P13|Overall Study|Lack of Efficacy|0
1472941|NCT00666926|4855158|P12|Overall Study|Lack of Efficacy|1
1472942|NCT00666926|4855159|P11|Overall Study|Lack of Efficacy|0
1472943|NCT00666926|4855160|P10|Overall Study|Lack of Efficacy|0
1472944|NCT00666926|4855161|P9|Overall Study|Lack of Efficacy|0
1472945|NCT00666926|4855162|P8|Overall Study|Lack of Efficacy|0
1472946|NCT00666926|4855163|P7|Overall Study|Lack of Efficacy|0
1472947|NCT00666926|4855164|P6|Overall Study|Lack of Efficacy|1
1472948|NCT00666926|4855165|P5|Overall Study|Lack of Efficacy|0
1472949|NCT00666926|4855166|P4|Overall Study|Lack of Efficacy|0
1472950|NCT00666926|4855167|P3|Overall Study|Lack of Efficacy|0
1472951|NCT00666926|4855168|P2|Overall Study|Lack of Efficacy|0
1472952|NCT00666926|4855169|P1|Overall Study|Lack of Efficacy|0
1472953|NCT00666926|4855154|P16|Overall Study|Laboratory abnormality|1
1472954|NCT00666926|4855155|P15|Overall Study|Laboratory abnormality|0
1472955|NCT00666926|4855156|P14|Overall Study|Laboratory abnormality|0
1472956|NCT00666926|4855157|P13|Overall Study|Laboratory abnormality|0
1472957|NCT00666926|4855158|P12|Overall Study|Laboratory abnormality|0
1472958|NCT00666926|4855159|P11|Overall Study|Laboratory abnormality|1
1472959|NCT00666926|4855160|P10|Overall Study|Laboratory abnormality|0
1472960|NCT00666926|4855161|P9|Overall Study|Laboratory abnormality|0
1472961|NCT00666926|4855162|P8|Overall Study|Laboratory abnormality|0
1472962|NCT00666926|4855163|P7|Overall Study|Laboratory abnormality|0
1472963|NCT00666926|4855164|P6|Overall Study|Laboratory abnormality|0
1472964|NCT00666926|4855165|P5|Overall Study|Laboratory abnormality|0
1472965|NCT00666926|4855166|P4|Overall Study|Laboratory abnormality|0
1472966|NCT00666926|4855167|P3|Overall Study|Laboratory abnormality|0
1472967|NCT00666926|4855168|P2|Overall Study|Laboratory abnormality|0
1472968|NCT00666926|4855169|P1|Overall Study|Laboratory abnormality|0
1472969|NCT00666926|4855154|P16|Overall Study|Adverse Event|0
1472970|NCT00666926|4855155|P15|Overall Study|Adverse Event|0
1472971|NCT00666926|4855156|P14|Overall Study|Adverse Event|1
1472972|NCT00666926|4855157|P13|Overall Study|Adverse Event|0
1472973|NCT00666926|4855158|P12|Overall Study|Adverse Event|2
1472974|NCT00666926|4855159|P11|Overall Study|Adverse Event|2
1472975|NCT00666926|4855160|P10|Overall Study|Adverse Event|2
1472976|NCT00666926|4855161|P9|Overall Study|Adverse Event|0
1472977|NCT00666926|4855162|P8|Overall Study|Adverse Event|0
1472978|NCT00666926|4855163|P7|Overall Study|Adverse Event|0
1472979|NCT00666926|4855164|P6|Overall Study|Adverse Event|0
1472980|NCT00666926|4855165|P5|Overall Study|Adverse Event|0
1472981|NCT00666926|4855166|P4|Overall Study|Adverse Event|0
1472982|NCT00666926|4855167|P3|Overall Study|Adverse Event|0
1472983|NCT00666926|4855168|P2|Overall Study|Adverse Event|0
1472984|NCT00666926|4855169|P1|Overall Study|Adverse Event|0
1472985|NCT00666835|4855478|P2|Overall Study|Physician Decision|2
1472986|NCT00666835|4855479|P1|Overall Study|Physician Decision|1
1472987|NCT00666835|4855478|P2|Overall Study|Planned operation|0
1472988|NCT00666835|4855479|P1|Overall Study|Planned operation|2
1472989|NCT00666835|4855478|P2|Overall Study|Hemoglobulin concentration|3
1472990|NCT00666835|4855479|P1|Overall Study|Hemoglobulin concentration|4
1472991|NCT00666835|4855478|P2|Overall Study|Kidney Transplantation (NTX)|2
1472992|NCT00666835|4855479|P1|Overall Study|Kidney Transplantation (NTX)|10
1472993|NCT00666835|4855478|P2|Overall Study|Death|4
1472994|NCT00666835|4855479|P1|Overall Study|Death|15
1472995|NCT00666835|4855478|P2|Overall Study|Protocol Violation|0
1472996|NCT00666835|4855479|P1|Overall Study|Protocol Violation|2
1472997|NCT00666835|4855478|P2|Overall Study|Adverse Event|6
1472998|NCT00666835|4855479|P1|Overall Study|Adverse Event|7
1472999|NCT00666835|4855478|P2|Overall Study|Incl./excl. not fulfilled|2
1473000|NCT00666835|4855479|P1|Overall Study|Incl./excl. not fulfilled|7
1473001|NCT00666835|4855478|P2|Overall Study|Lack of Efficacy|1
1473002|NCT00666835|4855479|P1|Overall Study|Lack of Efficacy|0
1473003|NCT00666835|4855478|P2|Overall Study|Withdrawal by Subject|2
1473004|NCT00666835|4855479|P1|Overall Study|Withdrawal by Subject|5
1473005|NCT00666757|4855489|P2|Overall Study|Sponsor decision|1
1473006|NCT00666757|4855490|P1|Overall Study|Sponsor decision|0
1473007|NCT00666757|4855489|P2|Overall Study|Physician Decision|2
1473008|NCT00666757|4855490|P1|Overall Study|Physician Decision|0
1473009|NCT00666757|4855489|P2|Overall Study|Lack of Efficacy|6
1473010|NCT00666757|4855490|P1|Overall Study|Lack of Efficacy|3
1473011|NCT00666757|4855489|P2|Overall Study|Withdrawal by Subject|17
1473012|NCT00666757|4855490|P1|Overall Study|Withdrawal by Subject|13
1473013|NCT00666757|4855489|P2|Overall Study|Adverse Event|12
1473014|NCT00666757|4855490|P1|Overall Study|Adverse Event|22
1473015|NCT00666757|4855489|P2|Overall Study|Protocol Violation|24
1473016|NCT00666757|4855490|P1|Overall Study|Protocol Violation|23
1473017|NCT00666757|4855489|P2|Overall Study|Lost to Follow-up|35
1473018|NCT00666757|4855490|P1|Overall Study|Lost to Follow-up|39
1473019|NCT00666718|4855549|P2|Overall Study|Physician Decision|2
1473020|NCT00666718|4855550|P1|Overall Study|Physician Decision|0
1473021|NCT00666718|4855549|P2|Overall Study|Withdrawal by Subject|12
1473022|NCT00666718|4855550|P1|Overall Study|Withdrawal by Subject|7
1473023|NCT00666718|4855549|P2|Overall Study|Protocol Violation|3
1473024|NCT00666718|4855550|P1|Overall Study|Protocol Violation|1
1473025|NCT00666718|4855549|P2|Overall Study|Entry Criteria Not Met|0
1473026|NCT00666718|4855550|P1|Overall Study|Entry Criteria Not Met|2
1473027|NCT00666718|4855549|P2|Overall Study|Lost to Follow-up|0
1473028|NCT00666718|4855550|P1|Overall Study|Lost to Follow-up|1
1473029|NCT00666718|4855549|P2|Overall Study|Death|0
1473030|NCT00666718|4855550|P1|Overall Study|Death|1
1473031|NCT00666718|4855549|P2|Overall Study|Adverse Event|1
1473032|NCT00666718|4855550|P1|Overall Study|Adverse Event|0
1473033|NCT00666705|4855576|P1|Overall Study|Withdrawal by Subject|1
1473034|NCT00666679|4855595|P2|Second Intervention|Death|1
1473035|NCT00666679|4855596|P1|Second Intervention|Death|0
1473036|NCT00666679|4855595|P2|Second Intervention|Adverse Event|0
1473037|NCT00666679|4855596|P1|Second Intervention|Adverse Event|1
1473038|NCT00666679|4855595|P2|Washout Period of 1 Week|Protocol Violation|1
1473039|NCT00666679|4855596|P1|Washout Period of 1 Week|Protocol Violation|0
1473040|NCT00666679|4855595|P2|Washout Period of 1 Week|Lost to Follow-up|1
1473041|NCT00666679|4855596|P1|Washout Period of 1 Week|Lost to Follow-up|0
1473042|NCT00666679|4855595|P2|First Intervention|Randomized did not start treatment|1
1473043|NCT00666679|4855596|P1|First Intervention|Randomized did not start treatment|1
1473044|NCT00666679|4855595|P2|First Intervention|Withdrawal by Subject|0
1473045|NCT00666679|4855596|P1|First Intervention|Withdrawal by Subject|1
1473046|NCT00666679|4855595|P2|First Intervention|Protocol Violation|0
1473047|NCT00666679|4855596|P1|First Intervention|Protocol Violation|1
1473048|NCT00666679|4855595|P2|First Intervention|Lost to Follow-up|0
1473049|NCT00666679|4855596|P1|First Intervention|Lost to Follow-up|1
1473050|NCT00666588|4855626|P4|Overall Study|inevaluable|0
1473051|NCT00666588|4855627|P3|Overall Study|inevaluable|0
1473052|NCT00666588|4855628|P2|Overall Study|inevaluable|0
1473053|NCT00666588|4855629|P1|Overall Study|inevaluable|2
1473054|NCT00666588|4855626|P4|Overall Study|ineligible|2
1473055|NCT00666588|4855627|P3|Overall Study|ineligible|0
1473056|NCT00666588|4855628|P2|Overall Study|ineligible|0
1473057|NCT00666588|4855629|P1|Overall Study|ineligible|2
1473058|NCT00666562|4855662|P3|Overall Study|Concomitant Medication|0
1473059|NCT00666562|4855663|P2|Overall Study|Concomitant Medication|1
1473060|NCT00666562|4855664|P1|Overall Study|Concomitant Medication|0
1473061|NCT00666562|4855662|P3|Overall Study|Withdrawal by Subject|0
1473062|NCT00666562|4855663|P2|Overall Study|Withdrawal by Subject|1
1473063|NCT00666562|4855664|P1|Overall Study|Withdrawal by Subject|0
1473064|NCT00666536|4855711|P2|Overall Study|Lost to Follow-up|3
1473065|NCT00666536|4855712|P1|Overall Study|Lost to Follow-up|4
1473066|NCT00666536|4855711|P2|Overall Study|Withdrawal by Subject|9
1473067|NCT00666536|4855712|P1|Overall Study|Withdrawal by Subject|10
1473068|NCT00666536|4855711|P2|Overall Study|Protocol deviation(s)|6
1473069|NCT00666536|4855712|P1|Overall Study|Protocol deviation(s)|8
1473070|NCT00666536|4855711|P2|Overall Study|Unsatisfactory therapeutic effect|0
1473071|NCT00666536|4855712|P1|Overall Study|Unsatisfactory therapeutic effect|2
1473072|NCT00666536|4855711|P2|Overall Study|Adverse Event|19
1473073|NCT00666536|4855712|P1|Overall Study|Adverse Event|9
1473074|NCT00666458|4855730|P2|Overall Study|Medical history of anemia|0
1473075|NCT00666458|4855731|P1|Overall Study|Medical history of anemia|1
1473076|NCT00666458|4855730|P2|Overall Study|Safety reasons|0
1473077|NCT00666458|4855731|P1|Overall Study|Safety reasons|1
1473078|NCT00666458|4855730|P2|Overall Study|Severe non-compliance to the protocol|1
1473079|NCT00666458|4855731|P1|Overall Study|Severe non-compliance to the protocol|1
1473080|NCT00666458|4855730|P2|Overall Study|Study specific discontinuation criteria|7
1473081|NCT00666458|4855731|P1|Overall Study|Study specific discontinuation criteria|14
1473082|NCT00666458|4855730|P2|Overall Study|Incorrect enrollment|1
1473083|NCT00666458|4855731|P1|Overall Study|Incorrect enrollment|7
1473260|NCT00664560|4856709|P3|Overall Study|Withdrawal by Subject|7
1473084|NCT00666458|4855730|P2|Overall Study|Administrative reason by sponsor|1
1473085|NCT00666458|4855731|P1|Overall Study|Administrative reason by sponsor|1
1473086|NCT00666458|4855730|P2|Overall Study|Lost to Follow-up|3
1473087|NCT00666458|4855731|P1|Overall Study|Lost to Follow-up|0
1473088|NCT00666458|4855730|P2|Overall Study|Withdrawal by Subject|4
1473089|NCT00666458|4855731|P1|Overall Study|Withdrawal by Subject|5
1473090|NCT00666458|4855730|P2|Overall Study|Adverse Event|7
1473091|NCT00666458|4855731|P1|Overall Study|Adverse Event|8
1473092|NCT00666328|4855819|P1|Overall Study|No longer met eligibility criteria|1
1473093|NCT00666328|4855819|P1|Overall Study|Lost to Follow-up|2
1473094|NCT00666328|4855819|P1|Overall Study|Death|2
1473095|NCT00666276|4855832|P1|Overall Study|Protocol Violation|34
1473096|NCT00666263|4855856|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
1473097|NCT00666263|4855857|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
1473098|NCT00666263|4855856|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
1473099|NCT00666263|4855857|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
1473100|NCT00666263|4855856|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
1473101|NCT00666263|4855857|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
1473102|NCT00666224|4856001|P2|Open-Label|Undefined/Unknown|1
1473103|NCT00666224|4856002|P1|Open-Label|Undefined/Unknown|1
1473104|NCT00666224|4856001|P2|Open-Label|Noncompliance|1
1473105|NCT00666224|4856002|P1|Open-Label|Noncompliance|2
1473106|NCT00666224|4856001|P2|Open-Label|Pregnancy|5
1473107|NCT00666224|4856002|P1|Open-Label|Pregnancy|1
1473108|NCT00666224|4856001|P2|Open-Label|Physician Decision|5
1473109|NCT00666224|4856002|P1|Open-Label|Physician Decision|7
1473110|NCT00666224|4856001|P2|Open-Label|Withdrawal by Subject|25
1473111|NCT00666224|4856002|P1|Open-Label|Withdrawal by Subject|12
1473112|NCT00666224|4856001|P2|Open-Label|Lost to Follow-up|5
1473113|NCT00666224|4856002|P1|Open-Label|Lost to Follow-up|4
1473114|NCT00666224|4856001|P2|Open-Label|Adverse Event|43
1473115|NCT00666224|4856002|P1|Open-Label|Adverse Event|8
1473116|NCT00666224|4856001|P2|Double-Blind|Undefined/Unknown|1
1473117|NCT00666224|4856002|P1|Double-Blind|Undefined/Unknown|4
1473118|NCT00666224|4856001|P2|Double-Blind|Death|0
1473119|NCT00666224|4856002|P1|Double-Blind|Death|1
1473120|NCT00666224|4856001|P2|Double-Blind|Noncompliance|0
1473121|NCT00666224|4856002|P1|Double-Blind|Noncompliance|1
1473122|NCT00666224|4856001|P2|Double-Blind|Pregnancy|2
1473123|NCT00666224|4856002|P1|Double-Blind|Pregnancy|3
1473124|NCT00666224|4856001|P2|Double-Blind|Sponsor decision|0
1473125|NCT00666224|4856002|P1|Double-Blind|Sponsor decision|1
1473126|NCT00666224|4856001|P2|Double-Blind|Physician Decision|3
1473127|NCT00666224|4856002|P1|Double-Blind|Physician Decision|0
1473128|NCT00666224|4856001|P2|Double-Blind|Withdrawal by Subject|14
1473129|NCT00666224|4856002|P1|Double-Blind|Withdrawal by Subject|18
1473130|NCT00666224|4856001|P2|Double-Blind|Lost to Follow-up|2
1473131|NCT00666224|4856002|P1|Double-Blind|Lost to Follow-up|2
1473132|NCT00666224|4856001|P2|Double-Blind|Adverse Event|5
1473133|NCT00666224|4856002|P1|Double-Blind|Adverse Event|15
1473134|NCT00666211|4856021|P2|Overall Study|Physician Decision|1
1473135|NCT00666211|4856022|P1|Overall Study|Physician Decision|0
1473136|NCT00666211|4856021|P2|Overall Study|off tx for other complicating disease|1
1473137|NCT00666211|4856022|P1|Overall Study|off tx for other complicating disease|0
1473138|NCT00666211|4856021|P2|Overall Study|Death|2
1473139|NCT00666211|4856022|P1|Overall Study|Death|0
1473140|NCT00666211|4856021|P2|Overall Study|hospital admission|5
1473141|NCT00666211|4856022|P1|Overall Study|hospital admission|0
1473142|NCT00666211|4856021|P2|Overall Study|toxicity|2
1473143|NCT00666211|4856022|P1|Overall Study|toxicity|0
1473144|NCT00666211|4856021|P2|Overall Study|Lost to Follow-up|0
1473145|NCT00666211|4856022|P1|Overall Study|Lost to Follow-up|2
1473146|NCT00666211|4856021|P2|Overall Study|disease progression|8
1473147|NCT00666211|4856022|P1|Overall Study|disease progression|1
1473148|NCT00666211|4856021|P2|Overall Study|patient non-compliant|6
1473149|NCT00666211|4856022|P1|Overall Study|patient non-compliant|6
1473150|NCT00666211|4856021|P2|Overall Study|went off medication, no more pain|0
1473151|NCT00666211|4856022|P1|Overall Study|went off medication, no more pain|1
1473152|NCT00666211|4856021|P2|Overall Study|Withdrawal by Subject|13
1473153|NCT00666211|4856022|P1|Overall Study|Withdrawal by Subject|10
1473154|NCT00666198|4856040|P1|Overall Study|No Drug Administration|4
1473155|NCT00666198|4856040|P1|Overall Study|Safety Not Assessable|6
1473156|NCT00666198|4856040|P1|Overall Study|No Visit After First Day of Treatment|13
1473157|NCT00666198|4856040|P1|Overall Study|Protocol Violation|10
1473158|NCT00665925|4856068|P4|Overall Study|Due to exclusion criteria|0
1473159|NCT00665925|4856069|P3|Overall Study|Due to exclusion criteria|0
1473160|NCT00665925|4856070|P2|Overall Study|Due to exclusion criteria|0
1473161|NCT00665925|4856071|P1|Overall Study|Due to exclusion criteria|1
1473162|NCT00665925|4856068|P4|Overall Study|Enrolled by mistake|1
1473163|NCT00665925|4856069|P3|Overall Study|Enrolled by mistake|0
1473164|NCT00665925|4856070|P2|Overall Study|Enrolled by mistake|0
1473165|NCT00665925|4856071|P1|Overall Study|Enrolled by mistake|0
1473166|NCT00665925|4856068|P4|Overall Study|Adverse Event|5
1473167|NCT00665925|4856069|P3|Overall Study|Adverse Event|10
1473168|NCT00665925|4856070|P2|Overall Study|Adverse Event|5
1473169|NCT00665925|4856071|P1|Overall Study|Adverse Event|1
1473170|NCT00665925|4856068|P4|Overall Study|Severe Non-Compliance to Protocol|1
1473171|NCT00665925|4856069|P3|Overall Study|Severe Non-Compliance to Protocol|1
1473172|NCT00665925|4856070|P2|Overall Study|Severe Non-Compliance to Protocol|0
1473173|NCT00665925|4856071|P1|Overall Study|Severe Non-Compliance to Protocol|0
1473174|NCT00665925|4856068|P4|Overall Study|Physician Decision|2
1473175|NCT00665925|4856069|P3|Overall Study|Physician Decision|1
1473176|NCT00665925|4856070|P2|Overall Study|Physician Decision|0
1473177|NCT00665925|4856071|P1|Overall Study|Physician Decision|0
1473178|NCT00665925|4856068|P4|Overall Study|Withdrawal by Subject|2
1473179|NCT00665925|4856069|P3|Overall Study|Withdrawal by Subject|3
1473180|NCT00665925|4856070|P2|Overall Study|Withdrawal by Subject|2
1473181|NCT00665925|4856071|P1|Overall Study|Withdrawal by Subject|2
1473182|NCT00665925|4856068|P4|Overall Study|Lost to Follow-up|2
1473183|NCT00665925|4856069|P3|Overall Study|Lost to Follow-up|2
1473184|NCT00665925|4856070|P2|Overall Study|Lost to Follow-up|2
1473185|NCT00665925|4856071|P1|Overall Study|Lost to Follow-up|1
1473186|NCT00665925|4856068|P4|Overall Study|Lack of Efficacy|8
1473187|NCT00665925|4856069|P3|Overall Study|Lack of Efficacy|9
1473188|NCT00665925|4856070|P2|Overall Study|Lack of Efficacy|8
1473189|NCT00665925|4856071|P1|Overall Study|Lack of Efficacy|10
1473190|NCT00665847|4856482|P1|Overall Study|Switch to Commercial Medication|1
1473191|NCT00665847|4856482|P1|Overall Study|Subject ineligible to continue the trial|1
1473192|NCT00665847|4856482|P1|Overall Study|Resistance to TMC125|1
1473193|NCT00665847|4856482|P1|Overall Study|Subject reached a virologic endpoint|4
1473194|NCT00665847|4856482|P1|Overall Study|Subject non-compliant|8
1473195|NCT00665847|4856482|P1|Overall Study|Withdrawal by Subject|2
1473196|NCT00665847|4856482|P1|Overall Study|Adverse Event|8
1473197|NCT00665626|4856501|P2|Overall Study|Death|0
1473198|NCT00665626|4856502|P1|Overall Study|Death|1
1473199|NCT00665626|4856501|P2|Overall Study|Unably to comply with dosing regimen|1
1473200|NCT00665626|4856502|P1|Overall Study|Unably to comply with dosing regimen|0
1473201|NCT00665626|4856501|P2|Overall Study|Did not fulfil inclusion criteria|1
1473202|NCT00665626|4856502|P1|Overall Study|Did not fulfil inclusion criteria|0
1473203|NCT00665626|4856501|P2|Overall Study|Due to exclusion criteria|1
1473204|NCT00665626|4856502|P1|Overall Study|Due to exclusion criteria|0
1473205|NCT00665626|4856501|P2|Overall Study|Adverse Event|9
1473206|NCT00665626|4856502|P1|Overall Study|Adverse Event|1
1473207|NCT00665626|4856501|P2|Overall Study|Protocol Violation|2
1473208|NCT00665626|4856502|P1|Overall Study|Protocol Violation|0
1473209|NCT00665626|4856501|P2|Overall Study|Withdrawal by Subject|1
1473210|NCT00665626|4856502|P1|Overall Study|Withdrawal by Subject|0
1473211|NCT00665626|4856501|P2|Overall Study|Lost to Follow-up|2
1473212|NCT00665626|4856502|P1|Overall Study|Lost to Follow-up|0
1473213|NCT00665626|4856501|P2|Overall Study|Lack of Efficacy|5
1473214|NCT00665626|4856502|P1|Overall Study|Lack of Efficacy|8
1473215|NCT00665444|4856584|P1|Overall Study|Study Terminated by Study Sponsor|1
1473216|NCT00665444|4856584|P1|Overall Study|Physician Decision|1
1473217|NCT00665431|4856596|P3|Overall Study|Other|2
1473218|NCT00665431|4856597|P2|Overall Study|Other|7
1473219|NCT00665431|4856598|P1|Overall Study|Other|4
1473220|NCT00665431|4856596|P3|Overall Study|Lost to Follow-up|1
1473221|NCT00665431|4856597|P2|Overall Study|Lost to Follow-up|3
1473222|NCT00665431|4856598|P1|Overall Study|Lost to Follow-up|3
1473223|NCT00665431|4856596|P3|Overall Study|Withdrawal by Subject|15
1473224|NCT00665431|4856597|P2|Overall Study|Withdrawal by Subject|25
1473225|NCT00665431|4856598|P1|Overall Study|Withdrawal by Subject|17
1473226|NCT00665431|4856596|P3|Overall Study|Adverse Event|6
1473227|NCT00665431|4856597|P2|Overall Study|Adverse Event|22
1473228|NCT00665431|4856598|P1|Overall Study|Adverse Event|16
1473229|NCT00665366|4856641|P2|Overall Study|Other reasons|1
1473230|NCT00665366|4856642|P1|Overall Study|Other reasons|4
1473231|NCT00665366|4856641|P2|Overall Study|No longer meets study criteria|1
1473232|NCT00665366|4856642|P1|Overall Study|No longer meets study criteria|0
1473233|NCT00665366|4856641|P2|Overall Study|Pregnancy|0
1473234|NCT00665366|4856642|P1|Overall Study|Pregnancy|1
1473235|NCT00665366|4856641|P2|Overall Study|Poor compliance/noncompliance|5
1473236|NCT00665366|4856642|P1|Overall Study|Poor compliance/noncompliance|3
1473237|NCT00665366|4856641|P2|Overall Study|Lost to Follow-up|5
1473238|NCT00665366|4856642|P1|Overall Study|Lost to Follow-up|3
1473239|NCT00665366|4856641|P2|Overall Study|Withdrawal by Subject|14
1473240|NCT00665366|4856642|P1|Overall Study|Withdrawal by Subject|11
1473241|NCT00665366|4856641|P2|Overall Study|Adverse Event|23
1473242|NCT00665366|4856642|P1|Overall Study|Adverse Event|25
1473243|NCT00665366|4856641|P2|Overall Study|Lack of Efficacy|10
1473244|NCT00665366|4856642|P1|Overall Study|Lack of Efficacy|11
1473245|NCT00665353|4856670|P1|Study Step 2|Lack of Efficacy|12
1473246|NCT00665353|4856670|P1|Study Step 2|Lost to Follow-up|2
1473247|NCT00665353|4856670|P1|Study Step 1|Withdrawal by Subject|2
1473248|NCT00665353|4856670|P1|Study Step 1|Adverse Event|1
1473249|NCT00665002|4856687|P1|Overall Study|Cytogenetic resistance|1
1473250|NCT00665002|4856687|P1|Overall Study|Progression/relapse during treatment|11
1473251|NCT00664742|4856701|P1|Overall Study|Lost to Follow-up|92
1473252|NCT00664742|4856701|P1|Overall Study|Withdrawal by Subject|31
1473253|NCT00664742|4856701|P1|Overall Study|Withdrawn due to adverse events|3
1473254|NCT00664560|4856709|P3|Overall Study|Other|5
1473255|NCT00664560|4856710|P2|Overall Study|Other|4
1473256|NCT00664560|4856711|P1|Overall Study|Other|11
1473257|NCT00664560|4856709|P3|Overall Study|Lost to Follow-up|0
1473258|NCT00664560|4856710|P2|Overall Study|Lost to Follow-up|2
1473259|NCT00664560|4856711|P1|Overall Study|Lost to Follow-up|0
1473261|NCT00664560|4856710|P2|Overall Study|Withdrawal by Subject|13
1473262|NCT00664560|4856711|P1|Overall Study|Withdrawal by Subject|9
1473263|NCT00664560|4856709|P3|Overall Study|Adverse Event|7
1473264|NCT00664560|4856710|P2|Overall Study|Adverse Event|16
1473265|NCT00664560|4856711|P1|Overall Study|Adverse Event|19
1473266|NCT00664534|4856754|P2|Overall Study|Sponsor decision|6
1473267|NCT00664534|4856755|P1|Overall Study|Sponsor decision|8
1473268|NCT00664534|4856754|P2|Overall Study|Physician Decision|0
1473269|NCT00664534|4856755|P1|Overall Study|Physician Decision|8
1473270|NCT00664534|4856754|P2|Overall Study|Withdrawal by Subject|6
1473271|NCT00664534|4856755|P1|Overall Study|Withdrawal by Subject|7
1473272|NCT00664534|4856754|P2|Overall Study|Protocol Violation|8
1473273|NCT00664534|4856755|P1|Overall Study|Protocol Violation|10
1473274|NCT00664534|4856754|P2|Overall Study|Lost to Follow-up|10
1473275|NCT00664534|4856755|P1|Overall Study|Lost to Follow-up|6
1473276|NCT00664534|4856754|P2|Overall Study|Adverse Event|3
1473277|NCT00664534|4856755|P1|Overall Study|Adverse Event|2
1473278|NCT00664521|4856783|P2|Overall Study|Other|0
1473279|NCT00664521|4856784|P1|Overall Study|Other|1
1473280|NCT00664521|4856783|P2|Overall Study|Lost to Follow-up|0
1473281|NCT00664521|4856784|P1|Overall Study|Lost to Follow-up|1
1473282|NCT00664521|4856783|P2|Overall Study|Adverse Event|1
1473283|NCT00664521|4856784|P1|Overall Study|Adverse Event|4
1473284|NCT00664326|4856810|P1|Overall Study|ongoing with treatment|6
1473285|NCT00664326|4856810|P1|Overall Study|Physician Decision|1
1473286|NCT00664326|4856810|P1|Overall Study|Withdrawal by Subject|1
1473287|NCT00664326|4856810|P1|Overall Study|Noncompliance with study medication|3
1473288|NCT00664326|4856810|P1|Overall Study|Adverse Event|13
1473289|NCT00664209|4856829|P1|Study Treatment Period|Withdrawal by Subject|2
1473290|NCT00664209|4856829|P1|Study Treatment Period|Physician Decision|4
1473291|NCT00664209|4856829|P1|Motor Fluctuations Screen|Negative for motor fluctuation|7
1473292|NCT00664105|4856837|P1|Overall Study|Disease progression|7
1473293|NCT00664105|4856837|P1|Overall Study|Adverse Event|9
1473294|NCT00664105|4856837|P1|Overall Study|Withdrawal by Subject|5
1473295|NCT00664105|4856837|P1|Overall Study|Death|3
1473296|NCT00664066|4856844|P1|Overall Study|Study terminated|3
1473297|NCT00663962|4856850|P2|Overall Study|somnolence|0
1473298|NCT00663962|4856851|P1|Overall Study|somnolence|1
1473299|NCT00663923|4856857|P1|Overall Study|Lost to Follow-up|2
1473300|NCT00663858|4856874|P3|Overall Study|Other|4
1473301|NCT00663858|4856875|P2|Overall Study|Other|2
1473302|NCT00663858|4856876|P1|Overall Study|Other|8
1473303|NCT00663858|4856874|P3|Overall Study|Protocol Violation|4
1473304|NCT00663858|4856875|P2|Overall Study|Protocol Violation|3
1473305|NCT00663858|4856876|P1|Overall Study|Protocol Violation|5
1473306|NCT00663858|4856874|P3|Overall Study|Withdrawal by Subject|3
1473307|NCT00663858|4856875|P2|Overall Study|Withdrawal by Subject|3
1473308|NCT00663858|4856876|P1|Overall Study|Withdrawal by Subject|7
1473309|NCT00663858|4856874|P3|Overall Study|Lack of Efficacy|3
1473310|NCT00663858|4856875|P2|Overall Study|Lack of Efficacy|1
1473311|NCT00663858|4856876|P1|Overall Study|Lack of Efficacy|5
1473312|NCT00663858|4856874|P3|Overall Study|Adverse Event|6
1473313|NCT00663858|4856875|P2|Overall Study|Adverse Event|1
1473314|NCT00663858|4856876|P1|Overall Study|Adverse Event|9
1473315|NCT00663702|4856914|P2|Overall Study|Lack of Efficacy|3
1473316|NCT00663702|4856915|P1|Overall Study|Lack of Efficacy|3
1473317|NCT00663702|4856914|P2|Overall Study|Death|1
1473318|NCT00663702|4856915|P1|Overall Study|Death|1
1473319|NCT00663702|4856914|P2|Overall Study|Lost to Follow-up|0
1473320|NCT00663702|4856915|P1|Overall Study|Lost to Follow-up|3
1473321|NCT00663702|4856914|P2|Overall Study|Pregnancy|1
1473322|NCT00663702|4856915|P1|Overall Study|Pregnancy|0
1473323|NCT00663702|4856914|P2|Overall Study|Withdrawal by Subject|1
1473324|NCT00663702|4856915|P1|Overall Study|Withdrawal by Subject|3
1473325|NCT00663702|4856914|P2|Overall Study|Adverse Event|4
1473326|NCT00663702|4856915|P1|Overall Study|Adverse Event|8
1473327|NCT00663260|4856951|P3|Overall Study|non-compliance, not met criteria, etc.|3
1473328|NCT00663260|4856952|P2|Overall Study|non-compliance, not met criteria, etc.|2
1473329|NCT00663260|4856953|P1|Overall Study|non-compliance, not met criteria, etc.|3
1473330|NCT00663260|4856951|P3|Overall Study|Lost to Follow-up|0
1473331|NCT00663260|4856952|P2|Overall Study|Lost to Follow-up|1
1473332|NCT00663260|4856953|P1|Overall Study|Lost to Follow-up|0
1473333|NCT00663260|4856951|P3|Overall Study|Death|1
1473334|NCT00663260|4856952|P2|Overall Study|Death|0
1473335|NCT00663260|4856953|P1|Overall Study|Death|1
1473336|NCT00663260|4856951|P3|Overall Study|Withdrawal by Subject|6
1473337|NCT00663260|4856952|P2|Overall Study|Withdrawal by Subject|1
1473338|NCT00663260|4856953|P1|Overall Study|Withdrawal by Subject|3
1473339|NCT00663260|4856951|P3|Overall Study|Adverse Event|6
1473340|NCT00663260|4856952|P2|Overall Study|Adverse Event|7
1473341|NCT00663260|4856953|P1|Overall Study|Adverse Event|12
1473342|NCT00663260|4856951|P3|Overall Study|Lack of Efficacy|0
1473343|NCT00663260|4856952|P2|Overall Study|Lack of Efficacy|0
1473344|NCT00663260|4856953|P1|Overall Study|Lack of Efficacy|2
1473345|NCT00663234|4856967|P1|Overall Study|Not willing to adhere to requirements|1
1473346|NCT00663208|4857000|P7|Follow-up Period|Other reason|1
1473347|NCT00663208|4857001|P6|Follow-up Period|Other reason|0
1473348|NCT00663208|4857002|P5|Follow-up Period|Other reason|0
1473349|NCT00663208|4857003|P4|Follow-up Period|Other reason|0
1473350|NCT00663208|4857004|P3|Follow-up Period|Other reason|0
1473351|NCT00663208|4857005|P2|Follow-up Period|Other reason|0
1473352|NCT00663208|4857006|P1|Follow-up Period|Other reason|1
1473353|NCT00663208|4857000|P7|Follow-up Period|Lost to Follow-up|0
1473354|NCT00663208|4857001|P6|Follow-up Period|Lost to Follow-up|0
1473355|NCT00663208|4857002|P5|Follow-up Period|Lost to Follow-up|0
1473356|NCT00663208|4857003|P4|Follow-up Period|Lost to Follow-up|2
1473357|NCT00663208|4857004|P3|Follow-up Period|Lost to Follow-up|3
1473358|NCT00663208|4857005|P2|Follow-up Period|Lost to Follow-up|0
1473359|NCT00663208|4857006|P1|Follow-up Period|Lost to Follow-up|2
1473360|NCT00663208|4857000|P7|Treatment Period|Lost to Follow-up|0
1473361|NCT00663208|4857001|P6|Treatment Period|Lost to Follow-up|0
1473362|NCT00663208|4857002|P5|Treatment Period|Lost to Follow-up|0
1473363|NCT00663208|4857003|P4|Treatment Period|Lost to Follow-up|0
1473364|NCT00663208|4857004|P3|Treatment Period|Lost to Follow-up|0
1473365|NCT00663208|4857005|P2|Treatment Period|Lost to Follow-up|1
1473366|NCT00663208|4857006|P1|Treatment Period|Lost to Follow-up|0
1473367|NCT00663117|4857184|P2|Overall Study|Lack of Efficacy|0
1473368|NCT00663117|4857185|P1|Overall Study|Lack of Efficacy|1
1473369|NCT00663052|4857199|P2|Overall Study|Other|1
1473370|NCT00663052|4857200|P1|Overall Study|Other|0
1473371|NCT00663052|4857199|P2|Overall Study|Unsatisfactory Response - Efficacy|1
1473372|NCT00663052|4857200|P1|Overall Study|Unsatisfactory Response - Efficacy|1
1473373|NCT00663052|4857199|P2|Overall Study|Withdrawal by Subject|5
1473374|NCT00663052|4857200|P1|Overall Study|Withdrawal by Subject|2
1473375|NCT00663052|4857199|P2|Overall Study|Protocol Violation|0
1473376|NCT00663052|4857200|P1|Overall Study|Protocol Violation|1
1473377|NCT00663052|4857199|P2|Overall Study|Discontinuation of Study by Sponsor|0
1473378|NCT00663052|4857200|P1|Overall Study|Discontinuation of Study by Sponsor|2
1473379|NCT00663052|4857199|P2|Overall Study|Adverse Event|3
1473380|NCT00663052|4857200|P1|Overall Study|Adverse Event|6
1473381|NCT00663026|4857283|P3|Overall Study|Withdrawal by Subject|1
1473382|NCT00663026|4857284|P2|Overall Study|Withdrawal by Subject|0
1473383|NCT00663026|4857285|P1|Overall Study|Withdrawal by Subject|0
1473384|NCT00663026|4857283|P3|Overall Study|Caregiver Request|0
1473385|NCT00663026|4857284|P2|Overall Study|Caregiver Request|2
1473386|NCT00663026|4857285|P1|Overall Study|Caregiver Request|0
1473387|NCT00663026|4857283|P3|Overall Study|Adverse Event|3
1473388|NCT00663026|4857284|P2|Overall Study|Adverse Event|2
1473389|NCT00663026|4857285|P1|Overall Study|Adverse Event|0
1473390|NCT00663026|4857283|P3|Overall Study|Other|0
1473391|NCT00663026|4857284|P2|Overall Study|Other|2
1473392|NCT00663026|4857285|P1|Overall Study|Other|1
1473393|NCT00663026|4857283|P3|Overall Study|Lost to Follow-up|0
1473394|NCT00663026|4857284|P2|Overall Study|Lost to Follow-up|0
1473395|NCT00663026|4857285|P1|Overall Study|Lost to Follow-up|1
1473396|NCT00662909|4857308|P3|Overall Study|Eligibility criterion not met|1
1473397|NCT00662909|4857309|P2|Overall Study|Eligibility criterion not met|1
1473398|NCT00662909|4857310|P1|Overall Study|Eligibility criterion not met|0
1473399|NCT00662909|4857308|P3|Overall Study|Physician Decision|2
1473400|NCT00662909|4857309|P2|Overall Study|Physician Decision|1
1473401|NCT00662909|4857310|P1|Overall Study|Physician Decision|1
1473402|NCT00662909|4857308|P3|Overall Study|Non-compliance with study procedures|2
1473403|NCT00662909|4857309|P2|Overall Study|Non-compliance with study procedures|3
1473404|NCT00662909|4857310|P1|Overall Study|Non-compliance with study procedures|3
1473405|NCT00662909|4857308|P3|Overall Study|Randomized- never received study drug|0
1473406|NCT00662909|4857309|P2|Overall Study|Randomized- never received study drug|0
1473407|NCT00662909|4857310|P1|Overall Study|Randomized- never received study drug|1
1473408|NCT00662909|4857308|P3|Overall Study|Protocol Violation|5
1473409|NCT00662909|4857309|P2|Overall Study|Protocol Violation|4
1473410|NCT00662909|4857310|P1|Overall Study|Protocol Violation|7
1473411|NCT00662909|4857308|P3|Overall Study|Lost to Follow-up|3
1473412|NCT00662909|4857309|P2|Overall Study|Lost to Follow-up|9
1473413|NCT00662909|4857310|P1|Overall Study|Lost to Follow-up|2
1473414|NCT00662909|4857308|P3|Overall Study|Withdrawal by Subject|16
1473415|NCT00662909|4857309|P2|Overall Study|Withdrawal by Subject|22
1473416|NCT00662909|4857310|P1|Overall Study|Withdrawal by Subject|29
1473417|NCT00662909|4857308|P3|Overall Study|Lack of Efficacy|5
1473418|NCT00662909|4857309|P2|Overall Study|Lack of Efficacy|1
1473419|NCT00662909|4857310|P1|Overall Study|Lack of Efficacy|9
1473420|NCT00662909|4857308|P3|Overall Study|Adverse Event|19
1473421|NCT00662909|4857309|P2|Overall Study|Adverse Event|18
1473422|NCT00662909|4857310|P1|Overall Study|Adverse Event|17
1473423|NCT00662857|4857408|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
1473424|NCT00662857|4857409|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
1473425|NCT00662857|4857408|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
1473426|NCT00662857|4857409|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
1473427|NCT00662857|4857408|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
1473428|NCT00662857|4857409|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
1473429|NCT00662831|4857424|P2|Overall Study|Adverse Event|16
1473430|NCT00662831|4857425|P1|Overall Study|Adverse Event|23
1473431|NCT00662831|4857424|P2|Overall Study|Protocol Violation|4
1473432|NCT00662831|4857425|P1|Overall Study|Protocol Violation|8
1473433|NCT00662831|4857424|P2|Overall Study|Other|31
1473434|NCT00662831|4857425|P1|Overall Study|Other|62
1473435|NCT00662831|4857424|P2|Overall Study|Withdrawal by Subject|1
1473436|NCT00662831|4857425|P1|Overall Study|Withdrawal by Subject|2
1473437|NCT00662831|4857424|P2|Overall Study|Lost to Follow-up|0
1473438|NCT00662831|4857425|P1|Overall Study|Lost to Follow-up|1
1473439|NCT00662831|4857424|P2|Overall Study|Lack of Efficacy|6
1473440|NCT00662831|4857425|P1|Overall Study|Lack of Efficacy|6
1473441|NCT00662831|4857424|P2|Overall Study|Death|1
1473442|NCT00662831|4857425|P1|Overall Study|Death|4
1473443|NCT00662649|4857505|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
1473444|NCT00662649|4857506|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
1473445|NCT00662649|4857507|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
1473446|NCT00662649|4857508|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
1473447|NCT00662649|4857509|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
1473448|NCT00662649|4857505|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
1473449|NCT00662649|4857506|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
1473450|NCT00662649|4857507|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
1473451|NCT00662649|4857508|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
1473452|NCT00662649|4857509|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
1473453|NCT00662649|4857505|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
1473454|NCT00662649|4857506|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
1473455|NCT00662649|4857507|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
1473456|NCT00662649|4857508|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
1473457|NCT00662649|4857509|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
1473458|NCT00662649|4857505|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
1473459|NCT00662649|4857506|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
1473460|NCT00662649|4857507|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
1473461|NCT00662649|4857508|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
1473462|NCT00662649|4857509|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
1473463|NCT00662649|4857505|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
1473464|NCT00662649|4857506|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
1473465|NCT00662649|4857507|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
1473466|NCT00662649|4857508|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
1473467|NCT00662649|4857509|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
1473468|NCT00662649|4857505|P5|Extension Study (Month 24 to 60)|Adverse Event|10
1473469|NCT00662649|4857506|P4|Extension Study (Month 24 to 60)|Adverse Event|6
1473470|NCT00662649|4857507|P3|Extension Study (Month 24 to 60)|Adverse Event|0
1473471|NCT00662649|4857508|P2|Extension Study (Month 24 to 60)|Adverse Event|9
1473472|NCT00662649|4857509|P1|Extension Study (Month 24 to 60)|Adverse Event|6
1473473|NCT00662649|4857505|P5|Extension Study (Month 24 to 60)|Administrative problems|0
1473474|NCT00662649|4857506|P4|Extension Study (Month 24 to 60)|Administrative problems|1
1473475|NCT00662649|4857507|P3|Extension Study (Month 24 to 60)|Administrative problems|0
1473476|NCT00662649|4857508|P2|Extension Study (Month 24 to 60)|Administrative problems|0
1473477|NCT00662649|4857509|P1|Extension Study (Month 24 to 60)|Administrative problems|0
1473478|NCT00662649|4857505|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
1473479|NCT00662649|4857506|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
1473480|NCT00662649|4857507|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
1473481|NCT00662649|4857508|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
1473482|NCT00662649|4857509|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
1473483|NCT00662649|4857505|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
1473484|NCT00662649|4857506|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
1473485|NCT00662649|4857507|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
1473486|NCT00662649|4857508|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
1473487|NCT00662649|4857509|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
1473488|NCT00662649|4857505|P5|Core Study (24 Months)|Death|0
1473489|NCT00662649|4857506|P4|Core Study (24 Months)|Death|0
1473490|NCT00662649|4857507|P3|Core Study (24 Months)|Death|2
1473491|NCT00662649|4857508|P2|Core Study (24 Months)|Death|0
1473492|NCT00662649|4857509|P1|Core Study (24 Months)|Death|1
1473493|NCT00662649|4857505|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
1473494|NCT00662649|4857506|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
1473495|NCT00662649|4857507|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
1473496|NCT00662649|4857508|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
1473497|NCT00662649|4857509|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
1473498|NCT00662649|4857505|P5|Core Study (24 Months)|Protocol Violation|0
1473499|NCT00662649|4857506|P4|Core Study (24 Months)|Protocol Violation|0
1473500|NCT00662649|4857507|P3|Core Study (24 Months)|Protocol Violation|4
1473501|NCT00662649|4857508|P2|Core Study (24 Months)|Protocol Violation|5
1473502|NCT00662649|4857509|P1|Core Study (24 Months)|Protocol Violation|5
1473503|NCT00662649|4857505|P5|Core Study (24 Months)|Lost to Follow-up|0
1473504|NCT00662649|4857506|P4|Core Study (24 Months)|Lost to Follow-up|0
1473505|NCT00662649|4857507|P3|Core Study (24 Months)|Lost to Follow-up|7
1473506|NCT00662649|4857508|P2|Core Study (24 Months)|Lost to Follow-up|5
1473507|NCT00662649|4857509|P1|Core Study (24 Months)|Lost to Follow-up|3
1473508|NCT00662649|4857505|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
1473509|NCT00662649|4857506|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
1473510|NCT00662649|4857507|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
1473511|NCT00662649|4857508|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
1473512|NCT00662649|4857509|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
1473513|NCT00662649|4857505|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
1473514|NCT00662649|4857506|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
1473515|NCT00662649|4857507|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
1473516|NCT00662649|4857508|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
1473517|NCT00662649|4857509|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
1473518|NCT00662649|4857505|P5|Core Study (24 Months)|Adverse Event|0
1473519|NCT00662649|4857506|P4|Core Study (24 Months)|Adverse Event|0
1473520|NCT00662649|4857507|P3|Core Study (24 Months)|Adverse Event|18
1473521|NCT00662649|4857508|P2|Core Study (24 Months)|Adverse Event|13
1473522|NCT00662649|4857509|P1|Core Study (24 Months)|Adverse Event|22
1473523|NCT00662649|4857505|P5|Core Study (24 Months)|Withdrawal by Subject|0
1473524|NCT00662649|4857506|P4|Core Study (24 Months)|Withdrawal by Subject|0
1473525|NCT00662649|4857507|P3|Core Study (24 Months)|Withdrawal by Subject|28
1473526|NCT00662649|4857508|P2|Core Study (24 Months)|Withdrawal by Subject|17
1473527|NCT00662649|4857509|P1|Core Study (24 Months)|Withdrawal by Subject|31
1473528|NCT00662558|4857549|P2|Overall Study|Randomized But Did Not Receive Treatment|8
1473529|NCT00662558|4857550|P1|Overall Study|Randomized But Did Not Receive Treatment|2
1473530|NCT00662558|4857549|P2|Overall Study|Withdrawal by Subject|12
1473531|NCT00662558|4857550|P1|Overall Study|Withdrawal by Subject|7
1473532|NCT00662558|4857549|P2|Overall Study|Other|14
1473533|NCT00662558|4857550|P1|Overall Study|Other|9
1473534|NCT00662558|4857549|P2|Overall Study|Lost to Follow-up|10
1473535|NCT00662558|4857550|P1|Overall Study|Lost to Follow-up|13
1473536|NCT00662558|4857549|P2|Overall Study|Lack of Efficacy|7
1473537|NCT00662558|4857550|P1|Overall Study|Lack of Efficacy|4
1473538|NCT00662558|4857549|P2|Overall Study|Adverse Event|59
1473539|NCT00662558|4857550|P1|Overall Study|Adverse Event|21
1473540|NCT00662532|4857601|P2|Overall Study|Lost to Follow-up|1
1473541|NCT00662532|4857602|P1|Overall Study|Lost to Follow-up|0
1473542|NCT00662532|4857601|P2|Overall Study|Adverse Event|1
1473543|NCT00662532|4857602|P1|Overall Study|Adverse Event|0
1473544|NCT00662363|4857617|P2|Overall Study|Protocol Violation|1
1473545|NCT00662363|4857618|P1|Overall Study|Protocol Violation|1
1473546|NCT00662363|4857617|P2|Overall Study|Discharged early from rehab|1
1473547|NCT00662363|4857618|P1|Overall Study|Discharged early from rehab|4
1473548|NCT00662363|4857617|P2|Overall Study|Adverse Event|3
1473549|NCT00662363|4857618|P1|Overall Study|Adverse Event|0
1473550|NCT00662363|4857617|P2|Overall Study|Withdrawal by Subject|5
1473551|NCT00662363|4857618|P1|Overall Study|Withdrawal by Subject|6
1473552|NCT00662311|4857629|P3|Overall Study|Respiratory Infection|0
1473553|NCT00662311|4857630|P2|Overall Study|Respiratory Infection|0
1473554|NCT00662311|4857631|P1|Overall Study|Respiratory Infection|1
1473555|NCT00662129|4857682|P1|Overall Study|Ineligible|1
1473556|NCT00662129|4857682|P1|Overall Study|Cancel prior to beginning treatment|1
1473557|NCT00662129|4857682|P1|Overall Study|Protocol Violation|1
1473558|NCT00662038|4857692|P1|Overall Study|Continued treatment|5
1473559|NCT00662038|4857692|P1|Overall Study|Adverse Event|358
1473560|NCT00662038|4857692|P1|Overall Study|Death|95
1473561|NCT00662038|4857692|P1|Overall Study|Lost to Follow-up|1
1473562|NCT00662038|4857692|P1|Overall Study|Lung transplantation|44
1473563|NCT00662038|4857692|P1|Overall Study|Physician Decision|19
1473564|NCT00662038|4857692|P1|Overall Study|Sponsor decision|1
1473565|NCT00662038|4857692|P1|Overall Study|Withdrawal by Subject|83
1473566|NCT00662038|4857692|P1|Overall Study|Withdrawn consent|22
1473567|NCT00662038|4857692|P1|Overall Study|Reason not specified|3
1473568|NCT00662025|4857696|P1|Overall Study|Domestic circumstances|1
1473569|NCT00662025|4857696|P1|Overall Study|Target lesion cannot be evaluated|1
1473570|NCT00662025|4857696|P1|Overall Study|Results of other clinical study|2
1473571|NCT00662025|4857696|P1|Overall Study|Withdrawal by Subject|1
1473572|NCT00662025|4857696|P1|Overall Study|Adverse Event|7
1473573|NCT00662025|4857696|P1|Overall Study|Objective progression or relapse|51
1473574|NCT00662012|4857716|P1|Overall Study|Withdrawal by Subject|1
1473575|NCT00662012|4857716|P1|Overall Study|Death|1
1473576|NCT00662012|4857716|P1|Overall Study|Lost to Follow-up|85
1473577|NCT00661999|4857724|P3|Overall Study|Other Medical Problems|9
1473578|NCT00661999|4857725|P2|Overall Study|Other Medical Problems|4
1473579|NCT00661999|4857726|P1|Overall Study|Other Medical Problems|4
1473580|NCT00661999|4857724|P3|Overall Study|Alternative Treatment|0
1473581|NCT00661999|4857725|P2|Overall Study|Alternative Treatment|0
1473582|NCT00661999|4857726|P1|Overall Study|Alternative Treatment|1
1473583|NCT00661999|4857724|P3|Overall Study|Withdrawal by Subject|14
1473584|NCT00661999|4857725|P2|Overall Study|Withdrawal by Subject|23
1473585|NCT00661999|4857726|P1|Overall Study|Withdrawal by Subject|30
1473586|NCT00661999|4857724|P3|Overall Study|Other Reasons|23
1473587|NCT00661999|4857725|P2|Overall Study|Other Reasons|12
1473588|NCT00661999|4857726|P1|Overall Study|Other Reasons|5
1473589|NCT00661999|4857724|P3|Overall Study|Death|3
1473590|NCT00661999|4857725|P2|Overall Study|Death|6
1473591|NCT00661999|4857726|P1|Overall Study|Death|8
1473592|NCT00661999|4857724|P3|Overall Study|Adverse Event|8
1473593|NCT00661999|4857725|P2|Overall Study|Adverse Event|5
1473594|NCT00661999|4857726|P1|Overall Study|Adverse Event|11
1473595|NCT00661830|4857803|P2|Overall Study|Other reason|5
1473596|NCT00661830|4857804|P1|Overall Study|Other reason|1
1473597|NCT00661830|4857803|P2|Overall Study|Withdrawal by Subject|1
1473598|NCT00661830|4857804|P1|Overall Study|Withdrawal by Subject|1
1473599|NCT00661830|4857803|P2|Overall Study|Lost to Follow-up|3
1473600|NCT00661830|4857804|P1|Overall Study|Lost to Follow-up|1
1473601|NCT00661830|4857803|P2|Overall Study|Death|33
1473602|NCT00661830|4857804|P1|Overall Study|Death|37
1473603|NCT00661778|4857816|P1|Overall Study|Withdrawal of Consent|1
1473604|NCT00661778|4857816|P1|Overall Study|Protocol Violation|2
1473605|NCT00661778|4857816|P1|Overall Study|Reason not Specified|6
1473606|NCT00661778|4857816|P1|Overall Study|Adverse Event|18
1473607|NCT00661778|4857816|P1|Overall Study|Disease Progression|23
1473608|NCT00661726|4857823|P1|Overall Study|Adverse Event|1
1473609|NCT00661713|4857846|P8|Overall Study|Inappropriate Enrollment|0
1473610|NCT00661713|4857847|P7|Overall Study|Inappropriate Enrollment|1
1473611|NCT00661713|4857848|P6|Overall Study|Inappropriate Enrollment|0
1473612|NCT00661713|4857849|P5|Overall Study|Inappropriate Enrollment|0
1473613|NCT00661713|4857850|P4|Overall Study|Inappropriate Enrollment|0
1473614|NCT00661713|4857851|P3|Overall Study|Inappropriate Enrollment|0
1473615|NCT00661713|4857852|P2|Overall Study|Inappropriate Enrollment|0
1473616|NCT00661713|4857853|P1|Overall Study|Inappropriate Enrollment|0
1473617|NCT00661713|4857846|P8|Overall Study|Adverse Event|0
1473618|NCT00661713|4857847|P7|Overall Study|Adverse Event|1
1473619|NCT00661713|4857848|P6|Overall Study|Adverse Event|0
1473620|NCT00661713|4857849|P5|Overall Study|Adverse Event|0
1473621|NCT00661713|4857850|P4|Overall Study|Adverse Event|0
1473622|NCT00661713|4857851|P3|Overall Study|Adverse Event|0
1473623|NCT00661713|4857852|P2|Overall Study|Adverse Event|0
1473624|NCT00661713|4857853|P1|Overall Study|Adverse Event|0
1473625|NCT00661713|4857846|P8|Overall Study|Administrative Reason|0
1473626|NCT00661713|4857847|P7|Overall Study|Administrative Reason|1
1473627|NCT00661713|4857848|P6|Overall Study|Administrative Reason|2
1473628|NCT00661713|4857849|P5|Overall Study|Administrative Reason|2
1473629|NCT00661713|4857850|P4|Overall Study|Administrative Reason|2
1473630|NCT00661713|4857851|P3|Overall Study|Administrative Reason|0
1473631|NCT00661713|4857852|P2|Overall Study|Administrative Reason|1
1473632|NCT00661713|4857853|P1|Overall Study|Administrative Reason|0
1473633|NCT00661713|4857846|P8|Overall Study|Lost to Follow-up|1
1473634|NCT00661713|4857847|P7|Overall Study|Lost to Follow-up|14
1473635|NCT00661713|4857848|P6|Overall Study|Lost to Follow-up|7
1473636|NCT00661713|4857849|P5|Overall Study|Lost to Follow-up|5
1473637|NCT00661713|4857850|P4|Overall Study|Lost to Follow-up|2
1473638|NCT00661713|4857851|P3|Overall Study|Lost to Follow-up|2
1473639|NCT00661713|4857852|P2|Overall Study|Lost to Follow-up|7
1473640|NCT00661713|4857853|P1|Overall Study|Lost to Follow-up|2
1473641|NCT00661713|4857846|P8|Overall Study|Withdrawal by Subject|9
1473642|NCT00661713|4857847|P7|Overall Study|Withdrawal by Subject|45
1473643|NCT00661713|4857848|P6|Overall Study|Withdrawal by Subject|26
1473644|NCT00661713|4857849|P5|Overall Study|Withdrawal by Subject|12
1473645|NCT00661713|4857850|P4|Overall Study|Withdrawal by Subject|21
1473646|NCT00661713|4857851|P3|Overall Study|Withdrawal by Subject|12
1473647|NCT00661713|4857852|P2|Overall Study|Withdrawal by Subject|25
1473648|NCT00661713|4857853|P1|Overall Study|Withdrawal by Subject|11
1473649|NCT00661713|4857846|P8|Overall Study|Protocol Violation|1
1473650|NCT00661713|4857847|P7|Overall Study|Protocol Violation|2
1473651|NCT00661713|4857848|P6|Overall Study|Protocol Violation|2
1473652|NCT00661713|4857849|P5|Overall Study|Protocol Violation|0
1473653|NCT00661713|4857850|P4|Overall Study|Protocol Violation|3
1473654|NCT00661713|4857851|P3|Overall Study|Protocol Violation|3
1473655|NCT00661713|4857852|P2|Overall Study|Protocol Violation|6
1473656|NCT00661713|4857853|P1|Overall Study|Protocol Violation|1
1473657|NCT00661713|4857846|P8|Overall Study|Unable to Classify|0
1473658|NCT00661713|4857847|P7|Overall Study|Unable to Classify|0
1473659|NCT00661713|4857848|P6|Overall Study|Unable to Classify|0
1473660|NCT00661713|4857849|P5|Overall Study|Unable to Classify|0
1473661|NCT00661713|4857850|P4|Overall Study|Unable to Classify|0
1473662|NCT00661713|4857851|P3|Overall Study|Unable to Classify|0
1473663|NCT00661713|4857852|P2|Overall Study|Unable to Classify|0
1473664|NCT00661713|4857853|P1|Overall Study|Unable to Classify|1
1473665|NCT00661713|4857846|P8|Overall Study|Death|0
1473666|NCT00661713|4857847|P7|Overall Study|Death|0
1473667|NCT00661713|4857848|P6|Overall Study|Death|0
1473668|NCT00661713|4857849|P5|Overall Study|Death|1
1473669|NCT00661713|4857850|P4|Overall Study|Death|0
1473670|NCT00661713|4857851|P3|Overall Study|Death|0
1473671|NCT00661713|4857852|P2|Overall Study|Death|0
1473672|NCT00661713|4857853|P1|Overall Study|Death|1
1473673|NCT00661687|4857943|P1|Overall Study|Adverse Event|2
1473674|NCT00661687|4857943|P1|Overall Study|Physician Decision|1
1473675|NCT00661687|4857943|P1|Overall Study|Inability to maintain wearing schedule|3
1473676|NCT00661687|4857943|P1|Overall Study|Positive slit lamp findings|4
1473677|NCT00661687|4857943|P1|Overall Study|Study related symptoms and complaints|5
1473678|NCT00661661|4857971|P2|Overall Study|Not assigned treatment|0
1473679|NCT00661661|4857972|P1|Overall Study|Not assigned treatment|1
1473680|NCT00661661|4857971|P2|Overall Study|Other|7
1473681|NCT00661661|4857972|P1|Overall Study|Other|22
1473682|NCT00661661|4857971|P2|Overall Study|Withdrawal by Subject|5
1473683|NCT00661661|4857972|P1|Overall Study|Withdrawal by Subject|15
1473684|NCT00661661|4857971|P2|Overall Study|Lost to Follow-up|1
1473685|NCT00661661|4857972|P1|Overall Study|Lost to Follow-up|0
1473686|NCT00661661|4857971|P2|Overall Study|Lack of Efficacy|2
1473687|NCT00661661|4857972|P1|Overall Study|Lack of Efficacy|3
1473688|NCT00661661|4857971|P2|Overall Study|Adverse Event|24
1473689|NCT00661661|4857972|P1|Overall Study|Adverse Event|99
1473690|NCT00661622|4858048|P2|Overall Study|Protocol Violation|0
1473691|NCT00661622|4858049|P1|Overall Study|Protocol Violation|1
1473692|NCT00661609|4858063|P1|Overall Study|Disease progression|3
1473693|NCT00661609|4858063|P1|Overall Study|Survival follow up stage discontinued|11
1473694|NCT00661609|4858063|P1|Overall Study|PI Decision|1
1473695|NCT00661609|4858063|P1|Overall Study|Withdrawal by Subject|2
1473696|NCT00661609|4858063|P1|Overall Study|Death|20
1473697|NCT00661609|4858063|P1|Overall Study|Adverse Event|4
1473698|NCT00661531|4858103|P1|Overall Study|Withdrawal by Subject|3
1473699|NCT00661505|4858108|P1|Overall Study|Not Specified|2
1473700|NCT00661505|4858108|P1|Overall Study|Lost to Follow-up|3
1473701|NCT00661505|4858108|P1|Overall Study|Withdrawal by Subject|8
1473702|NCT00661505|4858108|P1|Overall Study|Protocol Violation|14
1473703|NCT00661505|4858108|P1|Overall Study|Adverse Event|3
1473704|NCT00661492|4858136|P2|Overall Study|Other|0
1473705|NCT00661492|4858137|P1|Overall Study|Other|1
1473706|NCT00661492|4858136|P2|Overall Study|Lost to Follow-up|1
1473707|NCT00661492|4858137|P1|Overall Study|Lost to Follow-up|0
1473708|NCT00661492|4858136|P2|Overall Study|Investigator Request|0
1473709|NCT00661492|4858137|P1|Overall Study|Investigator Request|1
1473710|NCT00661492|4858136|P2|Overall Study|Patient Request|1
1473711|NCT00661492|4858137|P1|Overall Study|Patient Request|6
1473712|NCT00661492|4858136|P2|Overall Study|Disease Progression|14
1473713|NCT00661492|4858137|P1|Overall Study|Disease Progression|44
1473714|NCT00661492|4858136|P2|Overall Study|Adverse Event|13
1473715|NCT00661492|4858137|P1|Overall Study|Adverse Event|16
1473716|NCT00661427|4858183|P2|Overall Study|Patient not treated|2
1473717|NCT00661427|4858184|P1|Overall Study|Patient not treated|0
1473718|NCT00661427|4858183|P2|Overall Study|Adverse Event|5
1473719|NCT00661427|4858184|P1|Overall Study|Adverse Event|5
1473720|NCT00661388|4858192|P1|Overall Study|Administrative reasons|1
1473721|NCT00661388|4858192|P1|Overall Study|Dialysis initiation|1
1473722|NCT00661388|4858192|P1|Overall Study|Renal transplantation|1
1473723|NCT00661388|4858192|P1|Overall Study|Protocol Violation|7
1473724|NCT00661388|4858192|P1|Overall Study|Adverse Event|14
1473725|NCT00661362|4858215|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
1473726|NCT00661362|4858216|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
1473727|NCT00661362|4858215|P2|Overall Study|Safety reasons|0
1473728|NCT00661362|4858216|P1|Overall Study|Safety reasons|1
1473729|NCT00661362|4858215|P2|Overall Study|Severe non-compliance to protocol|1
1473730|NCT00661362|4858216|P1|Overall Study|Severe non-compliance to protocol|0
1473731|NCT00661362|4858215|P2|Overall Study|Lost to Follow-up|1
1473732|NCT00661362|4858216|P1|Overall Study|Lost to Follow-up|3
1473733|NCT00661362|4858215|P2|Overall Study|Withdrawal by Subject|23
1473734|NCT00661362|4858216|P1|Overall Study|Withdrawal by Subject|13
1473735|NCT00661362|4858215|P2|Overall Study|Study specific discontinuation criteria|11
1473736|NCT00661362|4858216|P1|Overall Study|Study specific discontinuation criteria|4
1473737|NCT00661362|4858215|P2|Overall Study|Incorrect enrollment|0
1473738|NCT00661362|4858216|P1|Overall Study|Incorrect enrollment|2
1473739|NCT00661362|4858215|P2|Overall Study|Adverse Event|4
1473740|NCT00661362|4858216|P1|Overall Study|Adverse Event|5
1473741|NCT00661271|4858234|P2|Overall Study|Lost to Follow-up|25
1473742|NCT00661271|4858235|P1|Overall Study|Lost to Follow-up|28
1473743|NCT00661258|4858245|P2|Overall Study|caught by police and in detox center|1
1473744|NCT00661258|4858246|P1|Overall Study|caught by police and in detox center|2
1473745|NCT00661258|4858245|P2|Overall Study|Death|0
1473746|NCT00661258|4858246|P1|Overall Study|Death|1
1473747|NCT00661193|4858256|P2|Overall Study|Not protocol specified|0
1473748|NCT00661193|4858257|P1|Overall Study|Not protocol specified|1
1473749|NCT00661193|4858256|P2|Overall Study|Progression|24
1473750|NCT00661193|4858257|P1|Overall Study|Progression|27
1473751|NCT00661193|4858256|P2|Overall Study|Withdrawal by Subject|1
1473752|NCT00661193|4858257|P1|Overall Study|Withdrawal by Subject|3
1473753|NCT00661193|4858256|P2|Overall Study|Adverse Event|1
1473754|NCT00661193|4858257|P1|Overall Study|Adverse Event|2
1473755|NCT00661089|4858482|P2|Overall Study|death at 8 weeks due to new stroke|1
1473756|NCT00661089|4858483|P1|Overall Study|death at 8 weeks due to new stroke|0
1473757|NCT00661089|4858482|P2|Overall Study|1 subject withdrawal|1
1473758|NCT00661089|4858483|P1|Overall Study|1 subject withdrawal|0
1473759|NCT00660907|4858531|P2|Overall Study|Various|8
1473760|NCT00660907|4858532|P1|Overall Study|Various|11
1473761|NCT00660907|4858531|P2|Overall Study|Death|3
1473762|NCT00660907|4858532|P1|Overall Study|Death|1
1473763|NCT00660907|4858531|P2|Overall Study|Safety|0
1473764|NCT00660907|4858532|P1|Overall Study|Safety|1
1473765|NCT00660907|4858531|P2|Overall Study|Poor/Non-Compliance|1
1473766|NCT00660907|4858532|P1|Overall Study|Poor/Non-Compliance|5
1473767|NCT00660907|4858531|P2|Overall Study|Lost to Follow-up|3
1473768|NCT00660907|4858532|P1|Overall Study|Lost to Follow-up|3
1473769|NCT00660907|4858531|P2|Overall Study|Withdrawal by Subject|32
1473770|NCT00660907|4858532|P1|Overall Study|Withdrawal by Subject|23
1473771|NCT00660907|4858531|P2|Overall Study|Subject No Longer Meets Study Criteria|27
1473772|NCT00660907|4858532|P1|Overall Study|Subject No Longer Meets Study Criteria|6
1473773|NCT00660907|4858531|P2|Overall Study|Adverse Event|19
1473774|NCT00660907|4858532|P1|Overall Study|Adverse Event|33
1473775|NCT00660907|4858531|P2|Overall Study|Incorrect Enrollment|1
1473776|NCT00660907|4858532|P1|Overall Study|Incorrect Enrollment|1
1473777|NCT00660829|4858546|P2|Overall Study|Other|4
1473778|NCT00660829|4858547|P1|Overall Study|Other|9
1473779|NCT00660829|4858546|P2|Overall Study|Lost to Follow-up|2
1473780|NCT00660829|4858547|P1|Overall Study|Lost to Follow-up|3
1473781|NCT00660829|4858546|P2|Overall Study|Withdrawal by Subject|2
1473782|NCT00660829|4858547|P1|Overall Study|Withdrawal by Subject|1
1473783|NCT00660829|4858546|P2|Overall Study|Non-Compliance|4
1473784|NCT00660829|4858547|P1|Overall Study|Non-Compliance|0
1473785|NCT00660829|4858546|P2|Overall Study|Lack of Efficacy|3
1473786|NCT00660829|4858547|P1|Overall Study|Lack of Efficacy|2
1473787|NCT00660829|4858546|P2|Overall Study|Adverse Event|4
1473788|NCT00660829|4858547|P1|Overall Study|Adverse Event|3
1473789|NCT00660816|4858565|P2|Overall Study|Complicating Disease|1
1473790|NCT00660816|4858566|P1|Overall Study|Complicating Disease|0
1473791|NCT00660816|4858565|P2|Overall Study|Disease Progression|12
1473792|NCT00660816|4858566|P1|Overall Study|Disease Progression|16
1473793|NCT00660816|4858565|P2|Overall Study|Protocol Violation|0
1473794|NCT00660816|4858566|P1|Overall Study|Protocol Violation|1
1473795|NCT00660816|4858565|P2|Overall Study|Physician Decision|2
1473796|NCT00660816|4858566|P1|Overall Study|Physician Decision|0
1473797|NCT00660816|4858565|P2|Overall Study|Lack of Efficacy|0
1473798|NCT00660816|4858566|P1|Overall Study|Lack of Efficacy|1
1473799|NCT00660816|4858565|P2|Overall Study|Death|2
1473800|NCT00660816|4858566|P1|Overall Study|Death|0
1473801|NCT00660816|4858565|P2|Overall Study|Withdrawal by Subject|0
1473802|NCT00660816|4858566|P1|Overall Study|Withdrawal by Subject|1
1473803|NCT00660816|4858565|P2|Overall Study|Adverse Event|2
1473804|NCT00660816|4858566|P1|Overall Study|Adverse Event|1
1473805|NCT00660699|4858578|P1|Overall Study|Withdrawal by Subject|2
1473806|NCT00660660|4858594|P2|Overall Study|New medication after randomization|0
1473807|NCT00660660|4858595|P1|Overall Study|New medication after randomization|1
1473808|NCT00660660|4858594|P2|Overall Study|Incorrect enrollment and other|1
1473809|NCT00660660|4858595|P1|Overall Study|Incorrect enrollment and other|0
1473810|NCT00660660|4858594|P2|Overall Study|Withdrawal by Subject|0
1473811|NCT00660660|4858595|P1|Overall Study|Withdrawal by Subject|3
1473812|NCT00660660|4858594|P2|Overall Study|Lack of Efficacy|2
1473813|NCT00660660|4858595|P1|Overall Study|Lack of Efficacy|0
1473814|NCT00660660|4858594|P2|Overall Study|Lost to Follow-up|6
1473815|NCT00660660|4858595|P1|Overall Study|Lost to Follow-up|0
1473816|NCT00660660|4858594|P2|Overall Study|Adverse Event|0
1473817|NCT00660660|4858595|P1|Overall Study|Adverse Event|1
1473818|NCT00660595|4858695|P2|Overall Study|Non Specified reasons|0
1473819|NCT00660595|4858696|P1|Overall Study|Non Specified reasons|5
1473820|NCT00660595|4858695|P2|Overall Study|Participant left hospital|0
1473821|NCT00660595|4858696|P1|Overall Study|Participant left hospital|1
1473822|NCT00660595|4858695|P2|Overall Study|Did not consent to participate in study|8
1473823|NCT00660595|4858696|P1|Overall Study|Did not consent to participate in study|12
1473824|NCT00660595|4858695|P2|Overall Study|Lost to Follow-up|1
1473825|NCT00660595|4858696|P1|Overall Study|Lost to Follow-up|0
1473826|NCT00660400|4858757|P1|Overall Study|Withdrawal by Subject|1
1473827|NCT00660400|4858757|P1|Overall Study|Intracranial hemorrhage|1
1473828|NCT00660400|4858757|P1|Overall Study|Suboptimal organ function|1
1473829|NCT00660400|4858757|P1|Overall Study|Lack of insurance approval|1
1473830|NCT00660387|4858766|P2|Overall Study|Protocol Violation|0
1473831|NCT00660387|4858767|P1|Overall Study|Protocol Violation|1
1473832|NCT00660387|4858766|P2|Overall Study|Lack of Efficacy|1
1473833|NCT00660387|4858767|P1|Overall Study|Lack of Efficacy|0
1473834|NCT00660387|4858766|P2|Overall Study|Adverse Event|2
1473835|NCT00660387|4858767|P1|Overall Study|Adverse Event|1
1473836|NCT00660348|4858821|P2|Overall Study|Withdrawal by Subject|0
1473837|NCT00660348|4858822|P1|Overall Study|Withdrawal by Subject|1
1473838|NCT00660309|4858830|P2|Overall Study|Withdrawal by Subject|3
1473839|NCT00660309|4858831|P1|Overall Study|Withdrawal by Subject|0
1473840|NCT00660309|4858830|P2|Overall Study|Adverse Event|0
1473841|NCT00660309|4858831|P1|Overall Study|Adverse Event|2
1473842|NCT00660192|4858872|P2|Overall Study|Lost to Follow-up|3
1473843|NCT00660192|4858873|P1|Overall Study|Lost to Follow-up|2
1473844|NCT00660179|4858884|P3|Overall Study|Incorrect randomization|0
1473845|NCT00660179|4858885|P2|Overall Study|Incorrect randomization|0
1473846|NCT00660179|4858886|P1|Overall Study|Incorrect randomization|1
1473847|NCT00660179|4858884|P3|Overall Study|Administrative reason|1
1473848|NCT00660179|4858885|P2|Overall Study|Administrative reason|0
1473849|NCT00660179|4858886|P1|Overall Study|Administrative reason|0
1473850|NCT00660179|4858884|P3|Overall Study|Lost to Follow-up|2
1473851|NCT00660179|4858885|P2|Overall Study|Lost to Follow-up|5
1473852|NCT00660179|4858886|P1|Overall Study|Lost to Follow-up|7
1473853|NCT00660179|4858884|P3|Overall Study|Withdrawal of consent|4
1473854|NCT00660179|4858885|P2|Overall Study|Withdrawal of consent|6
1473855|NCT00660179|4858886|P1|Overall Study|Withdrawal of consent|4
1473856|NCT00660179|4858884|P3|Overall Study|Death|34
1473857|NCT00660179|4858885|P2|Overall Study|Death|47
1473858|NCT00660179|4858886|P1|Overall Study|Death|44
1473859|NCT00660023|4858931|P1|Overall Study|Other Screening Failure|9
1473860|NCT00660023|4858931|P1|Overall Study|Missed Pregnancy Test|1
1473861|NCT00660023|4858931|P1|Overall Study|Withdrawal by Subject|1
1473862|NCT00660023|4858931|P1|Overall Study|Renal Transplantation|3
1473863|NCT00660023|4858931|P1|Overall Study|Blood Transfusion|5
1473864|NCT00660023|4858931|P1|Overall Study|Death|8
1473865|NCT00660023|4858931|P1|Overall Study|Adverse Event|2
1473866|NCT00660010|4858942|P1|Overall Study|Noncompliance with visit schedule|3
1473867|NCT00660010|4858942|P1|Overall Study|Adverse Event|1
1473868|NCT00660010|4858942|P1|Overall Study|Lost to Follow-up|3
1473869|NCT00660010|4858942|P1|Overall Study|Withdrawal by Subject|2
1473870|NCT00659984|4858956|P1|Overall Study|Adverse Event|1
1473871|NCT00659880|4858976|P1|Overall Study|Lost to Follow-up|5
1473872|NCT00659815|4858983|P2|Overall Study|Withdrawal by Subject|1
1473873|NCT00659815|4858984|P1|Overall Study|Withdrawal by Subject|1
1473874|NCT00659815|4858983|P2|Overall Study|Inability to maintain wearing schedule|2
1473875|NCT00659815|4858984|P1|Overall Study|Inability to maintain wearing schedule|1
1473876|NCT00659815|4858983|P2|Overall Study|Study related symptoms and complaints|1
1473877|NCT00659815|4858984|P1|Overall Study|Study related symptoms and complaints|2
1473878|NCT00659607|4859044|P1|Overall Study|Inconsistent BP measuring date|2
1473879|NCT00659607|4859044|P1|Overall Study|No recorded efficacy data|15
1473880|NCT00659607|4859044|P1|Overall Study|‘Unable to evaluate’ for the final asses|67
1473881|NCT00659607|4859044|P1|Overall Study|Unknown measuring date of blood pressure|85
1473882|NCT00659607|4859044|P1|Overall Study|No blood pressure recorded|147
1473883|NCT00659581|4859062|P1|Overall Study|Other|6393
1473884|NCT00659581|4859062|P1|Overall Study|Lack of Efficacy|1183
1473885|NCT00659581|4859062|P1|Overall Study|Adverse Event|1006
1473886|NCT00659529|4859074|P1|Overall Study|Screen failure|9
1473887|NCT00659529|4859074|P1|Overall Study|Protocol Violation|3
1473888|NCT00659529|4859074|P1|Overall Study|Withdrawal by Subject|4
1473889|NCT00659490|4859081|P3|Overall Study|Lost to Follow-up|1
1473890|NCT00659490|4859082|P2|Overall Study|Lost to Follow-up|0
1473891|NCT00659490|4859083|P1|Overall Study|Lost to Follow-up|2
1473892|NCT00659438|4859156|P2|Overall Study|Lost to Follow-up|0
1473893|NCT00659438|4859157|P1|Overall Study|Lost to Follow-up|1
1473894|NCT00659438|4859156|P2|Overall Study|Death|6
1473895|NCT00659438|4859157|P1|Overall Study|Death|11
1473896|NCT00659438|4859156|P2|Overall Study|Withdrawal by Subject|2
1473897|NCT00659438|4859157|P1|Overall Study|Withdrawal by Subject|2
1473898|NCT00659425|4859189|P10|Overall Study|Other|6
1473899|NCT00659425|4859190|P9|Overall Study|Other|0
1473900|NCT00659425|4859191|P8|Overall Study|Other|2
1473901|NCT00659425|4859192|P7|Overall Study|Other|3
1473902|NCT00659425|4859193|P6|Overall Study|Other|0
1473903|NCT00659425|4859194|P5|Overall Study|Other|4
1473904|NCT00659425|4859195|P4|Overall Study|Other|2
1473905|NCT00659425|4859196|P3|Overall Study|Other|1
1473906|NCT00659425|4859197|P2|Overall Study|Other|1
1473907|NCT00659425|4859198|P1|Overall Study|Other|0
1473908|NCT00659425|4859189|P10|Overall Study|Investigator Discretion|0
1473909|NCT00659425|4859190|P9|Overall Study|Investigator Discretion|0
1473910|NCT00659425|4859191|P8|Overall Study|Investigator Discretion|3
1473911|NCT00659425|4859192|P7|Overall Study|Investigator Discretion|0
1473912|NCT00659425|4859193|P6|Overall Study|Investigator Discretion|1
1473913|NCT00659425|4859194|P5|Overall Study|Investigator Discretion|0
1473914|NCT00659425|4859195|P4|Overall Study|Investigator Discretion|0
1473915|NCT00659425|4859196|P3|Overall Study|Investigator Discretion|0
1473916|NCT00659425|4859197|P2|Overall Study|Investigator Discretion|0
1473917|NCT00659425|4859198|P1|Overall Study|Investigator Discretion|0
1473918|NCT00659425|4859189|P10|Overall Study|Adverse Event|4
1473919|NCT00659425|4859190|P9|Overall Study|Adverse Event|1
1473920|NCT00659425|4859191|P8|Overall Study|Adverse Event|3
1473921|NCT00659425|4859192|P7|Overall Study|Adverse Event|0
1473922|NCT00659425|4859193|P6|Overall Study|Adverse Event|1
1473923|NCT00659425|4859194|P5|Overall Study|Adverse Event|0
1473924|NCT00659425|4859195|P4|Overall Study|Adverse Event|0
1473925|NCT00659425|4859196|P3|Overall Study|Adverse Event|0
1473926|NCT00659425|4859197|P2|Overall Study|Adverse Event|0
1473927|NCT00659425|4859198|P1|Overall Study|Adverse Event|0
1473928|NCT00659425|4859189|P10|Overall Study|Death|0
1473929|NCT00659425|4859190|P9|Overall Study|Death|0
1473930|NCT00659425|4859191|P8|Overall Study|Death|0
1473931|NCT00659425|4859192|P7|Overall Study|Death|1
1473932|NCT00659425|4859193|P6|Overall Study|Death|0
1473933|NCT00659425|4859194|P5|Overall Study|Death|0
1473934|NCT00659425|4859195|P4|Overall Study|Death|1
1473935|NCT00659425|4859196|P3|Overall Study|Death|0
1473936|NCT00659425|4859197|P2|Overall Study|Death|0
1473937|NCT00659425|4859198|P1|Overall Study|Death|0
1473938|NCT00659425|4859189|P10|Overall Study|Disease progression|3
1473939|NCT00659425|4859190|P9|Overall Study|Disease progression|5
1473940|NCT00659425|4859191|P8|Overall Study|Disease progression|3
1473941|NCT00659425|4859192|P7|Overall Study|Disease progression|4
1473942|NCT00659425|4859193|P6|Overall Study|Disease progression|2
1473943|NCT00659425|4859194|P5|Overall Study|Disease progression|0
1473944|NCT00659425|4859195|P4|Overall Study|Disease progression|1
1473945|NCT00659425|4859196|P3|Overall Study|Disease progression|0
1473946|NCT00659425|4859197|P2|Overall Study|Disease progression|0
1473947|NCT00659425|4859198|P1|Overall Study|Disease progression|1
1473948|NCT00659373|4859429|P2|Overall Study|Assessment Missed|2
1473949|NCT00659373|4859430|P1|Overall Study|Assessment Missed|2
1473950|NCT00659373|4859429|P2|Overall Study|Withdrawal by Subject|5
1473951|NCT00659373|4859430|P1|Overall Study|Withdrawal by Subject|3
1473952|NCT00659334|4859452|P7|Overall Study|Screen Failure|1
1473953|NCT00659334|4859453|P6|Overall Study|Screen Failure|0
1473954|NCT00659334|4859454|P5|Overall Study|Screen Failure|0
1473955|NCT00659334|4859455|P4|Overall Study|Screen Failure|0
1473956|NCT00659334|4859456|P3|Overall Study|Screen Failure|0
1473957|NCT00659334|4859457|P2|Overall Study|Screen Failure|5
1473958|NCT00659334|4859458|P1|Overall Study|Screen Failure|8
1473959|NCT00659269|4859485|P2|Overall Study|Physician Decision|1
1473960|NCT00659269|4859486|P1|Overall Study|Physician Decision|1
1473961|NCT00659230|4859516|P2|Overall Study|Did not return post-randomization|3
1473962|NCT00659230|4859517|P1|Overall Study|Did not return post-randomization|2
1473963|NCT00659230|4859516|P2|Overall Study|Lost source documentation|4
1473964|NCT00659230|4859517|P1|Overall Study|Lost source documentation|5
1473965|NCT00659230|4859516|P2|Overall Study|Lost to Follow-up|5
1473966|NCT00659230|4859517|P1|Overall Study|Lost to Follow-up|2
1473967|NCT00659061|4859540|P2|Overall Study|Migration due to political unrest|15
1473968|NCT00659061|4859541|P1|Overall Study|Migration due to political unrest|21
1473969|NCT00658996|4859559|P2|Second Intervention|Positive slit lamp finding|1
1473970|NCT00658996|4859560|P1|Second Intervention|Positive slit lamp finding|0
1473971|NCT00658996|4859559|P2|Second Intervention|Developed a stye on upper lid|0
1473972|NCT00658996|4859560|P1|Second Intervention|Developed a stye on upper lid|1
1473973|NCT00658996|4859559|P2|Crossover Period|Ineligible|1
1473974|NCT00658996|4859560|P1|Crossover Period|Ineligible|1
1473975|NCT00658996|4859559|P2|Crossover Period|Physician Decision|0
1473976|NCT00658996|4859560|P1|Crossover Period|Physician Decision|1
1473977|NCT00658996|4859559|P2|First Intervention|Lack of lenses|1
1473978|NCT00658996|4859560|P1|First Intervention|Lack of lenses|0
1473979|NCT00658996|4859559|P2|First Intervention|Positive slit lamp finding|0
1473980|NCT00658996|4859560|P1|First Intervention|Positive slit lamp finding|1
1473981|NCT00658814|4859572|P2|Maintenance Therapy|Not eligible|0
1473982|NCT00658814|4859573|P1|Maintenance Therapy|Not eligible|1
1473983|NCT00658814|4859572|P2|Maintenance Therapy|Not protocol specified|0
1473984|NCT00658814|4859573|P1|Maintenance Therapy|Not protocol specified|1
1473985|NCT00658814|4859572|P2|Maintenance Therapy|Adverse Event|1
1473986|NCT00658814|4859573|P1|Maintenance Therapy|Adverse Event|1
1473987|NCT00658814|4859572|P2|Consolidation Therapy|Not eligible|2
1473988|NCT00658814|4859573|P1|Consolidation Therapy|Not eligible|2
1473989|NCT00658814|4859572|P2|Consolidation Therapy|Not protocol specified|1
1473990|NCT00658814|4859573|P1|Consolidation Therapy|Not protocol specified|0
1473991|NCT00658814|4859572|P2|Remission Induction Chemotherapy|Not eligible|2
1473992|NCT00658814|4859573|P1|Remission Induction Chemotherapy|Not eligible|1
1473993|NCT00658814|4859572|P2|Remission Induction Chemotherapy|Not protocol specified|4
1473994|NCT00658814|4859573|P1|Remission Induction Chemotherapy|Not protocol specified|2
1473995|NCT00658814|4859572|P2|Remission Induction Chemotherapy|Death|4
1473996|NCT00658814|4859573|P1|Remission Induction Chemotherapy|Death|1
1473997|NCT00658814|4859572|P2|Remission Induction Chemotherapy|Progression/Relapse|1
1473998|NCT00658814|4859573|P1|Remission Induction Chemotherapy|Progression/Relapse|0
1473999|NCT00658814|4859572|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
1474000|NCT00658814|4859573|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
1474001|NCT00658814|4859572|P2|Remission Induction Chemotherapy|Adverse Event|3
1474002|NCT00658814|4859573|P1|Remission Induction Chemotherapy|Adverse Event|1
1474003|NCT00658788|4859587|P1|Overall Study|Treatment Discontinuation|32
1474004|NCT00658788|4859587|P1|Overall Study|Lost to Follow-up|18
1474005|NCT00658788|4859587|P1|Overall Study|Withdrawal by Subject|13
1474006|NCT00658788|4859587|P1|Overall Study|Adverse Event|11
1474007|NCT00658775|4859642|P2|Overall Study|Not specified|8
1474008|NCT00658775|4859643|P1|Overall Study|Not specified|7
1474009|NCT00658775|4859642|P2|Overall Study|Withdrawal of consent|7
1474010|NCT00658775|4859643|P1|Overall Study|Withdrawal of consent|8
1474011|NCT00658775|4859642|P2|Overall Study|Withdrawal by Subject|4
1474012|NCT00658775|4859643|P1|Overall Study|Withdrawal by Subject|6
1474013|NCT00658775|4859642|P2|Overall Study|Lost to Follow-up|18
1474014|NCT00658775|4859643|P1|Overall Study|Lost to Follow-up|17
1474015|NCT00658775|4859642|P2|Overall Study|Adverse Event|6
1474016|NCT00658775|4859643|P1|Overall Study|Adverse Event|4
1474017|NCT00658723|4859666|P3|Overall Study|Withdrawal by Subject|1
1474018|NCT00658723|4859667|P2|Overall Study|Withdrawal by Subject|0
1474019|NCT00658723|4859668|P1|Overall Study|Withdrawal by Subject|1
1474020|NCT00658723|4859666|P3|Overall Study|Scheduling Issue|0
1474021|NCT00658723|4859667|P2|Overall Study|Scheduling Issue|1
1474022|NCT00658723|4859668|P1|Overall Study|Scheduling Issue|1
1474023|NCT00658723|4859666|P3|Overall Study|Death|4
1474024|NCT00658723|4859667|P2|Overall Study|Death|1
1474025|NCT00658723|4859668|P1|Overall Study|Death|2
1474026|NCT00658723|4859666|P3|Overall Study|Lost to Follow-up|2
1474027|NCT00658723|4859667|P2|Overall Study|Lost to Follow-up|2
1474028|NCT00658723|4859668|P1|Overall Study|Lost to Follow-up|0
1474029|NCT00658684|4859706|P4|Overall Study|Pregnancy|0
1474030|NCT00658684|4859707|P3|Overall Study|Pregnancy|0
1474031|NCT00658684|4859708|P2|Overall Study|Pregnancy|1
1474032|NCT00658684|4859709|P1|Overall Study|Pregnancy|1
1474033|NCT00658684|4859706|P4|Overall Study|Protocol Violation|0
1474034|NCT00658684|4859707|P3|Overall Study|Protocol Violation|0
1474035|NCT00658684|4859708|P2|Overall Study|Protocol Violation|1
1474036|NCT00658684|4859709|P1|Overall Study|Protocol Violation|1
1474037|NCT00658684|4859706|P4|Overall Study|Lack of Efficacy|0
1474038|NCT00658684|4859707|P3|Overall Study|Lack of Efficacy|0
1474039|NCT00658684|4859708|P2|Overall Study|Lack of Efficacy|1
1474040|NCT00658684|4859709|P1|Overall Study|Lack of Efficacy|1
1474041|NCT00658684|4859706|P4|Overall Study|Withdrawal by Subject|1
1474042|NCT00658684|4859707|P3|Overall Study|Withdrawal by Subject|1
1474043|NCT00658684|4859708|P2|Overall Study|Withdrawal by Subject|4
1474044|NCT00658684|4859709|P1|Overall Study|Withdrawal by Subject|6
1474045|NCT00658684|4859706|P4|Overall Study|Adverse Event|0
1474046|NCT00658684|4859707|P3|Overall Study|Adverse Event|2
1474047|NCT00658684|4859708|P2|Overall Study|Adverse Event|8
1474048|NCT00658684|4859709|P1|Overall Study|Adverse Event|10
1474049|NCT00658658|4859764|P5|Overall Study|Other|1
1474050|NCT00658658|4859765|P4|Overall Study|Other|0
1474051|NCT00658658|4859766|P3|Overall Study|Other|0
1474052|NCT00658658|4859767|P2|Overall Study|Other|0
1474053|NCT00658658|4859768|P1|Overall Study|Other|0
1474054|NCT00658658|4859764|P5|Overall Study|Protocol-specified Criteria|0
1474055|NCT00658658|4859765|P4|Overall Study|Protocol-specified Criteria|0
1474056|NCT00658658|4859766|P3|Overall Study|Protocol-specified Criteria|0
1474057|NCT00658658|4859767|P2|Overall Study|Protocol-specified Criteria|0
1474058|NCT00658658|4859768|P1|Overall Study|Protocol-specified Criteria|1
1474059|NCT00658658|4859764|P5|Overall Study|Disease Progression|3
1474060|NCT00658658|4859765|P4|Overall Study|Disease Progression|1
1474061|NCT00658658|4859766|P3|Overall Study|Disease Progression|0
1474062|NCT00658658|4859767|P2|Overall Study|Disease Progression|1
1474063|NCT00658658|4859768|P1|Overall Study|Disease Progression|0
1474064|NCT00658658|4859764|P5|Overall Study|Death|1
1474065|NCT00658658|4859765|P4|Overall Study|Death|1
1474066|NCT00658658|4859766|P3|Overall Study|Death|0
1474067|NCT00658658|4859767|P2|Overall Study|Death|0
1474068|NCT00658658|4859768|P1|Overall Study|Death|4
1474069|NCT00658658|4859764|P5|Overall Study|Withdrawal by Subject|0
1474070|NCT00658658|4859765|P4|Overall Study|Withdrawal by Subject|0
1474071|NCT00658658|4859766|P3|Overall Study|Withdrawal by Subject|0
1474072|NCT00658658|4859767|P2|Overall Study|Withdrawal by Subject|1
1474073|NCT00658658|4859768|P1|Overall Study|Withdrawal by Subject|0
1474074|NCT00658632|4859827|P2|Overall Study|Not specified|8
1474075|NCT00658632|4859828|P1|Overall Study|Not specified|7
1474076|NCT00658632|4859827|P2|Overall Study|Pregnancy|1
1474077|NCT00658632|4859828|P1|Overall Study|Pregnancy|1
1474078|NCT00658632|4859827|P2|Overall Study|Withdrawal of consent|14
1474079|NCT00658632|4859828|P1|Overall Study|Withdrawal of consent|8
1474080|NCT00658632|4859827|P2|Overall Study|Lack of Efficacy|1
1474081|NCT00658632|4859828|P1|Overall Study|Lack of Efficacy|0
1474082|NCT00658632|4859827|P2|Overall Study|Withdrawal by Subject|7
1474083|NCT00658632|4859828|P1|Overall Study|Withdrawal by Subject|10
1474084|NCT00658632|4859827|P2|Overall Study|Lost to Follow-up|23
1474085|NCT00658632|4859828|P1|Overall Study|Lost to Follow-up|25
1474086|NCT00658632|4859827|P2|Overall Study|Adverse Event|11
1474087|NCT00658632|4859828|P1|Overall Study|Adverse Event|13
1474088|NCT00658606|4859869|P2|Overall Study|Lack of Compliance|3
1474089|NCT00658606|4859870|P1|Overall Study|Lack of Compliance|0
1474090|NCT00658606|4859869|P2|Overall Study|Withdrawal by Subject|16
1474091|NCT00658606|4859870|P1|Overall Study|Withdrawal by Subject|7
1474092|NCT00658606|4859869|P2|Overall Study|Lost to Follow-up|0
1474093|NCT00658606|4859870|P1|Overall Study|Lost to Follow-up|1
1474094|NCT00658606|4859869|P2|Overall Study|Lack of Efficacy|3
1474095|NCT00658606|4859870|P1|Overall Study|Lack of Efficacy|6
1474096|NCT00658606|4859869|P2|Overall Study|Adverse Event|1
1474097|NCT00658606|4859870|P1|Overall Study|Adverse Event|2
1474098|NCT00658567|4859899|P3|Overall Study|At Discretion of Sponsor|1
1474099|NCT00658567|4859900|P2|Overall Study|At Discretion of Sponsor|1
1474100|NCT00658567|4859901|P1|Overall Study|At Discretion of Sponsor|1
1474101|NCT00658567|4859899|P3|Overall Study|Physician Decision|0
1474102|NCT00658567|4859900|P2|Overall Study|Physician Decision|1
1474103|NCT00658567|4859901|P1|Overall Study|Physician Decision|0
1474104|NCT00658567|4859899|P3|Overall Study|Voluntary Withdrawal of Consent|2
1474105|NCT00658567|4859900|P2|Overall Study|Voluntary Withdrawal of Consent|0
1474106|NCT00658567|4859901|P1|Overall Study|Voluntary Withdrawal of Consent|2
1474107|NCT00658567|4859899|P3|Overall Study|Adverse Event|3
1474108|NCT00658567|4859900|P2|Overall Study|Adverse Event|2
1474109|NCT00658567|4859901|P1|Overall Study|Adverse Event|5
1474110|NCT00658541|4859912|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1474111|NCT00658541|4859913|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1474112|NCT00658541|4859912|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1474113|NCT00658541|4859913|P1|Washout Period of 7 Days|Withdrawal by Subject|1
1474114|NCT00658528|4859925|P2|Overall Study|Not specified|4
1474115|NCT00658528|4859926|P1|Overall Study|Not specified|8
1474116|NCT00658528|4859925|P2|Overall Study|Withdrawal of consent|6
1474117|NCT00658528|4859926|P1|Overall Study|Withdrawal of consent|5
1474118|NCT00658528|4859925|P2|Overall Study|Withdrawal by Subject|6
1474119|NCT00658528|4859926|P1|Overall Study|Withdrawal by Subject|8
1474120|NCT00658528|4859925|P2|Overall Study|Lost to Follow-up|22
1474121|NCT00658528|4859926|P1|Overall Study|Lost to Follow-up|14
1474122|NCT00658528|4859925|P2|Overall Study|Adverse Event|7
1474123|NCT00658528|4859926|P1|Overall Study|Adverse Event|5
1474124|NCT00658359|4859951|P3|Overall Study|Lack of Efficacy|0
1474125|NCT00658359|4859952|P2|Overall Study|Lack of Efficacy|1
1474126|NCT00658359|4859953|P1|Overall Study|Lack of Efficacy|0
1474127|NCT00658359|4859951|P3|Overall Study|Lost to Follow-up|4
1474128|NCT00658359|4859952|P2|Overall Study|Lost to Follow-up|2
1474129|NCT00658359|4859953|P1|Overall Study|Lost to Follow-up|2
1474130|NCT00658359|4859951|P3|Overall Study|Withdrawal by Subject|2
1474131|NCT00658359|4859952|P2|Overall Study|Withdrawal by Subject|4
1474132|NCT00658359|4859953|P1|Overall Study|Withdrawal by Subject|7
1474133|NCT00658359|4859951|P3|Overall Study|Includes protocol Amendments 3 and 4|29
1474134|NCT00658359|4859952|P2|Overall Study|Includes protocol Amendments 3 and 4|31
1474135|NCT00658359|4859953|P1|Overall Study|Includes protocol Amendments 3 and 4|2
1474136|NCT00658359|4859951|P3|Overall Study|Protocol Violation|0
1474137|NCT00658359|4859952|P2|Overall Study|Protocol Violation|0
1474138|NCT00658359|4859953|P1|Overall Study|Protocol Violation|1
1474139|NCT00658359|4859951|P3|Overall Study|Adverse Event|9
1474140|NCT00658359|4859952|P2|Overall Study|Adverse Event|6
1474141|NCT00658359|4859953|P1|Overall Study|Adverse Event|13
1474142|NCT00658359|4859951|P3|Overall Study|Death|2
1474143|NCT00658359|4859952|P2|Overall Study|Death|1
1474144|NCT00658359|4859953|P1|Overall Study|Death|3
1474145|NCT00658333|4860041|P2|Overall Study|Adverse Event|1
1474146|NCT00658333|4860042|P1|Overall Study|Adverse Event|2
1474147|NCT00658320|4860052|P2|Extension Study: After Month 24|Subject withdrew consent|0
1474148|NCT00658320|4860053|P1|Extension Study: After Month 24|Subject withdrew consent|2
1474149|NCT00658320|4860052|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
1474150|NCT00658320|4860053|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
1474151|NCT00658320|4860052|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
1474152|NCT00658320|4860053|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
1474153|NCT00658320|4860052|P2|Core Study: 12 Months|Subject withdrew consent|3
1474154|NCT00658320|4860053|P1|Core Study: 12 Months|Subject withdrew consent|5
1474155|NCT00657709|4860090|P5|Overall Study|Protocol Violation|2
1474156|NCT00657709|4860091|P4|Overall Study|Protocol Violation|1
1474157|NCT00657709|4860092|P3|Overall Study|Protocol Violation|0
1474158|NCT00657709|4860093|P2|Overall Study|Protocol Violation|2
1474159|NCT00657709|4860094|P1|Overall Study|Protocol Violation|0
1474160|NCT00657709|4860090|P5|Overall Study|Lost to Follow-up|21
1474161|NCT00657709|4860091|P4|Overall Study|Lost to Follow-up|1
1474162|NCT00657709|4860092|P3|Overall Study|Lost to Follow-up|7
1474163|NCT00657709|4860093|P2|Overall Study|Lost to Follow-up|9
1474164|NCT00657709|4860094|P1|Overall Study|Lost to Follow-up|9
1474165|NCT00657709|4860090|P5|Overall Study|Withdrawal by Subject|9
1474166|NCT00657709|4860091|P4|Overall Study|Withdrawal by Subject|5
1474167|NCT00657709|4860092|P3|Overall Study|Withdrawal by Subject|15
1474168|NCT00657709|4860093|P2|Overall Study|Withdrawal by Subject|15
1474169|NCT00657709|4860094|P1|Overall Study|Withdrawal by Subject|7
1474170|NCT00657709|4860090|P5|Overall Study|AE or Death|1
1474171|NCT00657709|4860091|P4|Overall Study|AE or Death|7
1474172|NCT00657709|4860092|P3|Overall Study|AE or Death|6
1474173|NCT00657709|4860093|P2|Overall Study|AE or Death|7
1474174|NCT00657709|4860094|P1|Overall Study|AE or Death|7
1474175|NCT00657618|4860143|P1|Overall Study|didn't start due to schedule conflicts|1
1474176|NCT00657618|4860143|P1|Overall Study|negative for leishmaniasis|2
1474177|NCT00657618|4860143|P1|Overall Study|Withdrawal by Subject|8
1474178|NCT00657618|4860143|P1|Overall Study|Adverse Event|32
1474179|NCT00657553|4860150|P2|Overall Study|low accrual, no analysis run|5
1474180|NCT00657553|4860151|P1|Overall Study|low accrual, no analysis run|5
1474181|NCT00657540|4860159|P2|Overall Study|Lost to Follow-up|4
1474182|NCT00657540|4860160|P1|Overall Study|Lost to Follow-up|1
1474183|NCT00657371|4860174|P1|Overall Study|Pre-existing medical condition|4
1474184|NCT00657371|4860174|P1|Overall Study|Device- related reasons|13
1474185|NCT00657371|4860174|P1|Overall Study|Protocol Violation|2
1474186|NCT00657371|4860174|P1|Overall Study|Unable to intubate the cecum|5
1474187|NCT00657371|4860174|P1|Overall Study|Poor bowel preparation|15
1474188|NCT00657358|4860179|P1|Overall Study|Lack of Efficacy|6
1474189|NCT00657267|4860191|P1|Overall Study|Adverse Event|9
1474190|NCT00657267|4860191|P1|Overall Study|Progressive disease|45
1474191|NCT00657150|4860201|P2|Treatment|Not Specified|15
1474192|NCT00657150|4860202|P1|Treatment|Not Specified|13
1474193|NCT00657150|4860201|P2|Treatment|Withdrawal by Subject|20
1474194|NCT00657150|4860202|P1|Treatment|Withdrawal by Subject|23
1474195|NCT00657150|4860201|P2|Treatment|Lost to Follow-up|0
1474196|NCT00657150|4860202|P1|Treatment|Lost to Follow-up|1
1474197|NCT00657150|4860201|P2|Treatment|Non-compliant with protocol|9
1474198|NCT00657150|4860202|P1|Treatment|Non-compliant with protocol|10
1474199|NCT00657150|4860201|P2|Treatment|Adverse Event|53
1474200|NCT00657150|4860202|P1|Treatment|Adverse Event|60
1474201|NCT00657150|4860201|P2|Overall Study|Not Specified|38
1474202|NCT00657150|4860202|P1|Overall Study|Not Specified|38
1474203|NCT00657150|4860201|P2|Overall Study|Withdrawal by Subject|36
1474204|NCT00657150|4860202|P1|Overall Study|Withdrawal by Subject|51
1474205|NCT00657150|4860201|P2|Overall Study|Lost to Follow-up|0
1474206|NCT00657150|4860202|P1|Overall Study|Lost to Follow-up|2
1474207|NCT00657150|4860201|P2|Overall Study|Non-compliant with protocol|9
1474208|NCT00657150|4860202|P1|Overall Study|Non-compliant with protocol|5
1474209|NCT00657150|4860201|P2|Overall Study|Adverse Event|10
1474210|NCT00657150|4860202|P1|Overall Study|Adverse Event|19
1474211|NCT00657046|4860233|P3|Overall Study|Surgery|1
1474212|NCT00657046|4860234|P2|Overall Study|Surgery|0
1474213|NCT00657046|4860235|P1|Overall Study|Surgery|0
1474214|NCT00657046|4860233|P3|Overall Study|Death|1
1474215|NCT00657046|4860234|P2|Overall Study|Death|0
1474216|NCT00657046|4860235|P1|Overall Study|Death|0
1474217|NCT00657046|4860233|P3|Overall Study|Withdrawal by Subject|0
1474218|NCT00657046|4860234|P2|Overall Study|Withdrawal by Subject|0
1474219|NCT00657046|4860235|P1|Overall Study|Withdrawal by Subject|1
1474220|NCT00657046|4860233|P3|Overall Study|Protocol Violation|0
1474221|NCT00657046|4860234|P2|Overall Study|Protocol Violation|2
1474222|NCT00657046|4860235|P1|Overall Study|Protocol Violation|2
1474223|NCT00657046|4860233|P3|Overall Study|Adverse Event|0
1474224|NCT00657046|4860234|P2|Overall Study|Adverse Event|1
1474225|NCT00657046|4860235|P1|Overall Study|Adverse Event|1
1474226|NCT00657020|4860267|P2|PERIOD 1|Adverse Event|1
1474227|NCT00657020|4860268|P1|PERIOD 1|Adverse Event|0
1474228|NCT00656851|4860318|P2|Overall Study|Withdrawal by Subject|4
1474229|NCT00656851|4860319|P1|Overall Study|Withdrawal by Subject|0
1474230|NCT00656799|4860341|P1|Overall Study|Death|2
1474231|NCT00656669|4860363|P1|AC (Cycles 6-9)|Did not start segment 3|1
1474232|NCT00656669|4860363|P1|AC (Cycles 6-9)|Adverse Event|1
1474233|NCT00656669|4860363|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
1474234|NCT00656669|4860363|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
1474235|NCT00656617|4860402|P1|Overall Study|Move to different clinical trial|2
1474236|NCT00656617|4860402|P1|Overall Study|Insurance Issues|2
1474237|NCT00656617|4860402|P1|Overall Study|Death|2
1474238|NCT00656617|4860402|P1|Overall Study|Adverse Event|1
1474239|NCT00656513|4860411|P3|Overall Study|Missing baseline form|5
1474240|NCT00656513|4860412|P2|Overall Study|Missing baseline form|5
1474241|NCT00656513|4860413|P1|Overall Study|Missing baseline form|0
1474242|NCT00656513|4860411|P3|Overall Study|Treatment completed outside of timeframe|1
1474243|NCT00656513|4860412|P2|Overall Study|Treatment completed outside of timeframe|3
1474244|NCT00656513|4860413|P1|Overall Study|Treatment completed outside of timeframe|0
1474245|NCT00656513|4860411|P3|Overall Study|Incomplete treatment|0
1474246|NCT00656513|4860412|P2|Overall Study|Incomplete treatment|0
1474247|NCT00656513|4860413|P1|Overall Study|Incomplete treatment|3
1474248|NCT00656513|4860411|P3|Overall Study|Missing data|9
1474249|NCT00656513|4860412|P2|Overall Study|Missing data|11
1474250|NCT00656513|4860413|P1|Overall Study|Missing data|0
1474251|NCT00656513|4860411|P3|Overall Study|Death|1
1474252|NCT00656513|4860412|P2|Overall Study|Death|0
1474253|NCT00656513|4860413|P1|Overall Study|Death|0
1474254|NCT00656513|4860411|P3|Overall Study|Withdrawal by Subject|4
1474255|NCT00656513|4860412|P2|Overall Study|Withdrawal by Subject|11
1474256|NCT00656513|4860413|P1|Overall Study|Withdrawal by Subject|0
1474257|NCT00656513|4860411|P3|Overall Study|Protocol Violation|2
1474258|NCT00656513|4860412|P2|Overall Study|Protocol Violation|0
1474259|NCT00656513|4860413|P1|Overall Study|Protocol Violation|1
1474260|NCT00656474|4860460|P1|Overall Study|Other Reason|1
1474261|NCT00656370|4860478|P1|Overall Study|Alternates|3
1474262|NCT00656370|4860478|P1|Overall Study|Screen Failures|7
1474263|NCT00656292|4860486|P2|Overall Study|Screen failure|2
1474264|NCT00656292|4860487|P1|Overall Study|Screen failure|1
1474265|NCT00656292|4860486|P2|Overall Study|Withdrawal by Subject|3
1474266|NCT00656292|4860487|P1|Overall Study|Withdrawal by Subject|2
1474267|NCT00656175|4860514|P2|Overall Study|Transportation issues|1
1474268|NCT00656175|4860515|P1|Overall Study|Transportation issues|0
1474269|NCT00656175|4860514|P2|Overall Study|Adverse Event|0
1474270|NCT00656175|4860515|P1|Overall Study|Adverse Event|1
1474271|NCT00656136|4860523|P2|Overall Study|Unknown and others|4
1474272|NCT00656136|4860524|P1|Overall Study|Unknown and others|4
1474273|NCT00656136|4860523|P2|Overall Study|Patient refused to take study medication|10
1474274|NCT00656136|4860524|P1|Overall Study|Patient refused to take study medication|7
1474275|NCT00656136|4860523|P2|Overall Study|Protocol Violation|3
1474276|NCT00656136|4860524|P1|Overall Study|Protocol Violation|2
1474277|NCT00656136|4860523|P2|Overall Study|Other Adverse Event|51
1474278|NCT00656136|4860524|P1|Overall Study|Other Adverse Event|5
1474279|NCT00656136|4860523|P2|Overall Study|Progressive disease|322
1474280|NCT00656136|4860524|P1|Overall Study|Progressive disease|177
1474281|NCT00656084|4860534|P1|Overall Study|Investigator Request|1
1474282|NCT00656084|4860534|P1|Overall Study|Patient Request|1
1474283|NCT00656084|4860534|P1|Overall Study|Withdrawal by Subject|1
1474284|NCT00656084|4860534|P1|Overall Study|Adverse Event|4
1474285|NCT00656058|4860541|P1|Overall Study|Withdrawal by Subject|4
1474286|NCT00656058|4860541|P1|Overall Study|Withdrawal by Subject|2
1474287|NCT00656019|4860554|P4|Overall Study|Lost to Follow-up|0
1474288|NCT00656019|4860555|P3|Overall Study|Lost to Follow-up|0
1474289|NCT00656019|4860556|P2|Overall Study|Lost to Follow-up|1
1474290|NCT00656019|4860557|P1|Overall Study|Lost to Follow-up|2
1474291|NCT00656019|4860554|P4|Overall Study|Withdrawal by Subject|0
1474292|NCT00656019|4860555|P3|Overall Study|Withdrawal by Subject|0
1474293|NCT00656019|4860556|P2|Overall Study|Withdrawal by Subject|0
1474294|NCT00656019|4860557|P1|Overall Study|Withdrawal by Subject|2
1474295|NCT00656019|4860554|P4|Overall Study|Not Eligible|0
1474296|NCT00656019|4860555|P3|Overall Study|Not Eligible|0
1474297|NCT00656019|4860556|P2|Overall Study|Not Eligible|0
1474298|NCT00656019|4860557|P1|Overall Study|Not Eligible|10
1474299|NCT00655889|4860567|P1|Overall Study|Protocol Violation|1
1474300|NCT00655889|4860567|P1|Overall Study|Inadequate cell growth|1
1474301|NCT00655876|4860574|P2|Overall Study|Protocol Violation|7
1474302|NCT00655876|4860575|P1|Overall Study|Protocol Violation|9
1474303|NCT00655863|4860594|P3|Overall Study|Lost to Follow-up|1
1474304|NCT00655863|4860595|P2|Overall Study|Lost to Follow-up|0
1474305|NCT00655863|4860596|P1|Overall Study|Lost to Follow-up|0
1474306|NCT00655850|4860655|P1|Overall Study|Withdrawal by Subject|1
1474307|NCT00655850|4860655|P1|Overall Study|Death|2
1474308|NCT00655824|4860662|P1|Overall Study|Deterioration of Trial Disease|2
1474309|NCT00655824|4860662|P1|Overall Study|Withdrawal by Subject|4
1474310|NCT00655824|4860662|P1|Overall Study|Protocol Violation|1
1474311|NCT00655824|4860662|P1|Overall Study|Early Termination of Study by Sponsor|74
1474312|NCT00655824|4860662|P1|Overall Study|Adverse Event|3
1474313|NCT00655746|4860710|P1|Overall Study|Withdrawal by Subject|1
1474314|NCT00655733|4860729|P2|Overall Study|Physician Decision|1
1474315|NCT00655733|4860730|P1|Overall Study|Physician Decision|0
1474316|NCT00655733|4860729|P2|Overall Study|Withdrawal by Subject|3
1474317|NCT00655733|4860730|P1|Overall Study|Withdrawal by Subject|3
1474318|NCT00655733|4860729|P2|Overall Study|Adverse Event|2
1474319|NCT00655733|4860730|P1|Overall Study|Adverse Event|2
1474320|NCT00655733|4860729|P2|Overall Study|Lost to Follow-up|2
1474321|NCT00655733|4860730|P1|Overall Study|Lost to Follow-up|2
1474322|NCT00655668|4860736|P1|Overall Study|Withdrawal by Subject|2
1474323|NCT00655668|4860736|P1|Overall Study|New Lymphoma Treatment Started|4
1474324|NCT00655668|4860736|P1|Overall Study|Other|1
1474325|NCT00655668|4860736|P1|Overall Study|Study Terminated|9
1474326|NCT00655668|4860736|P1|Overall Study|Disease Progression|27
1474327|NCT00655668|4860736|P1|Overall Study|Death|5
1474328|NCT00655668|4860736|P1|Overall Study|Adverse Event|6
1474329|NCT00655629|4860763|P2|Overall Study|consent withdrawn|4
1474330|NCT00655629|4860764|P1|Overall Study|consent withdrawn|6
1474331|NCT00655629|4860763|P2|Overall Study|Protocol Violation|3
1474332|NCT00655629|4860764|P1|Overall Study|Protocol Violation|5
1474333|NCT00655629|4860763|P2|Overall Study|Lost to Follow-up|3
1474334|NCT00655629|4860764|P1|Overall Study|Lost to Follow-up|4
1474335|NCT00655629|4860763|P2|Overall Study|Lack of Efficacy|12
1474336|NCT00655629|4860764|P1|Overall Study|Lack of Efficacy|2
1474337|NCT00655629|4860763|P2|Overall Study|Adverse Event|1
1474338|NCT00655629|4860764|P1|Overall Study|Adverse Event|4
1474339|NCT00655564|4860800|P1|Overall Study|Desired Alternate Therapy|1
1474340|NCT00655564|4860800|P1|Overall Study|Lost to Follow-up|1
1474341|NCT00655564|4860800|P1|Overall Study|Adverse Event|1
1474342|NCT00655551|4860808|P3|Period 4 (up to 7 Days)|Adverse Event|0
1474343|NCT00655551|4860809|P2|Period 4 (up to 7 Days)|Adverse Event|2
1474344|NCT00655551|4860810|P1|Period 4 (up to 7 Days)|Adverse Event|0
1474345|NCT00655551|4860808|P3|Period 3 (up to 7 Days)|Adverse Event|4
1474346|NCT00655551|4860809|P2|Period 3 (up to 7 Days)|Adverse Event|0
1474347|NCT00655551|4860810|P1|Period 3 (up to 7 Days)|Adverse Event|0
1474348|NCT00655551|4860808|P3|Period 2 (up to 7 Days)|Adverse Event|0
1474349|NCT00655551|4860809|P2|Period 2 (up to 7 Days)|Adverse Event|1
1474350|NCT00655551|4860810|P1|Period 2 (up to 7 Days)|Adverse Event|0
1474351|NCT00655551|4860808|P3|All Periods Combined|Adverse Event|4
1474352|NCT00655551|4860809|P2|All Periods Combined|Adverse Event|3
1474353|NCT00655551|4860810|P1|All Periods Combined|Adverse Event|0
1474354|NCT00655486|4860824|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
1474355|NCT00655486|4860824|P1|Overall Study|Other: Could not tolerate BID dosing|1
1474356|NCT00655486|4860824|P1|Overall Study|Other: Pregnancy|1
1474357|NCT00655486|4860824|P1|Overall Study|Unsatisfactory compliance|2
1474358|NCT00655486|4860824|P1|Overall Study|Protocol Violation|1
1474359|NCT00655486|4860824|P1|Overall Study|Withdrawal by Subject|4
1474360|NCT00655486|4860824|P1|Overall Study|Lack of Efficacy|8
1474361|NCT00655486|4860824|P1|Overall Study|Adverse Event|10
1474362|NCT00655356|4860831|P2|Overall Study|Other Reason|0
1474363|NCT00655356|4860832|P1|Overall Study|Other Reason|1
1474364|NCT00655356|4860831|P2|Overall Study|Protocol Violation|1
1474365|NCT00655356|4860832|P1|Overall Study|Protocol Violation|2
1474366|NCT00655356|4860831|P2|Overall Study|Adverse Event|1
1474367|NCT00655356|4860832|P1|Overall Study|Adverse Event|1
1474368|NCT00655356|4860831|P2|Overall Study|Sponsor Request|4
1474369|NCT00655356|4860832|P1|Overall Study|Sponsor Request|10
1474370|NCT00655356|4860831|P2|Overall Study|Withdrawal by Subject|4
1474371|NCT00655356|4860832|P1|Overall Study|Withdrawal by Subject|3
1474372|NCT00654940|4860883|P2|Period 1|Intolerable Pain Level|0
1474373|NCT00654940|4860884|P1|Period 1|Intolerable Pain Level|1
1474374|NCT00654940|4860883|P2|Period 1|Adverse Event|1
1474375|NCT00654940|4860884|P1|Period 1|Adverse Event|0
1474376|NCT00654901|4860908|P4|Overall Study|Withdrawal by Subject|0
1474377|NCT00654901|4860909|P3|Overall Study|Withdrawal by Subject|1
1474378|NCT00654901|4860910|P2|Overall Study|Withdrawal by Subject|0
1474379|NCT00654901|4860911|P1|Overall Study|Withdrawal by Subject|3
1474380|NCT00654901|4860908|P4|Overall Study|Lost to Follow-up|0
1474381|NCT00654901|4860909|P3|Overall Study|Lost to Follow-up|1
1474382|NCT00654901|4860910|P2|Overall Study|Lost to Follow-up|0
1474383|NCT00654901|4860911|P1|Overall Study|Lost to Follow-up|1
1474384|NCT00654875|4860931|P2|Overall Study|Administrative Problems|0
1474385|NCT00654875|4860932|P1|Overall Study|Administrative Problems|1
1474386|NCT00654875|4860931|P2|Overall Study|Abnormal Test Procedure Result(s)|0
1474387|NCT00654875|4860932|P1|Overall Study|Abnormal Test Procedure Result(s)|1
1474388|NCT00654875|4860931|P2|Overall Study|Lost to Follow-up|3
1474389|NCT00654875|4860932|P1|Overall Study|Lost to Follow-up|1
1474390|NCT00654875|4860931|P2|Overall Study|Lack of Efficacy|2
1474391|NCT00654875|4860932|P1|Overall Study|Lack of Efficacy|2
1474392|NCT00654875|4860931|P2|Overall Study|Protocol Violation|3
1474393|NCT00654875|4860932|P1|Overall Study|Protocol Violation|3
1474394|NCT00654875|4860931|P2|Overall Study|Withdrawal by Subject|4
1474395|NCT00654875|4860932|P1|Overall Study|Withdrawal by Subject|4
1474396|NCT00654875|4860931|P2|Overall Study|Adverse Event|5
1474397|NCT00654875|4860932|P1|Overall Study|Adverse Event|5
1474398|NCT00654745|4860965|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
1474399|NCT00654745|4860965|P1|Overall Study|Withdrawal by Subject|10
1474400|NCT00654745|4860965|P1|Overall Study|Protocol Violation|11
1474401|NCT00654745|4860965|P1|Overall Study|Lost to Follow-up|7
1474402|NCT00654745|4860965|P1|Overall Study|Adverse Event|12
1474403|NCT00654641|4861010|P2|Overall Study|Lost to Follow-up|3
1474404|NCT00654641|4861011|P1|Overall Study|Lost to Follow-up|2
1474405|NCT00654628|4861017|P1|6 –Week Extension Period (Single Site)|Lost to Follow-up|1
1474406|NCT00654628|4861017|P1|6 –Week Extension Period (Single Site)|Adverse Event|4
1474407|NCT00654628|4861017|P1|6-week Active Treatment Period|Out of window period|1
1474408|NCT00654628|4861017|P1|6-week Active Treatment Period|Transferred to branch hospital|1
1474409|NCT00654628|4861017|P1|6-week Active Treatment Period|Lost to Follow-up|10
1474410|NCT00654628|4861017|P1|6-week Active Treatment Period|Adverse Event|9
1474411|NCT00654498|4861066|P2|Overall Study|Other reason not defined above|5
1474412|NCT00654498|4861067|P1|Overall Study|Other reason not defined above|4
1474413|NCT00654498|4861066|P2|Overall Study|Withdrawal by Subject|0
1474414|NCT00654498|4861067|P1|Overall Study|Withdrawal by Subject|1
1474415|NCT00654498|4861066|P2|Overall Study|Lost to Follow-up|5
1474416|NCT00654498|4861067|P1|Overall Study|Lost to Follow-up|1
1474417|NCT00654498|4861066|P2|Overall Study|Protocol Violation|1
1474418|NCT00654498|4861067|P1|Overall Study|Protocol Violation|1
1474419|NCT00654498|4861066|P2|Overall Study|Adverse Event|1
1474420|NCT00654498|4861067|P1|Overall Study|Adverse Event|6
1474421|NCT00654498|4861066|P2|Overall Study|Not Treated|0
1474422|NCT00654498|4861067|P1|Overall Study|Not Treated|1
1474423|NCT00654420|4861099|P4|Phase II|Missing Disposition Record|0
1474424|NCT00654420|4861100|P3|Phase II|Missing Disposition Record|1
1474425|NCT00654420|4861101|P2|Phase II|Missing Disposition Record|0
1474426|NCT00654420|4861102|P1|Phase II|Missing Disposition Record|0
1474427|NCT00654420|4861099|P4|Phase II|Withdrawal by Subject|1
1474428|NCT00654420|4861100|P3|Phase II|Withdrawal by Subject|4
1474429|NCT00654420|4861101|P2|Phase II|Withdrawal by Subject|0
1474430|NCT00654420|4861102|P1|Phase II|Withdrawal by Subject|0
1474431|NCT00654420|4861099|P4|Phase II|Progressive Disease|29
1474432|NCT00654420|4861100|P3|Phase II|Progressive Disease|29
1474433|NCT00654420|4861101|P2|Phase II|Progressive Disease|0
1474434|NCT00654420|4861102|P1|Phase II|Progressive Disease|0
1474435|NCT00654420|4861099|P4|Phase II|Physician Decision|4
1474436|NCT00654420|4861100|P3|Phase II|Physician Decision|0
1474437|NCT00654420|4861101|P2|Phase II|Physician Decision|0
1474438|NCT00654420|4861102|P1|Phase II|Physician Decision|0
1474439|NCT00654420|4861099|P4|Phase II|Lost to Follow-up|1
1474440|NCT00654420|4861100|P3|Phase II|Lost to Follow-up|0
1474441|NCT00654420|4861101|P2|Phase II|Lost to Follow-up|0
1474442|NCT00654420|4861102|P1|Phase II|Lost to Follow-up|0
1474443|NCT00654420|4861099|P4|Phase II|Adverse Event|3
1474444|NCT00654420|4861100|P3|Phase II|Adverse Event|3
1474445|NCT00654420|4861101|P2|Phase II|Adverse Event|0
1474446|NCT00654420|4861102|P1|Phase II|Adverse Event|0
1474447|NCT00654420|4861099|P4|Phase I (Dose Escalation)|Progressive Disease|0
1474448|NCT00654420|4861100|P3|Phase I (Dose Escalation)|Progressive Disease|0
1474449|NCT00654420|4861101|P2|Phase I (Dose Escalation)|Progressive Disease|15
1474450|NCT00654420|4861102|P1|Phase I (Dose Escalation)|Progressive Disease|4
1474451|NCT00654420|4861099|P4|Phase I (Dose Escalation)|Adverse Event|0
1474452|NCT00654420|4861100|P3|Phase I (Dose Escalation)|Adverse Event|0
1474453|NCT00654420|4861101|P2|Phase I (Dose Escalation)|Adverse Event|1
1474454|NCT00654420|4861102|P1|Phase I (Dose Escalation)|Adverse Event|0
1474455|NCT00654381|4861128|P6|Extension Stage|Closure of the trial site|1
1474456|NCT00654381|4861129|P5|Extension Stage|Closure of the trial site|1
1474457|NCT00654381|4861130|P4|Extension Stage|Closure of the trial site|0
1474458|NCT00654381|4861131|P3|Extension Stage|Closure of the trial site|0
1474459|NCT00654381|4861132|P2|Extension Stage|Closure of the trial site|0
1474460|NCT00654381|4861133|P1|Extension Stage|Closure of the trial site|0
1474461|NCT00654381|4861128|P6|Extension Stage|Withdrawal by Subject|1
1474462|NCT00654381|4861129|P5|Extension Stage|Withdrawal by Subject|1
1474463|NCT00654381|4861130|P4|Extension Stage|Withdrawal by Subject|1
1474464|NCT00654381|4861131|P3|Extension Stage|Withdrawal by Subject|1
1474465|NCT00654381|4861132|P2|Extension Stage|Withdrawal by Subject|0
1474466|NCT00654381|4861133|P1|Extension Stage|Withdrawal by Subject|0
1474467|NCT00654381|4861128|P6|Extension Stage|Lack of Efficacy|0
1474468|NCT00654381|4861129|P5|Extension Stage|Lack of Efficacy|0
1474469|NCT00654381|4861130|P4|Extension Stage|Lack of Efficacy|0
1474470|NCT00654381|4861131|P3|Extension Stage|Lack of Efficacy|1
1474471|NCT00654381|4861132|P2|Extension Stage|Lack of Efficacy|0
1474472|NCT00654381|4861133|P1|Extension Stage|Lack of Efficacy|0
1474473|NCT00654381|4861128|P6|Extension Stage|Protocol Violation|0
1474474|NCT00654381|4861129|P5|Extension Stage|Protocol Violation|0
1474475|NCT00654381|4861130|P4|Extension Stage|Protocol Violation|1
1474476|NCT00654381|4861131|P3|Extension Stage|Protocol Violation|0
1474477|NCT00654381|4861132|P2|Extension Stage|Protocol Violation|0
1474478|NCT00654381|4861133|P1|Extension Stage|Protocol Violation|0
1474479|NCT00654381|4861128|P6|Extension Stage|Adverse Event|1
1474480|NCT00654381|4861129|P5|Extension Stage|Adverse Event|1
1474481|NCT00654381|4861130|P4|Extension Stage|Adverse Event|7
1474482|NCT00654381|4861131|P3|Extension Stage|Adverse Event|9
1474483|NCT00654381|4861132|P2|Extension Stage|Adverse Event|2
1474484|NCT00654381|4861133|P1|Extension Stage|Adverse Event|1
1474485|NCT00654381|4861128|P6|2nd Stage|Investigator's decision|0
1474486|NCT00654381|4861129|P5|2nd Stage|Investigator's decision|0
1474487|NCT00654381|4861130|P4|2nd Stage|Investigator's decision|1
1474488|NCT00654381|4861131|P3|2nd Stage|Investigator's decision|1
1474489|NCT00654381|4861132|P2|2nd Stage|Investigator's decision|0
1474490|NCT00654381|4861133|P1|2nd Stage|Investigator's decision|0
1474491|NCT00654381|4861128|P6|2nd Stage|Withdrawal by Subject|1
1474492|NCT00654381|4861129|P5|2nd Stage|Withdrawal by Subject|1
1474493|NCT00654381|4861130|P4|2nd Stage|Withdrawal by Subject|0
1474494|NCT00654381|4861131|P3|2nd Stage|Withdrawal by Subject|0
1474495|NCT00654381|4861132|P2|2nd Stage|Withdrawal by Subject|0
1474496|NCT00654381|4861133|P1|2nd Stage|Withdrawal by Subject|0
1474497|NCT00654381|4861128|P6|2nd Stage|Adverse Event|2
1474498|NCT00654381|4861129|P5|2nd Stage|Adverse Event|7
1474499|NCT00654381|4861130|P4|2nd Stage|Adverse Event|3
1474500|NCT00654381|4861131|P3|2nd Stage|Adverse Event|2
1474501|NCT00654381|4861132|P2|2nd Stage|Adverse Event|0
1474502|NCT00654381|4861133|P1|2nd Stage|Adverse Event|2
1474503|NCT00654381|4861128|P6|1st Stage|Investigator's decision|0
1474504|NCT00654381|4861129|P5|1st Stage|Investigator's decision|0
1474505|NCT00654381|4861130|P4|1st Stage|Investigator's decision|1
1474506|NCT00654381|4861131|P3|1st Stage|Investigator's decision|0
1474507|NCT00654381|4861132|P2|1st Stage|Investigator's decision|0
1474508|NCT00654381|4861133|P1|1st Stage|Investigator's decision|0
1474509|NCT00654381|4861128|P6|1st Stage|Withdrawal by Subject|1
1474510|NCT00654381|4861129|P5|1st Stage|Withdrawal by Subject|0
1474511|NCT00654381|4861130|P4|1st Stage|Withdrawal by Subject|1
1474512|NCT00654381|4861131|P3|1st Stage|Withdrawal by Subject|0
1474513|NCT00654381|4861132|P2|1st Stage|Withdrawal by Subject|0
1474514|NCT00654381|4861133|P1|1st Stage|Withdrawal by Subject|0
1474515|NCT00654381|4861128|P6|1st Stage|Adverse Event|1
1474516|NCT00654381|4861129|P5|1st Stage|Adverse Event|2
1474517|NCT00654381|4861130|P4|1st Stage|Adverse Event|3
1474518|NCT00654381|4861131|P3|1st Stage|Adverse Event|3
1474519|NCT00654381|4861132|P2|1st Stage|Adverse Event|3
1474520|NCT00654381|4861133|P1|1st Stage|Adverse Event|3
1474521|NCT00654368|4861170|P3|Overall Study|Adverse Event|6
1474522|NCT00654368|4861171|P2|Overall Study|Adverse Event|9
1474523|NCT00654368|4861172|P1|Overall Study|Adverse Event|14
1474524|NCT00654368|4861170|P3|Overall Study|Other|3
1474525|NCT00654368|4861171|P2|Overall Study|Other|2
1474526|NCT00654368|4861172|P1|Overall Study|Other|0
1474527|NCT00654368|4861170|P3|Overall Study|Pregnancy|2
1474528|NCT00654368|4861171|P2|Overall Study|Pregnancy|0
1474529|NCT00654368|4861172|P1|Overall Study|Pregnancy|0
1474530|NCT00654368|4861170|P3|Overall Study|Death|0
1474531|NCT00654368|4861171|P2|Overall Study|Death|0
1474532|NCT00654368|4861172|P1|Overall Study|Death|1
1474533|NCT00654368|4861170|P3|Overall Study|Physician Decision|2
1474534|NCT00654368|4861171|P2|Overall Study|Physician Decision|0
1474535|NCT00654368|4861172|P1|Overall Study|Physician Decision|0
1474536|NCT00654368|4861170|P3|Overall Study|Requirement for alternative therapy|1
1474537|NCT00654368|4861171|P2|Overall Study|Requirement for alternative therapy|1
1474538|NCT00654368|4861172|P1|Overall Study|Requirement for alternative therapy|1
1474539|NCT00654368|4861170|P3|Overall Study|Disease progression|13
1474540|NCT00654368|4861171|P2|Overall Study|Disease progression|31
1474541|NCT00654368|4861172|P1|Overall Study|Disease progression|21
1474542|NCT00654368|4861170|P3|Overall Study|Withdrawal by Subject|2
1474543|NCT00654368|4861171|P2|Overall Study|Withdrawal by Subject|2
1474544|NCT00654368|4861172|P1|Overall Study|Withdrawal by Subject|5
1474545|NCT00654368|4861170|P3|Overall Study|Non-compliance|2
1474546|NCT00654368|4861171|P2|Overall Study|Non-compliance|1
1474547|NCT00654368|4861172|P1|Overall Study|Non-compliance|2
1474548|NCT00654368|4861170|P3|Overall Study|Protocol deviation|1
1474549|NCT00654368|4861171|P2|Overall Study|Protocol deviation|2
1474550|NCT00654368|4861172|P1|Overall Study|Protocol deviation|3
1474551|NCT00654368|4861170|P3|Overall Study|Ineligibility determined|0
1474552|NCT00654368|4861171|P2|Overall Study|Ineligibility determined|0
1474553|NCT00654368|4861172|P1|Overall Study|Ineligibility determined|6
1474554|NCT00654355|4861205|P2|Overall Study|Lost to Follow-up|2
1474555|NCT00654355|4861206|P1|Overall Study|Lost to Follow-up|2
1474556|NCT00654186|4861237|P1|Overall Study|Withdrawal by Subject|5
1474557|NCT00654095|4861262|P1|Overall Study|Did not meet inclusion criteria|1
1474558|NCT00654095|4861262|P1|Overall Study|Adverse reaction did not improve (5)|4
1474559|NCT00654095|4861262|P1|Overall Study|Elevated alanine aminotransferase (4)|7
1474560|NCT00654095|4861262|P1|Overall Study|Withdrawal by Subject|5
1474561|NCT00654095|4861262|P1|Overall Study|Adverse Event|11
1474562|NCT00654095|4861262|P1|Overall Study|Elevated alanine aminotransferase (3)|1
1474563|NCT00654095|4861262|P1|Overall Study|Elevated triglyceride level (2)|1
1474564|NCT00654095|4861262|P1|Overall Study|Drop in low density lipoprotein (1)|2
1474565|NCT00654004|4861285|P2|Overall Study|Lost to Follow-up|0
1474566|NCT00654004|4861286|P1|Overall Study|Lost to Follow-up|1
1474567|NCT00653939|4861302|P2|Overall Study|Not Specified|6
1474568|NCT00653939|4861303|P1|Overall Study|Not Specified|2
1474569|NCT00653939|4861302|P2|Overall Study|Disease Progression|3
1474570|NCT00653939|4861303|P1|Overall Study|Disease Progression|2
1474571|NCT00653939|4861302|P2|Overall Study|Physician Decision|0
1474572|NCT00653939|4861303|P1|Overall Study|Physician Decision|4
1474573|NCT00653939|4861302|P2|Overall Study|Withdrawal by Subject|3
1474574|NCT00653939|4861303|P1|Overall Study|Withdrawal by Subject|3
1474575|NCT00653939|4861302|P2|Overall Study|Adverse Event|3
1474576|NCT00653939|4861303|P1|Overall Study|Adverse Event|1
1474577|NCT00653523|4861328|P1|Overall Study|Adverse reaction did not improve (4)|1
1474578|NCT00653523|4861328|P1|Overall Study|Elevated alanine aminotransferase (3)|2
1474579|NCT00653523|4861328|P1|Overall Study|Withdrawal by Subject|6
1474580|NCT00653523|4861328|P1|Overall Study|Adverse Event|7
1474581|NCT00653523|4861328|P1|Overall Study|Elevated creatine phosphokinase (2)|1
1474582|NCT00653523|4861328|P1|Overall Study|Drop in low density lipoprotein (1)|2
1474583|NCT00653328|4861332|P1|Overall Study|Drug manufacturer no longing making drug|2
1474584|NCT00653328|4861332|P1|Overall Study|Disease progression|10
1474585|NCT00653328|4861332|P1|Overall Study|Adverse Event|2
1474586|NCT00653328|4861332|P1|Overall Study|Withdrawal by Subject|1
1474587|NCT00653263|4861339|P1|Overall Study|Physician Decision|1
1474588|NCT00653263|4861339|P1|Overall Study|Withdrawal by Subject|1
1474589|NCT00653224|4861347|P2|Overall Study|Other|4
1474590|NCT00653224|4861348|P1|Overall Study|Other|2
1474591|NCT00653224|4861347|P2|Overall Study|Lost to Follow-up|0
1474592|NCT00653224|4861348|P1|Overall Study|Lost to Follow-up|1
1474593|NCT00653224|4861347|P2|Overall Study|Loss of efficacy|0
1474594|NCT00653224|4861348|P1|Overall Study|Loss of efficacy|1
1474595|NCT00653224|4861347|P2|Overall Study|Lack of Efficacy|2
1474596|NCT00653224|4861348|P1|Overall Study|Lack of Efficacy|1
1474597|NCT00653224|4861347|P2|Overall Study|Adverse Event|1
1474598|NCT00653224|4861348|P1|Overall Study|Adverse Event|2
1474599|NCT00653159|4861534|P2|Overall Study|Lost to Follow-up|2
1474600|NCT00653159|4861535|P1|Overall Study|Lost to Follow-up|1
1474601|NCT00653159|4861534|P2|Overall Study|Adverse Event|1
1474602|NCT00653159|4861535|P1|Overall Study|Adverse Event|4
1474603|NCT00653068|4861562|P1|Overall Study|Ineligible|2
1474604|NCT00653068|4861562|P1|Overall Study|Withdrawal by Subject|1
1474605|NCT00653068|4861562|P1|Overall Study|Physician Decision|4
1474606|NCT00653068|4861562|P1|Overall Study|Lack of Efficacy|34
1474607|NCT00653068|4861562|P1|Overall Study|Death|9
1474608|NCT00652938|4861576|P3|Overall Study|fear of blood sampling|0
1474609|NCT00652938|4861577|P2|Overall Study|fear of blood sampling|1
1474610|NCT00652938|4861578|P1|Overall Study|fear of blood sampling|0
1474611|NCT00652938|4861576|P3|Overall Study|Lost to Follow-up|2
1474612|NCT00652938|4861577|P2|Overall Study|Lost to Follow-up|0
1474613|NCT00652938|4861578|P1|Overall Study|Lost to Follow-up|0
1474614|NCT00652938|4861576|P3|Overall Study|Withdrawal by Subject|1
1474615|NCT00652938|4861577|P2|Overall Study|Withdrawal by Subject|6
1474616|NCT00652938|4861578|P1|Overall Study|Withdrawal by Subject|0
1474617|NCT00652938|4861576|P3|Overall Study|Adverse Event|2
1474618|NCT00652938|4861577|P2|Overall Study|Adverse Event|0
1474619|NCT00652938|4861578|P1|Overall Study|Adverse Event|1
1474620|NCT00652899|4861643|P1|Overall Study|Treating physician decision|1
1474621|NCT00652899|4861643|P1|Overall Study|Death|1
1474622|NCT00652834|4861653|P1|Overall Study|Lost to Follow-up|2
1474623|NCT00652834|4861653|P1|Overall Study|Withdrawal by Subject|3
1474624|NCT00652743|4861660|P3|Months 36-42|Other|8
1474625|NCT00652743|4861661|P2|Months 36-42|Other|2
1474626|NCT00652743|4861662|P1|Months 36-42|Other|4
1474627|NCT00652743|4861660|P3|Months 36-42|Migrated/moved from study area|0
1474628|NCT00652743|4861661|P2|Months 36-42|Migrated/moved from study area|0
1474629|NCT00652743|4861662|P1|Months 36-42|Migrated/moved from study area|1
1474630|NCT00652743|4861660|P3|Months 36-42|Lost to Follow-up|0
1474631|NCT00652743|4861661|P2|Months 36-42|Lost to Follow-up|1
1474632|NCT00652743|4861662|P1|Months 36-42|Lost to Follow-up|0
1474633|NCT00652743|4861660|P3|Months 36-42|Withdrawal by Subject|0
1474634|NCT00652743|4861661|P2|Months 36-42|Withdrawal by Subject|1
1474635|NCT00652743|4861662|P1|Months 36-42|Withdrawal by Subject|1
1474636|NCT00652743|4861660|P3|Months 36-42|Serious Adverse Events|1
1474637|NCT00652743|4861661|P2|Months 36-42|Serious Adverse Events|1
1474638|NCT00652743|4861662|P1|Months 36-42|Serious Adverse Events|0
1474639|NCT00652743|4861660|P3|Months 24-30|Other|11
1474640|NCT00652743|4861661|P2|Months 24-30|Other|1
1474641|NCT00652743|4861662|P1|Months 24-30|Other|5
1474642|NCT00652743|4861660|P3|Months 12-18|Lost to Follow-up|7
1474643|NCT00652743|4861661|P2|Months 12-18|Lost to Follow-up|2
1474644|NCT00652743|4861662|P1|Months 12-18|Lost to Follow-up|1
1474645|NCT00652626|4861744|P7|Extension Phase|Death|1
1474646|NCT00652626|4861745|P6|Extension Phase|Death|1
1474647|NCT00652626|4861746|P5|Extension Phase|Death|0
1474648|NCT00652626|4861747|P4|Extension Phase|Death|0
1474649|NCT00652626|4861748|P3|Extension Phase|Death|0
1474650|NCT00652626|4861749|P2|Extension Phase|Death|0
1474651|NCT00652626|4861750|P1|Extension Phase|Death|0
1474652|NCT00652626|4861744|P7|Extension Phase|Physician Decision|1
1474653|NCT00652626|4861745|P6|Extension Phase|Physician Decision|1
1474654|NCT00652626|4861746|P5|Extension Phase|Physician Decision|0
1474655|NCT00652626|4861747|P4|Extension Phase|Physician Decision|0
1474656|NCT00652626|4861748|P3|Extension Phase|Physician Decision|0
1474657|NCT00652626|4861749|P2|Extension Phase|Physician Decision|0
1474658|NCT00652626|4861750|P1|Extension Phase|Physician Decision|0
1474659|NCT00652626|4861744|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
1474660|NCT00652626|4861745|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
1474661|NCT00652626|4861746|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
1474662|NCT00652626|4861747|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
1474663|NCT00652626|4861748|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
1474664|NCT00652626|4861749|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
1474665|NCT00652626|4861750|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
1474666|NCT00652626|4861744|P7|Extension Phase|Adverse Event|1
1474667|NCT00652626|4861745|P6|Extension Phase|Adverse Event|2
1474668|NCT00652626|4861746|P5|Extension Phase|Adverse Event|0
1474669|NCT00652626|4861747|P4|Extension Phase|Adverse Event|0
1474670|NCT00652626|4861748|P3|Extension Phase|Adverse Event|0
1474671|NCT00652626|4861749|P2|Extension Phase|Adverse Event|0
1474672|NCT00652626|4861750|P1|Extension Phase|Adverse Event|0
1474673|NCT00652626|4861744|P7|Extension Phase|Withdrawal by Subject|0
1474674|NCT00652626|4861745|P6|Extension Phase|Withdrawal by Subject|2
1474675|NCT00652626|4861746|P5|Extension Phase|Withdrawal by Subject|0
1474676|NCT00652626|4861747|P4|Extension Phase|Withdrawal by Subject|0
1474677|NCT00652626|4861748|P3|Extension Phase|Withdrawal by Subject|0
1474678|NCT00652626|4861749|P2|Extension Phase|Withdrawal by Subject|0
1474679|NCT00652626|4861750|P1|Extension Phase|Withdrawal by Subject|0
1474680|NCT00652626|4861744|P7|Initial Treatment Phase|Lost to Follow-up|0
1474681|NCT00652626|4861745|P6|Initial Treatment Phase|Lost to Follow-up|0
1474682|NCT00652626|4861746|P5|Initial Treatment Phase|Lost to Follow-up|1
1474683|NCT00652626|4861747|P4|Initial Treatment Phase|Lost to Follow-up|0
1474684|NCT00652626|4861748|P3|Initial Treatment Phase|Lost to Follow-up|0
1474685|NCT00652626|4861749|P2|Initial Treatment Phase|Lost to Follow-up|0
1474686|NCT00652626|4861750|P1|Initial Treatment Phase|Lost to Follow-up|0
1474687|NCT00652626|4861744|P7|Initial Treatment Phase|Sponsor Request|0
1474688|NCT00652626|4861745|P6|Initial Treatment Phase|Sponsor Request|0
1474689|NCT00652626|4861746|P5|Initial Treatment Phase|Sponsor Request|0
1474690|NCT00652626|4861747|P4|Initial Treatment Phase|Sponsor Request|0
1474691|NCT00652626|4861748|P3|Initial Treatment Phase|Sponsor Request|1
1474692|NCT00652626|4861749|P2|Initial Treatment Phase|Sponsor Request|0
1474693|NCT00652626|4861750|P1|Initial Treatment Phase|Sponsor Request|0
1474694|NCT00652626|4861744|P7|Initial Treatment Phase|Physician Decision|0
1474695|NCT00652626|4861745|P6|Initial Treatment Phase|Physician Decision|0
1474696|NCT00652626|4861746|P5|Initial Treatment Phase|Physician Decision|1
1474697|NCT00652626|4861747|P4|Initial Treatment Phase|Physician Decision|0
1474698|NCT00652626|4861748|P3|Initial Treatment Phase|Physician Decision|0
1474699|NCT00652626|4861749|P2|Initial Treatment Phase|Physician Decision|0
1474700|NCT00652626|4861750|P1|Initial Treatment Phase|Physician Decision|0
1474701|NCT00652626|4861744|P7|Initial Treatment Phase|Protocol Violation|0
1474702|NCT00652626|4861745|P6|Initial Treatment Phase|Protocol Violation|0
1474703|NCT00652626|4861746|P5|Initial Treatment Phase|Protocol Violation|0
1474704|NCT00652626|4861747|P4|Initial Treatment Phase|Protocol Violation|1
1474705|NCT00652626|4861748|P3|Initial Treatment Phase|Protocol Violation|0
1474706|NCT00652626|4861749|P2|Initial Treatment Phase|Protocol Violation|0
1474707|NCT00652626|4861750|P1|Initial Treatment Phase|Protocol Violation|0
1474708|NCT00652626|4861744|P7|Initial Treatment Phase|Adverse Event|0
1474709|NCT00652626|4861745|P6|Initial Treatment Phase|Adverse Event|0
1474710|NCT00652626|4861746|P5|Initial Treatment Phase|Adverse Event|1
1474711|NCT00652626|4861747|P4|Initial Treatment Phase|Adverse Event|0
1474712|NCT00652626|4861748|P3|Initial Treatment Phase|Adverse Event|0
1474713|NCT00652626|4861749|P2|Initial Treatment Phase|Adverse Event|0
1474714|NCT00652626|4861750|P1|Initial Treatment Phase|Adverse Event|0
1474715|NCT00652366|4861819|P5|Overall Study|Not specified|0
1474716|NCT00652366|4861820|P4|Overall Study|Not specified|4
1474717|NCT00652366|4861821|P3|Overall Study|Not specified|3
1474718|NCT00652366|4861822|P2|Overall Study|Not specified|2
1474719|NCT00652366|4861823|P1|Overall Study|Not specified|5
1474720|NCT00652366|4861819|P5|Overall Study|Refused treatment|5
1474721|NCT00652366|4861820|P4|Overall Study|Refused treatment|17
1474722|NCT00652366|4861821|P3|Overall Study|Refused treatment|6
1474723|NCT00652366|4861822|P2|Overall Study|Refused treatment|7
1474724|NCT00652366|4861823|P1|Overall Study|Refused treatment|3
1474725|NCT00652366|4861819|P5|Overall Study|Protocol Violation|0
1474726|NCT00652366|4861820|P4|Overall Study|Protocol Violation|0
1474727|NCT00652366|4861821|P3|Overall Study|Protocol Violation|0
1474728|NCT00652366|4861822|P2|Overall Study|Protocol Violation|0
1474729|NCT00652366|4861823|P1|Overall Study|Protocol Violation|1
1474730|NCT00652366|4861819|P5|Overall Study|Violation of Selection Criteria|0
1474731|NCT00652366|4861820|P4|Overall Study|Violation of Selection Criteria|0
1474732|NCT00652366|4861821|P3|Overall Study|Violation of Selection Criteria|1
1474733|NCT00652366|4861822|P2|Overall Study|Violation of Selection Criteria|0
1474734|NCT00652366|4861823|P1|Overall Study|Violation of Selection Criteria|0
1474735|NCT00652366|4861819|P5|Overall Study|Lack of Efficacy|13
1474736|NCT00652366|4861820|P4|Overall Study|Lack of Efficacy|133
1474737|NCT00652366|4861821|P3|Overall Study|Lack of Efficacy|53
1474738|NCT00652366|4861822|P2|Overall Study|Lack of Efficacy|58
1474739|NCT00652366|4861823|P1|Overall Study|Lack of Efficacy|84
1474740|NCT00652366|4861819|P5|Overall Study|Death|5
1474741|NCT00652366|4861820|P4|Overall Study|Death|8
1474742|NCT00652366|4861821|P3|Overall Study|Death|1
1474743|NCT00652366|4861822|P2|Overall Study|Death|4
1474744|NCT00652366|4861823|P1|Overall Study|Death|5
1474745|NCT00652366|4861819|P5|Overall Study|Adverse Event|13
1474746|NCT00652366|4861820|P4|Overall Study|Adverse Event|17
1474747|NCT00652366|4861821|P3|Overall Study|Adverse Event|7
1474748|NCT00652366|4861822|P2|Overall Study|Adverse Event|4
1474749|NCT00652366|4861823|P1|Overall Study|Adverse Event|8
1474750|NCT00652340|4861858|P2|Overall Study|Had not progressed.|3
1474751|NCT00652340|4861859|P1|Overall Study|Had not progressed.|4
1474752|NCT00652327|4861869|P2|Overall Study|Lost to Follow-up|3
1474753|NCT00652327|4861870|P1|Overall Study|Lost to Follow-up|0
1474754|NCT00652327|4861869|P2|Overall Study|Adverse Event|2
1474755|NCT00652327|4861870|P1|Overall Study|Adverse Event|0
1474756|NCT00652093|4861912|P6|Overall Study|Physician Decision|0
1474757|NCT00652093|4861913|P5|Overall Study|Physician Decision|1
1474758|NCT00652093|4861914|P4|Overall Study|Physician Decision|0
1474759|NCT00652093|4861915|P3|Overall Study|Physician Decision|0
1474760|NCT00652093|4861916|P2|Overall Study|Physician Decision|0
1474761|NCT00652093|4861917|P1|Overall Study|Physician Decision|0
1474762|NCT00652093|4861912|P6|Overall Study|Withdrawal by Subject|0
1474763|NCT00652093|4861913|P5|Overall Study|Withdrawal by Subject|1
1474764|NCT00652093|4861914|P4|Overall Study|Withdrawal by Subject|0
1474765|NCT00652093|4861915|P3|Overall Study|Withdrawal by Subject|1
1474766|NCT00652093|4861916|P2|Overall Study|Withdrawal by Subject|0
1474767|NCT00652093|4861917|P1|Overall Study|Withdrawal by Subject|0
1474768|NCT00652028|4862001|P4|Overall Study|Physician Decision|0
1474769|NCT00652028|4862002|P3|Overall Study|Physician Decision|1
1474770|NCT00652028|4862003|P2|Overall Study|Physician Decision|0
1474771|NCT00652028|4862004|P1|Overall Study|Physician Decision|0
1474772|NCT00652028|4862001|P4|Overall Study|No Longer Meets Entry Criteria|0
1474773|NCT00652028|4862002|P3|Overall Study|No Longer Meets Entry Criteria|0
1474774|NCT00652028|4862003|P2|Overall Study|No Longer Meets Entry Criteria|1
1474775|NCT00652028|4862004|P1|Overall Study|No Longer Meets Entry Criteria|0
1474776|NCT00652028|4862001|P4|Overall Study|Adverse Event|0
1474777|NCT00652028|4862002|P3|Overall Study|Adverse Event|0
1474778|NCT00652028|4862003|P2|Overall Study|Adverse Event|0
1474779|NCT00652028|4862004|P1|Overall Study|Adverse Event|1
1474780|NCT00651924|4862048|P2|Overall Study|Withdrawal by Subject|5
1474781|NCT00651924|4862049|P1|Overall Study|Withdrawal by Subject|0
1474782|NCT00651924|4862048|P2|Overall Study|Withdrawal by PI|2
1474783|NCT00651924|4862049|P1|Overall Study|Withdrawal by PI|0
1474784|NCT00651820|4862055|P1|Overall Study|Lost to Follow-up|2
1474785|NCT00651755|4862087|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
1474786|NCT00651755|4862088|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
1474787|NCT00651755|4862087|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
1474788|NCT00651755|4862088|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
1474789|NCT00651313|4862133|P2|Overall Study|Adminstrative Discontinuation|3
1474790|NCT00651313|4862134|P1|Overall Study|Adminstrative Discontinuation|2
1474791|NCT00651313|4862133|P2|Overall Study|Lost to Follow-up|1
1474792|NCT00651313|4862134|P1|Overall Study|Lost to Follow-up|1
1474793|NCT00651313|4862133|P2|Overall Study|Withdrawal by Subject|1
1474794|NCT00651313|4862134|P1|Overall Study|Withdrawal by Subject|3
1474795|NCT00651313|4862133|P2|Overall Study|Adverse Event|1
1474796|NCT00651313|4862134|P1|Overall Study|Adverse Event|0
1474797|NCT00651261|4862142|P2|Overall Study|Never treated|3
1474798|NCT00651261|4862143|P1|Overall Study|Never treated|5
1474799|NCT00651261|4862142|P2|Overall Study|Other disease or participant decisions|23
1474800|NCT00651261|4862143|P1|Overall Study|Other disease or participant decisions|23
1474801|NCT00651261|4862142|P2|Overall Study|Alternative therapy|107
1474802|NCT00651261|4862143|P1|Overall Study|Alternative therapy|109
1474803|NCT00651261|4862142|P2|Overall Study|Disease progression|58
1474804|NCT00651261|4862143|P1|Overall Study|Disease progression|58
1474805|NCT00651261|4862142|P2|Overall Study|Induction failure|35
1474806|NCT00651261|4862143|P1|Overall Study|Induction failure|24
1474807|NCT00651261|4862142|P2|Overall Study|Withdrawal by Subject|40
1474808|NCT00651261|4862143|P1|Overall Study|Withdrawal by Subject|22
1474809|NCT00651261|4862142|P2|Overall Study|Death|18
1474810|NCT00651261|4862143|P1|Overall Study|Death|18
1474811|NCT00651261|4862142|P2|Overall Study|Adverse Event|22
1474812|NCT00651261|4862143|P1|Overall Study|Adverse Event|32
1474813|NCT00651183|4862159|P2|Overall Study|missing|0
1474814|NCT00651183|4862160|P1|Overall Study|missing|1
1474815|NCT00651183|4862159|P2|Overall Study|Other reasons|2
1474816|NCT00651183|4862160|P1|Overall Study|Other reasons|4
1474817|NCT00651183|4862159|P2|Overall Study|Lost to Follow-up|1
1474818|NCT00651183|4862160|P1|Overall Study|Lost to Follow-up|3
1474819|NCT00651183|4862159|P2|Overall Study|Withdrawal by Subject|3
1474820|NCT00651183|4862160|P1|Overall Study|Withdrawal by Subject|6
1474821|NCT00651183|4862159|P2|Overall Study|Tolerability insufficient +Patients wish|1
1474822|NCT00651183|4862160|P1|Overall Study|Tolerability insufficient +Patients wish|0
1474823|NCT00651183|4862159|P2|Overall Study|Tolerability insufficient|2
1474824|NCT00651183|4862160|P1|Overall Study|Tolerability insufficient|5
1474825|NCT00651183|4862159|P2|Overall Study|Efficacy insufficient + patients wish|1
1474826|NCT00651183|4862160|P1|Overall Study|Efficacy insufficient + patients wish|0
1474827|NCT00651183|4862159|P2|Overall Study|Lack of Efficacy|0
1474828|NCT00651183|4862160|P1|Overall Study|Lack of Efficacy|1
1474829|NCT00651157|4862172|P1|Overall Study|Protocol Violation|1
1474830|NCT00651157|4862172|P1|Overall Study|Death|1
1474831|NCT00651118|4862182|P4|Overall Study|Withdrawal by Subject|1
1474832|NCT00651118|4862183|P3|Overall Study|Withdrawal by Subject|1
1474833|NCT00651118|4862184|P2|Overall Study|Withdrawal by Subject|1
1474834|NCT00651118|4862185|P1|Overall Study|Withdrawal by Subject|0
1474835|NCT00651118|4862182|P4|Overall Study|administrative|1
1474836|NCT00651118|4862183|P3|Overall Study|administrative|2
1474837|NCT00651118|4862184|P2|Overall Study|administrative|4
1474838|NCT00651118|4862185|P1|Overall Study|administrative|1
1474839|NCT00651118|4862182|P4|Overall Study|Lost to Follow-up|2
1474840|NCT00651118|4862183|P3|Overall Study|Lost to Follow-up|1
1474841|NCT00651118|4862184|P2|Overall Study|Lost to Follow-up|0
1474842|NCT00651118|4862185|P1|Overall Study|Lost to Follow-up|2
1474843|NCT00651118|4862182|P4|Overall Study|Protocol Violation|2
1474844|NCT00651118|4862183|P3|Overall Study|Protocol Violation|6
1474845|NCT00651118|4862184|P2|Overall Study|Protocol Violation|2
1474846|NCT00651118|4862185|P1|Overall Study|Protocol Violation|2
1474847|NCT00651118|4862182|P4|Overall Study|Adverse Event|1
1474848|NCT00651118|4862183|P3|Overall Study|Adverse Event|1
1474849|NCT00651118|4862184|P2|Overall Study|Adverse Event|0
1474850|NCT00651118|4862185|P1|Overall Study|Adverse Event|4
1474851|NCT00650845|4862248|P2|Overall Study|Protocol Violation|13
1474852|NCT00650845|4862249|P1|Overall Study|Protocol Violation|0
1474853|NCT00650845|4862248|P2|Overall Study|Withdrawal by Subject|0
1474854|NCT00650845|4862249|P1|Overall Study|Withdrawal by Subject|5
1474855|NCT00650806|4862269|P4|Overall Study|Not specified|0
1474856|NCT00650806|4862270|P3|Overall Study|Not specified|2
1474857|NCT00650806|4862271|P2|Overall Study|Not specified|1
1474858|NCT00650806|4862272|P1|Overall Study|Not specified|1
1474859|NCT00650806|4862269|P4|Overall Study|Study terminated by sponsor|4
1474860|NCT00650806|4862270|P3|Overall Study|Study terminated by sponsor|5
1474861|NCT00650806|4862271|P2|Overall Study|Study terminated by sponsor|3
1474862|NCT00650806|4862272|P1|Overall Study|Study terminated by sponsor|2
1474863|NCT00650806|4862269|P4|Overall Study|Noncompliance with study drug regimen|0
1474864|NCT00650806|4862270|P3|Overall Study|Noncompliance with study drug regimen|0
1474865|NCT00650806|4862271|P2|Overall Study|Noncompliance with study drug regimen|1
1474866|NCT00650806|4862272|P1|Overall Study|Noncompliance with study drug regimen|1
1474867|NCT00650806|4862269|P4|Overall Study|Withdrawal by Subject|6
1474868|NCT00650806|4862270|P3|Overall Study|Withdrawal by Subject|8
1474869|NCT00650806|4862271|P2|Overall Study|Withdrawal by Subject|5
1474870|NCT00650806|4862272|P1|Overall Study|Withdrawal by Subject|7
1474871|NCT00650806|4862269|P4|Overall Study|Pregnancy|1
1474872|NCT00650806|4862270|P3|Overall Study|Pregnancy|0
1474873|NCT00650806|4862271|P2|Overall Study|Pregnancy|0
1474874|NCT00650806|4862272|P1|Overall Study|Pregnancy|0
1474875|NCT00650806|4862269|P4|Overall Study|Protocol Violation|1
1474876|NCT00650806|4862270|P3|Overall Study|Protocol Violation|0
1474877|NCT00650806|4862271|P2|Overall Study|Protocol Violation|0
1474878|NCT00650806|4862272|P1|Overall Study|Protocol Violation|0
1474879|NCT00650806|4862269|P4|Overall Study|Lost to Follow-up|10
1474880|NCT00650806|4862270|P3|Overall Study|Lost to Follow-up|11
1474881|NCT00650806|4862271|P2|Overall Study|Lost to Follow-up|6
1474882|NCT00650806|4862272|P1|Overall Study|Lost to Follow-up|7
1474883|NCT00650806|4862269|P4|Overall Study|Adverse Event|4
1474884|NCT00650806|4862270|P3|Overall Study|Adverse Event|3
1474885|NCT00650806|4862271|P2|Overall Study|Adverse Event|5
1474886|NCT00650806|4862272|P1|Overall Study|Adverse Event|0
1474887|NCT00650767|4862314|P4|Overall Study|Other|0
1474888|NCT00650767|4862315|P3|Overall Study|Other|0
1474889|NCT00650767|4862316|P2|Overall Study|Other|1
1474890|NCT00650767|4862317|P1|Overall Study|Other|1
1474891|NCT00650767|4862314|P4|Overall Study|Lost to Follow-up|0
1474892|NCT00650767|4862315|P3|Overall Study|Lost to Follow-up|1
1474893|NCT00650767|4862316|P2|Overall Study|Lost to Follow-up|1
1474894|NCT00650767|4862317|P1|Overall Study|Lost to Follow-up|1
1474895|NCT00650767|4862314|P4|Overall Study|Withdrawal by Subject|3
1474896|NCT00650767|4862315|P3|Overall Study|Withdrawal by Subject|3
1474897|NCT00650767|4862316|P2|Overall Study|Withdrawal by Subject|4
1474898|NCT00650767|4862317|P1|Overall Study|Withdrawal by Subject|2
1474899|NCT00650767|4862314|P4|Overall Study|Death|0
1474900|NCT00650767|4862315|P3|Overall Study|Death|0
1474901|NCT00650767|4862316|P2|Overall Study|Death|0
1474902|NCT00650767|4862317|P1|Overall Study|Death|1
1474903|NCT00650767|4862314|P4|Overall Study|Adverse Event|8
1474904|NCT00650767|4862315|P3|Overall Study|Adverse Event|10
1474905|NCT00650767|4862316|P2|Overall Study|Adverse Event|3
1474906|NCT00650767|4862317|P1|Overall Study|Adverse Event|0
1474907|NCT00650585|4862821|P2|Overall Study|Excluded/ruled ineligible|129
1474908|NCT00650585|4862822|P1|Overall Study|Excluded/ruled ineligible|357
1474909|NCT00650585|4862821|P2|Overall Study|No parental consent|866
1474910|NCT00650585|4862822|P1|Overall Study|No parental consent|935
1474911|NCT00650585|4862821|P2|Overall Study|Lost to Follow-up|482
1474912|NCT00650585|4862822|P1|Overall Study|Lost to Follow-up|505
1474913|NCT00650104|4862866|P1|Overall Study|Sponsor Terminated Dosing|1
1474914|NCT00650104|4862866|P1|Overall Study|Non-compliance|2
1474915|NCT00650104|4862866|P1|Overall Study|Lost to Follow-up|1
1474916|NCT00650104|4862866|P1|Overall Study|Physician Decision|7
1474917|NCT00650104|4862866|P1|Overall Study|Withdrawal by Subject|11
1474918|NCT00650104|4862866|P1|Overall Study|Death|2
1474919|NCT00650104|4862866|P1|Overall Study|Adverse Event|17
1474920|NCT00650091|4862881|P3|Amended Study Design|Not specified|0
1474921|NCT00650091|4862882|P2|Amended Study Design|Not specified|3
1474922|NCT00650091|4862883|P1|Amended Study Design|Not specified|1
1474923|NCT00650091|4862881|P3|Amended Study Design|Lung transplantation|0
1474924|NCT00650091|4862882|P2|Amended Study Design|Lung transplantation|2
1474925|NCT00650091|4862883|P1|Amended Study Design|Lung transplantation|4
1474926|NCT00650091|4862881|P3|Amended Study Design|Adverse Event|0
1474927|NCT00650091|4862882|P2|Amended Study Design|Adverse Event|4
1474928|NCT00650091|4862883|P1|Amended Study Design|Adverse Event|1
1474929|NCT00650091|4862881|P3|Amended Study Design|Physician Decision|0
1474930|NCT00650091|4862882|P2|Amended Study Design|Physician Decision|0
1474931|NCT00650091|4862883|P1|Amended Study Design|Physician Decision|5
1474932|NCT00650091|4862881|P3|Amended Study Design|Withdrawal by Subject|0
1474933|NCT00650091|4862882|P2|Amended Study Design|Withdrawal by Subject|11
1474934|NCT00650091|4862883|P1|Amended Study Design|Withdrawal by Subject|12
1474935|NCT00649428|4862926|P2|Overall Study|Physician Decision|1
1474936|NCT00649428|4862927|P1|Overall Study|Physician Decision|0
1474937|NCT00649428|4862926|P2|Overall Study|Protocol Violation|2
1474938|NCT00649428|4862927|P1|Overall Study|Protocol Violation|6
1474939|NCT00649428|4862926|P2|Overall Study|Insufficient manufacturing yield|1
1474940|NCT00649428|4862927|P1|Overall Study|Insufficient manufacturing yield|5
1474941|NCT00649428|4862926|P2|Overall Study|Lost to Follow-up|3
1474942|NCT00649428|4862927|P1|Overall Study|Lost to Follow-up|1
1474943|NCT00649428|4862926|P2|Overall Study|Withdrawal by Subject|6
1474944|NCT00649428|4862927|P1|Overall Study|Withdrawal by Subject|6
1474945|NCT00649428|4862926|P2|Overall Study|Adverse Event|2
1474946|NCT00649428|4862927|P1|Overall Study|Adverse Event|2
1474947|NCT00649389|4862943|P4|Overall Study|Other|6
1474948|NCT00649389|4862944|P3|Overall Study|Other|1
1474949|NCT00649389|4862945|P2|Overall Study|Other|9
1474950|NCT00649389|4862946|P1|Overall Study|Other|3
1474951|NCT00649389|4862943|P4|Overall Study|Withdrawal by Subject|23
1474952|NCT00649389|4862944|P3|Overall Study|Withdrawal by Subject|19
1474953|NCT00649389|4862945|P2|Overall Study|Withdrawal by Subject|21
1474954|NCT00649389|4862946|P1|Overall Study|Withdrawal by Subject|20
1474955|NCT00649389|4862943|P4|Overall Study|Protocol Violation|8
1474956|NCT00649389|4862944|P3|Overall Study|Protocol Violation|9
1474957|NCT00649389|4862945|P2|Overall Study|Protocol Violation|13
1474958|NCT00649389|4862946|P1|Overall Study|Protocol Violation|11
1474959|NCT00649389|4862943|P4|Overall Study|Lost to Follow-up|26
1474960|NCT00649389|4862944|P3|Overall Study|Lost to Follow-up|21
1474961|NCT00649389|4862945|P2|Overall Study|Lost to Follow-up|17
1474962|NCT00649389|4862946|P1|Overall Study|Lost to Follow-up|15
1474963|NCT00649389|4862943|P4|Overall Study|Adverse Event|48
1474964|NCT00649389|4862944|P3|Overall Study|Adverse Event|38
1474965|NCT00649389|4862945|P2|Overall Study|Adverse Event|46
1474966|NCT00649389|4862946|P1|Overall Study|Adverse Event|22
1474967|NCT00649220|4862968|P1|Overall Study|Withdrawal by Subject|1
1474968|NCT00649220|4862968|P1|Overall Study|Adverse Event|2
1474969|NCT00648895|4862989|P2|Overall Study|Lack of Efficacy|1
1474970|NCT00648895|4862990|P1|Overall Study|Lack of Efficacy|0
1474971|NCT00648167|4862996|P1|Overall Study|unable to swallow tablets|1
1474972|NCT00648167|4862996|P1|Overall Study|Adverse Event|6
1474973|NCT00648037|4863016|P1|Overall Study|Other|1
1474974|NCT00648037|4863016|P1|Overall Study|Relapse|2
1474975|NCT00648037|4863016|P1|Overall Study|Adverse Event|11
1474976|NCT00648037|4863016|P1|Overall Study|Withdrawal by Subject|1
1474977|NCT00648037|4863016|P1|Overall Study|Not Treated|1
1474978|NCT00647699|4863035|P2|Overall Study|Withdrawal by Subject|8
1474979|NCT00647699|4863036|P1|Overall Study|Withdrawal by Subject|3
1474980|NCT00647699|4863035|P2|Overall Study|Lost to Follow-up|4
1474981|NCT00647699|4863036|P1|Overall Study|Lost to Follow-up|5
1474982|NCT00647556|4863044|P2|Overall Study|Surgery for pre-existing neck pain|0
1474983|NCT00647556|4863045|P1|Overall Study|Surgery for pre-existing neck pain|1
1474984|NCT00647556|4863044|P2|Overall Study|Withdrawal by Subject|0
1474985|NCT00647556|4863045|P1|Overall Study|Withdrawal by Subject|1
1474986|NCT00647556|4863044|P2|Overall Study|Protocol Violation|1
1474987|NCT00647556|4863045|P1|Overall Study|Protocol Violation|0
1474988|NCT00647556|4863044|P2|Overall Study|Lost to Follow-up|0
1474989|NCT00647556|4863045|P1|Overall Study|Lost to Follow-up|1
1474990|NCT00647556|4863044|P2|Overall Study|Adverse Event|1
1474991|NCT00647556|4863045|P1|Overall Study|Adverse Event|0
1474992|NCT00647270|4863075|P3|Period 2, Placebo Switched to Adalimumab|Other|0
1474993|NCT00647270|4863076|P2|Period 2, Placebo Switched to Adalimumab|Other|6
1474994|NCT00647270|4863077|P1|Period 2, Placebo Switched to Adalimumab|Other|2
1474995|NCT00647270|4863075|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
1474996|NCT00647270|4863076|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
1474997|NCT00647270|4863077|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
1474998|NCT00647270|4863075|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
1474999|NCT00647270|4863076|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
1475000|NCT00647270|4863077|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
1475001|NCT00647270|4863075|P3|Period 1, Placebo-control (12 Weeks)|Other|8
1475002|NCT00647270|4863076|P2|Period 1, Placebo-control (12 Weeks)|Other|4
1475003|NCT00647270|4863077|P1|Period 1, Placebo-control (12 Weeks)|Other|4
1475004|NCT00647270|4863075|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
1475005|NCT00647270|4863076|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
1475006|NCT00647270|4863077|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
1475007|NCT00647270|4863075|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
1475008|NCT00647270|4863076|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
1475009|NCT00647270|4863077|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
1475010|NCT00647270|4863075|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
1475011|NCT00647270|4863076|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
1475012|NCT00647270|4863077|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
1475013|NCT00646958|4863103|P3|Overall Study|Did not receive study drug|2
1475014|NCT00646958|4863104|P2|Overall Study|Did not receive study drug|0
1475015|NCT00646958|4863105|P1|Overall Study|Did not receive study drug|2
1475016|NCT00646958|4863103|P3|Overall Study|Withdrawal by Subject|0
1475017|NCT00646958|4863104|P2|Overall Study|Withdrawal by Subject|2
1475018|NCT00646958|4863105|P1|Overall Study|Withdrawal by Subject|1
1475019|NCT00646958|4863103|P3|Overall Study|Abnormal screening lab tests|0
1475020|NCT00646958|4863104|P2|Overall Study|Abnormal screening lab tests|1
1475021|NCT00646958|4863105|P1|Overall Study|Abnormal screening lab tests|1
1475022|NCT00646958|4863103|P3|Overall Study|Protocol Violation|0
1475023|NCT00646958|4863104|P2|Overall Study|Protocol Violation|1
1475024|NCT00646958|4863105|P1|Overall Study|Protocol Violation|1
1475025|NCT00646958|4863103|P3|Overall Study|Lost to Follow-up|7
1475026|NCT00646958|4863104|P2|Overall Study|Lost to Follow-up|5
1475027|NCT00646958|4863105|P1|Overall Study|Lost to Follow-up|1
1475028|NCT00646958|4863103|P3|Overall Study|Adverse Event|0
1475029|NCT00646958|4863104|P2|Overall Study|Adverse Event|0
1475030|NCT00646958|4863105|P1|Overall Study|Adverse Event|4
1475031|NCT00646958|4863103|P3|Overall Study|Lack of Efficacy|0
1475032|NCT00646958|4863104|P2|Overall Study|Lack of Efficacy|0
1475033|NCT00646958|4863105|P1|Overall Study|Lack of Efficacy|1
1475034|NCT00646776|4863118|P2|Overall Study|Investigator discretion|4
1475035|NCT00646776|4863119|P1|Overall Study|Investigator discretion|0
1475036|NCT00646776|4863118|P2|Overall Study|Adverse Event|9
1475037|NCT00646776|4863119|P1|Overall Study|Adverse Event|1
1475038|NCT00646399|4863217|P2|Overall Study|Other Reason|11
1475039|NCT00646399|4863218|P1|Overall Study|Other Reason|11
1475040|NCT00646399|4863217|P2|Overall Study|Withdrawal by Subject|10
1475041|NCT00646399|4863218|P1|Overall Study|Withdrawal by Subject|9
1475042|NCT00646399|4863217|P2|Overall Study|Death|53
1475043|NCT00646399|4863218|P1|Overall Study|Death|63
1475044|NCT00646282|4863226|P2|Overall Study|Protocol terminated|4
1475045|NCT00646282|4863227|P1|Overall Study|Protocol terminated|4
1475046|NCT00645944|4863250|P2|Received Medication|Protocol Violation|1
1475047|NCT00645944|4863251|P1|Received Medication|Protocol Violation|2
1475048|NCT00645944|4863250|P2|Received Medication|Lost to Follow-up|0
1475049|NCT00645944|4863251|P1|Received Medication|Lost to Follow-up|1
1475050|NCT00645944|4863250|P2|Received Medication|Withdrawal by Subject|1
1475051|NCT00645944|4863251|P1|Received Medication|Withdrawal by Subject|1
1475052|NCT00645944|4863250|P2|Received Medication|Adverse Event|1
1475053|NCT00645944|4863251|P1|Received Medication|Adverse Event|2
1475054|NCT00645944|4863250|P2|Randomized|Withdrawal by Subject|2
1475055|NCT00645944|4863251|P1|Randomized|Withdrawal by Subject|1
1475056|NCT00645853|4863259|P2|Overall Study|recall of ICF, planned operation, death|4
1475057|NCT00645853|4863260|P1|Overall Study|recall of ICF, planned operation, death|7
1475058|NCT00645853|4863259|P2|Overall Study|Discontinuation criteria|2
1475059|NCT00645853|4863260|P1|Overall Study|Discontinuation criteria|2
1475060|NCT00645853|4863259|P2|Overall Study|Protocol Violation|2
1475061|NCT00645853|4863260|P1|Overall Study|Protocol Violation|0
1475062|NCT00645853|4863259|P2|Overall Study|Withdrawal by Subject|2
1475063|NCT00645853|4863260|P1|Overall Study|Withdrawal by Subject|5
1475064|NCT00645853|4863259|P2|Overall Study|AZ study closure in Hungary|40
1475065|NCT00645853|4863260|P1|Overall Study|AZ study closure in Hungary|60
1475066|NCT00645853|4863259|P2|Overall Study|Adverse Event|7
1475067|NCT00645853|4863260|P1|Overall Study|Adverse Event|18
1475068|NCT00645788|4863291|P4|Overall Study|Pulmonary exacerbation|9
1475069|NCT00645788|4863292|P3|Overall Study|Pulmonary exacerbation|11
1475070|NCT00645788|4863293|P2|Overall Study|Pulmonary exacerbation|16
1475071|NCT00645788|4863294|P1|Overall Study|Pulmonary exacerbation|13
1475072|NCT00645788|4863291|P4|Overall Study|Withdrawal by Subject|2
1475073|NCT00645788|4863292|P3|Overall Study|Withdrawal by Subject|0
1475074|NCT00645788|4863293|P2|Overall Study|Withdrawal by Subject|1
1475075|NCT00645788|4863294|P1|Overall Study|Withdrawal by Subject|0
1475076|NCT00645788|4863291|P4|Overall Study|Protocol Violation|0
1475077|NCT00645788|4863292|P3|Overall Study|Protocol Violation|2
1475078|NCT00645788|4863293|P2|Overall Study|Protocol Violation|0
1475079|NCT00645788|4863294|P1|Overall Study|Protocol Violation|1
1475080|NCT00645788|4863291|P4|Overall Study|Lost to Follow-up|0
1475081|NCT00645788|4863292|P3|Overall Study|Lost to Follow-up|0
1475082|NCT00645788|4863293|P2|Overall Study|Lost to Follow-up|0
1475083|NCT00645788|4863294|P1|Overall Study|Lost to Follow-up|1
1475084|NCT00645788|4863291|P4|Overall Study|Adverse Event|3
1475085|NCT00645788|4863292|P3|Overall Study|Adverse Event|5
1475086|NCT00645788|4863293|P2|Overall Study|Adverse Event|9
1475087|NCT00645788|4863294|P1|Overall Study|Adverse Event|4
1475088|NCT00645788|4863291|P4|Overall Study|Did not receive study drug|0
1475089|NCT00645788|4863292|P3|Overall Study|Did not receive study drug|0
1475090|NCT00645788|4863293|P2|Overall Study|Did not receive study drug|1
1475091|NCT00645788|4863294|P1|Overall Study|Did not receive study drug|1
1475092|NCT00645671|4863352|P2|Overall Study|Physician Decision|1
1475093|NCT00645671|4863353|P1|Overall Study|Physician Decision|0
1475094|NCT00645671|4863352|P2|Overall Study|Adverse Event|1
1475095|NCT00645671|4863353|P1|Overall Study|Adverse Event|0
1475096|NCT00645671|4863352|P2|Overall Study|Withdrawal by Subject|4
1475097|NCT00645671|4863353|P1|Overall Study|Withdrawal by Subject|0
1475098|NCT00645671|4863352|P2|Overall Study|Protocol Violation|0
1475099|NCT00645671|4863353|P1|Overall Study|Protocol Violation|1
1475100|NCT00645593|4863367|P2|Overall Study|Later found to be ineligible|0
1475101|NCT00645593|4863368|P1|Overall Study|Later found to be ineligible|1
1475102|NCT00645567|4863380|P1|Overall Study|Adverse Event|1
1475103|NCT00645528|4863388|P1|Overall Study|Did not show up for Visit 2|7
1475104|NCT00645411|4863401|P4|Overall Study|Unable to classify|4
1475105|NCT00645411|4863402|P3|Overall Study|Unable to classify|3
1475106|NCT00645411|4863403|P2|Overall Study|Unable to classify|0
1475107|NCT00645411|4863404|P1|Overall Study|Unable to classify|0
1475108|NCT00645411|4863401|P4|Overall Study|Inappropriate enrollment|1
1475109|NCT00645411|4863402|P3|Overall Study|Inappropriate enrollment|4
1475110|NCT00645411|4863403|P2|Overall Study|Inappropriate enrollment|0
1475111|NCT00645411|4863404|P1|Overall Study|Inappropriate enrollment|0
1475112|NCT00645411|4863401|P4|Overall Study|Protocol Violation|0
1475113|NCT00645411|4863402|P3|Overall Study|Protocol Violation|1
1475114|NCT00645411|4863403|P2|Overall Study|Protocol Violation|0
1475115|NCT00645411|4863404|P1|Overall Study|Protocol Violation|1
1475116|NCT00645411|4863401|P4|Overall Study|Lost to Follow-up|75
1475117|NCT00645411|4863402|P3|Overall Study|Lost to Follow-up|124
1475118|NCT00645411|4863403|P2|Overall Study|Lost to Follow-up|5
1475119|NCT00645411|4863404|P1|Overall Study|Lost to Follow-up|10
1475120|NCT00645411|4863401|P4|Overall Study|Withdrawal by Subject|21
1475121|NCT00645411|4863402|P3|Overall Study|Withdrawal by Subject|19
1475122|NCT00645411|4863403|P2|Overall Study|Withdrawal by Subject|1
1475123|NCT00645411|4863404|P1|Overall Study|Withdrawal by Subject|2
1475124|NCT00645411|4863401|P4|Overall Study|Adverse Event|2
1475125|NCT00645411|4863402|P3|Overall Study|Adverse Event|0
1475126|NCT00645411|4863403|P2|Overall Study|Adverse Event|0
1475127|NCT00645411|4863404|P1|Overall Study|Adverse Event|0
1475128|NCT00645164|4863446|P1|Overall Study|Protocol Violation|1
1475129|NCT00645164|4863446|P1|Overall Study|Withdrawal by Subject|4
1475130|NCT00645164|4863446|P1|Overall Study|Lost to Follow-up|2
1475131|NCT00645099|4863452|P2|Overall Study|Other|5
1475132|NCT00645099|4863453|P1|Overall Study|Other|9
1475133|NCT00645099|4863452|P2|Overall Study|Adverse Event|5
1475134|NCT00645099|4863453|P1|Overall Study|Adverse Event|11
1475135|NCT00645099|4863452|P2|Overall Study|Lost to Follow-up|4
1475136|NCT00645099|4863453|P1|Overall Study|Lost to Follow-up|6
1475137|NCT00645099|4863452|P2|Overall Study|Withdrawal by Subject|22
1475138|NCT00645099|4863453|P1|Overall Study|Withdrawal by Subject|30
1475139|NCT00645099|4863452|P2|Overall Study|Lack of Efficacy|6
1475140|NCT00645099|4863453|P1|Overall Study|Lack of Efficacy|15
1475141|NCT00644995|4863522|P2|Overall Study|Refused|0
1475142|NCT00644995|4863523|P1|Overall Study|Refused|1
1475143|NCT00644995|4863522|P2|Overall Study|Lost to Follow-up|4
1475144|NCT00644995|4863523|P1|Overall Study|Lost to Follow-up|1
1475145|NCT00644969|4863543|P2|Post Treatment Phase|Other|0
1475146|NCT00644969|4863544|P1|Post Treatment Phase|Other|1
1475147|NCT00644969|4863543|P2|Post Treatment Phase|Lost to Follow-up|1
1475148|NCT00644969|4863544|P1|Post Treatment Phase|Lost to Follow-up|4
1475149|NCT00644969|4863543|P2|Post Treatment Phase|Withdrawal by Subject|2
1475150|NCT00644969|4863544|P1|Post Treatment Phase|Withdrawal by Subject|4
1475151|NCT00644969|4863543|P2|Post Treatment Phase|Death|0
1475152|NCT00644969|4863544|P1|Post Treatment Phase|Death|1
1475153|NCT00644969|4863543|P2|Treatment Phase|Other|1
1475154|NCT00644969|4863544|P1|Treatment Phase|Other|4
1475155|NCT00644969|4863543|P2|Treatment Phase|Lost to Follow-up|2
1475156|NCT00644969|4863544|P1|Treatment Phase|Lost to Follow-up|2
1475157|NCT00644969|4863543|P2|Treatment Phase|Withdrawal by Subject|0
1475158|NCT00644969|4863544|P1|Treatment Phase|Withdrawal by Subject|4
1475159|NCT00644969|4863543|P2|Treatment Phase|Adverse Event|0
1475160|NCT00644969|4863544|P1|Treatment Phase|Adverse Event|3
1475161|NCT00644969|4863543|P2|Treatment Phase|Randomized, not treated|0
1475162|NCT00644969|4863544|P1|Treatment Phase|Randomized, not treated|1
1475163|NCT00644917|4863590|P1|Overall Study|Withdrawal by Subject|2
1475164|NCT00644787|4863598|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
1475165|NCT00644787|4863599|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
1475166|NCT00644787|4863600|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
1475167|NCT00644787|4863598|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
1475168|NCT00644787|4863599|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
1475169|NCT00644787|4863600|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
1475170|NCT00644787|4863598|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
1475171|NCT00644787|4863599|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
1475172|NCT00644787|4863600|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
1475173|NCT00644787|4863598|P3|Period 2: Double Blind Phase|Adverse Event|4
1475174|NCT00644787|4863599|P2|Period 2: Double Blind Phase|Adverse Event|2
1475175|NCT00644787|4863600|P1|Period 2: Double Blind Phase|Adverse Event|0
1475176|NCT00644787|4863598|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
1475177|NCT00644787|4863599|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
1475178|NCT00644787|4863600|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
1475179|NCT00644787|4863598|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
1475180|NCT00644787|4863599|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
1475181|NCT00644787|4863600|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
1475182|NCT00644787|4863598|P3|Period 1: Titration Phase|Worsening of symptoms|0
1475183|NCT00644787|4863599|P2|Period 1: Titration Phase|Worsening of symptoms|0
1475184|NCT00644787|4863600|P1|Period 1: Titration Phase|Worsening of symptoms|1
1475185|NCT00644787|4863598|P3|Period 1: Titration Phase|Worsening of complications|0
1475186|NCT00644787|4863599|P2|Period 1: Titration Phase|Worsening of complications|0
1475187|NCT00644787|4863600|P1|Period 1: Titration Phase|Worsening of complications|1
1475188|NCT00644787|4863598|P3|Period 1: Titration Phase|Worsening of underlying disease|0
1475189|NCT00644787|4863599|P2|Period 1: Titration Phase|Worsening of underlying disease|0
1475190|NCT00644787|4863600|P1|Period 1: Titration Phase|Worsening of underlying disease|5
1475191|NCT00644787|4863598|P3|Period 1: Titration Phase|Physician Decision|0
1475192|NCT00644787|4863599|P2|Period 1: Titration Phase|Physician Decision|0
1475193|NCT00644787|4863600|P1|Period 1: Titration Phase|Physician Decision|1
1475194|NCT00644787|4863598|P3|Period 1: Titration Phase|Withdrawal by Subject|0
1475195|NCT00644787|4863599|P2|Period 1: Titration Phase|Withdrawal by Subject|0
1475196|NCT00644787|4863600|P1|Period 1: Titration Phase|Withdrawal by Subject|2
1475197|NCT00644787|4863598|P3|Period 1: Titration Phase|Adverse Event|0
1475198|NCT00644787|4863599|P2|Period 1: Titration Phase|Adverse Event|0
1475199|NCT00644787|4863600|P1|Period 1: Titration Phase|Adverse Event|11
1475200|NCT00644358|4863642|P1|Overall Study|Other Unspecified|11
1475201|NCT00644358|4863642|P1|Overall Study|Noncompliance|14
1475202|NCT00644358|4863642|P1|Overall Study|Protocol Violation|5
1475203|NCT00644358|4863642|P1|Overall Study|Lack of Effectiveness|39
1475204|NCT00644358|4863642|P1|Overall Study|Consent Withdrawal|64
1475205|NCT00644358|4863642|P1|Overall Study|Lost to Follow-up|105
1475206|NCT00644358|4863642|P1|Overall Study|Adverse Event|124
1475207|NCT00644332|4863649|P1|Overall Study|Could Not Attend Scheduled Visits|1
1475208|NCT00644332|4863649|P1|Overall Study|Did Not Meet Eligibility Requirements|1
1475209|NCT00644332|4863649|P1|Overall Study|Completion Status Unknown|2
1475210|NCT00644332|4863649|P1|Overall Study|Withdrawal by Subject|6
1475211|NCT00644332|4863649|P1|Overall Study|Adverse Event|11
1475212|NCT00644228|4863675|P2|Maintenance|On Treatment|40
1475213|NCT00644228|4863676|P1|Maintenance|On Treatment|26
1475214|NCT00644228|4863675|P2|Maintenance|Not Protocol-Specified|15
1475215|NCT00644228|4863676|P1|Maintenance|Not Protocol-Specified|14
1475216|NCT00644228|4863675|P2|Maintenance|Death|3
1475217|NCT00644228|4863676|P1|Maintenance|Death|3
1475218|NCT00644228|4863675|P2|Maintenance|Progression/Relapse|42
1475219|NCT00644228|4863676|P1|Maintenance|Progression/Relapse|67
1475220|NCT00644228|4863675|P2|Maintenance|Withdrawal by Subject|4
1475221|NCT00644228|4863676|P1|Maintenance|Withdrawal by Subject|6
1475222|NCT00644228|4863675|P2|Maintenance|Adverse Event|31
1475223|NCT00644228|4863676|P1|Maintenance|Adverse Event|27
1475224|NCT00644228|4863675|P2|Induction Therapy|Not Protocol-Specified|28
1475225|NCT00644228|4863676|P1|Induction Therapy|Not Protocol-Specified|24
1475226|NCT00644228|4863675|P2|Induction Therapy|Death|7
1475227|NCT00644228|4863676|P1|Induction Therapy|Death|3
1475228|NCT00644228|4863675|P2|Induction Therapy|Progression/Relapse|12
1475229|NCT00644228|4863676|P1|Induction Therapy|Progression/Relapse|24
1475230|NCT00644228|4863675|P2|Induction Therapy|Withdrawal by Subject|3
1475231|NCT00644228|4863676|P1|Induction Therapy|Withdrawal by Subject|10
1475232|NCT00644228|4863675|P2|Induction Therapy|Adverse Event|55
1475233|NCT00644228|4863676|P1|Induction Therapy|Adverse Event|22
1475234|NCT00644228|4863675|P2|Randomization & Eligibility|Invalid Consent|1
1475235|NCT00644228|4863676|P1|Randomization & Eligibility|Invalid Consent|0
1475236|NCT00644228|4863675|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
1475237|NCT00644228|4863676|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
1475238|NCT00644228|4863675|P2|Randomization & Eligibility|Ineligible|21
1475239|NCT00644228|4863676|P1|Randomization & Eligibility|Ineligible|31
1475240|NCT00644059|4863705|P3|Overall Study|Unable to classify|3
1475241|NCT00644059|4863706|P2|Overall Study|Unable to classify|2
1475242|NCT00644059|4863707|P1|Overall Study|Unable to classify|6
1475243|NCT00644059|4863705|P3|Overall Study|Protocol Deviation/violation|15
1475244|NCT00644059|4863706|P2|Overall Study|Protocol Deviation/violation|19
1475245|NCT00644059|4863707|P1|Overall Study|Protocol Deviation/violation|20
1475246|NCT00644059|4863705|P3|Overall Study|Inappropriate Enrollment|0
1475247|NCT00644059|4863706|P2|Overall Study|Inappropriate Enrollment|3
1475248|NCT00644059|4863707|P1|Overall Study|Inappropriate Enrollment|1
1475249|NCT00644059|4863705|P3|Overall Study|Adverse Event|1
1475250|NCT00644059|4863706|P2|Overall Study|Adverse Event|5
1475251|NCT00644059|4863707|P1|Overall Study|Adverse Event|8
1475252|NCT00644059|4863705|P3|Overall Study|Withdrawal by Subject|30
1475253|NCT00644059|4863706|P2|Overall Study|Withdrawal by Subject|60
1475254|NCT00644059|4863707|P1|Overall Study|Withdrawal by Subject|52
1475255|NCT00644059|4863705|P3|Overall Study|Lost to Follow-up|16
1475256|NCT00644059|4863706|P2|Overall Study|Lost to Follow-up|34
1475257|NCT00644059|4863707|P1|Overall Study|Lost to Follow-up|37
1475258|NCT00643916|4863797|P6|Overall Study|Not Vaccinated|0
1475259|NCT00643916|4863798|P5|Overall Study|Not Vaccinated|2
1475260|NCT00643916|4863799|P4|Overall Study|Not Vaccinated|0
1475261|NCT00643916|4863800|P3|Overall Study|Not Vaccinated|3
1475262|NCT00643916|4863801|P2|Overall Study|Not Vaccinated|2
1475263|NCT00643916|4863802|P1|Overall Study|Not Vaccinated|2
1475264|NCT00643916|4863797|P6|Overall Study|Withdrawal by Subject|1
1475265|NCT00643916|4863798|P5|Overall Study|Withdrawal by Subject|0
1475266|NCT00643916|4863799|P4|Overall Study|Withdrawal by Subject|1
1475267|NCT00643916|4863800|P3|Overall Study|Withdrawal by Subject|2
1475268|NCT00643916|4863801|P2|Overall Study|Withdrawal by Subject|2
1475269|NCT00643916|4863802|P1|Overall Study|Withdrawal by Subject|2
1475270|NCT00643916|4863797|P6|Overall Study|Lost to Follow-up|0
1475271|NCT00643916|4863798|P5|Overall Study|Lost to Follow-up|0
1475272|NCT00643916|4863799|P4|Overall Study|Lost to Follow-up|0
1475273|NCT00643916|4863800|P3|Overall Study|Lost to Follow-up|0
1475274|NCT00643916|4863801|P2|Overall Study|Lost to Follow-up|1
1475275|NCT00643916|4863802|P1|Overall Study|Lost to Follow-up|0
1475276|NCT00643916|4863797|P6|Overall Study|Protocol Violation|0
1475277|NCT00643916|4863798|P5|Overall Study|Protocol Violation|0
1475278|NCT00643916|4863799|P4|Overall Study|Protocol Violation|1
1475279|NCT00643916|4863800|P3|Overall Study|Protocol Violation|1
1475280|NCT00643916|4863801|P2|Overall Study|Protocol Violation|1
1475281|NCT00643916|4863802|P1|Overall Study|Protocol Violation|0
1475282|NCT00643851|4863825|P3|Overall Study|Non-compl., not met criteria, etc.|6
1475283|NCT00643851|4863826|P2|Overall Study|Non-compl., not met criteria, etc.|4
1475284|NCT00643851|4863827|P1|Overall Study|Non-compl., not met criteria, etc.|3
1475285|NCT00643851|4863825|P3|Overall Study|Withdrawal by Subject|9
1475286|NCT00643851|4863826|P2|Overall Study|Withdrawal by Subject|15
1475287|NCT00643851|4863827|P1|Overall Study|Withdrawal by Subject|8
1475288|NCT00643851|4863825|P3|Overall Study|Lost to Follow-up|9
1475289|NCT00643851|4863826|P2|Overall Study|Lost to Follow-up|6
1475290|NCT00643851|4863827|P1|Overall Study|Lost to Follow-up|4
1475291|NCT00643851|4863825|P3|Overall Study|Adverse Event|6
1475292|NCT00643851|4863826|P2|Overall Study|Adverse Event|6
1475293|NCT00643851|4863827|P1|Overall Study|Adverse Event|2
1475294|NCT00643851|4863825|P3|Overall Study|Lack of Efficacy|0
1475295|NCT00643851|4863826|P2|Overall Study|Lack of Efficacy|1
1475296|NCT00643851|4863827|P1|Overall Study|Lack of Efficacy|0
1475297|NCT00643851|4863825|P3|Overall Study|Death|0
1475298|NCT00643851|4863826|P2|Overall Study|Death|1
1475299|NCT00643851|4863827|P1|Overall Study|Death|0
1475300|NCT00643760|4863855|P5|Overall Study|Withdrawal by Subject|1
1475301|NCT00643760|4863856|P4|Overall Study|Withdrawal by Subject|4
1475302|NCT00643760|4863857|P3|Overall Study|Withdrawal by Subject|2
1475303|NCT00643760|4863858|P2|Overall Study|Withdrawal by Subject|1
1475304|NCT00643760|4863859|P1|Overall Study|Withdrawal by Subject|3
1475305|NCT00643760|4863855|P5|Overall Study|Investigator Discretion|0
1475306|NCT00643760|4863856|P4|Overall Study|Investigator Discretion|2
1475307|NCT00643760|4863857|P3|Overall Study|Investigator Discretion|0
1475308|NCT00643760|4863858|P2|Overall Study|Investigator Discretion|0
1475309|NCT00643760|4863859|P1|Overall Study|Investigator Discretion|0
1475310|NCT00643760|4863855|P5|Overall Study|Lost to Follow-up|3
1475311|NCT00643760|4863856|P4|Overall Study|Lost to Follow-up|3
1475312|NCT00643760|4863857|P3|Overall Study|Lost to Follow-up|1
1475313|NCT00643760|4863858|P2|Overall Study|Lost to Follow-up|2
1475314|NCT00643760|4863859|P1|Overall Study|Lost to Follow-up|6
1475315|NCT00643760|4863855|P5|Overall Study|Protocol Violation|6
1475316|NCT00643760|4863856|P4|Overall Study|Protocol Violation|4
1475317|NCT00643760|4863857|P3|Overall Study|Protocol Violation|4
1475318|NCT00643760|4863858|P2|Overall Study|Protocol Violation|6
1475319|NCT00643760|4863859|P1|Overall Study|Protocol Violation|7
1475320|NCT00643760|4863855|P5|Overall Study|Lack of Efficacy|3
1475321|NCT00643760|4863856|P4|Overall Study|Lack of Efficacy|4
1475322|NCT00643760|4863857|P3|Overall Study|Lack of Efficacy|0
1475323|NCT00643760|4863858|P2|Overall Study|Lack of Efficacy|1
1475324|NCT00643760|4863859|P1|Overall Study|Lack of Efficacy|3
1475325|NCT00643760|4863855|P5|Overall Study|Adverse Event|6
1475326|NCT00643760|4863856|P4|Overall Study|Adverse Event|21
1475327|NCT00643760|4863857|P3|Overall Study|Adverse Event|12
1475328|NCT00643760|4863858|P2|Overall Study|Adverse Event|5
1475329|NCT00643760|4863859|P1|Overall Study|Adverse Event|11
1475330|NCT00643682|4863963|P2|Overall Study|did not keep appointment|509
1475331|NCT00643682|4863964|P1|Overall Study|did not keep appointment|522
1475332|NCT00643604|4863976|P1|Overall Study|Death|1
1475333|NCT00643565|4864004|P2|Overall Study|Lost to Follow-up|0
1475334|NCT00643565|4864005|P1|Overall Study|Lost to Follow-up|2
1475335|NCT00643565|4864004|P2|Overall Study|Withdrawal by Subject|1
1475336|NCT00643565|4864005|P1|Overall Study|Withdrawal by Subject|2
1475337|NCT00643565|4864004|P2|Overall Study|Ongoing in Follow-up|39
1475338|NCT00643565|4864005|P1|Overall Study|Ongoing in Follow-up|39
1475339|NCT00643565|4864004|P2|Overall Study|Death|34
1475340|NCT00643565|4864005|P1|Overall Study|Death|37
1475341|NCT00643487|4864027|P1|Overall Study|Technical difficulty|3
1475342|NCT00643448|4864034|P3|Overall Study|QTcF>550 ms|0
1475343|NCT00643448|4864035|P2|Overall Study|QTcF>550 ms|3
1475344|NCT00643448|4864036|P1|Overall Study|QTcF>550 ms|0
1475345|NCT00643448|4864034|P3|Overall Study|Adverse Event|2
1475346|NCT00643448|4864035|P2|Overall Study|Adverse Event|2
1475347|NCT00643448|4864036|P1|Overall Study|Adverse Event|2
1475348|NCT00643448|4864034|P3|Overall Study|Lack of Efficacy|4
1475349|NCT00643448|4864035|P2|Overall Study|Lack of Efficacy|0
1475350|NCT00643448|4864036|P1|Overall Study|Lack of Efficacy|2
1475351|NCT00643201|4864053|P2|Completed Study Follow Up|non-specified|0
1475352|NCT00643201|4864054|P1|Completed Study Follow Up|non-specified|1
1475353|NCT00643201|4864053|P2|Completed Study Follow Up|Lost to Follow-up|16
1475354|NCT00643201|4864054|P1|Completed Study Follow Up|Lost to Follow-up|18
1475355|NCT00643201|4864053|P2|Completed Study Follow Up|Withdrawal by Subject|29
1475356|NCT00643201|4864054|P1|Completed Study Follow Up|Withdrawal by Subject|23
1475357|NCT00643201|4864053|P2|Completed Study Follow Up|Death|34
1475358|NCT00643201|4864054|P1|Completed Study Follow Up|Death|28
1475359|NCT00643201|4864053|P2|Randomized, Completed 6 Months of Study|not specified|107
1475360|NCT00643201|4864054|P1|Randomized, Completed 6 Months of Study|not specified|107
1475361|NCT00643201|4864053|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
1475362|NCT00643201|4864054|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
1475363|NCT00643201|4864053|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
1475364|NCT00643201|4864054|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
1475365|NCT00643201|4864053|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
1475366|NCT00643201|4864054|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
1475367|NCT00643201|4864053|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
1475368|NCT00643201|4864054|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
1475369|NCT00643201|4864053|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
1475370|NCT00643201|4864054|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
1475371|NCT00643201|4864053|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
1475372|NCT00643201|4864054|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
1475373|NCT00643201|4864053|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
1475374|NCT00643201|4864054|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
1475375|NCT00643201|4864053|P2|Randomized, Completed 6 Months of Study|Death|26
1475376|NCT00643201|4864054|P1|Randomized, Completed 6 Months of Study|Death|20
1475377|NCT00643123|4864102|P2|Overall Study|Withdrawal by Subject|1
1475378|NCT00643123|4864103|P1|Overall Study|Withdrawal by Subject|1
1475379|NCT00643123|4864102|P2|Overall Study|Lost to Follow-up|0
1475380|NCT00643123|4864103|P1|Overall Study|Lost to Follow-up|4
1475381|NCT00643006|4864133|P2|Overall Study|Lost to Follow-up|4
1475382|NCT00643006|4864134|P1|Overall Study|Lost to Follow-up|5
1475383|NCT00642993|4864144|P2|Overall Study|Administrative|0
1475384|NCT00642993|4864145|P1|Overall Study|Administrative|1
1475385|NCT00642993|4864144|P2|Overall Study|Did not meet protocol eligibility|1
1475386|NCT00642993|4864145|P1|Overall Study|Did not meet protocol eligibility|0
1475387|NCT00642993|4864144|P2|Overall Study|Protocol Violation|4
1475388|NCT00642993|4864145|P1|Overall Study|Protocol Violation|1
1475389|NCT00642993|4864144|P2|Overall Study|Withdrew - reason unrelated to treatment|3
1475390|NCT00642993|4864145|P1|Overall Study|Withdrew - reason unrelated to treatment|11
1475391|NCT00642993|4864144|P2|Overall Study|Lost to Follow-up|4
1475392|NCT00642993|4864145|P1|Overall Study|Lost to Follow-up|8
1475393|NCT00642993|4864144|P2|Overall Study|Adverse Event|4
1475394|NCT00642993|4864145|P1|Overall Study|Adverse Event|85
1475395|NCT00642902|4864163|P4|Overall Study|Other|4
1475396|NCT00642902|4864164|P3|Overall Study|Other|1
1475397|NCT00642902|4864165|P2|Overall Study|Other|5
1475398|NCT00642902|4864166|P1|Overall Study|Other|1
1475399|NCT00642902|4864163|P4|Overall Study|Randomized, but not treated|0
1475400|NCT00642902|4864164|P3|Overall Study|Randomized, but not treated|1
1475401|NCT00642902|4864165|P2|Overall Study|Randomized, but not treated|0
1475402|NCT00642902|4864166|P1|Overall Study|Randomized, but not treated|0
1475403|NCT00642902|4864163|P4|Overall Study|Premature termination of clinical trial|35
1475404|NCT00642902|4864164|P3|Overall Study|Premature termination of clinical trial|35
1475405|NCT00642902|4864165|P2|Overall Study|Premature termination of clinical trial|32
1475406|NCT00642902|4864166|P1|Overall Study|Premature termination of clinical trial|37
1475407|NCT00642902|4864163|P4|Overall Study|Death|0
1475408|NCT00642902|4864164|P3|Overall Study|Death|0
1475409|NCT00642902|4864165|P2|Overall Study|Death|0
1475410|NCT00642902|4864166|P1|Overall Study|Death|1
1475411|NCT00642902|4864163|P4|Overall Study|Lack of Efficacy|0
1475412|NCT00642902|4864164|P3|Overall Study|Lack of Efficacy|3
1475413|NCT00642902|4864165|P2|Overall Study|Lack of Efficacy|3
1475414|NCT00642902|4864166|P1|Overall Study|Lack of Efficacy|0
1475415|NCT00642902|4864163|P4|Overall Study|Lost to Follow-up|0
1475416|NCT00642902|4864164|P3|Overall Study|Lost to Follow-up|0
1475417|NCT00642902|4864165|P2|Overall Study|Lost to Follow-up|1
1475418|NCT00642902|4864166|P1|Overall Study|Lost to Follow-up|1
1475419|NCT00642902|4864163|P4|Overall Study|Adverse Event|1
1475420|NCT00642902|4864164|P3|Overall Study|Adverse Event|3
1475421|NCT00642902|4864165|P2|Overall Study|Adverse Event|1
1475422|NCT00642902|4864166|P1|Overall Study|Adverse Event|0
1475423|NCT00642850|4864188|P1|Overall Study|Other reasons|7
1475424|NCT00642850|4864188|P1|Overall Study|Blood transfusion|6
1475425|NCT00642850|4864188|P1|Overall Study|Kidney transplantation|8
1475426|NCT00642850|4864188|P1|Overall Study|Protocol Violation|2
1475427|NCT00642850|4864188|P1|Overall Study|Lack of Efficacy|1
1475428|NCT00642850|4864188|P1|Overall Study|Adverse Event|2
1475429|NCT00642850|4864188|P1|Overall Study|Death|7
1475430|NCT00642811|4864204|P6|Overall Study|Other|0
1475431|NCT00642811|4864205|P5|Overall Study|Other|0
1475432|NCT00642811|4864206|P4|Overall Study|Other|1
1475433|NCT00642811|4864207|P3|Overall Study|Other|0
1475434|NCT00642811|4864208|P2|Overall Study|Other|1
1475435|NCT00642811|4864209|P1|Overall Study|Other|0
1475436|NCT00642811|4864204|P6|Overall Study|Severe Non-compliance to protocol|0
1475437|NCT00642811|4864205|P5|Overall Study|Severe Non-compliance to protocol|0
1475438|NCT00642811|4864206|P4|Overall Study|Severe Non-compliance to protocol|0
1475439|NCT00642811|4864207|P3|Overall Study|Severe Non-compliance to protocol|0
1475440|NCT00642811|4864208|P2|Overall Study|Severe Non-compliance to protocol|0
1475441|NCT00642811|4864209|P1|Overall Study|Severe Non-compliance to protocol|1
1475442|NCT00642811|4864204|P6|Overall Study|Developement of discontinuation criteria|0
1475443|NCT00642811|4864205|P5|Overall Study|Developement of discontinuation criteria|1
1475444|NCT00642811|4864206|P4|Overall Study|Developement of discontinuation criteria|0
1475445|NCT00642811|4864207|P3|Overall Study|Developement of discontinuation criteria|0
1475446|NCT00642811|4864208|P2|Overall Study|Developement of discontinuation criteria|0
1475447|NCT00642811|4864209|P1|Overall Study|Developement of discontinuation criteria|0
1475448|NCT00642811|4864204|P6|Overall Study|Adverse Event|1
1475449|NCT00642811|4864205|P5|Overall Study|Adverse Event|0
1475450|NCT00642811|4864206|P4|Overall Study|Adverse Event|0
1475451|NCT00642811|4864207|P3|Overall Study|Adverse Event|0
1475452|NCT00642811|4864208|P2|Overall Study|Adverse Event|3
1475453|NCT00642811|4864209|P1|Overall Study|Adverse Event|2
1475454|NCT00642772|4864231|P1|Overall Study|Withdrawal by Subject|7
1475455|NCT00642772|4864231|P1|Overall Study|Lost to Follow-up|3
1475456|NCT00642759|4864235|P1|Overall Study|Protocol Violation|1
1475457|NCT00642746|4864244|P2|Overall Study|Patient unevaluable|0
1475458|NCT00642746|4864245|P1|Overall Study|Patient unevaluable|1
1475459|NCT00642707|4864259|P4|Overall Study|Withdrawal by Subject|0
1475460|NCT00642707|4864260|P3|Overall Study|Withdrawal by Subject|0
1475461|NCT00642707|4864261|P2|Overall Study|Withdrawal by Subject|0
1475462|NCT00642707|4864262|P1|Overall Study|Withdrawal by Subject|1
1475463|NCT00642707|4864259|P4|Overall Study|Adverse Event|2
1475464|NCT00642707|4864260|P3|Overall Study|Adverse Event|0
1475465|NCT00642707|4864261|P2|Overall Study|Adverse Event|0
1475466|NCT00642707|4864262|P1|Overall Study|Adverse Event|0
1475467|NCT00642668|4864283|P1|Overall Study|Blood Transfusion|2
1475468|NCT00642668|4864283|P1|Overall Study|Dialysis Initiation|5
1475469|NCT00642668|4864283|P1|Overall Study|Failure to Return|1
1475470|NCT00642668|4864283|P1|Overall Study|Insufficient Therapeutic Response|1
1475471|NCT00642668|4864283|P1|Overall Study|Death|2
1475472|NCT00642668|4864283|P1|Overall Study|Adverse Event|2
1475473|NCT00642668|4864283|P1|Overall Study|Lost to Follow-up|1
1475474|NCT00642642|4864291|P1|Treatment & Follow Up|Lost to Follow-up|10
1475475|NCT00642642|4864291|P1|Treatment & Follow Up|Withdrawal by Subject|5
1475476|NCT00642642|4864291|P1|Treatment & Follow Up|Adverse Event|2
1475477|NCT00642616|4864308|P4|Overall Study|Physician Decision|1
1475478|NCT00642616|4864309|P3|Overall Study|Physician Decision|1
1475479|NCT00642616|4864310|P2|Overall Study|Physician Decision|0
1475480|NCT00642616|4864311|P1|Overall Study|Physician Decision|0
1475481|NCT00642616|4864308|P4|Overall Study|Protocol Violation|0
1475482|NCT00642616|4864309|P3|Overall Study|Protocol Violation|2
1475483|NCT00642616|4864310|P2|Overall Study|Protocol Violation|0
1475484|NCT00642616|4864311|P1|Overall Study|Protocol Violation|0
1475485|NCT00642616|4864308|P4|Overall Study|Withdrawal by Subject|1
1475486|NCT00642616|4864309|P3|Overall Study|Withdrawal by Subject|1
1475487|NCT00642616|4864310|P2|Overall Study|Withdrawal by Subject|1
1475488|NCT00642616|4864311|P1|Overall Study|Withdrawal by Subject|0
1475489|NCT00642616|4864308|P4|Overall Study|Study Terminated by Sponsor|5
1475490|NCT00642616|4864309|P3|Overall Study|Study Terminated by Sponsor|4
1475491|NCT00642616|4864310|P2|Overall Study|Study Terminated by Sponsor|6
1475492|NCT00642616|4864311|P1|Overall Study|Study Terminated by Sponsor|7
1475493|NCT00642616|4864308|P4|Overall Study|Adverse Event|0
1475494|NCT00642616|4864309|P3|Overall Study|Adverse Event|1
1475495|NCT00642616|4864310|P2|Overall Study|Adverse Event|0
1475496|NCT00642616|4864311|P1|Overall Study|Adverse Event|2
1475497|NCT00642473|4864344|P2|Overall Study|Other|2
1475498|NCT00642473|4864345|P1|Overall Study|Other|2
1475499|NCT00642473|4864344|P2|Overall Study|Progression or death|4
1475500|NCT00642473|4864345|P1|Overall Study|Progression or death|2
1475501|NCT00642473|4864344|P2|Overall Study|Withdrawal by Subject|5
1475502|NCT00642473|4864345|P1|Overall Study|Withdrawal by Subject|0
1475503|NCT00642460|4864359|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
1475504|NCT00642460|4864360|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
1475505|NCT00642460|4864361|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
1475506|NCT00642460|4864362|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
1475507|NCT00642460|4864363|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
1475508|NCT00642460|4864364|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
1475509|NCT00642460|4864359|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
1475510|NCT00642460|4864360|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
1475511|NCT00642460|4864361|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
1475512|NCT00642460|4864362|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
1475513|NCT00642460|4864363|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
1475514|NCT00642460|4864364|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
1475515|NCT00642460|4864359|P6|Part III: Open-Label Up to Week 260|Death|3
1475516|NCT00642460|4864360|P5|Part III: Open-Label Up to Week 260|Death|0
1475517|NCT00642460|4864361|P4|Part III: Open-Label Up to Week 260|Death|0
1475518|NCT00642460|4864362|P3|Part III: Open-Label Up to Week 260|Death|0
1475519|NCT00642460|4864363|P2|Part III: Open-Label Up to Week 260|Death|0
1475520|NCT00642460|4864364|P1|Part III: Open-Label Up to Week 260|Death|0
1475521|NCT00642460|4864359|P6|Part III: Open-Label Up to Week 260|Other|2
1475522|NCT00642460|4864360|P5|Part III: Open-Label Up to Week 260|Other|2
1475523|NCT00642460|4864361|P4|Part III: Open-Label Up to Week 260|Other|0
1475524|NCT00642460|4864362|P3|Part III: Open-Label Up to Week 260|Other|0
1475525|NCT00642460|4864363|P2|Part III: Open-Label Up to Week 260|Other|0
1475526|NCT00642460|4864364|P1|Part III: Open-Label Up to Week 260|Other|0
1475527|NCT00642460|4864359|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
1475528|NCT00642460|4864360|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
1475529|NCT00642460|4864361|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
1475530|NCT00642460|4864362|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
1475531|NCT00642460|4864363|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
1475532|NCT00642460|4864364|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
1475533|NCT00642460|4864359|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
1475534|NCT00642460|4864360|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
1475535|NCT00642460|4864361|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
1475536|NCT00642460|4864362|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
1475537|NCT00642460|4864363|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
1475538|NCT00642460|4864364|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
1475539|NCT00642460|4864359|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
1475540|NCT00642460|4864360|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
1475541|NCT00642460|4864361|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
1475542|NCT00642460|4864362|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
1475543|NCT00642460|4864363|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
1475544|NCT00642460|4864364|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
1475545|NCT00642460|4864359|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
1475546|NCT00642460|4864360|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
1475547|NCT00642460|4864361|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
1475548|NCT00642460|4864362|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
1475549|NCT00642460|4864363|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
1475550|NCT00642460|4864364|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
1475551|NCT00642460|4864359|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
1475552|NCT00642460|4864360|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
1475553|NCT00642460|4864361|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
1475554|NCT00642460|4864362|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
1475555|NCT00642460|4864363|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
1475556|NCT00642460|4864364|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
1475557|NCT00642460|4864359|P6|Part II: Open-Label Up to Week 92|Failure to return|0
1475558|NCT00642460|4864360|P5|Part II: Open-Label Up to Week 92|Failure to return|0
1475559|NCT00642460|4864361|P4|Part II: Open-Label Up to Week 92|Failure to return|0
1475560|NCT00642460|4864362|P3|Part II: Open-Label Up to Week 92|Failure to return|0
1475561|NCT00642460|4864363|P2|Part II: Open-Label Up to Week 92|Failure to return|1
1475562|NCT00642460|4864364|P1|Part II: Open-Label Up to Week 92|Failure to return|0
1475563|NCT00642460|4864359|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
1475564|NCT00642460|4864360|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
1475565|NCT00642460|4864361|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
1475566|NCT00642460|4864362|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
1475567|NCT00642460|4864363|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
1475568|NCT00642460|4864364|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
1475569|NCT00642460|4864359|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
1475570|NCT00642460|4864360|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
1475571|NCT00642460|4864361|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
1475572|NCT00642460|4864362|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
1475573|NCT00642460|4864363|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
1475574|NCT00642460|4864364|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
1475575|NCT00642460|4864359|P6|Part II: Open-Label Up to Week 92|Death|0
1475576|NCT00642460|4864360|P5|Part II: Open-Label Up to Week 92|Death|0
1475577|NCT00642460|4864361|P4|Part II: Open-Label Up to Week 92|Death|2
1475578|NCT00642460|4864362|P3|Part II: Open-Label Up to Week 92|Death|0
1475579|NCT00642460|4864363|P2|Part II: Open-Label Up to Week 92|Death|1
1475580|NCT00642460|4864364|P1|Part II: Open-Label Up to Week 92|Death|0
1475581|NCT00642460|4864359|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
1475582|NCT00642460|4864360|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
1475583|NCT00642460|4864361|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
1475584|NCT00642460|4864362|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
1475585|NCT00642460|4864363|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
1475586|NCT00642460|4864364|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
1475587|NCT00642460|4864359|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
1475588|NCT00642460|4864360|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
1475589|NCT00642460|4864361|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
1475590|NCT00642460|4864362|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
1475591|NCT00642460|4864363|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
1475592|NCT00642460|4864364|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
1475593|NCT00642460|4864359|P6|Part I: 12 Week Double-Blind|Adverse Event|0
1475594|NCT00642460|4864360|P5|Part I: 12 Week Double-Blind|Adverse Event|0
1475595|NCT00642460|4864361|P4|Part I: 12 Week Double-Blind|Adverse Event|0
1475596|NCT00642460|4864362|P3|Part I: 12 Week Double-Blind|Adverse Event|1
1475597|NCT00642460|4864363|P2|Part I: 12 Week Double-Blind|Adverse Event|1
1475598|NCT00642460|4864364|P1|Part I: 12 Week Double-Blind|Adverse Event|0
1475599|NCT00642369|4864439|P2|Overall Study|Lack of Efficacy|2
1475600|NCT00642369|4864440|P1|Overall Study|Lack of Efficacy|2
1475601|NCT00642369|4864439|P2|Overall Study|misdiagnosis|1
1475602|NCT00642369|4864440|P1|Overall Study|misdiagnosis|0
1475603|NCT00642369|4864439|P2|Overall Study|Withdrawal by Subject|0
1475604|NCT00642369|4864440|P1|Overall Study|Withdrawal by Subject|1
1475605|NCT00642369|4864439|P2|Overall Study|Adverse Event|3
1475606|NCT00642369|4864440|P1|Overall Study|Adverse Event|2
1475607|NCT00642356|4864450|P2|Overall Study|Lack of Efficacy|0
1475608|NCT00642356|4864451|P1|Overall Study|Lack of Efficacy|1
1475609|NCT00642356|4864450|P2|Overall Study|Protocol Violation|3
1475610|NCT00642356|4864451|P1|Overall Study|Protocol Violation|0
1475611|NCT00642356|4864450|P2|Overall Study|Adverse Event|0
1475612|NCT00642356|4864451|P1|Overall Study|Adverse Event|1
1475613|NCT00642304|4864459|P1|Overall Study|Transplantation|1
1475614|NCT00642304|4864459|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
1475615|NCT00642304|4864459|P1|Overall Study|Blood transfusion|2
1475616|NCT00642304|4864459|P1|Overall Study|Death|1
1475617|NCT00642304|4864459|P1|Overall Study|Adverse Event|1
1475618|NCT00642278|4864475|P7|Overall Study|Not specified|0
1475619|NCT00642278|4864476|P6|Overall Study|Not specified|1
1475620|NCT00642278|4864477|P5|Overall Study|Not specified|0
1475621|NCT00642278|4864478|P4|Overall Study|Not specified|1
1475622|NCT00642278|4864479|P3|Overall Study|Not specified|0
1475623|NCT00642278|4864480|P2|Overall Study|Not specified|1
1475624|NCT00642278|4864481|P1|Overall Study|Not specified|2
1475625|NCT00642278|4864475|P7|Overall Study|Noncompliance with study drug regimen|0
1475626|NCT00642278|4864476|P6|Overall Study|Noncompliance with study drug regimen|0
1475627|NCT00642278|4864477|P5|Overall Study|Noncompliance with study drug regimen|0
1475628|NCT00642278|4864478|P4|Overall Study|Noncompliance with study drug regimen|1
1475629|NCT00642278|4864479|P3|Overall Study|Noncompliance with study drug regimen|0
1475630|NCT00642278|4864480|P2|Overall Study|Noncompliance with study drug regimen|0
1475631|NCT00642278|4864481|P1|Overall Study|Noncompliance with study drug regimen|0
1475632|NCT00642278|4864475|P7|Overall Study|Withdrawal by Subject|2
1475633|NCT00642278|4864476|P6|Overall Study|Withdrawal by Subject|2
1475634|NCT00642278|4864477|P5|Overall Study|Withdrawal by Subject|6
1475635|NCT00642278|4864478|P4|Overall Study|Withdrawal by Subject|3
1475636|NCT00642278|4864479|P3|Overall Study|Withdrawal by Subject|1
1475637|NCT00642278|4864480|P2|Overall Study|Withdrawal by Subject|1
1475638|NCT00642278|4864481|P1|Overall Study|Withdrawal by Subject|1
1475639|NCT00642278|4864475|P7|Overall Study|Protocol Violation|2
1475640|NCT00642278|4864476|P6|Overall Study|Protocol Violation|1
1475641|NCT00642278|4864477|P5|Overall Study|Protocol Violation|0
1475642|NCT00642278|4864478|P4|Overall Study|Protocol Violation|1
1475643|NCT00642278|4864479|P3|Overall Study|Protocol Violation|1
1475644|NCT00642278|4864480|P2|Overall Study|Protocol Violation|0
1475645|NCT00642278|4864481|P1|Overall Study|Protocol Violation|0
1475646|NCT00642278|4864475|P7|Overall Study|Physician Decision|0
1475647|NCT00642278|4864476|P6|Overall Study|Physician Decision|0
1475648|NCT00642278|4864477|P5|Overall Study|Physician Decision|0
1475649|NCT00642278|4864478|P4|Overall Study|Physician Decision|1
1475650|NCT00642278|4864479|P3|Overall Study|Physician Decision|0
1475651|NCT00642278|4864480|P2|Overall Study|Physician Decision|0
1475652|NCT00642278|4864481|P1|Overall Study|Physician Decision|0
1475653|NCT00642278|4864475|P7|Overall Study|Lost to Follow-up|1
1475654|NCT00642278|4864476|P6|Overall Study|Lost to Follow-up|1
1475655|NCT00642278|4864477|P5|Overall Study|Lost to Follow-up|0
1475656|NCT00642278|4864478|P4|Overall Study|Lost to Follow-up|1
1475657|NCT00642278|4864479|P3|Overall Study|Lost to Follow-up|0
1475658|NCT00642278|4864480|P2|Overall Study|Lost to Follow-up|1
1475659|NCT00642278|4864481|P1|Overall Study|Lost to Follow-up|5
1475660|NCT00642278|4864475|P7|Overall Study|Lack of Efficacy|0
1475661|NCT00642278|4864476|P6|Overall Study|Lack of Efficacy|0
1475662|NCT00642278|4864477|P5|Overall Study|Lack of Efficacy|0
1475663|NCT00642278|4864478|P4|Overall Study|Lack of Efficacy|0
1475664|NCT00642278|4864479|P3|Overall Study|Lack of Efficacy|0
1475665|NCT00642278|4864480|P2|Overall Study|Lack of Efficacy|1
1475666|NCT00642278|4864481|P1|Overall Study|Lack of Efficacy|0
1475667|NCT00642278|4864475|P7|Overall Study|Adverse Event|0
1475668|NCT00642278|4864476|P6|Overall Study|Adverse Event|2
1475669|NCT00642278|4864477|P5|Overall Study|Adverse Event|2
1475670|NCT00642278|4864478|P4|Overall Study|Adverse Event|1
1475671|NCT00642278|4864479|P3|Overall Study|Adverse Event|3
1475672|NCT00642278|4864480|P2|Overall Study|Adverse Event|1
1475673|NCT00642278|4864481|P1|Overall Study|Adverse Event|2
1475674|NCT00642174|4864534|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
1475675|NCT00642174|4864535|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
1475676|NCT00641719|4864578|P2|Overall Study|Reason Not Specified|2
1475677|NCT00641719|4864579|P1|Overall Study|Reason Not Specified|1
1475678|NCT00641719|4864578|P2|Overall Study|Withdrawal by Subject|4
1475679|NCT00641719|4864579|P1|Overall Study|Withdrawal by Subject|4
1475680|NCT00641719|4864578|P2|Overall Study|Adverse Event|29
1475681|NCT00641719|4864579|P1|Overall Study|Adverse Event|24
1475682|NCT00641719|4864578|P2|Overall Study|Lack of Efficacy|2
1475683|NCT00641719|4864579|P1|Overall Study|Lack of Efficacy|1
1475684|NCT00641706|4864603|P2|Overall Study|Lead Investigator Decision|1
1475685|NCT00641706|4864604|P1|Overall Study|Lead Investigator Decision|0
1475686|NCT00641706|4864603|P2|Overall Study|Clinical Decline|0
1475687|NCT00641706|4864604|P1|Overall Study|Clinical Decline|1
1475688|NCT00641706|4864603|P2|Overall Study|Withdrawal by Subject|1
1475689|NCT00641706|4864604|P1|Overall Study|Withdrawal by Subject|6
1475690|NCT00641706|4864603|P2|Overall Study|Adverse Event|1
1475691|NCT00641706|4864604|P1|Overall Study|Adverse Event|2
1475692|NCT00641667|4864616|P1|Overall Study|Worsening of underlying disease|3
1475693|NCT00641667|4864616|P1|Overall Study|Physician Decision|1
1475694|NCT00641667|4864616|P1|Overall Study|Adverse Event|1
1475695|NCT00641667|4864616|P1|Overall Study|Withdrawal by Subject|1
1475696|NCT00641537|4864644|P8|24-Week Supplemental Follow-up Period|Other|1
1475697|NCT00641537|4864645|P7|24-Week Supplemental Follow-up Period|Other|1
1475698|NCT00641537|4864646|P6|24-Week Supplemental Follow-up Period|Other|0
1475699|NCT00641537|4864647|P5|24-Week Supplemental Follow-up Period|Other|3
1475700|NCT00641537|4864648|P4|24-Week Supplemental Follow-up Period|Other|1
1475701|NCT00641537|4864649|P3|24-Week Supplemental Follow-up Period|Other|2
1475702|NCT00641537|4864650|P2|24-Week Supplemental Follow-up Period|Other|2
1475703|NCT00641537|4864651|P1|24-Week Supplemental Follow-up Period|Other|0
1475704|NCT00641537|4864644|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
1475705|NCT00641537|4864645|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
1475706|NCT00641537|4864646|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
1475707|NCT00641537|4864647|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
1475708|NCT00641537|4864648|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
1475709|NCT00641537|4864649|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
1475710|NCT00641537|4864650|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
1475711|NCT00641537|4864651|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
1475712|NCT00641537|4864644|P8|96-week Period|Other|6
1475713|NCT00641537|4864645|P7|96-week Period|Other|4
1475714|NCT00641537|4864646|P6|96-week Period|Other|6
1475715|NCT00641537|4864647|P5|96-week Period|Other|12
1475716|NCT00641537|4864648|P4|96-week Period|Other|9
1475717|NCT00641537|4864649|P3|96-week Period|Other|14
1475718|NCT00641537|4864650|P2|96-week Period|Other|7
1475719|NCT00641537|4864651|P1|96-week Period|Other|4
1475720|NCT00641537|4864644|P8|96-week Period|Death|0
1475721|NCT00641537|4864645|P7|96-week Period|Death|0
1475722|NCT00641537|4864646|P6|96-week Period|Death|0
1475723|NCT00641537|4864647|P5|96-week Period|Death|0
1475724|NCT00641537|4864648|P4|96-week Period|Death|0
1475725|NCT00641537|4864649|P3|96-week Period|Death|1
1475726|NCT00641537|4864650|P2|96-week Period|Death|0
1475727|NCT00641537|4864651|P1|96-week Period|Death|2
1475728|NCT00641537|4864644|P8|96-week Period|Protocol Violation|0
1475729|NCT00641537|4864645|P7|96-week Period|Protocol Violation|0
1475730|NCT00641537|4864646|P6|96-week Period|Protocol Violation|1
1475731|NCT00641537|4864647|P5|96-week Period|Protocol Violation|0
1475732|NCT00641537|4864648|P4|96-week Period|Protocol Violation|1
1475733|NCT00641537|4864649|P3|96-week Period|Protocol Violation|0
1475734|NCT00641537|4864650|P2|96-week Period|Protocol Violation|1
1475735|NCT00641537|4864651|P1|96-week Period|Protocol Violation|0
1475736|NCT00641537|4864644|P8|96-week Period|Lost to Follow-up|0
1475737|NCT00641537|4864645|P7|96-week Period|Lost to Follow-up|1
1475738|NCT00641537|4864646|P6|96-week Period|Lost to Follow-up|0
1475739|NCT00641537|4864647|P5|96-week Period|Lost to Follow-up|4
1475740|NCT00641537|4864648|P4|96-week Period|Lost to Follow-up|2
1475741|NCT00641537|4864649|P3|96-week Period|Lost to Follow-up|2
1475742|NCT00641537|4864650|P2|96-week Period|Lost to Follow-up|1
1475743|NCT00641537|4864651|P1|96-week Period|Lost to Follow-up|3
1475744|NCT00641537|4864644|P8|96-week Period|Adverse Event|0
1475745|NCT00641537|4864645|P7|96-week Period|Adverse Event|0
1475746|NCT00641537|4864646|P6|96-week Period|Adverse Event|0
1475747|NCT00641537|4864647|P5|96-week Period|Adverse Event|2
1475748|NCT00641537|4864648|P4|96-week Period|Adverse Event|0
1475749|NCT00641537|4864649|P3|96-week Period|Adverse Event|3
1475750|NCT00641537|4864650|P2|96-week Period|Adverse Event|1
1475751|NCT00641537|4864651|P1|96-week Period|Adverse Event|0
1475752|NCT00641147|4864706|P2|Completed 16 Months.|Lost to Follow-up|0
1475753|NCT00641147|4864707|P1|Completed 16 Months.|Lost to Follow-up|1
1475754|NCT00641147|4864706|P2|Completed 16 Months.|Physician Decision|0
1475755|NCT00641147|4864707|P1|Completed 16 Months.|Physician Decision|1
1475756|NCT00641147|4864706|P2|Completed 12 Months.|Withdrawal by Subject|1
1475757|NCT00641147|4864707|P1|Completed 12 Months.|Withdrawal by Subject|0
1475758|NCT00641147|4864706|P2|Completed 12 Months.|Physician Decision|1
1475759|NCT00641147|4864707|P1|Completed 12 Months.|Physician Decision|1
1475760|NCT00641147|4864706|P2|Completed 8 Months.|Withdrawal by Subject|1
1475761|NCT00641147|4864707|P1|Completed 8 Months.|Withdrawal by Subject|0
1475762|NCT00641147|4864706|P2|Completed 8 Months.|non compliance|0
1475763|NCT00641147|4864707|P1|Completed 8 Months.|non compliance|1
1475764|NCT00641147|4864706|P2|Completed 8 Months.|Physician Decision|1
1475765|NCT00641147|4864707|P1|Completed 8 Months.|Physician Decision|2
1475766|NCT00641147|4864706|P2|Completed 4 Months.|Adverse Event|0
1475767|NCT00641147|4864707|P1|Completed 4 Months.|Adverse Event|1
1475768|NCT00641147|4864706|P2|Completed 4 Months.|Physician Decision|0
1475769|NCT00641147|4864707|P1|Completed 4 Months.|Physician Decision|1
1475770|NCT00641056|4864751|P2|Overall Study|Sponsor Decision|2
1475771|NCT00641056|4864752|P1|Overall Study|Sponsor Decision|1
1475772|NCT00641056|4864751|P2|Overall Study|Subject Decision|19
1475773|NCT00641056|4864752|P1|Overall Study|Subject Decision|6
1475774|NCT00641056|4864751|P2|Overall Study|Entry Criteria Not Met|0
1475775|NCT00641056|4864752|P1|Overall Study|Entry Criteria Not Met|3
1475776|NCT00641056|4864751|P2|Overall Study|Protocol Violation|0
1475777|NCT00641056|4864752|P1|Overall Study|Protocol Violation|2
1475778|NCT00641056|4864751|P2|Overall Study|Physician Decision|1
1475779|NCT00641056|4864752|P1|Overall Study|Physician Decision|3
1475780|NCT00641056|4864751|P2|Overall Study|Lost to Follow-up|1
1475781|NCT00641056|4864752|P1|Overall Study|Lost to Follow-up|2
1475782|NCT00641056|4864751|P2|Overall Study|Adverse Event|2
1475783|NCT00641056|4864752|P1|Overall Study|Adverse Event|12
1475784|NCT00641043|4864780|P2|Overall Study|Other incl. lack of efficacy|2
1475785|NCT00641043|4864781|P1|Overall Study|Other incl. lack of efficacy|4
1475786|NCT00641043|4864780|P2|Overall Study|Withdrawal by Subject|4
1475787|NCT00641043|4864781|P1|Overall Study|Withdrawal by Subject|4
1475788|NCT00641043|4864780|P2|Overall Study|Lost to Follow-up|2
1475789|NCT00641043|4864781|P1|Overall Study|Lost to Follow-up|3
1475790|NCT00641043|4864780|P2|Overall Study|Protocol Violation|3
1475791|NCT00641043|4864781|P1|Overall Study|Protocol Violation|2
1475792|NCT00641043|4864780|P2|Overall Study|Adverse Event|4
1475793|NCT00641043|4864781|P1|Overall Study|Adverse Event|6
1475794|NCT00640926|4864818|P3|Overall Study|Withdrawal by Subject|1
1475795|NCT00640926|4864819|P2|Overall Study|Withdrawal by Subject|0
1475796|NCT00640926|4864820|P1|Overall Study|Withdrawal by Subject|1
1475797|NCT00640926|4864818|P3|Overall Study|Lost to Follow-up|2
1475798|NCT00640926|4864819|P2|Overall Study|Lost to Follow-up|1
1475799|NCT00640926|4864820|P1|Overall Study|Lost to Follow-up|3
1475800|NCT00640926|4864818|P3|Overall Study|Protocol Violation|2
1475801|NCT00640926|4864819|P2|Overall Study|Protocol Violation|0
1475802|NCT00640926|4864820|P1|Overall Study|Protocol Violation|2
1475803|NCT00640926|4864818|P3|Overall Study|Lack of Efficacy|1
1475804|NCT00640926|4864819|P2|Overall Study|Lack of Efficacy|2
1475805|NCT00640926|4864820|P1|Overall Study|Lack of Efficacy|0
1475806|NCT00640926|4864818|P3|Overall Study|Adverse Event|2
1475807|NCT00640926|4864819|P2|Overall Study|Adverse Event|3
1475808|NCT00640926|4864820|P1|Overall Study|Adverse Event|2
1475809|NCT00640835|4864833|P2|Overall Study|Other Reason|4
1475810|NCT00640835|4864834|P1|Overall Study|Other Reason|19
1475811|NCT00640835|4864833|P2|Overall Study|Lost to Follow-up|13
1475812|NCT00640835|4864834|P1|Overall Study|Lost to Follow-up|17
1475813|NCT00640835|4864833|P2|Overall Study|Protocol Violation|2
1475814|NCT00640835|4864834|P1|Overall Study|Protocol Violation|2
1475815|NCT00640835|4864833|P2|Overall Study|Sponsor's Decision|7
1475816|NCT00640835|4864834|P1|Overall Study|Sponsor's Decision|11
1475817|NCT00640835|4864833|P2|Overall Study|Physician Decision|14
1475818|NCT00640835|4864834|P1|Overall Study|Physician Decision|10
1475819|NCT00640835|4864833|P2|Overall Study|Withdrawal by Subject|14
1475820|NCT00640835|4864834|P1|Overall Study|Withdrawal by Subject|12
1475821|NCT00640835|4864833|P2|Overall Study|Adverse Event|3
1475822|NCT00640835|4864834|P1|Overall Study|Adverse Event|5
1475823|NCT00640614|4864898|P2|Overall Study|Lost to Follow-up|0
1475824|NCT00640614|4864899|P1|Overall Study|Lost to Follow-up|1
1475825|NCT00640601|4864941|P1|Overall Study|treatment naive, combination therapy|10
1475826|NCT00640601|4864941|P1|Overall Study|Physician Decision|8
1475827|NCT00640601|4864941|P1|Overall Study|Lost to Follow-up|9
1475828|NCT00640601|4864941|P1|Overall Study|Lack of Efficacy|16
1475829|NCT00640601|4864941|P1|Overall Study|Protocol Violation|6
1475830|NCT00640601|4864941|P1|Overall Study|Withdrawal by Subject|20
1475831|NCT00640601|4864941|P1|Overall Study|Adverse Event|43
1475832|NCT00640562|4864957|P2|Overall Study|Glycosylated Hemoglobin >8|0
1475833|NCT00640562|4864958|P1|Overall Study|Glycosylated Hemoglobin >8|1
1475834|NCT00640562|4864957|P2|Overall Study|Low study drug dose|1
1475835|NCT00640562|4864958|P1|Overall Study|Low study drug dose|0
1475836|NCT00640562|4864957|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
1475837|NCT00640562|4864958|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
1475838|NCT00640562|4864957|P2|Overall Study|Known risperidone intolerance|1
1475839|NCT00640562|4864958|P1|Overall Study|Known risperidone intolerance|0
1475840|NCT00640562|4864957|P2|Overall Study|Withdrawal by Subject|10
1475841|NCT00640562|4864958|P1|Overall Study|Withdrawal by Subject|6
1475842|NCT00640562|4864957|P2|Overall Study|Protocol Violation|4
1475843|NCT00640562|4864958|P1|Overall Study|Protocol Violation|2
1475844|NCT00640562|4864957|P2|Overall Study|Lack of Efficacy|4
1475845|NCT00640562|4864958|P1|Overall Study|Lack of Efficacy|1
1475846|NCT00640562|4864957|P2|Overall Study|Adverse Event|5
1475847|NCT00640562|4864958|P1|Overall Study|Adverse Event|8
1475848|NCT00640510|4864986|P2|Overall Study|Physician Decision|1
1475849|NCT00640510|4864987|P1|Overall Study|Physician Decision|0
1475850|NCT00640510|4864986|P2|Overall Study|Protocol Violation|0
1475851|NCT00640510|4864987|P1|Overall Study|Protocol Violation|1
1475852|NCT00640510|4864986|P2|Overall Study|Lack of Efficacy|1
1475853|NCT00640510|4864987|P1|Overall Study|Lack of Efficacy|0
1475854|NCT00640393|4864999|P3|Part 2|Adverse Event|0
1475855|NCT00640393|4865000|P2|Part 2|Adverse Event|1
1475856|NCT00640393|4865001|P1|Part 2|Adverse Event|0
1475857|NCT00640393|4864999|P3|Part 2|Non-adherence|0
1475858|NCT00640393|4865000|P2|Part 2|Non-adherence|1
1475859|NCT00640393|4865001|P1|Part 2|Non-adherence|0
1475860|NCT00640393|4864999|P3|Part 2|Withdrawal by Subject|1
1475861|NCT00640393|4865000|P2|Part 2|Withdrawal by Subject|6
1475862|NCT00640393|4865001|P1|Part 2|Withdrawal by Subject|0
1475863|NCT00640393|4864999|P3|Part 2|Lost to Follow-up|2
1475864|NCT00640393|4865000|P2|Part 2|Lost to Follow-up|2
1475865|NCT00640393|4865001|P1|Part 2|Lost to Follow-up|0
1475866|NCT00640393|4864999|P3|Randomization|Never randomized by site|0
1475867|NCT00640393|4865000|P2|Randomization|Never randomized by site|0
1475868|NCT00640393|4865001|P1|Randomization|Never randomized by site|2
1475869|NCT00640393|4864999|P3|Randomization|Withdrawn per protocol|0
1475870|NCT00640393|4865000|P2|Randomization|Withdrawn per protocol|0
1475871|NCT00640393|4865001|P1|Randomization|Withdrawn per protocol|17
1475872|NCT00640393|4864999|P3|Part 1|Withdrawal by Subject|0
1475873|NCT00640393|4865000|P2|Part 1|Withdrawal by Subject|0
1475874|NCT00640393|4865001|P1|Part 1|Withdrawal by Subject|3
1475875|NCT00640393|4864999|P3|Part 1|Lost to Follow-up|0
1475876|NCT00640393|4865000|P2|Part 1|Lost to Follow-up|0
1475877|NCT00640393|4865001|P1|Part 1|Lost to Follow-up|2
1475878|NCT00640341|4865066|P3|Overall Study|Adverse event and positive slit lamp|0
1475879|NCT00640341|4865067|P2|Overall Study|Adverse event and positive slit lamp|0
1475880|NCT00640341|4865068|P1|Overall Study|Adverse event and positive slit lamp|1
1475881|NCT00640341|4865066|P3|Overall Study|Ineligable at Baseline|2
1475882|NCT00640341|4865067|P2|Overall Study|Ineligable at Baseline|3
1475883|NCT00640341|4865068|P1|Overall Study|Ineligable at Baseline|5
1475884|NCT00640341|4865066|P3|Overall Study|Poor fit/Uncomfortable|0
1475885|NCT00640341|4865067|P2|Overall Study|Poor fit/Uncomfortable|0
1475886|NCT00640341|4865068|P1|Overall Study|Poor fit/Uncomfortable|4
1475887|NCT00640341|4865066|P3|Overall Study|Unacceptable Lens Movement|0
1475888|NCT00640341|4865067|P2|Overall Study|Unacceptable Lens Movement|0
1475889|NCT00640341|4865068|P1|Overall Study|Unacceptable Lens Movement|1
1475890|NCT00640341|4865066|P3|Overall Study|Withdrawal by Subject|1
1475891|NCT00640341|4865067|P2|Overall Study|Withdrawal by Subject|0
1475892|NCT00640341|4865068|P1|Overall Study|Withdrawal by Subject|4
1475893|NCT00640341|4865066|P3|Overall Study|Lost to Follow-up|0
1475894|NCT00640341|4865067|P2|Overall Study|Lost to Follow-up|0
1475895|NCT00640341|4865068|P1|Overall Study|Lost to Follow-up|2
1475896|NCT00640341|4865066|P3|Overall Study|Failure to Follow Subject Instructions|0
1475897|NCT00640341|4865067|P2|Overall Study|Failure to Follow Subject Instructions|0
1475898|NCT00640341|4865068|P1|Overall Study|Failure to Follow Subject Instructions|1
1475899|NCT00640341|4865066|P3|Overall Study|Inability to Maintain Wearing Schedule|0
1475900|NCT00640341|4865067|P2|Overall Study|Inability to Maintain Wearing Schedule|1
1475901|NCT00640341|4865068|P1|Overall Study|Inability to Maintain Wearing Schedule|1
1475902|NCT00640341|4865066|P3|Overall Study|Study Related Symptoms/Complaints|2
1475903|NCT00640341|4865067|P2|Overall Study|Study Related Symptoms/Complaints|1
1475904|NCT00640341|4865068|P1|Overall Study|Study Related Symptoms/Complaints|2
1475905|NCT00640341|4865066|P3|Overall Study|Positive Slit Lamp Findings|1
1475906|NCT00640341|4865067|P2|Overall Study|Positive Slit Lamp Findings|0
1475907|NCT00640341|4865068|P1|Overall Study|Positive Slit Lamp Findings|0
1475908|NCT00640341|4865066|P3|Overall Study|Adverse Event|1
1475909|NCT00640341|4865067|P2|Overall Study|Adverse Event|0
1475910|NCT00640341|4865068|P1|Overall Study|Adverse Event|0
1475911|NCT00640328|4865088|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
1475912|NCT00640328|4865089|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
1475913|NCT00640328|4865090|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
1475914|NCT00640328|4865091|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
1475915|NCT00640328|4865092|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
1475916|NCT00640328|4865093|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
1475917|NCT00640328|4865088|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
1475918|NCT00640328|4865089|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
1475919|NCT00640328|4865090|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
1475920|NCT00640328|4865091|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
1475921|NCT00640328|4865092|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
1475922|NCT00640328|4865093|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
1475923|NCT00640328|4865088|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
1475924|NCT00640328|4865089|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
1475925|NCT00640328|4865090|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
1475926|NCT00640328|4865091|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
1475927|NCT00640328|4865092|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
1475928|NCT00640328|4865093|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
1475929|NCT00640328|4865088|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
1475930|NCT00640328|4865089|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
1475931|NCT00640328|4865090|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
1475932|NCT00640328|4865091|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
1475933|NCT00640328|4865092|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
1475934|NCT00640328|4865093|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
1475935|NCT00640315|4865259|P2|Overall Study|Withdrawal by Subject|1
1475936|NCT00640315|4865260|P1|Overall Study|Withdrawal by Subject|0
1475937|NCT00640224|4865493|P4|Overall Study|Headaches|0
1475938|NCT00640224|4865494|P3|Overall Study|Headaches|0
1475939|NCT00640224|4865495|P2|Overall Study|Headaches|1
1475940|NCT00640224|4865496|P1|Overall Study|Headaches|0
1475941|NCT00640224|4865493|P4|Overall Study|Withdrawal by Subject|0
1475942|NCT00640224|4865494|P3|Overall Study|Withdrawal by Subject|0
1475943|NCT00640224|4865495|P2|Overall Study|Withdrawal by Subject|0
1475944|NCT00640224|4865496|P1|Overall Study|Withdrawal by Subject|1
1475945|NCT00640224|4865493|P4|Overall Study|Lost to Follow-up|0
1475946|NCT00640224|4865494|P3|Overall Study|Lost to Follow-up|0
1475947|NCT00640224|4865495|P2|Overall Study|Lost to Follow-up|2
1475948|NCT00640224|4865496|P1|Overall Study|Lost to Follow-up|5
1475949|NCT00640042|4865594|P1|Enrollment|Did not receive study drug|83
1475950|NCT00640016|4865610|P4|Overall Study|Adverse Event|1
1475951|NCT00640016|4865611|P3|Overall Study|Adverse Event|0
1475952|NCT00640016|4865612|P2|Overall Study|Adverse Event|0
1475953|NCT00640016|4865613|P1|Overall Study|Adverse Event|0
1475954|NCT00640016|4865610|P4|Overall Study|Study termination|2
1475955|NCT00640016|4865611|P3|Overall Study|Study termination|3
1475956|NCT00640016|4865612|P2|Overall Study|Study termination|1
1475957|NCT00640016|4865613|P1|Overall Study|Study termination|2
1475958|NCT00640016|4865610|P4|Overall Study|Withdrawal by Subject|0
1475959|NCT00640016|4865611|P3|Overall Study|Withdrawal by Subject|0
1475960|NCT00640016|4865612|P2|Overall Study|Withdrawal by Subject|1
1475961|NCT00640016|4865613|P1|Overall Study|Withdrawal by Subject|0
1475962|NCT00639769|4865665|P1|Overall Study|Withdrawal by Subject|4
1475963|NCT00639769|4865665|P1|Overall Study|Disease progression|26
1475964|NCT00639769|4865665|P1|Overall Study|Lack of Efficacy|1
1475965|NCT00639769|4865665|P1|Overall Study|Adverse Event|7
1475966|NCT00639769|4865665|P1|Overall Study|Death|2
1475967|NCT00639678|4865682|P4|Overall Study|Lack of Compliance|0
1475968|NCT00639678|4865683|P3|Overall Study|Lack of Compliance|1
1475969|NCT00639678|4865684|P2|Overall Study|Lack of Compliance|0
1475970|NCT00639678|4865685|P1|Overall Study|Lack of Compliance|0
1475971|NCT00639678|4865682|P4|Overall Study|Adverse Event|0
1475972|NCT00639678|4865683|P3|Overall Study|Adverse Event|0
1475973|NCT00639678|4865684|P2|Overall Study|Adverse Event|1
1475974|NCT00639678|4865685|P1|Overall Study|Adverse Event|0
1475975|NCT00639678|4865682|P4|Overall Study|Lost to Follow-up|0
1475976|NCT00639678|4865683|P3|Overall Study|Lost to Follow-up|6
1475977|NCT00639678|4865684|P2|Overall Study|Lost to Follow-up|0
1475978|NCT00639678|4865685|P1|Overall Study|Lost to Follow-up|1
1475979|NCT00639678|4865682|P4|Overall Study|Withdrawal by Subject|0
1475980|NCT00639678|4865683|P3|Overall Study|Withdrawal by Subject|4
1475981|NCT00639678|4865684|P2|Overall Study|Withdrawal by Subject|0
1475982|NCT00639678|4865685|P1|Overall Study|Withdrawal by Subject|3
1475983|NCT00639509|4865750|P1|Overall Study|Death|1
1475984|NCT00639457|4865758|P2|Overall Study|Withdrawal by Subject|3
1475985|NCT00639457|4865759|P1|Overall Study|Withdrawal by Subject|2
1475986|NCT00639379|4865818|P2|Period 1 - 2 Weeks|lens issue|0
1475987|NCT00639379|4865819|P1|Period 1 - 2 Weeks|lens issue|3
1475988|NCT00639379|4865818|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
1475989|NCT00639379|4865819|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
1475990|NCT00639223|4865835|P2|Overall Study|Lost to Follow-up|2
1475991|NCT00639223|4865836|P1|Overall Study|Lost to Follow-up|0
1475992|NCT00639002|4865876|P1|Overall Study|Lack of Efficacy|1
1475993|NCT00639002|4865876|P1|Overall Study|Physician Decision|6
1475994|NCT00639002|4865876|P1|Overall Study|Disease progression|3
1475995|NCT00639002|4865876|P1|Overall Study|Protocol Violation|1
1475996|NCT00639002|4865876|P1|Overall Study|Adverse Event|1
1475997|NCT00639002|4865876|P1|Overall Study|Death|1
1475998|NCT00638989|4865885|P3|Overall Study|Lost to Follow-up|1
1475999|NCT00638989|4865886|P2|Overall Study|Lost to Follow-up|0
1476000|NCT00638989|4865887|P1|Overall Study|Lost to Follow-up|0
1476001|NCT00638963|4865927|P2|Overall Study|Withdrawal by Subject|0
1476002|NCT00638963|4865928|P1|Overall Study|Withdrawal by Subject|1
1476003|NCT00638846|4865969|P2|Overall Study|lens issue|3
1476004|NCT00638846|4865970|P1|Overall Study|lens issue|1
1476005|NCT00638846|4865969|P2|Overall Study|Lost to Follow-up|2
1476006|NCT00638846|4865970|P1|Overall Study|Lost to Follow-up|3
1476007|NCT00638846|4865969|P2|Overall Study|Adverse Event|1
1476008|NCT00638846|4865970|P1|Overall Study|Adverse Event|0
1476009|NCT00638690|4866014|P2|Overall Study|Lost to Follow-up|2
1476010|NCT00638690|4866015|P1|Overall Study|Lost to Follow-up|4
1476011|NCT00638690|4866014|P2|Overall Study|Withdrawal by Subject|5
1476012|NCT00638690|4866015|P1|Overall Study|Withdrawal by Subject|22
1476013|NCT00638690|4866014|P2|Overall Study|Death|335
1476014|NCT00638690|4866015|P1|Overall Study|Death|655
1476015|NCT00638508|4866035|P2|Overall Study|Physician Decision|2
1476016|NCT00638508|4866036|P1|Overall Study|Physician Decision|5
1476017|NCT00638443|4866080|P2|First Intervention|Adverse Event|1
1476018|NCT00638443|4866081|P1|First Intervention|Adverse Event|2
1476019|NCT00638404|4866111|P2|Overall Study|Physician Decision|0
1476020|NCT00638404|4866112|P1|Overall Study|Physician Decision|8
1476021|NCT00638378|4866124|P1|Overall Study|Physician Decision|4
1476022|NCT00638378|4866124|P1|Overall Study|Disease progression|15
1476023|NCT00638378|4866124|P1|Overall Study|Adverse Event|1
1476024|NCT00638378|4866124|P1|Overall Study|Death|2
1476025|NCT00638235|4866153|P9|Overall Study|Lost to Follow-up|18
1476026|NCT00638235|4866154|P8|Overall Study|Lost to Follow-up|1
1476027|NCT00638235|4866155|P7|Overall Study|Lost to Follow-up|0
1476028|NCT00638235|4866156|P6|Overall Study|Lost to Follow-up|26
1476029|NCT00638235|4866157|P5|Overall Study|Lost to Follow-up|13
1476030|NCT00638235|4866158|P4|Overall Study|Lost to Follow-up|10
1476031|NCT00638235|4866159|P3|Overall Study|Lost to Follow-up|18
1476032|NCT00638235|4866160|P2|Overall Study|Lost to Follow-up|3
1476033|NCT00638235|4866161|P1|Overall Study|Lost to Follow-up|31
1476034|NCT00638183|4866571|P1|Overall Study|Other reason not defined above|27
1476035|NCT00638183|4866571|P1|Overall Study|Lost to Follow-up|46
1476036|NCT00638183|4866571|P1|Overall Study|Physician Decision|9
1476037|NCT00638183|4866571|P1|Overall Study|Lack of Efficacy|14
1476038|NCT00638183|4866571|P1|Overall Study|Adverse Event|23
1476039|NCT00638157|4866580|P2|Overall Study|Randomized, not treated|0
1476040|NCT00638157|4866581|P1|Overall Study|Randomized, not treated|2
1476041|NCT00638157|4866580|P2|Overall Study|Not Specified|2
1476042|NCT00638157|4866581|P1|Overall Study|Not Specified|1
1476043|NCT00638157|4866580|P2|Overall Study|Physician Decision|0
1476044|NCT00638157|4866581|P1|Overall Study|Physician Decision|1
1476045|NCT00638157|4866580|P2|Overall Study|Lost to Follow-up|0
1476046|NCT00638157|4866581|P1|Overall Study|Lost to Follow-up|1
1476047|NCT00638157|4866580|P2|Overall Study|Microbiological failure|0
1476048|NCT00638157|4866581|P1|Overall Study|Microbiological failure|1
1476049|NCT00638157|4866580|P2|Overall Study|Clinical (symptomatic) failure|1
1476050|NCT00638157|4866581|P1|Overall Study|Clinical (symptomatic) failure|1
1476051|NCT00638157|4866580|P2|Overall Study|Adverse Event|1
1476052|NCT00638157|4866581|P1|Overall Study|Adverse Event|0
1476053|NCT00638027|4866591|P2|Overall Study|Adverse Event|2
1476054|NCT00638027|4866592|P1|Overall Study|Adverse Event|0
1476055|NCT00637806|4866639|P4|Extension Phase|Study Discontinued|1
1476056|NCT00637806|4866640|P3|Extension Phase|Study Discontinued|0
1476057|NCT00637806|4866641|P2|Extension Phase|Study Discontinued|0
1476058|NCT00637806|4866642|P1|Extension Phase|Study Discontinued|0
1476059|NCT00637806|4866639|P4|Double-blind Phase|Study Discontinued|0
1476060|NCT00637806|4866640|P3|Double-blind Phase|Study Discontinued|1
1476061|NCT00637806|4866641|P2|Double-blind Phase|Study Discontinued|0
1476062|NCT00637806|4866642|P1|Double-blind Phase|Study Discontinued|2
1476063|NCT00637728|4866677|P3|Double-blind Phase|Study Discontinued|0
1476064|NCT00637728|4866678|P2|Double-blind Phase|Study Discontinued|1
1476065|NCT00637728|4866679|P1|Double-blind Phase|Study Discontinued|1
1476066|NCT00637728|4866677|P3|Double-blind Phase|Non-compliance|0
1476067|NCT00637728|4866678|P2|Double-blind Phase|Non-compliance|0
1476068|NCT00637728|4866679|P1|Double-blind Phase|Non-compliance|2
1476069|NCT00637728|4866677|P3|Double-blind Phase|Adverse Event|0
1476070|NCT00637728|4866678|P2|Double-blind Phase|Adverse Event|0
1476071|NCT00637728|4866679|P1|Double-blind Phase|Adverse Event|1
1476072|NCT00637572|4866694|P2|Overall Study|Illicit Drug Use|0
1476073|NCT00637572|4866695|P1|Overall Study|Illicit Drug Use|1
1476074|NCT00637572|4866694|P2|Overall Study|Withdrawal by Subject|2
1476075|NCT00637572|4866695|P1|Overall Study|Withdrawal by Subject|0
1476076|NCT00637572|4866694|P2|Overall Study|Physician Decision|1
1476077|NCT00637572|4866695|P1|Overall Study|Physician Decision|1
1476078|NCT00637572|4866694|P2|Overall Study|Lost to Follow-up|1
1476079|NCT00637572|4866695|P1|Overall Study|Lost to Follow-up|0
1476080|NCT00637572|4866694|P2|Overall Study|Death|1
1476081|NCT00637572|4866695|P1|Overall Study|Death|0
1476082|NCT00637572|4866694|P2|Overall Study|Adverse Event|2
1476083|NCT00637572|4866695|P1|Overall Study|Adverse Event|1
1476084|NCT00637416|4866734|P2|Overall Study|Unable to take study drug|1
1476085|NCT00637416|4866735|P1|Overall Study|Unable to take study drug|0
1476086|NCT00637416|4866734|P2|Overall Study|Lost to Follow-up|1
1476087|NCT00637416|4866735|P1|Overall Study|Lost to Follow-up|1
1476088|NCT00637377|4866745|P4|Overall Study|Other (no further information available)|5
1476089|NCT00637377|4866746|P3|Overall Study|Other (no further information available)|10
1476090|NCT00637377|4866747|P2|Overall Study|Other (no further information available)|6
1476091|NCT00637377|4866748|P1|Overall Study|Other (no further information available)|7
1476092|NCT00637377|4866745|P4|Overall Study|Withdrawal by Subject|11
1476093|NCT00637377|4866746|P3|Overall Study|Withdrawal by Subject|13
1476094|NCT00637377|4866747|P2|Overall Study|Withdrawal by Subject|15
1476095|NCT00637377|4866748|P1|Overall Study|Withdrawal by Subject|11
1476096|NCT00637377|4866745|P4|Overall Study|Protocol Violation|0
1476097|NCT00637377|4866746|P3|Overall Study|Protocol Violation|1
1476098|NCT00637377|4866747|P2|Overall Study|Protocol Violation|1
1476099|NCT00637377|4866748|P1|Overall Study|Protocol Violation|2
1476100|NCT00637377|4866745|P4|Overall Study|Lost to Follow-up|2
1476101|NCT00637377|4866746|P3|Overall Study|Lost to Follow-up|2
1476102|NCT00637377|4866747|P2|Overall Study|Lost to Follow-up|1
1476103|NCT00637377|4866748|P1|Overall Study|Lost to Follow-up|4
1476104|NCT00637377|4866745|P4|Overall Study|Lack of Efficacy|1
1476105|NCT00637377|4866746|P3|Overall Study|Lack of Efficacy|1
1476106|NCT00637377|4866747|P2|Overall Study|Lack of Efficacy|0
1476107|NCT00637377|4866748|P1|Overall Study|Lack of Efficacy|0
1476108|NCT00637377|4866745|P4|Overall Study|Death|1
1476109|NCT00637377|4866746|P3|Overall Study|Death|2
1476110|NCT00637377|4866747|P2|Overall Study|Death|3
1476111|NCT00637377|4866748|P1|Overall Study|Death|1
1476112|NCT00637377|4866745|P4|Overall Study|Adverse Event|9
1476113|NCT00637377|4866746|P3|Overall Study|Adverse Event|8
1476114|NCT00637377|4866747|P2|Overall Study|Adverse Event|6
1476115|NCT00637377|4866748|P1|Overall Study|Adverse Event|2
1476116|NCT00637273|4866797|P3|Overall Study|Loss of Glucose Control|1
1476117|NCT00637273|4866798|P2|Overall Study|Loss of Glucose Control|1
1476118|NCT00637273|4866799|P1|Overall Study|Loss of Glucose Control|1
1476119|NCT00637273|4866797|P3|Overall Study|Administrative|0
1476120|NCT00637273|4866798|P2|Overall Study|Administrative|0
1476121|NCT00637273|4866799|P1|Overall Study|Administrative|2
1476122|NCT00637273|4866797|P3|Overall Study|Investigator Decision|1
1476123|NCT00637273|4866798|P2|Overall Study|Investigator Decision|3
1476124|NCT00637273|4866799|P1|Overall Study|Investigator Decision|1
1476125|NCT00637273|4866797|P3|Overall Study|Withdrawal of Consent|18
1476126|NCT00637273|4866798|P2|Overall Study|Withdrawal of Consent|6
1476127|NCT00637273|4866799|P1|Overall Study|Withdrawal of Consent|18
1476128|NCT00637273|4866797|P3|Overall Study|Protocol Violation|1
1476129|NCT00637273|4866798|P2|Overall Study|Protocol Violation|4
1476130|NCT00637273|4866799|P1|Overall Study|Protocol Violation|2
1476131|NCT00637273|4866797|P3|Overall Study|Lost to Follow-up|13
1476132|NCT00637273|4866798|P2|Overall Study|Lost to Follow-up|9
1476133|NCT00637273|4866799|P1|Overall Study|Lost to Follow-up|8
1476134|NCT00637273|4866797|P3|Overall Study|Adverse Event|7
1476135|NCT00637273|4866798|P2|Overall Study|Adverse Event|5
1476136|NCT00637273|4866799|P1|Overall Study|Adverse Event|11
1476137|NCT00637195|4866855|P2|Overall Study|Withdrawal by Subject|1
1476138|NCT00637195|4866856|P1|Overall Study|Withdrawal by Subject|0
1476139|NCT00637195|4866855|P2|Overall Study|Other|0
1476140|NCT00637195|4866856|P1|Overall Study|Other|2
1476141|NCT00637195|4866855|P2|Overall Study|Lost to Follow-up|0
1476142|NCT00637195|4866856|P1|Overall Study|Lost to Follow-up|1
1476143|NCT00637156|4866892|P2|Overall Study|Lost to Follow-up|16
1476144|NCT00637156|4866893|P1|Overall Study|Lost to Follow-up|10
1476145|NCT00637156|4866892|P2|Overall Study|Death|1
1476146|NCT00637156|4866893|P1|Overall Study|Death|0
1476147|NCT00637156|4866892|P2|Overall Study|Withdrawal by Subject|7
1476148|NCT00637156|4866893|P1|Overall Study|Withdrawal by Subject|0
1476149|NCT00637000|4866935|P2|Overall Study|Withdrawal by Subject|3
1476150|NCT00637000|4866936|P1|Overall Study|Withdrawal by Subject|4
1476151|NCT00636987|4866976|P1|Overall Study|5 year visit window not complete|69
1476152|NCT00636987|4866976|P1|Overall Study|Lost to Follow-up|63
1476153|NCT00636987|4866976|P1|Overall Study|Explanted|13
1476154|NCT00636987|4866976|P1|Overall Study|Death|44
1476155|NCT00636961|4866986|P2|Period 2|Adverse Event|0
1476156|NCT00636961|4866987|P1|Period 2|Adverse Event|1
1476157|NCT00636961|4866986|P2|Period 1|Administrative problems|1
1476158|NCT00636961|4866987|P1|Period 1|Administrative problems|1
1476159|NCT00636818|4867001|P1|Overall Study|Withdrawal by Subject|4
1476160|NCT00636818|4867001|P1|Overall Study|Protocol Violation|1
1476161|NCT00636818|4867001|P1|Overall Study|Entry Criteria Exclusion|3
1476162|NCT00636818|4867001|P1|Overall Study|Lost to Follow-up|2
1476163|NCT00636818|4867001|P1|Overall Study|Adverse Event|1
1476164|NCT00636792|4867026|P1|Overall Study|Other|3
1476165|NCT00636792|4867026|P1|Overall Study|Withdrawal by Subject|3
1476166|NCT00636792|4867026|P1|Overall Study|Progressive Disease|4
1476167|NCT00636792|4867026|P1|Overall Study|Physician Decision|7
1476168|NCT00636792|4867026|P1|Overall Study|Adverse Event|16
1476169|NCT00636636|4867073|P2|Overall Study|Withdrawal by Subject|9
1476170|NCT00636636|4867074|P1|Overall Study|Withdrawal by Subject|4
1476171|NCT00636636|4867073|P2|Overall Study|Death|1
1476172|NCT00636636|4867074|P1|Overall Study|Death|0
1476173|NCT00636636|4867073|P2|Overall Study|Lost to Follow-up|1
1476174|NCT00636636|4867074|P1|Overall Study|Lost to Follow-up|0
1476175|NCT00636636|4867073|P2|Overall Study|Protocol Violation|2
1476176|NCT00636636|4867074|P1|Overall Study|Protocol Violation|2
1476177|NCT00636636|4867073|P2|Overall Study|Lack of Efficacy|12
1476178|NCT00636636|4867074|P1|Overall Study|Lack of Efficacy|7
1476179|NCT00636636|4867073|P2|Overall Study|Adverse Event|8
1476180|NCT00636636|4867074|P1|Overall Study|Adverse Event|19
1476181|NCT00636636|4867073|P2|Overall Study|Other reason|6
1476182|NCT00636636|4867074|P1|Overall Study|Other reason|4
1476183|NCT00636610|4867090|P2|Overall Study|Reason for discontinuation not available|2
1476184|NCT00636610|4867091|P1|Overall Study|Reason for discontinuation not available|3
1476185|NCT00636610|4867090|P2|Overall Study|Disease progression - clinical|3
1476186|NCT00636610|4867091|P1|Overall Study|Disease progression - clinical|8
1476187|NCT00636610|4867090|P2|Overall Study|Disease progression - radiographic|51
1476188|NCT00636610|4867091|P1|Overall Study|Disease progression - radiographic|41
1476189|NCT00636610|4867090|P2|Overall Study|Subject decision to withdraw|11
1476190|NCT00636610|4867091|P1|Overall Study|Subject decision to withdraw|15
1476191|NCT00636610|4867090|P2|Overall Study|Physician decision to withdraw patient|9
1476192|NCT00636610|4867091|P1|Overall Study|Physician decision to withdraw patient|15
1476193|NCT00636610|4867090|P2|Overall Study|Death|3
1476194|NCT00636610|4867091|P1|Overall Study|Death|6
1476195|NCT00636610|4867090|P2|Overall Study|Adverse Event|4
1476196|NCT00636610|4867091|P1|Overall Study|Adverse Event|4
1476197|NCT00636441|4867108|P7|Overall Study|Screen Failure|17
1476198|NCT00636441|4867109|P6|Overall Study|Screen Failure|0
1476199|NCT00636441|4867110|P5|Overall Study|Screen Failure|0
1476200|NCT00636441|4867111|P4|Overall Study|Screen Failure|0
1476201|NCT00636441|4867112|P3|Overall Study|Screen Failure|0
1476202|NCT00636441|4867113|P2|Overall Study|Screen Failure|0
1476203|NCT00636441|4867114|P1|Overall Study|Screen Failure|0
1476204|NCT00636441|4867108|P7|Overall Study|Late, ineligible|1
1476205|NCT00636441|4867109|P6|Overall Study|Late, ineligible|0
1476206|NCT00636441|4867110|P5|Overall Study|Late, ineligible|0
1476207|NCT00636441|4867111|P4|Overall Study|Late, ineligible|0
1476208|NCT00636441|4867112|P3|Overall Study|Late, ineligible|0
1476209|NCT00636441|4867113|P2|Overall Study|Late, ineligible|0
1476210|NCT00636441|4867114|P1|Overall Study|Late, ineligible|0
1476211|NCT00636441|4867108|P7|Overall Study|Adverse Event|0
1476212|NCT00636441|4867109|P6|Overall Study|Adverse Event|1
1476213|NCT00636441|4867110|P5|Overall Study|Adverse Event|0
1476214|NCT00636441|4867111|P4|Overall Study|Adverse Event|0
1476215|NCT00636441|4867112|P3|Overall Study|Adverse Event|1
1476216|NCT00636441|4867113|P2|Overall Study|Adverse Event|1
1476217|NCT00636441|4867114|P1|Overall Study|Adverse Event|0
1476218|NCT00636363|4867157|P3|Overall Study|Withdrawal by Subject|2
1476219|NCT00636363|4867158|P2|Overall Study|Withdrawal by Subject|3
1476220|NCT00636363|4867159|P1|Overall Study|Withdrawal by Subject|1
1476221|NCT00636363|4867157|P3|Overall Study|Lost to Follow-up|2
1476222|NCT00636363|4867158|P2|Overall Study|Lost to Follow-up|4
1476223|NCT00636363|4867159|P1|Overall Study|Lost to Follow-up|3
1476224|NCT00636363|4867157|P3|Overall Study|Protocol Violation|0
1476225|NCT00636363|4867158|P2|Overall Study|Protocol Violation|3
1476226|NCT00636363|4867159|P1|Overall Study|Protocol Violation|0
1476227|NCT00636363|4867157|P3|Overall Study|Lack of motivation|1
1476228|NCT00636363|4867158|P2|Overall Study|Lack of motivation|0
1476229|NCT00636363|4867159|P1|Overall Study|Lack of motivation|1
1476230|NCT00636363|4867157|P3|Overall Study|Missed > 1 visit|3
1476231|NCT00636363|4867158|P2|Overall Study|Missed > 1 visit|1
1476232|NCT00636363|4867159|P1|Overall Study|Missed > 1 visit|0
1476233|NCT00636363|4867157|P3|Overall Study|Met ineligibility criteria|3
1476234|NCT00636363|4867158|P2|Overall Study|Met ineligibility criteria|0
1476235|NCT00636363|4867159|P1|Overall Study|Met ineligibility criteria|0
1476236|NCT00636363|4867157|P3|Overall Study|Study related symptoms/complaints|4
1476237|NCT00636363|4867158|P2|Overall Study|Study related symptoms/complaints|7
1476238|NCT00636363|4867159|P1|Overall Study|Study related symptoms/complaints|8
1476239|NCT00636363|4867157|P3|Overall Study|Positive slit lamp finding|1
1476240|NCT00636363|4867158|P2|Overall Study|Positive slit lamp finding|2
1476241|NCT00636363|4867159|P1|Overall Study|Positive slit lamp finding|0
1476242|NCT00636363|4867157|P3|Overall Study|Adverse Event|1
1476243|NCT00636363|4867158|P2|Overall Study|Adverse Event|0
1476244|NCT00636363|4867159|P1|Overall Study|Adverse Event|0
1476245|NCT00636363|4867157|P3|Overall Study|Conjunctivitis|1
1476246|NCT00636363|4867158|P2|Overall Study|Conjunctivitis|0
1476247|NCT00636363|4867159|P1|Overall Study|Conjunctivitis|0
1476248|NCT00636207|4867180|P7|Overall Study|Withdrawal by Subject|0
1476249|NCT00636207|4867181|P6|Overall Study|Withdrawal by Subject|0
1476250|NCT00636207|4867182|P5|Overall Study|Withdrawal by Subject|1
1476251|NCT00636207|4867183|P4|Overall Study|Withdrawal by Subject|0
1476252|NCT00636207|4867184|P3|Overall Study|Withdrawal by Subject|0
1476253|NCT00636207|4867185|P2|Overall Study|Withdrawal by Subject|1
1476254|NCT00636207|4867186|P1|Overall Study|Withdrawal by Subject|0
1476255|NCT00636207|4867180|P7|Overall Study|Adverse Event|0
1476256|NCT00636207|4867181|P6|Overall Study|Adverse Event|0
1476257|NCT00636207|4867182|P5|Overall Study|Adverse Event|0
1476258|NCT00636207|4867183|P4|Overall Study|Adverse Event|0
1476259|NCT00636207|4867184|P3|Overall Study|Adverse Event|0
1476260|NCT00636207|4867185|P2|Overall Study|Adverse Event|0
1476261|NCT00636207|4867186|P1|Overall Study|Adverse Event|1
1476262|NCT00636194|4867250|P2|Overall Study|Protocol Violation|0
1476263|NCT00636194|4867251|P1|Overall Study|Protocol Violation|2
1476264|NCT00636194|4867250|P2|Overall Study|Study related symptoms and complaints|0
1476265|NCT00636194|4867251|P1|Overall Study|Study related symptoms and complaints|1
1476266|NCT00636168|4867263|P2|Treated With Study Drug|Still remains on treatment|94
1476267|NCT00636168|4867264|P1|Treated With Study Drug|Still remains on treatment|48
1476268|NCT00636168|4867263|P2|Treated With Study Drug|non-specified|1
1476269|NCT00636168|4867264|P1|Treated With Study Drug|non-specified|1
1476270|NCT00636168|4867263|P2|Treated With Study Drug|No longer meets criteria|0
1476271|NCT00636168|4867264|P1|Treated With Study Drug|No longer meets criteria|1
1476272|NCT00636168|4867263|P2|Treated With Study Drug|Pregnancy|0
1476273|NCT00636168|4867264|P1|Treated With Study Drug|Pregnancy|1
1476274|NCT00636168|4867263|P2|Treated With Study Drug|Death|0
1476275|NCT00636168|4867264|P1|Treated With Study Drug|Death|3
1476276|NCT00636168|4867263|P2|Treated With Study Drug|Poor or non-compliance|3
1476277|NCT00636168|4867264|P1|Treated With Study Drug|Poor or non-compliance|1
1476278|NCT00636168|4867263|P2|Treated With Study Drug|Withdrawal by Subject|20
1476279|NCT00636168|4867264|P1|Treated With Study Drug|Withdrawal by Subject|16
1476280|NCT00636168|4867263|P2|Treated With Study Drug|Adverse Event|20
1476281|NCT00636168|4867264|P1|Treated With Study Drug|Adverse Event|244
1476282|NCT00636168|4867263|P2|Treated With Study Drug|Recurrence of disease|273
1476283|NCT00636168|4867264|P1|Treated With Study Drug|Recurrence of disease|132
1476284|NCT00636168|4867263|P2|Randomized to Study Drug|No longer met study criteria|0
1476285|NCT00636168|4867264|P1|Randomized to Study Drug|No longer met study criteria|1
1476286|NCT00636168|4867263|P2|Randomized to Study Drug|Adverse Event|0
1476287|NCT00636168|4867264|P1|Randomized to Study Drug|Adverse Event|1
1476288|NCT00636168|4867263|P2|Randomized to Study Drug|Withdrawal by Subject|2
1476289|NCT00636168|4867264|P1|Randomized to Study Drug|Withdrawal by Subject|2
1476290|NCT00636155|4867284|P1|Overall Study|Physician Decision|5
1476291|NCT00636155|4867284|P1|Overall Study|Stem cell transplant|1
1476292|NCT00636155|4867284|P1|Overall Study|Withdrawal by Subject|3
1476293|NCT00636155|4867284|P1|Overall Study|Lack of Efficacy|1
1476294|NCT00636155|4867284|P1|Overall Study|Adverse Event|8
1476295|NCT00635999|4867326|P3|Overall Study|Withdrawal by Subject|1
1476296|NCT00635999|4867327|P2|Overall Study|Withdrawal by Subject|2
1476297|NCT00635999|4867328|P1|Overall Study|Withdrawal by Subject|4
1476298|NCT00635882|4867345|P6|Overall Study|Protocol Violation|0
1476299|NCT00635882|4867346|P5|Overall Study|Protocol Violation|0
1476300|NCT00635882|4867347|P4|Overall Study|Protocol Violation|0
1476301|NCT00635882|4867348|P3|Overall Study|Protocol Violation|0
1476302|NCT00635882|4867349|P2|Overall Study|Protocol Violation|0
1476303|NCT00635882|4867350|P1|Overall Study|Protocol Violation|1
1476304|NCT00635804|4867480|P8|Overall Study|Withdrawal by Subject|0
1476305|NCT00635804|4867481|P7|Overall Study|Withdrawal by Subject|0
1476306|NCT00635804|4867482|P6|Overall Study|Withdrawal by Subject|0
1476307|NCT00635804|4867483|P5|Overall Study|Withdrawal by Subject|0
1476308|NCT00635804|4867484|P4|Overall Study|Withdrawal by Subject|0
1476309|NCT00635804|4867485|P3|Overall Study|Withdrawal by Subject|0
1476310|NCT00635804|4867486|P2|Overall Study|Withdrawal by Subject|0
1476311|NCT00635804|4867487|P1|Overall Study|Withdrawal by Subject|1
1476312|NCT00635804|4867480|P8|Overall Study|Adverse Event|0
1476313|NCT00635804|4867481|P7|Overall Study|Adverse Event|0
1476314|NCT00635804|4867482|P6|Overall Study|Adverse Event|1
1476315|NCT00635804|4867483|P5|Overall Study|Adverse Event|0
1476316|NCT00635804|4867484|P4|Overall Study|Adverse Event|0
1476317|NCT00635804|4867485|P3|Overall Study|Adverse Event|0
1476318|NCT00635804|4867486|P2|Overall Study|Adverse Event|0
1476319|NCT00635804|4867487|P1|Overall Study|Adverse Event|0
1476320|NCT00635661|4867593|P1|Overall Study|Withdrawal by Subject|4
1476321|NCT00635648|4867597|P1|Overall Study|Other reason|2
1476322|NCT00635648|4867597|P1|Overall Study|Noncompliance with protocol|1
1476323|NCT00635648|4867597|P1|Overall Study|No improvement after 7-10 days treatment|4
1476324|NCT00635648|4867597|P1|Overall Study|Use of other antifungal agent needed|1
1476325|NCT00635648|4867597|P1|Overall Study|Rapid progression of baseline disease|4
1476326|NCT00635648|4867597|P1|Overall Study|Physician Decision|4
1476327|NCT00635648|4867597|P1|Overall Study|Withdrawal by Subject|9
1476328|NCT00635648|4867597|P1|Overall Study|Adverse Event|12
1476329|NCT00635570|4867619|P2|Overall Study|Early termination(No sexual activity)|1
1476330|NCT00635570|4867620|P1|Overall Study|Early termination(No sexual activity)|1
1476331|NCT00635570|4867619|P2|Overall Study|Did not complete survey|1
1476332|NCT00635570|4867620|P1|Overall Study|Did not complete survey|2
1476333|NCT00635570|4867619|P2|Overall Study|Physician Decision|0
1476334|NCT00635570|4867620|P1|Overall Study|Physician Decision|1
1476335|NCT00635570|4867619|P2|Overall Study|Adverse Event|0
1476336|NCT00635570|4867620|P1|Overall Study|Adverse Event|2
1476337|NCT00635570|4867619|P2|Overall Study|Withdrawal by Subject|1
1476338|NCT00635570|4867620|P1|Overall Study|Withdrawal by Subject|1
1476339|NCT00635570|4867619|P2|Overall Study|Lost to Follow-up|8
1476340|NCT00635570|4867620|P1|Overall Study|Lost to Follow-up|8
1476341|NCT00635492|4867634|P2|Overall Study|Withdrawal by Subject|45
1476342|NCT00635492|4867635|P1|Overall Study|Withdrawal by Subject|82
1476343|NCT00635492|4867634|P2|Overall Study|Sponsor decision|3
1476344|NCT00635492|4867635|P1|Overall Study|Sponsor decision|2
1476345|NCT00635492|4867634|P2|Overall Study|Physician Decision|22
1476346|NCT00635492|4867635|P1|Overall Study|Physician Decision|32
1476347|NCT00635492|4867634|P2|Overall Study|Lost to Follow-up|172
1476348|NCT00635492|4867635|P1|Overall Study|Lost to Follow-up|151
1476349|NCT00635492|4867634|P2|Overall Study|Death|40
1476350|NCT00635492|4867635|P1|Overall Study|Death|12
1476351|NCT00635427|4867693|P5|Overall Study|Withdrawal Of Consent|2
1476352|NCT00635427|4867694|P4|Overall Study|Withdrawal Of Consent|2
1476353|NCT00635427|4867695|P3|Overall Study|Withdrawal Of Consent|0
1476354|NCT00635427|4867696|P2|Overall Study|Withdrawal Of Consent|0
1476355|NCT00635427|4867697|P1|Overall Study|Withdrawal Of Consent|0
1476356|NCT00635427|4867693|P5|Overall Study|Termination Of Study By Sponsor|6
1476357|NCT00635427|4867694|P4|Overall Study|Termination Of Study By Sponsor|6
1476358|NCT00635427|4867695|P3|Overall Study|Termination Of Study By Sponsor|10
1476359|NCT00635427|4867696|P2|Overall Study|Termination Of Study By Sponsor|6
1476360|NCT00635427|4867697|P1|Overall Study|Termination Of Study By Sponsor|12
1476361|NCT00635427|4867693|P5|Overall Study|Death|0
1476362|NCT00635427|4867694|P4|Overall Study|Death|1
1476363|NCT00635427|4867695|P3|Overall Study|Death|0
1476364|NCT00635427|4867696|P2|Overall Study|Death|0
1476365|NCT00635427|4867697|P1|Overall Study|Death|0
1476366|NCT00635427|4867693|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
1476367|NCT00635427|4867694|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
1476368|NCT00635427|4867695|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
1476369|NCT00635427|4867696|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
1476370|NCT00635427|4867697|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
1476371|NCT00635349|4867736|P2|Overall Study|Adverse Event|9
1476372|NCT00635349|4867737|P1|Overall Study|Adverse Event|11
1476373|NCT00635349|4867736|P2|Overall Study|Lost to Follow-up|3
1476374|NCT00635349|4867737|P1|Overall Study|Lost to Follow-up|4
1476375|NCT00635349|4867736|P2|Overall Study|Withdrawal by Subject|8
1476376|NCT00635349|4867737|P1|Overall Study|Withdrawal by Subject|3
1476377|NCT00635349|4867736|P2|Overall Study|Protocol Violation|22
1476378|NCT00635349|4867737|P1|Overall Study|Protocol Violation|18
1476379|NCT00635349|4867736|P2|Overall Study|Other|6
1476380|NCT00635349|4867737|P1|Overall Study|Other|8
1476381|NCT00635219|4867791|P5|Overall Study|Administrative or Other Reasons|1
1476382|NCT00635219|4867792|P4|Overall Study|Administrative or Other Reasons|0
1476383|NCT00635219|4867793|P3|Overall Study|Administrative or Other Reasons|1
1476384|NCT00635219|4867794|P2|Overall Study|Administrative or Other Reasons|1
1476385|NCT00635219|4867795|P1|Overall Study|Administrative or Other Reasons|0
1476386|NCT00635219|4867791|P5|Overall Study|Lost to Follow-up|3
1476387|NCT00635219|4867792|P4|Overall Study|Lost to Follow-up|0
1476388|NCT00635219|4867793|P3|Overall Study|Lost to Follow-up|2
1476389|NCT00635219|4867794|P2|Overall Study|Lost to Follow-up|0
1476390|NCT00635219|4867795|P1|Overall Study|Lost to Follow-up|0
1476391|NCT00635219|4867791|P5|Overall Study|Withdrawal of Consent|8
1476392|NCT00635219|4867792|P4|Overall Study|Withdrawal of Consent|11
1476393|NCT00635219|4867793|P3|Overall Study|Withdrawal of Consent|8
1476394|NCT00635219|4867794|P2|Overall Study|Withdrawal of Consent|6
1476395|NCT00635219|4867795|P1|Overall Study|Withdrawal of Consent|8
1476396|NCT00635219|4867791|P5|Overall Study|Protocol Violation|4
1476397|NCT00635219|4867792|P4|Overall Study|Protocol Violation|2
1476398|NCT00635219|4867793|P3|Overall Study|Protocol Violation|3
1476399|NCT00635219|4867794|P2|Overall Study|Protocol Violation|2
1476400|NCT00635219|4867795|P1|Overall Study|Protocol Violation|0
1476401|NCT00635219|4867791|P5|Overall Study|Non-compliance With Study Product|1
1476402|NCT00635219|4867792|P4|Overall Study|Non-compliance With Study Product|2
1476403|NCT00635219|4867793|P3|Overall Study|Non-compliance With Study Product|0
1476404|NCT00635219|4867794|P2|Overall Study|Non-compliance With Study Product|0
1476405|NCT00635219|4867795|P1|Overall Study|Non-compliance With Study Product|0
1476406|NCT00635219|4867791|P5|Overall Study|Lack of Efficacy|6
1476407|NCT00635219|4867792|P4|Overall Study|Lack of Efficacy|4
1476408|NCT00635219|4867793|P3|Overall Study|Lack of Efficacy|3
1476409|NCT00635219|4867794|P2|Overall Study|Lack of Efficacy|6
1476410|NCT00635219|4867795|P1|Overall Study|Lack of Efficacy|5
1476411|NCT00635219|4867791|P5|Overall Study|Adverse Event|19
1476412|NCT00635219|4867792|P4|Overall Study|Adverse Event|15
1476413|NCT00635219|4867793|P3|Overall Study|Adverse Event|18
1476414|NCT00635219|4867794|P2|Overall Study|Adverse Event|10
1476415|NCT00635219|4867795|P1|Overall Study|Adverse Event|12
1476416|NCT00635154|4867858|P1|Overall Study|Still on treatment|21
1476417|NCT00635154|4867858|P1|Overall Study|Other|4
1476418|NCT00635154|4867858|P1|Overall Study|Alternative Treatment|8
1476419|NCT00635102|4867901|P2|Overall Study|Withdrawal by Subject|8
1476420|NCT00635102|4867902|P1|Overall Study|Withdrawal by Subject|7
1476421|NCT00635089|4867996|P1|Overall Study|Not Specified|31
1476422|NCT00635089|4867996|P1|Overall Study|Lost to Follow-up|8
1476423|NCT00635089|4867996|P1|Overall Study|Protocol Deviation|4
1476424|NCT00635089|4867996|P1|Overall Study|Lack of Efficacy|28
1476425|NCT00635089|4867996|P1|Overall Study|Adverse Event|7
1476426|NCT00635050|4868023|P1|Overall Study|Withdrawal by Subject|1
1476427|NCT00635024|4868030|P1|Overall Study|Adverse Event|1
1476428|NCT00634933|4868041|P5|Part B: Week 24 to Week 52|Other|1
1476429|NCT00634933|4868042|P4|Part B: Week 24 to Week 52|Other|0
1476430|NCT00634933|4868043|P3|Part B: Week 24 to Week 52|Other|5
1476431|NCT00634933|4868044|P2|Part B: Week 24 to Week 52|Other|0
1476432|NCT00634933|4868045|P1|Part B: Week 24 to Week 52|Other|0
1476433|NCT00634933|4868041|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
1476434|NCT00634933|4868042|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
1476435|NCT00634933|4868043|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
1476436|NCT00634933|4868044|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
1476437|NCT00634933|4868045|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
1476438|NCT00634933|4868041|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
1476439|NCT00634933|4868042|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
1476440|NCT00634933|4868043|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
1476441|NCT00634933|4868044|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
1476442|NCT00634933|4868045|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
1476443|NCT00634933|4868041|P5|Part B: Week 24 to Week 52|Protocol Violation|1
1476444|NCT00634933|4868042|P4|Part B: Week 24 to Week 52|Protocol Violation|0
1476445|NCT00634933|4868043|P3|Part B: Week 24 to Week 52|Protocol Violation|0
1476446|NCT00634933|4868044|P2|Part B: Week 24 to Week 52|Protocol Violation|0
1476447|NCT00634933|4868045|P1|Part B: Week 24 to Week 52|Protocol Violation|0
1476448|NCT00634933|4868041|P5|Part B: Week 24 to Week 52|Physician Decision|0
1476449|NCT00634933|4868042|P4|Part B: Week 24 to Week 52|Physician Decision|0
1476450|NCT00634933|4868043|P3|Part B: Week 24 to Week 52|Physician Decision|1
1476451|NCT00634933|4868044|P2|Part B: Week 24 to Week 52|Physician Decision|1
1476452|NCT00634933|4868045|P1|Part B: Week 24 to Week 52|Physician Decision|0
1476453|NCT00634933|4868041|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
1476454|NCT00634933|4868042|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
1476455|NCT00634933|4868043|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
1476456|NCT00634933|4868044|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
1476457|NCT00634933|4868045|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
1476458|NCT00634933|4868041|P5|Part B: Week 24 to Week 52|Adverse Event|0
1476459|NCT00634933|4868042|P4|Part B: Week 24 to Week 52|Adverse Event|1
1476460|NCT00634933|4868043|P3|Part B: Week 24 to Week 52|Adverse Event|1
1476461|NCT00634933|4868044|P2|Part B: Week 24 to Week 52|Adverse Event|1
1476462|NCT00634933|4868045|P1|Part B: Week 24 to Week 52|Adverse Event|0
1476463|NCT00634933|4868041|P5|Between Part A and Part B|Physician Decision|0
1476464|NCT00634933|4868042|P4|Between Part A and Part B|Physician Decision|0
1476465|NCT00634933|4868043|P3|Between Part A and Part B|Physician Decision|0
1476466|NCT00634933|4868044|P2|Between Part A and Part B|Physician Decision|1
1476467|NCT00634933|4868045|P1|Between Part A and Part B|Physician Decision|0
1476468|NCT00634933|4868041|P5|Part A: Baseline to Week 24|Other|0
1476469|NCT00634933|4868042|P4|Part A: Baseline to Week 24|Other|0
1476470|NCT00634933|4868043|P3|Part A: Baseline to Week 24|Other|5
1476471|NCT00634933|4868044|P2|Part A: Baseline to Week 24|Other|8
1476472|NCT00634933|4868045|P1|Part A: Baseline to Week 24|Other|1
1476473|NCT00634933|4868041|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
1476474|NCT00634933|4868042|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
1476475|NCT00634933|4868043|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
1476476|NCT00634933|4868044|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
1476477|NCT00634933|4868045|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
1476478|NCT00634933|4868041|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
1476479|NCT00634933|4868042|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
1476480|NCT00634933|4868043|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
1476481|NCT00634933|4868044|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
1476482|NCT00634933|4868045|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
1476483|NCT00634933|4868041|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
1476484|NCT00634933|4868042|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
1476485|NCT00634933|4868043|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
1476486|NCT00634933|4868044|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
1476487|NCT00634933|4868045|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
1476488|NCT00634933|4868041|P5|Part A: Baseline to Week 24|Investigator Request|0
1476489|NCT00634933|4868042|P4|Part A: Baseline to Week 24|Investigator Request|0
1476490|NCT00634933|4868043|P3|Part A: Baseline to Week 24|Investigator Request|1
1476491|NCT00634933|4868044|P2|Part A: Baseline to Week 24|Investigator Request|1
1476492|NCT00634933|4868045|P1|Part A: Baseline to Week 24|Investigator Request|1
1476493|NCT00634933|4868041|P5|Part A: Baseline to Week 24|Failed to Return|0
1476494|NCT00634933|4868042|P4|Part A: Baseline to Week 24|Failed to Return|0
1476495|NCT00634933|4868043|P3|Part A: Baseline to Week 24|Failed to Return|0
1476496|NCT00634933|4868044|P2|Part A: Baseline to Week 24|Failed to Return|0
1476497|NCT00634933|4868045|P1|Part A: Baseline to Week 24|Failed to Return|1
1476498|NCT00634933|4868041|P5|Part A: Baseline to Week 24|Death|0
1476499|NCT00634933|4868042|P4|Part A: Baseline to Week 24|Death|0
1476500|NCT00634933|4868043|P3|Part A: Baseline to Week 24|Death|0
1476501|NCT00634933|4868044|P2|Part A: Baseline to Week 24|Death|0
1476502|NCT00634933|4868045|P1|Part A: Baseline to Week 24|Death|1
1476503|NCT00634933|4868041|P5|Part A: Baseline to Week 24|Adverse Event|0
1476504|NCT00634933|4868042|P4|Part A: Baseline to Week 24|Adverse Event|0
1476505|NCT00634933|4868043|P3|Part A: Baseline to Week 24|Adverse Event|8
1476506|NCT00634933|4868044|P2|Part A: Baseline to Week 24|Adverse Event|4
1476507|NCT00634933|4868045|P1|Part A: Baseline to Week 24|Adverse Event|4
1476508|NCT00634920|4868114|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
1476509|NCT00634920|4868115|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
1476510|NCT00634920|4868116|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
1476511|NCT00634920|4868114|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
1476512|NCT00634920|4868115|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
1476513|NCT00634920|4868116|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
1476514|NCT00634920|4868114|P3|Period 2 - Post-Randomization|Death|0
1476515|NCT00634920|4868115|P2|Period 2 - Post-Randomization|Death|5
1476516|NCT00634920|4868116|P1|Period 2 - Post-Randomization|Death|2
1476517|NCT00634920|4868114|P3|Period 2 - Post-Randomization|Rejection|0
1476518|NCT00634920|4868115|P2|Period 2 - Post-Randomization|Rejection|5
1476519|NCT00634920|4868116|P1|Period 2 - Post-Randomization|Rejection|11
1476520|NCT00634920|4868114|P3|Period 2 - Post-Randomization|Adverse Event|0
1476521|NCT00634920|4868115|P2|Period 2 - Post-Randomization|Adverse Event|9
1476522|NCT00634920|4868116|P1|Period 2 - Post-Randomization|Adverse Event|37
1476523|NCT00634920|4868114|P3|Period 1 - Pre-Randomization|Other issues|6
1476524|NCT00634920|4868115|P2|Period 1 - Pre-Randomization|Other issues|0
1476525|NCT00634920|4868116|P1|Period 1 - Pre-Randomization|Other issues|0
1476526|NCT00634920|4868114|P3|Period 1 - Pre-Randomization|Non-Compliance|3
1476527|NCT00634920|4868115|P2|Period 1 - Pre-Randomization|Non-Compliance|0
1476528|NCT00634920|4868116|P1|Period 1 - Pre-Randomization|Non-Compliance|0
1476529|NCT00634920|4868114|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
1476530|NCT00634920|4868115|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
1476531|NCT00634920|4868116|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
1476532|NCT00634920|4868114|P3|Period 1 - Pre-Randomization|Rejections|55
1476533|NCT00634920|4868115|P2|Period 1 - Pre-Randomization|Rejections|0
1476534|NCT00634920|4868116|P1|Period 1 - Pre-Randomization|Rejections|0
1476535|NCT00634920|4868114|P3|Period 1 - Pre-Randomization|Wound healing problems|16
1476536|NCT00634920|4868115|P2|Period 1 - Pre-Randomization|Wound healing problems|0
1476537|NCT00634920|4868116|P1|Period 1 - Pre-Randomization|Wound healing problems|0
1476538|NCT00634920|4868114|P3|Period 1 - Pre-Randomization|Adverse Event|36
1476539|NCT00634920|4868115|P2|Period 1 - Pre-Randomization|Adverse Event|0
1476540|NCT00634920|4868116|P1|Period 1 - Pre-Randomization|Adverse Event|0
1476541|NCT00634907|4868160|P2|Overall Study|Withdrawal by Subject|8
1476542|NCT00634907|4868161|P1|Overall Study|Withdrawal by Subject|11
1476543|NCT00634907|4868160|P2|Overall Study|Physician Decision|9
1476544|NCT00634907|4868161|P1|Overall Study|Physician Decision|3
1476545|NCT00634907|4868160|P2|Overall Study|Withdrawal by Subject|0
1476546|NCT00634907|4868161|P1|Overall Study|Withdrawal by Subject|3
1476547|NCT00634842|4868185|P2|Overall Study|Subject off study drug for too long|1
1476548|NCT00634842|4868186|P1|Overall Study|Subject off study drug for too long|0
1476549|NCT00634842|4868185|P2|Overall Study|No wish to keep taking Avandia|1
1476550|NCT00634842|4868186|P1|Overall Study|No wish to keep taking Avandia|0
1476551|NCT00634842|4868185|P2|Overall Study|No need of study drug to treat diabetes|1
1476552|NCT00634842|4868186|P1|Overall Study|No need of study drug to treat diabetes|0
1476553|NCT00634842|4868185|P2|Overall Study|Discontinued due to injection|2
1476554|NCT00634842|4868186|P1|Overall Study|Discontinued due to injection|0
1476555|NCT00634842|4868185|P2|Overall Study|Lack of time and intolerance to drug|1
1476556|NCT00634842|4868186|P1|Overall Study|Lack of time and intolerance to drug|0
1476557|NCT00634842|4868185|P2|Overall Study|Withdrawal by Subject|3
1476558|NCT00634842|4868186|P1|Overall Study|Withdrawal by Subject|1
1476559|NCT00634842|4868185|P2|Overall Study|Physician Decision|0
1476560|NCT00634842|4868186|P1|Overall Study|Physician Decision|1
1476561|NCT00634842|4868185|P2|Overall Study|Lost to Follow-up|2
1476562|NCT00634842|4868186|P1|Overall Study|Lost to Follow-up|1
1476563|NCT00634842|4868185|P2|Overall Study|Inclusion criteria were not met|0
1476564|NCT00634842|4868186|P1|Overall Study|Inclusion criteria were not met|1
1476565|NCT00634842|4868185|P2|Overall Study|Move to another state|0
1476566|NCT00634842|4868186|P1|Overall Study|Move to another state|1
1476567|NCT00634842|4868185|P2|Overall Study|Protocol Violation|4
1476568|NCT00634842|4868186|P1|Overall Study|Protocol Violation|8
1476569|NCT00634842|4868185|P2|Overall Study|Adverse Event|3
1476570|NCT00634842|4868186|P1|Overall Study|Adverse Event|2
1476571|NCT00634751|4868202|P4|Pancreatic and Bilial Tract Cancer|Death|1
1476572|NCT00634751|4868203|P3|Pancreatic and Bilial Tract Cancer|Death|1
1476573|NCT00634751|4868204|P2|Pancreatic and Bilial Tract Cancer|Death|0
1476574|NCT00634751|4868205|P1|Pancreatic and Bilial Tract Cancer|Death|0
1476575|NCT00634751|4868202|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
1476576|NCT00634751|4868203|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
1476577|NCT00634751|4868204|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
1476578|NCT00634751|4868205|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
1476579|NCT00634751|4868202|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
1476580|NCT00634751|4868203|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
1476581|NCT00634751|4868204|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
1476582|NCT00634751|4868205|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
1476583|NCT00634647|4868223|P1|Overall Study|declined to participate before treatment|1
1476584|NCT00634647|4868223|P1|Overall Study|refused further treatment|3
1476585|NCT00634647|4868223|P1|Overall Study|death on study|5
1476586|NCT00634569|4868242|P2|Overall Study|Physician Decision|1
1476587|NCT00634569|4868243|P1|Overall Study|Physician Decision|0
1476588|NCT00634569|4868242|P2|Overall Study|Withdrawal by Subject|4
1476589|NCT00634569|4868243|P1|Overall Study|Withdrawal by Subject|0
1476590|NCT00634543|4868257|P2|Overall Study|Lost to Follow-up|1
1476591|NCT00634543|4868258|P1|Overall Study|Lost to Follow-up|0
1476592|NCT00634543|4868257|P2|Overall Study|Withdrawal by Subject|4
1476593|NCT00634543|4868258|P1|Overall Study|Withdrawal by Subject|4
1476594|NCT00634543|4868257|P2|Overall Study|Adverse Event|11
1476595|NCT00634543|4868258|P1|Overall Study|Adverse Event|11
1476596|NCT00634543|4868257|P2|Overall Study|Protocol Violation|3
1476597|NCT00634543|4868258|P1|Overall Study|Protocol Violation|3
1476598|NCT00634543|4868257|P2|Overall Study|Other|2
1476599|NCT00634543|4868258|P1|Overall Study|Other|1
1476600|NCT00634504|4868276|P2|Overall Study|Protocol Violation|0
1476601|NCT00634504|4868277|P1|Overall Study|Protocol Violation|1
1476602|NCT00634244|4868328|P3|Overall Study|Other complicating disease|0
1476603|NCT00634244|4868329|P2|Overall Study|Other complicating disease|1
1476604|NCT00634244|4868330|P1|Overall Study|Other complicating disease|0
1476605|NCT00634244|4868328|P3|Overall Study|Disease progression/relapse|0
1476606|NCT00634244|4868329|P2|Overall Study|Disease progression/relapse|1
1476607|NCT00634244|4868330|P1|Overall Study|Disease progression/relapse|0
1476608|NCT00634244|4868328|P3|Overall Study|Physician Decision|0
1476609|NCT00634244|4868329|P2|Overall Study|Physician Decision|1
1476610|NCT00634244|4868330|P1|Overall Study|Physician Decision|0
1476611|NCT00634244|4868328|P3|Overall Study|Withdrawal by Subject|0
1476612|NCT00634244|4868329|P2|Overall Study|Withdrawal by Subject|1
1476613|NCT00634244|4868330|P1|Overall Study|Withdrawal by Subject|0
1476614|NCT00634244|4868328|P3|Overall Study|Adverse Event|0
1476615|NCT00634244|4868329|P2|Overall Study|Adverse Event|2
1476616|NCT00634244|4868330|P1|Overall Study|Adverse Event|0
1476617|NCT00634244|4868328|P3|Overall Study|Death|0
1476618|NCT00634244|4868329|P2|Overall Study|Death|6
1476619|NCT00634244|4868330|P1|Overall Study|Death|1
1476620|NCT00634244|4868328|P3|Overall Study|Never started treatment|0
1476621|NCT00634244|4868329|P2|Overall Study|Never started treatment|1
1476622|NCT00634244|4868330|P1|Overall Study|Never started treatment|0
1476623|NCT00634179|4868341|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
1476624|NCT00634114|4868360|P3|Overall Study|Other reason|1
1476625|NCT00634114|4868361|P2|Overall Study|Other reason|1
1476626|NCT00634114|4868362|P1|Overall Study|Other reason|1
1476627|NCT00634114|4868360|P3|Overall Study|Difficult to continue|1
1476628|NCT00634114|4868361|P2|Overall Study|Difficult to continue|1
1476629|NCT00634114|4868362|P1|Overall Study|Difficult to continue|3
1476630|NCT00634114|4868360|P3|Overall Study|Recurrence of reflux esophagitis|21
1476631|NCT00634114|4868361|P2|Overall Study|Recurrence of reflux esophagitis|15
1476632|NCT00634114|4868362|P1|Overall Study|Recurrence of reflux esophagitis|5
1476633|NCT00634114|4868360|P3|Overall Study|Incorrect enrolment|0
1476634|NCT00634114|4868361|P2|Overall Study|Incorrect enrolment|1
1476635|NCT00634114|4868362|P1|Overall Study|Incorrect enrolment|0
1476636|NCT00634114|4868360|P3|Overall Study|Pregnancy|0
1476637|NCT00634114|4868361|P2|Overall Study|Pregnancy|0
1476638|NCT00634114|4868362|P1|Overall Study|Pregnancy|1
1476639|NCT00634114|4868360|P3|Overall Study|Protocol Violation|1
1476640|NCT00634114|4868361|P2|Overall Study|Protocol Violation|3
1476641|NCT00634114|4868362|P1|Overall Study|Protocol Violation|3
1476642|NCT00634114|4868360|P3|Overall Study|Lost to Follow-up|1
1476643|NCT00634114|4868361|P2|Overall Study|Lost to Follow-up|0
1476644|NCT00634114|4868362|P1|Overall Study|Lost to Follow-up|0
1476645|NCT00634114|4868360|P3|Overall Study|Withdrawal by Subject|11
1476646|NCT00634114|4868361|P2|Overall Study|Withdrawal by Subject|6
1476647|NCT00634114|4868362|P1|Overall Study|Withdrawal by Subject|9
1476648|NCT00634114|4868360|P3|Overall Study|Adverse Event|3
1476649|NCT00634114|4868361|P2|Overall Study|Adverse Event|8
1476650|NCT00634114|4868362|P1|Overall Study|Adverse Event|6
1476651|NCT00634088|4868380|P4|Time Period 3: Dose Level 3|Progressive disease|0
1476652|NCT00634088|4868381|P3|Time Period 3: Dose Level 3|Progressive disease|1
1476653|NCT00634088|4868382|P2|Time Period 3: Dose Level 3|Progressive disease|0
1476654|NCT00634088|4868383|P1|Time Period 3: Dose Level 3|Progressive disease|0
1476655|NCT00634088|4868380|P4|Time Period 2: Dose Level 2|Progressive disease|0
1476656|NCT00634088|4868381|P3|Time Period 2: Dose Level 2|Progressive disease|0
1476657|NCT00634088|4868382|P2|Time Period 2: Dose Level 2|Progressive disease|1
1476658|NCT00634088|4868383|P1|Time Period 2: Dose Level 2|Progressive disease|0
1476659|NCT00634088|4868380|P4|Time Period 2: Dose Level 2|Adverse Event|0
1476660|NCT00634088|4868381|P3|Time Period 2: Dose Level 2|Adverse Event|0
1476661|NCT00634088|4868382|P2|Time Period 2: Dose Level 2|Adverse Event|2
1476662|NCT00634088|4868383|P1|Time Period 2: Dose Level 2|Adverse Event|0
1476663|NCT00634088|4868380|P4|Time Period 1: Dose Level 1|Adverse Event|0
1476664|NCT00634088|4868381|P3|Time Period 1: Dose Level 1|Adverse Event|0
1476665|NCT00634088|4868382|P2|Time Period 1: Dose Level 1|Adverse Event|0
1476666|NCT00634088|4868383|P1|Time Period 1: Dose Level 1|Adverse Event|3
1476667|NCT00634088|4868380|P4|Time Period 1: Dose Level 1|Physician Decision|0
1476668|NCT00634088|4868381|P3|Time Period 1: Dose Level 1|Physician Decision|0
1476669|NCT00634088|4868382|P2|Time Period 1: Dose Level 1|Physician Decision|0
1476670|NCT00634088|4868383|P1|Time Period 1: Dose Level 1|Physician Decision|1
1476671|NCT00634088|4868380|P4|Time Period 1: Dose Level 1|Disease progression|0
1476672|NCT00634088|4868381|P3|Time Period 1: Dose Level 1|Disease progression|0
1476673|NCT00634088|4868382|P2|Time Period 1: Dose Level 1|Disease progression|0
1476674|NCT00634088|4868383|P1|Time Period 1: Dose Level 1|Disease progression|2
1476675|NCT00634049|4868434|P1|Overall Study|Screening failure|1
1476676|NCT00634049|4868434|P1|Overall Study|Died prior to receiving study drug|1
1476677|NCT00634049|4868434|P1|Overall Study|Never received study drug|1
1476678|NCT00634036|4868513|P2|Overall Study|Withdrawal by Subject|1
1476679|NCT00634036|4868514|P1|Overall Study|Withdrawal by Subject|1
1476680|NCT00634036|4868513|P2|Overall Study|Lost to Follow-up|1
1476681|NCT00634036|4868514|P1|Overall Study|Lost to Follow-up|1
1476682|NCT00634010|4868528|P2|Overall Study|Non-Compliant|1
1476683|NCT00634010|4868529|P1|Overall Study|Non-Compliant|1
1476684|NCT00634010|4868528|P2|Overall Study|Disease Progression|1
1476685|NCT00634010|4868529|P1|Overall Study|Disease Progression|1
1476686|NCT00634010|4868528|P2|Overall Study|Physician Decision|1
1476687|NCT00634010|4868529|P1|Overall Study|Physician Decision|1
1476688|NCT00634010|4868528|P2|Overall Study|Withdrawal by Subject|6
1476689|NCT00634010|4868529|P1|Overall Study|Withdrawal by Subject|5
1476690|NCT00634010|4868528|P2|Overall Study|Adverse Event|5
1476691|NCT00634010|4868529|P1|Overall Study|Adverse Event|2
1476692|NCT00633984|4868537|P2|Overall Study|Hospitalized|0
1476693|NCT00633984|4868538|P1|Overall Study|Hospitalized|1
1476694|NCT00633984|4868537|P2|Overall Study|Withdrawal by Subject|7
1476695|NCT00633984|4868538|P1|Overall Study|Withdrawal by Subject|8
1476696|NCT00633984|4868537|P2|Overall Study|Lost to Follow-up|6
1476697|NCT00633984|4868538|P1|Overall Study|Lost to Follow-up|0
1476698|NCT00633932|4868549|P3|Overall Study|Moved Away|0
1476699|NCT00633932|4868550|P2|Overall Study|Moved Away|0
1476700|NCT00633932|4868551|P1|Overall Study|Moved Away|1
1476701|NCT00633932|4868549|P3|Overall Study|Doctor's judgement|0
1476702|NCT00633932|4868550|P2|Overall Study|Doctor's judgement|0
1476703|NCT00633932|4868551|P1|Overall Study|Doctor's judgement|1
1476704|NCT00633932|4868549|P3|Overall Study|Physician Decision|1
1476705|NCT00633932|4868550|P2|Overall Study|Physician Decision|0
1476706|NCT00633932|4868551|P1|Overall Study|Physician Decision|0
1476707|NCT00633932|4868549|P3|Overall Study|Protocol Violation|3
1476708|NCT00633932|4868550|P2|Overall Study|Protocol Violation|2
1476709|NCT00633932|4868551|P1|Overall Study|Protocol Violation|5
1476710|NCT00633932|4868549|P3|Overall Study|Lost to Follow-up|2
1476711|NCT00633932|4868550|P2|Overall Study|Lost to Follow-up|0
1476712|NCT00633932|4868551|P1|Overall Study|Lost to Follow-up|1
1476713|NCT00633932|4868549|P3|Overall Study|Withdrawal by Subject|1
1476714|NCT00633932|4868550|P2|Overall Study|Withdrawal by Subject|9
1476715|NCT00633932|4868551|P1|Overall Study|Withdrawal by Subject|3
1476716|NCT00633932|4868549|P3|Overall Study|Adverse Event|4
1476717|NCT00633932|4868550|P2|Overall Study|Adverse Event|3
1476718|NCT00633932|4868551|P1|Overall Study|Adverse Event|1
1476719|NCT00633893|4868582|P3|Overall Study|not specified|31
1476720|NCT00633893|4868583|P2|Overall Study|not specified|33
1476721|NCT00633893|4868584|P1|Overall Study|not specified|28
1476722|NCT00633893|4868582|P3|Overall Study|Not meet/no longer meets criteria|4
1476723|NCT00633893|4868583|P2|Overall Study|Not meet/no longer meets criteria|6
1476724|NCT00633893|4868584|P1|Overall Study|Not meet/no longer meets criteria|4
1476725|NCT00633893|4868582|P3|Overall Study|Pregnancy|1
1476726|NCT00633893|4868583|P2|Overall Study|Pregnancy|1
1476727|NCT00633893|4868584|P1|Overall Study|Pregnancy|2
1476728|NCT00633893|4868582|P3|Overall Study|Poor/non-compliance|3
1476729|NCT00633893|4868583|P2|Overall Study|Poor/non-compliance|12
1476730|NCT00633893|4868584|P1|Overall Study|Poor/non-compliance|5
1476731|NCT00633893|4868582|P3|Overall Study|Lost to Follow-up|8
1476732|NCT00633893|4868583|P2|Overall Study|Lost to Follow-up|4
1476733|NCT00633893|4868584|P1|Overall Study|Lost to Follow-up|2
1476734|NCT00633893|4868582|P3|Overall Study|Withdrawal by Subject|6
1476735|NCT00633893|4868583|P2|Overall Study|Withdrawal by Subject|12
1476736|NCT00633893|4868584|P1|Overall Study|Withdrawal by Subject|7
1476737|NCT00633893|4868582|P3|Overall Study|Adverse Event|126
1476738|NCT00633893|4868583|P2|Overall Study|Adverse Event|58
1476739|NCT00633893|4868584|P1|Overall Study|Adverse Event|65
1476740|NCT00633893|4868582|P3|Overall Study|Death|9
1476741|NCT00633893|4868583|P2|Overall Study|Death|3
1476742|NCT00633893|4868584|P1|Overall Study|Death|1
1476743|NCT00633880|4868658|P3|Open Label Titration|Withdrawal by Subject|0
1476744|NCT00633880|4868659|P2|Open Label Titration|Withdrawal by Subject|0
1476745|NCT00633880|4868660|P1|Open Label Titration|Withdrawal by Subject|4
1476746|NCT00633880|4868658|P3|Open Label Titration|Physician Decision|0
1476747|NCT00633880|4868659|P2|Open Label Titration|Physician Decision|0
1476748|NCT00633880|4868660|P1|Open Label Titration|Physician Decision|1
1476749|NCT00633880|4868658|P3|Open Label Titration|Protocol Violation|0
1476750|NCT00633880|4868659|P2|Open Label Titration|Protocol Violation|0
1476751|NCT00633880|4868660|P1|Open Label Titration|Protocol Violation|6
1476752|NCT00633880|4868658|P3|Open Label Titration|Treatment Failure|0
1476753|NCT00633880|4868659|P2|Open Label Titration|Treatment Failure|0
1476754|NCT00633880|4868660|P1|Open Label Titration|Treatment Failure|55
1476755|NCT00633880|4868658|P3|Open Label Titration|Adverse Event|0
1476756|NCT00633880|4868659|P2|Open Label Titration|Adverse Event|0
1476757|NCT00633880|4868660|P1|Open Label Titration|Adverse Event|13
1476758|NCT00633880|4868658|P3|Open Label Titration|Lack of Efficacy|0
1476759|NCT00633880|4868659|P2|Open Label Titration|Lack of Efficacy|0
1476760|NCT00633880|4868660|P1|Open Label Titration|Lack of Efficacy|1
1476761|NCT00633750|4868696|P1|Overall Study|Withdrawal by Subject|3
1476762|NCT00633750|4868696|P1|Overall Study|Adverse Event|2
1476763|NCT00633594|4868705|P3|Overall Study|Disease Progression|1
1476764|NCT00633594|4868706|P2|Overall Study|Disease Progression|0
1476765|NCT00633594|4868707|P1|Overall Study|Disease Progression|0
1476766|NCT00633594|4868705|P3|Overall Study|Death|2
1476767|NCT00633594|4868706|P2|Overall Study|Death|1
1476768|NCT00633594|4868707|P1|Overall Study|Death|0
1476769|NCT00633594|4868705|P3|Overall Study|Adverse Event|7
1476770|NCT00633594|4868706|P2|Overall Study|Adverse Event|4
1476771|NCT00633594|4868707|P1|Overall Study|Adverse Event|0
1476772|NCT00633477|4868736|P2|Overall Study|Randomized but not treated|0
1476773|NCT00633477|4868737|P1|Overall Study|Randomized but not treated|1
1476774|NCT00633477|4868736|P2|Overall Study|Death|0
1476775|NCT00633477|4868737|P1|Overall Study|Death|1
1476776|NCT00633464|4868753|P2|Overall Study|Never Treated (Randomized in error)|1
1476777|NCT00633464|4868754|P1|Overall Study|Never Treated (Randomized in error)|0
1476778|NCT00633464|4868753|P2|Overall Study|Never Treated (Not met study criteria)|1
1476779|NCT00633464|4868754|P1|Overall Study|Never Treated (Not met study criteria)|0
1476780|NCT00633360|4868789|P2|Overall Study|Protocol Violation|1
1476781|NCT00633360|4868790|P1|Overall Study|Protocol Violation|0
1476782|NCT00633360|4868789|P2|Overall Study|Adverse Event|1
1476783|NCT00633360|4868790|P1|Overall Study|Adverse Event|3
1476784|NCT00633360|4868789|P2|Overall Study|Lost to Follow-up|1
1476785|NCT00633360|4868790|P1|Overall Study|Lost to Follow-up|1
1476786|NCT00633243|4868813|P2|Overall Study|Couldn't tolerate side-effects|1
1476787|NCT00633243|4868814|P1|Overall Study|Couldn't tolerate side-effects|1
1476788|NCT00633243|4868813|P2|Overall Study|Mental Health--Depression|1
1476789|NCT00633243|4868814|P1|Overall Study|Mental Health--Depression|0
1476790|NCT00633243|4868813|P2|Overall Study|Not comfortable with self-injecting|1
1476791|NCT00633243|4868814|P1|Overall Study|Not comfortable with self-injecting|0
1476792|NCT00633243|4868813|P2|Overall Study|Homeless--no refrigeration for meds|1
1476793|NCT00633243|4868814|P1|Overall Study|Homeless--no refrigeration for meds|0
1476794|NCT00633243|4868813|P2|Overall Study|incarceration|2
1476795|NCT00633243|4868814|P1|Overall Study|incarceration|0
1476796|NCT00633243|4868813|P2|Overall Study|Withdrawal by Subject|1
1476797|NCT00633243|4868814|P1|Overall Study|Withdrawal by Subject|0
1476798|NCT00633217|4868822|P2|Overall Study|Withdrew Consent|3
1476799|NCT00633217|4868823|P1|Overall Study|Withdrew Consent|3
1476800|NCT00633217|4868822|P2|Overall Study|Investigator Discretion|0
1476801|NCT00633217|4868823|P1|Overall Study|Investigator Discretion|2
1476802|NCT00633217|4868822|P2|Overall Study|Lost to Follow-up|2
1476803|NCT00633217|4868823|P1|Overall Study|Lost to Follow-up|2
1476804|NCT00633217|4868822|P2|Overall Study|Protocol Violation|7
1476805|NCT00633217|4868823|P1|Overall Study|Protocol Violation|3
1476806|NCT00633217|4868822|P2|Overall Study|Lack of Efficacy|2
1476807|NCT00633217|4868823|P1|Overall Study|Lack of Efficacy|0
1476808|NCT00633217|4868822|P2|Overall Study|Adverse Event|9
1476809|NCT00633217|4868823|P1|Overall Study|Adverse Event|5
1476810|NCT00633152|4868835|P2|Overall Study|Miscellaneous Other|2
1476811|NCT00633152|4868836|P1|Overall Study|Miscellaneous Other|3
1476812|NCT00633152|4868835|P2|Overall Study|Lost to Follow-up|1
1476813|NCT00633152|4868836|P1|Overall Study|Lost to Follow-up|4
1476814|NCT00633152|4868835|P2|Overall Study|Withdrawal by Subject|1
1476815|NCT00633152|4868836|P1|Overall Study|Withdrawal by Subject|1
1476816|NCT00633152|4868835|P2|Overall Study|Randomized, did not receive study drug|2
1476817|NCT00633152|4868836|P1|Overall Study|Randomized, did not receive study drug|5
1476818|NCT00633152|4868835|P2|Overall Study|Adverse Event|0
1476819|NCT00633152|4868836|P1|Overall Study|Adverse Event|1
1476820|NCT00633139|4868847|P3|Overall Study|Withdrawal by Subject|0
1476821|NCT00633139|4868848|P2|Overall Study|Withdrawal by Subject|1
1476822|NCT00633139|4868849|P1|Overall Study|Withdrawal by Subject|0
1476823|NCT00633139|4868847|P3|Overall Study|Non compliance|1
1476824|NCT00633139|4868848|P2|Overall Study|Non compliance|0
1476825|NCT00633139|4868849|P1|Overall Study|Non compliance|0
1476826|NCT00633126|4868863|P1|Overall Study|Did not receive full dose|1
1476827|NCT00633074|4868877|P2|Overall Study|Adverse Event|0
1476828|NCT00633074|4868878|P1|Overall Study|Adverse Event|1
1476829|NCT00632931|4868933|P3|Part 2|Withdrawal by Subject|3
1476830|NCT00632931|4868934|P2|Part 2|Withdrawal by Subject|0
1476831|NCT00632931|4868935|P1|Part 2|Withdrawal by Subject|0
1476832|NCT00632931|4868933|P3|Part 2|Lack of Efficacy|17
1476833|NCT00632931|4868934|P2|Part 2|Lack of Efficacy|0
1476834|NCT00632931|4868935|P1|Part 2|Lack of Efficacy|0
1476835|NCT00632931|4868933|P3|Part 2|Death|1
1476836|NCT00632931|4868934|P2|Part 2|Death|0
1476837|NCT00632931|4868935|P1|Part 2|Death|0
1476838|NCT00632931|4868933|P3|Part 2|Adverse Event|3
1476839|NCT00632931|4868934|P2|Part 2|Adverse Event|0
1476840|NCT00632931|4868935|P1|Part 2|Adverse Event|0
1476841|NCT00632931|4868933|P3|Part 1, Period 1|Withdrawal by Subject|0
1476842|NCT00632931|4868934|P2|Part 1, Period 1|Withdrawal by Subject|0
1476843|NCT00632931|4868935|P1|Part 1, Period 1|Withdrawal by Subject|1
1476844|NCT00632931|4868933|P3|Part 1, Period 1|Protocol Violation|0
1476845|NCT00632931|4868934|P2|Part 1, Period 1|Protocol Violation|0
1476846|NCT00632931|4868935|P1|Part 1, Period 1|Protocol Violation|1
1476847|NCT00632749|4869005|P14|Overall Study|Reason other than those specified above|2
1476848|NCT00632749|4869006|P13|Overall Study|Reason other than those specified above|0
1476849|NCT00632749|4869007|P12|Overall Study|Reason other than those specified above|1
1476850|NCT00632749|4869008|P11|Overall Study|Reason other than those specified above|2
1476851|NCT00632749|4869009|P10|Overall Study|Reason other than those specified above|0
1476852|NCT00632749|4869010|P9|Overall Study|Reason other than those specified above|0
1476853|NCT00632749|4869011|P8|Overall Study|Reason other than those specified above|0
1476854|NCT00632749|4869012|P7|Overall Study|Reason other than those specified above|1
1476855|NCT00632749|4869013|P6|Overall Study|Reason other than those specified above|0
1476856|NCT00632749|4869014|P5|Overall Study|Reason other than those specified above|1
1476857|NCT00632749|4869015|P4|Overall Study|Reason other than those specified above|0
1476858|NCT00632749|4869016|P3|Overall Study|Reason other than those specified above|0
1476859|NCT00632749|4869017|P2|Overall Study|Reason other than those specified above|2
1476860|NCT00632749|4869018|P1|Overall Study|Reason other than those specified above|0
1476861|NCT00632749|4869005|P14|Overall Study|Refuse to continue medication|0
1476862|NCT00632749|4869006|P13|Overall Study|Refuse to continue medication|0
1476863|NCT00632749|4869007|P12|Overall Study|Refuse to continue medication|0
1476864|NCT00632749|4869008|P11|Overall Study|Refuse to continue medication|0
1476865|NCT00632749|4869009|P10|Overall Study|Refuse to continue medication|1
1476866|NCT00632749|4869010|P9|Overall Study|Refuse to continue medication|0
1476867|NCT00632749|4869011|P8|Overall Study|Refuse to continue medication|0
1476868|NCT00632749|4869012|P7|Overall Study|Refuse to continue medication|0
1476869|NCT00632749|4869013|P6|Overall Study|Refuse to continue medication|0
1476870|NCT00632749|4869014|P5|Overall Study|Refuse to continue medication|0
1476871|NCT00632749|4869015|P4|Overall Study|Refuse to continue medication|1
1476872|NCT00632749|4869016|P3|Overall Study|Refuse to continue medication|0
1476873|NCT00632749|4869017|P2|Overall Study|Refuse to continue medication|0
1476874|NCT00632749|4869018|P1|Overall Study|Refuse to continue medication|0
1476875|NCT00632749|4869005|P14|Overall Study|Other Adverse event|0
1476876|NCT00632749|4869006|P13|Overall Study|Other Adverse event|1
1476877|NCT00632749|4869007|P12|Overall Study|Other Adverse event|0
1476878|NCT00632749|4869008|P11|Overall Study|Other Adverse event|1
1476879|NCT00632749|4869009|P10|Overall Study|Other Adverse event|0
1476880|NCT00632749|4869010|P9|Overall Study|Other Adverse event|2
1476881|NCT00632749|4869011|P8|Overall Study|Other Adverse event|2
1476882|NCT00632749|4869012|P7|Overall Study|Other Adverse event|1
1476883|NCT00632749|4869013|P6|Overall Study|Other Adverse event|4
1476884|NCT00632749|4869014|P5|Overall Study|Other Adverse event|2
1476885|NCT00632749|4869015|P4|Overall Study|Other Adverse event|1
1476886|NCT00632749|4869016|P3|Overall Study|Other Adverse event|1
1476887|NCT00632749|4869017|P2|Overall Study|Other Adverse event|1
1476888|NCT00632749|4869018|P1|Overall Study|Other Adverse event|1
1476889|NCT00632749|4869005|P14|Overall Study|Progressive disease|4
1476890|NCT00632749|4869006|P13|Overall Study|Progressive disease|2
1476891|NCT00632749|4869007|P12|Overall Study|Progressive disease|3
1476892|NCT00632749|4869008|P11|Overall Study|Progressive disease|4
1476893|NCT00632749|4869009|P10|Overall Study|Progressive disease|2
1476894|NCT00632749|4869010|P9|Overall Study|Progressive disease|3
1476895|NCT00632749|4869011|P8|Overall Study|Progressive disease|2
1476896|NCT00632749|4869012|P7|Overall Study|Progressive disease|3
1476897|NCT00632749|4869013|P6|Overall Study|Progressive disease|4
1476898|NCT00632749|4869014|P5|Overall Study|Progressive disease|4
1476899|NCT00632749|4869015|P4|Overall Study|Progressive disease|2
1476900|NCT00632749|4869016|P3|Overall Study|Progressive disease|2
1476901|NCT00632749|4869017|P2|Overall Study|Progressive disease|2
1476902|NCT00632749|4869018|P1|Overall Study|Progressive disease|3
1476903|NCT00632736|4869312|P1|Overall Study|Other|16
1476904|NCT00632736|4869312|P1|Overall Study|Non-compliance|10
1476905|NCT00632736|4869312|P1|Overall Study|Sponsor terminated study|5
1476906|NCT00632736|4869312|P1|Overall Study|Lack of Efficacy|5
1476907|NCT00632736|4869312|P1|Overall Study|Withdrawal by Subject|99
1476908|NCT00632736|4869312|P1|Overall Study|Protocol Violation|14
1476909|NCT00632736|4869312|P1|Overall Study|Lost to Follow-up|15
1476910|NCT00632736|4869312|P1|Overall Study|Adverse Event|104
1476911|NCT00632541|4869347|P1|Overall Study|Adverse Event|7
1476912|NCT00632502|4869356|P2|Overall Study|Randomized not treated|0
1476913|NCT00632502|4869357|P1|Overall Study|Randomized not treated|3
1476914|NCT00632502|4869356|P2|Overall Study|Adverse Event|1
1476915|NCT00632502|4869357|P1|Overall Study|Adverse Event|0
1476916|NCT00632463|4869401|P3|Overall Study|Adverse Event|0
1476917|NCT00632463|4869402|P2|Overall Study|Adverse Event|1
1476918|NCT00632463|4869403|P1|Overall Study|Adverse Event|0
1476919|NCT00632424|4869420|P1|Overall Study|Study Drug Toxicity|1
1476920|NCT00632424|4869420|P1|Overall Study|Disease Progression|17
1476921|NCT00632229|4869458|P2|Overall Study|Undisclosed reasons within the first wee|1
1476922|NCT00632229|4869459|P1|Overall Study|Undisclosed reasons within the first wee|0
1476923|NCT00632229|4869458|P2|Overall Study|Lack of Efficacy|2
1476924|NCT00632229|4869459|P1|Overall Study|Lack of Efficacy|0
1476925|NCT00632229|4869458|P2|Overall Study|Lost to Follow-up|3
1476926|NCT00632229|4869459|P1|Overall Study|Lost to Follow-up|0
1476927|NCT00632229|4869458|P2|Overall Study|Adverse Event|0
1476928|NCT00632229|4869459|P1|Overall Study|Adverse Event|6
1476929|NCT00632203|4869469|P2|Overall Study|Did not start study treatment|0
1476930|NCT00632203|4869470|P1|Overall Study|Did not start study treatment|1
1476931|NCT00632125|4869488|P1|Overall Study|Moved to other dialysis unit, etc.|102
1476932|NCT00632125|4869488|P1|Overall Study|Development of uncontrolled hypertension|5
1476933|NCT00632125|4869488|P1|Overall Study|Non-compliance|8
1476934|NCT00632125|4869488|P1|Overall Study|Need for systemic immunosuppressive medi|8
1476935|NCT00632125|4869488|P1|Overall Study|Renal transplantation|17
1476936|NCT00632125|4869488|P1|Overall Study|Adverse Event|36
1476937|NCT00632125|4869488|P1|Overall Study|Withdrawal by Subject|44
1476938|NCT00632125|4869488|P1|Overall Study|Death|82
1476939|NCT00632099|4869494|P2|Overall Study|Lost to Follow-up|3
1476940|NCT00632099|4869495|P1|Overall Study|Lost to Follow-up|3
1476941|NCT00632021|4869503|P2|Overall Study|Withdrawal/death|7
1476942|NCT00632021|4869504|P1|Overall Study|Withdrawal/death|4
1476943|NCT00631969|4869514|P2|Overall Study|No Drug Exposure|2
1476944|NCT00631969|4869515|P1|Overall Study|No Drug Exposure|2
1476945|NCT00631969|4869514|P2|Overall Study|Noncompliant With Study Medication|1
1476946|NCT00631969|4869515|P1|Overall Study|Noncompliant With Study Medication|0
1476947|NCT00631969|4869514|P2|Overall Study|Consent Withdrawn|7
1476948|NCT00631969|4869515|P1|Overall Study|Consent Withdrawn|5
1476949|NCT00631969|4869514|P2|Overall Study|Protocol Violation|1
1476950|NCT00631969|4869515|P1|Overall Study|Protocol Violation|1
1476951|NCT00631969|4869514|P2|Overall Study|Lost to Follow-up|1
1476952|NCT00631969|4869515|P1|Overall Study|Lost to Follow-up|2
1476953|NCT00631969|4869514|P2|Overall Study|Lack of Efficacy|8
1476954|NCT00631969|4869515|P1|Overall Study|Lack of Efficacy|2
1476955|NCT00631969|4869514|P2|Overall Study|Adverse Event|1
1476956|NCT00631969|4869515|P1|Overall Study|Adverse Event|3
1476957|NCT00631917|4869561|P2|Overall Study|Death|0
1476958|NCT00631917|4869562|P1|Overall Study|Death|1
1476959|NCT00631917|4869561|P2|Overall Study|Administrative problems|0
1476960|NCT00631917|4869562|P1|Overall Study|Administrative problems|2
1476961|NCT00631917|4869561|P2|Overall Study|Lost to Follow-up|7
1476962|NCT00631917|4869562|P1|Overall Study|Lost to Follow-up|7
1476963|NCT00631917|4869561|P2|Overall Study|Subject withdrew consent|33
1476964|NCT00631917|4869562|P1|Overall Study|Subject withdrew consent|25
1476965|NCT00631917|4869561|P2|Overall Study|Protocol deviation|5
1476966|NCT00631917|4869562|P1|Overall Study|Protocol deviation|6
1476967|NCT00631917|4869561|P2|Overall Study|No longer required study drug|1
1476968|NCT00631917|4869562|P1|Overall Study|No longer required study drug|0
1476969|NCT00631917|4869561|P2|Overall Study|Unsatisfactory therapeutic effect|14
1476970|NCT00631917|4869562|P1|Overall Study|Unsatisfactory therapeutic effect|8
1476971|NCT00631917|4869561|P2|Overall Study|Abnormal test procedure result(s)|2
1476972|NCT00631917|4869562|P1|Overall Study|Abnormal test procedure result(s)|3
1476973|NCT00631917|4869561|P2|Overall Study|Abnormal laboratory value(s)|1
1476974|NCT00631917|4869562|P1|Overall Study|Abnormal laboratory value(s)|2
1476975|NCT00631917|4869561|P2|Overall Study|Adverse Event|45
1476976|NCT00631917|4869562|P1|Overall Study|Adverse Event|34
1476977|NCT00631696|4869589|P2|Overall Study|Adverse Event|0
1476978|NCT00631696|4869590|P1|Overall Study|Adverse Event|5
1476979|NCT00631696|4869589|P2|Overall Study|Study terminated by sponsor|3
1476980|NCT00631696|4869590|P1|Overall Study|Study terminated by sponsor|3
1476981|NCT00631696|4869589|P2|Overall Study|Protocol Violation|9
1476982|NCT00631696|4869590|P1|Overall Study|Protocol Violation|9
1476983|NCT00631696|4869589|P2|Overall Study|Other|8
1476984|NCT00631696|4869590|P1|Overall Study|Other|8
1476985|NCT00631696|4869589|P2|Overall Study|Withdrawal by Subject|9
1476986|NCT00631696|4869590|P1|Overall Study|Withdrawal by Subject|2
1476987|NCT00631696|4869589|P2|Overall Study|Lost to Follow-up|10
1476988|NCT00631696|4869590|P1|Overall Study|Lost to Follow-up|7
1476989|NCT00631696|4869589|P2|Overall Study|Follow up after database release date|0
1476990|NCT00631696|4869590|P1|Overall Study|Follow up after database release date|1
1476991|NCT00631696|4869589|P2|Overall Study|Discontinued after database release date|0
1476992|NCT00631696|4869590|P1|Overall Study|Discontinued after database release date|1
1476993|NCT00631696|4869589|P2|Overall Study|Entered, not randomized to treatment|1
1476994|NCT00631696|4869590|P1|Overall Study|Entered, not randomized to treatment|1
1476995|NCT00631657|4869633|P3|7-Day Discontinuation Period|Other|0
1476996|NCT00631657|4869634|P2|7-Day Discontinuation Period|Other|0
1476997|NCT00631657|4869635|P1|7-Day Discontinuation Period|Other|1
1476998|NCT00631657|4869633|P3|7-Day Discontinuation Period|Not Treated|1
1476999|NCT00631657|4869634|P2|7-Day Discontinuation Period|Not Treated|1
1477000|NCT00631657|4869635|P1|7-Day Discontinuation Period|Not Treated|1
1477001|NCT00631657|4869633|P3|6-Month Treatment Period|Not Treated|1
1477002|NCT00631657|4869634|P2|6-Month Treatment Period|Not Treated|0
1477003|NCT00631657|4869635|P1|6-Month Treatment Period|Not Treated|2
1477004|NCT00631657|4869633|P3|6-Month Treatment Period|Other|4
1477005|NCT00631657|4869634|P2|6-Month Treatment Period|Other|0
1477006|NCT00631657|4869635|P1|6-Month Treatment Period|Other|16
1477007|NCT00631657|4869633|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
1477008|NCT00631657|4869634|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
1477009|NCT00631657|4869635|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
1477010|NCT00631657|4869633|P3|6-Month Treatment Period|Lost to Follow-up|2
1477011|NCT00631657|4869634|P2|6-Month Treatment Period|Lost to Follow-up|0
1477012|NCT00631657|4869635|P1|6-Month Treatment Period|Lost to Follow-up|7
1477013|NCT00631657|4869633|P3|6-Month Treatment Period|Lack of Efficacy|25
1477014|NCT00631657|4869634|P2|6-Month Treatment Period|Lack of Efficacy|0
1477015|NCT00631657|4869635|P1|6-Month Treatment Period|Lack of Efficacy|34
1477016|NCT00631657|4869633|P3|6-Month Treatment Period|Withdrawal by Subject|5
1477017|NCT00631657|4869634|P2|6-Month Treatment Period|Withdrawal by Subject|0
1477018|NCT00631657|4869635|P1|6-Month Treatment Period|Withdrawal by Subject|14
1477019|NCT00631657|4869633|P3|6-Month Treatment Period|Adverse Event|7
1477020|NCT00631657|4869634|P2|6-Month Treatment Period|Adverse Event|0
1477021|NCT00631657|4869635|P1|6-Month Treatment Period|Adverse Event|47
1477022|NCT00631540|4869684|P1|Overall Study|Core Lab Data Unavailable|3
1477023|NCT00631540|4869684|P1|Overall Study|Lost to Follow-up|2
1477024|NCT00631540|4869684|P1|Overall Study|Death|4
1477025|NCT00631540|4869684|P1|Overall Study|Withdrawal by Subject|5
1477026|NCT00631488|4869696|P3|Overall Study|Protocol Violation|1
1477027|NCT00631488|4869697|P2|Overall Study|Protocol Violation|0
1477028|NCT00631488|4869698|P1|Overall Study|Protocol Violation|0
1477029|NCT00631488|4869696|P3|Overall Study|Physician Decision|1
1477030|NCT00631488|4869697|P2|Overall Study|Physician Decision|0
1477031|NCT00631488|4869698|P1|Overall Study|Physician Decision|1
1477032|NCT00631488|4869696|P3|Overall Study|Lost to Follow-up|0
1477033|NCT00631488|4869697|P2|Overall Study|Lost to Follow-up|2
1477034|NCT00631488|4869698|P1|Overall Study|Lost to Follow-up|2
1477035|NCT00631488|4869696|P3|Overall Study|Adverse Event|0
1477036|NCT00631488|4869697|P2|Overall Study|Adverse Event|0
1477037|NCT00631488|4869698|P1|Overall Study|Adverse Event|1
1477038|NCT00631475|4869718|P1|Overall Study|Preparation for lung transplant|8
1477039|NCT00631475|4869718|P1|Overall Study|Withdrew consent|5
1477040|NCT00631475|4869718|P1|Overall Study|Adverse Event|14
1477041|NCT00631475|4869718|P1|Overall Study|Death|18
1477042|NCT00631410|4869737|P2|Overall Study|Surgery|0
1477043|NCT00631410|4869738|P1|Overall Study|Surgery|1
1477044|NCT00631410|4869737|P2|Overall Study|Objective Progression or Relapse|3
1477045|NCT00631410|4869738|P1|Overall Study|Objective Progression or Relapse|4
1477046|NCT00631410|4869737|P2|Overall Study|Adverse Event|3
1477047|NCT00631410|4869738|P1|Overall Study|Adverse Event|1
1477048|NCT00631371|4869757|P2|Overall Study|Death|239
1477049|NCT00631371|4869758|P1|Overall Study|Death|263
1477050|NCT00631371|4869757|P2|Overall Study|Discontinuation of study by Sponsor|76
1477051|NCT00631371|4869758|P1|Overall Study|Discontinuation of study by Sponsor|70
1477052|NCT00631371|4869757|P2|Overall Study|subject request|45
1477053|NCT00631371|4869758|P1|Overall Study|subject request|38
1477054|NCT00631371|4869757|P2|Overall Study|Other reason|12
1477055|NCT00631371|4869758|P1|Overall Study|Other reason|5
1477056|NCT00631371|4869757|P2|Overall Study|Lost to Follow-up|19
1477057|NCT00631371|4869758|P1|Overall Study|Lost to Follow-up|24
1477058|NCT00631189|4869791|P4|Treatment Phase|patient did not take pravastatin|0
1477059|NCT00631189|4869792|P3|Treatment Phase|patient did not take pravastatin|1
1477060|NCT00631189|4869793|P2|Treatment Phase|patient did not take pravastatin|0
1477061|NCT00631189|4869794|P1|Treatment Phase|patient did not take pravastatin|0
1477062|NCT00631189|4869791|P4|Treatment Phase|Pregnancy|0
1477063|NCT00631189|4869792|P3|Treatment Phase|Pregnancy|1
1477064|NCT00631189|4869793|P2|Treatment Phase|Pregnancy|0
1477065|NCT00631189|4869794|P1|Treatment Phase|Pregnancy|0
1477066|NCT00631189|4869791|P4|Treatment Phase|Lost to Follow-up|0
1477067|NCT00631189|4869792|P3|Treatment Phase|Lost to Follow-up|0
1477068|NCT00631189|4869793|P2|Treatment Phase|Lost to Follow-up|1
1477069|NCT00631189|4869794|P1|Treatment Phase|Lost to Follow-up|0
1477070|NCT00631189|4869791|P4|Treatment Phase|Adverse Event|4
1477071|NCT00631189|4869792|P3|Treatment Phase|Adverse Event|2
1477072|NCT00631189|4869793|P2|Treatment Phase|Adverse Event|3
1477073|NCT00631189|4869794|P1|Treatment Phase|Adverse Event|0
1477074|NCT00631189|4869791|P4|Treatment Phase|Protocol Violation|2
1477075|NCT00631189|4869792|P3|Treatment Phase|Protocol Violation|6
1477076|NCT00631189|4869793|P2|Treatment Phase|Protocol Violation|1
1477077|NCT00631189|4869794|P1|Treatment Phase|Protocol Violation|0
1477078|NCT00631189|4869791|P4|Treatment Phase|Withdrawal by Subject|1
1477079|NCT00631189|4869792|P3|Treatment Phase|Withdrawal by Subject|1
1477080|NCT00631189|4869793|P2|Treatment Phase|Withdrawal by Subject|2
1477081|NCT00631189|4869794|P1|Treatment Phase|Withdrawal by Subject|0
1477082|NCT00631189|4869791|P4|Initial Phase|Withdrawal by Subject|0
1477083|NCT00631189|4869792|P3|Initial Phase|Withdrawal by Subject|0
1477084|NCT00631189|4869793|P2|Initial Phase|Withdrawal by Subject|0
1477085|NCT00631189|4869794|P1|Initial Phase|Withdrawal by Subject|4
1477086|NCT00631189|4869791|P4|Initial Phase|Protocol Violation|0
1477087|NCT00631189|4869792|P3|Initial Phase|Protocol Violation|0
1477088|NCT00631189|4869793|P2|Initial Phase|Protocol Violation|0
1477089|NCT00631189|4869794|P1|Initial Phase|Protocol Violation|347
1477090|NCT00631137|4869838|P2|Overall Study|Withdrawal by Subject|0
1477091|NCT00631137|4869839|P1|Overall Study|Withdrawal by Subject|1
1477092|NCT00631020|4869857|P1|Overall Study|Incarcerated|1
1477093|NCT00631020|4869857|P1|Overall Study|Lost to Follow-up|7
1477094|NCT00631007|4869872|P6|Overall Study|Other|0
1477095|NCT00631007|4869873|P5|Overall Study|Other|1
1477096|NCT00631007|4869874|P4|Overall Study|Other|0
1477097|NCT00631007|4869875|P3|Overall Study|Other|0
1477098|NCT00631007|4869876|P2|Overall Study|Other|1
1477099|NCT00631007|4869877|P1|Overall Study|Other|2
1477100|NCT00631007|4869872|P6|Overall Study|Withdrawal by Subject|3
1477101|NCT00631007|4869873|P5|Overall Study|Withdrawal by Subject|1
1477102|NCT00631007|4869874|P4|Overall Study|Withdrawal by Subject|2
1477103|NCT00631007|4869875|P3|Overall Study|Withdrawal by Subject|2
1477104|NCT00631007|4869876|P2|Overall Study|Withdrawal by Subject|5
1477105|NCT00631007|4869877|P1|Overall Study|Withdrawal by Subject|4
1477106|NCT00631007|4869872|P6|Overall Study|Persistent Hyperglycemia|5
1477107|NCT00631007|4869873|P5|Overall Study|Persistent Hyperglycemia|2
1477108|NCT00631007|4869874|P4|Overall Study|Persistent Hyperglycemia|1
1477109|NCT00631007|4869875|P3|Overall Study|Persistent Hyperglycemia|5
1477110|NCT00631007|4869876|P2|Overall Study|Persistent Hyperglycemia|2
1477111|NCT00631007|4869877|P1|Overall Study|Persistent Hyperglycemia|2
1477112|NCT00631007|4869872|P6|Overall Study|Physician Decision|2
1477113|NCT00631007|4869873|P5|Overall Study|Physician Decision|0
1477114|NCT00631007|4869874|P4|Overall Study|Physician Decision|0
1477115|NCT00631007|4869875|P3|Overall Study|Physician Decision|1
1477116|NCT00631007|4869876|P2|Overall Study|Physician Decision|0
1477117|NCT00631007|4869877|P1|Overall Study|Physician Decision|1
1477118|NCT00631007|4869872|P6|Overall Study|Lost to Follow-up|3
1477119|NCT00631007|4869873|P5|Overall Study|Lost to Follow-up|5
1477120|NCT00631007|4869874|P4|Overall Study|Lost to Follow-up|4
1477121|NCT00631007|4869875|P3|Overall Study|Lost to Follow-up|2
1477122|NCT00631007|4869876|P2|Overall Study|Lost to Follow-up|1
1477123|NCT00631007|4869877|P1|Overall Study|Lost to Follow-up|2
1477124|NCT00631007|4869872|P6|Overall Study|Adverse Event|2
1477125|NCT00631007|4869873|P5|Overall Study|Adverse Event|3
1477126|NCT00631007|4869874|P4|Overall Study|Adverse Event|2
1477127|NCT00631007|4869875|P3|Overall Study|Adverse Event|0
1477128|NCT00631007|4869876|P2|Overall Study|Adverse Event|2
1477129|NCT00631007|4869877|P1|Overall Study|Adverse Event|0
1477130|NCT00630994|4869897|P1|Overall Study|Other|1
1477131|NCT00630994|4869897|P1|Overall Study|Lack of Efficacy|1
1477132|NCT00630994|4869897|P1|Overall Study|Disease Progression|1
1477133|NCT00630994|4869897|P1|Overall Study|Adverse Event|1
1477134|NCT00630916|4869927|P1|Overall Study|Lack of Efficacy|3
1477135|NCT00630916|4869927|P1|Overall Study|Physician Decision|47
1477136|NCT00630916|4869927|P1|Overall Study|Protocol Violation|7
1477137|NCT00630916|4869927|P1|Overall Study|Withdrawal by Subject|30
1477138|NCT00630916|4869927|P1|Overall Study|Lost to Follow-up|5
1477139|NCT00630916|4869927|P1|Overall Study|Explant|8
1477140|NCT00630916|4869927|P1|Overall Study|Death|110
1477141|NCT00630877|4869937|P3|Overall Study|Personal reasons|1
1477142|NCT00630877|4869938|P2|Overall Study|Personal reasons|0
1477143|NCT00630877|4869939|P1|Overall Study|Personal reasons|0
1477144|NCT00630877|4869937|P3|Overall Study|Protocol violation|1
1477145|NCT00630877|4869938|P2|Overall Study|Protocol violation|0
1477146|NCT00630877|4869939|P1|Overall Study|Protocol violation|1
1477147|NCT00630877|4869937|P3|Overall Study|Noncompliance|1
1477148|NCT00630877|4869938|P2|Overall Study|Noncompliance|3
1477149|NCT00630877|4869939|P1|Overall Study|Noncompliance|2
1477150|NCT00630877|4869937|P3|Overall Study|Lost to Follow-up|0
1477151|NCT00630877|4869938|P2|Overall Study|Lost to Follow-up|0
1477152|NCT00630877|4869939|P1|Overall Study|Lost to Follow-up|2
1477153|NCT00630877|4869937|P3|Overall Study|Withdrawal by Subject|0
1477154|NCT00630877|4869938|P2|Overall Study|Withdrawal by Subject|4
1477155|NCT00630877|4869939|P1|Overall Study|Withdrawal by Subject|3
1477156|NCT00630877|4869937|P3|Overall Study|Adverse Event|7
1477157|NCT00630877|4869938|P2|Overall Study|Adverse Event|8
1477158|NCT00630877|4869939|P1|Overall Study|Adverse Event|11
1477159|NCT00630864|4869957|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
1477160|NCT00630864|4869957|P1|Part 1 (up to Week 6)|Adverse Event|1
1477161|NCT00630838|4869996|P2|Overall Study|Lost to Follow-up|1
1477162|NCT00630838|4869997|P1|Overall Study|Lost to Follow-up|0
1477163|NCT00630838|4869996|P2|Overall Study|Death|1
1477164|NCT00630838|4869997|P1|Overall Study|Death|0
1477165|NCT00630825|4870009|P4|Overall Study|Withdrawal by Subject|3
1477166|NCT00630825|4870010|P3|Overall Study|Withdrawal by Subject|2
1477167|NCT00630825|4870011|P2|Overall Study|Withdrawal by Subject|2
1477168|NCT00630825|4870012|P1|Overall Study|Withdrawal by Subject|2
1477169|NCT00630825|4870009|P4|Overall Study|Physician Decision|0
1477170|NCT00630825|4870010|P3|Overall Study|Physician Decision|0
1477171|NCT00630825|4870011|P2|Overall Study|Physician Decision|0
1477172|NCT00630825|4870012|P1|Overall Study|Physician Decision|1
1477173|NCT00630825|4870009|P4|Overall Study|Lost to Follow-up|1
1477174|NCT00630825|4870010|P3|Overall Study|Lost to Follow-up|1
1477175|NCT00630825|4870011|P2|Overall Study|Lost to Follow-up|1
1477176|NCT00630825|4870012|P1|Overall Study|Lost to Follow-up|1
1477177|NCT00630825|4870009|P4|Overall Study|Entry Criteria Not Met|1
1477178|NCT00630825|4870010|P3|Overall Study|Entry Criteria Not Met|2
1477179|NCT00630825|4870011|P2|Overall Study|Entry Criteria Not Met|0
1477180|NCT00630825|4870012|P1|Overall Study|Entry Criteria Not Met|1
1477181|NCT00630825|4870009|P4|Overall Study|Adverse Event|1
1477182|NCT00630825|4870010|P3|Overall Study|Adverse Event|3
1477183|NCT00630825|4870011|P2|Overall Study|Adverse Event|4
1477184|NCT00630825|4870012|P1|Overall Study|Adverse Event|4
1477185|NCT00630786|4870084|P3|Overall Study|Not specified|0
1477186|NCT00630786|4870085|P2|Overall Study|Not specified|0
1477187|NCT00630786|4870086|P1|Overall Study|Not specified|1
1477188|NCT00630786|4870084|P3|Overall Study|Lost to Follow-up|0
1477189|NCT00630786|4870085|P2|Overall Study|Lost to Follow-up|1
1477190|NCT00630786|4870086|P1|Overall Study|Lost to Follow-up|0
1477191|NCT00630786|4870084|P3|Overall Study|Withdrawal by Subject|1
1477192|NCT00630786|4870085|P2|Overall Study|Withdrawal by Subject|1
1477193|NCT00630786|4870086|P1|Overall Study|Withdrawal by Subject|0
1477194|NCT00630786|4870084|P3|Overall Study|Physician Decision|1
1477195|NCT00630786|4870085|P2|Overall Study|Physician Decision|0
1477196|NCT00630786|4870086|P1|Overall Study|Physician Decision|0
1477197|NCT00630747|4870105|P1|Overall Study|Returned to country of origin|1
1477198|NCT00630747|4870105|P1|Overall Study|Transferred to Study TKT031NPU|7
1477199|NCT00630747|4870105|P1|Overall Study|Death|1
1477200|NCT00630539|4870158|P4|Overall Study|Withdrawal by Subject|1
1477201|NCT00630539|4870159|P3|Overall Study|Withdrawal by Subject|0
1477202|NCT00630539|4870160|P2|Overall Study|Withdrawal by Subject|1
1477203|NCT00630539|4870161|P1|Overall Study|Withdrawal by Subject|0
1477204|NCT00630539|4870158|P4|Overall Study|Adverse Event|2
1477205|NCT00630539|4870159|P3|Overall Study|Adverse Event|1
1477206|NCT00630539|4870160|P2|Overall Study|Adverse Event|3
1477207|NCT00630539|4870161|P1|Overall Study|Adverse Event|1
1477208|NCT00630396|4870257|P1|Overall Study|Lost to Follow-up|3
1477209|NCT00630396|4870257|P1|Overall Study|Death|4
1477210|NCT00630344|4870263|P1|Overall Study|Other|1
1477211|NCT00630344|4870263|P1|Overall Study|Intercurrent Illness|1
1477212|NCT00630344|4870263|P1|Overall Study|Withdrawal by Subject|1
1477213|NCT00630344|4870263|P1|Overall Study|Physician Decision|9
1477214|NCT00630344|4870263|P1|Overall Study|Progressive Disease|19
1477215|NCT00630344|4870263|P1|Overall Study|Adverse Event|5
1477216|NCT00630331|4870275|P3|Overall Study|Protocol Violation|6
1477217|NCT00630331|4870276|P2|Overall Study|Protocol Violation|5
1477218|NCT00630331|4870277|P1|Overall Study|Protocol Violation|4
1477219|NCT00630331|4870275|P3|Overall Study|Unable to classify|3
1477220|NCT00630331|4870276|P2|Overall Study|Unable to classify|4
1477221|NCT00630331|4870277|P1|Overall Study|Unable to classify|9
1477222|NCT00630331|4870275|P3|Overall Study|Inappropriate enrollment|3
1477223|NCT00630331|4870276|P2|Overall Study|Inappropriate enrollment|6
1477224|NCT00630331|4870277|P1|Overall Study|Inappropriate enrollment|3
1477225|NCT00630331|4870275|P3|Overall Study|Lost to Follow-up|170
1477226|NCT00630331|4870276|P2|Overall Study|Lost to Follow-up|143
1477227|NCT00630331|4870277|P1|Overall Study|Lost to Follow-up|175
1477228|NCT00630331|4870275|P3|Overall Study|Withdrawal by Subject|5
1477229|NCT00630331|4870276|P2|Overall Study|Withdrawal by Subject|7
1477230|NCT00630331|4870277|P1|Overall Study|Withdrawal by Subject|12
1477231|NCT00630331|4870275|P3|Overall Study|Adverse Event|0
1477232|NCT00630331|4870276|P2|Overall Study|Adverse Event|0
1477233|NCT00630331|4870277|P1|Overall Study|Adverse Event|1
1477234|NCT00630331|4870275|P3|Overall Study|Death|1
1477235|NCT00630331|4870276|P2|Overall Study|Death|1
1477236|NCT00630331|4870277|P1|Overall Study|Death|2
1477237|NCT00630305|4870318|P1|Overall Study|Inability to insert contact lens|1
1477238|NCT00630305|4870318|P1|Overall Study|Withdrawal by Subject|1
1477239|NCT00630292|4870340|P1|Overall Study|Withdrawal by Subject|1
1477240|NCT00630058|4870346|P2|Overall Study|stopping criteria|2
1477241|NCT00630058|4870347|P1|Overall Study|stopping criteria|3
1477242|NCT00630058|4870346|P2|Overall Study|Withdrawal by Subject|1
1477243|NCT00630058|4870347|P1|Overall Study|Withdrawal by Subject|0
1477244|NCT00630058|4870346|P2|Overall Study|Adverse Event|1
1477245|NCT00630058|4870347|P1|Overall Study|Adverse Event|1
1477246|NCT00629772|4870378|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
1477247|NCT00629772|4870379|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
1477248|NCT00629772|4870378|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
1477249|NCT00629772|4870379|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
1477250|NCT00629707|4870399|P2|Overall Study|Physician Decision|1
1477251|NCT00629707|4870400|P1|Overall Study|Physician Decision|0
1477252|NCT00629707|4870399|P2|Overall Study|Withdrawal by Subject|1
1477253|NCT00629707|4870400|P1|Overall Study|Withdrawal by Subject|0
1477254|NCT00629265|4870420|P2|Overall Study|Unknown Reason|2
1477255|NCT00629265|4870421|P1|Overall Study|Unknown Reason|2
1477256|NCT00629265|4870420|P2|Overall Study|Unrelated Medical Complications|1
1477257|NCT00629265|4870421|P1|Overall Study|Unrelated Medical Complications|3
1477258|NCT00629265|4870420|P2|Overall Study|Needed Esophageal Dilation|1
1477259|NCT00629265|4870421|P1|Overall Study|Needed Esophageal Dilation|4
1477260|NCT00629265|4870420|P2|Overall Study|Other CA Requiring Treatment|3
1477261|NCT00629265|4870421|P1|Overall Study|Other CA Requiring Treatment|1
1477262|NCT00629265|4870420|P2|Overall Study|HNC Recurrence|0
1477263|NCT00629265|4870421|P1|Overall Study|HNC Recurrence|4
1477264|NCT00629265|4870420|P2|Overall Study|Adverse Event|0
1477265|NCT00629265|4870421|P1|Overall Study|Adverse Event|2
1477266|NCT00629265|4870420|P2|Overall Study|Death|0
1477267|NCT00629265|4870421|P1|Overall Study|Death|1
1477268|NCT00629265|4870420|P2|Overall Study|Withdrawal by Subject|8
1477269|NCT00629265|4870421|P1|Overall Study|Withdrawal by Subject|11
1477270|NCT00629265|4870420|P2|Overall Study|Lost to Follow-up|5
1477271|NCT00629265|4870421|P1|Overall Study|Lost to Follow-up|4
1477272|NCT00629239|4870431|P2|Overall Study|Physician Decision|0
1477273|NCT00629239|4870432|P1|Overall Study|Physician Decision|1
1477274|NCT00629239|4870431|P2|Overall Study|Adverse Event|4
1477275|NCT00629239|4870432|P1|Overall Study|Adverse Event|7
1477276|NCT00628927|4870496|P2|Overall Study|Equipment failure|0
1477277|NCT00628927|4870497|P1|Overall Study|Equipment failure|1
1477278|NCT00628927|4870496|P2|Overall Study|Lost to Follow-up|0
1477279|NCT00628927|4870497|P1|Overall Study|Lost to Follow-up|1
1477280|NCT00628927|4870496|P2|Overall Study|Problems performing blood draw|0
1477281|NCT00628927|4870497|P1|Overall Study|Problems performing blood draw|6
1477282|NCT00628862|4870542|P3|Overall Study|COPD Exacerbation|0
1477283|NCT00628862|4870543|P2|Overall Study|COPD Exacerbation|1
1477284|NCT00628862|4870544|P1|Overall Study|COPD Exacerbation|0
1477285|NCT00628862|4870542|P3|Overall Study|Protocol Violation|0
1477286|NCT00628862|4870543|P2|Overall Study|Protocol Violation|0
1477287|NCT00628862|4870544|P1|Overall Study|Protocol Violation|1
1477288|NCT00628862|4870542|P3|Overall Study|Lost to Follow-up|1
1477289|NCT00628862|4870543|P2|Overall Study|Lost to Follow-up|2
1477290|NCT00628862|4870544|P1|Overall Study|Lost to Follow-up|0
1477291|NCT00628862|4870542|P3|Overall Study|Withdrawal by Subject|11
1477292|NCT00628862|4870543|P2|Overall Study|Withdrawal by Subject|6
1477293|NCT00628862|4870544|P1|Overall Study|Withdrawal by Subject|4
1477294|NCT00628862|4870542|P3|Overall Study|Adverse Event|10
1477295|NCT00628862|4870543|P2|Overall Study|Adverse Event|8
1477296|NCT00628862|4870544|P1|Overall Study|Adverse Event|6
1477297|NCT00628758|4870590|P2|Overall Study|Treatment Failure|2
1477298|NCT00628758|4870591|P1|Overall Study|Treatment Failure|0
1477299|NCT00628758|4870590|P2|Overall Study|Investigator Moved|0
1477300|NCT00628758|4870591|P1|Overall Study|Investigator Moved|3
1477301|NCT00628758|4870590|P2|Overall Study|Pregnancy|2
1477302|NCT00628758|4870591|P1|Overall Study|Pregnancy|2
1477303|NCT00628758|4870590|P2|Overall Study|Lost to Follow-up|31
1477304|NCT00628758|4870591|P1|Overall Study|Lost to Follow-up|25
1477305|NCT00628758|4870590|P2|Overall Study|Protocol Violation|1
1477306|NCT00628758|4870591|P1|Overall Study|Protocol Violation|5
1477307|NCT00628758|4870590|P2|Overall Study|Death|0
1477308|NCT00628758|4870591|P1|Overall Study|Death|1
1477309|NCT00628758|4870590|P2|Overall Study|Withdrawal by Subject|3
1477310|NCT00628758|4870591|P1|Overall Study|Withdrawal by Subject|6
1477311|NCT00628758|4870590|P2|Overall Study|Adverse Event|3
1477312|NCT00628758|4870591|P1|Overall Study|Adverse Event|2
1477313|NCT00628446|4870635|P1|Overall Study|Protocol Violation|3
1477314|NCT00628446|4870635|P1|Overall Study|Withdrawal by Subject|1
1477315|NCT00628446|4870635|P1|Overall Study|Lost to Follow-up|3
1477316|NCT00628355|4870646|P2|Overall Study|Withdrawal by Subject|1
1477317|NCT00628355|4870647|P1|Overall Study|Withdrawal by Subject|1
1477318|NCT00628251|4870658|P3|Cross-over/ Continuation of Olaparib|Other|0
1477319|NCT00628251|4870659|P2|Cross-over/ Continuation of Olaparib|Other|1
1477320|NCT00628251|4870660|P1|Cross-over/ Continuation of Olaparib|Other|1
1477321|NCT00628251|4870658|P3|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|4
1477322|NCT00628251|4870659|P2|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|2
1477323|NCT00628251|4870660|P1|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|1
1477324|NCT00628251|4870658|P3|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|13
1477325|NCT00628251|4870659|P2|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|21
1477326|NCT00628251|4870660|P1|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|24
1477327|NCT00628251|4870658|P3|Cross-over/ Continuation of Olaparib|Adverse Event|0
1477328|NCT00628251|4870659|P2|Cross-over/ Continuation of Olaparib|Adverse Event|2
1477329|NCT00628251|4870660|P1|Cross-over/ Continuation of Olaparib|Adverse Event|1
1477330|NCT00628251|4870658|P3|Randomised Part|Did not receive cross over treatment|8
1477331|NCT00628251|4870659|P2|Randomised Part|Did not receive cross over treatment|0
1477332|NCT00628251|4870660|P1|Randomised Part|Did not receive cross over treatment|0
1477333|NCT00628212|4870703|P4|Overall Study|Physician Decision|3
1477334|NCT00628212|4870704|P3|Overall Study|Physician Decision|2
1477335|NCT00628212|4870705|P2|Overall Study|Physician Decision|1
1477336|NCT00628212|4870706|P1|Overall Study|Physician Decision|1
1477337|NCT00628212|4870703|P4|Overall Study|Adverse Event|2
1477338|NCT00628212|4870704|P3|Overall Study|Adverse Event|1
1477339|NCT00628212|4870705|P2|Overall Study|Adverse Event|0
1477340|NCT00628212|4870706|P1|Overall Study|Adverse Event|2
1477341|NCT00628108|4870754|P2|Overall Study|Withdrawal by Subject|0
1477342|NCT00628108|4870755|P1|Overall Study|Withdrawal by Subject|1
1477343|NCT00628108|4870754|P2|Overall Study|Adverse Event|3
1477344|NCT00628108|4870755|P1|Overall Study|Adverse Event|0
1477345|NCT00628030|4870787|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
1477346|NCT00628030|4870788|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
1477347|NCT00628030|4870787|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
1477348|NCT00628030|4870788|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
1477349|NCT00628030|4870787|P2|Baseline to Post-Assessment|Lost to Follow-up|29
1477350|NCT00628030|4870788|P1|Baseline to Post-Assessment|Lost to Follow-up|28
1477351|NCT00627926|4870814|P3|Overall Study|Noncompliance/unspecified|17
1477352|NCT00627926|4870815|P2|Overall Study|Noncompliance/unspecified|23
1477353|NCT00627926|4870816|P1|Overall Study|Noncompliance/unspecified|8
1477354|NCT00627926|4870814|P3|Overall Study|Lack of Efficacy|38
1477355|NCT00627926|4870815|P2|Overall Study|Lack of Efficacy|40
1477356|NCT00627926|4870816|P1|Overall Study|Lack of Efficacy|118
1477357|NCT00627926|4870814|P3|Overall Study|Withdrawal by Subject|0
1477358|NCT00627926|4870815|P2|Overall Study|Withdrawal by Subject|1
1477359|NCT00627926|4870816|P1|Overall Study|Withdrawal by Subject|2
1477360|NCT00627926|4870814|P3|Overall Study|Lost to Follow-up|4
1477361|NCT00627926|4870815|P2|Overall Study|Lost to Follow-up|3
1477362|NCT00627926|4870816|P1|Overall Study|Lost to Follow-up|4
1477363|NCT00627926|4870814|P3|Overall Study|Death|0
1477364|NCT00627926|4870815|P2|Overall Study|Death|0
1477365|NCT00627926|4870816|P1|Overall Study|Death|1
1477366|NCT00627926|4870814|P3|Overall Study|Adverse Event|36
1477367|NCT00627926|4870815|P2|Overall Study|Adverse Event|37
1477368|NCT00627926|4870816|P1|Overall Study|Adverse Event|26
1477369|NCT00627705|4870868|P2|Overall Study|Lost to Follow-up|1
1477370|NCT00627705|4870869|P1|Overall Study|Lost to Follow-up|0
1477371|NCT00627705|4870868|P2|Overall Study|Withdrawal by Subject|2
1477372|NCT00627705|4870869|P1|Overall Study|Withdrawal by Subject|0
1477373|NCT00627705|4870868|P2|Overall Study|Adverse Event|0
1477374|NCT00627705|4870869|P1|Overall Study|Adverse Event|1
1477375|NCT00627705|4870868|P2|Overall Study|Unwilling to take the compound (taste)|3
1477376|NCT00627705|4870869|P1|Overall Study|Unwilling to take the compound (taste)|1
1477377|NCT00627523|4870920|P2|Overall Study|Not specified|0
1477378|NCT00627523|4870921|P1|Overall Study|Not specified|1
1477379|NCT00627523|4870920|P2|Overall Study|Withdrawal by Subject|2
1477380|NCT00627523|4870921|P1|Overall Study|Withdrawal by Subject|0
1477381|NCT00627523|4870920|P2|Overall Study|Lack of Efficacy|0
1477382|NCT00627523|4870921|P1|Overall Study|Lack of Efficacy|1
1477383|NCT00627497|4870949|P4|Overall Study|Lost to Follow-up|0
1477384|NCT00627497|4870950|P3|Overall Study|Lost to Follow-up|0
1477385|NCT00627497|4870951|P2|Overall Study|Lost to Follow-up|1
1477386|NCT00627497|4870952|P1|Overall Study|Lost to Follow-up|1
1477387|NCT00627458|4871013|P3|Overall Study|Lost to Follow-up|0
1477388|NCT00627458|4871014|P2|Overall Study|Lost to Follow-up|1
1477389|NCT00627458|4871015|P1|Overall Study|Lost to Follow-up|1
1477390|NCT00627458|4871013|P3|Overall Study|Withdrawal by Subject|5
1477391|NCT00627458|4871014|P2|Overall Study|Withdrawal by Subject|6
1477392|NCT00627458|4871015|P1|Overall Study|Withdrawal by Subject|2
1477393|NCT00627458|4871013|P3|Overall Study|Migrated from study area|1
1477394|NCT00627458|4871014|P2|Overall Study|Migrated from study area|0
1477395|NCT00627458|4871015|P1|Overall Study|Migrated from study area|1
1477396|NCT00627445|4871090|P2|Overall Study|Other|8
1477397|NCT00627445|4871091|P1|Overall Study|Other|6
1477398|NCT00627445|4871090|P2|Overall Study|Lack of Efficacy|1
1477399|NCT00627445|4871091|P1|Overall Study|Lack of Efficacy|0
1477400|NCT00627445|4871090|P2|Overall Study|Adverse Event|3
1477401|NCT00627445|4871091|P1|Overall Study|Adverse Event|3
1477402|NCT00627393|4871134|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
1477403|NCT00627393|4871135|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
1477404|NCT00627393|4871134|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
1477405|NCT00627393|4871135|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
1477406|NCT00627393|4871134|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
1477407|NCT00627393|4871135|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
1477408|NCT00627393|4871134|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
1477409|NCT00627393|4871135|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
1477410|NCT00627094|4871171|P2|Overall Study|Other reason|0
1477411|NCT00627094|4871172|P1|Overall Study|Other reason|1
1477412|NCT00627094|4871171|P2|Overall Study|ulcer healed|7
1477413|NCT00627094|4871172|P1|Overall Study|ulcer healed|1
1477414|NCT00627094|4871171|P2|Overall Study|Withdrawal by Subject|1
1477415|NCT00627094|4871172|P1|Overall Study|Withdrawal by Subject|1
1477416|NCT00627094|4871171|P2|Overall Study|Lost to Follow-up|0
1477417|NCT00627094|4871172|P1|Overall Study|Lost to Follow-up|1
1477418|NCT00627094|4871171|P2|Overall Study|Adverse Event|7
1477419|NCT00627094|4871172|P1|Overall Study|Adverse Event|8
1477420|NCT00627042|4871184|P1|Overall Study|Withdrawal by Subject|2
1477421|NCT00627016|4871196|P2|Overall Study|Pregnancy|0
1477422|NCT00627016|4871197|P1|Overall Study|Pregnancy|1
1477423|NCT00627016|4871196|P2|Overall Study|Placed on Excluded Drugs|0
1477424|NCT00627016|4871197|P1|Overall Study|Placed on Excluded Drugs|1
1477425|NCT00627016|4871196|P2|Overall Study|Lack of Efficacy|0
1477426|NCT00627016|4871197|P1|Overall Study|Lack of Efficacy|1
1477427|NCT00627016|4871196|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
1477428|NCT00627016|4871197|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
1477429|NCT00627016|4871196|P2|Overall Study|Withdrawal by Subject|1
1477430|NCT00627016|4871197|P1|Overall Study|Withdrawal by Subject|2
1477431|NCT00627016|4871196|P2|Overall Study|Lost to Follow-up|1
1477432|NCT00627016|4871197|P1|Overall Study|Lost to Follow-up|0
1477433|NCT00627016|4871196|P2|Overall Study|Protocol Violation|2
1477434|NCT00627016|4871197|P1|Overall Study|Protocol Violation|0
1477435|NCT00627016|4871196|P2|Overall Study|Adverse Event|1
1477436|NCT00627016|4871197|P1|Overall Study|Adverse Event|1
1477437|NCT00626925|4871209|P2|Overall Study|Time constraints|1
1477438|NCT00626925|4871210|P1|Overall Study|Time constraints|3
1477439|NCT00626925|4871209|P2|Overall Study|Lack of Efficacy|4
1477440|NCT00626925|4871210|P1|Overall Study|Lack of Efficacy|1
1477441|NCT00626925|4871209|P2|Overall Study|Adverse effect|2
1477442|NCT00626925|4871210|P1|Overall Study|Adverse effect|6
1477443|NCT00626925|4871209|P2|Overall Study|relapse|0
1477444|NCT00626925|4871210|P1|Overall Study|relapse|1
1477445|NCT00626925|4871209|P2|Overall Study|Lost to Follow-up|2
1477446|NCT00626925|4871210|P1|Overall Study|Lost to Follow-up|1
1477447|NCT00626821|4871242|P1|Overall Study|other/unknown reason|104
1477448|NCT00626821|4871242|P1|Overall Study|Product dysfunction|21
1477449|NCT00626821|4871242|P1|Overall Study|Physician Decision|9
1477450|NCT00626821|4871242|P1|Overall Study|Withdrawal by Subject|10
1477451|NCT00626821|4871242|P1|Overall Study|Protocol Violation|33
1477452|NCT00626821|4871242|P1|Overall Study|Adverse Event|44
1477453|NCT00626795|4871322|P3|Blinded Treatment|Missing reason for withdrawal|5
1477454|NCT00626795|4871323|P2|Blinded Treatment|Missing reason for withdrawal|3
1477455|NCT00626795|4871324|P1|Blinded Treatment|Missing reason for withdrawal|5
1477456|NCT00626795|4871322|P3|Blinded Treatment|Other reasons|2
1477457|NCT00626795|4871323|P2|Blinded Treatment|Other reasons|0
1477458|NCT00626795|4871324|P1|Blinded Treatment|Other reasons|2
1477459|NCT00626795|4871322|P3|Blinded Treatment|Withdrawal by Subject|0
1477460|NCT00626795|4871323|P2|Blinded Treatment|Withdrawal by Subject|1
1477461|NCT00626795|4871324|P1|Blinded Treatment|Withdrawal by Subject|1
1477462|NCT00626795|4871322|P3|Blinded Treatment|Protocol Violation|1
1477463|NCT00626795|4871323|P2|Blinded Treatment|Protocol Violation|1
1477464|NCT00626795|4871324|P1|Blinded Treatment|Protocol Violation|0
1477465|NCT00626795|4871322|P3|Blinded Treatment|Unacceptable adverse event|1
1477466|NCT00626795|4871323|P2|Blinded Treatment|Unacceptable adverse event|0
1477467|NCT00626795|4871324|P1|Blinded Treatment|Unacceptable adverse event|0
1477468|NCT00626795|4871322|P3|Blinded Treatment|Lack of Efficacy|0
1477469|NCT00626795|4871323|P2|Blinded Treatment|Lack of Efficacy|0
1477470|NCT00626795|4871324|P1|Blinded Treatment|Lack of Efficacy|2
1477471|NCT00626795|4871322|P3|Open-label TD1414 Cream TID Treatment|Adverse Event|0
1477472|NCT00626795|4871323|P2|Open-label TD1414 Cream TID Treatment|Adverse Event|1
1477473|NCT00626795|4871324|P1|Open-label TD1414 Cream TID Treatment|Adverse Event|0
1477474|NCT00626639|4871375|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
1477475|NCT00626639|4871376|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
1477476|NCT00626561|4871422|P1|Overall Study|Disease Progression|2
1477477|NCT00626561|4871422|P1|Overall Study|Withdrawal by Subject|2
1477478|NCT00626548|4871428|P2|Overall Study|Other termination reason|613
1477479|NCT00626548|4871429|P1|Overall Study|Other termination reason|493
1477480|NCT00626548|4871428|P2|Overall Study|Lost to Follow-up|2
1477481|NCT00626548|4871429|P1|Overall Study|Lost to Follow-up|2
1477482|NCT00626548|4871428|P2|Overall Study|Protocol Violation|11
1477483|NCT00626548|4871429|P1|Overall Study|Protocol Violation|4
1477484|NCT00626548|4871428|P2|Overall Study|Withdrawal by Subject|46
1477485|NCT00626548|4871429|P1|Overall Study|Withdrawal by Subject|42
1477486|NCT00626548|4871428|P2|Overall Study|Adverse Event|44
1477487|NCT00626548|4871429|P1|Overall Study|Adverse Event|164
1477488|NCT00626522|4871443|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
1477489|NCT00626522|4871444|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
1477490|NCT00626522|4871445|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
1477491|NCT00626522|4871446|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
1477492|NCT00626522|4871447|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
1477493|NCT00626522|4871448|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
1477494|NCT00626522|4871443|P6|Overall Study|Inconsistent reason reported|0
1477495|NCT00626522|4871444|P5|Overall Study|Inconsistent reason reported|0
1477496|NCT00626522|4871445|P4|Overall Study|Inconsistent reason reported|0
1477497|NCT00626522|4871446|P3|Overall Study|Inconsistent reason reported|0
1477498|NCT00626522|4871447|P2|Overall Study|Inconsistent reason reported|0
1477499|NCT00626522|4871448|P1|Overall Study|Inconsistent reason reported|1
1477500|NCT00626522|4871443|P6|Overall Study|Lost to Follow-up|0
1477501|NCT00626522|4871444|P5|Overall Study|Lost to Follow-up|0
1477502|NCT00626522|4871445|P4|Overall Study|Lost to Follow-up|0
1477503|NCT00626522|4871446|P3|Overall Study|Lost to Follow-up|0
1477504|NCT00626522|4871447|P2|Overall Study|Lost to Follow-up|1
1477505|NCT00626522|4871448|P1|Overall Study|Lost to Follow-up|0
1477506|NCT00626522|4871443|P6|Overall Study|COPD exacerbation|0
1477507|NCT00626522|4871444|P5|Overall Study|COPD exacerbation|1
1477508|NCT00626522|4871445|P4|Overall Study|COPD exacerbation|1
1477509|NCT00626522|4871446|P3|Overall Study|COPD exacerbation|0
1477510|NCT00626522|4871447|P2|Overall Study|COPD exacerbation|0
1477511|NCT00626522|4871448|P1|Overall Study|COPD exacerbation|0
1477512|NCT00626522|4871443|P6|Overall Study|Withdrawal by Subject|1
1477513|NCT00626522|4871444|P5|Overall Study|Withdrawal by Subject|4
1477514|NCT00626522|4871445|P4|Overall Study|Withdrawal by Subject|0
1477515|NCT00626522|4871446|P3|Overall Study|Withdrawal by Subject|5
1477516|NCT00626522|4871447|P2|Overall Study|Withdrawal by Subject|5
1477517|NCT00626522|4871448|P1|Overall Study|Withdrawal by Subject|2
1477518|NCT00626522|4871443|P6|Overall Study|Adverse Event|1
1477519|NCT00626522|4871444|P5|Overall Study|Adverse Event|1
1477520|NCT00626522|4871445|P4|Overall Study|Adverse Event|0
1477521|NCT00626522|4871446|P3|Overall Study|Adverse Event|2
1477522|NCT00626522|4871447|P2|Overall Study|Adverse Event|1
1477523|NCT00626522|4871448|P1|Overall Study|Adverse Event|2
1477524|NCT00626522|4871443|P6|Overall Study|Protocol Violation|0
1477525|NCT00626522|4871444|P5|Overall Study|Protocol Violation|1
1477526|NCT00626522|4871445|P4|Overall Study|Protocol Violation|0
1477527|NCT00626522|4871446|P3|Overall Study|Protocol Violation|0
1477528|NCT00626522|4871447|P2|Overall Study|Protocol Violation|0
1477529|NCT00626522|4871448|P1|Overall Study|Protocol Violation|0
1477530|NCT00626405|4871511|P2|Overall Study|Withdrawal by Subject|1
1477531|NCT00626405|4871512|P1|Overall Study|Withdrawal by Subject|0
1477532|NCT00626405|4871511|P2|Overall Study|Deemed Ineligible|0
1477533|NCT00626405|4871512|P1|Overall Study|Deemed Ineligible|1
1477534|NCT00626392|4871528|P6|Coadministration Period|Other|1
1477535|NCT00626392|4871529|P5|Coadministration Period|Other|1
1477536|NCT00626392|4871530|P4|Coadministration Period|Other|1
1477537|NCT00626392|4871531|P3|Coadministration Period|Other|3
1477538|NCT00626392|4871532|P2|Coadministration Period|Other|2
1477539|NCT00626392|4871533|P1|Coadministration Period|Other|0
1477540|NCT00626392|4871528|P6|Coadministration Period|Protocol Violation|0
1477541|NCT00626392|4871529|P5|Coadministration Period|Protocol Violation|1
1477542|NCT00626392|4871530|P4|Coadministration Period|Protocol Violation|1
1477543|NCT00626392|4871531|P3|Coadministration Period|Protocol Violation|0
1477544|NCT00626392|4871532|P2|Coadministration Period|Protocol Violation|1
1477545|NCT00626392|4871533|P1|Coadministration Period|Protocol Violation|0
1477546|NCT00626392|4871528|P6|Coadministration Period|Withdrawal by Subject|1
1477547|NCT00626392|4871529|P5|Coadministration Period|Withdrawal by Subject|0
1477548|NCT00626392|4871530|P4|Coadministration Period|Withdrawal by Subject|1
1477549|NCT00626392|4871531|P3|Coadministration Period|Withdrawal by Subject|0
1477550|NCT00626392|4871532|P2|Coadministration Period|Withdrawal by Subject|1
1477551|NCT00626392|4871533|P1|Coadministration Period|Withdrawal by Subject|1
1477552|NCT00626392|4871528|P6|Coadministration Period|Adverse Event|4
1477553|NCT00626392|4871529|P5|Coadministration Period|Adverse Event|3
1477554|NCT00626392|4871530|P4|Coadministration Period|Adverse Event|4
1477555|NCT00626392|4871531|P3|Coadministration Period|Adverse Event|7
1477556|NCT00626392|4871532|P2|Coadministration Period|Adverse Event|1
1477557|NCT00626392|4871533|P1|Coadministration Period|Adverse Event|3
1477558|NCT00626392|4871528|P6|Run-in Period|Noncompliance|0
1477559|NCT00626392|4871529|P5|Run-in Period|Noncompliance|0
1477560|NCT00626392|4871530|P4|Run-in Period|Noncompliance|0
1477561|NCT00626392|4871531|P3|Run-in Period|Noncompliance|1
1477562|NCT00626392|4871532|P2|Run-in Period|Noncompliance|0
1477563|NCT00626392|4871533|P1|Run-in Period|Noncompliance|1
1477564|NCT00626392|4871528|P6|Run-in Period|Withdrawal by Subject|1
1477565|NCT00626392|4871529|P5|Run-in Period|Withdrawal by Subject|3
1477566|NCT00626392|4871530|P4|Run-in Period|Withdrawal by Subject|1
1477567|NCT00626392|4871531|P3|Run-in Period|Withdrawal by Subject|1
1477568|NCT00626392|4871532|P2|Run-in Period|Withdrawal by Subject|1
1477569|NCT00626392|4871533|P1|Run-in Period|Withdrawal by Subject|0
1477570|NCT00626392|4871528|P6|Run-in Period|Adverse Event|0
1477571|NCT00626392|4871529|P5|Run-in Period|Adverse Event|1
1477572|NCT00626392|4871530|P4|Run-in Period|Adverse Event|0
1477573|NCT00626392|4871531|P3|Run-in Period|Adverse Event|1
1477574|NCT00626392|4871532|P2|Run-in Period|Adverse Event|0
1477575|NCT00626392|4871533|P1|Run-in Period|Adverse Event|0
1477576|NCT00626327|4871552|P3|Overall Study|Protocol Violation|26
1477577|NCT00626327|4871553|P2|Overall Study|Protocol Violation|4
1477578|NCT00626327|4871554|P1|Overall Study|Protocol Violation|26
1477579|NCT00626327|4871552|P3|Overall Study|Administrative Reason|6
1477580|NCT00626327|4871553|P2|Overall Study|Administrative Reason|0
1477581|NCT00626327|4871554|P1|Overall Study|Administrative Reason|2
1477582|NCT00626327|4871552|P3|Overall Study|Inappropriate enrollment|3
1477583|NCT00626327|4871553|P2|Overall Study|Inappropriate enrollment|5
1477584|NCT00626327|4871554|P1|Overall Study|Inappropriate enrollment|4
1477585|NCT00626327|4871552|P3|Overall Study|Lost to Follow-up|23
1477586|NCT00626327|4871553|P2|Overall Study|Lost to Follow-up|21
1477587|NCT00626327|4871554|P1|Overall Study|Lost to Follow-up|24
1477588|NCT00626327|4871552|P3|Overall Study|Adverse Event|0
1477589|NCT00626327|4871553|P2|Overall Study|Adverse Event|0
1477590|NCT00626327|4871554|P1|Overall Study|Adverse Event|1
1477591|NCT00626327|4871552|P3|Overall Study|Withdrawal by Subject|30
1477592|NCT00626327|4871553|P2|Overall Study|Withdrawal by Subject|29
1477593|NCT00626327|4871554|P1|Overall Study|Withdrawal by Subject|21
1477594|NCT00626275|4871580|P8|Part B|Withdrawal by Subject|1
1477595|NCT00626275|4871581|P7|Part B|Withdrawal by Subject|0
1477596|NCT00626275|4871582|P6|Part B|Withdrawal by Subject|0
1477597|NCT00626275|4871583|P5|Part B|Withdrawal by Subject|0
1477598|NCT00626275|4871584|P4|Part B|Withdrawal by Subject|0
1477599|NCT00626275|4871585|P3|Part B|Withdrawal by Subject|0
1477600|NCT00626275|4871586|P2|Part B|Withdrawal by Subject|0
1477601|NCT00626275|4871587|P1|Part B|Withdrawal by Subject|0
1477602|NCT00626275|4871580|P8|Part B|Lost to Follow-up|0
1477603|NCT00626275|4871581|P7|Part B|Lost to Follow-up|1
1477604|NCT00626275|4871582|P6|Part B|Lost to Follow-up|0
1477605|NCT00626275|4871583|P5|Part B|Lost to Follow-up|0
1477606|NCT00626275|4871584|P4|Part B|Lost to Follow-up|0
1477607|NCT00626275|4871585|P3|Part B|Lost to Follow-up|0
1477608|NCT00626275|4871586|P2|Part B|Lost to Follow-up|0
1477609|NCT00626275|4871587|P1|Part B|Lost to Follow-up|0
1477610|NCT00626275|4871580|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
1477611|NCT00626275|4871581|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
1477612|NCT00626275|4871582|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
1477613|NCT00626275|4871583|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
1477614|NCT00626275|4871584|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
1477615|NCT00626275|4871585|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
1477616|NCT00626275|4871586|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
1477617|NCT00626275|4871587|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
1477618|NCT00626275|4871580|P8|Part A - Treatment Period 1|Adverse Event|0
1477619|NCT00626275|4871581|P7|Part A - Treatment Period 1|Adverse Event|0
1477620|NCT00626275|4871582|P6|Part A - Treatment Period 1|Adverse Event|0
1477621|NCT00626275|4871583|P5|Part A - Treatment Period 1|Adverse Event|0
1477622|NCT00626275|4871584|P4|Part A - Treatment Period 1|Adverse Event|0
1477623|NCT00626275|4871585|P3|Part A - Treatment Period 1|Adverse Event|0
1477624|NCT00626275|4871586|P2|Part A - Treatment Period 1|Adverse Event|0
1477625|NCT00626275|4871587|P1|Part A - Treatment Period 1|Adverse Event|1
1477626|NCT00626093|4871631|P1|Overall Study|One of the required devices not implante|6
1477627|NCT00626093|4871631|P1|Overall Study|Protocol Violation|1
1477628|NCT00626093|4871631|P1|Overall Study|Withdrawal by Subject|6
1477629|NCT00626093|4871631|P1|Overall Study|Physician Decision|4
1477630|NCT00626093|4871631|P1|Overall Study|Death|1
1477631|NCT00626093|4871631|P1|Overall Study|Lost to Follow-up|5
1477632|NCT00626028|4871638|P2|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|6
1477633|NCT00626028|4871639|P1|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|3
1477634|NCT00626028|4871638|P2|Treatment 1 NO First, O2 Last|Physician Decision|1
1477635|NCT00626028|4871639|P1|Treatment 1 NO First, O2 Last|Physician Decision|2
1477636|NCT00626028|4871638|P2|Treatment 1 NO First, O2 Last|Device Failure|1
1477637|NCT00626028|4871639|P1|Treatment 1 NO First, O2 Last|Device Failure|0
1477638|NCT00626028|4871638|P2|Treatment 1 NO First, O2 Last|Adverse Event|1
1477639|NCT00626028|4871639|P1|Treatment 1 NO First, O2 Last|Adverse Event|1
1477640|NCT00625872|4871659|P2|Overall Study|Randomized but not treated|1
1477641|NCT00625872|4871660|P1|Overall Study|Randomized but not treated|0
1477642|NCT00625872|4871659|P2|Overall Study|Terminated by sponsor|5
1477643|NCT00625872|4871660|P1|Overall Study|Terminated by sponsor|2
1477644|NCT00625872|4871659|P2|Overall Study|Does not meet inclusion criteria|0
1477645|NCT00625872|4871660|P1|Overall Study|Does not meet inclusion criteria|1
1477646|NCT00625872|4871659|P2|Overall Study|Withdrawal by Subject|0
1477647|NCT00625872|4871660|P1|Overall Study|Withdrawal by Subject|1
1477648|NCT00625820|4871770|P1|Overall Study|Withdrawal by Subject|1
1477649|NCT00625807|4871778|P2|Overall Study|schedule conflict|8
1477650|NCT00625807|4871779|P1|Overall Study|schedule conflict|2
1477651|NCT00625742|4871795|P1|Overall Study|Ineligible|1
1477652|NCT00625742|4871795|P1|Overall Study|Lost to Follow-up|4
1477653|NCT00625742|4871795|P1|Overall Study|Adverse Event|4
1477654|NCT00625742|4871795|P1|Overall Study|Withdrawal by Subject|1
1477655|NCT00625742|4871795|P1|Overall Study|Disease Progression|2
1477656|NCT00625586|4871809|P1|Overall Study|Adverse Event|1
1477657|NCT00625443|4871822|P3|Overall Study|Not specified|1
1477658|NCT00625443|4871823|P2|Overall Study|Not specified|1
1477659|NCT00625443|4871824|P1|Overall Study|Not specified|0
1477660|NCT00625443|4871822|P3|Overall Study|Physician Decision|2
1477661|NCT00625443|4871823|P2|Overall Study|Physician Decision|4
1477662|NCT00625443|4871824|P1|Overall Study|Physician Decision|0
1477663|NCT00625443|4871822|P3|Overall Study|Withdrawal by Subject|2
1477664|NCT00625443|4871823|P2|Overall Study|Withdrawal by Subject|1
1477665|NCT00625443|4871824|P1|Overall Study|Withdrawal by Subject|0
1477666|NCT00625443|4871822|P3|Overall Study|Platelet count increase >=500,000/mm3|0
1477667|NCT00625443|4871823|P2|Overall Study|Platelet count increase >=500,000/mm3|0
1477668|NCT00625443|4871824|P1|Overall Study|Platelet count increase >=500,000/mm3|1
1477669|NCT00625443|4871822|P3|Overall Study|Non-compliance with protocol|0
1477670|NCT00625443|4871823|P2|Overall Study|Non-compliance with protocol|1
1477671|NCT00625443|4871824|P1|Overall Study|Non-compliance with protocol|0
1477672|NCT00625443|4871822|P3|Overall Study|Adverse Event|0
1477673|NCT00625443|4871823|P2|Overall Study|Adverse Event|4
1477674|NCT00625443|4871824|P1|Overall Study|Adverse Event|1
1477675|NCT00625365|4871904|P1|Overall Study|VSD|1
1477676|NCT00625365|4871904|P1|Overall Study|No IV access|5
1477677|NCT00625365|4871904|P1|Overall Study|Withdrawal by Subject|1
1477678|NCT00625183|4871910|P1|Overall Study|Disease Progression|1
1477679|NCT00625131|4871921|P3|Overall Study|Withdrawal by Subject|5
1477680|NCT00625131|4871922|P2|Overall Study|Withdrawal by Subject|0
1477681|NCT00625131|4871923|P1|Overall Study|Withdrawal by Subject|1
1477682|NCT00625131|4871921|P3|Overall Study|Lost to Follow-up|0
1477683|NCT00625131|4871922|P2|Overall Study|Lost to Follow-up|2
1477684|NCT00625131|4871923|P1|Overall Study|Lost to Follow-up|3
1477685|NCT00624832|4871946|P4|Overall Study|Abnormal Laboratory Value|0
1477686|NCT00624832|4871947|P3|Overall Study|Abnormal Laboratory Value|0
1477687|NCT00624832|4871948|P2|Overall Study|Abnormal Laboratory Value|0
1477688|NCT00624832|4871949|P1|Overall Study|Abnormal Laboratory Value|2
1477689|NCT00624832|4871946|P4|Overall Study|Adverse Event|1
1477690|NCT00624832|4871947|P3|Overall Study|Adverse Event|0
1477691|NCT00624832|4871948|P2|Overall Study|Adverse Event|1
1477692|NCT00624832|4871949|P1|Overall Study|Adverse Event|0
1477693|NCT00624780|4871980|P6|Follow-up (Week 26)|Other|0
1477694|NCT00624780|4871981|P5|Follow-up (Week 26)|Other|0
1477695|NCT00624780|4871982|P4|Follow-up (Week 26)|Other|0
1477696|NCT00624780|4871983|P3|Follow-up (Week 26)|Other|0
1477697|NCT00624780|4871984|P2|Follow-up (Week 26)|Other|1
1477698|NCT00624780|4871985|P1|Follow-up (Week 26)|Other|1
1477699|NCT00624780|4871980|P6|Follow-up (Week 26)|Withdrawal by Subject|0
1477700|NCT00624780|4871981|P5|Follow-up (Week 26)|Withdrawal by Subject|0
1477701|NCT00624780|4871982|P4|Follow-up (Week 26)|Withdrawal by Subject|0
1477702|NCT00624780|4871983|P3|Follow-up (Week 26)|Withdrawal by Subject|0
1477703|NCT00624780|4871984|P2|Follow-up (Week 26)|Withdrawal by Subject|0
1477704|NCT00624780|4871985|P1|Follow-up (Week 26)|Withdrawal by Subject|1
1477705|NCT00624780|4871980|P6|Follow-up (Week 26)|Lost to Follow-up|0
1477706|NCT00624780|4871981|P5|Follow-up (Week 26)|Lost to Follow-up|1
1477707|NCT00624780|4871982|P4|Follow-up (Week 26)|Lost to Follow-up|0
1477708|NCT00624780|4871983|P3|Follow-up (Week 26)|Lost to Follow-up|1
1477709|NCT00624780|4871984|P2|Follow-up (Week 26)|Lost to Follow-up|0
1477710|NCT00624780|4871985|P1|Follow-up (Week 26)|Lost to Follow-up|0
1477711|NCT00624780|4871980|P6|Follow-up (Week 26)|Adverse Event|0
1477712|NCT00624780|4871981|P5|Follow-up (Week 26)|Adverse Event|1
1477713|NCT00624780|4871982|P4|Follow-up (Week 26)|Adverse Event|0
1477714|NCT00624780|4871983|P3|Follow-up (Week 26)|Adverse Event|0
1477715|NCT00624780|4871984|P2|Follow-up (Week 26)|Adverse Event|0
1477716|NCT00624780|4871985|P1|Follow-up (Week 26)|Adverse Event|0
1477717|NCT00624780|4871980|P6|Follow-up (Week 26)|Death|0
1477718|NCT00624780|4871981|P5|Follow-up (Week 26)|Death|0
1477719|NCT00624780|4871982|P4|Follow-up (Week 26)|Death|0
1477720|NCT00624780|4871983|P3|Follow-up (Week 26)|Death|1
1477721|NCT00624780|4871984|P2|Follow-up (Week 26)|Death|0
1477722|NCT00624780|4871985|P1|Follow-up (Week 26)|Death|0
1477723|NCT00624780|4871980|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
1477724|NCT00624780|4871981|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
1477725|NCT00624780|4871982|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
1477726|NCT00624780|4871983|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
1477727|NCT00624780|4871984|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
1477728|NCT00624780|4871985|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
1477729|NCT00624780|4871980|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
1477730|NCT00624780|4871981|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
1477731|NCT00624780|4871982|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
1477732|NCT00624780|4871983|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
1477733|NCT00624780|4871984|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
1477734|NCT00624780|4871985|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
1477735|NCT00624780|4871980|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
1477736|NCT00624780|4871981|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
1477737|NCT00624780|4871982|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
1477738|NCT00624780|4871983|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
1477739|NCT00624780|4871984|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
1477740|NCT00624780|4871985|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
1477741|NCT00624780|4871980|P6|Fixed Dosing (Week 13 to Week 24)|Other|3
1477742|NCT00624780|4871981|P5|Fixed Dosing (Week 13 to Week 24)|Other|4
1477743|NCT00624780|4871982|P4|Fixed Dosing (Week 13 to Week 24)|Other|1
1477744|NCT00624780|4871983|P3|Fixed Dosing (Week 13 to Week 24)|Other|4
1477745|NCT00624780|4871984|P2|Fixed Dosing (Week 13 to Week 24)|Other|3
1477746|NCT00624780|4871985|P1|Fixed Dosing (Week 13 to Week 24)|Other|5
1477747|NCT00624780|4871980|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
1477748|NCT00624780|4871981|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
1477749|NCT00624780|4871982|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
1477750|NCT00624780|4871983|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
1477751|NCT00624780|4871984|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
1477752|NCT00624780|4871985|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
1477753|NCT00624780|4871980|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
1477754|NCT00624780|4871981|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
1477755|NCT00624780|4871982|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
1477756|NCT00624780|4871983|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
1477757|NCT00624780|4871984|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
1477758|NCT00624780|4871985|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
1477759|NCT00624780|4871980|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
1477760|NCT00624780|4871981|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
1477761|NCT00624780|4871982|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
1477762|NCT00624780|4871983|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
1477763|NCT00624780|4871984|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
1477764|NCT00624780|4871985|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
1477765|NCT00624780|4871980|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
1477766|NCT00624780|4871981|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
1477767|NCT00624780|4871982|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
1477768|NCT00624780|4871983|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
1477769|NCT00624780|4871984|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
1477770|NCT00624780|4871985|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
1477771|NCT00624780|4871980|P6|Treatment Optimization (Up to Week 12)|Other|0
1477772|NCT00624780|4871981|P5|Treatment Optimization (Up to Week 12)|Other|9
1477773|NCT00624780|4871982|P4|Treatment Optimization (Up to Week 12)|Other|2
1477774|NCT00624780|4871983|P3|Treatment Optimization (Up to Week 12)|Other|8
1477775|NCT00624780|4871984|P2|Treatment Optimization (Up to Week 12)|Other|4
1477776|NCT00624780|4871985|P1|Treatment Optimization (Up to Week 12)|Other|10
1477777|NCT00624780|4871980|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
1477778|NCT00624780|4871981|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
1477779|NCT00624780|4871982|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
1477780|NCT00624780|4871983|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
1477781|NCT00624780|4871984|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
1477782|NCT00624780|4871985|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
1477783|NCT00624780|4871980|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
1477784|NCT00624780|4871981|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
1477785|NCT00624780|4871982|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
1477786|NCT00624780|4871983|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
1477787|NCT00624780|4871984|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
1477788|NCT00624780|4871985|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
1477789|NCT00624780|4871980|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
1477790|NCT00624780|4871981|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
1477791|NCT00624780|4871982|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
1477792|NCT00624780|4871983|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
1477793|NCT00624780|4871984|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
1477794|NCT00624780|4871985|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
1477795|NCT00624780|4871980|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
1477796|NCT00624780|4871981|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
1477797|NCT00624780|4871982|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
1477798|NCT00624780|4871983|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
1477799|NCT00624780|4871984|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
1477800|NCT00624780|4871985|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
1477801|NCT00624585|4872167|P1|Overall Study|Adverse Event|3
1477802|NCT00624585|4872167|P1|Overall Study|Disease Progression|6
1477803|NCT00624585|4872167|P1|Overall Study|Death|3
1477804|NCT00624520|4872197|P2|Overall Study|Death|1
1477805|NCT00624520|4872198|P1|Overall Study|Death|0
1477806|NCT00624520|4872197|P2|Overall Study|Withdrawal by Subject|7
1477807|NCT00624520|4872198|P1|Overall Study|Withdrawal by Subject|12
1477808|NCT00624468|4872225|P4|Safety Follow-up (SFU) Period|Other|1
1477809|NCT00624468|4872226|P3|Safety Follow-up (SFU) Period|Other|1
1477810|NCT00624468|4872227|P2|Safety Follow-up (SFU) Period|Other|0
1477811|NCT00624468|4872228|P1|Safety Follow-up (SFU) Period|Other|0
1477812|NCT00624468|4872225|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
1477813|NCT00624468|4872226|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
1477814|NCT00624468|4872227|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
1477815|NCT00624468|4872228|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
1477816|NCT00624468|4872225|P4|Double-blind Period|Withdrew Prematurely|0
1477817|NCT00624468|4872226|P3|Double-blind Period|Withdrew Prematurely|0
1477818|NCT00624468|4872227|P2|Double-blind Period|Withdrew Prematurely|1
1477819|NCT00624468|4872228|P1|Double-blind Period|Withdrew Prematurely|1
1477820|NCT00624468|4872225|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
1477821|NCT00624468|4872226|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
1477822|NCT00624468|4872227|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
1477823|NCT00624468|4872228|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
1477824|NCT00624377|4872295|P1|Overall Study|Non-evaluable population|84
1477825|NCT00624377|4872295|P1|Overall Study|Other|91
1477826|NCT00624377|4872295|P1|Overall Study|Adverse Event|14
1477827|NCT00624377|4872295|P1|Overall Study|Withdrawal by Subject|100
1477828|NCT00624377|4872295|P1|Overall Study|Lost to Follow-up|355
1477829|NCT00624338|4872309|P3|Overall Study|Randomized but not treated|3
1477830|NCT00624338|4872310|P2|Overall Study|Randomized but not treated|1
1477831|NCT00624338|4872311|P1|Overall Study|Randomized but not treated|2
1477832|NCT00624338|4872309|P3|Overall Study|Other|9
1477833|NCT00624338|4872310|P2|Overall Study|Other|5
1477834|NCT00624338|4872311|P1|Overall Study|Other|15
1477835|NCT00624338|4872309|P3|Overall Study|Termination of 150 mg group by Sponsor|0
1477836|NCT00624338|4872310|P2|Overall Study|Termination of 150 mg group by Sponsor|55
1477837|NCT00624338|4872311|P1|Overall Study|Termination of 150 mg group by Sponsor|0
1477838|NCT00624338|4872309|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
1477839|NCT00624338|4872310|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
1477840|NCT00624338|4872311|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
1477841|NCT00624338|4872309|P3|Overall Study|Death|0
1477842|NCT00624338|4872310|P2|Overall Study|Death|2
1477843|NCT00624338|4872311|P1|Overall Study|Death|0
1477844|NCT00624338|4872309|P3|Overall Study|Protocol Violation|2
1477845|NCT00624338|4872310|P2|Overall Study|Protocol Violation|3
1477846|NCT00624338|4872311|P1|Overall Study|Protocol Violation|3
1477847|NCT00624338|4872309|P3|Overall Study|Lack of Efficacy|14
1477848|NCT00624338|4872310|P2|Overall Study|Lack of Efficacy|3
1477849|NCT00624338|4872311|P1|Overall Study|Lack of Efficacy|11
1477850|NCT00624338|4872309|P3|Overall Study|Lost to Follow-up|0
1477851|NCT00624338|4872310|P2|Overall Study|Lost to Follow-up|0
1477852|NCT00624338|4872311|P1|Overall Study|Lost to Follow-up|1
1477853|NCT00624338|4872309|P3|Overall Study|Adverse Event|18
1477854|NCT00624338|4872310|P2|Overall Study|Adverse Event|14
1477855|NCT00624338|4872311|P1|Overall Study|Adverse Event|14
1477856|NCT00624286|4872333|P2|Overall Study|Death|1
1477857|NCT00624286|4872334|P1|Overall Study|Death|0
1477858|NCT00624286|4872333|P2|Overall Study|Abnormal test procedure result(s)|1
1477859|NCT00624286|4872334|P1|Overall Study|Abnormal test procedure result(s)|0
1477860|NCT00624286|4872333|P2|Overall Study|Not stated|1
1477861|NCT00624286|4872334|P1|Overall Study|Not stated|0
1477862|NCT00624286|4872333|P2|Overall Study|Lack of Efficacy|6
1477863|NCT00624286|4872334|P1|Overall Study|Lack of Efficacy|1
1477864|NCT00624286|4872333|P2|Overall Study|Administrative problems|0
1477865|NCT00624286|4872334|P1|Overall Study|Administrative problems|3
1477866|NCT00624286|4872333|P2|Overall Study|Lost to Follow-up|2
1477867|NCT00624286|4872334|P1|Overall Study|Lost to Follow-up|3
1477868|NCT00624286|4872333|P2|Overall Study|Withdrawal by Subject|4
1477869|NCT00624286|4872334|P1|Overall Study|Withdrawal by Subject|5
1477870|NCT00624286|4872333|P2|Overall Study|Adverse Event|3
1477871|NCT00624286|4872334|P1|Overall Study|Adverse Event|6
1477872|NCT00624286|4872333|P2|Overall Study|Protocol Deviation|9
1477873|NCT00624286|4872334|P1|Overall Study|Protocol Deviation|7
1477874|NCT00624065|4872387|P2|Overall Study|Met protocol-defined stopping criteria|9
1477875|NCT00624065|4872388|P1|Overall Study|Met protocol-defined stopping criteria|4
1477876|NCT00624065|4872387|P2|Overall Study|Lack of Efficacy|3
1477877|NCT00624065|4872388|P1|Overall Study|Lack of Efficacy|0
1477878|NCT00624065|4872387|P2|Overall Study|Consent withdrawn|5
1477879|NCT00624065|4872388|P1|Overall Study|Consent withdrawn|6
1477880|NCT00624065|4872387|P2|Overall Study|Lost to Follow-up|1
1477881|NCT00624065|4872388|P1|Overall Study|Lost to Follow-up|4
1477882|NCT00624065|4872387|P2|Overall Study|Adverse Event|6
1477883|NCT00624065|4872388|P1|Overall Study|Adverse Event|5
1477884|NCT00624052|4872400|P4|Overall Study|Changed job/ran out if meds|0
1477885|NCT00624052|4872401|P3|Overall Study|Changed job/ran out if meds|0
1477886|NCT00624052|4872402|P2|Overall Study|Changed job/ran out if meds|2
1477887|NCT00624052|4872403|P1|Overall Study|Changed job/ran out if meds|0
1477888|NCT00624052|4872400|P4|Overall Study|Consent withdrawn|0
1477889|NCT00624052|4872401|P3|Overall Study|Consent withdrawn|1
1477890|NCT00624052|4872402|P2|Overall Study|Consent withdrawn|1
1477891|NCT00624052|4872403|P1|Overall Study|Consent withdrawn|3
1477892|NCT00624052|4872400|P4|Overall Study|Non compliant with the protocol|1
1477893|NCT00624052|4872401|P3|Overall Study|Non compliant with the protocol|1
1477894|NCT00624052|4872402|P2|Overall Study|Non compliant with the protocol|1
1477895|NCT00624052|4872403|P1|Overall Study|Non compliant with the protocol|2
1477896|NCT00624052|4872400|P4|Overall Study|Lost to Follow-up|0
1477897|NCT00624052|4872401|P3|Overall Study|Lost to Follow-up|1
1477898|NCT00624052|4872402|P2|Overall Study|Lost to Follow-up|3
1477899|NCT00624052|4872403|P1|Overall Study|Lost to Follow-up|2
1477900|NCT00624052|4872400|P4|Overall Study|Lack of Efficacy|0
1477901|NCT00624052|4872401|P3|Overall Study|Lack of Efficacy|0
1477902|NCT00624052|4872402|P2|Overall Study|Lack of Efficacy|1
1477903|NCT00624052|4872403|P1|Overall Study|Lack of Efficacy|1
1477904|NCT00624052|4872400|P4|Overall Study|Adverse Event|3
1477905|NCT00624052|4872401|P3|Overall Study|Adverse Event|0
1477906|NCT00624052|4872402|P2|Overall Study|Adverse Event|6
1477907|NCT00624052|4872403|P1|Overall Study|Adverse Event|7
1477908|NCT00623935|4872480|P1|Overall Study|Patient Declined Transplant|1
1477909|NCT00623935|4872480|P1|Overall Study|Death|1
1477910|NCT00623831|4872487|P2|Overall Study|Progressive Disease|1
1477911|NCT00623831|4872488|P1|Overall Study|Progressive Disease|0
1477912|NCT00623831|4872487|P2|Overall Study|Withdrawal by Subject|0
1477913|NCT00623831|4872488|P1|Overall Study|Withdrawal by Subject|1
1477914|NCT00623805|4872500|P2|Overall Study|Reason not Specified|6
1477915|NCT00623805|4872501|P1|Overall Study|Reason not Specified|3
1477916|NCT00623805|4872500|P2|Overall Study|Protocol Violation|1
1477917|NCT00623805|4872501|P1|Overall Study|Protocol Violation|1
1477918|NCT00623805|4872500|P2|Overall Study|Lost to Follow-up|2
1477919|NCT00623805|4872501|P1|Overall Study|Lost to Follow-up|2
1477920|NCT00623805|4872500|P2|Overall Study|Lack of Efficacy|7
1477921|NCT00623805|4872501|P1|Overall Study|Lack of Efficacy|3
1477922|NCT00623805|4872500|P2|Overall Study|Death|0
1477923|NCT00623805|4872501|P1|Overall Study|Death|2
1477924|NCT00623805|4872500|P2|Overall Study|Adverse Event|6
1477925|NCT00623805|4872501|P1|Overall Study|Adverse Event|9
1477926|NCT00623779|4872518|P3|Overall Study|Criteria from CSR|1
1477927|NCT00623779|4872519|P2|Overall Study|Criteria from CSR|0
1477928|NCT00623779|4872520|P1|Overall Study|Criteria from CSR|2
1477929|NCT00623779|4872518|P3|Overall Study|Adverse Event|0
1477930|NCT00623779|4872519|P2|Overall Study|Adverse Event|3
1477931|NCT00623779|4872520|P1|Overall Study|Adverse Event|1
1477932|NCT00623766|4872569|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
1477933|NCT00623766|4872570|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
1477934|NCT00623766|4872569|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
1477935|NCT00623766|4872570|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
1477936|NCT00623766|4872569|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
1477937|NCT00623766|4872570|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
1477938|NCT00623766|4872569|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
1477939|NCT00623766|4872570|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
1477940|NCT00623766|4872569|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
1477941|NCT00623766|4872570|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
1477942|NCT00623727|4872594|P2|Open Label Follow-up|Participant convenience|1
1477943|NCT00623727|4872595|P1|Open Label Follow-up|Participant convenience|0
1477944|NCT00623727|4872594|P2|Open Label Follow-up|Study termination|6
1477945|NCT00623727|4872595|P1|Open Label Follow-up|Study termination|0
1477946|NCT00623727|4872594|P2|Open Label Follow-up|Withdrawal by Subject|1
1477947|NCT00623727|4872595|P1|Open Label Follow-up|Withdrawal by Subject|0
1477948|NCT00623727|4872594|P2|Double Blind (DB)|Protocol Violation|2
1477949|NCT00623727|4872595|P1|Double Blind (DB)|Protocol Violation|2
1477950|NCT00623727|4872594|P2|Double Blind (DB)|Lost to Follow-up|1
1477951|NCT00623727|4872595|P1|Double Blind (DB)|Lost to Follow-up|1
1477952|NCT00623727|4872594|P2|Double Blind (DB)|Termination of the double-blind period|21
1477953|NCT00623727|4872595|P1|Double Blind (DB)|Termination of the double-blind period|22
1477954|NCT00623727|4872594|P2|Double Blind (DB)|Lack of Efficacy|2
1477955|NCT00623727|4872595|P1|Double Blind (DB)|Lack of Efficacy|2
1477956|NCT00623727|4872594|P2|Double Blind (DB)|Withdrawal by Subject|2
1477957|NCT00623727|4872595|P1|Double Blind (DB)|Withdrawal by Subject|8
1477958|NCT00623727|4872594|P2|Double Blind (DB)|Physician Decision|1
1477959|NCT00623727|4872595|P1|Double Blind (DB)|Physician Decision|0
1477960|NCT00623727|4872594|P2|Double Blind (DB)|Adverse Event|3
1477961|NCT00623727|4872595|P1|Double Blind (DB)|Adverse Event|1
1477962|NCT00623597|4872650|P2|Overall Study|Failed to return|0
1477963|NCT00623597|4872651|P1|Overall Study|Failed to return|1
1477964|NCT00623545|4872714|P1|Overall Study|Withdrawal by Subject|4
1477965|NCT00623545|4872714|P1|Overall Study|Adverse Event|6
1477966|NCT00623480|4872734|P2|Overall Study|Site closed by sponsor|1
1477967|NCT00623480|4872735|P1|Overall Study|Site closed by sponsor|0
1477968|NCT00623480|4872734|P2|Overall Study|Protocol Violation|1
1477969|NCT00623480|4872735|P1|Overall Study|Protocol Violation|0
1477970|NCT00623480|4872734|P2|Overall Study|Non-compliant with study medication|0
1477971|NCT00623480|4872735|P1|Overall Study|Non-compliant with study medication|4
1477972|NCT00623480|4872734|P2|Overall Study|Lack of Efficacy|0
1477973|NCT00623480|4872735|P1|Overall Study|Lack of Efficacy|1
1477974|NCT00623480|4872734|P2|Overall Study|Withdrawal by Subject|4
1477975|NCT00623480|4872735|P1|Overall Study|Withdrawal by Subject|2
1477976|NCT00623480|4872734|P2|Overall Study|Lost to Follow-up|1
1477977|NCT00623480|4872735|P1|Overall Study|Lost to Follow-up|0
1477978|NCT00623467|4872747|P1|Overall Study|Withdrawal by Subject|2
1477979|NCT00623467|4872747|P1|Overall Study|Protocol Violation|4
1477980|NCT00623467|4872747|P1|Overall Study|Lost to Follow-up|1
1477981|NCT00623428|4872817|P2|Follow-up Period|Death|1
1477982|NCT00623428|4872818|P1|Follow-up Period|Death|0
1477983|NCT00623428|4872817|P2|Follow-up Period|Reason not specified|1
1477984|NCT00623428|4872818|P1|Follow-up Period|Reason not specified|1
1477985|NCT00623428|4872817|P2|Follow-up Period|Did not cooperate|3
1477986|NCT00623428|4872818|P1|Follow-up Period|Did not cooperate|0
1477987|NCT00623428|4872817|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
1477988|NCT00623428|4872818|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
1477989|NCT00623428|4872817|P2|Follow-up Period|Patient withdrew consent|4
1477990|NCT00623428|4872818|P1|Follow-up Period|Patient withdrew consent|5
1477991|NCT00623428|4872817|P2|Follow-up Period|Failure to return|2
1477992|NCT00623428|4872818|P1|Follow-up Period|Failure to return|10
1477993|NCT00623428|4872817|P2|Follow-up Period|Relapse post-treatment|3
1477994|NCT00623428|4872818|P1|Follow-up Period|Relapse post-treatment|11
1477995|NCT00623428|4872817|P2|Treatment Period|Withdrawal by Subject|1
1477996|NCT00623428|4872818|P1|Treatment Period|Withdrawal by Subject|0
1477997|NCT00623428|4872817|P2|Treatment Period|Other|1
1477998|NCT00623428|4872818|P1|Treatment Period|Other|0
1477999|NCT00623428|4872817|P2|Treatment Period|Insufficient therapeutic response|2
1478000|NCT00623428|4872818|P1|Treatment Period|Insufficient therapeutic response|0
1478001|NCT00623428|4872817|P2|Treatment Period|Did not cooperate / refused treatment|13
1478002|NCT00623428|4872818|P1|Treatment Period|Did not cooperate / refused treatment|0
1478003|NCT00623428|4872817|P2|Treatment Period|Death|1
1478004|NCT00623428|4872818|P1|Treatment Period|Death|0
1478005|NCT00623428|4872817|P2|Treatment Period|Adverse event/intercurrent illness|9
1478006|NCT00623428|4872818|P1|Treatment Period|Adverse event/intercurrent illness|0
1478007|NCT00623233|4872836|P1|Overall Study|Withdrawal by Subject|3
1478008|NCT00623233|4872836|P1|Overall Study|Lost to Follow-up|1
1478009|NCT00623233|4872836|P1|Overall Study|Physician Decision|10
1478010|NCT00623233|4872836|P1|Overall Study|Adverse Event|10
1478011|NCT00623194|4872843|P1|Overall Study|Unclassified|1
1478012|NCT00623194|4872843|P1|Overall Study|Protocol Violation|3
1478013|NCT00623194|4872843|P1|Overall Study|Lack of Efficacy|1
1478014|NCT00623103|4872880|P2|Overall Study|Protocol deviation|1
1478015|NCT00623103|4872881|P1|Overall Study|Protocol deviation|2
1478016|NCT00623103|4872880|P2|Overall Study|Death|11
1478017|NCT00623103|4872881|P1|Overall Study|Death|11
1478018|NCT00623103|4872880|P2|Overall Study|Administrative problems|4
1478019|NCT00623103|4872881|P1|Overall Study|Administrative problems|2
1478020|NCT00623103|4872880|P2|Overall Study|Lost to Follow-up|1
1478021|NCT00623103|4872881|P1|Overall Study|Lost to Follow-up|4
1478022|NCT00623103|4872880|P2|Overall Study|Withdrawal by Subject|24
1478023|NCT00623103|4872881|P1|Overall Study|Withdrawal by Subject|18
1478024|NCT00623103|4872880|P2|Overall Study|Unsatisfactory therapeutic effect|12
1478025|NCT00623103|4872881|P1|Overall Study|Unsatisfactory therapeutic effect|4
1478026|NCT00623103|4872880|P2|Overall Study|Adverse Event|60
1478027|NCT00623103|4872881|P1|Overall Study|Adverse Event|70
1478028|NCT00622908|4872909|P2|Overall Study|Termination by study sponser|1
1478029|NCT00622908|4872910|P1|Overall Study|Termination by study sponser|0
1478030|NCT00622908|4872909|P2|Overall Study|Refusal|1
1478031|NCT00622908|4872910|P1|Overall Study|Refusal|0
1478032|NCT00622908|4872909|P2|Overall Study|Lost to Follow-up|0
1478033|NCT00622908|4872910|P1|Overall Study|Lost to Follow-up|1
1478034|NCT00622908|4872909|P2|Overall Study|Lack of Efficacy|7
1478035|NCT00622908|4872910|P1|Overall Study|Lack of Efficacy|1
1478036|NCT00622908|4872909|P2|Overall Study|Adverse Event|1
1478037|NCT00622908|4872910|P1|Overall Study|Adverse Event|0
1478038|NCT00622908|4872909|P2|Overall Study|Protocol Violation|0
1478039|NCT00622908|4872910|P1|Overall Study|Protocol Violation|1
1478040|NCT00622869|4872940|P3|Overall Study|Missing|1
1478041|NCT00622869|4872941|P2|Overall Study|Missing|1
1478042|NCT00622869|4872942|P1|Overall Study|Missing|0
1478043|NCT00622869|4872940|P3|Overall Study|Graft Loss|2
1478044|NCT00622869|4872941|P2|Overall Study|Graft Loss|3
1478045|NCT00622869|4872942|P1|Overall Study|Graft Loss|5
1478046|NCT00622869|4872940|P3|Overall Study|Lost to Follow-up|2
1478047|NCT00622869|4872941|P2|Overall Study|Lost to Follow-up|4
1478048|NCT00622869|4872942|P1|Overall Study|Lost to Follow-up|2
1478049|NCT00622869|4872940|P3|Overall Study|Death|10
1478050|NCT00622869|4872941|P2|Overall Study|Death|15
1478051|NCT00622869|4872942|P1|Overall Study|Death|12
1478052|NCT00622869|4872940|P3|Overall Study|Administrative Problems|13
1478053|NCT00622869|4872941|P2|Overall Study|Administrative Problems|17
1478054|NCT00622869|4872942|P1|Overall Study|Administrative Problems|11
1478055|NCT00622869|4872940|P3|Overall Study|Subject Withdrew Consent|11
1478056|NCT00622869|4872941|P2|Overall Study|Subject Withdrew Consent|17
1478057|NCT00622869|4872942|P1|Overall Study|Subject Withdrew Consent|13
1478058|NCT00622739|4872961|P2|Overall Study|Lost to Follow-up|1
1478059|NCT00622739|4872962|P1|Overall Study|Lost to Follow-up|0
1478060|NCT00622739|4872961|P2|Overall Study|Withdrawal by Subject|1
1478061|NCT00622739|4872962|P1|Overall Study|Withdrawal by Subject|0
1478062|NCT00622739|4872961|P2|Overall Study|Lack of Efficacy|2
1478063|NCT00622739|4872962|P1|Overall Study|Lack of Efficacy|0
1478064|NCT00622739|4872961|P2|Overall Study|Adverse Event|2
1478065|NCT00622739|4872962|P1|Overall Study|Adverse Event|1
1478066|NCT00622739|4872961|P2|Overall Study|Physician Decision|0
1478067|NCT00622739|4872962|P1|Overall Study|Physician Decision|1
1478068|NCT00622726|4872970|P2|August, 2010 to April, 2013|Death|5
1478069|NCT00622726|4872971|P1|August, 2010 to April, 2013|Death|1
1478070|NCT00622726|4872970|P2|March, 2008 to August, 2010|Death|2
1478071|NCT00622726|4872971|P1|March, 2008 to August, 2010|Death|5
1478072|NCT00622713|4872981|P1|Overall Study|Did not meet eligibility criteria|1
1478073|NCT00622713|4872981|P1|Overall Study|Subject no longer required study drug|1
1478074|NCT00622713|4872981|P1|Overall Study|Death|2
1478075|NCT00622713|4872981|P1|Overall Study|Lost to Follow-up|5
1478076|NCT00622713|4872981|P1|Overall Study|Withdrawal by Subject|11
1478077|NCT00622713|4872981|P1|Overall Study|Administrative problems|4
1478078|NCT00622713|4872981|P1|Overall Study|Adverse Event|35
1478079|NCT00622700|4872992|P7|Extension Treatment Period|Other than specified above|1
1478080|NCT00622700|4872993|P6|Extension Treatment Period|Other than specified above|1
1478081|NCT00622700|4872994|P5|Extension Treatment Period|Other than specified above|0
1478082|NCT00622700|4872995|P4|Extension Treatment Period|Other than specified above|0
1478083|NCT00622700|4872996|P3|Extension Treatment Period|Other than specified above|0
1478084|NCT00622700|4872997|P2|Extension Treatment Period|Other than specified above|0
1478085|NCT00622700|4872998|P1|Extension Treatment Period|Other than specified above|0
1478086|NCT00622700|4872992|P7|Extension Treatment Period|Missing|0
1478087|NCT00622700|4872993|P6|Extension Treatment Period|Missing|1
1478088|NCT00622700|4872994|P5|Extension Treatment Period|Missing|3
1478089|NCT00622700|4872995|P4|Extension Treatment Period|Missing|2
1478090|NCT00622700|4872996|P3|Extension Treatment Period|Missing|0
1478091|NCT00622700|4872997|P2|Extension Treatment Period|Missing|0
1478092|NCT00622700|4872998|P1|Extension Treatment Period|Missing|0
1478093|NCT00622700|4872992|P7|Extension Treatment Period|Withdrawal by Subject|10
1478094|NCT00622700|4872993|P6|Extension Treatment Period|Withdrawal by Subject|6
1478095|NCT00622700|4872994|P5|Extension Treatment Period|Withdrawal by Subject|16
1478096|NCT00622700|4872995|P4|Extension Treatment Period|Withdrawal by Subject|11
1478097|NCT00622700|4872996|P3|Extension Treatment Period|Withdrawal by Subject|0
1478098|NCT00622700|4872997|P2|Extension Treatment Period|Withdrawal by Subject|0
1478099|NCT00622700|4872998|P1|Extension Treatment Period|Withdrawal by Subject|0
1478100|NCT00622700|4872992|P7|Extension Treatment Period|Progressive Disease|2
1478101|NCT00622700|4872993|P6|Extension Treatment Period|Progressive Disease|0
1478102|NCT00622700|4872994|P5|Extension Treatment Period|Progressive Disease|2
1478103|NCT00622700|4872995|P4|Extension Treatment Period|Progressive Disease|1
1478104|NCT00622700|4872996|P3|Extension Treatment Period|Progressive Disease|0
1478105|NCT00622700|4872997|P2|Extension Treatment Period|Progressive Disease|0
1478106|NCT00622700|4872998|P1|Extension Treatment Period|Progressive Disease|0
1478107|NCT00622700|4872992|P7|Extension Treatment Period|Lost to Follow-up|0
1478108|NCT00622700|4872993|P6|Extension Treatment Period|Lost to Follow-up|0
1478109|NCT00622700|4872994|P5|Extension Treatment Period|Lost to Follow-up|1
1478110|NCT00622700|4872995|P4|Extension Treatment Period|Lost to Follow-up|0
1478111|NCT00622700|4872996|P3|Extension Treatment Period|Lost to Follow-up|0
1478112|NCT00622700|4872997|P2|Extension Treatment Period|Lost to Follow-up|0
1478113|NCT00622700|4872998|P1|Extension Treatment Period|Lost to Follow-up|0
1478114|NCT00622700|4872992|P7|Extension Treatment Period|Protocol Violation|0
1478115|NCT00622700|4872993|P6|Extension Treatment Period|Protocol Violation|2
1478116|NCT00622700|4872994|P5|Extension Treatment Period|Protocol Violation|0
1478117|NCT00622700|4872995|P4|Extension Treatment Period|Protocol Violation|0
1478118|NCT00622700|4872996|P3|Extension Treatment Period|Protocol Violation|0
1478119|NCT00622700|4872997|P2|Extension Treatment Period|Protocol Violation|0
1478120|NCT00622700|4872998|P1|Extension Treatment Period|Protocol Violation|0
1478121|NCT00622700|4872992|P7|Extension Treatment Period|Lack of Efficacy|9
1478122|NCT00622700|4872993|P6|Extension Treatment Period|Lack of Efficacy|1
1478123|NCT00622700|4872994|P5|Extension Treatment Period|Lack of Efficacy|8
1478124|NCT00622700|4872995|P4|Extension Treatment Period|Lack of Efficacy|2
1478125|NCT00622700|4872996|P3|Extension Treatment Period|Lack of Efficacy|0
1478126|NCT00622700|4872997|P2|Extension Treatment Period|Lack of Efficacy|0
1478127|NCT00622700|4872998|P1|Extension Treatment Period|Lack of Efficacy|0
1478128|NCT00622700|4872992|P7|Extension Treatment Period|Adverse Event|8
1478129|NCT00622700|4872993|P6|Extension Treatment Period|Adverse Event|6
1478130|NCT00622700|4872994|P5|Extension Treatment Period|Adverse Event|9
1478131|NCT00622700|4872995|P4|Extension Treatment Period|Adverse Event|5
1478132|NCT00622700|4872996|P3|Extension Treatment Period|Adverse Event|0
1478133|NCT00622700|4872997|P2|Extension Treatment Period|Adverse Event|0
1478134|NCT00622700|4872998|P1|Extension Treatment Period|Adverse Event|0
1478135|NCT00622700|4872992|P7|Core Treatment Period|Other than specified above|0
1478136|NCT00622700|4872993|P6|Core Treatment Period|Other than specified above|0
1478137|NCT00622700|4872994|P5|Core Treatment Period|Other than specified above|0
1478138|NCT00622700|4872995|P4|Core Treatment Period|Other than specified above|0
1478139|NCT00622700|4872996|P3|Core Treatment Period|Other than specified above|5
1478140|NCT00622700|4872997|P2|Core Treatment Period|Other than specified above|2
1478141|NCT00622700|4872998|P1|Core Treatment Period|Other than specified above|2
1478142|NCT00622700|4872992|P7|Core Treatment Period|Withdrawal by Subject|0
1478143|NCT00622700|4872993|P6|Core Treatment Period|Withdrawal by Subject|0
1478144|NCT00622700|4872994|P5|Core Treatment Period|Withdrawal by Subject|0
1478145|NCT00622700|4872995|P4|Core Treatment Period|Withdrawal by Subject|0
1478146|NCT00622700|4872996|P3|Core Treatment Period|Withdrawal by Subject|15
1478147|NCT00622700|4872997|P2|Core Treatment Period|Withdrawal by Subject|18
1478148|NCT00622700|4872998|P1|Core Treatment Period|Withdrawal by Subject|12
1478149|NCT00622700|4872992|P7|Core Treatment Period|Progressive Disease|0
1478150|NCT00622700|4872993|P6|Core Treatment Period|Progressive Disease|0
1478151|NCT00622700|4872994|P5|Core Treatment Period|Progressive Disease|0
1478152|NCT00622700|4872995|P4|Core Treatment Period|Progressive Disease|0
1478153|NCT00622700|4872996|P3|Core Treatment Period|Progressive Disease|0
1478154|NCT00622700|4872997|P2|Core Treatment Period|Progressive Disease|1
1478155|NCT00622700|4872998|P1|Core Treatment Period|Progressive Disease|3
1478156|NCT00622700|4872992|P7|Core Treatment Period|Death|0
1478157|NCT00622700|4872993|P6|Core Treatment Period|Death|0
1478158|NCT00622700|4872994|P5|Core Treatment Period|Death|0
1478159|NCT00622700|4872995|P4|Core Treatment Period|Death|0
1478160|NCT00622700|4872996|P3|Core Treatment Period|Death|0
1478161|NCT00622700|4872997|P2|Core Treatment Period|Death|0
1478162|NCT00622700|4872998|P1|Core Treatment Period|Death|1
1478163|NCT00622700|4872992|P7|Core Treatment Period|Lost to Follow-up|0
1478164|NCT00622700|4872993|P6|Core Treatment Period|Lost to Follow-up|0
1478165|NCT00622700|4872994|P5|Core Treatment Period|Lost to Follow-up|0
1478166|NCT00622700|4872995|P4|Core Treatment Period|Lost to Follow-up|0
1478167|NCT00622700|4872996|P3|Core Treatment Period|Lost to Follow-up|1
1478168|NCT00622700|4872997|P2|Core Treatment Period|Lost to Follow-up|1
1478169|NCT00622700|4872998|P1|Core Treatment Period|Lost to Follow-up|1
1478170|NCT00622700|4872992|P7|Core Treatment Period|Lack of Efficacy|0
1478171|NCT00622700|4872993|P6|Core Treatment Period|Lack of Efficacy|0
1478172|NCT00622700|4872994|P5|Core Treatment Period|Lack of Efficacy|0
1478173|NCT00622700|4872995|P4|Core Treatment Period|Lack of Efficacy|0
1478174|NCT00622700|4872996|P3|Core Treatment Period|Lack of Efficacy|12
1478175|NCT00622700|4872997|P2|Core Treatment Period|Lack of Efficacy|6
1478176|NCT00622700|4872998|P1|Core Treatment Period|Lack of Efficacy|19
1478177|NCT00622700|4872992|P7|Core Treatment Period|Adverse Event|0
1478178|NCT00622700|4872993|P6|Core Treatment Period|Adverse Event|0
1478179|NCT00622700|4872994|P5|Core Treatment Period|Adverse Event|0
1478180|NCT00622700|4872995|P4|Core Treatment Period|Adverse Event|0
1478181|NCT00622700|4872996|P3|Core Treatment Period|Adverse Event|18
1478182|NCT00622700|4872997|P2|Core Treatment Period|Adverse Event|25
1478183|NCT00622700|4872998|P1|Core Treatment Period|Adverse Event|18
1478184|NCT00622700|4872992|P7|Core Treatment Period|Randomized but Not Treated|0
1478185|NCT00622700|4872993|P6|Core Treatment Period|Randomized but Not Treated|0
1478186|NCT00622700|4872994|P5|Core Treatment Period|Randomized but Not Treated|0
1478187|NCT00622700|4872995|P4|Core Treatment Period|Randomized but Not Treated|0
1478188|NCT00622700|4872996|P3|Core Treatment Period|Randomized but Not Treated|2
1478189|NCT00622700|4872997|P2|Core Treatment Period|Randomized but Not Treated|2
1478190|NCT00622700|4872998|P1|Core Treatment Period|Randomized but Not Treated|0
1478191|NCT00622635|4873057|P6|Treatment Period 3|Withdrawal by Subject|0
1478192|NCT00622635|4873058|P5|Treatment Period 3|Withdrawal by Subject|0
1478193|NCT00622635|4873059|P4|Treatment Period 3|Withdrawal by Subject|1
1478194|NCT00622635|4873060|P3|Treatment Period 3|Withdrawal by Subject|0
1478195|NCT00622635|4873061|P2|Treatment Period 3|Withdrawal by Subject|0
1478196|NCT00622635|4873062|P1|Treatment Period 3|Withdrawal by Subject|0
1478197|NCT00622635|4873057|P6|Treatment Period 3|Adverse Event|0
1478198|NCT00622635|4873058|P5|Treatment Period 3|Adverse Event|0
1478199|NCT00622635|4873059|P4|Treatment Period 3|Adverse Event|2
1478200|NCT00622635|4873060|P3|Treatment Period 3|Adverse Event|0
1478201|NCT00622635|4873061|P2|Treatment Period 3|Adverse Event|0
1478202|NCT00622635|4873062|P1|Treatment Period 3|Adverse Event|0
1478203|NCT00622635|4873057|P6|Treatment Period 2|Adverse Event|0
1478204|NCT00622635|4873058|P5|Treatment Period 2|Adverse Event|0
1478205|NCT00622635|4873059|P4|Treatment Period 2|Adverse Event|0
1478206|NCT00622635|4873060|P3|Treatment Period 2|Adverse Event|0
1478207|NCT00622635|4873061|P2|Treatment Period 2|Adverse Event|0
1478208|NCT00622635|4873062|P1|Treatment Period 2|Adverse Event|1
1478209|NCT00622635|4873057|P6|Treatment Period 1|Abnormal test procedure result(s)|0
1478210|NCT00622635|4873058|P5|Treatment Period 1|Abnormal test procedure result(s)|1
1478211|NCT00622635|4873059|P4|Treatment Period 1|Abnormal test procedure result(s)|0
1478212|NCT00622635|4873060|P3|Treatment Period 1|Abnormal test procedure result(s)|0
1478213|NCT00622635|4873061|P2|Treatment Period 1|Abnormal test procedure result(s)|0
1478214|NCT00622635|4873062|P1|Treatment Period 1|Abnormal test procedure result(s)|0
1478215|NCT00622635|4873057|P6|Treatment Period 1|Withdrawal by Subject|0
1478216|NCT00622635|4873058|P5|Treatment Period 1|Withdrawal by Subject|0
1478217|NCT00622635|4873059|P4|Treatment Period 1|Withdrawal by Subject|0
1478218|NCT00622635|4873060|P3|Treatment Period 1|Withdrawal by Subject|0
1478219|NCT00622635|4873061|P2|Treatment Period 1|Withdrawal by Subject|1
1478220|NCT00622635|4873062|P1|Treatment Period 1|Withdrawal by Subject|0
1478221|NCT00622635|4873057|P6|Treatment Period 1|Adverse Event|0
1478222|NCT00622635|4873058|P5|Treatment Period 1|Adverse Event|0
1478223|NCT00622635|4873059|P4|Treatment Period 1|Adverse Event|0
1478224|NCT00622635|4873060|P3|Treatment Period 1|Adverse Event|1
1478225|NCT00622635|4873061|P2|Treatment Period 1|Adverse Event|0
1478226|NCT00622635|4873062|P1|Treatment Period 1|Adverse Event|0
1478227|NCT00622440|4873145|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
1478228|NCT00622440|4873146|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
1478229|NCT00622440|4873145|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
1478230|NCT00622440|4873146|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
1478231|NCT00622440|4873145|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
1478232|NCT00622440|4873146|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
1478233|NCT00622440|4873145|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
1478234|NCT00622440|4873146|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
1478235|NCT00622401|4873172|P3|Overall Study|Disease progression prior to treatment|0
1478236|NCT00622401|4873173|P2|Overall Study|Disease progression prior to treatment|2
1478237|NCT00622401|4873174|P1|Overall Study|Disease progression prior to treatment|3
1478238|NCT00622388|4873181|P1|Overall Study|Insurance Expired|1
1478239|NCT00622388|4873181|P1|Overall Study|Withdrew Consent|1
1478240|NCT00622388|4873181|P1|Overall Study|Took Prohibited Medication|2
1478241|NCT00622388|4873181|P1|Overall Study|Received Alternate Anticancer Therapy|8
1478242|NCT00622388|4873181|P1|Overall Study|Death|3
1478243|NCT00622388|4873181|P1|Overall Study|Participant Refusal|1
1478244|NCT00622388|4873181|P1|Overall Study|Protocol Violation|3
1478245|NCT00622388|4873181|P1|Overall Study|Adverse Event|6
1478246|NCT00622388|4873181|P1|Overall Study|Disease Progression|47
1478247|NCT00622336|4873199|P1|Extension Phase|Other|9
1478248|NCT00622336|4873199|P1|Extension Phase|Lost to Follow-up|1
1478249|NCT00622336|4873199|P1|Extension Phase|Withdrawal by Subject|1
1478250|NCT00622336|4873199|P1|Extension Phase|Lack of therapeutic effect|2
1478251|NCT00622336|4873199|P1|Extension Phase|Progressive Disease|6
1478252|NCT00622336|4873199|P1|Extension Phase|Adverse Event|2
1478253|NCT00622336|4873199|P1|Treatment Phase|Lost to Follow-up|2
1478254|NCT00622336|4873199|P1|Treatment Phase|Withdrawal by Subject|13
1478255|NCT00622336|4873199|P1|Treatment Phase|Lack of therapeutic effect|13
1478256|NCT00622336|4873199|P1|Treatment Phase|Death|14
1478257|NCT00622336|4873199|P1|Treatment Phase|Other|40
1478258|NCT00622336|4873199|P1|Treatment Phase|Adverse Event|46
1478259|NCT00622336|4873199|P1|Treatment Phase|Progression of Disease|181
1478260|NCT00622284|4873210|P2|Overall Study|Other reason (not specified)|24
1478261|NCT00622284|4873211|P1|Overall Study|Other reason (not specified)|33
1478262|NCT00622284|4873210|P2|Overall Study|Withdrawal by Subject|24
1478263|NCT00622284|4873211|P1|Overall Study|Withdrawal by Subject|27
1478264|NCT00622284|4873210|P2|Overall Study|Lost to Follow-up|13
1478265|NCT00622284|4873211|P1|Overall Study|Lost to Follow-up|11
1478266|NCT00622284|4873210|P2|Overall Study|Protocol Violation|5
1478267|NCT00622284|4873211|P1|Overall Study|Protocol Violation|12
1478268|NCT00622284|4873210|P2|Overall Study|Adverse Event|90
1478269|NCT00622284|4873211|P1|Overall Study|Adverse Event|61
1478270|NCT00622284|4873210|P2|Overall Study|Lack of Efficacy|15
1478271|NCT00622284|4873211|P1|Overall Study|Lack of Efficacy|45
1478272|NCT00622167|4873273|P1|Overall Study|Did not meet angiographic criteria|20
1478273|NCT00621985|4873277|P1|Dexamethasone Admission|Adverse Event|1
1478274|NCT00621959|4873285|P2|Overall Study|Other|3
1478275|NCT00621959|4873286|P1|Overall Study|Other|1
1478276|NCT00621959|4873285|P2|Overall Study|Withdrawal by Subject|1
1478277|NCT00621959|4873286|P1|Overall Study|Withdrawal by Subject|1
1478278|NCT00621959|4873285|P2|Overall Study|Lost to Follow-up|2
1478279|NCT00621959|4873286|P1|Overall Study|Lost to Follow-up|0
1478280|NCT00621959|4873285|P2|Overall Study|Lack of Efficacy|1
1478281|NCT00621959|4873286|P1|Overall Study|Lack of Efficacy|1
1478282|NCT00621959|4873285|P2|Overall Study|Adverse Event|2
1478283|NCT00621959|4873286|P1|Overall Study|Adverse Event|4
1478284|NCT00621855|4873325|P5|Overall Study|Patients did not receive study drug|2
1478285|NCT00621855|4873326|P4|Overall Study|Patients did not receive study drug|4
1478286|NCT00621855|4873327|P3|Overall Study|Patients did not receive study drug|5
1478287|NCT00621855|4873328|P2|Overall Study|Patients did not receive study drug|3
1478288|NCT00621855|4873329|P1|Overall Study|Patients did not receive study drug|3
1478289|NCT00621855|4873325|P5|Overall Study|Other|4
1478290|NCT00621855|4873326|P4|Overall Study|Other|5
1478291|NCT00621855|4873327|P3|Overall Study|Other|6
1478292|NCT00621855|4873328|P2|Overall Study|Other|7
1478293|NCT00621855|4873329|P1|Overall Study|Other|9
1478294|NCT00621855|4873325|P5|Overall Study|Withdrawal by Subject|9
1478295|NCT00621855|4873326|P4|Overall Study|Withdrawal by Subject|13
1478296|NCT00621855|4873327|P3|Overall Study|Withdrawal by Subject|13
1478297|NCT00621855|4873328|P2|Overall Study|Withdrawal by Subject|11
1478298|NCT00621855|4873329|P1|Overall Study|Withdrawal by Subject|16
1478299|NCT00621855|4873325|P5|Overall Study|Protocol Violation|8
1478300|NCT00621855|4873326|P4|Overall Study|Protocol Violation|7
1478301|NCT00621855|4873327|P3|Overall Study|Protocol Violation|6
1478302|NCT00621855|4873328|P2|Overall Study|Protocol Violation|8
1478303|NCT00621855|4873329|P1|Overall Study|Protocol Violation|16
1478304|NCT00621855|4873325|P5|Overall Study|Lost to Follow-up|1
1478305|NCT00621855|4873326|P4|Overall Study|Lost to Follow-up|4
1478306|NCT00621855|4873327|P3|Overall Study|Lost to Follow-up|3
1478307|NCT00621855|4873328|P2|Overall Study|Lost to Follow-up|1
1478308|NCT00621855|4873329|P1|Overall Study|Lost to Follow-up|0
1478309|NCT00621855|4873325|P5|Overall Study|Adverse Event|31
1478310|NCT00621855|4873326|P4|Overall Study|Adverse Event|34
1478311|NCT00621855|4873327|P3|Overall Study|Adverse Event|48
1478312|NCT00621855|4873328|P2|Overall Study|Adverse Event|31
1478313|NCT00621855|4873329|P1|Overall Study|Adverse Event|32
1478314|NCT00621842|4873371|P1|Overall Study|Lack of Efficacy|2
1478315|NCT00621842|4873371|P1|Overall Study|Protocol Violation|4
1478316|NCT00621842|4873371|P1|Overall Study|Withdrawal by Subject|7
1478317|NCT00621842|4873371|P1|Overall Study|Adverse Event|6
1478318|NCT00621777|4873388|P2|Randomized Phase|Death|1
1478319|NCT00621777|4873389|P1|Randomized Phase|Death|0
1478320|NCT00621777|4873388|P2|Randomized Phase|administrative|3
1478321|NCT00621777|4873389|P1|Randomized Phase|administrative|0
1478322|NCT00621777|4873388|P2|Randomized Phase|Withdrawal by Subject|9
1478323|NCT00621777|4873389|P1|Randomized Phase|Withdrawal by Subject|1
1478324|NCT00621777|4873388|P2|Randomized Phase|Lost to Follow-up|3
1478325|NCT00621777|4873389|P1|Randomized Phase|Lost to Follow-up|3
1478326|NCT00621777|4873388|P2|Randomized Phase|Adverse Event|3
1478327|NCT00621777|4873389|P1|Randomized Phase|Adverse Event|3
1478328|NCT00621777|4873388|P2|Open Phase|Lost to Follow-up|0
1478329|NCT00621777|4873389|P1|Open Phase|Lost to Follow-up|10
1478330|NCT00621777|4873388|P2|Open Phase|administrative|0
1478331|NCT00621777|4873389|P1|Open Phase|administrative|13
1478332|NCT00621777|4873388|P2|Open Phase|Withdrawal by Subject|0
1478333|NCT00621777|4873389|P1|Open Phase|Withdrawal by Subject|17
1478334|NCT00621777|4873388|P2|Open Phase|Did not abstain during open phase|0
1478335|NCT00621777|4873389|P1|Open Phase|Did not abstain during open phase|56
1478336|NCT00621777|4873388|P2|Open Phase|Adverse Event|0
1478337|NCT00621777|4873389|P1|Open Phase|Adverse Event|20
1478338|NCT00621764|4873404|P4|Overall Study|Protocol Violation|1
1478339|NCT00621764|4873405|P3|Overall Study|Protocol Violation|0
1478340|NCT00621764|4873406|P2|Overall Study|Protocol Violation|0
1478341|NCT00621764|4873407|P1|Overall Study|Protocol Violation|0
1478342|NCT00621621|4873453|P2|Overall Study|Subjects were exited at EP study|0
1478343|NCT00621621|4873454|P1|Overall Study|Subjects were exited at EP study|30
1478344|NCT00621582|4873462|P1|Overall Study|issues not identified by investigators|18
1478345|NCT00621582|4873462|P1|Overall Study|Lost to Follow-up|24
1478346|NCT00621582|4873462|P1|Overall Study|Protocol Violation|57
1478347|NCT00621582|4873462|P1|Overall Study|Adverse Event|7
1478348|NCT00621543|4873469|P1|Overall Study|Lost to Follow-up|23
1478349|NCT00621517|4873493|P2|Overall Study|Adverse Event|0
1478350|NCT00621517|4873494|P1|Overall Study|Adverse Event|1
1478351|NCT00621517|4873493|P2|Overall Study|Withdrawal by Subject|4
1478352|NCT00621517|4873494|P1|Overall Study|Withdrawal by Subject|3
1478353|NCT00621517|4873493|P2|Overall Study|Lost to Follow-up|3
1478354|NCT00621517|4873494|P1|Overall Study|Lost to Follow-up|3
1478355|NCT00621504|4873502|P2|Overall Study|Death|6
1478356|NCT00621504|4873503|P1|Overall Study|Death|6
1478357|NCT00621504|4873502|P2|Overall Study|Other|0
1478358|NCT00621504|4873503|P1|Overall Study|Other|1
1478359|NCT00621504|4873502|P2|Overall Study|Lost to Follow-up|10
1478360|NCT00621504|4873503|P1|Overall Study|Lost to Follow-up|8
1478361|NCT00621504|4873502|P2|Overall Study|Withdrew consent|6
1478362|NCT00621504|4873503|P1|Overall Study|Withdrew consent|9
1478363|NCT00621504|4873502|P2|Overall Study|At the request of sponsor/investigator|0
1478364|NCT00621504|4873503|P1|Overall Study|At the request of sponsor/investigator|1
1478365|NCT00621504|4873502|P2|Overall Study|Adverse Event|3
1478366|NCT00621504|4873503|P1|Overall Study|Adverse Event|1
1478367|NCT00621322|4873537|P6|Overall Study|Migrated/moved from study area|2
1478368|NCT00621322|4873538|P5|Overall Study|Migrated/moved from study area|0
1478369|NCT00621322|4873539|P4|Overall Study|Migrated/moved from study area|1
1478370|NCT00621322|4873540|P3|Overall Study|Migrated/moved from study area|1
1478371|NCT00621322|4873541|P2|Overall Study|Migrated/moved from study area|0
1478372|NCT00621322|4873542|P1|Overall Study|Migrated/moved from study area|1
1478373|NCT00621322|4873537|P6|Overall Study|Withdrawal by Subject|2
1478374|NCT00621322|4873538|P5|Overall Study|Withdrawal by Subject|0
1478375|NCT00621322|4873539|P4|Overall Study|Withdrawal by Subject|1
1478376|NCT00621322|4873540|P3|Overall Study|Withdrawal by Subject|0
1478377|NCT00621322|4873541|P2|Overall Study|Withdrawal by Subject|0
1478378|NCT00621322|4873542|P1|Overall Study|Withdrawal by Subject|0
1478379|NCT00621322|4873537|P6|Overall Study|Physician Decision|0
1478380|NCT00621322|4873538|P5|Overall Study|Physician Decision|0
1478381|NCT00621322|4873539|P4|Overall Study|Physician Decision|1
1478382|NCT00621322|4873540|P3|Overall Study|Physician Decision|1
1478383|NCT00621322|4873541|P2|Overall Study|Physician Decision|0
1478384|NCT00621322|4873542|P1|Overall Study|Physician Decision|0
1478385|NCT00621322|4873537|P6|Overall Study|Lost to Follow-up|0
1478386|NCT00621322|4873538|P5|Overall Study|Lost to Follow-up|1
1478387|NCT00621322|4873539|P4|Overall Study|Lost to Follow-up|0
1478388|NCT00621322|4873540|P3|Overall Study|Lost to Follow-up|0
1478389|NCT00621322|4873541|P2|Overall Study|Lost to Follow-up|0
1478390|NCT00621322|4873542|P1|Overall Study|Lost to Follow-up|0
1478391|NCT00621296|4873622|P1|Overall Study|Stopping Criteria|3
1478392|NCT00621296|4873622|P1|Overall Study|Unmatch Criteria|1
1478393|NCT00621296|4873622|P1|Overall Study|Physician Decision|7
1478394|NCT00621296|4873622|P1|Overall Study|Lack of Efficacy|1
1478395|NCT00621296|4873622|P1|Overall Study|Adverse Event|2
1478396|NCT00621257|4873631|P5|Overall Study|Withdrawal by Subject|1
1478397|NCT00621257|4873632|P4|Overall Study|Withdrawal by Subject|1
1478398|NCT00621257|4873633|P3|Overall Study|Withdrawal by Subject|0
1478399|NCT00621257|4873634|P2|Overall Study|Withdrawal by Subject|0
1478400|NCT00621257|4873635|P1|Overall Study|Withdrawal by Subject|0
1478401|NCT00621257|4873631|P5|Overall Study|Physician Decision|1
1478402|NCT00621257|4873632|P4|Overall Study|Physician Decision|1
1478403|NCT00621257|4873633|P3|Overall Study|Physician Decision|0
1478404|NCT00621257|4873634|P2|Overall Study|Physician Decision|2
1478405|NCT00621257|4873635|P1|Overall Study|Physician Decision|0
1478406|NCT00621257|4873631|P5|Overall Study|Adverse Event|0
1478407|NCT00621257|4873632|P4|Overall Study|Adverse Event|0
1478408|NCT00621257|4873633|P3|Overall Study|Adverse Event|1
1478409|NCT00621257|4873634|P2|Overall Study|Adverse Event|1
1478410|NCT00621257|4873635|P1|Overall Study|Adverse Event|0
1478411|NCT00621257|4873631|P5|Overall Study|Lost to Follow-up|7
1478412|NCT00621257|4873632|P4|Overall Study|Lost to Follow-up|4
1478413|NCT00621257|4873633|P3|Overall Study|Lost to Follow-up|2
1478414|NCT00621257|4873634|P2|Overall Study|Lost to Follow-up|0
1478415|NCT00621257|4873635|P1|Overall Study|Lost to Follow-up|4
1478416|NCT00621244|4873651|P4|Overall Study|Administrative problems|2
1478417|NCT00621244|4873652|P3|Overall Study|Administrative problems|0
1478418|NCT00621244|4873653|P2|Overall Study|Administrative problems|1
1478419|NCT00621244|4873654|P1|Overall Study|Administrative problems|5
1478420|NCT00621244|4873651|P4|Overall Study|Adverse Event|2
1478421|NCT00621244|4873652|P3|Overall Study|Adverse Event|9
1478422|NCT00621244|4873653|P2|Overall Study|Adverse Event|7
1478423|NCT00621244|4873654|P1|Overall Study|Adverse Event|27
1478424|NCT00621244|4873651|P4|Overall Study|Death|1
1478425|NCT00621244|4873652|P3|Overall Study|Death|1
1478426|NCT00621244|4873653|P2|Overall Study|Death|3
1478427|NCT00621244|4873654|P1|Overall Study|Death|3
1478428|NCT00621244|4873651|P4|Overall Study|Disease progression|15
1478429|NCT00621244|4873652|P3|Overall Study|Disease progression|20
1478430|NCT00621244|4873653|P2|Overall Study|Disease progression|20
1478431|NCT00621244|4873654|P1|Overall Study|Disease progression|44
1478432|NCT00621244|4873651|P4|Overall Study|Withdrawal by Subject|3
1478433|NCT00621244|4873652|P3|Overall Study|Withdrawal by Subject|3
1478434|NCT00621244|4873653|P2|Overall Study|Withdrawal by Subject|3
1478435|NCT00621244|4873654|P1|Overall Study|Withdrawal by Subject|7
1478436|NCT00621192|4873758|P4|Overall Study|Final Assessments not Completed|1
1478437|NCT00621192|4873759|P3|Overall Study|Final Assessments not Completed|3
1478438|NCT00621192|4873760|P2|Overall Study|Final Assessments not Completed|0
1478439|NCT00621192|4873761|P1|Overall Study|Final Assessments not Completed|0
1478440|NCT00621192|4873758|P4|Overall Study|Death|0
1478441|NCT00621192|4873759|P3|Overall Study|Death|0
1478442|NCT00621192|4873760|P2|Overall Study|Death|5
1478443|NCT00621192|4873761|P1|Overall Study|Death|2
1478444|NCT00621192|4873758|P4|Overall Study|Adverse Event|1
1478445|NCT00621192|4873759|P3|Overall Study|Adverse Event|0
1478446|NCT00621192|4873760|P2|Overall Study|Adverse Event|1
1478447|NCT00621192|4873761|P1|Overall Study|Adverse Event|0
1478448|NCT00621192|4873758|P4|Overall Study|Protocol Violation|1
1478449|NCT00621192|4873759|P3|Overall Study|Protocol Violation|0
1478450|NCT00621192|4873760|P2|Overall Study|Protocol Violation|0
1478451|NCT00621192|4873761|P1|Overall Study|Protocol Violation|1
1478452|NCT00621192|4873758|P4|Overall Study|Physician Decision|0
1478453|NCT00621192|4873759|P3|Overall Study|Physician Decision|0
1478454|NCT00621192|4873760|P2|Overall Study|Physician Decision|3
1478455|NCT00621192|4873761|P1|Overall Study|Physician Decision|1
1478456|NCT00621192|4873758|P4|Overall Study|Withdrawal by Subject|0
1478457|NCT00621192|4873759|P3|Overall Study|Withdrawal by Subject|2
1478458|NCT00621192|4873760|P2|Overall Study|Withdrawal by Subject|0
1478459|NCT00621192|4873761|P1|Overall Study|Withdrawal by Subject|0
1478460|NCT00621153|4873785|P2|Overall Study|Withdrawal by Subject|5
1478461|NCT00621153|4873786|P1|Overall Study|Withdrawal by Subject|4
1478462|NCT00621153|4873785|P2|Overall Study|Lost to Follow-up|1
1478463|NCT00621153|4873786|P1|Overall Study|Lost to Follow-up|5
1478464|NCT00621153|4873785|P2|Overall Study|Adverse Event|2
1478465|NCT00621153|4873786|P1|Overall Study|Adverse Event|3
1478466|NCT00621153|4873785|P2|Overall Study|Safety Reason|7
1478467|NCT00621153|4873786|P1|Overall Study|Safety Reason|8
1478468|NCT00621140|4873794|P2|Overall Study|Other incl. lack of efficacy|5
1478469|NCT00621140|4873795|P1|Overall Study|Other incl. lack of efficacy|6
1478470|NCT00621140|4873794|P2|Overall Study|Withdrawal by Subject|6
1478471|NCT00621140|4873795|P1|Overall Study|Withdrawal by Subject|4
1478472|NCT00621140|4873794|P2|Overall Study|Lost to Follow-up|2
1478473|NCT00621140|4873795|P1|Overall Study|Lost to Follow-up|1
1478474|NCT00621140|4873794|P2|Overall Study|Adverse Event|5
1478475|NCT00621140|4873795|P1|Overall Study|Adverse Event|4
1478476|NCT00621023|4873842|P1|Overall Study|Follow up discontinued|1
1478477|NCT00621023|4873842|P1|Overall Study|Death|5
1478478|NCT00620854|4873859|P6|Washout 1|Withdrawal by Subject|0
1478479|NCT00620854|4873860|P5|Washout 1|Withdrawal by Subject|0
1478480|NCT00620854|4873861|P4|Washout 1|Withdrawal by Subject|1
1478481|NCT00620854|4873862|P3|Washout 1|Withdrawal by Subject|1
1478482|NCT00620854|4873863|P2|Washout 1|Withdrawal by Subject|0
1478483|NCT00620854|4873864|P1|Washout 1|Withdrawal by Subject|0
1478484|NCT00620815|4873895|P3|Overall Study|Protocol Violation|1
1478485|NCT00620815|4873896|P2|Overall Study|Protocol Violation|2
1478486|NCT00620815|4873897|P1|Overall Study|Protocol Violation|1
1478487|NCT00620815|4873895|P3|Overall Study|Inappropriate enrolment|1
1478488|NCT00620815|4873896|P2|Overall Study|Inappropriate enrolment|0
1478489|NCT00620815|4873897|P1|Overall Study|Inappropriate enrolment|0
1478490|NCT00620815|4873895|P3|Overall Study|Lost to Follow-up|3
1478491|NCT00620815|4873896|P2|Overall Study|Lost to Follow-up|6
1478492|NCT00620815|4873897|P1|Overall Study|Lost to Follow-up|1
1478493|NCT00620815|4873895|P3|Overall Study|Withdrawal by Subject|0
1478494|NCT00620815|4873896|P2|Overall Study|Withdrawal by Subject|2
1478495|NCT00620815|4873897|P1|Overall Study|Withdrawal by Subject|1
1478496|NCT00620815|4873895|P3|Overall Study|Adverse Event|2
1478497|NCT00620815|4873896|P2|Overall Study|Adverse Event|1
1478498|NCT00620815|4873897|P1|Overall Study|Adverse Event|1
1478499|NCT00620776|4873937|P2|Overall Study|Withdrawal by Subject|2
1478500|NCT00620776|4873938|P1|Overall Study|Withdrawal by Subject|3
1478501|NCT00620776|4873937|P2|Overall Study|Lost to Follow-up|5
1478502|NCT00620776|4873938|P1|Overall Study|Lost to Follow-up|2
1478503|NCT00620776|4873937|P2|Overall Study|Lack of Efficacy|1
1478504|NCT00620776|4873938|P1|Overall Study|Lack of Efficacy|2
1478505|NCT00620776|4873937|P2|Overall Study|Adverse Event|3
1478506|NCT00620776|4873938|P1|Overall Study|Adverse Event|2
1478507|NCT00620776|4873937|P2|Overall Study|Did not receive treatment|5
1478508|NCT00620776|4873938|P1|Overall Study|Did not receive treatment|3
1478509|NCT00620763|4873966|P2|Period: Second Intervention|Withdrawal by Subject|0
1478510|NCT00620763|4873967|P1|Period: Second Intervention|Withdrawal by Subject|1
1478511|NCT00620763|4873966|P2|Period: First Intervention|Protocol Violation|3
1478512|NCT00620763|4873967|P1|Period: First Intervention|Protocol Violation|0
1478513|NCT00620763|4873966|P2|Period: First Intervention|Withdrawal by Subject|2
1478514|NCT00620763|4873967|P1|Period: First Intervention|Withdrawal by Subject|0
1478515|NCT00620750|4873973|P1|Overall Study|Lost to Follow-up|25
1478516|NCT00620659|4873988|P6|Treatment Period 3|Withdrawal by Subject|0
1478517|NCT00620659|4873989|P5|Treatment Period 3|Withdrawal by Subject|0
1478518|NCT00620659|4873990|P4|Treatment Period 3|Withdrawal by Subject|1
1478519|NCT00620659|4873991|P3|Treatment Period 3|Withdrawal by Subject|0
1478520|NCT00620659|4873992|P2|Treatment Period 3|Withdrawal by Subject|0
1478521|NCT00620659|4873993|P1|Treatment Period 3|Withdrawal by Subject|0
1478522|NCT00620659|4873988|P6|Treatment Period 3|Adverse Event|0
1478523|NCT00620659|4873989|P5|Treatment Period 3|Adverse Event|0
1478524|NCT00620659|4873990|P4|Treatment Period 3|Adverse Event|0
1478525|NCT00620659|4873991|P3|Treatment Period 3|Adverse Event|0
1478526|NCT00620659|4873992|P2|Treatment Period 3|Adverse Event|2
1478527|NCT00620659|4873993|P1|Treatment Period 3|Adverse Event|0
1478528|NCT00620659|4873988|P6|Placebo Washout Period 2|Adverse Event|0
1478529|NCT00620659|4873989|P5|Placebo Washout Period 2|Adverse Event|0
1478530|NCT00620659|4873990|P4|Placebo Washout Period 2|Adverse Event|0
1478531|NCT00620659|4873991|P3|Placebo Washout Period 2|Adverse Event|0
1478532|NCT00620659|4873992|P2|Placebo Washout Period 2|Adverse Event|0
1478533|NCT00620659|4873993|P1|Placebo Washout Period 2|Adverse Event|2
1478534|NCT00620659|4873988|P6|Treatment Period 2|Withdrawal by Subject|0
1478535|NCT00620659|4873989|P5|Treatment Period 2|Withdrawal by Subject|3
1478536|NCT00620659|4873990|P4|Treatment Period 2|Withdrawal by Subject|0
1478537|NCT00620659|4873991|P3|Treatment Period 2|Withdrawal by Subject|1
1478538|NCT00620659|4873992|P2|Treatment Period 2|Withdrawal by Subject|0
1478539|NCT00620659|4873993|P1|Treatment Period 2|Withdrawal by Subject|0
1478540|NCT00620659|4873988|P6|Treatment Period 2|Adverse Event|0
1478541|NCT00620659|4873989|P5|Treatment Period 2|Adverse Event|2
1478542|NCT00620659|4873990|P4|Treatment Period 2|Adverse Event|0
1478543|NCT00620659|4873991|P3|Treatment Period 2|Adverse Event|0
1478544|NCT00620659|4873992|P2|Treatment Period 2|Adverse Event|3
1478545|NCT00620659|4873993|P1|Treatment Period 2|Adverse Event|0
1478546|NCT00620659|4873988|P6|Placebo Washout Period 1|Withdrawal by Subject|0
1478547|NCT00620659|4873989|P5|Placebo Washout Period 1|Withdrawal by Subject|0
1478548|NCT00620659|4873990|P4|Placebo Washout Period 1|Withdrawal by Subject|1
1478549|NCT00620659|4873991|P3|Placebo Washout Period 1|Withdrawal by Subject|0
1478550|NCT00620659|4873992|P2|Placebo Washout Period 1|Withdrawal by Subject|0
1478551|NCT00620659|4873993|P1|Placebo Washout Period 1|Withdrawal by Subject|0
1478552|NCT00620659|4873988|P6|Treatment Period 1|Withdrawal by Subject|0
1478553|NCT00620659|4873989|P5|Treatment Period 1|Withdrawal by Subject|1
1478554|NCT00620659|4873990|P4|Treatment Period 1|Withdrawal by Subject|0
1478555|NCT00620659|4873991|P3|Treatment Period 1|Withdrawal by Subject|1
1478556|NCT00620659|4873992|P2|Treatment Period 1|Withdrawal by Subject|0
1478557|NCT00620659|4873993|P1|Treatment Period 1|Withdrawal by Subject|1
1478558|NCT00620659|4873988|P6|Treatment Period 1|Protocol Violation|0
1478559|NCT00620659|4873989|P5|Treatment Period 1|Protocol Violation|0
1478560|NCT00620659|4873990|P4|Treatment Period 1|Protocol Violation|0
1478561|NCT00620659|4873991|P3|Treatment Period 1|Protocol Violation|0
1478562|NCT00620659|4873992|P2|Treatment Period 1|Protocol Violation|0
1478563|NCT00620659|4873993|P1|Treatment Period 1|Protocol Violation|1
1478564|NCT00620659|4873988|P6|Treatment Period 1|Adverse Event|0
1478565|NCT00620659|4873989|P5|Treatment Period 1|Adverse Event|0
1478566|NCT00620659|4873990|P4|Treatment Period 1|Adverse Event|3
1478567|NCT00620659|4873991|P3|Treatment Period 1|Adverse Event|0
1478568|NCT00620659|4873992|P2|Treatment Period 1|Adverse Event|0
1478569|NCT00620659|4873993|P1|Treatment Period 1|Adverse Event|1
1478570|NCT00620555|4874011|P1|Overall Study|Visit failure against planned|1
1478571|NCT00620555|4874011|P1|Overall Study|Choice of other treatment|1
1478572|NCT00620555|4874011|P1|Overall Study|Withdrawal by Subject|1
1478573|NCT00620555|4874011|P1|Overall Study|Lack of Efficacy|12
1478574|NCT00620555|4874011|P1|Overall Study|Protocol Violation|2
1478575|NCT00620555|4874011|P1|Overall Study|Adverse Event|4
1478576|NCT00620542|4874020|P4|Part B (2 Year Core Study)|IVUS not available|2
1478577|NCT00620542|4874021|P3|Part B (2 Year Core Study)|IVUS not available|3
1478578|NCT00620542|4874022|P2|Part B (2 Year Core Study)|IVUS not available|0
1478579|NCT00620542|4874023|P1|Part B (2 Year Core Study)|IVUS not available|0
1478580|NCT00620542|4874020|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
1478581|NCT00620542|4874021|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
1478582|NCT00620542|4874022|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
1478583|NCT00620542|4874023|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
1478584|NCT00620542|4874020|P4|Part B (2 Year Core Study)|Safety reasons|3
1478585|NCT00620542|4874021|P3|Part B (2 Year Core Study)|Safety reasons|2
1478586|NCT00620542|4874022|P2|Part B (2 Year Core Study)|Safety reasons|0
1478587|NCT00620542|4874023|P1|Part B (2 Year Core Study)|Safety reasons|0
1478588|NCT00620542|4874020|P4|Part B (2 Year Core Study)|Protocol Violation|16
1478589|NCT00620542|4874021|P3|Part B (2 Year Core Study)|Protocol Violation|13
1478590|NCT00620542|4874022|P2|Part B (2 Year Core Study)|Protocol Violation|0
1478591|NCT00620542|4874023|P1|Part B (2 Year Core Study)|Protocol Violation|0
1478592|NCT00620542|4874020|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
1478593|NCT00620542|4874021|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
1478594|NCT00620542|4874022|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
1478595|NCT00620542|4874023|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
1478596|NCT00620542|4874020|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
1478597|NCT00620542|4874021|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
1478598|NCT00620542|4874022|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
1478599|NCT00620542|4874023|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
1478600|NCT00620542|4874020|P4|Part B (2 Year Core Study)|Protocol Violation|5
1478601|NCT00620542|4874021|P3|Part B (2 Year Core Study)|Protocol Violation|3
1478602|NCT00620542|4874022|P2|Part B (2 Year Core Study)|Protocol Violation|0
1478603|NCT00620542|4874023|P1|Part B (2 Year Core Study)|Protocol Violation|0
1478604|NCT00620542|4874020|P4|Part B (2 Year Core Study)|Adverse Event|49
1478605|NCT00620542|4874021|P3|Part B (2 Year Core Study)|Adverse Event|46
1478606|NCT00620542|4874022|P2|Part B (2 Year Core Study)|Adverse Event|0
1478607|NCT00620542|4874023|P1|Part B (2 Year Core Study)|Adverse Event|0
1478608|NCT00620542|4874020|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
1478609|NCT00620542|4874021|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
1478610|NCT00620542|4874022|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
1478611|NCT00620542|4874023|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
1478612|NCT00620542|4874020|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
1478613|NCT00620542|4874021|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
1478614|NCT00620542|4874022|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
1478615|NCT00620542|4874023|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
1478616|NCT00620542|4874020|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
1478617|NCT00620542|4874021|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
1478618|NCT00620542|4874022|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
1478619|NCT00620542|4874023|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
1478620|NCT00620542|4874020|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
1478621|NCT00620542|4874021|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
1478622|NCT00620542|4874022|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
1478623|NCT00620542|4874023|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
1478624|NCT00620542|4874020|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
1478625|NCT00620542|4874021|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
1478626|NCT00620542|4874022|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
1478627|NCT00620542|4874023|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
1478628|NCT00620542|4874020|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
1478629|NCT00620542|4874021|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
1478630|NCT00620542|4874022|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
1478631|NCT00620542|4874023|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
1478632|NCT00620542|4874020|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
1478633|NCT00620542|4874021|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
1478634|NCT00620542|4874022|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
1478635|NCT00620542|4874023|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
1478636|NCT00620464|4874063|P2|Overall Study|Used prohibited medication|0
1478637|NCT00620464|4874064|P1|Overall Study|Used prohibited medication|1
1478638|NCT00620464|4874063|P2|Overall Study|Personal|2
1478639|NCT00620464|4874064|P1|Overall Study|Personal|2
1478640|NCT00620464|4874063|P2|Overall Study|Planning Pregnancy|4
1478641|NCT00620464|4874064|P1|Overall Study|Planning Pregnancy|1
1478642|NCT00620464|4874063|P2|Overall Study|Lost to Follow-up|1
1478643|NCT00620464|4874064|P1|Overall Study|Lost to Follow-up|1
1478644|NCT00620464|4874063|P2|Overall Study|Adverse Event|17
1478645|NCT00620464|4874064|P1|Overall Study|Adverse Event|15
1478646|NCT00620373|4874083|P1|Overall Study|Unverified cancer status|33
1478647|NCT00620282|4874102|P3|Overall Study|Withdrawal by Subject|0
1478648|NCT00620282|4874103|P2|Overall Study|Withdrawal by Subject|1
1478649|NCT00620282|4874104|P1|Overall Study|Withdrawal by Subject|0
1478650|NCT00620282|4874102|P3|Overall Study|Arterial line unable to be placed|1
1478651|NCT00620282|4874103|P2|Overall Study|Arterial line unable to be placed|0
1478652|NCT00620282|4874104|P1|Overall Study|Arterial line unable to be placed|0
1478653|NCT00620282|4874102|P3|Overall Study|Adverse Event|0
1478654|NCT00620282|4874103|P2|Overall Study|Adverse Event|1
1478655|NCT00620282|4874104|P1|Overall Study|Adverse Event|0
1478656|NCT00620113|4874168|P4|Overall Study|Withdrawal by Subject|5
1478657|NCT00620113|4874169|P3|Overall Study|Withdrawal by Subject|3
1478658|NCT00620113|4874170|P2|Overall Study|Withdrawal by Subject|1
1478659|NCT00620113|4874171|P1|Overall Study|Withdrawal by Subject|5
1478660|NCT00620113|4874168|P4|Overall Study|Protocol Violation|0
1478661|NCT00620113|4874169|P3|Overall Study|Protocol Violation|0
1478662|NCT00620113|4874170|P2|Overall Study|Protocol Violation|1
1478663|NCT00620113|4874171|P1|Overall Study|Protocol Violation|2
1478664|NCT00620113|4874168|P4|Overall Study|Physician Decision|2
1478665|NCT00620113|4874169|P3|Overall Study|Physician Decision|0
1478666|NCT00620113|4874170|P2|Overall Study|Physician Decision|0
1478667|NCT00620113|4874171|P1|Overall Study|Physician Decision|1
1478668|NCT00620113|4874168|P4|Overall Study|Lack of Efficacy|2
1478669|NCT00620113|4874169|P3|Overall Study|Lack of Efficacy|0
1478670|NCT00620113|4874170|P2|Overall Study|Lack of Efficacy|3
1478671|NCT00620113|4874171|P1|Overall Study|Lack of Efficacy|2
1478672|NCT00620113|4874168|P4|Overall Study|Adverse Event|1
1478673|NCT00620113|4874169|P3|Overall Study|Adverse Event|2
1478674|NCT00620113|4874170|P2|Overall Study|Adverse Event|2
1478675|NCT00620113|4874171|P1|Overall Study|Adverse Event|3
1478676|NCT00620074|4874221|P1|Overall Study|Adverse Event|1
1478677|NCT00620035|4874229|P1|Overall Study|Other Reason|38
1478678|NCT00620035|4874229|P1|Overall Study|Withdrawal of Informed Consent|1
1478679|NCT00620035|4874229|P1|Overall Study|Adverse Event|106
1478680|NCT00620022|4874239|P2|Treatment Period 2|Adverse Event|2
1478681|NCT00620022|4874240|P1|Treatment Period 2|Adverse Event|2
1478682|NCT00620022|4874239|P2|Treatment Period 1|Subject withdrew consent|0
1478683|NCT00620022|4874240|P1|Treatment Period 1|Subject withdrew consent|1
1478684|NCT00620022|4874239|P2|Treatment Period 1|Adverse Event|6
1478685|NCT00620022|4874240|P1|Treatment Period 1|Adverse Event|4
1478686|NCT00619983|4874252|P4|Test Drug Alone|Failure of daily diary device|2
1478687|NCT00619983|4874253|P3|Test Drug Alone|Failure of daily diary device|2
1478688|NCT00619983|4874254|P2|Test Drug Alone|Failure of daily diary device|1
1478689|NCT00619983|4874255|P1|Test Drug Alone|Failure of daily diary device|1
1478690|NCT00619983|4874252|P4|Test Drug Alone|Withdrawal by Subject|1
1478691|NCT00619983|4874253|P3|Test Drug Alone|Withdrawal by Subject|0
1478692|NCT00619983|4874254|P2|Test Drug Alone|Withdrawal by Subject|0
1478693|NCT00619983|4874255|P1|Test Drug Alone|Withdrawal by Subject|1
1478694|NCT00619957|4874282|P2|Month 48 Open-Label|Withdrawal by Subject|9
1478695|NCT00619957|4874283|P1|Month 48 Open-Label|Withdrawal by Subject|6
1478696|NCT00619957|4874282|P2|Month 48 Open-Label|Lost to Follow-up|4
1478697|NCT00619957|4874283|P1|Month 48 Open-Label|Lost to Follow-up|2
1478698|NCT00619957|4874282|P2|Month 48 Open-Label|Adverse Event|4
1478699|NCT00619957|4874283|P1|Month 48 Open-Label|Adverse Event|4
1478700|NCT00619957|4874282|P2|Month 24 Double-Blind|Did not take any study medication|1
1478701|NCT00619957|4874283|P1|Month 24 Double-Blind|Did not take any study medication|0
1478702|NCT00619957|4874282|P2|Month 24 Double-Blind|Lost to Follow-up|0
1478703|NCT00619957|4874283|P1|Month 24 Double-Blind|Lost to Follow-up|1
1478704|NCT00619957|4874282|P2|Month 24 Double-Blind|Withdrawal by Subject|9
1478705|NCT00619957|4874283|P1|Month 24 Double-Blind|Withdrawal by Subject|7
1478706|NCT00619957|4874282|P2|Month 24 Double-Blind|Protocol Violation|0
1478707|NCT00619957|4874283|P1|Month 24 Double-Blind|Protocol Violation|1
1478708|NCT00619957|4874282|P2|Month 24 Double-Blind|Adverse Event|7
1478709|NCT00619957|4874283|P1|Month 24 Double-Blind|Adverse Event|9
1478710|NCT00619918|4874365|P2|Overall Study|Left before receiving first dose|8
1478711|NCT00619918|4874366|P1|Overall Study|Left before receiving first dose|5
1478712|NCT00619918|4874365|P2|Overall Study|Transfer to outside facility|3
1478713|NCT00619918|4874366|P1|Overall Study|Transfer to outside facility|3
1478714|NCT00619918|4874365|P2|Overall Study|Physician Decision|8
1478715|NCT00619918|4874366|P1|Overall Study|Physician Decision|8
1478716|NCT00619918|4874365|P2|Overall Study|Withdrawal by Subject|3
1478717|NCT00619918|4874366|P1|Overall Study|Withdrawal by Subject|4
1478718|NCT00619892|4874376|P2|Overall Study|Intercurrent illness|1
1478719|NCT00619892|4874377|P1|Overall Study|Intercurrent illness|0
1478720|NCT00619892|4874376|P2|Overall Study|Lost to Follow-up|1
1478721|NCT00619892|4874377|P1|Overall Study|Lost to Follow-up|0
1478722|NCT00619892|4874376|P2|Overall Study|Adverse Event|0
1478723|NCT00619892|4874377|P1|Overall Study|Adverse Event|3
1478724|NCT00619827|4874387|P2|Overall Study|Withdrawal by Subject|2
1478725|NCT00619827|4874388|P1|Overall Study|Withdrawal by Subject|2
1478726|NCT00619827|4874387|P2|Overall Study|Adverse Event|2
1478727|NCT00619827|4874388|P1|Overall Study|Adverse Event|1
1478728|NCT00619801|4874396|P2|Overall Study|Loss of efficacy|1
1478729|NCT00619801|4874397|P1|Overall Study|Loss of efficacy|0
1478730|NCT00619801|4874396|P2|Overall Study|Withdrawal by Subject|1
1478731|NCT00619801|4874397|P1|Overall Study|Withdrawal by Subject|1
1478732|NCT00619801|4874396|P2|Overall Study|Lack of Efficacy|1
1478733|NCT00619801|4874397|P1|Overall Study|Lack of Efficacy|0
1478734|NCT00619645|4874454|P1|Overall Study|Adverse Event|1
1478735|NCT00619619|4874468|P8|Overall Study|Adverse Event|2
1478736|NCT00619619|4874469|P7|Overall Study|Adverse Event|0
1478737|NCT00619619|4874470|P6|Overall Study|Adverse Event|0
1478738|NCT00619619|4874471|P5|Overall Study|Adverse Event|2
1478739|NCT00619619|4874472|P4|Overall Study|Adverse Event|0
1478740|NCT00619619|4874473|P3|Overall Study|Adverse Event|0
1478741|NCT00619619|4874474|P2|Overall Study|Adverse Event|0
1478742|NCT00619619|4874475|P1|Overall Study|Adverse Event|0
1478743|NCT00619619|4874468|P8|Overall Study|Protocol Violation|1
1478744|NCT00619619|4874469|P7|Overall Study|Protocol Violation|1
1478745|NCT00619619|4874470|P6|Overall Study|Protocol Violation|0
1478746|NCT00619619|4874471|P5|Overall Study|Protocol Violation|0
1478747|NCT00619619|4874472|P4|Overall Study|Protocol Violation|1
1478748|NCT00619619|4874473|P3|Overall Study|Protocol Violation|0
1478749|NCT00619619|4874474|P2|Overall Study|Protocol Violation|0
1478750|NCT00619619|4874475|P1|Overall Study|Protocol Violation|0
1478751|NCT00619619|4874468|P8|Overall Study|Physician Decision|0
1478752|NCT00619619|4874469|P7|Overall Study|Physician Decision|0
1478753|NCT00619619|4874470|P6|Overall Study|Physician Decision|0
1478754|NCT00619619|4874471|P5|Overall Study|Physician Decision|0
1478755|NCT00619619|4874472|P4|Overall Study|Physician Decision|0
1478756|NCT00619619|4874473|P3|Overall Study|Physician Decision|1
1478757|NCT00619619|4874474|P2|Overall Study|Physician Decision|0
1478758|NCT00619619|4874475|P1|Overall Study|Physician Decision|0
1478759|NCT00619502|4874562|P2|Overall Study|Lost to Follow-up|10
1478760|NCT00619502|4874563|P1|Overall Study|Lost to Follow-up|8
1478761|NCT00619489|4874575|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
1478762|NCT00619489|4874576|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
1478763|NCT00619489|4874575|P2|Overall Study|Lack of Efficacy|11
1478764|NCT00619489|4874576|P1|Overall Study|Lack of Efficacy|0
1478765|NCT00619489|4874575|P2|Overall Study|Withdrawal by Subject|1
1478766|NCT00619489|4874576|P1|Overall Study|Withdrawal by Subject|1
1478767|NCT00619489|4874575|P2|Overall Study|Adverse Event|7
1478768|NCT00619489|4874576|P1|Overall Study|Adverse Event|0
1478769|NCT00619476|4874598|P4|Overall Study|Withdrawal by Subject|4
1478770|NCT00619476|4874599|P3|Overall Study|Withdrawal by Subject|5
1478771|NCT00619476|4874600|P2|Overall Study|Withdrawal by Subject|7
1478772|NCT00619476|4874601|P1|Overall Study|Withdrawal by Subject|5
1478773|NCT00619476|4874598|P4|Overall Study|Investigator Discretion|0
1478774|NCT00619476|4874599|P3|Overall Study|Investigator Discretion|2
1478775|NCT00619476|4874600|P2|Overall Study|Investigator Discretion|2
1478776|NCT00619476|4874601|P1|Overall Study|Investigator Discretion|2
1478777|NCT00619476|4874598|P4|Overall Study|Lost to Follow-up|1
1478778|NCT00619476|4874599|P3|Overall Study|Lost to Follow-up|0
1478779|NCT00619476|4874600|P2|Overall Study|Lost to Follow-up|2
1478780|NCT00619476|4874601|P1|Overall Study|Lost to Follow-up|1
1478781|NCT00619476|4874598|P4|Overall Study|Protocol Violation|9
1478782|NCT00619476|4874599|P3|Overall Study|Protocol Violation|4
1478783|NCT00619476|4874600|P2|Overall Study|Protocol Violation|4
1478784|NCT00619476|4874601|P1|Overall Study|Protocol Violation|5
1478785|NCT00619476|4874598|P4|Overall Study|Lack of Efficacy|4
1478786|NCT00619476|4874599|P3|Overall Study|Lack of Efficacy|1
1478787|NCT00619476|4874600|P2|Overall Study|Lack of Efficacy|1
1478788|NCT00619476|4874601|P1|Overall Study|Lack of Efficacy|6
1478789|NCT00619476|4874598|P4|Overall Study|Adverse Event|16
1478790|NCT00619476|4874599|P3|Overall Study|Adverse Event|12
1478791|NCT00619476|4874600|P2|Overall Study|Adverse Event|6
1478792|NCT00619476|4874601|P1|Overall Study|Adverse Event|12
1478793|NCT00619385|4874686|P3|Overall Study|Other|1
1478794|NCT00619385|4874687|P2|Overall Study|Other|2
1478795|NCT00619385|4874688|P1|Overall Study|Other|1
1478796|NCT00619385|4874686|P3|Overall Study|Adverse Event|3
1478797|NCT00619385|4874687|P2|Overall Study|Adverse Event|0
1478798|NCT00619385|4874688|P1|Overall Study|Adverse Event|0
1478799|NCT00619359|4874703|P2|Overall Study|Progressive Disease|1
1478800|NCT00619359|4874704|P1|Overall Study|Progressive Disease|3
1478801|NCT00619359|4874703|P2|Overall Study|Withdrawal by Subject|20
1478802|NCT00619359|4874704|P1|Overall Study|Withdrawal by Subject|19
1478803|NCT00619359|4874703|P2|Overall Study|Protocol Violation|1
1478804|NCT00619359|4874704|P1|Overall Study|Protocol Violation|1
1478805|NCT00619359|4874703|P2|Overall Study|Physician Decision|7
1478806|NCT00619359|4874704|P1|Overall Study|Physician Decision|0
1478807|NCT00619359|4874703|P2|Overall Study|Lost to Follow-up|16
1478808|NCT00619359|4874704|P1|Overall Study|Lost to Follow-up|12
1478809|NCT00619359|4874703|P2|Overall Study|Adverse Event|36
1478810|NCT00619359|4874704|P1|Overall Study|Adverse Event|32
1478811|NCT00619307|4874716|P2|Overall Study|MS attack plus steroids|1
1478812|NCT00619307|4874717|P1|Overall Study|MS attack plus steroids|0
1478813|NCT00619307|4874716|P2|Overall Study|Severe migraine|1
1478814|NCT00619307|4874717|P1|Overall Study|Severe migraine|0
1478815|NCT00619307|4874716|P2|Overall Study|Withdrew consent|0
1478816|NCT00619307|4874717|P1|Overall Study|Withdrew consent|1
1478817|NCT00619307|4874716|P2|Overall Study|Protocol Violation|0
1478818|NCT00619307|4874717|P1|Overall Study|Protocol Violation|3
1478819|NCT00619307|4874716|P2|Overall Study|Lost to Follow-up|1
1478820|NCT00619307|4874717|P1|Overall Study|Lost to Follow-up|0
1478821|NCT00619307|4874716|P2|Overall Study|Adverse Event|1
1478822|NCT00619307|4874717|P1|Overall Study|Adverse Event|0
1478823|NCT00619229|4874754|P2|Overall Study|Investigator planned Cataract Operation|0
1478824|NCT00619229|4874755|P1|Overall Study|Investigator planned Cataract Operation|1
1478825|NCT00619229|4874754|P2|Overall Study|Termination of the Study by the Sponsor|1
1478826|NCT00619229|4874755|P1|Overall Study|Termination of the Study by the Sponsor|1
1478827|NCT00619229|4874754|P2|Overall Study|Lost to Follow-up|0
1478828|NCT00619229|4874755|P1|Overall Study|Lost to Follow-up|1
1478829|NCT00619229|4874754|P2|Overall Study|Withdrawal by Subject|1
1478830|NCT00619229|4874755|P1|Overall Study|Withdrawal by Subject|1
1478831|NCT00619177|4874794|P1|Overall Study|Not specified reasons|6
1478832|NCT00619177|4874794|P1|Overall Study|Missing termination information|481
1478833|NCT00619177|4874794|P1|Overall Study|Lack of Efficacy|1
1478834|NCT00619177|4874794|P1|Overall Study|Lost to Follow-up|2
1478835|NCT00619177|4874794|P1|Overall Study|Adverse Event|18
1478836|NCT00619151|4874804|P2|Overall Study|Study terminated prior to followup|0
1478837|NCT00619151|4874805|P1|Overall Study|Study terminated prior to followup|1
1478838|NCT00619112|4874815|P2|Overall Study|Adverse Event|2
1478839|NCT00619112|4874816|P1|Overall Study|Adverse Event|1
1478840|NCT00619099|4874837|P2|Overall Study|Physician Decision|6
1478841|NCT00619099|4874838|P1|Overall Study|Physician Decision|9
1478842|NCT00619099|4874837|P2|Overall Study|Withdrawal by Subject|2
1478843|NCT00619099|4874838|P1|Overall Study|Withdrawal by Subject|10
1478844|NCT00619099|4874837|P2|Overall Study|Emergence of Clinically Significant Lab|2
1478845|NCT00619099|4874838|P1|Overall Study|Emergence of Clinically Significant Lab|1
1478846|NCT00619099|4874837|P2|Overall Study|Adverse Event|3
1478847|NCT00619099|4874838|P1|Overall Study|Adverse Event|4
1478848|NCT00619099|4874837|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
1478849|NCT00619099|4874838|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
1478850|NCT00619099|4874837|P2|Overall Study|Progressive Disease|5
1478851|NCT00619099|4874838|P1|Overall Study|Progressive Disease|7
1478852|NCT00618995|4874860|P4|Period 4|Adverse Event|0
1478853|NCT00618995|4874861|P3|Period 4|Adverse Event|0
1478854|NCT00618995|4874862|P2|Period 4|Adverse Event|0
1478855|NCT00618995|4874863|P1|Period 4|Adverse Event|1
1478856|NCT00618995|4874860|P4|Period 2|Protocol Violation|0
1478857|NCT00618995|4874861|P3|Period 2|Protocol Violation|1
1478858|NCT00618995|4874862|P2|Period 2|Protocol Violation|0
1478859|NCT00618995|4874863|P1|Period 2|Protocol Violation|0
1478860|NCT00618995|4874860|P4|Period 1|Protocol Violation|0
1478861|NCT00618995|4874861|P3|Period 1|Protocol Violation|1
1478862|NCT00618995|4874862|P2|Period 1|Protocol Violation|1
1478863|NCT00618995|4874863|P1|Period 1|Protocol Violation|0
1478864|NCT00618995|4874860|P4|Period 1|Adverse Event|0
1478865|NCT00618995|4874861|P3|Period 1|Adverse Event|1
1478866|NCT00618995|4874862|P2|Period 1|Adverse Event|0
1478867|NCT00618995|4874863|P1|Period 1|Adverse Event|0
1478868|NCT00618982|4874877|P1|Overall Study|ongoing, still treated with study med.|25
1478869|NCT00618982|4874877|P1|Overall Study|Protocol Violation|1
1478870|NCT00618982|4874877|P1|Overall Study|Withdrawal by Subject|1
1478871|NCT00618982|4874877|P1|Overall Study|Adverse Event|23
1478872|NCT00618956|4874900|P2|Overall Study|did not meet criteria, non-compliance|1
1478873|NCT00618956|4874901|P1|Overall Study|did not meet criteria, non-compliance|2
1478874|NCT00618956|4874900|P2|Overall Study|Protocol Violation|2
1478875|NCT00618956|4874901|P1|Overall Study|Protocol Violation|2
1478876|NCT00618956|4874900|P2|Overall Study|Lost to Follow-up|5
1478877|NCT00618956|4874901|P1|Overall Study|Lost to Follow-up|4
1478878|NCT00618956|4874900|P2|Overall Study|Withdrawal by Subject|7
1478879|NCT00618956|4874901|P1|Overall Study|Withdrawal by Subject|5
1478880|NCT00618956|4874900|P2|Overall Study|Lack of Efficacy|1
1478881|NCT00618956|4874901|P1|Overall Study|Lack of Efficacy|2
1478882|NCT00618956|4874900|P2|Overall Study|Adverse Event|34
1478883|NCT00618956|4874901|P1|Overall Study|Adverse Event|10
1478884|NCT00618826|4874926|P1|Overall Study|Adverse Event|1
1478885|NCT00618813|4874931|P1|Overall Study|Withdrawal by Subject|1
1478886|NCT00618813|4874931|P1|Overall Study|Physician Decision|2
1478887|NCT00618813|4874931|P1|Overall Study|Lack of Efficacy|1
1478888|NCT00618787|4874941|P2|Overall Study|Lost to Follow-up|0
1478889|NCT00618787|4874942|P1|Overall Study|Lost to Follow-up|1
1478890|NCT00618787|4874941|P2|Overall Study|Withdrawal by Subject|1
1478891|NCT00618787|4874942|P1|Overall Study|Withdrawal by Subject|2
1478892|NCT00618787|4874941|P2|Overall Study|Adverse Event|1
1478893|NCT00618787|4874942|P1|Overall Study|Adverse Event|0
1478894|NCT00618774|4874950|P2|Overall Study|Withdrawal by Subject|0
1478895|NCT00618774|4874951|P1|Overall Study|Withdrawal by Subject|1
1478896|NCT00618774|4874950|P2|Overall Study|Adverse Event|3
1478897|NCT00618774|4874951|P1|Overall Study|Adverse Event|5
1478898|NCT00618748|4874984|P3|Overall Study|Withdrawal by Subject|5
1478899|NCT00618748|4874985|P2|Overall Study|Withdrawal by Subject|1
1478900|NCT00618748|4874986|P1|Overall Study|Withdrawal by Subject|4
1478901|NCT00618748|4874984|P3|Overall Study|Physician Decision|1
1478902|NCT00618748|4874985|P2|Overall Study|Physician Decision|1
1478903|NCT00618748|4874986|P1|Overall Study|Physician Decision|3
1478904|NCT00618748|4874984|P3|Overall Study|Adverse Event|8
1478905|NCT00618748|4874985|P2|Overall Study|Adverse Event|3
1478906|NCT00618748|4874986|P1|Overall Study|Adverse Event|4
1478907|NCT00618722|4875031|P4|Overall Study|Miscellaneous Reasons|1
1478908|NCT00618722|4875032|P3|Overall Study|Miscellaneous Reasons|1
1478909|NCT00618722|4875033|P2|Overall Study|Miscellaneous Reasons|0
1478910|NCT00618722|4875034|P1|Overall Study|Miscellaneous Reasons|0
1478911|NCT00618722|4875031|P4|Overall Study|Lost to Follow-up|2
1478912|NCT00618722|4875032|P3|Overall Study|Lost to Follow-up|0
1478913|NCT00618722|4875033|P2|Overall Study|Lost to Follow-up|0
1478914|NCT00618722|4875034|P1|Overall Study|Lost to Follow-up|2
1478915|NCT00618722|4875031|P4|Overall Study|Inability to Complete Study Procedure|0
1478916|NCT00618722|4875032|P3|Overall Study|Inability to Complete Study Procedure|0
1478917|NCT00618722|4875033|P2|Overall Study|Inability to Complete Study Procedure|1
1478918|NCT00618722|4875034|P1|Overall Study|Inability to Complete Study Procedure|0
1478919|NCT00618722|4875031|P4|Overall Study|Patient Request|1
1478920|NCT00618722|4875032|P3|Overall Study|Patient Request|1
1478921|NCT00618722|4875033|P2|Overall Study|Patient Request|1
1478922|NCT00618722|4875034|P1|Overall Study|Patient Request|1
1478923|NCT00618722|4875031|P4|Overall Study|Refusal of Treatment|0
1478924|NCT00618722|4875032|P3|Overall Study|Refusal of Treatment|1
1478925|NCT00618722|4875033|P2|Overall Study|Refusal of Treatment|0
1478926|NCT00618722|4875034|P1|Overall Study|Refusal of Treatment|0
1478927|NCT00618618|4875072|P4|Overall Study|Death|0
1478928|NCT00618618|4875073|P3|Overall Study|Death|0
1478929|NCT00618618|4875074|P2|Overall Study|Death|1
1478930|NCT00618618|4875075|P1|Overall Study|Death|0
1478931|NCT00618618|4875072|P4|Overall Study|Did Not Meet Entry Criteria|0
1478932|NCT00618618|4875073|P3|Overall Study|Did Not Meet Entry Criteria|1
1478933|NCT00618618|4875074|P2|Overall Study|Did Not Meet Entry Criteria|0
1478934|NCT00618618|4875075|P1|Overall Study|Did Not Meet Entry Criteria|0
1478935|NCT00618618|4875072|P4|Overall Study|Non-compliance|0
1478936|NCT00618618|4875073|P3|Overall Study|Non-compliance|0
1478937|NCT00618618|4875074|P2|Overall Study|Non-compliance|1
1478938|NCT00618618|4875075|P1|Overall Study|Non-compliance|1
1478939|NCT00618618|4875072|P4|Overall Study|Lost to Follow-up|1
1478940|NCT00618618|4875073|P3|Overall Study|Lost to Follow-up|0
1478941|NCT00618618|4875074|P2|Overall Study|Lost to Follow-up|0
1478942|NCT00618618|4875075|P1|Overall Study|Lost to Follow-up|3
1478943|NCT00618618|4875072|P4|Overall Study|Inability to Complete Study Procedures|0
1478944|NCT00618618|4875073|P3|Overall Study|Inability to Complete Study Procedures|0
1478945|NCT00618618|4875074|P2|Overall Study|Inability to Complete Study Procedures|1
1478946|NCT00618618|4875075|P1|Overall Study|Inability to Complete Study Procedures|0
1478947|NCT00618618|4875072|P4|Overall Study|Patient Request|0
1478948|NCT00618618|4875073|P3|Overall Study|Patient Request|2
1478949|NCT00618618|4875074|P2|Overall Study|Patient Request|0
1478950|NCT00618618|4875075|P1|Overall Study|Patient Request|0
1478951|NCT00618514|4875134|P3|Overall Study|Lost to Follow-up|4
1478952|NCT00618514|4875135|P2|Overall Study|Lost to Follow-up|12
1478953|NCT00618514|4875136|P1|Overall Study|Lost to Follow-up|11
1478954|NCT00618449|4875156|P2|Overall Study|Lost to Follow-up|110
1478955|NCT00618449|4875157|P1|Overall Study|Lost to Follow-up|98
1478956|NCT00618410|4875176|P2|Washout Period (2 Weeks)|Physician Decision|1
1478957|NCT00618410|4875177|P1|Washout Period (2 Weeks)|Physician Decision|0
1478958|NCT00618371|4875193|P1|Overall Study|Withdrawal by Subject|2
1478959|NCT00618072|4875226|P3|Overall Study|Physician Decision|1
1478960|NCT00618072|4875227|P2|Overall Study|Physician Decision|1
1478961|NCT00618072|4875228|P1|Overall Study|Physician Decision|0
1478962|NCT00618072|4875226|P3|Overall Study|Lost to Follow-up|3
1478963|NCT00618072|4875227|P2|Overall Study|Lost to Follow-up|0
1478964|NCT00618072|4875228|P1|Overall Study|Lost to Follow-up|2
1478965|NCT00617929|4875284|P1|Overall Study|Physician Decision|1
1478966|NCT00617903|4875296|P2|Overall Study|noncompliance|1
1478967|NCT00617903|4875297|P1|Overall Study|noncompliance|0
1478968|NCT00617903|4875296|P2|Overall Study|Adverse Event|1
1478969|NCT00617903|4875297|P1|Overall Study|Adverse Event|0
1478970|NCT00617903|4875296|P2|Overall Study|Lack of Efficacy|1
1478971|NCT00617903|4875297|P1|Overall Study|Lack of Efficacy|0
1478972|NCT00617903|4875296|P2|Overall Study|Lost to Follow-up|1
1478973|NCT00617903|4875297|P1|Overall Study|Lost to Follow-up|1
1478974|NCT00617903|4875296|P2|Overall Study|Withdrawal by Subject|3
1478975|NCT00617903|4875297|P1|Overall Study|Withdrawal by Subject|2
1478976|NCT00617890|4875343|P4|Overall Study|Not treated|1
1478977|NCT00617890|4875344|P3|Overall Study|Not treated|1
1478978|NCT00617890|4875345|P2|Overall Study|Not treated|0
1478979|NCT00617890|4875346|P1|Overall Study|Not treated|1
1478980|NCT00617890|4875343|P4|Overall Study|Adverse Event|8
1478981|NCT00617890|4875344|P3|Overall Study|Adverse Event|3
1478982|NCT00617890|4875345|P2|Overall Study|Adverse Event|0
1478983|NCT00617890|4875346|P1|Overall Study|Adverse Event|1
1478984|NCT00617890|4875343|P4|Overall Study|Protocol Violation|0
1478985|NCT00617890|4875344|P3|Overall Study|Protocol Violation|0
1478986|NCT00617890|4875345|P2|Overall Study|Protocol Violation|1
1478987|NCT00617890|4875346|P1|Overall Study|Protocol Violation|2
1478988|NCT00617890|4875343|P4|Overall Study|Withdrawal by Subject|2
1478989|NCT00617890|4875344|P3|Overall Study|Withdrawal by Subject|0
1478990|NCT00617890|4875345|P2|Overall Study|Withdrawal by Subject|1
1478991|NCT00617890|4875346|P1|Overall Study|Withdrawal by Subject|4
1478992|NCT00617890|4875343|P4|Overall Study|Lost to Follow-up|2
1478993|NCT00617890|4875344|P3|Overall Study|Lost to Follow-up|1
1478994|NCT00617890|4875345|P2|Overall Study|Lost to Follow-up|0
1478995|NCT00617890|4875346|P1|Overall Study|Lost to Follow-up|0
1478996|NCT00617890|4875343|P4|Overall Study|Lack of Efficacy|97
1478997|NCT00617890|4875344|P3|Overall Study|Lack of Efficacy|30
1478998|NCT00617890|4875345|P2|Overall Study|Lack of Efficacy|26
1478999|NCT00617890|4875346|P1|Overall Study|Lack of Efficacy|23
1479000|NCT00617890|4875343|P4|Overall Study|Treatment ongoing at data cut-off|5
1479001|NCT00617890|4875344|P3|Overall Study|Treatment ongoing at data cut-off|0
1479002|NCT00617890|4875345|P2|Overall Study|Treatment ongoing at data cut-off|0
1479003|NCT00617890|4875346|P1|Overall Study|Treatment ongoing at data cut-off|0
1479004|NCT00617851|4875382|P4|Overall Study|Unable to classify|0
1479005|NCT00617851|4875383|P3|Overall Study|Unable to classify|1
1479006|NCT00617851|4875384|P2|Overall Study|Unable to classify|0
1479007|NCT00617851|4875385|P1|Overall Study|Unable to classify|1
1479008|NCT00617851|4875382|P4|Overall Study|Inappropriate Enrollment|1
1479009|NCT00617851|4875383|P3|Overall Study|Inappropriate Enrollment|1
1479010|NCT00617851|4875384|P2|Overall Study|Inappropriate Enrollment|4
1479011|NCT00617851|4875385|P1|Overall Study|Inappropriate Enrollment|5
1479012|NCT00617851|4875382|P4|Overall Study|Lost to Follow-up|19
1479013|NCT00617851|4875383|P3|Overall Study|Lost to Follow-up|31
1479014|NCT00617851|4875384|P2|Overall Study|Lost to Follow-up|29
1479015|NCT00617851|4875385|P1|Overall Study|Lost to Follow-up|27
1479016|NCT00617851|4875382|P4|Overall Study|Withdrawal by Subject|4
1479017|NCT00617851|4875383|P3|Overall Study|Withdrawal by Subject|12
1479018|NCT00617851|4875384|P2|Overall Study|Withdrawal by Subject|7
1479019|NCT00617851|4875385|P1|Overall Study|Withdrawal by Subject|14
1479020|NCT00617851|4875382|P4|Overall Study|Death|1
1479021|NCT00617851|4875383|P3|Overall Study|Death|0
1479022|NCT00617851|4875384|P2|Overall Study|Death|0
1479023|NCT00617851|4875385|P1|Overall Study|Death|0
1479024|NCT00617773|4875423|P1|Overall Study|Protocol Violation|1
1479025|NCT00617773|4875423|P1|Overall Study|Progressive disease|19
1479026|NCT00617773|4875423|P1|Overall Study|Death|1
1479027|NCT00617773|4875423|P1|Overall Study|Withdrawal by Subject|1
1479028|NCT00617773|4875423|P1|Overall Study|Lack of compliance with the protocol|1
1479029|NCT00617773|4875423|P1|Overall Study|Physician Decision|1
1479030|NCT00617734|4875440|P2|Overall Study|Lost to Follow-up|1
1479031|NCT00617734|4875441|P1|Overall Study|Lost to Follow-up|0
1479032|NCT00617734|4875440|P2|Overall Study|Found Ineligible After Randomization|4
1479033|NCT00617734|4875441|P1|Overall Study|Found Ineligible After Randomization|1
1479034|NCT00617734|4875440|P2|Overall Study|Protocol Violation|0
1479035|NCT00617734|4875441|P1|Overall Study|Protocol Violation|1
1479036|NCT00617734|4875440|P2|Overall Study|Adverse Event|1
1479037|NCT00617734|4875441|P1|Overall Study|Adverse Event|4
1479038|NCT00617734|4875440|P2|Overall Study|Withdrew Consent|0
1479039|NCT00617734|4875441|P1|Overall Study|Withdrew Consent|2
1479040|NCT00617708|4875462|P3|Overall Study|Not eligible|5
1479041|NCT00617708|4875463|P2|Overall Study|Not eligible|3
1479042|NCT00617708|4875464|P1|Overall Study|Not eligible|1
1479043|NCT00617708|4875462|P3|Overall Study|Not protocol specified|2
1479044|NCT00617708|4875463|P2|Overall Study|Not protocol specified|4
1479045|NCT00617708|4875464|P1|Overall Study|Not protocol specified|1
1479046|NCT00617708|4875462|P3|Overall Study|Progression/Relapse|36
1479047|NCT00617708|4875463|P2|Overall Study|Progression/Relapse|40
1479048|NCT00617708|4875464|P1|Overall Study|Progression/Relapse|7
1479049|NCT00617708|4875462|P3|Overall Study|Death|5
1479050|NCT00617708|4875463|P2|Overall Study|Death|6
1479051|NCT00617708|4875464|P1|Overall Study|Death|0
1479052|NCT00617708|4875462|P3|Overall Study|Withdrawal by Subject|7
1479053|NCT00617708|4875463|P2|Overall Study|Withdrawal by Subject|1
1479054|NCT00617708|4875464|P1|Overall Study|Withdrawal by Subject|1
1479055|NCT00617708|4875462|P3|Overall Study|Adverse Event|9
1479056|NCT00617708|4875463|P2|Overall Study|Adverse Event|6
1479057|NCT00617708|4875464|P1|Overall Study|Adverse Event|0
1479058|NCT00617669|4875481|P2|Overall Study|Patients randomized but not treated|3
1479059|NCT00617669|4875482|P1|Overall Study|Patients randomized but not treated|2
1479060|NCT00617669|4875481|P2|Overall Study|Reason not otherwise captured, eg; death|290
1479061|NCT00617669|4875482|P1|Overall Study|Reason not otherwise captured, eg; death|265
1479062|NCT00617669|4875481|P2|Overall Study|Protocol Violation|3
1479063|NCT00617669|4875482|P1|Overall Study|Protocol Violation|2
1479064|NCT00617669|4875481|P2|Overall Study|Adverse Event|76
1479065|NCT00617669|4875482|P1|Overall Study|Adverse Event|87
1479066|NCT00617669|4875481|P2|Overall Study|Lost to Follow-up|2
1479067|NCT00617669|4875482|P1|Overall Study|Lost to Follow-up|3
1479068|NCT00617669|4875481|P2|Overall Study|Withdrawal by Subject|77
1479069|NCT00617669|4875482|P1|Overall Study|Withdrawal by Subject|71
1479070|NCT00617604|4875504|P2|Overall Study|Randomized but Never Received Study Drug|3
1479071|NCT00617604|4875505|P1|Overall Study|Randomized but Never Received Study Drug|3
1479072|NCT00617604|4875504|P2|Overall Study|Withdrawal by Subject|6
1479073|NCT00617604|4875505|P1|Overall Study|Withdrawal by Subject|4
1479074|NCT00617604|4875504|P2|Overall Study|Miscellaneous Reasons|10
1479075|NCT00617604|4875505|P1|Overall Study|Miscellaneous Reasons|8
1479076|NCT00617604|4875504|P2|Overall Study|Lost to Follow-up|0
1479077|NCT00617604|4875505|P1|Overall Study|Lost to Follow-up|1
1479078|NCT00617604|4875504|P2|Overall Study|Death|1
1479079|NCT00617604|4875505|P1|Overall Study|Death|2
1479080|NCT00617591|4875549|P1|Overall Study|Withdrew consent during Maintenance|6
1479081|NCT00617591|4875549|P1|Overall Study|Withdrew consent during Induction|4
1479082|NCT00617461|4875565|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
1479083|NCT00617461|4875566|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
1479084|NCT00617461|4875565|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
1479085|NCT00617461|4875566|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
1479086|NCT00617461|4875565|P2|Second Treatment Intervention Period|Lack of Efficacy|3
1479087|NCT00617461|4875566|P1|Second Treatment Intervention Period|Lack of Efficacy|0
1479088|NCT00617461|4875565|P2|Second Treatment Intervention Period|Adverse Event|1
1479089|NCT00617461|4875566|P1|Second Treatment Intervention Period|Adverse Event|0
1479090|NCT00617461|4875565|P2|4-Day Crossover Period|Withdrawal by Subject|0
1479091|NCT00617461|4875566|P1|4-Day Crossover Period|Withdrawal by Subject|1
1479092|NCT00617461|4875565|P2|First Treatment Intervention Period|Withdrawal by Subject|0
1479093|NCT00617461|4875566|P1|First Treatment Intervention Period|Withdrawal by Subject|4
1479094|NCT00617461|4875565|P2|First Treatment Intervention Period|Investigator Discretion|1
1479095|NCT00617461|4875566|P1|First Treatment Intervention Period|Investigator Discretion|1
1479096|NCT00617461|4875565|P2|First Treatment Intervention Period|Lost to Follow-up|1
1479097|NCT00617461|4875566|P1|First Treatment Intervention Period|Lost to Follow-up|0
1479098|NCT00617461|4875565|P2|First Treatment Intervention Period|Protocol Violation|1
1479099|NCT00617461|4875566|P1|First Treatment Intervention Period|Protocol Violation|2
1479100|NCT00617461|4875565|P2|First Treatment Intervention Period|Lack of Efficacy|0
1479101|NCT00617461|4875566|P1|First Treatment Intervention Period|Lack of Efficacy|1
1479102|NCT00617461|4875565|P2|First Treatment Intervention Period|Adverse Event|0
1479103|NCT00617461|4875566|P1|First Treatment Intervention Period|Adverse Event|2
1479104|NCT00617409|4875622|P3|Overall Study|Alternative Therapy|0
1479105|NCT00617409|4875623|P2|Overall Study|Alternative Therapy|2
1479106|NCT00617409|4875624|P1|Overall Study|Alternative Therapy|1
1479107|NCT00617409|4875622|P3|Overall Study|Death|4
1479108|NCT00617409|4875623|P2|Overall Study|Death|5
1479109|NCT00617409|4875624|P1|Overall Study|Death|3
1479110|NCT00617409|4875622|P3|Overall Study|Disease Progression|18
1479111|NCT00617409|4875623|P2|Overall Study|Disease Progression|8
1479112|NCT00617409|4875624|P1|Overall Study|Disease Progression|8
1479113|NCT00617409|4875622|P3|Overall Study|Adverse Event|3
1479114|NCT00617409|4875623|P2|Overall Study|Adverse Event|2
1479115|NCT00617409|4875624|P1|Overall Study|Adverse Event|0
1479116|NCT00617409|4875622|P3|Overall Study|Withdrawal by Subject|2
1479117|NCT00617409|4875623|P2|Overall Study|Withdrawal by Subject|1
1479118|NCT00617409|4875624|P1|Overall Study|Withdrawal by Subject|4
1479119|NCT00617357|4875639|P1|Overall Study|Physician Decision|1
1479120|NCT00617357|4875639|P1|Overall Study|Withdrawal by Subject|1
1479121|NCT00617357|4875639|P1|Overall Study|insurance concerns|2
1479122|NCT00617357|4875639|P1|Overall Study|Death|5
1479123|NCT00617357|4875639|P1|Overall Study|Lost to Follow-up|7
1479124|NCT00617305|4875652|P3|Overall Study|Withdrawal by Subject|0
1479125|NCT00617305|4875653|P2|Overall Study|Withdrawal by Subject|0
1479126|NCT00617305|4875654|P1|Overall Study|Withdrawal by Subject|1
1479127|NCT00617305|4875652|P3|Overall Study|Protocol Violation|1
1479128|NCT00617305|4875653|P2|Overall Study|Protocol Violation|0
1479129|NCT00617305|4875654|P1|Overall Study|Protocol Violation|1
1479130|NCT00617305|4875652|P3|Overall Study|Physician Decision|0
1479131|NCT00617305|4875653|P2|Overall Study|Physician Decision|0
1479132|NCT00617305|4875654|P1|Overall Study|Physician Decision|1
1479133|NCT00617305|4875652|P3|Overall Study|Death|0
1479134|NCT00617305|4875653|P2|Overall Study|Death|0
1479135|NCT00617305|4875654|P1|Overall Study|Death|1
1479136|NCT00617305|4875652|P3|Overall Study|Adverse Event|0
1479137|NCT00617305|4875653|P2|Overall Study|Adverse Event|0
1479138|NCT00617305|4875654|P1|Overall Study|Adverse Event|4
1479139|NCT00617279|4875710|P2|Overall Study|Death|2
1479140|NCT00617279|4875711|P1|Overall Study|Death|1
1479141|NCT00617279|4875710|P2|Overall Study|Lost to Follow-up|0
1479142|NCT00617279|4875711|P1|Overall Study|Lost to Follow-up|1
1479143|NCT00617279|4875710|P2|Overall Study|Graft abandonment|0
1479144|NCT00617279|4875711|P1|Overall Study|Graft abandonment|2
1479145|NCT00617279|4875710|P2|Overall Study|Study terminated by Sponsor|15
1479146|NCT00617279|4875711|P1|Overall Study|Study terminated by Sponsor|10
1479147|NCT00617240|4875767|P2|Overall Study|Lack of Efficacy|0
1479148|NCT00617240|4875768|P1|Overall Study|Lack of Efficacy|1
1479149|NCT00617201|4875788|P2|Overall Study|Lost to Follow-up|13
1479150|NCT00617201|4875789|P1|Overall Study|Lost to Follow-up|9
1479151|NCT00617123|4875817|P2|Study Treatment Period|Noncompliance with Protocol|1
1479152|NCT00617123|4875818|P1|Study Treatment Period|Noncompliance with Protocol|0
1479153|NCT00617123|4875817|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
1479154|NCT00617123|4875818|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
1479155|NCT00617123|4875817|P2|Study Treatment Period|Adverse Event|3
1479156|NCT00617123|4875818|P1|Study Treatment Period|Adverse Event|7
1479157|NCT00617123|4875817|P2|Study Treatment Period|Withdrawal by Subject|12
1479158|NCT00617123|4875818|P1|Study Treatment Period|Withdrawal by Subject|8
1479159|NCT00617123|4875817|P2|Referral Screening Period|Adverse Event|1
1479160|NCT00617123|4875818|P1|Referral Screening Period|Adverse Event|0
1479161|NCT00617123|4875817|P2|Referral Screening Period|Did Not Wish To Continue|1
1479162|NCT00617123|4875818|P1|Referral Screening Period|Did Not Wish To Continue|3
1479163|NCT00617123|4875817|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
1479164|NCT00617123|4875818|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
1479165|NCT00617084|4875849|P2|Overall Study|Missed 12 Months visit|19
1479166|NCT00617084|4875850|P1|Overall Study|Missed 12 Months visit|16
1479167|NCT00617084|4875849|P2|Overall Study|Withdrawal by Subject|7
1479168|NCT00617084|4875850|P1|Overall Study|Withdrawal by Subject|5
1479169|NCT00616967|4875903|P3|Overall Study|Withdrawal by Subject|1
1479170|NCT00616967|4875904|P2|Overall Study|Withdrawal by Subject|0
1479171|NCT00616967|4875905|P1|Overall Study|Withdrawal by Subject|0
1479172|NCT00616941|4875917|P3|Overall Study|Vaccination Suspended|3
1479173|NCT00616941|4875918|P2|Overall Study|Vaccination Suspended|0
1479174|NCT00616941|4875919|P1|Overall Study|Vaccination Suspended|0
1479175|NCT00616941|4875917|P3|Overall Study|Unrelated Medical Illness/Complication|0
1479176|NCT00616941|4875918|P2|Overall Study|Unrelated Medical Illness/Complication|2
1479177|NCT00616941|4875919|P1|Overall Study|Unrelated Medical Illness/Complication|0
1479178|NCT00616941|4875917|P3|Overall Study|Subject Non-compliance|1
1479179|NCT00616941|4875918|P2|Overall Study|Subject Non-compliance|0
1479180|NCT00616941|4875919|P1|Overall Study|Subject Non-compliance|0
1479181|NCT00616941|4875917|P3|Overall Study|Adverse Event|1
1479182|NCT00616941|4875918|P2|Overall Study|Adverse Event|1
1479183|NCT00616941|4875919|P1|Overall Study|Adverse Event|0
1479184|NCT00616941|4875917|P3|Overall Study|Progressive Disease|1
1479185|NCT00616941|4875918|P2|Overall Study|Progressive Disease|2
1479186|NCT00616941|4875919|P1|Overall Study|Progressive Disease|1
1479187|NCT00616928|4875946|P4|Overall Study|Lost to Follow-up|0
1479188|NCT00616928|4875947|P3|Overall Study|Lost to Follow-up|0
1479189|NCT00616928|4875948|P2|Overall Study|Lost to Follow-up|7
1479190|NCT00616928|4875949|P1|Overall Study|Lost to Follow-up|5
1479191|NCT00616928|4875946|P4|Overall Study|Other|5
1479192|NCT00616928|4875947|P3|Overall Study|Other|15
1479193|NCT00616928|4875948|P2|Overall Study|Other|8
1479194|NCT00616928|4875949|P1|Overall Study|Other|51
1479195|NCT00616928|4875946|P4|Overall Study|Adverse Event|2
1479196|NCT00616928|4875947|P3|Overall Study|Adverse Event|2
1479197|NCT00616928|4875948|P2|Overall Study|Adverse Event|3
1479198|NCT00616928|4875949|P1|Overall Study|Adverse Event|6
1479199|NCT00616902|4876013|P2|Overall Study|Termination of study|6
1479200|NCT00616902|4876014|P1|Overall Study|Termination of study|6
1479201|NCT00616759|4876057|P2|Overall Study|Withdrawal by Subject|2
1479202|NCT00616759|4876058|P1|Overall Study|Withdrawal by Subject|1
1479203|NCT00616759|4876057|P2|Overall Study|Physician Decision|0
1479204|NCT00616759|4876058|P1|Overall Study|Physician Decision|2
1479205|NCT00616655|4876067|P3|Overall Study|Other|5
1479206|NCT00616655|4876068|P2|Overall Study|Other|6
1479207|NCT00616655|4876069|P1|Overall Study|Other|6
1479208|NCT00616655|4876067|P3|Overall Study|Does not meet in/ex criteria|2
1479209|NCT00616655|4876068|P2|Overall Study|Does not meet in/ex criteria|0
1479210|NCT00616655|4876069|P1|Overall Study|Does not meet in/ex criteria|0
1479211|NCT00616655|4876067|P3|Overall Study|Withdrawal by Subject|11
1479212|NCT00616655|4876068|P2|Overall Study|Withdrawal by Subject|7
1479213|NCT00616655|4876069|P1|Overall Study|Withdrawal by Subject|9
1479214|NCT00616655|4876067|P3|Overall Study|Protocol Violation|3
1479215|NCT00616655|4876068|P2|Overall Study|Protocol Violation|4
1479216|NCT00616655|4876069|P1|Overall Study|Protocol Violation|2
1479217|NCT00616655|4876067|P3|Overall Study|Lost to Follow-up|10
1479218|NCT00616655|4876068|P2|Overall Study|Lost to Follow-up|12
1479219|NCT00616655|4876069|P1|Overall Study|Lost to Follow-up|3
1479220|NCT00616655|4876067|P3|Overall Study|Lack of Efficacy|5
1479221|NCT00616655|4876068|P2|Overall Study|Lack of Efficacy|5
1479222|NCT00616655|4876069|P1|Overall Study|Lack of Efficacy|5
1479223|NCT00616655|4876067|P3|Overall Study|Adverse Event|12
1479224|NCT00616655|4876068|P2|Overall Study|Adverse Event|7
1479225|NCT00616655|4876069|P1|Overall Study|Adverse Event|10
1479226|NCT00616642|4876109|P2|Overall Study|Withdrawal by Subject|1
1479227|NCT00616642|4876110|P1|Overall Study|Withdrawal by Subject|0
1479228|NCT00616629|4876121|P5|Overall Study|AV-block|0
1479229|NCT00616629|4876122|P4|Overall Study|AV-block|0
1479230|NCT00616629|4876123|P3|Overall Study|AV-block|0
1479231|NCT00616629|4876124|P2|Overall Study|AV-block|0
1479232|NCT00616629|4876125|P1|Overall Study|AV-block|1
1479233|NCT00616629|4876121|P5|Overall Study|Protocol Violation|0
1479234|NCT00616629|4876122|P4|Overall Study|Protocol Violation|0
1479235|NCT00616629|4876123|P3|Overall Study|Protocol Violation|1
1479236|NCT00616629|4876124|P2|Overall Study|Protocol Violation|2
1479237|NCT00616629|4876125|P1|Overall Study|Protocol Violation|1
1479238|NCT00616603|4876170|P3|Overall Study|Physician Decision|2
1479239|NCT00616603|4876171|P2|Overall Study|Physician Decision|0
1479240|NCT00616603|4876172|P1|Overall Study|Physician Decision|2
1479241|NCT00616434|4876195|P2|Overall Study|Protocol deviation|1
1479242|NCT00616434|4876196|P1|Overall Study|Protocol deviation|0
1479243|NCT00616434|4876195|P2|Overall Study|Withdrawal by Subject|1
1479244|NCT00616434|4876196|P1|Overall Study|Withdrawal by Subject|1
1479245|NCT00616434|4876195|P2|Overall Study|Physician Decision|4
1479246|NCT00616434|4876196|P1|Overall Study|Physician Decision|0
1479247|NCT00616434|4876195|P2|Overall Study|Adverse Event|2
1479248|NCT00616434|4876196|P1|Overall Study|Adverse Event|5
1479249|NCT00616421|4876209|P3|Overall Study|Unable to classify|0
1479250|NCT00616421|4876210|P2|Overall Study|Unable to classify|0
1479251|NCT00616421|4876211|P1|Overall Study|Unable to classify|1
1479252|NCT00616421|4876209|P3|Overall Study|Protocol Violation|2
1479253|NCT00616421|4876210|P2|Overall Study|Protocol Violation|1
1479254|NCT00616421|4876211|P1|Overall Study|Protocol Violation|0
1479255|NCT00616421|4876209|P3|Overall Study|Administrative reason|0
1479256|NCT00616421|4876210|P2|Overall Study|Administrative reason|0
1479257|NCT00616421|4876211|P1|Overall Study|Administrative reason|1
1479258|NCT00616421|4876209|P3|Overall Study|Inappropriate enrollment|1
1479259|NCT00616421|4876210|P2|Overall Study|Inappropriate enrollment|0
1479260|NCT00616421|4876211|P1|Overall Study|Inappropriate enrollment|3
1479261|NCT00616421|4876209|P3|Overall Study|Lost to Follow-up|30
1479262|NCT00616421|4876210|P2|Overall Study|Lost to Follow-up|26
1479263|NCT00616421|4876211|P1|Overall Study|Lost to Follow-up|12
1479264|NCT00616421|4876209|P3|Overall Study|Withdrawal by Subject|8
1479265|NCT00616421|4876210|P2|Overall Study|Withdrawal by Subject|11
1479266|NCT00616421|4876211|P1|Overall Study|Withdrawal by Subject|9
1479267|NCT00616239|4876252|P1|Overall Study|Withdrawal by Subject|2
1479268|NCT00616018|4876276|P1|Overall Study|Protocol Violation|3
1479269|NCT00615992|4876281|P1|Overall Study|Protocol Violation|67
1479270|NCT00615914|4876307|P1|Overall Study|Irregularly enrolled patients|10
1479271|NCT00615914|4876307|P1|Overall Study|No treatment|2
1479272|NCT00615914|4876307|P1|Overall Study|No data was collected.|65
1479273|NCT00615914|4876307|P1|Overall Study|Physician Decision|4
1479274|NCT00615914|4876307|P1|Overall Study|Withdrawal by Subject|16
1479275|NCT00615914|4876307|P1|Overall Study|Lost to Follow-up|187
1479276|NCT00615914|4876307|P1|Overall Study|Lack of Efficacy|59
1479277|NCT00615914|4876307|P1|Overall Study|Death|20
1479278|NCT00615914|4876307|P1|Overall Study|Adverse Event|274
1479279|NCT00615901|4876314|P1|Overall Study|Adverse Event|7
1479280|NCT00615901|4876314|P1|Overall Study|Withdrawal by Subject|2
1479281|NCT00615836|4876322|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
1479282|NCT00615836|4876323|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
1479283|NCT00615836|4876324|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
1479284|NCT00615836|4876325|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
1479285|NCT00615836|4876326|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
1479286|NCT00615836|4876322|P5|Extension Study (FE992026 CS31)|Not reported|0
1479287|NCT00615836|4876323|P4|Extension Study (FE992026 CS31)|Not reported|4
1479288|NCT00615836|4876324|P3|Extension Study (FE992026 CS31)|Not reported|1
1479289|NCT00615836|4876325|P2|Extension Study (FE992026 CS31)|Not reported|4
1479290|NCT00615836|4876326|P1|Extension Study (FE992026 CS31)|Not reported|6
1479291|NCT00615836|4876322|P5|Extension Study (FE992026 CS31)|Not specified|0
1479292|NCT00615836|4876323|P4|Extension Study (FE992026 CS31)|Not specified|8
1479293|NCT00615836|4876324|P3|Extension Study (FE992026 CS31)|Not specified|8
1479294|NCT00615836|4876325|P2|Extension Study (FE992026 CS31)|Not specified|7
1479295|NCT00615836|4876326|P1|Extension Study (FE992026 CS31)|Not specified|10
1479296|NCT00615836|4876322|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
1479297|NCT00615836|4876323|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
1479298|NCT00615836|4876324|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
1479299|NCT00615836|4876325|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
1479300|NCT00615836|4876326|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
1479301|NCT00615836|4876322|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
1479302|NCT00615836|4876323|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
1479303|NCT00615836|4876324|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
1479304|NCT00615836|4876325|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
1479305|NCT00615836|4876326|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
1479306|NCT00615836|4876322|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
1479307|NCT00615836|4876323|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
1479308|NCT00615836|4876324|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
1479309|NCT00615836|4876325|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
1479310|NCT00615836|4876326|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
1479311|NCT00615836|4876322|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
1479312|NCT00615836|4876323|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
1479313|NCT00615836|4876324|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
1479314|NCT00615836|4876325|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
1479315|NCT00615836|4876326|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
1479316|NCT00615836|4876322|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
1479317|NCT00615836|4876323|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
1479318|NCT00615836|4876324|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
1479319|NCT00615836|4876325|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
1479320|NCT00615836|4876326|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
1479321|NCT00615836|4876322|P5|Extension Study (FE992026 CS31)|Adverse Event|0
1479322|NCT00615836|4876323|P4|Extension Study (FE992026 CS31)|Adverse Event|13
1479323|NCT00615836|4876324|P3|Extension Study (FE992026 CS31)|Adverse Event|15
1479324|NCT00615836|4876325|P2|Extension Study (FE992026 CS31)|Adverse Event|12
1479325|NCT00615836|4876326|P1|Extension Study (FE992026 CS31)|Adverse Event|7
1479326|NCT00615719|4876386|P1|Overall Study|Physician Decision|5
1479327|NCT00615550|4876400|P2|Overall Study|Lost to Follow-up|1
1479328|NCT00615550|4876401|P1|Overall Study|Lost to Follow-up|6
1479329|NCT00615459|4876424|P4|Period III|Unsatisfactory therapeutic effect|0
1479330|NCT00615459|4876425|P3|Period III|Unsatisfactory therapeutic effect|0
1479331|NCT00615459|4876426|P2|Period III|Unsatisfactory therapeutic effect|1
1479332|NCT00615459|4876427|P1|Period III|Unsatisfactory therapeutic effect|0
1479333|NCT00615459|4876424|P4|Period III|Administrative problems|0
1479334|NCT00615459|4876425|P3|Period III|Administrative problems|1
1479335|NCT00615459|4876426|P2|Period III|Administrative problems|1
1479336|NCT00615459|4876427|P1|Period III|Administrative problems|0
1479337|NCT00615459|4876424|P4|Period III|Adverse Event|0
1479338|NCT00615459|4876425|P3|Period III|Adverse Event|0
1479339|NCT00615459|4876426|P2|Period III|Adverse Event|1
1479340|NCT00615459|4876427|P1|Period III|Adverse Event|0
1479341|NCT00615459|4876424|P4|Period II|Lost to Follow-up|1
1479342|NCT00615459|4876425|P3|Period II|Lost to Follow-up|0
1479343|NCT00615459|4876426|P2|Period II|Lost to Follow-up|0
1479344|NCT00615459|4876427|P1|Period II|Lost to Follow-up|0
1479345|NCT00615459|4876424|P4|Period II|Adverse Event|0
1479346|NCT00615459|4876425|P3|Period II|Adverse Event|0
1479347|NCT00615459|4876426|P2|Period II|Adverse Event|0
1479348|NCT00615459|4876427|P1|Period II|Adverse Event|1
1479349|NCT00615459|4876424|P4|Period I|Abnormal test procedure results|0
1479350|NCT00615459|4876425|P3|Period I|Abnormal test procedure results|1
1479351|NCT00615459|4876426|P2|Period I|Abnormal test procedure results|1
1479352|NCT00615459|4876427|P1|Period I|Abnormal test procedure results|1
1479353|NCT00615459|4876424|P4|Period I|Subject withdrew consent|1
1479354|NCT00615459|4876425|P3|Period I|Subject withdrew consent|0
1479355|NCT00615459|4876426|P2|Period I|Subject withdrew consent|0
1479356|NCT00615459|4876427|P1|Period I|Subject withdrew consent|1
1479357|NCT00615459|4876424|P4|Period I|Adverse Event|0
1479358|NCT00615459|4876425|P3|Period I|Adverse Event|1
1479359|NCT00615459|4876426|P2|Period I|Adverse Event|0
1479360|NCT00615459|4876427|P1|Period I|Adverse Event|2
1479361|NCT00615290|4876462|P1|Overall Study|Other|2
1479362|NCT00615290|4876462|P1|Overall Study|Withdrawal by Subject|1
1479363|NCT00615290|4876462|P1|Overall Study|Lost to Follow-up|3
1479364|NCT00615290|4876462|P1|Overall Study|Adverse Event|2
1479365|NCT00615264|4876476|P2|Overall Study|Dermal Hypersensitivity|3
1479366|NCT00615264|4876477|P1|Overall Study|Dermal Hypersensitivity|0
1479367|NCT00615264|4876476|P2|Overall Study|Not defined|4
1479368|NCT00615264|4876477|P1|Overall Study|Not defined|7
1479369|NCT00615264|4876476|P2|Overall Study|Protocol Violation|7
1479370|NCT00615264|4876477|P1|Overall Study|Protocol Violation|11
1479371|NCT00615264|4876476|P2|Overall Study|Death|1
1479372|NCT00615264|4876477|P1|Overall Study|Death|1
1479373|NCT00615264|4876476|P2|Overall Study|Adverse Event|5
1479374|NCT00615264|4876477|P1|Overall Study|Adverse Event|8
1479375|NCT00615264|4876476|P2|Overall Study|Lost to Follow-up|13
1479376|NCT00615264|4876477|P1|Overall Study|Lost to Follow-up|6
1479377|NCT00615264|4876476|P2|Overall Study|Withdrawal by Subject|19
1479378|NCT00615264|4876477|P1|Overall Study|Withdrawal by Subject|17
1479379|NCT00615199|4876489|P4|Overall Study|Withdrawal by Subject|0
1479380|NCT00615199|4876490|P3|Overall Study|Withdrawal by Subject|0
1479381|NCT00615199|4876491|P2|Overall Study|Withdrawal by Subject|1
1479382|NCT00615199|4876492|P1|Overall Study|Withdrawal by Subject|2
1479383|NCT00615199|4876489|P4|Overall Study|Other|1
1479384|NCT00615199|4876490|P3|Overall Study|Other|0
1479385|NCT00615199|4876491|P2|Overall Study|Other|0
1479386|NCT00615199|4876492|P1|Overall Study|Other|0
1479387|NCT00615199|4876489|P4|Overall Study|Lost to Follow-up|0
1479388|NCT00615199|4876490|P3|Overall Study|Lost to Follow-up|0
1479389|NCT00615199|4876491|P2|Overall Study|Lost to Follow-up|0
1479390|NCT00615199|4876492|P1|Overall Study|Lost to Follow-up|1
1479391|NCT00615199|4876489|P4|Overall Study|Lack of Efficacy|1
1479392|NCT00615199|4876490|P3|Overall Study|Lack of Efficacy|0
1479393|NCT00615199|4876491|P2|Overall Study|Lack of Efficacy|0
1479394|NCT00615199|4876492|P1|Overall Study|Lack of Efficacy|2
1479395|NCT00615199|4876489|P4|Overall Study|Adverse Event|0
1479396|NCT00615199|4876490|P3|Overall Study|Adverse Event|1
1479397|NCT00615199|4876491|P2|Overall Study|Adverse Event|1
1479398|NCT00615199|4876492|P1|Overall Study|Adverse Event|3
1479399|NCT00615108|4876526|P1|Overall Study|Lost to Follow-up|15
1479400|NCT00615108|4876526|P1|Overall Study|Other|370
1479401|NCT00615108|4876526|P1|Overall Study|Adverse Event|122
1479402|NCT00615069|4876541|P1|Overall Study|Withdrawal by Subject|4
1479403|NCT00615069|4876541|P1|Overall Study|Physician Decision|2
1479404|NCT00615069|4876541|P1|Overall Study|Death|10
1479405|NCT00615056|4876550|P4|Overall Study|Randomized but not treated|0
1479406|NCT00615056|4876551|P3|Overall Study|Randomized but not treated|0
1479407|NCT00615056|4876552|P2|Overall Study|Randomized but not treated|0
1479408|NCT00615056|4876553|P1|Overall Study|Randomized but not treated|3
1479409|NCT00615056|4876550|P4|Overall Study|Discontinued by Sponsor|0
1479410|NCT00615056|4876551|P3|Overall Study|Discontinued by Sponsor|0
1479411|NCT00615056|4876552|P2|Overall Study|Discontinued by Sponsor|0
1479412|NCT00615056|4876553|P1|Overall Study|Discontinued by Sponsor|1
1479413|NCT00615056|4876550|P4|Overall Study|Withdrawal by Subject|0
1479414|NCT00615056|4876551|P3|Overall Study|Withdrawal by Subject|1
1479415|NCT00615056|4876552|P2|Overall Study|Withdrawal by Subject|1
1479416|NCT00615056|4876553|P1|Overall Study|Withdrawal by Subject|0
1479417|NCT00615056|4876550|P4|Overall Study|Objective progression or relapse|0
1479418|NCT00615056|4876551|P3|Overall Study|Objective progression or relapse|0
1479419|NCT00615056|4876552|P2|Overall Study|Objective progression or relapse|2
1479420|NCT00615056|4876553|P1|Overall Study|Objective progression or relapse|0
1479421|NCT00615056|4876550|P4|Overall Study|Other|7
1479422|NCT00615056|4876551|P3|Overall Study|Other|10
1479423|NCT00615056|4876552|P2|Overall Study|Other|15
1479424|NCT00615056|4876553|P1|Overall Study|Other|13
1479425|NCT00615056|4876550|P4|Overall Study|Lost to Follow-up|5
1479426|NCT00615056|4876551|P3|Overall Study|Lost to Follow-up|4
1479427|NCT00615056|4876552|P2|Overall Study|Lost to Follow-up|2
1479428|NCT00615056|4876553|P1|Overall Study|Lost to Follow-up|1
1479429|NCT00615056|4876550|P4|Overall Study|Death|23
1479430|NCT00615056|4876551|P3|Overall Study|Death|21
1479431|NCT00615056|4876552|P2|Overall Study|Death|31
1479432|NCT00615056|4876553|P1|Overall Study|Death|31
1479433|NCT00615030|4876583|P12|Period III|Administrative problems|0
1479434|NCT00615030|4876584|P11|Period III|Administrative problems|0
1479435|NCT00615030|4876585|P10|Period III|Administrative problems|0
1479436|NCT00615030|4876586|P9|Period III|Administrative problems|0
1479437|NCT00615030|4876587|P8|Period III|Administrative problems|0
1479438|NCT00615030|4876588|P7|Period III|Administrative problems|0
1479439|NCT00615030|4876589|P6|Period III|Administrative problems|0
1479440|NCT00615030|4876590|P5|Period III|Administrative problems|0
1479441|NCT00615030|4876591|P4|Period III|Administrative problems|1
1479442|NCT00615030|4876592|P3|Period III|Administrative problems|0
1479443|NCT00615030|4876593|P2|Period III|Administrative problems|0
1479444|NCT00615030|4876594|P1|Period III|Administrative problems|1
1479445|NCT00615030|4876583|P12|Period II|Subject withdrew consent|0
1479446|NCT00615030|4876584|P11|Period II|Subject withdrew consent|0
1479447|NCT00615030|4876585|P10|Period II|Subject withdrew consent|0
1479448|NCT00615030|4876586|P9|Period II|Subject withdrew consent|0
1479449|NCT00615030|4876587|P8|Period II|Subject withdrew consent|0
1479450|NCT00615030|4876588|P7|Period II|Subject withdrew consent|1
1479451|NCT00615030|4876589|P6|Period II|Subject withdrew consent|0
1479452|NCT00615030|4876590|P5|Period II|Subject withdrew consent|0
1479453|NCT00615030|4876591|P4|Period II|Subject withdrew consent|1
1479454|NCT00615030|4876592|P3|Period II|Subject withdrew consent|0
1479455|NCT00615030|4876593|P2|Period II|Subject withdrew consent|0
1479456|NCT00615030|4876594|P1|Period II|Subject withdrew consent|0
1479457|NCT00615030|4876583|P12|Period II|Adverse Event|0
1479458|NCT00615030|4876584|P11|Period II|Adverse Event|0
1479459|NCT00615030|4876585|P10|Period II|Adverse Event|0
1479460|NCT00615030|4876586|P9|Period II|Adverse Event|1
1479461|NCT00615030|4876587|P8|Period II|Adverse Event|0
1479462|NCT00615030|4876588|P7|Period II|Adverse Event|0
1479463|NCT00615030|4876589|P6|Period II|Adverse Event|0
1479464|NCT00615030|4876590|P5|Period II|Adverse Event|0
1479465|NCT00615030|4876591|P4|Period II|Adverse Event|0
1479466|NCT00615030|4876592|P3|Period II|Adverse Event|1
1479467|NCT00615030|4876593|P2|Period II|Adverse Event|0
1479468|NCT00615030|4876594|P1|Period II|Adverse Event|0
1479469|NCT00615030|4876583|P12|Period I|Abnormal laboratory value(s)|0
1479470|NCT00615030|4876584|P11|Period I|Abnormal laboratory value(s)|0
1479471|NCT00615030|4876585|P10|Period I|Abnormal laboratory value(s)|0
1479472|NCT00615030|4876586|P9|Period I|Abnormal laboratory value(s)|0
1479473|NCT00615030|4876587|P8|Period I|Abnormal laboratory value(s)|0
1479474|NCT00615030|4876588|P7|Period I|Abnormal laboratory value(s)|0
1479475|NCT00615030|4876589|P6|Period I|Abnormal laboratory value(s)|1
1479476|NCT00615030|4876590|P5|Period I|Abnormal laboratory value(s)|0
1479477|NCT00615030|4876591|P4|Period I|Abnormal laboratory value(s)|0
1479478|NCT00615030|4876592|P3|Period I|Abnormal laboratory value(s)|0
1479479|NCT00615030|4876593|P2|Period I|Abnormal laboratory value(s)|0
1479480|NCT00615030|4876594|P1|Period I|Abnormal laboratory value(s)|0
1479481|NCT00615030|4876583|P12|Period I|Subject withdrew consent|1
1479482|NCT00615030|4876584|P11|Period I|Subject withdrew consent|1
1479483|NCT00615030|4876585|P10|Period I|Subject withdrew consent|0
1479484|NCT00615030|4876586|P9|Period I|Subject withdrew consent|1
1479485|NCT00615030|4876587|P8|Period I|Subject withdrew consent|0
1479486|NCT00615030|4876588|P7|Period I|Subject withdrew consent|0
1479487|NCT00615030|4876589|P6|Period I|Subject withdrew consent|0
1479488|NCT00615030|4876590|P5|Period I|Subject withdrew consent|0
1479489|NCT00615030|4876591|P4|Period I|Subject withdrew consent|0
1479490|NCT00615030|4876592|P3|Period I|Subject withdrew consent|0
1479491|NCT00615030|4876593|P2|Period I|Subject withdrew consent|0
1479492|NCT00615030|4876594|P1|Period I|Subject withdrew consent|0
1479493|NCT00615030|4876583|P12|Period I|Protocol deviation|0
1479494|NCT00615030|4876584|P11|Period I|Protocol deviation|0
1479495|NCT00615030|4876585|P10|Period I|Protocol deviation|0
1479496|NCT00615030|4876586|P9|Period I|Protocol deviation|0
1479497|NCT00615030|4876587|P8|Period I|Protocol deviation|0
1479498|NCT00615030|4876588|P7|Period I|Protocol deviation|0
1479499|NCT00615030|4876589|P6|Period I|Protocol deviation|0
1479500|NCT00615030|4876590|P5|Period I|Protocol deviation|0
1479501|NCT00615030|4876591|P4|Period I|Protocol deviation|0
1479502|NCT00615030|4876592|P3|Period I|Protocol deviation|0
1479503|NCT00615030|4876593|P2|Period I|Protocol deviation|0
1479504|NCT00615030|4876594|P1|Period I|Protocol deviation|1
1479505|NCT00615030|4876583|P12|Period I|Administrative problem|0
1479506|NCT00615030|4876584|P11|Period I|Administrative problem|0
1479507|NCT00615030|4876585|P10|Period I|Administrative problem|0
1479508|NCT00615030|4876586|P9|Period I|Administrative problem|0
1479509|NCT00615030|4876587|P8|Period I|Administrative problem|0
1479510|NCT00615030|4876588|P7|Period I|Administrative problem|0
1479511|NCT00615030|4876589|P6|Period I|Administrative problem|0
1479512|NCT00615030|4876590|P5|Period I|Administrative problem|1
1479513|NCT00615030|4876591|P4|Period I|Administrative problem|0
1479514|NCT00615030|4876592|P3|Period I|Administrative problem|0
1479515|NCT00615030|4876593|P2|Period I|Administrative problem|0
1479516|NCT00615030|4876594|P1|Period I|Administrative problem|0
1479517|NCT00615017|4876614|P6|Overall Study|Physician discontinued drug|1
1479518|NCT00615017|4876615|P5|Overall Study|Physician discontinued drug|0
1479519|NCT00615017|4876616|P4|Overall Study|Physician discontinued drug|0
1479520|NCT00615017|4876617|P3|Overall Study|Physician discontinued drug|0
1479521|NCT00615017|4876618|P2|Overall Study|Physician discontinued drug|0
1479522|NCT00615017|4876619|P1|Overall Study|Physician discontinued drug|0
1479523|NCT00615017|4876614|P6|Overall Study|Transferred out of Intensive Care Unit|0
1479524|NCT00615017|4876615|P5|Overall Study|Transferred out of Intensive Care Unit|0
1479525|NCT00615017|4876616|P4|Overall Study|Transferred out of Intensive Care Unit|1
1479526|NCT00615017|4876617|P3|Overall Study|Transferred out of Intensive Care Unit|0
1479527|NCT00615017|4876618|P2|Overall Study|Transferred out of Intensive Care Unit|0
1479528|NCT00615017|4876619|P1|Overall Study|Transferred out of Intensive Care Unit|0
1479529|NCT00615017|4876614|P6|Overall Study|Sepsis resolved|0
1479530|NCT00615017|4876615|P5|Overall Study|Sepsis resolved|0
1479531|NCT00615017|4876616|P4|Overall Study|Sepsis resolved|0
1479532|NCT00615017|4876617|P3|Overall Study|Sepsis resolved|1
1479533|NCT00615017|4876618|P2|Overall Study|Sepsis resolved|0
1479534|NCT00615017|4876619|P1|Overall Study|Sepsis resolved|0
1479535|NCT00615017|4876614|P6|Overall Study|Death|1
1479536|NCT00615017|4876615|P5|Overall Study|Death|1
1479537|NCT00615017|4876616|P4|Overall Study|Death|0
1479538|NCT00615017|4876617|P3|Overall Study|Death|2
1479539|NCT00615017|4876618|P2|Overall Study|Death|0
1479540|NCT00615017|4876619|P1|Overall Study|Death|0
1479541|NCT00615017|4876614|P6|Overall Study|Adverse Event|1
1479542|NCT00615017|4876615|P5|Overall Study|Adverse Event|0
1479543|NCT00615017|4876616|P4|Overall Study|Adverse Event|0
1479544|NCT00615017|4876617|P3|Overall Study|Adverse Event|2
1479545|NCT00615017|4876618|P2|Overall Study|Adverse Event|1
1479546|NCT00615017|4876619|P1|Overall Study|Adverse Event|0
1479547|NCT00614991|4876777|P6|Overall Study|Adverse Event|0
1479548|NCT00614991|4876778|P5|Overall Study|Adverse Event|1
1479549|NCT00614991|4876779|P4|Overall Study|Adverse Event|0
1479550|NCT00614991|4876780|P3|Overall Study|Adverse Event|0
1479551|NCT00614991|4876781|P2|Overall Study|Adverse Event|3
1479552|NCT00614991|4876782|P1|Overall Study|Adverse Event|3
1479553|NCT00614939|4876816|P2|Overall Study|Hospitalized due to kidney transplant|0
1479554|NCT00614939|4876817|P1|Overall Study|Hospitalized due to kidney transplant|1
1479555|NCT00614939|4876816|P2|Overall Study|Poor/non-compliance|0
1479556|NCT00614939|4876817|P1|Overall Study|Poor/non-compliance|4
1479557|NCT00614939|4876816|P2|Overall Study|Death|3
1479558|NCT00614939|4876817|P1|Overall Study|Death|4
1479559|NCT00614939|4876816|P2|Overall Study|Incorrect enrollment|2
1479560|NCT00614939|4876817|P1|Overall Study|Incorrect enrollment|1
1479561|NCT00614939|4876816|P2|Overall Study|Adverse Event|5
1479562|NCT00614939|4876817|P1|Overall Study|Adverse Event|2
1479563|NCT00614939|4876816|P2|Overall Study|Study specific discontinuation criteris|16
1479564|NCT00614939|4876817|P1|Overall Study|Study specific discontinuation criteris|13
1479565|NCT00614939|4876816|P2|Overall Study|Withdrawal by Subject|17
1479566|NCT00614939|4876817|P1|Overall Study|Withdrawal by Subject|10
1479567|NCT00614926|4876851|P2|Overall Study|Adverse Event|0
1479568|NCT00614926|4876852|P1|Overall Study|Adverse Event|3
1479569|NCT00614926|4876851|P2|Overall Study|Burden of travel|0
1479570|NCT00614926|4876852|P1|Overall Study|Burden of travel|1
1479571|NCT00614874|4876865|P1|Overall Study|Withdrawal by Subject|1
1479572|NCT00614874|4876865|P1|Overall Study|Protocol Violation|1
1479573|NCT00614744|4876874|P2|Overall Study|Incomplete for Behavior Issues|2
1479574|NCT00614744|4876875|P1|Overall Study|Incomplete for Behavior Issues|0
1479575|NCT00614744|4876874|P2|Overall Study|Lost to Follow-up|4
1479576|NCT00614744|4876875|P1|Overall Study|Lost to Follow-up|5
1479577|NCT00614614|4876901|P5|Booster Vaccination Phase|Other|1
1479578|NCT00614614|4876902|P4|Booster Vaccination Phase|Other|2
1479579|NCT00614614|4876903|P3|Booster Vaccination Phase|Other|3
1479580|NCT00614614|4876904|P2|Booster Vaccination Phase|Other|1
1479581|NCT00614614|4876905|P1|Booster Vaccination Phase|Other|0
1479582|NCT00614614|4876901|P5|Booster Vaccination Phase|Protocol Violation|0
1479583|NCT00614614|4876902|P4|Booster Vaccination Phase|Protocol Violation|3
1479584|NCT00614614|4876903|P3|Booster Vaccination Phase|Protocol Violation|2
1479585|NCT00614614|4876904|P2|Booster Vaccination Phase|Protocol Violation|0
1479586|NCT00614614|4876905|P1|Booster Vaccination Phase|Protocol Violation|0
1479587|NCT00614614|4876901|P5|Booster Vaccination Phase|Lost to Follow-up|8
1479588|NCT00614614|4876902|P4|Booster Vaccination Phase|Lost to Follow-up|10
1479589|NCT00614614|4876903|P3|Booster Vaccination Phase|Lost to Follow-up|17
1479590|NCT00614614|4876904|P2|Booster Vaccination Phase|Lost to Follow-up|5
1479591|NCT00614614|4876905|P1|Booster Vaccination Phase|Lost to Follow-up|0
1479592|NCT00614614|4876901|P5|Booster Vaccination Phase|Withdrawal by Subject|4
1479593|NCT00614614|4876902|P4|Booster Vaccination Phase|Withdrawal by Subject|3
1479594|NCT00614614|4876903|P3|Booster Vaccination Phase|Withdrawal by Subject|4
1479595|NCT00614614|4876904|P2|Booster Vaccination Phase|Withdrawal by Subject|0
1479596|NCT00614614|4876905|P1|Booster Vaccination Phase|Withdrawal by Subject|0
1479597|NCT00614614|4876901|P5|Booster Vaccination Phase|Adverse Event|0
1479598|NCT00614614|4876902|P4|Booster Vaccination Phase|Adverse Event|1
1479599|NCT00614614|4876903|P3|Booster Vaccination Phase|Adverse Event|1
1479600|NCT00614614|4876904|P2|Booster Vaccination Phase|Adverse Event|0
1479601|NCT00614614|4876905|P1|Booster Vaccination Phase|Adverse Event|0
1479602|NCT00614614|4876901|P5|Primary Vaccination Phase|Other|0
1479603|NCT00614614|4876902|P4|Primary Vaccination Phase|Other|0
1479604|NCT00614614|4876903|P3|Primary Vaccination Phase|Other|0
1479605|NCT00614614|4876904|P2|Primary Vaccination Phase|Other|0
1479606|NCT00614614|4876905|P1|Primary Vaccination Phase|Other|4
1479607|NCT00614614|4876901|P5|Primary Vaccination Phase|Protocol Violation|0
1479608|NCT00614614|4876902|P4|Primary Vaccination Phase|Protocol Violation|0
1479609|NCT00614614|4876903|P3|Primary Vaccination Phase|Protocol Violation|0
1479610|NCT00614614|4876904|P2|Primary Vaccination Phase|Protocol Violation|3
1479611|NCT00614614|4876905|P1|Primary Vaccination Phase|Protocol Violation|9
1479612|NCT00614614|4876901|P5|Primary Vaccination Phase|Lost to Follow-up|0
1479613|NCT00614614|4876902|P4|Primary Vaccination Phase|Lost to Follow-up|0
1479614|NCT00614614|4876903|P3|Primary Vaccination Phase|Lost to Follow-up|0
1479615|NCT00614614|4876904|P2|Primary Vaccination Phase|Lost to Follow-up|8
1479616|NCT00614614|4876905|P1|Primary Vaccination Phase|Lost to Follow-up|26
1479617|NCT00614614|4876901|P5|Primary Vaccination Phase|Withdrawal by Subject|0
1479618|NCT00614614|4876902|P4|Primary Vaccination Phase|Withdrawal by Subject|0
1479619|NCT00614614|4876903|P3|Primary Vaccination Phase|Withdrawal by Subject|0
1479620|NCT00614614|4876904|P2|Primary Vaccination Phase|Withdrawal by Subject|6
1479621|NCT00614614|4876905|P1|Primary Vaccination Phase|Withdrawal by Subject|45
1479622|NCT00614614|4876901|P5|Primary Vaccination Phase|Adverse Event|0
1479623|NCT00614614|4876902|P4|Primary Vaccination Phase|Adverse Event|0
1479624|NCT00614614|4876903|P3|Primary Vaccination Phase|Adverse Event|0
1479625|NCT00614614|4876904|P2|Primary Vaccination Phase|Adverse Event|0
1479626|NCT00614614|4876905|P1|Primary Vaccination Phase|Adverse Event|6
1479627|NCT00614575|4877028|P1|Overall Study|No treatment|1
1479628|NCT00614575|4877028|P1|Overall Study|Irregularly enrolled patients|23
1479629|NCT00614575|4877028|P1|Overall Study|No data were collected.|18
1479630|NCT00614575|4877028|P1|Overall Study|Physician Decision|2
1479631|NCT00614575|4877028|P1|Overall Study|Death|3
1479632|NCT00614575|4877028|P1|Overall Study|Withdrawal by Subject|6
1479633|NCT00614575|4877028|P1|Overall Study|Lack of Efficacy|14
1479634|NCT00614575|4877028|P1|Overall Study|Lost to Follow-up|55
1479635|NCT00614575|4877028|P1|Overall Study|Adverse Event|106
1479636|NCT00614523|4877039|P2|Overall Study|Administrative Decision|46
1479637|NCT00614523|4877040|P1|Overall Study|Administrative Decision|23
1479638|NCT00614523|4877039|P2|Overall Study|Disease Progression|8
1479639|NCT00614523|4877040|P1|Overall Study|Disease Progression|0
1479640|NCT00614523|4877039|P2|Overall Study|Ineligibility Determined|2
1479641|NCT00614523|4877040|P1|Overall Study|Ineligibility Determined|1
1479642|NCT00614523|4877039|P2|Overall Study|Other|11
1479643|NCT00614523|4877040|P1|Overall Study|Other|6
1479644|NCT00614523|4877039|P2|Overall Study|Withdrawal by Subject|22
1479645|NCT00614523|4877040|P1|Overall Study|Withdrawal by Subject|12
1479646|NCT00614523|4877039|P2|Overall Study|Protocol Violation|2
1479647|NCT00614523|4877040|P1|Overall Study|Protocol Violation|3
1479648|NCT00614523|4877039|P2|Overall Study|Lost to Follow-up|1
1479649|NCT00614523|4877040|P1|Overall Study|Lost to Follow-up|0
1479650|NCT00614523|4877039|P2|Overall Study|Lack of Efficacy|11
1479651|NCT00614523|4877040|P1|Overall Study|Lack of Efficacy|9
1479652|NCT00614523|4877039|P2|Overall Study|Death|8
1479653|NCT00614523|4877040|P1|Overall Study|Death|5
1479654|NCT00614523|4877039|P2|Overall Study|Adverse Event|20
1479655|NCT00614523|4877040|P1|Overall Study|Adverse Event|4
1479656|NCT00614393|4877096|P5|Overall Study|Not Treated|2
1479657|NCT00614393|4877097|P4|Overall Study|Not Treated|0
1479658|NCT00614393|4877098|P3|Overall Study|Not Treated|0
1479659|NCT00614393|4877099|P2|Overall Study|Not Treated|0
1479660|NCT00614393|4877100|P1|Overall Study|Not Treated|0
1479661|NCT00614393|4877096|P5|Overall Study|Other|2
1479662|NCT00614393|4877097|P4|Overall Study|Other|4
1479663|NCT00614393|4877098|P3|Overall Study|Other|0
1479664|NCT00614393|4877099|P2|Overall Study|Other|0
1479665|NCT00614393|4877100|P1|Overall Study|Other|4
1479666|NCT00614393|4877096|P5|Overall Study|Withdrawal by Subject|13
1479667|NCT00614393|4877097|P4|Overall Study|Withdrawal by Subject|16
1479668|NCT00614393|4877098|P3|Overall Study|Withdrawal by Subject|1
1479669|NCT00614393|4877099|P2|Overall Study|Withdrawal by Subject|1
1479670|NCT00614393|4877100|P1|Overall Study|Withdrawal by Subject|20
1479671|NCT00614393|4877096|P5|Overall Study|Terminated by Sponsor|1
1479672|NCT00614393|4877097|P4|Overall Study|Terminated by Sponsor|0
1479673|NCT00614393|4877098|P3|Overall Study|Terminated by Sponsor|0
1479674|NCT00614393|4877099|P2|Overall Study|Terminated by Sponsor|0
1479675|NCT00614393|4877100|P1|Overall Study|Terminated by Sponsor|0
1479676|NCT00614393|4877096|P5|Overall Study|Protocol Violation|0
1479677|NCT00614393|4877097|P4|Overall Study|Protocol Violation|0
1479678|NCT00614393|4877098|P3|Overall Study|Protocol Violation|0
1479679|NCT00614393|4877099|P2|Overall Study|Protocol Violation|0
1479680|NCT00614393|4877100|P1|Overall Study|Protocol Violation|1
1479681|NCT00614393|4877096|P5|Overall Study|Progressive Disease|130
1479682|NCT00614393|4877097|P4|Overall Study|Progressive Disease|138
1479683|NCT00614393|4877098|P3|Overall Study|Progressive Disease|5
1479684|NCT00614393|4877099|P2|Overall Study|Progressive Disease|5
1479685|NCT00614393|4877100|P1|Overall Study|Progressive Disease|118
1479686|NCT00614393|4877096|P5|Overall Study|Physician Decision|9
1479687|NCT00614393|4877097|P4|Overall Study|Physician Decision|8
1479688|NCT00614393|4877098|P3|Overall Study|Physician Decision|1
1479689|NCT00614393|4877099|P2|Overall Study|Physician Decision|0
1479690|NCT00614393|4877100|P1|Overall Study|Physician Decision|17
1479691|NCT00614393|4877096|P5|Overall Study|Lost to Follow-up|2
1479692|NCT00614393|4877097|P4|Overall Study|Lost to Follow-up|1
1479693|NCT00614393|4877098|P3|Overall Study|Lost to Follow-up|0
1479694|NCT00614393|4877099|P2|Overall Study|Lost to Follow-up|0
1479695|NCT00614393|4877100|P1|Overall Study|Lost to Follow-up|0
1479696|NCT00614393|4877096|P5|Overall Study|Adverse Event|21
1479697|NCT00614393|4877097|P4|Overall Study|Adverse Event|13
1479698|NCT00614393|4877098|P3|Overall Study|Adverse Event|3
1479699|NCT00614393|4877099|P2|Overall Study|Adverse Event|2
1479700|NCT00614393|4877100|P1|Overall Study|Adverse Event|20
1479701|NCT00614380|4877146|P4|Overall Study|Consent withdrawn|0
1479702|NCT00614380|4877147|P3|Overall Study|Consent withdrawn|0
1479703|NCT00614380|4877148|P2|Overall Study|Consent withdrawn|1
1479704|NCT00614380|4877149|P1|Overall Study|Consent withdrawn|3
1479705|NCT00614380|4877146|P4|Overall Study|Non compliant with the protocol|2
1479706|NCT00614380|4877147|P3|Overall Study|Non compliant with the protocol|1
1479707|NCT00614380|4877148|P2|Overall Study|Non compliant with the protocol|2
1479708|NCT00614380|4877149|P1|Overall Study|Non compliant with the protocol|12
1479709|NCT00614380|4877146|P4|Overall Study|Lost to Follow-up|0
1479710|NCT00614380|4877147|P3|Overall Study|Lost to Follow-up|0
1479711|NCT00614380|4877148|P2|Overall Study|Lost to Follow-up|1
1479712|NCT00614380|4877149|P1|Overall Study|Lost to Follow-up|6
1479713|NCT00614380|4877146|P4|Overall Study|Adverse Event|0
1479714|NCT00614380|4877147|P3|Overall Study|Adverse Event|0
1479715|NCT00614380|4877148|P2|Overall Study|Adverse Event|4
1479716|NCT00614380|4877149|P1|Overall Study|Adverse Event|14
1479717|NCT00614120|4877216|P4|Overall Study|Lost to Follow-up|4
1479718|NCT00614120|4877217|P3|Overall Study|Lost to Follow-up|3
1479719|NCT00614120|4877218|P2|Overall Study|Lost to Follow-up|2
1479720|NCT00614120|4877219|P1|Overall Study|Lost to Follow-up|1
1479721|NCT00614120|4877216|P4|Overall Study|Taken inhibition medication eg Prandin|1
1479722|NCT00614120|4877217|P3|Overall Study|Taken inhibition medication eg Prandin|1
1479723|NCT00614120|4877218|P2|Overall Study|Taken inhibition medication eg Prandin|0
1479724|NCT00614120|4877219|P1|Overall Study|Taken inhibition medication eg Prandin|0
1479725|NCT00614120|4877216|P4|Overall Study|Late syphilis, latent|0
1479726|NCT00614120|4877217|P3|Overall Study|Late syphilis, latent|0
1479727|NCT00614120|4877218|P2|Overall Study|Late syphilis, latent|0
1479728|NCT00614120|4877219|P1|Overall Study|Late syphilis, latent|1
1479729|NCT00614120|4877216|P4|Overall Study|Lack of trial product|0
1479730|NCT00614120|4877217|P3|Overall Study|Lack of trial product|2
1479731|NCT00614120|4877218|P2|Overall Study|Lack of trial product|3
1479732|NCT00614120|4877219|P1|Overall Study|Lack of trial product|3
1479733|NCT00614120|4877216|P4|Overall Study|Hypoglycaemia|1
1479734|NCT00614120|4877217|P3|Overall Study|Hypoglycaemia|0
1479735|NCT00614120|4877218|P2|Overall Study|Hypoglycaemia|0
1479736|NCT00614120|4877219|P1|Overall Study|Hypoglycaemia|0
1479737|NCT00614120|4877216|P4|Overall Study|hCG positive (not pregnant)|0
1479738|NCT00614120|4877217|P3|Overall Study|hCG positive (not pregnant)|1
1479739|NCT00614120|4877218|P2|Overall Study|hCG positive (not pregnant)|0
1479740|NCT00614120|4877219|P1|Overall Study|hCG positive (not pregnant)|0
1479741|NCT00614120|4877216|P4|Overall Study|Did not meet trial criteria|1
1479742|NCT00614120|4877217|P3|Overall Study|Did not meet trial criteria|1
1479743|NCT00614120|4877218|P2|Overall Study|Did not meet trial criteria|1
1479744|NCT00614120|4877219|P1|Overall Study|Did not meet trial criteria|0
1479745|NCT00614120|4877216|P4|Overall Study|Withdrawal by Subject|3
1479746|NCT00614120|4877217|P3|Overall Study|Withdrawal by Subject|16
1479747|NCT00614120|4877218|P2|Overall Study|Withdrawal by Subject|10
1479748|NCT00614120|4877219|P1|Overall Study|Withdrawal by Subject|9
1479749|NCT00614120|4877216|P4|Overall Study|Withdrawal criteria|0
1479750|NCT00614120|4877217|P3|Overall Study|Withdrawal criteria|0
1479751|NCT00614120|4877218|P2|Overall Study|Withdrawal criteria|0
1479752|NCT00614120|4877219|P1|Overall Study|Withdrawal criteria|1
1479753|NCT00614120|4877216|P4|Overall Study|Protocol Violation|1
1479754|NCT00614120|4877217|P3|Overall Study|Protocol Violation|3
1479755|NCT00614120|4877218|P2|Overall Study|Protocol Violation|5
1479756|NCT00614120|4877219|P1|Overall Study|Protocol Violation|2
1479757|NCT00614120|4877216|P4|Overall Study|Lack of Efficacy|2
1479758|NCT00614120|4877217|P3|Overall Study|Lack of Efficacy|2
1479759|NCT00614120|4877218|P2|Overall Study|Lack of Efficacy|3
1479760|NCT00614120|4877219|P1|Overall Study|Lack of Efficacy|3
1479761|NCT00614120|4877216|P4|Overall Study|Adverse Event|3
1479762|NCT00614120|4877217|P3|Overall Study|Adverse Event|30
1479763|NCT00614120|4877218|P2|Overall Study|Adverse Event|22
1479764|NCT00614120|4877219|P1|Overall Study|Adverse Event|9
1479765|NCT00614055|4877260|P3|Overall Study|Unclassified|2
1479766|NCT00614055|4877261|P2|Overall Study|Unclassified|4
1479767|NCT00614055|4877262|P1|Overall Study|Unclassified|1
1479768|NCT00614055|4877260|P3|Overall Study|Lack of Efficacy|2
1479769|NCT00614055|4877261|P2|Overall Study|Lack of Efficacy|0
1479770|NCT00614055|4877262|P1|Overall Study|Lack of Efficacy|0
1479771|NCT00614055|4877260|P3|Overall Study|Protocol Violation|1
1479772|NCT00614055|4877261|P2|Overall Study|Protocol Violation|2
1479773|NCT00614055|4877262|P1|Overall Study|Protocol Violation|2
1479774|NCT00614055|4877260|P3|Overall Study|Adverse Event|0
1479775|NCT00614055|4877261|P2|Overall Study|Adverse Event|0
1479776|NCT00614055|4877262|P1|Overall Study|Adverse Event|1
1479777|NCT00613951|4877309|P3|Overall Study|Unclassified|2
1479778|NCT00613951|4877310|P2|Overall Study|Unclassified|3
1479779|NCT00613951|4877311|P1|Overall Study|Unclassified|5
1479780|NCT00613951|4877309|P3|Overall Study|Protocol Violation|1
1479781|NCT00613951|4877310|P2|Overall Study|Protocol Violation|1
1479782|NCT00613951|4877311|P1|Overall Study|Protocol Violation|1
1479783|NCT00613951|4877309|P3|Overall Study|Lack of Efficacy|1
1479784|NCT00613951|4877310|P2|Overall Study|Lack of Efficacy|1
1479785|NCT00613951|4877311|P1|Overall Study|Lack of Efficacy|0
1479786|NCT00613951|4877309|P3|Overall Study|Adverse Event|1
1479787|NCT00613951|4877310|P2|Overall Study|Adverse Event|0
1479788|NCT00613951|4877311|P1|Overall Study|Adverse Event|1
1479789|NCT00613938|4877356|P4|Overall Study|Other|3
1479790|NCT00613938|4877357|P3|Overall Study|Other|1
1479791|NCT00613938|4877358|P2|Overall Study|Other|2
1479792|NCT00613938|4877359|P1|Overall Study|Other|1
1479793|NCT00613938|4877356|P4|Overall Study|Lack of Efficacy|9
1479794|NCT00613938|4877357|P3|Overall Study|Lack of Efficacy|5
1479795|NCT00613938|4877358|P2|Overall Study|Lack of Efficacy|18
1479796|NCT00613938|4877359|P1|Overall Study|Lack of Efficacy|16
1479797|NCT00613938|4877356|P4|Overall Study|Adverse Event|5
1479798|NCT00613938|4877357|P3|Overall Study|Adverse Event|8
1479799|NCT00613938|4877358|P2|Overall Study|Adverse Event|4
1479800|NCT00613938|4877359|P1|Overall Study|Adverse Event|1
1479801|NCT00613938|4877356|P4|Overall Study|Withdrawal by Subject|9
1479802|NCT00613938|4877357|P3|Overall Study|Withdrawal by Subject|9
1479803|NCT00613938|4877358|P2|Overall Study|Withdrawal by Subject|4
1479804|NCT00613938|4877359|P1|Overall Study|Withdrawal by Subject|2
1479805|NCT00613925|4877391|P2|Overall Study|1 did not tolerate outpatient biopsy|1
1479806|NCT00613925|4877392|P1|Overall Study|1 did not tolerate outpatient biopsy|0
1479807|NCT00613821|4877402|P2|Overall Study|Physician Decision|1
1479808|NCT00613821|4877403|P1|Overall Study|Physician Decision|1
1479809|NCT00613821|4877402|P2|Overall Study|Withdrawal by Subject|0
1479810|NCT00613821|4877403|P1|Overall Study|Withdrawal by Subject|1
1479811|NCT00613730|4877409|P1|Overall Study|Administrative decision|1
1479812|NCT00613730|4877409|P1|Overall Study|Disease progression|2
1479813|NCT00613626|4877418|P3|Overall Study|Ineligible|0
1479814|NCT00613626|4877419|P2|Overall Study|Ineligible|1
1479815|NCT00613626|4877420|P1|Overall Study|Ineligible|0
1479816|NCT00613574|4877436|P1|Overall Study|Other|1
1479817|NCT00613574|4877436|P1|Overall Study|Lost to Follow-up|2
1479818|NCT00613574|4877436|P1|Overall Study|Adverse Event|3
1479819|NCT00613509|4877448|P2|Cycle 1|Other administrative reason|1
1479820|NCT00613509|4877449|P1|Cycle 1|Other administrative reason|0
1479821|NCT00613509|4877448|P2|Cycle 1|Unacceptable Toxicity|0
1479822|NCT00613509|4877449|P1|Cycle 1|Unacceptable Toxicity|1
1479823|NCT00613509|4877448|P2|Cycle 1|Disease Progression|6
1479824|NCT00613509|4877449|P1|Cycle 1|Disease Progression|2
1479825|NCT00613509|4877448|P2|Cycle 1|Adverse Event|1
1479826|NCT00613509|4877449|P1|Cycle 1|Adverse Event|2
1479827|NCT00613366|4877495|P2|Overall Study|Withdrawal by Subject|2
1479828|NCT00613366|4877496|P1|Overall Study|Withdrawal by Subject|3
1479829|NCT00613327|4877504|P1|Overall Study|Other|47
1479830|NCT00613327|4877504|P1|Overall Study|Protocol Violation|2
1479831|NCT00613327|4877504|P1|Overall Study|Withdrawal by Subject|6
1479832|NCT00613327|4877504|P1|Overall Study|Lost to Follow-up|8
1479833|NCT00613327|4877504|P1|Overall Study|Adverse Event|38
1479834|NCT00613314|4877523|P1|Overall Study|Other reason not defined above|90
1479835|NCT00613314|4877523|P1|Overall Study|Lost to Follow-up|46
1479836|NCT00613314|4877523|P1|Overall Study|Protocol Violation|14
1479837|NCT00613314|4877523|P1|Overall Study|Adverse Event|5
1479838|NCT00613301|4877531|P1|Overall Study|Irregularly enrolled patients|12
1479839|NCT00613301|4877531|P1|Overall Study|No data was collected|53
1479840|NCT00613301|4877531|P1|Overall Study|Physician Decision|2
1479841|NCT00613301|4877531|P1|Overall Study|Lack of Efficacy|13
1479842|NCT00613301|4877531|P1|Overall Study|Death|6
1479843|NCT00613301|4877531|P1|Overall Study|Withdrawal by Subject|5
1479844|NCT00613301|4877531|P1|Overall Study|Lost to Follow-up|88
1479845|NCT00613301|4877531|P1|Overall Study|Adverse Event|49
1479846|NCT00613106|4877540|P2|Overall Study|misc|3
1479847|NCT00613106|4877541|P1|Overall Study|misc|4
1479848|NCT00613106|4877540|P2|Overall Study|Lost to Follow-up|2
1479849|NCT00613106|4877541|P1|Overall Study|Lost to Follow-up|7
1479850|NCT00613106|4877540|P2|Overall Study|Withdrawal by Subject|3
1479851|NCT00613106|4877541|P1|Overall Study|Withdrawal by Subject|6
1479852|NCT00613106|4877540|P2|Overall Study|Adverse Event|1
1479853|NCT00613106|4877541|P1|Overall Study|Adverse Event|3
1479854|NCT00613080|4877547|P1|Overall Study|Ineligible / no protocol treatment|11
1479855|NCT00613015|4877582|P6|Overall Study|Lost to Follow-up|3
1479856|NCT00613015|4877583|P5|Overall Study|Lost to Follow-up|2
1479857|NCT00613015|4877584|P4|Overall Study|Lost to Follow-up|3
1479858|NCT00613015|4877585|P3|Overall Study|Lost to Follow-up|3
1479859|NCT00613015|4877586|P2|Overall Study|Lost to Follow-up|1
1479860|NCT00613015|4877587|P1|Overall Study|Lost to Follow-up|0
1479861|NCT00612807|4877623|P2|Overall Study|Withdrawal by Subject|0
1479862|NCT00612807|4877624|P1|Overall Study|Withdrawal by Subject|2
1479863|NCT00612690|4877659|P2|Overall Study|Withdrawal by Site|0
1479864|NCT00612690|4877660|P1|Overall Study|Withdrawal by Site|11
1479865|NCT00612690|4877659|P2|Overall Study|Withdrawal by Subject|20
1479866|NCT00612690|4877660|P1|Overall Study|Withdrawal by Subject|32
1479867|NCT00612690|4877659|P2|Overall Study|Lost to Follow-up|98
1479868|NCT00612690|4877660|P1|Overall Study|Lost to Follow-up|72
1479869|NCT00612677|4877668|P1|Overall Study|study closed before treatment started|1
1479870|NCT00612534|4877736|P4|Overall Study|Other Reason|0
1479871|NCT00612534|4877737|P3|Overall Study|Other Reason|0
1479872|NCT00612534|4877738|P2|Overall Study|Other Reason|1
1479873|NCT00612534|4877739|P1|Overall Study|Other Reason|0
1479874|NCT00612534|4877736|P4|Overall Study|Lack of Efficacy|16
1479875|NCT00612534|4877737|P3|Overall Study|Lack of Efficacy|5
1479876|NCT00612534|4877738|P2|Overall Study|Lack of Efficacy|12
1479877|NCT00612534|4877739|P1|Overall Study|Lack of Efficacy|13
1479878|NCT00612534|4877736|P4|Overall Study|Adverse Event|1
1479879|NCT00612534|4877737|P3|Overall Study|Adverse Event|2
1479880|NCT00612534|4877738|P2|Overall Study|Adverse Event|4
1479881|NCT00612534|4877739|P1|Overall Study|Adverse Event|0
1479882|NCT00612508|4877751|P2|Overall Study|Withdrawal by Subject|4
1479883|NCT00612508|4877752|P1|Overall Study|Withdrawal by Subject|3
1479884|NCT00612456|4877763|P3|Overall Study|Withdrawal by Subject|0
1479885|NCT00612456|4877764|P2|Overall Study|Withdrawal by Subject|1
1479886|NCT00612456|4877765|P1|Overall Study|Withdrawal by Subject|0
1479887|NCT00612456|4877763|P3|Overall Study|Lack of Efficacy|0
1479888|NCT00612456|4877764|P2|Overall Study|Lack of Efficacy|1
1479889|NCT00612456|4877765|P1|Overall Study|Lack of Efficacy|1
1479890|NCT00612456|4877763|P3|Overall Study|Adverse Event|0
1479891|NCT00612456|4877764|P2|Overall Study|Adverse Event|0
1479892|NCT00612456|4877765|P1|Overall Study|Adverse Event|1
1479893|NCT00612352|4877828|P2|Overall Study|didn't return calls/show up on test date|1
1479894|NCT00612352|4877829|P1|Overall Study|didn't return calls/show up on test date|4
1479895|NCT00612352|4877828|P2|Overall Study|moved out of state|0
1479896|NCT00612352|4877829|P1|Overall Study|moved out of state|1
1479897|NCT00612352|4877828|P2|Overall Study|Withdrawal by Subject|5
1479898|NCT00612352|4877829|P1|Overall Study|Withdrawal by Subject|3
1479899|NCT00612352|4877828|P2|Overall Study|Adverse Event|0
1479900|NCT00612352|4877829|P1|Overall Study|Adverse Event|1
1479901|NCT00612313|4877949|P2|Overall Study|Lost to Follow-up|4
1479902|NCT00612313|4877950|P1|Overall Study|Lost to Follow-up|11
1479903|NCT00612313|4877949|P2|Overall Study|Withdrawal by Subject|9
1479904|NCT00612313|4877950|P1|Overall Study|Withdrawal by Subject|6
1479905|NCT00612105|4877974|P2|Period Title 3: 3-Week Taper Phase|Other|0
1479906|NCT00612105|4877975|P1|Period Title 3: 3-Week Taper Phase|Other|1
1479907|NCT00612105|4877974|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
1479908|NCT00612105|4877975|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
1479909|NCT00612105|4877974|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
1480068|NCT00611130|4878657|P1|Overall Study|Incarceration|3
1479910|NCT00612105|4877975|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
1479911|NCT00612105|4877974|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
1479912|NCT00612105|4877975|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
1479913|NCT00612105|4877974|P2|Period Title 1: 6-Week Titration Phase|Other|1
1479914|NCT00612105|4877975|P1|Period Title 1: 6-Week Titration Phase|Other|0
1479915|NCT00612105|4877974|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
1479916|NCT00612105|4877975|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
1479917|NCT00612105|4877974|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
1479918|NCT00612105|4877975|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
1479919|NCT00612105|4877974|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
1479920|NCT00612105|4877975|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
1479921|NCT00612105|4877974|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
1479922|NCT00612105|4877975|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
1479923|NCT00612105|4877974|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
1479924|NCT00612105|4877975|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
1479925|NCT00612105|4877974|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
1479926|NCT00612105|4877975|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
1479927|NCT00612105|4877974|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
1479928|NCT00612105|4877975|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
1479929|NCT00612066|4878025|P1|Overall Study|Adverse Event|1
1479930|NCT00612040|4878032|P3|Overall Study|Unclassified|5
1479931|NCT00612040|4878033|P2|Overall Study|Unclassified|2
1479932|NCT00612040|4878034|P1|Overall Study|Unclassified|2
1479933|NCT00612040|4878032|P3|Overall Study|Lack of Efficacy|0
1479934|NCT00612040|4878033|P2|Overall Study|Lack of Efficacy|1
1479935|NCT00612040|4878034|P1|Overall Study|Lack of Efficacy|2
1479936|NCT00612040|4878032|P3|Overall Study|Protocol Violation|1
1479937|NCT00612040|4878033|P2|Overall Study|Protocol Violation|2
1479938|NCT00612040|4878034|P1|Overall Study|Protocol Violation|1
1479939|NCT00612040|4878032|P3|Overall Study|Adverse Event|1
1479940|NCT00612040|4878033|P2|Overall Study|Adverse Event|2
1479941|NCT00612040|4878034|P1|Overall Study|Adverse Event|0
1479942|NCT00611884|4878107|P4|Overall Study|Unclassified|3
1479943|NCT00611884|4878108|P3|Overall Study|Unclassified|2
1479944|NCT00611884|4878109|P2|Overall Study|Unclassified|4
1479945|NCT00611884|4878110|P1|Overall Study|Unclassified|7
1479946|NCT00611884|4878107|P4|Overall Study|Lack of Efficacy|0
1479947|NCT00611884|4878108|P3|Overall Study|Lack of Efficacy|0
1479948|NCT00611884|4878109|P2|Overall Study|Lack of Efficacy|1
1479949|NCT00611884|4878110|P1|Overall Study|Lack of Efficacy|0
1479950|NCT00611884|4878107|P4|Overall Study|Non-Compliance|2
1479951|NCT00611884|4878108|P3|Overall Study|Non-Compliance|2
1479952|NCT00611884|4878109|P2|Overall Study|Non-Compliance|4
1479953|NCT00611884|4878110|P1|Overall Study|Non-Compliance|1
1479954|NCT00611884|4878107|P4|Overall Study|Adverse Event|1
1479955|NCT00611884|4878108|P3|Overall Study|Adverse Event|0
1479956|NCT00611884|4878109|P2|Overall Study|Adverse Event|0
1479957|NCT00611884|4878110|P1|Overall Study|Adverse Event|1
1479958|NCT00611806|4878166|P2|Overall Study|Lost to Follow-up|0
1479959|NCT00611806|4878167|P1|Overall Study|Lost to Follow-up|6
1479960|NCT00611806|4878166|P2|Overall Study|Adverse Event|1
1479961|NCT00611806|4878167|P1|Overall Study|Adverse Event|2
1479962|NCT00611806|4878166|P2|Overall Study|Withdrawal by Subject|2
1479963|NCT00611806|4878167|P1|Overall Study|Withdrawal by Subject|8
1479964|NCT00611767|4878181|P2|Overall Study|Physician Decision|0
1479965|NCT00611767|4878182|P1|Overall Study|Physician Decision|1
1479966|NCT00611767|4878181|P2|Overall Study|didn't like the medication|1
1479967|NCT00611767|4878182|P1|Overall Study|didn't like the medication|1
1479968|NCT00611767|4878181|P2|Overall Study|Thiopental not available|0
1479969|NCT00611767|4878182|P1|Overall Study|Thiopental not available|3
1479970|NCT00611767|4878181|P2|Overall Study|Withdrawal by Subject|1
1479971|NCT00611767|4878182|P1|Overall Study|Withdrawal by Subject|4
1479972|NCT00611715|4878344|P2|Overall Study|two patients are still on treatment|0
1479973|NCT00611715|4878345|P1|Overall Study|two patients are still on treatment|2
1479974|NCT00611715|4878344|P2|Overall Study|Death|0
1479975|NCT00611715|4878345|P1|Overall Study|Death|1
1479976|NCT00611715|4878344|P2|Overall Study|Adverse Event|1
1479977|NCT00611715|4878345|P1|Overall Study|Adverse Event|9
1479978|NCT00611715|4878344|P2|Overall Study|Withdrawal by Subject|1
1479979|NCT00611715|4878345|P1|Overall Study|Withdrawal by Subject|5
1479980|NCT00611715|4878344|P2|Overall Study|Disease Progression|4
1479981|NCT00611715|4878345|P1|Overall Study|Disease Progression|24
1479982|NCT00611559|4878365|P3|Overall Study|Protocol Violation|1
1479983|NCT00611559|4878366|P2|Overall Study|Protocol Violation|0
1479984|NCT00611559|4878367|P1|Overall Study|Protocol Violation|1
1479985|NCT00611559|4878365|P3|Overall Study|Lost to Follow-up|0
1479986|NCT00611559|4878366|P2|Overall Study|Lost to Follow-up|1
1479987|NCT00611559|4878367|P1|Overall Study|Lost to Follow-up|0
1479988|NCT00611533|4878426|P2|Second Intervention (6 Weeks)|Adverse Event|2
1479989|NCT00611533|4878427|P1|Second Intervention (6 Weeks)|Adverse Event|0
1479990|NCT00611533|4878426|P2|First Intervention (6 Weeks)|Adverse Event|1
1479991|NCT00611533|4878427|P1|First Intervention (6 Weeks)|Adverse Event|0
1479992|NCT00611533|4878426|P2|First Intervention (6 Weeks)|Never started study|1
1479993|NCT00611533|4878427|P1|First Intervention (6 Weeks)|Never started study|0
1479994|NCT00611455|4878461|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
1479995|NCT00611455|4878462|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
1479996|NCT00611455|4878463|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
1479997|NCT00611455|4878461|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
1479998|NCT00611455|4878462|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
1479999|NCT00611455|4878463|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
1480000|NCT00611455|4878461|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
1480001|NCT00611455|4878462|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
1480002|NCT00611455|4878463|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
1480003|NCT00611455|4878461|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
1480004|NCT00611455|4878462|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
1480005|NCT00611455|4878463|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
1480006|NCT00611455|4878461|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
1480007|NCT00611455|4878462|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
1480008|NCT00611455|4878463|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
1480009|NCT00611455|4878461|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
1480010|NCT00611455|4878462|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
1480011|NCT00611455|4878463|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
1480012|NCT00611455|4878461|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
1480013|NCT00611455|4878462|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
1480014|NCT00611455|4878463|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
1480015|NCT00611455|4878461|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
1480016|NCT00611455|4878462|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
1480017|NCT00611455|4878463|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
1480018|NCT00611455|4878461|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
1480019|NCT00611455|4878462|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
1480020|NCT00611455|4878463|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
1480021|NCT00611455|4878461|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
1480022|NCT00611455|4878462|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
1480023|NCT00611455|4878463|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
1480024|NCT00611455|4878461|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
1480025|NCT00611455|4878462|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
1480026|NCT00611455|4878463|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
1480027|NCT00611455|4878461|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
1480028|NCT00611455|4878462|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
1480029|NCT00611455|4878463|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
1480030|NCT00611455|4878461|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
1480031|NCT00611455|4878462|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
1480032|NCT00611455|4878463|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
1480033|NCT00611455|4878461|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
1480034|NCT00611455|4878462|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
1480035|NCT00611455|4878463|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
1480036|NCT00611455|4878461|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
1480037|NCT00611455|4878462|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
1480038|NCT00611455|4878463|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
1480039|NCT00611455|4878461|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
1480040|NCT00611455|4878462|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
1480041|NCT00611455|4878463|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
1480042|NCT00611455|4878461|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
1480043|NCT00611455|4878462|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
1480044|NCT00611455|4878463|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
1480045|NCT00611455|4878461|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
1480046|NCT00611455|4878462|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
1480047|NCT00611455|4878463|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
1480048|NCT00611455|4878461|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
1480049|NCT00611455|4878462|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
1480050|NCT00611455|4878463|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
1480051|NCT00611455|4878461|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
1480052|NCT00611455|4878462|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
1480053|NCT00611455|4878463|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
1480054|NCT00611455|4878461|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
1480055|NCT00611455|4878462|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
1480056|NCT00611455|4878463|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
1480057|NCT00611247|4878643|P2|Overall Study|Lack of Efficacy|16
1480058|NCT00611247|4878644|P1|Overall Study|Lack of Efficacy|1
1480059|NCT00611247|4878643|P2|Overall Study|Death|5
1480060|NCT00611247|4878644|P1|Overall Study|Death|1
1480061|NCT00611130|4878656|P2|Overall Study|Death|0
1480062|NCT00611130|4878657|P1|Overall Study|Death|1
1480063|NCT00611130|4878656|P2|Overall Study|Adverse Event|0
1480064|NCT00611130|4878657|P1|Overall Study|Adverse Event|1
1480065|NCT00611130|4878656|P2|Overall Study|Administrative|1
1480066|NCT00611130|4878657|P1|Overall Study|Administrative|1
1480067|NCT00611130|4878656|P2|Overall Study|Incarceration|2
1480069|NCT00611130|4878656|P2|Overall Study|Other|4
1480070|NCT00611130|4878657|P1|Overall Study|Other|5
1480071|NCT00611130|4878656|P2|Overall Study|Withdrawal by Subject|5
1480072|NCT00611130|4878657|P1|Overall Study|Withdrawal by Subject|6
1480073|NCT00611130|4878656|P2|Overall Study|Protocol noncompliance|6
1480074|NCT00611130|4878657|P1|Overall Study|Protocol noncompliance|7
1480075|NCT00611130|4878656|P2|Overall Study|Lost to Follow-up|29
1480076|NCT00611130|4878657|P1|Overall Study|Lost to Follow-up|25
1480077|NCT00611026|4878667|P3|Double-blind Treatment Period|Other|18
1480078|NCT00611026|4878668|P2|Double-blind Treatment Period|Other|20
1480079|NCT00611026|4878669|P1|Double-blind Treatment Period|Other|13
1480080|NCT00611026|4878667|P3|Double-blind Treatment Period|Withdrawal by Subject|16
1480081|NCT00611026|4878668|P2|Double-blind Treatment Period|Withdrawal by Subject|19
1480082|NCT00611026|4878669|P1|Double-blind Treatment Period|Withdrawal by Subject|7
1480083|NCT00611026|4878667|P3|Double-blind Treatment Period|Lost to Follow-up|14
1480084|NCT00611026|4878668|P2|Double-blind Treatment Period|Lost to Follow-up|11
1480085|NCT00611026|4878669|P1|Double-blind Treatment Period|Lost to Follow-up|6
1480086|NCT00611026|4878667|P3|Double-blind Treatment Period|Lack of Efficacy|4
1480087|NCT00611026|4878668|P2|Double-blind Treatment Period|Lack of Efficacy|10
1480088|NCT00611026|4878669|P1|Double-blind Treatment Period|Lack of Efficacy|11
1480089|NCT00611026|4878667|P3|Double-blind Treatment Period|Adverse Event|46
1480090|NCT00611026|4878668|P2|Double-blind Treatment Period|Adverse Event|28
1480091|NCT00611026|4878669|P1|Double-blind Treatment Period|Adverse Event|9
1480092|NCT00611026|4878667|P3|Double-blind Treatment Period|Death|0
1480093|NCT00611026|4878668|P2|Double-blind Treatment Period|Death|0
1480094|NCT00611026|4878669|P1|Double-blind Treatment Period|Death|1
1480095|NCT00611026|4878667|P3|Randomized to Double-blind Treatment|Not treated|3
1480096|NCT00611026|4878668|P2|Randomized to Double-blind Treatment|Not treated|1
1480097|NCT00611026|4878669|P1|Randomized to Double-blind Treatment|Not treated|2
1480098|NCT00610857|4878746|P1|Overall Study|Not evaluable for response|2
1480099|NCT00610714|4878761|P2|Overall Study|Study completion at 120 PFS events|2
1480100|NCT00610714|4878762|P1|Overall Study|Study completion at 120 PFS events|2
1480101|NCT00610714|4878761|P2|Overall Study|Withdrawal by Subject|3
1480102|NCT00610714|4878762|P1|Overall Study|Withdrawal by Subject|9
1480103|NCT00610714|4878761|P2|Overall Study|Death|18
1480104|NCT00610714|4878762|P1|Overall Study|Death|12
1480105|NCT00610714|4878761|P2|Overall Study|Adverse Event|1
1480106|NCT00610714|4878762|P1|Overall Study|Adverse Event|3
1480107|NCT00610675|4878800|P1|Overall Study|Other reason (not specified)|25
1480108|NCT00610675|4878800|P1|Overall Study|Lost to Follow-up|31
1480109|NCT00610675|4878800|P1|Overall Study|Lack of Compliance|7
1480110|NCT00610675|4878800|P1|Overall Study|Reasons unrelated to trial|27
1480111|NCT00610675|4878800|P1|Overall Study|Withdrawal by Subject|28
1480112|NCT00610675|4878800|P1|Overall Study|Insufficient Effect|31
1480113|NCT00610675|4878800|P1|Overall Study|Adverse Event|67
1480114|NCT00610675|4878800|P1|Overall Study|Untreated|4
1480115|NCT00610649|4878822|P11|Overall Study|Withdrawal by Subject|0
1480116|NCT00610649|4878823|P10|Overall Study|Withdrawal by Subject|1
1480117|NCT00610649|4878824|P9|Overall Study|Withdrawal by Subject|0
1480118|NCT00610649|4878825|P8|Overall Study|Withdrawal by Subject|0
1480119|NCT00610649|4878826|P7|Overall Study|Withdrawal by Subject|0
1480120|NCT00610649|4878827|P6|Overall Study|Withdrawal by Subject|0
1480121|NCT00610649|4878828|P5|Overall Study|Withdrawal by Subject|0
1480122|NCT00610649|4878829|P4|Overall Study|Withdrawal by Subject|0
1480123|NCT00610649|4878830|P3|Overall Study|Withdrawal by Subject|0
1480124|NCT00610649|4878831|P2|Overall Study|Withdrawal by Subject|0
1480125|NCT00610649|4878832|P1|Overall Study|Withdrawal by Subject|0
1480126|NCT00610649|4878822|P11|Overall Study|Family Emergency|0
1480127|NCT00610649|4878823|P10|Overall Study|Family Emergency|0
1480128|NCT00610649|4878824|P9|Overall Study|Family Emergency|0
1480129|NCT00610649|4878825|P8|Overall Study|Family Emergency|0
1480130|NCT00610649|4878826|P7|Overall Study|Family Emergency|0
1480131|NCT00610649|4878827|P6|Overall Study|Family Emergency|0
1480132|NCT00610649|4878828|P5|Overall Study|Family Emergency|0
1480133|NCT00610649|4878829|P4|Overall Study|Family Emergency|0
1480134|NCT00610649|4878830|P3|Overall Study|Family Emergency|0
1480135|NCT00610649|4878831|P2|Overall Study|Family Emergency|1
1480136|NCT00610649|4878832|P1|Overall Study|Family Emergency|0
1480137|NCT00610649|4878822|P11|Overall Study|Adverse Event|1
1480138|NCT00610649|4878823|P10|Overall Study|Adverse Event|0
1480139|NCT00610649|4878824|P9|Overall Study|Adverse Event|0
1480140|NCT00610649|4878825|P8|Overall Study|Adverse Event|0
1480141|NCT00610649|4878826|P7|Overall Study|Adverse Event|0
1480142|NCT00610649|4878827|P6|Overall Study|Adverse Event|0
1480143|NCT00610649|4878828|P5|Overall Study|Adverse Event|0
1480144|NCT00610649|4878829|P4|Overall Study|Adverse Event|0
1480145|NCT00610649|4878830|P3|Overall Study|Adverse Event|0
1480146|NCT00610649|4878831|P2|Overall Study|Adverse Event|0
1480147|NCT00610649|4878832|P1|Overall Study|Adverse Event|1
1480148|NCT00610441|4878896|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
1480149|NCT00610441|4878897|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
1480150|NCT00610441|4878898|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
1480151|NCT00610441|4878899|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
1480152|NCT00610441|4878896|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
1480153|NCT00610441|4878897|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
1480154|NCT00610441|4878898|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
1481000|NCT00605280|4881469|P3|Year 1|Other|0
1480155|NCT00610441|4878899|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
1480156|NCT00610441|4878896|P4|Treatment Period 2 - 3 Weeks|Other|1
1480157|NCT00610441|4878897|P3|Treatment Period 2 - 3 Weeks|Other|0
1480158|NCT00610441|4878898|P2|Treatment Period 2 - 3 Weeks|Other|1
1480159|NCT00610441|4878899|P1|Treatment Period 2 - 3 Weeks|Other|1
1480160|NCT00610441|4878896|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
1480161|NCT00610441|4878897|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
1480162|NCT00610441|4878898|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
1480163|NCT00610441|4878899|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
1480164|NCT00610441|4878896|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
1480165|NCT00610441|4878897|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
1480166|NCT00610441|4878898|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
1480167|NCT00610441|4878899|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
1480168|NCT00610441|4878896|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
1480169|NCT00610441|4878897|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
1480170|NCT00610441|4878898|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
1480171|NCT00610441|4878899|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
1480172|NCT00610441|4878896|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
1480173|NCT00610441|4878897|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
1480174|NCT00610441|4878898|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
1480175|NCT00610441|4878899|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
1480176|NCT00610441|4878896|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
1480177|NCT00610441|4878897|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
1480178|NCT00610441|4878898|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
1480179|NCT00610441|4878899|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
1480180|NCT00610441|4878896|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
1480181|NCT00610441|4878897|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
1480182|NCT00610441|4878898|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
1480183|NCT00610441|4878899|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
1480184|NCT00610363|4879008|P2|Overall Study|Other than specified above|1
1480185|NCT00610363|4879009|P1|Overall Study|Other than specified above|1
1480186|NCT00610363|4879008|P2|Overall Study|Withdrawal by Subject|0
1480187|NCT00610363|4879009|P1|Overall Study|Withdrawal by Subject|1
1480188|NCT00610363|4879008|P2|Overall Study|Lost to Follow-up|0
1480189|NCT00610363|4879009|P1|Overall Study|Lost to Follow-up|4
1480190|NCT00610363|4879008|P2|Overall Study|Lack of Efficacy|0
1480191|NCT00610363|4879009|P1|Overall Study|Lack of Efficacy|2
1480192|NCT00610363|4879008|P2|Overall Study|Adverse Event|1
1480193|NCT00610363|4879009|P1|Overall Study|Adverse Event|3
1480194|NCT00610363|4879008|P2|Overall Study|Non-compliance with protocol|1
1480195|NCT00610363|4879009|P1|Overall Study|Non-compliance with protocol|0
1480196|NCT00610207|4879034|P1|Overall Study|Lost to Follow-up|3
1480197|NCT00610168|4879041|P2|Overall Study|Withdrawal by Subject|0
1480198|NCT00610168|4879042|P1|Overall Study|Withdrawal by Subject|2
1480199|NCT00610155|4879061|P6|Period 3|Adverse Event|0
1480200|NCT00610155|4879062|P5|Period 3|Adverse Event|0
1480201|NCT00610155|4879063|P4|Period 3|Adverse Event|0
1480202|NCT00610155|4879064|P3|Period 3|Adverse Event|0
1480203|NCT00610155|4879065|P2|Period 3|Adverse Event|0
1480204|NCT00610155|4879066|P1|Period 3|Adverse Event|1
1480205|NCT00610155|4879061|P6|Period 1|Withdrawal by Subject|0
1480206|NCT00610155|4879062|P5|Period 1|Withdrawal by Subject|0
1480207|NCT00610155|4879063|P4|Period 1|Withdrawal by Subject|0
1480208|NCT00610155|4879064|P3|Period 1|Withdrawal by Subject|1
1480209|NCT00610155|4879065|P2|Period 1|Withdrawal by Subject|0
1480210|NCT00610155|4879066|P1|Period 1|Withdrawal by Subject|0
1480211|NCT00610129|4879113|P1|Overall Study|Not treated since patients ineligible|3
1480212|NCT00609986|4879119|P2|Overall Study|Did not receive transplant or treatment|3
1480213|NCT00609986|4879120|P1|Overall Study|Did not receive transplant or treatment|8
1480214|NCT00609973|4879134|P2|Overall Study|Withdrawal by Subject|1
1480215|NCT00609973|4879135|P1|Overall Study|Withdrawal by Subject|0
1480216|NCT00609973|4879134|P2|Overall Study|Lost to Follow-up|1
1480217|NCT00609973|4879135|P1|Overall Study|Lost to Follow-up|2
1480218|NCT00609973|4879134|P2|Overall Study|Protocol Violation|3
1480219|NCT00609973|4879135|P1|Overall Study|Protocol Violation|4
1480220|NCT00609973|4879134|P2|Overall Study|Adverse Event|1
1480221|NCT00609973|4879135|P1|Overall Study|Adverse Event|2
1480222|NCT00609947|4879143|P1|Overall Study|Death|1
1480223|NCT00609869|4879148|P1|Overall Study|Mantle cell: not evaluable|4
1480224|NCT00609869|4879148|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
1480225|NCT00609869|4879148|P1|Overall Study|Hepatitis B infection|1
1480226|NCT00609869|4879148|P1|Overall Study|Severe tumor flare reaction|1
1480227|NCT00609869|4879148|P1|Overall Study|Seizures|1
1480228|NCT00609869|4879148|P1|Overall Study|Withdrawal by Subject|1
1480229|NCT00609869|4879148|P1|Overall Study|Severe hematologic toxicity|1
1480230|NCT00609869|4879148|P1|Overall Study|Withdrawn, ischemic stroke|1
1480231|NCT00609765|4879167|P1|Overall Study|Study ended prior to 12 months|1
1480232|NCT00609674|4879181|P2|Overall Study|Withdrew consent|1
1480233|NCT00609674|4879182|P1|Overall Study|Withdrew consent|2
1480234|NCT00609674|4879181|P2|Overall Study|Lost to Follow-up|0
1480235|NCT00609674|4879182|P1|Overall Study|Lost to Follow-up|1
1480236|NCT00609674|4879181|P2|Overall Study|Protocol Violation|5
1480237|NCT00609674|4879182|P1|Overall Study|Protocol Violation|3
1480238|NCT00609674|4879181|P2|Overall Study|Adverse Event|1
1480239|NCT00609674|4879182|P1|Overall Study|Adverse Event|1
1480240|NCT00609622|4879218|P2|Overall Study|Global deterioration of health status|2
1480241|NCT00609622|4879219|P1|Overall Study|Global deterioration of health status|6
1480242|NCT00609622|4879218|P2|Overall Study|Other|14
1480243|NCT00609622|4879219|P1|Overall Study|Other|7
1480244|NCT00609622|4879218|P2|Overall Study|Study terminated by sponsor|3
1480245|NCT00609622|4879219|P1|Overall Study|Study terminated by sponsor|16
1480246|NCT00609622|4879218|P2|Overall Study|Objective progression or relapse|41
1480247|NCT00609622|4879219|P1|Overall Study|Objective progression or relapse|47
1480248|NCT00609622|4879218|P2|Overall Study|Protocol Violation|1
1480249|NCT00609622|4879219|P1|Overall Study|Protocol Violation|1
1480250|NCT00609622|4879218|P2|Overall Study|Death|4
1480251|NCT00609622|4879219|P1|Overall Study|Death|1
1480252|NCT00609622|4879218|P2|Overall Study|Withdrawal by Subject|20
1480253|NCT00609622|4879219|P1|Overall Study|Withdrawal by Subject|4
1480254|NCT00609622|4879218|P2|Overall Study|Adverse Event|10
1480255|NCT00609622|4879219|P1|Overall Study|Adverse Event|14
1480256|NCT00609609|4879241|P2|Overall Study|Progression|2
1480257|NCT00609609|4879242|P1|Overall Study|Progression|4
1480258|NCT00609609|4879241|P2|Overall Study|Withdrawal by Subject|0
1480259|NCT00609609|4879242|P1|Overall Study|Withdrawal by Subject|2
1480260|NCT00609518|4879254|P2|Overall Study|Death from Adverse Event|2
1480261|NCT00609518|4879255|P1|Overall Study|Death from Adverse Event|2
1480262|NCT00609518|4879254|P2|Overall Study|Physician Decision|3
1480263|NCT00609518|4879255|P1|Overall Study|Physician Decision|1
1480264|NCT00609518|4879254|P2|Overall Study|Lost to Follow-up|0
1480265|NCT00609518|4879255|P1|Overall Study|Lost to Follow-up|3
1480266|NCT00609518|4879254|P2|Overall Study|Withdrawal by Subject|3
1480267|NCT00609518|4879255|P1|Overall Study|Withdrawal by Subject|5
1480268|NCT00609518|4879254|P2|Overall Study|Death from Study Disease|32
1480269|NCT00609518|4879255|P1|Overall Study|Death from Study Disease|32
1480270|NCT00609492|4879270|P3|Overall Study|Lost to Follow-up|4
1480271|NCT00609492|4879271|P2|Overall Study|Lost to Follow-up|1
1480272|NCT00609492|4879272|P1|Overall Study|Lost to Follow-up|1
1480273|NCT00609492|4879270|P3|Overall Study|Withdrawal by Subject|3
1480274|NCT00609492|4879271|P2|Overall Study|Withdrawal by Subject|2
1480275|NCT00609492|4879272|P1|Overall Study|Withdrawal by Subject|0
1480276|NCT00609466|4879357|P3|Overall Study|Lack of Efficacy|2
1480277|NCT00609466|4879358|P2|Overall Study|Lack of Efficacy|2
1480278|NCT00609466|4879359|P1|Overall Study|Lack of Efficacy|0
1480279|NCT00609466|4879357|P3|Overall Study|Adverse Event|1
1480280|NCT00609466|4879358|P2|Overall Study|Adverse Event|3
1480281|NCT00609466|4879359|P1|Overall Study|Adverse Event|2
1480282|NCT00609466|4879357|P3|Overall Study|Withdrawal by Subject|1
1480283|NCT00609466|4879358|P2|Overall Study|Withdrawal by Subject|1
1480284|NCT00609466|4879359|P1|Overall Study|Withdrawal by Subject|0
1480285|NCT00609362|4879387|P2|Overall Study|Adverse Event|0
1480286|NCT00609362|4879388|P1|Overall Study|Adverse Event|1
1480287|NCT00609362|4879387|P2|Overall Study|Withdrawal by Subject|1
1480288|NCT00609362|4879388|P1|Overall Study|Withdrawal by Subject|2
1480289|NCT00609336|4879398|P1|Overall Study|LA or Met at Surgery|9
1480290|NCT00609336|4879398|P1|Overall Study|Death|1
1480291|NCT00609336|4879398|P1|Overall Study|Protocol Violation|3
1480292|NCT00609245|4879410|P1|Overall Study|Adverse Event|1
1480293|NCT00609167|4879418|P2|Overall Study|Stem Cell Transplant|6
1480294|NCT00609167|4879419|P1|Overall Study|Stem Cell Transplant|0
1480295|NCT00609167|4879418|P2|Overall Study|Disease Progression|0
1480296|NCT00609167|4879419|P1|Overall Study|Disease Progression|1
1480297|NCT00609167|4879418|P2|Overall Study|Adverse Event|1
1480298|NCT00609167|4879419|P1|Overall Study|Adverse Event|5
1480299|NCT00609167|4879418|P2|Overall Study|Lack of Efficacy|0
1480300|NCT00609167|4879419|P1|Overall Study|Lack of Efficacy|1
1480301|NCT00609167|4879418|P2|Overall Study|Withdrawal by Subject|0
1480302|NCT00609167|4879419|P1|Overall Study|Withdrawal by Subject|1
1480303|NCT00608985|4879445|P4|Overall Study|Lost to Follow-up|0
1480304|NCT00608985|4879446|P3|Overall Study|Lost to Follow-up|0
1480305|NCT00608985|4879447|P2|Overall Study|Lost to Follow-up|1
1480306|NCT00608985|4879448|P1|Overall Study|Lost to Follow-up|2
1480307|NCT00608985|4879445|P4|Overall Study|Withdrawal of Consent|1
1480308|NCT00608985|4879446|P3|Overall Study|Withdrawal of Consent|1
1480309|NCT00608985|4879447|P2|Overall Study|Withdrawal of Consent|1
1480310|NCT00608985|4879448|P1|Overall Study|Withdrawal of Consent|5
1480311|NCT00608985|4879445|P4|Overall Study|Administrative/Other|2
1480312|NCT00608985|4879446|P3|Overall Study|Administrative/Other|1
1480313|NCT00608985|4879447|P2|Overall Study|Administrative/Other|4
1480314|NCT00608985|4879448|P1|Overall Study|Administrative/Other|7
1480315|NCT00608985|4879445|P4|Overall Study|Adverse Event|6
1480316|NCT00608985|4879446|P3|Overall Study|Adverse Event|4
1480317|NCT00608985|4879447|P2|Overall Study|Adverse Event|7
1480318|NCT00608985|4879448|P1|Overall Study|Adverse Event|2
1480319|NCT00608959|4879480|P1|Part 1|Did not meet eligibility criteria|1
1480320|NCT00608907|4879493|P3|Overall Study|Progressive Disease|0
1480321|NCT00608907|4879494|P2|Overall Study|Progressive Disease|0
1480322|NCT00608907|4879495|P1|Overall Study|Progressive Disease|1
1480323|NCT00608907|4879493|P3|Overall Study|Withdrawal by Subject|0
1480324|NCT00608907|4879494|P2|Overall Study|Withdrawal by Subject|0
1480325|NCT00608907|4879495|P1|Overall Study|Withdrawal by Subject|4
1480326|NCT00608907|4879493|P3|Overall Study|Death|0
1480327|NCT00608907|4879494|P2|Overall Study|Death|0
1480328|NCT00608907|4879495|P1|Overall Study|Death|1
1480329|NCT00608907|4879493|P3|Overall Study|Adverse Event|1
1480330|NCT00608907|4879494|P2|Overall Study|Adverse Event|0
1480331|NCT00608907|4879495|P1|Overall Study|Adverse Event|6
1480332|NCT00608881|4879505|P2|Overall Study|Institutionalized|2
1480333|NCT00608881|4879506|P1|Overall Study|Institutionalized|1
1480334|NCT00608881|4879505|P2|Overall Study|Physician Decision|5
1480335|NCT00608881|4879506|P1|Overall Study|Physician Decision|5
1480336|NCT00608881|4879505|P2|Overall Study|Withdrawal by Subject|29
1480337|NCT00608881|4879506|P1|Overall Study|Withdrawal by Subject|18
1480338|NCT00608881|4879505|P2|Overall Study|Lost to Follow-up|14
1480339|NCT00608881|4879506|P1|Overall Study|Lost to Follow-up|28
1480340|NCT00608881|4879505|P2|Overall Study|Adverse Event|3
1480341|NCT00608881|4879506|P1|Overall Study|Adverse Event|5
1480342|NCT00608881|4879505|P2|Overall Study|Death|13
1480343|NCT00608881|4879506|P1|Overall Study|Death|22
1480344|NCT00608868|4879540|P1|Overall Study|Physician Decision|2
1480345|NCT00608868|4879540|P1|Overall Study|Adverse Event|1
1480346|NCT00608868|4879540|P1|Overall Study|Lost to Follow-up|2
1480347|NCT00608868|4879540|P1|Overall Study|Protocol Violation|3
1480348|NCT00608868|4879540|P1|Overall Study|Withdrawal by Subject|7
1480349|NCT00608842|4879551|P4|Overall Study|Lost to Follow-up|0
1480350|NCT00608842|4879552|P3|Overall Study|Lost to Follow-up|0
1480351|NCT00608842|4879553|P2|Overall Study|Lost to Follow-up|0
1480352|NCT00608842|4879554|P1|Overall Study|Lost to Follow-up|1
1480353|NCT00608842|4879551|P4|Overall Study|Participant's Request|1
1480354|NCT00608842|4879552|P3|Overall Study|Participant's Request|2
1480355|NCT00608842|4879553|P2|Overall Study|Participant's Request|1
1480356|NCT00608842|4879554|P1|Overall Study|Participant's Request|0
1480357|NCT00608829|4879588|P1|Overall Study|Subject refuses to follow up or return.|5
1480358|NCT00608829|4879588|P1|Overall Study|Withdrawal by Subject|4
1480359|NCT00608829|4879588|P1|Overall Study|Death|6
1480360|NCT00608582|4879614|P2|Overall Study|Early stage Design Change|3
1480361|NCT00608582|4879615|P1|Overall Study|Early stage Design Change|0
1480362|NCT00608582|4879614|P2|Overall Study|Illicit Drug Use|0
1480363|NCT00608582|4879615|P1|Overall Study|Illicit Drug Use|1
1480364|NCT00608582|4879614|P2|Overall Study|No Best Response in Phase 1 located|1
1480365|NCT00608582|4879615|P1|Overall Study|No Best Response in Phase 1 located|1
1480366|NCT00608582|4879614|P2|Overall Study|Lost to Follow-up|0
1480367|NCT00608582|4879615|P1|Overall Study|Lost to Follow-up|2
1480368|NCT00608569|4879625|P2|Overall Study|Unable to adhere with study requirements|1
1480369|NCT00608569|4879626|P1|Overall Study|Unable to adhere with study requirements|0
1480370|NCT00608569|4879625|P2|Overall Study|Adverse Event|0
1480371|NCT00608569|4879626|P1|Overall Study|Adverse Event|1
1480372|NCT00608569|4879625|P2|Overall Study|Withdrawal by Subject|0
1480373|NCT00608569|4879626|P1|Overall Study|Withdrawal by Subject|1
1480374|NCT00608569|4879625|P2|Overall Study|Lost to Follow-up|5
1480375|NCT00608569|4879626|P1|Overall Study|Lost to Follow-up|4
1480376|NCT00608569|4879625|P2|Overall Study|Death|3
1480377|NCT00608569|4879626|P1|Overall Study|Death|4
1480378|NCT00608543|4879646|P1|Overall Study|Adverse Event|4
1480379|NCT00608530|4879659|P4|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
1480380|NCT00608530|4879660|P3|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
1480381|NCT00608530|4879661|P2|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
1480382|NCT00608530|4879662|P1|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
1480383|NCT00608530|4879659|P4|Study 2 Nurse-delivered Treatments|Time demands of study|1
1480384|NCT00608530|4879660|P3|Study 2 Nurse-delivered Treatments|Time demands of study|4
1480385|NCT00608530|4879661|P2|Study 2 Nurse-delivered Treatments|Time demands of study|0
1480386|NCT00608530|4879662|P1|Study 2 Nurse-delivered Treatments|Time demands of study|0
1480387|NCT00608530|4879659|P4|Study 2 Nurse-delivered Treatments|Protocol Violation|0
1480388|NCT00608530|4879660|P3|Study 2 Nurse-delivered Treatments|Protocol Violation|2
1480389|NCT00608530|4879661|P2|Study 2 Nurse-delivered Treatments|Protocol Violation|0
1480390|NCT00608530|4879662|P1|Study 2 Nurse-delivered Treatments|Protocol Violation|0
1480391|NCT00608530|4879659|P4|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
1480392|NCT00608530|4879660|P3|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
1480393|NCT00608530|4879661|P2|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
1480394|NCT00608530|4879662|P1|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
1480395|NCT00608530|4879659|P4|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
1480396|NCT00608530|4879660|P3|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
1480397|NCT00608530|4879661|P2|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
1480398|NCT00608530|4879662|P1|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
1480399|NCT00608530|4879659|P4|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
1480400|NCT00608530|4879660|P3|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
1480401|NCT00608530|4879661|P2|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
1480402|NCT00608530|4879662|P1|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
1480403|NCT00608517|4879683|P3|Overall Study|Death|0
1480404|NCT00608517|4879684|P2|Overall Study|Death|0
1480405|NCT00608517|4879685|P1|Overall Study|Death|1
1480406|NCT00608426|4879865|P2|Overall Study|refused, health issues, wrong address|348
1480407|NCT00608426|4879866|P1|Overall Study|refused, health issues, wrong address|319
1480408|NCT00608426|4879865|P2|Overall Study|Lost to Follow-up|521
1480409|NCT00608426|4879866|P1|Overall Study|Lost to Follow-up|485
1480410|NCT00608426|4879865|P2|Overall Study|Death|36
1480411|NCT00608426|4879866|P1|Overall Study|Death|32
1481001|NCT00605280|4881470|P2|Year 1|Other|1
1480412|NCT00608322|4879878|P2|Overall Study|Death|1
1480413|NCT00608322|4879879|P1|Overall Study|Death|2
1480414|NCT00608244|4879885|P1|Overall Study|Low trough levels|1
1480415|NCT00608244|4879885|P1|Overall Study|Adverse Event|1
1480416|NCT00608205|4879896|P2|Overall Study|Patient non-compliant|1
1480417|NCT00608205|4879897|P1|Overall Study|Patient non-compliant|0
1480418|NCT00608205|4879896|P2|Overall Study|Adverse Event|2
1480419|NCT00608205|4879897|P1|Overall Study|Adverse Event|3
1480420|NCT00608023|4880014|P3|Overall Study|Unknown reason|0
1480421|NCT00608023|4880015|P2|Overall Study|Unknown reason|3
1480422|NCT00608023|4880016|P1|Overall Study|Unknown reason|0
1480423|NCT00608023|4880014|P3|Overall Study|Protocol Violation|1
1480424|NCT00608023|4880015|P2|Overall Study|Protocol Violation|3
1480425|NCT00608023|4880016|P1|Overall Study|Protocol Violation|1
1480426|NCT00608023|4880014|P3|Overall Study|Lost to Follow-up|1
1480427|NCT00608023|4880015|P2|Overall Study|Lost to Follow-up|2
1480428|NCT00608023|4880016|P1|Overall Study|Lost to Follow-up|2
1480429|NCT00608023|4880014|P3|Overall Study|Adverse Event|5
1480430|NCT00608023|4880015|P2|Overall Study|Adverse Event|4
1480431|NCT00608023|4880016|P1|Overall Study|Adverse Event|1
1480432|NCT00608023|4880014|P3|Overall Study|Withdrawal by Subject|7
1480433|NCT00608023|4880015|P2|Overall Study|Withdrawal by Subject|10
1480434|NCT00608023|4880016|P1|Overall Study|Withdrawal by Subject|8
1480435|NCT00607997|4880040|P4|Overall Study|Other without explanation|1
1480436|NCT00607997|4880041|P3|Overall Study|Other without explanation|4
1480437|NCT00607997|4880042|P2|Overall Study|Other without explanation|0
1480438|NCT00607997|4880043|P1|Overall Study|Other without explanation|2
1480439|NCT00607997|4880040|P4|Overall Study|Relapse, recurrent illness|0
1480440|NCT00607997|4880041|P3|Overall Study|Relapse, recurrent illness|2
1480441|NCT00607997|4880042|P2|Overall Study|Relapse, recurrent illness|0
1480442|NCT00607997|4880043|P1|Overall Study|Relapse, recurrent illness|4
1480443|NCT00607997|4880040|P4|Overall Study|Physician Decision|0
1480444|NCT00607997|4880041|P3|Overall Study|Physician Decision|0
1480445|NCT00607997|4880042|P2|Overall Study|Physician Decision|1
1480446|NCT00607997|4880043|P1|Overall Study|Physician Decision|4
1480447|NCT00607997|4880040|P4|Overall Study|Adverse Event|0
1480448|NCT00607997|4880041|P3|Overall Study|Adverse Event|2
1480449|NCT00607997|4880042|P2|Overall Study|Adverse Event|1
1480450|NCT00607997|4880043|P1|Overall Study|Adverse Event|3
1480451|NCT00607997|4880040|P4|Overall Study|Death|5
1480452|NCT00607997|4880041|P3|Overall Study|Death|2
1480453|NCT00607997|4880042|P2|Overall Study|Death|5
1480454|NCT00607997|4880043|P1|Overall Study|Death|8
1480455|NCT00607997|4880040|P4|Overall Study|Lack of Efficacy|10
1480456|NCT00607997|4880041|P3|Overall Study|Lack of Efficacy|14
1480457|NCT00607997|4880042|P2|Overall Study|Lack of Efficacy|20
1480458|NCT00607997|4880043|P1|Overall Study|Lack of Efficacy|6
1480459|NCT00607919|4880101|P2|Open-Label Phase|Parent/Caregiver Decision|2
1480460|NCT00607919|4880102|P1|Open-Label Phase|Parent/Caregiver Decision|1
1480461|NCT00607919|4880101|P2|Open-Label Phase|Withdrawal by Subject|2
1480462|NCT00607919|4880102|P1|Open-Label Phase|Withdrawal by Subject|2
1480463|NCT00607919|4880101|P2|Open-Label Phase|Protocol Violation|2
1480464|NCT00607919|4880102|P1|Open-Label Phase|Protocol Violation|2
1480465|NCT00607919|4880101|P2|Open-Label Phase|Lost to Follow-up|1
1480466|NCT00607919|4880102|P1|Open-Label Phase|Lost to Follow-up|4
1480467|NCT00607919|4880101|P2|Open-Label Phase|Adverse Event|5
1480468|NCT00607919|4880102|P1|Open-Label Phase|Adverse Event|1
1480469|NCT00607919|4880101|P2|Acute Phase|Withdrawal by Subject|3
1480470|NCT00607919|4880102|P1|Acute Phase|Withdrawal by Subject|3
1480471|NCT00607919|4880101|P2|Acute Phase|Protocol Violation|1
1480472|NCT00607919|4880102|P1|Acute Phase|Protocol Violation|5
1480473|NCT00607919|4880101|P2|Acute Phase|Parent/Caregiver Decision|4
1480474|NCT00607919|4880102|P1|Acute Phase|Parent/Caregiver Decision|6
1480475|NCT00607919|4880101|P2|Acute Phase|Lost to Follow-up|3
1480476|NCT00607919|4880102|P1|Acute Phase|Lost to Follow-up|9
1480477|NCT00607919|4880101|P2|Acute Phase|Lack of Efficacy|2
1480478|NCT00607919|4880102|P1|Acute Phase|Lack of Efficacy|1
1480479|NCT00607919|4880101|P2|Acute Phase|Entry Criteria Not Met|1
1480480|NCT00607919|4880102|P1|Acute Phase|Entry Criteria Not Met|1
1480481|NCT00607919|4880101|P2|Acute Phase|Adverse Event|2
1480482|NCT00607919|4880102|P1|Acute Phase|Adverse Event|9
1480483|NCT00607893|4880160|P2|Overall Study|Withdrew due to hypertensive urgency|1
1480484|NCT00607893|4880161|P1|Overall Study|Withdrew due to hypertensive urgency|1
1480485|NCT00607893|4880160|P2|Overall Study|Declined to be treated|0
1480486|NCT00607893|4880161|P1|Overall Study|Declined to be treated|1
1480487|NCT00607893|4880160|P2|Overall Study|withdrew could not tolerate CPAP|1
1480488|NCT00607893|4880161|P1|Overall Study|withdrew could not tolerate CPAP|0
1480489|NCT00607893|4880160|P2|Overall Study|Withdrew due to osteomyelitis surgery|1
1480490|NCT00607893|4880161|P1|Overall Study|Withdrew due to osteomyelitis surgery|0
1480491|NCT00607893|4880160|P2|Overall Study|withdrew due to loss of interest|1
1480492|NCT00607893|4880161|P1|Overall Study|withdrew due to loss of interest|0
1480493|NCT00607893|4880160|P2|Overall Study|Lost to Follow-up|0
1480494|NCT00607893|4880161|P1|Overall Study|Lost to Follow-up|4
1480495|NCT00607880|4880189|P2|Overall Study|Unable to place port due to occlusion|0
1480496|NCT00607880|4880190|P1|Overall Study|Unable to place port due to occlusion|1
1480497|NCT00607789|4880240|P2|Overall Study|Withdrawal by Subject|0
1480498|NCT00607789|4880241|P1|Overall Study|Withdrawal by Subject|1
1480499|NCT00607789|4880240|P2|Overall Study|Lost to Follow-up|5
1480500|NCT00607789|4880241|P1|Overall Study|Lost to Follow-up|0
1480501|NCT00607789|4880240|P2|Overall Study|Inadequate adherence|0
1480502|NCT00607789|4880241|P1|Overall Study|Inadequate adherence|3
1480503|NCT00607789|4880240|P2|Overall Study|Lack of Efficacy|1
1480504|NCT00607789|4880241|P1|Overall Study|Lack of Efficacy|0
1480505|NCT00607789|4880240|P2|Overall Study|Adverse Event|0
1480506|NCT00607789|4880241|P1|Overall Study|Adverse Event|3
1480507|NCT00607724|4880256|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1480508|NCT00607724|4880257|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1480509|NCT00607724|4880258|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1480510|NCT00607724|4880259|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
1480511|NCT00607724|4880260|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1480512|NCT00607724|4880261|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1480513|NCT00607724|4880262|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1480514|NCT00607724|4880256|P7|Stage 2: Expanded Cohort|Physician Decision|0
1480515|NCT00607724|4880257|P6|Stage 2: Expanded Cohort|Physician Decision|1
1480516|NCT00607724|4880258|P5|Stage 2: Expanded Cohort|Physician Decision|1
1480517|NCT00607724|4880259|P4|Stage 2: Expanded Cohort|Physician Decision|0
1480518|NCT00607724|4880260|P3|Stage 2: Expanded Cohort|Physician Decision|0
1480519|NCT00607724|4880261|P2|Stage 2: Expanded Cohort|Physician Decision|0
1480520|NCT00607724|4880262|P1|Stage 2: Expanded Cohort|Physician Decision|0
1480521|NCT00607724|4880256|P7|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|10
1480522|NCT00607724|4880257|P6|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|11
1480523|NCT00607724|4880258|P5|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|8
1480524|NCT00607724|4880259|P4|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|4
1480525|NCT00607724|4880260|P3|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
1480526|NCT00607724|4880261|P2|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
1480527|NCT00607724|4880262|P1|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
1480528|NCT00607724|4880256|P7|Stage 2: Expanded Cohort|Adverse Event|1
1480529|NCT00607724|4880257|P6|Stage 2: Expanded Cohort|Adverse Event|0
1480530|NCT00607724|4880258|P5|Stage 2: Expanded Cohort|Adverse Event|0
1480531|NCT00607724|4880259|P4|Stage 2: Expanded Cohort|Adverse Event|0
1480532|NCT00607724|4880260|P3|Stage 2: Expanded Cohort|Adverse Event|0
1480533|NCT00607724|4880261|P2|Stage 2: Expanded Cohort|Adverse Event|0
1480534|NCT00607724|4880262|P1|Stage 2: Expanded Cohort|Adverse Event|0
1480535|NCT00607724|4880256|P7|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
1480536|NCT00607724|4880257|P6|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
1480537|NCT00607724|4880258|P5|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
1480538|NCT00607724|4880259|P4|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
1480539|NCT00607724|4880260|P3|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|4
1480540|NCT00607724|4880261|P2|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|8
1480541|NCT00607724|4880262|P1|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|7
1480542|NCT00607386|4880425|P1|Overall Study|Physician Decision|1
1480543|NCT00607373|4880440|P2|Follow-up Period|Withdrawal by Subject|3
1480544|NCT00607373|4880441|P1|Follow-up Period|Withdrawal by Subject|1
1480545|NCT00607373|4880440|P2|Follow-up Period|Protocol Violation|1
1480546|NCT00607373|4880441|P1|Follow-up Period|Protocol Violation|0
1480547|NCT00607373|4880440|P2|Follow-up Period|Not specified|1
1480548|NCT00607373|4880441|P1|Follow-up Period|Not specified|0
1480549|NCT00607373|4880440|P2|Treatment Period|Withdrawal by Subject|1
1480550|NCT00607373|4880441|P1|Treatment Period|Withdrawal by Subject|0
1480551|NCT00607373|4880440|P2|Treatment Period|Physician Decision|1
1480552|NCT00607373|4880441|P1|Treatment Period|Physician Decision|0
1480553|NCT00607373|4880440|P2|Treatment Period|Adverse Event|4
1480554|NCT00607373|4880441|P1|Treatment Period|Adverse Event|0
1480555|NCT00607087|4880543|P3|Period 3|Adverse Event|0
1480556|NCT00607087|4880544|P2|Period 3|Adverse Event|1
1480557|NCT00607087|4880545|P1|Period 3|Adverse Event|0
1480558|NCT00607087|4880543|P3|Period 3|Withdrawal by Subject|0
1480559|NCT00607087|4880544|P2|Period 3|Withdrawal by Subject|1
1480560|NCT00607087|4880545|P1|Period 3|Withdrawal by Subject|2
1480561|NCT00607087|4880543|P3|Period 2|Poor compliance to protocol|1
1480562|NCT00607087|4880544|P2|Period 2|Poor compliance to protocol|0
1480563|NCT00607087|4880545|P1|Period 2|Poor compliance to protocol|0
1480564|NCT00607087|4880543|P3|Period 2|Adverse Event|3
1480565|NCT00607087|4880544|P2|Period 2|Adverse Event|1
1480566|NCT00607087|4880545|P1|Period 2|Adverse Event|0
1480567|NCT00607087|4880543|P3|Period 2|Other reason|0
1480568|NCT00607087|4880544|P2|Period 2|Other reason|1
1480569|NCT00607087|4880545|P1|Period 2|Other reason|1
1480570|NCT00607087|4880543|P3|Period 2|Withdrawal by Subject|1
1480571|NCT00607087|4880544|P2|Period 2|Withdrawal by Subject|1
1480572|NCT00607087|4880545|P1|Period 2|Withdrawal by Subject|0
1480573|NCT00607087|4880543|P3|Period 1|Other reason|2
1480574|NCT00607087|4880544|P2|Period 1|Other reason|4
1480575|NCT00607087|4880545|P1|Period 1|Other reason|0
1480576|NCT00607087|4880543|P3|Period 1|Lost to Follow-up|0
1480577|NCT00607087|4880544|P2|Period 1|Lost to Follow-up|0
1480578|NCT00607087|4880545|P1|Period 1|Lost to Follow-up|1
1480579|NCT00607087|4880543|P3|Period 1|Poor compliance to protocol|0
1480580|NCT00607087|4880544|P2|Period 1|Poor compliance to protocol|0
1480581|NCT00607087|4880545|P1|Period 1|Poor compliance to protocol|1
1480582|NCT00607087|4880543|P3|Period 1|Adverse Event|0
1480583|NCT00607087|4880544|P2|Period 1|Adverse Event|0
1480584|NCT00607087|4880545|P1|Period 1|Adverse Event|3
1480585|NCT00607087|4880543|P3|Period 1|Withdrawal by Subject|3
1480586|NCT00607087|4880544|P2|Period 1|Withdrawal by Subject|2
1480587|NCT00607087|4880545|P1|Period 1|Withdrawal by Subject|7
1480588|NCT00607087|4880543|P3|Overall Study|Lost to Follow-up|0
1480589|NCT00607087|4880544|P2|Overall Study|Lost to Follow-up|0
1480590|NCT00607087|4880545|P1|Overall Study|Lost to Follow-up|1
1480591|NCT00607087|4880543|P3|Overall Study|Poor compliance to protocol|1
1480592|NCT00607087|4880544|P2|Overall Study|Poor compliance to protocol|0
1480593|NCT00607087|4880545|P1|Overall Study|Poor compliance to protocol|1
1480594|NCT00607087|4880543|P3|Overall Study|Other reason|2
1480595|NCT00607087|4880544|P2|Overall Study|Other reason|5
1480596|NCT00607087|4880545|P1|Overall Study|Other reason|1
1480597|NCT00607087|4880543|P3|Overall Study|Adverse Event|3
1480598|NCT00607087|4880544|P2|Overall Study|Adverse Event|2
1480599|NCT00607087|4880545|P1|Overall Study|Adverse Event|3
1480600|NCT00607087|4880543|P3|Overall Study|Withdrawal by Subject|4
1480601|NCT00607087|4880544|P2|Overall Study|Withdrawal by Subject|4
1480602|NCT00607087|4880545|P1|Overall Study|Withdrawal by Subject|9
1480603|NCT00607048|4880603|P6|Overall Study|Other|1
1480604|NCT00607048|4880604|P5|Overall Study|Other|0
1480605|NCT00607048|4880605|P4|Overall Study|Other|0
1480606|NCT00607048|4880606|P3|Overall Study|Other|0
1480607|NCT00607048|4880607|P2|Overall Study|Other|1
1480608|NCT00607048|4880608|P1|Overall Study|Other|1
1480609|NCT00607048|4880603|P6|Overall Study|Withdrawal by Subject|2
1480610|NCT00607048|4880604|P5|Overall Study|Withdrawal by Subject|0
1480611|NCT00607048|4880605|P4|Overall Study|Withdrawal by Subject|1
1480612|NCT00607048|4880606|P3|Overall Study|Withdrawal by Subject|0
1480613|NCT00607048|4880607|P2|Overall Study|Withdrawal by Subject|0
1480614|NCT00607048|4880608|P1|Overall Study|Withdrawal by Subject|0
1480615|NCT00607048|4880603|P6|Overall Study|Objective disease progression - relapse|2
1480616|NCT00607048|4880604|P5|Overall Study|Objective disease progression - relapse|2
1480617|NCT00607048|4880605|P4|Overall Study|Objective disease progression - relapse|2
1480618|NCT00607048|4880606|P3|Overall Study|Objective disease progression - relapse|4
1480619|NCT00607048|4880607|P2|Overall Study|Objective disease progression - relapse|2
1480620|NCT00607048|4880608|P1|Overall Study|Objective disease progression - relapse|1
1480621|NCT00607048|4880603|P6|Overall Study|Global deterioration of health|0
1480622|NCT00607048|4880604|P5|Overall Study|Global deterioration of health|0
1480623|NCT00607048|4880605|P4|Overall Study|Global deterioration of health|0
1480624|NCT00607048|4880606|P3|Overall Study|Global deterioration of health|0
1480625|NCT00607048|4880607|P2|Overall Study|Global deterioration of health|0
1480626|NCT00607048|4880608|P1|Overall Study|Global deterioration of health|1
1480627|NCT00607048|4880603|P6|Overall Study|Adverse Event|0
1480628|NCT00607048|4880604|P5|Overall Study|Adverse Event|4
1480629|NCT00607048|4880605|P4|Overall Study|Adverse Event|0
1480630|NCT00607048|4880606|P3|Overall Study|Adverse Event|0
1480631|NCT00607048|4880607|P2|Overall Study|Adverse Event|1
1480632|NCT00607048|4880608|P1|Overall Study|Adverse Event|0
1480633|NCT00607022|4880693|P3|Overall Study|Withdrawal by Subject|0
1480634|NCT00607022|4880694|P2|Overall Study|Withdrawal by Subject|0
1480635|NCT00607022|4880695|P1|Overall Study|Withdrawal by Subject|1
1480636|NCT00606931|4880712|P1|Overall Study|Withdrawal by Subject|3
1480637|NCT00606905|4880720|P2|Overall Study|Withdrew|5
1480638|NCT00606905|4880721|P1|Overall Study|Withdrew|5
1480639|NCT00606905|4880720|P2|Overall Study|Non-Index Pregnancy|4
1480640|NCT00606905|4880721|P1|Overall Study|Non-Index Pregnancy|1
1480641|NCT00606905|4880720|P2|Overall Study|No Pregnancy|6
1480642|NCT00606905|4880721|P1|Overall Study|No Pregnancy|9
1480643|NCT00606892|4880727|P2|First Intervention|Protocol Violation|4
1480644|NCT00606892|4880728|P1|First Intervention|Protocol Violation|1
1480645|NCT00606801|4880762|P2|Intervention|Protocol Violation|3
1480646|NCT00606801|4880763|P1|Intervention|Protocol Violation|3
1480647|NCT00606684|4880791|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
1480648|NCT00606684|4880792|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
1480649|NCT00606684|4880793|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
1480650|NCT00606684|4880794|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
1480651|NCT00606684|4880795|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
1480652|NCT00606684|4880796|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
1480653|NCT00606684|4880797|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
1480654|NCT00606684|4880791|P7|Double-Blind Treatment Period|Physician Decision|2
1480655|NCT00606684|4880792|P6|Double-Blind Treatment Period|Physician Decision|1
1480656|NCT00606684|4880793|P5|Double-Blind Treatment Period|Physician Decision|3
1480657|NCT00606684|4880794|P4|Double-Blind Treatment Period|Physician Decision|0
1480658|NCT00606684|4880795|P3|Double-Blind Treatment Period|Physician Decision|1
1480659|NCT00606684|4880796|P2|Double-Blind Treatment Period|Physician Decision|5
1480660|NCT00606684|4880797|P1|Double-Blind Treatment Period|Physician Decision|0
1480661|NCT00606684|4880791|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
1480662|NCT00606684|4880792|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
1480663|NCT00606684|4880793|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
1480664|NCT00606684|4880794|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
1480665|NCT00606684|4880795|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
1481002|NCT00605280|4881471|P1|Year 1|Other|2
1480666|NCT00606684|4880796|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
1480667|NCT00606684|4880797|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
1480668|NCT00606684|4880791|P7|Double-Blind Treatment Period|Protocol Violation|4
1480669|NCT00606684|4880792|P6|Double-Blind Treatment Period|Protocol Violation|3
1480670|NCT00606684|4880793|P5|Double-Blind Treatment Period|Protocol Violation|0
1480671|NCT00606684|4880794|P4|Double-Blind Treatment Period|Protocol Violation|3
1480672|NCT00606684|4880795|P3|Double-Blind Treatment Period|Protocol Violation|5
1480673|NCT00606684|4880796|P2|Double-Blind Treatment Period|Protocol Violation|5
1480674|NCT00606684|4880797|P1|Double-Blind Treatment Period|Protocol Violation|0
1480675|NCT00606684|4880791|P7|Double-Blind Treatment Period|Lack of Efficacy|0
1480676|NCT00606684|4880792|P6|Double-Blind Treatment Period|Lack of Efficacy|0
1480677|NCT00606684|4880793|P5|Double-Blind Treatment Period|Lack of Efficacy|1
1480678|NCT00606684|4880794|P4|Double-Blind Treatment Period|Lack of Efficacy|0
1480679|NCT00606684|4880795|P3|Double-Blind Treatment Period|Lack of Efficacy|0
1480680|NCT00606684|4880796|P2|Double-Blind Treatment Period|Lack of Efficacy|1
1480681|NCT00606684|4880797|P1|Double-Blind Treatment Period|Lack of Efficacy|0
1480682|NCT00606684|4880791|P7|Double-Blind Treatment Period|Adverse Event|1
1480683|NCT00606684|4880792|P6|Double-Blind Treatment Period|Adverse Event|0
1480684|NCT00606684|4880793|P5|Double-Blind Treatment Period|Adverse Event|2
1480685|NCT00606684|4880794|P4|Double-Blind Treatment Period|Adverse Event|4
1480686|NCT00606684|4880795|P3|Double-Blind Treatment Period|Adverse Event|2
1480687|NCT00606684|4880796|P2|Double-Blind Treatment Period|Adverse Event|3
1480688|NCT00606684|4880797|P1|Double-Blind Treatment Period|Adverse Event|0
1480689|NCT00606684|4880791|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1480690|NCT00606684|4880792|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1480691|NCT00606684|4880793|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1480692|NCT00606684|4880794|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1480693|NCT00606684|4880795|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1480694|NCT00606684|4880796|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1480695|NCT00606684|4880797|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
1480696|NCT00606684|4880791|P7|2-week Single-Blind Run-in Period|Adverse Event|0
1480697|NCT00606684|4880792|P6|2-week Single-Blind Run-in Period|Adverse Event|0
1480698|NCT00606684|4880793|P5|2-week Single-Blind Run-in Period|Adverse Event|0
1480699|NCT00606684|4880794|P4|2-week Single-Blind Run-in Period|Adverse Event|0
1480700|NCT00606684|4880795|P3|2-week Single-Blind Run-in Period|Adverse Event|0
1480701|NCT00606684|4880796|P2|2-week Single-Blind Run-in Period|Adverse Event|0
1480702|NCT00606684|4880797|P1|2-week Single-Blind Run-in Period|Adverse Event|2
1480703|NCT00606684|4880791|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1480704|NCT00606684|4880792|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1480705|NCT00606684|4880793|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1480706|NCT00606684|4880794|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1480707|NCT00606684|4880795|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1480708|NCT00606684|4880796|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1480709|NCT00606684|4880797|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
1480710|NCT00606684|4880791|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1480711|NCT00606684|4880792|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1480712|NCT00606684|4880793|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1480713|NCT00606684|4880794|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1480714|NCT00606684|4880795|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1480715|NCT00606684|4880796|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1480716|NCT00606684|4880797|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
1480717|NCT00606684|4880791|P7|2-week Single-Blind Run-in Period|Physician Decision|0
1480718|NCT00606684|4880792|P6|2-week Single-Blind Run-in Period|Physician Decision|0
1480719|NCT00606684|4880793|P5|2-week Single-Blind Run-in Period|Physician Decision|0
1480720|NCT00606684|4880794|P4|2-week Single-Blind Run-in Period|Physician Decision|0
1480721|NCT00606684|4880795|P3|2-week Single-Blind Run-in Period|Physician Decision|0
1480722|NCT00606684|4880796|P2|2-week Single-Blind Run-in Period|Physician Decision|0
1480723|NCT00606684|4880797|P1|2-week Single-Blind Run-in Period|Physician Decision|18
1480724|NCT00606684|4880791|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1480725|NCT00606684|4880792|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1480726|NCT00606684|4880793|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1480727|NCT00606684|4880794|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1480728|NCT00606684|4880795|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1480729|NCT00606684|4880796|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1480730|NCT00606684|4880797|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
1480731|NCT00606684|4880791|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1480732|NCT00606684|4880792|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1480733|NCT00606684|4880793|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1480734|NCT00606684|4880794|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1480735|NCT00606684|4880795|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1480736|NCT00606684|4880796|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1480737|NCT00606684|4880797|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
1480738|NCT00606632|4880829|P1|Overall Study|Miscellaneous reasons|9
1480739|NCT00606632|4880829|P1|Overall Study|Withdrawal by Subject|13
1480740|NCT00606593|4880836|P10|Overall Study|Administrative/Other|0
1480741|NCT00606593|4880837|P9|Overall Study|Administrative/Other|0
1480742|NCT00606593|4880838|P8|Overall Study|Administrative/Other|0
1480743|NCT00606593|4880839|P7|Overall Study|Administrative/Other|0
1480744|NCT00606593|4880840|P6|Overall Study|Administrative/Other|0
1480745|NCT00606593|4880841|P5|Overall Study|Administrative/Other|0
1480746|NCT00606593|4880842|P4|Overall Study|Administrative/Other|0
1480747|NCT00606593|4880843|P3|Overall Study|Administrative/Other|1
1480748|NCT00606593|4880844|P2|Overall Study|Administrative/Other|0
1480749|NCT00606593|4880845|P1|Overall Study|Administrative/Other|0
1480750|NCT00606593|4880836|P10|Overall Study|Withdrawal of consent|0
1480751|NCT00606593|4880837|P9|Overall Study|Withdrawal of consent|0
1480752|NCT00606593|4880838|P8|Overall Study|Withdrawal of consent|0
1480753|NCT00606593|4880839|P7|Overall Study|Withdrawal of consent|0
1480754|NCT00606593|4880840|P6|Overall Study|Withdrawal of consent|0
1480755|NCT00606593|4880841|P5|Overall Study|Withdrawal of consent|0
1480756|NCT00606593|4880842|P4|Overall Study|Withdrawal of consent|0
1480757|NCT00606593|4880843|P3|Overall Study|Withdrawal of consent|1
1480758|NCT00606593|4880844|P2|Overall Study|Withdrawal of consent|0
1480759|NCT00606593|4880845|P1|Overall Study|Withdrawal of consent|1
1480760|NCT00606593|4880836|P10|Overall Study|Adverse Event|0
1480761|NCT00606593|4880837|P9|Overall Study|Adverse Event|1
1480762|NCT00606593|4880838|P8|Overall Study|Adverse Event|2
1480763|NCT00606593|4880839|P7|Overall Study|Adverse Event|1
1480764|NCT00606593|4880840|P6|Overall Study|Adverse Event|0
1480765|NCT00606593|4880841|P5|Overall Study|Adverse Event|1
1480766|NCT00606593|4880842|P4|Overall Study|Adverse Event|1
1480767|NCT00606593|4880843|P3|Overall Study|Adverse Event|0
1480768|NCT00606593|4880844|P2|Overall Study|Adverse Event|0
1480769|NCT00606593|4880845|P1|Overall Study|Adverse Event|0
1480770|NCT00606580|4880866|P3|Overall Study|Withdrawal by Subject|0
1480771|NCT00606580|4880867|P2|Overall Study|Withdrawal by Subject|1
1480772|NCT00606580|4880868|P1|Overall Study|Withdrawal by Subject|0
1480773|NCT00606580|4880866|P3|Overall Study|Withdrawal by investigator|6
1480774|NCT00606580|4880867|P2|Overall Study|Withdrawal by investigator|1
1480775|NCT00606580|4880868|P1|Overall Study|Withdrawal by investigator|0
1480776|NCT00606580|4880866|P3|Overall Study|Clinical failures|12
1480777|NCT00606580|4880867|P2|Overall Study|Clinical failures|0
1480778|NCT00606580|4880868|P1|Overall Study|Clinical failures|1
1480779|NCT00606580|4880866|P3|Overall Study|Lost to Follow-up|4
1480780|NCT00606580|4880867|P2|Overall Study|Lost to Follow-up|1
1480781|NCT00606580|4880868|P1|Overall Study|Lost to Follow-up|1
1480782|NCT00606502|4880934|P2|Treatment|Treatment ongoing at time of data cutoff|3
1480783|NCT00606502|4880935|P1|Treatment|Treatment ongoing at time of data cutoff|0
1480784|NCT00606502|4880934|P2|Randomization|Randomized but not treated|0
1480785|NCT00606502|4880935|P1|Randomization|Randomized but not treated|3
1480786|NCT00606320|4880956|P1|Overall Study|Progression to depressive phase|4
1480787|NCT00606320|4880956|P1|Overall Study|Withdrawal by Subject|10
1480788|NCT00606320|4880956|P1|Overall Study|Protocol Violation|8
1480789|NCT00606320|4880956|P1|Overall Study|Physician Decision|7
1480790|NCT00606320|4880956|P1|Overall Study|Lack of Efficacy|5
1480791|NCT00606320|4880956|P1|Overall Study|Adverse Event|3
1480792|NCT00606281|4880963|P2|Overall Study|Change of residence or other commitments|1
1480793|NCT00606281|4880964|P1|Overall Study|Change of residence or other commitments|1
1480794|NCT00606281|4880963|P2|Overall Study|Progression to depressive phase|1
1480795|NCT00606281|4880964|P1|Overall Study|Progression to depressive phase|1
1480796|NCT00606281|4880963|P2|Overall Study|Withdrawal by Subject|13
1480797|NCT00606281|4880964|P1|Overall Study|Withdrawal by Subject|11
1480798|NCT00606281|4880963|P2|Overall Study|Protocol Violation|3
1480799|NCT00606281|4880964|P1|Overall Study|Protocol Violation|3
1480800|NCT00606281|4880963|P2|Overall Study|Physician Decision|1
1480801|NCT00606281|4880964|P1|Overall Study|Physician Decision|0
1480802|NCT00606281|4880963|P2|Overall Study|Lack of Efficacy|35
1480803|NCT00606281|4880964|P1|Overall Study|Lack of Efficacy|28
1480804|NCT00606281|4880963|P2|Overall Study|Death|0
1480805|NCT00606281|4880964|P1|Overall Study|Death|1
1480806|NCT00606281|4880963|P2|Overall Study|Adverse Event|12
1480807|NCT00606281|4880964|P1|Overall Study|Adverse Event|11
1480808|NCT00606229|4880972|P1|Overall Study|change of residence or other commitments|2
1480809|NCT00606229|4880972|P1|Overall Study|does not meet inclusion criterion 1-3|4
1480810|NCT00606229|4880972|P1|Overall Study|Withdrawal by Subject|4
1480811|NCT00606229|4880972|P1|Overall Study|Lack of Efficacy|1
1480812|NCT00606229|4880972|P1|Overall Study|Adverse Event|11
1480813|NCT00606177|4880979|P2|Overall Study|Change of residence or other commitments|1
1480814|NCT00606177|4880980|P1|Overall Study|Change of residence or other commitments|1
1480815|NCT00606177|4880979|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
1480816|NCT00606177|4880980|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
1480817|NCT00606177|4880979|P2|Overall Study|Progression to depressive phase|1
1480818|NCT00606177|4880980|P1|Overall Study|Progression to depressive phase|6
1480819|NCT00606177|4880979|P2|Overall Study|Withdrawal by Subject|6
1480820|NCT00606177|4880980|P1|Overall Study|Withdrawal by Subject|5
1480821|NCT00606177|4880979|P2|Overall Study|Protocol Violation|4
1480822|NCT00606177|4880980|P1|Overall Study|Protocol Violation|1
1480823|NCT00606177|4880979|P2|Overall Study|Physician Decision|0
1480824|NCT00606177|4880980|P1|Overall Study|Physician Decision|1
1480825|NCT00606177|4880979|P2|Overall Study|Lack of Efficacy|7
1480826|NCT00606177|4880980|P1|Overall Study|Lack of Efficacy|3
1480827|NCT00606177|4880979|P2|Overall Study|Adverse Event|5
1480828|NCT00606177|4880980|P1|Overall Study|Adverse Event|9
1480829|NCT00606086|4881007|P2|Overall Study|Randomized, not treated|2
1480830|NCT00606086|4881008|P1|Overall Study|Randomized, not treated|1
1480831|NCT00606086|4881007|P2|Overall Study|Non-compliance|1
1480832|NCT00606086|4881008|P1|Overall Study|Non-compliance|0
1480833|NCT00606086|4881007|P2|Overall Study|Withdrawal by Subject|3
1480834|NCT00606086|4881008|P1|Overall Study|Withdrawal by Subject|5
1480835|NCT00606086|4881007|P2|Overall Study|Protocol Violation|0
1480836|NCT00606086|4881008|P1|Overall Study|Protocol Violation|1
1480837|NCT00606086|4881007|P2|Overall Study|Lost to Follow-up|8
1480838|NCT00606086|4881008|P1|Overall Study|Lost to Follow-up|4
1480839|NCT00606086|4881007|P2|Overall Study|Adverse Event|1
1480840|NCT00606086|4881008|P1|Overall Study|Adverse Event|1
1480841|NCT00606034|4881014|P1|Overall Study|incarceration|1
1480842|NCT00606021|4881022|P3|Maintenance Phase|Lost to Follow-up|2
1480843|NCT00606021|4881023|P2|Maintenance Phase|Lost to Follow-up|5
1480844|NCT00606021|4881024|P1|Maintenance Phase|Lost to Follow-up|0
1480845|NCT00606021|4881022|P3|Maintenance Phase|Physician Decision|0
1480846|NCT00606021|4881023|P2|Maintenance Phase|Physician Decision|1
1480847|NCT00606021|4881024|P1|Maintenance Phase|Physician Decision|0
1480848|NCT00606021|4881022|P3|Maintenance Phase|Death|15
1480849|NCT00606021|4881023|P2|Maintenance Phase|Death|17
1480850|NCT00606021|4881024|P1|Maintenance Phase|Death|0
1480851|NCT00606021|4881022|P3|Induction Phase|Lost to Follow-up|0
1480852|NCT00606021|4881023|P2|Induction Phase|Lost to Follow-up|0
1480853|NCT00606021|4881024|P1|Induction Phase|Lost to Follow-up|10
1480854|NCT00606021|4881022|P3|Induction Phase|Withdrawal by Subject|0
1480855|NCT00606021|4881023|P2|Induction Phase|Withdrawal by Subject|0
1480856|NCT00606021|4881024|P1|Induction Phase|Withdrawal by Subject|2
1480857|NCT00606021|4881022|P3|Induction Phase|Physician Decision|0
1480858|NCT00606021|4881023|P2|Induction Phase|Physician Decision|0
1480859|NCT00606021|4881024|P1|Induction Phase|Physician Decision|2
1480860|NCT00606021|4881022|P3|Induction Phase|Death|0
1480861|NCT00606021|4881023|P2|Induction Phase|Death|0
1480862|NCT00606021|4881024|P1|Induction Phase|Death|73
1480863|NCT00606008|4881042|P1|Overall Study|Withdrawal by Subject|4
1480864|NCT00606008|4881042|P1|Overall Study|Adverse Event|1
1480865|NCT00605917|4881056|P1|Overall Study|Protocol Violation|79
1480866|NCT00605865|4881108|P1|Overall Study|Protocol Violation|115
1480867|NCT00605839|4881150|P3|Overall Study|Protocol Violation|0
1480868|NCT00605839|4881151|P2|Overall Study|Protocol Violation|0
1480869|NCT00605839|4881152|P1|Overall Study|Protocol Violation|1
1480870|NCT00605813|4881160|P1|Overall Study|Protocol Violation|25
1480871|NCT00605722|4881173|P1|Overall Study|Failure to return|1
1480872|NCT00605722|4881173|P1|Overall Study|Insufficient therapeutic response|44
1480873|NCT00605722|4881173|P1|Overall Study|Adverse Event|6
1480874|NCT00605657|4881194|P1|Overall Study|Protocol Violation|1
1480875|NCT00605657|4881194|P1|Overall Study|Adverse Event|1
1480876|NCT00605540|4881199|P1|Overall Study|Lost to Follow-up|23
1480877|NCT00605540|4881199|P1|Overall Study|Death|15
1480878|NCT00605475|4881217|P10|Overall Study|Withdrawal by Subject|1
1480879|NCT00605475|4881218|P9|Overall Study|Withdrawal by Subject|0
1480880|NCT00605475|4881219|P8|Overall Study|Withdrawal by Subject|0
1480881|NCT00605475|4881220|P7|Overall Study|Withdrawal by Subject|0
1480882|NCT00605475|4881221|P6|Overall Study|Withdrawal by Subject|2
1480883|NCT00605475|4881222|P5|Overall Study|Withdrawal by Subject|0
1480884|NCT00605475|4881223|P4|Overall Study|Withdrawal by Subject|0
1480885|NCT00605475|4881224|P3|Overall Study|Withdrawal by Subject|0
1480886|NCT00605475|4881225|P2|Overall Study|Withdrawal by Subject|0
1480887|NCT00605475|4881226|P1|Overall Study|Withdrawal by Subject|0
1480888|NCT00605475|4881217|P10|Overall Study|Protocol Violation|0
1480889|NCT00605475|4881218|P9|Overall Study|Protocol Violation|0
1480890|NCT00605475|4881219|P8|Overall Study|Protocol Violation|0
1480891|NCT00605475|4881220|P7|Overall Study|Protocol Violation|0
1480892|NCT00605475|4881221|P6|Overall Study|Protocol Violation|0
1480893|NCT00605475|4881222|P5|Overall Study|Protocol Violation|1
1480894|NCT00605475|4881223|P4|Overall Study|Protocol Violation|0
1480895|NCT00605475|4881224|P3|Overall Study|Protocol Violation|0
1480896|NCT00605475|4881225|P2|Overall Study|Protocol Violation|0
1480897|NCT00605475|4881226|P1|Overall Study|Protocol Violation|0
1480898|NCT00605475|4881217|P10|Overall Study|Lost to Follow-up|1
1480899|NCT00605475|4881218|P9|Overall Study|Lost to Follow-up|1
1480900|NCT00605475|4881219|P8|Overall Study|Lost to Follow-up|0
1480901|NCT00605475|4881220|P7|Overall Study|Lost to Follow-up|0
1480902|NCT00605475|4881221|P6|Overall Study|Lost to Follow-up|0
1480903|NCT00605475|4881222|P5|Overall Study|Lost to Follow-up|0
1480904|NCT00605475|4881223|P4|Overall Study|Lost to Follow-up|0
1480905|NCT00605475|4881224|P3|Overall Study|Lost to Follow-up|0
1480906|NCT00605475|4881225|P2|Overall Study|Lost to Follow-up|0
1480907|NCT00605475|4881226|P1|Overall Study|Lost to Follow-up|0
1480908|NCT00605475|4881217|P10|Overall Study|Administrative problems|0
1480909|NCT00605475|4881218|P9|Overall Study|Administrative problems|0
1480910|NCT00605475|4881219|P8|Overall Study|Administrative problems|0
1480911|NCT00605475|4881220|P7|Overall Study|Administrative problems|1
1480912|NCT00605475|4881221|P6|Overall Study|Administrative problems|0
1480913|NCT00605475|4881222|P5|Overall Study|Administrative problems|0
1480914|NCT00605475|4881223|P4|Overall Study|Administrative problems|0
1480915|NCT00605475|4881224|P3|Overall Study|Administrative problems|0
1480916|NCT00605475|4881225|P2|Overall Study|Administrative problems|0
1480917|NCT00605475|4881226|P1|Overall Study|Administrative problems|0
1480918|NCT00605475|4881217|P10|Overall Study|Abnormal Laboratory Values|0
1480919|NCT00605475|4881218|P9|Overall Study|Abnormal Laboratory Values|1
1480920|NCT00605475|4881219|P8|Overall Study|Abnormal Laboratory Values|0
1480921|NCT00605475|4881220|P7|Overall Study|Abnormal Laboratory Values|0
1480922|NCT00605475|4881221|P6|Overall Study|Abnormal Laboratory Values|0
1480923|NCT00605475|4881222|P5|Overall Study|Abnormal Laboratory Values|0
1480924|NCT00605475|4881223|P4|Overall Study|Abnormal Laboratory Values|0
1480925|NCT00605475|4881224|P3|Overall Study|Abnormal Laboratory Values|0
1480926|NCT00605475|4881225|P2|Overall Study|Abnormal Laboratory Values|0
1480927|NCT00605475|4881226|P1|Overall Study|Abnormal Laboratory Values|0
1480928|NCT00605345|4881403|P2|Overall Study|Protocol Violation|2
1480929|NCT00605345|4881404|P1|Overall Study|Protocol Violation|0
1480930|NCT00605345|4881403|P2|Overall Study|Adverse Event|1
1480931|NCT00605345|4881404|P1|Overall Study|Adverse Event|0
1480932|NCT00605345|4881403|P2|Overall Study|Withdrawal by Subject|0
1480933|NCT00605345|4881404|P1|Overall Study|Withdrawal by Subject|1
1480934|NCT00605319|4881420|P1|Overall Study|Adverse Event|6
1480935|NCT00605306|4881432|P2|Overall Study|Adverse Event|1
1480936|NCT00605306|4881433|P1|Overall Study|Adverse Event|0
1480937|NCT00605293|4881447|P2|Overall Study|Principal Investigator Decision|1
1480938|NCT00605293|4881448|P1|Overall Study|Principal Investigator Decision|0
1480939|NCT00605293|4881447|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
1480940|NCT00605293|4881448|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
1480941|NCT00605293|4881447|P2|Overall Study|Incorrect Epoetin Beta Administration|0
1480942|NCT00605293|4881448|P1|Overall Study|Incorrect Epoetin Beta Administration|1
1480943|NCT00605293|4881447|P2|Overall Study|Renal Transplantation|1
1480944|NCT00605293|4881448|P1|Overall Study|Renal Transplantation|3
1480945|NCT00605293|4881447|P2|Overall Study|Blood Transfusion|1
1480946|NCT00605293|4881448|P1|Overall Study|Blood Transfusion|7
1480947|NCT00605293|4881447|P2|Overall Study|Holidays Dialysis Out|0
1480948|NCT00605293|4881448|P1|Overall Study|Holidays Dialysis Out|1
1480949|NCT00605293|4881447|P2|Overall Study|Adverse Event|0
1480950|NCT00605293|4881448|P1|Overall Study|Adverse Event|1
1480951|NCT00605293|4881447|P2|Overall Study|Insufficient Therapeutic Response|0
1480952|NCT00605293|4881448|P1|Overall Study|Insufficient Therapeutic Response|2
1480953|NCT00605293|4881447|P2|Overall Study|Death|1
1480954|NCT00605293|4881448|P1|Overall Study|Death|2
1480955|NCT00605280|4881468|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
1480956|NCT00605280|4881469|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
1480957|NCT00605280|4881470|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
1480958|NCT00605280|4881471|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
1480959|NCT00605280|4881468|P4|Year 3 Extension|Other|0
1480960|NCT00605280|4881469|P3|Year 3 Extension|Other|0
1480961|NCT00605280|4881470|P2|Year 3 Extension|Other|0
1480962|NCT00605280|4881471|P1|Year 3 Extension|Other|2
1480963|NCT00605280|4881468|P4|Year 3 Extension|Withdrawal by Subject|5
1480964|NCT00605280|4881469|P3|Year 3 Extension|Withdrawal by Subject|0
1480965|NCT00605280|4881470|P2|Year 3 Extension|Withdrawal by Subject|0
1480966|NCT00605280|4881471|P1|Year 3 Extension|Withdrawal by Subject|2
1480967|NCT00605280|4881468|P4|Year 3 Extension|Physician Decision|2
1480968|NCT00605280|4881469|P3|Year 3 Extension|Physician Decision|0
1480969|NCT00605280|4881470|P2|Year 3 Extension|Physician Decision|0
1480970|NCT00605280|4881471|P1|Year 3 Extension|Physician Decision|0
1480971|NCT00605280|4881468|P4|Year 3 Extension|Adverse Event|2
1480972|NCT00605280|4881469|P3|Year 3 Extension|Adverse Event|0
1480973|NCT00605280|4881470|P2|Year 3 Extension|Adverse Event|0
1480974|NCT00605280|4881471|P1|Year 3 Extension|Adverse Event|2
1480975|NCT00605280|4881468|P4|Year 2|Lost to Follow-up or Patient non-comply|2
1480976|NCT00605280|4881469|P3|Year 2|Lost to Follow-up or Patient non-comply|0
1480977|NCT00605280|4881470|P2|Year 2|Lost to Follow-up or Patient non-comply|0
1480978|NCT00605280|4881471|P1|Year 2|Lost to Follow-up or Patient non-comply|4
1480979|NCT00605280|4881468|P4|Year 2|Other|1
1480980|NCT00605280|4881469|P3|Year 2|Other|0
1480981|NCT00605280|4881470|P2|Year 2|Other|0
1480982|NCT00605280|4881471|P1|Year 2|Other|1
1480983|NCT00605280|4881468|P4|Year 2|Withdrawal by Subject|4
1480984|NCT00605280|4881469|P3|Year 2|Withdrawal by Subject|0
1480985|NCT00605280|4881470|P2|Year 2|Withdrawal by Subject|0
1480986|NCT00605280|4881471|P1|Year 2|Withdrawal by Subject|4
1480987|NCT00605280|4881468|P4|Year 2|Physician Decision|11
1480988|NCT00605280|4881469|P3|Year 2|Physician Decision|4
1480989|NCT00605280|4881470|P2|Year 2|Physician Decision|6
1480990|NCT00605280|4881471|P1|Year 2|Physician Decision|11
1480991|NCT00605280|4881468|P4|Year 2|Adverse Event|4
1480992|NCT00605280|4881469|P3|Year 2|Adverse Event|2
1480993|NCT00605280|4881470|P2|Year 2|Adverse Event|0
1480994|NCT00605280|4881471|P1|Year 2|Adverse Event|4
1480995|NCT00605280|4881468|P4|Year 1|Lost to Follow-up or Patient non-comply|2
1480996|NCT00605280|4881469|P3|Year 1|Lost to Follow-up or Patient non-comply|0
1480997|NCT00605280|4881470|P2|Year 1|Lost to Follow-up or Patient non-comply|1
1480998|NCT00605280|4881471|P1|Year 1|Lost to Follow-up or Patient non-comply|5
1480999|NCT00605280|4881468|P4|Year 1|Other|1
1481003|NCT00605280|4881468|P4|Year 1|Withdrawal by Subject|4
1481004|NCT00605280|4881469|P3|Year 1|Withdrawal by Subject|0
1481005|NCT00605280|4881470|P2|Year 1|Withdrawal by Subject|4
1481006|NCT00605280|4881471|P1|Year 1|Withdrawal by Subject|2
1481007|NCT00605280|4881468|P4|Year 1|Physician Decision|6
1481008|NCT00605280|4881469|P3|Year 1|Physician Decision|0
1481009|NCT00605280|4881470|P2|Year 1|Physician Decision|4
1481010|NCT00605280|4881471|P1|Year 1|Physician Decision|7
1481011|NCT00605280|4881468|P4|Year 1|Adverse Event|5
1481012|NCT00605280|4881469|P3|Year 1|Adverse Event|1
1481013|NCT00605280|4881470|P2|Year 1|Adverse Event|1
1481014|NCT00605280|4881471|P1|Year 1|Adverse Event|3
1481015|NCT00605280|4881468|P4|Year 1|Protocol Violation|1
1481016|NCT00605280|4881469|P3|Year 1|Protocol Violation|0
1481017|NCT00605280|4881470|P2|Year 1|Protocol Violation|0
1481018|NCT00605280|4881471|P1|Year 1|Protocol Violation|0
1481019|NCT00605267|4881505|P2|Overall Study|Withdrawal by Subject|3
1481020|NCT00605267|4881506|P1|Overall Study|Withdrawal by Subject|2
1481021|NCT00605267|4881505|P2|Overall Study|Lack of Efficacy|5
1481022|NCT00605267|4881506|P1|Overall Study|Lack of Efficacy|1
1481023|NCT00605267|4881505|P2|Overall Study|Adverse Event|1
1481024|NCT00605267|4881506|P1|Overall Study|Adverse Event|0
1481025|NCT00605176|4881554|P3|Overall Study|Other (not due to AE)|0
1481026|NCT00605176|4881555|P2|Overall Study|Other (not due to AE)|1
1481027|NCT00605176|4881556|P1|Overall Study|Other (not due to AE)|1
1481028|NCT00605176|4881554|P3|Overall Study|Use of concomitant therapy|1
1481029|NCT00605176|4881555|P2|Overall Study|Use of concomitant therapy|0
1481030|NCT00605176|4881556|P1|Overall Study|Use of concomitant therapy|1
1481031|NCT00605176|4881554|P3|Overall Study|Non-complicance with study procedures|0
1481032|NCT00605176|4881555|P2|Overall Study|Non-complicance with study procedures|0
1481033|NCT00605176|4881556|P1|Overall Study|Non-complicance with study procedures|1
1481034|NCT00605176|4881554|P3|Overall Study|Lost to Follow-up|1
1481035|NCT00605176|4881555|P2|Overall Study|Lost to Follow-up|2
1481036|NCT00605176|4881556|P1|Overall Study|Lost to Follow-up|2
1481037|NCT00605176|4881554|P3|Overall Study|Withdrawal by Subject|4
1481038|NCT00605176|4881555|P2|Overall Study|Withdrawal by Subject|2
1481039|NCT00605176|4881556|P1|Overall Study|Withdrawal by Subject|4
1481040|NCT00605176|4881554|P3|Overall Study|Adverse Event|3
1481041|NCT00605176|4881555|P2|Overall Study|Adverse Event|1
1481042|NCT00605176|4881556|P1|Overall Study|Adverse Event|2
1481043|NCT00605085|4881579|P2|Overall Study|administrative reasons|8
1481044|NCT00605085|4881580|P1|Overall Study|administrative reasons|18
1481045|NCT00605085|4881579|P2|Overall Study|Lost to Follow-up|5
1481046|NCT00605085|4881580|P1|Overall Study|Lost to Follow-up|10
1481047|NCT00605085|4881579|P2|Overall Study|Protocol Violation|2
1481048|NCT00605085|4881580|P1|Overall Study|Protocol Violation|3
1481049|NCT00605085|4881579|P2|Overall Study|Pregnancy|0
1481050|NCT00605085|4881580|P1|Overall Study|Pregnancy|2
1481051|NCT00605085|4881579|P2|Overall Study|Adverse Event|5
1481052|NCT00605085|4881580|P1|Overall Study|Adverse Event|9
1481053|NCT00605085|4881579|P2|Overall Study|Withdrawal by Subject|5
1481054|NCT00605085|4881580|P1|Overall Study|Withdrawal by Subject|8
1481055|NCT00605033|4881613|P2|Overall Study|Protocol Violation|1
1481056|NCT00605033|4881614|P1|Overall Study|Protocol Violation|1
1481057|NCT00605033|4881613|P2|Overall Study|Withdrawal by Subject|4
1481058|NCT00605033|4881614|P1|Overall Study|Withdrawal by Subject|3
1481059|NCT00605033|4881613|P2|Overall Study|Lost to Follow-up|1
1481060|NCT00605033|4881614|P1|Overall Study|Lost to Follow-up|1
1481061|NCT00605033|4881613|P2|Overall Study|Adverse Event|2
1481062|NCT00605033|4881614|P1|Overall Study|Adverse Event|2
1481063|NCT00604825|4881637|P4|Overall Study|Exclusion criterion met|1
1481064|NCT00604825|4881638|P3|Overall Study|Exclusion criterion met|0
1481065|NCT00604825|4881639|P2|Overall Study|Exclusion criterion met|0
1481066|NCT00604825|4881640|P1|Overall Study|Exclusion criterion met|0
1481067|NCT00604825|4881637|P4|Overall Study|Physician Decision|1
1481068|NCT00604825|4881638|P3|Overall Study|Physician Decision|0
1481069|NCT00604825|4881639|P2|Overall Study|Physician Decision|0
1481070|NCT00604825|4881640|P1|Overall Study|Physician Decision|0
1481071|NCT00604825|4881637|P4|Overall Study|Did not meet eligibility criteria|0
1481072|NCT00604825|4881638|P3|Overall Study|Did not meet eligibility criteria|2
1481073|NCT00604825|4881639|P2|Overall Study|Did not meet eligibility criteria|0
1481074|NCT00604825|4881640|P1|Overall Study|Did not meet eligibility criteria|0
1481075|NCT00604825|4881637|P4|Overall Study|Lack of Efficacy|0
1481076|NCT00604825|4881638|P3|Overall Study|Lack of Efficacy|1
1481077|NCT00604825|4881639|P2|Overall Study|Lack of Efficacy|2
1481078|NCT00604825|4881640|P1|Overall Study|Lack of Efficacy|3
1481079|NCT00604825|4881637|P4|Overall Study|Withdrawal by Subject|5
1481080|NCT00604825|4881638|P3|Overall Study|Withdrawal by Subject|5
1481081|NCT00604825|4881639|P2|Overall Study|Withdrawal by Subject|3
1481082|NCT00604825|4881640|P1|Overall Study|Withdrawal by Subject|4
1481083|NCT00604825|4881637|P4|Overall Study|Protocol Violation|0
1481084|NCT00604825|4881638|P3|Overall Study|Protocol Violation|0
1481085|NCT00604825|4881639|P2|Overall Study|Protocol Violation|1
1481086|NCT00604825|4881640|P1|Overall Study|Protocol Violation|0
1481087|NCT00604825|4881637|P4|Overall Study|Lost to Follow-up|0
1481088|NCT00604825|4881638|P3|Overall Study|Lost to Follow-up|1
1481089|NCT00604825|4881639|P2|Overall Study|Lost to Follow-up|3
1481090|NCT00604825|4881640|P1|Overall Study|Lost to Follow-up|0
1481091|NCT00604825|4881637|P4|Overall Study|Adverse Event|4
1481092|NCT00604825|4881638|P3|Overall Study|Adverse Event|7
1481093|NCT00604825|4881639|P2|Overall Study|Adverse Event|6
1481094|NCT00604825|4881640|P1|Overall Study|Adverse Event|2
1481095|NCT00604786|4881868|P2|Overall Study|Lost to Follow-up|0
1481096|NCT00604786|4881869|P1|Overall Study|Lost to Follow-up|2
1481097|NCT00604721|4881875|P1|Overall Study|Withdrawal by Subject|1
1481098|NCT00604721|4881875|P1|Overall Study|Physician Decision|1
1481099|NCT00604708|4881883|P2|Overall Study|Adverse Event|6
1481100|NCT00604708|4881884|P1|Overall Study|Adverse Event|6
1481101|NCT00604708|4881883|P2|Overall Study|administrative reasons|11
1481102|NCT00604708|4881884|P1|Overall Study|administrative reasons|9
1481103|NCT00604708|4881883|P2|Overall Study|Lost to Follow-up|5
1481104|NCT00604708|4881884|P1|Overall Study|Lost to Follow-up|5
1481105|NCT00604708|4881883|P2|Overall Study|Protocol Violation|8
1481106|NCT00604708|4881884|P1|Overall Study|Protocol Violation|2
1481107|NCT00604708|4881883|P2|Overall Study|Withdrawal by Subject|10
1481108|NCT00604708|4881884|P1|Overall Study|Withdrawal by Subject|9
1481109|NCT00604695|4881894|P2|Overall Study|Did not receive first bolus.|4
1481110|NCT00604695|4881895|P1|Overall Study|Did not receive first bolus.|0
1481111|NCT00604669|4881917|P1|Overall Study|lack of information in chart|7
1481112|NCT00604565|4881923|P2|Overall Study|Study terminated|3
1481113|NCT00604565|4881924|P1|Overall Study|Study terminated|0
1481114|NCT00604500|4881943|P1|Overall Study|Did not meet protocol eligibility|1
1481115|NCT00604500|4881943|P1|Overall Study|Administrative|1
1481116|NCT00604500|4881943|P1|Overall Study|Withdrawal by Subject|4
1481117|NCT00604500|4881943|P1|Overall Study|Treatment Failure|1
1481118|NCT00604500|4881943|P1|Overall Study|Protocol Violation|2
1481119|NCT00604500|4881943|P1|Overall Study|Adverse Event|2
1481120|NCT00604383|4881957|P2|Overall Study|Physician Decision|3
1481121|NCT00604383|4881958|P1|Overall Study|Physician Decision|0
1481122|NCT00604383|4881957|P2|Overall Study|Adverse Event|9
1481123|NCT00604383|4881958|P1|Overall Study|Adverse Event|16
1481124|NCT00604383|4881957|P2|Overall Study|Death|22
1481125|NCT00604383|4881958|P1|Overall Study|Death|14
1481126|NCT00604383|4881957|P2|Overall Study|Lost to Follow-up|19
1481127|NCT00604383|4881958|P1|Overall Study|Lost to Follow-up|24
1481128|NCT00604383|4881957|P2|Overall Study|Withdrawal by Subject|31
1481129|NCT00604383|4881958|P1|Overall Study|Withdrawal by Subject|33
1481130|NCT00604279|4881974|P2|Overall Study|Other|4
1481131|NCT00604279|4881975|P1|Overall Study|Other|8
1481132|NCT00604279|4881974|P2|Overall Study|Adverse Event|5
1481133|NCT00604279|4881975|P1|Overall Study|Adverse Event|4
1481134|NCT00604279|4881974|P2|Overall Study|Withdrawal by Subject|5
1481135|NCT00604279|4881975|P1|Overall Study|Withdrawal by Subject|16
1481136|NCT00604279|4881974|P2|Overall Study|Protocol Violation|1
1481137|NCT00604279|4881975|P1|Overall Study|Protocol Violation|3
1481138|NCT00604279|4881974|P2|Overall Study|Pregnancy|0
1481139|NCT00604279|4881975|P1|Overall Study|Pregnancy|2
1481140|NCT00604279|4881974|P2|Overall Study|Lost to Follow-up|14
1481141|NCT00604279|4881975|P1|Overall Study|Lost to Follow-up|9
1481142|NCT00604279|4881974|P2|Overall Study|Lack of Efficacy|9
1481143|NCT00604279|4881975|P1|Overall Study|Lack of Efficacy|22
1481144|NCT00604214|4881991|P2|Day 91 to Day 180|Withdrawal by Subject|1
1481145|NCT00604214|4881992|P1|Day 91 to Day 180|Withdrawal by Subject|1
1481146|NCT00604214|4881991|P2|Day 91 to Day 180|Lost to Follow-up|8
1481147|NCT00604214|4881992|P1|Day 91 to Day 180|Lost to Follow-up|6
1481148|NCT00604214|4881991|P2|Day 91 to Day 180|Death|23
1481149|NCT00604214|4881992|P1|Day 91 to Day 180|Death|19
1481150|NCT00604214|4881991|P2|Day 29 to Day 90|Withdrawal by Subject|6
1481151|NCT00604214|4881992|P1|Day 29 to Day 90|Withdrawal by Subject|0
1481152|NCT00604214|4881991|P2|Day 29 to Day 90|Lost to Follow-up|6
1481153|NCT00604214|4881992|P1|Day 29 to Day 90|Lost to Follow-up|4
1481154|NCT00604214|4881991|P2|Day 29 to Day 90|Death|67
1481155|NCT00604214|4881992|P1|Day 29 to Day 90|Death|64
1481156|NCT00604214|4881991|P2|Baseline to Day 28|Withdrawal by Subject|7
1481157|NCT00604214|4881992|P1|Baseline to Day 28|Withdrawal by Subject|3
1481158|NCT00604214|4881991|P2|Baseline to Day 28|Lost to Follow-up|4
1481159|NCT00604214|4881992|P1|Baseline to Day 28|Lost to Follow-up|2
1481160|NCT00604214|4881991|P2|Baseline to Day 28|Death|202
1481161|NCT00604214|4881992|P1|Baseline to Day 28|Death|223
1481162|NCT00604188|4882024|P2|Overall Study|Did not receive study drug|1
1481163|NCT00604188|4882025|P1|Overall Study|Did not receive study drug|0
1481164|NCT00604188|4882024|P2|Overall Study|Non-compliance with protocol|4
1481165|NCT00604188|4882025|P1|Overall Study|Non-compliance with protocol|4
1481166|NCT00604188|4882024|P2|Overall Study|Withdrawal by Subject|1
1481167|NCT00604188|4882025|P1|Overall Study|Withdrawal by Subject|5
1481168|NCT00604188|4882024|P2|Overall Study|Lost to Follow-up|15
1481169|NCT00604188|4882025|P1|Overall Study|Lost to Follow-up|17
1481170|NCT00604188|4882024|P2|Overall Study|Adverse Event|4
1481171|NCT00604188|4882025|P1|Overall Study|Adverse Event|1
1481172|NCT00604175|4882048|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
1481173|NCT00604175|4882049|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
1481174|NCT00604175|4882050|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
1481175|NCT00604175|4882048|P3|Week 29 Through Week 72|Site closure|0
1481176|NCT00604175|4882049|P2|Week 29 Through Week 72|Site closure|1
1481177|NCT00604175|4882050|P1|Week 29 Through Week 72|Site closure|0
1481178|NCT00604175|4882048|P3|Week 29 Through Week 72|Lost to Follow-up|2
1481179|NCT00604175|4882049|P2|Week 29 Through Week 72|Lost to Follow-up|6
1481180|NCT00604175|4882050|P1|Week 29 Through Week 72|Lost to Follow-up|12
1481181|NCT00604175|4882048|P3|Week 29 Through Week 72|Death|1
1481182|NCT00604175|4882049|P2|Week 29 Through Week 72|Death|0
1481183|NCT00604175|4882050|P1|Week 29 Through Week 72|Death|0
1481184|NCT00604175|4882048|P3|Entry Through Week 28|Did not start intervention|1
1481185|NCT00604175|4882049|P2|Entry Through Week 28|Did not start intervention|0
1481186|NCT00604175|4882050|P1|Entry Through Week 28|Did not start intervention|2
1481187|NCT00604175|4882048|P3|Entry Through Week 28|Ineligible|0
1481188|NCT00604175|4882049|P2|Entry Through Week 28|Ineligible|0
1481189|NCT00604175|4882050|P1|Entry Through Week 28|Ineligible|1
1481190|NCT00604175|4882048|P3|Entry Through Week 28|Lost to Follow-up|0
1481191|NCT00604175|4882049|P2|Entry Through Week 28|Lost to Follow-up|3
1481192|NCT00604175|4882050|P1|Entry Through Week 28|Lost to Follow-up|4
1481193|NCT00604175|4882048|P3|Entry Through Week 28|Withdrawal by Subject|0
1481194|NCT00604175|4882049|P2|Entry Through Week 28|Withdrawal by Subject|0
1481195|NCT00604175|4882050|P1|Entry Through Week 28|Withdrawal by Subject|1
1481196|NCT00604175|4882048|P3|Entry Through Week 28|Death|0
1481197|NCT00604175|4882049|P2|Entry Through Week 28|Death|0
1481198|NCT00604175|4882050|P1|Entry Through Week 28|Death|2
1481199|NCT00604162|4882103|P1|Overall Study|Withdrawal by Subject|1
1481200|NCT00604162|4882103|P1|Overall Study|Physician Decision|3
1481201|NCT00603915|4882145|P1|Overall Study|Physician Decision|1
1481202|NCT00603837|4882175|P2|Overall Study|Physician Decision|0
1481203|NCT00603837|4882176|P1|Overall Study|Physician Decision|3
1481204|NCT00603798|4882185|P3|Overall Study|Not due to AE|4
1481205|NCT00603798|4882186|P2|Overall Study|Not due to AE|1
1481206|NCT00603798|4882187|P1|Overall Study|Not due to AE|1
1481207|NCT00603798|4882185|P3|Overall Study|Non-compliance with study procedures|0
1481208|NCT00603798|4882186|P2|Overall Study|Non-compliance with study procedures|1
1481209|NCT00603798|4882187|P1|Overall Study|Non-compliance with study procedures|0
1481210|NCT00603798|4882185|P3|Overall Study|Lost to Follow-up|1
1481211|NCT00603798|4882186|P2|Overall Study|Lost to Follow-up|0
1481212|NCT00603798|4882187|P1|Overall Study|Lost to Follow-up|1
1481213|NCT00603798|4882185|P3|Overall Study|Withdrawal by Subject|4
1481214|NCT00603798|4882186|P2|Overall Study|Withdrawal by Subject|3
1481215|NCT00603798|4882187|P1|Overall Study|Withdrawal by Subject|4
1481216|NCT00603798|4882185|P3|Overall Study|Adverse Event|1
1481217|NCT00603798|4882186|P2|Overall Study|Adverse Event|2
1481218|NCT00603798|4882187|P1|Overall Study|Adverse Event|4
1481219|NCT00603746|4882210|P6|Overall Study|Withdrawal by Subject|1
1481220|NCT00603746|4882211|P5|Overall Study|Withdrawal by Subject|3
1481221|NCT00603746|4882212|P4|Overall Study|Withdrawal by Subject|1
1481222|NCT00603746|4882213|P3|Overall Study|Withdrawal by Subject|0
1481223|NCT00603746|4882214|P2|Overall Study|Withdrawal by Subject|0
1481224|NCT00603746|4882215|P1|Overall Study|Withdrawal by Subject|1
1481225|NCT00603746|4882210|P6|Overall Study|Physician Decision|0
1481226|NCT00603746|4882211|P5|Overall Study|Physician Decision|1
1481227|NCT00603746|4882212|P4|Overall Study|Physician Decision|0
1481228|NCT00603746|4882213|P3|Overall Study|Physician Decision|0
1481229|NCT00603746|4882214|P2|Overall Study|Physician Decision|0
1481230|NCT00603746|4882215|P1|Overall Study|Physician Decision|1
1481231|NCT00603746|4882210|P6|Overall Study|Lost to Follow-up|0
1481232|NCT00603746|4882211|P5|Overall Study|Lost to Follow-up|0
1481233|NCT00603746|4882212|P4|Overall Study|Lost to Follow-up|0
1481234|NCT00603746|4882213|P3|Overall Study|Lost to Follow-up|1
1481235|NCT00603746|4882214|P2|Overall Study|Lost to Follow-up|1
1481236|NCT00603746|4882215|P1|Overall Study|Lost to Follow-up|0
1481237|NCT00603746|4882210|P6|Overall Study|Protocol Violation|0
1481238|NCT00603746|4882211|P5|Overall Study|Protocol Violation|1
1481239|NCT00603746|4882212|P4|Overall Study|Protocol Violation|0
1481240|NCT00603746|4882213|P3|Overall Study|Protocol Violation|1
1481241|NCT00603746|4882214|P2|Overall Study|Protocol Violation|3
1481242|NCT00603746|4882215|P1|Overall Study|Protocol Violation|0
1481243|NCT00603746|4882210|P6|Overall Study|Lack of Efficacy|8
1481244|NCT00603746|4882211|P5|Overall Study|Lack of Efficacy|12
1481245|NCT00603746|4882212|P4|Overall Study|Lack of Efficacy|11
1481246|NCT00603746|4882213|P3|Overall Study|Lack of Efficacy|6
1481247|NCT00603746|4882214|P2|Overall Study|Lack of Efficacy|11
1481248|NCT00603746|4882215|P1|Overall Study|Lack of Efficacy|34
1481249|NCT00603746|4882210|P6|Overall Study|Adverse Event|4
1481250|NCT00603746|4882211|P5|Overall Study|Adverse Event|0
1481251|NCT00603746|4882212|P4|Overall Study|Adverse Event|1
1481252|NCT00603746|4882213|P3|Overall Study|Adverse Event|0
1481253|NCT00603746|4882214|P2|Overall Study|Adverse Event|3
1481254|NCT00603746|4882215|P1|Overall Study|Adverse Event|2
1481255|NCT00603733|4882363|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
1481256|NCT00603733|4882364|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
1481257|NCT00603733|4882363|P2|Maintenance Phase ITT|Physician Decision|1
1481258|NCT00603733|4882364|P1|Maintenance Phase ITT|Physician Decision|0
1481259|NCT00603733|4882363|P2|Maintenance Phase ITT|Lack of Efficacy|2
1481260|NCT00603733|4882364|P1|Maintenance Phase ITT|Lack of Efficacy|2
1481261|NCT00603733|4882363|P2|Maintenance Phase ITT|Lost to Follow-up|1
1481262|NCT00603733|4882364|P1|Maintenance Phase ITT|Lost to Follow-up|0
1481263|NCT00603733|4882363|P2|Maintenance Phase ITT|Protocol Violation|1
1481264|NCT00603733|4882364|P1|Maintenance Phase ITT|Protocol Violation|1
1481265|NCT00603733|4882363|P2|Maintenance Phase ITT|Withdrawal by Subject|0
1481266|NCT00603733|4882364|P1|Maintenance Phase ITT|Withdrawal by Subject|1
1481267|NCT00603733|4882363|P2|Maintenance Phase ITT|Adverse Event|6
1481268|NCT00603733|4882364|P1|Maintenance Phase ITT|Adverse Event|3
1481269|NCT00603733|4882363|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
1481270|NCT00603733|4882364|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
1481271|NCT00603733|4882363|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
1481272|NCT00603733|4882364|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
1481273|NCT00603733|4882363|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
1481274|NCT00603733|4882364|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
1481275|NCT00603733|4882363|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
1481276|NCT00603733|4882364|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
1481277|NCT00603733|4882363|P2|Run-In Phase - 4 Weeks|Adverse Event|1
1481278|NCT00603733|4882364|P1|Run-In Phase - 4 Weeks|Adverse Event|2
1481279|NCT00603733|4882363|P2|Active Phase ITT|Subject moved, site closed|1
1481280|NCT00603733|4882364|P1|Active Phase ITT|Subject moved, site closed|1
1481281|NCT00603733|4882363|P2|Active Phase ITT|Lack of Efficacy|2
1481282|NCT00603733|4882364|P1|Active Phase ITT|Lack of Efficacy|1
1481283|NCT00603733|4882363|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
1481284|NCT00603733|4882364|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
1481285|NCT00603733|4882363|P2|Active Phase ITT|Lost to Follow-up|1
1481286|NCT00603733|4882364|P1|Active Phase ITT|Lost to Follow-up|0
1481287|NCT00603733|4882363|P2|Active Phase ITT|Withdrawal by Subject|3
1481288|NCT00603733|4882364|P1|Active Phase ITT|Withdrawal by Subject|0
1481289|NCT00603733|4882363|P2|Active Phase ITT|Adverse Event|7
1481290|NCT00603733|4882364|P1|Active Phase ITT|Adverse Event|8
1481291|NCT00603590|4882393|P2|Overall Study|Cardiovascular event|1
1481292|NCT00603590|4882394|P1|Overall Study|Cardiovascular event|0
1481293|NCT00603590|4882393|P2|Overall Study|Lost to Follow-up|4
1481294|NCT00603590|4882394|P1|Overall Study|Lost to Follow-up|8
1481295|NCT00603590|4882393|P2|Overall Study|Adverse Event|0
1481296|NCT00603590|4882394|P1|Overall Study|Adverse Event|2
1481297|NCT00603590|4882393|P2|Overall Study|Patient discontinued study drug|15
1481298|NCT00603590|4882394|P1|Overall Study|Patient discontinued study drug|22
1481299|NCT00603590|4882393|P2|Overall Study|Refused blood test|1
1481300|NCT00603590|4882394|P1|Overall Study|Refused blood test|5
1481301|NCT00603590|4882393|P2|Overall Study|Did not attend study clinic|30
1481302|NCT00603590|4882394|P1|Overall Study|Did not attend study clinic|39
1481303|NCT00603538|4882418|P3|Overall Study|Objective progression or relapse|0
1481304|NCT00603538|4882419|P2|Overall Study|Objective progression or relapse|0
1481305|NCT00603538|4882420|P1|Overall Study|Objective progression or relapse|3
1481306|NCT00603538|4882418|P3|Overall Study|Adverse Event|2
1481307|NCT00603538|4882419|P2|Overall Study|Adverse Event|4
1481308|NCT00603538|4882420|P1|Overall Study|Adverse Event|0
1481309|NCT00603525|4882460|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
1481310|NCT00603525|4882461|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
1481311|NCT00603525|4882462|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
1481312|NCT00603525|4882460|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
1481313|NCT00603525|4882461|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
1481314|NCT00603525|4882462|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
1481315|NCT00603525|4882460|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
1481316|NCT00603525|4882461|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
1481317|NCT00603525|4882462|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
1481318|NCT00603525|4882460|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
1481319|NCT00603525|4882461|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
1481320|NCT00603525|4882462|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
1481321|NCT00603525|4882460|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
1481322|NCT00603525|4882461|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
1481323|NCT00603525|4882462|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
1481324|NCT00603525|4882460|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
1481325|NCT00603525|4882461|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
1481326|NCT00603525|4882462|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
1481327|NCT00603525|4882460|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
1481328|NCT00603525|4882461|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
1481329|NCT00603525|4882462|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
1481330|NCT00603525|4882460|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
1481331|NCT00603525|4882461|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
1481332|NCT00603525|4882462|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
1481333|NCT00603525|4882460|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
1481334|NCT00603525|4882461|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
1481335|NCT00603525|4882462|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
1481336|NCT00603525|4882460|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
1481337|NCT00603525|4882461|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
1481338|NCT00603525|4882462|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
1481339|NCT00603525|4882460|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
1481340|NCT00603525|4882461|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
1481341|NCT00603525|4882462|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
1481342|NCT00603525|4882460|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
1481343|NCT00603525|4882461|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
1481344|NCT00603525|4882462|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
1481345|NCT00603525|4882460|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
1481346|NCT00603525|4882461|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
1481347|NCT00603525|4882462|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
1481348|NCT00603525|4882460|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
1481349|NCT00603525|4882461|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
1481350|NCT00603525|4882462|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
1481351|NCT00603525|4882460|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
1481352|NCT00603525|4882461|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
1481353|NCT00603525|4882462|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
1481354|NCT00603512|4882594|P5|Overall Study|Randomized but not treated|0
1481355|NCT00603512|4882595|P4|Overall Study|Randomized but not treated|2
1481356|NCT00603512|4882596|P3|Overall Study|Randomized but not treated|1
1481357|NCT00603512|4882597|P2|Overall Study|Randomized but not treated|1
1481358|NCT00603512|4882598|P1|Overall Study|Randomized but not treated|0
1481359|NCT00603512|4882594|P5|Overall Study|Withdrawal by Subject|1
1481360|NCT00603512|4882595|P4|Overall Study|Withdrawal by Subject|0
1481361|NCT00603512|4882596|P3|Overall Study|Withdrawal by Subject|0
1481362|NCT00603512|4882597|P2|Overall Study|Withdrawal by Subject|0
1481363|NCT00603512|4882598|P1|Overall Study|Withdrawal by Subject|0
1481364|NCT00603512|4882594|P5|Overall Study|Other|1
1481365|NCT00603512|4882595|P4|Overall Study|Other|1
1481366|NCT00603512|4882596|P3|Overall Study|Other|0
1481367|NCT00603512|4882597|P2|Overall Study|Other|1
1481368|NCT00603512|4882598|P1|Overall Study|Other|2
1481369|NCT00603512|4882594|P5|Overall Study|Lack of Efficacy|1
1481370|NCT00603512|4882595|P4|Overall Study|Lack of Efficacy|0
1481371|NCT00603512|4882596|P3|Overall Study|Lack of Efficacy|0
1481372|NCT00603512|4882597|P2|Overall Study|Lack of Efficacy|1
1481373|NCT00603512|4882598|P1|Overall Study|Lack of Efficacy|0
1481374|NCT00603512|4882594|P5|Overall Study|Adverse Event|2
1481375|NCT00603512|4882595|P4|Overall Study|Adverse Event|4
1481376|NCT00603512|4882596|P3|Overall Study|Adverse Event|4
1481377|NCT00603512|4882597|P2|Overall Study|Adverse Event|2
1481378|NCT00603512|4882598|P1|Overall Study|Adverse Event|0
1481379|NCT00603473|4882740|P1|Overall Study|Protocol Violation|1
1481380|NCT00603473|4882740|P1|Overall Study|Lack of Efficacy|4
1481381|NCT00603473|4882740|P1|Overall Study|Adverse Event|4
1481382|NCT00603447|4882753|P7|Overall Study|Withdrew Consent|1
1481383|NCT00603447|4882754|P6|Overall Study|Withdrew Consent|0
1481384|NCT00603447|4882755|P5|Overall Study|Withdrew Consent|1
1481385|NCT00603447|4882756|P4|Overall Study|Withdrew Consent|0
1481386|NCT00603447|4882757|P3|Overall Study|Withdrew Consent|0
1481387|NCT00603447|4882758|P2|Overall Study|Withdrew Consent|2
1481388|NCT00603447|4882759|P1|Overall Study|Withdrew Consent|0
1481389|NCT00603447|4882753|P7|Overall Study|Other|13
1481390|NCT00603447|4882754|P6|Overall Study|Other|0
1481391|NCT00603447|4882755|P5|Overall Study|Other|3
1481392|NCT00603447|4882756|P4|Overall Study|Other|0
1481393|NCT00603447|4882757|P3|Overall Study|Other|1
1481394|NCT00603447|4882758|P2|Overall Study|Other|0
1481395|NCT00603447|4882759|P1|Overall Study|Other|0
1481396|NCT00603447|4882753|P7|Overall Study|Adverse Event|10
1481397|NCT00603447|4882754|P6|Overall Study|Adverse Event|2
1481398|NCT00603447|4882755|P5|Overall Study|Adverse Event|1
1481399|NCT00603447|4882756|P4|Overall Study|Adverse Event|2
1481400|NCT00603447|4882757|P3|Overall Study|Adverse Event|1
1481401|NCT00603447|4882758|P2|Overall Study|Adverse Event|1
1481402|NCT00603447|4882759|P1|Overall Study|Adverse Event|0
1481403|NCT00603382|4882798|P6|Overall Study|Withdrawal by Subject|1
1481404|NCT00603382|4882799|P5|Overall Study|Withdrawal by Subject|0
1481405|NCT00603382|4882800|P4|Overall Study|Withdrawal by Subject|1
1481406|NCT00603382|4882801|P3|Overall Study|Withdrawal by Subject|1
1481407|NCT00603382|4882802|P2|Overall Study|Withdrawal by Subject|3
1481408|NCT00603382|4882803|P1|Overall Study|Withdrawal by Subject|3
1481409|NCT00603382|4882798|P6|Overall Study|Physician Decision|3
1481410|NCT00603382|4882799|P5|Overall Study|Physician Decision|1
1481411|NCT00603382|4882800|P4|Overall Study|Physician Decision|0
1481412|NCT00603382|4882801|P3|Overall Study|Physician Decision|2
1481413|NCT00603382|4882802|P2|Overall Study|Physician Decision|0
1481414|NCT00603382|4882803|P1|Overall Study|Physician Decision|0
1481415|NCT00603382|4882798|P6|Overall Study|Lost to Follow-up|1
1481416|NCT00603382|4882799|P5|Overall Study|Lost to Follow-up|0
1481417|NCT00603382|4882800|P4|Overall Study|Lost to Follow-up|1
1481418|NCT00603382|4882801|P3|Overall Study|Lost to Follow-up|1
1481419|NCT00603382|4882802|P2|Overall Study|Lost to Follow-up|1
1481420|NCT00603382|4882803|P1|Overall Study|Lost to Follow-up|0
1481421|NCT00603382|4882798|P6|Overall Study|Protocol Violation|0
1481422|NCT00603382|4882799|P5|Overall Study|Protocol Violation|1
1481423|NCT00603382|4882800|P4|Overall Study|Protocol Violation|2
1481424|NCT00603382|4882801|P3|Overall Study|Protocol Violation|1
1481425|NCT00603382|4882802|P2|Overall Study|Protocol Violation|0
1481426|NCT00603382|4882803|P1|Overall Study|Protocol Violation|1
1481427|NCT00603382|4882798|P6|Overall Study|Lack of Efficacy|11
1481428|NCT00603382|4882799|P5|Overall Study|Lack of Efficacy|6
1481429|NCT00603382|4882800|P4|Overall Study|Lack of Efficacy|6
1481430|NCT00603382|4882801|P3|Overall Study|Lack of Efficacy|3
1481431|NCT00603382|4882802|P2|Overall Study|Lack of Efficacy|9
1481432|NCT00603382|4882803|P1|Overall Study|Lack of Efficacy|14
1481433|NCT00603382|4882798|P6|Overall Study|Adverse Event|2
1481434|NCT00603382|4882799|P5|Overall Study|Adverse Event|1
1481435|NCT00603382|4882800|P4|Overall Study|Adverse Event|2
1481436|NCT00603382|4882801|P3|Overall Study|Adverse Event|1
1481437|NCT00603382|4882802|P2|Overall Study|Adverse Event|1
1481438|NCT00603382|4882803|P1|Overall Study|Adverse Event|0
1481439|NCT00603304|4882951|P2|Overall Study|Patient Decision|0
1481440|NCT00603304|4882952|P1|Overall Study|Patient Decision|2
1481441|NCT00603304|4882951|P2|Overall Study|Not Specified|0
1481442|NCT00603304|4882952|P1|Overall Study|Not Specified|2
1481443|NCT00603304|4882951|P2|Overall Study|Moved Away|2
1481444|NCT00603304|4882952|P1|Overall Study|Moved Away|0
1481445|NCT00603304|4882951|P2|Overall Study|Non-Compliant|1
1481446|NCT00603304|4882952|P1|Overall Study|Non-Compliant|0
1481447|NCT00603304|4882951|P2|Overall Study|Exclusionary Medication|3
1481448|NCT00603304|4882952|P1|Overall Study|Exclusionary Medication|2
1481449|NCT00603304|4882951|P2|Overall Study|Crossed Over to Open Label Therapy|3
1481450|NCT00603304|4882952|P1|Overall Study|Crossed Over to Open Label Therapy|3
1481451|NCT00603304|4882951|P2|Overall Study|Unacceptable Treatment Toxicity|8
1481452|NCT00603304|4882952|P1|Overall Study|Unacceptable Treatment Toxicity|5
1481453|NCT00603304|4882951|P2|Overall Study|Adverse Event|2
1481454|NCT00603304|4882952|P1|Overall Study|Adverse Event|4
1481455|NCT00603304|4882951|P2|Overall Study|Protocol Violation|0
1481456|NCT00603304|4882952|P1|Overall Study|Protocol Violation|1
1481457|NCT00603304|4882951|P2|Overall Study|Withdrawal by Subject|5
1481458|NCT00603304|4882952|P1|Overall Study|Withdrawal by Subject|8
1481459|NCT00603304|4882951|P2|Overall Study|Lost to Follow-up|7
1481460|NCT00603304|4882952|P1|Overall Study|Lost to Follow-up|5
1481461|NCT00603278|4883008|P6|Overall Study|Lost to Follow-up|0
1481462|NCT00603278|4883009|P5|Overall Study|Lost to Follow-up|1
1481463|NCT00603278|4883010|P4|Overall Study|Lost to Follow-up|0
1481464|NCT00603278|4883011|P3|Overall Study|Lost to Follow-up|0
1481465|NCT00603278|4883012|P2|Overall Study|Lost to Follow-up|0
1481466|NCT00603278|4883013|P1|Overall Study|Lost to Follow-up|1
1481467|NCT00603278|4883008|P6|Overall Study|Physician Decision|1
1481468|NCT00603278|4883009|P5|Overall Study|Physician Decision|2
1481469|NCT00603278|4883010|P4|Overall Study|Physician Decision|0
1481470|NCT00603278|4883011|P3|Overall Study|Physician Decision|0
1481471|NCT00603278|4883012|P2|Overall Study|Physician Decision|1
1481472|NCT00603278|4883013|P1|Overall Study|Physician Decision|0
1481473|NCT00603278|4883008|P6|Overall Study|Protocol Violation|1
1481474|NCT00603278|4883009|P5|Overall Study|Protocol Violation|0
1481475|NCT00603278|4883010|P4|Overall Study|Protocol Violation|1
1481476|NCT00603278|4883011|P3|Overall Study|Protocol Violation|1
1481477|NCT00603278|4883012|P2|Overall Study|Protocol Violation|0
1481478|NCT00603278|4883013|P1|Overall Study|Protocol Violation|3
1481479|NCT00603278|4883008|P6|Overall Study|Withdrawal by Subject|2
1481480|NCT00603278|4883009|P5|Overall Study|Withdrawal by Subject|1
1481481|NCT00603278|4883010|P4|Overall Study|Withdrawal by Subject|2
1481482|NCT00603278|4883011|P3|Overall Study|Withdrawal by Subject|1
1481483|NCT00603278|4883012|P2|Overall Study|Withdrawal by Subject|3
1481484|NCT00603278|4883013|P1|Overall Study|Withdrawal by Subject|2
1481485|NCT00603278|4883008|P6|Overall Study|Adverse Event|1
1481486|NCT00603278|4883009|P5|Overall Study|Adverse Event|2
1481487|NCT00603278|4883010|P4|Overall Study|Adverse Event|0
1481488|NCT00603278|4883011|P3|Overall Study|Adverse Event|1
1481489|NCT00603278|4883012|P2|Overall Study|Adverse Event|3
1481490|NCT00603278|4883013|P1|Overall Study|Adverse Event|0
1481491|NCT00603278|4883008|P6|Overall Study|Lack of Efficacy|14
1481492|NCT00603278|4883009|P5|Overall Study|Lack of Efficacy|7
1481493|NCT00603278|4883010|P4|Overall Study|Lack of Efficacy|8
1481494|NCT00603278|4883011|P3|Overall Study|Lack of Efficacy|11
1481495|NCT00603278|4883012|P2|Overall Study|Lack of Efficacy|10
1481496|NCT00603278|4883013|P1|Overall Study|Lack of Efficacy|35
1481497|NCT00603265|4883162|P3|Overall Study|Protocol Violation|0
1481498|NCT00603265|4883163|P2|Overall Study|Protocol Violation|0
1481499|NCT00603265|4883164|P1|Overall Study|Protocol Violation|1
1481500|NCT00603265|4883162|P3|Overall Study|Participant Left Country, No Responses|0
1481501|NCT00603265|4883163|P2|Overall Study|Participant Left Country, No Responses|1
1481502|NCT00603265|4883164|P1|Overall Study|Participant Left Country, No Responses|0
1481503|NCT00603265|4883162|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
1481504|NCT00603265|4883163|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
1481505|NCT00603265|4883164|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
1481506|NCT00603265|4883162|P3|Overall Study|Lost to Follow-up|0
1481507|NCT00603265|4883163|P2|Overall Study|Lost to Follow-up|1
1481508|NCT00603265|4883164|P1|Overall Study|Lost to Follow-up|0
1481509|NCT00603265|4883162|P3|Overall Study|Lack of Efficacy|3
1481510|NCT00603265|4883163|P2|Overall Study|Lack of Efficacy|0
1481511|NCT00603265|4883164|P1|Overall Study|Lack of Efficacy|3
1481512|NCT00603265|4883162|P3|Overall Study|Withdrawal by Subject|1
1481513|NCT00603265|4883163|P2|Overall Study|Withdrawal by Subject|2
1481514|NCT00603265|4883164|P1|Overall Study|Withdrawal by Subject|1
1481515|NCT00603265|4883162|P3|Overall Study|Adverse Event|1
1481516|NCT00603265|4883163|P2|Overall Study|Adverse Event|11
1481517|NCT00603265|4883164|P1|Overall Study|Adverse Event|2
1481518|NCT00603239|4883192|P2|Overall Study|Subject decision|1
1481519|NCT00603239|4883193|P1|Overall Study|Subject decision|2
1481520|NCT00603239|4883192|P2|Overall Study|Protocol Violation|0
1481521|NCT00603239|4883193|P1|Overall Study|Protocol Violation|2
1481522|NCT00603239|4883192|P2|Overall Study|Physician Decision|0
1481523|NCT00603239|4883193|P1|Overall Study|Physician Decision|2
1481524|NCT00603239|4883192|P2|Overall Study|Lost to Follow-up|1
1481525|NCT00603239|4883193|P1|Overall Study|Lost to Follow-up|2
1481526|NCT00603239|4883192|P2|Overall Study|Loss of glucose control|0
1481527|NCT00603239|4883193|P1|Overall Study|Loss of glucose control|3
1481528|NCT00603239|4883192|P2|Overall Study|Entry criteria not met|1
1481529|NCT00603239|4883193|P1|Overall Study|Entry criteria not met|0
1481530|NCT00603239|4883192|P2|Overall Study|Adverse Event|1
1481531|NCT00603239|4883193|P1|Overall Study|Adverse Event|4
1481532|NCT00602979|4883254|P5|Overall Study|Failed Intubation|0
1481533|NCT00602979|4883255|P4|Overall Study|Failed Intubation|1
1481534|NCT00602979|4883256|P3|Overall Study|Failed Intubation|0
1481535|NCT00602979|4883257|P2|Overall Study|Failed Intubation|1
1481536|NCT00602979|4883258|P1|Overall Study|Failed Intubation|0
1481537|NCT00602979|4883254|P5|Overall Study|Lost to Follow-up|3
1481538|NCT00602979|4883255|P4|Overall Study|Lost to Follow-up|2
1481539|NCT00602979|4883256|P3|Overall Study|Lost to Follow-up|3
1481540|NCT00602979|4883257|P2|Overall Study|Lost to Follow-up|2
1481541|NCT00602979|4883258|P1|Overall Study|Lost to Follow-up|3
1481542|NCT00602927|4883308|P2|Period 3: 13 Days|MRI data quality|2
1481543|NCT00602927|4883309|P1|Period 3: 13 Days|MRI data quality|2
1481544|NCT00602927|4883308|P2|Period 3: 13 Days|Protocol Violation|1
1481545|NCT00602927|4883309|P1|Period 3: 13 Days|Protocol Violation|0
1481546|NCT00602927|4883308|P2|Period 2: 14 Days|Protocol Violation|2
1481547|NCT00602927|4883309|P1|Period 2: 14 Days|Protocol Violation|0
1481548|NCT00602927|4883308|P2|Period 1: 13 Days|Claustrophobia|1
1481549|NCT00602927|4883309|P1|Period 1: 13 Days|Claustrophobia|0
1481550|NCT00602927|4883308|P2|Period 1: 13 Days|Time|0
1481551|NCT00602927|4883309|P1|Period 1: 13 Days|Time|1
1481552|NCT00602927|4883308|P2|Period 1: 13 Days|MRI scanner technical issue|0
1481553|NCT00602927|4883309|P1|Period 1: 13 Days|MRI scanner technical issue|1
1481554|NCT00602927|4883308|P2|Period 1: 13 Days|Protocol Violation|4
1481555|NCT00602927|4883309|P1|Period 1: 13 Days|Protocol Violation|2
1481556|NCT00602797|4883321|P1|Overall Study|Adverse Event|1
1481557|NCT00602641|4883338|P2|Overall Study|Other|1
1481558|NCT00602641|4883339|P1|Overall Study|Other|3
1481559|NCT00602641|4883338|P2|Overall Study|Administrative Closure|1
1481560|NCT00602641|4883339|P1|Overall Study|Administrative Closure|1
1481561|NCT00602641|4883338|P2|Overall Study|Physician Decision|4
1481562|NCT00602641|4883339|P1|Overall Study|Physician Decision|5
1481563|NCT00602641|4883338|P2|Overall Study|Other Complicating Disease|2
1481564|NCT00602641|4883339|P1|Overall Study|Other Complicating Disease|5
1481565|NCT00602641|4883338|P2|Overall Study|Alternative therapy|2
1481566|NCT00602641|4883339|P1|Overall Study|Alternative therapy|5
1481567|NCT00602641|4883338|P2|Overall Study|Withdrawal by Subject|12
1481568|NCT00602641|4883339|P1|Overall Study|Withdrawal by Subject|15
1481569|NCT00602641|4883338|P2|Overall Study|Death|5
1481570|NCT00602641|4883339|P1|Overall Study|Death|6
1481571|NCT00602641|4883338|P2|Overall Study|Disease progression|55
1481572|NCT00602641|4883339|P1|Overall Study|Disease progression|38
1481573|NCT00602641|4883338|P2|Overall Study|Adverse Event|53
1481574|NCT00602641|4883339|P1|Overall Study|Adverse Event|62
1481575|NCT00602641|4883338|P2|Overall Study|Still on treatment at time of analysis|15
1481576|NCT00602641|4883339|P1|Overall Study|Still on treatment at time of analysis|8
1481577|NCT00602641|4883338|P2|Overall Study|Never started protocol therapy|2
1481578|NCT00602641|4883339|P1|Overall Study|Never started protocol therapy|6
1481579|NCT00602537|4883353|P2|Follow Up Study Comparison|Withdrawal by Subject|2
1481580|NCT00602537|4883354|P1|Follow Up Study Comparison|Withdrawal by Subject|2
1481581|NCT00602537|4883353|P2|Follow Up Study Comparison|Lost to Follow-up|1
1481582|NCT00602537|4883354|P1|Follow Up Study Comparison|Lost to Follow-up|8
1481583|NCT00602537|4883353|P2|Follow Up Study Comparison|Adverse Event|0
1481584|NCT00602537|4883354|P1|Follow Up Study Comparison|Adverse Event|1
1481585|NCT00602537|4883353|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
1481586|NCT00602537|4883354|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
1481587|NCT00602537|4883353|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
1481588|NCT00602537|4883354|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
1481589|NCT00602537|4883353|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
1481590|NCT00602537|4883354|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
1481591|NCT00602537|4883353|P2|12 Week Double Blind Comparison|Adverse Event|5
1481592|NCT00602537|4883354|P1|12 Week Double Blind Comparison|Adverse Event|2
1481593|NCT00602472|4883364|P2|Overall Study|Other incl. lack of efficacy|2
1481594|NCT00602472|4883365|P1|Overall Study|Other incl. lack of efficacy|4
1481595|NCT00602472|4883364|P2|Overall Study|Withdrawal by Subject|14
1481596|NCT00602472|4883365|P1|Overall Study|Withdrawal by Subject|8
1481597|NCT00602472|4883364|P2|Overall Study|Protocol Violation|19
1481598|NCT00602472|4883365|P1|Overall Study|Protocol Violation|4
1481599|NCT00602472|4883364|P2|Overall Study|Adverse Event|23
1481600|NCT00602472|4883365|P1|Overall Study|Adverse Event|5
1481601|NCT00602420|4883425|P2|Overall Study|Adverse Event|0
1481602|NCT00602420|4883426|P1|Overall Study|Adverse Event|1
1481603|NCT00602420|4883425|P2|Overall Study|Withdrawal by Subject|17
1481604|NCT00602420|4883426|P1|Overall Study|Withdrawal by Subject|18
1481605|NCT00602420|4883425|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
1481606|NCT00602420|4883426|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
1481607|NCT00602420|4883425|P2|Overall Study|Death|4
1481608|NCT00602420|4883426|P1|Overall Study|Death|1
1481609|NCT00601900|4883534|P2|Overall Study|Withdrawal by Subject|3
1481610|NCT00601900|4883535|P1|Overall Study|Withdrawal by Subject|0
1481611|NCT00601835|4883551|P2|Overall Study|Relocate|2
1481612|NCT00601835|4883552|P1|Overall Study|Relocate|12
1481613|NCT00601835|4883551|P2|Overall Study|Adverse Event|1
1481614|NCT00601835|4883552|P1|Overall Study|Adverse Event|1
1481615|NCT00601835|4883551|P2|Overall Study|Lost to Follow-up|5
1481616|NCT00601835|4883552|P1|Overall Study|Lost to Follow-up|37
1481617|NCT00601835|4883551|P2|Overall Study|Physician Decision|0
1481618|NCT00601835|4883552|P1|Overall Study|Physician Decision|1
1481619|NCT00601835|4883551|P2|Overall Study|Withdrawal by Subject|6
1481620|NCT00601835|4883552|P1|Overall Study|Withdrawal by Subject|9
1481621|NCT00601640|4883644|P3|Overall Study|change in eligibility status|1
1481622|NCT00601640|4883645|P2|Overall Study|change in eligibility status|1
1481623|NCT00601640|4883646|P1|Overall Study|change in eligibility status|0
1481624|NCT00601640|4883644|P3|Overall Study|intercurrent illness|0
1481625|NCT00601640|4883645|P2|Overall Study|intercurrent illness|0
1481626|NCT00601640|4883646|P1|Overall Study|intercurrent illness|1
1481627|NCT00601640|4883644|P3|Overall Study|Adverse Event|2
1481628|NCT00601640|4883645|P2|Overall Study|Adverse Event|4
1481629|NCT00601640|4883646|P1|Overall Study|Adverse Event|0
1481630|NCT00601640|4883644|P3|Overall Study|Death|0
1481631|NCT00601640|4883645|P2|Overall Study|Death|0
1481632|NCT00601640|4883646|P1|Overall Study|Death|1
1481633|NCT00601640|4883644|P3|Overall Study|Withdrawal by Subject|7
1481634|NCT00601640|4883645|P2|Overall Study|Withdrawal by Subject|0
1481635|NCT00601640|4883646|P1|Overall Study|Withdrawal by Subject|3
1481636|NCT00601523|4883671|P2|Overall Study|not specified|1
1481637|NCT00601523|4883672|P1|Overall Study|not specified|9
1481638|NCT00601523|4883671|P2|Overall Study|Withdrawal by Subject|9
1481639|NCT00601523|4883672|P1|Overall Study|Withdrawal by Subject|18
1481640|NCT00601523|4883671|P2|Overall Study|Lost to Follow-up|1
1481641|NCT00601523|4883672|P1|Overall Study|Lost to Follow-up|0
1481642|NCT00601523|4883671|P2|Overall Study|Protocol Violation|1
1481643|NCT00601523|4883672|P1|Overall Study|Protocol Violation|5
1481644|NCT00601523|4883671|P2|Overall Study|Lack of Efficacy|0
1481645|NCT00601523|4883672|P1|Overall Study|Lack of Efficacy|3
1481646|NCT00601523|4883671|P2|Overall Study|Adverse Event|14
1481647|NCT00601523|4883672|P1|Overall Study|Adverse Event|42
1481648|NCT00601458|4883707|P3|Overall Study|Early Termination|1
1481649|NCT00601458|4883708|P2|Overall Study|Early Termination|1
1481650|NCT00601458|4883709|P1|Overall Study|Early Termination|0
1481651|NCT00601458|4883707|P3|Overall Study|Protocol Violation|1
1481652|NCT00601458|4883708|P2|Overall Study|Protocol Violation|2
1481653|NCT00601458|4883709|P1|Overall Study|Protocol Violation|3
1481654|NCT00601458|4883707|P3|Overall Study|Incomplete Data|0
1481655|NCT00601458|4883708|P2|Overall Study|Incomplete Data|2
1481656|NCT00601458|4883709|P1|Overall Study|Incomplete Data|0
1481657|NCT00601458|4883707|P3|Overall Study|Dosing Error|0
1481658|NCT00601458|4883708|P2|Overall Study|Dosing Error|0
1481659|NCT00601458|4883709|P1|Overall Study|Dosing Error|1
1481660|NCT00601419|4883720|P1|Overall Study|Missed Visits|1
1481661|NCT00601419|4883720|P1|Overall Study|Lost to Follow-up|3
1481662|NCT00601354|4883750|P2|Overall Study|Lost to Follow-up|5
1481663|NCT00601354|4883751|P1|Overall Study|Lost to Follow-up|4
1481664|NCT00601250|4883763|P2|Overall Study|Other incl. lack of efficacy|9
1481665|NCT00601250|4883764|P1|Overall Study|Other incl. lack of efficacy|2
1481666|NCT00601250|4883763|P2|Overall Study|Withdrawal by Subject|13
1481667|NCT00601250|4883764|P1|Overall Study|Withdrawal by Subject|4
1481668|NCT00601250|4883763|P2|Overall Study|Lost to Follow-up|6
1481669|NCT00601250|4883764|P1|Overall Study|Lost to Follow-up|2
1481670|NCT00601250|4883763|P2|Overall Study|Protocol Violation|2
1481671|NCT00601250|4883764|P1|Overall Study|Protocol Violation|3
1481672|NCT00601250|4883763|P2|Overall Study|Adverse Event|9
1481673|NCT00601250|4883764|P1|Overall Study|Adverse Event|3
1481674|NCT00601172|4883800|P2|Overall Study|Did not meet continuation criteria|20
1481675|NCT00601172|4883801|P1|Overall Study|Did not meet continuation criteria|19
1481676|NCT00601172|4883800|P2|Overall Study|Withdrawal by Subject|27
1481677|NCT00601172|4883801|P1|Overall Study|Withdrawal by Subject|35
1481678|NCT00601172|4883800|P2|Overall Study|Physician Decision|28
1481679|NCT00601172|4883801|P1|Overall Study|Physician Decision|27
1481680|NCT00601172|4883800|P2|Overall Study|Lost to Follow-up|3
1481681|NCT00601172|4883801|P1|Overall Study|Lost to Follow-up|4
1481682|NCT00601172|4883800|P2|Overall Study|Protocol Violation|5
1481683|NCT00601172|4883801|P1|Overall Study|Protocol Violation|2
1481684|NCT00601172|4883800|P2|Overall Study|Lack of Efficacy|12
1481685|NCT00601172|4883801|P1|Overall Study|Lack of Efficacy|11
1481686|NCT00601172|4883800|P2|Overall Study|Adverse Event|32
1481687|NCT00601172|4883801|P1|Overall Study|Adverse Event|43
1481688|NCT00601107|4883858|P4|Overall Study|Undefined|0
1481689|NCT00601107|4883859|P3|Overall Study|Undefined|1
1481690|NCT00601107|4883860|P2|Overall Study|Undefined|0
1481691|NCT00601107|4883861|P1|Overall Study|Undefined|1
1481692|NCT00601107|4883858|P4|Overall Study|Worsening of Psoriasis|4
1481693|NCT00601107|4883859|P3|Overall Study|Worsening of Psoriasis|1
1481694|NCT00601107|4883860|P2|Overall Study|Worsening of Psoriasis|1
1481695|NCT00601107|4883861|P1|Overall Study|Worsening of Psoriasis|4
1481696|NCT00601107|4883858|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
1481697|NCT00601107|4883859|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
1481698|NCT00601107|4883860|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
1481699|NCT00601107|4883861|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
1481700|NCT00601107|4883858|P4|Overall Study|Lost to Follow-up|3
1481701|NCT00601107|4883859|P3|Overall Study|Lost to Follow-up|0
1481702|NCT00601107|4883860|P2|Overall Study|Lost to Follow-up|3
1481703|NCT00601107|4883861|P1|Overall Study|Lost to Follow-up|3
1481704|NCT00601107|4883858|P4|Overall Study|Withdrawal by Subject|4
1481705|NCT00601107|4883859|P3|Overall Study|Withdrawal by Subject|7
1481706|NCT00601107|4883860|P2|Overall Study|Withdrawal by Subject|4
1481707|NCT00601107|4883861|P1|Overall Study|Withdrawal by Subject|5
1481708|NCT00601107|4883858|P4|Overall Study|Adverse Event|0
1481709|NCT00601107|4883859|P3|Overall Study|Adverse Event|3
1481710|NCT00601107|4883860|P2|Overall Study|Adverse Event|1
1481711|NCT00601107|4883861|P1|Overall Study|Adverse Event|0
1481712|NCT00600938|4883881|P4|Extension Study|Death|0
1481713|NCT00600938|4883882|P3|Extension Study|Death|0
1481714|NCT00600938|4883883|P2|Extension Study|Death|0
1481715|NCT00600938|4883884|P1|Extension Study|Death|1
1481716|NCT00600938|4883881|P4|Extension Study|Lost to Follow-up|0
1481717|NCT00600938|4883882|P3|Extension Study|Lost to Follow-up|2
1481718|NCT00600938|4883883|P2|Extension Study|Lost to Follow-up|1
1481719|NCT00600938|4883884|P1|Extension Study|Lost to Follow-up|1
1481720|NCT00600938|4883881|P4|Extension Study|Withdrawal by Subject|0
1481721|NCT00600938|4883882|P3|Extension Study|Withdrawal by Subject|3
1481722|NCT00600938|4883883|P2|Extension Study|Withdrawal by Subject|2
1481723|NCT00600938|4883884|P1|Extension Study|Withdrawal by Subject|2
1481724|NCT00600938|4883881|P4|Extension Study|Unsatisfactory therapeutic effect|0
1481725|NCT00600938|4883882|P3|Extension Study|Unsatisfactory therapeutic effect|1
1481726|NCT00600938|4883883|P2|Extension Study|Unsatisfactory therapeutic effect|1
1481727|NCT00600938|4883884|P1|Extension Study|Unsatisfactory therapeutic effect|4
1481728|NCT00600938|4883881|P4|Extension Study|Abnormal test procedure results|1
1481729|NCT00600938|4883882|P3|Extension Study|Abnormal test procedure results|1
1481730|NCT00600938|4883883|P2|Extension Study|Abnormal test procedure results|1
1481731|NCT00600938|4883884|P1|Extension Study|Abnormal test procedure results|0
1481732|NCT00600938|4883881|P4|Extension Study|Adverse Event|0
1481733|NCT00600938|4883882|P3|Extension Study|Adverse Event|2
1481734|NCT00600938|4883883|P2|Extension Study|Adverse Event|0
1481735|NCT00600938|4883884|P1|Extension Study|Adverse Event|1
1481736|NCT00600938|4883881|P4|Core Study|Protocol Violation|0
1481737|NCT00600938|4883882|P3|Core Study|Protocol Violation|0
1481738|NCT00600938|4883883|P2|Core Study|Protocol Violation|2
1481739|NCT00600938|4883884|P1|Core Study|Protocol Violation|1
1481740|NCT00600938|4883881|P4|Core Study|Death|0
1481741|NCT00600938|4883882|P3|Core Study|Death|0
1481742|NCT00600938|4883883|P2|Core Study|Death|1
1481743|NCT00600938|4883884|P1|Core Study|Death|1
1481744|NCT00600938|4883881|P4|Core Study|Lost to Follow-up|0
1481745|NCT00600938|4883882|P3|Core Study|Lost to Follow-up|0
1481746|NCT00600938|4883883|P2|Core Study|Lost to Follow-up|2
1481747|NCT00600938|4883884|P1|Core Study|Lost to Follow-up|3
1481748|NCT00600938|4883881|P4|Core Study|Patient withdrew consent|0
1481749|NCT00600938|4883882|P3|Core Study|Patient withdrew consent|0
1481750|NCT00600938|4883883|P2|Core Study|Patient withdrew consent|12
1481751|NCT00600938|4883884|P1|Core Study|Patient withdrew consent|7
1481752|NCT00600938|4883881|P4|Core Study|Unsatisfactory therapeutic effect|0
1481753|NCT00600938|4883882|P3|Core Study|Unsatisfactory therapeutic effect|0
1481754|NCT00600938|4883883|P2|Core Study|Unsatisfactory therapeutic effect|2
1481755|NCT00600938|4883884|P1|Core Study|Unsatisfactory therapeutic effect|1
1481756|NCT00600938|4883881|P4|Core Study|Abnormal test procedure result(s)|0
1481757|NCT00600938|4883882|P3|Core Study|Abnormal test procedure result(s)|0
1481758|NCT00600938|4883883|P2|Core Study|Abnormal test procedure result(s)|2
1481759|NCT00600938|4883884|P1|Core Study|Abnormal test procedure result(s)|3
1481760|NCT00600886|4883948|P2|Extension - After Crossover (CAS)|Death|0
1481761|NCT00600886|4883949|P1|Extension - After Crossover (CAS)|Death|1
1481762|NCT00600886|4883948|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
1481763|NCT00600886|4883949|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
1481764|NCT00600886|4883948|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
1481765|NCT00600886|4883949|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
1481766|NCT00600886|4883948|P2|Extension - After Crossover (CAS)|Administrative Problems|4
1481767|NCT00600886|4883949|P1|Extension - After Crossover (CAS)|Administrative Problems|4
1481768|NCT00600886|4883948|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
1481769|NCT00600886|4883949|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
1481770|NCT00600886|4883948|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
1481771|NCT00600886|4883949|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
1481772|NCT00600886|4883948|P2|Extension - After Crossover (CAS)|Adverse Event|1
1481773|NCT00600886|4883949|P1|Extension - After Crossover (CAS)|Adverse Event|19
1481774|NCT00600886|4883948|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
1481775|NCT00600886|4883949|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
1481776|NCT00600886|4883948|P2|Extension - Same Treatment (FAS)|Death|1
1481777|NCT00600886|4883949|P1|Extension - Same Treatment (FAS)|Death|1
1481778|NCT00600886|4883948|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
1481779|NCT00600886|4883949|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
1481780|NCT00600886|4883948|P2|Extension - Same Treatment (FAS)|Adverse Event|1
1481781|NCT00600886|4883949|P1|Extension - Same Treatment (FAS)|Adverse Event|4
1481782|NCT00600886|4883948|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
1481783|NCT00600886|4883949|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
1481784|NCT00600886|4883948|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
1481785|NCT00600886|4883949|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
1481786|NCT00600886|4883948|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
1481787|NCT00600886|4883949|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
1481788|NCT00600886|4883948|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
1481789|NCT00600886|4883949|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
1481790|NCT00600886|4883948|P2|Core Phase - Full Analysis Set (FAS)|Death|1
1481791|NCT00600886|4883949|P1|Core Phase - Full Analysis Set (FAS)|Death|0
1481792|NCT00600886|4883948|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
1481793|NCT00600886|4883949|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
1481794|NCT00600886|4883948|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
1481795|NCT00600886|4883949|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
1481796|NCT00600886|4883948|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
1481797|NCT00600886|4883949|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
1481798|NCT00600886|4883948|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
1481799|NCT00600886|4883949|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
1481800|NCT00600886|4883948|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
1481801|NCT00600886|4883949|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
1481802|NCT00600886|4883948|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
1481803|NCT00600886|4883949|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
1481804|NCT00600886|4883948|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
1481805|NCT00600886|4883949|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
1481806|NCT00600821|4884013|P2|Overall Study|Other|3
1481807|NCT00600821|4884014|P1|Overall Study|Other|2
1481808|NCT00600821|4884013|P2|Overall Study|Randomized but not treated|1
1481809|NCT00600821|4884014|P1|Overall Study|Randomized but not treated|0
1481810|NCT00600821|4884013|P2|Overall Study|Objective progression or relapse|1
1481811|NCT00600821|4884014|P1|Overall Study|Objective progression or relapse|0
1481812|NCT00600821|4884013|P2|Overall Study|Terminated by sponsor|6
1481813|NCT00600821|4884014|P1|Overall Study|Terminated by sponsor|8
1481814|NCT00600821|4884013|P2|Overall Study|Withdrawal by Subject|1
1481815|NCT00600821|4884014|P1|Overall Study|Withdrawal by Subject|1
1481816|NCT00600821|4884013|P2|Overall Study|Lost to Follow-up|2
1481817|NCT00600821|4884014|P1|Overall Study|Lost to Follow-up|2
1481818|NCT00600821|4884013|P2|Overall Study|Death|46
1481819|NCT00600821|4884014|P1|Overall Study|Death|45
1481820|NCT00600756|4884042|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
1481821|NCT00600756|4884043|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
1481822|NCT00600756|4884042|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
1481823|NCT00600756|4884043|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
1481824|NCT00600756|4884042|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
1481825|NCT00600756|4884043|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
1481826|NCT00600756|4884042|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
1481827|NCT00600756|4884043|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
1481828|NCT00600756|4884042|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
1481829|NCT00600756|4884043|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
1481830|NCT00600756|4884042|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
1481831|NCT00600756|4884043|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
1481832|NCT00600756|4884042|P2|Overall Study Analysis After 12 Months|Adverse Event|44
1481833|NCT00600756|4884043|P1|Overall Study Analysis After 12 Months|Adverse Event|53
1481834|NCT00600756|4884042|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
1481835|NCT00600756|4884043|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
1481836|NCT00600756|4884042|P2|Analysis After 6 Months|Lost to Follow-up|8
1481837|NCT00600756|4884043|P1|Analysis After 6 Months|Lost to Follow-up|10
1481838|NCT00600756|4884042|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
1481839|NCT00600756|4884043|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
1481840|NCT00600756|4884042|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
1481841|NCT00600756|4884043|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
1481842|NCT00600756|4884042|P2|Analysis After 6 Months|Incorrect Enrollment|21
1481843|NCT00600756|4884043|P1|Analysis After 6 Months|Incorrect Enrollment|12
1481844|NCT00600756|4884042|P2|Analysis After 6 Months|Withdrawal by Subject|30
1481845|NCT00600756|4884043|P1|Analysis After 6 Months|Withdrawal by Subject|38
1481846|NCT00600756|4884042|P2|Analysis After 6 Months|Adverse Event|33
1481847|NCT00600756|4884043|P1|Analysis After 6 Months|Adverse Event|43
1481848|NCT00600613|4884152|P1|Overall Study|Protocol Deviation|1
1481849|NCT00600353|4884158|P2|Overall Study|History of prepartive regimen|1
1481850|NCT00600353|4884159|P1|Overall Study|History of prepartive regimen|0
1481851|NCT00600353|4884158|P2|Overall Study|history of malignancy within 5 years|0
1481852|NCT00600353|4884159|P1|Overall Study|history of malignancy within 5 years|1
1481853|NCT00600171|4884177|P6|Overall Study|Lost to Follow-up|0
1481854|NCT00600171|4884178|P5|Overall Study|Lost to Follow-up|0
1481855|NCT00600171|4884179|P4|Overall Study|Lost to Follow-up|1
1481856|NCT00600171|4884180|P3|Overall Study|Lost to Follow-up|0
1481857|NCT00600171|4884181|P2|Overall Study|Lost to Follow-up|0
1481858|NCT00600171|4884182|P1|Overall Study|Lost to Follow-up|0
1481859|NCT00600171|4884177|P6|Overall Study|Physician Decision|2
1481860|NCT00600171|4884178|P5|Overall Study|Physician Decision|0
1481861|NCT00600171|4884179|P4|Overall Study|Physician Decision|1
1481862|NCT00600171|4884180|P3|Overall Study|Physician Decision|0
1481863|NCT00600171|4884181|P2|Overall Study|Physician Decision|1
1481864|NCT00600171|4884182|P1|Overall Study|Physician Decision|0
1481865|NCT00600171|4884177|P6|Overall Study|Withdrawal by Subject|1
1481866|NCT00600171|4884178|P5|Overall Study|Withdrawal by Subject|1
1481867|NCT00600171|4884179|P4|Overall Study|Withdrawal by Subject|1
1481868|NCT00600171|4884180|P3|Overall Study|Withdrawal by Subject|0
1481869|NCT00600171|4884181|P2|Overall Study|Withdrawal by Subject|0
1481870|NCT00600171|4884182|P1|Overall Study|Withdrawal by Subject|3
1481871|NCT00600171|4884177|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
1481872|NCT00600171|4884178|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
1481873|NCT00600171|4884179|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
1481874|NCT00600171|4884180|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
1481875|NCT00600171|4884181|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
1481876|NCT00600171|4884182|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
1481877|NCT00600171|4884177|P6|Overall Study|Protocol Violation|0
1481878|NCT00600171|4884178|P5|Overall Study|Protocol Violation|0
1481879|NCT00600171|4884179|P4|Overall Study|Protocol Violation|1
1481880|NCT00600171|4884180|P3|Overall Study|Protocol Violation|0
1481881|NCT00600171|4884181|P2|Overall Study|Protocol Violation|2
1481882|NCT00600171|4884182|P1|Overall Study|Protocol Violation|1
1481883|NCT00600171|4884177|P6|Overall Study|Lack of Efficacy|0
1481884|NCT00600171|4884178|P5|Overall Study|Lack of Efficacy|4
1481885|NCT00600171|4884179|P4|Overall Study|Lack of Efficacy|5
1481886|NCT00600171|4884180|P3|Overall Study|Lack of Efficacy|3
1481887|NCT00600171|4884181|P2|Overall Study|Lack of Efficacy|12
1481888|NCT00600171|4884182|P1|Overall Study|Lack of Efficacy|9
1481889|NCT00600171|4884177|P6|Overall Study|Adverse Event|0
1481890|NCT00600171|4884178|P5|Overall Study|Adverse Event|1
1481891|NCT00600171|4884179|P4|Overall Study|Adverse Event|0
1481892|NCT00600171|4884180|P3|Overall Study|Adverse Event|0
1481893|NCT00600171|4884181|P2|Overall Study|Adverse Event|1
1481894|NCT00600171|4884182|P1|Overall Study|Adverse Event|0
1481895|NCT00600119|4884256|P6|Follow-up Period|Other|0
1481896|NCT00600119|4884257|P5|Follow-up Period|Other|0
1481897|NCT00600119|4884258|P4|Follow-up Period|Other|0
1481898|NCT00600119|4884259|P3|Follow-up Period|Other|0
1481899|NCT00600119|4884260|P2|Follow-up Period|Other|0
1481900|NCT00600119|4884261|P1|Follow-up Period|Other|1
1481901|NCT00600119|4884256|P6|Follow-up Period|Adverse Event|1
1481902|NCT00600119|4884257|P5|Follow-up Period|Adverse Event|0
1481903|NCT00600119|4884258|P4|Follow-up Period|Adverse Event|0
1481904|NCT00600119|4884259|P3|Follow-up Period|Adverse Event|0
1481905|NCT00600119|4884260|P2|Follow-up Period|Adverse Event|0
1481906|NCT00600119|4884261|P1|Follow-up Period|Adverse Event|0
1481907|NCT00600119|4884256|P6|Double-blind Treatment Period|Adverse Event|10
1481908|NCT00600119|4884257|P5|Double-blind Treatment Period|Adverse Event|2
1481909|NCT00600119|4884258|P4|Double-blind Treatment Period|Adverse Event|1
1481910|NCT00600119|4884259|P3|Double-blind Treatment Period|Adverse Event|0
1481911|NCT00600119|4884260|P2|Double-blind Treatment Period|Adverse Event|1
1481912|NCT00600119|4884261|P1|Double-blind Treatment Period|Adverse Event|1
1481913|NCT00600119|4884256|P6|Double-blind Treatment Period|Lost to Follow-up|0
1481914|NCT00600119|4884257|P5|Double-blind Treatment Period|Lost to Follow-up|0
1481915|NCT00600119|4884258|P4|Double-blind Treatment Period|Lost to Follow-up|0
1481916|NCT00600119|4884259|P3|Double-blind Treatment Period|Lost to Follow-up|0
1481917|NCT00600119|4884260|P2|Double-blind Treatment Period|Lost to Follow-up|1
1481918|NCT00600119|4884261|P1|Double-blind Treatment Period|Lost to Follow-up|0
1481919|NCT00600119|4884256|P6|Double-blind Treatment Period|Physician Decision|0
1481920|NCT00600119|4884257|P5|Double-blind Treatment Period|Physician Decision|0
1481921|NCT00600119|4884258|P4|Double-blind Treatment Period|Physician Decision|0
1481922|NCT00600119|4884259|P3|Double-blind Treatment Period|Physician Decision|0
1481923|NCT00600119|4884260|P2|Double-blind Treatment Period|Physician Decision|0
1481924|NCT00600119|4884261|P1|Double-blind Treatment Period|Physician Decision|2
1481925|NCT00600119|4884256|P6|Double-blind Treatment Period|Sponsor Decision|0
1481926|NCT00600119|4884257|P5|Double-blind Treatment Period|Sponsor Decision|1
1481927|NCT00600119|4884258|P4|Double-blind Treatment Period|Sponsor Decision|0
1481928|NCT00600119|4884259|P3|Double-blind Treatment Period|Sponsor Decision|0
1481929|NCT00600119|4884260|P2|Double-blind Treatment Period|Sponsor Decision|1
1481930|NCT00600119|4884261|P1|Double-blind Treatment Period|Sponsor Decision|0
1481931|NCT00600119|4884256|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
1481932|NCT00600119|4884257|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
1481933|NCT00600119|4884258|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
1481934|NCT00600119|4884259|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
1481935|NCT00600119|4884260|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
1481936|NCT00600119|4884261|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
1481937|NCT00600119|4884256|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
1481938|NCT00600119|4884257|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
1481939|NCT00600119|4884258|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
1481940|NCT00600119|4884259|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
1481941|NCT00600119|4884260|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
1481942|NCT00600119|4884261|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
1481943|NCT00600119|4884256|P6|Double-blind Treatment Period|Other|1
1481944|NCT00600119|4884257|P5|Double-blind Treatment Period|Other|2
1481945|NCT00600119|4884258|P4|Double-blind Treatment Period|Other|0
1481946|NCT00600119|4884259|P3|Double-blind Treatment Period|Other|0
1481947|NCT00600119|4884260|P2|Double-blind Treatment Period|Other|0
1481948|NCT00600119|4884261|P1|Double-blind Treatment Period|Other|0
1481949|NCT00600119|4884256|P6|Double-blind Treatment Period|Withdrawal by Subject|3
1481950|NCT00600119|4884257|P5|Double-blind Treatment Period|Withdrawal by Subject|0
1481951|NCT00600119|4884258|P4|Double-blind Treatment Period|Withdrawal by Subject|1
1481952|NCT00600119|4884259|P3|Double-blind Treatment Period|Withdrawal by Subject|0
1481953|NCT00600119|4884260|P2|Double-blind Treatment Period|Withdrawal by Subject|0
1481954|NCT00600119|4884261|P1|Double-blind Treatment Period|Withdrawal by Subject|2
1481955|NCT00600119|4884256|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
1481956|NCT00600119|4884257|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
1481957|NCT00600119|4884258|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
1481958|NCT00600119|4884259|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
1481959|NCT00600119|4884260|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
1481960|NCT00600119|4884261|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
1481961|NCT00600119|4884256|P6|Single-blind Placebo run-in Period|Adverse Event|1
1481962|NCT00600119|4884257|P5|Single-blind Placebo run-in Period|Adverse Event|0
1481963|NCT00600119|4884258|P4|Single-blind Placebo run-in Period|Adverse Event|1
1481964|NCT00600119|4884259|P3|Single-blind Placebo run-in Period|Adverse Event|0
1481965|NCT00600119|4884260|P2|Single-blind Placebo run-in Period|Adverse Event|0
1481966|NCT00600119|4884261|P1|Single-blind Placebo run-in Period|Adverse Event|0
1481967|NCT00600119|4884256|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
1481968|NCT00600119|4884257|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
1481969|NCT00600119|4884258|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
1481970|NCT00600119|4884259|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
1481971|NCT00600119|4884260|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
1481972|NCT00600119|4884261|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
1481973|NCT00600119|4884256|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
1481974|NCT00600119|4884257|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
1481975|NCT00600119|4884258|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
1481976|NCT00600119|4884259|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
1481977|NCT00600119|4884260|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
1481978|NCT00600119|4884261|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
1481979|NCT00600119|4884256|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
1481980|NCT00600119|4884257|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
1481981|NCT00600119|4884258|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
1481982|NCT00600119|4884259|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
1481983|NCT00600119|4884260|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
1481984|NCT00600119|4884261|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
1481985|NCT00600119|4884256|P6|Single-blind Placebo run-in Period|Other - Not specified|1
1481986|NCT00600119|4884257|P5|Single-blind Placebo run-in Period|Other - Not specified|1
1481987|NCT00600119|4884258|P4|Single-blind Placebo run-in Period|Other - Not specified|0
1481988|NCT00600119|4884259|P3|Single-blind Placebo run-in Period|Other - Not specified|0
1481989|NCT00600119|4884260|P2|Single-blind Placebo run-in Period|Other - Not specified|0
1481990|NCT00600119|4884261|P1|Single-blind Placebo run-in Period|Other - Not specified|1
1481991|NCT00600106|4884295|P2|Overall Study|Withdrawal by Subject|1
1481992|NCT00600106|4884296|P1|Overall Study|Withdrawal by Subject|1
1481993|NCT00600067|4884343|P2|Overall Study|Lack of Efficacy|0
1481994|NCT00600067|4884344|P1|Overall Study|Lack of Efficacy|1
1481995|NCT00600067|4884343|P2|Overall Study|protocol non-compliance|3
1481996|NCT00600067|4884344|P1|Overall Study|protocol non-compliance|0
1481997|NCT00600067|4884343|P2|Overall Study|Lost to Follow-up|3
1481998|NCT00600067|4884344|P1|Overall Study|Lost to Follow-up|2
1481999|NCT00600067|4884343|P2|Overall Study|Adverse Event|1
1482000|NCT00600067|4884344|P1|Overall Study|Adverse Event|0
1482001|NCT00600028|4884354|P2|Second Intervention (12 Weeks)|Adverse Event|2
1482002|NCT00600028|4884355|P1|Second Intervention (12 Weeks)|Adverse Event|0
1482003|NCT00600028|4884354|P2|First Intervention (12 Weeks)|Adverse Event|1
1482004|NCT00600028|4884355|P1|First Intervention (12 Weeks)|Adverse Event|0
1482005|NCT00600028|4884354|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
1482006|NCT00600028|4884355|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
1482007|NCT00599924|4884385|P7|Overall Study|Other|2
1482008|NCT00599924|4884386|P6|Overall Study|Other|0
1482009|NCT00599924|4884387|P5|Overall Study|Other|2
1482010|NCT00599924|4884388|P4|Overall Study|Other|1
1482011|NCT00599924|4884389|P3|Overall Study|Other|0
1482012|NCT00599924|4884390|P2|Overall Study|Other|0
1482013|NCT00599924|4884391|P1|Overall Study|Other|0
1482014|NCT00599924|4884385|P7|Overall Study|Withdrawal by Subject|0
1482015|NCT00599924|4884386|P6|Overall Study|Withdrawal by Subject|0
1482016|NCT00599924|4884387|P5|Overall Study|Withdrawal by Subject|1
1482017|NCT00599924|4884388|P4|Overall Study|Withdrawal by Subject|0
1482018|NCT00599924|4884389|P3|Overall Study|Withdrawal by Subject|1
1482019|NCT00599924|4884390|P2|Overall Study|Withdrawal by Subject|0
1482020|NCT00599924|4884391|P1|Overall Study|Withdrawal by Subject|0
1482021|NCT00599924|4884385|P7|Overall Study|Protocol Violation|0
1482022|NCT00599924|4884386|P6|Overall Study|Protocol Violation|0
1482023|NCT00599924|4884387|P5|Overall Study|Protocol Violation|0
1482024|NCT00599924|4884388|P4|Overall Study|Protocol Violation|1
1482025|NCT00599924|4884389|P3|Overall Study|Protocol Violation|0
1482026|NCT00599924|4884390|P2|Overall Study|Protocol Violation|0
1482027|NCT00599924|4884391|P1|Overall Study|Protocol Violation|0
1482028|NCT00599924|4884385|P7|Overall Study|Death|1
1482029|NCT00599924|4884386|P6|Overall Study|Death|2
1482030|NCT00599924|4884387|P5|Overall Study|Death|0
1482031|NCT00599924|4884388|P4|Overall Study|Death|2
1482032|NCT00599924|4884389|P3|Overall Study|Death|0
1482033|NCT00599924|4884390|P2|Overall Study|Death|0
1482034|NCT00599924|4884391|P1|Overall Study|Death|0
1482035|NCT00599924|4884385|P7|Overall Study|Adverse Event|2
1482036|NCT00599924|4884386|P6|Overall Study|Adverse Event|0
1482037|NCT00599924|4884387|P5|Overall Study|Adverse Event|0
1482038|NCT00599924|4884388|P4|Overall Study|Adverse Event|2
1482039|NCT00599924|4884389|P3|Overall Study|Adverse Event|0
1482040|NCT00599924|4884390|P2|Overall Study|Adverse Event|0
1482041|NCT00599924|4884391|P1|Overall Study|Adverse Event|0
1482042|NCT00599924|4884385|P7|Overall Study|Lack of Efficacy|0
1482043|NCT00599924|4884386|P6|Overall Study|Lack of Efficacy|2
1482044|NCT00599924|4884387|P5|Overall Study|Lack of Efficacy|3
1482045|NCT00599924|4884388|P4|Overall Study|Lack of Efficacy|2
1482046|NCT00599924|4884389|P3|Overall Study|Lack of Efficacy|1
1482047|NCT00599924|4884390|P2|Overall Study|Lack of Efficacy|5
1482048|NCT00599924|4884391|P1|Overall Study|Lack of Efficacy|3
1482049|NCT00599755|4884495|P1|Overall Study|No data available|1
1482050|NCT00599755|4884495|P1|Overall Study|Other Reason|2
1482051|NCT00599755|4884495|P1|Overall Study|Progression of Disease|3
1482052|NCT00599755|4884495|P1|Overall Study|Withdrawal by Subject|2
1482053|NCT00599755|4884495|P1|Overall Study|Adverse Event|11
1482054|NCT00599521|4884506|P2|Overall Study|Pregnancy|2
1482055|NCT00599521|4884507|P1|Overall Study|Pregnancy|0
1482056|NCT00599521|4884506|P2|Overall Study|Lost to Follow-up|23
1482057|NCT00599521|4884507|P1|Overall Study|Lost to Follow-up|23
1482058|NCT00599521|4884506|P2|Overall Study|Protocol Violation|1
1482059|NCT00599521|4884507|P1|Overall Study|Protocol Violation|1
1482060|NCT00599521|4884506|P2|Overall Study|Withdrawal by Subject|34
1482061|NCT00599521|4884507|P1|Overall Study|Withdrawal by Subject|28
1482062|NCT00599521|4884506|P2|Overall Study|Adverse Event|1
1482063|NCT00599521|4884507|P1|Overall Study|Adverse Event|4
1482064|NCT00599521|4884506|P2|Overall Study|Lack of Efficacy|8
1482065|NCT00599521|4884507|P1|Overall Study|Lack of Efficacy|4
1482066|NCT00599339|4884521|P1|Overall Study|Study Termination Status Unknown|12
1482067|NCT00599339|4884521|P1|Overall Study|No valid data consent|36
1482068|NCT00599339|4884521|P1|Overall Study|Lost to Follow-up|221
1482069|NCT00599339|4884521|P1|Overall Study|Other Reason|179
1482070|NCT00599339|4884521|P1|Overall Study|Withdrawal by Subject|137
1482071|NCT00599339|4884521|P1|Overall Study|Adverse Event|79
1482072|NCT00599326|4884623|P1|Overall Study|Noncompliant|1
1482073|NCT00599326|4884623|P1|Overall Study|Lost to Follow-up|1
1482074|NCT00599313|4884628|P1|Overall Study|Ineligible|1
1482075|NCT00599313|4884628|P1|Overall Study|Patient Request|4
1482076|NCT00599313|4884628|P1|Overall Study|Disease Progression|12
1482077|NCT00599313|4884628|P1|Overall Study|Adverse Event|19
1482078|NCT00599196|4884670|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
1482079|NCT00599196|4884670|P1|Overall Study|Other: Patient Stopped Due To Moving|1
1482080|NCT00599196|4884670|P1|Overall Study|Other: Pt Moved To Australia|1
1482081|NCT00599196|4884670|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
1482082|NCT00599196|4884670|P1|Overall Study|Other: Spouse Withdrew Consent|1
1482083|NCT00599196|4884670|P1|Overall Study|Other: Patient Leaving For Israel|1
1482084|NCT00599196|4884670|P1|Overall Study|Lost to Follow-up|17
1482085|NCT00599196|4884670|P1|Overall Study|Study ended per sponsor|197
1482086|NCT00599196|4884670|P1|Overall Study|Subject withdrew consent|43
1482087|NCT00599196|4884670|P1|Overall Study|Unsatisfactory compliance of subject|3
1482088|NCT00599196|4884670|P1|Overall Study|Adverse Event|93
1482089|NCT00599196|4884670|P1|Overall Study|Lack of Efficacy|22
1482090|NCT00599027|4884701|P2|Overall Study|Treatment Failure|1
1482091|NCT00599027|4884702|P1|Overall Study|Treatment Failure|0
1482092|NCT00599027|4884701|P2|Overall Study|Adverse Event|1
1482093|NCT00599027|4884702|P1|Overall Study|Adverse Event|0
1482094|NCT00599027|4884701|P2|Overall Study|Withdrawal by Subject|1
1482095|NCT00599027|4884702|P1|Overall Study|Withdrawal by Subject|1
1482096|NCT00598871|4884715|P2|Overall Study|Adverse Event|1
1482097|NCT00598871|4884716|P1|Overall Study|Adverse Event|0
1482098|NCT00598832|4884726|P2|Overall Study|Non compliance|0
1482099|NCT00598832|4884727|P1|Overall Study|Non compliance|1
1482100|NCT00598832|4884726|P2|Overall Study|Physician Decision|4
1482101|NCT00598832|4884727|P1|Overall Study|Physician Decision|1
1482102|NCT00598832|4884726|P2|Overall Study|Pregnancy|2
1482103|NCT00598832|4884727|P1|Overall Study|Pregnancy|2
1482104|NCT00598832|4884726|P2|Overall Study|Lost to Follow-up|29
1482105|NCT00598832|4884727|P1|Overall Study|Lost to Follow-up|24
1482106|NCT00598832|4884726|P2|Overall Study|Protocol Violation|2
1482107|NCT00598832|4884727|P1|Overall Study|Protocol Violation|0
1482108|NCT00598832|4884726|P2|Overall Study|Withdrawal by Subject|36
1482109|NCT00598832|4884727|P1|Overall Study|Withdrawal by Subject|25
1482110|NCT00598832|4884726|P2|Overall Study|Adverse Event|2
1482111|NCT00598832|4884727|P1|Overall Study|Adverse Event|6
1482112|NCT00598832|4884726|P2|Overall Study|Lack of Efficacy|7
1482113|NCT00598832|4884727|P1|Overall Study|Lack of Efficacy|3
1482114|NCT00598702|4884780|P8|Overall Study|Dose limiting toxicity|0
1482115|NCT00598702|4884781|P7|Overall Study|Dose limiting toxicity|0
1482116|NCT00598702|4884782|P6|Overall Study|Dose limiting toxicity|1
1482117|NCT00598702|4884783|P5|Overall Study|Dose limiting toxicity|1
1482118|NCT00598702|4884784|P4|Overall Study|Dose limiting toxicity|1
1482119|NCT00598702|4884785|P3|Overall Study|Dose limiting toxicity|0
1482120|NCT00598702|4884786|P2|Overall Study|Dose limiting toxicity|0
1482121|NCT00598702|4884787|P1|Overall Study|Dose limiting toxicity|0
1482122|NCT00598702|4884780|P8|Overall Study|Physician Decision|0
1482123|NCT00598702|4884781|P7|Overall Study|Physician Decision|0
1482124|NCT00598702|4884782|P6|Overall Study|Physician Decision|0
1482125|NCT00598702|4884783|P5|Overall Study|Physician Decision|1
1482126|NCT00598702|4884784|P4|Overall Study|Physician Decision|0
1482127|NCT00598702|4884785|P3|Overall Study|Physician Decision|0
1482128|NCT00598702|4884786|P2|Overall Study|Physician Decision|0
1482129|NCT00598702|4884787|P1|Overall Study|Physician Decision|0
1482130|NCT00598702|4884780|P8|Overall Study|Withdrawal by Subject|0
1482131|NCT00598702|4884781|P7|Overall Study|Withdrawal by Subject|0
1482132|NCT00598702|4884782|P6|Overall Study|Withdrawal by Subject|0
1482133|NCT00598702|4884783|P5|Overall Study|Withdrawal by Subject|1
1482134|NCT00598702|4884784|P4|Overall Study|Withdrawal by Subject|1
1482135|NCT00598702|4884785|P3|Overall Study|Withdrawal by Subject|0
1482136|NCT00598702|4884786|P2|Overall Study|Withdrawal by Subject|0
1482137|NCT00598702|4884787|P1|Overall Study|Withdrawal by Subject|0
1482138|NCT00598702|4884780|P8|Overall Study|Adverse Event|0
1482139|NCT00598702|4884781|P7|Overall Study|Adverse Event|0
1482140|NCT00598702|4884782|P6|Overall Study|Adverse Event|0
1482141|NCT00598702|4884783|P5|Overall Study|Adverse Event|0
1482142|NCT00598702|4884784|P4|Overall Study|Adverse Event|1
1482143|NCT00598702|4884785|P3|Overall Study|Adverse Event|0
1482144|NCT00598702|4884786|P2|Overall Study|Adverse Event|0
1482145|NCT00598702|4884787|P1|Overall Study|Adverse Event|0
1482146|NCT00598702|4884780|P8|Overall Study|Early discharge from hospital|0
1482147|NCT00598702|4884781|P7|Overall Study|Early discharge from hospital|1
1482148|NCT00598702|4884782|P6|Overall Study|Early discharge from hospital|10
1482149|NCT00598702|4884783|P5|Overall Study|Early discharge from hospital|0
1482150|NCT00598702|4884784|P4|Overall Study|Early discharge from hospital|5
1482151|NCT00598702|4884785|P3|Overall Study|Early discharge from hospital|2
1482152|NCT00598702|4884786|P2|Overall Study|Early discharge from hospital|0
1482153|NCT00598702|4884787|P1|Overall Study|Early discharge from hospital|0
1482154|NCT00598702|4884780|P8|Overall Study|Not specified|0
1482155|NCT00598702|4884781|P7|Overall Study|Not specified|0
1482156|NCT00598702|4884782|P6|Overall Study|Not specified|1
1482157|NCT00598702|4884783|P5|Overall Study|Not specified|0
1482158|NCT00598702|4884784|P4|Overall Study|Not specified|0
1482159|NCT00598702|4884785|P3|Overall Study|Not specified|0
1482160|NCT00598702|4884786|P2|Overall Study|Not specified|2
1482161|NCT00598702|4884787|P1|Overall Study|Not specified|0
1482162|NCT00598650|4884842|P1|Overall Study|Physician Decision|2
1482163|NCT00598650|4884842|P1|Overall Study|Prohibited Concomitant Medication|2
1482164|NCT00598650|4884842|P1|Overall Study|Not eligible|1
1482165|NCT00598650|4884842|P1|Overall Study|No treatment for 3 weeks|1
1482166|NCT00598650|4884842|P1|Overall Study|Adverse Event|18
1482167|NCT00598650|4884842|P1|Overall Study|Withdrawal by Subject|3
1482168|NCT00598585|4884851|P2|Overall Study|Lost to Follow-up|0
1482169|NCT00598585|4884852|P1|Overall Study|Lost to Follow-up|1
1482170|NCT00598559|4884861|P3|Overall Study|Subject unable/unwilling to attend visit|0
1482171|NCT00598559|4884862|P2|Overall Study|Subject unable/unwilling to attend visit|7
1482172|NCT00598559|4884863|P1|Overall Study|Subject unable/unwilling to attend visit|4
1482173|NCT00598559|4884861|P3|Overall Study|Early discharge from hospital|3
1482174|NCT00598559|4884862|P2|Overall Study|Early discharge from hospital|12
1482175|NCT00598559|4884863|P1|Overall Study|Early discharge from hospital|9
1482176|NCT00598559|4884861|P3|Overall Study|Protocol Non-compliance|0
1482177|NCT00598559|4884862|P2|Overall Study|Protocol Non-compliance|0
1482178|NCT00598559|4884863|P1|Overall Study|Protocol Non-compliance|1
1482179|NCT00598559|4884861|P3|Overall Study|Withdrawal by Subject|0
1482180|NCT00598559|4884862|P2|Overall Study|Withdrawal by Subject|2
1482181|NCT00598559|4884863|P1|Overall Study|Withdrawal by Subject|2
1482182|NCT00598559|4884861|P3|Overall Study|Adverse Event|0
1482183|NCT00598559|4884862|P2|Overall Study|Adverse Event|7
1482184|NCT00598559|4884863|P1|Overall Study|Adverse Event|11
1482185|NCT00598442|4884890|P3|Overall Study|Started dialysis|0
1482186|NCT00598442|4884891|P2|Overall Study|Started dialysis|0
1482187|NCT00598442|4884892|P1|Overall Study|Started dialysis|1
1482188|NCT00598442|4884890|P3|Overall Study|Site closed by sponsor|1
1482189|NCT00598442|4884891|P2|Overall Study|Site closed by sponsor|2
1482190|NCT00598442|4884892|P1|Overall Study|Site closed by sponsor|5
1482191|NCT00598442|4884890|P3|Overall Study|Renal transplant|1
1482192|NCT00598442|4884891|P2|Overall Study|Renal transplant|0
1482193|NCT00598442|4884892|P1|Overall Study|Renal transplant|0
1482194|NCT00598442|4884890|P3|Overall Study|Relocation|0
1482195|NCT00598442|4884891|P2|Overall Study|Relocation|4
1482196|NCT00598442|4884892|P1|Overall Study|Relocation|1
1482197|NCT00598442|4884890|P3|Overall Study|Noncompliance|1
1482198|NCT00598442|4884891|P2|Overall Study|Noncompliance|2
1482199|NCT00598442|4884892|P1|Overall Study|Noncompliance|0
1482200|NCT00598442|4884890|P3|Overall Study|Withdrawal by Subject|6
1482201|NCT00598442|4884891|P2|Overall Study|Withdrawal by Subject|16
1482202|NCT00598442|4884892|P1|Overall Study|Withdrawal by Subject|8
1482203|NCT00598442|4884890|P3|Overall Study|Physician Decision|1
1482204|NCT00598442|4884891|P2|Overall Study|Physician Decision|1
1482205|NCT00598442|4884892|P1|Overall Study|Physician Decision|2
1482206|NCT00598442|4884890|P3|Overall Study|Lost to Follow-up|3
1482207|NCT00598442|4884891|P2|Overall Study|Lost to Follow-up|3
1482208|NCT00598442|4884892|P1|Overall Study|Lost to Follow-up|4
1482209|NCT00598442|4884890|P3|Overall Study|Death|11
1482210|NCT00598442|4884891|P2|Overall Study|Death|11
1482211|NCT00598442|4884892|P1|Overall Study|Death|19
1482212|NCT00598442|4884890|P3|Overall Study|Adverse Event|0
1482213|NCT00598442|4884891|P2|Overall Study|Adverse Event|0
1482214|NCT00598442|4884892|P1|Overall Study|Adverse Event|3
1482215|NCT00598273|4884909|P3|Overall Study|Started dialysis|5
1482216|NCT00598273|4884910|P2|Overall Study|Started dialysis|4
1482217|NCT00598273|4884911|P1|Overall Study|Started dialysis|6
1482218|NCT00598273|4884909|P3|Overall Study|Site elected to close|0
1482219|NCT00598273|4884910|P2|Overall Study|Site elected to close|0
1482220|NCT00598273|4884911|P1|Overall Study|Site elected to close|1
1482221|NCT00598273|4884909|P3|Overall Study|Renal transplant|1
1482222|NCT00598273|4884910|P2|Overall Study|Renal transplant|0
1482223|NCT00598273|4884911|P1|Overall Study|Renal transplant|1
1482224|NCT00598273|4884909|P3|Overall Study|Relocation|4
1482225|NCT00598273|4884910|P2|Overall Study|Relocation|2
1482226|NCT00598273|4884911|P1|Overall Study|Relocation|0
1482227|NCT00598273|4884909|P3|Overall Study|Noncompliance|3
1482228|NCT00598273|4884910|P2|Overall Study|Noncompliance|2
1482229|NCT00598273|4884911|P1|Overall Study|Noncompliance|3
1482230|NCT00598273|4884909|P3|Overall Study|Withdrawal by Subject|10
1482231|NCT00598273|4884910|P2|Overall Study|Withdrawal by Subject|10
1482232|NCT00598273|4884911|P1|Overall Study|Withdrawal by Subject|12
1482233|NCT00598273|4884909|P3|Overall Study|Physician Decision|1
1482234|NCT00598273|4884910|P2|Overall Study|Physician Decision|0
1482235|NCT00598273|4884911|P1|Overall Study|Physician Decision|0
1482236|NCT00598273|4884909|P3|Overall Study|Lost to Follow-up|5
1482237|NCT00598273|4884910|P2|Overall Study|Lost to Follow-up|3
1482238|NCT00598273|4884911|P1|Overall Study|Lost to Follow-up|8
1482239|NCT00598273|4884909|P3|Overall Study|Death|8
1482240|NCT00598273|4884910|P2|Overall Study|Death|12
1482241|NCT00598273|4884911|P1|Overall Study|Death|6
1482242|NCT00598273|4884909|P3|Overall Study|Adverse Event|2
1482243|NCT00598273|4884910|P2|Overall Study|Adverse Event|5
1482244|NCT00598273|4884911|P1|Overall Study|Adverse Event|4
1482245|NCT00598078|4884925|P2|Period 2 (Day 2)|Adverse Event|0
1482246|NCT00598078|4884926|P1|Period 2 (Day 2)|Adverse Event|1
1482247|NCT00597766|4884979|P3|Follow-up 2, Week 8|Lost to Follow-up|1
1482248|NCT00597766|4884980|P2|Follow-up 2, Week 8|Lost to Follow-up|0
1482249|NCT00597766|4884981|P1|Follow-up 2, Week 8|Lost to Follow-up|0
1482250|NCT00597766|4884979|P3|Follow-up 1, Week 4|Withdrawal by Subject|0
1482251|NCT00597766|4884980|P2|Follow-up 1, Week 4|Withdrawal by Subject|0
1482252|NCT00597766|4884981|P1|Follow-up 1, Week 4|Withdrawal by Subject|1
1482253|NCT00597753|4885000|P2|Overall Study|Site elected to close|4
1482254|NCT00597753|4885001|P1|Overall Study|Site elected to close|2
1482255|NCT00597753|4885000|P2|Overall Study|Site closed by sponsor|7
1482256|NCT00597753|4885001|P1|Overall Study|Site closed by sponsor|19
1482257|NCT00597753|4885000|P2|Overall Study|Renal transplant|3
1482258|NCT00597753|4885001|P1|Overall Study|Renal transplant|10
1482259|NCT00597753|4885000|P2|Overall Study|Relocation|6
1482260|NCT00597753|4885001|P1|Overall Study|Relocation|17
1482261|NCT00597753|4885000|P2|Overall Study|Noncompliance|1
1482262|NCT00597753|4885001|P1|Overall Study|Noncompliance|2
1482263|NCT00597753|4885000|P2|Overall Study|Never dosed|0
1482264|NCT00597753|4885001|P1|Overall Study|Never dosed|2
1482265|NCT00597753|4885000|P2|Overall Study|Discontinued Dialysis|1
1482266|NCT00597753|4885001|P1|Overall Study|Discontinued Dialysis|0
1482267|NCT00597753|4885000|P2|Overall Study|Withdrawal by Subject|12
1482268|NCT00597753|4885001|P1|Overall Study|Withdrawal by Subject|35
1482269|NCT00597753|4885000|P2|Overall Study|Pregnancy|0
1482270|NCT00597753|4885001|P1|Overall Study|Pregnancy|1
1482271|NCT00597753|4885000|P2|Overall Study|Physician Decision|1
1482272|NCT00597753|4885001|P1|Overall Study|Physician Decision|5
1482273|NCT00597753|4885000|P2|Overall Study|Lost to Follow-up|3
1482274|NCT00597753|4885001|P1|Overall Study|Lost to Follow-up|10
1482275|NCT00597753|4885000|P2|Overall Study|Lack of Efficacy|0
1482276|NCT00597753|4885001|P1|Overall Study|Lack of Efficacy|2
1482277|NCT00597753|4885000|P2|Overall Study|Death|29
1482278|NCT00597753|4885001|P1|Overall Study|Death|55
1482279|NCT00597753|4885000|P2|Overall Study|Adverse Event|2
1482280|NCT00597753|4885001|P1|Overall Study|Adverse Event|6
1482281|NCT00597714|4885035|P3|Overall Study|Recipient death|10
1482282|NCT00597714|4885036|P2|Overall Study|Recipient death|0
1482283|NCT00597714|4885037|P1|Overall Study|Recipient death|0
1482284|NCT00597714|4885035|P3|Overall Study|Death|0
1482285|NCT00597714|4885036|P2|Overall Study|Death|46
1482286|NCT00597714|4885037|P1|Overall Study|Death|56
1482287|NCT00597701|4885049|P2|Overall Study|Did not start intervention (pharmacy er)|2
1482288|NCT00597701|4885050|P1|Overall Study|Did not start intervention (pharmacy er)|0
1482289|NCT00597701|4885049|P2|Overall Study|Physician Decision|0
1482290|NCT00597701|4885050|P1|Overall Study|Physician Decision|2
1482291|NCT00597701|4885049|P2|Overall Study|Death|1
1482292|NCT00597701|4885050|P1|Overall Study|Death|0
1482293|NCT00597701|4885049|P2|Overall Study|Withdrawal by Subject|5
1482294|NCT00597701|4885050|P1|Overall Study|Withdrawal by Subject|5
1482295|NCT00597584|4885072|P2|Overall Study|Renal transplant|7
1482296|NCT00597584|4885073|P1|Overall Study|Renal transplant|9
1482297|NCT00597584|4885072|P2|Overall Study|Relocation|6
1482298|NCT00597584|4885073|P1|Overall Study|Relocation|8
1482299|NCT00597584|4885072|P2|Overall Study|Never dosed|0
1482300|NCT00597584|4885073|P1|Overall Study|Never dosed|1
1482301|NCT00597584|4885072|P2|Overall Study|Lost ability to consent|1
1482302|NCT00597584|4885073|P1|Overall Study|Lost ability to consent|1
1482303|NCT00597584|4885072|P2|Overall Study|Discontinued Dialysis|1
1482304|NCT00597584|4885073|P1|Overall Study|Discontinued Dialysis|0
1482305|NCT00597584|4885072|P2|Overall Study|Withdrawal by Subject|12
1482306|NCT00597584|4885073|P1|Overall Study|Withdrawal by Subject|44
1482307|NCT00597584|4885072|P2|Overall Study|Pregnancy|0
1482308|NCT00597584|4885073|P1|Overall Study|Pregnancy|2
1482309|NCT00597584|4885072|P2|Overall Study|Physician Decision|0
1482310|NCT00597584|4885073|P1|Overall Study|Physician Decision|3
1482311|NCT00597584|4885072|P2|Overall Study|Lost to Follow-up|4
1482312|NCT00597584|4885073|P1|Overall Study|Lost to Follow-up|2
1482313|NCT00597584|4885072|P2|Overall Study|Lack of Efficacy|0
1482314|NCT00597584|4885073|P1|Overall Study|Lack of Efficacy|1
1482315|NCT00597584|4885072|P2|Overall Study|Death|30
1482316|NCT00597584|4885073|P1|Overall Study|Death|53
1482317|NCT00597584|4885072|P2|Overall Study|Adverse Event|2
1482318|NCT00597584|4885073|P1|Overall Study|Adverse Event|4
1482319|NCT00597519|4885098|P1|Overall Study|Death|1
1482320|NCT00597506|4885102|P1|Overall Study|Subject is being followed for survival|1
1482321|NCT00597376|4885152|P2|Overall Study|Adverse Event|1
1482322|NCT00597376|4885153|P1|Overall Study|Adverse Event|4
1482323|NCT00597376|4885152|P2|Overall Study|Withdrawal by Subject|3
1482324|NCT00597376|4885153|P1|Overall Study|Withdrawal by Subject|4
1482325|NCT00597207|4885194|P2|Overall Study|Lost to Follow-up|7
1482326|NCT00597207|4885195|P1|Overall Study|Lost to Follow-up|5
1482327|NCT00597116|4885203|P2|Overall Study|Progressive disease|6
1482328|NCT00597116|4885204|P1|Overall Study|Progressive disease|11
1482329|NCT00597116|4885203|P2|Overall Study|Lost to Follow-up|0
1482330|NCT00597116|4885204|P1|Overall Study|Lost to Follow-up|1
1482331|NCT00597116|4885203|P2|Overall Study|Death|1
1482332|NCT00597116|4885204|P1|Overall Study|Death|0
1482333|NCT00597116|4885203|P2|Overall Study|Physician Decision|1
1482334|NCT00597116|4885204|P1|Overall Study|Physician Decision|0
1482335|NCT00597116|4885203|P2|Overall Study|Withdrawal by Subject|2
1482336|NCT00597116|4885204|P1|Overall Study|Withdrawal by Subject|0
1482337|NCT00597116|4885203|P2|Overall Study|Adverse Event|1
1482338|NCT00597116|4885204|P1|Overall Study|Adverse Event|2
1482339|NCT00597012|4885230|P2|Overall Study|Lost to Follow-up|2
1482340|NCT00597012|4885231|P1|Overall Study|Lost to Follow-up|0
1482341|NCT00597012|4885230|P2|Overall Study|Ineligible|0
1482342|NCT00597012|4885231|P1|Overall Study|Ineligible|2
1482343|NCT00597012|4885230|P2|Overall Study|Withdrawal by Subject|4
1482344|NCT00597012|4885231|P1|Overall Study|Withdrawal by Subject|7
1482345|NCT00597012|4885230|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
1482346|NCT00597012|4885231|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
1482347|NCT00597012|4885230|P2|Overall Study|Death|1
1482348|NCT00597012|4885231|P1|Overall Study|Death|1
1482349|NCT00596960|4885243|P2|Overall Study|No alcohol use data|1
1482350|NCT00596960|4885244|P1|Overall Study|No alcohol use data|0
1482351|NCT00596960|4885243|P2|Overall Study|Protocol Violation|1
1482352|NCT00596960|4885244|P1|Overall Study|Protocol Violation|0
1482353|NCT00596960|4885243|P2|Overall Study|Physician Decision|0
1482354|NCT00596960|4885244|P1|Overall Study|Physician Decision|1
1482355|NCT00596960|4885243|P2|Overall Study|Incarcerated|0
1482356|NCT00596960|4885244|P1|Overall Study|Incarcerated|2
1482357|NCT00596960|4885243|P2|Overall Study|Withdrawal by Subject|0
1482358|NCT00596960|4885244|P1|Overall Study|Withdrawal by Subject|1
1482359|NCT00596960|4885243|P2|Overall Study|Lost to Follow-up|5
1482360|NCT00596960|4885244|P1|Overall Study|Lost to Follow-up|6
1482361|NCT00596960|4885243|P2|Overall Study|Death|2
1482362|NCT00596960|4885244|P1|Overall Study|Death|1
1482363|NCT00596947|4885256|P2|Overall Study|Lost to Follow-up|0
1482364|NCT00596947|4885257|P1|Overall Study|Lost to Follow-up|1
1482365|NCT00596947|4885256|P2|Overall Study|study halted due to low enrollment|3
1482366|NCT00596947|4885257|P1|Overall Study|study halted due to low enrollment|5
1482367|NCT00596934|4885297|P1|Overall Study|Withdrawal by Subject|1
1482368|NCT00596934|4885297|P1|Overall Study|Protocol Violation|1
1482369|NCT00596830|4885310|P2|Overall Study|Randomized but not treated|7
1482370|NCT00596830|4885311|P1|Overall Study|Randomized but not treated|3
1482371|NCT00596830|4885310|P2|Overall Study|Follow-up was discontinued|0
1482372|NCT00596830|4885311|P1|Overall Study|Follow-up was discontinued|1
1482373|NCT00596830|4885310|P2|Overall Study|Study terminated by sponsor|62
1482374|NCT00596830|4885311|P1|Overall Study|Study terminated by sponsor|51
1482375|NCT00596830|4885310|P2|Overall Study|Withdrawal by Subject|12
1482376|NCT00596830|4885311|P1|Overall Study|Withdrawal by Subject|22
1482377|NCT00596830|4885310|P2|Overall Study|Lost to Follow-up|11
1482378|NCT00596830|4885311|P1|Overall Study|Lost to Follow-up|7
1482379|NCT00596830|4885310|P2|Overall Study|Death|247
1482380|NCT00596830|4885311|P1|Overall Study|Death|258
1482381|NCT00596817|4885337|P2|Double-blind Period|Other Reasons|18
1482382|NCT00596817|4885338|P1|Double-blind Period|Other Reasons|10
1482383|NCT00596817|4885337|P2|Double-blind Period|Lost to Follow-up|2
1482384|NCT00596817|4885338|P1|Double-blind Period|Lost to Follow-up|0
1482385|NCT00596817|4885337|P2|Double-blind Period|Withdrawal of Consent|3
1482386|NCT00596817|4885338|P1|Double-blind Period|Withdrawal of Consent|7
1482387|NCT00596817|4885337|P2|Double-blind Period|Protocol Violation|8
1482388|NCT00596817|4885338|P1|Double-blind Period|Protocol Violation|11
1482389|NCT00596817|4885337|P2|Double-blind Period|Non-compliance With Study Product|4
1482390|NCT00596817|4885338|P1|Double-blind Period|Non-compliance With Study Product|3
1482391|NCT00596817|4885337|P2|Double-blind Period|Lack of Efficacy|28
1482392|NCT00596817|4885338|P1|Double-blind Period|Lack of Efficacy|52
1482393|NCT00596817|4885337|P2|Double-blind Period|Adverse Event|16
1482394|NCT00596817|4885338|P1|Double-blind Period|Adverse Event|5
1482395|NCT00596817|4885337|P2|Open-label Period to Double-blind Period|Other Reasons|14
1482396|NCT00596817|4885338|P1|Open-label Period to Double-blind Period|Other Reasons|0
1482397|NCT00596817|4885337|P2|Open-label Period to Double-blind Period|Not Eligible|49
1482398|NCT00596817|4885338|P1|Open-label Period to Double-blind Period|Not Eligible|0
1482399|NCT00596817|4885337|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
1482400|NCT00596817|4885338|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
1482401|NCT00596817|4885337|P2|Open-label Period to Double-blind Period|Adverse Event|5
1482402|NCT00596817|4885338|P1|Open-label Period to Double-blind Period|Adverse Event|0
1482403|NCT00596817|4885337|P2|Open-label Period|Other Reasons|65
1482404|NCT00596817|4885338|P1|Open-label Period|Other Reasons|0
1482405|NCT00596817|4885337|P2|Open-label Period|Lack of Efficacy|33
1482406|NCT00596817|4885338|P1|Open-label Period|Lack of Efficacy|0
1482407|NCT00596817|4885337|P2|Open-label Period|Adverse Event|49
1482408|NCT00596817|4885338|P1|Open-label Period|Adverse Event|0
1482409|NCT00596752|4885363|P2|Overall Study|Protocol Violation|0
1482410|NCT00596752|4885364|P1|Overall Study|Protocol Violation|1
1482411|NCT00596752|4885363|P2|Overall Study|Lack of Efficacy|7
1482412|NCT00596752|4885364|P1|Overall Study|Lack of Efficacy|4
1482413|NCT00596752|4885363|P2|Overall Study|Unsatisfactory Compliance|6
1482414|NCT00596752|4885364|P1|Overall Study|Unsatisfactory Compliance|9
1482415|NCT00596752|4885363|P2|Overall Study|Withdrawal by Subject|9
1482416|NCT00596752|4885364|P1|Overall Study|Withdrawal by Subject|12
1482417|NCT00596752|4885363|P2|Overall Study|Lost to Follow-up|38
1482418|NCT00596752|4885364|P1|Overall Study|Lost to Follow-up|22
1482419|NCT00596752|4885363|P2|Overall Study|Adverse Event|34
1482420|NCT00596752|4885364|P1|Overall Study|Adverse Event|34
1482421|NCT00596752|4885363|P2|Overall Study|Other Reason|49
1482422|NCT00596752|4885364|P1|Overall Study|Other Reason|44
1482423|NCT00596687|4885394|P2|Overall Study|cancelled surgery|1
1482424|NCT00596687|4885395|P1|Overall Study|cancelled surgery|1
1482425|NCT00596687|4885394|P2|Overall Study|Withdrawal by Subject|1
1482426|NCT00596687|4885395|P1|Overall Study|Withdrawal by Subject|3
1482427|NCT00596687|4885394|P2|Overall Study|continuous insulin infusion during TPN|1
1482428|NCT00596687|4885395|P1|Overall Study|continuous insulin infusion during TPN|2
1482429|NCT00596687|4885394|P2|Overall Study|< 24 hours of insulin treatment|6
1482430|NCT00596687|4885395|P1|Overall Study|< 24 hours of insulin treatment|8
1482431|NCT00596635|4885406|P3|Overall Study|Could not provide urine specimen|2
1482432|NCT00596635|4885407|P2|Overall Study|Could not provide urine specimen|2
1482433|NCT00596635|4885408|P1|Overall Study|Could not provide urine specimen|1
1482434|NCT00596635|4885406|P3|Overall Study|Hip fracture|3
1482435|NCT00596635|4885407|P2|Overall Study|Hip fracture|3
1482436|NCT00596635|4885408|P1|Overall Study|Hip fracture|2
1482437|NCT00596635|4885406|P3|Overall Study|Treatment for symptomatic UTI|3
1482438|NCT00596635|4885407|P2|Overall Study|Treatment for symptomatic UTI|6
1482439|NCT00596635|4885408|P1|Overall Study|Treatment for symptomatic UTI|4
1482440|NCT00596635|4885406|P3|Overall Study|Lost to Follow-up|0
1482441|NCT00596635|4885407|P2|Overall Study|Lost to Follow-up|2
1482442|NCT00596635|4885408|P1|Overall Study|Lost to Follow-up|0
1482443|NCT00596466|4885434|P1|Overall Study|Enrolled, not treated|2
1482444|NCT00596466|4885434|P1|Overall Study|Unpecified|2
1482445|NCT00596466|4885434|P1|Overall Study|Protocol Violation|2
1482446|NCT00596466|4885434|P1|Overall Study|Withdrawal by Subject|2
1482447|NCT00596466|4885434|P1|Overall Study|Adverse Event|4
1482448|NCT00596466|4885434|P1|Overall Study|Lack of Efficacy|5
1482449|NCT00596427|4885464|P2|Overall Study|Protocol Violation|0
1482450|NCT00596427|4885465|P1|Overall Study|Protocol Violation|1
1482451|NCT00596427|4885464|P2|Overall Study|Increased Fasting Triacylglycerol level|0
1482452|NCT00596427|4885465|P1|Overall Study|Increased Fasting Triacylglycerol level|1
1482453|NCT00596427|4885464|P2|Overall Study|Withdrawal by Subject|2
1482454|NCT00596427|4885465|P1|Overall Study|Withdrawal by Subject|2
1482455|NCT00596362|4885493|P1|Overall Study|Progressive Disease|1
1482456|NCT00596011|4885529|P2|Overall Study|Adverse Event|7
1482457|NCT00596011|4885530|P1|Overall Study|Adverse Event|11
1482458|NCT00596011|4885529|P2|Overall Study|Withdrawal by Subject|3
1482459|NCT00596011|4885530|P1|Overall Study|Withdrawal by Subject|2
1482460|NCT00595959|4885546|P1|Overall Study|Lost to Follow-up|1
1482461|NCT00595959|4885546|P1|Overall Study|Withdrawal by Subject|1
1482462|NCT00595920|4885580|P1|Overall Study|The OLTERMS study was discontinued by th|116
1482463|NCT00595868|4885591|P2|Overall Study|Lost to Follow-up|50
1482464|NCT00595868|4885592|P1|Overall Study|Lost to Follow-up|45
1482465|NCT00595764|4885615|P2|Overall Study|Withdrawal by Subject|0
1482466|NCT00595764|4885616|P1|Overall Study|Withdrawal by Subject|4
1482467|NCT00595764|4885615|P2|Overall Study|Missed 3 PM visits|7
1482468|NCT00595764|4885616|P1|Overall Study|Missed 3 PM visits|1
1482469|NCT00595764|4885615|P2|Overall Study|Missed Medication >1 week|17
1482470|NCT00595764|4885616|P1|Overall Study|Missed Medication >1 week|10
1482471|NCT00595764|4885615|P2|Overall Study|Protocol Violation|19
1482472|NCT00595764|4885616|P1|Overall Study|Protocol Violation|24
1482473|NCT00595582|4885630|P1|Overall Study|Physician Decision|5
1482474|NCT00595582|4885630|P1|Overall Study|Adverse Event|2
1482475|NCT00595582|4885630|P1|Overall Study|Lost to Follow-up|1
1482476|NCT00595582|4885630|P1|Overall Study|Pilot study that PI terminated|2
1482477|NCT00595517|4885655|P1|Overall Study|No intention to attend regularly|1
1482478|NCT00595517|4885655|P1|Overall Study|usage of prohibited treatment|1
1482479|NCT00595517|4885655|P1|Overall Study|Recurrence of ulcer|5
1482480|NCT00595517|4885655|P1|Overall Study|Protocol Violation|2
1482481|NCT00595517|4885655|P1|Overall Study|Withdrawal by Subject|4
1482482|NCT00595517|4885655|P1|Overall Study|Adverse Event|6
1482483|NCT00595504|4885664|P2|Overall Study|Physician Decision|0
1482484|NCT00595504|4885665|P1|Overall Study|Physician Decision|1
1482485|NCT00595504|4885664|P2|Overall Study|Withdrawal by Subject|3
1482486|NCT00595504|4885665|P1|Overall Study|Withdrawal by Subject|1
1482487|NCT00595478|4885677|P2|36-week Follow-up Period|Withdrawal by Subject|4
1482488|NCT00595478|4885678|P1|36-week Follow-up Period|Withdrawal by Subject|4
1482489|NCT00595478|4885677|P2|36-week Follow-up Period|Lost to Follow-up|4
1482490|NCT00595478|4885678|P1|36-week Follow-up Period|Lost to Follow-up|5
1482491|NCT00595465|4885689|P3|Overall Study|administrative reason|1
1482492|NCT00595465|4885690|P2|Overall Study|administrative reason|0
1482493|NCT00595465|4885691|P1|Overall Study|administrative reason|0
1482494|NCT00595465|4885689|P3|Overall Study|Lost to Follow-up|2
1482495|NCT00595465|4885690|P2|Overall Study|Lost to Follow-up|0
1482496|NCT00595465|4885691|P1|Overall Study|Lost to Follow-up|0
1482497|NCT00595465|4885689|P3|Overall Study|Protocol Violation|0
1482498|NCT00595465|4885690|P2|Overall Study|Protocol Violation|1
1482499|NCT00595465|4885691|P1|Overall Study|Protocol Violation|2
1482500|NCT00595465|4885689|P3|Overall Study|Pregnancy|1
1482501|NCT00595465|4885690|P2|Overall Study|Pregnancy|0
1482502|NCT00595465|4885691|P1|Overall Study|Pregnancy|0
1482503|NCT00595465|4885689|P3|Overall Study|Adverse Event|3
1482504|NCT00595465|4885690|P2|Overall Study|Adverse Event|3
1482505|NCT00595465|4885691|P1|Overall Study|Adverse Event|4
1482506|NCT00595413|4885703|P4|Overall Study|Other|0
1482507|NCT00595413|4885704|P3|Overall Study|Other|5
1482508|NCT00595413|4885705|P2|Overall Study|Other|1
1482509|NCT00595413|4885706|P1|Overall Study|Other|5
1482510|NCT00595413|4885703|P4|Overall Study|Death|0
1482511|NCT00595413|4885704|P3|Overall Study|Death|1
1482512|NCT00595413|4885705|P2|Overall Study|Death|0
1482513|NCT00595413|4885706|P1|Overall Study|Death|0
1482514|NCT00595413|4885703|P4|Overall Study|Lost to Follow-up|3
1482515|NCT00595413|4885704|P3|Overall Study|Lost to Follow-up|1
1482516|NCT00595413|4885705|P2|Overall Study|Lost to Follow-up|2
1482517|NCT00595413|4885706|P1|Overall Study|Lost to Follow-up|2
1482518|NCT00595413|4885703|P4|Overall Study|Adverse Event|1
1482519|NCT00595413|4885704|P3|Overall Study|Adverse Event|1
1482520|NCT00595413|4885705|P2|Overall Study|Adverse Event|2
1482521|NCT00595413|4885706|P1|Overall Study|Adverse Event|0
1482522|NCT00595335|4885747|P2|Six Months to Twelve Months|Disease Progression|0
1482523|NCT00595335|4885748|P1|Six Months to Twelve Months|Disease Progression|1
1482524|NCT00595335|4885747|P2|Six Months to Twelve Months|Withdrawal by Subject|1
1482525|NCT00595335|4885748|P1|Six Months to Twelve Months|Withdrawal by Subject|0
1482526|NCT00595335|4885747|P2|Baseline to Six Months|Adverse Event|0
1482527|NCT00595335|4885748|P1|Baseline to Six Months|Adverse Event|1
1482528|NCT00595335|4885747|P2|Baseline to Six Months|Disease Progression|1
1482529|NCT00595335|4885748|P1|Baseline to Six Months|Disease Progression|1
1482530|NCT00595335|4885747|P2|Baseline to Six Months|Withdrawal by Subject|1
1482531|NCT00595335|4885748|P1|Baseline to Six Months|Withdrawal by Subject|0
1482532|NCT00595309|4885768|P1|Overall Study|personal reason|1
1482533|NCT00595309|4885768|P1|Overall Study|acute infection after V0|1
1482534|NCT00595309|4885768|P1|Overall Study|planned vaccination against yellow fever|1
1482535|NCT00595309|4885768|P1|Overall Study|Lost to Follow-up|1
1482536|NCT00595127|4885798|P1|Overall Study|joined another trial|1
1482537|NCT00595127|4885798|P1|Overall Study|Relapsed|3
1482538|NCT00595127|4885798|P1|Overall Study|Death|6
1482539|NCT00595075|4885820|P2|Overall Study|Withdrawal by Subject|0
1482540|NCT00595075|4885821|P1|Overall Study|Withdrawal by Subject|1
1482541|NCT00594958|4885842|P3|Overall Study|administrative|2
1482542|NCT00594958|4885843|P2|Overall Study|administrative|0
1482543|NCT00594958|4885844|P1|Overall Study|administrative|3
1482544|NCT00594958|4885842|P3|Overall Study|Lost to Follow-up|3
1482545|NCT00594958|4885843|P2|Overall Study|Lost to Follow-up|0
1482546|NCT00594958|4885844|P1|Overall Study|Lost to Follow-up|5
1482547|NCT00594958|4885842|P3|Overall Study|Protocol Violation|2
1482548|NCT00594958|4885843|P2|Overall Study|Protocol Violation|0
1482549|NCT00594958|4885844|P1|Overall Study|Protocol Violation|1
1482550|NCT00594958|4885842|P3|Overall Study|Pregnancy|0
1482551|NCT00594958|4885843|P2|Overall Study|Pregnancy|2
1482552|NCT00594958|4885844|P1|Overall Study|Pregnancy|0
1482553|NCT00594958|4885842|P3|Overall Study|Adverse Event|2
1482554|NCT00594958|4885843|P2|Overall Study|Adverse Event|1
1482555|NCT00594958|4885844|P1|Overall Study|Adverse Event|4
1482556|NCT00594958|4885842|P3|Overall Study|Withdrawal by Subject|1
1482557|NCT00594958|4885843|P2|Overall Study|Withdrawal by Subject|0
1482558|NCT00594958|4885844|P1|Overall Study|Withdrawal by Subject|1
1482559|NCT00594906|4885865|P2|Overall Study|Death|1
1482560|NCT00594906|4885866|P1|Overall Study|Death|0
1482561|NCT00594906|4885865|P2|Overall Study|Physician Decision|1
1482562|NCT00594906|4885866|P1|Overall Study|Physician Decision|0
1482563|NCT00594906|4885865|P2|Overall Study|Physician Decision|0
1482564|NCT00594906|4885866|P1|Overall Study|Physician Decision|1
1482565|NCT00594880|4885874|P2|Overall Study|Lost to Follow-up|0
1482566|NCT00594880|4885875|P1|Overall Study|Lost to Follow-up|1
1482567|NCT00594880|4885874|P2|Overall Study|Withdrawal by Subject|1
1482568|NCT00594880|4885875|P1|Overall Study|Withdrawal by Subject|1
1482569|NCT00594854|4885887|P2|Overall Study|Study terminated|10
1482570|NCT00594854|4885888|P1|Overall Study|Study terminated|7
1482571|NCT00594815|4885898|P1|Overall Study|Toxicity|4
1482572|NCT00594815|4885898|P1|Overall Study|Withdrawal by Subject|2
1482573|NCT00594815|4885898|P1|Overall Study|Never Treated|3
1482574|NCT00594659|4885923|P3|Overall Study|Lost to Follow-up|7
1482575|NCT00594659|4885924|P2|Overall Study|Lost to Follow-up|9
1482576|NCT00594659|4885925|P1|Overall Study|Lost to Follow-up|13
1482577|NCT00594646|4885936|P1|Overall Study|Lost to Follow-up|15
1482578|NCT00594646|4885936|P1|Overall Study|Withdrawal by Subject|1
1482579|NCT00594568|4885944|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
1482580|NCT00594568|4885945|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
1482581|NCT00594568|4885946|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
1482582|NCT00594568|4885944|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
1482583|NCT00594568|4885945|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
1482584|NCT00594568|4885946|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
1482585|NCT00594568|4885944|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
1482586|NCT00594568|4885945|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
1482587|NCT00594568|4885946|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
1482588|NCT00594568|4885944|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
1482589|NCT00594568|4885945|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
1482590|NCT00594568|4885946|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
1482591|NCT00594568|4885944|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
1482592|NCT00594568|4885945|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
1482593|NCT00594568|4885946|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
1482594|NCT00594568|4885944|P3|Safety Follow Up (SFU)-Optional|Death|0
1482595|NCT00594568|4885945|P2|Safety Follow Up (SFU)-Optional|Death|1
1482596|NCT00594568|4885946|P1|Safety Follow Up (SFU)-Optional|Death|0
1482597|NCT00594568|4885944|P3|Delayed Start|Sponsor Decision|59
1482598|NCT00594568|4885945|P2|Delayed Start|Sponsor Decision|66
1482599|NCT00594568|4885946|P1|Delayed Start|Sponsor Decision|77
1482600|NCT00594568|4885944|P3|Delayed Start|Caregiver Decision|2
1482601|NCT00594568|4885945|P2|Delayed Start|Caregiver Decision|6
1482602|NCT00594568|4885946|P1|Delayed Start|Caregiver Decision|5
1482603|NCT00594568|4885944|P3|Delayed Start|Lost to Follow-up|1
1482604|NCT00594568|4885945|P2|Delayed Start|Lost to Follow-up|0
1482605|NCT00594568|4885946|P1|Delayed Start|Lost to Follow-up|0
1482606|NCT00594568|4885944|P3|Delayed Start|Physician Decision|1
1482607|NCT00594568|4885945|P2|Delayed Start|Physician Decision|0
1482608|NCT00594568|4885946|P1|Delayed Start|Physician Decision|0
1482609|NCT00594568|4885944|P3|Delayed Start|Withdrawal by Subject|0
1482610|NCT00594568|4885945|P2|Delayed Start|Withdrawal by Subject|3
1482611|NCT00594568|4885946|P1|Delayed Start|Withdrawal by Subject|4
1482612|NCT00594568|4885944|P3|Delayed Start|Adverse Event|2
1482613|NCT00594568|4885945|P2|Delayed Start|Adverse Event|2
1482614|NCT00594568|4885946|P1|Delayed Start|Adverse Event|12
1482615|NCT00594568|4885944|P3|Delayed Start|Death|1
1482616|NCT00594568|4885945|P2|Delayed Start|Death|0
1482617|NCT00594568|4885946|P1|Delayed Start|Death|0
1482618|NCT00594568|4885944|P3|Initial Treatment|Entry criteria exclusion|1
1482619|NCT00594568|4885945|P2|Initial Treatment|Entry criteria exclusion|1
1482620|NCT00594568|4885946|P1|Initial Treatment|Entry criteria exclusion|0
1482621|NCT00594568|4885944|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
1482622|NCT00594568|4885945|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
1482623|NCT00594568|4885946|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
1482624|NCT00594568|4885944|P3|Initial Treatment|Caregiver decision|36
1482625|NCT00594568|4885945|P2|Initial Treatment|Caregiver decision|36
1482626|NCT00594568|4885946|P1|Initial Treatment|Caregiver decision|21
1482627|NCT00594568|4885944|P3|Initial Treatment|Sponsor decision|147
1482628|NCT00594568|4885945|P2|Initial Treatment|Sponsor decision|142
1482629|NCT00594568|4885946|P1|Initial Treatment|Sponsor decision|193
1482630|NCT00594568|4885944|P3|Initial Treatment|Withdrawal by Subject|46
1482631|NCT00594568|4885945|P2|Initial Treatment|Withdrawal by Subject|31
1482632|NCT00594568|4885946|P1|Initial Treatment|Withdrawal by Subject|25
1482633|NCT00594568|4885944|P3|Initial Treatment|Protocol Violation|5
1482634|NCT00594568|4885945|P2|Initial Treatment|Protocol Violation|2
1482635|NCT00594568|4885946|P1|Initial Treatment|Protocol Violation|2
1482636|NCT00594568|4885944|P3|Initial Treatment|Physician Decision|4
1482637|NCT00594568|4885945|P2|Initial Treatment|Physician Decision|2
1482638|NCT00594568|4885946|P1|Initial Treatment|Physician Decision|3
1482639|NCT00594568|4885944|P3|Initial Treatment|Lost to Follow-up|4
1482640|NCT00594568|4885945|P2|Initial Treatment|Lost to Follow-up|1
1482641|NCT00594568|4885946|P1|Initial Treatment|Lost to Follow-up|4
1482642|NCT00594568|4885944|P3|Initial Treatment|Death|15
1482643|NCT00594568|4885945|P2|Initial Treatment|Death|11
1482644|NCT00594568|4885946|P1|Initial Treatment|Death|6
1482645|NCT00594568|4885944|P3|Initial Treatment|Adverse Event|144
1482646|NCT00594568|4885945|P2|Initial Treatment|Adverse Event|121
1482647|NCT00594568|4885946|P1|Initial Treatment|Adverse Event|51
1482648|NCT00594516|4886034|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
1482649|NCT00594516|4886035|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
1482650|NCT00594516|4886036|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
1482651|NCT00594516|4886034|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
1482652|NCT00594516|4886035|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
1482653|NCT00594516|4886036|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
1482654|NCT00594516|4886034|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
1482655|NCT00594516|4886035|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
1482656|NCT00594516|4886036|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
1482657|NCT00594516|4886034|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
1482658|NCT00594516|4886035|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
1482659|NCT00594516|4886036|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
1482660|NCT00594516|4886034|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
1482661|NCT00594516|4886035|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
1482662|NCT00594516|4886036|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
1482663|NCT00594516|4886034|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
1482664|NCT00594516|4886035|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
1482665|NCT00594516|4886036|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
1482666|NCT00594516|4886034|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
1482667|NCT00594516|4886035|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
1482668|NCT00594516|4886036|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
1482669|NCT00594516|4886034|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
1482670|NCT00594516|4886035|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
1482671|NCT00594516|4886036|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
1482672|NCT00594516|4886034|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
1482673|NCT00594516|4886035|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
1482674|NCT00594516|4886036|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
1482675|NCT00594464|4886044|P1|Overall Study|Delay in operation|2
1482676|NCT00594464|4886044|P1|Overall Study|Withdrawal by Subject|1
1482677|NCT00594399|4886173|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
1482678|NCT00594399|4886174|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
1482679|NCT00594399|4886175|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
1482680|NCT00594399|4886173|P3|Rerandomization Arm 1 Only|Death|0
1482681|NCT00594399|4886174|P2|Rerandomization Arm 1 Only|Death|1
1482682|NCT00594399|4886175|P1|Rerandomization Arm 1 Only|Death|2
1482683|NCT00594399|4886173|P3|Initial 3 Month Counseling|Family illness|0
1482684|NCT00594399|4886174|P2|Initial 3 Month Counseling|Family illness|0
1482685|NCT00594399|4886175|P1|Initial 3 Month Counseling|Family illness|1
1482686|NCT00594399|4886173|P3|Initial 3 Month Counseling|Moved|0
1482687|NCT00594399|4886174|P2|Initial 3 Month Counseling|Moved|0
1482688|NCT00594399|4886175|P1|Initial 3 Month Counseling|Moved|1
1482689|NCT00594399|4886173|P3|Initial 3 Month Counseling|Pain|0
1482690|NCT00594399|4886174|P2|Initial 3 Month Counseling|Pain|0
1482691|NCT00594399|4886175|P1|Initial 3 Month Counseling|Pain|2
1482692|NCT00594399|4886173|P3|Initial 3 Month Counseling|Too busy|0
1482693|NCT00594399|4886174|P2|Initial 3 Month Counseling|Too busy|1
1482694|NCT00594399|4886175|P1|Initial 3 Month Counseling|Too busy|7
1482695|NCT00594399|4886173|P3|Initial 3 Month Counseling|Personal issues|0
1482696|NCT00594399|4886174|P2|Initial 3 Month Counseling|Personal issues|0
1482697|NCT00594399|4886175|P1|Initial 3 Month Counseling|Personal issues|2
1482698|NCT00594399|4886173|P3|Initial 3 Month Counseling|Lack of Interest|0
1482699|NCT00594399|4886174|P2|Initial 3 Month Counseling|Lack of Interest|3
1482700|NCT00594399|4886175|P1|Initial 3 Month Counseling|Lack of Interest|3
1482701|NCT00594399|4886173|P3|Initial 3 Month Counseling|Not ready to exercise|0
1482702|NCT00594399|4886174|P2|Initial 3 Month Counseling|Not ready to exercise|0
1482703|NCT00594399|4886175|P1|Initial 3 Month Counseling|Not ready to exercise|1
1482704|NCT00594386|4886197|P1|Overall Study|Other: Loss of drivers license|1
1482705|NCT00594386|4886197|P1|Overall Study|Other: Patient wants prescription Neupro|1
1482706|NCT00594386|4886197|P1|Overall Study|Other: Site terminated participation|1
1482707|NCT00594386|4886197|P1|Overall Study|Other: Sponsor closure of study|1
1482708|NCT00594386|4886197|P1|Overall Study|Other: Study terminated per investigator|2
1482709|NCT00594386|4886197|P1|Overall Study|Other: Subject admitted to nursing home|1
1482710|NCT00594386|4886197|P1|Overall Study|Other: Subject moved to Seattle|1
1482711|NCT00594386|4886197|P1|Overall Study|Other: Patient went off patch (hospital)|1
1482712|NCT00594386|4886197|P1|Overall Study|Lost to Follow-up|6
1482713|NCT00594386|4886197|P1|Overall Study|Study ended per sponsor|115
1482714|NCT00594386|4886197|P1|Overall Study|Subject withdrew consent|35
1482715|NCT00594386|4886197|P1|Overall Study|Unsatisfactory compliance of subject|11
1482716|NCT00594386|4886197|P1|Overall Study|Adverse Event|68
1482717|NCT00594386|4886197|P1|Overall Study|Lack of Efficacy|12
1482718|NCT00594386|4886197|P1|Overall Study|Major protocol violation|2
1482719|NCT00594204|4886230|P2|Overall Study|Randomized but not treated|1
1482720|NCT00594204|4886231|P1|Overall Study|Randomized but not treated|4
1482721|NCT00594204|4886230|P2|Overall Study|Lack of Efficacy|4
1482722|NCT00594204|4886231|P1|Overall Study|Lack of Efficacy|3
1482723|NCT00594204|4886230|P2|Overall Study|Other|3
1482724|NCT00594204|4886231|P1|Overall Study|Other|4
1482725|NCT00594204|4886230|P2|Overall Study|Withdrawal by Subject|29
1482726|NCT00594204|4886231|P1|Overall Study|Withdrawal by Subject|23
1482727|NCT00594204|4886230|P2|Overall Study|Lost to Follow-up|5
1482728|NCT00594204|4886231|P1|Overall Study|Lost to Follow-up|9
1482729|NCT00594204|4886230|P2|Overall Study|Adverse Event|3
1482730|NCT00594204|4886231|P1|Overall Study|Adverse Event|15
1482731|NCT00594178|4886241|P1|Overall Study|Physician Decision|5
1482732|NCT00594165|4886246|P1|Overall Study|Other: Site terminated participation|2
1482733|NCT00594165|4886246|P1|Overall Study|Other: Subject enrolled in other trial|1
1482734|NCT00594165|4886246|P1|Overall Study|Other: House bound; can't get to clinic|1
1482735|NCT00594165|4886246|P1|Overall Study|Other: Brain surgery controlled symptoms|1
1482736|NCT00594165|4886246|P1|Overall Study|Other: Subject moving|3
1482737|NCT00594165|4886246|P1|Overall Study|Other: PI discretion|5
1482738|NCT00594165|4886246|P1|Overall Study|Lost to Follow-up|4
1482739|NCT00594165|4886246|P1|Overall Study|Study ended per sponsor|102
1482740|NCT00594165|4886246|P1|Overall Study|Subject withdrew consent|27
1482741|NCT00594165|4886246|P1|Overall Study|Unsatisfactory compliance of subject|6
1482742|NCT00594165|4886246|P1|Overall Study|Adverse Event|52
1482743|NCT00594165|4886246|P1|Overall Study|Lack of Efficacy|12
1482744|NCT00594165|4886246|P1|Overall Study|Major protocol violation|1
1482745|NCT00594100|4886252|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
1482746|NCT00594100|4886252|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
1482747|NCT00594100|4886252|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
1482748|NCT00594100|4886252|P1|Procedure|Technical Failure|9
1482749|NCT00594035|4886268|P2|Overall Study|Subject couldn't return due to job|1
1482750|NCT00594035|4886269|P1|Overall Study|Subject couldn't return due to job|0
1482751|NCT00594035|4886268|P2|Overall Study|Subject transferred to nursing home|1
1482752|NCT00594035|4886269|P1|Overall Study|Subject transferred to nursing home|0
1482753|NCT00594035|4886268|P2|Overall Study|Withdrawal by Subject|0
1482754|NCT00594035|4886269|P1|Overall Study|Withdrawal by Subject|1
1482755|NCT00594035|4886268|P2|Overall Study|Lost to Follow-up|1
1482756|NCT00594035|4886269|P1|Overall Study|Lost to Follow-up|1
1482757|NCT00593957|4886295|P3|Overall Study|Physician Decision|2
1482758|NCT00593957|4886296|P2|Overall Study|Physician Decision|1
1482759|NCT00593957|4886297|P1|Overall Study|Physician Decision|0
1482760|NCT00593918|4886321|P2|Overall Study|Withdrawal by Subject|24
1482761|NCT00593918|4886322|P1|Overall Study|Withdrawal by Subject|5
1482762|NCT00593840|4886335|P1|Overall Study|Withdrawal by Subject|1
1482763|NCT00593827|4886347|P2|Overall Study|On Active Treatment/Pending|2
1482764|NCT00593827|4886348|P1|Overall Study|On Active Treatment/Pending|0
1482765|NCT00593814|4886372|P2|Overall Study|Physician Decision|0
1482766|NCT00593814|4886373|P1|Overall Study|Physician Decision|3
1482767|NCT00593814|4886372|P2|Overall Study|Lost to Follow-up|0
1482768|NCT00593814|4886373|P1|Overall Study|Lost to Follow-up|7
1482769|NCT00593814|4886372|P2|Overall Study|Withdrawal by Subject|0
1482770|NCT00593814|4886373|P1|Overall Study|Withdrawal by Subject|7
1482771|NCT00593814|4886372|P2|Overall Study|Death|0
1482772|NCT00593814|4886373|P1|Overall Study|Death|7
1482773|NCT00593736|4886385|P4|Treatment Period and Placebo Run-out|Various|0
1482774|NCT00593736|4886386|P3|Treatment Period and Placebo Run-out|Various|1
1482775|NCT00593736|4886387|P2|Treatment Period and Placebo Run-out|Various|1
1482776|NCT00593736|4886388|P1|Treatment Period and Placebo Run-out|Various|1
1482777|NCT00593736|4886385|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
1482778|NCT00593736|4886386|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
1482779|NCT00593736|4886387|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
1482780|NCT00593736|4886388|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
1482781|NCT00593736|4886385|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
1482782|NCT00593736|4886386|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
1482783|NCT00593736|4886387|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
1482784|NCT00593736|4886388|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
1482785|NCT00593736|4886385|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
1482786|NCT00593736|4886386|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
1482787|NCT00593736|4886387|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
1482788|NCT00593736|4886388|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
1482789|NCT00593736|4886385|P4|Screening Period and Placebo Run-in|Various|25
1482790|NCT00593736|4886386|P3|Screening Period and Placebo Run-in|Various|0
1482791|NCT00593736|4886387|P2|Screening Period and Placebo Run-in|Various|0
1482792|NCT00593736|4886388|P1|Screening Period and Placebo Run-in|Various|0
1482793|NCT00593736|4886385|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
1482794|NCT00593736|4886386|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
1482795|NCT00593736|4886387|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
1482796|NCT00593736|4886388|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
1482797|NCT00593736|4886385|P4|Screening Period and Placebo Run-in|Study Termination|15
1482798|NCT00593736|4886386|P3|Screening Period and Placebo Run-in|Study Termination|0
1482799|NCT00593736|4886387|P2|Screening Period and Placebo Run-in|Study Termination|0
1482800|NCT00593736|4886388|P1|Screening Period and Placebo Run-in|Study Termination|0
1482801|NCT00593736|4886385|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
1482802|NCT00593736|4886386|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
1482803|NCT00593736|4886387|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
1482804|NCT00593736|4886388|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
1482805|NCT00593736|4886385|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
1482806|NCT00593736|4886386|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
1482807|NCT00593736|4886387|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
1482808|NCT00593736|4886388|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
1482809|NCT00593736|4886385|P4|Screening Period and Placebo Run-in|Adverse Event|3
1482810|NCT00593736|4886386|P3|Screening Period and Placebo Run-in|Adverse Event|0
1482811|NCT00593736|4886387|P2|Screening Period and Placebo Run-in|Adverse Event|0
1482812|NCT00593736|4886388|P1|Screening Period and Placebo Run-in|Adverse Event|0
1482813|NCT00593684|4886636|P2|Overall Study|Death|1
1482814|NCT00593684|4886637|P1|Overall Study|Death|2
1482815|NCT00593606|4886663|P1|Overall Study|Screen Failure|3
1482816|NCT00593606|4886663|P1|Overall Study|Run-In Failure|5
1482817|NCT00593606|4886663|P1|Overall Study|Lost to Follow-up|2
1482818|NCT00593606|4886663|P1|Overall Study|Protocol Violation|3
1482819|NCT00593606|4886663|P1|Overall Study|Withdrawal by Subject|1
1482820|NCT00593606|4886663|P1|Overall Study|Adverse Event|13
1482821|NCT00593554|4886761|P2|Overall Study|Disease Progression|2
1482822|NCT00593554|4886762|P1|Overall Study|Disease Progression|1
1482823|NCT00593554|4886761|P2|Overall Study|Withdrawal by Subject|0
1482824|NCT00593554|4886762|P1|Overall Study|Withdrawal by Subject|1
1482825|NCT00593554|4886761|P2|Overall Study|Physician Decision|1
1482826|NCT00593554|4886762|P1|Overall Study|Physician Decision|0
1482827|NCT00593554|4886761|P2|Overall Study|Death|2
1482828|NCT00593554|4886762|P1|Overall Study|Death|1
1482829|NCT00593385|4886857|P1|Overall Study|Withdrawal by Subject|9
1482830|NCT00593385|4886857|P1|Overall Study|Lost to Follow-up|17
1482831|NCT00593385|4886857|P1|Overall Study|Death|14
1482832|NCT00593333|4886918|P2|Overall Study|Lost to Follow-up|11
1482833|NCT00593333|4886919|P1|Overall Study|Lost to Follow-up|10
1482834|NCT00593112|4886942|P2|Overall Study|Withdrawal by Subject|0
1482835|NCT00593112|4886943|P1|Overall Study|Withdrawal by Subject|5
1482836|NCT00593112|4886942|P2|Overall Study|Unreadable Scan|0
1482837|NCT00593112|4886943|P1|Overall Study|Unreadable Scan|1
1482838|NCT00593112|4886942|P2|Overall Study|Abnormal Scan|0
1482839|NCT00593112|4886943|P1|Overall Study|Abnormal Scan|1
1482840|NCT00593112|4886942|P2|Overall Study|Scan Anxiety|0
1482841|NCT00593112|4886943|P1|Overall Study|Scan Anxiety|3
1482842|NCT00592904|4886970|P4|Overall Study|Not specified|0
1482843|NCT00592904|4886971|P3|Overall Study|Not specified|0
1482844|NCT00592904|4886972|P2|Overall Study|Not specified|3
1482845|NCT00592904|4886973|P1|Overall Study|Not specified|3
1482846|NCT00592904|4886970|P4|Overall Study|Physician Decision|0
1482847|NCT00592904|4886971|P3|Overall Study|Physician Decision|1
1482848|NCT00592904|4886972|P2|Overall Study|Physician Decision|3
1482849|NCT00592904|4886973|P1|Overall Study|Physician Decision|0
1482850|NCT00592904|4886970|P4|Overall Study|Lack of Efficacy|3
1482851|NCT00592904|4886971|P3|Overall Study|Lack of Efficacy|2
1482852|NCT00592904|4886972|P2|Overall Study|Lack of Efficacy|7
1482853|NCT00592904|4886973|P1|Overall Study|Lack of Efficacy|2
1482854|NCT00592904|4886970|P4|Overall Study|Withdrawal by Subject|2
1482855|NCT00592904|4886971|P3|Overall Study|Withdrawal by Subject|1
1482856|NCT00592904|4886972|P2|Overall Study|Withdrawal by Subject|16
1482857|NCT00592904|4886973|P1|Overall Study|Withdrawal by Subject|4
1482858|NCT00592904|4886970|P4|Overall Study|Protocol Violation|1
1482859|NCT00592904|4886971|P3|Overall Study|Protocol Violation|0
1482860|NCT00592904|4886972|P2|Overall Study|Protocol Violation|1
1482861|NCT00592904|4886973|P1|Overall Study|Protocol Violation|1
1482862|NCT00592904|4886970|P4|Overall Study|Adverse Event|5
1482863|NCT00592904|4886971|P3|Overall Study|Adverse Event|13
1482864|NCT00592904|4886972|P2|Overall Study|Adverse Event|25
1482865|NCT00592904|4886973|P1|Overall Study|Adverse Event|15
1482866|NCT00592852|4886999|P1|Overall Study|Withdrawal by Subject|1
1482867|NCT00592852|4886999|P1|Overall Study|Found ineligible|1
1482868|NCT00592852|4886999|P1|Overall Study|Adverse Event|3
1482869|NCT00592852|4886999|P1|Overall Study|Non-compliance|1
1482870|NCT00592839|4887007|P3|Overall Study|Lost to Follow-up|1
1482871|NCT00592839|4887008|P2|Overall Study|Lost to Follow-up|1
1482872|NCT00592839|4887009|P1|Overall Study|Lost to Follow-up|0
1482873|NCT00592839|4887007|P3|Overall Study|Adverse Event|0
1482874|NCT00592839|4887008|P2|Overall Study|Adverse Event|1
1482875|NCT00592839|4887009|P1|Overall Study|Adverse Event|0
1482876|NCT00592839|4887007|P3|Overall Study|Protocol Violation|2
1482877|NCT00592839|4887008|P2|Overall Study|Protocol Violation|1
1482878|NCT00592839|4887009|P1|Overall Study|Protocol Violation|1
1482879|NCT00592839|4887007|P3|Overall Study|Withdrawal by Subject|3
1482880|NCT00592839|4887008|P2|Overall Study|Withdrawal by Subject|1
1482881|NCT00592839|4887009|P1|Overall Study|Withdrawal by Subject|1
1482882|NCT00592774|4887037|P5|Overall Study|Not specified|2
1482883|NCT00592774|4887038|P4|Overall Study|Not specified|0
1482884|NCT00592774|4887039|P3|Overall Study|Not specified|1
1482885|NCT00592774|4887040|P2|Overall Study|Not specified|1
1482886|NCT00592774|4887041|P1|Overall Study|Not specified|0
1482887|NCT00592774|4887037|P5|Overall Study|Physician Decision|1
1482888|NCT00592774|4887038|P4|Overall Study|Physician Decision|0
1482889|NCT00592774|4887039|P3|Overall Study|Physician Decision|1
1482890|NCT00592774|4887040|P2|Overall Study|Physician Decision|1
1482891|NCT00592774|4887041|P1|Overall Study|Physician Decision|0
1482892|NCT00592774|4887037|P5|Overall Study|Lack of Efficacy|2
1482893|NCT00592774|4887038|P4|Overall Study|Lack of Efficacy|0
1482894|NCT00592774|4887039|P3|Overall Study|Lack of Efficacy|0
1482895|NCT00592774|4887040|P2|Overall Study|Lack of Efficacy|3
1482896|NCT00592774|4887041|P1|Overall Study|Lack of Efficacy|3
1482897|NCT00592774|4887037|P5|Overall Study|Withdrawal by Subject|0
1482898|NCT00592774|4887038|P4|Overall Study|Withdrawal by Subject|0
1482899|NCT00592774|4887039|P3|Overall Study|Withdrawal by Subject|0
1482900|NCT00592774|4887040|P2|Overall Study|Withdrawal by Subject|7
1482901|NCT00592774|4887041|P1|Overall Study|Withdrawal by Subject|3
1482902|NCT00592774|4887037|P5|Overall Study|Protocol Violation|1
1482903|NCT00592774|4887038|P4|Overall Study|Protocol Violation|0
1482904|NCT00592774|4887039|P3|Overall Study|Protocol Violation|0
1482905|NCT00592774|4887040|P2|Overall Study|Protocol Violation|1
1482906|NCT00592774|4887041|P1|Overall Study|Protocol Violation|0
1482907|NCT00592774|4887037|P5|Overall Study|Adverse Event|8
1482908|NCT00592774|4887038|P4|Overall Study|Adverse Event|14
1482909|NCT00592774|4887039|P3|Overall Study|Adverse Event|2
1482910|NCT00592774|4887040|P2|Overall Study|Adverse Event|19
1482911|NCT00592774|4887041|P1|Overall Study|Adverse Event|5
1482912|NCT00592683|4887113|P2|Overall Study|Lost to Follow-up|1
1482913|NCT00592683|4887114|P1|Overall Study|Lost to Follow-up|0
1482914|NCT00592683|4887113|P2|Overall Study|Other|0
1482915|NCT00592683|4887114|P1|Overall Study|Other|1
1482916|NCT00592683|4887113|P2|Overall Study|Study drug expired|0
1482917|NCT00592683|4887114|P1|Overall Study|Study drug expired|1
1482918|NCT00592683|4887113|P2|Overall Study|Protocol Violation|0
1482919|NCT00592683|4887114|P1|Overall Study|Protocol Violation|1
1482920|NCT00592683|4887113|P2|Overall Study|Adverse Event|2
1482921|NCT00592683|4887114|P1|Overall Study|Adverse Event|0
1482922|NCT00592683|4887113|P2|Overall Study|Withdrawal by Subject|0
1482923|NCT00592683|4887114|P1|Overall Study|Withdrawal by Subject|1
1482924|NCT00592683|4887113|P2|Overall Study|Found ineligible|1
1482925|NCT00592683|4887114|P1|Overall Study|Found ineligible|0
1482926|NCT00592631|4887124|P2|Overall Study|Lost to Follow-up|2
1482927|NCT00592631|4887125|P1|Overall Study|Lost to Follow-up|0
1482928|NCT00592384|4887174|P2|Overall Study|Withdrawal by Subject|6
1482929|NCT00592384|4887175|P1|Overall Study|Withdrawal by Subject|5
1482930|NCT00592358|4887183|P1|Overall Study|Inability to swallow pills|1
1482931|NCT00592358|4887183|P1|Overall Study|Lack of Efficacy|2
1482932|NCT00592358|4887183|P1|Overall Study|Adverse Event|1
1482933|NCT00592358|4887183|P1|Overall Study|Withdrawal by Subject|2
1482934|NCT00592319|4887190|P2|Overall Study|Lost to Follow-up|3
1482935|NCT00592319|4887191|P1|Overall Study|Lost to Follow-up|0
1482936|NCT00592072|4887266|P2|Wash Out Period|Lost to Follow-up|1
1482937|NCT00592072|4887267|P1|Wash Out Period|Lost to Follow-up|1
1482938|NCT00592007|4887289|P1|Overall Study|patient ineligible (out of lab range)|1
1482939|NCT00592007|4887289|P1|Overall Study|Withdrawal by Subject|1
1482940|NCT00591864|4887301|P1|Overall Study|Incomplete Imaging|5
1482941|NCT00591851|4887307|P1|Overall Study|Progressive Disease|1
1482942|NCT00591851|4887307|P1|Overall Study|Adverse Event|2
1482943|NCT00591851|4887307|P1|Overall Study|Withdrawal by Subject|3
1482944|NCT00591773|4887347|P3|Overall Study|Other|4
1482945|NCT00591773|4887348|P2|Overall Study|Other|1
1482946|NCT00591773|4887349|P1|Overall Study|Other|1
1482947|NCT00591773|4887347|P3|Overall Study|Lack of Efficacy|2
1482948|NCT00591773|4887348|P2|Overall Study|Lack of Efficacy|2
1482949|NCT00591773|4887349|P1|Overall Study|Lack of Efficacy|1
1482950|NCT00591773|4887347|P3|Overall Study|Withdrawal by Subject|3
1482951|NCT00591773|4887348|P2|Overall Study|Withdrawal by Subject|5
1482952|NCT00591773|4887349|P1|Overall Study|Withdrawal by Subject|2
1482953|NCT00591773|4887347|P3|Overall Study|Lost to Follow-up|1
1482954|NCT00591773|4887348|P2|Overall Study|Lost to Follow-up|4
1482955|NCT00591773|4887349|P1|Overall Study|Lost to Follow-up|1
1482956|NCT00591773|4887347|P3|Overall Study|Protocol Violation|0
1482957|NCT00591773|4887348|P2|Overall Study|Protocol Violation|3
1482958|NCT00591773|4887349|P1|Overall Study|Protocol Violation|2
1482959|NCT00591773|4887347|P3|Overall Study|Adverse Event|6
1482960|NCT00591773|4887348|P2|Overall Study|Adverse Event|9
1482961|NCT00591773|4887349|P1|Overall Study|Adverse Event|9
1482962|NCT00591734|4887408|P1|Overall Study|Intercurrent Illness|8
1482963|NCT00591734|4887408|P1|Overall Study|Physician Decision|5
1482964|NCT00591734|4887408|P1|Overall Study|Adverse Event|5
1482965|NCT00591734|4887408|P1|Overall Study|Lack of Efficacy|35
1482966|NCT00591721|4887414|P2|Overall Study|Intervention not received|8
1482967|NCT00591721|4887415|P1|Overall Study|Intervention not received|10
1482968|NCT00591721|4887414|P2|Overall Study|Lost to Follow-up|4
1482969|NCT00591721|4887415|P1|Overall Study|Lost to Follow-up|1
1482970|NCT00591721|4887414|P2|Overall Study|Withdrawal by Subject|10
1482971|NCT00591721|4887415|P1|Overall Study|Withdrawal by Subject|10
1482972|NCT00591591|4887423|P2|Overall Study|Lack of Efficacy|2
1482973|NCT00591591|4887424|P1|Overall Study|Lack of Efficacy|10
1482974|NCT00591591|4887423|P2|Overall Study|Withdrawal by Subject|37
1482975|NCT00591591|4887424|P1|Overall Study|Withdrawal by Subject|1
1482976|NCT00591578|4887441|P3|Open-Label Extension Phase|Other|0
1482977|NCT00591578|4887442|P2|Open-Label Extension Phase|Other|0
1482978|NCT00591578|4887443|P1|Open-Label Extension Phase|Other|1
1482979|NCT00591578|4887441|P3|Open-Label Extension Phase|Withdrawal by Subject|0
1482980|NCT00591578|4887442|P2|Open-Label Extension Phase|Withdrawal by Subject|1
1482981|NCT00591578|4887443|P1|Open-Label Extension Phase|Withdrawal by Subject|1
1482982|NCT00591578|4887441|P3|Open-Label Extension Phase|Lost to Follow-up|0
1482983|NCT00591578|4887442|P2|Open-Label Extension Phase|Lost to Follow-up|4
1482984|NCT00591578|4887443|P1|Open-Label Extension Phase|Lost to Follow-up|1
1482985|NCT00591578|4887441|P3|Open-Label Extension Phase|Adverse Event|0
1482986|NCT00591578|4887442|P2|Open-Label Extension Phase|Adverse Event|5
1482987|NCT00591578|4887443|P1|Open-Label Extension Phase|Adverse Event|3
1482988|NCT00591578|4887441|P3|Double-Blind Treatment Phase|Other|4
1482989|NCT00591578|4887442|P2|Double-Blind Treatment Phase|Other|9
1482990|NCT00591578|4887443|P1|Double-Blind Treatment Phase|Other|4
1482991|NCT00591578|4887441|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
1482992|NCT00591578|4887442|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
1482993|NCT00591578|4887443|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
1482994|NCT00591578|4887441|P3|Double-Blind Treatment Phase|Pregnancy|0
1482995|NCT00591578|4887442|P2|Double-Blind Treatment Phase|Pregnancy|0
1482996|NCT00591578|4887443|P1|Double-Blind Treatment Phase|Pregnancy|1
1482997|NCT00591578|4887441|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
1482998|NCT00591578|4887442|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
1482999|NCT00591578|4887443|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
1483000|NCT00591578|4887441|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
1483001|NCT00591578|4887442|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
1483002|NCT00591578|4887443|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
1483003|NCT00591578|4887441|P3|Double-Blind Treatment Phase|Protocol Violation|3
1483004|NCT00591578|4887442|P2|Double-Blind Treatment Phase|Protocol Violation|2
1483005|NCT00591578|4887443|P1|Double-Blind Treatment Phase|Protocol Violation|3
1483006|NCT00591578|4887441|P3|Double-Blind Treatment Phase|Adverse Event|19
1483007|NCT00591578|4887442|P2|Double-Blind Treatment Phase|Adverse Event|26
1483008|NCT00591578|4887443|P1|Double-Blind Treatment Phase|Adverse Event|20
1483009|NCT00591565|4887494|P1|Overall Study|lost follow up, withdrawn|5
1483010|NCT00591370|4887498|P1|Overall Study|Not Treated|2
1483011|NCT00591344|4887506|P2|Overall Study|Did not want to come off medication|1
1483012|NCT00591344|4887507|P1|Overall Study|Did not want to come off medication|0
1483013|NCT00591344|4887506|P2|Overall Study|Lost to Follow-up|1
1483014|NCT00591344|4887507|P1|Overall Study|Lost to Follow-up|0
1483015|NCT00591344|4887506|P2|Overall Study|Death|1
1483016|NCT00591344|4887507|P1|Overall Study|Death|0
1483017|NCT00591344|4887506|P2|Overall Study|Underwent DBS|2
1483018|NCT00591344|4887507|P1|Overall Study|Underwent DBS|2
1483019|NCT00591344|4887506|P2|Overall Study|Medical complications|3
1483020|NCT00591344|4887507|P1|Overall Study|Medical complications|1
1483021|NCT00591344|4887506|P2|Overall Study|Moved out of state|0
1483022|NCT00591344|4887507|P1|Overall Study|Moved out of state|1
1483023|NCT00591344|4887506|P2|Overall Study|Transportation issues|0
1483024|NCT00591344|4887507|P1|Overall Study|Transportation issues|1
1483025|NCT00591266|4887533|P3|Overall Study|Other|5
1483026|NCT00591266|4887534|P2|Overall Study|Other|4
1483027|NCT00591266|4887535|P1|Overall Study|Other|1
1483028|NCT00591266|4887533|P3|Overall Study|Lack of Efficacy|0
1483029|NCT00591266|4887534|P2|Overall Study|Lack of Efficacy|2
1483030|NCT00591266|4887535|P1|Overall Study|Lack of Efficacy|0
1483031|NCT00591266|4887533|P3|Overall Study|Withdrawal by Subject|5
1483032|NCT00591266|4887534|P2|Overall Study|Withdrawal by Subject|2
1483033|NCT00591266|4887535|P1|Overall Study|Withdrawal by Subject|6
1483034|NCT00591266|4887533|P3|Overall Study|Protocol Violation|1
1483035|NCT00591266|4887534|P2|Overall Study|Protocol Violation|0
1483036|NCT00591266|4887535|P1|Overall Study|Protocol Violation|0
1483037|NCT00591266|4887533|P3|Overall Study|Lost to Follow-up|0
1483038|NCT00591266|4887534|P2|Overall Study|Lost to Follow-up|1
1483039|NCT00591266|4887535|P1|Overall Study|Lost to Follow-up|0
1483040|NCT00591266|4887533|P3|Overall Study|Adverse Event|3
1483041|NCT00591266|4887534|P2|Overall Study|Adverse Event|2
1483042|NCT00591266|4887535|P1|Overall Study|Adverse Event|2
1483043|NCT00591253|4887588|P3|Overall Study|Other|3
1483044|NCT00591253|4887589|P2|Overall Study|Other|5
1483045|NCT00591253|4887590|P1|Overall Study|Other|5
1483046|NCT00591253|4887588|P3|Overall Study|Lack of Efficacy|3
1483047|NCT00591253|4887589|P2|Overall Study|Lack of Efficacy|0
1483048|NCT00591253|4887590|P1|Overall Study|Lack of Efficacy|1
1483049|NCT00591253|4887588|P3|Overall Study|Withdrawal by Subject|6
1483050|NCT00591253|4887589|P2|Overall Study|Withdrawal by Subject|7
1483051|NCT00591253|4887590|P1|Overall Study|Withdrawal by Subject|1
1483052|NCT00591253|4887588|P3|Overall Study|Lost to Follow-up|0
1483053|NCT00591253|4887589|P2|Overall Study|Lost to Follow-up|4
1483054|NCT00591253|4887590|P1|Overall Study|Lost to Follow-up|2
1483055|NCT00591253|4887588|P3|Overall Study|Protocol Violation|2
1483056|NCT00591253|4887589|P2|Overall Study|Protocol Violation|2
1483057|NCT00591253|4887590|P1|Overall Study|Protocol Violation|2
1483058|NCT00591253|4887588|P3|Overall Study|Adverse Event|1
1483059|NCT00591253|4887589|P2|Overall Study|Adverse Event|3
1483060|NCT00591253|4887590|P1|Overall Study|Adverse Event|3
1483061|NCT00591214|4887658|P1|Overall Study|Withdrawal by Subject|1
1483062|NCT00591214|4887658|P1|Overall Study|Physician Decision|7
1483063|NCT00591149|4887667|P1|Overall Study|Withdrawal by Subject|1
1483064|NCT00591149|4887667|P1|Overall Study|Adverse Event|4
1483065|NCT00591006|4887683|P24|Overall Study|Adverse Event|0
1483066|NCT00591006|4887684|P23|Overall Study|Adverse Event|1
1483067|NCT00591006|4887685|P22|Overall Study|Adverse Event|0
1483068|NCT00591006|4887686|P21|Overall Study|Adverse Event|0
1483069|NCT00591006|4887687|P20|Overall Study|Adverse Event|0
1483070|NCT00591006|4887688|P19|Overall Study|Adverse Event|0
1483071|NCT00591006|4887689|P18|Overall Study|Adverse Event|0
1483072|NCT00591006|4887690|P17|Overall Study|Adverse Event|0
1483073|NCT00591006|4887691|P16|Overall Study|Adverse Event|0
1483074|NCT00591006|4887692|P15|Overall Study|Adverse Event|0
1483075|NCT00591006|4887693|P14|Overall Study|Adverse Event|0
1483076|NCT00591006|4887694|P13|Overall Study|Adverse Event|0
1483077|NCT00591006|4887695|P12|Overall Study|Adverse Event|0
1483078|NCT00591006|4887696|P11|Overall Study|Adverse Event|0
1483079|NCT00591006|4887697|P10|Overall Study|Adverse Event|0
1483080|NCT00591006|4887698|P9|Overall Study|Adverse Event|0
1483081|NCT00591006|4887699|P8|Overall Study|Adverse Event|0
1483082|NCT00591006|4887700|P7|Overall Study|Adverse Event|0
1483083|NCT00591006|4887701|P6|Overall Study|Adverse Event|0
1483084|NCT00591006|4887702|P5|Overall Study|Adverse Event|0
1483085|NCT00591006|4887703|P4|Overall Study|Adverse Event|0
1483086|NCT00591006|4887704|P3|Overall Study|Adverse Event|0
1483087|NCT00591006|4887705|P2|Overall Study|Adverse Event|0
1483088|NCT00591006|4887706|P1|Overall Study|Adverse Event|0
1483089|NCT00591006|4887683|P24|Overall Study|Withdrawal by Subject|1
1483090|NCT00591006|4887684|P23|Overall Study|Withdrawal by Subject|0
1483091|NCT00591006|4887685|P22|Overall Study|Withdrawal by Subject|0
1483092|NCT00591006|4887686|P21|Overall Study|Withdrawal by Subject|0
1483093|NCT00591006|4887687|P20|Overall Study|Withdrawal by Subject|0
1483094|NCT00591006|4887688|P19|Overall Study|Withdrawal by Subject|0
1483095|NCT00591006|4887689|P18|Overall Study|Withdrawal by Subject|0
1483096|NCT00591006|4887690|P17|Overall Study|Withdrawal by Subject|0
1483097|NCT00591006|4887691|P16|Overall Study|Withdrawal by Subject|1
1483098|NCT00591006|4887692|P15|Overall Study|Withdrawal by Subject|0
1483099|NCT00591006|4887693|P14|Overall Study|Withdrawal by Subject|0
1483100|NCT00591006|4887694|P13|Overall Study|Withdrawal by Subject|0
1483101|NCT00591006|4887695|P12|Overall Study|Withdrawal by Subject|0
1483102|NCT00591006|4887696|P11|Overall Study|Withdrawal by Subject|0
1483103|NCT00591006|4887697|P10|Overall Study|Withdrawal by Subject|0
1483104|NCT00591006|4887698|P9|Overall Study|Withdrawal by Subject|0
1483105|NCT00591006|4887699|P8|Overall Study|Withdrawal by Subject|0
1483106|NCT00591006|4887700|P7|Overall Study|Withdrawal by Subject|0
1483107|NCT00591006|4887701|P6|Overall Study|Withdrawal by Subject|0
1483108|NCT00591006|4887702|P5|Overall Study|Withdrawal by Subject|0
1483109|NCT00591006|4887703|P4|Overall Study|Withdrawal by Subject|0
1483110|NCT00591006|4887704|P3|Overall Study|Withdrawal by Subject|0
1483111|NCT00591006|4887705|P2|Overall Study|Withdrawal by Subject|0
1483112|NCT00591006|4887706|P1|Overall Study|Withdrawal by Subject|0
1483113|NCT00590980|4887724|P1|Overall Study|Did not meet all inclusion criteria|10
1483114|NCT00590967|4887730|P2|Overall Study|Did not receive chemo per protocol|0
1483115|NCT00590967|4887731|P1|Overall Study|Did not receive chemo per protocol|1
1483116|NCT00590967|4887730|P2|Overall Study|Did not sign consent form|1
1483117|NCT00590967|4887731|P1|Overall Study|Did not sign consent form|0
1483118|NCT00590967|4887730|P2|Overall Study|Non-compliant|2
1483119|NCT00590967|4887731|P1|Overall Study|Non-compliant|0
1483120|NCT00590967|4887730|P2|Overall Study|Poor performance status|1
1483121|NCT00590967|4887731|P1|Overall Study|Poor performance status|0
1483122|NCT00590967|4887730|P2|Overall Study|Ineligible|0
1483123|NCT00590967|4887731|P1|Overall Study|Ineligible|1
1483124|NCT00590967|4887730|P2|Overall Study|Withdrawal by Subject|1
1483125|NCT00590967|4887731|P1|Overall Study|Withdrawal by Subject|1
1483126|NCT00590902|4887743|P1|Overall Study|Death|1
1483127|NCT00590759|4887778|P1|Overall Study|Lost to Follow-up|28
1483128|NCT00590759|4887778|P1|Overall Study|Death|52
1483129|NCT00590720|4887785|P2|Overall Study|Withdrawal by Subject|1
1483130|NCT00590720|4887786|P1|Overall Study|Withdrawal by Subject|0
1483131|NCT00590720|4887785|P2|Overall Study|Lost to Follow-up|0
1483132|NCT00590720|4887786|P1|Overall Study|Lost to Follow-up|1
1483133|NCT00590590|4887848|P3|Overall Study|Did not complete study|0
1483134|NCT00590590|4887849|P2|Overall Study|Did not complete study|1
1483135|NCT00590590|4887850|P1|Overall Study|Did not complete study|0
1483136|NCT00590590|4887848|P3|Overall Study|Did not complete due to study closure|1
1483137|NCT00590590|4887849|P2|Overall Study|Did not complete due to study closure|1
1483138|NCT00590590|4887850|P1|Overall Study|Did not complete due to study closure|1
1483139|NCT00590590|4887848|P3|Overall Study|Withdrawal by Subject|1
1483140|NCT00590590|4887849|P2|Overall Study|Withdrawal by Subject|1
1483141|NCT00590590|4887850|P1|Overall Study|Withdrawal by Subject|0
1483142|NCT00590590|4887848|P3|Overall Study|Lost to Follow-up|2
1483143|NCT00590590|4887849|P2|Overall Study|Lost to Follow-up|1
1483144|NCT00590590|4887850|P1|Overall Study|Lost to Follow-up|4
1483145|NCT00590590|4887848|P3|Overall Study|Protocol Violation|2
1483146|NCT00590590|4887849|P2|Overall Study|Protocol Violation|0
1483147|NCT00590590|4887850|P1|Overall Study|Protocol Violation|0
1483148|NCT00590590|4887848|P3|Overall Study|Adverse Event|0
1483149|NCT00590590|4887849|P2|Overall Study|Adverse Event|0
1483150|NCT00590590|4887850|P1|Overall Study|Adverse Event|1
1483151|NCT00590590|4887848|P3|Overall Study|Lack of Efficacy|0
1483152|NCT00590590|4887849|P2|Overall Study|Lack of Efficacy|2
1483153|NCT00590590|4887850|P1|Overall Study|Lack of Efficacy|1
1483154|NCT00590577|4887877|P4|Overall Study|Various reasons|2
1483155|NCT00590577|4887878|P3|Overall Study|Various reasons|1
1483156|NCT00590577|4887879|P2|Overall Study|Various reasons|3
1483157|NCT00590577|4887880|P1|Overall Study|Various reasons|1
1483158|NCT00590577|4887877|P4|Overall Study|Pregnancy|0
1483159|NCT00590577|4887878|P3|Overall Study|Pregnancy|0
1483160|NCT00590577|4887879|P2|Overall Study|Pregnancy|1
1483161|NCT00590577|4887880|P1|Overall Study|Pregnancy|0
1483162|NCT00590577|4887877|P4|Overall Study|Lost to Follow-up|9
1483163|NCT00590577|4887878|P3|Overall Study|Lost to Follow-up|6
1483164|NCT00590577|4887879|P2|Overall Study|Lost to Follow-up|6
1483165|NCT00590577|4887880|P1|Overall Study|Lost to Follow-up|12
1483166|NCT00590577|4887877|P4|Overall Study|Adverse Event|11
1483167|NCT00590577|4887878|P3|Overall Study|Adverse Event|13
1483168|NCT00590577|4887879|P2|Overall Study|Adverse Event|10
1483169|NCT00590577|4887880|P1|Overall Study|Adverse Event|10
1483170|NCT00590577|4887877|P4|Overall Study|Withdrawal by Subject|26
1483171|NCT00590577|4887878|P3|Overall Study|Withdrawal by Subject|30
1483172|NCT00590577|4887879|P2|Overall Study|Withdrawal by Subject|28
1483173|NCT00590577|4887880|P1|Overall Study|Withdrawal by Subject|23
1483174|NCT00590577|4887877|P4|Overall Study|Lack of Efficacy|45
1483175|NCT00590577|4887878|P3|Overall Study|Lack of Efficacy|23
1483176|NCT00590577|4887879|P2|Overall Study|Lack of Efficacy|28
1483177|NCT00590577|4887880|P1|Overall Study|Lack of Efficacy|31
1483178|NCT00590564|4887898|P1|Overall Study|Patient Non-compliance|6
1483179|NCT00590564|4887898|P1|Overall Study|Patient Found to be Ineligible|1
1483180|NCT00590564|4887898|P1|Overall Study|Protocol Violation|1
1483181|NCT00590564|4887898|P1|Overall Study|Lost to Follow-up|6
1483182|NCT00590564|4887898|P1|Overall Study|Withdrawal by Subject|4
1483183|NCT00590538|4887902|P1|Overall Study|Study terminated before completed|2
1483184|NCT00590317|4887944|P2|Overall Study|Lack of Efficacy|5
1483185|NCT00590317|4887945|P1|Overall Study|Lack of Efficacy|1
1483186|NCT00590135|4887975|P1|Overall Study|Primary endpoint measure not obtainable|59
1483187|NCT00590044|4887985|P2|Overall Study|Protocol Violation|0
1483188|NCT00590044|4887986|P1|Overall Study|Protocol Violation|1
1483189|NCT00590044|4887985|P2|Overall Study|wrong insulin arm assigned|0
1483190|NCT00590044|4887986|P1|Overall Study|wrong insulin arm assigned|1
1483191|NCT00590044|4887985|P2|Overall Study|Withdrawal by Subject|2
1483192|NCT00590044|4887986|P1|Overall Study|Withdrawal by Subject|2
1483193|NCT00590031|4887992|P1|Overall Study|Admin Hold|1
1483194|NCT00590031|4887992|P1|Overall Study|Metastatic Disease|1
1483195|NCT00590031|4887992|P1|Overall Study|Withdrawal by Subject|1
1483196|NCT00590031|4887992|P1|Overall Study|Adverse Event|3
1483197|NCT00589979|4888019|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
1483198|NCT00589979|4888020|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
1483199|NCT00589979|4888021|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
1483200|NCT00589979|4888019|P3|Double-Blind Treatment Period 3|Protocol Violation|0
1483201|NCT00589979|4888020|P2|Double-Blind Treatment Period 3|Protocol Violation|1
1483202|NCT00589979|4888021|P1|Double-Blind Treatment Period 3|Protocol Violation|0
1483203|NCT00589979|4888019|P3|Double-Blind Treatment Period 2|Other|1
1483204|NCT00589979|4888020|P2|Double-Blind Treatment Period 2|Other|0
1483205|NCT00589979|4888021|P1|Double-Blind Treatment Period 2|Other|0
1483206|NCT00589979|4888019|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
1483207|NCT00589979|4888020|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
1483208|NCT00589979|4888021|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
1483209|NCT00589979|4888019|P3|Double-Blind Treatment Period 2|Adverse Event|0
1483210|NCT00589979|4888020|P2|Double-Blind Treatment Period 2|Adverse Event|1
1483211|NCT00589979|4888021|P1|Double-Blind Treatment Period 2|Adverse Event|0
1483212|NCT00589979|4888019|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
1483213|NCT00589979|4888020|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
1483214|NCT00589979|4888021|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
1483215|NCT00589979|4888019|P3|Double-Blind Treatment Period 1|Protocol Violation|1
1483216|NCT00589979|4888020|P2|Double-Blind Treatment Period 1|Protocol Violation|1
1483217|NCT00589979|4888021|P1|Double-Blind Treatment Period 1|Protocol Violation|0
1483218|NCT00589979|4888019|P3|Double-Blind Treatment Period 1|Adverse Event|0
1483219|NCT00589979|4888020|P2|Double-Blind Treatment Period 1|Adverse Event|1
1483220|NCT00589979|4888021|P1|Double-Blind Treatment Period 1|Adverse Event|0
1483221|NCT00589979|4888019|P3|Run-In Period|Informed Consent Withdrawn|0
1483222|NCT00589979|4888020|P2|Run-In Period|Informed Consent Withdrawn|0
1483223|NCT00589979|4888021|P1|Run-In Period|Informed Consent Withdrawn|4
1483224|NCT00589979|4888019|P3|Run-In Period|Withdrawal by Subject|0
1483225|NCT00589979|4888020|P2|Run-In Period|Withdrawal by Subject|0
1483226|NCT00589979|4888021|P1|Run-In Period|Withdrawal by Subject|10
1483227|NCT00589979|4888019|P3|Run-In Period|Did not qualify for randomization|0
1483228|NCT00589979|4888020|P2|Run-In Period|Did not qualify for randomization|0
1483229|NCT00589979|4888021|P1|Run-In Period|Did not qualify for randomization|54
1483230|NCT00589979|4888019|P3|Run-In Period|Protocol Violation|0
1483231|NCT00589979|4888020|P2|Run-In Period|Protocol Violation|0
1483232|NCT00589979|4888021|P1|Run-In Period|Protocol Violation|3
1483233|NCT00589979|4888019|P3|Run-In Period|Adverse Event|0
1483234|NCT00589979|4888020|P2|Run-In Period|Adverse Event|0
1483235|NCT00589979|4888021|P1|Run-In Period|Adverse Event|5
1483236|NCT00589914|4888060|P2|Overall Study|Other|17
1483237|NCT00589914|4888061|P1|Overall Study|Other|22
1483238|NCT00589914|4888060|P2|Overall Study|Withdrawal by Subject|49
1483239|NCT00589914|4888061|P1|Overall Study|Withdrawal by Subject|55
1483240|NCT00589914|4888060|P2|Overall Study|Pregnancy|0
1483241|NCT00589914|4888061|P1|Overall Study|Pregnancy|1
1483242|NCT00589914|4888060|P2|Overall Study|Lost to Follow-up|18
1483243|NCT00589914|4888061|P1|Overall Study|Lost to Follow-up|11
1483244|NCT00589914|4888060|P2|Overall Study|Lack of Efficacy|43
1483245|NCT00589914|4888061|P1|Overall Study|Lack of Efficacy|40
1483246|NCT00589914|4888060|P2|Overall Study|Death|0
1483247|NCT00589914|4888061|P1|Overall Study|Death|2
1483248|NCT00589914|4888060|P2|Overall Study|Adverse Event|10
1483249|NCT00589914|4888061|P1|Overall Study|Adverse Event|19
1483250|NCT00589784|4888097|P2|Overall Study|Adverse Event|4
1483251|NCT00589784|4888098|P1|Overall Study|Adverse Event|0
1483252|NCT00589784|4888097|P2|Overall Study|Patient inevaluable|0
1483253|NCT00589784|4888098|P1|Overall Study|Patient inevaluable|1
1483254|NCT00589784|4888097|P2|Overall Study|Withdrawal by Subject|6
1483255|NCT00589784|4888098|P1|Overall Study|Withdrawal by Subject|0
1483256|NCT00589693|4888105|P2|Overall Study|Protocol Violation|1
1483257|NCT00589693|4888106|P1|Overall Study|Protocol Violation|1
1483258|NCT00589693|4888105|P2|Overall Study|Physician Decision|1
1483259|NCT00589693|4888106|P1|Overall Study|Physician Decision|0
1483260|NCT00589693|4888105|P2|Overall Study|Lost to Follow-up|0
1483261|NCT00589693|4888106|P1|Overall Study|Lost to Follow-up|1
1483262|NCT00589693|4888105|P2|Overall Study|Lack of Efficacy|1
1483263|NCT00589693|4888106|P1|Overall Study|Lack of Efficacy|0
1483264|NCT00589693|4888105|P2|Overall Study|Death|16
1483265|NCT00589693|4888106|P1|Overall Study|Death|26
1483266|NCT00589693|4888105|P2|Overall Study|Adverse Event|4
1483267|NCT00589693|4888106|P1|Overall Study|Adverse Event|4
1483268|NCT00589693|4888105|P2|Overall Study|randomized in error|6
1483269|NCT00589693|4888106|P1|Overall Study|randomized in error|12
1483270|NCT00589667|4888120|P1|Overall Study|Withdrawal by Subject|1
1483271|NCT00589667|4888120|P1|Overall Study|Adverse Event|2
1483272|NCT00589628|4888127|P2|Overall Study|Lost to Follow-up|1
1483273|NCT00589628|4888128|P1|Overall Study|Lost to Follow-up|0
1483274|NCT00589602|4888134|P1|Overall Study|Did not collect enough CD34+ cells|1
1483275|NCT00589472|4888169|P1|Overall Study|Adverse Event|1
1483276|NCT00589303|4888181|P2|Overall Study|Withdrawal by Subject|1
1483277|NCT00589303|4888182|P1|Overall Study|Withdrawal by Subject|2
1483278|NCT00589290|4888188|P1|Overall Study|Withdrawal by Subject|1
1483279|NCT00589121|4888211|P2|Overall Study|No protocol treatment received|1
1483280|NCT00589121|4888212|P1|Overall Study|No protocol treatment received|0
1483281|NCT00589121|4888211|P2|Overall Study|Protocol Violation|6
1483282|NCT00589121|4888212|P1|Overall Study|Protocol Violation|2
1483283|NCT00589108|4888232|P3|Overall Study|Death|4
1483284|NCT00589108|4888233|P2|Overall Study|Death|3
1483285|NCT00589108|4888234|P1|Overall Study|Death|3
1483286|NCT00589108|4888232|P3|Overall Study|Lost to Follow-up|1
1483287|NCT00589108|4888233|P2|Overall Study|Lost to Follow-up|1
1483288|NCT00589108|4888234|P1|Overall Study|Lost to Follow-up|1
1483289|NCT00588952|4888264|P2|Overall Study|Withdrawal by Subject|5
1483290|NCT00588952|4888265|P1|Overall Study|Withdrawal by Subject|3
1483291|NCT00588952|4888264|P2|Overall Study|Adverse Event|2
1483292|NCT00588952|4888265|P1|Overall Study|Adverse Event|0
1483293|NCT00588861|4888293|P2|10 Years|Incomplete due to study termination|114
1483294|NCT00588861|4888294|P1|10 Years|Incomplete due to study termination|107
1483295|NCT00588861|4888293|P2|8 Years|Patients did not return for follow-up|114
1483296|NCT00588861|4888294|P1|8 Years|Patients did not return for follow-up|105
1483297|NCT00588861|4888293|P2|6 Years|Patients did not return for follow-up|109
1483298|NCT00588861|4888294|P1|6 Years|Patients did not return for follow-up|104
1483299|NCT00588861|4888293|P2|4 Years|Patients did not return for follow-up|103
1483300|NCT00588861|4888294|P1|4 Years|Patients did not return for follow-up|91
1483301|NCT00588861|4888293|P2|2 Years|Patients did not return for follow-up|87
1483302|NCT00588861|4888294|P1|2 Years|Patients did not return for follow-up|92
1483303|NCT00588861|4888293|P2|1 Year|Patients did not return for follow-up|82
1483304|NCT00588861|4888294|P1|1 Year|Patients did not return for follow-up|89
1483305|NCT00588861|4888293|P2|6 Months|Patients did not return for follow-up|73
1483306|NCT00588861|4888294|P1|6 Months|Patients did not return for follow-up|98
1483307|NCT00588861|4888293|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
1483308|NCT00588861|4888294|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
1483309|NCT00588822|4888315|P1|Overall Study|progression of disease|8
1483310|NCT00588731|4888335|P2|Overall Study|Withdrawal by Subject|2
1483311|NCT00588731|4888336|P1|Overall Study|Withdrawal by Subject|3
1483312|NCT00588692|4888346|P2|Overall Study|Death|0
1483313|NCT00588692|4888347|P1|Overall Study|Death|1
1483314|NCT00588692|4888346|P2|Overall Study|Cancer|0
1483315|NCT00588692|4888347|P1|Overall Study|Cancer|1
1483316|NCT00588692|4888346|P2|Overall Study|Severe Peptic Ulcer Disease|0
1483317|NCT00588692|4888347|P1|Overall Study|Severe Peptic Ulcer Disease|1
1483318|NCT00588692|4888346|P2|Overall Study|Hip Surgery|1
1483319|NCT00588692|4888347|P1|Overall Study|Hip Surgery|0
1483320|NCT00588692|4888346|P2|Overall Study|Withdrawal by Subject|2
1483321|NCT00588692|4888347|P1|Overall Study|Withdrawal by Subject|4
1483322|NCT00588666|4888383|P1|Overall Study|Adverse Event|4
1483323|NCT00588640|4888388|P1|Overall Study|Ineligible Patient|1
1483324|NCT00588640|4888388|P1|Overall Study|Physician Decision|1
1483325|NCT00588445|4888407|P1|Overall Study|Not Treated|10
1483326|NCT00588445|4888407|P1|Overall Study|Disease Progression|1
1483327|NCT00588445|4888407|P1|Overall Study|Withdrawal by Subject|3
1483328|NCT00588445|4888407|P1|Overall Study|Protocol Violation|1
1483329|NCT00588354|4888431|P2|Baseline to 4 Weeks|Lost to Follow-up|1
1483330|NCT00588354|4888432|P1|Baseline to 4 Weeks|Lost to Follow-up|0
1483331|NCT00588354|4888431|P2|Baseline to 2 Weeks|Lack of Efficacy|0
1483332|NCT00588354|4888432|P1|Baseline to 2 Weeks|Lack of Efficacy|1
1483333|NCT00588354|4888431|P2|Baseline to 2 Weeks|Adverse Event|0
1483334|NCT00588354|4888432|P1|Baseline to 2 Weeks|Adverse Event|1
1483335|NCT00588341|4888452|P1|Overall Study|Patient ineligible|1
1483336|NCT00588341|4888452|P1|Overall Study|Not treated due to metastatic disease|1
1483337|NCT00588341|4888452|P1|Overall Study|Withdrawal by Subject|3
1483338|NCT00588237|4888456|P1|Overall Study|Patien not treated|1
1483339|NCT00588237|4888456|P1|Overall Study|Evaluable for toxicity only|3
1483340|NCT00588146|4888479|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
1483341|NCT00588146|4888480|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
1483342|NCT00588094|4888486|P1|Overall Study|Progression of Disease|2
1483343|NCT00588094|4888486|P1|Overall Study|Adverse Event|3
1483344|NCT00587964|4888509|P1|Overall Study|Progression of Disease|4
1483345|NCT00587964|4888509|P1|Overall Study|Patient did not receive intervention|5
1483346|NCT00587964|4888509|P1|Overall Study|Patient found to be ineligible|1
1483347|NCT00587964|4888509|P1|Overall Study|Lost to Follow-up|1
1483348|NCT00587964|4888509|P1|Overall Study|Withdrawal by Subject|1
1483349|NCT00587860|4888515|P2|Overall Study|Withdrawal by Subject|3
1483350|NCT00587860|4888516|P1|Overall Study|Withdrawal by Subject|3
1483351|NCT00587860|4888515|P2|Overall Study|Lost to Follow-up|2
1483352|NCT00587860|4888516|P1|Overall Study|Lost to Follow-up|2
1483353|NCT00587847|4888536|P1|Overall Study|Adverse Event|2
1483354|NCT00587847|4888536|P1|Overall Study|Lack of Efficacy|5
1483355|NCT00587795|4888559|P2|Overall Study|Withdrawal by Subject|0
1483356|NCT00587795|4888560|P1|Overall Study|Withdrawal by Subject|1
1483357|NCT00587639|4888614|P1|Overall Study|Withdrawal by Subject|1
1483358|NCT00587587|4888621|P2|Overall Study|Lost to Follow-up|1
1483359|NCT00587587|4888622|P1|Overall Study|Lost to Follow-up|6
1483360|NCT00587457|4888676|P3|Overall Study|Development of neutralizing Abs|1
1483361|NCT00587457|4888677|P2|Overall Study|Development of neutralizing Abs|0
1483362|NCT00587457|4888678|P1|Overall Study|Development of neutralizing Abs|0
1483363|NCT00587457|4888676|P3|Overall Study|Undefined|1
1483364|NCT00587457|4888677|P2|Overall Study|Undefined|0
1483365|NCT00587457|4888678|P1|Overall Study|Undefined|0
1483366|NCT00587457|4888676|P3|Overall Study|Initiation of alternative therapy|0
1483367|NCT00587457|4888677|P2|Overall Study|Initiation of alternative therapy|1
1483368|NCT00587457|4888678|P1|Overall Study|Initiation of alternative therapy|0
1483369|NCT00587457|4888676|P3|Overall Study|Disease progression|2
1483370|NCT00587457|4888677|P2|Overall Study|Disease progression|0
1483371|NCT00587457|4888678|P1|Overall Study|Disease progression|2
1483372|NCT00587457|4888676|P3|Overall Study|Adverse Event|1
1483373|NCT00587457|4888677|P2|Overall Study|Adverse Event|2
1483374|NCT00587457|4888678|P1|Overall Study|Adverse Event|1
1483375|NCT00587431|4888715|P2|Overall Study|Withdrawal by Subject|1
1483376|NCT00587431|4888716|P1|Overall Study|Withdrawal by Subject|0
1483377|NCT00587431|4888715|P2|Overall Study|Adverse Event|0
1483378|NCT00587431|4888716|P1|Overall Study|Adverse Event|1
1483379|NCT00587288|4888727|P2|Overall Study|Protocol Violation|0
1483380|NCT00587288|4888728|P1|Overall Study|Protocol Violation|1
1483381|NCT00587288|4888727|P2|Overall Study|Lack of Efficacy|8
1483382|NCT00587288|4888728|P1|Overall Study|Lack of Efficacy|2
1483383|NCT00587288|4888727|P2|Overall Study|Adverse Event|1
1483384|NCT00587288|4888728|P1|Overall Study|Adverse Event|0
1483385|NCT00587223|4888746|P1|Overall Study|Adverse Event|1
1483386|NCT00587171|4888763|P2|Overall Study|Lost to Follow-up|1
1483387|NCT00587171|4888764|P1|Overall Study|Lost to Follow-up|1
1483388|NCT00587158|4888794|P2|Overall Study|Subject did not want to take study med|1
1483389|NCT00587158|4888795|P1|Overall Study|Subject did not want to take study med|0
1483390|NCT00587158|4888794|P2|Overall Study|Death|1
1483391|NCT00587158|4888795|P1|Overall Study|Death|0
1483392|NCT00587158|4888794|P2|Overall Study|Lost to Follow-up|2
1483393|NCT00587158|4888795|P1|Overall Study|Lost to Follow-up|1
1483394|NCT00587158|4888794|P2|Overall Study|Physician Decision|1
1483395|NCT00587158|4888795|P1|Overall Study|Physician Decision|0
1483396|NCT00587158|4888794|P2|Overall Study|Did not want to do 24 hr urine collect.|3
1483397|NCT00587158|4888795|P1|Overall Study|Did not want to do 24 hr urine collect.|4
1483398|NCT00587054|4888848|P1|Overall Study|Patient not treated|9
1483399|NCT00586898|4888868|P1|Overall Study|Evaluable for Toxicity Only|5
1483400|NCT00586898|4888868|P1|Overall Study|Patiemt Non-compliance|1
1483401|NCT00586898|4888868|P1|Overall Study|Adverse Event|1
1483402|NCT00586846|4888872|P1|Overall Study|Evaluable for Toxicity Only|4
1483403|NCT00586846|4888872|P1|Overall Study|Death|1
1483404|NCT00586846|4888872|P1|Overall Study|Physician Decision|1
1483405|NCT00586820|4888878|P2|Overall Study|Unsuccessful PCI|0
1483406|NCT00586820|4888879|P1|Overall Study|Unsuccessful PCI|1
1483407|NCT00586703|4888910|P1|Overall Study|Death|12
1483408|NCT00586690|4888917|P2|Overall Study|Lab can't accommodate|0
1483409|NCT00586690|4888918|P1|Overall Study|Lab can't accommodate|1
1483410|NCT00586690|4888917|P2|Overall Study|Lack of Efficacy|0
1483411|NCT00586690|4888918|P1|Overall Study|Lack of Efficacy|2
1483412|NCT00586690|4888917|P2|Overall Study|Adverse Event|0
1483413|NCT00586690|4888918|P1|Overall Study|Adverse Event|1
1483414|NCT00586690|4888917|P2|Overall Study|Disease Progression|0
1483415|NCT00586690|4888918|P1|Overall Study|Disease Progression|10
1483416|NCT00586690|4888917|P2|Overall Study|Death|0
1483417|NCT00586690|4888918|P1|Overall Study|Death|2
1483418|NCT00586664|4888928|P3|Overall Study|Exclusion criteria met|0
1483419|NCT00586664|4888929|P2|Overall Study|Exclusion criteria met|0
1483420|NCT00586664|4888930|P1|Overall Study|Exclusion criteria met|2
1483421|NCT00586664|4888928|P3|Overall Study|Withdrawal by Subject|1
1483422|NCT00586664|4888929|P2|Overall Study|Withdrawal by Subject|7
1483423|NCT00586664|4888930|P1|Overall Study|Withdrawal by Subject|3
1483424|NCT00586625|4888976|P2|Overall Study|Subject unable to return for visit|0
1483425|NCT00586625|4888977|P1|Overall Study|Subject unable to return for visit|2
1483426|NCT00586625|4888976|P2|Overall Study|Subject non-compliance|1
1483427|NCT00586625|4888977|P1|Overall Study|Subject non-compliance|0
1483428|NCT00586625|4888976|P2|Overall Study|Withdrawal by Subject|10
1483429|NCT00586625|4888977|P1|Overall Study|Withdrawal by Subject|32
1483430|NCT00586625|4888976|P2|Overall Study|Protocol Violation|0
1483431|NCT00586625|4888977|P1|Overall Study|Protocol Violation|3
1483432|NCT00586625|4888976|P2|Overall Study|Adverse Event|6
1483433|NCT00586625|4888977|P1|Overall Study|Adverse Event|6
1483434|NCT00586612|4888985|P2|Booster Phase|Lost to Follow-up|1
1483435|NCT00586612|4888986|P1|Booster Phase|Lost to Follow-up|3
1483436|NCT00586612|4888985|P2|Primary Phase|Withdrawal by Subject|2
1483437|NCT00586612|4888986|P1|Primary Phase|Withdrawal by Subject|0
1483438|NCT00586612|4888985|P2|Primary Phase|Lost to Follow-up|1
1483439|NCT00586612|4888986|P1|Primary Phase|Lost to Follow-up|0
1483440|NCT00586612|4888985|P2|Primary Phase|Protocol Violation|0
1483441|NCT00586612|4888986|P1|Primary Phase|Protocol Violation|1
1483442|NCT00586521|4889056|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
1483443|NCT00586495|4889063|P1|Follow-up|Switch to commercial drug|10
1483444|NCT00586495|4889063|P1|Follow-up|Protocol driven decision point|37
1483445|NCT00586495|4889063|P1|Follow-up|Withdrawal by Subject|4
1483446|NCT00586495|4889063|P1|Follow-up|Lost to Follow-up|1
1483447|NCT00586495|4889063|P1|Follow-up|Death|40
1483448|NCT00586495|4889063|P1|Treatment Period|Switch to commercial drug|10
1483449|NCT00586495|4889063|P1|Treatment Period|Disease progression, recurrence/relapse|71
1483450|NCT00586495|4889063|P1|Treatment Period|Withdrawal by Subject|1
1483451|NCT00586495|4889063|P1|Treatment Period|Protocol Violation|1
1483452|NCT00586495|4889063|P1|Treatment Period|Death|1
1483453|NCT00586495|4889063|P1|Treatment Period|Adverse Event|11
1483454|NCT00586469|4889092|P2|Overall Study|Adverse Event|1
1483455|NCT00586469|4889093|P1|Overall Study|Adverse Event|0
1483456|NCT00586339|4889120|P3|Overall Study|Withdrawal by Subject|1
1483457|NCT00586339|4889121|P2|Overall Study|Withdrawal by Subject|3
1483458|NCT00586339|4889122|P1|Overall Study|Withdrawal by Subject|1
1483459|NCT00586339|4889120|P3|Overall Study|Lost to Follow-up|5
1483460|NCT00586339|4889121|P2|Overall Study|Lost to Follow-up|4
1483461|NCT00586339|4889122|P1|Overall Study|Lost to Follow-up|6
1483462|NCT00586326|4889220|P1|Treated Through 5-yr Follow Up-Treated|Other|2
1483463|NCT00586326|4889220|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
1483464|NCT00586326|4889220|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
1483465|NCT00586326|4889220|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
1483466|NCT00586326|4889220|P1|Treated Through 5-yr Follow Up-Treated|Death|2
1483467|NCT00586326|4889220|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
1483468|NCT00586326|4889220|P1|Device Placed toTreatment-ITT|Physician Decision|1
1483469|NCT00586326|4889220|P1|Device Placed toTreatment-ITT|Positive Margins|3
1483470|NCT00586326|4889220|P1|Device Placed toTreatment-ITT|Microinvasion|1
1483471|NCT00586326|4889220|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
1483472|NCT00586326|4889220|P1|Device Placed toTreatment-ITT|Skin Distance|7
1483473|NCT00586326|4889220|P1|Enrollment to Device Placement-Enrolled|Other|1
1483474|NCT00586326|4889220|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
1483475|NCT00586326|4889220|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
1483476|NCT00586326|4889220|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
1483477|NCT00586326|4889220|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
1483478|NCT00586326|4889220|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
1483479|NCT00586313|4889231|P1|Overall Study|Lack of Efficacy|2
1483480|NCT00586157|4889267|P2|Second Intervention|Adverse Event|1
1483481|NCT00586157|4889268|P1|Second Intervention|Adverse Event|0
1483482|NCT00586157|4889267|P2|Second Intervention|Worsening behavior|0
1483483|NCT00586157|4889268|P1|Second Intervention|Worsening behavior|1
1483484|NCT00586157|4889267|P2|Second Intervention|Withdrawal by Subject|0
1483485|NCT00586157|4889268|P1|Second Intervention|Withdrawal by Subject|1
1483486|NCT00586157|4889267|P2|First Intervention|Worsening behavior|0
1483487|NCT00586157|4889268|P1|First Intervention|Worsening behavior|1
1483488|NCT00586105|4889278|P1|Overall Study|Reason not reported|1
1483489|NCT00586105|4889278|P1|Overall Study|Switched to commercial drug|9
1483490|NCT00586105|4889278|P1|Overall Study|Disease progression|19
1483491|NCT00586105|4889278|P1|Overall Study|Withdrawal by Subject|3
1483492|NCT00586105|4889278|P1|Overall Study|Protocol Violation|1
1483493|NCT00586105|4889278|P1|Overall Study|Death|2
1483494|NCT00586105|4889278|P1|Overall Study|Adverse Event|4
1483495|NCT00586066|4889293|P2|Overall Study|Withdrawal of consent|2
1483496|NCT00586066|4889294|P1|Overall Study|Withdrawal of consent|4
1483497|NCT00586066|4889293|P2|Overall Study|Physician Decision|0
1483498|NCT00586066|4889294|P1|Overall Study|Physician Decision|1
1483499|NCT00586066|4889293|P2|Overall Study|Adverse Event|2
1483500|NCT00586066|4889294|P1|Overall Study|Adverse Event|2
1483501|NCT00586066|4889293|P2|Overall Study|Lack of Efficacy|3
1483502|NCT00586066|4889294|P1|Overall Study|Lack of Efficacy|5
1483503|NCT00586066|4889293|P2|Overall Study|Lost to Follow-up|3
1483504|NCT00586066|4889294|P1|Overall Study|Lost to Follow-up|6
1483505|NCT00585975|4889306|P2|Overall Study|Enrollment met/over-enrolled|9
1483506|NCT00585975|4889307|P1|Overall Study|Enrollment met/over-enrolled|10
1483507|NCT00585975|4889306|P2|Overall Study|Lost to Follow-up|1
1483508|NCT00585975|4889307|P1|Overall Study|Lost to Follow-up|2
1483509|NCT00585975|4889306|P2|Overall Study|Withdrawal by Subject|3
1483510|NCT00585975|4889307|P1|Overall Study|Withdrawal by Subject|3
1483511|NCT00585923|4889317|P2|Overall Study|Physician decided not to continue|33
1483512|NCT00585923|4889318|P1|Overall Study|Physician decided not to continue|31
1483513|NCT00585689|4889349|P1|Overall Study|Death|1
1483514|NCT00585689|4889349|P1|Overall Study|Patient had unresectable disease|1
1483515|NCT00585689|4889349|P1|Overall Study|Patient Declined Surgery|1
1483516|NCT00585689|4889349|P1|Overall Study|Adverse Event|1
1483517|NCT00585689|4889349|P1|Overall Study|Received different ABI-007 schedule|3
1483518|NCT00585585|4889395|P1|Overall Study|Adverse Event|1
1483519|NCT00585546|4889399|P1|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
1483520|NCT00585546|4889399|P1|Clenbuterol Treatment - up to 12 Months|Death|1
1483521|NCT00585533|4889413|P1|Overall Study|objective or symptomatic progression|9
1483522|NCT00585468|4889422|P2|First Intervention|Withdrawal by Subject|1
1483523|NCT00585468|4889423|P1|First Intervention|Withdrawal by Subject|1
1483524|NCT00585351|4889455|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1483525|NCT00585351|4889456|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1483526|NCT00585351|4889457|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
1483527|NCT00585351|4889458|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
1483528|NCT00585351|4889459|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1483529|NCT00585351|4889460|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1483530|NCT00585351|4889461|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1483531|NCT00585351|4889462|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1483532|NCT00585351|4889455|P8|Enrollment Period (Intervention)|Death|0
1483533|NCT00585351|4889456|P7|Enrollment Period (Intervention)|Death|1
1483534|NCT00585351|4889457|P6|Enrollment Period (Intervention)|Death|0
1483535|NCT00585351|4889458|P5|Enrollment Period (Intervention)|Death|1
1483536|NCT00585351|4889459|P4|Enrollment Period (Intervention)|Death|0
1483537|NCT00585351|4889460|P3|Enrollment Period (Intervention)|Death|0
1483538|NCT00585351|4889461|P2|Enrollment Period (Intervention)|Death|0
1483539|NCT00585351|4889462|P1|Enrollment Period (Intervention)|Death|0
1483540|NCT00585351|4889455|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
1483541|NCT00585351|4889456|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
1483542|NCT00585351|4889457|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
1483543|NCT00585351|4889458|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
1483544|NCT00585351|4889459|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
1483545|NCT00585351|4889460|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
1483546|NCT00585351|4889461|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
1483547|NCT00585351|4889462|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
1483548|NCT00585351|4889455|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1483549|NCT00585351|4889456|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1483550|NCT00585351|4889457|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1483551|NCT00585351|4889458|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1483552|NCT00585351|4889459|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1483553|NCT00585351|4889460|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1483554|NCT00585351|4889461|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
1483555|NCT00585351|4889462|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
1483556|NCT00585351|4889455|P8|Notification Period (Informed Consent)|No study medication on flight|0
1483557|NCT00585351|4889456|P7|Notification Period (Informed Consent)|No study medication on flight|0
1483558|NCT00585351|4889457|P6|Notification Period (Informed Consent)|No study medication on flight|0
1483559|NCT00585351|4889458|P5|Notification Period (Informed Consent)|No study medication on flight|0
1483560|NCT00585351|4889459|P4|Notification Period (Informed Consent)|No study medication on flight|0
1483561|NCT00585351|4889460|P3|Notification Period (Informed Consent)|No study medication on flight|0
1483562|NCT00585351|4889461|P2|Notification Period (Informed Consent)|No study medication on flight|1
1483563|NCT00585351|4889462|P1|Notification Period (Informed Consent)|No study medication on flight|0
1483564|NCT00585351|4889455|P8|Notification Period (Informed Consent)|Flight aborted|0
1483565|NCT00585351|4889456|P7|Notification Period (Informed Consent)|Flight aborted|0
1483566|NCT00585351|4889457|P6|Notification Period (Informed Consent)|Flight aborted|0
1483567|NCT00585351|4889458|P5|Notification Period (Informed Consent)|Flight aborted|0
1483568|NCT00585351|4889459|P4|Notification Period (Informed Consent)|Flight aborted|0
1483569|NCT00585351|4889460|P3|Notification Period (Informed Consent)|Flight aborted|0
1483570|NCT00585351|4889461|P2|Notification Period (Informed Consent)|Flight aborted|1
1483571|NCT00585351|4889462|P1|Notification Period (Informed Consent)|Flight aborted|2
1483572|NCT00585351|4889455|P8|Notification Period (Informed Consent)|Physician Decision|0
1483573|NCT00585351|4889456|P7|Notification Period (Informed Consent)|Physician Decision|0
1483574|NCT00585351|4889457|P6|Notification Period (Informed Consent)|Physician Decision|0
1483575|NCT00585351|4889458|P5|Notification Period (Informed Consent)|Physician Decision|0
1483576|NCT00585351|4889459|P4|Notification Period (Informed Consent)|Physician Decision|0
1483577|NCT00585351|4889460|P3|Notification Period (Informed Consent)|Physician Decision|0
1483578|NCT00585351|4889461|P2|Notification Period (Informed Consent)|Physician Decision|2
1483579|NCT00585351|4889462|P1|Notification Period (Informed Consent)|Physician Decision|0
1483580|NCT00585325|4889478|P2|Overall Study|Withdrawal by Subject|1
1483581|NCT00585325|4889479|P1|Overall Study|Withdrawal by Subject|1
1483582|NCT00585312|4889487|P2|Overall Study|Study terminated by the sponsor|31
1483583|NCT00585312|4889488|P1|Overall Study|Study terminated by the sponsor|34
1483584|NCT00585312|4889487|P2|Overall Study|Withdrawal by Subject|1
1483585|NCT00585312|4889488|P1|Overall Study|Withdrawal by Subject|5
1483586|NCT00585312|4889487|P2|Overall Study|Reason not specified|0
1483587|NCT00585312|4889488|P1|Overall Study|Reason not specified|2
1483588|NCT00585312|4889487|P2|Overall Study|Lost to Follow-up|1
1483589|NCT00585312|4889488|P1|Overall Study|Lost to Follow-up|1
1483590|NCT00585312|4889487|P2|Overall Study|Lack of Efficacy|11
1483591|NCT00585312|4889488|P1|Overall Study|Lack of Efficacy|6
1483592|NCT00585312|4889487|P2|Overall Study|Adverse Event|0
1483593|NCT00585312|4889488|P1|Overall Study|Adverse Event|3
1483594|NCT00585286|4889500|P1|Overall Study|Lost to Follow-up|1
1483595|NCT00585221|4889516|P1|Overall Study|Protocol Violation|8
1483596|NCT00585169|4889526|P1|Overall Study|Withdrawal by Subject|1
1483597|NCT00585078|4889536|P1|Overall Study|Death|1
1483598|NCT00585078|4889536|P1|Overall Study|Adverse Event|10
1483599|NCT00585078|4889536|P1|Overall Study|Disease Progression|24
1483600|NCT00585078|4889536|P1|Overall Study|Poor performance status|1
1483601|NCT00585078|4889536|P1|Overall Study|Withdrawal by Subject|4
1483602|NCT00585052|4889543|P1|Overall Study|Withdrawal by Subject|1
1483603|NCT00585039|4889550|P2|Overall Study|medication spilled|0
1483604|NCT00585039|4889551|P1|Overall Study|medication spilled|2
1483605|NCT00584987|4889580|P4|Overall Study|Adverse Event|1
1483606|NCT00584987|4889581|P3|Overall Study|Adverse Event|0
1483607|NCT00584987|4889582|P2|Overall Study|Adverse Event|0
1483608|NCT00584987|4889583|P1|Overall Study|Adverse Event|0
1483609|NCT00584987|4889580|P4|Overall Study|Protocol Violation|0
1483610|NCT00584987|4889581|P3|Overall Study|Protocol Violation|1
1483611|NCT00584987|4889582|P2|Overall Study|Protocol Violation|1
1483612|NCT00584987|4889583|P1|Overall Study|Protocol Violation|1
1483613|NCT00584909|4889631|P1|Overall Study|Adverse Event|4
1483614|NCT00584844|4889641|P1|Overall Study|Screen Failure|20
1483615|NCT00584844|4889641|P1|Overall Study|Withdrawal by Subject|59
1483616|NCT00584740|4889693|P2|Overall Study|Lost to Follow-up|1
1483617|NCT00584740|4889694|P1|Overall Study|Lost to Follow-up|0
1483618|NCT00584740|4889693|P2|Overall Study|Withdrawal by Subject|2
1483619|NCT00584740|4889694|P1|Overall Study|Withdrawal by Subject|3
1483620|NCT00584740|4889693|P2|Overall Study|Lack of Efficacy|2
1483621|NCT00584740|4889694|P1|Overall Study|Lack of Efficacy|8
1483622|NCT00584740|4889693|P2|Overall Study|Adverse Event|1
1483623|NCT00584740|4889694|P1|Overall Study|Adverse Event|1
1483624|NCT00584727|4889712|P6|Third Intervention|Protocol Violation|2
1483625|NCT00584727|4889713|P5|Third Intervention|Protocol Violation|4
1483626|NCT00584727|4889714|P4|Third Intervention|Protocol Violation|0
1483627|NCT00584727|4889715|P3|Third Intervention|Protocol Violation|1
1483628|NCT00584727|4889716|P2|Third Intervention|Protocol Violation|0
1483629|NCT00584727|4889717|P1|Third Intervention|Protocol Violation|0
1483630|NCT00584727|4889712|P6|First Intervention|Discontinuation|0
1483631|NCT00584727|4889713|P5|First Intervention|Discontinuation|0
1483632|NCT00584727|4889714|P4|First Intervention|Discontinuation|0
1483633|NCT00584727|4889715|P3|First Intervention|Discontinuation|1
1483634|NCT00584727|4889716|P2|First Intervention|Discontinuation|0
1483635|NCT00584727|4889717|P1|First Intervention|Discontinuation|0
1483636|NCT00584454|4889755|P1|Overall Study|Clinical Hold|2
1483637|NCT00584454|4889755|P1|Overall Study|Relocation|1
1483638|NCT00584454|4889755|P1|Overall Study|Adverse Event|1
1483639|NCT00584415|4889759|P1|Overall Study|Adverse Event|7
1483640|NCT00584194|4889778|P1|Overall Study|Not specified|135
1483641|NCT00583947|4889792|P2|Cross-over Period|not specified|1
1483642|NCT00583947|4889793|P1|Cross-over Period|not specified|1
1483643|NCT00583947|4889792|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
1483644|NCT00583947|4889793|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
1483645|NCT00583947|4889792|P2|Cross-over Period|Withdrawal by Subject|0
1483646|NCT00583947|4889793|P1|Cross-over Period|Withdrawal by Subject|2
1483647|NCT00583947|4889792|P2|Cross-over Period|Adverse Event|0
1483648|NCT00583947|4889793|P1|Cross-over Period|Adverse Event|2
1483649|NCT00583596|4889965|P1|Overall Study|Outside f-up window|26
1483650|NCT00583596|4889965|P1|Overall Study|Not consented|15
1483651|NCT00583596|4889965|P1|Overall Study|Data not complete|1
1483652|NCT00583596|4889965|P1|Overall Study|Lost to Follow-up|94
1483653|NCT00583596|4889965|P1|Overall Study|Withdrawal by Subject|6
1483654|NCT00583596|4889965|P1|Overall Study|Death|2
1483655|NCT00583596|4889965|P1|Overall Study|Excluded due to Hurricane Katrina|30
1483656|NCT00583596|4889965|P1|Overall Study|Lost to Follow-up|110
1483657|NCT00583557|4889970|P1|Overall Study|Did not receive belimumab in LBRA99|2
1483658|NCT00583557|4889970|P1|Overall Study|Other|5
1483659|NCT00583557|4889970|P1|Overall Study|Lack of Compliance|5
1483660|NCT00583557|4889970|P1|Overall Study|Lack of Efficacy|31
1483661|NCT00583557|4889970|P1|Overall Study|Adverse Event|9
1483662|NCT00583557|4889970|P1|Overall Study|Withdrawal by Subject|18
1483663|NCT00583453|4890001|P2|Overall Study|discontinued intervention|2
1483664|NCT00583453|4890002|P1|Overall Study|discontinued intervention|0
1483665|NCT00583362|4890035|P1|Overall Study|Withdrawal by Subject|57
1483666|NCT00583362|4890035|P1|Overall Study|Protocol Violation|2
1483667|NCT00583362|4890035|P1|Overall Study|Physician Decision|19
1483668|NCT00583362|4890035|P1|Overall Study|Sponsor request due to missed doses|1
1483669|NCT00583362|4890035|P1|Overall Study|Behavioral problems and non-compliance|1
1483670|NCT00583362|4890035|P1|Overall Study|Misunderstanding of protocol|1
1483671|NCT00583362|4890035|P1|Overall Study|Missed visits due to staff changes|1
1483672|NCT00583362|4890035|P1|Overall Study|Subject moved out of the country/state|2
1483673|NCT00583362|4890035|P1|Overall Study|Subject not dosed in LBSL99|1
1483674|NCT00583362|4890035|P1|Overall Study|Current site closed|7
1483675|NCT00583362|4890035|P1|Overall Study|Miscommunication of visit window|5
1483676|NCT00583362|4890035|P1|Overall Study|Pregnancy|7
1483677|NCT00583362|4890035|P1|Overall Study|Non-compliance with study drug|28
1483678|NCT00583362|4890035|P1|Overall Study|Lost to Follow-up|4
1483679|NCT00583362|4890035|P1|Overall Study|Lack of Efficacy|22
1483680|NCT00583362|4890035|P1|Overall Study|Adverse Event|44
1483681|NCT00583219|4890059|P1|Phase 2|Withdrawal by Subject|1
1483682|NCT00583115|4890076|P1|Overall Study|Death|1
1483683|NCT00583102|4890081|P1|Overall Study|Adverse Event|3
1483684|NCT00582972|4890085|P1|Overall Study|Protocol Violation|2
1483685|NCT00582933|4890094|P1|Overall Study|Physician Decision|3
1483686|NCT00582907|4890098|P4|2nd Course|Lack of Efficacy|0
1483687|NCT00582907|4890099|P3|2nd Course|Lack of Efficacy|0
1483688|NCT00582907|4890100|P2|2nd Course|Lack of Efficacy|0
1483689|NCT00582907|4890101|P1|2nd Course|Lack of Efficacy|1
1483690|NCT00582907|4890098|P4|1st Course|Lost to Follow-up|1
1483691|NCT00582907|4890099|P3|1st Course|Lost to Follow-up|0
1483692|NCT00582907|4890100|P2|1st Course|Lost to Follow-up|0
1483693|NCT00582907|4890101|P1|1st Course|Lost to Follow-up|0
1483694|NCT00582907|4890098|P4|1st Course|Withdrawal by Subject|0
1483695|NCT00582907|4890099|P3|1st Course|Withdrawal by Subject|0
1483696|NCT00582907|4890100|P2|1st Course|Withdrawal by Subject|0
1483697|NCT00582907|4890101|P1|1st Course|Withdrawal by Subject|1
1483698|NCT00582816|4890140|P1|Overall Study|Engraftment Failure|3
1483699|NCT00582790|4890150|P1|Overall Study|Rapid progression of disease|1
1483700|NCT00582738|4890159|P2|Overall Study|Withdrawal by Subject|3
1483701|NCT00582738|4890160|P1|Overall Study|Withdrawal by Subject|0
1483702|NCT00582738|4890159|P2|Overall Study|Protocol Violation|1
1483703|NCT00582738|4890160|P1|Overall Study|Protocol Violation|1
1483704|NCT00582738|4890159|P2|Overall Study|Other|0
1483705|NCT00582738|4890160|P1|Overall Study|Other|1
1483706|NCT00582738|4890159|P2|Overall Study|Graft Lost|1
1483707|NCT00582738|4890160|P1|Overall Study|Graft Lost|0
1483708|NCT00582738|4890159|P2|Overall Study|Adverse Event|5
1483709|NCT00582738|4890160|P1|Overall Study|Adverse Event|0
1483710|NCT00582738|4890159|P2|Overall Study|Administrative Problems|8
1483711|NCT00582738|4890160|P1|Overall Study|Administrative Problems|7
1483712|NCT00582712|4890184|P1|Overall Study|Complicating disease requiring treatment|1
1483713|NCT00582712|4890184|P1|Overall Study|Withdrawal by Subject|1
1483714|NCT00582712|4890184|P1|Overall Study|Lack of Efficacy|1
1483715|NCT00582712|4890184|P1|Overall Study|Adverse Event|1
1483716|NCT00582608|4890199|P1|Overall Study|Lack of accrual|4
1483717|NCT00582608|4890199|P1|Overall Study|Patient Ineligible|1
1483718|NCT00582608|4890199|P1|Overall Study|Not Treated|7
1483719|NCT00582556|4890206|P3|Overall Study|Physician Decision|1
1483720|NCT00582556|4890207|P2|Overall Study|Physician Decision|0
1483721|NCT00582556|4890208|P1|Overall Study|Physician Decision|0
1483722|NCT00582556|4890206|P3|Overall Study|Withdrawal by Subject|1
1483723|NCT00582556|4890207|P2|Overall Study|Withdrawal by Subject|1
1483724|NCT00582556|4890208|P1|Overall Study|Withdrawal by Subject|0
1483725|NCT00582491|4890236|P2|Overall Study|Withdrawal by Subject|0
1483726|NCT00582491|4890237|P1|Overall Study|Withdrawal by Subject|1
1483727|NCT00582426|4890261|P2|Overall Study|Use of illicit drugs|0
1483728|NCT00582426|4890262|P1|Overall Study|Use of illicit drugs|1
1483729|NCT00582426|4890261|P2|Overall Study|Disease Progression|2
1483730|NCT00582426|4890262|P1|Overall Study|Disease Progression|2
1483731|NCT00582426|4890261|P2|Overall Study|Withdrawal by Subject|2
1483732|NCT00582426|4890262|P1|Overall Study|Withdrawal by Subject|3
1483733|NCT00582426|4890261|P2|Overall Study|Death|3
1483734|NCT00582426|4890262|P1|Overall Study|Death|4
1483735|NCT00582426|4890261|P2|Overall Study|Protocol Violation|2
1483736|NCT00582426|4890262|P1|Overall Study|Protocol Violation|6
1483737|NCT00582426|4890261|P2|Overall Study|Adverse Event|2
1483738|NCT00582426|4890262|P1|Overall Study|Adverse Event|4
1483739|NCT00582426|4890261|P2|Overall Study|Lost to Follow-up|2
1483740|NCT00582426|4890262|P1|Overall Study|Lost to Follow-up|0
1483741|NCT00582309|4890309|P3|Overall Study|Protocol Violation|2
1483742|NCT00582309|4890310|P2|Overall Study|Protocol Violation|0
1483743|NCT00582309|4890311|P1|Overall Study|Protocol Violation|0
1483744|NCT00582166|4890324|P1|Overall Study|Ineligible pathology|1
1483745|NCT00582166|4890324|P1|Overall Study|Death|1
1483746|NCT00582114|4890334|P2|Overall Study|Stopped by data safety monitoring board|20
1483747|NCT00582114|4890335|P1|Overall Study|Stopped by data safety monitoring board|19
1483748|NCT00582114|4890334|P2|Overall Study|Physician Decision|6
1483749|NCT00582114|4890335|P1|Overall Study|Physician Decision|0
1483750|NCT00582114|4890334|P2|Overall Study|Adverse Event|1
1483751|NCT00582114|4890335|P1|Overall Study|Adverse Event|1
1483752|NCT00582114|4890334|P2|Overall Study|Withdrawal by Subject|16
1483753|NCT00582114|4890335|P1|Overall Study|Withdrawal by Subject|8
1483754|NCT00582114|4890334|P2|Overall Study|Lost to Follow-up|6
1483755|NCT00582114|4890335|P1|Overall Study|Lost to Follow-up|7
1483756|NCT00582114|4890334|P2|Overall Study|Kidney Transplant|1
1483757|NCT00582114|4890335|P1|Overall Study|Kidney Transplant|3
1483758|NCT00582114|4890334|P2|Overall Study|Death|4
1483759|NCT00582114|4890335|P1|Overall Study|Death|4
1483760|NCT00582036|4890350|P2|Overall Study|Withdrawal by Subject|1
1483761|NCT00582036|4890351|P1|Overall Study|Withdrawal by Subject|0
1483762|NCT00582010|4890359|P2|Overall Study|Death|1
1483763|NCT00582010|4890360|P1|Overall Study|Death|0
1483764|NCT00581945|4890389|P2|Overall Study|Death|0
1483765|NCT00581945|4890390|P1|Overall Study|Death|1
1483766|NCT00581945|4890389|P2|Overall Study|Withdrawal by Subject|6
1483767|NCT00581945|4890390|P1|Overall Study|Withdrawal by Subject|2
1483768|NCT00581945|4890389|P2|Overall Study|Unsatisfactory therapeutic effect|0
1483769|NCT00581945|4890390|P1|Overall Study|Unsatisfactory therapeutic effect|2
1483770|NCT00581945|4890389|P2|Overall Study|Adverse Event|4
1483771|NCT00581945|4890390|P1|Overall Study|Adverse Event|4
1483772|NCT00581919|4890406|P1|Overall Study|Withdrawal by Subject|1
1483773|NCT00581919|4890406|P1|Overall Study|Started Non-Protocol Therapy|2
1483774|NCT00581919|4890406|P1|Overall Study|Other Complicating Disease|1
1483775|NCT00581919|4890406|P1|Overall Study|Physician Decision|1
1483776|NCT00581919|4890406|P1|Overall Study|Disease Progression|10
1483777|NCT00581919|4890406|P1|Overall Study|Death|1
1483778|NCT00581919|4890406|P1|Overall Study|Adverse Event|8
1483779|NCT00581828|4890425|P1|Overall Study|Protocol Violation|1
1483780|NCT00581776|4890429|P1|Overall Study|Disease progression or no response|3
1483781|NCT00581555|4890447|P2|Overall Study|Other reasons|4
1483782|NCT00581555|4890448|P1|Overall Study|Other reasons|16
1483783|NCT00581555|4890447|P2|Overall Study|Lost to Follow-up|2
1483784|NCT00581555|4890448|P1|Overall Study|Lost to Follow-up|2
1483785|NCT00581555|4890447|P2|Overall Study|Withdrawal by Subject|9
1483786|NCT00581555|4890448|P1|Overall Study|Withdrawal by Subject|18
1483787|NCT00581555|4890447|P2|Overall Study|Physician Decision|2
1483788|NCT00581555|4890448|P1|Overall Study|Physician Decision|3
1483789|NCT00581555|4890447|P2|Overall Study|Adverse Event|3
1483790|NCT00581555|4890448|P1|Overall Study|Adverse Event|4
1483791|NCT00581542|4890472|P2|Overall Study|Lost to Follow-up|21
1483792|NCT00581542|4890473|P1|Overall Study|Lost to Follow-up|9
1483793|NCT00581542|4890472|P2|Overall Study|they met an exclusion criteria|2
1483794|NCT00581542|4890473|P1|Overall Study|they met an exclusion criteria|2
1483795|NCT00581360|4890527|P1|Overall Study|Withdrawal by Subject|1
1483796|NCT00581308|4890546|P1|Month 12|Other|1
1483797|NCT00581308|4890546|P1|Month 12|Device Removed|1
1483798|NCT00581308|4890546|P1|Month 12|Withdrawal by Subject|3
1483799|NCT00581308|4890546|P1|Month 12|Lost to Follow-up|14
1483800|NCT00581308|4890546|P1|Month 12|Death|1
1483801|NCT00581308|4890546|P1|Month 6|Withdrawal by Subject|2
1483802|NCT00581308|4890546|P1|Month 6|Lost to Follow-up|1
1483803|NCT00581308|4890546|P1|Month 1|Uknown|1
1483804|NCT00581308|4890546|P1|Month 1|Device Removed|2
1483805|NCT00581308|4890546|P1|Month 1|Withdrawal by Subject|2
1483806|NCT00581308|4890546|P1|Month 1|Lost to Follow-up|3
1483807|NCT00581308|4890546|P1|Pre Discharge|Device Removed|1
1483808|NCT00581308|4890546|P1|Pre Discharge|Lost to Follow-up|1
1483809|NCT00581113|4890577|P2|Overall Study|Withdrawal by Subject|1
1483810|NCT00581113|4890578|P1|Overall Study|Withdrawal by Subject|0
1483811|NCT00581100|4890588|P2|Overall Study|Other|0
1483812|NCT00581100|4890589|P1|Overall Study|Other|3
1483813|NCT00581100|4890588|P2|Overall Study|Withdrawal by Subject|4
1483814|NCT00581100|4890589|P1|Overall Study|Withdrawal by Subject|1
1483815|NCT00581100|4890588|P2|Overall Study|Adverse Event|1
1483816|NCT00581100|4890589|P1|Overall Study|Adverse Event|2
1483817|NCT00581100|4890588|P2|Overall Study|Death|0
1483818|NCT00581100|4890589|P1|Overall Study|Death|1
1483819|NCT00580983|4890642|P1|Overall Study|Did not complete 12 mon post RT studies|7
1483820|NCT00580970|4890649|P1|Treatment (Lovastatin)|Death|1
1483821|NCT00580970|4890649|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
1483822|NCT00580970|4890649|P1|Treatment (Lovastatin)|Physician Decision|4
1483823|NCT00580970|4890649|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
1483824|NCT00580970|4890649|P1|Treatment (Lovastatin)|Non-compliance|6
1483825|NCT00580970|4890649|P1|Pre-treatment|Non-compliance|1
1483826|NCT00580866|4890664|P2|Overall Study|Lost to Follow-up|2
1483827|NCT00580866|4890665|P1|Overall Study|Lost to Follow-up|2
1483828|NCT00580840|4890689|P4|Double-Blind|Other: Forbidden Medication|0
1483829|NCT00580840|4890690|P3|Double-Blind|Other: Forbidden Medication|1
1483830|NCT00580840|4890691|P2|Double-Blind|Other: Forbidden Medication|0
1483831|NCT00580840|4890692|P1|Double-Blind|Other: Forbidden Medication|0
1483832|NCT00580840|4890689|P4|Double-Blind|Other: Discontinued Methotrexate|0
1483833|NCT00580840|4890690|P3|Double-Blind|Other: Discontinued Methotrexate|0
1483834|NCT00580840|4890691|P2|Double-Blind|Other: Discontinued Methotrexate|1
1483835|NCT00580840|4890692|P1|Double-Blind|Other: Discontinued Methotrexate|0
1483836|NCT00580840|4890689|P4|Double-Blind|Withdrawal by Subject|2
1483837|NCT00580840|4890690|P3|Double-Blind|Withdrawal by Subject|2
1483838|NCT00580840|4890691|P2|Double-Blind|Withdrawal by Subject|1
1483839|NCT00580840|4890692|P1|Double-Blind|Withdrawal by Subject|0
1483840|NCT00580840|4890689|P4|Double-Blind|Lost to Follow-up|2
1483841|NCT00580840|4890690|P3|Double-Blind|Lost to Follow-up|0
1483842|NCT00580840|4890691|P2|Double-Blind|Lost to Follow-up|1
1483843|NCT00580840|4890692|P1|Double-Blind|Lost to Follow-up|0
1483844|NCT00580840|4890689|P4|Double-Blind|Loss of Efficacy|10
1483845|NCT00580840|4890690|P3|Double-Blind|Loss of Efficacy|2
1483846|NCT00580840|4890691|P2|Double-Blind|Loss of Efficacy|1
1483847|NCT00580840|4890692|P1|Double-Blind|Loss of Efficacy|0
1483848|NCT00580840|4890689|P4|Double-Blind|Adverse Event|1
1483849|NCT00580840|4890690|P3|Double-Blind|Adverse Event|4
1483850|NCT00580840|4890691|P2|Double-Blind|Adverse Event|3
1483851|NCT00580840|4890692|P1|Double-Blind|Adverse Event|0
1483852|NCT00580840|4890689|P4|Run-in|Other: Exclusionary Lab Value|0
1483853|NCT00580840|4890690|P3|Run-in|Other: Exclusionary Lab Value|0
1483854|NCT00580840|4890691|P2|Run-in|Other: Exclusionary Lab Value|0
1483855|NCT00580840|4890692|P1|Run-in|Other: Exclusionary Lab Value|1
1483856|NCT00580840|4890689|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
1483857|NCT00580840|4890690|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
1483858|NCT00580840|4890691|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
1483859|NCT00580840|4890692|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
1483860|NCT00580840|4890689|P4|Run-in|Other: Per Sponsor Request|0
1483861|NCT00580840|4890690|P3|Run-in|Other: Per Sponsor Request|0
1483862|NCT00580840|4890691|P2|Run-in|Other: Per Sponsor Request|0
1483863|NCT00580840|4890692|P1|Run-in|Other: Per Sponsor Request|2
1483864|NCT00580840|4890689|P4|Run-in|Withdrawal by Subject|0
1483865|NCT00580840|4890690|P3|Run-in|Withdrawal by Subject|0
1483866|NCT00580840|4890691|P2|Run-in|Withdrawal by Subject|0
1483867|NCT00580840|4890692|P1|Run-in|Withdrawal by Subject|5
1483868|NCT00580840|4890689|P4|Run-in|Lost to Follow-up|0
1483869|NCT00580840|4890690|P3|Run-in|Lost to Follow-up|0
1483870|NCT00580840|4890691|P2|Run-in|Lost to Follow-up|0
1483871|NCT00580840|4890692|P1|Run-in|Lost to Follow-up|4
1483872|NCT00580840|4890689|P4|Run-in|Loss of Efficacy|0
1483873|NCT00580840|4890690|P3|Run-in|Loss of Efficacy|0
1483874|NCT00580840|4890691|P2|Run-in|Loss of Efficacy|0
1483875|NCT00580840|4890692|P1|Run-in|Loss of Efficacy|1
1483876|NCT00580840|4890689|P4|Run-in|Lack of Efficacy|0
1483877|NCT00580840|4890690|P3|Run-in|Lack of Efficacy|0
1483878|NCT00580840|4890691|P2|Run-in|Lack of Efficacy|0
1483879|NCT00580840|4890692|P1|Run-in|Lack of Efficacy|93
1483880|NCT00580840|4890689|P4|Run-in|Adverse Event|0
1483881|NCT00580840|4890690|P3|Run-in|Adverse Event|0
1483882|NCT00580840|4890691|P2|Run-in|Adverse Event|0
1483883|NCT00580840|4890692|P1|Run-in|Adverse Event|17
1483884|NCT00580801|4890800|P3|Overall Study|Travel|0
1483885|NCT00580801|4890801|P2|Overall Study|Travel|0
1483886|NCT00580801|4890802|P1|Overall Study|Travel|1
1483887|NCT00580801|4890800|P3|Overall Study|Participant non-compliant|1
1483888|NCT00580801|4890801|P2|Overall Study|Participant non-compliant|0
1483889|NCT00580801|4890802|P1|Overall Study|Participant non-compliant|0
1483890|NCT00580801|4890800|P3|Overall Study|Reached a virologic endpoint|2
1483891|NCT00580801|4890801|P2|Overall Study|Reached a virologic endpoint|1
1483892|NCT00580801|4890802|P1|Overall Study|Reached a virologic endpoint|0
1483893|NCT00580801|4890800|P3|Overall Study|Lost to Follow-up|0
1483894|NCT00580801|4890801|P2|Overall Study|Lost to Follow-up|0
1483895|NCT00580801|4890802|P1|Overall Study|Lost to Follow-up|2
1483896|NCT00580801|4890800|P3|Overall Study|Adverse Event|0
1483897|NCT00580801|4890801|P2|Overall Study|Adverse Event|0
1483898|NCT00580801|4890802|P1|Overall Study|Adverse Event|2
1483899|NCT00580801|4890800|P3|Overall Study|Physician Decision|0
1483900|NCT00580801|4890801|P2|Overall Study|Physician Decision|0
1483901|NCT00580801|4890802|P1|Overall Study|Physician Decision|1
1483902|NCT00580788|4890841|P4|Overall Study|Adverse Event|1
1483903|NCT00580788|4890842|P3|Overall Study|Adverse Event|0
1483904|NCT00580788|4890843|P2|Overall Study|Adverse Event|0
1483905|NCT00580788|4890844|P1|Overall Study|Adverse Event|0
1483906|NCT00580723|4890902|P1|Overall Study|Lost to Follow-up|5
1483907|NCT00580723|4890902|P1|Overall Study|Did not want to participate in extension|3
1483908|NCT00580606|4890945|P2|Open Label (OL)|Needed Prohibited Medication|1
1483909|NCT00580606|4890946|P1|Open Label (OL)|Needed Prohibited Medication|0
1483910|NCT00580606|4890945|P2|Open Label (OL)|Physician Decision|1
1483911|NCT00580606|4890946|P1|Open Label (OL)|Physician Decision|1
1483912|NCT00580606|4890945|P2|Open Label (OL)|Non-compliance|0
1483913|NCT00580606|4890946|P1|Open Label (OL)|Non-compliance|2
1483914|NCT00580606|4890945|P2|Open Label (OL)|Pregnancy|1
1483915|NCT00580606|4890946|P1|Open Label (OL)|Pregnancy|0
1483916|NCT00580606|4890945|P2|Open Label (OL)|Lost to Follow-up|1
1483917|NCT00580606|4890946|P1|Open Label (OL)|Lost to Follow-up|0
1483918|NCT00580606|4890945|P2|Open Label (OL)|Dosing Symptoms|1
1483919|NCT00580606|4890946|P1|Open Label (OL)|Dosing Symptoms|0
1483920|NCT00580606|4890945|P2|Open Label (OL)|Withdrawal by Subject|6
1483921|NCT00580606|4890946|P1|Open Label (OL)|Withdrawal by Subject|4
1483922|NCT00580606|4890945|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
1483923|NCT00580606|4890946|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
1483924|NCT00580047|4891027|P3|Overall Study|Withdrawal by Subject|0
1483925|NCT00580047|4891028|P2|Overall Study|Withdrawal by Subject|0
1483926|NCT00580047|4891029|P1|Overall Study|Withdrawal by Subject|1
1483927|NCT00580047|4891027|P3|Overall Study|Withdrawal by Subject|2
1483928|NCT00580047|4891028|P2|Overall Study|Withdrawal by Subject|1
1483929|NCT00580047|4891029|P1|Overall Study|Withdrawal by Subject|1
1483930|NCT00580047|4891027|P3|Overall Study|Lost to Follow-up|0
1483931|NCT00580047|4891028|P2|Overall Study|Lost to Follow-up|1
1483932|NCT00580047|4891029|P1|Overall Study|Lost to Follow-up|1
1483933|NCT00580034|4891040|P2|Overall Study|Toxicity|0
1483934|NCT00580034|4891041|P1|Overall Study|Toxicity|10
1483935|NCT00579982|4891047|P1|Overall Study|Protocol Violation|4
1483936|NCT00579982|4891047|P1|Overall Study|Adverse Event|4
1483937|NCT00579826|4891068|P2|Overall Study|Withdrawal by Subject|3
1483938|NCT00579826|4891069|P1|Overall Study|Withdrawal by Subject|5
1483939|NCT00579670|4891103|P5|Overall Study|Withdrawal by Subject|0
1483940|NCT00579670|4891104|P4|Overall Study|Withdrawal by Subject|0
1483941|NCT00579670|4891105|P3|Overall Study|Withdrawal by Subject|1
1483942|NCT00579670|4891106|P2|Overall Study|Withdrawal by Subject|0
1483943|NCT00579670|4891107|P1|Overall Study|Withdrawal by Subject|0
1483944|NCT00579670|4891103|P5|Overall Study|Other|0
1483945|NCT00579670|4891104|P4|Overall Study|Other|2
1483946|NCT00579670|4891105|P3|Overall Study|Other|1
1483947|NCT00579670|4891106|P2|Overall Study|Other|0
1483948|NCT00579670|4891107|P1|Overall Study|Other|0
1483949|NCT00579670|4891103|P5|Overall Study|Lost to Follow-up|0
1483950|NCT00579670|4891104|P4|Overall Study|Lost to Follow-up|4
1483951|NCT00579670|4891105|P3|Overall Study|Lost to Follow-up|0
1483952|NCT00579670|4891106|P2|Overall Study|Lost to Follow-up|1
1483953|NCT00579670|4891107|P1|Overall Study|Lost to Follow-up|0
1483954|NCT00579670|4891103|P5|Overall Study|Lack of Efficacy|0
1483955|NCT00579670|4891104|P4|Overall Study|Lack of Efficacy|14
1483956|NCT00579670|4891105|P3|Overall Study|Lack of Efficacy|1
1483957|NCT00579670|4891106|P2|Overall Study|Lack of Efficacy|0
1483958|NCT00579670|4891107|P1|Overall Study|Lack of Efficacy|0
1483959|NCT00579670|4891103|P5|Overall Study|Adverse Event|0
1483960|NCT00579670|4891104|P4|Overall Study|Adverse Event|2
1483961|NCT00579670|4891105|P3|Overall Study|Adverse Event|1
1483962|NCT00579670|4891106|P2|Overall Study|Adverse Event|0
1483963|NCT00579670|4891107|P1|Overall Study|Adverse Event|1
1483964|NCT00579670|4891103|P5|Overall Study|Death|0
1483965|NCT00579670|4891104|P4|Overall Study|Death|0
1483966|NCT00579670|4891105|P3|Overall Study|Death|0
1483967|NCT00579670|4891106|P2|Overall Study|Death|0
1483968|NCT00579670|4891107|P1|Overall Study|Death|1
1483969|NCT00579501|4891319|P1|Overall Study|Radiation therapy before surgery|1
1483970|NCT00579501|4891319|P1|Overall Study|Secondary lesion|1
1483971|NCT00579501|4891319|P1|Overall Study|toxicity|1
1483972|NCT00579501|4891319|P1|Overall Study|End of neoadjuvant therapy|25
1483973|NCT00579501|4891319|P1|Overall Study|Death|1
1483974|NCT00579345|4891347|P8|Overall Study|Death|0
1483975|NCT00579345|4891348|P7|Overall Study|Death|0
1483976|NCT00579345|4891349|P6|Overall Study|Death|0
1483977|NCT00579345|4891350|P5|Overall Study|Death|0
1483978|NCT00579345|4891351|P4|Overall Study|Death|1
1483979|NCT00579345|4891352|P3|Overall Study|Death|1
1483980|NCT00579345|4891353|P2|Overall Study|Death|1
1483981|NCT00579345|4891354|P1|Overall Study|Death|1
1483982|NCT00579345|4891347|P8|Overall Study|Protocol Violation|1
1483983|NCT00579345|4891348|P7|Overall Study|Protocol Violation|0
1483984|NCT00579345|4891349|P6|Overall Study|Protocol Violation|0
1483985|NCT00579345|4891350|P5|Overall Study|Protocol Violation|0
1483986|NCT00579345|4891351|P4|Overall Study|Protocol Violation|0
1483987|NCT00579345|4891352|P3|Overall Study|Protocol Violation|0
1483988|NCT00579345|4891353|P2|Overall Study|Protocol Violation|0
1483989|NCT00579345|4891354|P1|Overall Study|Protocol Violation|1
1483990|NCT00579345|4891347|P8|Overall Study|Adverse Event|0
1483991|NCT00579345|4891348|P7|Overall Study|Adverse Event|0
1483992|NCT00579345|4891349|P6|Overall Study|Adverse Event|0
1483993|NCT00579345|4891350|P5|Overall Study|Adverse Event|0
1483994|NCT00579345|4891351|P4|Overall Study|Adverse Event|0
1483995|NCT00579345|4891352|P3|Overall Study|Adverse Event|1
1483996|NCT00579345|4891353|P2|Overall Study|Adverse Event|0
1483997|NCT00579345|4891354|P1|Overall Study|Adverse Event|0
1483998|NCT00579345|4891347|P8|Overall Study|Lost to Follow-up|0
1483999|NCT00579345|4891348|P7|Overall Study|Lost to Follow-up|0
1484000|NCT00579345|4891349|P6|Overall Study|Lost to Follow-up|0
1484001|NCT00579345|4891350|P5|Overall Study|Lost to Follow-up|0
1484002|NCT00579345|4891351|P4|Overall Study|Lost to Follow-up|0
1484003|NCT00579345|4891352|P3|Overall Study|Lost to Follow-up|0
1484004|NCT00579345|4891353|P2|Overall Study|Lost to Follow-up|0
1484005|NCT00579345|4891354|P1|Overall Study|Lost to Follow-up|1
1484006|NCT00579345|4891347|P8|Overall Study|Withdrawal by Subject|1
1484007|NCT00579345|4891348|P7|Overall Study|Withdrawal by Subject|0
1484008|NCT00579345|4891349|P6|Overall Study|Withdrawal by Subject|0
1484009|NCT00579345|4891350|P5|Overall Study|Withdrawal by Subject|0
1484010|NCT00579345|4891351|P4|Overall Study|Withdrawal by Subject|0
1484011|NCT00579345|4891352|P3|Overall Study|Withdrawal by Subject|0
1484012|NCT00579345|4891353|P2|Overall Study|Withdrawal by Subject|0
1484013|NCT00579345|4891354|P1|Overall Study|Withdrawal by Subject|2
1484014|NCT00579254|4891386|P1|Overall Study|Discontinued when study terminated|73
1484015|NCT00579254|4891386|P1|Overall Study|Lost to Follow-up|39
1484016|NCT00579098|4891410|P2|Overall Study|AF returned after ablation|2
1484017|NCT00579098|4891411|P1|Overall Study|AF returned after ablation|3
1484018|NCT00579098|4891410|P2|Overall Study|Withdrawal by Subject|3
1484019|NCT00579098|4891411|P1|Overall Study|Withdrawal by Subject|2
1484020|NCT00579098|4891410|P2|Overall Study|Adverse Event|3
1484021|NCT00579098|4891411|P1|Overall Study|Adverse Event|2
1484022|NCT00579098|4891410|P2|Overall Study|Lost to Follow-up|0
1484023|NCT00579098|4891411|P1|Overall Study|Lost to Follow-up|2
1484024|NCT00579059|4891427|P2|Overall Study|Study Canceled at 1 Year|10
1484025|NCT00579059|4891428|P1|Overall Study|Study Canceled at 1 Year|21
1484026|NCT00578942|4891502|P1|Overall Study|Lost to Follow-up|1
1484027|NCT00578877|4891541|P2|Overall Study|did not provide follow-up data|17
1484028|NCT00578877|4891542|P1|Overall Study|did not provide follow-up data|12
1484029|NCT00578877|4891541|P2|Overall Study|early discontinue|101
1484030|NCT00578877|4891542|P1|Overall Study|early discontinue|61
1484031|NCT00578877|4891541|P2|Overall Study|Lost to Follow-up|10
1484032|NCT00578877|4891542|P1|Overall Study|Lost to Follow-up|8
1484033|NCT00578864|4891550|P2|Overall Study|Death|0
1484034|NCT00578864|4891551|P1|Overall Study|Death|1
1484035|NCT00578812|4891567|P2|Overall Study|Not treated|7
1484036|NCT00578812|4891568|P1|Overall Study|Not treated|6
1484037|NCT00578786|4891607|P3|Overall Study|Qualified but Not Enrolled in Extension|0
1484038|NCT00578786|4891608|P2|Overall Study|Qualified but Not Enrolled in Extension|3
1484039|NCT00578786|4891609|P1|Overall Study|Qualified but Not Enrolled in Extension|0
1484040|NCT00578786|4891607|P3|Overall Study|Not Otherwise Specified|1
1484041|NCT00578786|4891608|P2|Overall Study|Not Otherwise Specified|4
1484042|NCT00578786|4891609|P1|Overall Study|Not Otherwise Specified|0
1484043|NCT00578786|4891607|P3|Overall Study|Pregnancy|0
1484044|NCT00578786|4891608|P2|Overall Study|Pregnancy|1
1484045|NCT00578786|4891609|P1|Overall Study|Pregnancy|0
1484046|NCT00578786|4891607|P3|Overall Study|Lost to Follow-up|0
1484047|NCT00578786|4891608|P2|Overall Study|Lost to Follow-up|4
1484048|NCT00578786|4891609|P1|Overall Study|Lost to Follow-up|0
1484049|NCT00578786|4891607|P3|Overall Study|Sponsor Decision|1
1484050|NCT00578786|4891608|P2|Overall Study|Sponsor Decision|0
1484051|NCT00578786|4891609|P1|Overall Study|Sponsor Decision|0
1484052|NCT00578786|4891607|P3|Overall Study|Physician Decision|1
1484053|NCT00578786|4891608|P2|Overall Study|Physician Decision|0
1484054|NCT00578786|4891609|P1|Overall Study|Physician Decision|1
1484055|NCT00578786|4891607|P3|Overall Study|Protocol Violation|1
1484056|NCT00578786|4891608|P2|Overall Study|Protocol Violation|3
1484057|NCT00578786|4891609|P1|Overall Study|Protocol Violation|0
1484058|NCT00578786|4891607|P3|Overall Study|Withdrawal by Subject|5
1484059|NCT00578786|4891608|P2|Overall Study|Withdrawal by Subject|8
1484060|NCT00578786|4891609|P1|Overall Study|Withdrawal by Subject|7
1484061|NCT00578786|4891607|P3|Overall Study|Early Escape from Prior Study|2
1484062|NCT00578786|4891608|P2|Overall Study|Early Escape from Prior Study|1
1484063|NCT00578786|4891609|P1|Overall Study|Early Escape from Prior Study|2
1484064|NCT00578786|4891607|P3|Overall Study|Lack of Efficacy|2
1484065|NCT00578786|4891608|P2|Overall Study|Lack of Efficacy|5
1484066|NCT00578786|4891609|P1|Overall Study|Lack of Efficacy|2
1484067|NCT00578786|4891607|P3|Overall Study|Adverse Event|17
1484068|NCT00578786|4891608|P2|Overall Study|Adverse Event|37
1484069|NCT00578786|4891609|P1|Overall Study|Adverse Event|27
1484070|NCT00578565|4891708|P1|Overall Study|Adverse Event|3
1484071|NCT00578448|4891738|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
1484072|NCT00578448|4891738|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
1484073|NCT00578448|4891738|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
1484074|NCT00578448|4891738|P1|Day 1 up to 3 Years of Planned Study|Death|1
1484075|NCT00578318|4891802|P2|Overall Study|Physician Decision|0
1484076|NCT00578318|4891803|P1|Overall Study|Physician Decision|1
1484077|NCT00578318|4891802|P2|Overall Study|Lost to Follow-up|0
1484078|NCT00578318|4891803|P1|Overall Study|Lost to Follow-up|2
1484079|NCT00578227|4891885|P3|Overall Study|Withdrawal by Subject|3
1484080|NCT00578227|4891886|P2|Overall Study|Withdrawal by Subject|1
1484081|NCT00578227|4891887|P1|Overall Study|Withdrawal by Subject|5
1484082|NCT00578227|4891885|P3|Overall Study|Lost to Follow-up|1
1484083|NCT00578227|4891886|P2|Overall Study|Lost to Follow-up|1
1484084|NCT00578227|4891887|P1|Overall Study|Lost to Follow-up|0
1484085|NCT00578136|4892093|P2|Overall Study|Not given intervention|1
1484086|NCT00578136|4892094|P1|Overall Study|Not given intervention|1
1484087|NCT00577889|4892112|P3|Overall Study|Withdrawal by Subject|0
1484088|NCT00577889|4892113|P2|Overall Study|Withdrawal by Subject|0
1484089|NCT00577889|4892114|P1|Overall Study|Withdrawal by Subject|1
1484090|NCT00577863|4892133|P2|Overall Study|Did Not Receive at Least One Injection|1
1484091|NCT00577863|4892134|P1|Overall Study|Did Not Receive at Least One Injection|0
1484092|NCT00577863|4892133|P2|Overall Study|Sponsor Decision|7
1484093|NCT00577863|4892134|P1|Overall Study|Sponsor Decision|2
1484094|NCT00577863|4892133|P2|Overall Study|Withdrawal by Subject|2
1484095|NCT00577863|4892134|P1|Overall Study|Withdrawal by Subject|0
1484096|NCT00577863|4892133|P2|Overall Study|Entry Criteria Exclusion|0
1484097|NCT00577863|4892134|P1|Overall Study|Entry Criteria Exclusion|1
1484098|NCT00577863|4892133|P2|Overall Study|Lost to Follow-up|2
1484099|NCT00577863|4892134|P1|Overall Study|Lost to Follow-up|2
1484100|NCT00577863|4892133|P2|Overall Study|Death|0
1484101|NCT00577863|4892134|P1|Overall Study|Death|1
1484102|NCT00577863|4892133|P2|Overall Study|Adverse Event|2
1484103|NCT00577863|4892134|P1|Overall Study|Adverse Event|4
1484104|NCT00577824|4892176|P3|Overall Study|Protocol Violation|0
1484105|NCT00577824|4892177|P2|Overall Study|Protocol Violation|1
1484106|NCT00577824|4892178|P1|Overall Study|Protocol Violation|1
1484107|NCT00577824|4892176|P3|Overall Study|Patient decision|1
1484108|NCT00577824|4892177|P2|Overall Study|Patient decision|1
1484109|NCT00577824|4892178|P1|Overall Study|Patient decision|0
1484110|NCT00577824|4892176|P3|Overall Study|Adverse Event|1
1484111|NCT00577824|4892177|P2|Overall Study|Adverse Event|18
1484112|NCT00577824|4892178|P1|Overall Study|Adverse Event|6
1484113|NCT00577772|4892236|P2|Overall Study|Lost to Follow-up|1
1484114|NCT00577772|4892237|P1|Overall Study|Lost to Follow-up|0
1484115|NCT00577720|4892247|P4|Overall Study|Withdrawal by Subject|2
1484116|NCT00577720|4892248|P3|Overall Study|Withdrawal by Subject|0
1484117|NCT00577720|4892249|P2|Overall Study|Withdrawal by Subject|0
1484118|NCT00577720|4892250|P1|Overall Study|Withdrawal by Subject|2
1484119|NCT00577720|4892247|P4|Overall Study|Protocol Violation|1
1484120|NCT00577720|4892248|P3|Overall Study|Protocol Violation|0
1484121|NCT00577720|4892249|P2|Overall Study|Protocol Violation|0
1484122|NCT00577720|4892250|P1|Overall Study|Protocol Violation|0
1484123|NCT00577720|4892247|P4|Overall Study|Lost to Follow-up|0
1484124|NCT00577720|4892248|P3|Overall Study|Lost to Follow-up|1
1484125|NCT00577720|4892249|P2|Overall Study|Lost to Follow-up|0
1484126|NCT00577720|4892250|P1|Overall Study|Lost to Follow-up|0
1484127|NCT00577720|4892247|P4|Overall Study|Adverse Event|4
1484128|NCT00577720|4892248|P3|Overall Study|Adverse Event|0
1484129|NCT00577720|4892249|P2|Overall Study|Adverse Event|1
1484130|NCT00577720|4892250|P1|Overall Study|Adverse Event|2
1484131|NCT00577707|4892268|P1|Overall Study|Withdrawal by Subject|3
1484132|NCT00577655|4892276|P2|Overall Study|Lost to Follow-up|1
1484133|NCT00577655|4892277|P1|Overall Study|Lost to Follow-up|1
1484134|NCT00577655|4892276|P2|Overall Study|Protocol Violation|1
1484135|NCT00577655|4892277|P1|Overall Study|Protocol Violation|0
1484136|NCT00577655|4892276|P2|Overall Study|Patient Request|2
1484137|NCT00577655|4892277|P1|Overall Study|Patient Request|0
1484138|NCT00577642|4892315|P1|Overall Study|Clinical Disease Progression|1
1484139|NCT00577629|4892319|P1|Long Term Follow-Up|Physician Decision|1
1484140|NCT00577629|4892319|P1|Long Term Follow-Up|Withdrawal by Subject|4
1484141|NCT00577629|4892319|P1|Long Term Follow-Up|Lost to Follow-up|5
1484142|NCT00577629|4892319|P1|Long Term Follow-Up|Death|15
1484143|NCT00577629|4892319|P1|Treatment Period|Death|1
1484144|NCT00577473|4892346|P2|Overall Study|Lack of Efficacy|7
1484145|NCT00577473|4892347|P1|Overall Study|Lack of Efficacy|8
1484146|NCT00577473|4892346|P2|Overall Study|Physician Decision|2
1484147|NCT00577473|4892347|P1|Overall Study|Physician Decision|2
1484148|NCT00577473|4892346|P2|Overall Study|Withdrawal by Subject|6
1484149|NCT00577473|4892347|P1|Overall Study|Withdrawal by Subject|2
1484150|NCT00577473|4892346|P2|Overall Study|Adverse Event|5
1484151|NCT00577473|4892347|P1|Overall Study|Adverse Event|8
1484152|NCT00577473|4892346|P2|Overall Study|Protocol Violation|4
1484153|NCT00577473|4892347|P1|Overall Study|Protocol Violation|1
1484154|NCT00577460|4892378|P3|Overall Study|not specified|2
1484155|NCT00577460|4892379|P2|Overall Study|not specified|3
1484156|NCT00577460|4892380|P1|Overall Study|not specified|0
1484157|NCT00577460|4892378|P3|Overall Study|Withdrawal by Subject|6
1484158|NCT00577460|4892379|P2|Overall Study|Withdrawal by Subject|5
1484159|NCT00577460|4892380|P1|Overall Study|Withdrawal by Subject|5
1484160|NCT00577460|4892378|P3|Overall Study|Lost to Follow-up|4
1484161|NCT00577460|4892379|P2|Overall Study|Lost to Follow-up|3
1484162|NCT00577460|4892380|P1|Overall Study|Lost to Follow-up|0
1484163|NCT00577460|4892378|P3|Overall Study|Protocol Violation|1
1484164|NCT00577460|4892379|P2|Overall Study|Protocol Violation|1
1484165|NCT00577460|4892380|P1|Overall Study|Protocol Violation|0
1484166|NCT00577460|4892378|P3|Overall Study|Adverse Event|14
1484167|NCT00577460|4892379|P2|Overall Study|Adverse Event|7
1484168|NCT00577460|4892380|P1|Overall Study|Adverse Event|11
1484169|NCT00577408|4892489|P2|Overall Study|Psychiatric hospitalization|1
1484170|NCT00577408|4892490|P1|Overall Study|Psychiatric hospitalization|0
1484171|NCT00577408|4892489|P2|Overall Study|Death|1
1484172|NCT00577408|4892490|P1|Overall Study|Death|0
1484173|NCT00577408|4892489|P2|Overall Study|Scheduling Issues|3
1484174|NCT00577408|4892490|P1|Overall Study|Scheduling Issues|0
1484175|NCT00577408|4892489|P2|Overall Study|Moved out of state|1
1484176|NCT00577408|4892490|P1|Overall Study|Moved out of state|0
1484177|NCT00577408|4892489|P2|Overall Study|Refused Oral Naltrexone|1
1484178|NCT00577408|4892490|P1|Overall Study|Refused Oral Naltrexone|0
1484179|NCT00577408|4892489|P2|Overall Study|Non-compliance with study meds|3
1484180|NCT00577408|4892490|P1|Overall Study|Non-compliance with study meds|0
1484181|NCT00577408|4892489|P2|Overall Study|Continued opioid use|2
1484182|NCT00577408|4892490|P1|Overall Study|Continued opioid use|3
1484183|NCT00577408|4892489|P2|Overall Study|Stopped attending study visits|11
1484184|NCT00577408|4892490|P1|Overall Study|Stopped attending study visits|9
1484185|NCT00577395|4892498|P2|Overall Study|Study was terminated early by Sponsor|6
1484186|NCT00577395|4892499|P1|Overall Study|Study was terminated early by Sponsor|7
1484187|NCT00577382|4892509|P2|Overall Study|Lost to Follow-up|2
1484188|NCT00577382|4892510|P1|Overall Study|Lost to Follow-up|2
1484189|NCT00577382|4892509|P2|Overall Study|Death|1
1484190|NCT00577382|4892510|P1|Overall Study|Death|1
1484191|NCT00577382|4892509|P2|Overall Study|Intercurrent Illness|2
1484192|NCT00577382|4892510|P1|Overall Study|Intercurrent Illness|1
1484193|NCT00577382|4892509|P2|Overall Study|Progressive Disease|19
1484194|NCT00577382|4892510|P1|Overall Study|Progressive Disease|17
1484195|NCT00577382|4892509|P2|Overall Study|Withdrawal by Subject|1
1484196|NCT00577382|4892510|P1|Overall Study|Withdrawal by Subject|0
1484197|NCT00577382|4892509|P2|Overall Study|Adverse Event|6
1484198|NCT00577382|4892510|P1|Overall Study|Adverse Event|0
1484199|NCT00577122|4892653|P2|Overall Study|Alternative Therapy|1
1484200|NCT00577122|4892654|P1|Overall Study|Alternative Therapy|0
1484201|NCT00577122|4892653|P2|Overall Study|Prog, refract disease during active trt|5
1484202|NCT00577122|4892654|P1|Overall Study|Prog, refract disease during active trt|8
1484203|NCT00577122|4892653|P2|Overall Study|Progression, relapse during active trt|8
1484204|NCT00577122|4892654|P1|Overall Study|Progression, relapse during active trt|6
1484205|NCT00577122|4892653|P2|Overall Study|Adverse Event|2
1484206|NCT00577122|4892654|P1|Overall Study|Adverse Event|0
1484207|NCT00577096|4892668|P2|Short Term Participation|Death|1
1484208|NCT00577096|4892669|P1|Short Term Participation|Death|1
1484209|NCT00577096|4892668|P2|Short Term Participation|Withdrawal by Subject|5
1484210|NCT00577096|4892669|P1|Short Term Participation|Withdrawal by Subject|3
1484211|NCT00577096|4892668|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
1484212|NCT00577096|4892669|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
1484213|NCT00577031|4892702|P1|Overall Study|Death|6
1484214|NCT00577031|4892702|P1|Overall Study|Medical decision|14
1484215|NCT00577031|4892702|P1|Overall Study|Need for surgery|17
1484216|NCT00577031|4892702|P1|Overall Study|Participant non-compliance|5
1484217|NCT00577031|4892702|P1|Overall Study|Participant withdrew consent|13
1484218|NCT00577031|4892702|P1|Overall Study|Protocol Violation|5
1484219|NCT00577031|4892702|P1|Overall Study|Progression of disease|93
1484220|NCT00577031|4892702|P1|Overall Study|Adverse Event|52
1484221|NCT00577005|4892723|P2|Overall Study|Withdrawal by Subject|1
1484222|NCT00577005|4892724|P1|Overall Study|Withdrawal by Subject|2
1484223|NCT00577005|4892723|P2|Overall Study|Lost to Follow-up|2
1484224|NCT00577005|4892724|P1|Overall Study|Lost to Follow-up|3
1484225|NCT00576927|4892738|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
1484226|NCT00576927|4892738|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
1484227|NCT00576927|4892738|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
1484228|NCT00576927|4892738|P1|Sleep Hygiene Behavioral Intervention|Death|1
1484229|NCT00576927|4892738|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
1484230|NCT00576927|4892738|P1|Baseline|Withdrawal by Subject|3
1484231|NCT00576927|4892738|P1|Baseline|Medication Change by PCP of subject|1
1484232|NCT00576927|4892738|P1|Baseline|Physician Decision|9
1484233|NCT00576927|4892738|P1|Clinical Assessment|Physician Decision|1
1484234|NCT00576927|4892738|P1|Clinical Assessment|Withdrawal by Subject|10
1484235|NCT00576927|4892738|P1|Clinical Assessment|Death|1
1484236|NCT00576927|4892738|P1|Clinical Assessment|Lack of Efficacy|24
1484237|NCT00576901|4892750|P1|Overall Study|Protocol Violation|1
1484238|NCT00576901|4892750|P1|Overall Study|Disease course|1
1484239|NCT00576901|4892750|P1|Overall Study|Withdrawal by Subject|1
1484240|NCT00576823|4892761|P3|40-week Safety Extension Phase|Lack of Efficacy|0
1484241|NCT00576823|4892762|P2|40-week Safety Extension Phase|Lack of Efficacy|0
1484242|NCT00576823|4892763|P1|40-week Safety Extension Phase|Lack of Efficacy|1
1484243|NCT00576823|4892761|P3|12-week Efficacy Phase|Parentʼs schedule issue|0
1484244|NCT00576823|4892762|P2|12-week Efficacy Phase|Parentʼs schedule issue|0
1484245|NCT00576823|4892763|P1|12-week Efficacy Phase|Parentʼs schedule issue|1
1484246|NCT00576758|4892779|P2|Follow-up Period|Withdrew consent|1
1484247|NCT00576758|4892780|P1|Follow-up Period|Withdrew consent|2
1484248|NCT00576758|4892779|P2|Follow-up Period|Insufficient therapeutic response|5
1484249|NCT00576758|4892780|P1|Follow-up Period|Insufficient therapeutic response|16
1484250|NCT00576758|4892779|P2|Follow-up Period|Death|3
1484251|NCT00576758|4892780|P1|Follow-up Period|Death|3
1484252|NCT00576758|4892779|P2|Follow-up Period|Administrative/Other|8
1484253|NCT00576758|4892780|P1|Follow-up Period|Administrative/Other|6
1484254|NCT00576758|4892779|P2|Extension Treatment Period|Administrative/Other|1
1484255|NCT00576758|4892780|P1|Extension Treatment Period|Administrative/Other|3
1484256|NCT00576758|4892779|P2|Extension Treatment Period|Insufficient therapeutic response|33
1484257|NCT00576758|4892780|P1|Extension Treatment Period|Insufficient therapeutic response|30
1484258|NCT00576758|4892779|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
1484259|NCT00576758|4892780|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
1484260|NCT00576758|4892779|P2|Extension Treatment Period|Death|1
1484261|NCT00576758|4892780|P1|Extension Treatment Period|Death|1
1484262|NCT00576758|4892779|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
1484263|NCT00576758|4892780|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
1484264|NCT00576758|4892779|P2|Induction Treatment Period|Withdrew consent|0
1484265|NCT00576758|4892780|P1|Induction Treatment Period|Withdrew consent|1
1484266|NCT00576758|4892779|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
1484267|NCT00576758|4892780|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
1484268|NCT00576758|4892779|P2|Induction Treatment Period|Death|0
1484269|NCT00576758|4892780|P1|Induction Treatment Period|Death|1
1484270|NCT00576758|4892779|P2|Induction Treatment Period|Violation of selection criteria at entry|1
1484271|NCT00576758|4892780|P1|Induction Treatment Period|Violation of selection criteria at entry|1
1484272|NCT00576758|4892779|P2|Induction Treatment Period|Insufficient therapeutic response|0
1484273|NCT00576758|4892780|P1|Induction Treatment Period|Insufficient therapeutic response|2
1484274|NCT00576758|4892779|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
1484275|NCT00576758|4892780|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
1484276|NCT00576732|4892826|P6|OPEN LABEL|Protocol Violation|0
1484277|NCT00576732|4892827|P5|OPEN LABEL|Protocol Violation|1
1484278|NCT00576732|4892828|P4|OPEN LABEL|Protocol Violation|2
1484279|NCT00576732|4892829|P3|OPEN LABEL|Protocol Violation|0
1484280|NCT00576732|4892830|P2|OPEN LABEL|Protocol Violation|0
1484281|NCT00576732|4892831|P1|OPEN LABEL|Protocol Violation|0
1484282|NCT00576732|4892826|P6|OPEN LABEL|Lack of Efficacy|3
1484283|NCT00576732|4892827|P5|OPEN LABEL|Lack of Efficacy|2
1484284|NCT00576732|4892828|P4|OPEN LABEL|Lack of Efficacy|2
1484285|NCT00576732|4892829|P3|OPEN LABEL|Lack of Efficacy|0
1484286|NCT00576732|4892830|P2|OPEN LABEL|Lack of Efficacy|0
1484287|NCT00576732|4892831|P1|OPEN LABEL|Lack of Efficacy|0
1484288|NCT00576732|4892826|P6|OPEN LABEL|OTHER|2
1484289|NCT00576732|4892827|P5|OPEN LABEL|OTHER|0
1484290|NCT00576732|4892828|P4|OPEN LABEL|OTHER|0
1484291|NCT00576732|4892829|P3|OPEN LABEL|OTHER|0
1484292|NCT00576732|4892830|P2|OPEN LABEL|OTHER|0
1484293|NCT00576732|4892831|P1|OPEN LABEL|OTHER|0
1484294|NCT00576732|4892826|P6|OPEN LABEL|Withdrawal by Subject|1
1484295|NCT00576732|4892827|P5|OPEN LABEL|Withdrawal by Subject|0
1484296|NCT00576732|4892828|P4|OPEN LABEL|Withdrawal by Subject|1
1484297|NCT00576732|4892829|P3|OPEN LABEL|Withdrawal by Subject|0
1484298|NCT00576732|4892830|P2|OPEN LABEL|Withdrawal by Subject|0
1484299|NCT00576732|4892831|P1|OPEN LABEL|Withdrawal by Subject|0
1484300|NCT00576732|4892826|P6|OPEN LABEL|Lost to Follow-up|1
1484301|NCT00576732|4892827|P5|OPEN LABEL|Lost to Follow-up|1
1484302|NCT00576732|4892828|P4|OPEN LABEL|Lost to Follow-up|2
1484303|NCT00576732|4892829|P3|OPEN LABEL|Lost to Follow-up|0
1484304|NCT00576732|4892830|P2|OPEN LABEL|Lost to Follow-up|0
1484305|NCT00576732|4892831|P1|OPEN LABEL|Lost to Follow-up|0
1484306|NCT00576732|4892826|P6|OPEN LABEL|Adverse Event|1
1484307|NCT00576732|4892827|P5|OPEN LABEL|Adverse Event|0
1484308|NCT00576732|4892828|P4|OPEN LABEL|Adverse Event|4
1484309|NCT00576732|4892829|P3|OPEN LABEL|Adverse Event|0
1484310|NCT00576732|4892830|P2|OPEN LABEL|Adverse Event|0
1484311|NCT00576732|4892831|P1|OPEN LABEL|Adverse Event|0
1484312|NCT00576732|4892826|P6|DOUBLE BLIND|Protocol Violation|0
1484313|NCT00576732|4892827|P5|DOUBLE BLIND|Protocol Violation|0
1484314|NCT00576732|4892828|P4|DOUBLE BLIND|Protocol Violation|0
1484315|NCT00576732|4892829|P3|DOUBLE BLIND|Protocol Violation|0
1484316|NCT00576732|4892830|P2|DOUBLE BLIND|Protocol Violation|0
1484317|NCT00576732|4892831|P1|DOUBLE BLIND|Protocol Violation|1
1484318|NCT00576732|4892826|P6|DOUBLE BLIND|Lack of Efficacy|0
1484319|NCT00576732|4892827|P5|DOUBLE BLIND|Lack of Efficacy|0
1484320|NCT00576732|4892828|P4|DOUBLE BLIND|Lack of Efficacy|0
1484321|NCT00576732|4892829|P3|DOUBLE BLIND|Lack of Efficacy|0
1484322|NCT00576732|4892830|P2|DOUBLE BLIND|Lack of Efficacy|1
1484323|NCT00576732|4892831|P1|DOUBLE BLIND|Lack of Efficacy|6
1484324|NCT00576732|4892826|P6|DOUBLE BLIND|OTHER|0
1484325|NCT00576732|4892827|P5|DOUBLE BLIND|OTHER|0
1484326|NCT00576732|4892828|P4|DOUBLE BLIND|OTHER|0
1484327|NCT00576732|4892829|P3|DOUBLE BLIND|OTHER|1
1484328|NCT00576732|4892830|P2|DOUBLE BLIND|OTHER|2
1484329|NCT00576732|4892831|P1|DOUBLE BLIND|OTHER|0
1484330|NCT00576732|4892826|P6|DOUBLE BLIND|Withdrawal by Subject|0
1484331|NCT00576732|4892827|P5|DOUBLE BLIND|Withdrawal by Subject|0
1484332|NCT00576732|4892828|P4|DOUBLE BLIND|Withdrawal by Subject|0
1484333|NCT00576732|4892829|P3|DOUBLE BLIND|Withdrawal by Subject|3
1484334|NCT00576732|4892830|P2|DOUBLE BLIND|Withdrawal by Subject|1
1484335|NCT00576732|4892831|P1|DOUBLE BLIND|Withdrawal by Subject|1
1484336|NCT00576732|4892826|P6|DOUBLE BLIND|Lost to Follow-up|0
1484337|NCT00576732|4892827|P5|DOUBLE BLIND|Lost to Follow-up|0
1484338|NCT00576732|4892828|P4|DOUBLE BLIND|Lost to Follow-up|0
1484339|NCT00576732|4892829|P3|DOUBLE BLIND|Lost to Follow-up|1
1484340|NCT00576732|4892830|P2|DOUBLE BLIND|Lost to Follow-up|1
1484341|NCT00576732|4892831|P1|DOUBLE BLIND|Lost to Follow-up|0
1484342|NCT00576732|4892826|P6|DOUBLE BLIND|Adverse Event|0
1484343|NCT00576732|4892827|P5|DOUBLE BLIND|Adverse Event|0
1484344|NCT00576732|4892828|P4|DOUBLE BLIND|Adverse Event|0
1484345|NCT00576732|4892829|P3|DOUBLE BLIND|Adverse Event|1
1484346|NCT00576732|4892830|P2|DOUBLE BLIND|Adverse Event|0
1484347|NCT00576732|4892831|P1|DOUBLE BLIND|Adverse Event|0
1484348|NCT00576693|4892863|P2|Overall Study|Withdrawal by Subject|13
1484349|NCT00576693|4892864|P1|Overall Study|Withdrawal by Subject|3
1484350|NCT00576693|4892863|P2|Overall Study|Lost to Follow-up|11
1484351|NCT00576693|4892864|P1|Overall Study|Lost to Follow-up|7
1484352|NCT00576628|4892870|P1|Overall Study|Dialysis|15
1484353|NCT00576628|4892870|P1|Overall Study|Transplantation|1
1484354|NCT00576628|4892870|P1|Overall Study|The patient move into other town|1
1484355|NCT00576628|4892870|P1|Overall Study|Progression of Renal Failure|1
1484356|NCT00576628|4892870|P1|Overall Study|Progression of Kidney Disease|1
1484357|NCT00576628|4892870|P1|Overall Study|RBC transfusion|1
1484358|NCT00576628|4892870|P1|Overall Study|Pregnancy|1
1484359|NCT00576628|4892870|P1|Overall Study|Refused Treatment|8
1484360|NCT00576628|4892870|P1|Overall Study|Failure to return|1
1484361|NCT00576628|4892870|P1|Overall Study|Death|2
1484362|NCT00576628|4892870|P1|Overall Study|Adverse Event|11
1484363|NCT00576576|4892890|P1|Overall Study|Protocol Violation|1
1484364|NCT00576576|4892890|P1|Overall Study|Lost to Follow-up|6
1484365|NCT00576472|4892924|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
1484366|NCT00576472|4892925|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
1484367|NCT00576472|4892926|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
1484368|NCT00576472|4892927|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
1484369|NCT00576472|4892928|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
1484370|NCT00576472|4892929|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
1484371|NCT00576472|4892930|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
1484372|NCT00576472|4892931|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
1484373|NCT00576472|4892932|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
1484374|NCT00576472|4892933|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
1484375|NCT00576472|4892934|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
1484376|NCT00576472|4892935|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
1484377|NCT00576472|4892936|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
1484378|NCT00576472|4892937|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
1484379|NCT00576472|4892938|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
1484380|NCT00576472|4892924|P15|MPH Home Maintenance Phase|Medical reasons|6
1484381|NCT00576472|4892925|P14|MPH Home Maintenance Phase|Medical reasons|0
1484382|NCT00576472|4892926|P13|MPH Home Maintenance Phase|Medical reasons|0
1484383|NCT00576472|4892927|P12|MPH Home Maintenance Phase|Medical reasons|0
1484384|NCT00576472|4892928|P11|MPH Home Maintenance Phase|Medical reasons|0
1484385|NCT00576472|4892929|P10|MPH Home Maintenance Phase|Medical reasons|0
1484386|NCT00576472|4892930|P9|MPH Home Maintenance Phase|Medical reasons|0
1484387|NCT00576472|4892931|P8|MPH Home Maintenance Phase|Medical reasons|0
1484388|NCT00576472|4892932|P7|MPH Home Maintenance Phase|Medical reasons|0
1484389|NCT00576472|4892933|P6|MPH Home Maintenance Phase|Medical reasons|0
1484390|NCT00576472|4892934|P5|MPH Home Maintenance Phase|Medical reasons|0
1484391|NCT00576472|4892935|P4|MPH Home Maintenance Phase|Medical reasons|0
1484392|NCT00576472|4892936|P3|MPH Home Maintenance Phase|Medical reasons|0
1484393|NCT00576472|4892937|P2|MPH Home Maintenance Phase|Medical reasons|0
1484394|NCT00576472|4892938|P1|MPH Home Maintenance Phase|Medical reasons|0
1484395|NCT00576472|4892924|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
1484396|NCT00576472|4892925|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
1484397|NCT00576472|4892926|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
1484398|NCT00576472|4892927|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
1484399|NCT00576472|4892928|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
1484400|NCT00576472|4892929|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
1484401|NCT00576472|4892930|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
1484402|NCT00576472|4892931|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
1484403|NCT00576472|4892932|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
1484404|NCT00576472|4892933|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
1484405|NCT00576472|4892934|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
1484406|NCT00576472|4892935|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
1484407|NCT00576472|4892936|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
1484408|NCT00576472|4892937|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
1484409|NCT00576472|4892938|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
1484410|NCT00576472|4892924|P15|MPH Home Maintenance Phase|Side effects|8
1484411|NCT00576472|4892925|P14|MPH Home Maintenance Phase|Side effects|0
1484412|NCT00576472|4892926|P13|MPH Home Maintenance Phase|Side effects|0
1484413|NCT00576472|4892927|P12|MPH Home Maintenance Phase|Side effects|0
1484414|NCT00576472|4892928|P11|MPH Home Maintenance Phase|Side effects|0
1484415|NCT00576472|4892929|P10|MPH Home Maintenance Phase|Side effects|0
1484416|NCT00576472|4892930|P9|MPH Home Maintenance Phase|Side effects|0
1484417|NCT00576472|4892931|P8|MPH Home Maintenance Phase|Side effects|0
1484418|NCT00576472|4892932|P7|MPH Home Maintenance Phase|Side effects|0
1484419|NCT00576472|4892933|P6|MPH Home Maintenance Phase|Side effects|0
1484420|NCT00576472|4892934|P5|MPH Home Maintenance Phase|Side effects|0
1484421|NCT00576472|4892935|P4|MPH Home Maintenance Phase|Side effects|0
1484422|NCT00576472|4892936|P3|MPH Home Maintenance Phase|Side effects|0
1484423|NCT00576472|4892937|P2|MPH Home Maintenance Phase|Side effects|0
1484424|NCT00576472|4892938|P1|MPH Home Maintenance Phase|Side effects|0
1484425|NCT00576472|4892924|P15|MPH Home Maintenance Phase|Insufficient data|0
1484426|NCT00576472|4892925|P14|MPH Home Maintenance Phase|Insufficient data|4
1484427|NCT00576472|4892926|P13|MPH Home Maintenance Phase|Insufficient data|0
1484428|NCT00576472|4892927|P12|MPH Home Maintenance Phase|Insufficient data|0
1484429|NCT00576472|4892928|P11|MPH Home Maintenance Phase|Insufficient data|0
1484430|NCT00576472|4892929|P10|MPH Home Maintenance Phase|Insufficient data|0
1484431|NCT00576472|4892930|P9|MPH Home Maintenance Phase|Insufficient data|0
1484432|NCT00576472|4892931|P8|MPH Home Maintenance Phase|Insufficient data|0
1484433|NCT00576472|4892932|P7|MPH Home Maintenance Phase|Insufficient data|0
1484434|NCT00576472|4892933|P6|MPH Home Maintenance Phase|Insufficient data|0
1484435|NCT00576472|4892934|P5|MPH Home Maintenance Phase|Insufficient data|0
1484436|NCT00576472|4892935|P4|MPH Home Maintenance Phase|Insufficient data|0
1484437|NCT00576472|4892936|P3|MPH Home Maintenance Phase|Insufficient data|0
1484438|NCT00576472|4892937|P2|MPH Home Maintenance Phase|Insufficient data|0
1484439|NCT00576472|4892938|P1|MPH Home Maintenance Phase|Insufficient data|0
1484440|NCT00576472|4892924|P15|MPH Home Maintenance Phase|Declined to participate|0
1484441|NCT00576472|4892925|P14|MPH Home Maintenance Phase|Declined to participate|7
1484442|NCT00576472|4892926|P13|MPH Home Maintenance Phase|Declined to participate|0
1484443|NCT00576472|4892927|P12|MPH Home Maintenance Phase|Declined to participate|0
1484444|NCT00576472|4892928|P11|MPH Home Maintenance Phase|Declined to participate|0
1484445|NCT00576472|4892929|P10|MPH Home Maintenance Phase|Declined to participate|0
1484446|NCT00576472|4892930|P9|MPH Home Maintenance Phase|Declined to participate|0
1484447|NCT00576472|4892931|P8|MPH Home Maintenance Phase|Declined to participate|0
1484448|NCT00576472|4892932|P7|MPH Home Maintenance Phase|Declined to participate|0
1484449|NCT00576472|4892933|P6|MPH Home Maintenance Phase|Declined to participate|0
1484450|NCT00576472|4892934|P5|MPH Home Maintenance Phase|Declined to participate|0
1484451|NCT00576472|4892935|P4|MPH Home Maintenance Phase|Declined to participate|0
1484452|NCT00576472|4892936|P3|MPH Home Maintenance Phase|Declined to participate|0
1484453|NCT00576472|4892937|P2|MPH Home Maintenance Phase|Declined to participate|0
1484454|NCT00576472|4892938|P1|MPH Home Maintenance Phase|Declined to participate|0
1484455|NCT00576472|4892924|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
1484456|NCT00576472|4892925|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
1484457|NCT00576472|4892926|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
1484458|NCT00576472|4892927|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
1484459|NCT00576472|4892928|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
1484460|NCT00576472|4892929|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
1484461|NCT00576472|4892930|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
1484462|NCT00576472|4892931|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
1484463|NCT00576472|4892932|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
1484464|NCT00576472|4892933|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
1484465|NCT00576472|4892934|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
1484466|NCT00576472|4892935|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
1484467|NCT00576472|4892936|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
1484468|NCT00576472|4892937|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
1484469|NCT00576472|4892938|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
1484470|NCT00576472|4892924|P15|MPH Cross Over Phase|Did not complete cross over phase|0
1484471|NCT00576472|4892925|P14|MPH Cross Over Phase|Did not complete cross over phase|0
1484472|NCT00576472|4892926|P13|MPH Cross Over Phase|Did not complete cross over phase|0
1484473|NCT00576472|4892927|P12|MPH Cross Over Phase|Did not complete cross over phase|1
1484474|NCT00576472|4892928|P11|MPH Cross Over Phase|Did not complete cross over phase|1
1484475|NCT00576472|4892929|P10|MPH Cross Over Phase|Did not complete cross over phase|0
1484476|NCT00576472|4892930|P9|MPH Cross Over Phase|Did not complete cross over phase|2
1484477|NCT00576472|4892931|P8|MPH Cross Over Phase|Did not complete cross over phase|0
1484478|NCT00576472|4892932|P7|MPH Cross Over Phase|Did not complete cross over phase|0
1484479|NCT00576472|4892933|P6|MPH Cross Over Phase|Did not complete cross over phase|0
1484480|NCT00576472|4892934|P5|MPH Cross Over Phase|Did not complete cross over phase|0
1484481|NCT00576472|4892935|P4|MPH Cross Over Phase|Did not complete cross over phase|0
1484482|NCT00576472|4892936|P3|MPH Cross Over Phase|Did not complete cross over phase|0
1484483|NCT00576472|4892937|P2|MPH Cross Over Phase|Did not complete cross over phase|0
1484484|NCT00576472|4892938|P1|MPH Cross Over Phase|Did not complete cross over phase|0
1484485|NCT00576472|4892924|P15|MPH Cross Over Phase|Physician Decision|0
1484486|NCT00576472|4892925|P14|MPH Cross Over Phase|Physician Decision|0
1484487|NCT00576472|4892926|P13|MPH Cross Over Phase|Physician Decision|0
1484488|NCT00576472|4892927|P12|MPH Cross Over Phase|Physician Decision|0
1484489|NCT00576472|4892928|P11|MPH Cross Over Phase|Physician Decision|0
1484490|NCT00576472|4892929|P10|MPH Cross Over Phase|Physician Decision|0
1484491|NCT00576472|4892930|P9|MPH Cross Over Phase|Physician Decision|0
1484492|NCT00576472|4892931|P8|MPH Cross Over Phase|Physician Decision|0
1484493|NCT00576472|4892932|P7|MPH Cross Over Phase|Physician Decision|4
1484494|NCT00576472|4892933|P6|MPH Cross Over Phase|Physician Decision|0
1484495|NCT00576472|4892934|P5|MPH Cross Over Phase|Physician Decision|0
1484496|NCT00576472|4892935|P4|MPH Cross Over Phase|Physician Decision|0
1484497|NCT00576472|4892936|P3|MPH Cross Over Phase|Physician Decision|0
1484498|NCT00576472|4892937|P2|MPH Cross Over Phase|Physician Decision|0
1484499|NCT00576472|4892938|P1|MPH Cross Over Phase|Physician Decision|0
1484500|NCT00576472|4892924|P15|MPH Cross Over Phase|Ineligible due to disease|0
1484501|NCT00576472|4892925|P14|MPH Cross Over Phase|Ineligible due to disease|0
1484502|NCT00576472|4892926|P13|MPH Cross Over Phase|Ineligible due to disease|0
1484503|NCT00576472|4892927|P12|MPH Cross Over Phase|Ineligible due to disease|0
1484504|NCT00576472|4892928|P11|MPH Cross Over Phase|Ineligible due to disease|0
1484505|NCT00576472|4892929|P10|MPH Cross Over Phase|Ineligible due to disease|0
1484506|NCT00576472|4892930|P9|MPH Cross Over Phase|Ineligible due to disease|0
1484507|NCT00576472|4892931|P8|MPH Cross Over Phase|Ineligible due to disease|0
1484508|NCT00576472|4892932|P7|MPH Cross Over Phase|Ineligible due to disease|2
1484509|NCT00576472|4892933|P6|MPH Cross Over Phase|Ineligible due to disease|0
1484510|NCT00576472|4892934|P5|MPH Cross Over Phase|Ineligible due to disease|0
1484511|NCT00576472|4892935|P4|MPH Cross Over Phase|Ineligible due to disease|0
1484512|NCT00576472|4892936|P3|MPH Cross Over Phase|Ineligible due to disease|0
1484513|NCT00576472|4892937|P2|MPH Cross Over Phase|Ineligible due to disease|0
1484514|NCT00576472|4892938|P1|MPH Cross Over Phase|Ineligible due to disease|0
1484515|NCT00576472|4892924|P15|MPH Cross Over Phase|Withdrawal by Subject|0
1484516|NCT00576472|4892925|P14|MPH Cross Over Phase|Withdrawal by Subject|0
1484517|NCT00576472|4892926|P13|MPH Cross Over Phase|Withdrawal by Subject|0
1484518|NCT00576472|4892927|P12|MPH Cross Over Phase|Withdrawal by Subject|0
1484519|NCT00576472|4892928|P11|MPH Cross Over Phase|Withdrawal by Subject|0
1484520|NCT00576472|4892929|P10|MPH Cross Over Phase|Withdrawal by Subject|0
1484521|NCT00576472|4892930|P9|MPH Cross Over Phase|Withdrawal by Subject|0
1484522|NCT00576472|4892931|P8|MPH Cross Over Phase|Withdrawal by Subject|0
1484523|NCT00576472|4892932|P7|MPH Cross Over Phase|Withdrawal by Subject|6
1484524|NCT00576472|4892933|P6|MPH Cross Over Phase|Withdrawal by Subject|0
1484525|NCT00576472|4892934|P5|MPH Cross Over Phase|Withdrawal by Subject|0
1484526|NCT00576472|4892935|P4|MPH Cross Over Phase|Withdrawal by Subject|0
1484527|NCT00576472|4892936|P3|MPH Cross Over Phase|Withdrawal by Subject|0
1484528|NCT00576472|4892937|P2|MPH Cross Over Phase|Withdrawal by Subject|0
1484529|NCT00576472|4892938|P1|MPH Cross Over Phase|Withdrawal by Subject|0
1484530|NCT00576472|4892924|P15|MPH In-Lab Phase|Psychiatric exclusion|0
1484531|NCT00576472|4892925|P14|MPH In-Lab Phase|Psychiatric exclusion|0
1484532|NCT00576472|4892926|P13|MPH In-Lab Phase|Psychiatric exclusion|0
1484533|NCT00576472|4892927|P12|MPH In-Lab Phase|Psychiatric exclusion|0
1484534|NCT00576472|4892928|P11|MPH In-Lab Phase|Psychiatric exclusion|0
1484535|NCT00576472|4892929|P10|MPH In-Lab Phase|Psychiatric exclusion|0
1484536|NCT00576472|4892930|P9|MPH In-Lab Phase|Psychiatric exclusion|0
1484537|NCT00576472|4892931|P8|MPH In-Lab Phase|Psychiatric exclusion|0
1484538|NCT00576472|4892932|P7|MPH In-Lab Phase|Psychiatric exclusion|0
1484539|NCT00576472|4892933|P6|MPH In-Lab Phase|Psychiatric exclusion|0
1484540|NCT00576472|4892934|P5|MPH In-Lab Phase|Psychiatric exclusion|0
1484541|NCT00576472|4892935|P4|MPH In-Lab Phase|Psychiatric exclusion|10
1484542|NCT00576472|4892936|P3|MPH In-Lab Phase|Psychiatric exclusion|0
1484543|NCT00576472|4892937|P2|MPH In-Lab Phase|Psychiatric exclusion|0
1484544|NCT00576472|4892938|P1|MPH In-Lab Phase|Psychiatric exclusion|0
1484545|NCT00576472|4892924|P15|MPH In-Lab Phase|No attention/academic problems|0
1484546|NCT00576472|4892925|P14|MPH In-Lab Phase|No attention/academic problems|0
1484547|NCT00576472|4892926|P13|MPH In-Lab Phase|No attention/academic problems|0
1484548|NCT00576472|4892927|P12|MPH In-Lab Phase|No attention/academic problems|0
1484549|NCT00576472|4892928|P11|MPH In-Lab Phase|No attention/academic problems|0
1484550|NCT00576472|4892929|P10|MPH In-Lab Phase|No attention/academic problems|0
1484551|NCT00576472|4892930|P9|MPH In-Lab Phase|No attention/academic problems|0
1484552|NCT00576472|4892931|P8|MPH In-Lab Phase|No attention/academic problems|0
1484553|NCT00576472|4892932|P7|MPH In-Lab Phase|No attention/academic problems|0
1484554|NCT00576472|4892933|P6|MPH In-Lab Phase|No attention/academic problems|0
1484555|NCT00576472|4892934|P5|MPH In-Lab Phase|No attention/academic problems|0
1484556|NCT00576472|4892935|P4|MPH In-Lab Phase|No attention/academic problems|245
1484557|NCT00576472|4892936|P3|MPH In-Lab Phase|No attention/academic problems|0
1484558|NCT00576472|4892937|P2|MPH In-Lab Phase|No attention/academic problems|0
1484559|NCT00576472|4892938|P1|MPH In-Lab Phase|No attention/academic problems|0
1484560|NCT00576472|4892924|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1484561|NCT00576472|4892925|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1484562|NCT00576472|4892926|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1484563|NCT00576472|4892927|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1484564|NCT00576472|4892928|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1484565|NCT00576472|4892929|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1484566|NCT00576472|4892930|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1484567|NCT00576472|4892931|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1484568|NCT00576472|4892932|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1484569|NCT00576472|4892933|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1484570|NCT00576472|4892934|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1484571|NCT00576472|4892935|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
1484572|NCT00576472|4892936|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1484573|NCT00576472|4892937|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1484574|NCT00576472|4892938|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1484575|NCT00576472|4892924|P15|MPH In-Lab Phase|Lost to Follow-up|0
1484576|NCT00576472|4892925|P14|MPH In-Lab Phase|Lost to Follow-up|0
1484577|NCT00576472|4892926|P13|MPH In-Lab Phase|Lost to Follow-up|0
1484578|NCT00576472|4892927|P12|MPH In-Lab Phase|Lost to Follow-up|0
1484579|NCT00576472|4892928|P11|MPH In-Lab Phase|Lost to Follow-up|0
1484580|NCT00576472|4892929|P10|MPH In-Lab Phase|Lost to Follow-up|0
1484581|NCT00576472|4892930|P9|MPH In-Lab Phase|Lost to Follow-up|0
1484582|NCT00576472|4892931|P8|MPH In-Lab Phase|Lost to Follow-up|0
1484583|NCT00576472|4892932|P7|MPH In-Lab Phase|Lost to Follow-up|0
1484584|NCT00576472|4892933|P6|MPH In-Lab Phase|Lost to Follow-up|0
1484585|NCT00576472|4892934|P5|MPH In-Lab Phase|Lost to Follow-up|0
1484586|NCT00576472|4892935|P4|MPH In-Lab Phase|Lost to Follow-up|1
1484587|NCT00576472|4892936|P3|MPH In-Lab Phase|Lost to Follow-up|0
1484588|NCT00576472|4892937|P2|MPH In-Lab Phase|Lost to Follow-up|0
1484589|NCT00576472|4892938|P1|MPH In-Lab Phase|Lost to Follow-up|0
1484590|NCT00576472|4892924|P15|MPH In-Lab Phase|Declined participation in medication pha|0
1484591|NCT00576472|4892925|P14|MPH In-Lab Phase|Declined participation in medication pha|0
1484592|NCT00576472|4892926|P13|MPH In-Lab Phase|Declined participation in medication pha|0
1484593|NCT00576472|4892927|P12|MPH In-Lab Phase|Declined participation in medication pha|0
1484594|NCT00576472|4892928|P11|MPH In-Lab Phase|Declined participation in medication pha|0
1484595|NCT00576472|4892929|P10|MPH In-Lab Phase|Declined participation in medication pha|0
1484596|NCT00576472|4892930|P9|MPH In-Lab Phase|Declined participation in medication pha|0
1484597|NCT00576472|4892931|P8|MPH In-Lab Phase|Declined participation in medication pha|0
1484598|NCT00576472|4892932|P7|MPH In-Lab Phase|Declined participation in medication pha|0
1484599|NCT00576472|4892933|P6|MPH In-Lab Phase|Declined participation in medication pha|0
1484600|NCT00576472|4892934|P5|MPH In-Lab Phase|Declined participation in medication pha|0
1484601|NCT00576472|4892935|P4|MPH In-Lab Phase|Declined participation in medication pha|75
1484602|NCT00576472|4892936|P3|MPH In-Lab Phase|Declined participation in medication pha|0
1484603|NCT00576472|4892937|P2|MPH In-Lab Phase|Declined participation in medication pha|0
1484604|NCT00576472|4892938|P1|MPH In-Lab Phase|Declined participation in medication pha|0
1484605|NCT00576420|4893031|P3|Overall Study|Death|1
1484606|NCT00576420|4893032|P2|Overall Study|Death|0
1484607|NCT00576420|4893033|P1|Overall Study|Death|0
1484608|NCT00576381|4893198|P1|Overall Study|Adverse Event|4
1484609|NCT00576381|4893198|P1|Overall Study|Reoperation|3
1484610|NCT00576316|4893202|P1|Overall Study|Protocol Violation|9
1484611|NCT00576316|4893202|P1|Overall Study|Withdrawal by Subject|2
1484612|NCT00576316|4893202|P1|Overall Study|Adverse Event|9
1484613|NCT00576303|4893207|P1|Long Term Safety Period|Early withdrawal|16
1484614|NCT00576303|4893207|P1|Efficacy Evaluation Period|Early withdrawal|5
1484615|NCT00576303|4893207|P1|Dose Titration Period|Early withdrawal|17
1484616|NCT00576199|4893225|P1|Overall Study|Reason Unspecified|2
1484617|NCT00576199|4893225|P1|Overall Study|Refused Treatment|2
1484618|NCT00576199|4893225|P1|Overall Study|Insufficient Therapeutic Response|14
1484619|NCT00576199|4893225|P1|Overall Study|Adverse Event|12
1484620|NCT00576056|4893238|P1|Overall Study|Physician Decision|1
1484621|NCT00576056|4893238|P1|Overall Study|did not meet eligibility criteria|8
1484622|NCT00576056|4893238|P1|Overall Study|Withdrawal by Subject|2
1484623|NCT00576056|4893238|P1|Overall Study|Lack of Efficacy|1
1484624|NCT00576056|4893238|P1|Overall Study|Death|1
1484625|NCT00576056|4893238|P1|Overall Study|Adverse Event|1
1484626|NCT00575666|4893254|P2|Overall Study|Physician Decision|1
1484627|NCT00575666|4893255|P1|Overall Study|Physician Decision|1
1484628|NCT00575666|4893254|P2|Overall Study|Withdrawal by Subject|2
1484629|NCT00575666|4893255|P1|Overall Study|Withdrawal by Subject|3
1484630|NCT00575588|4893295|P2|Overall Study|Impossible to determine HbA1c|1
1484631|NCT00575588|4893296|P1|Overall Study|Impossible to determine HbA1c|0
1484632|NCT00575588|4893295|P2|Overall Study|Patient moved|3
1484633|NCT00575588|4893296|P1|Overall Study|Patient moved|1
1484634|NCT00575588|4893295|P2|Overall Study|Elevated triglyceride|0
1484635|NCT00575588|4893296|P1|Overall Study|Elevated triglyceride|1
1484636|NCT00575588|4893295|P2|Overall Study|Safety reasons|1
1484637|NCT00575588|4893296|P1|Overall Study|Safety reasons|2
1484638|NCT00575588|4893295|P2|Overall Study|Severe non-compliance to protocol|7
1484639|NCT00575588|4893296|P1|Overall Study|Severe non-compliance to protocol|5
1484640|NCT00575588|4893295|P2|Overall Study|Study specific discontinuation criteria|218
1484641|NCT00575588|4893296|P1|Overall Study|Study specific discontinuation criteria|203
1484642|NCT00575588|4893295|P2|Overall Study|Incorrect enrollment|4
1484643|NCT00575588|4893296|P1|Overall Study|Incorrect enrollment|8
1484644|NCT00575588|4893295|P2|Overall Study|Death|2
1484645|NCT00575588|4893296|P1|Overall Study|Death|4
1484646|NCT00575588|4893295|P2|Overall Study|Lost to Follow-up|3
1484647|NCT00575588|4893296|P1|Overall Study|Lost to Follow-up|1
1484648|NCT00575588|4893295|P2|Overall Study|Withdrawal by Subject|31
1484649|NCT00575588|4893296|P1|Overall Study|Withdrawal by Subject|27
1484650|NCT00575588|4893295|P2|Overall Study|Adverse Event|13
1484651|NCT00575588|4893296|P1|Overall Study|Adverse Event|11
1484652|NCT00575510|4893319|P3|Overall Study|Pregnancy|1
1484653|NCT00575510|4893320|P2|Overall Study|Pregnancy|0
1484654|NCT00575510|4893321|P1|Overall Study|Pregnancy|0
1484655|NCT00575510|4893319|P3|Overall Study|Clinic Called Patient|7
1484656|NCT00575510|4893320|P2|Overall Study|Clinic Called Patient|7
1484657|NCT00575510|4893321|P1|Overall Study|Clinic Called Patient|7
1484658|NCT00575510|4893319|P3|Overall Study|Withdrawal by Subject|0
1484659|NCT00575510|4893320|P2|Overall Study|Withdrawal by Subject|0
1484660|NCT00575510|4893321|P1|Overall Study|Withdrawal by Subject|1
1484661|NCT00575510|4893319|P3|Overall Study|Lost to Follow-up|9
1484662|NCT00575510|4893320|P2|Overall Study|Lost to Follow-up|6
1484663|NCT00575510|4893321|P1|Overall Study|Lost to Follow-up|4
1484664|NCT00575380|4893334|P2|Overall Study|Various|2
1484665|NCT00575380|4893335|P1|Overall Study|Various|0
1484666|NCT00575380|4893334|P2|Overall Study|Adverse Event|1
1484667|NCT00575380|4893335|P1|Overall Study|Adverse Event|0
1484668|NCT00575380|4893334|P2|Overall Study|Withdrawal by Subject|0
1484669|NCT00575380|4893335|P1|Overall Study|Withdrawal by Subject|1
1484670|NCT00575094|4893477|P1|Overall Study|Withdrawal by Subject|1
1484671|NCT00575094|4893477|P1|Overall Study|Adverse Event|2
1484672|NCT00575042|4893481|P1|Overall Study|Lost to Follow-up|1
1484673|NCT00575042|4893481|P1|Overall Study|Adverse Event|2
1484674|NCT00574951|4893532|P1|Overall Study|Ineligible - improper prior treatment|1
1484675|NCT00574912|4893540|P1|Overall Study|Physician Decision|2
1484676|NCT00574912|4893540|P1|Overall Study|scheduling conflicts|3
1484677|NCT00574912|4893540|P1|Overall Study|Could not place IV lines.|3
1484678|NCT00574873|4893554|P2|Overall Study|Extension Study|0
1484679|NCT00574873|4893555|P1|Overall Study|Extension Study|126
1484680|NCT00574873|4893554|P2|Overall Study|Blank, site closed per local regulations|2
1484681|NCT00574873|4893555|P1|Overall Study|Blank, site closed per local regulations|2
1484682|NCT00574873|4893554|P2|Overall Study|Discontinuation of study by sponsor|199
1484683|NCT00574873|4893555|P1|Overall Study|Discontinuation of study by sponsor|5
1484684|NCT00574873|4893554|P2|Overall Study|Other|4
1484685|NCT00574873|4893555|P1|Overall Study|Other|40
1484686|NCT00574873|4893554|P2|Overall Study|Lost to Follow-up|5
1484687|NCT00574873|4893555|P1|Overall Study|Lost to Follow-up|14
1484688|NCT00574873|4893554|P2|Overall Study|Death|14
1484689|NCT00574873|4893555|P1|Overall Study|Death|15
1484690|NCT00574873|4893554|P2|Overall Study|Investigator request|8
1484691|NCT00574873|4893555|P1|Overall Study|Investigator request|18
1484692|NCT00574873|4893554|P2|Overall Study|Withdrawal by Subject|19
1484693|NCT00574873|4893555|P1|Overall Study|Withdrawal by Subject|18
1484694|NCT00574847|4893573|P2|Overall Study|Did not receive medication (declined)|5
1484695|NCT00574847|4893574|P1|Overall Study|Did not receive medication (declined)|2
1484696|NCT00574847|4893573|P2|Overall Study|Physician Decision|0
1484697|NCT00574847|4893574|P1|Overall Study|Physician Decision|1
1484698|NCT00574847|4893573|P2|Overall Study|Withdrawal by Subject|2
1484699|NCT00574847|4893574|P1|Overall Study|Withdrawal by Subject|2
1484700|NCT00574847|4893573|P2|Overall Study|Death|0
1484701|NCT00574847|4893574|P1|Overall Study|Death|1
1484702|NCT00574847|4893573|P2|Overall Study|Adverse Event|0
1484703|NCT00574847|4893574|P1|Overall Study|Adverse Event|2
1484704|NCT00574795|4893619|P1|Toddler Dose|Withdrawal by Subject|1
1484705|NCT00574795|4893619|P1|After Infant Series|Adverse Event|2
1484706|NCT00574795|4893619|P1|After Infant Series|Withdrawal by Subject|1
1484707|NCT00574795|4893619|P1|Infant Series|Adverse Event|1
1484708|NCT00574795|4893619|P1|Infant Series|Protocol Violation|2
1484709|NCT00574795|4893619|P1|Infant Series|Withdrawal by Subject|2
1484710|NCT00574405|4893702|P2|Overall Study|Withdrawal by Subject|2
1484711|NCT00574405|4893703|P1|Overall Study|Withdrawal by Subject|3
1484712|NCT00574288|4893723|P7|Overall Study|Other|0
1484713|NCT00574288|4893724|P6|Overall Study|Other|0
1484714|NCT00574288|4893725|P5|Overall Study|Other|0
1484715|NCT00574288|4893726|P4|Overall Study|Other|0
1484716|NCT00574288|4893727|P3|Overall Study|Other|0
1484717|NCT00574288|4893728|P2|Overall Study|Other|1
1484718|NCT00574288|4893729|P1|Overall Study|Other|1
1484719|NCT00574288|4893723|P7|Overall Study|Progressive Disease|0
1484720|NCT00574288|4893724|P6|Overall Study|Progressive Disease|0
1484721|NCT00574288|4893725|P5|Overall Study|Progressive Disease|1
1484722|NCT00574288|4893726|P4|Overall Study|Progressive Disease|2
1484723|NCT00574288|4893727|P3|Overall Study|Progressive Disease|3
1484724|NCT00574288|4893728|P2|Overall Study|Progressive Disease|2
1484725|NCT00574288|4893729|P1|Overall Study|Progressive Disease|17
1484726|NCT00574288|4893723|P7|Overall Study|Study Terminated By Sponsor|5
1484727|NCT00574288|4893724|P6|Overall Study|Study Terminated By Sponsor|0
1484728|NCT00574288|4893725|P5|Overall Study|Study Terminated By Sponsor|0
1484729|NCT00574288|4893726|P4|Overall Study|Study Terminated By Sponsor|0
1484730|NCT00574288|4893727|P3|Overall Study|Study Terminated By Sponsor|0
1484731|NCT00574288|4893728|P2|Overall Study|Study Terminated By Sponsor|0
1484732|NCT00574288|4893729|P1|Overall Study|Study Terminated By Sponsor|0
1484733|NCT00574288|4893723|P7|Overall Study|Lost to Follow-up|2
1484734|NCT00574288|4893724|P6|Overall Study|Lost to Follow-up|1
1484735|NCT00574288|4893725|P5|Overall Study|Lost to Follow-up|0
1484736|NCT00574288|4893726|P4|Overall Study|Lost to Follow-up|0
1484737|NCT00574288|4893727|P3|Overall Study|Lost to Follow-up|0
1484738|NCT00574288|4893728|P2|Overall Study|Lost to Follow-up|0
1484739|NCT00574288|4893729|P1|Overall Study|Lost to Follow-up|0
1484740|NCT00574288|4893723|P7|Overall Study|Death|21
1484741|NCT00574288|4893724|P6|Overall Study|Death|25
1484742|NCT00574288|4893725|P5|Overall Study|Death|0
1484743|NCT00574288|4893726|P4|Overall Study|Death|0
1484744|NCT00574288|4893727|P3|Overall Study|Death|0
1484745|NCT00574288|4893728|P2|Overall Study|Death|0
1484746|NCT00574288|4893729|P1|Overall Study|Death|0
1484747|NCT00574288|4893723|P7|Overall Study|Adverse Event|0
1484748|NCT00574288|4893724|P6|Overall Study|Adverse Event|0
1484749|NCT00574288|4893725|P5|Overall Study|Adverse Event|1
1484750|NCT00574288|4893726|P4|Overall Study|Adverse Event|0
1484751|NCT00574288|4893727|P3|Overall Study|Adverse Event|0
1484752|NCT00574288|4893728|P2|Overall Study|Adverse Event|0
1484753|NCT00574288|4893729|P1|Overall Study|Adverse Event|2
1484754|NCT00574275|4893767|P2|Overall Study|Operation for curative intent|1
1484755|NCT00574275|4893768|P1|Overall Study|Operation for curative intent|0
1484756|NCT00574275|4893767|P2|Overall Study|Insurance change|1
1484757|NCT00574275|4893768|P1|Overall Study|Insurance change|0
1484758|NCT00574275|4893767|P2|Overall Study|Patient and Investigator decision|1
1484759|NCT00574275|4893768|P1|Overall Study|Patient and Investigator decision|0
1484760|NCT00574275|4893767|P2|Overall Study|Protocol Violation|1
1484761|NCT00574275|4893768|P1|Overall Study|Protocol Violation|0
1484762|NCT00574275|4893767|P2|Overall Study|Physician Decision|1
1484763|NCT00574275|4893768|P1|Overall Study|Physician Decision|1
1484764|NCT00574275|4893767|P2|Overall Study|Error calculating tumor measurement|0
1484765|NCT00574275|4893768|P1|Overall Study|Error calculating tumor measurement|1
1484766|NCT00574275|4893767|P2|Overall Study|Withdrawal by Subject|17
1484767|NCT00574275|4893768|P1|Overall Study|Withdrawal by Subject|15
1484768|NCT00574275|4893767|P2|Overall Study|Study stopped based on DMC decision|23
1484769|NCT00574275|4893768|P1|Overall Study|Study stopped based on DMC decision|62
1484770|NCT00574275|4893767|P2|Overall Study|Lost to Follow-up|1
1484771|NCT00574275|4893768|P1|Overall Study|Lost to Follow-up|2
1484772|NCT00574275|4893767|P2|Overall Study|Disease progression|146
1484773|NCT00574275|4893768|P1|Overall Study|Disease progression|160
1484774|NCT00574275|4893767|P2|Overall Study|Adverse Event|76
1484775|NCT00574275|4893768|P1|Overall Study|Adverse Event|32
1484776|NCT00574275|4893767|P2|Overall Study|Randomized but not treated|3
1484777|NCT00574275|4893768|P1|Overall Study|Randomized but not treated|2
1484778|NCT00574249|4893786|P2|Overall Study|PPD test taken twice|1
1484779|NCT00574249|4893787|P1|Overall Study|PPD test taken twice|0
1484780|NCT00574249|4893786|P2|Overall Study|Excluded by company|1
1484781|NCT00574249|4893787|P1|Overall Study|Excluded by company|0
1484782|NCT00574249|4893786|P2|Overall Study|Pregnancy|0
1484783|NCT00574249|4893787|P1|Overall Study|Pregnancy|1
1484784|NCT00574249|4893786|P2|Overall Study|Physician Decision|0
1484785|NCT00574249|4893787|P1|Overall Study|Physician Decision|1
1484786|NCT00574249|4893786|P2|Overall Study|Withdrawal by Subject|0
1484787|NCT00574249|4893787|P1|Overall Study|Withdrawal by Subject|3
1484788|NCT00574249|4893786|P2|Overall Study|History of carcinoma|0
1484789|NCT00574249|4893787|P1|Overall Study|History of carcinoma|1
1484790|NCT00574249|4893786|P2|Overall Study|Protocol Violation|2
1484791|NCT00574249|4893787|P1|Overall Study|Protocol Violation|5
1484792|NCT00574249|4893786|P2|Overall Study|Lost to Follow-up|3
1484793|NCT00574249|4893787|P1|Overall Study|Lost to Follow-up|4
1484794|NCT00574249|4893786|P2|Overall Study|Lack of Efficacy|3
1484795|NCT00574249|4893787|P1|Overall Study|Lack of Efficacy|5
1484796|NCT00574249|4893786|P2|Overall Study|Adverse Event|18
1484797|NCT00574249|4893787|P1|Overall Study|Adverse Event|6
1484798|NCT00574145|4893838|P2|Overall Study|Withdrawal by Subject|1
1484799|NCT00574145|4893839|P1|Overall Study|Withdrawal by Subject|2
1484800|NCT00574080|4893851|P2|Overall Study|Death|10
1484801|NCT00574080|4893852|P1|Overall Study|Death|10
1484802|NCT00573937|4893901|P2|Overall Study|Study Terminated|1
1484803|NCT00573937|4893902|P1|Overall Study|Study Terminated|0
1484804|NCT00573859|4893916|P1|Smoking Versus Abstinence|Scheduling conflicts|12
1484805|NCT00573859|4893916|P1|Medication Versus Placebo|Scheduling conflicts|12
1484806|NCT00573833|4893922|P1|Overall Study|Not Treated|2
1484807|NCT00573794|4893929|P1|Overall Study|Not Specified|46
1484808|NCT00573794|4893929|P1|Overall Study|Lack of Efficacy|94
1484809|NCT00573794|4893929|P1|Overall Study|Protocol Violation|6
1484810|NCT00573794|4893929|P1|Overall Study|Lost to Follow-up|13
1484811|NCT00573794|4893929|P1|Overall Study|Withdrew Consent|90
1484812|NCT00573794|4893929|P1|Overall Study|Adverse Event|81
1484813|NCT00573768|4893960|P3|Overall Study|Lost to Follow-up|1
1484814|NCT00573768|4893961|P2|Overall Study|Lost to Follow-up|0
1484815|NCT00573768|4893962|P1|Overall Study|Lost to Follow-up|0
1484816|NCT00573768|4893960|P3|Overall Study|Withdrawal by Subject|0
1484817|NCT00573768|4893961|P2|Overall Study|Withdrawal by Subject|1
1484818|NCT00573768|4893962|P1|Overall Study|Withdrawal by Subject|0
1484819|NCT00573768|4893960|P3|Overall Study|Protocol Violation|1
1484820|NCT00573768|4893961|P2|Overall Study|Protocol Violation|0
1484821|NCT00573768|4893962|P1|Overall Study|Protocol Violation|1
1484822|NCT00573768|4893960|P3|Overall Study|Adverse Event|2
1484823|NCT00573768|4893961|P2|Overall Study|Adverse Event|1
1484824|NCT00573768|4893962|P1|Overall Study|Adverse Event|1
1484825|NCT00573755|4893972|P2|Overall Study|Still receiving treatment|0
1484826|NCT00573755|4893973|P1|Overall Study|Still receiving treatment|1
1484827|NCT00573534|4893989|P1|Overall Study|oppositional behavior|3
1484828|NCT00573469|4894030|P3|Overall Study|Not Specified|3
1484829|NCT00573469|4894031|P2|Overall Study|Not Specified|1
1484830|NCT00573469|4894032|P1|Overall Study|Not Specified|5
1484831|NCT00573469|4894030|P3|Overall Study|Withdrawal by Subject|0
1484832|NCT00573469|4894031|P2|Overall Study|Withdrawal by Subject|2
1484833|NCT00573469|4894032|P1|Overall Study|Withdrawal by Subject|0
1484834|NCT00573469|4894030|P3|Overall Study|Adverse Event|1
1484835|NCT00573469|4894031|P2|Overall Study|Adverse Event|1
1484836|NCT00573469|4894032|P1|Overall Study|Adverse Event|1
1484837|NCT00573443|4894055|P3|Open-Label Extension Phase|Not Specified|0
1484838|NCT00573443|4894056|P2|Open-Label Extension Phase|Not Specified|0
1484839|NCT00573443|4894057|P1|Open-Label Extension Phase|Not Specified|2
1484840|NCT00573443|4894055|P3|Open-Label Extension Phase|Protocol Violation|0
1484841|NCT00573443|4894056|P2|Open-Label Extension Phase|Protocol Violation|0
1484842|NCT00573443|4894057|P1|Open-Label Extension Phase|Protocol Violation|2
1484843|NCT00573443|4894055|P3|Open-Label Extension Phase|Withdrawal by Subject|0
1484844|NCT00573443|4894056|P2|Open-Label Extension Phase|Withdrawal by Subject|0
1484845|NCT00573443|4894057|P1|Open-Label Extension Phase|Withdrawal by Subject|3
1484846|NCT00573443|4894055|P3|Open-Label Extension Phase|Serious Adverse Event|0
1484847|NCT00573443|4894056|P2|Open-Label Extension Phase|Serious Adverse Event|0
1484848|NCT00573443|4894057|P1|Open-Label Extension Phase|Serious Adverse Event|5
1484849|NCT00573443|4894055|P3|Open-Label Extension Phase|Adverse Event|0
1484850|NCT00573443|4894056|P2|Open-Label Extension Phase|Adverse Event|0
1484851|NCT00573443|4894057|P1|Open-Label Extension Phase|Adverse Event|3
1484852|NCT00573443|4894055|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
1484853|NCT00573443|4894056|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
1484854|NCT00573443|4894057|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
1484855|NCT00573443|4894055|P3|Open-Label Extension Phase|Lost to Follow-up|0
1484856|NCT00573443|4894056|P2|Open-Label Extension Phase|Lost to Follow-up|0
1484857|NCT00573443|4894057|P1|Open-Label Extension Phase|Lost to Follow-up|1
1484858|NCT00573443|4894055|P3|Double-Blind Phase|Not specified|3
1484859|NCT00573443|4894056|P2|Double-Blind Phase|Not specified|2
1484860|NCT00573443|4894057|P1|Double-Blind Phase|Not specified|0
1484861|NCT00573443|4894055|P3|Double-Blind Phase|Protocol Violation|1
1484862|NCT00573443|4894056|P2|Double-Blind Phase|Protocol Violation|2
1484863|NCT00573443|4894057|P1|Double-Blind Phase|Protocol Violation|0
1484864|NCT00573443|4894055|P3|Double-Blind Phase|Withdrawal by Subject|7
1484865|NCT00573443|4894056|P2|Double-Blind Phase|Withdrawal by Subject|2
1484866|NCT00573443|4894057|P1|Double-Blind Phase|Withdrawal by Subject|2
1484867|NCT00573443|4894055|P3|Double-Blind Phase|Medication refusal due to AE|0
1484868|NCT00573443|4894056|P2|Double-Blind Phase|Medication refusal due to AE|2
1484869|NCT00573443|4894057|P1|Double-Blind Phase|Medication refusal due to AE|2
1484870|NCT00573443|4894055|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
1484871|NCT00573443|4894056|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
1484872|NCT00573443|4894057|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
1484873|NCT00573443|4894055|P3|Double-Blind Phase|Adverse Event|0
1484874|NCT00573443|4894056|P2|Double-Blind Phase|Adverse Event|5
1484875|NCT00573443|4894057|P1|Double-Blind Phase|Adverse Event|1
1484876|NCT00573443|4894055|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
1484877|NCT00573443|4894056|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
1484878|NCT00573443|4894057|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
1484879|NCT00573443|4894055|P3|Double-Blind Phase|Lost to Follow-up|2
1484880|NCT00573443|4894056|P2|Double-Blind Phase|Lost to Follow-up|3
1484881|NCT00573443|4894057|P1|Double-Blind Phase|Lost to Follow-up|1
1484882|NCT00573430|4894087|P3|Overall Study|Eligibility criteria not fulfilled|3
1484883|NCT00573430|4894088|P2|Overall Study|Eligibility criteria not fulfilled|0
1484884|NCT00573430|4894089|P1|Overall Study|Eligibility criteria not fulfilled|0
1484885|NCT00573430|4894087|P3|Overall Study|Protocol Violation|1
1484886|NCT00573430|4894088|P2|Overall Study|Protocol Violation|1
1484887|NCT00573430|4894089|P1|Overall Study|Protocol Violation|0
1484888|NCT00573430|4894087|P3|Overall Study|Withdrawal by Subject|1
1484889|NCT00573430|4894088|P2|Overall Study|Withdrawal by Subject|0
1484890|NCT00573430|4894089|P1|Overall Study|Withdrawal by Subject|1
1484891|NCT00573430|4894087|P3|Overall Study|Adverse Event|2
1484892|NCT00573430|4894088|P2|Overall Study|Adverse Event|0
1484893|NCT00573430|4894089|P1|Overall Study|Adverse Event|0
1484894|NCT00573430|4894087|P3|Overall Study|Incorrect enrollment of randomization|3
1484895|NCT00573430|4894088|P2|Overall Study|Incorrect enrollment of randomization|4
1484896|NCT00573430|4894089|P1|Overall Study|Incorrect enrollment of randomization|0
1484897|NCT00573391|4894111|P2|Overall Study|Death|0
1484898|NCT00573391|4894112|P1|Overall Study|Death|1
1484899|NCT00573391|4894111|P2|Overall Study|study stopped|2
1484900|NCT00573391|4894112|P1|Overall Study|study stopped|2
1484901|NCT00573313|4894122|P4|Overall Study|Protocol Violation|0
1484902|NCT00573313|4894123|P3|Overall Study|Protocol Violation|6
1484903|NCT00573313|4894124|P2|Overall Study|Protocol Violation|0
1484904|NCT00573313|4894125|P1|Overall Study|Protocol Violation|5
1484905|NCT00573248|4894175|P2|Overall Study|scheduling conflicts|11
1484906|NCT00573248|4894176|P1|Overall Study|scheduling conflicts|15
1484907|NCT00573183|4894190|P2|Overall Study|Other|2
1484908|NCT00573183|4894191|P1|Overall Study|Other|5
1484909|NCT00573183|4894190|P2|Overall Study|Incarceration|8
1484910|NCT00573183|4894191|P1|Overall Study|Incarceration|5
1484911|NCT00573183|4894190|P2|Overall Study|Adverse Event|0
1484912|NCT00573183|4894191|P1|Overall Study|Adverse Event|2
1484913|NCT00573183|4894190|P2|Overall Study|Death|1
1484914|NCT00573183|4894191|P1|Overall Study|Death|0
1484915|NCT00573183|4894190|P2|Overall Study|Withdrawal by Subject|2
1484916|NCT00573183|4894191|P1|Overall Study|Withdrawal by Subject|8
1484917|NCT00573183|4894190|P2|Overall Study|Lost to Follow-up|50
1484918|NCT00573183|4894191|P1|Overall Study|Lost to Follow-up|52
1484919|NCT00573170|4894199|P6|Third Treatment Period|Lost to Follow-up|2
1484920|NCT00573170|4894200|P5|Third Treatment Period|Lost to Follow-up|0
1484921|NCT00573170|4894201|P4|Third Treatment Period|Lost to Follow-up|0
1484922|NCT00573170|4894202|P3|Third Treatment Period|Lost to Follow-up|0
1484923|NCT00573170|4894203|P2|Third Treatment Period|Lost to Follow-up|0
1484924|NCT00573170|4894204|P1|Third Treatment Period|Lost to Follow-up|0
1484925|NCT00573170|4894199|P6|Third Treatment Period|Withdrawal by Subject|0
1484926|NCT00573170|4894200|P5|Third Treatment Period|Withdrawal by Subject|0
1484927|NCT00573170|4894201|P4|Third Treatment Period|Withdrawal by Subject|0
1484928|NCT00573170|4894202|P3|Third Treatment Period|Withdrawal by Subject|0
1484929|NCT00573170|4894203|P2|Third Treatment Period|Withdrawal by Subject|0
1484930|NCT00573170|4894204|P1|Third Treatment Period|Withdrawal by Subject|1
1484931|NCT00573170|4894199|P6|Second Washout Period|Other|2
1484932|NCT00573170|4894200|P5|Second Washout Period|Other|6
1484933|NCT00573170|4894201|P4|Second Washout Period|Other|4
1484934|NCT00573170|4894202|P3|Second Washout Period|Other|1
1484935|NCT00573170|4894203|P2|Second Washout Period|Other|2
1484936|NCT00573170|4894204|P1|Second Washout Period|Other|1
1484937|NCT00573170|4894199|P6|Second Washout Period|Lost to Follow-up|0
1484938|NCT00573170|4894200|P5|Second Washout Period|Lost to Follow-up|0
1484939|NCT00573170|4894201|P4|Second Washout Period|Lost to Follow-up|1
1484940|NCT00573170|4894202|P3|Second Washout Period|Lost to Follow-up|0
1484941|NCT00573170|4894203|P2|Second Washout Period|Lost to Follow-up|0
1484942|NCT00573170|4894204|P1|Second Washout Period|Lost to Follow-up|0
1484943|NCT00573170|4894199|P6|Second Washout Period|Withdrawal by Subject|0
1484944|NCT00573170|4894200|P5|Second Washout Period|Withdrawal by Subject|1
1484945|NCT00573170|4894201|P4|Second Washout Period|Withdrawal by Subject|0
1484946|NCT00573170|4894202|P3|Second Washout Period|Withdrawal by Subject|2
1484947|NCT00573170|4894203|P2|Second Washout Period|Withdrawal by Subject|1
1484948|NCT00573170|4894204|P1|Second Washout Period|Withdrawal by Subject|1
1484949|NCT00573170|4894199|P6|Second Washout Period|Protocol Violation|0
1484950|NCT00573170|4894200|P5|Second Washout Period|Protocol Violation|0
1484951|NCT00573170|4894201|P4|Second Washout Period|Protocol Violation|0
1484952|NCT00573170|4894202|P3|Second Washout Period|Protocol Violation|1
1484953|NCT00573170|4894203|P2|Second Washout Period|Protocol Violation|1
1484954|NCT00573170|4894204|P1|Second Washout Period|Protocol Violation|2
1484955|NCT00573170|4894199|P6|Second Washout Period|Adverse Event|0
1484956|NCT00573170|4894200|P5|Second Washout Period|Adverse Event|1
1484957|NCT00573170|4894201|P4|Second Washout Period|Adverse Event|0
1484958|NCT00573170|4894202|P3|Second Washout Period|Adverse Event|0
1484959|NCT00573170|4894203|P2|Second Washout Period|Adverse Event|0
1484960|NCT00573170|4894204|P1|Second Washout Period|Adverse Event|1
1484961|NCT00573170|4894199|P6|First Washout Period|Other|0
1484962|NCT00573170|4894200|P5|First Washout Period|Other|0
1484963|NCT00573170|4894201|P4|First Washout Period|Other|1
1484964|NCT00573170|4894202|P3|First Washout Period|Other|1
1484965|NCT00573170|4894203|P2|First Washout Period|Other|0
1484966|NCT00573170|4894204|P1|First Washout Period|Other|4
1484967|NCT00573170|4894199|P6|First Washout Period|Withdrawal by Subject|3
1484968|NCT00573170|4894200|P5|First Washout Period|Withdrawal by Subject|3
1484969|NCT00573170|4894201|P4|First Washout Period|Withdrawal by Subject|2
1484970|NCT00573170|4894202|P3|First Washout Period|Withdrawal by Subject|0
1484971|NCT00573170|4894203|P2|First Washout Period|Withdrawal by Subject|0
1484972|NCT00573170|4894204|P1|First Washout Period|Withdrawal by Subject|2
1484973|NCT00573170|4894199|P6|First Washout Period|Lost to Follow-up|2
1484974|NCT00573170|4894200|P5|First Washout Period|Lost to Follow-up|0
1484975|NCT00573170|4894201|P4|First Washout Period|Lost to Follow-up|2
1484976|NCT00573170|4894202|P3|First Washout Period|Lost to Follow-up|0
1484977|NCT00573170|4894203|P2|First Washout Period|Lost to Follow-up|1
1484978|NCT00573170|4894204|P1|First Washout Period|Lost to Follow-up|1
1484979|NCT00573170|4894199|P6|First Washout Period|Lack of Efficacy|1
1484980|NCT00573170|4894200|P5|First Washout Period|Lack of Efficacy|0
1484981|NCT00573170|4894201|P4|First Washout Period|Lack of Efficacy|0
1484982|NCT00573170|4894202|P3|First Washout Period|Lack of Efficacy|0
1484983|NCT00573170|4894203|P2|First Washout Period|Lack of Efficacy|0
1484984|NCT00573170|4894204|P1|First Washout Period|Lack of Efficacy|0
1484985|NCT00573170|4894199|P6|First Washout Period|Adverse Event|1
1484986|NCT00573170|4894200|P5|First Washout Period|Adverse Event|0
1484987|NCT00573170|4894201|P4|First Washout Period|Adverse Event|0
1484988|NCT00573170|4894202|P3|First Washout Period|Adverse Event|0
1484989|NCT00573170|4894203|P2|First Washout Period|Adverse Event|1
1484990|NCT00573170|4894204|P1|First Washout Period|Adverse Event|1
1484991|NCT00573170|4894199|P6|First Treatment Period|Did Not Treat Attack 1|0
1484992|NCT00573170|4894200|P5|First Treatment Period|Did Not Treat Attack 1|1
1484993|NCT00573170|4894201|P4|First Treatment Period|Did Not Treat Attack 1|0
1484994|NCT00573170|4894202|P3|First Treatment Period|Did Not Treat Attack 1|0
1484995|NCT00573170|4894203|P2|First Treatment Period|Did Not Treat Attack 1|0
1484996|NCT00573170|4894204|P1|First Treatment Period|Did Not Treat Attack 1|0
1484997|NCT00573157|4894280|P2|Overall Study|Other|1
1484998|NCT00573157|4894281|P1|Overall Study|Other|1
1484999|NCT00573157|4894280|P2|Overall Study|Adverse Event|1
1485000|NCT00573157|4894281|P1|Overall Study|Adverse Event|3
1485001|NCT00573144|4894293|P2|Overall Study|Withdrawal by Subject|3
1485002|NCT00573144|4894294|P1|Overall Study|Withdrawal by Subject|2
1485003|NCT00573131|4894306|P2|Overall Study|Withdrawal by Subject|8
1485004|NCT00573131|4894307|P1|Overall Study|Withdrawal by Subject|10
1485005|NCT00573066|4894313|P1|Overall Study|Postoperative bleeding|1
1485006|NCT00573066|4894313|P1|Overall Study|IV malfunction|1
1485007|NCT00573066|4894313|P1|Overall Study|Exclusion criteria|18
1485008|NCT00572910|4894357|P11|Overall Study|Withdrawal by Subject|1
1485009|NCT00572910|4894358|P10|Overall Study|Withdrawal by Subject|2
1485010|NCT00572910|4894359|P9|Overall Study|Withdrawal by Subject|2
1485011|NCT00572910|4894360|P8|Overall Study|Withdrawal by Subject|2
1485012|NCT00572910|4894361|P7|Overall Study|Withdrawal by Subject|0
1485013|NCT00572910|4894362|P6|Overall Study|Withdrawal by Subject|3
1485014|NCT00572910|4894363|P5|Overall Study|Withdrawal by Subject|1
1485015|NCT00572910|4894364|P4|Overall Study|Withdrawal by Subject|0
1485016|NCT00572910|4894365|P3|Overall Study|Withdrawal by Subject|1
1485017|NCT00572910|4894366|P2|Overall Study|Withdrawal by Subject|0
1485018|NCT00572910|4894367|P1|Overall Study|Withdrawal by Subject|3
1485019|NCT00572910|4894357|P11|Overall Study|Lost to Follow-up|0
1485020|NCT00572910|4894358|P10|Overall Study|Lost to Follow-up|1
1485021|NCT00572910|4894359|P9|Overall Study|Lost to Follow-up|0
1485022|NCT00572910|4894360|P8|Overall Study|Lost to Follow-up|0
1485023|NCT00572910|4894361|P7|Overall Study|Lost to Follow-up|0
1485024|NCT00572910|4894362|P6|Overall Study|Lost to Follow-up|0
1485025|NCT00572910|4894363|P5|Overall Study|Lost to Follow-up|1
1485026|NCT00572910|4894364|P4|Overall Study|Lost to Follow-up|2
1485027|NCT00572910|4894365|P3|Overall Study|Lost to Follow-up|1
1485028|NCT00572910|4894366|P2|Overall Study|Lost to Follow-up|1
1485029|NCT00572910|4894367|P1|Overall Study|Lost to Follow-up|0
1485030|NCT00572910|4894357|P11|Overall Study|Adverse Event|2
1485031|NCT00572910|4894358|P10|Overall Study|Adverse Event|3
1485032|NCT00572910|4894359|P9|Overall Study|Adverse Event|1
1485033|NCT00572910|4894360|P8|Overall Study|Adverse Event|2
1485034|NCT00572910|4894361|P7|Overall Study|Adverse Event|4
1485035|NCT00572910|4894362|P6|Overall Study|Adverse Event|0
1485036|NCT00572910|4894363|P5|Overall Study|Adverse Event|0
1485037|NCT00572910|4894364|P4|Overall Study|Adverse Event|2
1485038|NCT00572910|4894365|P3|Overall Study|Adverse Event|0
1485039|NCT00572910|4894366|P2|Overall Study|Adverse Event|2
1485040|NCT00572910|4894367|P1|Overall Study|Adverse Event|1
1485041|NCT00572832|4894434|P2|Overall Study|Pregnancy|1
1485042|NCT00572832|4894435|P1|Overall Study|Pregnancy|0
1485043|NCT00572832|4894434|P2|Overall Study|Lost to Follow-up|11
1485044|NCT00572832|4894435|P1|Overall Study|Lost to Follow-up|0
1485045|NCT00572728|4894441|P1|Overall Study|Pathology missing|1
1485046|NCT00572728|4894441|P1|Overall Study|FLT2 after second chemotherapy initiated|7
1485047|NCT00572728|4894441|P1|Overall Study|Second chemotherapy not initiated|1
1485048|NCT00572728|4894441|P1|Overall Study|FLT2 not completed|5
1485049|NCT00572728|4894441|P1|Overall Study|First Chemotherapy not initiated|2
1485050|NCT00572728|4894441|P1|Overall Study|FLT1 not completed|4
1485051|NCT00572728|4894441|P1|Overall Study|Offstudy due to complicating disease|1
1485052|NCT00572728|4894441|P1|Overall Study|Enrolled under Amendment 4|5
1485053|NCT00572728|4894441|P1|Overall Study|Ineligible|3
1485054|NCT00572728|4894441|P1|Overall Study|Withdrawal by Subject|10
1485055|NCT00572624|4894455|P2|Overall Study|Health issues unrelated to the study|0
1485056|NCT00572624|4894456|P1|Overall Study|Health issues unrelated to the study|1
1485057|NCT00572624|4894455|P2|Overall Study|Problem with vascular access|0
1485058|NCT00572624|4894456|P1|Overall Study|Problem with vascular access|1
1485059|NCT00572624|4894455|P2|Overall Study|Refused to do the stress test|0
1485060|NCT00572624|4894456|P1|Overall Study|Refused to do the stress test|1
1485061|NCT00572624|4894455|P2|Overall Study|Admitted to being a smoker|0
1485062|NCT00572624|4894456|P1|Overall Study|Admitted to being a smoker|1
1485063|NCT00572624|4894455|P2|Overall Study|Started a new job-- no time for study|0
1485064|NCT00572624|4894456|P1|Overall Study|Started a new job-- no time for study|1
1485065|NCT00572624|4894455|P2|Overall Study|Medication change|0
1485066|NCT00572624|4894456|P1|Overall Study|Medication change|1
1485067|NCT00572624|4894455|P2|Overall Study|Wanted to do a different diet program|0
1485068|NCT00572624|4894456|P1|Overall Study|Wanted to do a different diet program|1
1485069|NCT00572624|4894455|P2|Overall Study|Lost to Follow-up|4
1485070|NCT00572624|4894456|P1|Overall Study|Lost to Follow-up|10
1485071|NCT00572572|4894484|P2|Overall Study|Withdrawal by Subject|6
1485072|NCT00572572|4894485|P1|Overall Study|Withdrawal by Subject|3
1485073|NCT00572533|4894503|P2|Overall Study|Transfer out of Facility|1
1485074|NCT00572533|4894504|P1|Overall Study|Transfer out of Facility|0
1485075|NCT00572533|4894503|P2|Overall Study|Social Issues|0
1485076|NCT00572533|4894504|P1|Overall Study|Social Issues|1
1485077|NCT00572533|4894503|P2|Overall Study|Received Kidney Transplant|1
1485078|NCT00572533|4894504|P1|Overall Study|Received Kidney Transplant|2
1485079|NCT00572533|4894503|P2|Overall Study|Death|1
1485080|NCT00572533|4894504|P1|Overall Study|Death|4
1485081|NCT00572156|4894543|P4|Overall Study|Sponsor Decision|19
1485082|NCT00572156|4894544|P3|Overall Study|Sponsor Decision|17
1485083|NCT00572156|4894545|P2|Overall Study|Sponsor Decision|16
1485084|NCT00572156|4894546|P1|Overall Study|Sponsor Decision|20
1485085|NCT00572156|4894543|P4|Overall Study|Patient/Parent Decision|3
1485086|NCT00572156|4894544|P3|Overall Study|Patient/Parent Decision|4
1485087|NCT00572156|4894545|P2|Overall Study|Patient/Parent Decision|6
1485088|NCT00572156|4894546|P1|Overall Study|Patient/Parent Decision|1
1485089|NCT00572156|4894543|P4|Overall Study|Protocol Violation|2
1485090|NCT00572156|4894544|P3|Overall Study|Protocol Violation|0
1485091|NCT00572156|4894545|P2|Overall Study|Protocol Violation|2
1485092|NCT00572156|4894546|P1|Overall Study|Protocol Violation|1
1485093|NCT00572156|4894543|P4|Overall Study|Lost to Follow-up|0
1485094|NCT00572156|4894544|P3|Overall Study|Lost to Follow-up|1
1485095|NCT00572156|4894545|P2|Overall Study|Lost to Follow-up|1
1485096|NCT00572156|4894546|P1|Overall Study|Lost to Follow-up|1
1485097|NCT00572156|4894543|P4|Overall Study|Adverse Event|1
1485098|NCT00572156|4894544|P3|Overall Study|Adverse Event|5
1485099|NCT00572156|4894545|P2|Overall Study|Adverse Event|1
1485100|NCT00572156|4894546|P1|Overall Study|Adverse Event|3
1485101|NCT00572039|4894617|P2|Overall Study|Ill|1
1485102|NCT00572039|4894618|P1|Overall Study|Ill|5
1485103|NCT00572039|4894617|P2|Overall Study|Death|3
1485104|NCT00572039|4894618|P1|Overall Study|Death|2
1485105|NCT00572039|4894617|P2|Overall Study|Withdrawal by Subject|6
1485106|NCT00572039|4894618|P1|Overall Study|Withdrawal by Subject|9
1485107|NCT00571948|4894650|P2|Overall Study|Parent were afraid of blood colection|5
1485108|NCT00571948|4894651|P1|Overall Study|Parent were afraid of blood colection|2
1485109|NCT00571948|4894650|P2|Overall Study|infant refused study meal|4
1485110|NCT00571948|4894651|P1|Overall Study|infant refused study meal|3
1485111|NCT00571948|4894650|P2|Overall Study|Protocol Violation|3
1485112|NCT00571948|4894651|P1|Overall Study|Protocol Violation|3
1485113|NCT00571948|4894650|P2|Overall Study|Withdrawal by Subject|2
1485114|NCT00571948|4894651|P1|Overall Study|Withdrawal by Subject|1
1485115|NCT00571948|4894650|P2|Overall Study|Lost to Follow-up|0
1485116|NCT00571948|4894651|P1|Overall Study|Lost to Follow-up|2
1485117|NCT00571922|4894659|P2|Overall Study|Completion unknown|36
1485118|NCT00571922|4894660|P1|Overall Study|Completion unknown|36
1485119|NCT00571701|4894670|P2|Second Intervention 12 Months|Withdrawal by Subject|0
1485120|NCT00571701|4894671|P1|Second Intervention 12 Months|Withdrawal by Subject|3
1485121|NCT00571701|4894670|P2|Second Intervention 12 Months|Adverse Event|1
1485122|NCT00571701|4894671|P1|Second Intervention 12 Months|Adverse Event|0
1485123|NCT00571701|4894670|P2|First Intervention 12 Months|Death|0
1485124|NCT00571701|4894671|P1|First Intervention 12 Months|Death|1
1485125|NCT00571701|4894670|P2|First Intervention 12 Months|Withdrawal by Subject|1
1485126|NCT00571701|4894671|P1|First Intervention 12 Months|Withdrawal by Subject|2
1485127|NCT00571688|4894697|P2|Overall Study|subject moved out of the area|0
1485128|NCT00571688|4894698|P1|Overall Study|subject moved out of the area|1
1485129|NCT00571688|4894697|P2|Overall Study|subject did not tolerate Consta|0
1485130|NCT00571688|4894698|P1|Overall Study|subject did not tolerate Consta|1
1485131|NCT00571688|4894697|P2|Overall Study|Lost to Follow-up|6
1485132|NCT00571688|4894698|P1|Overall Study|Lost to Follow-up|3
1485133|NCT00571662|4894704|P1|Overall Study|Adverse Event|5
1485134|NCT00571662|4894704|P1|Overall Study|psychiatric instability|1
1485135|NCT00571662|4894704|P1|Overall Study|Withdrawal by Subject|2
1485136|NCT00571649|4894712|P2|Follow-up Period|Protocol Violation|12
1485137|NCT00571649|4894713|P1|Follow-up Period|Protocol Violation|5
1485138|NCT00571649|4894712|P2|Follow-up Period|Patient convenience|121
1485139|NCT00571649|4894713|P1|Follow-up Period|Patient convenience|136
1485140|NCT00571649|4894712|P2|Follow-up Period|Lost to Follow-up|92
1485141|NCT00571649|4894713|P1|Follow-up Period|Lost to Follow-up|95
1485142|NCT00571649|4894712|P2|Follow-up Period|Physician Decision|13
1485143|NCT00571649|4894713|P1|Follow-up Period|Physician Decision|7
1485144|NCT00571649|4894712|P2|Follow-up Period|Death|133
1485145|NCT00571649|4894713|P1|Follow-up Period|Death|132
1485146|NCT00571649|4894712|P2|Follow-up Period|Withdrawal by Subject|115
1485147|NCT00571649|4894713|P1|Follow-up Period|Withdrawal by Subject|119
1485148|NCT00571649|4894712|P2|Follow-up Period|Clinical endpoint reached|2
1485149|NCT00571649|4894713|P1|Follow-up Period|Clinical endpoint reached|5
1485150|NCT00571649|4894712|P2|Follow-up Period|Adverse Event|40
1485151|NCT00571649|4894713|P1|Follow-up Period|Adverse Event|46
1485152|NCT00571649|4894712|P2|Treatment Period|Technical problems|5
1485153|NCT00571649|4894713|P1|Treatment Period|Technical problems|3
1485154|NCT00571649|4894712|P2|Treatment Period|Protocol Violation|92
1485155|NCT00571649|4894713|P1|Treatment Period|Protocol Violation|90
1485156|NCT00571649|4894712|P2|Treatment Period|Patient convenience|13
1485157|NCT00571649|4894713|P1|Treatment Period|Patient convenience|11
1485158|NCT00571649|4894712|P2|Treatment Period|Non-compliant with study medication|89
1485159|NCT00571649|4894713|P1|Treatment Period|Non-compliant with study medication|88
1485160|NCT00571649|4894712|P2|Treatment Period|Lost to Follow-up|41
1485161|NCT00571649|4894713|P1|Treatment Period|Lost to Follow-up|43
1485162|NCT00571649|4894712|P2|Treatment Period|Physician Decision|9
1485163|NCT00571649|4894713|P1|Treatment Period|Physician Decision|8
1485164|NCT00571649|4894712|P2|Treatment Period|Death|59
1485165|NCT00571649|4894713|P1|Treatment Period|Death|76
1485166|NCT00571649|4894712|P2|Treatment Period|Withdrawal by Subject|255
1485167|NCT00571649|4894713|P1|Treatment Period|Withdrawal by Subject|285
1485168|NCT00571649|4894712|P2|Treatment Period|Clinical endpoint reached|56
1485169|NCT00571649|4894713|P1|Treatment Period|Clinical endpoint reached|50
1485170|NCT00571649|4894712|P2|Treatment Period|Adverse Event|385
1485171|NCT00571649|4894713|P1|Treatment Period|Adverse Event|438
1485172|NCT00571103|4894811|P1|Overall Study|Lost to Follow-up|1
1485173|NCT00571103|4894811|P1|Overall Study|Withdrawal by Subject|1
1485174|NCT00571064|4894816|P1|Overall Study|Not specified|2
1485175|NCT00571064|4894816|P1|Overall Study|Withdrawal by Subject|2
1485176|NCT00571064|4894816|P1|Overall Study|Protocol Violation|4
1485177|NCT00571064|4894816|P1|Overall Study|Adverse Event|13
1485178|NCT00571038|4894831|P2|Overall Study|Moved out of state|2
1485179|NCT00571038|4894832|P1|Overall Study|Moved out of state|2
1485180|NCT00571038|4894831|P2|Overall Study|Withdrawal by Subject|3
1485181|NCT00571038|4894832|P1|Overall Study|Withdrawal by Subject|1
1485182|NCT00571038|4894831|P2|Overall Study|Death|5
1485183|NCT00571038|4894832|P1|Overall Study|Death|7
1485184|NCT00571038|4894831|P2|Overall Study|Lost to Follow-up|4
1485185|NCT00571038|4894832|P1|Overall Study|Lost to Follow-up|1
1485186|NCT00570921|4894887|P1|Overall Study|Physician Decision|1
1485187|NCT00570921|4894887|P1|Overall Study|Protocol Violation|1
1485188|NCT00570908|4894893|P1|Overall Study|Withdrawal by Subject|2
1485189|NCT00570908|4894893|P1|Overall Study|Adverse Event|5
1485190|NCT00570778|4894897|P4|Overall Study|Subject no longer requires study drug|0
1485191|NCT00570778|4894898|P3|Overall Study|Subject no longer requires study drug|0
1485192|NCT00570778|4894899|P2|Overall Study|Subject no longer requires study drug|1
1485193|NCT00570778|4894900|P1|Overall Study|Subject no longer requires study drug|0
1485194|NCT00570778|4894897|P4|Overall Study|Lost to Follow-up|0
1485195|NCT00570778|4894898|P3|Overall Study|Lost to Follow-up|1
1485196|NCT00570778|4894899|P2|Overall Study|Lost to Follow-up|0
1485197|NCT00570778|4894900|P1|Overall Study|Lost to Follow-up|0
1485198|NCT00570778|4894897|P4|Overall Study|Unsatisfactory therapeutic effect|0
1485199|NCT00570778|4894898|P3|Overall Study|Unsatisfactory therapeutic effect|0
1485200|NCT00570778|4894899|P2|Overall Study|Unsatisfactory therapeutic effect|0
1485201|NCT00570778|4894900|P1|Overall Study|Unsatisfactory therapeutic effect|1
1485202|NCT00570778|4894897|P4|Overall Study|Abnormal test procedure|0
1485203|NCT00570778|4894898|P3|Overall Study|Abnormal test procedure|0
1485204|NCT00570778|4894899|P2|Overall Study|Abnormal test procedure|0
1485205|NCT00570778|4894900|P1|Overall Study|Abnormal test procedure|1
1485206|NCT00570778|4894897|P4|Overall Study|Subject withdrew consent|1
1485207|NCT00570778|4894898|P3|Overall Study|Subject withdrew consent|0
1485208|NCT00570778|4894899|P2|Overall Study|Subject withdrew consent|1
1485209|NCT00570778|4894900|P1|Overall Study|Subject withdrew consent|0
1485210|NCT00570778|4894897|P4|Overall Study|Adverse Event|1
1485211|NCT00570778|4894898|P3|Overall Study|Adverse Event|4
1485212|NCT00570778|4894899|P2|Overall Study|Adverse Event|1
1485213|NCT00570778|4894900|P1|Overall Study|Adverse Event|0
1485214|NCT00570778|4894897|P4|Overall Study|Protocol deviation|2
1485215|NCT00570778|4894898|P3|Overall Study|Protocol deviation|2
1485216|NCT00570778|4894899|P2|Overall Study|Protocol deviation|1
1485217|NCT00570778|4894900|P1|Overall Study|Protocol deviation|2
1485218|NCT00570739|4894941|P4|Overall Study|Not specified|3
1485219|NCT00570739|4894942|P3|Overall Study|Not specified|5
1485220|NCT00570739|4894943|P2|Overall Study|Not specified|2
1485221|NCT00570739|4894944|P1|Overall Study|Not specified|0
1485222|NCT00570739|4894941|P4|Overall Study|Met discontinuation criteria|1
1485223|NCT00570739|4894942|P3|Overall Study|Met discontinuation criteria|1
1485224|NCT00570739|4894943|P2|Overall Study|Met discontinuation criteria|0
1485225|NCT00570739|4894944|P1|Overall Study|Met discontinuation criteria|1
1485226|NCT00570739|4894941|P4|Overall Study|Required restricted medication|0
1485227|NCT00570739|4894942|P3|Overall Study|Required restricted medication|1
1485228|NCT00570739|4894943|P2|Overall Study|Required restricted medication|0
1485229|NCT00570739|4894944|P1|Overall Study|Required restricted medication|0
1485230|NCT00570739|4894941|P4|Overall Study|Withdrawal by Subject|5
1485231|NCT00570739|4894942|P3|Overall Study|Withdrawal by Subject|3
1485232|NCT00570739|4894943|P2|Overall Study|Withdrawal by Subject|7
1485233|NCT00570739|4894944|P1|Overall Study|Withdrawal by Subject|7
1485234|NCT00570739|4894941|P4|Overall Study|Physician Decision|0
1485235|NCT00570739|4894942|P3|Overall Study|Physician Decision|0
1485236|NCT00570739|4894943|P2|Overall Study|Physician Decision|1
1485237|NCT00570739|4894944|P1|Overall Study|Physician Decision|1
1485238|NCT00570739|4894941|P4|Overall Study|Lost to Follow-up|1
1485239|NCT00570739|4894942|P3|Overall Study|Lost to Follow-up|4
1485240|NCT00570739|4894943|P2|Overall Study|Lost to Follow-up|5
1485241|NCT00570739|4894944|P1|Overall Study|Lost to Follow-up|4
1485242|NCT00570739|4894941|P4|Overall Study|Adverse Event|2
1485243|NCT00570739|4894942|P3|Overall Study|Adverse Event|2
1485244|NCT00570739|4894943|P2|Overall Study|Adverse Event|6
1485245|NCT00570739|4894944|P1|Overall Study|Adverse Event|8
1485246|NCT00570713|4895096|P2|Overall Study|Discontinuation of Study by the Sponsor|7
1485247|NCT00570713|4895097|P1|Overall Study|Discontinuation of Study by the Sponsor|10
1485248|NCT00570713|4895096|P2|Overall Study|Withdrawal by Subject|3
1485249|NCT00570713|4895097|P1|Overall Study|Withdrawal by Subject|3
1485250|NCT00570713|4895096|P2|Overall Study|Physician Decision|2
1485251|NCT00570713|4895097|P1|Overall Study|Physician Decision|2
1485252|NCT00570713|4895096|P2|Overall Study|Lack of Efficacy|49
1485253|NCT00570713|4895097|P1|Overall Study|Lack of Efficacy|40
1485254|NCT00570713|4895096|P2|Overall Study|Death|7
1485255|NCT00570713|4895097|P1|Overall Study|Death|7
1485256|NCT00570713|4895096|P2|Overall Study|Adverse Event|9
1485257|NCT00570713|4895097|P1|Overall Study|Adverse Event|16
1485258|NCT00570687|4895115|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485259|NCT00570687|4895116|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485260|NCT00570687|4895117|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485261|NCT00570687|4895118|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
1485262|NCT00570687|4895119|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485263|NCT00570687|4895120|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485264|NCT00570687|4895121|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485265|NCT00570687|4895122|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485266|NCT00570687|4895123|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485267|NCT00570687|4895124|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485268|NCT00570687|4895115|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485269|NCT00570687|4895116|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
1485270|NCT00570687|4895117|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485271|NCT00570687|4895118|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485272|NCT00570687|4895119|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485273|NCT00570687|4895120|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485274|NCT00570687|4895121|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485275|NCT00570687|4895122|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485276|NCT00570687|4895123|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485277|NCT00570687|4895124|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485278|NCT00570687|4895115|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
1485279|NCT00570687|4895116|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
1485280|NCT00570687|4895117|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
1485281|NCT00570687|4895118|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
1485282|NCT00570687|4895119|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
1485283|NCT00570687|4895120|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
1485284|NCT00570687|4895121|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485285|NCT00570687|4895122|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485286|NCT00570687|4895123|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485287|NCT00570687|4895124|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1485288|NCT00570674|4895150|P7|Overall Study|Withdrawal by Subject|0
1485289|NCT00570674|4895151|P6|Overall Study|Withdrawal by Subject|0
1485290|NCT00570674|4895152|P5|Overall Study|Withdrawal by Subject|0
1485291|NCT00570674|4895153|P4|Overall Study|Withdrawal by Subject|0
1485292|NCT00570674|4895154|P3|Overall Study|Withdrawal by Subject|1
1485293|NCT00570674|4895155|P2|Overall Study|Withdrawal by Subject|0
1485294|NCT00570674|4895156|P1|Overall Study|Withdrawal by Subject|0
1485295|NCT00570505|4895179|P1|Overall Study|Other loss to follow-up|4
1485296|NCT00570505|4895179|P1|Overall Study|Lost to Follow-up|23
1485297|NCT00570505|4895179|P1|Overall Study|Withdrawal by Subject|7
1485298|NCT00570505|4895179|P1|Overall Study|Adverse Event|7
1485299|NCT00570492|4895192|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
1485300|NCT00570492|4895193|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
1485301|NCT00570492|4895194|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
1485302|NCT00570492|4895192|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
1485303|NCT00570492|4895193|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
1485304|NCT00570492|4895194|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
1485305|NCT00570492|4895192|P3|52-week Double-blind Treatment Period|Physician Decision|4
1485306|NCT00570492|4895193|P2|52-week Double-blind Treatment Period|Physician Decision|2
1485307|NCT00570492|4895194|P1|52-week Double-blind Treatment Period|Physician Decision|0
1485308|NCT00570492|4895192|P3|52-week Double-blind Treatment Period|Adverse Event|5
1485309|NCT00570492|4895193|P2|52-week Double-blind Treatment Period|Adverse Event|5
1485310|NCT00570492|4895194|P1|52-week Double-blind Treatment Period|Adverse Event|0
1485311|NCT00570492|4895192|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
1485312|NCT00570492|4895193|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
1485313|NCT00570492|4895194|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
1485314|NCT00570492|4895192|P3|52-week Double-blind Treatment Period|Protocol Violation|15
1485315|NCT00570492|4895193|P2|52-week Double-blind Treatment Period|Protocol Violation|12
1485316|NCT00570492|4895194|P1|52-week Double-blind Treatment Period|Protocol Violation|0
1485317|NCT00570492|4895192|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
1485318|NCT00570492|4895193|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
1485319|NCT00570492|4895194|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
1485320|NCT00570492|4895192|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
1485321|NCT00570492|4895193|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
1485322|NCT00570492|4895194|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
1485323|NCT00570492|4895192|P3|16-week Single-blind Baseline Period|Adverse Event|0
1485324|NCT00570492|4895193|P2|16-week Single-blind Baseline Period|Adverse Event|0
1485325|NCT00570492|4895194|P1|16-week Single-blind Baseline Period|Adverse Event|1
1485326|NCT00570492|4895192|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
1485327|NCT00570492|4895193|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
1485328|NCT00570492|4895194|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
1485329|NCT00570492|4895192|P3|16-week Single-blind Baseline Period|Protocol Violation|0
1485330|NCT00570492|4895193|P2|16-week Single-blind Baseline Period|Protocol Violation|0
1485331|NCT00570492|4895194|P1|16-week Single-blind Baseline Period|Protocol Violation|15
1485332|NCT00570492|4895192|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
1485333|NCT00570492|4895193|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
1485334|NCT00570492|4895194|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
1485335|NCT00570492|4895192|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
1485336|NCT00570492|4895193|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
1485337|NCT00570492|4895194|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
1485338|NCT00570492|4895192|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
1485339|NCT00570492|4895193|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
1485340|NCT00570492|4895194|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
1485341|NCT00570401|4895232|P1|Overall Study|Adverse Event|2
1485342|NCT00570310|4895266|P2|Overall Study|Lack of Efficacy|4
1485343|NCT00570310|4895267|P1|Overall Study|Lack of Efficacy|1
1485344|NCT00570310|4895266|P2|Overall Study|Adverse Event|2
1485345|NCT00570310|4895267|P1|Overall Study|Adverse Event|1
1485346|NCT00570232|4895275|P1|Overall Study|discontinued due to noncompliance|2
1485347|NCT00570232|4895275|P1|Overall Study|discontinued due to recurrence|8
1485348|NCT00570232|4895275|P1|Overall Study|discontinued due to medical condition|3
1485349|NCT00570232|4895275|P1|Overall Study|Adverse Event|10
1485350|NCT00570141|4895281|P1|Overall Study|Lost to Follow-up|1
1485351|NCT00570141|4895281|P1|Overall Study|Missed visits|1
1485352|NCT00570141|4895281|P1|Overall Study|Adverse Event|1
1485353|NCT00570063|4895297|P2|Overall Study|Sponsor's Decision|3
1485354|NCT00570063|4895298|P1|Overall Study|Sponsor's Decision|7
1485355|NCT00570063|4895297|P2|Overall Study|Withdrawal by Subject|3
1485356|NCT00570063|4895298|P1|Overall Study|Withdrawal by Subject|4
1485357|NCT00570063|4895297|P2|Overall Study|Lack of Efficacy|1
1485358|NCT00570063|4895298|P1|Overall Study|Lack of Efficacy|0
1485359|NCT00570063|4895297|P2|Overall Study|Adverse Event|1
1485360|NCT00570063|4895298|P1|Overall Study|Adverse Event|4
1485361|NCT00570037|4895364|P2|Overall Study|Could not reach for 6-8 week contact|69
1485362|NCT00570037|4895365|P1|Overall Study|Could not reach for 6-8 week contact|44
1485363|NCT00569946|4895375|P1|Overall Study|Global Deterioration of Health Status|1
1485364|NCT00569946|4895375|P1|Overall Study|Objective Progression or Relapse|42
1485365|NCT00569946|4895375|P1|Overall Study|Adverse Event|16
1485366|NCT00569803|4895407|P8|Overall Study|Withdrawal by Subject|1
1485367|NCT00569803|4895408|P7|Overall Study|Withdrawal by Subject|0
1485368|NCT00569803|4895409|P6|Overall Study|Withdrawal by Subject|0
1485369|NCT00569803|4895410|P5|Overall Study|Withdrawal by Subject|0
1485370|NCT00569803|4895411|P4|Overall Study|Withdrawal by Subject|0
1485371|NCT00569803|4895412|P3|Overall Study|Withdrawal by Subject|0
1485372|NCT00569803|4895413|P2|Overall Study|Withdrawal by Subject|0
1485373|NCT00569803|4895414|P1|Overall Study|Withdrawal by Subject|0
1485374|NCT00569803|4895407|P8|Overall Study|injection syringe leaked during dosing|0
1485375|NCT00569803|4895408|P7|Overall Study|injection syringe leaked during dosing|0
1485376|NCT00569803|4895409|P6|Overall Study|injection syringe leaked during dosing|0
1485377|NCT00569803|4895410|P5|Overall Study|injection syringe leaked during dosing|0
1485378|NCT00569803|4895411|P4|Overall Study|injection syringe leaked during dosing|1
1485379|NCT00569803|4895412|P3|Overall Study|injection syringe leaked during dosing|0
1485380|NCT00569803|4895413|P2|Overall Study|injection syringe leaked during dosing|0
1485381|NCT00569803|4895414|P1|Overall Study|injection syringe leaked during dosing|0
1485382|NCT00569803|4895407|P8|Overall Study|Lost to Follow-up|0
1485383|NCT00569803|4895408|P7|Overall Study|Lost to Follow-up|0
1485384|NCT00569803|4895409|P6|Overall Study|Lost to Follow-up|0
1485385|NCT00569803|4895410|P5|Overall Study|Lost to Follow-up|0
1485386|NCT00569803|4895411|P4|Overall Study|Lost to Follow-up|0
1485387|NCT00569803|4895412|P3|Overall Study|Lost to Follow-up|0
1485388|NCT00569803|4895413|P2|Overall Study|Lost to Follow-up|0
1485389|NCT00569803|4895414|P1|Overall Study|Lost to Follow-up|1
1485390|NCT00569777|4895541|P2|Overall Study|pregnant|0
1485391|NCT00569777|4895542|P1|Overall Study|pregnant|1
1485392|NCT00569777|4895541|P2|Overall Study|did not meet exclusion criteria|2
1485393|NCT00569777|4895542|P1|Overall Study|did not meet exclusion criteria|1
1485394|NCT00569777|4895541|P2|Overall Study|scheduled eye surgery|1
1485395|NCT00569777|4895542|P1|Overall Study|scheduled eye surgery|0
1485396|NCT00569777|4895541|P2|Overall Study|Lost to Follow-up|0
1485397|NCT00569777|4895542|P1|Overall Study|Lost to Follow-up|1
1485398|NCT00569777|4895541|P2|Overall Study|Adverse Event|0
1485399|NCT00569777|4895542|P1|Overall Study|Adverse Event|3
1485400|NCT00569777|4895541|P2|Overall Study|Withdrawal by Subject|0
1485401|NCT00569777|4895542|P1|Overall Study|Withdrawal by Subject|4
1485402|NCT00569582|4895593|P1|Overall Study|Subject was non-compliant.|1
1485403|NCT00569582|4895593|P1|Overall Study|Subject was too ill to travel.|1
1485404|NCT00569582|4895593|P1|Overall Study|Adverse Event|7
1485405|NCT00569582|4895593|P1|Overall Study|Death|2
1485406|NCT00569582|4895593|P1|Overall Study|Withdrawal by Subject|5
1485407|NCT00569374|4895609|P1|Overall Study|Withdrawal by Subject|4
1485408|NCT00569270|4895628|P2|Period: First Intervention|Protocol Violation|1
1485409|NCT00569270|4895629|P1|Period: First Intervention|Protocol Violation|0
1485410|NCT00569231|4895664|P1|Overall Study|Non-compliance|2
1485411|NCT00569231|4895664|P1|Overall Study|Car accident injury|1
1485412|NCT00569231|4895664|P1|Overall Study|Withdrawal by Subject|1
1485413|NCT00569231|4895664|P1|Overall Study|Airfare expense|2
1485414|NCT00569231|4895664|P1|Overall Study|Study unrelated surgery|1
1485415|NCT00569166|4895702|P3|Overall Study|Lost to Follow-up|1
1485416|NCT00569166|4895703|P2|Overall Study|Lost to Follow-up|1
1485417|NCT00569166|4895704|P1|Overall Study|Lost to Follow-up|2
1485418|NCT00569166|4895702|P3|Overall Study|Withdrawal by Subject|3
1485419|NCT00569166|4895703|P2|Overall Study|Withdrawal by Subject|5
1485420|NCT00569166|4895704|P1|Overall Study|Withdrawal by Subject|7
1485421|NCT00569127|4895738|P2|Overall Study|Still on Treatment|3
1485422|NCT00569127|4895739|P1|Overall Study|Still on Treatment|7
1485423|NCT00569127|4895738|P2|Overall Study|Not Eligible|11
1485424|NCT00569127|4895739|P1|Overall Study|Not Eligible|14
1485425|NCT00569127|4895738|P2|Overall Study|Lost to Follow-up|3
1485426|NCT00569127|4895739|P1|Overall Study|Lost to Follow-up|0
1485427|NCT00569127|4895738|P2|Overall Study|Not Specified|19
1485428|NCT00569127|4895739|P1|Overall Study|Not Specified|20
1485429|NCT00569127|4895738|P2|Overall Study|Death|3
1485430|NCT00569127|4895739|P1|Overall Study|Death|4
1485431|NCT00569127|4895738|P2|Overall Study|Progression|100
1485432|NCT00569127|4895739|P1|Overall Study|Progression|99
1485433|NCT00569127|4895738|P2|Overall Study|Withdrawal by Subject|27
1485434|NCT00569127|4895739|P1|Overall Study|Withdrawal by Subject|13
1485435|NCT00569127|4895738|P2|Overall Study|Adverse Event|47
1485436|NCT00569127|4895739|P1|Overall Study|Adverse Event|57
1485437|NCT00568958|4895774|P2|Follow-Up|Family Emergency|0
1485438|NCT00568958|4895775|P1|Follow-Up|Family Emergency|1
1485439|NCT00568958|4895774|P2|Follow-Up|Physician Decision|1
1485440|NCT00568958|4895775|P1|Follow-Up|Physician Decision|1
1485441|NCT00568958|4895774|P2|Follow-Up|Withdrawal by Subject|3
1485442|NCT00568958|4895775|P1|Follow-Up|Withdrawal by Subject|6
1485443|NCT00568958|4895774|P2|Allocation|Physician Decision|0
1485444|NCT00568958|4895775|P1|Allocation|Physician Decision|2
1485445|NCT00568958|4895774|P2|Allocation|Withdrawal by Subject|3
1485446|NCT00568958|4895775|P1|Allocation|Withdrawal by Subject|7
1485447|NCT00568776|4895808|P4|Overall Study|Miscellaeneous|4
1485448|NCT00568776|4895809|P3|Overall Study|Miscellaeneous|1
1485449|NCT00568776|4895810|P2|Overall Study|Miscellaeneous|3
1485450|NCT00568776|4895811|P1|Overall Study|Miscellaeneous|3
1485451|NCT00568776|4895808|P4|Overall Study|Sponsor Decision|42
1485452|NCT00568776|4895809|P3|Overall Study|Sponsor Decision|41
1485453|NCT00568776|4895810|P2|Overall Study|Sponsor Decision|2
1485454|NCT00568776|4895811|P1|Overall Study|Sponsor Decision|2
1485455|NCT00568776|4895808|P4|Overall Study|Loss of Caregiver|2
1485456|NCT00568776|4895809|P3|Overall Study|Loss of Caregiver|1
1485457|NCT00568776|4895810|P2|Overall Study|Loss of Caregiver|2
1485458|NCT00568776|4895811|P1|Overall Study|Loss of Caregiver|0
1485459|NCT00568776|4895808|P4|Overall Study|Withdrawal by Subject|7
1485460|NCT00568776|4895809|P3|Overall Study|Withdrawal by Subject|13
1485461|NCT00568776|4895810|P2|Overall Study|Withdrawal by Subject|15
1485462|NCT00568776|4895811|P1|Overall Study|Withdrawal by Subject|13
1485463|NCT00568776|4895808|P4|Overall Study|Protocol Violation|1
1485464|NCT00568776|4895809|P3|Overall Study|Protocol Violation|1
1485465|NCT00568776|4895810|P2|Overall Study|Protocol Violation|0
1485466|NCT00568776|4895811|P1|Overall Study|Protocol Violation|1
1485467|NCT00568776|4895808|P4|Overall Study|Lost to Follow-up|1
1485468|NCT00568776|4895809|P3|Overall Study|Lost to Follow-up|1
1485469|NCT00568776|4895810|P2|Overall Study|Lost to Follow-up|1
1485470|NCT00568776|4895811|P1|Overall Study|Lost to Follow-up|1
1485471|NCT00568776|4895808|P4|Overall Study|Lack of Efficacy|4
1485472|NCT00568776|4895809|P3|Overall Study|Lack of Efficacy|2
1485473|NCT00568776|4895810|P2|Overall Study|Lack of Efficacy|2
1485474|NCT00568776|4895811|P1|Overall Study|Lack of Efficacy|2
1485475|NCT00568776|4895808|P4|Overall Study|Physician Decision|0
1485476|NCT00568776|4895809|P3|Overall Study|Physician Decision|0
1485477|NCT00568776|4895810|P2|Overall Study|Physician Decision|2
1485478|NCT00568776|4895811|P1|Overall Study|Physician Decision|0
1485479|NCT00568776|4895808|P4|Overall Study|Death|3
1485480|NCT00568776|4895809|P3|Overall Study|Death|4
1485481|NCT00568776|4895810|P2|Overall Study|Death|1
1485482|NCT00568776|4895811|P1|Overall Study|Death|0
1485483|NCT00568776|4895808|P4|Overall Study|Adverse Event|8
1485484|NCT00568776|4895809|P3|Overall Study|Adverse Event|10
1485485|NCT00568776|4895810|P2|Overall Study|Adverse Event|8
1485486|NCT00568776|4895811|P1|Overall Study|Adverse Event|8
1485487|NCT00568685|4895848|P3|Overall Study|Protocol Violation|0
1485488|NCT00568685|4895849|P2|Overall Study|Protocol Violation|0
1485489|NCT00568685|4895850|P1|Overall Study|Protocol Violation|1
1485490|NCT00568685|4895848|P3|Overall Study|Withdrawal by Subject|2
1485491|NCT00568685|4895849|P2|Overall Study|Withdrawal by Subject|2
1485492|NCT00568685|4895850|P1|Overall Study|Withdrawal by Subject|7
1485493|NCT00568685|4895848|P3|Overall Study|Adverse Event|3
1485494|NCT00568685|4895849|P2|Overall Study|Adverse Event|3
1485495|NCT00568685|4895850|P1|Overall Study|Adverse Event|2
1485496|NCT00568555|4895884|P2|Overall Study|Withdrawal by Subject|1
1485497|NCT00568555|4895885|P1|Overall Study|Withdrawal by Subject|1
1485498|NCT00568451|4895903|P4|Overall Study|Disease Progression|7
1485499|NCT00568451|4895904|P3|Overall Study|Disease Progression|2
1485500|NCT00568451|4895905|P2|Overall Study|Disease Progression|0
1485501|NCT00568451|4895906|P1|Overall Study|Disease Progression|0
1485502|NCT00568399|4895922|P1|Overall Study|Withdrawal by Subject|8
1485503|NCT00568399|4895922|P1|Overall Study|Adverse Event|5
1485504|NCT00568399|4895922|P1|Overall Study|Death|2
1485505|NCT00568334|4895937|P2|Overall Study|Lost to Follow-up|0
1485506|NCT00568334|4895938|P1|Overall Study|Lost to Follow-up|1
1485507|NCT00568334|4895937|P2|Overall Study|Withdrawal by Subject|1
1485508|NCT00568334|4895938|P1|Overall Study|Withdrawal by Subject|0
1485509|NCT00568178|4895964|P6|Open Label Extension|Withdrawal by Subject|4
1485510|NCT00568178|4895965|P5|Open Label Extension|Withdrawal by Subject|4
1485511|NCT00568178|4895966|P4|Open Label Extension|Withdrawal by Subject|0
1485512|NCT00568178|4895967|P3|Open Label Extension|Withdrawal by Subject|0
1485513|NCT00568178|4895968|P2|Open Label Extension|Withdrawal by Subject|0
1485514|NCT00568178|4895969|P1|Open Label Extension|Withdrawal by Subject|0
1485515|NCT00568178|4895964|P6|Open Label Extension|Termination of Trial|47
1485516|NCT00568178|4895965|P5|Open Label Extension|Termination of Trial|45
1485517|NCT00568178|4895966|P4|Open Label Extension|Termination of Trial|0
1485518|NCT00568178|4895967|P3|Open Label Extension|Termination of Trial|0
1485519|NCT00568178|4895968|P2|Open Label Extension|Termination of Trial|0
1485520|NCT00568178|4895969|P1|Open Label Extension|Termination of Trial|0
1485521|NCT00568178|4895964|P6|Open Label Extension|Progressive Disease|1
1485522|NCT00568178|4895965|P5|Open Label Extension|Progressive Disease|3
1485523|NCT00568178|4895966|P4|Open Label Extension|Progressive Disease|0
1485524|NCT00568178|4895967|P3|Open Label Extension|Progressive Disease|0
1485525|NCT00568178|4895968|P2|Open Label Extension|Progressive Disease|0
1485526|NCT00568178|4895969|P1|Open Label Extension|Progressive Disease|0
1485527|NCT00568178|4895964|P6|Open Label Extension|Pregnancy|1
1485528|NCT00568178|4895965|P5|Open Label Extension|Pregnancy|0
1485529|NCT00568178|4895966|P4|Open Label Extension|Pregnancy|0
1485530|NCT00568178|4895967|P3|Open Label Extension|Pregnancy|0
1485531|NCT00568178|4895968|P2|Open Label Extension|Pregnancy|0
1485532|NCT00568178|4895969|P1|Open Label Extension|Pregnancy|0
1485533|NCT00568178|4895964|P6|Open Label Extension|Physician Decision|8
1485534|NCT00568178|4895965|P5|Open Label Extension|Physician Decision|9
1485535|NCT00568178|4895966|P4|Open Label Extension|Physician Decision|0
1485536|NCT00568178|4895967|P3|Open Label Extension|Physician Decision|0
1485537|NCT00568178|4895968|P2|Open Label Extension|Physician Decision|0
1485538|NCT00568178|4895969|P1|Open Label Extension|Physician Decision|0
1485539|NCT00568178|4895964|P6|Open Label Extension|Lost to Follow-up|11
1485540|NCT00568178|4895965|P5|Open Label Extension|Lost to Follow-up|6
1485541|NCT00568178|4895966|P4|Open Label Extension|Lost to Follow-up|0
1485542|NCT00568178|4895967|P3|Open Label Extension|Lost to Follow-up|0
1485543|NCT00568178|4895968|P2|Open Label Extension|Lost to Follow-up|0
1485544|NCT00568178|4895969|P1|Open Label Extension|Lost to Follow-up|0
1485545|NCT00568178|4895964|P6|Open Label Extension|Protocol Violation|0
1485546|NCT00568178|4895965|P5|Open Label Extension|Protocol Violation|1
1485547|NCT00568178|4895966|P4|Open Label Extension|Protocol Violation|0
1485548|NCT00568178|4895967|P3|Open Label Extension|Protocol Violation|0
1485549|NCT00568178|4895968|P2|Open Label Extension|Protocol Violation|0
1485550|NCT00568178|4895969|P1|Open Label Extension|Protocol Violation|0
1485551|NCT00568178|4895964|P6|Open Label Extension|Adverse Event|8
1485552|NCT00568178|4895965|P5|Open Label Extension|Adverse Event|11
1485553|NCT00568178|4895966|P4|Open Label Extension|Adverse Event|0
1485554|NCT00568178|4895967|P3|Open Label Extension|Adverse Event|0
1485555|NCT00568178|4895968|P2|Open Label Extension|Adverse Event|0
1485556|NCT00568178|4895969|P1|Open Label Extension|Adverse Event|0
1485557|NCT00568178|4895964|P6|Double Blind Base Study|Progressive Disease|0
1485558|NCT00568178|4895965|P5|Double Blind Base Study|Progressive Disease|0
1485559|NCT00568178|4895966|P4|Double Blind Base Study|Progressive Disease|1
1485560|NCT00568178|4895967|P3|Double Blind Base Study|Progressive Disease|0
1485561|NCT00568178|4895968|P2|Double Blind Base Study|Progressive Disease|0
1485562|NCT00568178|4895969|P1|Double Blind Base Study|Progressive Disease|0
1485563|NCT00568178|4895964|P6|Double Blind Base Study|Withdrawal by Subject|0
1485564|NCT00568178|4895965|P5|Double Blind Base Study|Withdrawal by Subject|0
1485565|NCT00568178|4895966|P4|Double Blind Base Study|Withdrawal by Subject|0
1485566|NCT00568178|4895967|P3|Double Blind Base Study|Withdrawal by Subject|0
1485567|NCT00568178|4895968|P2|Double Blind Base Study|Withdrawal by Subject|1
1485568|NCT00568178|4895969|P1|Double Blind Base Study|Withdrawal by Subject|1
1485569|NCT00568178|4895964|P6|Double Blind Base Study|Protocol Violation|0
1485570|NCT00568178|4895965|P5|Double Blind Base Study|Protocol Violation|0
1485571|NCT00568178|4895966|P4|Double Blind Base Study|Protocol Violation|0
1485572|NCT00568178|4895967|P3|Double Blind Base Study|Protocol Violation|0
1485573|NCT00568178|4895968|P2|Double Blind Base Study|Protocol Violation|2
1485574|NCT00568178|4895969|P1|Double Blind Base Study|Protocol Violation|3
1485575|NCT00568178|4895964|P6|Double Blind Base Study|Physician Decision|0
1485576|NCT00568178|4895965|P5|Double Blind Base Study|Physician Decision|0
1485577|NCT00568178|4895966|P4|Double Blind Base Study|Physician Decision|1
1485578|NCT00568178|4895967|P3|Double Blind Base Study|Physician Decision|0
1485579|NCT00568178|4895968|P2|Double Blind Base Study|Physician Decision|1
1485580|NCT00568178|4895969|P1|Double Blind Base Study|Physician Decision|1
1485581|NCT00568178|4895964|P6|Double Blind Base Study|Lost to Follow-up|0
1485582|NCT00568178|4895965|P5|Double Blind Base Study|Lost to Follow-up|0
1485583|NCT00568178|4895966|P4|Double Blind Base Study|Lost to Follow-up|1
1485584|NCT00568178|4895967|P3|Double Blind Base Study|Lost to Follow-up|0
1485585|NCT00568178|4895968|P2|Double Blind Base Study|Lost to Follow-up|0
1485586|NCT00568178|4895969|P1|Double Blind Base Study|Lost to Follow-up|1
1485587|NCT00568178|4895964|P6|Double Blind Base Study|Adverse Event|0
1485588|NCT00568178|4895965|P5|Double Blind Base Study|Adverse Event|0
1485589|NCT00568178|4895966|P4|Double Blind Base Study|Adverse Event|2
1485590|NCT00568178|4895967|P3|Double Blind Base Study|Adverse Event|1
1485591|NCT00568178|4895968|P2|Double Blind Base Study|Adverse Event|2
1485592|NCT00568178|4895969|P1|Double Blind Base Study|Adverse Event|0
1485593|NCT00568061|4896000|P2|Overall Study|Adverse Event|1
1485594|NCT00568061|4896001|P1|Overall Study|Adverse Event|0
1485595|NCT00568061|4896000|P2|Overall Study|Inclusion / exclusion criteria|1
1485596|NCT00568061|4896001|P1|Overall Study|Inclusion / exclusion criteria|5
1485597|NCT00567996|4896045|P3|Overall Study|Patient's inability to use the device|0
1485598|NCT00567996|4896046|P2|Overall Study|Patient's inability to use the device|1
1485599|NCT00567996|4896047|P1|Overall Study|Patient's inability to use the device|0
1485600|NCT00567996|4896045|P3|Overall Study|Death|2
1485601|NCT00567996|4896046|P2|Overall Study|Death|0
1485602|NCT00567996|4896047|P1|Overall Study|Death|1
1485603|NCT00567996|4896045|P3|Overall Study|Administrative problems|0
1485604|NCT00567996|4896046|P2|Overall Study|Administrative problems|1
1485605|NCT00567996|4896047|P1|Overall Study|Administrative problems|1
1485606|NCT00567996|4896045|P3|Overall Study|Unsatisfactory therapeutic effect|15
1485607|NCT00567996|4896046|P2|Overall Study|Unsatisfactory therapeutic effect|2
1485608|NCT00567996|4896047|P1|Overall Study|Unsatisfactory therapeutic effect|1
1485609|NCT00567996|4896045|P3|Overall Study|Lost to Follow-up|2
1485610|NCT00567996|4896046|P2|Overall Study|Lost to Follow-up|5
1485611|NCT00567996|4896047|P1|Overall Study|Lost to Follow-up|2
1485612|NCT00567996|4896045|P3|Overall Study|Abnormal test procedure result(s)|1
1485613|NCT00567996|4896046|P2|Overall Study|Abnormal test procedure result(s)|1
1485614|NCT00567996|4896047|P1|Overall Study|Abnormal test procedure result(s)|2
1485615|NCT00567996|4896045|P3|Overall Study|Abnormal Lab value(s)|2
1485616|NCT00567996|4896046|P2|Overall Study|Abnormal Lab value(s)|1
1485617|NCT00567996|4896047|P1|Overall Study|Abnormal Lab value(s)|2
1485618|NCT00567996|4896045|P3|Overall Study|Withdrawal by Subject|22
1485619|NCT00567996|4896046|P2|Overall Study|Withdrawal by Subject|12
1485620|NCT00567996|4896047|P1|Overall Study|Withdrawal by Subject|8
1485621|NCT00567996|4896045|P3|Overall Study|Protocol Deviation|13
1485622|NCT00567996|4896046|P2|Overall Study|Protocol Deviation|11
1485623|NCT00567996|4896047|P1|Overall Study|Protocol Deviation|9
1485624|NCT00567996|4896045|P3|Overall Study|Adverse Event|13
1485625|NCT00567996|4896046|P2|Overall Study|Adverse Event|16
1485626|NCT00567996|4896047|P1|Overall Study|Adverse Event|18
1485627|NCT00567892|4896063|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
1485628|NCT00567892|4896064|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1485629|NCT00567892|4896065|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1485630|NCT00567892|4896066|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1485631|NCT00567892|4896063|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
1485632|NCT00567892|4896064|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
1485633|NCT00567892|4896065|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1485634|NCT00567892|4896066|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1485635|NCT00567879|4896084|P6|Overall Study|Disease progression|3
1485636|NCT00567879|4896085|P5|Overall Study|Disease progression|11
1485637|NCT00567879|4896086|P4|Overall Study|Disease progression|5
1485638|NCT00567879|4896087|P3|Overall Study|Disease progression|15
1485639|NCT00567879|4896088|P2|Overall Study|Disease progression|7
1485640|NCT00567879|4896089|P1|Overall Study|Disease progression|5
1485641|NCT00567879|4896084|P6|Overall Study|New cancer therapy|0
1485642|NCT00567879|4896085|P5|Overall Study|New cancer therapy|0
1485643|NCT00567879|4896086|P4|Overall Study|New cancer therapy|0
1485644|NCT00567879|4896087|P3|Overall Study|New cancer therapy|1
1485645|NCT00567879|4896088|P2|Overall Study|New cancer therapy|0
1485646|NCT00567879|4896089|P1|Overall Study|New cancer therapy|0
1485647|NCT00567879|4896084|P6|Overall Study|Withdrawal by Subject|0
1485648|NCT00567879|4896085|P5|Overall Study|Withdrawal by Subject|0
1485649|NCT00567879|4896086|P4|Overall Study|Withdrawal by Subject|1
1485650|NCT00567879|4896087|P3|Overall Study|Withdrawal by Subject|3
1485651|NCT00567879|4896088|P2|Overall Study|Withdrawal by Subject|0
1485652|NCT00567879|4896089|P1|Overall Study|Withdrawal by Subject|0
1485653|NCT00567879|4896084|P6|Overall Study|Abnormal test procedure(s)|0
1485654|NCT00567879|4896085|P5|Overall Study|Abnormal test procedure(s)|0
1485655|NCT00567879|4896086|P4|Overall Study|Abnormal test procedure(s)|0
1485656|NCT00567879|4896087|P3|Overall Study|Abnormal test procedure(s)|1
1485657|NCT00567879|4896088|P2|Overall Study|Abnormal test procedure(s)|0
1485658|NCT00567879|4896089|P1|Overall Study|Abnormal test procedure(s)|0
1485659|NCT00567879|4896084|P6|Overall Study|Adverse Event|0
1485660|NCT00567879|4896085|P5|Overall Study|Adverse Event|1
1485661|NCT00567879|4896086|P4|Overall Study|Adverse Event|0
1485662|NCT00567879|4896087|P3|Overall Study|Adverse Event|1
1485663|NCT00567879|4896088|P2|Overall Study|Adverse Event|0
1485664|NCT00567879|4896089|P1|Overall Study|Adverse Event|2
1485665|NCT00567593|4896156|P1|Overall Study|Physician Decision|1
1485666|NCT00567593|4896156|P1|Overall Study|Adverse Event|1
1485667|NCT00567567|4896163|P3|Overall Study|Unable adequate stem cell for transplant|2
1485668|NCT00567567|4896164|P2|Overall Study|Unable adequate stem cell for transplant|0
1485669|NCT00567567|4896165|P1|Overall Study|Unable adequate stem cell for transplant|0
1485670|NCT00567567|4896163|P3|Overall Study|Enrolled another COG therapeutic study|0
1485671|NCT00567567|4896164|P2|Overall Study|Enrolled another COG therapeutic study|80
1485672|NCT00567567|4896165|P1|Overall Study|Enrolled another COG therapeutic study|99
1485673|NCT00567567|4896163|P3|Overall Study|Refusal by patient/parent/guardian|122
1485674|NCT00567567|4896164|P2|Overall Study|Refusal by patient/parent/guardian|16
1485675|NCT00567567|4896165|P1|Overall Study|Refusal by patient/parent/guardian|9
1485676|NCT00567567|4896163|P3|Overall Study|Ineligible|9
1485677|NCT00567567|4896164|P2|Overall Study|Ineligible|0
1485678|NCT00567567|4896165|P1|Overall Study|Ineligible|4
1485679|NCT00567567|4896163|P3|Overall Study|Withdrawal by Subject|2
1485680|NCT00567567|4896164|P2|Overall Study|Withdrawal by Subject|0
1485681|NCT00567567|4896165|P1|Overall Study|Withdrawal by Subject|0
1485682|NCT00567567|4896163|P3|Overall Study|Physician Decision|84
1485683|NCT00567567|4896164|P2|Overall Study|Physician Decision|18
1485684|NCT00567567|4896165|P1|Overall Study|Physician Decision|16
1485685|NCT00567567|4896163|P3|Overall Study|Lost to Follow-up|1
1485686|NCT00567567|4896164|P2|Overall Study|Lost to Follow-up|0
1485687|NCT00567567|4896165|P1|Overall Study|Lost to Follow-up|0
1485688|NCT00567567|4896163|P3|Overall Study|Lack of Efficacy|48
1485689|NCT00567567|4896164|P2|Overall Study|Lack of Efficacy|17
1485690|NCT00567567|4896165|P1|Overall Study|Lack of Efficacy|16
1485691|NCT00567567|4896163|P3|Overall Study|Death|5
1485692|NCT00567567|4896164|P2|Overall Study|Death|1
1485693|NCT00567567|4896165|P1|Overall Study|Death|8
1485694|NCT00567567|4896163|P3|Overall Study|Adverse Event|5
1485695|NCT00567567|4896164|P2|Overall Study|Adverse Event|2
1485696|NCT00567567|4896165|P1|Overall Study|Adverse Event|0
1485697|NCT00567541|4896191|P2|Overall Study|Adverse Event|1
1485698|NCT00567541|4896192|P1|Overall Study|Adverse Event|0
1485699|NCT00567502|4896202|P4|Overall Study|Never Initiated Treatment|72
1485700|NCT00567502|4896203|P3|Overall Study|Never Initiated Treatment|0
1485701|NCT00567502|4896204|P2|Overall Study|Never Initiated Treatment|0
1485702|NCT00567502|4896205|P1|Overall Study|Never Initiated Treatment|0
1485703|NCT00567502|4896202|P4|Overall Study|Sponsor request|1
1485704|NCT00567502|4896203|P3|Overall Study|Sponsor request|30
1485705|NCT00567502|4896204|P2|Overall Study|Sponsor request|0
1485706|NCT00567502|4896205|P1|Overall Study|Sponsor request|9
1485707|NCT00567502|4896202|P4|Overall Study|Participant request|1
1485708|NCT00567502|4896203|P3|Overall Study|Participant request|33
1485709|NCT00567502|4896204|P2|Overall Study|Participant request|1
1485710|NCT00567502|4896205|P1|Overall Study|Participant request|12
1485711|NCT00567502|4896202|P4|Overall Study|Other|6
1485712|NCT00567502|4896203|P3|Overall Study|Other|134
1485713|NCT00567502|4896204|P2|Overall Study|Other|2
1485714|NCT00567502|4896205|P1|Overall Study|Other|64
1485715|NCT00567502|4896202|P4|Overall Study|Death|5
1485716|NCT00567502|4896203|P3|Overall Study|Death|360
1485717|NCT00567502|4896204|P2|Overall Study|Death|16
1485718|NCT00567502|4896205|P1|Overall Study|Death|65
1485719|NCT00567502|4896202|P4|Overall Study|Lost to Follow-up|2
1485720|NCT00567502|4896203|P3|Overall Study|Lost to Follow-up|351
1485721|NCT00567502|4896204|P2|Overall Study|Lost to Follow-up|14
1485722|NCT00567502|4896205|P1|Overall Study|Lost to Follow-up|91
1485723|NCT00567476|4896242|P2|Overall Study|Non-adherence to protocol|1
1485724|NCT00567476|4896243|P1|Overall Study|Non-adherence to protocol|0
1485725|NCT00567476|4896242|P2|Overall Study|Medical Decision|1
1485726|NCT00567476|4896243|P1|Overall Study|Medical Decision|0
1485727|NCT00567476|4896242|P2|Overall Study|Administrative issues|0
1485728|NCT00567476|4896243|P1|Overall Study|Administrative issues|1
1485729|NCT00567476|4896242|P2|Overall Study|Lost to Follow-up|1
1485730|NCT00567476|4896243|P1|Overall Study|Lost to Follow-up|0
1485731|NCT00567476|4896242|P2|Overall Study|Protocol Violation|1
1485732|NCT00567476|4896243|P1|Overall Study|Protocol Violation|4
1485733|NCT00567476|4896242|P2|Overall Study|Pregnancy|0
1485734|NCT00567476|4896243|P1|Overall Study|Pregnancy|1
1485735|NCT00567476|4896242|P2|Overall Study|Adverse Event|0
1485736|NCT00567476|4896243|P1|Overall Study|Adverse Event|2
1485737|NCT00567268|4896285|P1|Overall Study|"Safety Evaluation Not Assessable"|1
1485738|NCT00567268|4896285|P1|Overall Study|No Drug Administration|4
1485739|NCT00567268|4896285|P1|Overall Study|No Visit After First Day of Treatment|2
1485740|NCT00567268|4896285|P1|Overall Study|Lost to Follow-up|36
1485741|NCT00567268|4896285|P1|Overall Study|Protocol Violation|7
1485742|NCT00567255|4896336|P2|Overall Study|Drug noncompliance,moved,other|15
1485743|NCT00567255|4896337|P1|Overall Study|Drug noncompliance,moved,other|25
1485744|NCT00567255|4896336|P2|Overall Study|Pregnancy|0
1485745|NCT00567255|4896337|P1|Overall Study|Pregnancy|6
1485746|NCT00567255|4896336|P2|Overall Study|Protocol Violation|8
1485747|NCT00567255|4896337|P1|Overall Study|Protocol Violation|20
1485748|NCT00567255|4896336|P2|Overall Study|Lack of Efficacy|33
1485749|NCT00567255|4896337|P1|Overall Study|Lack of Efficacy|19
1485750|NCT00567255|4896336|P2|Overall Study|Withdrawal by Subject|56
1485751|NCT00567255|4896337|P1|Overall Study|Withdrawal by Subject|75
1485752|NCT00567255|4896336|P2|Overall Study|Lost to Follow-up|48
1485753|NCT00567255|4896337|P1|Overall Study|Lost to Follow-up|77
1485754|NCT00567255|4896336|P2|Overall Study|Adverse Event|68
1485755|NCT00567255|4896337|P1|Overall Study|Adverse Event|241
1485756|NCT00567190|4896400|P2|Overall Study|Withdrew Consent or Lost to Follow-up|43
1485757|NCT00567190|4896401|P1|Overall Study|Withdrew Consent or Lost to Follow-up|42
1485758|NCT00567190|4896400|P2|Overall Study|Death|221
1485759|NCT00567190|4896401|P1|Overall Study|Death|168
1485760|NCT00567164|4896421|P3|Overall Study|Missing|0
1485761|NCT00567164|4896422|P2|Overall Study|Missing|0
1485762|NCT00567164|4896423|P1|Overall Study|Missing|1
1485763|NCT00567164|4896421|P3|Overall Study|Primary Reason coded as 'Other'|16
1485764|NCT00567164|4896422|P2|Overall Study|Primary Reason coded as 'Other'|8
1485765|NCT00567164|4896423|P1|Overall Study|Primary Reason coded as 'Other'|37
1485766|NCT00567164|4896421|P3|Overall Study|Pregnancy|6
1485767|NCT00567164|4896422|P2|Overall Study|Pregnancy|4
1485768|NCT00567164|4896423|P1|Overall Study|Pregnancy|20
1485769|NCT00567164|4896421|P3|Overall Study|Lost to Follow-up|21
1485770|NCT00567164|4896422|P2|Overall Study|Lost to Follow-up|23
1485771|NCT00567164|4896423|P1|Overall Study|Lost to Follow-up|202
1485772|NCT00567164|4896421|P3|Overall Study|Death|1
1485773|NCT00567164|4896422|P2|Overall Study|Death|0
1485774|NCT00567164|4896423|P1|Overall Study|Death|0
1485775|NCT00567164|4896421|P3|Overall Study|Adverse Event|9
1485776|NCT00567164|4896422|P2|Overall Study|Adverse Event|13
1485777|NCT00567164|4896423|P1|Overall Study|Adverse Event|92
1485778|NCT00567164|4896421|P3|Overall Study|Protocol Violation|2
1485779|NCT00567164|4896422|P2|Overall Study|Protocol Violation|4
1485780|NCT00567164|4896423|P1|Overall Study|Protocol Violation|23
1485781|NCT00567164|4896421|P3|Overall Study|Withdrawal by Subject|17
1485782|NCT00567164|4896422|P2|Overall Study|Withdrawal by Subject|21
1485783|NCT00567164|4896423|P1|Overall Study|Withdrawal by Subject|171
1485784|NCT00567112|4896495|P3|Washout Period 3 (3 Days)|Protocol Violation|0
1485785|NCT00567112|4896496|P2|Washout Period 3 (3 Days)|Protocol Violation|0
1485786|NCT00567112|4896497|P1|Washout Period 3 (3 Days)|Protocol Violation|1
1485787|NCT00567112|4896495|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
1485788|NCT00567112|4896496|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
1485789|NCT00567112|4896497|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
1485790|NCT00567112|4896495|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
1485791|NCT00567112|4896496|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
1485792|NCT00567112|4896497|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
1485793|NCT00566995|4896528|P1|Overall Study|Withdrew consent|4
1485794|NCT00566995|4896528|P1|Overall Study|Physician Decision|1
1485795|NCT00566995|4896528|P1|Overall Study|Toxicity|3
1485796|NCT00566982|4896535|P2|Overall Study|Other-family problems & doctor's request|2
1485797|NCT00566982|4896536|P1|Overall Study|Other-family problems & doctor's request|0
1485798|NCT00566982|4896535|P2|Overall Study|Lost to Follow-up|1
1485799|NCT00566982|4896536|P1|Overall Study|Lost to Follow-up|0
1485800|NCT00566982|4896535|P2|Overall Study|Protocol Violation|4
1485801|NCT00566982|4896536|P1|Overall Study|Protocol Violation|1
1485802|NCT00566982|4896535|P2|Overall Study|Withdrawal by Subject|14
1485803|NCT00566982|4896536|P1|Overall Study|Withdrawal by Subject|1
1485804|NCT00566982|4896535|P2|Overall Study|Adverse Event|48
1485805|NCT00566982|4896536|P1|Overall Study|Adverse Event|6
1485806|NCT00566852|4896601|P2|Overall Study|Missing reason not reported|20
1485807|NCT00566852|4896602|P1|Overall Study|Missing reason not reported|16
1485808|NCT00566852|4896601|P2|Overall Study|Missing reason not specified|2
1485809|NCT00566852|4896602|P1|Overall Study|Missing reason not specified|1
1485810|NCT00566852|4896601|P2|Overall Study|Not tested due to disability|12
1485811|NCT00566852|4896602|P1|Overall Study|Not tested due to disability|6
1485812|NCT00566852|4896601|P2|Overall Study|Patient refusal|37
1485813|NCT00566852|4896602|P1|Overall Study|Patient refusal|37
1485814|NCT00566852|4896601|P2|Overall Study|Withdrawal by Subject|25
1485815|NCT00566852|4896602|P1|Overall Study|Withdrawal by Subject|30
1485816|NCT00566852|4896601|P2|Overall Study|Death|78
1485817|NCT00566852|4896602|P1|Overall Study|Death|95
1485818|NCT00566852|4896601|P2|Overall Study|Protocol Violation|24
1485819|NCT00566852|4896602|P1|Overall Study|Protocol Violation|22
1485820|NCT00566735|4896620|P2|Overall Study|Switched into a manic episode|1
1485821|NCT00566735|4896621|P1|Overall Study|Switched into a manic episode|0
1485822|NCT00566735|4896620|P2|Overall Study|Refused neuropsychological testing|5
1485823|NCT00566735|4896621|P1|Overall Study|Refused neuropsychological testing|2
1485824|NCT00566735|4896620|P2|Overall Study|Withdrawal by Subject|1
1485825|NCT00566735|4896621|P1|Overall Study|Withdrawal by Subject|0
1485826|NCT00566722|4896634|P3|Overall Study|Noncompliant with drug administration|1
1485827|NCT00566722|4896635|P2|Overall Study|Noncompliant with drug administration|0
1485828|NCT00566722|4896636|P1|Overall Study|Noncompliant with drug administration|0
1485829|NCT00566722|4896634|P3|Overall Study|Serious adverse event|0
1485830|NCT00566722|4896635|P2|Overall Study|Serious adverse event|1
1485831|NCT00566722|4896636|P1|Overall Study|Serious adverse event|0
1485832|NCT00566722|4896634|P3|Overall Study|Did not meet exclusion criteria|2
1485833|NCT00566722|4896635|P2|Overall Study|Did not meet exclusion criteria|0
1485834|NCT00566722|4896636|P1|Overall Study|Did not meet exclusion criteria|0
1485835|NCT00566722|4896634|P3|Overall Study|Lack of Efficacy|4
1485836|NCT00566722|4896635|P2|Overall Study|Lack of Efficacy|2
1485837|NCT00566722|4896636|P1|Overall Study|Lack of Efficacy|1
1485838|NCT00566722|4896634|P3|Overall Study|Lost to Follow-up|1
1485839|NCT00566722|4896635|P2|Overall Study|Lost to Follow-up|1
1485840|NCT00566722|4896636|P1|Overall Study|Lost to Follow-up|1
1485841|NCT00566722|4896634|P3|Overall Study|Withdrawal by Subject|1
1485842|NCT00566722|4896635|P2|Overall Study|Withdrawal by Subject|0
1485843|NCT00566722|4896636|P1|Overall Study|Withdrawal by Subject|0
1485844|NCT00566722|4896634|P3|Overall Study|Adverse Event|0
1485845|NCT00566722|4896635|P2|Overall Study|Adverse Event|1
1485846|NCT00566722|4896636|P1|Overall Study|Adverse Event|0
1485847|NCT00566709|4896682|P2|Overall Study|Protocol Violation|0
1485848|NCT00566709|4896683|P1|Overall Study|Protocol Violation|5
1485849|NCT00566696|4896699|P1|Overall Study|Non-Patient Donors|37
1485850|NCT00566696|4896699|P1|Overall Study|Physician Decision|1
1485851|NCT00566696|4896699|P1|Overall Study|Health Status Change|1
1485852|NCT00566696|4896699|P1|Overall Study|Muromonab not available|1
1485853|NCT00566696|4896699|P1|Overall Study|Met Exclusion Criteria|2
1485854|NCT00566631|4896707|P1|Part 2: Extension Phase|Other|5
1485855|NCT00566631|4896707|P1|Part 2: Extension Phase|Death|1
1485856|NCT00566631|4896707|P1|Part 2: Extension Phase|Lost to Follow-up|6
1485857|NCT00566631|4896707|P1|Part 2: Extension Phase|Adverse Event|11
1485858|NCT00566631|4896707|P1|Part 2: Extension Phase|Withdrawal by Subject|34
1485859|NCT00566631|4896707|P1|Part 2: Extension Phase|Lack of Efficacy|25
1485860|NCT00566631|4896707|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
1485861|NCT00566631|4896707|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
1485862|NCT00566631|4896707|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
1485863|NCT00566631|4896707|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
1485864|NCT00566631|4896707|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
1485865|NCT00566631|4896707|P1|Part 1: Core Treatment Phase|Adverse Event|9
1485866|NCT00566631|4896707|P1|Part 1: Core Treatment Phase|Physician Decision|1
1485867|NCT00566631|4896707|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
1485868|NCT00566527|4896734|P3|Overall Study|Withdrawal by Subject|43
1485869|NCT00566527|4896735|P2|Overall Study|Withdrawal by Subject|43
1485870|NCT00566527|4896736|P1|Overall Study|Withdrawal by Subject|6
1485871|NCT00566527|4896734|P3|Overall Study|Lost to Follow-up|4
1485872|NCT00566527|4896735|P2|Overall Study|Lost to Follow-up|4
1485873|NCT00566527|4896736|P1|Overall Study|Lost to Follow-up|3
1485874|NCT00566527|4896734|P3|Overall Study|Physician Decision|20
1485875|NCT00566527|4896735|P2|Overall Study|Physician Decision|8
1485876|NCT00566527|4896736|P1|Overall Study|Physician Decision|3
1485877|NCT00566527|4896734|P3|Overall Study|Adverse Event|1
1485878|NCT00566527|4896735|P2|Overall Study|Adverse Event|0
1485879|NCT00566527|4896736|P1|Overall Study|Adverse Event|2
1485880|NCT00566527|4896734|P3|Overall Study|Reason not provided|10
1485881|NCT00566527|4896735|P2|Overall Study|Reason not provided|11
1485882|NCT00566527|4896736|P1|Overall Study|Reason not provided|3
1485883|NCT00566254|4896797|P2|Overall Study|Not Specified|2
1485884|NCT00566254|4896798|P1|Overall Study|Not Specified|0
1485885|NCT00566254|4896797|P2|Overall Study|Lack of Efficacy|6
1485886|NCT00566254|4896798|P1|Overall Study|Lack of Efficacy|5
1485887|NCT00566254|4896797|P2|Overall Study|Withdrawal by Subject|2
1485888|NCT00566254|4896798|P1|Overall Study|Withdrawal by Subject|1
1485889|NCT00566254|4896797|P2|Overall Study|Protocol Violation|3
1485890|NCT00566254|4896798|P1|Overall Study|Protocol Violation|1
1485891|NCT00566254|4896797|P2|Overall Study|Adverse Event|1
1485892|NCT00566254|4896798|P1|Overall Study|Adverse Event|3
1485893|NCT00566228|4896812|P2|Overall Study|progressed before infusion could occur|1
1485894|NCT00566228|4896813|P1|Overall Study|progressed before infusion could occur|0
1485895|NCT00566228|4896812|P2|Overall Study|Unable to collect sufficient CD34 cells|2
1485896|NCT00566228|4896813|P1|Overall Study|Unable to collect sufficient CD34 cells|3
1485897|NCT00566228|4896812|P2|Overall Study|Attempt to mobilize stem cells failed|2
1485898|NCT00566228|4896813|P1|Overall Study|Attempt to mobilize stem cells failed|2
1485899|NCT00566228|4896812|P2|Overall Study|Withdrawal by Subject|0
1485900|NCT00566228|4896813|P1|Overall Study|Withdrawal by Subject|1
1485901|NCT00566111|4896846|P2|Overall Study|Adverse Event|2
1485902|NCT00566111|4896847|P1|Overall Study|Adverse Event|0
1485903|NCT00566020|4896861|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
1485904|NCT00566020|4896862|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
1485905|NCT00566020|4896861|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
1485906|NCT00566020|4896862|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
1485907|NCT00566020|4896861|P2|46-week Long-term Administration Phase|Physician Decision|7
1485908|NCT00566020|4896862|P1|46-week Long-term Administration Phase|Physician Decision|0
1485909|NCT00566020|4896861|P2|46-week Long-term Administration Phase|Adverse Event|7
1485910|NCT00566020|4896862|P1|46-week Long-term Administration Phase|Adverse Event|0
1485911|NCT00566020|4896861|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
1485912|NCT00566020|4896862|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
1485913|NCT00566020|4896861|P2|6-week Dosage Adjustment Phase|Adverse Event|0
1485914|NCT00566020|4896862|P1|6-week Dosage Adjustment Phase|Adverse Event|5
1485915|NCT00565812|4896942|P3|Overall Study|Physician Decision|0
1485916|NCT00565812|4896943|P2|Overall Study|Physician Decision|0
1485917|NCT00565812|4896944|P1|Overall Study|Physician Decision|2
1485918|NCT00565812|4896942|P3|Overall Study|Follow-up Visit Not Completed|1
1485919|NCT00565812|4896943|P2|Overall Study|Follow-up Visit Not Completed|0
1485920|NCT00565812|4896944|P1|Overall Study|Follow-up Visit Not Completed|2
1485921|NCT00565812|4896942|P3|Overall Study|Low Compliance|1
1485922|NCT00565812|4896943|P2|Overall Study|Low Compliance|0
1485923|NCT00565812|4896944|P1|Overall Study|Low Compliance|1
1485924|NCT00565812|4896942|P3|Overall Study|Surgical Intervention|2
1485925|NCT00565812|4896943|P2|Overall Study|Surgical Intervention|1
1485926|NCT00565812|4896944|P1|Overall Study|Surgical Intervention|0
1485927|NCT00565812|4896942|P3|Overall Study|Research Site Closure|8
1485928|NCT00565812|4896943|P2|Overall Study|Research Site Closure|1
1485929|NCT00565812|4896944|P1|Overall Study|Research Site Closure|6
1485930|NCT00565812|4896942|P3|Overall Study|Domestic Reasons|3
1485931|NCT00565812|4896943|P2|Overall Study|Domestic Reasons|1
1485932|NCT00565812|4896944|P1|Overall Study|Domestic Reasons|7
1485933|NCT00565812|4896942|P3|Overall Study|Sponsor Decision|1
1485934|NCT00565812|4896943|P2|Overall Study|Sponsor Decision|5
1485935|NCT00565812|4896944|P1|Overall Study|Sponsor Decision|1
1485936|NCT00565812|4896942|P3|Overall Study|Relocated Out of Area|9
1485937|NCT00565812|4896943|P2|Overall Study|Relocated Out of Area|8
1485938|NCT00565812|4896944|P1|Overall Study|Relocated Out of Area|5
1485939|NCT00565812|4896942|P3|Overall Study|Jury Duty|0
1485940|NCT00565812|4896943|P2|Overall Study|Jury Duty|0
1485941|NCT00565812|4896944|P1|Overall Study|Jury Duty|1
1485942|NCT00565812|4896942|P3|Overall Study|Adverse Event|40
1485943|NCT00565812|4896943|P2|Overall Study|Adverse Event|54
1485944|NCT00565812|4896944|P1|Overall Study|Adverse Event|41
1485945|NCT00565812|4896942|P3|Overall Study|Protocol Violation|4
1485946|NCT00565812|4896943|P2|Overall Study|Protocol Violation|6
1485947|NCT00565812|4896944|P1|Overall Study|Protocol Violation|2
1485948|NCT00565812|4896942|P3|Overall Study|Work Schedule|1
1485949|NCT00565812|4896943|P2|Overall Study|Work Schedule|3
1485950|NCT00565812|4896944|P1|Overall Study|Work Schedule|5
1485951|NCT00565812|4896942|P3|Overall Study|Withdrawal by Subject|48
1485952|NCT00565812|4896943|P2|Overall Study|Withdrawal by Subject|47
1485953|NCT00565812|4896944|P1|Overall Study|Withdrawal by Subject|58
1485954|NCT00565812|4896942|P3|Overall Study|Lost to Follow-up|8
1485955|NCT00565812|4896943|P2|Overall Study|Lost to Follow-up|8
1485956|NCT00565812|4896944|P1|Overall Study|Lost to Follow-up|10
1485957|NCT00565812|4896942|P3|Overall Study|Did not Meet Entrance Criteria|1
1485958|NCT00565812|4896943|P2|Overall Study|Did not Meet Entrance Criteria|0
1485959|NCT00565812|4896944|P1|Overall Study|Did not Meet Entrance Criteria|1
1485960|NCT00565812|4896942|P3|Overall Study|Death|3
1485961|NCT00565812|4896943|P2|Overall Study|Death|1
1485962|NCT00565812|4896944|P1|Overall Study|Death|2
1485963|NCT00565747|4897083|P2|Overall Study|No embryo transfer|73
1485964|NCT00565747|4897084|P1|Overall Study|No embryo transfer|67
1485965|NCT00565721|4897094|P1|Overall Study|Other reasons|6
1485966|NCT00565721|4897094|P1|Overall Study|Physician Decision|2
1485967|NCT00565721|4897094|P1|Overall Study|Technical Problems|1
1485968|NCT00565721|4897094|P1|Overall Study|Lost to Follow-up|6
1485969|NCT00565721|4897094|P1|Overall Study|Screen Failure|2
1485970|NCT00565617|4897134|P1|Overall Study|Withdrawal by Subject|1
1485971|NCT00565604|4897138|P1|Overall Study|Lost to Follow-up|2
1485972|NCT00565604|4897138|P1|Overall Study|Failure to treat|2
1485973|NCT00565448|4897166|P2|Overall Study|Withdrawal by Subject|0
1485974|NCT00565448|4897167|P1|Overall Study|Withdrawal by Subject|1
1485975|NCT00565448|4897166|P2|Overall Study|Disease progression|0
1485976|NCT00565448|4897167|P1|Overall Study|Disease progression|1
1485977|NCT00565448|4897166|P2|Overall Study|Adverse Event|2
1485978|NCT00565448|4897167|P1|Overall Study|Adverse Event|1
1485979|NCT00565409|4897178|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
1485980|NCT00565409|4897179|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
1485981|NCT00565409|4897180|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
1485982|NCT00565409|4897181|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
1485983|NCT00565409|4897178|P4|Period 2 Double-Blind|Other|9
1485984|NCT00565409|4897179|P3|Period 2 Double-Blind|Other|5
1485985|NCT00565409|4897180|P2|Period 2 Double-Blind|Other|4
1485986|NCT00565409|4897181|P1|Period 2 Double-Blind|Other|0
1485987|NCT00565409|4897178|P4|Period 2 Double-Blind|Lost to Follow-up|0
1485988|NCT00565409|4897179|P3|Period 2 Double-Blind|Lost to Follow-up|1
1485989|NCT00565409|4897180|P2|Period 2 Double-Blind|Lost to Follow-up|0
1485990|NCT00565409|4897181|P1|Period 2 Double-Blind|Lost to Follow-up|0
1485991|NCT00565409|4897178|P4|Period 2 Double-Blind|Protocol Violation|2
1485992|NCT00565409|4897179|P3|Period 2 Double-Blind|Protocol Violation|6
1485993|NCT00565409|4897180|P2|Period 2 Double-Blind|Protocol Violation|4
1485994|NCT00565409|4897181|P1|Period 2 Double-Blind|Protocol Violation|0
1485995|NCT00565409|4897178|P4|Period 2 Double-Blind|Death|0
1485996|NCT00565409|4897179|P3|Period 2 Double-Blind|Death|0
1485997|NCT00565409|4897180|P2|Period 2 Double-Blind|Death|2
1485998|NCT00565409|4897181|P1|Period 2 Double-Blind|Death|0
1485999|NCT00565409|4897178|P4|Period 2 Double-Blind|Adverse Event|5
1486000|NCT00565409|4897179|P3|Period 2 Double-Blind|Adverse Event|4
1486001|NCT00565409|4897180|P2|Period 2 Double-Blind|Adverse Event|7
1486002|NCT00565409|4897181|P1|Period 2 Double-Blind|Adverse Event|0
1486003|NCT00565409|4897178|P4|After Period 1, Prior to Period 2|did not meet criteria|0
1486004|NCT00565409|4897179|P3|After Period 1, Prior to Period 2|did not meet criteria|0
1486005|NCT00565409|4897180|P2|After Period 1, Prior to Period 2|did not meet criteria|0
1486006|NCT00565409|4897181|P1|After Period 1, Prior to Period 2|did not meet criteria|152
1486007|NCT00565409|4897178|P4|Period 1 Open Label|no conclusion of participation record|0
1486008|NCT00565409|4897179|P3|Period 1 Open Label|no conclusion of participation record|0
1486009|NCT00565409|4897180|P2|Period 1 Open Label|no conclusion of participation record|0
1486010|NCT00565409|4897181|P1|Period 1 Open Label|no conclusion of participation record|1
1486011|NCT00565409|4897178|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
1486012|NCT00565409|4897179|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
1486013|NCT00565409|4897180|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
1486014|NCT00565409|4897181|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
1486015|NCT00565409|4897178|P4|Period 1 Open Label|Protocol Violation|0
1486016|NCT00565409|4897179|P3|Period 1 Open Label|Protocol Violation|0
1486017|NCT00565409|4897180|P2|Period 1 Open Label|Protocol Violation|0
1486018|NCT00565409|4897181|P1|Period 1 Open Label|Protocol Violation|14
1486019|NCT00565409|4897178|P4|Period 1 Open Label|Other|0
1486020|NCT00565409|4897179|P3|Period 1 Open Label|Other|0
1486021|NCT00565409|4897180|P2|Period 1 Open Label|Other|0
1486022|NCT00565409|4897181|P1|Period 1 Open Label|Other|21
1486023|NCT00565409|4897178|P4|Period 1 Open Label|Lost to Follow-up|0
1486024|NCT00565409|4897179|P3|Period 1 Open Label|Lost to Follow-up|0
1486025|NCT00565409|4897180|P2|Period 1 Open Label|Lost to Follow-up|0
1486026|NCT00565409|4897181|P1|Period 1 Open Label|Lost to Follow-up|1
1486027|NCT00565409|4897178|P4|Period 1 Open Label|Death|0
1486028|NCT00565409|4897179|P3|Period 1 Open Label|Death|0
1486029|NCT00565409|4897180|P2|Period 1 Open Label|Death|0
1486030|NCT00565409|4897181|P1|Period 1 Open Label|Death|2
1486031|NCT00565409|4897178|P4|Period 1 Open Label|Adverse Event|0
1486032|NCT00565409|4897179|P3|Period 1 Open Label|Adverse Event|0
1486033|NCT00565409|4897180|P2|Period 1 Open Label|Adverse Event|0
1486034|NCT00565409|4897181|P1|Period 1 Open Label|Adverse Event|17
1486035|NCT00565136|4897317|P1|Overall Study|Protocol Violation|1
1486036|NCT00565136|4897317|P1|Overall Study|Withdrawal by Subject|1
1486037|NCT00565136|4897317|P1|Overall Study|Lost to Follow-up|1
1486038|NCT00565058|4897358|P2|Overall Study|Adverse Event|0
1486039|NCT00565058|4897359|P1|Overall Study|Adverse Event|1
1486040|NCT00564902|4897406|P3|Overall Study|Death|0
1486041|NCT00564902|4897407|P2|Overall Study|Death|1
1486042|NCT00564902|4897408|P1|Overall Study|Death|1
1486043|NCT00564902|4897406|P3|Overall Study|Withdrawal by Subject|4
1486044|NCT00564902|4897407|P2|Overall Study|Withdrawal by Subject|3
1486045|NCT00564902|4897408|P1|Overall Study|Withdrawal by Subject|0
1486046|NCT00564889|4897440|P1|Overall Study|Other, not specified|4
1486047|NCT00564889|4897440|P1|Overall Study|Disease progression|3
1486048|NCT00564889|4897440|P1|Overall Study|Alternative treatment|3
1486049|NCT00564889|4897440|P1|Overall Study|Adverse Event|12
1486050|NCT00564889|4897440|P1|Overall Study|Death|7
1486051|NCT00564850|4897455|P1|Overall Study|Protocol Violation|2
1486052|NCT00564733|4897473|P1|Overall Study|Ineligible|5
1486053|NCT00564733|4897473|P1|Overall Study|Withdrawal by Subject|4
1486054|NCT00564629|4897507|P2|Overall Study|Vomited within 2 hours of receiving drug|9
1486055|NCT00564629|4897508|P1|Overall Study|Vomited within 2 hours of receiving drug|15
1486056|NCT00564486|4897533|P4|Overall Study|Lost to Follow-up|2
1486057|NCT00564486|4897534|P3|Overall Study|Lost to Follow-up|2
1486058|NCT00564486|4897535|P2|Overall Study|Lost to Follow-up|0
1486059|NCT00564486|4897536|P1|Overall Study|Lost to Follow-up|3
1486060|NCT00564486|4897533|P4|Overall Study|Subject refused to have blood drawn|0
1486061|NCT00564486|4897534|P3|Overall Study|Subject refused to have blood drawn|1
1486062|NCT00564486|4897535|P2|Overall Study|Subject refused to have blood drawn|0
1486063|NCT00564486|4897536|P1|Overall Study|Subject refused to have blood drawn|0
1486064|NCT00564486|4897533|P4|Overall Study|Withdrawal by Subject|5
1486065|NCT00564486|4897534|P3|Overall Study|Withdrawal by Subject|0
1486066|NCT00564486|4897535|P2|Overall Study|Withdrawal by Subject|0
1486067|NCT00564486|4897536|P1|Overall Study|Withdrawal by Subject|4
1486068|NCT00564486|4897533|P4|Overall Study|Adverse Event|0
1486069|NCT00564486|4897534|P3|Overall Study|Adverse Event|0
1486070|NCT00564486|4897535|P2|Overall Study|Adverse Event|1
1486071|NCT00564486|4897536|P1|Overall Study|Adverse Event|0
1486072|NCT00564395|4897585|P2|First Intervention (10 Days)|Trouble with the CGM tracing|2
1486073|NCT00564395|4897586|P1|First Intervention (10 Days)|Trouble with the CGM tracing|1
1486074|NCT00564395|4897585|P2|First Intervention (10 Days)|Withdrawal by Subject|0
1486075|NCT00564395|4897586|P1|First Intervention (10 Days)|Withdrawal by Subject|1
1486076|NCT00564278|4897594|P2|Overall Study|Withdrawal by Subject|7
1486077|NCT00564278|4897595|P1|Overall Study|Withdrawal by Subject|11
1486078|NCT00564278|4897594|P2|Overall Study|Physician Decision|2
1486079|NCT00564278|4897595|P1|Overall Study|Physician Decision|1
1486080|NCT00564278|4897594|P2|Overall Study|Lost to Follow-up|33
1486081|NCT00564278|4897595|P1|Overall Study|Lost to Follow-up|35
1486082|NCT00564070|4897617|P2|Overall Study|Worsening depression, referred to care|0
1486083|NCT00564070|4897618|P1|Overall Study|Worsening depression, referred to care|3
1486084|NCT00564070|4897617|P2|Overall Study|Lost to Follow-up|7
1486085|NCT00564070|4897618|P1|Overall Study|Lost to Follow-up|9
1486086|NCT00563797|4897644|P2|Overall Study|Lost to Follow-up|2
1486087|NCT00563797|4897645|P1|Overall Study|Lost to Follow-up|7
1486088|NCT00563706|4897666|P9|DB Treatment Period (Day 1 up to Day 28)|Other|2
1486089|NCT00563706|4897667|P8|DB Treatment Period (Day 1 up to Day 28)|Other|1
1486090|NCT00563706|4897668|P7|DB Treatment Period (Day 1 up to Day 28)|Other|0
1486091|NCT00563706|4897669|P6|DB Treatment Period (Day 1 up to Day 28)|Other|0
1486092|NCT00563706|4897670|P5|DB Treatment Period (Day 1 up to Day 28)|Other|0
1486093|NCT00563706|4897671|P4|DB Treatment Period (Day 1 up to Day 28)|Other|0
1486094|NCT00563706|4897672|P3|DB Treatment Period (Day 1 up to Day 28)|Other|0
1486095|NCT00563706|4897673|P2|DB Treatment Period (Day 1 up to Day 28)|Other|0
1486096|NCT00563706|4897674|P1|DB Treatment Period (Day 1 up to Day 28)|Other|0
1486097|NCT00563706|4897666|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1486098|NCT00563706|4897667|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
1486099|NCT00563706|4897668|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1486100|NCT00563706|4897669|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1486101|NCT00563706|4897670|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1486102|NCT00563706|4897671|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1486103|NCT00563706|4897672|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1486104|NCT00563706|4897673|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1486105|NCT00563706|4897674|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
1486106|NCT00563706|4897666|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
1486107|NCT00563706|4897667|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
1486108|NCT00563706|4897668|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
1486109|NCT00563706|4897669|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
1486110|NCT00563706|4897670|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
1486111|NCT00563706|4897671|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
1486112|NCT00563706|4897672|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
1486113|NCT00563706|4897673|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
1486114|NCT00563706|4897674|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
1486115|NCT00563706|4897666|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
1486116|NCT00563706|4897667|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
1486117|NCT00563706|4897668|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
1486118|NCT00563706|4897669|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
1486119|NCT00563706|4897670|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
1486120|NCT00563706|4897671|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
1486121|NCT00563706|4897672|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
1486122|NCT00563706|4897673|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
1486123|NCT00563706|4897674|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
1486124|NCT00563706|4897666|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
1486125|NCT00563706|4897667|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
1486126|NCT00563706|4897668|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
1486127|NCT00563706|4897669|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
1486128|NCT00563706|4897670|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
1486129|NCT00563706|4897671|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
1486130|NCT00563706|4897672|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
1486131|NCT00563706|4897673|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
1486132|NCT00563706|4897674|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
1486133|NCT00563381|4897790|P2|Overall Study|Individual different reasons|34
1486134|NCT00563381|4897791|P1|Overall Study|Individual different reasons|24
1486135|NCT00563381|4897790|P2|Overall Study|Lack of Efficacy|24
1486136|NCT00563381|4897791|P1|Overall Study|Lack of Efficacy|32
1486137|NCT00563381|4897790|P2|Overall Study|Withdrawal by Subject|209
1486138|NCT00563381|4897791|P1|Overall Study|Withdrawal by Subject|192
1486139|NCT00563381|4897790|P2|Overall Study|Lost to Follow-up|15
1486140|NCT00563381|4897791|P1|Overall Study|Lost to Follow-up|7
1486141|NCT00563381|4897790|P2|Overall Study|Protocol Violation|74
1486142|NCT00563381|4897791|P1|Overall Study|Protocol Violation|66
1486143|NCT00563381|4897790|P2|Overall Study|Adverse Event|292
1486144|NCT00563381|4897791|P1|Overall Study|Adverse Event|264
1486145|NCT00563368|4897864|P7|Overall Study|not specified|0
1486146|NCT00563368|4897865|P6|Overall Study|not specified|4
1486147|NCT00563368|4897866|P5|Overall Study|not specified|4
1486148|NCT00563368|4897867|P4|Overall Study|not specified|4
1486149|NCT00563368|4897868|P3|Overall Study|not specified|3
1486150|NCT00563368|4897869|P2|Overall Study|not specified|5
1486151|NCT00563368|4897870|P1|Overall Study|not specified|5
1486152|NCT00563368|4897864|P7|Overall Study|requirement for restricted medication|0
1486153|NCT00563368|4897865|P6|Overall Study|requirement for restricted medication|0
1486154|NCT00563368|4897866|P5|Overall Study|requirement for restricted medication|0
1486155|NCT00563368|4897867|P4|Overall Study|requirement for restricted medication|0
1486156|NCT00563368|4897868|P3|Overall Study|requirement for restricted medication|2
1486157|NCT00563368|4897869|P2|Overall Study|requirement for restricted medication|0
1486158|NCT00563368|4897870|P1|Overall Study|requirement for restricted medication|0
1486159|NCT00563368|4897864|P7|Overall Study|Pregnancy|0
1486160|NCT00563368|4897865|P6|Overall Study|Pregnancy|2
1486161|NCT00563368|4897866|P5|Overall Study|Pregnancy|1
1486162|NCT00563368|4897867|P4|Overall Study|Pregnancy|2
1486163|NCT00563368|4897868|P3|Overall Study|Pregnancy|1
1486164|NCT00563368|4897869|P2|Overall Study|Pregnancy|0
1486165|NCT00563368|4897870|P1|Overall Study|Pregnancy|1
1486166|NCT00563368|4897864|P7|Overall Study|protocol non-compliance|3
1486167|NCT00563368|4897865|P6|Overall Study|protocol non-compliance|1
1486168|NCT00563368|4897866|P5|Overall Study|protocol non-compliance|0
1486169|NCT00563368|4897867|P4|Overall Study|protocol non-compliance|1
1486170|NCT00563368|4897868|P3|Overall Study|protocol non-compliance|2
1486171|NCT00563368|4897869|P2|Overall Study|protocol non-compliance|1
1486172|NCT00563368|4897870|P1|Overall Study|protocol non-compliance|1
1486173|NCT00563368|4897864|P7|Overall Study|Withdrawal by Subject|4
1486174|NCT00563368|4897865|P6|Overall Study|Withdrawal by Subject|5
1486175|NCT00563368|4897866|P5|Overall Study|Withdrawal by Subject|8
1486176|NCT00563368|4897867|P4|Overall Study|Withdrawal by Subject|7
1486177|NCT00563368|4897868|P3|Overall Study|Withdrawal by Subject|5
1486178|NCT00563368|4897869|P2|Overall Study|Withdrawal by Subject|6
1486179|NCT00563368|4897870|P1|Overall Study|Withdrawal by Subject|11
1486180|NCT00563368|4897864|P7|Overall Study|Adverse Event|17
1486181|NCT00563368|4897865|P6|Overall Study|Adverse Event|10
1486182|NCT00563368|4897866|P5|Overall Study|Adverse Event|6
1486183|NCT00563368|4897867|P4|Overall Study|Adverse Event|9
1486184|NCT00563368|4897868|P3|Overall Study|Adverse Event|5
1486185|NCT00563368|4897869|P2|Overall Study|Adverse Event|4
1486186|NCT00563368|4897870|P1|Overall Study|Adverse Event|3
1486187|NCT00563368|4897864|P7|Overall Study|Lost to Follow-up|9
1486188|NCT00563368|4897865|P6|Overall Study|Lost to Follow-up|8
1486189|NCT00563368|4897866|P5|Overall Study|Lost to Follow-up|9
1486190|NCT00563368|4897867|P4|Overall Study|Lost to Follow-up|6
1486191|NCT00563368|4897868|P3|Overall Study|Lost to Follow-up|12
1486192|NCT00563368|4897869|P2|Overall Study|Lost to Follow-up|14
1486193|NCT00563368|4897870|P1|Overall Study|Lost to Follow-up|14
1486194|NCT00563316|4897893|P1|Overall Study|Other|1
1486195|NCT00563316|4897893|P1|Overall Study|On-going in study as of 16 July 2009.|5
1486196|NCT00563316|4897893|P1|Overall Study|Death|1
1486197|NCT00563316|4897893|P1|Overall Study|Lost to Follow-up|2
1486198|NCT00563316|4897893|P1|Overall Study|Physician Decision|1
1486199|NCT00563316|4897893|P1|Overall Study|Adverse Event|2
1486200|NCT00562965|4897918|P2|Overall Study|Other|1
1486201|NCT00562965|4897919|P1|Overall Study|Other|0
1486202|NCT00562965|4897918|P2|Overall Study|Lost to Follow-up|0
1486203|NCT00562965|4897919|P1|Overall Study|Lost to Follow-up|1
1486204|NCT00562965|4897918|P2|Overall Study|Death|4
1486205|NCT00562965|4897919|P1|Overall Study|Death|2
1486206|NCT00562965|4897918|P2|Overall Study|Withdrawal by Subject|1
1486207|NCT00562965|4897919|P1|Overall Study|Withdrawal by Subject|0
1486208|NCT00562861|4897940|P2|Overall Study|Lost to Follow-up|3
1486209|NCT00562861|4897941|P1|Overall Study|Lost to Follow-up|7
1486210|NCT00562861|4897940|P2|Overall Study|noncompliance, moved|2
1486211|NCT00562861|4897941|P1|Overall Study|noncompliance, moved|7
1486212|NCT00562861|4897940|P2|Overall Study|Lack of Efficacy|5
1486213|NCT00562861|4897941|P1|Overall Study|Lack of Efficacy|5
1486214|NCT00562861|4897940|P2|Overall Study|Adverse Event|1
1486215|NCT00562861|4897941|P1|Overall Study|Adverse Event|1
1486216|NCT00562627|4897950|P3|Overall Study|Protocol Violation|1
1486217|NCT00562627|4897951|P2|Overall Study|Protocol Violation|1
1486218|NCT00562627|4897952|P1|Overall Study|Protocol Violation|1
1486219|NCT00562588|4897968|P2|Overall Study|Other|2
1486220|NCT00562588|4897969|P1|Overall Study|Other|0
1486221|NCT00562588|4897968|P2|Overall Study|Withdrawal by Subject|9
1486222|NCT00562588|4897969|P1|Overall Study|Withdrawal by Subject|10
1486223|NCT00562588|4897968|P2|Overall Study|Lost to Follow-up|4
1486224|NCT00562588|4897969|P1|Overall Study|Lost to Follow-up|12
1486225|NCT00562588|4897968|P2|Overall Study|Protocol Violation|26
1486226|NCT00562588|4897969|P1|Overall Study|Protocol Violation|30
1486227|NCT00562588|4897968|P2|Overall Study|Adverse Event|58
1486228|NCT00562588|4897969|P1|Overall Study|Adverse Event|40
1486229|NCT00562484|4897999|P2|Overall Study|Reason not provided or not specified|12
1486230|NCT00562484|4898000|P1|Overall Study|Reason not provided or not specified|25
1486231|NCT00562484|4897999|P2|Overall Study|Lost to Follow-up|71
1486232|NCT00562484|4898000|P1|Overall Study|Lost to Follow-up|132
1486233|NCT00562484|4897999|P2|Overall Study|Moved away from the study area|9
1486234|NCT00562484|4898000|P1|Overall Study|Moved away from the study area|20
1486235|NCT00562484|4897999|P2|Overall Study|Withdrawal by Subject|9
1486236|NCT00562484|4898000|P1|Overall Study|Withdrawal by Subject|12
1486237|NCT00562484|4897999|P2|Overall Study|Protocol Violation|2
1486238|NCT00562484|4898000|P1|Overall Study|Protocol Violation|11
1486239|NCT00562484|4897999|P2|Overall Study|Adverse Event|1
1486240|NCT00562484|4898000|P1|Overall Study|Adverse Event|6
1486241|NCT00562354|4898032|P2|Overall Study|Lost to Follow-up|1
1486242|NCT00562354|4898033|P1|Overall Study|Lost to Follow-up|0
1486243|NCT00562354|4898032|P2|Overall Study|Physician Decision|1
1486244|NCT00562354|4898033|P1|Overall Study|Physician Decision|0
1486245|NCT00562302|4898095|P2|Overall Study|Not stated|4
1486246|NCT00562302|4898096|P1|Overall Study|Not stated|1
1486247|NCT00562302|4898095|P2|Overall Study|Lung resection prior to study completion|7
1486248|NCT00562302|4898096|P1|Overall Study|Lung resection prior to study completion|7
1486249|NCT00562302|4898095|P2|Overall Study|Death|2
1486250|NCT00562302|4898096|P1|Overall Study|Death|1
1486251|NCT00562302|4898095|P2|Overall Study|Withdrawal by Subject|8
1486252|NCT00562302|4898096|P1|Overall Study|Withdrawal by Subject|7
1486253|NCT00562302|4898095|P2|Overall Study|Non-compliance|2
1486254|NCT00562302|4898096|P1|Overall Study|Non-compliance|1
1486255|NCT00562302|4898095|P2|Overall Study|Adverse Event|6
1486256|NCT00562302|4898096|P1|Overall Study|Adverse Event|0
1486257|NCT00562302|4898095|P2|Overall Study|Lost to Follow-up|3
1486258|NCT00562302|4898096|P1|Overall Study|Lost to Follow-up|3
1486259|NCT00562159|4898118|P2|Overall Study|Did not meet protocol eligibility|1
1486260|NCT00562159|4898119|P1|Overall Study|Did not meet protocol eligibility|1
1486261|NCT00562159|4898118|P2|Overall Study|Protocol Violation|12
1486262|NCT00562159|4898119|P1|Overall Study|Protocol Violation|12
1486263|NCT00562159|4898118|P2|Overall Study|Withdrawal by Subject|8
1486264|NCT00562159|4898119|P1|Overall Study|Withdrawal by Subject|9
1486265|NCT00562159|4898118|P2|Overall Study|Lost to Follow-up|4
1486266|NCT00562159|4898119|P1|Overall Study|Lost to Follow-up|5
1486267|NCT00562159|4898118|P2|Overall Study|Adverse Event|8
1486268|NCT00562159|4898119|P1|Overall Study|Adverse Event|11
1486269|NCT00562120|4898131|P4|First Intervention Period|Randomized but not Treated|0
1486270|NCT00562120|4898132|P3|First Intervention Period|Randomized but not Treated|0
1486271|NCT00562120|4898133|P2|First Intervention Period|Randomized but not Treated|0
1486272|NCT00562120|4898134|P1|First Intervention Period|Randomized but not Treated|1
1486273|NCT00562120|4898131|P4|First Intervention Period|Adverse Event|0
1486274|NCT00562120|4898132|P3|First Intervention Period|Adverse Event|0
1486275|NCT00562120|4898133|P2|First Intervention Period|Adverse Event|0
1486276|NCT00562120|4898134|P1|First Intervention Period|Adverse Event|1
1486277|NCT00562094|4898166|P1|Overall Study|Lost to Follow-up|62
1486278|NCT00561977|4898181|P3|Overall Study|Pregnancy|1
1486279|NCT00561977|4898182|P2|Overall Study|Pregnancy|1
1486280|NCT00561977|4898183|P1|Overall Study|Pregnancy|0
1486281|NCT00561977|4898181|P3|Overall Study|Withdrawal by Subject|1
1486282|NCT00561977|4898182|P2|Overall Study|Withdrawal by Subject|2
1486283|NCT00561977|4898183|P1|Overall Study|Withdrawal by Subject|0
1486284|NCT00561951|4898209|P3|Overall Study|Adverse Event Occured Before Treatment|1
1486285|NCT00561951|4898210|P2|Overall Study|Adverse Event Occured Before Treatment|2
1486286|NCT00561951|4898211|P1|Overall Study|Adverse Event Occured Before Treatment|1
1486287|NCT00561951|4898209|P3|Overall Study|Meet Withdrawal Criterion|1
1486288|NCT00561951|4898210|P2|Overall Study|Meet Withdrawal Criterion|1
1486289|NCT00561951|4898211|P1|Overall Study|Meet Withdrawal Criterion|0
1486290|NCT00561951|4898209|P3|Overall Study|Pregnancy|0
1486291|NCT00561951|4898210|P2|Overall Study|Pregnancy|1
1486292|NCT00561951|4898211|P1|Overall Study|Pregnancy|0
1486293|NCT00561951|4898209|P3|Overall Study|Physician Decision|0
1486294|NCT00561951|4898210|P2|Overall Study|Physician Decision|0
1486295|NCT00561951|4898211|P1|Overall Study|Physician Decision|1
1486296|NCT00561951|4898209|P3|Overall Study|Protocol Violation|4
1486297|NCT00561951|4898210|P2|Overall Study|Protocol Violation|3
1486298|NCT00561951|4898211|P1|Overall Study|Protocol Violation|4
1486299|NCT00561951|4898209|P3|Overall Study|Withdrawal by Subject|10
1486300|NCT00561951|4898210|P2|Overall Study|Withdrawal by Subject|9
1486301|NCT00561951|4898211|P1|Overall Study|Withdrawal by Subject|10
1486302|NCT00561951|4898209|P3|Overall Study|Lost to Follow-up|0
1486303|NCT00561951|4898210|P2|Overall Study|Lost to Follow-up|1
1486304|NCT00561951|4898211|P1|Overall Study|Lost to Follow-up|1
1486305|NCT00561951|4898209|P3|Overall Study|Lack of Efficacy|2
1486306|NCT00561951|4898210|P2|Overall Study|Lack of Efficacy|3
1486307|NCT00561951|4898211|P1|Overall Study|Lack of Efficacy|5
1486308|NCT00561951|4898209|P3|Overall Study|Adverse Event|14
1486309|NCT00561951|4898210|P2|Overall Study|Adverse Event|14
1486310|NCT00561951|4898211|P1|Overall Study|Adverse Event|11
1486311|NCT00561925|4898267|P5|Open-Label Extension Period|Declined entry into extension period|50
1486312|NCT00561925|4898268|P4|Open-Label Extension Period|Declined entry into extension period|43
1486313|NCT00561925|4898269|P3|Open-Label Extension Period|Declined entry into extension period|0
1486314|NCT00561925|4898270|P2|Open-Label Extension Period|Declined entry into extension period|0
1486315|NCT00561925|4898271|P1|Open-Label Extension Period|Declined entry into extension period|0
1486316|NCT00561925|4898267|P5|144-week Double-blind, Double-dummy|Other|0
1486317|NCT00561925|4898268|P4|144-week Double-blind, Double-dummy|Other|0
1486318|NCT00561925|4898269|P3|144-week Double-blind, Double-dummy|Other|11
1486319|NCT00561925|4898270|P2|144-week Double-blind, Double-dummy|Other|8
1486320|NCT00561925|4898271|P1|144-week Double-blind, Double-dummy|Other|0
1486321|NCT00561925|4898267|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
1486322|NCT00561925|4898268|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
1486323|NCT00561925|4898269|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
1486324|NCT00561925|4898270|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
1486325|NCT00561925|4898271|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
1486326|NCT00561925|4898267|P5|144-week Double-blind, Double-dummy|Death|0
1486327|NCT00561925|4898268|P4|144-week Double-blind, Double-dummy|Death|0
1486328|NCT00561925|4898269|P3|144-week Double-blind, Double-dummy|Death|3
1486329|NCT00561925|4898270|P2|144-week Double-blind, Double-dummy|Death|6
1486330|NCT00561925|4898271|P1|144-week Double-blind, Double-dummy|Death|0
1486331|NCT00561925|4898267|P5|144-week Double-blind, Double-dummy|Pregnancy|0
1486332|NCT00561925|4898268|P4|144-week Double-blind, Double-dummy|Pregnancy|0
1486333|NCT00561925|4898269|P3|144-week Double-blind, Double-dummy|Pregnancy|9
1486334|NCT00561925|4898270|P2|144-week Double-blind, Double-dummy|Pregnancy|1
1486335|NCT00561925|4898271|P1|144-week Double-blind, Double-dummy|Pregnancy|0
1486336|NCT00561925|4898267|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
1486337|NCT00561925|4898268|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
1486338|NCT00561925|4898269|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
1486339|NCT00561925|4898270|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
1486340|NCT00561925|4898271|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
1486341|NCT00561925|4898267|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
1486342|NCT00561925|4898268|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
1486343|NCT00561925|4898269|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
1486344|NCT00561925|4898270|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
1486345|NCT00561925|4898271|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
1486346|NCT00561925|4898267|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
1486347|NCT00561925|4898268|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
1486348|NCT00561925|4898269|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
1486349|NCT00561925|4898270|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
1486350|NCT00561925|4898271|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
1486351|NCT00561925|4898267|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
1486352|NCT00561925|4898268|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
1486353|NCT00561925|4898269|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
1486354|NCT00561925|4898270|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
1486355|NCT00561925|4898271|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
1486356|NCT00561925|4898267|P5|144-week Double-blind, Double-dummy|Adverse Event|0
1486357|NCT00561925|4898268|P4|144-week Double-blind, Double-dummy|Adverse Event|0
1486358|NCT00561925|4898269|P3|144-week Double-blind, Double-dummy|Adverse Event|43
1486359|NCT00561925|4898270|P2|144-week Double-blind, Double-dummy|Adverse Event|48
1486360|NCT00561925|4898271|P1|144-week Double-blind, Double-dummy|Adverse Event|0
1486361|NCT00561925|4898267|P5|14 Day Lead-In Period|Other|0
1486362|NCT00561925|4898268|P4|14 Day Lead-In Period|Other|0
1486363|NCT00561925|4898269|P3|14 Day Lead-In Period|Other|0
1486364|NCT00561925|4898270|P2|14 Day Lead-In Period|Other|0
1486365|NCT00561925|4898271|P1|14 Day Lead-In Period|Other|5
1486366|NCT00561925|4898267|P5|14 Day Lead-In Period|Withdrawal by Subject|0
1486367|NCT00561925|4898268|P4|14 Day Lead-In Period|Withdrawal by Subject|0
1486368|NCT00561925|4898269|P3|14 Day Lead-In Period|Withdrawal by Subject|0
1486369|NCT00561925|4898270|P2|14 Day Lead-In Period|Withdrawal by Subject|0
1486370|NCT00561925|4898271|P1|14 Day Lead-In Period|Withdrawal by Subject|4
1486371|NCT00561925|4898267|P5|14 Day Lead-In Period|Lost to Follow-up|0
1486372|NCT00561925|4898268|P4|14 Day Lead-In Period|Lost to Follow-up|0
1486373|NCT00561925|4898269|P3|14 Day Lead-In Period|Lost to Follow-up|0
1486374|NCT00561925|4898270|P2|14 Day Lead-In Period|Lost to Follow-up|0
1486375|NCT00561925|4898271|P1|14 Day Lead-In Period|Lost to Follow-up|4
1486376|NCT00561925|4898267|P5|14 Day Lead-In Period|In/Exclusion criteria|0
1486377|NCT00561925|4898268|P4|14 Day Lead-In Period|In/Exclusion criteria|0
1486378|NCT00561925|4898269|P3|14 Day Lead-In Period|In/Exclusion criteria|0
1486379|NCT00561925|4898270|P2|14 Day Lead-In Period|In/Exclusion criteria|0
1486380|NCT00561925|4898271|P1|14 Day Lead-In Period|In/Exclusion criteria|4
1486381|NCT00561925|4898267|P5|14 Day Lead-In Period|Adverse Event|0
1486382|NCT00561925|4898268|P4|14 Day Lead-In Period|Adverse Event|0
1486383|NCT00561925|4898269|P3|14 Day Lead-In Period|Adverse Event|0
1486384|NCT00561925|4898270|P2|14 Day Lead-In Period|Adverse Event|0
1486385|NCT00561925|4898271|P1|14 Day Lead-In Period|Adverse Event|38
1486386|NCT00561912|4898320|P1|Overall Study|ineligible|1
1486387|NCT00561821|4898332|P4|Overall Study|Adverse Event|1
1486388|NCT00561821|4898333|P3|Overall Study|Adverse Event|1
1486389|NCT00561821|4898334|P2|Overall Study|Adverse Event|3
1486390|NCT00561821|4898335|P1|Overall Study|Adverse Event|2
1486391|NCT00561821|4898332|P4|Overall Study|Other (reason not specified)|0
1486392|NCT00561821|4898333|P3|Overall Study|Other (reason not specified)|0
1486393|NCT00561821|4898334|P2|Overall Study|Other (reason not specified)|1
1486394|NCT00561821|4898335|P1|Overall Study|Other (reason not specified)|1
1486395|NCT00561821|4898332|P4|Overall Study|Reasons not related to trial|0
1486396|NCT00561821|4898333|P3|Overall Study|Reasons not related to trial|0
1486397|NCT00561821|4898334|P2|Overall Study|Reasons not related to trial|1
1486398|NCT00561821|4898335|P1|Overall Study|Reasons not related to trial|2
1486399|NCT00561821|4898332|P4|Overall Study|Withdrawal by Subject|2
1486400|NCT00561821|4898333|P3|Overall Study|Withdrawal by Subject|0
1486401|NCT00561821|4898334|P2|Overall Study|Withdrawal by Subject|1
1486402|NCT00561821|4898335|P1|Overall Study|Withdrawal by Subject|0
1486403|NCT00561821|4898332|P4|Overall Study|Not treated|0
1486404|NCT00561821|4898333|P3|Overall Study|Not treated|1
1486405|NCT00561821|4898334|P2|Overall Study|Not treated|0
1486406|NCT00561821|4898335|P1|Overall Study|Not treated|0
1486407|NCT00561795|4898411|P4|Overall Study|Physician Decision|0
1486408|NCT00561795|4898412|P3|Overall Study|Physician Decision|0
1486409|NCT00561795|4898413|P2|Overall Study|Physician Decision|0
1486410|NCT00561795|4898414|P1|Overall Study|Physician Decision|1
1486411|NCT00561795|4898411|P4|Overall Study|Study Closed/Terminated|0
1486412|NCT00561795|4898412|P3|Overall Study|Study Closed/Terminated|0
1486413|NCT00561795|4898413|P2|Overall Study|Study Closed/Terminated|3
1486414|NCT00561795|4898414|P1|Overall Study|Study Closed/Terminated|0
1486415|NCT00561795|4898411|P4|Overall Study|Adverse Event|0
1486416|NCT00561795|4898412|P3|Overall Study|Adverse Event|0
1486417|NCT00561795|4898413|P2|Overall Study|Adverse Event|3
1486418|NCT00561795|4898414|P1|Overall Study|Adverse Event|3
1486419|NCT00561730|4898434|P1|Overall Study|Not specified reasons|1
1486420|NCT00561730|4898434|P1|Overall Study|Lost to Follow-up|5
1486421|NCT00561730|4898434|P1|Overall Study|Handling of the drug|1
1486422|NCT00561730|4898434|P1|Overall Study|Adverse Event|2
1486423|NCT00561678|4898450|P2|Overall Study|anesthesia provider refusal|0
1486424|NCT00561678|4898451|P1|Overall Study|anesthesia provider refusal|1
1486425|NCT00561678|4898450|P2|Overall Study|surgery rescheduled to different site|2
1486426|NCT00561678|4898451|P1|Overall Study|surgery rescheduled to different site|2
1486427|NCT00561678|4898450|P2|Overall Study|surgery cancelled|1
1486428|NCT00561678|4898451|P1|Overall Study|surgery cancelled|1
1486429|NCT00561678|4898450|P2|Overall Study|Withdrawal by Subject|3
1486430|NCT00561678|4898451|P1|Overall Study|Withdrawal by Subject|4
1486431|NCT00561652|4898469|P2|Overall Study|Withdrawal by Subject|1
1486432|NCT00561652|4898470|P1|Overall Study|Withdrawal by Subject|0
1486433|NCT00561574|4898553|P2|Overall Study|Other|7
1486434|NCT00561574|4898554|P1|Overall Study|Other|5
1486435|NCT00561574|4898553|P2|Overall Study|Lost to Follow-up|0
1486436|NCT00561574|4898554|P1|Overall Study|Lost to Follow-up|1
1486437|NCT00561574|4898553|P2|Overall Study|Reason Unrelated to Trial|2
1486438|NCT00561574|4898554|P1|Overall Study|Reason Unrelated to Trial|6
1486439|NCT00561574|4898553|P2|Overall Study|Withdrawal by Subject|4
1486440|NCT00561574|4898554|P1|Overall Study|Withdrawal by Subject|4
1486441|NCT00561574|4898553|P2|Overall Study|Lack of Efficacy|21
1486442|NCT00561574|4898554|P1|Overall Study|Lack of Efficacy|11
1486443|NCT00561574|4898553|P2|Overall Study|Adverse Event|24
1486444|NCT00561574|4898554|P1|Overall Study|Adverse Event|21
1486445|NCT00561470|4898580|P2|Overall Study|Ongoing Treatment|14
1486446|NCT00561470|4898581|P1|Overall Study|Ongoing Treatment|11
1486447|NCT00561470|4898580|P2|Overall Study|Planning surgery|1
1486448|NCT00561470|4898581|P1|Overall Study|Planning surgery|1
1486449|NCT00561470|4898580|P2|Overall Study|Missed visit window|4
1486450|NCT00561470|4898581|P1|Overall Study|Missed visit window|1
1486451|NCT00561470|4898580|P2|Overall Study|Randomized but not treated|5
1486452|NCT00561470|4898581|P1|Overall Study|Randomized but not treated|5
1486453|NCT00561470|4898580|P2|Overall Study|Unauthorized procedure|1
1486454|NCT00561470|4898581|P1|Overall Study|Unauthorized procedure|3
1486455|NCT00561470|4898580|P2|Overall Study|Metastatic surgery|12
1486456|NCT00561470|4898581|P1|Overall Study|Metastatic surgery|10
1486457|NCT00561470|4898580|P2|Overall Study|Subject request|77
1486458|NCT00561470|4898581|P1|Overall Study|Subject request|43
1486459|NCT00561470|4898580|P2|Overall Study|Consent Withdrawn|6
1486460|NCT00561470|4898581|P1|Overall Study|Consent Withdrawn|2
1486461|NCT00561470|4898580|P2|Overall Study|Physician Decision|20
1486462|NCT00561470|4898581|P1|Overall Study|Physician Decision|21
1486463|NCT00561470|4898580|P2|Overall Study|Lost to Follow-up|0
1486464|NCT00561470|4898581|P1|Overall Study|Lost to Follow-up|2
1486465|NCT00561470|4898580|P2|Overall Study|poor compliance to protocol|4
1486466|NCT00561470|4898581|P1|Overall Study|poor compliance to protocol|4
1486467|NCT00561470|4898580|P2|Overall Study|Disease progression|305
1486468|NCT00561470|4898581|P1|Overall Study|Disease progression|437
1486469|NCT00561470|4898580|P2|Overall Study|Adverse Event|163
1486470|NCT00561470|4898581|P1|Overall Study|Adverse Event|74
1486471|NCT00561392|4898617|P1|Overall Study|Administrative problems|4
1486472|NCT00561392|4898617|P1|Overall Study|Withdrawal by Subject|8
1486473|NCT00561392|4898617|P1|Overall Study|Protocol Violation|1
1486474|NCT00561392|4898617|P1|Overall Study|Lack of Efficacy|2
1486475|NCT00561392|4898617|P1|Overall Study|Adverse Event|38
1486476|NCT00561353|4898639|P10|Overall Study|Withdrawal by Subject|0
1486477|NCT00561353|4898640|P9|Overall Study|Withdrawal by Subject|0
1486478|NCT00561353|4898641|P8|Overall Study|Withdrawal by Subject|0
1486479|NCT00561353|4898642|P7|Overall Study|Withdrawal by Subject|0
1486480|NCT00561353|4898643|P6|Overall Study|Withdrawal by Subject|0
1486481|NCT00561353|4898644|P5|Overall Study|Withdrawal by Subject|0
1486482|NCT00561353|4898645|P4|Overall Study|Withdrawal by Subject|0
1486483|NCT00561353|4898646|P3|Overall Study|Withdrawal by Subject|0
1486484|NCT00561353|4898647|P2|Overall Study|Withdrawal by Subject|2
1486485|NCT00561353|4898648|P1|Overall Study|Withdrawal by Subject|0
1486486|NCT00561353|4898639|P10|Overall Study|Lost to Follow-up|0
1486487|NCT00561353|4898640|P9|Overall Study|Lost to Follow-up|0
1486488|NCT00561353|4898641|P8|Overall Study|Lost to Follow-up|0
1486489|NCT00561353|4898642|P7|Overall Study|Lost to Follow-up|0
1486490|NCT00561353|4898643|P6|Overall Study|Lost to Follow-up|0
1486491|NCT00561353|4898644|P5|Overall Study|Lost to Follow-up|0
1486492|NCT00561353|4898645|P4|Overall Study|Lost to Follow-up|0
1486493|NCT00561353|4898646|P3|Overall Study|Lost to Follow-up|1
1486494|NCT00561353|4898647|P2|Overall Study|Lost to Follow-up|0
1486495|NCT00561353|4898648|P1|Overall Study|Lost to Follow-up|2
1486496|NCT00561353|4898639|P10|Overall Study|Adverse Event|1
1486497|NCT00561353|4898640|P9|Overall Study|Adverse Event|0
1486498|NCT00561353|4898641|P8|Overall Study|Adverse Event|0
1486499|NCT00561353|4898642|P7|Overall Study|Adverse Event|1
1486500|NCT00561353|4898643|P6|Overall Study|Adverse Event|0
1486501|NCT00561353|4898644|P5|Overall Study|Adverse Event|0
1486502|NCT00561353|4898645|P4|Overall Study|Adverse Event|2
1486503|NCT00561353|4898646|P3|Overall Study|Adverse Event|0
1486504|NCT00561353|4898647|P2|Overall Study|Adverse Event|0
1486505|NCT00561353|4898648|P1|Overall Study|Adverse Event|0
1486506|NCT00561353|4898639|P10|Overall Study|Not specified|0
1486507|NCT00561353|4898640|P9|Overall Study|Not specified|0
1486508|NCT00561353|4898641|P8|Overall Study|Not specified|0
1486509|NCT00561353|4898642|P7|Overall Study|Not specified|0
1486510|NCT00561353|4898643|P6|Overall Study|Not specified|2
1486511|NCT00561353|4898644|P5|Overall Study|Not specified|0
1486512|NCT00561353|4898645|P4|Overall Study|Not specified|0
1486513|NCT00561353|4898646|P3|Overall Study|Not specified|1
1486514|NCT00561353|4898647|P2|Overall Study|Not specified|0
1486515|NCT00561353|4898648|P1|Overall Study|Not specified|1
1486516|NCT00561353|4898639|P10|Overall Study|Subject ineligible to continue the trial|1
1486517|NCT00561353|4898640|P9|Overall Study|Subject ineligible to continue the trial|2
1486518|NCT00561353|4898641|P8|Overall Study|Subject ineligible to continue the trial|0
1486519|NCT00561353|4898642|P7|Overall Study|Subject ineligible to continue the trial|1
1486520|NCT00561353|4898643|P6|Overall Study|Subject ineligible to continue the trial|1
1486521|NCT00561353|4898644|P5|Overall Study|Subject ineligible to continue the trial|0
1486522|NCT00561353|4898645|P4|Overall Study|Subject ineligible to continue the trial|0
1486523|NCT00561353|4898646|P3|Overall Study|Subject ineligible to continue the trial|0
1486524|NCT00561353|4898647|P2|Overall Study|Subject ineligible to continue the trial|0
1486525|NCT00561353|4898648|P1|Overall Study|Subject ineligible to continue the trial|0
1486526|NCT00561353|4898639|P10|Overall Study|Subject reached a virologic endpoint|0
1486527|NCT00561353|4898640|P9|Overall Study|Subject reached a virologic endpoint|5
1486528|NCT00561353|4898641|P8|Overall Study|Subject reached a virologic endpoint|4
1486529|NCT00561353|4898642|P7|Overall Study|Subject reached a virologic endpoint|4
1486530|NCT00561353|4898643|P6|Overall Study|Subject reached a virologic endpoint|3
1486531|NCT00561353|4898644|P5|Overall Study|Subject reached a virologic endpoint|1
1486532|NCT00561353|4898645|P4|Overall Study|Subject reached a virologic endpoint|4
1486533|NCT00561353|4898646|P3|Overall Study|Subject reached a virologic endpoint|1
1486534|NCT00561353|4898647|P2|Overall Study|Subject reached a virologic endpoint|1
1486535|NCT00561353|4898648|P1|Overall Study|Subject reached a virologic endpoint|2
1486536|NCT00561340|4898803|P2|Overall Study|refused to drink pediasure|0
1486537|NCT00561340|4898804|P1|Overall Study|refused to drink pediasure|6
1486538|NCT00561080|4898824|P3|12-month Post Last Dose Follow-up|Lost to Follow-up|0
1486539|NCT00561080|4898825|P2|12-month Post Last Dose Follow-up|Lost to Follow-up|0
1486540|NCT00561080|4898826|P1|12-month Post Last Dose Follow-up|Lost to Follow-up|2
1486541|NCT00561080|4898824|P3|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
1486542|NCT00561080|4898825|P2|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
1486543|NCT00561080|4898826|P1|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
1486544|NCT00561080|4898824|P3|12-month Post Last Dose Follow-up|Protocol Violation|4
1486545|NCT00561080|4898825|P2|12-month Post Last Dose Follow-up|Protocol Violation|0
1486546|NCT00561080|4898826|P1|12-month Post Last Dose Follow-up|Protocol Violation|0
1486547|NCT00561080|4898824|P3|12-month Post Last Dose Follow-up|Adverse Event|1
1486548|NCT00561080|4898825|P2|12-month Post Last Dose Follow-up|Adverse Event|3
1486549|NCT00561080|4898826|P1|12-month Post Last Dose Follow-up|Adverse Event|3
1486550|NCT00561080|4898824|P3|Vaccination Period (up to Month 4)|Other|1
1486551|NCT00561080|4898825|P2|Vaccination Period (up to Month 4)|Other|2
1486552|NCT00561080|4898826|P1|Vaccination Period (up to Month 4)|Other|0
1486553|NCT00561080|4898824|P3|Vaccination Period (up to Month 4)|Lost to Follow-up|0
1486554|NCT00561080|4898825|P2|Vaccination Period (up to Month 4)|Lost to Follow-up|1
1486555|NCT00561080|4898826|P1|Vaccination Period (up to Month 4)|Lost to Follow-up|0
1486556|NCT00561080|4898824|P3|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
1486557|NCT00561080|4898825|P2|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
1486558|NCT00561080|4898826|P1|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
1486559|NCT00561080|4898824|P3|Vaccination Period (up to Month 4)|Protocol Violation|3
1486560|NCT00561080|4898825|P2|Vaccination Period (up to Month 4)|Protocol Violation|1
1486561|NCT00561080|4898826|P1|Vaccination Period (up to Month 4)|Protocol Violation|0
1486562|NCT00561080|4898824|P3|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
1486563|NCT00561080|4898825|P2|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
1486564|NCT00561080|4898826|P1|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
1486565|NCT00561080|4898824|P3|Vaccination Period (up to Month 4)|Adverse Event|6
1486566|NCT00561080|4898825|P2|Vaccination Period (up to Month 4)|Adverse Event|4
1486567|NCT00561080|4898826|P1|Vaccination Period (up to Month 4)|Adverse Event|0
1486568|NCT00561015|4898903|P6|Overall Study|Participant non-compliance|0
1486569|NCT00561015|4898904|P5|Overall Study|Participant non-compliance|0
1486570|NCT00561015|4898905|P4|Overall Study|Participant non-compliance|0
1486571|NCT00561015|4898906|P3|Overall Study|Participant non-compliance|0
1486572|NCT00561015|4898907|P2|Overall Study|Participant non-compliance|0
1486573|NCT00561015|4898908|P1|Overall Study|Participant non-compliance|2
1486574|NCT00561015|4898903|P6|Overall Study|Lost to Follow-up|3
1486575|NCT00561015|4898904|P5|Overall Study|Lost to Follow-up|0
1486576|NCT00561015|4898905|P4|Overall Study|Lost to Follow-up|1
1486577|NCT00561015|4898906|P3|Overall Study|Lost to Follow-up|0
1486578|NCT00561015|4898907|P2|Overall Study|Lost to Follow-up|0
1486579|NCT00561015|4898908|P1|Overall Study|Lost to Follow-up|2
1486580|NCT00561015|4898903|P6|Overall Study|Adverse Event|0
1486581|NCT00561015|4898904|P5|Overall Study|Adverse Event|1
1486582|NCT00561015|4898905|P4|Overall Study|Adverse Event|0
1486583|NCT00561015|4898906|P3|Overall Study|Adverse Event|0
1486584|NCT00561015|4898907|P2|Overall Study|Adverse Event|0
1486585|NCT00561015|4898908|P1|Overall Study|Adverse Event|0
1486586|NCT00560950|4898999|P2|Overall Study|Lost to Follow-up|0
1486587|NCT00560950|4899000|P1|Overall Study|Lost to Follow-up|1
1486588|NCT00560937|4899038|P2|Overall Study|Physician Decision|1
1486589|NCT00560937|4899039|P1|Overall Study|Physician Decision|1
1486590|NCT00560937|4899038|P2|Overall Study|Withdrawal by Subject|1
1486591|NCT00560937|4899039|P1|Overall Study|Withdrawal by Subject|0
1486592|NCT00560885|4899055|P1|Overall Study|Withdrawal by Subject|1
1486593|NCT00560885|4899055|P1|Overall Study|Death|7
1486594|NCT00560833|4899080|P5|Overall Study|Never received drug|1
1486595|NCT00560833|4899081|P4|Overall Study|Never received drug|0
1486596|NCT00560833|4899082|P3|Overall Study|Never received drug|0
1486597|NCT00560833|4899083|P2|Overall Study|Never received drug|1
1486598|NCT00560833|4899084|P1|Overall Study|Never received drug|0
1486599|NCT00560833|4899080|P5|Overall Study|Other|0
1486600|NCT00560833|4899081|P4|Overall Study|Other|0
1486601|NCT00560833|4899082|P3|Overall Study|Other|3
1486602|NCT00560833|4899083|P2|Overall Study|Other|1
1486603|NCT00560833|4899084|P1|Overall Study|Other|1
1486604|NCT00560833|4899080|P5|Overall Study|Participant uncooperative|2
1486605|NCT00560833|4899081|P4|Overall Study|Participant uncooperative|4
1486606|NCT00560833|4899082|P3|Overall Study|Participant uncooperative|4
1486607|NCT00560833|4899083|P2|Overall Study|Participant uncooperative|5
1486608|NCT00560833|4899084|P1|Overall Study|Participant uncooperative|5
1486609|NCT00560833|4899080|P5|Overall Study|Lack of Efficacy|4
1486610|NCT00560833|4899081|P4|Overall Study|Lack of Efficacy|4
1486611|NCT00560833|4899082|P3|Overall Study|Lack of Efficacy|6
1486612|NCT00560833|4899083|P2|Overall Study|Lack of Efficacy|9
1486613|NCT00560833|4899084|P1|Overall Study|Lack of Efficacy|22
1486614|NCT00560833|4899080|P5|Overall Study|Lost to Follow-up|0
1486615|NCT00560833|4899081|P4|Overall Study|Lost to Follow-up|0
1486616|NCT00560833|4899082|P3|Overall Study|Lost to Follow-up|1
1486617|NCT00560833|4899083|P2|Overall Study|Lost to Follow-up|0
1486618|NCT00560833|4899084|P1|Overall Study|Lost to Follow-up|0
1486619|NCT00560833|4899080|P5|Overall Study|Adverse Event|35
1486620|NCT00560833|4899081|P4|Overall Study|Adverse Event|23
1486621|NCT00560833|4899082|P3|Overall Study|Adverse Event|25
1486622|NCT00560833|4899083|P2|Overall Study|Adverse Event|10
1486623|NCT00560833|4899084|P1|Overall Study|Adverse Event|16
1486711|NCT00560404|4899344|P1|Overall Study|Death|3
1486624|NCT00560794|4899116|P1|Overall Study|Received Bone Marrow Transplant|6
1486625|NCT00560794|4899116|P1|Overall Study|Hematological Relapse|1
1486626|NCT00560794|4899116|P1|Overall Study|Minimal Residual Disease Relapse|1
1486627|NCT00560794|4899116|P1|Overall Study|Patient was not Compliant|1
1486628|NCT00560794|4899116|P1|Overall Study|Adverse Event|2
1486629|NCT00560755|4899133|P1|Overall Study|Physician Decision|2
1486630|NCT00560755|4899133|P1|Overall Study|Adverse Event|8
1486631|NCT00560755|4899133|P1|Overall Study|Lost to Follow-up|9
1486632|NCT00560755|4899133|P1|Overall Study|Withdrawal by Subject|26
1486633|NCT00560755|4899133|P1|Overall Study|Protocol Violation|15
1486634|NCT00560703|4899154|P2|Overall Study|non-compliance|1
1486635|NCT00560703|4899155|P1|Overall Study|non-compliance|0
1486636|NCT00560703|4899154|P2|Overall Study|Withdrawal by Subject|1
1486637|NCT00560703|4899155|P1|Overall Study|Withdrawal by Subject|0
1486638|NCT00560703|4899154|P2|Overall Study|Protocol Violation|2
1486639|NCT00560703|4899155|P1|Overall Study|Protocol Violation|0
1486640|NCT00560703|4899154|P2|Overall Study|Adverse Event|2
1486641|NCT00560703|4899155|P1|Overall Study|Adverse Event|0
1486642|NCT00560573|4899172|P6|Overall Study|Enrolled, not treated|0
1486643|NCT00560573|4899173|P5|Overall Study|Enrolled, not treated|1
1486644|NCT00560573|4899174|P4|Overall Study|Enrolled, not treated|0
1486645|NCT00560573|4899175|P3|Overall Study|Enrolled, not treated|0
1486646|NCT00560573|4899176|P2|Overall Study|Enrolled, not treated|0
1486647|NCT00560573|4899177|P1|Overall Study|Enrolled, not treated|0
1486648|NCT00560573|4899172|P6|Overall Study|Other|3
1486649|NCT00560573|4899173|P5|Overall Study|Other|3
1486650|NCT00560573|4899174|P4|Overall Study|Other|3
1486651|NCT00560573|4899175|P3|Overall Study|Other|2
1486652|NCT00560573|4899176|P2|Overall Study|Other|2
1486653|NCT00560573|4899177|P1|Overall Study|Other|2
1486654|NCT00560573|4899172|P6|Overall Study|Withdrawal by Subject|0
1486655|NCT00560573|4899173|P5|Overall Study|Withdrawal by Subject|1
1486656|NCT00560573|4899174|P4|Overall Study|Withdrawal by Subject|1
1486657|NCT00560573|4899175|P3|Overall Study|Withdrawal by Subject|0
1486658|NCT00560573|4899176|P2|Overall Study|Withdrawal by Subject|0
1486659|NCT00560573|4899177|P1|Overall Study|Withdrawal by Subject|0
1486660|NCT00560573|4899172|P6|Overall Study|Lost to Follow-up|0
1486661|NCT00560573|4899173|P5|Overall Study|Lost to Follow-up|1
1486662|NCT00560573|4899174|P4|Overall Study|Lost to Follow-up|1
1486663|NCT00560573|4899175|P3|Overall Study|Lost to Follow-up|0
1486664|NCT00560573|4899176|P2|Overall Study|Lost to Follow-up|0
1486665|NCT00560573|4899177|P1|Overall Study|Lost to Follow-up|0
1486666|NCT00560573|4899172|P6|Overall Study|Death|10
1486667|NCT00560573|4899173|P5|Overall Study|Death|1
1486668|NCT00560573|4899174|P4|Overall Study|Death|5
1486669|NCT00560573|4899175|P3|Overall Study|Death|4
1486670|NCT00560573|4899176|P2|Overall Study|Death|1
1486671|NCT00560573|4899177|P1|Overall Study|Death|4
1486672|NCT00560508|4899254|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
1486673|NCT00560508|4899255|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
1486674|NCT00560508|4899254|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
1486675|NCT00560508|4899255|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
1486676|NCT00560508|4899254|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
1486677|NCT00560508|4899255|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
1486678|NCT00560508|4899254|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
1486679|NCT00560508|4899255|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
1486680|NCT00560508|4899254|P2|12 Week Double-blind Period|Withdrawal by Subject|1
1486681|NCT00560508|4899255|P1|12 Week Double-blind Period|Withdrawal by Subject|1
1486682|NCT00560508|4899254|P2|12 Week Double-blind Period|Protocol Violation|0
1486683|NCT00560508|4899255|P1|12 Week Double-blind Period|Protocol Violation|1
1486684|NCT00560508|4899254|P2|12 Week Double-blind Period|Adverse Event|2
1486685|NCT00560508|4899255|P1|12 Week Double-blind Period|Adverse Event|3
1486686|NCT00560417|4899314|P2|Overall Study|Withdrawal by Subject|3
1486687|NCT00560417|4899315|P1|Overall Study|Withdrawal by Subject|3
1486688|NCT00560417|4899314|P2|Overall Study|Sponsor Decision|0
1486689|NCT00560417|4899315|P1|Overall Study|Sponsor Decision|2
1486690|NCT00560417|4899314|P2|Overall Study|Protocol Violation|5
1486691|NCT00560417|4899315|P1|Overall Study|Protocol Violation|6
1486692|NCT00560417|4899314|P2|Overall Study|Physician Decision|6
1486693|NCT00560417|4899315|P1|Overall Study|Physician Decision|2
1486694|NCT00560417|4899314|P2|Overall Study|Lost to Follow-up|1
1486695|NCT00560417|4899315|P1|Overall Study|Lost to Follow-up|0
1486696|NCT00560417|4899314|P2|Overall Study|Entry Criteria Not Met|0
1486697|NCT00560417|4899315|P1|Overall Study|Entry Criteria Not Met|1
1486698|NCT00560417|4899314|P2|Overall Study|Adverse Event|2
1486699|NCT00560417|4899315|P1|Overall Study|Adverse Event|3
1486700|NCT00560404|4899343|P2|Overall Study|Other withdrawal reason|5
1486701|NCT00560404|4899344|P1|Overall Study|Other withdrawal reason|13
1486702|NCT00560404|4899343|P2|Overall Study|Failure to return|2
1486703|NCT00560404|4899344|P1|Overall Study|Failure to return|1
1486704|NCT00560404|4899343|P2|Overall Study|Withdrew Consent|0
1486705|NCT00560404|4899344|P1|Overall Study|Withdrew Consent|4
1486706|NCT00560404|4899343|P2|Overall Study|Administrative Reasons|1
1486707|NCT00560404|4899344|P1|Overall Study|Administrative Reasons|1
1486708|NCT00560404|4899343|P2|Overall Study|Protocol Violation|7
1486709|NCT00560404|4899344|P1|Overall Study|Protocol Violation|12
1486710|NCT00560404|4899343|P2|Overall Study|Death|3
1486712|NCT00560404|4899343|P2|Overall Study|Adverse Event|3
1486713|NCT00560404|4899344|P1|Overall Study|Adverse Event|2
1486714|NCT00560391|4899391|P5|Overall Study|Still on treatment|2
1486715|NCT00560391|4899392|P4|Overall Study|Still on treatment|1
1486716|NCT00560391|4899393|P3|Overall Study|Still on treatment|0
1486717|NCT00560391|4899394|P2|Overall Study|Still on treatment|0
1486718|NCT00560391|4899395|P1|Overall Study|Still on treatment|0
1486719|NCT00560352|4899451|P3|Overall Study|Maximum clinical benefit|0
1486720|NCT00560352|4899452|P2|Overall Study|Maximum clinical benefit|0
1486721|NCT00560352|4899453|P1|Overall Study|Maximum clinical benefit|1
1486722|NCT00560352|4899451|P3|Overall Study|Withdrawal by Subject|1
1486723|NCT00560352|4899452|P2|Overall Study|Withdrawal by Subject|1
1486724|NCT00560352|4899453|P1|Overall Study|Withdrawal by Subject|1
1486725|NCT00560352|4899451|P3|Overall Study|Disease progression|1
1486726|NCT00560352|4899452|P2|Overall Study|Disease progression|1
1486727|NCT00560352|4899453|P1|Overall Study|Disease progression|0
1486728|NCT00560352|4899451|P3|Overall Study|Study drug toxicity|1
1486729|NCT00560352|4899452|P2|Overall Study|Study drug toxicity|0
1486730|NCT00560352|4899453|P1|Overall Study|Study drug toxicity|3
1486731|NCT00560352|4899451|P3|Overall Study|Adverse event unrelated to study drug|1
1486732|NCT00560352|4899452|P2|Overall Study|Adverse event unrelated to study drug|1
1486733|NCT00560352|4899453|P1|Overall Study|Adverse event unrelated to study drug|2
1486734|NCT00560313|4899470|P1|Overall Study|Protocol Violation|1
1486735|NCT00560313|4899470|P1|Overall Study|Lost to Follow-up|1
1486736|NCT00560313|4899470|P1|Overall Study|Withdrawal by Subject|2
1486737|NCT00560313|4899470|P1|Overall Study|Adverse Events or Death|2
1486738|NCT00560235|4899497|P3|Phase 2|Ongoing at Date of Cut-Off|1
1486739|NCT00560235|4899498|P2|Phase 2|Ongoing at Date of Cut-Off|0
1486740|NCT00560235|4899499|P1|Phase 2|Ongoing at Date of Cut-Off|0
1486741|NCT00560235|4899497|P3|Phase 2|Discontinued|96
1486742|NCT00560235|4899498|P2|Phase 2|Discontinued|0
1486743|NCT00560235|4899499|P1|Phase 2|Discontinued|0
1486744|NCT00560235|4899497|P3|Phase 1B|Discontinued|0
1486745|NCT00560235|4899498|P2|Phase 1B|Discontinued|19
1486746|NCT00560235|4899499|P1|Phase 1B|Discontinued|0
1486747|NCT00560235|4899497|P3|Phase 1|Discontinued|0
1486748|NCT00560235|4899498|P2|Phase 1|Discontinued|0
1486749|NCT00560235|4899499|P1|Phase 1|Discontinued|8
1486750|NCT00560105|4899530|P2|Overall Study|musculoskeletal chest discomfort with us|2
1486751|NCT00560105|4899531|P1|Overall Study|musculoskeletal chest discomfort with us|1
1486752|NCT00560066|4899545|P2|Overall Study|Missing primary reason|2
1486753|NCT00560066|4899546|P1|Overall Study|Missing primary reason|0
1486754|NCT00560066|4899545|P2|Overall Study|Administrative reason|5
1486755|NCT00560066|4899546|P1|Overall Study|Administrative reason|0
1486756|NCT00560066|4899545|P2|Overall Study|Protocol Violation|1
1486757|NCT00560066|4899546|P1|Overall Study|Protocol Violation|0
1486758|NCT00560066|4899545|P2|Overall Study|Lost to Follow-up|10
1486759|NCT00560066|4899546|P1|Overall Study|Lost to Follow-up|4
1486760|NCT00560066|4899545|P2|Overall Study|Withdrawal by Subject|3
1486761|NCT00560066|4899546|P1|Overall Study|Withdrawal by Subject|0
1486762|NCT00560066|4899545|P2|Overall Study|Death|1
1486763|NCT00560066|4899546|P1|Overall Study|Death|2
1486764|NCT00559988|4899578|P2|Overall Study|ICD device explanted|17
1486765|NCT00559988|4899579|P1|Overall Study|ICD device explanted|10
1486766|NCT00559988|4899578|P2|Overall Study|Lost to Follow-up|56
1486767|NCT00559988|4899579|P1|Overall Study|Lost to Follow-up|42
1486768|NCT00559988|4899578|P2|Overall Study|Withdrawal by Subject|139
1486769|NCT00559988|4899579|P1|Overall Study|Withdrawal by Subject|152
1486770|NCT00559988|4899578|P2|Overall Study|Death|140
1486771|NCT00559988|4899579|P1|Overall Study|Death|147
1486772|NCT00559962|4899609|P8|Overall Study|Inclusion/exclusion criteria not met|0
1486773|NCT00559962|4899610|P7|Overall Study|Inclusion/exclusion criteria not met|1
1486774|NCT00559962|4899611|P6|Overall Study|Inclusion/exclusion criteria not met|0
1486775|NCT00559962|4899612|P5|Overall Study|Inclusion/exclusion criteria not met|0
1486776|NCT00559962|4899613|P4|Overall Study|Inclusion/exclusion criteria not met|0
1486777|NCT00559962|4899614|P3|Overall Study|Inclusion/exclusion criteria not met|0
1486778|NCT00559962|4899615|P2|Overall Study|Inclusion/exclusion criteria not met|0
1486779|NCT00559962|4899616|P1|Overall Study|Inclusion/exclusion criteria not met|0
1486780|NCT00559962|4899609|P8|Overall Study|Withdrawal by Subject|2
1486781|NCT00559962|4899610|P7|Overall Study|Withdrawal by Subject|0
1486782|NCT00559962|4899611|P6|Overall Study|Withdrawal by Subject|1
1486783|NCT00559962|4899612|P5|Overall Study|Withdrawal by Subject|3
1486784|NCT00559962|4899613|P4|Overall Study|Withdrawal by Subject|0
1486785|NCT00559962|4899614|P3|Overall Study|Withdrawal by Subject|2
1486786|NCT00559962|4899615|P2|Overall Study|Withdrawal by Subject|1
1486787|NCT00559962|4899616|P1|Overall Study|Withdrawal by Subject|1
1486788|NCT00559962|4899609|P8|Overall Study|Lost to Follow-up|0
1486789|NCT00559962|4899610|P7|Overall Study|Lost to Follow-up|0
1486790|NCT00559962|4899611|P6|Overall Study|Lost to Follow-up|0
1486791|NCT00559962|4899612|P5|Overall Study|Lost to Follow-up|0
1486792|NCT00559962|4899613|P4|Overall Study|Lost to Follow-up|0
1486793|NCT00559962|4899614|P3|Overall Study|Lost to Follow-up|0
1486794|NCT00559962|4899615|P2|Overall Study|Lost to Follow-up|1
1486795|NCT00559962|4899616|P1|Overall Study|Lost to Follow-up|0
1486796|NCT00559962|4899609|P8|Overall Study|Adverse Event|2
1486797|NCT00559962|4899610|P7|Overall Study|Adverse Event|4
1486798|NCT00559962|4899611|P6|Overall Study|Adverse Event|4
1486799|NCT00559962|4899612|P5|Overall Study|Adverse Event|11
1486800|NCT00559962|4899613|P4|Overall Study|Adverse Event|5
1486801|NCT00559962|4899614|P3|Overall Study|Adverse Event|8
1486802|NCT00559962|4899615|P2|Overall Study|Adverse Event|7
1486803|NCT00559962|4899616|P1|Overall Study|Adverse Event|1
1486804|NCT00559949|4899636|P1|Overall Study|No disease evaluation per protocol|1
1486805|NCT00559949|4899636|P1|Overall Study|Withdrawal by Subject|4
1486806|NCT00559949|4899636|P1|Overall Study|Adverse Event|1
1486807|NCT00559949|4899636|P1|Overall Study|Progressive Disease during cycle 1|1
1486808|NCT00559845|4899652|P1|Overall Study|Premature Surgery-Investigator Decision|1
1486809|NCT00559845|4899652|P1|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
1486810|NCT00559845|4899652|P1|Overall Study|Adverse Event|3
1486811|NCT00559845|4899652|P1|Overall Study|Disease Progression|1
1486812|NCT00559845|4899652|P1|Overall Study|Withdrew Consent|1
1486813|NCT00559754|4899661|P1|Overall Study|Withdrawal by Subject|2
1486814|NCT00559754|4899661|P1|Overall Study|Investigator criteria|2
1486815|NCT00559754|4899661|P1|Overall Study|Protocol Violation|1
1486816|NCT00559754|4899661|P1|Overall Study|Adverse Event|5
1486817|NCT00559754|4899661|P1|Overall Study|Disease progression|1
1486818|NCT00559637|4899685|P1|Overall Study|Inclusion or exclusion criteria violated|2
1486819|NCT00559637|4899685|P1|Overall Study|Change of home|1
1486820|NCT00559637|4899685|P1|Overall Study|Change of center|1
1486821|NCT00559637|4899685|P1|Overall Study|Delayed administration of C.E.R.A|1
1486822|NCT00559637|4899685|P1|Overall Study|Participation in another study|1
1486823|NCT00559637|4899685|P1|Overall Study|Suspected lung cancer|1
1486824|NCT00559637|4899685|P1|Overall Study|Started requiring dialysis after month 7|2
1486825|NCT00559637|4899685|P1|Overall Study|Insufficient response|3
1486826|NCT00559637|4899685|P1|Overall Study|Failure to return|6
1486827|NCT00559637|4899685|P1|Overall Study|Withdrawal criteria fulfilled|4
1486828|NCT00559637|4899685|P1|Overall Study|Protocol Violation|6
1486829|NCT00559637|4899685|P1|Overall Study|Withdrawal by Subject|4
1486830|NCT00559637|4899685|P1|Overall Study|Adverse Event|22
1486831|NCT00559585|4899698|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
1486832|NCT00559585|4899699|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
1486833|NCT00559585|4899698|P2|Open Label LT Period Main + Sub-Study|non-specified|0
1486834|NCT00559585|4899699|P1|Open Label LT Period Main + Sub-Study|non-specified|71
1486835|NCT00559585|4899698|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
1486836|NCT00559585|4899699|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
1486837|NCT00559585|4899698|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
1486838|NCT00559585|4899699|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
1486839|NCT00559585|4899698|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
1486840|NCT00559585|4899699|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
1486841|NCT00559585|4899698|P2|Open Label LT Period Main + Sub-Study|Death|0
1486842|NCT00559585|4899699|P1|Open Label LT Period Main + Sub-Study|Death|20
1486843|NCT00559585|4899698|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
1486844|NCT00559585|4899699|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
1486845|NCT00559585|4899698|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
1486846|NCT00559585|4899699|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
1486847|NCT00559585|4899698|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
1486848|NCT00559585|4899699|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
1486849|NCT00559585|4899698|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
1486850|NCT00559585|4899699|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
1486851|NCT00559585|4899698|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
1486852|NCT00559585|4899699|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
1486853|NCT00559585|4899698|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
1486854|NCT00559585|4899699|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
1486855|NCT00559585|4899698|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
1486856|NCT00559585|4899699|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
1486857|NCT00559585|4899698|P2|Double Blind ST Period Main Study|Investigator Decision|1
1486858|NCT00559585|4899699|P1|Double Blind ST Period Main Study|Investigator Decision|0
1486859|NCT00559585|4899698|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
1486860|NCT00559585|4899699|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
1486861|NCT00559585|4899698|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
1486862|NCT00559585|4899699|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
1486863|NCT00559585|4899698|P2|Double Blind ST Period Main Study|Early Discontinuation|1
1486864|NCT00559585|4899699|P1|Double Blind ST Period Main Study|Early Discontinuation|0
1486865|NCT00559585|4899698|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
1486866|NCT00559585|4899699|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
1486867|NCT00559585|4899698|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
1486868|NCT00559585|4899699|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
1486869|NCT00559585|4899698|P2|Double Blind ST Period Main Study|Missed Doses|1
1486870|NCT00559585|4899699|P1|Double Blind ST Period Main Study|Missed Doses|0
1486871|NCT00559585|4899698|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
1486872|NCT00559585|4899699|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
1486873|NCT00559585|4899698|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
1486874|NCT00559585|4899699|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
1486875|NCT00559585|4899698|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
1486876|NCT00559585|4899699|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
1486877|NCT00559585|4899698|P2|Double Blind ST Period Main Study|Death|1
1486878|NCT00559585|4899699|P1|Double Blind ST Period Main Study|Death|1
1486879|NCT00559585|4899698|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
1486880|NCT00559585|4899699|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
1486881|NCT00559585|4899698|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
1486882|NCT00559585|4899699|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
1486883|NCT00559585|4899698|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
1486884|NCT00559585|4899699|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
1486885|NCT00559585|4899698|P2|Double Blind ST Period Main Study|Adverse Event|25
1486886|NCT00559585|4899699|P1|Double Blind ST Period Main Study|Adverse Event|17
1486887|NCT00559507|4899759|P1|Overall Study|Not treated, patient ineligible|3
1486888|NCT00559377|4899765|P1|Overall Study|Withdrawal by Subject|9
1486889|NCT00559364|4899775|P2|Overall Study|Inclusion/exclusion criteria failure|0
1486890|NCT00559364|4899776|P1|Overall Study|Inclusion/exclusion criteria failure|1
1486891|NCT00559273|4899788|P2|Evaluation Period (8 Weeks)|Physician Decision|1
1486892|NCT00559273|4899789|P1|Evaluation Period (8 Weeks)|Physician Decision|0
1486893|NCT00559273|4899788|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
1486894|NCT00559273|4899789|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
1486895|NCT00559273|4899788|P2|Evaluation Period (8 Weeks)|Adverse Event|1
1486896|NCT00559273|4899789|P1|Evaluation Period (8 Weeks)|Adverse Event|0
1486897|NCT00559273|4899788|P2|Evaluation Period (8 Weeks)|Death|3
1486898|NCT00559273|4899789|P1|Evaluation Period (8 Weeks)|Death|1
1486899|NCT00559273|4899788|P2|Correction Period (20 Weeks)|Did not received study treatment|0
1486900|NCT00559273|4899789|P1|Correction Period (20 Weeks)|Did not received study treatment|2
1486901|NCT00559273|4899788|P2|Correction Period (20 Weeks)|Participant treated by another center|1
1486902|NCT00559273|4899789|P1|Correction Period (20 Weeks)|Participant treated by another center|0
1486903|NCT00559273|4899788|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
1486904|NCT00559273|4899789|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
1486905|NCT00559273|4899788|P2|Correction Period (20 Weeks)|Adverse Event|1
1486906|NCT00559273|4899789|P1|Correction Period (20 Weeks)|Adverse Event|2
1486907|NCT00559273|4899788|P2|Correction Period (20 Weeks)|Death|4
1486908|NCT00559273|4899789|P1|Correction Period (20 Weeks)|Death|3
1486909|NCT00559104|4899811|P2|Overall Study|Lack of Efficacy|0
1486910|NCT00559104|4899812|P1|Overall Study|Lack of Efficacy|9
1486911|NCT00558896|4899833|P7|Overall Study|Continues on treatment|6
1486912|NCT00558896|4899834|P6|Overall Study|Continues on treatment|25
1486913|NCT00558896|4899835|P5|Overall Study|Continues on treatment|9
1486914|NCT00558896|4899836|P4|Overall Study|Continues on treatment|1
1486915|NCT00558896|4899837|P3|Overall Study|Continues on treatment|0
1486916|NCT00558896|4899838|P2|Overall Study|Continues on treatment|1
1486917|NCT00558896|4899839|P1|Overall Study|Continues on treatment|10
1486918|NCT00558896|4899833|P7|Overall Study|Physician discretion|3
1486919|NCT00558896|4899834|P6|Overall Study|Physician discretion|3
1486920|NCT00558896|4899835|P5|Overall Study|Physician discretion|1
1486921|NCT00558896|4899836|P4|Overall Study|Physician discretion|2
1486922|NCT00558896|4899837|P3|Overall Study|Physician discretion|1
1486923|NCT00558896|4899838|P2|Overall Study|Physician discretion|2
1486924|NCT00558896|4899839|P1|Overall Study|Physician discretion|3
1486925|NCT00558896|4899833|P7|Overall Study|Alternative Treatment|1
1486926|NCT00558896|4899834|P6|Overall Study|Alternative Treatment|7
1486927|NCT00558896|4899835|P5|Overall Study|Alternative Treatment|6
1486928|NCT00558896|4899836|P4|Overall Study|Alternative Treatment|2
1486929|NCT00558896|4899837|P3|Overall Study|Alternative Treatment|0
1486930|NCT00558896|4899838|P2|Overall Study|Alternative Treatment|2
1486931|NCT00558896|4899839|P1|Overall Study|Alternative Treatment|2
1486932|NCT00558896|4899833|P7|Overall Study|Withdrawal by Subject|5
1486933|NCT00558896|4899834|P6|Overall Study|Withdrawal by Subject|5
1486934|NCT00558896|4899835|P5|Overall Study|Withdrawal by Subject|1
1486935|NCT00558896|4899836|P4|Overall Study|Withdrawal by Subject|1
1486936|NCT00558896|4899837|P3|Overall Study|Withdrawal by Subject|1
1486937|NCT00558896|4899838|P2|Overall Study|Withdrawal by Subject|1
1486938|NCT00558896|4899839|P1|Overall Study|Withdrawal by Subject|2
1486939|NCT00558896|4899833|P7|Overall Study|Death|6
1486940|NCT00558896|4899834|P6|Overall Study|Death|2
1486941|NCT00558896|4899835|P5|Overall Study|Death|2
1486942|NCT00558896|4899836|P4|Overall Study|Death|3
1486943|NCT00558896|4899837|P3|Overall Study|Death|2
1486944|NCT00558896|4899838|P2|Overall Study|Death|0
1486945|NCT00558896|4899839|P1|Overall Study|Death|3
1486946|NCT00558896|4899833|P7|Overall Study|Adverse Event|3
1486947|NCT00558896|4899834|P6|Overall Study|Adverse Event|10
1486948|NCT00558896|4899835|P5|Overall Study|Adverse Event|4
1486949|NCT00558896|4899836|P4|Overall Study|Adverse Event|3
1486950|NCT00558896|4899837|P3|Overall Study|Adverse Event|1
1486951|NCT00558896|4899838|P2|Overall Study|Adverse Event|1
1486952|NCT00558896|4899839|P1|Overall Study|Adverse Event|1
1486953|NCT00558831|4899880|P1|Overall Study|Lost to Follow-up|1
1486954|NCT00558753|4899937|P2|Overall Study|Lost to Follow-up|7
1486955|NCT00558753|4899938|P1|Overall Study|Lost to Follow-up|5
1486956|NCT00558701|4899950|P2|Overall Study|Protocol Deviations|4
1486957|NCT00558701|4899951|P1|Overall Study|Protocol Deviations|1
1486958|NCT00558636|4899959|P2|Follow-up|Premature termination of the study|7
1486959|NCT00558636|4899960|P1|Follow-up|Premature termination of the study|12
1486960|NCT00558636|4899959|P2|Treatment|Disease progression|5
1486961|NCT00558636|4899960|P1|Treatment|Disease progression|1
1486962|NCT00558636|4899959|P2|Treatment|Premature termination of the study|37
1486963|NCT00558636|4899960|P1|Treatment|Premature termination of the study|35
1486964|NCT00558636|4899959|P2|Treatment|Withdrawal by Subject|0
1486965|NCT00558636|4899960|P1|Treatment|Withdrawal by Subject|2
1486966|NCT00558636|4899959|P2|Treatment|Adverse Event|2
1486967|NCT00558636|4899960|P1|Treatment|Adverse Event|9
1486968|NCT00558558|4900060|P1|Overall Study|Lack of Efficacy|4
1486969|NCT00558558|4900060|P1|Overall Study|Withdrawal by Subject|1
1486970|NCT00558558|4900060|P1|Overall Study|Unable to swallow|1
1486971|NCT00558467|4900066|P2|Overall Study|Patient moving out of state|1
1486972|NCT00558467|4900067|P1|Overall Study|Patient moving out of state|0
1486973|NCT00558467|4900066|P2|Overall Study|Lack of Efficacy|1
1486974|NCT00558467|4900067|P1|Overall Study|Lack of Efficacy|0
1486975|NCT00558467|4900066|P2|Overall Study|Adverse Event|2
1486976|NCT00558467|4900067|P1|Overall Study|Adverse Event|1
1486977|NCT00558428|4900127|P4|Overall Study|Other|1
1486978|NCT00558428|4900128|P3|Overall Study|Other|0
1486979|NCT00558428|4900129|P2|Overall Study|Other|0
1486980|NCT00558428|4900130|P1|Overall Study|Other|3
1486981|NCT00558428|4900127|P4|Overall Study|Consent withdrawn|1
1486982|NCT00558428|4900128|P3|Overall Study|Consent withdrawn|0
1486983|NCT00558428|4900129|P2|Overall Study|Consent withdrawn|1
1486984|NCT00558428|4900130|P1|Overall Study|Consent withdrawn|2
1486985|NCT00558428|4900127|P4|Overall Study|Non compliant with protocol|3
1486986|NCT00558428|4900128|P3|Overall Study|Non compliant with protocol|0
1486987|NCT00558428|4900129|P2|Overall Study|Non compliant with protocol|0
1486988|NCT00558428|4900130|P1|Overall Study|Non compliant with protocol|1
1486989|NCT00558428|4900127|P4|Overall Study|Lack of Efficacy|2
1486990|NCT00558428|4900128|P3|Overall Study|Lack of Efficacy|1
1486991|NCT00558428|4900129|P2|Overall Study|Lack of Efficacy|0
1486992|NCT00558428|4900130|P1|Overall Study|Lack of Efficacy|0
1486993|NCT00558428|4900127|P4|Overall Study|Lost to Follow-up|0
1486994|NCT00558428|4900128|P3|Overall Study|Lost to Follow-up|0
1486995|NCT00558428|4900129|P2|Overall Study|Lost to Follow-up|1
1486996|NCT00558428|4900130|P1|Overall Study|Lost to Follow-up|0
1486997|NCT00558428|4900127|P4|Overall Study|Adverse Event|4
1486998|NCT00558428|4900128|P3|Overall Study|Adverse Event|3
1486999|NCT00558428|4900129|P2|Overall Study|Adverse Event|22
1487000|NCT00558428|4900130|P1|Overall Study|Adverse Event|6
1487001|NCT00558363|4900170|P2|Overall Study|Hospitalized; Unable to Continue|1
1487002|NCT00558363|4900171|P1|Overall Study|Hospitalized; Unable to Continue|0
1487003|NCT00558363|4900170|P2|Overall Study|Randomized in Error|2
1487004|NCT00558363|4900171|P1|Overall Study|Randomized in Error|1
1487005|NCT00558363|4900170|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
1487006|NCT00558363|4900171|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
1487007|NCT00558363|4900170|P2|Overall Study|Lost to Follow-up|1
1487008|NCT00558363|4900171|P1|Overall Study|Lost to Follow-up|0
1487009|NCT00558363|4900170|P2|Overall Study|Protocol Violation|1
1487010|NCT00558363|4900171|P1|Overall Study|Protocol Violation|2
1487011|NCT00558363|4900170|P2|Overall Study|Lack of Efficacy|2
1487012|NCT00558363|4900171|P1|Overall Study|Lack of Efficacy|2
1487013|NCT00558363|4900170|P2|Overall Study|Adverse Event|5
1487014|NCT00558363|4900171|P1|Overall Study|Adverse Event|5
1487015|NCT00558363|4900170|P2|Overall Study|Withdrawal by Subject|4
1487016|NCT00558363|4900171|P1|Overall Study|Withdrawal by Subject|11
1487017|NCT00558363|4900170|P2|Overall Study|Physician Decision|4
1487018|NCT00558363|4900171|P1|Overall Study|Physician Decision|18
1487019|NCT00558285|4900226|P5|Overall Study|Protocol deviation|0
1487020|NCT00558285|4900227|P4|Overall Study|Protocol deviation|1
1487021|NCT00558285|4900228|P3|Overall Study|Protocol deviation|0
1487022|NCT00558285|4900229|P2|Overall Study|Protocol deviation|1
1487023|NCT00558285|4900230|P1|Overall Study|Protocol deviation|1
1487024|NCT00558285|4900226|P5|Overall Study|Administrative problems|1
1487025|NCT00558285|4900227|P4|Overall Study|Administrative problems|1
1487026|NCT00558285|4900228|P3|Overall Study|Administrative problems|0
1487027|NCT00558285|4900229|P2|Overall Study|Administrative problems|0
1487028|NCT00558285|4900230|P1|Overall Study|Administrative problems|0
1487029|NCT00558285|4900226|P5|Overall Study|Lost to Follow-up|0
1487030|NCT00558285|4900227|P4|Overall Study|Lost to Follow-up|0
1487031|NCT00558285|4900228|P3|Overall Study|Lost to Follow-up|0
1487032|NCT00558285|4900229|P2|Overall Study|Lost to Follow-up|1
1487033|NCT00558285|4900230|P1|Overall Study|Lost to Follow-up|1
1487034|NCT00558285|4900226|P5|Overall Study|Subject withdrew consent|1
1487035|NCT00558285|4900227|P4|Overall Study|Subject withdrew consent|1
1487036|NCT00558285|4900228|P3|Overall Study|Subject withdrew consent|1
1487037|NCT00558285|4900229|P2|Overall Study|Subject withdrew consent|0
1487038|NCT00558285|4900230|P1|Overall Study|Subject withdrew consent|2
1487039|NCT00558285|4900226|P5|Overall Study|Abnormal test procedure result(s)|0
1487040|NCT00558285|4900227|P4|Overall Study|Abnormal test procedure result(s)|0
1487041|NCT00558285|4900228|P3|Overall Study|Abnormal test procedure result(s)|0
1487042|NCT00558285|4900229|P2|Overall Study|Abnormal test procedure result(s)|0
1487043|NCT00558285|4900230|P1|Overall Study|Abnormal test procedure result(s)|1
1487044|NCT00558285|4900226|P5|Overall Study|Adverse Event|2
1487045|NCT00558285|4900227|P4|Overall Study|Adverse Event|1
1487046|NCT00558285|4900228|P3|Overall Study|Adverse Event|4
1487047|NCT00558285|4900229|P2|Overall Study|Adverse Event|1
1487048|NCT00558285|4900230|P1|Overall Study|Adverse Event|1
1487049|NCT00558272|4900274|P2|Overall Study|Withdrawal by Subject|1
1487050|NCT00558272|4900275|P1|Overall Study|Withdrawal by Subject|0
1487051|NCT00558272|4900274|P2|Overall Study|Incorrectly enrolled|0
1487052|NCT00558272|4900275|P1|Overall Study|Incorrectly enrolled|1
1487053|NCT00558272|4900274|P2|Overall Study|AZ study team decision|1
1487054|NCT00558272|4900275|P1|Overall Study|AZ study team decision|0
1487055|NCT00558272|4900274|P2|Overall Study|Dev. of study specific discon. criteria|0
1487056|NCT00558272|4900275|P1|Overall Study|Dev. of study specific discon. criteria|1
1487057|NCT00558272|4900274|P2|Overall Study|Death|0
1487058|NCT00558272|4900275|P1|Overall Study|Death|1
1487059|NCT00558272|4900274|P2|Overall Study|Adverse Event|0
1487060|NCT00558272|4900275|P1|Overall Study|Adverse Event|10
1487061|NCT00558259|4900315|P2|Overall Study|Withdrawal by Subject|13
1487062|NCT00558259|4900316|P1|Overall Study|Withdrawal by Subject|12
1487063|NCT00558259|4900315|P2|Overall Study|Protocol Violation|5
1487064|NCT00558259|4900316|P1|Overall Study|Protocol Violation|9
1487065|NCT00558259|4900315|P2|Overall Study|Adverse Event|81
1487066|NCT00558259|4900316|P1|Overall Study|Adverse Event|50
1487067|NCT00558103|4900356|P6|Monotherapy Extension Phase|Disease Progression|8
1487068|NCT00558103|4900357|P5|Monotherapy Extension Phase|Disease Progression|0
1487069|NCT00558103|4900358|P4|Monotherapy Extension Phase|Disease Progression|0
1487070|NCT00558103|4900359|P3|Monotherapy Extension Phase|Disease Progression|0
1487071|NCT00558103|4900360|P2|Monotherapy Extension Phase|Disease Progression|0
1487072|NCT00558103|4900361|P1|Monotherapy Extension Phase|Disease Progression|0
1487073|NCT00558103|4900356|P6|Monotherapy Extension Phase|Protocol Violation|1
1487074|NCT00558103|4900357|P5|Monotherapy Extension Phase|Protocol Violation|0
1487075|NCT00558103|4900358|P4|Monotherapy Extension Phase|Protocol Violation|0
1487076|NCT00558103|4900359|P3|Monotherapy Extension Phase|Protocol Violation|0
1487077|NCT00558103|4900360|P2|Monotherapy Extension Phase|Protocol Violation|0
1487078|NCT00558103|4900361|P1|Monotherapy Extension Phase|Protocol Violation|0
1487079|NCT00558103|4900356|P6|Randomized Treatment Phase|Adverse Event|0
1487080|NCT00558103|4900357|P5|Randomized Treatment Phase|Adverse Event|1
1487081|NCT00558103|4900358|P4|Randomized Treatment Phase|Adverse Event|1
1487082|NCT00558103|4900359|P3|Randomized Treatment Phase|Adverse Event|0
1487083|NCT00558103|4900360|P2|Randomized Treatment Phase|Adverse Event|0
1487084|NCT00558103|4900361|P1|Randomized Treatment Phase|Adverse Event|0
1487085|NCT00558103|4900356|P6|Randomized Treatment Phase|Disease Progression|0
1487086|NCT00558103|4900357|P5|Randomized Treatment Phase|Disease Progression|0
1487087|NCT00558103|4900358|P4|Randomized Treatment Phase|Disease Progression|0
1487088|NCT00558103|4900359|P3|Randomized Treatment Phase|Disease Progression|1
1487089|NCT00558103|4900360|P2|Randomized Treatment Phase|Disease Progression|0
1487090|NCT00558103|4900361|P1|Randomized Treatment Phase|Disease Progression|1
1487091|NCT00558103|4900356|P6|Randomized Treatment Phase|Withdrawal by Subject|0
1487092|NCT00558103|4900357|P5|Randomized Treatment Phase|Withdrawal by Subject|1
1487093|NCT00558103|4900358|P4|Randomized Treatment Phase|Withdrawal by Subject|0
1487094|NCT00558103|4900359|P3|Randomized Treatment Phase|Withdrawal by Subject|0
1487095|NCT00558103|4900360|P2|Randomized Treatment Phase|Withdrawal by Subject|2
1487096|NCT00558103|4900361|P1|Randomized Treatment Phase|Withdrawal by Subject|2
1487097|NCT00558103|4900356|P6|Randomized Treatment Phase|Lost to Follow-up|0
1487098|NCT00558103|4900357|P5|Randomized Treatment Phase|Lost to Follow-up|3
1487099|NCT00558103|4900358|P4|Randomized Treatment Phase|Lost to Follow-up|1
1487100|NCT00558103|4900359|P3|Randomized Treatment Phase|Lost to Follow-up|2
1487101|NCT00558103|4900360|P2|Randomized Treatment Phase|Lost to Follow-up|2
1487102|NCT00558103|4900361|P1|Randomized Treatment Phase|Lost to Follow-up|2
1487103|NCT00558064|4900391|P2|Overall Study|No visit within allowance period|0
1487104|NCT00558064|4900392|P1|Overall Study|No visit within allowance period|1
1487105|NCT00558064|4900391|P2|Overall Study|Withdrawal by Subject|1
1487106|NCT00558064|4900392|P1|Overall Study|Withdrawal by Subject|0
1487107|NCT00558064|4900391|P2|Overall Study|Lost to Follow-up|1
1487108|NCT00558064|4900392|P1|Overall Study|Lost to Follow-up|0
1487109|NCT00558064|4900391|P2|Overall Study|Protocol Violation|0
1487110|NCT00558064|4900392|P1|Overall Study|Protocol Violation|1
1487111|NCT00558064|4900391|P2|Overall Study|Lack of Efficacy|1
1487112|NCT00558064|4900392|P1|Overall Study|Lack of Efficacy|0
1487113|NCT00558064|4900391|P2|Overall Study|Adverse Event|2
1487114|NCT00558064|4900392|P1|Overall Study|Adverse Event|3
1487115|NCT00558025|4900414|P2|Overall Study|Protocol Violation|0
1487116|NCT00558025|4900415|P1|Overall Study|Protocol Violation|1
1487117|NCT00558025|4900414|P2|Overall Study|Withdrawal by Subject|2
1487118|NCT00558025|4900415|P1|Overall Study|Withdrawal by Subject|2
1487119|NCT00558025|4900414|P2|Overall Study|Adverse Event|1
1487120|NCT00558025|4900415|P1|Overall Study|Adverse Event|1
1487121|NCT00557856|4900462|P9|Part 2: Exploratory Phase|global deterioration of health status|1
1487122|NCT00557856|4900463|P8|Part 2: Exploratory Phase|global deterioration of health status|0
1487123|NCT00557856|4900464|P7|Part 2: Exploratory Phase|global deterioration of health status|0
1487124|NCT00557856|4900465|P6|Part 2: Exploratory Phase|global deterioration of health status|0
1487125|NCT00557856|4900466|P5|Part 2: Exploratory Phase|global deterioration of health status|0
1487126|NCT00557856|4900467|P4|Part 2: Exploratory Phase|global deterioration of health status|0
1487127|NCT00557856|4900468|P3|Part 2: Exploratory Phase|global deterioration of health status|0
1487128|NCT00557856|4900469|P2|Part 2: Exploratory Phase|global deterioration of health status|0
1487129|NCT00557856|4900470|P1|Part 2: Exploratory Phase|global deterioration of health status|0
1487130|NCT00557856|4900462|P9|Part 2: Exploratory Phase|Death|2
1487131|NCT00557856|4900463|P8|Part 2: Exploratory Phase|Death|0
1487132|NCT00557856|4900464|P7|Part 2: Exploratory Phase|Death|0
1487133|NCT00557856|4900465|P6|Part 2: Exploratory Phase|Death|0
1487134|NCT00557856|4900466|P5|Part 2: Exploratory Phase|Death|0
1487135|NCT00557856|4900467|P4|Part 2: Exploratory Phase|Death|0
1487136|NCT00557856|4900468|P3|Part 2: Exploratory Phase|Death|0
1487137|NCT00557856|4900469|P2|Part 2: Exploratory Phase|Death|0
1487138|NCT00557856|4900470|P1|Part 2: Exploratory Phase|Death|0
1487139|NCT00557856|4900462|P9|Part 2: Exploratory Phase|Other|1
1487140|NCT00557856|4900463|P8|Part 2: Exploratory Phase|Other|0
1487141|NCT00557856|4900464|P7|Part 2: Exploratory Phase|Other|0
1487142|NCT00557856|4900465|P6|Part 2: Exploratory Phase|Other|0
1487143|NCT00557856|4900466|P5|Part 2: Exploratory Phase|Other|0
1487144|NCT00557856|4900467|P4|Part 2: Exploratory Phase|Other|0
1487145|NCT00557856|4900468|P3|Part 2: Exploratory Phase|Other|0
1487146|NCT00557856|4900469|P2|Part 2: Exploratory Phase|Other|0
1487147|NCT00557856|4900470|P1|Part 2: Exploratory Phase|Other|0
1487148|NCT00557856|4900462|P9|Part 2: Exploratory Phase|Adverse Event|4
1487149|NCT00557856|4900463|P8|Part 2: Exploratory Phase|Adverse Event|0
1487150|NCT00557856|4900464|P7|Part 2: Exploratory Phase|Adverse Event|0
1487151|NCT00557856|4900465|P6|Part 2: Exploratory Phase|Adverse Event|0
1487152|NCT00557856|4900466|P5|Part 2: Exploratory Phase|Adverse Event|0
1487153|NCT00557856|4900467|P4|Part 2: Exploratory Phase|Adverse Event|0
1487154|NCT00557856|4900468|P3|Part 2: Exploratory Phase|Adverse Event|0
1487155|NCT00557856|4900469|P2|Part 2: Exploratory Phase|Adverse Event|0
1487156|NCT00557856|4900470|P1|Part 2: Exploratory Phase|Adverse Event|0
1487157|NCT00557856|4900462|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
1487158|NCT00557856|4900463|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
1487159|NCT00557856|4900464|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
1487160|NCT00557856|4900465|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
1487161|NCT00557856|4900466|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
1487162|NCT00557856|4900467|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
1487163|NCT00557856|4900468|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
1487164|NCT00557856|4900469|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
1487165|NCT00557856|4900470|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
1487166|NCT00557856|4900462|P9|Part 2: Exploratory Phase|objective progression or relapse|15
1487167|NCT00557856|4900463|P8|Part 2: Exploratory Phase|objective progression or relapse|0
1487168|NCT00557856|4900464|P7|Part 2: Exploratory Phase|objective progression or relapse|0
1487169|NCT00557856|4900465|P6|Part 2: Exploratory Phase|objective progression or relapse|0
1487170|NCT00557856|4900466|P5|Part 2: Exploratory Phase|objective progression or relapse|0
1487171|NCT00557856|4900467|P4|Part 2: Exploratory Phase|objective progression or relapse|0
1487172|NCT00557856|4900468|P3|Part 2: Exploratory Phase|objective progression or relapse|0
1487173|NCT00557856|4900469|P2|Part 2: Exploratory Phase|objective progression or relapse|0
1487174|NCT00557856|4900470|P1|Part 2: Exploratory Phase|objective progression or relapse|0
1487175|NCT00557856|4900462|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
1487176|NCT00557856|4900463|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
1487177|NCT00557856|4900464|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
1487178|NCT00557856|4900465|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
1487179|NCT00557856|4900466|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
1487180|NCT00557856|4900467|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
1487181|NCT00557856|4900468|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
1487182|NCT00557856|4900469|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
1487183|NCT00557856|4900470|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
1487184|NCT00557856|4900462|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
1487185|NCT00557856|4900463|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
1487186|NCT00557856|4900464|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
1487187|NCT00557856|4900465|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
1487188|NCT00557856|4900466|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
1487189|NCT00557856|4900467|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
1487190|NCT00557856|4900468|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
1487191|NCT00557856|4900469|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
1487192|NCT00557856|4900470|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
1487193|NCT00557856|4900462|P9|Part 1: Dose Escalation Phase|Death|0
1487194|NCT00557856|4900463|P8|Part 1: Dose Escalation Phase|Death|0
1487195|NCT00557856|4900464|P7|Part 1: Dose Escalation Phase|Death|0
1487196|NCT00557856|4900465|P6|Part 1: Dose Escalation Phase|Death|1
1487197|NCT00557856|4900466|P5|Part 1: Dose Escalation Phase|Death|0
1487198|NCT00557856|4900467|P4|Part 1: Dose Escalation Phase|Death|0
1487199|NCT00557856|4900468|P3|Part 1: Dose Escalation Phase|Death|0
1487200|NCT00557856|4900469|P2|Part 1: Dose Escalation Phase|Death|0
1487201|NCT00557856|4900470|P1|Part 1: Dose Escalation Phase|Death|0
1487202|NCT00557856|4900462|P9|Part 1: Dose Escalation Phase|Other|0
1487203|NCT00557856|4900463|P8|Part 1: Dose Escalation Phase|Other|1
1487204|NCT00557856|4900464|P7|Part 1: Dose Escalation Phase|Other|0
1487205|NCT00557856|4900465|P6|Part 1: Dose Escalation Phase|Other|0
1487206|NCT00557856|4900466|P5|Part 1: Dose Escalation Phase|Other|0
1487207|NCT00557856|4900467|P4|Part 1: Dose Escalation Phase|Other|1
1487208|NCT00557856|4900468|P3|Part 1: Dose Escalation Phase|Other|1
1487209|NCT00557856|4900469|P2|Part 1: Dose Escalation Phase|Other|0
1487210|NCT00557856|4900470|P1|Part 1: Dose Escalation Phase|Other|0
1487211|NCT00557856|4900462|P9|Part 1: Dose Escalation Phase|Adverse Event|0
1487212|NCT00557856|4900463|P8|Part 1: Dose Escalation Phase|Adverse Event|2
1487213|NCT00557856|4900464|P7|Part 1: Dose Escalation Phase|Adverse Event|1
1487214|NCT00557856|4900465|P6|Part 1: Dose Escalation Phase|Adverse Event|3
1487215|NCT00557856|4900466|P5|Part 1: Dose Escalation Phase|Adverse Event|1
1487216|NCT00557856|4900467|P4|Part 1: Dose Escalation Phase|Adverse Event|1
1487217|NCT00557856|4900468|P3|Part 1: Dose Escalation Phase|Adverse Event|1
1487218|NCT00557856|4900469|P2|Part 1: Dose Escalation Phase|Adverse Event|0
1487219|NCT00557856|4900470|P1|Part 1: Dose Escalation Phase|Adverse Event|1
1487220|NCT00557856|4900462|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1487221|NCT00557856|4900463|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1487222|NCT00557856|4900464|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1487223|NCT00557856|4900465|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1487224|NCT00557856|4900466|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1487225|NCT00557856|4900467|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1487226|NCT00557856|4900468|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
1487227|NCT00557856|4900469|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1487228|NCT00557856|4900470|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
1487229|NCT00557856|4900462|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
1487230|NCT00557856|4900463|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
1487231|NCT00557856|4900464|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
1487232|NCT00557856|4900465|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
1487233|NCT00557856|4900466|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
1487234|NCT00557856|4900467|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
1487235|NCT00557856|4900468|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
1487236|NCT00557856|4900469|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
1487237|NCT00557856|4900470|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
1487238|NCT00557830|4900669|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
1487239|NCT00557830|4900670|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
1487240|NCT00557830|4900671|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
1487241|NCT00557830|4900669|P3|Screening Treatment Phase|Adverse Event|0
1487242|NCT00557830|4900670|P2|Screening Treatment Phase|Adverse Event|0
1487243|NCT00557830|4900671|P1|Screening Treatment Phase|Adverse Event|2
1487244|NCT00557830|4900669|P3|Screening Treatment Phase|Withdrawal by Subject|0
1487245|NCT00557830|4900670|P2|Screening Treatment Phase|Withdrawal by Subject|0
1487246|NCT00557830|4900671|P1|Screening Treatment Phase|Withdrawal by Subject|1
1487247|NCT00557622|4900693|P2|12-Week Treatment Phase|Lost to Follow-up|1
1487248|NCT00557622|4900694|P1|12-Week Treatment Phase|Lost to Follow-up|0
1487249|NCT00557622|4900693|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
1487250|NCT00557622|4900694|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
1487251|NCT00557622|4900693|P2|4-Week Run-in Phase|Withdrawal by Subject|0
1487252|NCT00557622|4900694|P1|4-Week Run-in Phase|Withdrawal by Subject|1
1487253|NCT00557505|4900723|P9|Overall Study|Withdrawal by Subject|1
1487254|NCT00557505|4900724|P8|Overall Study|Withdrawal by Subject|0
1487255|NCT00557505|4900725|P7|Overall Study|Withdrawal by Subject|0
1487256|NCT00557505|4900726|P6|Overall Study|Withdrawal by Subject|0
1487257|NCT00557505|4900727|P5|Overall Study|Withdrawal by Subject|0
1487258|NCT00557505|4900728|P4|Overall Study|Withdrawal by Subject|1
1487259|NCT00557505|4900729|P3|Overall Study|Withdrawal by Subject|0
1487260|NCT00557505|4900730|P2|Overall Study|Withdrawal by Subject|0
1487261|NCT00557505|4900731|P1|Overall Study|Withdrawal by Subject|0
1487262|NCT00557505|4900723|P9|Overall Study|Objective progression or relapse|15
1487263|NCT00557505|4900724|P8|Overall Study|Objective progression or relapse|5
1487264|NCT00557505|4900725|P7|Overall Study|Objective progression or relapse|2
1487265|NCT00557505|4900726|P6|Overall Study|Objective progression or relapse|3
1487266|NCT00557505|4900727|P5|Overall Study|Objective progression or relapse|2
1487267|NCT00557505|4900728|P4|Overall Study|Objective progression or relapse|2
1487268|NCT00557505|4900729|P3|Overall Study|Objective progression or relapse|3
1487269|NCT00557505|4900730|P2|Overall Study|Objective progression or relapse|3
1487270|NCT00557505|4900731|P1|Overall Study|Objective progression or relapse|2
1487271|NCT00557505|4900723|P9|Overall Study|Global deterioration of health|0
1487272|NCT00557505|4900724|P8|Overall Study|Global deterioration of health|0
1487273|NCT00557505|4900725|P7|Overall Study|Global deterioration of health|0
1487274|NCT00557505|4900726|P6|Overall Study|Global deterioration of health|0
1487275|NCT00557505|4900727|P5|Overall Study|Global deterioration of health|0
1487276|NCT00557505|4900728|P4|Overall Study|Global deterioration of health|0
1487277|NCT00557505|4900729|P3|Overall Study|Global deterioration of health|0
1487278|NCT00557505|4900730|P2|Overall Study|Global deterioration of health|0
1487279|NCT00557505|4900731|P1|Overall Study|Global deterioration of health|1
1487280|NCT00557505|4900723|P9|Overall Study|Adverse Event|0
1487281|NCT00557505|4900724|P8|Overall Study|Adverse Event|0
1487282|NCT00557505|4900725|P7|Overall Study|Adverse Event|1
1487283|NCT00557505|4900726|P6|Overall Study|Adverse Event|0
1487284|NCT00557505|4900727|P5|Overall Study|Adverse Event|0
1487285|NCT00557505|4900728|P4|Overall Study|Adverse Event|0
1487286|NCT00557505|4900729|P3|Overall Study|Adverse Event|1
1487287|NCT00557505|4900730|P2|Overall Study|Adverse Event|0
1487288|NCT00557505|4900731|P1|Overall Study|Adverse Event|0
1487289|NCT00557505|4900723|P9|Overall Study|Death|1
1487290|NCT00557505|4900724|P8|Overall Study|Death|0
1487291|NCT00557505|4900725|P7|Overall Study|Death|0
1487292|NCT00557505|4900726|P6|Overall Study|Death|0
1487293|NCT00557505|4900727|P5|Overall Study|Death|0
1487294|NCT00557505|4900728|P4|Overall Study|Death|0
1487295|NCT00557505|4900729|P3|Overall Study|Death|0
1487296|NCT00557505|4900730|P2|Overall Study|Death|0
1487297|NCT00557505|4900731|P1|Overall Study|Death|0
1487298|NCT00557492|4900895|P1|Overall Study|Change in health insurance|1
1487299|NCT00557466|4900913|P6|Overall Study|Lost to Follow-up|0
1487300|NCT00557466|4900914|P5|Overall Study|Lost to Follow-up|0
1487301|NCT00557466|4900915|P4|Overall Study|Lost to Follow-up|1
1487302|NCT00557466|4900916|P3|Overall Study|Lost to Follow-up|0
1487303|NCT00557466|4900917|P2|Overall Study|Lost to Follow-up|0
1487304|NCT00557466|4900918|P1|Overall Study|Lost to Follow-up|0
1487305|NCT00557466|4900913|P6|Overall Study|Abnormal test procedure results|0
1487306|NCT00557466|4900914|P5|Overall Study|Abnormal test procedure results|0
1487307|NCT00557466|4900915|P4|Overall Study|Abnormal test procedure results|0
1487308|NCT00557466|4900916|P3|Overall Study|Abnormal test procedure results|1
1487309|NCT00557466|4900917|P2|Overall Study|Abnormal test procedure results|0
1487310|NCT00557466|4900918|P1|Overall Study|Abnormal test procedure results|0
1487311|NCT00557466|4900913|P6|Overall Study|Administrative problems|0
1487312|NCT00557466|4900914|P5|Overall Study|Administrative problems|0
1487313|NCT00557466|4900915|P4|Overall Study|Administrative problems|0
1487314|NCT00557466|4900916|P3|Overall Study|Administrative problems|1
1487315|NCT00557466|4900917|P2|Overall Study|Administrative problems|1
1487316|NCT00557466|4900918|P1|Overall Study|Administrative problems|0
1487317|NCT00557466|4900913|P6|Overall Study|Subject withdrew consent|2
1487318|NCT00557466|4900914|P5|Overall Study|Subject withdrew consent|1
1487319|NCT00557466|4900915|P4|Overall Study|Subject withdrew consent|0
1487320|NCT00557466|4900916|P3|Overall Study|Subject withdrew consent|0
1487321|NCT00557466|4900917|P2|Overall Study|Subject withdrew consent|0
1487322|NCT00557466|4900918|P1|Overall Study|Subject withdrew consent|0
1487323|NCT00557466|4900913|P6|Overall Study|Protocol deviation|0
1487324|NCT00557466|4900914|P5|Overall Study|Protocol deviation|0
1487325|NCT00557466|4900915|P4|Overall Study|Protocol deviation|2
1487326|NCT00557466|4900916|P3|Overall Study|Protocol deviation|0
1487327|NCT00557466|4900917|P2|Overall Study|Protocol deviation|1
1487328|NCT00557466|4900918|P1|Overall Study|Protocol deviation|0
1487329|NCT00557466|4900913|P6|Overall Study|Abnormal laboratory value(s)|0
1487330|NCT00557466|4900914|P5|Overall Study|Abnormal laboratory value(s)|0
1487331|NCT00557466|4900915|P4|Overall Study|Abnormal laboratory value(s)|0
1487332|NCT00557466|4900916|P3|Overall Study|Abnormal laboratory value(s)|0
1487333|NCT00557466|4900917|P2|Overall Study|Abnormal laboratory value(s)|2
1487334|NCT00557466|4900918|P1|Overall Study|Abnormal laboratory value(s)|1
1487335|NCT00557466|4900913|P6|Overall Study|Adverse Event|4
1487336|NCT00557466|4900914|P5|Overall Study|Adverse Event|2
1487337|NCT00557466|4900915|P4|Overall Study|Adverse Event|1
1487338|NCT00557466|4900916|P3|Overall Study|Adverse Event|4
1487339|NCT00557466|4900917|P2|Overall Study|Adverse Event|1
1487340|NCT00557466|4900918|P1|Overall Study|Adverse Event|3
1487341|NCT00557440|4900971|P3|Treatment Period 1|Adverse Event|1
1487342|NCT00557440|4900972|P2|Treatment Period 1|Adverse Event|0
1487343|NCT00557440|4900973|P1|Treatment Period 1|Adverse Event|0
1487344|NCT00557323|4901027|P1|Overall Study|Administrative change|2
1487345|NCT00557323|4901027|P1|Overall Study|Withdrawal by Subject|2
1487346|NCT00557323|4901027|P1|Overall Study|Death|3
1487347|NCT00557310|4901032|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
1487348|NCT00557310|4901032|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
1487349|NCT00557310|4901032|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
1487350|NCT00557310|4901032|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
1487351|NCT00557310|4901032|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
1487352|NCT00557310|4901032|P1|Main Study (0 - 18 Months)|Adverse Event|4
1487353|NCT00557245|4901078|P3|Overall Study|Ineligible|2
1487354|NCT00557245|4901079|P2|Overall Study|Ineligible|4
1487355|NCT00557245|4901080|P1|Overall Study|Ineligible|5
1487356|NCT00557245|4901078|P3|Overall Study|Lost to Follow-up|10
1487357|NCT00557245|4901079|P2|Overall Study|Lost to Follow-up|8
1487358|NCT00557245|4901080|P1|Overall Study|Lost to Follow-up|7
1487359|NCT00557076|4901120|P2|Overall Study|Unblinding|1
1487360|NCT00557076|4901121|P1|Overall Study|Unblinding|0
1487361|NCT00556998|4901129|P1|Voriconazole Oral|Intolerant of oral treatment|1
1487362|NCT00556998|4901129|P1|Voriconazole Oral|Adverse Event|1
1487363|NCT00556998|4901129|P1|Voriconazole Intravenous (IV)|Other|4
1487364|NCT00556998|4901129|P1|Voriconazole Intravenous (IV)|Adverse Event|1
1487365|NCT00556933|4901164|P4|CNI Withdrawal vs. Minimization|Death|1
1487366|NCT00556933|4901165|P3|CNI Withdrawal vs. Minimization|Death|0
1487367|NCT00556933|4901166|P2|CNI Withdrawal vs. Minimization|Death|0
1487368|NCT00556933|4901167|P1|CNI Withdrawal vs. Minimization|Death|0
1487369|NCT00556933|4901164|P4|CNI Withdrawal vs. Minimization|Graft loss|0
1487370|NCT00556933|4901165|P3|CNI Withdrawal vs. Minimization|Graft loss|2
1487371|NCT00556933|4901166|P2|CNI Withdrawal vs. Minimization|Graft loss|1
1487372|NCT00556933|4901167|P1|CNI Withdrawal vs. Minimization|Graft loss|0
1487373|NCT00556933|4901164|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
1487374|NCT00556933|4901165|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
1487375|NCT00556933|4901166|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
1487376|NCT00556933|4901167|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
1487377|NCT00556933|4901164|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
1487378|NCT00556933|4901165|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
1487379|NCT00556933|4901166|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
1487380|NCT00556933|4901167|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
1487381|NCT00556933|4901164|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
1487382|NCT00556933|4901165|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
1487383|NCT00556933|4901166|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
1487384|NCT00556933|4901167|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
1487385|NCT00556933|4901164|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
1487386|NCT00556933|4901165|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
1487387|NCT00556933|4901166|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
1487388|NCT00556933|4901167|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
1487389|NCT00556933|4901164|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
1487390|NCT00556933|4901165|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
1487391|NCT00556933|4901166|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
1487392|NCT00556933|4901167|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
1487393|NCT00556933|4901164|P4|Single vs. Divided-dose rATG Induction|Death|0
1487394|NCT00556933|4901165|P3|Single vs. Divided-dose rATG Induction|Death|0
1487395|NCT00556933|4901166|P2|Single vs. Divided-dose rATG Induction|Death|1
1487396|NCT00556933|4901167|P1|Single vs. Divided-dose rATG Induction|Death|0
1487397|NCT00556933|4901164|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
1487398|NCT00556933|4901165|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
1487399|NCT00556933|4901166|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
1487400|NCT00556933|4901167|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
1487401|NCT00556933|4901164|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
1487402|NCT00556933|4901165|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
1487403|NCT00556933|4901166|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
1487404|NCT00556933|4901167|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
1487405|NCT00556933|4901164|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
1487406|NCT00556933|4901165|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
1487407|NCT00556933|4901166|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
1487408|NCT00556933|4901167|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
1487409|NCT00556894|4901224|P3|Overall Study|Withdrawal by Subject|1
1487410|NCT00556894|4901225|P2|Overall Study|Withdrawal by Subject|1
1487411|NCT00556894|4901226|P1|Overall Study|Withdrawal by Subject|1
1487412|NCT00556894|4901224|P3|Overall Study|Change in therapy|2
1487413|NCT00556894|4901225|P2|Overall Study|Change in therapy|1
1487414|NCT00556894|4901226|P1|Overall Study|Change in therapy|2
1487415|NCT00556894|4901224|P3|Overall Study|regulatory decision in Bulgaria|13
1487416|NCT00556894|4901225|P2|Overall Study|regulatory decision in Bulgaria|14
1487417|NCT00556894|4901226|P1|Overall Study|regulatory decision in Bulgaria|10
1487418|NCT00556894|4901224|P3|Overall Study|Death|0
1487419|NCT00556894|4901225|P2|Overall Study|Death|0
1487420|NCT00556894|4901226|P1|Overall Study|Death|1
1487421|NCT00556894|4901224|P3|Overall Study|Adverse Event|3
1487422|NCT00556894|4901225|P2|Overall Study|Adverse Event|3
1487423|NCT00556894|4901226|P1|Overall Study|Adverse Event|2
1487424|NCT00556712|4901236|P2|Overall Study|Ongoing at Data Cutoff|66
1487425|NCT00556712|4901237|P1|Overall Study|Ongoing at Data Cutoff|32
1487426|NCT00556712|4901236|P2|Overall Study|Not Specified|2
1487427|NCT00556712|4901237|P1|Overall Study|Not Specified|2
1487428|NCT00556712|4901236|P2|Overall Study|Failure to Return|3
1487429|NCT00556712|4901237|P1|Overall Study|Failure to Return|2
1487430|NCT00556712|4901236|P2|Overall Study|Refused Treatment|16
1487431|NCT00556712|4901237|P1|Overall Study|Refused Treatment|17
1487432|NCT00556712|4901236|P2|Overall Study|Protocol Violation|2
1487433|NCT00556712|4901237|P1|Overall Study|Protocol Violation|3
1487434|NCT00556712|4901236|P2|Overall Study|Progressive Disease|320
1487435|NCT00556712|4901237|P1|Overall Study|Progressive Disease|383
1487436|NCT00556712|4901236|P2|Overall Study|Death|10
1487437|NCT00556712|4901237|P1|Overall Study|Death|5
1487438|NCT00556712|4901236|P2|Overall Study|Adverse Event|19
1487439|NCT00556712|4901237|P1|Overall Study|Adverse Event|7
1487440|NCT00556673|4901315|P2|Overall Study|Protocol deviation|2
1487441|NCT00556673|4901316|P1|Overall Study|Protocol deviation|3
1487442|NCT00556439|4901452|P4|After Week 12 (Randomized Study Period)|Severe infection|0
1487443|NCT00556439|4901453|P3|After Week 12 (Randomized Study Period)|Severe infection|0
1487444|NCT00556439|4901454|P2|After Week 12 (Randomized Study Period)|Severe infection|0
1487445|NCT00556439|4901455|P1|After Week 12 (Randomized Study Period)|Severe infection|1
1487446|NCT00556439|4901452|P4|After Week 12 (Randomized Study Period)|Malignancy|1
1487447|NCT00556439|4901453|P3|After Week 12 (Randomized Study Period)|Malignancy|0
1487448|NCT00556439|4901454|P2|After Week 12 (Randomized Study Period)|Malignancy|1
1487449|NCT00556439|4901455|P1|After Week 12 (Randomized Study Period)|Malignancy|0
1487450|NCT00556439|4901452|P4|After Week 12 (Randomized Study Period)|Physician Decision|0
1487451|NCT00556439|4901453|P3|After Week 12 (Randomized Study Period)|Physician Decision|0
1487452|NCT00556439|4901454|P2|After Week 12 (Randomized Study Period)|Physician Decision|0
1487453|NCT00556439|4901455|P1|After Week 12 (Randomized Study Period)|Physician Decision|1
1487454|NCT00556439|4901452|P4|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
1487455|NCT00556439|4901453|P3|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
1487456|NCT00556439|4901454|P2|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
1487457|NCT00556439|4901455|P1|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
1487458|NCT00556439|4901452|P4|Study Entry to Week 12|Malignancy|0
1487459|NCT00556439|4901453|P3|Study Entry to Week 12|Malignancy|1
1487460|NCT00556439|4901454|P2|Study Entry to Week 12|Malignancy|0
1487461|NCT00556439|4901455|P1|Study Entry to Week 12|Malignancy|0
1487462|NCT00556439|4901452|P4|Study Entry to Week 12|Recurrent infection|0
1487463|NCT00556439|4901453|P3|Study Entry to Week 12|Recurrent infection|0
1487464|NCT00556439|4901454|P2|Study Entry to Week 12|Recurrent infection|0
1487465|NCT00556439|4901455|P1|Study Entry to Week 12|Recurrent infection|1
1487466|NCT00556439|4901452|P4|Study Entry to Week 12|Withdrawal by Subject|0
1487467|NCT00556439|4901453|P3|Study Entry to Week 12|Withdrawal by Subject|1
1487468|NCT00556439|4901454|P2|Study Entry to Week 12|Withdrawal by Subject|0
1487469|NCT00556439|4901455|P1|Study Entry to Week 12|Withdrawal by Subject|1
1487470|NCT00556439|4901452|P4|Study Entry to Week 12|Physician Decision|0
1487471|NCT00556439|4901453|P3|Study Entry to Week 12|Physician Decision|0
1487472|NCT00556439|4901454|P2|Study Entry to Week 12|Physician Decision|0
1487473|NCT00556439|4901455|P1|Study Entry to Week 12|Physician Decision|1
1487474|NCT00556439|4901452|P4|Study Entry to Week 12|Lack of Efficacy|0
1487475|NCT00556439|4901453|P3|Study Entry to Week 12|Lack of Efficacy|6
1487476|NCT00556439|4901454|P2|Study Entry to Week 12|Lack of Efficacy|0
1487477|NCT00556439|4901455|P1|Study Entry to Week 12|Lack of Efficacy|5
1487478|NCT00556426|4901465|P1|Overall Study|Death|6
1487479|NCT00556426|4901465|P1|Overall Study|Withdrawal by Subject|3
1487480|NCT00556374|4901487|P2|Overall Study|Lost to Follow-up|5
1487481|NCT00556374|4901488|P1|Overall Study|Lost to Follow-up|7
1487482|NCT00556374|4901487|P2|Overall Study|Death|43
1487483|NCT00556374|4901488|P1|Overall Study|Death|50
1487484|NCT00556374|4901487|P2|Overall Study|Withdrawal by Subject|172
1487485|NCT00556374|4901488|P1|Overall Study|Withdrawal by Subject|190
1487486|NCT00556322|4901506|P2|Overall Study|Death|14
1487487|NCT00556322|4901507|P1|Overall Study|Death|20
1487488|NCT00556322|4901506|P2|Overall Study|Ongoing at data cutoff|5
1487489|NCT00556322|4901507|P1|Overall Study|Ongoing at data cutoff|3
1487490|NCT00556322|4901506|P2|Overall Study|Protocol Violation|1
1487491|NCT00556322|4901507|P1|Overall Study|Protocol Violation|5
1487492|NCT00556322|4901506|P2|Overall Study|Withdrawal by Subject|7
1487493|NCT00556322|4901507|P1|Overall Study|Withdrawal by Subject|19
1487494|NCT00556322|4901506|P2|Overall Study|Lost to Follow-up|3
1487495|NCT00556322|4901507|P1|Overall Study|Lost to Follow-up|5
1487496|NCT00556322|4901506|P2|Overall Study|Other|1
1487497|NCT00556322|4901507|P1|Overall Study|Other|4
1487498|NCT00556322|4901506|P2|Overall Study|Adverse Event|4
1487499|NCT00556322|4901507|P1|Overall Study|Adverse Event|7
1487500|NCT00556322|4901506|P2|Overall Study|Insufficient therapeutic response|168
1487501|NCT00556322|4901507|P1|Overall Study|Insufficient therapeutic response|158
1487502|NCT00556166|4901555|P1|Overall Study|Withdrawal by Subject|1
1487503|NCT00556075|4901568|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
1487504|NCT00556075|4901569|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
1487505|NCT00556075|4901570|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
1487506|NCT00556075|4901568|P3|Overall Study|Personal issues|0
1487507|NCT00556075|4901569|P2|Overall Study|Personal issues|1
1487508|NCT00556075|4901570|P1|Overall Study|Personal issues|4
1487509|NCT00556075|4901568|P3|Overall Study|Adverse Event|0
1487510|NCT00556075|4901569|P2|Overall Study|Adverse Event|2
1487511|NCT00556075|4901570|P1|Overall Study|Adverse Event|1
1487512|NCT00556075|4901568|P3|Overall Study|Not eligible|2
1487513|NCT00556075|4901569|P2|Overall Study|Not eligible|1
1487514|NCT00556075|4901570|P1|Overall Study|Not eligible|1
1487515|NCT00556075|4901568|P3|Overall Study|Protocol Violation|3
1487516|NCT00556075|4901569|P2|Overall Study|Protocol Violation|1
1487517|NCT00556075|4901570|P1|Overall Study|Protocol Violation|1
1487518|NCT00556075|4901568|P3|Overall Study|Withdrawal by Subject|0
1487519|NCT00556075|4901569|P2|Overall Study|Withdrawal by Subject|3
1487520|NCT00556075|4901570|P1|Overall Study|Withdrawal by Subject|3
1487521|NCT00556075|4901568|P3|Overall Study|Lost to Follow-up|3
1487522|NCT00556075|4901569|P2|Overall Study|Lost to Follow-up|0
1487523|NCT00556075|4901570|P1|Overall Study|Lost to Follow-up|3
1487524|NCT00555906|4901622|P5|Phase 2|Randomized but not Treated|2
1487525|NCT00555906|4901623|P4|Phase 2|Randomized but not Treated|0
1487526|NCT00555906|4901624|P3|Phase 2|Randomized but not Treated|0
1487527|NCT00555906|4901625|P2|Phase 2|Randomized but not Treated|0
1487528|NCT00555906|4901626|P1|Phase 2|Randomized but not Treated|0
1487529|NCT00555906|4901622|P5|Phase 2|Other|6
1487530|NCT00555906|4901623|P4|Phase 2|Other|0
1487531|NCT00555906|4901624|P3|Phase 2|Other|0
1487532|NCT00555906|4901625|P2|Phase 2|Other|0
1487533|NCT00555906|4901626|P1|Phase 2|Other|0
1487534|NCT00555906|4901622|P5|Phase 2|Withdrawal by Subject|2
1487535|NCT00555906|4901623|P4|Phase 2|Withdrawal by Subject|0
1487536|NCT00555906|4901624|P3|Phase 2|Withdrawal by Subject|0
1487537|NCT00555906|4901625|P2|Phase 2|Withdrawal by Subject|0
1487538|NCT00555906|4901626|P1|Phase 2|Withdrawal by Subject|0
1487539|NCT00555906|4901622|P5|Phase 2|Objective Progression or Relapse|16
1487540|NCT00555906|4901623|P4|Phase 2|Objective Progression or Relapse|0
1487541|NCT00555906|4901624|P3|Phase 2|Objective Progression or Relapse|0
1487542|NCT00555906|4901625|P2|Phase 2|Objective Progression or Relapse|0
1487543|NCT00555906|4901626|P1|Phase 2|Objective Progression or Relapse|0
1487544|NCT00555906|4901622|P5|Phase 2|Global Deterioration of Health Status|2
1487545|NCT00555906|4901623|P4|Phase 2|Global Deterioration of Health Status|0
1487546|NCT00555906|4901624|P3|Phase 2|Global Deterioration of Health Status|0
1487547|NCT00555906|4901625|P2|Phase 2|Global Deterioration of Health Status|0
1487548|NCT00555906|4901626|P1|Phase 2|Global Deterioration of Health Status|0
1487549|NCT00555906|4901622|P5|Phase 2|Adverse Event|4
1487550|NCT00555906|4901623|P4|Phase 2|Adverse Event|0
1487551|NCT00555906|4901624|P3|Phase 2|Adverse Event|0
1487552|NCT00555906|4901625|P2|Phase 2|Adverse Event|0
1487553|NCT00555906|4901626|P1|Phase 2|Adverse Event|0
1487554|NCT00555906|4901622|P5|Phase 1|Withdrawal by Subject|0
1487555|NCT00555906|4901623|P4|Phase 1|Withdrawal by Subject|1
1487556|NCT00555906|4901624|P3|Phase 1|Withdrawal by Subject|0
1487557|NCT00555906|4901625|P2|Phase 1|Withdrawal by Subject|0
1487558|NCT00555906|4901626|P1|Phase 1|Withdrawal by Subject|0
1487559|NCT00555906|4901622|P5|Phase 1|Adverse Event|0
1487560|NCT00555906|4901623|P4|Phase 1|Adverse Event|2
1487561|NCT00555906|4901624|P3|Phase 1|Adverse Event|3
1487562|NCT00555906|4901625|P2|Phase 1|Adverse Event|0
1487563|NCT00555906|4901626|P1|Phase 1|Adverse Event|0
1487564|NCT00555906|4901622|P5|Phase 1|Global Deterioration of Health Status|0
1487565|NCT00555906|4901623|P4|Phase 1|Global Deterioration of Health Status|1
1487566|NCT00555906|4901624|P3|Phase 1|Global Deterioration of Health Status|1
1487567|NCT00555906|4901625|P2|Phase 1|Global Deterioration of Health Status|1
1487568|NCT00555906|4901626|P1|Phase 1|Global Deterioration of Health Status|0
1487569|NCT00555906|4901622|P5|Phase 1|Objective Progression or Relapse|0
1487570|NCT00555906|4901623|P4|Phase 1|Objective Progression or Relapse|1
1487571|NCT00555906|4901624|P3|Phase 1|Objective Progression or Relapse|3
1487572|NCT00555906|4901625|P2|Phase 1|Objective Progression or Relapse|5
1487573|NCT00555906|4901626|P1|Phase 1|Objective Progression or Relapse|3
1487574|NCT00555672|4901742|P2|Overall Study|Participant refused|0
1487575|NCT00555672|4901743|P1|Overall Study|Participant refused|2
1487576|NCT00555672|4901742|P2|Overall Study|Other|1
1487577|NCT00555672|4901743|P1|Overall Study|Other|3
1487578|NCT00555672|4901742|P2|Overall Study|Objective progression or relapse|5
1487579|NCT00555672|4901743|P1|Overall Study|Objective progression or relapse|11
1487580|NCT00555672|4901742|P2|Overall Study|Adverse Event|2
1487581|NCT00555672|4901743|P1|Overall Study|Adverse Event|8
1487582|NCT00555672|4901742|P2|Overall Study|Death|2
1487583|NCT00555672|4901743|P1|Overall Study|Death|0
1487584|NCT00555620|4901768|P6|Overall Study|Not specified|3
1487585|NCT00555620|4901769|P5|Overall Study|Not specified|0
1487586|NCT00555620|4901770|P4|Overall Study|Not specified|1
1487587|NCT00555620|4901771|P3|Overall Study|Not specified|0
1487588|NCT00555620|4901772|P2|Overall Study|Not specified|0
1487589|NCT00555620|4901773|P1|Overall Study|Not specified|0
1487590|NCT00555620|4901768|P6|Overall Study|Participant refused treatment|1
1487591|NCT00555620|4901769|P5|Overall Study|Participant refused treatment|0
1487592|NCT00555620|4901770|P4|Overall Study|Participant refused treatment|0
1487593|NCT00555620|4901771|P3|Overall Study|Participant refused treatment|1
1487594|NCT00555620|4901772|P2|Overall Study|Participant refused treatment|1
1487595|NCT00555620|4901773|P1|Overall Study|Participant refused treatment|0
1487596|NCT00555620|4901768|P6|Overall Study|Objective progression or relapse|16
1487597|NCT00555620|4901769|P5|Overall Study|Objective progression or relapse|3
1487598|NCT00555620|4901770|P4|Overall Study|Objective progression or relapse|17
1487599|NCT00555620|4901771|P3|Overall Study|Objective progression or relapse|12
1487600|NCT00555620|4901772|P2|Overall Study|Objective progression or relapse|5
1487601|NCT00555620|4901773|P1|Overall Study|Objective progression or relapse|6
1487602|NCT00555620|4901768|P6|Overall Study|Adverse Event|1
1487603|NCT00555620|4901769|P5|Overall Study|Adverse Event|0
1487604|NCT00555620|4901770|P4|Overall Study|Adverse Event|5
1487605|NCT00555620|4901771|P3|Overall Study|Adverse Event|1
1487606|NCT00555620|4901772|P2|Overall Study|Adverse Event|0
1487607|NCT00555620|4901773|P1|Overall Study|Adverse Event|0
1487608|NCT00555620|4901768|P6|Overall Study|Study terminated by sponsor|0
1487609|NCT00555620|4901769|P5|Overall Study|Study terminated by sponsor|0
1487610|NCT00555620|4901770|P4|Overall Study|Study terminated by sponsor|0
1487611|NCT00555620|4901771|P3|Overall Study|Study terminated by sponsor|1
1487612|NCT00555620|4901772|P2|Overall Study|Study terminated by sponsor|0
1487613|NCT00555620|4901773|P1|Overall Study|Study terminated by sponsor|0
1487614|NCT00555620|4901768|P6|Overall Study|Death|1
1487615|NCT00555620|4901769|P5|Overall Study|Death|0
1487616|NCT00555620|4901770|P4|Overall Study|Death|0
1487617|NCT00555620|4901771|P3|Overall Study|Death|0
1487618|NCT00555620|4901772|P2|Overall Study|Death|1
1487619|NCT00555620|4901773|P1|Overall Study|Death|0
1487620|NCT00555568|4901897|P3|Overall Study|Lost to Follow-up|16
1487621|NCT00555568|4901898|P2|Overall Study|Lost to Follow-up|16
1487622|NCT00555568|4901899|P1|Overall Study|Lost to Follow-up|26
1487623|NCT00555477|4901921|P2|Overall Study|Physician Decision|2
1487624|NCT00555477|4901922|P1|Overall Study|Physician Decision|1
1487625|NCT00555477|4901921|P2|Overall Study|Withdrawal by Subject|2
1487626|NCT00555477|4901922|P1|Overall Study|Withdrawal by Subject|1
1487627|NCT00555477|4901921|P2|Overall Study|Adverse Event|9
1487628|NCT00555477|4901922|P1|Overall Study|Adverse Event|0
1487629|NCT00555438|4901938|P1|Between 10 Days and 30 Days Postoperativ|Death|5
1487630|NCT00555438|4901938|P1|10 Days Post-operative|Death|4
1487631|NCT00555425|4901948|P2|Overall Study|Became pregnant and transferred care|1
1487632|NCT00555425|4901949|P1|Overall Study|Became pregnant and transferred care|0
1487633|NCT00555425|4901948|P2|Overall Study|Met criteria for protective transfer|3
1487634|NCT00555425|4901949|P1|Overall Study|Met criteria for protective transfer|16
1487635|NCT00555425|4901948|P2|Overall Study|Missed 3 physician management visits|0
1487636|NCT00555425|4901949|P1|Overall Study|Missed 3 physician management visits|1
1487637|NCT00555425|4901948|P2|Overall Study|Missed Medication > 1 wk|15
1487638|NCT00555425|4901949|P1|Overall Study|Missed Medication > 1 wk|34
1487639|NCT00555321|4901985|P5|Long-term Extension Phase|Other Reason|0
1487640|NCT00555321|4901986|P4|Long-term Extension Phase|Other Reason|0
1487641|NCT00555321|4901987|P3|Long-term Extension Phase|Other Reason|2
1487642|NCT00555321|4901988|P2|Long-term Extension Phase|Other Reason|0
1487643|NCT00555321|4901989|P1|Long-term Extension Phase|Other Reason|1
1487644|NCT00555321|4901985|P5|Long-term Extension Phase|Participant did not meet study criteria|1
1487645|NCT00555321|4901986|P4|Long-term Extension Phase|Participant did not meet study criteria|0
1487646|NCT00555321|4901987|P3|Long-term Extension Phase|Participant did not meet study criteria|0
1487647|NCT00555321|4901988|P2|Long-term Extension Phase|Participant did not meet study criteria|0
1487648|NCT00555321|4901989|P1|Long-term Extension Phase|Participant did not meet study criteria|0
1487649|NCT00555321|4901985|P5|Long-term Extension Phase|Death|0
1487650|NCT00555321|4901986|P4|Long-term Extension Phase|Death|3
1487651|NCT00555321|4901987|P3|Long-term Extension Phase|Death|0
1487652|NCT00555321|4901988|P2|Long-term Extension Phase|Death|0
1487653|NCT00555321|4901989|P1|Long-term Extension Phase|Death|2
1487654|NCT00555321|4901985|P5|Long-term Extension Phase|Administrative reason by sponsor|23
1487655|NCT00555321|4901986|P4|Long-term Extension Phase|Administrative reason by sponsor|31
1487656|NCT00555321|4901987|P3|Long-term Extension Phase|Administrative reason by sponsor|18
1487657|NCT00555321|4901988|P2|Long-term Extension Phase|Administrative reason by sponsor|21
1487658|NCT00555321|4901989|P1|Long-term Extension Phase|Administrative reason by sponsor|23
1487659|NCT00555321|4901985|P5|Long-term Extension Phase|Withdrawal by Subject|2
1487660|NCT00555321|4901986|P4|Long-term Extension Phase|Withdrawal by Subject|3
1487661|NCT00555321|4901987|P3|Long-term Extension Phase|Withdrawal by Subject|2
1487662|NCT00555321|4901988|P2|Long-term Extension Phase|Withdrawal by Subject|1
1487663|NCT00555321|4901989|P1|Long-term Extension Phase|Withdrawal by Subject|2
1487664|NCT00555321|4901985|P5|Long-term Extension Phase|Adverse Event|0
1487665|NCT00555321|4901986|P4|Long-term Extension Phase|Adverse Event|1
1487666|NCT00555321|4901987|P3|Long-term Extension Phase|Adverse Event|2
1487667|NCT00555321|4901988|P2|Long-term Extension Phase|Adverse Event|5
1487668|NCT00555321|4901989|P1|Long-term Extension Phase|Adverse Event|2
1487669|NCT00555321|4901985|P5|Treatment Phase up to 12-months|Never treated|4
1487670|NCT00555321|4901986|P4|Treatment Phase up to 12-months|Never treated|0
1487671|NCT00555321|4901987|P3|Treatment Phase up to 12-months|Never treated|1
1487672|NCT00555321|4901988|P2|Treatment Phase up to 12-months|Never treated|3
1487673|NCT00555321|4901989|P1|Treatment Phase up to 12-months|Never treated|2
1487674|NCT00555321|4901985|P5|Treatment Phase up to 12-months|Other Reason|0
1487675|NCT00555321|4901986|P4|Treatment Phase up to 12-months|Other Reason|0
1487676|NCT00555321|4901987|P3|Treatment Phase up to 12-months|Other Reason|2
1487677|NCT00555321|4901988|P2|Treatment Phase up to 12-months|Other Reason|3
1487678|NCT00555321|4901989|P1|Treatment Phase up to 12-months|Other Reason|1
1487679|NCT00555321|4901985|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
1487680|NCT00555321|4901986|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
1487681|NCT00555321|4901987|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
1487682|NCT00555321|4901988|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
1487683|NCT00555321|4901989|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
1487684|NCT00555321|4901985|P5|Treatment Phase up to 12-months|Death|0
1487685|NCT00555321|4901986|P4|Treatment Phase up to 12-months|Death|0
1487686|NCT00555321|4901987|P3|Treatment Phase up to 12-months|Death|4
1487687|NCT00555321|4901988|P2|Treatment Phase up to 12-months|Death|1
1487688|NCT00555321|4901989|P1|Treatment Phase up to 12-months|Death|2
1487689|NCT00555321|4901985|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
1487690|NCT00555321|4901986|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
1487691|NCT00555321|4901987|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
1487692|NCT00555321|4901988|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
1487693|NCT00555321|4901989|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
1487694|NCT00555321|4901985|P5|Treatment Phase up to 12-months|Adverse Event|18
1487695|NCT00555321|4901986|P4|Treatment Phase up to 12-months|Adverse Event|7
1487696|NCT00555321|4901987|P3|Treatment Phase up to 12-months|Adverse Event|11
1487697|NCT00555321|4901988|P2|Treatment Phase up to 12-months|Adverse Event|7
1487698|NCT00555321|4901989|P1|Treatment Phase up to 12-months|Adverse Event|6
1487699|NCT00555217|4902293|P2|Overall Study|close out sites|17
1487700|NCT00555217|4902294|P1|Overall Study|close out sites|21
1487701|NCT00555217|4902293|P2|Overall Study|Lost to Follow-up|20
1487702|NCT00555217|4902294|P1|Overall Study|Lost to Follow-up|19
1487703|NCT00555217|4902293|P2|Overall Study|Withdrawal by Subject|31
1487704|NCT00555217|4902294|P1|Overall Study|Withdrawal by Subject|35
1487705|NCT00555061|4902331|P1|Overall Study|Participant enrolled, but never treated|1
1487706|NCT00555061|4902331|P1|Overall Study|Withdrawal by Subject|2
1487707|NCT00555061|4902331|P1|Overall Study|Lost to Follow-up|2
1487708|NCT00555061|4902331|P1|Overall Study|Protocol Violation|1
1487709|NCT00555061|4902331|P1|Overall Study|Adverse Event|3
1487710|NCT00555009|4902350|P2|Overall Study|Terminated by Sponsor|5
1487711|NCT00555009|4902351|P1|Overall Study|Terminated by Sponsor|2
1487712|NCT00555009|4902350|P2|Overall Study|Withdrawal by Subject|1
1487713|NCT00555009|4902351|P1|Overall Study|Withdrawal by Subject|0
1487714|NCT00554840|4902431|P2|Overall Study|Physician Decision|1
1487715|NCT00554840|4902432|P1|Overall Study|Physician Decision|0
1487716|NCT00554801|4902450|P2|Overall Study|Withdrawal by Subject|0
1487717|NCT00554801|4902451|P1|Overall Study|Withdrawal by Subject|14
1487718|NCT00554801|4902450|P2|Overall Study|left area before completion|0
1487719|NCT00554801|4902451|P1|Overall Study|left area before completion|5
1487720|NCT00554619|4902479|P1|Overall Study|Liver Function Test Abnormality|1
1487721|NCT00554619|4902479|P1|Overall Study|Physician Decision|1
1487722|NCT00554619|4902479|P1|Overall Study|Adverse Event|1
1487723|NCT00554515|4902491|P1|Overall Study|Misc|15
1487724|NCT00554515|4902491|P1|Overall Study|Other|1
1487725|NCT00554515|4902491|P1|Overall Study|Achieved Stable Disease|7
1487726|NCT00554515|4902491|P1|Overall Study|Death|2
1487727|NCT00554515|4902491|P1|Overall Study|Adverse Event|9
1487728|NCT00554515|4902491|P1|Overall Study|Withdrawal by Subject|11
1487729|NCT00554515|4902491|P1|Overall Study|Physician Decision|18
1487730|NCT00554515|4902491|P1|Overall Study|Disease progression|52
1487731|NCT00554515|4902491|P1|Overall Study|Withdrawal by Subject|3
1487732|NCT00554229|4902548|P2|Overall Study|Randomised but no treatment received|0
1487733|NCT00554229|4902549|P1|Overall Study|Randomised but no treatment received|1
1487734|NCT00554229|4902548|P2|Overall Study|Reason not otherwise captured, eg; death|140
1487735|NCT00554229|4902549|P1|Overall Study|Reason not otherwise captured, eg; death|119
1487736|NCT00554229|4902548|P2|Overall Study|Protocol Violation|3
1487737|NCT00554229|4902549|P1|Overall Study|Protocol Violation|3
1487738|NCT00554229|4902548|P2|Overall Study|Adverse Event|39
1487739|NCT00554229|4902549|P1|Overall Study|Adverse Event|71
1487740|NCT00554229|4902548|P2|Overall Study|Withdrawal by Subject|37
1487741|NCT00554229|4902549|P1|Overall Study|Withdrawal by Subject|29
1487742|NCT00554229|4902548|P2|Overall Study|Lost to Follow-up|6
1487743|NCT00554229|4902549|P1|Overall Study|Lost to Follow-up|3
1487744|NCT00554216|4902574|P3|Overall Study|Lack of Efficacy|0
1487745|NCT00554216|4902575|P2|Overall Study|Lack of Efficacy|3
1487746|NCT00554216|4902576|P1|Overall Study|Lack of Efficacy|15
1487747|NCT00554216|4902574|P3|Overall Study|not specified|10
1487748|NCT00554216|4902575|P2|Overall Study|not specified|7
1487749|NCT00554216|4902576|P1|Overall Study|not specified|12
1487750|NCT00554216|4902574|P3|Overall Study|Restricted med|1
1487751|NCT00554216|4902575|P2|Overall Study|Restricted med|1
1487752|NCT00554216|4902576|P1|Overall Study|Restricted med|3
1487753|NCT00554216|4902574|P3|Overall Study|Pregnancy|14
1487754|NCT00554216|4902575|P2|Overall Study|Pregnancy|1
1487755|NCT00554216|4902576|P1|Overall Study|Pregnancy|2
1487756|NCT00554216|4902574|P3|Overall Study|Non compliance|5
1487757|NCT00554216|4902575|P2|Overall Study|Non compliance|4
1487758|NCT00554216|4902576|P1|Overall Study|Non compliance|10
1487759|NCT00554216|4902574|P3|Overall Study|Withdrawal by Subject|43
1487760|NCT00554216|4902575|P2|Overall Study|Withdrawal by Subject|31
1487761|NCT00554216|4902576|P1|Overall Study|Withdrawal by Subject|92
1487762|NCT00554216|4902574|P3|Overall Study|Adverse Event|36
1487763|NCT00554216|4902575|P2|Overall Study|Adverse Event|16
1487764|NCT00554216|4902576|P1|Overall Study|Adverse Event|16
1487765|NCT00554216|4902574|P3|Overall Study|Lost to Follow-up|63
1487766|NCT00554216|4902575|P2|Overall Study|Lost to Follow-up|31
1487767|NCT00554216|4902576|P1|Overall Study|Lost to Follow-up|92
1487768|NCT00554190|4902587|P1|Overall Study|Termination forms not completed|10
1487769|NCT00554099|4902596|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
1487770|NCT00554099|4902597|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
1487771|NCT00554099|4902598|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
1487772|NCT00554099|4902596|P3|Non-Treatment Phase (9 Months)|Relapse|1
1487773|NCT00554099|4902597|P2|Non-Treatment Phase (9 Months)|Relapse|1
1487774|NCT00554099|4902598|P1|Non-Treatment Phase (9 Months)|Relapse|2
1487775|NCT00554099|4902596|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
1487776|NCT00554099|4902597|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
1487777|NCT00554099|4902598|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
1487778|NCT00554099|4902596|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
1487779|NCT00554099|4902597|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
1487780|NCT00554099|4902598|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
1487781|NCT00554099|4902596|P3|Treatment Period (12 Weeks)|Protocol Violation|2
1487782|NCT00554099|4902597|P2|Treatment Period (12 Weeks)|Protocol Violation|0
1487783|NCT00554099|4902598|P1|Treatment Period (12 Weeks)|Protocol Violation|0
1487784|NCT00554099|4902596|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
1487785|NCT00554099|4902597|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
1487786|NCT00554099|4902598|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
1487787|NCT00554099|4902596|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
1487788|NCT00554099|4902597|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
1487789|NCT00554099|4902598|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
1487790|NCT00554099|4902596|P3|Treatment Period (12 Weeks)|Physician Decision|0
1487791|NCT00554099|4902597|P2|Treatment Period (12 Weeks)|Physician Decision|0
1487792|NCT00554099|4902598|P1|Treatment Period (12 Weeks)|Physician Decision|3
1487793|NCT00554099|4902596|P3|Treatment Period (12 Weeks)|Adverse Event|1
1487794|NCT00554099|4902597|P2|Treatment Period (12 Weeks)|Adverse Event|5
1487795|NCT00554099|4902598|P1|Treatment Period (12 Weeks)|Adverse Event|3
1487796|NCT00553787|4902653|P3|Overall Study|not specified|13
1487797|NCT00553787|4902654|P2|Overall Study|not specified|10
1487798|NCT00553787|4902655|P1|Overall Study|not specified|18
1487799|NCT00553787|4902653|P3|Overall Study|Requirement for restricted medication|5
1487800|NCT00553787|4902654|P2|Overall Study|Requirement for restricted medication|7
1487801|NCT00553787|4902655|P1|Overall Study|Requirement for restricted medication|8
1487802|NCT00553787|4902653|P3|Overall Study|non compliance|11
1487803|NCT00553787|4902654|P2|Overall Study|non compliance|0
1487804|NCT00553787|4902655|P1|Overall Study|non compliance|4
1487805|NCT00553787|4902653|P3|Overall Study|Pregnancy|2
1487806|NCT00553787|4902654|P2|Overall Study|Pregnancy|1
1487807|NCT00553787|4902655|P1|Overall Study|Pregnancy|0
1487808|NCT00553787|4902653|P3|Overall Study|Lack of Efficacy|3
1487809|NCT00553787|4902654|P2|Overall Study|Lack of Efficacy|1
1487810|NCT00553787|4902655|P1|Overall Study|Lack of Efficacy|31
1487811|NCT00553787|4902653|P3|Overall Study|Withdrawal by Subject|83
1487812|NCT00553787|4902654|P2|Overall Study|Withdrawal by Subject|40
1487813|NCT00553787|4902655|P1|Overall Study|Withdrawal by Subject|151
1487814|NCT00553787|4902653|P3|Overall Study|Lost to Follow-up|78
1487815|NCT00553787|4902654|P2|Overall Study|Lost to Follow-up|44
1487816|NCT00553787|4902655|P1|Overall Study|Lost to Follow-up|132
1487817|NCT00553787|4902653|P3|Overall Study|Adverse Event|67
1487818|NCT00553787|4902654|P2|Overall Study|Adverse Event|21
1487819|NCT00553787|4902655|P1|Overall Study|Adverse Event|34
1487820|NCT00553696|4902687|P4|Overall Study|Withdrawal by Subject|0
1487821|NCT00553696|4902688|P3|Overall Study|Withdrawal by Subject|0
1487822|NCT00553696|4902689|P2|Overall Study|Withdrawal by Subject|1
1487823|NCT00553696|4902690|P1|Overall Study|Withdrawal by Subject|0
1487824|NCT00553696|4902687|P4|Overall Study|Objective progression or relapse|0
1487825|NCT00553696|4902688|P3|Overall Study|Objective progression or relapse|6
1487826|NCT00553696|4902689|P2|Overall Study|Objective progression or relapse|9
1487827|NCT00553696|4902690|P1|Overall Study|Objective progression or relapse|2
1487828|NCT00553696|4902687|P4|Overall Study|Global deterioration of health status|0
1487829|NCT00553696|4902688|P3|Overall Study|Global deterioration of health status|0
1487830|NCT00553696|4902689|P2|Overall Study|Global deterioration of health status|2
1487831|NCT00553696|4902690|P1|Overall Study|Global deterioration of health status|0
1487832|NCT00553696|4902687|P4|Overall Study|Adverse Event|1
1487833|NCT00553696|4902688|P3|Overall Study|Adverse Event|0
1487834|NCT00553696|4902689|P2|Overall Study|Adverse Event|4
1487835|NCT00553696|4902690|P1|Overall Study|Adverse Event|2
1487836|NCT00553644|4902728|P1|Overall Study|Alternative therapy|6
1487837|NCT00553644|4902728|P1|Overall Study|Physician Decision|1
1487838|NCT00553644|4902728|P1|Overall Study|Withdrawal by Subject|4
1487839|NCT00553644|4902728|P1|Overall Study|Adverse Event|17
1487840|NCT00553631|4902737|P2|Overall Study|Lost to Follow-up|0
1487841|NCT00553631|4902738|P1|Overall Study|Lost to Follow-up|1
1487842|NCT00553631|4902737|P2|Overall Study|Withdrawal by Subject|1
1487843|NCT00553631|4902738|P1|Overall Study|Withdrawal by Subject|0
1487844|NCT00553605|4902760|P2|Overall Study|Randomized but not treated|0
1487845|NCT00553605|4902761|P1|Overall Study|Randomized but not treated|2
1487846|NCT00553605|4902760|P2|Overall Study|Did not receive full dose|0
1487847|NCT00553605|4902761|P1|Overall Study|Did not receive full dose|1
1487848|NCT00553605|4902760|P2|Overall Study|Did not meet entrance criteria|3
1487849|NCT00553605|4902761|P1|Overall Study|Did not meet entrance criteria|1
1487850|NCT00553514|4902790|P5|Overall Study|Other|1
1487851|NCT00553514|4902791|P4|Overall Study|Other|0
1487852|NCT00553514|4902792|P3|Overall Study|Other|0
1487853|NCT00553514|4902793|P2|Overall Study|Other|1
1487854|NCT00553514|4902794|P1|Overall Study|Other|1
1487855|NCT00553514|4902790|P5|Overall Study|Risk of multiple pregnancy|0
1487856|NCT00553514|4902791|P4|Overall Study|Risk of multiple pregnancy|1
1487857|NCT00553514|4902792|P3|Overall Study|Risk of multiple pregnancy|0
1487858|NCT00553514|4902793|P2|Overall Study|Risk of multiple pregnancy|2
1487859|NCT00553514|4902794|P1|Overall Study|Risk of multiple pregnancy|0
1487860|NCT00553514|4902790|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
1487861|NCT00553514|4902791|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
1487862|NCT00553514|4902792|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
1487863|NCT00553514|4902793|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
1487864|NCT00553514|4902794|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
1487865|NCT00553514|4902790|P5|Overall Study|Lack of ovarian response|6
1487866|NCT00553514|4902791|P4|Overall Study|Lack of ovarian response|5
1487867|NCT00553514|4902792|P3|Overall Study|Lack of ovarian response|5
1487868|NCT00553514|4902793|P2|Overall Study|Lack of ovarian response|5
1487869|NCT00553514|4902794|P1|Overall Study|Lack of ovarian response|4
1487870|NCT00553514|4902790|P5|Overall Study|Protocol deviation|0
1487871|NCT00553514|4902791|P4|Overall Study|Protocol deviation|1
1487872|NCT00553514|4902792|P3|Overall Study|Protocol deviation|0
1487873|NCT00553514|4902793|P2|Overall Study|Protocol deviation|0
1487874|NCT00553514|4902794|P1|Overall Study|Protocol deviation|0
1487875|NCT00553501|4902831|P1|Overall Study|Progression|1
1487876|NCT00553501|4902831|P1|Overall Study|Death|1
1487877|NCT00553501|4902831|P1|Overall Study|Adverse Event|2
1487878|NCT00553475|4902840|P3|Overall Study|Due to moving|0
1487879|NCT00553475|4902841|P2|Overall Study|Due to moving|1
1487880|NCT00553475|4902842|P1|Overall Study|Due to moving|0
1487881|NCT00553475|4902840|P3|Overall Study|Physician Decision|0
1487882|NCT00553475|4902841|P2|Overall Study|Physician Decision|0
1487883|NCT00553475|4902842|P1|Overall Study|Physician Decision|1
1487884|NCT00553475|4902840|P3|Overall Study|Withdrawal by Subject|0
1487885|NCT00553475|4902841|P2|Overall Study|Withdrawal by Subject|1
1487886|NCT00553475|4902842|P1|Overall Study|Withdrawal by Subject|1
1487887|NCT00553475|4902840|P3|Overall Study|Lack of Efficacy|0
1487888|NCT00553475|4902841|P2|Overall Study|Lack of Efficacy|1
1487889|NCT00553475|4902842|P1|Overall Study|Lack of Efficacy|7
1487890|NCT00553475|4902840|P3|Overall Study|Adverse Event|13
1487891|NCT00553475|4902841|P2|Overall Study|Adverse Event|17
1487892|NCT00553475|4902842|P1|Overall Study|Adverse Event|7
1487893|NCT00553462|4902964|P1|Overall Study|Physician Decision|1
1487894|NCT00553462|4902964|P1|Overall Study|Withdrawal by Subject|5
1487895|NCT00553462|4902964|P1|Overall Study|Progression|4
1487896|NCT00553462|4902964|P1|Overall Study|Adverse Event|4
1487897|NCT00553436|4902970|P1|Overall Study|Conversion to another procedure|1
1487898|NCT00553358|4902979|P3|Overall Study|Other: Reason Not Specified|20
1487899|NCT00553358|4902980|P2|Overall Study|Other: Reason Not Specified|4
1487900|NCT00553358|4902981|P1|Overall Study|Other: Reason Not Specified|15
1487901|NCT00553358|4902979|P3|Overall Study|Missing|1
1487902|NCT00553358|4902980|P2|Overall Study|Missing|1
1487903|NCT00553358|4902981|P1|Overall Study|Missing|1
1487904|NCT00553358|4902979|P3|Overall Study|Participant Withdrawal from Drug|3
1487905|NCT00553358|4902980|P2|Overall Study|Participant Withdrawal from Drug|0
1487906|NCT00553358|4902981|P1|Overall Study|Participant Withdrawal from Drug|0
1487907|NCT00553358|4902979|P3|Overall Study|Recurrence of Disease|1
1487908|NCT00553358|4902980|P2|Overall Study|Recurrence of Disease|4
1487909|NCT00553358|4902981|P1|Overall Study|Recurrence of Disease|3
1487910|NCT00553358|4902979|P3|Overall Study|Withdrawal by Subject|1
1487911|NCT00553358|4902980|P2|Overall Study|Withdrawal by Subject|0
1487912|NCT00553358|4902981|P1|Overall Study|Withdrawal by Subject|5
1487913|NCT00553358|4902979|P3|Overall Study|Protocol Violation|1
1487914|NCT00553358|4902980|P2|Overall Study|Protocol Violation|1
1487915|NCT00553358|4902981|P1|Overall Study|Protocol Violation|0
1487916|NCT00553358|4902979|P3|Overall Study|Lost to Follow-up|1
1487917|NCT00553358|4902980|P2|Overall Study|Lost to Follow-up|0
1487918|NCT00553358|4902981|P1|Overall Study|Lost to Follow-up|0
1487919|NCT00553358|4902979|P3|Overall Study|Adverse Event|32
1487920|NCT00553358|4902980|P2|Overall Study|Adverse Event|2
1487921|NCT00553358|4902981|P1|Overall Study|Adverse Event|29
1487922|NCT00553332|4903007|P1|Overall Study|ineligible, incorrect diagnosis|1
1487923|NCT00553319|4903019|P3|Overall Study|moved|1
1487924|NCT00553319|4903020|P2|Overall Study|moved|0
1487925|NCT00553319|4903021|P1|Overall Study|moved|1
1487926|NCT00553319|4903019|P3|Overall Study|incarceration|0
1487927|NCT00553319|4903020|P2|Overall Study|incarceration|0
1487928|NCT00553319|4903021|P1|Overall Study|incarceration|1
1487929|NCT00553319|4903019|P3|Overall Study|non-compliance|2
1487930|NCT00553319|4903020|P2|Overall Study|non-compliance|0
1487931|NCT00553319|4903021|P1|Overall Study|non-compliance|0
1487932|NCT00553319|4903019|P3|Overall Study|wanted treatment elsewhere|1
1487933|NCT00553319|4903020|P2|Overall Study|wanted treatment elsewhere|1
1487934|NCT00553319|4903021|P1|Overall Study|wanted treatment elsewhere|2
1487935|NCT00553319|4903019|P3|Overall Study|Lost to Follow-up|5
1487936|NCT00553319|4903020|P2|Overall Study|Lost to Follow-up|9
1487937|NCT00553319|4903021|P1|Overall Study|Lost to Follow-up|10
1487938|NCT00553280|4903032|P1|Overall Study|Physician Decision|1
1487939|NCT00553280|4903032|P1|Overall Study|Withdrawal by Subject|3
1487940|NCT00553280|4903032|P1|Overall Study|Lack of Efficacy|3
1487941|NCT00553280|4903032|P1|Overall Study|Adverse Event|19
1487942|NCT00553267|4903044|P3|Overall Study|Specified category|1
1487943|NCT00553267|4903045|P2|Overall Study|Specified category|2
1487944|NCT00553267|4903046|P1|Overall Study|Specified category|1
1487945|NCT00553267|4903044|P3|Overall Study|Consent withdrawn|1
1487946|NCT00553267|4903045|P2|Overall Study|Consent withdrawn|3
1487947|NCT00553267|4903046|P1|Overall Study|Consent withdrawn|2
1487948|NCT00553267|4903044|P3|Overall Study|Lost to Follow-up|1
1487949|NCT00553267|4903045|P2|Overall Study|Lost to Follow-up|0
1487950|NCT00553267|4903046|P1|Overall Study|Lost to Follow-up|0
1487951|NCT00553267|4903044|P3|Overall Study|Non compliant with protocol|2
1487952|NCT00553267|4903045|P2|Overall Study|Non compliant with protocol|3
1487953|NCT00553267|4903046|P1|Overall Study|Non compliant with protocol|3
1487954|NCT00553267|4903044|P3|Overall Study|Adverse Event|5
1487955|NCT00553267|4903045|P2|Overall Study|Adverse Event|10
1487956|NCT00553267|4903046|P1|Overall Study|Adverse Event|8
1487957|NCT00553202|4903081|P1|Overall Study|Fails to meet organ function|6
1487958|NCT00553202|4903081|P1|Overall Study|No donor identified|16
1487959|NCT00553202|4903081|P1|Overall Study|Withdrawal by Subject|1
1487960|NCT00553202|4903081|P1|Overall Study|Physician Decision|28
1487961|NCT00553202|4903081|P1|Overall Study|Lost to Follow-up|1
1487962|NCT00553202|4903081|P1|Overall Study|Death|16
1487963|NCT00553150|4903091|P4|Overall Study|Ineligible|1
1487964|NCT00553150|4903092|P3|Overall Study|Ineligible|0
1487965|NCT00553150|4903093|P2|Overall Study|Ineligible|0
1487966|NCT00553150|4903094|P1|Overall Study|Ineligible|0
1487967|NCT00553150|4903091|P4|Overall Study|Protocol Violation|1
1487968|NCT00553150|4903092|P3|Overall Study|Protocol Violation|0
1487969|NCT00553150|4903093|P2|Overall Study|Protocol Violation|0
1487970|NCT00553150|4903094|P1|Overall Study|Protocol Violation|0
1487971|NCT00553150|4903091|P4|Overall Study|Withdrawal by Subject|2
1487972|NCT00553150|4903092|P3|Overall Study|Withdrawal by Subject|0
1487973|NCT00553150|4903093|P2|Overall Study|Withdrawal by Subject|0
1487974|NCT00553150|4903094|P1|Overall Study|Withdrawal by Subject|0
1487975|NCT00552760|4903139|P2|Overall Study|Medication Change|0
1487976|NCT00552760|4903140|P1|Overall Study|Medication Change|1
1487977|NCT00552760|4903139|P2|Overall Study|Withdrawal by Subject|0
1487978|NCT00552760|4903140|P1|Overall Study|Withdrawal by Subject|3
1487979|NCT00552760|4903139|P2|Overall Study|Medical Condition|1
1487980|NCT00552760|4903140|P1|Overall Study|Medical Condition|1
1487981|NCT00552760|4903139|P2|Overall Study|Non-compliance|1
1487982|NCT00552760|4903140|P1|Overall Study|Non-compliance|1
1487983|NCT00552760|4903139|P2|Overall Study|Lost to Follow-up|1
1487984|NCT00552760|4903140|P1|Overall Study|Lost to Follow-up|1
1487985|NCT00552760|4903139|P2|Overall Study|Protocol Violation|1
1487986|NCT00552760|4903140|P1|Overall Study|Protocol Violation|0
1487987|NCT00552760|4903139|P2|Overall Study|Relapsed- Mixed Event|5
1487988|NCT00552760|4903140|P1|Overall Study|Relapsed- Mixed Event|3
1487989|NCT00552760|4903139|P2|Overall Study|Relapse- Manic Event|3
1487990|NCT00552760|4903140|P1|Overall Study|Relapse- Manic Event|3
1487991|NCT00552760|4903139|P2|Overall Study|Relapsed- Depressed Event|16
1487992|NCT00552760|4903140|P1|Overall Study|Relapsed- Depressed Event|10
1487993|NCT00552760|4903139|P2|Overall Study|Adverse Event|5
1487994|NCT00552760|4903140|P1|Overall Study|Adverse Event|3
1487995|NCT00552669|4903167|P2|Overall Study|Death|7
1487996|NCT00552669|4903168|P1|Overall Study|Death|3
1487997|NCT00552578|4903180|P2|Overall Study|Lost to Follow-up|1
1487998|NCT00552578|4903181|P1|Overall Study|Lost to Follow-up|1
1487999|NCT00552513|4903193|P2|Overall Study|Lost to Follow-up|1
1488000|NCT00552513|4903194|P1|Overall Study|Lost to Follow-up|5
1488001|NCT00552396|4903239|P7|Overall Study|protocol withdrawal criteria|9
1488002|NCT00552396|4903240|P6|Overall Study|protocol withdrawal criteria|3
1488003|NCT00552396|4903241|P5|Overall Study|protocol withdrawal criteria|3
1488004|NCT00552396|4903242|P4|Overall Study|protocol withdrawal criteria|6
1488005|NCT00552396|4903243|P3|Overall Study|protocol withdrawal criteria|3
1488006|NCT00552396|4903244|P2|Overall Study|protocol withdrawal criteria|3
1488007|NCT00552396|4903245|P1|Overall Study|protocol withdrawal criteria|3
1488008|NCT00552344|4903282|P1|Overall Study|Other Reason|22
1488009|NCT00552344|4903282|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
1488010|NCT00552344|4903282|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
1488011|NCT00552344|4903282|P1|Overall Study|AE, non-serious non-fatal|38
1488012|NCT00552344|4903282|P1|Overall Study|SAE, non-fatal|6
1488013|NCT00552344|4903282|P1|Overall Study|Withdrawal by Subject|48
1488014|NCT00552344|4903282|P1|Overall Study|Lost to Follow-up|8
1488015|NCT00552344|4903282|P1|Overall Study|Loss of efficacy|75
1488016|NCT00552344|4903282|P1|Overall Study|Lack of Efficacy|55
1488017|NCT00552305|4903291|P1|Overall Study|Other: Subject went to rehab|1
1488018|NCT00552305|4903291|P1|Overall Study|Other: Subject incarcerated|1
1488019|NCT00552305|4903291|P1|Overall Study|Other: Subject moved from area|2
1488020|NCT00552305|4903291|P1|Overall Study|Other: Health problems, not drug related|1
1488021|NCT00552305|4903291|P1|Overall Study|Other: Subject became pregnant|1
1488022|NCT00552305|4903291|P1|Overall Study|Other: Subject underwent surgery|4
1488023|NCT00552305|4903291|P1|Overall Study|Other: Unable to attend visits|1
1488024|NCT00552305|4903291|P1|Overall Study|Other: Personal problems|1
1488025|NCT00552305|4903291|P1|Overall Study|Other: Site closed|4
1488026|NCT00552305|4903291|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
1488027|NCT00552305|4903291|P1|Overall Study|AE/Other: prohibited drug required|1
1488028|NCT00552305|4903291|P1|Overall Study|Poor compliance/lost to follow-up|1
1488029|NCT00552305|4903291|P1|Overall Study|Unsatisfactory compliance|11
1488030|NCT00552305|4903291|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
1488031|NCT00552305|4903291|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
1488032|NCT00552305|4903291|P1|Overall Study|Lack of efficacy/withdrew consent|1
1488033|NCT00552305|4903291|P1|Overall Study|Withdrawal by Subject|44
1488034|NCT00552305|4903291|P1|Overall Study|Protocol Violation|3
1488035|NCT00552305|4903291|P1|Overall Study|Lost to Follow-up|4
1488036|NCT00552305|4903291|P1|Overall Study|Lack of Efficacy|120
1488037|NCT00552305|4903291|P1|Overall Study|Adverse Event|43
1488038|NCT00552279|4903301|P2|Overall Study|Other|1
1488039|NCT00552279|4903302|P1|Overall Study|Other|1
1488040|NCT00552279|4903301|P2|Overall Study|Lost to Follow-up|0
1488041|NCT00552279|4903302|P1|Overall Study|Lost to Follow-up|1
1488042|NCT00552279|4903301|P2|Overall Study|Withdrawal by Subject|1
1488043|NCT00552279|4903302|P1|Overall Study|Withdrawal by Subject|12
1488044|NCT00552279|4903301|P2|Overall Study|Adverse Event|1
1488045|NCT00552279|4903302|P1|Overall Study|Adverse Event|0
1488046|NCT00552240|4903328|P2|Overall Study|not specified|0
1488047|NCT00552240|4903329|P1|Overall Study|not specified|1
1488048|NCT00552240|4903328|P2|Overall Study|Lack of Efficacy|0
1488049|NCT00552240|4903329|P1|Overall Study|Lack of Efficacy|6
1488050|NCT00552240|4903328|P2|Overall Study|Withdrawal by Subject|2
1488051|NCT00552240|4903329|P1|Overall Study|Withdrawal by Subject|2
1488052|NCT00552240|4903328|P2|Overall Study|Lost to Follow-up|6
1488053|NCT00552240|4903329|P1|Overall Study|Lost to Follow-up|5
1488054|NCT00552240|4903328|P2|Overall Study|Protocol Violation|1
1488055|NCT00552240|4903329|P1|Overall Study|Protocol Violation|1
1488056|NCT00552240|4903328|P2|Overall Study|Adverse Event|9
1488057|NCT00552240|4903329|P1|Overall Study|Adverse Event|9
1488058|NCT00552188|4903431|P2|Overall Study|Subject returned to home country|1
1488059|NCT00552188|4903432|P1|Overall Study|Subject returned to home country|0
1488060|NCT00552188|4903431|P2|Overall Study|Withdrawal of consent|1
1488061|NCT00552188|4903432|P1|Overall Study|Withdrawal of consent|0
1488062|NCT00552188|4903431|P2|Overall Study|Lost to Follow-up|1
1488063|NCT00552188|4903432|P1|Overall Study|Lost to Follow-up|2
1488064|NCT00552188|4903431|P2|Overall Study|Adverse Event|2
1488065|NCT00552188|4903432|P1|Overall Study|Adverse Event|0
1488066|NCT00552175|4903443|P3|Overall Study|Reason Not Specified|1
1488067|NCT00552175|4903444|P2|Overall Study|Reason Not Specified|1
1488068|NCT00552175|4903445|P1|Overall Study|Reason Not Specified|3
1488069|NCT00552175|4903443|P3|Overall Study|Entry Criteria Not Met|0
1488070|NCT00552175|4903444|P2|Overall Study|Entry Criteria Not Met|1
1488071|NCT00552175|4903445|P1|Overall Study|Entry Criteria Not Met|1
1488072|NCT00552175|4903443|P3|Overall Study|Lost to Follow-up|1
1488073|NCT00552175|4903444|P2|Overall Study|Lost to Follow-up|0
1488074|NCT00552175|4903445|P1|Overall Study|Lost to Follow-up|0
1488075|NCT00552175|4903443|P3|Overall Study|Withdrawal by Subject|1
1488076|NCT00552175|4903444|P2|Overall Study|Withdrawal by Subject|2
1488077|NCT00552175|4903445|P1|Overall Study|Withdrawal by Subject|2
1488078|NCT00552175|4903443|P3|Overall Study|Adverse Event|10
1488079|NCT00552175|4903444|P2|Overall Study|Adverse Event|9
1488080|NCT00552175|4903445|P1|Overall Study|Adverse Event|9
1488081|NCT00552175|4903443|P3|Overall Study|Lack of Efficacy|1
1488082|NCT00552175|4903444|P2|Overall Study|Lack of Efficacy|0
1488083|NCT00552175|4903445|P1|Overall Study|Lack of Efficacy|2
1488084|NCT00552110|4903485|P5|Overall Study|Nonserious Adverse Event (AE)|0
1488085|NCT00552110|4903486|P4|Overall Study|Nonserious Adverse Event (AE)|1
1488086|NCT00552110|4903487|P3|Overall Study|Nonserious Adverse Event (AE)|0
1488087|NCT00552110|4903488|P2|Overall Study|Nonserious Adverse Event (AE)|0
1488088|NCT00552110|4903489|P1|Overall Study|Nonserious Adverse Event (AE)|1
1488089|NCT00552110|4903485|P5|Overall Study|Increased Blood Pressure at Visit 2|0
1488090|NCT00552110|4903486|P4|Overall Study|Increased Blood Pressure at Visit 2|1
1488091|NCT00552110|4903487|P3|Overall Study|Increased Blood Pressure at Visit 2|0
1488092|NCT00552110|4903488|P2|Overall Study|Increased Blood Pressure at Visit 2|0
1488093|NCT00552110|4903489|P1|Overall Study|Increased Blood Pressure at Visit 2|0
1488094|NCT00552110|4903485|P5|Overall Study|Delay of Study due to Relabeling|0
1488095|NCT00552110|4903486|P4|Overall Study|Delay of Study due to Relabeling|1
1488096|NCT00552110|4903487|P3|Overall Study|Delay of Study due to Relabeling|0
1488097|NCT00552110|4903488|P2|Overall Study|Delay of Study due to Relabeling|0
1488098|NCT00552110|4903489|P1|Overall Study|Delay of Study due to Relabeling|0
1488099|NCT00552110|4903485|P5|Overall Study|Use of Prohibited Medication|0
1488100|NCT00552110|4903486|P4|Overall Study|Use of Prohibited Medication|0
1488101|NCT00552110|4903487|P3|Overall Study|Use of Prohibited Medication|0
1488102|NCT00552110|4903488|P2|Overall Study|Use of Prohibited Medication|1
1488103|NCT00552110|4903489|P1|Overall Study|Use of Prohibited Medication|1
1488104|NCT00552110|4903485|P5|Overall Study|Withdrawn per Sponsor|1
1488105|NCT00552110|4903486|P4|Overall Study|Withdrawn per Sponsor|0
1488106|NCT00552110|4903487|P3|Overall Study|Withdrawn per Sponsor|0
1488107|NCT00552110|4903488|P2|Overall Study|Withdrawn per Sponsor|1
1488108|NCT00552110|4903489|P1|Overall Study|Withdrawn per Sponsor|0
1488109|NCT00552110|4903485|P5|Overall Study|Failed to Comply With Study Requirements|1
1488110|NCT00552110|4903486|P4|Overall Study|Failed to Comply With Study Requirements|0
1488111|NCT00552110|4903487|P3|Overall Study|Failed to Comply With Study Requirements|1
1488112|NCT00552110|4903488|P2|Overall Study|Failed to Comply With Study Requirements|1
1488113|NCT00552110|4903489|P1|Overall Study|Failed to Comply With Study Requirements|1
1488114|NCT00552110|4903485|P5|Overall Study|Lost to Follow-up|1
1488115|NCT00552110|4903486|P4|Overall Study|Lost to Follow-up|1
1488116|NCT00552110|4903487|P3|Overall Study|Lost to Follow-up|0
1488117|NCT00552110|4903488|P2|Overall Study|Lost to Follow-up|0
1488118|NCT00552110|4903489|P1|Overall Study|Lost to Follow-up|0
1488119|NCT00552110|4903485|P5|Overall Study|Withdrawal by Subject|2
1488120|NCT00552110|4903486|P4|Overall Study|Withdrawal by Subject|3
1488121|NCT00552110|4903487|P3|Overall Study|Withdrawal by Subject|0
1488122|NCT00552110|4903488|P2|Overall Study|Withdrawal by Subject|2
1488123|NCT00552110|4903489|P1|Overall Study|Withdrawal by Subject|0
1488124|NCT00552110|4903485|P5|Overall Study|Lack of Efficacy|4
1488125|NCT00552110|4903486|P4|Overall Study|Lack of Efficacy|1
1488126|NCT00552110|4903487|P3|Overall Study|Lack of Efficacy|0
1488127|NCT00552110|4903488|P2|Overall Study|Lack of Efficacy|0
1488128|NCT00552110|4903489|P1|Overall Study|Lack of Efficacy|1
1488129|NCT00552110|4903485|P5|Overall Study|Serious or Life-Threatening AE|0
1488130|NCT00552110|4903486|P4|Overall Study|Serious or Life-Threatening AE|0
1488131|NCT00552110|4903487|P3|Overall Study|Serious or Life-Threatening AE|1
1488132|NCT00552110|4903488|P2|Overall Study|Serious or Life-Threatening AE|0
1488133|NCT00552110|4903489|P1|Overall Study|Serious or Life-Threatening AE|0
1488134|NCT00552084|4903508|P2|Overall Study|change in anti-arrythmic drug|1
1488135|NCT00552084|4903509|P1|Overall Study|change in anti-arrythmic drug|1
1488136|NCT00552084|4903508|P2|Overall Study|Protocol Violation|0
1488137|NCT00552084|4903509|P1|Overall Study|Protocol Violation|1
1488138|NCT00552084|4903508|P2|Overall Study|Withdrawal by Subject|5
1488139|NCT00552084|4903509|P1|Overall Study|Withdrawal by Subject|4
1488140|NCT00552084|4903508|P2|Overall Study|Adverse Event|3
1488141|NCT00552084|4903509|P1|Overall Study|Adverse Event|2
1488142|NCT00552058|4903517|P2|Overall Study|Other: Early Roll Over|0
1488143|NCT00552058|4903518|P1|Overall Study|Other: Early Roll Over|1
1488144|NCT00552058|4903517|P2|Overall Study|Other: Sponsors Decision|1
1488145|NCT00552058|4903518|P1|Overall Study|Other: Sponsors Decision|0
1488146|NCT00552058|4903517|P2|Overall Study|Other: Randomized in error|1
1488147|NCT00552058|4903518|P1|Overall Study|Other: Randomized in error|0
1488148|NCT00552058|4903517|P2|Overall Study|Other: Positive Stool Result|1
1488149|NCT00552058|4903518|P1|Overall Study|Other: Positive Stool Result|0
1488150|NCT00552058|4903517|P2|Overall Study|Other: Low CDAI score, entry violation|1
1488151|NCT00552058|4903518|P1|Overall Study|Other: Low CDAI score, entry violation|0
1488152|NCT00552058|4903517|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
1488153|NCT00552058|4903518|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
1488154|NCT00552058|4903517|P2|Overall Study|Other: Non Compliance|2
1488155|NCT00552058|4903518|P1|Overall Study|Other: Non Compliance|1
1488156|NCT00552058|4903517|P2|Overall Study|Other: Protocol Violation|1
1488157|NCT00552058|4903518|P1|Overall Study|Other: Protocol Violation|0
1488158|NCT00552058|4903517|P2|Overall Study|Withdrawal by Subject|4
1488159|NCT00552058|4903518|P1|Overall Study|Withdrawal by Subject|4
1488160|NCT00552058|4903517|P2|Overall Study|Lost to Follow-up|0
1488161|NCT00552058|4903518|P1|Overall Study|Lost to Follow-up|1
1488162|NCT00552058|4903517|P2|Overall Study|Lack of Efficacy|5
1488163|NCT00552058|4903518|P1|Overall Study|Lack of Efficacy|1
1488164|NCT00552058|4903517|P2|Overall Study|Adverse Event|7
1488165|NCT00552058|4903518|P1|Overall Study|Adverse Event|8
1488166|NCT00552032|4903558|P2|Overall Study|Lost to Follow-up|5
1488167|NCT00552032|4903559|P1|Overall Study|Lost to Follow-up|8
1488168|NCT00552032|4903558|P2|Overall Study|Protocol Violation|12
1488169|NCT00552032|4903559|P1|Overall Study|Protocol Violation|7
1488170|NCT00552032|4903558|P2|Overall Study|Withdrawal by Subject|2
1488171|NCT00552032|4903559|P1|Overall Study|Withdrawal by Subject|2
1488172|NCT00551759|4903603|P1|Overall Study|Ineligible|1
1488173|NCT00551759|4903603|P1|Overall Study|Death|5
1488174|NCT00551759|4903603|P1|Overall Study|Adverse Event|7
1488175|NCT00551642|4903644|P2|Overall Study|Inclusion/Exclusion criteria|4
1488176|NCT00551642|4903645|P1|Overall Study|Inclusion/Exclusion criteria|4
1488177|NCT00551642|4903644|P2|Overall Study|Delivery device failure|3
1488178|NCT00551642|4903645|P1|Overall Study|Delivery device failure|1
1488179|NCT00551642|4903644|P2|Overall Study|Physician Decision|1
1488180|NCT00551642|4903645|P1|Overall Study|Physician Decision|0
1488181|NCT00551642|4903644|P2|Overall Study|Protocol Violation|11
1488182|NCT00551642|4903645|P1|Overall Study|Protocol Violation|6
1488183|NCT00551642|4903644|P2|Overall Study|Death|31
1488184|NCT00551642|4903645|P1|Overall Study|Death|33
1488185|NCT00551642|4903644|P2|Overall Study|Adverse Event|12
1488186|NCT00551642|4903645|P1|Overall Study|Adverse Event|15
1488187|NCT00551642|4903644|P2|Overall Study|Withdrawal by Subject|1
1488188|NCT00551642|4903645|P1|Overall Study|Withdrawal by Subject|2
1488189|NCT00551525|4903651|P1|Overall Study|Protocol Violation|5
1488190|NCT00551460|4903660|P1|Overall Study|Not analyzable (did not start treatment)|4
1488191|NCT00551460|4903660|P1|Overall Study|Ineligible|4
1488192|NCT00551460|4903660|P1|Overall Study|Death|7
1488193|NCT00551460|4903660|P1|Overall Study|Physician Decision|1
1488194|NCT00551460|4903660|P1|Overall Study|Withdrawal by Subject|1
1488195|NCT00551460|4903660|P1|Overall Study|Adverse Event|1
1488196|NCT00551421|4903666|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
1488197|NCT00551369|4903673|P1|Overall Study|Not treated per protocol and re|1
1488198|NCT00551369|4903673|P1|Overall Study|Withdrawal by Subject|1
1488199|NCT00551369|4903673|P1|Overall Study|Protocol Violation|5
1488200|NCT00551291|4903681|P1|Overall Study|Physician Decision|1
1488201|NCT00551213|4903689|P2|Overall Study|Not Treated|2
1488202|NCT00551213|4903690|P1|Overall Study|Not Treated|1
1488203|NCT00551213|4903689|P2|Overall Study|Withdrawal by Subject|0
1488204|NCT00551213|4903690|P1|Overall Study|Withdrawal by Subject|2
1488205|NCT00551213|4903689|P2|Overall Study|Progressive Disease|12
1488206|NCT00551213|4903690|P1|Overall Study|Progressive Disease|41
1488207|NCT00551213|4903689|P2|Overall Study|Adverse Event|3
1488208|NCT00551213|4903690|P1|Overall Study|Adverse Event|6
1488209|NCT00551161|4903734|P1|Overall Study|Withdrawal by Subject|1
1488210|NCT00551135|4903742|P4|Overall Study|Withdrawal by Subject|1
1488211|NCT00551135|4903743|P3|Overall Study|Withdrawal by Subject|3
1488212|NCT00551135|4903744|P2|Overall Study|Withdrawal by Subject|0
1488213|NCT00551135|4903745|P1|Overall Study|Withdrawal by Subject|1
1488214|NCT00551135|4903742|P4|Overall Study|Other|2
1488215|NCT00551135|4903743|P3|Overall Study|Other|1
1488216|NCT00551135|4903744|P2|Overall Study|Other|2
1488217|NCT00551135|4903745|P1|Overall Study|Other|3
1488218|NCT00551135|4903742|P4|Overall Study|Lost to Follow-up|1
1488219|NCT00551135|4903743|P3|Overall Study|Lost to Follow-up|0
1488220|NCT00551135|4903744|P2|Overall Study|Lost to Follow-up|0
1488221|NCT00551135|4903745|P1|Overall Study|Lost to Follow-up|0
1488222|NCT00551135|4903742|P4|Overall Study|Adverse Event|1
1488223|NCT00551135|4903743|P3|Overall Study|Adverse Event|1
1488224|NCT00551135|4903744|P2|Overall Study|Adverse Event|0
1488225|NCT00551135|4903745|P1|Overall Study|Adverse Event|1
1488226|NCT00551031|4903874|P5|Overall Study|Did not receive vaccine|0
1488227|NCT00551031|4903875|P4|Overall Study|Did not receive vaccine|0
1488228|NCT00551031|4903876|P3|Overall Study|Did not receive vaccine|0
1488229|NCT00551031|4903877|P2|Overall Study|Did not receive vaccine|2
1488230|NCT00551031|4903878|P1|Overall Study|Did not receive vaccine|1
1488231|NCT00551031|4903874|P5|Overall Study|Serious Adverse Event|0
1488232|NCT00551031|4903875|P4|Overall Study|Serious Adverse Event|0
1488233|NCT00551031|4903876|P3|Overall Study|Serious Adverse Event|1
1488234|NCT00551031|4903877|P2|Overall Study|Serious Adverse Event|2
1488235|NCT00551031|4903878|P1|Overall Study|Serious Adverse Event|0
1488236|NCT00551031|4903874|P5|Overall Study|Withdrawal by Subject|0
1488237|NCT00551031|4903875|P4|Overall Study|Withdrawal by Subject|2
1488238|NCT00551031|4903876|P3|Overall Study|Withdrawal by Subject|1
1488239|NCT00551031|4903877|P2|Overall Study|Withdrawal by Subject|4
1488240|NCT00551031|4903878|P1|Overall Study|Withdrawal by Subject|0
1488241|NCT00551031|4903874|P5|Overall Study|Lost to Follow-up|1
1488242|NCT00551031|4903875|P4|Overall Study|Lost to Follow-up|1
1488243|NCT00551031|4903876|P3|Overall Study|Lost to Follow-up|0
1488244|NCT00551031|4903877|P2|Overall Study|Lost to Follow-up|1
1488245|NCT00551031|4903878|P1|Overall Study|Lost to Follow-up|0
1488246|NCT00551031|4903874|P5|Overall Study|Protocol Violation|0
1488247|NCT00551031|4903875|P4|Overall Study|Protocol Violation|0
1488248|NCT00551031|4903876|P3|Overall Study|Protocol Violation|0
1488249|NCT00551031|4903877|P2|Overall Study|Protocol Violation|1
1488250|NCT00551031|4903878|P1|Overall Study|Protocol Violation|1
1488251|NCT00551031|4903874|P5|Overall Study|Adverse Event|0
1488252|NCT00551031|4903875|P4|Overall Study|Adverse Event|0
1488253|NCT00551031|4903876|P3|Overall Study|Adverse Event|0
1488254|NCT00551031|4903877|P2|Overall Study|Adverse Event|1
1488255|NCT00551031|4903878|P1|Overall Study|Adverse Event|0
1488256|NCT00550953|4903907|P2|Overall Study|Not able to visit the site|3
1488257|NCT00550953|4903908|P1|Overall Study|Not able to visit the site|2
1488258|NCT00550953|4903907|P2|Overall Study|Adverse Event|3
1488259|NCT00550953|4903908|P1|Overall Study|Adverse Event|4
1488260|NCT00550836|4903955|P2|Overall Study|Withdrawal by Subject|9
1488261|NCT00550836|4903956|P1|Overall Study|Withdrawal by Subject|3
1488262|NCT00550771|4903972|P2|Overall Study|Protocol Violation|5
1488263|NCT00550771|4903973|P1|Overall Study|Protocol Violation|4
1488264|NCT00550771|4903972|P2|Overall Study|Withdrawal by Subject|1
1488265|NCT00550771|4903973|P1|Overall Study|Withdrawal by Subject|0
1488266|NCT00550771|4903972|P2|Overall Study|Physician Decision|0
1488267|NCT00550771|4903973|P1|Overall Study|Physician Decision|2
1488268|NCT00550771|4903972|P2|Overall Study|Discontinued for study-related reasons|1
1488269|NCT00550771|4903973|P1|Overall Study|Discontinued for study-related reasons|0
1488270|NCT00550771|4903972|P2|Overall Study|Adverse Event|3
1488271|NCT00550771|4903973|P1|Overall Study|Adverse Event|11
1488272|NCT00550745|4903987|P2|Overall Study|Screen failure|0
1488273|NCT00550745|4903988|P1|Overall Study|Screen failure|1
1488274|NCT00550745|4903987|P2|Overall Study|Withdrawal by Subject|10
1488275|NCT00550745|4903988|P1|Overall Study|Withdrawal by Subject|17
1488276|NCT00550745|4903987|P2|Overall Study|Protocol Violation|2
1488277|NCT00550745|4903988|P1|Overall Study|Protocol Violation|4
1488278|NCT00550745|4903987|P2|Overall Study|Physician Decision|2
1488279|NCT00550745|4903988|P1|Overall Study|Physician Decision|0
1488280|NCT00550745|4903987|P2|Overall Study|Lost to Follow-up|30
1488281|NCT00550745|4903988|P1|Overall Study|Lost to Follow-up|45
1488282|NCT00550745|4903987|P2|Overall Study|Death|16
1488283|NCT00550745|4903988|P1|Overall Study|Death|20
1488284|NCT00550732|4903996|P1|Overall Study|Adverse Event|1
1488285|NCT00550732|4903996|P1|Overall Study|Palliative care|1
1488286|NCT00550732|4903996|P1|Overall Study|Lost to Follow-up|1
1488287|NCT00550732|4903996|P1|Overall Study|Physician Decision|2
1488288|NCT00550732|4903996|P1|Overall Study|Withdrawal by Subject|2
1488289|NCT00550732|4903996|P1|Overall Study|Death|4
1488290|NCT00550680|4904007|P1|Overall Study|Screen Failure|6
1488291|NCT00550680|4904007|P1|Overall Study|Refused Treatment|19
1488292|NCT00550680|4904007|P1|Overall Study|Protocol Violation|7
1488293|NCT00550680|4904007|P1|Overall Study|Not Specified|10
1488294|NCT00550680|4904007|P1|Overall Study|Lack of Efficacy|1
1488295|NCT00550680|4904007|P1|Overall Study|Lost to Follow-up|3
1488296|NCT00550680|4904007|P1|Overall Study|Early Improvement|1
1488297|NCT00550680|4904007|P1|Overall Study|Death|3
1488298|NCT00550680|4904007|P1|Overall Study|Adverse Event|5
1488299|NCT00550680|4904007|P1|Overall Study|Administrative Reasons|1
1488300|NCT00550550|4904039|P2|Overall Study|Randomized But Not Treated|0
1488301|NCT00550550|4904040|P1|Overall Study|Randomized But Not Treated|1
1488302|NCT00550550|4904039|P2|Overall Study|Did Not Meet Protocol Eligibility|1
1488303|NCT00550550|4904040|P1|Overall Study|Did Not Meet Protocol Eligibility|1
1488304|NCT00550550|4904039|P2|Overall Study|Protocol Violation|14
1488305|NCT00550550|4904040|P1|Overall Study|Protocol Violation|5
1488306|NCT00550550|4904039|P2|Overall Study|Withdrawal by Subject|8
1488307|NCT00550550|4904040|P1|Overall Study|Withdrawal by Subject|10
1488308|NCT00550550|4904039|P2|Overall Study|Lost to Follow-up|0
1488309|NCT00550550|4904040|P1|Overall Study|Lost to Follow-up|4
1488310|NCT00550550|4904039|P2|Overall Study|Treatment Failure|1
1488311|NCT00550550|4904040|P1|Overall Study|Treatment Failure|0
1488312|NCT00550550|4904039|P2|Overall Study|Adverse Event|5
1488313|NCT00550550|4904040|P1|Overall Study|Adverse Event|13
1488314|NCT00550537|4904052|P1|Overall Study|Treated closer to home|4
1488315|NCT00550537|4904052|P1|Overall Study|Declining performance status|2
1488316|NCT00550537|4904052|P1|Overall Study|Other complicating ilness|3
1488317|NCT00550537|4904052|P1|Overall Study|Change in treatment plan|4
1488318|NCT00550537|4904052|P1|Overall Study|Withdrawal by Subject|7
1488319|NCT00550537|4904052|P1|Overall Study|Disease progression before|46
1488320|NCT00550537|4904052|P1|Overall Study|Adverse Event|20
1488321|NCT00550537|4904052|P1|Overall Study|Death|18
1488322|NCT00550459|4904069|P2|Overall Study|Withdrawal by Subject|1
1488323|NCT00550459|4904070|P1|Overall Study|Withdrawal by Subject|1
1488324|NCT00550459|4904069|P2|Overall Study|Adverse Event|2
1488325|NCT00550459|4904070|P1|Overall Study|Adverse Event|0
1488326|NCT00550446|4904139|P11|Post Week 12|Other|0
1488327|NCT00550446|4904140|P10|Post Week 12|Other|1
1488328|NCT00550446|4904141|P9|Post Week 12|Other|1
1488329|NCT00550446|4904142|P8|Post Week 12|Other|0
1488330|NCT00550446|4904143|P7|Post Week 12|Other|1
1488331|NCT00550446|4904144|P6|Post Week 12|Other|0
1488332|NCT00550446|4904145|P5|Post Week 12|Other|0
1488333|NCT00550446|4904146|P4|Post Week 12|Other|1
1488334|NCT00550446|4904147|P3|Post Week 12|Other|0
1488335|NCT00550446|4904148|P2|Post Week 12|Other|1
1488336|NCT00550446|4904149|P1|Post Week 12|Other|1
1488337|NCT00550446|4904139|P11|Post Week 12|Withdrawal by Subject|0
1488338|NCT00550446|4904140|P10|Post Week 12|Withdrawal by Subject|0
1488339|NCT00550446|4904141|P9|Post Week 12|Withdrawal by Subject|0
1488340|NCT00550446|4904142|P8|Post Week 12|Withdrawal by Subject|0
1488341|NCT00550446|4904143|P7|Post Week 12|Withdrawal by Subject|0
1488342|NCT00550446|4904144|P6|Post Week 12|Withdrawal by Subject|0
1488343|NCT00550446|4904145|P5|Post Week 12|Withdrawal by Subject|1
1488344|NCT00550446|4904146|P4|Post Week 12|Withdrawal by Subject|0
1488345|NCT00550446|4904147|P3|Post Week 12|Withdrawal by Subject|0
1488346|NCT00550446|4904148|P2|Post Week 12|Withdrawal by Subject|0
1488347|NCT00550446|4904149|P1|Post Week 12|Withdrawal by Subject|0
1488348|NCT00550446|4904139|P11|Post Week 12|Lost to Follow-up|0
1488349|NCT00550446|4904140|P10|Post Week 12|Lost to Follow-up|0
1488350|NCT00550446|4904141|P9|Post Week 12|Lost to Follow-up|0
1488351|NCT00550446|4904142|P8|Post Week 12|Lost to Follow-up|0
1488352|NCT00550446|4904143|P7|Post Week 12|Lost to Follow-up|1
1488353|NCT00550446|4904144|P6|Post Week 12|Lost to Follow-up|0
1488354|NCT00550446|4904145|P5|Post Week 12|Lost to Follow-up|0
1488355|NCT00550446|4904146|P4|Post Week 12|Lost to Follow-up|1
1488356|NCT00550446|4904147|P3|Post Week 12|Lost to Follow-up|1
1488357|NCT00550446|4904148|P2|Post Week 12|Lost to Follow-up|0
1488358|NCT00550446|4904149|P1|Post Week 12|Lost to Follow-up|0
1488359|NCT00550446|4904139|P11|Post Week 12|Lack of Efficacy|1
1488360|NCT00550446|4904140|P10|Post Week 12|Lack of Efficacy|2
1488361|NCT00550446|4904141|P9|Post Week 12|Lack of Efficacy|1
1488362|NCT00550446|4904142|P8|Post Week 12|Lack of Efficacy|1
1488363|NCT00550446|4904143|P7|Post Week 12|Lack of Efficacy|0
1488364|NCT00550446|4904144|P6|Post Week 12|Lack of Efficacy|0
1488365|NCT00550446|4904145|P5|Post Week 12|Lack of Efficacy|0
1488366|NCT00550446|4904146|P4|Post Week 12|Lack of Efficacy|0
1488367|NCT00550446|4904147|P3|Post Week 12|Lack of Efficacy|1
1488368|NCT00550446|4904148|P2|Post Week 12|Lack of Efficacy|0
1488369|NCT00550446|4904149|P1|Post Week 12|Lack of Efficacy|0
1488370|NCT00550446|4904139|P11|Post Week 12|Adverse Event|0
1488371|NCT00550446|4904140|P10|Post Week 12|Adverse Event|4
1488372|NCT00550446|4904141|P9|Post Week 12|Adverse Event|0
1488373|NCT00550446|4904142|P8|Post Week 12|Adverse Event|0
1488374|NCT00550446|4904143|P7|Post Week 12|Adverse Event|0
1488375|NCT00550446|4904144|P6|Post Week 12|Adverse Event|1
1488376|NCT00550446|4904145|P5|Post Week 12|Adverse Event|1
1488377|NCT00550446|4904146|P4|Post Week 12|Adverse Event|1
1488378|NCT00550446|4904147|P3|Post Week 12|Adverse Event|1
1488379|NCT00550446|4904148|P2|Post Week 12|Adverse Event|1
1488380|NCT00550446|4904149|P1|Post Week 12|Adverse Event|2
1488381|NCT00550446|4904139|P11|Up To Week 12|Randomized not treated|0
1488382|NCT00550446|4904140|P10|Up To Week 12|Randomized not treated|0
1488383|NCT00550446|4904141|P9|Up To Week 12|Randomized not treated|0
1488384|NCT00550446|4904142|P8|Up To Week 12|Randomized not treated|0
1488385|NCT00550446|4904143|P7|Up To Week 12|Randomized not treated|0
1488386|NCT00550446|4904144|P6|Up To Week 12|Randomized not treated|0
1488387|NCT00550446|4904145|P5|Up To Week 12|Randomized not treated|0
1488388|NCT00550446|4904146|P4|Up To Week 12|Randomized not treated|0
1488389|NCT00550446|4904147|P3|Up To Week 12|Randomized not treated|1
1488390|NCT00550446|4904148|P2|Up To Week 12|Randomized not treated|1
1488391|NCT00550446|4904149|P1|Up To Week 12|Randomized not treated|0
1488392|NCT00550446|4904139|P11|Up To Week 12|Other|0
1488393|NCT00550446|4904140|P10|Up To Week 12|Other|0
1488394|NCT00550446|4904141|P9|Up To Week 12|Other|0
1488395|NCT00550446|4904142|P8|Up To Week 12|Other|0
1488396|NCT00550446|4904143|P7|Up To Week 12|Other|4
1488397|NCT00550446|4904144|P6|Up To Week 12|Other|1
1488398|NCT00550446|4904145|P5|Up To Week 12|Other|0
1488399|NCT00550446|4904146|P4|Up To Week 12|Other|0
1488400|NCT00550446|4904147|P3|Up To Week 12|Other|0
1488401|NCT00550446|4904148|P2|Up To Week 12|Other|0
1488402|NCT00550446|4904149|P1|Up To Week 12|Other|3
1488403|NCT00550446|4904139|P11|Up To Week 12|Withdrawal by Subject|0
1488404|NCT00550446|4904140|P10|Up To Week 12|Withdrawal by Subject|0
1488405|NCT00550446|4904141|P9|Up To Week 12|Withdrawal by Subject|0
1488406|NCT00550446|4904142|P8|Up To Week 12|Withdrawal by Subject|0
1488407|NCT00550446|4904143|P7|Up To Week 12|Withdrawal by Subject|3
1488408|NCT00550446|4904144|P6|Up To Week 12|Withdrawal by Subject|1
1488409|NCT00550446|4904145|P5|Up To Week 12|Withdrawal by Subject|0
1488410|NCT00550446|4904146|P4|Up To Week 12|Withdrawal by Subject|2
1488411|NCT00550446|4904147|P3|Up To Week 12|Withdrawal by Subject|3
1488412|NCT00550446|4904148|P2|Up To Week 12|Withdrawal by Subject|0
1488413|NCT00550446|4904149|P1|Up To Week 12|Withdrawal by Subject|2
1488414|NCT00550446|4904139|P11|Up To Week 12|Lost to Follow-up|0
1488415|NCT00550446|4904140|P10|Up To Week 12|Lost to Follow-up|0
1488416|NCT00550446|4904141|P9|Up To Week 12|Lost to Follow-up|0
1488417|NCT00550446|4904142|P8|Up To Week 12|Lost to Follow-up|0
1488418|NCT00550446|4904143|P7|Up To Week 12|Lost to Follow-up|2
1488419|NCT00550446|4904144|P6|Up To Week 12|Lost to Follow-up|1
1488420|NCT00550446|4904145|P5|Up To Week 12|Lost to Follow-up|1
1488421|NCT00550446|4904146|P4|Up To Week 12|Lost to Follow-up|0
1488422|NCT00550446|4904147|P3|Up To Week 12|Lost to Follow-up|0
1488423|NCT00550446|4904148|P2|Up To Week 12|Lost to Follow-up|1
1488424|NCT00550446|4904149|P1|Up To Week 12|Lost to Follow-up|0
1488425|NCT00550446|4904139|P11|Up To Week 12|Lack of Efficacy|0
1488426|NCT00550446|4904140|P10|Up To Week 12|Lack of Efficacy|0
1488427|NCT00550446|4904141|P9|Up To Week 12|Lack of Efficacy|0
1488428|NCT00550446|4904142|P8|Up To Week 12|Lack of Efficacy|0
1488429|NCT00550446|4904143|P7|Up To Week 12|Lack of Efficacy|3
1488430|NCT00550446|4904144|P6|Up To Week 12|Lack of Efficacy|3
1488431|NCT00550446|4904145|P5|Up To Week 12|Lack of Efficacy|0
1488432|NCT00550446|4904146|P4|Up To Week 12|Lack of Efficacy|1
1488433|NCT00550446|4904147|P3|Up To Week 12|Lack of Efficacy|0
1488434|NCT00550446|4904148|P2|Up To Week 12|Lack of Efficacy|1
1488435|NCT00550446|4904149|P1|Up To Week 12|Lack of Efficacy|3
1488436|NCT00550446|4904139|P11|Up To Week 12|Adverse Event|0
1488437|NCT00550446|4904140|P10|Up To Week 12|Adverse Event|0
1488438|NCT00550446|4904141|P9|Up To Week 12|Adverse Event|0
1488439|NCT00550446|4904142|P8|Up To Week 12|Adverse Event|0
1488440|NCT00550446|4904143|P7|Up To Week 12|Adverse Event|1
1488441|NCT00550446|4904144|P6|Up To Week 12|Adverse Event|2
1488442|NCT00550446|4904145|P5|Up To Week 12|Adverse Event|2
1488443|NCT00550446|4904146|P4|Up To Week 12|Adverse Event|0
1488444|NCT00550446|4904147|P3|Up To Week 12|Adverse Event|0
1488445|NCT00550446|4904148|P2|Up To Week 12|Adverse Event|2
1488446|NCT00550446|4904149|P1|Up To Week 12|Adverse Event|2
1488447|NCT00550420|4904581|P1|Overall Study|Prohibited medicine|1
1488448|NCT00550420|4904581|P1|Overall Study|Exclusion criteria|1
1488449|NCT00550420|4904581|P1|Overall Study|Out of Electrocardiogram criteria|1
1488450|NCT00550420|4904581|P1|Overall Study|Caregiver's decision to withdraw|1
1488451|NCT00550420|4904581|P1|Overall Study|Unethical stop of enrollment|2
1488452|NCT00550420|4904581|P1|Overall Study|Lack of curative effect|1
1488453|NCT00550420|4904581|P1|Overall Study|Investigators opinion|1
1488454|NCT00550420|4904581|P1|Overall Study|Prolonged QT Interval Electrocardiogram|12
1488455|NCT00550420|4904581|P1|Overall Study|Missing|2
1488456|NCT00550420|4904581|P1|Overall Study|Still in study at termination|206
1488457|NCT00550420|4904581|P1|Overall Study|Withdrawal by Subject|30
1488458|NCT00550420|4904581|P1|Overall Study|Protocol Violation|11
1488459|NCT00550420|4904581|P1|Overall Study|Lost to Follow-up|8
1488460|NCT00550420|4904581|P1|Overall Study|Adverse Event|28
1488461|NCT00550407|4904604|P3|26-Week Randomized Phase|Withdrawal by Subject|3
1488462|NCT00550407|4904605|P2|26-Week Randomized Phase|Withdrawal by Subject|1
1488463|NCT00550407|4904606|P1|26-Week Randomized Phase|Withdrawal by Subject|0
1488464|NCT00550407|4904604|P3|26-Week Randomized Phase|Investigator Discretion|0
1488465|NCT00550407|4904605|P2|26-Week Randomized Phase|Investigator Discretion|1
1488466|NCT00550407|4904606|P1|26-Week Randomized Phase|Investigator Discretion|0
1488467|NCT00550407|4904604|P3|26-Week Randomized Phase|Lack of Efficacy|19
1488468|NCT00550407|4904605|P2|26-Week Randomized Phase|Lack of Efficacy|36
1488469|NCT00550407|4904606|P1|26-Week Randomized Phase|Lack of Efficacy|0
1488470|NCT00550407|4904604|P3|26-Week Randomized Phase|Adverse Event|2
1488471|NCT00550407|4904605|P2|26-Week Randomized Phase|Adverse Event|5
1488472|NCT00550407|4904606|P1|26-Week Randomized Phase|Adverse Event|0
1488473|NCT00550407|4904604|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
1488474|NCT00550407|4904605|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
1488475|NCT00550407|4904606|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
1488476|NCT00550407|4904604|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
1488477|NCT00550407|4904605|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
1488478|NCT00550407|4904606|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
1488479|NCT00550407|4904604|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
1488480|NCT00550407|4904605|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
1488481|NCT00550407|4904606|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
1488482|NCT00550407|4904604|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
1488483|NCT00550407|4904605|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
1488484|NCT00550407|4904606|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
1488485|NCT00550407|4904604|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
1488486|NCT00550407|4904605|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
1488487|NCT00550407|4904606|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
1488488|NCT00550407|4904604|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
1488489|NCT00550407|4904605|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
1488490|NCT00550407|4904606|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
1488491|NCT00550407|4904604|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
1488492|NCT00550407|4904605|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
1488493|NCT00550407|4904606|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
1488494|NCT00550407|4904604|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
1488495|NCT00550407|4904605|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
1488496|NCT00550407|4904606|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
1488497|NCT00550173|4904672|P3|Overall Study|Lost to Follow-up|3
1488498|NCT00550173|4904673|P2|Overall Study|Lost to Follow-up|4
1488499|NCT00550173|4904674|P1|Overall Study|Lost to Follow-up|4
1488500|NCT00550173|4904672|P3|Overall Study|Sponsor Decision|1
1488501|NCT00550173|4904673|P2|Overall Study|Sponsor Decision|7
1488502|NCT00550173|4904674|P1|Overall Study|Sponsor Decision|13
1488503|NCT00550173|4904672|P3|Overall Study|Withdrawal by Subject|17
1488504|NCT00550173|4904673|P2|Overall Study|Withdrawal by Subject|12
1488505|NCT00550173|4904674|P1|Overall Study|Withdrawal by Subject|9
1488506|NCT00550173|4904672|P3|Overall Study|Physician Decision|2
1488507|NCT00550173|4904673|P2|Overall Study|Physician Decision|2
1488508|NCT00550173|4904674|P1|Overall Study|Physician Decision|1
1488509|NCT00550173|4904672|P3|Overall Study|Death|50
1488510|NCT00550173|4904673|P2|Overall Study|Death|38
1488511|NCT00550173|4904674|P1|Overall Study|Death|45
1488512|NCT00550147|4904703|P1|Quetiapine Addition Treatment Period|Moved out of state|1
1488513|NCT00550147|4904703|P1|Quetiapine Addition Treatment Period|Noncompliance|2
1488514|NCT00550147|4904703|P1|Quetiapine Addition Treatment Period|Adverse Event|3
1488515|NCT00550147|4904703|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
1488516|NCT00550147|4904703|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
1488517|NCT00550043|4904726|P5|Overall Study|Other Reasons- Unspecified|0
1488518|NCT00550043|4904727|P4|Overall Study|Other Reasons- Unspecified|1
1488519|NCT00550043|4904728|P3|Overall Study|Other Reasons- Unspecified|0
1488520|NCT00550043|4904729|P2|Overall Study|Other Reasons- Unspecified|1
1488521|NCT00550043|4904730|P1|Overall Study|Other Reasons- Unspecified|0
1488522|NCT00550043|4904726|P5|Overall Study|Subject Withdrew Consent|0
1488523|NCT00550043|4904727|P4|Overall Study|Subject Withdrew Consent|0
1488524|NCT00550043|4904728|P3|Overall Study|Subject Withdrew Consent|1
1488525|NCT00550043|4904729|P2|Overall Study|Subject Withdrew Consent|2
1488526|NCT00550043|4904730|P1|Overall Study|Subject Withdrew Consent|0
1488527|NCT00550043|4904726|P5|Overall Study|Adverse Event|1
1488528|NCT00550043|4904727|P4|Overall Study|Adverse Event|1
1488529|NCT00550043|4904728|P3|Overall Study|Adverse Event|0
1488530|NCT00550043|4904729|P2|Overall Study|Adverse Event|0
1488531|NCT00550043|4904730|P1|Overall Study|Adverse Event|0
1488532|NCT00549939|4904785|P3|40-week Open Label Treatment Period|Other|4
1488533|NCT00549939|4904786|P2|40-week Open Label Treatment Period|Other|1
1488534|NCT00549939|4904787|P1|40-week Open Label Treatment Period|Other|0
1488535|NCT00549939|4904785|P3|40-week Open Label Treatment Period|Protocol Violation|0
1488536|NCT00549939|4904786|P2|40-week Open Label Treatment Period|Protocol Violation|1
1488537|NCT00549939|4904787|P1|40-week Open Label Treatment Period|Protocol Violation|0
1488538|NCT00549939|4904785|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
1488539|NCT00549939|4904786|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
1488540|NCT00549939|4904787|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
1488541|NCT00549939|4904785|P3|40-week Open Label Treatment Period|Adverse Event|1
1488542|NCT00549939|4904786|P2|40-week Open Label Treatment Period|Adverse Event|2
1488543|NCT00549939|4904787|P1|40-week Open Label Treatment Period|Adverse Event|0
1488544|NCT00549939|4904785|P3|12-week Double Blind Treatment Period|Too many blood draws|0
1488545|NCT00549939|4904786|P2|12-week Double Blind Treatment Period|Too many blood draws|1
1488546|NCT00549939|4904787|P1|12-week Double Blind Treatment Period|Too many blood draws|0
1488547|NCT00549939|4904785|P3|12-week Double Blind Treatment Period|Adverse Event|2
1488548|NCT00549939|4904786|P2|12-week Double Blind Treatment Period|Adverse Event|1
1488549|NCT00549939|4904787|P1|12-week Double Blind Treatment Period|Adverse Event|1
1488550|NCT00549900|4904814|P1|Overall Study|Adverse Event|1
1488551|NCT00549770|4904870|P8|Overall Study|Adverse Event|4
1488552|NCT00549770|4904871|P7|Overall Study|Adverse Event|5
1488553|NCT00549770|4904872|P6|Overall Study|Adverse Event|0
1488554|NCT00549770|4904873|P5|Overall Study|Adverse Event|1
1488555|NCT00549770|4904874|P4|Overall Study|Adverse Event|2
1488556|NCT00549770|4904875|P3|Overall Study|Adverse Event|1
1488557|NCT00549770|4904876|P2|Overall Study|Adverse Event|3
1488558|NCT00549770|4904877|P1|Overall Study|Adverse Event|1
1488559|NCT00549770|4904870|P8|Overall Study|Abnormal laboratory values|0
1488560|NCT00549770|4904871|P7|Overall Study|Abnormal laboratory values|0
1488561|NCT00549770|4904872|P6|Overall Study|Abnormal laboratory values|1
1488562|NCT00549770|4904873|P5|Overall Study|Abnormal laboratory values|0
1488563|NCT00549770|4904874|P4|Overall Study|Abnormal laboratory values|0
1488564|NCT00549770|4904875|P3|Overall Study|Abnormal laboratory values|0
1488565|NCT00549770|4904876|P2|Overall Study|Abnormal laboratory values|0
1488566|NCT00549770|4904877|P1|Overall Study|Abnormal laboratory values|0
1488567|NCT00549770|4904870|P8|Overall Study|Abnormal test procedure results|1
1488568|NCT00549770|4904871|P7|Overall Study|Abnormal test procedure results|1
1488569|NCT00549770|4904872|P6|Overall Study|Abnormal test procedure results|1
1488570|NCT00549770|4904873|P5|Overall Study|Abnormal test procedure results|0
1488571|NCT00549770|4904874|P4|Overall Study|Abnormal test procedure results|2
1488572|NCT00549770|4904875|P3|Overall Study|Abnormal test procedure results|0
1488573|NCT00549770|4904876|P2|Overall Study|Abnormal test procedure results|0
1488574|NCT00549770|4904877|P1|Overall Study|Abnormal test procedure results|0
1488575|NCT00549770|4904870|P8|Overall Study|Lack of Efficacy|8
1488576|NCT00549770|4904871|P7|Overall Study|Lack of Efficacy|3
1488577|NCT00549770|4904872|P6|Overall Study|Lack of Efficacy|1
1488578|NCT00549770|4904873|P5|Overall Study|Lack of Efficacy|5
1488579|NCT00549770|4904874|P4|Overall Study|Lack of Efficacy|3
1488580|NCT00549770|4904875|P3|Overall Study|Lack of Efficacy|2
1488581|NCT00549770|4904876|P2|Overall Study|Lack of Efficacy|0
1488582|NCT00549770|4904877|P1|Overall Study|Lack of Efficacy|1
1488583|NCT00549770|4904870|P8|Overall Study|Withdrawal by Subject|9
1488584|NCT00549770|4904871|P7|Overall Study|Withdrawal by Subject|4
1488585|NCT00549770|4904872|P6|Overall Study|Withdrawal by Subject|6
1488586|NCT00549770|4904873|P5|Overall Study|Withdrawal by Subject|6
1488587|NCT00549770|4904874|P4|Overall Study|Withdrawal by Subject|5
1488588|NCT00549770|4904875|P3|Overall Study|Withdrawal by Subject|4
1488589|NCT00549770|4904876|P2|Overall Study|Withdrawal by Subject|6
1488590|NCT00549770|4904877|P1|Overall Study|Withdrawal by Subject|4
1488591|NCT00549770|4904870|P8|Overall Study|Lost to Follow-up|0
1488592|NCT00549770|4904871|P7|Overall Study|Lost to Follow-up|0
1488593|NCT00549770|4904872|P6|Overall Study|Lost to Follow-up|2
1488594|NCT00549770|4904873|P5|Overall Study|Lost to Follow-up|3
1488595|NCT00549770|4904874|P4|Overall Study|Lost to Follow-up|2
1488596|NCT00549770|4904875|P3|Overall Study|Lost to Follow-up|2
1488597|NCT00549770|4904876|P2|Overall Study|Lost to Follow-up|0
1488598|NCT00549770|4904877|P1|Overall Study|Lost to Follow-up|0
1488599|NCT00549770|4904870|P8|Overall Study|Administrative problems|1
1488600|NCT00549770|4904871|P7|Overall Study|Administrative problems|0
1488601|NCT00549770|4904872|P6|Overall Study|Administrative problems|0
1488602|NCT00549770|4904873|P5|Overall Study|Administrative problems|0
1488603|NCT00549770|4904874|P4|Overall Study|Administrative problems|0
1488604|NCT00549770|4904875|P3|Overall Study|Administrative problems|0
1488605|NCT00549770|4904876|P2|Overall Study|Administrative problems|1
1488606|NCT00549770|4904877|P1|Overall Study|Administrative problems|0
1488607|NCT00549770|4904870|P8|Overall Study|Protocol deviation|2
1488608|NCT00549770|4904871|P7|Overall Study|Protocol deviation|1
1488609|NCT00549770|4904872|P6|Overall Study|Protocol deviation|2
1488610|NCT00549770|4904873|P5|Overall Study|Protocol deviation|2
1488611|NCT00549770|4904874|P4|Overall Study|Protocol deviation|2
1488612|NCT00549770|4904875|P3|Overall Study|Protocol deviation|1
1488613|NCT00549770|4904876|P2|Overall Study|Protocol deviation|1
1488614|NCT00549770|4904877|P1|Overall Study|Protocol deviation|1
1488615|NCT00549757|4904961|P2|Extension Period (in Average 9 Months)|Patient's request|436
1488616|NCT00549757|4904962|P1|Extension Period (in Average 9 Months)|Patient's request|421
1488617|NCT00549757|4904961|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
1488618|NCT00549757|4904962|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
1488619|NCT00549757|4904961|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
1488620|NCT00549757|4904962|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
1488621|NCT00549757|4904961|P2|Extension Period (in Average 9 Months)|Death|136
1488622|NCT00549757|4904962|P1|Extension Period (in Average 9 Months)|Death|143
1488623|NCT00549757|4904961|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
1488624|NCT00549757|4904962|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
1488625|NCT00549757|4904961|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
1488626|NCT00549757|4904962|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
1488627|NCT00549757|4904961|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
1488628|NCT00549757|4904962|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
1488629|NCT00549757|4904961|P2|Active Treatment Phase: Max. 50 Months|Death|200
1488630|NCT00549757|4904962|P1|Active Treatment Phase: Max. 50 Months|Death|188
1488631|NCT00549757|4904961|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
1488632|NCT00549757|4904962|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
1488633|NCT00549757|4904961|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
1488634|NCT00549757|4904962|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
1488635|NCT00549757|4904961|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
1488636|NCT00549757|4904962|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
1488637|NCT00549757|4904961|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
1488638|NCT00549757|4904962|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
1488639|NCT00549757|4904961|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
1488640|NCT00549757|4904962|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
1488641|NCT00549757|4904961|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
1488730|NCT00549302|4905195|P3|Open-Label|Other|3
1488642|NCT00549757|4904962|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
1488643|NCT00549757|4904961|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
1488644|NCT00549757|4904962|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
1488645|NCT00549718|4905024|P4|Overall Study|Administrative|1
1488646|NCT00549718|4905025|P3|Overall Study|Administrative|2
1488647|NCT00549718|4905026|P2|Overall Study|Administrative|2
1488648|NCT00549718|4905027|P1|Overall Study|Administrative|2
1488649|NCT00549718|4905024|P4|Overall Study|Withdrawal by Subject|13
1488650|NCT00549718|4905025|P3|Overall Study|Withdrawal by Subject|12
1488651|NCT00549718|4905026|P2|Overall Study|Withdrawal by Subject|18
1488652|NCT00549718|4905027|P1|Overall Study|Withdrawal by Subject|9
1488653|NCT00549718|4905024|P4|Overall Study|Lost to Follow-up|6
1488654|NCT00549718|4905025|P3|Overall Study|Lost to Follow-up|0
1488655|NCT00549718|4905026|P2|Overall Study|Lost to Follow-up|2
1488656|NCT00549718|4905027|P1|Overall Study|Lost to Follow-up|4
1488657|NCT00549718|4905024|P4|Overall Study|Adverse Event|3
1488658|NCT00549718|4905025|P3|Overall Study|Adverse Event|7
1488659|NCT00549718|4905026|P2|Overall Study|Adverse Event|8
1488660|NCT00549718|4905027|P1|Overall Study|Adverse Event|6
1488661|NCT00549718|4905024|P4|Overall Study|Insufficient clinical response|32
1488662|NCT00549718|4905025|P3|Overall Study|Insufficient clinical response|18
1488663|NCT00549718|4905026|P2|Overall Study|Insufficient clinical response|7
1488664|NCT00549718|4905027|P1|Overall Study|Insufficient clinical response|20
1488665|NCT00549640|4905043|P2|Overall Study|Lost to Follow-up|4
1488666|NCT00549640|4905044|P1|Overall Study|Lost to Follow-up|7
1488667|NCT00549640|4905043|P2|Overall Study|Adverse Event|0
1488668|NCT00549640|4905044|P1|Overall Study|Adverse Event|5
1488669|NCT00549640|4905043|P2|Overall Study|Withdrawal by Subject|12
1488670|NCT00549640|4905044|P1|Overall Study|Withdrawal by Subject|6
1488671|NCT00549601|4905057|P3|Received Study Drug|Withdrawal by Subject|1
1488672|NCT00549601|4905058|P2|Received Study Drug|Withdrawal by Subject|0
1488673|NCT00549601|4905059|P1|Received Study Drug|Withdrawal by Subject|2
1488674|NCT00549601|4905057|P3|Received Study Drug|Protocol Violation|1
1488675|NCT00549601|4905058|P2|Received Study Drug|Protocol Violation|4
1488676|NCT00549601|4905059|P1|Received Study Drug|Protocol Violation|3
1488677|NCT00549601|4905057|P3|Received Study Drug|Lost to Follow-up|1
1488678|NCT00549601|4905058|P2|Received Study Drug|Lost to Follow-up|1
1488679|NCT00549601|4905059|P1|Received Study Drug|Lost to Follow-up|0
1488680|NCT00549601|4905057|P3|Received Study Drug|Death|0
1488681|NCT00549601|4905058|P2|Received Study Drug|Death|1
1488682|NCT00549601|4905059|P1|Received Study Drug|Death|0
1488683|NCT00549601|4905057|P3|Received Study Drug|Adverse Event|1
1488684|NCT00549601|4905058|P2|Received Study Drug|Adverse Event|5
1488685|NCT00549601|4905059|P1|Received Study Drug|Adverse Event|2
1488686|NCT00549601|4905057|P3|Randomized|Withdrawal by Subject|1
1488687|NCT00549601|4905058|P2|Randomized|Withdrawal by Subject|1
1488688|NCT00549601|4905059|P1|Randomized|Withdrawal by Subject|0
1488689|NCT00549601|4905057|P3|Randomized|Protocol Violation|1
1488690|NCT00549601|4905058|P2|Randomized|Protocol Violation|0
1488691|NCT00549601|4905059|P1|Randomized|Protocol Violation|0
1488692|NCT00549562|4905081|P1|Overall Study|Lack of Efficacy|1
1488693|NCT00549562|4905081|P1|Overall Study|Adverse Event|1
1488694|NCT00549549|4905093|P4|Overall Study|Randomized but not treated|1
1488695|NCT00549549|4905094|P3|Overall Study|Randomized but not treated|1
1488696|NCT00549549|4905095|P2|Overall Study|Randomized but not treated|0
1488697|NCT00549549|4905096|P1|Overall Study|Randomized but not treated|0
1488698|NCT00549549|4905093|P4|Overall Study|Other|11
1488699|NCT00549549|4905094|P3|Overall Study|Other|9
1488700|NCT00549549|4905095|P2|Overall Study|Other|9
1488701|NCT00549549|4905096|P1|Overall Study|Other|9
1488702|NCT00549549|4905093|P4|Overall Study|Withdrawal by Subject|0
1488703|NCT00549549|4905094|P3|Overall Study|Withdrawal by Subject|1
1488704|NCT00549549|4905095|P2|Overall Study|Withdrawal by Subject|4
1488705|NCT00549549|4905096|P1|Overall Study|Withdrawal by Subject|0
1488706|NCT00549549|4905093|P4|Overall Study|Lost to Follow-up|2
1488707|NCT00549549|4905094|P3|Overall Study|Lost to Follow-up|1
1488708|NCT00549549|4905095|P2|Overall Study|Lost to Follow-up|0
1488709|NCT00549549|4905096|P1|Overall Study|Lost to Follow-up|1
1488710|NCT00549549|4905093|P4|Overall Study|Lack of Efficacy|2
1488711|NCT00549549|4905094|P3|Overall Study|Lack of Efficacy|4
1488712|NCT00549549|4905095|P2|Overall Study|Lack of Efficacy|6
1488713|NCT00549549|4905096|P1|Overall Study|Lack of Efficacy|9
1488714|NCT00549549|4905093|P4|Overall Study|Adverse Event|9
1488715|NCT00549549|4905094|P3|Overall Study|Adverse Event|1
1488716|NCT00549549|4905095|P2|Overall Study|Adverse Event|3
1488717|NCT00549549|4905096|P1|Overall Study|Adverse Event|5
1488718|NCT00549445|4905164|P2|Overall Study|Sputum & Blood Samples Not Available|17
1488719|NCT00549445|4905165|P1|Overall Study|Sputum & Blood Samples Not Available|15
1488720|NCT00549328|4905184|P1|Overall Study|Use of Prohibited Medication|1
1488721|NCT00549328|4905184|P1|Overall Study|Death|1
1488722|NCT00549328|4905184|P1|Overall Study|Disease Progression|10
1488723|NCT00549328|4905184|P1|Overall Study|Adverse Event|2
1488724|NCT00549302|4905195|P3|Open-Label|Withdrawal by Subject|6
1488725|NCT00549302|4905196|P2|Open-Label|Withdrawal by Subject|0
1488726|NCT00549302|4905197|P1|Open-Label|Withdrawal by Subject|0
1488727|NCT00549302|4905195|P3|Open-Label|New drug pulmonary atrial hypertension|2
1488728|NCT00549302|4905196|P2|Open-Label|New drug pulmonary atrial hypertension|0
1488729|NCT00549302|4905197|P1|Open-Label|New drug pulmonary atrial hypertension|0
1488731|NCT00549302|4905196|P2|Open-Label|Other|0
1488732|NCT00549302|4905197|P1|Open-Label|Other|0
1488733|NCT00549302|4905195|P3|Open-Label|Lost to Follow-up|2
1488734|NCT00549302|4905196|P2|Open-Label|Lost to Follow-up|0
1488735|NCT00549302|4905197|P1|Open-Label|Lost to Follow-up|0
1488736|NCT00549302|4905195|P3|Open-Label|Investigator Decision|5
1488737|NCT00549302|4905196|P2|Open-Label|Investigator Decision|0
1488738|NCT00549302|4905197|P1|Open-Label|Investigator Decision|0
1488739|NCT00549302|4905195|P3|Open-Label|Death|40
1488740|NCT00549302|4905196|P2|Open-Label|Death|0
1488741|NCT00549302|4905197|P1|Open-Label|Death|0
1488742|NCT00549302|4905195|P3|Open-Label|Adverse Event|11
1488743|NCT00549302|4905196|P2|Open-Label|Adverse Event|0
1488744|NCT00549302|4905197|P1|Open-Label|Adverse Event|0
1488745|NCT00549302|4905195|P3|Double-Blind|New condition or starts new therapy|0
1488746|NCT00549302|4905196|P2|Double-Blind|New condition or starts new therapy|2
1488747|NCT00549302|4905197|P1|Double-Blind|New condition or starts new therapy|0
1488748|NCT00549302|4905195|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
1488749|NCT00549302|4905196|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
1488750|NCT00549302|4905197|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
1488751|NCT00549302|4905195|P3|Double-Blind|Lost to Follow-up|0
1488752|NCT00549302|4905196|P2|Double-Blind|Lost to Follow-up|2
1488753|NCT00549302|4905197|P1|Double-Blind|Lost to Follow-up|1
1488754|NCT00549302|4905195|P3|Double-Blind|Sponsor Decision|0
1488755|NCT00549302|4905196|P2|Double-Blind|Sponsor Decision|1
1488756|NCT00549302|4905197|P1|Double-Blind|Sponsor Decision|0
1488757|NCT00549302|4905195|P3|Double-Blind|Investigator Decision|0
1488758|NCT00549302|4905196|P2|Double-Blind|Investigator Decision|5
1488759|NCT00549302|4905197|P1|Double-Blind|Investigator Decision|1
1488760|NCT00549302|4905195|P3|Double-Blind|Withdrawal by Subject|0
1488761|NCT00549302|4905196|P2|Double-Blind|Withdrawal by Subject|8
1488762|NCT00549302|4905197|P1|Double-Blind|Withdrawal by Subject|3
1488763|NCT00549302|4905195|P3|Double-Blind|Adverse Event|0
1488764|NCT00549302|4905196|P2|Double-Blind|Adverse Event|16
1488765|NCT00549302|4905197|P1|Double-Blind|Adverse Event|3
1488766|NCT00549302|4905195|P3|Double-Blind|Death|0
1488767|NCT00549302|4905196|P2|Double-Blind|Death|9
1488768|NCT00549302|4905197|P1|Double-Blind|Death|2
1488769|NCT00549198|4905209|P2|Overall Study|Not Exposed to Study Drug|4
1488770|NCT00549198|4905210|P1|Overall Study|Not Exposed to Study Drug|3
1488771|NCT00549198|4905209|P2|Overall Study|Pregnancy|3
1488772|NCT00549198|4905210|P1|Overall Study|Pregnancy|0
1488773|NCT00549198|4905209|P2|Overall Study|No scan facilities|2
1488774|NCT00549198|4905210|P1|Overall Study|No scan facilities|0
1488775|NCT00549198|4905209|P2|Overall Study|Participant overweight, no scan possible|0
1488776|NCT00549198|4905210|P1|Overall Study|Participant overweight, no scan possible|1
1488777|NCT00549198|4905209|P2|Overall Study|Participant planning pregnancy|0
1488778|NCT00549198|4905210|P1|Overall Study|Participant planning pregnancy|1
1488779|NCT00549198|4905209|P2|Overall Study|Prohibited Medication|2
1488780|NCT00549198|4905210|P1|Overall Study|Prohibited Medication|1
1488781|NCT00549198|4905209|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
1488782|NCT00549198|4905210|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
1488783|NCT00549198|4905209|P2|Overall Study|Participant not able to perform Week 96|0
1488784|NCT00549198|4905210|P1|Overall Study|Participant not able to perform Week 96|1
1488785|NCT00549198|4905209|P2|Overall Study|Participant Moved|0
1488786|NCT00549198|4905210|P1|Overall Study|Participant Moved|2
1488787|NCT00549198|4905209|P2|Overall Study|Disease Progression|0
1488788|NCT00549198|4905210|P1|Overall Study|Disease Progression|1
1488789|NCT00549198|4905209|P2|Overall Study|Withdrawal by Subject|7
1488790|NCT00549198|4905210|P1|Overall Study|Withdrawal by Subject|7
1488791|NCT00549198|4905209|P2|Overall Study|Investigator Decision|3
1488792|NCT00549198|4905210|P1|Overall Study|Investigator Decision|4
1488793|NCT00549198|4905209|P2|Overall Study|Protocol Violation|2
1488794|NCT00549198|4905210|P1|Overall Study|Protocol Violation|7
1488795|NCT00549198|4905209|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
1488796|NCT00549198|4905210|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
1488797|NCT00549198|4905209|P2|Overall Study|Lost to Follow-up|8
1488798|NCT00549198|4905210|P1|Overall Study|Lost to Follow-up|7
1488799|NCT00549198|4905209|P2|Overall Study|Non-compliance|4
1488800|NCT00549198|4905210|P1|Overall Study|Non-compliance|2
1488801|NCT00549198|4905209|P2|Overall Study|Protocol-defined Virological Failure|0
1488802|NCT00549198|4905210|P1|Overall Study|Protocol-defined Virological Failure|7
1488803|NCT00549198|4905209|P2|Overall Study|Insufficient Viral Load Response|2
1488804|NCT00549198|4905210|P1|Overall Study|Insufficient Viral Load Response|4
1488805|NCT00549198|4905209|P2|Overall Study|Adverse Event|26
1488806|NCT00549198|4905210|P1|Overall Study|Adverse Event|28
1488807|NCT00549055|4905347|P1|Overall Study|Very low visual acuity (VA)|1
1488808|NCT00549055|4905347|P1|Overall Study|Choroidal neovascularization|1
1488809|NCT00549055|4905347|P1|Overall Study|Growth choroidal neovascularisation|1
1488810|NCT00549055|4905347|P1|Overall Study|Vitreous hemorrhage|1
1488811|NCT00549055|4905347|P1|Overall Study|Active choroidal neovascula increased|1
1488812|NCT00549055|4905347|P1|Overall Study|Decrease of size|1
1488813|NCT00549055|4905347|P1|Overall Study|Progression to fibrosis|2
1488814|NCT00549055|4905347|P1|Overall Study|Stabilization|5
1488815|NCT00549055|4905347|P1|Overall Study|Lack of efficacy|18
1488816|NCT00549055|4905347|P1|Overall Study|Adverse Event|4
1488817|NCT00548847|4905371|P1|Overall Study|Disease progression|7
1488818|NCT00548808|4905378|P2|Overall Study|Sponsor Decision|1
1488819|NCT00548808|4905379|P1|Overall Study|Sponsor Decision|1
1488820|NCT00548808|4905378|P2|Overall Study|Lack of Efficacy|0
1488821|NCT00548808|4905379|P1|Overall Study|Lack of Efficacy|2
1488822|NCT00548808|4905378|P2|Overall Study|Entry Criteria Not Met|2
1488823|NCT00548808|4905379|P1|Overall Study|Entry Criteria Not Met|2
1488824|NCT00548808|4905378|P2|Overall Study|Death|0
1488825|NCT00548808|4905379|P1|Overall Study|Death|2
1488826|NCT00548808|4905378|P2|Overall Study|Adverse Event|5
1488827|NCT00548808|4905379|P1|Overall Study|Adverse Event|4
1488828|NCT00548808|4905378|P2|Overall Study|Physician Decision|3
1488829|NCT00548808|4905379|P1|Overall Study|Physician Decision|6
1488830|NCT00548808|4905378|P2|Overall Study|Withdrawal by Subject|4
1488831|NCT00548808|4905379|P1|Overall Study|Withdrawal by Subject|8
1488832|NCT00548808|4905378|P2|Overall Study|Protocol Violation|8
1488833|NCT00548808|4905379|P1|Overall Study|Protocol Violation|8
1488834|NCT00548808|4905378|P2|Overall Study|Lost to Follow-up|3
1488835|NCT00548808|4905379|P1|Overall Study|Lost to Follow-up|9
1488836|NCT00548717|4905403|P2|Overall Study|Alternative treatment for GVHD|0
1488837|NCT00548717|4905404|P1|Overall Study|Alternative treatment for GVHD|1
1488838|NCT00548717|4905403|P2|Overall Study|Relapse|0
1488839|NCT00548717|4905404|P1|Overall Study|Relapse|3
1488840|NCT00548717|4905403|P2|Overall Study|Death|2
1488841|NCT00548717|4905404|P1|Overall Study|Death|5
1488842|NCT00548548|4905432|P2|Overall Study|Lost to Follow-up|18
1488843|NCT00548548|4905433|P1|Overall Study|Lost to Follow-up|17
1488844|NCT00548548|4905432|P2|Overall Study|Death|348
1488845|NCT00548548|4905433|P1|Overall Study|Death|345
1488846|NCT00548405|4905476|P3|Overall Study|Randomized but not treated|0
1488847|NCT00548405|4905477|P2|Overall Study|Randomized but not treated|0
1488848|NCT00548405|4905478|P1|Overall Study|Randomized but not treated|1
1488849|NCT00548405|4905476|P3|Overall Study|Sponsor decision|0
1488850|NCT00548405|4905477|P2|Overall Study|Sponsor decision|0
1488851|NCT00548405|4905478|P1|Overall Study|Sponsor decision|1
1488852|NCT00548405|4905476|P3|Overall Study|Death|1
1488853|NCT00548405|4905477|P2|Overall Study|Death|1
1488854|NCT00548405|4905478|P1|Overall Study|Death|0
1488855|NCT00548405|4905476|P3|Overall Study|Lost to Follow-up|2
1488856|NCT00548405|4905477|P2|Overall Study|Lost to Follow-up|1
1488857|NCT00548405|4905478|P1|Overall Study|Lost to Follow-up|1
1488858|NCT00548405|4905476|P3|Overall Study|Withdrawal by Subject|5
1488859|NCT00548405|4905477|P2|Overall Study|Withdrawal by Subject|12
1488860|NCT00548405|4905478|P1|Overall Study|Withdrawal by Subject|36
1488861|NCT00548405|4905476|P3|Overall Study|Protocol Violation|0
1488862|NCT00548405|4905477|P2|Overall Study|Protocol Violation|0
1488863|NCT00548405|4905478|P1|Overall Study|Protocol Violation|1
1488864|NCT00548405|4905476|P3|Overall Study|Pregnancy|0
1488865|NCT00548405|4905477|P2|Overall Study|Pregnancy|0
1488866|NCT00548405|4905478|P1|Overall Study|Pregnancy|1
1488867|NCT00548405|4905476|P3|Overall Study|Physician Decision|1
1488868|NCT00548405|4905477|P2|Overall Study|Physician Decision|4
1488869|NCT00548405|4905478|P1|Overall Study|Physician Decision|3
1488870|NCT00548405|4905476|P3|Overall Study|Lack of Efficacy|0
1488871|NCT00548405|4905477|P2|Overall Study|Lack of Efficacy|0
1488872|NCT00548405|4905478|P1|Overall Study|Lack of Efficacy|6
1488873|NCT00548405|4905476|P3|Overall Study|Adverse Event|0
1488874|NCT00548405|4905477|P2|Overall Study|Adverse Event|2
1488875|NCT00548405|4905478|P1|Overall Study|Adverse Event|6
1488876|NCT00548340|4905499|P3|Overall Study|Other|1
1488877|NCT00548340|4905500|P2|Overall Study|Other|1
1488878|NCT00548340|4905501|P1|Overall Study|Other|1
1488879|NCT00548340|4905499|P3|Overall Study|Withdrawal by Subject|3
1488880|NCT00548340|4905500|P2|Overall Study|Withdrawal by Subject|4
1488881|NCT00548340|4905501|P1|Overall Study|Withdrawal by Subject|2
1488882|NCT00548340|4905499|P3|Overall Study|Lost to Follow-up|0
1488883|NCT00548340|4905500|P2|Overall Study|Lost to Follow-up|1
1488884|NCT00548340|4905501|P1|Overall Study|Lost to Follow-up|1
1488885|NCT00548340|4905499|P3|Overall Study|Adverse Event|2
1488886|NCT00548340|4905500|P2|Overall Study|Adverse Event|2
1488887|NCT00548340|4905501|P1|Overall Study|Adverse Event|2
1488888|NCT00548340|4905499|P3|Overall Study|Protocol Violation|3
1488889|NCT00548340|4905500|P2|Overall Study|Protocol Violation|3
1488890|NCT00548340|4905501|P1|Overall Study|Protocol Violation|2
1488891|NCT00548327|4905520|P2|Overall Study|Adverse Event|1
1488892|NCT00548327|4905521|P1|Overall Study|Adverse Event|0
1488893|NCT00548262|4905539|P1|Overall Study|Withdrawal by Subject|1
1488894|NCT00548262|4905539|P1|Overall Study|Other|3
1488895|NCT00548262|4905539|P1|Overall Study|Lost to Follow-up|1
1488896|NCT00548262|4905539|P1|Overall Study|Lack of Efficacy|4
1488897|NCT00548262|4905539|P1|Overall Study|Adverse Event|2
1488898|NCT00548262|4905539|P1|Overall Study|Death|21
1488899|NCT00548249|4905569|P5|Overall Study|Sponsor's request|0
1488900|NCT00548249|4905570|P4|Overall Study|Sponsor's request|1
1488901|NCT00548249|4905571|P3|Overall Study|Sponsor's request|0
1488902|NCT00548249|4905572|P2|Overall Study|Sponsor's request|0
1488903|NCT00548249|4905573|P1|Overall Study|Sponsor's request|0
1488904|NCT00548249|4905569|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
1488905|NCT00548249|4905570|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
1488906|NCT00548249|4905571|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
1488907|NCT00548249|4905572|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
1488908|NCT00548249|4905573|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
1488909|NCT00548249|4905569|P5|Overall Study|Withdrawal by Subject|0
1488910|NCT00548249|4905570|P4|Overall Study|Withdrawal by Subject|0
1488911|NCT00548249|4905571|P3|Overall Study|Withdrawal by Subject|0
1488912|NCT00548249|4905572|P2|Overall Study|Withdrawal by Subject|0
1488913|NCT00548249|4905573|P1|Overall Study|Withdrawal by Subject|2
1488914|NCT00548249|4905569|P5|Overall Study|Prolonged hospitalization|0
1488915|NCT00548249|4905570|P4|Overall Study|Prolonged hospitalization|1
1488916|NCT00548249|4905571|P3|Overall Study|Prolonged hospitalization|2
1488917|NCT00548249|4905572|P2|Overall Study|Prolonged hospitalization|0
1488918|NCT00548249|4905573|P1|Overall Study|Prolonged hospitalization|0
1488919|NCT00548249|4905569|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
1488920|NCT00548249|4905570|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
1488921|NCT00548249|4905571|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
1488922|NCT00548249|4905572|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
1488923|NCT00548249|4905573|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
1488924|NCT00548249|4905569|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
1488925|NCT00548249|4905570|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
1488926|NCT00548249|4905571|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
1488927|NCT00548249|4905572|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
1488928|NCT00548249|4905573|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
1488929|NCT00548249|4905569|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
1488930|NCT00548249|4905570|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
1488931|NCT00548249|4905571|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
1488932|NCT00548249|4905572|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
1488933|NCT00548249|4905573|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
1488934|NCT00548249|4905569|P5|Overall Study|Adverse Event|1
1488935|NCT00548249|4905570|P4|Overall Study|Adverse Event|1
1488936|NCT00548249|4905571|P3|Overall Study|Adverse Event|0
1488937|NCT00548249|4905572|P2|Overall Study|Adverse Event|2
1488938|NCT00548249|4905573|P1|Overall Study|Adverse Event|2
1488939|NCT00548249|4905569|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
1488940|NCT00548249|4905570|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
1488941|NCT00548249|4905571|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
1488942|NCT00548249|4905572|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
1488943|NCT00548249|4905573|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
1488944|NCT00548249|4905569|P5|Overall Study|Miscellaneous|2
1488945|NCT00548249|4905570|P4|Overall Study|Miscellaneous|0
1488946|NCT00548249|4905571|P3|Overall Study|Miscellaneous|2
1488947|NCT00548249|4905572|P2|Overall Study|Miscellaneous|3
1488948|NCT00548249|4905573|P1|Overall Study|Miscellaneous|2
1488949|NCT00548249|4905569|P5|Overall Study|Protocol Violation|3
1488950|NCT00548249|4905570|P4|Overall Study|Protocol Violation|0
1488951|NCT00548249|4905571|P3|Overall Study|Protocol Violation|4
1488952|NCT00548249|4905572|P2|Overall Study|Protocol Violation|1
1488953|NCT00548249|4905573|P1|Overall Study|Protocol Violation|1
1488954|NCT00548249|4905569|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
1488955|NCT00548249|4905570|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
1488956|NCT00548249|4905571|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
1488957|NCT00548249|4905572|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
1488958|NCT00548249|4905573|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
1488959|NCT00548249|4905569|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
1488960|NCT00548249|4905570|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
1488961|NCT00548249|4905571|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
1488962|NCT00548249|4905572|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
1488963|NCT00548249|4905573|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
1488964|NCT00548184|4905610|P1|Overall Study|Found Her2 negative|1
1488965|NCT00548184|4905610|P1|Overall Study|took other drug|1
1488966|NCT00548184|4905610|P1|Overall Study|Adverse Event|3
1488967|NCT00548145|4905616|P2|Overall Study|Physician Decision|1
1488968|NCT00548145|4905617|P1|Overall Study|Physician Decision|1
1488969|NCT00548145|4905616|P2|Overall Study|Withdrawal by Subject|2
1488970|NCT00548145|4905617|P1|Overall Study|Withdrawal by Subject|0
1488971|NCT00548145|4905616|P2|Overall Study|Death|1
1488972|NCT00548145|4905617|P1|Overall Study|Death|0
1488973|NCT00547911|4905642|P6|Overall Study|Adverse Event|0
1488974|NCT00547911|4905643|P5|Overall Study|Adverse Event|0
1488975|NCT00547911|4905644|P4|Overall Study|Adverse Event|1
1488976|NCT00547911|4905645|P3|Overall Study|Adverse Event|0
1488977|NCT00547911|4905646|P2|Overall Study|Adverse Event|0
1488978|NCT00547911|4905647|P1|Overall Study|Adverse Event|0
1488979|NCT00547703|4905678|P2|Overall Study|Lost to Follow-up|0
1488980|NCT00547703|4905679|P1|Overall Study|Lost to Follow-up|1
1488981|NCT00547534|4905704|P1|Overall Study|Disease Progression|4
1488982|NCT00547534|4905704|P1|Overall Study|Adverse Event|7
1488983|NCT00547521|4905712|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
1488984|NCT00547521|4905713|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
1488985|NCT00547521|4905712|P2|Long Term Extension (LTE) Study|Not Specified|2
1488986|NCT00547521|4905713|P1|Long Term Extension (LTE) Study|Not Specified|0
1488987|NCT00547521|4905712|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
1488988|NCT00547521|4905713|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
1488989|NCT00547521|4905712|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
1488990|NCT00547521|4905713|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
1488991|NCT00547521|4905712|P2|Long Term Extension (LTE) Study|Adverse Event|9
1488992|NCT00547521|4905713|P1|Long Term Extension (LTE) Study|Adverse Event|0
1488993|NCT00547521|4905712|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
1488994|NCT00547521|4905713|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
1488995|NCT00547521|4905712|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
1488996|NCT00547521|4905713|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
1488997|NCT00547521|4905712|P2|Short Term Study (4 Months)|Withdrawal of consent|1
1488998|NCT00547521|4905713|P1|Short Term Study (4 Months)|Withdrawal of consent|0
1488999|NCT00547521|4905712|P2|Short Term Study (4 Months)|Lack of Efficacy|2
1489000|NCT00547521|4905713|P1|Short Term Study (4 Months)|Lack of Efficacy|0
1489001|NCT00547521|4905712|P2|Short Term Study (4 Months)|Adverse Event|0
1489002|NCT00547521|4905713|P1|Short Term Study (4 Months)|Adverse Event|1
1489003|NCT00547378|4905790|P3|All Implanted Cohort|Other reasons|1
1489004|NCT00547378|4905791|P2|All Implanted Cohort|Other reasons|0
1489005|NCT00547378|4905792|P1|All Implanted Cohort|Other reasons|1
1489006|NCT00547378|4905790|P3|All Implanted Cohort|Site closure|1
1489007|NCT00547378|4905791|P2|All Implanted Cohort|Site closure|0
1489008|NCT00547378|4905792|P1|All Implanted Cohort|Site closure|2
1489009|NCT00547378|4905790|P3|All Implanted Cohort|Physician Decision|6
1489010|NCT00547378|4905791|P2|All Implanted Cohort|Physician Decision|2
1489011|NCT00547378|4905792|P1|All Implanted Cohort|Physician Decision|0
1489012|NCT00547378|4905790|P3|All Implanted Cohort|Death|4
1489013|NCT00547378|4905791|P2|All Implanted Cohort|Death|1
1489014|NCT00547378|4905792|P1|All Implanted Cohort|Death|3
1489015|NCT00547378|4905790|P3|All Implanted Cohort|Lost to Follow-up|14
1489016|NCT00547378|4905791|P2|All Implanted Cohort|Lost to Follow-up|1
1489017|NCT00547378|4905792|P1|All Implanted Cohort|Lost to Follow-up|0
1489018|NCT00547378|4905790|P3|All Implanted Cohort|Adverse Event|17
1489019|NCT00547378|4905791|P2|All Implanted Cohort|Adverse Event|10
1489020|NCT00547378|4905792|P1|All Implanted Cohort|Adverse Event|4
1489021|NCT00547378|4905790|P3|All Implanted Cohort|Withdrawal by Subject|27
1489022|NCT00547378|4905791|P2|All Implanted Cohort|Withdrawal by Subject|4
1489023|NCT00547378|4905792|P1|All Implanted Cohort|Withdrawal by Subject|5
1489024|NCT00547378|4905790|P3|Randomized Cohort|Other reasons|0
1489025|NCT00547378|4905791|P2|Randomized Cohort|Other reasons|0
1489026|NCT00547378|4905792|P1|Randomized Cohort|Other reasons|2
1489027|NCT00547378|4905790|P3|Randomized Cohort|Adverse Event|0
1489028|NCT00547378|4905791|P2|Randomized Cohort|Adverse Event|0
1489029|NCT00547378|4905792|P1|Randomized Cohort|Adverse Event|1
1489030|NCT00547378|4905790|P3|Randomized Cohort|Lost to Follow-up|0
1489031|NCT00547378|4905791|P2|Randomized Cohort|Lost to Follow-up|0
1489032|NCT00547378|4905792|P1|Randomized Cohort|Lost to Follow-up|1
1489033|NCT00547378|4905790|P3|Randomized Cohort|Death|0
1489034|NCT00547378|4905791|P2|Randomized Cohort|Death|1
1489035|NCT00547378|4905792|P1|Randomized Cohort|Death|0
1489036|NCT00547378|4905790|P3|Randomized Cohort|Withdrawal by Subject|0
1489037|NCT00547378|4905791|P2|Randomized Cohort|Withdrawal by Subject|5
1489038|NCT00547378|4905792|P1|Randomized Cohort|Withdrawal by Subject|7
1489039|NCT00547365|4905802|P1|Overall Study|death (not related to study)|4
1489040|NCT00547365|4905802|P1|Overall Study|Protocol Violation|2
1489041|NCT00547365|4905802|P1|Overall Study|Lost to Follow-up|1
1489042|NCT00547365|4905802|P1|Overall Study|Physician Decision|1
1489043|NCT00547157|4905809|P2|Overall Study|Lost to Follow-up|2
1489044|NCT00547157|4905810|P1|Overall Study|Lost to Follow-up|4
1489045|NCT00547157|4905809|P2|Overall Study|Administrative decision|2
1489046|NCT00547157|4905810|P1|Overall Study|Administrative decision|3
1489047|NCT00547157|4905809|P2|Overall Study|Withdrawal by Subject|1
1489048|NCT00547157|4905810|P1|Overall Study|Withdrawal by Subject|3
1489049|NCT00547157|4905809|P2|Overall Study|Death|18
1489050|NCT00547157|4905810|P1|Overall Study|Death|38
1489051|NCT00547157|4905809|P2|Overall Study|Other|0
1489052|NCT00547157|4905810|P1|Overall Study|Other|1
1489053|NCT00547118|4905828|P2|Overall Study|Study suspended|8
1489054|NCT00547118|4905829|P1|Overall Study|Study suspended|7
1489055|NCT00547118|4905828|P2|Overall Study|Did not qualify prior to starting drug|1
1489056|NCT00547118|4905829|P1|Overall Study|Did not qualify prior to starting drug|1
1489057|NCT00546910|4905873|P2|Overall Study|Withdrawal by Subject|0
1489058|NCT00546910|4905874|P1|Overall Study|Withdrawal by Subject|2
1489059|NCT00546910|4905873|P2|Overall Study|Physician Decision|1
1489060|NCT00546910|4905874|P1|Overall Study|Physician Decision|0
1489061|NCT00546910|4905873|P2|Overall Study|Lack of Efficacy|7
1489062|NCT00546910|4905874|P1|Overall Study|Lack of Efficacy|5
1489063|NCT00546910|4905873|P2|Overall Study|Adverse Event|3
1489064|NCT00546910|4905874|P1|Overall Study|Adverse Event|2
1489065|NCT00546871|4905940|P2|Study Extension Period|Withdrawal by Subject|1
1489066|NCT00546871|4905941|P1|Study Extension Period|Withdrawal by Subject|0
1489067|NCT00546871|4905940|P2|Study Extension Period|Protocol Violation|0
1489068|NCT00546871|4905941|P1|Study Extension Period|Protocol Violation|1
1489069|NCT00546871|4905940|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
1489070|NCT00546871|4905941|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
1489071|NCT00546871|4905940|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
1489072|NCT00546871|4905941|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
1489073|NCT00546871|4905940|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
1489074|NCT00546871|4905941|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
1489075|NCT00546819|4906046|P2|Overall Study|Withdrawal by Subject|2
1489076|NCT00546819|4906047|P1|Overall Study|Withdrawal by Subject|4
1489077|NCT00546819|4906046|P2|Overall Study|Lost to Follow-up|1
1489078|NCT00546819|4906047|P1|Overall Study|Lost to Follow-up|2
1489079|NCT00546819|4906046|P2|Overall Study|Adverse Event|3
1489080|NCT00546819|4906047|P1|Overall Study|Adverse Event|2
1489081|NCT00546754|4906059|P2|Overall Study|Missing|7
1489082|NCT00546754|4906060|P1|Overall Study|Missing|14
1489083|NCT00546754|4906059|P2|Overall Study|Patient's Decision|1
1489084|NCT00546754|4906060|P1|Overall Study|Patient's Decision|0
1489085|NCT00546754|4906059|P2|Overall Study|Elevated Creatinine and Potassium levels|1
1489086|NCT00546754|4906060|P1|Overall Study|Elevated Creatinine and Potassium levels|0
1489087|NCT00546754|4906059|P2|Overall Study|Missing Cooperation|0
1489088|NCT00546754|4906060|P1|Overall Study|Missing Cooperation|1
1489089|NCT00546754|4906059|P2|Overall Study|Suicide|0
1489090|NCT00546754|4906060|P1|Overall Study|Suicide|1
1489091|NCT00546754|4906059|P2|Overall Study|Hip Replacement|0
1489092|NCT00546754|4906060|P1|Overall Study|Hip Replacement|1
1489093|NCT00546754|4906059|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
1489094|NCT00546754|4906060|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
1489095|NCT00546754|4906059|P2|Overall Study|Dyspnea|0
1489096|NCT00546754|4906060|P1|Overall Study|Dyspnea|1
1489097|NCT00546754|4906059|P2|Overall Study|Withdrawal by Subject|7
1489098|NCT00546754|4906060|P1|Overall Study|Withdrawal by Subject|6
1489099|NCT00546754|4906059|P2|Overall Study|Protocol Violation|0
1489100|NCT00546754|4906060|P1|Overall Study|Protocol Violation|3
1489101|NCT00546754|4906059|P2|Overall Study|Lost to Follow-up|15
1489102|NCT00546754|4906060|P1|Overall Study|Lost to Follow-up|9
1489103|NCT00546754|4906059|P2|Overall Study|Lack of Efficacy|1
1489104|NCT00546754|4906060|P1|Overall Study|Lack of Efficacy|1
1489105|NCT00546754|4906059|P2|Overall Study|Adverse Event|16
1489106|NCT00546754|4906060|P1|Overall Study|Adverse Event|11
1489107|NCT00546754|4906059|P2|Overall Study|Serious Adverse Event|1
1489108|NCT00546754|4906060|P1|Overall Study|Serious Adverse Event|1
1489109|NCT00546715|4906103|P4|Overall Study|Withdrawal by Subject|0
1489110|NCT00546715|4906104|P3|Overall Study|Withdrawal by Subject|0
1489111|NCT00546715|4906105|P2|Overall Study|Withdrawal by Subject|1
1489112|NCT00546715|4906106|P1|Overall Study|Withdrawal by Subject|0
1489113|NCT00546637|4906161|P2|Overall Study|Randomized, but not treated|1
1489114|NCT00546637|4906162|P1|Overall Study|Randomized, but not treated|3
1489115|NCT00546637|4906161|P2|Overall Study|Withdrawal by Subject|9
1489116|NCT00546637|4906162|P1|Overall Study|Withdrawal by Subject|7
1489117|NCT00546637|4906161|P2|Overall Study|Other|12
1489118|NCT00546637|4906162|P1|Overall Study|Other|10
1489119|NCT00546637|4906161|P2|Overall Study|Lost to Follow-up|2
1489120|NCT00546637|4906162|P1|Overall Study|Lost to Follow-up|2
1489121|NCT00546637|4906161|P2|Overall Study|Lack of Efficacy|5
1489122|NCT00546637|4906162|P1|Overall Study|Lack of Efficacy|5
1489123|NCT00546637|4906161|P2|Overall Study|Adverse Event|20
1489124|NCT00546637|4906162|P1|Overall Study|Adverse Event|46
1489125|NCT00546572|4906236|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
1489126|NCT00546572|4906237|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
1489127|NCT00546572|4906236|P2|Vax 2 / Year 1|Adverse Event|0
1489128|NCT00546572|4906237|P1|Vax 2 / Year 1|Adverse Event|1
1489129|NCT00546572|4906236|P2|Vax 2 / Year 1|Other|1
1489130|NCT00546572|4906237|P1|Vax 2 / Year 1|Other|1
1489131|NCT00546572|4906236|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
1489132|NCT00546572|4906237|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
1489133|NCT00546572|4906236|P2|Vax 1 / Year 0|Lost to Follow-up|1
1489134|NCT00546572|4906237|P1|Vax 1 / Year 0|Lost to Follow-up|0
1489135|NCT00546572|4906236|P2|Vax 1 / Year 0|Adverse Event|1
1489136|NCT00546572|4906237|P1|Vax 1 / Year 0|Adverse Event|0
1489137|NCT00546572|4906236|P2|Vax 1 / Year 0|Death|2
1489138|NCT00546572|4906237|P1|Vax 1 / Year 0|Death|2
1489139|NCT00546572|4906236|P2|Vax 1 / Year 0|Protocol Violation|4
1489140|NCT00546572|4906237|P1|Vax 1 / Year 0|Protocol Violation|3
1489141|NCT00546572|4906236|P2|Vax 1 / Year 0|Withdrawal by Subject|2
1489142|NCT00546572|4906237|P1|Vax 1 / Year 0|Withdrawal by Subject|3
1489143|NCT00546572|4906236|P2|Vax 1 / Year 0|Randomized, not treated|1
1489144|NCT00546572|4906237|P1|Vax 1 / Year 0|Randomized, not treated|1
1489145|NCT00546481|4906281|P3|Maintenance Phase (CERA)|Other Reason|1
1489146|NCT00546481|4906282|P2|Maintenance Phase (CERA)|Other Reason|0
1489147|NCT00546481|4906283|P1|Maintenance Phase (CERA)|Other Reason|0
1489148|NCT00546481|4906281|P3|Maintenance Phase (CERA)|Kidney transplantation|1
1489149|NCT00546481|4906282|P2|Maintenance Phase (CERA)|Kidney transplantation|0
1489150|NCT00546481|4906283|P1|Maintenance Phase (CERA)|Kidney transplantation|0
1489151|NCT00546481|4906281|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
1489152|NCT00546481|4906282|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
1489153|NCT00546481|4906283|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
1489154|NCT00546481|4906281|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
1489155|NCT00546481|4906282|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
1489156|NCT00546481|4906283|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
1489157|NCT00546481|4906281|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
1489158|NCT00546481|4906282|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
1489159|NCT00546481|4906283|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
1489160|NCT00546481|4906281|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
1489161|NCT00546481|4906282|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
1489162|NCT00546481|4906283|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
1489163|NCT00546481|4906281|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
1489164|NCT00546481|4906282|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
1489165|NCT00546481|4906283|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
1489166|NCT00546481|4906281|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
1489167|NCT00546481|4906282|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
1489168|NCT00546481|4906283|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
1489169|NCT00546481|4906281|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
1489170|NCT00546481|4906282|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
1489171|NCT00546481|4906283|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
1489172|NCT00546377|4906310|P1|Overall Study|Adverse Event|6
1489173|NCT00546377|4906310|P1|Overall Study|Deemed ineligible|1
1489174|NCT00546364|4906318|P3|Overall Study|Sponsor decision|1
1489175|NCT00546364|4906319|P2|Overall Study|Sponsor decision|0
1489176|NCT00546364|4906320|P1|Overall Study|Sponsor decision|0
1489177|NCT00546364|4906318|P3|Overall Study|Physician Decision|1
1489178|NCT00546364|4906319|P2|Overall Study|Physician Decision|0
1489179|NCT00546364|4906320|P1|Overall Study|Physician Decision|0
1489180|NCT00546364|4906318|P3|Overall Study|Target lesions resected|0
1489181|NCT00546364|4906319|P2|Overall Study|Target lesions resected|0
1489182|NCT00546364|4906320|P1|Overall Study|Target lesions resected|1
1489183|NCT00546364|4906318|P3|Overall Study|Palliative treatment|1
1489184|NCT00546364|4906319|P2|Overall Study|Palliative treatment|0
1489185|NCT00546364|4906320|P1|Overall Study|Palliative treatment|1
1489186|NCT00546364|4906318|P3|Overall Study|Mixed response|0
1489187|NCT00546364|4906319|P2|Overall Study|Mixed response|0
1489188|NCT00546364|4906320|P1|Overall Study|Mixed response|1
1489189|NCT00546364|4906318|P3|Overall Study|Prior taxotere|0
1489190|NCT00546364|4906319|P2|Overall Study|Prior taxotere|0
1489191|NCT00546364|4906320|P1|Overall Study|Prior taxotere|1
1489192|NCT00546364|4906318|P3|Overall Study|Withdrawal by Subject|3
1489193|NCT00546364|4906319|P2|Overall Study|Withdrawal by Subject|6
1489194|NCT00546364|4906320|P1|Overall Study|Withdrawal by Subject|5
1489195|NCT00546364|4906318|P3|Overall Study|No longer meets study criteria|0
1489196|NCT00546364|4906319|P2|Overall Study|No longer meets study criteria|1
1489197|NCT00546364|4906320|P1|Overall Study|No longer meets study criteria|1
1489198|NCT00546364|4906318|P3|Overall Study|Poor compliance/noncompliance|1
1489199|NCT00546364|4906319|P2|Overall Study|Poor compliance/noncompliance|0
1489200|NCT00546364|4906320|P1|Overall Study|Poor compliance/noncompliance|0
1489201|NCT00546364|4906318|P3|Overall Study|Administrative reason by sponsor|0
1489202|NCT00546364|4906319|P2|Overall Study|Administrative reason by sponsor|0
1489203|NCT00546364|4906320|P1|Overall Study|Administrative reason by sponsor|1
1489204|NCT00546364|4906318|P3|Overall Study|Completed and off treatment|2
1489205|NCT00546364|4906319|P2|Overall Study|Completed and off treatment|0
1489206|NCT00546364|4906320|P1|Overall Study|Completed and off treatment|1
1489207|NCT00546364|4906318|P3|Overall Study|Disease progression|8
1489208|NCT00546364|4906319|P2|Overall Study|Disease progression|11
1489209|NCT00546364|4906320|P1|Overall Study|Disease progression|5
1489210|NCT00546351|4906355|P1|Overall Study|Other reasons for premature termination|17
1489211|NCT00546351|4906355|P1|Overall Study|Unsatisfactory compliance|9
1489212|NCT00546351|4906355|P1|Overall Study|Protocol Deviation|1
1489213|NCT00546351|4906355|P1|Overall Study|Lost to Follow-up|9
1489214|NCT00546351|4906355|P1|Overall Study|Withdrawal by Subject|109
1489215|NCT00546351|4906355|P1|Overall Study|Lack of Efficacy|15
1489216|NCT00546351|4906355|P1|Overall Study|Adverse Event|76
1489217|NCT00546260|4906401|P2|Overall Study|Drug not given pre diagnostic angiogr|2
1489218|NCT00546260|4906402|P1|Overall Study|Drug not given pre diagnostic angiogr|8
1489219|NCT00546117|4906424|P2|Overall Study|Inability to schedule follow-up visit|0
1489220|NCT00546117|4906425|P1|Overall Study|Inability to schedule follow-up visit|1
1489221|NCT00546117|4906424|P2|Overall Study|Withdrawal by Subject|0
1489222|NCT00546117|4906425|P1|Overall Study|Withdrawal by Subject|3
1489223|NCT00546078|4906450|P2|Overall Study|Other reason|1
1489224|NCT00546078|4906451|P1|Overall Study|Other reason|1
1489225|NCT00546078|4906450|P2|Overall Study|Withdrawal by Subject|3
1489226|NCT00546078|4906451|P1|Overall Study|Withdrawal by Subject|2
1489227|NCT00546078|4906450|P2|Overall Study|Lost to Follow-up|3
1489228|NCT00546078|4906451|P1|Overall Study|Lost to Follow-up|1
1489229|NCT00546052|4906489|P1|Overall Study|Non Compliance|7
1489230|NCT00546052|4906489|P1|Overall Study|Withdrawal by Subject|20
1489231|NCT00546052|4906489|P1|Overall Study|Protocol Violation|9
1489232|NCT00546052|4906489|P1|Overall Study|Lost to Follow-up|144
1489233|NCT00546052|4906489|P1|Overall Study|Adverse Event|47
1489234|NCT00546000|4906507|P1|Overall Study|Baseline HPA Axis Supression|2
1489235|NCT00546000|4906507|P1|Overall Study|Lost to Follow-up|1
1489236|NCT00546000|4906507|P1|Overall Study|Adverse Event|1
1489237|NCT00545948|4906526|P3|Overall Study|Not Treated|7
1489238|NCT00545948|4906527|P2|Overall Study|Not Treated|1
1489239|NCT00545948|4906528|P1|Overall Study|Not Treated|1
1489240|NCT00545844|4906538|P1|Overall Study|Withdrawal by Subject|2
1489241|NCT00545844|4906538|P1|Overall Study|Protocol Violation|1
1489242|NCT00545844|4906538|P1|Overall Study|Lost to Follow-up|9
1489243|NCT00545792|4906552|P1|Overall Study|Withdrawal by Subject|1
1489244|NCT00545779|4906557|P1|Overall Study|Failure to return|3
1489245|NCT00545779|4906557|P1|Overall Study|Adverse Event/intercurrent illness|5
1489246|NCT00545779|4906557|P1|Overall Study|Withdrawal by Subject|20
1489247|NCT00545779|4906557|P1|Overall Study|Did not cooperate|7
1489248|NCT00545779|4906557|P1|Overall Study|Other protocol violation|1
1489249|NCT00545779|4906557|P1|Overall Study|Violation of selection criteria at entry|8
1489250|NCT00545753|4906577|P3|Overall Study|Protocol Violation|4
1489251|NCT00545753|4906578|P2|Overall Study|Protocol Violation|1
1489252|NCT00545753|4906579|P1|Overall Study|Protocol Violation|3
1489253|NCT00545753|4906577|P3|Overall Study|Lost to Follow-up|12
1489254|NCT00545753|4906578|P2|Overall Study|Lost to Follow-up|3
1489255|NCT00545753|4906579|P1|Overall Study|Lost to Follow-up|13
1489256|NCT00545753|4906577|P3|Overall Study|Withdrawal by Subject|10
1489257|NCT00545753|4906578|P2|Overall Study|Withdrawal by Subject|1
1489258|NCT00545753|4906579|P1|Overall Study|Withdrawal by Subject|0
1489259|NCT00545740|4906592|P4|Overall Study|Husband against study|0
1489260|NCT00545740|4906593|P3|Overall Study|Husband against study|1
1489261|NCT00545740|4906594|P2|Overall Study|Husband against study|0
1489262|NCT00545740|4906595|P1|Overall Study|Husband against study|0
1489263|NCT00545740|4906592|P4|Overall Study|Patient difficulties|0
1489264|NCT00545740|4906593|P3|Overall Study|Patient difficulties|0
1489265|NCT00545740|4906594|P2|Overall Study|Patient difficulties|1
1489266|NCT00545740|4906595|P1|Overall Study|Patient difficulties|0
1489267|NCT00545740|4906592|P4|Overall Study|Non-adherence to visits|0
1489268|NCT00545740|4906593|P3|Overall Study|Non-adherence to visits|0
1489269|NCT00545740|4906594|P2|Overall Study|Non-adherence to visits|1
1489270|NCT00545740|4906595|P1|Overall Study|Non-adherence to visits|0
1489271|NCT00545740|4906592|P4|Overall Study|Lack of time|0
1489272|NCT00545740|4906593|P3|Overall Study|Lack of time|0
1489273|NCT00545740|4906594|P2|Overall Study|Lack of time|1
1489274|NCT00545740|4906595|P1|Overall Study|Lack of time|0
1489275|NCT00545740|4906592|P4|Overall Study|Sponsor decision|0
1489276|NCT00545740|4906593|P3|Overall Study|Sponsor decision|0
1489277|NCT00545740|4906594|P2|Overall Study|Sponsor decision|1
1489278|NCT00545740|4906595|P1|Overall Study|Sponsor decision|0
1489279|NCT00545740|4906592|P4|Overall Study|Accepted only monthly telephone calls|0
1489280|NCT00545740|4906593|P3|Overall Study|Accepted only monthly telephone calls|0
1489281|NCT00545740|4906594|P2|Overall Study|Accepted only monthly telephone calls|0
1489282|NCT00545740|4906595|P1|Overall Study|Accepted only monthly telephone calls|1
1489283|NCT00545740|4906592|P4|Overall Study|Physician Decision|0
1489284|NCT00545740|4906593|P3|Overall Study|Physician Decision|3
1489285|NCT00545740|4906594|P2|Overall Study|Physician Decision|0
1489286|NCT00545740|4906595|P1|Overall Study|Physician Decision|0
1489287|NCT00545740|4906592|P4|Overall Study|Missed visit|0
1489288|NCT00545740|4906593|P3|Overall Study|Missed visit|0
1489289|NCT00545740|4906594|P2|Overall Study|Missed visit|0
1489290|NCT00545740|4906595|P1|Overall Study|Missed visit|1
1489291|NCT00545740|4906592|P4|Overall Study|Site closure|0
1489292|NCT00545740|4906593|P3|Overall Study|Site closure|0
1489293|NCT00545740|4906594|P2|Overall Study|Site closure|0
1489294|NCT00545740|4906595|P1|Overall Study|Site closure|1
1489295|NCT00545740|4906592|P4|Overall Study|Suspected Diverticulitis Recurrence|1
1489296|NCT00545740|4906593|P3|Overall Study|Suspected Diverticulitis Recurrence|1
1489297|NCT00545740|4906594|P2|Overall Study|Suspected Diverticulitis Recurrence|1
1489298|NCT00545740|4906595|P1|Overall Study|Suspected Diverticulitis Recurrence|1
1489299|NCT00545740|4906592|P4|Overall Study|Diverticulitis attack|1
1489300|NCT00545740|4906593|P3|Overall Study|Diverticulitis attack|1
1489301|NCT00545740|4906594|P2|Overall Study|Diverticulitis attack|0
1489302|NCT00545740|4906595|P1|Overall Study|Diverticulitis attack|0
1489303|NCT00545740|4906592|P4|Overall Study|Moved|0
1489304|NCT00545740|4906593|P3|Overall Study|Moved|1
1489305|NCT00545740|4906594|P2|Overall Study|Moved|0
1489306|NCT00545740|4906595|P1|Overall Study|Moved|2
1489307|NCT00545740|4906592|P4|Overall Study|Non-compliance|0
1489308|NCT00545740|4906593|P3|Overall Study|Non-compliance|1
1489309|NCT00545740|4906594|P2|Overall Study|Non-compliance|2
1489310|NCT00545740|4906595|P1|Overall Study|Non-compliance|0
1489311|NCT00545740|4906592|P4|Overall Study|Protocol Violation|0
1489312|NCT00545740|4906593|P3|Overall Study|Protocol Violation|1
1489313|NCT00545740|4906594|P2|Overall Study|Protocol Violation|3
1489314|NCT00545740|4906595|P1|Overall Study|Protocol Violation|1
1489315|NCT00545740|4906592|P4|Overall Study|Lost to Follow-up|6
1489316|NCT00545740|4906593|P3|Overall Study|Lost to Follow-up|5
1489317|NCT00545740|4906594|P2|Overall Study|Lost to Follow-up|5
1489318|NCT00545740|4906595|P1|Overall Study|Lost to Follow-up|7
1489319|NCT00545740|4906592|P4|Overall Study|Adverse Event|9
1489320|NCT00545740|4906593|P3|Overall Study|Adverse Event|19
1489321|NCT00545740|4906594|P2|Overall Study|Adverse Event|18
1489322|NCT00545740|4906595|P1|Overall Study|Adverse Event|10
1489323|NCT00545740|4906592|P4|Overall Study|Withdrawal by Subject|18
1489324|NCT00545740|4906593|P3|Overall Study|Withdrawal by Subject|16
1489325|NCT00545740|4906594|P2|Overall Study|Withdrawal by Subject|15
1489326|NCT00545740|4906595|P1|Overall Study|Withdrawal by Subject|17
1489327|NCT00545740|4906592|P4|Overall Study|Lack of Efficacy|36
1489328|NCT00545740|4906593|P3|Overall Study|Lack of Efficacy|47
1489329|NCT00545740|4906594|P2|Overall Study|Lack of Efficacy|35
1489330|NCT00545740|4906595|P1|Overall Study|Lack of Efficacy|34
1489331|NCT00545688|4906633|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
1489332|NCT00545688|4906634|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
1489333|NCT00545688|4906635|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
1489334|NCT00545688|4906636|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
1489335|NCT00545688|4906633|P4|Follow-Up Period|Unspecified Reason|8
1489336|NCT00545688|4906634|P3|Follow-Up Period|Unspecified Reason|6
1489337|NCT00545688|4906635|P2|Follow-Up Period|Unspecified Reason|5
1489338|NCT00545688|4906636|P1|Follow-Up Period|Unspecified Reason|2
1489339|NCT00545688|4906633|P4|Follow-Up Period|Lost to Follow-up|1
1489340|NCT00545688|4906634|P3|Follow-Up Period|Lost to Follow-up|3
1489341|NCT00545688|4906635|P2|Follow-Up Period|Lost to Follow-up|3
1489342|NCT00545688|4906636|P1|Follow-Up Period|Lost to Follow-up|3
1489343|NCT00545688|4906633|P4|Follow-Up Period|Refused Treatment|2
1489344|NCT00545688|4906634|P3|Follow-Up Period|Refused Treatment|0
1489345|NCT00545688|4906635|P2|Follow-Up Period|Refused Treatment|2
1489346|NCT00545688|4906636|P1|Follow-Up Period|Refused Treatment|6
1489347|NCT00545688|4906633|P4|Follow-Up Period|Disease Progression|9
1489348|NCT00545688|4906634|P3|Follow-Up Period|Disease Progression|9
1489349|NCT00545688|4906635|P2|Follow-Up Period|Disease Progression|5
1489350|NCT00545688|4906636|P1|Follow-Up Period|Disease Progression|6
1489351|NCT00545688|4906633|P4|Follow-Up Period|Death|6
1489352|NCT00545688|4906634|P3|Follow-Up Period|Death|2
1489353|NCT00545688|4906635|P2|Follow-Up Period|Death|2
1489354|NCT00545688|4906636|P1|Follow-Up Period|Death|4
1489355|NCT00545688|4906633|P4|Adjuvant Treatment Period|Unknown Reason|0
1489356|NCT00545688|4906634|P3|Adjuvant Treatment Period|Unknown Reason|0
1489357|NCT00545688|4906635|P2|Adjuvant Treatment Period|Unknown Reason|1
1489358|NCT00545688|4906636|P1|Adjuvant Treatment Period|Unknown Reason|0
1489359|NCT00545688|4906633|P4|Adjuvant Treatment Period|Adverse Event|2
1489360|NCT00545688|4906634|P3|Adjuvant Treatment Period|Adverse Event|2
1489361|NCT00545688|4906635|P2|Adjuvant Treatment Period|Adverse Event|3
1489362|NCT00545688|4906636|P1|Adjuvant Treatment Period|Adverse Event|0
1489363|NCT00545688|4906633|P4|Adjuvant Treatment Period|Lost to Follow-up|0
1489364|NCT00545688|4906634|P3|Adjuvant Treatment Period|Lost to Follow-up|1
1489365|NCT00545688|4906635|P2|Adjuvant Treatment Period|Lost to Follow-up|0
1489366|NCT00545688|4906636|P1|Adjuvant Treatment Period|Lost to Follow-up|1
1489367|NCT00545688|4906633|P4|Adjuvant Treatment Period|Refused Treatment|5
1489368|NCT00545688|4906634|P3|Adjuvant Treatment Period|Refused Treatment|1
1489369|NCT00545688|4906635|P2|Adjuvant Treatment Period|Refused Treatment|1
1489370|NCT00545688|4906636|P1|Adjuvant Treatment Period|Refused Treatment|1
1489371|NCT00545688|4906633|P4|Adjuvant Treatment Period|Disease Progression|7
1489372|NCT00545688|4906634|P3|Adjuvant Treatment Period|Disease Progression|0
1489373|NCT00545688|4906635|P2|Adjuvant Treatment Period|Disease Progression|3
1489374|NCT00545688|4906636|P1|Adjuvant Treatment Period|Disease Progression|3
1489375|NCT00545688|4906633|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
1489376|NCT00545688|4906634|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
1489377|NCT00545688|4906635|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
1489378|NCT00545688|4906636|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
1489379|NCT00545688|4906633|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
1489380|NCT00545688|4906634|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
1489381|NCT00545688|4906635|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
1489382|NCT00545688|4906636|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
1489383|NCT00545688|4906633|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
1489384|NCT00545688|4906634|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
1489385|NCT00545688|4906635|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
1489386|NCT00545688|4906636|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
1489387|NCT00545688|4906633|P4|Neo-Adjuvant Treatment Period|Death|0
1489388|NCT00545688|4906634|P3|Neo-Adjuvant Treatment Period|Death|0
1489389|NCT00545688|4906635|P2|Neo-Adjuvant Treatment Period|Death|1
1489390|NCT00545688|4906636|P1|Neo-Adjuvant Treatment Period|Death|0
1489391|NCT00545688|4906633|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
1489392|NCT00545688|4906634|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
1489393|NCT00545688|4906635|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
1489394|NCT00545688|4906636|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
1489395|NCT00545688|4906633|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
1489396|NCT00545688|4906634|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
1489397|NCT00545688|4906635|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
1489398|NCT00545688|4906636|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
1489399|NCT00545688|4906633|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
1489400|NCT00545688|4906634|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
1489401|NCT00545688|4906635|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
1489402|NCT00545688|4906636|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
1489403|NCT00545584|4906735|P3|Overall Study|Two or more reasons for discontinuation|8
1489404|NCT00545584|4906736|P2|Overall Study|Two or more reasons for discontinuation|19
1489405|NCT00545584|4906737|P1|Overall Study|Two or more reasons for discontinuation|17
1489406|NCT00545584|4906735|P3|Overall Study|Only one reason for discontinuation|48
1489407|NCT00545584|4906736|P2|Overall Study|Only one reason for discontinuation|61
1489408|NCT00545584|4906737|P1|Overall Study|Only one reason for discontinuation|62
1489409|NCT00545571|4906748|P1|Overall Study|Kidney Transplantation|3
1489410|NCT00545571|4906748|P1|Overall Study|Early Termination of Study|24
1489411|NCT00545571|4906748|P1|Overall Study|Transfusion|12
1489412|NCT00545571|4906748|P1|Overall Study|Screen Failure|16
1489413|NCT00545571|4906748|P1|Overall Study|Refused Treatment|1
1489414|NCT00545571|4906748|P1|Overall Study|Protocol Violation|2
1489415|NCT00545571|4906748|P1|Overall Study|Lack of Efficacy|1
1489416|NCT00545571|4906748|P1|Overall Study|Death|5
1489417|NCT00545571|4906748|P1|Overall Study|Adverse Event|2
1489418|NCT00545571|4906748|P1|Overall Study|Administrative Reasons|1
1489419|NCT00545532|4906763|P2|Overall Study|Death|1
1489420|NCT00545532|4906764|P1|Overall Study|Death|0
1489421|NCT00545532|4906763|P2|Overall Study|Lost to Follow-up|6
1489422|NCT00545532|4906764|P1|Overall Study|Lost to Follow-up|5
1489423|NCT00545532|4906763|P2|Overall Study|Withdrawal by Subject|3
1489424|NCT00545532|4906764|P1|Overall Study|Withdrawal by Subject|1
1489425|NCT00545441|4906855|P2|Overall Study|Patients were not treated|3
1489426|NCT00545441|4906856|P1|Overall Study|Patients were not treated|1
1489427|NCT00545441|4906855|P2|Overall Study|Persistence or recurrence of fistula|2
1489428|NCT00545441|4906856|P1|Overall Study|Persistence or recurrence of fistula|5
1489429|NCT00545441|4906855|P2|Overall Study|Withdrawal by Subject|1
1489430|NCT00545441|4906856|P1|Overall Study|Withdrawal by Subject|1
1489431|NCT00545441|4906855|P2|Overall Study|Technical failure|1
1489432|NCT00545441|4906856|P1|Overall Study|Technical failure|0
1489433|NCT00545441|4906855|P2|Overall Study|Lost to Follow-up|5
1489434|NCT00545441|4906856|P1|Overall Study|Lost to Follow-up|9
1489435|NCT00545441|4906855|P2|Overall Study|Fistula draining at 6 months|4
1489436|NCT00545441|4906856|P1|Overall Study|Fistula draining at 6 months|2
1489437|NCT00545402|4906864|P2|Overall Study|Reason not specified|1
1489438|NCT00545402|4906865|P1|Overall Study|Reason not specified|1
1489439|NCT00545402|4906864|P2|Overall Study|Protocol Violation|0
1489440|NCT00545402|4906865|P1|Overall Study|Protocol Violation|1
1489441|NCT00545402|4906864|P2|Overall Study|Withdrawal by Subject|1
1489442|NCT00545402|4906865|P1|Overall Study|Withdrawal by Subject|0
1489443|NCT00545402|4906864|P2|Overall Study|Graft loss|4
1489444|NCT00545402|4906865|P1|Overall Study|Graft loss|2
1489445|NCT00545402|4906864|P2|Overall Study|Death|7
1489446|NCT00545402|4906865|P1|Overall Study|Death|5
1489447|NCT00545402|4906864|P2|Overall Study|Use of unauthorized immunosuppressant|7
1489448|NCT00545402|4906865|P1|Overall Study|Use of unauthorized immunosuppressant|8
1489449|NCT00545402|4906864|P2|Overall Study|Discontinuation of treatment|9
1489450|NCT00545402|4906865|P1|Overall Study|Discontinuation of treatment|17
1489451|NCT00545363|4906883|P2|Overall Study|Other|1
1489452|NCT00545363|4906884|P1|Overall Study|Other|1
1489453|NCT00545363|4906883|P2|Overall Study|Lost to Follow-up|0
1489454|NCT00545363|4906884|P1|Overall Study|Lost to Follow-up|2
1489455|NCT00545363|4906883|P2|Overall Study|Did not meet entry criteria|1
1489456|NCT00545363|4906884|P1|Overall Study|Did not meet entry criteria|1
1489457|NCT00545363|4906883|P2|Overall Study|Non-compliance|1
1489458|NCT00545363|4906884|P1|Overall Study|Non-compliance|3
1489459|NCT00545363|4906883|P2|Overall Study|Withdrawal by Subject|5
1489460|NCT00545363|4906884|P1|Overall Study|Withdrawal by Subject|6
1489461|NCT00545363|4906883|P2|Overall Study|Adverse Event|7
1489462|NCT00545363|4906884|P1|Overall Study|Adverse Event|6
1489463|NCT00545298|4906899|P3|Overall Study|Issues with Standard of Care|1
1489464|NCT00545298|4906900|P2|Overall Study|Issues with Standard of Care|0
1489465|NCT00545298|4906901|P1|Overall Study|Issues with Standard of Care|2
1489466|NCT00545272|4906918|P6|Overall Study|Lost to Follow-up|0
1489467|NCT00545272|4906919|P5|Overall Study|Lost to Follow-up|1
1489468|NCT00545272|4906920|P4|Overall Study|Lost to Follow-up|0
1489469|NCT00545272|4906921|P3|Overall Study|Lost to Follow-up|0
1489470|NCT00545272|4906922|P2|Overall Study|Lost to Follow-up|0
1489471|NCT00545272|4906923|P1|Overall Study|Lost to Follow-up|0
1489472|NCT00545272|4906918|P6|Overall Study|Abnormal test procedure result(s)|0
1489473|NCT00545272|4906919|P5|Overall Study|Abnormal test procedure result(s)|1
1489474|NCT00545272|4906920|P4|Overall Study|Abnormal test procedure result(s)|0
1489475|NCT00545272|4906921|P3|Overall Study|Abnormal test procedure result(s)|0
1489476|NCT00545272|4906922|P2|Overall Study|Abnormal test procedure result(s)|0
1489477|NCT00545272|4906923|P1|Overall Study|Abnormal test procedure result(s)|0
1489478|NCT00545272|4906918|P6|Overall Study|Abnormal laboratory value(s)|1
1489479|NCT00545272|4906919|P5|Overall Study|Abnormal laboratory value(s)|0
1489480|NCT00545272|4906920|P4|Overall Study|Abnormal laboratory value(s)|0
1489481|NCT00545272|4906921|P3|Overall Study|Abnormal laboratory value(s)|0
1489482|NCT00545272|4906922|P2|Overall Study|Abnormal laboratory value(s)|0
1489483|NCT00545272|4906923|P1|Overall Study|Abnormal laboratory value(s)|0
1489484|NCT00545272|4906918|P6|Overall Study|Adverse Event|1
1489485|NCT00545272|4906919|P5|Overall Study|Adverse Event|0
1489486|NCT00545272|4906920|P4|Overall Study|Adverse Event|0
1489487|NCT00545272|4906921|P3|Overall Study|Adverse Event|1
1489488|NCT00545272|4906922|P2|Overall Study|Adverse Event|0
1489489|NCT00545272|4906923|P1|Overall Study|Adverse Event|0
1489490|NCT00545272|4906918|P6|Overall Study|Protocol deviation|1
1489491|NCT00545272|4906919|P5|Overall Study|Protocol deviation|0
1489492|NCT00545272|4906920|P4|Overall Study|Protocol deviation|1
1489493|NCT00545272|4906921|P3|Overall Study|Protocol deviation|0
1489494|NCT00545272|4906922|P2|Overall Study|Protocol deviation|1
1489495|NCT00545272|4906923|P1|Overall Study|Protocol deviation|0
1489496|NCT00545233|4906975|P2|Overall Study|Physician Decision|1
1489497|NCT00545233|4906976|P1|Overall Study|Physician Decision|2
1489498|NCT00545233|4906975|P2|Overall Study|Insufficient response|15
1489499|NCT00545233|4906976|P1|Overall Study|Insufficient response|14
1489500|NCT00545233|4906975|P2|Overall Study|Failure to Return|6
1489501|NCT00545233|4906976|P1|Overall Study|Failure to Return|4
1489502|NCT00545233|4906975|P2|Overall Study|Refused Treatment|7
1489503|NCT00545233|4906976|P1|Overall Study|Refused Treatment|9
1489504|NCT00545233|4906975|P2|Overall Study|Protocol Violation|0
1489505|NCT00545233|4906976|P1|Overall Study|Protocol Violation|2
1489506|NCT00545233|4906975|P2|Overall Study|Violation of Selection Criteria at Entry|1
1489507|NCT00545233|4906976|P1|Overall Study|Violation of Selection Criteria at Entry|5
1489508|NCT00545233|4906975|P2|Overall Study|Adverse Event|5
1489509|NCT00545233|4906976|P1|Overall Study|Adverse Event|10
1489510|NCT00545168|4907035|P3|Overall Study|Visit for Day 21 was not done in error|2
1489511|NCT00545168|4907036|P2|Overall Study|Visit for Day 21 was not done in error|0
1489512|NCT00545168|4907037|P1|Overall Study|Visit for Day 21 was not done in error|1
1489513|NCT00545168|4907035|P3|Overall Study|Protocol Violation|1
1489514|NCT00545168|4907036|P2|Overall Study|Protocol Violation|0
1489515|NCT00545168|4907037|P1|Overall Study|Protocol Violation|1
1489516|NCT00545168|4907035|P3|Overall Study|Withdrawal by Subject|13
1489517|NCT00545168|4907036|P2|Overall Study|Withdrawal by Subject|0
1489518|NCT00545168|4907037|P1|Overall Study|Withdrawal by Subject|9
1489519|NCT00545168|4907035|P3|Overall Study|Lost to Follow-up|5
1489520|NCT00545168|4907036|P2|Overall Study|Lost to Follow-up|5
1489521|NCT00545168|4907037|P1|Overall Study|Lost to Follow-up|5
1489522|NCT00545103|4907063|P4|Overall Study|Death|0
1489523|NCT00545103|4907064|P3|Overall Study|Death|0
1489524|NCT00545103|4907065|P2|Overall Study|Death|1
1489525|NCT00545103|4907066|P1|Overall Study|Death|0
1489526|NCT00545103|4907063|P4|Overall Study|Subject met endpoint under protocol v. 1|0
1489527|NCT00545103|4907064|P3|Overall Study|Subject met endpoint under protocol v. 1|1
1489528|NCT00545103|4907065|P2|Overall Study|Subject met endpoint under protocol v. 1|0
1489529|NCT00545103|4907066|P1|Overall Study|Subject met endpoint under protocol v. 1|0
1489530|NCT00545103|4907063|P4|Overall Study|Does not want to take study drug anymore|0
1489531|NCT00545103|4907064|P3|Overall Study|Does not want to take study drug anymore|1
1489532|NCT00545103|4907065|P2|Overall Study|Does not want to take study drug anymore|0
1489533|NCT00545103|4907066|P1|Overall Study|Does not want to take study drug anymore|1
1489534|NCT00545103|4907063|P4|Overall Study|Use of prohibited medication|0
1489535|NCT00545103|4907064|P3|Overall Study|Use of prohibited medication|1
1489536|NCT00545103|4907065|P2|Overall Study|Use of prohibited medication|0
1489537|NCT00545103|4907066|P1|Overall Study|Use of prohibited medication|0
1489538|NCT00545103|4907063|P4|Overall Study|Subject moved|0
1489539|NCT00545103|4907064|P3|Overall Study|Subject moved|0
1489540|NCT00545103|4907065|P2|Overall Study|Subject moved|1
1489541|NCT00545103|4907066|P1|Overall Study|Subject moved|0
1489542|NCT00545103|4907063|P4|Overall Study|Investigator decision|0
1489543|NCT00545103|4907064|P3|Overall Study|Investigator decision|1
1489544|NCT00545103|4907065|P2|Overall Study|Investigator decision|0
1489545|NCT00545103|4907066|P1|Overall Study|Investigator decision|0
1489546|NCT00545103|4907063|P4|Overall Study|Noncompliance|0
1489547|NCT00545103|4907064|P3|Overall Study|Noncompliance|0
1489548|NCT00545103|4907065|P2|Overall Study|Noncompliance|1
1489549|NCT00545103|4907066|P1|Overall Study|Noncompliance|0
1489550|NCT00545103|4907063|P4|Overall Study|Subject's decision|0
1489551|NCT00545103|4907064|P3|Overall Study|Subject's decision|0
1489552|NCT00545103|4907065|P2|Overall Study|Subject's decision|0
1489553|NCT00545103|4907066|P1|Overall Study|Subject's decision|1
1489554|NCT00545103|4907063|P4|Overall Study|Personal reasons|0
1489555|NCT00545103|4907064|P3|Overall Study|Personal reasons|0
1489556|NCT00545103|4907065|P2|Overall Study|Personal reasons|0
1489557|NCT00545103|4907066|P1|Overall Study|Personal reasons|1
1489558|NCT00545103|4907063|P4|Overall Study|Diverticulitis crisis|1
1489559|NCT00545103|4907064|P3|Overall Study|Diverticulitis crisis|0
1489560|NCT00545103|4907065|P2|Overall Study|Diverticulitis crisis|0
1489561|NCT00545103|4907066|P1|Overall Study|Diverticulitis crisis|0
1489562|NCT00545103|4907063|P4|Overall Study|Wish to start a family|1
1489563|NCT00545103|4907064|P3|Overall Study|Wish to start a family|0
1489564|NCT00545103|4907065|P2|Overall Study|Wish to start a family|0
1489565|NCT00545103|4907066|P1|Overall Study|Wish to start a family|0
1489566|NCT00545103|4907063|P4|Overall Study|Investigational product not taken|1
1489567|NCT00545103|4907064|P3|Overall Study|Investigational product not taken|0
1489568|NCT00545103|4907065|P2|Overall Study|Investigational product not taken|0
1489569|NCT00545103|4907066|P1|Overall Study|Investigational product not taken|1
1489570|NCT00545103|4907063|P4|Overall Study|Difficult to open package|1
1489571|NCT00545103|4907064|P3|Overall Study|Difficult to open package|0
1489572|NCT00545103|4907065|P2|Overall Study|Difficult to open package|0
1489573|NCT00545103|4907066|P1|Overall Study|Difficult to open package|0
1489574|NCT00545103|4907063|P4|Overall Study|Suspected recurrence of diverticulitis|3
1489575|NCT00545103|4907064|P3|Overall Study|Suspected recurrence of diverticulitis|0
1489576|NCT00545103|4907065|P2|Overall Study|Suspected recurrence of diverticulitis|0
1489577|NCT00545103|4907066|P1|Overall Study|Suspected recurrence of diverticulitis|1
1489578|NCT00545103|4907063|P4|Overall Study|Protocol Violation|0
1489579|NCT00545103|4907064|P3|Overall Study|Protocol Violation|3
1489580|NCT00545103|4907065|P2|Overall Study|Protocol Violation|2
1489581|NCT00545103|4907066|P1|Overall Study|Protocol Violation|1
1489582|NCT00545103|4907063|P4|Overall Study|Lost to Follow-up|4
1489583|NCT00545103|4907064|P3|Overall Study|Lost to Follow-up|3
1489584|NCT00545103|4907065|P2|Overall Study|Lost to Follow-up|6
1489585|NCT00545103|4907066|P1|Overall Study|Lost to Follow-up|4
1489586|NCT00545103|4907063|P4|Overall Study|Adverse Event|10
1489587|NCT00545103|4907064|P3|Overall Study|Adverse Event|17
1489588|NCT00545103|4907065|P2|Overall Study|Adverse Event|12
1489589|NCT00545103|4907066|P1|Overall Study|Adverse Event|11
1489590|NCT00545103|4907063|P4|Overall Study|Withdrawal by Subject|22
1489591|NCT00545103|4907064|P3|Overall Study|Withdrawal by Subject|18
1489592|NCT00545103|4907065|P2|Overall Study|Withdrawal by Subject|10
1489593|NCT00545103|4907066|P1|Overall Study|Withdrawal by Subject|6
1489594|NCT00545103|4907063|P4|Overall Study|Lack of Efficacy|27
1489595|NCT00545103|4907064|P3|Overall Study|Lack of Efficacy|31
1489596|NCT00545103|4907065|P2|Overall Study|Lack of Efficacy|45
1489597|NCT00545103|4907066|P1|Overall Study|Lack of Efficacy|48
1489598|NCT00545064|4907100|P1|Overall Study|inclement weather|1
1489599|NCT00545064|4907100|P1|Overall Study|cancel all appointments, no rebooking|1
1489600|NCT00545064|4907100|P1|Overall Study|did not complete course of treatment|1
1489601|NCT00545064|4907100|P1|Overall Study|Withdrawal by Subject|2
1489602|NCT00545064|4907100|P1|Overall Study|Lost to Follow-up|3
1489603|NCT00545051|4907111|P2|Overall Study|Administrative reasons|1
1489604|NCT00545051|4907112|P1|Overall Study|Administrative reasons|0
1489605|NCT00545051|4907111|P2|Overall Study|Withdrawal by Subject|1
1489606|NCT00545051|4907112|P1|Overall Study|Withdrawal by Subject|0
1489607|NCT00545051|4907111|P2|Overall Study|Protocol Violation|0
1489608|NCT00545051|4907112|P1|Overall Study|Protocol Violation|1
1489609|NCT00545051|4907111|P2|Overall Study|Violation of inclusion/exclusion|2
1489610|NCT00545051|4907112|P1|Overall Study|Violation of inclusion/exclusion|0
1489611|NCT00545051|4907111|P2|Overall Study|Death|0
1489612|NCT00545051|4907112|P1|Overall Study|Death|1
1489613|NCT00545051|4907111|P2|Overall Study|Adverse Event|3
1489614|NCT00545051|4907112|P1|Overall Study|Adverse Event|7
1489615|NCT00544882|4907156|P3|Cycle 3: Follow-up|Pregnancy|0
1489616|NCT00544882|4907157|P2|Cycle 3: Follow-up|Pregnancy|1
1489617|NCT00544882|4907158|P1|Cycle 3: Follow-up|Pregnancy|0
1489618|NCT00544882|4907156|P3|Cycle 3: Follow-up|Noncompliance|0
1489619|NCT00544882|4907157|P2|Cycle 3: Follow-up|Noncompliance|1
1489620|NCT00544882|4907158|P1|Cycle 3: Follow-up|Noncompliance|0
1489621|NCT00544882|4907156|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
1489622|NCT00544882|4907157|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
1489623|NCT00544882|4907158|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
1489624|NCT00544882|4907156|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
1489625|NCT00544882|4907157|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
1489626|NCT00544882|4907158|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
1489627|NCT00544882|4907156|P3|Cycle 1: Run-in Cycle|Adverse Event|0
1489628|NCT00544882|4907157|P2|Cycle 1: Run-in Cycle|Adverse Event|0
1489629|NCT00544882|4907158|P1|Cycle 1: Run-in Cycle|Adverse Event|1
1489630|NCT00544882|4907156|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
1489631|NCT00544882|4907157|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
1489632|NCT00544882|4907158|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
1489633|NCT00544869|4907183|P3|Overall Study|Physician Decision|0
1489634|NCT00544869|4907184|P2|Overall Study|Physician Decision|0
1489635|NCT00544869|4907185|P1|Overall Study|Physician Decision|2
1489636|NCT00544869|4907183|P3|Overall Study|Lack of Efficacy|0
1489637|NCT00544869|4907184|P2|Overall Study|Lack of Efficacy|1
1489638|NCT00544869|4907185|P1|Overall Study|Lack of Efficacy|1
1489639|NCT00544869|4907183|P3|Overall Study|Adverse Event|0
1489640|NCT00544869|4907184|P2|Overall Study|Adverse Event|1
1489641|NCT00544869|4907185|P1|Overall Study|Adverse Event|6
1489642|NCT00544869|4907183|P3|Overall Study|Rsolution of congenitive symptoms|0
1489643|NCT00544869|4907184|P2|Overall Study|Rsolution of congenitive symptoms|0
1489644|NCT00544869|4907185|P1|Overall Study|Rsolution of congenitive symptoms|3
1489645|NCT00544817|4907193|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
1489646|NCT00544817|4907193|P1|Follow-up Systemic Therapy|Physician Decision|3
1489647|NCT00544817|4907193|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
1489648|NCT00544817|4907193|P1|No Treatment Interval|Adverse Event|1
1489649|NCT00544817|4907193|P1|No Treatment Interval|Physician Decision|3
1489650|NCT00544817|4907193|P1|No Treatment Interval|Lack of Efficacy|8
1489651|NCT00544817|4907193|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
1489652|NCT00544817|4907193|P1|Combined Modality|Adverse Event|2
1489653|NCT00544817|4907193|P1|Combined Modality|Worsening Neurologic Symptoms|2
1489654|NCT00544817|4907193|P1|Combined Modality|Lack of Efficacy|2
1489655|NCT00544648|4907242|P2|Overall Study|progression of disease|0
1489656|NCT00544648|4907243|P1|Overall Study|progression of disease|1
1489657|NCT00544648|4907242|P2|Overall Study|Adverse Event|1
1489658|NCT00544648|4907243|P1|Overall Study|Adverse Event|1
1489659|NCT00544648|4907242|P2|Overall Study|Withdrawal by Subject|0
1489660|NCT00544648|4907243|P1|Overall Study|Withdrawal by Subject|1
1489661|NCT00544557|4907257|P1|Overall Study|Other|98
1489662|NCT00544557|4907257|P1|Overall Study|Lack of Efficacy|196
1489663|NCT00544557|4907257|P1|Overall Study|Adverse Event|140
1489664|NCT00544544|4907288|P1|Overall Study|Lost to Follow-up|1
1489665|NCT00544544|4907288|P1|Overall Study|Adverse Event|1
1489666|NCT00544544|4907288|P1|Overall Study|Withdrawal by Subject|1
1489667|NCT00544440|4907295|P1|Overall Study|Other|5
1489668|NCT00544440|4907295|P1|Overall Study|Progressive Disease|47
1489669|NCT00544440|4907295|P1|Overall Study|Subject Non-compliance|1
1489670|NCT00544440|4907295|P1|Overall Study|Withdrawal by Subject|2
1489671|NCT00544440|4907295|P1|Overall Study|Adverse Event|1
1489672|NCT00544440|4907295|P1|Overall Study|Other|1
1489673|NCT00544167|4907302|P1|Overall Study|Physician Decision|8
1489674|NCT00544167|4907302|P1|Overall Study|Adverse Event|21
1489675|NCT00543985|4907306|P1|Overall Study|Withdrawal by Subject|4
1489676|NCT00543855|4907317|P4|Overall Study|Protocol Violation|0
1489677|NCT00543855|4907318|P3|Overall Study|Protocol Violation|0
1489678|NCT00543855|4907319|P2|Overall Study|Protocol Violation|0
1489679|NCT00543855|4907320|P1|Overall Study|Protocol Violation|1
1489680|NCT00543855|4907317|P4|Overall Study|Withdrawal by Subject|0
1489681|NCT00543855|4907318|P3|Overall Study|Withdrawal by Subject|2
1489682|NCT00543855|4907319|P2|Overall Study|Withdrawal by Subject|1
1489683|NCT00543855|4907320|P1|Overall Study|Withdrawal by Subject|0
1489684|NCT00543855|4907317|P4|Overall Study|Lost to Follow-up|0
1489685|NCT00543855|4907318|P3|Overall Study|Lost to Follow-up|1
1489686|NCT00543855|4907319|P2|Overall Study|Lost to Follow-up|0
1489687|NCT00543855|4907320|P1|Overall Study|Lost to Follow-up|0
1489688|NCT00543855|4907317|P4|Overall Study|Adverse Event|4
1489689|NCT00543855|4907318|P3|Overall Study|Adverse Event|3
1489690|NCT00543855|4907319|P2|Overall Study|Adverse Event|1
1489691|NCT00543855|4907320|P1|Overall Study|Adverse Event|3
1489692|NCT00543803|4907342|P1|Overall Study|not specified|86
1489693|NCT00543803|4907342|P1|Overall Study|Lost to Follow-up|20
1489694|NCT00543803|4907342|P1|Overall Study|Lack of Efficacy|22
1489695|NCT00543803|4907342|P1|Overall Study|Adverse Event|14
1489696|NCT00543725|4907370|P2|Overall Study|Not specified|3
1489697|NCT00543725|4907371|P1|Overall Study|Not specified|3
1489698|NCT00543725|4907370|P2|Overall Study|Lost to Follow-up|11
1489699|NCT00543725|4907371|P1|Overall Study|Lost to Follow-up|15
1489700|NCT00543725|4907370|P2|Overall Study|Withdrawal by Subject|13
1489701|NCT00543725|4907371|P1|Overall Study|Withdrawal by Subject|4
1489702|NCT00543725|4907370|P2|Overall Study|Protocol Violation|1
1489703|NCT00543725|4907371|P1|Overall Study|Protocol Violation|0
1489704|NCT00543725|4907370|P2|Overall Study|Subject Reached A Virologic Endpoint|14
1489705|NCT00543725|4907371|P1|Overall Study|Subject Reached A Virologic Endpoint|22
1489706|NCT00543725|4907370|P2|Overall Study|Subject Ineligible To Continue The Trial|0
1489707|NCT00543725|4907371|P1|Overall Study|Subject Ineligible To Continue The Trial|2
1489708|NCT00543725|4907370|P2|Overall Study|Subject Non-Compliant|4
1489709|NCT00543725|4907371|P1|Overall Study|Subject Non-Compliant|4
1489710|NCT00543725|4907370|P2|Overall Study|Sponsor's Decision|1
1489711|NCT00543725|4907371|P1|Overall Study|Sponsor's Decision|0
1489712|NCT00543725|4907370|P2|Overall Study|Adverse Event|27
1489713|NCT00543725|4907371|P1|Overall Study|Adverse Event|18
1489714|NCT00543569|4907397|P4|Overall Study|Randomized but never received study drug|3
1489715|NCT00543569|4907398|P3|Overall Study|Randomized but never received study drug|5
1489716|NCT00543569|4907399|P2|Overall Study|Randomized but never received study drug|3
1489717|NCT00543569|4907400|P1|Overall Study|Randomized but never received study drug|3
1489718|NCT00543569|4907397|P4|Overall Study|Miscellaneous Reasons|4
1489719|NCT00543569|4907398|P3|Overall Study|Miscellaneous Reasons|11
1489720|NCT00543569|4907399|P2|Overall Study|Miscellaneous Reasons|3
1489721|NCT00543569|4907400|P1|Overall Study|Miscellaneous Reasons|7
1489722|NCT00543569|4907397|P4|Overall Study|Lost to Follow-up|1
1489723|NCT00543569|4907398|P3|Overall Study|Lost to Follow-up|1
1489724|NCT00543569|4907399|P2|Overall Study|Lost to Follow-up|0
1489725|NCT00543569|4907400|P1|Overall Study|Lost to Follow-up|0
1489726|NCT00543569|4907397|P4|Overall Study|Death|1
1489727|NCT00543569|4907398|P3|Overall Study|Death|3
1489728|NCT00543569|4907399|P2|Overall Study|Death|2
1489729|NCT00543569|4907400|P1|Overall Study|Death|2
1489730|NCT00543543|4907506|P4|Extension Study|Withdrawal by Subject|120
1489731|NCT00543543|4907507|P3|Extension Study|Withdrawal by Subject|0
1489732|NCT00543543|4907508|P2|Extension Study|Withdrawal by Subject|0
1489733|NCT00543543|4907509|P1|Extension Study|Withdrawal by Subject|0
1489734|NCT00543543|4907506|P4|Extension Study|Protocol Violation|11
1489735|NCT00543543|4907507|P3|Extension Study|Protocol Violation|0
1489736|NCT00543543|4907508|P2|Extension Study|Protocol Violation|0
1489737|NCT00543543|4907509|P1|Extension Study|Protocol Violation|0
1489738|NCT00543543|4907506|P4|Extension Study|Pregnancy|6
1489739|NCT00543543|4907507|P3|Extension Study|Pregnancy|0
1489740|NCT00543543|4907508|P2|Extension Study|Pregnancy|0
1489741|NCT00543543|4907509|P1|Extension Study|Pregnancy|0
1489742|NCT00543543|4907506|P4|Extension Study|Physician Decision|7
1489743|NCT00543543|4907507|P3|Extension Study|Physician Decision|0
1489744|NCT00543543|4907508|P2|Extension Study|Physician Decision|0
1489745|NCT00543543|4907509|P1|Extension Study|Physician Decision|0
1489746|NCT00543543|4907506|P4|Extension Study|Lost to Follow-up|77
1489747|NCT00543543|4907507|P3|Extension Study|Lost to Follow-up|0
1489748|NCT00543543|4907508|P2|Extension Study|Lost to Follow-up|0
1489749|NCT00543543|4907509|P1|Extension Study|Lost to Follow-up|0
1489750|NCT00543543|4907506|P4|Extension Study|Adverse Event|5
1489751|NCT00543543|4907507|P3|Extension Study|Adverse Event|0
1489752|NCT00543543|4907508|P2|Extension Study|Adverse Event|0
1489753|NCT00543543|4907509|P1|Extension Study|Adverse Event|0
1489754|NCT00543543|4907506|P4|Base Study|Withdrawal by Subject|503
1489755|NCT00543543|4907507|P3|Base Study|Withdrawal by Subject|5
1489756|NCT00543543|4907508|P2|Base Study|Withdrawal by Subject|482
1489757|NCT00543543|4907509|P1|Base Study|Withdrawal by Subject|7
1489758|NCT00543543|4907506|P4|Base Study|Protocol Violation|6
1489759|NCT00543543|4907507|P3|Base Study|Protocol Violation|0
1489760|NCT00543543|4907508|P2|Base Study|Protocol Violation|6
1489761|NCT00543543|4907509|P1|Base Study|Protocol Violation|0
1489762|NCT00543543|4907506|P4|Base Study|Physician Decision|7
1489763|NCT00543543|4907507|P3|Base Study|Physician Decision|0
1489764|NCT00543543|4907508|P2|Base Study|Physician Decision|4
1489765|NCT00543543|4907509|P1|Base Study|Physician Decision|0
1489766|NCT00543543|4907506|P4|Base Study|Lost to Follow-up|701
1489767|NCT00543543|4907507|P3|Base Study|Lost to Follow-up|9
1489768|NCT00543543|4907508|P2|Base Study|Lost to Follow-up|749
1489769|NCT00543543|4907509|P1|Base Study|Lost to Follow-up|12
1489770|NCT00543543|4907506|P4|Base Study|Adverse Event|5
1489771|NCT00543543|4907507|P3|Base Study|Adverse Event|0
1489772|NCT00543543|4907508|P2|Base Study|Adverse Event|11
1489773|NCT00543543|4907509|P1|Base Study|Adverse Event|1
1489774|NCT00543309|4907570|P3|Overall Study|Physician Decision|0
1489775|NCT00543309|4907571|P2|Overall Study|Physician Decision|1
1489776|NCT00543309|4907572|P1|Overall Study|Physician Decision|0
1489777|NCT00543296|4907622|P1|Overall Study|Physician Decision|7
1489778|NCT00543140|4907629|P1|Overall Study|Conversion to different procedure|1
1489779|NCT00543140|4907629|P1|Overall Study|Subject moved|1
1489780|NCT00543140|4907629|P1|Overall Study|Death|1
1489781|NCT00543140|4907629|P1|Overall Study|SAE leading to explant of SAGB|3
1489782|NCT00543140|4907629|P1|Overall Study|Insufficient weight loss|10
1489783|NCT00543140|4907629|P1|Overall Study|Protocol Violation|10
1489784|NCT00543140|4907629|P1|Overall Study|Withdrawal by Subject|13
1489785|NCT00543140|4907629|P1|Overall Study|Lost to Follow-up|33
1489786|NCT00542997|4907652|P1|Efficacy Period|Adverse Event|3
1489787|NCT00542997|4907652|P1|Wash in / Wash Out Period|Adverse Event|3
1489788|NCT00542997|4907652|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
1489789|NCT00542880|4907674|P2|Period 3|Adverse Event|2
1489790|NCT00542880|4907675|P1|Period 3|Adverse Event|0
1489791|NCT00542880|4907674|P2|Period 2|Not specified|1
1489792|NCT00542880|4907675|P1|Period 2|Not specified|0
1489793|NCT00542880|4907674|P2|Period 2|Severe non-compliance|1
1489794|NCT00542880|4907675|P1|Period 2|Severe non-compliance|0
1489795|NCT00542880|4907674|P2|Period 2|Discontinuation criteria|0
1489796|NCT00542880|4907675|P1|Period 2|Discontinuation criteria|2
1489797|NCT00542880|4907674|P2|Period 2|Eligibility not fulfilled|1
1489798|NCT00542880|4907675|P1|Period 2|Eligibility not fulfilled|0
1489799|NCT00542880|4907674|P2|Period 2|Adverse Event|7
1489800|NCT00542880|4907675|P1|Period 2|Adverse Event|5
1489801|NCT00542880|4907674|P2|Period 1|Protocol Violation|1
1489802|NCT00542880|4907675|P1|Period 1|Protocol Violation|0
1489803|NCT00542880|4907674|P2|Period 1|Withdrawal by Subject|1
1489804|NCT00542880|4907675|P1|Period 1|Withdrawal by Subject|1
1489805|NCT00542880|4907674|P2|Period 1|Development of study-specific criteria|2
1489806|NCT00542880|4907675|P1|Period 1|Development of study-specific criteria|1
1489807|NCT00542880|4907674|P2|Period 1|Adverse Event|2
1489808|NCT00542880|4907675|P1|Period 1|Adverse Event|2
1489809|NCT00542880|4907674|P2|Period 1|Eligibility criteria not fulfilled|6
1489810|NCT00542880|4907675|P1|Period 1|Eligibility criteria not fulfilled|2
1489811|NCT00542828|4907711|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
1489812|NCT00542828|4907711|P1|Overall Study|Study Prematurely Discontinued|7
1489813|NCT00542828|4907711|P1|Overall Study|Need for Prohibited Treatment|3
1489814|NCT00542828|4907711|P1|Overall Study|Physician Decision|1
1489815|NCT00542815|4907729|P3|Overall Study|Other reasons|10
1489816|NCT00542815|4907730|P2|Overall Study|Other reasons|10
1489817|NCT00542815|4907731|P1|Overall Study|Other reasons|24
1489818|NCT00542815|4907729|P3|Overall Study|Withdrawal by Subject|8
1489819|NCT00542815|4907730|P2|Overall Study|Withdrawal by Subject|5
1489820|NCT00542815|4907731|P1|Overall Study|Withdrawal by Subject|41
1489821|NCT00542815|4907729|P3|Overall Study|Protocol Violation|2
1489822|NCT00542815|4907730|P2|Overall Study|Protocol Violation|1
1489823|NCT00542815|4907731|P1|Overall Study|Protocol Violation|1
1489824|NCT00542815|4907729|P3|Overall Study|Physician Decision|0
1489825|NCT00542815|4907730|P2|Overall Study|Physician Decision|1
1489826|NCT00542815|4907731|P1|Overall Study|Physician Decision|2
1489827|NCT00542815|4907729|P3|Overall Study|Lack of Efficacy|0
1489828|NCT00542815|4907730|P2|Overall Study|Lack of Efficacy|2
1489829|NCT00542815|4907731|P1|Overall Study|Lack of Efficacy|9
1489830|NCT00542815|4907729|P3|Overall Study|Death|3
1489831|NCT00542815|4907730|P2|Overall Study|Death|7
1489832|NCT00542815|4907731|P1|Overall Study|Death|10
1489833|NCT00542815|4907729|P3|Overall Study|Adverse Event|9
1489834|NCT00542815|4907730|P2|Overall Study|Adverse Event|6
1489835|NCT00542815|4907731|P1|Overall Study|Adverse Event|19
1489836|NCT00542789|4907744|P2|Overall Study|Recurrence of Gastric Ulcer|57
1489837|NCT00542789|4907745|P1|Overall Study|Recurrence of Gastric Ulcer|8
1489838|NCT00542789|4907744|P2|Overall Study|Protocol Violation|1
1489839|NCT00542789|4907745|P1|Overall Study|Protocol Violation|8
1489840|NCT00542789|4907744|P2|Overall Study|Withdrawal by Subject|3
1489841|NCT00542789|4907745|P1|Overall Study|Withdrawal by Subject|7
1489842|NCT00542789|4907744|P2|Overall Study|Adverse Event|17
1489843|NCT00542789|4907745|P1|Overall Study|Adverse Event|18
1489844|NCT00542425|4907845|P5|Extended 24 Weeks of Treatment|Other|1
1489845|NCT00542425|4907846|P4|Extended 24 Weeks of Treatment|Other|0
1489846|NCT00542425|4907847|P3|Extended 24 Weeks of Treatment|Other|0
1489847|NCT00542425|4907848|P2|Extended 24 Weeks of Treatment|Other|1
1489848|NCT00542425|4907849|P1|Extended 24 Weeks of Treatment|Other|1
1489849|NCT00542425|4907845|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
1489850|NCT00542425|4907846|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
1489851|NCT00542425|4907847|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
1489852|NCT00542425|4907848|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
1489853|NCT00542425|4907849|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
1489854|NCT00542425|4907845|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
1489855|NCT00542425|4907846|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
1489856|NCT00542425|4907847|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
1489857|NCT00542425|4907848|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
1489858|NCT00542425|4907849|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
1489859|NCT00542425|4907845|P5|Extended 24 Weeks of Treatment|Adverse Event|0
1489860|NCT00542425|4907846|P4|Extended 24 Weeks of Treatment|Adverse Event|1
1489861|NCT00542425|4907847|P3|Extended 24 Weeks of Treatment|Adverse Event|1
1489862|NCT00542425|4907848|P2|Extended 24 Weeks of Treatment|Adverse Event|0
1489863|NCT00542425|4907849|P1|Extended 24 Weeks of Treatment|Adverse Event|0
1489864|NCT00542425|4907845|P5|Initial 24 Weeks|Other|0
1489865|NCT00542425|4907846|P4|Initial 24 Weeks|Other|0
1489866|NCT00542425|4907847|P3|Initial 24 Weeks|Other|1
1489867|NCT00542425|4907848|P2|Initial 24 Weeks|Other|2
1489868|NCT00542425|4907849|P1|Initial 24 Weeks|Other|0
1489869|NCT00542425|4907845|P5|Initial 24 Weeks|Refusal of treatment|1
1489870|NCT00542425|4907846|P4|Initial 24 Weeks|Refusal of treatment|4
1489871|NCT00542425|4907847|P3|Initial 24 Weeks|Refusal of treatment|1
1489872|NCT00542425|4907848|P2|Initial 24 Weeks|Refusal of treatment|2
1489873|NCT00542425|4907849|P1|Initial 24 Weeks|Refusal of treatment|2
1489874|NCT00542425|4907845|P5|Initial 24 Weeks|Protocol Violation|0
1489875|NCT00542425|4907846|P4|Initial 24 Weeks|Protocol Violation|1
1489876|NCT00542425|4907847|P3|Initial 24 Weeks|Protocol Violation|0
1489877|NCT00542425|4907848|P2|Initial 24 Weeks|Protocol Violation|0
1489878|NCT00542425|4907849|P1|Initial 24 Weeks|Protocol Violation|0
1489879|NCT00542425|4907845|P5|Initial 24 Weeks|Non-compliance|1
1489880|NCT00542425|4907846|P4|Initial 24 Weeks|Non-compliance|1
1489881|NCT00542425|4907847|P3|Initial 24 Weeks|Non-compliance|0
1489882|NCT00542425|4907848|P2|Initial 24 Weeks|Non-compliance|0
1489883|NCT00542425|4907849|P1|Initial 24 Weeks|Non-compliance|0
1489884|NCT00542425|4907845|P5|Initial 24 Weeks|Lost to Follow-up|0
1489885|NCT00542425|4907846|P4|Initial 24 Weeks|Lost to Follow-up|0
1489886|NCT00542425|4907847|P3|Initial 24 Weeks|Lost to Follow-up|1
1489887|NCT00542425|4907848|P2|Initial 24 Weeks|Lost to Follow-up|2
1489888|NCT00542425|4907849|P1|Initial 24 Weeks|Lost to Follow-up|2
1489889|NCT00542425|4907845|P5|Initial 24 Weeks|Inability to complete procedures|2
1489890|NCT00542425|4907846|P4|Initial 24 Weeks|Inability to complete procedures|1
1489891|NCT00542425|4907847|P3|Initial 24 Weeks|Inability to complete procedures|2
1489892|NCT00542425|4907848|P2|Initial 24 Weeks|Inability to complete procedures|3
1489893|NCT00542425|4907849|P1|Initial 24 Weeks|Inability to complete procedures|0
1489894|NCT00542425|4907845|P5|Initial 24 Weeks|Adverse Event|2
1489895|NCT00542425|4907846|P4|Initial 24 Weeks|Adverse Event|3
1489896|NCT00542425|4907847|P3|Initial 24 Weeks|Adverse Event|1
1489897|NCT00542425|4907848|P2|Initial 24 Weeks|Adverse Event|1
1489898|NCT00542425|4907849|P1|Initial 24 Weeks|Adverse Event|0
1489899|NCT00542425|4907845|P5|Initial 24 Weeks|Administrative reasons|0
1489900|NCT00542425|4907846|P4|Initial 24 Weeks|Administrative reasons|1
1489901|NCT00542425|4907847|P3|Initial 24 Weeks|Administrative reasons|1
1489902|NCT00542425|4907848|P2|Initial 24 Weeks|Administrative reasons|0
1489903|NCT00542425|4907849|P1|Initial 24 Weeks|Administrative reasons|0
1489904|NCT00542386|4907887|P6|Overall Study|Other Reasons|2
1489905|NCT00542386|4907888|P5|Overall Study|Other Reasons|4
1489906|NCT00542386|4907889|P4|Overall Study|Other Reasons|3
1489907|NCT00542386|4907890|P3|Overall Study|Other Reasons|4
1489908|NCT00542386|4907891|P2|Overall Study|Other Reasons|1
1489909|NCT00542386|4907892|P1|Overall Study|Other Reasons|4
1489910|NCT00542386|4907887|P6|Overall Study|Withdrawal by Subject|7
1489911|NCT00542386|4907888|P5|Overall Study|Withdrawal by Subject|15
1489912|NCT00542386|4907889|P4|Overall Study|Withdrawal by Subject|11
1489913|NCT00542386|4907890|P3|Overall Study|Withdrawal by Subject|10
1489914|NCT00542386|4907891|P2|Overall Study|Withdrawal by Subject|8
1489915|NCT00542386|4907892|P1|Overall Study|Withdrawal by Subject|5
1489916|NCT00542386|4907887|P6|Overall Study|Protocol Violation|4
1489917|NCT00542386|4907888|P5|Overall Study|Protocol Violation|0
1489918|NCT00542386|4907889|P4|Overall Study|Protocol Violation|0
1489919|NCT00542386|4907890|P3|Overall Study|Protocol Violation|1
1489920|NCT00542386|4907891|P2|Overall Study|Protocol Violation|0
1489921|NCT00542386|4907892|P1|Overall Study|Protocol Violation|0
1489922|NCT00542386|4907887|P6|Overall Study|Physician Decision|0
1489923|NCT00542386|4907888|P5|Overall Study|Physician Decision|0
1489924|NCT00542386|4907889|P4|Overall Study|Physician Decision|1
1489925|NCT00542386|4907890|P3|Overall Study|Physician Decision|0
1489926|NCT00542386|4907891|P2|Overall Study|Physician Decision|0
1489927|NCT00542386|4907892|P1|Overall Study|Physician Decision|1
1489928|NCT00542386|4907887|P6|Overall Study|Lack of Efficacy|31
1489929|NCT00542386|4907888|P5|Overall Study|Lack of Efficacy|7
1489930|NCT00542386|4907889|P4|Overall Study|Lack of Efficacy|13
1489931|NCT00542386|4907890|P3|Overall Study|Lack of Efficacy|10
1489932|NCT00542386|4907891|P2|Overall Study|Lack of Efficacy|12
1489933|NCT00542386|4907892|P1|Overall Study|Lack of Efficacy|32
1489934|NCT00542386|4907887|P6|Overall Study|Death|2
1489935|NCT00542386|4907888|P5|Overall Study|Death|1
1489936|NCT00542386|4907889|P4|Overall Study|Death|2
1489937|NCT00542386|4907890|P3|Overall Study|Death|1
1489938|NCT00542386|4907891|P2|Overall Study|Death|0
1489939|NCT00542386|4907892|P1|Overall Study|Death|0
1489940|NCT00542386|4907887|P6|Overall Study|Adverse Event|4
1489941|NCT00542386|4907888|P5|Overall Study|Adverse Event|13
1489942|NCT00542386|4907889|P4|Overall Study|Adverse Event|8
1489943|NCT00542386|4907890|P3|Overall Study|Adverse Event|7
1489944|NCT00542386|4907891|P2|Overall Study|Adverse Event|7
1489945|NCT00542386|4907892|P1|Overall Study|Adverse Event|1
1489946|NCT00542321|4907914|P2|Overall Study|Death|1
1489947|NCT00542321|4907915|P1|Overall Study|Death|0
1489948|NCT00542269|4907937|P3|Overall Study|Administrative problems|1
1489949|NCT00542269|4907938|P2|Overall Study|Administrative problems|1
1489950|NCT00542269|4907939|P1|Overall Study|Administrative problems|1
1489951|NCT00542269|4907937|P3|Overall Study|Withdrawal by Subject|0
1489952|NCT00542269|4907938|P2|Overall Study|Withdrawal by Subject|0
1489953|NCT00542269|4907939|P1|Overall Study|Withdrawal by Subject|1
1489954|NCT00542269|4907937|P3|Overall Study|Protocol Violation|0
1489955|NCT00542269|4907938|P2|Overall Study|Protocol Violation|1
1489956|NCT00542269|4907939|P1|Overall Study|Protocol Violation|1
1489957|NCT00542269|4907937|P3|Overall Study|Adverse Event|5
1489958|NCT00542269|4907938|P2|Overall Study|Adverse Event|4
1489959|NCT00542269|4907939|P1|Overall Study|Adverse Event|10
1489960|NCT00542178|4907974|P8|Overall Study|did not complete year 4 follow-up|85
1489961|NCT00542178|4907975|P7|Overall Study|did not complete year 4 follow-up|87
1489962|NCT00542178|4907976|P6|Overall Study|did not complete year 4 follow-up|89
1489963|NCT00542178|4907977|P5|Overall Study|did not complete year 4 follow-up|64
1489964|NCT00542178|4907978|P4|Overall Study|did not complete year 4 follow-up|62
1489965|NCT00542178|4907979|P3|Overall Study|did not complete year 4 follow-up|74
1489966|NCT00542178|4907980|P2|Overall Study|did not complete year 4 follow-up|80
1489967|NCT00542178|4907981|P1|Overall Study|did not complete year 4 follow-up|75
1489968|NCT00541970|4908017|P4|Month 60|Protocol Violation|72
1489969|NCT00541970|4908018|P3|Month 60|Protocol Violation|82
1489970|NCT00541970|4908019|P2|Month 60|Protocol Violation|77
1489971|NCT00541970|4908020|P1|Month 60|Protocol Violation|78
1489972|NCT00541970|4908017|P4|Month 48|Lost to Follow-up|73
1489973|NCT00541970|4908018|P3|Month 48|Lost to Follow-up|68
1489974|NCT00541970|4908019|P2|Month 48|Lost to Follow-up|68
1489975|NCT00541970|4908020|P1|Month 48|Lost to Follow-up|66
1489976|NCT00541970|4908017|P4|Month 48|Other|0
1489977|NCT00541970|4908018|P3|Month 48|Other|1
1489978|NCT00541970|4908019|P2|Month 48|Other|1
1489979|NCT00541970|4908020|P1|Month 48|Other|3
1489980|NCT00541970|4908017|P4|Month 48|Withdrawal by Subject|2
1489981|NCT00541970|4908018|P3|Month 48|Withdrawal by Subject|4
1489982|NCT00541970|4908019|P2|Month 48|Withdrawal by Subject|4
1489983|NCT00541970|4908020|P1|Month 48|Withdrawal by Subject|2
1489984|NCT00541970|4908017|P4|Month 36|Protocol Violation|60
1489985|NCT00541970|4908018|P3|Month 36|Protocol Violation|66
1489986|NCT00541970|4908019|P2|Month 36|Protocol Violation|66
1489987|NCT00541970|4908020|P1|Month 36|Protocol Violation|61
1489988|NCT00541970|4908017|P4|Month 24|Protocol Violation|21
1489989|NCT00541970|4908018|P3|Month 24|Protocol Violation|31
1489990|NCT00541970|4908019|P2|Month 24|Protocol Violation|31
1489991|NCT00541970|4908020|P1|Month 24|Protocol Violation|29
1489992|NCT00541970|4908017|P4|Month 24|Adverse Event|1
1489993|NCT00541970|4908018|P3|Month 24|Adverse Event|1
1489994|NCT00541970|4908019|P2|Month 24|Adverse Event|1
1489995|NCT00541970|4908020|P1|Month 24|Adverse Event|0
1489996|NCT00541970|4908017|P4|Month 18|Protocol Violation|16
1489997|NCT00541970|4908018|P3|Month 18|Protocol Violation|24
1489998|NCT00541970|4908019|P2|Month 18|Protocol Violation|23
1489999|NCT00541970|4908020|P1|Month 18|Protocol Violation|14
1490000|NCT00541970|4908017|P4|Month 18|Adverse Event|1
1490001|NCT00541970|4908018|P3|Month 18|Adverse Event|1
1490002|NCT00541970|4908019|P2|Month 18|Adverse Event|1
1490003|NCT00541970|4908020|P1|Month 18|Adverse Event|0
1490004|NCT00541970|4908017|P4|Month 12|Protocol Violation|15
1490005|NCT00541970|4908018|P3|Month 12|Protocol Violation|20
1490006|NCT00541970|4908019|P2|Month 12|Protocol Violation|21
1490007|NCT00541970|4908020|P1|Month 12|Protocol Violation|12
1490008|NCT00541970|4908017|P4|Month 12|Adverse Event|1
1490009|NCT00541970|4908018|P3|Month 12|Adverse Event|1
1490010|NCT00541970|4908019|P2|Month 12|Adverse Event|1
1490011|NCT00541970|4908020|P1|Month 12|Adverse Event|0
1490012|NCT00541970|4908017|P4|Month 7|Protocol Violation|5
1490013|NCT00541970|4908018|P3|Month 7|Protocol Violation|11
1490014|NCT00541970|4908019|P2|Month 7|Protocol Violation|13
1490015|NCT00541970|4908020|P1|Month 7|Protocol Violation|9
1490016|NCT00541931|4908171|P2|Overall Study|Transportation Issue|1
1490017|NCT00541931|4908172|P1|Overall Study|Transportation Issue|0
1490018|NCT00541931|4908171|P2|Overall Study|Withdrawal by Subject|0
1490019|NCT00541931|4908172|P1|Overall Study|Withdrawal by Subject|1
1490020|NCT00541931|4908171|P2|Overall Study|Lost to Follow-up|3
1490021|NCT00541931|4908172|P1|Overall Study|Lost to Follow-up|3
1490022|NCT00541931|4908171|P2|Overall Study|Adverse Event|0
1490023|NCT00541931|4908172|P1|Overall Study|Adverse Event|1
1490024|NCT00541866|4908185|P5|Overall Study|Physician Decision|0
1490025|NCT00541866|4908186|P4|Overall Study|Physician Decision|1
1490026|NCT00541866|4908187|P3|Overall Study|Physician Decision|2
1490027|NCT00541866|4908188|P2|Overall Study|Physician Decision|0
1490028|NCT00541866|4908189|P1|Overall Study|Physician Decision|0
1490029|NCT00541866|4908185|P5|Overall Study|Not Reported or Other|1
1490030|NCT00541866|4908186|P4|Overall Study|Not Reported or Other|3
1490031|NCT00541866|4908187|P3|Overall Study|Not Reported or Other|3
1490032|NCT00541866|4908188|P2|Overall Study|Not Reported or Other|3
1490033|NCT00541866|4908189|P1|Overall Study|Not Reported or Other|11
1490034|NCT00541866|4908185|P5|Overall Study|Lack of Efficacy|14
1490035|NCT00541866|4908186|P4|Overall Study|Lack of Efficacy|12
1490036|NCT00541866|4908187|P3|Overall Study|Lack of Efficacy|10
1490037|NCT00541866|4908188|P2|Overall Study|Lack of Efficacy|15
1490038|NCT00541866|4908189|P1|Overall Study|Lack of Efficacy|19
1490039|NCT00541866|4908185|P5|Overall Study|Death|0
1490040|NCT00541866|4908186|P4|Overall Study|Death|0
1490041|NCT00541866|4908187|P3|Overall Study|Death|0
1490042|NCT00541866|4908188|P2|Overall Study|Death|0
1490043|NCT00541866|4908189|P1|Overall Study|Death|1
1490044|NCT00541866|4908185|P5|Overall Study|Adverse Event|0
1490045|NCT00541866|4908186|P4|Overall Study|Adverse Event|0
1490046|NCT00541866|4908187|P3|Overall Study|Adverse Event|0
1490047|NCT00541866|4908188|P2|Overall Study|Adverse Event|0
1490048|NCT00541866|4908189|P1|Overall Study|Adverse Event|3
1490049|NCT00541775|4908230|P3|Overall Study|Withdrawal by Subject and Other|2
1490050|NCT00541775|4908231|P2|Overall Study|Withdrawal by Subject and Other|0
1490051|NCT00541775|4908232|P1|Overall Study|Withdrawal by Subject and Other|5
1490052|NCT00541775|4908230|P3|Overall Study|Protocol Violation|0
1490053|NCT00541775|4908231|P2|Overall Study|Protocol Violation|0
1490054|NCT00541775|4908232|P1|Overall Study|Protocol Violation|1
1490055|NCT00541775|4908230|P3|Overall Study|Lost to Follow-up|2
1490056|NCT00541775|4908231|P2|Overall Study|Lost to Follow-up|0
1490057|NCT00541775|4908232|P1|Overall Study|Lost to Follow-up|0
1490058|NCT00541775|4908230|P3|Overall Study|Lack of Efficacy|3
1490059|NCT00541775|4908231|P2|Overall Study|Lack of Efficacy|0
1490060|NCT00541775|4908232|P1|Overall Study|Lack of Efficacy|0
1490061|NCT00541775|4908230|P3|Overall Study|Adverse Event|1
1490062|NCT00541775|4908231|P2|Overall Study|Adverse Event|2
1490063|NCT00541775|4908232|P1|Overall Study|Adverse Event|3
1490064|NCT00541658|4908258|P3|Overall Study|Took No Study Drug|0
1490065|NCT00541658|4908259|P2|Overall Study|Took No Study Drug|0
1490066|NCT00541658|4908260|P1|Overall Study|Took No Study Drug|1
1490067|NCT00541658|4908258|P3|Overall Study|Withdrawal by Subject|32
1490068|NCT00541658|4908259|P2|Overall Study|Withdrawal by Subject|32
1490069|NCT00541658|4908260|P1|Overall Study|Withdrawal by Subject|28
1490070|NCT00541658|4908258|P3|Overall Study|Protocol Violation|1
1490071|NCT00541658|4908259|P2|Overall Study|Protocol Violation|1
1490072|NCT00541658|4908260|P1|Overall Study|Protocol Violation|0
1490073|NCT00541658|4908258|P3|Overall Study|Lost to Follow-up|6
1490074|NCT00541658|4908259|P2|Overall Study|Lost to Follow-up|3
1490075|NCT00541658|4908260|P1|Overall Study|Lost to Follow-up|3
1490076|NCT00541658|4908258|P3|Overall Study|Physician Decision|4
1490077|NCT00541658|4908259|P2|Overall Study|Physician Decision|0
1490078|NCT00541658|4908260|P1|Overall Study|Physician Decision|0
1490079|NCT00541658|4908258|P3|Overall Study|Adverse Event|25
1490080|NCT00541658|4908259|P2|Overall Study|Adverse Event|37
1490081|NCT00541658|4908260|P1|Overall Study|Adverse Event|28
1490082|NCT00541450|4908423|P2|Phase B|Withdrawal by Subject|6
1490083|NCT00541450|4908424|P1|Phase B|Withdrawal by Subject|8
1490084|NCT00541450|4908423|P2|Phase B|Protocol Violation|3
1490085|NCT00541450|4908424|P1|Phase B|Protocol Violation|3
1490086|NCT00541450|4908423|P2|Phase B|Pregnancy|1
1490087|NCT00541450|4908424|P1|Phase B|Pregnancy|0
1490088|NCT00541450|4908423|P2|Phase B|Physician Decision|2
1490089|NCT00541450|4908424|P1|Phase B|Physician Decision|4
1490090|NCT00541450|4908423|P2|Phase B|Lost to Follow-up|4
1490091|NCT00541450|4908424|P1|Phase B|Lost to Follow-up|6
1490092|NCT00541450|4908423|P2|Phase B|Hyperglycemia|9
1490093|NCT00541450|4908424|P1|Phase B|Hyperglycemia|10
1490094|NCT00541450|4908423|P2|Phase B|Adverse Event|6
1490095|NCT00541450|4908424|P1|Phase B|Adverse Event|6
1490096|NCT00541450|4908423|P2|Phase A|Withdrawal by Subject|7
1490097|NCT00541450|4908424|P1|Phase A|Withdrawal by Subject|7
1490098|NCT00541450|4908423|P2|Phase A|Protocol Violation|3
1490099|NCT00541450|4908424|P1|Phase A|Protocol Violation|2
1490100|NCT00541450|4908423|P2|Phase A|Physician Decision|0
1490101|NCT00541450|4908424|P1|Phase A|Physician Decision|2
1490102|NCT00541450|4908423|P2|Phase A|Lost to Follow-up|4
1490103|NCT00541450|4908424|P1|Phase A|Lost to Follow-up|6
1490104|NCT00541450|4908423|P2|Phase A|Hyperglycemia|1
1490105|NCT00541450|4908424|P1|Phase A|Hyperglycemia|0
1490106|NCT00541450|4908423|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
1490107|NCT00541450|4908424|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
1490108|NCT00541450|4908423|P2|Phase A|Adverse Event|0
1490109|NCT00541450|4908424|P1|Phase A|Adverse Event|3
1490110|NCT00541346|4908442|P1|Follow-up|Adverse Event|1
1490111|NCT00541307|4908456|P1|Overall Study|Surgical Bypass|5
1490112|NCT00541307|4908456|P1|Overall Study|Subject returned early (outside window)|1
1490113|NCT00541307|4908456|P1|Overall Study|Lost to Follow-up|4
1490114|NCT00541307|4908456|P1|Overall Study|Withdrawal by Subject|6
1490115|NCT00541307|4908456|P1|Overall Study|Physician Decision|3
1490116|NCT00541307|4908456|P1|Overall Study|Death|5
1490117|NCT00541229|4908481|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
1490118|NCT00541229|4908482|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
1490119|NCT00541229|4908483|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
1490120|NCT00541229|4908484|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
1490121|NCT00541229|4908485|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
1490122|NCT00541229|4908486|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
1490123|NCT00541229|4908481|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
1490124|NCT00541229|4908482|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
1490125|NCT00541229|4908483|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
1490126|NCT00541229|4908484|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
1490127|NCT00541229|4908485|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
1490128|NCT00541229|4908486|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
1490129|NCT00541229|4908481|P6|Treatment Period III (Week 11)|Adverse Event|0
1490130|NCT00541229|4908482|P5|Treatment Period III (Week 11)|Adverse Event|1
1490131|NCT00541229|4908483|P4|Treatment Period III (Week 11)|Adverse Event|0
1490132|NCT00541229|4908484|P3|Treatment Period III (Week 11)|Adverse Event|0
1490133|NCT00541229|4908485|P2|Treatment Period III (Week 11)|Adverse Event|0
1490134|NCT00541229|4908486|P1|Treatment Period III (Week 11)|Adverse Event|0
1490135|NCT00541229|4908481|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
1490136|NCT00541229|4908482|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
1490137|NCT00541229|4908483|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
1490138|NCT00541229|4908484|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
1490139|NCT00541229|4908485|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
1490140|NCT00541229|4908486|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
1490141|NCT00541229|4908481|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
1490142|NCT00541229|4908482|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
1490143|NCT00541229|4908483|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
1490144|NCT00541229|4908484|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
1490145|NCT00541229|4908485|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
1490146|NCT00541229|4908486|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
1490147|NCT00541229|4908481|P6|Washout Period II (Week 7-10)|Protocol Violation|0
1490148|NCT00541229|4908482|P5|Washout Period II (Week 7-10)|Protocol Violation|0
1490149|NCT00541229|4908483|P4|Washout Period II (Week 7-10)|Protocol Violation|0
1490150|NCT00541229|4908484|P3|Washout Period II (Week 7-10)|Protocol Violation|0
1490151|NCT00541229|4908485|P2|Washout Period II (Week 7-10)|Protocol Violation|0
1490152|NCT00541229|4908486|P1|Washout Period II (Week 7-10)|Protocol Violation|1
1490153|NCT00541229|4908481|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
1490154|NCT00541229|4908482|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
1490155|NCT00541229|4908483|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
1490156|NCT00541229|4908484|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
1490157|NCT00541229|4908485|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
1490158|NCT00541229|4908486|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
1490159|NCT00541229|4908481|P6|Treatment Period II (Week 6)|Protocol Violation|1
1490160|NCT00541229|4908482|P5|Treatment Period II (Week 6)|Protocol Violation|1
1490161|NCT00541229|4908483|P4|Treatment Period II (Week 6)|Protocol Violation|0
1490162|NCT00541229|4908484|P3|Treatment Period II (Week 6)|Protocol Violation|0
1490163|NCT00541229|4908485|P2|Treatment Period II (Week 6)|Protocol Violation|0
1490164|NCT00541229|4908486|P1|Treatment Period II (Week 6)|Protocol Violation|0
1490165|NCT00541229|4908481|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
1490166|NCT00541229|4908482|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
1490167|NCT00541229|4908483|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
1490168|NCT00541229|4908484|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
1490169|NCT00541229|4908485|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
1490170|NCT00541229|4908486|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
1490171|NCT00541229|4908481|P6|Washout Period I (Week 2-5)|Protocol Violation|1
1490172|NCT00541229|4908482|P5|Washout Period I (Week 2-5)|Protocol Violation|0
1490173|NCT00541229|4908483|P4|Washout Period I (Week 2-5)|Protocol Violation|0
1490174|NCT00541229|4908484|P3|Washout Period I (Week 2-5)|Protocol Violation|0
1490175|NCT00541229|4908485|P2|Washout Period I (Week 2-5)|Protocol Violation|0
1490176|NCT00541229|4908486|P1|Washout Period I (Week 2-5)|Protocol Violation|0
1490177|NCT00541229|4908481|P6|Washout Period I (Week 2-5)|Physician Decision|0
1490178|NCT00541229|4908482|P5|Washout Period I (Week 2-5)|Physician Decision|0
1490179|NCT00541229|4908483|P4|Washout Period I (Week 2-5)|Physician Decision|1
1490180|NCT00541229|4908484|P3|Washout Period I (Week 2-5)|Physician Decision|0
1490181|NCT00541229|4908485|P2|Washout Period I (Week 2-5)|Physician Decision|0
1490182|NCT00541229|4908486|P1|Washout Period I (Week 2-5)|Physician Decision|0
1490183|NCT00541229|4908481|P6|Washout Period I (Week 2-5)|Adverse Event|0
1490184|NCT00541229|4908482|P5|Washout Period I (Week 2-5)|Adverse Event|0
1490185|NCT00541229|4908483|P4|Washout Period I (Week 2-5)|Adverse Event|0
1490186|NCT00541229|4908484|P3|Washout Period I (Week 2-5)|Adverse Event|1
1490187|NCT00541229|4908485|P2|Washout Period I (Week 2-5)|Adverse Event|0
1490188|NCT00541229|4908486|P1|Washout Period I (Week 2-5)|Adverse Event|1
1490189|NCT00541229|4908481|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
1490190|NCT00541229|4908482|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
1490191|NCT00541229|4908483|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
1490192|NCT00541229|4908484|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
1490193|NCT00541229|4908485|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
1490194|NCT00541229|4908486|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
1490195|NCT00541229|4908481|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
1490196|NCT00541229|4908482|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
1490197|NCT00541229|4908483|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
1490198|NCT00541229|4908484|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
1490199|NCT00541229|4908485|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
1490200|NCT00541229|4908486|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
1490201|NCT00541229|4908481|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
1490202|NCT00541229|4908482|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
1490203|NCT00541229|4908483|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
1490204|NCT00541229|4908484|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
1490205|NCT00541229|4908485|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
1490206|NCT00541229|4908486|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
1490207|NCT00541229|4908481|P6|Treatment Period I (Week 1)|Physician Decision|0
1490208|NCT00541229|4908482|P5|Treatment Period I (Week 1)|Physician Decision|0
1490209|NCT00541229|4908483|P4|Treatment Period I (Week 1)|Physician Decision|0
1490210|NCT00541229|4908484|P3|Treatment Period I (Week 1)|Physician Decision|1
1490211|NCT00541229|4908485|P2|Treatment Period I (Week 1)|Physician Decision|0
1490212|NCT00541229|4908486|P1|Treatment Period I (Week 1)|Physician Decision|0
1490213|NCT00541099|4908505|P1|Overall Study|Ineligible|3
1490214|NCT00541034|4908511|P1|Overall Study|Non-Compliance|3
1490215|NCT00540644|4908538|P2|Overall Study|Noncomplilance|0
1490216|NCT00540644|4908539|P1|Overall Study|Noncomplilance|1
1490217|NCT00540644|4908538|P2|Overall Study|Withdrawal by Subject|2
1490218|NCT00540644|4908539|P1|Overall Study|Withdrawal by Subject|2
1490219|NCT00540644|4908538|P2|Overall Study|Physician Decision|5
1490220|NCT00540644|4908539|P1|Overall Study|Physician Decision|0
1490221|NCT00540644|4908538|P2|Overall Study|Disease Progression|1
1490222|NCT00540644|4908539|P1|Overall Study|Disease Progression|3
1490223|NCT00540644|4908538|P2|Overall Study|Adverse Event|1
1490224|NCT00540644|4908539|P1|Overall Study|Adverse Event|3
1490225|NCT00540592|4908559|P10|Overall Study|Withdrawal by Subject|0
1490226|NCT00540592|4908560|P9|Overall Study|Withdrawal by Subject|0
1490227|NCT00540592|4908561|P8|Overall Study|Withdrawal by Subject|0
1490228|NCT00540592|4908562|P7|Overall Study|Withdrawal by Subject|0
1490229|NCT00540592|4908563|P6|Overall Study|Withdrawal by Subject|0
1490230|NCT00540592|4908564|P5|Overall Study|Withdrawal by Subject|0
1490231|NCT00540592|4908565|P4|Overall Study|Withdrawal by Subject|1
1490232|NCT00540592|4908566|P3|Overall Study|Withdrawal by Subject|1
1490233|NCT00540592|4908567|P2|Overall Study|Withdrawal by Subject|0
1490234|NCT00540592|4908568|P1|Overall Study|Withdrawal by Subject|0
1490235|NCT00540592|4908559|P10|Overall Study|Lost to Follow-up|0
1490236|NCT00540592|4908560|P9|Overall Study|Lost to Follow-up|0
1490237|NCT00540592|4908561|P8|Overall Study|Lost to Follow-up|0
1490238|NCT00540592|4908562|P7|Overall Study|Lost to Follow-up|0
1490239|NCT00540592|4908563|P6|Overall Study|Lost to Follow-up|0
1490240|NCT00540592|4908564|P5|Overall Study|Lost to Follow-up|0
1490241|NCT00540592|4908565|P4|Overall Study|Lost to Follow-up|0
1490242|NCT00540592|4908566|P3|Overall Study|Lost to Follow-up|0
1490243|NCT00540592|4908567|P2|Overall Study|Lost to Follow-up|0
1490244|NCT00540592|4908568|P1|Overall Study|Lost to Follow-up|2
1490245|NCT00540592|4908559|P10|Overall Study|Adverse Event|2
1490246|NCT00540592|4908560|P9|Overall Study|Adverse Event|1
1490247|NCT00540592|4908561|P8|Overall Study|Adverse Event|1
1490248|NCT00540592|4908562|P7|Overall Study|Adverse Event|0
1490249|NCT00540592|4908563|P6|Overall Study|Adverse Event|0
1490250|NCT00540592|4908564|P5|Overall Study|Adverse Event|1
1490251|NCT00540592|4908565|P4|Overall Study|Adverse Event|0
1490252|NCT00540592|4908566|P3|Overall Study|Adverse Event|0
1490253|NCT00540592|4908567|P2|Overall Study|Adverse Event|1
1490254|NCT00540592|4908568|P1|Overall Study|Adverse Event|0
1490255|NCT00540514|4908807|P2|Overall Study|Paclitaxel not available|2
1490256|NCT00540514|4908808|P1|Overall Study|Paclitaxel not available|0
1490257|NCT00540514|4908807|P2|Overall Study|Excluded prior to treatment|7
1490258|NCT00540514|4908808|P1|Overall Study|Excluded prior to treatment|7
1490259|NCT00540514|4908807|P2|Overall Study|Withdrawal by Subject|67
1490260|NCT00540514|4908808|P1|Overall Study|Withdrawal by Subject|65
1490261|NCT00540514|4908807|P2|Overall Study|Lost to Follow-up|1
1490262|NCT00540514|4908808|P1|Overall Study|Lost to Follow-up|1
1490263|NCT00540514|4908807|P2|Overall Study|Protocol Deviation|4
1490264|NCT00540514|4908808|P1|Overall Study|Protocol Deviation|3
1490265|NCT00540514|4908807|P2|Overall Study|Physician Decision|99
1490266|NCT00540514|4908808|P1|Overall Study|Physician Decision|86
1490267|NCT00540514|4908807|P2|Overall Study|Adverse Event|24
1490268|NCT00540514|4908808|P1|Overall Study|Adverse Event|20
1490269|NCT00540514|4908807|P2|Overall Study|Unacceptable Toxicity|62
1490270|NCT00540514|4908808|P1|Overall Study|Unacceptable Toxicity|61
1490271|NCT00540514|4908807|P2|Overall Study|Still on treatment|0
1490272|NCT00540514|4908808|P1|Overall Study|Still on treatment|3
1490273|NCT00540449|4908840|P2|Overall Study|Not specified|4
1490274|NCT00540449|4908841|P1|Overall Study|Not specified|1
1490275|NCT00540449|4908840|P2|Overall Study|Withdrawal by Subject|10
1490276|NCT00540449|4908841|P1|Overall Study|Withdrawal by Subject|10
1490277|NCT00540449|4908840|P2|Overall Study|Subject Reached A Virologic Endpoint|8
1490278|NCT00540449|4908841|P1|Overall Study|Subject Reached A Virologic Endpoint|32
1490279|NCT00540449|4908840|P2|Overall Study|Subject Non-Compliant|5
1490280|NCT00540449|4908841|P1|Overall Study|Subject Non-Compliant|7
1490281|NCT00540449|4908840|P2|Overall Study|Lost to Follow-up|17
1490282|NCT00540449|4908841|P1|Overall Study|Lost to Follow-up|19
1490283|NCT00540449|4908840|P2|Overall Study|Subject Ineligible To Continue The Trial|1
1490284|NCT00540449|4908841|P1|Overall Study|Subject Ineligible To Continue The Trial|2
1490285|NCT00540449|4908840|P2|Overall Study|Sponsor's Decision|1
1490286|NCT00540449|4908841|P1|Overall Study|Sponsor's Decision|1
1490287|NCT00540449|4908840|P2|Overall Study|Adverse Event|32
1490288|NCT00540449|4908841|P1|Overall Study|Adverse Event|12
1490289|NCT00540436|4908863|P1|Second 12-Week Treatment Period|Adverse Event|1
1490290|NCT00540436|4908863|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
1490291|NCT00540436|4908863|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
1490292|NCT00540436|4908863|P1|First 12-Week Treatment Period|Adverse Event|1
1490293|NCT00540423|4908878|P3|Open-Label Treatment Period|Lack of Efficacy|2
1490294|NCT00540423|4908879|P2|Open-Label Treatment Period|Lack of Efficacy|0
1490295|NCT00540423|4908880|P1|Open-Label Treatment Period|Lack of Efficacy|0
1490296|NCT00540423|4908878|P3|Double-Blind Treatment Period|Adverse Event|0
1490297|NCT00540423|4908879|P2|Double-Blind Treatment Period|Adverse Event|1
1490298|NCT00540423|4908880|P1|Double-Blind Treatment Period|Adverse Event|0
1490299|NCT00540293|4908930|P1|Overall Study|Protocol violation, & subject schedule|12
1490300|NCT00540293|4908930|P1|Overall Study|Withdrawal by Subject|6
1490301|NCT00540293|4908930|P1|Overall Study|Adverse event not related to study drug|7
1490302|NCT00540293|4908930|P1|Overall Study|Adverse event related to study drug|10
1490303|NCT00540228|4908978|P5|Overall Study|Lost to Follow-up|0
1490304|NCT00540228|4908979|P4|Overall Study|Lost to Follow-up|0
1490305|NCT00540228|4908980|P3|Overall Study|Lost to Follow-up|0
1490306|NCT00540228|4908981|P2|Overall Study|Lost to Follow-up|1
1490307|NCT00540228|4908982|P1|Overall Study|Lost to Follow-up|1
1490308|NCT00540228|4908978|P5|Overall Study|Adverse Event|0
1490309|NCT00540228|4908979|P4|Overall Study|Adverse Event|0
1490310|NCT00540228|4908980|P3|Overall Study|Adverse Event|0
1490311|NCT00540228|4908981|P2|Overall Study|Adverse Event|0
1490312|NCT00540228|4908982|P1|Overall Study|Adverse Event|2
1490313|NCT00540124|4909052|P3|Overall Study|Withdrawal by Subject|0
1490314|NCT00540124|4909053|P2|Overall Study|Withdrawal by Subject|1
1490315|NCT00540124|4909054|P1|Overall Study|Withdrawal by Subject|1
1490316|NCT00540124|4909052|P3|Overall Study|Lack of Efficacy|0
1490317|NCT00540124|4909053|P2|Overall Study|Lack of Efficacy|0
1490318|NCT00540124|4909054|P1|Overall Study|Lack of Efficacy|1
1490319|NCT00540124|4909052|P3|Overall Study|Entry Criteria Not Met|0
1490320|NCT00540124|4909053|P2|Overall Study|Entry Criteria Not Met|0
1490321|NCT00540124|4909054|P1|Overall Study|Entry Criteria Not Met|2
1490322|NCT00540124|4909052|P3|Overall Study|Adverse Event|1
1490323|NCT00540124|4909053|P2|Overall Study|Adverse Event|2
1490324|NCT00540124|4909054|P1|Overall Study|Adverse Event|0
1490325|NCT00540046|4909100|P2|Overall Study|Lost to Follow-up|23
1490326|NCT00540046|4909101|P1|Overall Study|Lost to Follow-up|33
1490327|NCT00539994|4909137|P3|Overall Study|Physician Decision|1
1490328|NCT00539994|4909138|P2|Overall Study|Physician Decision|0
1490329|NCT00539994|4909139|P1|Overall Study|Physician Decision|0
1490330|NCT00539994|4909137|P3|Overall Study|Withdrawal by Subject|1
1490331|NCT00539994|4909138|P2|Overall Study|Withdrawal by Subject|0
1490332|NCT00539994|4909139|P1|Overall Study|Withdrawal by Subject|1
1490333|NCT00539994|4909137|P3|Overall Study|Lost to Follow-up|0
1490334|NCT00539994|4909138|P2|Overall Study|Lost to Follow-up|1
1490335|NCT00539994|4909139|P1|Overall Study|Lost to Follow-up|2
1490336|NCT00539864|4909189|P2|Overall Study|Withdrawal by Subject|1
1490337|NCT00539864|4909190|P1|Overall Study|Withdrawal by Subject|1
1490338|NCT00539864|4909189|P2|Overall Study|Lost to Follow-up|1
1490339|NCT00539864|4909190|P1|Overall Study|Lost to Follow-up|0
1490340|NCT00539734|4909202|P1|Overall Study|Protocol Violation|1
1490341|NCT00539591|4909221|P3|Overall Study|Disease progression|3
1490342|NCT00539591|4909222|P2|Overall Study|Disease progression|2
1490343|NCT00539591|4909223|P1|Overall Study|Disease progression|2
1490344|NCT00539591|4909221|P3|Overall Study|Toxicity|0
1490345|NCT00539591|4909222|P2|Overall Study|Toxicity|0
1490346|NCT00539591|4909223|P1|Overall Study|Toxicity|3
1490347|NCT00539513|4909375|P2|Overall Study|Lost to Follow-up|1
1490348|NCT00539513|4909376|P1|Overall Study|Lost to Follow-up|0
1490349|NCT00539513|4909375|P2|Overall Study|Withdrawal by Subject|1
1490350|NCT00539513|4909376|P1|Overall Study|Withdrawal by Subject|2
1490351|NCT00539305|4909390|P2|Overall Study|Withdrawal by Subject|1
1490352|NCT00539305|4909391|P1|Overall Study|Withdrawal by Subject|0
1490353|NCT00539305|4909390|P2|Overall Study|Substance Use|1
1490354|NCT00539305|4909391|P1|Overall Study|Substance Use|0
1490355|NCT00539305|4909390|P2|Overall Study|Adverse Event|0
1490356|NCT00539305|4909391|P1|Overall Study|Adverse Event|1
1490357|NCT00539279|4909405|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
1490358|NCT00539279|4909406|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
1490359|NCT00539279|4909405|P2|Post-Treatment Assessment|Lost to Follow-up|9
1490360|NCT00539279|4909406|P1|Post-Treatment Assessment|Lost to Follow-up|12
1490361|NCT00539279|4909405|P2|Treatment|Death|0
1490362|NCT00539279|4909406|P1|Treatment|Death|1
1490363|NCT00539279|4909405|P2|Treatment|Withdrawal by Subject|8
1490364|NCT00539279|4909406|P1|Treatment|Withdrawal by Subject|10
1490365|NCT00539240|4909432|P3|Overall Study|Adverse Event|10
1490366|NCT00539240|4909433|P2|Overall Study|Adverse Event|1
1490367|NCT00539240|4909434|P1|Overall Study|Adverse Event|3
1490368|NCT00539240|4909432|P3|Overall Study|Lost to Follow-up|1
1490369|NCT00539240|4909433|P2|Overall Study|Lost to Follow-up|3
1490370|NCT00539240|4909434|P1|Overall Study|Lost to Follow-up|2
1490371|NCT00539240|4909432|P3|Overall Study|Protocol Violation|4
1490372|NCT00539240|4909433|P2|Overall Study|Protocol Violation|1
1490373|NCT00539240|4909434|P1|Overall Study|Protocol Violation|1
1490374|NCT00539240|4909432|P3|Overall Study|Withdrawal by Subject|0
1490375|NCT00539240|4909433|P2|Overall Study|Withdrawal by Subject|2
1490376|NCT00539240|4909434|P1|Overall Study|Withdrawal by Subject|0
1490377|NCT00539188|4909453|P2|Overall Study|Lost to Follow-up|1
1490378|NCT00539188|4909454|P1|Overall Study|Lost to Follow-up|2
1490379|NCT00539188|4909453|P2|Overall Study|Withdrawal by Subject|0
1490380|NCT00539188|4909454|P1|Overall Study|Withdrawal by Subject|1
1490381|NCT00539032|4909477|P2|Overall Study|Withdrawal by Subject|1
1490382|NCT00539032|4909478|P1|Overall Study|Withdrawal by Subject|2
1490383|NCT00539006|4909492|P4|Treatment Period 2|Other|0
1490384|NCT00539006|4909493|P3|Treatment Period 2|Other|0
1490385|NCT00539006|4909494|P2|Treatment Period 2|Other|1
1490386|NCT00539006|4909495|P1|Treatment Period 2|Other|0
1490387|NCT00539006|4909492|P4|Treatment Period 2|Protocol Violation|0
1490388|NCT00539006|4909493|P3|Treatment Period 2|Protocol Violation|0
1490389|NCT00539006|4909494|P2|Treatment Period 2|Protocol Violation|0
1490390|NCT00539006|4909495|P1|Treatment Period 2|Protocol Violation|1
1490391|NCT00539006|4909492|P4|Washout|Other|3
1490392|NCT00539006|4909493|P3|Washout|Other|2
1490393|NCT00539006|4909494|P2|Washout|Other|1
1490394|NCT00539006|4909495|P1|Washout|Other|1
1490395|NCT00539006|4909492|P4|Washout|Failed to meet continuation criteria|6
1490396|NCT00539006|4909493|P3|Washout|Failed to meet continuation criteria|14
1490397|NCT00539006|4909494|P2|Washout|Failed to meet continuation criteria|5
1490398|NCT00539006|4909495|P1|Washout|Failed to meet continuation criteria|16
1490399|NCT00539006|4909492|P4|Washout|Withdrawal by Subject|0
1490400|NCT00539006|4909493|P3|Washout|Withdrawal by Subject|0
1490401|NCT00539006|4909494|P2|Washout|Withdrawal by Subject|2
1490402|NCT00539006|4909495|P1|Washout|Withdrawal by Subject|0
1490403|NCT00539006|4909492|P4|Washout|Protocol Violation|0
1490404|NCT00539006|4909493|P3|Washout|Protocol Violation|0
1490405|NCT00539006|4909494|P2|Washout|Protocol Violation|1
1490406|NCT00539006|4909495|P1|Washout|Protocol Violation|1
1490407|NCT00539006|4909492|P4|Washout|Adverse Event|0
1490408|NCT00539006|4909493|P3|Washout|Adverse Event|0
1490409|NCT00539006|4909494|P2|Washout|Adverse Event|1
1490410|NCT00539006|4909495|P1|Washout|Adverse Event|2
1490411|NCT00539006|4909492|P4|Treatment Period 1|Lack of Efficacy|1
1490412|NCT00539006|4909493|P3|Treatment Period 1|Lack of Efficacy|0
1490413|NCT00539006|4909494|P2|Treatment Period 1|Lack of Efficacy|0
1490414|NCT00539006|4909495|P1|Treatment Period 1|Lack of Efficacy|0
1490415|NCT00539006|4909492|P4|Treatment Period 1|Protocol Violation|0
1490416|NCT00539006|4909493|P3|Treatment Period 1|Protocol Violation|1
1490417|NCT00539006|4909494|P2|Treatment Period 1|Protocol Violation|0
1490418|NCT00539006|4909495|P1|Treatment Period 1|Protocol Violation|0
1490419|NCT00539006|4909492|P4|Treatment Period 1|Lost to Follow-up|0
1490420|NCT00539006|4909493|P3|Treatment Period 1|Lost to Follow-up|1
1490421|NCT00539006|4909494|P2|Treatment Period 1|Lost to Follow-up|0
1490422|NCT00539006|4909495|P1|Treatment Period 1|Lost to Follow-up|0
1490423|NCT00539006|4909492|P4|Pre-treatment|Other|0
1490424|NCT00539006|4909493|P3|Pre-treatment|Other|0
1490425|NCT00539006|4909494|P2|Pre-treatment|Other|1
1490426|NCT00539006|4909495|P1|Pre-treatment|Other|0
1490427|NCT00538902|4909540|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
1490428|NCT00538902|4909541|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
1490429|NCT00538902|4909542|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
1490430|NCT00538902|4909540|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
1490431|NCT00538902|4909541|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
1490432|NCT00538902|4909542|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
1490433|NCT00538902|4909540|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
1490434|NCT00538902|4909541|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
1490435|NCT00538902|4909542|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
1490436|NCT00538902|4909540|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
1490437|NCT00538902|4909541|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
1490438|NCT00538902|4909542|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
1490439|NCT00538902|4909540|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
1490440|NCT00538902|4909541|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
1490441|NCT00538902|4909542|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
1490442|NCT00538902|4909540|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
1490443|NCT00538902|4909541|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
1490444|NCT00538902|4909542|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
1490445|NCT00538902|4909540|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
1490446|NCT00538902|4909541|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
1490447|NCT00538902|4909542|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
1490448|NCT00538902|4909540|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
1490449|NCT00538902|4909541|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
1490450|NCT00538902|4909542|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
1490451|NCT00538785|4909603|P2|Overall Study|Lost to Follow-up|0
1490452|NCT00538785|4909604|P1|Overall Study|Lost to Follow-up|1
1490453|NCT00538785|4909603|P2|Overall Study|Withdrawal of consent|7
1490454|NCT00538785|4909604|P1|Overall Study|Withdrawal of consent|9
1490455|NCT00538785|4909603|P2|Overall Study|Death|10
1490456|NCT00538785|4909604|P1|Overall Study|Death|9
1490457|NCT00538733|4909625|P1|Overall Study|still on therapy|1
1490458|NCT00538733|4909625|P1|Overall Study|declined to participate|2
1490459|NCT00538733|4909625|P1|Overall Study|Death|1
1490460|NCT00538733|4909625|P1|Overall Study|Adverse Event|8
1490461|NCT00538629|4909675|P1|Overall Study|Subject's untimely distrust of medicine|1
1490462|NCT00538629|4909675|P1|Overall Study|Lost to Follow-up|6
1490463|NCT00538629|4909675|P1|Overall Study|Lack of Efficacy|12
1490464|NCT00538629|4909675|P1|Overall Study|Adverse Event|2
1490465|NCT00538629|4909675|P1|Overall Study|At subject's request|1
1490466|NCT00538590|4909731|P2|Overall Study|Death|0
1490467|NCT00538590|4909732|P1|Overall Study|Death|1
1490468|NCT00538473|4909770|P2|Overall Study|Adverse Event|0
1490469|NCT00538473|4909771|P1|Overall Study|Adverse Event|1
1490470|NCT00538291|4909851|P1|Overall Study|Withdrawal by Subject|1
1490471|NCT00538291|4909851|P1|Overall Study|Adverse Event|2
1490472|NCT00537979|4909909|P2|Overall Study|Heart failure|1
1490473|NCT00537979|4909910|P1|Overall Study|Heart failure|0
1490474|NCT00537979|4909909|P2|Overall Study|Kidney transplant|3
1490475|NCT00537979|4909910|P1|Overall Study|Kidney transplant|0
1490476|NCT00537979|4909909|P2|Overall Study|Death|3
1490477|NCT00537979|4909910|P1|Overall Study|Death|0
1490478|NCT00537979|4909909|P2|Overall Study|Non-compliance with treatment/procedure|2
1490479|NCT00537979|4909910|P1|Overall Study|Non-compliance with treatment/procedure|2
1490480|NCT00537979|4909909|P2|Overall Study|Lack of Efficacy|1
1490481|NCT00537979|4909910|P1|Overall Study|Lack of Efficacy|0
1490482|NCT00537979|4909909|P2|Overall Study|Lost to Follow-up|4
1490483|NCT00537979|4909910|P1|Overall Study|Lost to Follow-up|1
1490484|NCT00537979|4909909|P2|Overall Study|Withdrawal by Subject|4
1490485|NCT00537979|4909910|P1|Overall Study|Withdrawal by Subject|1
1490486|NCT00537979|4909909|P2|Overall Study|Adverse Event|2
1490487|NCT00537979|4909910|P1|Overall Study|Adverse Event|2
1490488|NCT00537940|4909926|P2|Overall Study|Other|12
1490489|NCT00537940|4909927|P1|Overall Study|Other|10
1490490|NCT00537940|4909926|P2|Overall Study|Study terminated by sponsor|3
1490491|NCT00537940|4909927|P1|Overall Study|Study terminated by sponsor|2
1490492|NCT00537940|4909926|P2|Overall Study|Pregnancy|1
1490493|NCT00537940|4909927|P1|Overall Study|Pregnancy|1
1490494|NCT00537940|4909926|P2|Overall Study|Protocol Violation|4
1490495|NCT00537940|4909927|P1|Overall Study|Protocol Violation|6
1490496|NCT00537940|4909926|P2|Overall Study|Withdrawal by Subject|95
1490497|NCT00537940|4909927|P1|Overall Study|Withdrawal by Subject|113
1490498|NCT00537940|4909926|P2|Overall Study|Lost to Follow-up|29
1490499|NCT00537940|4909927|P1|Overall Study|Lost to Follow-up|23
1490500|NCT00537940|4909926|P2|Overall Study|Lack of Efficacy|16
1490501|NCT00537940|4909927|P1|Overall Study|Lack of Efficacy|8
1490502|NCT00537940|4909926|P2|Overall Study|Adverse Event|19
1490503|NCT00537940|4909927|P1|Overall Study|Adverse Event|20
1490504|NCT00537823|4909951|P2|Overall Study|Adverse Event|0
1490505|NCT00537823|4909952|P1|Overall Study|Adverse Event|2
1490506|NCT00537810|4909978|P4|Overall Study|Medically withdrawn|1
1490507|NCT00537810|4909979|P3|Overall Study|Medically withdrawn|0
1490508|NCT00537810|4909980|P2|Overall Study|Medically withdrawn|2
1490509|NCT00537810|4909981|P1|Overall Study|Medically withdrawn|2
1490510|NCT00537810|4909978|P4|Overall Study|Withdrawal by Subject|3
1490511|NCT00537810|4909979|P3|Overall Study|Withdrawal by Subject|4
1490512|NCT00537810|4909980|P2|Overall Study|Withdrawal by Subject|11
1490513|NCT00537810|4909981|P1|Overall Study|Withdrawal by Subject|4
1490514|NCT00537771|4909997|P2|Overall Study|Severe Non-Compliance to Protocol|2
1490515|NCT00537771|4909998|P1|Overall Study|Severe Non-Compliance to Protocol|4
1490516|NCT00537771|4909997|P2|Overall Study|Protocol Violation|6
1490517|NCT00537771|4909998|P1|Overall Study|Protocol Violation|2
1490518|NCT00537771|4909997|P2|Overall Study|Lost to Follow-up|15
1490519|NCT00537771|4909998|P1|Overall Study|Lost to Follow-up|9
1490520|NCT00537771|4909997|P2|Overall Study|Adverse Event|15
1490521|NCT00537771|4909998|P1|Overall Study|Adverse Event|8
1490522|NCT00537771|4909997|P2|Overall Study|Withdrawal by Subject|23
1490523|NCT00537771|4909998|P1|Overall Study|Withdrawal by Subject|6
1490524|NCT00537745|4910008|P1|Overall Study|Subject unable to provide Interlock info|1
1490525|NCT00537745|4910008|P1|Overall Study|Withdrawal by Subject|2
1490526|NCT00537745|4910008|P1|Overall Study|Did not meet eligibility criteria|2
1490527|NCT00537485|4910053|P2|Overall Study|Physician Decision|0
1490528|NCT00537485|4910054|P1|Overall Study|Physician Decision|1
1490529|NCT00537485|4910053|P2|Overall Study|Withdrawal by Subject|3
1490530|NCT00537485|4910054|P1|Overall Study|Withdrawal by Subject|1
1490531|NCT00537485|4910053|P2|Overall Study|Withdrawal by Subject|2
1490532|NCT00537485|4910054|P1|Overall Study|Withdrawal by Subject|3
1490533|NCT00537485|4910053|P2|Overall Study|Adverse Event|5
1490534|NCT00537485|4910054|P1|Overall Study|Adverse Event|10
1490535|NCT00537394|4910127|P3|2nd Year of Follow-up|Clinic site closure|0
1490536|NCT00537394|4910128|P2|2nd Year of Follow-up|Clinic site closure|0
1490537|NCT00537394|4910129|P1|2nd Year of Follow-up|Clinic site closure|1
1490538|NCT00537394|4910127|P3|2nd Year of Follow-up|Lost to Follow-up|2
1490539|NCT00537394|4910128|P2|2nd Year of Follow-up|Lost to Follow-up|7
1490540|NCT00537394|4910129|P1|2nd Year of Follow-up|Lost to Follow-up|6
1490541|NCT00537394|4910127|P3|2nd Year of Follow-up|Withdrawal by Subject|2
1490542|NCT00537394|4910128|P2|2nd Year of Follow-up|Withdrawal by Subject|1
1490543|NCT00537394|4910129|P1|2nd Year of Follow-up|Withdrawal by Subject|0
1490544|NCT00537394|4910127|P3|2nd Year of Follow-up|Death|2
1490545|NCT00537394|4910128|P2|2nd Year of Follow-up|Death|1
1490546|NCT00537394|4910129|P1|2nd Year of Follow-up|Death|4
1490547|NCT00537394|4910127|P3|First Year of Follow-up|Lost to Follow-up|1
1490548|NCT00537394|4910128|P2|First Year of Follow-up|Lost to Follow-up|5
1490549|NCT00537394|4910129|P1|First Year of Follow-up|Lost to Follow-up|1
1490550|NCT00537394|4910127|P3|First Year of Follow-up|Withdrawal by Subject|1
1490551|NCT00537394|4910128|P2|First Year of Follow-up|Withdrawal by Subject|6
1490552|NCT00537394|4910129|P1|First Year of Follow-up|Withdrawal by Subject|3
1490553|NCT00537394|4910127|P3|First Year of Follow-up|Severe debilitation|1
1490554|NCT00537394|4910128|P2|First Year of Follow-up|Severe debilitation|0
1490555|NCT00537394|4910129|P1|First Year of Follow-up|Severe debilitation|1
1490556|NCT00537394|4910127|P3|First Year of Follow-up|Death|0
1490557|NCT00537394|4910128|P2|First Year of Follow-up|Death|0
1490558|NCT00537394|4910129|P1|First Year of Follow-up|Death|7
1490559|NCT00537381|4910165|P2|Overall Study|Other|3
1490560|NCT00537381|4910166|P1|Overall Study|Other|5
1490561|NCT00537381|4910165|P2|Overall Study|Sponsor decision|9
1490562|NCT00537381|4910166|P1|Overall Study|Sponsor decision|14
1490563|NCT00537381|4910165|P2|Overall Study|Disease Progression|18
1490564|NCT00537381|4910166|P1|Overall Study|Disease Progression|9
1490565|NCT00537381|4910165|P2|Overall Study|Physician Decision|6
1490566|NCT00537381|4910166|P1|Overall Study|Physician Decision|7
1490567|NCT00537381|4910165|P2|Overall Study|Withdrawal by Subject|14
1490568|NCT00537381|4910166|P1|Overall Study|Withdrawal by Subject|5
1490569|NCT00537381|4910165|P2|Overall Study|Death|3
1490570|NCT00537381|4910166|P1|Overall Study|Death|3
1490571|NCT00537381|4910165|P2|Overall Study|Adverse Event|9
1490572|NCT00537381|4910166|P1|Overall Study|Adverse Event|13
1490573|NCT00537329|4910186|P1|Overall Study|Other|1
1490574|NCT00537329|4910186|P1|Overall Study|Withdrawal by Subject|4
1490575|NCT00537329|4910186|P1|Overall Study|Lost to Follow-up|6
1490576|NCT00537329|4910186|P1|Overall Study|Lack of Efficacy|2
1490577|NCT00537329|4910186|P1|Overall Study|Adverse Event|3
1490578|NCT00537329|4910186|P1|Overall Study|Death|10
1490579|NCT00537316|4910206|P7|Part 2|Administrative|1
1490580|NCT00537316|4910207|P6|Part 2|Administrative|4
1490581|NCT00537316|4910208|P5|Part 2|Administrative|1
1490582|NCT00537316|4910209|P4|Part 2|Administrative|3
1490583|NCT00537316|4910210|P3|Part 2|Administrative|24
1490584|NCT00537316|4910211|P2|Part 2|Administrative|8
1490585|NCT00537316|4910212|P1|Part 2|Administrative|16
1490586|NCT00537316|4910206|P7|Part 2|Withdrawal by Subject|0
1490587|NCT00537316|4910207|P6|Part 2|Withdrawal by Subject|0
1490588|NCT00537316|4910208|P5|Part 2|Withdrawal by Subject|0
1490589|NCT00537316|4910209|P4|Part 2|Withdrawal by Subject|0
1490590|NCT00537316|4910210|P3|Part 2|Withdrawal by Subject|4
1490591|NCT00537316|4910211|P2|Part 2|Withdrawal by Subject|1
1490592|NCT00537316|4910212|P1|Part 2|Withdrawal by Subject|5
1490593|NCT00537316|4910206|P7|Part 2|Lost to Follow-up|0
1490594|NCT00537316|4910207|P6|Part 2|Lost to Follow-up|0
1490595|NCT00537316|4910208|P5|Part 2|Lost to Follow-up|0
1490596|NCT00537316|4910209|P4|Part 2|Lost to Follow-up|0
1490597|NCT00537316|4910210|P3|Part 2|Lost to Follow-up|2
1490598|NCT00537316|4910211|P2|Part 2|Lost to Follow-up|0
1490599|NCT00537316|4910212|P1|Part 2|Lost to Follow-up|1
1490600|NCT00537316|4910206|P7|Part 2|Adverse Event|0
1490601|NCT00537316|4910207|P6|Part 2|Adverse Event|0
1490602|NCT00537316|4910208|P5|Part 2|Adverse Event|0
1490603|NCT00537316|4910209|P4|Part 2|Adverse Event|0
1490604|NCT00537316|4910210|P3|Part 2|Adverse Event|2
1490605|NCT00537316|4910211|P2|Part 2|Adverse Event|0
1490606|NCT00537316|4910212|P1|Part 2|Adverse Event|4
1490607|NCT00537316|4910206|P7|Part 2|Never entered follow-up|1
1490608|NCT00537316|4910207|P6|Part 2|Never entered follow-up|0
1490609|NCT00537316|4910208|P5|Part 2|Never entered follow-up|0
1490610|NCT00537316|4910209|P4|Part 2|Never entered follow-up|0
1490611|NCT00537316|4910210|P3|Part 2|Never entered follow-up|0
1490612|NCT00537316|4910211|P2|Part 2|Never entered follow-up|0
1490613|NCT00537316|4910212|P1|Part 2|Never entered follow-up|0
1490614|NCT00537316|4910206|P7|Part 1|Administrative|0
1490615|NCT00537316|4910207|P6|Part 1|Administrative|0
1490616|NCT00537316|4910208|P5|Part 1|Administrative|0
1490617|NCT00537316|4910209|P4|Part 1|Administrative|0
1490618|NCT00537316|4910210|P3|Part 1|Administrative|2
1490619|NCT00537316|4910211|P2|Part 1|Administrative|0
1490620|NCT00537316|4910212|P1|Part 1|Administrative|0
1490621|NCT00537316|4910206|P7|Part 1|Did not meet protocol eligibility|0
1490622|NCT00537316|4910207|P6|Part 1|Did not meet protocol eligibility|0
1490623|NCT00537316|4910208|P5|Part 1|Did not meet protocol eligibility|0
1490624|NCT00537316|4910209|P4|Part 1|Did not meet protocol eligibility|0
1490625|NCT00537316|4910210|P3|Part 1|Did not meet protocol eligibility|2
1490626|NCT00537316|4910211|P2|Part 1|Did not meet protocol eligibility|3
1490627|NCT00537316|4910212|P1|Part 1|Did not meet protocol eligibility|1
1490628|NCT00537316|4910206|P7|Part 1|Protocol Violation|0
1490629|NCT00537316|4910207|P6|Part 1|Protocol Violation|0
1490630|NCT00537316|4910208|P5|Part 1|Protocol Violation|0
1490631|NCT00537316|4910209|P4|Part 1|Protocol Violation|0
1490632|NCT00537316|4910210|P3|Part 1|Protocol Violation|1
1490633|NCT00537316|4910211|P2|Part 1|Protocol Violation|5
1490634|NCT00537316|4910212|P1|Part 1|Protocol Violation|1
1490635|NCT00537316|4910206|P7|Part 1|Withdrawal by Subject|0
1490636|NCT00537316|4910207|P6|Part 1|Withdrawal by Subject|0
1490637|NCT00537316|4910208|P5|Part 1|Withdrawal by Subject|0
1490638|NCT00537316|4910209|P4|Part 1|Withdrawal by Subject|0
1490639|NCT00537316|4910210|P3|Part 1|Withdrawal by Subject|4
1490640|NCT00537316|4910211|P2|Part 1|Withdrawal by Subject|8
1490641|NCT00537316|4910212|P1|Part 1|Withdrawal by Subject|3
1490642|NCT00537316|4910206|P7|Part 1|Lost to Follow-up|0
1490643|NCT00537316|4910207|P6|Part 1|Lost to Follow-up|0
1490644|NCT00537316|4910208|P5|Part 1|Lost to Follow-up|0
1490645|NCT00537316|4910209|P4|Part 1|Lost to Follow-up|0
1490646|NCT00537316|4910210|P3|Part 1|Lost to Follow-up|0
1490647|NCT00537316|4910211|P2|Part 1|Lost to Follow-up|0
1490648|NCT00537316|4910212|P1|Part 1|Lost to Follow-up|1
1490649|NCT00537316|4910206|P7|Part 1|Protocol defined clinical event|0
1490650|NCT00537316|4910207|P6|Part 1|Protocol defined clinical event|0
1490651|NCT00537316|4910208|P5|Part 1|Protocol defined clinical event|0
1490652|NCT00537316|4910209|P4|Part 1|Protocol defined clinical event|0
1490653|NCT00537316|4910210|P3|Part 1|Protocol defined clinical event|0
1490654|NCT00537316|4910211|P2|Part 1|Protocol defined clinical event|0
1490655|NCT00537316|4910212|P1|Part 1|Protocol defined clinical event|1
1490656|NCT00537316|4910206|P7|Part 1|Adverse Event|0
1490657|NCT00537316|4910207|P6|Part 1|Adverse Event|0
1490658|NCT00537316|4910208|P5|Part 1|Adverse Event|0
1490659|NCT00537316|4910209|P4|Part 1|Adverse Event|0
1490660|NCT00537316|4910210|P3|Part 1|Adverse Event|8
1490661|NCT00537316|4910211|P2|Part 1|Adverse Event|11
1490662|NCT00537316|4910212|P1|Part 1|Adverse Event|7
1490663|NCT00537303|4910239|P2|Overall Study|Unclassified|7
1490664|NCT00537303|4910240|P1|Overall Study|Unclassified|8
1490665|NCT00537303|4910239|P2|Overall Study|Withdrawal criteria|3
1490666|NCT00537303|4910240|P1|Overall Study|Withdrawal criteria|3
1490667|NCT00537303|4910239|P2|Overall Study|Protocol Violation|4
1490668|NCT00537303|4910240|P1|Overall Study|Protocol Violation|8
1490669|NCT00537303|4910239|P2|Overall Study|Lack of Efficacy|7
1490670|NCT00537303|4910240|P1|Overall Study|Lack of Efficacy|6
1490671|NCT00537303|4910239|P2|Overall Study|Adverse Event|4
1490672|NCT00537303|4910240|P1|Overall Study|Adverse Event|1
1490673|NCT00537277|4910261|P1|Overall Study|Non-compliance with trial procedures|15
1490674|NCT00537277|4910261|P1|Overall Study|Inability to tolerate trial medication|4
1490675|NCT00537277|4910261|P1|Overall Study|Unclassified|4
1490676|NCT00537277|4910261|P1|Overall Study|Protocol Violation|11
1490677|NCT00537277|4910261|P1|Overall Study|Lost to Follow-up|12
1490678|NCT00537277|4910261|P1|Overall Study|Lack of Efficacy|2
1490679|NCT00537277|4910261|P1|Overall Study|Adverse Event|1
1490680|NCT00537238|4910272|P2|Overall Study|Other|52
1490681|NCT00537238|4910273|P1|Overall Study|Other|44
1490682|NCT00537238|4910272|P2|Overall Study|Does not meet entrance criteria|2
1490683|NCT00537238|4910273|P1|Overall Study|Does not meet entrance criteria|0
1490684|NCT00537238|4910272|P2|Overall Study|Protocol Violation|19
1490685|NCT00537238|4910273|P1|Overall Study|Protocol Violation|15
1490686|NCT00537238|4910272|P2|Overall Study|Withdrawal by Subject|47
1490687|NCT00537238|4910273|P1|Overall Study|Withdrawal by Subject|51
1490688|NCT00537238|4910272|P2|Overall Study|Lost to Follow-up|8
1490689|NCT00537238|4910273|P1|Overall Study|Lost to Follow-up|12
1490690|NCT00537238|4910272|P2|Overall Study|Lack of Efficacy|21
1490691|NCT00537238|4910273|P1|Overall Study|Lack of Efficacy|20
1490692|NCT00537238|4910272|P2|Overall Study|Adverse Event|22
1490693|NCT00537238|4910273|P1|Overall Study|Adverse Event|31
1490694|NCT00537238|4910272|P2|Overall Study|Death|2
1490695|NCT00537238|4910273|P1|Overall Study|Death|1
1490696|NCT00537199|4910293|P1|Overall Study|Study Terminated|1
1490697|NCT00537095|4910299|P2|Overall Study|Incorrect enrolment|1
1490698|NCT00537095|4910300|P1|Overall Study|Incorrect enrolment|0
1490699|NCT00537095|4910299|P2|Overall Study|subjective disease progression|1
1490700|NCT00537095|4910300|P1|Overall Study|subjective disease progression|0
1490701|NCT00537095|4910299|P2|Overall Study|Withdrawal by Subject|2
1490702|NCT00537095|4910300|P1|Overall Study|Withdrawal by Subject|2
1490703|NCT00537095|4910299|P2|Overall Study|Death|1
1490704|NCT00537095|4910300|P1|Overall Study|Death|3
1490705|NCT00537095|4910299|P2|Overall Study|disease progression|48
1490706|NCT00537095|4910300|P1|Overall Study|disease progression|21
1490707|NCT00537095|4910299|P2|Overall Study|Adverse Event|4
1490708|NCT00537095|4910300|P1|Overall Study|Adverse Event|24
1490709|NCT00537095|4910299|P2|Overall Study|surgery|0
1490710|NCT00537095|4910300|P1|Overall Study|surgery|1
1490711|NCT00537082|4910315|P3|Overall Study|Discontinued before initiating treatment|0
1490712|NCT00537082|4910316|P2|Overall Study|Discontinued before initiating treatment|0
1490713|NCT00537082|4910317|P1|Overall Study|Discontinued before initiating treatment|3
1490714|NCT00537082|4910315|P3|Overall Study|Withdrawal by Subject|0
1490715|NCT00537082|4910316|P2|Overall Study|Withdrawal by Subject|1
1490716|NCT00537082|4910317|P1|Overall Study|Withdrawal by Subject|0
1490717|NCT00537082|4910315|P3|Overall Study|Lack of Efficacy|2
1490718|NCT00537082|4910316|P2|Overall Study|Lack of Efficacy|0
1490719|NCT00537082|4910317|P1|Overall Study|Lack of Efficacy|0
1490720|NCT00537082|4910315|P3|Overall Study|Protocol Violation|1
1490721|NCT00537082|4910316|P2|Overall Study|Protocol Violation|2
1490722|NCT00537082|4910317|P1|Overall Study|Protocol Violation|0
1490723|NCT00537082|4910315|P3|Overall Study|Adverse Event|3
1490724|NCT00537082|4910316|P2|Overall Study|Adverse Event|6
1490725|NCT00537082|4910317|P1|Overall Study|Adverse Event|6
1490726|NCT00537056|4910334|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
1490727|NCT00537030|4910346|P1|Overall Study|Inevaluable|3
1490728|NCT00537030|4910346|P1|Overall Study|Confirm patient ineligibility|1
1490729|NCT00537030|4910346|P1|Overall Study|Disease progression or relapse during ac|1
1490730|NCT00537030|4910346|P1|Overall Study|Greater then or equal to a Grade 2 aller|7
1490731|NCT00537030|4910346|P1|Overall Study|Withdrawal by Subject|2
1490732|NCT00537030|4910346|P1|Overall Study|Physician Decision|2
1490733|NCT00537017|4910350|P1|Follow-up Phase|Withdrawal by Subject|9
1490734|NCT00537017|4910350|P1|Treatment Phase|Protocol Violation|2
1490735|NCT00537017|4910350|P1|Treatment Phase|Withdrawal by Subject|13
1490736|NCT00537017|4910350|P1|Treatment Phase|Adverse Event|19
1490737|NCT00536991|4910361|P1|Overall Study|patient ineligible|2
1490738|NCT00536991|4910361|P1|Overall Study|Physician Decision|1
1490739|NCT00536991|4910361|P1|Overall Study|Withdrawal by Subject|10
1490740|NCT00536978|4910368|P1|Overall Study|Not eligible for Adback Infusion|22
1490741|NCT00536874|4910397|P1|Overall Study|Withdrawal by Subject|1
1490742|NCT00536874|4910397|P1|Overall Study|Death|2
1490743|NCT00536874|4910397|P1|Overall Study|Adverse Event|1
1490744|NCT00536809|4910407|P1|Phase II|Referred for surgical resection|1
1490745|NCT00536809|4910407|P1|Phase II|Adverse Event|1
1490746|NCT00536744|4910430|P2|Overall Study|PI tried alternative treatment|3
1490747|NCT00536744|4910431|P1|Overall Study|PI tried alternative treatment|1
1490748|NCT00536744|4910430|P2|Overall Study|Withdrawal by Subject|8
1490749|NCT00536744|4910431|P1|Overall Study|Withdrawal by Subject|7
1490750|NCT00536744|4910430|P2|Overall Study|Lost to Follow-up|5
1490751|NCT00536744|4910431|P1|Overall Study|Lost to Follow-up|3
1490752|NCT00536744|4910430|P2|Overall Study|Physician Decision|1
1490753|NCT00536744|4910431|P1|Overall Study|Physician Decision|3
1490754|NCT00536744|4910430|P2|Overall Study|Death|1
1490755|NCT00536744|4910431|P1|Overall Study|Death|2
1490756|NCT00536744|4910430|P2|Overall Study|Adverse Event|10
1490757|NCT00536744|4910431|P1|Overall Study|Adverse Event|13
1490758|NCT00536731|4910440|P3|Overall Study|Other|0
1490759|NCT00536731|4910441|P2|Overall Study|Other|1
1490760|NCT00536731|4910442|P1|Overall Study|Other|1
1490761|NCT00536731|4910440|P3|Overall Study|Safety reasons|1
1490762|NCT00536731|4910441|P2|Overall Study|Safety reasons|0
1490763|NCT00536731|4910442|P1|Overall Study|Safety reasons|0
1490764|NCT00536731|4910440|P3|Overall Study|Intake of prohibited conc. medication|1
1490765|NCT00536731|4910441|P2|Overall Study|Intake of prohibited conc. medication|0
1490766|NCT00536731|4910442|P1|Overall Study|Intake of prohibited conc. medication|0
1490767|NCT00536731|4910440|P3|Overall Study|Withdrawal by Subject|0
1490768|NCT00536731|4910441|P2|Overall Study|Withdrawal by Subject|2
1490769|NCT00536731|4910442|P1|Overall Study|Withdrawal by Subject|0
1490770|NCT00536731|4910440|P3|Overall Study|Adverse Event|3
1490771|NCT00536731|4910441|P2|Overall Study|Adverse Event|2
1490772|NCT00536731|4910442|P1|Overall Study|Adverse Event|3
1490773|NCT00536575|4910486|P1|Overall Study|Death|1
1490774|NCT00536575|4910486|P1|Overall Study|Withdrawal by Subject|1
1490775|NCT00536510|4910492|P2|Overall Study|Patient Discontinued for Other Reasons|2
1490776|NCT00536510|4910493|P1|Overall Study|Patient Discontinued for Other Reasons|2
1490777|NCT00536510|4910492|P2|Overall Study|Laboratory Adverse Event|1
1490778|NCT00536510|4910493|P1|Overall Study|Laboratory Adverse Event|2
1490779|NCT00536510|4910492|P2|Overall Study|Flushing with Product|0
1490780|NCT00536510|4910493|P1|Overall Study|Flushing with Product|20
1490781|NCT00536510|4910492|P2|Overall Study|Withdrawal by Subject|9
1490782|NCT00536510|4910493|P1|Overall Study|Withdrawal by Subject|16
1490783|NCT00536510|4910492|P2|Overall Study|Protocol Violation|5
1490784|NCT00536510|4910493|P1|Overall Study|Protocol Violation|4
1490785|NCT00536510|4910492|P2|Overall Study|Lost to Follow-up|8
1490786|NCT00536510|4910493|P1|Overall Study|Lost to Follow-up|11
1490787|NCT00536510|4910492|P2|Overall Study|Adverse Event|4
1490788|NCT00536510|4910493|P1|Overall Study|Adverse Event|27
1490789|NCT00536484|4910503|P2|Overall Study|Other|0
1490790|NCT00536484|4910504|P1|Overall Study|Other|4
1490791|NCT00536484|4910503|P2|Overall Study|Lack of Efficacy|5
1490792|NCT00536484|4910504|P1|Overall Study|Lack of Efficacy|16
1490793|NCT00536484|4910503|P2|Overall Study|Lost to Follow-up|6
1490794|NCT00536484|4910504|P1|Overall Study|Lost to Follow-up|8
1490795|NCT00536484|4910503|P2|Overall Study|Withdrawal by Subject|11
1490796|NCT00536484|4910504|P1|Overall Study|Withdrawal by Subject|11
1490797|NCT00536484|4910503|P2|Overall Study|Adverse Event|34
1490798|NCT00536484|4910504|P1|Overall Study|Adverse Event|21
1490799|NCT00536471|4910538|P4|Overall Study|Sponsor Decision|2
1490800|NCT00536471|4910539|P3|Overall Study|Sponsor Decision|3
1490801|NCT00536471|4910540|P2|Overall Study|Sponsor Decision|1
1490802|NCT00536471|4910541|P1|Overall Study|Sponsor Decision|0
1490803|NCT00536471|4910538|P4|Overall Study|Death|2
1490804|NCT00536471|4910539|P3|Overall Study|Death|1
1490805|NCT00536471|4910540|P2|Overall Study|Death|0
1490806|NCT00536471|4910541|P1|Overall Study|Death|0
1490807|NCT00536471|4910538|P4|Overall Study|Physician Decision|2
1490808|NCT00536471|4910539|P3|Overall Study|Physician Decision|3
1490809|NCT00536471|4910540|P2|Overall Study|Physician Decision|1
1490810|NCT00536471|4910541|P1|Overall Study|Physician Decision|11
1490811|NCT00536471|4910538|P4|Overall Study|Protocol Violation|3
1490812|NCT00536471|4910539|P3|Overall Study|Protocol Violation|2
1490813|NCT00536471|4910540|P2|Overall Study|Protocol Violation|1
1490814|NCT00536471|4910541|P1|Overall Study|Protocol Violation|8
1490815|NCT00536471|4910538|P4|Overall Study|Lack of Efficacy|9
1490816|NCT00536471|4910539|P3|Overall Study|Lack of Efficacy|11
1490817|NCT00536471|4910540|P2|Overall Study|Lack of Efficacy|18
1490818|NCT00536471|4910541|P1|Overall Study|Lack of Efficacy|17
1490819|NCT00536471|4910538|P4|Overall Study|Withdrawal by Subject|21
1490820|NCT00536471|4910539|P3|Overall Study|Withdrawal by Subject|43
1490821|NCT00536471|4910540|P2|Overall Study|Withdrawal by Subject|24
1490822|NCT00536471|4910541|P1|Overall Study|Withdrawal by Subject|40
1490823|NCT00536471|4910538|P4|Overall Study|Adverse Event|13
1490824|NCT00536471|4910539|P3|Overall Study|Adverse Event|28
1490825|NCT00536471|4910540|P2|Overall Study|Adverse Event|16
1490826|NCT00536471|4910541|P1|Overall Study|Adverse Event|32
1490827|NCT00536471|4910538|P4|Overall Study|Lost to Follow-up|22
1490828|NCT00536471|4910539|P3|Overall Study|Lost to Follow-up|48
1490829|NCT00536471|4910540|P2|Overall Study|Lost to Follow-up|23
1490830|NCT00536471|4910541|P1|Overall Study|Lost to Follow-up|48
1490831|NCT00536380|4910786|P3|Overall Study|Administrative|1
1490832|NCT00536380|4910787|P2|Overall Study|Administrative|0
1490833|NCT00536380|4910788|P1|Overall Study|Administrative|0
1490834|NCT00536380|4910786|P3|Overall Study|Did not meet protocol eligibility|1
1490835|NCT00536380|4910787|P2|Overall Study|Did not meet protocol eligibility|0
1490836|NCT00536380|4910788|P1|Overall Study|Did not meet protocol eligibility|0
1490837|NCT00536380|4910786|P3|Overall Study|Noncompliance with protocol|2
1490838|NCT00536380|4910787|P2|Overall Study|Noncompliance with protocol|2
1490839|NCT00536380|4910788|P1|Overall Study|Noncompliance with protocol|3
1490840|NCT00536380|4910786|P3|Overall Study|Withdrawal related to study drug|2
1490841|NCT00536380|4910787|P2|Overall Study|Withdrawal related to study drug|5
1490842|NCT00536380|4910788|P1|Overall Study|Withdrawal related to study drug|7
1490843|NCT00536380|4910786|P3|Overall Study|Withdrawal unrelated to study drug|1
1490844|NCT00536380|4910787|P2|Overall Study|Withdrawal unrelated to study drug|0
1490845|NCT00536380|4910788|P1|Overall Study|Withdrawal unrelated to study drug|2
1490846|NCT00536380|4910786|P3|Overall Study|Lost to Follow-up|1
1490847|NCT00536380|4910787|P2|Overall Study|Lost to Follow-up|0
1490848|NCT00536380|4910788|P1|Overall Study|Lost to Follow-up|0
1490849|NCT00536380|4910786|P3|Overall Study|Adverse Event|2
1490850|NCT00536380|4910787|P2|Overall Study|Adverse Event|2
1490851|NCT00536380|4910788|P1|Overall Study|Adverse Event|0
1490852|NCT00536263|4910812|P3|Overall Study|Did not meet protocol eligibility|2
1490853|NCT00536263|4910813|P2|Overall Study|Did not meet protocol eligibility|2
1490854|NCT00536263|4910814|P1|Overall Study|Did not meet protocol eligibility|1
1490855|NCT00536263|4910812|P3|Overall Study|Noncompliance with protocol|1
1490856|NCT00536263|4910813|P2|Overall Study|Noncompliance with protocol|0
1490857|NCT00536263|4910814|P1|Overall Study|Noncompliance with protocol|0
1490858|NCT00536263|4910812|P3|Overall Study|Subject withdrew - treatment related|2
1490859|NCT00536263|4910813|P2|Overall Study|Subject withdrew - treatment related|3
1490860|NCT00536263|4910814|P1|Overall Study|Subject withdrew - treatment related|0
1490861|NCT00536263|4910812|P3|Overall Study|Subject withdrew - not treatment related|5
1490862|NCT00536263|4910813|P2|Overall Study|Subject withdrew - not treatment related|0
1490863|NCT00536263|4910814|P1|Overall Study|Subject withdrew - not treatment related|2
1490864|NCT00536263|4910812|P3|Overall Study|Lost to Follow-up|4
1490865|NCT00536263|4910813|P2|Overall Study|Lost to Follow-up|4
1490866|NCT00536263|4910814|P1|Overall Study|Lost to Follow-up|3
1490867|NCT00536263|4910812|P3|Overall Study|Adverse Event|7
1490868|NCT00536263|4910813|P2|Overall Study|Adverse Event|5
1490869|NCT00536263|4910814|P1|Overall Study|Adverse Event|5
1490870|NCT00536198|4910854|P2|Overall Study|Protocol Violation|1
1490871|NCT00536198|4910855|P1|Overall Study|Protocol Violation|0
1490872|NCT00536198|4910854|P2|Overall Study|Pregnancy|1
1490873|NCT00536198|4910855|P1|Overall Study|Pregnancy|1
1490874|NCT00536198|4910854|P2|Overall Study|Rescue|9
1490875|NCT00536198|4910855|P1|Overall Study|Rescue|3
1490876|NCT00536198|4910854|P2|Overall Study|Adverse Event|2
1490877|NCT00536198|4910855|P1|Overall Study|Adverse Event|2
1490878|NCT00536198|4910854|P2|Overall Study|Withdrawal by Subject|12
1490879|NCT00536198|4910855|P1|Overall Study|Withdrawal by Subject|16
1490880|NCT00536198|4910854|P2|Overall Study|Lost to Follow-up|14
1490881|NCT00536198|4910855|P1|Overall Study|Lost to Follow-up|15
1490882|NCT00536120|4910894|P2|Overall Study|Missed Study Visit|1
1490883|NCT00536120|4910895|P1|Overall Study|Missed Study Visit|0
1490884|NCT00536120|4910894|P2|Overall Study|Steroid Use|2
1490885|NCT00536120|4910895|P1|Overall Study|Steroid Use|0
1490886|NCT00536120|4910894|P2|Overall Study|Sponsor Decision Due to Lab Values|0
1490887|NCT00536120|4910895|P1|Overall Study|Sponsor Decision Due to Lab Values|1
1490888|NCT00536120|4910894|P2|Overall Study|Non-compliance|0
1490889|NCT00536120|4910895|P1|Overall Study|Non-compliance|1
1490890|NCT00536120|4910894|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
1490891|NCT00536120|4910895|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
1490892|NCT00536120|4910894|P2|Overall Study|Lost to Follow-up|0
1490893|NCT00536120|4910895|P1|Overall Study|Lost to Follow-up|1
1490894|NCT00536107|4910909|P2|Overall Study|Study Termination|4
1490895|NCT00536107|4910910|P1|Overall Study|Study Termination|2
1490896|NCT00536107|4910909|P2|Overall Study|Withdrawal by Subject|1
1490897|NCT00536107|4910910|P1|Overall Study|Withdrawal by Subject|0
1490898|NCT00536107|4910909|P2|Overall Study|Incorrect enrolment|0
1490899|NCT00536107|4910910|P1|Overall Study|Incorrect enrolment|1
1490900|NCT00536107|4910909|P2|Overall Study|Death|1
1490901|NCT00536107|4910910|P1|Overall Study|Death|5
1490902|NCT00535847|4910964|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
1490903|NCT00535847|4910965|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
1490904|NCT00535847|4910966|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
1490905|NCT00535847|4910964|P3|Overall Study|Non compliance|0
1490906|NCT00535847|4910965|P2|Overall Study|Non compliance|1
1490907|NCT00535847|4910966|P1|Overall Study|Non compliance|1
1490908|NCT00535847|4910964|P3|Overall Study|Adverse Event|2
1490909|NCT00535847|4910965|P2|Overall Study|Adverse Event|3
1490910|NCT00535847|4910966|P1|Overall Study|Adverse Event|5
1490911|NCT00535730|4911032|P2|Overall Study|Withdrawal by Subject|4
1490912|NCT00535730|4911033|P1|Overall Study|Withdrawal by Subject|0
1490913|NCT00535730|4911032|P2|Overall Study|Protocol Violation|0
1490914|NCT00535730|4911033|P1|Overall Study|Protocol Violation|1
1490915|NCT00535730|4911032|P2|Overall Study|Physician Decision|1
1490916|NCT00535730|4911033|P1|Overall Study|Physician Decision|0
1490917|NCT00535730|4911032|P2|Overall Study|Lost to Follow-up|1
1490918|NCT00535730|4911033|P1|Overall Study|Lost to Follow-up|0
1490919|NCT00535730|4911032|P2|Overall Study|Adverse Event|1
1490920|NCT00535730|4911033|P1|Overall Study|Adverse Event|1
1490921|NCT00535626|4911054|P1|Overall Study|Unable to return|2
1490922|NCT00535626|4911054|P1|Overall Study|Subject terminated|31
1490923|NCT00535626|4911054|P1|Overall Study|Removal/revision of study component|8
1490924|NCT00535626|4911054|P1|Overall Study|Withdrawal by Subject|20
1490925|NCT00535626|4911054|P1|Overall Study|Lost to Follow-up|29
1490926|NCT00535626|4911054|P1|Overall Study|Death|15
1490927|NCT00535496|4911081|P4|Overall Study|Not treated with sugammadex|0
1490928|NCT00535496|4911082|P3|Overall Study|Not treated with sugammadex|0
1490929|NCT00535496|4911083|P2|Overall Study|Not treated with sugammadex|1
1490930|NCT00535496|4911084|P1|Overall Study|Not treated with sugammadex|0
1490931|NCT00535496|4911081|P4|Overall Study|Lost to Follow-up|0
1490932|NCT00535496|4911082|P3|Overall Study|Lost to Follow-up|0
1490933|NCT00535496|4911083|P2|Overall Study|Lost to Follow-up|1
1490934|NCT00535496|4911084|P1|Overall Study|Lost to Follow-up|0
1490935|NCT00535405|4911104|P5|Overall Study|Withdrawal by Subject|8
1490936|NCT00535405|4911105|P4|Overall Study|Withdrawal by Subject|10
1490937|NCT00535405|4911106|P3|Overall Study|Withdrawal by Subject|10
1490938|NCT00535405|4911107|P2|Overall Study|Withdrawal by Subject|11
1490939|NCT00535405|4911108|P1|Overall Study|Withdrawal by Subject|5
1490940|NCT00535405|4911104|P5|Overall Study|Protocol Violation|0
1490941|NCT00535405|4911105|P4|Overall Study|Protocol Violation|1
1490942|NCT00535405|4911106|P3|Overall Study|Protocol Violation|2
1490943|NCT00535405|4911107|P2|Overall Study|Protocol Violation|2
1490944|NCT00535405|4911108|P1|Overall Study|Protocol Violation|2
1490945|NCT00535405|4911104|P5|Overall Study|Physician Decision|1
1490946|NCT00535405|4911105|P4|Overall Study|Physician Decision|1
1490947|NCT00535405|4911106|P3|Overall Study|Physician Decision|0
1490948|NCT00535405|4911107|P2|Overall Study|Physician Decision|2
1490949|NCT00535405|4911108|P1|Overall Study|Physician Decision|3
1490950|NCT00535405|4911104|P5|Overall Study|Lost to Follow-up|1
1490951|NCT00535405|4911105|P4|Overall Study|Lost to Follow-up|2
1490952|NCT00535405|4911106|P3|Overall Study|Lost to Follow-up|3
1490953|NCT00535405|4911107|P2|Overall Study|Lost to Follow-up|3
1490954|NCT00535405|4911108|P1|Overall Study|Lost to Follow-up|1
1490955|NCT00535405|4911104|P5|Overall Study|Adverse Event|6
1490956|NCT00535405|4911105|P4|Overall Study|Adverse Event|8
1490957|NCT00535405|4911106|P3|Overall Study|Adverse Event|3
1490958|NCT00535405|4911107|P2|Overall Study|Adverse Event|8
1490959|NCT00535405|4911108|P1|Overall Study|Adverse Event|6
1490960|NCT00535288|4911169|P5|Overall Study|Not specified|1
1490961|NCT00535288|4911170|P4|Overall Study|Not specified|2
1490962|NCT00535288|4911171|P3|Overall Study|Not specified|1
1490963|NCT00535288|4911172|P2|Overall Study|Not specified|1
1490964|NCT00535288|4911173|P1|Overall Study|Not specified|2
1490965|NCT00535288|4911169|P5|Overall Study|Unwilling to cooperate|4
1490966|NCT00535288|4911170|P4|Overall Study|Unwilling to cooperate|3
1490967|NCT00535288|4911171|P3|Overall Study|Unwilling to cooperate|3
1490968|NCT00535288|4911172|P2|Overall Study|Unwilling to cooperate|6
1490969|NCT00535288|4911173|P1|Overall Study|Unwilling to cooperate|6
1490970|NCT00535288|4911169|P5|Overall Study|Lack of Efficacy|7
1490971|NCT00535288|4911170|P4|Overall Study|Lack of Efficacy|4
1490972|NCT00535288|4911171|P3|Overall Study|Lack of Efficacy|4
1490973|NCT00535288|4911172|P2|Overall Study|Lack of Efficacy|3
1490974|NCT00535288|4911173|P1|Overall Study|Lack of Efficacy|26
1490975|NCT00535288|4911169|P5|Overall Study|Lost to Follow-up|0
1490976|NCT00535288|4911170|P4|Overall Study|Lost to Follow-up|0
1490977|NCT00535288|4911171|P3|Overall Study|Lost to Follow-up|0
1490978|NCT00535288|4911172|P2|Overall Study|Lost to Follow-up|3
1490979|NCT00535288|4911173|P1|Overall Study|Lost to Follow-up|0
1490980|NCT00535288|4911169|P5|Overall Study|Adverse Event|30
1490981|NCT00535288|4911170|P4|Overall Study|Adverse Event|20
1490982|NCT00535288|4911171|P3|Overall Study|Adverse Event|25
1490983|NCT00535288|4911172|P2|Overall Study|Adverse Event|19
1490984|NCT00535288|4911173|P1|Overall Study|Adverse Event|20
1490985|NCT00535262|4911250|P1|Overall Study|No funding|3
1490986|NCT00535223|4911256|P2|Overall Study|Withdrawal by Subject|1
1490987|NCT00535223|4911257|P1|Overall Study|Withdrawal by Subject|4
1490988|NCT00535145|4911265|P1|Phase II|Subject non-compliance|2
1490989|NCT00535145|4911265|P1|Phase II|Withdrawal by Subject|5
1490990|NCT00535145|4911265|P1|Phase II|Lost to Follow-up|5
1490991|NCT00535145|4911265|P1|Phase II|Lack of Efficacy|1
1490992|NCT00535145|4911265|P1|Phase II|Adverse Event|2
1490993|NCT00535145|4911265|P1|Phase I|(diagnosis)|3
1490994|NCT00535145|4911265|P1|Phase I|(PI decision)|1
1490995|NCT00535145|4911265|P1|Phase I|(protocol violation)|1
1490996|NCT00535145|4911265|P1|Phase I|(eligibility)|8
1490997|NCT00535145|4911265|P1|Phase I|Withdrawal by Subject|6
1490998|NCT00535145|4911265|P1|Phase I|Lost to Follow-up|7
1490999|NCT00535145|4911265|P1|Phase I|Adverse Event|3
1491000|NCT00535132|4911277|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
1491001|NCT00535132|4911278|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
1491002|NCT00535132|4911277|P2|Safety Analysis Set|Did Not Receive Study Medication|2
1491003|NCT00535132|4911278|P1|Safety Analysis Set|Did Not Receive Study Medication|2
1491004|NCT00534976|4911359|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
1491005|NCT00534976|4911360|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
1491006|NCT00534976|4911359|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
1491007|NCT00534976|4911360|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
1491008|NCT00534976|4911359|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
1491009|NCT00534976|4911360|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
1491010|NCT00534638|4911421|P2|Overall Study|Refused participation to study|883
1491011|NCT00534638|4911422|P1|Overall Study|Refused participation to study|1665
1491012|NCT00534638|4911421|P2|Overall Study|Rejected origin of signature|2
1491013|NCT00534638|4911422|P1|Overall Study|Rejected origin of signature|0
1491014|NCT00534638|4911421|P2|Overall Study|Received without ICF|1
1491015|NCT00534638|4911422|P1|Overall Study|Received without ICF|0
1491016|NCT00534638|4911421|P2|Overall Study|Subject unable to read|1
1491017|NCT00534638|4911422|P1|Overall Study|Subject unable to read|0
1491018|NCT00534638|4911421|P2|Overall Study|ICF not returned|1
1491019|NCT00534638|4911422|P1|Overall Study|ICF not returned|0
1491020|NCT00534638|4911421|P2|Overall Study|Mentally disabled|0
1491021|NCT00534638|4911422|P1|Overall Study|Mentally disabled|1
1491022|NCT00534638|4911421|P2|Overall Study|Death|5
1491023|NCT00534638|4911422|P1|Overall Study|Death|5
1491024|NCT00534638|4911421|P2|Overall Study|Pregnancy|4
1491025|NCT00534638|4911422|P1|Overall Study|Pregnancy|6
1491026|NCT00534638|4911421|P2|Overall Study|Blinded treatment broken|0
1491027|NCT00534638|4911422|P1|Overall Study|Blinded treatment broken|2
1491028|NCT00534638|4911421|P2|Overall Study|Urticaria|0
1491029|NCT00534638|4911422|P1|Overall Study|Urticaria|1
1491030|NCT00534638|4911421|P2|Overall Study|Already received HPV vaccine|1
1491031|NCT00534638|4911422|P1|Overall Study|Already received HPV vaccine|0
1491032|NCT00534638|4911421|P2|Overall Study|Lost to Follow-up|10875
1491033|NCT00534638|4911422|P1|Overall Study|Lost to Follow-up|4793
1491034|NCT00534638|4911421|P2|Overall Study|Migrated/moved from study area|13
1491035|NCT00534638|4911422|P1|Overall Study|Migrated/moved from study area|14
1491036|NCT00534638|4911421|P2|Overall Study|Withdrawal by Subject|5
1491037|NCT00534638|4911422|P1|Overall Study|Withdrawal by Subject|4
1491038|NCT00534599|4911457|P2|Overall Study|Other|0
1491039|NCT00534599|4911458|P1|Overall Study|Other|7
1491040|NCT00534599|4911457|P2|Overall Study|Withdrawal by Subject|6
1491041|NCT00534599|4911458|P1|Overall Study|Withdrawal by Subject|4
1491042|NCT00534599|4911457|P2|Overall Study|Lost to Follow-up|14
1491043|NCT00534599|4911458|P1|Overall Study|Lost to Follow-up|11
1491044|NCT00534599|4911457|P2|Overall Study|Protocol Violation|3
1491045|NCT00534599|4911458|P1|Overall Study|Protocol Violation|1
1491046|NCT00534599|4911457|P2|Overall Study|Generalized anxiety disorder worsened|1
1491047|NCT00534599|4911458|P1|Overall Study|Generalized anxiety disorder worsened|0
1491048|NCT00534599|4911457|P2|Overall Study|Lack of Efficacy|1
1491049|NCT00534599|4911458|P1|Overall Study|Lack of Efficacy|0
1491050|NCT00534599|4911457|P2|Overall Study|Developed study-specific d/c criteria|0
1491051|NCT00534599|4911458|P1|Overall Study|Developed study-specific d/c criteria|5
1491052|NCT00534599|4911457|P2|Overall Study|Mis-randomization|2
1491053|NCT00534599|4911458|P1|Overall Study|Mis-randomization|2
1491054|NCT00534599|4911457|P2|Overall Study|Incorrect enrollment|1
1491055|NCT00534599|4911458|P1|Overall Study|Incorrect enrollment|2
1491056|NCT00534599|4911457|P2|Overall Study|Adverse Event|4
1491057|NCT00534599|4911458|P1|Overall Study|Adverse Event|25
1491058|NCT00534495|4911494|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
1491059|NCT00534495|4911495|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
1491060|NCT00534495|4911496|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
1491061|NCT00534495|4911494|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
1491062|NCT00534495|4911495|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
1491063|NCT00534495|4911496|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
1491064|NCT00534495|4911494|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
1491065|NCT00534495|4911495|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
1491066|NCT00534495|4911496|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
1491067|NCT00534495|4911494|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
1491068|NCT00534495|4911495|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
1491069|NCT00534495|4911496|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
1491070|NCT00534495|4911494|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
1491071|NCT00534495|4911495|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
1491072|NCT00534495|4911496|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
1491073|NCT00534495|4911494|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
1491074|NCT00534495|4911495|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
1491075|NCT00534495|4911496|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
1491076|NCT00534495|4911494|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
1491077|NCT00534495|4911495|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
1491078|NCT00534495|4911496|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
1491079|NCT00534495|4911494|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
1491080|NCT00534495|4911495|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
1491081|NCT00534495|4911496|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
1491082|NCT00534495|4911494|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
1491083|NCT00534495|4911495|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
1491084|NCT00534495|4911496|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
1491085|NCT00534404|4911534|P3|Overall Study|Lost to Follow-up|201
1491086|NCT00534404|4911535|P2|Overall Study|Lost to Follow-up|138
1491087|NCT00534404|4911536|P1|Overall Study|Lost to Follow-up|170
1491088|NCT00534404|4911534|P3|Overall Study|Removed by study staff|1
1491089|NCT00534404|4911535|P2|Overall Study|Removed by study staff|3
1491090|NCT00534404|4911536|P1|Overall Study|Removed by study staff|2
1491091|NCT00534404|4911534|P3|Overall Study|Withdrawal by Subject|38
1491092|NCT00534404|4911535|P2|Overall Study|Withdrawal by Subject|2
1491093|NCT00534404|4911536|P1|Overall Study|Withdrawal by Subject|8
1491094|NCT00534404|4911534|P3|Overall Study|Death|2
1491095|NCT00534404|4911535|P2|Overall Study|Death|0
1491096|NCT00534404|4911536|P1|Overall Study|Death|0
1491097|NCT00534352|4911567|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
1491098|NCT00534352|4911567|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
1491099|NCT00534352|4911567|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
1491100|NCT00534352|4911567|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
1491101|NCT00534352|4911567|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
1491102|NCT00534352|4911567|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
1491103|NCT00534313|4911611|P4|Long-term Period|Not specified|2
1491104|NCT00534313|4911612|P3|Long-term Period|Not specified|2
1491105|NCT00534313|4911613|P2|Long-term Period|Not specified|2
1491106|NCT00534313|4911614|P1|Long-term Period|Not specified|1
1491107|NCT00534313|4911611|P4|Long-term Period|Administrative reason by sponsor|18
1491108|NCT00534313|4911612|P3|Long-term Period|Administrative reason by sponsor|26
1491109|NCT00534313|4911613|P2|Long-term Period|Administrative reason by sponsor|15
1491110|NCT00534313|4911614|P1|Long-term Period|Administrative reason by sponsor|17
1491111|NCT00534313|4911611|P4|Long-term Period|Poor compliance/noncompliance|0
1491112|NCT00534313|4911612|P3|Long-term Period|Poor compliance/noncompliance|1
1491113|NCT00534313|4911613|P2|Long-term Period|Poor compliance/noncompliance|1
1491114|NCT00534313|4911614|P1|Long-term Period|Poor compliance/noncompliance|0
1491115|NCT00534313|4911611|P4|Long-term Period|No longer meets study criteria|0
1491116|NCT00534313|4911612|P3|Long-term Period|No longer meets study criteria|0
1491117|NCT00534313|4911613|P2|Long-term Period|No longer meets study criteria|1
1491118|NCT00534313|4911614|P1|Long-term Period|No longer meets study criteria|0
1491119|NCT00534313|4911611|P4|Long-term Period|Withdrawal by Subject|0
1491120|NCT00534313|4911612|P3|Long-term Period|Withdrawal by Subject|0
1491121|NCT00534313|4911613|P2|Long-term Period|Withdrawal by Subject|2
1491122|NCT00534313|4911614|P1|Long-term Period|Withdrawal by Subject|2
1491123|NCT00534313|4911611|P4|Long-term Period|Lost to Follow-up|0
1491124|NCT00534313|4911612|P3|Long-term Period|Lost to Follow-up|0
1491125|NCT00534313|4911613|P2|Long-term Period|Lost to Follow-up|2
1491126|NCT00534313|4911614|P1|Long-term Period|Lost to Follow-up|1
1491127|NCT00534313|4911611|P4|Long-term Period|Lack of Efficacy|12
1491128|NCT00534313|4911612|P3|Long-term Period|Lack of Efficacy|14
1491129|NCT00534313|4911613|P2|Long-term Period|Lack of Efficacy|10
1491130|NCT00534313|4911614|P1|Long-term Period|Lack of Efficacy|14
1491131|NCT00534313|4911611|P4|Long-term Period|Adverse Event|1
1491132|NCT00534313|4911612|P3|Long-term Period|Adverse Event|0
1491133|NCT00534313|4911613|P2|Long-term Period|Adverse Event|1
1491134|NCT00534313|4911614|P1|Long-term Period|Adverse Event|2
1491135|NCT00534313|4911611|P4|Short-term Period|Pregnancy|0
1491136|NCT00534313|4911612|P3|Short-term Period|Pregnancy|1
1491137|NCT00534313|4911613|P2|Short-term Period|Pregnancy|0
1491138|NCT00534313|4911614|P1|Short-term Period|Pregnancy|0
1491139|NCT00534313|4911611|P4|Short-term Period|Participant withdrew consent|2
1491140|NCT00534313|4911612|P3|Short-term Period|Participant withdrew consent|0
1491141|NCT00534313|4911613|P2|Short-term Period|Participant withdrew consent|0
1491142|NCT00534313|4911614|P1|Short-term Period|Participant withdrew consent|2
1491143|NCT00534313|4911611|P4|Short-term Period|Participant not meeting study criteria|1
1491144|NCT00534313|4911612|P3|Short-term Period|Participant not meeting study criteria|0
1491145|NCT00534313|4911613|P2|Short-term Period|Participant not meeting study criteria|0
1491146|NCT00534313|4911614|P1|Short-term Period|Participant not meeting study criteria|0
1491147|NCT00534313|4911611|P4|Short-term Period|Lack of Efficacy|3
1491148|NCT00534313|4911612|P3|Short-term Period|Lack of Efficacy|0
1491149|NCT00534313|4911613|P2|Short-term Period|Lack of Efficacy|4
1491150|NCT00534313|4911614|P1|Short-term Period|Lack of Efficacy|3
1491151|NCT00534313|4911611|P4|Short-term Period|Adverse Event|3
1491152|NCT00534313|4911612|P3|Short-term Period|Adverse Event|1
1491153|NCT00534313|4911613|P2|Short-term Period|Adverse Event|2
1491154|NCT00534313|4911614|P1|Short-term Period|Adverse Event|1
1491155|NCT00534248|4911709|P2|Overall Study|Withdrawal by Subject|255
1491156|NCT00534248|4911710|P1|Overall Study|Withdrawal by Subject|263
1491157|NCT00534248|4911709|P2|Overall Study|Protocol Violation|4
1491158|NCT00534248|4911710|P1|Overall Study|Protocol Violation|3
1491159|NCT00534248|4911709|P2|Overall Study|Physician Decision|7
1491160|NCT00534248|4911710|P1|Overall Study|Physician Decision|10
1491161|NCT00534248|4911709|P2|Overall Study|Other protocol specified criteria|3
1491162|NCT00534248|4911710|P1|Overall Study|Other protocol specified criteria|13
1491163|NCT00534248|4911709|P2|Overall Study|Lost to Follow-up|375
1491164|NCT00534248|4911710|P1|Overall Study|Lost to Follow-up|353
1491165|NCT00534248|4911709|P2|Overall Study|Adverse Event|29
1491166|NCT00534248|4911710|P1|Overall Study|Adverse Event|19
1491167|NCT00534105|4911740|P2|Overall Study|Lost to Follow-up|39
1491168|NCT00534105|4911741|P1|Overall Study|Lost to Follow-up|23
1491169|NCT00534092|4911755|P2|Overall Study|personal reasons/family concerns|0
1491170|NCT00534092|4911756|P1|Overall Study|personal reasons/family concerns|1
1491171|NCT00534092|4911755|P2|Overall Study|Lost to Follow-up|0
1491172|NCT00534092|4911756|P1|Overall Study|Lost to Follow-up|1
1491173|NCT00533949|4911794|P4|Overall Study|Withdrawal by Subject|1
1491174|NCT00533949|4911795|P3|Overall Study|Withdrawal by Subject|1
1491175|NCT00533949|4911796|P2|Overall Study|Withdrawal by Subject|2
1491176|NCT00533949|4911797|P1|Overall Study|Withdrawal by Subject|3
1491177|NCT00533949|4911794|P4|Overall Study|Protocol Violation|9
1491178|NCT00533949|4911795|P3|Overall Study|Protocol Violation|9
1491179|NCT00533949|4911796|P2|Overall Study|Protocol Violation|12
1491180|NCT00533949|4911797|P1|Overall Study|Protocol Violation|12
1491181|NCT00533897|4911828|P8|Long Term Extension (LTE)|not specified|6
1491182|NCT00533897|4911829|P7|Long Term Extension (LTE)|not specified|1
1491183|NCT00533897|4911830|P6|Long Term Extension (LTE)|not specified|0
1491184|NCT00533897|4911831|P5|Long Term Extension (LTE)|not specified|0
1491185|NCT00533897|4911832|P4|Long Term Extension (LTE)|not specified|0
1491186|NCT00533897|4911833|P3|Long Term Extension (LTE)|not specified|0
1491187|NCT00533897|4911834|P2|Long Term Extension (LTE)|not specified|0
1491188|NCT00533897|4911835|P1|Long Term Extension (LTE)|not specified|0
1491189|NCT00533897|4911828|P8|Long Term Extension (LTE)|Lost to Follow-up|1
1491190|NCT00533897|4911829|P7|Long Term Extension (LTE)|Lost to Follow-up|1
1491191|NCT00533897|4911830|P6|Long Term Extension (LTE)|Lost to Follow-up|0
1491192|NCT00533897|4911831|P5|Long Term Extension (LTE)|Lost to Follow-up|0
1491193|NCT00533897|4911832|P4|Long Term Extension (LTE)|Lost to Follow-up|0
1491194|NCT00533897|4911833|P3|Long Term Extension (LTE)|Lost to Follow-up|0
1491195|NCT00533897|4911834|P2|Long Term Extension (LTE)|Lost to Follow-up|0
1491196|NCT00533897|4911835|P1|Long Term Extension (LTE)|Lost to Follow-up|0
1491197|NCT00533897|4911828|P8|Long Term Extension (LTE)|Pregnancy|2
1491198|NCT00533897|4911829|P7|Long Term Extension (LTE)|Pregnancy|0
1491199|NCT00533897|4911830|P6|Long Term Extension (LTE)|Pregnancy|0
1491200|NCT00533897|4911831|P5|Long Term Extension (LTE)|Pregnancy|0
1491201|NCT00533897|4911832|P4|Long Term Extension (LTE)|Pregnancy|0
1491202|NCT00533897|4911833|P3|Long Term Extension (LTE)|Pregnancy|0
1491203|NCT00533897|4911834|P2|Long Term Extension (LTE)|Pregnancy|0
1491204|NCT00533897|4911835|P1|Long Term Extension (LTE)|Pregnancy|0
1491205|NCT00533897|4911828|P8|Long Term Extension (LTE)|Adverse Event|5
1491206|NCT00533897|4911829|P7|Long Term Extension (LTE)|Adverse Event|2
1491207|NCT00533897|4911830|P6|Long Term Extension (LTE)|Adverse Event|0
1491208|NCT00533897|4911831|P5|Long Term Extension (LTE)|Adverse Event|0
1491209|NCT00533897|4911832|P4|Long Term Extension (LTE)|Adverse Event|0
1491210|NCT00533897|4911833|P3|Long Term Extension (LTE)|Adverse Event|0
1491211|NCT00533897|4911834|P2|Long Term Extension (LTE)|Adverse Event|0
1491212|NCT00533897|4911835|P1|Long Term Extension (LTE)|Adverse Event|0
1491213|NCT00533897|4911828|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
1491214|NCT00533897|4911829|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
1491215|NCT00533897|4911830|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
1491216|NCT00533897|4911831|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
1491217|NCT00533897|4911832|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
1491218|NCT00533897|4911833|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
1491219|NCT00533897|4911834|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
1491220|NCT00533897|4911835|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
1491221|NCT00533897|4911828|P8|Long Term Extension (LTE)|Lack of Efficacy|3
1491222|NCT00533897|4911829|P7|Long Term Extension (LTE)|Lack of Efficacy|5
1491223|NCT00533897|4911830|P6|Long Term Extension (LTE)|Lack of Efficacy|0
1491224|NCT00533897|4911831|P5|Long Term Extension (LTE)|Lack of Efficacy|0
1491225|NCT00533897|4911832|P4|Long Term Extension (LTE)|Lack of Efficacy|0
1491226|NCT00533897|4911833|P3|Long Term Extension (LTE)|Lack of Efficacy|0
1491227|NCT00533897|4911834|P2|Long Term Extension (LTE)|Lack of Efficacy|0
1491228|NCT00533897|4911835|P1|Long Term Extension (LTE)|Lack of Efficacy|0
1491229|NCT00533897|4911828|P8|Long Term Extension (LTE)|Death|3
1491230|NCT00533897|4911829|P7|Long Term Extension (LTE)|Death|1
1491231|NCT00533897|4911830|P6|Long Term Extension (LTE)|Death|0
1491232|NCT00533897|4911831|P5|Long Term Extension (LTE)|Death|0
1491233|NCT00533897|4911832|P4|Long Term Extension (LTE)|Death|0
1491234|NCT00533897|4911833|P3|Long Term Extension (LTE)|Death|0
1491235|NCT00533897|4911834|P2|Long Term Extension (LTE)|Death|0
1491236|NCT00533897|4911835|P1|Long Term Extension (LTE)|Death|0
1491237|NCT00533897|4911828|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
1491238|NCT00533897|4911829|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
1491239|NCT00533897|4911830|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
1491240|NCT00533897|4911831|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
1491241|NCT00533897|4911832|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
1491242|NCT00533897|4911833|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
1491243|NCT00533897|4911834|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
1491244|NCT00533897|4911835|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
1491245|NCT00533897|4911828|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1491246|NCT00533897|4911829|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1491247|NCT00533897|4911830|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
1491248|NCT00533897|4911831|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1491249|NCT00533897|4911832|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1491250|NCT00533897|4911833|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1491251|NCT00533897|4911834|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1491252|NCT00533897|4911835|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1491253|NCT00533897|4911828|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1491254|NCT00533897|4911829|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1491255|NCT00533897|4911830|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
1491256|NCT00533897|4911831|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1491257|NCT00533897|4911832|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1491258|NCT00533897|4911833|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1491259|NCT00533897|4911834|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1491260|NCT00533897|4911835|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1491261|NCT00533897|4911828|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1491262|NCT00533897|4911829|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1491263|NCT00533897|4911830|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1491264|NCT00533897|4911831|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1491265|NCT00533897|4911832|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1491266|NCT00533897|4911833|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
1491267|NCT00533897|4911834|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1491268|NCT00533897|4911835|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1491269|NCT00533897|4911828|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1491270|NCT00533897|4911829|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1491271|NCT00533897|4911830|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1491272|NCT00533897|4911831|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1491273|NCT00533897|4911832|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1491274|NCT00533897|4911833|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
1491275|NCT00533897|4911834|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
1491276|NCT00533897|4911835|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1491277|NCT00533897|4911828|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1491278|NCT00533897|4911829|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1491279|NCT00533897|4911830|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1491280|NCT00533897|4911831|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1491281|NCT00533897|4911832|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1491282|NCT00533897|4911833|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1491283|NCT00533897|4911834|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1491284|NCT00533897|4911835|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
1491285|NCT00533897|4911828|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
1491286|NCT00533897|4911829|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
1491287|NCT00533897|4911830|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
1491288|NCT00533897|4911831|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
1491289|NCT00533897|4911832|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
1491290|NCT00533897|4911833|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
1491291|NCT00533897|4911834|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
1491292|NCT00533897|4911835|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
1491293|NCT00533897|4911828|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1491294|NCT00533897|4911829|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1491295|NCT00533897|4911830|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1491296|NCT00533897|4911831|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1491297|NCT00533897|4911832|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1491298|NCT00533897|4911833|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1491299|NCT00533897|4911834|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1491300|NCT00533897|4911835|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
1491301|NCT00533897|4911828|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
1491302|NCT00533897|4911829|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
1491303|NCT00533897|4911830|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
1491304|NCT00533897|4911831|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
1491305|NCT00533897|4911832|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
1491306|NCT00533897|4911833|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
1491307|NCT00533897|4911834|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
1491308|NCT00533897|4911835|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
1491309|NCT00533897|4911828|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1491310|NCT00533897|4911829|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1491311|NCT00533897|4911830|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1491312|NCT00533897|4911831|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1491313|NCT00533897|4911832|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1491314|NCT00533897|4911833|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1491315|NCT00533897|4911834|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1491316|NCT00533897|4911835|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
1491317|NCT00533897|4911828|P8|Lead-in (LI) Period 1|Adverse Event|0
1491318|NCT00533897|4911829|P7|Lead-in (LI) Period 1|Adverse Event|0
1491319|NCT00533897|4911830|P6|Lead-in (LI) Period 1|Adverse Event|0
1491320|NCT00533897|4911831|P5|Lead-in (LI) Period 1|Adverse Event|0
1491321|NCT00533897|4911832|P4|Lead-in (LI) Period 1|Adverse Event|0
1491322|NCT00533897|4911833|P3|Lead-in (LI) Period 1|Adverse Event|0
1491323|NCT00533897|4911834|P2|Lead-in (LI) Period 1|Adverse Event|0
1491324|NCT00533897|4911835|P1|Lead-in (LI) Period 1|Adverse Event|1
1491325|NCT00533702|4911975|P2|Overall Study|Found ineligible after randomization|1
1491326|NCT00533702|4911976|P1|Overall Study|Found ineligible after randomization|2
1491327|NCT00533702|4911975|P2|Overall Study|Withdrawal by Subject|1
1491328|NCT00533702|4911976|P1|Overall Study|Withdrawal by Subject|3
1491329|NCT00533507|4912007|P1|Overall Study|Withdrawal by Subject|1
1491330|NCT00533273|4912052|P2|Open-label|Withdrawal by Subject|0
1491331|NCT00533273|4912053|P1|Open-label|Withdrawal by Subject|6
1491332|NCT00533273|4912052|P2|Double-blind|Withdrew consent|2
1491333|NCT00533273|4912053|P1|Double-blind|Withdrew consent|0
1491334|NCT00532948|4912102|P3|Overall Study|Failure to return|0
1491335|NCT00532948|4912103|P2|Overall Study|Failure to return|1
1491336|NCT00532948|4912104|P1|Overall Study|Failure to return|0
1491337|NCT00532948|4912102|P3|Overall Study|Violation of selection criteria at entry|0
1491338|NCT00532948|4912103|P2|Overall Study|Violation of selection criteria at entry|1
1491339|NCT00532948|4912104|P1|Overall Study|Violation of selection criteria at entry|0
1491340|NCT00532948|4912102|P3|Overall Study|Death|4
1491341|NCT00532948|4912103|P2|Overall Study|Death|3
1491342|NCT00532948|4912104|P1|Overall Study|Death|3
1491343|NCT00532948|4912102|P3|Overall Study|Protocol Violation|0
1491344|NCT00532948|4912103|P2|Overall Study|Protocol Violation|0
1491345|NCT00532948|4912104|P1|Overall Study|Protocol Violation|1
1491346|NCT00532935|4912136|P2|Overall Study|Protocol Specific Criteria|15
1491347|NCT00532935|4912137|P1|Overall Study|Protocol Specific Criteria|11
1491348|NCT00532935|4912136|P2|Overall Study|Withdrawal by Subject|9
1491349|NCT00532935|4912137|P1|Overall Study|Withdrawal by Subject|10
1491350|NCT00532935|4912136|P2|Overall Study|Protocol Violation|2
1491351|NCT00532935|4912137|P1|Overall Study|Protocol Violation|4
1491352|NCT00532935|4912136|P2|Overall Study|Pregnancy|0
1491353|NCT00532935|4912137|P1|Overall Study|Pregnancy|1
1491354|NCT00532935|4912136|P2|Overall Study|Physician Decision|5
1491355|NCT00532935|4912137|P1|Overall Study|Physician Decision|4
1491356|NCT00532935|4912136|P2|Overall Study|Lost to Follow-up|6
1491357|NCT00532935|4912137|P1|Overall Study|Lost to Follow-up|10
1491358|NCT00532935|4912136|P2|Overall Study|Lack of Efficacy|3
1491359|NCT00532935|4912137|P1|Overall Study|Lack of Efficacy|0
1491360|NCT00532935|4912136|P2|Overall Study|Adverse Event|12
1491361|NCT00532935|4912137|P1|Overall Study|Adverse Event|11
1491362|NCT00532883|4912155|P4|Overall Study|Early Study Termination|4
1491363|NCT00532883|4912156|P3|Overall Study|Early Study Termination|1
1491364|NCT00532883|4912157|P2|Overall Study|Early Study Termination|4
1491365|NCT00532883|4912158|P1|Overall Study|Early Study Termination|4
1491366|NCT00532883|4912155|P4|Overall Study|Subject was Nonadherent|0
1491367|NCT00532883|4912156|P3|Overall Study|Subject was Nonadherent|1
1491368|NCT00532883|4912157|P2|Overall Study|Subject was Nonadherent|1
1491369|NCT00532883|4912158|P1|Overall Study|Subject was Nonadherent|0
1491370|NCT00532883|4912155|P4|Overall Study|Withdrawal by Subject|0
1491371|NCT00532883|4912156|P3|Overall Study|Withdrawal by Subject|1
1491372|NCT00532883|4912157|P2|Overall Study|Withdrawal by Subject|1
1491373|NCT00532883|4912158|P1|Overall Study|Withdrawal by Subject|0
1491374|NCT00532883|4912155|P4|Overall Study|Lost to Follow-up|0
1491375|NCT00532883|4912156|P3|Overall Study|Lost to Follow-up|1
1491376|NCT00532883|4912157|P2|Overall Study|Lost to Follow-up|1
1491377|NCT00532883|4912158|P1|Overall Study|Lost to Follow-up|1
1491378|NCT00532883|4912155|P4|Overall Study|Adverse Event|1
1491379|NCT00532883|4912156|P3|Overall Study|Adverse Event|0
1491380|NCT00532883|4912157|P2|Overall Study|Adverse Event|0
1491381|NCT00532883|4912158|P1|Overall Study|Adverse Event|1
1491382|NCT00532779|4912171|P3|Overall Study|Drug noncompliance, moved, other|29
1491383|NCT00532779|4912172|P2|Overall Study|Drug noncompliance, moved, other|23
1491384|NCT00532779|4912173|P1|Overall Study|Drug noncompliance, moved, other|14
1491385|NCT00532779|4912171|P3|Overall Study|Death|0
1491386|NCT00532779|4912172|P2|Overall Study|Death|1
1491387|NCT00532779|4912173|P1|Overall Study|Death|0
1491388|NCT00532779|4912171|P3|Overall Study|Pregnancy|3
1491389|NCT00532779|4912172|P2|Overall Study|Pregnancy|5
1491390|NCT00532779|4912173|P1|Overall Study|Pregnancy|2
1491391|NCT00532779|4912171|P3|Overall Study|Protocol Violation|7
1491392|NCT00532779|4912172|P2|Overall Study|Protocol Violation|9
1491393|NCT00532779|4912173|P1|Overall Study|Protocol Violation|5
1491394|NCT00532779|4912171|P3|Overall Study|Lack of Efficacy|40
1491395|NCT00532779|4912172|P2|Overall Study|Lack of Efficacy|12
1491396|NCT00532779|4912173|P1|Overall Study|Lack of Efficacy|12
1491397|NCT00532779|4912171|P3|Overall Study|Withdrawal by Subject|90
1491398|NCT00532779|4912172|P2|Overall Study|Withdrawal by Subject|60
1491399|NCT00532779|4912173|P1|Overall Study|Withdrawal by Subject|63
1491400|NCT00532779|4912171|P3|Overall Study|Lost to Follow-up|66
1491401|NCT00532779|4912172|P2|Overall Study|Lost to Follow-up|65
1491402|NCT00532779|4912173|P1|Overall Study|Lost to Follow-up|76
1491403|NCT00532779|4912171|P3|Overall Study|Adverse Event|56
1491404|NCT00532779|4912172|P2|Overall Study|Adverse Event|112
1491405|NCT00532779|4912173|P1|Overall Study|Adverse Event|122
1491406|NCT00532493|4912234|P2|Overall Study|Contraindicative Medication|0
1491407|NCT00532493|4912235|P1|Overall Study|Contraindicative Medication|1
1491408|NCT00532493|4912234|P2|Overall Study|Subject Moved Away|1
1491409|NCT00532493|4912235|P1|Overall Study|Subject Moved Away|3
1491410|NCT00532493|4912234|P2|Overall Study|Protocol Deviation|0
1491411|NCT00532493|4912235|P1|Overall Study|Protocol Deviation|1
1491412|NCT00532493|4912234|P2|Overall Study|Adverse Event|5
1491413|NCT00532493|4912235|P1|Overall Study|Adverse Event|6
1491414|NCT00532493|4912234|P2|Overall Study|Physician Decision|6
1491415|NCT00532493|4912235|P1|Overall Study|Physician Decision|1
1491416|NCT00532493|4912234|P2|Overall Study|Withdrawal by Subject|9
1491417|NCT00532493|4912235|P1|Overall Study|Withdrawal by Subject|7
1491418|NCT00532493|4912234|P2|Overall Study|Lost to Follow-up|7
1491419|NCT00532493|4912235|P1|Overall Study|Lost to Follow-up|10
1491420|NCT00532493|4912234|P2|Overall Study|Death|1
1491421|NCT00532493|4912235|P1|Overall Study|Death|1
1491422|NCT00532441|4912269|P2|Overall Study|Death|0
1491423|NCT00532441|4912270|P1|Overall Study|Death|1
1491424|NCT00532298|4912285|P6|Overall Study|Lost to Follow-up|1
1491425|NCT00532298|4912286|P5|Overall Study|Lost to Follow-up|0
1491426|NCT00532298|4912287|P4|Overall Study|Lost to Follow-up|0
1491427|NCT00532298|4912288|P3|Overall Study|Lost to Follow-up|1
1491428|NCT00532298|4912289|P2|Overall Study|Lost to Follow-up|1
1491429|NCT00532298|4912290|P1|Overall Study|Lost to Follow-up|1
1491430|NCT00532298|4912285|P6|Overall Study|Adverse Event|1
1491431|NCT00532298|4912286|P5|Overall Study|Adverse Event|1
1491432|NCT00532298|4912287|P4|Overall Study|Adverse Event|0
1491433|NCT00532298|4912288|P3|Overall Study|Adverse Event|0
1491434|NCT00532298|4912289|P2|Overall Study|Adverse Event|0
1491435|NCT00532298|4912290|P1|Overall Study|Adverse Event|1
1491436|NCT00532259|4912370|P1|Overall Study|Protocol Violation|1
1491437|NCT00532259|4912370|P1|Overall Study|Physician Decision|3
1491438|NCT00532259|4912370|P1|Overall Study|Lost to Follow-up|3
1491439|NCT00532259|4912370|P1|Overall Study|Lack of Efficacy|21
1491440|NCT00532259|4912370|P1|Overall Study|Death|1
1491441|NCT00532259|4912370|P1|Overall Study|Adverse Event|1
1491442|NCT00532259|4912370|P1|Overall Study|Withdrawal by Subject|2
1491443|NCT00532155|4912377|P2|Overall Study|Did not receive study medication|6
1491444|NCT00532155|4912378|P1|Overall Study|Did not receive study medication|2
1491445|NCT00532155|4912377|P2|Overall Study|Study termination stop further treatment|0
1491446|NCT00532155|4912378|P1|Overall Study|Study termination stop further treatment|4
1491447|NCT00532155|4912377|P2|Overall Study|Study terminated by sponsor|0
1491448|NCT00532155|4912378|P1|Overall Study|Study terminated by sponsor|1
1491449|NCT00532155|4912377|P2|Overall Study|Study stopped|0
1491450|NCT00532155|4912378|P1|Overall Study|Study stopped|1
1491451|NCT00532155|4912377|P2|Overall Study|Had brain metastasis, was mis-randomized|0
1491452|NCT00532155|4912378|P1|Overall Study|Had brain metastasis, was mis-randomized|1
1491453|NCT00532155|4912377|P2|Overall Study|Progressive disease (by incorrect scan)|1
1491454|NCT00532155|4912378|P1|Overall Study|Progressive disease (by incorrect scan)|0
1491455|NCT00532155|4912377|P2|Overall Study|Promotor ended study|0
1491456|NCT00532155|4912378|P1|Overall Study|Promotor ended study|1
1491457|NCT00532155|4912377|P2|Overall Study|Occurence of a secondary cancer|1
1491458|NCT00532155|4912378|P1|Overall Study|Occurence of a secondary cancer|0
1491459|NCT00532155|4912377|P2|Overall Study|Occurence of a second cancer|1
1491460|NCT00532155|4912378|P1|Overall Study|Occurence of a second cancer|0
1491461|NCT00532155|4912377|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
1491462|NCT00532155|4912378|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
1491463|NCT00532155|4912377|P2|Overall Study|Moved|0
1491464|NCT00532155|4912378|P1|Overall Study|Moved|1
1491465|NCT00532155|4912377|P2|Overall Study|Consent withdrawn|7
1491466|NCT00532155|4912378|P1|Overall Study|Consent withdrawn|5
1491467|NCT00532155|4912377|P2|Overall Study|Withdrawal by Subject|44
1491468|NCT00532155|4912378|P1|Overall Study|Withdrawal by Subject|23
1491469|NCT00532155|4912377|P2|Overall Study|Physician Decision|15
1491470|NCT00532155|4912378|P1|Overall Study|Physician Decision|16
1491471|NCT00532155|4912377|P2|Overall Study|Lost to Follow-up|0
1491472|NCT00532155|4912378|P1|Overall Study|Lost to Follow-up|2
1491473|NCT00532155|4912377|P2|Overall Study|Protocol Violation|3
1491474|NCT00532155|4912378|P1|Overall Study|Protocol Violation|1
1491475|NCT00532155|4912377|P2|Overall Study|Lack of Efficacy|255
1491476|NCT00532155|4912378|P1|Overall Study|Lack of Efficacy|332
1491477|NCT00532155|4912377|P2|Overall Study|Adverse Event|123
1491478|NCT00532155|4912378|P1|Overall Study|Adverse Event|66
1491479|NCT00532129|4912392|P1|Follow-up Period|Other|6
1491480|NCT00532129|4912392|P1|Follow-up Period|Lost to Follow-up|1
1491481|NCT00532129|4912392|P1|Follow-up Period|Disease progression|57
1491482|NCT00532129|4912392|P1|Follow-up Period|Adverse event/Serious adverse event|1
1491483|NCT00532129|4912392|P1|Treatment Period|Other|5
1491484|NCT00532129|4912392|P1|Treatment Period|Protocol Violation|1
1491485|NCT00532129|4912392|P1|Treatment Period|Disease progression|3
1491486|NCT00532129|4912392|P1|Treatment Period|Physician Decision|15
1491487|NCT00532129|4912392|P1|Treatment Period|Adverse event/Serious adverse event|25
1491488|NCT00531960|4912412|P2|Overall Study|Not Specified|10
1491489|NCT00531960|4912413|P1|Overall Study|Not Specified|4
1491490|NCT00531960|4912412|P2|Overall Study|Refused Treatment|6
1491491|NCT00531960|4912413|P1|Overall Study|Refused Treatment|5
1491492|NCT00531960|4912412|P2|Overall Study|Violation of Selection Criteria|0
1491493|NCT00531960|4912413|P1|Overall Study|Violation of Selection Criteria|2
1491494|NCT00531960|4912412|P2|Overall Study|Lack of Efficacy|41
1491495|NCT00531960|4912413|P1|Overall Study|Lack of Efficacy|42
1491496|NCT00531960|4912412|P2|Overall Study|Death|2
1491497|NCT00531960|4912413|P1|Overall Study|Death|3
1491498|NCT00531960|4912412|P2|Overall Study|Adverse Event|4
1491499|NCT00531960|4912413|P1|Overall Study|Adverse Event|5
1491500|NCT00531947|4912431|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
1491501|NCT00531947|4912432|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
1491502|NCT00531947|4912431|P2|Overall Study|Non-Compliance|7
1491503|NCT00531947|4912432|P1|Overall Study|Non-Compliance|4
1491504|NCT00531947|4912431|P2|Overall Study|Protocol Violation|1
1491505|NCT00531947|4912432|P1|Overall Study|Protocol Violation|2
1491506|NCT00531947|4912431|P2|Overall Study|Withdrawal by Subject|19
1491507|NCT00531947|4912432|P1|Overall Study|Withdrawal by Subject|14
1491508|NCT00531947|4912431|P2|Overall Study|Lost to Follow-up|9
1491509|NCT00531947|4912432|P1|Overall Study|Lost to Follow-up|12
1491510|NCT00531947|4912431|P2|Overall Study|Adverse Event|10
1491511|NCT00531947|4912432|P1|Overall Study|Adverse Event|5
1491512|NCT00531934|4912476|P2|Overall Study|Not specified|2
1491513|NCT00531934|4912477|P1|Overall Study|Not specified|2
1491514|NCT00531934|4912476|P2|Overall Study|Withdrawal by Subject|1
1491515|NCT00531934|4912477|P1|Overall Study|Withdrawal by Subject|1
1491516|NCT00531934|4912476|P2|Overall Study|Death|10
1491517|NCT00531934|4912477|P1|Overall Study|Death|7
1491518|NCT00531934|4912476|P2|Overall Study|Progression|42
1491519|NCT00531934|4912477|P1|Overall Study|Progression|52
1491520|NCT00531934|4912476|P2|Overall Study|Adverse Event|8
1491521|NCT00531934|4912477|P1|Overall Study|Adverse Event|4
1491522|NCT00531752|4912605|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
1491523|NCT00531752|4912606|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
1491524|NCT00531752|4912607|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
1491525|NCT00531752|4912608|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
1491526|NCT00531752|4912605|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
1491527|NCT00531752|4912606|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
1491528|NCT00531752|4912607|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
1491529|NCT00531752|4912608|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
1491530|NCT00531752|4912605|P4|Second Double-blind Intervention Period|Other|0
1491531|NCT00531752|4912606|P3|Second Double-blind Intervention Period|Other|0
1491532|NCT00531752|4912607|P2|Second Double-blind Intervention Period|Other|1
1491533|NCT00531752|4912608|P1|Second Double-blind Intervention Period|Other|1
1491534|NCT00531752|4912605|P4|Second Double-blind Intervention Period|Adverse Event|0
1491535|NCT00531752|4912606|P3|Second Double-blind Intervention Period|Adverse Event|0
1491536|NCT00531752|4912607|P2|Second Double-blind Intervention Period|Adverse Event|1
1491537|NCT00531752|4912608|P1|Second Double-blind Intervention Period|Adverse Event|1
1491538|NCT00531752|4912605|P4|First Double-blind Intervention Period|Randomized but not treated|0
1491539|NCT00531752|4912606|P3|First Double-blind Intervention Period|Randomized but not treated|0
1491540|NCT00531752|4912607|P2|First Double-blind Intervention Period|Randomized but not treated|0
1491541|NCT00531752|4912608|P1|First Double-blind Intervention Period|Randomized but not treated|1
1491542|NCT00531752|4912605|P4|First Double-blind Intervention Period|Lost to Follow-up|1
1491543|NCT00531752|4912606|P3|First Double-blind Intervention Period|Lost to Follow-up|1
1491544|NCT00531752|4912607|P2|First Double-blind Intervention Period|Lost to Follow-up|0
1491545|NCT00531752|4912608|P1|First Double-blind Intervention Period|Lost to Follow-up|0
1491546|NCT00531752|4912605|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
1491547|NCT00531752|4912606|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
1491548|NCT00531752|4912607|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
1491549|NCT00531752|4912608|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
1491550|NCT00531752|4912605|P4|First Double-blind Intervention Period|Other|0
1491551|NCT00531752|4912606|P3|First Double-blind Intervention Period|Other|4
1491552|NCT00531752|4912607|P2|First Double-blind Intervention Period|Other|4
1491553|NCT00531752|4912608|P1|First Double-blind Intervention Period|Other|1
1491554|NCT00531752|4912605|P4|First Double-blind Intervention Period|Adverse Event|1
1491555|NCT00531752|4912606|P3|First Double-blind Intervention Period|Adverse Event|1
1491556|NCT00531752|4912607|P2|First Double-blind Intervention Period|Adverse Event|0
1491557|NCT00531752|4912608|P1|First Double-blind Intervention Period|Adverse Event|2
1491558|NCT00531479|4912719|P2|Overall Study|Did not receive treatment|3
1491559|NCT00531479|4912720|P1|Overall Study|Did not receive treatment|2
1491560|NCT00531479|4912719|P2|Overall Study|Withdrawal by Subject|6
1491561|NCT00531479|4912720|P1|Overall Study|Withdrawal by Subject|6
1491562|NCT00531479|4912719|P2|Overall Study|Other|1
1491563|NCT00531479|4912720|P1|Overall Study|Other|0
1491564|NCT00531479|4912719|P2|Overall Study|Lost to Follow-up|2
1491565|NCT00531479|4912720|P1|Overall Study|Lost to Follow-up|0
1491566|NCT00531479|4912719|P2|Overall Study|Death|71
1491567|NCT00531479|4912720|P1|Overall Study|Death|68
1491568|NCT00531427|4912751|P2|Overall Study|Administrative|9
1491569|NCT00531427|4912752|P1|Overall Study|Administrative|4
1491570|NCT00531427|4912751|P2|Overall Study|Lack of Efficacy|39
1491571|NCT00531427|4912752|P1|Overall Study|Lack of Efficacy|14
1491572|NCT00531427|4912751|P2|Overall Study|Lost to Follow-up|3
1491573|NCT00531427|4912752|P1|Overall Study|Lost to Follow-up|4
1491574|NCT00531427|4912751|P2|Overall Study|Adverse Event|30
1491575|NCT00531427|4912752|P1|Overall Study|Adverse Event|44
1491576|NCT00531427|4912751|P2|Overall Study|Withdrawal by Subject|13
1491577|NCT00531427|4912752|P1|Overall Study|Withdrawal by Subject|7
1491578|NCT00531284|4912780|P17|Overall Study|Other|0
1491579|NCT00531284|4912781|P16|Overall Study|Other|0
1491580|NCT00531284|4912782|P15|Overall Study|Other|1
1491581|NCT00531284|4912783|P14|Overall Study|Other|0
1491582|NCT00531284|4912784|P13|Overall Study|Other|0
1491583|NCT00531284|4912785|P12|Overall Study|Other|2
1491584|NCT00531284|4912786|P11|Overall Study|Other|0
1491585|NCT00531284|4912787|P10|Overall Study|Other|1
1491586|NCT00531284|4912788|P9|Overall Study|Other|2
1491587|NCT00531284|4912789|P8|Overall Study|Other|0
1491588|NCT00531284|4912790|P7|Overall Study|Other|0
1491589|NCT00531284|4912791|P6|Overall Study|Other|1
1491590|NCT00531284|4912792|P5|Overall Study|Other|2
1491591|NCT00531284|4912793|P4|Overall Study|Other|10
1491592|NCT00531284|4912794|P3|Overall Study|Other|0
1491593|NCT00531284|4912795|P2|Overall Study|Other|0
1491594|NCT00531284|4912796|P1|Overall Study|Other|1
1491595|NCT00531284|4912780|P17|Overall Study|Withdrawal by Subject|1
1491596|NCT00531284|4912781|P16|Overall Study|Withdrawal by Subject|1
1491597|NCT00531284|4912782|P15|Overall Study|Withdrawal by Subject|0
1491598|NCT00531284|4912783|P14|Overall Study|Withdrawal by Subject|1
1491599|NCT00531284|4912784|P13|Overall Study|Withdrawal by Subject|0
1491600|NCT00531284|4912785|P12|Overall Study|Withdrawal by Subject|3
1491601|NCT00531284|4912786|P11|Overall Study|Withdrawal by Subject|0
1491602|NCT00531284|4912787|P10|Overall Study|Withdrawal by Subject|0
1491603|NCT00531284|4912788|P9|Overall Study|Withdrawal by Subject|0
1491604|NCT00531284|4912789|P8|Overall Study|Withdrawal by Subject|0
1491605|NCT00531284|4912790|P7|Overall Study|Withdrawal by Subject|0
1491606|NCT00531284|4912791|P6|Overall Study|Withdrawal by Subject|0
1491607|NCT00531284|4912792|P5|Overall Study|Withdrawal by Subject|0
1491608|NCT00531284|4912793|P4|Overall Study|Withdrawal by Subject|4
1491609|NCT00531284|4912794|P3|Overall Study|Withdrawal by Subject|0
1491610|NCT00531284|4912795|P2|Overall Study|Withdrawal by Subject|0
1491611|NCT00531284|4912796|P1|Overall Study|Withdrawal by Subject|1
1491612|NCT00531284|4912780|P17|Overall Study|Adverse Event|2
1491613|NCT00531284|4912781|P16|Overall Study|Adverse Event|0
1491614|NCT00531284|4912782|P15|Overall Study|Adverse Event|1
1491615|NCT00531284|4912783|P14|Overall Study|Adverse Event|1
1491616|NCT00531284|4912784|P13|Overall Study|Adverse Event|0
1491617|NCT00531284|4912785|P12|Overall Study|Adverse Event|5
1491618|NCT00531284|4912786|P11|Overall Study|Adverse Event|0
1491619|NCT00531284|4912787|P10|Overall Study|Adverse Event|0
1491620|NCT00531284|4912788|P9|Overall Study|Adverse Event|3
1491621|NCT00531284|4912789|P8|Overall Study|Adverse Event|2
1491622|NCT00531284|4912790|P7|Overall Study|Adverse Event|3
1491623|NCT00531284|4912791|P6|Overall Study|Adverse Event|2
1491624|NCT00531284|4912792|P5|Overall Study|Adverse Event|0
1491625|NCT00531284|4912793|P4|Overall Study|Adverse Event|7
1491626|NCT00531284|4912794|P3|Overall Study|Adverse Event|1
1491627|NCT00531284|4912795|P2|Overall Study|Adverse Event|1
1491628|NCT00531284|4912796|P1|Overall Study|Adverse Event|0
1491629|NCT00531284|4912780|P17|Overall Study|Progressive Disease|5
1491630|NCT00531284|4912781|P16|Overall Study|Progressive Disease|11
1491631|NCT00531284|4912782|P15|Overall Study|Progressive Disease|2
1491632|NCT00531284|4912783|P14|Overall Study|Progressive Disease|1
1491633|NCT00531284|4912784|P13|Overall Study|Progressive Disease|2
1491634|NCT00531284|4912785|P12|Overall Study|Progressive Disease|14
1491635|NCT00531284|4912786|P11|Overall Study|Progressive Disease|3
1491636|NCT00531284|4912787|P10|Overall Study|Progressive Disease|3
1491637|NCT00531284|4912788|P9|Overall Study|Progressive Disease|6
1491638|NCT00531284|4912789|P8|Overall Study|Progressive Disease|8
1491639|NCT00531284|4912790|P7|Overall Study|Progressive Disease|3
1491640|NCT00531284|4912791|P6|Overall Study|Progressive Disease|4
1491641|NCT00531284|4912792|P5|Overall Study|Progressive Disease|4
1491642|NCT00531284|4912793|P4|Overall Study|Progressive Disease|42
1491643|NCT00531284|4912794|P3|Overall Study|Progressive Disease|5
1491644|NCT00531284|4912795|P2|Overall Study|Progressive Disease|3
1491645|NCT00531284|4912796|P1|Overall Study|Progressive Disease|1
1491646|NCT00531206|4912946|P1|Overall Study|including non-related adverse events|8
1491647|NCT00531206|4912946|P1|Overall Study|Lost to Follow-up|5
1491648|NCT00531206|4912946|P1|Overall Study|Lack of Efficacy|2
1491649|NCT00531206|4912946|P1|Overall Study|Adverse Event related|5
1491650|NCT00531050|4912976|P6|Part 2: Period 3|Abnormal test procedure|1
1491651|NCT00531050|4912977|P5|Part 2: Period 3|Abnormal test procedure|0
1491652|NCT00531050|4912978|P4|Part 2: Period 3|Abnormal test procedure|0
1491653|NCT00531050|4912979|P3|Part 2: Period 3|Abnormal test procedure|0
1491654|NCT00531050|4912980|P2|Part 2: Period 3|Abnormal test procedure|0
1491655|NCT00531050|4912981|P1|Part 2: Period 3|Abnormal test procedure|1
1491656|NCT00531050|4912976|P6|Part 2: Period 1|Adverse Event|1
1491657|NCT00531050|4912977|P5|Part 2: Period 1|Adverse Event|0
1491658|NCT00531050|4912978|P4|Part 2: Period 1|Adverse Event|0
1491659|NCT00531050|4912979|P3|Part 2: Period 1|Adverse Event|0
1491660|NCT00531050|4912980|P2|Part 2: Period 1|Adverse Event|0
1491661|NCT00531050|4912981|P1|Part 2: Period 1|Adverse Event|0
1491662|NCT00531050|4912976|P6|Part 1: Period 3|Adverse Event|0
1491663|NCT00531050|4912977|P5|Part 1: Period 3|Adverse Event|0
1491664|NCT00531050|4912978|P4|Part 1: Period 3|Adverse Event|0
1491665|NCT00531050|4912979|P3|Part 1: Period 3|Adverse Event|0
1491666|NCT00531050|4912980|P2|Part 1: Period 3|Adverse Event|0
1491667|NCT00531050|4912981|P1|Part 1: Period 3|Adverse Event|1
1491668|NCT00531050|4912976|P6|Part 1: Period 1|Protocol Deviation|0
1491669|NCT00531050|4912977|P5|Part 1: Period 1|Protocol Deviation|0
1491670|NCT00531050|4912978|P4|Part 1: Period 1|Protocol Deviation|1
1491671|NCT00531050|4912979|P3|Part 1: Period 1|Protocol Deviation|0
1491672|NCT00531050|4912980|P2|Part 1: Period 1|Protocol Deviation|0
1491673|NCT00531050|4912981|P1|Part 1: Period 1|Protocol Deviation|0
1491674|NCT00531050|4912976|P6|Part 1: Period 1|Adverse Event|0
1491675|NCT00531050|4912977|P5|Part 1: Period 1|Adverse Event|0
1491676|NCT00531050|4912978|P4|Part 1: Period 1|Adverse Event|0
1491677|NCT00531050|4912979|P3|Part 1: Period 1|Adverse Event|0
1491678|NCT00531050|4912980|P2|Part 1: Period 1|Adverse Event|1
1491679|NCT00531050|4912981|P1|Part 1: Period 1|Adverse Event|0
1491680|NCT00531011|4913010|P2|Overall Study|Physician Decision|3
1491681|NCT00531011|4913011|P1|Overall Study|Physician Decision|0
1491682|NCT00531011|4913010|P2|Overall Study|Lost to Follow-up|0
1491683|NCT00531011|4913011|P1|Overall Study|Lost to Follow-up|1
1491684|NCT00531011|4913010|P2|Overall Study|Death|0
1491685|NCT00531011|4913011|P1|Overall Study|Death|1
1491686|NCT00531011|4913010|P2|Overall Study|Withdrawal by Subject|4
1491687|NCT00531011|4913011|P1|Overall Study|Withdrawal by Subject|2
1491688|NCT00530946|4913057|P4|Overall Study|Noncompliance|0
1491689|NCT00530946|4913058|P3|Overall Study|Noncompliance|0
1491690|NCT00530946|4913059|P2|Overall Study|Noncompliance|0
1491691|NCT00530946|4913060|P1|Overall Study|Noncompliance|1
1491692|NCT00530946|4913057|P4|Overall Study|Protocol Violation|1
1491693|NCT00530946|4913058|P3|Overall Study|Protocol Violation|0
1491694|NCT00530946|4913059|P2|Overall Study|Protocol Violation|0
1491695|NCT00530946|4913060|P1|Overall Study|Protocol Violation|0
1491696|NCT00530946|4913057|P4|Overall Study|Adverse Event|1
1491697|NCT00530946|4913058|P3|Overall Study|Adverse Event|1
1491698|NCT00530946|4913059|P2|Overall Study|Adverse Event|2
1491699|NCT00530946|4913060|P1|Overall Study|Adverse Event|1
1491700|NCT00530920|4913113|P3|Overall Study|Withdrawal by Subject|1
1491701|NCT00530920|4913114|P2|Overall Study|Withdrawal by Subject|0
1491702|NCT00530920|4913115|P1|Overall Study|Withdrawal by Subject|0
1491703|NCT00530920|4913113|P3|Overall Study|Adverse Event|3
1491704|NCT00530920|4913114|P2|Overall Study|Adverse Event|0
1491705|NCT00530920|4913115|P1|Overall Study|Adverse Event|0
1491706|NCT00530920|4913113|P3|Overall Study|Randomized but not treated|0
1491707|NCT00530920|4913114|P2|Overall Study|Randomized but not treated|2
1491708|NCT00530920|4913115|P1|Overall Study|Randomized but not treated|0
1491709|NCT00530894|4913175|P4|Overall Study|Alive and censored prior to 1 year|0
1491710|NCT00530894|4913176|P3|Overall Study|Alive and censored prior to 1 year|0
1491711|NCT00530894|4913177|P2|Overall Study|Alive and censored prior to 1 year|0
1491712|NCT00530894|4913178|P1|Overall Study|Alive and censored prior to 1 year|2
1491713|NCT00530894|4913175|P4|Overall Study|Withdrawal by Subject|5
1491714|NCT00530894|4913176|P3|Overall Study|Withdrawal by Subject|0
1491715|NCT00530894|4913177|P2|Overall Study|Withdrawal by Subject|23
1491716|NCT00530894|4913178|P1|Overall Study|Withdrawal by Subject|1
1491717|NCT00530894|4913175|P4|Overall Study|Lost to Follow-up|0
1491718|NCT00530894|4913176|P3|Overall Study|Lost to Follow-up|0
1491719|NCT00530894|4913177|P2|Overall Study|Lost to Follow-up|3
1491720|NCT00530894|4913178|P1|Overall Study|Lost to Follow-up|1
1491721|NCT00530894|4913175|P4|Overall Study|Death|89
1491722|NCT00530894|4913176|P3|Overall Study|Death|55
1491723|NCT00530894|4913177|P2|Overall Study|Death|89
1491724|NCT00530894|4913178|P1|Overall Study|Death|84
1491725|NCT00530855|4913206|P1|Overall Study|Other reason for premature termination|17
1491726|NCT00530855|4913206|P1|Overall Study|Lost to Follow-up|9
1491727|NCT00530855|4913206|P1|Overall Study|Unsatisfactory compliance of subject|11
1491728|NCT00530855|4913206|P1|Overall Study|Protocol Violation|3
1491729|NCT00530855|4913206|P1|Overall Study|Non Fatal Non Serious AE|12
1491730|NCT00530855|4913206|P1|Overall Study|Non Fatal Serious AE|7
1491731|NCT00530855|4913206|P1|Overall Study|Fatal Serious AE|3
1491732|NCT00530855|4913206|P1|Overall Study|Withdrawal by Subject|30
1491733|NCT00530855|4913206|P1|Overall Study|Lack of Efficacy|20
1491734|NCT00530842|4913215|P2|Period 2|Individual different reasons|0
1491735|NCT00530842|4913216|P1|Period 2|Individual different reasons|2
1491736|NCT00530842|4913215|P2|Period 2|Withdrawal by Subject|2
1491737|NCT00530842|4913216|P1|Period 2|Withdrawal by Subject|1
1491738|NCT00530842|4913215|P2|Period 2|Protocol Violation|0
1491739|NCT00530842|4913216|P1|Period 2|Protocol Violation|1
1491740|NCT00530842|4913215|P2|Period 2|Lost to Follow-up|4
1491741|NCT00530842|4913216|P1|Period 2|Lost to Follow-up|0
1491742|NCT00530842|4913215|P2|Period 2|Lack of Efficacy|0
1491743|NCT00530842|4913216|P1|Period 2|Lack of Efficacy|1
1491744|NCT00530842|4913215|P2|Period 2|Adverse Event|3
1491745|NCT00530842|4913216|P1|Period 2|Adverse Event|3
1491746|NCT00530842|4913215|P2|Period 1|Individual different reasons|3
1491747|NCT00530842|4913216|P1|Period 1|Individual different reasons|2
1491748|NCT00530842|4913215|P2|Period 1|Withdrawal by Subject|3
1491749|NCT00530842|4913216|P1|Period 1|Withdrawal by Subject|2
1491750|NCT00530842|4913215|P2|Period 1|Protocol Violation|1
1491751|NCT00530842|4913216|P1|Period 1|Protocol Violation|2
1491752|NCT00530842|4913215|P2|Period 1|Lack of Efficacy|1
1491753|NCT00530842|4913216|P1|Period 1|Lack of Efficacy|1
1491754|NCT00530842|4913215|P2|Period 1|Adverse Event|3
1491755|NCT00530842|4913216|P1|Period 1|Adverse Event|7
1491756|NCT00530842|4913215|P2|Overall Study|Individual different reasons|3
1491757|NCT00530842|4913216|P1|Overall Study|Individual different reasons|4
1491758|NCT00530842|4913215|P2|Overall Study|Withdrawal by Subject|5
1491759|NCT00530842|4913216|P1|Overall Study|Withdrawal by Subject|4
1491760|NCT00530842|4913215|P2|Overall Study|Protocol Violation|2
1491761|NCT00530842|4913216|P1|Overall Study|Protocol Violation|3
1491762|NCT00530842|4913215|P2|Overall Study|Lost to Follow-up|4
1491763|NCT00530842|4913216|P1|Overall Study|Lost to Follow-up|0
1491764|NCT00530842|4913215|P2|Overall Study|Lack of Efficacy|1
1491765|NCT00530842|4913216|P1|Overall Study|Lack of Efficacy|2
1491766|NCT00530842|4913215|P2|Overall Study|Adverse Event|6
1491767|NCT00530842|4913216|P1|Overall Study|Adverse Event|10
1491768|NCT00530816|4913343|P3|Overall Study|Withdrawal by Subject|6
1491769|NCT00530816|4913344|P2|Overall Study|Withdrawal by Subject|2
1491770|NCT00530816|4913345|P1|Overall Study|Withdrawal by Subject|1
1491771|NCT00530816|4913343|P3|Overall Study|Other|4
1491772|NCT00530816|4913344|P2|Overall Study|Other|3
1491773|NCT00530816|4913345|P1|Overall Study|Other|3
1491774|NCT00530816|4913343|P3|Overall Study|Adverse Event|7
1491775|NCT00530816|4913344|P2|Overall Study|Adverse Event|13
1491776|NCT00530816|4913345|P1|Overall Study|Adverse Event|6
1491777|NCT00530816|4913343|P3|Overall Study|Progressive Disease|24
1491778|NCT00530816|4913344|P2|Overall Study|Progressive Disease|24
1491779|NCT00530816|4913345|P1|Overall Study|Progressive Disease|16
1491780|NCT00530790|4913388|P1|Overall Study|Physician Decision|1
1491781|NCT00530790|4913388|P1|Overall Study|Withdrawal by Subject|2
1491782|NCT00530790|4913388|P1|Overall Study|Adverse Event|2
1491783|NCT00530777|4913410|P2|Overall Study|Unable to adhere to visit schedule|1
1491784|NCT00530777|4913411|P1|Overall Study|Unable to adhere to visit schedule|5
1491785|NCT00530777|4913410|P2|Overall Study|Withdrawal by Subject|1
1491786|NCT00530777|4913411|P1|Overall Study|Withdrawal by Subject|0
1491787|NCT00530777|4913410|P2|Overall Study|Physician Decision|0
1491788|NCT00530777|4913411|P1|Overall Study|Physician Decision|1
1491789|NCT00530777|4913410|P2|Overall Study|Death|2
1491790|NCT00530777|4913411|P1|Overall Study|Death|1
1491791|NCT00530777|4913410|P2|Overall Study|Lost to Follow-up|1
1491792|NCT00530777|4913411|P1|Overall Study|Lost to Follow-up|0
1491793|NCT00530712|4913468|P1|12 Month Follow-up Visit|Death|9
1491794|NCT00530712|4913468|P1|12 Month Follow-up Visit|Lost to Follow-up|7
1491795|NCT00530712|4913468|P1|12 Month Follow-up Visit|Missed Visit|3
1491796|NCT00530712|4913468|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
1491797|NCT00530712|4913468|P1|6 Month Follow-up Visit|Death|2
1491798|NCT00530712|4913468|P1|6 Month Follow-up Visit|Lost to Follow-up|3
1491799|NCT00530712|4913468|P1|6 Month Follow-up Visit|Missed Visit|3
1491800|NCT00530712|4913468|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
1491801|NCT00530712|4913468|P1|30 Day Follow-up Visit|Missed Visit|5
1491802|NCT00530712|4913468|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
1491803|NCT00530504|4913487|P1|Overall Study|Exited study due to other reasons|33
1491804|NCT00530504|4913487|P1|Overall Study|Withdrawal by Subject|39
1491805|NCT00530504|4913487|P1|Overall Study|Lost to Follow-up|26
1491806|NCT00530504|4913487|P1|Overall Study|Death|54
1491807|NCT00530439|4913493|P2|Overall Study|Severe malformation/abortion|3
1491808|NCT00530439|4913494|P1|Overall Study|Severe malformation/abortion|0
1491809|NCT00530439|4913493|P2|Overall Study|Twin pregnancy|2
1491810|NCT00530439|4913494|P1|Overall Study|Twin pregnancy|0
1491811|NCT00530439|4913493|P2|Overall Study|Misclassification|0
1491812|NCT00530439|4913494|P1|Overall Study|Misclassification|2
1491813|NCT00530439|4913493|P2|Overall Study|Missed abortion|4
1491814|NCT00530439|4913494|P1|Overall Study|Missed abortion|1
1491815|NCT00530439|4913493|P2|Overall Study|Withdraw|14
1491816|NCT00530439|4913494|P1|Overall Study|Withdraw|18
1491817|NCT00530439|4913493|P2|Overall Study|GDM|3
1491818|NCT00530439|4913494|P1|Overall Study|GDM|9
1491819|NCT00530348|4913502|P2|Overall Study|Noncompliance with inclusion criterion 3|1
1491820|NCT00530348|4913503|P1|Overall Study|Noncompliance with inclusion criterion 3|0
1491821|NCT00530348|4913502|P2|Overall Study|Randomised in error|0
1491822|NCT00530348|4913503|P1|Overall Study|Randomised in error|1
1491823|NCT00530348|4913502|P2|Overall Study|Withdrawal by Subject|12
1491824|NCT00530348|4913503|P1|Overall Study|Withdrawal by Subject|12
1491825|NCT00530348|4913502|P2|Overall Study|Pregnancy|0
1491826|NCT00530348|4913503|P1|Overall Study|Pregnancy|1
1491827|NCT00530348|4913502|P2|Overall Study|Physician Decision|2
1491828|NCT00530348|4913503|P1|Overall Study|Physician Decision|1
1491829|NCT00530348|4913502|P2|Overall Study|Lost to Follow-up|2
1491830|NCT00530348|4913503|P1|Overall Study|Lost to Follow-up|0
1491831|NCT00530348|4913502|P2|Overall Study|Lack of Efficacy|0
1491832|NCT00530348|4913503|P1|Overall Study|Lack of Efficacy|2
1491833|NCT00530348|4913502|P2|Overall Study|Death|1
1491834|NCT00530348|4913503|P1|Overall Study|Death|0
1491835|NCT00530348|4913502|P2|Overall Study|Adverse Event|1
1491836|NCT00530348|4913503|P1|Overall Study|Adverse Event|5
1491837|NCT00530335|4913519|P1|Overall Study|Physician Decision|1
1491838|NCT00530335|4913519|P1|Overall Study|Withdrawal by Subject|1
1491839|NCT00530335|4913519|P1|Overall Study|Protocol Violation|1
1491840|NCT00530335|4913519|P1|Overall Study|Adverse Event|3
1491841|NCT00530270|4913536|P2|Overall Study|Protocol Violation|0
1491842|NCT00530270|4913537|P1|Overall Study|Protocol Violation|1
1491843|NCT00530257|4913551|P1|Overall Study|Lost to Follow-up|1
1491844|NCT00530218|4913579|P1|Overall Study|Death|12
1491845|NCT00530218|4913579|P1|Overall Study|CMV Not Detected|13
1491846|NCT00530088|4913586|P1|Overall Study|Other Not Specified|2
1491847|NCT00530088|4913586|P1|Overall Study|Physician Decision|4
1491848|NCT00530088|4913586|P1|Overall Study|Disease Progression|4
1491849|NCT00530075|4913591|P1|Overall Study|Withdrawal by Subject|1
1491850|NCT00530075|4913591|P1|Overall Study|Protocol Violation|1
1491851|NCT00530075|4913591|P1|Overall Study|Lack of Efficacy|3
1491852|NCT00530075|4913591|P1|Overall Study|Death|1
1491853|NCT00530075|4913591|P1|Overall Study|Adverse Event|1
1491854|NCT00530023|4913604|P2|Overall Study|Withdrawal by Subject|1
1491855|NCT00530023|4913605|P1|Overall Study|Withdrawal by Subject|0
1491856|NCT00529802|4913619|P1|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
1491857|NCT00529802|4913619|P1|Evaluable for Primary Endpoint|Lost to Follow-up|1
1491858|NCT00529802|4913619|P1|Evaluable for Primary Endpoint|Lack of Efficacy|1
1491859|NCT00529802|4913619|P1|Evaluable for Primary Endpoint|Death|1
1491860|NCT00529802|4913619|P1|Evaluable for Primary Endpoint|Adverse Event|2
1491861|NCT00529802|4913619|P1|Evaluable for Primary Endpoint|Worsening performance status|2
1491862|NCT00529802|4913619|P1|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
1491863|NCT00529789|4913625|P1|Study Period IV|Lost to Follow-up|3
1491864|NCT00529789|4913625|P1|Study Period IV|Lack of Efficacy|1
1491865|NCT00529789|4913625|P1|Study Period IV|Adverse Event|1
1491866|NCT00529789|4913625|P1|Study Period IV|Parent/Caregiver Decision|1
1491867|NCT00529789|4913625|P1|Study Period II/III|Lost to Follow-up|3
1491868|NCT00529789|4913625|P1|Study Period II/III|Physician Decision|3
1491869|NCT00529789|4913625|P1|Study Period II/III|Protocol Violation|3
1491870|NCT00529789|4913625|P1|Study Period II/III|Withdrawal by Subject|1
1491871|NCT00529789|4913625|P1|Study Period II/III|Lack of Efficacy|2
1491872|NCT00529789|4913625|P1|Study Period II/III|Adverse Event|3
1491873|NCT00529789|4913625|P1|Study Period II/III|Parent/Caregiver Decision|9
1491874|NCT00529763|4913650|P3|Overall Study|Patient Withdrew Consent|2
1491875|NCT00529763|4913651|P2|Overall Study|Patient Withdrew Consent|3
1491876|NCT00529763|4913652|P1|Overall Study|Patient Withdrew Consent|2
1491877|NCT00529763|4913650|P3|Overall Study|Study Drug Toxicity|1
1491878|NCT00529763|4913651|P2|Overall Study|Study Drug Toxicity|6
1491879|NCT00529763|4913652|P1|Overall Study|Study Drug Toxicity|1
1491880|NCT00529763|4913650|P3|Overall Study|Stem Cell Transplant|0
1491881|NCT00529763|4913651|P2|Overall Study|Stem Cell Transplant|3
1491882|NCT00529763|4913652|P1|Overall Study|Stem Cell Transplant|0
1491883|NCT00529763|4913650|P3|Overall Study|Lost to Follow-up|1
1491884|NCT00529763|4913651|P2|Overall Study|Lost to Follow-up|1
1491885|NCT00529763|4913652|P1|Overall Study|Lost to Follow-up|0
1491886|NCT00529763|4913650|P3|Overall Study|Disease Progression|1
1491887|NCT00529763|4913651|P2|Overall Study|Disease Progression|16
1491888|NCT00529763|4913652|P1|Overall Study|Disease Progression|6
1491889|NCT00529763|4913650|P3|Overall Study|Death|1
1491890|NCT00529763|4913651|P2|Overall Study|Death|1
1491891|NCT00529763|4913652|P1|Overall Study|Death|0
1491892|NCT00529763|4913650|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
1491893|NCT00529763|4913651|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
1491894|NCT00529763|4913652|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
1491895|NCT00529659|4913690|P2|Overall Study|Withdrawal by Subject|6
1491896|NCT00529659|4913691|P1|Overall Study|Withdrawal by Subject|1
1491897|NCT00529659|4913690|P2|Overall Study|Protocol Violation|6
1491898|NCT00529659|4913691|P1|Overall Study|Protocol Violation|2
1491899|NCT00529659|4913690|P2|Overall Study|Physician Decision|2
1491900|NCT00529659|4913691|P1|Overall Study|Physician Decision|0
1491901|NCT00529659|4913690|P2|Overall Study|Lost to Follow-up|2
1491902|NCT00529659|4913691|P1|Overall Study|Lost to Follow-up|0
1491903|NCT00529659|4913690|P2|Overall Study|Adverse Event|7
1491904|NCT00529659|4913691|P1|Overall Study|Adverse Event|8
1491905|NCT00529633|4913709|P2|Overall Study|Withdrawal by Subject|1
1491906|NCT00529633|4913710|P1|Overall Study|Withdrawal by Subject|1
1491907|NCT00529568|4913722|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
1491908|NCT00529568|4913723|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
1491909|NCT00529568|4913724|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
1491910|NCT00529568|4913722|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
1491911|NCT00529568|4913723|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
1491912|NCT00529568|4913724|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
1491913|NCT00529568|4913722|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
1491914|NCT00529568|4913723|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
1491915|NCT00529568|4913724|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
1491916|NCT00529568|4913722|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
1491997|NCT00529451|4913979|P4|Overall Study|Subject withdrew consent|12
1491917|NCT00529568|4913723|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
1491918|NCT00529568|4913724|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
1491919|NCT00529568|4913722|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
1491920|NCT00529568|4913723|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
1491921|NCT00529568|4913724|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
1491922|NCT00529568|4913722|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
1491923|NCT00529568|4913723|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
1491924|NCT00529568|4913724|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
1491925|NCT00529568|4913722|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
1491926|NCT00529568|4913723|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
1491927|NCT00529568|4913724|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
1491928|NCT00529568|4913722|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
1491929|NCT00529568|4913723|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
1491930|NCT00529568|4913724|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
1491931|NCT00529568|4913722|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
1491932|NCT00529568|4913723|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
1491933|NCT00529568|4913724|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
1491934|NCT00529568|4913722|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
1491935|NCT00529568|4913723|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
1491936|NCT00529568|4913724|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
1491937|NCT00529568|4913722|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
1491938|NCT00529568|4913723|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
1491939|NCT00529568|4913724|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
1491940|NCT00529542|4913787|P2|Overall Study|Lost to Follow-up|1
1491941|NCT00529542|4913788|P1|Overall Study|Lost to Follow-up|0
1491942|NCT00529542|4913787|P2|Overall Study|Withdrawal by Subject|0
1491943|NCT00529542|4913788|P1|Overall Study|Withdrawal by Subject|1
1491944|NCT00529529|4913831|P3|Overall Study|Administrative problems|3
1491945|NCT00529529|4913832|P2|Overall Study|Administrative problems|0
1491946|NCT00529529|4913833|P1|Overall Study|Administrative problems|1
1491947|NCT00529529|4913831|P3|Overall Study|Abnormal test procedure result(s)|0
1491948|NCT00529529|4913832|P2|Overall Study|Abnormal test procedure result(s)|0
1491949|NCT00529529|4913833|P1|Overall Study|Abnormal test procedure result(s)|1
1491950|NCT00529529|4913831|P3|Overall Study|Death|0
1491951|NCT00529529|4913832|P2|Overall Study|Death|0
1491952|NCT00529529|4913833|P1|Overall Study|Death|2
1491953|NCT00529529|4913831|P3|Overall Study|Unsatisfactory therapeutic effect|2
1491954|NCT00529529|4913832|P2|Overall Study|Unsatisfactory therapeutic effect|2
1491955|NCT00529529|4913833|P1|Overall Study|Unsatisfactory therapeutic effect|2
1491956|NCT00529529|4913831|P3|Overall Study|Lost to Follow-up|1
1491957|NCT00529529|4913832|P2|Overall Study|Lost to Follow-up|3
1491958|NCT00529529|4913833|P1|Overall Study|Lost to Follow-up|5
1491959|NCT00529529|4913831|P3|Overall Study|Protocol deviation|5
1491960|NCT00529529|4913832|P2|Overall Study|Protocol deviation|12
1491961|NCT00529529|4913833|P1|Overall Study|Protocol deviation|8
1491962|NCT00529529|4913831|P3|Overall Study|Subject withdrew consent|12
1491963|NCT00529529|4913832|P2|Overall Study|Subject withdrew consent|9
1491964|NCT00529529|4913833|P1|Overall Study|Subject withdrew consent|12
1491965|NCT00529529|4913831|P3|Overall Study|Adverse Event|8
1491966|NCT00529529|4913832|P2|Overall Study|Adverse Event|17
1491967|NCT00529529|4913833|P1|Overall Study|Adverse Event|12
1491968|NCT00529516|4913892|P3|Overall Study|Lost to Follow-up|1
1491969|NCT00529516|4913893|P2|Overall Study|Lost to Follow-up|0
1491970|NCT00529516|4913894|P1|Overall Study|Lost to Follow-up|0
1491971|NCT00529516|4913892|P3|Overall Study|Withdrawal by Subject|0
1491972|NCT00529516|4913893|P2|Overall Study|Withdrawal by Subject|1
1491973|NCT00529516|4913894|P1|Overall Study|Withdrawal by Subject|1
1491974|NCT00529516|4913892|P3|Overall Study|Adverse Event|0
1491975|NCT00529516|4913893|P2|Overall Study|Adverse Event|1
1491976|NCT00529516|4913894|P1|Overall Study|Adverse Event|2
1491977|NCT00529451|4913979|P4|Overall Study|Administrative problems|2
1491978|NCT00529451|4913980|P3|Overall Study|Administrative problems|0
1491979|NCT00529451|4913981|P2|Overall Study|Administrative problems|1
1491980|NCT00529451|4913982|P1|Overall Study|Administrative problems|1
1491981|NCT00529451|4913979|P4|Overall Study|Protocol deviation|1
1491982|NCT00529451|4913980|P3|Overall Study|Protocol deviation|4
1491983|NCT00529451|4913981|P2|Overall Study|Protocol deviation|1
1491984|NCT00529451|4913982|P1|Overall Study|Protocol deviation|1
1491985|NCT00529451|4913979|P4|Overall Study|Lost to Follow-up|4
1491986|NCT00529451|4913980|P3|Overall Study|Lost to Follow-up|4
1491987|NCT00529451|4913981|P2|Overall Study|Lost to Follow-up|7
1491988|NCT00529451|4913982|P1|Overall Study|Lost to Follow-up|4
1491989|NCT00529451|4913979|P4|Overall Study|Unsatisfactory therapeutic response|4
1491990|NCT00529451|4913980|P3|Overall Study|Unsatisfactory therapeutic response|5
1491991|NCT00529451|4913981|P2|Overall Study|Unsatisfactory therapeutic response|2
1491992|NCT00529451|4913982|P1|Overall Study|Unsatisfactory therapeutic response|6
1491993|NCT00529451|4913979|P4|Overall Study|Adverse Event|8
1491994|NCT00529451|4913980|P3|Overall Study|Adverse Event|14
1491995|NCT00529451|4913981|P2|Overall Study|Adverse Event|16
1491996|NCT00529451|4913982|P1|Overall Study|Adverse Event|9
1491998|NCT00529451|4913980|P3|Overall Study|Subject withdrew consent|13
1491999|NCT00529451|4913981|P2|Overall Study|Subject withdrew consent|21
1492000|NCT00529451|4913982|P1|Overall Study|Subject withdrew consent|16
1492001|NCT00529399|4914009|P3|Overall Study|Non-compliant|0
1492002|NCT00529399|4914010|P2|Overall Study|Non-compliant|1
1492003|NCT00529399|4914011|P1|Overall Study|Non-compliant|0
1492004|NCT00529399|4914009|P3|Overall Study|Withdrawal by Subject|1
1492005|NCT00529399|4914010|P2|Overall Study|Withdrawal by Subject|0
1492006|NCT00529399|4914011|P1|Overall Study|Withdrawal by Subject|1
1492007|NCT00529399|4914009|P3|Overall Study|Lost to Follow-up|1
1492008|NCT00529399|4914010|P2|Overall Study|Lost to Follow-up|0
1492009|NCT00529399|4914011|P1|Overall Study|Lost to Follow-up|1
1492010|NCT00529308|4914021|P2|Overall Study|Withdrawal by Subject|1
1492011|NCT00529308|4914022|P1|Overall Study|Withdrawal by Subject|1
1492012|NCT00529243|4914051|P1|Overall Study|Relocated|1
1492013|NCT00529243|4914051|P1|Overall Study|Death|1
1492014|NCT00529243|4914051|P1|Overall Study|Adverse Event|1
1492015|NCT00529217|4914056|P1|Overall Study|Unable to adhere to study schedule|2
1492016|NCT00529217|4914056|P1|Overall Study|Lack of Efficacy|2
1492017|NCT00529152|4914092|P1|Overall Study|Lost to Follow-up|1
1492018|NCT00529152|4914092|P1|Overall Study|Withdrawal by Subject|2
1492019|NCT00529152|4914092|P1|Overall Study|Adverse Event|2
1492020|NCT00529100|4914116|P2|Overall Study|Participant Ineligibility|1
1492021|NCT00529100|4914117|P1|Overall Study|Participant Ineligibility|0
1492022|NCT00529100|4914116|P2|Overall Study|Withdrawal by Subject|1
1492023|NCT00529100|4914117|P1|Overall Study|Withdrawal by Subject|0
1492024|NCT00529100|4914116|P2|Overall Study|Progressive Disease|1
1492025|NCT00529100|4914117|P1|Overall Study|Progressive Disease|0
1492026|NCT00529100|4914116|P2|Overall Study|Protocol Violation|1
1492027|NCT00529100|4914117|P1|Overall Study|Protocol Violation|0
1492028|NCT00529100|4914116|P2|Overall Study|Adverse Event|5
1492029|NCT00529100|4914117|P1|Overall Study|Adverse Event|0
1492030|NCT00529087|4914134|P3|Overall Study|Protocol deviation|2
1492031|NCT00529087|4914135|P2|Overall Study|Protocol deviation|1
1492032|NCT00529087|4914136|P1|Overall Study|Protocol deviation|1
1492033|NCT00529087|4914134|P3|Overall Study|Withdrawal by Subject|3
1492034|NCT00529087|4914135|P2|Overall Study|Withdrawal by Subject|3
1492035|NCT00529087|4914136|P1|Overall Study|Withdrawal by Subject|3
1492036|NCT00529087|4914134|P3|Overall Study|Protocol Violation|6
1492037|NCT00529087|4914135|P2|Overall Study|Protocol Violation|7
1492038|NCT00529087|4914136|P1|Overall Study|Protocol Violation|8
1492039|NCT00529087|4914134|P3|Overall Study|Lost to Follow-up|1
1492040|NCT00529087|4914135|P2|Overall Study|Lost to Follow-up|4
1492041|NCT00529087|4914136|P1|Overall Study|Lost to Follow-up|6
1492042|NCT00529087|4914134|P3|Overall Study|Adverse Event|4
1492043|NCT00529087|4914135|P2|Overall Study|Adverse Event|13
1492044|NCT00529087|4914136|P1|Overall Study|Adverse Event|10
1492045|NCT00529035|4914200|P1|Overall Study|Withdrawal by Subject|1
1492046|NCT00528957|4914213|P2|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
1492047|NCT00528957|4914214|P1|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
1492048|NCT00528957|4914213|P2|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
1492049|NCT00528957|4914214|P1|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
1492050|NCT00528957|4914213|P2|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
1492051|NCT00528957|4914214|P1|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
1492052|NCT00528957|4914213|P2|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
1492053|NCT00528957|4914214|P1|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
1492054|NCT00528957|4914213|P2|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
1492055|NCT00528957|4914214|P1|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
1492056|NCT00528957|4914213|P2|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
1492057|NCT00528957|4914214|P1|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
1492058|NCT00528957|4914213|P2|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
1492059|NCT00528957|4914214|P1|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
1492060|NCT00528957|4914213|P2|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
1492061|NCT00528957|4914214|P1|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
1492062|NCT00528957|4914213|P2|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
1492063|NCT00528957|4914214|P1|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
1492064|NCT00528957|4914213|P2|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
1492065|NCT00528957|4914214|P1|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
1492066|NCT00528957|4914213|P2|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
1492067|NCT00528957|4914214|P1|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
1492068|NCT00528957|4914213|P2|First Extension (Week 48 to Week 144)|Withdrew Consent|1
1492069|NCT00528957|4914214|P1|First Extension (Week 48 to Week 144)|Withdrew Consent|0
1492070|NCT00528957|4914213|P2|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
1492071|NCT00528957|4914214|P1|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
1492072|NCT00528957|4914213|P2|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
1492073|NCT00528957|4914214|P1|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
1492074|NCT00528957|4914213|P2|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
1492075|NCT00528957|4914214|P1|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
1492076|NCT00528957|4914213|P2|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
1492077|NCT00528957|4914214|P1|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
1492078|NCT00528931|4914355|P1|Overall Study|Lost to Follow-up|1
1492079|NCT00528879|4914367|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
1492080|NCT00528879|4914368|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
1492081|NCT00528879|4914369|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
1492082|NCT00528879|4914370|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
1492083|NCT00528879|4914367|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
1492084|NCT00528879|4914368|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
1492085|NCT00528879|4914369|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
1492086|NCT00528879|4914370|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
1492087|NCT00528879|4914367|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
1492088|NCT00528879|4914368|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
1492089|NCT00528879|4914369|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
1492090|NCT00528879|4914370|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
1492091|NCT00528879|4914367|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
1492092|NCT00528879|4914368|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
1492093|NCT00528879|4914369|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
1492094|NCT00528879|4914370|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
1492095|NCT00528879|4914367|P4|Long-term Period (Weeks 24 to 102)|Death|0
1492096|NCT00528879|4914368|P3|Long-term Period (Weeks 24 to 102)|Death|0
1492097|NCT00528879|4914369|P2|Long-term Period (Weeks 24 to 102)|Death|1
1492098|NCT00528879|4914370|P1|Long-term Period (Weeks 24 to 102)|Death|0
1492099|NCT00528879|4914367|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
1492100|NCT00528879|4914368|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
1492101|NCT00528879|4914369|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
1492102|NCT00528879|4914370|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
1492103|NCT00528879|4914367|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
1492104|NCT00528879|4914368|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
1492105|NCT00528879|4914369|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
1492106|NCT00528879|4914370|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
1492107|NCT00528879|4914367|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
1492108|NCT00528879|4914368|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
1492109|NCT00528879|4914369|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
1492110|NCT00528879|4914370|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
1492111|NCT00528879|4914367|P4|Short-term Period (Day 1 to Week 24)|Not specified|1
1492112|NCT00528879|4914368|P3|Short-term Period (Day 1 to Week 24)|Not specified|1
1492113|NCT00528879|4914369|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
1492114|NCT00528879|4914370|P1|Short-term Period (Day 1 to Week 24)|Not specified|0
1492115|NCT00528879|4914367|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
1492116|NCT00528879|4914368|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
1492117|NCT00528879|4914369|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
1492118|NCT00528879|4914370|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
1492119|NCT00528879|4914367|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
1492120|NCT00528879|4914368|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
1492121|NCT00528879|4914369|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
1492122|NCT00528879|4914370|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
1492123|NCT00528879|4914367|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
1492124|NCT00528879|4914368|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
1492125|NCT00528879|4914369|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
1492126|NCT00528879|4914370|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
1492127|NCT00528879|4914367|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
1492128|NCT00528879|4914368|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
1492129|NCT00528879|4914369|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
1492130|NCT00528879|4914370|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
1492131|NCT00528879|4914367|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
1492132|NCT00528879|4914368|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
1492133|NCT00528879|4914369|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
1492134|NCT00528879|4914370|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
1492135|NCT00528879|4914367|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
1492136|NCT00528879|4914368|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
1492137|NCT00528879|4914369|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
1492138|NCT00528879|4914370|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
1492139|NCT00528879|4914367|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
1492140|NCT00528879|4914368|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
1492141|NCT00528879|4914369|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
1492142|NCT00528879|4914370|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
1492143|NCT00528866|4914436|P1|Overall Study|Protocol Violation|6
1492144|NCT00528840|4914448|P1|Overall Study|Not Specified|2
1492145|NCT00528840|4914448|P1|Overall Study|Administrative Reasons|1
1492146|NCT00528840|4914448|P1|Overall Study|Death|2
1492147|NCT00528840|4914448|P1|Overall Study|Withdrawal by Subject|17
1492148|NCT00528840|4914448|P1|Overall Study|Adverse Event|1
1492149|NCT00528840|4914448|P1|Overall Study|Lost to Follow-up|10
1492150|NCT00528801|4914462|P2|Overall Study|Administrative Reasons|1
1492151|NCT00528801|4914463|P1|Overall Study|Administrative Reasons|0
1492152|NCT00528801|4914462|P2|Overall Study|Lost to Follow-up|4
1492153|NCT00528801|4914463|P1|Overall Study|Lost to Follow-up|15
1492154|NCT00528801|4914462|P2|Overall Study|Protocol Violation|5
1492155|NCT00528801|4914463|P1|Overall Study|Protocol Violation|11
1492156|NCT00528801|4914462|P2|Overall Study|Withdrawal by Subject|1
1492157|NCT00528801|4914463|P1|Overall Study|Withdrawal by Subject|1
1492158|NCT00528775|4914477|P1|Overall Study|Other not specified|1
1492159|NCT00528645|4914485|P1|Overall Study|Adverse Event|3
1492160|NCT00528606|4914494|P2|Overall Study|Not specified|0
1492161|NCT00528606|4914495|P1|Overall Study|Not specified|2
1492162|NCT00528606|4914494|P2|Overall Study|Adverse Event|0
1492163|NCT00528606|4914495|P1|Overall Study|Adverse Event|3
1492164|NCT00528606|4914494|P2|Overall Study|Lost to Follow-up|1
1492165|NCT00528606|4914495|P1|Overall Study|Lost to Follow-up|4
1492166|NCT00528606|4914494|P2|Overall Study|Withdrew consent|3
1492167|NCT00528606|4914495|P1|Overall Study|Withdrew consent|4
1492168|NCT00528567|4914528|P2|Overall Study|Administrative/Other|75
1492169|NCT00528567|4914529|P1|Overall Study|Administrative/Other|22
1492170|NCT00528567|4914528|P2|Overall Study|Other Protocol Violation|21
1492171|NCT00528567|4914529|P1|Overall Study|Other Protocol Violation|5
1492172|NCT00528567|4914528|P2|Overall Study|Failure to Return|4
1492173|NCT00528567|4914529|P1|Overall Study|Failure to Return|1
1492174|NCT00528567|4914528|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
1492175|NCT00528567|4914529|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
1492176|NCT00528567|4914528|P2|Overall Study|Withdrew Consent|55
1492177|NCT00528567|4914529|P1|Overall Study|Withdrew Consent|59
1492178|NCT00528567|4914528|P2|Overall Study|Violation Criteria at Entry|17
1492179|NCT00528567|4914529|P1|Overall Study|Violation Criteria at Entry|3
1492180|NCT00528567|4914528|P2|Overall Study|Adverse Event/Intermittent Illness|29
1492181|NCT00528567|4914529|P1|Overall Study|Adverse Event/Intermittent Illness|255
1492182|NCT00528567|4914528|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
1492183|NCT00528567|4914529|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
1492184|NCT00528567|4914528|P2|Overall Study|Death|5
1492185|NCT00528567|4914529|P1|Overall Study|Death|4
1492186|NCT00528528|4914596|P4|Overall Study|Ongoing participant|0
1492187|NCT00528528|4914597|P3|Overall Study|Ongoing participant|1
1492188|NCT00528528|4914598|P2|Overall Study|Ongoing participant|0
1492189|NCT00528528|4914599|P1|Overall Study|Ongoing participant|0
1492190|NCT00528528|4914596|P4|Overall Study|Withdrawal by Subject|1
1492191|NCT00528528|4914597|P3|Overall Study|Withdrawal by Subject|1
1492192|NCT00528528|4914598|P2|Overall Study|Withdrawal by Subject|2
1492193|NCT00528528|4914599|P1|Overall Study|Withdrawal by Subject|3
1492194|NCT00528528|4914596|P4|Overall Study|Other|0
1492195|NCT00528528|4914597|P3|Overall Study|Other|0
1492196|NCT00528528|4914598|P2|Overall Study|Other|1
1492197|NCT00528528|4914599|P1|Overall Study|Other|0
1492198|NCT00528528|4914596|P4|Overall Study|Ineligible to continue the trial|1
1492199|NCT00528528|4914597|P3|Overall Study|Ineligible to continue the trial|0
1492200|NCT00528528|4914598|P2|Overall Study|Ineligible to continue the trial|0
1492201|NCT00528528|4914599|P1|Overall Study|Ineligible to continue the trial|0
1492202|NCT00528528|4914596|P4|Overall Study|Lost to Follow-up|1
1492203|NCT00528528|4914597|P3|Overall Study|Lost to Follow-up|1
1492204|NCT00528528|4914598|P2|Overall Study|Lost to Follow-up|0
1492205|NCT00528528|4914599|P1|Overall Study|Lost to Follow-up|0
1492206|NCT00528424|4914637|P1|Overall Study|Not specified|12
1492207|NCT00528424|4914637|P1|Overall Study|Administrative reason|2
1492208|NCT00528424|4914637|P1|Overall Study|Withdrew consent|2
1492209|NCT00528424|4914637|P1|Overall Study|Lost to Follow-up|13
1492210|NCT00528411|4914652|P3|Overall Study|Prior commitment medication|0
1492211|NCT00528411|4914653|P2|Overall Study|Prior commitment medication|1
1492212|NCT00528411|4914654|P1|Overall Study|Prior commitment medication|0
1492213|NCT00528411|4914652|P3|Overall Study|Severe non-compliance to protocol|0
1492214|NCT00528411|4914653|P2|Overall Study|Severe non-compliance to protocol|1
1492215|NCT00528411|4914654|P1|Overall Study|Severe non-compliance to protocol|0
1492216|NCT00528411|4914652|P3|Overall Study|Incorrect Enrolment|0
1492217|NCT00528411|4914653|P2|Overall Study|Incorrect Enrolment|1
1492218|NCT00528411|4914654|P1|Overall Study|Incorrect Enrolment|1
1492219|NCT00528411|4914652|P3|Overall Study|Adverse Event|1
1492220|NCT00528411|4914653|P2|Overall Study|Adverse Event|0
1492221|NCT00528411|4914654|P1|Overall Study|Adverse Event|4
1492222|NCT00528372|4914791|P9|Long-term (LT) Period (Weeks 24-102)|Not specified|0
1492223|NCT00528372|4914792|P8|Long-term (LT) Period (Weeks 24-102)|Not specified|1
1492224|NCT00528372|4914793|P7|Long-term (LT) Period (Weeks 24-102)|Not specified|3
1492225|NCT00528372|4914794|P6|Long-term (LT) Period (Weeks 24-102)|Not specified|0
1492226|NCT00528372|4914795|P5|Long-term (LT) Period (Weeks 24-102)|Not specified|3
1492227|NCT00528372|4914796|P4|Long-term (LT) Period (Weeks 24-102)|Not specified|2
1492228|NCT00528372|4914797|P3|Long-term (LT) Period (Weeks 24-102)|Not specified|1
1492229|NCT00528372|4914798|P2|Long-term (LT) Period (Weeks 24-102)|Not specified|2
1492230|NCT00528372|4914799|P1|Long-term (LT) Period (Weeks 24-102)|Not specified|2
1492231|NCT00528372|4914791|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
1492232|NCT00528372|4914792|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1492233|NCT00528372|4914793|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
1492234|NCT00528372|4914794|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1492235|NCT00528372|4914795|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1492236|NCT00528372|4914796|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1492237|NCT00528372|4914797|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1492238|NCT00528372|4914798|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
1492239|NCT00528372|4914799|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1492240|NCT00528372|4914791|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1492241|NCT00528372|4914792|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1492242|NCT00528372|4914793|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1492243|NCT00528372|4914794|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
1492244|NCT00528372|4914795|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
1492245|NCT00528372|4914796|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1492246|NCT00528372|4914797|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1492247|NCT00528372|4914798|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1492248|NCT00528372|4914799|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1492249|NCT00528372|4914791|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
1492250|NCT00528372|4914792|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
1492251|NCT00528372|4914793|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
1492252|NCT00528372|4914794|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
1492253|NCT00528372|4914795|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
1492254|NCT00528372|4914796|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
1492255|NCT00528372|4914797|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
1492256|NCT00528372|4914798|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
1492257|NCT00528372|4914799|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
1492258|NCT00528372|4914791|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
1492259|NCT00528372|4914792|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
1492260|NCT00528372|4914793|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
1492261|NCT00528372|4914794|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
1492262|NCT00528372|4914795|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
1492263|NCT00528372|4914796|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
1492264|NCT00528372|4914797|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
1492265|NCT00528372|4914798|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
1492266|NCT00528372|4914799|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
1492267|NCT00528372|4914791|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
1492268|NCT00528372|4914792|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
1492269|NCT00528372|4914793|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
1492270|NCT00528372|4914794|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
1492271|NCT00528372|4914795|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
1492272|NCT00528372|4914796|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
1492273|NCT00528372|4914797|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
1492274|NCT00528372|4914798|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
1492275|NCT00528372|4914799|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
1492276|NCT00528372|4914791|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
1492277|NCT00528372|4914792|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
1492278|NCT00528372|4914793|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
1492279|NCT00528372|4914794|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
1492280|NCT00528372|4914795|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
1492281|NCT00528372|4914796|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
1492282|NCT00528372|4914797|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
1492283|NCT00528372|4914798|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
1492284|NCT00528372|4914799|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
1492285|NCT00528372|4914791|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
1492286|NCT00528372|4914792|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
1492287|NCT00528372|4914793|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
1492288|NCT00528372|4914794|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
1492289|NCT00528372|4914795|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
1492290|NCT00528372|4914796|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
1492291|NCT00528372|4914797|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
1492292|NCT00528372|4914798|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
1492293|NCT00528372|4914799|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
1492294|NCT00528372|4914791|P9|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
1492295|NCT00528372|4914792|P8|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
1492296|NCT00528372|4914793|P7|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
1492297|NCT00528372|4914794|P6|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
1492298|NCT00528372|4914795|P5|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
1492299|NCT00528372|4914796|P4|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
1492300|NCT00528372|4914797|P3|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
1492301|NCT00528372|4914798|P2|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
1492302|NCT00528372|4914799|P1|Short-term (ST) Period (Day 1-Week 24)|Not specified|3
1492303|NCT00528372|4914791|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1492304|NCT00528372|4914792|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1492305|NCT00528372|4914793|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1492306|NCT00528372|4914794|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
1492307|NCT00528372|4914795|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1492308|NCT00528372|4914796|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1492309|NCT00528372|4914797|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
1492310|NCT00528372|4914798|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1492311|NCT00528372|4914799|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
1492312|NCT00528372|4914791|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1492313|NCT00528372|4914792|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1492314|NCT00528372|4914793|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1492315|NCT00528372|4914794|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
1492316|NCT00528372|4914795|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1492317|NCT00528372|4914796|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
1492318|NCT00528372|4914797|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1492319|NCT00528372|4914798|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1492320|NCT00528372|4914799|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1492321|NCT00528372|4914791|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
1492322|NCT00528372|4914792|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
1492323|NCT00528372|4914793|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
1492324|NCT00528372|4914794|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
1492325|NCT00528372|4914795|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
1492326|NCT00528372|4914796|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
1492327|NCT00528372|4914797|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
1492328|NCT00528372|4914798|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
1492329|NCT00528372|4914799|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
1492330|NCT00528372|4914791|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
1492331|NCT00528372|4914792|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
1492332|NCT00528372|4914793|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
1492333|NCT00528372|4914794|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
1492334|NCT00528372|4914795|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
1492335|NCT00528372|4914796|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
1492336|NCT00528372|4914797|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
1492337|NCT00528372|4914798|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
1492338|NCT00528372|4914799|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
1492339|NCT00528372|4914791|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
1492340|NCT00528372|4914792|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
1492341|NCT00528372|4914793|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
1492342|NCT00528372|4914794|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
1492343|NCT00528372|4914795|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
1492344|NCT00528372|4914796|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
1492345|NCT00528372|4914797|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
1492346|NCT00528372|4914798|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
1492347|NCT00528372|4914799|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
1492348|NCT00528372|4914791|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1492349|NCT00528372|4914792|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1492350|NCT00528372|4914793|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1492351|NCT00528372|4914794|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1492352|NCT00528372|4914795|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1492353|NCT00528372|4914796|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1492354|NCT00528372|4914797|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1492355|NCT00528372|4914798|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1492356|NCT00528372|4914799|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
1492357|NCT00528112|4914931|P2|Extension Phase|Protocol Violation|2
1492358|NCT00528112|4914932|P1|Extension Phase|Protocol Violation|0
1492359|NCT00528112|4914931|P2|Extension Phase|Adverse Event|36
1492360|NCT00528112|4914932|P1|Extension Phase|Adverse Event|0
1492361|NCT00528112|4914931|P2|Extension Phase|Death|1
1492362|NCT00528112|4914932|P1|Extension Phase|Death|0
1492363|NCT00528112|4914931|P2|Extension Phase|Lost to Follow-up|12
1492364|NCT00528112|4914932|P1|Extension Phase|Lost to Follow-up|0
1492365|NCT00528112|4914931|P2|Extension Phase|Pregnancy|3
1492366|NCT00528112|4914932|P1|Extension Phase|Pregnancy|0
1492367|NCT00528112|4914931|P2|Extension Phase|Other reasons|100
1492368|NCT00528112|4914932|P1|Extension Phase|Other reasons|0
1492369|NCT00528112|4914931|P2|Extension Phase|Withdrawal by Subject|3
1492370|NCT00528112|4914932|P1|Extension Phase|Withdrawal by Subject|0
1492371|NCT00528112|4914931|P2|Treatment up to 3 Years|Other reasons|186
1492372|NCT00528112|4914932|P1|Treatment up to 3 Years|Other reasons|186
1492373|NCT00528112|4914931|P2|Treatment up to 3 Years|Pregnancy|10
1492374|NCT00528112|4914932|P1|Treatment up to 3 Years|Pregnancy|9
1492375|NCT00528112|4914931|P2|Treatment up to 3 Years|Lost to Follow-up|61
1492376|NCT00528112|4914932|P1|Treatment up to 3 Years|Lost to Follow-up|63
1492377|NCT00528112|4914931|P2|Treatment up to 3 Years|Death|1
1492378|NCT00528112|4914932|P1|Treatment up to 3 Years|Death|0
1492379|NCT00528112|4914931|P2|Treatment up to 3 Years|Protocol Violation|16
1492380|NCT00528112|4914932|P1|Treatment up to 3 Years|Protocol Violation|16
1492381|NCT00528112|4914931|P2|Treatment up to 3 Years|Withdrawal by Subject|31
1492382|NCT00528112|4914932|P1|Treatment up to 3 Years|Withdrawal by Subject|26
1492383|NCT00528112|4914931|P2|Treatment up to 3 Years|Adverse Event|278
1492384|NCT00528112|4914932|P1|Treatment up to 3 Years|Adverse Event|313
1492385|NCT00528021|4914990|P4|Overall Study|Lack of Efficacy|9
1492386|NCT00528021|4914991|P3|Overall Study|Lack of Efficacy|7
1492387|NCT00528021|4914992|P2|Overall Study|Lack of Efficacy|13
1492388|NCT00528021|4914993|P1|Overall Study|Lack of Efficacy|17
1492389|NCT00527982|4915005|P2|Overall Study|Physician Decision|0
1492390|NCT00527982|4915006|P1|Overall Study|Physician Decision|1
1492391|NCT00527904|4915047|P1|Overall Study|misc|22
1492392|NCT00527904|4915047|P1|Overall Study|Lost to Follow-up|8
1492393|NCT00527904|4915047|P1|Overall Study|Withdrawal by Subject|21
1492394|NCT00527904|4915047|P1|Overall Study|Adverse Event|45
1492395|NCT00527826|4915066|P2|Overall Study|Participant moved away|1
1492396|NCT00527826|4915067|P1|Overall Study|Participant moved away|0
1492397|NCT00527826|4915066|P2|Overall Study|Additional Intake of Viani forte|1
1492398|NCT00527826|4915067|P1|Overall Study|Additional Intake of Viani forte|0
1492399|NCT00527826|4915066|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
1492400|NCT00527826|4915067|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
1492401|NCT00527826|4915066|P2|Overall Study|Inclusion Criteria Not Met|3
1492402|NCT00527826|4915067|P1|Overall Study|Inclusion Criteria Not Met|3
1492403|NCT00527826|4915066|P2|Overall Study|Withdrawal by Subject|8
1492404|NCT00527826|4915067|P1|Overall Study|Withdrawal by Subject|5
1492405|NCT00527826|4915066|P2|Overall Study|Lost to Follow-up|2
1492406|NCT00527826|4915067|P1|Overall Study|Lost to Follow-up|3
1492407|NCT00527826|4915066|P2|Overall Study|Adverse Event|10
1492408|NCT00527826|4915067|P1|Overall Study|Adverse Event|10
1492409|NCT00527787|4915116|P2|Overall Study|misc|2
1492410|NCT00527787|4915117|P1|Overall Study|misc|5
1492411|NCT00527787|4915116|P2|Overall Study|Duodenal Ulcer|10
1492412|NCT00527787|4915117|P1|Overall Study|Duodenal Ulcer|1
1492413|NCT00527787|4915116|P2|Overall Study|Lost to Follow-up|2
1492414|NCT00527787|4915117|P1|Overall Study|Lost to Follow-up|5
1492415|NCT00527787|4915116|P2|Overall Study|Withdrawal by Subject|25
1492416|NCT00527787|4915117|P1|Overall Study|Withdrawal by Subject|13
1492417|NCT00527787|4915116|P2|Overall Study|Adverse Event|24
1492418|NCT00527787|4915117|P1|Overall Study|Adverse Event|14
1492419|NCT00527748|4915139|P1|Overall Study|Other|3
1492420|NCT00527735|4915146|P3|Overall Study|Completed treatment during maintenance|1
1492421|NCT00527735|4915147|P2|Overall Study|Completed treatment during maintenance|2
1492422|NCT00527735|4915148|P1|Overall Study|Completed treatment during maintenance|2
1492423|NCT00527735|4915146|P3|Overall Study|Poor compliance or noncompliance|1
1492424|NCT00527735|4915147|P2|Overall Study|Poor compliance or noncompliance|1
1492425|NCT00527735|4915148|P1|Overall Study|Poor compliance or noncompliance|0
1492426|NCT00527735|4915146|P3|Overall Study|Lost to Follow-up|3
1492427|NCT00527735|4915147|P2|Overall Study|Lost to Follow-up|0
1492428|NCT00527735|4915148|P1|Overall Study|Lost to Follow-up|0
1492429|NCT00527735|4915146|P3|Overall Study|No longer met study criteria|1
1492430|NCT00527735|4915147|P2|Overall Study|No longer met study criteria|2
1492431|NCT00527735|4915148|P1|Overall Study|No longer met study criteria|2
1492432|NCT00527735|4915146|P3|Overall Study|Withdrawal by Subject|3
1492433|NCT00527735|4915147|P2|Overall Study|Withdrawal by Subject|4
1492434|NCT00527735|4915148|P1|Overall Study|Withdrawal by Subject|5
1492435|NCT00527735|4915146|P3|Overall Study|Not identified|5
1492436|NCT00527735|4915147|P2|Overall Study|Not identified|5
1492437|NCT00527735|4915148|P1|Overall Study|Not identified|5
1492438|NCT00527735|4915146|P3|Overall Study|Adverse Event|7
1492439|NCT00527735|4915147|P2|Overall Study|Adverse Event|6
1492440|NCT00527735|4915148|P1|Overall Study|Adverse Event|10
1492441|NCT00527735|4915146|P3|Overall Study|Completed treatment in treatment phase|18
1492442|NCT00527735|4915147|P2|Overall Study|Completed treatment in treatment phase|13
1492443|NCT00527735|4915148|P1|Overall Study|Completed treatment in treatment phase|14
1492444|NCT00527735|4915146|P3|Overall Study|Death|15
1492445|NCT00527735|4915147|P2|Overall Study|Death|13
1492446|NCT00527735|4915148|P1|Overall Study|Death|23
1492447|NCT00527735|4915146|P3|Overall Study|Disease progression|53
1492448|NCT00527735|4915147|P2|Overall Study|Disease progression|61
1492449|NCT00527735|4915148|P1|Overall Study|Disease progression|47
1492450|NCT00527618|4915234|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
1492451|NCT00527618|4915235|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
1492452|NCT00527618|4915234|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
1492453|NCT00527618|4915235|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
1492454|NCT00527618|4915234|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
1492455|NCT00527618|4915235|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
1492456|NCT00527618|4915234|P2|Week 13-14 (Washout)|Lost to Follow-up|0
1492457|NCT00527618|4915235|P1|Week 13-14 (Washout)|Lost to Follow-up|1
1492458|NCT00527618|4915234|P2|Week 1-12 (First Intervention)|Adverse Event|1
1492459|NCT00527618|4915235|P1|Week 1-12 (First Intervention)|Adverse Event|0
1492460|NCT00527618|4915234|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
1492461|NCT00527618|4915235|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
1492462|NCT00527605|4915250|P2|Overall Study|Protocol Violation|2
1492463|NCT00527605|4915251|P1|Overall Study|Protocol Violation|1
1492464|NCT00527605|4915250|P2|Overall Study|Lost to Follow-up|2
1492465|NCT00527605|4915251|P1|Overall Study|Lost to Follow-up|6
1492466|NCT00527605|4915250|P2|Overall Study|Withdrawal by Subject|7
1492467|NCT00527605|4915251|P1|Overall Study|Withdrawal by Subject|3
1492468|NCT00527605|4915250|P2|Overall Study|Adverse Event|0
1492469|NCT00527605|4915251|P1|Overall Study|Adverse Event|3
1492470|NCT00527514|4915302|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
1492471|NCT00527514|4915302|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
1492472|NCT00527514|4915302|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
1492473|NCT00527514|4915302|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
1492474|NCT00527514|4915302|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
1492475|NCT00527514|4915302|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
1492476|NCT00527514|4915302|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
1492477|NCT00527488|4915318|P4|Overall Study|Withdrawn prior to dosing|0
1492478|NCT00527488|4915319|P3|Overall Study|Withdrawn prior to dosing|1
1492479|NCT00527488|4915320|P2|Overall Study|Withdrawn prior to dosing|1
1492480|NCT00527488|4915321|P1|Overall Study|Withdrawn prior to dosing|0
1492481|NCT00527423|4915404|P1|Overall Study|Death|9
1492482|NCT00527423|4915404|P1|Overall Study|OTHER|4
1492483|NCT00527423|4915404|P1|Overall Study|Lost to Follow-up|4
1492484|NCT00527423|4915404|P1|Overall Study|Withdrawal by Subject|10
1492485|NCT00527423|4915404|P1|Overall Study|Physician Decision|4
1492486|NCT00527423|4915404|P1|Overall Study|Adverse Event|5
1492487|NCT00527423|4915404|P1|Overall Study|Protocol Violation|1
1492488|NCT00527397|4915410|P1|Overall Study|Study terminated by sponsor|13
1492489|NCT00527397|4915410|P1|Overall Study|Withdrawal by Subject|6
1492490|NCT00527397|4915410|P1|Overall Study|Protocol Violation|1
1492491|NCT00527397|4915410|P1|Overall Study|Lack of Efficacy|1
1492492|NCT00527397|4915410|P1|Overall Study|Adverse Event|3
1492493|NCT00527332|4915436|P2|Overall Study|Withdrew consent|1
1492494|NCT00527332|4915437|P1|Overall Study|Withdrew consent|5
1492495|NCT00527332|4915436|P2|Overall Study|Protocol Violation|8
1492496|NCT00527332|4915437|P1|Overall Study|Protocol Violation|4
1492497|NCT00527319|4915446|P3|Overall Study|Adverse Event|1
1492498|NCT00527319|4915447|P2|Overall Study|Adverse Event|0
1492499|NCT00527319|4915448|P1|Overall Study|Adverse Event|0
1492500|NCT00527319|4915446|P3|Overall Study|Intercurrent Medical Illness|3
1492501|NCT00527319|4915447|P2|Overall Study|Intercurrent Medical Illness|1
1492502|NCT00527319|4915448|P1|Overall Study|Intercurrent Medical Illness|0
1492503|NCT00527319|4915446|P3|Overall Study|Death|1
1492504|NCT00527319|4915447|P2|Overall Study|Death|3
1492505|NCT00527319|4915448|P1|Overall Study|Death|0
1492506|NCT00527319|4915446|P3|Overall Study|Lost to Follow-up|0
1492507|NCT00527319|4915447|P2|Overall Study|Lost to Follow-up|0
1492508|NCT00527319|4915448|P1|Overall Study|Lost to Follow-up|1
1492509|NCT00527319|4915446|P3|Overall Study|Withdrawal by Subject|1
1492510|NCT00527319|4915447|P2|Overall Study|Withdrawal by Subject|0
1492511|NCT00527319|4915448|P1|Overall Study|Withdrawal by Subject|5
1492512|NCT00527111|4915478|P2|Overall Study|Other|2
1492513|NCT00527111|4915479|P1|Overall Study|Other|2
1492514|NCT00527111|4915478|P2|Overall Study|Patient Request|5
1492515|NCT00527111|4915479|P1|Overall Study|Patient Request|2
1492516|NCT00527111|4915478|P2|Overall Study|Investigator Request|1
1492517|NCT00527111|4915479|P1|Overall Study|Investigator Request|2
1492518|NCT00527111|4915478|P2|Overall Study|Death|1
1492519|NCT00527111|4915479|P1|Overall Study|Death|0
1492520|NCT00527111|4915478|P2|Overall Study|Adverse Event|13
1492521|NCT00527111|4915479|P1|Overall Study|Adverse Event|14
1492522|NCT00527072|4915501|P1|Overall Study|Withdrawal by Subject|7
1492523|NCT00527072|4915501|P1|Overall Study|Protocol Violation|2
1492524|NCT00527072|4915501|P1|Overall Study|Lost to Follow-up|3
1492525|NCT00527072|4915501|P1|Overall Study|Lack of Efficacy|11
1492526|NCT00527072|4915501|P1|Overall Study|Adverse Event|13
1492527|NCT00526994|4915510|P3|Overall Study|incarcerated, impaired, incomplete|3
1492528|NCT00526994|4915511|P2|Overall Study|incarcerated, impaired, incomplete|3
1492529|NCT00526994|4915512|P1|Overall Study|incarcerated, impaired, incomplete|4
1492530|NCT00526994|4915510|P3|Overall Study|Withdrawal by Subject|5
1492531|NCT00526994|4915511|P2|Overall Study|Withdrawal by Subject|7
1492532|NCT00526994|4915512|P1|Overall Study|Withdrawal by Subject|2
1492533|NCT00526994|4915510|P3|Overall Study|Death|3
1492534|NCT00526994|4915511|P2|Overall Study|Death|3
1492535|NCT00526994|4915512|P1|Overall Study|Death|4
1492536|NCT00526994|4915510|P3|Overall Study|Lost to Follow-up|96
1492537|NCT00526994|4915511|P2|Overall Study|Lost to Follow-up|108
1492538|NCT00526994|4915512|P1|Overall Study|Lost to Follow-up|98
1492539|NCT00526890|4915529|P1|Overall Study|Adverse Event|2
1492540|NCT00526799|4915541|P2|Overall Study|Intercurrent Complicating Disease|1
1492541|NCT00526799|4915542|P1|Overall Study|Intercurrent Complicating Disease|0
1492542|NCT00526799|4915541|P2|Overall Study|Withdrawal by Subject|0
1492543|NCT00526799|4915542|P1|Overall Study|Withdrawal by Subject|1
1492544|NCT00526669|4915550|P2|Combined Treatment Phase|Death|2
1492545|NCT00526669|4915551|P1|Combined Treatment Phase|Death|0
1492546|NCT00526669|4915550|P2|Combined Treatment Phase|Sponsor Terminated Study|2
1492547|NCT00526669|4915551|P1|Combined Treatment Phase|Sponsor Terminated Study|0
1492548|NCT00526669|4915550|P2|Combined Treatment Phase|Withdrawal by Subject|2
1492549|NCT00526669|4915551|P1|Combined Treatment Phase|Withdrawal by Subject|0
1492550|NCT00526669|4915550|P2|Combined Treatment Phase|Lost to Follow-up|2
1492551|NCT00526669|4915551|P1|Combined Treatment Phase|Lost to Follow-up|0
1492552|NCT00526630|4915580|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
1492553|NCT00526630|4915581|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
1492554|NCT00526630|4915580|P2|First Intervention Period - 12 Weeks|Withdrawn|3
1492555|NCT00526630|4915581|P1|First Intervention Period - 12 Weeks|Withdrawn|0
1492556|NCT00526331|4915680|P1|Overall Study|Sponsor Termination|55
1492557|NCT00526227|4915688|P1|Overall Study|Death|1
1492558|NCT00526227|4915688|P1|Overall Study|Device not implanted|1
1492559|NCT00526162|4915699|P1|Overall Study|Device not implanted|3
1492560|NCT00526110|4915729|P2|Overall Study|Poor Tolerance|5
1492561|NCT00526110|4915730|P1|Overall Study|Poor Tolerance|0
1492562|NCT00526110|4915729|P2|Overall Study|Withdrawal by Subject|2
1492563|NCT00526110|4915730|P1|Overall Study|Withdrawal by Subject|0
1492564|NCT00526110|4915729|P2|Overall Study|Maximal Response|6
1492565|NCT00526110|4915730|P1|Overall Study|Maximal Response|0
1492566|NCT00526110|4915729|P2|Overall Study|Disease Progression|19
1492567|NCT00526110|4915730|P1|Overall Study|Disease Progression|0
1492568|NCT00526110|4915729|P2|Overall Study|Adverse Event|9
1492569|NCT00526110|4915730|P1|Overall Study|Adverse Event|2
1492570|NCT00526097|4915739|P2|Overall Study|Other|1
1492571|NCT00526097|4915740|P1|Overall Study|Other|2
1492572|NCT00526097|4915739|P2|Overall Study|Withdrawal by Subject|1
1492573|NCT00526097|4915740|P1|Overall Study|Withdrawal by Subject|3
1492574|NCT00526097|4915739|P2|Overall Study|Protocol Violation|10
1492575|NCT00526097|4915740|P1|Overall Study|Protocol Violation|4
1492576|NCT00526097|4915739|P2|Overall Study|Adverse Event|44
1492577|NCT00526097|4915740|P1|Overall Study|Adverse Event|6
1492578|NCT00525915|4915933|P2|Overall Study|Unrelated illness|0
1492579|NCT00525915|4915934|P1|Overall Study|Unrelated illness|1
1492580|NCT00525915|4915933|P2|Overall Study|Refused Surgery|2
1492581|NCT00525915|4915934|P1|Overall Study|Refused Surgery|1
1492582|NCT00525915|4915933|P2|Overall Study|Withdrawal by Subject|0
1492583|NCT00525915|4915934|P1|Overall Study|Withdrawal by Subject|1
1492584|NCT00525915|4915933|P2|Overall Study|Disease Progression|6
1492585|NCT00525915|4915934|P1|Overall Study|Disease Progression|5
1492586|NCT00525915|4915933|P2|Overall Study|Non-Compliance|1
1492587|NCT00525915|4915934|P1|Overall Study|Non-Compliance|0
1492588|NCT00525902|4915940|P1|Overall Study|Lack of Efficacy|1
1492589|NCT00525824|4915962|P4|Overall Study|Other|1
1492590|NCT00525824|4915963|P3|Overall Study|Other|3
1492591|NCT00525824|4915964|P2|Overall Study|Other|3
1492592|NCT00525824|4915965|P1|Overall Study|Other|1
1492593|NCT00525824|4915962|P4|Overall Study|Safety reasons|0
1492594|NCT00525824|4915963|P3|Overall Study|Safety reasons|1
1492595|NCT00525824|4915964|P2|Overall Study|Safety reasons|0
1492596|NCT00525824|4915965|P1|Overall Study|Safety reasons|1
1492597|NCT00525824|4915962|P4|Overall Study|Severe non-compliance|1
1492598|NCT00525824|4915963|P3|Overall Study|Severe non-compliance|1
1492599|NCT00525824|4915964|P2|Overall Study|Severe non-compliance|1
1492600|NCT00525824|4915965|P1|Overall Study|Severe non-compliance|0
1492601|NCT00525824|4915962|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
1492602|NCT00525824|4915963|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
1492603|NCT00525824|4915964|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
1492604|NCT00525824|4915965|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
1492605|NCT00525824|4915962|P4|Overall Study|Lost to Follow-up|0
1492606|NCT00525824|4915963|P3|Overall Study|Lost to Follow-up|4
1492607|NCT00525824|4915964|P2|Overall Study|Lost to Follow-up|2
1492608|NCT00525824|4915965|P1|Overall Study|Lost to Follow-up|4
1492609|NCT00525824|4915962|P4|Overall Study|Withdrawal by Subject|4
1492610|NCT00525824|4915963|P3|Overall Study|Withdrawal by Subject|3
1492611|NCT00525824|4915964|P2|Overall Study|Withdrawal by Subject|9
1492612|NCT00525824|4915965|P1|Overall Study|Withdrawal by Subject|5
1492613|NCT00525824|4915962|P4|Overall Study|Adverse Event|7
1492614|NCT00525824|4915963|P3|Overall Study|Adverse Event|6
1492615|NCT00525824|4915964|P2|Overall Study|Adverse Event|11
1492616|NCT00525824|4915965|P1|Overall Study|Adverse Event|7
1492617|NCT00525512|4916070|P4|Open-Label Phase|Other reason (not specified)|5
1492618|NCT00525512|4916071|P3|Open-Label Phase|Other reason (not specified)|4
1492619|NCT00525512|4916072|P2|Open-Label Phase|Other reason (not specified)|0
1492620|NCT00525512|4916073|P1|Open-Label Phase|Other reason (not specified)|0
1492621|NCT00525512|4916070|P4|Open-Label Phase|Lost to Follow-up|0
1492622|NCT00525512|4916071|P3|Open-Label Phase|Lost to Follow-up|1
1492623|NCT00525512|4916072|P2|Open-Label Phase|Lost to Follow-up|0
1492624|NCT00525512|4916073|P1|Open-Label Phase|Lost to Follow-up|0
1492625|NCT00525512|4916070|P4|Open-Label Phase|Adverse Event|0
1492626|NCT00525512|4916071|P3|Open-Label Phase|Adverse Event|1
1492627|NCT00525512|4916072|P2|Open-Label Phase|Adverse Event|0
1492628|NCT00525512|4916073|P1|Open-Label Phase|Adverse Event|0
1492629|NCT00525512|4916070|P4|Double-Blind Phase|Other reason (not specified)|0
1492630|NCT00525512|4916071|P3|Double-Blind Phase|Other reason (not specified)|0
1492631|NCT00525512|4916072|P2|Double-Blind Phase|Other reason (not specified)|13
1492632|NCT00525512|4916073|P1|Double-Blind Phase|Other reason (not specified)|12
1492633|NCT00525512|4916070|P4|Double-Blind Phase|Lack of Efficacy|0
1492634|NCT00525512|4916071|P3|Double-Blind Phase|Lack of Efficacy|0
1492635|NCT00525512|4916072|P2|Double-Blind Phase|Lack of Efficacy|5
1492636|NCT00525512|4916073|P1|Double-Blind Phase|Lack of Efficacy|13
1492637|NCT00525512|4916070|P4|Double-Blind Phase|Withdrawal by Subject|0
1492638|NCT00525512|4916071|P3|Double-Blind Phase|Withdrawal by Subject|0
1492639|NCT00525512|4916072|P2|Double-Blind Phase|Withdrawal by Subject|12
1492640|NCT00525512|4916073|P1|Double-Blind Phase|Withdrawal by Subject|17
1492641|NCT00525512|4916070|P4|Double-Blind Phase|Lost to Follow-up|0
1492642|NCT00525512|4916071|P3|Double-Blind Phase|Lost to Follow-up|0
1492643|NCT00525512|4916072|P2|Double-Blind Phase|Lost to Follow-up|7
1492644|NCT00525512|4916073|P1|Double-Blind Phase|Lost to Follow-up|3
1492645|NCT00525512|4916070|P4|Double-Blind Phase|Protocol Violation|0
1492646|NCT00525512|4916071|P3|Double-Blind Phase|Protocol Violation|0
1492647|NCT00525512|4916072|P2|Double-Blind Phase|Protocol Violation|1
1492648|NCT00525512|4916073|P1|Double-Blind Phase|Protocol Violation|3
1492649|NCT00525512|4916070|P4|Double-Blind Phase|Adverse Event|0
1492650|NCT00525512|4916071|P3|Double-Blind Phase|Adverse Event|0
1492651|NCT00525512|4916072|P2|Double-Blind Phase|Adverse Event|28
1492652|NCT00525512|4916073|P1|Double-Blind Phase|Adverse Event|48
1492653|NCT00525499|4916215|P4|Overall Study|Protocol Violation|0
1492654|NCT00525499|4916216|P3|Overall Study|Protocol Violation|1
1492655|NCT00525499|4916217|P2|Overall Study|Protocol Violation|1
1492656|NCT00525499|4916218|P1|Overall Study|Protocol Violation|0
1492657|NCT00525499|4916215|P4|Overall Study|Withdrawal by Subject|2
1492658|NCT00525499|4916216|P3|Overall Study|Withdrawal by Subject|5
1492659|NCT00525499|4916217|P2|Overall Study|Withdrawal by Subject|1
1492660|NCT00525499|4916218|P1|Overall Study|Withdrawal by Subject|5
1492661|NCT00525499|4916215|P4|Overall Study|Adverse Event|1
1492662|NCT00525499|4916216|P3|Overall Study|Adverse Event|0
1492663|NCT00525499|4916217|P2|Overall Study|Adverse Event|1
1492664|NCT00525499|4916218|P1|Overall Study|Adverse Event|0
1492665|NCT00525499|4916215|P4|Overall Study|Lost to Follow-up|4
1492666|NCT00525499|4916216|P3|Overall Study|Lost to Follow-up|1
1492667|NCT00525499|4916217|P2|Overall Study|Lost to Follow-up|4
1492668|NCT00525499|4916218|P1|Overall Study|Lost to Follow-up|2
1492669|NCT00525265|4916245|P2|Overall Study|Protocol Violation|0
1492670|NCT00525265|4916246|P1|Overall Study|Protocol Violation|1
1492671|NCT00525161|4916303|P1|Overall Study|Adverse Event|1
1492672|NCT00525148|4916313|P4|Overall Study|Other than stated|3
1492673|NCT00525148|4916314|P3|Overall Study|Other than stated|0
1492674|NCT00525148|4916315|P2|Overall Study|Other than stated|1
1492675|NCT00525148|4916316|P1|Overall Study|Other than stated|2
1492676|NCT00525148|4916313|P4|Overall Study|Refused continuation of study medication|1
1492677|NCT00525148|4916314|P3|Overall Study|Refused continuation of study medication|0
1492678|NCT00525148|4916315|P2|Overall Study|Refused continuation of study medication|2
1492679|NCT00525148|4916316|P1|Overall Study|Refused continuation of study medication|0
1492680|NCT00525148|4916313|P4|Overall Study|Progressive disease|49
1492681|NCT00525148|4916314|P3|Overall Study|Progressive disease|6
1492682|NCT00525148|4916315|P2|Overall Study|Progressive disease|30
1492683|NCT00525148|4916316|P1|Overall Study|Progressive disease|18
1492684|NCT00525148|4916313|P4|Overall Study|Other Adverse Event|8
1492685|NCT00525148|4916314|P3|Overall Study|Other Adverse Event|1
1492686|NCT00525148|4916315|P2|Overall Study|Other Adverse Event|5
1492687|NCT00525148|4916316|P1|Overall Study|Other Adverse Event|3
1492688|NCT00525031|4916344|P2|Overall Study|Disease Progression|1
1492689|NCT00525031|4916345|P1|Overall Study|Disease Progression|1
1492690|NCT00524771|4916359|P2|Overall Study|Protocol Violation|585
1492691|NCT00524771|4916360|P1|Overall Study|Protocol Violation|220
1492692|NCT00524745|4916374|P4|Overall Study|subject withdrawal or lost to follow up|22
1492693|NCT00524745|4916375|P3|Overall Study|subject withdrawal or lost to follow up|29
1492694|NCT00524745|4916376|P2|Overall Study|subject withdrawal or lost to follow up|13
1492695|NCT00524745|4916377|P1|Overall Study|subject withdrawal or lost to follow up|34
1492696|NCT00524680|4916403|P4|Overall Study|Withdrawal by Subject|1
1492697|NCT00524680|4916404|P3|Overall Study|Withdrawal by Subject|1
1492698|NCT00524680|4916405|P2|Overall Study|Withdrawal by Subject|0
1492699|NCT00524680|4916406|P1|Overall Study|Withdrawal by Subject|1
1492700|NCT00524680|4916403|P4|Overall Study|not specified|3
1492701|NCT00524680|4916404|P3|Overall Study|not specified|2
1492702|NCT00524680|4916405|P2|Overall Study|not specified|1
1492703|NCT00524680|4916406|P1|Overall Study|not specified|0
1492704|NCT00524680|4916403|P4|Overall Study|Adverse Event|1
1492705|NCT00524680|4916404|P3|Overall Study|Adverse Event|0
1492706|NCT00524680|4916405|P2|Overall Study|Adverse Event|0
1492707|NCT00524680|4916406|P1|Overall Study|Adverse Event|2
1492708|NCT00524680|4916403|P4|Overall Study|progression|1
1492709|NCT00524680|4916404|P3|Overall Study|progression|0
1492710|NCT00524680|4916405|P2|Overall Study|progression|0
1492711|NCT00524680|4916406|P1|Overall Study|progression|0
1492712|NCT00524589|4916428|P1|Overall Study|Disease Progression|16
1492713|NCT00524589|4916428|P1|Overall Study|Withdrawal by Subject|2
1492714|NCT00524485|4916479|P1|Overall Study|Withdrawal by Subject|5
1492715|NCT00524459|4916489|P1|Overall Study|Other|1
1492716|NCT00524459|4916489|P1|Overall Study|Withdrawal by Subject|1
1492717|NCT00524420|4916499|P2|Overall Study|Lack of Efficacy|0
1492718|NCT00524420|4916500|P1|Overall Study|Lack of Efficacy|1
1492719|NCT00524368|4916518|P2|Overall Study|Other|2
1492720|NCT00524368|4916519|P1|Overall Study|Other|3
1492721|NCT00524368|4916518|P2|Overall Study|Ineligible to Continue the study|5
1492722|NCT00524368|4916519|P1|Overall Study|Ineligible to Continue the study|2
1492723|NCT00524368|4916518|P2|Overall Study|Sponsor's Decision|0
1492724|NCT00524368|4916519|P1|Overall Study|Sponsor's Decision|2
1492725|NCT00524368|4916518|P2|Overall Study|Reached a Virologic Endpoint|2
1492726|NCT00524368|4916519|P1|Overall Study|Reached a Virologic Endpoint|3
1492727|NCT00524368|4916518|P2|Overall Study|Non-compliant|9
1492728|NCT00524368|4916519|P1|Overall Study|Non-compliant|8
1492729|NCT00524368|4916518|P2|Overall Study|Withdrawal by Subject|5
1492730|NCT00524368|4916519|P1|Overall Study|Withdrawal by Subject|4
1492731|NCT00524368|4916518|P2|Overall Study|Lost to Follow-up|13
1492732|NCT00524368|4916519|P1|Overall Study|Lost to Follow-up|9
1492733|NCT00524368|4916518|P2|Overall Study|Adverse Event|12
1492734|NCT00524368|4916519|P1|Overall Study|Adverse Event|10
1492735|NCT00524316|4916553|P1|Overall Study|Disease Progression|7
1492736|NCT00524316|4916553|P1|Overall Study|Adverse Event|7
1492737|NCT00524316|4916553|P1|Overall Study|Withdrawal by Subject|2
1492738|NCT00524303|4916565|P3|Overall Study|Completed 5 years|1
1492739|NCT00524303|4916566|P2|Overall Study|Completed 5 years|0
1492740|NCT00524303|4916567|P1|Overall Study|Completed 5 years|0
1492741|NCT00524303|4916565|P3|Overall Study|Physician Decision|1
1492742|NCT00524303|4916566|P2|Overall Study|Physician Decision|0
1492743|NCT00524303|4916567|P1|Overall Study|Physician Decision|0
1492744|NCT00524303|4916565|P3|Overall Study|Sponsor Request|1
1492745|NCT00524303|4916566|P2|Overall Study|Sponsor Request|0
1492746|NCT00524303|4916567|P1|Overall Study|Sponsor Request|0
1492747|NCT00524303|4916565|P3|Overall Study|Disease Recurrence|0
1492748|NCT00524303|4916566|P2|Overall Study|Disease Recurrence|1
1492749|NCT00524303|4916567|P1|Overall Study|Disease Recurrence|0
1492750|NCT00524303|4916565|P3|Overall Study|Disease Progression|1
1492751|NCT00524303|4916566|P2|Overall Study|Disease Progression|4
1492752|NCT00524303|4916567|P1|Overall Study|Disease Progression|0
1492753|NCT00524303|4916565|P3|Overall Study|Worsening Peripheral Neuropathy|0
1492754|NCT00524303|4916566|P2|Overall Study|Worsening Peripheral Neuropathy|0
1492755|NCT00524303|4916567|P1|Overall Study|Worsening Peripheral Neuropathy|1
1492756|NCT00524303|4916565|P3|Overall Study|Did not Complete Study Dosing|0
1492757|NCT00524303|4916566|P2|Overall Study|Did not Complete Study Dosing|0
1492758|NCT00524303|4916567|P1|Overall Study|Did not Complete Study Dosing|1
1492759|NCT00524303|4916565|P3|Overall Study|Adverse Event|3
1492760|NCT00524303|4916566|P2|Overall Study|Adverse Event|2
1492761|NCT00524303|4916567|P1|Overall Study|Adverse Event|1
1492762|NCT00524303|4916565|P3|Overall Study|Death|3
1492763|NCT00524303|4916566|P2|Overall Study|Death|2
1492764|NCT00524303|4916567|P1|Overall Study|Death|0
1492765|NCT00524303|4916565|P3|Overall Study|Withdrawal by Subject|4
1492766|NCT00524303|4916566|P2|Overall Study|Withdrawal by Subject|0
1492767|NCT00524303|4916567|P1|Overall Study|Withdrawal by Subject|3
1492768|NCT00524303|4916565|P3|Overall Study|Protocol Violation|1
1492769|NCT00524303|4916566|P2|Overall Study|Protocol Violation|1
1492770|NCT00524303|4916567|P1|Overall Study|Protocol Violation|0
1492771|NCT00524303|4916565|P3|Overall Study|Lost to Follow-up|3
1492772|NCT00524303|4916566|P2|Overall Study|Lost to Follow-up|0
1492773|NCT00524303|4916567|P1|Overall Study|Lost to Follow-up|6
1492774|NCT00524173|4916619|P2|Overall Study|Had not reached endpoint at study close|1
1492775|NCT00524173|4916620|P1|Overall Study|Had not reached endpoint at study close|4
1492776|NCT00524173|4916619|P2|Overall Study|Death|0
1492777|NCT00524173|4916620|P1|Overall Study|Death|1
1492778|NCT00524173|4916619|P2|Overall Study|Lost to Follow-up|1
1492779|NCT00524173|4916620|P1|Overall Study|Lost to Follow-up|0
1492780|NCT00524134|4916632|P1|Overall Study|Physician Decision|1
1492781|NCT00524134|4916632|P1|Overall Study|Withdrawal by Subject|1
1492782|NCT00524121|4916639|P1|Overall Study|Not treated (changed mind)|1
1492783|NCT00524121|4916639|P1|Overall Study|Not treated (became ineligible)|4
1492784|NCT00524121|4916639|P1|Overall Study|Death|1
1492785|NCT00524121|4916639|P1|Overall Study|Other|1
1492786|NCT00524121|4916639|P1|Overall Study|Patient refused|2
1492787|NCT00524121|4916639|P1|Overall Study|Adverse Event|4
1492788|NCT00524121|4916639|P1|Overall Study|Disease progression|6
1492789|NCT00524043|4916659|P3|Overall Study|Various (eg, incarceration)|0
1492790|NCT00524043|4916660|P2|Overall Study|Various (eg, incarceration)|1
1492791|NCT00524043|4916661|P1|Overall Study|Various (eg, incarceration)|2
1492792|NCT00524043|4916659|P3|Overall Study|Lost to Follow-up|3
1492793|NCT00524043|4916660|P2|Overall Study|Lost to Follow-up|5
1492794|NCT00524043|4916661|P1|Overall Study|Lost to Follow-up|3
1492795|NCT00524043|4916659|P3|Overall Study|Adverse Event|7
1492796|NCT00524043|4916660|P2|Overall Study|Adverse Event|2
1492797|NCT00524043|4916661|P1|Overall Study|Adverse Event|5
1492798|NCT00524043|4916659|P3|Overall Study|Withdrawal by Subject|7
1492799|NCT00524043|4916660|P2|Overall Study|Withdrawal by Subject|7
1492800|NCT00524043|4916661|P1|Overall Study|Withdrawal by Subject|5
1492801|NCT00524043|4916659|P3|Overall Study|Lack of Efficacy|14
1492802|NCT00524043|4916660|P2|Overall Study|Lack of Efficacy|13
1492803|NCT00524043|4916661|P1|Overall Study|Lack of Efficacy|15
1492804|NCT00524030|4916683|P2|Overall Study|Death|1
1492805|NCT00524030|4916684|P1|Overall Study|Death|0
1492806|NCT00524030|4916683|P2|Overall Study|Adverse Event|21
1492807|NCT00524030|4916684|P1|Overall Study|Adverse Event|3
1492808|NCT00524030|4916683|P2|Overall Study|Pregnancy|0
1492809|NCT00524030|4916684|P1|Overall Study|Pregnancy|1
1492810|NCT00524030|4916683|P2|Overall Study|Protocol Violation|1
1492811|NCT00524030|4916684|P1|Overall Study|Protocol Violation|0
1492812|NCT00524030|4916683|P2|Overall Study|Noncompliance/Investigator discretion|2
1492813|NCT00524030|4916684|P1|Overall Study|Noncompliance/Investigator discretion|0
1492814|NCT00524030|4916683|P2|Overall Study|Withdrawal by Subject|8
1492815|NCT00524030|4916684|P1|Overall Study|Withdrawal by Subject|3
1492816|NCT00524030|4916683|P2|Overall Study|Lost to Follow-up|2
1492817|NCT00524030|4916684|P1|Overall Study|Lost to Follow-up|0
1492818|NCT00524030|4916683|P2|Overall Study|Lack of Efficacy|24
1492819|NCT00524030|4916684|P1|Overall Study|Lack of Efficacy|10
1492820|NCT00523991|4916702|P2|Overall Study|Other reason (not specified)|0
1492821|NCT00523991|4916703|P1|Overall Study|Other reason (not specified)|3
1492822|NCT00523991|4916702|P2|Overall Study|Withdrawal by Subject|17
1492823|NCT00523991|4916703|P1|Overall Study|Withdrawal by Subject|7
1492824|NCT00523991|4916702|P2|Overall Study|Lost to Follow-up|1
1492825|NCT00523991|4916703|P1|Overall Study|Lost to Follow-up|4
1492826|NCT00523991|4916702|P2|Overall Study|Protocol Violation|4
1492827|NCT00523991|4916703|P1|Overall Study|Protocol Violation|1
1492828|NCT00523991|4916702|P2|Overall Study|Adverse Event|5
1492829|NCT00523991|4916703|P1|Overall Study|Adverse Event|6
1492830|NCT00523978|4916983|P2|Overall Study|Death|0
1492831|NCT00523978|4916984|P1|Overall Study|Death|1
1492832|NCT00523978|4916983|P2|Overall Study|Screen Failures|1
1492833|NCT00523978|4916984|P1|Overall Study|Screen Failures|5
1492834|NCT00523978|4916983|P2|Overall Study|Withdrawal by Subject|7
1492835|NCT00523978|4916984|P1|Overall Study|Withdrawal by Subject|3
1492836|NCT00523848|4917006|P1|Overall Study|Other, unspecified|4
1492837|NCT00523848|4917006|P1|Overall Study|Disease Progression|5
1492838|NCT00523848|4917006|P1|Overall Study|NOT TREATED (Became ineligible)|2
1492839|NCT00523848|4917006|P1|Overall Study|Withdrawal by Subject|2
1492840|NCT00523848|4917006|P1|Overall Study|Adverse Event|11
1492841|NCT00523744|4917016|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
1492842|NCT00523744|4917016|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
1492843|NCT00523744|4917016|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
1492844|NCT00523744|4917016|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
1492845|NCT00523744|4917016|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
1492846|NCT00523744|4917016|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
1492847|NCT00523718|4917035|P2|Overall Study|Protocol Violation|0
1492848|NCT00523718|4917036|P1|Overall Study|Protocol Violation|2
1492849|NCT00523718|4917035|P2|Overall Study|Withdrawal by Subject|0
1492850|NCT00523718|4917036|P1|Overall Study|Withdrawal by Subject|1
1492851|NCT00523705|4917050|P2|Overall Study|No time for study.|1
1492852|NCT00523705|4917051|P1|Overall Study|No time for study.|0
1492853|NCT00523640|4917063|P1|Overall Study|Death|1
1492854|NCT00523549|4917080|P2|Overall Study|Lost to Follow-up|5
1492855|NCT00523549|4917081|P1|Overall Study|Lost to Follow-up|3
1492856|NCT00523549|4917080|P2|Overall Study|Patient withdrew consent|6
1492857|NCT00523549|4917081|P1|Overall Study|Patient withdrew consent|7
1492858|NCT00523549|4917080|P2|Overall Study|Protocol Deviation|1
1492859|NCT00523549|4917081|P1|Overall Study|Protocol Deviation|3
1492860|NCT00523549|4917080|P2|Overall Study|Unsatisfactory therapeutic effect|1
1492861|NCT00523549|4917081|P1|Overall Study|Unsatisfactory therapeutic effect|0
1492862|NCT00523549|4917080|P2|Overall Study|Adverse Event|3
1492863|NCT00523549|4917081|P1|Overall Study|Adverse Event|6
1492864|NCT00523419|4917099|P1|Overall Study|Death due to Adverse Event|2
1492865|NCT00523419|4917099|P1|Overall Study|Death due to Study Disease|4
1492866|NCT00523419|4917099|P1|Overall Study|Progressive Disease|22
1492867|NCT00523419|4917099|P1|Overall Study|Physician Decision|2
1492868|NCT00523419|4917099|P1|Overall Study|Withdrawal by Subject|1
1492869|NCT00523419|4917099|P1|Overall Study|Adverse Event|1
1492870|NCT00523367|4917109|P1|Overall Study|4 Withdrawn by PI|4
1492871|NCT00523367|4917109|P1|Overall Study|19 screen failures|19
1492872|NCT00523341|4917115|P2|Overall Study|Disease Progression|0
1492873|NCT00523341|4917116|P1|Overall Study|Disease Progression|1
1492874|NCT00523341|4917115|P2|Overall Study|Ineligibility Determined|4
1492875|NCT00523341|4917116|P1|Overall Study|Ineligibility Determined|3
1492876|NCT00523341|4917115|P2|Overall Study|Protocol Deviation|5
1492877|NCT00523341|4917116|P1|Overall Study|Protocol Deviation|6
1492878|NCT00523341|4917115|P2|Overall Study|Requirement for Alternative Therapy|14
1492879|NCT00523341|4917116|P1|Overall Study|Requirement for Alternative Therapy|4
1492880|NCT00523341|4917115|P2|Overall Study|Physician Decision|13
1492881|NCT00523341|4917116|P1|Overall Study|Physician Decision|14
1492882|NCT00523341|4917115|P2|Overall Study|Non-compliance|13
1492883|NCT00523341|4917116|P1|Overall Study|Non-compliance|20
1492884|NCT00523341|4917115|P2|Overall Study|Lost to Follow-up|61
1492885|NCT00523341|4917116|P1|Overall Study|Lost to Follow-up|73
1492886|NCT00523341|4917115|P2|Overall Study|Death|110
1492887|NCT00523341|4917116|P1|Overall Study|Death|101
1492888|NCT00523341|4917115|P2|Overall Study|Adverse Event|155
1492889|NCT00523341|4917116|P1|Overall Study|Adverse Event|122
1492890|NCT00523341|4917115|P2|Overall Study|Other|198
1492891|NCT00523341|4917116|P1|Overall Study|Other|181
1492892|NCT00523341|4917115|P2|Overall Study|Withdrawal by Subject|427
1492893|NCT00523341|4917116|P1|Overall Study|Withdrawal by Subject|399
1492894|NCT00522951|4917233|P2|Period 2|residual contrast medium|1
1492895|NCT00522951|4917234|P1|Period 2|residual contrast medium|1
1492896|NCT00522951|4917233|P2|Period 2|Withdrawal by Subject|0
1492897|NCT00522951|4917234|P1|Period 2|Withdrawal by Subject|1
1492898|NCT00522951|4917233|P2|Washout Period|Death|1
1492899|NCT00522951|4917234|P1|Washout Period|Death|0
1492900|NCT00522951|4917233|P2|Washout Period|Adverse Event|1
1492901|NCT00522951|4917234|P1|Washout Period|Adverse Event|0
1492902|NCT00522951|4917233|P2|Period 1|body motion|1
1492903|NCT00522951|4917234|P1|Period 1|body motion|0
1492904|NCT00522873|4917289|P2|Overall Study|Never Received Medication|0
1492905|NCT00522873|4917290|P1|Overall Study|Never Received Medication|1
1492906|NCT00522873|4917289|P2|Overall Study|Medication Errors|1
1492907|NCT00522873|4917290|P1|Overall Study|Medication Errors|1
1492908|NCT00522873|4917289|P2|Overall Study|Personal Reasons|1
1492909|NCT00522873|4917290|P1|Overall Study|Personal Reasons|8
1492910|NCT00522873|4917289|P2|Overall Study|Lost to Follow-up|3
1492911|NCT00522873|4917290|P1|Overall Study|Lost to Follow-up|11
1492912|NCT00522873|4917289|P2|Overall Study|Protocol Violation|4
1492913|NCT00522873|4917290|P1|Overall Study|Protocol Violation|14
1492914|NCT00522873|4917289|P2|Overall Study|Withdrawal by Subject|9
1492915|NCT00522873|4917290|P1|Overall Study|Withdrawal by Subject|20
1492916|NCT00522873|4917289|P2|Overall Study|Adverse Event|26
1492917|NCT00522873|4917290|P1|Overall Study|Adverse Event|41
1492918|NCT00522626|4917303|P1|Overall Study|Lost to Follow-up|7
1492919|NCT00522548|4917309|P2|Overall Study|Withdrawal by Subject|2
1492920|NCT00522548|4917310|P1|Overall Study|Withdrawal by Subject|0
1492921|NCT00522548|4917309|P2|Overall Study|Adverse Event|2
1492922|NCT00522548|4917310|P1|Overall Study|Adverse Event|2
1492923|NCT00522457|4917338|P1|Overall Study|Adverse Event|2
1492924|NCT00522457|4917338|P1|Overall Study|Due to disease progression|16
1492925|NCT00522431|4917344|P1|Overall Study|Other/unknown|1
1492926|NCT00522431|4917344|P1|Overall Study|Subject non-compliance|1
1492927|NCT00522431|4917344|P1|Overall Study|Withdrawal by Subject|2
1492928|NCT00522431|4917344|P1|Overall Study|Protocol Violation|2
1492929|NCT00522431|4917344|P1|Overall Study|Adverse Event|5
1492930|NCT00522418|4917351|P2|Overall Study|Lack of Efficacy|1
1492931|NCT00522418|4917352|P1|Overall Study|Lack of Efficacy|0
1492932|NCT00522418|4917351|P2|Overall Study|Consent Withdraw|2
1492933|NCT00522418|4917352|P1|Overall Study|Consent Withdraw|1
1492934|NCT00522418|4917351|P2|Overall Study|Reason Not Specified|1
1492935|NCT00522418|4917352|P1|Overall Study|Reason Not Specified|3
1492936|NCT00522418|4917351|P2|Overall Study|Noncompliance|2
1492937|NCT00522418|4917352|P1|Overall Study|Noncompliance|2
1492938|NCT00522418|4917351|P2|Overall Study|Early Study Termination|47
1492939|NCT00522418|4917352|P1|Overall Study|Early Study Termination|46
1492940|NCT00522418|4917351|P2|Overall Study|Local IRB Consent Violation|5
1492941|NCT00522418|4917352|P1|Overall Study|Local IRB Consent Violation|5
1492942|NCT00522392|4917400|P2|Overall Study|Non-compliance|1
1492943|NCT00522392|4917401|P1|Overall Study|Non-compliance|0
1492944|NCT00522392|4917400|P2|Overall Study|Physician Decision|1
1492945|NCT00522392|4917401|P1|Overall Study|Physician Decision|0
1492946|NCT00522392|4917400|P2|Overall Study|Withdrawal by Subject|1
1492947|NCT00522392|4917401|P1|Overall Study|Withdrawal by Subject|1
1492948|NCT00522392|4917400|P2|Overall Study|Adverse Event|7
1492949|NCT00522392|4917401|P1|Overall Study|Adverse Event|7
1492950|NCT00522392|4917400|P2|Overall Study|Disease progression|3
1492951|NCT00522392|4917401|P1|Overall Study|Disease progression|0
1492952|NCT00522379|4917418|P5|Overall Study|Subject Withdrawal|0
1492953|NCT00522379|4917419|P4|Overall Study|Subject Withdrawal|1
1492954|NCT00522379|4917420|P3|Overall Study|Subject Withdrawal|0
1492955|NCT00522379|4917421|P2|Overall Study|Subject Withdrawal|0
1492956|NCT00522379|4917422|P1|Overall Study|Subject Withdrawal|0
1492957|NCT00522379|4917418|P5|Overall Study|Site Closed|0
1492958|NCT00522379|4917419|P4|Overall Study|Site Closed|1
1492959|NCT00522379|4917420|P3|Overall Study|Site Closed|0
1492960|NCT00522379|4917421|P2|Overall Study|Site Closed|0
1492961|NCT00522379|4917422|P1|Overall Study|Site Closed|0
1492962|NCT00522379|4917418|P5|Overall Study|Family Problem|0
1492963|NCT00522379|4917419|P4|Overall Study|Family Problem|0
1492964|NCT00522379|4917420|P3|Overall Study|Family Problem|1
1492965|NCT00522379|4917421|P2|Overall Study|Family Problem|0
1492966|NCT00522379|4917422|P1|Overall Study|Family Problem|0
1492967|NCT00522379|4917418|P5|Overall Study|Sponsor Request|0
1492968|NCT00522379|4917419|P4|Overall Study|Sponsor Request|0
1492969|NCT00522379|4917420|P3|Overall Study|Sponsor Request|0
1492970|NCT00522379|4917421|P2|Overall Study|Sponsor Request|1
1492971|NCT00522379|4917422|P1|Overall Study|Sponsor Request|0
1492972|NCT00522379|4917418|P5|Overall Study|Subject Moved|0
1492973|NCT00522379|4917419|P4|Overall Study|Subject Moved|0
1492974|NCT00522379|4917420|P3|Overall Study|Subject Moved|0
1492975|NCT00522379|4917421|P2|Overall Study|Subject Moved|1
1492976|NCT00522379|4917422|P1|Overall Study|Subject Moved|1
1492977|NCT00522379|4917418|P5|Overall Study|Dispensing error|0
1492978|NCT00522379|4917419|P4|Overall Study|Dispensing error|1
1492979|NCT00522379|4917420|P3|Overall Study|Dispensing error|0
1492980|NCT00522379|4917421|P2|Overall Study|Dispensing error|0
1492981|NCT00522379|4917422|P1|Overall Study|Dispensing error|1
1492982|NCT00522379|4917418|P5|Overall Study|Randomization error|1
1492983|NCT00522379|4917419|P4|Overall Study|Randomization error|0
1492984|NCT00522379|4917420|P3|Overall Study|Randomization error|0
1492985|NCT00522379|4917421|P2|Overall Study|Randomization error|0
1492986|NCT00522379|4917422|P1|Overall Study|Randomization error|0
1492987|NCT00522379|4917418|P5|Overall Study|Lost to Follow-up|2
1492988|NCT00522379|4917419|P4|Overall Study|Lost to Follow-up|2
1492989|NCT00522379|4917420|P3|Overall Study|Lost to Follow-up|4
1492990|NCT00522379|4917421|P2|Overall Study|Lost to Follow-up|0
1492991|NCT00522379|4917422|P1|Overall Study|Lost to Follow-up|1
1492992|NCT00522379|4917418|P5|Overall Study|Unsatisfactory Subject Compliance|0
1492993|NCT00522379|4917419|P4|Overall Study|Unsatisfactory Subject Compliance|0
1492994|NCT00522379|4917420|P3|Overall Study|Unsatisfactory Subject Compliance|0
1492995|NCT00522379|4917421|P2|Overall Study|Unsatisfactory Subject Compliance|2
1492996|NCT00522379|4917422|P1|Overall Study|Unsatisfactory Subject Compliance|1
1492997|NCT00522379|4917418|P5|Overall Study|Protocol Violation|0
1492998|NCT00522379|4917419|P4|Overall Study|Protocol Violation|0
1492999|NCT00522379|4917420|P3|Overall Study|Protocol Violation|2
1493000|NCT00522379|4917421|P2|Overall Study|Protocol Violation|1
1493001|NCT00522379|4917422|P1|Overall Study|Protocol Violation|1
1493002|NCT00522379|4917418|P5|Overall Study|Withdrawal by Subject|0
1493003|NCT00522379|4917419|P4|Overall Study|Withdrawal by Subject|2
1493004|NCT00522379|4917420|P3|Overall Study|Withdrawal by Subject|1
1493005|NCT00522379|4917421|P2|Overall Study|Withdrawal by Subject|3
1493006|NCT00522379|4917422|P1|Overall Study|Withdrawal by Subject|2
1493007|NCT00522379|4917418|P5|Overall Study|Lack of Efficacy|7
1493008|NCT00522379|4917419|P4|Overall Study|Lack of Efficacy|2
1493009|NCT00522379|4917420|P3|Overall Study|Lack of Efficacy|2
1493010|NCT00522379|4917421|P2|Overall Study|Lack of Efficacy|0
1493011|NCT00522379|4917422|P1|Overall Study|Lack of Efficacy|3
1493012|NCT00522379|4917418|P5|Overall Study|Adverse Event|17
1493013|NCT00522379|4917419|P4|Overall Study|Adverse Event|5
1493014|NCT00522379|4917420|P3|Overall Study|Adverse Event|12
1493015|NCT00522379|4917421|P2|Overall Study|Adverse Event|15
1493016|NCT00522379|4917422|P1|Overall Study|Adverse Event|12
1493017|NCT00522301|4917524|P1|Overall Study|Adverse Event|5
1493018|NCT00522301|4917524|P1|Overall Study|Withdrawal by Subject|1
1493019|NCT00522275|4917528|P1|Overall Study|Other: Subject had surgery for epilepsy|2
1493020|NCT00522275|4917528|P1|Overall Study|Other: Subject ran out of medication|1
1493021|NCT00522275|4917528|P1|Overall Study|Other: Sponsor request|2
1493022|NCT00522275|4917528|P1|Overall Study|Other: Travel to / from site difficulty|3
1493023|NCT00522275|4917528|P1|Overall Study|Other: Site / clinic closed|4
1493024|NCT00522275|4917528|P1|Overall Study|Other: Subject arrested|1
1493025|NCT00522275|4917528|P1|Overall Study|Other: Subject relocated|2
1493026|NCT00522275|4917528|P1|Overall Study|Other: Subject is pregnant|2
1493027|NCT00522275|4917528|P1|Overall Study|Other: Subject wants to become pregnant|2
1493028|NCT00522275|4917528|P1|Overall Study|Lost to Follow-up|8
1493029|NCT00522275|4917528|P1|Overall Study|Unsatisfactory compliance|11
1493030|NCT00522275|4917528|P1|Overall Study|Protocol deviation|1
1493031|NCT00522275|4917528|P1|Overall Study|Subject withdrew consent|16
1493032|NCT00522275|4917528|P1|Overall Study|Lack of Efficacy|80
1493033|NCT00522275|4917528|P1|Overall Study|Adverse Event|35
1493034|NCT00522041|4917549|P2|Overall Study|Did not receive treatment|1
1493035|NCT00522041|4917550|P1|Overall Study|Did not receive treatment|0
1493036|NCT00522041|4917549|P2|Overall Study|Voluntary withdrawal|4
1493037|NCT00522041|4917550|P1|Overall Study|Voluntary withdrawal|5
1493038|NCT00522041|4917549|P2|Overall Study|Lost to Follow-up|4
1493039|NCT00522041|4917550|P1|Overall Study|Lost to Follow-up|1
1493040|NCT00522041|4917549|P2|Overall Study|Protocol Violation|0
1493041|NCT00522041|4917550|P1|Overall Study|Protocol Violation|2
1493042|NCT00522041|4917549|P2|Overall Study|Adverse Event|3
1493043|NCT00522041|4917550|P1|Overall Study|Adverse Event|9
1493044|NCT00521599|4917609|P3|Overall Study|Did not meet protocol eligibility|1
1493045|NCT00521599|4917610|P2|Overall Study|Did not meet protocol eligibility|2
1493046|NCT00521599|4917611|P1|Overall Study|Did not meet protocol eligibility|2
1493047|NCT00521599|4917609|P3|Overall Study|Protocol Violation|2
1493048|NCT00521599|4917610|P2|Overall Study|Protocol Violation|4
1493049|NCT00521599|4917611|P1|Overall Study|Protocol Violation|2
1493050|NCT00521599|4917609|P3|Overall Study|Withdrawal by subject treatment related|2
1493051|NCT00521599|4917610|P2|Overall Study|Withdrawal by subject treatment related|1
1493052|NCT00521599|4917611|P1|Overall Study|Withdrawal by subject treatment related|3
1493053|NCT00521599|4917609|P3|Overall Study|Withdrawal by Subject|1
1493054|NCT00521599|4917610|P2|Overall Study|Withdrawal by Subject|5
1493055|NCT00521599|4917611|P1|Overall Study|Withdrawal by Subject|3
1493056|NCT00521599|4917609|P3|Overall Study|Lost to Follow-up|2
1493057|NCT00521599|4917610|P2|Overall Study|Lost to Follow-up|1
1493058|NCT00521599|4917611|P1|Overall Study|Lost to Follow-up|2
1493059|NCT00521599|4917609|P3|Overall Study|Treatment Failure|22
1493060|NCT00521599|4917610|P2|Overall Study|Treatment Failure|9
1493061|NCT00521599|4917611|P1|Overall Study|Treatment Failure|8
1493062|NCT00521599|4917609|P3|Overall Study|Adverse Event|6
1493063|NCT00521599|4917610|P2|Overall Study|Adverse Event|7
1493064|NCT00521599|4917611|P1|Overall Study|Adverse Event|5
1493065|NCT00521586|4917622|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
1493066|NCT00521586|4917623|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
1493067|NCT00521586|4917622|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
1493068|NCT00521586|4917623|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
1493069|NCT00521586|4917622|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
1493070|NCT00521586|4917623|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
1493071|NCT00521586|4917622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
1493072|NCT00521586|4917623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
1493073|NCT00521586|4917622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
1493074|NCT00521586|4917623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
1493075|NCT00521586|4917622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
1493076|NCT00521586|4917623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
1493077|NCT00521586|4917622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
1493078|NCT00521586|4917623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
1493079|NCT00521586|4917622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
1493080|NCT00521586|4917623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
1493081|NCT00521586|4917622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
1493082|NCT00521586|4917623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
1493083|NCT00521586|4917622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
1493084|NCT00521586|4917623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
1493085|NCT00521586|4917622|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
1493086|NCT00521586|4917623|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
1493087|NCT00521586|4917622|P2|Initial Vaccination (Year 0)|Failed to return|1
1493088|NCT00521586|4917623|P1|Initial Vaccination (Year 0)|Failed to return|0
1493089|NCT00521586|4917622|P2|Initial Vaccination (Year 0)|Death|0
1493090|NCT00521586|4917623|P1|Initial Vaccination (Year 0)|Death|1
1493091|NCT00521586|4917622|P2|Initial Vaccination (Year 0)|Adverse Event|1
1493092|NCT00521586|4917623|P1|Initial Vaccination (Year 0)|Adverse Event|0
1493093|NCT00521586|4917622|P2|Initial Vaccination (Year 0)|Investigator request|0
1493094|NCT00521586|4917623|P1|Initial Vaccination (Year 0)|Investigator request|2
1493095|NCT00521586|4917622|P2|Initial Vaccination (Year 0)|Other, unspecified|1
1493096|NCT00521586|4917623|P1|Initial Vaccination (Year 0)|Other, unspecified|3
1493097|NCT00521586|4917622|P2|Initial Vaccination (Year 0)|Protocol Violation|5
1493098|NCT00521586|4917623|P1|Initial Vaccination (Year 0)|Protocol Violation|2
1493099|NCT00521586|4917622|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
1493100|NCT00521586|4917623|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
1493101|NCT00521586|4917622|P2|Initial Vaccination (Year 0)|Subject request|11
1493102|NCT00521586|4917623|P1|Initial Vaccination (Year 0)|Subject request|8
1493103|NCT00521365|4917696|P1|Overall Study|Usage of not allowed drugs|6
1493104|NCT00521365|4917696|P1|Overall Study|Drug compliance|3
1493105|NCT00521365|4917696|P1|Overall Study|Protocol deviation|2
1493106|NCT00521365|4917696|P1|Overall Study|Lost to Follow-up|6
1493107|NCT00521365|4917696|P1|Overall Study|Adverse Event|3
1493108|NCT00521339|4917726|P3|Treatment Extension Phase|Death|1
1493109|NCT00521339|4917727|P2|Treatment Extension Phase|Death|0
1493110|NCT00521339|4917728|P1|Treatment Extension Phase|Death|0
1493111|NCT00521339|4917726|P3|Treatment Extension Phase|Withdrawal by Subject|2
1493112|NCT00521339|4917727|P2|Treatment Extension Phase|Withdrawal by Subject|0
1493113|NCT00521339|4917728|P1|Treatment Extension Phase|Withdrawal by Subject|0
1493114|NCT00521339|4917726|P3|Treatment Phase|Protocol Violation|0
1493115|NCT00521339|4917727|P2|Treatment Phase|Protocol Violation|0
1493116|NCT00521339|4917728|P1|Treatment Phase|Protocol Violation|1
1493117|NCT00521339|4917726|P3|Treatment Phase|Lost to Follow-up|0
1493118|NCT00521339|4917727|P2|Treatment Phase|Lost to Follow-up|0
1493119|NCT00521339|4917728|P1|Treatment Phase|Lost to Follow-up|1
1493120|NCT00521339|4917726|P3|Treatment Phase|Withdrawal by Subject|0
1493121|NCT00521339|4917727|P2|Treatment Phase|Withdrawal by Subject|0
1493122|NCT00521339|4917728|P1|Treatment Phase|Withdrawal by Subject|3
1493123|NCT00521339|4917726|P3|Treatment Phase|Lack of Efficacy|0
1493124|NCT00521339|4917727|P2|Treatment Phase|Lack of Efficacy|0
1493125|NCT00521339|4917728|P1|Treatment Phase|Lack of Efficacy|3
1493126|NCT00521339|4917726|P3|Treatment Phase|Intolerability to study drug|0
1493127|NCT00521339|4917727|P2|Treatment Phase|Intolerability to study drug|0
1493128|NCT00521339|4917728|P1|Treatment Phase|Intolerability to study drug|2
1493129|NCT00521339|4917726|P3|Treatment Phase|Adverse Event|0
1493130|NCT00521339|4917727|P2|Treatment Phase|Adverse Event|0
1493131|NCT00521339|4917728|P1|Treatment Phase|Adverse Event|2
1493132|NCT00521144|4917796|P5|Overall Study|Progressive Disease|6
1493133|NCT00521144|4917797|P4|Overall Study|Progressive Disease|0
1493134|NCT00521144|4917798|P3|Overall Study|Progressive Disease|2
1493135|NCT00521144|4917799|P2|Overall Study|Progressive Disease|2
1493136|NCT00521144|4917800|P1|Overall Study|Progressive Disease|4
1493137|NCT00521144|4917796|P5|Overall Study|Adverse Event|1
1493138|NCT00521144|4917797|P4|Overall Study|Adverse Event|0
1493139|NCT00521144|4917798|P3|Overall Study|Adverse Event|0
1493140|NCT00521144|4917799|P2|Overall Study|Adverse Event|1
1493141|NCT00521144|4917800|P1|Overall Study|Adverse Event|0
1493142|NCT00521144|4917796|P5|Overall Study|Not Treated|0
1493143|NCT00521144|4917797|P4|Overall Study|Not Treated|1
1493144|NCT00521144|4917798|P3|Overall Study|Not Treated|0
1493145|NCT00521144|4917799|P2|Overall Study|Not Treated|0
1493146|NCT00521144|4917800|P1|Overall Study|Not Treated|0
1493147|NCT00521079|4917814|P2|Overall Study|Withdrawal by Subject|3
1493148|NCT00521079|4917815|P1|Overall Study|Withdrawal by Subject|5
1493149|NCT00521079|4917814|P2|Overall Study|Lost to Follow-up|1
1493150|NCT00521079|4917815|P1|Overall Study|Lost to Follow-up|2
1493151|NCT00521079|4917814|P2|Overall Study|Adverse Event|1
1493152|NCT00521079|4917815|P1|Overall Study|Adverse Event|7
1493153|NCT00521053|4917825|P1|Observation Phase|Physician Decision|1
1493243|NCT00520572|4917975|P6|Overall Study|Did not receive Treatment|0
1493154|NCT00521053|4917825|P1|Observation Phase|Other non-study melanoma treatment|1
1493155|NCT00521053|4917825|P1|Observation Phase|Adverse Event|1
1493156|NCT00521053|4917825|P1|Observation Phase|Death|2
1493157|NCT00521053|4917825|P1|Observation Phase|Additional PV-10 via alternate protocol|8
1493158|NCT00521053|4917825|P1|Observation Phase|Disease Progression|55
1493159|NCT00521014|4917835|P1|Overall Study|Inevaluable, not treated|1
1493160|NCT00521001|4917839|P1|Overall Study|Ineligible|1
1493161|NCT00520975|4917848|P2|Overall Study|Not start protocol therapy|2
1493162|NCT00520975|4917849|P1|Overall Study|Not start protocol therapy|1
1493163|NCT00520975|4917848|P2|Overall Study|Other reasons|2
1493164|NCT00520975|4917849|P1|Overall Study|Other reasons|4
1493165|NCT00520975|4917848|P2|Overall Study|Other therapy|4
1493166|NCT00520975|4917849|P1|Overall Study|Other therapy|2
1493167|NCT00520975|4917848|P2|Overall Study|Withdrawal by Subject|5
1493168|NCT00520975|4917849|P1|Overall Study|Withdrawal by Subject|3
1493169|NCT00520975|4917848|P2|Overall Study|Death|2
1493170|NCT00520975|4917849|P1|Overall Study|Death|0
1493171|NCT00520975|4917848|P2|Overall Study|Adverse Event|10
1493172|NCT00520975|4917849|P1|Overall Study|Adverse Event|7
1493173|NCT00520975|4917848|P2|Overall Study|Disease progression|23
1493174|NCT00520975|4917849|P1|Overall Study|Disease progression|31
1493175|NCT00520936|4917881|P8|Overall Study|Protocol Violation|0
1493176|NCT00520936|4917882|P7|Overall Study|Protocol Violation|1
1493177|NCT00520936|4917883|P6|Overall Study|Protocol Violation|0
1493178|NCT00520936|4917884|P5|Overall Study|Protocol Violation|1
1493179|NCT00520936|4917885|P4|Overall Study|Protocol Violation|0
1493180|NCT00520936|4917886|P3|Overall Study|Protocol Violation|1
1493181|NCT00520936|4917887|P2|Overall Study|Protocol Violation|1
1493182|NCT00520936|4917888|P1|Overall Study|Protocol Violation|0
1493183|NCT00520936|4917881|P8|Overall Study|Death|0
1493184|NCT00520936|4917882|P7|Overall Study|Death|1
1493185|NCT00520936|4917883|P6|Overall Study|Death|0
1493186|NCT00520936|4917884|P5|Overall Study|Death|0
1493187|NCT00520936|4917885|P4|Overall Study|Death|0
1493188|NCT00520936|4917886|P3|Overall Study|Death|0
1493189|NCT00520936|4917887|P2|Overall Study|Death|0
1493190|NCT00520936|4917888|P1|Overall Study|Death|0
1493191|NCT00520936|4917881|P8|Overall Study|Toxicity Requiring Removal from Study|0
1493192|NCT00520936|4917882|P7|Overall Study|Toxicity Requiring Removal from Study|2
1493193|NCT00520936|4917883|P6|Overall Study|Toxicity Requiring Removal from Study|0
1493194|NCT00520936|4917884|P5|Overall Study|Toxicity Requiring Removal from Study|0
1493195|NCT00520936|4917885|P4|Overall Study|Toxicity Requiring Removal from Study|0
1493196|NCT00520936|4917886|P3|Overall Study|Toxicity Requiring Removal from Study|0
1493197|NCT00520936|4917887|P2|Overall Study|Toxicity Requiring Removal from Study|1
1493198|NCT00520936|4917888|P1|Overall Study|Toxicity Requiring Removal from Study|0
1493199|NCT00520936|4917881|P8|Overall Study|Withdrawal by Subject|1
1493200|NCT00520936|4917882|P7|Overall Study|Withdrawal by Subject|0
1493201|NCT00520936|4917883|P6|Overall Study|Withdrawal by Subject|0
1493202|NCT00520936|4917884|P5|Overall Study|Withdrawal by Subject|0
1493203|NCT00520936|4917885|P4|Overall Study|Withdrawal by Subject|0
1493204|NCT00520936|4917886|P3|Overall Study|Withdrawal by Subject|0
1493205|NCT00520936|4917887|P2|Overall Study|Withdrawal by Subject|0
1493206|NCT00520936|4917888|P1|Overall Study|Withdrawal by Subject|0
1493207|NCT00520936|4917881|P8|Overall Study|Physician Decision|0
1493208|NCT00520936|4917882|P7|Overall Study|Physician Decision|0
1493209|NCT00520936|4917883|P6|Overall Study|Physician Decision|0
1493210|NCT00520936|4917884|P5|Overall Study|Physician Decision|0
1493211|NCT00520936|4917885|P4|Overall Study|Physician Decision|0
1493212|NCT00520936|4917886|P3|Overall Study|Physician Decision|1
1493213|NCT00520936|4917887|P2|Overall Study|Physician Decision|2
1493214|NCT00520936|4917888|P1|Overall Study|Physician Decision|0
1493215|NCT00520845|4917915|P1|Overall Study|Alternative Therapy|1
1493216|NCT00520845|4917915|P1|Overall Study|Withdrawal by Subject|1
1493217|NCT00520845|4917915|P1|Overall Study|Disease Progression, relapse|13
1493218|NCT00520845|4917915|P1|Overall Study|Adverse Event|4
1493219|NCT00520845|4917915|P1|Overall Study|Death|3
1493220|NCT00520767|4917923|P1|Overall Study|Death|2
1493221|NCT00520741|4917929|P2|Overall Study|Other reasons for premature termination|6
1493222|NCT00520741|4917930|P1|Overall Study|Other reasons for premature termination|0
1493223|NCT00520741|4917929|P2|Overall Study|Lost to Follow-up|4
1493224|NCT00520741|4917930|P1|Overall Study|Lost to Follow-up|4
1493225|NCT00520741|4917929|P2|Overall Study|Unsatisfactory compliance of subject|3
1493226|NCT00520741|4917930|P1|Overall Study|Unsatisfactory compliance of subject|4
1493227|NCT00520741|4917929|P2|Overall Study|Protocol Violation|15
1493228|NCT00520741|4917930|P1|Overall Study|Protocol Violation|2
1493229|NCT00520741|4917929|P2|Overall Study|Withdrawal by Subject|11
1493230|NCT00520741|4917930|P1|Overall Study|Withdrawal by Subject|0
1493231|NCT00520741|4917929|P2|Overall Study|Lack of Efficacy|30
1493232|NCT00520741|4917930|P1|Overall Study|Lack of Efficacy|11
1493233|NCT00520741|4917929|P2|Overall Study|Adverse Event|56
1493234|NCT00520741|4917930|P1|Overall Study|Adverse Event|16
1493235|NCT00520676|4917948|P2|Overall Study|Withdrawal by Subject|11
1493236|NCT00520676|4917949|P1|Overall Study|Withdrawal by Subject|7
1493237|NCT00520676|4917948|P2|Overall Study|Physician Decision|1
1493238|NCT00520676|4917949|P1|Overall Study|Physician Decision|4
1493239|NCT00520676|4917948|P2|Overall Study|Lost to Follow-up|10
1493240|NCT00520676|4917949|P1|Overall Study|Lost to Follow-up|6
1493241|NCT00520676|4917948|P2|Overall Study|Death|81
1493242|NCT00520676|4917949|P1|Overall Study|Death|84
1493244|NCT00520572|4917976|P5|Overall Study|Did not receive Treatment|0
1493245|NCT00520572|4917977|P4|Overall Study|Did not receive Treatment|0
1493246|NCT00520572|4917978|P3|Overall Study|Did not receive Treatment|1
1493247|NCT00520572|4917979|P2|Overall Study|Did not receive Treatment|0
1493248|NCT00520572|4917980|P1|Overall Study|Did not receive Treatment|1
1493249|NCT00520572|4917975|P6|Overall Study|Long break in taking Medication|0
1493250|NCT00520572|4917976|P5|Overall Study|Long break in taking Medication|0
1493251|NCT00520572|4917977|P4|Overall Study|Long break in taking Medication|1
1493252|NCT00520572|4917978|P3|Overall Study|Long break in taking Medication|0
1493253|NCT00520572|4917979|P2|Overall Study|Long break in taking Medication|0
1493254|NCT00520572|4917980|P1|Overall Study|Long break in taking Medication|0
1493255|NCT00520572|4917975|P6|Overall Study|Oral corticotherapy for acute urticaria|0
1493256|NCT00520572|4917976|P5|Overall Study|Oral corticotherapy for acute urticaria|0
1493257|NCT00520572|4917977|P4|Overall Study|Oral corticotherapy for acute urticaria|0
1493258|NCT00520572|4917978|P3|Overall Study|Oral corticotherapy for acute urticaria|0
1493259|NCT00520572|4917979|P2|Overall Study|Oral corticotherapy for acute urticaria|1
1493260|NCT00520572|4917980|P1|Overall Study|Oral corticotherapy for acute urticaria|0
1493261|NCT00520572|4917975|P6|Overall Study|Incorrect enrollment|0
1493262|NCT00520572|4917976|P5|Overall Study|Incorrect enrollment|1
1493263|NCT00520572|4917977|P4|Overall Study|Incorrect enrollment|0
1493264|NCT00520572|4917978|P3|Overall Study|Incorrect enrollment|1
1493265|NCT00520572|4917979|P2|Overall Study|Incorrect enrollment|0
1493266|NCT00520572|4917980|P1|Overall Study|Incorrect enrollment|1
1493267|NCT00520572|4917975|P6|Overall Study|Lost to Follow-up|0
1493268|NCT00520572|4917976|P5|Overall Study|Lost to Follow-up|1
1493269|NCT00520572|4917977|P4|Overall Study|Lost to Follow-up|0
1493270|NCT00520572|4917978|P3|Overall Study|Lost to Follow-up|0
1493271|NCT00520572|4917979|P2|Overall Study|Lost to Follow-up|0
1493272|NCT00520572|4917980|P1|Overall Study|Lost to Follow-up|0
1493273|NCT00520572|4917975|P6|Overall Study|Lack of Efficacy|0
1493274|NCT00520572|4917976|P5|Overall Study|Lack of Efficacy|1
1493275|NCT00520572|4917977|P4|Overall Study|Lack of Efficacy|2
1493276|NCT00520572|4917978|P3|Overall Study|Lack of Efficacy|1
1493277|NCT00520572|4917979|P2|Overall Study|Lack of Efficacy|1
1493278|NCT00520572|4917980|P1|Overall Study|Lack of Efficacy|1
1493279|NCT00520572|4917975|P6|Overall Study|Protocol Violation|0
1493280|NCT00520572|4917976|P5|Overall Study|Protocol Violation|0
1493281|NCT00520572|4917977|P4|Overall Study|Protocol Violation|0
1493282|NCT00520572|4917978|P3|Overall Study|Protocol Violation|1
1493283|NCT00520572|4917979|P2|Overall Study|Protocol Violation|0
1493284|NCT00520572|4917980|P1|Overall Study|Protocol Violation|0
1493285|NCT00520572|4917975|P6|Overall Study|Withdrawal by Subject|0
1493286|NCT00520572|4917976|P5|Overall Study|Withdrawal by Subject|2
1493287|NCT00520572|4917977|P4|Overall Study|Withdrawal by Subject|2
1493288|NCT00520572|4917978|P3|Overall Study|Withdrawal by Subject|5
1493289|NCT00520572|4917979|P2|Overall Study|Withdrawal by Subject|9
1493290|NCT00520572|4917980|P1|Overall Study|Withdrawal by Subject|0
1493291|NCT00520572|4917975|P6|Overall Study|Adverse Event|2
1493292|NCT00520572|4917976|P5|Overall Study|Adverse Event|7
1493293|NCT00520572|4917977|P4|Overall Study|Adverse Event|9
1493294|NCT00520572|4917978|P3|Overall Study|Adverse Event|6
1493295|NCT00520572|4917979|P2|Overall Study|Adverse Event|3
1493296|NCT00520572|4917980|P1|Overall Study|Adverse Event|9
1493297|NCT00520546|4918018|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
1493298|NCT00520546|4918018|P1|Overall Study|Withdrawal by Subject|1
1493299|NCT00520494|4918033|P1|Overall Study|Withdrawal by Subject|1
1493300|NCT00520481|4918058|P2|Overall Study|Withdrawal by Subject|0
1493301|NCT00520481|4918059|P1|Overall Study|Withdrawal by Subject|3
1493302|NCT00520481|4918058|P2|Overall Study|Adverse Event|1
1493303|NCT00520481|4918059|P1|Overall Study|Adverse Event|4
1493304|NCT00520403|4918083|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
1493305|NCT00520403|4918083|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
1493306|NCT00520403|4918083|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
1493307|NCT00520403|4918083|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
1493308|NCT00520403|4918083|P1|Bevacizumab + IFN/Vinblastine|Death|2
1493309|NCT00520403|4918083|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
1493310|NCT00520403|4918083|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
1493311|NCT00520403|4918083|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
1493312|NCT00520351|4918092|P2|First Intervention|Withdrawal by Subject|1
1493313|NCT00520351|4918093|P1|First Intervention|Withdrawal by Subject|1
1493314|NCT00520299|4918108|P3|Overall Study|Progressive disease|4
1493315|NCT00520299|4918109|P2|Overall Study|Progressive disease|3
1493316|NCT00520299|4918110|P1|Overall Study|Progressive disease|0
1493317|NCT00520299|4918108|P3|Overall Study|Withdrawal by Subject|2
1493318|NCT00520299|4918109|P2|Overall Study|Withdrawal by Subject|0
1493319|NCT00520299|4918110|P1|Overall Study|Withdrawal by Subject|0
1493320|NCT00520130|4918165|P2|Overall Study|Physician Decision|1
1493321|NCT00520130|4918166|P1|Overall Study|Physician Decision|1
1493322|NCT00520130|4918165|P2|Overall Study|Disease progression on study|0
1493323|NCT00520130|4918166|P1|Overall Study|Disease progression on study|4
1493324|NCT00520039|4918208|P2|Overall Study|Exclusion criteria met at first visit|5
1493325|NCT00520039|4918209|P1|Overall Study|Exclusion criteria met at first visit|7
1493326|NCT00520013|4918222|P3|Overall Study|Physician Decision|3
1493327|NCT00520013|4918223|P2|Overall Study|Physician Decision|0
1493328|NCT00520013|4918224|P1|Overall Study|Physician Decision|0
1493329|NCT00520013|4918222|P3|Overall Study|Death|0
1493330|NCT00520013|4918223|P2|Overall Study|Death|1
1493331|NCT00520013|4918224|P1|Overall Study|Death|0
1493332|NCT00520013|4918222|P3|Overall Study|Clinical Progression|0
1493333|NCT00520013|4918223|P2|Overall Study|Clinical Progression|1
1493334|NCT00520013|4918224|P1|Overall Study|Clinical Progression|3
1493335|NCT00520013|4918222|P3|Overall Study|Progressive Disease|0
1493336|NCT00520013|4918223|P2|Overall Study|Progressive Disease|3
1493337|NCT00520013|4918224|P1|Overall Study|Progressive Disease|7
1493338|NCT00520013|4918222|P3|Overall Study|Adverse Event|7
1493339|NCT00520013|4918223|P2|Overall Study|Adverse Event|10
1493340|NCT00520013|4918224|P1|Overall Study|Adverse Event|2
1493341|NCT00520013|4918222|P3|Overall Study|Withdrawal by Subject|1
1493342|NCT00520013|4918223|P2|Overall Study|Withdrawal by Subject|0
1493343|NCT00520013|4918224|P1|Overall Study|Withdrawal by Subject|0
1493344|NCT00519896|4918234|P1|Overall Study|Adverse Event|1
1493345|NCT00519896|4918234|P1|Overall Study|Protocol Violation|1
1493346|NCT00519831|4918240|P1|Overall Study|Adverse Event|3
1493347|NCT00519779|4918257|P2|Overall Study|Withdrawal by Subject|1
1493348|NCT00519779|4918258|P1|Overall Study|Withdrawal by Subject|0
1493349|NCT00519649|4918274|P1|Overall Study|Withdrawal by Subject|1
1493350|NCT00519636|4918287|P4|Post Study Period|Subject randomized in error|1
1493351|NCT00519636|4918288|P3|Post Study Period|Subject randomized in error|0
1493352|NCT00519636|4918289|P2|Post Study Period|Subject randomized in error|0
1493353|NCT00519636|4918290|P1|Post Study Period|Subject randomized in error|0
1493354|NCT00519636|4918287|P4|Treatment Period 2|Subject misrandomized|1
1493355|NCT00519636|4918288|P3|Treatment Period 2|Subject misrandomized|0
1493356|NCT00519636|4918289|P2|Treatment Period 2|Subject misrandomized|0
1493357|NCT00519636|4918290|P1|Treatment Period 2|Subject misrandomized|0
1493358|NCT00519636|4918287|P4|Treatment Period 2|Per doctors request|0
1493359|NCT00519636|4918288|P3|Treatment Period 2|Per doctors request|1
1493360|NCT00519636|4918289|P2|Treatment Period 2|Per doctors request|0
1493361|NCT00519636|4918290|P1|Treatment Period 2|Per doctors request|0
1493362|NCT00519636|4918287|P4|Treatment Period 2|Subject randomized in error|0
1493363|NCT00519636|4918288|P3|Treatment Period 2|Subject randomized in error|0
1493364|NCT00519636|4918289|P2|Treatment Period 2|Subject randomized in error|1
1493365|NCT00519636|4918290|P1|Treatment Period 2|Subject randomized in error|0
1493366|NCT00519636|4918287|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
1493367|NCT00519636|4918288|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
1493368|NCT00519636|4918289|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
1493369|NCT00519636|4918290|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
1493370|NCT00519636|4918287|P4|Washout Period|Prohibited medications|0
1493371|NCT00519636|4918288|P3|Washout Period|Prohibited medications|1
1493372|NCT00519636|4918289|P2|Washout Period|Prohibited medications|0
1493373|NCT00519636|4918290|P1|Washout Period|Prohibited medications|0
1493374|NCT00519636|4918287|P4|Washout Period|Subject randomized in error|0
1493375|NCT00519636|4918288|P3|Washout Period|Subject randomized in error|1
1493376|NCT00519636|4918289|P2|Washout Period|Subject randomized in error|0
1493377|NCT00519636|4918290|P1|Washout Period|Subject randomized in error|0
1493378|NCT00519636|4918287|P4|Washout Period|Per doctors request|0
1493379|NCT00519636|4918288|P3|Washout Period|Per doctors request|0
1493380|NCT00519636|4918289|P2|Washout Period|Per doctors request|1
1493381|NCT00519636|4918290|P1|Washout Period|Per doctors request|0
1493382|NCT00519636|4918287|P4|Washout Period|Non-compliant|0
1493383|NCT00519636|4918288|P3|Washout Period|Non-compliant|0
1493384|NCT00519636|4918289|P2|Washout Period|Non-compliant|1
1493385|NCT00519636|4918290|P1|Washout Period|Non-compliant|0
1493386|NCT00519636|4918287|P4|Washout Period|Participating in study at another site|0
1493387|NCT00519636|4918288|P3|Washout Period|Participating in study at another site|0
1493388|NCT00519636|4918289|P2|Washout Period|Participating in study at another site|0
1493389|NCT00519636|4918290|P1|Washout Period|Participating in study at another site|1
1493390|NCT00519636|4918287|P4|Washout Period|Out of pollen area > 48 hours|0
1493391|NCT00519636|4918288|P3|Washout Period|Out of pollen area > 48 hours|0
1493392|NCT00519636|4918289|P2|Washout Period|Out of pollen area > 48 hours|0
1493393|NCT00519636|4918290|P1|Washout Period|Out of pollen area > 48 hours|1
1493394|NCT00519636|4918287|P4|Washout Period|Failed to meet continuation criteria|3
1493395|NCT00519636|4918288|P3|Washout Period|Failed to meet continuation criteria|9
1493396|NCT00519636|4918289|P2|Washout Period|Failed to meet continuation criteria|11
1493397|NCT00519636|4918290|P1|Washout Period|Failed to meet continuation criteria|14
1493398|NCT00519636|4918287|P4|Washout Period|Withdrawal by Subject|0
1493399|NCT00519636|4918288|P3|Washout Period|Withdrawal by Subject|1
1493400|NCT00519636|4918289|P2|Washout Period|Withdrawal by Subject|0
1493401|NCT00519636|4918290|P1|Washout Period|Withdrawal by Subject|1
1493402|NCT00519636|4918287|P4|Washout Period|Protocol Violation|2
1493403|NCT00519636|4918288|P3|Washout Period|Protocol Violation|1
1493404|NCT00519636|4918289|P2|Washout Period|Protocol Violation|0
1493405|NCT00519636|4918290|P1|Washout Period|Protocol Violation|0
1493406|NCT00519636|4918287|P4|Washout Period|Lost to Follow-up|0
1493407|NCT00519636|4918288|P3|Washout Period|Lost to Follow-up|0
1493408|NCT00519636|4918289|P2|Washout Period|Lost to Follow-up|0
1493409|NCT00519636|4918290|P1|Washout Period|Lost to Follow-up|1
1493410|NCT00519636|4918287|P4|Washout Period|Adverse Event|0
1493411|NCT00519636|4918288|P3|Washout Period|Adverse Event|1
1493412|NCT00519636|4918289|P2|Washout Period|Adverse Event|1
1493413|NCT00519636|4918290|P1|Washout Period|Adverse Event|2
1493414|NCT00519636|4918287|P4|Treatment Period 1|Sponsor request due to missed visit|0
1493415|NCT00519636|4918288|P3|Treatment Period 1|Sponsor request due to missed visit|0
1493416|NCT00519636|4918289|P2|Treatment Period 1|Sponsor request due to missed visit|0
1493417|NCT00519636|4918290|P1|Treatment Period 1|Sponsor request due to missed visit|1
1493418|NCT00519636|4918287|P4|Treatment Period 1|Adverse Event|0
1493419|NCT00519636|4918288|P3|Treatment Period 1|Adverse Event|1
1493420|NCT00519636|4918289|P2|Treatment Period 1|Adverse Event|0
1493421|NCT00519636|4918290|P1|Treatment Period 1|Adverse Event|1
1493422|NCT00519623|4918320|P1|Overall Study|Adverse Event|1
1493423|NCT00519532|4918354|P1|Overall Study|Lost to Follow-up|2
1493424|NCT00519532|4918354|P1|Overall Study|Withdrawal by Subject|5
1493425|NCT00519532|4918354|P1|Overall Study|Adverse Event|11
1493426|NCT00519428|4918364|P3|Overall Study|unstated|2
1493427|NCT00519428|4918365|P2|Overall Study|unstated|3
1493428|NCT00519428|4918366|P1|Overall Study|unstated|1
1493429|NCT00519428|4918364|P3|Overall Study|Withdrawal by Subject|7
1493430|NCT00519428|4918365|P2|Overall Study|Withdrawal by Subject|3
1493431|NCT00519428|4918366|P1|Overall Study|Withdrawal by Subject|8
1493432|NCT00519428|4918364|P3|Overall Study|Lost to Follow-up|6
1493433|NCT00519428|4918365|P2|Overall Study|Lost to Follow-up|7
1493434|NCT00519428|4918366|P1|Overall Study|Lost to Follow-up|7
1493435|NCT00519428|4918364|P3|Overall Study|Adverse Event|10
1493436|NCT00519428|4918365|P2|Overall Study|Adverse Event|2
1493437|NCT00519428|4918366|P1|Overall Study|Adverse Event|5
1493438|NCT00519376|4918386|P16|Treatment Period 4|Lost to Follow-up|0
1493439|NCT00519376|4918387|P15|Treatment Period 4|Lost to Follow-up|0
1493440|NCT00519376|4918388|P14|Treatment Period 4|Lost to Follow-up|0
1493441|NCT00519376|4918389|P13|Treatment Period 4|Lost to Follow-up|0
1493442|NCT00519376|4918390|P12|Treatment Period 4|Lost to Follow-up|0
1493443|NCT00519376|4918391|P11|Treatment Period 4|Lost to Follow-up|0
1493444|NCT00519376|4918392|P10|Treatment Period 4|Lost to Follow-up|0
1493445|NCT00519376|4918393|P9|Treatment Period 4|Lost to Follow-up|0
1493446|NCT00519376|4918394|P8|Treatment Period 4|Lost to Follow-up|0
1493447|NCT00519376|4918395|P7|Treatment Period 4|Lost to Follow-up|0
1493448|NCT00519376|4918396|P6|Treatment Period 4|Lost to Follow-up|0
1493449|NCT00519376|4918397|P5|Treatment Period 4|Lost to Follow-up|0
1493450|NCT00519376|4918398|P4|Treatment Period 4|Lost to Follow-up|0
1493451|NCT00519376|4918399|P3|Treatment Period 4|Lost to Follow-up|1
1493452|NCT00519376|4918400|P2|Treatment Period 4|Lost to Follow-up|0
1493453|NCT00519376|4918401|P1|Treatment Period 4|Lost to Follow-up|0
1493454|NCT00519376|4918386|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1493455|NCT00519376|4918387|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1493456|NCT00519376|4918388|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1493457|NCT00519376|4918389|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
1493458|NCT00519376|4918390|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1493459|NCT00519376|4918391|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1493460|NCT00519376|4918392|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1493461|NCT00519376|4918393|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1493462|NCT00519376|4918394|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1493463|NCT00519376|4918395|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1493464|NCT00519376|4918396|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1493465|NCT00519376|4918397|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1493466|NCT00519376|4918398|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1493467|NCT00519376|4918399|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1493468|NCT00519376|4918400|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1493469|NCT00519376|4918401|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1493470|NCT00519285|4918525|P2|Overall Study|Treatment ongoing|2
1493471|NCT00519285|4918526|P1|Overall Study|Treatment ongoing|1
1493472|NCT00519285|4918525|P2|Overall Study|Not treated|7
1493473|NCT00519285|4918526|P1|Overall Study|Not treated|8
1493474|NCT00519285|4918525|P2|Overall Study|Reason unspecified|8
1493475|NCT00519285|4918526|P1|Overall Study|Reason unspecified|5
1493476|NCT00519285|4918525|P2|Overall Study|Poor compliance to protocol|7
1493477|NCT00519285|4918526|P1|Overall Study|Poor compliance to protocol|5
1493478|NCT00519285|4918525|P2|Overall Study|Consent withdrawn|5
1493479|NCT00519285|4918526|P1|Overall Study|Consent withdrawn|4
1493480|NCT00519285|4918525|P2|Overall Study|Participant's request|84
1493481|NCT00519285|4918526|P1|Overall Study|Participant's request|53
1493482|NCT00519285|4918525|P2|Overall Study|Physician Decision|47
1493483|NCT00519285|4918526|P1|Overall Study|Physician Decision|75
1493484|NCT00519285|4918525|P2|Overall Study|Disease progression|186
1493485|NCT00519285|4918526|P1|Overall Study|Disease progression|334
1493486|NCT00519285|4918525|P2|Overall Study|Adverse Event|266
1493487|NCT00519285|4918526|P1|Overall Study|Adverse Event|127
1493488|NCT00519194|4918552|P1|Overall Study|Lost to Follow-up|3
1493489|NCT00519194|4918552|P1|Overall Study|Death|9
1493490|NCT00519194|4918552|P1|Overall Study|Withdrawal by Subject|9
1493491|NCT00519077|4918567|P1|Overall Study|Other|2
1493492|NCT00519077|4918567|P1|Overall Study|Death|6
1493493|NCT00518986|4918574|P2|Overall Study|Non-Specific|1
1493494|NCT00518986|4918575|P1|Overall Study|Non-Specific|2
1493495|NCT00518986|4918574|P2|Overall Study|Withdrawal by Subject|4
1493496|NCT00518986|4918575|P1|Overall Study|Withdrawal by Subject|4
1493497|NCT00518986|4918574|P2|Overall Study|Protocol Violation|7
1493498|NCT00518986|4918575|P1|Overall Study|Protocol Violation|5
1493499|NCT00518986|4918574|P2|Overall Study|Physician Decision|3
1493500|NCT00518986|4918575|P1|Overall Study|Physician Decision|0
1493501|NCT00518986|4918574|P2|Overall Study|Lost to Follow-up|2
1493502|NCT00518986|4918575|P1|Overall Study|Lost to Follow-up|3
1493503|NCT00518986|4918574|P2|Overall Study|Lack of Efficacy|2
1493504|NCT00518986|4918575|P1|Overall Study|Lack of Efficacy|0
1493505|NCT00518986|4918574|P2|Overall Study|Adverse Event|7
1493506|NCT00518986|4918575|P1|Overall Study|Adverse Event|12
1493507|NCT00518882|4918701|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
1493508|NCT00518882|4918702|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
1493509|NCT00518882|4918701|P2|Open-Label Extension, Week 26-78|Subject decision|0
1493510|NCT00518882|4918702|P1|Open-Label Extension, Week 26-78|Subject decision|2
1493511|NCT00518882|4918701|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
1493512|NCT00518882|4918702|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
1493513|NCT00518882|4918701|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
1493514|NCT00518882|4918702|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
1493515|NCT00518882|4918701|P2|Open-Label Extension, Week 26-78|Creatine increased|0
1493516|NCT00518882|4918702|P1|Open-Label Extension, Week 26-78|Creatine increased|1
1493517|NCT00518882|4918701|P2|Open-Label Extension, Week 26-78|Change in treatment|1
1493518|NCT00518882|4918702|P1|Open-Label Extension, Week 26-78|Change in treatment|1
1493519|NCT00518882|4918701|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
1493520|NCT00518882|4918702|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
1493521|NCT00518882|4918701|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
1493522|NCT00518882|4918702|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
1493523|NCT00518882|4918701|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
1493524|NCT00518882|4918702|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
1493525|NCT00518882|4918701|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
1493526|NCT00518882|4918702|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
1493527|NCT00518882|4918701|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
1493528|NCT00518882|4918702|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
1493529|NCT00518882|4918701|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
1493530|NCT00518882|4918702|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
1493531|NCT00518882|4918701|P2|Open-Label Extension, Week 26-78|Adverse Event|9
1493532|NCT00518882|4918702|P1|Open-Label Extension, Week 26-78|Adverse Event|3
1493533|NCT00518882|4918701|P2|Double-Blind, Week 0-26|Mutual consent|1
1493534|NCT00518882|4918702|P1|Double-Blind, Week 0-26|Mutual consent|0
1493535|NCT00518882|4918701|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
1493536|NCT00518882|4918702|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
1493537|NCT00518882|4918701|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
1493538|NCT00518882|4918702|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
1493539|NCT00518882|4918701|P2|Double-Blind, Week 0-26|Loss of trust|1
1493540|NCT00518882|4918702|P1|Double-Blind, Week 0-26|Loss of trust|0
1493541|NCT00518882|4918701|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
1493542|NCT00518882|4918702|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
1493543|NCT00518882|4918701|P2|Double-Blind, Week 0-26|Subject decision|1
1493544|NCT00518882|4918702|P1|Double-Blind, Week 0-26|Subject decision|1
1493545|NCT00518882|4918701|P2|Double-Blind, Week 0-26|Lost to follow up|1
1493546|NCT00518882|4918702|P1|Double-Blind, Week 0-26|Lost to follow up|2
1493547|NCT00518882|4918701|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
1493548|NCT00518882|4918702|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
1493549|NCT00518882|4918701|P2|Double-Blind, Week 0-26|Protocol Violation|3
1493550|NCT00518882|4918702|P1|Double-Blind, Week 0-26|Protocol Violation|4
1493551|NCT00518882|4918701|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
1493552|NCT00518882|4918702|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
1493553|NCT00518882|4918701|P2|Double-Blind, Week 0-26|Adverse Event|31
1493554|NCT00518882|4918702|P1|Double-Blind, Week 0-26|Adverse Event|23
1493555|NCT00518687|4918883|P2|Overall Study|Withdrawal by Subject|110
1493556|NCT00518687|4918884|P1|Overall Study|Withdrawal by Subject|110
1493557|NCT00518687|4918883|P2|Overall Study|Study terminated by sponsor|918
1493558|NCT00518687|4918884|P1|Overall Study|Study terminated by sponsor|930
1493559|NCT00518687|4918883|P2|Overall Study|Protocol Violation|10
1493560|NCT00518687|4918884|P1|Overall Study|Protocol Violation|8
1493561|NCT00518687|4918883|P2|Overall Study|Progressive disease|2
1493562|NCT00518687|4918884|P1|Overall Study|Progressive disease|2
1493563|NCT00518687|4918883|P2|Overall Study|Physician Decision|48
1493564|NCT00518687|4918884|P1|Overall Study|Physician Decision|42
1493565|NCT00518687|4918883|P2|Overall Study|Lost to Follow-up|155
1493566|NCT00518687|4918884|P1|Overall Study|Lost to Follow-up|144
1493567|NCT00518687|4918883|P2|Overall Study|Adverse Event|177
1493568|NCT00518687|4918884|P1|Overall Study|Adverse Event|201
1493569|NCT00518622|4918904|P8|Overall Study|Study medication taken incorrectly|0
1493570|NCT00518622|4918905|P7|Overall Study|Study medication taken incorrectly|0
1493571|NCT00518622|4918906|P6|Overall Study|Study medication taken incorrectly|0
1493572|NCT00518622|4918907|P5|Overall Study|Study medication taken incorrectly|0
1493573|NCT00518622|4918908|P4|Overall Study|Study medication taken incorrectly|0
1493574|NCT00518622|4918909|P3|Overall Study|Study medication taken incorrectly|0
1493575|NCT00518622|4918910|P2|Overall Study|Study medication taken incorrectly|1
1493576|NCT00518622|4918911|P1|Overall Study|Study medication taken incorrectly|0
1493577|NCT00518622|4918904|P8|Overall Study|Lost to Follow-up|0
1493578|NCT00518622|4918905|P7|Overall Study|Lost to Follow-up|0
1493579|NCT00518622|4918906|P6|Overall Study|Lost to Follow-up|0
1493580|NCT00518622|4918907|P5|Overall Study|Lost to Follow-up|0
1493581|NCT00518622|4918908|P4|Overall Study|Lost to Follow-up|0
1493582|NCT00518622|4918909|P3|Overall Study|Lost to Follow-up|1
1493583|NCT00518622|4918910|P2|Overall Study|Lost to Follow-up|0
1493584|NCT00518622|4918911|P1|Overall Study|Lost to Follow-up|0
1493585|NCT00518531|4918939|P2|Treatment Period 2|Non-compliance|2
1493586|NCT00518531|4918940|P1|Treatment Period 2|Non-compliance|1
1493587|NCT00518531|4918939|P2|Treatment Period 2|Protocol-specified criteria|1
1493588|NCT00518531|4918940|P1|Treatment Period 2|Protocol-specified criteria|0
1493589|NCT00518531|4918939|P2|Treatment Period 2|Adverse Event|7
1493590|NCT00518531|4918940|P1|Treatment Period 2|Adverse Event|1
1493591|NCT00518531|4918939|P2|Treatment Period 2|Complete out of scheduled visit window|2
1493592|NCT00518531|4918940|P1|Treatment Period 2|Complete out of scheduled visit window|1
1493593|NCT00518531|4918939|P2|Treatment Period 2|Withdrawal by Subject|8
1493594|NCT00518531|4918940|P1|Treatment Period 2|Withdrawal by Subject|0
1493595|NCT00518531|4918939|P2|Treatment Period 1|Early crossover|3
1493596|NCT00518531|4918940|P1|Treatment Period 1|Early crossover|1
1493597|NCT00518531|4918939|P2|Treatment Period 1|Withdrawal by Subject|6
1493598|NCT00518531|4918940|P1|Treatment Period 1|Withdrawal by Subject|4
1493599|NCT00518531|4918939|P2|Treatment Period 1|Protocol Violation|0
1493600|NCT00518531|4918940|P1|Treatment Period 1|Protocol Violation|2
1493601|NCT00518531|4918939|P2|Treatment Period 1|Physician Decision|0
1493602|NCT00518531|4918940|P1|Treatment Period 1|Physician Decision|1
1493603|NCT00518531|4918939|P2|Treatment Period 1|Lost to Follow-up|3
1493604|NCT00518531|4918940|P1|Treatment Period 1|Lost to Follow-up|5
1493605|NCT00518531|4918939|P2|Treatment Period 1|Adverse Event|0
1493606|NCT00518531|4918940|P1|Treatment Period 1|Adverse Event|5
1493607|NCT00518336|4918985|P2|Year 9|Personal reasons|0
1493608|NCT00518336|4918986|P1|Year 9|Personal reasons|1
1493609|NCT00518336|4918985|P2|Year 9|Lost to Follow-up|0
1493610|NCT00518336|4918986|P1|Year 9|Lost to Follow-up|3
1493611|NCT00518336|4918985|P2|Year 9|Migrated/moved from study area|1
1493612|NCT00518336|4918986|P1|Year 9|Migrated/moved from study area|1
1493613|NCT00518336|4918985|P2|Year 8|Could not attend in time|1
1493614|NCT00518336|4918986|P1|Year 8|Could not attend in time|0
1493615|NCT00518336|4918985|P2|Year 8|Lost to Follow-up|1
1493616|NCT00518336|4918986|P1|Year 8|Lost to Follow-up|1
1493617|NCT00518336|4918985|P2|Year 7|Could not attend in time|3
1493618|NCT00518336|4918986|P1|Year 7|Could not attend in time|0
1493619|NCT00518336|4918985|P2|Year 7|Lost to Follow-up|0
1493620|NCT00518336|4918986|P1|Year 7|Lost to Follow-up|2
1493621|NCT00518323|4919152|P4|Overall Study|Prohibited medication and others|0
1493622|NCT00518323|4919153|P3|Overall Study|Prohibited medication and others|1
1493623|NCT00518323|4919154|P2|Overall Study|Prohibited medication and others|1
1493624|NCT00518323|4919155|P1|Overall Study|Prohibited medication and others|3
1493625|NCT00518323|4919152|P4|Overall Study|Adverse Event|0
1493626|NCT00518323|4919153|P3|Overall Study|Adverse Event|1
1493627|NCT00518323|4919154|P2|Overall Study|Adverse Event|1
1493628|NCT00518323|4919155|P1|Overall Study|Adverse Event|1
1493629|NCT00518323|4919152|P4|Overall Study|Lost to Follow-up|3
1493630|NCT00518323|4919153|P3|Overall Study|Lost to Follow-up|1
1493631|NCT00518323|4919154|P2|Overall Study|Lost to Follow-up|2
1493632|NCT00518323|4919155|P1|Overall Study|Lost to Follow-up|0
1493633|NCT00518323|4919152|P4|Overall Study|Withdrawal by Subject|2
1493634|NCT00518323|4919153|P3|Overall Study|Withdrawal by Subject|4
1493635|NCT00518323|4919154|P2|Overall Study|Withdrawal by Subject|2
1493636|NCT00518323|4919155|P1|Overall Study|Withdrawal by Subject|1
1493637|NCT00518323|4919152|P4|Overall Study|Lack of Efficacy|20
1493638|NCT00518323|4919153|P3|Overall Study|Lack of Efficacy|4
1493639|NCT00518323|4919154|P2|Overall Study|Lack of Efficacy|2
1493640|NCT00518323|4919155|P1|Overall Study|Lack of Efficacy|14
1493641|NCT00518284|4919185|P4|Overall Study|Study Termination|2
1493642|NCT00518284|4919186|P3|Overall Study|Study Termination|1
1493643|NCT00518284|4919187|P2|Overall Study|Study Termination|2
1493644|NCT00518284|4919188|P1|Overall Study|Study Termination|0
1493645|NCT00518284|4919185|P4|Overall Study|Adverse Event|0
1493646|NCT00518284|4919186|P3|Overall Study|Adverse Event|0
1493647|NCT00518284|4919187|P2|Overall Study|Adverse Event|1
1493648|NCT00518284|4919188|P1|Overall Study|Adverse Event|0
1493649|NCT00518206|4919244|P2|Overall Study|Completion Status Unknown|0
1493650|NCT00518206|4919245|P1|Overall Study|Completion Status Unknown|1
1493651|NCT00518206|4919244|P2|Overall Study|Reason Unknown|0
1493652|NCT00518206|4919245|P1|Overall Study|Reason Unknown|1
1493653|NCT00518206|4919244|P2|Overall Study|Drug Supply Issue|0
1493654|NCT00518206|4919245|P1|Overall Study|Drug Supply Issue|1
1493655|NCT00518206|4919244|P2|Overall Study|Withdrawal by Subject|0
1493656|NCT00518206|4919245|P1|Overall Study|Withdrawal by Subject|2
1493657|NCT00518206|4919244|P2|Overall Study|Disease Progression Requiring Therapy|6
1493658|NCT00518206|4919245|P1|Overall Study|Disease Progression Requiring Therapy|6
1493659|NCT00518180|4919262|P3|Overall Study|Adverse Event|0
1493660|NCT00518180|4919263|P2|Overall Study|Adverse Event|0
1493661|NCT00518180|4919264|P1|Overall Study|Adverse Event|1
1493662|NCT00518180|4919262|P3|Overall Study|Unable to classify|0
1493663|NCT00518180|4919263|P2|Overall Study|Unable to classify|2
1493664|NCT00518180|4919264|P1|Overall Study|Unable to classify|0
1493665|NCT00518180|4919262|P3|Overall Study|Protocol Violation|4
1493666|NCT00518180|4919263|P2|Overall Study|Protocol Violation|7
1493667|NCT00518180|4919264|P1|Overall Study|Protocol Violation|5
1493668|NCT00518180|4919262|P3|Overall Study|Administrative reason|2
1493669|NCT00518180|4919263|P2|Overall Study|Administrative reason|2
1493670|NCT00518180|4919264|P1|Overall Study|Administrative reason|0
1493671|NCT00518180|4919262|P3|Overall Study|Lost to Follow-up|34
1493672|NCT00518180|4919263|P2|Overall Study|Lost to Follow-up|28
1493673|NCT00518180|4919264|P1|Overall Study|Lost to Follow-up|30
1493674|NCT00518180|4919262|P3|Overall Study|Withdrawal by Subject|42
1493675|NCT00518180|4919263|P2|Overall Study|Withdrawal by Subject|30
1493676|NCT00518180|4919264|P1|Overall Study|Withdrawal by Subject|29
1493677|NCT00518115|4919316|P10|Overall Study|Moved Out of State|1
1493678|NCT00518115|4919317|P9|Overall Study|Moved Out of State|0
1493679|NCT00518115|4919318|P8|Overall Study|Moved Out of State|0
1493680|NCT00518115|4919319|P7|Overall Study|Moved Out of State|0
1493681|NCT00518115|4919320|P6|Overall Study|Moved Out of State|0
1493682|NCT00518115|4919321|P5|Overall Study|Moved Out of State|0
1493683|NCT00518115|4919322|P4|Overall Study|Moved Out of State|0
1493684|NCT00518115|4919323|P3|Overall Study|Moved Out of State|0
1493685|NCT00518115|4919324|P2|Overall Study|Moved Out of State|0
1493686|NCT00518115|4919325|P1|Overall Study|Moved Out of State|0
1493687|NCT00518115|4919316|P10|Overall Study|Withdrew Consent|0
1493688|NCT00518115|4919317|P9|Overall Study|Withdrew Consent|0
1493689|NCT00518115|4919318|P8|Overall Study|Withdrew Consent|0
1493690|NCT00518115|4919319|P7|Overall Study|Withdrew Consent|0
1493691|NCT00518115|4919320|P6|Overall Study|Withdrew Consent|1
1493692|NCT00518115|4919321|P5|Overall Study|Withdrew Consent|0
1493693|NCT00518115|4919322|P4|Overall Study|Withdrew Consent|0
1493694|NCT00518115|4919323|P3|Overall Study|Withdrew Consent|0
1493695|NCT00518115|4919324|P2|Overall Study|Withdrew Consent|0
1493696|NCT00518115|4919325|P1|Overall Study|Withdrew Consent|0
1493697|NCT00518115|4919316|P10|Overall Study|Family Emergency; Had to Go to England|0
1493698|NCT00518115|4919317|P9|Overall Study|Family Emergency; Had to Go to England|0
1493699|NCT00518115|4919318|P8|Overall Study|Family Emergency; Had to Go to England|0
1493700|NCT00518115|4919319|P7|Overall Study|Family Emergency; Had to Go to England|0
1493701|NCT00518115|4919320|P6|Overall Study|Family Emergency; Had to Go to England|0
1493702|NCT00518115|4919321|P5|Overall Study|Family Emergency; Had to Go to England|1
1493703|NCT00518115|4919322|P4|Overall Study|Family Emergency; Had to Go to England|0
1493704|NCT00518115|4919323|P3|Overall Study|Family Emergency; Had to Go to England|0
1493705|NCT00518115|4919324|P2|Overall Study|Family Emergency; Had to Go to England|0
1493706|NCT00518115|4919325|P1|Overall Study|Family Emergency; Had to Go to England|0
1493707|NCT00518115|4919316|P10|Overall Study|Violation of Exclusion Criteria|0
1493708|NCT00518115|4919317|P9|Overall Study|Violation of Exclusion Criteria|0
1493709|NCT00518115|4919318|P8|Overall Study|Violation of Exclusion Criteria|0
1493710|NCT00518115|4919319|P7|Overall Study|Violation of Exclusion Criteria|1
1493711|NCT00518115|4919320|P6|Overall Study|Violation of Exclusion Criteria|0
1493712|NCT00518115|4919321|P5|Overall Study|Violation of Exclusion Criteria|0
1493713|NCT00518115|4919322|P4|Overall Study|Violation of Exclusion Criteria|1
1493714|NCT00518115|4919323|P3|Overall Study|Violation of Exclusion Criteria|0
1493715|NCT00518115|4919324|P2|Overall Study|Violation of Exclusion Criteria|0
1493716|NCT00518115|4919325|P1|Overall Study|Violation of Exclusion Criteria|0
1493717|NCT00518115|4919316|P10|Overall Study|Wrong Monotherapy Administered|0
1493718|NCT00518115|4919317|P9|Overall Study|Wrong Monotherapy Administered|0
1493719|NCT00518115|4919318|P8|Overall Study|Wrong Monotherapy Administered|0
1493720|NCT00518115|4919319|P7|Overall Study|Wrong Monotherapy Administered|1
1493721|NCT00518115|4919320|P6|Overall Study|Wrong Monotherapy Administered|0
1493722|NCT00518115|4919321|P5|Overall Study|Wrong Monotherapy Administered|0
1493723|NCT00518115|4919322|P4|Overall Study|Wrong Monotherapy Administered|0
1493724|NCT00518115|4919323|P3|Overall Study|Wrong Monotherapy Administered|1
1493725|NCT00518115|4919324|P2|Overall Study|Wrong Monotherapy Administered|0
1493726|NCT00518115|4919325|P1|Overall Study|Wrong Monotherapy Administered|0
1493727|NCT00518115|4919316|P10|Overall Study|Different Monotherapy Diabetic Drug|0
1493728|NCT00518115|4919317|P9|Overall Study|Different Monotherapy Diabetic Drug|1
1493729|NCT00518115|4919318|P8|Overall Study|Different Monotherapy Diabetic Drug|0
1493730|NCT00518115|4919319|P7|Overall Study|Different Monotherapy Diabetic Drug|0
1493731|NCT00518115|4919320|P6|Overall Study|Different Monotherapy Diabetic Drug|0
1493732|NCT00518115|4919321|P5|Overall Study|Different Monotherapy Diabetic Drug|0
1493733|NCT00518115|4919322|P4|Overall Study|Different Monotherapy Diabetic Drug|0
1493734|NCT00518115|4919323|P3|Overall Study|Different Monotherapy Diabetic Drug|1
1493735|NCT00518115|4919324|P2|Overall Study|Different Monotherapy Diabetic Drug|0
1493736|NCT00518115|4919325|P1|Overall Study|Different Monotherapy Diabetic Drug|0
1493737|NCT00518115|4919316|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
1493738|NCT00518115|4919317|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
1493739|NCT00518115|4919318|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
1493740|NCT00518115|4919319|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
1493741|NCT00518115|4919320|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
1493742|NCT00518115|4919321|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
1493743|NCT00518115|4919322|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
1493744|NCT00518115|4919323|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
1493745|NCT00518115|4919324|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
1493746|NCT00518115|4919325|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
1493747|NCT00518115|4919316|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
1493748|NCT00518115|4919317|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
1493749|NCT00518115|4919318|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
1493750|NCT00518115|4919319|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
1493751|NCT00518115|4919320|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
1493752|NCT00518115|4919321|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
1493753|NCT00518115|4919322|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
1493754|NCT00518115|4919323|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
1493755|NCT00518115|4919324|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
1493756|NCT00518115|4919325|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
1493757|NCT00518115|4919316|P10|Overall Study|Non-Compliance|1
1493758|NCT00518115|4919317|P9|Overall Study|Non-Compliance|0
1493759|NCT00518115|4919318|P8|Overall Study|Non-Compliance|1
1493760|NCT00518115|4919319|P7|Overall Study|Non-Compliance|1
1493761|NCT00518115|4919320|P6|Overall Study|Non-Compliance|1
1493762|NCT00518115|4919321|P5|Overall Study|Non-Compliance|1
1493763|NCT00518115|4919322|P4|Overall Study|Non-Compliance|0
1493764|NCT00518115|4919323|P3|Overall Study|Non-Compliance|1
1493765|NCT00518115|4919324|P2|Overall Study|Non-Compliance|0
1493766|NCT00518115|4919325|P1|Overall Study|Non-Compliance|1
1493767|NCT00518115|4919316|P10|Overall Study|Lack of Efficacy|0
1493768|NCT00518115|4919317|P9|Overall Study|Lack of Efficacy|0
1493769|NCT00518115|4919318|P8|Overall Study|Lack of Efficacy|1
1493770|NCT00518115|4919319|P7|Overall Study|Lack of Efficacy|0
1493771|NCT00518115|4919320|P6|Overall Study|Lack of Efficacy|0
1493772|NCT00518115|4919321|P5|Overall Study|Lack of Efficacy|0
1493773|NCT00518115|4919322|P4|Overall Study|Lack of Efficacy|1
1493774|NCT00518115|4919323|P3|Overall Study|Lack of Efficacy|1
1493775|NCT00518115|4919324|P2|Overall Study|Lack of Efficacy|0
1493776|NCT00518115|4919325|P1|Overall Study|Lack of Efficacy|1
1493777|NCT00518115|4919316|P10|Overall Study|Withdrawal by Subject|3
1493778|NCT00518115|4919317|P9|Overall Study|Withdrawal by Subject|1
1493779|NCT00518115|4919318|P8|Overall Study|Withdrawal by Subject|2
1493780|NCT00518115|4919319|P7|Overall Study|Withdrawal by Subject|0
1493781|NCT00518115|4919320|P6|Overall Study|Withdrawal by Subject|1
1493782|NCT00518115|4919321|P5|Overall Study|Withdrawal by Subject|2
1493783|NCT00518115|4919322|P4|Overall Study|Withdrawal by Subject|0
1493784|NCT00518115|4919323|P3|Overall Study|Withdrawal by Subject|5
1493785|NCT00518115|4919324|P2|Overall Study|Withdrawal by Subject|1
1493786|NCT00518115|4919325|P1|Overall Study|Withdrawal by Subject|1
1493787|NCT00518115|4919316|P10|Overall Study|Protocol Violation|0
1493788|NCT00518115|4919317|P9|Overall Study|Protocol Violation|0
1493789|NCT00518115|4919318|P8|Overall Study|Protocol Violation|0
1493790|NCT00518115|4919319|P7|Overall Study|Protocol Violation|0
1493791|NCT00518115|4919320|P6|Overall Study|Protocol Violation|0
1493792|NCT00518115|4919321|P5|Overall Study|Protocol Violation|0
1493793|NCT00518115|4919322|P4|Overall Study|Protocol Violation|0
1493794|NCT00518115|4919323|P3|Overall Study|Protocol Violation|1
1493795|NCT00518115|4919324|P2|Overall Study|Protocol Violation|3
1493796|NCT00518115|4919325|P1|Overall Study|Protocol Violation|1
1493797|NCT00518115|4919316|P10|Overall Study|Lost to Follow-up|1
1493798|NCT00518115|4919317|P9|Overall Study|Lost to Follow-up|1
1493799|NCT00518115|4919318|P8|Overall Study|Lost to Follow-up|1
1493800|NCT00518115|4919319|P7|Overall Study|Lost to Follow-up|0
1493801|NCT00518115|4919320|P6|Overall Study|Lost to Follow-up|3
1493802|NCT00518115|4919321|P5|Overall Study|Lost to Follow-up|1
1493803|NCT00518115|4919322|P4|Overall Study|Lost to Follow-up|3
1493804|NCT00518115|4919323|P3|Overall Study|Lost to Follow-up|2
1493805|NCT00518115|4919324|P2|Overall Study|Lost to Follow-up|0
1493806|NCT00518115|4919325|P1|Overall Study|Lost to Follow-up|0
1493807|NCT00518115|4919316|P10|Overall Study|Adverse Event|9
1493808|NCT00518115|4919317|P9|Overall Study|Adverse Event|2
1493809|NCT00518115|4919318|P8|Overall Study|Adverse Event|10
1493810|NCT00518115|4919319|P7|Overall Study|Adverse Event|5
1493811|NCT00518115|4919320|P6|Overall Study|Adverse Event|5
1493812|NCT00518115|4919321|P5|Overall Study|Adverse Event|5
1493813|NCT00518115|4919322|P4|Overall Study|Adverse Event|6
1493814|NCT00518115|4919323|P3|Overall Study|Adverse Event|5
1493815|NCT00518115|4919324|P2|Overall Study|Adverse Event|1
1493816|NCT00518115|4919325|P1|Overall Study|Adverse Event|6
1493817|NCT00518011|4919500|P2|Overall Study|Withdrawal by Subject|0
1493818|NCT00518011|4919501|P1|Overall Study|Withdrawal by Subject|1
1493819|NCT00518011|4919500|P2|Overall Study|Other Reasons|2
1493820|NCT00518011|4919501|P1|Overall Study|Other Reasons|3
1493821|NCT00518011|4919500|P2|Overall Study|Disease Progression|2
1493822|NCT00518011|4919501|P1|Overall Study|Disease Progression|2
1493823|NCT00518011|4919500|P2|Overall Study|Adverse Event|3
1493824|NCT00518011|4919501|P1|Overall Study|Adverse Event|2
1493825|NCT00518011|4919500|P2|Overall Study|Death|1
1493826|NCT00518011|4919501|P1|Overall Study|Death|1
1493827|NCT00517933|4919523|P2|Period 2|Underwent lung transplant|2
1493828|NCT00517933|4919524|P1|Period 2|Underwent lung transplant|0
1493829|NCT00517933|4919523|P2|Period 2|Withdrawal by Subject|3
1493830|NCT00517933|4919524|P1|Period 2|Withdrawal by Subject|1
1493831|NCT00517933|4919523|P2|Period 2|Physician Decision|0
1493832|NCT00517933|4919524|P1|Period 2|Physician Decision|1
1493833|NCT00517933|4919523|P2|Period 2|Adverse Event|4
1493834|NCT00517933|4919524|P1|Period 2|Adverse Event|2
1493835|NCT00517933|4919523|P2|Period 2|Death|4
1493836|NCT00517933|4919524|P1|Period 2|Death|2
1493837|NCT00517933|4919523|P2|Period 1|Underwent lung transplant|1
1493838|NCT00517933|4919524|P1|Period 1|Underwent lung transplant|0
1493839|NCT00517933|4919523|P2|Period 1|Lost to Follow-up|0
1493840|NCT00517933|4919524|P1|Period 1|Lost to Follow-up|2
1493841|NCT00517933|4919523|P2|Period 1|Adverse Event|4
1493842|NCT00517933|4919524|P1|Period 1|Adverse Event|4
1493843|NCT00517933|4919523|P2|Period 1|Death|1
1493844|NCT00517933|4919524|P1|Period 1|Death|2
1493845|NCT00517881|4919588|P1|Overall Study|Renal transplantation|2
1493846|NCT00517881|4919588|P1|Overall Study|Adverse Event|1
1493847|NCT00517881|4919588|P1|Overall Study|Protocol Violation|2
1493848|NCT00517829|4919600|P2|Overall Study|Other|1
1493849|NCT00517829|4919601|P1|Overall Study|Other|3
1493850|NCT00517829|4919600|P2|Overall Study|Investigator Request|3
1493851|NCT00517829|4919601|P1|Overall Study|Investigator Request|5
1493852|NCT00517829|4919600|P2|Overall Study|Patient Request|5
1493853|NCT00517829|4919601|P1|Overall Study|Patient Request|6
1493854|NCT00517829|4919600|P2|Overall Study|Disease Progression|32
1493855|NCT00517829|4919601|P1|Overall Study|Disease Progression|39
1493856|NCT00517829|4919600|P2|Overall Study|Adverse Event|34
1493857|NCT00517829|4919601|P1|Overall Study|Adverse Event|22
1493858|NCT00517751|4919615|P1|Overall Study|Missing|3
1493859|NCT00517751|4919615|P1|Overall Study|Patient not due for visit|76
1493860|NCT00517751|4919615|P1|Overall Study|patient not over due|6
1493861|NCT00517751|4919615|P1|Overall Study|Lost to Follow-up|4
1493862|NCT00517751|4919615|P1|Overall Study|Withdrawal by Subject|37
1493863|NCT00517751|4919615|P1|Overall Study|Death|3
1493864|NCT00517699|4919638|P1|Overall Study|Study terminated by Sponsor|2
1493865|NCT00517699|4919638|P1|Overall Study|Administrative error|1
1493866|NCT00517699|4919638|P1|Overall Study|Lack of Efficacy|1
1493867|NCT00517699|4919638|P1|Overall Study|Withdrawal by Subject|1
1493868|NCT00517634|4919646|P6|Second Treatment Period|Withdrawal by Subject|0
1493869|NCT00517634|4919647|P5|Second Treatment Period|Withdrawal by Subject|1
1493870|NCT00517634|4919648|P4|Second Treatment Period|Withdrawal by Subject|0
1493871|NCT00517634|4919649|P3|Second Treatment Period|Withdrawal by Subject|0
1493872|NCT00517634|4919650|P2|Second Treatment Period|Withdrawal by Subject|0
1493873|NCT00517634|4919651|P1|Second Treatment Period|Withdrawal by Subject|0
1493874|NCT00517413|4919753|P1|Overall Study|Other-Reasons|23
1493875|NCT00517413|4919753|P1|Overall Study|Failure to return|1
1493876|NCT00517413|4919753|P1|Overall Study|Withdrawal by Subject|2
1493877|NCT00517413|4919753|P1|Overall Study|Protocol Violation|15
1493878|NCT00517413|4919753|P1|Overall Study|Death|13
1493879|NCT00517413|4919753|P1|Overall Study|Adverse Event|7
1493880|NCT00517361|4919774|P1|Overall Study|The study was terminated|5
1493881|NCT00517361|4919774|P1|Overall Study|Death|6
1493882|NCT00517296|4919783|P2|Overall Study|Withdrawal by Subject|0
1493883|NCT00517296|4919784|P1|Overall Study|Withdrawal by Subject|1
1493884|NCT00517192|4919796|P2|Overall Study|Early termination of the trial|18
1493885|NCT00517192|4919797|P1|Overall Study|Early termination of the trial|16
1493886|NCT00517192|4919796|P2|Overall Study|Withdrawal by Subject|0
1493887|NCT00517192|4919797|P1|Overall Study|Withdrawal by Subject|1
1493888|NCT00517192|4919796|P2|Overall Study|Lost to Follow-up|1
1493889|NCT00517192|4919797|P1|Overall Study|Lost to Follow-up|1
1493890|NCT00517192|4919796|P2|Overall Study|Adverse Event|1
1493891|NCT00517192|4919797|P1|Overall Study|Adverse Event|1
1493892|NCT00516906|4919904|P2|Overall Study|Final Dressing Removal Data not captured|2
1493893|NCT00516906|4919905|P1|Overall Study|Final Dressing Removal Data not captured|6
1493894|NCT00516893|4919915|P1|Overall Study|Received Medication From Another Study|1
1493895|NCT00516893|4919915|P1|Overall Study|Pregnancy|1
1493896|NCT00516893|4919915|P1|Overall Study|Relocated|1
1493897|NCT00516893|4919915|P1|Overall Study|Persistent Antibodies per Protocol|6
1493898|NCT00516893|4919915|P1|Overall Study|Death|1
1493899|NCT00516893|4919915|P1|Overall Study|Noncompliance|2
1493900|NCT00516893|4919915|P1|Overall Study|Withdrawal by Subject|2
1493901|NCT00516893|4919915|P1|Overall Study|Adverse Event|3
1493902|NCT00516893|4919915|P1|Overall Study|Lost to Follow-up|4
1493903|NCT00516737|4919924|P2|Overall Study|Lack of Qualifying Event|6
1493904|NCT00516737|4919925|P1|Overall Study|Lack of Qualifying Event|9
1493905|NCT00516737|4919924|P2|Overall Study|Withdrawal by Subject|1
1493906|NCT00516737|4919925|P1|Overall Study|Withdrawal by Subject|0
1493907|NCT00516737|4919924|P2|Overall Study|Physician Decision|1
1493908|NCT00516737|4919925|P1|Overall Study|Physician Decision|0
1493909|NCT00516737|4919924|P2|Overall Study|Lost to Follow-up|0
1493910|NCT00516737|4919925|P1|Overall Study|Lost to Follow-up|2
1493911|NCT00516386|4919964|P1|Overall Study|Lost to Follow-up|2
1493912|NCT00516386|4919964|P1|Overall Study|not interested in the study|4
1493913|NCT00516321|4919971|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
1493914|NCT00516321|4919972|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
1493915|NCT00516321|4919973|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
1493916|NCT00516321|4919971|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
1493917|NCT00516321|4919972|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
1493918|NCT00516321|4919973|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
1493919|NCT00516321|4919971|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
1493920|NCT00516321|4919972|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
1493921|NCT00516321|4919973|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
1493922|NCT00516321|4919971|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
1493923|NCT00516321|4919972|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
1493924|NCT00516321|4919973|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
1493925|NCT00516321|4919971|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
1493926|NCT00516321|4919972|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
1493927|NCT00516321|4919973|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
1493928|NCT00516321|4919971|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
1493929|NCT00516321|4919972|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
1493930|NCT00516321|4919973|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
1493931|NCT00516321|4919971|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
1493932|NCT00516321|4919972|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
1493933|NCT00516321|4919973|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
1493934|NCT00516321|4919971|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
1493935|NCT00516321|4919972|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
1493936|NCT00516321|4919973|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
1493937|NCT00516321|4919971|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
1493938|NCT00516321|4919972|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
1493939|NCT00516321|4919973|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
1493940|NCT00516321|4919971|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
1493941|NCT00516321|4919972|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
1493942|NCT00516321|4919973|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
1493943|NCT00516321|4919971|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
1493944|NCT00516321|4919972|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
1493945|NCT00516321|4919973|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
1493946|NCT00516295|4920024|P3|Overall Study|Ineligible|0
1493947|NCT00516295|4920025|P2|Overall Study|Ineligible|0
1493948|NCT00516295|4920026|P1|Overall Study|Ineligible|1
1493949|NCT00516295|4920024|P3|Overall Study|Lack of Efficacy|0
1493950|NCT00516295|4920025|P2|Overall Study|Lack of Efficacy|0
1493951|NCT00516295|4920026|P1|Overall Study|Lack of Efficacy|2
1493952|NCT00516269|4920039|P2|Overall Study|Protocol Violation|1
1493953|NCT00516269|4920040|P1|Overall Study|Protocol Violation|0
1493954|NCT00516269|4920039|P2|Overall Study|Lost to Follow-up|1
1493955|NCT00516269|4920040|P1|Overall Study|Lost to Follow-up|0
1493956|NCT00516269|4920039|P2|Overall Study|Adverse Event|1
1493957|NCT00516269|4920040|P1|Overall Study|Adverse Event|2
1493958|NCT00516139|4920061|P1|Overall Study|Lack of Efficacy|1
1493959|NCT00516139|4920061|P1|Overall Study|Withdrawal by Subject|8
1493960|NCT00516139|4920061|P1|Overall Study|Protocol Violation|1
1493961|NCT00516139|4920061|P1|Overall Study|Lost to Follow-up|1
1493962|NCT00516139|4920061|P1|Overall Study|Adverse Event|27
1493963|NCT00516074|4920092|P2|Overall Study|Loss of Glucose Control|0
1493964|NCT00516074|4920093|P1|Overall Study|Loss of Glucose Control|2
1493965|NCT00516074|4920092|P2|Overall Study|Subject Decision|2
1493966|NCT00516074|4920093|P1|Overall Study|Subject Decision|4
1493967|NCT00516074|4920092|P2|Overall Study|Adverse Event|1
1493968|NCT00516074|4920093|P1|Overall Study|Adverse Event|0
1493969|NCT00516048|4920111|P3|Overall Study|Subject Decision|0
1493970|NCT00516048|4920112|P2|Overall Study|Subject Decision|2
1493971|NCT00516048|4920113|P1|Overall Study|Subject Decision|0
1493972|NCT00516048|4920111|P3|Overall Study|Death|1
1493973|NCT00516048|4920112|P2|Overall Study|Death|0
1493974|NCT00516048|4920113|P1|Overall Study|Death|0
1493975|NCT00515827|4920140|P2|Second Intervention (12 Weeks)|Consent withdraw|0
1493976|NCT00515827|4920141|P1|Second Intervention (12 Weeks)|Consent withdraw|1
1493977|NCT00515827|4920140|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
1493978|NCT00515827|4920141|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
1493979|NCT00515671|4920176|P2|Overall Study|incarcerated|2
1493980|NCT00515671|4920177|P1|Overall Study|incarcerated|1
1493981|NCT00515671|4920176|P2|Overall Study|Withdrawal by Subject|5
1493982|NCT00515671|4920177|P1|Overall Study|Withdrawal by Subject|3
1493983|NCT00515671|4920176|P2|Overall Study|Lost to Follow-up|10
1493984|NCT00515671|4920177|P1|Overall Study|Lost to Follow-up|13
1493985|NCT00515619|4920185|P1|Overall Study|Other: Subject interested in other AED|1
1493986|NCT00515619|4920185|P1|Overall Study|Other: Drug available on license|1
1493987|NCT00515619|4920185|P1|Overall Study|Other: Request from sponsor|1
1493988|NCT00515619|4920185|P1|Overall Study|Other: Subject became pregnant|1
1493989|NCT00515619|4920185|P1|Overall Study|Other: Investigator decision|1
1493990|NCT00515619|4920185|P1|Overall Study|Other: Subject moved to another country|1
1493991|NCT00515619|4920185|P1|Overall Study|Other: Subject required surgery|1
1493992|NCT00515619|4920185|P1|Overall Study|Other: Subject cannot attend visits|2
1493993|NCT00515619|4920185|P1|Overall Study|Other: Site discontinuing trials|2
1493994|NCT00515619|4920185|P1|Overall Study|Unsatisfactory compliance|6
1493995|NCT00515619|4920185|P1|Overall Study|Lost to Follow-up|4
1493996|NCT00515619|4920185|P1|Overall Study|Protocol Violation|3
1493997|NCT00515619|4920185|P1|Overall Study|Withdrawal by Subject|66
1493998|NCT00515619|4920185|P1|Overall Study|Lack of Efficacy|92
1493999|NCT00515619|4920185|P1|Overall Study|Adverse Event|34
1494000|NCT00515541|4920197|P4|Overall Study|Withdrawal by Subject|2
1494001|NCT00515541|4920198|P3|Overall Study|Withdrawal by Subject|0
1494002|NCT00515541|4920199|P2|Overall Study|Withdrawal by Subject|2
1494003|NCT00515541|4920200|P1|Overall Study|Withdrawal by Subject|0
1494004|NCT00515541|4920197|P4|Overall Study|No show for appointments|2
1494005|NCT00515541|4920198|P3|Overall Study|No show for appointments|0
1494006|NCT00515541|4920199|P2|Overall Study|No show for appointments|1
1494007|NCT00515541|4920200|P1|Overall Study|No show for appointments|0
1494008|NCT00515541|4920197|P4|Overall Study|Physician Decision|1
1494009|NCT00515541|4920198|P3|Overall Study|Physician Decision|0
1494010|NCT00515541|4920199|P2|Overall Study|Physician Decision|2
1494011|NCT00515541|4920200|P1|Overall Study|Physician Decision|0
1494012|NCT00515502|4920222|P12|Treatment Period 2|Adverse Event|0
1494013|NCT00515502|4920223|P11|Treatment Period 2|Adverse Event|0
1494014|NCT00515502|4920224|P10|Treatment Period 2|Adverse Event|0
1494015|NCT00515502|4920225|P9|Treatment Period 2|Adverse Event|0
1494016|NCT00515502|4920226|P8|Treatment Period 2|Adverse Event|0
1494017|NCT00515502|4920227|P7|Treatment Period 2|Adverse Event|0
1494018|NCT00515502|4920228|P6|Treatment Period 2|Adverse Event|0
1494019|NCT00515502|4920229|P5|Treatment Period 2|Adverse Event|0
1494020|NCT00515502|4920230|P4|Treatment Period 2|Adverse Event|0
1494021|NCT00515502|4920231|P3|Treatment Period 2|Adverse Event|0
1494022|NCT00515502|4920232|P2|Treatment Period 2|Adverse Event|1
1494023|NCT00515502|4920233|P1|Treatment Period 2|Adverse Event|0
1494024|NCT00515502|4920222|P12|Treatment Period 1|Adverse Event|1
1494025|NCT00515502|4920223|P11|Treatment Period 1|Adverse Event|0
1494026|NCT00515502|4920224|P10|Treatment Period 1|Adverse Event|0
1494027|NCT00515502|4920225|P9|Treatment Period 1|Adverse Event|1
1494028|NCT00515502|4920226|P8|Treatment Period 1|Adverse Event|0
1494029|NCT00515502|4920227|P7|Treatment Period 1|Adverse Event|1
1494030|NCT00515502|4920228|P6|Treatment Period 1|Adverse Event|0
1494031|NCT00515502|4920229|P5|Treatment Period 1|Adverse Event|0
1494032|NCT00515502|4920230|P4|Treatment Period 1|Adverse Event|0
1494033|NCT00515502|4920231|P3|Treatment Period 1|Adverse Event|0
1494034|NCT00515502|4920232|P2|Treatment Period 1|Adverse Event|0
1494035|NCT00515502|4920233|P1|Treatment Period 1|Adverse Event|0
1494036|NCT00515463|4920393|P2|Overall Study|Other|1
1494037|NCT00515463|4920394|P1|Overall Study|Other|0
1494038|NCT00515463|4920393|P2|Overall Study|Lost to Follow-up|5
1494039|NCT00515463|4920394|P1|Overall Study|Lost to Follow-up|6
1494040|NCT00515463|4920393|P2|Overall Study|Withdrawal by Subject|4
1494041|NCT00515463|4920394|P1|Overall Study|Withdrawal by Subject|3
1494042|NCT00515463|4920393|P2|Overall Study|Adverse Event|2
1494043|NCT00515463|4920394|P1|Overall Study|Adverse Event|1
1494044|NCT00515463|4920393|P2|Overall Study|Physician Decision|2
1494045|NCT00515463|4920394|P1|Overall Study|Physician Decision|4
1494046|NCT00515294|4920577|P4|Overall Study|Caffeine amount inaccurate|0
1494047|NCT00515294|4920578|P3|Overall Study|Caffeine amount inaccurate|7
1494048|NCT00515294|4920579|P2|Overall Study|Caffeine amount inaccurate|0
1494049|NCT00515294|4920580|P1|Overall Study|Caffeine amount inaccurate|5
1494050|NCT00515294|4920577|P4|Overall Study|Driver simulator problems|3
1494051|NCT00515294|4920578|P3|Overall Study|Driver simulator problems|1
1494052|NCT00515294|4920579|P2|Overall Study|Driver simulator problems|1
1494053|NCT00515294|4920580|P1|Overall Study|Driver simulator problems|1
1494054|NCT00515294|4920577|P4|Overall Study|Lost to Follow-up|1
1494055|NCT00515294|4920578|P3|Overall Study|Lost to Follow-up|3
1494056|NCT00515294|4920579|P2|Overall Study|Lost to Follow-up|2
1494057|NCT00515294|4920580|P1|Overall Study|Lost to Follow-up|3
1494058|NCT00515216|4920594|P1|Overall Study|Withdrawal by Subject|1
1494059|NCT00515112|4920656|P2|Overall Study|The study was terminated|2
1494060|NCT00515112|4920657|P1|Overall Study|The study was terminated|3
1494061|NCT00515112|4920656|P2|Overall Study|Death|1
1494062|NCT00515112|4920657|P1|Overall Study|Death|0
1494063|NCT00515099|4920667|P2|Overall Study|IRB Recommendation|0
1494064|NCT00515099|4920668|P1|Overall Study|IRB Recommendation|1
1494065|NCT00515099|4920667|P2|Overall Study|Withdrawal by Subject|0
1494066|NCT00515099|4920668|P1|Overall Study|Withdrawal by Subject|2
1494067|NCT00515099|4920667|P2|Overall Study|Lost to Follow-up|4
1494068|NCT00515099|4920668|P1|Overall Study|Lost to Follow-up|0
1494069|NCT00515086|4920690|P4|Overall Study|Death|0
1494070|NCT00515086|4920691|P3|Overall Study|Death|0
1494071|NCT00515086|4920692|P2|Overall Study|Death|0
1494072|NCT00515086|4920693|P1|Overall Study|Death|2
1494073|NCT00515086|4920690|P4|Overall Study|Study drug no longer required|0
1494074|NCT00515086|4920691|P3|Overall Study|Study drug no longer required|0
1494075|NCT00515086|4920692|P2|Overall Study|Study drug no longer required|1
1494076|NCT00515086|4920693|P1|Overall Study|Study drug no longer required|0
1494077|NCT00515086|4920690|P4|Overall Study|Lost to Follow-up|0
1494078|NCT00515086|4920691|P3|Overall Study|Lost to Follow-up|0
1494079|NCT00515086|4920692|P2|Overall Study|Lost to Follow-up|0
1494080|NCT00515086|4920693|P1|Overall Study|Lost to Follow-up|1
1494081|NCT00515086|4920690|P4|Overall Study|Unsatisfactory therapeutic effect|2
1494082|NCT00515086|4920691|P3|Overall Study|Unsatisfactory therapeutic effect|3
1494083|NCT00515086|4920692|P2|Overall Study|Unsatisfactory therapeutic effect|3
1494084|NCT00515086|4920693|P1|Overall Study|Unsatisfactory therapeutic effect|18
1494085|NCT00515086|4920690|P4|Overall Study|Withdrawal by Subject|1
1494086|NCT00515086|4920691|P3|Overall Study|Withdrawal by Subject|0
1494087|NCT00515086|4920692|P2|Overall Study|Withdrawal by Subject|0
1494088|NCT00515086|4920693|P1|Overall Study|Withdrawal by Subject|1
1494089|NCT00515086|4920690|P4|Overall Study|Administrative|0
1494090|NCT00515086|4920691|P3|Overall Study|Administrative|0
1494091|NCT00515086|4920692|P2|Overall Study|Administrative|1
1494092|NCT00515086|4920693|P1|Overall Study|Administrative|1
1494093|NCT00515086|4920690|P4|Overall Study|Adverse Event|3
1494094|NCT00515086|4920691|P3|Overall Study|Adverse Event|2
1494095|NCT00515086|4920692|P2|Overall Study|Adverse Event|1
1494096|NCT00515086|4920693|P1|Overall Study|Adverse Event|1
1494097|NCT00515073|4920720|P1|Overall Study|Physician Decision|1
1494098|NCT00515073|4920720|P1|Overall Study|Withdrawal by Subject|1
1494099|NCT00515034|4920728|P4|Overall Study|Other|1
1494100|NCT00515034|4920729|P3|Overall Study|Other|2
1494101|NCT00515034|4920730|P2|Overall Study|Other|0
1494102|NCT00515034|4920731|P1|Overall Study|Other|1
1494103|NCT00515034|4920728|P4|Overall Study|Physician Decision|1
1494104|NCT00515034|4920729|P3|Overall Study|Physician Decision|1
1494105|NCT00515034|4920730|P2|Overall Study|Physician Decision|0
1494106|NCT00515034|4920731|P1|Overall Study|Physician Decision|0
1494107|NCT00515034|4920728|P4|Overall Study|Withdrawal by Subject|0
1494108|NCT00515034|4920729|P3|Overall Study|Withdrawal by Subject|3
1494109|NCT00515034|4920730|P2|Overall Study|Withdrawal by Subject|0
1494110|NCT00515034|4920731|P1|Overall Study|Withdrawal by Subject|1
1494111|NCT00515034|4920728|P4|Overall Study|Death|3
1494112|NCT00515034|4920729|P3|Overall Study|Death|1
1494113|NCT00515034|4920730|P2|Overall Study|Death|2
1494114|NCT00515034|4920731|P1|Overall Study|Death|4
1494115|NCT00515034|4920728|P4|Overall Study|Adverse Event|0
1494116|NCT00515034|4920729|P3|Overall Study|Adverse Event|1
1494117|NCT00515034|4920730|P2|Overall Study|Adverse Event|0
1494118|NCT00515034|4920731|P1|Overall Study|Adverse Event|2
1494119|NCT00515008|4920751|P2|Overall Study|Scheduling conflict|0
1494120|NCT00515008|4920752|P1|Overall Study|Scheduling conflict|1
1494121|NCT00515008|4920751|P2|Overall Study|Left the Boston Area|1
1494122|NCT00515008|4920752|P1|Overall Study|Left the Boston Area|1
1494123|NCT00515008|4920751|P2|Overall Study|Declined|3
1494124|NCT00515008|4920752|P1|Overall Study|Declined|0
1494125|NCT00515008|4920751|P2|Overall Study|Lost to Follow-up|0
1494126|NCT00515008|4920752|P1|Overall Study|Lost to Follow-up|1
1494127|NCT00514943|4920776|P2|Stage 2|Other than stated above|2
1494128|NCT00514943|4920777|P1|Stage 2|Other than stated above|0
1494129|NCT00514943|4920776|P2|Stage 2|Patient refused to continue study meds|0
1494130|NCT00514943|4920777|P1|Stage 2|Patient refused to continue study meds|2
1494131|NCT00514943|4920776|P2|Stage 2|Other Adverse Event|10
1494132|NCT00514943|4920777|P1|Stage 2|Other Adverse Event|3
1494133|NCT00514943|4920776|P2|Stage 2|Progressive disease|24
1494134|NCT00514943|4920777|P1|Stage 2|Progressive disease|27
1494135|NCT00514943|4920776|P2|Stage 1|Other than stated above|7
1494136|NCT00514943|4920777|P1|Stage 1|Other than stated above|1
1494137|NCT00514943|4920776|P2|Stage 1|Patient refused to continue study meds|3
1494138|NCT00514943|4920777|P1|Stage 1|Patient refused to continue study meds|8
1494139|NCT00514943|4920776|P2|Stage 1|Not treated|2
1494140|NCT00514943|4920777|P1|Stage 1|Not treated|1
1494141|NCT00514943|4920776|P2|Stage 1|Other Adverse Event|6
1494142|NCT00514943|4920777|P1|Stage 1|Other Adverse Event|16
1494143|NCT00514943|4920776|P2|Stage 1|Progressive disease|8
1494144|NCT00514943|4920777|P1|Stage 1|Progressive disease|4
1494145|NCT00514917|4920835|P2|Overall Study|Undefined|5
1494146|NCT00514917|4920836|P1|Overall Study|Undefined|11
1494147|NCT00514917|4920835|P2|Overall Study|Discontinued due to study closure|81
1494148|NCT00514917|4920836|P1|Overall Study|Discontinued due to study closure|88
1494149|NCT00514917|4920835|P2|Overall Study|Withdrawal by Subject|16
1494150|NCT00514917|4920836|P1|Overall Study|Withdrawal by Subject|18
1494151|NCT00514917|4920835|P2|Overall Study|Lost to Follow-up|3
1494152|NCT00514917|4920836|P1|Overall Study|Lost to Follow-up|4
1494153|NCT00514917|4920835|P2|Overall Study|Protocol Violation|0
1494154|NCT00514917|4920836|P1|Overall Study|Protocol Violation|1
1494155|NCT00514917|4920835|P2|Overall Study|Death|10
1494156|NCT00514917|4920836|P1|Overall Study|Death|4
1494157|NCT00514904|4920864|P2|Overall Study|Lost to Follow-up|3
1494158|NCT00514904|4920865|P1|Overall Study|Lost to Follow-up|21
1494159|NCT00514904|4920864|P2|Overall Study|Withdrawal by Subject|2
1494160|NCT00514904|4920865|P1|Overall Study|Withdrawal by Subject|3
1494161|NCT00514813|4920930|P4|Overall Study|Death|2
1494162|NCT00514813|4920931|P3|Overall Study|Death|3
1494163|NCT00514813|4920932|P2|Overall Study|Death|2
1494164|NCT00514813|4920933|P1|Overall Study|Death|0
1494165|NCT00514813|4920930|P4|Overall Study|Kidney transplant|0
1494166|NCT00514813|4920931|P3|Overall Study|Kidney transplant|2
1494167|NCT00514813|4920932|P2|Overall Study|Kidney transplant|6
1494168|NCT00514813|4920933|P1|Overall Study|Kidney transplant|0
1494169|NCT00514813|4920930|P4|Overall Study|Lack of Efficacy|0
1494170|NCT00514813|4920931|P3|Overall Study|Lack of Efficacy|0
1494171|NCT00514813|4920932|P2|Overall Study|Lack of Efficacy|1
1494172|NCT00514813|4920933|P1|Overall Study|Lack of Efficacy|0
1494173|NCT00514813|4920930|P4|Overall Study|Withdrawal by Subject|0
1494174|NCT00514813|4920931|P3|Overall Study|Withdrawal by Subject|0
1494175|NCT00514813|4920932|P2|Overall Study|Withdrawal by Subject|1
1494176|NCT00514813|4920933|P1|Overall Study|Withdrawal by Subject|0
1494177|NCT00514813|4920930|P4|Overall Study|Protocol Violation|0
1494178|NCT00514813|4920931|P3|Overall Study|Protocol Violation|0
1494179|NCT00514813|4920932|P2|Overall Study|Protocol Violation|0
1494180|NCT00514813|4920933|P1|Overall Study|Protocol Violation|1
1494181|NCT00514813|4920930|P4|Overall Study|Adverse Event|0
1494182|NCT00514813|4920931|P3|Overall Study|Adverse Event|2
1494183|NCT00514813|4920932|P2|Overall Study|Adverse Event|2
1494184|NCT00514813|4920933|P1|Overall Study|Adverse Event|0
1494185|NCT00514813|4920930|P4|Overall Study|Study terminated|2
1494186|NCT00514813|4920931|P3|Overall Study|Study terminated|40
1494187|NCT00514813|4920932|P2|Overall Study|Study terminated|74
1494188|NCT00514813|4920933|P1|Overall Study|Study terminated|14
1494189|NCT00514735|4920953|P2|Overall Study|Lost to Follow-up|1
1494190|NCT00514735|4920954|P1|Overall Study|Lost to Follow-up|0
1494191|NCT00514735|4920953|P2|Overall Study|Death|0
1494192|NCT00514735|4920954|P1|Overall Study|Death|1
1494193|NCT00514735|4920953|P2|Overall Study|Withdrawal by Subject|5
1494194|NCT00514735|4920954|P1|Overall Study|Withdrawal by Subject|13
1494195|NCT00514683|4920990|P5|Overall Study|Reason other than listed above|1
1494196|NCT00514683|4920991|P4|Overall Study|Reason other than listed above|0
1494197|NCT00514683|4920992|P3|Overall Study|Reason other than listed above|2
1494198|NCT00514683|4920993|P2|Overall Study|Reason other than listed above|1
1494199|NCT00514683|4920994|P1|Overall Study|Reason other than listed above|0
1494200|NCT00514683|4920990|P5|Overall Study|Withdrawal by Subject|4
1494201|NCT00514683|4920991|P4|Overall Study|Withdrawal by Subject|0
1494202|NCT00514683|4920992|P3|Overall Study|Withdrawal by Subject|1
1494203|NCT00514683|4920993|P2|Overall Study|Withdrawal by Subject|2
1494204|NCT00514683|4920994|P1|Overall Study|Withdrawal by Subject|2
1494205|NCT00514683|4920990|P5|Overall Study|Protocol Violation|0
1494206|NCT00514683|4920991|P4|Overall Study|Protocol Violation|1
1494207|NCT00514683|4920992|P3|Overall Study|Protocol Violation|0
1494208|NCT00514683|4920993|P2|Overall Study|Protocol Violation|1
1494209|NCT00514683|4920994|P1|Overall Study|Protocol Violation|1
1494210|NCT00514683|4920990|P5|Overall Study|Adverse Event|27
1494211|NCT00514683|4920991|P4|Overall Study|Adverse Event|13
1494212|NCT00514683|4920992|P3|Overall Study|Adverse Event|15
1494213|NCT00514683|4920993|P2|Overall Study|Adverse Event|20
1494214|NCT00514683|4920994|P1|Overall Study|Adverse Event|21
1494215|NCT00514683|4920990|P5|Overall Study|Not treated|1
1494216|NCT00514683|4920991|P4|Overall Study|Not treated|0
1494217|NCT00514683|4920992|P3|Overall Study|Not treated|0
1494218|NCT00514683|4920993|P2|Overall Study|Not treated|1
1494219|NCT00514683|4920994|P1|Overall Study|Not treated|2
1494220|NCT00514514|4921193|P3|Extension - 4 Years|Adverse Event|3
1494221|NCT00514514|4921194|P2|Extension - 4 Years|Adverse Event|6
1494222|NCT00514514|4921195|P1|Extension - 4 Years|Adverse Event|9
1494223|NCT00514514|4921193|P3|Extension - 4 Years|Death|6
1494224|NCT00514514|4921194|P2|Extension - 4 Years|Death|3
1494225|NCT00514514|4921195|P1|Extension - 4 Years|Death|8
1494226|NCT00514514|4921193|P3|Extension - 4 Years|Administrative problems|1
1494227|NCT00514514|4921194|P2|Extension - 4 Years|Administrative problems|1
1494228|NCT00514514|4921195|P1|Extension - 4 Years|Administrative problems|3
1494229|NCT00514514|4921193|P3|Extension - 4 Years|Lost to Follow-up|9
1494230|NCT00514514|4921194|P2|Extension - 4 Years|Lost to Follow-up|10
1494231|NCT00514514|4921195|P1|Extension - 4 Years|Lost to Follow-up|12
1494232|NCT00514514|4921193|P3|Extension - 4 Years|Withdrawal by Subject|2
1494233|NCT00514514|4921194|P2|Extension - 4 Years|Withdrawal by Subject|2
1494234|NCT00514514|4921195|P1|Extension - 4 Years|Withdrawal by Subject|5
1494235|NCT00514514|4921193|P3|Randomized - 9 Month|Adverse Event|27
1494236|NCT00514514|4921194|P2|Randomized - 9 Month|Adverse Event|44
1494237|NCT00514514|4921195|P1|Randomized - 9 Month|Adverse Event|25
1494238|NCT00514514|4921193|P3|Randomized - 9 Month|Abnormal laboratory values|1
1494239|NCT00514514|4921194|P2|Randomized - 9 Month|Abnormal laboratory values|3
1494240|NCT00514514|4921195|P1|Randomized - 9 Month|Abnormal laboratory values|0
1494241|NCT00514514|4921193|P3|Randomized - 9 Month|Lack of Efficacy|1
1494242|NCT00514514|4921194|P2|Randomized - 9 Month|Lack of Efficacy|3
1494243|NCT00514514|4921195|P1|Randomized - 9 Month|Lack of Efficacy|2
1494244|NCT00514514|4921193|P3|Randomized - 9 Month|Protocol Violation|0
1494245|NCT00514514|4921194|P2|Randomized - 9 Month|Protocol Violation|1
1494246|NCT00514514|4921195|P1|Randomized - 9 Month|Protocol Violation|1
1494247|NCT00514514|4921193|P3|Randomized - 9 Month|Withdrawal by Subject|5
1494248|NCT00514514|4921194|P2|Randomized - 9 Month|Withdrawal by Subject|7
1494249|NCT00514514|4921195|P1|Randomized - 9 Month|Withdrawal by Subject|7
1494250|NCT00514514|4921193|P3|Randomized - 9 Month|Administrative problems|2
1494251|NCT00514514|4921194|P2|Randomized - 9 Month|Administrative problems|1
1494252|NCT00514514|4921195|P1|Randomized - 9 Month|Administrative problems|1
1494253|NCT00514514|4921193|P3|Randomized - 9 Month|Death|2
1494254|NCT00514514|4921194|P2|Randomized - 9 Month|Death|2
1494255|NCT00514514|4921195|P1|Randomized - 9 Month|Death|3
1494256|NCT00514514|4921193|P3|Pre-phase|Withdrawal by Subject|0
1494257|NCT00514514|4921194|P2|Pre-phase|Withdrawal by Subject|0
1494258|NCT00514514|4921195|P1|Pre-phase|Withdrawal by Subject|66
1494259|NCT00514514|4921193|P3|Pre-phase|Adverse Event|0
1494260|NCT00514514|4921194|P2|Pre-phase|Adverse Event|0
1494261|NCT00514514|4921195|P1|Pre-phase|Adverse Event|137
1494262|NCT00514514|4921193|P3|Pre-phase|Lack of Efficacy|0
1494263|NCT00514514|4921194|P2|Pre-phase|Lack of Efficacy|0
1494264|NCT00514514|4921195|P1|Pre-phase|Lack of Efficacy|35
1494265|NCT00514514|4921193|P3|Pre-phase|abnormal lab values|0
1494266|NCT00514514|4921194|P2|Pre-phase|abnormal lab values|0
1494267|NCT00514514|4921195|P1|Pre-phase|abnormal lab values|23
1494268|NCT00514514|4921193|P3|Pre-phase|Lost to Follow-up|0
1494269|NCT00514514|4921194|P2|Pre-phase|Lost to Follow-up|0
1494270|NCT00514514|4921195|P1|Pre-phase|Lost to Follow-up|2
1494271|NCT00514514|4921193|P3|Pre-phase|abnormal test procedure results|0
1494272|NCT00514514|4921194|P2|Pre-phase|abnormal test procedure results|0
1494273|NCT00514514|4921195|P1|Pre-phase|abnormal test procedure results|15
1494274|NCT00514514|4921193|P3|Pre-phase|condition no longer requires study drug|0
1494275|NCT00514514|4921194|P2|Pre-phase|condition no longer requires study drug|0
1494276|NCT00514514|4921195|P1|Pre-phase|condition no longer requires study drug|7
1494277|NCT00514514|4921193|P3|Pre-phase|Protocol Violation|0
1494278|NCT00514514|4921194|P2|Pre-phase|Protocol Violation|0
1494279|NCT00514514|4921195|P1|Pre-phase|Protocol Violation|6
1494280|NCT00514514|4921193|P3|Pre-phase|administrative problems|0
1494281|NCT00514514|4921194|P2|Pre-phase|administrative problems|0
1494282|NCT00514514|4921195|P1|Pre-phase|administrative problems|2
1494283|NCT00514514|4921193|P3|Pre-phase|Death|0
1494284|NCT00514514|4921194|P2|Pre-phase|Death|0
1494285|NCT00514514|4921195|P1|Pre-phase|Death|10
1494286|NCT00514449|4921247|P2|Overall Study|Lost to Follow-up|0
1494287|NCT00514449|4921248|P1|Overall Study|Lost to Follow-up|1
1494288|NCT00514449|4921247|P2|Overall Study|Protocol Violation|2
1494289|NCT00514449|4921248|P1|Overall Study|Protocol Violation|1
1494290|NCT00514449|4921247|P2|Overall Study|Withdrawal by Subject|2
1494291|NCT00514449|4921248|P1|Overall Study|Withdrawal by Subject|1
1494292|NCT00514020|4921269|P1|Overall Study|"patients moved to the no tx group"|6
1494293|NCT00514020|4921269|P1|Overall Study|patient went to radiation treatment|1
1494294|NCT00514020|4921269|P1|Overall Study|other complicating disease|2
1494295|NCT00514020|4921269|P1|Overall Study|disease progression|9
1494296|NCT00514020|4921269|P1|Overall Study|Physician Decision|1
1494297|NCT00514020|4921269|P1|Overall Study|Withdrawal by Subject|3
1494298|NCT00514020|4921269|P1|Overall Study|Adverse Event|6
1494299|NCT00513708|4921301|P3|Overall Study|Lost to Follow-up|4
1494300|NCT00513708|4921302|P2|Overall Study|Lost to Follow-up|4
1494301|NCT00513708|4921303|P1|Overall Study|Lost to Follow-up|4
1494302|NCT00513695|4921317|P1|Overall Study|Progression prior to surgery|3
1494303|NCT00513695|4921317|P1|Overall Study|Discontinued therapy|2
1494304|NCT00513682|4921326|P1|Washout Phase|Adverse Event|2
1494305|NCT00513604|4921356|P5|Overall Study|Death during treatment|0
1494306|NCT00513604|4921357|P4|Overall Study|Death during treatment|0
1494307|NCT00513604|4921358|P3|Overall Study|Death during treatment|2
1494308|NCT00513604|4921359|P2|Overall Study|Death during treatment|3
1494309|NCT00513604|4921360|P1|Overall Study|Death during treatment|0
1494310|NCT00513604|4921356|P5|Overall Study|Not treated|0
1494311|NCT00513604|4921357|P4|Overall Study|Not treated|0
1494312|NCT00513604|4921358|P3|Overall Study|Not treated|1
1494313|NCT00513604|4921359|P2|Overall Study|Not treated|0
1494314|NCT00513604|4921360|P1|Overall Study|Not treated|2
1494315|NCT00513500|4921394|P2|Overall Study|Hospitalized|14
1494316|NCT00513500|4921395|P1|Overall Study|Hospitalized|4
1494317|NCT00513500|4921394|P2|Overall Study|Death|1
1494318|NCT00513500|4921395|P1|Overall Study|Death|2
1494319|NCT00513500|4921394|P2|Overall Study|Lost to Follow-up|39
1494320|NCT00513500|4921395|P1|Overall Study|Lost to Follow-up|35
1494321|NCT00513474|4921407|P2|Overall Study|Participant Withdrew Consent|0
1494322|NCT00513474|4921408|P1|Overall Study|Participant Withdrew Consent|1
1494323|NCT00513474|4921407|P2|Overall Study|Death|9
1494324|NCT00513474|4921408|P1|Overall Study|Death|6
1494325|NCT00513409|4921464|P2|Overall Study|Visit 3 not done|2
1494326|NCT00513409|4921465|P1|Overall Study|Visit 3 not done|1
1494327|NCT00513409|4921464|P2|Overall Study|Physician Decision|0
1494328|NCT00513409|4921465|P1|Overall Study|Physician Decision|1
1494329|NCT00513409|4921464|P2|Overall Study|Lost to Follow-up|1
1494330|NCT00513409|4921465|P1|Overall Study|Lost to Follow-up|0
1494331|NCT00513409|4921464|P2|Overall Study|Withdrawal by Subject|2
1494332|NCT00513409|4921465|P1|Overall Study|Withdrawal by Subject|0
1494333|NCT00513409|4921464|P2|Overall Study|Adverse Event|1
1494334|NCT00513409|4921465|P1|Overall Study|Adverse Event|0
1494335|NCT00513357|4921521|P2|Overall Study|Disease Progression|1
1494336|NCT00513357|4921522|P1|Overall Study|Disease Progression|2
1494337|NCT00513357|4921521|P2|Overall Study|Withdrawal by Subject|4
1494338|NCT00513357|4921522|P1|Overall Study|Withdrawal by Subject|5
1494339|NCT00513357|4921521|P2|Overall Study|Death|0
1494340|NCT00513357|4921522|P1|Overall Study|Death|2
1494341|NCT00513357|4921521|P2|Overall Study|Adverse Event|2
1494342|NCT00513357|4921522|P1|Overall Study|Adverse Event|4
1494343|NCT00513357|4921521|P2|Overall Study|did not receive allocated placebo|3
1494344|NCT00513357|4921522|P1|Overall Study|did not receive allocated placebo|2
1494345|NCT00513305|4921541|P2|Overall Study|Sponsor Decision|2
1494346|NCT00513305|4921542|P1|Overall Study|Sponsor Decision|0
1494347|NCT00513305|4921541|P2|Overall Study|Persistent hypocellularity|1
1494348|NCT00513305|4921542|P1|Overall Study|Persistent hypocellularity|0
1494349|NCT00513305|4921541|P2|Overall Study|Physician Decision|0
1494350|NCT00513305|4921542|P1|Overall Study|Physician Decision|1
1494351|NCT00513305|4921541|P2|Overall Study|Hematologic counts did not recover|0
1494352|NCT00513305|4921542|P1|Overall Study|Hematologic counts did not recover|1
1494353|NCT00513305|4921541|P2|Overall Study|Eligible for stem cell transplant|0
1494354|NCT00513305|4921542|P1|Overall Study|Eligible for stem cell transplant|1
1494355|NCT00513305|4921541|P2|Overall Study|Disease progression|5
1494356|NCT00513305|4921542|P1|Overall Study|Disease progression|8
1494357|NCT00513305|4921541|P2|Overall Study|Withdrawal by Subject|2
1494358|NCT00513305|4921542|P1|Overall Study|Withdrawal by Subject|1
1494359|NCT00513305|4921541|P2|Overall Study|Lack of Efficacy|13
1494360|NCT00513305|4921542|P1|Overall Study|Lack of Efficacy|8
1494361|NCT00513305|4921541|P2|Overall Study|Death (through Consolidation Treatment)|2
1494362|NCT00513305|4921542|P1|Overall Study|Death (through Consolidation Treatment)|2
1494363|NCT00513305|4921541|P2|Overall Study|Adverse Event|2
1494364|NCT00513305|4921542|P1|Overall Study|Adverse Event|6
1494365|NCT00513240|4921579|P2|Overall Study|Withdrawal by Subject|4
1494366|NCT00513240|4921580|P1|Overall Study|Withdrawal by Subject|7
1494367|NCT00513240|4921579|P2|Overall Study|Death|3
1494368|NCT00513240|4921580|P1|Overall Study|Death|3
1494369|NCT00513240|4921579|P2|Overall Study|Did not have intended surgery|0
1494370|NCT00513240|4921580|P1|Overall Study|Did not have intended surgery|3
1494371|NCT00513071|4921587|P1|Overall Study|Physician Decision|3
1494372|NCT00513071|4921587|P1|Overall Study|Withdrawal by Subject|1
1494373|NCT00513071|4921587|P1|Overall Study|Adverse Event|1
1494374|NCT00513019|4921599|P2|Overall Study|Withdrawal by Subject|5
1494375|NCT00513019|4921600|P1|Overall Study|Withdrawal by Subject|4
1494376|NCT00513019|4921599|P2|Overall Study|Adverse Event|0
1494377|NCT00513019|4921600|P1|Overall Study|Adverse Event|1
1494378|NCT00512902|4921606|P1|Overall Study|Lost to Follow-up|1
1494379|NCT00512902|4921606|P1|Overall Study|Adverse Event|7
1494380|NCT00512798|4921621|P2|Overall Study|Withdrawal by Subject|0
1494381|NCT00512798|4921622|P1|Overall Study|Withdrawal by Subject|3
1494382|NCT00512798|4921621|P2|Overall Study|Progression of disease|20
1494383|NCT00512798|4921622|P1|Overall Study|Progression of disease|14
1494384|NCT00512798|4921621|P2|Overall Study|Adverse Event|4
1494385|NCT00512798|4921622|P1|Overall Study|Adverse Event|2
1494386|NCT00512798|4921621|P2|Overall Study|Death|3
1494387|NCT00512798|4921622|P1|Overall Study|Death|0
1494388|NCT00512707|4921633|P2|Overall Study|Unable to tolerate the smell of the gel|0
1494389|NCT00512707|4921634|P1|Overall Study|Unable to tolerate the smell of the gel|1
1494390|NCT00512707|4921633|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
1494391|NCT00512707|4921634|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
1494392|NCT00512707|4921633|P2|Overall Study|Developed skin irritation|1
1494393|NCT00512707|4921634|P1|Overall Study|Developed skin irritation|2
1494394|NCT00512707|4921633|P2|Overall Study|Lost to Follow-up|11
1494395|NCT00512707|4921634|P1|Overall Study|Lost to Follow-up|5
1494396|NCT00512252|4921684|P3|Overall Study|Death|1
1494397|NCT00512252|4921685|P2|Overall Study|Death|0
1494398|NCT00512252|4921686|P1|Overall Study|Death|0
1494399|NCT00512252|4921684|P3|Overall Study|Protocol Violation|1
1494400|NCT00512252|4921685|P2|Overall Study|Protocol Violation|0
1494401|NCT00512252|4921686|P1|Overall Study|Protocol Violation|0
1494402|NCT00512252|4921684|P3|Overall Study|Lost to Follow-up|1
1494403|NCT00512252|4921685|P2|Overall Study|Lost to Follow-up|0
1494404|NCT00512252|4921686|P1|Overall Study|Lost to Follow-up|0
1494405|NCT00512148|4921714|P1|Primay Study Period|Withdrawal by Subject|1
1494406|NCT00512096|4921720|P1|Overall Study|Lack of Efficacy|3
1494407|NCT00512096|4921720|P1|Overall Study|Withdrawal by Subject|2
1494408|NCT00512096|4921720|P1|Overall Study|Adverse Event|2
1494409|NCT00511901|4921748|P2|Overall Study|Withdrawal by Subject|3
1494410|NCT00511901|4921749|P1|Overall Study|Withdrawal by Subject|1
1494411|NCT00511836|4921787|P2|Double-blind Period|Lost to Follow-up|0
1494412|NCT00511836|4921788|P1|Double-blind Period|Lost to Follow-up|1
1494413|NCT00511810|4921805|P2|Overall Study|Refused second scn|1
1494414|NCT00511810|4921806|P1|Overall Study|Refused second scn|0
1494415|NCT00511810|4921805|P2|Overall Study|Lack of Efficacy|2
1494416|NCT00511810|4921806|P1|Overall Study|Lack of Efficacy|0
1494417|NCT00511810|4921805|P2|Overall Study|Lost to Follow-up|2
1494418|NCT00511810|4921806|P1|Overall Study|Lost to Follow-up|1
1494419|NCT00511797|4921816|P4|Overall Study|Other (moving etc)|2
1494420|NCT00511797|4921817|P3|Overall Study|Other (moving etc)|1
1494421|NCT00511797|4921818|P2|Overall Study|Other (moving etc)|0
1494422|NCT00511797|4921819|P1|Overall Study|Other (moving etc)|1
1494423|NCT00511797|4921816|P4|Overall Study|Partially missing diary|0
1494424|NCT00511797|4921817|P3|Overall Study|Partially missing diary|1
1494425|NCT00511797|4921818|P2|Overall Study|Partially missing diary|0
1494426|NCT00511797|4921819|P1|Overall Study|Partially missing diary|0
1494427|NCT00511797|4921816|P4|Overall Study|Study drug not taken|1
1494428|NCT00511797|4921817|P3|Overall Study|Study drug not taken|0
1494429|NCT00511797|4921818|P2|Overall Study|Study drug not taken|1
1494430|NCT00511797|4921819|P1|Overall Study|Study drug not taken|0
1494431|NCT00511797|4921816|P4|Overall Study|Never dispensed|3
1494432|NCT00511797|4921817|P3|Overall Study|Never dispensed|1
1494433|NCT00511797|4921818|P2|Overall Study|Never dispensed|0
1494434|NCT00511797|4921819|P1|Overall Study|Never dispensed|1
1494435|NCT00511797|4921816|P4|Overall Study|Withdrawal by Subject|2
1494436|NCT00511797|4921817|P3|Overall Study|Withdrawal by Subject|4
1494437|NCT00511797|4921818|P2|Overall Study|Withdrawal by Subject|3
1494438|NCT00511797|4921819|P1|Overall Study|Withdrawal by Subject|3
1494439|NCT00511797|4921816|P4|Overall Study|Protocol Violation|3
1494440|NCT00511797|4921817|P3|Overall Study|Protocol Violation|2
1494441|NCT00511797|4921818|P2|Overall Study|Protocol Violation|2
1494442|NCT00511797|4921819|P1|Overall Study|Protocol Violation|0
1494443|NCT00511797|4921816|P4|Overall Study|Pregnancy|1
1494444|NCT00511797|4921817|P3|Overall Study|Pregnancy|0
1494445|NCT00511797|4921818|P2|Overall Study|Pregnancy|0
1494446|NCT00511797|4921819|P1|Overall Study|Pregnancy|0
1494447|NCT00511797|4921816|P4|Overall Study|Lost to Follow-up|1
1494448|NCT00511797|4921817|P3|Overall Study|Lost to Follow-up|0
1494449|NCT00511797|4921818|P2|Overall Study|Lost to Follow-up|0
1494450|NCT00511797|4921819|P1|Overall Study|Lost to Follow-up|1
1494451|NCT00511797|4921816|P4|Overall Study|Adverse Event|2
1494452|NCT00511797|4921817|P3|Overall Study|Adverse Event|2
1494453|NCT00511797|4921818|P2|Overall Study|Adverse Event|2
1494454|NCT00511797|4921819|P1|Overall Study|Adverse Event|1
1494455|NCT00511667|4921938|P2|Overall Study|Other|1
1494456|NCT00511667|4921939|P1|Overall Study|Other|2
1494457|NCT00511667|4921938|P2|Overall Study|Site terminated|1
1494458|NCT00511667|4921939|P1|Overall Study|Site terminated|6
1494459|NCT00511667|4921938|P2|Overall Study|Withdrawal by Subject|0
1494460|NCT00511667|4921939|P1|Overall Study|Withdrawal by Subject|2
1494461|NCT00511667|4921938|P2|Overall Study|Protocol Violation|1
1494462|NCT00511667|4921939|P1|Overall Study|Protocol Violation|1
1494463|NCT00511667|4921938|P2|Overall Study|Adverse Event|0
1494464|NCT00511667|4921939|P1|Overall Study|Adverse Event|1
1494465|NCT00511472|4921974|P2|Overall Study|Not reported|2
1494466|NCT00511472|4921975|P1|Overall Study|Not reported|2
1494467|NCT00511472|4921974|P2|Overall Study|Laboratory Adverse Event|2
1494468|NCT00511472|4921975|P1|Overall Study|Laboratory Adverse Event|0
1494469|NCT00511472|4921974|P2|Overall Study|Clinical Adverse Event|2
1494470|NCT00511472|4921975|P1|Overall Study|Clinical Adverse Event|1
1494471|NCT00511433|4921994|P2|Overall Study|Other Reason|1
1494472|NCT00511433|4921995|P1|Overall Study|Other Reason|1
1494473|NCT00511433|4921994|P2|Overall Study|Adverse Event|0
1494474|NCT00511433|4921995|P1|Overall Study|Adverse Event|5
1494475|NCT00511355|4922035|P2|Overall Study|Other reason pre-treatment|1
1494476|NCT00511355|4922036|P1|Overall Study|Other reason pre-treatment|0
1494477|NCT00511355|4922035|P2|Overall Study|Withdrawal of informed consent|1
1494478|NCT00511355|4922036|P1|Overall Study|Withdrawal of informed consent|0
1494479|NCT00511355|4922035|P2|Overall Study|Pre-treatment (serious) adverse event|1
1494480|NCT00511355|4922036|P1|Overall Study|Pre-treatment (serious) adverse event|0
1494481|NCT00511355|4922035|P2|Overall Study|Other Reason|1
1494482|NCT00511355|4922036|P1|Overall Study|Other Reason|0
1494483|NCT00511355|4922035|P2|Overall Study|Lost to Follow-up|1
1494484|NCT00511355|4922036|P1|Overall Study|Lost to Follow-up|2
1494485|NCT00511355|4922035|P2|Overall Study|Pregnancy Wish|0
1494486|NCT00511355|4922036|P1|Overall Study|Pregnancy Wish|1
1494487|NCT00511355|4922035|P2|Overall Study|Adverse Event|4
1494488|NCT00511355|4922036|P1|Overall Study|Adverse Event|4
1494489|NCT00511342|4922136|P2|Overall Study|Other Reason|2
1494490|NCT00511342|4922137|P1|Overall Study|Other Reason|2
1494491|NCT00511342|4922136|P2|Overall Study|Lost to Follow-up|5
1494492|NCT00511342|4922137|P1|Overall Study|Lost to Follow-up|1
1494493|NCT00511342|4922136|P2|Overall Study|Pregnancy wish|1
1494494|NCT00511342|4922137|P1|Overall Study|Pregnancy wish|0
1494495|NCT00511342|4922136|P2|Overall Study|Pregnancy|1
1494496|NCT00511342|4922137|P1|Overall Study|Pregnancy|0
1494497|NCT00511342|4922136|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
1494498|NCT00511342|4922137|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
1494499|NCT00511342|4922136|P2|Overall Study|Unacceptable vaginal bleeding|1
1494500|NCT00511342|4922137|P1|Overall Study|Unacceptable vaginal bleeding|2
1494501|NCT00511238|4922168|P2|Overall Study|various reasons|14
1494502|NCT00511238|4922169|P1|Overall Study|various reasons|4
1494503|NCT00511238|4922168|P2|Overall Study|Progressive Disease|157
1494504|NCT00511238|4922169|P1|Overall Study|Progressive Disease|23
1494505|NCT00511238|4922168|P2|Overall Study|Withdrawal by Subject|22
1494506|NCT00511238|4922169|P1|Overall Study|Withdrawal by Subject|2
1494507|NCT00511238|4922168|P2|Overall Study|Adverse Event|33
1494508|NCT00511238|4922169|P1|Overall Study|Adverse Event|13
1494509|NCT00511199|4922188|P2|Overall Study|Other Reason|37
1494510|NCT00511199|4922189|P1|Overall Study|Other Reason|78
1494511|NCT00511199|4922188|P2|Overall Study|Lost to Follow-up|17
1494512|NCT00511199|4922189|P1|Overall Study|Lost to Follow-up|40
1494513|NCT00511199|4922188|P2|Overall Study|Pregnancy Wish|8
1494514|NCT00511199|4922189|P1|Overall Study|Pregnancy Wish|16
1494515|NCT00511199|4922188|P2|Overall Study|Pregnancy|3
1494516|NCT00511199|4922189|P1|Overall Study|Pregnancy|6
1494517|NCT00511199|4922188|P2|Overall Study|Withdrawal of Informed Consent|4
1494518|NCT00511199|4922189|P1|Overall Study|Withdrawal of Informed Consent|19
1494519|NCT00511199|4922188|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
1494520|NCT00511199|4922189|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
1494521|NCT00511199|4922188|P2|Overall Study|Unacceptable Vaginal Bleeding|4
1494522|NCT00511199|4922189|P1|Overall Study|Unacceptable Vaginal Bleeding|63
1494523|NCT00511147|4922218|P1|Overall Study|Required platelet transfusion|1
1494524|NCT00511147|4922218|P1|Overall Study|Disease progression|5
1494525|NCT00511147|4922218|P1|Overall Study|Withdrawal by Subject|1
1494526|NCT00511134|4922227|P2|Overall Study|Withdrawal by Subject|2
1494527|NCT00511134|4922228|P1|Overall Study|Withdrawal by Subject|0
1494528|NCT00511108|4922240|P4|Overall Study|Withdrawal by Subject|2
1494529|NCT00511108|4922241|P3|Overall Study|Withdrawal by Subject|3
1494530|NCT00511108|4922242|P2|Overall Study|Withdrawal by Subject|0
1494531|NCT00511108|4922243|P1|Overall Study|Withdrawal by Subject|4
1494532|NCT00511108|4922240|P4|Overall Study|Physician Decision|1
1494533|NCT00511108|4922241|P3|Overall Study|Physician Decision|0
1494534|NCT00511108|4922242|P2|Overall Study|Physician Decision|0
1494535|NCT00511108|4922243|P1|Overall Study|Physician Decision|0
1494536|NCT00511108|4922240|P4|Overall Study|Lost to Follow-up|0
1494537|NCT00511108|4922241|P3|Overall Study|Lost to Follow-up|1
1494538|NCT00511108|4922242|P2|Overall Study|Lost to Follow-up|2
1494539|NCT00511108|4922243|P1|Overall Study|Lost to Follow-up|0
1494540|NCT00511108|4922240|P4|Overall Study|Adverse Event|2
1494541|NCT00511108|4922241|P3|Overall Study|Adverse Event|1
1494542|NCT00511108|4922242|P2|Overall Study|Adverse Event|0
1494543|NCT00511108|4922243|P1|Overall Study|Adverse Event|2
1494544|NCT00511004|4922270|P3|Overall Study|Lost to Follow-up|4
1494545|NCT00511004|4922271|P2|Overall Study|Lost to Follow-up|0
1494546|NCT00511004|4922272|P1|Overall Study|Lost to Follow-up|0
1494547|NCT00510952|4922291|P2|Overall Study|Did Not Receive Study Drug|0
1494548|NCT00510952|4922292|P1|Overall Study|Did Not Receive Study Drug|2
1494549|NCT00510952|4922291|P2|Overall Study|Withdrawal by Subject|7
1494550|NCT00510952|4922292|P1|Overall Study|Withdrawal by Subject|6
1494551|NCT00510952|4922291|P2|Overall Study|Sponsor Decision|0
1494552|NCT00510952|4922292|P1|Overall Study|Sponsor Decision|1
1494553|NCT00510952|4922291|P2|Overall Study|Protocol Violation|4
1494554|NCT00510952|4922292|P1|Overall Study|Protocol Violation|7
1494555|NCT00510952|4922291|P2|Overall Study|Physician Decision|1
1494556|NCT00510952|4922292|P1|Overall Study|Physician Decision|1
1494557|NCT00510952|4922291|P2|Overall Study|Lost to Follow-up|3
1494558|NCT00510952|4922292|P1|Overall Study|Lost to Follow-up|5
1494559|NCT00510952|4922291|P2|Overall Study|Entry Criteria Not Met|1
1494560|NCT00510952|4922292|P1|Overall Study|Entry Criteria Not Met|3
1494561|NCT00510952|4922291|P2|Overall Study|Adverse Event|0
1494562|NCT00510952|4922292|P1|Overall Study|Adverse Event|1
1494563|NCT00510887|4922318|P1|Overall Study|Lost to Follow-up|1
1494564|NCT00510874|4922334|P7|Overall Study|Lost to Follow-up|1
1494565|NCT00510874|4922335|P6|Overall Study|Lost to Follow-up|0
1494566|NCT00510874|4922336|P5|Overall Study|Lost to Follow-up|4
1494567|NCT00510874|4922337|P4|Overall Study|Lost to Follow-up|3
1494568|NCT00510874|4922338|P3|Overall Study|Lost to Follow-up|1
1494569|NCT00510874|4922339|P2|Overall Study|Lost to Follow-up|3
1494570|NCT00510874|4922340|P1|Overall Study|Lost to Follow-up|2
1494571|NCT00510874|4922334|P7|Overall Study|Withdrawal by Subject|0
1494572|NCT00510874|4922335|P6|Overall Study|Withdrawal by Subject|0
1494573|NCT00510874|4922336|P5|Overall Study|Withdrawal by Subject|3
1494574|NCT00510874|4922337|P4|Overall Study|Withdrawal by Subject|0
1494575|NCT00510874|4922338|P3|Overall Study|Withdrawal by Subject|0
1494576|NCT00510874|4922339|P2|Overall Study|Withdrawal by Subject|1
1494577|NCT00510874|4922340|P1|Overall Study|Withdrawal by Subject|1
1494578|NCT00510835|4922443|P3|Overall Study|Withdrawal by Subject|2
1494579|NCT00510835|4922444|P2|Overall Study|Withdrawal by Subject|2
1494580|NCT00510835|4922445|P1|Overall Study|Withdrawal by Subject|6
1494581|NCT00510783|4922471|P2|Overall Study|Protocol Violation|1
1494582|NCT00510783|4922472|P1|Overall Study|Protocol Violation|0
1494583|NCT00510783|4922471|P2|Overall Study|Withdrawal by Subject|3
1494584|NCT00510783|4922472|P1|Overall Study|Withdrawal by Subject|2
1494585|NCT00510783|4922471|P2|Overall Study|Lost to Follow-up|25
1494586|NCT00510783|4922472|P1|Overall Study|Lost to Follow-up|29
1494587|NCT00510692|4922484|P2|Overall Study|Withdrawal by Subject|0
1494588|NCT00510692|4922485|P1|Overall Study|Withdrawal by Subject|1
1494589|NCT00510692|4922484|P2|Overall Study|Adverse Event|3
1494590|NCT00510692|4922485|P1|Overall Study|Adverse Event|1
1494591|NCT00510653|4922499|P1|Overall Study|Monetary|3
1494592|NCT00510653|4922499|P1|Overall Study|Withdrawal by Subject|8
1494593|NCT00510510|4922506|P3|Overall Study|Protocol Violation|4
1494594|NCT00510510|4922507|P2|Overall Study|Protocol Violation|3
1494595|NCT00510510|4922508|P1|Overall Study|Protocol Violation|0
1494596|NCT00510510|4922506|P3|Overall Study|Lost to Follow-up|1
1494597|NCT00510510|4922507|P2|Overall Study|Lost to Follow-up|0
1494598|NCT00510510|4922508|P1|Overall Study|Lost to Follow-up|0
1494599|NCT00510510|4922506|P3|Overall Study|Withdrawal by Subject|3
1494600|NCT00510510|4922507|P2|Overall Study|Withdrawal by Subject|2
1494601|NCT00510510|4922508|P1|Overall Study|Withdrawal by Subject|1
1494602|NCT00510510|4922506|P3|Overall Study|Subjects no longer requires study drug|2
1494603|NCT00510510|4922507|P2|Overall Study|Subjects no longer requires study drug|0
1494604|NCT00510510|4922508|P1|Overall Study|Subjects no longer requires study drug|0
1494605|NCT00510510|4922506|P3|Overall Study|Lack of Efficacy|1
1494606|NCT00510510|4922507|P2|Overall Study|Lack of Efficacy|1
1494607|NCT00510510|4922508|P1|Overall Study|Lack of Efficacy|0
1494608|NCT00510510|4922506|P3|Overall Study|Adverse Event|6
1494609|NCT00510510|4922507|P2|Overall Study|Adverse Event|3
1494610|NCT00510510|4922508|P1|Overall Study|Adverse Event|4
1494611|NCT00510484|4922526|P2|Wash-out Period|Adverse Event|1
1494612|NCT00510484|4922527|P1|Wash-out Period|Adverse Event|0
1494613|NCT00510458|4922547|P1|Overall Study|Revision|2
1494614|NCT00510458|4922547|P1|Overall Study|Withdrawal by Subject|3
1494615|NCT00510458|4922547|P1|Overall Study|Lost to Follow-up|6
1494616|NCT00510458|4922547|P1|Overall Study|Terminated|14
1494617|NCT00510458|4922547|P1|Overall Study|Death|1
1494618|NCT00510458|4922547|P1|Overall Study|5 year not evaluable/missed|21
1494619|NCT00510289|4922560|P1|Overall Study|Progressed prior to starting drug|2
1494620|NCT00510289|4922560|P1|Overall Study|Lost to Follow-up|1
1494621|NCT00510289|4922560|P1|Overall Study|Refused bone marrow biopsy|2
1494622|NCT00510289|4922560|P1|Overall Study|Withdrawal by Subject|7
1494623|NCT00510276|4922570|P2|Extension Open-Label Phase|Subject Decision|9
1494624|NCT00510276|4922571|P1|Extension Open-Label Phase|Subject Decision|7
1494625|NCT00510276|4922570|P2|Extension Open-Label Phase|Sponsor Decision|0
1494626|NCT00510276|4922571|P1|Extension Open-Label Phase|Sponsor Decision|1
1494627|NCT00510276|4922570|P2|Extension Open-Label Phase|Protocol Violation|1
1494628|NCT00510276|4922571|P1|Extension Open-Label Phase|Protocol Violation|0
1494629|NCT00510276|4922570|P2|Extension Open-Label Phase|Physician Decision|3
1494630|NCT00510276|4922571|P1|Extension Open-Label Phase|Physician Decision|2
1494631|NCT00510276|4922570|P2|Extension Open-Label Phase|Lost to Follow-up|10
1494632|NCT00510276|4922571|P1|Extension Open-Label Phase|Lost to Follow-up|12
1494633|NCT00510276|4922570|P2|Extension Open-Label Phase|Lack of Efficacy|7
1494634|NCT00510276|4922571|P1|Extension Open-Label Phase|Lack of Efficacy|2
1494635|NCT00510276|4922570|P2|Extension Open-Label Phase|Adverse Event|18
1494636|NCT00510276|4922571|P1|Extension Open-Label Phase|Adverse Event|9
1494637|NCT00510276|4922570|P2|Acute Double-Blind Phase|Subject Decision|28
1494638|NCT00510276|4922571|P1|Acute Double-Blind Phase|Subject Decision|26
1494639|NCT00510276|4922570|P2|Acute Double-Blind Phase|Sponsor Decision|1
1494640|NCT00510276|4922571|P1|Acute Double-Blind Phase|Sponsor Decision|2
1494641|NCT00510276|4922570|P2|Acute Double-Blind Phase|Protocol Violation|3
1494642|NCT00510276|4922571|P1|Acute Double-Blind Phase|Protocol Violation|4
1494643|NCT00510276|4922570|P2|Acute Double-Blind Phase|Physician Decision|3
1494644|NCT00510276|4922571|P1|Acute Double-Blind Phase|Physician Decision|0
1494645|NCT00510276|4922570|P2|Acute Double-Blind Phase|Lost to Follow-up|49
1494646|NCT00510276|4922571|P1|Acute Double-Blind Phase|Lost to Follow-up|48
1494647|NCT00510276|4922570|P2|Acute Double-Blind Phase|Lack of Efficacy|4
1494648|NCT00510276|4922571|P1|Acute Double-Blind Phase|Lack of Efficacy|3
1494649|NCT00510276|4922570|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
1494650|NCT00510276|4922571|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
1494651|NCT00510276|4922570|P2|Acute Double-Blind Phase|Adverse Event|6
1494652|NCT00510276|4922571|P1|Acute Double-Blind Phase|Adverse Event|21
1494653|NCT00510146|4922665|P2|Open-Label Treatment|Sponsor Decision|0
1494654|NCT00510146|4922666|P1|Open-Label Treatment|Sponsor Decision|2
1494655|NCT00510146|4922665|P2|Open-Label Treatment|Clinical Relapse|1
1494656|NCT00510146|4922666|P1|Open-Label Treatment|Clinical Relapse|1
1494657|NCT00510146|4922665|P2|Open-Label Treatment|Withdrawal by Subject|12
1494658|NCT00510146|4922666|P1|Open-Label Treatment|Withdrawal by Subject|24
1494659|NCT00510146|4922665|P2|Open-Label Treatment|Protocol Violation|2
1494660|NCT00510146|4922666|P1|Open-Label Treatment|Protocol Violation|4
1494661|NCT00510146|4922665|P2|Open-Label Treatment|Physician Decision|1
1494662|NCT00510146|4922666|P1|Open-Label Treatment|Physician Decision|3
1494663|NCT00510146|4922665|P2|Open-Label Treatment|Lost to Follow-up|1
1494664|NCT00510146|4922666|P1|Open-Label Treatment|Lost to Follow-up|10
1494665|NCT00510146|4922665|P2|Open-Label Treatment|Lack of Efficacy|0
1494666|NCT00510146|4922666|P1|Open-Label Treatment|Lack of Efficacy|4
1494667|NCT00510146|4922665|P2|Open-Label Treatment|Death|1
1494668|NCT00510146|4922666|P1|Open-Label Treatment|Death|1
1494669|NCT00510146|4922665|P2|Open-Label Treatment|Adverse Event|8
1494670|NCT00510146|4922666|P1|Open-Label Treatment|Adverse Event|22
1494671|NCT00510146|4922665|P2|Double-Blind Treatment|Entry Criteria Not Met|0
1494672|NCT00510146|4922666|P1|Double-Blind Treatment|Entry Criteria Not Met|3
1494673|NCT00510146|4922665|P2|Double-Blind Treatment|Clinical Relapse|1
1494674|NCT00510146|4922666|P1|Double-Blind Treatment|Clinical Relapse|0
1494675|NCT00510146|4922665|P2|Double-Blind Treatment|Withdrawal by Subject|13
1494676|NCT00510146|4922666|P1|Double-Blind Treatment|Withdrawal by Subject|27
1494677|NCT00510146|4922665|P2|Double-Blind Treatment|Protocol Violation|2
1494678|NCT00510146|4922666|P1|Double-Blind Treatment|Protocol Violation|1
1494679|NCT00510146|4922665|P2|Double-Blind Treatment|Physician Decision|0
1494680|NCT00510146|4922666|P1|Double-Blind Treatment|Physician Decision|6
1494681|NCT00510146|4922665|P2|Double-Blind Treatment|Lost to Follow-up|7
1494682|NCT00510146|4922666|P1|Double-Blind Treatment|Lost to Follow-up|3
1494683|NCT00510146|4922665|P2|Double-Blind Treatment|Lack of Efficacy|13
1494684|NCT00510146|4922666|P1|Double-Blind Treatment|Lack of Efficacy|6
1494685|NCT00510146|4922665|P2|Double-Blind Treatment|Adverse Event|13
1494686|NCT00510146|4922666|P1|Double-Blind Treatment|Adverse Event|30
1494687|NCT00510068|4922755|P2|Open-label Period|Abnormal laboratory value (s)|0
1494688|NCT00510068|4922756|P1|Open-label Period|Abnormal laboratory value (s)|1
1494689|NCT00510068|4922755|P2|Open-label Period|Protocol Violation|0
1494690|NCT00510068|4922756|P1|Open-label Period|Protocol Violation|2
1494691|NCT00510068|4922755|P2|Open-label Period|New cancer therapy|0
1494692|NCT00510068|4922756|P1|Open-label Period|New cancer therapy|7
1494693|NCT00510068|4922755|P2|Open-label Period|Death|0
1494694|NCT00510068|4922756|P1|Open-label Period|Death|7
1494695|NCT00510068|4922755|P2|Open-label Period|Administrative problems|0
1494696|NCT00510068|4922756|P1|Open-label Period|Administrative problems|17
1494697|NCT00510068|4922755|P2|Open-label Period|Withdrawal by Subject|0
1494698|NCT00510068|4922756|P1|Open-label Period|Withdrawal by Subject|21
1494699|NCT00510068|4922755|P2|Open-label Period|Adverse Event|0
1494700|NCT00510068|4922756|P1|Open-label Period|Adverse Event|46
1494701|NCT00510068|4922755|P2|Open-label Period|Disease Progression|0
1494702|NCT00510068|4922756|P1|Open-label Period|Disease Progression|124
1494703|NCT00510068|4922755|P2|Double-blind Period|Protocol Violation|0
1494704|NCT00510068|4922756|P1|Double-blind Period|Protocol Violation|6
1494705|NCT00510068|4922755|P2|Double-blind Period|Lost to Follow-up|0
1494706|NCT00510068|4922756|P1|Double-blind Period|Lost to Follow-up|1
1494707|NCT00510068|4922755|P2|Double-blind Period|Abnormal test result (s)|0
1494708|NCT00510068|4922756|P1|Double-blind Period|Abnormal test result (s)|1
1494709|NCT00510068|4922755|P2|Double-blind Period|Death|3
1494710|NCT00510068|4922756|P1|Double-blind Period|Death|4
1494711|NCT00510068|4922755|P2|Double-blind Period|Withdrawal by Subject|6
1494712|NCT00510068|4922756|P1|Double-blind Period|Withdrawal by Subject|8
1494713|NCT00510068|4922755|P2|Double-blind Period|Adverse Event|7
1494714|NCT00510068|4922756|P1|Double-blind Period|Adverse Event|37
1494715|NCT00510068|4922755|P2|Double-blind Period|Final primary analysis|18
1494716|NCT00510068|4922756|P1|Double-blind Period|Final primary analysis|52
1494717|NCT00510068|4922755|P2|Double-blind Period|Disease progression|169
1494718|NCT00510068|4922756|P1|Double-blind Period|Disease progression|98
1494719|NCT00509925|4922797|P2|Overall Study|Personal reasons|1
1494720|NCT00509925|4922798|P1|Overall Study|Personal reasons|0
1494721|NCT00509899|4922846|P8|Overall Study|Lack of Efficacy|0
1494722|NCT00509899|4922847|P7|Overall Study|Lack of Efficacy|0
1494723|NCT00509899|4922848|P6|Overall Study|Lack of Efficacy|1
1494724|NCT00509899|4922849|P5|Overall Study|Lack of Efficacy|0
1494725|NCT00509899|4922850|P4|Overall Study|Lack of Efficacy|0
1494726|NCT00509899|4922851|P3|Overall Study|Lack of Efficacy|2
1494727|NCT00509899|4922852|P2|Overall Study|Lack of Efficacy|0
1494728|NCT00509899|4922853|P1|Overall Study|Lack of Efficacy|1
1494729|NCT00509899|4922846|P8|Overall Study|Death|1
1494730|NCT00509899|4922847|P7|Overall Study|Death|1
1494731|NCT00509899|4922848|P6|Overall Study|Death|1
1494732|NCT00509899|4922849|P5|Overall Study|Death|1
1494733|NCT00509899|4922850|P4|Overall Study|Death|0
1494734|NCT00509899|4922851|P3|Overall Study|Death|3
1494735|NCT00509899|4922852|P2|Overall Study|Death|2
1494736|NCT00509899|4922853|P1|Overall Study|Death|2
1494737|NCT00509899|4922846|P8|Overall Study|Intercurrent Illness|0
1494738|NCT00509899|4922847|P7|Overall Study|Intercurrent Illness|0
1494739|NCT00509899|4922848|P6|Overall Study|Intercurrent Illness|1
1494740|NCT00509899|4922849|P5|Overall Study|Intercurrent Illness|0
1494741|NCT00509899|4922850|P4|Overall Study|Intercurrent Illness|1
1494742|NCT00509899|4922851|P3|Overall Study|Intercurrent Illness|0
1494743|NCT00509899|4922852|P2|Overall Study|Intercurrent Illness|0
1494744|NCT00509899|4922853|P1|Overall Study|Intercurrent Illness|1
1494745|NCT00509899|4922846|P8|Overall Study|Physician Decision|0
1494746|NCT00509899|4922847|P7|Overall Study|Physician Decision|0
1494747|NCT00509899|4922848|P6|Overall Study|Physician Decision|4
1494748|NCT00509899|4922849|P5|Overall Study|Physician Decision|1
1494749|NCT00509899|4922850|P4|Overall Study|Physician Decision|0
1494750|NCT00509899|4922851|P3|Overall Study|Physician Decision|7
1494751|NCT00509899|4922852|P2|Overall Study|Physician Decision|2
1494752|NCT00509899|4922853|P1|Overall Study|Physician Decision|4
1494753|NCT00509899|4922846|P8|Overall Study|Withdrawal by Subject|0
1494754|NCT00509899|4922847|P7|Overall Study|Withdrawal by Subject|0
1494755|NCT00509899|4922848|P6|Overall Study|Withdrawal by Subject|2
1494756|NCT00509899|4922849|P5|Overall Study|Withdrawal by Subject|3
1494757|NCT00509899|4922850|P4|Overall Study|Withdrawal by Subject|0
1494758|NCT00509899|4922851|P3|Overall Study|Withdrawal by Subject|3
1494759|NCT00509899|4922852|P2|Overall Study|Withdrawal by Subject|2
1494760|NCT00509899|4922853|P1|Overall Study|Withdrawal by Subject|6
1494761|NCT00509899|4922846|P8|Overall Study|Unacceptable Toxicity|0
1494762|NCT00509899|4922847|P7|Overall Study|Unacceptable Toxicity|0
1494763|NCT00509899|4922848|P6|Overall Study|Unacceptable Toxicity|0
1494764|NCT00509899|4922849|P5|Overall Study|Unacceptable Toxicity|0
1494765|NCT00509899|4922850|P4|Overall Study|Unacceptable Toxicity|2
1494766|NCT00509899|4922851|P3|Overall Study|Unacceptable Toxicity|0
1494767|NCT00509899|4922852|P2|Overall Study|Unacceptable Toxicity|0
1494768|NCT00509899|4922853|P1|Overall Study|Unacceptable Toxicity|1
1494769|NCT00509899|4922846|P8|Overall Study|Progressive disease|0
1494770|NCT00509899|4922847|P7|Overall Study|Progressive disease|0
1494771|NCT00509899|4922848|P6|Overall Study|Progressive disease|1
1494772|NCT00509899|4922849|P5|Overall Study|Progressive disease|0
1494773|NCT00509899|4922850|P4|Overall Study|Progressive disease|1
1494774|NCT00509899|4922851|P3|Overall Study|Progressive disease|5
1494775|NCT00509899|4922852|P2|Overall Study|Progressive disease|3
1494776|NCT00509899|4922853|P1|Overall Study|Progressive disease|1
1494777|NCT00509795|4922912|P4|Overall Study|Withdrawal by Subject|8
1494778|NCT00509795|4922913|P3|Overall Study|Withdrawal by Subject|7
1494779|NCT00509795|4922914|P2|Overall Study|Withdrawal by Subject|5
1494780|NCT00509795|4922915|P1|Overall Study|Withdrawal by Subject|10
1494781|NCT00509795|4922912|P4|Overall Study|Protocol Violation|1
1494782|NCT00509795|4922913|P3|Overall Study|Protocol Violation|3
1494783|NCT00509795|4922914|P2|Overall Study|Protocol Violation|0
1494784|NCT00509795|4922915|P1|Overall Study|Protocol Violation|3
1494785|NCT00509795|4922912|P4|Overall Study|OTHER|1
1494786|NCT00509795|4922913|P3|Overall Study|OTHER|4
1494787|NCT00509795|4922914|P2|Overall Study|OTHER|0
1494788|NCT00509795|4922915|P1|Overall Study|OTHER|1
1494789|NCT00509795|4922912|P4|Overall Study|Lost to Follow-up|4
1494790|NCT00509795|4922913|P3|Overall Study|Lost to Follow-up|4
1494791|NCT00509795|4922914|P2|Overall Study|Lost to Follow-up|2
1494792|NCT00509795|4922915|P1|Overall Study|Lost to Follow-up|1
1494793|NCT00509795|4922912|P4|Overall Study|Lack of Efficacy|2
1494794|NCT00509795|4922913|P3|Overall Study|Lack of Efficacy|2
1494795|NCT00509795|4922914|P2|Overall Study|Lack of Efficacy|0
1494796|NCT00509795|4922915|P1|Overall Study|Lack of Efficacy|0
1494797|NCT00509795|4922912|P4|Overall Study|Death|7
1494798|NCT00509795|4922913|P3|Overall Study|Death|2
1494799|NCT00509795|4922914|P2|Overall Study|Death|1
1494800|NCT00509795|4922915|P1|Overall Study|Death|3
1494801|NCT00509795|4922912|P4|Overall Study|Adverse Event|4
1494802|NCT00509795|4922913|P3|Overall Study|Adverse Event|5
1494803|NCT00509795|4922914|P2|Overall Study|Adverse Event|3
1494804|NCT00509795|4922915|P1|Overall Study|Adverse Event|4
1494805|NCT00509769|4922946|P1|Overall Study|Use of prohibited therapies during study|1
1494806|NCT00509769|4922946|P1|Overall Study|Physician Decision|8
1494807|NCT00509769|4922946|P1|Overall Study|Patient’s decision|1
1494808|NCT00509769|4922946|P1|Overall Study|Adverse Event|4
1494809|NCT00509769|4922946|P1|Overall Study|Progressive disease|77
1494810|NCT00509600|4922965|P1|Overall Study|Adverse Event|1
1494811|NCT00509366|4923044|P5|Overall Study|Not Treated (Screen Failure)|0
1494812|NCT00509366|4923045|P4|Overall Study|Not Treated (Screen Failure)|0
1494813|NCT00509366|4923046|P3|Overall Study|Not Treated (Screen Failure)|1
1494814|NCT00509366|4923047|P2|Overall Study|Not Treated (Screen Failure)|1
1494815|NCT00509366|4923048|P1|Overall Study|Not Treated (Screen Failure)|1
1494816|NCT00509262|4923072|P2|Overall Study|Withdrawal by Subject|11
1494817|NCT00509262|4923073|P1|Overall Study|Withdrawal by Subject|24
1494818|NCT00509262|4923072|P2|Overall Study|Protocol Violation|2
1494819|NCT00509262|4923073|P1|Overall Study|Protocol Violation|2
1494820|NCT00509262|4923072|P2|Overall Study|Physician Decision|3
1494821|NCT00509262|4923073|P1|Overall Study|Physician Decision|1
1494822|NCT00509262|4923072|P2|Overall Study|Lost to Follow-up|6
1494823|NCT00509262|4923073|P1|Overall Study|Lost to Follow-up|1
1494824|NCT00509262|4923072|P2|Overall Study|Lack of Efficacy|0
1494825|NCT00509262|4923073|P1|Overall Study|Lack of Efficacy|1
1494826|NCT00509262|4923072|P2|Overall Study|Not specified|2
1494827|NCT00509262|4923073|P1|Overall Study|Not specified|2
1494828|NCT00509262|4923072|P2|Overall Study|Adverse Event|18
1494829|NCT00509262|4923073|P1|Overall Study|Adverse Event|16
1494830|NCT00509236|4923091|P2|Overall Study|Scheduled Kidney Transplant|0
1494831|NCT00509236|4923092|P1|Overall Study|Scheduled Kidney Transplant|1
1494832|NCT00509236|4923091|P2|Overall Study|Excluded Medication|1
1494833|NCT00509236|4923092|P1|Overall Study|Excluded Medication|1
1494834|NCT00509236|4923091|P2|Overall Study|Protocol Violation|0
1494835|NCT00509236|4923092|P1|Overall Study|Protocol Violation|3
1494836|NCT00509236|4923091|P2|Overall Study|Withdrawal by Subject|10
1494837|NCT00509236|4923092|P1|Overall Study|Withdrawal by Subject|5
1494838|NCT00509236|4923091|P2|Overall Study|Adverse Event|9
1494839|NCT00509236|4923092|P1|Overall Study|Adverse Event|7
1494840|NCT00509223|4923107|P2|Overall Study|Did not meet revised inclusion criteria|62
1494841|NCT00509223|4923108|P1|Overall Study|Did not meet revised inclusion criteria|56
1494842|NCT00509223|4923107|P2|Overall Study|Including: subject change of address|2
1494843|NCT00509223|4923108|P1|Overall Study|Including: subject change of address|5
1494844|NCT00509223|4923107|P2|Overall Study|Withdrawal by Subject|6
1494845|NCT00509223|4923108|P1|Overall Study|Withdrawal by Subject|25
1494846|NCT00509223|4923107|P2|Overall Study|Adverse Event|1
1494847|NCT00509223|4923108|P1|Overall Study|Adverse Event|1
1494848|NCT00509223|4923107|P2|Overall Study|Lost to Follow-up|1
1494849|NCT00509223|4923108|P1|Overall Study|Lost to Follow-up|1
1494850|NCT00509106|4923131|P2|Overall Study|Death|6
1494851|NCT00509106|4923132|P1|Overall Study|Death|6
1494852|NCT00509106|4923131|P2|Overall Study|Other|0
1494853|NCT00509106|4923132|P1|Overall Study|Other|1
1494854|NCT00509106|4923131|P2|Overall Study|Lost to Follow-up|10
1494855|NCT00509106|4923132|P1|Overall Study|Lost to Follow-up|16
1494856|NCT00509106|4923131|P2|Overall Study|Withdrew consent|8
1494857|NCT00509106|4923132|P1|Overall Study|Withdrew consent|4
1494858|NCT00509106|4923131|P2|Overall Study|At the request of sponsor/investigator|2
1494859|NCT00509106|4923132|P1|Overall Study|At the request of sponsor/investigator|1
1494860|NCT00509106|4923131|P2|Overall Study|Noncompliance|1
1494861|NCT00509106|4923132|P1|Overall Study|Noncompliance|0
1494862|NCT00509106|4923131|P2|Overall Study|Adverse Event|2
1494863|NCT00509106|4923132|P1|Overall Study|Adverse Event|3
1494864|NCT00509067|4923140|P2|Overall Study|Protocol Violation|3
1494865|NCT00509067|4923141|P1|Overall Study|Protocol Violation|0
1494866|NCT00509067|4923140|P2|Overall Study|Adverse Event|1
1494867|NCT00509067|4923141|P1|Overall Study|Adverse Event|3
1494868|NCT00509067|4923140|P2|Overall Study|Lost to Follow-up|1
1494869|NCT00509067|4923141|P1|Overall Study|Lost to Follow-up|1
1494870|NCT00509028|4923160|P2|Overall Study|Non-compliance|1
1494871|NCT00509028|4923161|P1|Overall Study|Non-compliance|2
1494872|NCT00509028|4923160|P2|Overall Study|Protocol Violation|2
1494873|NCT00509028|4923161|P1|Overall Study|Protocol Violation|4
1494874|NCT00509028|4923160|P2|Overall Study|Lost to Follow-up|1
1494875|NCT00509028|4923161|P1|Overall Study|Lost to Follow-up|0
1494876|NCT00509028|4923160|P2|Overall Study|Withdrawal by Subject|3
1494877|NCT00509028|4923161|P1|Overall Study|Withdrawal by Subject|4
1494878|NCT00509028|4923160|P2|Overall Study|Adverse Event|0
1494879|NCT00509028|4923161|P1|Overall Study|Adverse Event|2
1494880|NCT00508924|4923201|P4|Overall Study|Protocol Violation|1
1494881|NCT00508924|4923202|P3|Overall Study|Protocol Violation|1
1494882|NCT00508924|4923203|P2|Overall Study|Protocol Violation|0
1494883|NCT00508924|4923204|P1|Overall Study|Protocol Violation|0
1494884|NCT00508872|4923218|P1|Overall Study|Physician Decision|1
1494885|NCT00508872|4923218|P1|Overall Study|Lost to Follow-up|1
1494886|NCT00508820|4923224|P2|Overall Study|Protocol-specified Criteria|12
1494887|NCT00508820|4923225|P1|Overall Study|Protocol-specified Criteria|3
1494888|NCT00508820|4923224|P2|Overall Study|Requirement for alternative therapy|15
1494889|NCT00508820|4923225|P1|Overall Study|Requirement for alternative therapy|7
1494890|NCT00508820|4923224|P2|Overall Study|Noncompliance|0
1494891|NCT00508820|4923225|P1|Overall Study|Noncompliance|1
1494892|NCT00508820|4923224|P2|Overall Study|Other|2
1494893|NCT00508820|4923225|P1|Overall Study|Other|11
1494894|NCT00508820|4923224|P2|Overall Study|Withdrawal by Subject|12
1494895|NCT00508820|4923225|P1|Overall Study|Withdrawal by Subject|10
1494896|NCT00508820|4923224|P2|Overall Study|Protocol Violation|0
1494897|NCT00508820|4923225|P1|Overall Study|Protocol Violation|2
1494898|NCT00508820|4923224|P2|Overall Study|Pregnancy|2
1494899|NCT00508820|4923225|P1|Overall Study|Pregnancy|0
1494900|NCT00508820|4923224|P2|Overall Study|Physician Decision|2
1494901|NCT00508820|4923225|P1|Overall Study|Physician Decision|8
1494902|NCT00508820|4923224|P2|Overall Study|Lost to Follow-up|1
1494903|NCT00508820|4923225|P1|Overall Study|Lost to Follow-up|1
1494904|NCT00508820|4923224|P2|Overall Study|Death|8
1494905|NCT00508820|4923225|P1|Overall Study|Death|6
1494906|NCT00508820|4923224|P2|Overall Study|Adverse Event|10
1494907|NCT00508820|4923225|P1|Overall Study|Adverse Event|6
1494908|NCT00508755|4923235|P1|Overall Study|Withdrawal by Subject|1
1494909|NCT00508742|4923243|P2|Period 3: Toddler Dose|Other|4
1494910|NCT00508742|4923244|P1|Period 3: Toddler Dose|Other|5
1494911|NCT00508742|4923243|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
1494912|NCT00508742|4923244|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
1494913|NCT00508742|4923243|P2|Period 3: Toddler Dose|Lost to Follow-up|3
1494914|NCT00508742|4923244|P1|Period 3: Toddler Dose|Lost to Follow-up|2
1494915|NCT00508742|4923243|P2|Period 3: Toddler Dose|Adverse Event|0
1494916|NCT00508742|4923244|P1|Period 3: Toddler Dose|Adverse Event|1
1494917|NCT00508742|4923243|P2|Period 2: After Infant Series|Other|1
1494918|NCT00508742|4923244|P1|Period 2: After Infant Series|Other|2
1494919|NCT00508742|4923243|P2|Period 2: After Infant Series|Failed to Return|0
1494920|NCT00508742|4923244|P1|Period 2: After Infant Series|Failed to Return|1
1494921|NCT00508742|4923243|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
1494922|NCT00508742|4923244|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
1494923|NCT00508742|4923243|P2|Period 2: After Infant Series|Protocol Violation|0
1494924|NCT00508742|4923244|P1|Period 2: After Infant Series|Protocol Violation|1
1494925|NCT00508742|4923243|P2|Period 2: After Infant Series|Lost to Follow-up|1
1494926|NCT00508742|4923244|P1|Period 2: After Infant Series|Lost to Follow-up|1
1494927|NCT00508742|4923243|P2|Period 2: After Infant Series|Adverse Event|6
1494928|NCT00508742|4923244|P1|Period 2: After Infant Series|Adverse Event|2
1494929|NCT00508742|4923243|P2|Period 1: Infant Series|Other|1
1494930|NCT00508742|4923244|P1|Period 1: Infant Series|Other|4
1494931|NCT00508742|4923243|P2|Period 1: Infant Series|Physician Decision|0
1494932|NCT00508742|4923244|P1|Period 1: Infant Series|Physician Decision|1
1494933|NCT00508742|4923243|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
1494934|NCT00508742|4923244|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
1494935|NCT00508742|4923243|P2|Period 1: Infant Series|Protocol Violation|0
1494936|NCT00508742|4923244|P1|Period 1: Infant Series|Protocol Violation|1
1494937|NCT00508742|4923243|P2|Period 1: Infant Series|Adverse Event|4
1494938|NCT00508742|4923244|P1|Period 1: Infant Series|Adverse Event|5
1494939|NCT00508651|4923269|P2|Overall Study|Withdrawal by Subject|1
1494940|NCT00508651|4923270|P1|Overall Study|Withdrawal by Subject|1
1494941|NCT00508651|4923269|P2|Overall Study|Lost to Follow-up|1
1494942|NCT00508651|4923270|P1|Overall Study|Lost to Follow-up|3
1494943|NCT00508482|4923351|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
1494944|NCT00508482|4923352|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
1494945|NCT00508482|4923353|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
1494946|NCT00508482|4923351|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
1494947|NCT00508482|4923352|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
1494948|NCT00508482|4923353|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
1494949|NCT00508482|4923351|P3|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|4
1494950|NCT00508482|4923352|P2|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|7
1494951|NCT00508482|4923353|P1|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|9
1494952|NCT00508404|4923397|P1|Overall Study|Other - Not Specified|3
1494953|NCT00508404|4923397|P1|Overall Study|Lost to Follow-up|2
1494954|NCT00508404|4923397|P1|Overall Study|Protocol-specified Criteria|2
1494955|NCT00508404|4923397|P1|Overall Study|Withdrawal by Subject|3
1494956|NCT00508404|4923397|P1|Overall Study|Physician Decision|2
1494957|NCT00508404|4923397|P1|Overall Study|Death|16
1494958|NCT00508404|4923397|P1|Overall Study|Adverse Event|2
1494959|NCT00508404|4923397|P1|Overall Study|Ongoing at Data Cut-off|12
1494960|NCT00508391|4923424|P2|Second Treatment|Withdrawal by Subject|0
1494961|NCT00508391|4923425|P1|Second Treatment|Withdrawal by Subject|2
1494962|NCT00508391|4923424|P2|First Treatment|Withdrawal by Subject|3
1494963|NCT00508391|4923425|P1|First Treatment|Withdrawal by Subject|6
1494964|NCT00508274|4923436|P1|Overall Study|Withdrawal by Subject|1
1494965|NCT00508274|4923436|P1|Overall Study|Adverse Event|1
1494966|NCT00508157|4923464|P2|Overall Study|Other known cause|1
1494967|NCT00508157|4923465|P1|Overall Study|Other known cause|0
1494968|NCT00508157|4923464|P2|Overall Study|Subject no longer met study criteria|1
1494969|NCT00508157|4923465|P1|Overall Study|Subject no longer met study criteria|0
1494970|NCT00508157|4923464|P2|Overall Study|Lost to Follow-up|0
1494971|NCT00508157|4923465|P1|Overall Study|Lost to Follow-up|1
1494972|NCT00508157|4923464|P2|Overall Study|Subject Withdrew Consent|0
1494973|NCT00508157|4923465|P1|Overall Study|Subject Withdrew Consent|1
1494974|NCT00508157|4923464|P2|Overall Study|Adverse Event|1
1494975|NCT00508157|4923465|P1|Overall Study|Adverse Event|0
1494976|NCT00508144|4923487|P1|Overall Study|Death|5
1494977|NCT00508144|4923487|P1|Overall Study|Not eligible|6
1494978|NCT00508027|4923513|P1|Dose Level 2|Withdrawal by Subject|2
1494979|NCT00508027|4923513|P1|Dose Level 2|Lost to Follow-up|2
1494980|NCT00508027|4923513|P1|Dose Level 1|Physician Decision|2
1494981|NCT00508027|4923513|P1|Dose Level 1|Withdrawal by Subject|2
1494982|NCT00508027|4923513|P1|Dose Level 1|Lost to Follow-up|4
1494983|NCT00508001|4923554|P3|Overall Study|Withdrawal by Subject|1
1494984|NCT00508001|4923555|P2|Overall Study|Withdrawal by Subject|4
1494985|NCT00508001|4923556|P1|Overall Study|Withdrawal by Subject|4
1494986|NCT00508001|4923554|P3|Overall Study|Death|1
1494987|NCT00508001|4923555|P2|Overall Study|Death|1
1494988|NCT00508001|4923556|P1|Overall Study|Death|0
1494989|NCT00508001|4923554|P3|Overall Study|condition under investigation worsened|1
1494990|NCT00508001|4923555|P2|Overall Study|condition under investigation worsened|7
1494991|NCT00508001|4923556|P1|Overall Study|condition under investigation worsened|13
1494992|NCT00508001|4923554|P3|Overall Study|Adverse Event|4
1494993|NCT00508001|4923555|P2|Overall Study|Adverse Event|0
1494994|NCT00508001|4923556|P1|Overall Study|Adverse Event|2
1494995|NCT00507819|4923573|P2|Washout (6 Weeks)|Withdrawal by Subject|0
1494996|NCT00507819|4923574|P1|Washout (6 Weeks)|Withdrawal by Subject|1
1494997|NCT00507689|4923593|P2|Randomized Period|Withdrawal by Subject|1
1494998|NCT00507689|4923594|P1|Randomized Period|Withdrawal by Subject|0
1494999|NCT00507689|4923593|P2|Randomized Period|Adverse Event|1
1495000|NCT00507689|4923594|P1|Randomized Period|Adverse Event|1
1495001|NCT00507689|4923593|P2|Pre-Randomization Period|Withdrawal by Subject|0
1495002|NCT00507689|4923594|P1|Pre-Randomization Period|Withdrawal by Subject|1
1495003|NCT00507689|4923593|P2|Pre-Randomization Period|Physician Decision|0
1495004|NCT00507689|4923594|P1|Pre-Randomization Period|Physician Decision|1
1495005|NCT00507689|4923593|P2|Pre-Randomization Period|Adverse Event|0
1495006|NCT00507689|4923594|P1|Pre-Randomization Period|Adverse Event|1
1495007|NCT00507546|4923626|P2|Overall Study|Physician Decision|1
1495008|NCT00507546|4923627|P1|Overall Study|Physician Decision|0
1495009|NCT00507546|4923626|P2|Overall Study|Protocol Violation|0
1495010|NCT00507546|4923627|P1|Overall Study|Protocol Violation|1
1495011|NCT00507546|4923626|P2|Overall Study|Withdrawal by Subject|0
1495012|NCT00507546|4923627|P1|Overall Study|Withdrawal by Subject|1
1495013|NCT00507507|4923637|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
1495014|NCT00507507|4923638|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
1495015|NCT00507507|4923637|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
1495016|NCT00507507|4923638|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
1495017|NCT00507507|4923637|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
1495018|NCT00507507|4923638|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
1495019|NCT00507507|4923637|P2|Treatment Period|Withdrawal by Subject|47
1495020|NCT00507507|4923638|P1|Treatment Period|Withdrawal by Subject|46
1495021|NCT00507507|4923637|P2|Treatment Period|Adverse Event|1
1495022|NCT00507507|4923638|P1|Treatment Period|Adverse Event|1
1495023|NCT00507507|4923637|P2|Treatment Period|Protocol Violation|2
1495024|NCT00507507|4923638|P1|Treatment Period|Protocol Violation|1
1495025|NCT00507507|4923637|P2|Treatment Period|Physician Decision|1
1495026|NCT00507507|4923638|P1|Treatment Period|Physician Decision|4
1495027|NCT00507507|4923637|P2|Treatment Period|Lost to Follow-up|2
1495028|NCT00507507|4923638|P1|Treatment Period|Lost to Follow-up|0
1495029|NCT00507455|4923673|P3|Overall Study|Other - miscellaneous reason|1
1495030|NCT00507455|4923674|P2|Overall Study|Other - miscellaneous reason|0
1495031|NCT00507455|4923675|P1|Overall Study|Other - miscellaneous reason|1
1495032|NCT00507455|4923673|P3|Overall Study|Lack of Efficacy|0
1495033|NCT00507455|4923674|P2|Overall Study|Lack of Efficacy|1
1495034|NCT00507455|4923675|P1|Overall Study|Lack of Efficacy|0
1495035|NCT00507455|4923673|P3|Overall Study|Lost to Follow-up|2
1495036|NCT00507455|4923674|P2|Overall Study|Lost to Follow-up|0
1495037|NCT00507455|4923675|P1|Overall Study|Lost to Follow-up|2
1495038|NCT00507455|4923673|P3|Overall Study|Protocol Violation|1
1495039|NCT00507455|4923674|P2|Overall Study|Protocol Violation|1
1495040|NCT00507455|4923675|P1|Overall Study|Protocol Violation|4
1495041|NCT00507455|4923673|P3|Overall Study|Withdrawal by Subject|2
1495042|NCT00507455|4923674|P2|Overall Study|Withdrawal by Subject|1
1495043|NCT00507455|4923675|P1|Overall Study|Withdrawal by Subject|2
1495044|NCT00507455|4923673|P3|Overall Study|Adverse Event|6
1495045|NCT00507455|4923674|P2|Overall Study|Adverse Event|3
1495046|NCT00507455|4923675|P1|Overall Study|Adverse Event|3
1495047|NCT00507442|4923738|P4|Overall Study|Not Specified|2
1495048|NCT00507442|4923739|P3|Overall Study|Not Specified|2
1495049|NCT00507442|4923740|P2|Overall Study|Not Specified|5
1495050|NCT00507442|4923741|P1|Overall Study|Not Specified|2
1495051|NCT00507442|4923738|P4|Overall Study|Withdrawal by Subject|1
1495052|NCT00507442|4923739|P3|Overall Study|Withdrawal by Subject|2
1495053|NCT00507442|4923740|P2|Overall Study|Withdrawal by Subject|4
1495054|NCT00507442|4923741|P1|Overall Study|Withdrawal by Subject|4
1495055|NCT00507442|4923738|P4|Overall Study|Progressive Disease|0
1495056|NCT00507442|4923739|P3|Overall Study|Progressive Disease|2
1495057|NCT00507442|4923740|P2|Overall Study|Progressive Disease|4
1495058|NCT00507442|4923741|P1|Overall Study|Progressive Disease|2
1495059|NCT00507442|4923738|P4|Overall Study|Physician Decision|1
1495060|NCT00507442|4923739|P3|Overall Study|Physician Decision|4
1495061|NCT00507442|4923740|P2|Overall Study|Physician Decision|2
1495062|NCT00507442|4923741|P1|Overall Study|Physician Decision|0
1495063|NCT00507442|4923738|P4|Overall Study|Lost to Follow-up|0
1495064|NCT00507442|4923739|P3|Overall Study|Lost to Follow-up|1
1495065|NCT00507442|4923740|P2|Overall Study|Lost to Follow-up|0
1495066|NCT00507442|4923741|P1|Overall Study|Lost to Follow-up|0
1495067|NCT00507442|4923738|P4|Overall Study|Protocol Violation|0
1495068|NCT00507442|4923739|P3|Overall Study|Protocol Violation|0
1495069|NCT00507442|4923740|P2|Overall Study|Protocol Violation|1
1495070|NCT00507442|4923741|P1|Overall Study|Protocol Violation|0
1495071|NCT00507442|4923738|P4|Overall Study|Adverse Event|1
1495072|NCT00507442|4923739|P3|Overall Study|Adverse Event|4
1495073|NCT00507442|4923740|P2|Overall Study|Adverse Event|11
1495074|NCT00507442|4923741|P1|Overall Study|Adverse Event|8
1495075|NCT00507429|4923793|P2|Maintenance Phase|Progressive Disease|0
1495076|NCT00507429|4923794|P1|Maintenance Phase|Progressive Disease|14
1495077|NCT00507429|4923793|P2|Treatment Phase|Other|3
1495078|NCT00507429|4923794|P1|Treatment Phase|Other|6
1495079|NCT00507429|4923793|P2|Treatment Phase|Physician Decision|2
1495080|NCT00507429|4923794|P1|Treatment Phase|Physician Decision|4
1495081|NCT00507429|4923793|P2|Treatment Phase|Withdrawal by Subject|3
1495082|NCT00507429|4923794|P1|Treatment Phase|Withdrawal by Subject|3
1495083|NCT00507429|4923793|P2|Treatment Phase|Adverse Event|5
1495084|NCT00507429|4923794|P1|Treatment Phase|Adverse Event|12
1495085|NCT00507429|4923793|P2|Treatment Phase|Disease Progression|5
1495086|NCT00507429|4923794|P1|Treatment Phase|Disease Progression|12
1495087|NCT00507416|4923805|P3|Overall Study|Did not Receive Study Treatment|4
1495088|NCT00507416|4923806|P2|Overall Study|Did not Receive Study Treatment|9
1495089|NCT00507416|4923807|P1|Overall Study|Did not Receive Study Treatment|3
1495090|NCT00507416|4923805|P3|Overall Study|Other|13
1495091|NCT00507416|4923806|P2|Overall Study|Other|16
1495092|NCT00507416|4923807|P1|Overall Study|Other|11
1495093|NCT00507416|4923805|P3|Overall Study|Patient declined further treatment|11
1495094|NCT00507416|4923806|P2|Overall Study|Patient declined further treatment|14
1495095|NCT00507416|4923807|P1|Overall Study|Patient declined further treatment|18
1495096|NCT00507416|4923805|P3|Overall Study|Progressive Disease|13
1495097|NCT00507416|4923806|P2|Overall Study|Progressive Disease|10
1495098|NCT00507416|4923807|P1|Overall Study|Progressive Disease|20
1495099|NCT00507416|4923805|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
1495100|NCT00507416|4923806|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
1495101|NCT00507416|4923807|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
1495102|NCT00507416|4923805|P3|Overall Study|Protocol Violation|0
1495103|NCT00507416|4923806|P2|Overall Study|Protocol Violation|2
1495104|NCT00507416|4923807|P1|Overall Study|Protocol Violation|1
1495105|NCT00507416|4923805|P3|Overall Study|Adverse Event|65
1495106|NCT00507416|4923806|P2|Overall Study|Adverse Event|67
1495107|NCT00507416|4923807|P1|Overall Study|Adverse Event|58
1495108|NCT00507130|4923849|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
1495109|NCT00507130|4923850|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
1495110|NCT00507130|4923851|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
1495111|NCT00507130|4923852|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
1495112|NCT00507130|4923849|P4|Overall Study|Lost to Follow-up|1
1495113|NCT00507130|4923850|P3|Overall Study|Lost to Follow-up|1
1495114|NCT00507130|4923851|P2|Overall Study|Lost to Follow-up|0
1495115|NCT00507130|4923852|P1|Overall Study|Lost to Follow-up|0
1495116|NCT00506948|4923894|P1|Overall Study|Physician Decision|1
1495117|NCT00506948|4923894|P1|Overall Study|Adverse Event|5
1495118|NCT00506948|4923894|P1|Overall Study|Death|4
1495119|NCT00506922|4923903|P5|Overall Study|Withdrawal by Subject|1
1495120|NCT00506922|4923904|P4|Overall Study|Withdrawal by Subject|0
1495121|NCT00506922|4923905|P3|Overall Study|Withdrawal by Subject|0
1495122|NCT00506922|4923906|P2|Overall Study|Withdrawal by Subject|0
1495123|NCT00506922|4923907|P1|Overall Study|Withdrawal by Subject|0
1495124|NCT00506922|4923903|P5|Overall Study|Physician Decision|0
1495125|NCT00506922|4923904|P4|Overall Study|Physician Decision|2
1495126|NCT00506922|4923905|P3|Overall Study|Physician Decision|0
1495127|NCT00506922|4923906|P2|Overall Study|Physician Decision|0
1495128|NCT00506922|4923907|P1|Overall Study|Physician Decision|0
1495129|NCT00506883|4923918|P3|Overall Study|Other|1
1495130|NCT00506883|4923919|P2|Overall Study|Other|1
1495131|NCT00506883|4923920|P1|Overall Study|Other|5
1495132|NCT00506883|4923918|P3|Overall Study|Lack of Efficacy|1
1495133|NCT00506883|4923919|P2|Overall Study|Lack of Efficacy|1
1495134|NCT00506883|4923920|P1|Overall Study|Lack of Efficacy|0
1495135|NCT00506883|4923918|P3|Overall Study|Withdrawal by Subject|1
1495136|NCT00506883|4923919|P2|Overall Study|Withdrawal by Subject|0
1495137|NCT00506883|4923920|P1|Overall Study|Withdrawal by Subject|1
1495138|NCT00506883|4923918|P3|Overall Study|Lost to Follow-up|1
1495139|NCT00506883|4923919|P2|Overall Study|Lost to Follow-up|1
1495140|NCT00506883|4923920|P1|Overall Study|Lost to Follow-up|1
1495141|NCT00506831|4923933|P1|Overall Study|Withdrawal by Subject|1
1495142|NCT00506831|4923933|P1|Overall Study|Death|1
1495143|NCT00506662|4923972|P2|Overall Study|Not recorded|6
1495144|NCT00506662|4923973|P1|Overall Study|Not recorded|4
1495145|NCT00506662|4923972|P2|Overall Study|Trial terminated|16
1495146|NCT00506662|4923973|P1|Overall Study|Trial terminated|10
1495147|NCT00506662|4923972|P2|Overall Study|Protocol Violation|4
1495148|NCT00506662|4923973|P1|Overall Study|Protocol Violation|2
1495149|NCT00506662|4923972|P2|Overall Study|Lack of Efficacy|0
1495150|NCT00506662|4923973|P1|Overall Study|Lack of Efficacy|1
1495151|NCT00506662|4923972|P2|Overall Study|Adverse Event|2
1495152|NCT00506662|4923973|P1|Overall Study|Adverse Event|0
1495153|NCT00506493|4924007|P1|Overall Study|Withdrawal by Subject|5
1495154|NCT00506493|4924007|P1|Overall Study|Death|6
1495155|NCT00506454|4924016|P2|Overall Study|Withdrawal by Subject|1
1495156|NCT00506454|4924017|P1|Overall Study|Withdrawal by Subject|1
1495157|NCT00506441|4924023|P2|Period 2; Double-blind Period|Other Reason|1
1495158|NCT00506441|4924024|P1|Period 2; Double-blind Period|Other Reason|1
1495159|NCT00506441|4924023|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
1495160|NCT00506441|4924024|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
1495161|NCT00506441|4924023|P2|Period 2; Double-blind Period|Physician Decision|1
1495162|NCT00506441|4924024|P1|Period 2; Double-blind Period|Physician Decision|1
1495163|NCT00506441|4924023|P2|Period 2; Double-blind Period|Lack of Efficacy|2
1495164|NCT00506441|4924024|P1|Period 2; Double-blind Period|Lack of Efficacy|0
1495165|NCT00506441|4924023|P2|Period 2; Double-blind Period|Adverse Event|1
1495166|NCT00506441|4924024|P1|Period 2; Double-blind Period|Adverse Event|0
1495167|NCT00506441|4924023|P2|Period 1; Open-label Period|Other Reasons|0
1495168|NCT00506441|4924024|P1|Period 1; Open-label Period|Other Reasons|13
1495169|NCT00506441|4924023|P2|Period 1; Open-label Period|Withdrawal by Subject|0
1495170|NCT00506441|4924024|P1|Period 1; Open-label Period|Withdrawal by Subject|13
1495171|NCT00506441|4924023|P2|Period 1; Open-label Period|Protocol Violation|0
1495172|NCT00506441|4924024|P1|Period 1; Open-label Period|Protocol Violation|9
1495173|NCT00506441|4924023|P2|Period 1; Open-label Period|Physician Decision|0
1495174|NCT00506441|4924024|P1|Period 1; Open-label Period|Physician Decision|5
1495175|NCT00506441|4924023|P2|Period 1; Open-label Period|Lost to Follow-up|0
1495176|NCT00506441|4924024|P1|Period 1; Open-label Period|Lost to Follow-up|2
1495177|NCT00506441|4924023|P2|Period 1; Open-label Period|Lack of Efficacy|0
1495178|NCT00506441|4924024|P1|Period 1; Open-label Period|Lack of Efficacy|13
1495179|NCT00506441|4924023|P2|Period 1; Open-label Period|Adverse Event|0
1495180|NCT00506441|4924024|P1|Period 1; Open-label Period|Adverse Event|21
1495181|NCT00506415|4924032|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
1495182|NCT00506415|4924033|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
1495183|NCT00506415|4924034|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
1495184|NCT00506415|4924035|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
1495185|NCT00506415|4924032|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
1495186|NCT00506415|4924033|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1495187|NCT00506415|4924034|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1495188|NCT00506415|4924035|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1495189|NCT00506415|4924032|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
1495190|NCT00506415|4924033|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
1495191|NCT00506415|4924034|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
1495192|NCT00506415|4924035|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
1495193|NCT00506415|4924032|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
1495194|NCT00506415|4924033|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1495195|NCT00506415|4924034|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1495196|NCT00506415|4924035|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1495197|NCT00506415|4924032|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
1495198|NCT00506415|4924033|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1495199|NCT00506415|4924034|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1495200|NCT00506415|4924035|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1495201|NCT00506415|4924032|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
1495202|NCT00506415|4924033|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
1495203|NCT00506415|4924034|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
1495204|NCT00506415|4924035|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
1495205|NCT00506415|4924032|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
1495206|NCT00506415|4924033|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
1495207|NCT00506415|4924034|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
1495208|NCT00506415|4924035|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
1495209|NCT00506415|4924032|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
1495210|NCT00506415|4924033|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
1495211|NCT00506415|4924034|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
1495212|NCT00506415|4924035|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
1495213|NCT00506415|4924032|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
1495214|NCT00506415|4924033|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
1495215|NCT00506415|4924034|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
1495216|NCT00506415|4924035|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
1495217|NCT00506415|4924032|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
1495218|NCT00506415|4924033|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
1495219|NCT00506415|4924034|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
1495220|NCT00506415|4924035|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
1495221|NCT00506415|4924032|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
1495222|NCT00506415|4924033|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
1495223|NCT00506415|4924034|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
1495224|NCT00506415|4924035|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
1495225|NCT00506415|4924032|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
1495226|NCT00506415|4924033|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
1495227|NCT00506415|4924034|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
1495228|NCT00506415|4924035|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
1495229|NCT00506415|4924032|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
1495230|NCT00506415|4924033|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
1495231|NCT00506415|4924034|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
1495232|NCT00506415|4924035|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
1495233|NCT00506415|4924032|P4|Double Blind (Maximum 48 Weeks )|Death|0
1495234|NCT00506415|4924033|P3|Double Blind (Maximum 48 Weeks )|Death|3
1495235|NCT00506415|4924034|P2|Double Blind (Maximum 48 Weeks )|Death|5
1495236|NCT00506415|4924035|P1|Double Blind (Maximum 48 Weeks )|Death|0
1495237|NCT00506415|4924032|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
1495238|NCT00506415|4924033|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
1495239|NCT00506415|4924034|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
1495240|NCT00506415|4924035|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
1495241|NCT00506415|4924032|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
1495242|NCT00506415|4924033|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
1495243|NCT00506415|4924034|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
1495244|NCT00506415|4924035|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
1495245|NCT00506415|4924032|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
1495246|NCT00506415|4924033|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
1495247|NCT00506415|4924034|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
1495248|NCT00506415|4924035|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
1495249|NCT00506415|4924032|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
1495250|NCT00506415|4924033|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
1495251|NCT00506415|4924034|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
1495252|NCT00506415|4924035|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
1495253|NCT00506415|4924032|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1495254|NCT00506415|4924033|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1495255|NCT00506415|4924034|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1495256|NCT00506415|4924035|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
1495257|NCT00506415|4924032|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1495258|NCT00506415|4924033|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1495259|NCT00506415|4924034|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1495260|NCT00506415|4924035|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
1495261|NCT00506415|4924032|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1495262|NCT00506415|4924033|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1495263|NCT00506415|4924034|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1495264|NCT00506415|4924035|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
1495265|NCT00506415|4924032|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
1495266|NCT00506415|4924033|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
1495267|NCT00506415|4924034|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
1495268|NCT00506415|4924035|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
1495269|NCT00506415|4924032|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
1495270|NCT00506415|4924033|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
1495271|NCT00506415|4924034|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
1495272|NCT00506415|4924035|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
1495273|NCT00506415|4924032|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
1495274|NCT00506415|4924033|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
1495275|NCT00506415|4924034|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
1495276|NCT00506415|4924035|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
1495277|NCT00506389|4924060|P3|In-treatment Period|Randomized but not treated|1
1495278|NCT00506389|4924061|P2|In-treatment Period|Randomized but not treated|1
1495279|NCT00506389|4924062|P1|In-treatment Period|Randomized but not treated|4
1495280|NCT00506389|4924060|P3|In-treatment Period|Adverse Event|2
1495281|NCT00506389|4924061|P2|In-treatment Period|Adverse Event|5
1495282|NCT00506389|4924062|P1|In-treatment Period|Adverse Event|11
1495283|NCT00506389|4924060|P3|In-treatment Period|Lack of Efficacy|0
1495284|NCT00506389|4924061|P2|In-treatment Period|Lack of Efficacy|2
1495285|NCT00506389|4924062|P1|In-treatment Period|Lack of Efficacy|0
1495286|NCT00506389|4924060|P3|In-treatment Period|Withdrawal by Subject|4
1495287|NCT00506389|4924061|P2|In-treatment Period|Withdrawal by Subject|3
1495288|NCT00506389|4924062|P1|In-treatment Period|Withdrawal by Subject|3
1495289|NCT00506389|4924060|P3|In-treatment Period|Reasons not related to trial|0
1495378|NCT00506077|4924259|P2|Treatment Period 1|Withdrawal by Subject|0
1495290|NCT00506389|4924061|P2|In-treatment Period|Reasons not related to trial|1
1495291|NCT00506389|4924062|P1|In-treatment Period|Reasons not related to trial|4
1495292|NCT00506389|4924060|P3|In-treatment Period|Lack of compliance|0
1495293|NCT00506389|4924061|P2|In-treatment Period|Lack of compliance|0
1495294|NCT00506389|4924062|P1|In-treatment Period|Lack of compliance|1
1495295|NCT00506389|4924060|P3|In-treatment Period|Lost to Follow-up|1
1495296|NCT00506389|4924061|P2|In-treatment Period|Lost to Follow-up|0
1495297|NCT00506389|4924062|P1|In-treatment Period|Lost to Follow-up|0
1495298|NCT00506389|4924060|P3|In-treatment Period|Not specified|4
1495299|NCT00506389|4924061|P2|In-treatment Period|Not specified|3
1495300|NCT00506389|4924062|P1|In-treatment Period|Not specified|3
1495301|NCT00506350|4924088|P9|Overall Study|Not specified|2
1495302|NCT00506350|4924089|P8|Overall Study|Not specified|2
1495303|NCT00506350|4924090|P7|Overall Study|Not specified|0
1495304|NCT00506350|4924091|P6|Overall Study|Not specified|0
1495305|NCT00506350|4924092|P5|Overall Study|Not specified|3
1495306|NCT00506350|4924093|P4|Overall Study|Not specified|0
1495307|NCT00506350|4924094|P3|Overall Study|Not specified|3
1495308|NCT00506350|4924095|P2|Overall Study|Not specified|1
1495309|NCT00506350|4924096|P1|Overall Study|Not specified|1
1495310|NCT00506350|4924088|P9|Overall Study|Medical Reason|0
1495311|NCT00506350|4924089|P8|Overall Study|Medical Reason|0
1495312|NCT00506350|4924090|P7|Overall Study|Medical Reason|0
1495313|NCT00506350|4924091|P6|Overall Study|Medical Reason|0
1495314|NCT00506350|4924092|P5|Overall Study|Medical Reason|1
1495315|NCT00506350|4924093|P4|Overall Study|Medical Reason|0
1495316|NCT00506350|4924094|P3|Overall Study|Medical Reason|0
1495317|NCT00506350|4924095|P2|Overall Study|Medical Reason|0
1495318|NCT00506350|4924096|P1|Overall Study|Medical Reason|0
1495319|NCT00506350|4924088|P9|Overall Study|Lost to Follow-up|2
1495320|NCT00506350|4924089|P8|Overall Study|Lost to Follow-up|0
1495321|NCT00506350|4924090|P7|Overall Study|Lost to Follow-up|0
1495322|NCT00506350|4924091|P6|Overall Study|Lost to Follow-up|1
1495323|NCT00506350|4924092|P5|Overall Study|Lost to Follow-up|2
1495324|NCT00506350|4924093|P4|Overall Study|Lost to Follow-up|1
1495325|NCT00506350|4924094|P3|Overall Study|Lost to Follow-up|1
1495326|NCT00506350|4924095|P2|Overall Study|Lost to Follow-up|1
1495327|NCT00506350|4924096|P1|Overall Study|Lost to Follow-up|1
1495328|NCT00506350|4924088|P9|Overall Study|Withdrawal by Subject|0
1495329|NCT00506350|4924089|P8|Overall Study|Withdrawal by Subject|2
1495330|NCT00506350|4924090|P7|Overall Study|Withdrawal by Subject|1
1495331|NCT00506350|4924091|P6|Overall Study|Withdrawal by Subject|1
1495332|NCT00506350|4924092|P5|Overall Study|Withdrawal by Subject|4
1495333|NCT00506350|4924093|P4|Overall Study|Withdrawal by Subject|1
1495334|NCT00506350|4924094|P3|Overall Study|Withdrawal by Subject|1
1495335|NCT00506350|4924095|P2|Overall Study|Withdrawal by Subject|1
1495336|NCT00506350|4924096|P1|Overall Study|Withdrawal by Subject|0
1495337|NCT00506350|4924088|P9|Overall Study|Protocol Violation|0
1495338|NCT00506350|4924089|P8|Overall Study|Protocol Violation|0
1495339|NCT00506350|4924090|P7|Overall Study|Protocol Violation|1
1495340|NCT00506350|4924091|P6|Overall Study|Protocol Violation|0
1495341|NCT00506350|4924092|P5|Overall Study|Protocol Violation|0
1495342|NCT00506350|4924093|P4|Overall Study|Protocol Violation|0
1495343|NCT00506350|4924094|P3|Overall Study|Protocol Violation|1
1495344|NCT00506350|4924095|P2|Overall Study|Protocol Violation|0
1495345|NCT00506350|4924096|P1|Overall Study|Protocol Violation|0
1495346|NCT00506350|4924088|P9|Overall Study|Adverse Event|1
1495347|NCT00506350|4924089|P8|Overall Study|Adverse Event|1
1495348|NCT00506350|4924090|P7|Overall Study|Adverse Event|0
1495349|NCT00506350|4924091|P6|Overall Study|Adverse Event|0
1495350|NCT00506350|4924092|P5|Overall Study|Adverse Event|0
1495351|NCT00506350|4924093|P4|Overall Study|Adverse Event|0
1495352|NCT00506350|4924094|P3|Overall Study|Adverse Event|0
1495353|NCT00506350|4924095|P2|Overall Study|Adverse Event|0
1495354|NCT00506350|4924096|P1|Overall Study|Adverse Event|0
1495355|NCT00506350|4924088|P9|Overall Study|Serious Adverse Event|0
1495356|NCT00506350|4924089|P8|Overall Study|Serious Adverse Event|0
1495357|NCT00506350|4924090|P7|Overall Study|Serious Adverse Event|0
1495358|NCT00506350|4924091|P6|Overall Study|Serious Adverse Event|0
1495359|NCT00506350|4924092|P5|Overall Study|Serious Adverse Event|0
1495360|NCT00506350|4924093|P4|Overall Study|Serious Adverse Event|0
1495361|NCT00506350|4924094|P3|Overall Study|Serious Adverse Event|0
1495362|NCT00506350|4924095|P2|Overall Study|Serious Adverse Event|0
1495363|NCT00506350|4924096|P1|Overall Study|Serious Adverse Event|1
1495364|NCT00506285|4924243|P2|6-month Open Label Phase|Withdrawal by Subject|5
1495365|NCT00506285|4924244|P1|6-month Open Label Phase|Withdrawal by Subject|9
1495366|NCT00506285|4924243|P2|6-month Open Label Phase|Lost to Follow-up|7
1495367|NCT00506285|4924244|P1|6-month Open Label Phase|Lost to Follow-up|1
1495368|NCT00506285|4924243|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
1495369|NCT00506285|4924244|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
1495370|NCT00506285|4924243|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
1495371|NCT00506285|4924244|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
1495372|NCT00506285|4924243|P2|3 Week Screening Phase|Withdrawal by Subject|10
1495373|NCT00506285|4924244|P1|3 Week Screening Phase|Withdrawal by Subject|17
1495374|NCT00506077|4924259|P2|Treatment Period 2|Withdrawal by Subject|0
1495375|NCT00506077|4924260|P1|Treatment Period 2|Withdrawal by Subject|1
1495376|NCT00506077|4924259|P2|Treatment Period 2|Adverse Event|1
1495377|NCT00506077|4924260|P1|Treatment Period 2|Adverse Event|0
1495379|NCT00506077|4924260|P1|Treatment Period 1|Withdrawal by Subject|2
1495380|NCT00506077|4924259|P2|Treatment Period 1|Lost to Follow-up|2
1495381|NCT00506077|4924260|P1|Treatment Period 1|Lost to Follow-up|0
1495382|NCT00506077|4924259|P2|Treatment Period 1|Adverse Event|1
1495383|NCT00506077|4924260|P1|Treatment Period 1|Adverse Event|2
1495384|NCT00505934|4924302|P1|Overall Study|Other: IV dose needed to be changed|1
1495385|NCT00505934|4924302|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
1495386|NCT00505934|4924302|P1|Overall Study|Adverse Event|1
1495387|NCT00505921|4924308|P1|Overall Study|Failed to Mobilize|8
1495388|NCT00505921|4924308|P1|Overall Study|Ineligible|1
1495389|NCT00505778|4924325|P2|Overall Study|Took No Study Drug|2
1495390|NCT00505778|4924326|P1|Overall Study|Took No Study Drug|2
1495391|NCT00505778|4924325|P2|Overall Study|Relapse|65
1495392|NCT00505778|4924326|P1|Overall Study|Relapse|65
1495393|NCT00505778|4924325|P2|Overall Study|Withdrawal by Subject|14
1495394|NCT00505778|4924326|P1|Overall Study|Withdrawal by Subject|29
1495395|NCT00505778|4924325|P2|Overall Study|Protocol Violation|9
1495396|NCT00505778|4924326|P1|Overall Study|Protocol Violation|7
1495397|NCT00505778|4924325|P2|Overall Study|Unable to Meet Protocol Criteria|1
1495398|NCT00505778|4924326|P1|Overall Study|Unable to Meet Protocol Criteria|4
1495399|NCT00505778|4924325|P2|Overall Study|Lost to Follow-up|23
1495400|NCT00505778|4924326|P1|Overall Study|Lost to Follow-up|17
1495401|NCT00505778|4924325|P2|Overall Study|Physician Decision|14
1495402|NCT00505778|4924326|P1|Overall Study|Physician Decision|8
1495403|NCT00505778|4924325|P2|Overall Study|Adverse Event|7
1495404|NCT00505778|4924326|P1|Overall Study|Adverse Event|2
1495405|NCT00505765|4924345|P3|Overall Study|Noncompliance|3
1495406|NCT00505765|4924346|P2|Overall Study|Noncompliance|1
1495407|NCT00505765|4924347|P1|Overall Study|Noncompliance|0
1495408|NCT00505765|4924345|P3|Overall Study|Adverse Event|0
1495409|NCT00505765|4924346|P2|Overall Study|Adverse Event|2
1495410|NCT00505765|4924347|P1|Overall Study|Adverse Event|1
1495411|NCT00505765|4924345|P3|Overall Study|Withdrawal by Subject|0
1495412|NCT00505765|4924346|P2|Overall Study|Withdrawal by Subject|0
1495413|NCT00505765|4924347|P1|Overall Study|Withdrawal by Subject|1
1495414|NCT00505752|4924374|P4|Overall Study|Other|2
1495415|NCT00505752|4924375|P3|Overall Study|Other|1
1495416|NCT00505752|4924376|P2|Overall Study|Other|2
1495417|NCT00505752|4924377|P1|Overall Study|Other|1
1495418|NCT00505752|4924374|P4|Overall Study|All embryos/blastocysts discarded|1
1495419|NCT00505752|4924375|P3|Overall Study|All embryos/blastocysts discarded|1
1495420|NCT00505752|4924376|P2|Overall Study|All embryos/blastocysts discarded|0
1495421|NCT00505752|4924377|P1|Overall Study|All embryos/blastocysts discarded|0
1495422|NCT00505752|4924374|P4|Overall Study|No Fertilization|1
1495423|NCT00505752|4924375|P3|Overall Study|No Fertilization|2
1495424|NCT00505752|4924376|P2|Overall Study|No Fertilization|1
1495425|NCT00505752|4924377|P1|Overall Study|No Fertilization|1
1495426|NCT00505752|4924374|P4|Overall Study|No oocytes retrieved|1
1495427|NCT00505752|4924375|P3|Overall Study|No oocytes retrieved|0
1495428|NCT00505752|4924376|P2|Overall Study|No oocytes retrieved|2
1495429|NCT00505752|4924377|P1|Overall Study|No oocytes retrieved|0
1495430|NCT00505752|4924374|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
1495431|NCT00505752|4924375|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
1495432|NCT00505752|4924376|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
1495433|NCT00505752|4924377|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
1495434|NCT00505752|4924374|P4|Overall Study|Lack of ovarian response|0
1495435|NCT00505752|4924375|P3|Overall Study|Lack of ovarian response|0
1495436|NCT00505752|4924376|P2|Overall Study|Lack of ovarian response|3
1495437|NCT00505752|4924377|P1|Overall Study|Lack of ovarian response|1
1495438|NCT00505752|4924374|P4|Overall Study|Lost to Follow-up|0
1495439|NCT00505752|4924375|P3|Overall Study|Lost to Follow-up|0
1495440|NCT00505752|4924376|P2|Overall Study|Lost to Follow-up|0
1495441|NCT00505752|4924377|P1|Overall Study|Lost to Follow-up|1
1495442|NCT00505752|4924374|P4|Overall Study|Adverse Event|0
1495443|NCT00505752|4924375|P3|Overall Study|Adverse Event|1
1495444|NCT00505752|4924376|P2|Overall Study|Adverse Event|0
1495445|NCT00505752|4924377|P1|Overall Study|Adverse Event|1
1495446|NCT00505687|4924391|P1|Overall Study|Other: As Per Sponsor|8
1495447|NCT00505687|4924391|P1|Overall Study|Other: Disease Progression|1
1495448|NCT00505687|4924391|P1|Overall Study|Other: Neupro Given In Hospital|1
1495449|NCT00505687|4924391|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
1495450|NCT00505687|4924391|P1|Overall Study|Other: Prolonged Hospitalization|1
1495451|NCT00505687|4924391|P1|Overall Study|Other: Scheduled DBS Surgery|1
1495452|NCT00505687|4924391|P1|Overall Study|Other: Underwent Implantation Of DBS|1
1495453|NCT00505687|4924391|P1|Overall Study|Lost to Follow-up|1
1495454|NCT00505687|4924391|P1|Overall Study|Subject withdrew consent|15
1495455|NCT00505687|4924391|P1|Overall Study|Adverse Event|48
1495456|NCT00505687|4924391|P1|Overall Study|Lack of Efficacy|15
1495457|NCT00505687|4924391|P1|Overall Study|Important protocol violation|2
1495458|NCT00505661|4924397|P1|Overall Study|Not Eligible|4
1495459|NCT00505622|4924408|P3|Overall Study|Study termination by sponsor|90
1495460|NCT00505622|4924409|P2|Overall Study|Study termination by sponsor|98
1495461|NCT00505622|4924410|P1|Overall Study|Study termination by sponsor|115
1495462|NCT00505622|4924408|P3|Overall Study|Withdrawal by Subject|2
1495463|NCT00505622|4924409|P2|Overall Study|Withdrawal by Subject|3
1495464|NCT00505622|4924410|P1|Overall Study|Withdrawal by Subject|0
1495465|NCT00505622|4924408|P3|Overall Study|Protocol Violation|0
1495466|NCT00505622|4924409|P2|Overall Study|Protocol Violation|1
1495467|NCT00505622|4924410|P1|Overall Study|Protocol Violation|1
1495468|NCT00505622|4924408|P3|Overall Study|Adverse Event|4
1495469|NCT00505622|4924409|P2|Overall Study|Adverse Event|6
1495470|NCT00505622|4924410|P1|Overall Study|Adverse Event|5
1495471|NCT00505414|4924435|P5|Maintenance Phase|underlying disease and therapy required|0
1495472|NCT00505414|4924436|P4|Maintenance Phase|underlying disease and therapy required|0
1495473|NCT00505414|4924437|P3|Maintenance Phase|underlying disease and therapy required|2
1495474|NCT00505414|4924438|P2|Maintenance Phase|underlying disease and therapy required|2
1495475|NCT00505414|4924439|P1|Maintenance Phase|underlying disease and therapy required|0
1495476|NCT00505414|4924435|P5|Maintenance Phase|Withdrawal by Subject|0
1495477|NCT00505414|4924436|P4|Maintenance Phase|Withdrawal by Subject|0
1495478|NCT00505414|4924437|P3|Maintenance Phase|Withdrawal by Subject|1
1495479|NCT00505414|4924438|P2|Maintenance Phase|Withdrawal by Subject|0
1495480|NCT00505414|4924439|P1|Maintenance Phase|Withdrawal by Subject|0
1495481|NCT00505414|4924435|P5|Maintenance Phase|Lack of Efficacy|0
1495482|NCT00505414|4924436|P4|Maintenance Phase|Lack of Efficacy|0
1495483|NCT00505414|4924437|P3|Maintenance Phase|Lack of Efficacy|1
1495484|NCT00505414|4924438|P2|Maintenance Phase|Lack of Efficacy|1
1495485|NCT00505414|4924439|P1|Maintenance Phase|Lack of Efficacy|2
1495486|NCT00505414|4924435|P5|Maintenance Phase|Death|0
1495487|NCT00505414|4924436|P4|Maintenance Phase|Death|0
1495488|NCT00505414|4924437|P3|Maintenance Phase|Death|1
1495489|NCT00505414|4924438|P2|Maintenance Phase|Death|0
1495490|NCT00505414|4924439|P1|Maintenance Phase|Death|2
1495491|NCT00505414|4924435|P5|Maintenance Phase|Adverse Event|0
1495492|NCT00505414|4924436|P4|Maintenance Phase|Adverse Event|0
1495493|NCT00505414|4924437|P3|Maintenance Phase|Adverse Event|3
1495494|NCT00505414|4924438|P2|Maintenance Phase|Adverse Event|2
1495495|NCT00505414|4924439|P1|Maintenance Phase|Adverse Event|2
1495496|NCT00505414|4924435|P5|Titration Phase|Underlying disease and therapy required|3
1495497|NCT00505414|4924436|P4|Titration Phase|Underlying disease and therapy required|7
1495498|NCT00505414|4924437|P3|Titration Phase|Underlying disease and therapy required|0
1495499|NCT00505414|4924438|P2|Titration Phase|Underlying disease and therapy required|0
1495500|NCT00505414|4924439|P1|Titration Phase|Underlying disease and therapy required|0
1495501|NCT00505414|4924435|P5|Titration Phase|Withdrawal by Subject|4
1495502|NCT00505414|4924436|P4|Titration Phase|Withdrawal by Subject|3
1495503|NCT00505414|4924437|P3|Titration Phase|Withdrawal by Subject|0
1495504|NCT00505414|4924438|P2|Titration Phase|Withdrawal by Subject|0
1495505|NCT00505414|4924439|P1|Titration Phase|Withdrawal by Subject|0
1495506|NCT00505414|4924435|P5|Titration Phase|Protocol Violation|1
1495507|NCT00505414|4924436|P4|Titration Phase|Protocol Violation|0
1495508|NCT00505414|4924437|P3|Titration Phase|Protocol Violation|0
1495509|NCT00505414|4924438|P2|Titration Phase|Protocol Violation|0
1495510|NCT00505414|4924439|P1|Titration Phase|Protocol Violation|0
1495511|NCT00505414|4924435|P5|Titration Phase|Lack of Efficacy|1
1495512|NCT00505414|4924436|P4|Titration Phase|Lack of Efficacy|10
1495513|NCT00505414|4924437|P3|Titration Phase|Lack of Efficacy|0
1495514|NCT00505414|4924438|P2|Titration Phase|Lack of Efficacy|0
1495515|NCT00505414|4924439|P1|Titration Phase|Lack of Efficacy|0
1495516|NCT00505414|4924435|P5|Titration Phase|Death|0
1495517|NCT00505414|4924436|P4|Titration Phase|Death|2
1495518|NCT00505414|4924437|P3|Titration Phase|Death|0
1495519|NCT00505414|4924438|P2|Titration Phase|Death|0
1495520|NCT00505414|4924439|P1|Titration Phase|Death|0
1495521|NCT00505414|4924435|P5|Titration Phase|Adverse Event|3
1495522|NCT00505414|4924436|P4|Titration Phase|Adverse Event|8
1495523|NCT00505414|4924437|P3|Titration Phase|Adverse Event|0
1495524|NCT00505414|4924438|P2|Titration Phase|Adverse Event|0
1495525|NCT00505414|4924439|P1|Titration Phase|Adverse Event|0
1495526|NCT00505375|4924456|P2|Overall Study|Travel issues|1
1495527|NCT00505375|4924457|P1|Overall Study|Travel issues|0
1495528|NCT00505375|4924456|P2|Overall Study|Pregnancy|0
1495529|NCT00505375|4924457|P1|Overall Study|Pregnancy|1
1495530|NCT00505375|4924456|P2|Overall Study|Lost to Follow-up|2
1495531|NCT00505375|4924457|P1|Overall Study|Lost to Follow-up|0
1495532|NCT00505375|4924456|P2|Overall Study|Withdrawal by Subject|2
1495533|NCT00505375|4924457|P1|Overall Study|Withdrawal by Subject|2
1495534|NCT00505375|4924456|P2|Overall Study|Death|0
1495535|NCT00505375|4924457|P1|Overall Study|Death|1
1495536|NCT00505284|4924479|P5|Overall Study|Not specified|4
1495537|NCT00505284|4924480|P4|Overall Study|Not specified|4
1495538|NCT00505284|4924481|P3|Overall Study|Not specified|0
1495539|NCT00505284|4924482|P2|Overall Study|Not specified|0
1495540|NCT00505284|4924483|P1|Overall Study|Not specified|5
1495541|NCT00505284|4924479|P5|Overall Study|Physician Decision|0
1495542|NCT00505284|4924480|P4|Overall Study|Physician Decision|0
1495543|NCT00505284|4924481|P3|Overall Study|Physician Decision|0
1495544|NCT00505284|4924482|P2|Overall Study|Physician Decision|1
1495545|NCT00505284|4924483|P1|Overall Study|Physician Decision|0
1495546|NCT00505284|4924479|P5|Overall Study|Lack of Efficacy|1
1495547|NCT00505284|4924480|P4|Overall Study|Lack of Efficacy|1
1495548|NCT00505284|4924481|P3|Overall Study|Lack of Efficacy|1
1495549|NCT00505284|4924482|P2|Overall Study|Lack of Efficacy|1
1495550|NCT00505284|4924483|P1|Overall Study|Lack of Efficacy|0
1495551|NCT00505284|4924479|P5|Overall Study|Withdrawal by Subject|6
1495552|NCT00505284|4924480|P4|Overall Study|Withdrawal by Subject|0
1495553|NCT00505284|4924481|P3|Overall Study|Withdrawal by Subject|1
1495554|NCT00505284|4924482|P2|Overall Study|Withdrawal by Subject|6
1495555|NCT00505284|4924483|P1|Overall Study|Withdrawal by Subject|2
1495556|NCT00505284|4924479|P5|Overall Study|Protocol Violation|0
1495557|NCT00505284|4924480|P4|Overall Study|Protocol Violation|0
1495558|NCT00505284|4924481|P3|Overall Study|Protocol Violation|1
1495559|NCT00505284|4924482|P2|Overall Study|Protocol Violation|1
1495560|NCT00505284|4924483|P1|Overall Study|Protocol Violation|0
1495561|NCT00505284|4924479|P5|Overall Study|Adverse Event|22
1495562|NCT00505284|4924480|P4|Overall Study|Adverse Event|14
1495563|NCT00505284|4924481|P3|Overall Study|Adverse Event|9
1495564|NCT00505284|4924482|P2|Overall Study|Adverse Event|7
1495565|NCT00505284|4924483|P1|Overall Study|Adverse Event|3
1495566|NCT00505076|4924553|P3|Overall Study|Withdrawal by Subject|2
1495567|NCT00505076|4924554|P2|Overall Study|Withdrawal by Subject|1
1495568|NCT00505076|4924555|P1|Overall Study|Withdrawal by Subject|0
1495569|NCT00505076|4924553|P3|Overall Study|Protocol Violation|2
1495570|NCT00505076|4924554|P2|Overall Study|Protocol Violation|1
1495571|NCT00505076|4924555|P1|Overall Study|Protocol Violation|2
1495572|NCT00505076|4924553|P3|Overall Study|Adverse Event|1
1495573|NCT00505076|4924554|P2|Overall Study|Adverse Event|0
1495574|NCT00505076|4924555|P1|Overall Study|Adverse Event|1
1495575|NCT00504881|4924584|P2|Overall Study|AE of unknown type|0
1495576|NCT00504881|4924585|P1|Overall Study|AE of unknown type|1
1495577|NCT00504881|4924584|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
1495578|NCT00504881|4924585|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1495579|NCT00504881|4924584|P2|Overall Study|AE, non-serious non-fatal|14
1495580|NCT00504881|4924585|P1|Overall Study|AE, non-serious non-fatal|4
1495581|NCT00504881|4924584|P2|Overall Study|SAE, non-fatal|6
1495582|NCT00504881|4924585|P1|Overall Study|SAE, non-fatal|2
1495583|NCT00504881|4924584|P2|Overall Study|AE, serious fatal|1
1495584|NCT00504881|4924585|P1|Overall Study|AE, serious fatal|0
1495585|NCT00504881|4924584|P2|Overall Study|Safety Visit not performed|1
1495586|NCT00504881|4924585|P1|Overall Study|Safety Visit not performed|0
1495587|NCT00504881|4924584|P2|Overall Study|No Birth Control|1
1495588|NCT00504881|4924585|P1|Overall Study|No Birth Control|0
1495589|NCT00504881|4924584|P2|Overall Study|Non-Compliance|0
1495590|NCT00504881|4924585|P1|Overall Study|Non-Compliance|1
1495591|NCT00504881|4924584|P2|Overall Study|Withdrawal by Subject|4
1495592|NCT00504881|4924585|P1|Overall Study|Withdrawal by Subject|1
1495593|NCT00504881|4924584|P2|Overall Study|Lost to Follow-up|2
1495594|NCT00504881|4924585|P1|Overall Study|Lost to Follow-up|0
1495595|NCT00504881|4924584|P2|Overall Study|Lack of Efficacy|5
1495596|NCT00504881|4924585|P1|Overall Study|Lack of Efficacy|1
1495597|NCT00504777|4924635|P1|Overall Study|Adverse Event|1
1495598|NCT00504725|4924648|P2|Overall Study|Protocol Violation|0
1495599|NCT00504725|4924649|P1|Overall Study|Protocol Violation|1
1495600|NCT00504595|4924672|P4|Overall Study|Not specified|0
1495601|NCT00504595|4924673|P3|Overall Study|Not specified|2
1495602|NCT00504595|4924674|P2|Overall Study|Not specified|0
1495603|NCT00504595|4924675|P1|Overall Study|Not specified|0
1495604|NCT00504595|4924672|P4|Overall Study|Lack of Efficacy|0
1495605|NCT00504595|4924673|P3|Overall Study|Lack of Efficacy|0
1495606|NCT00504595|4924674|P2|Overall Study|Lack of Efficacy|0
1495607|NCT00504595|4924675|P1|Overall Study|Lack of Efficacy|1
1495608|NCT00504556|4924692|P5|Overall Study|not in safety analysis set|1
1495609|NCT00504556|4924693|P4|Overall Study|not in safety analysis set|0
1495610|NCT00504556|4924694|P3|Overall Study|not in safety analysis set|1
1495611|NCT00504556|4924695|P2|Overall Study|not in safety analysis set|1
1495612|NCT00504556|4924696|P1|Overall Study|not in safety analysis set|0
1495613|NCT00504556|4924692|P5|Overall Study|not specified|0
1495614|NCT00504556|4924693|P4|Overall Study|not specified|3
1495615|NCT00504556|4924694|P3|Overall Study|not specified|2
1495616|NCT00504556|4924695|P2|Overall Study|not specified|2
1495617|NCT00504556|4924696|P1|Overall Study|not specified|2
1495618|NCT00504556|4924692|P5|Overall Study|data monitor committee decision|0
1495619|NCT00504556|4924693|P4|Overall Study|data monitor committee decision|100
1495620|NCT00504556|4924694|P3|Overall Study|data monitor committee decision|0
1495621|NCT00504556|4924695|P2|Overall Study|data monitor committee decision|0
1495622|NCT00504556|4924696|P1|Overall Study|data monitor committee decision|0
1495623|NCT00504556|4924692|P5|Overall Study|did not meet entry criteria|0
1495624|NCT00504556|4924693|P4|Overall Study|did not meet entry criteria|1
1495625|NCT00504556|4924694|P3|Overall Study|did not meet entry criteria|1
1495626|NCT00504556|4924695|P2|Overall Study|did not meet entry criteria|0
1495627|NCT00504556|4924696|P1|Overall Study|did not meet entry criteria|2
1495628|NCT00504556|4924692|P5|Overall Study|administrative reasons|2
1495629|NCT00504556|4924693|P4|Overall Study|administrative reasons|1
1495630|NCT00504556|4924694|P3|Overall Study|administrative reasons|2
1495631|NCT00504556|4924695|P2|Overall Study|administrative reasons|2
1495632|NCT00504556|4924696|P1|Overall Study|administrative reasons|0
1495633|NCT00504556|4924692|P5|Overall Study|Withdrawal by Subject|12
1495634|NCT00504556|4924693|P4|Overall Study|Withdrawal by Subject|8
1495635|NCT00504556|4924694|P3|Overall Study|Withdrawal by Subject|7
1495636|NCT00504556|4924695|P2|Overall Study|Withdrawal by Subject|16
1495637|NCT00504556|4924696|P1|Overall Study|Withdrawal by Subject|16
1495638|NCT00504556|4924692|P5|Overall Study|Lost to Follow-up|1
1495639|NCT00504556|4924693|P4|Overall Study|Lost to Follow-up|1
1495640|NCT00504556|4924694|P3|Overall Study|Lost to Follow-up|1
1495641|NCT00504556|4924695|P2|Overall Study|Lost to Follow-up|0
1495642|NCT00504556|4924696|P1|Overall Study|Lost to Follow-up|0
1495643|NCT00504556|4924692|P5|Overall Study|Protocol Violation|2
1495644|NCT00504556|4924693|P4|Overall Study|Protocol Violation|1
1495645|NCT00504556|4924694|P3|Overall Study|Protocol Violation|2
1495646|NCT00504556|4924695|P2|Overall Study|Protocol Violation|3
1495647|NCT00504556|4924696|P1|Overall Study|Protocol Violation|1
1495648|NCT00504556|4924692|P5|Overall Study|Death|2
1495649|NCT00504556|4924693|P4|Overall Study|Death|0
1495650|NCT00504556|4924694|P3|Overall Study|Death|1
1495651|NCT00504556|4924695|P2|Overall Study|Death|3
1495652|NCT00504556|4924696|P1|Overall Study|Death|3
1495653|NCT00504556|4924692|P5|Overall Study|Adverse Event|5
1495654|NCT00504556|4924693|P4|Overall Study|Adverse Event|13
1495655|NCT00504556|4924694|P3|Overall Study|Adverse Event|14
1495656|NCT00504556|4924695|P2|Overall Study|Adverse Event|11
1495657|NCT00504556|4924696|P1|Overall Study|Adverse Event|11
1495658|NCT00504426|4924764|P4|Overall Study|Withdrawal by Subject|0
1495659|NCT00504426|4924765|P3|Overall Study|Withdrawal by Subject|0
1495660|NCT00504426|4924766|P2|Overall Study|Withdrawal by Subject|0
1495661|NCT00504426|4924767|P1|Overall Study|Withdrawal by Subject|2
1495662|NCT00504426|4924764|P4|Overall Study|Protocol Violation|0
1495663|NCT00504426|4924765|P3|Overall Study|Protocol Violation|2
1495664|NCT00504426|4924766|P2|Overall Study|Protocol Violation|1
1495665|NCT00504426|4924767|P1|Overall Study|Protocol Violation|1
1495666|NCT00504426|4924764|P4|Overall Study|Adverse Event|0
1495667|NCT00504426|4924765|P3|Overall Study|Adverse Event|2
1495668|NCT00504426|4924766|P2|Overall Study|Adverse Event|0
1495669|NCT00504426|4924767|P1|Overall Study|Adverse Event|0
1495670|NCT00504309|4924787|P6|Overall Study|Withdrawal by Subject|0
1495671|NCT00504309|4924788|P5|Overall Study|Withdrawal by Subject|0
1495672|NCT00504309|4924789|P4|Overall Study|Withdrawal by Subject|0
1495673|NCT00504309|4924790|P3|Overall Study|Withdrawal by Subject|1
1495674|NCT00504309|4924791|P2|Overall Study|Withdrawal by Subject|0
1495675|NCT00504309|4924792|P1|Overall Study|Withdrawal by Subject|0
1495676|NCT00504309|4924787|P6|Overall Study|Death|0
1495677|NCT00504309|4924788|P5|Overall Study|Death|1
1495678|NCT00504309|4924789|P4|Overall Study|Death|0
1495679|NCT00504309|4924790|P3|Overall Study|Death|0
1495680|NCT00504309|4924791|P2|Overall Study|Death|0
1495681|NCT00504309|4924792|P1|Overall Study|Death|0
1495682|NCT00504257|4924830|P1|Overall Study|ineligible histology|2
1495683|NCT00504257|4924830|P1|Overall Study|Withdrawal by Subject|2
1495684|NCT00504231|4924842|P4|Overall Study|Discrepant chart documentation re route|0
1495685|NCT00504231|4924843|P3|Overall Study|Discrepant chart documentation re route|1
1495686|NCT00504231|4924844|P2|Overall Study|Discrepant chart documentation re route|0
1495687|NCT00504231|4924845|P1|Overall Study|Discrepant chart documentation re route|0
1495688|NCT00504166|4924865|P2|Overall Study|Lost to Follow-up|3
1495689|NCT00504166|4924866|P1|Overall Study|Lost to Follow-up|1
1495690|NCT00504166|4924865|P2|Overall Study|Physician Decision|1
1495691|NCT00504166|4924866|P1|Overall Study|Physician Decision|1
1495692|NCT00504166|4924865|P2|Overall Study|Withdrawal by Subject|6
1495693|NCT00504166|4924866|P1|Overall Study|Withdrawal by Subject|3
1495694|NCT00504166|4924865|P2|Overall Study|Adverse Event|4
1495695|NCT00504166|4924866|P1|Overall Study|Adverse Event|1
1495696|NCT00504153|4924872|P1|Overall Study|Death|1
1495697|NCT00504153|4924872|P1|Overall Study|Adverse Event|4
1495698|NCT00504153|4924872|P1|Overall Study|Withdrawal by Subject|1
1495699|NCT00504075|4924880|P1|Overall Study|Required other therapeutic intervention|1
1495700|NCT00504075|4924880|P1|Overall Study|Withdrawal by Subject|1
1495701|NCT00504075|4924880|P1|Overall Study|Lost to Follow-up|5
1495702|NCT00504075|4924880|P1|Overall Study|Adverse Event|1
1495703|NCT00503997|4924890|P1|Overall Study|Withdrawal by Subject|1
1495704|NCT00503997|4924890|P1|Overall Study|Death|1
1495705|NCT00503997|4924890|P1|Overall Study|Adverse Event|5
1495706|NCT00503997|4924890|P1|Overall Study|disease progression|1
1495707|NCT00503984|4924896|P6|Overall Study|Death|0
1495708|NCT00503984|4924897|P5|Overall Study|Death|1
1495709|NCT00503984|4924898|P4|Overall Study|Death|0
1495710|NCT00503984|4924899|P3|Overall Study|Death|0
1495711|NCT00503984|4924900|P2|Overall Study|Death|0
1495712|NCT00503984|4924901|P1|Overall Study|Death|0
1495713|NCT00503984|4924896|P6|Overall Study|Adverse Event|0
1495714|NCT00503984|4924897|P5|Overall Study|Adverse Event|0
1495715|NCT00503984|4924898|P4|Overall Study|Adverse Event|0
1495716|NCT00503984|4924899|P3|Overall Study|Adverse Event|0
1495717|NCT00503984|4924900|P2|Overall Study|Adverse Event|1
1495718|NCT00503984|4924901|P1|Overall Study|Adverse Event|0
1495719|NCT00503984|4924896|P6|Overall Study|Protocol Violation|0
1495720|NCT00503984|4924897|P5|Overall Study|Protocol Violation|0
1495721|NCT00503984|4924898|P4|Overall Study|Protocol Violation|0
1495722|NCT00503984|4924899|P3|Overall Study|Protocol Violation|0
1495723|NCT00503984|4924900|P2|Overall Study|Protocol Violation|1
1495724|NCT00503984|4924901|P1|Overall Study|Protocol Violation|0
1495725|NCT00503906|4924927|P1|Overall Study|Withdrawal by Subject|1
1495726|NCT00503841|4924949|P1|Overall Study|All screen failures|44
1495727|NCT00503776|4924957|P4|Overall Study|Physician Decision|1
1495728|NCT00503776|4924958|P3|Overall Study|Physician Decision|1
1495729|NCT00503776|4924959|P2|Overall Study|Physician Decision|0
1495730|NCT00503776|4924960|P1|Overall Study|Physician Decision|0
1495731|NCT00503776|4924957|P4|Overall Study|Withdrawal by Subject|1
1495732|NCT00503776|4924958|P3|Overall Study|Withdrawal by Subject|1
1495733|NCT00503776|4924959|P2|Overall Study|Withdrawal by Subject|0
1495734|NCT00503776|4924960|P1|Overall Study|Withdrawal by Subject|1
1495735|NCT00503698|4924993|P2|Overall Study|Not exposed to trial drug|6
1495736|NCT00503698|4924994|P1|Overall Study|Not exposed to trial drug|11
1495737|NCT00503698|4924993|P2|Overall Study|Unclassified|32
1495738|NCT00503698|4924994|P1|Overall Study|Unclassified|48
1495739|NCT00503698|4924993|P2|Overall Study|Critically ill|0
1495740|NCT00503698|4924994|P1|Overall Study|Critically ill|2
1495741|NCT00503698|4924993|P2|Overall Study|Move to nonparticipating dialysis center|1
1495742|NCT00503698|4924994|P1|Overall Study|Move to nonparticipating dialysis center|2
1495743|NCT00503698|4924993|P2|Overall Study|Switch to peritoneal or home dialysis|2
1495744|NCT00503698|4924994|P1|Overall Study|Switch to peritoneal or home dialysis|2
1495745|NCT00503698|4924993|P2|Overall Study|Any condition in exclusion criteria|6
1495746|NCT00503698|4924994|P1|Overall Study|Any condition in exclusion criteria|4
1495747|NCT00503698|4924993|P2|Overall Study|Pregnancy/intention to become pregnant|0
1495748|NCT00503698|4924994|P1|Overall Study|Pregnancy/intention to become pregnant|1
1495749|NCT00503698|4924993|P2|Overall Study|End hemodialysis due to renal transplant|4
1495750|NCT00503698|4924994|P1|Overall Study|End hemodialysis due to renal transplant|10
1495751|NCT00503698|4924993|P2|Overall Study|Trial terminated|253
1495752|NCT00503698|4924994|P1|Overall Study|Trial terminated|216
1495753|NCT00503698|4924993|P2|Overall Study|Lack of Efficacy|4
1495754|NCT00503698|4924994|P1|Overall Study|Lack of Efficacy|3
1495755|NCT00503698|4924993|P2|Overall Study|Death|0
1495756|NCT00503698|4924994|P1|Overall Study|Death|1
1495757|NCT00503698|4924993|P2|Overall Study|Adverse Event|41
1495758|NCT00503698|4924994|P1|Overall Study|Adverse Event|52
1495759|NCT00503698|4924993|P2|Overall Study|Protocol Violation|6
1495760|NCT00503698|4924994|P1|Overall Study|Protocol Violation|5
1495761|NCT00503685|4925011|P3|Overall Study|Eligibility Criteria Not Met|0
1495762|NCT00503685|4925012|P2|Overall Study|Eligibility Criteria Not Met|1
1495763|NCT00503685|4925013|P1|Overall Study|Eligibility Criteria Not Met|0
1495764|NCT00503685|4925011|P3|Overall Study|Protocol Violation|0
1495765|NCT00503685|4925012|P2|Overall Study|Protocol Violation|1
1495766|NCT00503685|4925013|P1|Overall Study|Protocol Violation|0
1495767|NCT00503685|4925011|P3|Overall Study|Withdrawal by Subject|0
1495768|NCT00503685|4925012|P2|Overall Study|Withdrawal by Subject|1
1495769|NCT00503685|4925013|P1|Overall Study|Withdrawal by Subject|0
1495770|NCT00503685|4925011|P3|Overall Study|Adverse Event|2
1495771|NCT00503685|4925012|P2|Overall Study|Adverse Event|0
1495772|NCT00503685|4925013|P1|Overall Study|Adverse Event|0
1495773|NCT00503425|4925055|P1|Overall Study|Missing Data/Unknown|4
1495774|NCT00503425|4925055|P1|Overall Study|Death|3
1495775|NCT00503425|4925055|P1|Overall Study|Lost to Follow-up|3
1495776|NCT00503425|4925055|P1|Overall Study|Withdrawal by Subject|8
1495777|NCT00503425|4925055|P1|Overall Study|Lack of Efficacy|25
1495778|NCT00503425|4925055|P1|Overall Study|Adverse Event|5
1495779|NCT00503425|4925055|P1|Overall Study|Participant files lost|6
1495780|NCT00503399|4925065|P2|Overall Study|Lost to Follow-up|2
1495781|NCT00503399|4925066|P1|Overall Study|Lost to Follow-up|0
1495782|NCT00503399|4925065|P2|Overall Study|Adverse Event|3
1495783|NCT00503399|4925066|P1|Overall Study|Adverse Event|0
1495784|NCT00503399|4925065|P2|Overall Study|Withdrawal by Subject|2
1495785|NCT00503399|4925066|P1|Overall Study|Withdrawal by Subject|4
1495786|NCT00503399|4925065|P2|Overall Study|Protocol Violation|0
1495787|NCT00503399|4925066|P1|Overall Study|Protocol Violation|1
1495788|NCT00503399|4925065|P2|Overall Study|Death|1
1495789|NCT00503399|4925066|P1|Overall Study|Death|2
1495790|NCT00503308|4925090|P2|Overall Study|Protocol Violation|1
1495791|NCT00503308|4925091|P1|Overall Study|Protocol Violation|2
1495792|NCT00503139|4925097|P1|Overall Study|Protocol Violation|4
1495793|NCT00503139|4925097|P1|Overall Study|Case Report Forms were not collected|4
1495794|NCT00503009|4925145|P3|Overall Study|Physician Decision|1
1495795|NCT00503009|4925146|P2|Overall Study|Physician Decision|1
1495796|NCT00503009|4925147|P1|Overall Study|Physician Decision|0
1495797|NCT00503009|4925145|P3|Overall Study|Withdrawal by Subject|1
1495798|NCT00503009|4925146|P2|Overall Study|Withdrawal by Subject|1
1495799|NCT00503009|4925147|P1|Overall Study|Withdrawal by Subject|0
1495800|NCT00503009|4925145|P3|Overall Study|Protocol Violation|1
1495801|NCT00503009|4925146|P2|Overall Study|Protocol Violation|0
1495802|NCT00503009|4925147|P1|Overall Study|Protocol Violation|1
1495803|NCT00502996|4925164|P1|Overall Study|Adverse Event|2
1495804|NCT00502996|4925164|P1|Overall Study|Withdrawal Informed Consent|6
1495805|NCT00502996|4925164|P1|Overall Study|Treatment failure|25
1495806|NCT00502996|4925164|P1|Overall Study|Protocol Violation|2
1495807|NCT00502996|4925164|P1|Overall Study|Lost to Follow-up|9
1495808|NCT00502840|4925232|P1|Overall Study|Not specified|20
1495809|NCT00502840|4925232|P1|Overall Study|Administrative problems|1
1495810|NCT00502840|4925232|P1|Overall Study|Lost to Follow-up|6
1495811|NCT00502840|4925232|P1|Overall Study|Withdrawal by Subject|5
1495812|NCT00502840|4925232|P1|Overall Study|Protocol Violation|4
1495813|NCT00502840|4925232|P1|Overall Study|Lack of Efficacy|11
1495814|NCT00502840|4925232|P1|Overall Study|Additional or changed therapy|48
1495815|NCT00502840|4925232|P1|Overall Study|Adverse Event|5
1495816|NCT00502801|4925260|P1|End of Therapy to Test of Cure|OTHER|2
1495817|NCT00502801|4925260|P1|End of Therapy to Test of Cure|Death|3
1495818|NCT00502801|4925260|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
1495819|NCT00502801|4925260|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
1495820|NCT00502801|4925260|P1|Treatment Period|OTHER|30
1495821|NCT00502801|4925260|P1|Treatment Period|Death|14
1495822|NCT00502801|4925260|P1|Treatment Period|Adverse Event|7
1495823|NCT00502801|4925260|P1|Treatment Period|Withdrawal by Subject|3
1495824|NCT00502775|4925268|P3|Overall Study|Subject took disallowed drug|1
1495825|NCT00502775|4925269|P2|Overall Study|Subject took disallowed drug|0
1495826|NCT00502775|4925270|P1|Overall Study|Subject took disallowed drug|0
1495827|NCT00502775|4925268|P3|Overall Study|Subject in jail|0
1495828|NCT00502775|4925269|P2|Overall Study|Subject in jail|1
1495829|NCT00502775|4925270|P1|Overall Study|Subject in jail|0
1495830|NCT00502775|4925268|P3|Overall Study|Declining pollen counts|1
1495831|NCT00502775|4925269|P2|Overall Study|Declining pollen counts|1
1495832|NCT00502775|4925270|P1|Overall Study|Declining pollen counts|0
1495833|NCT00502775|4925268|P3|Overall Study|Outside pollen area more than 48 hours|0
1495834|NCT00502775|4925269|P2|Overall Study|Outside pollen area more than 48 hours|1
1495835|NCT00502775|4925270|P1|Overall Study|Outside pollen area more than 48 hours|0
1495836|NCT00502775|4925268|P3|Overall Study|Non-compliance|2
1495837|NCT00502775|4925269|P2|Overall Study|Non-compliance|2
1495838|NCT00502775|4925270|P1|Overall Study|Non-compliance|0
1495839|NCT00502775|4925268|P3|Overall Study|Randomized in error|1
1495840|NCT00502775|4925269|P2|Overall Study|Randomized in error|1
1495841|NCT00502775|4925270|P1|Overall Study|Randomized in error|0
1495842|NCT00502775|4925268|P3|Overall Study|Logpad compliance <80%|0
1495843|NCT00502775|4925269|P2|Overall Study|Logpad compliance <80%|0
1495844|NCT00502775|4925270|P1|Overall Study|Logpad compliance <80%|1
1495845|NCT00502775|4925268|P3|Overall Study|Subject unable to swallow capsule|1
1495846|NCT00502775|4925269|P2|Overall Study|Subject unable to swallow capsule|0
1495847|NCT00502775|4925270|P1|Overall Study|Subject unable to swallow capsule|1
1495848|NCT00502775|4925268|P3|Overall Study|Non-compliance with eDiary|1
1495849|NCT00502775|4925269|P2|Overall Study|Non-compliance with eDiary|1
1495850|NCT00502775|4925270|P1|Overall Study|Non-compliance with eDiary|4
1495851|NCT00502775|4925268|P3|Overall Study|Sponsor Terminated Study|1
1495852|NCT00502775|4925269|P2|Overall Study|Sponsor Terminated Study|0
1495853|NCT00502775|4925270|P1|Overall Study|Sponsor Terminated Study|1
1495854|NCT00502775|4925268|P3|Overall Study|Withdrawal by Subject|2
1495855|NCT00502775|4925269|P2|Overall Study|Withdrawal by Subject|1
1495856|NCT00502775|4925270|P1|Overall Study|Withdrawal by Subject|1
1495857|NCT00502775|4925268|P3|Overall Study|Protocol Violation|2
1495858|NCT00502775|4925269|P2|Overall Study|Protocol Violation|5
1495859|NCT00502775|4925270|P1|Overall Study|Protocol Violation|1
1495860|NCT00502775|4925268|P3|Overall Study|Adverse Event|1
1495861|NCT00502775|4925269|P2|Overall Study|Adverse Event|2
1495862|NCT00502775|4925270|P1|Overall Study|Adverse Event|1
1495863|NCT00502697|4925313|P2|Overall Study|did not meet assignment criteria|2
1495864|NCT00502697|4925314|P1|Overall Study|did not meet assignment criteria|4
1495865|NCT00502697|4925313|P2|Overall Study|found not to meet eligibility criteria|4
1495866|NCT00502697|4925314|P1|Overall Study|found not to meet eligibility criteria|3
1495867|NCT00502697|4925313|P2|Overall Study|disenrolled due to pregnancy loss|5
1495868|NCT00502697|4925314|P1|Overall Study|disenrolled due to pregnancy loss|3
1495869|NCT00502697|4925313|P2|Overall Study|Withdrawal by Subject|1
1495870|NCT00502697|4925314|P1|Overall Study|Withdrawal by Subject|3
1495871|NCT00502671|4925322|P1|Overall Study|Adverse Event|19
1495872|NCT00502671|4925322|P1|Overall Study|Protocol Violation|16
1495873|NCT00502671|4925322|P1|Overall Study|Lost to Follow-up|7
1495874|NCT00502671|4925322|P1|Overall Study|Personal Reasons|22
1495875|NCT00502671|4925322|P1|Overall Study|Disease Progression|13
1495876|NCT00502593|4925339|P12|Overall Study|Lost to Follow-up|0
1495877|NCT00502593|4925340|P11|Overall Study|Lost to Follow-up|1
1495878|NCT00502593|4925341|P10|Overall Study|Lost to Follow-up|0
1495879|NCT00502593|4925342|P9|Overall Study|Lost to Follow-up|3
1495880|NCT00502593|4925343|P8|Overall Study|Lost to Follow-up|0
1495881|NCT00502593|4925344|P7|Overall Study|Lost to Follow-up|0
1495882|NCT00502593|4925345|P6|Overall Study|Lost to Follow-up|0
1495883|NCT00502593|4925346|P5|Overall Study|Lost to Follow-up|0
1495884|NCT00502593|4925347|P4|Overall Study|Lost to Follow-up|1
1495885|NCT00502593|4925348|P3|Overall Study|Lost to Follow-up|1
1495886|NCT00502593|4925349|P2|Overall Study|Lost to Follow-up|1
1495887|NCT00502593|4925350|P1|Overall Study|Lost to Follow-up|2
1495888|NCT00502593|4925339|P12|Overall Study|Withdrawal by Subject|0
1495889|NCT00502593|4925340|P11|Overall Study|Withdrawal by Subject|1
1495890|NCT00502593|4925341|P10|Overall Study|Withdrawal by Subject|0
1495891|NCT00502593|4925342|P9|Overall Study|Withdrawal by Subject|3
1495892|NCT00502593|4925343|P8|Overall Study|Withdrawal by Subject|0
1495893|NCT00502593|4925344|P7|Overall Study|Withdrawal by Subject|3
1495894|NCT00502593|4925345|P6|Overall Study|Withdrawal by Subject|0
1495895|NCT00502593|4925346|P5|Overall Study|Withdrawal by Subject|2
1495896|NCT00502593|4925347|P4|Overall Study|Withdrawal by Subject|2
1495897|NCT00502593|4925348|P3|Overall Study|Withdrawal by Subject|6
1495898|NCT00502593|4925349|P2|Overall Study|Withdrawal by Subject|0
1495899|NCT00502593|4925350|P1|Overall Study|Withdrawal by Subject|0
1495900|NCT00502593|4925339|P12|Overall Study|Withdrawn unspecified reason|0
1495901|NCT00502593|4925340|P11|Overall Study|Withdrawn unspecified reason|0
1495902|NCT00502593|4925341|P10|Overall Study|Withdrawn unspecified reason|0
1495903|NCT00502593|4925342|P9|Overall Study|Withdrawn unspecified reason|0
1495904|NCT00502593|4925343|P8|Overall Study|Withdrawn unspecified reason|0
1495905|NCT00502593|4925344|P7|Overall Study|Withdrawn unspecified reason|2
1495906|NCT00502593|4925345|P6|Overall Study|Withdrawn unspecified reason|0
1495907|NCT00502593|4925346|P5|Overall Study|Withdrawn unspecified reason|2
1495908|NCT00502593|4925347|P4|Overall Study|Withdrawn unspecified reason|1
1495909|NCT00502593|4925348|P3|Overall Study|Withdrawn unspecified reason|3
1495910|NCT00502593|4925349|P2|Overall Study|Withdrawn unspecified reason|1
1495911|NCT00502593|4925350|P1|Overall Study|Withdrawn unspecified reason|1
1495912|NCT00502320|4925866|P2|Overall Study|Adverse Event|5
1495913|NCT00502320|4925867|P1|Overall Study|Adverse Event|3
1495914|NCT00502320|4925866|P2|Overall Study|Screen Failure|1
1495915|NCT00502320|4925867|P1|Overall Study|Screen Failure|0
1495916|NCT00502320|4925866|P2|Overall Study|No longer met criteria|0
1495917|NCT00502320|4925867|P1|Overall Study|No longer met criteria|1
1495918|NCT00502320|4925866|P2|Overall Study|Withdrew Consent|0
1495919|NCT00502320|4925867|P1|Overall Study|Withdrew Consent|1
1495920|NCT00502320|4925866|P2|Overall Study|Lost to Follow-up|1
1495921|NCT00502320|4925867|P1|Overall Study|Lost to Follow-up|1
1495922|NCT00502242|4925879|P2|Overall Study|Withdrawal by Subject|7
1495923|NCT00502242|4925880|P1|Overall Study|Withdrawal by Subject|6
1495924|NCT00502242|4925879|P2|Overall Study|Protocol Violation|1
1495925|NCT00502242|4925880|P1|Overall Study|Protocol Violation|3
1495926|NCT00502242|4925879|P2|Overall Study|Other - Unspecified|14
1495927|NCT00502242|4925880|P1|Overall Study|Other - Unspecified|8
1495928|NCT00502242|4925879|P2|Overall Study|Physician Decision|3
1495929|NCT00502242|4925880|P1|Overall Study|Physician Decision|2
1495930|NCT00502242|4925879|P2|Overall Study|Adverse Event|20
1495931|NCT00502242|4925880|P1|Overall Study|Adverse Event|31
1495932|NCT00502242|4925879|P2|Overall Study|Lack of Efficacy|11
1495933|NCT00502242|4925880|P1|Overall Study|Lack of Efficacy|1
1495934|NCT00502203|4925944|P1|Overall Study|Inevaluable|1
1495935|NCT00501969|4925953|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
1495936|NCT00501969|4925953|P1|Overall Study|Other: Admin Request from the Sponsor|3
1495937|NCT00501969|4925953|P1|Overall Study|Other: As Required by Local EC|2
1495938|NCT00501969|4925953|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
1495939|NCT00501969|4925953|P1|Overall Study|Other: Pat Pending Surgery for PD|1
1495940|NCT00501969|4925953|P1|Overall Study|Other: Patient is Going to Have DBS|1
1495941|NCT00501969|4925953|P1|Overall Study|Other: Patients + Investigator Agreement|1
1495942|NCT00501969|4925953|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
1495943|NCT00501969|4925953|P1|Overall Study|Other: Sponsor Stopped Study|12
1495944|NCT00501969|4925953|P1|Overall Study|Other: Sponsor Termination at Site|1
1495945|NCT00501969|4925953|P1|Overall Study|Other: Sponsors Request|10
1495946|NCT00501969|4925953|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
1495947|NCT00501969|4925953|P1|Overall Study|Lost to Follow-up|4
1495948|NCT00501969|4925953|P1|Overall Study|Subject withdrew consent|51
1495949|NCT00501969|4925953|P1|Overall Study|Unsatisfactory compliance of subject|7
1495950|NCT00501969|4925953|P1|Overall Study|Adverse Event|76
1495951|NCT00501969|4925953|P1|Overall Study|Lack of Efficacy|29
1495952|NCT00501969|4925953|P1|Overall Study|Major Protocol Violation|4
1495953|NCT00501852|4925985|P1|Overall Study|Withdrawal by Subject|2
1495954|NCT00501852|4925985|P1|Overall Study|Adverse Event|3
1495955|NCT00501644|4926005|P1|Overall Study|Withdrawal by Subject|1
1495956|NCT00501644|4926005|P1|Overall Study|Adverse Event|4
1495957|NCT00501540|4926034|P1|Overall Study|Death|5
1495958|NCT00501293|4926046|P2|Maintenance Period|Application site reaction|0
1495959|NCT00501293|4926047|P1|Maintenance Period|Application site reaction|1
1495960|NCT00501293|4926046|P2|Maintenance Period|Would not wear patch|0
1495961|NCT00501293|4926047|P1|Maintenance Period|Would not wear patch|1
1495962|NCT00501293|4926046|P2|Maintenance Period|Went into rehabilitation|0
1495963|NCT00501293|4926047|P1|Maintenance Period|Went into rehabilitation|1
1495964|NCT00501293|4926046|P2|Maintenance Period|Noncompliant with study medication|0
1495965|NCT00501293|4926047|P1|Maintenance Period|Noncompliant with study medication|5
1495966|NCT00501293|4926046|P2|Maintenance Period|Lack of Efficacy|1
1495967|NCT00501293|4926047|P1|Maintenance Period|Lack of Efficacy|4
1495968|NCT00501293|4926046|P2|Maintenance Period|Protocol Violation|1
1495969|NCT00501293|4926047|P1|Maintenance Period|Protocol Violation|2
1495970|NCT00501293|4926046|P2|Maintenance Period|Adverse Event|6
1495971|NCT00501293|4926047|P1|Maintenance Period|Adverse Event|6
1495972|NCT00501293|4926046|P2|Maintenance Period|Lost to Follow-up|7
1495973|NCT00501293|4926047|P1|Maintenance Period|Lost to Follow-up|12
1495974|NCT00501293|4926046|P2|Maintenance Period|Withdrawal by Subject|13
1495975|NCT00501293|4926047|P1|Maintenance Period|Withdrawal by Subject|14
1495976|NCT00501293|4926046|P2|Optimization Period|Enrolled in error|0
1495977|NCT00501293|4926047|P1|Optimization Period|Enrolled in error|1
1495978|NCT00501228|4926074|P1|Overall Study|Withdrawal by Subject|1
1495979|NCT00501085|4926078|P1|Overall Study|Other loss to follow-up|32
1495980|NCT00501085|4926078|P1|Overall Study|Study closed by sponsor|109
1495981|NCT00501085|4926078|P1|Overall Study|Non-Compliance|24
1495982|NCT00501085|4926078|P1|Overall Study|Adverse Event|4
1495983|NCT00501085|4926078|P1|Overall Study|Explantation Surgery|26
1495984|NCT00501085|4926078|P1|Overall Study|Revision Surgery|7
1495985|NCT00501085|4926078|P1|Overall Study|Subject Decision|1
1495986|NCT00501085|4926078|P1|Overall Study|Withdrawal by Subject|34
1495987|NCT00501085|4926078|P1|Overall Study|Lost to Follow-up|195
1495988|NCT00501059|4926088|P2|Overall Study|Not treated|17
1495989|NCT00501059|4926089|P1|Overall Study|Not treated|25
1495990|NCT00501059|4926088|P2|Overall Study|Lost to Follow-up|198
1495991|NCT00501059|4926089|P1|Overall Study|Lost to Follow-up|210
1495992|NCT00501059|4926088|P2|Overall Study|Adverse Event|122
1495993|NCT00501059|4926089|P1|Overall Study|Adverse Event|129
1495994|NCT00501059|4926088|P2|Overall Study|Reason not given|1
1495995|NCT00501059|4926089|P1|Overall Study|Reason not given|3
1495996|NCT00501059|4926088|P2|Overall Study|Non-compliant with study treatment|16
1495997|NCT00501059|4926089|P1|Overall Study|Non-compliant with study treatment|23
1495998|NCT00501059|4926088|P2|Overall Study|Consent withdrawn by subject|873
1495999|NCT00501059|4926089|P1|Overall Study|Consent withdrawn by subject|817
1496000|NCT00501059|4926088|P2|Overall Study|Insufficient therapeutic effect|5
1496001|NCT00501059|4926089|P1|Overall Study|Insufficient therapeutic effect|4
1496002|NCT00501059|4926088|P2|Overall Study|Clinical endpoint reached|123
1496003|NCT00501059|4926089|P1|Overall Study|Clinical endpoint reached|110
1496004|NCT00501059|4926088|P2|Overall Study|Missing end-of-study page|92
1496005|NCT00501059|4926089|P1|Overall Study|Missing end-of-study page|91
1496006|NCT00501059|4926088|P2|Overall Study|Other|239
1496007|NCT00501059|4926089|P1|Overall Study|Other|236
1496008|NCT00501059|4926088|P2|Overall Study|Death|137
1496009|NCT00501059|4926089|P1|Overall Study|Death|140
1496010|NCT00501059|4926088|P2|Overall Study|Protocol Violation|69
1496011|NCT00501059|4926089|P1|Overall Study|Protocol Violation|80
1496012|NCT00501046|4926109|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
1496013|NCT00501046|4926110|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
1496014|NCT00501046|4926109|P2|Overall Study|Withdrawal by Subject|83
1496015|NCT00501046|4926110|P1|Overall Study|Withdrawal by Subject|84
1496016|NCT00501046|4926109|P2|Overall Study|Protocol Violation|1
1496017|NCT00501046|4926110|P1|Overall Study|Protocol Violation|2
1496018|NCT00501046|4926109|P2|Overall Study|Pregnancy|3
1496019|NCT00501046|4926110|P1|Overall Study|Pregnancy|0
1496020|NCT00501046|4926109|P2|Overall Study|Physician Decision|2
1496021|NCT00501046|4926110|P1|Overall Study|Physician Decision|7
1496022|NCT00501046|4926109|P2|Overall Study|Lost to Follow-up|13
1496023|NCT00501046|4926110|P1|Overall Study|Lost to Follow-up|14
1496024|NCT00501046|4926109|P2|Overall Study|Death|30
1496025|NCT00501046|4926110|P1|Overall Study|Death|23
1496026|NCT00501046|4926109|P2|Overall Study|Adverse Event|25
1496027|NCT00501046|4926110|P1|Overall Study|Adverse Event|21
1496028|NCT00501007|4926116|P2|Overall Study|Inclusion criteria not met.|25
1496029|NCT00501007|4926117|P1|Overall Study|Inclusion criteria not met.|29
1496030|NCT00500760|4926125|P2|Overall Study|Other|2
1496031|NCT00500760|4926126|P1|Overall Study|Other|1
1496032|NCT00500760|4926125|P2|Overall Study|Lost to Follow-up|0
1496033|NCT00500760|4926126|P1|Overall Study|Lost to Follow-up|3
1496034|NCT00500760|4926125|P2|Overall Study|Administrative decision|0
1496035|NCT00500760|4926126|P1|Overall Study|Administrative decision|2
1496036|NCT00500760|4926125|P2|Overall Study|Withdrawal by Subject|7
1496037|NCT00500760|4926126|P1|Overall Study|Withdrawal by Subject|5
1496038|NCT00500760|4926125|P2|Overall Study|Death|15
1496039|NCT00500760|4926126|P1|Overall Study|Death|32
1496040|NCT00500682|4926146|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
1496041|NCT00500682|4926147|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
1496042|NCT00500682|4926146|P2|Overall Study|Withdrawal by Subject|74
1496043|NCT00500682|4926147|P1|Overall Study|Withdrawal by Subject|80
1496044|NCT00500682|4926146|P2|Overall Study|Protocol Violation|3
1496045|NCT00500682|4926147|P1|Overall Study|Protocol Violation|1
1496046|NCT00500682|4926146|P2|Overall Study|Pregnancy|0
1496047|NCT00500682|4926147|P1|Overall Study|Pregnancy|2
1496048|NCT00500682|4926146|P2|Overall Study|Physician Decision|10
1496049|NCT00500682|4926147|P1|Overall Study|Physician Decision|6
1496050|NCT00500682|4926146|P2|Overall Study|Lost to Follow-up|11
1496051|NCT00500682|4926147|P1|Overall Study|Lost to Follow-up|11
1496052|NCT00500682|4926146|P2|Overall Study|Death|16
1496053|NCT00500682|4926147|P1|Overall Study|Death|25
1496054|NCT00500682|4926146|P2|Overall Study|Adverse Event|29
1496055|NCT00500682|4926147|P1|Overall Study|Adverse Event|37
1496056|NCT00500539|4926181|P1|Follow-up Period (16 Weeks)|Missing|3
1496057|NCT00500539|4926181|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
1496058|NCT00500539|4926181|P1|Follow-up Period (16 Weeks)|Death|1
1496059|NCT00500539|4926181|P1|Follow-up Period (16 Weeks)|Administrative problems|1
1496060|NCT00500539|4926181|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
1496061|NCT00500539|4926181|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
1496062|NCT00500539|4926181|P1|Follow-up Period (16 Weeks)|Adverse Event|1
1496063|NCT00500539|4926181|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
1496064|NCT00500539|4926181|P1|Treatment Period (24 Weeks)|Administrative problems|2
1496065|NCT00500539|4926181|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
1496066|NCT00500539|4926181|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
1496067|NCT00500539|4926181|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
1496068|NCT00500539|4926181|P1|Treatment Period (24 Weeks)|Adverse Event|4
1496069|NCT00500370|4926207|P2|Overall Study|Subject Decision|17
1496070|NCT00500370|4926208|P1|Overall Study|Subject Decision|10
1496071|NCT00500370|4926207|P2|Overall Study|Sponsor Decision|0
1496072|NCT00500370|4926208|P1|Overall Study|Sponsor Decision|2
1496073|NCT00500370|4926207|P2|Overall Study|Protocol Violation|4
1496074|NCT00500370|4926208|P1|Overall Study|Protocol Violation|2
1496075|NCT00500370|4926207|P2|Overall Study|Lost to Follow-up|10
1496076|NCT00500370|4926208|P1|Overall Study|Lost to Follow-up|10
1496077|NCT00500370|4926207|P2|Overall Study|Adverse Event|3
1496078|NCT00500370|4926208|P1|Overall Study|Adverse Event|9
1496079|NCT00500357|4926244|P1|Overall Study|Death|1
1496080|NCT00500331|4926270|P7|Overall Study|Protocol violated|0
1496081|NCT00500331|4926271|P6|Overall Study|Protocol violated|0
1496082|NCT00500331|4926272|P5|Overall Study|Protocol violated|0
1496083|NCT00500331|4926273|P4|Overall Study|Protocol violated|1
1496084|NCT00500331|4926274|P3|Overall Study|Protocol violated|0
1496085|NCT00500331|4926275|P2|Overall Study|Protocol violated|0
1496086|NCT00500331|4926276|P1|Overall Study|Protocol violated|0
1496087|NCT00500331|4926270|P7|Overall Study|State ban of biological samples export|0
1496088|NCT00500331|4926271|P6|Overall Study|State ban of biological samples export|0
1496089|NCT00500331|4926272|P5|Overall Study|State ban of biological samples export|0
1496090|NCT00500331|4926273|P4|Overall Study|State ban of biological samples export|1
1496091|NCT00500331|4926274|P3|Overall Study|State ban of biological samples export|0
1496092|NCT00500331|4926275|P2|Overall Study|State ban of biological samples export|0
1496093|NCT00500331|4926276|P1|Overall Study|State ban of biological samples export|0
1496094|NCT00500331|4926270|P7|Overall Study|Diabetologist nurse in the study|0
1496095|NCT00500331|4926271|P6|Overall Study|Diabetologist nurse in the study|0
1496096|NCT00500331|4926272|P5|Overall Study|Diabetologist nurse in the study|0
1496097|NCT00500331|4926273|P4|Overall Study|Diabetologist nurse in the study|0
1496098|NCT00500331|4926274|P3|Overall Study|Diabetologist nurse in the study|1
1496099|NCT00500331|4926275|P2|Overall Study|Diabetologist nurse in the study|0
1496100|NCT00500331|4926276|P1|Overall Study|Diabetologist nurse in the study|0
1496101|NCT00500331|4926270|P7|Overall Study|Participant was randomized by mistake|0
1496102|NCT00500331|4926271|P6|Overall Study|Participant was randomized by mistake|0
1496103|NCT00500331|4926272|P5|Overall Study|Participant was randomized by mistake|0
1496104|NCT00500331|4926273|P4|Overall Study|Participant was randomized by mistake|0
1496105|NCT00500331|4926274|P3|Overall Study|Participant was randomized by mistake|0
1496106|NCT00500331|4926275|P2|Overall Study|Participant was randomized by mistake|0
1496107|NCT00500331|4926276|P1|Overall Study|Participant was randomized by mistake|1
1496108|NCT00500331|4926270|P7|Overall Study|Sponsor decided to withdraw participant|0
1496109|NCT00500331|4926271|P6|Overall Study|Sponsor decided to withdraw participant|0
1496110|NCT00500331|4926272|P5|Overall Study|Sponsor decided to withdraw participant|0
1496111|NCT00500331|4926273|P4|Overall Study|Sponsor decided to withdraw participant|0
1496112|NCT00500331|4926274|P3|Overall Study|Sponsor decided to withdraw participant|0
1496113|NCT00500331|4926275|P2|Overall Study|Sponsor decided to withdraw participant|0
1496114|NCT00500331|4926276|P1|Overall Study|Sponsor decided to withdraw participant|1
1496115|NCT00500331|4926270|P7|Overall Study|Exclusion citeria not met on Visit 4|0
1496116|NCT00500331|4926271|P6|Overall Study|Exclusion citeria not met on Visit 4|0
1496117|NCT00500331|4926272|P5|Overall Study|Exclusion citeria not met on Visit 4|0
1496118|NCT00500331|4926273|P4|Overall Study|Exclusion citeria not met on Visit 4|0
1496119|NCT00500331|4926274|P3|Overall Study|Exclusion citeria not met on Visit 4|0
1496120|NCT00500331|4926275|P2|Overall Study|Exclusion citeria not met on Visit 4|0
1496121|NCT00500331|4926276|P1|Overall Study|Exclusion citeria not met on Visit 4|1
1496122|NCT00500331|4926270|P7|Overall Study|Didn't return for continuation of study|0
1496123|NCT00500331|4926271|P6|Overall Study|Didn't return for continuation of study|0
1496124|NCT00500331|4926272|P5|Overall Study|Didn't return for continuation of study|0
1496125|NCT00500331|4926273|P4|Overall Study|Didn't return for continuation of study|0
1496126|NCT00500331|4926274|P3|Overall Study|Didn't return for continuation of study|0
1496127|NCT00500331|4926275|P2|Overall Study|Didn't return for continuation of study|0
1496128|NCT00500331|4926276|P1|Overall Study|Didn't return for continuation of study|1
1496129|NCT00500331|4926270|P7|Overall Study|Increased serum creatinine from Baseline|0
1496130|NCT00500331|4926271|P6|Overall Study|Increased serum creatinine from Baseline|1
1496131|NCT00500331|4926272|P5|Overall Study|Increased serum creatinine from Baseline|0
1496132|NCT00500331|4926273|P4|Overall Study|Increased serum creatinine from Baseline|0
1496133|NCT00500331|4926274|P3|Overall Study|Increased serum creatinine from Baseline|0
1496134|NCT00500331|4926275|P2|Overall Study|Increased serum creatinine from Baseline|0
1496135|NCT00500331|4926276|P1|Overall Study|Increased serum creatinine from Baseline|0
1496136|NCT00500331|4926270|P7|Overall Study|Liver function test abnormality|0
1496137|NCT00500331|4926271|P6|Overall Study|Liver function test abnormality|0
1496138|NCT00500331|4926272|P5|Overall Study|Liver function test abnormality|0
1496139|NCT00500331|4926273|P4|Overall Study|Liver function test abnormality|0
1496140|NCT00500331|4926274|P3|Overall Study|Liver function test abnormality|1
1496141|NCT00500331|4926275|P2|Overall Study|Liver function test abnormality|0
1496142|NCT00500331|4926276|P1|Overall Study|Liver function test abnormality|0
1496143|NCT00500331|4926270|P7|Overall Study|Lack of Efficacy|0
1496144|NCT00500331|4926271|P6|Overall Study|Lack of Efficacy|0
1496145|NCT00500331|4926272|P5|Overall Study|Lack of Efficacy|0
1496146|NCT00500331|4926273|P4|Overall Study|Lack of Efficacy|0
1496147|NCT00500331|4926274|P3|Overall Study|Lack of Efficacy|0
1496148|NCT00500331|4926275|P2|Overall Study|Lack of Efficacy|1
1496149|NCT00500331|4926276|P1|Overall Study|Lack of Efficacy|3
1496150|NCT00500331|4926270|P7|Overall Study|Withdrawal by Subject|1
1496151|NCT00500331|4926271|P6|Overall Study|Withdrawal by Subject|1
1496152|NCT00500331|4926272|P5|Overall Study|Withdrawal by Subject|0
1496153|NCT00500331|4926273|P4|Overall Study|Withdrawal by Subject|5
1496154|NCT00500331|4926274|P3|Overall Study|Withdrawal by Subject|1
1496155|NCT00500331|4926275|P2|Overall Study|Withdrawal by Subject|0
1496156|NCT00500331|4926276|P1|Overall Study|Withdrawal by Subject|4
1496157|NCT00500331|4926270|P7|Overall Study|Protocol Violation|1
1496158|NCT00500331|4926271|P6|Overall Study|Protocol Violation|1
1496159|NCT00500331|4926272|P5|Overall Study|Protocol Violation|1
1496160|NCT00500331|4926273|P4|Overall Study|Protocol Violation|0
1496161|NCT00500331|4926274|P3|Overall Study|Protocol Violation|1
1496162|NCT00500331|4926275|P2|Overall Study|Protocol Violation|1
1496163|NCT00500331|4926276|P1|Overall Study|Protocol Violation|3
1496164|NCT00500331|4926270|P7|Overall Study|Lost to Follow-up|0
1496165|NCT00500331|4926271|P6|Overall Study|Lost to Follow-up|0
1496166|NCT00500331|4926272|P5|Overall Study|Lost to Follow-up|1
1496167|NCT00500331|4926273|P4|Overall Study|Lost to Follow-up|2
1496168|NCT00500331|4926274|P3|Overall Study|Lost to Follow-up|1
1496169|NCT00500331|4926275|P2|Overall Study|Lost to Follow-up|1
1496170|NCT00500331|4926276|P1|Overall Study|Lost to Follow-up|1
1496171|NCT00500331|4926270|P7|Overall Study|Adverse Event|0
1496172|NCT00500331|4926271|P6|Overall Study|Adverse Event|2
1496173|NCT00500331|4926272|P5|Overall Study|Adverse Event|2
1496174|NCT00500331|4926273|P4|Overall Study|Adverse Event|1
1496175|NCT00500331|4926274|P3|Overall Study|Adverse Event|0
1496176|NCT00500331|4926275|P2|Overall Study|Adverse Event|2
1496177|NCT00500331|4926276|P1|Overall Study|Adverse Event|0
1496178|NCT00500318|4926413|P2|Overall Study|Other Reason|1
1496179|NCT00500318|4926414|P1|Overall Study|Other Reason|0
1496180|NCT00500318|4926413|P2|Overall Study|Lack of Efficacy|3
1496181|NCT00500318|4926414|P1|Overall Study|Lack of Efficacy|0
1496182|NCT00500318|4926413|P2|Overall Study|Withdrawal by Subject|2
1496183|NCT00500318|4926414|P1|Overall Study|Withdrawal by Subject|1
1496184|NCT00500318|4926413|P2|Overall Study|Protocol Violation|3
1496185|NCT00500318|4926414|P1|Overall Study|Protocol Violation|1
1496186|NCT00500318|4926413|P2|Overall Study|Adverse Event|8
1496187|NCT00500318|4926414|P1|Overall Study|Adverse Event|3
1496188|NCT00500292|4926431|P3|Overall Study|Other|4
1496189|NCT00500292|4926432|P2|Overall Study|Other|1
1496190|NCT00500292|4926433|P1|Overall Study|Other|1
1496191|NCT00500292|4926431|P3|Overall Study|Withdrawal by Subject|0
1496192|NCT00500292|4926432|P2|Overall Study|Withdrawal by Subject|1
1496193|NCT00500292|4926433|P1|Overall Study|Withdrawal by Subject|0
1496194|NCT00500292|4926431|P3|Overall Study|Condition under investigation worsened|19
1496195|NCT00500292|4926432|P2|Overall Study|Condition under investigation worsened|23
1496196|NCT00500292|4926433|P1|Overall Study|Condition under investigation worsened|21
1496197|NCT00500292|4926431|P3|Overall Study|Adverse Event|4
1496198|NCT00500292|4926432|P2|Overall Study|Adverse Event|6
1496199|NCT00500292|4926433|P1|Overall Study|Adverse Event|3
1496200|NCT00500149|4926454|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
1496201|NCT00500149|4926455|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
1496202|NCT00500149|4926454|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
1496203|NCT00500149|4926455|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
1496204|NCT00500149|4926454|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
1496205|NCT00500149|4926455|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
1496206|NCT00500149|4926454|P2|First Intervention (Cross-over Phase)|Adverse Event|1
1496207|NCT00500149|4926455|P1|First Intervention (Cross-over Phase)|Adverse Event|0
1496208|NCT00500149|4926454|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
1496209|NCT00500149|4926455|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
1496210|NCT00500149|4926454|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
1496211|NCT00500149|4926455|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
1496212|NCT00500149|4926454|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
1496213|NCT00500149|4926455|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
1496214|NCT00500110|4926463|P1|Overall Study|Withdrawal by Subject|3
1496215|NCT00500071|4926467|P1|30-day Safety Follow-up|Lost to Follow-up|17
1496216|NCT00500071|4926467|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
1496217|NCT00500071|4926467|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
1496218|NCT00500071|4926467|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
1496219|NCT00500071|4926467|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
1496220|NCT00500071|4926467|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
1496221|NCT00500071|4926467|P1|Screening and Washout Phase|Protocol Violation|1
1496222|NCT00499889|4926485|P1|Overall Study|Infection prior to treatment|1
1496223|NCT00499863|4926493|P2|Overall Study|Lost to Follow-up|1
1496224|NCT00499863|4926494|P1|Overall Study|Lost to Follow-up|1
1496225|NCT00499863|4926493|P2|Overall Study|Sponsor decision|2
1496226|NCT00499863|4926494|P1|Overall Study|Sponsor decision|2
1496227|NCT00499863|4926493|P2|Overall Study|Adverse Event|2
1496228|NCT00499863|4926494|P1|Overall Study|Adverse Event|8
1496229|NCT00499863|4926493|P2|Overall Study|Withdrawal by Subject|4
1496230|NCT00499863|4926494|P1|Overall Study|Withdrawal by Subject|6
1496231|NCT00499863|4926493|P2|Overall Study|Protocol Violation|7
1496232|NCT00499863|4926494|P1|Overall Study|Protocol Violation|12
1496233|NCT00499863|4926493|P2|Overall Study|Lack of Efficacy|27
1496234|NCT00499863|4926494|P1|Overall Study|Lack of Efficacy|21
1496235|NCT00500266|4926522|P1|Overall Study|Assigned, not treated|4
1496236|NCT00500266|4926522|P1|Overall Study|Withdrawal by Subject|3
1496237|NCT00500266|4926522|P1|Overall Study|Lost to Follow-up|3
1496238|NCT00500266|4926522|P1|Overall Study|Death|3
1496239|NCT00499746|4926529|P1|Phase 1(6-9 One Day Sessions)|Unable to determine|1
1496240|NCT00499746|4926529|P1|Phase 1(6-9 One Day Sessions)|Investigator decision|1
1496241|NCT00499746|4926529|P1|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
1496242|NCT00499746|4926529|P1|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
1496243|NCT00499694|4926598|P1|Overall Study|Patient never received treatment.|1
1496244|NCT00499681|4926607|P2|Overall Study|disease progression|1
1496245|NCT00499681|4926608|P1|Overall Study|disease progression|0
1496246|NCT00499681|4926607|P2|Overall Study|toxicity|1
1496247|NCT00499681|4926608|P1|Overall Study|toxicity|0
1496248|NCT00499616|4926635|P4|Overall Study|Patient/Parent Refusal|0
1496249|NCT00499616|4926636|P3|Overall Study|Patient/Parent Refusal|3
1496250|NCT00499616|4926637|P2|Overall Study|Patient/Parent Refusal|5
1496251|NCT00499616|4926638|P1|Overall Study|Patient/Parent Refusal|1
1496252|NCT00499616|4926635|P4|Overall Study|Not evaluable|41
1496253|NCT00499616|4926636|P3|Overall Study|Not evaluable|0
1496254|NCT00499616|4926637|P2|Overall Study|Not evaluable|0
1496255|NCT00499616|4926638|P1|Overall Study|Not evaluable|0
1496256|NCT00499616|4926635|P4|Overall Study|Ineligible|15
1496257|NCT00499616|4926636|P3|Overall Study|Ineligible|0
1496258|NCT00499616|4926637|P2|Overall Study|Ineligible|2
1496259|NCT00499616|4926638|P1|Overall Study|Ineligible|1
1496260|NCT00499616|4926635|P4|Overall Study|Withdrawal by Subject|0
1496261|NCT00499616|4926636|P3|Overall Study|Withdrawal by Subject|1
1496262|NCT00499616|4926637|P2|Overall Study|Withdrawal by Subject|0
1496263|NCT00499616|4926638|P1|Overall Study|Withdrawal by Subject|1
1496264|NCT00499616|4926635|P4|Overall Study|Physician Decision|0
1496265|NCT00499616|4926636|P3|Overall Study|Physician Decision|9
1496266|NCT00499616|4926637|P2|Overall Study|Physician Decision|16
1496267|NCT00499616|4926638|P1|Overall Study|Physician Decision|6
1496268|NCT00499616|4926635|P4|Overall Study|Lost to Follow-up|0
1496269|NCT00499616|4926636|P3|Overall Study|Lost to Follow-up|1
1496270|NCT00499616|4926637|P2|Overall Study|Lost to Follow-up|0
1496271|NCT00499616|4926638|P1|Overall Study|Lost to Follow-up|0
1496272|NCT00499616|4926635|P4|Overall Study|Lack of Efficacy|0
1496273|NCT00499616|4926636|P3|Overall Study|Lack of Efficacy|19
1496274|NCT00499616|4926637|P2|Overall Study|Lack of Efficacy|0
1496275|NCT00499616|4926638|P1|Overall Study|Lack of Efficacy|5
1496276|NCT00499616|4926635|P4|Overall Study|Death|1
1496277|NCT00499616|4926636|P3|Overall Study|Death|3
1496278|NCT00499616|4926637|P2|Overall Study|Death|5
1496279|NCT00499616|4926638|P1|Overall Study|Death|1
1496280|NCT00499603|4926675|P2|Overall Study|Adverse Event|1
1496281|NCT00499603|4926676|P1|Overall Study|Adverse Event|0
1496282|NCT00499590|4926689|P3|Overall Study|Not treated|1
1496283|NCT00499590|4926690|P2|Overall Study|Not treated|0
1496284|NCT00499590|4926691|P1|Overall Study|Not treated|1
1496285|NCT00499590|4926689|P3|Overall Study|Study Terminated|112
1496286|NCT00499590|4926690|P2|Overall Study|Study Terminated|112
1496287|NCT00499590|4926691|P1|Overall Study|Study Terminated|112
1496288|NCT00499486|4926702|P1|Overall Study|Withdrawal by Subject|16
1496289|NCT00499460|4926729|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
1496290|NCT00499460|4926730|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
1496291|NCT00499460|4926729|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
1496292|NCT00499460|4926730|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
1496293|NCT00499460|4926729|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
1496294|NCT00499460|4926730|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
1496295|NCT00499369|4926759|P5|Overall Study|Ineligible|0
1496296|NCT00499369|4926760|P4|Overall Study|Ineligible|1
1496297|NCT00499369|4926761|P3|Overall Study|Ineligible|1
1496298|NCT00499369|4926762|P2|Overall Study|Ineligible|2
1496299|NCT00499369|4926763|P1|Overall Study|Ineligible|2
1496300|NCT00499369|4926759|P5|Overall Study|Not protocol specified|0
1496301|NCT00499369|4926760|P4|Overall Study|Not protocol specified|1
1496302|NCT00499369|4926761|P3|Overall Study|Not protocol specified|3
1496303|NCT00499369|4926762|P2|Overall Study|Not protocol specified|0
1496304|NCT00499369|4926763|P1|Overall Study|Not protocol specified|2
1496305|NCT00499369|4926759|P5|Overall Study|Death|0
1496306|NCT00499369|4926760|P4|Overall Study|Death|0
1496307|NCT00499369|4926761|P3|Overall Study|Death|0
1496308|NCT00499369|4926762|P2|Overall Study|Death|1
1496309|NCT00499369|4926763|P1|Overall Study|Death|0
1496310|NCT00499369|4926759|P5|Overall Study|Progression|10
1496311|NCT00499369|4926760|P4|Overall Study|Progression|6
1496312|NCT00499369|4926761|P3|Overall Study|Progression|9
1496313|NCT00499369|4926762|P2|Overall Study|Progression|12
1496314|NCT00499369|4926763|P1|Overall Study|Progression|10
1496315|NCT00499369|4926759|P5|Overall Study|Withdrawal by Subject|0
1496316|NCT00499369|4926760|P4|Overall Study|Withdrawal by Subject|0
1496317|NCT00499369|4926761|P3|Overall Study|Withdrawal by Subject|1
1496318|NCT00499369|4926762|P2|Overall Study|Withdrawal by Subject|1
1496319|NCT00499369|4926763|P1|Overall Study|Withdrawal by Subject|0
1496320|NCT00499369|4926759|P5|Overall Study|Adverse Event|2
1496321|NCT00499369|4926760|P4|Overall Study|Adverse Event|1
1496322|NCT00499369|4926761|P3|Overall Study|Adverse Event|3
1496323|NCT00499369|4926762|P2|Overall Study|Adverse Event|2
1496324|NCT00499369|4926763|P1|Overall Study|Adverse Event|2
1496325|NCT00499252|4926799|P1|Overall Study|<no further label>|3
1496326|NCT00499252|4926799|P1|Overall Study|Ineligible|4
1496327|NCT00499252|4926799|P1|Overall Study|Refused further treatment|2
1496328|NCT00499252|4926799|P1|Overall Study|Adverse Event|3
1496329|NCT00499122|4926809|P1|Overall Study|Withdrawal by Subject|2
1496330|NCT00499083|4926852|P1|Overall Study|Not evaluable|3
1496331|NCT00499031|4926859|P1|Overall Study|Never treated|1
1496332|NCT00499031|4926859|P1|Overall Study|Required test not done|1
1496333|NCT00499031|4926859|P1|Overall Study|Improper pre-protocol treatment|1
1496334|NCT00498797|4926882|P2|Overall Study|Other|1
1496335|NCT00498797|4926883|P1|Overall Study|Other|3
1496336|NCT00498797|4926882|P2|Overall Study|Condition under investigation worsened|21
1496337|NCT00498797|4926883|P1|Overall Study|Condition under investigation worsened|19
1496338|NCT00498797|4926882|P2|Overall Study|Adverse Event|5
1496339|NCT00498797|4926883|P1|Overall Study|Adverse Event|12
1496340|NCT00498797|4926882|P2|Overall Study|Withdrawal by Subject|2
1496341|NCT00498797|4926883|P1|Overall Study|Withdrawal by Subject|4
1496342|NCT00498602|4926941|P7|Overall Study|Not specified|0
1496343|NCT00498602|4926942|P6|Overall Study|Not specified|3
1496344|NCT00498602|4926943|P5|Overall Study|Not specified|0
1496345|NCT00498602|4926944|P4|Overall Study|Not specified|0
1496346|NCT00498602|4926945|P3|Overall Study|Not specified|1
1496347|NCT00498602|4926946|P2|Overall Study|Not specified|3
1496348|NCT00498602|4926947|P1|Overall Study|Not specified|2
1496349|NCT00498602|4926941|P7|Overall Study|Subject Request|1
1496350|NCT00498602|4926942|P6|Overall Study|Subject Request|4
1496351|NCT00498602|4926943|P5|Overall Study|Subject Request|1
1496352|NCT00498602|4926944|P4|Overall Study|Subject Request|1
1496353|NCT00498602|4926945|P3|Overall Study|Subject Request|1
1496354|NCT00498602|4926946|P2|Overall Study|Subject Request|0
1496355|NCT00498602|4926947|P1|Overall Study|Subject Request|3
1496356|NCT00498602|4926941|P7|Overall Study|Investigator Request|0
1496357|NCT00498602|4926942|P6|Overall Study|Investigator Request|0
1496358|NCT00498602|4926943|P5|Overall Study|Investigator Request|0
1496359|NCT00498602|4926944|P4|Overall Study|Investigator Request|0
1496360|NCT00498602|4926945|P3|Overall Study|Investigator Request|1
1496361|NCT00498602|4926946|P2|Overall Study|Investigator Request|0
1496362|NCT00498602|4926947|P1|Overall Study|Investigator Request|0
1496363|NCT00498602|4926941|P7|Overall Study|Caregiver Request|0
1496364|NCT00498602|4926942|P6|Overall Study|Caregiver Request|2
1496365|NCT00498602|4926943|P5|Overall Study|Caregiver Request|1
1496366|NCT00498602|4926944|P4|Overall Study|Caregiver Request|0
1496367|NCT00498602|4926945|P3|Overall Study|Caregiver Request|2
1496368|NCT00498602|4926946|P2|Overall Study|Caregiver Request|2
1496369|NCT00498602|4926947|P1|Overall Study|Caregiver Request|2
1496370|NCT00498602|4926941|P7|Overall Study|AE not related to Study Drug|1
1496371|NCT00498602|4926942|P6|Overall Study|AE not related to Study Drug|2
1496372|NCT00498602|4926943|P5|Overall Study|AE not related to Study Drug|2
1496373|NCT00498602|4926944|P4|Overall Study|AE not related to Study Drug|0
1496374|NCT00498602|4926945|P3|Overall Study|AE not related to Study Drug|0
1496375|NCT00498602|4926946|P2|Overall Study|AE not related to Study Drug|3
1496376|NCT00498602|4926947|P1|Overall Study|AE not related to Study Drug|1
1496377|NCT00498602|4926941|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
1496378|NCT00498602|4926942|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
1496379|NCT00498602|4926943|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
1496380|NCT00498602|4926944|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
1496381|NCT00498602|4926945|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
1496382|NCT00498602|4926946|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
1496383|NCT00498602|4926947|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
1496384|NCT00498602|4926941|P7|Overall Study|Lost to Follow-up|0
1496385|NCT00498602|4926942|P6|Overall Study|Lost to Follow-up|0
1496386|NCT00498602|4926943|P5|Overall Study|Lost to Follow-up|0
1496387|NCT00498602|4926944|P4|Overall Study|Lost to Follow-up|2
1496388|NCT00498602|4926945|P3|Overall Study|Lost to Follow-up|0
1496389|NCT00498602|4926946|P2|Overall Study|Lost to Follow-up|2
1496390|NCT00498602|4926947|P1|Overall Study|Lost to Follow-up|0
1496391|NCT00498602|4926941|P7|Overall Study|Lack of Efficacy|0
1496392|NCT00498602|4926942|P6|Overall Study|Lack of Efficacy|0
1496393|NCT00498602|4926943|P5|Overall Study|Lack of Efficacy|0
1496394|NCT00498602|4926944|P4|Overall Study|Lack of Efficacy|0
1496395|NCT00498602|4926945|P3|Overall Study|Lack of Efficacy|0
1496396|NCT00498602|4926946|P2|Overall Study|Lack of Efficacy|0
1496397|NCT00498602|4926947|P1|Overall Study|Lack of Efficacy|1
1496398|NCT00498602|4926941|P7|Overall Study|Death|0
1496399|NCT00498602|4926942|P6|Overall Study|Death|1
1496400|NCT00498602|4926943|P5|Overall Study|Death|0
1496401|NCT00498602|4926944|P4|Overall Study|Death|0
1496402|NCT00498602|4926945|P3|Overall Study|Death|0
1496403|NCT00498602|4926946|P2|Overall Study|Death|0
1496404|NCT00498602|4926947|P1|Overall Study|Death|0
1496405|NCT00498485|4926995|P2|Overall Study|Adverse Event|5
1496406|NCT00498485|4926996|P1|Overall Study|Adverse Event|1
1496407|NCT00498433|4927007|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
1496408|NCT00498433|4927008|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
1496409|NCT00498433|4927009|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
1496410|NCT00498433|4927007|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
1496411|NCT00498433|4927008|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
1496412|NCT00498433|4927009|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
1496413|NCT00498433|4927007|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
1496414|NCT00498433|4927008|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
1496415|NCT00498433|4927009|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
1496416|NCT00498433|4927007|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
1496417|NCT00498433|4927008|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
1496418|NCT00498433|4927009|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
1496419|NCT00498368|4927054|P2|Overall Study|Withdrawal by Subject|2
1496420|NCT00498368|4927055|P1|Overall Study|Withdrawal by Subject|3
1496421|NCT00498355|4927067|P1|Overall Study|Lost to Follow-up|1
1496422|NCT00498186|4927075|P1|Overall Study|Other|10
1496423|NCT00498186|4927075|P1|Overall Study|Lost to Follow-up|3
1496424|NCT00498186|4927075|P1|Overall Study|Withdrawal by Subject|18
1496425|NCT00498186|4927075|P1|Overall Study|Unsatisfactory compliance of subject|12
1496426|NCT00498186|4927075|P1|Overall Study|Adverse Event|89
1496427|NCT00498186|4927075|P1|Overall Study|Lack of Efficacy|31
1496428|NCT00498186|4927075|P1|Overall Study|Protocol Violation|10
1496429|NCT00498173|4927082|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
1496430|NCT00498173|4927083|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
1496431|NCT00498173|4927084|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
1496432|NCT00497874|4927114|P2|Overall Study|Unable to schedule|24
1496433|NCT00497874|4927115|P1|Overall Study|Unable to schedule|37
1496434|NCT00497874|4927114|P2|Overall Study|Unable to contact|67
1496435|NCT00497874|4927115|P1|Overall Study|Unable to contact|52
1496436|NCT00497874|4927114|P2|Overall Study|Death|4
1496437|NCT00497874|4927115|P1|Overall Study|Death|2
1496438|NCT00497874|4927114|P2|Overall Study|Illness|4
1496439|NCT00497874|4927115|P1|Overall Study|Illness|8
1496440|NCT00497874|4927114|P2|Overall Study|Withdrawal by Subject|17
1496441|NCT00497874|4927115|P1|Overall Study|Withdrawal by Subject|48
1496442|NCT00497796|4927133|P2|Overall Study|Not applicable (randomized not treated)|4
1496443|NCT00497796|4927134|P1|Overall Study|Not applicable (randomized not treated)|0
1496444|NCT00497796|4927133|P2|Overall Study|Lost to Follow-up|1
1496445|NCT00497796|4927134|P1|Overall Study|Lost to Follow-up|0
1496446|NCT00497796|4927133|P2|Overall Study|Investigator/sponsor discretion|34
1496447|NCT00497796|4927134|P1|Overall Study|Investigator/sponsor discretion|31
1496448|NCT00497796|4927133|P2|Overall Study|Consent withdrawn|3
1496449|NCT00497796|4927134|P1|Overall Study|Consent withdrawn|10
1496450|NCT00497796|4927133|P2|Overall Study|CMV infection or disease treatment|4
1496451|NCT00497796|4927134|P1|Overall Study|CMV infection or disease treatment|30
1496452|NCT00497796|4927133|P2|Overall Study|Adverse event (related)|4
1496453|NCT00497796|4927134|P1|Overall Study|Adverse event (related)|5
1496454|NCT00497796|4927133|P2|Overall Study|Adverse event (not related)|9
1496455|NCT00497796|4927134|P1|Overall Study|Adverse event (not related)|9
1496456|NCT00497198|4927221|P2|Overall Study|Withdrawal by Subject|1
1496457|NCT00497198|4927222|P1|Overall Study|Withdrawal by Subject|0
1496458|NCT00497198|4927221|P2|Overall Study|Physician Decision|2
1496459|NCT00497198|4927222|P1|Overall Study|Physician Decision|1
1496460|NCT00497198|4927221|P2|Overall Study|Adverse Event|2
1496461|NCT00497198|4927222|P1|Overall Study|Adverse Event|4
1496462|NCT00497146|4927238|P2|Long-term Follow-up Period|Other|1
1496463|NCT00497146|4927239|P1|Long-term Follow-up Period|Other|0
1496464|NCT00497146|4927238|P2|Long-term Follow-up Period|Lost to Follow-up|1
1496465|NCT00497146|4927239|P1|Long-term Follow-up Period|Lost to Follow-up|5
1496466|NCT00497146|4927238|P2|Long-term Follow-up Period|Withdrawal by Subject|2
1496467|NCT00497146|4927239|P1|Long-term Follow-up Period|Withdrawal by Subject|8
1496468|NCT00497146|4927238|P2|Long-term Follow-up Period|Adverse Event|2
1496469|NCT00497146|4927239|P1|Long-term Follow-up Period|Adverse Event|2
1496470|NCT00497146|4927238|P2|Treatment Period|Other Reason|3
1496471|NCT00497146|4927239|P1|Treatment Period|Other Reason|2
1496472|NCT00497146|4927238|P2|Treatment Period|Unable to dose reduce per protocol|1
1496473|NCT00497146|4927239|P1|Treatment Period|Unable to dose reduce per protocol|4
1496474|NCT00497146|4927238|P2|Treatment Period|Change in RAAS inhibitor therapy|2
1496475|NCT00497146|4927239|P1|Treatment Period|Change in RAAS inhibitor therapy|5
1496476|NCT00497146|4927238|P2|Treatment Period|Required dialysis|1
1496477|NCT00497146|4927239|P1|Treatment Period|Required dialysis|4
1496478|NCT00497146|4927238|P2|Treatment Period|Lost to Follow-up|3
1496479|NCT00497146|4927239|P1|Treatment Period|Lost to Follow-up|1
1496480|NCT00497146|4927238|P2|Treatment Period|Withdrawal by Subject|9
1496481|NCT00497146|4927239|P1|Treatment Period|Withdrawal by Subject|5
1496482|NCT00497146|4927238|P2|Treatment Period|Adverse Event|2
1496483|NCT00497146|4927239|P1|Treatment Period|Adverse Event|6
1496484|NCT00496964|4927307|P2|Overall Study|Withdrawal by Subject|1
1496485|NCT00496964|4927308|P1|Overall Study|Withdrawal by Subject|0
1496486|NCT00496873|4927326|P1|Overall Study|Withdrawal by Subject|3
1496487|NCT00496873|4927326|P1|Overall Study|Death|2
1496488|NCT00496873|4927326|P1|Overall Study|Ineligible|2
1496489|NCT00496834|4927359|P2|Overall Study|Blood Pressure control failure|1
1496490|NCT00496834|4927360|P1|Overall Study|Blood Pressure control failure|2
1496491|NCT00496834|4927359|P2|Overall Study|Lost to Follow-up|0
1496492|NCT00496834|4927360|P1|Overall Study|Lost to Follow-up|2
1496493|NCT00496834|4927359|P2|Overall Study|IP administration violation|0
1496494|NCT00496834|4927360|P1|Overall Study|IP administration violation|2
1496495|NCT00496834|4927359|P2|Overall Study|Adverse Event|3
1496496|NCT00496834|4927360|P1|Overall Study|Adverse Event|5
1496497|NCT00496834|4927359|P2|Overall Study|Inclusion/exclusion criteria not met|2
1496498|NCT00496834|4927360|P1|Overall Study|Inclusion/exclusion criteria not met|3
1496499|NCT00496834|4927359|P2|Overall Study|Contraindicated medication administered|1
1496500|NCT00496834|4927360|P1|Overall Study|Contraindicated medication administered|0
1496501|NCT00496834|4927359|P2|Overall Study|Withdrawal by Subject|6
1496502|NCT00496834|4927360|P1|Overall Study|Withdrawal by Subject|4
1496503|NCT00496782|4927379|P2|Overall Study|Protocol Violation|2
1496504|NCT00496782|4927380|P1|Overall Study|Protocol Violation|1
1496505|NCT00496769|4927414|P3|Open Label|>=1 reason assigned per patient|1011
1496506|NCT00496769|4927415|P2|Open Label|>=1 reason assigned per patient|0
1496507|NCT00496769|4927416|P1|Open Label|>=1 reason assigned per patient|0
1496508|NCT00496769|4927414|P3|Double Blind|>=1 reason assigned per patient|0
1496509|NCT00496769|4927415|P2|Double Blind|>=1 reason assigned per patient|649
1496510|NCT00496769|4927416|P1|Double Blind|>=1 reason assigned per patient|558
1496511|NCT00496730|4927441|P2|Overall Study|Withdrawal by Subject|2
1496512|NCT00496730|4927442|P1|Overall Study|Withdrawal by Subject|2
1496513|NCT00496730|4927441|P2|Overall Study|Lost to Follow-up|3
1496514|NCT00496730|4927442|P1|Overall Study|Lost to Follow-up|4
1496515|NCT00496626|4927454|P2|Overall Study|Relocated|1
1496516|NCT00496626|4927455|P1|Overall Study|Relocated|0
1496517|NCT00496626|4927454|P2|Overall Study|Withdrawal by Subject|4
1496518|NCT00496626|4927455|P1|Overall Study|Withdrawal by Subject|5
1496519|NCT00496626|4927454|P2|Overall Study|Protocol Violation|0
1496520|NCT00496626|4927455|P1|Overall Study|Protocol Violation|1
1496521|NCT00496626|4927454|P2|Overall Study|Lost to Follow-up|1
1496522|NCT00496626|4927455|P1|Overall Study|Lost to Follow-up|0
1496523|NCT00496587|4927467|P1|Overall Study|Complications unrelated|2
1496524|NCT00496587|4927467|P1|Overall Study|Death|1
1496525|NCT00496587|4927467|P1|Overall Study|Withdrawal by Subject|2
1496526|NCT00496587|4927467|P1|Overall Study|Progressive Disease|24
1496527|NCT00496587|4927467|P1|Overall Study|Adverse Event|2
1496528|NCT00496483|4927473|P1|Overall Study|Lack of Efficacy|1
1496529|NCT00496483|4927473|P1|Overall Study|Adverse Event|2
1496530|NCT00496483|4927473|P1|Overall Study|Not dosed|9
1496531|NCT00496470|4927490|P2|Overall Study|Other reason|2
1496532|NCT00496470|4927491|P1|Overall Study|Other reason|0
1496533|NCT00496470|4927490|P2|Overall Study|Incorrectly enrolled|5
1496534|NCT00496470|4927491|P1|Overall Study|Incorrectly enrolled|13
1496535|NCT00496470|4927490|P2|Overall Study|Withdrawal by Subject|12
1496536|NCT00496470|4927491|P1|Overall Study|Withdrawal by Subject|5
1496537|NCT00496470|4927490|P2|Overall Study|Adverse Event|10
1496538|NCT00496470|4927491|P1|Overall Study|Adverse Event|8
1496539|NCT00496366|4927577|P1|Overall Study|Death|1
1496540|NCT00496197|4927608|P1|Overall Study|Protocol Violation|8
1496541|NCT00496197|4927608|P1|Overall Study|Other|14
1496542|NCT00496197|4927608|P1|Overall Study|Pathogen not isolated baseline specimen|4
1496543|NCT00496197|4927608|P1|Overall Study|Withdrawal by Subject|11
1496544|NCT00496197|4927608|P1|Overall Study|Lost to Follow-up|11
1496545|NCT00496197|4927608|P1|Overall Study|Insufficient bacteriological response|10
1496546|NCT00496197|4927608|P1|Overall Study|Insufficient clinical response|3
1496547|NCT00496197|4927608|P1|Overall Study|Does not meet entrance criteria|5
1496548|NCT00496197|4927608|P1|Overall Study|Adverse Event|13
1496549|NCT00496197|4927608|P1|Overall Study|Discontinued study due to death|43
1496550|NCT00496080|4927635|P1|Overall Study|Physician Decision|6
1496551|NCT00496080|4927635|P1|Overall Study|Withdrawal by Subject|5
1496552|NCT00496080|4927635|P1|Overall Study|Surgical re-intervention|7
1496553|NCT00496080|4927635|P1|Overall Study|Lost to Follow-up|9
1496554|NCT00496054|4927645|P1|Overall Study|Lost to Follow-up|7
1496555|NCT00496054|4927645|P1|Overall Study|Adverse Event|1
1496556|NCT00495820|4927674|P2|Overall Study|Adverse Event|1
1496557|NCT00495820|4927675|P1|Overall Study|Adverse Event|1
1496558|NCT00495794|4927687|P2|Overall Study|Pharmacist did not activate patient|0
1496559|NCT00495794|4927688|P1|Overall Study|Pharmacist did not activate patient|522
1496560|NCT00495755|4927698|P1|Overall Study|Adverse Event|3
1496561|NCT00495677|4927710|P7|Stage 1 (25 Days)|Adverse Event|0
1496562|NCT00495677|4927711|P6|Stage 1 (25 Days)|Adverse Event|0
1496563|NCT00495677|4927712|P5|Stage 1 (25 Days)|Adverse Event|0
1496564|NCT00495677|4927713|P4|Stage 1 (25 Days)|Adverse Event|0
1496565|NCT00495677|4927714|P3|Stage 1 (25 Days)|Adverse Event|1
1496566|NCT00495677|4927715|P2|Stage 1 (25 Days)|Adverse Event|0
1496567|NCT00495677|4927716|P1|Stage 1 (25 Days)|Adverse Event|0
1496568|NCT00495625|4927771|P1|Overall Study|Did not complete at least 1 42 day cycle|10
1496569|NCT00495612|4927782|P2|Overall Study|Subject's Decision to Withdraw|0
1496570|NCT00495612|4927783|P1|Overall Study|Subject's Decision to Withdraw|3
1496571|NCT00495612|4927782|P2|Overall Study|Lost to Follow-up|0
1496572|NCT00495612|4927783|P1|Overall Study|Lost to Follow-up|1
1496573|NCT00495586|4927801|P2|Overall Study|Withdrawal by Subject|4
1496574|NCT00495586|4927802|P1|Overall Study|Withdrawal by Subject|4
1496575|NCT00495521|4927812|P2|Overall Study|Physician Decision|1
1496576|NCT00495521|4927813|P1|Overall Study|Physician Decision|0
1496577|NCT00495495|4927843|P1|Overall Study|Protocol Violation|99
1496578|NCT00495469|4927863|P7|Overall Study|ST depression at randomisation in ECG|0
1496579|NCT00495469|4927864|P6|Overall Study|ST depression at randomisation in ECG|0
1496580|NCT00495469|4927865|P5|Overall Study|ST depression at randomisation in ECG|0
1496581|NCT00495469|4927866|P4|Overall Study|ST depression at randomisation in ECG|0
1496582|NCT00495469|4927867|P3|Overall Study|ST depression at randomisation in ECG|0
1496583|NCT00495469|4927868|P2|Overall Study|ST depression at randomisation in ECG|1
1496584|NCT00495469|4927869|P1|Overall Study|ST depression at randomisation in ECG|0
1496585|NCT00495469|4927863|P7|Overall Study|Liver function test abnormality|0
1496586|NCT00495469|4927864|P6|Overall Study|Liver function test abnormality|0
1496587|NCT00495469|4927865|P5|Overall Study|Liver function test abnormality|0
1496588|NCT00495469|4927866|P4|Overall Study|Liver function test abnormality|0
1496589|NCT00495469|4927867|P3|Overall Study|Liver function test abnormality|0
1496590|NCT00495469|4927868|P2|Overall Study|Liver function test abnormality|1
1496591|NCT00495469|4927869|P1|Overall Study|Liver function test abnormality|0
1496592|NCT00495469|4927863|P7|Overall Study|Lack of Efficacy|1
1496593|NCT00495469|4927864|P6|Overall Study|Lack of Efficacy|0
1496594|NCT00495469|4927865|P5|Overall Study|Lack of Efficacy|0
1496595|NCT00495469|4927866|P4|Overall Study|Lack of Efficacy|0
1496596|NCT00495469|4927867|P3|Overall Study|Lack of Efficacy|0
1496597|NCT00495469|4927868|P2|Overall Study|Lack of Efficacy|0
1496598|NCT00495469|4927869|P1|Overall Study|Lack of Efficacy|0
1496599|NCT00495469|4927863|P7|Overall Study|Withdrawal by Subject|3
1496600|NCT00495469|4927864|P6|Overall Study|Withdrawal by Subject|2
1496601|NCT00495469|4927865|P5|Overall Study|Withdrawal by Subject|3
1496602|NCT00495469|4927866|P4|Overall Study|Withdrawal by Subject|3
1496603|NCT00495469|4927867|P3|Overall Study|Withdrawal by Subject|1
1496604|NCT00495469|4927868|P2|Overall Study|Withdrawal by Subject|3
1496605|NCT00495469|4927869|P1|Overall Study|Withdrawal by Subject|5
1496606|NCT00495469|4927863|P7|Overall Study|Protocol Violation|0
1496607|NCT00495469|4927864|P6|Overall Study|Protocol Violation|2
1496608|NCT00495469|4927865|P5|Overall Study|Protocol Violation|1
1496609|NCT00495469|4927866|P4|Overall Study|Protocol Violation|0
1496610|NCT00495469|4927867|P3|Overall Study|Protocol Violation|0
1496611|NCT00495469|4927868|P2|Overall Study|Protocol Violation|0
1496612|NCT00495469|4927869|P1|Overall Study|Protocol Violation|0
1496613|NCT00495469|4927863|P7|Overall Study|Lost to Follow-up|0
1496614|NCT00495469|4927864|P6|Overall Study|Lost to Follow-up|0
1496615|NCT00495469|4927865|P5|Overall Study|Lost to Follow-up|0
1496616|NCT00495469|4927866|P4|Overall Study|Lost to Follow-up|1
1496617|NCT00495469|4927867|P3|Overall Study|Lost to Follow-up|3
1496618|NCT00495469|4927868|P2|Overall Study|Lost to Follow-up|1
1496619|NCT00495469|4927869|P1|Overall Study|Lost to Follow-up|1
1496620|NCT00495469|4927863|P7|Overall Study|Adverse Event|1
1496621|NCT00495469|4927864|P6|Overall Study|Adverse Event|1
1496622|NCT00495469|4927865|P5|Overall Study|Adverse Event|1
1496623|NCT00495469|4927866|P4|Overall Study|Adverse Event|0
1496624|NCT00495469|4927867|P3|Overall Study|Adverse Event|3
1496625|NCT00495469|4927868|P2|Overall Study|Adverse Event|1
1496626|NCT00495469|4927869|P1|Overall Study|Adverse Event|0
1496627|NCT00495391|4928013|P2|Overall Study|Withdrawal by Subject|3
1496628|NCT00495391|4928014|P1|Overall Study|Withdrawal by Subject|2
1496629|NCT00495391|4928013|P2|Overall Study|Lack of Efficacy|18
1496630|NCT00495391|4928014|P1|Overall Study|Lack of Efficacy|34
1496631|NCT00495131|4928052|P2|Overall Study|Withdrawal by Subject|0
1496632|NCT00495131|4928053|P1|Overall Study|Withdrawal by Subject|1
1496633|NCT00495131|4928052|P2|Overall Study|Lost to Follow-up|2
1496634|NCT00495131|4928053|P1|Overall Study|Lost to Follow-up|0
1496635|NCT00495131|4928052|P2|Overall Study|Lack of Efficacy|2
1496636|NCT00495131|4928053|P1|Overall Study|Lack of Efficacy|0
1496637|NCT00495131|4928052|P2|Overall Study|Adverse Event|2
1496638|NCT00495131|4928053|P1|Overall Study|Adverse Event|6
1496639|NCT00494871|4928081|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
1496640|NCT00494871|4928082|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
1496641|NCT00494871|4928081|P2|Follow-up (FU) Period|Withdrawal by Subject|5
1496642|NCT00494871|4928082|P1|Follow-up (FU) Period|Withdrawal by Subject|5
1496643|NCT00494871|4928081|P2|Follow-up (FU) Period|Protocol Violation|0
1496644|NCT00494871|4928082|P1|Follow-up (FU) Period|Protocol Violation|1
1496645|NCT00494871|4928081|P2|Follow-up (FU) Period|Physician Decision|1
1496646|NCT00494871|4928082|P1|Follow-up (FU) Period|Physician Decision|0
1496647|NCT00494871|4928081|P2|Follow-up (FU) Period|Lost to Follow-up|2
1496648|NCT00494871|4928082|P1|Follow-up (FU) Period|Lost to Follow-up|6
1496649|NCT00494871|4928081|P2|Follow-up (FU) Period|Death|12
1496650|NCT00494871|4928082|P1|Follow-up (FU) Period|Death|13
1496651|NCT00494871|4928081|P2|Follow-up (FU) Period|Adverse Event|1
1496652|NCT00494871|4928082|P1|Follow-up (FU) Period|Adverse Event|1
1496653|NCT00494871|4928081|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
1496654|NCT00494871|4928082|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
1496655|NCT00494871|4928081|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
1496656|NCT00494871|4928082|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
1496657|NCT00494871|4928081|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
1496658|NCT00494871|4928082|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
1496659|NCT00494871|4928081|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
1496660|NCT00494871|4928082|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
1496661|NCT00494871|4928081|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
1496662|NCT00494871|4928082|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
1496663|NCT00494871|4928081|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
1496664|NCT00494871|4928082|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
1496665|NCT00494871|4928081|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
1496666|NCT00494871|4928082|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
1496667|NCT00494871|4928081|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
1496668|NCT00494871|4928082|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
1496669|NCT00494871|4928081|P2|Double-blind (DB) Treatment Period|Physician Decision|13
1496670|NCT00494871|4928082|P1|Double-blind (DB) Treatment Period|Physician Decision|4
1496671|NCT00494871|4928081|P2|Double-blind (DB) Treatment Period|Death|3
1496672|NCT00494871|4928082|P1|Double-blind (DB) Treatment Period|Death|8
1496673|NCT00494871|4928081|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
1496674|NCT00494871|4928082|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
1496675|NCT00494871|4928081|P2|Double-blind (DB) Treatment Period|Adverse Event|70
1496676|NCT00494871|4928082|P1|Double-blind (DB) Treatment Period|Adverse Event|73
1496677|NCT00494780|4928123|P2|Overall Study|Insurance Issues|1
1496678|NCT00494780|4928124|P1|Overall Study|Insurance Issues|0
1496679|NCT00494780|4928123|P2|Overall Study|Residual Tumour Mass|1
1496680|NCT00494780|4928124|P1|Overall Study|Residual Tumour Mass|0
1496681|NCT00494780|4928123|P2|Overall Study|Non-compliance|0
1496682|NCT00494780|4928124|P1|Overall Study|Non-compliance|1
1496683|NCT00494780|4928123|P2|Overall Study|New Treatment|2
1496684|NCT00494780|4928124|P1|Overall Study|New Treatment|2
1496685|NCT00494780|4928123|P2|Overall Study|Progression of Study Disease|8
1496686|NCT00494780|4928124|P1|Overall Study|Progression of Study Disease|7
1496687|NCT00494780|4928123|P2|Overall Study|Withdrew before Dosed|1
1496688|NCT00494780|4928124|P1|Overall Study|Withdrew before Dosed|0
1496689|NCT00494780|4928123|P2|Overall Study|Adverse Event|0
1496690|NCT00494780|4928124|P1|Overall Study|Adverse Event|1
1496691|NCT00494676|4928162|P2|Second Intervention|Withdrawal by Subject|1
1496692|NCT00494676|4928163|P1|Second Intervention|Withdrawal by Subject|1
1496693|NCT00494676|4928162|P2|First Intervention|Withdrawal by Subject|3
1496694|NCT00494676|4928163|P1|First Intervention|Withdrawal by Subject|1
1496695|NCT00494676|4928162|P2|Allocation|Withdrawal by Subject|4
1496696|NCT00494676|4928163|P1|Allocation|Withdrawal by Subject|2
1496697|NCT00494507|4928178|P4|Open-Label Phase|Worsening Disease|2
1496698|NCT00494507|4928179|P3|Open-Label Phase|Worsening Disease|0
1496699|NCT00494507|4928180|P2|Open-Label Phase|Worsening Disease|0
1496700|NCT00494507|4928181|P1|Open-Label Phase|Worsening Disease|0
1496701|NCT00494507|4928178|P4|Open-Label Phase|Adverse Event|3
1496702|NCT00494507|4928179|P3|Open-Label Phase|Adverse Event|5
1496703|NCT00494507|4928180|P2|Open-Label Phase|Adverse Event|1
1496704|NCT00494507|4928181|P1|Open-Label Phase|Adverse Event|0
1496705|NCT00494507|4928178|P4|Double-Blind Phase|Negative DNA test|1
1496706|NCT00494507|4928179|P3|Double-Blind Phase|Negative DNA test|0
1496707|NCT00494507|4928180|P2|Double-Blind Phase|Negative DNA test|0
1496708|NCT00494507|4928181|P1|Double-Blind Phase|Negative DNA test|0
1496709|NCT00494507|4928178|P4|Double-Blind Phase|Subject Non-compliance|0
1496710|NCT00494507|4928179|P3|Double-Blind Phase|Subject Non-compliance|1
1496711|NCT00494507|4928180|P2|Double-Blind Phase|Subject Non-compliance|0
1496712|NCT00494507|4928181|P1|Double-Blind Phase|Subject Non-compliance|0
1496713|NCT00494507|4928178|P4|Double-Blind Phase|Withdrawal by Subject|0
1496714|NCT00494507|4928179|P3|Double-Blind Phase|Withdrawal by Subject|0
1496715|NCT00494507|4928180|P2|Double-Blind Phase|Withdrawal by Subject|0
1496716|NCT00494507|4928181|P1|Double-Blind Phase|Withdrawal by Subject|1
1496717|NCT00494507|4928178|P4|Double-Blind Phase|Adverse Event|0
1496718|NCT00494507|4928179|P3|Double-Blind Phase|Adverse Event|1
1496719|NCT00494507|4928180|P2|Double-Blind Phase|Adverse Event|0
1496720|NCT00494507|4928181|P1|Double-Blind Phase|Adverse Event|2
1496721|NCT00494481|4928248|P2|Overall Study|Never received IP|0
1496722|NCT00494481|4928249|P1|Overall Study|Never received IP|2
1496723|NCT00494481|4928248|P2|Overall Study|Other|0
1496724|NCT00494481|4928249|P1|Overall Study|Other|1
1496725|NCT00494481|4928248|P2|Overall Study|Adverse Event|11
1496726|NCT00494481|4928249|P1|Overall Study|Adverse Event|15
1496727|NCT00494481|4928248|P2|Overall Study|Condition under investigation worsened|13
1496728|NCT00494481|4928249|P1|Overall Study|Condition under investigation worsened|11
1496729|NCT00494442|4928257|P2|Overall Study|Intercurrent illness|1
1496730|NCT00494442|4928258|P1|Overall Study|Intercurrent illness|0
1496731|NCT00494442|4928257|P2|Overall Study|Non-compliance|1
1496732|NCT00494442|4928258|P1|Overall Study|Non-compliance|0
1496733|NCT00494442|4928257|P2|Overall Study|Physician Decision|1
1496734|NCT00494442|4928258|P1|Overall Study|Physician Decision|0
1496735|NCT00494442|4928257|P2|Overall Study|Adverse Event|2
1496736|NCT00494442|4928258|P1|Overall Study|Adverse Event|0
1496737|NCT00494442|4928257|P2|Overall Study|Lack of Efficacy|10
1496738|NCT00494442|4928258|P1|Overall Study|Lack of Efficacy|16
1496739|NCT00494442|4928257|P2|Overall Study|Death|1
1496740|NCT00494442|4928258|P1|Overall Study|Death|1
1496741|NCT00494299|4928274|P2|Overall Study|Protocol Driven Decision Point|22
1496742|NCT00494299|4928275|P1|Overall Study|Protocol Driven Decision Point|11
1496743|NCT00494299|4928274|P2|Overall Study|Site Closed by Sponsor|0
1496744|NCT00494299|4928275|P1|Overall Study|Site Closed by Sponsor|6
1496745|NCT00494299|4928274|P2|Overall Study|Participant Did Not Take Study Drug|2
1496746|NCT00494299|4928275|P1|Overall Study|Participant Did Not Take Study Drug|0
1496747|NCT00494299|4928274|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
1496748|NCT00494299|4928275|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
1496749|NCT00494299|4928274|P2|Overall Study|Withdrawal by Subject|3
1496750|NCT00494299|4928275|P1|Overall Study|Withdrawal by Subject|8
1496751|NCT00494299|4928274|P2|Overall Study|Protocol Violation|2
1496752|NCT00494299|4928275|P1|Overall Study|Protocol Violation|1
1496753|NCT00494299|4928274|P2|Overall Study|Physician Decision|2
1496754|NCT00494299|4928275|P1|Overall Study|Physician Decision|0
1496755|NCT00494299|4928274|P2|Overall Study|Lost to Follow-up|0
1496756|NCT00494299|4928275|P1|Overall Study|Lost to Follow-up|1
1496757|NCT00494299|4928274|P2|Overall Study|Adverse Event|13
1496758|NCT00494299|4928275|P1|Overall Study|Adverse Event|93
1496759|NCT00494234|4928287|P2|Overall Study|Death|1
1496760|NCT00494234|4928288|P1|Overall Study|Death|2
1496761|NCT00494234|4928287|P2|Overall Study|Withdrawal by Subject|0
1496762|NCT00494234|4928288|P1|Overall Study|Withdrawal by Subject|1
1496763|NCT00494234|4928287|P2|Overall Study|Lack of Efficacy|9
1496764|NCT00494234|4928288|P1|Overall Study|Lack of Efficacy|12
1496765|NCT00494221|4928307|P3|Overall Study|Withdrawal by Subject|0
1496766|NCT00494221|4928308|P2|Overall Study|Withdrawal by Subject|2
1496767|NCT00494221|4928309|P1|Overall Study|Withdrawal by Subject|1
1496768|NCT00494221|4928307|P3|Overall Study|Death|14
1496769|NCT00494221|4928308|P2|Overall Study|Death|9
1496770|NCT00494221|4928309|P1|Overall Study|Death|15
1496771|NCT00494091|4928350|P2|Overall Study|Withdrawal by Subject|7
1496772|NCT00494091|4928351|P1|Overall Study|Withdrawal by Subject|0
1496773|NCT00494091|4928350|P2|Overall Study|Not Specified|11
1496774|NCT00494091|4928351|P1|Overall Study|Not Specified|1
1496775|NCT00494091|4928350|P2|Overall Study|Lost to Follow-up|4
1496776|NCT00494091|4928351|P1|Overall Study|Lost to Follow-up|0
1496777|NCT00494091|4928350|P2|Overall Study|Death|54
1496778|NCT00494091|4928351|P1|Overall Study|Death|5
1496779|NCT00494026|4928373|P1|Overall Study|Sponsor Decision|4
1496780|NCT00494013|4928383|P2|Overall Study|Sponsor Decision|1
1496781|NCT00494013|4928384|P1|Overall Study|Sponsor Decision|0
1496782|NCT00494013|4928383|P2|Overall Study|Withdrawal by Subject|14
1496783|NCT00494013|4928384|P1|Overall Study|Withdrawal by Subject|13
1496784|NCT00494013|4928383|P2|Overall Study|Protocol Violation|5
1496785|NCT00494013|4928384|P1|Overall Study|Protocol Violation|8
1496786|NCT00494013|4928383|P2|Overall Study|Physician Decision|5
1496787|NCT00494013|4928384|P1|Overall Study|Physician Decision|3
1496788|NCT00494013|4928383|P2|Overall Study|Lost to Follow-up|6
1496789|NCT00494013|4928384|P1|Overall Study|Lost to Follow-up|5
1496790|NCT00494013|4928383|P2|Overall Study|Entry Criteria Not Met|4
1496791|NCT00494013|4928384|P1|Overall Study|Entry Criteria Not Met|1
1496792|NCT00494013|4928383|P2|Overall Study|Adverse Event|1
1496793|NCT00494013|4928384|P1|Overall Study|Adverse Event|0
1496794|NCT00493974|4928414|P2|Overall Study|Lost to Follow-up|6
1496795|NCT00493974|4928415|P1|Overall Study|Lost to Follow-up|4
1496796|NCT00493974|4928414|P2|Overall Study|Withdrawal by Subject|6
1496797|NCT00493974|4928415|P1|Overall Study|Withdrawal by Subject|8
1496798|NCT00493974|4928414|P2|Overall Study|Death|2
1496799|NCT00493974|4928415|P1|Overall Study|Death|1
1496800|NCT00493779|4928442|P1|Overall Study|Logistical issue at site|1
1496801|NCT00493649|4928449|P1|Overall Study|Other|13
1496802|NCT00493649|4928449|P1|Overall Study|Lost to Follow-up|1
1496803|NCT00493649|4928449|P1|Overall Study|Disease Progression|1
1496804|NCT00493649|4928449|P1|Overall Study|Investigator Request|2
1496805|NCT00493649|4928449|P1|Overall Study|Patient Request|21
1496806|NCT00493649|4928449|P1|Overall Study|Adverse Event|44
1496807|NCT00493636|4928462|P2|Overall Study|Mis-randomization|1
1496808|NCT00493636|4928463|P1|Overall Study|Mis-randomization|1
1496809|NCT00493636|4928462|P2|Overall Study|Disease progression/recurrence/relapse|1
1496810|NCT00493636|4928463|P1|Overall Study|Disease progression/recurrence/relapse|0
1496811|NCT00493636|4928462|P2|Overall Study|Withdrawal by Subject|0
1496812|NCT00493636|4928463|P1|Overall Study|Withdrawal by Subject|1
1496813|NCT00493454|4928477|P1|Overall Study|Withdrawal by Subject|1
1496814|NCT00493311|4928483|P2|Overall Study|Need for rescue medication|2
1496815|NCT00493311|4928484|P1|Overall Study|Need for rescue medication|2
1496816|NCT00493285|4928504|P6|Overall Study|Lost to Follow-up|0
1496817|NCT00493285|4928505|P5|Overall Study|Lost to Follow-up|1
1496818|NCT00493285|4928506|P4|Overall Study|Lost to Follow-up|0
1496819|NCT00493285|4928507|P3|Overall Study|Lost to Follow-up|0
1496820|NCT00493285|4928508|P2|Overall Study|Lost to Follow-up|0
1496821|NCT00493285|4928509|P1|Overall Study|Lost to Follow-up|0
1496822|NCT00493246|4928741|P8|Overall Study|Lost to Follow-up|0
1496823|NCT00493246|4928742|P7|Overall Study|Lost to Follow-up|1
1496824|NCT00493246|4928743|P6|Overall Study|Lost to Follow-up|0
1496825|NCT00493246|4928744|P5|Overall Study|Lost to Follow-up|0
1496826|NCT00493246|4928745|P4|Overall Study|Lost to Follow-up|0
1496827|NCT00493246|4928746|P3|Overall Study|Lost to Follow-up|0
1496828|NCT00493246|4928747|P2|Overall Study|Lost to Follow-up|0
1496829|NCT00493246|4928748|P1|Overall Study|Lost to Follow-up|0
1496830|NCT00493246|4928741|P8|Overall Study|No access to draw blood|0
1496831|NCT00493246|4928742|P7|Overall Study|No access to draw blood|0
1496832|NCT00493246|4928743|P6|Overall Study|No access to draw blood|1
1496833|NCT00493246|4928744|P5|Overall Study|No access to draw blood|0
1496834|NCT00493246|4928745|P4|Overall Study|No access to draw blood|0
1496835|NCT00493246|4928746|P3|Overall Study|No access to draw blood|0
1496836|NCT00493246|4928747|P2|Overall Study|No access to draw blood|0
1496837|NCT00493246|4928748|P1|Overall Study|No access to draw blood|0
1496838|NCT00493246|4928741|P8|Overall Study|Withdrawal by Subject|0
1496839|NCT00493246|4928742|P7|Overall Study|Withdrawal by Subject|0
1496840|NCT00493246|4928743|P6|Overall Study|Withdrawal by Subject|0
1496841|NCT00493246|4928744|P5|Overall Study|Withdrawal by Subject|1
1496842|NCT00493246|4928745|P4|Overall Study|Withdrawal by Subject|0
1496843|NCT00493246|4928746|P3|Overall Study|Withdrawal by Subject|0
1496844|NCT00493246|4928747|P2|Overall Study|Withdrawal by Subject|0
1496845|NCT00493246|4928748|P1|Overall Study|Withdrawal by Subject|0
1496846|NCT00493220|4928812|P6|Third Intervention|Withdrawal by Subject|0
1496847|NCT00493220|4928813|P5|Third Intervention|Withdrawal by Subject|0
1496848|NCT00493220|4928814|P4|Third Intervention|Withdrawal by Subject|0
1496849|NCT00493220|4928815|P3|Third Intervention|Withdrawal by Subject|0
1496850|NCT00493220|4928816|P2|Third Intervention|Withdrawal by Subject|0
1496851|NCT00493220|4928817|P1|Third Intervention|Withdrawal by Subject|1
1496852|NCT00493038|4928840|P2|Follow-up|Lost to Follow-up|0
1496853|NCT00493038|4928841|P1|Follow-up|Lost to Follow-up|1
1496854|NCT00493038|4928840|P2|Treatment|Other|1
1496855|NCT00493038|4928841|P1|Treatment|Other|0
1496856|NCT00493038|4928840|P2|Treatment|Withdrawal by Subject|12
1496857|NCT00493038|4928841|P1|Treatment|Withdrawal by Subject|11
1496858|NCT00493038|4928840|P2|Treatment|Lost to Follow-up|3
1496859|NCT00493038|4928841|P1|Treatment|Lost to Follow-up|5
1496860|NCT00493038|4928840|P2|Treatment|Adverse Event|4
1496861|NCT00493038|4928841|P1|Treatment|Adverse Event|8
1496862|NCT00493012|4928857|P2|Overall Study|Lost to Follow-up|17
1496863|NCT00493012|4928858|P1|Overall Study|Lost to Follow-up|18
1496864|NCT00492856|4928901|P4|Post-consolidation|Observation Arm|0
1496865|NCT00492856|4928902|P3|Post-consolidation|Observation Arm|27
1496866|NCT00492856|4928903|P2|Post-consolidation|Observation Arm|0
1496867|NCT00492856|4928904|P1|Post-consolidation|Observation Arm|0
1496868|NCT00492856|4928901|P4|Post-consolidation|Lost to Follow-up|0
1496869|NCT00492856|4928902|P3|Post-consolidation|Lost to Follow-up|0
1496870|NCT00492856|4928903|P2|Post-consolidation|Lost to Follow-up|2
1496871|NCT00492856|4928904|P1|Post-consolidation|Lost to Follow-up|0
1496872|NCT00492856|4928901|P4|Post-consolidation|Not protocol specified|0
1496873|NCT00492856|4928902|P3|Post-consolidation|Not protocol specified|0
1496874|NCT00492856|4928903|P2|Post-consolidation|Not protocol specified|1
1496875|NCT00492856|4928904|P1|Post-consolidation|Not protocol specified|0
1496876|NCT00492856|4928901|P4|Post-consolidation|Death|0
1496877|NCT00492856|4928902|P3|Post-consolidation|Death|0
1496878|NCT00492856|4928903|P2|Post-consolidation|Death|1
1496879|NCT00492856|4928904|P1|Post-consolidation|Death|0
1496880|NCT00492856|4928901|P4|Post-consolidation|Withdrawal by Subject|0
1496881|NCT00492856|4928902|P3|Post-consolidation|Withdrawal by Subject|0
1496882|NCT00492856|4928903|P2|Post-consolidation|Withdrawal by Subject|4
1496883|NCT00492856|4928904|P1|Post-consolidation|Withdrawal by Subject|0
1496884|NCT00492856|4928901|P4|Post-consolidation|Adverse Event|1
1496885|NCT00492856|4928902|P3|Post-consolidation|Adverse Event|0
1496886|NCT00492856|4928903|P2|Post-consolidation|Adverse Event|4
1496887|NCT00492856|4928904|P1|Post-consolidation|Adverse Event|0
1496888|NCT00492856|4928901|P4|Consolidation|Lost to Follow-up|0
1496889|NCT00492856|4928902|P3|Consolidation|Lost to Follow-up|0
1496890|NCT00492856|4928903|P2|Consolidation|Lost to Follow-up|0
1496891|NCT00492856|4928904|P1|Consolidation|Lost to Follow-up|1
1496892|NCT00492856|4928901|P4|Consolidation|Not protocol specified|0
1496893|NCT00492856|4928902|P3|Consolidation|Not protocol specified|0
1496894|NCT00492856|4928903|P2|Consolidation|Not protocol specified|0
1496895|NCT00492856|4928904|P1|Consolidation|Not protocol specified|2
1496896|NCT00492856|4928901|P4|Consolidation|Adverse Event|0
1496897|NCT00492856|4928902|P3|Consolidation|Adverse Event|0
1496898|NCT00492856|4928903|P2|Consolidation|Adverse Event|0
1496899|NCT00492856|4928904|P1|Consolidation|Adverse Event|6
1496900|NCT00492856|4928901|P4|Induction|Death|0
1496901|NCT00492856|4928902|P3|Induction|Death|0
1496902|NCT00492856|4928903|P2|Induction|Death|0
1496903|NCT00492856|4928904|P1|Induction|Death|3
1496904|NCT00492856|4928901|P4|Induction|Withdrawal by Subject|0
1496905|NCT00492856|4928902|P3|Induction|Withdrawal by Subject|0
1496906|NCT00492856|4928903|P2|Induction|Withdrawal by Subject|0
1496907|NCT00492856|4928904|P1|Induction|Withdrawal by Subject|1
1496908|NCT00492856|4928901|P4|Induction|Adverse Event|0
1496909|NCT00492856|4928902|P3|Induction|Adverse Event|0
1496910|NCT00492856|4928903|P2|Induction|Adverse Event|0
1496911|NCT00492856|4928904|P1|Induction|Adverse Event|2
1496912|NCT00492752|4928918|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
1496913|NCT00492752|4928919|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
1496914|NCT00492752|4928920|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
1496915|NCT00492752|4928921|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
1496916|NCT00492752|4928918|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
1496917|NCT00492752|4928919|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
1496918|NCT00492752|4928920|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
1496919|NCT00492752|4928921|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
1496920|NCT00492752|4928918|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
1496921|NCT00492752|4928919|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
1496922|NCT00492752|4928920|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
1496923|NCT00492752|4928921|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
1496924|NCT00492752|4928918|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
1496925|NCT00492752|4928919|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
1496926|NCT00492752|4928920|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
1496927|NCT00492752|4928921|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
1496928|NCT00492752|4928918|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
1496929|NCT00492752|4928919|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
1496930|NCT00492752|4928920|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
1496931|NCT00492752|4928921|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
1496932|NCT00492752|4928918|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
1496933|NCT00492752|4928919|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
1496934|NCT00492752|4928920|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
1496935|NCT00492752|4928921|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
1496936|NCT00492752|4928918|P4|Follow-up and/or Open Label Sorafenib|Death|1
1496937|NCT00492752|4928919|P3|Follow-up and/or Open Label Sorafenib|Death|45
1496938|NCT00492752|4928920|P2|Follow-up and/or Open Label Sorafenib|Death|5
1496939|NCT00492752|4928921|P1|Follow-up and/or Open Label Sorafenib|Death|75
1496940|NCT00492752|4928918|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
1496941|NCT00492752|4928919|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
1496942|NCT00492752|4928920|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
1496943|NCT00492752|4928921|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
1496944|NCT00492752|4928918|P4|Double Blind Treatment|Protocol Violation|0
1496945|NCT00492752|4928919|P3|Double Blind Treatment|Protocol Violation|1
1496946|NCT00492752|4928920|P2|Double Blind Treatment|Protocol Violation|0
1496947|NCT00492752|4928921|P1|Double Blind Treatment|Protocol Violation|0
1496948|NCT00492752|4928918|P4|Double Blind Treatment|Adverse Event|0
1496949|NCT00492752|4928919|P3|Double Blind Treatment|Adverse Event|0
1496950|NCT00492752|4928920|P2|Double Blind Treatment|Adverse Event|0
1496951|NCT00492752|4928921|P1|Double Blind Treatment|Adverse Event|1
1496952|NCT00492752|4928918|P4|Double Blind Treatment|Death|0
1496953|NCT00492752|4928919|P3|Double Blind Treatment|Death|2
1496954|NCT00492752|4928920|P2|Double Blind Treatment|Death|0
1496955|NCT00492752|4928921|P1|Double Blind Treatment|Death|13
1496956|NCT00492726|4928956|P2|Overall Study|Non compliant with study medication|3
1496957|NCT00492726|4928957|P1|Overall Study|Non compliant with study medication|0
1496958|NCT00492726|4928956|P2|Overall Study|Withdrawal by Subject|3
1496959|NCT00492726|4928957|P1|Overall Study|Withdrawal by Subject|6
1496960|NCT00492726|4928956|P2|Overall Study|Physician Decision|1
1496961|NCT00492726|4928957|P1|Overall Study|Physician Decision|0
1496962|NCT00492726|4928956|P2|Overall Study|Lost to Follow-up|19
1496963|NCT00492726|4928957|P1|Overall Study|Lost to Follow-up|27
1496964|NCT00492726|4928956|P2|Overall Study|Lack of Efficacy|2
1496965|NCT00492726|4928957|P1|Overall Study|Lack of Efficacy|0
1496966|NCT00492726|4928956|P2|Overall Study|Death|2
1496967|NCT00492726|4928957|P1|Overall Study|Death|7
1496968|NCT00492726|4928956|P2|Overall Study|Adverse Event|6
1496969|NCT00492726|4928957|P1|Overall Study|Adverse Event|10
1496970|NCT00492557|4929002|P2|Overall Study|Lost to Follow-up|1
1496971|NCT00492557|4929003|P1|Overall Study|Lost to Follow-up|0
1496972|NCT00492557|4929002|P2|Overall Study|Failed to return|0
1496973|NCT00492557|4929003|P1|Overall Study|Failed to return|1
1496974|NCT00492557|4929002|P2|Overall Study|Adverse Event|0
1496975|NCT00492557|4929003|P1|Overall Study|Adverse Event|1
1496976|NCT00492557|4929002|P2|Overall Study|Death|1
1496977|NCT00492557|4929003|P1|Overall Study|Death|1
1496978|NCT00492557|4929002|P2|Overall Study|Other|2
1496979|NCT00492557|4929003|P1|Overall Study|Other|2
1496980|NCT00492557|4929002|P2|Overall Study|Protocol Violation|8
1496981|NCT00492557|4929003|P1|Overall Study|Protocol Violation|7
1496982|NCT00492557|4929002|P2|Overall Study|Subject request|11
1496983|NCT00492557|4929003|P1|Overall Study|Subject request|12
1496984|NCT00492531|4929033|P2|Overall Study|Withdrawn(More than one reason selected)|23
1496985|NCT00492531|4929034|P1|Overall Study|Withdrawn(More than one reason selected)|22
1496986|NCT00492297|4929107|P1|Survival Only Follow-up|Study terminated by sponsor|12
1496987|NCT00492297|4929107|P1|Survival Only Follow-up|Lack of Efficacy|1
1496988|NCT00492297|4929107|P1|Survival Only Follow-up|Death|46
1496989|NCT00492297|4929107|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
1496990|NCT00492297|4929107|P1|Active Follow-up 30(+4) Days Duration|Death|17
1496991|NCT00492297|4929107|P1|Treatment|Study terminated by sponsor|3
1496992|NCT00492297|4929107|P1|Treatment|Death|2
1496993|NCT00492284|4929125|P4|Overall Study|Withdrawal by Subject|2
1496994|NCT00492284|4929126|P3|Overall Study|Withdrawal by Subject|0
1496995|NCT00492284|4929127|P2|Overall Study|Withdrawal by Subject|0
1496996|NCT00492284|4929128|P1|Overall Study|Withdrawal by Subject|1
1496997|NCT00492284|4929125|P4|Overall Study|Death|5
1496998|NCT00492284|4929126|P3|Overall Study|Death|2
1496999|NCT00492284|4929127|P2|Overall Study|Death|3
1497000|NCT00492284|4929128|P1|Overall Study|Death|0
1497001|NCT00492284|4929125|P4|Overall Study|Lost to Follow-up|1
1497002|NCT00492284|4929126|P3|Overall Study|Lost to Follow-up|3
1497003|NCT00492284|4929127|P2|Overall Study|Lost to Follow-up|0
1497004|NCT00492284|4929128|P1|Overall Study|Lost to Follow-up|0
1497005|NCT00492284|4929125|P4|Overall Study|Adverse Event|2
1497006|NCT00492284|4929126|P3|Overall Study|Adverse Event|1
1497007|NCT00492284|4929127|P2|Overall Study|Adverse Event|1
1497008|NCT00492284|4929128|P1|Overall Study|Adverse Event|0
1497009|NCT00492232|4929172|P2|Open-Label Treatment|Withdrawal by Subject|0
1497010|NCT00492232|4929173|P1|Open-Label Treatment|Withdrawal by Subject|1
1497011|NCT00492232|4929172|P2|Double-Blind Treatment|Randomized not treated|0
1497012|NCT00492232|4929173|P1|Double-Blind Treatment|Randomized not treated|1
1497013|NCT00492232|4929172|P2|Double-Blind Treatment|Other|5
1497014|NCT00492232|4929173|P1|Double-Blind Treatment|Other|6
1497015|NCT00492232|4929172|P2|Double-Blind Treatment|Lack of Efficacy|0
1497016|NCT00492232|4929173|P1|Double-Blind Treatment|Lack of Efficacy|1
1497017|NCT00492232|4929172|P2|Double-Blind Treatment|Withdrawal by Subject|8
1497018|NCT00492232|4929173|P1|Double-Blind Treatment|Withdrawal by Subject|4
1497019|NCT00492232|4929172|P2|Double-Blind Treatment|Lost to Follow-up|3
1497020|NCT00492232|4929173|P1|Double-Blind Treatment|Lost to Follow-up|2
1497021|NCT00492232|4929172|P2|Double-Blind Treatment|Protocol Violation|7
1497022|NCT00492232|4929173|P1|Double-Blind Treatment|Protocol Violation|3
1497023|NCT00492232|4929172|P2|Double-Blind Treatment|Adverse Event|2
1497024|NCT00492232|4929173|P1|Double-Blind Treatment|Adverse Event|1
1497025|NCT00492232|4929172|P2|Placebo Run-in|Missing|2
1497026|NCT00492232|4929173|P1|Placebo Run-in|Missing|0
1497027|NCT00492232|4929172|P2|Placebo Run-in|Other|6
1497028|NCT00492232|4929173|P1|Placebo Run-in|Other|0
1497029|NCT00492232|4929172|P2|Placebo Run-in|Entrance criteria not met|45
1497030|NCT00492232|4929173|P1|Placebo Run-in|Entrance criteria not met|0
1497031|NCT00492232|4929172|P2|Placebo Run-in|Pregnancy|1
1497032|NCT00492232|4929173|P1|Placebo Run-in|Pregnancy|0
1497033|NCT00492232|4929172|P2|Placebo Run-in|Withdrawal by Subject|8
1497034|NCT00492232|4929173|P1|Placebo Run-in|Withdrawal by Subject|0
1497035|NCT00492232|4929172|P2|Placebo Run-in|Lost to Follow-up|3
1497036|NCT00492232|4929173|P1|Placebo Run-in|Lost to Follow-up|0
1497037|NCT00492232|4929172|P2|Placebo Run-in|Protocol Violation|3
1497038|NCT00492232|4929173|P1|Placebo Run-in|Protocol Violation|0
1497039|NCT00492232|4929172|P2|Placebo Run-in|Adverse Event|2
1497040|NCT00492232|4929173|P1|Placebo Run-in|Adverse Event|0
1497041|NCT00492115|4929214|P2|Overall Study|Withdrawal by Subject|4
1497042|NCT00492115|4929215|P1|Overall Study|Withdrawal by Subject|3
1497043|NCT00492063|4929236|P4|Overall Study|Protocol Violation|1
1497044|NCT00492063|4929237|P3|Overall Study|Protocol Violation|0
1497045|NCT00492063|4929238|P2|Overall Study|Protocol Violation|0
1497046|NCT00492063|4929239|P1|Overall Study|Protocol Violation|0
1497047|NCT00492063|4929236|P4|Overall Study|Lost to Follow-up|3
1497048|NCT00492063|4929237|P3|Overall Study|Lost to Follow-up|5
1497049|NCT00492063|4929238|P2|Overall Study|Lost to Follow-up|11
1497050|NCT00492063|4929239|P1|Overall Study|Lost to Follow-up|6
1497051|NCT00492063|4929236|P4|Overall Study|Withdrawal by Subject|4
1497052|NCT00492063|4929237|P3|Overall Study|Withdrawal by Subject|5
1497053|NCT00492063|4929238|P2|Overall Study|Withdrawal by Subject|3
1497054|NCT00492063|4929239|P1|Overall Study|Withdrawal by Subject|4
1497055|NCT00492063|4929236|P4|Overall Study|Death|2
1497056|NCT00492063|4929237|P3|Overall Study|Death|1
1497057|NCT00492063|4929238|P2|Overall Study|Death|0
1497058|NCT00492063|4929239|P1|Overall Study|Death|0
1497059|NCT00492024|4929263|P2|Follow up|Lost to Follow-up|1
1497060|NCT00492024|4929264|P1|Follow up|Lost to Follow-up|1
1497061|NCT00492024|4929263|P2|Follow up|Lack of Efficacy|1
1497062|NCT00492024|4929264|P1|Follow up|Lack of Efficacy|0
1497063|NCT00492024|4929263|P2|Treatment|Withdrawal by Subject|0
1497064|NCT00492024|4929264|P1|Treatment|Withdrawal by Subject|2
1497065|NCT00492024|4929263|P2|Treatment|Lost to Follow-up|1
1497066|NCT00492024|4929264|P1|Treatment|Lost to Follow-up|3
1497067|NCT00492024|4929263|P2|Treatment|Lack of Efficacy|20
1497068|NCT00492024|4929264|P1|Treatment|Lack of Efficacy|21
1497069|NCT00492024|4929263|P2|Treatment|Adverse Event|1
1497070|NCT00492024|4929264|P1|Treatment|Adverse Event|3
1497071|NCT00491894|4929280|P1|Overall Study|Other-Intake of prohibited medication|1
1497072|NCT00491894|4929280|P1|Overall Study|Protocol Violation|2
1497073|NCT00491894|4929280|P1|Overall Study|Physician Decision|2
1497074|NCT00491894|4929280|P1|Overall Study|Other-Failed to meet any criteria|2
1497075|NCT00491894|4929280|P1|Overall Study|Lack of Efficacy|2
1497076|NCT00491894|4929280|P1|Overall Study|Lost to Follow-up|3
1497077|NCT00491894|4929280|P1|Overall Study|Death|3
1497078|NCT00491894|4929280|P1|Overall Study|Withdrawal by Subject|5
1497079|NCT00491894|4929280|P1|Overall Study|Adverse Event|14
1497080|NCT00491764|4929307|P6|Overall Study|Administrative|0
1497081|NCT00491764|4929308|P5|Overall Study|Administrative|0
1497082|NCT00491764|4929309|P4|Overall Study|Administrative|1
1497083|NCT00491764|4929310|P3|Overall Study|Administrative|2
1497084|NCT00491764|4929311|P2|Overall Study|Administrative|0
1497085|NCT00491764|4929312|P1|Overall Study|Administrative|1
1497086|NCT00491764|4929307|P6|Overall Study|Did not Meet Protocol Eligibility|1
1497087|NCT00491764|4929308|P5|Overall Study|Did not Meet Protocol Eligibility|1
1497088|NCT00491764|4929309|P4|Overall Study|Did not Meet Protocol Eligibility|0
1497089|NCT00491764|4929310|P3|Overall Study|Did not Meet Protocol Eligibility|1
1497090|NCT00491764|4929311|P2|Overall Study|Did not Meet Protocol Eligibility|1
1497091|NCT00491764|4929312|P1|Overall Study|Did not Meet Protocol Eligibility|0
1497092|NCT00491764|4929307|P6|Overall Study|Non Compliance with the Protocol|0
1497093|NCT00491764|4929308|P5|Overall Study|Non Compliance with the Protocol|0
1497094|NCT00491764|4929309|P4|Overall Study|Non Compliance with the Protocol|0
1497095|NCT00491764|4929310|P3|Overall Study|Non Compliance with the Protocol|0
1497096|NCT00491764|4929311|P2|Overall Study|Non Compliance with the Protocol|0
1497097|NCT00491764|4929312|P1|Overall Study|Non Compliance with the Protocol|1
1497098|NCT00491764|4929307|P6|Overall Study|Withdrawal by Subject|4
1497099|NCT00491764|4929308|P5|Overall Study|Withdrawal by Subject|2
1497100|NCT00491764|4929309|P4|Overall Study|Withdrawal by Subject|2
1497101|NCT00491764|4929310|P3|Overall Study|Withdrawal by Subject|1
1497102|NCT00491764|4929311|P2|Overall Study|Withdrawal by Subject|3
1497103|NCT00491764|4929312|P1|Overall Study|Withdrawal by Subject|2
1497104|NCT00491764|4929307|P6|Overall Study|Lost to Follow-up|3
1497105|NCT00491764|4929308|P5|Overall Study|Lost to Follow-up|0
1497106|NCT00491764|4929309|P4|Overall Study|Lost to Follow-up|1
1497107|NCT00491764|4929310|P3|Overall Study|Lost to Follow-up|0
1497108|NCT00491764|4929311|P2|Overall Study|Lost to Follow-up|1
1497109|NCT00491764|4929312|P1|Overall Study|Lost to Follow-up|0
1497110|NCT00491764|4929307|P6|Overall Study|Adverse Event|1
1497111|NCT00491764|4929308|P5|Overall Study|Adverse Event|0
1497112|NCT00491764|4929309|P4|Overall Study|Adverse Event|4
1497113|NCT00491764|4929310|P3|Overall Study|Adverse Event|4
1497114|NCT00491764|4929311|P2|Overall Study|Adverse Event|2
1497115|NCT00491764|4929312|P1|Overall Study|Adverse Event|1
1497116|NCT00491608|4929360|P1|Overall Study|Withdrawal by Subject|1
1497117|NCT00491608|4929360|P1|Overall Study|Death|2
1497118|NCT00491556|4929371|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
1497119|NCT00491556|4929372|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
1497120|NCT00491556|4929371|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
1497121|NCT00491556|4929372|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
1497122|NCT00491556|4929371|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|0
1497123|NCT00491556|4929372|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|2
1497124|NCT00491556|4929371|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
1497125|NCT00491556|4929372|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
1497126|NCT00491556|4929371|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
1497127|NCT00491556|4929372|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
1497128|NCT00491556|4929371|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
1497129|NCT00491556|4929372|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
1497130|NCT00491556|4929371|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
1497131|NCT00491556|4929372|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
1497132|NCT00491556|4929371|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
1497133|NCT00491556|4929372|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
1497134|NCT00491556|4929371|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
1497135|NCT00491556|4929372|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
1497136|NCT00491556|4929371|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
1497137|NCT00491556|4929372|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
1497138|NCT00491556|4929371|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
1497139|NCT00491556|4929372|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
1497140|NCT00491556|4929371|P2|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|0
1497141|NCT00491556|4929372|P1|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|3
1497142|NCT00491556|4929371|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
1497143|NCT00491556|4929372|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
1497144|NCT00491556|4929371|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
1497145|NCT00491556|4929372|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
1497146|NCT00491556|4929371|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
1497147|NCT00491556|4929372|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
1497148|NCT00491556|4929371|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
1497149|NCT00491556|4929372|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
1497150|NCT00491556|4929371|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
1497151|NCT00491556|4929372|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
1497152|NCT00491556|4929371|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
1497153|NCT00491556|4929372|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
1497154|NCT00491556|4929371|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
1497155|NCT00491556|4929372|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
1497156|NCT00491556|4929371|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
1497157|NCT00491556|4929372|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
1497158|NCT00491530|4929431|P3|Overall Study|Use of Prohibited Medication|1
1497159|NCT00491530|4929432|P2|Overall Study|Use of Prohibited Medication|0
1497160|NCT00491530|4929433|P1|Overall Study|Use of Prohibited Medication|0
1497161|NCT00491530|4929431|P3|Overall Study|Patient Request|0
1497162|NCT00491530|4929432|P2|Overall Study|Patient Request|1
1497163|NCT00491530|4929433|P1|Overall Study|Patient Request|0
1497164|NCT00491530|4929431|P3|Overall Study|Investigator Discretion|0
1497165|NCT00491530|4929432|P2|Overall Study|Investigator Discretion|1
1497166|NCT00491530|4929433|P1|Overall Study|Investigator Discretion|0
1497167|NCT00491530|4929431|P3|Overall Study|Lack of Efficacy|0
1497168|NCT00491530|4929432|P2|Overall Study|Lack of Efficacy|1
1497169|NCT00491530|4929433|P1|Overall Study|Lack of Efficacy|0
1497170|NCT00491530|4929431|P3|Overall Study|Lost to Follow-up|2
1497171|NCT00491530|4929432|P2|Overall Study|Lost to Follow-up|2
1497172|NCT00491530|4929433|P1|Overall Study|Lost to Follow-up|3
1497173|NCT00491530|4929431|P3|Overall Study|Withdrawal by Subject|0
1497174|NCT00491530|4929432|P2|Overall Study|Withdrawal by Subject|0
1497175|NCT00491530|4929433|P1|Overall Study|Withdrawal by Subject|3
1497176|NCT00491530|4929431|P3|Overall Study|Adverse Event|2
1497177|NCT00491530|4929432|P2|Overall Study|Adverse Event|1
1497178|NCT00491530|4929433|P1|Overall Study|Adverse Event|6
1497179|NCT00491504|4929463|P4|Overall Study|Protocol Violation|2
1497180|NCT00491504|4929464|P3|Overall Study|Protocol Violation|3
1497181|NCT00491504|4929465|P2|Overall Study|Protocol Violation|0
1497182|NCT00491504|4929466|P1|Overall Study|Protocol Violation|0
1497183|NCT00491504|4929463|P4|Overall Study|Withdrawal by Subject|2
1497184|NCT00491504|4929464|P3|Overall Study|Withdrawal by Subject|1
1497185|NCT00491504|4929465|P2|Overall Study|Withdrawal by Subject|0
1497186|NCT00491504|4929466|P1|Overall Study|Withdrawal by Subject|0
1497187|NCT00491504|4929463|P4|Overall Study|Adverse Event|0
1497188|NCT00491504|4929464|P3|Overall Study|Adverse Event|0
1497189|NCT00491504|4929465|P2|Overall Study|Adverse Event|1
1497190|NCT00491504|4929466|P1|Overall Study|Adverse Event|0
1497191|NCT00491400|4929476|P2|Overall Study|Withdrawal by Subject|4
1497192|NCT00491400|4929477|P1|Overall Study|Withdrawal by Subject|5
1497193|NCT00491387|4929485|P1|Overall Study|study terminated|20
1497194|NCT00491322|4929500|P2|Overall Study|Pregnancy|1
1497195|NCT00491322|4929501|P1|Overall Study|Pregnancy|0
1497196|NCT00491322|4929500|P2|Overall Study|Protocol Violation|0
1497197|NCT00491322|4929501|P1|Overall Study|Protocol Violation|1
1497198|NCT00491179|4929520|P2|Overall Study|Withdrawal by Subject|1
1497199|NCT00491179|4929521|P1|Overall Study|Withdrawal by Subject|2
1497200|NCT00491179|4929520|P2|Overall Study|Adverse Event|1
1497201|NCT00491179|4929521|P1|Overall Study|Adverse Event|5
1497202|NCT00491075|4929529|P1|Overall Study|Physician Decision|1
1497203|NCT00491075|4929529|P1|Overall Study|Withdrawal by Subject|1
1497204|NCT00490971|4929535|P5|Maintenance|Not specified|3
1497205|NCT00490971|4929536|P4|Maintenance|Not specified|9
1497206|NCT00490971|4929537|P3|Maintenance|Not specified|11
1497207|NCT00490971|4929538|P2|Maintenance|Not specified|0
1497208|NCT00490971|4929539|P1|Maintenance|Not specified|0
1497209|NCT00490971|4929535|P5|Maintenance|Withdrawal by Subject|18
1497210|NCT00490971|4929536|P4|Maintenance|Withdrawal by Subject|28
1497211|NCT00490971|4929537|P3|Maintenance|Withdrawal by Subject|26
1497212|NCT00490971|4929538|P2|Maintenance|Withdrawal by Subject|0
1497213|NCT00490971|4929539|P1|Maintenance|Withdrawal by Subject|0
1497214|NCT00490971|4929535|P5|Maintenance|Protocol Violation|1
1497215|NCT00490971|4929536|P4|Maintenance|Protocol Violation|1
1497216|NCT00490971|4929537|P3|Maintenance|Protocol Violation|4
1497217|NCT00490971|4929538|P2|Maintenance|Protocol Violation|0
1497218|NCT00490971|4929539|P1|Maintenance|Protocol Violation|0
1497219|NCT00490971|4929535|P5|Maintenance|Pregnancy|0
1497220|NCT00490971|4929536|P4|Maintenance|Pregnancy|0
1497221|NCT00490971|4929537|P3|Maintenance|Pregnancy|1
1497222|NCT00490971|4929538|P2|Maintenance|Pregnancy|0
1497223|NCT00490971|4929539|P1|Maintenance|Pregnancy|0
1497224|NCT00490971|4929535|P5|Maintenance|Lost to Follow-up|10
1497225|NCT00490971|4929536|P4|Maintenance|Lost to Follow-up|8
1497226|NCT00490971|4929537|P3|Maintenance|Lost to Follow-up|5
1497227|NCT00490971|4929538|P2|Maintenance|Lost to Follow-up|0
1497228|NCT00490971|4929539|P1|Maintenance|Lost to Follow-up|0
1497229|NCT00490971|4929535|P5|Maintenance|Death|0
1497230|NCT00490971|4929536|P4|Maintenance|Death|2
1497231|NCT00490971|4929537|P3|Maintenance|Death|0
1497232|NCT00490971|4929538|P2|Maintenance|Death|0
1497233|NCT00490971|4929539|P1|Maintenance|Death|0
1497234|NCT00490971|4929535|P5|Maintenance|Adverse Event|7
1497235|NCT00490971|4929536|P4|Maintenance|Adverse Event|5
1497236|NCT00490971|4929537|P3|Maintenance|Adverse Event|4
1497237|NCT00490971|4929538|P2|Maintenance|Adverse Event|0
1497238|NCT00490971|4929539|P1|Maintenance|Adverse Event|0
1497239|NCT00490971|4929535|P5|Acute/Continuation|Not specified|0
1497240|NCT00490971|4929536|P4|Acute/Continuation|Not specified|0
1497241|NCT00490971|4929537|P3|Acute/Continuation|Not specified|0
1497242|NCT00490971|4929538|P2|Acute/Continuation|Not specified|4
1497243|NCT00490971|4929539|P1|Acute/Continuation|Not specified|11
1497244|NCT00490971|4929535|P5|Acute/Continuation|Withdrawal by Subject|0
1497245|NCT00490971|4929536|P4|Acute/Continuation|Withdrawal by Subject|0
1497246|NCT00490971|4929537|P3|Acute/Continuation|Withdrawal by Subject|0
1497247|NCT00490971|4929538|P2|Acute/Continuation|Withdrawal by Subject|24
1497248|NCT00490971|4929539|P1|Acute/Continuation|Withdrawal by Subject|92
1497249|NCT00490971|4929535|P5|Acute/Continuation|Protocol Violation|0
1497250|NCT00490971|4929536|P4|Acute/Continuation|Protocol Violation|0
1497251|NCT00490971|4929537|P3|Acute/Continuation|Protocol Violation|0
1497252|NCT00490971|4929538|P2|Acute/Continuation|Protocol Violation|2
1497253|NCT00490971|4929539|P1|Acute/Continuation|Protocol Violation|10
1497254|NCT00490971|4929535|P5|Acute/Continuation|Lost to Follow-up|0
1497255|NCT00490971|4929536|P4|Acute/Continuation|Lost to Follow-up|0
1497256|NCT00490971|4929537|P3|Acute/Continuation|Lost to Follow-up|0
1497257|NCT00490971|4929538|P2|Acute/Continuation|Lost to Follow-up|7
1497258|NCT00490971|4929539|P1|Acute/Continuation|Lost to Follow-up|23
1497259|NCT00490971|4929535|P5|Acute/Continuation|Lack of Efficacy|0
1497260|NCT00490971|4929536|P4|Acute/Continuation|Lack of Efficacy|0
1497261|NCT00490971|4929537|P3|Acute/Continuation|Lack of Efficacy|0
1497262|NCT00490971|4929538|P2|Acute/Continuation|Lack of Efficacy|12
1497263|NCT00490971|4929539|P1|Acute/Continuation|Lack of Efficacy|106
1497264|NCT00490971|4929535|P5|Acute/Continuation|Death|0
1497265|NCT00490971|4929536|P4|Acute/Continuation|Death|0
1497266|NCT00490971|4929537|P3|Acute/Continuation|Death|0
1497267|NCT00490971|4929538|P2|Acute/Continuation|Death|0
1497268|NCT00490971|4929539|P1|Acute/Continuation|Death|2
1497269|NCT00490971|4929535|P5|Acute/Continuation|Adverse Event|0
1497270|NCT00490971|4929536|P4|Acute/Continuation|Adverse Event|0
1497271|NCT00490971|4929537|P3|Acute/Continuation|Adverse Event|0
1497272|NCT00490971|4929538|P2|Acute/Continuation|Adverse Event|13
1497273|NCT00490971|4929539|P1|Acute/Continuation|Adverse Event|62
1497274|NCT00490945|4929586|P5|Overall Study|Adverse Event|0
1497275|NCT00490945|4929587|P4|Overall Study|Adverse Event|0
1497276|NCT00490945|4929588|P3|Overall Study|Adverse Event|0
1497277|NCT00490945|4929589|P2|Overall Study|Adverse Event|1
1497278|NCT00490945|4929590|P1|Overall Study|Adverse Event|0
1497279|NCT00490919|4929626|P3|Double-blind Phase|Administrative|6
1497280|NCT00490919|4929627|P2|Double-blind Phase|Administrative|6
1497281|NCT00490919|4929628|P1|Double-blind Phase|Administrative|0
1497282|NCT00490919|4929626|P3|Double-blind Phase|Lack of Efficacy|36
1497283|NCT00490919|4929627|P2|Double-blind Phase|Lack of Efficacy|22
1497284|NCT00490919|4929628|P1|Double-blind Phase|Lack of Efficacy|0
1497285|NCT00490919|4929626|P3|Double-blind Phase|Lost to Follow-up|11
1497286|NCT00490919|4929627|P2|Double-blind Phase|Lost to Follow-up|8
1497287|NCT00490919|4929628|P1|Double-blind Phase|Lost to Follow-up|0
1497288|NCT00490919|4929626|P3|Double-blind Phase|Withdrawal by Subject|11
1497289|NCT00490919|4929627|P2|Double-blind Phase|Withdrawal by Subject|10
1497290|NCT00490919|4929628|P1|Double-blind Phase|Withdrawal by Subject|0
1497291|NCT00490919|4929626|P3|Double-blind Phase|Adverse Event|20
1497292|NCT00490919|4929627|P2|Double-blind Phase|Adverse Event|40
1497293|NCT00490919|4929628|P1|Double-blind Phase|Adverse Event|0
1497294|NCT00490919|4929626|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
1497295|NCT00490919|4929627|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
1497296|NCT00490919|4929628|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
1497297|NCT00490919|4929626|P3|Open-label Run-in Period|Administrative|0
1497298|NCT00490919|4929627|P2|Open-label Run-in Period|Administrative|0
1497299|NCT00490919|4929628|P1|Open-label Run-in Period|Administrative|40
1497300|NCT00490919|4929626|P3|Open-label Run-in Period|Lack of Efficacy|0
1497301|NCT00490919|4929627|P2|Open-label Run-in Period|Lack of Efficacy|0
1497302|NCT00490919|4929628|P1|Open-label Run-in Period|Lack of Efficacy|143
1497303|NCT00490919|4929626|P3|Open-label Run-in Period|Lost to Follow-up|0
1497304|NCT00490919|4929627|P2|Open-label Run-in Period|Lost to Follow-up|0
1497305|NCT00490919|4929628|P1|Open-label Run-in Period|Lost to Follow-up|21
1497306|NCT00490919|4929626|P3|Open-label Run-in Period|Withdrawal by Subject|0
1497307|NCT00490919|4929627|P2|Open-label Run-in Period|Withdrawal by Subject|0
1497308|NCT00490919|4929628|P1|Open-label Run-in Period|Withdrawal by Subject|37
1497309|NCT00490919|4929626|P3|Open-label Run-in Period|Adverse Event|0
1497310|NCT00490919|4929627|P2|Open-label Run-in Period|Adverse Event|0
1497311|NCT00490919|4929628|P1|Open-label Run-in Period|Adverse Event|239
1497312|NCT00490841|4929639|P1|Overall Study|30 day f/u, only non-study stent used|3
1497313|NCT00490841|4929639|P1|Overall Study|Lost to Follow-up|1
1497314|NCT00490841|4929639|P1|Overall Study|Withdrawal by Subject|4
1497315|NCT00490841|4929639|P1|Overall Study|Death|5
1497316|NCT00490815|4929661|P2|Overall Study|Death|3
1497317|NCT00490815|4929662|P1|Overall Study|Death|1
1497318|NCT00490815|4929661|P2|Overall Study|Lost to Follow-up|3
1497319|NCT00490815|4929662|P1|Overall Study|Lost to Follow-up|1
1497320|NCT00490815|4929661|P2|Overall Study|Withdrawal by Subject|0
1497321|NCT00490815|4929662|P1|Overall Study|Withdrawal by Subject|4
1497322|NCT00490815|4929661|P2|Overall Study|Adverse Event|3
1497323|NCT00490815|4929662|P1|Overall Study|Adverse Event|2
1497324|NCT00490724|4929690|P3|Period II|Treatment Discontinuation|3
1497325|NCT00490724|4929691|P2|Period II|Treatment Discontinuation|1
1497326|NCT00490724|4929692|P1|Period II|Treatment Discontinuation|3
1497327|NCT00490724|4929690|P3|Period I|Physician Decision|1
1497328|NCT00490724|4929691|P2|Period I|Physician Decision|0
1497329|NCT00490724|4929692|P1|Period I|Physician Decision|0
1497330|NCT00490698|4929757|P1|Overall Study|Physician Decision|2
1497331|NCT00490698|4929757|P1|Overall Study|Disease Progression|7
1497332|NCT00490698|4929757|P1|Overall Study|Withdrawal by Subject|1
1497333|NCT00490646|4929763|P2|Overall Study|Never Treated (withdrew consent)|1
1497334|NCT00490646|4929764|P1|Overall Study|Never Treated (withdrew consent)|0
1497335|NCT00490646|4929763|P2|Overall Study|Never Treated (had an adverse event)|0
1497336|NCT00490646|4929764|P1|Overall Study|Never Treated (had an adverse event)|1
1497337|NCT00490646|4929763|P2|Overall Study|Still on trastuzumab monotherapy|1
1497338|NCT00490646|4929764|P1|Overall Study|Still on trastuzumab monotherapy|1
1497339|NCT00490568|4929784|P1|Overall Study|Participant withdrawal due to surgery|1
1497340|NCT00490568|4929784|P1|Overall Study|Participant died|1
1497341|NCT00490568|4929784|P1|Overall Study|Efficacy related|3
1497342|NCT00490568|4929784|P1|Overall Study|Non-Compliance|7
1497343|NCT00490568|4929784|P1|Overall Study|Investigator decision|3
1497344|NCT00490568|4929784|P1|Overall Study|Unmet inclusion-exclusion criteria|5
1497345|NCT00490568|4929784|P1|Overall Study|Disease progression|4
1497346|NCT00490568|4929784|P1|Overall Study|Legal representative withdrew consent|1
1497347|NCT00490568|4929784|P1|Overall Study|Participant refused follow-up|9
1497348|NCT00490568|4929784|P1|Overall Study|Abnormal ECG|25
1497349|NCT00490568|4929784|P1|Overall Study|Caregiver related|20
1497350|NCT00490568|4929784|P1|Overall Study|Exclusion criteria met|1
1497351|NCT00490568|4929784|P1|Overall Study|Other|1
1497352|NCT00490568|4929784|P1|Overall Study|Still in the study at termination|974
1497353|NCT00490568|4929784|P1|Overall Study|Withdrawal by Subject|135
1497354|NCT00490568|4929784|P1|Overall Study|Protocol Violation|45
1497355|NCT00490568|4929784|P1|Overall Study|Lost to Follow-up|13
1497356|NCT00490568|4929784|P1|Overall Study|Adverse Event|116
1497357|NCT00490555|4929808|P4|Overall Study|noncompliant with drug administration|0
1497358|NCT00490555|4929809|P3|Overall Study|noncompliant with drug administration|2
1497359|NCT00490555|4929810|P2|Overall Study|noncompliant with drug administration|0
1497360|NCT00490555|4929811|P1|Overall Study|noncompliant with drug administration|0
1497361|NCT00490542|4929839|P2|Overall Study|Lack of Efficacy|1
1497362|NCT00490542|4929840|P1|Overall Study|Lack of Efficacy|1
1497363|NCT00490542|4929839|P2|Overall Study|Adverse Event|3
1497364|NCT00490542|4929840|P1|Overall Study|Adverse Event|3
1497365|NCT00490542|4929839|P2|Overall Study|Lost to Follow-up|0
1497366|NCT00490542|4929840|P1|Overall Study|Lost to Follow-up|3
1497367|NCT00490490|4929846|P1|Completed Assessment for TTP|Lost to Follow-up|2
1497368|NCT00490490|4929846|P1|Completed Assessment for TTP|Withdrawal by Subject|1
1497369|NCT00490451|4929863|P2|Overall Study|Progressive Disease|34
1497370|NCT00490451|4929864|P1|Overall Study|Progressive Disease|53
1497371|NCT00490451|4929863|P2|Overall Study|Protocol Violation|0
1497372|NCT00490451|4929864|P1|Overall Study|Protocol Violation|1
1497373|NCT00490451|4929863|P2|Overall Study|Investigator Decision|0
1497374|NCT00490451|4929864|P1|Overall Study|Investigator Decision|1
1497375|NCT00490451|4929863|P2|Overall Study|Withdrawal by Subject|0
1497376|NCT00490451|4929864|P1|Overall Study|Withdrawal by Subject|2
1497377|NCT00490451|4929863|P2|Overall Study|Death|1
1497378|NCT00490451|4929864|P1|Overall Study|Death|3
1497379|NCT00490451|4929863|P2|Overall Study|Adverse Event|3
1497380|NCT00490451|4929864|P1|Overall Study|Adverse Event|3
1497381|NCT00490139|4929906|P4|Overall Study|Participant Withdrew Consent|116
1497382|NCT00490139|4929907|P3|Overall Study|Participant Withdrew Consent|208
1497383|NCT00490139|4929908|P2|Overall Study|Participant Withdrew Consent|110
1497384|NCT00490139|4929909|P1|Overall Study|Participant Withdrew Consent|146
1497385|NCT00490139|4929906|P4|Overall Study|Lost to Follow-up|56
1497386|NCT00490139|4929907|P3|Overall Study|Lost to Follow-up|58
1497387|NCT00490139|4929908|P2|Overall Study|Lost to Follow-up|46
1497388|NCT00490139|4929909|P1|Overall Study|Lost to Follow-up|56
1497389|NCT00490139|4929906|P4|Overall Study|Death|135
1497390|NCT00490139|4929907|P3|Overall Study|Death|168
1497391|NCT00490139|4929908|P2|Overall Study|Death|119
1497392|NCT00490139|4929909|P1|Overall Study|Death|106
1497393|NCT00490061|4929944|P1|Overall Study|Physician Decision|1
1497394|NCT00490035|4929953|P4|Overall Study|AE of unknown type|0
1497395|NCT00490035|4929954|P3|Overall Study|AE of unknown type|2
1497396|NCT00490035|4929955|P2|Overall Study|AE of unknown type|0
1497397|NCT00490035|4929956|P1|Overall Study|AE of unknown type|0
1497398|NCT00490035|4929953|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
1497399|NCT00490035|4929954|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
1497400|NCT00490035|4929955|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
1497401|NCT00490035|4929956|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
1497402|NCT00490035|4929953|P4|Overall Study|AE, serious fatal|0
1497403|NCT00490035|4929954|P3|Overall Study|AE, serious fatal|0
1497404|NCT00490035|4929955|P2|Overall Study|AE, serious fatal|0
1497405|NCT00490035|4929956|P1|Overall Study|AE, serious fatal|1
1497406|NCT00490035|4929953|P4|Overall Study|Other reason|1
1497407|NCT00490035|4929954|P3|Overall Study|Other reason|3
1497408|NCT00490035|4929955|P2|Overall Study|Other reason|1
1497409|NCT00490035|4929956|P1|Overall Study|Other reason|0
1497410|NCT00490035|4929953|P4|Overall Study|Withdrawal by Subject|0
1497411|NCT00490035|4929954|P3|Overall Study|Withdrawal by Subject|1
1497412|NCT00490035|4929955|P2|Overall Study|Withdrawal by Subject|1
1497413|NCT00490035|4929956|P1|Overall Study|Withdrawal by Subject|2
1497414|NCT00490035|4929953|P4|Overall Study|Lost to Follow-up|0
1497415|NCT00490035|4929954|P3|Overall Study|Lost to Follow-up|1
1497416|NCT00490035|4929955|P2|Overall Study|Lost to Follow-up|0
1497417|NCT00490035|4929956|P1|Overall Study|Lost to Follow-up|2
1497418|NCT00490035|4929953|P4|Overall Study|AE, non-serious non-fatal|5
1497419|NCT00490035|4929954|P3|Overall Study|AE, non-serious non-fatal|4
1497420|NCT00490035|4929955|P2|Overall Study|AE, non-serious non-fatal|4
1497421|NCT00490035|4929956|P1|Overall Study|AE, non-serious non-fatal|3
1497422|NCT00490022|4930056|P2|Overall Study|Subject failed to disclose concommitant|1
1497423|NCT00490022|4930057|P1|Overall Study|Subject failed to disclose concommitant|0
1497424|NCT00490022|4930056|P2|Overall Study|Withdrawal by Subject|0
1497425|NCT00490022|4930057|P1|Overall Study|Withdrawal by Subject|1
1497426|NCT00490022|4930056|P2|Overall Study|Adverse Event|2
1497427|NCT00490022|4930057|P1|Overall Study|Adverse Event|0
1497428|NCT00489918|4930103|P5|Overall Study|Physician Decision|0
1497429|NCT00489918|4930104|P4|Overall Study|Physician Decision|0
1497430|NCT00489918|4930105|P3|Overall Study|Physician Decision|1
1497431|NCT00489918|4930106|P2|Overall Study|Physician Decision|0
1497432|NCT00489918|4930107|P1|Overall Study|Physician Decision|0
1497433|NCT00489918|4930103|P5|Overall Study|Lost to Follow-up|0
1497434|NCT00489918|4930104|P4|Overall Study|Lost to Follow-up|1
1497435|NCT00489918|4930105|P3|Overall Study|Lost to Follow-up|1
1497436|NCT00489918|4930106|P2|Overall Study|Lost to Follow-up|0
1497437|NCT00489918|4930107|P1|Overall Study|Lost to Follow-up|0
1497438|NCT00489918|4930103|P5|Overall Study|Adverse Event|0
1497439|NCT00489918|4930104|P4|Overall Study|Adverse Event|0
1497440|NCT00489918|4930105|P3|Overall Study|Adverse Event|1
1497441|NCT00489918|4930106|P2|Overall Study|Adverse Event|1
1497442|NCT00489918|4930107|P1|Overall Study|Adverse Event|0
1497443|NCT00489918|4930103|P5|Overall Study|Withdrawal by Subject|1
1497444|NCT00489918|4930104|P4|Overall Study|Withdrawal by Subject|0
1497445|NCT00489918|4930105|P3|Overall Study|Withdrawal by Subject|1
1497446|NCT00489918|4930106|P2|Overall Study|Withdrawal by Subject|1
1497447|NCT00489918|4930107|P1|Overall Study|Withdrawal by Subject|2
1497448|NCT00489853|4930156|P3|Treatment Period 3|Study specific discontinuation criteria|0
1497449|NCT00489853|4930157|P2|Treatment Period 3|Study specific discontinuation criteria|1
1497450|NCT00489853|4930158|P1|Treatment Period 3|Study specific discontinuation criteria|0
1497451|NCT00489853|4930156|P3|Wash-out Period 2|Study specific discontinuation criteria|2
1497452|NCT00489853|4930157|P2|Wash-out Period 2|Study specific discontinuation criteria|2
1497453|NCT00489853|4930158|P1|Wash-out Period 2|Study specific discontinuation criteria|3
1497454|NCT00489853|4930156|P3|Wash-out Period 2|Adverse Event|0
1497455|NCT00489853|4930157|P2|Wash-out Period 2|Adverse Event|1
1497456|NCT00489853|4930158|P1|Wash-out Period 2|Adverse Event|1
1497457|NCT00489853|4930156|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
1497458|NCT00489853|4930157|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
1497459|NCT00489853|4930158|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
1497460|NCT00489853|4930156|P3|Wash-out Period 1|Protocol Violation|1
1497461|NCT00489853|4930157|P2|Wash-out Period 1|Protocol Violation|1
1497462|NCT00489853|4930158|P1|Wash-out Period 1|Protocol Violation|0
1497463|NCT00489853|4930156|P3|Wash-out Period 1|Adverse Event|1
1497464|NCT00489853|4930157|P2|Wash-out Period 1|Adverse Event|1
1497465|NCT00489853|4930158|P1|Wash-out Period 1|Adverse Event|0
1497466|NCT00489853|4930156|P3|Wash-out Period 1|Withdrawal by Subject|0
1497467|NCT00489853|4930157|P2|Wash-out Period 1|Withdrawal by Subject|0
1497468|NCT00489853|4930158|P1|Wash-out Period 1|Withdrawal by Subject|1
1497469|NCT00489736|4930255|P2|Overall Study|Not coded/ Not pre-specified|8
1497470|NCT00489736|4930256|P1|Overall Study|Not coded/ Not pre-specified|5
1497471|NCT00489736|4930255|P2|Overall Study|Poor compliance|2
1497472|NCT00489736|4930256|P1|Overall Study|Poor compliance|6
1497473|NCT00489736|4930255|P2|Overall Study|Adverse Event|45
1497474|NCT00489736|4930256|P1|Overall Study|Adverse Event|32
1497475|NCT00489736|4930255|P2|Overall Study|Lack of Efficacy|14
1497476|NCT00489736|4930256|P1|Overall Study|Lack of Efficacy|53
1497477|NCT00489554|4930266|P1|Overall Study|Lost to Follow-up|1
1497478|NCT00489554|4930266|P1|Overall Study|Withdrawal by Subject|1
1497479|NCT00489554|4930266|P1|Overall Study|Adverse Event|2
1497480|NCT00489541|4930286|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
1497481|NCT00489541|4930287|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
1497482|NCT00489541|4930286|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
1497483|NCT00489541|4930287|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
1497484|NCT00489541|4930286|P2|12-Month Clinical Follow-up|Death|2
1497485|NCT00489541|4930287|P1|12-Month Clinical Follow-up|Death|3
1497486|NCT00489541|4930286|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
1497487|NCT00489541|4930287|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
1497488|NCT00489541|4930286|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
1497489|NCT00489541|4930287|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
1497490|NCT00489541|4930286|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
1497491|NCT00489541|4930287|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
1497492|NCT00489489|4930298|P3|Overall Study|Other than above|0
1497493|NCT00489489|4930299|P2|Overall Study|Other than above|1
1497494|NCT00489489|4930300|P1|Overall Study|Other than above|0
1497495|NCT00489489|4930298|P3|Overall Study|Participant did not wish to continue|0
1497496|NCT00489489|4930299|P2|Overall Study|Participant did not wish to continue|1
1497497|NCT00489489|4930300|P1|Overall Study|Participant did not wish to continue|1
1497498|NCT00489489|4930298|P3|Overall Study|Progressive disease|0
1497499|NCT00489489|4930299|P2|Overall Study|Progressive disease|1
1497500|NCT00489489|4930300|P1|Overall Study|Progressive disease|0
1497501|NCT00489489|4930298|P3|Overall Study|Protocol Violation|1
1497502|NCT00489489|4930299|P2|Overall Study|Protocol Violation|0
1497503|NCT00489489|4930300|P1|Overall Study|Protocol Violation|1
1497504|NCT00489489|4930298|P3|Overall Study|Adverse Event|1
1497505|NCT00489489|4930299|P2|Overall Study|Adverse Event|1
1497506|NCT00489489|4930300|P1|Overall Study|Adverse Event|1
1497507|NCT00489489|4930298|P3|Overall Study|Not treated due to protocol violation|1
1497508|NCT00489489|4930299|P2|Overall Study|Not treated due to protocol violation|1
1497509|NCT00489489|4930300|P1|Overall Study|Not treated due to protocol violation|0
1497510|NCT00489476|4930332|P4|Overall Study|Lost to Follow-up|0
1497511|NCT00489476|4930333|P3|Overall Study|Lost to Follow-up|0
1497512|NCT00489476|4930334|P2|Overall Study|Lost to Follow-up|1
1497513|NCT00489476|4930335|P1|Overall Study|Lost to Follow-up|0
1497514|NCT00489424|4930356|P3|Overall Study|Administrative problems|1
1497515|NCT00489424|4930357|P2|Overall Study|Administrative problems|2
1497516|NCT00489424|4930358|P1|Overall Study|Administrative problems|0
1497517|NCT00489424|4930356|P3|Overall Study|Lack of Efficacy|0
1497518|NCT00489424|4930357|P2|Overall Study|Lack of Efficacy|0
1497519|NCT00489424|4930358|P1|Overall Study|Lack of Efficacy|1
1497520|NCT00489424|4930356|P3|Overall Study|Adverse Event|4
1497521|NCT00489424|4930357|P2|Overall Study|Adverse Event|3
1497522|NCT00489424|4930358|P1|Overall Study|Adverse Event|3
1497523|NCT00489411|4930389|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
1497524|NCT00489411|4930390|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
1497525|NCT00489411|4930389|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
1497526|NCT00489411|4930390|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
1497527|NCT00489411|4930389|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
1497528|NCT00489411|4930390|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
1497529|NCT00489411|4930389|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
1497530|NCT00489411|4930390|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
1497531|NCT00489411|4930389|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
1497532|NCT00489411|4930390|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
1497533|NCT00489359|4930404|P2|Overall Study|Adverse Event|16
1497534|NCT00489359|4930405|P1|Overall Study|Adverse Event|0
1497535|NCT00489359|4930404|P2|Overall Study|Withdrawal by Subject|5
1497536|NCT00489359|4930405|P1|Overall Study|Withdrawal by Subject|1
1497537|NCT00489359|4930404|P2|Overall Study|Lost to Follow-up|0
1497538|NCT00489359|4930405|P1|Overall Study|Lost to Follow-up|1
1497539|NCT00489359|4930404|P2|Overall Study|Progressive Disease|6
1497540|NCT00489359|4930405|P1|Overall Study|Progressive Disease|5
1497541|NCT00489359|4930404|P2|Overall Study|Death|2
1497542|NCT00489359|4930405|P1|Overall Study|Death|0
1497543|NCT00489255|4930466|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
1497544|NCT00489255|4930467|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
1497545|NCT00489255|4930466|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
1497546|NCT00489255|4930467|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
1497547|NCT00489255|4930466|P2|Period 3: Days 57 to 84|Adverse Event|3
1497548|NCT00489255|4930467|P1|Period 3: Days 57 to 84|Adverse Event|3
1497549|NCT00489255|4930466|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
1497550|NCT00489255|4930467|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
1497551|NCT00489255|4930466|P2|Period 2: Days 29 to 56|Adverse Event|1
1497552|NCT00489255|4930467|P1|Period 2: Days 29 to 56|Adverse Event|3
1497553|NCT00489255|4930466|P2|Period 1: Days 1 to 28|Noncompliance|0
1497554|NCT00489255|4930467|P1|Period 1: Days 1 to 28|Noncompliance|2
1497555|NCT00489255|4930466|P2|Period 1: Days 1 to 28|Physician Decision|4
1497556|NCT00489255|4930467|P1|Period 1: Days 1 to 28|Physician Decision|1
1497557|NCT00489255|4930466|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
1497558|NCT00489255|4930467|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
1497559|NCT00489255|4930466|P2|Period 1: Days 1 to 28|Adverse Event|8
1497560|NCT00489255|4930467|P1|Period 1: Days 1 to 28|Adverse Event|21
1497561|NCT00489255|4930466|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
1497562|NCT00489255|4930467|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
1497563|NCT00489216|4930515|P1|Overall Study|Adverse Event|1
1497564|NCT00488826|4930537|P3|Overall Study|Protocol Deviations|1
1497565|NCT00488826|4930538|P2|Overall Study|Protocol Deviations|1
1497566|NCT00488826|4930539|P1|Overall Study|Protocol Deviations|2
1497567|NCT00488826|4930537|P3|Overall Study|Lost to Follow-up|0
1497568|NCT00488826|4930538|P2|Overall Study|Lost to Follow-up|1
1497569|NCT00488826|4930539|P1|Overall Study|Lost to Follow-up|5
1497570|NCT00488826|4930537|P3|Overall Study|Adverse Event|4
1497571|NCT00488826|4930538|P2|Overall Study|Adverse Event|15
1497572|NCT00488826|4930539|P1|Overall Study|Adverse Event|9
1497573|NCT00488826|4930537|P3|Overall Study|Protocol Violation|2
1497574|NCT00488826|4930538|P2|Overall Study|Protocol Violation|0
1497575|NCT00488826|4930539|P1|Overall Study|Protocol Violation|0
1497576|NCT00488826|4930537|P3|Overall Study|Withdrawal by Subject|19
1497577|NCT00488826|4930538|P2|Overall Study|Withdrawal by Subject|35
1497578|NCT00488826|4930539|P1|Overall Study|Withdrawal by Subject|40
1497579|NCT00488774|4930554|P4|Overall Study|Lost to Follow-up|1
1497580|NCT00488774|4930555|P3|Overall Study|Lost to Follow-up|1
1497581|NCT00488774|4930556|P2|Overall Study|Lost to Follow-up|0
1497582|NCT00488774|4930557|P1|Overall Study|Lost to Follow-up|0
1497583|NCT00488774|4930554|P4|Overall Study|Other|2
1497584|NCT00488774|4930555|P3|Overall Study|Other|2
1497585|NCT00488774|4930556|P2|Overall Study|Other|3
1497586|NCT00488774|4930557|P1|Overall Study|Other|6
1497587|NCT00488774|4930554|P4|Overall Study|Withdrawal of consent|0
1497588|NCT00488774|4930555|P3|Overall Study|Withdrawal of consent|2
1497589|NCT00488774|4930556|P2|Overall Study|Withdrawal of consent|2
1497590|NCT00488774|4930557|P1|Overall Study|Withdrawal of consent|2
1497591|NCT00488683|4930574|P3|Overall Study|Unable to Classify|0
1497592|NCT00488683|4930575|P2|Overall Study|Unable to Classify|0
1497593|NCT00488683|4930576|P1|Overall Study|Unable to Classify|1
1497594|NCT00488683|4930574|P3|Overall Study|Protocol Violation|0
1497595|NCT00488683|4930575|P2|Overall Study|Protocol Violation|1
1497596|NCT00488683|4930576|P1|Overall Study|Protocol Violation|5
1497597|NCT00488683|4930574|P3|Overall Study|Lost to Follow-up|0
1497598|NCT00488683|4930575|P2|Overall Study|Lost to Follow-up|3
1497599|NCT00488683|4930576|P1|Overall Study|Lost to Follow-up|5
1497600|NCT00488683|4930574|P3|Overall Study|Withdrawal by Subject|2
1497601|NCT00488683|4930575|P2|Overall Study|Withdrawal by Subject|2
1497602|NCT00488683|4930576|P1|Overall Study|Withdrawal by Subject|1
1497603|NCT00488644|4930635|P1|Overall Study|Not Evaluable|1
1497604|NCT00488644|4930635|P1|Overall Study|Not Eligible|1
1497605|NCT00488631|4930645|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1497606|NCT00488631|4930646|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
1497607|NCT00488631|4930647|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
1497608|NCT00488631|4930648|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
1497609|NCT00488631|4930649|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1497610|NCT00488631|4930650|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1497611|NCT00488631|4930651|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1497612|NCT00488631|4930652|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1497613|NCT00488631|4930653|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1497614|NCT00488631|4930654|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1497615|NCT00488631|4930645|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1497616|NCT00488631|4930646|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
1497617|NCT00488631|4930647|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1497618|NCT00488631|4930648|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
1497619|NCT00488631|4930649|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1497620|NCT00488631|4930650|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1497621|NCT00488631|4930651|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1497622|NCT00488631|4930652|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1497623|NCT00488631|4930653|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1497624|NCT00488631|4930654|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1497625|NCT00488631|4930645|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
1497626|NCT00488631|4930646|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
1497627|NCT00488631|4930647|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
1497628|NCT00488631|4930648|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
1497629|NCT00488631|4930649|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1497630|NCT00488631|4930650|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1497631|NCT00488631|4930651|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1497632|NCT00488631|4930652|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1497633|NCT00488631|4930653|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1497634|NCT00488631|4930654|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1497635|NCT00488631|4930645|P10|Open Label Study Extension (Week 54-228)|Death|0
1497636|NCT00488631|4930646|P9|Open Label Study Extension (Week 54-228)|Death|1
1497637|NCT00488631|4930647|P8|Open Label Study Extension (Week 54-228)|Death|0
1497638|NCT00488631|4930648|P7|Open Label Study Extension (Week 54-228)|Death|0
1497639|NCT00488631|4930649|P6|Open Label Study Extension (Week 54-228)|Death|0
1497640|NCT00488631|4930650|P5|Open Label Study Extension (Week 54-228)|Death|0
1497641|NCT00488631|4930651|P4|Open Label Study Extension (Week 54-228)|Death|0
1497642|NCT00488631|4930652|P3|Open Label Study Extension (Week 54-228)|Death|0
1497643|NCT00488631|4930653|P2|Open Label Study Extension (Week 54-228)|Death|0
1497644|NCT00488631|4930654|P1|Open Label Study Extension (Week 54-228)|Death|0
1497645|NCT00488631|4930645|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
1497646|NCT00488631|4930646|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
1497647|NCT00488631|4930647|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
1497648|NCT00488631|4930648|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
1497649|NCT00488631|4930649|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
1497650|NCT00488631|4930650|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
1497651|NCT00488631|4930651|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
1497652|NCT00488631|4930652|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
1497653|NCT00488631|4930653|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
1497654|NCT00488631|4930654|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
1497655|NCT00488631|4930645|P10|Double Blind Period (Week 0-54)|Other|0
1497656|NCT00488631|4930646|P9|Double Blind Period (Week 0-54)|Other|0
1497657|NCT00488631|4930647|P8|Double Blind Period (Week 0-54)|Other|0
1497658|NCT00488631|4930648|P7|Double Blind Period (Week 0-54)|Other|0
1497659|NCT00488631|4930649|P6|Double Blind Period (Week 0-54)|Other|34
1497660|NCT00488631|4930650|P5|Double Blind Period (Week 0-54)|Other|14
1497661|NCT00488631|4930651|P4|Double Blind Period (Week 0-54)|Other|11
1497662|NCT00488631|4930652|P3|Double Blind Period (Week 0-54)|Other|10
1497663|NCT00488631|4930653|P2|Double Blind Period (Week 0-54)|Other|12
1497664|NCT00488631|4930654|P1|Double Blind Period (Week 0-54)|Other|6
1497665|NCT00488631|4930645|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
1497666|NCT00488631|4930646|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
1497667|NCT00488631|4930647|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
1497668|NCT00488631|4930648|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
1497669|NCT00488631|4930649|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
1497670|NCT00488631|4930650|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
1497671|NCT00488631|4930651|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
1497672|NCT00488631|4930652|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
1497673|NCT00488631|4930653|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
1497674|NCT00488631|4930654|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
1497675|NCT00488631|4930645|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
1497676|NCT00488631|4930646|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
1497677|NCT00488631|4930647|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
1497678|NCT00488631|4930648|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
1497679|NCT00488631|4930649|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
1497680|NCT00488631|4930650|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
1497681|NCT00488631|4930651|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
1497682|NCT00488631|4930652|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
1497683|NCT00488631|4930653|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
1497684|NCT00488631|4930654|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
1497685|NCT00488631|4930645|P10|Double Blind Period (Week 0-54)|Death|0
1497686|NCT00488631|4930646|P9|Double Blind Period (Week 0-54)|Death|0
1497687|NCT00488631|4930647|P8|Double Blind Period (Week 0-54)|Death|0
1497688|NCT00488631|4930648|P7|Double Blind Period (Week 0-54)|Death|0
1497689|NCT00488631|4930649|P6|Double Blind Period (Week 0-54)|Death|1
1497690|NCT00488631|4930650|P5|Double Blind Period (Week 0-54)|Death|0
1497691|NCT00488631|4930651|P4|Double Blind Period (Week 0-54)|Death|0
1497692|NCT00488631|4930652|P3|Double Blind Period (Week 0-54)|Death|0
1497693|NCT00488631|4930653|P2|Double Blind Period (Week 0-54)|Death|0
1497694|NCT00488631|4930654|P1|Double Blind Period (Week 0-54)|Death|0
1497695|NCT00488631|4930645|P10|Double Blind Period (Week 0-54)|Adverse Event|0
1497696|NCT00488631|4930646|P9|Double Blind Period (Week 0-54)|Adverse Event|0
1497697|NCT00488631|4930647|P8|Double Blind Period (Week 0-54)|Adverse Event|0
1497698|NCT00488631|4930648|P7|Double Blind Period (Week 0-54)|Adverse Event|0
1497699|NCT00488631|4930649|P6|Double Blind Period (Week 0-54)|Adverse Event|50
1497700|NCT00488631|4930650|P5|Double Blind Period (Week 0-54)|Adverse Event|30
1497701|NCT00488631|4930651|P4|Double Blind Period (Week 0-54)|Adverse Event|12
1497702|NCT00488631|4930652|P3|Double Blind Period (Week 0-54)|Adverse Event|12
1497703|NCT00488631|4930653|P2|Double Blind Period (Week 0-54)|Adverse Event|12
1497704|NCT00488631|4930654|P1|Double Blind Period (Week 0-54)|Adverse Event|17
1497705|NCT00488618|4930691|P2|Overall Study|Lost to Follow-up|0
1497706|NCT00488618|4930692|P1|Overall Study|Lost to Follow-up|1
1497707|NCT00488618|4930691|P2|Overall Study|Withdrawal of Consent|13
1497708|NCT00488618|4930692|P1|Overall Study|Withdrawal of Consent|15
1497709|NCT00488618|4930691|P2|Overall Study|Protocol Violation|2
1497710|NCT00488618|4930692|P1|Overall Study|Protocol Violation|0
1497711|NCT00488618|4930691|P2|Overall Study|Insufficient Therapeutic Response|11
1497712|NCT00488618|4930692|P1|Overall Study|Insufficient Therapeutic Response|18
1497713|NCT00488618|4930691|P2|Overall Study|Adverse Event|17
1497714|NCT00488618|4930692|P1|Overall Study|Adverse Event|13
1497715|NCT00488592|4930700|P1|Overall Study|Enrolled but not treated|1
1497716|NCT00488592|4930700|P1|Overall Study|Disease progression|1
1497717|NCT00488592|4930700|P1|Overall Study|Withdrawal by Subject|1
1497718|NCT00488514|4930704|P1|Overall Study|Increased use of concomitant medication|1
1497719|NCT00488514|4930704|P1|Overall Study|Increase in number of migraines|2
1497720|NCT00488514|4930704|P1|Overall Study|Participant had too few migraines|5
1497721|NCT00488514|4930704|P1|Overall Study|Investigator decision|1
1497722|NCT00488514|4930704|P1|Overall Study|Withdrawn per medical monitor decision|2
1497723|NCT00488514|4930704|P1|Overall Study|Postive drug screen|1
1497724|NCT00488514|4930704|P1|Overall Study|Did not meet criteria for treatment|30
1497725|NCT00488514|4930704|P1|Overall Study|Lack of Efficacy|28
1497726|NCT00488514|4930704|P1|Overall Study|Withdrawal by Subject|106
1497727|NCT00488514|4930704|P1|Overall Study|Protocol Violation|32
1497728|NCT00488514|4930704|P1|Overall Study|Lost to Follow-up|44
1497729|NCT00488514|4930704|P1|Overall Study|Adverse Event|41
1497730|NCT00488475|4930792|P1|Overall Study|Other|1754
1497731|NCT00488345|4930821|P3|Overall Study|Parent/legal guardian request|1
1497732|NCT00488345|4930822|P2|Overall Study|Parent/legal guardian request|1
1497733|NCT00488345|4930823|P1|Overall Study|Parent/legal guardian request|0
1497734|NCT00488345|4930821|P3|Overall Study|Surgical team recommendation|0
1497735|NCT00488345|4930822|P2|Overall Study|Surgical team recommendation|1
1497736|NCT00488345|4930823|P1|Overall Study|Surgical team recommendation|0
1497737|NCT00488345|4930821|P3|Overall Study|Institutional Review Board review|1
1497738|NCT00488345|4930822|P2|Overall Study|Institutional Review Board review|0
1497739|NCT00488345|4930823|P1|Overall Study|Institutional Review Board review|0
1497740|NCT00488345|4930821|P3|Overall Study|Unable to administer antibiotics at home|0
1497741|NCT00488345|4930822|P2|Overall Study|Unable to administer antibiotics at home|1
1497742|NCT00488345|4930823|P1|Overall Study|Unable to administer antibiotics at home|0
1497743|NCT00488345|4930821|P3|Overall Study|Adverse Event|1
1497744|NCT00488345|4930822|P2|Overall Study|Adverse Event|1
1497745|NCT00488345|4930823|P1|Overall Study|Adverse Event|0
1497746|NCT00488319|4930849|P3|Overall Study|Other reasons for withdrawal|12
1497747|NCT00488319|4930850|P2|Overall Study|Other reasons for withdrawal|4
1497748|NCT00488319|4930851|P1|Overall Study|Other reasons for withdrawal|0
1497749|NCT00488319|4930849|P3|Overall Study|Withdrawal by Subject|44
1497750|NCT00488319|4930850|P2|Overall Study|Withdrawal by Subject|20
1497751|NCT00488319|4930851|P1|Overall Study|Withdrawal by Subject|5
1497752|NCT00488319|4930849|P3|Overall Study|Lost to Follow-up|16
1497753|NCT00488319|4930850|P2|Overall Study|Lost to Follow-up|5
1497754|NCT00488319|4930851|P1|Overall Study|Lost to Follow-up|3
1497755|NCT00488319|4930849|P3|Overall Study|Lack of Efficacy|27
1497756|NCT00488319|4930850|P2|Overall Study|Lack of Efficacy|12
1497757|NCT00488319|4930851|P1|Overall Study|Lack of Efficacy|6
1497758|NCT00488319|4930849|P3|Overall Study|Adverse Event|23
1497759|NCT00488319|4930850|P2|Overall Study|Adverse Event|2
1497760|NCT00488319|4930851|P1|Overall Study|Adverse Event|1
1497761|NCT00488293|4930938|P2|Overall Study|Misrandomization/Other Unspecified|1
1497762|NCT00488293|4930939|P1|Overall Study|Misrandomization/Other Unspecified|1
1497763|NCT00488293|4930938|P2|Overall Study|Death|1
1497764|NCT00488293|4930939|P1|Overall Study|Death|2
1497765|NCT00488293|4930938|P2|Overall Study|Withdrawal by Subject|3
1497766|NCT00488293|4930939|P1|Overall Study|Withdrawal by Subject|5
1497767|NCT00488293|4930938|P2|Overall Study|Lost to Follow-up|25
1497768|NCT00488293|4930939|P1|Overall Study|Lost to Follow-up|28
1497769|NCT00488033|4930984|P2|Overall Study|Withdrawal by Subject|0
1497770|NCT00488033|4930985|P1|Overall Study|Withdrawal by Subject|1
1497771|NCT00487981|4931001|P1|Overall Study|Hypothyroidism diagnosis|1
1497772|NCT00487942|4931009|P4|Overall Study|Withdrawal by Subject|0
1497773|NCT00487942|4931010|P3|Overall Study|Withdrawal by Subject|2
1497774|NCT00487942|4931011|P2|Overall Study|Withdrawal by Subject|1
1497775|NCT00487942|4931012|P1|Overall Study|Withdrawal by Subject|0
1497776|NCT00487942|4931009|P4|Overall Study|Protocol Violation|0
1497777|NCT00487942|4931010|P3|Overall Study|Protocol Violation|0
1497778|NCT00487942|4931011|P2|Overall Study|Protocol Violation|1
1497779|NCT00487942|4931012|P1|Overall Study|Protocol Violation|1
1497780|NCT00487942|4931009|P4|Overall Study|Lost to Follow-up|1
1497781|NCT00487942|4931010|P3|Overall Study|Lost to Follow-up|0
1497782|NCT00487942|4931011|P2|Overall Study|Lost to Follow-up|0
1497783|NCT00487942|4931012|P1|Overall Study|Lost to Follow-up|1
1497784|NCT00487942|4931009|P4|Overall Study|Adverse Event|1
1497785|NCT00487942|4931010|P3|Overall Study|Adverse Event|1
1497786|NCT00487942|4931011|P2|Overall Study|Adverse Event|1
1497787|NCT00487942|4931012|P1|Overall Study|Adverse Event|1
1497788|NCT00487825|4931396|P2|Overall Study|not specified|2
1497789|NCT00487825|4931397|P1|Overall Study|not specified|3
1497790|NCT00487825|4931396|P2|Overall Study|Lack of Efficacy|1
1497791|NCT00487825|4931397|P1|Overall Study|Lack of Efficacy|1
1497792|NCT00487825|4931396|P2|Overall Study|Adverse Event|2
1497793|NCT00487825|4931397|P1|Overall Study|Adverse Event|2
1497794|NCT00487747|4931409|P1|Overall Study|Lack of Efficacy|1
1497795|NCT00487747|4931409|P1|Overall Study|Lost to Follow-up|9
1497796|NCT00487747|4931409|P1|Overall Study|Adverse Event|1
1497797|NCT00487695|4931426|P2|Second Procedure|Withdrawal by Subject|2
1497798|NCT00487695|4931427|P1|Second Procedure|Withdrawal by Subject|1
1497799|NCT00487695|4931426|P2|Second Procedure|active wheezing|1
1497800|NCT00487695|4931427|P1|Second Procedure|active wheezing|0
1497801|NCT00487695|4931426|P2|First Procedure|esophageal stricture found (excl crit)|0
1497802|NCT00487695|4931427|P1|First Procedure|esophageal stricture found (excl crit)|1
1497803|NCT00487695|4931426|P2|First Procedure|active wheezing (did not have procedure)|0
1497804|NCT00487695|4931427|P1|First Procedure|active wheezing (did not have procedure)|1
1497805|NCT00487695|4931426|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
1497806|NCT00487695|4931427|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
1497807|NCT00487578|4931455|P2|Overall Study|Lost to Follow-up|1
1497808|NCT00487578|4931456|P1|Overall Study|Lost to Follow-up|0
1497809|NCT00487578|4931455|P2|Overall Study|Lack of Efficacy|1
1497810|NCT00487578|4931456|P1|Overall Study|Lack of Efficacy|0
1497811|NCT00487578|4931455|P2|Overall Study|Adverse Event|2
1497812|NCT00487578|4931456|P1|Overall Study|Adverse Event|1
1497813|NCT00487552|4931476|P1|Overall Study|Stent not placed|1
1497814|NCT00487552|4931476|P1|Overall Study|Death due to progressive malignancy|2
1497815|NCT00487552|4931476|P1|Overall Study|Unsuccessful magnet placements|3
1497816|NCT00487539|4931485|P4|Overall Study|Other|2
1497817|NCT00487539|4931486|P3|Overall Study|Other|2
1497818|NCT00487539|4931487|P2|Overall Study|Other|1
1497819|NCT00487539|4931488|P1|Overall Study|Other|3
1497820|NCT00487539|4931485|P4|Overall Study|Unsatisfactory therapeutic effect|1
1497821|NCT00487539|4931486|P3|Overall Study|Unsatisfactory therapeutic effect|0
1497822|NCT00487539|4931487|P2|Overall Study|Unsatisfactory therapeutic effect|0
1497823|NCT00487539|4931488|P1|Overall Study|Unsatisfactory therapeutic effect|1
1497824|NCT00487539|4931485|P4|Overall Study|Adverse Event|1
1497825|NCT00487539|4931486|P3|Overall Study|Adverse Event|1
1497826|NCT00487539|4931487|P2|Overall Study|Adverse Event|2
1497827|NCT00487539|4931488|P1|Overall Study|Adverse Event|3
1497828|NCT00487435|4931522|P1|Overall Study|Other|83
1497829|NCT00487435|4931522|P1|Overall Study|Study Medication Non-Compliant|32
1497830|NCT00487435|4931522|P1|Overall Study|Resolution Of Pain|1
1497831|NCT00487435|4931522|P1|Overall Study|Withdrawal by Subject|132
1497832|NCT00487435|4931522|P1|Overall Study|Pregnancy|2
1497833|NCT00487435|4931522|P1|Overall Study|Lost to Follow-up|54
1497834|NCT00487435|4931522|P1|Overall Study|Lack of Efficacy|33
1497835|NCT00487435|4931522|P1|Overall Study|Death|2
1497836|NCT00487435|4931522|P1|Overall Study|Adverse Event|146
1497837|NCT00487279|4931535|P2|Overall Study|Withdrawal by Subject|2
1497838|NCT00487279|4931536|P1|Overall Study|Withdrawal by Subject|0
1497839|NCT00487279|4931535|P2|Overall Study|Death|0
1497840|NCT00487279|4931536|P1|Overall Study|Death|1
1497841|NCT00487240|4931546|P2|Overall Study|Physician Decision|0
1497842|NCT00487240|4931547|P1|Overall Study|Physician Decision|2
1497843|NCT00487240|4931546|P2|Overall Study|Sponsor Decision|1
1497844|NCT00487240|4931547|P1|Overall Study|Sponsor Decision|2
1497845|NCT00487240|4931546|P2|Overall Study|Entry Criteria Not Met|4
1497846|NCT00487240|4931547|P1|Overall Study|Entry Criteria Not Met|3
1497847|NCT00487240|4931546|P2|Overall Study|Protocol Violation|5
1497848|NCT00487240|4931547|P1|Overall Study|Protocol Violation|5
1497849|NCT00487240|4931546|P2|Overall Study|Adverse Event|4
1497850|NCT00487240|4931547|P1|Overall Study|Adverse Event|0
1497851|NCT00487240|4931546|P2|Overall Study|Lost to Follow-up|6
1497852|NCT00487240|4931547|P1|Overall Study|Lost to Follow-up|7
1497853|NCT00487240|4931546|P2|Overall Study|Withdrawal by Subject|6
1497854|NCT00487240|4931547|P1|Overall Study|Withdrawal by Subject|12
1497855|NCT00487188|4931575|P3|Maintenance Phase|Administrative|1
1497856|NCT00487188|4931576|P2|Maintenance Phase|Administrative|0
1497857|NCT00487188|4931577|P1|Maintenance Phase|Administrative|0
1497858|NCT00487188|4931575|P3|Maintenance Phase|Lost to Follow-up|0
1497859|NCT00487188|4931576|P2|Maintenance Phase|Lost to Follow-up|0
1497860|NCT00487188|4931577|P1|Maintenance Phase|Lost to Follow-up|1
1497861|NCT00487188|4931575|P3|Maintenance Phase|Death|0
1497862|NCT00487188|4931576|P2|Maintenance Phase|Death|0
1497863|NCT00487188|4931577|P1|Maintenance Phase|Death|1
1497864|NCT00487188|4931575|P3|Maintenance Phase|Adverse Event|0
1497865|NCT00487188|4931576|P2|Maintenance Phase|Adverse Event|0
1497866|NCT00487188|4931577|P1|Maintenance Phase|Adverse Event|1
1497867|NCT00487188|4931575|P3|Induction Phase|Administrative|0
1497868|NCT00487188|4931576|P2|Induction Phase|Administrative|1
1497869|NCT00487188|4931577|P1|Induction Phase|Administrative|0
1497870|NCT00487188|4931575|P3|Induction Phase|Lost to Follow-up|0
1497871|NCT00487188|4931576|P2|Induction Phase|Lost to Follow-up|2
1497872|NCT00487188|4931577|P1|Induction Phase|Lost to Follow-up|2
1497873|NCT00487188|4931575|P3|Induction Phase|Refused Treatment|0
1497874|NCT00487188|4931576|P2|Induction Phase|Refused Treatment|2
1497875|NCT00487188|4931577|P1|Induction Phase|Refused Treatment|1
1497876|NCT00487188|4931575|P3|Induction Phase|Protocol Violation|0
1497877|NCT00487188|4931576|P2|Induction Phase|Protocol Violation|0
1497878|NCT00487188|4931577|P1|Induction Phase|Protocol Violation|1
1497879|NCT00487188|4931575|P3|Induction Phase|Lack of Efficacy|0
1497880|NCT00487188|4931576|P2|Induction Phase|Lack of Efficacy|1
1497881|NCT00487188|4931577|P1|Induction Phase|Lack of Efficacy|0
1497882|NCT00487188|4931575|P3|Induction Phase|Adverse Event|0
1497883|NCT00487188|4931576|P2|Induction Phase|Adverse Event|0
1497884|NCT00487188|4931577|P1|Induction Phase|Adverse Event|5
1497885|NCT00487188|4931575|P3|Induction Phase|Abnormality of Laboratory Test|0
1497886|NCT00487188|4931576|P2|Induction Phase|Abnormality of Laboratory Test|1
1497887|NCT00487188|4931577|P1|Induction Phase|Abnormality of Laboratory Test|0
1497888|NCT00487162|4931616|P2|Overall Study|Withdrawal by Subject|3
1497889|NCT00487162|4931617|P1|Overall Study|Withdrawal by Subject|2
1497890|NCT00487162|4931616|P2|Overall Study|Physician Decision|1
1497891|NCT00487162|4931617|P1|Overall Study|Physician Decision|0
1497892|NCT00487162|4931616|P2|Overall Study|Adverse Event|1
1497893|NCT00487162|4931617|P1|Overall Study|Adverse Event|0
1497894|NCT00487084|4931628|P3|Overall Study|Did not receive intervention|5
1497895|NCT00487084|4931629|P2|Overall Study|Did not receive intervention|3
1497896|NCT00487084|4931630|P1|Overall Study|Did not receive intervention|4
1497897|NCT00486954|4931651|P5|Randomized Part|Sponsor Terminated Study|13
1497898|NCT00486954|4931652|P4|Randomized Part|Sponsor Terminated Study|19
1497899|NCT00486954|4931653|P3|Randomized Part|Sponsor Terminated Study|0
1497900|NCT00486954|4931654|P2|Randomized Part|Sponsor Terminated Study|0
1497901|NCT00486954|4931655|P1|Randomized Part|Sponsor Terminated Study|0
1497902|NCT00486954|4931651|P5|Randomized Part|Withdrawal by Subject|0
1497903|NCT00486954|4931652|P4|Randomized Part|Withdrawal by Subject|1
1497904|NCT00486954|4931653|P3|Randomized Part|Withdrawal by Subject|0
1497905|NCT00486954|4931654|P2|Randomized Part|Withdrawal by Subject|0
1497906|NCT00486954|4931655|P1|Randomized Part|Withdrawal by Subject|0
1497907|NCT00486954|4931651|P5|Randomized Part|Lost to Follow-up|1
1497908|NCT00486954|4931652|P4|Randomized Part|Lost to Follow-up|0
1497909|NCT00486954|4931653|P3|Randomized Part|Lost to Follow-up|0
1497910|NCT00486954|4931654|P2|Randomized Part|Lost to Follow-up|0
1497911|NCT00486954|4931655|P1|Randomized Part|Lost to Follow-up|0
1497912|NCT00486954|4931651|P5|Pilot Part|Disease Progression|0
1497913|NCT00486954|4931652|P4|Pilot Part|Disease Progression|0
1497914|NCT00486954|4931653|P3|Pilot Part|Disease Progression|1
1497915|NCT00486954|4931654|P2|Pilot Part|Disease Progression|0
1497916|NCT00486954|4931655|P1|Pilot Part|Disease Progression|2
1497917|NCT00486954|4931651|P5|Pilot Part|Adverse Event|0
1497918|NCT00486954|4931652|P4|Pilot Part|Adverse Event|0
1497919|NCT00486954|4931653|P3|Pilot Part|Adverse Event|5
1497920|NCT00486954|4931654|P2|Pilot Part|Adverse Event|0
1497921|NCT00486954|4931655|P1|Pilot Part|Adverse Event|4
1497922|NCT00486902|4931753|P2|Overall Study|No toradol due to hemmorhage or allergy|1
1497923|NCT00486902|4931754|P1|Overall Study|No toradol due to hemmorhage or allergy|3
1497924|NCT00486902|4931753|P2|Overall Study|Did not meet inclusion criteria|0
1497925|NCT00486902|4931754|P1|Overall Study|Did not meet inclusion criteria|1
1497926|NCT00486902|4931753|P2|Overall Study|spinal anesthetic protocal violation|1
1497927|NCT00486902|4931754|P1|Overall Study|spinal anesthetic protocal violation|1
1497928|NCT00486902|4931753|P2|Overall Study|decision for postpartum tubal ligation|1
1497929|NCT00486902|4931754|P1|Overall Study|decision for postpartum tubal ligation|3
1497930|NCT00486902|4931753|P2|Overall Study|Withdrawal by Subject|2
1497931|NCT00486902|4931754|P1|Overall Study|Withdrawal by Subject|1
1497932|NCT00486837|4931821|P2|Overall Study|No sputum, devise issues, exacerbation|4
1497933|NCT00486837|4931822|P1|Overall Study|No sputum, devise issues, exacerbation|3
1497934|NCT00486837|4931821|P2|Overall Study|Protocol Violation|2
1497935|NCT00486837|4931822|P1|Overall Study|Protocol Violation|4
1497936|NCT00486837|4931821|P2|Overall Study|Adverse Event|1
1497937|NCT00486837|4931822|P1|Overall Study|Adverse Event|1
1497938|NCT00486837|4931821|P2|Overall Study|Withdrawal by Subject|0
1497939|NCT00486837|4931822|P1|Overall Study|Withdrawal by Subject|1
1497940|NCT00486811|4931841|P3|Overall Study|All other|7
1497941|NCT00486811|4931842|P2|Overall Study|All other|11
1497942|NCT00486811|4931843|P1|Overall Study|All other|18
1497943|NCT00486811|4931841|P3|Overall Study|Study drug non-compliant|3
1497944|NCT00486811|4931842|P2|Overall Study|Study drug non-compliant|6
1497945|NCT00486811|4931843|P1|Overall Study|Study drug non-compliant|5
1497946|NCT00486811|4931841|P3|Overall Study|Withdrawal by Subject|58
1497947|NCT00486811|4931842|P2|Overall Study|Withdrawal by Subject|44
1497948|NCT00486811|4931843|P1|Overall Study|Withdrawal by Subject|33
1497949|NCT00486811|4931841|P3|Overall Study|Lost to Follow-up|4
1497950|NCT00486811|4931842|P2|Overall Study|Lost to Follow-up|6
1497951|NCT00486811|4931843|P1|Overall Study|Lost to Follow-up|4
1497952|NCT00486811|4931841|P3|Overall Study|Lack of Efficacy|7
1497953|NCT00486811|4931842|P2|Overall Study|Lack of Efficacy|14
1497954|NCT00486811|4931843|P1|Overall Study|Lack of Efficacy|34
1497955|NCT00486811|4931841|P3|Overall Study|Adverse Event|135
1497956|NCT00486811|4931842|P2|Overall Study|Adverse Event|60
1497957|NCT00486811|4931843|P1|Overall Study|Adverse Event|28
1497958|NCT00486759|4931886|P2|Safety Follow-up|Adverse event/intercurrent illness|0
1497959|NCT00486759|4931887|P1|Safety Follow-up|Adverse event/intercurrent illness|4
1497960|NCT00486759|4931886|P2|Safety Follow-up|Refused treatment/did not cooperate|4
1497961|NCT00486759|4931887|P1|Safety Follow-up|Refused treatment/did not cooperate|6
1497962|NCT00486759|4931886|P2|Safety Follow-up|Administrative/not specified|6
1497963|NCT00486759|4931887|P1|Safety Follow-up|Administrative/not specified|8
1497964|NCT00486759|4931886|P2|Safety Follow-up|Failure to return|6
1497965|NCT00486759|4931887|P1|Safety Follow-up|Failure to return|9
1497966|NCT00486759|4931886|P2|Safety Follow-up|Withdrew consent|23
1497967|NCT00486759|4931887|P1|Safety Follow-up|Withdrew consent|32
1497968|NCT00486759|4931886|P2|Safety Follow-up|Death|29
1497969|NCT00486759|4931887|P1|Safety Follow-up|Death|40
1497970|NCT00486759|4931886|P2|Safety Follow-up|Insufficient therapeutic response|50
1497971|NCT00486759|4931887|P1|Safety Follow-up|Insufficient therapeutic response|40
1497972|NCT00486759|4931886|P2|Treatment|Failure to return|1
1497973|NCT00486759|4931887|P1|Treatment|Failure to return|1
1497974|NCT00486759|4931886|P2|Treatment|Other protocol violation|5
1497975|NCT00486759|4931887|P1|Treatment|Other protocol violation|1
1497976|NCT00486759|4931886|P2|Treatment|Violation of selection criteria at entry|3
1497977|NCT00486759|4931887|P1|Treatment|Violation of selection criteria at entry|3
1497978|NCT00486759|4931886|P2|Treatment|Refused treatment|7
1497979|NCT00486759|4931887|P1|Treatment|Refused treatment|10
1497980|NCT00486759|4931886|P2|Treatment|Administrative/reason not specified|21
1497981|NCT00486759|4931887|P1|Treatment|Administrative/reason not specified|17
1497982|NCT00486759|4931886|P2|Treatment|Withdrew consent|12
1497983|NCT00486759|4931887|P1|Treatment|Withdrew consent|15
1497984|NCT00486759|4931886|P2|Treatment|Death|10
1497985|NCT00486759|4931887|P1|Treatment|Death|17
1497986|NCT00486759|4931886|P2|Treatment|Insufficient therapeutic response|39
1497987|NCT00486759|4931887|P1|Treatment|Insufficient therapeutic response|37
1497988|NCT00486759|4931886|P2|Treatment|Adverse event/intercurrent illness|39
1497989|NCT00486759|4931887|P1|Treatment|Adverse event/intercurrent illness|86
1497990|NCT00486720|4931899|P2|Overall Study|Progressive Disease|1
1497991|NCT00486720|4931900|P1|Overall Study|Progressive Disease|0
1497992|NCT00486720|4931899|P2|Overall Study|Withdrawal by Subject|1
1497993|NCT00486720|4931900|P1|Overall Study|Withdrawal by Subject|3
1497994|NCT00486720|4931899|P2|Overall Study|Protocol Violation|0
1497995|NCT00486720|4931900|P1|Overall Study|Protocol Violation|1
1497996|NCT00486720|4931899|P2|Overall Study|Physician Decision|2
1497997|NCT00486720|4931900|P1|Overall Study|Physician Decision|1
1497998|NCT00486720|4931899|P2|Overall Study|Lack of Efficacy|6
1497999|NCT00486720|4931900|P1|Overall Study|Lack of Efficacy|4
1498000|NCT00486720|4931899|P2|Overall Study|Adverse Event|2
1498001|NCT00486720|4931900|P1|Overall Study|Adverse Event|1
1498002|NCT00486434|4931959|P2|Overall Study|Personal reasons|6
1498003|NCT00486434|4931960|P1|Overall Study|Personal reasons|5
1498004|NCT00486434|4931959|P2|Overall Study|Death|2
1498005|NCT00486434|4931960|P1|Overall Study|Death|1
1498006|NCT00486434|4931959|P2|Overall Study|Lost to Follow-up|3
1498007|NCT00486434|4931960|P1|Overall Study|Lost to Follow-up|2
1498008|NCT00486434|4931959|P2|Overall Study|Lack of Efficacy|19
1498009|NCT00486434|4931960|P1|Overall Study|Lack of Efficacy|12
1498010|NCT00486434|4931959|P2|Overall Study|Protocol Violation|21
1498011|NCT00486434|4931960|P1|Overall Study|Protocol Violation|22
1498012|NCT00486434|4931959|P2|Overall Study|Adverse Event|44
1498013|NCT00486434|4931960|P1|Overall Study|Adverse Event|118
1498014|NCT00486434|4931959|P2|Overall Study|Withdrawal by Subject|39
1498015|NCT00486434|4931960|P1|Overall Study|Withdrawal by Subject|34
1498016|NCT00486330|4931970|P1|Overall Study|Adverse Event|2
1498017|NCT00486291|4931976|P2|Overall Study|requirement for restricted medication|3
1498018|NCT00486291|4931977|P1|Overall Study|requirement for restricted medication|0
1498019|NCT00486291|4931976|P2|Overall Study|protocol non-compliance|15
1498020|NCT00486291|4931977|P1|Overall Study|protocol non-compliance|10
1498021|NCT00486291|4931976|P2|Overall Study|Lost to Follow-up|7
1498022|NCT00486291|4931977|P1|Overall Study|Lost to Follow-up|3
1498023|NCT00486291|4931976|P2|Overall Study|Adverse Event|4
1498024|NCT00486291|4931977|P1|Overall Study|Adverse Event|3
1498025|NCT00486278|4931985|P1|Overall Study|Physician Decision|2
1498026|NCT00486278|4931985|P1|Overall Study|Withdrawal by Subject|2
1498027|NCT00486278|4931985|P1|Overall Study|Adverse Event|5
1498028|NCT00486265|4932119|P1|Overall Study|Lack of Efficacy|8
1498029|NCT00486265|4932119|P1|Overall Study|Adverse Event|1
1498030|NCT00486252|4932123|P1|Overall Study|Other|18
1498031|NCT00486252|4932123|P1|Overall Study|Lost to Follow-up|24
1498032|NCT00486252|4932123|P1|Overall Study|Lack of Efficacy|9
1498033|NCT00486252|4932123|P1|Overall Study|Adverse Event|7
1498034|NCT00486226|4932138|P1|Overall Study|Lost to Follow-up|8
1498035|NCT00486226|4932138|P1|Overall Study|Withdrawal by Subject|1
1498036|NCT00486226|4932138|P1|Overall Study|Adverse Event|1
1498037|NCT00486226|4932138|P1|Overall Study|Death|3
1498038|NCT00486044|4932148|P2|Overall Study|Lost to Follow-up|1
1498039|NCT00486044|4932149|P1|Overall Study|Lost to Follow-up|0
1498040|NCT00486044|4932148|P2|Overall Study|Adverse Event|1
1498041|NCT00486044|4932149|P1|Overall Study|Adverse Event|0
1498042|NCT00486044|4932148|P2|Overall Study|Withdrawal by Subject|1
1498043|NCT00486044|4932149|P1|Overall Study|Withdrawal by Subject|2
1498044|NCT00485758|4932242|P2|Overall Study|Study Terminated by Sponsor|0
1498045|NCT00485758|4932243|P1|Overall Study|Study Terminated by Sponsor|3
1498046|NCT00485758|4932242|P2|Overall Study|Withdrawal by Subject|27
1498047|NCT00485758|4932243|P1|Overall Study|Withdrawal by Subject|32
1498048|NCT00485758|4932242|P2|Overall Study|Protocol Violation|2
1498049|NCT00485758|4932243|P1|Overall Study|Protocol Violation|11
1498050|NCT00485758|4932242|P2|Overall Study|Physician Decision|3
1498051|NCT00485758|4932243|P1|Overall Study|Physician Decision|3
1498052|NCT00485758|4932242|P2|Overall Study|Lost to Follow-up|1
1498053|NCT00485758|4932243|P1|Overall Study|Lost to Follow-up|5
1498054|NCT00485758|4932242|P2|Overall Study|Death|1
1498055|NCT00485758|4932243|P1|Overall Study|Death|0
1498056|NCT00485758|4932242|P2|Overall Study|Adverse Event|31
1498057|NCT00485758|4932243|P1|Overall Study|Adverse Event|102
1498058|NCT00485732|4932255|P2|Overall Study|Lost to Follow-up|2
1498059|NCT00485732|4932256|P1|Overall Study|Lost to Follow-up|2
1498060|NCT00485732|4932255|P2|Overall Study|Withdrawal by Subject|4
1498061|NCT00485732|4932256|P1|Overall Study|Withdrawal by Subject|5
1498062|NCT00485732|4932255|P2|Overall Study|Protocol Violation|3
1498063|NCT00485732|4932256|P1|Overall Study|Protocol Violation|1
1498064|NCT00485472|4932294|P2|Overall Study|Lost to Follow-up|1
1498065|NCT00485472|4932295|P1|Overall Study|Lost to Follow-up|0
1498066|NCT00485472|4932294|P2|Overall Study|Other|1
1498067|NCT00485472|4932295|P1|Overall Study|Other|2
1498068|NCT00485472|4932294|P2|Overall Study|Protocol Violation|1
1498069|NCT00485472|4932295|P1|Overall Study|Protocol Violation|0
1498070|NCT00485472|4932294|P2|Overall Study|Withdrawal by Subject|0
1498071|NCT00485472|4932295|P1|Overall Study|Withdrawal by Subject|1
1498072|NCT00485472|4932294|P2|Overall Study|Lack of Efficacy|4
1498073|NCT00485472|4932295|P1|Overall Study|Lack of Efficacy|5
1498074|NCT00485472|4932294|P2|Overall Study|Adverse Event|5
1498075|NCT00485472|4932295|P1|Overall Study|Adverse Event|8
1498076|NCT00485303|4932332|P1|Overall Study|Treatment ongoing at cutoff date|2
1498077|NCT00485303|4932332|P1|Overall Study|Initiation of new anti-cancer treatment|2
1498078|NCT00485303|4932332|P1|Overall Study|Other|3
1498079|NCT00485303|4932332|P1|Overall Study|Progressive Disease|44
1498080|NCT00485303|4932332|P1|Overall Study|Adverse Event|5
1498081|NCT00485264|4932350|P6|Overall Study|Other Reason|0
1498082|NCT00485264|4932351|P5|Overall Study|Other Reason|0
1498083|NCT00485264|4932352|P4|Overall Study|Other Reason|0
1498084|NCT00485264|4932353|P3|Overall Study|Other Reason|0
1498085|NCT00485264|4932354|P2|Overall Study|Other Reason|0
1498086|NCT00485264|4932355|P1|Overall Study|Other Reason|3
1498087|NCT00485264|4932350|P6|Overall Study|Lost to Follow-up|1
1498088|NCT00485264|4932351|P5|Overall Study|Lost to Follow-up|0
1498089|NCT00485264|4932352|P4|Overall Study|Lost to Follow-up|0
1498090|NCT00485264|4932353|P3|Overall Study|Lost to Follow-up|1
1498091|NCT00485264|4932354|P2|Overall Study|Lost to Follow-up|1
1498092|NCT00485264|4932355|P1|Overall Study|Lost to Follow-up|2
1498093|NCT00485264|4932350|P6|Overall Study|Non-Compliant|0
1498094|NCT00485264|4932351|P5|Overall Study|Non-Compliant|1
1498095|NCT00485264|4932352|P4|Overall Study|Non-Compliant|0
1498096|NCT00485264|4932353|P3|Overall Study|Non-Compliant|1
1498097|NCT00485264|4932354|P2|Overall Study|Non-Compliant|2
1498098|NCT00485264|4932355|P1|Overall Study|Non-Compliant|17
1498099|NCT00485264|4932350|P6|Overall Study|Not Able to Attend Clinic|2
1498100|NCT00485264|4932351|P5|Overall Study|Not Able to Attend Clinic|1
1498101|NCT00485264|4932352|P4|Overall Study|Not Able to Attend Clinic|1
1498102|NCT00485264|4932353|P3|Overall Study|Not Able to Attend Clinic|0
1498103|NCT00485264|4932354|P2|Overall Study|Not Able to Attend Clinic|0
1498104|NCT00485264|4932355|P1|Overall Study|Not Able to Attend Clinic|5
1498105|NCT00485264|4932350|P6|Overall Study|Intolerance/Unable to Tolerate Dose|0
1498106|NCT00485264|4932351|P5|Overall Study|Intolerance/Unable to Tolerate Dose|0
1498107|NCT00485264|4932352|P4|Overall Study|Intolerance/Unable to Tolerate Dose|0
1498108|NCT00485264|4932353|P3|Overall Study|Intolerance/Unable to Tolerate Dose|1
1498109|NCT00485264|4932354|P2|Overall Study|Intolerance/Unable to Tolerate Dose|0
1498110|NCT00485264|4932355|P1|Overall Study|Intolerance/Unable to Tolerate Dose|0
1498111|NCT00485264|4932350|P6|Overall Study|Physician Decision|0
1498112|NCT00485264|4932351|P5|Overall Study|Physician Decision|0
1498113|NCT00485264|4932352|P4|Overall Study|Physician Decision|0
1498114|NCT00485264|4932353|P3|Overall Study|Physician Decision|0
1498115|NCT00485264|4932354|P2|Overall Study|Physician Decision|2
1498116|NCT00485264|4932355|P1|Overall Study|Physician Decision|0
1498117|NCT00485264|4932350|P6|Overall Study|Guardian Consent Withdrawn|0
1498118|NCT00485264|4932351|P5|Overall Study|Guardian Consent Withdrawn|1
1498119|NCT00485264|4932352|P4|Overall Study|Guardian Consent Withdrawn|0
1498120|NCT00485264|4932353|P3|Overall Study|Guardian Consent Withdrawn|0
1498121|NCT00485264|4932354|P2|Overall Study|Guardian Consent Withdrawn|0
1498122|NCT00485264|4932355|P1|Overall Study|Guardian Consent Withdrawn|1
1498123|NCT00485264|4932350|P6|Overall Study|Lack of Efficacy|0
1498124|NCT00485264|4932351|P5|Overall Study|Lack of Efficacy|0
1498125|NCT00485264|4932352|P4|Overall Study|Lack of Efficacy|0
1498126|NCT00485264|4932353|P3|Overall Study|Lack of Efficacy|0
1498127|NCT00485264|4932354|P2|Overall Study|Lack of Efficacy|1
1498128|NCT00485264|4932355|P1|Overall Study|Lack of Efficacy|0
1498129|NCT00485264|4932350|P6|Overall Study|Number/Volume/Timing of Study Meds|0
1498130|NCT00485264|4932351|P5|Overall Study|Number/Volume/Timing of Study Meds|0
1498131|NCT00485264|4932352|P4|Overall Study|Number/Volume/Timing of Study Meds|0
1498132|NCT00485264|4932353|P3|Overall Study|Number/Volume/Timing of Study Meds|1
1498133|NCT00485264|4932354|P2|Overall Study|Number/Volume/Timing of Study Meds|1
1498134|NCT00485264|4932355|P1|Overall Study|Number/Volume/Timing of Study Meds|2
1498135|NCT00485264|4932350|P6|Overall Study|Disallowed Medication|1
1498136|NCT00485264|4932351|P5|Overall Study|Disallowed Medication|0
1498137|NCT00485264|4932352|P4|Overall Study|Disallowed Medication|0
1498138|NCT00485264|4932353|P3|Overall Study|Disallowed Medication|0
1498139|NCT00485264|4932354|P2|Overall Study|Disallowed Medication|0
1498140|NCT00485264|4932355|P1|Overall Study|Disallowed Medication|0
1498141|NCT00485264|4932350|P6|Overall Study|Pregnancy|0
1498142|NCT00485264|4932351|P5|Overall Study|Pregnancy|0
1498143|NCT00485264|4932352|P4|Overall Study|Pregnancy|0
1498144|NCT00485264|4932353|P3|Overall Study|Pregnancy|0
1498145|NCT00485264|4932354|P2|Overall Study|Pregnancy|0
1498146|NCT00485264|4932355|P1|Overall Study|Pregnancy|4
1498147|NCT00485264|4932350|P6|Overall Study|Adverse Event|3
1498148|NCT00485264|4932351|P5|Overall Study|Adverse Event|1
1498149|NCT00485264|4932352|P4|Overall Study|Adverse Event|3
1498150|NCT00485264|4932353|P3|Overall Study|Adverse Event|2
1498151|NCT00485264|4932354|P2|Overall Study|Adverse Event|0
1498152|NCT00485264|4932355|P1|Overall Study|Adverse Event|1
1498153|NCT00485264|4932350|P6|Overall Study|Death|0
1498154|NCT00485264|4932351|P5|Overall Study|Death|1
1498155|NCT00485264|4932352|P4|Overall Study|Death|0
1498156|NCT00485264|4932353|P3|Overall Study|Death|0
1498157|NCT00485264|4932354|P2|Overall Study|Death|0
1498158|NCT00485264|4932355|P1|Overall Study|Death|1
1498159|NCT00485264|4932350|P6|Overall Study|Enrolled But Not Given Treatment|0
1498160|NCT00485264|4932351|P5|Overall Study|Enrolled But Not Given Treatment|1
1498161|NCT00485264|4932352|P4|Overall Study|Enrolled But Not Given Treatment|0
1498162|NCT00485264|4932353|P3|Overall Study|Enrolled But Not Given Treatment|0
1498163|NCT00485264|4932354|P2|Overall Study|Enrolled But Not Given Treatment|0
1498164|NCT00485264|4932355|P1|Overall Study|Enrolled But Not Given Treatment|0
1498165|NCT00485173|4932443|P2|Overall Study|Lost to Follow-up|61
1498166|NCT00485173|4932444|P1|Overall Study|Lost to Follow-up|32
1498167|NCT00485173|4932443|P2|Overall Study|Death|3
1498168|NCT00485173|4932444|P1|Overall Study|Death|4
1498169|NCT00485134|4932492|P8|Overall Study|Pregnancy|0
1498170|NCT00485134|4932493|P7|Overall Study|Pregnancy|1
1498171|NCT00485134|4932494|P6|Overall Study|Pregnancy|0
1498172|NCT00485134|4932495|P5|Overall Study|Pregnancy|0
1498173|NCT00485134|4932496|P4|Overall Study|Pregnancy|0
1498174|NCT00485134|4932497|P3|Overall Study|Pregnancy|0
1498175|NCT00485134|4932498|P2|Overall Study|Pregnancy|0
1498176|NCT00485134|4932499|P1|Overall Study|Pregnancy|0
1498177|NCT00485134|4932492|P8|Overall Study|Unable to comply with study schedule|1
1498178|NCT00485134|4932493|P7|Overall Study|Unable to comply with study schedule|0
1498179|NCT00485134|4932494|P6|Overall Study|Unable to comply with study schedule|0
1498180|NCT00485134|4932495|P5|Overall Study|Unable to comply with study schedule|0
1498181|NCT00485134|4932496|P4|Overall Study|Unable to comply with study schedule|0
1498182|NCT00485134|4932497|P3|Overall Study|Unable to comply with study schedule|0
1498183|NCT00485134|4932498|P2|Overall Study|Unable to comply with study schedule|0
1498184|NCT00485134|4932499|P1|Overall Study|Unable to comply with study schedule|0
1498185|NCT00485134|4932492|P8|Overall Study|Non-compliance|0
1498186|NCT00485134|4932493|P7|Overall Study|Non-compliance|2
1498187|NCT00485134|4932494|P6|Overall Study|Non-compliance|2
1498188|NCT00485134|4932495|P5|Overall Study|Non-compliance|1
1498189|NCT00485134|4932496|P4|Overall Study|Non-compliance|0
1498190|NCT00485134|4932497|P3|Overall Study|Non-compliance|0
1498191|NCT00485134|4932498|P2|Overall Study|Non-compliance|0
1498192|NCT00485134|4932499|P1|Overall Study|Non-compliance|0
1498193|NCT00485134|4932492|P8|Overall Study|Positive drug test|0
1498194|NCT00485134|4932493|P7|Overall Study|Positive drug test|0
1498195|NCT00485134|4932494|P6|Overall Study|Positive drug test|1
1498196|NCT00485134|4932495|P5|Overall Study|Positive drug test|2
1498197|NCT00485134|4932496|P4|Overall Study|Positive drug test|0
1498198|NCT00485134|4932497|P3|Overall Study|Positive drug test|0
1498199|NCT00485134|4932498|P2|Overall Study|Positive drug test|0
1498200|NCT00485134|4932499|P1|Overall Study|Positive drug test|0
1498201|NCT00485134|4932492|P8|Overall Study|Withdrew for adverse event|0
1498202|NCT00485134|4932493|P7|Overall Study|Withdrew for adverse event|0
1498203|NCT00485134|4932494|P6|Overall Study|Withdrew for adverse event|0
1498204|NCT00485134|4932495|P5|Overall Study|Withdrew for adverse event|0
1498205|NCT00485134|4932496|P4|Overall Study|Withdrew for adverse event|0
1498206|NCT00485134|4932497|P3|Overall Study|Withdrew for adverse event|1
1498207|NCT00485134|4932498|P2|Overall Study|Withdrew for adverse event|0
1498208|NCT00485134|4932499|P1|Overall Study|Withdrew for adverse event|0
1498209|NCT00485134|4932492|P8|Overall Study|Change in health status|0
1498210|NCT00485134|4932493|P7|Overall Study|Change in health status|0
1498211|NCT00485134|4932494|P6|Overall Study|Change in health status|1
1498212|NCT00485134|4932495|P5|Overall Study|Change in health status|0
1498213|NCT00485134|4932496|P4|Overall Study|Change in health status|1
1498214|NCT00485134|4932497|P3|Overall Study|Change in health status|2
1498215|NCT00485134|4932498|P2|Overall Study|Change in health status|1
1498216|NCT00485134|4932499|P1|Overall Study|Change in health status|0
1498217|NCT00485134|4932492|P8|Overall Study|Withdrawal by Subject|0
1498218|NCT00485134|4932493|P7|Overall Study|Withdrawal by Subject|0
1498219|NCT00485134|4932494|P6|Overall Study|Withdrawal by Subject|0
1498220|NCT00485134|4932495|P5|Overall Study|Withdrawal by Subject|0
1498221|NCT00485134|4932496|P4|Overall Study|Withdrawal by Subject|0
1498222|NCT00485134|4932497|P3|Overall Study|Withdrawal by Subject|0
1498223|NCT00485134|4932498|P2|Overall Study|Withdrawal by Subject|1
1498224|NCT00485134|4932499|P1|Overall Study|Withdrawal by Subject|0
1498225|NCT00485134|4932492|P8|Overall Study|Lost to Follow-up|0
1498226|NCT00485134|4932493|P7|Overall Study|Lost to Follow-up|0
1498227|NCT00485134|4932494|P6|Overall Study|Lost to Follow-up|0
1498228|NCT00485134|4932495|P5|Overall Study|Lost to Follow-up|0
1498229|NCT00485134|4932496|P4|Overall Study|Lost to Follow-up|0
1498230|NCT00485134|4932497|P3|Overall Study|Lost to Follow-up|0
1498231|NCT00485134|4932498|P2|Overall Study|Lost to Follow-up|0
1498232|NCT00485134|4932499|P1|Overall Study|Lost to Follow-up|1
1498233|NCT00485069|4932521|P2|Overall Study|Withdrawal by Subject|6
1498234|NCT00485069|4932522|P1|Overall Study|Withdrawal by Subject|6
1498235|NCT00485069|4932521|P2|Overall Study|Protocol Violation|1
1498236|NCT00485069|4932522|P1|Overall Study|Protocol Violation|0
1498237|NCT00485069|4932521|P2|Overall Study|Lack of Efficacy|1
1498238|NCT00485069|4932522|P1|Overall Study|Lack of Efficacy|2
1498239|NCT00485069|4932521|P2|Overall Study|Adverse Event|4
1498240|NCT00485069|4932522|P1|Overall Study|Adverse Event|10
1498241|NCT00484939|4932567|P2|Overall Study|Reason Not Specified|6
1498242|NCT00484939|4932568|P1|Overall Study|Reason Not Specified|11
1498243|NCT00484939|4932567|P2|Overall Study|Screen Failure|2
1498244|NCT00484939|4932568|P1|Overall Study|Screen Failure|2
1498245|NCT00484939|4932567|P2|Overall Study|Disease progression|88
1498246|NCT00484939|4932568|P1|Overall Study|Disease progression|67
1498247|NCT00484939|4932567|P2|Overall Study|Discretion of Investigator or Sponsor|3
1498248|NCT00484939|4932568|P1|Overall Study|Discretion of Investigator or Sponsor|7
1498249|NCT00484939|4932567|P2|Overall Study|Lost to Follow-up|3
1498250|NCT00484939|4932568|P1|Overall Study|Lost to Follow-up|0
1498251|NCT00484939|4932567|P2|Overall Study|Protocol Violation|3
1498252|NCT00484939|4932568|P1|Overall Study|Protocol Violation|3
1498253|NCT00484939|4932567|P2|Overall Study|Patient Withdrew Consent|10
1498254|NCT00484939|4932568|P1|Overall Study|Patient Withdrew Consent|19
1498255|NCT00484939|4932567|P2|Overall Study|Adverse Event|12
1498256|NCT00484939|4932568|P1|Overall Study|Adverse Event|22
1498257|NCT00484939|4932567|P2|Overall Study|Death|13
1498258|NCT00484939|4932568|P1|Overall Study|Death|9
1498259|NCT00484679|4932595|P1|Overall Study|Withdrawal by Subject|3
1498260|NCT00484419|4932602|P3|Overall Study|sponsor decision, randomized in error|2
1498261|NCT00484419|4932603|P2|Overall Study|sponsor decision, randomized in error|0
1498262|NCT00484419|4932604|P1|Overall Study|sponsor decision, randomized in error|0
1498263|NCT00484419|4932602|P3|Overall Study|subject relocated|0
1498264|NCT00484419|4932603|P2|Overall Study|subject relocated|1
1498265|NCT00484419|4932604|P1|Overall Study|subject relocated|0
1498266|NCT00484419|4932602|P3|Overall Study|subject unable to receive medication|0
1498267|NCT00484419|4932603|P2|Overall Study|subject unable to receive medication|0
1498268|NCT00484419|4932604|P1|Overall Study|subject unable to receive medication|1
1498269|NCT00484419|4932602|P3|Overall Study|Physician Decision|1
1498270|NCT00484419|4932603|P2|Overall Study|Physician Decision|1
1498271|NCT00484419|4932604|P1|Overall Study|Physician Decision|1
1498272|NCT00484419|4932602|P3|Overall Study|required restricted medication|1
1498273|NCT00484419|4932603|P2|Overall Study|required restricted medication|0
1498274|NCT00484419|4932604|P1|Overall Study|required restricted medication|1
1498275|NCT00484419|4932602|P3|Overall Study|subject met discontinuation criteria|4
1498276|NCT00484419|4932603|P2|Overall Study|subject met discontinuation criteria|2
1498277|NCT00484419|4932604|P1|Overall Study|subject met discontinuation criteria|2
1498278|NCT00484419|4932602|P3|Overall Study|Withdrawal by Subject|1
1498279|NCT00484419|4932603|P2|Overall Study|Withdrawal by Subject|1
1498280|NCT00484419|4932604|P1|Overall Study|Withdrawal by Subject|3
1498281|NCT00484419|4932602|P3|Overall Study|Lost to Follow-up|2
1498282|NCT00484419|4932603|P2|Overall Study|Lost to Follow-up|0
1498283|NCT00484419|4932604|P1|Overall Study|Lost to Follow-up|1
1498284|NCT00484419|4932602|P3|Overall Study|Adverse Event|0
1498285|NCT00484419|4932603|P2|Overall Study|Adverse Event|0
1498286|NCT00484419|4932604|P1|Overall Study|Adverse Event|3
1498287|NCT00484315|4932671|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
1498288|NCT00484315|4932672|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
1498289|NCT00484315|4932671|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
1498290|NCT00484315|4932672|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
1498291|NCT00484315|4932671|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
1498292|NCT00484315|4932672|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
1498293|NCT00484315|4932671|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
1498294|NCT00484315|4932672|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
1498295|NCT00484315|4932671|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
1498296|NCT00484315|4932672|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
1498297|NCT00484315|4932671|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
1498298|NCT00484315|4932672|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
1498299|NCT00484315|4932671|P2|12-Month Clinical Follow-up|Death|2
1498300|NCT00484315|4932672|P1|12-Month Clinical Follow-up|Death|6
1498301|NCT00484289|4932683|P3|Post Marketing Phase|Adverse Event|0
1498302|NCT00484289|4932684|P2|Post Marketing Phase|Adverse Event|1
1498303|NCT00484289|4932685|P1|Post Marketing Phase|Adverse Event|0
1498304|NCT00484289|4932683|P3|Long Term Phase|Other Reason|1
1498305|NCT00484289|4932684|P2|Long Term Phase|Other Reason|5
1498306|NCT00484289|4932685|P1|Long Term Phase|Other Reason|0
1498307|NCT00484289|4932683|P3|Long Term Phase|Inadequate response|4
1498308|NCT00484289|4932684|P2|Long Term Phase|Inadequate response|7
1498309|NCT00484289|4932685|P1|Long Term Phase|Inadequate response|2
1498310|NCT00484289|4932683|P3|Long Term Phase|Withdrawal by Subject|6
1498311|NCT00484289|4932684|P2|Long Term Phase|Withdrawal by Subject|7
1498312|NCT00484289|4932685|P1|Long Term Phase|Withdrawal by Subject|0
1498313|NCT00484289|4932683|P3|Long Term Phase|Adverse Event|5
1498314|NCT00484289|4932684|P2|Long Term Phase|Adverse Event|17
1498315|NCT00484289|4932685|P1|Long Term Phase|Adverse Event|1
1498316|NCT00484185|4932757|P1|Overall Study|Death|2
1498317|NCT00484185|4932757|P1|Overall Study|Randomized but not treated|5
1498318|NCT00484185|4932757|P1|Overall Study|Other|20
1498319|NCT00484185|4932757|P1|Overall Study|Lost to Follow-up|44
1498320|NCT00484159|4932779|P3|Overall Study|Lost to Follow-up|0
1498321|NCT00484159|4932780|P2|Overall Study|Lost to Follow-up|1
1498322|NCT00484159|4932781|P1|Overall Study|Lost to Follow-up|1
1498323|NCT00484094|4932792|P1|Overall Study|Other|3
1498324|NCT00484094|4932792|P1|Overall Study|Discontinued|39
1498325|NCT00483938|4932808|P7|Overall Study|Other|32
1498326|NCT00483938|4932809|P6|Overall Study|Other|4
1498327|NCT00483938|4932810|P5|Overall Study|Other|0
1498328|NCT00483938|4932811|P4|Overall Study|Other|4
1498329|NCT00483938|4932812|P3|Overall Study|Other|0
1498330|NCT00483938|4932813|P2|Overall Study|Other|9
1498331|NCT00483938|4932814|P1|Overall Study|Other|3
1498332|NCT00483938|4932808|P7|Overall Study|Death|0
1498333|NCT00483938|4932809|P6|Overall Study|Death|0
1498334|NCT00483938|4932810|P5|Overall Study|Death|0
1498335|NCT00483938|4932811|P4|Overall Study|Death|0
1498336|NCT00483938|4932812|P3|Overall Study|Death|0
1498337|NCT00483938|4932813|P2|Overall Study|Death|2
1498338|NCT00483938|4932814|P1|Overall Study|Death|0
1498339|NCT00483938|4932808|P7|Overall Study|Lost to Follow-up|3
1498340|NCT00483938|4932809|P6|Overall Study|Lost to Follow-up|1
1498341|NCT00483938|4932810|P5|Overall Study|Lost to Follow-up|1
1498342|NCT00483938|4932811|P4|Overall Study|Lost to Follow-up|2
1498343|NCT00483938|4932812|P3|Overall Study|Lost to Follow-up|0
1498344|NCT00483938|4932813|P2|Overall Study|Lost to Follow-up|2
1498345|NCT00483938|4932814|P1|Overall Study|Lost to Follow-up|1
1498346|NCT00483938|4932808|P7|Overall Study|Withdrawal by Subject|2
1498347|NCT00483938|4932809|P6|Overall Study|Withdrawal by Subject|3
1498348|NCT00483938|4932810|P5|Overall Study|Withdrawal by Subject|1
1498349|NCT00483938|4932811|P4|Overall Study|Withdrawal by Subject|0
1498350|NCT00483938|4932812|P3|Overall Study|Withdrawal by Subject|0
1498351|NCT00483938|4932813|P2|Overall Study|Withdrawal by Subject|6
1498352|NCT00483938|4932814|P1|Overall Study|Withdrawal by Subject|1
1498353|NCT00483938|4932808|P7|Overall Study|Protocol Violation|3
1498354|NCT00483938|4932809|P6|Overall Study|Protocol Violation|0
1498355|NCT00483938|4932810|P5|Overall Study|Protocol Violation|0
1498356|NCT00483938|4932811|P4|Overall Study|Protocol Violation|0
1498357|NCT00483938|4932812|P3|Overall Study|Protocol Violation|0
1498358|NCT00483938|4932813|P2|Overall Study|Protocol Violation|0
1498359|NCT00483938|4932814|P1|Overall Study|Protocol Violation|0
1498360|NCT00483756|4932838|P3|Overall Study|Randomized, Not Treated|4
1498361|NCT00483756|4932839|P2|Overall Study|Randomized, Not Treated|4
1498362|NCT00483756|4932840|P1|Overall Study|Randomized, Not Treated|1
1498363|NCT00483756|4932838|P3|Overall Study|Other|3
1498364|NCT00483756|4932839|P2|Overall Study|Other|4
1498365|NCT00483756|4932840|P1|Overall Study|Other|2
1498366|NCT00483756|4932838|P3|Overall Study|Withdrawal by Subject|4
1498367|NCT00483756|4932839|P2|Overall Study|Withdrawal by Subject|3
1498368|NCT00483756|4932840|P1|Overall Study|Withdrawal by Subject|5
1498369|NCT00483756|4932838|P3|Overall Study|Lost to Follow-up|0
1498370|NCT00483756|4932839|P2|Overall Study|Lost to Follow-up|1
1498371|NCT00483756|4932840|P1|Overall Study|Lost to Follow-up|3
1498372|NCT00483756|4932838|P3|Overall Study|Lack of Efficacy|0
1498373|NCT00483756|4932839|P2|Overall Study|Lack of Efficacy|0
1498374|NCT00483756|4932840|P1|Overall Study|Lack of Efficacy|1
1498375|NCT00483756|4932838|P3|Overall Study|Adverse Event|40
1498376|NCT00483756|4932839|P2|Overall Study|Adverse Event|38
1498377|NCT00483756|4932840|P1|Overall Study|Adverse Event|19
1498378|NCT00483756|4932838|P3|Overall Study|Death|1
1498379|NCT00483756|4932839|P2|Overall Study|Death|0
1498380|NCT00483756|4932840|P1|Overall Study|Death|2
1498381|NCT00483717|4932904|P2|Overall Study|Withdrawal by Subject|0
1498382|NCT00483717|4932905|P1|Overall Study|Withdrawal by Subject|1
1498383|NCT00483717|4932904|P2|Overall Study|Lost to Follow-up|0
1498384|NCT00483717|4932905|P1|Overall Study|Lost to Follow-up|1
1498385|NCT00483717|4932904|P2|Overall Study|No treatment for migraine|13
1498386|NCT00483717|4932905|P1|Overall Study|No treatment for migraine|16
1498387|NCT00483717|4932904|P2|Overall Study|Time of dosing missing|1
1498388|NCT00483717|4932905|P1|Overall Study|Time of dosing missing|1
1498389|NCT00483717|4932904|P2|Overall Study|Protocol Violation|7
1498390|NCT00483717|4932905|P1|Overall Study|Protocol Violation|5
1498391|NCT00483704|4932928|P3|Treatment|Physician Decision|4
1498392|NCT00483704|4932929|P2|Treatment|Physician Decision|1
1498393|NCT00483704|4932930|P1|Treatment|Physician Decision|0
1498394|NCT00483704|4932928|P3|Treatment|Pregnancy|0
1498395|NCT00483704|4932929|P2|Treatment|Pregnancy|1
1498396|NCT00483704|4932930|P1|Treatment|Pregnancy|0
1498397|NCT00483704|4932928|P3|Treatment|Lack of Efficacy|1
1498398|NCT00483704|4932929|P2|Treatment|Lack of Efficacy|1
1498399|NCT00483704|4932930|P1|Treatment|Lack of Efficacy|1
1498400|NCT00483704|4932928|P3|Treatment|Lost to Follow-up|5
1498401|NCT00483704|4932929|P2|Treatment|Lost to Follow-up|7
1498402|NCT00483704|4932930|P1|Treatment|Lost to Follow-up|2
1498403|NCT00483704|4932928|P3|Treatment|Protocol Violation|5
1498404|NCT00483704|4932929|P2|Treatment|Protocol Violation|3
1498405|NCT00483704|4932930|P1|Treatment|Protocol Violation|6
1498406|NCT00483704|4932928|P3|Treatment|Withdrawal by Subject|21
1498407|NCT00483704|4932929|P2|Treatment|Withdrawal by Subject|12
1498408|NCT00483704|4932930|P1|Treatment|Withdrawal by Subject|16
1498409|NCT00483704|4932928|P3|Treatment|Adverse Event|4
1498410|NCT00483704|4932929|P2|Treatment|Adverse Event|5
1498411|NCT00483704|4932930|P1|Treatment|Adverse Event|3
1498412|NCT00483704|4932928|P3|Treatment|Lack of qualifying migraines|116
1498413|NCT00483704|4932929|P2|Treatment|Lack of qualifying migraines|99
1498414|NCT00483704|4932930|P1|Treatment|Lack of qualifying migraines|101
1498415|NCT00483704|4932928|P3|Randomization|Lack of qualifying migraines|31
1498416|NCT00483704|4932929|P2|Randomization|Lack of qualifying migraines|25
1498417|NCT00483704|4932930|P1|Randomization|Lack of qualifying migraines|21
1498418|NCT00483704|4932928|P3|Randomization|Progressive disease|1
1498419|NCT00483704|4932929|P2|Randomization|Progressive disease|0
1498420|NCT00483704|4932930|P1|Randomization|Progressive disease|0
1498421|NCT00483704|4932928|P3|Randomization|Physician Decision|0
1498422|NCT00483704|4932929|P2|Randomization|Physician Decision|4
1498423|NCT00483704|4932930|P1|Randomization|Physician Decision|2
1498424|NCT00483704|4932928|P3|Randomization|Pregnancy|0
1498425|NCT00483704|4932929|P2|Randomization|Pregnancy|0
1498426|NCT00483704|4932930|P1|Randomization|Pregnancy|1
1498427|NCT00483704|4932928|P3|Randomization|Lost to Follow-up|19
1498428|NCT00483704|4932929|P2|Randomization|Lost to Follow-up|14
1498429|NCT00483704|4932930|P1|Randomization|Lost to Follow-up|14
1498430|NCT00483704|4932928|P3|Randomization|Protocol Violation|22
1498431|NCT00483704|4932929|P2|Randomization|Protocol Violation|25
1498432|NCT00483704|4932930|P1|Randomization|Protocol Violation|14
1498433|NCT00483704|4932928|P3|Randomization|Withdrawal by Subject|18
1498434|NCT00483704|4932929|P2|Randomization|Withdrawal by Subject|28
1498435|NCT00483704|4932930|P1|Randomization|Withdrawal by Subject|19
1498436|NCT00483652|4932976|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
1498437|NCT00483652|4932977|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
1498438|NCT00483652|4932976|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
1498439|NCT00483652|4932977|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
1498440|NCT00483652|4932976|P2|Double-blind Treatment Period|Adverse Event|4
1498441|NCT00483652|4932977|P1|Double-blind Treatment Period|Adverse Event|3
1498442|NCT00483652|4932976|P2|Double-blind Treatment Period|Protocol Violation|1
1498443|NCT00483652|4932977|P1|Double-blind Treatment Period|Protocol Violation|2
1498444|NCT00483574|4932987|P2|Overall Study|Withdrawal by Subject|0
1498445|NCT00483574|4932988|P1|Overall Study|Withdrawal by Subject|52
1498446|NCT00483574|4932987|P2|Overall Study|Lost to Follow-up|4
1498447|NCT00483574|4932988|P1|Overall Study|Lost to Follow-up|16
1498448|NCT00483574|4932987|P2|Overall Study|Protocol Violation|9
1498449|NCT00483574|4932988|P1|Overall Study|Protocol Violation|28
1498450|NCT00483574|4932987|P2|Overall Study|Adverse Event|0
1498451|NCT00483574|4932988|P1|Overall Study|Adverse Event|6
1498452|NCT00483548|4933002|P2|Overall Study|Withdrawal by Subject|2
1498453|NCT00483548|4933003|P1|Overall Study|Withdrawal by Subject|5
1498454|NCT00483548|4933002|P2|Overall Study|Lost to Follow-up|4
1498455|NCT00483548|4933003|P1|Overall Study|Lost to Follow-up|3
1498456|NCT00483548|4933002|P2|Overall Study|Non-compliance with medication|0
1498457|NCT00483548|4933003|P1|Overall Study|Non-compliance with medication|2
1498458|NCT00483548|4933002|P2|Overall Study|Unable to comply with protocol schedule|0
1498459|NCT00483548|4933003|P1|Overall Study|Unable to comply with protocol schedule|1
1498460|NCT00483548|4933002|P2|Overall Study|Protocol required discontinuation|6
1498461|NCT00483548|4933003|P1|Overall Study|Protocol required discontinuation|6
1498462|NCT00483548|4933002|P2|Overall Study|Pregnancy|0
1498463|NCT00483548|4933003|P1|Overall Study|Pregnancy|1
1498464|NCT00483548|4933002|P2|Overall Study|Protocol Violation|7
1498465|NCT00483548|4933003|P1|Overall Study|Protocol Violation|11
1498466|NCT00483548|4933002|P2|Overall Study|Lack of Efficacy|8
1498467|NCT00483548|4933003|P1|Overall Study|Lack of Efficacy|4
1498468|NCT00483548|4933002|P2|Overall Study|Laboratory abnormality|2
1498469|NCT00483548|4933003|P1|Overall Study|Laboratory abnormality|1
1498470|NCT00483548|4933002|P2|Overall Study|Adverse Event|14
1498471|NCT00483548|4933003|P1|Overall Study|Adverse Event|25
1498472|NCT00483548|4933002|P2|Overall Study|Randomized; not treated with study drug|3
1498473|NCT00483548|4933003|P1|Overall Study|Randomized; not treated with study drug|1
1498474|NCT00483405|4933053|P1|Overall Study|Other complicating disease|1
1498475|NCT00483405|4933053|P1|Overall Study|Withdrawal by Subject|2
1498476|NCT00483405|4933053|P1|Overall Study|Death|3
1498477|NCT00483405|4933053|P1|Overall Study|Lack of Efficacy|14
1498478|NCT00483405|4933053|P1|Overall Study|Adverse Event|8
1498479|NCT00483379|4933062|P2|Treatment Period|Withdrawal by Subject|0
1498480|NCT00483379|4933063|P1|Treatment Period|Withdrawal by Subject|1
1498481|NCT00483379|4933062|P2|Treatment Period|Adverse Event|0
1498482|NCT00483379|4933063|P1|Treatment Period|Adverse Event|1
1498483|NCT00483327|4933099|P1|Overall Study|Patient Non Compliance|2
1498484|NCT00483327|4933099|P1|Overall Study|Lost to Follow-up|4
1498485|NCT00483327|4933099|P1|Overall Study|Withdrawal by Subject|3
1498486|NCT00483327|4933099|P1|Overall Study|Adverse Event|1
1498487|NCT00483184|4933131|P3|Overall Study|Protocol Violation|1
1498488|NCT00483184|4933132|P2|Overall Study|Protocol Violation|0
1498489|NCT00483184|4933133|P1|Overall Study|Protocol Violation|1
1498490|NCT00483184|4933131|P3|Overall Study|Adverse Event|2
1498491|NCT00483184|4933132|P2|Overall Study|Adverse Event|2
1498492|NCT00483184|4933133|P1|Overall Study|Adverse Event|1
1498493|NCT00483184|4933131|P3|Overall Study|Lost to Follow-up|0
1498494|NCT00483184|4933132|P2|Overall Study|Lost to Follow-up|0
1498495|NCT00483184|4933133|P1|Overall Study|Lost to Follow-up|1
1498496|NCT00483184|4933131|P3|Overall Study|Withdrawal by Subject|0
1498497|NCT00483184|4933132|P2|Overall Study|Withdrawal by Subject|2
1498498|NCT00483184|4933133|P1|Overall Study|Withdrawal by Subject|2
1498499|NCT00483119|4933143|P2|Overall Study|Physician Decision|0
1498500|NCT00483119|4933144|P1|Overall Study|Physician Decision|1
1498501|NCT00483119|4933143|P2|Overall Study|Adverse Event|1
1498502|NCT00483119|4933144|P1|Overall Study|Adverse Event|0
1498503|NCT00483041|4933158|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
1498504|NCT00483041|4933159|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
1498505|NCT00483002|4933189|P1|Overall Study|Other|967
1498506|NCT00483002|4933189|P1|Overall Study|Other|2
1498507|NCT00483002|4933189|P1|Overall Study|Lost to Follow-up|962
1498508|NCT00483002|4933189|P1|Overall Study|Lack of Efficacy|555
1498509|NCT00483002|4933189|P1|Overall Study|Adverse Event|68
1498510|NCT00482729|4933214|P2|Overall Study|Withdrawal by Subject|69
1498511|NCT00482729|4933215|P1|Overall Study|Withdrawal by Subject|67
1498512|NCT00482729|4933214|P2|Overall Study|Protocol Violation|18
1498513|NCT00482729|4933215|P1|Overall Study|Protocol Violation|10
1498514|NCT00482729|4933214|P2|Overall Study|Pregnancy|2
1498515|NCT00482729|4933215|P1|Overall Study|Pregnancy|4
1498516|NCT00482729|4933214|P2|Overall Study|Physician Decision|7
1498517|NCT00482729|4933215|P1|Overall Study|Physician Decision|10
1498518|NCT00482729|4933214|P2|Overall Study|Lost to Follow-up|66
1498519|NCT00482729|4933215|P1|Overall Study|Lost to Follow-up|86
1498520|NCT00482729|4933214|P2|Overall Study|Lack of Efficacy|16
1498521|NCT00482729|4933215|P1|Overall Study|Lack of Efficacy|4
1498522|NCT00482729|4933214|P2|Overall Study|Hyperglycemia Criteria|5
1498523|NCT00482729|4933215|P1|Overall Study|Hyperglycemia Criteria|7
1498524|NCT00482729|4933214|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
1498525|NCT00482729|4933215|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
1498526|NCT00482729|4933214|P2|Overall Study|Adverse Event|33
1498527|NCT00482729|4933215|P1|Overall Study|Adverse Event|29
1498528|NCT00482703|4933231|P2|Overall Study|Poor compliance|0
1498529|NCT00482703|4933232|P1|Overall Study|Poor compliance|1
1498530|NCT00482612|4933303|P4|Follow-up Period|Reasons not related to trial|3
1498531|NCT00482612|4933304|P3|Follow-up Period|Reasons not related to trial|1
1498532|NCT00482612|4933305|P2|Follow-up Period|Reasons not related to trial|0
1498533|NCT00482612|4933306|P1|Follow-up Period|Reasons not related to trial|1
1498534|NCT00482612|4933303|P4|Follow-up Period|Withdrawal by Subject|2
1498535|NCT00482612|4933304|P3|Follow-up Period|Withdrawal by Subject|7
1498536|NCT00482612|4933305|P2|Follow-up Period|Withdrawal by Subject|5
1498537|NCT00482612|4933306|P1|Follow-up Period|Withdrawal by Subject|3
1498538|NCT00482612|4933303|P4|Follow-up Period|Lack of Efficacy|0
1498539|NCT00482612|4933304|P3|Follow-up Period|Lack of Efficacy|1
1498540|NCT00482612|4933305|P2|Follow-up Period|Lack of Efficacy|0
1498541|NCT00482612|4933306|P1|Follow-up Period|Lack of Efficacy|2
1498542|NCT00482612|4933303|P4|Follow-up Period|Adverse Event|0
1498543|NCT00482612|4933304|P3|Follow-up Period|Adverse Event|9
1498544|NCT00482612|4933305|P2|Follow-up Period|Adverse Event|7
1498545|NCT00482612|4933306|P1|Follow-up Period|Adverse Event|4
1498546|NCT00482612|4933303|P4|Follow-up Period|Lost to Follow-up|1
1498547|NCT00482612|4933304|P3|Follow-up Period|Lost to Follow-up|2
1498548|NCT00482612|4933305|P2|Follow-up Period|Lost to Follow-up|4
1498549|NCT00482612|4933306|P1|Follow-up Period|Lost to Follow-up|0
1498550|NCT00482612|4933303|P4|Follow-up Period|Lack of compliance|0
1498551|NCT00482612|4933304|P3|Follow-up Period|Lack of compliance|1
1498552|NCT00482612|4933305|P2|Follow-up Period|Lack of compliance|0
1498553|NCT00482612|4933306|P1|Follow-up Period|Lack of compliance|0
1498554|NCT00482612|4933303|P4|Follow-up Period|Other|2
1498555|NCT00482612|4933304|P3|Follow-up Period|Other|1
1498556|NCT00482612|4933305|P2|Follow-up Period|Other|2
1498557|NCT00482612|4933306|P1|Follow-up Period|Other|4
1498558|NCT00482612|4933303|P4|In-treatment Period|No study medication administered|0
1498559|NCT00482612|4933304|P3|In-treatment Period|No study medication administered|1
1498560|NCT00482612|4933305|P2|In-treatment Period|No study medication administered|0
1498561|NCT00482612|4933306|P1|In-treatment Period|No study medication administered|0
1498562|NCT00482391|4933355|P1|Overall Study|Death|1
1498563|NCT00482391|4933355|P1|Overall Study|Adverse Event|1
1498564|NCT00482391|4933355|P1|Overall Study|Withdrawal by Subject|1
1498565|NCT00482274|4933360|P1|Overall Study|Adverse Event|1
1498566|NCT00482170|4933370|P2|Overall Study|Unspecified reason|2
1498567|NCT00482170|4933371|P1|Overall Study|Unspecified reason|0
1498568|NCT00482170|4933370|P2|Overall Study|Lost to Follow-up|0
1498569|NCT00482170|4933371|P1|Overall Study|Lost to Follow-up|2
1498570|NCT00482170|4933370|P2|Overall Study|Protocol Violation|3
1498571|NCT00482170|4933371|P1|Overall Study|Protocol Violation|2
1498572|NCT00482170|4933370|P2|Overall Study|Withdrawal by Subject|1
1498573|NCT00482170|4933371|P1|Overall Study|Withdrawal by Subject|6
1498574|NCT00482170|4933370|P2|Overall Study|Adverse Event|14
1498575|NCT00482170|4933371|P1|Overall Study|Adverse Event|5
1498576|NCT00482053|4933489|P1|Inter-treatment Period|Disease progression|1
1498577|NCT00482014|4933503|P4|Overall Study|Sponsor Decision|1
1498578|NCT00482014|4933504|P3|Overall Study|Sponsor Decision|1
1498579|NCT00482014|4933505|P2|Overall Study|Sponsor Decision|2
1498580|NCT00482014|4933506|P1|Overall Study|Sponsor Decision|1
1498581|NCT00482014|4933503|P4|Overall Study|Lack of Efficacy|6
1498582|NCT00482014|4933504|P3|Overall Study|Lack of Efficacy|4
1498583|NCT00482014|4933505|P2|Overall Study|Lack of Efficacy|0
1498584|NCT00482014|4933506|P1|Overall Study|Lack of Efficacy|1
1498585|NCT00482014|4933503|P4|Overall Study|Death|4
1498586|NCT00482014|4933504|P3|Overall Study|Death|1
1498587|NCT00482014|4933505|P2|Overall Study|Death|2
1498588|NCT00482014|4933506|P1|Overall Study|Death|1
1498589|NCT00482014|4933503|P4|Overall Study|Adverse Event|8
1498590|NCT00482014|4933504|P3|Overall Study|Adverse Event|2
1498591|NCT00482014|4933505|P2|Overall Study|Adverse Event|0
1498592|NCT00482014|4933506|P1|Overall Study|Adverse Event|3
1498593|NCT00482014|4933503|P4|Overall Study|Withdrawal by Subject|4
1498594|NCT00482014|4933504|P3|Overall Study|Withdrawal by Subject|3
1498595|NCT00482014|4933505|P2|Overall Study|Withdrawal by Subject|2
1498596|NCT00482014|4933506|P1|Overall Study|Withdrawal by Subject|1
1498597|NCT00481988|4933530|P2|Overall Study|Withdrawal by Subject|1
1498598|NCT00481988|4933531|P1|Overall Study|Withdrawal by Subject|1
1498599|NCT00481871|4933544|P5|Overall Study|Progressive Disease - pt withdrew|0
1498600|NCT00481871|4933545|P4|Overall Study|Progressive Disease - pt withdrew|0
1498601|NCT00481871|4933546|P3|Overall Study|Progressive Disease - pt withdrew|1
1498602|NCT00481871|4933547|P2|Overall Study|Progressive Disease - pt withdrew|0
1498603|NCT00481871|4933548|P1|Overall Study|Progressive Disease - pt withdrew|0
1498604|NCT00481832|4933573|P1|Inter-transplant Period|Lack of allogeneic donor|5
1498605|NCT00481832|4933573|P1|Inter-transplant Period|Disease relapse|11
1498606|NCT00481832|4933573|P1|Inter-transplant Period|Physician Decision|4
1498607|NCT00481832|4933573|P1|Inter-transplant Period|Death|3
1498608|NCT00481832|4933573|P1|Inter-transplant Period|Adverse Event|4
1498609|NCT00481832|4933573|P1|Enrollment|Unable to collect enough stem cells|2
1498610|NCT00481832|4933573|P1|Enrollment|Physician Decision|8
1498611|NCT00481767|4933588|P2|Overall Study|Lost to Follow-up|10
1498612|NCT00481767|4933589|P1|Overall Study|Lost to Follow-up|16
1498613|NCT00481767|4933588|P2|Overall Study|Withdrawal by Subject|11
1498614|NCT00481767|4933589|P1|Overall Study|Withdrawal by Subject|16
1498615|NCT00481676|4933623|P2|Overall Study|Administrative problem|0
1498616|NCT00481676|4933624|P1|Overall Study|Administrative problem|1
1498617|NCT00481676|4933623|P2|Overall Study|Unsatisfactory therapeutic effect|4
1498618|NCT00481676|4933624|P1|Overall Study|Unsatisfactory therapeutic effect|1
1498619|NCT00481676|4933623|P2|Overall Study|Adverse Event|1
1498620|NCT00481676|4933624|P1|Overall Study|Adverse Event|0
1498621|NCT00481247|4933674|P2|Overall Study|Did not receive treatment|2
1498622|NCT00481247|4933675|P1|Overall Study|Did not receive treatment|1
1498623|NCT00481247|4933674|P2|Overall Study|Varied|15
1498624|NCT00481247|4933675|P1|Overall Study|Varied|6
1498625|NCT00481247|4933674|P2|Overall Study|Administrative reason by sponsor|162
1498626|NCT00481247|4933675|P1|Overall Study|Administrative reason by sponsor|157
1498627|NCT00481247|4933674|P2|Overall Study|Poor compliance/noncompliance|7
1498628|NCT00481247|4933675|P1|Overall Study|Poor compliance/noncompliance|1
1498629|NCT00481247|4933674|P2|Overall Study|Lost to Follow-up|2
1498630|NCT00481247|4933675|P1|Overall Study|Lost to Follow-up|1
1498631|NCT00481247|4933674|P2|Overall Study|Pregnancy|1
1498632|NCT00481247|4933675|P1|Overall Study|Pregnancy|2
1498633|NCT00481247|4933674|P2|Overall Study|Withdrawal by Subject|13
1498634|NCT00481247|4933675|P1|Overall Study|Withdrawal by Subject|8
1498635|NCT00481247|4933674|P2|Overall Study|AE unrelated to study drug|4
1498636|NCT00481247|4933675|P1|Overall Study|AE unrelated to study drug|13
1498637|NCT00481247|4933674|P2|Overall Study|Treatment failure|14
1498638|NCT00481247|4933675|P1|Overall Study|Treatment failure|10
1498639|NCT00481247|4933674|P2|Overall Study|Intolerance|17
1498640|NCT00481247|4933675|P1|Overall Study|Intolerance|42
1498641|NCT00481247|4933674|P2|Overall Study|Disease progression|22
1498642|NCT00481247|4933675|P1|Overall Study|Disease progression|18
1498643|NCT00481247|4933674|P2|Overall Study|Death|1
1498644|NCT00481247|4933675|P1|Overall Study|Death|0
1498645|NCT00481195|4933699|P2|Overall Study|Miscellaneous|2
1498646|NCT00481195|4933700|P1|Overall Study|Miscellaneous|2
1498647|NCT00481195|4933699|P2|Overall Study|Withdrawal by Subject|9
1498648|NCT00481195|4933700|P1|Overall Study|Withdrawal by Subject|3
1498649|NCT00481195|4933699|P2|Overall Study|Protocol Violation|7
1498650|NCT00481195|4933700|P1|Overall Study|Protocol Violation|10
1498651|NCT00481195|4933699|P2|Overall Study|Physician Decision|1
1498652|NCT00481195|4933700|P1|Overall Study|Physician Decision|3
1498653|NCT00481195|4933699|P2|Overall Study|Lost to Follow-up|6
1498654|NCT00481195|4933700|P1|Overall Study|Lost to Follow-up|4
1498655|NCT00481195|4933699|P2|Overall Study|Lack of Efficacy|3
1498656|NCT00481195|4933700|P1|Overall Study|Lack of Efficacy|1
1498657|NCT00481195|4933699|P2|Overall Study|Adverse Event|11
1498658|NCT00481195|4933700|P1|Overall Study|Adverse Event|16
1498659|NCT00481078|4933786|P2|Overall Study|Brain metastasis|1
1498660|NCT00481078|4933787|P1|Overall Study|Brain metastasis|0
1498661|NCT00481078|4933786|P2|Overall Study|Received other treatment|1
1498662|NCT00481078|4933787|P1|Overall Study|Received other treatment|2
1498663|NCT00481078|4933786|P2|Overall Study|Information not available|0
1498664|NCT00481078|4933787|P1|Overall Study|Information not available|1
1498665|NCT00481078|4933786|P2|Overall Study|Withdrawal by Subject|1
1498666|NCT00481078|4933787|P1|Overall Study|Withdrawal by Subject|7
1498667|NCT00481078|4933786|P2|Overall Study|Intercurrent illness|0
1498668|NCT00481078|4933787|P1|Overall Study|Intercurrent illness|1
1498669|NCT00481078|4933786|P2|Overall Study|Death|3
1498670|NCT00481078|4933787|P1|Overall Study|Death|5
1498671|NCT00481078|4933786|P2|Overall Study|Adverse Event|3
1498672|NCT00481078|4933787|P1|Overall Study|Adverse Event|15
1498673|NCT00481078|4933786|P2|Overall Study|Progression of disease|11
1498674|NCT00481078|4933787|P1|Overall Study|Progression of disease|11
1498675|NCT00481065|4933805|P8|Overall Study|Unable to classify|0
1498676|NCT00481065|4933806|P7|Overall Study|Unable to classify|0
1498677|NCT00481065|4933807|P6|Overall Study|Unable to classify|0
1498678|NCT00481065|4933808|P5|Overall Study|Unable to classify|1
1498679|NCT00481065|4933809|P4|Overall Study|Unable to classify|0
1498680|NCT00481065|4933810|P3|Overall Study|Unable to classify|2
1498681|NCT00481065|4933811|P2|Overall Study|Unable to classify|1
1498682|NCT00481065|4933812|P1|Overall Study|Unable to classify|0
1498683|NCT00481065|4933805|P8|Overall Study|Protocol Violation|2
1498684|NCT00481065|4933806|P7|Overall Study|Protocol Violation|3
1498685|NCT00481065|4933807|P6|Overall Study|Protocol Violation|6
1498686|NCT00481065|4933808|P5|Overall Study|Protocol Violation|2
1498687|NCT00481065|4933809|P4|Overall Study|Protocol Violation|1
1498688|NCT00481065|4933810|P3|Overall Study|Protocol Violation|1
1498689|NCT00481065|4933811|P2|Overall Study|Protocol Violation|1
1498690|NCT00481065|4933812|P1|Overall Study|Protocol Violation|2
1498691|NCT00481065|4933805|P8|Overall Study|Administrative reason|0
1498692|NCT00481065|4933806|P7|Overall Study|Administrative reason|1
1498693|NCT00481065|4933807|P6|Overall Study|Administrative reason|2
1498694|NCT00481065|4933808|P5|Overall Study|Administrative reason|0
1498695|NCT00481065|4933809|P4|Overall Study|Administrative reason|0
1498696|NCT00481065|4933810|P3|Overall Study|Administrative reason|0
1498697|NCT00481065|4933811|P2|Overall Study|Administrative reason|0
1498698|NCT00481065|4933812|P1|Overall Study|Administrative reason|0
1498699|NCT00481065|4933805|P8|Overall Study|Inappropriate enrollment|1
1498700|NCT00481065|4933806|P7|Overall Study|Inappropriate enrollment|0
1498701|NCT00481065|4933807|P6|Overall Study|Inappropriate enrollment|1
1498702|NCT00481065|4933808|P5|Overall Study|Inappropriate enrollment|2
1498703|NCT00481065|4933809|P4|Overall Study|Inappropriate enrollment|0
1498704|NCT00481065|4933810|P3|Overall Study|Inappropriate enrollment|2
1498705|NCT00481065|4933811|P2|Overall Study|Inappropriate enrollment|0
1498706|NCT00481065|4933812|P1|Overall Study|Inappropriate enrollment|4
1498707|NCT00481065|4933805|P8|Overall Study|Lost to Follow-up|5
1498708|NCT00481065|4933806|P7|Overall Study|Lost to Follow-up|2
1498709|NCT00481065|4933807|P6|Overall Study|Lost to Follow-up|3
1498710|NCT00481065|4933808|P5|Overall Study|Lost to Follow-up|3
1498711|NCT00481065|4933809|P4|Overall Study|Lost to Follow-up|3
1498712|NCT00481065|4933810|P3|Overall Study|Lost to Follow-up|4
1498713|NCT00481065|4933811|P2|Overall Study|Lost to Follow-up|2
1498714|NCT00481065|4933812|P1|Overall Study|Lost to Follow-up|4
1498715|NCT00481065|4933805|P8|Overall Study|Withdrawal by Subject|10
1498716|NCT00481065|4933806|P7|Overall Study|Withdrawal by Subject|9
1498717|NCT00481065|4933807|P6|Overall Study|Withdrawal by Subject|12
1498718|NCT00481065|4933808|P5|Overall Study|Withdrawal by Subject|13
1498719|NCT00481065|4933809|P4|Overall Study|Withdrawal by Subject|11
1498720|NCT00481065|4933810|P3|Overall Study|Withdrawal by Subject|7
1498721|NCT00481065|4933811|P2|Overall Study|Withdrawal by Subject|12
1498722|NCT00481065|4933812|P1|Overall Study|Withdrawal by Subject|11
1498723|NCT00481065|4933805|P8|Overall Study|Adverse event or death|1
1498724|NCT00481065|4933806|P7|Overall Study|Adverse event or death|1
1498725|NCT00481065|4933807|P6|Overall Study|Adverse event or death|0
1498726|NCT00481065|4933808|P5|Overall Study|Adverse event or death|2
1498727|NCT00481065|4933809|P4|Overall Study|Adverse event or death|0
1498728|NCT00481065|4933810|P3|Overall Study|Adverse event or death|3
1498729|NCT00481065|4933811|P2|Overall Study|Adverse event or death|1
1498730|NCT00481065|4933812|P1|Overall Study|Adverse event or death|1
1498731|NCT00480857|4933902|P1|Overall Study|Lack of Efficacy|2
1498732|NCT00480779|4933912|P2|Overall Study|Job and Health-related|3
1498733|NCT00480779|4933913|P1|Overall Study|Job and Health-related|0
1498734|NCT00480779|4933912|P2|Overall Study|Other|0
1498735|NCT00480779|4933913|P1|Overall Study|Other|2
1498736|NCT00480636|4933950|P1|Overall Study|Lost to follow-up; subsequently died|1
1498737|NCT00480636|4933950|P1|Overall Study|Other|2
1498738|NCT00480636|4933950|P1|Overall Study|Lost to Follow-up|4
1498739|NCT00480636|4933950|P1|Overall Study|Death|12
1498740|NCT00480532|4933962|P4|Overall Study|Protocol Violation|0
1498741|NCT00480532|4933963|P3|Overall Study|Protocol Violation|1
1498742|NCT00480532|4933964|P2|Overall Study|Protocol Violation|0
1498743|NCT00480532|4933965|P1|Overall Study|Protocol Violation|0
1498744|NCT00480532|4933962|P4|Overall Study|Withdrawal by Subject|1
1498745|NCT00480532|4933963|P3|Overall Study|Withdrawal by Subject|3
1498746|NCT00480532|4933964|P2|Overall Study|Withdrawal by Subject|4
1498747|NCT00480532|4933965|P1|Overall Study|Withdrawal by Subject|2
1498748|NCT00480493|4933985|P2|Overall Study|moved|7
1498749|NCT00480493|4933986|P1|Overall Study|moved|2
1498750|NCT00480324|4933998|P2|Overall Study|Subject’s mother pregnant|1
1498751|NCT00480324|4933999|P1|Overall Study|Subject’s mother pregnant|0
1498752|NCT00480324|4933998|P2|Overall Study|Lost to Follow-up|8
1498753|NCT00480324|4933999|P1|Overall Study|Lost to Follow-up|17
1498754|NCT00480324|4933998|P2|Overall Study|Withdrawal by Subject|5
1498755|NCT00480324|4933999|P1|Overall Study|Withdrawal by Subject|14
1498756|NCT00480324|4933998|P2|Overall Study|Protocol Violation|1
1498757|NCT00480324|4933999|P1|Overall Study|Protocol Violation|0
1498758|NCT00480324|4933998|P2|Overall Study|Adverse Event|1
1498759|NCT00480324|4933999|P1|Overall Study|Adverse Event|1
1498760|NCT00479882|4934029|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
1498761|NCT00479882|4934030|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
1498762|NCT00479882|4934031|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
1498763|NCT00479882|4934032|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
1498764|NCT00479882|4934029|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
1498765|NCT00479882|4934030|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
1498766|NCT00479882|4934031|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
1498767|NCT00479882|4934032|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
1498768|NCT00479882|4934029|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
1498769|NCT00479882|4934030|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
1498770|NCT00479882|4934031|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
1498771|NCT00479882|4934032|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
1498772|NCT00479882|4934029|P4|Crossover: Period III (Weeks 13-20)|Other|2
1498773|NCT00479882|4934030|P3|Crossover: Period III (Weeks 13-20)|Other|2
1498774|NCT00479882|4934031|P2|Crossover: Period III (Weeks 13-20)|Other|0
1498775|NCT00479882|4934032|P1|Crossover: Period III (Weeks 13-20)|Other|5
1498776|NCT00479882|4934029|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
1498777|NCT00479882|4934030|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
1498778|NCT00479882|4934031|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
1498779|NCT00479882|4934032|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
1498780|NCT00479882|4934029|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
1498781|NCT00479882|4934030|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
1498782|NCT00479882|4934031|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
1498783|NCT00479882|4934032|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
1498784|NCT00479882|4934029|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
1498785|NCT00479882|4934030|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
1498786|NCT00479882|4934031|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
1498787|NCT00479882|4934032|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
1498788|NCT00479882|4934029|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
1498789|NCT00479882|4934030|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
1498790|NCT00479882|4934031|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
1498791|NCT00479882|4934032|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
1498792|NCT00479882|4934029|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
1498793|NCT00479882|4934030|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
1498794|NCT00479882|4934031|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
1498795|NCT00479882|4934032|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
1498796|NCT00479882|4934029|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
1498797|NCT00479882|4934030|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
1498798|NCT00479882|4934031|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
1498799|NCT00479882|4934032|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
1498800|NCT00479882|4934029|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
1498801|NCT00479882|4934030|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
1498802|NCT00479882|4934031|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
1498803|NCT00479882|4934032|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
1498804|NCT00479882|4934029|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
1498805|NCT00479882|4934030|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
1498806|NCT00479882|4934031|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
1498807|NCT00479882|4934032|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
1498808|NCT00479882|4934029|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
1498809|NCT00479882|4934030|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
1498810|NCT00479882|4934031|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
1498811|NCT00479882|4934032|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
1498812|NCT00479882|4934029|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
1498813|NCT00479882|4934030|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
1498814|NCT00479882|4934031|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
1498815|NCT00479882|4934032|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
1498816|NCT00479856|4934162|P1|Overall Study|Physician Decision|1
1498817|NCT00479856|4934162|P1|Overall Study|Withdrawal by Subject|1
1498818|NCT00479856|4934162|P1|Overall Study|Adverse Event|1
1498819|NCT00479765|4934171|P1|Overall Study|study terminated|4
1498820|NCT00479713|4934177|P2|Overall Study|Withdrawal by Subject|1
1498821|NCT00479713|4934178|P1|Overall Study|Withdrawal by Subject|4
1498822|NCT00479713|4934177|P2|Overall Study|Protocol Violation|1
1498823|NCT00479713|4934178|P1|Overall Study|Protocol Violation|0
1498824|NCT00479713|4934177|P2|Overall Study|Lost to Follow-up|1
1498825|NCT00479713|4934178|P1|Overall Study|Lost to Follow-up|0
1498826|NCT00479713|4934177|P2|Overall Study|Death|0
1498827|NCT00479713|4934178|P1|Overall Study|Death|1
1498828|NCT00479713|4934177|P2|Overall Study|Adverse Event|6
1498829|NCT00479713|4934178|P1|Overall Study|Adverse Event|8
1498830|NCT00479674|4934202|P1|Overall Study|none provided|3
1498831|NCT00479674|4934202|P1|Overall Study|Physician Decision|14
1498832|NCT00479674|4934202|P1|Overall Study|Withdrawal by Subject|6
1498833|NCT00479674|4934202|P1|Overall Study|Adverse Event|18
1498834|NCT00479557|4934217|P7|Overall Study|Not specified|0
1498835|NCT00479557|4934218|P6|Overall Study|Not specified|3
1498836|NCT00479557|4934219|P5|Overall Study|Not specified|0
1498837|NCT00479557|4934220|P4|Overall Study|Not specified|0
1498838|NCT00479557|4934221|P3|Overall Study|Not specified|1
1498839|NCT00479557|4934222|P2|Overall Study|Not specified|3
1498840|NCT00479557|4934223|P1|Overall Study|Not specified|2
1498841|NCT00479557|4934217|P7|Overall Study|Subject Request|1
1498842|NCT00479557|4934218|P6|Overall Study|Subject Request|4
1498843|NCT00479557|4934219|P5|Overall Study|Subject Request|1
1498844|NCT00479557|4934220|P4|Overall Study|Subject Request|1
1498845|NCT00479557|4934221|P3|Overall Study|Subject Request|1
1498846|NCT00479557|4934222|P2|Overall Study|Subject Request|0
1498847|NCT00479557|4934223|P1|Overall Study|Subject Request|3
1498848|NCT00479557|4934217|P7|Overall Study|Investigator Request|0
1498849|NCT00479557|4934218|P6|Overall Study|Investigator Request|0
1498850|NCT00479557|4934219|P5|Overall Study|Investigator Request|0
1498851|NCT00479557|4934220|P4|Overall Study|Investigator Request|0
1498852|NCT00479557|4934221|P3|Overall Study|Investigator Request|1
1498853|NCT00479557|4934222|P2|Overall Study|Investigator Request|0
1498854|NCT00479557|4934223|P1|Overall Study|Investigator Request|0
1498855|NCT00479557|4934217|P7|Overall Study|Caregiver Request|0
1498856|NCT00479557|4934218|P6|Overall Study|Caregiver Request|2
1498857|NCT00479557|4934219|P5|Overall Study|Caregiver Request|1
1498858|NCT00479557|4934220|P4|Overall Study|Caregiver Request|0
1498859|NCT00479557|4934221|P3|Overall Study|Caregiver Request|2
1498860|NCT00479557|4934222|P2|Overall Study|Caregiver Request|2
1498861|NCT00479557|4934223|P1|Overall Study|Caregiver Request|2
1498862|NCT00479557|4934217|P7|Overall Study|AE not related to Study Drug|1
1498863|NCT00479557|4934218|P6|Overall Study|AE not related to Study Drug|2
1498864|NCT00479557|4934219|P5|Overall Study|AE not related to Study Drug|2
1498865|NCT00479557|4934220|P4|Overall Study|AE not related to Study Drug|0
1498866|NCT00479557|4934221|P3|Overall Study|AE not related to Study Drug|0
1498867|NCT00479557|4934222|P2|Overall Study|AE not related to Study Drug|3
1498868|NCT00479557|4934223|P1|Overall Study|AE not related to Study Drug|1
1498869|NCT00479557|4934217|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
1498870|NCT00479557|4934218|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
1498871|NCT00479557|4934219|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
1498872|NCT00479557|4934220|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
1498873|NCT00479557|4934221|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
1498874|NCT00479557|4934222|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
1498875|NCT00479557|4934223|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
1498876|NCT00479557|4934217|P7|Overall Study|Lost to Follow-up|0
1498877|NCT00479557|4934218|P6|Overall Study|Lost to Follow-up|0
1498878|NCT00479557|4934219|P5|Overall Study|Lost to Follow-up|0
1498879|NCT00479557|4934220|P4|Overall Study|Lost to Follow-up|2
1498880|NCT00479557|4934221|P3|Overall Study|Lost to Follow-up|0
1498881|NCT00479557|4934222|P2|Overall Study|Lost to Follow-up|2
1498882|NCT00479557|4934223|P1|Overall Study|Lost to Follow-up|0
1498883|NCT00479557|4934217|P7|Overall Study|Lack of Efficacy|0
1498884|NCT00479557|4934218|P6|Overall Study|Lack of Efficacy|0
1498885|NCT00479557|4934219|P5|Overall Study|Lack of Efficacy|0
1498886|NCT00479557|4934220|P4|Overall Study|Lack of Efficacy|0
1498887|NCT00479557|4934221|P3|Overall Study|Lack of Efficacy|0
1498888|NCT00479557|4934222|P2|Overall Study|Lack of Efficacy|0
1498889|NCT00479557|4934223|P1|Overall Study|Lack of Efficacy|1
1498890|NCT00479557|4934217|P7|Overall Study|Death|0
1498891|NCT00479557|4934218|P6|Overall Study|Death|1
1498892|NCT00479557|4934219|P5|Overall Study|Death|0
1498893|NCT00479557|4934220|P4|Overall Study|Death|0
1498894|NCT00479557|4934221|P3|Overall Study|Death|0
1498895|NCT00479557|4934222|P2|Overall Study|Death|0
1498896|NCT00479557|4934223|P1|Overall Study|Death|0
1498897|NCT00479466|4934266|P6|Overall Study|Withdrawal by Subject|1
1498898|NCT00479466|4934267|P5|Overall Study|Withdrawal by Subject|3
1498899|NCT00479466|4934268|P4|Overall Study|Withdrawal by Subject|2
1498900|NCT00479466|4934269|P3|Overall Study|Withdrawal by Subject|0
1498901|NCT00479466|4934270|P2|Overall Study|Withdrawal by Subject|5
1498902|NCT00479466|4934271|P1|Overall Study|Withdrawal by Subject|3
1498903|NCT00479466|4934266|P6|Overall Study|Protocol Violation|0
1498904|NCT00479466|4934267|P5|Overall Study|Protocol Violation|0
1498905|NCT00479466|4934268|P4|Overall Study|Protocol Violation|0
1498906|NCT00479466|4934269|P3|Overall Study|Protocol Violation|0
1498907|NCT00479466|4934270|P2|Overall Study|Protocol Violation|0
1498908|NCT00479466|4934271|P1|Overall Study|Protocol Violation|1
1498909|NCT00479466|4934266|P6|Overall Study|Pregnancy|0
1498910|NCT00479466|4934267|P5|Overall Study|Pregnancy|1
1498911|NCT00479466|4934268|P4|Overall Study|Pregnancy|0
1498912|NCT00479466|4934269|P3|Overall Study|Pregnancy|0
1498913|NCT00479466|4934270|P2|Overall Study|Pregnancy|0
1498914|NCT00479466|4934271|P1|Overall Study|Pregnancy|0
1498915|NCT00479466|4934266|P6|Overall Study|Physician Decision|0
1498916|NCT00479466|4934267|P5|Overall Study|Physician Decision|0
1498917|NCT00479466|4934268|P4|Overall Study|Physician Decision|0
1498918|NCT00479466|4934269|P3|Overall Study|Physician Decision|1
1498919|NCT00479466|4934270|P2|Overall Study|Physician Decision|1
1498920|NCT00479466|4934271|P1|Overall Study|Physician Decision|2
1498921|NCT00479466|4934266|P6|Overall Study|Lost to Follow-up|2
1498922|NCT00479466|4934267|P5|Overall Study|Lost to Follow-up|2
1498923|NCT00479466|4934268|P4|Overall Study|Lost to Follow-up|0
1498924|NCT00479466|4934269|P3|Overall Study|Lost to Follow-up|1
1498925|NCT00479466|4934270|P2|Overall Study|Lost to Follow-up|1
1498926|NCT00479466|4934271|P1|Overall Study|Lost to Follow-up|0
1498927|NCT00479466|4934266|P6|Overall Study|Lack of Efficacy|0
1498928|NCT00479466|4934267|P5|Overall Study|Lack of Efficacy|0
1498929|NCT00479466|4934268|P4|Overall Study|Lack of Efficacy|0
1498930|NCT00479466|4934269|P3|Overall Study|Lack of Efficacy|1
1498931|NCT00479466|4934270|P2|Overall Study|Lack of Efficacy|0
1498932|NCT00479466|4934271|P1|Overall Study|Lack of Efficacy|2
1498933|NCT00479466|4934266|P6|Overall Study|Hyperglycemia|1
1498934|NCT00479466|4934267|P5|Overall Study|Hyperglycemia|0
1498935|NCT00479466|4934268|P4|Overall Study|Hyperglycemia|0
1498936|NCT00479466|4934269|P3|Overall Study|Hyperglycemia|0
1498937|NCT00479466|4934270|P2|Overall Study|Hyperglycemia|0
1498938|NCT00479466|4934271|P1|Overall Study|Hyperglycemia|0
1498939|NCT00479466|4934266|P6|Overall Study|Adverse Event|0
1498940|NCT00479466|4934267|P5|Overall Study|Adverse Event|2
1498941|NCT00479466|4934268|P4|Overall Study|Adverse Event|1
1498942|NCT00479466|4934269|P3|Overall Study|Adverse Event|0
1498943|NCT00479466|4934270|P2|Overall Study|Adverse Event|1
1498944|NCT00479466|4934271|P1|Overall Study|Adverse Event|5
1498945|NCT00479401|4934300|P3|Overall Study|Exclusion criteria, relocation|0
1498946|NCT00479401|4934301|P2|Overall Study|Exclusion criteria, relocation|3
1498947|NCT00479401|4934302|P1|Overall Study|Exclusion criteria, relocation|4
1498948|NCT00479401|4934300|P3|Overall Study|Withdrawal by Subject|2
1498949|NCT00479401|4934301|P2|Overall Study|Withdrawal by Subject|10
1498950|NCT00479401|4934302|P1|Overall Study|Withdrawal by Subject|16
1498951|NCT00479401|4934300|P3|Overall Study|Lost to Follow-up|1
1498952|NCT00479401|4934301|P2|Overall Study|Lost to Follow-up|1
1498953|NCT00479401|4934302|P1|Overall Study|Lost to Follow-up|1
1498954|NCT00479401|4934300|P3|Overall Study|Protocol Violation|1
1498955|NCT00479401|4934301|P2|Overall Study|Protocol Violation|1
1498956|NCT00479401|4934302|P1|Overall Study|Protocol Violation|2
1498957|NCT00479401|4934300|P3|Overall Study|Lack of Efficacy|4
1498958|NCT00479401|4934301|P2|Overall Study|Lack of Efficacy|2
1498959|NCT00479401|4934302|P1|Overall Study|Lack of Efficacy|2
1498960|NCT00479401|4934300|P3|Overall Study|Adverse Event|4
1498961|NCT00479401|4934301|P2|Overall Study|Adverse Event|20
1498962|NCT00479401|4934302|P1|Overall Study|Adverse Event|24
1498963|NCT00479388|4934357|P2|Overall Study|Withdrawal by Subject|17
1498964|NCT00479388|4934358|P1|Overall Study|Withdrawal by Subject|32
1498965|NCT00479388|4934357|P2|Overall Study|Protocol Violation|9
1498966|NCT00479388|4934358|P1|Overall Study|Protocol Violation|10
1498967|NCT00479388|4934357|P2|Overall Study|Lost to Follow-up|2
1498968|NCT00479388|4934358|P1|Overall Study|Lost to Follow-up|0
1498969|NCT00479388|4934357|P2|Overall Study|Adverse Event|45
1498970|NCT00479388|4934358|P1|Overall Study|Adverse Event|90
1498971|NCT00479336|4934372|P4|Overall Study|Resolution of all hepatic edema findings|0
1498972|NCT00479336|4934373|P3|Overall Study|Resolution of all hepatic edema findings|0
1498973|NCT00479336|4934374|P2|Overall Study|Resolution of all hepatic edema findings|1
1498974|NCT00479336|4934375|P1|Overall Study|Resolution of all hepatic edema findings|1
1498975|NCT00479336|4934372|P4|Overall Study|Physician Decision|2
1498976|NCT00479336|4934373|P3|Overall Study|Physician Decision|0
1498977|NCT00479336|4934374|P2|Overall Study|Physician Decision|1
1498978|NCT00479336|4934375|P1|Overall Study|Physician Decision|0
1498979|NCT00479336|4934372|P4|Overall Study|Withdrawal by Subject|0
1498980|NCT00479336|4934373|P3|Overall Study|Withdrawal by Subject|0
1498981|NCT00479336|4934374|P2|Overall Study|Withdrawal by Subject|2
1498982|NCT00479336|4934375|P1|Overall Study|Withdrawal by Subject|1
1498983|NCT00479336|4934372|P4|Overall Study|Protocol Violation|0
1498984|NCT00479336|4934373|P3|Overall Study|Protocol Violation|0
1498985|NCT00479336|4934374|P2|Overall Study|Protocol Violation|1
1498986|NCT00479336|4934375|P1|Overall Study|Protocol Violation|0
1498987|NCT00479336|4934372|P4|Overall Study|Lack of Efficacy|0
1498988|NCT00479336|4934373|P3|Overall Study|Lack of Efficacy|0
1498989|NCT00479336|4934374|P2|Overall Study|Lack of Efficacy|0
1498990|NCT00479336|4934375|P1|Overall Study|Lack of Efficacy|1
1498991|NCT00479336|4934372|P4|Overall Study|Adverse Event|3
1498992|NCT00479336|4934373|P3|Overall Study|Adverse Event|1
1498993|NCT00479336|4934374|P2|Overall Study|Adverse Event|1
1498994|NCT00479336|4934375|P1|Overall Study|Adverse Event|1
1498995|NCT00479232|4934398|P6|Overall Study|Withdrew Consent|3
1498996|NCT00479232|4934399|P5|Overall Study|Withdrew Consent|1
1498997|NCT00479232|4934400|P4|Overall Study|Withdrew Consent|0
1498998|NCT00479232|4934401|P3|Overall Study|Withdrew Consent|6
1498999|NCT00479232|4934402|P2|Overall Study|Withdrew Consent|2
1499000|NCT00479232|4934403|P1|Overall Study|Withdrew Consent|0
1499001|NCT00479232|4934398|P6|Overall Study|Progressive Disease|12
1499002|NCT00479232|4934399|P5|Overall Study|Progressive Disease|3
1499003|NCT00479232|4934400|P4|Overall Study|Progressive Disease|3
1499004|NCT00479232|4934401|P3|Overall Study|Progressive Disease|12
1499005|NCT00479232|4934402|P2|Overall Study|Progressive Disease|1
1499006|NCT00479232|4934403|P1|Overall Study|Progressive Disease|3
1499007|NCT00479232|4934398|P6|Overall Study|Physician Decision|1
1499008|NCT00479232|4934399|P5|Overall Study|Physician Decision|0
1499009|NCT00479232|4934400|P4|Overall Study|Physician Decision|0
1499010|NCT00479232|4934401|P3|Overall Study|Physician Decision|2
1499011|NCT00479232|4934402|P2|Overall Study|Physician Decision|0
1499012|NCT00479232|4934403|P1|Overall Study|Physician Decision|0
1499013|NCT00479232|4934398|P6|Overall Study|Lack of Efficacy|4
1499014|NCT00479232|4934399|P5|Overall Study|Lack of Efficacy|0
1499015|NCT00479232|4934400|P4|Overall Study|Lack of Efficacy|0
1499016|NCT00479232|4934401|P3|Overall Study|Lack of Efficacy|2
1499017|NCT00479232|4934402|P2|Overall Study|Lack of Efficacy|0
1499018|NCT00479232|4934403|P1|Overall Study|Lack of Efficacy|0
1499019|NCT00479232|4934398|P6|Overall Study|Deviation from Protocol|0
1499020|NCT00479232|4934399|P5|Overall Study|Deviation from Protocol|0
1499021|NCT00479232|4934400|P4|Overall Study|Deviation from Protocol|0
1499022|NCT00479232|4934401|P3|Overall Study|Deviation from Protocol|1
1499023|NCT00479232|4934402|P2|Overall Study|Deviation from Protocol|0
1499024|NCT00479232|4934403|P1|Overall Study|Deviation from Protocol|0
1499025|NCT00479232|4934398|P6|Overall Study|Adverse Event|10
1499026|NCT00479232|4934399|P5|Overall Study|Adverse Event|0
1499027|NCT00479232|4934400|P4|Overall Study|Adverse Event|0
1499028|NCT00479232|4934401|P3|Overall Study|Adverse Event|5
1499029|NCT00479232|4934402|P2|Overall Study|Adverse Event|0
1499030|NCT00479232|4934403|P1|Overall Study|Adverse Event|0
1499031|NCT00478933|4934456|P1|Overall Study|Inadequate data available|53
1499032|NCT00478933|4934456|P1|Overall Study|Informed consent not verified|3
1499033|NCT00478933|4934456|P1|Overall Study|Protocol Violation|22
1499034|NCT00478881|4934482|P2|Overall Study|Non-Compliance with Study Medication|2
1499035|NCT00478881|4934483|P1|Overall Study|Non-Compliance with Study Medication|0
1499036|NCT00478881|4934482|P2|Overall Study|Withdrawal by Subject|2
1499037|NCT00478881|4934483|P1|Overall Study|Withdrawal by Subject|6
1499038|NCT00478881|4934482|P2|Overall Study|Protocol Violation|2
1499039|NCT00478881|4934483|P1|Overall Study|Protocol Violation|2
1499040|NCT00478881|4934482|P2|Overall Study|Lost to Follow-up|1
1499041|NCT00478881|4934483|P1|Overall Study|Lost to Follow-up|0
1499042|NCT00478881|4934482|P2|Overall Study|Lack of Efficacy|3
1499043|NCT00478881|4934483|P1|Overall Study|Lack of Efficacy|0
1499044|NCT00478881|4934482|P2|Overall Study|Adverse Event|12
1499045|NCT00478881|4934483|P1|Overall Study|Adverse Event|31
1499046|NCT00478777|4934507|P1|Overall Study|Not treated with lenalidomide|6
1499047|NCT00478777|4934507|P1|Overall Study|End of therapy|2
1499048|NCT00478777|4934507|P1|Overall Study|Lymphocytes infusion|1
1499049|NCT00478777|4934507|P1|Overall Study|Lack of compliance|1
1499050|NCT00478777|4934507|P1|Overall Study|Intolerance of therapy|1
1499051|NCT00478777|4934507|P1|Overall Study|Physician Decision|1
1499052|NCT00478777|4934507|P1|Overall Study|Lost to Follow-up|3
1499053|NCT00478777|4934507|P1|Overall Study|Protocol Violation|3
1499054|NCT00478777|4934507|P1|Overall Study|Death|3
1499055|NCT00478777|4934507|P1|Overall Study|Withdrawal by Subject|4
1499056|NCT00478777|4934507|P1|Overall Study|Lack of Efficacy|23
1499057|NCT00478777|4934507|P1|Overall Study|Adverse Event|29
1499058|NCT00478673|4934514|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
1499059|NCT00478673|4934514|P1|12-Months Post-Procedure|Missed Visit|25
1499060|NCT00478673|4934514|P1|12-Months Post-Procedure|Withdrawal by Subject|6
1499061|NCT00478673|4934514|P1|12-Months Post-Procedure|Lost to Follow-up|4
1499062|NCT00478673|4934514|P1|12-Months Post-Procedure|Death|23
1499063|NCT00478673|4934514|P1|30-Days Post-Procedure|Missed Visit|7
1499064|NCT00478673|4934514|P1|30-Days Post-Procedure|Withdrawal by Subject|1
1499065|NCT00478673|4934514|P1|30-Days Post-Procedure|Death|2
1499066|NCT00478647|4934519|P1|Overall Study|Withdrawal by Subject|1
1499067|NCT00478647|4934519|P1|Overall Study|Adverse Event|1
1499068|NCT00478608|4934527|P1|Overall Study|Protocol Violation|3
1499069|NCT00478608|4934527|P1|Overall Study|Withdrawal by Subject|2
1499070|NCT00478608|4934527|P1|Overall Study|Serious Adverse Event|14
1499071|NCT00478608|4934527|P1|Overall Study|Adverse Event|1
1499072|NCT00478257|4934571|P2|Overall Study|Withdrawal by Subject|3
1499073|NCT00478257|4934572|P1|Overall Study|Withdrawal by Subject|8
1499074|NCT00478244|4934578|P1|Overall Study|Did not receive transplant|1
1499075|NCT00478231|4934591|P1|Overall Study|Randomized, not treated|3
1499076|NCT00478231|4934591|P1|Overall Study|Adverse Event|5
1499077|NCT00478231|4934591|P1|Overall Study|Other|9
1499078|NCT00478231|4934591|P1|Overall Study|Withdrawal by Subject|6
1499079|NCT00478231|4934591|P1|Overall Study|Lost to Follow-up|7
1499080|NCT00478231|4934591|P1|Overall Study|Lack of Efficacy|47
1499081|NCT00478231|4934591|P1|Overall Study|Death|7
1499082|NCT00478205|4934627|P2|Overall Study|Not specified|12
1499083|NCT00478205|4934628|P1|Overall Study|Not specified|24
1499084|NCT00478205|4934627|P2|Overall Study|Lack of Efficacy|0
1499085|NCT00478205|4934628|P1|Overall Study|Lack of Efficacy|1
1499086|NCT00478205|4934627|P2|Overall Study|Withdrawal by Subject|22
1499087|NCT00478205|4934628|P1|Overall Study|Withdrawal by Subject|61
1499088|NCT00478205|4934627|P2|Overall Study|Request of Investigator or Sponsor|5
1499089|NCT00478205|4934628|P1|Overall Study|Request of Investigator or Sponsor|4
1499090|NCT00478205|4934627|P2|Overall Study|Protocol Violation|5
1499091|NCT00478205|4934628|P1|Overall Study|Protocol Violation|15
1499092|NCT00478205|4934627|P2|Overall Study|Medication Non-compliance|4
1499093|NCT00478205|4934628|P1|Overall Study|Medication Non-compliance|9
1499094|NCT00478205|4934627|P2|Overall Study|Adverse Event|39
1499095|NCT00478205|4934628|P1|Overall Study|Adverse Event|182
1499096|NCT00478140|4934672|P1|Overall Study|Disease Progression|3
1499097|NCT00478023|4934701|P5|Overall Study|Lack of pain, Technical difficulties|3
1499098|NCT00478023|4934702|P4|Overall Study|Lack of pain, Technical difficulties|6
1499099|NCT00478023|4934703|P3|Overall Study|Lack of pain, Technical difficulties|5
1499100|NCT00478023|4934704|P2|Overall Study|Lack of pain, Technical difficulties|3
1499101|NCT00478023|4934705|P1|Overall Study|Lack of pain, Technical difficulties|7
1499102|NCT00478023|4934701|P5|Overall Study|Withdrawal by Subject|5
1499103|NCT00478023|4934702|P4|Overall Study|Withdrawal by Subject|4
1499104|NCT00478023|4934703|P3|Overall Study|Withdrawal by Subject|2
1499105|NCT00478023|4934704|P2|Overall Study|Withdrawal by Subject|3
1499106|NCT00478023|4934705|P1|Overall Study|Withdrawal by Subject|2
1499107|NCT00478023|4934701|P5|Overall Study|Lost to Follow-up|0
1499108|NCT00478023|4934702|P4|Overall Study|Lost to Follow-up|1
1499109|NCT00478023|4934703|P3|Overall Study|Lost to Follow-up|1
1499110|NCT00478023|4934704|P2|Overall Study|Lost to Follow-up|1
1499111|NCT00478023|4934705|P1|Overall Study|Lost to Follow-up|3
1499112|NCT00478023|4934701|P5|Overall Study|Lack of Efficacy|41
1499113|NCT00478023|4934702|P4|Overall Study|Lack of Efficacy|5
1499114|NCT00478023|4934703|P3|Overall Study|Lack of Efficacy|4
1499115|NCT00478023|4934704|P2|Overall Study|Lack of Efficacy|10
1499116|NCT00478023|4934705|P1|Overall Study|Lack of Efficacy|11
1499117|NCT00478023|4934701|P5|Overall Study|Death|0
1499118|NCT00478023|4934702|P4|Overall Study|Death|0
1499119|NCT00478023|4934703|P3|Overall Study|Death|0
1499120|NCT00478023|4934704|P2|Overall Study|Death|0
1499121|NCT00478023|4934705|P1|Overall Study|Death|1
1499122|NCT00478023|4934701|P5|Overall Study|Adverse Event|6
1499123|NCT00478023|4934702|P4|Overall Study|Adverse Event|14
1499124|NCT00478023|4934703|P3|Overall Study|Adverse Event|8
1499125|NCT00478023|4934704|P2|Overall Study|Adverse Event|7
1499126|NCT00478023|4934705|P1|Overall Study|Adverse Event|11
1499127|NCT00477971|4934724|P2|Overall Study|Alternative treatment|1
1499128|NCT00477971|4934725|P1|Overall Study|Alternative treatment|3
1499129|NCT00477971|4934724|P2|Overall Study|Death|4
1499130|NCT00477971|4934725|P1|Overall Study|Death|2
1499131|NCT00477971|4934724|P2|Overall Study|Adverse Event|0
1499132|NCT00477971|4934725|P1|Overall Study|Adverse Event|3
1499133|NCT00477971|4934724|P2|Overall Study|Withdrawal by Subject|1
1499134|NCT00477971|4934725|P1|Overall Study|Withdrawal by Subject|3
1499135|NCT00477971|4934724|P2|Overall Study|Disease progression|0
1499136|NCT00477971|4934725|P1|Overall Study|Disease progression|6
1499137|NCT00477750|4934737|P1|Overall Study|Currently Receiving Treatment|11
1499138|NCT00477672|4934749|P3|Overall Study|Discretion of Sponsor|0
1499139|NCT00477672|4934750|P2|Overall Study|Discretion of Sponsor|2
1499140|NCT00477672|4934751|P1|Overall Study|Discretion of Sponsor|1
1499141|NCT00477672|4934749|P3|Overall Study|Consent withdrawn|10
1499142|NCT00477672|4934750|P2|Overall Study|Consent withdrawn|5
1499143|NCT00477672|4934751|P1|Overall Study|Consent withdrawn|2
1499144|NCT00477672|4934749|P3|Overall Study|Protocol noncompliance|0
1499145|NCT00477672|4934750|P2|Overall Study|Protocol noncompliance|2
1499146|NCT00477672|4934751|P1|Overall Study|Protocol noncompliance|0
1499147|NCT00477672|4934749|P3|Overall Study|Physician Decision|0
1499148|NCT00477672|4934750|P2|Overall Study|Physician Decision|0
1499149|NCT00477672|4934751|P1|Overall Study|Physician Decision|1
1499150|NCT00477672|4934749|P3|Overall Study|Disease progression|0
1499151|NCT00477672|4934750|P2|Overall Study|Disease progression|1
1499152|NCT00477672|4934751|P1|Overall Study|Disease progression|0
1499153|NCT00477672|4934749|P3|Overall Study|Death|0
1499154|NCT00477672|4934750|P2|Overall Study|Death|1
1499155|NCT00477672|4934751|P1|Overall Study|Death|0
1499156|NCT00477672|4934749|P3|Overall Study|Adverse Event|6
1499157|NCT00477672|4934750|P2|Overall Study|Adverse Event|5
1499158|NCT00477672|4934751|P1|Overall Study|Adverse Event|3
1499159|NCT00477633|4934762|P1|Overall Study|Various (Moving, Enrollment closed)|75
1499160|NCT00477633|4934762|P1|Overall Study|Protocol Violation|25
1499161|NCT00477633|4934762|P1|Overall Study|Withdrawal by Subject|149
1499162|NCT00477633|4934762|P1|Overall Study|Lost to Follow-up|271
1499163|NCT00477633|4934762|P1|Overall Study|Pregnancy|23
1499164|NCT00477633|4934762|P1|Overall Study|Adverse Event|143
1499165|NCT00477633|4934762|P1|Overall Study|Did not receive treatment|23
1499166|NCT00477607|4934770|P2|Overall Study|Lost to Follow-up|7
1499167|NCT00477607|4934771|P1|Overall Study|Lost to Follow-up|7
1499168|NCT00477594|4934783|P2|Follow-up Period|Other|0
1499169|NCT00477594|4934784|P1|Follow-up Period|Other|1
1499170|NCT00477594|4934783|P2|Follow-up Period|Withdrawal by Subject|1
1499171|NCT00477594|4934784|P1|Follow-up Period|Withdrawal by Subject|2
1499172|NCT00477594|4934783|P2|Year 3|Withdrawal by Subject|0
1499173|NCT00477594|4934784|P1|Year 3|Withdrawal by Subject|1
1499174|NCT00477594|4934783|P2|Year 3|Adverse Event|0
1499175|NCT00477594|4934784|P1|Year 3|Adverse Event|1
1499176|NCT00477594|4934783|P2|Year 1 and Year 2|Other|0
1499177|NCT00477594|4934784|P1|Year 1 and Year 2|Other|1
1499178|NCT00477594|4934783|P2|Year 1 and Year 2|Withdrawal by Subject|1
1499179|NCT00477594|4934784|P1|Year 1 and Year 2|Withdrawal by Subject|2
1499180|NCT00477594|4934783|P2|Year 1 and Year 2|Physician Decision|1
1499181|NCT00477594|4934784|P1|Year 1 and Year 2|Physician Decision|2
1499182|NCT00477594|4934783|P2|Year 1 and Year 2|Adverse Event|2
1499183|NCT00477594|4934784|P1|Year 1 and Year 2|Adverse Event|4
1499184|NCT00477490|4934845|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
1499185|NCT00477490|4934846|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
1499186|NCT00477490|4934847|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
1499187|NCT00477490|4934848|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
1499188|NCT00477490|4934849|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
1499189|NCT00477490|4934850|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
1499190|NCT00477490|4934851|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
1499191|NCT00477490|4934852|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
1499192|NCT00477490|4934853|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
1499193|NCT00477490|4934845|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
1499194|NCT00477490|4934846|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
1499195|NCT00477490|4934847|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
1499196|NCT00477490|4934848|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
1499197|NCT00477490|4934849|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
1499198|NCT00477490|4934850|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
1499199|NCT00477490|4934851|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
1499200|NCT00477490|4934852|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
1499201|NCT00477490|4934853|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
1499202|NCT00477490|4934845|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1499203|NCT00477490|4934846|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1499204|NCT00477490|4934847|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1499205|NCT00477490|4934848|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1499206|NCT00477490|4934849|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1499207|NCT00477490|4934850|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1499208|NCT00477490|4934851|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1499209|NCT00477490|4934852|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
1499210|NCT00477490|4934853|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1499211|NCT00477490|4934845|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
1499212|NCT00477490|4934846|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
1499213|NCT00477490|4934847|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1499214|NCT00477490|4934848|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1499215|NCT00477490|4934849|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
1499216|NCT00477490|4934850|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1499217|NCT00477490|4934851|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1499218|NCT00477490|4934852|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1499219|NCT00477490|4934853|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1499220|NCT00477490|4934845|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
1499221|NCT00477490|4934846|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
1499222|NCT00477490|4934847|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
1499223|NCT00477490|4934848|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
1499224|NCT00477490|4934849|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
1499225|NCT00477490|4934850|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
1499226|NCT00477490|4934851|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
1499227|NCT00477490|4934852|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
1499228|NCT00477490|4934853|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
1499229|NCT00477490|4934845|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
1499230|NCT00477490|4934846|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
1499231|NCT00477490|4934847|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
1499232|NCT00477490|4934848|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
1499233|NCT00477490|4934849|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
1499234|NCT00477490|4934850|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
1499235|NCT00477490|4934851|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
1499236|NCT00477490|4934852|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
1499237|NCT00477490|4934853|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
1499238|NCT00477490|4934845|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
1499239|NCT00477490|4934846|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
1499240|NCT00477490|4934847|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
1499241|NCT00477490|4934848|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
1499242|NCT00477490|4934849|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
1499243|NCT00477490|4934850|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
1499244|NCT00477490|4934851|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
1499245|NCT00477490|4934852|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
1499246|NCT00477490|4934853|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
1499247|NCT00477490|4934845|P9|Part I: 4 Week Efficacy|Not Reported|0
1499248|NCT00477490|4934846|P8|Part I: 4 Week Efficacy|Not Reported|0
1499249|NCT00477490|4934847|P7|Part I: 4 Week Efficacy|Not Reported|0
1499250|NCT00477490|4934848|P6|Part I: 4 Week Efficacy|Not Reported|0
1499251|NCT00477490|4934849|P5|Part I: 4 Week Efficacy|Not Reported|1
1499252|NCT00477490|4934850|P4|Part I: 4 Week Efficacy|Not Reported|0
1499253|NCT00477490|4934851|P3|Part I: 4 Week Efficacy|Not Reported|3
1499254|NCT00477490|4934852|P2|Part I: 4 Week Efficacy|Not Reported|2
1499255|NCT00477490|4934853|P1|Part I: 4 Week Efficacy|Not Reported|1
1499256|NCT00477490|4934845|P9|Part I: 4 Week Efficacy|Other, not specified|0
1499257|NCT00477490|4934846|P8|Part I: 4 Week Efficacy|Other, not specified|0
1499258|NCT00477490|4934847|P7|Part I: 4 Week Efficacy|Other, not specified|0
1499259|NCT00477490|4934848|P6|Part I: 4 Week Efficacy|Other, not specified|0
1499260|NCT00477490|4934849|P5|Part I: 4 Week Efficacy|Other, not specified|1
1499261|NCT00477490|4934850|P4|Part I: 4 Week Efficacy|Other, not specified|1
1499262|NCT00477490|4934851|P3|Part I: 4 Week Efficacy|Other, not specified|0
1499263|NCT00477490|4934852|P2|Part I: 4 Week Efficacy|Other, not specified|4
1499264|NCT00477490|4934853|P1|Part I: 4 Week Efficacy|Other, not specified|2
1499265|NCT00477490|4934845|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
1499266|NCT00477490|4934846|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
1499267|NCT00477490|4934847|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
1499268|NCT00477490|4934848|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
1499269|NCT00477490|4934849|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
1499270|NCT00477490|4934850|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
1499271|NCT00477490|4934851|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
1499272|NCT00477490|4934852|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
1499273|NCT00477490|4934853|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
1499274|NCT00477490|4934845|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
1499275|NCT00477490|4934846|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
1499276|NCT00477490|4934847|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
1499277|NCT00477490|4934848|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
1499278|NCT00477490|4934849|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
1499279|NCT00477490|4934850|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
1499280|NCT00477490|4934851|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
1499281|NCT00477490|4934852|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
1499282|NCT00477490|4934853|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
1499283|NCT00477490|4934845|P9|Part I: 4 Week Efficacy|Protocol Violation|0
1499284|NCT00477490|4934846|P8|Part I: 4 Week Efficacy|Protocol Violation|0
1499285|NCT00477490|4934847|P7|Part I: 4 Week Efficacy|Protocol Violation|0
1499286|NCT00477490|4934848|P6|Part I: 4 Week Efficacy|Protocol Violation|0
1499287|NCT00477490|4934849|P5|Part I: 4 Week Efficacy|Protocol Violation|1
1499288|NCT00477490|4934850|P4|Part I: 4 Week Efficacy|Protocol Violation|0
1499289|NCT00477490|4934851|P3|Part I: 4 Week Efficacy|Protocol Violation|0
1499290|NCT00477490|4934852|P2|Part I: 4 Week Efficacy|Protocol Violation|0
1499291|NCT00477490|4934853|P1|Part I: 4 Week Efficacy|Protocol Violation|2
1499292|NCT00477490|4934845|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1499293|NCT00477490|4934846|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1499294|NCT00477490|4934847|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1499295|NCT00477490|4934848|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1499296|NCT00477490|4934849|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
1499297|NCT00477490|4934850|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
1499298|NCT00477490|4934851|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1499299|NCT00477490|4934852|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1499300|NCT00477490|4934853|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
1499301|NCT00477490|4934845|P9|Part I: 4 Week Efficacy|Adverse Event|0
1499302|NCT00477490|4934846|P8|Part I: 4 Week Efficacy|Adverse Event|0
1499303|NCT00477490|4934847|P7|Part I: 4 Week Efficacy|Adverse Event|0
1499304|NCT00477490|4934848|P6|Part I: 4 Week Efficacy|Adverse Event|0
1499305|NCT00477490|4934849|P5|Part I: 4 Week Efficacy|Adverse Event|6
1499306|NCT00477490|4934850|P4|Part I: 4 Week Efficacy|Adverse Event|5
1499307|NCT00477490|4934851|P3|Part I: 4 Week Efficacy|Adverse Event|0
1499308|NCT00477490|4934852|P2|Part I: 4 Week Efficacy|Adverse Event|4
1499309|NCT00477490|4934853|P1|Part I: 4 Week Efficacy|Adverse Event|1
1499310|NCT00477464|4934937|P1|Overall Study|Completion of protocol-defined follow-up|14
1499311|NCT00477464|4934937|P1|Overall Study|Death|36
1499312|NCT00477464|4934937|P1|Overall Study|Lost to Follow-up|1
1499313|NCT00477386|4934981|P2|Overall Study|Withdrawal by Subject|0
1499314|NCT00477386|4934982|P1|Overall Study|Withdrawal by Subject|1
1499315|NCT00477386|4934981|P2|Overall Study|Physician Decision|0
1499316|NCT00477386|4934982|P1|Overall Study|Physician Decision|1
1499317|NCT00477386|4934981|P2|Overall Study|Other|2
1499318|NCT00477386|4934982|P1|Overall Study|Other|1
1499319|NCT00477386|4934981|P2|Overall Study|Disease progression, refractory|3
1499320|NCT00477386|4934982|P1|Overall Study|Disease progression, refractory|1
1499321|NCT00477386|4934981|P2|Overall Study|Disease progression, relapse|4
1499322|NCT00477386|4934982|P1|Overall Study|Disease progression, relapse|3
1499323|NCT00477386|4934981|P2|Overall Study|Adverse Event|8
1499324|NCT00477386|4934982|P1|Overall Study|Adverse Event|4
1499325|NCT00477334|4934992|P2|Overall Study|Protocol Violation|1
1499326|NCT00477334|4934993|P1|Overall Study|Protocol Violation|7
1499327|NCT00477334|4934992|P2|Overall Study|Administrative Problems|15
1499328|NCT00477334|4934993|P1|Overall Study|Administrative Problems|39
1499329|NCT00477334|4934992|P2|Overall Study|Lost to Follow-up|4
1499330|NCT00477334|4934993|P1|Overall Study|Lost to Follow-up|15
1499331|NCT00477334|4934992|P2|Overall Study|Withdrawal by Subject|1
1499332|NCT00477334|4934993|P1|Overall Study|Withdrawal by Subject|2
1499333|NCT00477334|4934992|P2|Overall Study|Adverse Event|2
1499334|NCT00477334|4934993|P1|Overall Study|Adverse Event|1
1499335|NCT00477334|4934992|P2|Overall Study|Discontinued prior to taking study drug|53
1499336|NCT00477334|4934993|P1|Overall Study|Discontinued prior to taking study drug|106
1499337|NCT00477295|4935019|P2|Overall Study|Not specified|3
1499338|NCT00477295|4935020|P1|Overall Study|Not specified|4
1499339|NCT00477295|4935019|P2|Overall Study|Lost to Follow-up|11
1499340|NCT00477295|4935020|P1|Overall Study|Lost to Follow-up|21
1499341|NCT00477295|4935019|P2|Overall Study|Physician Decision|5
1499342|NCT00477295|4935020|P1|Overall Study|Physician Decision|4
1499343|NCT00477295|4935019|P2|Overall Study|Protocol Violation|8
1499344|NCT00477295|4935020|P1|Overall Study|Protocol Violation|3
1499345|NCT00477295|4935019|P2|Overall Study|Lack of Efficacy|23
1499346|NCT00477295|4935020|P1|Overall Study|Lack of Efficacy|23
1499347|NCT00477295|4935019|P2|Overall Study|Withdrawal by Subject|24
1499348|NCT00477295|4935020|P1|Overall Study|Withdrawal by Subject|35
1499349|NCT00477295|4935019|P2|Overall Study|Adverse Event|35
1499350|NCT00477295|4935020|P1|Overall Study|Adverse Event|31
1499351|NCT00477269|4935048|P3|Open Label Extension|Death|4
1499352|NCT00477269|4935049|P2|Open Label Extension|Death|0
1499353|NCT00477269|4935050|P1|Open Label Extension|Death|0
1499354|NCT00477269|4935048|P3|Open Label Extension|Adminiatrative problems|2
1499355|NCT00477269|4935049|P2|Open Label Extension|Adminiatrative problems|0
1499356|NCT00477269|4935050|P1|Open Label Extension|Adminiatrative problems|0
1499357|NCT00477269|4935048|P3|Open Label Extension|unsatisfactory therapeutic effects|2
1499358|NCT00477269|4935049|P2|Open Label Extension|unsatisfactory therapeutic effects|0
1499359|NCT00477269|4935050|P1|Open Label Extension|unsatisfactory therapeutic effects|0
1499360|NCT00477269|4935048|P3|Open Label Extension|Abnormal laboratory values|1
1499361|NCT00477269|4935049|P2|Open Label Extension|Abnormal laboratory values|0
1499362|NCT00477269|4935050|P1|Open Label Extension|Abnormal laboratory values|0
1499363|NCT00477269|4935048|P3|Open Label Extension|Adverse Event|4
1499364|NCT00477269|4935049|P2|Open Label Extension|Adverse Event|0
1499365|NCT00477269|4935050|P1|Open Label Extension|Adverse Event|0
1499366|NCT00477269|4935048|P3|Core Study|Withdrawn Consent|0
1499367|NCT00477269|4935049|P2|Core Study|Withdrawn Consent|1
1499368|NCT00477269|4935050|P1|Core Study|Withdrawn Consent|0
1499369|NCT00477269|4935048|P3|Core Study|Death|0
1499370|NCT00477269|4935049|P2|Core Study|Death|3
1499371|NCT00477269|4935050|P1|Core Study|Death|3
1499372|NCT00477269|4935048|P3|Core Study|Adverse Event|0
1499373|NCT00477269|4935049|P2|Core Study|Adverse Event|4
1499374|NCT00477269|4935050|P1|Core Study|Adverse Event|6
1499375|NCT00477165|4935129|P2|Overall Study|Adverse Event|2
1499376|NCT00477165|4935130|P1|Overall Study|Adverse Event|7
1499377|NCT00477152|4935142|P1|Overall Study|Adverse Event|1
1499378|NCT00477152|4935142|P1|Overall Study|Parent withdrew consent|2
1499379|NCT00476957|4935157|P2|Overall Study|Lost to Follow-up|193
1499380|NCT00476957|4935158|P1|Overall Study|Lost to Follow-up|176
1499381|NCT00476593|4935222|P4|Overall Study|Lost to Follow-up|22
1499382|NCT00476593|4935223|P3|Overall Study|Lost to Follow-up|8
1499383|NCT00476593|4935224|P2|Overall Study|Lost to Follow-up|2
1499384|NCT00476593|4935225|P1|Overall Study|Lost to Follow-up|10
1499385|NCT00476476|4935237|P2|Overall Study|Progressive Disease|17
1499386|NCT00476476|4935238|P1|Overall Study|Progressive Disease|0
1499387|NCT00476476|4935237|P2|Overall Study|Adverse Event|7
1499388|NCT00476476|4935238|P1|Overall Study|Adverse Event|2
1499389|NCT00476229|4935256|P1|Overall Study|Progressive shortness of breath|1
1499390|NCT00476151|4935262|P2|Overall Study|Physician Decision|2
1499391|NCT00476151|4935263|P1|Overall Study|Physician Decision|0
1499392|NCT00476151|4935262|P2|Overall Study|Withdrawal by Subject|0
1499393|NCT00476151|4935263|P1|Overall Study|Withdrawal by Subject|2
1499394|NCT00476151|4935262|P2|Overall Study|Protocol Violation|3
1499395|NCT00476151|4935263|P1|Overall Study|Protocol Violation|1
1499396|NCT00476151|4935262|P2|Overall Study|Adverse Event|2
1499397|NCT00476151|4935263|P1|Overall Study|Adverse Event|0
1499398|NCT00476086|4935269|P1|Overall Study|Progressive Disease|4
1499399|NCT00476086|4935269|P1|Overall Study|Alternative therapy|1
1499400|NCT00476047|4935275|P1|Overall Study|Lost to Follow-up|1
1499401|NCT00476008|4935301|P2|Overall Study|Death|0
1499402|NCT00476008|4935302|P1|Overall Study|Death|1
1499403|NCT00476008|4935301|P2|Overall Study|Withdrawal by Subject|1
1499404|NCT00476008|4935302|P1|Overall Study|Withdrawal by Subject|0
1499405|NCT00476008|4935301|P2|Overall Study|Physician Decision: Medication Noncompli|1
1499406|NCT00476008|4935302|P1|Overall Study|Physician Decision: Medication Noncompli|2
1499407|NCT00476008|4935301|P2|Overall Study|Placebo concerns|2
1499408|NCT00476008|4935302|P1|Overall Study|Placebo concerns|2
1499409|NCT00476008|4935301|P2|Overall Study|Adverse Event|4
1499410|NCT00476008|4935302|P1|Overall Study|Adverse Event|4
1499411|NCT00475865|4935356|P3|Overall Study|Other than above|0
1499412|NCT00475865|4935357|P2|Overall Study|Other than above|1
1499413|NCT00475865|4935358|P1|Overall Study|Other than above|0
1499414|NCT00475865|4935356|P3|Overall Study|Participant did not wish to continue|0
1499415|NCT00475865|4935357|P2|Overall Study|Participant did not wish to continue|0
1499416|NCT00475865|4935358|P1|Overall Study|Participant did not wish to continue|1
1499417|NCT00475865|4935356|P3|Overall Study|Progressive disease|2
1499418|NCT00475865|4935357|P2|Overall Study|Progressive disease|1
1499419|NCT00475865|4935358|P1|Overall Study|Progressive disease|0
1499420|NCT00475865|4935356|P3|Overall Study|Lack of Efficacy|0
1499421|NCT00475865|4935357|P2|Overall Study|Lack of Efficacy|0
1499422|NCT00475865|4935358|P1|Overall Study|Lack of Efficacy|1
1499423|NCT00475865|4935356|P3|Overall Study|Adverse Event|4
1499424|NCT00475865|4935357|P2|Overall Study|Adverse Event|3
1499425|NCT00475865|4935358|P1|Overall Study|Adverse Event|0
1499426|NCT00475852|4935388|P2|Overall Study|Lost to Follow-up|68
1499427|NCT00475852|4935389|P1|Overall Study|Lost to Follow-up|54
1499428|NCT00475852|4935388|P2|Overall Study|Withdrawal by Subject|24
1499429|NCT00475852|4935389|P1|Overall Study|Withdrawal by Subject|19
1499430|NCT00475852|4935388|P2|Overall Study|Death|456
1499431|NCT00475852|4935389|P1|Overall Study|Death|444
1499432|NCT00475735|4935440|P6|Treatment Period 2|Withdrawal by Subject|0
1499433|NCT00475735|4935441|P5|Treatment Period 2|Withdrawal by Subject|1
1499434|NCT00475735|4935442|P4|Treatment Period 2|Withdrawal by Subject|0
1499435|NCT00475735|4935443|P3|Treatment Period 2|Withdrawal by Subject|0
1499436|NCT00475735|4935444|P2|Treatment Period 2|Withdrawal by Subject|0
1499437|NCT00475735|4935445|P1|Treatment Period 2|Withdrawal by Subject|0
1499438|NCT00475735|4935440|P6|Treatment Period 2|Lack of Efficacy|1
1499439|NCT00475735|4935441|P5|Treatment Period 2|Lack of Efficacy|0
1499440|NCT00475735|4935442|P4|Treatment Period 2|Lack of Efficacy|0
1499441|NCT00475735|4935443|P3|Treatment Period 2|Lack of Efficacy|0
1499442|NCT00475735|4935444|P2|Treatment Period 2|Lack of Efficacy|0
1499443|NCT00475735|4935445|P1|Treatment Period 2|Lack of Efficacy|0
1499444|NCT00475735|4935440|P6|Treatment Period 2|Adverse Event|0
1499445|NCT00475735|4935441|P5|Treatment Period 2|Adverse Event|0
1499446|NCT00475735|4935442|P4|Treatment Period 2|Adverse Event|2
1499447|NCT00475735|4935443|P3|Treatment Period 2|Adverse Event|0
1499448|NCT00475735|4935444|P2|Treatment Period 2|Adverse Event|1
1499449|NCT00475735|4935445|P1|Treatment Period 2|Adverse Event|0
1499450|NCT00475735|4935440|P6|Treatment Washout|Protocol Violation|0
1499451|NCT00475735|4935441|P5|Treatment Washout|Protocol Violation|0
1499452|NCT00475735|4935442|P4|Treatment Washout|Protocol Violation|0
1499453|NCT00475735|4935443|P3|Treatment Washout|Protocol Violation|0
1499454|NCT00475735|4935444|P2|Treatment Washout|Protocol Violation|1
1499455|NCT00475735|4935445|P1|Treatment Washout|Protocol Violation|0
1499456|NCT00475735|4935440|P6|Treatment Washout|Lost to Follow-up|0
1499457|NCT00475735|4935441|P5|Treatment Washout|Lost to Follow-up|0
1499458|NCT00475735|4935442|P4|Treatment Washout|Lost to Follow-up|0
1499459|NCT00475735|4935443|P3|Treatment Washout|Lost to Follow-up|0
1499460|NCT00475735|4935444|P2|Treatment Washout|Lost to Follow-up|1
1499461|NCT00475735|4935445|P1|Treatment Washout|Lost to Follow-up|0
1499462|NCT00475735|4935440|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
1499463|NCT00475735|4935441|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
1499464|NCT00475735|4935442|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
1499465|NCT00475735|4935443|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
1499466|NCT00475735|4935444|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
1499467|NCT00475735|4935445|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
1499468|NCT00475735|4935440|P6|Treatment Period 1|DC due to AE but continuing|2
1499469|NCT00475735|4935441|P5|Treatment Period 1|DC due to AE but continuing|2
1499470|NCT00475735|4935442|P4|Treatment Period 1|DC due to AE but continuing|1
1499471|NCT00475735|4935443|P3|Treatment Period 1|DC due to AE but continuing|0
1499472|NCT00475735|4935444|P2|Treatment Period 1|DC due to AE but continuing|0
1499473|NCT00475735|4935445|P1|Treatment Period 1|DC due to AE but continuing|0
1499474|NCT00475735|4935440|P6|Treatment Period 1|Withdrawal by Subject|0
1499475|NCT00475735|4935441|P5|Treatment Period 1|Withdrawal by Subject|0
1499476|NCT00475735|4935442|P4|Treatment Period 1|Withdrawal by Subject|0
1499477|NCT00475735|4935443|P3|Treatment Period 1|Withdrawal by Subject|0
1499478|NCT00475735|4935444|P2|Treatment Period 1|Withdrawal by Subject|1
1499479|NCT00475735|4935445|P1|Treatment Period 1|Withdrawal by Subject|1
1499480|NCT00475735|4935440|P6|Treatment Period 1|Protocol Violation|0
1499481|NCT00475735|4935441|P5|Treatment Period 1|Protocol Violation|0
1499482|NCT00475735|4935442|P4|Treatment Period 1|Protocol Violation|1
1499483|NCT00475735|4935443|P3|Treatment Period 1|Protocol Violation|0
1499484|NCT00475735|4935444|P2|Treatment Period 1|Protocol Violation|0
1499485|NCT00475735|4935445|P1|Treatment Period 1|Protocol Violation|0
1499486|NCT00475735|4935440|P6|Treatment Period 1|Lost to Follow-up|1
1499487|NCT00475735|4935441|P5|Treatment Period 1|Lost to Follow-up|0
1499488|NCT00475735|4935442|P4|Treatment Period 1|Lost to Follow-up|0
1499489|NCT00475735|4935443|P3|Treatment Period 1|Lost to Follow-up|0
1499490|NCT00475735|4935444|P2|Treatment Period 1|Lost to Follow-up|0
1499491|NCT00475735|4935445|P1|Treatment Period 1|Lost to Follow-up|0
1499492|NCT00475735|4935440|P6|Treatment Period 1|Lack of Efficacy|0
1499493|NCT00475735|4935441|P5|Treatment Period 1|Lack of Efficacy|0
1499494|NCT00475735|4935442|P4|Treatment Period 1|Lack of Efficacy|0
1499495|NCT00475735|4935443|P3|Treatment Period 1|Lack of Efficacy|0
1499496|NCT00475735|4935444|P2|Treatment Period 1|Lack of Efficacy|0
1499497|NCT00475735|4935445|P1|Treatment Period 1|Lack of Efficacy|1
1499498|NCT00475735|4935440|P6|Treatment Period 1|Adverse Event|0
1499499|NCT00475735|4935441|P5|Treatment Period 1|Adverse Event|0
1499500|NCT00475735|4935442|P4|Treatment Period 1|Adverse Event|0
1499501|NCT00475735|4935443|P3|Treatment Period 1|Adverse Event|0
1499502|NCT00475735|4935444|P2|Treatment Period 1|Adverse Event|0
1499503|NCT00475735|4935445|P1|Treatment Period 1|Adverse Event|2
1499504|NCT00475722|4935458|P2|Overall Study|Protocol Violation|0
1499505|NCT00475722|4935459|P1|Overall Study|Protocol Violation|3
1499506|NCT00475722|4935458|P2|Overall Study|Withdrawal by Subject|12
1499507|NCT00475722|4935459|P1|Overall Study|Withdrawal by Subject|12
1499508|NCT00475709|4935465|P1|Overall Study|Lost to Follow-up|21
1499509|NCT00475709|4935465|P1|Overall Study|Device Explant|6
1499510|NCT00475709|4935465|P1|Overall Study|Death|41
1499511|NCT00475709|4935465|P1|Overall Study|Did not meet eligibility criteria|8
1499512|NCT00475670|4935473|P2|Overall Study|Not Specified|3
1499513|NCT00475670|4935474|P1|Overall Study|Not Specified|0
1499514|NCT00475670|4935473|P2|Overall Study|Failure to Return|1
1499515|NCT00475670|4935474|P1|Overall Study|Failure to Return|0
1499516|NCT00475670|4935473|P2|Overall Study|Refused treatment|2
1499517|NCT00475670|4935474|P1|Overall Study|Refused treatment|0
1499518|NCT00475670|4935473|P2|Overall Study|Lack of Efficacy|34
1499519|NCT00475670|4935474|P1|Overall Study|Lack of Efficacy|3
1499520|NCT00475670|4935473|P2|Overall Study|Death|1
1499521|NCT00475670|4935474|P1|Overall Study|Death|0
1499522|NCT00475657|4935498|P1|Overall Study|Sponsor's Decision|3
1499523|NCT00475657|4935498|P1|Overall Study|Death|1
1499524|NCT00475423|4935563|P1|Overall Study|Lost to Follow-up|7
1499525|NCT00475423|4935563|P1|Overall Study|Reason not specified|1
1499526|NCT00475423|4935563|P1|Overall Study|Death|1
1499527|NCT00475423|4935563|P1|Overall Study|Lack of Efficacy|8
1499528|NCT00475423|4935563|P1|Overall Study|Withdrawal by Subject|6
1499529|NCT00475423|4935563|P1|Overall Study|Adverse Event|4
1499530|NCT00475423|4935563|P1|Overall Study|Protocol Violation|5
1499531|NCT00475306|4935609|P4|Overall Study|Protocol Violation|1
1499532|NCT00475306|4935610|P3|Overall Study|Protocol Violation|0
1499533|NCT00475306|4935611|P2|Overall Study|Protocol Violation|1
1499534|NCT00475306|4935612|P1|Overall Study|Protocol Violation|1
1499535|NCT00475228|4935637|P2|Overall Study|Lost to Follow-up|17
1499536|NCT00475228|4935638|P1|Overall Study|Lost to Follow-up|17
1499537|NCT00475176|4935648|P1|Overall Study|Protocol Violation|1
1499538|NCT00475176|4935648|P1|Overall Study|Withdrawal by Subject|1
1499539|NCT00475176|4935648|P1|Overall Study|Adverse Event|2
1499540|NCT00475033|4935688|P2|Toddler Dose|Lost to Follow-up|0
1499541|NCT00475033|4935689|P1|Toddler Dose|Lost to Follow-up|1
1499542|NCT00475033|4935688|P2|Toddler Dose|Failed to return|0
1499543|NCT00475033|4935689|P1|Toddler Dose|Failed to return|1
1499544|NCT00475033|4935688|P2|Toddler Dose|Parent or legal guardian request|0
1499545|NCT00475033|4935689|P1|Toddler Dose|Parent or legal guardian request|2
1499546|NCT00475033|4935688|P2|After the Infant Series|Other|1
1499547|NCT00475033|4935689|P1|After the Infant Series|Other|0
1499548|NCT00475033|4935688|P2|After the Infant Series|Lost to Follow-up|0
1499549|NCT00475033|4935689|P1|After the Infant Series|Lost to Follow-up|1
1499550|NCT00475033|4935688|P2|After the Infant Series|Protocol Violation|0
1499551|NCT00475033|4935689|P1|After the Infant Series|Protocol Violation|1
1499552|NCT00475033|4935688|P2|After the Infant Series|Failed to return|1
1499553|NCT00475033|4935689|P1|After the Infant Series|Failed to return|2
1499554|NCT00475033|4935688|P2|After the Infant Series|Parent or legal guardian request|2
1499555|NCT00475033|4935689|P1|After the Infant Series|Parent or legal guardian request|2
1499556|NCT00475033|4935688|P2|After the Infant Series|Adverse Event|4
1499557|NCT00475033|4935689|P1|After the Infant Series|Adverse Event|0
1499558|NCT00475033|4935688|P2|Infant Series|Adverse Event|2
1499559|NCT00475033|4935689|P1|Infant Series|Adverse Event|0
1499560|NCT00475033|4935688|P2|Infant Series|Lost to Follow-up|0
1499561|NCT00475033|4935689|P1|Infant Series|Lost to Follow-up|2
1499562|NCT00475033|4935688|P2|Infant Series|Protocol Violation|2
1499563|NCT00475033|4935689|P1|Infant Series|Protocol Violation|1
1499564|NCT00475033|4935688|P2|Infant Series|Parent or legal guardian request|5
1499565|NCT00475033|4935689|P1|Infant Series|Parent or legal guardian request|1
1499566|NCT00475033|4935688|P2|Infant Series|Failed to return|4
1499567|NCT00475033|4935689|P1|Infant Series|Failed to return|3
1499568|NCT00474994|4935737|P1|Overall Study|Patient found to be ineligible|1
1499569|NCT00474994|4935737|P1|Overall Study|Patient evaluable for toxicity only|3
1499570|NCT00474994|4935737|P1|Overall Study|Patient Not treated|1
1499571|NCT00474968|4935743|P2|Overall Study|Sample not collected|1
1499572|NCT00474968|4935744|P1|Overall Study|Sample not collected|1
1499573|NCT00474968|4935743|P2|Overall Study|Protocol Violation|8
1499574|NCT00474968|4935744|P1|Overall Study|Protocol Violation|9
1499575|NCT00474968|4935743|P2|Overall Study|Withdrawal by Subject|7
1499576|NCT00474968|4935744|P1|Overall Study|Withdrawal by Subject|8
1499577|NCT00474955|4935754|P1|Overall Study|Personal reasons|5
1499578|NCT00474955|4935754|P1|Overall Study|Drug unavailability|1
1499579|NCT00474955|4935754|P1|Overall Study|Adverse Event|2
1499580|NCT00474929|4935770|P5|Overall Study|Physician Decision|0
1499581|NCT00474929|4935771|P4|Overall Study|Physician Decision|2
1499582|NCT00474929|4935772|P3|Overall Study|Physician Decision|1
1499583|NCT00474929|4935773|P2|Overall Study|Physician Decision|0
1499584|NCT00474929|4935774|P1|Overall Study|Physician Decision|0
1499585|NCT00474929|4935770|P5|Overall Study|Unrelated medical condition|0
1499586|NCT00474929|4935771|P4|Overall Study|Unrelated medical condition|0
1499587|NCT00474929|4935772|P3|Overall Study|Unrelated medical condition|1
1499588|NCT00474929|4935773|P2|Overall Study|Unrelated medical condition|0
1499589|NCT00474929|4935774|P1|Overall Study|Unrelated medical condition|0
1499590|NCT00474929|4935770|P5|Overall Study|Withdrawal by Subject|0
1499591|NCT00474929|4935771|P4|Overall Study|Withdrawal by Subject|0
1499592|NCT00474929|4935772|P3|Overall Study|Withdrawal by Subject|0
1499593|NCT00474929|4935773|P2|Overall Study|Withdrawal by Subject|1
1499594|NCT00474929|4935774|P1|Overall Study|Withdrawal by Subject|0
1499595|NCT00474903|4935791|P3|Overall Study|Protocol Violation|2
1499596|NCT00474903|4935792|P2|Overall Study|Protocol Violation|5
1499597|NCT00474903|4935793|P1|Overall Study|Protocol Violation|1
1499598|NCT00474812|4935815|P1|Overall Study|No Initiation of treatment|2
1499599|NCT00474812|4935815|P1|Overall Study|Withdrawal by Subject|5
1499600|NCT00474786|4935825|P2|Overall Study|Not specified|0
1499601|NCT00474786|4935826|P1|Overall Study|Not specified|5
1499602|NCT00474786|4935825|P2|Overall Study|Withdrawal by Subject|15
1499603|NCT00474786|4935826|P1|Overall Study|Withdrawal by Subject|15
1499604|NCT00474786|4935825|P2|Overall Study|Protocol Violation|0
1499605|NCT00474786|4935826|P1|Overall Study|Protocol Violation|2
1499606|NCT00474786|4935825|P2|Overall Study|Lost to Follow-up|7
1499607|NCT00474786|4935826|P1|Overall Study|Lost to Follow-up|4
1499608|NCT00474786|4935825|P2|Overall Study|Discontinuation of Study by Sponsor|59
1499609|NCT00474786|4935826|P1|Overall Study|Discontinuation of Study by Sponsor|42
1499610|NCT00474786|4935825|P2|Overall Study|Death|170
1499611|NCT00474786|4935826|P1|Overall Study|Death|189
1499612|NCT00474786|4935825|P2|Overall Study|Investigator Request|1
1499613|NCT00474786|4935826|P1|Overall Study|Investigator Request|2
1499614|NCT00474786|4935825|P2|Overall Study|Not Meeting Study Criteria|1
1499615|NCT00474786|4935826|P1|Overall Study|Not Meeting Study Criteria|0
1499616|NCT00474760|4935851|P7|Overall Study|Terminated by sponsor|2
1499617|NCT00474760|4935852|P6|Overall Study|Terminated by sponsor|0
1499618|NCT00474760|4935853|P5|Overall Study|Terminated by sponsor|0
1499619|NCT00474760|4935854|P4|Overall Study|Terminated by sponsor|0
1499620|NCT00474760|4935855|P3|Overall Study|Terminated by sponsor|0
1499621|NCT00474760|4935856|P2|Overall Study|Terminated by sponsor|0
1499622|NCT00474760|4935857|P1|Overall Study|Terminated by sponsor|0
1499623|NCT00474760|4935851|P7|Overall Study|Progressive disease|7
1499624|NCT00474760|4935852|P6|Overall Study|Progressive disease|20
1499625|NCT00474760|4935853|P5|Overall Study|Progressive disease|8
1499626|NCT00474760|4935854|P4|Overall Study|Progressive disease|2
1499627|NCT00474760|4935855|P3|Overall Study|Progressive disease|3
1499628|NCT00474760|4935856|P2|Overall Study|Progressive disease|2
1499629|NCT00474760|4935857|P1|Overall Study|Progressive disease|3
1499630|NCT00474760|4935851|P7|Overall Study|Other|0
1499631|NCT00474760|4935852|P6|Overall Study|Other|0
1499632|NCT00474760|4935853|P5|Overall Study|Other|1
1499633|NCT00474760|4935854|P4|Overall Study|Other|0
1499634|NCT00474760|4935855|P3|Overall Study|Other|0
1499635|NCT00474760|4935856|P2|Overall Study|Other|1
1499636|NCT00474760|4935857|P1|Overall Study|Other|0
1499637|NCT00474760|4935851|P7|Overall Study|Withdrawal by Subject|1
1499638|NCT00474760|4935852|P6|Overall Study|Withdrawal by Subject|1
1499639|NCT00474760|4935853|P5|Overall Study|Withdrawal by Subject|0
1499640|NCT00474760|4935854|P4|Overall Study|Withdrawal by Subject|1
1499641|NCT00474760|4935855|P3|Overall Study|Withdrawal by Subject|0
1499642|NCT00474760|4935856|P2|Overall Study|Withdrawal by Subject|0
1499643|NCT00474760|4935857|P1|Overall Study|Withdrawal by Subject|0
1499644|NCT00474760|4935851|P7|Overall Study|Laboratory abnormality|0
1499645|NCT00474760|4935852|P6|Overall Study|Laboratory abnormality|1
1499646|NCT00474760|4935853|P5|Overall Study|Laboratory abnormality|0
1499647|NCT00474760|4935854|P4|Overall Study|Laboratory abnormality|0
1499648|NCT00474760|4935855|P3|Overall Study|Laboratory abnormality|0
1499649|NCT00474760|4935856|P2|Overall Study|Laboratory abnormality|0
1499650|NCT00474760|4935857|P1|Overall Study|Laboratory abnormality|0
1499651|NCT00474760|4935851|P7|Overall Study|Adverse Event|0
1499652|NCT00474760|4935852|P6|Overall Study|Adverse Event|7
1499653|NCT00474760|4935853|P5|Overall Study|Adverse Event|1
1499654|NCT00474760|4935854|P4|Overall Study|Adverse Event|0
1499655|NCT00474760|4935855|P3|Overall Study|Adverse Event|0
1499656|NCT00474760|4935856|P2|Overall Study|Adverse Event|0
1499657|NCT00474760|4935857|P1|Overall Study|Adverse Event|0
1499658|NCT00474760|4935851|P7|Overall Study|Death|0
1499659|NCT00474760|4935852|P6|Overall Study|Death|0
1499660|NCT00474760|4935853|P5|Overall Study|Death|2
1499661|NCT00474760|4935854|P4|Overall Study|Death|0
1499662|NCT00474760|4935855|P3|Overall Study|Death|0
1499663|NCT00474760|4935856|P2|Overall Study|Death|0
1499664|NCT00474760|4935857|P1|Overall Study|Death|0
1499665|NCT00474708|4935964|P2|Overall Study|Physician Decision|6
1499666|NCT00474708|4935965|P1|Overall Study|Physician Decision|9
1499667|NCT00474708|4935964|P2|Overall Study|Lost to Follow-up|9
1499668|NCT00474708|4935965|P1|Overall Study|Lost to Follow-up|18
1499669|NCT00474708|4935964|P2|Overall Study|Lack of compliance|4
1499670|NCT00474708|4935965|P1|Overall Study|Lack of compliance|12
1499671|NCT00474708|4935964|P2|Overall Study|Withdrawal by Subject|0
1499672|NCT00474708|4935965|P1|Overall Study|Withdrawal by Subject|7
1499673|NCT00474708|4935964|P2|Overall Study|Suicide ideation/behavior|1
1499674|NCT00474708|4935965|P1|Overall Study|Suicide ideation/behavior|0
1499675|NCT00474708|4935964|P2|Overall Study|Lack of Efficacy|5
1499676|NCT00474708|4935965|P1|Overall Study|Lack of Efficacy|11
1499677|NCT00474630|4935975|P2|Overall Study|Drug noncompliance, other|4
1499678|NCT00474630|4935976|P1|Overall Study|Drug noncompliance, other|11
1499679|NCT00474630|4935975|P2|Overall Study|Lack of Efficacy|6
1499680|NCT00474630|4935976|P1|Overall Study|Lack of Efficacy|5
1499681|NCT00474630|4935975|P2|Overall Study|Protocol Violation|4
1499682|NCT00474630|4935976|P1|Overall Study|Protocol Violation|3
1499683|NCT00474630|4935975|P2|Overall Study|Withdrawal by Subject|15
1499684|NCT00474630|4935976|P1|Overall Study|Withdrawal by Subject|21
1499685|NCT00474630|4935975|P2|Overall Study|Lost to Follow-up|15
1499686|NCT00474630|4935976|P1|Overall Study|Lost to Follow-up|22
1499687|NCT00474630|4935975|P2|Overall Study|Adverse Event|26
1499688|NCT00474630|4935976|P1|Overall Study|Adverse Event|98
1499689|NCT00474539|4936032|P2|Toddler Dose|Protocol Violation|0
1499690|NCT00474539|4936033|P1|Toddler Dose|Protocol Violation|1
1499691|NCT00474539|4936032|P2|After Infant Series|Withdrawal by Subject|0
1499692|NCT00474539|4936033|P1|After Infant Series|Withdrawal by Subject|1
1499693|NCT00474539|4936032|P2|After Infant Series|Lost to Follow-up|0
1499694|NCT00474539|4936033|P1|After Infant Series|Lost to Follow-up|3
1499695|NCT00474539|4936032|P2|Infant Series|Protocol Violation|1
1499696|NCT00474539|4936033|P1|Infant Series|Protocol Violation|0
1499697|NCT00474539|4936032|P2|Infant Series|Lost to Follow-up|1
1499698|NCT00474539|4936033|P1|Infant Series|Lost to Follow-up|2
1499699|NCT00474539|4936032|P2|Infant Series|Randomization error|0
1499700|NCT00474539|4936033|P1|Infant Series|Randomization error|5
1499701|NCT00474539|4936032|P2|Infant Series|Withdrawal by Subject|4
1499702|NCT00474539|4936033|P1|Infant Series|Withdrawal by Subject|3
1499703|NCT00474526|4936098|P17|Overall Study|Withdrawal by Subject|1
1499704|NCT00474526|4936099|P16|Overall Study|Withdrawal by Subject|1
1499705|NCT00474526|4936100|P15|Overall Study|Withdrawal by Subject|22
1499706|NCT00474526|4936101|P14|Overall Study|Withdrawal by Subject|37
1499707|NCT00474526|4936102|P13|Overall Study|Withdrawal by Subject|4
1499708|NCT00474526|4936103|P12|Overall Study|Withdrawal by Subject|4
1499709|NCT00474526|4936104|P11|Overall Study|Withdrawal by Subject|5
1499710|NCT00474526|4936105|P10|Overall Study|Withdrawal by Subject|13
1499711|NCT00474526|4936106|P9|Overall Study|Withdrawal by Subject|4
1499712|NCT00474526|4936107|P8|Overall Study|Withdrawal by Subject|4
1499713|NCT00474526|4936108|P7|Overall Study|Withdrawal by Subject|12
1499714|NCT00474526|4936109|P6|Overall Study|Withdrawal by Subject|6
1499715|NCT00474526|4936110|P5|Overall Study|Withdrawal by Subject|38
1499716|NCT00474526|4936111|P4|Overall Study|Withdrawal by Subject|52
1499717|NCT00474526|4936112|P3|Overall Study|Withdrawal by Subject|21
1499718|NCT00474526|4936113|P2|Overall Study|Withdrawal by Subject|24
1499719|NCT00474526|4936114|P1|Overall Study|Withdrawal by Subject|9
1499720|NCT00474526|4936098|P17|Overall Study|UNABLE TO CLASSIFY|1
1499721|NCT00474526|4936099|P16|Overall Study|UNABLE TO CLASSIFY|6
1499722|NCT00474526|4936100|P15|Overall Study|UNABLE TO CLASSIFY|12
1499723|NCT00474526|4936101|P14|Overall Study|UNABLE TO CLASSIFY|20
1499724|NCT00474526|4936102|P13|Overall Study|UNABLE TO CLASSIFY|0
1499725|NCT00474526|4936103|P12|Overall Study|UNABLE TO CLASSIFY|0
1499726|NCT00474526|4936104|P11|Overall Study|UNABLE TO CLASSIFY|0
1499727|NCT00474526|4936105|P10|Overall Study|UNABLE TO CLASSIFY|3
1499728|NCT00474526|4936106|P9|Overall Study|UNABLE TO CLASSIFY|0
1499729|NCT00474526|4936107|P8|Overall Study|UNABLE TO CLASSIFY|1
1499730|NCT00474526|4936108|P7|Overall Study|UNABLE TO CLASSIFY|0
1499731|NCT00474526|4936109|P6|Overall Study|UNABLE TO CLASSIFY|2
1499732|NCT00474526|4936110|P5|Overall Study|UNABLE TO CLASSIFY|3
1499733|NCT00474526|4936111|P4|Overall Study|UNABLE TO CLASSIFY|1
1499734|NCT00474526|4936112|P3|Overall Study|UNABLE TO CLASSIFY|0
1499735|NCT00474526|4936113|P2|Overall Study|UNABLE TO CLASSIFY|0
1499736|NCT00474526|4936114|P1|Overall Study|UNABLE TO CLASSIFY|1
1499737|NCT00474526|4936098|P17|Overall Study|Protocol Violation|2
1499738|NCT00474526|4936099|P16|Overall Study|Protocol Violation|6
1499739|NCT00474526|4936100|P15|Overall Study|Protocol Violation|9
1499740|NCT00474526|4936101|P14|Overall Study|Protocol Violation|19
1499741|NCT00474526|4936102|P13|Overall Study|Protocol Violation|4
1499742|NCT00474526|4936103|P12|Overall Study|Protocol Violation|2
1499743|NCT00474526|4936104|P11|Overall Study|Protocol Violation|2
1499744|NCT00474526|4936105|P10|Overall Study|Protocol Violation|4
1499745|NCT00474526|4936106|P9|Overall Study|Protocol Violation|0
1499746|NCT00474526|4936107|P8|Overall Study|Protocol Violation|0
1499747|NCT00474526|4936108|P7|Overall Study|Protocol Violation|3
1499748|NCT00474526|4936109|P6|Overall Study|Protocol Violation|1
1499749|NCT00474526|4936110|P5|Overall Study|Protocol Violation|3
1499750|NCT00474526|4936111|P4|Overall Study|Protocol Violation|12
1499751|NCT00474526|4936112|P3|Overall Study|Protocol Violation|4
1499752|NCT00474526|4936113|P2|Overall Study|Protocol Violation|6
1499753|NCT00474526|4936114|P1|Overall Study|Protocol Violation|2
1499754|NCT00474526|4936098|P17|Overall Study|Lost to Follow-up|5
1499755|NCT00474526|4936099|P16|Overall Study|Lost to Follow-up|4
1499756|NCT00474526|4936100|P15|Overall Study|Lost to Follow-up|29
1499757|NCT00474526|4936101|P14|Overall Study|Lost to Follow-up|74
1499758|NCT00474526|4936102|P13|Overall Study|Lost to Follow-up|6
1499759|NCT00474526|4936103|P12|Overall Study|Lost to Follow-up|4
1499760|NCT00474526|4936104|P11|Overall Study|Lost to Follow-up|2
1499761|NCT00474526|4936105|P10|Overall Study|Lost to Follow-up|6
1499762|NCT00474526|4936106|P9|Overall Study|Lost to Follow-up|0
1499763|NCT00474526|4936107|P8|Overall Study|Lost to Follow-up|1
1499764|NCT00474526|4936108|P7|Overall Study|Lost to Follow-up|8
1499765|NCT00474526|4936109|P6|Overall Study|Lost to Follow-up|5
1499766|NCT00474526|4936110|P5|Overall Study|Lost to Follow-up|11
1499767|NCT00474526|4936111|P4|Overall Study|Lost to Follow-up|29
1499768|NCT00474526|4936112|P3|Overall Study|Lost to Follow-up|13
1499769|NCT00474526|4936113|P2|Overall Study|Lost to Follow-up|6
1499770|NCT00474526|4936114|P1|Overall Study|Lost to Follow-up|8
1499771|NCT00474526|4936098|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
1499772|NCT00474526|4936099|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
1499773|NCT00474526|4936100|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
1499774|NCT00474526|4936101|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
1499775|NCT00474526|4936102|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
1499776|NCT00474526|4936103|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
1499777|NCT00474526|4936104|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
1499778|NCT00474526|4936105|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
1499779|NCT00474526|4936106|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
1499780|NCT00474526|4936107|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
1499781|NCT00474526|4936108|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
1499782|NCT00474526|4936109|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
1499783|NCT00474526|4936110|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
1499784|NCT00474526|4936111|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
1499785|NCT00474526|4936112|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
1499786|NCT00474526|4936113|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
1499787|NCT00474526|4936114|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
1499788|NCT00474526|4936098|P17|Overall Study|Death|0
1499789|NCT00474526|4936099|P16|Overall Study|Death|0
1499790|NCT00474526|4936100|P15|Overall Study|Death|0
1499791|NCT00474526|4936101|P14|Overall Study|Death|3
1499792|NCT00474526|4936102|P13|Overall Study|Death|0
1499793|NCT00474526|4936103|P12|Overall Study|Death|0
1499794|NCT00474526|4936104|P11|Overall Study|Death|0
1499795|NCT00474526|4936105|P10|Overall Study|Death|0
1499796|NCT00474526|4936106|P9|Overall Study|Death|0
1499797|NCT00474526|4936107|P8|Overall Study|Death|0
1499798|NCT00474526|4936108|P7|Overall Study|Death|0
1499799|NCT00474526|4936109|P6|Overall Study|Death|0
1499800|NCT00474526|4936110|P5|Overall Study|Death|0
1499801|NCT00474526|4936111|P4|Overall Study|Death|0
1499802|NCT00474526|4936112|P3|Overall Study|Death|0
1499803|NCT00474526|4936113|P2|Overall Study|Death|0
1499804|NCT00474526|4936114|P1|Overall Study|Death|0
1499805|NCT00474526|4936098|P17|Overall Study|Adverse Event|0
1499806|NCT00474526|4936099|P16|Overall Study|Adverse Event|1
1499807|NCT00474526|4936100|P15|Overall Study|Adverse Event|1
1499808|NCT00474526|4936101|P14|Overall Study|Adverse Event|0
1499809|NCT00474526|4936102|P13|Overall Study|Adverse Event|0
1499810|NCT00474526|4936103|P12|Overall Study|Adverse Event|0
1499811|NCT00474526|4936104|P11|Overall Study|Adverse Event|0
1499812|NCT00474526|4936105|P10|Overall Study|Adverse Event|0
1499813|NCT00474526|4936106|P9|Overall Study|Adverse Event|0
1499814|NCT00474526|4936107|P8|Overall Study|Adverse Event|0
1499815|NCT00474526|4936108|P7|Overall Study|Adverse Event|1
1499816|NCT00474526|4936109|P6|Overall Study|Adverse Event|1
1499817|NCT00474526|4936110|P5|Overall Study|Adverse Event|2
1499818|NCT00474526|4936111|P4|Overall Study|Adverse Event|4
1499819|NCT00474526|4936112|P3|Overall Study|Adverse Event|2
1499820|NCT00474526|4936113|P2|Overall Study|Adverse Event|0
1499821|NCT00474526|4936114|P1|Overall Study|Adverse Event|2
1499822|NCT00474526|4936098|P17|Overall Study|ADMINISTRATIVE REASON|0
1499823|NCT00474526|4936099|P16|Overall Study|ADMINISTRATIVE REASON|0
1499824|NCT00474526|4936100|P15|Overall Study|ADMINISTRATIVE REASON|2
1499825|NCT00474526|4936101|P14|Overall Study|ADMINISTRATIVE REASON|1
1499826|NCT00474526|4936102|P13|Overall Study|ADMINISTRATIVE REASON|1
1499827|NCT00474526|4936103|P12|Overall Study|ADMINISTRATIVE REASON|1
1499828|NCT00474526|4936104|P11|Overall Study|ADMINISTRATIVE REASON|1
1499829|NCT00474526|4936105|P10|Overall Study|ADMINISTRATIVE REASON|1
1499830|NCT00474526|4936106|P9|Overall Study|ADMINISTRATIVE REASON|2
1499831|NCT00474526|4936107|P8|Overall Study|ADMINISTRATIVE REASON|0
1499832|NCT00474526|4936108|P7|Overall Study|ADMINISTRATIVE REASON|1
1499833|NCT00474526|4936109|P6|Overall Study|ADMINISTRATIVE REASON|1
1499834|NCT00474526|4936110|P5|Overall Study|ADMINISTRATIVE REASON|9
1499835|NCT00474526|4936111|P4|Overall Study|ADMINISTRATIVE REASON|20
1499836|NCT00474526|4936112|P3|Overall Study|ADMINISTRATIVE REASON|9
1499837|NCT00474526|4936113|P2|Overall Study|ADMINISTRATIVE REASON|9
1499838|NCT00474526|4936114|P1|Overall Study|ADMINISTRATIVE REASON|11
1499839|NCT00474487|4936279|P4|Overall Study|Death|0
1499840|NCT00474487|4936280|P3|Overall Study|Death|0
1499841|NCT00474487|4936281|P2|Overall Study|Death|1
1499842|NCT00474487|4936282|P1|Overall Study|Death|0
1499843|NCT00474487|4936279|P4|Overall Study|Inappropriate enrollment|0
1499844|NCT00474487|4936280|P3|Overall Study|Inappropriate enrollment|7
1499845|NCT00474487|4936281|P2|Overall Study|Inappropriate enrollment|0
1499846|NCT00474487|4936282|P1|Overall Study|Inappropriate enrollment|4
1499847|NCT00474487|4936279|P4|Overall Study|Lost to Follow-up|0
1499848|NCT00474487|4936280|P3|Overall Study|Lost to Follow-up|7
1499849|NCT00474487|4936281|P2|Overall Study|Lost to Follow-up|1
1499850|NCT00474487|4936282|P1|Overall Study|Lost to Follow-up|20
1499851|NCT00474487|4936279|P4|Overall Study|Withdrawal by Subject|0
1499852|NCT00474487|4936280|P3|Overall Study|Withdrawal by Subject|0
1499853|NCT00474487|4936281|P2|Overall Study|Withdrawal by Subject|0
1499854|NCT00474487|4936282|P1|Overall Study|Withdrawal by Subject|6
1499855|NCT00474383|4936302|P2|Extension|Progressive Disease|5
1499856|NCT00474383|4936303|P1|Extension|Progressive Disease|0
1499857|NCT00474383|4936302|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
1499858|NCT00474383|4936303|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
1499859|NCT00474383|4936302|P2|Main Study|Other|0
1499860|NCT00474383|4936303|P1|Main Study|Other|1
1499861|NCT00474383|4936302|P2|Main Study|Progressive Disease|0
1499862|NCT00474383|4936303|P1|Main Study|Progressive Disease|23
1499863|NCT00474383|4936302|P2|Main Study|Symptomatic Deterioration|0
1499864|NCT00474383|4936303|P1|Main Study|Symptomatic Deterioration|1
1499865|NCT00474383|4936302|P2|Main Study|Adverse Event|0
1499866|NCT00474383|4936303|P1|Main Study|Adverse Event|11
1499867|NCT00474266|4936318|P4|Overall Study|Withdrawal by Subject|7
1499868|NCT00474266|4936319|P3|Overall Study|Withdrawal by Subject|4
1499869|NCT00474266|4936320|P2|Overall Study|Withdrawal by Subject|20
1499870|NCT00474266|4936321|P1|Overall Study|Withdrawal by Subject|7
1499871|NCT00474240|4936429|P6|Overall Study|Removed due to lab value|1
1499872|NCT00474240|4936430|P5|Overall Study|Removed due to lab value|0
1499873|NCT00474240|4936431|P4|Overall Study|Removed due to lab value|0
1499874|NCT00474240|4936432|P3|Overall Study|Removed due to lab value|0
1499875|NCT00474240|4936433|P2|Overall Study|Removed due to lab value|0
1499876|NCT00474240|4936434|P1|Overall Study|Removed due to lab value|0
1499877|NCT00474240|4936429|P6|Overall Study|Adverse Event|16
1499878|NCT00474240|4936430|P5|Overall Study|Adverse Event|5
1499879|NCT00474240|4936431|P4|Overall Study|Adverse Event|14
1499880|NCT00474240|4936432|P3|Overall Study|Adverse Event|9
1499881|NCT00474240|4936433|P2|Overall Study|Adverse Event|0
1499882|NCT00474240|4936434|P1|Overall Study|Adverse Event|0
1499883|NCT00474240|4936429|P6|Overall Study|Withdrawal by Subject|1
1499884|NCT00474240|4936430|P5|Overall Study|Withdrawal by Subject|3
1499885|NCT00474240|4936431|P4|Overall Study|Withdrawal by Subject|2
1499886|NCT00474240|4936432|P3|Overall Study|Withdrawal by Subject|0
1499887|NCT00474240|4936433|P2|Overall Study|Withdrawal by Subject|1
1499888|NCT00474240|4936434|P1|Overall Study|Withdrawal by Subject|1
1499889|NCT00474188|4936459|P1|Overall Study|Study discontinued by sponsor|5
1499890|NCT00474188|4936459|P1|Overall Study|Withdrawal by Subject|1
1499891|NCT00474175|4936469|P3|Overall Study|Administrative|0
1499892|NCT00474175|4936470|P2|Overall Study|Administrative|1
1499893|NCT00474175|4936471|P1|Overall Study|Administrative|0
1499894|NCT00474175|4936469|P3|Overall Study|Protocol Violation|1
1499895|NCT00474175|4936470|P2|Overall Study|Protocol Violation|2
1499896|NCT00474175|4936471|P1|Overall Study|Protocol Violation|0
1499897|NCT00474175|4936469|P3|Overall Study|Ineligible|1
1499898|NCT00474175|4936470|P2|Overall Study|Ineligible|3
1499899|NCT00474175|4936471|P1|Overall Study|Ineligible|1
1499900|NCT00474175|4936469|P3|Overall Study|Withdrawal by Subject|1
1499901|NCT00474175|4936470|P2|Overall Study|Withdrawal by Subject|1
1499902|NCT00474175|4936471|P1|Overall Study|Withdrawal by Subject|0
1499903|NCT00474175|4936469|P3|Overall Study|Lack of Efficacy|1
1499904|NCT00474175|4936470|P2|Overall Study|Lack of Efficacy|0
1499905|NCT00474175|4936471|P1|Overall Study|Lack of Efficacy|0
1499906|NCT00474058|4936535|P2|Overall Study|Other|0
1499907|NCT00474058|4936536|P1|Overall Study|Other|2
1499908|NCT00474058|4936535|P2|Overall Study|Withdrawal by Subject|7
1499909|NCT00474058|4936536|P1|Overall Study|Withdrawal by Subject|11
1499910|NCT00474058|4936535|P2|Overall Study|Lack of Efficacy|4
1499911|NCT00474058|4936536|P1|Overall Study|Lack of Efficacy|0
1499912|NCT00474058|4936535|P2|Overall Study|Adverse Event|6
1499913|NCT00474058|4936536|P1|Overall Study|Adverse Event|11
1499914|NCT00474045|4936550|P2|Overall Study|Withdrawal criteria|50
1499915|NCT00474045|4936551|P1|Overall Study|Withdrawal criteria|60
1499916|NCT00474045|4936550|P2|Overall Study|Withdrawal by Subject|18
1499917|NCT00474045|4936551|P1|Overall Study|Withdrawal by Subject|16
1499918|NCT00474045|4936550|P2|Overall Study|Protocol Violation|12
1499919|NCT00474045|4936551|P1|Overall Study|Protocol Violation|10
1499920|NCT00474045|4936550|P2|Overall Study|Lost to Follow-up|1
1499921|NCT00474045|4936551|P1|Overall Study|Lost to Follow-up|1
1499922|NCT00474045|4936550|P2|Overall Study|Lack of Efficacy|9
1499923|NCT00474045|4936551|P1|Overall Study|Lack of Efficacy|0
1499924|NCT00474045|4936550|P2|Overall Study|Unclassified|3
1499925|NCT00474045|4936551|P1|Overall Study|Unclassified|1
1499926|NCT00474045|4936550|P2|Overall Study|Adverse Event|8
1499927|NCT00474045|4936551|P1|Overall Study|Adverse Event|18
1499928|NCT00473889|4936651|P2|Overall Study|Withdrawal by Subject|0
1499929|NCT00473889|4936652|P1|Overall Study|Withdrawal by Subject|5
1499930|NCT00473889|4936651|P2|Overall Study|Trial Terminated|6
1499931|NCT00473889|4936652|P1|Overall Study|Trial Terminated|3
1499932|NCT00473889|4936651|P2|Overall Study|Physician Decision|5
1499933|NCT00473889|4936652|P1|Overall Study|Physician Decision|10
1499934|NCT00473889|4936651|P2|Overall Study|Lost to Follow-up|1
1499935|NCT00473889|4936652|P1|Overall Study|Lost to Follow-up|2
1499936|NCT00473889|4936651|P2|Overall Study|Lack of Efficacy|29
1499937|NCT00473889|4936652|P1|Overall Study|Lack of Efficacy|28
1499938|NCT00473889|4936651|P2|Overall Study|Protocol Violation|2
1499939|NCT00473889|4936652|P1|Overall Study|Protocol Violation|4
1499940|NCT00473889|4936651|P2|Overall Study|Adverse Event|17
1499941|NCT00473889|4936652|P1|Overall Study|Adverse Event|30
1499942|NCT00473889|4936651|P2|Overall Study|Did not receive study medication|4
1499943|NCT00473889|4936652|P1|Overall Study|Did not receive study medication|1
1499944|NCT00473876|4936664|P2|Overall Study|Lost to Follow-up|1
1499945|NCT00473876|4936665|P1|Overall Study|Lost to Follow-up|3
1499946|NCT00473824|4936684|P2|Overall Study|Withdrawal by physician|0
1499947|NCT00473824|4936685|P1|Overall Study|Withdrawal by physician|1
1499948|NCT00473824|4936684|P2|Overall Study|Lost to Follow-up|0
1499949|NCT00473824|4936685|P1|Overall Study|Lost to Follow-up|1
1499950|NCT00473824|4936684|P2|Overall Study|Death|0
1499951|NCT00473824|4936685|P1|Overall Study|Death|1
1499952|NCT00473824|4936684|P2|Overall Study|Adverse Event|0
1499953|NCT00473824|4936685|P1|Overall Study|Adverse Event|1
1499954|NCT00473824|4936684|P2|Overall Study|Virologic Breakthrough|0
1499955|NCT00473824|4936685|P1|Overall Study|Virologic Breakthrough|1
1499956|NCT00473746|4936696|P5|Period 2 (Phase 2)|Reason not specified|3
1499957|NCT00473746|4936697|P4|Period 2 (Phase 2)|Reason not specified|0
1499958|NCT00473746|4936698|P3|Period 2 (Phase 2)|Reason not specified|0
1499959|NCT00473746|4936699|P2|Period 2 (Phase 2)|Reason not specified|0
1499960|NCT00473746|4936700|P1|Period 2 (Phase 2)|Reason not specified|0
1499961|NCT00473746|4936696|P5|Period 2 (Phase 2)|Progressive Disease|20
1499962|NCT00473746|4936697|P4|Period 2 (Phase 2)|Progressive Disease|0
1499963|NCT00473746|4936698|P3|Period 2 (Phase 2)|Progressive Disease|0
1499964|NCT00473746|4936699|P2|Period 2 (Phase 2)|Progressive Disease|0
1499965|NCT00473746|4936700|P1|Period 2 (Phase 2)|Progressive Disease|0
1499966|NCT00473746|4936696|P5|Period 2 (Phase 2)|Death|1
1499967|NCT00473746|4936697|P4|Period 2 (Phase 2)|Death|0
1499968|NCT00473746|4936698|P3|Period 2 (Phase 2)|Death|0
1499969|NCT00473746|4936699|P2|Period 2 (Phase 2)|Death|0
1499970|NCT00473746|4936700|P1|Period 2 (Phase 2)|Death|0
1499971|NCT00473746|4936696|P5|Period 2 (Phase 2)|Adverse Event|3
1499972|NCT00473746|4936697|P4|Period 2 (Phase 2)|Adverse Event|0
1499973|NCT00473746|4936698|P3|Period 2 (Phase 2)|Adverse Event|0
1499974|NCT00473746|4936699|P2|Period 2 (Phase 2)|Adverse Event|0
1499975|NCT00473746|4936700|P1|Period 2 (Phase 2)|Adverse Event|0
1499976|NCT00473746|4936696|P5|Period 1 (Phase 1)|Reason not specified|0
1499977|NCT00473746|4936697|P4|Period 1 (Phase 1)|Reason not specified|0
1499978|NCT00473746|4936698|P3|Period 1 (Phase 1)|Reason not specified|0
1499979|NCT00473746|4936699|P2|Period 1 (Phase 1)|Reason not specified|1
1499980|NCT00473746|4936700|P1|Period 1 (Phase 1)|Reason not specified|0
1499981|NCT00473746|4936696|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
1499982|NCT00473746|4936697|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
1499983|NCT00473746|4936698|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
1499984|NCT00473746|4936699|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
1499985|NCT00473746|4936700|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
1499986|NCT00473746|4936696|P5|Period 1 (Phase 1)|Progressive Disease|0
1499987|NCT00473746|4936697|P4|Period 1 (Phase 1)|Progressive Disease|10
1499988|NCT00473746|4936698|P3|Period 1 (Phase 1)|Progressive Disease|6
1499989|NCT00473746|4936699|P2|Period 1 (Phase 1)|Progressive Disease|6
1499990|NCT00473746|4936700|P1|Period 1 (Phase 1)|Progressive Disease|5
1499991|NCT00473746|4936696|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
1499992|NCT00473746|4936697|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
1499993|NCT00473746|4936698|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
1499994|NCT00473746|4936699|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
1499995|NCT00473746|4936700|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
1499996|NCT00473746|4936696|P5|Period 1 (Phase 1)|Adverse Event|0
1499997|NCT00473746|4936697|P4|Period 1 (Phase 1)|Adverse Event|0
1499998|NCT00473746|4936698|P3|Period 1 (Phase 1)|Adverse Event|0
1499999|NCT00473746|4936699|P2|Period 1 (Phase 1)|Adverse Event|0
1500000|NCT00473746|4936700|P1|Period 1 (Phase 1)|Adverse Event|1
1500001|NCT00473668|4936748|P3|Overall Study|Other|4
1500002|NCT00473668|4936749|P2|Overall Study|Other|3
1500003|NCT00473668|4936750|P1|Overall Study|Other|2
1500004|NCT00473668|4936748|P3|Overall Study|Lost to Follow-up|6
1500005|NCT00473668|4936749|P2|Overall Study|Lost to Follow-up|4
1500006|NCT00473668|4936750|P1|Overall Study|Lost to Follow-up|0
1500007|NCT00473668|4936748|P3|Overall Study|Migrated/moved from study area|0
1500008|NCT00473668|4936749|P2|Overall Study|Migrated/moved from study area|2
1500009|NCT00473668|4936750|P1|Overall Study|Migrated/moved from study area|3
1500010|NCT00473668|4936748|P3|Overall Study|Withdrawal by Subject|0
1500011|NCT00473668|4936749|P2|Overall Study|Withdrawal by Subject|2
1500012|NCT00473668|4936750|P1|Overall Study|Withdrawal by Subject|0
1500013|NCT00473655|4936803|P3|Overall Study|Lost to Follow-up|8
1500014|NCT00473655|4936804|P2|Overall Study|Lost to Follow-up|5
1500015|NCT00473655|4936805|P1|Overall Study|Lost to Follow-up|9
1500016|NCT00473590|4936852|P2|Overall Study|Other|1
1500017|NCT00473590|4936853|P1|Overall Study|Other|0
1500018|NCT00473590|4936852|P2|Overall Study|Withdrawal by Subject|3
1500019|NCT00473590|4936853|P1|Overall Study|Withdrawal by Subject|5
1500020|NCT00473590|4936852|P2|Overall Study|Physician Decision|4
1500021|NCT00473590|4936853|P1|Overall Study|Physician Decision|2
1500022|NCT00473590|4936852|P2|Overall Study|Non–protocol-specified therapy|5
1500023|NCT00473590|4936853|P1|Overall Study|Non–protocol-specified therapy|7
1500024|NCT00473590|4936852|P2|Overall Study|Progression not resulting in death|20
1500025|NCT00473590|4936853|P1|Overall Study|Progression not resulting in death|24
1500026|NCT00473590|4936852|P2|Overall Study|Death|2
1500027|NCT00473590|4936853|P1|Overall Study|Death|4
1500028|NCT00473590|4936852|P2|Overall Study|Adverse Event|3
1500029|NCT00473590|4936853|P1|Overall Study|Adverse Event|3
1500030|NCT00473564|4936869|P1|Overall Study|robot surgery aborted in OR|23
1500031|NCT00473512|4936879|P5|Period 2 (Phase 2)|Other|0
1500032|NCT00473512|4936880|P4|Period 2 (Phase 2)|Other|3
1500033|NCT00473512|4936881|P3|Period 2 (Phase 2)|Other|0
1500034|NCT00473512|4936882|P2|Period 2 (Phase 2)|Other|0
1500035|NCT00473512|4936883|P1|Period 2 (Phase 2)|Other|1
1500036|NCT00473512|4936879|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
1500037|NCT00473512|4936880|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
1500038|NCT00473512|4936881|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
1500039|NCT00473512|4936882|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
1500040|NCT00473512|4936883|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
1500041|NCT00473512|4936879|P5|Period 2 (Phase 2)|Disease Progression|1
1500042|NCT00473512|4936880|P4|Period 2 (Phase 2)|Disease Progression|17
1500043|NCT00473512|4936881|P3|Period 2 (Phase 2)|Disease Progression|2
1500044|NCT00473512|4936882|P2|Period 2 (Phase 2)|Disease Progression|2
1500045|NCT00473512|4936883|P1|Period 2 (Phase 2)|Disease Progression|0
1500046|NCT00473512|4936879|P5|Period 2 (Phase 2)|Death|1
1500047|NCT00473512|4936880|P4|Period 2 (Phase 2)|Death|1
1500048|NCT00473512|4936881|P3|Period 2 (Phase 2)|Death|0
1500049|NCT00473512|4936882|P2|Period 2 (Phase 2)|Death|0
1500050|NCT00473512|4936883|P1|Period 2 (Phase 2)|Death|0
1500051|NCT00473512|4936879|P5|Period 2 (Phase 2)|Adverse Event|0
1500052|NCT00473512|4936880|P4|Period 2 (Phase 2)|Adverse Event|1
1500053|NCT00473512|4936881|P3|Period 2 (Phase 2)|Adverse Event|0
1500054|NCT00473512|4936882|P2|Period 2 (Phase 2)|Adverse Event|0
1500055|NCT00473512|4936883|P1|Period 2 (Phase 2)|Adverse Event|0
1500056|NCT00473512|4936879|P5|Period 1 (Phase 1)|Other|0
1500057|NCT00473512|4936880|P4|Period 1 (Phase 1)|Other|1
1500058|NCT00473512|4936881|P3|Period 1 (Phase 1)|Other|0
1500059|NCT00473512|4936882|P2|Period 1 (Phase 1)|Other|0
1500060|NCT00473512|4936883|P1|Period 1 (Phase 1)|Other|0
1500061|NCT00473512|4936879|P5|Period 1 (Phase 1)|Disease Progression|1
1500062|NCT00473512|4936880|P4|Period 1 (Phase 1)|Disease Progression|10
1500063|NCT00473512|4936881|P3|Period 1 (Phase 1)|Disease Progression|0
1500064|NCT00473512|4936882|P2|Period 1 (Phase 1)|Disease Progression|1
1500065|NCT00473512|4936883|P1|Period 1 (Phase 1)|Disease Progression|1
1500066|NCT00473512|4936879|P5|Period 1 (Phase 1)|Death|0
1500067|NCT00473512|4936880|P4|Period 1 (Phase 1)|Death|1
1500068|NCT00473512|4936881|P3|Period 1 (Phase 1)|Death|0
1500069|NCT00473512|4936882|P2|Period 1 (Phase 1)|Death|0
1500070|NCT00473512|4936883|P1|Period 1 (Phase 1)|Death|0
1500071|NCT00473512|4936879|P5|Period 1 (Phase 1)|Adverse Event|0
1500072|NCT00473512|4936880|P4|Period 1 (Phase 1)|Adverse Event|5
1500073|NCT00473512|4936881|P3|Period 1 (Phase 1)|Adverse Event|0
1500074|NCT00473512|4936882|P2|Period 1 (Phase 1)|Adverse Event|0
1500075|NCT00473512|4936883|P1|Period 1 (Phase 1)|Adverse Event|0
1500076|NCT00473434|4936941|P1|Overall Study|No longer required|1
1500077|NCT00473434|4936941|P1|Overall Study|Switching to trial medication|1
1500078|NCT00473434|4936941|P1|Overall Study|Ceased in favor of Paliperidone|1
1500079|NCT00473434|4936941|P1|Overall Study|Reason not specified|6
1500080|NCT00473434|4936941|P1|Overall Study|Safety evaluation|1
1500081|NCT00473434|4936941|P1|Overall Study|Patient was selling medication to others|1
1500082|NCT00473434|4936941|P1|Overall Study|Adverse Event|3
1500083|NCT00473434|4936941|P1|Overall Study|Lack of Efficacy|3
1500084|NCT00473434|4936941|P1|Overall Study|Compliance|3
1500085|NCT00473434|4936941|P1|Overall Study|Withdrawal by Subject|9
1500086|NCT00473434|4936941|P1|Overall Study|Physician Decision|3
1500087|NCT00473382|4937006|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
1500088|NCT00473382|4937007|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
1500089|NCT00473382|4937008|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
1500090|NCT00473382|4937006|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|69
1500091|NCT00473382|4937007|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|70
1500092|NCT00473382|4937008|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|75
1500093|NCT00473382|4937006|P3|Open-label Extension Through Month 60|Subject's Decision|6
1500094|NCT00473382|4937007|P2|Open-label Extension Through Month 60|Subject's Decision|1
1500095|NCT00473382|4937008|P1|Open-label Extension Through Month 60|Subject's Decision|7
1500096|NCT00473382|4937006|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
1500097|NCT00473382|4937007|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
1500098|NCT00473382|4937008|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
1500099|NCT00473382|4937006|P3|Open-label Extension Through Month 60|Death|4
1500100|NCT00473382|4937007|P2|Open-label Extension Through Month 60|Death|7
1500101|NCT00473382|4937008|P1|Open-label Extension Through Month 60|Death|1
1500102|NCT00473382|4937006|P3|Open-label Extension Through Month 60|Adverse Event|2
1500103|NCT00473382|4937007|P2|Open-label Extension Through Month 60|Adverse Event|0
1500104|NCT00473382|4937008|P1|Open-label Extension Through Month 60|Adverse Event|0
1500105|NCT00473382|4937006|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
1500106|NCT00473382|4937007|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
1500107|NCT00473382|4937008|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
1500108|NCT00473382|4937006|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|36
1500109|NCT00473382|4937007|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|34
1500110|NCT00473382|4937008|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|41
1500111|NCT00473382|4937006|P3|Open-label Extension Through Month 48|Subject's Decision|6
1500112|NCT00473382|4937007|P2|Open-label Extension Through Month 48|Subject's Decision|1
1500113|NCT00473382|4937008|P1|Open-label Extension Through Month 48|Subject's Decision|5
1500114|NCT00473382|4937006|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
1500115|NCT00473382|4937007|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
1500116|NCT00473382|4937008|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
1500117|NCT00473382|4937006|P3|Open-label Extension Through Month 48|Death|3
1500118|NCT00473382|4937007|P2|Open-label Extension Through Month 48|Death|3
1500119|NCT00473382|4937008|P1|Open-label Extension Through Month 48|Death|1
1500120|NCT00473382|4937006|P3|Open-label Extension Through Month 48|Adverse Event|1
1500121|NCT00473382|4937007|P2|Open-label Extension Through Month 48|Adverse Event|0
1500122|NCT00473382|4937008|P1|Open-label Extension Through Month 48|Adverse Event|0
1500123|NCT00473382|4937006|P3|Core Study|Subject's decision|10
1500124|NCT00473382|4937007|P2|Core Study|Subject's decision|11
1500125|NCT00473382|4937008|P1|Core Study|Subject's decision|12
1500126|NCT00473382|4937006|P3|Core Study|Subject needed other treatment|2
1500127|NCT00473382|4937007|P2|Core Study|Subject needed other treatment|3
1500128|NCT00473382|4937008|P1|Core Study|Subject needed other treatment|1
1500129|NCT00473382|4937006|P3|Core Study|Subject non-compliance|1
1500130|NCT00473382|4937007|P2|Core Study|Subject non-compliance|2
1500131|NCT00473382|4937008|P1|Core Study|Subject non-compliance|5
1500132|NCT00473382|4937006|P3|Core Study|Physician Decision|2
1500133|NCT00473382|4937007|P2|Core Study|Physician Decision|2
1500134|NCT00473382|4937008|P1|Core Study|Physician Decision|1
1500135|NCT00473382|4937006|P3|Core Study|Lost to Follow-up|3
1500136|NCT00473382|4937007|P2|Core Study|Lost to Follow-up|3
1500137|NCT00473382|4937008|P1|Core Study|Lost to Follow-up|3
1500138|NCT00473382|4937006|P3|Core Study|Death|10
1500139|NCT00473382|4937007|P2|Core Study|Death|5
1500140|NCT00473382|4937008|P1|Core Study|Death|3
1500141|NCT00473382|4937006|P3|Core Study|Adverse Event|1
1500142|NCT00473382|4937007|P2|Core Study|Adverse Event|1
1500143|NCT00473382|4937008|P1|Core Study|Adverse Event|3
1500144|NCT00473330|4937066|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
1500145|NCT00473330|4937067|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
1500146|NCT00473330|4937068|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
1500147|NCT00473330|4937066|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
1500148|NCT00473330|4937067|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
1500149|NCT00473330|4937068|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
1500150|NCT00473330|4937066|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|62
1500151|NCT00473330|4937067|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|71
1500152|NCT00473330|4937068|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|77
1500153|NCT00473330|4937066|P3|Open-label Extension Through Month 60|Subject's Decision|4
1500154|NCT00473330|4937067|P2|Open-label Extension Through Month 60|Subject's Decision|3
1500155|NCT00473330|4937068|P1|Open-label Extension Through Month 60|Subject's Decision|1
1500156|NCT00473330|4937066|P3|Open-label Extension Through Month 60|Physician's Decision|3
1500157|NCT00473330|4937067|P2|Open-label Extension Through Month 60|Physician's Decision|1
1500158|NCT00473330|4937068|P1|Open-label Extension Through Month 60|Physician's Decision|2
1500159|NCT00473330|4937066|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
1500160|NCT00473330|4937067|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
1500161|NCT00473330|4937068|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
1500162|NCT00473330|4937066|P3|Open-label Extension Through Month 60|Death|1
1500163|NCT00473330|4937067|P2|Open-label Extension Through Month 60|Death|2
1500164|NCT00473330|4937068|P1|Open-label Extension Through Month 60|Death|2
1500165|NCT00473330|4937066|P3|Open-label Extension Through Month 60|Adverse Event|2
1500166|NCT00473330|4937067|P2|Open-label Extension Through Month 60|Adverse Event|0
1500167|NCT00473330|4937068|P1|Open-label Extension Through Month 60|Adverse Event|0
1500168|NCT00473330|4937066|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
1500169|NCT00473330|4937067|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
1500170|NCT00473330|4937068|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
1500171|NCT00473330|4937066|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
1500172|NCT00473330|4937067|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
1500173|NCT00473330|4937068|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
1500258|NCT00472303|4937275|P1|Maintenance Phase|Death|3
1500174|NCT00473330|4937066|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|16
1500175|NCT00473330|4937067|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|15
1500176|NCT00473330|4937068|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|18
1500177|NCT00473330|4937066|P3|Open-label Extension Through Month 48|Subject's Decision|3
1500178|NCT00473330|4937067|P2|Open-label Extension Through Month 48|Subject's Decision|3
1500179|NCT00473330|4937068|P1|Open-label Extension Through Month 48|Subject's Decision|1
1500180|NCT00473330|4937066|P3|Open-label Extension Through Month 48|Physician's Decision|3
1500181|NCT00473330|4937067|P2|Open-label Extension Through Month 48|Physician's Decision|1
1500182|NCT00473330|4937068|P1|Open-label Extension Through Month 48|Physician's Decision|2
1500183|NCT00473330|4937066|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
1500184|NCT00473330|4937067|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
1500185|NCT00473330|4937068|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
1500186|NCT00473330|4937066|P3|Open-label Extension Through Month 48|Death|0
1500187|NCT00473330|4937067|P2|Open-label Extension Through Month 48|Death|0
1500188|NCT00473330|4937068|P1|Open-label Extension Through Month 48|Death|2
1500189|NCT00473330|4937066|P3|Open-label Extension Through Month 48|Adverse Event|2
1500190|NCT00473330|4937067|P2|Open-label Extension Through Month 48|Adverse Event|0
1500191|NCT00473330|4937068|P1|Open-label Extension Through Month 48|Adverse Event|0
1500192|NCT00473330|4937066|P3|Core Study|Subject's Decision|19
1500193|NCT00473330|4937067|P2|Core Study|Subject's Decision|8
1500194|NCT00473330|4937068|P1|Core Study|Subject's Decision|9
1500195|NCT00473330|4937066|P3|Core Study|Subject Required Other Therapy|3
1500196|NCT00473330|4937067|P2|Core Study|Subject Required Other Therapy|1
1500197|NCT00473330|4937068|P1|Core Study|Subject Required Other Therapy|0
1500198|NCT00473330|4937066|P3|Core Study|Subject Non-compliance|1
1500199|NCT00473330|4937067|P2|Core Study|Subject Non-compliance|2
1500200|NCT00473330|4937068|P1|Core Study|Subject Non-compliance|1
1500201|NCT00473330|4937066|P3|Core Study|Physician Decision|3
1500202|NCT00473330|4937067|P2|Core Study|Physician Decision|1
1500203|NCT00473330|4937068|P1|Core Study|Physician Decision|2
1500204|NCT00473330|4937066|P3|Core Study|Lost to Follow-up|10
1500205|NCT00473330|4937067|P2|Core Study|Lost to Follow-up|5
1500206|NCT00473330|4937068|P1|Core Study|Lost to Follow-up|5
1500207|NCT00473330|4937066|P3|Core Study|Death|4
1500208|NCT00473330|4937067|P2|Core Study|Death|4
1500209|NCT00473330|4937068|P1|Core Study|Death|6
1500210|NCT00473330|4937066|P3|Core Study|Adverse Event|1
1500211|NCT00473330|4937067|P2|Core Study|Adverse Event|4
1500212|NCT00473330|4937068|P1|Core Study|Adverse Event|4
1500213|NCT00473265|4937123|P1|Overall Study|Off treatment early|15
1500214|NCT00473265|4937123|P1|Overall Study|Unrelated adverse event|5
1500215|NCT00473083|4937135|P3|Overall Study|Adverse Event|0
1500216|NCT00473083|4937136|P2|Overall Study|Adverse Event|0
1500217|NCT00473083|4937137|P1|Overall Study|Adverse Event|1
1500218|NCT00472641|4937212|P1|Overall Study|Lost to Follow-up|1
1500219|NCT00472641|4937212|P1|Overall Study|Adverse Event|3
1500220|NCT00472641|4937212|P1|Overall Study|Lack of Efficacy|3
1500221|NCT00472446|4937232|P4|Overall Study|Questionnaires not returned|4
1500222|NCT00472446|4937233|P3|Overall Study|Questionnaires not returned|6
1500223|NCT00472446|4937234|P2|Overall Study|Questionnaires not returned|6
1500224|NCT00472446|4937235|P1|Overall Study|Questionnaires not returned|5
1500225|NCT00472446|4937232|P4|Overall Study|Reintervention|1
1500226|NCT00472446|4937233|P3|Overall Study|Reintervention|1
1500227|NCT00472446|4937234|P2|Overall Study|Reintervention|0
1500228|NCT00472446|4937235|P1|Overall Study|Reintervention|0
1500229|NCT00472446|4937232|P4|Overall Study|Protocol Violation|1
1500230|NCT00472446|4937233|P3|Overall Study|Protocol Violation|0
1500231|NCT00472446|4937234|P2|Overall Study|Protocol Violation|0
1500232|NCT00472446|4937235|P1|Overall Study|Protocol Violation|0
1500233|NCT00472420|4937265|P1|Follow-up Period|Protocol Violation|1
1500234|NCT00472420|4937265|P1|Follow-up Period|Lost to Follow-up|2
1500235|NCT00472420|4937265|P1|Follow-up Period|Physician Decision|9
1500236|NCT00472420|4937265|P1|Follow-up Period|Death|5
1500237|NCT00472420|4937265|P1|Induction Treatment Period|Death|3
1500238|NCT00472420|4937265|P1|Induction Treatment Period|Non-compliance|1
1500239|NCT00472420|4937265|P1|Induction Treatment Period|Adverse Event|3
1500240|NCT00472420|4937265|P1|Induction Treatment Period|Physician Decision|9
1500241|NCT00472303|4937273|P3|Maintenance Phase|not specified|0
1500242|NCT00472303|4937274|P2|Maintenance Phase|not specified|1
1500243|NCT00472303|4937275|P1|Maintenance Phase|not specified|1
1500244|NCT00472303|4937273|P3|Maintenance Phase|Resolution of pain|1
1500245|NCT00472303|4937274|P2|Maintenance Phase|Resolution of pain|0
1500246|NCT00472303|4937275|P1|Maintenance Phase|Resolution of pain|0
1500247|NCT00472303|4937273|P3|Maintenance Phase|Trial medication non-compliant|1
1500248|NCT00472303|4937274|P2|Maintenance Phase|Trial medication non-compliant|0
1500249|NCT00472303|4937275|P1|Maintenance Phase|Trial medication non-compliant|0
1500250|NCT00472303|4937273|P3|Maintenance Phase|Withdrawal by Subject|3
1500251|NCT00472303|4937274|P2|Maintenance Phase|Withdrawal by Subject|7
1500252|NCT00472303|4937275|P1|Maintenance Phase|Withdrawal by Subject|6
1500253|NCT00472303|4937273|P3|Maintenance Phase|Lack of Efficacy|4
1500254|NCT00472303|4937274|P2|Maintenance Phase|Lack of Efficacy|2
1500255|NCT00472303|4937275|P1|Maintenance Phase|Lack of Efficacy|2
1500256|NCT00472303|4937273|P3|Maintenance Phase|Death|2
1500257|NCT00472303|4937274|P2|Maintenance Phase|Death|0
1500259|NCT00472303|4937273|P3|Maintenance Phase|Adverse Event|6
1500260|NCT00472303|4937274|P2|Maintenance Phase|Adverse Event|6
1500261|NCT00472303|4937275|P1|Maintenance Phase|Adverse Event|5
1500262|NCT00472303|4937273|P3|Discontinuations After Titration Phase|not specified|0
1500263|NCT00472303|4937274|P2|Discontinuations After Titration Phase|not specified|0
1500264|NCT00472303|4937275|P1|Discontinuations After Titration Phase|not specified|5
1500265|NCT00472303|4937273|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
1500266|NCT00472303|4937274|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
1500267|NCT00472303|4937275|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
1500268|NCT00472303|4937273|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
1500269|NCT00472303|4937274|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
1500270|NCT00472303|4937275|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
1500271|NCT00472303|4937273|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
1500272|NCT00472303|4937274|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
1500273|NCT00472303|4937275|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
1500274|NCT00472303|4937273|P3|Discontinuations After Titration Phase|Adverse Event|0
1500275|NCT00472303|4937274|P2|Discontinuations After Titration Phase|Adverse Event|0
1500276|NCT00472303|4937275|P1|Discontinuations After Titration Phase|Adverse Event|6
1500277|NCT00472303|4937273|P3|Titration Phase|not specified|0
1500278|NCT00472303|4937274|P2|Titration Phase|not specified|1
1500279|NCT00472303|4937275|P1|Titration Phase|not specified|3
1500280|NCT00472303|4937273|P3|Titration Phase|Trial Medication non-compliant|0
1500281|NCT00472303|4937274|P2|Titration Phase|Trial Medication non-compliant|1
1500282|NCT00472303|4937275|P1|Titration Phase|Trial Medication non-compliant|4
1500283|NCT00472303|4937273|P3|Titration Phase|Withdrawal by Subject|0
1500284|NCT00472303|4937274|P2|Titration Phase|Withdrawal by Subject|13
1500285|NCT00472303|4937275|P1|Titration Phase|Withdrawal by Subject|16
1500286|NCT00472303|4937273|P3|Titration Phase|Lack of Efficacy|0
1500287|NCT00472303|4937274|P2|Titration Phase|Lack of Efficacy|0
1500288|NCT00472303|4937275|P1|Titration Phase|Lack of Efficacy|10
1500289|NCT00472303|4937273|P3|Titration Phase|Death|0
1500290|NCT00472303|4937274|P2|Titration Phase|Death|2
1500291|NCT00472303|4937275|P1|Titration Phase|Death|4
1500292|NCT00472303|4937273|P3|Titration Phase|Adverse Event|0
1500293|NCT00472303|4937274|P2|Titration Phase|Adverse Event|12
1500294|NCT00472303|4937275|P1|Titration Phase|Adverse Event|22
1500295|NCT00472290|4937338|P1|Overall Study|Requirement for alternative therapy|7
1500296|NCT00472290|4937338|P1|Overall Study|Adverse Event|6
1500297|NCT00472290|4937338|P1|Overall Study|Withdrawal by Subject|5
1500298|NCT00472290|4937338|P1|Overall Study|Disease Progression|4
1500299|NCT00472290|4937338|P1|Overall Study|Lack of Efficacy|1
1500300|NCT00472290|4937338|P1|Overall Study|Lost to Follow-up|1
1500301|NCT00472290|4937338|P1|Overall Study|Death|3
1500302|NCT00472290|4937338|P1|Overall Study|Administrative Decision|37
1500303|NCT00472290|4937338|P1|Overall Study|Protocol Specified Criteria|7
1500304|NCT00472290|4937338|P1|Overall Study|Progression of Therapy-Related MDS|1
1500305|NCT00472199|4937350|P2|Overall Study|patient was asymptomatic|0
1500306|NCT00472199|4937351|P1|Overall Study|patient was asymptomatic|1
1500307|NCT00472199|4937350|P2|Overall Study|personal reason|1
1500308|NCT00472199|4937351|P1|Overall Study|personal reason|0
1500309|NCT00472199|4937350|P2|Overall Study|Withdrawal by Subject|5
1500310|NCT00472199|4937351|P1|Overall Study|Withdrawal by Subject|6
1500311|NCT00472199|4937350|P2|Overall Study|Protocol Violation|2
1500312|NCT00472199|4937351|P1|Overall Study|Protocol Violation|3
1500313|NCT00472199|4937350|P2|Overall Study|Lost to Follow-up|4
1500314|NCT00472199|4937351|P1|Overall Study|Lost to Follow-up|2
1500315|NCT00472199|4937350|P2|Overall Study|Lack of Efficacy|25
1500316|NCT00472199|4937351|P1|Overall Study|Lack of Efficacy|4
1500317|NCT00472199|4937350|P2|Overall Study|Adverse Event|23
1500318|NCT00472199|4937351|P1|Overall Study|Adverse Event|19
1500319|NCT00472082|4937417|P1|Overall Study|Study prematurely terminated|5
1500320|NCT00472030|4937439|P2|Overall Study|Physician Decision|0
1500321|NCT00472030|4937440|P1|Overall Study|Physician Decision|1
1500322|NCT00471822|4937456|P1|Overall Study|Protocol Violation|2
1500323|NCT00471718|4937464|P1|Overall Study|Withdrawal by Subject|1
1500324|NCT00471718|4937464|P1|Overall Study|disease progression|22
1500325|NCT00471718|4937464|P1|Overall Study|other complicating disease|1
1500326|NCT00471718|4937464|P1|Overall Study|Adverse Event|3
1500327|NCT00471536|4937492|P1|Overall Study|Withdrawal by Subject|1
1500328|NCT00471497|4937504|P3|Overall Study|Sub optimal response or treat. failure|0
1500329|NCT00471497|4937505|P2|Overall Study|Sub optimal response or treat. failure|3
1500330|NCT00471497|4937506|P1|Overall Study|Sub optimal response or treat. failure|8
1500331|NCT00471497|4937504|P3|Overall Study|Protocol Violation|5
1500332|NCT00471497|4937505|P2|Overall Study|Protocol Violation|3
1500333|NCT00471497|4937506|P1|Overall Study|Protocol Violation|3
1500334|NCT00471497|4937504|P3|Overall Study|Disease Progression|2
1500335|NCT00471497|4937505|P2|Overall Study|Disease Progression|2
1500336|NCT00471497|4937506|P1|Overall Study|Disease Progression|8
1500337|NCT00471497|4937504|P3|Overall Study|Death|0
1500338|NCT00471497|4937505|P2|Overall Study|Death|2
1500339|NCT00471497|4937506|P1|Overall Study|Death|0
1500340|NCT00471497|4937504|P3|Overall Study|Lost to Follow-up|1
1500341|NCT00471497|4937505|P2|Overall Study|Lost to Follow-up|2
1500342|NCT00471497|4937506|P1|Overall Study|Lost to Follow-up|1
1500343|NCT00471497|4937504|P3|Overall Study|Withdrawal by Subject|5
1500344|NCT00471497|4937505|P2|Overall Study|Withdrawal by Subject|5
1500345|NCT00471497|4937506|P1|Overall Study|Withdrawal by Subject|3
1500346|NCT00471497|4937504|P3|Overall Study|Condition no longer requires study drug|0
1500347|NCT00471497|4937505|P2|Overall Study|Condition no longer requires study drug|1
1500348|NCT00471497|4937506|P1|Overall Study|Condition no longer requires study drug|0
1500349|NCT00471497|4937504|P3|Overall Study|Abnormal Test Procedure|1
1500350|NCT00471497|4937505|P2|Overall Study|Abnormal Test Procedure|0
1500351|NCT00471497|4937506|P1|Overall Study|Abnormal Test Procedure|1
1500352|NCT00471497|4937504|P3|Overall Study|Abnormal Laboratory Value|4
1500353|NCT00471497|4937505|P2|Overall Study|Abnormal Laboratory Value|6
1500354|NCT00471497|4937506|P1|Overall Study|Abnormal Laboratory Value|3
1500355|NCT00471497|4937504|P3|Overall Study|Adverse Event|22
1500356|NCT00471497|4937505|P2|Overall Study|Adverse Event|11
1500357|NCT00471497|4937506|P1|Overall Study|Adverse Event|19
1500358|NCT00471445|4937516|P2|Overall Study|Protocol Violation|1
1500359|NCT00471445|4937517|P1|Overall Study|Protocol Violation|0
1500360|NCT00471445|4937516|P2|Overall Study|Ineligible|0
1500361|NCT00471445|4937517|P1|Overall Study|Ineligible|1
1500362|NCT00471445|4937516|P2|Overall Study|Withdrawal by Subject|1
1500363|NCT00471445|4937517|P1|Overall Study|Withdrawal by Subject|1
1500364|NCT00471354|4937530|P1|Overall Study|Patient/Caregiver Decision|12
1500365|NCT00471354|4937530|P1|Overall Study|Lack of Efficacy|5
1500366|NCT00471354|4937530|P1|Overall Study|Lost to Follow-up|3
1500367|NCT00471354|4937530|P1|Overall Study|Sponsor Decision|1
1500368|NCT00471354|4937530|P1|Overall Study|Physician Decision|4
1500369|NCT00471354|4937530|P1|Overall Study|Withdrawal by Subject|1
1500370|NCT00471354|4937530|P1|Overall Study|Protocol Violation|12
1500371|NCT00471354|4937530|P1|Overall Study|Adverse Event|13
1500372|NCT00471354|4937530|P1|Overall Study|Protocol Entry Criteria Not Met|1
1500373|NCT00471328|4937542|P2|Extension Phase|Administrative Problem|0
1500374|NCT00471328|4937543|P1|Extension Phase|Administrative Problem|1
1500375|NCT00471328|4937542|P2|Extension Phase|New cancer Therapy|0
1500376|NCT00471328|4937543|P1|Extension Phase|New cancer Therapy|1
1500377|NCT00471328|4937542|P2|Extension Phase|Disease Progression|44
1500378|NCT00471328|4937543|P1|Extension Phase|Disease Progression|32
1500379|NCT00471328|4937542|P2|Extension Phase|Treatment duration as per protocol|1
1500380|NCT00471328|4937543|P1|Extension Phase|Treatment duration as per protocol|0
1500381|NCT00471328|4937542|P2|Extension Phase|Protocol Deviation|1
1500382|NCT00471328|4937543|P1|Extension Phase|Protocol Deviation|3
1500383|NCT00471328|4937542|P2|Extension Phase|Death|7
1500384|NCT00471328|4937543|P1|Extension Phase|Death|1
1500385|NCT00471328|4937542|P2|Extension Phase|Withdrawal by Subject|2
1500386|NCT00471328|4937543|P1|Extension Phase|Withdrawal by Subject|0
1500387|NCT00471328|4937542|P2|Extension Phase|Adverse Event|12
1500388|NCT00471328|4937543|P1|Extension Phase|Adverse Event|3
1500389|NCT00471328|4937542|P2|Core Phase|Protocol Deviation|1
1500390|NCT00471328|4937543|P1|Core Phase|Protocol Deviation|0
1500391|NCT00471328|4937542|P2|Core Phase|Administrative Problem|1
1500392|NCT00471328|4937543|P1|Core Phase|Administrative Problem|0
1500393|NCT00471328|4937542|P2|Core Phase|Disease Progression|53
1500394|NCT00471328|4937543|P1|Core Phase|Disease Progression|78
1500395|NCT00471328|4937542|P2|Core Phase|Abnormal laboratory value|0
1500396|NCT00471328|4937543|P1|Core Phase|Abnormal laboratory value|1
1500397|NCT00471328|4937542|P2|Core Phase|Withdrawal by Subject|2
1500398|NCT00471328|4937543|P1|Core Phase|Withdrawal by Subject|2
1500399|NCT00471328|4937542|P2|Core Phase|Death|4
1500400|NCT00471328|4937543|P1|Core Phase|Death|8
1500401|NCT00471328|4937542|P2|Core Phase|Adverse Event|6
1500402|NCT00471328|4937543|P1|Core Phase|Adverse Event|18
1500403|NCT00471315|4937562|P1|Overall Study|Withdrawal by Subject|1
1500404|NCT00471315|4937562|P1|Overall Study|Adverse Event|7
1500405|NCT00471276|4937567|P1|Overall Study|Refused treatment|6
1500406|NCT00471276|4937567|P1|Overall Study|Other|3
1500407|NCT00471276|4937567|P1|Overall Study|Global deterioration of health status|1
1500408|NCT00471276|4937567|P1|Overall Study|Objective progression or relapse|54
1500409|NCT00471276|4937567|P1|Overall Study|Protocol Violation|1
1500410|NCT00471276|4937567|P1|Overall Study|Adverse Event|16
1500411|NCT00471276|4937567|P1|Overall Study|Death|2
1500412|NCT00471237|4937597|P7|Overall Study|Participant's decision|0
1500413|NCT00471237|4937598|P6|Overall Study|Participant's decision|1
1500414|NCT00471237|4937599|P5|Overall Study|Participant's decision|0
1500415|NCT00471237|4937600|P4|Overall Study|Participant's decision|0
1500416|NCT00471237|4937601|P3|Overall Study|Participant's decision|0
1500417|NCT00471237|4937602|P2|Overall Study|Participant's decision|0
1500418|NCT00471237|4937603|P1|Overall Study|Participant's decision|0
1500419|NCT00471237|4937597|P7|Overall Study|Participant shifted residence|0
1500420|NCT00471237|4937598|P6|Overall Study|Participant shifted residence|0
1500421|NCT00471237|4937599|P5|Overall Study|Participant shifted residence|1
1500422|NCT00471237|4937600|P4|Overall Study|Participant shifted residence|0
1500423|NCT00471237|4937601|P3|Overall Study|Participant shifted residence|0
1500424|NCT00471237|4937602|P2|Overall Study|Participant shifted residence|0
1500425|NCT00471237|4937603|P1|Overall Study|Participant shifted residence|0
1500426|NCT00471237|4937597|P7|Overall Study|Administration of prohibited medicine|0
1500427|NCT00471237|4937598|P6|Overall Study|Administration of prohibited medicine|0
1500428|NCT00471237|4937599|P5|Overall Study|Administration of prohibited medicine|1
1500429|NCT00471237|4937600|P4|Overall Study|Administration of prohibited medicine|0
1500430|NCT00471237|4937601|P3|Overall Study|Administration of prohibited medicine|0
1500431|NCT00471237|4937602|P2|Overall Study|Administration of prohibited medicine|0
1500432|NCT00471237|4937603|P1|Overall Study|Administration of prohibited medicine|0
1500433|NCT00471237|4937597|P7|Overall Study|Participant lost medication|0
1500434|NCT00471237|4937598|P6|Overall Study|Participant lost medication|0
1500435|NCT00471237|4937599|P5|Overall Study|Participant lost medication|1
1500436|NCT00471237|4937600|P4|Overall Study|Participant lost medication|0
1500437|NCT00471237|4937601|P3|Overall Study|Participant lost medication|0
1500438|NCT00471237|4937602|P2|Overall Study|Participant lost medication|0
1500439|NCT00471237|4937603|P1|Overall Study|Participant lost medication|0
1500440|NCT00471237|4937597|P7|Overall Study|High parathyroid hormone|0
1500441|NCT00471237|4937598|P6|Overall Study|High parathyroid hormone|0
1500442|NCT00471237|4937599|P5|Overall Study|High parathyroid hormone|0
1500443|NCT00471237|4937600|P4|Overall Study|High parathyroid hormone|0
1500444|NCT00471237|4937601|P3|Overall Study|High parathyroid hormone|1
1500445|NCT00471237|4937602|P2|Overall Study|High parathyroid hormone|0
1500446|NCT00471237|4937603|P1|Overall Study|High parathyroid hormone|0
1500447|NCT00471237|4937597|P7|Overall Study|Participant planned to travel to abraod|0
1500448|NCT00471237|4937598|P6|Overall Study|Participant planned to travel to abraod|1
1500449|NCT00471237|4937599|P5|Overall Study|Participant planned to travel to abraod|0
1500450|NCT00471237|4937600|P4|Overall Study|Participant planned to travel to abraod|0
1500451|NCT00471237|4937601|P3|Overall Study|Participant planned to travel to abraod|0
1500452|NCT00471237|4937602|P2|Overall Study|Participant planned to travel to abraod|0
1500453|NCT00471237|4937603|P1|Overall Study|Participant planned to travel to abraod|1
1500454|NCT00471237|4937597|P7|Overall Study|Early stopping due to non-efficacy|0
1500455|NCT00471237|4937598|P6|Overall Study|Early stopping due to non-efficacy|0
1500456|NCT00471237|4937599|P5|Overall Study|Early stopping due to non-efficacy|1
1500457|NCT00471237|4937600|P4|Overall Study|Early stopping due to non-efficacy|0
1500458|NCT00471237|4937601|P3|Overall Study|Early stopping due to non-efficacy|0
1500459|NCT00471237|4937602|P2|Overall Study|Early stopping due to non-efficacy|0
1500460|NCT00471237|4937603|P1|Overall Study|Early stopping due to non-efficacy|1
1500461|NCT00471237|4937597|P7|Overall Study|Met serum creatinine withdrawal criteria|0
1500462|NCT00471237|4937598|P6|Overall Study|Met serum creatinine withdrawal criteria|0
1500463|NCT00471237|4937599|P5|Overall Study|Met serum creatinine withdrawal criteria|0
1500464|NCT00471237|4937600|P4|Overall Study|Met serum creatinine withdrawal criteria|2
1500465|NCT00471237|4937601|P3|Overall Study|Met serum creatinine withdrawal criteria|2
1500466|NCT00471237|4937602|P2|Overall Study|Met serum creatinine withdrawal criteria|0
1500467|NCT00471237|4937603|P1|Overall Study|Met serum creatinine withdrawal criteria|1
1500468|NCT00471237|4937597|P7|Overall Study|Non-compliance|0
1500469|NCT00471237|4937598|P6|Overall Study|Non-compliance|0
1500470|NCT00471237|4937599|P5|Overall Study|Non-compliance|0
1500471|NCT00471237|4937600|P4|Overall Study|Non-compliance|1
1500472|NCT00471237|4937601|P3|Overall Study|Non-compliance|0
1500473|NCT00471237|4937602|P2|Overall Study|Non-compliance|1
1500474|NCT00471237|4937603|P1|Overall Study|Non-compliance|0
1500475|NCT00471237|4937597|P7|Overall Study|Sponsor terminated study|0
1500476|NCT00471237|4937598|P6|Overall Study|Sponsor terminated study|24
1500477|NCT00471237|4937599|P5|Overall Study|Sponsor terminated study|18
1500478|NCT00471237|4937600|P4|Overall Study|Sponsor terminated study|22
1500479|NCT00471237|4937601|P3|Overall Study|Sponsor terminated study|19
1500480|NCT00471237|4937602|P2|Overall Study|Sponsor terminated study|23
1500481|NCT00471237|4937603|P1|Overall Study|Sponsor terminated study|20
1500482|NCT00471237|4937597|P7|Overall Study|Withdrawal by Subject|2
1500483|NCT00471237|4937598|P6|Overall Study|Withdrawal by Subject|4
1500484|NCT00471237|4937599|P5|Overall Study|Withdrawal by Subject|7
1500485|NCT00471237|4937600|P4|Overall Study|Withdrawal by Subject|8
1500486|NCT00471237|4937601|P3|Overall Study|Withdrawal by Subject|5
1500487|NCT00471237|4937602|P2|Overall Study|Withdrawal by Subject|6
1500488|NCT00471237|4937603|P1|Overall Study|Withdrawal by Subject|8
1500489|NCT00471237|4937597|P7|Overall Study|Protocol Violation|1
1500490|NCT00471237|4937598|P6|Overall Study|Protocol Violation|4
1500491|NCT00471237|4937599|P5|Overall Study|Protocol Violation|2
1500492|NCT00471237|4937600|P4|Overall Study|Protocol Violation|2
1500493|NCT00471237|4937601|P3|Overall Study|Protocol Violation|3
1500494|NCT00471237|4937602|P2|Overall Study|Protocol Violation|6
1500495|NCT00471237|4937603|P1|Overall Study|Protocol Violation|3
1500496|NCT00471237|4937597|P7|Overall Study|Lost to Follow-up|0
1500497|NCT00471237|4937598|P6|Overall Study|Lost to Follow-up|0
1500498|NCT00471237|4937599|P5|Overall Study|Lost to Follow-up|3
1500499|NCT00471237|4937600|P4|Overall Study|Lost to Follow-up|2
1500500|NCT00471237|4937601|P3|Overall Study|Lost to Follow-up|0
1500501|NCT00471237|4937602|P2|Overall Study|Lost to Follow-up|1
1500502|NCT00471237|4937603|P1|Overall Study|Lost to Follow-up|1
1500503|NCT00471237|4937597|P7|Overall Study|Adverse Event|0
1500504|NCT00471237|4937598|P6|Overall Study|Adverse Event|5
1500505|NCT00471237|4937599|P5|Overall Study|Adverse Event|7
1500506|NCT00471237|4937600|P4|Overall Study|Adverse Event|8
1500507|NCT00471237|4937601|P3|Overall Study|Adverse Event|4
1500508|NCT00471237|4937602|P2|Overall Study|Adverse Event|5
1500509|NCT00471237|4937603|P1|Overall Study|Adverse Event|6
1500510|NCT00471146|4937753|P2|Overall Study|Other|5
1500511|NCT00471146|4937754|P1|Overall Study|Other|4
1500512|NCT00471146|4937753|P2|Overall Study|Randomized but not treated|8
1500513|NCT00471146|4937754|P1|Overall Study|Randomized but not treated|9
1500514|NCT00471146|4937753|P2|Overall Study|Global deterioration of health status|14
1500515|NCT00471146|4937754|P1|Overall Study|Global deterioration of health status|12
1500516|NCT00471146|4937753|P2|Overall Study|Objective progression or relapse|87
1500517|NCT00471146|4937754|P1|Overall Study|Objective progression or relapse|84
1500518|NCT00471146|4937753|P2|Overall Study|Protocol Violation|2
1500519|NCT00471146|4937754|P1|Overall Study|Protocol Violation|2
1500520|NCT00471146|4937753|P2|Overall Study|Lost to Follow-up|2
1500521|NCT00471146|4937754|P1|Overall Study|Lost to Follow-up|4
1500522|NCT00471146|4937753|P2|Overall Study|Death|12
1500523|NCT00471146|4937754|P1|Overall Study|Death|11
1500524|NCT00471146|4937753|P2|Overall Study|Withdrawal by Subject|11
1500525|NCT00471146|4937754|P1|Overall Study|Withdrawal by Subject|14
1500526|NCT00471146|4937753|P2|Overall Study|Adverse Event|33
1500527|NCT00471146|4937754|P1|Overall Study|Adverse Event|32
1500528|NCT00471107|4937779|P3|Overall Study|Technical problems/data loss|3
1500529|NCT00471107|4937780|P2|Overall Study|Technical problems/data loss|1
1500530|NCT00471107|4937781|P1|Overall Study|Technical problems/data loss|3
1500531|NCT00470847|4937798|P1|Overall Study|Pt still receiving treatment|1
1500532|NCT00470834|4937811|P2|Extension Period (24 Months)|Disease Progression|1
1500533|NCT00470834|4937812|P1|Extension Period (24 Months)|Disease Progression|0
1500534|NCT00470834|4937811|P2|Extension Period (24 Months)|Non-compliance|1
1500535|NCT00470834|4937812|P1|Extension Period (24 Months)|Non-compliance|0
1500536|NCT00470834|4937811|P2|Extension Period (24 Months)|Lost to Follow-up|1
1500537|NCT00470834|4937812|P1|Extension Period (24 Months)|Lost to Follow-up|0
1500538|NCT00470834|4937811|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
1500539|NCT00470834|4937812|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
1500540|NCT00470834|4937811|P2|Extension Period (24 Months)|Physician Decision|3
1500541|NCT00470834|4937812|P1|Extension Period (24 Months)|Physician Decision|4
1500542|NCT00470834|4937811|P2|Extension Period (24 Months)|Withdrawal by Subject|5
1500543|NCT00470834|4937812|P1|Extension Period (24 Months)|Withdrawal by Subject|2
1500544|NCT00470834|4937811|P2|Extension Period (24 Months)|Adverse Event|4
1500545|NCT00470834|4937812|P1|Extension Period (24 Months)|Adverse Event|3
1500546|NCT00470834|4937811|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
1500547|NCT00470834|4937812|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
1500548|NCT00470834|4937811|P2|Treatment Period (18 Months)|Lack of Efficacy|0
1500549|NCT00470834|4937812|P1|Treatment Period (18 Months)|Lack of Efficacy|1
1500550|NCT00470834|4937811|P2|Treatment Period (18 Months)|Non-compliance|0
1500551|NCT00470834|4937812|P1|Treatment Period (18 Months)|Non-compliance|1
1500552|NCT00470834|4937811|P2|Treatment Period (18 Months)|Lost to Follow-up|0
1500553|NCT00470834|4937812|P1|Treatment Period (18 Months)|Lost to Follow-up|1
1500554|NCT00470834|4937811|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
1500555|NCT00470834|4937812|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
1500556|NCT00470834|4937811|P2|Treatment Period (18 Months)|Protocol Violation|1
1500557|NCT00470834|4937812|P1|Treatment Period (18 Months)|Protocol Violation|3
1500558|NCT00470834|4937811|P2|Treatment Period (18 Months)|Physician Decision|4
1500559|NCT00470834|4937812|P1|Treatment Period (18 Months)|Physician Decision|4
1500560|NCT00470834|4937811|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
1500561|NCT00470834|4937812|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
1500562|NCT00470834|4937811|P2|Treatment Period (18 Months)|Adverse Event|6
1500563|NCT00470834|4937812|P1|Treatment Period (18 Months)|Adverse Event|7
1500564|NCT00470834|4937811|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
1500565|NCT00470834|4937812|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
1500566|NCT00470626|4937826|P1|Overall Study|Withdrawal by Subject|7
1500567|NCT00470626|4937826|P1|Overall Study|Lost to Follow-up|10
1500568|NCT00470535|4937868|P1|Overall Study|Other|2
1500569|NCT00470535|4937868|P1|Overall Study|Death|1
1500570|NCT00470535|4937868|P1|Overall Study|Adverse Event|1
1500571|NCT00470535|4937868|P1|Overall Study|Withdrawal by Subject|1
1500572|NCT00470535|4937868|P1|Overall Study|Disease Progression|13
1500573|NCT00470470|4937877|P1|Overall Study|Not treated|1
1500574|NCT00470470|4937877|P1|Overall Study|Death|2
1500575|NCT00470470|4937877|P1|Overall Study|Adverse Event|2
1500576|NCT00470418|4937884|P2|Overall Study|Withdrawal by Subject|0
1500577|NCT00470418|4937885|P1|Overall Study|Withdrawal by Subject|1
1500578|NCT00470366|4937906|P1|Overall Study|Poor compliance|1
1500579|NCT00470366|4937906|P1|Overall Study|Adverse Event|3
1500580|NCT00470275|4937917|P1|Overall Study|Withdrawal by Subject|2
1500581|NCT00470275|4937917|P1|Overall Study|Lack of Efficacy|7
1500582|NCT00470275|4937917|P1|Overall Study|Death|1
1500583|NCT00470262|4937923|P2|Overall Study|Withdrawal by Subject|0
1500584|NCT00470262|4937924|P1|Overall Study|Withdrawal by Subject|2
1500585|NCT00470184|4937932|P1|Overall Study|recurrence|1
1500586|NCT00470184|4937932|P1|Overall Study|other|5
1500587|NCT00470184|4937932|P1|Overall Study|Withdrawal by Subject|4
1500588|NCT00470184|4937932|P1|Overall Study|Adverse Event|3
1500589|NCT00470184|4937932|P1|Overall Study|disease Progression|4
1500590|NCT00470184|4937932|P1|Overall Study|Not treated (other)|1
1500591|NCT00470184|4937932|P1|Overall Study|Not Treated(became ineligible)|4
1500592|NCT00470158|4937944|P5|Overall Study|Protocol Violation|0
1500593|NCT00470158|4937945|P4|Overall Study|Protocol Violation|0
1500594|NCT00470158|4937946|P3|Overall Study|Protocol Violation|0
1500595|NCT00470158|4937947|P2|Overall Study|Protocol Violation|0
1500596|NCT00470158|4937948|P1|Overall Study|Protocol Violation|1
1500597|NCT00470158|4937944|P5|Overall Study|Lost to Follow-up|4
1500598|NCT00470158|4937945|P4|Overall Study|Lost to Follow-up|5
1500599|NCT00470158|4937946|P3|Overall Study|Lost to Follow-up|8
1500600|NCT00470158|4937947|P2|Overall Study|Lost to Follow-up|8
1500601|NCT00470158|4937948|P1|Overall Study|Lost to Follow-up|7
1500602|NCT00470158|4937944|P5|Overall Study|Death|2
1500603|NCT00470158|4937945|P4|Overall Study|Death|0
1500604|NCT00470158|4937946|P3|Overall Study|Death|0
1500605|NCT00470158|4937947|P2|Overall Study|Death|0
1500606|NCT00470158|4937948|P1|Overall Study|Death|0
1500607|NCT00470067|4937981|P1|Overall Study|Disease Progression|6
1500608|NCT00470067|4937981|P1|Overall Study|Death|1
1500609|NCT00470054|4937985|P1|Overall Study|Ineligible|1
1500610|NCT00469898|4937993|P1|Overall Study|Decreased performance status|1
1500611|NCT00469898|4937993|P1|Overall Study|Disease progression|9
1500612|NCT00469898|4937993|P1|Overall Study|Death|4
1500613|NCT00469898|4937993|P1|Overall Study|Withdrawal by Subject|4
1500614|NCT00469898|4937993|P1|Overall Study|Adverse Event|7
1500615|NCT00469859|4938002|P2|Overall Study|Inevaluable|2
1500616|NCT00469859|4938003|P1|Overall Study|Inevaluable|0
1500617|NCT00469833|4938011|P1|Overall Study|No IV access|2
1500618|NCT00469456|4938038|P2|Overall Study|Withdrawal by Subject|1
1500619|NCT00469456|4938039|P1|Overall Study|Withdrawal by Subject|4
1500620|NCT00469456|4938038|P2|Overall Study|Protocol Violation|0
1500621|NCT00469456|4938039|P1|Overall Study|Protocol Violation|1
1500622|NCT00469456|4938038|P2|Overall Study|Adverse Event|3
1500623|NCT00469456|4938039|P1|Overall Study|Adverse Event|4
1500624|NCT00469209|4938068|P3|Overall Study|Adverse Event|1
1500625|NCT00469209|4938069|P2|Overall Study|Adverse Event|0
1500626|NCT00469209|4938070|P1|Overall Study|Adverse Event|1
1500627|NCT00469092|4938080|P2|Overall Study|Use of Corticosteroid|0
1500628|NCT00469092|4938081|P1|Overall Study|Use of Corticosteroid|1
1500629|NCT00469092|4938080|P2|Overall Study|Abnormal lab value|0
1500630|NCT00469092|4938081|P1|Overall Study|Abnormal lab value|1
1500631|NCT00469092|4938080|P2|Overall Study|Hypoglycaemic Episodes|1
1500632|NCT00469092|4938081|P1|Overall Study|Hypoglycaemic Episodes|1
1500633|NCT00469092|4938080|P2|Overall Study|Use of lipid lowering drug|0
1500634|NCT00469092|4938081|P1|Overall Study|Use of lipid lowering drug|1
1500635|NCT00469092|4938080|P2|Overall Study|Contraindication metformin/glimepiride|0
1500636|NCT00469092|4938081|P1|Overall Study|Contraindication metformin/glimepiride|1
1500637|NCT00469092|4938080|P2|Overall Study|Incorrectly Randomised|3
1500638|NCT00469092|4938081|P1|Overall Study|Incorrectly Randomised|4
1500639|NCT00469092|4938080|P2|Overall Study|Withdrawal Criteria|4
1500640|NCT00469092|4938081|P1|Overall Study|Withdrawal Criteria|3
1500641|NCT00469092|4938080|P2|Overall Study|Withdrawal by Subject|4
1500642|NCT00469092|4938081|P1|Overall Study|Withdrawal by Subject|4
1500643|NCT00469092|4938080|P2|Overall Study|Protocol Violation|3
1500644|NCT00469092|4938081|P1|Overall Study|Protocol Violation|3
1500645|NCT00469092|4938080|P2|Overall Study|Lost to Follow-up|2
1500646|NCT00469092|4938081|P1|Overall Study|Lost to Follow-up|1
1500647|NCT00469092|4938080|P2|Overall Study|Lack of Efficacy|0
1500648|NCT00469092|4938081|P1|Overall Study|Lack of Efficacy|1
1500649|NCT00469092|4938080|P2|Overall Study|Adverse Event|4
1500650|NCT00469092|4938081|P1|Overall Study|Adverse Event|5
1500651|NCT00469079|4938100|P3|Overall Study|Ineligible|0
1500652|NCT00469079|4938101|P2|Overall Study|Ineligible|1
1500653|NCT00469079|4938102|P1|Overall Study|Ineligible|0
1500654|NCT00469079|4938100|P3|Overall Study|Withdrawal by Subject|2
1500655|NCT00469079|4938101|P2|Overall Study|Withdrawal by Subject|2
1500656|NCT00469079|4938102|P1|Overall Study|Withdrawal by Subject|1
1500657|NCT00469079|4938100|P3|Overall Study|Lost to Follow-up|10
1500658|NCT00469079|4938101|P2|Overall Study|Lost to Follow-up|8
1500659|NCT00469079|4938102|P1|Overall Study|Lost to Follow-up|4
1500660|NCT00469079|4938100|P3|Overall Study|Adverse Event|2
1500661|NCT00469079|4938101|P2|Overall Study|Adverse Event|3
1500662|NCT00469079|4938102|P1|Overall Study|Adverse Event|1
1500663|NCT00469079|4938100|P3|Overall Study|Lack of Efficacy|5
1500664|NCT00469079|4938101|P2|Overall Study|Lack of Efficacy|8
1500665|NCT00469079|4938102|P1|Overall Study|Lack of Efficacy|3
1500666|NCT00468910|4938121|P2|Overall Study|Medical Contraindication|1
1500667|NCT00468910|4938122|P1|Overall Study|Medical Contraindication|0
1500668|NCT00468910|4938121|P2|Overall Study|Withdrawal by Subject|1
1500669|NCT00468910|4938122|P1|Overall Study|Withdrawal by Subject|2
1500670|NCT00468910|4938121|P2|Overall Study|Lost to Follow-up|1
1500671|NCT00468910|4938122|P1|Overall Study|Lost to Follow-up|2
1500672|NCT00468858|4938141|P3|Overall Study|Other|1
1500673|NCT00468858|4938142|P2|Overall Study|Other|0
1500674|NCT00468858|4938143|P1|Overall Study|Other|0
1500675|NCT00468858|4938141|P3|Overall Study|Lost to Follow-up|5
1500676|NCT00468858|4938142|P2|Overall Study|Lost to Follow-up|2
1500677|NCT00468858|4938143|P1|Overall Study|Lost to Follow-up|1
1500678|NCT00468858|4938141|P3|Overall Study|Relocation|3
1500679|NCT00468858|4938142|P2|Overall Study|Relocation|3
1500680|NCT00468858|4938143|P1|Overall Study|Relocation|1
1500681|NCT00468858|4938141|P3|Overall Study|Withdrawal by Subject|5
1500682|NCT00468858|4938142|P2|Overall Study|Withdrawal by Subject|4
1500683|NCT00468858|4938143|P1|Overall Study|Withdrawal by Subject|7
1500684|NCT00468858|4938141|P3|Overall Study|Adverse Event|0
1500685|NCT00468858|4938142|P2|Overall Study|Adverse Event|1
1500686|NCT00468858|4938143|P1|Overall Study|Adverse Event|0
1500687|NCT00468845|4938264|P3|Overall Study|Randomized, not treated|2
1500688|NCT00468845|4938265|P2|Overall Study|Randomized, not treated|4
1500689|NCT00468845|4938266|P1|Overall Study|Randomized, not treated|1
1500690|NCT00468845|4938264|P3|Overall Study|No longer willing to participate|10
1500691|NCT00468845|4938265|P2|Overall Study|No longer willing to participate|6
1500692|NCT00468845|4938266|P1|Overall Study|No longer willing to participate|5
1500693|NCT00468845|4938264|P3|Overall Study|Other|5
1500694|NCT00468845|4938265|P2|Overall Study|Other|9
1500695|NCT00468845|4938266|P1|Overall Study|Other|4
1500696|NCT00468845|4938264|P3|Overall Study|Lost to Follow-up|2
1500697|NCT00468845|4938265|P2|Overall Study|Lost to Follow-up|1
1500698|NCT00468845|4938266|P1|Overall Study|Lost to Follow-up|2
1500699|NCT00468845|4938264|P3|Overall Study|Adverse Event|11
1500700|NCT00468845|4938265|P2|Overall Study|Adverse Event|14
1500701|NCT00468845|4938266|P1|Overall Study|Adverse Event|9
1500702|NCT00468819|4938403|P3|Overall Study|Drop-outs (Treatment never received)|0
1500703|NCT00468819|4938404|P2|Overall Study|Drop-outs (Treatment never received)|0
1500704|NCT00468819|4938405|P1|Overall Study|Drop-outs (Treatment never received)|2
1500705|NCT00468819|4938403|P3|Overall Study|Lost to Follow-up|1
1500706|NCT00468819|4938404|P2|Overall Study|Lost to Follow-up|0
1500707|NCT00468819|4938405|P1|Overall Study|Lost to Follow-up|0
1500708|NCT00468819|4938403|P3|Overall Study|Withdrawal by Subject|1
1500709|NCT00468819|4938404|P2|Overall Study|Withdrawal by Subject|0
1500710|NCT00468819|4938405|P1|Overall Study|Withdrawal by Subject|4
1500711|NCT00468728|4938485|P2|Follow-up|mITT failure|31
1500712|NCT00468728|4938486|P1|Follow-up|mITT failure|34
1500713|NCT00468728|4938485|P2|Treatment|criteria for mITT population|11
1500714|NCT00468728|4938486|P1|Treatment|criteria for mITT population|4
1500715|NCT00468676|4938498|P2|Overall Study|Death|1
1500716|NCT00468676|4938499|P1|Overall Study|Death|2
1500717|NCT00468676|4938498|P2|Overall Study|Lost to Follow-up|11
1500718|NCT00468676|4938499|P1|Overall Study|Lost to Follow-up|14
1500719|NCT00468650|4938516|P1|Overall Study|Protocol Violation|1
1500720|NCT00468650|4938516|P1|Overall Study|Withdrawal by Subject|2
1500721|NCT00468650|4938516|P1|Overall Study|Lost to Follow-up|4
1500722|NCT00468585|4938564|P4|Overall Study|Withdrawal by Subject|1
1500723|NCT00468585|4938565|P3|Overall Study|Withdrawal by Subject|2
1500724|NCT00468585|4938566|P2|Overall Study|Withdrawal by Subject|0
1500725|NCT00468585|4938567|P1|Overall Study|Withdrawal by Subject|0
1500726|NCT00468585|4938564|P4|Overall Study|Adverse Event|0
1500727|NCT00468585|4938565|P3|Overall Study|Adverse Event|1
1500728|NCT00468585|4938566|P2|Overall Study|Adverse Event|0
1500729|NCT00468585|4938567|P1|Overall Study|Adverse Event|0
1500730|NCT00468585|4938564|P4|Overall Study|Patient found to be ineligible|0
1500731|NCT00468585|4938565|P3|Overall Study|Patient found to be ineligible|1
1500732|NCT00468585|4938566|P2|Overall Study|Patient found to be ineligible|0
1500733|NCT00468585|4938567|P1|Overall Study|Patient found to be ineligible|0
1500734|NCT00468585|4938564|P4|Overall Study|Patient not treated|0
1500735|NCT00468585|4938565|P3|Overall Study|Patient not treated|1
1500736|NCT00468585|4938566|P2|Overall Study|Patient not treated|0
1500737|NCT00468585|4938567|P1|Overall Study|Patient not treated|1
1500738|NCT00468559|4938579|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
1500739|NCT00468559|4938580|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
1500740|NCT00468559|4938581|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
1500741|NCT00468559|4938579|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
1500742|NCT00468559|4938580|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
1500743|NCT00468559|4938581|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
1500744|NCT00468559|4938579|P3|Open-label Treatment Phase|Withdrawal by Subject|0
1500745|NCT00468559|4938580|P2|Open-label Treatment Phase|Withdrawal by Subject|0
1500746|NCT00468559|4938581|P1|Open-label Treatment Phase|Withdrawal by Subject|4
1500747|NCT00468559|4938579|P3|Open-label Treatment Phase|Lack of Efficacy|0
1500748|NCT00468559|4938580|P2|Open-label Treatment Phase|Lack of Efficacy|0
1500749|NCT00468559|4938581|P1|Open-label Treatment Phase|Lack of Efficacy|9
1500750|NCT00468559|4938579|P3|Open-label Treatment Phase|Adverse Event|0
1500751|NCT00468559|4938580|P2|Open-label Treatment Phase|Adverse Event|0
1500752|NCT00468559|4938581|P1|Open-label Treatment Phase|Adverse Event|5
1500753|NCT00468546|4938609|P2|Week 24 to Week 104 Analysis|Other|14
1500754|NCT00468546|4938610|P1|Week 24 to Week 104 Analysis|Other|17
1500755|NCT00468546|4938609|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
1500756|NCT00468546|4938610|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
1500757|NCT00468546|4938609|P2|Week 24 to Week 104 Analysis|Failure to return|2
1500758|NCT00468546|4938610|P1|Week 24 to Week 104 Analysis|Failure to return|1
1500759|NCT00468546|4938609|P2|Week 24 to Week 104 Analysis|Refused treatment|7
1500760|NCT00468546|4938610|P1|Week 24 to Week 104 Analysis|Refused treatment|4
1500761|NCT00468546|4938609|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
1500762|NCT00468546|4938610|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
1500763|NCT00468546|4938609|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
1500764|NCT00468546|4938610|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
1500765|NCT00468546|4938609|P2|Week 24 to Week 104 Analysis|Death|0
1500766|NCT00468546|4938610|P1|Week 24 to Week 104 Analysis|Death|1
1500767|NCT00468546|4938609|P2|Week 24 to Week 104 Analysis|Adverse Event|5
1500768|NCT00468546|4938610|P1|Week 24 to Week 104 Analysis|Adverse Event|2
1500769|NCT00468546|4938609|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
1500770|NCT00468546|4938610|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
1500771|NCT00468546|4938609|P2|Week 24 Analysis|Went onto rescue therapy|0
1500772|NCT00468546|4938610|P1|Week 24 Analysis|Went onto rescue therapy|1
1500773|NCT00468546|4938609|P2|Week 24 Analysis|Due to clinical hold|0
1500774|NCT00468546|4938610|P1|Week 24 Analysis|Due to clinical hold|1
1500775|NCT00468546|4938609|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
1500776|NCT00468546|4938610|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
1500777|NCT00468546|4938609|P2|Week 24 Analysis|Rescue therapy|0
1500778|NCT00468546|4938610|P1|Week 24 Analysis|Rescue therapy|2
1500779|NCT00468546|4938609|P2|Week 24 Analysis|Failure to return|4
1500780|NCT00468546|4938610|P1|Week 24 Analysis|Failure to return|3
1500781|NCT00468546|4938609|P2|Week 24 Analysis|Adverse Event|8
1500782|NCT00468546|4938610|P1|Week 24 Analysis|Adverse Event|1
1500783|NCT00468546|4938609|P2|Week 24 Analysis|Refused treatment|5
1500784|NCT00468546|4938610|P1|Week 24 Analysis|Refused treatment|5
1500785|NCT00468546|4938609|P2|Week 24 Analysis|Lack of Efficacy|37
1500786|NCT00468546|4938610|P1|Week 24 Analysis|Lack of Efficacy|83
1500787|NCT00468481|4938640|P2|Overall Study|Other|0
1500788|NCT00468481|4938641|P1|Overall Study|Other|6
1500789|NCT00468481|4938640|P2|Overall Study|Non-Compliance|0
1500790|NCT00468481|4938641|P1|Overall Study|Non-Compliance|5
1500791|NCT00468481|4938640|P2|Overall Study|Moved out of area|1
1500792|NCT00468481|4938641|P1|Overall Study|Moved out of area|4
1500793|NCT00468481|4938640|P2|Overall Study|Egg Donor|0
1500794|NCT00468481|4938641|P1|Overall Study|Egg Donor|1
1500795|NCT00468481|4938640|P2|Overall Study|Prohibited Medication|1
1500796|NCT00468481|4938641|P1|Overall Study|Prohibited Medication|1
1500797|NCT00468481|4938640|P2|Overall Study|susp/diag malignant/premalignant disease|0
1500798|NCT00468481|4938641|P1|Overall Study|susp/diag malignant/premalignant disease|1
1500799|NCT00468481|4938640|P2|Overall Study|Withdrawal by Subject|3
1500800|NCT00468481|4938641|P1|Overall Study|Withdrawal by Subject|12
1500801|NCT00468481|4938640|P2|Overall Study|Protocol Violation|8
1500802|NCT00468481|4938641|P1|Overall Study|Protocol Violation|18
1500803|NCT00468481|4938640|P2|Overall Study|Pregnancy|0
1500804|NCT00468481|4938641|P1|Overall Study|Pregnancy|2
1500805|NCT00468481|4938640|P2|Overall Study|Lost to Follow-up|8
1500806|NCT00468481|4938641|P1|Overall Study|Lost to Follow-up|25
1500807|NCT00468481|4938640|P2|Overall Study|Adverse Event|3
1500808|NCT00468481|4938641|P1|Overall Study|Adverse Event|13
1500809|NCT00468312|4938741|P2|Overall Study|Did not meet protocol eligibility|1
1500810|NCT00468312|4938742|P1|Overall Study|Did not meet protocol eligibility|0
1500811|NCT00468312|4938741|P2|Overall Study|Protocol Violation|1
1500812|NCT00468312|4938742|P1|Overall Study|Protocol Violation|2
1500813|NCT00468312|4938741|P2|Overall Study|Withdrawal by Subject|1
1500814|NCT00468312|4938742|P1|Overall Study|Withdrawal by Subject|0
1500815|NCT00468312|4938741|P2|Overall Study|Lack of Efficacy|1
1500816|NCT00468312|4938742|P1|Overall Study|Lack of Efficacy|0
1500817|NCT00468312|4938741|P2|Overall Study|Adverse Event|1
1500818|NCT00468312|4938742|P1|Overall Study|Adverse Event|2
1500819|NCT00468299|4938758|P2|Overall Study|Withdrawal by Subject|1
1500820|NCT00468299|4938759|P1|Overall Study|Withdrawal by Subject|0
1500821|NCT00468286|4938769|P2|Overall Study|Physician Decision|1
1500822|NCT00468286|4938770|P1|Overall Study|Physician Decision|0
1500823|NCT00468286|4938769|P2|Overall Study|Withdrawal by Subject|3
1500824|NCT00468286|4938770|P1|Overall Study|Withdrawal by Subject|4
1500825|NCT00468286|4938769|P2|Overall Study|Protocol Violation|2
1500826|NCT00468286|4938770|P1|Overall Study|Protocol Violation|2
1500827|NCT00468286|4938769|P2|Overall Study|Adverse Event|6
1500828|NCT00468286|4938770|P1|Overall Study|Adverse Event|1
1500829|NCT00468143|4938800|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
1500830|NCT00468143|4938801|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
1500831|NCT00468143|4938800|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
1500832|NCT00468143|4938801|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
1500833|NCT00468104|4938815|P2|Second Intervention|discarded for malposition of chest tube|2
1500834|NCT00468104|4938816|P1|Second Intervention|discarded for malposition of chest tube|0
1500835|NCT00468104|4938815|P2|Second Intervention|Withdrawal by Subject|2
1500836|NCT00468104|4938816|P1|Second Intervention|Withdrawal by Subject|5
1500837|NCT00468104|4938815|P2|First Intervention|trapped lung|0
1500838|NCT00468104|4938816|P1|First Intervention|trapped lung|1
1500839|NCT00468104|4938815|P2|First Intervention|associated prolonged pneumothorax|0
1500840|NCT00468104|4938816|P1|First Intervention|associated prolonged pneumothorax|1
1500841|NCT00468104|4938815|P2|First Intervention|large lung mass with minimal effusion|0
1500842|NCT00468104|4938816|P1|First Intervention|large lung mass with minimal effusion|1
1500843|NCT00468104|4938815|P2|First Intervention|malposition/blocked chest tube tube|0
1500844|NCT00468104|4938816|P1|First Intervention|malposition/blocked chest tube tube|2
1500845|NCT00468104|4938815|P2|First Intervention|died within 3 weeks|0
1500846|NCT00468104|4938816|P1|First Intervention|died within 3 weeks|1
1500847|NCT00468104|4938815|P2|First Intervention|bleeding at chest tube site--first dose|0
1500848|NCT00468104|4938816|P1|First Intervention|bleeding at chest tube site--first dose|1
1500849|NCT00468104|4938815|P2|First Intervention|Protocol Violation|1
1500850|NCT00468104|4938816|P1|First Intervention|Protocol Violation|2
1500851|NCT00468052|4938833|P2|Overall Study|Protocol Violation|8
1500852|NCT00468052|4938834|P1|Overall Study|Protocol Violation|7
1500853|NCT00467961|4938852|P1|Overall Study|Disease Progression|2
1500854|NCT00467961|4938852|P1|Overall Study|Technical Failures|5
1500855|NCT00467896|4938856|P1|Overall Study|Patient had no improvement|1
1500856|NCT00467896|4938856|P1|Overall Study|Started inhaled Remodulin|1
1500857|NCT00467896|4938856|P1|Overall Study|Started intravenous prostacyclin|1
1500858|NCT00467896|4938856|P1|Overall Study|Mainly used Prodose not I-neb® device|1
1500859|NCT00467896|4938856|P1|Overall Study|Patient weaned off iloprost|1
1500860|NCT00467896|4938856|P1|Overall Study|Patient had atrial septostomy|1
1500861|NCT00467896|4938856|P1|Overall Study|Patient received transplant|2
1500862|NCT00467896|4938856|P1|Overall Study|Changed therapy|2
1500863|NCT00467896|4938856|P1|Overall Study|Non-compliance|3
1500864|NCT00467896|4938856|P1|Overall Study|Serious Adverse Event|13
1500865|NCT00467896|4938856|P1|Overall Study|Adverse Event|7
1500866|NCT00467896|4938856|P1|Overall Study|Consent Withdrawal|18
1500867|NCT00467870|4938882|P6|Overall Study|Other/Unknown|0
1500868|NCT00467870|4938883|P5|Overall Study|Other/Unknown|4
1500869|NCT00467870|4938884|P4|Overall Study|Other/Unknown|5
1500870|NCT00467870|4938885|P3|Overall Study|Other/Unknown|1
1500871|NCT00467870|4938886|P2|Overall Study|Other/Unknown|5
1500872|NCT00467870|4938887|P1|Overall Study|Other/Unknown|8
1500873|NCT00467870|4938882|P6|Overall Study|Subject Non-compliance|0
1500874|NCT00467870|4938883|P5|Overall Study|Subject Non-compliance|5
1500875|NCT00467870|4938884|P4|Overall Study|Subject Non-compliance|1
1500876|NCT00467870|4938885|P3|Overall Study|Subject Non-compliance|0
1500877|NCT00467870|4938886|P2|Overall Study|Subject Non-compliance|4
1500878|NCT00467870|4938887|P1|Overall Study|Subject Non-compliance|3
1500879|NCT00467870|4938882|P6|Overall Study|Lost to Follow-up|0
1500880|NCT00467870|4938883|P5|Overall Study|Lost to Follow-up|3
1500881|NCT00467870|4938884|P4|Overall Study|Lost to Follow-up|1
1500882|NCT00467870|4938885|P3|Overall Study|Lost to Follow-up|1
1500883|NCT00467870|4938886|P2|Overall Study|Lost to Follow-up|3
1500884|NCT00467870|4938887|P1|Overall Study|Lost to Follow-up|5
1500885|NCT00467870|4938882|P6|Overall Study|Withdrawal by Subject|1
1500886|NCT00467870|4938883|P5|Overall Study|Withdrawal by Subject|10
1500887|NCT00467870|4938884|P4|Overall Study|Withdrawal by Subject|9
1500888|NCT00467870|4938885|P3|Overall Study|Withdrawal by Subject|0
1500889|NCT00467870|4938886|P2|Overall Study|Withdrawal by Subject|21
1500890|NCT00467870|4938887|P1|Overall Study|Withdrawal by Subject|14
1500891|NCT00467870|4938882|P6|Overall Study|Protocol Violation|0
1500892|NCT00467870|4938883|P5|Overall Study|Protocol Violation|0
1500893|NCT00467870|4938884|P4|Overall Study|Protocol Violation|2
1500894|NCT00467870|4938885|P3|Overall Study|Protocol Violation|1
1500895|NCT00467870|4938886|P2|Overall Study|Protocol Violation|1
1500896|NCT00467870|4938887|P1|Overall Study|Protocol Violation|2
1500897|NCT00467870|4938882|P6|Overall Study|Adverse Event|1
1500898|NCT00467870|4938883|P5|Overall Study|Adverse Event|15
1500899|NCT00467870|4938884|P4|Overall Study|Adverse Event|15
1500900|NCT00467870|4938885|P3|Overall Study|Adverse Event|1
1500901|NCT00467870|4938886|P2|Overall Study|Adverse Event|9
1500902|NCT00467870|4938887|P1|Overall Study|Adverse Event|13
1500903|NCT00467857|4938930|P2|Overall Study|Discontinuation reason missing|3
1500904|NCT00467857|4938931|P1|Overall Study|Discontinuation reason missing|0
1500905|NCT00467857|4938930|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
1500906|NCT00467857|4938931|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
1500907|NCT00467857|4938930|P2|Overall Study|Emergency care required|1
1500908|NCT00467857|4938931|P1|Overall Study|Emergency care required|0
1500909|NCT00467857|4938930|P2|Overall Study|Discharged from court service|1
1500910|NCT00467857|4938931|P1|Overall Study|Discharged from court service|0
1500911|NCT00467857|4938930|P2|Overall Study|Death|1
1500912|NCT00467857|4938931|P1|Overall Study|Death|0
1500913|NCT00467857|4938930|P2|Overall Study|Withdrew consent|0
1500914|NCT00467857|4938931|P1|Overall Study|Withdrew consent|2
1500915|NCT00467857|4938930|P2|Overall Study|Adverse Event|0
1500916|NCT00467857|4938931|P1|Overall Study|Adverse Event|1
1500917|NCT00467831|4938979|P1|Overall Study|Withdrawal by Subject|1
1500918|NCT00467831|4938979|P1|Overall Study|Death|2
1500919|NCT00467779|4938998|P15|Stage 3|Unspecified Reason|5
1500920|NCT00467779|4938999|P14|Stage 3|Unspecified Reason|0
1500921|NCT00467779|4939000|P13|Stage 3|Unspecified Reason|0
1500922|NCT00467779|4939001|P12|Stage 3|Unspecified Reason|0
1500923|NCT00467779|4939002|P11|Stage 3|Unspecified Reason|0
1500924|NCT00467779|4939003|P10|Stage 3|Unspecified Reason|0
1500925|NCT00467779|4939004|P9|Stage 3|Unspecified Reason|0
1500926|NCT00467779|4939005|P8|Stage 3|Unspecified Reason|0
1500927|NCT00467779|4939006|P7|Stage 3|Unspecified Reason|0
1500928|NCT00467779|4939007|P6|Stage 3|Unspecified Reason|0
1500929|NCT00467779|4939008|P5|Stage 3|Unspecified Reason|0
1500930|NCT00467779|4939009|P4|Stage 3|Unspecified Reason|0
1500931|NCT00467779|4939010|P3|Stage 3|Unspecified Reason|0
1500932|NCT00467779|4939011|P2|Stage 3|Unspecified Reason|0
1500933|NCT00467779|4939012|P1|Stage 3|Unspecified Reason|0
1500934|NCT00467779|4938998|P15|Stage 3|Disease Progression|9
1500935|NCT00467779|4938999|P14|Stage 3|Disease Progression|0
1500936|NCT00467779|4939000|P13|Stage 3|Disease Progression|0
1500937|NCT00467779|4939001|P12|Stage 3|Disease Progression|0
1500938|NCT00467779|4939002|P11|Stage 3|Disease Progression|0
1500939|NCT00467779|4939003|P10|Stage 3|Disease Progression|0
1500940|NCT00467779|4939004|P9|Stage 3|Disease Progression|0
1500941|NCT00467779|4939005|P8|Stage 3|Disease Progression|0
1500942|NCT00467779|4939006|P7|Stage 3|Disease Progression|0
1500943|NCT00467779|4939007|P6|Stage 3|Disease Progression|0
1500944|NCT00467779|4939008|P5|Stage 3|Disease Progression|0
1500945|NCT00467779|4939009|P4|Stage 3|Disease Progression|0
1500946|NCT00467779|4939010|P3|Stage 3|Disease Progression|0
1500947|NCT00467779|4939011|P2|Stage 3|Disease Progression|0
1500948|NCT00467779|4939012|P1|Stage 3|Disease Progression|0
1500949|NCT00467779|4938998|P15|Stage 3|Death|1
1500950|NCT00467779|4938999|P14|Stage 3|Death|0
1500951|NCT00467779|4939000|P13|Stage 3|Death|0
1500952|NCT00467779|4939001|P12|Stage 3|Death|0
1500953|NCT00467779|4939002|P11|Stage 3|Death|0
1500954|NCT00467779|4939003|P10|Stage 3|Death|0
1500955|NCT00467779|4939004|P9|Stage 3|Death|0
1500956|NCT00467779|4939005|P8|Stage 3|Death|0
1500957|NCT00467779|4939006|P7|Stage 3|Death|0
1500958|NCT00467779|4939007|P6|Stage 3|Death|0
1500959|NCT00467779|4939008|P5|Stage 3|Death|0
1500960|NCT00467779|4939009|P4|Stage 3|Death|0
1500961|NCT00467779|4939010|P3|Stage 3|Death|0
1500962|NCT00467779|4939011|P2|Stage 3|Death|0
1500963|NCT00467779|4939012|P1|Stage 3|Death|0
1500964|NCT00467779|4938998|P15|Stage 3|Adverse Event|2
1500965|NCT00467779|4938999|P14|Stage 3|Adverse Event|0
1500966|NCT00467779|4939000|P13|Stage 3|Adverse Event|0
1500967|NCT00467779|4939001|P12|Stage 3|Adverse Event|0
1500968|NCT00467779|4939002|P11|Stage 3|Adverse Event|0
1500969|NCT00467779|4939003|P10|Stage 3|Adverse Event|0
1500970|NCT00467779|4939004|P9|Stage 3|Adverse Event|0
1500971|NCT00467779|4939005|P8|Stage 3|Adverse Event|0
1500972|NCT00467779|4939006|P7|Stage 3|Adverse Event|0
1500973|NCT00467779|4939007|P6|Stage 3|Adverse Event|0
1500974|NCT00467779|4939008|P5|Stage 3|Adverse Event|0
1500975|NCT00467779|4939009|P4|Stage 3|Adverse Event|0
1500976|NCT00467779|4939010|P3|Stage 3|Adverse Event|0
1500977|NCT00467779|4939011|P2|Stage 3|Adverse Event|0
1500978|NCT00467779|4939012|P1|Stage 3|Adverse Event|0
1500979|NCT00467779|4938998|P15|Stage 2A|Withdrawal by Subject|0
1500980|NCT00467779|4938999|P14|Stage 2A|Withdrawal by Subject|1
1500981|NCT00467779|4939000|P13|Stage 2A|Withdrawal by Subject|0
1500982|NCT00467779|4939001|P12|Stage 2A|Withdrawal by Subject|0
1500983|NCT00467779|4939002|P11|Stage 2A|Withdrawal by Subject|0
1500984|NCT00467779|4939003|P10|Stage 2A|Withdrawal by Subject|0
1500985|NCT00467779|4939004|P9|Stage 2A|Withdrawal by Subject|0
1500986|NCT00467779|4939005|P8|Stage 2A|Withdrawal by Subject|0
1500987|NCT00467779|4939006|P7|Stage 2A|Withdrawal by Subject|0
1500988|NCT00467779|4939007|P6|Stage 2A|Withdrawal by Subject|0
1500989|NCT00467779|4939008|P5|Stage 2A|Withdrawal by Subject|0
1500990|NCT00467779|4939009|P4|Stage 2A|Withdrawal by Subject|0
1500991|NCT00467779|4939010|P3|Stage 2A|Withdrawal by Subject|0
1500992|NCT00467779|4939011|P2|Stage 2A|Withdrawal by Subject|0
1500993|NCT00467779|4939012|P1|Stage 2A|Withdrawal by Subject|0
1500994|NCT00467779|4938998|P15|Stage 2A|Unspecified Reason|0
1500995|NCT00467779|4938999|P14|Stage 2A|Unspecified Reason|7
1500996|NCT00467779|4939000|P13|Stage 2A|Unspecified Reason|0
1500997|NCT00467779|4939001|P12|Stage 2A|Unspecified Reason|0
1500998|NCT00467779|4939002|P11|Stage 2A|Unspecified Reason|0
1500999|NCT00467779|4939003|P10|Stage 2A|Unspecified Reason|0
1501000|NCT00467779|4939004|P9|Stage 2A|Unspecified Reason|0
1501001|NCT00467779|4939005|P8|Stage 2A|Unspecified Reason|0
1501002|NCT00467779|4939006|P7|Stage 2A|Unspecified Reason|0
1501003|NCT00467779|4939007|P6|Stage 2A|Unspecified Reason|0
1501004|NCT00467779|4939008|P5|Stage 2A|Unspecified Reason|0
1501005|NCT00467779|4939009|P4|Stage 2A|Unspecified Reason|0
1501006|NCT00467779|4939010|P3|Stage 2A|Unspecified Reason|0
1501007|NCT00467779|4939011|P2|Stage 2A|Unspecified Reason|0
1501008|NCT00467779|4939012|P1|Stage 2A|Unspecified Reason|0
1501009|NCT00467779|4938998|P15|Stage 2A|Disease Progression|0
1501010|NCT00467779|4938999|P14|Stage 2A|Disease Progression|10
1501011|NCT00467779|4939000|P13|Stage 2A|Disease Progression|0
1501012|NCT00467779|4939001|P12|Stage 2A|Disease Progression|0
1501013|NCT00467779|4939002|P11|Stage 2A|Disease Progression|0
1501014|NCT00467779|4939003|P10|Stage 2A|Disease Progression|0
1501015|NCT00467779|4939004|P9|Stage 2A|Disease Progression|0
1501016|NCT00467779|4939005|P8|Stage 2A|Disease Progression|0
1501017|NCT00467779|4939006|P7|Stage 2A|Disease Progression|0
1501018|NCT00467779|4939007|P6|Stage 2A|Disease Progression|0
1501019|NCT00467779|4939008|P5|Stage 2A|Disease Progression|0
1501020|NCT00467779|4939009|P4|Stage 2A|Disease Progression|0
1501021|NCT00467779|4939010|P3|Stage 2A|Disease Progression|0
1501022|NCT00467779|4939011|P2|Stage 2A|Disease Progression|0
1501023|NCT00467779|4939012|P1|Stage 2A|Disease Progression|0
1501024|NCT00467779|4938998|P15|Stage 2A|Death|0
1501025|NCT00467779|4938999|P14|Stage 2A|Death|1
1501026|NCT00467779|4939000|P13|Stage 2A|Death|0
1501027|NCT00467779|4939001|P12|Stage 2A|Death|0
1501028|NCT00467779|4939002|P11|Stage 2A|Death|0
1501029|NCT00467779|4939003|P10|Stage 2A|Death|0
1501030|NCT00467779|4939004|P9|Stage 2A|Death|0
1501031|NCT00467779|4939005|P8|Stage 2A|Death|0
1501032|NCT00467779|4939006|P7|Stage 2A|Death|0
1501033|NCT00467779|4939007|P6|Stage 2A|Death|0
1501034|NCT00467779|4939008|P5|Stage 2A|Death|0
1501035|NCT00467779|4939009|P4|Stage 2A|Death|0
1501036|NCT00467779|4939010|P3|Stage 2A|Death|0
1501037|NCT00467779|4939011|P2|Stage 2A|Death|0
1501038|NCT00467779|4939012|P1|Stage 2A|Death|0
1501039|NCT00467779|4938998|P15|Stage 2A|Adverse Event|0
1501040|NCT00467779|4938999|P14|Stage 2A|Adverse Event|2
1501041|NCT00467779|4939000|P13|Stage 2A|Adverse Event|0
1501042|NCT00467779|4939001|P12|Stage 2A|Adverse Event|0
1501043|NCT00467779|4939002|P11|Stage 2A|Adverse Event|0
1501044|NCT00467779|4939003|P10|Stage 2A|Adverse Event|0
1501045|NCT00467779|4939004|P9|Stage 2A|Adverse Event|0
1501046|NCT00467779|4939005|P8|Stage 2A|Adverse Event|0
1501047|NCT00467779|4939006|P7|Stage 2A|Adverse Event|0
1501048|NCT00467779|4939007|P6|Stage 2A|Adverse Event|0
1501049|NCT00467779|4939008|P5|Stage 2A|Adverse Event|0
1501050|NCT00467779|4939009|P4|Stage 2A|Adverse Event|0
1501051|NCT00467779|4939010|P3|Stage 2A|Adverse Event|0
1501052|NCT00467779|4939011|P2|Stage 2A|Adverse Event|0
1501053|NCT00467779|4939012|P1|Stage 2A|Adverse Event|0
1501054|NCT00467779|4938998|P15|Stage 2|Unspecified Reason|0
1501055|NCT00467779|4938999|P14|Stage 2|Unspecified Reason|0
1501056|NCT00467779|4939000|P13|Stage 2|Unspecified Reason|0
1501057|NCT00467779|4939001|P12|Stage 2|Unspecified Reason|0
1501058|NCT00467779|4939002|P11|Stage 2|Unspecified Reason|0
1501059|NCT00467779|4939003|P10|Stage 2|Unspecified Reason|0
1501060|NCT00467779|4939004|P9|Stage 2|Unspecified Reason|3
1501061|NCT00467779|4939005|P8|Stage 2|Unspecified Reason|0
1501062|NCT00467779|4939006|P7|Stage 2|Unspecified Reason|0
1501063|NCT00467779|4939007|P6|Stage 2|Unspecified Reason|0
1501064|NCT00467779|4939008|P5|Stage 2|Unspecified Reason|0
1501065|NCT00467779|4939009|P4|Stage 2|Unspecified Reason|0
1501066|NCT00467779|4939010|P3|Stage 2|Unspecified Reason|0
1501067|NCT00467779|4939011|P2|Stage 2|Unspecified Reason|0
1501068|NCT00467779|4939012|P1|Stage 2|Unspecified Reason|0
1501069|NCT00467779|4938998|P15|Stage 2|Disease Progression|0
1501070|NCT00467779|4938999|P14|Stage 2|Disease Progression|0
1501071|NCT00467779|4939000|P13|Stage 2|Disease Progression|0
1501072|NCT00467779|4939001|P12|Stage 2|Disease Progression|0
1501073|NCT00467779|4939002|P11|Stage 2|Disease Progression|0
1501074|NCT00467779|4939003|P10|Stage 2|Disease Progression|0
1501075|NCT00467779|4939004|P9|Stage 2|Disease Progression|16
1501076|NCT00467779|4939005|P8|Stage 2|Disease Progression|0
1501077|NCT00467779|4939006|P7|Stage 2|Disease Progression|0
1501078|NCT00467779|4939007|P6|Stage 2|Disease Progression|0
1501079|NCT00467779|4939008|P5|Stage 2|Disease Progression|0
1501080|NCT00467779|4939009|P4|Stage 2|Disease Progression|0
1501081|NCT00467779|4939010|P3|Stage 2|Disease Progression|0
1501082|NCT00467779|4939011|P2|Stage 2|Disease Progression|0
1501083|NCT00467779|4939012|P1|Stage 2|Disease Progression|0
1501084|NCT00467779|4938998|P15|Stage 2|Death|0
1501085|NCT00467779|4938999|P14|Stage 2|Death|0
1501086|NCT00467779|4939000|P13|Stage 2|Death|0
1501087|NCT00467779|4939001|P12|Stage 2|Death|0
1501088|NCT00467779|4939002|P11|Stage 2|Death|0
1501089|NCT00467779|4939003|P10|Stage 2|Death|0
1501090|NCT00467779|4939004|P9|Stage 2|Death|1
1501091|NCT00467779|4939005|P8|Stage 2|Death|0
1501092|NCT00467779|4939006|P7|Stage 2|Death|0
1501093|NCT00467779|4939007|P6|Stage 2|Death|0
1501094|NCT00467779|4939008|P5|Stage 2|Death|0
1501095|NCT00467779|4939009|P4|Stage 2|Death|0
1501096|NCT00467779|4939010|P3|Stage 2|Death|0
1501097|NCT00467779|4939011|P2|Stage 2|Death|0
1501098|NCT00467779|4939012|P1|Stage 2|Death|0
1501099|NCT00467779|4938998|P15|Stage 2|Adverse Event|0
1501100|NCT00467779|4938999|P14|Stage 2|Adverse Event|0
1501101|NCT00467779|4939000|P13|Stage 2|Adverse Event|0
1501102|NCT00467779|4939001|P12|Stage 2|Adverse Event|0
1501103|NCT00467779|4939002|P11|Stage 2|Adverse Event|0
1501104|NCT00467779|4939003|P10|Stage 2|Adverse Event|0
1501105|NCT00467779|4939004|P9|Stage 2|Adverse Event|1
1501106|NCT00467779|4939005|P8|Stage 2|Adverse Event|0
1501107|NCT00467779|4939006|P7|Stage 2|Adverse Event|0
1501108|NCT00467779|4939007|P6|Stage 2|Adverse Event|0
1501109|NCT00467779|4939008|P5|Stage 2|Adverse Event|0
1501110|NCT00467779|4939009|P4|Stage 2|Adverse Event|0
1501111|NCT00467779|4939010|P3|Stage 2|Adverse Event|0
1501112|NCT00467779|4939011|P2|Stage 2|Adverse Event|0
1501113|NCT00467779|4939012|P1|Stage 2|Adverse Event|0
1501114|NCT00467779|4938998|P15|Stage 1A|Unspecified Reason|0
1501115|NCT00467779|4938999|P14|Stage 1A|Unspecified Reason|0
1501116|NCT00467779|4939000|P13|Stage 1A|Unspecified Reason|1
1501117|NCT00467779|4939001|P12|Stage 1A|Unspecified Reason|1
1501118|NCT00467779|4939002|P11|Stage 1A|Unspecified Reason|0
1501119|NCT00467779|4939003|P10|Stage 1A|Unspecified Reason|0
1501120|NCT00467779|4939004|P9|Stage 1A|Unspecified Reason|0
1501121|NCT00467779|4939005|P8|Stage 1A|Unspecified Reason|0
1501122|NCT00467779|4939006|P7|Stage 1A|Unspecified Reason|0
1501123|NCT00467779|4939007|P6|Stage 1A|Unspecified Reason|0
1501124|NCT00467779|4939008|P5|Stage 1A|Unspecified Reason|0
1501125|NCT00467779|4939009|P4|Stage 1A|Unspecified Reason|0
1501126|NCT00467779|4939010|P3|Stage 1A|Unspecified Reason|0
1501127|NCT00467779|4939011|P2|Stage 1A|Unspecified Reason|0
1501128|NCT00467779|4939012|P1|Stage 1A|Unspecified Reason|0
1501129|NCT00467779|4938998|P15|Stage 1A|Withdrawal by Subject|0
1501130|NCT00467779|4938999|P14|Stage 1A|Withdrawal by Subject|0
1501131|NCT00467779|4939000|P13|Stage 1A|Withdrawal by Subject|1
1501132|NCT00467779|4939001|P12|Stage 1A|Withdrawal by Subject|1
1501133|NCT00467779|4939002|P11|Stage 1A|Withdrawal by Subject|1
1501134|NCT00467779|4939003|P10|Stage 1A|Withdrawal by Subject|0
1501135|NCT00467779|4939004|P9|Stage 1A|Withdrawal by Subject|0
1501136|NCT00467779|4939005|P8|Stage 1A|Withdrawal by Subject|0
1501137|NCT00467779|4939006|P7|Stage 1A|Withdrawal by Subject|0
1501138|NCT00467779|4939007|P6|Stage 1A|Withdrawal by Subject|0
1501139|NCT00467779|4939008|P5|Stage 1A|Withdrawal by Subject|0
1501140|NCT00467779|4939009|P4|Stage 1A|Withdrawal by Subject|0
1501141|NCT00467779|4939010|P3|Stage 1A|Withdrawal by Subject|0
1501142|NCT00467779|4939011|P2|Stage 1A|Withdrawal by Subject|0
1501143|NCT00467779|4939012|P1|Stage 1A|Withdrawal by Subject|0
1501144|NCT00467779|4938998|P15|Stage 1A|Physician Decision|0
1501145|NCT00467779|4938999|P14|Stage 1A|Physician Decision|0
1501146|NCT00467779|4939000|P13|Stage 1A|Physician Decision|0
1501147|NCT00467779|4939001|P12|Stage 1A|Physician Decision|0
1501148|NCT00467779|4939002|P11|Stage 1A|Physician Decision|0
1501149|NCT00467779|4939003|P10|Stage 1A|Physician Decision|1
1501150|NCT00467779|4939004|P9|Stage 1A|Physician Decision|0
1501151|NCT00467779|4939005|P8|Stage 1A|Physician Decision|0
1501152|NCT00467779|4939006|P7|Stage 1A|Physician Decision|0
1501153|NCT00467779|4939007|P6|Stage 1A|Physician Decision|0
1501154|NCT00467779|4939008|P5|Stage 1A|Physician Decision|0
1501155|NCT00467779|4939009|P4|Stage 1A|Physician Decision|0
1501156|NCT00467779|4939010|P3|Stage 1A|Physician Decision|0
1501157|NCT00467779|4939011|P2|Stage 1A|Physician Decision|0
1501158|NCT00467779|4939012|P1|Stage 1A|Physician Decision|0
1501159|NCT00467779|4938998|P15|Stage 1A|Disease Progression|0
1501160|NCT00467779|4938999|P14|Stage 1A|Disease Progression|0
1501161|NCT00467779|4939000|P13|Stage 1A|Disease Progression|2
1501162|NCT00467779|4939001|P12|Stage 1A|Disease Progression|5
1501163|NCT00467779|4939002|P11|Stage 1A|Disease Progression|2
1501164|NCT00467779|4939003|P10|Stage 1A|Disease Progression|2
1501165|NCT00467779|4939004|P9|Stage 1A|Disease Progression|0
1501166|NCT00467779|4939005|P8|Stage 1A|Disease Progression|0
1501167|NCT00467779|4939006|P7|Stage 1A|Disease Progression|0
1501168|NCT00467779|4939007|P6|Stage 1A|Disease Progression|0
1501169|NCT00467779|4939008|P5|Stage 1A|Disease Progression|0
1501170|NCT00467779|4939009|P4|Stage 1A|Disease Progression|0
1501171|NCT00467779|4939010|P3|Stage 1A|Disease Progression|0
1501172|NCT00467779|4939011|P2|Stage 1A|Disease Progression|0
1501173|NCT00467779|4939012|P1|Stage 1A|Disease Progression|0
1501174|NCT00467779|4938998|P15|Stage 1A|Death|0
1501175|NCT00467779|4938999|P14|Stage 1A|Death|0
1501176|NCT00467779|4939000|P13|Stage 1A|Death|1
1501177|NCT00467779|4939001|P12|Stage 1A|Death|1
1501178|NCT00467779|4939002|P11|Stage 1A|Death|0
1501179|NCT00467779|4939003|P10|Stage 1A|Death|0
1501180|NCT00467779|4939004|P9|Stage 1A|Death|0
1501181|NCT00467779|4939005|P8|Stage 1A|Death|0
1501182|NCT00467779|4939006|P7|Stage 1A|Death|0
1501183|NCT00467779|4939007|P6|Stage 1A|Death|0
1501184|NCT00467779|4939008|P5|Stage 1A|Death|0
1501185|NCT00467779|4939009|P4|Stage 1A|Death|0
1501186|NCT00467779|4939010|P3|Stage 1A|Death|0
1501187|NCT00467779|4939011|P2|Stage 1A|Death|0
1501188|NCT00467779|4939012|P1|Stage 1A|Death|0
1501189|NCT00467779|4938998|P15|Stage 1A|Adverse Event|0
1501190|NCT00467779|4938999|P14|Stage 1A|Adverse Event|0
1501191|NCT00467779|4939000|P13|Stage 1A|Adverse Event|1
1501192|NCT00467779|4939001|P12|Stage 1A|Adverse Event|0
1501193|NCT00467779|4939002|P11|Stage 1A|Adverse Event|0
1501194|NCT00467779|4939003|P10|Stage 1A|Adverse Event|0
1501195|NCT00467779|4939004|P9|Stage 1A|Adverse Event|0
1501196|NCT00467779|4939005|P8|Stage 1A|Adverse Event|0
1501197|NCT00467779|4939006|P7|Stage 1A|Adverse Event|0
1501198|NCT00467779|4939007|P6|Stage 1A|Adverse Event|0
1501199|NCT00467779|4939008|P5|Stage 1A|Adverse Event|0
1501200|NCT00467779|4939009|P4|Stage 1A|Adverse Event|0
1501201|NCT00467779|4939010|P3|Stage 1A|Adverse Event|0
1501202|NCT00467779|4939011|P2|Stage 1A|Adverse Event|0
1501203|NCT00467779|4939012|P1|Stage 1A|Adverse Event|0
1501204|NCT00467779|4938998|P15|Stage 1|Withdrawal by Subject|0
1501205|NCT00467779|4938999|P14|Stage 1|Withdrawal by Subject|0
1501206|NCT00467779|4939000|P13|Stage 1|Withdrawal by Subject|0
1501207|NCT00467779|4939001|P12|Stage 1|Withdrawal by Subject|0
1501208|NCT00467779|4939002|P11|Stage 1|Withdrawal by Subject|0
1501209|NCT00467779|4939003|P10|Stage 1|Withdrawal by Subject|0
1501210|NCT00467779|4939004|P9|Stage 1|Withdrawal by Subject|0
1501211|NCT00467779|4939005|P8|Stage 1|Withdrawal by Subject|1
1501212|NCT00467779|4939006|P7|Stage 1|Withdrawal by Subject|1
1501213|NCT00467779|4939007|P6|Stage 1|Withdrawal by Subject|0
1501214|NCT00467779|4939008|P5|Stage 1|Withdrawal by Subject|0
1501215|NCT00467779|4939009|P4|Stage 1|Withdrawal by Subject|0
1501216|NCT00467779|4939010|P3|Stage 1|Withdrawal by Subject|0
1501217|NCT00467779|4939011|P2|Stage 1|Withdrawal by Subject|0
1501218|NCT00467779|4939012|P1|Stage 1|Withdrawal by Subject|0
1501219|NCT00467779|4938998|P15|Stage 1|Physician Decision|0
1501220|NCT00467779|4938999|P14|Stage 1|Physician Decision|0
1501221|NCT00467779|4939000|P13|Stage 1|Physician Decision|0
1501222|NCT00467779|4939001|P12|Stage 1|Physician Decision|0
1501223|NCT00467779|4939002|P11|Stage 1|Physician Decision|0
1501224|NCT00467779|4939003|P10|Stage 1|Physician Decision|0
1501225|NCT00467779|4939004|P9|Stage 1|Physician Decision|0
1501226|NCT00467779|4939005|P8|Stage 1|Physician Decision|0
1501227|NCT00467779|4939006|P7|Stage 1|Physician Decision|0
1501228|NCT00467779|4939007|P6|Stage 1|Physician Decision|0
1501229|NCT00467779|4939008|P5|Stage 1|Physician Decision|0
1501230|NCT00467779|4939009|P4|Stage 1|Physician Decision|0
1501231|NCT00467779|4939010|P3|Stage 1|Physician Decision|0
1501232|NCT00467779|4939011|P2|Stage 1|Physician Decision|1
1501233|NCT00467779|4939012|P1|Stage 1|Physician Decision|0
1501234|NCT00467779|4938998|P15|Stage 1|Unspecified Reason|0
1501235|NCT00467779|4938999|P14|Stage 1|Unspecified Reason|0
1501236|NCT00467779|4939000|P13|Stage 1|Unspecified Reason|0
1501237|NCT00467779|4939001|P12|Stage 1|Unspecified Reason|0
1501238|NCT00467779|4939002|P11|Stage 1|Unspecified Reason|0
1501239|NCT00467779|4939003|P10|Stage 1|Unspecified Reason|0
1501240|NCT00467779|4939004|P9|Stage 1|Unspecified Reason|0
1501241|NCT00467779|4939005|P8|Stage 1|Unspecified Reason|0
1501242|NCT00467779|4939006|P7|Stage 1|Unspecified Reason|0
1501243|NCT00467779|4939007|P6|Stage 1|Unspecified Reason|2
1501244|NCT00467779|4939008|P5|Stage 1|Unspecified Reason|1
1501245|NCT00467779|4939009|P4|Stage 1|Unspecified Reason|0
1501246|NCT00467779|4939010|P3|Stage 1|Unspecified Reason|1
1501247|NCT00467779|4939011|P2|Stage 1|Unspecified Reason|0
1501248|NCT00467779|4939012|P1|Stage 1|Unspecified Reason|1
1501249|NCT00467779|4938998|P15|Stage 1|Disease Progression|0
1501250|NCT00467779|4938999|P14|Stage 1|Disease Progression|0
1501251|NCT00467779|4939000|P13|Stage 1|Disease Progression|0
1501252|NCT00467779|4939001|P12|Stage 1|Disease Progression|0
1501253|NCT00467779|4939002|P11|Stage 1|Disease Progression|0
1501254|NCT00467779|4939003|P10|Stage 1|Disease Progression|0
1501255|NCT00467779|4939004|P9|Stage 1|Disease Progression|0
1501256|NCT00467779|4939005|P8|Stage 1|Disease Progression|5
1501257|NCT00467779|4939006|P7|Stage 1|Disease Progression|4
1501258|NCT00467779|4939007|P6|Stage 1|Disease Progression|2
1501259|NCT00467779|4939008|P5|Stage 1|Disease Progression|2
1501260|NCT00467779|4939009|P4|Stage 1|Disease Progression|3
1501261|NCT00467779|4939010|P3|Stage 1|Disease Progression|2
1501262|NCT00467779|4939011|P2|Stage 1|Disease Progression|2
1501263|NCT00467779|4939012|P1|Stage 1|Disease Progression|2
1501264|NCT00467779|4938998|P15|Stage 1|Adverse Event|0
1501265|NCT00467779|4938999|P14|Stage 1|Adverse Event|0
1501266|NCT00467779|4939000|P13|Stage 1|Adverse Event|0
1501267|NCT00467779|4939001|P12|Stage 1|Adverse Event|0
1501268|NCT00467779|4939002|P11|Stage 1|Adverse Event|0
1501269|NCT00467779|4939003|P10|Stage 1|Adverse Event|0
1501270|NCT00467779|4939004|P9|Stage 1|Adverse Event|0
1501271|NCT00467779|4939005|P8|Stage 1|Adverse Event|1
1501272|NCT00467779|4939006|P7|Stage 1|Adverse Event|2
1501273|NCT00467779|4939007|P6|Stage 1|Adverse Event|1
1501274|NCT00467779|4939008|P5|Stage 1|Adverse Event|0
1501275|NCT00467779|4939009|P4|Stage 1|Adverse Event|0
1501276|NCT00467779|4939010|P3|Stage 1|Adverse Event|0
1501277|NCT00467779|4939011|P2|Stage 1|Adverse Event|0
1501278|NCT00467779|4939012|P1|Stage 1|Adverse Event|1
1501279|NCT00467753|4939186|P2|Overall Study|Adverse Event|0
1501280|NCT00467753|4939187|P1|Overall Study|Adverse Event|2
1501281|NCT00467753|4939186|P2|Overall Study|Lost to Follow-up|2
1501282|NCT00467753|4939187|P1|Overall Study|Lost to Follow-up|1
1501283|NCT00467740|4939198|P5|Overall Study|Lack of Efficacy|0
1501284|NCT00467740|4939199|P4|Overall Study|Lack of Efficacy|0
1501285|NCT00467740|4939200|P3|Overall Study|Lack of Efficacy|0
1501286|NCT00467740|4939201|P2|Overall Study|Lack of Efficacy|1
1501287|NCT00467740|4939202|P1|Overall Study|Lack of Efficacy|0
1501288|NCT00467740|4939198|P5|Overall Study|Withdrawal by Subject|0
1501289|NCT00467740|4939199|P4|Overall Study|Withdrawal by Subject|1
1501290|NCT00467740|4939200|P3|Overall Study|Withdrawal by Subject|0
1501291|NCT00467740|4939201|P2|Overall Study|Withdrawal by Subject|1
1501292|NCT00467740|4939202|P1|Overall Study|Withdrawal by Subject|1
1501293|NCT00467740|4939198|P5|Overall Study|Lost to Follow-up|0
1501294|NCT00467740|4939199|P4|Overall Study|Lost to Follow-up|0
1501295|NCT00467740|4939200|P3|Overall Study|Lost to Follow-up|0
1501296|NCT00467740|4939201|P2|Overall Study|Lost to Follow-up|1
1501297|NCT00467740|4939202|P1|Overall Study|Lost to Follow-up|0
1501298|NCT00467740|4939198|P5|Overall Study|Protocol Violation|0
1501299|NCT00467740|4939199|P4|Overall Study|Protocol Violation|0
1501300|NCT00467740|4939200|P3|Overall Study|Protocol Violation|1
1501301|NCT00467740|4939201|P2|Overall Study|Protocol Violation|0
1501302|NCT00467740|4939202|P1|Overall Study|Protocol Violation|0
1501303|NCT00467740|4939198|P5|Overall Study|Adverse Event|0
1501304|NCT00467740|4939199|P4|Overall Study|Adverse Event|0
1501305|NCT00467740|4939200|P3|Overall Study|Adverse Event|1
1501306|NCT00467740|4939201|P2|Overall Study|Adverse Event|0
1501307|NCT00467740|4939202|P1|Overall Study|Adverse Event|0
1501308|NCT00467649|4939391|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
1501309|NCT00467649|4939392|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
1501310|NCT00467649|4939393|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
1501311|NCT00467649|4939394|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
1501312|NCT00467649|4939395|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
1501313|NCT00467649|4939396|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
1501314|NCT00467649|4939391|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
1501315|NCT00467649|4939392|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
1501316|NCT00467649|4939393|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
1501317|NCT00467649|4939394|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
1501318|NCT00467649|4939395|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
1501319|NCT00467649|4939396|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
1501320|NCT00467649|4939391|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
1501321|NCT00467649|4939392|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
1501322|NCT00467649|4939393|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
1501323|NCT00467649|4939394|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
1501324|NCT00467649|4939395|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
1501325|NCT00467649|4939396|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
1501326|NCT00467649|4939391|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
1501327|NCT00467649|4939392|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
1501328|NCT00467649|4939393|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
1501329|NCT00467649|4939394|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
1501330|NCT00467649|4939395|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
1501331|NCT00467649|4939396|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
1501332|NCT00467649|4939391|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
1501333|NCT00467649|4939392|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
1501334|NCT00467649|4939393|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
1501335|NCT00467649|4939394|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
1501336|NCT00467649|4939395|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
1501337|NCT00467649|4939396|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
1501338|NCT00467649|4939391|P6|Phase 1 (Randomized Population)|Investigator Decision|0
1501339|NCT00467649|4939392|P5|Phase 1 (Randomized Population)|Investigator Decision|0
1501340|NCT00467649|4939393|P4|Phase 1 (Randomized Population)|Investigator Decision|0
1501341|NCT00467649|4939394|P3|Phase 1 (Randomized Population)|Investigator Decision|0
1501342|NCT00467649|4939395|P2|Phase 1 (Randomized Population)|Investigator Decision|0
1501343|NCT00467649|4939396|P1|Phase 1 (Randomized Population)|Investigator Decision|1
1501344|NCT00467649|4939391|P6|Phase 1 (Randomized Population)|Adverse Event|0
1501345|NCT00467649|4939392|P5|Phase 1 (Randomized Population)|Adverse Event|0
1501346|NCT00467649|4939393|P4|Phase 1 (Randomized Population)|Adverse Event|0
1501347|NCT00467649|4939394|P3|Phase 1 (Randomized Population)|Adverse Event|0
1501348|NCT00467649|4939395|P2|Phase 1 (Randomized Population)|Adverse Event|0
1501349|NCT00467649|4939396|P1|Phase 1 (Randomized Population)|Adverse Event|2
1501350|NCT00467610|4939436|P1|Overall Study|Withdrawal by Subject|1
1501351|NCT00467597|4939447|P2|Overall Study|Withdrawal by Subject|0
1501352|NCT00467597|4939448|P1|Overall Study|Withdrawal by Subject|2
1501353|NCT00467584|4939461|P3|Overall Study|Withdrawal by Subject|1
1501354|NCT00467584|4939462|P2|Overall Study|Withdrawal by Subject|5
1501355|NCT00467584|4939463|P1|Overall Study|Withdrawal by Subject|4
1501356|NCT00467558|4939473|P2|Overall Study|Lost to Follow-up|0
1501357|NCT00467558|4939474|P1|Overall Study|Lost to Follow-up|2
1501358|NCT00467519|4939484|P2|Overall Study|Withdrawal by Subject|10
1501359|NCT00467519|4939485|P1|Overall Study|Withdrawal by Subject|4
1501360|NCT00467519|4939484|P2|Overall Study|Lost to Follow-up|9
1501361|NCT00467519|4939485|P1|Overall Study|Lost to Follow-up|2
1501362|NCT00467519|4939484|P2|Overall Study|Protocol Violation|4
1501363|NCT00467519|4939485|P1|Overall Study|Protocol Violation|8
1501364|NCT00467363|4939514|P2|Overall Study|Lost to Follow-up|70
1501365|NCT00467363|4939515|P1|Overall Study|Lost to Follow-up|80
1501366|NCT00467285|4939562|P2|Overall Study|Lost to Follow-up|4
1501367|NCT00467285|4939563|P1|Overall Study|Lost to Follow-up|4
1501368|NCT00467259|4939583|P2|Overall Study|Site Closed|1
1501369|NCT00467259|4939584|P1|Overall Study|Site Closed|2
1501370|NCT00467259|4939583|P2|Overall Study|Lost to Follow-up|34
1501371|NCT00467259|4939584|P1|Overall Study|Lost to Follow-up|14
1501372|NCT00467259|4939583|P2|Overall Study|Physician Decision|2
1501373|NCT00467259|4939584|P1|Overall Study|Physician Decision|0
1501374|NCT00467259|4939583|P2|Overall Study|Withdrawal by Subject|108
1501375|NCT00467259|4939584|P1|Overall Study|Withdrawal by Subject|34
1501376|NCT00467259|4939583|P2|Overall Study|Protocol Violation|7
1501377|NCT00467259|4939584|P1|Overall Study|Protocol Violation|1
1501378|NCT00467259|4939583|P2|Overall Study|Adverse Event|90
1501379|NCT00467259|4939584|P1|Overall Study|Adverse Event|24
1501380|NCT00467051|4939601|P1|Overall Study|Adverse Event|2
1501381|NCT00466947|4939628|P2|Study End Analysis Period|Other – Unconformity in team’s treatment|1
1501382|NCT00466947|4939629|P1|Study End Analysis Period|Other – Unconformity in team’s treatment|0
1501383|NCT00466947|4939628|P2|Study End Analysis Period|Other – Subject without a legal guardian|0
1501384|NCT00466947|4939629|P1|Study End Analysis Period|Other – Subject without a legal guardian|1
1501385|NCT00466947|4939628|P2|Study End Analysis Period|Other – Forbidden vaccination|10
1501386|NCT00466947|4939629|P1|Study End Analysis Period|Other – Forbidden vaccination|21
1501387|NCT00466947|4939628|P2|Study End Analysis Period|Withdrawal by Subject|1267
1501388|NCT00466947|4939629|P1|Study End Analysis Period|Withdrawal by Subject|1264
1501389|NCT00466947|4939628|P2|Study End Analysis Period|Protocol Violation|17
1501390|NCT00466947|4939629|P1|Study End Analysis Period|Protocol Violation|9
1501391|NCT00466947|4939628|P2|Study End Analysis Period|Physician Decision|29
1501392|NCT00466947|4939629|P1|Study End Analysis Period|Physician Decision|29
1501393|NCT00466947|4939628|P2|Study End Analysis Period|Lost to Follow-up|1167
1501394|NCT00466947|4939629|P1|Study End Analysis Period|Lost to Follow-up|1137
1501395|NCT00466947|4939628|P2|Study End Analysis Period|Adverse Event|43
1501396|NCT00466947|4939629|P1|Study End Analysis Period|Adverse Event|35
1501397|NCT00466947|4939628|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
1501398|NCT00466947|4939629|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
1501399|NCT00466726|4939824|P1|Overall Study|Not evaluable for response|14
1501400|NCT00466687|4939830|P1|Overall Study|Disease progression|29
1501401|NCT00466687|4939830|P1|Overall Study|Withdrawal by Subject|1
1501402|NCT00466687|4939830|P1|Overall Study|Other complicating illness|3
1501403|NCT00466687|4939830|P1|Overall Study|Adverse Event|1
1501404|NCT00466505|4939837|P1|Overall Study|Adverse Event|4
1501405|NCT00466505|4939837|P1|Overall Study|disease progression|13
1501406|NCT00466193|4939887|P2|Overall Study|Patient refused Visit 4 procedures|0
1501407|NCT00466193|4939888|P1|Overall Study|Patient refused Visit 4 procedures|1
1501408|NCT00466193|4939887|P2|Overall Study|Withdrawal by Subject|2
1501409|NCT00466193|4939888|P1|Overall Study|Withdrawal by Subject|7
1501410|NCT00466193|4939887|P2|Overall Study|Protocol Violation|1
1501411|NCT00466193|4939888|P1|Overall Study|Protocol Violation|1
1501412|NCT00466193|4939887|P2|Overall Study|Physician Decision|0
1501413|NCT00466193|4939888|P1|Overall Study|Physician Decision|1
1501414|NCT00466193|4939887|P2|Overall Study|Lost to Follow-up|4
1501415|NCT00466193|4939888|P1|Overall Study|Lost to Follow-up|2
1501416|NCT00466193|4939887|P2|Overall Study|Adverse Event|1
1501417|NCT00466193|4939888|P1|Overall Study|Adverse Event|0
1501418|NCT00466167|4939915|P3|Overall Study|Not treated|0
1501419|NCT00466167|4939916|P2|Overall Study|Not treated|0
1501420|NCT00466167|4939917|P1|Overall Study|Not treated|1
1501421|NCT00466167|4939915|P3|Overall Study|patient did not meet inclusion criteria|1
1501422|NCT00466167|4939916|P2|Overall Study|patient did not meet inclusion criteria|0
1501423|NCT00466167|4939917|P1|Overall Study|patient did not meet inclusion criteria|1
1501424|NCT00466167|4939915|P3|Overall Study|Withdrawal by Subject|6
1501425|NCT00466167|4939916|P2|Overall Study|Withdrawal by Subject|1
1501426|NCT00466167|4939917|P1|Overall Study|Withdrawal by Subject|4
1501427|NCT00466167|4939915|P3|Overall Study|Lost to Follow-up|2
1501428|NCT00466167|4939916|P2|Overall Study|Lost to Follow-up|2
1501429|NCT00466167|4939917|P1|Overall Study|Lost to Follow-up|3
1501430|NCT00466167|4939915|P3|Overall Study|Protocol Violation|2
1501431|NCT00466167|4939916|P2|Overall Study|Protocol Violation|1
1501432|NCT00466167|4939917|P1|Overall Study|Protocol Violation|1
1501433|NCT00466167|4939915|P3|Overall Study|Lack of Efficacy|3
1501434|NCT00466167|4939916|P2|Overall Study|Lack of Efficacy|0
1501435|NCT00466167|4939917|P1|Overall Study|Lack of Efficacy|2
1501436|NCT00466167|4939915|P3|Overall Study|Adverse Event|7
1501437|NCT00466167|4939916|P2|Overall Study|Adverse Event|8
1501438|NCT00466167|4939917|P1|Overall Study|Adverse Event|8
1501439|NCT00465985|4939978|P2|Part III - Open-label Treatment Period|Adverse Event|0
1501440|NCT00465985|4939979|P1|Part III - Open-label Treatment Period|Adverse Event|1
1501441|NCT00465985|4939978|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
1501442|NCT00465985|4939979|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
1501443|NCT00465985|4939978|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
1501444|NCT00465985|4939979|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
1501445|NCT00465985|4939978|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
1501446|NCT00465985|4939979|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
1501447|NCT00465972|4940002|P2|Overall Study|Withdrawal by Subject|1
1501448|NCT00465972|4940003|P1|Overall Study|Withdrawal by Subject|2
1501449|NCT00465816|4940023|P3|Overall Study|Lost to Follow-up|2
1501450|NCT00465816|4940024|P2|Overall Study|Lost to Follow-up|0
1501451|NCT00465816|4940025|P1|Overall Study|Lost to Follow-up|0
1501452|NCT00465738|4940088|P2|Overall Study|Other|5
1501453|NCT00465738|4940089|P1|Overall Study|Other|2
1501454|NCT00465738|4940088|P2|Overall Study|Withdrawal by Subject|0
1501455|NCT00465738|4940089|P1|Overall Study|Withdrawal by Subject|2
1501456|NCT00465738|4940088|P2|Overall Study|Adverse Event|1
1501457|NCT00465738|4940089|P1|Overall Study|Adverse Event|0
1501458|NCT00465738|4940088|P2|Overall Study|Lost to Follow-up|0
1501459|NCT00465738|4940089|P1|Overall Study|Lost to Follow-up|2
1501460|NCT00465647|4940183|P4|Overall Study|"The other reasons included loss of IV"|2
1501461|NCT00465647|4940184|P3|Overall Study|"The other reasons included loss of IV"|3
1501462|NCT00465647|4940185|P2|Overall Study|"The other reasons included loss of IV"|4
1501463|NCT00465647|4940186|P1|Overall Study|"The other reasons included loss of IV"|8
1501464|NCT00465647|4940183|P4|Overall Study|Withdrawal by Subject|7
1501465|NCT00465647|4940184|P3|Overall Study|Withdrawal by Subject|2
1501466|NCT00465647|4940185|P2|Overall Study|Withdrawal by Subject|2
1501467|NCT00465647|4940186|P1|Overall Study|Withdrawal by Subject|1
1501468|NCT00465647|4940183|P4|Overall Study|Adverse Event|2
1501469|NCT00465647|4940184|P3|Overall Study|Adverse Event|3
1501470|NCT00465647|4940185|P2|Overall Study|Adverse Event|0
1501471|NCT00465647|4940186|P1|Overall Study|Adverse Event|2
1501472|NCT00465647|4940183|P4|Overall Study|Administrative|2
1501473|NCT00465647|4940184|P3|Overall Study|Administrative|3
1501474|NCT00465647|4940185|P2|Overall Study|Administrative|2
1501475|NCT00465647|4940186|P1|Overall Study|Administrative|2
1501476|NCT00465569|4940234|P2|Overall Study|persistent eczema during dose escalation|0
1501477|NCT00465569|4940235|P1|Overall Study|persistent eczema during dose escalation|1
1501478|NCT00465361|4940258|P1|Baseline Assessment|Personal Issues/Scheduling|4
1501479|NCT00465179|4940262|P1|Overall Study|Progression of Disease|47
1501480|NCT00465179|4940262|P1|Overall Study|Withdrawal by Subject|2
1501481|NCT00465179|4940262|P1|Overall Study|Adverse Event|4
1501482|NCT00465101|4940268|P1|Overall Study|Withdrew consent prior to procedure|3
1501483|NCT00465101|4940268|P1|Overall Study|Physician Decision|1
1501484|NCT00465101|4940268|P1|Overall Study|Withdrawal by Subject|25
1501485|NCT00465101|4940268|P1|Overall Study|Death|3
1501486|NCT00465101|4940268|P1|Overall Study|Unable to obtain IRB approval|1
1501487|NCT00465101|4940268|P1|Overall Study|Site closed due to IRB expiration|1
1501488|NCT00465101|4940268|P1|Overall Study|Patient postponed procedure|1
1501489|NCT00465101|4940268|P1|Overall Study|Pt. Insurance not accepted at center|2
1501490|NCT00465101|4940268|P1|Overall Study|Other|6
1501491|NCT00465101|4940268|P1|Overall Study|Lost to Follow-up|5
1501492|NCT00465101|4940268|P1|Overall Study|Did not meet study criteria|4
1501493|NCT00465101|4940268|P1|Overall Study|Change in health precluded follow up|4
1501494|NCT00465101|4940268|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
1501495|NCT00464945|4940338|P2|Toddler Dose|Lost to Follow-up|1
1501496|NCT00464945|4940339|P1|Toddler Dose|Lost to Follow-up|0
1501497|NCT00464945|4940338|P2|After Infant Series|Withdrawal by Subject|2
1501498|NCT00464945|4940339|P1|After Infant Series|Withdrawal by Subject|0
1501499|NCT00464945|4940338|P2|Infant Series|Lost to Follow-up|0
1501500|NCT00464945|4940339|P1|Infant Series|Lost to Follow-up|1
1501501|NCT00464945|4940338|P2|Infant Series|Protocol Violation|0
1501502|NCT00464945|4940339|P1|Infant Series|Protocol Violation|1
1501503|NCT00464945|4940338|P2|Infant Series|Withdrawal by parent/guardian request|1
1501504|NCT00464945|4940339|P1|Infant Series|Withdrawal by parent/guardian request|2
1501505|NCT00464815|4940369|P2|Overall Study|Withdrawal by Subject|3
1501506|NCT00464815|4940370|P1|Overall Study|Withdrawal by Subject|6
1501507|NCT00464737|4940403|P3|Overall Study|Other: Subject's disability per sponsor|1
1501508|NCT00464737|4940404|P2|Overall Study|Other: Subject's disability per sponsor|0
1501509|NCT00464737|4940405|P1|Overall Study|Other: Subject's disability per sponsor|0
1501510|NCT00464737|4940403|P3|Overall Study|Other: Personal family reasons|1
1501511|NCT00464737|4940404|P2|Overall Study|Other: Personal family reasons|0
1501512|NCT00464737|4940405|P1|Overall Study|Other: Personal family reasons|0
1501513|NCT00464737|4940403|P3|Overall Study|Other: Study demands too great|0
1501514|NCT00464737|4940404|P2|Overall Study|Other: Study demands too great|1
1501515|NCT00464737|4940405|P1|Overall Study|Other: Study demands too great|0
1501516|NCT00464737|4940403|P3|Overall Study|Other: Subject left town; family illness|0
1501517|NCT00464737|4940404|P2|Overall Study|Other: Subject left town; family illness|0
1501518|NCT00464737|4940405|P1|Overall Study|Other: Subject left town; family illness|1
1501519|NCT00464737|4940403|P3|Overall Study|Other: Subject's schedule doesn't permit|0
1501520|NCT00464737|4940404|P2|Overall Study|Other: Subject's schedule doesn't permit|0
1501521|NCT00464737|4940405|P1|Overall Study|Other: Subject's schedule doesn't permit|1
1501522|NCT00464737|4940403|P3|Overall Study|Lost to Follow-up|5
1501523|NCT00464737|4940404|P2|Overall Study|Lost to Follow-up|2
1501524|NCT00464737|4940405|P1|Overall Study|Lost to Follow-up|5
1501525|NCT00464737|4940403|P3|Overall Study|Non-compliance|1
1501526|NCT00464737|4940404|P2|Overall Study|Non-compliance|1
1501527|NCT00464737|4940405|P1|Overall Study|Non-compliance|0
1501528|NCT00464737|4940403|P3|Overall Study|Protocol Violation|5
1501529|NCT00464737|4940404|P2|Overall Study|Protocol Violation|1
1501530|NCT00464737|4940405|P1|Overall Study|Protocol Violation|1
1501531|NCT00464737|4940403|P3|Overall Study|Withdrawal by Subject|5
1501532|NCT00464737|4940404|P2|Overall Study|Withdrawal by Subject|3
1501533|NCT00464737|4940405|P1|Overall Study|Withdrawal by Subject|5
1501534|NCT00464737|4940403|P3|Overall Study|Lack of Efficacy|4
1501535|NCT00464737|4940404|P2|Overall Study|Lack of Efficacy|7
1501536|NCT00464737|4940405|P1|Overall Study|Lack of Efficacy|7
1501537|NCT00464737|4940403|P3|Overall Study|Adverse Event|33
1501538|NCT00464737|4940404|P2|Overall Study|Adverse Event|17
1501539|NCT00464737|4940405|P1|Overall Study|Adverse Event|12
1501540|NCT00464672|4940485|P6|Overall Study|Lost to Follow-up|0
1501541|NCT00464672|4940486|P5|Overall Study|Lost to Follow-up|1
1501542|NCT00464672|4940487|P4|Overall Study|Lost to Follow-up|0
1501543|NCT00464672|4940488|P3|Overall Study|Lost to Follow-up|0
1501544|NCT00464672|4940489|P2|Overall Study|Lost to Follow-up|10
1501545|NCT00464672|4940490|P1|Overall Study|Lost to Follow-up|25
1501546|NCT00464672|4940485|P6|Overall Study|withdrawal of consent|4
1501547|NCT00464672|4940486|P5|Overall Study|withdrawal of consent|9
1501548|NCT00464672|4940487|P4|Overall Study|withdrawal of consent|1
1501549|NCT00464672|4940488|P3|Overall Study|withdrawal of consent|0
1501550|NCT00464672|4940489|P2|Overall Study|withdrawal of consent|0
1501551|NCT00464672|4940490|P1|Overall Study|withdrawal of consent|0
1501552|NCT00464568|4940569|P1|Overall Study|Adverse Event|2
1501553|NCT00464542|4940642|P1|Pre-treatment|Withdrawal by Subject|2
1501554|NCT00464490|4940649|P2|Overall Study|Physician Decision|11
1501555|NCT00464490|4940650|P1|Overall Study|Physician Decision|11
1501556|NCT00464334|4940697|P11|Overall Study|Withdrawal by Subject|0
1501557|NCT00464334|4940698|P10|Overall Study|Withdrawal by Subject|0
1501558|NCT00464334|4940699|P9|Overall Study|Withdrawal by Subject|3
1501559|NCT00464334|4940700|P8|Overall Study|Withdrawal by Subject|1
1501560|NCT00464334|4940701|P7|Overall Study|Withdrawal by Subject|2
1501561|NCT00464334|4940702|P6|Overall Study|Withdrawal by Subject|2
1501562|NCT00464334|4940703|P5|Overall Study|Withdrawal by Subject|2
1501563|NCT00464334|4940704|P4|Overall Study|Withdrawal by Subject|2
1501564|NCT00464334|4940705|P3|Overall Study|Withdrawal by Subject|4
1501565|NCT00464334|4940706|P2|Overall Study|Withdrawal by Subject|7
1501566|NCT00464334|4940707|P1|Overall Study|Withdrawal by Subject|1
1501567|NCT00464334|4940697|P11|Overall Study|Study Terminated by Sponsor|0
1501568|NCT00464334|4940698|P10|Overall Study|Study Terminated by Sponsor|0
1501569|NCT00464334|4940699|P9|Overall Study|Study Terminated by Sponsor|0
1501570|NCT00464334|4940700|P8|Overall Study|Study Terminated by Sponsor|0
1501571|NCT00464334|4940701|P7|Overall Study|Study Terminated by Sponsor|0
1501572|NCT00464334|4940702|P6|Overall Study|Study Terminated by Sponsor|0
1501573|NCT00464334|4940703|P5|Overall Study|Study Terminated by Sponsor|0
1501574|NCT00464334|4940704|P4|Overall Study|Study Terminated by Sponsor|1
1501575|NCT00464334|4940705|P3|Overall Study|Study Terminated by Sponsor|0
1501576|NCT00464334|4940706|P2|Overall Study|Study Terminated by Sponsor|0
1501577|NCT00464334|4940707|P1|Overall Study|Study Terminated by Sponsor|0
1501578|NCT00464334|4940697|P11|Overall Study|Progressive Disease|0
1501579|NCT00464334|4940698|P10|Overall Study|Progressive Disease|0
1501580|NCT00464334|4940699|P9|Overall Study|Progressive Disease|1
1501581|NCT00464334|4940700|P8|Overall Study|Progressive Disease|0
1501582|NCT00464334|4940701|P7|Overall Study|Progressive Disease|0
1501583|NCT00464334|4940702|P6|Overall Study|Progressive Disease|1
1501584|NCT00464334|4940703|P5|Overall Study|Progressive Disease|0
1501585|NCT00464334|4940704|P4|Overall Study|Progressive Disease|0
1501586|NCT00464334|4940705|P3|Overall Study|Progressive Disease|0
1501587|NCT00464334|4940706|P2|Overall Study|Progressive Disease|0
1501588|NCT00464334|4940707|P1|Overall Study|Progressive Disease|0
1501589|NCT00464334|4940697|P11|Overall Study|Lost to Follow-up|2
1501590|NCT00464334|4940698|P10|Overall Study|Lost to Follow-up|0
1501591|NCT00464334|4940699|P9|Overall Study|Lost to Follow-up|0
1501592|NCT00464334|4940700|P8|Overall Study|Lost to Follow-up|0
1501593|NCT00464334|4940701|P7|Overall Study|Lost to Follow-up|1
1501594|NCT00464334|4940702|P6|Overall Study|Lost to Follow-up|0
1501595|NCT00464334|4940703|P5|Overall Study|Lost to Follow-up|1
1501596|NCT00464334|4940704|P4|Overall Study|Lost to Follow-up|0
1501597|NCT00464334|4940705|P3|Overall Study|Lost to Follow-up|1
1501598|NCT00464334|4940706|P2|Overall Study|Lost to Follow-up|0
1501599|NCT00464334|4940707|P1|Overall Study|Lost to Follow-up|0
1501600|NCT00464334|4940697|P11|Overall Study|Lack of Efficacy|0
1501601|NCT00464334|4940698|P10|Overall Study|Lack of Efficacy|0
1501602|NCT00464334|4940699|P9|Overall Study|Lack of Efficacy|0
1501603|NCT00464334|4940700|P8|Overall Study|Lack of Efficacy|0
1501604|NCT00464334|4940701|P7|Overall Study|Lack of Efficacy|0
1501605|NCT00464334|4940702|P6|Overall Study|Lack of Efficacy|0
1501606|NCT00464334|4940703|P5|Overall Study|Lack of Efficacy|0
1501607|NCT00464334|4940704|P4|Overall Study|Lack of Efficacy|0
1501608|NCT00464334|4940705|P3|Overall Study|Lack of Efficacy|0
1501609|NCT00464334|4940706|P2|Overall Study|Lack of Efficacy|1
1501610|NCT00464334|4940707|P1|Overall Study|Lack of Efficacy|0
1501611|NCT00464334|4940697|P11|Overall Study|Adverse Event|2
1501612|NCT00464334|4940698|P10|Overall Study|Adverse Event|1
1501613|NCT00464334|4940699|P9|Overall Study|Adverse Event|2
1501614|NCT00464334|4940700|P8|Overall Study|Adverse Event|0
1501615|NCT00464334|4940701|P7|Overall Study|Adverse Event|0
1501616|NCT00464334|4940702|P6|Overall Study|Adverse Event|1
1501617|NCT00464334|4940703|P5|Overall Study|Adverse Event|1
1501618|NCT00464334|4940704|P4|Overall Study|Adverse Event|1
1501619|NCT00464334|4940705|P3|Overall Study|Adverse Event|0
1501620|NCT00464334|4940706|P2|Overall Study|Adverse Event|0
1501621|NCT00464334|4940707|P1|Overall Study|Adverse Event|0
1501622|NCT00464308|4940767|P3|Overall Study|Physician Decision|0
1501623|NCT00464308|4940768|P2|Overall Study|Physician Decision|0
1501624|NCT00464308|4940769|P1|Overall Study|Physician Decision|1
1501625|NCT00464308|4940767|P3|Overall Study|Patient discontinued and other reasons|23
1501626|NCT00464308|4940768|P2|Overall Study|Patient discontinued and other reasons|17
1501627|NCT00464308|4940769|P1|Overall Study|Patient discontinued and other reasons|17
1501628|NCT00464308|4940767|P3|Overall Study|Lost to Follow-up|20
1501629|NCT00464308|4940768|P2|Overall Study|Lost to Follow-up|19
1501630|NCT00464308|4940769|P1|Overall Study|Lost to Follow-up|29
1501631|NCT00464308|4940767|P3|Overall Study|Adverse Event|16
1501632|NCT00464308|4940768|P2|Overall Study|Adverse Event|27
1501633|NCT00464308|4940769|P1|Overall Study|Adverse Event|22
1501634|NCT00464269|4940799|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1501635|NCT00464269|4940800|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
1501636|NCT00464269|4940801|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1501637|NCT00464269|4940802|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1501638|NCT00464269|4940799|P4|Overall Study|AE, non-serious non-fatal|4
1501639|NCT00464269|4940800|P3|Overall Study|AE, non-serious non-fatal|3
1501640|NCT00464269|4940801|P2|Overall Study|AE, non-serious non-fatal|8
1501641|NCT00464269|4940802|P1|Overall Study|AE, non-serious non-fatal|2
1501642|NCT00464269|4940799|P4|Overall Study|SAE, non-fatal|1
1501643|NCT00464269|4940800|P3|Overall Study|SAE, non-fatal|0
1501644|NCT00464269|4940801|P2|Overall Study|SAE, non-fatal|0
1501645|NCT00464269|4940802|P1|Overall Study|SAE, non-fatal|0
1501646|NCT00464269|4940799|P4|Overall Study|AE, serious fatal|1
1501647|NCT00464269|4940800|P3|Overall Study|AE, serious fatal|1
1501648|NCT00464269|4940801|P2|Overall Study|AE, serious fatal|0
1501649|NCT00464269|4940802|P1|Overall Study|AE, serious fatal|0
1501650|NCT00464269|4940799|P4|Overall Study|Other reason|1
1501651|NCT00464269|4940800|P3|Overall Study|Other reason|1
1501652|NCT00464269|4940801|P2|Overall Study|Other reason|3
1501653|NCT00464269|4940802|P1|Overall Study|Other reason|3
1501654|NCT00464269|4940799|P4|Overall Study|Withdrawal by Subject|1
1501655|NCT00464269|4940800|P3|Overall Study|Withdrawal by Subject|1
1501656|NCT00464269|4940801|P2|Overall Study|Withdrawal by Subject|2
1501657|NCT00464269|4940802|P1|Overall Study|Withdrawal by Subject|0
1501658|NCT00464269|4940799|P4|Overall Study|Lost to Follow-up|1
1501659|NCT00464269|4940800|P3|Overall Study|Lost to Follow-up|0
1501660|NCT00464269|4940801|P2|Overall Study|Lost to Follow-up|4
1501661|NCT00464269|4940802|P1|Overall Study|Lost to Follow-up|0
1501662|NCT00464269|4940799|P4|Overall Study|Lack of Efficacy|0
1501663|NCT00464269|4940800|P3|Overall Study|Lack of Efficacy|0
1501664|NCT00464269|4940801|P2|Overall Study|Lack of Efficacy|0
1501665|NCT00464269|4940802|P1|Overall Study|Lack of Efficacy|1
1501666|NCT00464087|4940940|P3|Overall Study|No PCI per inclusion criteria|29
1501667|NCT00464087|4940941|P2|Overall Study|No PCI per inclusion criteria|0
1501668|NCT00464087|4940942|P1|Overall Study|No PCI per inclusion criteria|0
1501669|NCT00463866|4940960|P2|Overall Study|Other|22
1501670|NCT00463866|4940961|P1|Overall Study|Other|22
1501671|NCT00463866|4940960|P2|Overall Study|Mis-Randomization of subject|1
1501672|NCT00463866|4940961|P1|Overall Study|Mis-Randomization of subject|0
1501673|NCT00463866|4940960|P2|Overall Study|Safety Reason|3
1501674|NCT00463866|4940961|P1|Overall Study|Safety Reason|1
1501675|NCT00463866|4940960|P2|Overall Study|Severe Non-Compliance to Protocol|21
1501676|NCT00463866|4940961|P1|Overall Study|Severe Non-Compliance to Protocol|25
1501677|NCT00463866|4940960|P2|Overall Study|Incorrect Enrolment|66
1501678|NCT00463866|4940961|P1|Overall Study|Incorrect Enrolment|64
1501679|NCT00463866|4940960|P2|Overall Study|Lost to Follow-up|55
1501680|NCT00463866|4940961|P1|Overall Study|Lost to Follow-up|46
1501681|NCT00463866|4940960|P2|Overall Study|Withdrawal by Subject|79
1501682|NCT00463866|4940961|P1|Overall Study|Withdrawal by Subject|81
1501683|NCT00463866|4940960|P2|Overall Study|Adverse Event|93
1501684|NCT00463866|4940961|P1|Overall Study|Adverse Event|70
1501685|NCT00463840|4940981|P1|Overall Study|Adverse Event|3
1501686|NCT00463840|4940981|P1|Overall Study|Withdrawal by Subject|2
1501687|NCT00463840|4940981|P1|Overall Study|Disease progression|7
1501688|NCT00463801|4940986|P1|Overall Study|No longer require therapy|1
1501689|NCT00463801|4940986|P1|Overall Study|Lost to Follow-up|5
1501690|NCT00463801|4940986|P1|Overall Study|Adverse Event|4
1501691|NCT00463801|4940986|P1|Overall Study|Lack of Efficacy|2
1501692|NCT00463801|4940986|P1|Overall Study|Protocol Violation|1
1501693|NCT00463788|4940992|P2|Overall Study|Randomized but not treated|1
1501694|NCT00463788|4940993|P1|Overall Study|Randomized but not treated|1
1501695|NCT00463788|4940992|P2|Overall Study|Other|0
1501696|NCT00463788|4940993|P1|Overall Study|Other|3
1501697|NCT00463788|4940992|P2|Overall Study|Protocol Violation|1
1501698|NCT00463788|4940993|P1|Overall Study|Protocol Violation|0
1501699|NCT00463788|4940992|P2|Overall Study|Lost to Follow-up|0
1501700|NCT00463788|4940993|P1|Overall Study|Lost to Follow-up|1
1501701|NCT00463788|4940992|P2|Overall Study|Symptomatic Deterioration|3
1501702|NCT00463788|4940993|P1|Overall Study|Symptomatic Deterioration|2
1501703|NCT00463788|4940992|P2|Overall Study|Death|3
1501704|NCT00463788|4940993|P1|Overall Study|Death|4
1501705|NCT00463788|4940992|P2|Overall Study|Withdrawal by Subject|2
1501706|NCT00463788|4940993|P1|Overall Study|Withdrawal by Subject|6
1501707|NCT00463788|4940992|P2|Overall Study|Adverse Event|2
1501708|NCT00463788|4940993|P1|Overall Study|Adverse Event|6
1501709|NCT00463788|4940992|P2|Overall Study|Progressive Disease|42
1501710|NCT00463788|4940993|P1|Overall Study|Progressive Disease|86
1501711|NCT00463606|4941011|P3|Overall Study|Protocol Violation|1
1501712|NCT00463606|4941012|P2|Overall Study|Protocol Violation|0
1501713|NCT00463606|4941013|P1|Overall Study|Protocol Violation|0
1501714|NCT00463606|4941011|P3|Overall Study|Participation in another ABT-335 trial|0
1501715|NCT00463606|4941012|P2|Overall Study|Participation in another ABT-335 trial|0
1501716|NCT00463606|4941013|P1|Overall Study|Participation in another ABT-335 trial|1
1501717|NCT00463606|4941011|P3|Overall Study|Patient randomized in error|0
1501718|NCT00463606|4941012|P2|Overall Study|Patient randomized in error|0
1501719|NCT00463606|4941013|P1|Overall Study|Patient randomized in error|1
1501720|NCT00463606|4941011|P3|Overall Study|Coordinator error|0
1501721|NCT00463606|4941012|P2|Overall Study|Coordinator error|0
1501722|NCT00463606|4941013|P1|Overall Study|Coordinator error|1
1501723|NCT00463606|4941011|P3|Overall Study|Exclusion criteria violation|0
1501724|NCT00463606|4941012|P2|Overall Study|Exclusion criteria violation|0
1501725|NCT00463606|4941013|P1|Overall Study|Exclusion criteria violation|2
1501726|NCT00463606|4941011|P3|Overall Study|Sponsor request|0
1501727|NCT00463606|4941012|P2|Overall Study|Sponsor request|1
1501728|NCT00463606|4941013|P1|Overall Study|Sponsor request|0
1501729|NCT00463606|4941011|P3|Overall Study|Physician Decision|0
1501730|NCT00463606|4941012|P2|Overall Study|Physician Decision|1
1501731|NCT00463606|4941013|P1|Overall Study|Physician Decision|0
1501732|NCT00463606|4941011|P3|Overall Study|Subject moved out of town|0
1501733|NCT00463606|4941012|P2|Overall Study|Subject moved out of town|0
1501734|NCT00463606|4941013|P1|Overall Study|Subject moved out of town|1
1501735|NCT00463606|4941011|P3|Overall Study|Subject noncompliance|0
1501736|NCT00463606|4941012|P2|Overall Study|Subject noncompliance|1
1501737|NCT00463606|4941013|P1|Overall Study|Subject noncompliance|1
1501738|NCT00463606|4941011|P3|Overall Study|Lost to Follow-up|3
1501739|NCT00463606|4941012|P2|Overall Study|Lost to Follow-up|2
1501740|NCT00463606|4941013|P1|Overall Study|Lost to Follow-up|2
1501741|NCT00463606|4941011|P3|Overall Study|Withdrawal by Subject|5
1501742|NCT00463606|4941012|P2|Overall Study|Withdrawal by Subject|11
1501743|NCT00463606|4941013|P1|Overall Study|Withdrawal by Subject|11
1501744|NCT00463606|4941011|P3|Overall Study|Adverse Event|11
1501745|NCT00463606|4941012|P2|Overall Study|Adverse Event|18
1501746|NCT00463606|4941013|P1|Overall Study|Adverse Event|21
1501747|NCT00463580|4941038|P2|Overall Study|Medical/psychiatric complications|2
1501748|NCT00463580|4941039|P1|Overall Study|Medical/psychiatric complications|0
1501749|NCT00463580|4941038|P2|Overall Study|schedule conflict|0
1501750|NCT00463580|4941039|P1|Overall Study|schedule conflict|2
1501751|NCT00463580|4941038|P2|Overall Study|Lost to Follow-up|0
1501752|NCT00463580|4941039|P1|Overall Study|Lost to Follow-up|1
1501753|NCT00463567|4941054|P7|Overall Study|Death|0
1501754|NCT00463567|4941055|P6|Overall Study|Death|0
1501755|NCT00463567|4941056|P5|Overall Study|Death|0
1501756|NCT00463567|4941057|P4|Overall Study|Death|0
1501757|NCT00463567|4941058|P3|Overall Study|Death|2
1501758|NCT00463567|4941059|P2|Overall Study|Death|0
1501759|NCT00463567|4941060|P1|Overall Study|Death|1
1501760|NCT00463567|4941054|P7|Overall Study|Abnormal test procedure result(s)|0
1501761|NCT00463567|4941055|P6|Overall Study|Abnormal test procedure result(s)|2
1501762|NCT00463567|4941056|P5|Overall Study|Abnormal test procedure result(s)|0
1501763|NCT00463567|4941057|P4|Overall Study|Abnormal test procedure result(s)|2
1501764|NCT00463567|4941058|P3|Overall Study|Abnormal test procedure result(s)|6
1501765|NCT00463567|4941059|P2|Overall Study|Abnormal test procedure result(s)|1
1501766|NCT00463567|4941060|P1|Overall Study|Abnormal test procedure result(s)|1
1501767|NCT00463567|4941054|P7|Overall Study|Abnormal lab value(s)|0
1501768|NCT00463567|4941055|P6|Overall Study|Abnormal lab value(s)|0
1501769|NCT00463567|4941056|P5|Overall Study|Abnormal lab value(s)|1
1501770|NCT00463567|4941057|P4|Overall Study|Abnormal lab value(s)|1
1501771|NCT00463567|4941058|P3|Overall Study|Abnormal lab value(s)|2
1501772|NCT00463567|4941059|P2|Overall Study|Abnormal lab value(s)|1
1501773|NCT00463567|4941060|P1|Overall Study|Abnormal lab value(s)|1
1501774|NCT00463567|4941054|P7|Overall Study|Lack of Efficacy|1
1501775|NCT00463567|4941055|P6|Overall Study|Lack of Efficacy|0
1501776|NCT00463567|4941056|P5|Overall Study|Lack of Efficacy|1
1501777|NCT00463567|4941057|P4|Overall Study|Lack of Efficacy|17
1501778|NCT00463567|4941058|P3|Overall Study|Lack of Efficacy|9
1501779|NCT00463567|4941059|P2|Overall Study|Lack of Efficacy|9
1501780|NCT00463567|4941060|P1|Overall Study|Lack of Efficacy|4
1501781|NCT00463567|4941054|P7|Overall Study|Administrative problems|2
1501782|NCT00463567|4941055|P6|Overall Study|Administrative problems|2
1501783|NCT00463567|4941056|P5|Overall Study|Administrative problems|3
1501784|NCT00463567|4941057|P4|Overall Study|Administrative problems|9
1501785|NCT00463567|4941058|P3|Overall Study|Administrative problems|6
1501786|NCT00463567|4941059|P2|Overall Study|Administrative problems|3
1501787|NCT00463567|4941060|P1|Overall Study|Administrative problems|5
1501788|NCT00463567|4941054|P7|Overall Study|Lost to Follow-up|1
1501789|NCT00463567|4941055|P6|Overall Study|Lost to Follow-up|1
1501790|NCT00463567|4941056|P5|Overall Study|Lost to Follow-up|1
1501791|NCT00463567|4941057|P4|Overall Study|Lost to Follow-up|8
1501792|NCT00463567|4941058|P3|Overall Study|Lost to Follow-up|13
1501793|NCT00463567|4941059|P2|Overall Study|Lost to Follow-up|6
1501794|NCT00463567|4941060|P1|Overall Study|Lost to Follow-up|12
1501795|NCT00463567|4941054|P7|Overall Study|Protocol Deviation|2
1501796|NCT00463567|4941055|P6|Overall Study|Protocol Deviation|1
1501797|NCT00463567|4941056|P5|Overall Study|Protocol Deviation|1
1501798|NCT00463567|4941057|P4|Overall Study|Protocol Deviation|11
1501799|NCT00463567|4941058|P3|Overall Study|Protocol Deviation|14
1501800|NCT00463567|4941059|P2|Overall Study|Protocol Deviation|9
1501801|NCT00463567|4941060|P1|Overall Study|Protocol Deviation|13
1501802|NCT00463567|4941054|P7|Overall Study|Withdrawal by Subject|1
1501803|NCT00463567|4941055|P6|Overall Study|Withdrawal by Subject|5
1501804|NCT00463567|4941056|P5|Overall Study|Withdrawal by Subject|6
1501805|NCT00463567|4941057|P4|Overall Study|Withdrawal by Subject|37
1501806|NCT00463567|4941058|P3|Overall Study|Withdrawal by Subject|20
1501807|NCT00463567|4941059|P2|Overall Study|Withdrawal by Subject|22
1501808|NCT00463567|4941060|P1|Overall Study|Withdrawal by Subject|29
1501809|NCT00463567|4941054|P7|Overall Study|Adverse Event|4
1501810|NCT00463567|4941055|P6|Overall Study|Adverse Event|10
1501811|NCT00463567|4941056|P5|Overall Study|Adverse Event|10
1501812|NCT00463567|4941057|P4|Overall Study|Adverse Event|46
1501813|NCT00463567|4941058|P3|Overall Study|Adverse Event|17
1501814|NCT00463567|4941059|P2|Overall Study|Adverse Event|26
1501815|NCT00463567|4941060|P1|Overall Study|Adverse Event|29
1501816|NCT00463385|4941164|P4|Overall Study|1 participant received commercial drug|0
1501817|NCT00463385|4941165|P3|Overall Study|1 participant received commercial drug|0
1501818|NCT00463385|4941166|P2|Overall Study|1 participant received commercial drug|1
1501819|NCT00463385|4941167|P1|Overall Study|1 participant received commercial drug|0
1501820|NCT00463385|4941164|P4|Overall Study|Missing|2
1501821|NCT00463385|4941165|P3|Overall Study|Missing|0
1501822|NCT00463385|4941166|P2|Overall Study|Missing|0
1501823|NCT00463385|4941167|P1|Overall Study|Missing|2
1501824|NCT00463385|4941164|P4|Overall Study|Death|0
1501825|NCT00463385|4941165|P3|Overall Study|Death|2
1501826|NCT00463385|4941166|P2|Overall Study|Death|1
1501827|NCT00463385|4941167|P1|Overall Study|Death|2
1501828|NCT00463385|4941164|P4|Overall Study|Lost to Follow-up|1
1501829|NCT00463385|4941165|P3|Overall Study|Lost to Follow-up|0
1501830|NCT00463385|4941166|P2|Overall Study|Lost to Follow-up|0
1501831|NCT00463385|4941167|P1|Overall Study|Lost to Follow-up|0
1501832|NCT00463385|4941164|P4|Overall Study|Withdrawal by Subject|4
1501833|NCT00463385|4941165|P3|Overall Study|Withdrawal by Subject|3
1501834|NCT00463385|4941166|P2|Overall Study|Withdrawal by Subject|3
1501835|NCT00463385|4941167|P1|Overall Study|Withdrawal by Subject|3
1501836|NCT00463385|4941164|P4|Overall Study|Lack of Efficacy|9
1501837|NCT00463385|4941165|P3|Overall Study|Lack of Efficacy|7
1501838|NCT00463385|4941166|P2|Overall Study|Lack of Efficacy|6
1501839|NCT00463385|4941167|P1|Overall Study|Lack of Efficacy|6
1501840|NCT00463385|4941164|P4|Overall Study|Adverse Event|2
1501841|NCT00463385|4941165|P3|Overall Study|Adverse Event|4
1501842|NCT00463385|4941166|P2|Overall Study|Adverse Event|8
1501843|NCT00463385|4941167|P1|Overall Study|Adverse Event|5
1501844|NCT00463385|4941164|P4|Overall Study|Other|4
1501845|NCT00463385|4941165|P3|Overall Study|Other|6
1501846|NCT00463385|4941166|P2|Overall Study|Other|3
1501847|NCT00463385|4941167|P1|Overall Study|Other|4
1501848|NCT00463346|4941219|P2|Overall Study|Withdrawal by Subject|3
1501849|NCT00463346|4941220|P1|Overall Study|Withdrawal by Subject|3
1501850|NCT00463229|4941230|P2|Overall Study|Death|3
1501851|NCT00463229|4941231|P1|Overall Study|Death|4
1501852|NCT00463229|4941230|P2|Overall Study|Lost to Follow-up|7
1501853|NCT00463229|4941231|P1|Overall Study|Lost to Follow-up|5
1501854|NCT00463060|4941239|P1|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
1501855|NCT00463060|4941239|P1|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
1501856|NCT00463047|4941253|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
1501857|NCT00463047|4941254|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
1501858|NCT00463047|4941253|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
1501859|NCT00463047|4941254|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
1501860|NCT00463047|4941253|P2|Double-Blind Treatment Period 2|Adverse Event|1
1501861|NCT00463047|4941254|P1|Double-Blind Treatment Period 2|Adverse Event|0
1501862|NCT00463047|4941253|P2|Double-Blind Treatment Period 1|Not specified|0
1501863|NCT00463047|4941254|P1|Double-Blind Treatment Period 1|Not specified|1
1501864|NCT00463047|4941253|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
1501865|NCT00463047|4941254|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
1501866|NCT00463047|4941253|P2|Double-Blind Treatment Period 1|Protocol Violation|2
1501867|NCT00463047|4941254|P1|Double-Blind Treatment Period 1|Protocol Violation|1
1501868|NCT00463047|4941253|P2|Double-Blind Treatment Period 1|Adverse Event|2
1501869|NCT00463047|4941254|P1|Double-Blind Treatment Period 1|Adverse Event|0
1501870|NCT00463047|4941253|P2|Titration Period 2|Not specified|2
1501871|NCT00463047|4941254|P1|Titration Period 2|Not specified|3
1501872|NCT00463047|4941253|P2|Titration Period 2|Non-compliance procedures|1
1501873|NCT00463047|4941254|P1|Titration Period 2|Non-compliance procedures|4
1501874|NCT00463047|4941253|P2|Titration Period 2|Non-compliance study medication|2
1501875|NCT00463047|4941254|P1|Titration Period 2|Non-compliance study medication|4
1501876|NCT00463047|4941253|P2|Titration Period 2|Lost to Follow-up|2
1501877|NCT00463047|4941254|P1|Titration Period 2|Lost to Follow-up|1
1501878|NCT00463047|4941253|P2|Titration Period 2|Protocol Violation|3
1501879|NCT00463047|4941254|P1|Titration Period 2|Protocol Violation|2
1501880|NCT00463047|4941253|P2|Titration Period 2|Withdrawal by Subject|0
1501881|NCT00463047|4941254|P1|Titration Period 2|Withdrawal by Subject|1
1501882|NCT00463047|4941253|P2|Titration Period 2|Lack of Efficacy|4
1501883|NCT00463047|4941254|P1|Titration Period 2|Lack of Efficacy|6
1501884|NCT00463047|4941253|P2|Titration Period 2|Adverse Event|9
1501885|NCT00463047|4941254|P1|Titration Period 2|Adverse Event|9
1501886|NCT00463047|4941253|P2|Titration Period 1|Not specified|2
1501887|NCT00463047|4941254|P1|Titration Period 1|Not specified|0
1501888|NCT00463047|4941253|P2|Titration Period 1|Non-compliance procedures|10
1501889|NCT00463047|4941254|P1|Titration Period 1|Non-compliance procedures|4
1501890|NCT00463047|4941253|P2|Titration Period 1|Withdrawal by Subject|5
1501891|NCT00463047|4941254|P1|Titration Period 1|Withdrawal by Subject|3
1501892|NCT00463047|4941253|P2|Titration Period 1|Protocol Violation|5
1501893|NCT00463047|4941254|P1|Titration Period 1|Protocol Violation|5
1501894|NCT00463047|4941253|P2|Titration Period 1|Non-compliance with study medication|5
1501895|NCT00463047|4941254|P1|Titration Period 1|Non-compliance with study medication|3
1501896|NCT00463047|4941253|P2|Titration Period 1|Lost to Follow-up|0
1501897|NCT00463047|4941254|P1|Titration Period 1|Lost to Follow-up|2
1501898|NCT00463047|4941253|P2|Titration Period 1|Lack of Efficacy|4
1501899|NCT00463047|4941254|P1|Titration Period 1|Lack of Efficacy|10
1501900|NCT00463047|4941253|P2|Titration Period 1|Adverse Event|8
1501901|NCT00463047|4941254|P1|Titration Period 1|Adverse Event|10
1501902|NCT00462982|4941339|P1|Overall Study|Patient Not Treated|2
1501903|NCT00462982|4941339|P1|Overall Study|Adverse Event|1
1501904|NCT00462943|4941346|P3|Overall Study|Withdrawal by Subject|0
1501905|NCT00462943|4941347|P2|Overall Study|Withdrawal by Subject|1
1501906|NCT00462943|4941348|P1|Overall Study|Withdrawal by Subject|0
1501907|NCT00462943|4941346|P3|Overall Study|Physician Decision|0
1501908|NCT00462943|4941347|P2|Overall Study|Physician Decision|0
1501909|NCT00462943|4941348|P1|Overall Study|Physician Decision|1
1501910|NCT00462943|4941346|P3|Overall Study|Transplant - not specified|1
1501911|NCT00462943|4941347|P2|Overall Study|Transplant - not specified|0
1501912|NCT00462943|4941348|P1|Overall Study|Transplant - not specified|1
1501913|NCT00462943|4941346|P3|Overall Study|Required Lymphocyte Infusion|0
1501914|NCT00462943|4941347|P2|Overall Study|Required Lymphocyte Infusion|0
1501915|NCT00462943|4941348|P1|Overall Study|Required Lymphocyte Infusion|1
1501916|NCT00462943|4941346|P3|Overall Study|Bone Marrow Transplant|0
1501917|NCT00462943|4941347|P2|Overall Study|Bone Marrow Transplant|0
1501918|NCT00462943|4941348|P1|Overall Study|Bone Marrow Transplant|1
1501919|NCT00462943|4941346|P3|Overall Study|Stem Cell Transplant|0
1501920|NCT00462943|4941347|P2|Overall Study|Stem Cell Transplant|1
1501921|NCT00462943|4941348|P1|Overall Study|Stem Cell Transplant|1
1501922|NCT00462943|4941346|P3|Overall Study|Death|7
1501923|NCT00462943|4941347|P2|Overall Study|Death|2
1501924|NCT00462943|4941348|P1|Overall Study|Death|5
1501925|NCT00462943|4941346|P3|Overall Study|Disease Progression|9
1501926|NCT00462943|4941347|P2|Overall Study|Disease Progression|15
1501927|NCT00462943|4941348|P1|Overall Study|Disease Progression|15
1501928|NCT00462943|4941346|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
1501929|NCT00462943|4941347|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
1501930|NCT00462943|4941348|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
1501931|NCT00462943|4941346|P3|Overall Study|Protocol Violation|0
1501932|NCT00462943|4941347|P2|Overall Study|Protocol Violation|0
1501933|NCT00462943|4941348|P1|Overall Study|Protocol Violation|1
1501934|NCT00462943|4941346|P3|Overall Study|Adverse Event|1
1501935|NCT00462943|4941347|P2|Overall Study|Adverse Event|4
1501936|NCT00462943|4941348|P1|Overall Study|Adverse Event|6
1501937|NCT00462943|4941346|P3|Overall Study|Failure to achieve a response|1
1501938|NCT00462943|4941347|P2|Overall Study|Failure to achieve a response|5
1501939|NCT00462943|4941348|P1|Overall Study|Failure to achieve a response|5
1501940|NCT00462865|4941440|P1|Overall Study|Adverse Event|1
1501941|NCT00462826|4941459|P1|Overall Study|Never treated|1
1501942|NCT00462826|4941459|P1|Overall Study|Ineligible - wrong primary|2
1501943|NCT00462826|4941459|P1|Overall Study|Ineligible - wrong cell type|1
1501944|NCT00462826|4941459|P1|Overall Study|Ineligible - second primary|1
1501945|NCT00462748|4941475|P3|Overall Study|Discontinued after 41 days Rx|0
1501946|NCT00462748|4941476|P2|Overall Study|Discontinued after 41 days Rx|0
1501947|NCT00462748|4941477|P1|Overall Study|Discontinued after 41 days Rx|1
1501948|NCT00462748|4941475|P3|Overall Study|Lost to Follow-up|1
1501949|NCT00462748|4941476|P2|Overall Study|Lost to Follow-up|1
1501950|NCT00462748|4941477|P1|Overall Study|Lost to Follow-up|1
1501951|NCT00462748|4941475|P3|Overall Study|Withdrew consent|0
1501952|NCT00462748|4941476|P2|Overall Study|Withdrew consent|3
1501953|NCT00462748|4941477|P1|Overall Study|Withdrew consent|3
1501954|NCT00462748|4941475|P3|Overall Study|Protocol Violation|1
1501955|NCT00462748|4941476|P2|Overall Study|Protocol Violation|2
1501956|NCT00462748|4941477|P1|Overall Study|Protocol Violation|0
1501957|NCT00462748|4941475|P3|Overall Study|Adverse Event|9
1501958|NCT00462748|4941476|P2|Overall Study|Adverse Event|5
1501959|NCT00462748|4941477|P1|Overall Study|Adverse Event|7
1501960|NCT00462709|4941530|P1|Overall Study|Withdrew to start treatment with Cetor|1
1501961|NCT00462709|4941530|P1|Overall Study|Physician Decision|1
1501962|NCT00462709|4941530|P1|Overall Study|Logistical reasons|2
1501963|NCT00462709|4941530|P1|Overall Study|Death|2
1501964|NCT00462709|4941530|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
1501965|NCT00462709|4941530|P1|Overall Study|Withdrawal by Subject|8
1501966|NCT00462709|4941530|P1|Overall Study|Lost to Follow-up|10
1501967|NCT00462709|4941530|P1|Overall Study|Transitioned to commercial C1INH-nf|40
1501968|NCT00462670|4941539|P2|Overall Study|Resolution of signs and symptoms|2
1501969|NCT00462670|4941540|P1|Overall Study|Resolution of signs and symptoms|0
1501970|NCT00462670|4941539|P2|Overall Study|Protocol Violation|0
1501971|NCT00462670|4941540|P1|Overall Study|Protocol Violation|1
1501972|NCT00462670|4941539|P2|Overall Study|Lack of Efficacy|0
1501973|NCT00462670|4941540|P1|Overall Study|Lack of Efficacy|1
1501974|NCT00462670|4941539|P2|Overall Study|Adverse Event|5
1501975|NCT00462670|4941540|P1|Overall Study|Adverse Event|3
1501976|NCT00462501|4941577|P1|Overall Study|Adverse Event|2
1501977|NCT00462501|4941577|P1|Overall Study|Not treated|3
1501978|NCT00462462|4941583|P2|Overall Study|Physician Decision|1
1501979|NCT00462462|4941584|P1|Overall Study|Physician Decision|0
1501980|NCT00462384|4941612|P1|Overall Study|Other|4
1501981|NCT00462384|4941612|P1|Overall Study|Withdrawal by Subject|1
1501982|NCT00462384|4941612|P1|Overall Study|Death|2
1501983|NCT00462384|4941612|P1|Overall Study|Adverse Event|2
1501984|NCT00462345|4941620|P1|Overall Study|Did not complete second course|1
1501985|NCT00462345|4941620|P1|Overall Study|Withdrawal by Subject|2
1501986|NCT00462306|4941655|P2|Overall Study|insufficient data|13
1501987|NCT00462306|4941656|P1|Overall Study|insufficient data|0
1501988|NCT00461981|4941782|P2|Overall Study|Withdrawal by Subject|3
1501989|NCT00461981|4941783|P1|Overall Study|Withdrawal by Subject|2
1501990|NCT00461981|4941782|P2|Overall Study|Lost to Follow-up|6
1501991|NCT00461981|4941783|P1|Overall Study|Lost to Follow-up|9
1501992|NCT00461812|4941899|P1|Overall Study|study terminated|10
1501993|NCT00461786|4941904|P1|Overall Study|Inevaluable (Never Treated)|1
1501994|NCT00461786|4941904|P1|Overall Study|Entry Criteria Not Met|2
1501995|NCT00461708|4941949|P2|Overall Study|Death|1
1501996|NCT00461708|4941950|P1|Overall Study|Death|8
1501997|NCT00461708|4941949|P2|Overall Study|Not specified|4
1501998|NCT00461708|4941950|P1|Overall Study|Not specified|4
1501999|NCT00461708|4941949|P2|Overall Study|Withdrawal by Subject|2
1502000|NCT00461708|4941950|P1|Overall Study|Withdrawal by Subject|8
1502001|NCT00461708|4941949|P2|Overall Study|Physician Decision|4
1502002|NCT00461708|4941950|P1|Overall Study|Physician Decision|10
1502003|NCT00461708|4941949|P2|Overall Study|Lack of Efficacy|20
1502004|NCT00461708|4941950|P1|Overall Study|Lack of Efficacy|68
1502005|NCT00461708|4941949|P2|Overall Study|Adverse Event|7
1502006|NCT00461708|4941950|P1|Overall Study|Adverse Event|17
1502007|NCT00461682|4941976|P1|Overall Study|Protocol Violation|1
1502008|NCT00461630|4942004|P2|Overall Study|Lost to Follow-up|95
1502009|NCT00461630|4942005|P1|Overall Study|Lost to Follow-up|108
1502010|NCT00461630|4942004|P2|Overall Study|Death|732
1502011|NCT00461630|4942005|P1|Overall Study|Death|798
1502012|NCT00461500|4942057|P2|Overall Study|Lost to Follow-up|2
1502013|NCT00461500|4942058|P1|Overall Study|Lost to Follow-up|2
1502014|NCT00461500|4942057|P2|Overall Study|No Longer Willing to Take Part in Study|0
1502015|NCT00461500|4942058|P1|Overall Study|No Longer Willing to Take Part in Study|1
1502016|NCT00461500|4942057|P2|Overall Study|Drug Treatment Misuse|0
1502017|NCT00461500|4942058|P1|Overall Study|Drug Treatment Misuse|1
1502018|NCT00461500|4942057|P2|Overall Study|Study Stopped|2
1502019|NCT00461500|4942058|P1|Overall Study|Study Stopped|1
1502020|NCT00461500|4942057|P2|Overall Study|Expired Drug Treatment|1
1502021|NCT00461500|4942058|P1|Overall Study|Expired Drug Treatment|1
1502022|NCT00461500|4942057|P2|Overall Study|Lack of Efficacy|1
1502023|NCT00461500|4942058|P1|Overall Study|Lack of Efficacy|0
1502024|NCT00461500|4942057|P2|Overall Study|Adverse Event|0
1502025|NCT00461500|4942058|P1|Overall Study|Adverse Event|1
1502026|NCT00461305|4942101|P2|Continued Treatment|Other (missing drug etc)|0
1502027|NCT00461305|4942102|P1|Continued Treatment|Other (missing drug etc)|2
1502028|NCT00461305|4942101|P2|Continued Treatment|Partially missing diary|0
1502029|NCT00461305|4942102|P1|Continued Treatment|Partially missing diary|2
1502030|NCT00461305|4942101|P2|Continued Treatment|Withdrawal by Subject|0
1502031|NCT00461305|4942102|P1|Continued Treatment|Withdrawal by Subject|48
1502032|NCT00461305|4942101|P2|Continued Treatment|Protocol Violation|0
1502033|NCT00461305|4942102|P1|Continued Treatment|Protocol Violation|13
1502034|NCT00461305|4942101|P2|Continued Treatment|Lost to Follow-up|0
1502035|NCT00461305|4942102|P1|Continued Treatment|Lost to Follow-up|4
1502036|NCT00461305|4942101|P2|Continued Treatment|Adverse Event|0
1502037|NCT00461305|4942102|P1|Continued Treatment|Adverse Event|26
1502038|NCT00461305|4942101|P2|Treatment|Other (missing drug etc)|0
1502039|NCT00461305|4942102|P1|Treatment|Other (missing drug etc)|2
1502040|NCT00461305|4942101|P2|Treatment|Partially missing diary|0
1502041|NCT00461305|4942102|P1|Treatment|Partially missing diary|2
1502042|NCT00461305|4942101|P2|Treatment|Study drug not taken|0
1502043|NCT00461305|4942102|P1|Treatment|Study drug not taken|1
1502044|NCT00461305|4942101|P2|Treatment|Never dispensed|0
1502045|NCT00461305|4942102|P1|Treatment|Never dispensed|5
1502046|NCT00461305|4942101|P2|Treatment|Withdrawal by Subject|2
1502047|NCT00461305|4942102|P1|Treatment|Withdrawal by Subject|48
1502048|NCT00461305|4942101|P2|Treatment|Protocol Violation|2
1502049|NCT00461305|4942102|P1|Treatment|Protocol Violation|13
1502050|NCT00461305|4942101|P2|Treatment|Lost to Follow-up|2
1502051|NCT00461305|4942102|P1|Treatment|Lost to Follow-up|4
1502052|NCT00461305|4942101|P2|Treatment|Adverse Event|3
1502053|NCT00461305|4942102|P1|Treatment|Adverse Event|26
1502054|NCT00461253|4942186|P2|Overall Study|administrative|7773
1502055|NCT00461253|4942187|P1|Overall Study|administrative|773
1502056|NCT00461253|4942186|P2|Overall Study|no response|11789
1502057|NCT00461253|4942187|P1|Overall Study|no response|2609
1502058|NCT00461253|4942186|P2|Overall Study|Protocol Violation|236
1502059|NCT00461253|4942187|P1|Overall Study|Protocol Violation|613
1502060|NCT00461253|4942186|P2|Overall Study|Death|0
1502061|NCT00461253|4942187|P1|Overall Study|Death|985
1502062|NCT00461175|4942195|P2|Overall Study|Protocol Violation|365
1502063|NCT00461175|4942196|P1|Overall Study|Protocol Violation|522
1502064|NCT00461123|4942206|P2|Overall Study|Withdrawal by Subject|3
1502065|NCT00461123|4942207|P1|Overall Study|Withdrawal by Subject|1
1502066|NCT00461123|4942206|P2|Overall Study|Protocol Violation|2
1502067|NCT00461123|4942207|P1|Overall Study|Protocol Violation|3
1502068|NCT00461123|4942206|P2|Overall Study|Lost to Follow-up|1
1502069|NCT00461123|4942207|P1|Overall Study|Lost to Follow-up|1
1502070|NCT00461123|4942206|P2|Overall Study|Adverse Event|0
1502071|NCT00461123|4942207|P1|Overall Study|Adverse Event|1
1502072|NCT00461032|4942252|P2|Overall Study|Not Specified|5
1502073|NCT00461032|4942253|P1|Overall Study|Not Specified|7
1502074|NCT00461032|4942252|P2|Overall Study|Patient Moved or Relocated|1
1502075|NCT00461032|4942253|P1|Overall Study|Patient Moved or Relocated|2
1502076|NCT00461032|4942252|P2|Overall Study|Withdrawal by Subject|15
1502077|NCT00461032|4942253|P1|Overall Study|Withdrawal by Subject|7
1502078|NCT00461032|4942252|P2|Overall Study|Protocol Violation|4
1502079|NCT00461032|4942253|P1|Overall Study|Protocol Violation|4
1502080|NCT00461032|4942252|P2|Overall Study|Lost to Follow-up|12
1502081|NCT00461032|4942253|P1|Overall Study|Lost to Follow-up|7
1502082|NCT00461032|4942252|P2|Overall Study|Lack of Efficacy|1
1502083|NCT00461032|4942253|P1|Overall Study|Lack of Efficacy|5
1502084|NCT00461032|4942252|P2|Overall Study|Adverse Event|6
1502085|NCT00461032|4942253|P1|Overall Study|Adverse Event|5
1502086|NCT00460811|4942279|P5|Overall Study|Lost to Follow-up|6
1502087|NCT00460811|4942280|P4|Overall Study|Lost to Follow-up|3
1502088|NCT00460811|4942281|P3|Overall Study|Lost to Follow-up|5
1502089|NCT00460811|4942282|P2|Overall Study|Lost to Follow-up|2
1502090|NCT00460811|4942283|P1|Overall Study|Lost to Follow-up|3
1502091|NCT00460811|4942279|P5|Overall Study|Physician Decision|0
1502092|NCT00460811|4942280|P4|Overall Study|Physician Decision|0
1502093|NCT00460811|4942281|P3|Overall Study|Physician Decision|0
1502094|NCT00460811|4942282|P2|Overall Study|Physician Decision|0
1502095|NCT00460811|4942283|P1|Overall Study|Physician Decision|1
1502096|NCT00460811|4942279|P5|Overall Study|Withdrawal by Subject|11
1502097|NCT00460811|4942280|P4|Overall Study|Withdrawal by Subject|3
1502098|NCT00460811|4942281|P3|Overall Study|Withdrawal by Subject|6
1502099|NCT00460811|4942282|P2|Overall Study|Withdrawal by Subject|7
1502100|NCT00460811|4942283|P1|Overall Study|Withdrawal by Subject|7
1502101|NCT00460811|4942279|P5|Overall Study|Noncompliance|1
1502102|NCT00460811|4942280|P4|Overall Study|Noncompliance|2
1502103|NCT00460811|4942281|P3|Overall Study|Noncompliance|0
1502104|NCT00460811|4942282|P2|Overall Study|Noncompliance|0
1502105|NCT00460811|4942283|P1|Overall Study|Noncompliance|1
1502106|NCT00460811|4942279|P5|Overall Study|Adverse Event|2
1502107|NCT00460811|4942280|P4|Overall Study|Adverse Event|10
1502108|NCT00460811|4942281|P3|Overall Study|Adverse Event|3
1502109|NCT00460811|4942282|P2|Overall Study|Adverse Event|6
1502110|NCT00460811|4942283|P1|Overall Study|Adverse Event|4
1502111|NCT00460798|4942325|P1|Overall Study|Missing/Incomplete Dosing Information|27
1502112|NCT00460798|4942325|P1|Overall Study|Ongoing at Date of Cut-Off|82
1502113|NCT00460798|4942325|P1|Overall Study|Other|27
1502114|NCT00460798|4942325|P1|Overall Study|Progressive Disease|99
1502115|NCT00460798|4942325|P1|Overall Study|Lost to Follow-up|19
1502116|NCT00460798|4942325|P1|Overall Study|Adverse Event|27
1502117|NCT00460798|4942325|P1|Overall Study|Death|59
1502118|NCT00460746|4942333|P1|Overall Study|Lost to Follow-up|1
1502119|NCT00460746|4942333|P1|Overall Study|Adverse Event|1
1502120|NCT00460655|4942348|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
1502121|NCT00460655|4942349|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
1502122|NCT00460655|4942350|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
1502123|NCT00460655|4942351|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
1502124|NCT00460655|4942348|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
1502125|NCT00460655|4942349|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
1502126|NCT00460655|4942350|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1502127|NCT00460655|4942351|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1502128|NCT00460655|4942348|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
1502129|NCT00460655|4942349|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
1502130|NCT00460655|4942350|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
1502131|NCT00460655|4942351|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
1502132|NCT00460655|4942348|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
1502133|NCT00460655|4942349|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
1502134|NCT00460655|4942350|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
1502135|NCT00460655|4942351|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
1502136|NCT00460655|4942348|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1502137|NCT00460655|4942349|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1502138|NCT00460655|4942350|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1502139|NCT00460655|4942351|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
1502140|NCT00460655|4942348|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
1502141|NCT00460655|4942349|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
1502142|NCT00460655|4942350|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
1502143|NCT00460655|4942351|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
1502144|NCT00460603|4942395|P12|Phase 2|Randomized, but not treated|0
1502145|NCT00460603|4942396|P11|Phase 2|Randomized, but not treated|0
1502146|NCT00460603|4942397|P10|Phase 2|Randomized, but not treated|3
1502147|NCT00460603|4942398|P9|Phase 2|Randomized, but not treated|0
1502148|NCT00460603|4942399|P8|Phase 2|Randomized, but not treated|0
1502149|NCT00460603|4942400|P7|Phase 2|Randomized, but not treated|0
1502150|NCT00460603|4942401|P6|Phase 2|Randomized, but not treated|0
1502151|NCT00460603|4942402|P5|Phase 2|Randomized, but not treated|0
1502152|NCT00460603|4942403|P4|Phase 2|Randomized, but not treated|0
1502153|NCT00460603|4942404|P3|Phase 2|Randomized, but not treated|0
1502154|NCT00460603|4942405|P2|Phase 2|Randomized, but not treated|0
1502155|NCT00460603|4942406|P1|Phase 2|Randomized, but not treated|0
1502156|NCT00460603|4942395|P12|Phase 2|Withdrawal by Subject|5
1502157|NCT00460603|4942396|P11|Phase 2|Withdrawal by Subject|4
1502158|NCT00460603|4942397|P10|Phase 2|Withdrawal by Subject|5
1502159|NCT00460603|4942398|P9|Phase 2|Withdrawal by Subject|0
1502160|NCT00460603|4942399|P8|Phase 2|Withdrawal by Subject|0
1502161|NCT00460603|4942400|P7|Phase 2|Withdrawal by Subject|0
1502162|NCT00460603|4942401|P6|Phase 2|Withdrawal by Subject|0
1502163|NCT00460603|4942402|P5|Phase 2|Withdrawal by Subject|0
1502164|NCT00460603|4942403|P4|Phase 2|Withdrawal by Subject|0
1502165|NCT00460603|4942404|P3|Phase 2|Withdrawal by Subject|0
1502166|NCT00460603|4942405|P2|Phase 2|Withdrawal by Subject|0
1502167|NCT00460603|4942406|P1|Phase 2|Withdrawal by Subject|0
1502168|NCT00460603|4942395|P12|Phase 2|Global Deterioration of Health Status|0
1502169|NCT00460603|4942396|P11|Phase 2|Global Deterioration of Health Status|1
1502170|NCT00460603|4942397|P10|Phase 2|Global Deterioration of Health Status|0
1502171|NCT00460603|4942398|P9|Phase 2|Global Deterioration of Health Status|0
1502172|NCT00460603|4942399|P8|Phase 2|Global Deterioration of Health Status|0
1502173|NCT00460603|4942400|P7|Phase 2|Global Deterioration of Health Status|0
1502174|NCT00460603|4942401|P6|Phase 2|Global Deterioration of Health Status|0
1502175|NCT00460603|4942402|P5|Phase 2|Global Deterioration of Health Status|0
1502176|NCT00460603|4942403|P4|Phase 2|Global Deterioration of Health Status|0
1502177|NCT00460603|4942404|P3|Phase 2|Global Deterioration of Health Status|0
1502178|NCT00460603|4942405|P2|Phase 2|Global Deterioration of Health Status|0
1502179|NCT00460603|4942406|P1|Phase 2|Global Deterioration of Health Status|0
1502180|NCT00460603|4942395|P12|Phase 2|Objective Progression or Relapse|17
1502181|NCT00460603|4942396|P11|Phase 2|Objective Progression or Relapse|10
1502182|NCT00460603|4942397|P10|Phase 2|Objective Progression or Relapse|9
1502183|NCT00460603|4942398|P9|Phase 2|Objective Progression or Relapse|0
1502184|NCT00460603|4942399|P8|Phase 2|Objective Progression or Relapse|0
1502185|NCT00460603|4942400|P7|Phase 2|Objective Progression or Relapse|0
1502186|NCT00460603|4942401|P6|Phase 2|Objective Progression or Relapse|0
1502187|NCT00460603|4942402|P5|Phase 2|Objective Progression or Relapse|0
1502188|NCT00460603|4942403|P4|Phase 2|Objective Progression or Relapse|0
1502189|NCT00460603|4942404|P3|Phase 2|Objective Progression or Relapse|0
1502190|NCT00460603|4942405|P2|Phase 2|Objective Progression or Relapse|0
1502191|NCT00460603|4942406|P1|Phase 2|Objective Progression or Relapse|0
1502192|NCT00460603|4942395|P12|Phase 2|Other|7
1502193|NCT00460603|4942396|P11|Phase 2|Other|16
1502194|NCT00460603|4942397|P10|Phase 2|Other|6
1502195|NCT00460603|4942398|P9|Phase 2|Other|0
1502196|NCT00460603|4942399|P8|Phase 2|Other|0
1502197|NCT00460603|4942400|P7|Phase 2|Other|0
1502198|NCT00460603|4942401|P6|Phase 2|Other|0
1502199|NCT00460603|4942402|P5|Phase 2|Other|0
1502200|NCT00460603|4942403|P4|Phase 2|Other|0
1502201|NCT00460603|4942404|P3|Phase 2|Other|0
1502202|NCT00460603|4942405|P2|Phase 2|Other|0
1502203|NCT00460603|4942406|P1|Phase 2|Other|0
1502204|NCT00460603|4942395|P12|Phase 2|Lost to Follow-up|0
1502205|NCT00460603|4942396|P11|Phase 2|Lost to Follow-up|0
1502206|NCT00460603|4942397|P10|Phase 2|Lost to Follow-up|1
1502207|NCT00460603|4942398|P9|Phase 2|Lost to Follow-up|0
1502208|NCT00460603|4942399|P8|Phase 2|Lost to Follow-up|0
1502209|NCT00460603|4942400|P7|Phase 2|Lost to Follow-up|0
1502210|NCT00460603|4942401|P6|Phase 2|Lost to Follow-up|0
1502211|NCT00460603|4942402|P5|Phase 2|Lost to Follow-up|0
1502212|NCT00460603|4942403|P4|Phase 2|Lost to Follow-up|0
1502213|NCT00460603|4942404|P3|Phase 2|Lost to Follow-up|0
1502214|NCT00460603|4942405|P2|Phase 2|Lost to Follow-up|0
1502215|NCT00460603|4942406|P1|Phase 2|Lost to Follow-up|0
1502216|NCT00460603|4942395|P12|Phase 2|Protocol Violation|0
1502217|NCT00460603|4942396|P11|Phase 2|Protocol Violation|1
1502218|NCT00460603|4942397|P10|Phase 2|Protocol Violation|1
1502219|NCT00460603|4942398|P9|Phase 2|Protocol Violation|0
1502220|NCT00460603|4942399|P8|Phase 2|Protocol Violation|0
1502221|NCT00460603|4942400|P7|Phase 2|Protocol Violation|0
1502222|NCT00460603|4942401|P6|Phase 2|Protocol Violation|0
1502223|NCT00460603|4942402|P5|Phase 2|Protocol Violation|0
1502224|NCT00460603|4942403|P4|Phase 2|Protocol Violation|0
1502225|NCT00460603|4942404|P3|Phase 2|Protocol Violation|0
1502226|NCT00460603|4942405|P2|Phase 2|Protocol Violation|0
1502227|NCT00460603|4942406|P1|Phase 2|Protocol Violation|0
1502228|NCT00460603|4942395|P12|Phase 2|Death|2
1502229|NCT00460603|4942396|P11|Phase 2|Death|2
1502230|NCT00460603|4942397|P10|Phase 2|Death|4
1502231|NCT00460603|4942398|P9|Phase 2|Death|0
1502232|NCT00460603|4942399|P8|Phase 2|Death|0
1502233|NCT00460603|4942400|P7|Phase 2|Death|0
1502234|NCT00460603|4942401|P6|Phase 2|Death|0
1502235|NCT00460603|4942402|P5|Phase 2|Death|0
1502236|NCT00460603|4942403|P4|Phase 2|Death|0
1502237|NCT00460603|4942404|P3|Phase 2|Death|0
1502238|NCT00460603|4942405|P2|Phase 2|Death|0
1502239|NCT00460603|4942406|P1|Phase 2|Death|0
1502240|NCT00460603|4942395|P12|Phase 2|Adverse Event|10
1502241|NCT00460603|4942396|P11|Phase 2|Adverse Event|9
1502242|NCT00460603|4942397|P10|Phase 2|Adverse Event|12
1502243|NCT00460603|4942398|P9|Phase 2|Adverse Event|0
1502244|NCT00460603|4942399|P8|Phase 2|Adverse Event|0
1502245|NCT00460603|4942400|P7|Phase 2|Adverse Event|0
1502246|NCT00460603|4942401|P6|Phase 2|Adverse Event|0
1502247|NCT00460603|4942402|P5|Phase 2|Adverse Event|0
1502248|NCT00460603|4942403|P4|Phase 2|Adverse Event|0
1502249|NCT00460603|4942404|P3|Phase 2|Adverse Event|0
1502250|NCT00460603|4942405|P2|Phase 2|Adverse Event|0
1502251|NCT00460603|4942406|P1|Phase 2|Adverse Event|0
1502252|NCT00460603|4942395|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1502253|NCT00460603|4942396|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1502254|NCT00460603|4942397|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
1502255|NCT00460603|4942398|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1502256|NCT00460603|4942399|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1502257|NCT00460603|4942400|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1502258|NCT00460603|4942401|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1502259|NCT00460603|4942402|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1502260|NCT00460603|4942403|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1502261|NCT00460603|4942404|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1502262|NCT00460603|4942405|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1502263|NCT00460603|4942406|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1502264|NCT00460603|4942395|P12|Phase 1|Other|0
1502265|NCT00460603|4942396|P11|Phase 1|Other|0
1502266|NCT00460603|4942397|P10|Phase 1|Other|0
1502267|NCT00460603|4942398|P9|Phase 1|Other|0
1502268|NCT00460603|4942399|P8|Phase 1|Other|1
1502269|NCT00460603|4942400|P7|Phase 1|Other|0
1502270|NCT00460603|4942401|P6|Phase 1|Other|2
1502271|NCT00460603|4942402|P5|Phase 1|Other|1
1502272|NCT00460603|4942403|P4|Phase 1|Other|1
1502273|NCT00460603|4942404|P3|Phase 1|Other|1
1502274|NCT00460603|4942405|P2|Phase 1|Other|3
1502275|NCT00460603|4942406|P1|Phase 1|Other|0
1502276|NCT00460603|4942395|P12|Phase 1|Withdrawal by Subject|0
1502277|NCT00460603|4942396|P11|Phase 1|Withdrawal by Subject|0
1502278|NCT00460603|4942397|P10|Phase 1|Withdrawal by Subject|0
1502279|NCT00460603|4942398|P9|Phase 1|Withdrawal by Subject|2
1502280|NCT00460603|4942399|P8|Phase 1|Withdrawal by Subject|0
1502281|NCT00460603|4942400|P7|Phase 1|Withdrawal by Subject|1
1502282|NCT00460603|4942401|P6|Phase 1|Withdrawal by Subject|0
1502283|NCT00460603|4942402|P5|Phase 1|Withdrawal by Subject|3
1502284|NCT00460603|4942403|P4|Phase 1|Withdrawal by Subject|1
1502285|NCT00460603|4942404|P3|Phase 1|Withdrawal by Subject|1
1502286|NCT00460603|4942405|P2|Phase 1|Withdrawal by Subject|2
1502287|NCT00460603|4942406|P1|Phase 1|Withdrawal by Subject|1
1502288|NCT00460603|4942395|P12|Phase 1|Lack of Efficacy|0
1502289|NCT00460603|4942396|P11|Phase 1|Lack of Efficacy|0
1502290|NCT00460603|4942397|P10|Phase 1|Lack of Efficacy|0
1502291|NCT00460603|4942398|P9|Phase 1|Lack of Efficacy|11
1502292|NCT00460603|4942399|P8|Phase 1|Lack of Efficacy|2
1502293|NCT00460603|4942400|P7|Phase 1|Lack of Efficacy|2
1502294|NCT00460603|4942401|P6|Phase 1|Lack of Efficacy|2
1502295|NCT00460603|4942402|P5|Phase 1|Lack of Efficacy|2
1502296|NCT00460603|4942403|P4|Phase 1|Lack of Efficacy|2
1502297|NCT00460603|4942404|P3|Phase 1|Lack of Efficacy|1
1502298|NCT00460603|4942405|P2|Phase 1|Lack of Efficacy|0
1502299|NCT00460603|4942406|P1|Phase 1|Lack of Efficacy|1
1502300|NCT00460603|4942395|P12|Phase 1|Adverse Event|0
1502301|NCT00460603|4942396|P11|Phase 1|Adverse Event|0
1502302|NCT00460603|4942397|P10|Phase 1|Adverse Event|0
1502303|NCT00460603|4942398|P9|Phase 1|Adverse Event|4
1502304|NCT00460603|4942399|P8|Phase 1|Adverse Event|0
1502305|NCT00460603|4942400|P7|Phase 1|Adverse Event|3
1502306|NCT00460603|4942401|P6|Phase 1|Adverse Event|0
1502307|NCT00460603|4942402|P5|Phase 1|Adverse Event|0
1502308|NCT00460603|4942403|P4|Phase 1|Adverse Event|2
1502309|NCT00460603|4942404|P3|Phase 1|Adverse Event|1
1502310|NCT00460603|4942405|P2|Phase 1|Adverse Event|1
1502311|NCT00460603|4942406|P1|Phase 1|Adverse Event|3
1502312|NCT00460603|4942395|P12|Phase 1|Death|0
1502313|NCT00460603|4942396|P11|Phase 1|Death|0
1502314|NCT00460603|4942397|P10|Phase 1|Death|0
1502315|NCT00460603|4942398|P9|Phase 1|Death|1
1502316|NCT00460603|4942399|P8|Phase 1|Death|0
1502317|NCT00460603|4942400|P7|Phase 1|Death|0
1502318|NCT00460603|4942401|P6|Phase 1|Death|0
1502319|NCT00460603|4942402|P5|Phase 1|Death|0
1502320|NCT00460603|4942403|P4|Phase 1|Death|2
1502321|NCT00460603|4942404|P3|Phase 1|Death|0
1502322|NCT00460603|4942405|P2|Phase 1|Death|0
1502323|NCT00460603|4942406|P1|Phase 1|Death|1
1502324|NCT00460577|4942500|P2|Overall Study|Protocol Violation|6
1502325|NCT00460577|4942501|P1|Overall Study|Protocol Violation|2
1502326|NCT00460564|4942519|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1502327|NCT00460564|4942520|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1502328|NCT00460564|4942521|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1502329|NCT00460564|4942522|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
1502330|NCT00460564|4942523|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1502331|NCT00460564|4942524|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1502332|NCT00460564|4942525|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1502333|NCT00460564|4942526|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1502334|NCT00460564|4942519|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1502335|NCT00460564|4942520|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1502336|NCT00460564|4942521|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
1502337|NCT00460564|4942522|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
1502338|NCT00460564|4942523|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1502339|NCT00460564|4942524|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1502340|NCT00460564|4942525|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1502341|NCT00460564|4942526|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1502342|NCT00460564|4942519|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
1502343|NCT00460564|4942520|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
1502344|NCT00460564|4942521|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
1502345|NCT00460564|4942522|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
1502346|NCT00460564|4942523|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
1502347|NCT00460564|4942524|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
1502348|NCT00460564|4942525|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
1502349|NCT00460564|4942526|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
1502350|NCT00460564|4942519|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1502351|NCT00460564|4942520|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1502352|NCT00460564|4942521|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1502353|NCT00460564|4942522|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1502354|NCT00460564|4942523|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1502355|NCT00460564|4942524|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1502356|NCT00460564|4942525|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1502357|NCT00460564|4942526|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
1502358|NCT00460564|4942519|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
1502359|NCT00460564|4942520|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
1502360|NCT00460564|4942521|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
1502361|NCT00460564|4942522|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
1502362|NCT00460564|4942523|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
1502363|NCT00460564|4942524|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
1502364|NCT00460564|4942525|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
1502365|NCT00460564|4942526|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
1502366|NCT00460434|4942670|P2|Overall Study|Lost to Follow-up|7
1502367|NCT00460434|4942671|P1|Overall Study|Lost to Follow-up|3
1502368|NCT00460408|4942750|P4|Overall Study|Other|0
1502369|NCT00460408|4942751|P3|Overall Study|Other|0
1502370|NCT00460408|4942752|P2|Overall Study|Other|2
1502371|NCT00460408|4942753|P1|Overall Study|Other|12
1502372|NCT00460408|4942750|P4|Overall Study|Insufficient clinical response|0
1502373|NCT00460408|4942751|P3|Overall Study|Insufficient clinical response|5
1502374|NCT00460408|4942752|P2|Overall Study|Insufficient clinical response|1
1502375|NCT00460408|4942753|P1|Overall Study|Insufficient clinical response|5
1502376|NCT00460408|4942750|P4|Overall Study|Withdrawal by Subject|0
1502377|NCT00460408|4942751|P3|Overall Study|Withdrawal by Subject|0
1502378|NCT00460408|4942752|P2|Overall Study|Withdrawal by Subject|0
1502379|NCT00460408|4942753|P1|Overall Study|Withdrawal by Subject|31
1502380|NCT00460408|4942750|P4|Overall Study|Lost to Follow-up|0
1502381|NCT00460408|4942751|P3|Overall Study|Lost to Follow-up|1
1502382|NCT00460408|4942752|P2|Overall Study|Lost to Follow-up|0
1502383|NCT00460408|4942753|P1|Overall Study|Lost to Follow-up|11
1502384|NCT00460408|4942750|P4|Overall Study|Death|0
1502385|NCT00460408|4942751|P3|Overall Study|Death|0
1502386|NCT00460408|4942752|P2|Overall Study|Death|0
1502387|NCT00460408|4942753|P1|Overall Study|Death|7
1502388|NCT00460408|4942750|P4|Overall Study|Adverse Event|0
1502389|NCT00460408|4942751|P3|Overall Study|Adverse Event|0
1502390|NCT00460408|4942752|P2|Overall Study|Adverse Event|0
1502391|NCT00460408|4942753|P1|Overall Study|Adverse Event|1
1502392|NCT00460265|4942790|P2|Overall Study|Ongoing|47
1502393|NCT00460265|4942791|P1|Overall Study|Ongoing|60
1502394|NCT00460265|4942790|P2|Overall Study|Withdrawal by Subject|25
1502395|NCT00460265|4942791|P1|Overall Study|Withdrawal by Subject|10
1502396|NCT00460265|4942790|P2|Overall Study|Physician Decision|2
1502397|NCT00460265|4942791|P1|Overall Study|Physician Decision|1
1502398|NCT00460265|4942790|P2|Overall Study|Lost to Follow-up|15
1502399|NCT00460265|4942791|P1|Overall Study|Lost to Follow-up|14
1502400|NCT00460239|4942807|P9|Overall Study|Withdrawal by Subject|0
1502401|NCT00460239|4942808|P8|Overall Study|Withdrawal by Subject|0
1502402|NCT00460239|4942809|P7|Overall Study|Withdrawal by Subject|0
1502403|NCT00460239|4942810|P6|Overall Study|Withdrawal by Subject|1
1502404|NCT00460239|4942811|P5|Overall Study|Withdrawal by Subject|0
1502405|NCT00460239|4942812|P4|Overall Study|Withdrawal by Subject|0
1502406|NCT00460239|4942813|P3|Overall Study|Withdrawal by Subject|0
1502407|NCT00460239|4942814|P2|Overall Study|Withdrawal by Subject|0
1502408|NCT00460239|4942815|P1|Overall Study|Withdrawal by Subject|0
1502409|NCT00460239|4942807|P9|Overall Study|Physician Decision|0
1502410|NCT00460239|4942808|P8|Overall Study|Physician Decision|0
1502411|NCT00460239|4942809|P7|Overall Study|Physician Decision|0
1502412|NCT00460239|4942810|P6|Overall Study|Physician Decision|2
1502413|NCT00460239|4942811|P5|Overall Study|Physician Decision|0
1502414|NCT00460239|4942812|P4|Overall Study|Physician Decision|0
1502415|NCT00460239|4942813|P3|Overall Study|Physician Decision|0
1502416|NCT00460239|4942814|P2|Overall Study|Physician Decision|1
1502417|NCT00460239|4942815|P1|Overall Study|Physician Decision|0
1502418|NCT00460109|4942884|P1|Overall Study|Death|1
1502419|NCT00460031|4942892|P1|Overall Study|Death|1
1502420|NCT00460031|4942892|P1|Overall Study|Withdrawal by Subject|5
1502421|NCT00460031|4942892|P1|Overall Study|Adverse Event|5
1502422|NCT00459979|4942900|P1|Overall Study|Protocol Violation|1
1502423|NCT00459979|4942900|P1|Overall Study|Withdrawal by Subject|1
1502424|NCT00459953|4942912|P2|Overall Study|not analyzed-household member in study|1
1502425|NCT00459953|4942913|P1|Overall Study|not analyzed-household member in study|1
1502426|NCT00459875|4942919|P1|Overall Study|Adverse Event|2
1502427|NCT00459875|4942919|P1|Overall Study|Ineligible participant|1
1502428|NCT00459706|4942955|P2|Overall Study|Other|1
1502429|NCT00459706|4942956|P1|Overall Study|Other|0
1502430|NCT00459706|4942955|P2|Overall Study|Failed to Return|0
1502431|NCT00459706|4942956|P1|Overall Study|Failed to Return|1
1502432|NCT00459706|4942955|P2|Overall Study|Protocol Violation|1
1502433|NCT00459706|4942956|P1|Overall Study|Protocol Violation|2
1502434|NCT00459706|4942955|P2|Overall Study|Discontinuation of Study by Sponsor|0
1502435|NCT00459706|4942956|P1|Overall Study|Discontinuation of Study by Sponsor|1
1502436|NCT00459706|4942955|P2|Overall Study|Physician Decision|0
1502437|NCT00459706|4942956|P1|Overall Study|Physician Decision|2
1502438|NCT00459706|4942955|P2|Overall Study|Withdrawal by Subject|6
1502439|NCT00459706|4942956|P1|Overall Study|Withdrawal by Subject|1
1502440|NCT00459706|4942955|P2|Overall Study|Adverse Event|13
1502441|NCT00459706|4942956|P1|Overall Study|Adverse Event|19
1502442|NCT00459667|4943099|P3|Overall Study|No treatment administered|1
1502443|NCT00459667|4943100|P2|Overall Study|No treatment administered|3
1502444|NCT00459667|4943101|P1|Overall Study|No treatment administered|6
1502445|NCT00459667|4943099|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
1502446|NCT00459667|4943100|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
1502447|NCT00459667|4943101|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
1502785|NCT00455429|4944237|P3|Overall Study|Non-compliance|0
1502448|NCT00459667|4943099|P3|Overall Study|Other disease modifying treatment|1
1502449|NCT00459667|4943100|P2|Overall Study|Other disease modifying treatment|2
1502450|NCT00459667|4943101|P1|Overall Study|Other disease modifying treatment|1
1502451|NCT00459667|4943099|P3|Overall Study|Withdrawal by Subject|5
1502452|NCT00459667|4943100|P2|Overall Study|Withdrawal by Subject|5
1502453|NCT00459667|4943101|P1|Overall Study|Withdrawal by Subject|3
1502454|NCT00459667|4943099|P3|Overall Study|Protocol Violation|0
1502455|NCT00459667|4943100|P2|Overall Study|Protocol Violation|0
1502456|NCT00459667|4943101|P1|Overall Study|Protocol Violation|1
1502457|NCT00459667|4943099|P3|Overall Study|Pregnancy|1
1502458|NCT00459667|4943100|P2|Overall Study|Pregnancy|1
1502459|NCT00459667|4943101|P1|Overall Study|Pregnancy|1
1502460|NCT00459667|4943099|P3|Overall Study|Lost to Follow-up|3
1502461|NCT00459667|4943100|P2|Overall Study|Lost to Follow-up|9
1502462|NCT00459667|4943101|P1|Overall Study|Lost to Follow-up|5
1502463|NCT00459667|4943099|P3|Overall Study|Adverse Event|8
1502464|NCT00459667|4943100|P2|Overall Study|Adverse Event|12
1502465|NCT00459667|4943101|P1|Overall Study|Adverse Event|9
1502466|NCT00459537|4943123|P2|Overall Study|Missing|0
1502467|NCT00459537|4943124|P1|Overall Study|Missing|1
1502468|NCT00459537|4943123|P2|Overall Study|Protocol Violation|3
1502469|NCT00459537|4943124|P1|Overall Study|Protocol Violation|4
1502470|NCT00459537|4943123|P2|Overall Study|Administrative problems|0
1502471|NCT00459537|4943124|P1|Overall Study|Administrative problems|3
1502472|NCT00459537|4943123|P2|Overall Study|Lost to Follow-up|30
1502473|NCT00459537|4943124|P1|Overall Study|Lost to Follow-up|27
1502474|NCT00459537|4943123|P2|Overall Study|Withdrawal by Subject|26
1502475|NCT00459537|4943124|P1|Overall Study|Withdrawal by Subject|20
1502476|NCT00459537|4943123|P2|Overall Study|Lack of Efficacy|11
1502477|NCT00459537|4943124|P1|Overall Study|Lack of Efficacy|10
1502478|NCT00459537|4943123|P2|Overall Study|Adverse Event|6
1502479|NCT00459537|4943124|P1|Overall Study|Adverse Event|1
1502480|NCT00459355|4943159|P2|Overall Study|Subject no longer met inc criteria|18
1502481|NCT00459355|4943160|P1|Overall Study|Subject no longer met inc criteria|20
1502482|NCT00459342|4943172|P1|Overall Study|Not eligible|1
1502483|NCT00459316|4943181|P3|Step 3|Withdrawal by Subject|1
1502484|NCT00459316|4943182|P2|Step 3|Withdrawal by Subject|0
1502485|NCT00459316|4943183|P1|Step 3|Withdrawal by Subject|3
1502486|NCT00459316|4943181|P3|Steps 1 & 2|Lost to Follow-up|2
1502487|NCT00459316|4943182|P2|Steps 1 & 2|Lost to Follow-up|0
1502488|NCT00459316|4943183|P1|Steps 1 & 2|Lost to Follow-up|5
1502489|NCT00459316|4943181|P3|Steps 1 & 2|Not willing to adhere to regulations|0
1502490|NCT00459316|4943182|P2|Steps 1 & 2|Not willing to adhere to regulations|0
1502491|NCT00459316|4943183|P1|Steps 1 & 2|Not willing to adhere to regulations|1
1502492|NCT00459316|4943181|P3|Steps 1 & 2|Withdrawal by Subject|0
1502493|NCT00459316|4943182|P2|Steps 1 & 2|Withdrawal by Subject|1
1502494|NCT00459316|4943183|P1|Steps 1 & 2|Withdrawal by Subject|6
1502495|NCT00459316|4943181|P3|Steps 1 & 2|Not able to get to clinic|0
1502496|NCT00459316|4943182|P2|Steps 1 & 2|Not able to get to clinic|4
1502497|NCT00459316|4943183|P1|Steps 1 & 2|Not able to get to clinic|7
1502498|NCT00459316|4943181|P3|Steps 1 & 2|Death|0
1502499|NCT00459316|4943182|P2|Steps 1 & 2|Death|1
1502500|NCT00459316|4943183|P1|Steps 1 & 2|Death|1
1502501|NCT00459316|4943181|P3|Steps 1 & 2|Other eligibility failure|0
1502502|NCT00459316|4943182|P2|Steps 1 & 2|Other eligibility failure|1
1502503|NCT00459316|4943183|P1|Steps 1 & 2|Other eligibility failure|1
1502504|NCT00459290|4943248|P1|Overall Study|Ineligible|2
1502505|NCT00459290|4943248|P1|Overall Study|Adverse Event|3
1502506|NCT00459186|4943263|P1|PET Imaging and Assessment|Adverse Event|3
1502507|NCT00459186|4943263|P1|Single Agent RAD001|Withdrawal by Subject|1
1502508|NCT00459134|4943270|P2|Overall Study|Multiple Reasons|3
1502509|NCT00459134|4943271|P1|Overall Study|Multiple Reasons|2
1502510|NCT00459134|4943270|P2|Overall Study|Progression|0
1502511|NCT00459134|4943271|P1|Overall Study|Progression|1
1502512|NCT00459134|4943270|P2|Overall Study|Toxicity|5
1502513|NCT00459134|4943271|P1|Overall Study|Toxicity|4
1502514|NCT00459134|4943270|P2|Overall Study|Surgery|2
1502515|NCT00459134|4943271|P1|Overall Study|Surgery|1
1502516|NCT00459134|4943270|P2|Overall Study|Lost to Follow-up|7
1502517|NCT00459134|4943271|P1|Overall Study|Lost to Follow-up|6
1502518|NCT00459134|4943270|P2|Overall Study|Withdrawal by Subject|7
1502519|NCT00459134|4943271|P1|Overall Study|Withdrawal by Subject|8
1502520|NCT00459134|4943270|P2|Overall Study|Physician Decision|1
1502521|NCT00459134|4943271|P1|Overall Study|Physician Decision|1
1502522|NCT00459108|4943283|P1|Overall Study|Progression|1
1502523|NCT00459108|4943283|P1|Overall Study|Death|2
1502524|NCT00459108|4943283|P1|Overall Study|Adverse Event|3
1502525|NCT00459108|4943283|P1|Overall Study|Withdrawal by Subject|5
1502526|NCT00459056|4943293|P2|First Intervention (First Three Months)|Lost to Follow-up|1
1502527|NCT00459056|4943294|P1|First Intervention (First Three Months)|Lost to Follow-up|1
1502528|NCT00459043|4943302|P2|Overall Study|Withdrawal by Subject|0
1502529|NCT00459043|4943303|P1|Overall Study|Withdrawal by Subject|1
1502530|NCT00458705|4943324|P1|Overall Study|Not Treated|1
1502531|NCT00458705|4943324|P1|Overall Study|Adverse Event|4
1502532|NCT00458536|4943328|P1|Overall Study|Progressive disease during treatment|2
1502533|NCT00458536|4943328|P1|Overall Study|Withdrawal by Subject|1
1502534|NCT00458536|4943328|P1|Overall Study|Ineligible due to toxicity|1
1502535|NCT00458536|4943328|P1|Overall Study|Patient did not have surgery|1
1502536|NCT00458536|4943328|P1|Overall Study|Did not have renal cell carcinoma|2
1502537|NCT00458536|4943328|P1|Overall Study|No measurable disease after surgery|2
1502538|NCT00458536|4943328|P1|Overall Study|Unable to make vaccine|3
1502539|NCT00458536|4943328|P1|Overall Study|Disease progression prior to treatment|7
1502540|NCT00458393|4943355|P2|Overall Study|Sites marked other on the form.|20
1502541|NCT00458393|4943356|P1|Overall Study|Sites marked other on the form.|19
1502542|NCT00458393|4943355|P2|Overall Study|Lost to Follow-up|92
1502543|NCT00458393|4943356|P1|Overall Study|Lost to Follow-up|115
1502544|NCT00458393|4943355|P2|Overall Study|Relocated|81
1502545|NCT00458393|4943356|P1|Overall Study|Relocated|77
1502546|NCT00458393|4943355|P2|Overall Study|Physician Decision|22
1502547|NCT00458393|4943356|P1|Overall Study|Physician Decision|31
1502548|NCT00458393|4943355|P2|Overall Study|Withdrawal by Subject|80
1502549|NCT00458393|4943356|P1|Overall Study|Withdrawal by Subject|67
1502550|NCT00458302|4943404|P2|Overall Study|Other|2
1502551|NCT00458302|4943405|P1|Overall Study|Other|4
1502552|NCT00458302|4943404|P2|Overall Study|Lost to Follow-up|0
1502553|NCT00458302|4943405|P1|Overall Study|Lost to Follow-up|2
1502554|NCT00458302|4943404|P2|Overall Study|Study Termination By Sponsor|0
1502555|NCT00458302|4943405|P1|Overall Study|Study Termination By Sponsor|1
1502556|NCT00458302|4943404|P2|Overall Study|Inc/Exc Criteria Not Met|1
1502557|NCT00458302|4943405|P1|Overall Study|Inc/Exc Criteria Not Met|1
1502558|NCT00458302|4943404|P2|Overall Study|Withdrawal by Subject|4
1502559|NCT00458302|4943405|P1|Overall Study|Withdrawal by Subject|6
1502560|NCT00458302|4943404|P2|Overall Study|Protocol Violation|2
1502561|NCT00458302|4943405|P1|Overall Study|Protocol Violation|0
1502562|NCT00458302|4943404|P2|Overall Study|Pregnancy|1
1502563|NCT00458302|4943405|P1|Overall Study|Pregnancy|2
1502564|NCT00458302|4943404|P2|Overall Study|Adverse Event|14
1502565|NCT00458302|4943405|P1|Overall Study|Adverse Event|4
1502566|NCT00458211|4943450|P1|Overall Study|Protocol Violation|2
1502567|NCT00458211|4943450|P1|Overall Study|Withdrawal by Subject|2
1502568|NCT00458211|4943450|P1|Overall Study|Lack of Efficacy|12
1502569|NCT00457821|4943492|P8|Part 2|Withdrawal by Subject|1
1502570|NCT00457821|4943493|P7|Part 2|Withdrawal by Subject|0
1502571|NCT00457821|4943494|P6|Part 2|Withdrawal by Subject|0
1502572|NCT00457821|4943495|P5|Part 2|Withdrawal by Subject|0
1502573|NCT00457821|4943496|P4|Part 2|Withdrawal by Subject|0
1502574|NCT00457821|4943497|P3|Part 2|Withdrawal by Subject|0
1502575|NCT00457821|4943498|P2|Part 2|Withdrawal by Subject|0
1502576|NCT00457821|4943499|P1|Part 2|Withdrawal by Subject|0
1502577|NCT00457743|4943538|P3|Overall Study|Lack of Efficacy|3
1502578|NCT00457743|4943539|P2|Overall Study|Lack of Efficacy|23
1502579|NCT00457743|4943540|P1|Overall Study|Lack of Efficacy|3
1502580|NCT00457743|4943538|P3|Overall Study|Adverse Event|0
1502581|NCT00457743|4943539|P2|Overall Study|Adverse Event|4
1502582|NCT00457743|4943540|P1|Overall Study|Adverse Event|0
1502583|NCT00457691|4943597|P2|Overall Study|Disease progression, study terminated|196
1502584|NCT00457691|4943598|P1|Overall Study|Disease progression, study terminated|180
1502585|NCT00457691|4943597|P2|Overall Study|Subject refused (reason other than AE)|19
1502586|NCT00457691|4943598|P1|Overall Study|Subject refused (reason other than AE)|14
1502587|NCT00457691|4943597|P2|Overall Study|Study terminated by Sponsor|1
1502588|NCT00457691|4943598|P1|Overall Study|Study terminated by Sponsor|1
1502589|NCT00457691|4943597|P2|Overall Study|Lost to Follow-up|14
1502590|NCT00457691|4943598|P1|Overall Study|Lost to Follow-up|23
1502591|NCT00457691|4943597|P2|Overall Study|Protocol Violation|3
1502592|NCT00457691|4943598|P1|Overall Study|Protocol Violation|1
1502593|NCT00457691|4943597|P2|Overall Study|Death|148
1502594|NCT00457691|4943598|P1|Overall Study|Death|163
1502595|NCT00457691|4943597|P2|Overall Study|Adverse Event|1
1502596|NCT00457691|4943598|P1|Overall Study|Adverse Event|4
1502597|NCT00457418|4943618|P1|Post PK Maintenance|Lost to Follow-up|1
1502598|NCT00457418|4943618|P1|Post PK Maintenance|Withdrawal by Subject|11
1502599|NCT00457418|4943618|P1|Post PK Maintenance|Progression of Disease|6
1502600|NCT00457418|4943618|P1|Post PK Maintenance|Adverse Event|10
1502601|NCT00457418|4943618|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
1502602|NCT00457418|4943618|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
1502603|NCT00457418|4943618|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
1502604|NCT00457392|4943630|P2|Overall Study|Randomized, Not Treated|3
1502605|NCT00457392|4943631|P1|Overall Study|Randomized, Not Treated|7
1502606|NCT00457392|4943630|P2|Overall Study|Study Terminated by Sponsor|4
1502607|NCT00457392|4943631|P1|Overall Study|Study Terminated by Sponsor|1
1502608|NCT00457392|4943630|P2|Overall Study|Other|4
1502609|NCT00457392|4943631|P1|Overall Study|Other|7
1502610|NCT00457392|4943630|P2|Overall Study|Protocol Violation|3
1502611|NCT00457392|4943631|P1|Overall Study|Protocol Violation|4
1502612|NCT00457392|4943630|P2|Overall Study|Lost to Follow-up|7
1502613|NCT00457392|4943631|P1|Overall Study|Lost to Follow-up|6
1502614|NCT00457392|4943630|P2|Overall Study|Withdrawal by Subject|8
1502615|NCT00457392|4943631|P1|Overall Study|Withdrawal by Subject|14
1502616|NCT00457392|4943630|P2|Overall Study|Global Deterioration of Health Status|8
1502617|NCT00457392|4943631|P1|Overall Study|Global Deterioration of Health Status|22
1502618|NCT00457392|4943630|P2|Overall Study|Adverse Event|41
1502619|NCT00457392|4943631|P1|Overall Study|Adverse Event|84
1502620|NCT00457392|4943630|P2|Overall Study|Death|106
1502621|NCT00457392|4943631|P1|Overall Study|Death|106
1502622|NCT00457392|4943630|P2|Overall Study|Objective Progression or Relapse|296
1502623|NCT00457392|4943631|P1|Overall Study|Objective Progression or Relapse|229
1502624|NCT00457301|4943649|P2|Overall Study|Death|7
1502625|NCT00457301|4943650|P1|Overall Study|Death|5
1502626|NCT00457301|4943649|P2|Overall Study|Censored out of the study|14
1502627|NCT00457301|4943650|P1|Overall Study|Censored out of the study|15
1502628|NCT00457301|4943649|P2|Overall Study|Withdrawal by Subject|3
1502629|NCT00457301|4943650|P1|Overall Study|Withdrawal by Subject|3
1502630|NCT00457249|4943664|P2|Overall Study|Serious Adverse Events|0
1502631|NCT00457249|4943665|P1|Overall Study|Serious Adverse Events|2
1502632|NCT00457249|4943664|P2|Overall Study|Withdrawal by Subject|1
1502633|NCT00457249|4943665|P1|Overall Study|Withdrawal by Subject|3
1502634|NCT00457249|4943664|P2|Overall Study|Protocol Violation|1
1502635|NCT00457249|4943665|P1|Overall Study|Protocol Violation|4
1502636|NCT00457249|4943664|P2|Overall Study|Lost to Follow-up|0
1502637|NCT00457249|4943665|P1|Overall Study|Lost to Follow-up|3
1502638|NCT00457015|4943704|P2|Overall Study|Left study site against medical advice|1
1502639|NCT00457015|4943705|P1|Overall Study|Left study site against medical advice|0
1502640|NCT00457002|4943721|P2|Overall Study|treated for 1 day; missing status/reason|0
1502641|NCT00457002|4943722|P1|Overall Study|treated for 1 day; missing status/reason|1
1502642|NCT00457002|4943721|P2|Overall Study|non-specified|38
1502643|NCT00457002|4943722|P1|Overall Study|non-specified|29
1502644|NCT00457002|4943721|P2|Overall Study|Administrative reason by Sponsor|0
1502645|NCT00457002|4943722|P1|Overall Study|Administrative reason by Sponsor|1
1502646|NCT00457002|4943721|P2|Overall Study|No longer met criteria|37
1502647|NCT00457002|4943722|P1|Overall Study|No longer met criteria|41
1502648|NCT00457002|4943721|P2|Overall Study|Poor/Non-compliance|33
1502649|NCT00457002|4943722|P1|Overall Study|Poor/Non-compliance|46
1502650|NCT00457002|4943721|P2|Overall Study|Lost to Follow-up|71
1502651|NCT00457002|4943722|P1|Overall Study|Lost to Follow-up|72
1502652|NCT00457002|4943721|P2|Overall Study|Withdrawal by Subject|271
1502653|NCT00457002|4943722|P1|Overall Study|Withdrawal by Subject|299
1502654|NCT00457002|4943721|P2|Overall Study|Adverse Event|260
1502655|NCT00457002|4943722|P1|Overall Study|Adverse Event|284
1502656|NCT00457002|4943721|P2|Overall Study|Death|47
1502657|NCT00457002|4943722|P1|Overall Study|Death|40
1502658|NCT00456846|4943826|P2|Overall Study|Other|2
1502659|NCT00456846|4943827|P1|Overall Study|Other|0
1502660|NCT00456846|4943826|P2|Overall Study|Participant Discretion|5
1502661|NCT00456846|4943827|P1|Overall Study|Participant Discretion|1
1502662|NCT00456846|4943826|P2|Overall Study|Protocol Deviation|0
1502663|NCT00456846|4943827|P1|Overall Study|Protocol Deviation|2
1502664|NCT00456846|4943826|P2|Overall Study|Physician Decision|6
1502665|NCT00456846|4943827|P1|Overall Study|Physician Decision|11
1502666|NCT00456846|4943826|P2|Overall Study|Adverse Event|15
1502667|NCT00456846|4943827|P1|Overall Study|Adverse Event|2
1502668|NCT00456755|4943868|P2|Overall Study|Lost to Follow-up|1
1502669|NCT00456755|4943869|P1|Overall Study|Lost to Follow-up|2
1502670|NCT00456612|4943883|P1|Overall Study|Withdrawal by Subject|3
1502671|NCT00456599|4943888|P1|Overall Study|Withdrawal by Subject|2
1502672|NCT00456599|4943888|P1|Overall Study|Non-compliance|1
1502673|NCT00456521|4943911|P2|Overall Study|Drug non-compliance, moved, other|11
1502674|NCT00456521|4943912|P1|Overall Study|Drug non-compliance, moved, other|26
1502675|NCT00456521|4943911|P2|Overall Study|Pregnancy|1
1502676|NCT00456521|4943912|P1|Overall Study|Pregnancy|1
1502677|NCT00456521|4943911|P2|Overall Study|Protocol Violation|0
1502678|NCT00456521|4943912|P1|Overall Study|Protocol Violation|4
1502679|NCT00456521|4943911|P2|Overall Study|Lack of Efficacy|6
1502680|NCT00456521|4943912|P1|Overall Study|Lack of Efficacy|3
1502681|NCT00456521|4943911|P2|Overall Study|Lost to Follow-up|17
1502682|NCT00456521|4943912|P1|Overall Study|Lost to Follow-up|22
1502683|NCT00456521|4943911|P2|Overall Study|Withdrawal by Subject|24
1502684|NCT00456521|4943912|P1|Overall Study|Withdrawal by Subject|43
1502685|NCT00456521|4943911|P2|Overall Study|Adverse Event|25
1502686|NCT00456521|4943912|P1|Overall Study|Adverse Event|150
1502687|NCT00456495|4943958|P1|Overall Study|Physician Decision|2
1502688|NCT00456365|4943965|P2|Overall Study|oncologic diagnosis|1
1502689|NCT00456365|4943966|P1|Overall Study|oncologic diagnosis|1
1502690|NCT00456365|4943965|P2|Overall Study|Pregnancy|1
1502691|NCT00456365|4943966|P1|Overall Study|Pregnancy|1
1502692|NCT00456365|4943965|P2|Overall Study|Withdrawal by Subject|7
1502693|NCT00456365|4943966|P1|Overall Study|Withdrawal by Subject|4
1502694|NCT00456365|4943965|P2|Overall Study|Lost to Follow-up|3
1502695|NCT00456365|4943966|P1|Overall Study|Lost to Follow-up|1
1502696|NCT00455923|4944023|P2|Overall Study|Other|1
1502697|NCT00455923|4944024|P1|Overall Study|Other|3
1502698|NCT00455923|4944023|P2|Overall Study|Pregnancy|2
1502699|NCT00455923|4944024|P1|Overall Study|Pregnancy|0
1502700|NCT00455858|4944040|P1|Overall Study|Withdrawal|1
1502701|NCT00455858|4944040|P1|Overall Study|Well controlled FPG without insulin|1
1502702|NCT00455858|4944040|P1|Overall Study|Lack of Efficacy|1
1502703|NCT00455858|4944040|P1|Overall Study|Protocol Violation|1
1502704|NCT00455858|4944040|P1|Overall Study|Lost to Follow-up|2
1502705|NCT00455741|4944050|P2|Overall Study|Physician Decision|1
1502706|NCT00455741|4944051|P1|Overall Study|Physician Decision|0
1502707|NCT00455533|4944147|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
1502708|NCT00455533|4944148|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
1502709|NCT00455533|4944149|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
1502710|NCT00455533|4944147|P3|Period Two: Randomized Period|Study Drug Toxicity|0
1502711|NCT00455533|4944148|P2|Period Two: Randomized Period|Study Drug Toxicity|2
1502712|NCT00455533|4944149|P1|Period Two: Randomized Period|Study Drug Toxicity|0
1502713|NCT00455533|4944147|P3|Period Two: Randomized Period|Other - need reasons|0
1502714|NCT00455533|4944148|P2|Period Two: Randomized Period|Other - need reasons|1
1502715|NCT00455533|4944149|P1|Period Two: Randomized Period|Other - need reasons|0
1502716|NCT00455533|4944147|P3|Period Two: Randomized Period|Lost to Follow-up|1
1502717|NCT00455533|4944148|P2|Period Two: Randomized Period|Lost to Follow-up|0
1502718|NCT00455533|4944149|P1|Period Two: Randomized Period|Lost to Follow-up|0
1502719|NCT00455533|4944147|P3|Period Two: Randomized Period|Disease Progression|1
1502720|NCT00455533|4944148|P2|Period Two: Randomized Period|Disease Progression|1
1502721|NCT00455533|4944149|P1|Period Two: Randomized Period|Disease Progression|0
1502722|NCT00455533|4944147|P3|Period Two: Randomized Period|Death|3
1502723|NCT00455533|4944148|P2|Period Two: Randomized Period|Death|0
1502724|NCT00455533|4944149|P1|Period Two: Randomized Period|Death|0
1502725|NCT00455533|4944147|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
1502726|NCT00455533|4944148|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
1502727|NCT00455533|4944149|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
1502728|NCT00455533|4944147|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
1502729|NCT00455533|4944148|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
1502730|NCT00455533|4944149|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
1502731|NCT00455533|4944147|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
1502732|NCT00455533|4944148|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
1502733|NCT00455533|4944149|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
1502734|NCT00455533|4944147|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
1502735|NCT00455533|4944148|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
1502736|NCT00455533|4944149|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
1502737|NCT00455533|4944147|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
1502738|NCT00455533|4944148|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
1502739|NCT00455533|4944149|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
1502740|NCT00455533|4944147|P3|Period One: Initial Chemotherapy|Not Reported|0
1502741|NCT00455533|4944148|P2|Period One: Initial Chemotherapy|Not Reported|0
1502742|NCT00455533|4944149|P1|Period One: Initial Chemotherapy|Not Reported|1
1502743|NCT00455533|4944147|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
1502744|NCT00455533|4944148|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
1502745|NCT00455533|4944149|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
1502746|NCT00455533|4944147|P3|Period One: Initial Chemotherapy|Disease Progression|0
1502747|NCT00455533|4944148|P2|Period One: Initial Chemotherapy|Disease Progression|0
1502748|NCT00455533|4944149|P1|Period One: Initial Chemotherapy|Disease Progression|5
1502749|NCT00455533|4944147|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
1502750|NCT00455533|4944148|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
1502751|NCT00455533|4944149|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
1502752|NCT00455520|4944198|P2|Double Blind Tapentadol ER vs Placebo|All other|6
1502753|NCT00455520|4944199|P1|Double Blind Tapentadol ER vs Placebo|All other|4
1502754|NCT00455520|4944198|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
1502755|NCT00455520|4944199|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
1502756|NCT00455520|4944198|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
1502757|NCT00455520|4944199|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
1502758|NCT00455520|4944198|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
1502759|NCT00455520|4944199|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
1502760|NCT00455520|4944198|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
1502761|NCT00455520|4944199|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
1502762|NCT00455520|4944198|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
1502763|NCT00455520|4944199|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
1502764|NCT00455520|4944198|P2|Open Label Tapentadol Extended Release|All other|0
1502765|NCT00455520|4944199|P1|Open Label Tapentadol Extended Release|All other|33
1502766|NCT00455520|4944198|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
1502767|NCT00455520|4944199|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
1502768|NCT00455520|4944198|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
1502769|NCT00455520|4944199|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
1502770|NCT00455520|4944198|P2|Open Label Tapentadol Extended Release|Adverse Event|0
1502771|NCT00455520|4944199|P1|Open Label Tapentadol Extended Release|Adverse Event|100
1502772|NCT00455520|4944198|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
1502773|NCT00455520|4944199|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
1502774|NCT00455520|4944198|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
1502775|NCT00455520|4944199|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
1502776|NCT00455455|4944215|P2|Washout|Withdrawal by Subject|0
1502777|NCT00455455|4944216|P1|Washout|Withdrawal by Subject|1
1502778|NCT00455455|4944215|P2|Washout|Withdrawal by Subject|1
1502779|NCT00455455|4944216|P1|Washout|Withdrawal by Subject|0
1502780|NCT00455429|4944236|P4|Overall Study|Other|1
1502781|NCT00455429|4944237|P3|Overall Study|Other|0
1502782|NCT00455429|4944238|P2|Overall Study|Other|2
1502783|NCT00455429|4944239|P1|Overall Study|Other|0
1502784|NCT00455429|4944236|P4|Overall Study|Non-compliance|1
1502786|NCT00455429|4944238|P2|Overall Study|Non-compliance|0
1502787|NCT00455429|4944239|P1|Overall Study|Non-compliance|0
1502788|NCT00455429|4944236|P4|Overall Study|Personal Reason|0
1502789|NCT00455429|4944237|P3|Overall Study|Personal Reason|0
1502790|NCT00455429|4944238|P2|Overall Study|Personal Reason|0
1502791|NCT00455429|4944239|P1|Overall Study|Personal Reason|1
1502792|NCT00455429|4944236|P4|Overall Study|Randomly assigned but not treated|2
1502793|NCT00455429|4944237|P3|Overall Study|Randomly assigned but not treated|0
1502794|NCT00455429|4944238|P2|Overall Study|Randomly assigned but not treated|0
1502795|NCT00455429|4944239|P1|Overall Study|Randomly assigned but not treated|0
1502796|NCT00455429|4944236|P4|Overall Study|Adverse Event|3
1502797|NCT00455429|4944237|P3|Overall Study|Adverse Event|0
1502798|NCT00455429|4944238|P2|Overall Study|Adverse Event|1
1502799|NCT00455429|4944239|P1|Overall Study|Adverse Event|0
1502800|NCT00455429|4944236|P4|Overall Study|Lack of Efficacy|1
1502801|NCT00455429|4944237|P3|Overall Study|Lack of Efficacy|0
1502802|NCT00455429|4944238|P2|Overall Study|Lack of Efficacy|1
1502803|NCT00455429|4944239|P1|Overall Study|Lack of Efficacy|0
1502804|NCT00455429|4944236|P4|Overall Study|Withdrawal by Subject|0
1502805|NCT00455429|4944237|P3|Overall Study|Withdrawal by Subject|1
1502806|NCT00455429|4944238|P2|Overall Study|Withdrawal by Subject|1
1502807|NCT00455429|4944239|P1|Overall Study|Withdrawal by Subject|0
1502808|NCT00455429|4944236|P4|Overall Study|Lost to Follow-up|3
1502809|NCT00455429|4944237|P3|Overall Study|Lost to Follow-up|0
1502810|NCT00455429|4944238|P2|Overall Study|Lost to Follow-up|0
1502811|NCT00455429|4944239|P1|Overall Study|Lost to Follow-up|1
1502812|NCT00455429|4944236|P4|Overall Study|Study Terminated by Sponsor|3
1502813|NCT00455429|4944237|P3|Overall Study|Study Terminated by Sponsor|0
1502814|NCT00455429|4944238|P2|Overall Study|Study Terminated by Sponsor|0
1502815|NCT00455429|4944239|P1|Overall Study|Study Terminated by Sponsor|0
1502816|NCT00455312|4944298|P2|Overall Study|Death|1
1502817|NCT00455312|4944299|P1|Overall Study|Death|0
1502818|NCT00455195|4944325|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
1502819|NCT00455195|4944326|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
1502820|NCT00455195|4944325|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
1502821|NCT00455195|4944326|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
1502822|NCT00455195|4944325|P2|Double-blind Study AGLU02704|Death|0
1502823|NCT00455195|4944326|P1|Double-blind Study AGLU02704|Death|1
1502824|NCT00455195|4944325|P2|Double-blind Study AGLU02704|Adverse Event|1
1502825|NCT00455195|4944326|P1|Double-blind Study AGLU02704|Adverse Event|2
1502826|NCT00455013|4944343|P3|Long Term Extension (LTE)|non-specified|1
1502827|NCT00455013|4944344|P2|Long Term Extension (LTE)|non-specified|0
1502828|NCT00455013|4944345|P1|Long Term Extension (LTE)|non-specified|0
1502829|NCT00455013|4944343|P3|Long Term Extension (LTE)|Poor non-compliance|0
1502830|NCT00455013|4944344|P2|Long Term Extension (LTE)|Poor non-compliance|1
1502831|NCT00455013|4944345|P1|Long Term Extension (LTE)|Poor non-compliance|0
1502832|NCT00455013|4944343|P3|Long Term Extension (LTE)|Subject Request or refused|3
1502833|NCT00455013|4944344|P2|Long Term Extension (LTE)|Subject Request or refused|0
1502834|NCT00455013|4944345|P1|Long Term Extension (LTE)|Subject Request or refused|0
1502835|NCT00455013|4944343|P3|Long Term Extension (LTE)|No longer met criteria|1
1502836|NCT00455013|4944344|P2|Long Term Extension (LTE)|No longer met criteria|0
1502837|NCT00455013|4944345|P1|Long Term Extension (LTE)|No longer met criteria|0
1502838|NCT00455013|4944343|P3|Long Term Extension (LTE)|Death|0
1502839|NCT00455013|4944344|P2|Long Term Extension (LTE)|Death|1
1502840|NCT00455013|4944345|P1|Long Term Extension (LTE)|Death|1
1502841|NCT00455013|4944343|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
1502842|NCT00455013|4944344|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
1502843|NCT00455013|4944345|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
1502844|NCT00455013|4944343|P3|Long Term Extension (LTE)|Adverse Event|1
1502845|NCT00455013|4944344|P2|Long Term Extension (LTE)|Adverse Event|1
1502846|NCT00455013|4944345|P1|Long Term Extension (LTE)|Adverse Event|0
1502847|NCT00455013|4944343|P3|Short Term Period|Other|1
1502848|NCT00455013|4944344|P2|Short Term Period|Other|0
1502849|NCT00455013|4944345|P1|Short Term Period|Other|0
1502850|NCT00455013|4944343|P3|Short Term Period|Lack of Efficacy|0
1502851|NCT00455013|4944344|P2|Short Term Period|Lack of Efficacy|0
1502852|NCT00455013|4944345|P1|Short Term Period|Lack of Efficacy|4
1502853|NCT00455013|4944343|P3|Short Term Period|Withdrawal by Subject|1
1502854|NCT00455013|4944344|P2|Short Term Period|Withdrawal by Subject|0
1502855|NCT00455013|4944345|P1|Short Term Period|Withdrawal by Subject|0
1502856|NCT00455013|4944343|P3|Short Term Period|Adverse Event|0
1502857|NCT00455013|4944344|P2|Short Term Period|Adverse Event|5
1502858|NCT00455013|4944345|P1|Short Term Period|Adverse Event|2
1502859|NCT00454987|4944413|P3|Booster Period|Lost to Follow-up|0
1502860|NCT00454987|4944414|P2|Booster Period|Lost to Follow-up|0
1502861|NCT00454987|4944415|P1|Booster Period|Lost to Follow-up|1
1502862|NCT00454987|4944413|P3|Booster Period|Withdrawal by Subject|0
1502863|NCT00454987|4944414|P2|Booster Period|Withdrawal by Subject|1
1502864|NCT00454987|4944415|P1|Booster Period|Withdrawal by Subject|0
1502865|NCT00454987|4944413|P3|Booster Period|Adverse Event|0
1502866|NCT00454987|4944414|P2|Booster Period|Adverse Event|0
1502867|NCT00454987|4944415|P1|Booster Period|Adverse Event|1
1502868|NCT00454909|4944489|P3|Overall Study|Others|0
1502869|NCT00454909|4944490|P2|Overall Study|Others|0
1502870|NCT00454909|4944491|P1|Overall Study|Others|1
1502871|NCT00454909|4944489|P3|Overall Study|Lost to follow-up (complete vaccination)|1
1502872|NCT00454909|4944490|P2|Overall Study|Lost to follow-up (complete vaccination)|3
1502873|NCT00454909|4944491|P1|Overall Study|Lost to follow-up (complete vaccination)|5
1502874|NCT00454909|4944489|P3|Overall Study|Migrated/moved from study area|1
1502875|NCT00454909|4944490|P2|Overall Study|Migrated/moved from study area|0
1502876|NCT00454909|4944491|P1|Overall Study|Migrated/moved from study area|0
1502877|NCT00454909|4944489|P3|Overall Study|Withdrawal by Subject|0
1502878|NCT00454909|4944490|P2|Overall Study|Withdrawal by Subject|0
1502879|NCT00454909|4944491|P1|Overall Study|Withdrawal by Subject|1
1502880|NCT00454857|4944529|P1|Overall Study|Reason unknown|1
1502881|NCT00454857|4944529|P1|Overall Study|Other|11
1502882|NCT00454857|4944529|P1|Overall Study|Death|5
1502883|NCT00454857|4944529|P1|Overall Study|Noncompliance|6
1502884|NCT00454857|4944529|P1|Overall Study|Lost to Follow-up|16
1502885|NCT00454857|4944529|P1|Overall Study|Withdrawal by Subject|15
1502886|NCT00454818|4944554|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
1502887|NCT00454818|4944555|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
1502888|NCT00454818|4944556|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
1502889|NCT00454818|4944557|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
1502890|NCT00454818|4944558|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
1502891|NCT00454818|4944554|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
1502892|NCT00454818|4944555|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
1502893|NCT00454818|4944556|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
1502894|NCT00454818|4944557|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
1502895|NCT00454818|4944558|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
1502896|NCT00454818|4944554|P5|Phase 2: Randomized Double-blind|Death|1
1502897|NCT00454818|4944555|P4|Phase 2: Randomized Double-blind|Death|0
1502898|NCT00454818|4944556|P3|Phase 2: Randomized Double-blind|Death|0
1502899|NCT00454818|4944557|P2|Phase 2: Randomized Double-blind|Death|1
1502900|NCT00454818|4944558|P1|Phase 2: Randomized Double-blind|Death|0
1502901|NCT00454818|4944554|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
1502902|NCT00454818|4944555|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
1502903|NCT00454818|4944556|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
1502904|NCT00454818|4944557|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
1502905|NCT00454818|4944558|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
1502906|NCT00454818|4944554|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
1502907|NCT00454818|4944555|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
1502908|NCT00454818|4944556|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
1502909|NCT00454818|4944557|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
1502910|NCT00454818|4944558|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
1502911|NCT00454818|4944554|P5|Phase I: Open-label Dose-escalation|Death|0
1502912|NCT00454818|4944555|P4|Phase I: Open-label Dose-escalation|Death|0
1502913|NCT00454818|4944556|P3|Phase I: Open-label Dose-escalation|Death|0
1502914|NCT00454818|4944557|P2|Phase I: Open-label Dose-escalation|Death|1
1502915|NCT00454818|4944558|P1|Phase I: Open-label Dose-escalation|Death|0
1502916|NCT00454818|4944554|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
1502917|NCT00454818|4944555|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
1502918|NCT00454818|4944556|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
1502919|NCT00454818|4944557|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
1502920|NCT00454818|4944558|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
1502921|NCT00454805|4944637|P2|Overall Study|In order to begin radiotherapy|0
1502922|NCT00454805|4944638|P1|Overall Study|In order to begin radiotherapy|1
1502923|NCT00454805|4944637|P2|Overall Study|Disease progression|19
1502924|NCT00454805|4944638|P1|Overall Study|Disease progression|16
1502925|NCT00454805|4944637|P2|Overall Study|Death|2
1502926|NCT00454805|4944638|P1|Overall Study|Death|0
1502927|NCT00454805|4944637|P2|Overall Study|Withdrawal by Subject|2
1502928|NCT00454805|4944638|P1|Overall Study|Withdrawal by Subject|9
1502929|NCT00454779|4944654|P2|Second-line Treatment Phase|Ongoing|1
1502930|NCT00454779|4944655|P1|Second-line Treatment Phase|Ongoing|0
1502931|NCT00454779|4944654|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
1502932|NCT00454779|4944655|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
1502933|NCT00454779|4944654|P2|Second-line Treatment Phase|Withdrawal by Subject|1
1502934|NCT00454779|4944655|P1|Second-line Treatment Phase|Withdrawal by Subject|0
1502935|NCT00454779|4944654|P2|First-line Treatment Phase|Ongoing|0
1502936|NCT00454779|4944655|P1|First-line Treatment Phase|Ongoing|1
1502937|NCT00454779|4944654|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
1502938|NCT00454779|4944655|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
1502939|NCT00454779|4944654|P2|First-line Treatment Phase|Protocol Violation|1
1502940|NCT00454779|4944655|P1|First-line Treatment Phase|Protocol Violation|0
1502941|NCT00454779|4944654|P2|First-line Treatment Phase|Lost to Follow-up|0
1502942|NCT00454779|4944655|P1|First-line Treatment Phase|Lost to Follow-up|1
1502943|NCT00454779|4944654|P2|First-line Treatment Phase|Withdrawal by Subject|4
1502944|NCT00454779|4944655|P1|First-line Treatment Phase|Withdrawal by Subject|2
1502945|NCT00454779|4944654|P2|First-line Treatment Phase|Lack of Efficacy|2
1502946|NCT00454779|4944655|P1|First-line Treatment Phase|Lack of Efficacy|0
1502947|NCT00454649|4944693|P10|Overall Study|Withdrawal by Subject|0
1502948|NCT00454649|4944694|P9|Overall Study|Withdrawal by Subject|1
1502949|NCT00454649|4944695|P8|Overall Study|Withdrawal by Subject|2
1502950|NCT00454649|4944696|P7|Overall Study|Withdrawal by Subject|0
1502951|NCT00454649|4944697|P6|Overall Study|Withdrawal by Subject|1
1502952|NCT00454649|4944698|P5|Overall Study|Withdrawal by Subject|0
1502953|NCT00454649|4944699|P4|Overall Study|Withdrawal by Subject|0
1502954|NCT00454649|4944700|P3|Overall Study|Withdrawal by Subject|0
1502955|NCT00454649|4944701|P2|Overall Study|Withdrawal by Subject|0
1502956|NCT00454649|4944702|P1|Overall Study|Withdrawal by Subject|0
1502957|NCT00454649|4944693|P10|Overall Study|Other|1
1502958|NCT00454649|4944694|P9|Overall Study|Other|3
1502959|NCT00454649|4944695|P8|Overall Study|Other|0
1502960|NCT00454649|4944696|P7|Overall Study|Other|0
1502961|NCT00454649|4944697|P6|Overall Study|Other|0
1502962|NCT00454649|4944698|P5|Overall Study|Other|0
1502963|NCT00454649|4944699|P4|Overall Study|Other|3
1502964|NCT00454649|4944700|P3|Overall Study|Other|5
1502965|NCT00454649|4944701|P2|Overall Study|Other|1
1502966|NCT00454649|4944702|P1|Overall Study|Other|1
1502967|NCT00454649|4944693|P10|Overall Study|Lost to Follow-up|0
1502968|NCT00454649|4944694|P9|Overall Study|Lost to Follow-up|0
1502969|NCT00454649|4944695|P8|Overall Study|Lost to Follow-up|0
1502970|NCT00454649|4944696|P7|Overall Study|Lost to Follow-up|1
1502971|NCT00454649|4944697|P6|Overall Study|Lost to Follow-up|0
1502972|NCT00454649|4944698|P5|Overall Study|Lost to Follow-up|0
1502973|NCT00454649|4944699|P4|Overall Study|Lost to Follow-up|0
1502974|NCT00454649|4944700|P3|Overall Study|Lost to Follow-up|1
1502975|NCT00454649|4944701|P2|Overall Study|Lost to Follow-up|0
1502976|NCT00454649|4944702|P1|Overall Study|Lost to Follow-up|0
1502977|NCT00454649|4944693|P10|Overall Study|Adverse Event|2
1502978|NCT00454649|4944694|P9|Overall Study|Adverse Event|6
1502979|NCT00454649|4944695|P8|Overall Study|Adverse Event|4
1502980|NCT00454649|4944696|P7|Overall Study|Adverse Event|3
1502981|NCT00454649|4944697|P6|Overall Study|Adverse Event|2
1502982|NCT00454649|4944698|P5|Overall Study|Adverse Event|1
1502983|NCT00454649|4944699|P4|Overall Study|Adverse Event|0
1502984|NCT00454649|4944700|P3|Overall Study|Adverse Event|3
1502985|NCT00454649|4944701|P2|Overall Study|Adverse Event|1
1502986|NCT00454649|4944702|P1|Overall Study|Adverse Event|0
1502987|NCT00454649|4944693|P10|Overall Study|Lack of Efficacy|2
1502988|NCT00454649|4944694|P9|Overall Study|Lack of Efficacy|10
1502989|NCT00454649|4944695|P8|Overall Study|Lack of Efficacy|13
1502990|NCT00454649|4944696|P7|Overall Study|Lack of Efficacy|5
1502991|NCT00454649|4944697|P6|Overall Study|Lack of Efficacy|4
1502992|NCT00454649|4944698|P5|Overall Study|Lack of Efficacy|0
1502993|NCT00454649|4944699|P4|Overall Study|Lack of Efficacy|3
1502994|NCT00454649|4944700|P3|Overall Study|Lack of Efficacy|10
1502995|NCT00454649|4944701|P2|Overall Study|Lack of Efficacy|2
1502996|NCT00454649|4944702|P1|Overall Study|Lack of Efficacy|2
1502997|NCT00454636|4944831|P4|Overall Study|Lost to Follow-up|0
1502998|NCT00454636|4944832|P3|Overall Study|Lost to Follow-up|0
1502999|NCT00454636|4944833|P2|Overall Study|Lost to Follow-up|1
1503000|NCT00454636|4944834|P1|Overall Study|Lost to Follow-up|0
1503001|NCT00454636|4944831|P4|Overall Study|Patient refusal|2
1503002|NCT00454636|4944832|P3|Overall Study|Patient refusal|3
1503003|NCT00454636|4944833|P2|Overall Study|Patient refusal|1
1503004|NCT00454636|4944834|P1|Overall Study|Patient refusal|1
1503005|NCT00454636|4944831|P4|Overall Study|Death|1
1503006|NCT00454636|4944832|P3|Overall Study|Death|1
1503007|NCT00454636|4944833|P2|Overall Study|Death|1
1503008|NCT00454636|4944834|P1|Overall Study|Death|6
1503009|NCT00454636|4944831|P4|Overall Study|Protocol Violation|3
1503010|NCT00454636|4944832|P3|Overall Study|Protocol Violation|3
1503011|NCT00454636|4944833|P2|Overall Study|Protocol Violation|2
1503012|NCT00454636|4944834|P1|Overall Study|Protocol Violation|3
1503013|NCT00454636|4944831|P4|Overall Study|Disease Progression|11
1503014|NCT00454636|4944832|P3|Overall Study|Disease Progression|4
1503015|NCT00454636|4944833|P2|Overall Study|Disease Progression|12
1503016|NCT00454636|4944834|P1|Overall Study|Disease Progression|11
1503017|NCT00454636|4944831|P4|Overall Study|Adverse Event|15
1503018|NCT00454636|4944832|P3|Overall Study|Adverse Event|9
1503019|NCT00454636|4944833|P2|Overall Study|Adverse Event|6
1503020|NCT00454636|4944834|P1|Overall Study|Adverse Event|10
1503021|NCT00454584|4944867|P6|After Controlled Period|Other|17
1503022|NCT00454584|4944868|P5|After Controlled Period|Other|5
1503023|NCT00454584|4944869|P4|After Controlled Period|Other|13
1503024|NCT00454584|4944870|P3|After Controlled Period|Other|0
1503025|NCT00454584|4944871|P2|After Controlled Period|Other|0
1503026|NCT00454584|4944872|P1|After Controlled Period|Other|0
1503027|NCT00454584|4944867|P6|After Controlled Period|Other|0
1503028|NCT00454584|4944868|P5|After Controlled Period|Other|0
1503029|NCT00454584|4944869|P4|After Controlled Period|Other|1
1503030|NCT00454584|4944870|P3|After Controlled Period|Other|0
1503031|NCT00454584|4944871|P2|After Controlled Period|Other|0
1503032|NCT00454584|4944872|P1|After Controlled Period|Other|0
1503033|NCT00454584|4944867|P6|After Controlled Period|Lost to Follow-up|6
1503034|NCT00454584|4944868|P5|After Controlled Period|Lost to Follow-up|4
1503035|NCT00454584|4944869|P4|After Controlled Period|Lost to Follow-up|2
1503036|NCT00454584|4944870|P3|After Controlled Period|Lost to Follow-up|0
1503037|NCT00454584|4944871|P2|After Controlled Period|Lost to Follow-up|0
1503038|NCT00454584|4944872|P1|After Controlled Period|Lost to Follow-up|0
1503039|NCT00454584|4944867|P6|After Controlled Period|Lack of Efficacy|0
1503040|NCT00454584|4944868|P5|After Controlled Period|Lack of Efficacy|0
1503041|NCT00454584|4944869|P4|After Controlled Period|Lack of Efficacy|1
1503042|NCT00454584|4944870|P3|After Controlled Period|Lack of Efficacy|0
1503043|NCT00454584|4944871|P2|After Controlled Period|Lack of Efficacy|0
1503044|NCT00454584|4944872|P1|After Controlled Period|Lack of Efficacy|0
1503045|NCT00454584|4944867|P6|After Controlled Period|Adverse Event|9
1503046|NCT00454584|4944868|P5|After Controlled Period|Adverse Event|3
1503047|NCT00454584|4944869|P4|After Controlled Period|Adverse Event|9
1503048|NCT00454584|4944870|P3|After Controlled Period|Adverse Event|0
1503049|NCT00454584|4944871|P2|After Controlled Period|Adverse Event|0
1503050|NCT00454584|4944872|P1|After Controlled Period|Adverse Event|0
1503051|NCT00454584|4944867|P6|Controlled Period|Other|0
1503052|NCT00454584|4944868|P5|Controlled Period|Other|0
1503053|NCT00454584|4944869|P4|Controlled Period|Other|0
1503054|NCT00454584|4944870|P3|Controlled Period|Other|2
1503055|NCT00454584|4944871|P2|Controlled Period|Other|4
1503056|NCT00454584|4944872|P1|Controlled Period|Other|5
1503057|NCT00454584|4944867|P6|Controlled Period|Lost to Follow-up|0
1503058|NCT00454584|4944868|P5|Controlled Period|Lost to Follow-up|0
1503059|NCT00454584|4944869|P4|Controlled Period|Lost to Follow-up|0
1503060|NCT00454584|4944870|P3|Controlled Period|Lost to Follow-up|2
1503061|NCT00454584|4944871|P2|Controlled Period|Lost to Follow-up|2
1503062|NCT00454584|4944872|P1|Controlled Period|Lost to Follow-up|1
1503063|NCT00454584|4944867|P6|Controlled Period|Adverse Event|0
1503064|NCT00454584|4944868|P5|Controlled Period|Adverse Event|0
1503065|NCT00454584|4944869|P4|Controlled Period|Adverse Event|0
1503066|NCT00454584|4944870|P3|Controlled Period|Adverse Event|1
1503067|NCT00454584|4944871|P2|Controlled Period|Adverse Event|2
1503068|NCT00454584|4944872|P1|Controlled Period|Adverse Event|5
1503069|NCT00454571|4944894|P2|Overall Study|Withdrawal by Subject|5
1503070|NCT00454571|4944895|P1|Overall Study|Withdrawal by Subject|10
1503071|NCT00454571|4944894|P2|Overall Study|Protocol Violation|0
1503072|NCT00454571|4944895|P1|Overall Study|Protocol Violation|1
1503073|NCT00454571|4944894|P2|Overall Study|Physician Decision|1
1503074|NCT00454571|4944895|P1|Overall Study|Physician Decision|0
1503075|NCT00454571|4944894|P2|Overall Study|Adverse Event|0
1503076|NCT00454571|4944895|P1|Overall Study|Adverse Event|2
1503077|NCT00454363|4944930|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
1503078|NCT00454363|4944931|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
1503079|NCT00454363|4944930|P2|Overall Study|Adverse Event|2
1503080|NCT00454363|4944931|P1|Overall Study|Adverse Event|1
1503081|NCT00454246|4944956|P3|Overall Study|Early termination of study|9
1503082|NCT00454246|4944957|P2|Overall Study|Early termination of study|26
1503083|NCT00454246|4944958|P1|Overall Study|Early termination of study|62
1503084|NCT00454246|4944956|P3|Overall Study|Failure to return|0
1503085|NCT00454246|4944957|P2|Overall Study|Failure to return|0
1503086|NCT00454246|4944958|P1|Overall Study|Failure to return|1
1503087|NCT00454246|4944956|P3|Overall Study|Refused Treatment|0
1503088|NCT00454246|4944957|P2|Overall Study|Refused Treatment|1
1503089|NCT00454246|4944958|P1|Overall Study|Refused Treatment|1
1503090|NCT00454246|4944956|P3|Overall Study|Protocol Violation|0
1503091|NCT00454246|4944957|P2|Overall Study|Protocol Violation|0
1503092|NCT00454246|4944958|P1|Overall Study|Protocol Violation|1
1503093|NCT00454246|4944956|P3|Overall Study|Violation of selection criteria at entry|0
1503094|NCT00454246|4944957|P2|Overall Study|Violation of selection criteria at entry|0
1503095|NCT00454246|4944958|P1|Overall Study|Violation of selection criteria at entry|6
1503096|NCT00454246|4944956|P3|Overall Study|Adverse Event|0
1503097|NCT00454246|4944957|P2|Overall Study|Adverse Event|2
1503098|NCT00454246|4944958|P1|Overall Study|Adverse Event|2
1503099|NCT00454207|4944974|P2|Overall Study|Protocol Violation|1
1503100|NCT00454207|4944975|P1|Overall Study|Protocol Violation|0
1503101|NCT00454207|4944974|P2|Overall Study|Lack of Efficacy|0
1503102|NCT00454207|4944975|P1|Overall Study|Lack of Efficacy|1
1503103|NCT00454207|4944974|P2|Overall Study|Adverse Event|1
1503104|NCT00454207|4944975|P1|Overall Study|Adverse Event|3
1503105|NCT00454194|4945020|P2|Overall Study|Other Unspecified Reason|2
1503106|NCT00454194|4945021|P1|Overall Study|Other Unspecified Reason|2
1503107|NCT00454194|4945020|P2|Overall Study|Other Medical Problems|2
1503108|NCT00454194|4945021|P1|Overall Study|Other Medical Problems|1
1503109|NCT00454194|4945020|P2|Overall Study|Withdrawal by Subject|8
1503110|NCT00454194|4945021|P1|Overall Study|Withdrawal by Subject|12
1503111|NCT00454194|4945020|P2|Overall Study|Adverse Event|2
1503112|NCT00454194|4945021|P1|Overall Study|Adverse Event|7
1503113|NCT00454181|4945039|P2|Overall Study|Withdrawal by Subject|0
1503114|NCT00454181|4945040|P1|Overall Study|Withdrawal by Subject|2
1503115|NCT00454181|4945039|P2|Overall Study|Protocol Violation|1
1503116|NCT00454181|4945040|P1|Overall Study|Protocol Violation|1
1503117|NCT00454181|4945039|P2|Overall Study|Lost to Follow-up|1
1503118|NCT00454181|4945040|P1|Overall Study|Lost to Follow-up|11
1503119|NCT00454181|4945039|P2|Overall Study|Adverse Event|1
1503120|NCT00454181|4945040|P1|Overall Study|Adverse Event|1
1503121|NCT00454142|4945056|P1|Overall Study|Withdrawal by Subject|1
1503122|NCT00454116|4945074|P3|Overall Study|Other|0
1503123|NCT00454116|4945075|P2|Overall Study|Other|2
1503124|NCT00454116|4945076|P1|Overall Study|Other|2
1503125|NCT00454116|4945074|P3|Overall Study|Withdrawal by Subject|1
1503126|NCT00454116|4945075|P2|Overall Study|Withdrawal by Subject|3
1503127|NCT00454116|4945076|P1|Overall Study|Withdrawal by Subject|3
1503128|NCT00454116|4945074|P3|Overall Study|Condition under investigation worsened|18
1503129|NCT00454116|4945075|P2|Overall Study|Condition under investigation worsened|13
1503130|NCT00454116|4945076|P1|Overall Study|Condition under investigation worsened|17
1503131|NCT00454116|4945074|P3|Overall Study|Adverse Event|9
1503132|NCT00454116|4945075|P2|Overall Study|Adverse Event|11
1503133|NCT00454116|4945076|P1|Overall Study|Adverse Event|5
1503134|NCT00454051|4945086|P2|Overall Study|Protocol Violation|1
1503135|NCT00454051|4945087|P1|Overall Study|Protocol Violation|1
1503136|NCT00454051|4945086|P2|Overall Study|Withdrawal by Subject|0
1503137|NCT00454051|4945087|P1|Overall Study|Withdrawal by Subject|1
1503138|NCT00454051|4945086|P2|Overall Study|Adverse Event|2
1503139|NCT00454051|4945087|P1|Overall Study|Adverse Event|1
1503140|NCT00453999|4945120|P3|Overall Study|Subject Request|0
1503141|NCT00453999|4945121|P2|Overall Study|Subject Request|1
1503142|NCT00453999|4945122|P1|Overall Study|Subject Request|2
1503143|NCT00453999|4945120|P3|Overall Study|Withdrawal by Subject|1
1503144|NCT00453999|4945121|P2|Overall Study|Withdrawal by Subject|1
1503145|NCT00453999|4945122|P1|Overall Study|Withdrawal by Subject|2
1503146|NCT00453999|4945120|P3|Overall Study|Lost to Follow-up|1
1503147|NCT00453999|4945121|P2|Overall Study|Lost to Follow-up|1
1503148|NCT00453999|4945122|P1|Overall Study|Lost to Follow-up|0
1503149|NCT00453999|4945120|P3|Overall Study|Adverse Event|1
1503150|NCT00453999|4945121|P2|Overall Study|Adverse Event|2
1503151|NCT00453999|4945122|P1|Overall Study|Adverse Event|1
1503152|NCT00453986|4945150|P5|Overall Study|Lost to Follow-up|0
1503153|NCT00453986|4945151|P4|Overall Study|Lost to Follow-up|2
1503154|NCT00453986|4945152|P3|Overall Study|Lost to Follow-up|6
1503155|NCT00453986|4945153|P2|Overall Study|Lost to Follow-up|5
1503156|NCT00453986|4945154|P1|Overall Study|Lost to Follow-up|6
1503157|NCT00453973|4945249|P2|Overall Study|Sponsor Decision to Terminate Study|30
1503158|NCT00453973|4945250|P1|Overall Study|Sponsor Decision to Terminate Study|35
1503159|NCT00453973|4945249|P2|Overall Study|Site closed by sponsor|0
1503160|NCT00453973|4945250|P1|Overall Study|Site closed by sponsor|3
1503161|NCT00453973|4945249|P2|Overall Study|Renal transplant|1
1503162|NCT00453973|4945250|P1|Overall Study|Renal transplant|1
1503163|NCT00453973|4945249|P2|Overall Study|Relocation|0
1503164|NCT00453973|4945250|P1|Overall Study|Relocation|1
1503165|NCT00453973|4945249|P2|Overall Study|PI Decision|2
1503166|NCT00453973|4945250|P1|Overall Study|PI Decision|0
1503167|NCT00453973|4945249|P2|Overall Study|Withdrawal by Subject|6
1503168|NCT00453973|4945250|P1|Overall Study|Withdrawal by Subject|7
1503169|NCT00453973|4945249|P2|Overall Study|Adverse Event|9
1503170|NCT00453973|4945250|P1|Overall Study|Adverse Event|4
1503171|NCT00453921|4945260|P4|Overall Study|Lost to Follow-up|0
1503172|NCT00453921|4945261|P3|Overall Study|Lost to Follow-up|1
1503173|NCT00453921|4945262|P2|Overall Study|Lost to Follow-up|0
1503174|NCT00453921|4945263|P1|Overall Study|Lost to Follow-up|0
1503175|NCT00453921|4945260|P4|Overall Study|Withdrawal by Subject|1
1503176|NCT00453921|4945261|P3|Overall Study|Withdrawal by Subject|1
1503177|NCT00453921|4945262|P2|Overall Study|Withdrawal by Subject|1
1503178|NCT00453921|4945263|P1|Overall Study|Withdrawal by Subject|1
1503179|NCT00453362|4945402|P1|Overall Study|Screening Failure|14
1503180|NCT00453362|4945402|P1|Overall Study|Progression of disease|56
1503181|NCT00453362|4945402|P1|Overall Study|Withdrawal by Subject|3
1503182|NCT00453362|4945402|P1|Overall Study|Physician Decision|2
1503183|NCT00453362|4945402|P1|Overall Study|Death|7
1503184|NCT00453362|4945402|P1|Overall Study|Adverse Event|5
1503185|NCT00453349|4945428|P2|Completed Study|Lost to follow up after study treatment|11
1503186|NCT00453349|4945429|P1|Completed Study|Lost to follow up after study treatment|2
1503187|NCT00453349|4945428|P2|Completed Study|Withdrawal by Subject|5
1503188|NCT00453349|4945429|P1|Completed Study|Withdrawal by Subject|3
1503189|NCT00453349|4945428|P2|Completed Study|Protocol Violation|1
1503190|NCT00453349|4945429|P1|Completed Study|Protocol Violation|1
1503191|NCT00453349|4945428|P2|Completed Study|Lost to Follow-up|5
1503192|NCT00453349|4945429|P1|Completed Study|Lost to Follow-up|7
1503193|NCT00453349|4945428|P2|Completed Study|Lack of Efficacy|1
1503194|NCT00453349|4945429|P1|Completed Study|Lack of Efficacy|2
1503195|NCT00453349|4945428|P2|Completed Study|Adverse Event|11
1503196|NCT00453349|4945429|P1|Completed Study|Adverse Event|12
1503197|NCT00453349|4945428|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
1503198|NCT00453349|4945429|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
1503199|NCT00453349|4945428|P2|Randomized|Withdrawal by Subject|5
1503200|NCT00453349|4945429|P1|Randomized|Withdrawal by Subject|3
1503201|NCT00453349|4945428|P2|Randomized|Protocol Violation|1
1503202|NCT00453349|4945429|P1|Randomized|Protocol Violation|1
1503203|NCT00453349|4945428|P2|Randomized|Lost to Follow-up|5
1503204|NCT00453349|4945429|P1|Randomized|Lost to Follow-up|7
1503205|NCT00453349|4945428|P2|Randomized|Lack of Efficacy|1
1503206|NCT00453349|4945429|P1|Randomized|Lack of Efficacy|2
1503207|NCT00453349|4945428|P2|Randomized|Adverse Event|11
1503208|NCT00453349|4945429|P1|Randomized|Adverse Event|12
1503209|NCT00453310|4945460|P1|Overall Study|Progression of Disease|10
1503210|NCT00453206|4945464|P1|Overall Study|Death|1
1503211|NCT00453180|4945474|P2|Overall Study|Adverse Event|2
1503212|NCT00453180|4945475|P1|Overall Study|Adverse Event|1
1503213|NCT00453180|4945474|P2|Overall Study|Lost to Follow-up|1
1503214|NCT00453180|4945475|P1|Overall Study|Lost to Follow-up|2
1503215|NCT00453154|4945494|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
1503216|NCT00453154|4945495|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
1503217|NCT00453154|4945496|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
1503218|NCT00453154|4945497|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
1503219|NCT00453154|4945494|P4|Double BIind Maintenance|Medical Issues|1
1503220|NCT00453154|4945495|P3|Double BIind Maintenance|Medical Issues|3
1503221|NCT00453154|4945496|P2|Double BIind Maintenance|Medical Issues|0
1503222|NCT00453154|4945497|P1|Double BIind Maintenance|Medical Issues|0
1503223|NCT00453154|4945494|P4|Double BIind Maintenance|Progression|26
1503224|NCT00453154|4945495|P3|Double BIind Maintenance|Progression|29
1503225|NCT00453154|4945496|P2|Double BIind Maintenance|Progression|0
1503226|NCT00453154|4945497|P1|Double BIind Maintenance|Progression|0
1503227|NCT00453154|4945494|P4|Double BIind Maintenance|Withdrawal by Subject|4
1503228|NCT00453154|4945495|P3|Double BIind Maintenance|Withdrawal by Subject|4
1503229|NCT00453154|4945496|P2|Double BIind Maintenance|Withdrawal by Subject|0
1503230|NCT00453154|4945497|P1|Double BIind Maintenance|Withdrawal by Subject|0
1503231|NCT00453154|4945494|P4|Double BIind Maintenance|Death|1
1503232|NCT00453154|4945495|P3|Double BIind Maintenance|Death|2
1503233|NCT00453154|4945496|P2|Double BIind Maintenance|Death|0
1503234|NCT00453154|4945497|P1|Double BIind Maintenance|Death|0
1503235|NCT00453154|4945494|P4|Double BIind Maintenance|Adverse Event|12
1503236|NCT00453154|4945495|P3|Double BIind Maintenance|Adverse Event|3
1503237|NCT00453154|4945496|P2|Double BIind Maintenance|Adverse Event|0
1503238|NCT00453154|4945497|P1|Double BIind Maintenance|Adverse Event|0
1503239|NCT00453102|4945510|P1|Overall Study|Withdrawal by Subject|2
1503240|NCT00453063|4945521|P2|Overall Study|Protocol Violation|0
1503241|NCT00453063|4945522|P1|Overall Study|Protocol Violation|1
1503242|NCT00453063|4945521|P2|Overall Study|Withdrawal by Subject|1
1503243|NCT00453063|4945522|P1|Overall Study|Withdrawal by Subject|1
1503244|NCT00453063|4945521|P2|Overall Study|Adverse Event|2
1503245|NCT00453063|4945522|P1|Overall Study|Adverse Event|1
1503246|NCT00452790|4945542|P2|Toddler Dose|Parent/legal guardian request|1
1503247|NCT00452790|4945543|P1|Toddler Dose|Parent/legal guardian request|0
1503248|NCT00452790|4945542|P2|Toddler Dose|Failed to return|1
1503249|NCT00452790|4945543|P1|Toddler Dose|Failed to return|0
1503250|NCT00452790|4945542|P2|After Infant Series|Other reasons|0
1503251|NCT00452790|4945543|P1|After Infant Series|Other reasons|1
1503252|NCT00452790|4945542|P2|After Infant Series|Failed to return|0
1503253|NCT00452790|4945543|P1|After Infant Series|Failed to return|1
1503254|NCT00452790|4945542|P2|After Infant Series|Lost to Follow-up|0
1503255|NCT00452790|4945543|P1|After Infant Series|Lost to Follow-up|4
1503256|NCT00452790|4945542|P2|After Infant Series|Parent/legal guardian request|3
1503257|NCT00452790|4945543|P1|After Infant Series|Parent/legal guardian request|1
1503258|NCT00452790|4945542|P2|After Infant Series|Adverse Event|1
1503259|NCT00452790|4945543|P1|After Infant Series|Adverse Event|4
1503260|NCT00452790|4945542|P2|After Infant Series|Investigator request|10
1503261|NCT00452790|4945543|P1|After Infant Series|Investigator request|10
1503262|NCT00452790|4945542|P2|Infant Series|Death|1
1503263|NCT00452790|4945543|P1|Infant Series|Death|0
1503264|NCT00452790|4945542|P2|Infant Series|Investigator request|1
1503265|NCT00452790|4945543|P1|Infant Series|Investigator request|0
1503266|NCT00452790|4945542|P2|Infant Series|Other reasons|2
1503267|NCT00452790|4945543|P1|Infant Series|Other reasons|1
1503268|NCT00452790|4945542|P2|Infant Series|Adverse Event|2
1503269|NCT00452790|4945543|P1|Infant Series|Adverse Event|1
1503270|NCT00452790|4945542|P2|Infant Series|Lost to Follow-up|2
1503271|NCT00452790|4945543|P1|Infant Series|Lost to Follow-up|2
1503272|NCT00452790|4945542|P2|Infant Series|Protocol Violation|3
1503273|NCT00452790|4945543|P1|Infant Series|Protocol Violation|1
1503274|NCT00452790|4945542|P2|Infant Series|Failed to return|1
1503275|NCT00452790|4945543|P1|Infant Series|Failed to return|4
1503276|NCT00452790|4945542|P2|Infant Series|Parent/legal guardian request|6
1503277|NCT00452790|4945543|P1|Infant Series|Parent/legal guardian request|8
1503278|NCT00452790|4945542|P2|Infant Series|Clinical hold - consent withdrawn|123
1503279|NCT00452790|4945543|P1|Infant Series|Clinical hold - consent withdrawn|118
1503280|NCT00452699|4945579|P2|Overall Study|Other|7
1503281|NCT00452699|4945580|P1|Overall Study|Other|12
1503282|NCT00452699|4945579|P2|Overall Study|Withdrawal by Subject|25
1503283|NCT00452699|4945580|P1|Overall Study|Withdrawal by Subject|26
1503284|NCT00452699|4945579|P2|Overall Study|Protocol Violation|25
1503285|NCT00452699|4945580|P1|Overall Study|Protocol Violation|21
1503286|NCT00452699|4945579|P2|Overall Study|Lost to Follow-up|9
1503287|NCT00452699|4945580|P1|Overall Study|Lost to Follow-up|6
1503288|NCT00452699|4945579|P2|Overall Study|Lack of Efficacy|4
1503289|NCT00452699|4945580|P1|Overall Study|Lack of Efficacy|6
1503290|NCT00452699|4945579|P2|Overall Study|Adverse Event|3
1503291|NCT00452699|4945580|P1|Overall Study|Adverse Event|10
1503292|NCT00452673|4945596|P5|Dose Expansion Period|not specified|2
1503293|NCT00452673|4945597|P4|Dose Expansion Period|not specified|0
1503294|NCT00452673|4945598|P3|Dose Expansion Period|not specified|0
1503295|NCT00452673|4945599|P2|Dose Expansion Period|not specified|0
1503296|NCT00452673|4945600|P1|Dose Expansion Period|not specified|0
1503297|NCT00452673|4945596|P5|Dose Expansion Period|Disease Progression|19
1503298|NCT00452673|4945597|P4|Dose Expansion Period|Disease Progression|0
1503299|NCT00452673|4945598|P3|Dose Expansion Period|Disease Progression|0
1503300|NCT00452673|4945599|P2|Dose Expansion Period|Disease Progression|0
1503301|NCT00452673|4945600|P1|Dose Expansion Period|Disease Progression|0
1503302|NCT00452673|4945596|P5|Dose Escalation Period|Withdrawal by Subject|0
1503303|NCT00452673|4945597|P4|Dose Escalation Period|Withdrawal by Subject|1
1503304|NCT00452673|4945598|P3|Dose Escalation Period|Withdrawal by Subject|0
1503305|NCT00452673|4945599|P2|Dose Escalation Period|Withdrawal by Subject|0
1503306|NCT00452673|4945600|P1|Dose Escalation Period|Withdrawal by Subject|0
1503307|NCT00452673|4945596|P5|Dose Escalation Period|Adverse Event|0
1503308|NCT00452673|4945597|P4|Dose Escalation Period|Adverse Event|1
1503309|NCT00452673|4945598|P3|Dose Escalation Period|Adverse Event|0
1503310|NCT00452673|4945599|P2|Dose Escalation Period|Adverse Event|0
1503311|NCT00452673|4945600|P1|Dose Escalation Period|Adverse Event|0
1503312|NCT00452673|4945596|P5|Dose Escalation Period|not specified|0
1503313|NCT00452673|4945597|P4|Dose Escalation Period|not specified|0
1503314|NCT00452673|4945598|P3|Dose Escalation Period|not specified|1
1503315|NCT00452673|4945599|P2|Dose Escalation Period|not specified|0
1503316|NCT00452673|4945600|P1|Dose Escalation Period|not specified|0
1503317|NCT00452673|4945596|P5|Dose Escalation Period|study drug toxicity|0
1503318|NCT00452673|4945597|P4|Dose Escalation Period|study drug toxicity|1
1503319|NCT00452673|4945598|P3|Dose Escalation Period|study drug toxicity|3
1503320|NCT00452673|4945599|P2|Dose Escalation Period|study drug toxicity|3
1503321|NCT00452673|4945600|P1|Dose Escalation Period|study drug toxicity|1
1503322|NCT00452673|4945596|P5|Dose Escalation Period|Disease Progression|0
1503323|NCT00452673|4945597|P4|Dose Escalation Period|Disease Progression|6
1503324|NCT00452673|4945598|P3|Dose Escalation Period|Disease Progression|2
1503325|NCT00452673|4945599|P2|Dose Escalation Period|Disease Progression|6
1503326|NCT00452673|4945600|P1|Dose Escalation Period|Disease Progression|6
1503327|NCT00452530|4945647|P2|Overall Study|Not specified|11
1503328|NCT00452530|4945648|P1|Overall Study|Not specified|7
1503329|NCT00452530|4945647|P2|Overall Study|No longer met study criteria|22
1503330|NCT00452530|4945648|P1|Overall Study|No longer met study criteria|18
1503331|NCT00452530|4945647|P2|Overall Study|Poor compliance/noncompliance|2
1503332|NCT00452530|4945648|P1|Overall Study|Poor compliance/noncompliance|1
1503333|NCT00452530|4945647|P2|Overall Study|Lost to Follow-up|0
1503334|NCT00452530|4945648|P1|Overall Study|Lost to Follow-up|1
1503335|NCT00452530|4945647|P2|Overall Study|Withdrawal by Subject|57
1503336|NCT00452530|4945648|P1|Overall Study|Withdrawal by Subject|68
1503337|NCT00452530|4945647|P2|Overall Study|Adverse Event|44
1503338|NCT00452530|4945648|P1|Overall Study|Adverse Event|40
1503339|NCT00452530|4945647|P2|Overall Study|Death|0
1503340|NCT00452530|4945648|P1|Overall Study|Death|1
1503341|NCT00452452|4945669|P3|Overall Study|Lost to Follow-up|0
1503342|NCT00452452|4945670|P2|Overall Study|Lost to Follow-up|0
1503343|NCT00452452|4945671|P1|Overall Study|Lost to Follow-up|1
1503344|NCT00452452|4945669|P3|Overall Study|Withdrawal by Subject|0
1503345|NCT00452452|4945670|P2|Overall Study|Withdrawal by Subject|0
1503346|NCT00452452|4945671|P1|Overall Study|Withdrawal by Subject|1
1503347|NCT00452452|4945669|P3|Overall Study|Protocol Violation|1
1503348|NCT00452452|4945670|P2|Overall Study|Protocol Violation|0
1503349|NCT00452452|4945671|P1|Overall Study|Protocol Violation|0
1503350|NCT00452400|4945716|P5|Overall Study|Other reasons not listed above|1
1503351|NCT00452400|4945717|P4|Overall Study|Other reasons not listed above|1
1503352|NCT00452400|4945718|P3|Overall Study|Other reasons not listed above|0
1503353|NCT00452400|4945719|P2|Overall Study|Other reasons not listed above|0
1503354|NCT00452400|4945720|P1|Overall Study|Other reasons not listed above|0
1503355|NCT00452400|4945716|P5|Overall Study|Lack of Efficacy|0
1503356|NCT00452400|4945717|P4|Overall Study|Lack of Efficacy|0
1503357|NCT00452400|4945718|P3|Overall Study|Lack of Efficacy|0
1503358|NCT00452400|4945719|P2|Overall Study|Lack of Efficacy|0
1503359|NCT00452400|4945720|P1|Overall Study|Lack of Efficacy|2
1503360|NCT00452400|4945716|P5|Overall Study|Withdrawal by Subject|0
1503361|NCT00452400|4945717|P4|Overall Study|Withdrawal by Subject|0
1503362|NCT00452400|4945718|P3|Overall Study|Withdrawal by Subject|1
1503363|NCT00452400|4945719|P2|Overall Study|Withdrawal by Subject|0
1503364|NCT00452400|4945720|P1|Overall Study|Withdrawal by Subject|1
1503365|NCT00452400|4945716|P5|Overall Study|Lost to Follow-up|0
1503366|NCT00452400|4945717|P4|Overall Study|Lost to Follow-up|0
1503367|NCT00452400|4945718|P3|Overall Study|Lost to Follow-up|0
1503368|NCT00452400|4945719|P2|Overall Study|Lost to Follow-up|0
1503369|NCT00452400|4945720|P1|Overall Study|Lost to Follow-up|1
1503370|NCT00452400|4945716|P5|Overall Study|Protocol Violation|0
1503371|NCT00452400|4945717|P4|Overall Study|Protocol Violation|0
1503372|NCT00452400|4945718|P3|Overall Study|Protocol Violation|1
1503373|NCT00452400|4945719|P2|Overall Study|Protocol Violation|0
1503374|NCT00452400|4945720|P1|Overall Study|Protocol Violation|0
1503375|NCT00452400|4945716|P5|Overall Study|Adverse Event|2
1503376|NCT00452400|4945717|P4|Overall Study|Adverse Event|0
1503377|NCT00452400|4945718|P3|Overall Study|Adverse Event|5
1503378|NCT00452400|4945719|P2|Overall Study|Adverse Event|1
1503379|NCT00452400|4945720|P1|Overall Study|Adverse Event|1
1503380|NCT00452361|4945907|P2|Overall Study|Premature termination|9
1503381|NCT00452361|4945908|P1|Overall Study|Premature termination|13
1503382|NCT00452361|4945907|P2|Overall Study|Withdrawal by Subject|1
1503383|NCT00452361|4945908|P1|Overall Study|Withdrawal by Subject|0
1503384|NCT00452361|4945907|P2|Overall Study|Adverse Event|0
1503385|NCT00452361|4945908|P1|Overall Study|Adverse Event|8
1503386|NCT00452348|4945952|P2|Overall Study|Other|9
1503387|NCT00452348|4945953|P1|Overall Study|Other|9
1503388|NCT00452348|4945952|P2|Overall Study|Withdrawal by Subject|21
1503389|NCT00452348|4945953|P1|Overall Study|Withdrawal by Subject|18
1503390|NCT00452348|4945952|P2|Overall Study|Protocol Violation|28
1503391|NCT00452348|4945953|P1|Overall Study|Protocol Violation|22
1503392|NCT00452348|4945952|P2|Overall Study|Lost to Follow-up|8
1503393|NCT00452348|4945953|P1|Overall Study|Lost to Follow-up|14
1503394|NCT00452348|4945952|P2|Overall Study|Lack of Efficacy|9
1503395|NCT00452348|4945953|P1|Overall Study|Lack of Efficacy|10
1503396|NCT00452348|4945952|P2|Overall Study|Adverse Event|9
1503397|NCT00452348|4945953|P1|Overall Study|Adverse Event|6
1503398|NCT00452114|4946007|P2|Overall Study|Physician Decision|3
1503399|NCT00452114|4946008|P1|Overall Study|Physician Decision|3
1503400|NCT00451958|4946018|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
1503401|NCT00451958|4946019|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
1503402|NCT00451958|4946020|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
1503403|NCT00451958|4946021|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
1503404|NCT00451958|4946022|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
1503405|NCT00451958|4946018|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
1503406|NCT00451958|4946019|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
1503407|NCT00451958|4946020|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
1503408|NCT00451958|4946021|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
1503409|NCT00451958|4946022|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
1503410|NCT00451958|4946018|P5|CS21A (NCT00451958)|Physician Decision|0
1503411|NCT00451958|4946019|P4|CS21A (NCT00451958)|Physician Decision|4
1503412|NCT00451958|4946020|P3|CS21A (NCT00451958)|Physician Decision|4
1503413|NCT00451958|4946021|P2|CS21A (NCT00451958)|Physician Decision|4
1503414|NCT00451958|4946022|P1|CS21A (NCT00451958)|Physician Decision|2
1503415|NCT00451958|4946018|P5|CS21A (NCT00451958)|Protocol Violation|0
1503416|NCT00451958|4946019|P4|CS21A (NCT00451958)|Protocol Violation|0
1503417|NCT00451958|4946020|P3|CS21A (NCT00451958)|Protocol Violation|2
1503418|NCT00451958|4946021|P2|CS21A (NCT00451958)|Protocol Violation|3
1503419|NCT00451958|4946022|P1|CS21A (NCT00451958)|Protocol Violation|1
1503420|NCT00451958|4946018|P5|CS21A (NCT00451958)|Lost to Follow-up|0
1503421|NCT00451958|4946019|P4|CS21A (NCT00451958)|Lost to Follow-up|1
1503422|NCT00451958|4946020|P3|CS21A (NCT00451958)|Lost to Follow-up|1
1503423|NCT00451958|4946021|P2|CS21A (NCT00451958)|Lost to Follow-up|5
1503424|NCT00451958|4946022|P1|CS21A (NCT00451958)|Lost to Follow-up|6
1503425|NCT00451958|4946018|P5|CS21A (NCT00451958)|Adverse Event|0
1503426|NCT00451958|4946019|P4|CS21A (NCT00451958)|Adverse Event|17
1503427|NCT00451958|4946020|P3|CS21A (NCT00451958)|Adverse Event|14
1503428|NCT00451958|4946021|P2|CS21A (NCT00451958)|Adverse Event|34
1503429|NCT00451958|4946022|P1|CS21A (NCT00451958)|Adverse Event|21
1503430|NCT00451906|4946052|P1|Overall Study|Did not complete final visit|4
1503431|NCT00451906|4946052|P1|Overall Study|Other Reasons|121
1503432|NCT00451906|4946052|P1|Overall Study|Termination of the study|108
1503433|NCT00451906|4946052|P1|Overall Study|Progressive disease|1328
1503434|NCT00451906|4946052|P1|Overall Study|Protocol Violation|21
1503435|NCT00451906|4946052|P1|Overall Study|Withdrawal by Subject|111
1503436|NCT00451906|4946052|P1|Overall Study|Lost to Follow-up|31
1503437|NCT00451906|4946052|P1|Overall Study|Adverse Event|515
1503438|NCT00451451|4946075|P4|Overall Study|Other Reasons for Not Completing Study|14
1503439|NCT00451451|4946076|P3|Overall Study|Other Reasons for Not Completing Study|17
1503440|NCT00451451|4946077|P2|Overall Study|Other Reasons for Not Completing Study|30
1503441|NCT00451451|4946078|P1|Overall Study|Other Reasons for Not Completing Study|34
1503442|NCT00451451|4946075|P4|Overall Study|Death|1
1503443|NCT00451451|4946076|P3|Overall Study|Death|0
1503444|NCT00451451|4946077|P2|Overall Study|Death|0
1503445|NCT00451451|4946078|P1|Overall Study|Death|1
1503446|NCT00451451|4946075|P4|Overall Study|Subject Non-Compliance|3
1503447|NCT00451451|4946076|P3|Overall Study|Subject Non-Compliance|3
1503448|NCT00451451|4946077|P2|Overall Study|Subject Non-Compliance|4
1503449|NCT00451451|4946078|P1|Overall Study|Subject Non-Compliance|8
1503450|NCT00451451|4946075|P4|Overall Study|Investigator Decision|2
1503451|NCT00451451|4946076|P3|Overall Study|Investigator Decision|1
1503452|NCT00451451|4946077|P2|Overall Study|Investigator Decision|2
1503453|NCT00451451|4946078|P1|Overall Study|Investigator Decision|6
1503454|NCT00451451|4946075|P4|Overall Study|Consent Withdrawn|17
1503455|NCT00451451|4946076|P3|Overall Study|Consent Withdrawn|17
1503456|NCT00451451|4946077|P2|Overall Study|Consent Withdrawn|9
1503457|NCT00451451|4946078|P1|Overall Study|Consent Withdrawn|14
1503458|NCT00451451|4946075|P4|Overall Study|Lost to Follow-up|11
1503459|NCT00451451|4946076|P3|Overall Study|Lost to Follow-up|8
1503460|NCT00451451|4946077|P2|Overall Study|Lost to Follow-up|9
1503461|NCT00451451|4946078|P1|Overall Study|Lost to Follow-up|11
1503462|NCT00451451|4946075|P4|Overall Study|Adverse Event|10
1503463|NCT00451451|4946076|P3|Overall Study|Adverse Event|26
1503464|NCT00451451|4946077|P2|Overall Study|Adverse Event|21
1503465|NCT00451451|4946078|P1|Overall Study|Adverse Event|11
1503466|NCT00451321|4946113|P8|Overall Study|Sponsor decision to amend protocol|3
1503467|NCT00451321|4946114|P7|Overall Study|Sponsor decision to amend protocol|1
1503468|NCT00451321|4946115|P6|Overall Study|Sponsor decision to amend protocol|1
1503469|NCT00451321|4946116|P5|Overall Study|Sponsor decision to amend protocol|0
1503470|NCT00451321|4946117|P4|Overall Study|Sponsor decision to amend protocol|0
1503471|NCT00451321|4946118|P3|Overall Study|Sponsor decision to amend protocol|0
1503472|NCT00451321|4946119|P2|Overall Study|Sponsor decision to amend protocol|0
1503473|NCT00451321|4946120|P1|Overall Study|Sponsor decision to amend protocol|0
1503474|NCT00451321|4946113|P8|Overall Study|Study closed/terminated|3
1503475|NCT00451321|4946114|P7|Overall Study|Study closed/terminated|5
1503476|NCT00451321|4946115|P6|Overall Study|Study closed/terminated|7
1503477|NCT00451321|4946116|P5|Overall Study|Study closed/terminated|7
1503478|NCT00451321|4946117|P4|Overall Study|Study closed/terminated|5
1503479|NCT00451321|4946118|P3|Overall Study|Study closed/terminated|17
1503480|NCT00451321|4946119|P2|Overall Study|Study closed/terminated|1
1503481|NCT00451321|4946120|P1|Overall Study|Study closed/terminated|1
1503482|NCT00451321|4946113|P8|Overall Study|Withdrawal by Subject|0
1503483|NCT00451321|4946114|P7|Overall Study|Withdrawal by Subject|0
1503484|NCT00451321|4946115|P6|Overall Study|Withdrawal by Subject|0
1503485|NCT00451321|4946116|P5|Overall Study|Withdrawal by Subject|0
1503486|NCT00451321|4946117|P4|Overall Study|Withdrawal by Subject|4
1503487|NCT00451321|4946118|P3|Overall Study|Withdrawal by Subject|0
1503488|NCT00451321|4946119|P2|Overall Study|Withdrawal by Subject|1
1503489|NCT00451321|4946120|P1|Overall Study|Withdrawal by Subject|3
1503490|NCT00451321|4946113|P8|Overall Study|Lost to Follow-up|0
1503491|NCT00451321|4946114|P7|Overall Study|Lost to Follow-up|0
1503492|NCT00451321|4946115|P6|Overall Study|Lost to Follow-up|1
1503493|NCT00451321|4946116|P5|Overall Study|Lost to Follow-up|0
1503494|NCT00451321|4946117|P4|Overall Study|Lost to Follow-up|3
1503495|NCT00451321|4946118|P3|Overall Study|Lost to Follow-up|1
1503496|NCT00451321|4946119|P2|Overall Study|Lost to Follow-up|3
1503497|NCT00451321|4946120|P1|Overall Study|Lost to Follow-up|3
1503498|NCT00451282|4946292|P2|Overall Study|Lost to Follow-up|5
1503499|NCT00451282|4946293|P1|Overall Study|Lost to Follow-up|6
1503500|NCT00451204|4946307|P2|Overall Study|Other|2
1503501|NCT00451204|4946308|P1|Overall Study|Other|1
1503502|NCT00451204|4946307|P2|Overall Study|Patient refusal|4
1503503|NCT00451204|4946308|P1|Overall Study|Patient refusal|8
1503504|NCT00451204|4946307|P2|Overall Study|Protocol Violation|0
1503505|NCT00451204|4946308|P1|Overall Study|Protocol Violation|1
1503506|NCT00451204|4946307|P2|Overall Study|Lost to Follow-up|4
1503507|NCT00451204|4946308|P1|Overall Study|Lost to Follow-up|4
1503508|NCT00451204|4946307|P2|Overall Study|Lack of Efficacy|4
1503509|NCT00451204|4946308|P1|Overall Study|Lack of Efficacy|4
1503510|NCT00451204|4946307|P2|Overall Study|Adverse Event|6
1503511|NCT00451204|4946308|P1|Overall Study|Adverse Event|4
1503512|NCT00451191|4946326|P2|Overall Study|withdrawal or received alternate tx|11
1503513|NCT00451191|4946327|P1|Overall Study|withdrawal or received alternate tx|15
1503514|NCT00450866|4946349|P2|Overall Study|Physician Decision|0
1503515|NCT00450866|4946350|P1|Overall Study|Physician Decision|1
1503516|NCT00450866|4946349|P2|Overall Study|Death|0
1503517|NCT00450866|4946350|P1|Overall Study|Death|1
1503518|NCT00450866|4946349|P2|Overall Study|Withdrawal by Subject|2
1503519|NCT00450866|4946350|P1|Overall Study|Withdrawal by Subject|5
1503520|NCT00450866|4946349|P2|Overall Study|Adverse Event|1
1503521|NCT00450866|4946350|P1|Overall Study|Adverse Event|0
1503522|NCT00450801|4946360|P1|Overall Study|Death|1
1503523|NCT00450749|4946374|P3|Overall Study|Noncompliant|0
1503524|NCT00450749|4946375|P2|Overall Study|Noncompliant|1
1503525|NCT00450749|4946376|P1|Overall Study|Noncompliant|0
1503526|NCT00450749|4946374|P3|Overall Study|Withdrawal by Subject|2
1503527|NCT00450749|4946375|P2|Overall Study|Withdrawal by Subject|0
1503528|NCT00450749|4946376|P1|Overall Study|Withdrawal by Subject|0
1503529|NCT00450723|4946384|P1|Overall Study|Physician Decision|5
1503530|NCT00450658|4946392|P2|Overall Study|misc|10
1503531|NCT00450658|4946393|P1|Overall Study|misc|21
1503532|NCT00450658|4946392|P2|Overall Study|UGI ulcer|34
1503533|NCT00450658|4946393|P1|Overall Study|UGI ulcer|33
1503534|NCT00450658|4946392|P2|Overall Study|Lost to Follow-up|5
1503535|NCT00450658|4946393|P1|Overall Study|Lost to Follow-up|22
1503536|NCT00450658|4946392|P2|Overall Study|Withdrawal by Subject|26
1503537|NCT00450658|4946393|P1|Overall Study|Withdrawal by Subject|43
1503538|NCT00450658|4946392|P2|Overall Study|Adverse Event|15
1503539|NCT00450658|4946393|P1|Overall Study|Adverse Event|24
1503540|NCT00450619|4946407|P2|Overall Study|Adverse Event|0
1503541|NCT00450619|4946408|P1|Overall Study|Adverse Event|1
1503542|NCT00450619|4946407|P2|Overall Study|did not progress; refused further trmt|1
1503543|NCT00450619|4946408|P1|Overall Study|did not progress; refused further trmt|1
1503544|NCT00450619|4946407|P2|Overall Study|refused treatment after randomization|0
1503545|NCT00450619|4946408|P1|Overall Study|refused treatment after randomization|2
1503546|NCT00450580|4946434|P2|Overall Study|Withdrawal due to pregnancy|1
1503547|NCT00450580|4946435|P1|Overall Study|Withdrawal due to pregnancy|0
1503548|NCT00450580|4946434|P2|Overall Study|Patient could not swallow Norvir|0
1503549|NCT00450580|4946435|P1|Overall Study|Patient could not swallow Norvir|1
1503550|NCT00450580|4946434|P2|Overall Study|Patient went to Brazil|0
1503551|NCT00450580|4946435|P1|Overall Study|Patient went to Brazil|1
1503552|NCT00450580|4946434|P2|Overall Study|Could not comply with scheduled visits|0
1503553|NCT00450580|4946435|P1|Overall Study|Could not comply with scheduled visits|1
1503554|NCT00450580|4946434|P2|Overall Study|Protocol-defined virologic failure|0
1503555|NCT00450580|4946435|P1|Overall Study|Protocol-defined virologic failure|1
1503556|NCT00450580|4946434|P2|Overall Study|Protocol Violation|1
1503557|NCT00450580|4946435|P1|Overall Study|Protocol Violation|1
1503558|NCT00450580|4946434|P2|Overall Study|Withdrawal by Subject|2
1503559|NCT00450580|4946435|P1|Overall Study|Withdrawal by Subject|2
1503560|NCT00450580|4946434|P2|Overall Study|Lost to Follow-up|5
1503561|NCT00450580|4946435|P1|Overall Study|Lost to Follow-up|4
1503562|NCT00450580|4946434|P2|Overall Study|Adverse Event|7
1503563|NCT00450580|4946435|P1|Overall Study|Adverse Event|5
1503564|NCT00450450|4946455|P2|Overall Study|Missing Data|0
1503565|NCT00450450|4946456|P1|Overall Study|Missing Data|2
1503566|NCT00450450|4946455|P2|Overall Study|Relapse|0
1503567|NCT00450450|4946456|P1|Overall Study|Relapse|2
1503568|NCT00450450|4946455|P2|Overall Study|Death|3
1503569|NCT00450450|4946456|P1|Overall Study|Death|1
1503570|NCT00450437|4946480|P4|Overall Study|Unable to Classify|0
1503571|NCT00450437|4946481|P3|Overall Study|Unable to Classify|1
1503572|NCT00450437|4946482|P2|Overall Study|Unable to Classify|0
1503573|NCT00450437|4946483|P1|Overall Study|Unable to Classify|1
1503574|NCT00450437|4946480|P4|Overall Study|Administrative reason|0
1503575|NCT00450437|4946481|P3|Overall Study|Administrative reason|1
1503576|NCT00450437|4946482|P2|Overall Study|Administrative reason|0
1503577|NCT00450437|4946483|P1|Overall Study|Administrative reason|0
1503578|NCT00450437|4946480|P4|Overall Study|Inappropriate enrollment|0
1503579|NCT00450437|4946481|P3|Overall Study|Inappropriate enrollment|3
1503580|NCT00450437|4946482|P2|Overall Study|Inappropriate enrollment|1
1503581|NCT00450437|4946483|P1|Overall Study|Inappropriate enrollment|4
1503582|NCT00450437|4946480|P4|Overall Study|Protocol Violation|1
1503583|NCT00450437|4946481|P3|Overall Study|Protocol Violation|0
1503584|NCT00450437|4946482|P2|Overall Study|Protocol Violation|1
1503585|NCT00450437|4946483|P1|Overall Study|Protocol Violation|0
1503586|NCT00450437|4946480|P4|Overall Study|Lost to Follow-up|9
1503587|NCT00450437|4946481|P3|Overall Study|Lost to Follow-up|19
1503588|NCT00450437|4946482|P2|Overall Study|Lost to Follow-up|12
1503589|NCT00450437|4946483|P1|Overall Study|Lost to Follow-up|31
1503590|NCT00450437|4946480|P4|Overall Study|Withdrawal by Subject|1
1503591|NCT00450437|4946481|P3|Overall Study|Withdrawal by Subject|0
1503592|NCT00450437|4946482|P2|Overall Study|Withdrawal by Subject|2
1503593|NCT00450437|4946483|P1|Overall Study|Withdrawal by Subject|10
1503594|NCT00450411|4946514|P1|Overall Study|No protocol treatment|2
1503595|NCT00450411|4946514|P1|Overall Study|Protocol Violation|6
1503596|NCT00450385|4946519|P1|Overall Study|Other|3
1503597|NCT00450385|4946519|P1|Overall Study|Physician Decision|1
1503598|NCT00450385|4946519|P1|Overall Study|Adverse Event|1
1503599|NCT00450385|4946519|P1|Overall Study|Lack of Efficacy|2
1503600|NCT00450385|4946519|P1|Overall Study|Withdrawal by Subject|2
1503601|NCT00450385|4946519|P1|Overall Study|Protocol Violation|1
1503602|NCT00450385|4946519|P1|Overall Study|Death|3
1503603|NCT00450372|4946528|P1|Overall Study|Physician Decision|1
1503604|NCT00450333|4946541|P4|Overall Study|Death|2
1503605|NCT00450333|4946542|P3|Overall Study|Death|2
1503606|NCT00450333|4946543|P2|Overall Study|Death|2
1503607|NCT00450333|4946544|P1|Overall Study|Death|3
1503608|NCT00450333|4946541|P4|Overall Study|Kidney transplant|3
1503609|NCT00450333|4946542|P3|Overall Study|Kidney transplant|1
1503610|NCT00450333|4946543|P2|Overall Study|Kidney transplant|0
1503611|NCT00450333|4946544|P1|Overall Study|Kidney transplant|1
1503612|NCT00450333|4946541|P4|Overall Study|Withdrawal by Subject|0
1503613|NCT00450333|4946542|P3|Overall Study|Withdrawal by Subject|3
1503614|NCT00450333|4946543|P2|Overall Study|Withdrawal by Subject|0
1503615|NCT00450333|4946544|P1|Overall Study|Withdrawal by Subject|1
1503616|NCT00450333|4946541|P4|Overall Study|Protocol Violation|0
1503617|NCT00450333|4946542|P3|Overall Study|Protocol Violation|1
1503618|NCT00450333|4946543|P2|Overall Study|Protocol Violation|0
1503619|NCT00450333|4946544|P1|Overall Study|Protocol Violation|1
1503620|NCT00450333|4946541|P4|Overall Study|Adverse Event|2
1503621|NCT00450333|4946542|P3|Overall Study|Adverse Event|2
1503622|NCT00450333|4946543|P2|Overall Study|Adverse Event|7
1503623|NCT00450333|4946544|P1|Overall Study|Adverse Event|1
1503624|NCT00450333|4946541|P4|Overall Study|Study terminated|21
1503625|NCT00450333|4946542|P3|Overall Study|Study terminated|16
1503626|NCT00450333|4946543|P2|Overall Study|Study terminated|54
1503627|NCT00450333|4946544|P1|Overall Study|Study terminated|47
1503628|NCT00450255|4946567|P1|Overall Study|Prior RFA ablation of liver|1
1503629|NCT00450216|4946592|P2|Overall Study|misc|20
1503630|NCT00450216|4946593|P1|Overall Study|misc|21
1503631|NCT00450216|4946592|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
1503632|NCT00450216|4946593|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
1503633|NCT00450216|4946592|P2|Overall Study|Lost to Follow-up|9
1503634|NCT00450216|4946593|P1|Overall Study|Lost to Follow-up|16
1503635|NCT00450216|4946592|P2|Overall Study|Withdrawal by Subject|26
1503636|NCT00450216|4946593|P1|Overall Study|Withdrawal by Subject|48
1503637|NCT00450216|4946592|P2|Overall Study|Adverse Event|23
1503638|NCT00450216|4946593|P1|Overall Study|Adverse Event|38
1503639|NCT00450190|4946605|P1|Overall Study|Withdrawal by Subject|2
1503640|NCT00450112|4946615|P2|Overall Study|Others|3
1503641|NCT00450112|4946616|P1|Overall Study|Others|2
1503642|NCT00450112|4946615|P2|Overall Study|Lost to Follow-up|1
1503643|NCT00450112|4946616|P1|Overall Study|Lost to Follow-up|2
1503644|NCT00450112|4946615|P2|Overall Study|Withdrawal by Subject|1
1503645|NCT00450112|4946616|P1|Overall Study|Withdrawal by Subject|4
1503646|NCT00450112|4946615|P2|Overall Study|Other Treatment Required|1
1503647|NCT00450112|4946616|P1|Overall Study|Other Treatment Required|5
1503648|NCT00449956|4946654|P3|Overall Study|Physician Decision|1
1503649|NCT00449956|4946655|P2|Overall Study|Physician Decision|1
1503650|NCT00449956|4946656|P1|Overall Study|Physician Decision|2
1503651|NCT00449956|4946654|P3|Overall Study|Withdrawal by Subject|0
1503652|NCT00449956|4946655|P2|Overall Study|Withdrawal by Subject|1
1503653|NCT00449956|4946656|P1|Overall Study|Withdrawal by Subject|0
1503654|NCT00449956|4946654|P3|Overall Study|Protocol Violation|1
1503655|NCT00449956|4946655|P2|Overall Study|Protocol Violation|1
1503656|NCT00449956|4946656|P1|Overall Study|Protocol Violation|1
1503657|NCT00449956|4946654|P3|Overall Study|Lack of Efficacy|1
1503658|NCT00449956|4946655|P2|Overall Study|Lack of Efficacy|0
1503659|NCT00449956|4946656|P1|Overall Study|Lack of Efficacy|0
1503660|NCT00449956|4946654|P3|Overall Study|Adverse Event|6
1503661|NCT00449956|4946655|P2|Overall Study|Adverse Event|1
1503662|NCT00449956|4946656|P1|Overall Study|Adverse Event|7
1503663|NCT00449930|4946672|P2|Overall Study|Glycemic discontinuation criteria|1
1503664|NCT00449930|4946673|P1|Overall Study|Glycemic discontinuation criteria|1
1503665|NCT00449930|4946672|P2|Overall Study|Withdrawal by Subject|23
1503666|NCT00449930|4946673|P1|Overall Study|Withdrawal by Subject|16
1503667|NCT00449930|4946672|P2|Overall Study|Protocol Violation|15
1503668|NCT00449930|4946673|P1|Overall Study|Protocol Violation|14
1503669|NCT00449930|4946672|P2|Overall Study|Physician Decision|2
1503670|NCT00449930|4946673|P1|Overall Study|Physician Decision|1
1503671|NCT00449930|4946672|P2|Overall Study|Lost to Follow-up|14
1503672|NCT00449930|4946673|P1|Overall Study|Lost to Follow-up|9
1503673|NCT00449930|4946672|P2|Overall Study|Lack of Efficacy|1
1503674|NCT00449930|4946673|P1|Overall Study|Lack of Efficacy|10
1503675|NCT00449930|4946672|P2|Overall Study|Trial Terminated ( Site Closed)|0
1503676|NCT00449930|4946673|P1|Overall Study|Trial Terminated ( Site Closed)|1
1503677|NCT00449930|4946672|P2|Overall Study|Adverse Event|19
1503678|NCT00449930|4946673|P1|Overall Study|Adverse Event|9
1503679|NCT00449865|4946689|P2|Overall Study|Study was stopped|328
1503680|NCT00449865|4946690|P1|Overall Study|Study was stopped|324
1503681|NCT00449865|4946689|P2|Overall Study|Protocol Violation|7
1503682|NCT00449865|4946690|P1|Overall Study|Protocol Violation|8
1503683|NCT00449865|4946689|P2|Overall Study|Death|40
1503684|NCT00449865|4946690|P1|Overall Study|Death|31
1503685|NCT00449865|4946689|P2|Overall Study|Physician Decision|12
1503686|NCT00449865|4946690|P1|Overall Study|Physician Decision|13
1503687|NCT00449865|4946689|P2|Overall Study|Lost to Follow-up|37
1503688|NCT00449865|4946690|P1|Overall Study|Lost to Follow-up|36
1503689|NCT00449865|4946689|P2|Overall Study|Withdrawal by Subject|110
1503690|NCT00449865|4946690|P1|Overall Study|Withdrawal by Subject|110
1503691|NCT00449787|4946698|P2|Overall Study|Did not require medication|92
1503692|NCT00449787|4946699|P1|Overall Study|Did not require medication|95
1503693|NCT00449787|4946698|P2|Overall Study|Lost to Follow-up|8
1503694|NCT00449787|4946699|P1|Overall Study|Lost to Follow-up|10
1503695|NCT00449696|4946715|P2|Overall Study|Others|0
1503696|NCT00449696|4946716|P1|Overall Study|Others|7
1503697|NCT00449696|4946715|P2|Overall Study|Lost to Follow-up|3
1503698|NCT00449696|4946716|P1|Overall Study|Lost to Follow-up|2
1503699|NCT00449696|4946715|P2|Overall Study|Withdrawal by Subject|5
1503700|NCT00449696|4946716|P1|Overall Study|Withdrawal by Subject|5
1503701|NCT00449696|4946715|P2|Overall Study|Other Treatment Required|1
1503702|NCT00449696|4946716|P1|Overall Study|Other Treatment Required|6
1503703|NCT00449644|4946742|P4|Overall Study|Rolled-over to treatment with TMC207|1
1503704|NCT00449644|4946743|P3|Overall Study|Rolled-over to treatment with TMC207|0
1503705|NCT00449644|4946744|P2|Overall Study|Rolled-over to treatment with TMC207|0
1503706|NCT00449644|4946745|P1|Overall Study|Rolled-over to treatment with TMC207|0
1503707|NCT00449644|4946742|P4|Overall Study|Not specified|0
1503708|NCT00449644|4946743|P3|Overall Study|Not specified|1
1503709|NCT00449644|4946744|P2|Overall Study|Not specified|4
1503710|NCT00449644|4946745|P1|Overall Study|Not specified|1
1503711|NCT00449644|4946742|P4|Overall Study|Inclusion/exclusion criteria not met|6
1503712|NCT00449644|4946743|P3|Overall Study|Inclusion/exclusion criteria not met|2
1503713|NCT00449644|4946744|P2|Overall Study|Inclusion/exclusion criteria not met|0
1503714|NCT00449644|4946745|P1|Overall Study|Inclusion/exclusion criteria not met|0
1503715|NCT00449644|4946742|P4|Overall Study|Withdrawal by Subject|7
1503716|NCT00449644|4946743|P3|Overall Study|Withdrawal by Subject|6
1503717|NCT00449644|4946744|P2|Overall Study|Withdrawal by Subject|4
1503718|NCT00449644|4946745|P1|Overall Study|Withdrawal by Subject|3
1503719|NCT00449644|4946742|P4|Overall Study|Protocol Violation|7
1503720|NCT00449644|4946743|P3|Overall Study|Protocol Violation|3
1503721|NCT00449644|4946744|P2|Overall Study|Protocol Violation|4
1503722|NCT00449644|4946745|P1|Overall Study|Protocol Violation|4
1503723|NCT00449644|4946742|P4|Overall Study|Pregnancy|2
1503724|NCT00449644|4946743|P3|Overall Study|Pregnancy|3
1503725|NCT00449644|4946744|P2|Overall Study|Pregnancy|0
1503726|NCT00449644|4946745|P1|Overall Study|Pregnancy|0
1503727|NCT00449644|4946742|P4|Overall Study|Lost to Follow-up|3
1503728|NCT00449644|4946743|P3|Overall Study|Lost to Follow-up|5
1503729|NCT00449644|4946744|P2|Overall Study|Lost to Follow-up|1
1503730|NCT00449644|4946745|P1|Overall Study|Lost to Follow-up|1
1503731|NCT00449644|4946742|P4|Overall Study|Death|1
1503732|NCT00449644|4946743|P3|Overall Study|Death|6
1503733|NCT00449644|4946744|P2|Overall Study|Death|0
1503734|NCT00449644|4946745|P1|Overall Study|Death|1
1503735|NCT00449644|4946742|P4|Overall Study|Adverse Event|5
1503736|NCT00449644|4946743|P3|Overall Study|Adverse Event|3
1503737|NCT00449644|4946744|P2|Overall Study|Adverse Event|0
1503738|NCT00449644|4946745|P1|Overall Study|Adverse Event|0
1503739|NCT00449540|4946765|P3|Treatment Phase|did not experience or treat migraine|17
1503740|NCT00449540|4946766|P2|Treatment Phase|did not experience or treat migraine|20
1503741|NCT00449540|4946767|P1|Treatment Phase|did not experience or treat migraine|0
1503742|NCT00449540|4946765|P3|Pretreatment Phase|No migraine experienced|0
1503743|NCT00449540|4946766|P2|Pretreatment Phase|No migraine experienced|0
1503744|NCT00449540|4946767|P1|Pretreatment Phase|No migraine experienced|66
1503745|NCT00449176|4946784|P3|Overall Study|all other|20
1503746|NCT00449176|4946785|P2|Overall Study|all other|19
1503747|NCT00449176|4946786|P1|Overall Study|all other|22
1503748|NCT00449176|4946784|P3|Overall Study|Study drug non-compliant|11
1503749|NCT00449176|4946785|P2|Overall Study|Study drug non-compliant|11
1503750|NCT00449176|4946786|P1|Overall Study|Study drug non-compliant|14
1503751|NCT00449176|4946784|P3|Overall Study|Lack of Efficacy|50
1503752|NCT00449176|4946785|P2|Overall Study|Lack of Efficacy|7
1503753|NCT00449176|4946786|P1|Overall Study|Lack of Efficacy|13
1503754|NCT00449176|4946784|P3|Overall Study|Adverse Event|15
1503755|NCT00449176|4946785|P2|Overall Study|Adverse Event|107
1503756|NCT00449176|4946786|P1|Overall Study|Adverse Event|51
1503757|NCT00449176|4946784|P3|Overall Study|Lost to Follow-up|12
1503758|NCT00449176|4946785|P2|Overall Study|Lost to Follow-up|8
1503759|NCT00449176|4946786|P1|Overall Study|Lost to Follow-up|13
1503760|NCT00449176|4946784|P3|Overall Study|Withdrawal by Subject|59
1503761|NCT00449176|4946785|P2|Overall Study|Withdrawal by Subject|43
1503762|NCT00449176|4946786|P1|Overall Study|Withdrawal by Subject|39
1503763|NCT00449163|4946812|P1|Overall Study|Physician Decision|3
1503764|NCT00449150|4946822|P3|Overall Study|Protocol Violation|1
1503765|NCT00449150|4946823|P2|Overall Study|Protocol Violation|2
1503766|NCT00449150|4946824|P1|Overall Study|Protocol Violation|1
1503767|NCT00449150|4946822|P3|Overall Study|Withdrawal by Subject|21
1503768|NCT00449150|4946823|P2|Overall Study|Withdrawal by Subject|18
1503769|NCT00449150|4946824|P1|Overall Study|Withdrawal by Subject|17
1503770|NCT00449150|4946822|P3|Overall Study|Not specified|14
1503771|NCT00449150|4946823|P2|Overall Study|Not specified|13
1503772|NCT00449150|4946824|P1|Overall Study|Not specified|16
1503773|NCT00449150|4946822|P3|Overall Study|Lack of Efficacy|2
1503774|NCT00449150|4946823|P2|Overall Study|Lack of Efficacy|2
1503775|NCT00449150|4946824|P1|Overall Study|Lack of Efficacy|1
1503776|NCT00449150|4946822|P3|Overall Study|Adverse Event|9
1503777|NCT00449150|4946823|P2|Overall Study|Adverse Event|18
1503778|NCT00449150|4946824|P1|Overall Study|Adverse Event|11
1503779|NCT00449072|4946837|P2|Overall Study|Relocation|2
1503780|NCT00449072|4946838|P1|Overall Study|Relocation|3
1503781|NCT00449072|4946837|P2|Overall Study|Sponsor decision|3
1503782|NCT00449072|4946838|P1|Overall Study|Sponsor decision|1
1503783|NCT00449072|4946837|P2|Overall Study|Non-compliance|5
1503784|NCT00449072|4946838|P1|Overall Study|Non-compliance|2
1503785|NCT00449072|4946837|P2|Overall Study|Excluded medication|2
1503786|NCT00449072|4946838|P1|Overall Study|Excluded medication|0
1503787|NCT00449072|4946837|P2|Overall Study|Not treated|1
1503788|NCT00449072|4946838|P1|Overall Study|Not treated|0
1503789|NCT00449072|4946837|P2|Overall Study|Physician Decision|0
1503790|NCT00449072|4946838|P1|Overall Study|Physician Decision|1
1503791|NCT00449072|4946837|P2|Overall Study|Lack of Efficacy|1
1503792|NCT00449072|4946838|P1|Overall Study|Lack of Efficacy|1
1503793|NCT00449072|4946837|P2|Overall Study|Withdrawal by Subject|8
1503794|NCT00449072|4946838|P1|Overall Study|Withdrawal by Subject|11
1503795|NCT00449072|4946837|P2|Overall Study|Lost to Follow-up|7
1503796|NCT00449072|4946838|P1|Overall Study|Lost to Follow-up|5
1503797|NCT00449072|4946837|P2|Overall Study|Protocol Violation|12
1503798|NCT00449072|4946838|P1|Overall Study|Protocol Violation|14
1503799|NCT00449072|4946837|P2|Overall Study|Adverse Event|1
1503800|NCT00449072|4946838|P1|Overall Study|Adverse Event|3
1503801|NCT00449033|4946875|P2|Follow-up Period|Reason Missing|113
1503802|NCT00449033|4946876|P1|Follow-up Period|Reason Missing|120
1503803|NCT00449033|4946875|P2|Follow-up Period|Lost to Follow-up|10
1503804|NCT00449033|4946876|P1|Follow-up Period|Lost to Follow-up|6
1503805|NCT00449033|4946875|P2|Follow-up Period|Death|311
1503806|NCT00449033|4946876|P1|Follow-up Period|Death|299
1503807|NCT00449033|4946875|P2|Treatment Period|Treatment Ongoing|4
1503808|NCT00449033|4946876|P1|Treatment Period|Treatment Ongoing|6
1503809|NCT00449033|4946875|P2|Treatment Period|Reason Missing|4
1503810|NCT00449033|4946876|P1|Treatment Period|Reason Missing|0
1503811|NCT00449033|4946875|P2|Treatment Period|Second Malignancy|1
1503812|NCT00449033|4946876|P1|Treatment Period|Second Malignancy|0
1503813|NCT00449033|4946875|P2|Treatment Period|Non-compliance|8
1503814|NCT00449033|4946876|P1|Treatment Period|Non-compliance|7
1503815|NCT00449033|4946875|P2|Treatment Period|Amended Protocol Criteria|18
1503816|NCT00449033|4946876|P1|Treatment Period|Amended Protocol Criteria|22
1503817|NCT00449033|4946875|P2|Treatment Period|Consent Withdrawn|20
1503818|NCT00449033|4946876|P1|Treatment Period|Consent Withdrawn|36
1503819|NCT00449033|4946875|P2|Treatment Period|Disease Progression|288
1503820|NCT00449033|4946876|P1|Treatment Period|Disease Progression|231
1503821|NCT00449033|4946875|P2|Treatment Period|Protocol Violation|7
1503822|NCT00449033|4946876|P1|Treatment Period|Protocol Violation|8
1503823|NCT00449033|4946875|P2|Treatment Period|Physician Decision|5
1503824|NCT00449033|4946876|P1|Treatment Period|Physician Decision|4
1503825|NCT00449033|4946875|P2|Treatment Period|Lost to Follow-up|2
1503826|NCT00449033|4946876|P1|Treatment Period|Lost to Follow-up|0
1503827|NCT00449033|4946875|P2|Treatment Period|Death|12
1503828|NCT00449033|4946876|P1|Treatment Period|Death|21
1503829|NCT00449033|4946875|P2|Treatment Period|Adverse Event|83
1503830|NCT00449033|4946876|P1|Treatment Period|Adverse Event|117
1503831|NCT00448916|4946914|P4|Overall Study|Protocol Violation|1
1503832|NCT00448916|4946915|P3|Overall Study|Protocol Violation|0
1503833|NCT00448916|4946916|P2|Overall Study|Protocol Violation|0
1503834|NCT00448916|4946917|P1|Overall Study|Protocol Violation|0
1503835|NCT00448916|4946914|P4|Overall Study|Lost to Follow-up|1
1503836|NCT00448916|4946915|P3|Overall Study|Lost to Follow-up|0
1503837|NCT00448916|4946916|P2|Overall Study|Lost to Follow-up|1
1503838|NCT00448916|4946917|P1|Overall Study|Lost to Follow-up|0
1503839|NCT00448916|4946914|P4|Overall Study|Not specified|0
1503840|NCT00448916|4946915|P3|Overall Study|Not specified|0
1503841|NCT00448916|4946916|P2|Overall Study|Not specified|0
1503842|NCT00448916|4946917|P1|Overall Study|Not specified|1
1503843|NCT00448916|4946914|P4|Overall Study|Withdrawal by Subject|1
1503844|NCT00448916|4946915|P3|Overall Study|Withdrawal by Subject|1
1503845|NCT00448916|4946916|P2|Overall Study|Withdrawal by Subject|3
1503846|NCT00448916|4946917|P1|Overall Study|Withdrawal by Subject|3
1503847|NCT00448916|4946914|P4|Overall Study|Lack of Efficacy|1
1503848|NCT00448916|4946915|P3|Overall Study|Lack of Efficacy|2
1503849|NCT00448916|4946916|P2|Overall Study|Lack of Efficacy|0
1503850|NCT00448916|4946917|P1|Overall Study|Lack of Efficacy|1
1503851|NCT00448916|4946914|P4|Overall Study|Adverse Event|2
1503852|NCT00448916|4946915|P3|Overall Study|Adverse Event|3
1503853|NCT00448916|4946916|P2|Overall Study|Adverse Event|2
1503854|NCT00448916|4946917|P1|Overall Study|Adverse Event|2
1503855|NCT00448864|4946991|P3|Overall Study|Protocol Violation|0
1503856|NCT00448864|4946992|P2|Overall Study|Protocol Violation|2
1503857|NCT00448864|4946993|P1|Overall Study|Protocol Violation|0
1503858|NCT00448864|4946991|P3|Overall Study|Withdrawal by Subject|0
1503859|NCT00448864|4946992|P2|Overall Study|Withdrawal by Subject|2
1503860|NCT00448864|4946993|P1|Overall Study|Withdrawal by Subject|0
1503861|NCT00448864|4946991|P3|Overall Study|Physician Decision|1
1503862|NCT00448864|4946992|P2|Overall Study|Physician Decision|0
1503863|NCT00448864|4946993|P1|Overall Study|Physician Decision|1
1503864|NCT00448864|4946991|P3|Overall Study|Lost to Follow-up|0
1503865|NCT00448864|4946992|P2|Overall Study|Lost to Follow-up|1
1503866|NCT00448864|4946993|P1|Overall Study|Lost to Follow-up|3
1503867|NCT00448864|4946991|P3|Overall Study|Death|0
1503868|NCT00448864|4946992|P2|Overall Study|Death|0
1503869|NCT00448864|4946993|P1|Overall Study|Death|1
1503870|NCT00448760|4947009|P1|Overall Study|Death|3
1503871|NCT00448708|4947018|P2|Overall Study|not listed|2
1503872|NCT00448708|4947019|P1|Overall Study|not listed|0
1503873|NCT00448708|4947018|P2|Overall Study|Lost to Follow-up|8
1503874|NCT00448708|4947019|P1|Overall Study|Lost to Follow-up|6
1503875|NCT00448708|4947018|P2|Overall Study|Withdrawal by Subject|4
1503876|NCT00448708|4947019|P1|Overall Study|Withdrawal by Subject|8
1503877|NCT00448708|4947018|P2|Overall Study|Death|17
1503878|NCT00448708|4947019|P1|Overall Study|Death|21
1503879|NCT00448591|4947078|P1|Overall Study|Termination of Study|70
1503880|NCT00448591|4947078|P1|Overall Study|Not specified|154
1503881|NCT00448591|4947078|P1|Overall Study|Treatment Regimen Completed|70
1503882|NCT00448591|4947078|P1|Overall Study|Lost to Follow-up|19
1503883|NCT00448591|4947078|P1|Overall Study|Protocol Violation|41
1503884|NCT00448591|4947078|P1|Overall Study|Adverse Event|382
1503885|NCT00448591|4947078|P1|Overall Study|Progressive Disease|1382
1503886|NCT00448591|4947078|P1|Overall Study|Withdrawal by Subject|178
1503887|NCT00448539|4947089|P2|Overall Study|Lost to Follow-up|3
1503888|NCT00448539|4947090|P1|Overall Study|Lost to Follow-up|1
1503889|NCT00448539|4947089|P2|Overall Study|Change of meds|3
1503890|NCT00448539|4947090|P1|Overall Study|Change of meds|2
1503891|NCT00448539|4947089|P2|Overall Study|Miscellaneous|1
1503892|NCT00448539|4947090|P1|Overall Study|Miscellaneous|2
1503893|NCT00448539|4947089|P2|Overall Study|Lack of Efficacy|40
1503894|NCT00448539|4947090|P1|Overall Study|Lack of Efficacy|27
1503895|NCT00448539|4947089|P2|Overall Study|Adverse Event|26
1503896|NCT00448539|4947090|P1|Overall Study|Adverse Event|9
1503897|NCT00448539|4947089|P2|Overall Study|Diary non-compliance|0
1503898|NCT00448539|4947090|P1|Overall Study|Diary non-compliance|1
1503899|NCT00448539|4947089|P2|Overall Study|Withdrawal by Subject|24
1503900|NCT00448539|4947090|P1|Overall Study|Withdrawal by Subject|20
1503901|NCT00448539|4947089|P2|Overall Study|Request of the investigator or sponsor|54
1503902|NCT00448539|4947090|P1|Overall Study|Request of the investigator or sponsor|67
1503903|NCT00448539|4947089|P2|Overall Study|Protocol Violation|0
1503904|NCT00448539|4947090|P1|Overall Study|Protocol Violation|1
1503905|NCT00448539|4947089|P2|Overall Study|Medication non-compliance|1
1503906|NCT00448539|4947090|P1|Overall Study|Medication non-compliance|4
1503907|NCT00448448|4947098|P2|Overall Study|Signed consent lost|1
1503908|NCT00448448|4947099|P1|Overall Study|Signed consent lost|0
1503909|NCT00448448|4947098|P2|Overall Study|Wrong diagnosis (n=3) or other|1
1503910|NCT00448448|4947099|P1|Overall Study|Wrong diagnosis (n=3) or other|2
1503911|NCT00448448|4947098|P2|Overall Study|Lost to Follow-up|1
1503912|NCT00448448|4947099|P1|Overall Study|Lost to Follow-up|2
1503913|NCT00448448|4947098|P2|Overall Study|On protocol when study ended|36
1503914|NCT00448448|4947099|P1|Overall Study|On protocol when study ended|83
1503915|NCT00448448|4947098|P2|Overall Study|Withdrawal by Subject|2
1503916|NCT00448448|4947099|P1|Overall Study|Withdrawal by Subject|13
1503917|NCT00448435|4947105|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
1503918|NCT00448435|4947106|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
1503919|NCT00448344|4947157|P2|Overall Study|Physician Decision|2
1503920|NCT00448344|4947158|P1|Overall Study|Physician Decision|1
1503921|NCT00448344|4947157|P2|Overall Study|Death|4
1503922|NCT00448344|4947158|P1|Overall Study|Death|3
1503923|NCT00448344|4947157|P2|Overall Study|Withdrawal by Subject|8
1503924|NCT00448344|4947158|P1|Overall Study|Withdrawal by Subject|6
1503925|NCT00448344|4947157|P2|Overall Study|Lost to Follow-up|22
1503926|NCT00448344|4947158|P1|Overall Study|Lost to Follow-up|20
1503927|NCT00448279|4947168|P2|Overall Study|Protocol Violation|1
1503928|NCT00448279|4947169|P1|Overall Study|Protocol Violation|0
1503929|NCT00448279|4947168|P2|Overall Study|Not specified|4
1503930|NCT00448279|4947169|P1|Overall Study|Not specified|6
1503931|NCT00448279|4947168|P2|Overall Study|Withdrawal by Subject|3
1503932|NCT00448279|4947169|P1|Overall Study|Withdrawal by Subject|4
1503933|NCT00448279|4947168|P2|Overall Study|Disease progression|18
1503934|NCT00448279|4947169|P1|Overall Study|Disease progression|16
1503935|NCT00448279|4947168|P2|Overall Study|Adverse Event|1
1503936|NCT00448279|4947169|P1|Overall Study|Adverse Event|1
1503937|NCT00448279|4947168|P2|Overall Study|Lost to Follow-up|2
1503938|NCT00448279|4947169|P1|Overall Study|Lost to Follow-up|2
1503939|NCT00448136|4947232|P2|Overall Study|Investigator's decision (progression)|0
1503940|NCT00448136|4947233|P1|Overall Study|Investigator's decision (progression)|1
1503941|NCT00448136|4947232|P2|Overall Study|Death|8
1503942|NCT00448136|4947233|P1|Overall Study|Death|3
1503943|NCT00448123|4947271|P2|Overall Study|Physician Decision|6
1503944|NCT00448123|4947272|P1|Overall Study|Physician Decision|6
1503945|NCT00448123|4947271|P2|Overall Study|Lost to Follow-up|6
1503946|NCT00448123|4947272|P1|Overall Study|Lost to Follow-up|9
1503947|NCT00448019|4947282|P1|Overall Study|Insurance Issues|1
1503948|NCT00448019|4947282|P1|Overall Study|Death|2
1503949|NCT00448019|4947282|P1|Overall Study|Disease progression|1
1503950|NCT00448019|4947282|P1|Overall Study|Withdrawal by Subject|3
1503951|NCT00447902|4947290|P2|Overall Study|Lack of Efficacy|1
1503952|NCT00447902|4947291|P1|Overall Study|Lack of Efficacy|2
1503953|NCT00447902|4947290|P2|Overall Study|included patients who discontinued|1
1503954|NCT00447902|4947291|P1|Overall Study|included patients who discontinued|1
1503955|NCT00447902|4947290|P2|Overall Study|Withdrawal by Subject|1
1503956|NCT00447902|4947291|P1|Overall Study|Withdrawal by Subject|0
1503957|NCT00447902|4947290|P2|Overall Study|Protocol Violation|0
1503958|NCT00447902|4947291|P1|Overall Study|Protocol Violation|1
1503959|NCT00447902|4947290|P2|Overall Study|Adverse Event|3
1503960|NCT00447902|4947291|P1|Overall Study|Adverse Event|0
1503961|NCT00447876|4947333|P2|Overall Study|Deterioration of symptomology|0
1503962|NCT00447876|4947334|P1|Overall Study|Deterioration of symptomology|1
1503963|NCT00447876|4947333|P2|Overall Study|Lost to Follow-up|0
1503964|NCT00447876|4947334|P1|Overall Study|Lost to Follow-up|1
1503965|NCT00447876|4947333|P2|Overall Study|Withdrawal by Subject|4
1503966|NCT00447876|4947334|P1|Overall Study|Withdrawal by Subject|1
1503967|NCT00447772|4947364|P1|Overall Study|Premature re-injection required|1
1503968|NCT00447772|4947364|P1|Overall Study|Chemotherapy for lung cancer|1
1503969|NCT00447772|4947364|P1|Overall Study|Incomplete documentation at visit 1|1
1503970|NCT00447772|4947364|P1|Overall Study|Patient relocated|1
1503971|NCT00447772|4947364|P1|Overall Study|Adverse Event|1
1503972|NCT00447772|4947364|P1|Overall Study|Unable to attend all study visits|2
1503973|NCT00447772|4947364|P1|Overall Study|Withdrawal by Subject|1
1503974|NCT00447772|4947364|P1|Overall Study|Lost to Follow-up|9
1503975|NCT00447772|4947364|P1|Overall Study|Discontinuation of drug therapy|1
1503976|NCT00447772|4947364|P1|Overall Study|Insufficient compliance|6
1503977|NCT00447772|4947364|P1|Overall Study|Lack of Efficacy|3
1503978|NCT00447603|4947384|P3|Filter Period|Study terminated by Sponsor|10
1503979|NCT00447603|4947385|P2|Filter Period|Study terminated by Sponsor|1
1503980|NCT00447603|4947386|P1|Filter Period|Study terminated by Sponsor|0
1503981|NCT00447603|4947384|P3|Filter Period|Screen Failure|4
1503982|NCT00447603|4947385|P2|Filter Period|Screen Failure|3
1503983|NCT00447603|4947386|P1|Filter Period|Screen Failure|0
1503984|NCT00447603|4947384|P3|Filter Period|Adverse Event|1
1503985|NCT00447603|4947385|P2|Filter Period|Adverse Event|0
1503986|NCT00447603|4947386|P1|Filter Period|Adverse Event|0
1503987|NCT00447603|4947384|P3|Screening|Study Terminated by Sponsor|0
1503988|NCT00447603|4947385|P2|Screening|Study Terminated by Sponsor|0
1503989|NCT00447603|4947386|P1|Screening|Study Terminated by Sponsor|15
1503990|NCT00447603|4947384|P3|Screening|Screen Failure|0
1503991|NCT00447603|4947385|P2|Screening|Screen Failure|0
1503992|NCT00447603|4947386|P1|Screening|Screen Failure|4
1503993|NCT00447603|4947384|P3|Screening|Protocol Violation|0
1503994|NCT00447603|4947385|P2|Screening|Protocol Violation|0
1503995|NCT00447603|4947386|P1|Screening|Protocol Violation|1
1503996|NCT00447603|4947384|P3|Screening|Withdrawal by Subject|0
1503997|NCT00447603|4947385|P2|Screening|Withdrawal by Subject|0
1503998|NCT00447603|4947386|P1|Screening|Withdrawal by Subject|1
1503999|NCT00447590|4947406|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
1504000|NCT00447590|4947406|P1|Overall Study|Lost to Follow-up|24
1504001|NCT00447590|4947406|P1|Overall Study|Withdrawal by Subject|26
1504002|NCT00447499|4947415|P1|Overall Study|Physician Decision|1
1504003|NCT00447499|4947415|P1|Overall Study|Sponsor Decision|1
1504004|NCT00447499|4947415|P1|Overall Study|Patient Decision|4
1504005|NCT00447499|4947415|P1|Overall Study|Adverse Event|1
1504006|NCT00447421|4947425|P1|Overall Study|Sponsor Decision|2
1504007|NCT00447421|4947425|P1|Overall Study|Adverse Event|3
1504008|NCT00447421|4947425|P1|Overall Study|Lack of Efficacy|1
1504009|NCT00447382|4947437|P2|Overall Study|Unclassified|5
1504010|NCT00447382|4947438|P1|Overall Study|Unclassified|2
1504011|NCT00447382|4947437|P2|Overall Study|Protocol Violation|0
1504012|NCT00447382|4947438|P1|Overall Study|Protocol Violation|2
1504013|NCT00447382|4947437|P2|Overall Study|Lack of Efficacy|0
1504014|NCT00447382|4947438|P1|Overall Study|Lack of Efficacy|1
1504015|NCT00447382|4947437|P2|Overall Study|Adverse Event|1
1504016|NCT00447382|4947438|P1|Overall Study|Adverse Event|1
1504017|NCT00447278|4947499|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
1504018|NCT00447278|4947500|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
1504019|NCT00447278|4947499|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
1504020|NCT00447278|4947500|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
1504021|NCT00447278|4947499|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
1504022|NCT00447278|4947500|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
1504023|NCT00447278|4947499|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
1504024|NCT00447278|4947500|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
1504025|NCT00447278|4947499|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
1504026|NCT00447278|4947500|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
1504027|NCT00447278|4947499|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
1504028|NCT00447278|4947500|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
1504029|NCT00447278|4947499|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
1504030|NCT00447278|4947500|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
1504031|NCT00447278|4947499|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
1504032|NCT00447278|4947500|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
1504033|NCT00447278|4947499|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
1504034|NCT00447278|4947500|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
1504035|NCT00447278|4947499|P2|Period II (6 Month Open-Label)|Physician Decision|1
1504036|NCT00447278|4947500|P1|Period II (6 Month Open-Label)|Physician Decision|4
1504037|NCT00447278|4947499|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
1504038|NCT00447278|4947500|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
1504039|NCT00447278|4947499|P2|Period II (6 Month Open-Label)|Protocol Violation|7
1504040|NCT00447278|4947500|P1|Period II (6 Month Open-Label)|Protocol Violation|10
1504041|NCT00447278|4947499|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
1504042|NCT00447278|4947500|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
1504043|NCT00447278|4947499|P2|Period II (6 Month Open-Label)|Adverse Event|3
1504044|NCT00447278|4947500|P1|Period II (6 Month Open-Label)|Adverse Event|7
1504045|NCT00447265|4947521|P2|Overall Study|Physician Decision|0
1504046|NCT00447265|4947522|P1|Overall Study|Physician Decision|1
1504047|NCT00447226|4947535|P2|Double-blind Phase|Disease Progression|3
1504048|NCT00447226|4947536|P1|Double-blind Phase|Disease Progression|4
1504049|NCT00447226|4947535|P2|12-Week Open-label Phase|Physician Decision|1
1504050|NCT00447226|4947536|P1|12-Week Open-label Phase|Physician Decision|0
1504051|NCT00447226|4947535|P2|12-Week Open-label Phase|Disease Progression|20
1504052|NCT00447226|4947536|P1|12-Week Open-label Phase|Disease Progression|0
1504053|NCT00447226|4947535|P2|12-Week Open-label Phase|Protocol Violation|1
1504054|NCT00447226|4947536|P1|12-Week Open-label Phase|Protocol Violation|0
1504055|NCT00447226|4947535|P2|12-Week Open-label Phase|Adverse Event|3
1504056|NCT00447226|4947536|P1|12-Week Open-label Phase|Adverse Event|0
1504057|NCT00447057|4947562|P4|Overall Study|Death, study drug related|0
1504058|NCT00447057|4947563|P3|Overall Study|Death, study drug related|0
1504059|NCT00447057|4947564|P2|Overall Study|Death, study drug related|1
1504060|NCT00447057|4947565|P1|Overall Study|Death, study drug related|0
1504061|NCT00447057|4947562|P4|Overall Study|Death due to adverse event|2
1504062|NCT00447057|4947563|P3|Overall Study|Death due to adverse event|1
1504063|NCT00447057|4947564|P2|Overall Study|Death due to adverse event|0
1504064|NCT00447057|4947565|P1|Overall Study|Death due to adverse event|0
1504065|NCT00447057|4947562|P4|Overall Study|Progressive disease|18
1504066|NCT00447057|4947563|P3|Overall Study|Progressive disease|13
1504067|NCT00447057|4947564|P2|Overall Study|Progressive disease|43
1504068|NCT00447057|4947565|P1|Overall Study|Progressive disease|58
1504069|NCT00447057|4947562|P4|Overall Study|Sponsor decision|0
1504070|NCT00447057|4947563|P3|Overall Study|Sponsor decision|0
1504071|NCT00447057|4947564|P2|Overall Study|Sponsor decision|1
1504072|NCT00447057|4947565|P1|Overall Study|Sponsor decision|1
1504073|NCT00447057|4947562|P4|Overall Study|Physician Decision|1
1504074|NCT00447057|4947563|P3|Overall Study|Physician Decision|3
1504075|NCT00447057|4947564|P2|Overall Study|Physician Decision|6
1504076|NCT00447057|4947565|P1|Overall Study|Physician Decision|9
1504077|NCT00447057|4947562|P4|Overall Study|Withdrawal by Subject|1
1504078|NCT00447057|4947563|P3|Overall Study|Withdrawal by Subject|1
1504079|NCT00447057|4947564|P2|Overall Study|Withdrawal by Subject|5
1504080|NCT00447057|4947565|P1|Overall Study|Withdrawal by Subject|4
1504081|NCT00447057|4947562|P4|Overall Study|Protocol Violation|0
1504082|NCT00447057|4947563|P3|Overall Study|Protocol Violation|0
1504083|NCT00447057|4947564|P2|Overall Study|Protocol Violation|1
1504084|NCT00447057|4947565|P1|Overall Study|Protocol Violation|0
1504085|NCT00447057|4947562|P4|Overall Study|Entry criteria not met|0
1504086|NCT00447057|4947563|P3|Overall Study|Entry criteria not met|0
1504087|NCT00447057|4947564|P2|Overall Study|Entry criteria not met|1
1504088|NCT00447057|4947565|P1|Overall Study|Entry criteria not met|1
1504089|NCT00447057|4947562|P4|Overall Study|Lost to Follow-up|0
1504090|NCT00447057|4947563|P3|Overall Study|Lost to Follow-up|0
1504091|NCT00447057|4947564|P2|Overall Study|Lost to Follow-up|1
1504092|NCT00447057|4947565|P1|Overall Study|Lost to Follow-up|0
1504093|NCT00447057|4947562|P4|Overall Study|Death due to study disease|1
1504094|NCT00447057|4947563|P3|Overall Study|Death due to study disease|1
1504095|NCT00447057|4947564|P2|Overall Study|Death due to study disease|4
1504096|NCT00447057|4947565|P1|Overall Study|Death due to study disease|6
1504097|NCT00447057|4947562|P4|Overall Study|Adverse Event|3
1504098|NCT00447057|4947563|P3|Overall Study|Adverse Event|0
1504099|NCT00447057|4947564|P2|Overall Study|Adverse Event|10
1504100|NCT00447057|4947565|P1|Overall Study|Adverse Event|4
1504101|NCT00447005|4947583|P1|Overall Study|Lack of Efficacy|11
1504102|NCT00447005|4947583|P1|Overall Study|Adverse Event|1
1504103|NCT00446992|4947597|P1|Overall Study|Lost to Follow-up|5
1504104|NCT00446992|4947597|P1|Overall Study|Adverse Event|11
1504105|NCT00446849|4947609|P1|Maintenance Phase|concomitant medication use|1
1504106|NCT00446849|4947609|P1|Maintenance Phase|hydrocodone use|1
1504107|NCT00446849|4947609|P1|Maintenance Phase|study closure|1
1504108|NCT00446849|4947609|P1|Maintenance Phase|antibiotic use|1
1504109|NCT00446849|4947609|P1|Maintenance Phase|prohibited medication use|2
1504110|NCT00446849|4947609|P1|Maintenance Phase|noncompliance|2
1504111|NCT00446849|4947609|P1|Maintenance Phase|Pregnancy|1
1504112|NCT00446849|4947609|P1|Maintenance Phase|Lost to Follow-up|3
1504113|NCT00446849|4947609|P1|Maintenance Phase|Consent withdrawn|5
1504114|NCT00446849|4947609|P1|Maintenance Phase|Adverse Event|6
1504115|NCT00446849|4947609|P1|Maintenance Phase|Protocol Violation|7
1504116|NCT00446849|4947609|P1|Maintenance Phase|Lack of Efficacy|40
1504117|NCT00446849|4947609|P1|Acute Phase|noncompliance|1
1504118|NCT00446849|4947609|P1|Acute Phase|Physician Decision|1
1504119|NCT00446849|4947609|P1|Acute Phase|Lost to Follow-up|2
1504120|NCT00446849|4947609|P1|Acute Phase|Consent withdrawn|4
1504121|NCT00446849|4947609|P1|Acute Phase|Protocol Violation|10
1504122|NCT00446849|4947609|P1|Acute Phase|Lack of Efficacy|64
1504123|NCT00446797|4947621|P2|Overall Study|did not meet entrance criteria|1
1504124|NCT00446797|4947622|P1|Overall Study|did not meet entrance criteria|0
1504125|NCT00446797|4947621|P2|Overall Study|subject entered at another site|1
1504126|NCT00446797|4947622|P1|Overall Study|subject entered at another site|0
1504127|NCT00446797|4947621|P2|Overall Study|Protocol Violation|3
1504128|NCT00446797|4947622|P1|Overall Study|Protocol Violation|1
1504129|NCT00446797|4947621|P2|Overall Study|Withdrawal by Subject|2
1504130|NCT00446797|4947622|P1|Overall Study|Withdrawal by Subject|2
1504131|NCT00446797|4947621|P2|Overall Study|Lost to Follow-up|3
1504132|NCT00446797|4947622|P1|Overall Study|Lost to Follow-up|5
1504133|NCT00446797|4947621|P2|Overall Study|Lack of Efficacy|2
1504134|NCT00446797|4947622|P1|Overall Study|Lack of Efficacy|0
1504135|NCT00446654|4947668|P2|Overall Study|Adverse Event|0
1504136|NCT00446654|4947669|P1|Overall Study|Adverse Event|1
1504137|NCT00446654|4947668|P2|Overall Study|Withdrawal by Subject|0
1504138|NCT00446654|4947669|P1|Overall Study|Withdrawal by Subject|1
1504139|NCT00446641|4947677|P2|Overall Study|Lost to Follow-up|1
1504140|NCT00446641|4947678|P1|Overall Study|Lost to Follow-up|1
1504141|NCT00446641|4947677|P2|Overall Study|poor compliance|6
1504142|NCT00446641|4947678|P1|Overall Study|poor compliance|8
1504143|NCT00446641|4947677|P2|Overall Study|Withdrawal by Subject|3
1504144|NCT00446641|4947678|P1|Overall Study|Withdrawal by Subject|8
1504145|NCT00446563|4947698|P2|Overall Study|Administrative problems|1
1504146|NCT00446563|4947699|P1|Overall Study|Administrative problems|0
1504147|NCT00446563|4947698|P2|Overall Study|Withdrawal by Subject|1
1504148|NCT00446563|4947699|P1|Overall Study|Withdrawal by Subject|2
1504149|NCT00446563|4947698|P2|Overall Study|Unsatisfactory therapeutic effect|3
1504150|NCT00446563|4947699|P1|Overall Study|Unsatisfactory therapeutic effect|0
1504151|NCT00446563|4947698|P2|Overall Study|Abnormal test procedure result(s)|0
1504152|NCT00446563|4947699|P1|Overall Study|Abnormal test procedure result(s)|1
1504153|NCT00446563|4947698|P2|Overall Study|Abnormal laboratory value(s)|1
1504154|NCT00446563|4947699|P1|Overall Study|Abnormal laboratory value(s)|0
1504155|NCT00446563|4947698|P2|Overall Study|Adverse Event|3
1504156|NCT00446563|4947699|P1|Overall Study|Adverse Event|4
1504157|NCT00446550|4947735|P2|Overall Study|Adverse Event|0
1504158|NCT00446550|4947736|P1|Overall Study|Adverse Event|1
1504159|NCT00446511|4947748|P4|Overall Study|Administrative Problems|1
1504160|NCT00446511|4947749|P3|Overall Study|Administrative Problems|4
1504161|NCT00446511|4947750|P2|Overall Study|Administrative Problems|0
1504162|NCT00446511|4947751|P1|Overall Study|Administrative Problems|3
1504163|NCT00446511|4947748|P4|Overall Study|Withdrawal by Subject|3
1504164|NCT00446511|4947749|P3|Overall Study|Withdrawal by Subject|0
1504165|NCT00446511|4947750|P2|Overall Study|Withdrawal by Subject|0
1504166|NCT00446511|4947751|P1|Overall Study|Withdrawal by Subject|0
1504167|NCT00446511|4947748|P4|Overall Study|Protocol Violation|1
1504168|NCT00446511|4947749|P3|Overall Study|Protocol Violation|0
1504169|NCT00446511|4947750|P2|Overall Study|Protocol Violation|0
1504170|NCT00446511|4947751|P1|Overall Study|Protocol Violation|0
1504171|NCT00446511|4947748|P4|Overall Study|Adverse Event|1
1504172|NCT00446511|4947749|P3|Overall Study|Adverse Event|3
1504173|NCT00446511|4947750|P2|Overall Study|Adverse Event|2
1504174|NCT00446511|4947751|P1|Overall Study|Adverse Event|7
1504175|NCT00446459|4947775|P1|12 Months|14 subjects to MMF + Rituximab Study|14
1504176|NCT00446459|4947775|P1|12 Months|Protocol Violation|4
1504177|NCT00446459|4947775|P1|8 Months|Protocol Violation|12
1504178|NCT00446446|4947783|P1|Overall Study|On Treatment at Time of Data Cut-off|1
1504179|NCT00446446|4947783|P1|Overall Study|Adverse Event|1
1504180|NCT00446446|4947783|P1|Overall Study|Disease Progession|2
1504181|NCT00446446|4947783|P1|Overall Study|Other|4
1504182|NCT00446446|4947783|P1|Overall Study|Withdrawal by Subject|6
1504183|NCT00446446|4947783|P1|Overall Study|Death|10
1504184|NCT00446251|4947807|P1|Overall Study|Lost to Follow-up|1
1504185|NCT00446251|4947807|P1|Overall Study|Rituximab Infusion Reaction|2
1504186|NCT00446251|4947807|P1|Overall Study|On-study Transplants|2
1504187|NCT00446199|4947817|P4|Overall Study|Move|0
1504188|NCT00446199|4947818|P3|Overall Study|Move|0
1504189|NCT00446199|4947819|P2|Overall Study|Move|1
1504190|NCT00446199|4947820|P1|Overall Study|Move|0
1504191|NCT00446199|4947817|P4|Overall Study|In-/Exclusion criterion violated|1
1504192|NCT00446199|4947818|P3|Overall Study|In-/Exclusion criterion violated|2
1504193|NCT00446199|4947819|P2|Overall Study|In-/Exclusion criterion violated|1
1504194|NCT00446199|4947820|P1|Overall Study|In-/Exclusion criterion violated|2
1504195|NCT00446199|4947817|P4|Overall Study|Lost interest in study participation|0
1504196|NCT00446199|4947818|P3|Overall Study|Lost interest in study participation|0
1504197|NCT00446199|4947819|P2|Overall Study|Lost interest in study participation|1
1504198|NCT00446199|4947820|P1|Overall Study|Lost interest in study participation|0
1504199|NCT00446199|4947817|P4|Overall Study|Hormone fear|1
1504200|NCT00446199|4947818|P3|Overall Study|Hormone fear|0
1504201|NCT00446199|4947819|P2|Overall Study|Hormone fear|0
1504202|NCT00446199|4947820|P1|Overall Study|Hormone fear|0
1504203|NCT00446199|4947817|P4|Overall Study|Non-compliant with visit schedule|2
1504204|NCT00446199|4947818|P3|Overall Study|Non-compliant with visit schedule|1
1504205|NCT00446199|4947819|P2|Overall Study|Non-compliant with visit schedule|1
1504206|NCT00446199|4947820|P1|Overall Study|Non-compliant with visit schedule|1
1504207|NCT00446199|4947817|P4|Overall Study|Non-compliant with study drug|0
1504208|NCT00446199|4947818|P3|Overall Study|Non-compliant with study drug|5
1504209|NCT00446199|4947819|P2|Overall Study|Non-compliant with study drug|0
1504210|NCT00446199|4947820|P1|Overall Study|Non-compliant with study drug|1
1504211|NCT00446199|4947817|P4|Overall Study|Lack of Efficacy|1
1504212|NCT00446199|4947818|P3|Overall Study|Lack of Efficacy|0
1504213|NCT00446199|4947819|P2|Overall Study|Lack of Efficacy|0
1504214|NCT00446199|4947820|P1|Overall Study|Lack of Efficacy|1
1504215|NCT00446199|4947817|P4|Overall Study|Randomization in Error|1
1504216|NCT00446199|4947818|P3|Overall Study|Randomization in Error|1
1504217|NCT00446199|4947819|P2|Overall Study|Randomization in Error|0
1504218|NCT00446199|4947820|P1|Overall Study|Randomization in Error|2
1504219|NCT00446199|4947817|P4|Overall Study|Site termination|1
1504220|NCT00446199|4947818|P3|Overall Study|Site termination|0
1504221|NCT00446199|4947819|P2|Overall Study|Site termination|0
1504222|NCT00446199|4947820|P1|Overall Study|Site termination|2
1504223|NCT00446199|4947817|P4|Overall Study|Withdrawal by Subject|10
1504224|NCT00446199|4947818|P3|Overall Study|Withdrawal by Subject|9
1504225|NCT00446199|4947819|P2|Overall Study|Withdrawal by Subject|5
1504226|NCT00446199|4947820|P1|Overall Study|Withdrawal by Subject|2
1504227|NCT00446199|4947817|P4|Overall Study|Protocol Violation|3
1504228|NCT00446199|4947818|P3|Overall Study|Protocol Violation|1
1504229|NCT00446199|4947819|P2|Overall Study|Protocol Violation|2
1504230|NCT00446199|4947820|P1|Overall Study|Protocol Violation|1
1504231|NCT00446199|4947817|P4|Overall Study|Lost to Follow-up|6
1504232|NCT00446199|4947818|P3|Overall Study|Lost to Follow-up|2
1504233|NCT00446199|4947819|P2|Overall Study|Lost to Follow-up|5
1504234|NCT00446199|4947820|P1|Overall Study|Lost to Follow-up|4
1504235|NCT00446199|4947817|P4|Overall Study|Adverse Event|4
1504236|NCT00446199|4947818|P3|Overall Study|Adverse Event|6
1504237|NCT00446199|4947819|P2|Overall Study|Adverse Event|4
1504238|NCT00446199|4947820|P1|Overall Study|Adverse Event|7
1504239|NCT00446134|4947913|P4|Overall Study|Reason Not Completed|2
1504240|NCT00446134|4947914|P3|Overall Study|Reason Not Completed|1
1504241|NCT00446134|4947915|P2|Overall Study|Reason Not Completed|0
1504242|NCT00446134|4947916|P1|Overall Study|Reason Not Completed|3
1504243|NCT00446134|4947913|P4|Overall Study|Adverse Event-Diarrhea|0
1504244|NCT00446134|4947914|P3|Overall Study|Adverse Event-Diarrhea|2
1504245|NCT00446134|4947915|P2|Overall Study|Adverse Event-Diarrhea|1
1504246|NCT00446134|4947916|P1|Overall Study|Adverse Event-Diarrhea|1
1504247|NCT00446134|4947913|P4|Overall Study|Physician Decision|2
1504248|NCT00446134|4947914|P3|Overall Study|Physician Decision|0
1504249|NCT00446134|4947915|P2|Overall Study|Physician Decision|0
1504250|NCT00446134|4947916|P1|Overall Study|Physician Decision|0
1504251|NCT00446134|4947913|P4|Overall Study|Withdrawal by Subject|3
1504252|NCT00446134|4947914|P3|Overall Study|Withdrawal by Subject|1
1504253|NCT00446134|4947915|P2|Overall Study|Withdrawal by Subject|3
1504254|NCT00446134|4947916|P1|Overall Study|Withdrawal by Subject|3
1504255|NCT00446134|4947913|P4|Overall Study|Lost to Follow-up|1
1504256|NCT00446134|4947914|P3|Overall Study|Lost to Follow-up|1
1504257|NCT00446134|4947915|P2|Overall Study|Lost to Follow-up|3
1504258|NCT00446134|4947916|P1|Overall Study|Lost to Follow-up|1
1504259|NCT00446134|4947913|P4|Overall Study|Protocol Violation|0
1504260|NCT00446134|4947914|P3|Overall Study|Protocol Violation|1
1504261|NCT00446134|4947915|P2|Overall Study|Protocol Violation|2
1504262|NCT00446134|4947916|P1|Overall Study|Protocol Violation|0
1504263|NCT00446134|4947913|P4|Overall Study|Lack of Efficacy|19
1504264|NCT00446134|4947914|P3|Overall Study|Lack of Efficacy|24
1504265|NCT00446134|4947915|P2|Overall Study|Lack of Efficacy|19
1504266|NCT00446134|4947916|P1|Overall Study|Lack of Efficacy|19
1504267|NCT00446134|4947913|P4|Overall Study|Adverse Event|18
1504268|NCT00446134|4947914|P3|Overall Study|Adverse Event|13
1504269|NCT00446134|4947915|P2|Overall Study|Adverse Event|17
1504270|NCT00446134|4947916|P1|Overall Study|Adverse Event|7
1504271|NCT00446095|4947943|P5|Phase I (28 Days)|Lack of Efficacy|3
1504272|NCT00446095|4947944|P4|Phase I (28 Days)|Lack of Efficacy|0
1504273|NCT00446095|4947945|P3|Phase I (28 Days)|Lack of Efficacy|0
1504274|NCT00446095|4947946|P2|Phase I (28 Days)|Lack of Efficacy|0
1504275|NCT00446095|4947947|P1|Phase I (28 Days)|Lack of Efficacy|0
1504276|NCT00446095|4947943|P5|Phase I (28 Days)|Adverse Event|0
1504277|NCT00446095|4947944|P4|Phase I (28 Days)|Adverse Event|1
1504278|NCT00446095|4947945|P3|Phase I (28 Days)|Adverse Event|0
1504279|NCT00446095|4947946|P2|Phase I (28 Days)|Adverse Event|0
1504280|NCT00446095|4947947|P1|Phase I (28 Days)|Adverse Event|0
1504281|NCT00446095|4947943|P5|Phase II (8 Weeks)|Ongoing|0
1504282|NCT00446095|4947944|P4|Phase II (8 Weeks)|Ongoing|0
1504283|NCT00446095|4947945|P3|Phase II (8 Weeks)|Ongoing|1
1504284|NCT00446095|4947946|P2|Phase II (8 Weeks)|Ongoing|0
1504285|NCT00446095|4947947|P1|Phase II (8 Weeks)|Ongoing|0
1504286|NCT00446095|4947943|P5|Phase II (8 Weeks)|Lack of Efficacy|0
1504287|NCT00446095|4947944|P4|Phase II (8 Weeks)|Lack of Efficacy|0
1504288|NCT00446095|4947945|P3|Phase II (8 Weeks)|Lack of Efficacy|1
1504289|NCT00446095|4947946|P2|Phase II (8 Weeks)|Lack of Efficacy|2
1504290|NCT00446095|4947947|P1|Phase II (8 Weeks)|Lack of Efficacy|9
1504291|NCT00446095|4947943|P5|Phase II (8 Weeks)|Physician Decision|0
1504292|NCT00446095|4947944|P4|Phase II (8 Weeks)|Physician Decision|0
1504293|NCT00446095|4947945|P3|Phase II (8 Weeks)|Physician Decision|0
1504294|NCT00446095|4947946|P2|Phase II (8 Weeks)|Physician Decision|0
1504295|NCT00446095|4947947|P1|Phase II (8 Weeks)|Physician Decision|1
1504296|NCT00446095|4947943|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
1504297|NCT00446095|4947944|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
1504298|NCT00446095|4947945|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
1504299|NCT00446095|4947946|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
1504300|NCT00446095|4947947|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
1504301|NCT00446095|4947943|P5|Phase II (8 Weeks)|Adverse Event|0
1504302|NCT00446095|4947944|P4|Phase II (8 Weeks)|Adverse Event|0
1504303|NCT00446095|4947945|P3|Phase II (8 Weeks)|Adverse Event|1
1504304|NCT00446095|4947946|P2|Phase II (8 Weeks)|Adverse Event|1
1504305|NCT00446095|4947947|P1|Phase II (8 Weeks)|Adverse Event|0
1504306|NCT00446095|4947943|P5|Phase II (8 Weeks)|Lost to Follow-up|0
1504307|NCT00446095|4947944|P4|Phase II (8 Weeks)|Lost to Follow-up|0
1504308|NCT00446095|4947945|P3|Phase II (8 Weeks)|Lost to Follow-up|0
1504309|NCT00446095|4947946|P2|Phase II (8 Weeks)|Lost to Follow-up|0
1504310|NCT00446095|4947947|P1|Phase II (8 Weeks)|Lost to Follow-up|1
1504311|NCT00446030|4947970|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
1504312|NCT00446030|4947971|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
1504313|NCT00446030|4947970|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
1504314|NCT00446030|4947971|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
1504315|NCT00446030|4947970|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
1504316|NCT00446030|4947971|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
1504317|NCT00446030|4947970|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
1504318|NCT00446030|4947971|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
1504319|NCT00446030|4947970|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
1504320|NCT00446030|4947971|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
1504321|NCT00446030|4947970|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
1504322|NCT00446030|4947971|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
1504323|NCT00446030|4947970|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
1504324|NCT00446030|4947971|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
1504325|NCT00446030|4947970|P2|FOLLOW-UP (up to 2-years)|Death|2
1504326|NCT00446030|4947971|P1|FOLLOW-UP (up to 2-years)|Death|2
1504327|NCT00446030|4947970|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
1504328|NCT00446030|4947971|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
1504329|NCT00446030|4947970|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
1504330|NCT00446030|4947971|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
1504331|NCT00446030|4947970|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
1504332|NCT00446030|4947971|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
1504333|NCT00446030|4947970|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
1504334|NCT00446030|4947971|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
1504335|NCT00446030|4947970|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
1504336|NCT00446030|4947971|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
1504337|NCT00446030|4947970|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
1504338|NCT00446030|4947971|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
1504339|NCT00446030|4947970|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
1504340|NCT00446030|4947971|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
1504341|NCT00446030|4947970|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
1504342|NCT00446030|4947971|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
1504343|NCT00446030|4947970|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
1504344|NCT00446030|4947971|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
1504345|NCT00446030|4947970|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
1504346|NCT00446030|4947971|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
1504347|NCT00446030|4947970|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
1504348|NCT00446030|4947971|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
1504349|NCT00445939|4947982|P4|Period B - Week 4 - Week 8|Adverse Event|1
1504350|NCT00445939|4947983|P3|Period B - Week 4 - Week 8|Adverse Event|0
1504351|NCT00445939|4947984|P2|Period B - Week 4 - Week 8|Adverse Event|0
1504352|NCT00445939|4947985|P1|Period B - Week 4 - Week 8|Adverse Event|2
1504353|NCT00445939|4947982|P4|Period A - Week 0 - Week 4|Adverse Event|0
1504354|NCT00445939|4947983|P3|Period A - Week 0 - Week 4|Adverse Event|0
1504355|NCT00445939|4947984|P2|Period A - Week 0 - Week 4|Adverse Event|2
1504356|NCT00445939|4947985|P1|Period A - Week 0 - Week 4|Adverse Event|1
1504357|NCT00445848|4948033|P1|Overall Study|Other-Not protocol specified|5
1504358|NCT00445848|4948033|P1|Overall Study|Progression|62
1504359|NCT00445848|4948033|P1|Overall Study|Withdrawal by Subject|4
1504360|NCT00445848|4948033|P1|Overall Study|Adverse Event|14
1504361|NCT00445770|4948043|P3|Overall Study|Not specified|6
1504362|NCT00445770|4948044|P2|Overall Study|Not specified|5
1504363|NCT00445770|4948045|P1|Overall Study|Not specified|6
1504364|NCT00445770|4948043|P3|Overall Study|Lost to Follow-up|0
1504365|NCT00445770|4948044|P2|Overall Study|Lost to Follow-up|2
1504366|NCT00445770|4948045|P1|Overall Study|Lost to Follow-up|0
1504367|NCT00445770|4948043|P3|Overall Study|Lack of Efficacy|6
1504368|NCT00445770|4948044|P2|Overall Study|Lack of Efficacy|13
1504369|NCT00445770|4948045|P1|Overall Study|Lack of Efficacy|38
1504370|NCT00445770|4948043|P3|Overall Study|Adverse Event|19
1504371|NCT00445770|4948044|P2|Overall Study|Adverse Event|15
1504372|NCT00445770|4948045|P1|Overall Study|Adverse Event|9
1504373|NCT00445692|4948146|P1|Overall Study|Lack of Efficacy|5
1504374|NCT00445692|4948146|P1|Overall Study|Adverse Event|11
1504375|NCT00445679|4948156|P4|Overall Study|Lack of Efficacy|0
1504376|NCT00445679|4948157|P3|Overall Study|Lack of Efficacy|2
1504377|NCT00445679|4948158|P2|Overall Study|Lack of Efficacy|6
1504378|NCT00445679|4948159|P1|Overall Study|Lack of Efficacy|2
1504379|NCT00445679|4948156|P4|Overall Study|Withdrawal by Subject|18
1504380|NCT00445679|4948157|P3|Overall Study|Withdrawal by Subject|20
1504381|NCT00445679|4948158|P2|Overall Study|Withdrawal by Subject|14
1504382|NCT00445679|4948159|P1|Overall Study|Withdrawal by Subject|8
1504383|NCT00445679|4948156|P4|Overall Study|Protocol Violation|1
1504384|NCT00445679|4948157|P3|Overall Study|Protocol Violation|3
1504385|NCT00445679|4948158|P2|Overall Study|Protocol Violation|3
1504386|NCT00445679|4948159|P1|Overall Study|Protocol Violation|2
1504387|NCT00445679|4948156|P4|Overall Study|Withdrawal of Informed Consent|0
1504388|NCT00445679|4948157|P3|Overall Study|Withdrawal of Informed Consent|1
1504389|NCT00445679|4948158|P2|Overall Study|Withdrawal of Informed Consent|0
1504390|NCT00445679|4948159|P1|Overall Study|Withdrawal of Informed Consent|0
1504391|NCT00445679|4948156|P4|Overall Study|Compliance|2
1504392|NCT00445679|4948157|P3|Overall Study|Compliance|1
1504393|NCT00445679|4948158|P2|Overall Study|Compliance|2
1504394|NCT00445679|4948159|P1|Overall Study|Compliance|3
1504395|NCT00445679|4948156|P4|Overall Study|Lost to Follow-up|5
1504396|NCT00445679|4948157|P3|Overall Study|Lost to Follow-up|6
1504397|NCT00445679|4948158|P2|Overall Study|Lost to Follow-up|6
1504398|NCT00445679|4948159|P1|Overall Study|Lost to Follow-up|10
1504399|NCT00445679|4948156|P4|Overall Study|Physician Decision|0
1504400|NCT00445679|4948157|P3|Overall Study|Physician Decision|1
1504401|NCT00445679|4948158|P2|Overall Study|Physician Decision|0
1504402|NCT00445679|4948159|P1|Overall Study|Physician Decision|0
1504403|NCT00445679|4948156|P4|Overall Study|Failed to return|2
1504404|NCT00445679|4948157|P3|Overall Study|Failed to return|2
1504405|NCT00445679|4948158|P2|Overall Study|Failed to return|3
1504406|NCT00445679|4948159|P1|Overall Study|Failed to return|1
1504407|NCT00445679|4948156|P4|Overall Study|Adverse Event|19
1504408|NCT00445679|4948157|P3|Overall Study|Adverse Event|30
1504409|NCT00445679|4948158|P2|Overall Study|Adverse Event|12
1504410|NCT00445679|4948159|P1|Overall Study|Adverse Event|22
1504411|NCT00445601|4948195|P2|Overall Study|Death prior to TURBT|1
1504412|NCT00445601|4948196|P1|Overall Study|Death prior to TURBT|0
1504413|NCT00445601|4948195|P2|Overall Study|Adverse Event|0
1504414|NCT00445601|4948196|P1|Overall Study|Adverse Event|2
1504415|NCT00445601|4948195|P2|Overall Study|Drug Delivery Issue|2
1504416|NCT00445601|4948196|P1|Overall Study|Drug Delivery Issue|2
1504417|NCT00445601|4948195|P2|Overall Study|Incorrect Disease Status|6
1504418|NCT00445601|4948196|P1|Overall Study|Incorrect Disease Status|6
1504419|NCT00445601|4948195|P2|Overall Study|TURBT Complication|8
1504420|NCT00445601|4948196|P1|Overall Study|TURBT Complication|12
1504421|NCT00445601|4948195|P2|Overall Study|Withdrawal by Subject|11
1504422|NCT00445601|4948196|P1|Overall Study|Withdrawal by Subject|11
1504423|NCT00445549|4948213|P1|Overall Study|progressive disease|12
1504424|NCT00445458|4948237|P4|Overall Study|Surgery|0
1504425|NCT00445458|4948238|P3|Overall Study|Surgery|1
1504426|NCT00445458|4948239|P2|Overall Study|Surgery|0
1504427|NCT00445458|4948240|P1|Overall Study|Surgery|0
1504428|NCT00445458|4948237|P4|Overall Study|Physician Decision|1
1504429|NCT00445458|4948238|P3|Overall Study|Physician Decision|1
1504430|NCT00445458|4948239|P2|Overall Study|Physician Decision|0
1504431|NCT00445458|4948240|P1|Overall Study|Physician Decision|0
1504432|NCT00445458|4948237|P4|Overall Study|Death|0
1504433|NCT00445458|4948238|P3|Overall Study|Death|2
1504434|NCT00445458|4948239|P2|Overall Study|Death|1
1504435|NCT00445458|4948240|P1|Overall Study|Death|0
1504436|NCT00445458|4948237|P4|Overall Study|Adverse Event|0
1504437|NCT00445458|4948238|P3|Overall Study|Adverse Event|3
1504438|NCT00445458|4948239|P2|Overall Study|Adverse Event|0
1504439|NCT00445458|4948240|P1|Overall Study|Adverse Event|0
1504440|NCT00445458|4948237|P4|Overall Study|Withdrawal by Subject|0
1504441|NCT00445458|4948238|P3|Overall Study|Withdrawal by Subject|7
1504442|NCT00445458|4948239|P2|Overall Study|Withdrawal by Subject|0
1504443|NCT00445458|4948240|P1|Overall Study|Withdrawal by Subject|0
1504444|NCT00445458|4948237|P4|Overall Study|Disease Progression|27
1504445|NCT00445458|4948238|P3|Overall Study|Disease Progression|54
1504446|NCT00445458|4948239|P2|Overall Study|Disease Progression|4
1504447|NCT00445458|4948240|P1|Overall Study|Disease Progression|3
1504448|NCT00445432|4948258|P4|148 Weeks of Adalimumab Treatment|Not specified|9
1504449|NCT00445432|4948259|P3|148 Weeks of Adalimumab Treatment|Not specified|0
1504450|NCT00445432|4948260|P2|148 Weeks of Adalimumab Treatment|Not specified|0
1504451|NCT00445432|4948261|P1|148 Weeks of Adalimumab Treatment|Not specified|0
1504452|NCT00445432|4948258|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
1504453|NCT00445432|4948259|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
1504454|NCT00445432|4948260|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
1504455|NCT00445432|4948261|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
1504456|NCT00445432|4948258|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
1504457|NCT00445432|4948259|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
1504458|NCT00445432|4948260|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
1504459|NCT00445432|4948261|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
1504460|NCT00445432|4948258|P4|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
1504461|NCT00445432|4948259|P3|Through Week 52 of NCT00445432 (M06-837)|Not specified|2
1504462|NCT00445432|4948260|P2|Through Week 52 of NCT00445432 (M06-837)|Not specified|1
1504463|NCT00445432|4948261|P1|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
1504464|NCT00445432|4948258|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
1504465|NCT00445432|4948259|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
1504466|NCT00445432|4948260|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
1504467|NCT00445432|4948261|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
1504468|NCT00445432|4948258|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
1504469|NCT00445432|4948259|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
1504470|NCT00445432|4948260|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
1504471|NCT00445432|4948261|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
1504472|NCT00445432|4948258|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
1504473|NCT00445432|4948259|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
1504474|NCT00445432|4948260|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
1504475|NCT00445432|4948261|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
1504476|NCT00445341|4948294|P1|Overall Study|taken off treatment too early|1
1504477|NCT00445341|4948294|P1|Overall Study|refused further treatment|1
1504478|NCT00445328|4948301|P2|Overall Study|Protocol Violation|0
1504479|NCT00445328|4948302|P1|Overall Study|Protocol Violation|1
1504480|NCT00445328|4948301|P2|Overall Study|Withdrawal by Subject|0
1504481|NCT00445328|4948302|P1|Overall Study|Withdrawal by Subject|2
1504482|NCT00445328|4948301|P2|Overall Study|Other|2
1504483|NCT00445328|4948302|P1|Overall Study|Other|0
1504484|NCT00445328|4948301|P2|Overall Study|Adverse Event|3
1504485|NCT00445328|4948302|P1|Overall Study|Adverse Event|0
1504486|NCT00445328|4948301|P2|Overall Study|Death|1
1504487|NCT00445328|4948302|P1|Overall Study|Death|0
1504488|NCT00445224|4948463|P2|Specific Exercises|Withdrawal by Subject|0
1504489|NCT00445224|4948464|P1|Specific Exercises|Withdrawal by Subject|1
1504490|NCT00445224|4948463|P2|Specific Exercises|Withdrawal by Subject|3
1504491|NCT00445224|4948464|P1|Specific Exercises|Withdrawal by Subject|3
1504492|NCT00445146|4948491|P1|Overall Study|Pregnancy|1
1504493|NCT00445146|4948491|P1|Overall Study|Protocol Violation|4
1504494|NCT00445146|4948491|P1|Overall Study|Death|9
1504495|NCT00445146|4948491|P1|Overall Study|Lost to Follow-up|13
1504496|NCT00445146|4948491|P1|Overall Study|Adverse Event|13
1504497|NCT00445146|4948491|P1|Overall Study|Investigator’s Discretion|22
1504498|NCT00445146|4948491|P1|Overall Study|Lack of Efficacy|28
1504499|NCT00445146|4948491|P1|Overall Study|Withdrew Consent|29
1504500|NCT00445003|4948513|P3|Overall Study|Dropped|2
1504501|NCT00445003|4948514|P2|Overall Study|Dropped|3
1504502|NCT00445003|4948515|P1|Overall Study|Dropped|1
1504503|NCT00445003|4948513|P3|Overall Study|Missed Visit|1
1504504|NCT00445003|4948514|P2|Overall Study|Missed Visit|5
1504505|NCT00445003|4948515|P1|Overall Study|Missed Visit|3
1504506|NCT00445003|4948513|P3|Overall Study|Death|1
1504507|NCT00445003|4948514|P2|Overall Study|Death|2
1504508|NCT00445003|4948515|P1|Overall Study|Death|1
1504509|NCT00444951|4948547|P3|Overall Study|Withdrawal by Subject|3
1504510|NCT00444951|4948548|P2|Overall Study|Withdrawal by Subject|5
1504511|NCT00444951|4948549|P1|Overall Study|Withdrawal by Subject|4
1504512|NCT00444951|4948547|P3|Overall Study|Lost to Follow-up|0
1504513|NCT00444951|4948548|P2|Overall Study|Lost to Follow-up|1
1504514|NCT00444951|4948549|P1|Overall Study|Lost to Follow-up|1
1504515|NCT00444925|4948566|P3|Double-blind Treatment Period|Other|12
1504516|NCT00444925|4948567|P2|Double-blind Treatment Period|Other|7
1504517|NCT00444925|4948568|P1|Double-blind Treatment Period|Other|7
1504518|NCT00444925|4948566|P3|Double-blind Treatment Period|Withdrawal by Subject|7
1504519|NCT00444925|4948567|P2|Double-blind Treatment Period|Withdrawal by Subject|8
1504520|NCT00444925|4948568|P1|Double-blind Treatment Period|Withdrawal by Subject|6
1504521|NCT00444925|4948566|P3|Double-blind Treatment Period|Lost to Follow-up|5
1504522|NCT00444925|4948567|P2|Double-blind Treatment Period|Lost to Follow-up|8
1504523|NCT00444925|4948568|P1|Double-blind Treatment Period|Lost to Follow-up|4
1504524|NCT00444925|4948566|P3|Double-blind Treatment Period|Lack of Efficacy|13
1504525|NCT00444925|4948567|P2|Double-blind Treatment Period|Lack of Efficacy|5
1504526|NCT00444925|4948568|P1|Double-blind Treatment Period|Lack of Efficacy|5
1504527|NCT00444925|4948566|P3|Double-blind Treatment Period|Adverse Event|44
1504528|NCT00444925|4948567|P2|Double-blind Treatment Period|Adverse Event|28
1504529|NCT00444925|4948568|P1|Double-blind Treatment Period|Adverse Event|6
1504530|NCT00444925|4948566|P3|Double-blind Treatment Period|Death|0
1504531|NCT00444925|4948567|P2|Double-blind Treatment Period|Death|0
1504532|NCT00444925|4948568|P1|Double-blind Treatment Period|Death|2
1504533|NCT00444925|4948566|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
1504534|NCT00444925|4948567|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
1504535|NCT00444925|4948568|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
1504536|NCT00444912|4948632|P2|Overall Study|Participant Failed Mobilization|0
1504537|NCT00444912|4948633|P1|Overall Study|Participant Failed Mobilization|1
1504538|NCT00444912|4948632|P2|Overall Study|Lost to Follow-up|0
1504539|NCT00444912|4948633|P1|Overall Study|Lost to Follow-up|1
1504540|NCT00444912|4948632|P2|Overall Study|Death|2
1504541|NCT00444912|4948633|P1|Overall Study|Death|1
1504542|NCT00444795|4948674|P1|Overall Study|Treated Prior to the Contract Date|2
1504543|NCT00444795|4948674|P1|Overall Study|Not Treated|1
1504544|NCT00444626|4948679|P1|Initial Treatment Period|Lost to Follow-up|9
1504545|NCT00444626|4948679|P1|Initial Treatment Period|Adverse Event|1
1504546|NCT00444626|4948679|P1|Initial Treatment Period|Withdrawal by Subject|2
1504547|NCT00444600|4948709|P4|Overall Study|Missed visit|1
1504548|NCT00444600|4948710|P3|Overall Study|Missed visit|0
1504549|NCT00444600|4948711|P2|Overall Study|Missed visit|0
1504550|NCT00444600|4948712|P1|Overall Study|Missed visit|1
1504551|NCT00444600|4948709|P4|Overall Study|Dropped|7
1504552|NCT00444600|4948710|P3|Overall Study|Dropped|7
1504553|NCT00444600|4948711|P2|Overall Study|Dropped|11
1504554|NCT00444600|4948712|P1|Overall Study|Dropped|11
1504555|NCT00444600|4948709|P4|Overall Study|Death|2
1504556|NCT00444600|4948710|P3|Overall Study|Death|3
1504557|NCT00444600|4948711|P2|Overall Study|Death|5
1504558|NCT00444600|4948712|P1|Overall Study|Death|7
1504559|NCT00444587|4948804|P2|Overall Study|Missing|5
1504560|NCT00444587|4948805|P1|Overall Study|Missing|0
1504561|NCT00444587|4948804|P2|Overall Study|Protocol Violation|0
1504562|NCT00444587|4948805|P1|Overall Study|Protocol Violation|1
1504563|NCT00444587|4948804|P2|Overall Study|Investigator decision|0
1504564|NCT00444587|4948805|P1|Overall Study|Investigator decision|3
1504565|NCT00444587|4948804|P2|Overall Study|Refused treatment/did not cooperate|1
1504566|NCT00444587|4948805|P1|Overall Study|Refused treatment/did not cooperate|4
1504567|NCT00444587|4948804|P2|Overall Study|Progression of the disease|8
1504568|NCT00444587|4948805|P1|Overall Study|Progression of the disease|73
1504569|NCT00444587|4948804|P2|Overall Study|Death|1
1504570|NCT00444587|4948805|P1|Overall Study|Death|2
1504571|NCT00444535|4948826|P1|Overall Study|Adverse Event|3
1504572|NCT00444535|4948826|P1|Overall Study|Investigator decision|2
1504573|NCT00444535|4948826|P1|Overall Study|Withdrawal by Subject|3
1504574|NCT00444535|4948826|P1|Overall Study|Treatment is ongoing|16
1504575|NCT00444457|4948837|P4|Toddler Dose|Protocol Violation|1
1504576|NCT00444457|4948838|P3|Toddler Dose|Protocol Violation|0
1504577|NCT00444457|4948839|P2|Toddler Dose|Protocol Violation|0
1504578|NCT00444457|4948840|P1|Toddler Dose|Protocol Violation|1
1504579|NCT00444457|4948837|P4|Toddler Dose|Parent or legal guardian request|1
1504580|NCT00444457|4948838|P3|Toddler Dose|Parent or legal guardian request|2
1504581|NCT00444457|4948839|P2|Toddler Dose|Parent or legal guardian request|3
1504582|NCT00444457|4948840|P1|Toddler Dose|Parent or legal guardian request|0
1504583|NCT00444457|4948837|P4|Toddler Dose|Failed to return|3
1504584|NCT00444457|4948838|P3|Toddler Dose|Failed to return|1
1504585|NCT00444457|4948839|P2|Toddler Dose|Failed to return|2
1504586|NCT00444457|4948840|P1|Toddler Dose|Failed to return|2
1504587|NCT00444457|4948837|P4|Toddler Dose|Lost to Follow-up|3
1504588|NCT00444457|4948838|P3|Toddler Dose|Lost to Follow-up|1
1504589|NCT00444457|4948839|P2|Toddler Dose|Lost to Follow-up|1
1504590|NCT00444457|4948840|P1|Toddler Dose|Lost to Follow-up|4
1504591|NCT00444457|4948837|P4|After Infant Series|Other|0
1504592|NCT00444457|4948838|P3|After Infant Series|Other|0
1504593|NCT00444457|4948839|P2|After Infant Series|Other|1
1504594|NCT00444457|4948840|P1|After Infant Series|Other|0
1504595|NCT00444457|4948837|P4|After Infant Series|Investigator request|1
1504596|NCT00444457|4948838|P3|After Infant Series|Investigator request|0
1504597|NCT00444457|4948839|P2|After Infant Series|Investigator request|0
1504598|NCT00444457|4948840|P1|After Infant Series|Investigator request|0
1504599|NCT00444457|4948837|P4|After Infant Series|Adverse Event|0
1504600|NCT00444457|4948838|P3|After Infant Series|Adverse Event|0
1504601|NCT00444457|4948839|P2|After Infant Series|Adverse Event|2
1504602|NCT00444457|4948840|P1|After Infant Series|Adverse Event|2
1504603|NCT00444457|4948837|P4|After Infant Series|Protocol Violation|2
1504604|NCT00444457|4948838|P3|After Infant Series|Protocol Violation|2
1504605|NCT00444457|4948839|P2|After Infant Series|Protocol Violation|4
1504606|NCT00444457|4948840|P1|After Infant Series|Protocol Violation|2
1504607|NCT00444457|4948837|P4|After Infant Series|Lost to Follow-up|2
1504608|NCT00444457|4948838|P3|After Infant Series|Lost to Follow-up|5
1504609|NCT00444457|4948839|P2|After Infant Series|Lost to Follow-up|5
1504610|NCT00444457|4948840|P1|After Infant Series|Lost to Follow-up|5
1504611|NCT00444457|4948837|P4|After Infant Series|Failed to return|1
1504612|NCT00444457|4948838|P3|After Infant Series|Failed to return|5
1504613|NCT00444457|4948839|P2|After Infant Series|Failed to return|6
1504614|NCT00444457|4948840|P1|After Infant Series|Failed to return|7
1504615|NCT00444457|4948837|P4|After Infant Series|Parent or legal guardian request|3
1504616|NCT00444457|4948838|P3|After Infant Series|Parent or legal guardian request|6
1504617|NCT00444457|4948839|P2|After Infant Series|Parent or legal guardian request|11
1504618|NCT00444457|4948840|P1|After Infant Series|Parent or legal guardian request|4
1504619|NCT00444457|4948837|P4|After Infant Series|Other|1
1504620|NCT00444457|4948838|P3|After Infant Series|Other|1
1504621|NCT00444457|4948839|P2|After Infant Series|Other|1
1504622|NCT00444457|4948840|P1|After Infant Series|Other|0
1504623|NCT00444457|4948837|P4|Infant Series|Death|1
1504624|NCT00444457|4948838|P3|Infant Series|Death|1
1504625|NCT00444457|4948839|P2|Infant Series|Death|1
1504626|NCT00444457|4948840|P1|Infant Series|Death|0
1504627|NCT00444457|4948837|P4|Infant Series|Adverse Event|0
1504628|NCT00444457|4948838|P3|Infant Series|Adverse Event|2
1504629|NCT00444457|4948839|P2|Infant Series|Adverse Event|2
1504630|NCT00444457|4948840|P1|Infant Series|Adverse Event|1
1504631|NCT00444457|4948837|P4|Infant Series|Other|0
1504632|NCT00444457|4948838|P3|Infant Series|Other|4
1504633|NCT00444457|4948839|P2|Infant Series|Other|2
1504634|NCT00444457|4948840|P1|Infant Series|Other|0
1504635|NCT00444457|4948837|P4|Infant Series|Investigator request|2
1504636|NCT00444457|4948838|P3|Infant Series|Investigator request|3
1504637|NCT00444457|4948839|P2|Infant Series|Investigator request|3
1504638|NCT00444457|4948840|P1|Infant Series|Investigator request|4
1504639|NCT00444457|4948837|P4|Infant Series|Failed to return|2
1504640|NCT00444457|4948838|P3|Infant Series|Failed to return|4
1504641|NCT00444457|4948839|P2|Infant Series|Failed to return|4
1504642|NCT00444457|4948840|P1|Infant Series|Failed to return|5
1504643|NCT00444457|4948837|P4|Infant Series|Protocol Violation|3
1504644|NCT00444457|4948838|P3|Infant Series|Protocol Violation|6
1504645|NCT00444457|4948839|P2|Infant Series|Protocol Violation|8
1504646|NCT00444457|4948840|P1|Infant Series|Protocol Violation|16
1504647|NCT00444457|4948837|P4|Infant Series|Lost to Follow-up|6
1504648|NCT00444457|4948838|P3|Infant Series|Lost to Follow-up|7
1504649|NCT00444457|4948839|P2|Infant Series|Lost to Follow-up|11
1504650|NCT00444457|4948840|P1|Infant Series|Lost to Follow-up|10
1504651|NCT00444457|4948837|P4|Infant Series|Parent or legal guardian request|14
1504652|NCT00444457|4948838|P3|Infant Series|Parent or legal guardian request|34
1504653|NCT00444457|4948839|P2|Infant Series|Parent or legal guardian request|29
1504654|NCT00444457|4948840|P1|Infant Series|Parent or legal guardian request|18
1504655|NCT00444457|4948837|P4|Infant Series|Other|0
1504656|NCT00444457|4948838|P3|Infant Series|Other|0
1504657|NCT00444457|4948839|P2|Infant Series|Other|1
1504658|NCT00444457|4948840|P1|Infant Series|Other|0
1504659|NCT00444275|4948905|P5|Maintenance Treatment Phase|Ineffectiveness|14
1504660|NCT00444275|4948906|P4|Maintenance Treatment Phase|Ineffectiveness|3
1504661|NCT00444275|4948907|P3|Maintenance Treatment Phase|Ineffectiveness|5
1504662|NCT00444275|4948908|P2|Maintenance Treatment Phase|Ineffectiveness|0
1504663|NCT00444275|4948909|P1|Maintenance Treatment Phase|Ineffectiveness|0
1504664|NCT00444275|4948905|P5|Maintenance Treatment Phase|Protocol Violation|87
1504665|NCT00444275|4948906|P4|Maintenance Treatment Phase|Protocol Violation|88
1504666|NCT00444275|4948907|P3|Maintenance Treatment Phase|Protocol Violation|103
1504667|NCT00444275|4948908|P2|Maintenance Treatment Phase|Protocol Violation|0
1504668|NCT00444275|4948909|P1|Maintenance Treatment Phase|Protocol Violation|0
1504669|NCT00444275|4948905|P5|Maintenance Treatment Phase|Patient's wish|20
1504670|NCT00444275|4948906|P4|Maintenance Treatment Phase|Patient's wish|9
1504671|NCT00444275|4948907|P3|Maintenance Treatment Phase|Patient's wish|19
1504672|NCT00444275|4948908|P2|Maintenance Treatment Phase|Patient's wish|0
1504673|NCT00444275|4948909|P1|Maintenance Treatment Phase|Patient's wish|0
1504674|NCT00444275|4948905|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
1504675|NCT00444275|4948906|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
1504676|NCT00444275|4948907|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
1504677|NCT00444275|4948908|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
1504678|NCT00444275|4948909|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
1504679|NCT00444275|4948905|P5|Maintenance Treatment Phase|Adverse Event|13
1504680|NCT00444275|4948906|P4|Maintenance Treatment Phase|Adverse Event|2
1504681|NCT00444275|4948907|P3|Maintenance Treatment Phase|Adverse Event|3
1504682|NCT00444275|4948908|P2|Maintenance Treatment Phase|Adverse Event|0
1504683|NCT00444275|4948909|P1|Maintenance Treatment Phase|Adverse Event|0
1504684|NCT00444275|4948905|P5|Maintenance Treatment Phase|Lost to Follow-up|10
1504685|NCT00444275|4948906|P4|Maintenance Treatment Phase|Lost to Follow-up|14
1504686|NCT00444275|4948907|P3|Maintenance Treatment Phase|Lost to Follow-up|8
1504687|NCT00444275|4948908|P2|Maintenance Treatment Phase|Lost to Follow-up|0
1504688|NCT00444275|4948909|P1|Maintenance Treatment Phase|Lost to Follow-up|0
1504689|NCT00444275|4948905|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
1504690|NCT00444275|4948906|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
1504691|NCT00444275|4948907|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
1504692|NCT00444275|4948908|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
1504693|NCT00444275|4948909|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
1504694|NCT00444145|4948959|P1|Overall Study|Screen Failures|5
1504695|NCT00444145|4948959|P1|Overall Study|non-compliant|11
1504696|NCT00444145|4948959|P1|Overall Study|Lost to Follow-up|1
1504697|NCT00444145|4948959|P1|Overall Study|Withdrawal by Subject|2
1504698|NCT00444106|4948966|P3|Overall Study|Abnormal Test Procedure Results|1
1504699|NCT00444106|4948967|P2|Overall Study|Abnormal Test Procedure Results|0
1504700|NCT00444106|4948968|P1|Overall Study|Abnormal Test Procedure Results|0
1504701|NCT00444106|4948966|P3|Overall Study|Lost to Follow-up|0
1504702|NCT00444106|4948967|P2|Overall Study|Lost to Follow-up|1
1504703|NCT00444106|4948968|P1|Overall Study|Lost to Follow-up|2
1504704|NCT00444067|4948985|P2|Overall Study|Lost to Follow-up|1
1504705|NCT00444067|4948986|P1|Overall Study|Lost to Follow-up|0
1504706|NCT00443898|4949000|P4|Overall Study|Death|0
1504707|NCT00443898|4949001|P3|Overall Study|Death|0
1504708|NCT00443898|4949002|P2|Overall Study|Death|1
1504709|NCT00443898|4949003|P1|Overall Study|Death|0
1504710|NCT00443898|4949000|P4|Overall Study|Lost to Follow-up|10
1504711|NCT00443898|4949001|P3|Overall Study|Lost to Follow-up|14
1504712|NCT00443898|4949002|P2|Overall Study|Lost to Follow-up|10
1504713|NCT00443898|4949003|P1|Overall Study|Lost to Follow-up|10
1504714|NCT00443898|4949000|P4|Overall Study|Withdrawal by Subject|6
1504715|NCT00443898|4949001|P3|Overall Study|Withdrawal by Subject|10
1504716|NCT00443898|4949002|P2|Overall Study|Withdrawal by Subject|10
1504717|NCT00443898|4949003|P1|Overall Study|Withdrawal by Subject|11
1504718|NCT00443898|4949000|P4|Overall Study|Protocol Violation|0
1504719|NCT00443898|4949001|P3|Overall Study|Protocol Violation|1
1504720|NCT00443898|4949002|P2|Overall Study|Protocol Violation|1
1504721|NCT00443898|4949003|P1|Overall Study|Protocol Violation|1
1504722|NCT00443898|4949000|P4|Overall Study|Lack of Efficacy|1
1504723|NCT00443898|4949001|P3|Overall Study|Lack of Efficacy|3
1504724|NCT00443898|4949002|P2|Overall Study|Lack of Efficacy|3
1504725|NCT00443898|4949003|P1|Overall Study|Lack of Efficacy|2
1504726|NCT00443898|4949000|P4|Overall Study|Adverse Event|1
1504727|NCT00443898|4949001|P3|Overall Study|Adverse Event|1
1504728|NCT00443898|4949002|P2|Overall Study|Adverse Event|0
1504729|NCT00443898|4949003|P1|Overall Study|Adverse Event|0
1504730|NCT00443872|4949025|P1|Overall Study|Adverse Event|8
1504731|NCT00443872|4949025|P1|Overall Study|Lost to Follow-up|2
1504732|NCT00443872|4949025|P1|Overall Study|Protocol Violation|7
1504733|NCT00443846|4949040|P2|Overall Study|Lost to Follow-up|2
1504734|NCT00443846|4949041|P1|Overall Study|Lost to Follow-up|1
1504735|NCT00443846|4949040|P2|Overall Study|Personal reason|3
1504736|NCT00443846|4949041|P1|Overall Study|Personal reason|8
1504737|NCT00443846|4949040|P2|Overall Study|Adverse Event|1
1504738|NCT00443846|4949041|P1|Overall Study|Adverse Event|0
1504739|NCT00443846|4949040|P2|Overall Study|Not vaccinated, no blood sample drawn|0
1504740|NCT00443846|4949041|P1|Overall Study|Not vaccinated, no blood sample drawn|1
1504741|NCT00443846|4949040|P2|Overall Study|Withdrawn due to intercurrent disease|0
1504742|NCT00443846|4949041|P1|Overall Study|Withdrawn due to intercurrent disease|1
1504743|NCT00443820|4949051|P4|Overall Study|Death|0
1504744|NCT00443820|4949052|P3|Overall Study|Death|1
1504745|NCT00443820|4949053|P2|Overall Study|Death|0
1504746|NCT00443820|4949054|P1|Overall Study|Death|0
1504747|NCT00443820|4949051|P4|Overall Study|Administrative problems|1
1504748|NCT00443820|4949052|P3|Overall Study|Administrative problems|0
1504749|NCT00443820|4949053|P2|Overall Study|Administrative problems|0
1504750|NCT00443820|4949054|P1|Overall Study|Administrative problems|0
1504751|NCT00443820|4949051|P4|Overall Study|Lost to Follow-up|5
1504752|NCT00443820|4949052|P3|Overall Study|Lost to Follow-up|6
1504753|NCT00443820|4949053|P2|Overall Study|Lost to Follow-up|8
1504754|NCT00443820|4949054|P1|Overall Study|Lost to Follow-up|9
1504755|NCT00443820|4949051|P4|Overall Study|Withdrawal by Subject|9
1504756|NCT00443820|4949052|P3|Overall Study|Withdrawal by Subject|8
1504757|NCT00443820|4949053|P2|Overall Study|Withdrawal by Subject|7
1504758|NCT00443820|4949054|P1|Overall Study|Withdrawal by Subject|6
1504759|NCT00443820|4949051|P4|Overall Study|Protocol Violation|1
1504760|NCT00443820|4949052|P3|Overall Study|Protocol Violation|2
1504761|NCT00443820|4949053|P2|Overall Study|Protocol Violation|1
1504762|NCT00443820|4949054|P1|Overall Study|Protocol Violation|2
1504763|NCT00443820|4949051|P4|Overall Study|Lack of Efficacy|1
1504764|NCT00443820|4949052|P3|Overall Study|Lack of Efficacy|1
1504765|NCT00443820|4949053|P2|Overall Study|Lack of Efficacy|2
1504766|NCT00443820|4949054|P1|Overall Study|Lack of Efficacy|3
1504767|NCT00443820|4949051|P4|Overall Study|Adverse Event|0
1504768|NCT00443820|4949052|P3|Overall Study|Adverse Event|0
1504769|NCT00443820|4949053|P2|Overall Study|Adverse Event|1
1504770|NCT00443820|4949054|P1|Overall Study|Adverse Event|1
1504771|NCT00443781|4949076|P1|Overall Study|PD/FAD not done|1
1504772|NCT00443781|4949076|P1|Overall Study|Insurance not covered|2
1504773|NCT00443781|4949076|P1|Overall Study|Investigator terminated participation|1
1504774|NCT00443781|4949076|P1|Overall Study|Unable to comply with study follow up|2
1504775|NCT00443781|4949076|P1|Overall Study|Withdrawal by Subject|6
1504776|NCT00443781|4949076|P1|Overall Study|Protocol Violation|1
1504777|NCT00443781|4949076|P1|Overall Study|Physician Decision|2
1504778|NCT00443781|4949076|P1|Overall Study|Lost to Follow-up|10
1504779|NCT00443755|4949082|P2|Overall Study|Withdrawal by Subject|1
1504780|NCT00443755|4949083|P1|Overall Study|Withdrawal by Subject|2
1504781|NCT00443729|4949117|P2|Overall Study|Withdrawal by Subject|1
1504782|NCT00443729|4949118|P1|Overall Study|Withdrawal by Subject|3
1504783|NCT00443729|4949117|P2|Overall Study|Protocol Violation|1
1504784|NCT00443729|4949118|P1|Overall Study|Protocol Violation|1
1504785|NCT00443729|4949117|P2|Overall Study|Physician Decision|1
1504786|NCT00443729|4949118|P1|Overall Study|Physician Decision|2
1504787|NCT00443729|4949117|P2|Overall Study|Lost to Follow-up|1
1504788|NCT00443729|4949118|P1|Overall Study|Lost to Follow-up|0
1504789|NCT00443729|4949117|P2|Overall Study|Lack of Efficacy|2
1504790|NCT00443729|4949118|P1|Overall Study|Lack of Efficacy|4
1504791|NCT00443729|4949117|P2|Overall Study|Never Treated|1
1504792|NCT00443729|4949118|P1|Overall Study|Never Treated|0
1504793|NCT00443703|4949166|P2|Overall Study|Progressive Disease|0
1504794|NCT00443703|4949167|P1|Overall Study|Progressive Disease|1
1504795|NCT00443703|4949166|P2|Overall Study|Withdrawal by Subject|6
1504796|NCT00443703|4949167|P1|Overall Study|Withdrawal by Subject|9
1504797|NCT00443703|4949166|P2|Overall Study|Protocol Violation|1
1504798|NCT00443703|4949167|P1|Overall Study|Protocol Violation|1
1504799|NCT00443703|4949166|P2|Overall Study|Physician Decision|2
1504800|NCT00443703|4949167|P1|Overall Study|Physician Decision|4
1504801|NCT00443703|4949166|P2|Overall Study|Lost to Follow-up|4
1504802|NCT00443703|4949167|P1|Overall Study|Lost to Follow-up|0
1504803|NCT00443703|4949166|P2|Overall Study|Lack of Efficacy|1
1504804|NCT00443703|4949167|P1|Overall Study|Lack of Efficacy|3
1504805|NCT00443703|4949166|P2|Overall Study|Adverse Event|3
1504806|NCT00443703|4949167|P1|Overall Study|Adverse Event|7
1504807|NCT00443703|4949166|P2|Overall Study|Never Treated|1
1504808|NCT00443703|4949167|P1|Overall Study|Never Treated|3
1504809|NCT00443651|4949219|P2|Overall Study|Pregnancy|1
1504810|NCT00443651|4949220|P1|Overall Study|Pregnancy|0
1504811|NCT00443651|4949219|P2|Overall Study|Physician Decision|4
1504812|NCT00443651|4949220|P1|Overall Study|Physician Decision|13
1504813|NCT00443651|4949219|P2|Overall Study|Patient's/Guardian's Decision|30
1504814|NCT00443651|4949220|P1|Overall Study|Patient's/Guardian's Decision|58
1504815|NCT00443651|4949219|P2|Overall Study|Lost to Follow-up|12
1504816|NCT00443651|4949220|P1|Overall Study|Lost to Follow-up|18
1504817|NCT00443651|4949219|P2|Overall Study|Adverse Event|6
1504818|NCT00443651|4949220|P1|Overall Study|Adverse Event|5
1504819|NCT00443651|4949219|P2|Overall Study|Death|5
1504820|NCT00443651|4949220|P1|Overall Study|Death|1
1504821|NCT00443599|4949240|P2|Overall Study|Cardiopulmonary bypass canceled|1
1504822|NCT00443599|4949241|P1|Overall Study|Cardiopulmonary bypass canceled|3
1504823|NCT00443599|4949240|P2|Overall Study|Death|1
1504824|NCT00443599|4949241|P1|Overall Study|Death|1
1504825|NCT00443599|4949240|P2|Overall Study|Physician Decision|1
1504826|NCT00443599|4949241|P1|Overall Study|Physician Decision|2
1504827|NCT00443560|4949275|P2|Overall Study|Multiple pregnancies or fetal demise|4
1504828|NCT00443560|4949276|P1|Overall Study|Multiple pregnancies or fetal demise|2
1504829|NCT00443560|4949275|P2|Overall Study|No intrathecal dose|26
1504830|NCT00443560|4949276|P1|Overall Study|No intrathecal dose|58
1504831|NCT00443534|4949286|P1|Overall Study|Enrolled, Not Treated|1
1504832|NCT00443534|4949286|P1|Overall Study|Other|10
1504833|NCT00443534|4949286|P1|Overall Study|Study Terminated by Sponsor|12
1504834|NCT00443534|4949286|P1|Overall Study|Withdrawal by Subject|8
1504835|NCT00443534|4949286|P1|Overall Study|Death|9
1504836|NCT00443534|4949286|P1|Overall Study|Adverse Event|16
1504837|NCT00443534|4949286|P1|Overall Study|Lack of Efficacy|67
1504838|NCT00443456|4949293|P1|Overall Study|Withdrawal by Subject|1
1504839|NCT00443456|4949293|P1|Overall Study|Move|1
1504840|NCT00443456|4949293|P1|Overall Study|Adverse Event|16
1504841|NCT00443430|4949328|P2|Overall Study|Adverse Event|1
1504842|NCT00443430|4949329|P1|Overall Study|Adverse Event|1
1504843|NCT00443430|4949328|P2|Overall Study|Lack of Efficacy|3
1504844|NCT00443430|4949329|P1|Overall Study|Lack of Efficacy|3
1504845|NCT00443261|4949343|P1|Overall Study|Death|1
1504846|NCT00443209|4949349|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
1504847|NCT00443209|4949350|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
1504848|NCT00443209|4949349|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
1504849|NCT00443209|4949350|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
1504850|NCT00443209|4949349|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
1504851|NCT00443209|4949350|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
1504852|NCT00443209|4949349|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
1504853|NCT00443209|4949350|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
1504854|NCT00443209|4949349|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
1504855|NCT00443209|4949350|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
1504856|NCT00443209|4949349|P2|Months 13 to 18 Treatment Period|Adverse Event|0
1504857|NCT00443209|4949350|P1|Months 13 to 18 Treatment Period|Adverse Event|1
1504858|NCT00443209|4949349|P2|Months 1 to 12 Treatment Period|Not Treated|43
1504859|NCT00443209|4949350|P1|Months 1 to 12 Treatment Period|Not Treated|71
1504860|NCT00443209|4949349|P2|Months 1 to 12 Treatment Period|Missing|1
1504861|NCT00443209|4949350|P1|Months 1 to 12 Treatment Period|Missing|2
1504862|NCT00443209|4949349|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
1504863|NCT00443209|4949350|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
1504864|NCT00443209|4949349|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
1504865|NCT00443209|4949350|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
1504866|NCT00443209|4949349|P2|Months 1 to 12 Treatment Period|Pregnancy|4
1504867|NCT00443209|4949350|P1|Months 1 to 12 Treatment Period|Pregnancy|3
1504868|NCT00443209|4949349|P2|Months 1 to 12 Treatment Period|Physician Decision|4
1504869|NCT00443209|4949350|P1|Months 1 to 12 Treatment Period|Physician Decision|8
1504870|NCT00443209|4949349|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
1504871|NCT00443209|4949350|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
1504872|NCT00443209|4949349|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
1504873|NCT00443209|4949350|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
1504874|NCT00443209|4949349|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
1504875|NCT00443209|4949350|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
1504876|NCT00443209|4949349|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
1504877|NCT00443209|4949350|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
1504878|NCT00443209|4949349|P2|Months 1 to 12 Treatment Period|Adverse Event|11
1504879|NCT00443209|4949350|P1|Months 1 to 12 Treatment Period|Adverse Event|22
1504880|NCT00443118|4949367|P3|Overall Study|Withdrawal by Subject|0
1504881|NCT00443118|4949368|P2|Overall Study|Withdrawal by Subject|0
1504882|NCT00443118|4949369|P1|Overall Study|Withdrawal by Subject|1
1504883|NCT00443118|4949367|P3|Overall Study|unknown primary outcome|0
1504884|NCT00443118|4949368|P2|Overall Study|unknown primary outcome|1
1504885|NCT00443118|4949369|P1|Overall Study|unknown primary outcome|3
1504886|NCT00443053|4949418|P2|Overall Study|Physician Decision|4
1504887|NCT00443053|4949419|P1|Overall Study|Physician Decision|0
1504888|NCT00443053|4949418|P2|Overall Study|Other|4
1504889|NCT00443053|4949419|P1|Overall Study|Other|3
1504890|NCT00443053|4949418|P2|Overall Study|Noncompliance|1
1504891|NCT00443053|4949419|P1|Overall Study|Noncompliance|2
1504892|NCT00443053|4949418|P2|Overall Study|Did Not Meet Eligibility Criteria|0
1504893|NCT00443053|4949419|P1|Overall Study|Did Not Meet Eligibility Criteria|1
1504894|NCT00443053|4949418|P2|Overall Study|Lost to Follow-up|5
1504895|NCT00443053|4949419|P1|Overall Study|Lost to Follow-up|4
1504896|NCT00443053|4949418|P2|Overall Study|Withdrawal by Subject|18
1504897|NCT00443053|4949419|P1|Overall Study|Withdrawal by Subject|9
1504898|NCT00443053|4949418|P2|Overall Study|Adverse Event|1
1504899|NCT00443053|4949419|P1|Overall Study|Adverse Event|2
1504900|NCT00443040|4949440|P3|Overall Study|Converted to an open laparotomy|1
1504901|NCT00443040|4949441|P2|Overall Study|Converted to an open laparotomy|0
1504902|NCT00443040|4949442|P1|Overall Study|Converted to an open laparotomy|3
1504903|NCT00443040|4949440|P3|Overall Study|Withdrawal by Subject|0
1504904|NCT00443040|4949441|P2|Overall Study|Withdrawal by Subject|0
1504905|NCT00443040|4949442|P1|Overall Study|Withdrawal by Subject|1
1504906|NCT00442962|4949450|P1|Overall Study|Lost to Follow-up|7
1504907|NCT00442962|4949450|P1|Overall Study|Pregnancy|1
1504908|NCT00442936|4949468|P4|Overall Study|Protocol Violation|1
1504909|NCT00442936|4949469|P3|Overall Study|Protocol Violation|1
1504910|NCT00442936|4949470|P2|Overall Study|Protocol Violation|0
1504911|NCT00442936|4949471|P1|Overall Study|Protocol Violation|1
1504912|NCT00442897|4949519|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
1504913|NCT00442897|4949520|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
1504914|NCT00442897|4949519|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
1504915|NCT00442897|4949520|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
1504916|NCT00442897|4949519|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
1504917|NCT00442897|4949520|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
1504918|NCT00442897|4949519|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
1504919|NCT00442897|4949520|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
1504920|NCT00442897|4949519|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
1504921|NCT00442897|4949520|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
1504922|NCT00442897|4949519|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
1504923|NCT00442897|4949520|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
1504924|NCT00442897|4949519|P2|Base Study (12 Week Follow-up)|Death|1
1504925|NCT00442897|4949520|P1|Base Study (12 Week Follow-up)|Death|0
1504926|NCT00442897|4949519|P2|Base Study (12 Week Follow-up)|Adverse Event|0
1504927|NCT00442897|4949520|P1|Base Study (12 Week Follow-up)|Adverse Event|1
1504928|NCT00442702|4949538|P2|Evaluation Period|Site closure|1
1504929|NCT00442702|4949539|P1|Evaluation Period|Site closure|0
1504930|NCT00442702|4949538|P2|Evaluation Period|Failure to return|0
1504931|NCT00442702|4949539|P1|Evaluation Period|Failure to return|1
1504932|NCT00442702|4949538|P2|Evaluation Period|Renal transplant|1
1504933|NCT00442702|4949539|P1|Evaluation Period|Renal transplant|0
1504934|NCT00442702|4949538|P2|Evaluation Period|Refused treatment|1
1504935|NCT00442702|4949539|P1|Evaluation Period|Refused treatment|1
1504936|NCT00442702|4949538|P2|Evaluation Period|Insufficient Therapeutic Response|0
1504937|NCT00442702|4949539|P1|Evaluation Period|Insufficient Therapeutic Response|1
1504938|NCT00442702|4949538|P2|Evaluation Period|Death|1
1504939|NCT00442702|4949539|P1|Evaluation Period|Death|1
1504940|NCT00442702|4949538|P2|Evaluation Period|Adverse Event|0
1504941|NCT00442702|4949539|P1|Evaluation Period|Adverse Event|1
1504942|NCT00442702|4949538|P2|Titration Period|Hospitalized in another hospital|0
1504943|NCT00442702|4949539|P1|Titration Period|Hospitalized in another hospital|1
1504944|NCT00442702|4949538|P2|Titration Period|Failure to return|0
1504945|NCT00442702|4949539|P1|Titration Period|Failure to return|1
1504946|NCT00442702|4949538|P2|Titration Period|Refused Treatment|1
1504947|NCT00442702|4949539|P1|Titration Period|Refused Treatment|4
1504948|NCT00442702|4949538|P2|Titration Period|Insufficient Therapeutic Response|0
1504949|NCT00442702|4949539|P1|Titration Period|Insufficient Therapeutic Response|1
1504950|NCT00442702|4949538|P2|Titration Period|Death|2
1504951|NCT00442702|4949539|P1|Titration Period|Death|3
1504952|NCT00442702|4949538|P2|Titration Period|Adverse Event|0
1504953|NCT00442702|4949539|P1|Titration Period|Adverse Event|2
1504954|NCT00442598|4949604|P3|Overall Study|Death|0
1504955|NCT00442598|4949605|P2|Overall Study|Death|1
1504956|NCT00442598|4949606|P1|Overall Study|Death|0
1504957|NCT00442598|4949604|P3|Overall Study|Reduced creatinine clearance|0
1504958|NCT00442598|4949605|P2|Overall Study|Reduced creatinine clearance|0
1504959|NCT00442598|4949606|P1|Overall Study|Reduced creatinine clearance|1
1504960|NCT00442598|4949604|P3|Overall Study|CA125 progression|0
1504961|NCT00442598|4949605|P2|Overall Study|CA125 progression|1
1504962|NCT00442598|4949606|P1|Overall Study|CA125 progression|0
1504963|NCT00442598|4949604|P3|Overall Study|Clinical deterioration|0
1504964|NCT00442598|4949605|P2|Overall Study|Clinical deterioration|2
1504965|NCT00442598|4949606|P1|Overall Study|Clinical deterioration|1
1504966|NCT00442598|4949604|P3|Overall Study|Tumor progression|0
1504967|NCT00442598|4949605|P2|Overall Study|Tumor progression|4
1504968|NCT00442598|4949606|P1|Overall Study|Tumor progression|3
1504969|NCT00442598|4949604|P3|Overall Study|Adverse Event|0
1504970|NCT00442598|4949605|P2|Overall Study|Adverse Event|0
1504971|NCT00442598|4949606|P1|Overall Study|Adverse Event|1
1504972|NCT00442572|4949624|P2|Overall Study|Withdrawal by Subject|1
1504973|NCT00442572|4949625|P1|Overall Study|Withdrawal by Subject|0
1504974|NCT00442572|4949624|P2|Overall Study|Lost to Follow-up|1
1504975|NCT00442572|4949625|P1|Overall Study|Lost to Follow-up|0
1504976|NCT00442572|4949624|P2|Overall Study|Relapse|1
1504977|NCT00442572|4949625|P1|Overall Study|Relapse|8
1504978|NCT00442559|4949665|P2|Overall Study|Withdrawal by Subject|0
1504979|NCT00442559|4949666|P1|Overall Study|Withdrawal by Subject|1
1504980|NCT00442559|4949665|P2|Overall Study|Protocol Violation|1
1504981|NCT00442559|4949666|P1|Overall Study|Protocol Violation|1
1504982|NCT00442559|4949665|P2|Overall Study|Lost to Follow-up|34
1504983|NCT00442559|4949666|P1|Overall Study|Lost to Follow-up|32
1504984|NCT00442546|4949681|P3|Overall Study|Randomized But Not Treated|6
1504985|NCT00442546|4949682|P2|Overall Study|Randomized But Not Treated|4
1504986|NCT00442546|4949683|P1|Overall Study|Randomized But Not Treated|5
1504987|NCT00442546|4949681|P3|Overall Study|Withdrawal by Subject|7
1504988|NCT00442546|4949682|P2|Overall Study|Withdrawal by Subject|5
1504989|NCT00442546|4949683|P1|Overall Study|Withdrawal by Subject|5
1504990|NCT00442546|4949681|P3|Overall Study|Other|6
1504991|NCT00442546|4949682|P2|Overall Study|Other|9
1504992|NCT00442546|4949683|P1|Overall Study|Other|4
1504993|NCT00442546|4949681|P3|Overall Study|Lost to Follow-up|1
1504994|NCT00442546|4949682|P2|Overall Study|Lost to Follow-up|2
1504995|NCT00442546|4949683|P1|Overall Study|Lost to Follow-up|1
1504996|NCT00442546|4949681|P3|Overall Study|Adverse Event|13
1504997|NCT00442546|4949682|P2|Overall Study|Adverse Event|17
1504998|NCT00442546|4949683|P1|Overall Study|Adverse Event|11
1504999|NCT00442468|4949812|P1|Overall Study|Did not complete all study procedures|88
1505000|NCT00442468|4949812|P1|Overall Study|Withdrawal by Subject|91
1505001|NCT00442468|4949812|P1|Overall Study|Adverse Event|4
1505002|NCT00442416|4949842|P2|Overall Study|Administrative/Other|33
1505003|NCT00442416|4949843|P1|Overall Study|Administrative/Other|27
1505004|NCT00442416|4949842|P2|Overall Study|Withdrew consent|2
1505005|NCT00442416|4949843|P1|Overall Study|Withdrew consent|1
1505006|NCT00442416|4949842|P2|Overall Study|Protocol Violation|3
1505007|NCT00442416|4949843|P1|Overall Study|Protocol Violation|2
1505008|NCT00442416|4949842|P2|Overall Study|Lack of Efficacy|0
1505009|NCT00442416|4949843|P1|Overall Study|Lack of Efficacy|2
1505010|NCT00442416|4949842|P2|Overall Study|Death|0
1505011|NCT00442416|4949843|P1|Overall Study|Death|1
1505012|NCT00442416|4949842|P2|Overall Study|Adverse Event|1
1505013|NCT00442416|4949843|P1|Overall Study|Adverse Event|4
1505014|NCT00442351|4949882|P2|Overall Study|Not specified|1
1505015|NCT00442351|4949883|P1|Overall Study|Not specified|0
1505016|NCT00442351|4949882|P2|Overall Study|Did not meet protocol eligibility|0
1505017|NCT00442351|4949883|P1|Overall Study|Did not meet protocol eligibility|1
1505018|NCT00442351|4949882|P2|Overall Study|Administrative|5
1505019|NCT00442351|4949883|P1|Overall Study|Administrative|6
1505020|NCT00442286|4949905|P2|Overall Study|Patient Injury|0
1505021|NCT00442286|4949906|P1|Overall Study|Patient Injury|1
1505022|NCT00442286|4949905|P2|Overall Study|System explanted|0
1505023|NCT00442286|4949906|P1|Overall Study|System explanted|1
1505024|NCT00442286|4949905|P2|Overall Study|Withdrawal by Subject|0
1505025|NCT00442286|4949906|P1|Overall Study|Withdrawal by Subject|2
1505026|NCT00442286|4949905|P2|Overall Study|Lost to Follow-up|0
1505027|NCT00442286|4949906|P1|Overall Study|Lost to Follow-up|1
1505028|NCT00442286|4949905|P2|Overall Study|Death|2
1505029|NCT00442286|4949906|P1|Overall Study|Death|2
1505030|NCT00442117|4949968|P2|Overall Study|Met Withdrawal Criteria|1
1505031|NCT00442117|4949969|P1|Overall Study|Met Withdrawal Criteria|2
1505032|NCT00442117|4949968|P2|Overall Study|Non compliance with protocol|5
1505033|NCT00442117|4949969|P1|Overall Study|Non compliance with protocol|3
1505034|NCT00442117|4949968|P2|Overall Study|Major Deviation|20
1505035|NCT00442117|4949969|P1|Overall Study|Major Deviation|25
1505036|NCT00442117|4949968|P2|Overall Study|Withdrawal by Subject|2
1505037|NCT00442117|4949969|P1|Overall Study|Withdrawal by Subject|2
1505038|NCT00442117|4949968|P2|Overall Study|Lost to Follow-up|2
1505039|NCT00442117|4949969|P1|Overall Study|Lost to Follow-up|1
1505040|NCT00442117|4949968|P2|Overall Study|Lack of Efficacy|6
1505041|NCT00442117|4949969|P1|Overall Study|Lack of Efficacy|2
1505042|NCT00442117|4949968|P2|Overall Study|Adverse Event|2
1505043|NCT00442117|4949969|P1|Overall Study|Adverse Event|3
1505044|NCT00441974|4950000|P1|Overall Study|Protocol Violation|7
1505045|NCT00441974|4950000|P1|Overall Study|Lost to Follow-up|80
1505046|NCT00441974|4950000|P1|Overall Study|Consent Withdrawn|35
1505047|NCT00441974|4950000|P1|Overall Study|Adverse Event|6
1505048|NCT00441792|4950016|P2|Overall Study|Lost to Follow-up|2
1505049|NCT00441792|4950017|P1|Overall Study|Lost to Follow-up|0
1505050|NCT00441727|4950057|P3|Overall Study|Various reason specified|5
1505051|NCT00441727|4950058|P2|Overall Study|Various reason specified|8
1505052|NCT00441727|4950059|P1|Overall Study|Various reason specified|6
1505053|NCT00441727|4950057|P3|Overall Study|Safety Reasons|3
1505054|NCT00441727|4950058|P2|Overall Study|Safety Reasons|1
1505055|NCT00441727|4950059|P1|Overall Study|Safety Reasons|3
1505056|NCT00441727|4950057|P3|Overall Study|Lost to Follow-up|5
1505057|NCT00441727|4950058|P2|Overall Study|Lost to Follow-up|6
1505058|NCT00441727|4950059|P1|Overall Study|Lost to Follow-up|5
1505059|NCT00441727|4950057|P3|Overall Study|Withdrawal by Subject|47
1505060|NCT00441727|4950058|P2|Overall Study|Withdrawal by Subject|34
1505061|NCT00441727|4950059|P1|Overall Study|Withdrawal by Subject|40
1505062|NCT00441727|4950057|P3|Overall Study|Lack of Efficacy|48
1505063|NCT00441727|4950058|P2|Overall Study|Lack of Efficacy|8
1505064|NCT00441727|4950059|P1|Overall Study|Lack of Efficacy|7
1505065|NCT00441727|4950057|P3|Overall Study|Adverse Event|28
1505066|NCT00441727|4950058|P2|Overall Study|Adverse Event|33
1505067|NCT00441727|4950059|P1|Overall Study|Adverse Event|26
1505068|NCT00441727|4950057|P3|Overall Study|Protocol Violation|32
1505069|NCT00441727|4950058|P2|Overall Study|Protocol Violation|28
1505070|NCT00441727|4950059|P1|Overall Study|Protocol Violation|19
1505071|NCT00441701|4950092|P10|Overall Study|Withdrawal by Subject|0
1505072|NCT00441701|4950093|P9|Overall Study|Withdrawal by Subject|0
1505073|NCT00441701|4950094|P8|Overall Study|Withdrawal by Subject|0
1505074|NCT00441701|4950095|P7|Overall Study|Withdrawal by Subject|0
1505075|NCT00441701|4950096|P6|Overall Study|Withdrawal by Subject|0
1505076|NCT00441701|4950097|P5|Overall Study|Withdrawal by Subject|0
1505077|NCT00441701|4950098|P4|Overall Study|Withdrawal by Subject|1
1505078|NCT00441701|4950099|P3|Overall Study|Withdrawal by Subject|1
1505079|NCT00441701|4950100|P2|Overall Study|Withdrawal by Subject|2
1505080|NCT00441701|4950101|P1|Overall Study|Withdrawal by Subject|0
1505081|NCT00441701|4950092|P10|Overall Study|Lack of Efficacy|0
1505082|NCT00441701|4950093|P9|Overall Study|Lack of Efficacy|0
1505083|NCT00441701|4950094|P8|Overall Study|Lack of Efficacy|0
1505084|NCT00441701|4950095|P7|Overall Study|Lack of Efficacy|0
1505085|NCT00441701|4950096|P6|Overall Study|Lack of Efficacy|1
1505086|NCT00441701|4950097|P5|Overall Study|Lack of Efficacy|0
1505087|NCT00441701|4950098|P4|Overall Study|Lack of Efficacy|2
1505088|NCT00441701|4950099|P3|Overall Study|Lack of Efficacy|2
1505089|NCT00441701|4950100|P2|Overall Study|Lack of Efficacy|0
1505090|NCT00441701|4950101|P1|Overall Study|Lack of Efficacy|2
1505091|NCT00441701|4950092|P10|Overall Study|Adverse Event|0
1505092|NCT00441701|4950093|P9|Overall Study|Adverse Event|0
1505093|NCT00441701|4950094|P8|Overall Study|Adverse Event|0
1505094|NCT00441701|4950095|P7|Overall Study|Adverse Event|0
1505095|NCT00441701|4950096|P6|Overall Study|Adverse Event|2
1505096|NCT00441701|4950097|P5|Overall Study|Adverse Event|2
1505097|NCT00441701|4950098|P4|Overall Study|Adverse Event|0
1505098|NCT00441701|4950099|P3|Overall Study|Adverse Event|1
1505099|NCT00441701|4950100|P2|Overall Study|Adverse Event|2
1505100|NCT00441701|4950101|P1|Overall Study|Adverse Event|3
1505101|NCT00441584|4950183|P1|Overall Study|Failure to meet eligibility criteria|3
1505102|NCT00441584|4950183|P1|Overall Study|Lost to Follow-up|4
1505103|NCT00441584|4950183|P1|Overall Study|Protocol Violation|5
1505104|NCT00441584|4950183|P1|Overall Study|Adverse Event|6
1505105|NCT00441584|4950183|P1|Overall Study|Withdrawal by Subject|8
1505106|NCT00441584|4950183|P1|Overall Study|Lack of Efficacy|79
1505107|NCT00441545|4950191|P2|Second Intervention|Subject moved|1
1505108|NCT00441545|4950192|P1|Second Intervention|Subject moved|0
1505109|NCT00441545|4950191|P2|Second Intervention|Subject exceeded safety criteria|0
1505110|NCT00441545|4950192|P1|Second Intervention|Subject exceeded safety criteria|1
1505111|NCT00441545|4950191|P2|Second Intervention|Lack of Efficacy|1
1505112|NCT00441545|4950192|P1|Second Intervention|Lack of Efficacy|0
1505113|NCT00441545|4950191|P2|Second Intervention|Kidney Transplant|1
1505114|NCT00441545|4950192|P1|Second Intervention|Kidney Transplant|1
1505115|NCT00441545|4950191|P2|Second Intervention|Withdrawal by Subject|1
1505116|NCT00441545|4950192|P1|Second Intervention|Withdrawal by Subject|1
1505117|NCT00441545|4950191|P2|Second Intervention|Protocol Violation|1
1505118|NCT00441545|4950192|P1|Second Intervention|Protocol Violation|4
1505119|NCT00441545|4950191|P2|Second Intervention|Adverse Event|2
1505120|NCT00441545|4950192|P1|Second Intervention|Adverse Event|5
1505121|NCT00441545|4950191|P2|First Intervention|Sponsor's request|0
1505122|NCT00441545|4950192|P1|First Intervention|Sponsor's request|1
1505123|NCT00441545|4950191|P2|First Intervention|Site error|0
1505124|NCT00441545|4950192|P1|First Intervention|Site error|1
1505125|NCT00441545|4950191|P2|First Intervention|Extended hospitalization|0
1505126|NCT00441545|4950192|P1|First Intervention|Extended hospitalization|1
1505127|NCT00441545|4950191|P2|First Intervention|Subject met an exclusionary criteria|0
1505128|NCT00441545|4950192|P1|First Intervention|Subject met an exclusionary criteria|1
1505129|NCT00441545|4950191|P2|First Intervention|Subject exceeded safety criteria|1
1505130|NCT00441545|4950192|P1|First Intervention|Subject exceeded safety criteria|0
1505131|NCT00441545|4950191|P2|First Intervention|Lack of Efficacy|0
1505132|NCT00441545|4950192|P1|First Intervention|Lack of Efficacy|2
1505133|NCT00441545|4950191|P2|First Intervention|Kidney transplant|1
1505134|NCT00441545|4950192|P1|First Intervention|Kidney transplant|1
1505135|NCT00441545|4950191|P2|First Intervention|Withdrawal by Subject|3
1505136|NCT00441545|4950192|P1|First Intervention|Withdrawal by Subject|3
1505137|NCT00441545|4950191|P2|First Intervention|Protocol Violation|2
1505138|NCT00441545|4950192|P1|First Intervention|Protocol Violation|2
1505139|NCT00441545|4950191|P2|First Intervention|Adverse Event|5
1505140|NCT00441545|4950192|P1|First Intervention|Adverse Event|6
1505141|NCT00441480|4950206|P2|Overall Study|Withdrawal by Subject|3
1505142|NCT00441480|4950207|P1|Overall Study|Withdrawal by Subject|2
1505143|NCT00441480|4950206|P2|Overall Study|Protocol Violation|1
1505144|NCT00441480|4950207|P1|Overall Study|Protocol Violation|1
1505145|NCT00441467|4950239|P1|Overall Study|Progressive disease|9
1505146|NCT00441467|4950239|P1|Overall Study|Withdrawal by Subject|3
1505147|NCT00441467|4950239|P1|Overall Study|Adverse Event|6
1505148|NCT00441441|4950247|P2|Overall Study|Not specified|3
1505149|NCT00441441|4950248|P1|Overall Study|Not specified|3
1505150|NCT00441441|4950247|P2|Overall Study|Withdrawal by Subject|2
1505151|NCT00441441|4950248|P1|Overall Study|Withdrawal by Subject|1
1505152|NCT00441441|4950247|P2|Overall Study|Exacerbation of asthma|2
1505153|NCT00441441|4950248|P1|Overall Study|Exacerbation of asthma|1
1505154|NCT00441441|4950247|P2|Overall Study|Protocol Violation|6
1505155|NCT00441441|4950248|P1|Overall Study|Protocol Violation|4
1505156|NCT00441441|4950247|P2|Overall Study|Adverse Event|1
1505157|NCT00441441|4950248|P1|Overall Study|Adverse Event|2
1505158|NCT00441363|4950308|P2|Overall Study|not specified|0
1505159|NCT00441363|4950309|P1|Overall Study|not specified|2
1505160|NCT00441363|4950308|P2|Overall Study|Lost to Follow-up|2
1505161|NCT00441363|4950309|P1|Overall Study|Lost to Follow-up|2
1505162|NCT00441363|4950308|P2|Overall Study|Physician Decision|7
1505163|NCT00441363|4950309|P1|Overall Study|Physician Decision|6
1505164|NCT00441363|4950308|P2|Overall Study|Withdrawal by Subject|4
1505165|NCT00441363|4950309|P1|Overall Study|Withdrawal by Subject|3
1505166|NCT00441363|4950308|P2|Overall Study|Adverse Event|2
1505167|NCT00441363|4950309|P1|Overall Study|Adverse Event|4
1505168|NCT00441337|4950321|P4|Overall Study|Did not meet inclusion criteria|0
1505169|NCT00441337|4950322|P3|Overall Study|Did not meet inclusion criteria|1
1505170|NCT00441337|4950323|P2|Overall Study|Did not meet inclusion criteria|0
1505171|NCT00441337|4950324|P1|Overall Study|Did not meet inclusion criteria|0
1505172|NCT00441337|4950321|P4|Overall Study|Sponsor Decision|2
1505173|NCT00441337|4950322|P3|Overall Study|Sponsor Decision|1
1505174|NCT00441337|4950323|P2|Overall Study|Sponsor Decision|0
1505175|NCT00441337|4950324|P1|Overall Study|Sponsor Decision|0
1505176|NCT00441337|4950321|P4|Overall Study|Lost to Follow-up|1
1505177|NCT00441337|4950322|P3|Overall Study|Lost to Follow-up|0
1505178|NCT00441337|4950323|P2|Overall Study|Lost to Follow-up|0
1505179|NCT00441337|4950324|P1|Overall Study|Lost to Follow-up|0
1505180|NCT00441337|4950321|P4|Overall Study|Disease Progression|18
1505181|NCT00441337|4950322|P3|Overall Study|Disease Progression|4
1505182|NCT00441337|4950323|P2|Overall Study|Disease Progression|6
1505183|NCT00441337|4950324|P1|Overall Study|Disease Progression|6
1505184|NCT00441272|4950437|P2|Overall Study|Study terminated prior to enrollment|25
1505185|NCT00441272|4950438|P1|Overall Study|Study terminated prior to enrollment|25
1505186|NCT00441168|4950465|P2|Follow-up Period|Other|3
1505187|NCT00441168|4950466|P1|Follow-up Period|Other|1
1505188|NCT00441168|4950465|P2|Follow-up Period|Withdrawal by Subject|0
1505189|NCT00441168|4950466|P1|Follow-up Period|Withdrawal by Subject|3
1505190|NCT00441168|4950465|P2|Follow-up Period|Lost to Follow-up|6
1505191|NCT00441168|4950466|P1|Follow-up Period|Lost to Follow-up|5
1505192|NCT00441168|4950465|P2|Follow-up Period|Death|0
1505193|NCT00441168|4950466|P1|Follow-up Period|Death|3
1505194|NCT00441168|4950465|P2|Treatment Period|refractory disease|0
1505195|NCT00441168|4950466|P1|Treatment Period|refractory disease|1
1505196|NCT00441168|4950465|P2|Treatment Period|qualified for stem-cell transplantation|0
1505197|NCT00441168|4950466|P1|Treatment Period|qualified for stem-cell transplantation|3
1505198|NCT00441168|4950465|P2|Treatment Period|Withdrawal by Subject|0
1505199|NCT00441168|4950466|P1|Treatment Period|Withdrawal by Subject|3
1505200|NCT00441168|4950465|P2|Treatment Period|Lost to Follow-up|1
1505201|NCT00441168|4950466|P1|Treatment Period|Lost to Follow-up|0
1505202|NCT00441168|4950465|P2|Treatment Period|Protocol Violation|1
1505203|NCT00441168|4950466|P1|Treatment Period|Protocol Violation|0
1505204|NCT00441168|4950465|P2|Treatment Period|Progressive Disease|2
1505205|NCT00441168|4950466|P1|Treatment Period|Progressive Disease|0
1505206|NCT00441168|4950465|P2|Treatment Period|Adverse Event|2
1505207|NCT00441168|4950466|P1|Treatment Period|Adverse Event|1
1505208|NCT00441168|4950465|P2|Treatment Period|Death|0
1505209|NCT00441168|4950466|P1|Treatment Period|Death|3
1505210|NCT00441142|4950480|P4|Overall Study|Death|1
1505211|NCT00441142|4950481|P3|Overall Study|Death|0
1505212|NCT00441142|4950482|P2|Overall Study|Death|0
1505213|NCT00441142|4950483|P1|Overall Study|Death|0
1505214|NCT00441142|4950480|P4|Overall Study|Physician Decision|1
1505215|NCT00441142|4950481|P3|Overall Study|Physician Decision|0
1505216|NCT00441142|4950482|P2|Overall Study|Physician Decision|1
1505217|NCT00441142|4950483|P1|Overall Study|Physician Decision|0
1505218|NCT00441142|4950480|P4|Overall Study|Patient still receiving active study tx|2
1505219|NCT00441142|4950481|P3|Overall Study|Patient still receiving active study tx|0
1505220|NCT00441142|4950482|P2|Overall Study|Patient still receiving active study tx|0
1505221|NCT00441142|4950483|P1|Overall Study|Patient still receiving active study tx|1
1505222|NCT00441142|4950480|P4|Overall Study|Withdrawal by Subject|10
1505223|NCT00441142|4950481|P3|Overall Study|Withdrawal by Subject|2
1505224|NCT00441142|4950482|P2|Overall Study|Withdrawal by Subject|0
1505225|NCT00441142|4950483|P1|Overall Study|Withdrawal by Subject|0
1505226|NCT00441142|4950480|P4|Overall Study|Lack of Efficacy|32
1505227|NCT00441142|4950481|P3|Overall Study|Lack of Efficacy|17
1505228|NCT00441142|4950482|P2|Overall Study|Lack of Efficacy|3
1505229|NCT00441142|4950483|P1|Overall Study|Lack of Efficacy|3
1505230|NCT00441142|4950480|P4|Overall Study|Adverse Event|22
1505231|NCT00441142|4950481|P3|Overall Study|Adverse Event|3
1505232|NCT00441142|4950482|P2|Overall Study|Adverse Event|3
1505233|NCT00441142|4950483|P1|Overall Study|Adverse Event|2
1505234|NCT00441116|4950501|P2|Overall Study|Did not meet Eligibility Criteria|1
1505235|NCT00441116|4950502|P1|Overall Study|Did not meet Eligibility Criteria|1
1505236|NCT00441116|4950501|P2|Overall Study|Withdrawal by Subject|0
1505237|NCT00441116|4950502|P1|Overall Study|Withdrawal by Subject|1
1505238|NCT00441116|4950501|P2|Overall Study|Adverse Event|1
1505239|NCT00441116|4950502|P1|Overall Study|Adverse Event|1
1505240|NCT00441103|4950570|P2|Overall Study|Participant decided to stop|1
1505241|NCT00441103|4950571|P1|Overall Study|Participant decided to stop|0
1505242|NCT00441103|4950570|P2|Overall Study|Participant's reason|1
1505243|NCT00441103|4950571|P1|Overall Study|Participant's reason|0
1505244|NCT00441103|4950570|P2|Overall Study|Participant decided to withdraw|0
1505245|NCT00441103|4950571|P1|Overall Study|Participant decided to withdraw|1
1505246|NCT00441103|4950570|P2|Overall Study|Non-compliant|1
1505247|NCT00441103|4950571|P1|Overall Study|Non-compliant|0
1505248|NCT00441103|4950570|P2|Overall Study|Inclusion criteria absent|0
1505249|NCT00441103|4950571|P1|Overall Study|Inclusion criteria absent|1
1505250|NCT00441103|4950570|P2|Overall Study|Participant refused MRI|0
1505251|NCT00441103|4950571|P1|Overall Study|Participant refused MRI|1
1505252|NCT00441103|4950570|P2|Overall Study|Participant unable to use Rebiject II|0
1505253|NCT00441103|4950571|P1|Overall Study|Participant unable to use Rebiject II|1
1505254|NCT00441103|4950570|P2|Overall Study|Protocol Violation|0
1505255|NCT00441103|4950571|P1|Overall Study|Protocol Violation|1
1505256|NCT00441103|4950570|P2|Overall Study|Lost to Follow-up|0
1505257|NCT00441103|4950571|P1|Overall Study|Lost to Follow-up|1
1505258|NCT00441103|4950570|P2|Overall Study|Disease Progression|0
1505259|NCT00441103|4950571|P1|Overall Study|Disease Progression|2
1505260|NCT00441103|4950570|P2|Overall Study|Death|0
1505261|NCT00441103|4950571|P1|Overall Study|Death|1
1505262|NCT00441103|4950570|P2|Overall Study|Adverse Event|1
1505263|NCT00441103|4950571|P1|Overall Study|Adverse Event|2
1505264|NCT00441090|4950587|P5|Overall Study|Lack of Efficacy|0
1505265|NCT00441090|4950588|P4|Overall Study|Lack of Efficacy|0
1505266|NCT00441090|4950589|P3|Overall Study|Lack of Efficacy|0
1505267|NCT00441090|4950590|P2|Overall Study|Lack of Efficacy|0
1505268|NCT00441090|4950591|P1|Overall Study|Lack of Efficacy|1
1505269|NCT00441090|4950587|P5|Overall Study|Withdrawal by Subject|0
1505270|NCT00441090|4950588|P4|Overall Study|Withdrawal by Subject|0
1505271|NCT00441090|4950589|P3|Overall Study|Withdrawal by Subject|1
1505272|NCT00441090|4950590|P2|Overall Study|Withdrawal by Subject|0
1505273|NCT00441090|4950591|P1|Overall Study|Withdrawal by Subject|1
1505274|NCT00441090|4950587|P5|Overall Study|Platelet increase;more than 500,000 mm^3|0
1505275|NCT00441090|4950588|P4|Overall Study|Platelet increase;more than 500,000 mm^3|2
1505276|NCT00441090|4950589|P3|Overall Study|Platelet increase;more than 500,000 mm^3|0
1505277|NCT00441090|4950590|P2|Overall Study|Platelet increase;more than 500,000 mm^3|0
1505278|NCT00441090|4950591|P1|Overall Study|Platelet increase;more than 500,000 mm^3|0
1505279|NCT00441090|4950587|P5|Overall Study|Adverse Event|0
1505280|NCT00441090|4950588|P4|Overall Study|Adverse Event|0
1505281|NCT00441090|4950589|P3|Overall Study|Adverse Event|1
1505282|NCT00441090|4950590|P2|Overall Study|Adverse Event|1
1505283|NCT00441090|4950591|P1|Overall Study|Adverse Event|0
1505284|NCT00441064|4950635|P2|Overall Study|Patient withdrew consent|2
1505285|NCT00441064|4950636|P1|Overall Study|Patient withdrew consent|5
1505286|NCT00441064|4950635|P2|Overall Study|Protocol Deviation|2
1505287|NCT00441064|4950636|P1|Overall Study|Protocol Deviation|3
1505288|NCT00441064|4950635|P2|Overall Study|Unsatisfactory therapeutic effect|0
1505289|NCT00441064|4950636|P1|Overall Study|Unsatisfactory therapeutic effect|1
1505290|NCT00441064|4950635|P2|Overall Study|Abnormal test procedure results|1
1505291|NCT00441064|4950636|P1|Overall Study|Abnormal test procedure results|0
1505292|NCT00441064|4950635|P2|Overall Study|Abnormal laboratory values|2
1505293|NCT00441064|4950636|P1|Overall Study|Abnormal laboratory values|0
1505294|NCT00441064|4950635|P2|Overall Study|Adverse Event|0
1505295|NCT00441064|4950636|P1|Overall Study|Adverse Event|1
1505296|NCT00441012|4950648|P2|Overall Study|Subject Randomized but Not Vaccinated|0
1505297|NCT00441012|4950649|P1|Overall Study|Subject Randomized but Not Vaccinated|1
1505298|NCT00441012|4950648|P2|Overall Study|Withdrawal by Subject|0
1505299|NCT00441012|4950649|P1|Overall Study|Withdrawal by Subject|4
1505300|NCT00441012|4950648|P2|Overall Study|Protocol Violation|9
1505301|NCT00441012|4950649|P1|Overall Study|Protocol Violation|10
1505302|NCT00441012|4950648|P2|Overall Study|Lost to Follow-up|3
1505303|NCT00441012|4950649|P1|Overall Study|Lost to Follow-up|3
1505304|NCT00441012|4950648|P2|Overall Study|Adverse Event|1
1505305|NCT00441012|4950649|P1|Overall Study|Adverse Event|0
1505306|NCT00440947|4950663|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
1505307|NCT00440947|4950664|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
1505308|NCT00440947|4950665|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
1505309|NCT00440947|4950666|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
1505310|NCT00440947|4950667|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
1505311|NCT00440947|4950663|P5|Optional 60-Week Extension Phase|Physician Decision|1
1505312|NCT00440947|4950664|P4|Optional 60-Week Extension Phase|Physician Decision|0
1505313|NCT00440947|4950665|P3|Optional 60-Week Extension Phase|Physician Decision|0
1505314|NCT00440947|4950666|P2|Optional 60-Week Extension Phase|Physician Decision|0
1505315|NCT00440947|4950667|P1|Optional 60-Week Extension Phase|Physician Decision|0
1505316|NCT00440947|4950663|P5|Optional 60-Week Extension Phase|Other|0
1505317|NCT00440947|4950664|P4|Optional 60-Week Extension Phase|Other|1
1505318|NCT00440947|4950665|P3|Optional 60-Week Extension Phase|Other|0
1505319|NCT00440947|4950666|P2|Optional 60-Week Extension Phase|Other|0
1505320|NCT00440947|4950667|P1|Optional 60-Week Extension Phase|Other|0
1505321|NCT00440947|4950663|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
1505322|NCT00440947|4950664|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
1505323|NCT00440947|4950665|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
1505324|NCT00440947|4950666|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
1505325|NCT00440947|4950667|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
1505326|NCT00440947|4950663|P5|Optional 60-Week Extension Phase|Sponsor Request|1
1505327|NCT00440947|4950664|P4|Optional 60-Week Extension Phase|Sponsor Request|1
1505328|NCT00440947|4950665|P3|Optional 60-Week Extension Phase|Sponsor Request|0
1505329|NCT00440947|4950666|P2|Optional 60-Week Extension Phase|Sponsor Request|0
1505330|NCT00440947|4950667|P1|Optional 60-Week Extension Phase|Sponsor Request|0
1505331|NCT00440947|4950663|P5|Optional 60-Week Extension Phase|Participant Moved|1
1505332|NCT00440947|4950664|P4|Optional 60-Week Extension Phase|Participant Moved|1
1505333|NCT00440947|4950665|P3|Optional 60-Week Extension Phase|Participant Moved|0
1505334|NCT00440947|4950666|P2|Optional 60-Week Extension Phase|Participant Moved|0
1505335|NCT00440947|4950667|P1|Optional 60-Week Extension Phase|Participant Moved|0
1505336|NCT00440947|4950663|P5|Optional 60-Week Extension Phase|Pregnancy|0
1505337|NCT00440947|4950664|P4|Optional 60-Week Extension Phase|Pregnancy|3
1505338|NCT00440947|4950665|P3|Optional 60-Week Extension Phase|Pregnancy|0
1505339|NCT00440947|4950666|P2|Optional 60-Week Extension Phase|Pregnancy|0
1505340|NCT00440947|4950667|P1|Optional 60-Week Extension Phase|Pregnancy|0
1505341|NCT00440947|4950663|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
1505342|NCT00440947|4950664|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
1505343|NCT00440947|4950665|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
1505344|NCT00440947|4950666|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
1505345|NCT00440947|4950667|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
1505346|NCT00440947|4950663|P5|Optional 60-Week Extension Phase|Protocol Violation|0
1505347|NCT00440947|4950664|P4|Optional 60-Week Extension Phase|Protocol Violation|1
1505348|NCT00440947|4950665|P3|Optional 60-Week Extension Phase|Protocol Violation|0
1505349|NCT00440947|4950666|P2|Optional 60-Week Extension Phase|Protocol Violation|0
1505350|NCT00440947|4950667|P1|Optional 60-Week Extension Phase|Protocol Violation|0
1505351|NCT00440947|4950663|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
1505352|NCT00440947|4950664|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
1505353|NCT00440947|4950665|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
1505354|NCT00440947|4950666|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
1505355|NCT00440947|4950667|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
1505356|NCT00440947|4950663|P5|Optional 60-Week Extension Phase|Non-compliance|1
1505357|NCT00440947|4950664|P4|Optional 60-Week Extension Phase|Non-compliance|1
1505358|NCT00440947|4950665|P3|Optional 60-Week Extension Phase|Non-compliance|0
1505359|NCT00440947|4950666|P2|Optional 60-Week Extension Phase|Non-compliance|0
1505360|NCT00440947|4950667|P1|Optional 60-Week Extension Phase|Non-compliance|0
1505361|NCT00440947|4950663|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
1505362|NCT00440947|4950664|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
1505363|NCT00440947|4950665|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
1505364|NCT00440947|4950666|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
1505365|NCT00440947|4950667|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
1505366|NCT00440947|4950663|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
1505367|NCT00440947|4950664|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
1505368|NCT00440947|4950665|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
1505369|NCT00440947|4950666|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
1505370|NCT00440947|4950667|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
1505371|NCT00440947|4950663|P5|Optional 60-Week Extension Phase|Adverse Event|3
1505372|NCT00440947|4950664|P4|Optional 60-Week Extension Phase|Adverse Event|1
1505373|NCT00440947|4950665|P3|Optional 60-Week Extension Phase|Adverse Event|0
1505374|NCT00440947|4950666|P2|Optional 60-Week Extension Phase|Adverse Event|0
1505375|NCT00440947|4950667|P1|Optional 60-Week Extension Phase|Adverse Event|0
1505376|NCT00440947|4950663|P5|48-Week Randomization Phase|Physician Decision|0
1505377|NCT00440947|4950664|P4|48-Week Randomization Phase|Physician Decision|0
1505378|NCT00440947|4950665|P3|48-Week Randomization Phase|Physician Decision|0
1505379|NCT00440947|4950666|P2|48-Week Randomization Phase|Physician Decision|2
1505380|NCT00440947|4950667|P1|48-Week Randomization Phase|Physician Decision|0
1505381|NCT00440947|4950663|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
1505382|NCT00440947|4950664|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
1505383|NCT00440947|4950665|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
1505384|NCT00440947|4950666|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
1505385|NCT00440947|4950667|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
1505386|NCT00440947|4950663|P5|48-Week Randomization Phase|Incarceration|0
1505387|NCT00440947|4950664|P4|48-Week Randomization Phase|Incarceration|0
1505388|NCT00440947|4950665|P3|48-Week Randomization Phase|Incarceration|0
1505389|NCT00440947|4950666|P2|48-Week Randomization Phase|Incarceration|3
1505390|NCT00440947|4950667|P1|48-Week Randomization Phase|Incarceration|0
1505391|NCT00440947|4950663|P5|48-Week Randomization Phase|Pregnancy|0
1505392|NCT00440947|4950664|P4|48-Week Randomization Phase|Pregnancy|0
1505393|NCT00440947|4950665|P3|48-Week Randomization Phase|Pregnancy|1
1505394|NCT00440947|4950666|P2|48-Week Randomization Phase|Pregnancy|0
1505395|NCT00440947|4950667|P1|48-Week Randomization Phase|Pregnancy|0
1505396|NCT00440947|4950663|P5|48-Week Randomization Phase|Withdrawal by Subject|0
1505397|NCT00440947|4950664|P4|48-Week Randomization Phase|Withdrawal by Subject|0
1505398|NCT00440947|4950665|P3|48-Week Randomization Phase|Withdrawal by Subject|4
1505399|NCT00440947|4950666|P2|48-Week Randomization Phase|Withdrawal by Subject|2
1505400|NCT00440947|4950667|P1|48-Week Randomization Phase|Withdrawal by Subject|0
1505401|NCT00440947|4950663|P5|48-Week Randomization Phase|Protocol Violation|0
1505402|NCT00440947|4950664|P4|48-Week Randomization Phase|Protocol Violation|0
1505403|NCT00440947|4950665|P3|48-Week Randomization Phase|Protocol Violation|1
1505404|NCT00440947|4950666|P2|48-Week Randomization Phase|Protocol Violation|0
1505405|NCT00440947|4950667|P1|48-Week Randomization Phase|Protocol Violation|0
1505406|NCT00440947|4950663|P5|48-Week Randomization Phase|Lost to Follow-up|0
1505407|NCT00440947|4950664|P4|48-Week Randomization Phase|Lost to Follow-up|0
1505408|NCT00440947|4950665|P3|48-Week Randomization Phase|Lost to Follow-up|8
1505409|NCT00440947|4950666|P2|48-Week Randomization Phase|Lost to Follow-up|2
1505410|NCT00440947|4950667|P1|48-Week Randomization Phase|Lost to Follow-up|0
1505411|NCT00440947|4950663|P5|48-Week Randomization Phase|Non-compliance|0
1505412|NCT00440947|4950664|P4|48-Week Randomization Phase|Non-compliance|0
1505413|NCT00440947|4950665|P3|48-Week Randomization Phase|Non-compliance|4
1505414|NCT00440947|4950666|P2|48-Week Randomization Phase|Non-compliance|3
1505415|NCT00440947|4950667|P1|48-Week Randomization Phase|Non-compliance|0
1505416|NCT00440947|4950663|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
1505417|NCT00440947|4950664|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
1505418|NCT00440947|4950665|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
1505419|NCT00440947|4950666|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
1505420|NCT00440947|4950667|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
1505421|NCT00440947|4950663|P5|48-Week Randomization Phase|Adverse Event|0
1505422|NCT00440947|4950664|P4|48-Week Randomization Phase|Adverse Event|0
1505423|NCT00440947|4950665|P3|48-Week Randomization Phase|Adverse Event|5
1505424|NCT00440947|4950666|P2|48-Week Randomization Phase|Adverse Event|2
1505425|NCT00440947|4950667|P1|48-Week Randomization Phase|Adverse Event|0
1505426|NCT00440947|4950663|P5|36-Week Induction Phase|Pregnancy|0
1505427|NCT00440947|4950664|P4|36-Week Induction Phase|Pregnancy|0
1505428|NCT00440947|4950665|P3|36-Week Induction Phase|Pregnancy|0
1505429|NCT00440947|4950666|P2|36-Week Induction Phase|Pregnancy|0
1505430|NCT00440947|4950667|P1|36-Week Induction Phase|Pregnancy|1
1505431|NCT00440947|4950663|P5|36-Week Induction Phase|Incarceration|0
1505432|NCT00440947|4950664|P4|36-Week Induction Phase|Incarceration|0
1505433|NCT00440947|4950665|P3|36-Week Induction Phase|Incarceration|0
1505434|NCT00440947|4950666|P2|36-Week Induction Phase|Incarceration|0
1505435|NCT00440947|4950667|P1|36-Week Induction Phase|Incarceration|3
1505436|NCT00440947|4950663|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
1505437|NCT00440947|4950664|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
1505438|NCT00440947|4950665|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
1505439|NCT00440947|4950666|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
1505440|NCT00440947|4950667|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
1505441|NCT00440947|4950663|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
1505442|NCT00440947|4950664|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
1505443|NCT00440947|4950665|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
1505444|NCT00440947|4950666|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
1505445|NCT00440947|4950667|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
1505446|NCT00440947|4950663|P5|36-Week Induction Phase|Took Exclusionary Medications|0
1505447|NCT00440947|4950664|P4|36-Week Induction Phase|Took Exclusionary Medications|0
1505448|NCT00440947|4950665|P3|36-Week Induction Phase|Took Exclusionary Medications|0
1505449|NCT00440947|4950666|P2|36-Week Induction Phase|Took Exclusionary Medications|0
1505450|NCT00440947|4950667|P1|36-Week Induction Phase|Took Exclusionary Medications|1
1505451|NCT00440947|4950663|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
1505452|NCT00440947|4950664|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
1505453|NCT00440947|4950665|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
1505454|NCT00440947|4950666|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
1505455|NCT00440947|4950667|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
1505456|NCT00440947|4950663|P5|36-Week Induction Phase|Withdrawal by Subject|0
1505457|NCT00440947|4950664|P4|36-Week Induction Phase|Withdrawal by Subject|0
1505458|NCT00440947|4950665|P3|36-Week Induction Phase|Withdrawal by Subject|0
1505459|NCT00440947|4950666|P2|36-Week Induction Phase|Withdrawal by Subject|0
1505460|NCT00440947|4950667|P1|36-Week Induction Phase|Withdrawal by Subject|7
1505461|NCT00440947|4950663|P5|36-Week Induction Phase|Lost to Follow-up|0
1505462|NCT00440947|4950664|P4|36-Week Induction Phase|Lost to Follow-up|0
1505463|NCT00440947|4950665|P3|36-Week Induction Phase|Lost to Follow-up|0
1505464|NCT00440947|4950666|P2|36-Week Induction Phase|Lost to Follow-up|0
1505465|NCT00440947|4950667|P1|36-Week Induction Phase|Lost to Follow-up|16
1505466|NCT00440947|4950663|P5|36-Week Induction Phase|Non-compliance|0
1505467|NCT00440947|4950664|P4|36-Week Induction Phase|Non-compliance|0
1505468|NCT00440947|4950665|P3|36-Week Induction Phase|Non-compliance|0
1505469|NCT00440947|4950666|P2|36-Week Induction Phase|Non-compliance|0
1505470|NCT00440947|4950667|P1|36-Week Induction Phase|Non-compliance|10
1505471|NCT00440947|4950663|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
1505472|NCT00440947|4950664|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
1505473|NCT00440947|4950665|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
1505474|NCT00440947|4950666|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
1505475|NCT00440947|4950667|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
1505476|NCT00440947|4950663|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
1505477|NCT00440947|4950664|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
1505478|NCT00440947|4950665|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
1505479|NCT00440947|4950666|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
1505480|NCT00440947|4950667|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
1505481|NCT00440947|4950663|P5|36-Week Induction Phase|Adverse Event|0
1505482|NCT00440947|4950664|P4|36-Week Induction Phase|Adverse Event|0
1505483|NCT00440947|4950665|P3|36-Week Induction Phase|Adverse Event|0
1505484|NCT00440947|4950666|P2|36-Week Induction Phase|Adverse Event|0
1505485|NCT00440947|4950667|P1|36-Week Induction Phase|Adverse Event|16
1505486|NCT00440700|4950742|P3|Overall Study|Withdrawal by Subject|4
1505487|NCT00440700|4950743|P2|Overall Study|Withdrawal by Subject|8
1505488|NCT00440700|4950744|P1|Overall Study|Withdrawal by Subject|8
1505489|NCT00440557|4950767|P3|Overall Study|Patient had surgery|0
1505490|NCT00440557|4950768|P2|Overall Study|Patient had surgery|0
1505491|NCT00440557|4950769|P1|Overall Study|Patient had surgery|1
1505492|NCT00440557|4950767|P3|Overall Study|Patient transferred to nursing home|0
1505493|NCT00440557|4950768|P2|Overall Study|Patient transferred to nursing home|1
1505494|NCT00440557|4950769|P1|Overall Study|Patient transferred to nursing home|0
1505495|NCT00440557|4950767|P3|Overall Study|Principal Investigator's office closed|4
1505496|NCT00440557|4950768|P2|Overall Study|Principal Investigator's office closed|6
1505497|NCT00440557|4950769|P1|Overall Study|Principal Investigator's office closed|3
1505498|NCT00440557|4950767|P3|Overall Study|Patient moved|1
1505499|NCT00440557|4950768|P2|Overall Study|Patient moved|2
1505500|NCT00440557|4950769|P1|Overall Study|Patient moved|1
1505501|NCT00440557|4950767|P3|Overall Study|Principal Investigator decision|1
1505502|NCT00440557|4950768|P2|Overall Study|Principal Investigator decision|3
1505503|NCT00440557|4950769|P1|Overall Study|Principal Investigator decision|0
1505504|NCT00440557|4950767|P3|Overall Study|Began Dialysis|4
1505505|NCT00440557|4950768|P2|Overall Study|Began Dialysis|1
1505506|NCT00440557|4950769|P1|Overall Study|Began Dialysis|4
1505507|NCT00440557|4950767|P3|Overall Study|Death|3
1505508|NCT00440557|4950768|P2|Overall Study|Death|6
1505509|NCT00440557|4950769|P1|Overall Study|Death|2
1505510|NCT00440557|4950767|P3|Overall Study|Adverse Event|5
1505511|NCT00440557|4950768|P2|Overall Study|Adverse Event|3
1505512|NCT00440557|4950769|P1|Overall Study|Adverse Event|3
1505513|NCT00440557|4950767|P3|Overall Study|Lost to Follow-up|6
1505514|NCT00440557|4950768|P2|Overall Study|Lost to Follow-up|2
1505515|NCT00440557|4950769|P1|Overall Study|Lost to Follow-up|1
1505516|NCT00440557|4950767|P3|Overall Study|Withdrawal by Subject|11
1505517|NCT00440557|4950768|P2|Overall Study|Withdrawal by Subject|5
1505518|NCT00440557|4950769|P1|Overall Study|Withdrawal by Subject|10
1505519|NCT00440531|4950801|P3|Overall Study|see pre-assignment details|0
1505520|NCT00440531|4950802|P2|Overall Study|see pre-assignment details|0
1505521|NCT00440531|4950803|P1|Overall Study|see pre-assignment details|2
1505522|NCT00440531|4950801|P3|Overall Study|Lost to Follow-up|5
1505523|NCT00440531|4950802|P2|Overall Study|Lost to Follow-up|3
1505524|NCT00440531|4950803|P1|Overall Study|Lost to Follow-up|4
1505525|NCT00440531|4950801|P3|Overall Study|Protocol Violation|0
1505526|NCT00440531|4950802|P2|Overall Study|Protocol Violation|2
1505527|NCT00440531|4950803|P1|Overall Study|Protocol Violation|1
1505528|NCT00440531|4950801|P3|Overall Study|Withdrawal by Subject|0
1505529|NCT00440531|4950802|P2|Overall Study|Withdrawal by Subject|0
1505530|NCT00440531|4950803|P1|Overall Study|Withdrawal by Subject|2
1505531|NCT00440531|4950801|P3|Overall Study|Adverse Event|2
1505532|NCT00440531|4950802|P2|Overall Study|Adverse Event|0
1505533|NCT00440531|4950803|P1|Overall Study|Adverse Event|1
1505534|NCT00440518|4950820|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
1505535|NCT00440518|4950821|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
1505536|NCT00440518|4950822|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
1505537|NCT00440518|4950820|P3|Maintenance and Safety Follow-up Periods|Other|2
1505538|NCT00440518|4950821|P2|Maintenance and Safety Follow-up Periods|Other|0
1505539|NCT00440518|4950822|P1|Maintenance and Safety Follow-up Periods|Other|0
1505540|NCT00440518|4950820|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
1505541|NCT00440518|4950821|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
1505542|NCT00440518|4950822|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
1505543|NCT00440518|4950820|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
1505544|NCT00440518|4950821|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
1505545|NCT00440518|4950822|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
1505546|NCT00440518|4950820|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
1505547|NCT00440518|4950821|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
1505548|NCT00440518|4950822|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
1505549|NCT00440518|4950820|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
1505550|NCT00440518|4950821|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
1505551|NCT00440518|4950822|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
1505552|NCT00440518|4950820|P3|Randomized /Titration Period|Adverse Event|0
1505553|NCT00440518|4950821|P2|Randomized /Titration Period|Adverse Event|3
1505554|NCT00440518|4950822|P1|Randomized /Titration Period|Adverse Event|2
1505555|NCT00440518|4950820|P3|Randomized /Titration Period|Lost to Follow-up|1
1505556|NCT00440518|4950821|P2|Randomized /Titration Period|Lost to Follow-up|2
1505557|NCT00440518|4950822|P1|Randomized /Titration Period|Lost to Follow-up|2
1505558|NCT00440518|4950820|P3|Randomized /Titration Period|Other|0
1505559|NCT00440518|4950821|P2|Randomized /Titration Period|Other|0
1505560|NCT00440518|4950822|P1|Randomized /Titration Period|Other|1
1505561|NCT00440518|4950820|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
1505562|NCT00440518|4950821|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
1505563|NCT00440518|4950822|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
1505564|NCT00440518|4950820|P3|Randomized /Titration Period|Protocol Deviation|0
1505565|NCT00440518|4950821|P2|Randomized /Titration Period|Protocol Deviation|0
1505566|NCT00440518|4950822|P1|Randomized /Titration Period|Protocol Deviation|1
1505567|NCT00440518|4950820|P3|Randomized /Titration Period|Subject Withdrew Consent|0
1505568|NCT00440518|4950821|P2|Randomized /Titration Period|Subject Withdrew Consent|1
1505569|NCT00440518|4950822|P1|Randomized /Titration Period|Subject Withdrew Consent|4
1505570|NCT00440518|4950820|P3|Randomized /Titration Period|Lack of Efficacy|1
1505571|NCT00440518|4950821|P2|Randomized /Titration Period|Lack of Efficacy|0
1505572|NCT00440518|4950822|P1|Randomized /Titration Period|Lack of Efficacy|1
1505573|NCT00440466|4950867|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
1505574|NCT00440466|4950868|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
1505575|NCT00440466|4950869|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
1505576|NCT00440466|4950867|P3|Overall Study|Began Dialysis|1
1505577|NCT00440466|4950868|P2|Overall Study|Began Dialysis|0
1505578|NCT00440466|4950869|P1|Overall Study|Began Dialysis|0
1505579|NCT00440466|4950867|P3|Overall Study|Withdrawal by Subject|9
1505580|NCT00440466|4950868|P2|Overall Study|Withdrawal by Subject|5
1505581|NCT00440466|4950869|P1|Overall Study|Withdrawal by Subject|2
1505582|NCT00440466|4950867|P3|Overall Study|Protocol Violation|4
1505583|NCT00440466|4950868|P2|Overall Study|Protocol Violation|0
1505584|NCT00440466|4950869|P1|Overall Study|Protocol Violation|2
1505585|NCT00440466|4950867|P3|Overall Study|Physician Decision|1
1505586|NCT00440466|4950868|P2|Overall Study|Physician Decision|0
1505587|NCT00440466|4950869|P1|Overall Study|Physician Decision|2
1505588|NCT00440466|4950867|P3|Overall Study|Lost to Follow-up|2
1505589|NCT00440466|4950868|P2|Overall Study|Lost to Follow-up|0
1505590|NCT00440466|4950869|P1|Overall Study|Lost to Follow-up|1
1505591|NCT00440466|4950867|P3|Overall Study|Adverse Event|11
1505592|NCT00440466|4950868|P2|Overall Study|Adverse Event|4
1505593|NCT00440466|4950869|P1|Overall Study|Adverse Event|3
1505594|NCT00440466|4950867|P3|Overall Study|Death|9
1505595|NCT00440466|4950868|P2|Overall Study|Death|2
1505596|NCT00440466|4950869|P1|Overall Study|Death|3
1505597|NCT00440401|4950903|P2|Overall Study|Not specified|5
1505598|NCT00440401|4950904|P1|Overall Study|Not specified|2
1505599|NCT00440401|4950903|P2|Overall Study|Adverse Event|1
1505600|NCT00440401|4950904|P1|Overall Study|Adverse Event|2
1505601|NCT00440310|4950914|P2|Overall Study|Status Unknown|3
1505602|NCT00440310|4950915|P1|Overall Study|Status Unknown|1
1505603|NCT00440310|4950914|P2|Overall Study|Other|0
1505604|NCT00440310|4950915|P1|Overall Study|Other|1
1505605|NCT00440310|4950914|P2|Overall Study|No Reply at EOS|7
1505606|NCT00440310|4950915|P1|Overall Study|No Reply at EOS|7
1505607|NCT00440310|4950914|P2|Overall Study|Withdrawal by Subject|14
1505608|NCT00440310|4950915|P1|Overall Study|Withdrawal by Subject|15
1505609|NCT00440310|4950914|P2|Overall Study|Protocol Violation|1
1505610|NCT00440310|4950915|P1|Overall Study|Protocol Violation|0
1505611|NCT00440310|4950914|P2|Overall Study|Lost to Follow-up|5
1505612|NCT00440310|4950915|P1|Overall Study|Lost to Follow-up|4
1505613|NCT00440297|4950923|P2|Overall Study|Randomized by mistake|0
1505614|NCT00440297|4950924|P1|Overall Study|Randomized by mistake|1
1505615|NCT00440297|4950923|P2|Overall Study|Withdrawal by Subject|6
1505616|NCT00440297|4950924|P1|Overall Study|Withdrawal by Subject|1
1505617|NCT00440297|4950923|P2|Overall Study|Protocol Violation|7
1505618|NCT00440297|4950924|P1|Overall Study|Protocol Violation|11
1505619|NCT00440297|4950923|P2|Overall Study|Physician Decision|0
1505620|NCT00440297|4950924|P1|Overall Study|Physician Decision|1
1505621|NCT00440297|4950923|P2|Overall Study|Lost to Follow-up|0
1505622|NCT00440297|4950924|P1|Overall Study|Lost to Follow-up|1
1505623|NCT00440297|4950923|P2|Overall Study|Adverse Event|5
1505624|NCT00440297|4950924|P1|Overall Study|Adverse Event|8
1505625|NCT00440271|4950940|P2|Overall Study|Other|0
1505626|NCT00440271|4950941|P1|Overall Study|Other|2
1505627|NCT00440271|4950940|P2|Overall Study|Due to closure of trial|10
1505628|NCT00440271|4950941|P1|Overall Study|Due to closure of trial|8
1505629|NCT00440271|4950940|P2|Overall Study|Lack of Efficacy|1
1505630|NCT00440271|4950941|P1|Overall Study|Lack of Efficacy|0
1505631|NCT00440271|4950940|P2|Overall Study|Withdrawal by Subject|2
1505632|NCT00440271|4950941|P1|Overall Study|Withdrawal by Subject|0
1505633|NCT00440271|4950940|P2|Overall Study|Lost to Follow-up|0
1505634|NCT00440271|4950941|P1|Overall Study|Lost to Follow-up|1
1505635|NCT00440271|4950940|P2|Overall Study|Adverse Event|1
1505636|NCT00440271|4950941|P1|Overall Study|Adverse Event|0
1505637|NCT00440271|4950940|P2|Overall Study|Protocol Violation|1
1505638|NCT00440271|4950941|P1|Overall Study|Protocol Violation|1
1505639|NCT00440232|4950975|P2|Overall Study|Onset of headache within 4 hours of fast|2
1505640|NCT00440232|4950976|P1|Overall Study|Onset of headache within 4 hours of fast|2
1505641|NCT00440232|4950975|P2|Overall Study|Unable to treat within allowed time|1
1505642|NCT00440232|4950976|P1|Overall Study|Unable to treat within allowed time|0
1505643|NCT00440232|4950975|P2|Overall Study|Lost to Follow-up|1
1505644|NCT00440232|4950976|P1|Overall Study|Lost to Follow-up|1
1505645|NCT00440193|4950986|P2|Observational Period|Participant convenience|0
1505646|NCT00440193|4950987|P1|Observational Period|Participant convenience|2
1505647|NCT00440193|4950986|P2|Observational Period|Clinical endpoint reached|0
1505648|NCT00440193|4950987|P1|Observational Period|Clinical endpoint reached|1
1505649|NCT00440193|4950986|P2|Observational Period|Physician Decision|0
1505650|NCT00440193|4950987|P1|Observational Period|Physician Decision|1
1505651|NCT00440193|4950986|P2|Observational Period|Withdrawal by Subject|8
1505652|NCT00440193|4950987|P1|Observational Period|Withdrawal by Subject|11
1505653|NCT00440193|4950986|P2|Observational Period|Protocol Violation|0
1505654|NCT00440193|4950987|P1|Observational Period|Protocol Violation|1
1505655|NCT00440193|4950986|P2|Observational Period|Lost to Follow-up|8
1505656|NCT00440193|4950987|P1|Observational Period|Lost to Follow-up|12
1505657|NCT00440193|4950986|P2|Observational Period|Death|20
1505658|NCT00440193|4950987|P1|Observational Period|Death|15
1505659|NCT00440193|4950986|P2|Observational Period|Adverse Event|2
1505660|NCT00440193|4950987|P1|Observational Period|Adverse Event|2
1505661|NCT00440193|4950986|P2|Treatment Period|Site closed by investigator|2
1505662|NCT00440193|4950987|P1|Treatment Period|Site closed by investigator|0
1505663|NCT00440193|4950986|P2|Treatment Period|Participant did not receive treatment|13
1505664|NCT00440193|4950987|P1|Treatment Period|Participant did not receive treatment|7
1505665|NCT00440193|4950986|P2|Treatment Period|Participant convenience|2
1505666|NCT00440193|4950987|P1|Treatment Period|Participant convenience|5
1505667|NCT00440193|4950986|P2|Treatment Period|Technical problems|1
1505668|NCT00440193|4950987|P1|Treatment Period|Technical problems|1
1505669|NCT00440193|4950986|P2|Treatment Period|Switch to commercial drug|2
1505670|NCT00440193|4950987|P1|Treatment Period|Switch to commercial drug|0
1505671|NCT00440193|4950986|P2|Treatment Period|Protocol driven decision point|2
1505672|NCT00440193|4950987|P1|Treatment Period|Protocol driven decision point|2
1505673|NCT00440193|4950986|P2|Treatment Period|Study terminated by sponsor|94
1505674|NCT00440193|4950987|P1|Treatment Period|Study terminated by sponsor|102
1505675|NCT00440193|4950986|P2|Treatment Period|Clinical endpoint reached|25
1505676|NCT00440193|4950987|P1|Treatment Period|Clinical endpoint reached|28
1505677|NCT00440193|4950986|P2|Treatment Period|Withdrawal by Subject|77
1505678|NCT00440193|4950987|P1|Treatment Period|Withdrawal by Subject|36
1505679|NCT00440193|4950986|P2|Treatment Period|Protocol Violation|19
1505680|NCT00440193|4950987|P1|Treatment Period|Protocol Violation|16
1505681|NCT00440193|4950986|P2|Treatment Period|Physician Decision|6
1505682|NCT00440193|4950987|P1|Treatment Period|Physician Decision|3
1505683|NCT00440193|4950986|P2|Treatment Period|Lost to Follow-up|18
1505684|NCT00440193|4950987|P1|Treatment Period|Lost to Follow-up|12
1505685|NCT00440193|4950986|P2|Treatment Period|Lack of Efficacy|1
1505686|NCT00440193|4950987|P1|Treatment Period|Lack of Efficacy|0
1505687|NCT00440193|4950986|P2|Treatment Period|Death|22
1505688|NCT00440193|4950987|P1|Treatment Period|Death|19
1505689|NCT00440193|4950986|P2|Treatment Period|Adverse Event|67
1505690|NCT00440193|4950987|P1|Treatment Period|Adverse Event|74
1505691|NCT00440115|4951033|P3|Overall Study|Incarceration|1
1505692|NCT00440115|4951034|P2|Overall Study|Incarceration|2
1505693|NCT00440115|4951035|P1|Overall Study|Incarceration|0
1505694|NCT00440115|4951033|P3|Overall Study|Death|5
1505695|NCT00440115|4951034|P2|Overall Study|Death|9
1505696|NCT00440115|4951035|P1|Overall Study|Death|7
1505697|NCT00440011|4951066|P2|Overall Study|Withdrawal by Subject|0
1505698|NCT00440011|4951067|P1|Overall Study|Withdrawal by Subject|1
1505699|NCT00440011|4951066|P2|Overall Study|Protocol Violation|1
1505700|NCT00440011|4951067|P1|Overall Study|Protocol Violation|1
1505701|NCT00440011|4951066|P2|Overall Study|Lost to Follow-up|2
1505702|NCT00440011|4951067|P1|Overall Study|Lost to Follow-up|0
1505703|NCT00440011|4951066|P2|Overall Study|Adverse Event|0
1505704|NCT00440011|4951067|P1|Overall Study|Adverse Event|2
1505705|NCT00439777|4951094|P2|Observational Period|Technical problems|1
1505706|NCT00439777|4951095|P1|Observational Period|Technical problems|0
1505707|NCT00439777|4951094|P2|Observational Period|Lack of Efficacy|0
1505708|NCT00439777|4951095|P1|Observational Period|Lack of Efficacy|1
1505709|NCT00439777|4951094|P2|Observational Period|Protocol driven decision point|1
1505710|NCT00439777|4951095|P1|Observational Period|Protocol driven decision point|0
1505711|NCT00439777|4951094|P2|Observational Period|Study terminated by sponsor|1
1505712|NCT00439777|4951095|P1|Observational Period|Study terminated by sponsor|3
1505713|NCT00439777|4951094|P2|Observational Period|Death|20
1505714|NCT00439777|4951095|P1|Observational Period|Death|27
1505715|NCT00439777|4951094|P2|Observational Period|Lost to Follow-up|11
1505716|NCT00439777|4951095|P1|Observational Period|Lost to Follow-up|1
1505717|NCT00439777|4951094|P2|Observational Period|Withdrawal by Subject|5
1505718|NCT00439777|4951095|P1|Observational Period|Withdrawal by Subject|9
1505719|NCT00439777|4951094|P2|Observational Period|Protocol Violation|2
1505720|NCT00439777|4951095|P1|Observational Period|Protocol Violation|0
1505721|NCT00439777|4951094|P2|Treatment Period|Participant convenience|8
1505722|NCT00439777|4951095|P1|Treatment Period|Participant convenience|12
1505723|NCT00439777|4951094|P2|Treatment Period|Technical problems|1
1505724|NCT00439777|4951095|P1|Treatment Period|Technical problems|3
1505725|NCT00439777|4951094|P2|Treatment Period|Clinical endpoint reached|13
1505726|NCT00439777|4951095|P1|Treatment Period|Clinical endpoint reached|26
1505727|NCT00439777|4951094|P2|Treatment Period|Physician Decision|18
1505728|NCT00439777|4951095|P1|Treatment Period|Physician Decision|7
1505729|NCT00439777|4951094|P2|Treatment Period|Protocol driven decision point|3
1505730|NCT00439777|4951095|P1|Treatment Period|Protocol driven decision point|1
1505731|NCT00439777|4951094|P2|Treatment Period|Lost to Follow-up|10
1505732|NCT00439777|4951095|P1|Treatment Period|Lost to Follow-up|8
1505733|NCT00439777|4951094|P2|Treatment Period|Lack of Efficacy|4
1505734|NCT00439777|4951095|P1|Treatment Period|Lack of Efficacy|1
1505735|NCT00439777|4951094|P2|Treatment Period|Withdrawal by Subject|118
1505736|NCT00439777|4951095|P1|Treatment Period|Withdrawal by Subject|66
1505737|NCT00439777|4951094|P2|Treatment Period|Protocol Violation|30
1505738|NCT00439777|4951095|P1|Treatment Period|Protocol Violation|23
1505739|NCT00439777|4951094|P2|Treatment Period|Adverse Event|92
1505740|NCT00439777|4951095|P1|Treatment Period|Adverse Event|111
1505741|NCT00439777|4951094|P2|Treatment Period|Did not take study treatment|8
1505742|NCT00439777|4951095|P1|Treatment Period|Did not take study treatment|7
1505743|NCT00439777|4951094|P2|Treatment Period|Site closed by investigator|1
1505744|NCT00439777|4951095|P1|Treatment Period|Site closed by investigator|0
1505745|NCT00439777|4951094|P2|Treatment Period|Study terminated by sponsor|132
1505746|NCT00439777|4951095|P1|Treatment Period|Study terminated by sponsor|125
1505747|NCT00439777|4951094|P2|Treatment Period|Death|21
1505748|NCT00439777|4951095|P1|Treatment Period|Death|29
1505749|NCT00439738|4951133|P2|Overall Study|Abnormal Lab Values|0
1505750|NCT00439738|4951134|P1|Overall Study|Abnormal Lab Values|1
1505751|NCT00439738|4951133|P2|Overall Study|Lack of Efficacy|2
1505752|NCT00439738|4951134|P1|Overall Study|Lack of Efficacy|2
1505753|NCT00439738|4951133|P2|Overall Study|Protocol Violation|3
1505754|NCT00439738|4951134|P1|Overall Study|Protocol Violation|6
1505755|NCT00439738|4951133|P2|Overall Study|Lost to Follow-up|6
1505756|NCT00439738|4951134|P1|Overall Study|Lost to Follow-up|5
1505757|NCT00439738|4951133|P2|Overall Study|Adverse Event|4
1505758|NCT00439738|4951134|P1|Overall Study|Adverse Event|6
1505759|NCT00439738|4951133|P2|Overall Study|Withdrawal by Subject|13
1505760|NCT00439738|4951134|P1|Overall Study|Withdrawal by Subject|16
1505761|NCT00439725|4951152|P2|Observational Period|Participant convenience|0
1505762|NCT00439725|4951153|P1|Observational Period|Participant convenience|1
1505763|NCT00439725|4951152|P2|Observational Period|Technical problems|0
1505764|NCT00439725|4951153|P1|Observational Period|Technical problems|1
1505765|NCT00439725|4951152|P2|Observational Period|Clinical endpoint reached|1
1505766|NCT00439725|4951153|P1|Observational Period|Clinical endpoint reached|3
1505767|NCT00439725|4951152|P2|Observational Period|Study termination by sponsor|1
1505768|NCT00439725|4951153|P1|Observational Period|Study termination by sponsor|1
1505769|NCT00439725|4951152|P2|Observational Period|Death|2
1505770|NCT00439725|4951153|P1|Observational Period|Death|0
1505771|NCT00439725|4951152|P2|Observational Period|Lost to Follow-up|1
1505772|NCT00439725|4951153|P1|Observational Period|Lost to Follow-up|0
1505773|NCT00439725|4951152|P2|Observational Period|Withdrawal by Subject|2
1505774|NCT00439725|4951153|P1|Observational Period|Withdrawal by Subject|2
1505775|NCT00439725|4951152|P2|Treatment Period|Participant did not receive treatment|4
1505776|NCT00439725|4951153|P1|Treatment Period|Participant did not receive treatment|4
1505777|NCT00439725|4951152|P2|Treatment Period|Death|1
1505778|NCT00439725|4951153|P1|Treatment Period|Death|1
1505779|NCT00439725|4951152|P2|Treatment Period|Protocol driven decision point|1
1505780|NCT00439725|4951153|P1|Treatment Period|Protocol driven decision point|1
1505781|NCT00439725|4951152|P2|Treatment Period|Participant convenience|0
1505782|NCT00439725|4951153|P1|Treatment Period|Participant convenience|1
1505783|NCT00439725|4951152|P2|Treatment Period|Lost to Follow-up|1
1505784|NCT00439725|4951153|P1|Treatment Period|Lost to Follow-up|1
1505785|NCT00439725|4951152|P2|Treatment Period|Technical problems|0
1505786|NCT00439725|4951153|P1|Treatment Period|Technical problems|1
1505787|NCT00439725|4951152|P2|Treatment Period|Clinical endpoint reached|50
1505788|NCT00439725|4951153|P1|Treatment Period|Clinical endpoint reached|6
1505789|NCT00439725|4951152|P2|Treatment Period|Protocol Violation|1
1505790|NCT00439725|4951153|P1|Treatment Period|Protocol Violation|2
1505791|NCT00439725|4951152|P2|Treatment Period|Physician Decision|1
1505792|NCT00439725|4951153|P1|Treatment Period|Physician Decision|1
1505793|NCT00439725|4951152|P2|Treatment Period|Adverse Event|18
1505794|NCT00439725|4951153|P1|Treatment Period|Adverse Event|39
1505795|NCT00439725|4951152|P2|Treatment Period|Site closed by investigator|2
1505796|NCT00439725|4951153|P1|Treatment Period|Site closed by investigator|1
1505797|NCT00439725|4951152|P2|Treatment Period|Study terminated by sponsor|148
1505798|NCT00439725|4951153|P1|Treatment Period|Study terminated by sponsor|156
1505799|NCT00439725|4951152|P2|Treatment Period|Withdrawal by Subject|19
1505800|NCT00439725|4951153|P1|Treatment Period|Withdrawal by Subject|22
1505801|NCT00439647|4951204|P2|Overall Study|Lack of Efficacy|4
1505802|NCT00439647|4951205|P1|Overall Study|Lack of Efficacy|0
1505803|NCT00439647|4951204|P2|Overall Study|Protocol Violation|4
1505804|NCT00439647|4951205|P1|Overall Study|Protocol Violation|3
1505805|NCT00439647|4951204|P2|Overall Study|Lost to Follow-up|12
1505806|NCT00439647|4951205|P1|Overall Study|Lost to Follow-up|4
1505807|NCT00439647|4951204|P2|Overall Study|Adverse Event|11
1505808|NCT00439647|4951205|P1|Overall Study|Adverse Event|11
1505809|NCT00439647|4951204|P2|Overall Study|Death|18
1505810|NCT00439647|4951205|P1|Overall Study|Death|15
1505811|NCT00439647|4951204|P2|Overall Study|Withdrawal by Subject|22
1505812|NCT00439647|4951205|P1|Overall Study|Withdrawal by Subject|25
1505813|NCT00439569|4951242|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
1505814|NCT00439569|4951242|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
1505815|NCT00439569|4951242|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
1505816|NCT00439517|4951255|P2|Overall Study|Subject in survival follow-up|0
1505817|NCT00439517|4951256|P1|Overall Study|Subject in survival follow-up|1
1505818|NCT00439517|4951255|P2|Overall Study|Subject on treatment|0
1505819|NCT00439517|4951256|P1|Overall Study|Subject on treatment|1
1505820|NCT00439309|4951324|P2|Follow-Up|Late response by subject|1
1505821|NCT00439309|4951325|P1|Follow-Up|Late response by subject|0
1505822|NCT00439309|4951324|P2|Follow-Up|Withdrawal by Subject|1
1505823|NCT00439309|4951325|P1|Follow-Up|Withdrawal by Subject|0
1505824|NCT00439309|4951324|P2|Follow-Up|Lost to Follow-up|0
1505825|NCT00439309|4951325|P1|Follow-Up|Lost to Follow-up|2
1505826|NCT00439309|4951324|P2|Follow-Up|Death|0
1505827|NCT00439309|4951325|P1|Follow-Up|Death|1
1505828|NCT00439270|4951344|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
1505829|NCT00439270|4951345|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
1505830|NCT00439270|4951346|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
1505831|NCT00439270|4951347|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
1505832|NCT00439270|4951348|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
1505833|NCT00439270|4951344|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
1505834|NCT00439270|4951345|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
1505835|NCT00439270|4951346|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
1505836|NCT00439270|4951347|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
1505837|NCT00439270|4951348|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
1505838|NCT00439270|4951344|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
1505839|NCT00439270|4951345|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
1505840|NCT00439270|4951346|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
1505841|NCT00439270|4951347|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
1505842|NCT00439270|4951348|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
1505843|NCT00439270|4951344|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
1505844|NCT00439270|4951345|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
1505845|NCT00439270|4951346|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
1505846|NCT00439270|4951347|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
1505847|NCT00439270|4951348|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
1505848|NCT00439270|4951344|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
1505849|NCT00439270|4951345|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
1505850|NCT00439270|4951346|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
1505851|NCT00439270|4951347|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
1505852|NCT00439270|4951348|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
1505853|NCT00439270|4951344|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
1505854|NCT00439270|4951345|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
1505855|NCT00439270|4951346|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
1505856|NCT00439270|4951347|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
1505857|NCT00439270|4951348|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
1505858|NCT00439270|4951344|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
1505859|NCT00439270|4951345|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
1505860|NCT00439270|4951346|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
1505861|NCT00439270|4951347|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
1505862|NCT00439270|4951348|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
1505863|NCT00439270|4951344|P5|Phase 2 (51.6 Months)|Disease progression|0
1505864|NCT00439270|4951345|P4|Phase 2 (51.6 Months)|Disease progression|18
1505865|NCT00439270|4951346|P3|Phase 2 (51.6 Months)|Disease progression|0
1505866|NCT00439270|4951347|P2|Phase 2 (51.6 Months)|Disease progression|0
1505867|NCT00439270|4951348|P1|Phase 2 (51.6 Months)|Disease progression|0
1505868|NCT00439270|4951344|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
1505869|NCT00439270|4951345|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
1505870|NCT00439270|4951346|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
1505871|NCT00439270|4951347|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
1505872|NCT00439270|4951348|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
1505873|NCT00439270|4951344|P5|Phase 1 (18.1 Months)|Disease progression|3
1505874|NCT00439270|4951345|P4|Phase 1 (18.1 Months)|Disease progression|0
1505875|NCT00439270|4951346|P3|Phase 1 (18.1 Months)|Disease progression|3
1505876|NCT00439270|4951347|P2|Phase 1 (18.1 Months)|Disease progression|2
1505877|NCT00439270|4951348|P1|Phase 1 (18.1 Months)|Disease progression|3
1505878|NCT00439244|4951390|P3|Overall Study|Administrative problems|0
1505879|NCT00439244|4951391|P2|Overall Study|Administrative problems|0
1505880|NCT00439244|4951392|P1|Overall Study|Administrative problems|1
1505881|NCT00439244|4951390|P3|Overall Study|Protocol Violation|0
1505882|NCT00439244|4951391|P2|Overall Study|Protocol Violation|1
1505883|NCT00439244|4951392|P1|Overall Study|Protocol Violation|0
1505884|NCT00439244|4951390|P3|Overall Study|Death|0
1505885|NCT00439244|4951391|P2|Overall Study|Death|1
1505886|NCT00439244|4951392|P1|Overall Study|Death|0
1505887|NCT00439244|4951390|P3|Overall Study|Lost to Follow-up|2
1505888|NCT00439244|4951391|P2|Overall Study|Lost to Follow-up|1
1505889|NCT00439244|4951392|P1|Overall Study|Lost to Follow-up|2
1505890|NCT00439244|4951390|P3|Overall Study|Withdrawal by Subject|2
1505891|NCT00439244|4951391|P2|Overall Study|Withdrawal by Subject|1
1505892|NCT00439244|4951392|P1|Overall Study|Withdrawal by Subject|3
1505893|NCT00439244|4951390|P3|Overall Study|Adverse Event|3
1505894|NCT00439244|4951391|P2|Overall Study|Adverse Event|2
1505895|NCT00439244|4951392|P1|Overall Study|Adverse Event|5
1505896|NCT00439231|4951412|P1|Overall Study|Lack of Efficacy|28
1505897|NCT00439218|4951416|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
1505898|NCT00439179|4951431|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
1505899|NCT00439179|4951432|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
1505900|NCT00439179|4951433|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
1505901|NCT00439179|4951434|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
1505902|NCT00439140|4951451|P3|Treatment Cycle 2|Lost to Follow-up|0
1505903|NCT00439140|4951452|P2|Treatment Cycle 2|Lost to Follow-up|1
1505904|NCT00439140|4951453|P1|Treatment Cycle 2|Lost to Follow-up|1
1505905|NCT00439140|4951451|P3|Treatment Cycle 2|Withdrawal by Subject|0
1505906|NCT00439140|4951452|P2|Treatment Cycle 2|Withdrawal by Subject|0
1505907|NCT00439140|4951453|P1|Treatment Cycle 2|Withdrawal by Subject|1
1505908|NCT00439140|4951451|P3|Treatment Cycle 1|Withdrawal by Subject|0
1505909|NCT00439140|4951452|P2|Treatment Cycle 1|Withdrawal by Subject|1
1505910|NCT00439140|4951453|P1|Treatment Cycle 1|Withdrawal by Subject|0
1505911|NCT00439140|4951451|P3|Treatment Cycle 1|Personal reasons|0
1505912|NCT00439140|4951452|P2|Treatment Cycle 1|Personal reasons|2
1505913|NCT00439140|4951453|P1|Treatment Cycle 1|Personal reasons|0
1505914|NCT00439140|4951451|P3|Treatment Cycle 1|Lost to Follow-up|1
1505915|NCT00439140|4951452|P2|Treatment Cycle 1|Lost to Follow-up|1
1505916|NCT00439140|4951453|P1|Treatment Cycle 1|Lost to Follow-up|1
1505917|NCT00438815|4951536|P1|Overall Study|Death|1
1505918|NCT00438815|4951536|P1|Overall Study|Withdrawal by Subject|6
1505919|NCT00438815|4951536|P1|Overall Study|Lost to Follow-up|6
1505920|NCT00438815|4951536|P1|Overall Study|Transitioned to commercial C1INH-nf|6
1505921|NCT00438815|4951536|P1|Overall Study|Noncompliance with protocol requirements|9
1505922|NCT00438815|4951536|P1|Overall Study|3-month follow-up no longer required|12
1505923|NCT00438815|4951536|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
1505924|NCT00438672|4951586|P2|Overall Study|Lost to Follow-up|9
1505925|NCT00438672|4951587|P1|Overall Study|Lost to Follow-up|7
1505926|NCT00438659|4951597|P2|Overall Study|Cancel|2
1505927|NCT00438659|4951598|P1|Overall Study|Cancel|5
1505928|NCT00438659|4951597|P2|Overall Study|Discontinued Mometasone/Placebo|2
1505929|NCT00438659|4951598|P1|Overall Study|Discontinued Mometasone/Placebo|1
1505930|NCT00438464|4951637|P2|Overall Study|Incomplete data submission|2
1505931|NCT00438464|4951638|P1|Overall Study|Incomplete data submission|0
1505932|NCT00438464|4951637|P2|Overall Study|Terminated Early|5
1505933|NCT00438464|4951638|P1|Overall Study|Terminated Early|14
1505934|NCT00438399|4951739|P6|Overall Study|Patien stopped study at visit 4 by error|0
1505935|NCT00438399|4951740|P5|Overall Study|Patien stopped study at visit 4 by error|0
1505936|NCT00438399|4951741|P4|Overall Study|Patien stopped study at visit 4 by error|0
1505937|NCT00438399|4951742|P3|Overall Study|Patien stopped study at visit 4 by error|0
1505938|NCT00438399|4951743|P2|Overall Study|Patien stopped study at visit 4 by error|0
1505939|NCT00438399|4951744|P1|Overall Study|Patien stopped study at visit 4 by error|1
1505940|NCT00438399|4951739|P6|Overall Study|Pregnancy|1
1505941|NCT00438399|4951740|P5|Overall Study|Pregnancy|0
1505942|NCT00438399|4951741|P4|Overall Study|Pregnancy|0
1505943|NCT00438399|4951742|P3|Overall Study|Pregnancy|0
1505944|NCT00438399|4951743|P2|Overall Study|Pregnancy|0
1505945|NCT00438399|4951744|P1|Overall Study|Pregnancy|0
1505946|NCT00438399|4951739|P6|Overall Study|Subje stopped study|0
1505947|NCT00438399|4951740|P5|Overall Study|Subje stopped study|0
1505948|NCT00438399|4951741|P4|Overall Study|Subje stopped study|0
1505949|NCT00438399|4951742|P3|Overall Study|Subje stopped study|1
1505950|NCT00438399|4951743|P2|Overall Study|Subje stopped study|0
1505951|NCT00438399|4951744|P1|Overall Study|Subje stopped study|0
1505952|NCT00438399|4951739|P6|Overall Study|Protocol Violation|1
1505953|NCT00438399|4951740|P5|Overall Study|Protocol Violation|0
1505954|NCT00438399|4951741|P4|Overall Study|Protocol Violation|0
1505955|NCT00438399|4951742|P3|Overall Study|Protocol Violation|1
1505956|NCT00438399|4951743|P2|Overall Study|Protocol Violation|0
1505957|NCT00438399|4951744|P1|Overall Study|Protocol Violation|0
1505958|NCT00438399|4951739|P6|Overall Study|Withdrawal by Subject|2
1505959|NCT00438399|4951740|P5|Overall Study|Withdrawal by Subject|2
1505960|NCT00438399|4951741|P4|Overall Study|Withdrawal by Subject|2
1505961|NCT00438399|4951742|P3|Overall Study|Withdrawal by Subject|3
1505962|NCT00438399|4951743|P2|Overall Study|Withdrawal by Subject|6
1505963|NCT00438399|4951744|P1|Overall Study|Withdrawal by Subject|5
1505964|NCT00438399|4951739|P6|Overall Study|Adverse Event|1
1505965|NCT00438399|4951740|P5|Overall Study|Adverse Event|0
1505966|NCT00438399|4951741|P4|Overall Study|Adverse Event|1
1505967|NCT00438399|4951742|P3|Overall Study|Adverse Event|1
1505968|NCT00438399|4951743|P2|Overall Study|Adverse Event|0
1505969|NCT00438399|4951744|P1|Overall Study|Adverse Event|0
1505970|NCT00438399|4951739|P6|Overall Study|Lost to Follow-up|1
1505971|NCT00438399|4951740|P5|Overall Study|Lost to Follow-up|1
1505972|NCT00438399|4951741|P4|Overall Study|Lost to Follow-up|1
1505973|NCT00438399|4951742|P3|Overall Study|Lost to Follow-up|1
1505974|NCT00438399|4951743|P2|Overall Study|Lost to Follow-up|2
1505975|NCT00438399|4951744|P1|Overall Study|Lost to Follow-up|2
1505976|NCT00438360|4951755|P2|Overall Study|not specified|15
1505977|NCT00438360|4951756|P1|Overall Study|not specified|24
1505978|NCT00438360|4951755|P2|Overall Study|Lack of Efficacy|27
1505979|NCT00438360|4951756|P1|Overall Study|Lack of Efficacy|42
1505980|NCT00438360|4951755|P2|Overall Study|Adverse Event|1
1505981|NCT00438360|4951756|P1|Overall Study|Adverse Event|6
1505982|NCT00437983|4951804|P2|Overall Study|Withdrawal by Subject|6
1505983|NCT00437983|4951805|P1|Overall Study|Withdrawal by Subject|5
1505984|NCT00437983|4951804|P2|Overall Study|Protocol Violation|1
1505985|NCT00437983|4951805|P1|Overall Study|Protocol Violation|2
1505986|NCT00437983|4951804|P2|Overall Study|Adverse Event|6
1505987|NCT00437983|4951805|P1|Overall Study|Adverse Event|6
1505988|NCT00437645|4951817|P2|Overall Study|Condition no longer requires study drug|1
1505989|NCT00437645|4951818|P1|Overall Study|Condition no longer requires study drug|1
1505990|NCT00437645|4951817|P2|Overall Study|Lack of Efficacy|1
1505991|NCT00437645|4951818|P1|Overall Study|Lack of Efficacy|2
1505992|NCT00437645|4951817|P2|Overall Study|Administrative problems|1
1505993|NCT00437645|4951818|P1|Overall Study|Administrative problems|2
1505994|NCT00437645|4951817|P2|Overall Study|Lost to Follow-up|3
1505995|NCT00437645|4951818|P1|Overall Study|Lost to Follow-up|2
1505996|NCT00437645|4951817|P2|Overall Study|Protocol Violation|3
1505997|NCT00437645|4951818|P1|Overall Study|Protocol Violation|3
1505998|NCT00437645|4951817|P2|Overall Study|Withdrawal by Subject|22
1505999|NCT00437645|4951818|P1|Overall Study|Withdrawal by Subject|10
1506000|NCT00437645|4951817|P2|Overall Study|Adverse Event|84
1506001|NCT00437645|4951818|P1|Overall Study|Adverse Event|15
1506002|NCT00437489|4951834|P2|Overall Study|Lost to Follow-up|1
1506003|NCT00437489|4951835|P1|Overall Study|Lost to Follow-up|0
1506004|NCT00437489|4951834|P2|Overall Study|Study terminated by sponsor|21
1506005|NCT00437489|4951835|P1|Overall Study|Study terminated by sponsor|23
1506006|NCT00437281|4951872|P20|Overall Study|Lost to Follow-up|1
1506007|NCT00437281|4951873|P19|Overall Study|Lost to Follow-up|0
1506008|NCT00437281|4951874|P18|Overall Study|Lost to Follow-up|0
1506009|NCT00437281|4951875|P17|Overall Study|Lost to Follow-up|0
1506010|NCT00437281|4951876|P16|Overall Study|Lost to Follow-up|0
1506011|NCT00437281|4951877|P15|Overall Study|Lost to Follow-up|0
1506012|NCT00437281|4951878|P14|Overall Study|Lost to Follow-up|0
1506013|NCT00437281|4951879|P13|Overall Study|Lost to Follow-up|0
1506014|NCT00437281|4951880|P12|Overall Study|Lost to Follow-up|0
1506015|NCT00437281|4951881|P11|Overall Study|Lost to Follow-up|0
1506016|NCT00437281|4951882|P10|Overall Study|Lost to Follow-up|0
1506017|NCT00437281|4951883|P9|Overall Study|Lost to Follow-up|0
1506018|NCT00437281|4951884|P8|Overall Study|Lost to Follow-up|0
1506019|NCT00437281|4951885|P7|Overall Study|Lost to Follow-up|0
1506020|NCT00437281|4951886|P6|Overall Study|Lost to Follow-up|0
1506021|NCT00437281|4951887|P5|Overall Study|Lost to Follow-up|0
1506022|NCT00437281|4951888|P4|Overall Study|Lost to Follow-up|0
1506023|NCT00437281|4951889|P3|Overall Study|Lost to Follow-up|0
1506024|NCT00437281|4951890|P2|Overall Study|Lost to Follow-up|0
1506025|NCT00437281|4951891|P1|Overall Study|Lost to Follow-up|0
1506026|NCT00437281|4951872|P20|Overall Study|Adverse Event|0
1506027|NCT00437281|4951873|P19|Overall Study|Adverse Event|1
1506028|NCT00437281|4951874|P18|Overall Study|Adverse Event|0
1506029|NCT00437281|4951875|P17|Overall Study|Adverse Event|0
1506030|NCT00437281|4951876|P16|Overall Study|Adverse Event|0
1506031|NCT00437281|4951877|P15|Overall Study|Adverse Event|1
1506032|NCT00437281|4951878|P14|Overall Study|Adverse Event|1
1506033|NCT00437281|4951879|P13|Overall Study|Adverse Event|0
1506034|NCT00437281|4951880|P12|Overall Study|Adverse Event|0
1506035|NCT00437281|4951881|P11|Overall Study|Adverse Event|0
1506036|NCT00437281|4951882|P10|Overall Study|Adverse Event|1
1506037|NCT00437281|4951883|P9|Overall Study|Adverse Event|0
1506038|NCT00437281|4951884|P8|Overall Study|Adverse Event|0
1506039|NCT00437281|4951885|P7|Overall Study|Adverse Event|0
1506040|NCT00437281|4951886|P6|Overall Study|Adverse Event|1
1506041|NCT00437281|4951887|P5|Overall Study|Adverse Event|0
1506042|NCT00437281|4951888|P4|Overall Study|Adverse Event|1
1506043|NCT00437281|4951889|P3|Overall Study|Adverse Event|0
1506044|NCT00437281|4951890|P2|Overall Study|Adverse Event|0
1506045|NCT00437281|4951891|P1|Overall Study|Adverse Event|0
1506046|NCT00437203|4952195|P10|Overall Study|Other|0
1506047|NCT00437203|4952196|P9|Overall Study|Other|0
1506048|NCT00437203|4952197|P8|Overall Study|Other|0
1506049|NCT00437203|4952198|P7|Overall Study|Other|1
1506050|NCT00437203|4952199|P6|Overall Study|Other|0
1506051|NCT00437203|4952200|P5|Overall Study|Other|0
1506052|NCT00437203|4952201|P4|Overall Study|Other|0
1506053|NCT00437203|4952202|P3|Overall Study|Other|0
1506054|NCT00437203|4952203|P2|Overall Study|Other|1
1506055|NCT00437203|4952204|P1|Overall Study|Other|0
1506056|NCT00437203|4952195|P10|Overall Study|Objective progression or relapse|2
1506057|NCT00437203|4952196|P9|Overall Study|Objective progression or relapse|2
1506058|NCT00437203|4952197|P8|Overall Study|Objective progression or relapse|1
1506059|NCT00437203|4952198|P7|Overall Study|Objective progression or relapse|6
1506060|NCT00437203|4952199|P6|Overall Study|Objective progression or relapse|3
1506061|NCT00437203|4952200|P5|Overall Study|Objective progression or relapse|3
1506062|NCT00437203|4952201|P4|Overall Study|Objective progression or relapse|3
1506063|NCT00437203|4952202|P3|Overall Study|Objective progression or relapse|2
1506064|NCT00437203|4952203|P2|Overall Study|Objective progression or relapse|6
1506065|NCT00437203|4952204|P1|Overall Study|Objective progression or relapse|5
1506066|NCT00437203|4952195|P10|Overall Study|Study terminated by sponsor|0
1506067|NCT00437203|4952196|P9|Overall Study|Study terminated by sponsor|1
1506068|NCT00437203|4952197|P8|Overall Study|Study terminated by sponsor|0
1506069|NCT00437203|4952198|P7|Overall Study|Study terminated by sponsor|0
1506070|NCT00437203|4952199|P6|Overall Study|Study terminated by sponsor|0
1506071|NCT00437203|4952200|P5|Overall Study|Study terminated by sponsor|0
1506072|NCT00437203|4952201|P4|Overall Study|Study terminated by sponsor|0
1506073|NCT00437203|4952202|P3|Overall Study|Study terminated by sponsor|0
1506074|NCT00437203|4952203|P2|Overall Study|Study terminated by sponsor|0
1506075|NCT00437203|4952204|P1|Overall Study|Study terminated by sponsor|0
1506076|NCT00437203|4952195|P10|Overall Study|Adverse Event|1
1506077|NCT00437203|4952196|P9|Overall Study|Adverse Event|0
1506078|NCT00437203|4952197|P8|Overall Study|Adverse Event|1
1506079|NCT00437203|4952198|P7|Overall Study|Adverse Event|0
1506080|NCT00437203|4952199|P6|Overall Study|Adverse Event|0
1506081|NCT00437203|4952200|P5|Overall Study|Adverse Event|0
1506082|NCT00437203|4952201|P4|Overall Study|Adverse Event|0
1506083|NCT00437203|4952202|P3|Overall Study|Adverse Event|0
1506084|NCT00437203|4952203|P2|Overall Study|Adverse Event|1
1506085|NCT00437203|4952204|P1|Overall Study|Adverse Event|1
1506086|NCT00437203|4952195|P10|Overall Study|Death|1
1506087|NCT00437203|4952196|P9|Overall Study|Death|0
1506088|NCT00437203|4952197|P8|Overall Study|Death|1
1506089|NCT00437203|4952198|P7|Overall Study|Death|0
1506090|NCT00437203|4952199|P6|Overall Study|Death|0
1506091|NCT00437203|4952200|P5|Overall Study|Death|0
1506092|NCT00437203|4952201|P4|Overall Study|Death|0
1506093|NCT00437203|4952202|P3|Overall Study|Death|1
1506094|NCT00437203|4952203|P2|Overall Study|Death|0
1506095|NCT00437203|4952204|P1|Overall Study|Death|0
1506096|NCT00437125|4952308|P1|Overall Study|Physician Decision|1
1506097|NCT00437125|4952308|P1|Overall Study|Withdrawal by Caregiver|2
1506098|NCT00437125|4952308|P1|Overall Study|Withdrawal by Subject|13
1506099|NCT00437125|4952308|P1|Overall Study|Lost to Follow-up|1
1506100|NCT00437125|4952308|P1|Overall Study|Lack of Efficacy|1
1506101|NCT00437125|4952308|P1|Overall Study|Clinical Relapse|1
1506102|NCT00437125|4952308|P1|Overall Study|Death|1
1506103|NCT00437125|4952308|P1|Overall Study|Adverse Event|12
1506104|NCT00437073|4952329|P2|Overall Study|Physician Decision|1
1506105|NCT00437073|4952330|P1|Overall Study|Physician Decision|0
1506106|NCT00437073|4952329|P2|Overall Study|Sponsor Terminated Study|0
1506107|NCT00437073|4952330|P1|Overall Study|Sponsor Terminated Study|1
1506108|NCT00437034|4952358|P1|Overall Study|Disease progression during treatment|5
1506109|NCT00437034|4952358|P1|Overall Study|Adverse Event|1
1506110|NCT00436982|4952364|P2|Overall Study|no RSA data|2
1506111|NCT00436982|4952365|P1|Overall Study|no RSA data|1
1506112|NCT00436982|4952364|P2|Overall Study|Did not receive allocated intervention|1
1506113|NCT00436982|4952365|P1|Overall Study|Did not receive allocated intervention|0
1506114|NCT00436982|4952364|P2|Overall Study|Withdrawal by Subject|1
1506115|NCT00436982|4952365|P1|Overall Study|Withdrawal by Subject|3
1506116|NCT00436956|4952436|P2|Overall Study|Not evaluable|0
1506117|NCT00436956|4952437|P1|Overall Study|Not evaluable|1
1506118|NCT00436917|4952446|P1|Overall Study|Still on treatment|47
1506119|NCT00436917|4952446|P1|Overall Study|Adverse Event|1
1506120|NCT00436917|4952446|P1|Overall Study|Withdrawal by Subject|6
1506121|NCT00436852|4952461|P2|Overall Study|Ineligible|0
1506122|NCT00436852|4952462|P1|Overall Study|Ineligible|1
1506123|NCT00436852|4952461|P2|Overall Study|Withdrawal by Subject|4
1506124|NCT00436852|4952462|P1|Overall Study|Withdrawal by Subject|2
1506125|NCT00436852|4952461|P2|Overall Study|Lack of Efficacy|7
1506126|NCT00436852|4952462|P1|Overall Study|Lack of Efficacy|9
1506127|NCT00436852|4952461|P2|Overall Study|Death|34
1506128|NCT00436852|4952462|P1|Overall Study|Death|23
1506129|NCT00436826|4952472|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
1506130|NCT00436826|4952473|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
1506131|NCT00436826|4952474|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
1506132|NCT00436826|4952475|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
1506133|NCT00436826|4952476|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
1506134|NCT00436826|4952477|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
1506135|NCT00436826|4952472|P6|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
1506136|NCT00436826|4952473|P5|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
1506137|NCT00436826|4952474|P4|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|24
1506138|NCT00436826|4952475|P3|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|44
1506139|NCT00436826|4952476|P2|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
1506140|NCT00436826|4952477|P1|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
1506141|NCT00436826|4952472|P6|Double Blind Period|Other|0
1506142|NCT00436826|4952473|P5|Double Blind Period|Other|0
1506143|NCT00436826|4952474|P4|Double Blind Period|Other|0
1506144|NCT00436826|4952475|P3|Double Blind Period|Other|0
1506145|NCT00436826|4952476|P2|Double Blind Period|Other|11
1506146|NCT00436826|4952477|P1|Double Blind Period|Other|10
1506147|NCT00436826|4952472|P6|Double Blind Period|Protocol Violation|0
1506148|NCT00436826|4952473|P5|Double Blind Period|Protocol Violation|0
1506149|NCT00436826|4952474|P4|Double Blind Period|Protocol Violation|0
1506150|NCT00436826|4952475|P3|Double Blind Period|Protocol Violation|0
1506151|NCT00436826|4952476|P2|Double Blind Period|Protocol Violation|0
1506152|NCT00436826|4952477|P1|Double Blind Period|Protocol Violation|1
1506153|NCT00436826|4952472|P6|Double Blind Period|Adverse Event|0
1506154|NCT00436826|4952473|P5|Double Blind Period|Adverse Event|0
1506155|NCT00436826|4952474|P4|Double Blind Period|Adverse Event|0
1506156|NCT00436826|4952475|P3|Double Blind Period|Adverse Event|0
1506157|NCT00436826|4952476|P2|Double Blind Period|Adverse Event|0
1506158|NCT00436826|4952477|P1|Double Blind Period|Adverse Event|2
1506159|NCT00436748|4952499|P2|Overall Study|Other|0
1506160|NCT00436748|4952500|P1|Overall Study|Other|3
1506161|NCT00436748|4952499|P2|Overall Study|Protocol-specified Criteria|4
1506162|NCT00436748|4952500|P1|Overall Study|Protocol-specified Criteria|5
1506163|NCT00436748|4952499|P2|Overall Study|Lost to Follow-up|1
1506164|NCT00436748|4952500|P1|Overall Study|Lost to Follow-up|0
1506165|NCT00436748|4952499|P2|Overall Study|Administrative Decision|0
1506166|NCT00436748|4952500|P1|Overall Study|Administrative Decision|1
1506167|NCT00436748|4952499|P2|Overall Study|Consent Withdrawn|4
1506168|NCT00436748|4952500|P1|Overall Study|Consent Withdrawn|1
1506169|NCT00436748|4952499|P2|Overall Study|Adverse Event|2
1506170|NCT00436748|4952500|P1|Overall Study|Adverse Event|0
1506171|NCT00436748|4952499|P2|Overall Study|Ineligibility Determined|1
1506172|NCT00436748|4952500|P1|Overall Study|Ineligibility Determined|1
1506173|NCT00436644|4952534|P1|Overall Study|Death|1
1506174|NCT00436644|4952534|P1|Overall Study|Adverse Event|2
1506175|NCT00436618|4952544|P3|Overall Study|Still on treatment|7
1506176|NCT00436618|4952545|P2|Overall Study|Still on treatment|2
1506177|NCT00436618|4952546|P1|Overall Study|Still on treatment|1
1506178|NCT00436618|4952544|P3|Overall Study|New Primary or Other Reasons|12
1506179|NCT00436618|4952545|P2|Overall Study|New Primary or Other Reasons|2
1506180|NCT00436618|4952546|P1|Overall Study|New Primary or Other Reasons|6
1506181|NCT00436618|4952544|P3|Overall Study|Death|3
1506182|NCT00436618|4952545|P2|Overall Study|Death|2
1506183|NCT00436618|4952546|P1|Overall Study|Death|4
1506184|NCT00436618|4952544|P3|Overall Study|Other Medical Problems|7
1506185|NCT00436618|4952545|P2|Overall Study|Other Medical Problems|1
1506186|NCT00436618|4952546|P1|Overall Study|Other Medical Problems|3
1506187|NCT00436618|4952544|P3|Overall Study|Alternate Treatment|12
1506188|NCT00436618|4952545|P2|Overall Study|Alternate Treatment|4
1506189|NCT00436618|4952546|P1|Overall Study|Alternate Treatment|3
1506190|NCT00436618|4952544|P3|Overall Study|Adverse Event|9
1506191|NCT00436618|4952545|P2|Overall Study|Adverse Event|8
1506192|NCT00436618|4952546|P1|Overall Study|Adverse Event|8
1506193|NCT00436618|4952544|P3|Overall Study|Withdrawal by Subject|11
1506194|NCT00436618|4952545|P2|Overall Study|Withdrawal by Subject|8
1506195|NCT00436618|4952546|P1|Overall Study|Withdrawal by Subject|5
1506196|NCT00436605|4952563|P1|Overall Study|Protocol Violation|3
1506197|NCT00436566|4952568|P1|Overall Study|Protocol Violation|1
1506198|NCT00436566|4952568|P1|Overall Study|Withdrawal by Subject|2
1506199|NCT00436553|4952575|P3|Overall Study|Withdrawal by Subject|3
1506200|NCT00436553|4952576|P2|Overall Study|Withdrawal by Subject|6
1506201|NCT00436553|4952577|P1|Overall Study|Withdrawal by Subject|5
1506202|NCT00436553|4952575|P3|Overall Study|Protocol Violation|0
1506203|NCT00436553|4952576|P2|Overall Study|Protocol Violation|0
1506204|NCT00436553|4952577|P1|Overall Study|Protocol Violation|1
1506205|NCT00436553|4952575|P3|Overall Study|Lost to Follow-up|0
1506206|NCT00436553|4952576|P2|Overall Study|Lost to Follow-up|2
1506207|NCT00436553|4952577|P1|Overall Study|Lost to Follow-up|0
1506208|NCT00436553|4952575|P3|Overall Study|Death|3
1506209|NCT00436553|4952576|P2|Overall Study|Death|1
1506210|NCT00436553|4952577|P1|Overall Study|Death|3
1506211|NCT00436553|4952575|P3|Overall Study|Adverse Event|4
1506212|NCT00436553|4952576|P2|Overall Study|Adverse Event|3
1506213|NCT00436553|4952577|P1|Overall Study|Adverse Event|4
1506214|NCT00436501|4952598|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
1506215|NCT00436501|4952599|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
1506216|NCT00436501|4952598|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
1506217|NCT00436501|4952599|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
1506218|NCT00436436|4952610|P1|Overall Study|Death|6
1506219|NCT00436436|4952610|P1|Overall Study|Adverse Event|2
1506220|NCT00436436|4952610|P1|Overall Study|Progression|4
1506221|NCT00436345|4952621|P2|Overall Study|ICU resident beyond follow-up period|0
1506222|NCT00436345|4952622|P1|Overall Study|ICU resident beyond follow-up period|3
1506223|NCT00436332|4952675|P1|Overall Study|Never Received Treatment|3
1506224|NCT00436332|4952675|P1|Overall Study|Ineligible|2
1506225|NCT00436332|4952675|P1|Overall Study|Not Protocol Specified|6
1506226|NCT00436332|4952675|P1|Overall Study|Death|2
1506227|NCT00436332|4952675|P1|Overall Study|Progression|59
1506228|NCT00436332|4952675|P1|Overall Study|Withdrawal by Subject|2
1506229|NCT00436332|4952675|P1|Overall Study|Adverse Event|9
1506230|NCT00436215|4952682|P1|Overall Study|Small bowel obstruction|1
1506231|NCT00436215|4952682|P1|Overall Study|Refused further treatment|3
1506232|NCT00436163|4952688|P1|Overall Study|Adverse Event|1
1506233|NCT00436163|4952688|P1|Overall Study|Lost to Follow-up|2
1506234|NCT00436007|4952736|P3|Overall Study|Other|1
1506235|NCT00436007|4952737|P2|Overall Study|Other|0
1506236|NCT00436007|4952738|P1|Overall Study|Other|0
1506237|NCT00436007|4952736|P3|Overall Study|Death|3
1506238|NCT00436007|4952737|P2|Overall Study|Death|1
1506239|NCT00436007|4952738|P1|Overall Study|Death|0
1506240|NCT00436007|4952736|P3|Overall Study|Physician Decision|2
1506241|NCT00436007|4952737|P2|Overall Study|Physician Decision|0
1506242|NCT00436007|4952738|P1|Overall Study|Physician Decision|0
1506243|NCT00436007|4952736|P3|Overall Study|Lost to Follow-up|13
1506244|NCT00436007|4952737|P2|Overall Study|Lost to Follow-up|10
1506245|NCT00436007|4952738|P1|Overall Study|Lost to Follow-up|14
1506246|NCT00436007|4952736|P3|Overall Study|Withdrawal by Subject|4
1506247|NCT00436007|4952737|P2|Overall Study|Withdrawal by Subject|3
1506248|NCT00436007|4952738|P1|Overall Study|Withdrawal by Subject|5
1506249|NCT00435994|4952786|P3|Overall Study|Lost to Follow-up|0
1506250|NCT00435994|4952787|P2|Overall Study|Lost to Follow-up|0
1506251|NCT00435994|4952788|P1|Overall Study|Lost to Follow-up|7
1506252|NCT00435942|4952799|P2|Overall Study|Other|1
1506253|NCT00435942|4952800|P1|Overall Study|Other|0
1506254|NCT00435942|4952799|P2|Overall Study|Technical Failure|0
1506255|NCT00435942|4952800|P1|Overall Study|Technical Failure|3
1506256|NCT00435942|4952799|P2|Overall Study|Conversion to Open Repair|0
1506257|NCT00435942|4952800|P1|Overall Study|Conversion to Open Repair|1
1506258|NCT00435942|4952799|P2|Overall Study|Lost to Follow-up|16
1506259|NCT00435942|4952800|P1|Overall Study|Lost to Follow-up|0
1506260|NCT00435942|4952799|P2|Overall Study|Withdrawal by Subject|0
1506261|NCT00435942|4952800|P1|Overall Study|Withdrawal by Subject|2
1506262|NCT00435942|4952799|P2|Overall Study|Death|10
1506263|NCT00435942|4952800|P1|Overall Study|Death|17
1506264|NCT00435825|4952840|P4|Overall Study|Did not complete full follow-up period|5
1506265|NCT00435825|4952841|P3|Overall Study|Did not complete full follow-up period|4
1506266|NCT00435825|4952842|P2|Overall Study|Did not complete full follow-up period|6
1506267|NCT00435825|4952843|P1|Overall Study|Did not complete full follow-up period|6
1506268|NCT00435825|4952840|P4|Overall Study|Did not enter follow-up|3
1506269|NCT00435825|4952841|P3|Overall Study|Did not enter follow-up|1
1506270|NCT00435825|4952842|P2|Overall Study|Did not enter follow-up|4
1506271|NCT00435825|4952843|P1|Overall Study|Did not enter follow-up|0
1506272|NCT00435825|4952840|P4|Overall Study|Did not receive study drug|0
1506273|NCT00435825|4952841|P3|Overall Study|Did not receive study drug|2
1506274|NCT00435825|4952842|P2|Overall Study|Did not receive study drug|0
1506275|NCT00435825|4952843|P1|Overall Study|Did not receive study drug|1
1506276|NCT00435825|4952840|P4|Overall Study|Failure to return|0
1506277|NCT00435825|4952841|P3|Overall Study|Failure to return|4
1506278|NCT00435825|4952842|P2|Overall Study|Failure to return|0
1506279|NCT00435825|4952843|P1|Overall Study|Failure to return|5
1506280|NCT00435825|4952840|P4|Overall Study|Refused treatment|5
1506281|NCT00435825|4952841|P3|Overall Study|Refused treatment|0
1506282|NCT00435825|4952842|P2|Overall Study|Refused treatment|0
1506283|NCT00435825|4952843|P1|Overall Study|Refused treatment|2
1506284|NCT00435825|4952840|P4|Overall Study|Other Protocol Violation|0
1506285|NCT00435825|4952841|P3|Overall Study|Other Protocol Violation|0
1506286|NCT00435825|4952842|P2|Overall Study|Other Protocol Violation|0
1506287|NCT00435825|4952843|P1|Overall Study|Other Protocol Violation|1
1506288|NCT00435825|4952840|P4|Overall Study|Insufficient Therapeutic Response|3
1506289|NCT00435825|4952841|P3|Overall Study|Insufficient Therapeutic Response|0
1506290|NCT00435825|4952842|P2|Overall Study|Insufficient Therapeutic Response|1
1506291|NCT00435825|4952843|P1|Overall Study|Insufficient Therapeutic Response|3
1506292|NCT00435825|4952840|P4|Overall Study|Abnormality of Laboratory Test|0
1506293|NCT00435825|4952841|P3|Overall Study|Abnormality of Laboratory Test|0
1506294|NCT00435825|4952842|P2|Overall Study|Abnormality of Laboratory Test|1
1506295|NCT00435825|4952843|P1|Overall Study|Abnormality of Laboratory Test|0
1506296|NCT00435487|4952966|P2|Overall Study|Received Drug in Other Treatment Group|1
1506297|NCT00435487|4952967|P1|Overall Study|Received Drug in Other Treatment Group|0
1506298|NCT00435487|4952966|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
1506299|NCT00435487|4952967|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
1506300|NCT00435487|4952966|P2|Overall Study|Withdrawal by Subject|1
1506301|NCT00435487|4952967|P1|Overall Study|Withdrawal by Subject|2
1506302|NCT00435487|4952966|P2|Overall Study|Other|2
1506303|NCT00435487|4952967|P1|Overall Study|Other|5
1506304|NCT00435487|4952966|P2|Overall Study|Lost to Follow-up|2
1506305|NCT00435487|4952967|P1|Overall Study|Lost to Follow-up|2
1506306|NCT00435487|4952966|P2|Overall Study|Adverse Event|3
1506307|NCT00435487|4952967|P1|Overall Study|Adverse Event|0
1506308|NCT00435487|4952966|P2|Overall Study|Death|4
1506309|NCT00435487|4952967|P1|Overall Study|Death|3
1506310|NCT00435461|4952986|P3|Overall Study|Lost to Follow-up|2
1506311|NCT00435461|4952987|P2|Overall Study|Lost to Follow-up|1
1506312|NCT00435461|4952988|P1|Overall Study|Lost to Follow-up|1
1506313|NCT00435461|4952986|P3|Overall Study|Non-Compliance of diary|1
1506314|NCT00435461|4952987|P2|Overall Study|Non-Compliance of diary|0
1506315|NCT00435461|4952988|P1|Overall Study|Non-Compliance of diary|2
1506316|NCT00435461|4952986|P3|Overall Study|Adverse Event|6
1506317|NCT00435461|4952987|P2|Overall Study|Adverse Event|2
1506318|NCT00435461|4952988|P1|Overall Study|Adverse Event|1
1506319|NCT00435461|4952986|P3|Overall Study|Noncompliance with study requirements|1
1506320|NCT00435461|4952987|P2|Overall Study|Noncompliance with study requirements|1
1506321|NCT00435461|4952988|P1|Overall Study|Noncompliance with study requirements|1
1506322|NCT00435461|4952986|P3|Overall Study|Participant ended study one day early|0
1506323|NCT00435461|4952987|P2|Overall Study|Participant ended study one day early|0
1506324|NCT00435461|4952988|P1|Overall Study|Participant ended study one day early|1
1506325|NCT00435461|4952986|P3|Overall Study|Participant moved eDiary,studymedication|0
1506326|NCT00435461|4952987|P2|Overall Study|Participant moved eDiary,studymedication|0
1506327|NCT00435461|4952988|P1|Overall Study|Participant moved eDiary,studymedication|1
1506328|NCT00435461|4952986|P3|Overall Study|Pregnancy|0
1506329|NCT00435461|4952987|P2|Overall Study|Pregnancy|0
1506330|NCT00435461|4952988|P1|Overall Study|Pregnancy|2
1506331|NCT00435461|4952986|P3|Overall Study|Participant could not swallow capsule|1
1506332|NCT00435461|4952987|P2|Overall Study|Participant could not swallow capsule|0
1506333|NCT00435461|4952988|P1|Overall Study|Participant could not swallow capsule|0
1506334|NCT00435461|4952986|P3|Overall Study|Participant could not tolerate symptoms|1
1506335|NCT00435461|4952987|P2|Overall Study|Participant could not tolerate symptoms|0
1506336|NCT00435461|4952988|P1|Overall Study|Participant could not tolerate symptoms|0
1506337|NCT00435461|4952986|P3|Overall Study|Randomized in error|0
1506338|NCT00435461|4952987|P2|Overall Study|Randomized in error|0
1506339|NCT00435461|4952988|P1|Overall Study|Randomized in error|1
1506340|NCT00435461|4952986|P3|Overall Study|Withdrawal by Subject|2
1506341|NCT00435461|4952987|P2|Overall Study|Withdrawal by Subject|0
1506342|NCT00435461|4952988|P1|Overall Study|Withdrawal by Subject|1
1506343|NCT00435461|4952986|P3|Overall Study|Lack of Efficacy|0
1506344|NCT00435461|4952987|P2|Overall Study|Lack of Efficacy|1
1506345|NCT00435461|4952988|P1|Overall Study|Lack of Efficacy|2
1506346|NCT00435461|4952986|P3|Overall Study|In error, two study medications switched|0
1506347|NCT00435461|4952987|P2|Overall Study|In error, two study medications switched|0
1506348|NCT00435461|4952988|P1|Overall Study|In error, two study medications switched|1
1506349|NCT00435461|4952986|P3|Overall Study|Compliance less than 80 percent|0
1506350|NCT00435461|4952987|P2|Overall Study|Compliance less than 80 percent|0
1506351|NCT00435461|4952988|P1|Overall Study|Compliance less than 80 percent|1
1506352|NCT00435461|4952986|P3|Overall Study|Participant randomized(inadequate score)|0
1506353|NCT00435461|4952987|P2|Overall Study|Participant randomized(inadequate score)|0
1506354|NCT00435461|4952988|P1|Overall Study|Participant randomized(inadequate score)|1
1506355|NCT00435461|4952986|P3|Overall Study|Protocol Violation|10
1506356|NCT00435461|4952987|P2|Overall Study|Protocol Violation|9
1506357|NCT00435461|4952988|P1|Overall Study|Protocol Violation|6
1506358|NCT00435461|4952986|P3|Overall Study|Visit changed to EarlyWithdrawn Visit|0
1506359|NCT00435461|4952987|P2|Overall Study|Visit changed to EarlyWithdrawn Visit|0
1506360|NCT00435461|4952988|P1|Overall Study|Visit changed to EarlyWithdrawn Visit|1
1506361|NCT00435409|4953025|P3|Overall Study|Sponsor decision|0
1506362|NCT00435409|4953026|P2|Overall Study|Sponsor decision|3
1506363|NCT00435409|4953027|P1|Overall Study|Sponsor decision|0
1506364|NCT00435409|4953025|P3|Overall Study|Adverse Event|8
1506365|NCT00435409|4953026|P2|Overall Study|Adverse Event|0
1506366|NCT00435409|4953027|P1|Overall Study|Adverse Event|0
1506367|NCT00435409|4953025|P3|Overall Study|Not specified|1
1506368|NCT00435409|4953026|P2|Overall Study|Not specified|30
1506369|NCT00435409|4953027|P1|Overall Study|Not specified|45
1506370|NCT00435409|4953025|P3|Overall Study|Withdrawal by Subject|1
1506371|NCT00435409|4953026|P2|Overall Study|Withdrawal by Subject|7
1506372|NCT00435409|4953027|P1|Overall Study|Withdrawal by Subject|8
1506373|NCT00435409|4953025|P3|Overall Study|Global deterioration of health status|4
1506374|NCT00435409|4953026|P2|Overall Study|Global deterioration of health status|0
1506375|NCT00435409|4953027|P1|Overall Study|Global deterioration of health status|0
1506460|NCT00434967|4953226|P4|Overall Study|Adverse Event|3
1506376|NCT00435409|4953025|P3|Overall Study|Objective progression or relapse|58
1506377|NCT00435409|4953026|P2|Overall Study|Objective progression or relapse|93
1506378|NCT00435409|4953027|P1|Overall Study|Objective progression or relapse|158
1506379|NCT00435409|4953025|P3|Overall Study|Death|6
1506380|NCT00435409|4953026|P2|Overall Study|Death|6
1506381|NCT00435409|4953027|P1|Overall Study|Death|8
1506382|NCT00435409|4953025|P3|Overall Study|Lost to Follow-up|0
1506383|NCT00435409|4953026|P2|Overall Study|Lost to Follow-up|2
1506384|NCT00435409|4953027|P1|Overall Study|Lost to Follow-up|1
1506385|NCT00435409|4953025|P3|Overall Study|Protocol Violation|0
1506386|NCT00435409|4953026|P2|Overall Study|Protocol Violation|2
1506387|NCT00435409|4953027|P1|Overall Study|Protocol Violation|1
1506388|NCT00435370|4953049|P2|Overall Study|Antipsychotic medication changed|2
1506389|NCT00435370|4953050|P1|Overall Study|Antipsychotic medication changed|4
1506390|NCT00435370|4953049|P2|Overall Study|Withdrawal by Subject|10
1506391|NCT00435370|4953050|P1|Overall Study|Withdrawal by Subject|10
1506392|NCT00435370|4953049|P2|Overall Study|Adverse Event|8
1506393|NCT00435370|4953050|P1|Overall Study|Adverse Event|8
1506394|NCT00435188|4953058|P2|Overall Study|Lost to Follow-up|6
1506395|NCT00435188|4953059|P1|Overall Study|Lost to Follow-up|5
1506396|NCT00435188|4953058|P2|Overall Study|Withdrawal by Subject|11
1506397|NCT00435188|4953059|P1|Overall Study|Withdrawal by Subject|16
1506398|NCT00435188|4953058|P2|Overall Study|Death|6
1506399|NCT00435188|4953059|P1|Overall Study|Death|1
1506400|NCT00435162|4953102|P6|Period 2 (2 Weeks)|Adverse Event|0
1506401|NCT00435162|4953103|P5|Period 2 (2 Weeks)|Adverse Event|0
1506402|NCT00435162|4953104|P4|Period 2 (2 Weeks)|Adverse Event|0
1506403|NCT00435162|4953105|P3|Period 2 (2 Weeks)|Adverse Event|0
1506404|NCT00435162|4953106|P2|Period 2 (2 Weeks)|Adverse Event|1
1506405|NCT00435162|4953107|P1|Period 2 (2 Weeks)|Adverse Event|0
1506406|NCT00435045|4953127|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
1506407|NCT00435045|4953128|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
1506408|NCT00435045|4953127|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
1506409|NCT00435045|4953128|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
1506410|NCT00435045|4953127|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
1506411|NCT00435045|4953128|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
1506412|NCT00435045|4953127|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
1506413|NCT00435045|4953128|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
1506414|NCT00435045|4953127|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
1506415|NCT00435045|4953128|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
1506416|NCT00435045|4953127|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
1506417|NCT00435045|4953128|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
1506418|NCT00435045|4953127|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
1506419|NCT00435045|4953128|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
1506420|NCT00435045|4953127|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
1506421|NCT00435045|4953128|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
1506422|NCT00435045|4953127|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
1506423|NCT00435045|4953128|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
1506424|NCT00435045|4953127|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
1506425|NCT00435045|4953128|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
1506426|NCT00435045|4953127|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
1506427|NCT00435045|4953128|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
1506428|NCT00435019|4953184|P2|Overall Study|Personal reasons for withdrawal|7
1506429|NCT00435019|4953185|P1|Overall Study|Personal reasons for withdrawal|8
1506430|NCT00435019|4953184|P2|Overall Study|Protocol Violation|1
1506431|NCT00435019|4953185|P1|Overall Study|Protocol Violation|3
1506432|NCT00435019|4953184|P2|Overall Study|Lack of Efficacy|2
1506433|NCT00435019|4953185|P1|Overall Study|Lack of Efficacy|1
1506434|NCT00435019|4953184|P2|Overall Study|Adverse Event|0
1506435|NCT00435019|4953185|P1|Overall Study|Adverse Event|1
1506436|NCT00434967|4953226|P4|Overall Study|Patient Disposition Challenges|3
1506437|NCT00434967|4953227|P3|Overall Study|Patient Disposition Challenges|0
1506438|NCT00434967|4953228|P2|Overall Study|Patient Disposition Challenges|0
1506439|NCT00434967|4953229|P1|Overall Study|Patient Disposition Challenges|2
1506440|NCT00434967|4953226|P4|Overall Study|Physician Decision|0
1506441|NCT00434967|4953227|P3|Overall Study|Physician Decision|1
1506442|NCT00434967|4953228|P2|Overall Study|Physician Decision|1
1506443|NCT00434967|4953229|P1|Overall Study|Physician Decision|1
1506444|NCT00434967|4953226|P4|Overall Study|Protocol Violation|1
1506445|NCT00434967|4953227|P3|Overall Study|Protocol Violation|0
1506446|NCT00434967|4953228|P2|Overall Study|Protocol Violation|1
1506447|NCT00434967|4953229|P1|Overall Study|Protocol Violation|0
1506448|NCT00434967|4953226|P4|Overall Study|Randomized in error|1
1506449|NCT00434967|4953227|P3|Overall Study|Randomized in error|0
1506450|NCT00434967|4953228|P2|Overall Study|Randomized in error|0
1506451|NCT00434967|4953229|P1|Overall Study|Randomized in error|0
1506452|NCT00434967|4953226|P4|Overall Study|Withdrawal by Subject|6
1506453|NCT00434967|4953227|P3|Overall Study|Withdrawal by Subject|4
1506454|NCT00434967|4953228|P2|Overall Study|Withdrawal by Subject|2
1506455|NCT00434967|4953229|P1|Overall Study|Withdrawal by Subject|2
1506456|NCT00434967|4953226|P4|Overall Study|Lost to Follow-up|0
1506457|NCT00434967|4953227|P3|Overall Study|Lost to Follow-up|1
1506458|NCT00434967|4953228|P2|Overall Study|Lost to Follow-up|0
1506459|NCT00434967|4953229|P1|Overall Study|Lost to Follow-up|0
1506461|NCT00434967|4953227|P3|Overall Study|Adverse Event|3
1506462|NCT00434967|4953228|P2|Overall Study|Adverse Event|4
1506463|NCT00434967|4953229|P1|Overall Study|Adverse Event|2
1506464|NCT00434954|4953249|P2|Overall Study|Subject decision|22
1506465|NCT00434954|4953250|P1|Overall Study|Subject decision|8
1506466|NCT00434954|4953249|P2|Overall Study|Sponsor decision|0
1506467|NCT00434954|4953250|P1|Overall Study|Sponsor decision|1
1506468|NCT00434954|4953249|P2|Overall Study|Protocol Violation|27
1506469|NCT00434954|4953250|P1|Overall Study|Protocol Violation|36
1506470|NCT00434954|4953249|P2|Overall Study|Physician Decision|3
1506471|NCT00434954|4953250|P1|Overall Study|Physician Decision|6
1506472|NCT00434954|4953249|P2|Overall Study|Lost to Follow-up|1
1506473|NCT00434954|4953250|P1|Overall Study|Lost to Follow-up|0
1506474|NCT00434954|4953249|P2|Overall Study|Entry criteria not met|16
1506475|NCT00434954|4953250|P1|Overall Study|Entry criteria not met|14
1506476|NCT00434954|4953249|P2|Overall Study|Adverse Event|2
1506477|NCT00434954|4953250|P1|Overall Study|Adverse Event|17
1506478|NCT00434876|4953280|P2|Overall Study|Lost to Follow-up|1
1506479|NCT00434876|4953281|P1|Overall Study|Lost to Follow-up|1
1506480|NCT00434759|4953295|P2|Overall Study|family affairs|0
1506481|NCT00434759|4953296|P1|Overall Study|family affairs|2
1506482|NCT00434759|4953295|P2|Overall Study|Withdrawal by Subject|1
1506483|NCT00434759|4953296|P1|Overall Study|Withdrawal by Subject|17
1506484|NCT00434759|4953295|P2|Overall Study|Lack of Efficacy|4
1506485|NCT00434759|4953296|P1|Overall Study|Lack of Efficacy|5
1506486|NCT00434642|4953312|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
1506487|NCT00434642|4953313|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
1506488|NCT00434642|4953312|P2|Open-label Treatment Phase|Adverse Event|5
1506489|NCT00434642|4953313|P1|Open-label Treatment Phase|Adverse Event|0
1506490|NCT00434642|4953312|P2|Blinded Treatment Phase|Did not Receive Treatment|1
1506491|NCT00434642|4953313|P1|Blinded Treatment Phase|Did not Receive Treatment|4
1506492|NCT00434642|4953312|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
1506493|NCT00434642|4953313|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
1506494|NCT00434642|4953312|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
1506495|NCT00434642|4953313|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
1506496|NCT00434642|4953312|P2|Blinded Treatment Phase|Physician Decision|27
1506497|NCT00434642|4953313|P1|Blinded Treatment Phase|Physician Decision|19
1506498|NCT00434642|4953312|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
1506499|NCT00434642|4953313|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
1506500|NCT00434642|4953312|P2|Blinded Treatment Phase|Clinical Disease Progression|5
1506501|NCT00434642|4953313|P1|Blinded Treatment Phase|Clinical Disease Progression|4
1506502|NCT00434642|4953312|P2|Blinded Treatment Phase|Adverse Event|58
1506503|NCT00434642|4953313|P1|Blinded Treatment Phase|Adverse Event|12
1506504|NCT00434590|4953331|P2|Overall Study|Administrative problems|5
1506505|NCT00434590|4953332|P1|Overall Study|Administrative problems|5
1506506|NCT00434421|4953354|P1|Overall Study|Non-compliance with study treatment|1
1506507|NCT00434421|4953354|P1|Overall Study|Withdrawal by Subject|1
1506508|NCT00434330|4953382|P6|Overall Study|Subject Not Compliant With Study|0
1506509|NCT00434330|4953383|P5|Overall Study|Subject Not Compliant With Study|0
1506510|NCT00434330|4953384|P4|Overall Study|Subject Not Compliant With Study|0
1506511|NCT00434330|4953385|P3|Overall Study|Subject Not Compliant With Study|1
1506512|NCT00434330|4953386|P2|Overall Study|Subject Not Compliant With Study|0
1506513|NCT00434330|4953387|P1|Overall Study|Subject Not Compliant With Study|0
1506514|NCT00434330|4953382|P6|Overall Study|Renal transplant|0
1506515|NCT00434330|4953383|P5|Overall Study|Renal transplant|0
1506516|NCT00434330|4953384|P4|Overall Study|Renal transplant|1
1506517|NCT00434330|4953385|P3|Overall Study|Renal transplant|0
1506518|NCT00434330|4953386|P2|Overall Study|Renal transplant|0
1506519|NCT00434330|4953387|P1|Overall Study|Renal transplant|0
1506520|NCT00434330|4953382|P6|Overall Study|Withdrawal by Subject|0
1506521|NCT00434330|4953383|P5|Overall Study|Withdrawal by Subject|0
1506522|NCT00434330|4953384|P4|Overall Study|Withdrawal by Subject|1
1506523|NCT00434330|4953385|P3|Overall Study|Withdrawal by Subject|1
1506524|NCT00434330|4953386|P2|Overall Study|Withdrawal by Subject|0
1506525|NCT00434330|4953387|P1|Overall Study|Withdrawal by Subject|0
1506526|NCT00434330|4953382|P6|Overall Study|Death|1
1506527|NCT00434330|4953383|P5|Overall Study|Death|1
1506528|NCT00434330|4953384|P4|Overall Study|Death|0
1506529|NCT00434330|4953385|P3|Overall Study|Death|0
1506530|NCT00434330|4953386|P2|Overall Study|Death|0
1506531|NCT00434330|4953387|P1|Overall Study|Death|1
1506532|NCT00434330|4953382|P6|Overall Study|Adverse Event|0
1506533|NCT00434330|4953383|P5|Overall Study|Adverse Event|0
1506534|NCT00434330|4953384|P4|Overall Study|Adverse Event|0
1506535|NCT00434330|4953385|P3|Overall Study|Adverse Event|1
1506536|NCT00434330|4953386|P2|Overall Study|Adverse Event|0
1506537|NCT00434330|4953387|P1|Overall Study|Adverse Event|0
1506538|NCT00434304|4953419|P1|Overall Study|Withdrawal by Subject|4
1506539|NCT00434304|4953419|P1|Overall Study|Lack of Efficacy|2
1506540|NCT00434304|4953419|P1|Overall Study|Adverse Event|14
1506541|NCT00434252|4953468|P2|Overall Study|Withdrawal by Subject|7
1506542|NCT00434252|4953469|P1|Overall Study|Withdrawal by Subject|3
1506543|NCT00434252|4953468|P2|Overall Study|Physician Decision|8
1506544|NCT00434252|4953469|P1|Overall Study|Physician Decision|4
1506545|NCT00434252|4953468|P2|Overall Study|Lost to Follow-up|1
1506546|NCT00434252|4953469|P1|Overall Study|Lost to Follow-up|0
1506547|NCT00434252|4953468|P2|Overall Study|Death|2
1506548|NCT00434252|4953469|P1|Overall Study|Death|1
1506549|NCT00434252|4953468|P2|Overall Study|Adverse Event|13
1506550|NCT00434252|4953469|P1|Overall Study|Adverse Event|6
1506551|NCT00434252|4953468|P2|Overall Study|Lack of Efficacy|100
1506552|NCT00434252|4953469|P1|Overall Study|Lack of Efficacy|50
1506553|NCT00434213|4953503|P1|Overall Study|Non-compliant to study schedule|1
1506554|NCT00434213|4953503|P1|Overall Study|Application site reaction|1
1506555|NCT00434213|4953503|P1|Overall Study|Unable to comply with study visit window|2
1506556|NCT00434213|4953503|P1|Overall Study|Protocol Violation|3
1506557|NCT00434213|4953503|P1|Overall Study|Withdrawal by Subject|7
1506558|NCT00434213|4953503|P1|Overall Study|Lost to Follow-up|14
1506559|NCT00434213|4953503|P1|Overall Study|Lack of Efficacy|9
1506560|NCT00434213|4953503|P1|Overall Study|Adverse Event|12
1506561|NCT00434161|4953511|P3|Overall Study|Logistical error study assessments|3
1506562|NCT00434161|4953512|P2|Overall Study|Logistical error study assessments|0
1506563|NCT00434161|4953513|P1|Overall Study|Logistical error study assessments|1
1506564|NCT00434161|4953511|P3|Overall Study|Withdrawal by Subject|3
1506565|NCT00434161|4953512|P2|Overall Study|Withdrawal by Subject|0
1506566|NCT00434161|4953513|P1|Overall Study|Withdrawal by Subject|2
1506567|NCT00434161|4953511|P3|Overall Study|Non-Compliance|0
1506568|NCT00434161|4953512|P2|Overall Study|Non-Compliance|1
1506569|NCT00434161|4953513|P1|Overall Study|Non-Compliance|1
1506570|NCT00434161|4953511|P3|Overall Study|Death|1
1506571|NCT00434161|4953512|P2|Overall Study|Death|0
1506572|NCT00434161|4953513|P1|Overall Study|Death|1
1506573|NCT00434161|4953511|P3|Overall Study|Lost to Follow-up|0
1506574|NCT00434161|4953512|P2|Overall Study|Lost to Follow-up|1
1506575|NCT00434161|4953513|P1|Overall Study|Lost to Follow-up|0
1506576|NCT00434161|4953511|P3|Overall Study|Adverse Event|4
1506577|NCT00434161|4953512|P2|Overall Study|Adverse Event|1
1506578|NCT00434161|4953513|P1|Overall Study|Adverse Event|5
1506579|NCT00434148|4953557|P2|Overall Study|Abnormal test procedure result|1
1506580|NCT00434148|4953558|P1|Overall Study|Abnormal test procedure result|0
1506581|NCT00434148|4953557|P2|Overall Study|Condition no longer requires study drug|0
1506582|NCT00434148|4953558|P1|Overall Study|Condition no longer requires study drug|1
1506583|NCT00434148|4953557|P2|Overall Study|Lost to Follow-up|1
1506584|NCT00434148|4953558|P1|Overall Study|Lost to Follow-up|0
1506585|NCT00434148|4953557|P2|Overall Study|Administrative problems|10
1506586|NCT00434148|4953558|P1|Overall Study|Administrative problems|6
1506587|NCT00434148|4953557|P2|Overall Study|Protocol Violation|0
1506588|NCT00434148|4953558|P1|Overall Study|Protocol Violation|4
1506589|NCT00434148|4953557|P2|Overall Study|Withdrawal by Subject|15
1506590|NCT00434148|4953558|P1|Overall Study|Withdrawal by Subject|15
1506591|NCT00434148|4953557|P2|Overall Study|Lack of Efficacy|28
1506592|NCT00434148|4953558|P1|Overall Study|Lack of Efficacy|25
1506593|NCT00434148|4953557|P2|Overall Study|Adverse Event|18
1506594|NCT00434148|4953558|P1|Overall Study|Adverse Event|18
1506595|NCT00434122|4953594|P2|Overall Study|Travelling of subject.|0
1506596|NCT00434122|4953595|P1|Overall Study|Travelling of subject.|1
1506597|NCT00434122|4953594|P2|Overall Study|Low follicular response.|2
1506598|NCT00434122|4953595|P1|Overall Study|Low follicular response.|1
1506599|NCT00434122|4953594|P2|Overall Study|Large follicle size|2
1506600|NCT00434122|4953595|P1|Overall Study|Large follicle size|2
1506601|NCT00434122|4953594|P2|Overall Study|Personal reasons|1
1506602|NCT00434122|4953595|P1|Overall Study|Personal reasons|1
1506603|NCT00434122|4953594|P2|Overall Study|loss of subject contact|1
1506604|NCT00434122|4953595|P1|Overall Study|loss of subject contact|1
1506605|NCT00434122|4953594|P2|Overall Study|Non-compliance with protocol|1
1506606|NCT00434122|4953595|P1|Overall Study|Non-compliance with protocol|0
1506607|NCT00434109|4953604|P1|Overall Study|had embolism, did not receive sunitinib|3
1506608|NCT00434109|4953604|P1|Overall Study|Protocol Violation|1
1506609|NCT00434109|4953604|P1|Overall Study|Adverse Event|5
1506610|NCT00434109|4953604|P1|Overall Study|Physician Decision|9
1506611|NCT00434057|4953613|P1|Overall Study|Withdrawal by Subject|1
1506612|NCT00433966|4953651|P4|Stent Intervention/Randomization|Lost to Follow-up|47
1506613|NCT00433966|4953652|P3|Stent Intervention/Randomization|Lost to Follow-up|113
1506614|NCT00433966|4953653|P2|Stent Intervention/Randomization|Lost to Follow-up|0
1506615|NCT00433966|4953654|P1|Stent Intervention/Randomization|Lost to Follow-up|0
1506616|NCT00433966|4953651|P4|Stent Intervention/Randomization|Withdrawal by Subject|15
1506617|NCT00433966|4953652|P3|Stent Intervention/Randomization|Withdrawal by Subject|41
1506618|NCT00433966|4953653|P2|Stent Intervention/Randomization|Withdrawal by Subject|0
1506619|NCT00433966|4953654|P1|Stent Intervention/Randomization|Withdrawal by Subject|0
1506620|NCT00433966|4953651|P4|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
1506621|NCT00433966|4953652|P3|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
1506622|NCT00433966|4953653|P2|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
1506623|NCT00433966|4953654|P1|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
1506624|NCT00433966|4953651|P4|Pharmacology Intervention/Randomization|Lost to Follow-up|0
1506625|NCT00433966|4953652|P3|Pharmacology Intervention/Randomization|Lost to Follow-up|0
1506626|NCT00433966|4953653|P2|Pharmacology Intervention/Randomization|Lost to Follow-up|103
1506627|NCT00433966|4953654|P1|Pharmacology Intervention/Randomization|Lost to Follow-up|97
1506628|NCT00433966|4953651|P4|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
1506710|NCT00433290|4953815|P1|Overall Study|Physician Decision|2
1506629|NCT00433966|4953652|P3|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
1506630|NCT00433966|4953653|P2|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
1506631|NCT00433966|4953654|P1|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
1506632|NCT00433914|4953676|P2|Overall Study|Lost to Follow-up|1
1506633|NCT00433914|4953677|P1|Overall Study|Lost to Follow-up|0
1506634|NCT00433914|4953676|P2|Overall Study|Withdrawal by Subject|2
1506635|NCT00433914|4953677|P1|Overall Study|Withdrawal by Subject|0
1506636|NCT00433836|4953697|P2|Overall Study|Abnormal laboratory values|1
1506637|NCT00433836|4953698|P1|Overall Study|Abnormal laboratory values|0
1506638|NCT00433836|4953697|P2|Overall Study|Condition no longer requires study drug|1
1506639|NCT00433836|4953698|P1|Overall Study|Condition no longer requires study drug|0
1506640|NCT00433836|4953697|P2|Overall Study|Protocol Violation|2
1506641|NCT00433836|4953698|P1|Overall Study|Protocol Violation|0
1506642|NCT00433836|4953697|P2|Overall Study|Unsatisfactory therapeutic effect|1
1506643|NCT00433836|4953698|P1|Overall Study|Unsatisfactory therapeutic effect|1
1506644|NCT00433836|4953697|P2|Overall Study|Withdrawal by Subject|1
1506645|NCT00433836|4953698|P1|Overall Study|Withdrawal by Subject|2
1506646|NCT00433836|4953697|P2|Overall Study|Lost to Follow-up|0
1506647|NCT00433836|4953698|P1|Overall Study|Lost to Follow-up|3
1506648|NCT00433836|4953697|P2|Overall Study|Adverse Event|0
1506649|NCT00433836|4953698|P1|Overall Study|Adverse Event|7
1506650|NCT00433771|4953710|P1|Overall Study|Failure to deploy stent|1
1506651|NCT00433771|4953710|P1|Overall Study|Death|2
1506652|NCT00433771|4953710|P1|Overall Study|Treated and later found to be ineligible|2
1506653|NCT00433771|4953710|P1|Overall Study|screen fail|14
1506654|NCT00433654|4953733|P2|Overall Study|Withdrawal by Subject|2
1506655|NCT00433654|4953734|P1|Overall Study|Withdrawal by Subject|1
1506656|NCT00433654|4953733|P2|Overall Study|Subject not yet due for visit|0
1506657|NCT00433654|4953734|P1|Overall Study|Subject not yet due for visit|4
1506658|NCT00433654|4953733|P2|Overall Study|Missed visit|3
1506659|NCT00433654|4953734|P1|Overall Study|Missed visit|6
1506660|NCT00433654|4953733|P2|Overall Study|Death|0
1506661|NCT00433654|4953734|P1|Overall Study|Death|4
1506662|NCT00433537|4953780|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
1506663|NCT00433537|4953781|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
1506664|NCT00433537|4953782|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
1506665|NCT00433537|4953780|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
1506666|NCT00433537|4953781|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
1506667|NCT00433537|4953782|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
1506668|NCT00433537|4953780|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
1506669|NCT00433537|4953781|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
1506670|NCT00433537|4953782|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
1506671|NCT00433537|4953780|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
1506672|NCT00433537|4953781|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
1506673|NCT00433537|4953782|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
1506674|NCT00433537|4953780|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
1506675|NCT00433537|4953781|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
1506676|NCT00433537|4953782|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
1506677|NCT00433537|4953780|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
1506678|NCT00433537|4953781|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
1506679|NCT00433537|4953782|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
1506680|NCT00433537|4953780|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
1506681|NCT00433537|4953781|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
1506682|NCT00433537|4953782|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
1506683|NCT00433537|4953780|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
1506684|NCT00433537|4953781|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
1506685|NCT00433537|4953782|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
1506686|NCT00433537|4953780|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
1506687|NCT00433537|4953781|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
1506688|NCT00433537|4953782|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
1506689|NCT00433446|4953791|P1|Overall Study|Ineligible|9
1506690|NCT00433446|4953791|P1|Overall Study|Other - Not Protocol specified|3
1506691|NCT00433446|4953791|P1|Overall Study|Progression|44
1506692|NCT00433446|4953791|P1|Overall Study|Refusal Unrelated to Adverse Event|1
1506693|NCT00433446|4953791|P1|Overall Study|Adverse Event|4
1506694|NCT00433381|4953801|P2|Overall Study|Lost to follow-up before 6 months|0
1506695|NCT00433381|4953802|P1|Overall Study|Lost to follow-up before 6 months|2
1506696|NCT00433381|4953801|P2|Overall Study|Ineligible / no protocol treatment|3
1506697|NCT00433381|4953802|P1|Overall Study|Ineligible / no protocol treatment|3
1506698|NCT00433329|4953808|P1|Overall Study|Physician Decision|1
1506699|NCT00433329|4953808|P1|Overall Study|Lost to Follow-up|1
1506700|NCT00433329|4953808|P1|Overall Study|Moved out of state|1
1506701|NCT00433329|4953808|P1|Overall Study|Discontinued sildenafil|2
1506702|NCT00433329|4953808|P1|Overall Study|Withdrew consent|3
1506703|NCT00433329|4953808|P1|Overall Study|Death|4
1506704|NCT00433329|4953808|P1|Overall Study|Adverse Event|9
1506705|NCT00433290|4953814|P2|Overall Study|Lost to Follow-up|0
1506706|NCT00433290|4953815|P1|Overall Study|Lost to Follow-up|1
1506707|NCT00433290|4953814|P2|Overall Study|Entry Criteria Not Met|1
1506708|NCT00433290|4953815|P1|Overall Study|Entry Criteria Not Met|0
1506709|NCT00433290|4953814|P2|Overall Study|Physician Decision|0
1506711|NCT00433290|4953814|P2|Overall Study|Protocol Violation|2
1506712|NCT00433290|4953815|P1|Overall Study|Protocol Violation|3
1506713|NCT00433290|4953814|P2|Overall Study|Withdrawal by Subject|2
1506714|NCT00433290|4953815|P1|Overall Study|Withdrawal by Subject|4
1506715|NCT00433290|4953814|P2|Overall Study|Lack of Efficacy|5
1506716|NCT00433290|4953815|P1|Overall Study|Lack of Efficacy|1
1506717|NCT00433290|4953814|P2|Overall Study|Adverse Event|7
1506718|NCT00433290|4953815|P1|Overall Study|Adverse Event|24
1506719|NCT00433199|4953884|P2|Open-Label Period|Administrative|1
1506720|NCT00433199|4953885|P1|Open-Label Period|Administrative|0
1506721|NCT00433199|4953884|P2|Open-Label Period|Protocol Violation|2
1506722|NCT00433199|4953885|P1|Open-Label Period|Protocol Violation|0
1506723|NCT00433199|4953884|P2|Open-Label Period|Withdrawal by Subject|7
1506724|NCT00433199|4953885|P1|Open-Label Period|Withdrawal by Subject|0
1506725|NCT00433199|4953884|P2|Open-Label Period|Lost to Follow-up|3
1506726|NCT00433199|4953885|P1|Open-Label Period|Lost to Follow-up|0
1506727|NCT00433199|4953884|P2|Open-Label Period|Lack of Efficacy|2
1506728|NCT00433199|4953885|P1|Open-Label Period|Lack of Efficacy|0
1506729|NCT00433199|4953884|P2|Open-Label Period|Adverse Event|19
1506730|NCT00433199|4953885|P1|Open-Label Period|Adverse Event|0
1506731|NCT00433199|4953884|P2|Double-Blind Period|Administrative|5
1506732|NCT00433199|4953885|P1|Double-Blind Period|Administrative|1
1506733|NCT00433199|4953884|P2|Double-Blind Period|Protocol Violation|10
1506734|NCT00433199|4953885|P1|Double-Blind Period|Protocol Violation|1
1506735|NCT00433199|4953884|P2|Double-Blind Period|Withdrawal by Subject|19
1506736|NCT00433199|4953885|P1|Double-Blind Period|Withdrawal by Subject|8
1506737|NCT00433199|4953884|P2|Double-Blind Period|Lost to Follow-up|5
1506738|NCT00433199|4953885|P1|Double-Blind Period|Lost to Follow-up|2
1506739|NCT00433199|4953884|P2|Double-Blind Period|Lack of Efficacy|2
1506740|NCT00433199|4953885|P1|Double-Blind Period|Lack of Efficacy|0
1506741|NCT00433199|4953884|P2|Double-Blind Period|Adverse Event|25
1506742|NCT00433199|4953885|P1|Double-Blind Period|Adverse Event|0
1506743|NCT00433160|4953905|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
1506744|NCT00433160|4953906|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
1506745|NCT00433160|4953905|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
1506746|NCT00433160|4953906|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
1506747|NCT00433160|4953905|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
1506748|NCT00433160|4953906|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
1506749|NCT00433160|4953905|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
1506750|NCT00433160|4953906|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
1506751|NCT00433160|4953905|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
1506752|NCT00433160|4953906|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
1506753|NCT00433160|4953905|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
1506754|NCT00433160|4953906|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
1506755|NCT00433160|4953905|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
1506756|NCT00433160|4953906|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
1506757|NCT00433160|4953905|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
1506758|NCT00433160|4953906|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
1506759|NCT00433160|4953905|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
1506760|NCT00433160|4953906|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
1506761|NCT00433160|4953905|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
1506762|NCT00433160|4953906|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
1506763|NCT00433160|4953905|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
1506764|NCT00433160|4953906|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
1506765|NCT00433160|4953905|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
1506766|NCT00433160|4953906|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
1506767|NCT00433160|4953905|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
1506768|NCT00433160|4953906|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
1506769|NCT00433160|4953905|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
1506770|NCT00433160|4953906|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
1506771|NCT00433160|4953905|P2|52-Week Double-Blind (DB) Period|Death|0
1506772|NCT00433160|4953906|P1|52-Week Double-Blind (DB) Period|Death|0
1506773|NCT00433160|4953905|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
1506774|NCT00433160|4953906|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
1506775|NCT00433147|4953958|P4|Overall Study|Adverse Event|0
1506776|NCT00433147|4953959|P3|Overall Study|Adverse Event|0
1506777|NCT00433147|4953960|P2|Overall Study|Adverse Event|1
1506778|NCT00433147|4953961|P1|Overall Study|Adverse Event|0
1506779|NCT00433017|4953977|P2|Overall Study|Subject no longer requires study drug|1
1506780|NCT00433017|4953978|P1|Overall Study|Subject no longer requires study drug|1
1506781|NCT00433017|4953977|P2|Overall Study|Death|2
1506782|NCT00433017|4953978|P1|Overall Study|Death|2
1506783|NCT00433017|4953977|P2|Overall Study|Protocol Violation|0
1506784|NCT00433017|4953978|P1|Overall Study|Protocol Violation|1
1506785|NCT00433017|4953977|P2|Overall Study|Administrative problems|86
1506786|NCT00433017|4953978|P1|Overall Study|Administrative problems|80
1506787|NCT00433017|4953977|P2|Overall Study|Lost to Follow-up|4
1506788|NCT00433017|4953978|P1|Overall Study|Lost to Follow-up|3
1506789|NCT00433017|4953977|P2|Overall Study|Withdrawal by Subject|5
1506790|NCT00433017|4953978|P1|Overall Study|Withdrawal by Subject|4
1506791|NCT00433017|4953977|P2|Overall Study|Adverse Event|3
1506792|NCT00433017|4953978|P1|Overall Study|Adverse Event|5
1506793|NCT00433004|4953994|P2|Overall Study|Lost to Follow-up|7
1506794|NCT00433004|4953995|P1|Overall Study|Lost to Follow-up|5
1506795|NCT00432991|4954007|P2|Overall Study|Protocol Violation|12
1506796|NCT00432991|4954008|P1|Overall Study|Protocol Violation|7
1506797|NCT00432965|4954020|P2|Overall Study|Incomplete Data|3
1506798|NCT00432965|4954021|P1|Overall Study|Incomplete Data|4
1506799|NCT00432965|4954020|P2|Overall Study|Exclusionary Methods|2
1506800|NCT00432965|4954021|P1|Overall Study|Exclusionary Methods|1
1506801|NCT00432965|4954020|P2|Overall Study|Death|4
1506802|NCT00432965|4954021|P1|Overall Study|Death|3
1506803|NCT00432965|4954020|P2|Overall Study|Adverse Event|19
1506804|NCT00432965|4954021|P1|Overall Study|Adverse Event|22
1506805|NCT00432965|4954020|P2|Overall Study|Non-compliance|0
1506806|NCT00432965|4954021|P1|Overall Study|Non-compliance|7
1506807|NCT00432965|4954020|P2|Overall Study|Lack of Efficacy|13
1506808|NCT00432965|4954021|P1|Overall Study|Lack of Efficacy|8
1506809|NCT00432965|4954020|P2|Overall Study|Physician Decision|13
1506810|NCT00432965|4954021|P1|Overall Study|Physician Decision|14
1506811|NCT00432965|4954020|P2|Overall Study|Withdrawal by Subject|13
1506812|NCT00432965|4954021|P1|Overall Study|Withdrawal by Subject|13
1506813|NCT00432965|4954020|P2|Overall Study|Lost to Follow-up|19
1506814|NCT00432965|4954021|P1|Overall Study|Lost to Follow-up|22
1506815|NCT00432835|4954029|P2|Overall Study|Adverse event: lead dislodgement.|7
1506816|NCT00432835|4954030|P1|Overall Study|Adverse event: lead dislodgement.|6
1506817|NCT00432809|4954043|P3|1 Year Follow-up|Withdrawal by Subject|1
1506818|NCT00432809|4954044|P2|1 Year Follow-up|Withdrawal by Subject|0
1506819|NCT00432809|4954045|P1|1 Year Follow-up|Withdrawal by Subject|7
1506820|NCT00432809|4954043|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
1506821|NCT00432809|4954044|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
1506822|NCT00432809|4954045|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
1506823|NCT00432744|4954118|P2|Months 7 - 12|Too disabled to score|1
1506824|NCT00432744|4954119|P1|Months 7 - 12|Too disabled to score|0
1506825|NCT00432744|4954118|P2|Months 7 - 12|Withdrawal by Subject|0
1506826|NCT00432744|4954119|P1|Months 7 - 12|Withdrawal by Subject|1
1506827|NCT00432744|4954118|P2|Months 0-6|Too disabled to score|0
1506828|NCT00432744|4954119|P1|Months 0-6|Too disabled to score|1
1506829|NCT00432744|4954118|P2|Months 0-6|Withdrawal by Subject|4
1506830|NCT00432744|4954119|P1|Months 0-6|Withdrawal by Subject|4
1506831|NCT00432666|4954131|P2|Open-Label Extension Period|Physician Decision|0
1506832|NCT00432666|4954132|P1|Open-Label Extension Period|Physician Decision|3
1506833|NCT00432666|4954131|P2|Open-Label Extension Period|Consent withdrawn|0
1506834|NCT00432666|4954132|P1|Open-Label Extension Period|Consent withdrawn|10
1506835|NCT00432666|4954131|P2|Open-Label Extension Period|Adverse Event|0
1506836|NCT00432666|4954132|P1|Open-Label Extension Period|Adverse Event|5
1506837|NCT00432666|4954131|P2|Open-Label Extension Period|Lack of Efficacy|0
1506838|NCT00432666|4954132|P1|Open-Label Extension Period|Lack of Efficacy|6
1506839|NCT00432666|4954131|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
1506840|NCT00432666|4954132|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
1506841|NCT00432666|4954131|P2|Main Period|Consent Withdrawn|0
1506842|NCT00432666|4954132|P1|Main Period|Consent Withdrawn|1
1506843|NCT00432666|4954131|P2|Main Period|Adverse Event|1
1506844|NCT00432666|4954132|P1|Main Period|Adverse Event|1
1506845|NCT00432562|4954305|P2|Overall Study|Death|0
1506846|NCT00432562|4954306|P1|Overall Study|Death|3
1506847|NCT00432380|4954358|P3|Overall Study|Adverse Event|0
1506848|NCT00432380|4954359|P2|Overall Study|Adverse Event|0
1506849|NCT00432380|4954360|P1|Overall Study|Adverse Event|1
1506850|NCT00432380|4954358|P3|Overall Study|Migrated/moved from study area|1
1506851|NCT00432380|4954359|P2|Overall Study|Migrated/moved from study area|4
1506852|NCT00432380|4954360|P1|Overall Study|Migrated/moved from study area|3
1506853|NCT00432276|4954413|P2|Overall Study|Other|3
1506854|NCT00432276|4954414|P1|Overall Study|Other|2
1506855|NCT00432276|4954413|P2|Overall Study|Physician Decision|8
1506856|NCT00432276|4954414|P1|Overall Study|Physician Decision|6
1506857|NCT00432276|4954413|P2|Overall Study|Withdrawal by Subject|20
1506858|NCT00432276|4954414|P1|Overall Study|Withdrawal by Subject|25
1506859|NCT00432276|4954413|P2|Overall Study|Lost to Follow-up|2
1506860|NCT00432276|4954414|P1|Overall Study|Lost to Follow-up|6
1506861|NCT00432276|4954413|P2|Overall Study|Protocol Violation|20
1506862|NCT00432276|4954414|P1|Overall Study|Protocol Violation|25
1506863|NCT00432276|4954413|P2|Overall Study|Adverse Event|16
1506864|NCT00432276|4954414|P1|Overall Study|Adverse Event|13
1506865|NCT00432276|4954413|P2|Overall Study|Hyperglycemic Rescue|87
1506866|NCT00432276|4954414|P1|Overall Study|Hyperglycemic Rescue|44
1506867|NCT00432237|4954504|P4|Overall Study|Lack of Qualifying Event|84
1506868|NCT00432237|4954505|P3|Overall Study|Lack of Qualifying Event|69
1506869|NCT00432237|4954506|P2|Overall Study|Lack of Qualifying Event|71
1506870|NCT00432237|4954507|P1|Overall Study|Lack of Qualifying Event|38
1506871|NCT00432237|4954504|P4|Overall Study|Withdrawal by Subject|11
1506872|NCT00432237|4954505|P3|Overall Study|Withdrawal by Subject|9
1506873|NCT00432237|4954506|P2|Overall Study|Withdrawal by Subject|6
1506874|NCT00432237|4954507|P1|Overall Study|Withdrawal by Subject|5
1506875|NCT00432237|4954504|P4|Overall Study|Protocol Violation|8
1506876|NCT00432237|4954505|P3|Overall Study|Protocol Violation|11
1506877|NCT00432237|4954506|P2|Overall Study|Protocol Violation|10
1506878|NCT00432237|4954507|P1|Overall Study|Protocol Violation|13
1506879|NCT00432237|4954504|P4|Overall Study|Pregnancy|0
1506880|NCT00432237|4954505|P3|Overall Study|Pregnancy|0
1506881|NCT00432237|4954506|P2|Overall Study|Pregnancy|1
1506882|NCT00432237|4954507|P1|Overall Study|Pregnancy|0
1506883|NCT00432237|4954504|P4|Overall Study|Physician Decision|1
1506884|NCT00432237|4954505|P3|Overall Study|Physician Decision|2
1506885|NCT00432237|4954506|P2|Overall Study|Physician Decision|3
1506886|NCT00432237|4954507|P1|Overall Study|Physician Decision|1
1506887|NCT00432237|4954504|P4|Overall Study|Lost to Follow-up|18
1506888|NCT00432237|4954505|P3|Overall Study|Lost to Follow-up|18
1506889|NCT00432237|4954506|P2|Overall Study|Lost to Follow-up|10
1506890|NCT00432237|4954507|P1|Overall Study|Lost to Follow-up|10
1506891|NCT00432237|4954504|P4|Overall Study|Lack of Efficacy|1
1506892|NCT00432237|4954505|P3|Overall Study|Lack of Efficacy|0
1506893|NCT00432237|4954506|P2|Overall Study|Lack of Efficacy|0
1506894|NCT00432237|4954507|P1|Overall Study|Lack of Efficacy|0
1506895|NCT00432237|4954504|P4|Overall Study|Adverse Event|1
1506896|NCT00432237|4954505|P3|Overall Study|Adverse Event|0
1506897|NCT00432237|4954506|P2|Overall Study|Adverse Event|0
1506898|NCT00432237|4954507|P1|Overall Study|Adverse Event|0
1506899|NCT00432159|4954550|P5|Overall Study|Missing NDI and/or neuro. assessment|7
1506900|NCT00432159|4954551|P4|Overall Study|Missing NDI and/or neuro. assessment|3
1506901|NCT00432159|4954552|P3|Overall Study|Missing NDI and/or neuro. assessment|1
1506902|NCT00432159|4954553|P2|Overall Study|Missing NDI and/or neuro. assessment|24
1506903|NCT00432159|4954554|P1|Overall Study|Missing NDI and/or neuro. assessment|13
1506904|NCT00432159|4954550|P5|Overall Study|Failure|3
1506905|NCT00432159|4954551|P4|Overall Study|Failure|2
1506906|NCT00432159|4954552|P3|Overall Study|Failure|3
1506907|NCT00432159|4954553|P2|Overall Study|Failure|5
1506908|NCT00432159|4954554|P1|Overall Study|Failure|9
1506909|NCT00432159|4954550|P5|Overall Study|Death|0
1506910|NCT00432159|4954551|P4|Overall Study|Death|0
1506911|NCT00432159|4954552|P3|Overall Study|Death|0
1506912|NCT00432159|4954553|P2|Overall Study|Death|1
1506913|NCT00432159|4954554|P1|Overall Study|Death|0
1506914|NCT00432042|4954661|P3|Overall Study|Lost to Follow-up|0
1506915|NCT00432042|4954662|P2|Overall Study|Lost to Follow-up|1
1506916|NCT00432042|4954663|P1|Overall Study|Lost to Follow-up|5
1506917|NCT00432042|4954661|P3|Overall Study|Withdrawal by Subject|2
1506918|NCT00432042|4954662|P2|Overall Study|Withdrawal by Subject|0
1506919|NCT00432042|4954663|P1|Overall Study|Withdrawal by Subject|0
1506920|NCT00432042|4954661|P3|Overall Study|Protocol Violation|0
1506921|NCT00432042|4954662|P2|Overall Study|Protocol Violation|0
1506922|NCT00432042|4954663|P1|Overall Study|Protocol Violation|2
1506923|NCT00431964|4954676|P2|Overall Study|Due to Unstable Health|1
1506924|NCT00431964|4954677|P1|Overall Study|Due to Unstable Health|0
1506925|NCT00431964|4954676|P2|Overall Study|Parental Consent Withdrawn|2
1506926|NCT00431964|4954677|P1|Overall Study|Parental Consent Withdrawn|0
1506927|NCT00431964|4954676|P2|Overall Study|Withdrawal by Subject|1
1506928|NCT00431964|4954677|P1|Overall Study|Withdrawal by Subject|2
1506929|NCT00431964|4954676|P2|Overall Study|Physician Decision|2
1506930|NCT00431964|4954677|P1|Overall Study|Physician Decision|2
1506931|NCT00431964|4954676|P2|Overall Study|Lost to Follow-up|2
1506932|NCT00431964|4954677|P1|Overall Study|Lost to Follow-up|1
1506933|NCT00431964|4954676|P2|Overall Study|Adverse Event|0
1506934|NCT00431964|4954677|P1|Overall Study|Adverse Event|1
1506935|NCT00431951|4954687|P4|Overall Study|Adverse Event|0
1506936|NCT00431951|4954688|P3|Overall Study|Adverse Event|1
1506937|NCT00431951|4954689|P2|Overall Study|Adverse Event|0
1506938|NCT00431951|4954690|P1|Overall Study|Adverse Event|0
1506939|NCT00431951|4954687|P4|Overall Study|Withdrawal by Subject|0
1506940|NCT00431951|4954688|P3|Overall Study|Withdrawal by Subject|0
1506941|NCT00431951|4954689|P2|Overall Study|Withdrawal by Subject|1
1506942|NCT00431951|4954690|P1|Overall Study|Withdrawal by Subject|0
1506943|NCT00431951|4954687|P4|Overall Study|Lost to Follow-up|0
1506944|NCT00431951|4954688|P3|Overall Study|Lost to Follow-up|0
1506945|NCT00431951|4954689|P2|Overall Study|Lost to Follow-up|1
1506946|NCT00431951|4954690|P1|Overall Study|Lost to Follow-up|0
1506947|NCT00431951|4954687|P4|Overall Study|Inability to follow study procedures|2
1506948|NCT00431951|4954688|P3|Overall Study|Inability to follow study procedures|1
1506949|NCT00431951|4954689|P2|Overall Study|Inability to follow study procedures|0
1506950|NCT00431951|4954690|P1|Overall Study|Inability to follow study procedures|1
1506951|NCT00431847|4954752|P5|Overall Study|Protocol Violation|1
1506952|NCT00431847|4954753|P4|Overall Study|Protocol Violation|0
1506953|NCT00431847|4954754|P3|Overall Study|Protocol Violation|0
1506954|NCT00431847|4954755|P2|Overall Study|Protocol Violation|0
1506955|NCT00431847|4954756|P1|Overall Study|Protocol Violation|0
1506956|NCT00431847|4954752|P5|Overall Study|completion of less than two study visits|0
1506957|NCT00431847|4954753|P4|Overall Study|completion of less than two study visits|14
1506958|NCT00431847|4954754|P3|Overall Study|completion of less than two study visits|4
1506959|NCT00431847|4954755|P2|Overall Study|completion of less than two study visits|3
1506960|NCT00431847|4954756|P1|Overall Study|completion of less than two study visits|6
1506961|NCT00431834|4954830|P1|Overall Study|Lost to Follow-up|1
1506962|NCT00431834|4954830|P1|Overall Study|Missed Endpoint Visit|2
1506963|NCT00431834|4954830|P1|Overall Study|Death|3
1506964|NCT00431834|4954830|P1|Overall Study|Withdrawal by Subject|7
1506965|NCT00431496|4954846|P1|Overall Study|Protocol-specified criteria|5
1506966|NCT00431496|4954846|P1|Overall Study|Withdrawal by Subject|2
1506967|NCT00431496|4954846|P1|Overall Study|Lost to Follow-up|1
1506968|NCT00431496|4954846|P1|Overall Study|Adverse Event|3
1506969|NCT00431444|4954857|P2|Overall Study|Administrative Problems|1
1506970|NCT00431444|4954858|P1|Overall Study|Administrative Problems|0
1506971|NCT00431444|4954857|P2|Overall Study|Lost to Follow-up|0
1506972|NCT00431444|4954858|P1|Overall Study|Lost to Follow-up|1
1506973|NCT00431444|4954857|P2|Overall Study|Withdrawal by Subject|1
1506974|NCT00431444|4954858|P1|Overall Study|Withdrawal by Subject|1
1506975|NCT00431444|4954857|P2|Overall Study|Adverse Event|1
1506976|NCT00431444|4954858|P1|Overall Study|Adverse Event|2
1506977|NCT00431444|4954857|P2|Overall Study|Protocol Violation|4
1506978|NCT00431444|4954858|P1|Overall Study|Protocol Violation|1
1506979|NCT00431067|4954898|P1|Overall Study|Non-compliance,lost to follow-up|2
1506980|NCT00431067|4954898|P1|Overall Study|Progressive disease|30
1506981|NCT00431067|4954898|P1|Overall Study|Other Adverse Event|9
1506982|NCT00430950|4954923|P2|Overall Study|concomitant medication,etc.|7
1506983|NCT00430950|4954924|P1|Overall Study|concomitant medication,etc.|5
1506984|NCT00430950|4954923|P2|Overall Study|Withdrawal by Subject|0
1506985|NCT00430950|4954924|P1|Overall Study|Withdrawal by Subject|1
1506986|NCT00430950|4954923|P2|Overall Study|Adverse Event|6
1506987|NCT00430950|4954924|P1|Overall Study|Adverse Event|7
1506988|NCT00430937|4954938|P2|Overall Study|Unable to classify|1
1506989|NCT00430937|4954939|P1|Overall Study|Unable to classify|0
1506990|NCT00430937|4954938|P2|Overall Study|Protocol discontinuation criteria met|2
1506991|NCT00430937|4954939|P1|Overall Study|Protocol discontinuation criteria met|1
1506992|NCT00430937|4954938|P2|Overall Study|Administrative reasons|0
1506993|NCT00430937|4954939|P1|Overall Study|Administrative reasons|1
1506994|NCT00430937|4954938|P2|Overall Study|Inappropriate enrollment|1
1506995|NCT00430937|4954939|P1|Overall Study|Inappropriate enrollment|2
1506996|NCT00430937|4954938|P2|Overall Study|Lack of Efficacy|5
1506997|NCT00430937|4954939|P1|Overall Study|Lack of Efficacy|6
1506998|NCT00430937|4954938|P2|Overall Study|Protocol Violation|2
1506999|NCT00430937|4954939|P1|Overall Study|Protocol Violation|3
1507000|NCT00430937|4954938|P2|Overall Study|Withdrawal by Subject|2
1507001|NCT00430937|4954939|P1|Overall Study|Withdrawal by Subject|5
1507002|NCT00430937|4954938|P2|Overall Study|Lost to Follow-up|6
1507003|NCT00430937|4954939|P1|Overall Study|Lost to Follow-up|6
1507004|NCT00430937|4954938|P2|Overall Study|Death|1
1507005|NCT00430937|4954939|P1|Overall Study|Death|0
1507006|NCT00430937|4954938|P2|Overall Study|Adverse Event|8
1507007|NCT00430937|4954939|P1|Overall Study|Adverse Event|3
1507008|NCT00430781|4954950|P3|End-of-Study Analysis; 28 July 2011|Other|0
1507009|NCT00430781|4954951|P2|End-of-Study Analysis; 28 July 2011|Other|1
1507010|NCT00430781|4954952|P1|End-of-Study Analysis; 28 July 2011|Other|4
1507011|NCT00430781|4954950|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
1507012|NCT00430781|4954951|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
1507013|NCT00430781|4954952|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
1507014|NCT00430781|4954950|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
1507015|NCT00430781|4954951|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
1507016|NCT00430781|4954952|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
1507017|NCT00430781|4954950|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
1507018|NCT00430781|4954951|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
1507019|NCT00430781|4954952|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
1507020|NCT00430781|4954950|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
1507021|NCT00430781|4954951|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
1507022|NCT00430781|4954952|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
1507023|NCT00430781|4954950|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
1507024|NCT00430781|4954951|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
1507025|NCT00430781|4954952|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
1507026|NCT00430781|4954950|P3|Final Analysis; 31 July 2008|Ongoing|32
1507027|NCT00430781|4954951|P2|Final Analysis; 31 July 2008|Ongoing|29
1507028|NCT00430781|4954952|P1|Final Analysis; 31 July 2008|Ongoing|0
1507029|NCT00430781|4954950|P3|Final Analysis; 31 July 2008|Other|0
1507030|NCT00430781|4954951|P2|Final Analysis; 31 July 2008|Other|1
1507031|NCT00430781|4954952|P1|Final Analysis; 31 July 2008|Other|0
1507032|NCT00430781|4954950|P3|Final Analysis; 31 July 2008|Physician Decision|6
1507033|NCT00430781|4954951|P2|Final Analysis; 31 July 2008|Physician Decision|6
1507034|NCT00430781|4954952|P1|Final Analysis; 31 July 2008|Physician Decision|0
1507035|NCT00430781|4954950|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
1507036|NCT00430781|4954951|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
1507037|NCT00430781|4954952|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
1507038|NCT00430781|4954950|P3|Final Analysis; 31 July 2008|Protocol Violation|0
1507039|NCT00430781|4954951|P2|Final Analysis; 31 July 2008|Protocol Violation|1
1507040|NCT00430781|4954952|P1|Final Analysis; 31 July 2008|Protocol Violation|0
1507041|NCT00430781|4954950|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
1507042|NCT00430781|4954951|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
1507043|NCT00430781|4954952|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
1507044|NCT00430781|4954950|P3|Interim Analysis; 11 February 2008|Ongoing|25
1507045|NCT00430781|4954951|P2|Interim Analysis; 11 February 2008|Ongoing|20
1507046|NCT00430781|4954952|P1|Interim Analysis; 11 February 2008|Ongoing|23
1507047|NCT00430781|4954950|P3|Interim Analysis; 11 February 2008|Physician Decision|3
1507048|NCT00430781|4954951|P2|Interim Analysis; 11 February 2008|Physician Decision|3
1507049|NCT00430781|4954952|P1|Interim Analysis; 11 February 2008|Physician Decision|2
1507050|NCT00430781|4954950|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
1507051|NCT00430781|4954951|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
1507052|NCT00430781|4954952|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
1507053|NCT00430781|4954950|P3|Interim Analysis; 11 February 2008|Death|0
1507054|NCT00430781|4954951|P2|Interim Analysis; 11 February 2008|Death|1
1507055|NCT00430781|4954952|P1|Interim Analysis; 11 February 2008|Death|0
1507056|NCT00430781|4954950|P3|Interim Analysis; 11 February 2008|Disease Progression|22
1507057|NCT00430781|4954951|P2|Interim Analysis; 11 February 2008|Disease Progression|30
1507058|NCT00430781|4954952|P1|Interim Analysis; 11 February 2008|Disease Progression|16
1507059|NCT00430781|4954950|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
1507060|NCT00430781|4954951|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
1507061|NCT00430781|4954952|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
1507062|NCT00430781|4954950|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
1507063|NCT00430781|4954951|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
1507064|NCT00430781|4954952|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
1507065|NCT00430781|4954950|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
1507066|NCT00430781|4954951|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
1507067|NCT00430781|4954952|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
1507068|NCT00430781|4954950|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
1507069|NCT00430781|4954951|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
1507070|NCT00430781|4954952|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
1507071|NCT00430781|4954950|P3|Interim Analysis; 11 February 2008|Adverse Event|7
1507072|NCT00430781|4954951|P2|Interim Analysis; 11 February 2008|Adverse Event|3
1507073|NCT00430781|4954952|P1|Interim Analysis; 11 February 2008|Adverse Event|10
1507074|NCT00430755|4954994|P1|Overall Study|Withdrawal by Subject|53
1507075|NCT00430716|4955001|P3|Open Label Phase|Study terminated by sponsor|4
1507076|NCT00430716|4955002|P2|Open Label Phase|Study terminated by sponsor|5
1507077|NCT00430716|4955003|P1|Open Label Phase|Study terminated by sponsor|4
1507078|NCT00430716|4955001|P3|Open Label Phase|Protocol Violation|0
1507079|NCT00430716|4955002|P2|Open Label Phase|Protocol Violation|0
1507080|NCT00430716|4955003|P1|Open Label Phase|Protocol Violation|1
1507081|NCT00430716|4955001|P3|Open Label Phase|Other|1
1507082|NCT00430716|4955002|P2|Open Label Phase|Other|1
1507083|NCT00430716|4955003|P1|Open Label Phase|Other|3
1507084|NCT00430716|4955001|P3|Open Label Phase|No longer willing to participate|1
1507085|NCT00430716|4955002|P2|Open Label Phase|No longer willing to participate|1
1507086|NCT00430716|4955003|P1|Open Label Phase|No longer willing to participate|0
1507087|NCT00430716|4955001|P3|Open Label Phase|Lost to Follow-up|1
1507088|NCT00430716|4955002|P2|Open Label Phase|Lost to Follow-up|0
1507089|NCT00430716|4955003|P1|Open Label Phase|Lost to Follow-up|1
1507090|NCT00430716|4955001|P3|Double Blind Phase|Not met eligibility criteria|0
1507091|NCT00430716|4955002|P2|Double Blind Phase|Not met eligibility criteria|0
1507092|NCT00430716|4955003|P1|Double Blind Phase|Not met eligibility criteria|1
1507093|NCT00430716|4955001|P3|Double Blind Phase|Adverse Event|3
1507094|NCT00430716|4955002|P2|Double Blind Phase|Adverse Event|1
1507095|NCT00430716|4955003|P1|Double Blind Phase|Adverse Event|1
1507096|NCT00430716|4955001|P3|Double Blind Phase|Study terminated by sponsor|2
1507097|NCT00430716|4955002|P2|Double Blind Phase|Study terminated by sponsor|1
1507098|NCT00430716|4955003|P1|Double Blind Phase|Study terminated by sponsor|1
1507099|NCT00430716|4955001|P3|Double Blind Phase|Other|0
1507100|NCT00430716|4955002|P2|Double Blind Phase|Other|2
1507101|NCT00430716|4955003|P1|Double Blind Phase|Other|0
1507102|NCT00430716|4955001|P3|Double Blind Phase|No longer willing to participate|1
1507103|NCT00430716|4955002|P2|Double Blind Phase|No longer willing to participate|1
1507104|NCT00430716|4955003|P1|Double Blind Phase|No longer willing to participate|2
1507105|NCT00430716|4955001|P3|Double Blind Phase|Death|0
1507106|NCT00430716|4955002|P2|Double Blind Phase|Death|0
1507107|NCT00430716|4955003|P1|Double Blind Phase|Death|1
1507108|NCT00430677|4955035|P3|Long-term Extension Period|Poor compliance/noncompliance|0
1507109|NCT00430677|4955036|P2|Long-term Extension Period|Poor compliance/noncompliance|0
1507110|NCT00430677|4955037|P1|Long-term Extension Period|Poor compliance/noncompliance|1
1507111|NCT00430677|4955035|P3|Long-term Extension Period|Not specified|1
1507112|NCT00430677|4955036|P2|Long-term Extension Period|Not specified|1
1507113|NCT00430677|4955037|P1|Long-term Extension Period|Not specified|2
1507114|NCT00430677|4955035|P3|Long-term Extension Period|Administrative reason by sponsor|46
1507115|NCT00430677|4955036|P2|Long-term Extension Period|Administrative reason by sponsor|49
1507116|NCT00430677|4955037|P1|Long-term Extension Period|Administrative reason by sponsor|41
1507117|NCT00430677|4955035|P3|Long-term Extension Period|Pregnancy|0
1507118|NCT00430677|4955036|P2|Long-term Extension Period|Pregnancy|1
1507119|NCT00430677|4955037|P1|Long-term Extension Period|Pregnancy|1
1507120|NCT00430677|4955035|P3|Long-term Extension Period|Withdrawal by Subject|2
1507121|NCT00430677|4955036|P2|Long-term Extension Period|Withdrawal by Subject|1
1507122|NCT00430677|4955037|P1|Long-term Extension Period|Withdrawal by Subject|5
1507123|NCT00430677|4955035|P3|Long-term Extension Period|Lost to Follow-up|1
1507124|NCT00430677|4955036|P2|Long-term Extension Period|Lost to Follow-up|1
1507125|NCT00430677|4955037|P1|Long-term Extension Period|Lost to Follow-up|1
1507126|NCT00430677|4955035|P3|Long-term Extension Period|Lack of Efficacy|8
1507127|NCT00430677|4955036|P2|Long-term Extension Period|Lack of Efficacy|3
1507128|NCT00430677|4955037|P1|Long-term Extension Period|Lack of Efficacy|5
1507129|NCT00430677|4955035|P3|Long-term Extension Period|Adverse Event|5
1507130|NCT00430677|4955036|P2|Long-term Extension Period|Adverse Event|2
1507131|NCT00430677|4955037|P1|Long-term Extension Period|Adverse Event|3
1507132|NCT00430677|4955035|P3|Long-term Extension Period|Death|0
1507133|NCT00430677|4955036|P2|Long-term Extension Period|Death|0
1507134|NCT00430677|4955037|P1|Long-term Extension Period|Death|1
1507135|NCT00430677|4955035|P3|Short-term Period|Pregnancy|0
1507136|NCT00430677|4955036|P2|Short-term Period|Pregnancy|2
1507137|NCT00430677|4955037|P1|Short-term Period|Pregnancy|0
1507138|NCT00430677|4955035|P3|Short-term Period|Poor compliance/ noncompliance|0
1507139|NCT00430677|4955036|P2|Short-term Period|Poor compliance/ noncompliance|1
1507140|NCT00430677|4955037|P1|Short-term Period|Poor compliance/ noncompliance|0
1507141|NCT00430677|4955035|P3|Short-term Period|Participant no longer met study criteria|2
1507142|NCT00430677|4955036|P2|Short-term Period|Participant no longer met study criteria|1
1507143|NCT00430677|4955037|P1|Short-term Period|Participant no longer met study criteria|1
1507144|NCT00430677|4955035|P3|Short-term Period|Withdrawal by Subject|2
1507145|NCT00430677|4955036|P2|Short-term Period|Withdrawal by Subject|1
1507146|NCT00430677|4955037|P1|Short-term Period|Withdrawal by Subject|1
1507147|NCT00430677|4955035|P3|Short-term Period|Lack of Efficacy|4
1507148|NCT00430677|4955036|P2|Short-term Period|Lack of Efficacy|6
1507149|NCT00430677|4955037|P1|Short-term Period|Lack of Efficacy|5
1507150|NCT00430677|4955035|P3|Short-term Period|Adverse Event|9
1507151|NCT00430677|4955036|P2|Short-term Period|Adverse Event|13
1507152|NCT00430677|4955037|P1|Short-term Period|Adverse Event|15
1507153|NCT00430677|4955035|P3|Short-term Period|Death|5
1507154|NCT00430677|4955036|P2|Short-term Period|Death|1
1507155|NCT00430677|4955037|P1|Short-term Period|Death|1
1507156|NCT00430638|4955160|P2|Overall Study|Not specified|2
1507157|NCT00430638|4955161|P1|Overall Study|Not specified|2
1507158|NCT00430638|4955160|P2|Overall Study|Non-compliant|1
1507159|NCT00430638|4955161|P1|Overall Study|Non-compliant|2
1507160|NCT00430638|4955160|P2|Overall Study|Withdrawal by Subject|6
1507161|NCT00430638|4955161|P1|Overall Study|Withdrawal by Subject|4
1507162|NCT00430638|4955160|P2|Overall Study|Protocol Violation|4
1507163|NCT00430638|4955161|P1|Overall Study|Protocol Violation|6
1507164|NCT00430638|4955160|P2|Overall Study|Lost to Follow-up|7
1507165|NCT00430638|4955161|P1|Overall Study|Lost to Follow-up|1
1507166|NCT00430638|4955160|P2|Overall Study|Uncontrolled blood pressure|13
1507167|NCT00430638|4955161|P1|Overall Study|Uncontrolled blood pressure|48
1507168|NCT00430638|4955160|P2|Overall Study|Adverse Event|15
1507169|NCT00430638|4955161|P1|Overall Study|Adverse Event|15
1507170|NCT00430573|4955196|P1|Overall Study|Withdrawal by Subject|5
1507171|NCT00430508|4955205|P4|Overall Study|not specified|0
1507172|NCT00430508|4955206|P3|Overall Study|not specified|3
1507173|NCT00430508|4955207|P2|Overall Study|not specified|1
1507174|NCT00430508|4955208|P1|Overall Study|not specified|1
1507175|NCT00430508|4955205|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
1507176|NCT00430508|4955206|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
1507177|NCT00430508|4955207|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
1507178|NCT00430508|4955208|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
1507179|NCT00430508|4955205|P4|Overall Study|responder at visit 4|0
1507180|NCT00430508|4955206|P3|Overall Study|responder at visit 4|2
1507181|NCT00430508|4955207|P2|Overall Study|responder at visit 4|0
1507182|NCT00430508|4955208|P1|Overall Study|responder at visit 4|0
1507183|NCT00430508|4955205|P4|Overall Study|Withdrawal by Subject|1
1507184|NCT00430508|4955206|P3|Overall Study|Withdrawal by Subject|1
1507185|NCT00430508|4955207|P2|Overall Study|Withdrawal by Subject|1
1507186|NCT00430508|4955208|P1|Overall Study|Withdrawal by Subject|0
1507187|NCT00430508|4955205|P4|Overall Study|Adverse Event|3
1507188|NCT00430508|4955206|P3|Overall Study|Adverse Event|5
1507189|NCT00430508|4955207|P2|Overall Study|Adverse Event|3
1507190|NCT00430508|4955208|P1|Overall Study|Adverse Event|2
1507191|NCT00430495|4955246|P4|Overall Study|Randomized but not Treated|0
1507192|NCT00430495|4955247|P3|Overall Study|Randomized but not Treated|0
1507193|NCT00430495|4955248|P2|Overall Study|Randomized but not Treated|0
1507194|NCT00430495|4955249|P1|Overall Study|Randomized but not Treated|2
1507195|NCT00430495|4955246|P4|Overall Study|Other|4
1507196|NCT00430495|4955247|P3|Overall Study|Other|5
1507197|NCT00430495|4955248|P2|Overall Study|Other|2
1507198|NCT00430495|4955249|P1|Overall Study|Other|8
1507199|NCT00430495|4955246|P4|Overall Study|Disease Progression|0
1507200|NCT00430495|4955247|P3|Overall Study|Disease Progression|0
1507201|NCT00430495|4955248|P2|Overall Study|Disease Progression|1
1507202|NCT00430495|4955249|P1|Overall Study|Disease Progression|1
1507203|NCT00430495|4955246|P4|Overall Study|Protocol Violation|0
1507204|NCT00430495|4955247|P3|Overall Study|Protocol Violation|1
1507205|NCT00430495|4955248|P2|Overall Study|Protocol Violation|0
1507206|NCT00430495|4955249|P1|Overall Study|Protocol Violation|1
1507207|NCT00430495|4955246|P4|Overall Study|Lost to Follow-up|0
1507208|NCT00430495|4955247|P3|Overall Study|Lost to Follow-up|4
1507209|NCT00430495|4955248|P2|Overall Study|Lost to Follow-up|1
1507210|NCT00430495|4955249|P1|Overall Study|Lost to Follow-up|0
1507211|NCT00430495|4955246|P4|Overall Study|Death|0
1507212|NCT00430495|4955247|P3|Overall Study|Death|1
1507213|NCT00430495|4955248|P2|Overall Study|Death|0
1507214|NCT00430495|4955249|P1|Overall Study|Death|0
1507215|NCT00430495|4955246|P4|Overall Study|Adverse Event|0
1507216|NCT00430495|4955247|P3|Overall Study|Adverse Event|2
1507217|NCT00430495|4955248|P2|Overall Study|Adverse Event|3
1507218|NCT00430495|4955249|P1|Overall Study|Adverse Event|2
1507219|NCT00430352|4955287|P1|Overall Study|Not specified|48
1507220|NCT00430352|4955287|P1|Overall Study|Death|5
1507221|NCT00430352|4955287|P1|Overall Study|Adverse Event|16
1507222|NCT00430352|4955287|P1|Overall Study|Withdrawal by Subject|11
1507223|NCT00430352|4955287|P1|Overall Study|Disease progression|58
1507224|NCT00430300|4955305|P4|Overall Study|Other|1
1507225|NCT00430300|4955306|P3|Overall Study|Other|0
1507226|NCT00430300|4955307|P2|Overall Study|Other|0
1507227|NCT00430300|4955308|P1|Overall Study|Other|0
1507228|NCT00430300|4955305|P4|Overall Study|Laboratory abnormality|0
1507229|NCT00430300|4955306|P3|Overall Study|Laboratory abnormality|0
1507230|NCT00430300|4955307|P2|Overall Study|Laboratory abnormality|0
1507231|NCT00430300|4955308|P1|Overall Study|Laboratory abnormality|1
1507232|NCT00430300|4955305|P4|Overall Study|Withdrawal by Subject|0
1507233|NCT00430300|4955306|P3|Overall Study|Withdrawal by Subject|5
1507234|NCT00430300|4955307|P2|Overall Study|Withdrawal by Subject|0
1507235|NCT00430300|4955308|P1|Overall Study|Withdrawal by Subject|1
1507236|NCT00430300|4955305|P4|Overall Study|Adverse Event|1
1507237|NCT00430300|4955306|P3|Overall Study|Adverse Event|1
1507238|NCT00430300|4955307|P2|Overall Study|Adverse Event|2
1507239|NCT00430300|4955308|P1|Overall Study|Adverse Event|0
1507240|NCT00430248|4955413|P3|Overall Study|Reason Not Specified|11
1507241|NCT00430248|4955414|P2|Overall Study|Reason Not Specified|8
1507242|NCT00430248|4955415|P1|Overall Study|Reason Not Specified|8
1507243|NCT00430248|4955413|P3|Overall Study|Gout Flare|2
1507244|NCT00430248|4955414|P2|Overall Study|Gout Flare|7
1507245|NCT00430248|4955415|P1|Overall Study|Gout Flare|3
1507246|NCT00430248|4955413|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1507247|NCT00430248|4955414|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
1507248|NCT00430248|4955415|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1507249|NCT00430248|4955413|P3|Overall Study|Withdrawal by Subject|16
1507250|NCT00430248|4955414|P2|Overall Study|Withdrawal by Subject|20
1507251|NCT00430248|4955415|P1|Overall Study|Withdrawal by Subject|14
1507252|NCT00430248|4955413|P3|Overall Study|Therapeutic Failure|1
1507253|NCT00430248|4955414|P2|Overall Study|Therapeutic Failure|1
1507254|NCT00430248|4955415|P1|Overall Study|Therapeutic Failure|1
1507255|NCT00430248|4955413|P3|Overall Study|Lost to Follow-up|28
1507256|NCT00430248|4955414|P2|Overall Study|Lost to Follow-up|33
1507257|NCT00430248|4955415|P1|Overall Study|Lost to Follow-up|28
1507258|NCT00430248|4955413|P3|Overall Study|Personal Reasons|9
1507259|NCT00430248|4955414|P2|Overall Study|Personal Reasons|24
1507260|NCT00430248|4955415|P1|Overall Study|Personal Reasons|12
1507261|NCT00430248|4955413|P3|Overall Study|Protocol Violation|4
1507262|NCT00430248|4955414|P2|Overall Study|Protocol Violation|2
1507263|NCT00430248|4955415|P1|Overall Study|Protocol Violation|10
1507264|NCT00430248|4955413|P3|Overall Study|Adverse Event|64
1507265|NCT00430248|4955414|P2|Overall Study|Adverse Event|61
1507266|NCT00430248|4955415|P1|Overall Study|Adverse Event|49
1507267|NCT00430092|4955474|P3|Overall Study|Withdrawal by Subject|1
1507268|NCT00430092|4955475|P2|Overall Study|Withdrawal by Subject|1
1507269|NCT00430092|4955476|P1|Overall Study|Withdrawal by Subject|0
1507270|NCT00430092|4955474|P3|Overall Study|Protocol Violation|1
1507271|NCT00430092|4955475|P2|Overall Study|Protocol Violation|1
1507272|NCT00430092|4955476|P1|Overall Study|Protocol Violation|0
1507273|NCT00430092|4955474|P3|Overall Study|Lost to Follow-up|0
1507274|NCT00430092|4955475|P2|Overall Study|Lost to Follow-up|0
1507275|NCT00430092|4955476|P1|Overall Study|Lost to Follow-up|1
1507276|NCT00430092|4955474|P3|Overall Study|Lack of Efficacy|54
1507277|NCT00430092|4955475|P2|Overall Study|Lack of Efficacy|2
1507278|NCT00430092|4955476|P1|Overall Study|Lack of Efficacy|5
1507279|NCT00430092|4955474|P3|Overall Study|Adverse Event|1
1507280|NCT00430092|4955475|P2|Overall Study|Adverse Event|0
1507281|NCT00430092|4955476|P1|Overall Study|Adverse Event|0
1507282|NCT00430027|4955481|P1|Overall Study|Study terminated|8
1507283|NCT00429923|4955498|P3|Overall Study|Early Termination|0
1507284|NCT00429923|4955499|P2|Overall Study|Early Termination|1
1507285|NCT00429923|4955500|P1|Overall Study|Early Termination|0
1507286|NCT00429923|4955498|P3|Overall Study|Withdrew Consent|1
1507287|NCT00429923|4955499|P2|Overall Study|Withdrew Consent|0
1507288|NCT00429923|4955500|P1|Overall Study|Withdrew Consent|1
1507289|NCT00429923|4955498|P3|Overall Study|Lost to Follow-up|2
1507290|NCT00429923|4955499|P2|Overall Study|Lost to Follow-up|0
1507291|NCT00429923|4955500|P1|Overall Study|Lost to Follow-up|0
1507292|NCT00429923|4955498|P3|Overall Study|Lack of Efficacy|33
1507293|NCT00429923|4955499|P2|Overall Study|Lack of Efficacy|1
1507294|NCT00429923|4955500|P1|Overall Study|Lack of Efficacy|4
1507295|NCT00429923|4955498|P3|Overall Study|Adverse Event|3
1507296|NCT00429923|4955499|P2|Overall Study|Adverse Event|2
1507297|NCT00429923|4955500|P1|Overall Study|Adverse Event|0
1507298|NCT00429793|4955505|P1|Overall Study|Non-measurable|1
1507299|NCT00429793|4955505|P1|Overall Study|Never treated|1
1507300|NCT00429793|4955505|P1|Overall Study|Required test not done|1
1507301|NCT00429793|4955505|P1|Overall Study|Improper pre-protocol treatment|3
1507302|NCT00429663|4955532|P2|Overall Study|Death|0
1507303|NCT00429663|4955533|P1|Overall Study|Death|4
1507304|NCT00429663|4955532|P2|Overall Study|Withdrawal by Subject|5
1507305|NCT00429663|4955533|P1|Overall Study|Withdrawal by Subject|2
1507306|NCT00429663|4955532|P2|Overall Study|Physician Decision|3
1507307|NCT00429663|4955533|P1|Overall Study|Physician Decision|6
1507308|NCT00429663|4955532|P2|Overall Study|Lost to Follow-up|31
1507309|NCT00429663|4955533|P1|Overall Study|Lost to Follow-up|24
1507310|NCT00429572|4955547|P1|Overall Study|Disease progression|1
1507311|NCT00429494|4955559|P1|Overall Study|Death|6
1507312|NCT00429494|4955559|P1|Overall Study|Withdrawal by Subject|9
1507313|NCT00429416|4955563|P1|Overall Study|Death|1
1507314|NCT00429364|4955582|P2|Overall Study|Pregnancy|1
1507315|NCT00429364|4955583|P1|Overall Study|Pregnancy|0
1507316|NCT00429364|4955582|P2|Overall Study|Underwent aortic root surgery|18
1507317|NCT00429364|4955583|P1|Overall Study|Underwent aortic root surgery|10
1507318|NCT00429364|4955582|P2|Overall Study|Death|1
1507319|NCT00429364|4955583|P1|Overall Study|Death|0
1507320|NCT00429364|4955582|P2|Overall Study|Lost to Follow-up|6
1507321|NCT00429364|4955583|P1|Overall Study|Lost to Follow-up|7
1507322|NCT00429364|4955582|P2|Overall Study|Physician Decision|2
1507323|NCT00429364|4955583|P1|Overall Study|Physician Decision|4
1507324|NCT00429364|4955582|P2|Overall Study|Withdrawal by Subject|5
1507325|NCT00429364|4955583|P1|Overall Study|Withdrawal by Subject|11
1507326|NCT00429299|4955642|P3|Overall Study|Withdrawal by Subject|3
1507327|NCT00429299|4955643|P2|Overall Study|Withdrawal by Subject|1
1507328|NCT00429299|4955644|P1|Overall Study|Withdrawal by Subject|0
1507329|NCT00429299|4955642|P3|Overall Study|Protocol Violation|0
1507330|NCT00429299|4955643|P2|Overall Study|Protocol Violation|0
1507331|NCT00429299|4955644|P1|Overall Study|Protocol Violation|1
1507332|NCT00429299|4955642|P3|Overall Study|Adverse Event|1
1507333|NCT00429299|4955643|P2|Overall Study|Adverse Event|5
1507334|NCT00429299|4955644|P1|Overall Study|Adverse Event|2
1507335|NCT00429299|4955642|P3|Overall Study|Disease Progression|0
1507336|NCT00429299|4955643|P2|Overall Study|Disease Progression|1
1507337|NCT00429299|4955644|P1|Overall Study|Disease Progression|1
1507338|NCT00429273|4955676|P3|Overall Study|Adverse Event|2
1507339|NCT00429273|4955677|P2|Overall Study|Adverse Event|1
1507340|NCT00429273|4955678|P1|Overall Study|Adverse Event|1
1507341|NCT00429273|4955676|P3|Overall Study|Physician Decision|5
1507342|NCT00429273|4955677|P2|Overall Study|Physician Decision|5
1507343|NCT00429273|4955678|P1|Overall Study|Physician Decision|6
1507344|NCT00429273|4955676|P3|Overall Study|Lost to Follow-up|2
1507345|NCT00429273|4955677|P2|Overall Study|Lost to Follow-up|2
1507346|NCT00429273|4955678|P1|Overall Study|Lost to Follow-up|1
1507347|NCT00429182|4955686|P1|Overall Study|Not eligible|5
1507348|NCT00429182|4955686|P1|Overall Study|Not evaluable, Disease Progression|2
1507349|NCT00429169|4955693|P2|Overall Study|Ineligibility discovered after entry|1
1507350|NCT00429169|4955694|P1|Overall Study|Ineligibility discovered after entry|2
1507351|NCT00429169|4955693|P2|Overall Study|Lost to Follow-up|1
1507352|NCT00429169|4955694|P1|Overall Study|Lost to Follow-up|0
1507353|NCT00429104|4955712|P1|Overall Study|Protocol Violation|1
1507354|NCT00429026|4955717|P1|Overall Study|Inevaluable for response.|40
1507355|NCT00428948|4955744|P2|Overall Study|Protocol Deviation|1
1507356|NCT00428948|4955745|P1|Overall Study|Protocol Deviation|1
1507357|NCT00428948|4955744|P2|Overall Study|Subject Withdrew Consent|30
1507358|NCT00428948|4955745|P1|Overall Study|Subject Withdrew Consent|50
1507359|NCT00428948|4955744|P2|Overall Study|Investigator Withdrew Subject|4
1507360|NCT00428948|4955745|P1|Overall Study|Investigator Withdrew Subject|3
1507361|NCT00428948|4955744|P2|Overall Study|Subject Met Withdrawal Criteria|0
1507362|NCT00428948|4955745|P1|Overall Study|Subject Met Withdrawal Criteria|4
1507363|NCT00428948|4955744|P2|Overall Study|Adverse Event|24
1507364|NCT00428948|4955745|P1|Overall Study|Adverse Event|148
1507365|NCT00428948|4955744|P2|Overall Study|Lost to Follow-up|8
1507366|NCT00428948|4955745|P1|Overall Study|Lost to Follow-up|15
1507367|NCT00428844|4955773|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
1507368|NCT00428844|4955774|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
1507369|NCT00428844|4955775|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
1507370|NCT00428844|4955773|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
1507371|NCT00428844|4955774|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
1507372|NCT00428844|4955775|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
1507373|NCT00428844|4955773|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
1507374|NCT00428844|4955774|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
1507375|NCT00428844|4955775|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
1507376|NCT00428844|4955773|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
1507377|NCT00428844|4955774|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
1507378|NCT00428844|4955775|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
1507379|NCT00428844|4955773|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
1507380|NCT00428844|4955774|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
1507381|NCT00428844|4955775|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
1507382|NCT00428844|4955773|P3|Completed Study Drug Treatment|Randomized Not Treated|1
1507383|NCT00428844|4955774|P2|Completed Study Drug Treatment|Randomized Not Treated|0
1507384|NCT00428844|4955775|P1|Completed Study Drug Treatment|Randomized Not Treated|0
1507385|NCT00428844|4955773|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
1507386|NCT00428844|4955774|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
1507387|NCT00428844|4955775|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
1507388|NCT00428844|4955773|P3|Completed Study Drug Treatment|Protocol Violation|1
1507476|NCT00428116|4956006|P2|Overall Study|Lost to Follow-up|0
1507389|NCT00428844|4955774|P2|Completed Study Drug Treatment|Protocol Violation|1
1507390|NCT00428844|4955775|P1|Completed Study Drug Treatment|Protocol Violation|0
1507391|NCT00428844|4955773|P3|Completed Study Drug Treatment|Adverse Event|4
1507392|NCT00428844|4955774|P2|Completed Study Drug Treatment|Adverse Event|4
1507393|NCT00428844|4955775|P1|Completed Study Drug Treatment|Adverse Event|2
1507394|NCT00428792|4955798|P2|Overall Study|Lost to Follow-up|1
1507395|NCT00428792|4955799|P1|Overall Study|Lost to Follow-up|0
1507396|NCT00428792|4955798|P2|Overall Study|Lack of Efficacy|3
1507397|NCT00428792|4955799|P1|Overall Study|Lack of Efficacy|1
1507398|NCT00428610|4955826|P3|Overall Study|Withdrawal by Subject|0
1507399|NCT00428610|4955827|P2|Overall Study|Withdrawal by Subject|0
1507400|NCT00428610|4955828|P1|Overall Study|Withdrawal by Subject|4
1507401|NCT00428610|4955826|P3|Overall Study|Progressive Disease|22
1507402|NCT00428610|4955827|P2|Overall Study|Progressive Disease|14
1507403|NCT00428610|4955828|P1|Overall Study|Progressive Disease|42
1507404|NCT00428610|4955826|P3|Overall Study|Investigator Decision|1
1507405|NCT00428610|4955827|P2|Overall Study|Investigator Decision|1
1507406|NCT00428610|4955828|P1|Overall Study|Investigator Decision|2
1507407|NCT00428610|4955826|P3|Overall Study|Adverse Event|2
1507408|NCT00428610|4955827|P2|Overall Study|Adverse Event|3
1507409|NCT00428610|4955828|P1|Overall Study|Adverse Event|2
1507410|NCT00428610|4955826|P3|Overall Study|Death Due to Progressive Disease|2
1507411|NCT00428610|4955827|P2|Overall Study|Death Due to Progressive Disease|0
1507412|NCT00428610|4955828|P1|Overall Study|Death Due to Progressive Disease|0
1507413|NCT00428610|4955826|P3|Overall Study|Death Due to Adverse Event|5
1507414|NCT00428610|4955827|P2|Overall Study|Death Due to Adverse Event|0
1507415|NCT00428610|4955828|P1|Overall Study|Death Due to Adverse Event|3
1507416|NCT00428597|4955862|P2|Overall Study|Death|3
1507417|NCT00428597|4955863|P1|Overall Study|Death|1
1507418|NCT00428597|4955862|P2|Overall Study|Pregnancy|0
1507419|NCT00428597|4955863|P1|Overall Study|Pregnancy|1
1507420|NCT00428597|4955862|P2|Overall Study|Lost to Follow-up|1
1507421|NCT00428597|4955863|P1|Overall Study|Lost to Follow-up|0
1507422|NCT00428597|4955862|P2|Overall Study|Other|1
1507423|NCT00428597|4955863|P1|Overall Study|Other|1
1507424|NCT00428597|4955862|P2|Overall Study|Withdrawal by Subject|1
1507425|NCT00428597|4955863|P1|Overall Study|Withdrawal by Subject|2
1507426|NCT00428597|4955862|P2|Overall Study|Protocol Violation|1
1507427|NCT00428597|4955863|P1|Overall Study|Protocol Violation|2
1507428|NCT00428597|4955862|P2|Overall Study|Global Deterioration of Health Status|5
1507429|NCT00428597|4955863|P1|Overall Study|Global Deterioration of Health Status|1
1507430|NCT00428597|4955862|P2|Overall Study|Adverse Event|7
1507431|NCT00428597|4955863|P1|Overall Study|Adverse Event|15
1507432|NCT00428597|4955862|P2|Overall Study|Study Terminated by Sponsor|16
1507433|NCT00428597|4955863|P1|Overall Study|Study Terminated by Sponsor|41
1507434|NCT00428597|4955862|P2|Overall Study|Objective Progression or Relapse|47
1507435|NCT00428597|4955863|P1|Overall Study|Objective Progression or Relapse|19
1507436|NCT00428597|4955862|P2|Overall Study|Randomized but not treated|3
1507437|NCT00428597|4955863|P1|Overall Study|Randomized but not treated|3
1507438|NCT00428441|4955930|P1|Overall Study|Lost to Follow-up|1
1507439|NCT00428389|4955936|P2|Extension Phase|Administrative problems|1
1507440|NCT00428389|4955937|P1|Extension Phase|Administrative problems|1
1507441|NCT00428389|4955936|P2|Extension Phase|Protocol Violation|2
1507442|NCT00428389|4955937|P1|Extension Phase|Protocol Violation|3
1507443|NCT00428389|4955936|P2|Extension Phase|Death|0
1507444|NCT00428389|4955937|P1|Extension Phase|Death|1
1507445|NCT00428389|4955936|P2|Extension Phase|Lost to Follow-up|3
1507446|NCT00428389|4955937|P1|Extension Phase|Lost to Follow-up|0
1507447|NCT00428389|4955936|P2|Extension Phase|Withdrawal by Subject|6
1507448|NCT00428389|4955937|P1|Extension Phase|Withdrawal by Subject|6
1507449|NCT00428389|4955936|P2|Extension Phase|Lack of Efficacy|3
1507450|NCT00428389|4955937|P1|Extension Phase|Lack of Efficacy|4
1507451|NCT00428389|4955936|P2|Extension Phase|Adverse Event|11
1507452|NCT00428389|4955937|P1|Extension Phase|Adverse Event|17
1507453|NCT00428389|4955936|P2|Core Phase|Protocol deviation|2
1507454|NCT00428389|4955937|P1|Core Phase|Protocol deviation|0
1507455|NCT00428389|4955936|P2|Core Phase|Withdrawal by Subject|4
1507456|NCT00428389|4955937|P1|Core Phase|Withdrawal by Subject|3
1507457|NCT00428389|4955936|P2|Core Phase|Abnormal test procedure result(s)|1
1507458|NCT00428389|4955937|P1|Core Phase|Abnormal test procedure result(s)|0
1507459|NCT00428389|4955936|P2|Core Phase|Lack of Efficacy|0
1507460|NCT00428389|4955937|P1|Core Phase|Lack of Efficacy|2
1507461|NCT00428389|4955936|P2|Core Phase|Adverse Event|4
1507462|NCT00428389|4955937|P1|Core Phase|Adverse Event|6
1507463|NCT00428246|4955971|P3|Overall Study|Adverse Event|0
1507464|NCT00428246|4955972|P2|Overall Study|Adverse Event|0
1507465|NCT00428246|4955973|P1|Overall Study|Adverse Event|1
1507466|NCT00428246|4955971|P3|Overall Study|Withdrawal by Subject|1
1507467|NCT00428246|4955972|P2|Overall Study|Withdrawal by Subject|0
1507468|NCT00428246|4955973|P1|Overall Study|Withdrawal by Subject|0
1507469|NCT00428220|4955981|P1|Overall Study|Other|23
1507470|NCT00428220|4955981|P1|Overall Study|Adverse Event|51
1507471|NCT00428220|4955981|P1|Overall Study|Participant refused continued treatment|7
1507472|NCT00428220|4955981|P1|Overall Study|Objective progression or relapse|123
1507473|NCT00428220|4955981|P1|Overall Study|Lost to Follow-up|4
1507474|NCT00428220|4955981|P1|Overall Study|Global deterioration of health status|7
1507475|NCT00428220|4955981|P1|Overall Study|Participant died|8
1507477|NCT00428116|4956007|P1|Overall Study|Lost to Follow-up|1
1507478|NCT00428116|4956006|P2|Overall Study|Withdrawal by Subject|0
1507479|NCT00428116|4956007|P1|Overall Study|Withdrawal by Subject|1
1507480|NCT00428116|4956006|P2|Overall Study|Death|0
1507481|NCT00428116|4956007|P1|Overall Study|Death|1
1507482|NCT00428090|4956019|P4|Overall Study|Raised Creatinine Value|1
1507483|NCT00428090|4956020|P3|Overall Study|Raised Creatinine Value|0
1507484|NCT00428090|4956021|P2|Overall Study|Raised Creatinine Value|0
1507485|NCT00428090|4956022|P1|Overall Study|Raised Creatinine Value|0
1507486|NCT00428090|4956019|P4|Overall Study|Excluded for heart insufficiency|0
1507487|NCT00428090|4956020|P3|Overall Study|Excluded for heart insufficiency|1
1507488|NCT00428090|4956021|P2|Overall Study|Excluded for heart insufficiency|0
1507489|NCT00428090|4956022|P1|Overall Study|Excluded for heart insufficiency|0
1507490|NCT00428090|4956019|P4|Overall Study|Serious adverse event|0
1507491|NCT00428090|4956020|P3|Overall Study|Serious adverse event|1
1507492|NCT00428090|4956021|P2|Overall Study|Serious adverse event|0
1507493|NCT00428090|4956022|P1|Overall Study|Serious adverse event|0
1507494|NCT00428090|4956019|P4|Overall Study|Deterioration of cognitive status|0
1507495|NCT00428090|4956020|P3|Overall Study|Deterioration of cognitive status|1
1507496|NCT00428090|4956021|P2|Overall Study|Deterioration of cognitive status|0
1507497|NCT00428090|4956022|P1|Overall Study|Deterioration of cognitive status|0
1507498|NCT00428090|4956019|P4|Overall Study|High MMSE scores|0
1507499|NCT00428090|4956020|P3|Overall Study|High MMSE scores|1
1507500|NCT00428090|4956021|P2|Overall Study|High MMSE scores|0
1507501|NCT00428090|4956022|P1|Overall Study|High MMSE scores|0
1507502|NCT00428090|4956019|P4|Overall Study|Insufficient AD documentation|0
1507503|NCT00428090|4956020|P3|Overall Study|Insufficient AD documentation|1
1507504|NCT00428090|4956021|P2|Overall Study|Insufficient AD documentation|0
1507505|NCT00428090|4956022|P1|Overall Study|Insufficient AD documentation|0
1507506|NCT00428090|4956019|P4|Overall Study|Excluded for concerning QTc value|0
1507507|NCT00428090|4956020|P3|Overall Study|Excluded for concerning QTc value|1
1507508|NCT00428090|4956021|P2|Overall Study|Excluded for concerning QTc value|0
1507509|NCT00428090|4956022|P1|Overall Study|Excluded for concerning QTc value|0
1507510|NCT00428090|4956019|P4|Overall Study|Worsening of AD|0
1507511|NCT00428090|4956020|P3|Overall Study|Worsening of AD|1
1507512|NCT00428090|4956021|P2|Overall Study|Worsening of AD|0
1507513|NCT00428090|4956022|P1|Overall Study|Worsening of AD|0
1507514|NCT00428090|4956019|P4|Overall Study|Mental status of par. was|0
1507515|NCT00428090|4956020|P3|Overall Study|Mental status of par. was|0
1507516|NCT00428090|4956021|P2|Overall Study|Mental status of par. was|1
1507517|NCT00428090|4956022|P1|Overall Study|Mental status of par. was|0
1507518|NCT00428090|4956019|P4|Overall Study|Medical monitor terminated par.|0
1507519|NCT00428090|4956020|P3|Overall Study|Medical monitor terminated par.|0
1507520|NCT00428090|4956021|P2|Overall Study|Medical monitor terminated par.|1
1507521|NCT00428090|4956022|P1|Overall Study|Medical monitor terminated par.|0
1507522|NCT00428090|4956019|P4|Overall Study|Visit 7 exceed the visit window|0
1507523|NCT00428090|4956020|P3|Overall Study|Visit 7 exceed the visit window|0
1507524|NCT00428090|4956021|P2|Overall Study|Visit 7 exceed the visit window|1
1507525|NCT00428090|4956022|P1|Overall Study|Visit 7 exceed the visit window|0
1507526|NCT00428090|4956019|P4|Overall Study|Death of par.|0
1507527|NCT00428090|4956020|P3|Overall Study|Death of par.|1
1507528|NCT00428090|4956021|P2|Overall Study|Death of par.|0
1507529|NCT00428090|4956022|P1|Overall Study|Death of par.|1
1507530|NCT00428090|4956019|P4|Overall Study|Prohibited medication used for SAE|0
1507531|NCT00428090|4956020|P3|Overall Study|Prohibited medication used for SAE|0
1507532|NCT00428090|4956021|P2|Overall Study|Prohibited medication used for SAE|0
1507533|NCT00428090|4956022|P1|Overall Study|Prohibited medication used for SAE|1
1507534|NCT00428090|4956019|P4|Overall Study|Follow-Up visit not possible|0
1507535|NCT00428090|4956020|P3|Overall Study|Follow-Up visit not possible|0
1507536|NCT00428090|4956021|P2|Overall Study|Follow-Up visit not possible|0
1507537|NCT00428090|4956022|P1|Overall Study|Follow-Up visit not possible|1
1507538|NCT00428090|4956019|P4|Overall Study|Par. did not returned to visit|1
1507539|NCT00428090|4956020|P3|Overall Study|Par. did not returned to visit|0
1507540|NCT00428090|4956021|P2|Overall Study|Par. did not returned to visit|0
1507541|NCT00428090|4956022|P1|Overall Study|Par. did not returned to visit|1
1507542|NCT00428090|4956019|P4|Overall Study|Non-compliance|3
1507543|NCT00428090|4956020|P3|Overall Study|Non-compliance|1
1507544|NCT00428090|4956021|P2|Overall Study|Non-compliance|0
1507545|NCT00428090|4956022|P1|Overall Study|Non-compliance|4
1507546|NCT00428090|4956019|P4|Overall Study|Sponsor terminated study|0
1507547|NCT00428090|4956020|P3|Overall Study|Sponsor terminated study|0
1507548|NCT00428090|4956021|P2|Overall Study|Sponsor terminated study|1
1507549|NCT00428090|4956022|P1|Overall Study|Sponsor terminated study|0
1507550|NCT00428090|4956019|P4|Overall Study|Withdrawal by Subject|5
1507551|NCT00428090|4956020|P3|Overall Study|Withdrawal by Subject|15
1507552|NCT00428090|4956021|P2|Overall Study|Withdrawal by Subject|12
1507553|NCT00428090|4956022|P1|Overall Study|Withdrawal by Subject|10
1507554|NCT00428090|4956019|P4|Overall Study|Protocol Violation|3
1507555|NCT00428090|4956020|P3|Overall Study|Protocol Violation|3
1507556|NCT00428090|4956021|P2|Overall Study|Protocol Violation|1
1507557|NCT00428090|4956022|P1|Overall Study|Protocol Violation|3
1507558|NCT00428090|4956019|P4|Overall Study|Lost to Follow-up|4
1507559|NCT00428090|4956020|P3|Overall Study|Lost to Follow-up|1
1507560|NCT00428090|4956021|P2|Overall Study|Lost to Follow-up|6
1507561|NCT00428090|4956022|P1|Overall Study|Lost to Follow-up|3
1507562|NCT00428090|4956019|P4|Overall Study|Adverse Event|11
1507563|NCT00428090|4956020|P3|Overall Study|Adverse Event|10
1507564|NCT00428090|4956021|P2|Overall Study|Adverse Event|8
1507565|NCT00428090|4956022|P1|Overall Study|Adverse Event|10
1507566|NCT00427999|4956140|P1|Overall Study|Death|1
1507567|NCT00427999|4956140|P1|Overall Study|Withdrawal by Subject|9
1507568|NCT00427999|4956140|P1|Overall Study|Protocol Violation|2
1507569|NCT00427999|4956140|P1|Overall Study|Unsatisfactory therapeutic effect|13
1507570|NCT00427999|4956140|P1|Overall Study|Abnormal laboratory values|1
1507571|NCT00427999|4956140|P1|Overall Study|Adverse Event|6
1507572|NCT00427960|4956158|P2|Overall Study|Not Specified|1
1507573|NCT00427960|4956159|P1|Overall Study|Not Specified|0
1507574|NCT00427960|4956158|P2|Overall Study|Withdrawal by Subject|3
1507575|NCT00427960|4956159|P1|Overall Study|Withdrawal by Subject|0
1507576|NCT00427960|4956158|P2|Overall Study|Adverse Event|0
1507577|NCT00427960|4956159|P1|Overall Study|Adverse Event|2
1507578|NCT00427934|4956197|P4|Overall Study|Withdrawal by Subject|3
1507579|NCT00427934|4956198|P3|Overall Study|Withdrawal by Subject|1
1507580|NCT00427934|4956199|P2|Overall Study|Withdrawal by Subject|0
1507581|NCT00427934|4956200|P1|Overall Study|Withdrawal by Subject|0
1507582|NCT00427934|4956197|P4|Overall Study|Other|5
1507583|NCT00427934|4956198|P3|Overall Study|Other|11
1507584|NCT00427934|4956199|P2|Overall Study|Other|0
1507585|NCT00427934|4956200|P1|Overall Study|Other|0
1507586|NCT00427934|4956197|P4|Overall Study|Randomized But Did Not Receive Treatment|1
1507587|NCT00427934|4956198|P3|Overall Study|Randomized But Did Not Receive Treatment|1
1507588|NCT00427934|4956199|P2|Overall Study|Randomized But Did Not Receive Treatment|0
1507589|NCT00427934|4956200|P1|Overall Study|Randomized But Did Not Receive Treatment|0
1507590|NCT00427934|4956197|P4|Overall Study|Lack of Efficacy|2
1507591|NCT00427934|4956198|P3|Overall Study|Lack of Efficacy|5
1507592|NCT00427934|4956199|P2|Overall Study|Lack of Efficacy|0
1507593|NCT00427934|4956200|P1|Overall Study|Lack of Efficacy|0
1507594|NCT00427934|4956197|P4|Overall Study|Adverse Event|4
1507595|NCT00427934|4956198|P3|Overall Study|Adverse Event|5
1507596|NCT00427934|4956199|P2|Overall Study|Adverse Event|0
1507597|NCT00427934|4956200|P1|Overall Study|Adverse Event|1
1507598|NCT00427921|4956268|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
1507599|NCT00427921|4956268|P1|Overall Study|Adverse Event + Withdrawn from Study|1
1507600|NCT00427921|4956268|P1|Overall Study|Adverse Event + Lost Response|1
1507601|NCT00427921|4956268|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
1507602|NCT00427921|4956268|P1|Overall Study|Adverse Event + Worsening of CD|1
1507603|NCT00427921|4956268|P1|Overall Study|Adverse Event + No Response|1
1507604|NCT00427921|4956268|P1|Overall Study|Adverse Event + Withdrew Consent|1
1507605|NCT00427921|4956268|P1|Overall Study|Adverse Event + Hospitalization|1
1507606|NCT00427921|4956268|P1|Overall Study|Other reason not specified|10
1507607|NCT00427921|4956268|P1|Overall Study|Lost to Follow-up|2
1507608|NCT00427921|4956268|P1|Overall Study|Withdrawal by Subject|4
1507609|NCT00427921|4956268|P1|Overall Study|Adverse Event|26
1507610|NCT00427908|4956291|P4|Primary Phase|Adverse Event|0
1507611|NCT00427908|4956292|P3|Primary Phase|Adverse Event|0
1507612|NCT00427908|4956293|P2|Primary Phase|Adverse Event|1
1507613|NCT00427908|4956294|P1|Primary Phase|Adverse Event|0
1507614|NCT00427908|4956291|P4|Primary Phase|Withdrawal by Subject|0
1507615|NCT00427908|4956292|P3|Primary Phase|Withdrawal by Subject|1
1507616|NCT00427908|4956293|P2|Primary Phase|Withdrawal by Subject|2
1507617|NCT00427908|4956294|P1|Primary Phase|Withdrawal by Subject|1
1507618|NCT00427908|4956291|P4|Primary Phase|Lost to Follow-up|0
1507619|NCT00427908|4956292|P3|Primary Phase|Lost to Follow-up|2
1507620|NCT00427908|4956293|P2|Primary Phase|Lost to Follow-up|0
1507621|NCT00427908|4956294|P1|Primary Phase|Lost to Follow-up|4
1507622|NCT00427895|4956494|P8|Vax 2/Year 3 to 4|Failed to Return|0
1507623|NCT00427895|4956495|P7|Vax 2/Year 3 to 4|Failed to Return|0
1507624|NCT00427895|4956496|P6|Vax 2/Year 3 to 4|Failed to Return|0
1507625|NCT00427895|4956497|P5|Vax 2/Year 3 to 4|Failed to Return|1
1507626|NCT00427895|4956498|P4|Vax 2/Year 3 to 4|Failed to Return|0
1507627|NCT00427895|4956499|P3|Vax 2/Year 3 to 4|Failed to Return|0
1507628|NCT00427895|4956500|P2|Vax 2/Year 3 to 4|Failed to Return|0
1507629|NCT00427895|4956501|P1|Vax 2/Year 3 to 4|Failed to Return|0
1507630|NCT00427895|4956494|P8|Vax 2/Year 3 to 4|Protocol Violation|1
1507631|NCT00427895|4956495|P7|Vax 2/Year 3 to 4|Protocol Violation|0
1507632|NCT00427895|4956496|P6|Vax 2/Year 3 to 4|Protocol Violation|0
1507633|NCT00427895|4956497|P5|Vax 2/Year 3 to 4|Protocol Violation|0
1507634|NCT00427895|4956498|P4|Vax 2/Year 3 to 4|Protocol Violation|0
1507635|NCT00427895|4956499|P3|Vax 2/Year 3 to 4|Protocol Violation|0
1507636|NCT00427895|4956500|P2|Vax 2/Year 3 to 4|Protocol Violation|0
1507637|NCT00427895|4956501|P1|Vax 2/Year 3 to 4|Protocol Violation|0
1507638|NCT00427895|4956494|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
1507639|NCT00427895|4956495|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
1507640|NCT00427895|4956496|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
1507641|NCT00427895|4956497|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
1507642|NCT00427895|4956498|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
1507643|NCT00427895|4956499|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
1507644|NCT00427895|4956500|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
1507645|NCT00427895|4956501|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
1507646|NCT00427895|4956494|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1507804|NCT00426842|4956703|P1|Overall Study|Lost to Follow-up|1
1507647|NCT00427895|4956495|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1507648|NCT00427895|4956496|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1507649|NCT00427895|4956497|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1507650|NCT00427895|4956498|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
1507651|NCT00427895|4956499|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
1507652|NCT00427895|4956500|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
1507653|NCT00427895|4956501|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
1507654|NCT00427895|4956494|P8|Vax 1/Year 1 Follow-up|Other|0
1507655|NCT00427895|4956495|P7|Vax 1/Year 1 Follow-up|Other|0
1507656|NCT00427895|4956496|P6|Vax 1/Year 1 Follow-up|Other|0
1507657|NCT00427895|4956497|P5|Vax 1/Year 1 Follow-up|Other|0
1507658|NCT00427895|4956498|P4|Vax 1/Year 1 Follow-up|Other|2
1507659|NCT00427895|4956499|P3|Vax 1/Year 1 Follow-up|Other|0
1507660|NCT00427895|4956500|P2|Vax 1/Year 1 Follow-up|Other|0
1507661|NCT00427895|4956501|P1|Vax 1/Year 1 Follow-up|Other|0
1507662|NCT00427895|4956494|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
1507663|NCT00427895|4956495|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
1507664|NCT00427895|4956496|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
1507665|NCT00427895|4956497|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
1507666|NCT00427895|4956498|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
1507667|NCT00427895|4956499|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
1507668|NCT00427895|4956500|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
1507669|NCT00427895|4956501|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
1507670|NCT00427895|4956494|P8|Vax 1/Year 1 Follow-up|Death|0
1507671|NCT00427895|4956495|P7|Vax 1/Year 1 Follow-up|Death|0
1507672|NCT00427895|4956496|P6|Vax 1/Year 1 Follow-up|Death|0
1507673|NCT00427895|4956497|P5|Vax 1/Year 1 Follow-up|Death|0
1507674|NCT00427895|4956498|P4|Vax 1/Year 1 Follow-up|Death|0
1507675|NCT00427895|4956499|P3|Vax 1/Year 1 Follow-up|Death|0
1507676|NCT00427895|4956500|P2|Vax 1/Year 1 Follow-up|Death|0
1507677|NCT00427895|4956501|P1|Vax 1/Year 1 Follow-up|Death|1
1507678|NCT00427895|4956494|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
1507679|NCT00427895|4956495|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
1507680|NCT00427895|4956496|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
1507681|NCT00427895|4956497|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
1507682|NCT00427895|4956498|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
1507683|NCT00427895|4956499|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
1507684|NCT00427895|4956500|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
1507685|NCT00427895|4956501|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
1507686|NCT00427895|4956494|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1507687|NCT00427895|4956495|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1507688|NCT00427895|4956496|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1507689|NCT00427895|4956497|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1507690|NCT00427895|4956498|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
1507691|NCT00427895|4956499|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
1507692|NCT00427895|4956500|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
1507693|NCT00427895|4956501|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
1507694|NCT00427895|4956494|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
1507695|NCT00427895|4956495|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
1507696|NCT00427895|4956496|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
1507697|NCT00427895|4956497|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
1507698|NCT00427895|4956498|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
1507699|NCT00427895|4956499|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
1507700|NCT00427895|4956500|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
1507701|NCT00427895|4956501|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
1507702|NCT00427895|4956494|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1507703|NCT00427895|4956495|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1507704|NCT00427895|4956496|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1507705|NCT00427895|4956497|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1507706|NCT00427895|4956498|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
1507707|NCT00427895|4956499|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
1507708|NCT00427895|4956500|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
1507709|NCT00427895|4956501|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1507710|NCT00427895|4956494|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1507711|NCT00427895|4956495|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1507712|NCT00427895|4956496|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1507713|NCT00427895|4956497|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1507714|NCT00427895|4956498|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
1507715|NCT00427895|4956499|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1507716|NCT00427895|4956500|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1507717|NCT00427895|4956501|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1507718|NCT00427895|4956494|P8|Vax 1 Baseline/6-Month Follow-up|Other|0
1507719|NCT00427895|4956495|P7|Vax 1 Baseline/6-Month Follow-up|Other|0
1507720|NCT00427895|4956496|P6|Vax 1 Baseline/6-Month Follow-up|Other|0
1507721|NCT00427895|4956497|P5|Vax 1 Baseline/6-Month Follow-up|Other|0
1507722|NCT00427895|4956498|P4|Vax 1 Baseline/6-Month Follow-up|Other|2
1507723|NCT00427895|4956499|P3|Vax 1 Baseline/6-Month Follow-up|Other|1
1507724|NCT00427895|4956500|P2|Vax 1 Baseline/6-Month Follow-up|Other|0
1507725|NCT00427895|4956501|P1|Vax 1 Baseline/6-Month Follow-up|Other|0
1507726|NCT00427895|4956494|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1507805|NCT00426764|4956709|P1|Overall Study|Other|2
1507727|NCT00427895|4956495|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1507728|NCT00427895|4956496|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1507729|NCT00427895|4956497|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1507730|NCT00427895|4956498|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
1507731|NCT00427895|4956499|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
1507732|NCT00427895|4956500|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
1507733|NCT00427895|4956501|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
1507734|NCT00427895|4956494|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1507735|NCT00427895|4956495|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1507736|NCT00427895|4956496|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1507737|NCT00427895|4956497|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1507738|NCT00427895|4956498|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
1507739|NCT00427895|4956499|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1507740|NCT00427895|4956500|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1507741|NCT00427895|4956501|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1507742|NCT00427895|4956494|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1507743|NCT00427895|4956495|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1507744|NCT00427895|4956496|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1507745|NCT00427895|4956497|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1507746|NCT00427895|4956498|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
1507747|NCT00427895|4956499|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
1507748|NCT00427895|4956500|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
1507749|NCT00427895|4956501|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
1507750|NCT00427895|4956494|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1507751|NCT00427895|4956495|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1507752|NCT00427895|4956496|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1507753|NCT00427895|4956497|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1507754|NCT00427895|4956498|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1507755|NCT00427895|4956499|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1507756|NCT00427895|4956500|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
1507757|NCT00427895|4956501|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
1507758|NCT00427895|4956494|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1507759|NCT00427895|4956495|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1507760|NCT00427895|4956496|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1507761|NCT00427895|4956497|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1507762|NCT00427895|4956498|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
1507763|NCT00427895|4956499|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
1507764|NCT00427895|4956500|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1507765|NCT00427895|4956501|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
1507766|NCT00427895|4956494|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1507767|NCT00427895|4956495|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1507768|NCT00427895|4956496|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1507769|NCT00427895|4956497|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1507770|NCT00427895|4956498|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
1507771|NCT00427895|4956499|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
1507772|NCT00427895|4956500|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
1507773|NCT00427895|4956501|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1507774|NCT00427778|4956576|P2|First Intervention (4 Weeks)|anxious about using ring|0
1507775|NCT00427778|4956577|P1|First Intervention (4 Weeks)|anxious about using ring|1
1507776|NCT00427778|4956576|P2|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
1507777|NCT00427778|4956577|P1|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
1507778|NCT00427778|4956576|P2|First Intervention (4 Weeks)|Not successfully fitted with ring|0
1507779|NCT00427778|4956577|P1|First Intervention (4 Weeks)|Not successfully fitted with ring|2
1507780|NCT00427778|4956576|P2|First Intervention (4 Weeks)|no longer interested|0
1507781|NCT00427778|4956577|P1|First Intervention (4 Weeks)|no longer interested|1
1507782|NCT00427700|4956602|P2|Overall Study|Pregnancy|2
1507783|NCT00427700|4956603|P1|Overall Study|Pregnancy|0
1507784|NCT00427700|4956602|P2|Overall Study|no induction of menses|4
1507785|NCT00427700|4956603|P1|Overall Study|no induction of menses|1
1507786|NCT00427700|4956602|P2|Overall Study|Lost to Follow-up|5
1507787|NCT00427700|4956603|P1|Overall Study|Lost to Follow-up|2
1507788|NCT00427635|4956619|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
1507789|NCT00427635|4956620|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
1507790|NCT00427635|4956619|P2|Treatment Phase|Withdrawal by Subject|0
1507791|NCT00427635|4956620|P1|Treatment Phase|Withdrawal by Subject|1
1507792|NCT00427349|4956652|P1|Overall Study|Never started therapy|1
1507793|NCT00427349|4956652|P1|Overall Study|Ineligible|1
1507794|NCT00427349|4956652|P1|Overall Study|Other|2
1507795|NCT00427349|4956652|P1|Overall Study|Alternative therapy|1
1507796|NCT00427349|4956652|P1|Overall Study|Withdrawal by Subject|3
1507797|NCT00427349|4956652|P1|Overall Study|Death|1
1507798|NCT00427349|4956652|P1|Overall Study|Adverse Event|14
1507799|NCT00427349|4956652|P1|Overall Study|Lack of Efficacy|23
1507800|NCT00427011|4956688|P1|Overall Study|Not specified|12
1507801|NCT00427011|4956688|P1|Overall Study|Lack of Efficacy|2
1507802|NCT00427011|4956688|P1|Overall Study|Withdrawal by Subject|1
1507803|NCT00427011|4956688|P1|Overall Study|Adverse Event|10
1507806|NCT00426764|4956709|P1|Overall Study|Protocol Violation|1
1507807|NCT00426764|4956709|P1|Overall Study|Physician Decision|1
1507808|NCT00426764|4956709|P1|Overall Study|Withdrawal by Subject|3
1507809|NCT00426764|4956709|P1|Overall Study|Adverse Event|19
1507810|NCT00426764|4956709|P1|Overall Study|Progressive disease|72
1507811|NCT00426751|4956725|P2|Overall Study|Other Reasons|12
1507812|NCT00426751|4956726|P1|Overall Study|Other Reasons|7
1507813|NCT00426751|4956725|P2|Overall Study|Consent Withdrawn|1
1507814|NCT00426751|4956726|P1|Overall Study|Consent Withdrawn|0
1507815|NCT00426751|4956725|P2|Overall Study|Lost to Follow-up|6
1507816|NCT00426751|4956726|P1|Overall Study|Lost to Follow-up|7
1507817|NCT00426751|4956725|P2|Overall Study|Adverse Event|1
1507818|NCT00426751|4956726|P1|Overall Study|Adverse Event|8
1507819|NCT00426660|4956770|P1|Overall Study|Enrolled Not Treated|15
1507820|NCT00426660|4956770|P1|Overall Study|Protocol Violation|1
1507821|NCT00426660|4956770|P1|Overall Study|Withdrawal by Subject|18
1507822|NCT00426660|4956770|P1|Overall Study|Other|23
1507823|NCT00426660|4956770|P1|Overall Study|Lost to Follow-up|15
1507824|NCT00426660|4956770|P1|Overall Study|Insufficient Clinical Response|22
1507825|NCT00426660|4956770|P1|Overall Study|Adverse Event|23
1507826|NCT00426660|4956770|P1|Overall Study|Death|14
1507827|NCT00426556|4956801|P4|Phase II - Extension Phase|Adverse Event|2
1507828|NCT00426556|4956802|P3|Phase II - Extension Phase|Adverse Event|0
1507829|NCT00426556|4956803|P2|Phase II - Extension Phase|Adverse Event|0
1507830|NCT00426556|4956804|P1|Phase II - Extension Phase|Adverse Event|0
1507831|NCT00426556|4956801|P4|Phase II - Extension Phase|Disease Progression|21
1507832|NCT00426556|4956802|P3|Phase II - Extension Phase|Disease Progression|0
1507833|NCT00426556|4956803|P2|Phase II - Extension Phase|Disease Progression|0
1507834|NCT00426556|4956804|P1|Phase II - Extension Phase|Disease Progression|0
1507835|NCT00426556|4956801|P4|Phase II - Core Phase|Adverse Event|8
1507836|NCT00426556|4956802|P3|Phase II - Core Phase|Adverse Event|0
1507837|NCT00426556|4956803|P2|Phase II - Core Phase|Adverse Event|0
1507838|NCT00426556|4956804|P1|Phase II - Core Phase|Adverse Event|0
1507839|NCT00426556|4956801|P4|Phase II - Core Phase|Disease Progression|16
1507840|NCT00426556|4956802|P3|Phase II - Core Phase|Disease Progression|0
1507841|NCT00426556|4956803|P2|Phase II - Core Phase|Disease Progression|0
1507842|NCT00426556|4956804|P1|Phase II - Core Phase|Disease Progression|0
1507843|NCT00426556|4956801|P4|Phase II - Core Phase|Withdrawal by Subject|3
1507844|NCT00426556|4956802|P3|Phase II - Core Phase|Withdrawal by Subject|0
1507845|NCT00426556|4956803|P2|Phase II - Core Phase|Withdrawal by Subject|0
1507846|NCT00426556|4956804|P1|Phase II - Core Phase|Withdrawal by Subject|0
1507847|NCT00426556|4956801|P4|Phase I - Extension Phase|Disease Progression|0
1507848|NCT00426556|4956802|P3|Phase I - Extension Phase|Disease Progression|6
1507849|NCT00426556|4956803|P2|Phase I - Extension Phase|Disease Progression|5
1507850|NCT00426556|4956804|P1|Phase I - Extension Phase|Disease Progression|5
1507851|NCT00426556|4956801|P4|Phase I - Extension Phase|Adverse Event|0
1507852|NCT00426556|4956802|P3|Phase I - Extension Phase|Adverse Event|1
1507853|NCT00426556|4956803|P2|Phase I - Extension Phase|Adverse Event|1
1507854|NCT00426556|4956804|P1|Phase I - Extension Phase|Adverse Event|0
1507855|NCT00426556|4956801|P4|Phase I - Core Phase|Death|0
1507856|NCT00426556|4956802|P3|Phase I - Core Phase|Death|0
1507857|NCT00426556|4956803|P2|Phase I - Core Phase|Death|1
1507858|NCT00426556|4956804|P1|Phase I - Core Phase|Death|0
1507859|NCT00426556|4956801|P4|Phase I - Core Phase|Adverse Event|0
1507860|NCT00426556|4956802|P3|Phase I - Core Phase|Adverse Event|1
1507861|NCT00426556|4956803|P2|Phase I - Core Phase|Adverse Event|3
1507862|NCT00426556|4956804|P1|Phase I - Core Phase|Adverse Event|1
1507863|NCT00426556|4956801|P4|Phase I - Core Phase|Disease Progression|0
1507864|NCT00426556|4956802|P3|Phase I - Core Phase|Disease Progression|2
1507865|NCT00426556|4956803|P2|Phase I - Core Phase|Disease Progression|6
1507866|NCT00426556|4956804|P1|Phase I - Core Phase|Disease Progression|0
1507867|NCT00426361|4956829|P3|Overall Study|Withdrawal by Subject|0
1507868|NCT00426361|4956830|P2|Overall Study|Withdrawal by Subject|3
1507869|NCT00426361|4956831|P1|Overall Study|Withdrawal by Subject|1
1507870|NCT00426361|4956829|P3|Overall Study|Lost to Follow-up|5
1507871|NCT00426361|4956830|P2|Overall Study|Lost to Follow-up|2
1507872|NCT00426361|4956831|P1|Overall Study|Lost to Follow-up|3
1507873|NCT00426270|4956890|P1|Overall Study|Adverse Event|5
1507874|NCT00426270|4956890|P1|Overall Study|Incorrectly Enrolled in the Study|1
1507875|NCT00426231|4956900|P2|Overall Study|Withdrawal by Subject|12
1507876|NCT00426231|4956901|P1|Overall Study|Withdrawal by Subject|9
1507877|NCT00426127|4956924|P1|Overall Study|Removed due to disease progression|1
1507878|NCT00426127|4956924|P1|Overall Study|Adverse Event|1
1507879|NCT00425945|4956932|P2|Overall Study|Moved from area|1
1507880|NCT00425945|4956933|P1|Overall Study|Moved from area|0
1507881|NCT00425945|4956932|P2|Overall Study|Began cancer treatments|0
1507882|NCT00425945|4956933|P1|Overall Study|Began cancer treatments|1
1507883|NCT00425945|4956932|P2|Overall Study|Began hypertension medication|0
1507884|NCT00425945|4956933|P1|Overall Study|Began hypertension medication|1
1507885|NCT00425945|4956932|P2|Overall Study|Lost to Follow-up|2
1507886|NCT00425945|4956933|P1|Overall Study|Lost to Follow-up|0
1507887|NCT00425945|4956932|P2|Overall Study|Inconvenience|2
1507888|NCT00425945|4956933|P1|Overall Study|Inconvenience|0
1507889|NCT00425945|4956932|P2|Overall Study|Concern about Supplement|0
1507890|NCT00425945|4956933|P1|Overall Study|Concern about Supplement|2
1507891|NCT00425854|4956971|P2|Overall Study|Other Adverse Event|2
1507892|NCT00425854|4956972|P1|Overall Study|Other Adverse Event|2
1507893|NCT00425854|4956971|P2|Overall Study|Dose reduction toxicity AE|7
1507894|NCT00425854|4956972|P1|Overall Study|Dose reduction toxicity AE|8
1507895|NCT00425854|4956971|P2|Overall Study|Progressive Disease|12
1507896|NCT00425854|4956972|P1|Overall Study|Progressive Disease|19
1507897|NCT00425750|4957005|P1|Overall Study|Progression of disease|18
1507898|NCT00425750|4957005|P1|Overall Study|Adverse Event|3
1507899|NCT00425750|4957005|P1|Overall Study|Withdrawal by Subject|3
1507900|NCT00425750|4957005|P1|Overall Study|Death|1
1507901|NCT00425698|4957013|P2|Overall Study|Withdrawal by Subject|1
1507902|NCT00425698|4957014|P1|Overall Study|Withdrawal by Subject|0
1507903|NCT00425698|4957013|P2|Overall Study|Adverse Event|1
1507904|NCT00425698|4957014|P1|Overall Study|Adverse Event|3
1507905|NCT00425607|4957029|P1|Overall Study|Withdrawal by Subject|1
1507906|NCT00425607|4957029|P1|Overall Study|Death|1
1507907|NCT00425503|4957033|P1|Overall Study|Protocol Violation|1
1507908|NCT00425503|4957033|P1|Overall Study|Adverse Event|2
1507909|NCT00425438|4957039|P2|Overall Study|Termination by Sponsor|27
1507910|NCT00425438|4957040|P1|Overall Study|Termination by Sponsor|25
1507911|NCT00425373|4957074|P9|Overall Study|Lack of Efficacy|5
1507912|NCT00425373|4957075|P8|Overall Study|Lack of Efficacy|0
1507913|NCT00425373|4957076|P7|Overall Study|Lack of Efficacy|3
1507914|NCT00425373|4957077|P6|Overall Study|Lack of Efficacy|3
1507915|NCT00425373|4957078|P5|Overall Study|Lack of Efficacy|1
1507916|NCT00425373|4957079|P4|Overall Study|Lack of Efficacy|0
1507917|NCT00425373|4957080|P3|Overall Study|Lack of Efficacy|0
1507918|NCT00425373|4957081|P2|Overall Study|Lack of Efficacy|0
1507919|NCT00425373|4957082|P1|Overall Study|Lack of Efficacy|0
1507920|NCT00425373|4957074|P9|Overall Study|Withdrawal by Subject|2
1507921|NCT00425373|4957075|P8|Overall Study|Withdrawal by Subject|2
1507922|NCT00425373|4957076|P7|Overall Study|Withdrawal by Subject|2
1507923|NCT00425373|4957077|P6|Overall Study|Withdrawal by Subject|0
1507924|NCT00425373|4957078|P5|Overall Study|Withdrawal by Subject|4
1507925|NCT00425373|4957079|P4|Overall Study|Withdrawal by Subject|1
1507926|NCT00425373|4957080|P3|Overall Study|Withdrawal by Subject|2
1507927|NCT00425373|4957081|P2|Overall Study|Withdrawal by Subject|0
1507928|NCT00425373|4957082|P1|Overall Study|Withdrawal by Subject|2
1507929|NCT00425373|4957074|P9|Overall Study|Protocol Violation|3
1507930|NCT00425373|4957075|P8|Overall Study|Protocol Violation|5
1507931|NCT00425373|4957076|P7|Overall Study|Protocol Violation|0
1507932|NCT00425373|4957077|P6|Overall Study|Protocol Violation|0
1507933|NCT00425373|4957078|P5|Overall Study|Protocol Violation|0
1507934|NCT00425373|4957079|P4|Overall Study|Protocol Violation|0
1507935|NCT00425373|4957080|P3|Overall Study|Protocol Violation|1
1507936|NCT00425373|4957081|P2|Overall Study|Protocol Violation|0
1507937|NCT00425373|4957082|P1|Overall Study|Protocol Violation|1
1507938|NCT00425373|4957074|P9|Overall Study|Lost to Follow-up|0
1507939|NCT00425373|4957075|P8|Overall Study|Lost to Follow-up|0
1507940|NCT00425373|4957076|P7|Overall Study|Lost to Follow-up|0
1507941|NCT00425373|4957077|P6|Overall Study|Lost to Follow-up|0
1507942|NCT00425373|4957078|P5|Overall Study|Lost to Follow-up|1
1507943|NCT00425373|4957079|P4|Overall Study|Lost to Follow-up|0
1507944|NCT00425373|4957080|P3|Overall Study|Lost to Follow-up|0
1507945|NCT00425373|4957081|P2|Overall Study|Lost to Follow-up|1
1507946|NCT00425373|4957082|P1|Overall Study|Lost to Follow-up|0
1507947|NCT00425373|4957074|P9|Overall Study|Adverse Event|8
1507948|NCT00425373|4957075|P8|Overall Study|Adverse Event|3
1507949|NCT00425373|4957076|P7|Overall Study|Adverse Event|2
1507950|NCT00425373|4957077|P6|Overall Study|Adverse Event|6
1507951|NCT00425373|4957078|P5|Overall Study|Adverse Event|4
1507952|NCT00425373|4957079|P4|Overall Study|Adverse Event|1
1507953|NCT00425373|4957080|P3|Overall Study|Adverse Event|0
1507954|NCT00425373|4957081|P2|Overall Study|Adverse Event|2
1507955|NCT00425373|4957082|P1|Overall Study|Adverse Event|2
1507956|NCT00425308|4957140|P2|Overall Study|Death|0
1507957|NCT00425308|4957141|P1|Overall Study|Death|1
1507958|NCT00425308|4957140|P2|Overall Study|Withdrawal by Subject|0
1507959|NCT00425308|4957141|P1|Overall Study|Withdrawal by Subject|1
1507960|NCT00425308|4957140|P2|Overall Study|Adverse Event|1
1507961|NCT00425308|4957141|P1|Overall Study|Adverse Event|2
1507962|NCT00425269|4957171|P2|Overall Study|moved or medical reason|4
1507963|NCT00425269|4957172|P1|Overall Study|moved or medical reason|5
1507964|NCT00425269|4957171|P2|Overall Study|Lost to Follow-up|9
1507965|NCT00425269|4957172|P1|Overall Study|Lost to Follow-up|9
1507966|NCT00425269|4957171|P2|Overall Study|Pregnancy|7
1507967|NCT00425269|4957172|P1|Overall Study|Pregnancy|5
1507968|NCT00425113|4957250|P2|Overall Study|Withdrawal by Subject|0
1507969|NCT00425113|4957251|P1|Overall Study|Withdrawal by Subject|1
1507970|NCT00425113|4957250|P2|Overall Study|missing study drug more than 14 days|1
1507971|NCT00425113|4957251|P1|Overall Study|missing study drug more than 14 days|0
1507972|NCT00425113|4957250|P2|Overall Study|diagnosis of abdominal TB|1
1507973|NCT00425113|4957251|P1|Overall Study|diagnosis of abdominal TB|0
1507974|NCT00425113|4957250|P2|Overall Study|uncontrolled diabetes mellitus|0
1507975|NCT00425113|4957251|P1|Overall Study|uncontrolled diabetes mellitus|1
1507976|NCT00425100|4957259|P1|Overall Study|Withdrawal by Subject|7
1507977|NCT00425100|4957259|P1|Overall Study|Protocol Violation|4
1507978|NCT00425100|4957259|P1|Overall Study|Lost to Follow-up|2
1507979|NCT00425100|4957259|P1|Overall Study|Lack of Efficacy|4
1507980|NCT00425100|4957259|P1|Overall Study|Adverse Event|36
1507981|NCT00425061|4957303|P7|Overall Study|Other|1
1507982|NCT00425061|4957304|P6|Overall Study|Other|0
1507983|NCT00425061|4957305|P5|Overall Study|Other|3
1507984|NCT00425061|4957306|P4|Overall Study|Other|0
1507985|NCT00425061|4957307|P3|Overall Study|Other|0
1507986|NCT00425061|4957308|P2|Overall Study|Other|0
1507987|NCT00425061|4957309|P1|Overall Study|Other|0
1507988|NCT00425061|4957303|P7|Overall Study|Physician Decision|0
1507989|NCT00425061|4957304|P6|Overall Study|Physician Decision|0
1507990|NCT00425061|4957305|P5|Overall Study|Physician Decision|1
1507991|NCT00425061|4957306|P4|Overall Study|Physician Decision|0
1507992|NCT00425061|4957307|P3|Overall Study|Physician Decision|0
1507993|NCT00425061|4957308|P2|Overall Study|Physician Decision|0
1507994|NCT00425061|4957309|P1|Overall Study|Physician Decision|0
1507995|NCT00425061|4957303|P7|Overall Study|Sponsor's request|15
1507996|NCT00425061|4957304|P6|Overall Study|Sponsor's request|4
1507997|NCT00425061|4957305|P5|Overall Study|Sponsor's request|19
1507998|NCT00425061|4957306|P4|Overall Study|Sponsor's request|0
1507999|NCT00425061|4957307|P3|Overall Study|Sponsor's request|0
1508000|NCT00425061|4957308|P2|Overall Study|Sponsor's request|0
1508001|NCT00425061|4957309|P1|Overall Study|Sponsor's request|0
1508002|NCT00425061|4957303|P7|Overall Study|Withdrawal by Subject|3
1508003|NCT00425061|4957304|P6|Overall Study|Withdrawal by Subject|0
1508004|NCT00425061|4957305|P5|Overall Study|Withdrawal by Subject|1
1508005|NCT00425061|4957306|P4|Overall Study|Withdrawal by Subject|0
1508006|NCT00425061|4957307|P3|Overall Study|Withdrawal by Subject|0
1508007|NCT00425061|4957308|P2|Overall Study|Withdrawal by Subject|1
1508008|NCT00425061|4957309|P1|Overall Study|Withdrawal by Subject|0
1508009|NCT00425061|4957303|P7|Overall Study|Protocol Violation|0
1508010|NCT00425061|4957304|P6|Overall Study|Protocol Violation|0
1508011|NCT00425061|4957305|P5|Overall Study|Protocol Violation|0
1508012|NCT00425061|4957306|P4|Overall Study|Protocol Violation|0
1508013|NCT00425061|4957307|P3|Overall Study|Protocol Violation|0
1508014|NCT00425061|4957308|P2|Overall Study|Protocol Violation|0
1508015|NCT00425061|4957309|P1|Overall Study|Protocol Violation|1
1508016|NCT00425061|4957303|P7|Overall Study|Lost to Follow-up|0
1508017|NCT00425061|4957304|P6|Overall Study|Lost to Follow-up|0
1508018|NCT00425061|4957305|P5|Overall Study|Lost to Follow-up|0
1508019|NCT00425061|4957306|P4|Overall Study|Lost to Follow-up|0
1508020|NCT00425061|4957307|P3|Overall Study|Lost to Follow-up|0
1508021|NCT00425061|4957308|P2|Overall Study|Lost to Follow-up|1
1508022|NCT00425061|4957309|P1|Overall Study|Lost to Follow-up|0
1508023|NCT00425061|4957303|P7|Overall Study|Adverse Event|0
1508024|NCT00425061|4957304|P6|Overall Study|Adverse Event|0
1508025|NCT00425061|4957305|P5|Overall Study|Adverse Event|2
1508026|NCT00425061|4957306|P4|Overall Study|Adverse Event|2
1508027|NCT00425061|4957307|P3|Overall Study|Adverse Event|0
1508028|NCT00425061|4957308|P2|Overall Study|Adverse Event|0
1508029|NCT00425061|4957309|P1|Overall Study|Adverse Event|1
1508030|NCT00424827|4957425|P1|Overall Study|Adverse Event|1
1508031|NCT00424775|4957433|P2|Overall Study|Lack of Efficacy|0
1508032|NCT00424775|4957434|P1|Overall Study|Lack of Efficacy|1
1508033|NCT00424775|4957433|P2|Overall Study|Adverse Event|0
1508034|NCT00424775|4957434|P1|Overall Study|Adverse Event|2
1508035|NCT00424762|4957444|P2|Overall Study|Lost to Follow-up|3
1508036|NCT00424762|4957445|P1|Overall Study|Lost to Follow-up|2
1508037|NCT00424762|4957444|P2|Overall Study|Withdrawal by Subject|19
1508038|NCT00424762|4957445|P1|Overall Study|Withdrawal by Subject|18
1508039|NCT00424749|4957455|P1|Overall Study|Withdrawal by Subject|1
1508040|NCT00424645|4957462|P2|Overall Study|Death|0
1508041|NCT00424645|4957463|P1|Overall Study|Death|1
1508042|NCT00424632|4957471|P10|Overall Study|Other|0
1508043|NCT00424632|4957472|P9|Overall Study|Other|1
1508044|NCT00424632|4957473|P8|Overall Study|Other|0
1508045|NCT00424632|4957474|P7|Overall Study|Other|0
1508046|NCT00424632|4957475|P6|Overall Study|Other|0
1508047|NCT00424632|4957476|P5|Overall Study|Other|0
1508048|NCT00424632|4957477|P4|Overall Study|Other|1
1508049|NCT00424632|4957478|P3|Overall Study|Other|0
1508050|NCT00424632|4957479|P2|Overall Study|Other|0
1508051|NCT00424632|4957480|P1|Overall Study|Other|0
1508052|NCT00424632|4957471|P10|Overall Study|Objective progression or relapse|4
1508053|NCT00424632|4957472|P9|Overall Study|Objective progression or relapse|12
1508054|NCT00424632|4957473|P8|Overall Study|Objective progression or relapse|3
1508055|NCT00424632|4957474|P7|Overall Study|Objective progression or relapse|7
1508056|NCT00424632|4957475|P6|Overall Study|Objective progression or relapse|13
1508057|NCT00424632|4957476|P5|Overall Study|Objective progression or relapse|2
1508058|NCT00424632|4957477|P4|Overall Study|Objective progression or relapse|2
1508059|NCT00424632|4957478|P3|Overall Study|Objective progression or relapse|1
1508060|NCT00424632|4957479|P2|Overall Study|Objective progression or relapse|1
1508061|NCT00424632|4957480|P1|Overall Study|Objective progression or relapse|1
1508062|NCT00424632|4957471|P10|Overall Study|Global deterioration of health status|0
1508063|NCT00424632|4957472|P9|Overall Study|Global deterioration of health status|0
1508064|NCT00424632|4957473|P8|Overall Study|Global deterioration of health status|0
1508065|NCT00424632|4957474|P7|Overall Study|Global deterioration of health status|0
1508066|NCT00424632|4957475|P6|Overall Study|Global deterioration of health status|0
1508067|NCT00424632|4957476|P5|Overall Study|Global deterioration of health status|1
1508068|NCT00424632|4957477|P4|Overall Study|Global deterioration of health status|1
1508069|NCT00424632|4957478|P3|Overall Study|Global deterioration of health status|0
1508070|NCT00424632|4957479|P2|Overall Study|Global deterioration of health status|0
1508071|NCT00424632|4957480|P1|Overall Study|Global deterioration of health status|0
1508072|NCT00424632|4957471|P10|Overall Study|Adverse Event|2
1508073|NCT00424632|4957472|P9|Overall Study|Adverse Event|3
1508074|NCT00424632|4957473|P8|Overall Study|Adverse Event|0
1508075|NCT00424632|4957474|P7|Overall Study|Adverse Event|0
1508076|NCT00424632|4957475|P6|Overall Study|Adverse Event|0
1508077|NCT00424632|4957476|P5|Overall Study|Adverse Event|0
1508078|NCT00424632|4957477|P4|Overall Study|Adverse Event|0
1508079|NCT00424632|4957478|P3|Overall Study|Adverse Event|0
1508080|NCT00424632|4957479|P2|Overall Study|Adverse Event|0
1508081|NCT00424632|4957480|P1|Overall Study|Adverse Event|0
1508082|NCT00424632|4957471|P10|Overall Study|Death|0
1508083|NCT00424632|4957472|P9|Overall Study|Death|0
1508084|NCT00424632|4957473|P8|Overall Study|Death|0
1508085|NCT00424632|4957474|P7|Overall Study|Death|0
1508086|NCT00424632|4957475|P6|Overall Study|Death|2
1508087|NCT00424632|4957476|P5|Overall Study|Death|0
1508088|NCT00424632|4957477|P4|Overall Study|Death|0
1508089|NCT00424632|4957478|P3|Overall Study|Death|0
1508090|NCT00424632|4957479|P2|Overall Study|Death|0
1508091|NCT00424632|4957480|P1|Overall Study|Death|0
1508092|NCT00424593|4957650|P2|Dose-Blind Extension Period|Physician Decision|0
1508093|NCT00424593|4957651|P1|Dose-Blind Extension Period|Physician Decision|3
1508094|NCT00424593|4957650|P2|Dose-Blind Extension Period|Lost to Follow-up|0
1508095|NCT00424593|4957651|P1|Dose-Blind Extension Period|Lost to Follow-up|6
1508096|NCT00424593|4957650|P2|Dose-Blind Extension Period|Protocol Violation|0
1508097|NCT00424593|4957651|P1|Dose-Blind Extension Period|Protocol Violation|9
1508098|NCT00424593|4957650|P2|Dose-Blind Extension Period|Lack of Efficacy|0
1508099|NCT00424593|4957651|P1|Dose-Blind Extension Period|Lack of Efficacy|9
1508100|NCT00424593|4957650|P2|Dose-Blind Extension Period|Adverse Event|0
1508101|NCT00424593|4957651|P1|Dose-Blind Extension Period|Adverse Event|18
1508102|NCT00424593|4957650|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
1508103|NCT00424593|4957651|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
1508104|NCT00424593|4957650|P2|Acute Double-Blind Period|Lack of Efficacy|1
1508105|NCT00424593|4957651|P1|Acute Double-Blind Period|Lack of Efficacy|0
1508106|NCT00424593|4957650|P2|Acute Double-Blind Period|Lost to Follow-up|1
1508107|NCT00424593|4957651|P1|Acute Double-Blind Period|Lost to Follow-up|1
1508108|NCT00424593|4957650|P2|Acute Double-Blind Period|Physician Decision|2
1508109|NCT00424593|4957651|P1|Acute Double-Blind Period|Physician Decision|1
1508110|NCT00424593|4957650|P2|Acute Double-Blind Period|Protocol Violation|2
1508111|NCT00424593|4957651|P1|Acute Double-Blind Period|Protocol Violation|2
1508112|NCT00424593|4957650|P2|Acute Double-Blind Period|Withdrawal by Subject|10
1508113|NCT00424593|4957651|P1|Acute Double-Blind Period|Withdrawal by Subject|11
1508114|NCT00424593|4957650|P2|Acute Double-Blind Period|Adverse Event|7
1508115|NCT00424593|4957651|P1|Acute Double-Blind Period|Adverse Event|16
1508116|NCT00424528|4957715|P3|Overall Study|noncompliance with study requirements|2
1508117|NCT00424528|4957716|P2|Overall Study|noncompliance with study requirements|1
1508118|NCT00424528|4957717|P1|Overall Study|noncompliance with study requirements|2
1508119|NCT00424528|4957715|P3|Overall Study|Lost to Follow-up|0
1508120|NCT00424528|4957716|P2|Overall Study|Lost to Follow-up|1
1508121|NCT00424528|4957717|P1|Overall Study|Lost to Follow-up|0
1508122|NCT00424528|4957715|P3|Overall Study|Protocol Violation|0
1508123|NCT00424528|4957716|P2|Overall Study|Protocol Violation|1
1508124|NCT00424528|4957717|P1|Overall Study|Protocol Violation|1
1508125|NCT00424528|4957715|P3|Overall Study|Adverse Event|2
1508126|NCT00424528|4957716|P2|Overall Study|Adverse Event|1
1508127|NCT00424528|4957717|P1|Overall Study|Adverse Event|2
1508128|NCT00424515|4957772|P2|Overall Study|Withdrawal by Subject|0
1508129|NCT00424515|4957773|P1|Overall Study|Withdrawal by Subject|1
1508130|NCT00424515|4957772|P2|Overall Study|Intercurrent Illness|1
1508131|NCT00424515|4957773|P1|Overall Study|Intercurrent Illness|0
1508132|NCT00424515|4957772|P2|Overall Study|Adverse Event|1
1508133|NCT00424515|4957773|P1|Overall Study|Adverse Event|0
1508134|NCT00424515|4957772|P2|Overall Study|Progressive Disease|11
1508135|NCT00424515|4957773|P1|Overall Study|Progressive Disease|10
1508136|NCT00424489|4957792|P1|Overall Study|Death|3
1508137|NCT00424476|4957799|P3|Overall Study|Other|9
1508138|NCT00424476|4957800|P2|Overall Study|Other|3
1508139|NCT00424476|4957801|P1|Overall Study|Other|4
1508140|NCT00424476|4957799|P3|Overall Study|Physician Decision|3
1508141|NCT00424476|4957800|P2|Overall Study|Physician Decision|2
1508142|NCT00424476|4957801|P1|Overall Study|Physician Decision|3
1508143|NCT00424476|4957799|P3|Overall Study|Protocol Violation|3
1508144|NCT00424476|4957800|P2|Overall Study|Protocol Violation|2
1508145|NCT00424476|4957801|P1|Overall Study|Protocol Violation|7
1508146|NCT00424476|4957799|P3|Overall Study|Lost to Follow-up|3
1508147|NCT00424476|4957800|P2|Overall Study|Lost to Follow-up|6
1508148|NCT00424476|4957801|P1|Overall Study|Lost to Follow-up|4
1508149|NCT00424476|4957799|P3|Overall Study|Lack of Compliance|1
1508150|NCT00424476|4957800|P2|Overall Study|Lack of Compliance|1
1508151|NCT00424476|4957801|P1|Overall Study|Lack of Compliance|1
1508152|NCT00424476|4957799|P3|Overall Study|Lack of Efficacy|12
1508153|NCT00424476|4957800|P2|Overall Study|Lack of Efficacy|12
1508154|NCT00424476|4957801|P1|Overall Study|Lack of Efficacy|16
1508155|NCT00424476|4957799|P3|Overall Study|Adverse Event|15
1508156|NCT00424476|4957800|P2|Overall Study|Adverse Event|16
1508157|NCT00424476|4957801|P1|Overall Study|Adverse Event|19
1508158|NCT00424476|4957799|P3|Overall Study|Withdrawal by Subject|3
1508159|NCT00424476|4957800|P2|Overall Study|Withdrawal by Subject|6
1508160|NCT00424476|4957801|P1|Overall Study|Withdrawal by Subject|7
1508161|NCT00424463|4957827|P3|Overall Study|Patient’s convenience|1
1508162|NCT00424463|4957828|P2|Overall Study|Patient’s convenience|0
1508163|NCT00424463|4957829|P1|Overall Study|Patient’s convenience|0
1508164|NCT00424463|4957827|P3|Overall Study|Tracheotomy due to worsening of ALS|6
1508165|NCT00424463|4957828|P2|Overall Study|Tracheotomy due to worsening of ALS|7
1508166|NCT00424463|4957829|P1|Overall Study|Tracheotomy due to worsening of ALS|1
1508167|NCT00424463|4957827|P3|Overall Study|Withdrawal by Subject|5
1508168|NCT00424463|4957828|P2|Overall Study|Withdrawal by Subject|2
1508169|NCT00424463|4957829|P1|Overall Study|Withdrawal by Subject|4
1508170|NCT00424463|4957827|P3|Overall Study|Physician Decision|2
1508171|NCT00424463|4957828|P2|Overall Study|Physician Decision|2
1508172|NCT00424463|4957829|P1|Overall Study|Physician Decision|0
1508173|NCT00424463|4957827|P3|Overall Study|Adverse Event|2
1508174|NCT00424463|4957828|P2|Overall Study|Adverse Event|3
1508175|NCT00424463|4957829|P1|Overall Study|Adverse Event|2
1508176|NCT00424398|4957858|P3|Overall Study|Subject met exclusion criteria|0
1508177|NCT00424398|4957859|P2|Overall Study|Subject met exclusion criteria|0
1508178|NCT00424398|4957860|P1|Overall Study|Subject met exclusion criteria|1
1508179|NCT00424398|4957858|P3|Overall Study|Withdrawal by Subject|0
1508180|NCT00424398|4957859|P2|Overall Study|Withdrawal by Subject|1
1508181|NCT00424398|4957860|P1|Overall Study|Withdrawal by Subject|2
1508182|NCT00424385|4957904|P1|Cohort 1|Withdrawal by Subject|1
1508183|NCT00424385|4957904|P1|Cohort 0|Physician Decision|1
1508184|NCT00424385|4957904|P1|Cohort 0|Withdrawal by Subject|5
1508185|NCT00424372|4957911|P1|Overall Study|Lack of Efficacy|6
1508186|NCT00424372|4957911|P1|Overall Study|Protocol Violation|1
1508187|NCT00424372|4957911|P1|Overall Study|Withdrawal by Subject|4
1508188|NCT00424372|4957911|P1|Overall Study|Health deterioration|1
1508189|NCT00424372|4957911|P1|Overall Study|Adverse Event|18
1508190|NCT00424372|4957911|P1|Overall Study|Death|1
1508191|NCT00424346|4957923|P4|Extension Phase|Protocol Violation|0
1508192|NCT00424346|4957924|P3|Extension Phase|Protocol Violation|1
1508193|NCT00424346|4957925|P2|Extension Phase|Protocol Violation|1
1508194|NCT00424346|4957926|P1|Extension Phase|Protocol Violation|0
1508195|NCT00424346|4957923|P4|Extension Phase|Death|1
1508196|NCT00424346|4957924|P3|Extension Phase|Death|0
1508197|NCT00424346|4957925|P2|Extension Phase|Death|0
1508198|NCT00424346|4957926|P1|Extension Phase|Death|0
1508199|NCT00424346|4957923|P4|Extension Phase|Administrative Problems|35
1508200|NCT00424346|4957924|P3|Extension Phase|Administrative Problems|32
1508201|NCT00424346|4957925|P2|Extension Phase|Administrative Problems|69
1508202|NCT00424346|4957926|P1|Extension Phase|Administrative Problems|0
1508203|NCT00424346|4957923|P4|Extension Phase|Lost to Follow-up|0
1508204|NCT00424346|4957924|P3|Extension Phase|Lost to Follow-up|0
1508205|NCT00424346|4957925|P2|Extension Phase|Lost to Follow-up|2
1508206|NCT00424346|4957926|P1|Extension Phase|Lost to Follow-up|0
1508207|NCT00424346|4957923|P4|Extension Phase|Withdrawal by Subject|4
1508208|NCT00424346|4957924|P3|Extension Phase|Withdrawal by Subject|3
1508209|NCT00424346|4957925|P2|Extension Phase|Withdrawal by Subject|5
1508210|NCT00424346|4957926|P1|Extension Phase|Withdrawal by Subject|0
1508211|NCT00424346|4957923|P4|Extension Phase|Lack of Efficacy|11
1508212|NCT00424346|4957924|P3|Extension Phase|Lack of Efficacy|14
1508213|NCT00424346|4957925|P2|Extension Phase|Lack of Efficacy|16
1508214|NCT00424346|4957926|P1|Extension Phase|Lack of Efficacy|0
1508215|NCT00424346|4957923|P4|Extension Phase|Adverse Event|4
1508216|NCT00424346|4957924|P3|Extension Phase|Adverse Event|5
1508217|NCT00424346|4957925|P2|Extension Phase|Adverse Event|9
1508218|NCT00424346|4957926|P1|Extension Phase|Adverse Event|0
1508219|NCT00424346|4957923|P4|Core Study|Protocol Violation|0
1508220|NCT00424346|4957924|P3|Core Study|Protocol Violation|2
1508221|NCT00424346|4957925|P2|Core Study|Protocol Violation|0
1508222|NCT00424346|4957926|P1|Core Study|Protocol Violation|0
1508223|NCT00424346|4957923|P4|Core Study|Administrative Problems|0
1508224|NCT00424346|4957924|P3|Core Study|Administrative Problems|1
1508225|NCT00424346|4957925|P2|Core Study|Administrative Problems|0
1508226|NCT00424346|4957926|P1|Core Study|Administrative Problems|1
1508227|NCT00424346|4957923|P4|Core Study|Lost to Follow-up|0
1508228|NCT00424346|4957924|P3|Core Study|Lost to Follow-up|0
1508229|NCT00424346|4957925|P2|Core Study|Lost to Follow-up|1
1508230|NCT00424346|4957926|P1|Core Study|Lost to Follow-up|1
1508231|NCT00424346|4957923|P4|Core Study|Withdrawal by Subject|2
1508232|NCT00424346|4957924|P3|Core Study|Withdrawal by Subject|0
1508233|NCT00424346|4957925|P2|Core Study|Withdrawal by Subject|0
1508234|NCT00424346|4957926|P1|Core Study|Withdrawal by Subject|1
1508235|NCT00424346|4957923|P4|Core Study|Lack of Efficacy|4
1508236|NCT00424346|4957924|P3|Core Study|Lack of Efficacy|0
1508237|NCT00424346|4957925|P2|Core Study|Lack of Efficacy|3
1508238|NCT00424346|4957926|P1|Core Study|Lack of Efficacy|1
1508239|NCT00424346|4957923|P4|Core Study|Abnormal Laboratory Values|0
1508240|NCT00424346|4957924|P3|Core Study|Abnormal Laboratory Values|0
1508241|NCT00424346|4957925|P2|Core Study|Abnormal Laboratory Values|1
1508242|NCT00424346|4957926|P1|Core Study|Abnormal Laboratory Values|0
1508243|NCT00424346|4957923|P4|Core Study|Adverse Event|1
1508244|NCT00424346|4957924|P3|Core Study|Adverse Event|1
1508245|NCT00424346|4957925|P2|Core Study|Adverse Event|3
1508246|NCT00424346|4957926|P1|Core Study|Adverse Event|5
1508247|NCT00424294|4958041|P2|Overall Study|Randomized but not Treated|0
1508248|NCT00424294|4958042|P1|Overall Study|Randomized but not Treated|1
1508249|NCT00424294|4958041|P2|Overall Study|Other|2
1508250|NCT00424294|4958042|P1|Overall Study|Other|0
1508251|NCT00424294|4958041|P2|Overall Study|Withdrawal by Subject|2
1508252|NCT00424294|4958042|P1|Overall Study|Withdrawal by Subject|1
1508253|NCT00424294|4958041|P2|Overall Study|Lack of Efficacy|1
1508254|NCT00424294|4958042|P1|Overall Study|Lack of Efficacy|2
1508255|NCT00424294|4958041|P2|Overall Study|Adverse Event|10
1508256|NCT00424294|4958042|P1|Overall Study|Adverse Event|4
1508257|NCT00424255|4958109|P2|Overall Study|Sponsor Terminated Study|167
1508258|NCT00424255|4958110|P1|Overall Study|Sponsor Terminated Study|161
1508259|NCT00424255|4958109|P2|Overall Study|Disease Progression|2
1508260|NCT00424255|4958110|P1|Overall Study|Disease Progression|0
1508261|NCT00424255|4958109|P2|Overall Study|Fatigue|0
1508262|NCT00424255|4958110|P1|Overall Study|Fatigue|1
1508263|NCT00424255|4958109|P2|Overall Study|Non-compliance by Participants|0
1508264|NCT00424255|4958110|P1|Overall Study|Non-compliance by Participants|1
1508265|NCT00424255|4958109|P2|Overall Study|Cognitive Disturbance|0
1508266|NCT00424255|4958110|P1|Overall Study|Cognitive Disturbance|1
1508267|NCT00424255|4958109|P2|Overall Study|Physician Decision|7
1508268|NCT00424255|4958110|P1|Overall Study|Physician Decision|3
1508269|NCT00424255|4958109|P2|Overall Study|Withdrawal by Subject|38
1508270|NCT00424255|4958110|P1|Overall Study|Withdrawal by Subject|34
1508271|NCT00424255|4958109|P2|Overall Study|Protocol Violation|1
1508272|NCT00424255|4958110|P1|Overall Study|Protocol Violation|0
1508273|NCT00424255|4958109|P2|Overall Study|Lost to Follow-up|20
1508274|NCT00424255|4958110|P1|Overall Study|Lost to Follow-up|26
1508275|NCT00424255|4958109|P2|Overall Study|Death|111
1508276|NCT00424255|4958110|P1|Overall Study|Death|115
1508277|NCT00424190|4958158|P2|Overall Study|Other|21
1508278|NCT00424190|4958159|P1|Overall Study|Other|15
1508279|NCT00424190|4958158|P2|Overall Study|Diagnosis of osteomyelitis|1
1508280|NCT00424190|4958159|P1|Overall Study|Diagnosis of osteomyelitis|0
1508281|NCT00424190|4958158|P2|Overall Study|Request of sponsor or investigator|2
1508282|NCT00424190|4958159|P1|Overall Study|Request of sponsor or investigator|0
1508283|NCT00424190|4958158|P2|Overall Study|Noncompliance|2
1508284|NCT00424190|4958159|P1|Overall Study|Noncompliance|1
1508285|NCT00424190|4958158|P2|Overall Study|Death|0
1508286|NCT00424190|4958159|P1|Overall Study|Death|3
1508287|NCT00424190|4958158|P2|Overall Study|Withdrew consent|4
1508288|NCT00424190|4958159|P1|Overall Study|Withdrew consent|3
1508289|NCT00424177|4958165|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
1508290|NCT00424177|4958165|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
1508291|NCT00424177|4958165|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
1508292|NCT00424177|4958165|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
1508293|NCT00424177|4958165|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
1508294|NCT00424177|4958165|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
1508295|NCT00424177|4958165|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
1508296|NCT00424177|4958165|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
1508297|NCT00424177|4958165|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
1508298|NCT00424177|4958165|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
1508299|NCT00424047|4958194|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
1508300|NCT00424047|4958195|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
1508301|NCT00424047|4958194|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
1508302|NCT00424047|4958195|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
1508303|NCT00424047|4958194|P2|Long Term Extension (Up to 25 Jun 2013)|Other|4
1508304|NCT00424047|4958195|P1|Long Term Extension (Up to 25 Jun 2013)|Other|12
1508305|NCT00424047|4958194|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
1508306|NCT00424047|4958195|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
1508307|NCT00424047|4958194|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
1508308|NCT00424047|4958195|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
1508309|NCT00424047|4958194|P2|On Study at Time of Unblinding|Other|4
1508310|NCT00424047|4958195|P1|On Study at Time of Unblinding|Other|5
1508311|NCT00424047|4958194|P2|On Study at Time of Unblinding|Death|11
1508312|NCT00424047|4958195|P1|On Study at Time of Unblinding|Death|11
1508313|NCT00424047|4958194|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
1508314|NCT00424047|4958195|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
1508315|NCT00424047|4958194|P2|On Study at Time of Unblinding|Lack of Efficacy|3
1508316|NCT00424047|4958195|P1|On Study at Time of Unblinding|Lack of Efficacy|1
1508317|NCT00424047|4958194|P2|On Study at Time of Unblinding|Progression of disease|128
1508318|NCT00424047|4958195|P1|On Study at Time of Unblinding|Progression of disease|92
1508319|NCT00424047|4958194|P2|On Study at Time of Unblinding|Adverse Event|12
1508320|NCT00424047|4958195|P1|On Study at Time of Unblinding|Adverse Event|22
1508321|NCT00424047|4958194|P2|Blinded Treatment (Up to 03 Aug 2005)|Other|1
1508322|NCT00424047|4958195|P1|Blinded Treatment (Up to 03 Aug 2005)|Other|2
1508323|NCT00424047|4958194|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
1508324|NCT00424047|4958195|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
1508325|NCT00424047|4958194|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
1508326|NCT00424047|4958195|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
1508327|NCT00424047|4958194|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
1508328|NCT00424047|4958195|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
1508329|NCT00424047|4958194|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
1508330|NCT00424047|4958195|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
1508331|NCT00424047|4958194|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
1508332|NCT00424047|4958195|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
1508333|NCT00424021|4958227|P4|AMB-220-E Study Period|Physician Decision|1
1508334|NCT00424021|4958228|P3|AMB-220-E Study Period|Physician Decision|0
1508335|NCT00424021|4958229|P2|AMB-220-E Study Period|Physician Decision|0
1508336|NCT00424021|4958230|P1|AMB-220-E Study Period|Physician Decision|0
1508337|NCT00424021|4958227|P4|AMB-220-E Study Period|Lost to Follow-up|1
1508338|NCT00424021|4958228|P3|AMB-220-E Study Period|Lost to Follow-up|1
1508339|NCT00424021|4958229|P2|AMB-220-E Study Period|Lost to Follow-up|1
1508340|NCT00424021|4958230|P1|AMB-220-E Study Period|Lost to Follow-up|0
1508341|NCT00424021|4958227|P4|AMB-220-E Study Period|Death|1
1508342|NCT00424021|4958228|P3|AMB-220-E Study Period|Death|1
1508343|NCT00424021|4958229|P2|AMB-220-E Study Period|Death|0
1508344|NCT00424021|4958230|P1|AMB-220-E Study Period|Death|0
1508345|NCT00424021|4958227|P4|AMB-220-E Study Period|Adverse Event|7
1508346|NCT00424021|4958228|P3|AMB-220-E Study Period|Adverse Event|3
1508347|NCT00424021|4958229|P2|AMB-220-E Study Period|Adverse Event|1
1508348|NCT00424021|4958230|P1|AMB-220-E Study Period|Adverse Event|1
1508349|NCT00424021|4958227|P4|NCT00046319 Study Period|Lost to Follow-up|0
1508350|NCT00424021|4958228|P3|NCT00046319 Study Period|Lost to Follow-up|0
1508351|NCT00424021|4958229|P2|NCT00046319 Study Period|Lost to Follow-up|1
1508352|NCT00424021|4958230|P1|NCT00046319 Study Period|Lost to Follow-up|0
1508353|NCT00424021|4958227|P4|NCT00046319 Study Period|Sponsor discretion|0
1508354|NCT00424021|4958228|P3|NCT00046319 Study Period|Sponsor discretion|0
1508355|NCT00424021|4958229|P2|NCT00046319 Study Period|Sponsor discretion|1
1508356|NCT00424021|4958230|P1|NCT00046319 Study Period|Sponsor discretion|0
1508357|NCT00424021|4958227|P4|NCT00046319 Study Period|Withdrawal by Subject|0
1508358|NCT00424021|4958228|P3|NCT00046319 Study Period|Withdrawal by Subject|0
1508359|NCT00424021|4958229|P2|NCT00046319 Study Period|Withdrawal by Subject|1
1508360|NCT00424021|4958230|P1|NCT00046319 Study Period|Withdrawal by Subject|0
1508361|NCT00424021|4958227|P4|NCT00046319 Study Period|Adverse Event|1
1508362|NCT00424021|4958228|P3|NCT00046319 Study Period|Adverse Event|1
1508363|NCT00424021|4958229|P2|NCT00046319 Study Period|Adverse Event|0
1508364|NCT00424021|4958230|P1|NCT00046319 Study Period|Adverse Event|1
1508365|NCT00424008|4958273|P2|Overall Study|Administrative|257
1508366|NCT00424008|4958274|P1|Overall Study|Administrative|266
1508367|NCT00424008|4958273|P2|Overall Study|Did not meet protocol eligibility|21
1508368|NCT00424008|4958274|P1|Overall Study|Did not meet protocol eligibility|16
1508369|NCT00424008|4958273|P2|Overall Study|Noncompliance with protocol|7
1508370|NCT00424008|4958274|P1|Overall Study|Noncompliance with protocol|13
1508371|NCT00424008|4958273|P2|Overall Study|Withdrawal by Subject|8
1508372|NCT00424008|4958274|P1|Overall Study|Withdrawal by Subject|5
1508373|NCT00424008|4958273|P2|Overall Study|Lost to Follow-up|2
1508374|NCT00424008|4958274|P1|Overall Study|Lost to Follow-up|1
1508375|NCT00424008|4958273|P2|Overall Study|Lack of Efficacy|34
1508376|NCT00424008|4958274|P1|Overall Study|Lack of Efficacy|40
1508377|NCT00424008|4958273|P2|Overall Study|Adverse Event|6
1508378|NCT00424008|4958274|P1|Overall Study|Adverse Event|8
1508379|NCT00423943|4958289|P2|Overall Study|Withdrawal by Subject|1
1508380|NCT00423943|4958290|P1|Overall Study|Withdrawal by Subject|3
1508381|NCT00423930|4958304|P1|Overall Study|Withdrawal by Subject|2
1508382|NCT00423917|4958309|P1|Overall Study|Ineligible|1
1508383|NCT00423917|4958309|P1|Overall Study|Cancel|2
1508384|NCT00423891|4958322|P3|Post-Dosing Follow Up|Lost to Follow-up|0
1508385|NCT00423891|4958323|P2|Post-Dosing Follow Up|Lost to Follow-up|0
1508386|NCT00423891|4958324|P1|Post-Dosing Follow Up|Lost to Follow-up|2
1508387|NCT00423891|4958322|P3|Post-Dosing Follow Up|Withdrawal by Subject|2
1508388|NCT00423891|4958323|P2|Post-Dosing Follow Up|Withdrawal by Subject|3
1508389|NCT00423891|4958324|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
1508390|NCT00423891|4958322|P3|Treatment|Lost to Follow-up|0
1508391|NCT00423891|4958323|P2|Treatment|Lost to Follow-up|0
1508392|NCT00423891|4958324|P1|Treatment|Lost to Follow-up|1
1508393|NCT00423891|4958322|P3|Treatment|Withdrawal by Subject|0
1508394|NCT00423891|4958323|P2|Treatment|Withdrawal by Subject|0
1508395|NCT00423891|4958324|P1|Treatment|Withdrawal by Subject|1
1508396|NCT00423891|4958322|P3|Enrolled|No longer met criteria|1
1508397|NCT00423891|4958323|P2|Enrolled|No longer met criteria|2
1508398|NCT00423891|4958324|P1|Enrolled|No longer met criteria|11
1508399|NCT00423891|4958322|P3|Enrolled|Lost to Follow-up|1
1508400|NCT00423891|4958323|P2|Enrolled|Lost to Follow-up|0
1508401|NCT00423891|4958324|P1|Enrolled|Lost to Follow-up|0
1508402|NCT00423891|4958322|P3|Enrolled|Withdrawal by Subject|1
1508403|NCT00423891|4958323|P2|Enrolled|Withdrawal by Subject|0
1508404|NCT00423891|4958324|P1|Enrolled|Withdrawal by Subject|0
1508405|NCT00423852|4958402|P1|Overall Study|Removed pior to the high-dose portion|3
1508406|NCT00423813|4958410|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
1508407|NCT00423813|4958411|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
1508408|NCT00423813|4958412|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
1508409|NCT00423813|4958410|P3|Overall Study|Will start exclusionary medications|0
1508410|NCT00423813|4958411|P2|Overall Study|Will start exclusionary medications|1
1508411|NCT00423813|4958412|P1|Overall Study|Will start exclusionary medications|0
1508412|NCT00423813|4958410|P3|Overall Study|Subject started night shift work|0
1508413|NCT00423813|4958411|P2|Overall Study|Subject started night shift work|0
1508414|NCT00423813|4958412|P1|Overall Study|Subject started night shift work|1
1508415|NCT00423813|4958410|P3|Overall Study|Pregnancy|1
1508416|NCT00423813|4958411|P2|Overall Study|Pregnancy|0
1508417|NCT00423813|4958412|P1|Overall Study|Pregnancy|0
1508418|NCT00423813|4958410|P3|Overall Study|Protocol Violation|4
1508419|NCT00423813|4958411|P2|Overall Study|Protocol Violation|4
1508420|NCT00423813|4958412|P1|Overall Study|Protocol Violation|9
1508421|NCT00423813|4958410|P3|Overall Study|Sponsor Decision|0
1508422|NCT00423813|4958411|P2|Overall Study|Sponsor Decision|1
1508423|NCT00423813|4958412|P1|Overall Study|Sponsor Decision|0
1508424|NCT00423813|4958410|P3|Overall Study|Physician Decision|0
1508425|NCT00423813|4958411|P2|Overall Study|Physician Decision|0
1508426|NCT00423813|4958412|P1|Overall Study|Physician Decision|2
1508427|NCT00423813|4958410|P3|Overall Study|Lack of Efficacy|19
1508428|NCT00423813|4958411|P2|Overall Study|Lack of Efficacy|18
1508429|NCT00423813|4958412|P1|Overall Study|Lack of Efficacy|23
1508430|NCT00423813|4958410|P3|Overall Study|Lost to Follow-up|4
1508431|NCT00423813|4958411|P2|Overall Study|Lost to Follow-up|4
1508432|NCT00423813|4958412|P1|Overall Study|Lost to Follow-up|5
1508433|NCT00423813|4958410|P3|Overall Study|Withdrawal by Subject|5
1508434|NCT00423813|4958411|P2|Overall Study|Withdrawal by Subject|8
1508435|NCT00423813|4958412|P1|Overall Study|Withdrawal by Subject|6
1508436|NCT00423813|4958410|P3|Overall Study|Adverse Event|40
1508437|NCT00423813|4958411|P2|Overall Study|Adverse Event|30
1508438|NCT00423813|4958412|P1|Overall Study|Adverse Event|11
1508439|NCT00423800|4958422|P2|Overall Study|Protocol Violation|1
1508440|NCT00423800|4958423|P1|Overall Study|Protocol Violation|0
1508441|NCT00423735|4958435|P3|Overall Study|Ineligible / No protocol treatment|0
1508442|NCT00423735|4958436|P2|Overall Study|Ineligible / No protocol treatment|6
1508443|NCT00423735|4958437|P1|Overall Study|Ineligible / No protocol treatment|8
1508444|NCT00423722|4958460|P2|Overall Study|Withdrawal by Subject|2
1508445|NCT00423722|4958461|P1|Overall Study|Withdrawal by Subject|4
1508446|NCT00423722|4958460|P2|Overall Study|Unable to complete questionnaires|4
1508447|NCT00423722|4958461|P1|Overall Study|Unable to complete questionnaires|4
1508448|NCT00423722|4958460|P2|Overall Study|Declined to participate|3
1508449|NCT00423722|4958461|P1|Overall Study|Declined to participate|2
1508450|NCT00423722|4958460|P2|Overall Study|Death|4
1508451|NCT00423722|4958461|P1|Overall Study|Death|4
1508452|NCT00423670|4958503|P8|Follow-up Period|Non-compliance with protocol|2
1508453|NCT00423670|4958504|P7|Follow-up Period|Non-compliance with protocol|3
1508454|NCT00423670|4958505|P6|Follow-up Period|Non-compliance with protocol|0
1508455|NCT00423670|4958506|P5|Follow-up Period|Non-compliance with protocol|0
1508456|NCT00423670|4958507|P4|Follow-up Period|Non-compliance with protocol|1
1508457|NCT00423670|4958508|P3|Follow-up Period|Non-compliance with protocol|1
1508458|NCT00423670|4958509|P2|Follow-up Period|Non-compliance with protocol|0
1508459|NCT00423670|4958510|P1|Follow-up Period|Non-compliance with protocol|2
1508460|NCT00423670|4958503|P8|Follow-up Period|Subject withdrew (not treatment related)|1
1508461|NCT00423670|4958504|P7|Follow-up Period|Subject withdrew (not treatment related)|1
1508462|NCT00423670|4958505|P6|Follow-up Period|Subject withdrew (not treatment related)|0
1508463|NCT00423670|4958506|P5|Follow-up Period|Subject withdrew (not treatment related)|1
1508464|NCT00423670|4958507|P4|Follow-up Period|Subject withdrew (not treatment related)|1
1508465|NCT00423670|4958508|P3|Follow-up Period|Subject withdrew (not treatment related)|2
1508466|NCT00423670|4958509|P2|Follow-up Period|Subject withdrew (not treatment related)|4
1508467|NCT00423670|4958510|P1|Follow-up Period|Subject withdrew (not treatment related)|1
1508468|NCT00423670|4958503|P8|Follow-up Period|Lost to Follow-up|0
1508469|NCT00423670|4958504|P7|Follow-up Period|Lost to Follow-up|5
1508470|NCT00423670|4958505|P6|Follow-up Period|Lost to Follow-up|0
1508471|NCT00423670|4958506|P5|Follow-up Period|Lost to Follow-up|1
1508472|NCT00423670|4958507|P4|Follow-up Period|Lost to Follow-up|3
1508473|NCT00423670|4958508|P3|Follow-up Period|Lost to Follow-up|8
1508474|NCT00423670|4958509|P2|Follow-up Period|Lost to Follow-up|12
1508475|NCT00423670|4958510|P1|Follow-up Period|Lost to Follow-up|0
1508476|NCT00423670|4958503|P8|Treatment Period|Non-compliance with protocol|2
1508477|NCT00423670|4958504|P7|Treatment Period|Non-compliance with protocol|2
1508478|NCT00423670|4958505|P6|Treatment Period|Non-compliance with protocol|0
1508479|NCT00423670|4958506|P5|Treatment Period|Non-compliance with protocol|2
1508480|NCT00423670|4958507|P4|Treatment Period|Non-compliance with protocol|3
1508481|NCT00423670|4958508|P3|Treatment Period|Non-compliance with protocol|1
1508482|NCT00423670|4958509|P2|Treatment Period|Non-compliance with protocol|1
1508483|NCT00423670|4958510|P1|Treatment Period|Non-compliance with protocol|3
1508484|NCT00423670|4958503|P8|Treatment Period|Investigator decision|1
1508485|NCT00423670|4958504|P7|Treatment Period|Investigator decision|0
1508486|NCT00423670|4958505|P6|Treatment Period|Investigator decision|0
1508487|NCT00423670|4958506|P5|Treatment Period|Investigator decision|0
1508488|NCT00423670|4958507|P4|Treatment Period|Investigator decision|0
1508489|NCT00423670|4958508|P3|Treatment Period|Investigator decision|0
1508490|NCT00423670|4958509|P2|Treatment Period|Investigator decision|0
1508491|NCT00423670|4958510|P1|Treatment Period|Investigator decision|0
1508492|NCT00423670|4958503|P8|Treatment Period|Subject withdrew (not treatment related)|0
1508493|NCT00423670|4958504|P7|Treatment Period|Subject withdrew (not treatment related)|3
1508578|NCT00423449|4958619|P2|Overall Study|Progressive Disease|3
1508494|NCT00423670|4958505|P6|Treatment Period|Subject withdrew (not treatment related)|0
1508495|NCT00423670|4958506|P5|Treatment Period|Subject withdrew (not treatment related)|5
1508496|NCT00423670|4958507|P4|Treatment Period|Subject withdrew (not treatment related)|4
1508497|NCT00423670|4958508|P3|Treatment Period|Subject withdrew (not treatment related)|4
1508498|NCT00423670|4958509|P2|Treatment Period|Subject withdrew (not treatment related)|9
1508499|NCT00423670|4958510|P1|Treatment Period|Subject withdrew (not treatment related)|3
1508500|NCT00423670|4958503|P8|Treatment Period|Lost to Follow-up|1
1508501|NCT00423670|4958504|P7|Treatment Period|Lost to Follow-up|3
1508502|NCT00423670|4958505|P6|Treatment Period|Lost to Follow-up|0
1508503|NCT00423670|4958506|P5|Treatment Period|Lost to Follow-up|6
1508504|NCT00423670|4958507|P4|Treatment Period|Lost to Follow-up|1
1508505|NCT00423670|4958508|P3|Treatment Period|Lost to Follow-up|3
1508506|NCT00423670|4958509|P2|Treatment Period|Lost to Follow-up|1
1508507|NCT00423670|4958510|P1|Treatment Period|Lost to Follow-up|2
1508508|NCT00423670|4958503|P8|Treatment Period|Protocol-defined clinical event|15
1508509|NCT00423670|4958504|P7|Treatment Period|Protocol-defined clinical event|16
1508510|NCT00423670|4958505|P6|Treatment Period|Protocol-defined clinical event|4
1508511|NCT00423670|4958506|P5|Treatment Period|Protocol-defined clinical event|5
1508512|NCT00423670|4958507|P4|Treatment Period|Protocol-defined clinical event|12
1508513|NCT00423670|4958508|P3|Treatment Period|Protocol-defined clinical event|4
1508514|NCT00423670|4958509|P2|Treatment Period|Protocol-defined clinical event|7
1508515|NCT00423670|4958510|P1|Treatment Period|Protocol-defined clinical event|0
1508516|NCT00423670|4958503|P8|Treatment Period|Adverse Event|2
1508517|NCT00423670|4958504|P7|Treatment Period|Adverse Event|7
1508518|NCT00423670|4958505|P6|Treatment Period|Adverse Event|4
1508519|NCT00423670|4958506|P5|Treatment Period|Adverse Event|9
1508520|NCT00423670|4958507|P4|Treatment Period|Adverse Event|20
1508521|NCT00423670|4958508|P3|Treatment Period|Adverse Event|15
1508522|NCT00423670|4958509|P2|Treatment Period|Adverse Event|12
1508523|NCT00423670|4958510|P1|Treatment Period|Adverse Event|8
1508524|NCT00423670|4958503|P8|Treatment Period|Switched to Arm 8 at TW 24|0
1508525|NCT00423670|4958504|P7|Treatment Period|Switched to Arm 8 at TW 24|0
1508526|NCT00423670|4958505|P6|Treatment Period|Switched to Arm 8 at TW 24|0
1508527|NCT00423670|4958506|P5|Treatment Period|Switched to Arm 8 at TW 24|0
1508528|NCT00423670|4958507|P4|Treatment Period|Switched to Arm 8 at TW 24|0
1508529|NCT00423670|4958508|P3|Treatment Period|Switched to Arm 8 at TW 24|0
1508530|NCT00423670|4958509|P2|Treatment Period|Switched to Arm 8 at TW 24|0
1508531|NCT00423670|4958510|P1|Treatment Period|Switched to Arm 8 at TW 24|36
1508532|NCT00423657|4958568|P2|Overall Study|Request of sponsor/investigator|0
1508533|NCT00423657|4958569|P1|Overall Study|Request of sponsor/investigator|1
1508534|NCT00423657|4958568|P2|Overall Study|Other|16
1508535|NCT00423657|4958569|P1|Overall Study|Other|15
1508536|NCT00423657|4958568|P2|Overall Study|Non-compliance|1
1508537|NCT00423657|4958569|P1|Overall Study|Non-compliance|0
1508538|NCT00423657|4958568|P2|Overall Study|Withdrew consent|8
1508539|NCT00423657|4958569|P1|Overall Study|Withdrew consent|10
1508540|NCT00423605|4958575|P1|Overall Study|Not one of the pre-specified options|5
1508541|NCT00423605|4958575|P1|Overall Study|Protocol Violation|7
1508542|NCT00423605|4958575|P1|Overall Study|Physician Decision|8
1508543|NCT00423605|4958575|P1|Overall Study|Sponsor Decision|3
1508544|NCT00423605|4958575|P1|Overall Study|Lack of Efficacy|38
1508545|NCT00423605|4958575|P1|Overall Study|Lost to Follow-up|15
1508546|NCT00423605|4958575|P1|Overall Study|Withdrawal by Subject|36
1508547|NCT00423605|4958575|P1|Overall Study|Adverse Event|129
1508548|NCT00423592|4958579|P1|Overall Study|Adverse Event (post Week 12)|5
1508549|NCT00423592|4958579|P1|Overall Study|Adverse Event (through Week 12)|2
1508550|NCT00423579|4958600|P2|Overall Study|Diagnosis of diabetes|1
1508551|NCT00423579|4958601|P1|Overall Study|Diagnosis of diabetes|0
1508552|NCT00423579|4958600|P2|Overall Study|Protocol Violation|3
1508553|NCT00423579|4958601|P1|Overall Study|Protocol Violation|1
1508554|NCT00423579|4958600|P2|Overall Study|Lost to Follow-up|0
1508555|NCT00423579|4958601|P1|Overall Study|Lost to Follow-up|3
1508556|NCT00423488|4958609|P2|Overall Study|No post baseline data|0
1508557|NCT00423488|4958610|P1|Overall Study|No post baseline data|3
1508558|NCT00423488|4958609|P2|Overall Study|No evidence of study drug intake|1
1508559|NCT00423488|4958610|P1|Overall Study|No evidence of study drug intake|2
1508560|NCT00423449|4958616|P5|Overall Study|Protocol Violation|0
1508561|NCT00423449|4958617|P4|Overall Study|Protocol Violation|1
1508562|NCT00423449|4958618|P3|Overall Study|Protocol Violation|2
1508563|NCT00423449|4958619|P2|Overall Study|Protocol Violation|0
1508564|NCT00423449|4958620|P1|Overall Study|Protocol Violation|0
1508565|NCT00423449|4958616|P5|Overall Study|Not Specified|0
1508566|NCT00423449|4958617|P4|Overall Study|Not Specified|1
1508567|NCT00423449|4958618|P3|Overall Study|Not Specified|0
1508568|NCT00423449|4958619|P2|Overall Study|Not Specified|0
1508569|NCT00423449|4958620|P1|Overall Study|Not Specified|0
1508570|NCT00423449|4958616|P5|Overall Study|Laboratory Adverse Event|0
1508571|NCT00423449|4958617|P4|Overall Study|Laboratory Adverse Event|0
1508572|NCT00423449|4958618|P3|Overall Study|Laboratory Adverse Event|2
1508573|NCT00423449|4958619|P2|Overall Study|Laboratory Adverse Event|1
1508574|NCT00423449|4958620|P1|Overall Study|Laboratory Adverse Event|0
1508575|NCT00423449|4958616|P5|Overall Study|Progressive Disease|4
1508576|NCT00423449|4958617|P4|Overall Study|Progressive Disease|11
1508577|NCT00423449|4958618|P3|Overall Study|Progressive Disease|8
1508579|NCT00423449|4958620|P1|Overall Study|Progressive Disease|1
1508580|NCT00423449|4958616|P5|Overall Study|Death|1
1508581|NCT00423449|4958617|P4|Overall Study|Death|1
1508582|NCT00423449|4958618|P3|Overall Study|Death|2
1508583|NCT00423449|4958619|P2|Overall Study|Death|0
1508584|NCT00423449|4958620|P1|Overall Study|Death|1
1508585|NCT00423449|4958616|P5|Overall Study|Clinical Adverse Event|2
1508586|NCT00423449|4958617|P4|Overall Study|Clinical Adverse Event|8
1508587|NCT00423449|4958618|P3|Overall Study|Clinical Adverse Event|1
1508588|NCT00423449|4958619|P2|Overall Study|Clinical Adverse Event|0
1508589|NCT00423449|4958620|P1|Overall Study|Clinical Adverse Event|1
1508590|NCT00423332|4958667|P2|Overall Study|Unblinded before 12 weeks|3
1508591|NCT00423332|4958668|P1|Overall Study|Unblinded before 12 weeks|1
1508592|NCT00423332|4958667|P2|Overall Study|Progressive at Week 6|1
1508593|NCT00423332|4958668|P1|Overall Study|Progressive at Week 6|0
1508594|NCT00423332|4958667|P2|Overall Study|Condition under investigation worsened|1
1508595|NCT00423332|4958668|P1|Overall Study|Condition under investigation worsened|1
1508596|NCT00423332|4958667|P2|Overall Study|Withdrawal by Subject|0
1508597|NCT00423332|4958668|P1|Overall Study|Withdrawal by Subject|1
1508598|NCT00423332|4958667|P2|Overall Study|Adverse Event|2
1508599|NCT00423332|4958668|P1|Overall Study|Adverse Event|6
1508600|NCT00423319|4958687|P2|Overall Study|Not specified|22
1508601|NCT00423319|4958688|P1|Overall Study|Not specified|23
1508602|NCT00423319|4958687|P2|Overall Study|No longer meets study criteria|15
1508603|NCT00423319|4958688|P1|Overall Study|No longer meets study criteria|15
1508604|NCT00423319|4958687|P2|Overall Study|Poor compliance or noncompliance|1
1508605|NCT00423319|4958688|P1|Overall Study|Poor compliance or noncompliance|1
1508606|NCT00423319|4958687|P2|Overall Study|Lost to Follow-up|3
1508607|NCT00423319|4958688|P1|Overall Study|Lost to Follow-up|4
1508608|NCT00423319|4958687|P2|Overall Study|Withdrawal by Subject|99
1508609|NCT00423319|4958688|P1|Overall Study|Withdrawal by Subject|86
1508610|NCT00423319|4958687|P2|Overall Study|Adverse Event|112
1508611|NCT00423319|4958688|P1|Overall Study|Adverse Event|93
1508612|NCT00423319|4958687|P2|Overall Study|Death|0
1508613|NCT00423319|4958688|P1|Overall Study|Death|2
1508614|NCT00423293|4958720|P1|Overall Study|Ineligible / No protocol treatment|11
1508615|NCT00423267|4958726|P2|Period A|Administrative|0
1508616|NCT00423267|4958727|P1|Period A|Administrative|1
1508617|NCT00423267|4958726|P2|Period A|Non-compliance with protocol|0
1508618|NCT00423267|4958727|P1|Period A|Non-compliance with protocol|1
1508619|NCT00423267|4958726|P2|Period A|Withdrawal by Subject|1
1508620|NCT00423267|4958727|P1|Period A|Withdrawal by Subject|0
1508621|NCT00423189|4958747|P3|Overall Study|Death|0
1508622|NCT00423189|4958748|P2|Overall Study|Death|1
1508623|NCT00423189|4958749|P1|Overall Study|Death|0
1508624|NCT00423176|4958771|P2|Overall Study|Did not meet protocol eligibility|4
1508625|NCT00423176|4958772|P1|Overall Study|Did not meet protocol eligibility|2
1508626|NCT00423176|4958771|P2|Overall Study|Protocol Violation|3
1508627|NCT00423176|4958772|P1|Overall Study|Protocol Violation|1
1508628|NCT00423176|4958771|P2|Overall Study|Withdrawal by Subject|3
1508629|NCT00423176|4958772|P1|Overall Study|Withdrawal by Subject|4
1508630|NCT00423176|4958771|P2|Overall Study|Lost to Follow-up|7
1508631|NCT00423176|4958772|P1|Overall Study|Lost to Follow-up|4
1508632|NCT00423176|4958771|P2|Overall Study|Treatment Failure|6
1508633|NCT00423176|4958772|P1|Overall Study|Treatment Failure|1
1508634|NCT00423176|4958771|P2|Overall Study|Adverse Event|6
1508635|NCT00423176|4958772|P1|Overall Study|Adverse Event|4
1508636|NCT00423150|4958780|P1|Overall Study|Administrative|4
1508637|NCT00423150|4958780|P1|Overall Study|Non-compliance with protocol|1
1508638|NCT00423150|4958780|P1|Overall Study|Withdrawal by Subject|1
1508639|NCT00423150|4958780|P1|Overall Study|Progression of disease being studied|69
1508640|NCT00423150|4958780|P1|Overall Study|Adverse Event|11
1508641|NCT00423098|4958786|P2|Overall Study|Death|0
1508642|NCT00423098|4958787|P1|Overall Study|Death|2
1508643|NCT00423098|4958786|P2|Overall Study|Administrative problems|1
1508644|NCT00423098|4958787|P1|Overall Study|Administrative problems|0
1508645|NCT00423098|4958786|P2|Overall Study|Unsatisfactory therapeutic effect|1
1508646|NCT00423098|4958787|P1|Overall Study|Unsatisfactory therapeutic effect|0
1508647|NCT00423098|4958786|P2|Overall Study|Adverse Event|2
1508648|NCT00423098|4958787|P1|Overall Study|Adverse Event|1
1508649|NCT00423085|4958814|P4|52-Week Open-Label Extension Phase|Death|2
1508650|NCT00423085|4958815|P3|52-Week Open-Label Extension Phase|Death|0
1508651|NCT00423085|4958816|P2|52-Week Open-Label Extension Phase|Death|0
1508652|NCT00423085|4958817|P1|52-Week Open-Label Extension Phase|Death|0
1508653|NCT00423085|4958814|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
1508654|NCT00423085|4958815|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
1508655|NCT00423085|4958816|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
1508656|NCT00423085|4958817|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
1508657|NCT00423085|4958814|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
1508658|NCT00423085|4958815|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
1508659|NCT00423085|4958816|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
1508660|NCT00423085|4958817|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
1508661|NCT00423085|4958814|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
1508662|NCT00423085|4958815|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
1508663|NCT00423085|4958816|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
1508664|NCT00423085|4958817|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
1508665|NCT00423085|4958814|P4|52-Week Open-Label Extension Phase|Adverse Event|97
1508666|NCT00423085|4958815|P3|52-Week Open-Label Extension Phase|Adverse Event|0
1508667|NCT00423085|4958816|P2|52-Week Open-Label Extension Phase|Adverse Event|0
1508668|NCT00423085|4958817|P1|52-Week Open-Label Extension Phase|Adverse Event|0
1508669|NCT00423085|4958814|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
1508670|NCT00423085|4958815|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
1508671|NCT00423085|4958816|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
1508672|NCT00423085|4958817|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
1508673|NCT00423085|4958814|P4|24-Week Double-Blind Treatment Phase|Death|0
1508674|NCT00423085|4958815|P3|24-Week Double-Blind Treatment Phase|Death|0
1508675|NCT00423085|4958816|P2|24-Week Double-Blind Treatment Phase|Death|1
1508676|NCT00423085|4958817|P1|24-Week Double-Blind Treatment Phase|Death|1
1508677|NCT00423085|4958814|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
1508678|NCT00423085|4958815|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
1508679|NCT00423085|4958816|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
1508680|NCT00423085|4958817|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
1508681|NCT00423085|4958814|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
1508682|NCT00423085|4958815|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
1508683|NCT00423085|4958816|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
1508684|NCT00423085|4958817|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
1508685|NCT00423085|4958814|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
1508686|NCT00423085|4958815|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
1508687|NCT00423085|4958816|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
1508688|NCT00423085|4958817|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
1508689|NCT00423085|4958814|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
1508690|NCT00423085|4958815|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
1508691|NCT00423085|4958816|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
1508692|NCT00423085|4958817|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
1508693|NCT00423046|4958846|P2|Overall Study|Other|345
1508694|NCT00423046|4958847|P1|Overall Study|Other|340
1508695|NCT00422942|4958913|P1|Overall Study|Study terminated by Sponsor|3
1508696|NCT00422903|4958932|P2|Overall Study|Informed Consent Withdrawn|2
1508697|NCT00422903|4958933|P1|Overall Study|Informed Consent Withdrawn|1
1508698|NCT00422903|4958932|P2|Overall Study|Adverse Event|2
1508699|NCT00422903|4958933|P1|Overall Study|Adverse Event|0
1508700|NCT00422903|4958932|P2|Overall Study|Disease Progression|1
1508701|NCT00422903|4958933|P1|Overall Study|Disease Progression|3
1508702|NCT00422799|4958982|P1|Overall Study|Adverse Event|7
1508703|NCT00422799|4958982|P1|Overall Study|Withdrawal by Subject|6
1508704|NCT00422734|4958991|P2|Overall Study|Partner Decision|3
1508705|NCT00422734|4958992|P1|Overall Study|Partner Decision|0
1508706|NCT00422734|4958991|P2|Overall Study|Adverse Event|3
1508707|NCT00422734|4958992|P1|Overall Study|Adverse Event|0
1508708|NCT00422734|4958991|P2|Overall Study|Withdrawal by Subject|8
1508709|NCT00422734|4958992|P1|Overall Study|Withdrawal by Subject|12
1508710|NCT00422734|4958991|P2|Overall Study|Protocol Violation|6
1508711|NCT00422734|4958992|P1|Overall Study|Protocol Violation|1
1508712|NCT00422734|4958991|P2|Overall Study|Physician Decision|1
1508713|NCT00422734|4958992|P1|Overall Study|Physician Decision|1
1508714|NCT00422669|4959038|P3|Overall Study|The study was terminated early.|7
1508715|NCT00422669|4959039|P2|Overall Study|The study was terminated early.|100
1508716|NCT00422669|4959040|P1|Overall Study|The study was terminated early.|98
1508717|NCT00422591|4959068|P1|Overall Study|Withdrawal by Subject|2
1508718|NCT00422591|4959068|P1|Overall Study|Physician Decision|4
1508719|NCT00422513|4959076|P2|Overall Study|Death|7
1508720|NCT00422513|4959077|P1|Overall Study|Death|3
1508721|NCT00422513|4959076|P2|Overall Study|Adverse Event|4
1508722|NCT00422513|4959077|P1|Overall Study|Adverse Event|4
1508723|NCT00422513|4959076|P2|Overall Study|early termination of the study|80
1508724|NCT00422513|4959077|P1|Overall Study|early termination of the study|67
1508725|NCT00422513|4959076|P2|Overall Study|Withdrawal by Subject|1
1508726|NCT00422513|4959077|P1|Overall Study|Withdrawal by Subject|2
1508727|NCT00422513|4959076|P2|Overall Study|Refused Treatment|2
1508728|NCT00422513|4959077|P1|Overall Study|Refused Treatment|4
1508729|NCT00422513|4959076|P2|Overall Study|Protocol Violation|7
1508730|NCT00422513|4959077|P1|Overall Study|Protocol Violation|23
1508731|NCT00422513|4959076|P2|Overall Study|Lack of Efficacy|5
1508732|NCT00422513|4959077|P1|Overall Study|Lack of Efficacy|4
1508733|NCT00422422|4959094|P1|Overall Study|AE, non-serious non-fatal|5
1508734|NCT00422422|4959094|P1|Overall Study|SAE, non-fatal|1
1508735|NCT00422422|4959094|P1|Overall Study|Withdrawal by Subject|2
1508736|NCT00422422|4959094|P1|Overall Study|Protocol Violation|1
1508737|NCT00422422|4959094|P1|Overall Study|Lack of Efficacy|1
1508738|NCT00422383|4959111|P5|Overall Study|Withdrawal by Subject|1
1508739|NCT00422383|4959112|P4|Overall Study|Withdrawal by Subject|0
1508740|NCT00422383|4959113|P3|Overall Study|Withdrawal by Subject|0
1508741|NCT00422383|4959114|P2|Overall Study|Withdrawal by Subject|5
1508742|NCT00422383|4959115|P1|Overall Study|Withdrawal by Subject|5
1508743|NCT00422383|4959111|P5|Overall Study|Protocol Violation|0
1508744|NCT00422383|4959112|P4|Overall Study|Protocol Violation|0
1508745|NCT00422383|4959113|P3|Overall Study|Protocol Violation|1
1508746|NCT00422383|4959114|P2|Overall Study|Protocol Violation|1
1508747|NCT00422383|4959115|P1|Overall Study|Protocol Violation|1
1508748|NCT00422383|4959111|P5|Overall Study|Lost to Follow-up|1
1508749|NCT00422383|4959112|P4|Overall Study|Lost to Follow-up|0
1508750|NCT00422383|4959113|P3|Overall Study|Lost to Follow-up|0
1508751|NCT00422383|4959114|P2|Overall Study|Lost to Follow-up|1
1508752|NCT00422383|4959115|P1|Overall Study|Lost to Follow-up|0
1508753|NCT00422383|4959111|P5|Overall Study|Lack of Efficacy|1
1508754|NCT00422383|4959112|P4|Overall Study|Lack of Efficacy|1
1508755|NCT00422383|4959113|P3|Overall Study|Lack of Efficacy|2
1508756|NCT00422383|4959114|P2|Overall Study|Lack of Efficacy|4
1508757|NCT00422383|4959115|P1|Overall Study|Lack of Efficacy|4
1508758|NCT00422383|4959111|P5|Overall Study|Adverse Event|0
1508759|NCT00422383|4959112|P4|Overall Study|Adverse Event|1
1508760|NCT00422383|4959113|P3|Overall Study|Adverse Event|1
1508761|NCT00422383|4959114|P2|Overall Study|Adverse Event|3
1508762|NCT00422383|4959115|P1|Overall Study|Adverse Event|5
1508763|NCT00422292|4959258|P4|Overall Study|Withdrawal by Subject|13
1508764|NCT00422292|4959259|P3|Overall Study|Withdrawal by Subject|7
1508765|NCT00422292|4959260|P2|Overall Study|Withdrawal by Subject|25
1508766|NCT00422292|4959261|P1|Overall Study|Withdrawal by Subject|6
1508767|NCT00422292|4959258|P4|Overall Study|Lost to Follow-up|6
1508768|NCT00422292|4959259|P3|Overall Study|Lost to Follow-up|6
1508769|NCT00422292|4959260|P2|Overall Study|Lost to Follow-up|12
1508770|NCT00422292|4959261|P1|Overall Study|Lost to Follow-up|6
1508771|NCT00422292|4959258|P4|Overall Study|Protocol Violation|5
1508772|NCT00422292|4959259|P3|Overall Study|Protocol Violation|8
1508773|NCT00422292|4959260|P2|Overall Study|Protocol Violation|25
1508774|NCT00422292|4959261|P1|Overall Study|Protocol Violation|4
1508775|NCT00422292|4959258|P4|Overall Study|Adverse Event|0
1508776|NCT00422292|4959259|P3|Overall Study|Adverse Event|1
1508777|NCT00422292|4959260|P2|Overall Study|Adverse Event|0
1508778|NCT00422292|4959261|P1|Overall Study|Adverse Event|1
1508779|NCT00422292|4959258|P4|Overall Study|Serious adverse events|0
1508780|NCT00422292|4959259|P3|Overall Study|Serious adverse events|0
1508781|NCT00422292|4959260|P2|Overall Study|Serious adverse events|4
1508782|NCT00422292|4959261|P1|Overall Study|Serious adverse events|1
1508783|NCT00422227|4959300|P2|Overall Study|Withdrawal by Subject|4
1508784|NCT00422227|4959301|P1|Overall Study|Withdrawal by Subject|0
1508785|NCT00422227|4959300|P2|Overall Study|Lost to Follow-up|3
1508786|NCT00422227|4959301|P1|Overall Study|Lost to Follow-up|1
1508787|NCT00422227|4959300|P2|Overall Study|Adverse Event|8
1508788|NCT00422227|4959301|P1|Overall Study|Adverse Event|3
1508789|NCT00422162|4959331|P2|Overall Study|Didn't Receive Treatment|1
1508790|NCT00422162|4959332|P1|Overall Study|Didn't Receive Treatment|0
1508791|NCT00422162|4959331|P2|Overall Study|Not Specified|1
1508792|NCT00422162|4959332|P1|Overall Study|Not Specified|0
1508793|NCT00422162|4959331|P2|Overall Study|Non-Compliant with Protocol|1
1508794|NCT00422162|4959332|P1|Overall Study|Non-Compliant with Protocol|1
1508795|NCT00422162|4959331|P2|Overall Study|Lost to Follow-up|2
1508796|NCT00422162|4959332|P1|Overall Study|Lost to Follow-up|1
1508797|NCT00422162|4959331|P2|Overall Study|Withdrawal by Subject|6
1508798|NCT00422162|4959332|P1|Overall Study|Withdrawal by Subject|7
1508799|NCT00422162|4959331|P2|Overall Study|Lack of Efficacy|10
1508800|NCT00422162|4959332|P1|Overall Study|Lack of Efficacy|4
1508801|NCT00422162|4959331|P2|Overall Study|Adverse Event|9
1508802|NCT00422162|4959332|P1|Overall Study|Adverse Event|11
1508803|NCT00422097|4959392|P8|Dose Level 2|Still on treatment|0
1508804|NCT00422097|4959393|P7|Dose Level 2|Still on treatment|0
1508805|NCT00422097|4959394|P6|Dose Level 2|Still on treatment|0
1508806|NCT00422097|4959395|P5|Dose Level 2|Still on treatment|0
1508807|NCT00422097|4959396|P4|Dose Level 2|Still on treatment|0
1508808|NCT00422097|4959397|P3|Dose Level 2|Still on treatment|0
1508809|NCT00422097|4959398|P2|Dose Level 2|Still on treatment|1
1508810|NCT00422097|4959399|P1|Dose Level 2|Still on treatment|0
1508811|NCT00422058|4959464|P6|Open-Label Extension, Week 20-104|Other|18
1508812|NCT00422058|4959465|P5|Open-Label Extension, Week 20-104|Other|16
1508813|NCT00422058|4959466|P4|Open-Label Extension, Week 20-104|Other|13
1508814|NCT00422058|4959467|P3|Open-Label Extension, Week 20-104|Other|6
1508815|NCT00422058|4959468|P2|Open-Label Extension, Week 20-104|Other|14
1508816|NCT00422058|4959469|P1|Open-Label Extension, Week 20-104|Other|13
1508817|NCT00422058|4959464|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
1508818|NCT00422058|4959465|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
1508819|NCT00422058|4959466|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
1508820|NCT00422058|4959467|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
1508821|NCT00422058|4959468|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
1508822|NCT00422058|4959469|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
1508823|NCT00422058|4959464|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
1508824|NCT00422058|4959465|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
1508825|NCT00422058|4959466|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
1508826|NCT00422058|4959467|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
1508827|NCT00422058|4959468|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
1508828|NCT00422058|4959469|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
1508829|NCT00422058|4959464|P6|Open-Label Extension, Week 20-104|Adverse Event|0
1508830|NCT00422058|4959465|P5|Open-Label Extension, Week 20-104|Adverse Event|4
1508831|NCT00422058|4959466|P4|Open-Label Extension, Week 20-104|Adverse Event|4
1508832|NCT00422058|4959467|P3|Open-Label Extension, Week 20-104|Adverse Event|7
1508833|NCT00422058|4959468|P2|Open-Label Extension, Week 20-104|Adverse Event|4
1508834|NCT00422058|4959469|P1|Open-Label Extension, Week 20-104|Adverse Event|3
1508835|NCT00422058|4959464|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
1508836|NCT00422058|4959465|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
1508837|NCT00422058|4959466|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
1508838|NCT00422058|4959467|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
1508839|NCT00422058|4959468|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
1508840|NCT00422058|4959469|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
1508841|NCT00422058|4959464|P6|Double-Blind, Week 0-20|Other|10
1508842|NCT00422058|4959465|P5|Double-Blind, Week 0-20|Other|4
1508843|NCT00422058|4959466|P4|Double-Blind, Week 0-20|Other|8
1508844|NCT00422058|4959467|P3|Double-Blind, Week 0-20|Other|8
1508845|NCT00422058|4959468|P2|Double-Blind, Week 0-20|Other|3
1508846|NCT00422058|4959469|P1|Double-Blind, Week 0-20|Other|11
1508847|NCT00422058|4959464|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
1508848|NCT00422058|4959465|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
1508849|NCT00422058|4959466|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
1508850|NCT00422058|4959467|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
1508851|NCT00422058|4959468|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
1508852|NCT00422058|4959469|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
1508853|NCT00422058|4959464|P6|Double-Blind, Week 0-20|Protocol Violation|2
1508854|NCT00422058|4959465|P5|Double-Blind, Week 0-20|Protocol Violation|2
1508855|NCT00422058|4959466|P4|Double-Blind, Week 0-20|Protocol Violation|3
1508856|NCT00422058|4959467|P3|Double-Blind, Week 0-20|Protocol Violation|2
1508857|NCT00422058|4959468|P2|Double-Blind, Week 0-20|Protocol Violation|2
1508858|NCT00422058|4959469|P1|Double-Blind, Week 0-20|Protocol Violation|3
1508859|NCT00422058|4959464|P6|Double-Blind, Week 0-20|Adverse Event|3
1508860|NCT00422058|4959465|P5|Double-Blind, Week 0-20|Adverse Event|5
1508861|NCT00422058|4959466|P4|Double-Blind, Week 0-20|Adverse Event|9
1508862|NCT00422058|4959467|P3|Double-Blind, Week 0-20|Adverse Event|5
1508863|NCT00422058|4959468|P2|Double-Blind, Week 0-20|Adverse Event|4
1508864|NCT00422058|4959469|P1|Double-Blind, Week 0-20|Adverse Event|3
1508865|NCT00421993|4959610|P4|Overall Study|Subject transportation issues|1
1508866|NCT00421993|4959611|P3|Overall Study|Subject transportation issues|0
1508867|NCT00421993|4959612|P2|Overall Study|Subject transportation issues|0
1508868|NCT00421993|4959613|P1|Overall Study|Subject transportation issues|0
1508869|NCT00421993|4959610|P4|Overall Study|Pregnancy|2
1508870|NCT00421993|4959611|P3|Overall Study|Pregnancy|1
1508871|NCT00421993|4959612|P2|Overall Study|Pregnancy|1
1508872|NCT00421993|4959613|P1|Overall Study|Pregnancy|0
1508873|NCT00421993|4959610|P4|Overall Study|Lack of Efficacy|5
1508874|NCT00421993|4959611|P3|Overall Study|Lack of Efficacy|0
1508875|NCT00421993|4959612|P2|Overall Study|Lack of Efficacy|3
1508876|NCT00421993|4959613|P1|Overall Study|Lack of Efficacy|0
1508877|NCT00421993|4959610|P4|Overall Study|Protocol Violation|1
1508878|NCT00421993|4959611|P3|Overall Study|Protocol Violation|0
1508879|NCT00421993|4959612|P2|Overall Study|Protocol Violation|2
1508880|NCT00421993|4959613|P1|Overall Study|Protocol Violation|2
1508881|NCT00421993|4959610|P4|Overall Study|Adverse Event|4
1508882|NCT00421993|4959611|P3|Overall Study|Adverse Event|6
1508883|NCT00421993|4959612|P2|Overall Study|Adverse Event|1
1508884|NCT00421993|4959613|P1|Overall Study|Adverse Event|11
1508885|NCT00421993|4959610|P4|Overall Study|Lost to Follow-up|20
1508886|NCT00421993|4959611|P3|Overall Study|Lost to Follow-up|22
1508887|NCT00421993|4959612|P2|Overall Study|Lost to Follow-up|19
1508888|NCT00421993|4959613|P1|Overall Study|Lost to Follow-up|18
1508889|NCT00421993|4959610|P4|Overall Study|Withdrawal by Subject|24
1508890|NCT00421993|4959611|P3|Overall Study|Withdrawal by Subject|23
1508891|NCT00421993|4959612|P2|Overall Study|Withdrawal by Subject|23
1508892|NCT00421993|4959613|P1|Overall Study|Withdrawal by Subject|22
1508893|NCT00421928|4959650|P3|Overall Study|Death|0
1508894|NCT00421928|4959651|P2|Overall Study|Death|1
1508895|NCT00421928|4959652|P1|Overall Study|Death|0
1508896|NCT00421928|4959650|P3|Overall Study|All other|27
1508897|NCT00421928|4959651|P2|Overall Study|All other|21
1508898|NCT00421928|4959652|P1|Overall Study|All other|26
1508899|NCT00421928|4959650|P3|Overall Study|Study drug non-compliant|4
1508900|NCT00421928|4959651|P2|Overall Study|Study drug non-compliant|7
1508901|NCT00421928|4959652|P1|Overall Study|Study drug non-compliant|6
1508902|NCT00421928|4959650|P3|Overall Study|Lack of Efficacy|35
1508903|NCT00421928|4959651|P2|Overall Study|Lack of Efficacy|7
1508904|NCT00421928|4959652|P1|Overall Study|Lack of Efficacy|15
1508905|NCT00421928|4959650|P3|Overall Study|Withdrawal by Subject|43
1508906|NCT00421928|4959651|P2|Overall Study|Withdrawal by Subject|48
1508907|NCT00421928|4959652|P1|Overall Study|Withdrawal by Subject|50
1508908|NCT00421928|4959650|P3|Overall Study|Lost to Follow-up|3
1508909|NCT00421928|4959651|P2|Overall Study|Lost to Follow-up|0
1508910|NCT00421928|4959652|P1|Overall Study|Lost to Follow-up|5
1508911|NCT00421928|4959650|P3|Overall Study|Adverse Event|22
1508912|NCT00421928|4959651|P2|Overall Study|Adverse Event|140
1508913|NCT00421928|4959652|P1|Overall Study|Adverse Event|61
1508914|NCT00421889|4959687|P9|Overall Study|Lost to Follow-up|1
1508915|NCT00421889|4959688|P8|Overall Study|Lost to Follow-up|0
1508916|NCT00421889|4959689|P7|Overall Study|Lost to Follow-up|0
1508917|NCT00421889|4959690|P6|Overall Study|Lost to Follow-up|0
1508918|NCT00421889|4959691|P5|Overall Study|Lost to Follow-up|0
1508919|NCT00421889|4959692|P4|Overall Study|Lost to Follow-up|0
1508920|NCT00421889|4959693|P3|Overall Study|Lost to Follow-up|0
1508921|NCT00421889|4959694|P2|Overall Study|Lost to Follow-up|0
1508922|NCT00421889|4959695|P1|Overall Study|Lost to Follow-up|0
1508923|NCT00421889|4959687|P9|Overall Study|Patient/Investigator request|3
1508924|NCT00421889|4959688|P8|Overall Study|Patient/Investigator request|1
1508925|NCT00421889|4959689|P7|Overall Study|Patient/Investigator request|0
1508926|NCT00421889|4959690|P6|Overall Study|Patient/Investigator request|9
1508927|NCT00421889|4959691|P5|Overall Study|Patient/Investigator request|0
1508928|NCT00421889|4959692|P4|Overall Study|Patient/Investigator request|0
1508929|NCT00421889|4959693|P3|Overall Study|Patient/Investigator request|0
1508930|NCT00421889|4959694|P2|Overall Study|Patient/Investigator request|0
1508931|NCT00421889|4959695|P1|Overall Study|Patient/Investigator request|0
1508932|NCT00421889|4959687|P9|Overall Study|Progressive disease|5
1508933|NCT00421889|4959688|P8|Overall Study|Progressive disease|1
1508934|NCT00421889|4959689|P7|Overall Study|Progressive disease|3
1508935|NCT00421889|4959690|P6|Overall Study|Progressive disease|21
1508936|NCT00421889|4959691|P5|Overall Study|Progressive disease|2
1508937|NCT00421889|4959692|P4|Overall Study|Progressive disease|3
1508938|NCT00421889|4959693|P3|Overall Study|Progressive disease|2
1508939|NCT00421889|4959694|P2|Overall Study|Progressive disease|2
1508940|NCT00421889|4959695|P1|Overall Study|Progressive disease|3
1508941|NCT00421889|4959687|P9|Overall Study|Death|0
1508942|NCT00421889|4959688|P8|Overall Study|Death|0
1508943|NCT00421889|4959689|P7|Overall Study|Death|0
1508944|NCT00421889|4959690|P6|Overall Study|Death|1
1508945|NCT00421889|4959691|P5|Overall Study|Death|1
1508946|NCT00421889|4959692|P4|Overall Study|Death|0
1508947|NCT00421889|4959693|P3|Overall Study|Death|0
1508948|NCT00421889|4959694|P2|Overall Study|Death|0
1508949|NCT00421889|4959695|P1|Overall Study|Death|0
1508950|NCT00421889|4959687|P9|Overall Study|Withdrawal by Subject|0
1508951|NCT00421889|4959688|P8|Overall Study|Withdrawal by Subject|0
1508952|NCT00421889|4959689|P7|Overall Study|Withdrawal by Subject|0
1508953|NCT00421889|4959690|P6|Overall Study|Withdrawal by Subject|0
1508954|NCT00421889|4959691|P5|Overall Study|Withdrawal by Subject|2
1508955|NCT00421889|4959692|P4|Overall Study|Withdrawal by Subject|0
1508956|NCT00421889|4959693|P3|Overall Study|Withdrawal by Subject|0
1508957|NCT00421889|4959694|P2|Overall Study|Withdrawal by Subject|3
1508958|NCT00421889|4959695|P1|Overall Study|Withdrawal by Subject|1
1508959|NCT00421889|4959687|P9|Overall Study|Adverse Event|2
1508960|NCT00421889|4959688|P8|Overall Study|Adverse Event|0
1508961|NCT00421889|4959689|P7|Overall Study|Adverse Event|1
1508962|NCT00421889|4959690|P6|Overall Study|Adverse Event|4
1508963|NCT00421889|4959691|P5|Overall Study|Adverse Event|1
1508964|NCT00421889|4959692|P4|Overall Study|Adverse Event|1
1508965|NCT00421889|4959693|P3|Overall Study|Adverse Event|1
1508966|NCT00421889|4959694|P2|Overall Study|Adverse Event|0
1508967|NCT00421889|4959695|P1|Overall Study|Adverse Event|1
1508968|NCT00421733|4959740|P3|Overall Study|Protocol deviation|2
1508969|NCT00421733|4959741|P2|Overall Study|Protocol deviation|7
1508970|NCT00421733|4959742|P1|Overall Study|Protocol deviation|4
1508971|NCT00421733|4959740|P3|Overall Study|Sponsor request|3
1508972|NCT00421733|4959741|P2|Overall Study|Sponsor request|0
1508973|NCT00421733|4959742|P1|Overall Study|Sponsor request|1
1508974|NCT00421733|4959740|P3|Overall Study|Did not satisfy entry criteria|2
1508975|NCT00421733|4959741|P2|Overall Study|Did not satisfy entry criteria|3
1508976|NCT00421733|4959742|P1|Overall Study|Did not satisfy entry criteria|1
1508977|NCT00421733|4959740|P3|Overall Study|Administrative|0
1508978|NCT00421733|4959741|P2|Overall Study|Administrative|0
1508979|NCT00421733|4959742|P1|Overall Study|Administrative|2
1508980|NCT00421733|4959740|P3|Overall Study|Required dialysis|0
1508981|NCT00421733|4959741|P2|Overall Study|Required dialysis|0
1508982|NCT00421733|4959742|P1|Overall Study|Required dialysis|1
1508983|NCT00421733|4959740|P3|Overall Study|Death|0
1508984|NCT00421733|4959741|P2|Overall Study|Death|3
1508985|NCT00421733|4959742|P1|Overall Study|Death|0
1508986|NCT00421733|4959740|P3|Overall Study|Withdrawal by Subject|7
1508987|NCT00421733|4959741|P2|Overall Study|Withdrawal by Subject|2
1508988|NCT00421733|4959742|P1|Overall Study|Withdrawal by Subject|1
1508989|NCT00421733|4959740|P3|Overall Study|Lost to Follow-up|4
1508990|NCT00421733|4959741|P2|Overall Study|Lost to Follow-up|2
1508991|NCT00421733|4959742|P1|Overall Study|Lost to Follow-up|1
1508992|NCT00421733|4959740|P3|Overall Study|Adverse Event|2
1508993|NCT00421733|4959741|P2|Overall Study|Adverse Event|9
1508994|NCT00421733|4959742|P1|Overall Study|Adverse Event|4
1508995|NCT00421707|4959762|P2|Period 3:Treatment Period 2|Adverse Event|2
1508996|NCT00421707|4959763|P1|Period 3:Treatment Period 2|Adverse Event|0
1508997|NCT00421707|4959762|P2|Period 3:Treatment Period 2|Protocol Violation|0
1508998|NCT00421707|4959763|P1|Period 3:Treatment Period 2|Protocol Violation|1
1508999|NCT00421707|4959762|P2|Period 3:Treatment Period 2|Withdrawal by Subject|1
1509000|NCT00421707|4959763|P1|Period 3:Treatment Period 2|Withdrawal by Subject|1
1509001|NCT00421707|4959762|P2|Period 2: Washout|Other: Pregnancy|1
1509002|NCT00421707|4959763|P1|Period 2: Washout|Other: Pregnancy|0
1509003|NCT00421707|4959762|P2|Period 2: Washout|Lost to Follow-up|1
1509004|NCT00421707|4959763|P1|Period 2: Washout|Lost to Follow-up|0
1509005|NCT00421707|4959762|P2|Period 2: Washout|Withdrawal by Subject|1
1509006|NCT00421707|4959763|P1|Period 2: Washout|Withdrawal by Subject|0
1509007|NCT00421707|4959762|P2|Period 2: Washout|Adverse Event|1
1509008|NCT00421707|4959763|P1|Period 2: Washout|Adverse Event|1
1509009|NCT00421707|4959762|P2|Period 1: Treatment Period 1|Protocol Violation|0
1509010|NCT00421707|4959763|P1|Period 1: Treatment Period 1|Protocol Violation|1
1509011|NCT00421707|4959762|P2|Period 1: Treatment Period 1|Lost to Follow-up|2
1509012|NCT00421707|4959763|P1|Period 1: Treatment Period 1|Lost to Follow-up|2
1509013|NCT00421707|4959762|P2|Period 1: Treatment Period 1|Adverse Event|2
1509014|NCT00421707|4959763|P1|Period 1: Treatment Period 1|Adverse Event|7
1509015|NCT00421707|4959762|P2|Period 1: Treatment Period 1|Withdrawal by Subject|5
1509016|NCT00421707|4959763|P1|Period 1: Treatment Period 1|Withdrawal by Subject|1
1509017|NCT00421408|4959814|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
1509018|NCT00421408|4959815|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
1509019|NCT00421408|4959814|P2|Overall Study|Lost to Follow-up|20
1509020|NCT00421408|4959815|P1|Overall Study|Lost to Follow-up|30
1509021|NCT00421343|4959833|P1|Overall Study|Lost to follow-up|3
1509022|NCT00421343|4959833|P1|Overall Study|Withdrawal by Subject|2
1509023|NCT00421343|4959833|P1|Overall Study|Death|1
1509024|NCT00421174|4959839|P2|Overall Study|Ineligible due to infection|0
1509025|NCT00421174|4959840|P1|Overall Study|Ineligible due to infection|2
1509026|NCT00421174|4959839|P2|Overall Study|Withdrawal by Subject|1
1509027|NCT00421174|4959840|P1|Overall Study|Withdrawal by Subject|0
1509028|NCT00420927|4959885|P7|Period 2|Took prohibited medication|0
1509029|NCT00420927|4959886|P6|Period 2|Took prohibited medication|0
1509030|NCT00420927|4959887|P5|Period 2|Took prohibited medication|1
1509031|NCT00420927|4959888|P4|Period 2|Took prohibited medication|0
1509032|NCT00420927|4959889|P3|Period 2|Took prohibited medication|0
1509033|NCT00420927|4959890|P2|Period 2|Took prohibited medication|0
1509034|NCT00420927|4959891|P1|Period 2|Took prohibited medication|0
1509035|NCT00420927|4959885|P7|Period 2|Methotrexate intolerance|1
1509036|NCT00420927|4959886|P6|Period 2|Methotrexate intolerance|0
1509037|NCT00420927|4959887|P5|Period 2|Methotrexate intolerance|0
1509038|NCT00420927|4959888|P4|Period 2|Methotrexate intolerance|0
1509039|NCT00420927|4959889|P3|Period 2|Methotrexate intolerance|0
1509040|NCT00420927|4959890|P2|Period 2|Methotrexate intolerance|0
1509041|NCT00420927|4959891|P1|Period 2|Methotrexate intolerance|0
1509042|NCT00420927|4959885|P7|Period 2|Noncompliant with study drug|2
1509043|NCT00420927|4959886|P6|Period 2|Noncompliant with study drug|0
1509044|NCT00420927|4959887|P5|Period 2|Noncompliant with study drug|0
1509045|NCT00420927|4959888|P4|Period 2|Noncompliant with study drug|1
1509046|NCT00420927|4959889|P3|Period 2|Noncompliant with study drug|0
1509047|NCT00420927|4959890|P2|Period 2|Noncompliant with study drug|0
1509048|NCT00420927|4959891|P1|Period 2|Noncompliant with study drug|0
1509049|NCT00420927|4959885|P7|Period 2|Randomization error|0
1509050|NCT00420927|4959886|P6|Period 2|Randomization error|1
1509051|NCT00420927|4959887|P5|Period 2|Randomization error|1
1509052|NCT00420927|4959888|P4|Period 2|Randomization error|0
1509053|NCT00420927|4959889|P3|Period 2|Randomization error|0
1509054|NCT00420927|4959890|P2|Period 2|Randomization error|0
1509055|NCT00420927|4959891|P1|Period 2|Randomization error|0
1509056|NCT00420927|4959885|P7|Period 2|Sponsor decision|1
1509057|NCT00420927|4959886|P6|Period 2|Sponsor decision|0
1509058|NCT00420927|4959887|P5|Period 2|Sponsor decision|0
1509059|NCT00420927|4959888|P4|Period 2|Sponsor decision|0
1509060|NCT00420927|4959889|P3|Period 2|Sponsor decision|1
1509061|NCT00420927|4959890|P2|Period 2|Sponsor decision|0
1509062|NCT00420927|4959891|P1|Period 2|Sponsor decision|0
1509063|NCT00420927|4959885|P7|Period 2|Physician Decision|0
1509064|NCT00420927|4959886|P6|Period 2|Physician Decision|1
1509065|NCT00420927|4959887|P5|Period 2|Physician Decision|1
1509066|NCT00420927|4959888|P4|Period 2|Physician Decision|0
1509067|NCT00420927|4959889|P3|Period 2|Physician Decision|0
1509068|NCT00420927|4959890|P2|Period 2|Physician Decision|0
1509069|NCT00420927|4959891|P1|Period 2|Physician Decision|0
1509070|NCT00420927|4959885|P7|Period 2|Subject unable to find transportation|1
1509071|NCT00420927|4959886|P6|Period 2|Subject unable to find transportation|0
1509072|NCT00420927|4959887|P5|Period 2|Subject unable to find transportation|0
1509073|NCT00420927|4959888|P4|Period 2|Subject unable to find transportation|0
1509074|NCT00420927|4959889|P3|Period 2|Subject unable to find transportation|0
1509075|NCT00420927|4959890|P2|Period 2|Subject unable to find transportation|0
1509076|NCT00420927|4959891|P1|Period 2|Subject unable to find transportation|0
1509077|NCT00420927|4959885|P7|Period 2|Received wrong treatment/incorrect dose|1
1509078|NCT00420927|4959886|P6|Period 2|Received wrong treatment/incorrect dose|0
1509079|NCT00420927|4959887|P5|Period 2|Received wrong treatment/incorrect dose|0
1509080|NCT00420927|4959888|P4|Period 2|Received wrong treatment/incorrect dose|0
1509081|NCT00420927|4959889|P3|Period 2|Received wrong treatment/incorrect dose|0
1509082|NCT00420927|4959890|P2|Period 2|Received wrong treatment/incorrect dose|0
1509083|NCT00420927|4959891|P1|Period 2|Received wrong treatment/incorrect dose|0
1509084|NCT00420927|4959885|P7|Period 2|Lack of efficacy/Loss of efficacy|6
1509085|NCT00420927|4959886|P6|Period 2|Lack of efficacy/Loss of efficacy|2
1509086|NCT00420927|4959887|P5|Period 2|Lack of efficacy/Loss of efficacy|6
1509087|NCT00420927|4959888|P4|Period 2|Lack of efficacy/Loss of efficacy|1
1509088|NCT00420927|4959889|P3|Period 2|Lack of efficacy/Loss of efficacy|2
1509089|NCT00420927|4959890|P2|Period 2|Lack of efficacy/Loss of efficacy|0
1509090|NCT00420927|4959891|P1|Period 2|Lack of efficacy/Loss of efficacy|0
1509091|NCT00420927|4959885|P7|Period 2|Lost to Follow-up|9
1509092|NCT00420927|4959886|P6|Period 2|Lost to Follow-up|3
1509093|NCT00420927|4959887|P5|Period 2|Lost to Follow-up|6
1509094|NCT00420927|4959888|P4|Period 2|Lost to Follow-up|2
1509095|NCT00420927|4959889|P3|Period 2|Lost to Follow-up|2
1509096|NCT00420927|4959890|P2|Period 2|Lost to Follow-up|0
1509097|NCT00420927|4959891|P1|Period 2|Lost to Follow-up|0
1509098|NCT00420927|4959885|P7|Period 2|Withdrawal by Subject|12
1509099|NCT00420927|4959886|P6|Period 2|Withdrawal by Subject|2
1509100|NCT00420927|4959887|P5|Period 2|Withdrawal by Subject|11
1509101|NCT00420927|4959888|P4|Period 2|Withdrawal by Subject|3
1509102|NCT00420927|4959889|P3|Period 2|Withdrawal by Subject|1
1509103|NCT00420927|4959890|P2|Period 2|Withdrawal by Subject|0
1509104|NCT00420927|4959891|P1|Period 2|Withdrawal by Subject|0
1509105|NCT00420927|4959885|P7|Period 2|Adverse Event|20
1509106|NCT00420927|4959886|P6|Period 2|Adverse Event|6
1509107|NCT00420927|4959887|P5|Period 2|Adverse Event|17
1509108|NCT00420927|4959888|P4|Period 2|Adverse Event|3
1509109|NCT00420927|4959889|P3|Period 2|Adverse Event|7
1509110|NCT00420927|4959890|P2|Period 2|Adverse Event|0
1509111|NCT00420927|4959891|P1|Period 2|Adverse Event|0
1509112|NCT00420927|4959885|P7|Period 1|Took prohibited medication|0
1509113|NCT00420927|4959886|P6|Period 1|Took prohibited medication|0
1509114|NCT00420927|4959887|P5|Period 1|Took prohibited medication|0
1509115|NCT00420927|4959888|P4|Period 1|Took prohibited medication|0
1509116|NCT00420927|4959889|P3|Period 1|Took prohibited medication|0
1509117|NCT00420927|4959890|P2|Period 1|Took prohibited medication|3
1509118|NCT00420927|4959891|P1|Period 1|Took prohibited medication|1
1509119|NCT00420927|4959885|P7|Period 1|Failed to meet entry criteria|0
1509120|NCT00420927|4959886|P6|Period 1|Failed to meet entry criteria|0
1509121|NCT00420927|4959887|P5|Period 1|Failed to meet entry criteria|0
1509122|NCT00420927|4959888|P4|Period 1|Failed to meet entry criteria|0
1509123|NCT00420927|4959889|P3|Period 1|Failed to meet entry criteria|0
1509124|NCT00420927|4959890|P2|Period 1|Failed to meet entry criteria|7
1509125|NCT00420927|4959891|P1|Period 1|Failed to meet entry criteria|8
1509126|NCT00420927|4959885|P7|Period 1|Received wrong treatment/incorrect dose|0
1509127|NCT00420927|4959886|P6|Period 1|Received wrong treatment/incorrect dose|0
1509128|NCT00420927|4959887|P5|Period 1|Received wrong treatment/incorrect dose|0
1509129|NCT00420927|4959888|P4|Period 1|Received wrong treatment/incorrect dose|0
1509130|NCT00420927|4959889|P3|Period 1|Received wrong treatment/incorrect dose|0
1509131|NCT00420927|4959890|P2|Period 1|Received wrong treatment/incorrect dose|1
1509132|NCT00420927|4959891|P1|Period 1|Received wrong treatment/incorrect dose|0
1509133|NCT00420927|4959885|P7|Period 1|Subject received new diagnosis|0
1509134|NCT00420927|4959886|P6|Period 1|Subject received new diagnosis|0
1509135|NCT00420927|4959887|P5|Period 1|Subject received new diagnosis|0
1509136|NCT00420927|4959888|P4|Period 1|Subject received new diagnosis|0
1509137|NCT00420927|4959889|P3|Period 1|Subject received new diagnosis|0
1509138|NCT00420927|4959890|P2|Period 1|Subject received new diagnosis|2
1509139|NCT00420927|4959891|P1|Period 1|Subject received new diagnosis|0
1509140|NCT00420927|4959885|P7|Period 1|Study site closure|0
1509141|NCT00420927|4959886|P6|Period 1|Study site closure|0
1509142|NCT00420927|4959887|P5|Period 1|Study site closure|0
1509143|NCT00420927|4959888|P4|Period 1|Study site closure|0
1509144|NCT00420927|4959889|P3|Period 1|Study site closure|0
1509145|NCT00420927|4959890|P2|Period 1|Study site closure|1
1509146|NCT00420927|4959891|P1|Period 1|Study site closure|0
1509147|NCT00420927|4959885|P7|Period 1|Suspected tuberculosis/positive test|0
1509148|NCT00420927|4959886|P6|Period 1|Suspected tuberculosis/positive test|0
1509149|NCT00420927|4959887|P5|Period 1|Suspected tuberculosis/positive test|0
1509150|NCT00420927|4959888|P4|Period 1|Suspected tuberculosis/positive test|0
1509151|NCT00420927|4959889|P3|Period 1|Suspected tuberculosis/positive test|0
1509152|NCT00420927|4959890|P2|Period 1|Suspected tuberculosis/positive test|1
1509153|NCT00420927|4959891|P1|Period 1|Suspected tuberculosis/positive test|1
1509154|NCT00420927|4959885|P7|Period 1|Randomization error|0
1509155|NCT00420927|4959886|P6|Period 1|Randomization error|0
1509156|NCT00420927|4959887|P5|Period 1|Randomization error|0
1509157|NCT00420927|4959888|P4|Period 1|Randomization error|0
1509158|NCT00420927|4959889|P3|Period 1|Randomization error|0
1509159|NCT00420927|4959890|P2|Period 1|Randomization error|0
1509160|NCT00420927|4959891|P1|Period 1|Randomization error|1
1509161|NCT00420927|4959885|P7|Period 1|Noncompliant with study drug|0
1509162|NCT00420927|4959886|P6|Period 1|Noncompliant with study drug|0
1509163|NCT00420927|4959887|P5|Period 1|Noncompliant with study drug|0
1509164|NCT00420927|4959888|P4|Period 1|Noncompliant with study drug|0
1509165|NCT00420927|4959889|P3|Period 1|Noncompliant with study drug|0
1509166|NCT00420927|4959890|P2|Period 1|Noncompliant with study drug|1
1509167|NCT00420927|4959891|P1|Period 1|Noncompliant with study drug|1
1509168|NCT00420927|4959885|P7|Period 1|Subject moved/relocated|0
1509169|NCT00420927|4959886|P6|Period 1|Subject moved/relocated|0
1509170|NCT00420927|4959887|P5|Period 1|Subject moved/relocated|0
1509171|NCT00420927|4959888|P4|Period 1|Subject moved/relocated|0
1509172|NCT00420927|4959889|P3|Period 1|Subject moved/relocated|0
1509173|NCT00420927|4959890|P2|Period 1|Subject moved/relocated|2
1509174|NCT00420927|4959891|P1|Period 1|Subject moved/relocated|0
1509175|NCT00420927|4959885|P7|Period 1|Death|0
1509176|NCT00420927|4959886|P6|Period 1|Death|0
1509177|NCT00420927|4959887|P5|Period 1|Death|0
1509178|NCT00420927|4959888|P4|Period 1|Death|0
1509179|NCT00420927|4959889|P3|Period 1|Death|0
1509180|NCT00420927|4959890|P2|Period 1|Death|0
1509181|NCT00420927|4959891|P1|Period 1|Death|2
1509182|NCT00420927|4959885|P7|Period 1|Lack of efficacy/Loss of efficacy|0
1509183|NCT00420927|4959886|P6|Period 1|Lack of efficacy/Loss of efficacy|0
1509184|NCT00420927|4959887|P5|Period 1|Lack of efficacy/Loss of efficacy|0
1509185|NCT00420927|4959888|P4|Period 1|Lack of efficacy/Loss of efficacy|0
1509186|NCT00420927|4959889|P3|Period 1|Lack of efficacy/Loss of efficacy|0
1509187|NCT00420927|4959890|P2|Period 1|Lack of efficacy/Loss of efficacy|6
1509188|NCT00420927|4959891|P1|Period 1|Lack of efficacy/Loss of efficacy|1
1509189|NCT00420927|4959885|P7|Period 1|Lost to Follow-up|0
1509190|NCT00420927|4959886|P6|Period 1|Lost to Follow-up|0
1509191|NCT00420927|4959887|P5|Period 1|Lost to Follow-up|0
1509192|NCT00420927|4959888|P4|Period 1|Lost to Follow-up|0
1509193|NCT00420927|4959889|P3|Period 1|Lost to Follow-up|0
1509194|NCT00420927|4959890|P2|Period 1|Lost to Follow-up|6
1509195|NCT00420927|4959891|P1|Period 1|Lost to Follow-up|8
1509196|NCT00420927|4959885|P7|Period 1|Withdrawal by Subject|0
1509197|NCT00420927|4959886|P6|Period 1|Withdrawal by Subject|0
1509198|NCT00420927|4959887|P5|Period 1|Withdrawal by Subject|0
1509199|NCT00420927|4959888|P4|Period 1|Withdrawal by Subject|0
1509200|NCT00420927|4959889|P3|Period 1|Withdrawal by Subject|0
1509201|NCT00420927|4959890|P2|Period 1|Withdrawal by Subject|12
1509202|NCT00420927|4959891|P1|Period 1|Withdrawal by Subject|7
1509203|NCT00420927|4959885|P7|Period 1|Adverse Event|0
1509204|NCT00420927|4959886|P6|Period 1|Adverse Event|0
1509205|NCT00420927|4959887|P5|Period 1|Adverse Event|0
1509206|NCT00420927|4959888|P4|Period 1|Adverse Event|0
1509207|NCT00420927|4959889|P3|Period 1|Adverse Event|0
1509208|NCT00420927|4959890|P2|Period 1|Adverse Event|15
1509209|NCT00420927|4959891|P1|Period 1|Adverse Event|19
1509210|NCT00420849|4959995|P1|Overall Study|Lost to Follow-up|1
1509211|NCT00420849|4959995|P1|Overall Study|Protocol Violation|1
1509212|NCT00420849|4959995|P1|Overall Study|Transplant|8
1509213|NCT00420849|4959995|P1|Overall Study|Not specified|14
1509214|NCT00420849|4959995|P1|Overall Study|Death|18
1509215|NCT00420849|4959995|P1|Overall Study|Withdrawal by Subject|28
1509216|NCT00420849|4959995|P1|Overall Study|Adverse Event|107
1509217|NCT00420849|4959995|P1|Overall Study|Lack of Efficacy|154
1509218|NCT00420784|4960064|P4|Overall Study|Other|5
1509219|NCT00420784|4960065|P3|Overall Study|Other|0
1509220|NCT00420784|4960066|P2|Overall Study|Other|2
1509221|NCT00420784|4960067|P1|Overall Study|Other|1
1509222|NCT00420784|4960064|P4|Overall Study|Virologic Stopping Rule|67
1509223|NCT00420784|4960065|P3|Overall Study|Virologic Stopping Rule|41
1509224|NCT00420784|4960066|P2|Overall Study|Virologic Stopping Rule|26
1509225|NCT00420784|4960067|P1|Overall Study|Virologic Stopping Rule|17
1509226|NCT00420784|4960064|P4|Overall Study|Lost to Follow-up|1
1509227|NCT00420784|4960065|P3|Overall Study|Lost to Follow-up|2
1509228|NCT00420784|4960066|P2|Overall Study|Lost to Follow-up|0
1509229|NCT00420784|4960067|P1|Overall Study|Lost to Follow-up|0
1509230|NCT00420784|4960064|P4|Overall Study|Withdrawal by Subject|0
1509231|NCT00420784|4960065|P3|Overall Study|Withdrawal by Subject|0
1509232|NCT00420784|4960066|P2|Overall Study|Withdrawal by Subject|1
1509233|NCT00420784|4960067|P1|Overall Study|Withdrawal by Subject|0
1509234|NCT00420784|4960064|P4|Overall Study|Adverse Event|5
1509235|NCT00420784|4960065|P3|Overall Study|Adverse Event|10
1509236|NCT00420784|4960066|P2|Overall Study|Adverse Event|29
1509237|NCT00420784|4960067|P1|Overall Study|Adverse Event|11
1509238|NCT00420745|4960105|P2|Overall Study|Age limit exceeded for Dose 2|0
1509239|NCT00420745|4960106|P1|Overall Study|Age limit exceeded for Dose 2|1
1509240|NCT00420745|4960105|P2|Overall Study|Recurrent pneumonia & bronchitis|1
1509241|NCT00420745|4960106|P1|Overall Study|Recurrent pneumonia & bronchitis|0
1509242|NCT00420745|4960105|P2|Overall Study|Physician Decision|1
1509243|NCT00420745|4960106|P1|Overall Study|Physician Decision|1
1509244|NCT00420745|4960105|P2|Overall Study|Protocol Violation|0
1509245|NCT00420745|4960106|P1|Overall Study|Protocol Violation|1
1509246|NCT00420745|4960105|P2|Overall Study|Lost to Follow-up|2
1509247|NCT00420745|4960106|P1|Overall Study|Lost to Follow-up|10
1509248|NCT00420745|4960105|P2|Overall Study|Adverse Event|2
1509249|NCT00420745|4960106|P1|Overall Study|Adverse Event|2
1509250|NCT00420641|4960125|P3|Overall Study|Other|3
1509251|NCT00420641|4960126|P2|Overall Study|Other|4
1509252|NCT00420641|4960127|P1|Overall Study|Other|4
1509253|NCT00420641|4960125|P3|Overall Study|Non-compliance|4
1509254|NCT00420641|4960126|P2|Overall Study|Non-compliance|5
1509255|NCT00420641|4960127|P1|Overall Study|Non-compliance|7
1509256|NCT00420641|4960125|P3|Overall Study|Lack of Efficacy|4
1509257|NCT00420641|4960126|P2|Overall Study|Lack of Efficacy|5
1509258|NCT00420641|4960127|P1|Overall Study|Lack of Efficacy|6
1509259|NCT00420641|4960125|P3|Overall Study|Withdrawal by Subject|14
1509260|NCT00420641|4960126|P2|Overall Study|Withdrawal by Subject|21
1509261|NCT00420641|4960127|P1|Overall Study|Withdrawal by Subject|15
1509262|NCT00420641|4960125|P3|Overall Study|Protocol Violation|7
1509263|NCT00420641|4960126|P2|Overall Study|Protocol Violation|8
1509264|NCT00420641|4960127|P1|Overall Study|Protocol Violation|8
1509265|NCT00420641|4960125|P3|Overall Study|Lost to Follow-up|2
1509266|NCT00420641|4960126|P2|Overall Study|Lost to Follow-up|4
1509267|NCT00420641|4960127|P1|Overall Study|Lost to Follow-up|2
1509268|NCT00420641|4960125|P3|Overall Study|Adverse Event|10
1509269|NCT00420641|4960126|P2|Overall Study|Adverse Event|25
1509270|NCT00420641|4960127|P1|Overall Study|Adverse Event|3
1509271|NCT00420628|4960203|P2|Overall Study|Adverse Event|0
1509272|NCT00420628|4960204|P1|Overall Study|Adverse Event|1
1509273|NCT00420628|4960203|P2|Overall Study|Lost to Follow-up|2
1509274|NCT00420628|4960204|P1|Overall Study|Lost to Follow-up|3
1509275|NCT00420628|4960203|P2|Overall Study|Withdrawn by parent or gaurdian|2
1509276|NCT00420628|4960204|P1|Overall Study|Withdrawn by parent or gaurdian|5
1509277|NCT00420511|4960220|P2|Overall Study|Lost to Follow-up|0
1509278|NCT00420511|4960221|P1|Overall Study|Lost to Follow-up|1
1509279|NCT00420511|4960220|P2|Overall Study|Adverse Event|1
1509280|NCT00420511|4960221|P1|Overall Study|Adverse Event|1
1509281|NCT00420420|4960242|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
1509282|NCT00420420|4960243|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
1509283|NCT00420420|4960242|P2|Overall Study|Withdrawal by Subject|0
1509284|NCT00420420|4960243|P1|Overall Study|Withdrawal by Subject|1
1509285|NCT00420420|4960242|P2|Overall Study|Protocol Violation|1
1509286|NCT00420420|4960243|P1|Overall Study|Protocol Violation|1
1509287|NCT00420420|4960242|P2|Overall Study|Adverse Event|3
1509288|NCT00420420|4960243|P1|Overall Study|Adverse Event|5
1509289|NCT00420407|4960261|P2|Overall Study|Withdrawal by Subject|2
1509290|NCT00420407|4960262|P1|Overall Study|Withdrawal by Subject|0
1509291|NCT00420407|4960261|P2|Overall Study|subject identified as Jehovah's witness|0
1509292|NCT00420407|4960262|P1|Overall Study|subject identified as Jehovah's witness|1
1509293|NCT00420407|4960261|P2|Overall Study|subject identified as detainee|0
1509294|NCT00420407|4960262|P1|Overall Study|subject identified as detainee|1
1509295|NCT00420407|4960261|P2|Overall Study|Physician Decision|1
1509296|NCT00420407|4960262|P1|Overall Study|Physician Decision|2
1509297|NCT00420407|4960261|P2|Overall Study|Lost to Follow-up|3
1509298|NCT00420407|4960262|P1|Overall Study|Lost to Follow-up|0
1509299|NCT00420342|4960271|P3|Overall Study|Withdrawal by Subject|0
1509300|NCT00420342|4960272|P2|Overall Study|Withdrawal by Subject|2
1509301|NCT00420342|4960273|P1|Overall Study|Withdrawal by Subject|0
1509302|NCT00420342|4960271|P3|Overall Study|Lost to Follow-up|1
1509303|NCT00420342|4960272|P2|Overall Study|Lost to Follow-up|0
1509304|NCT00420342|4960273|P1|Overall Study|Lost to Follow-up|1
1509305|NCT00420316|4960316|P2|Overall Study|Lost to Follow-up|8
1509306|NCT00420316|4960317|P1|Overall Study|Lost to Follow-up|12
1509307|NCT00420316|4960316|P2|Overall Study|Withdrawal by Subject|1
1509308|NCT00420316|4960317|P1|Overall Study|Withdrawal by Subject|0
1509309|NCT00420303|4960341|P2|Overall Study|Physician Decision|1
1509310|NCT00420303|4960342|P1|Overall Study|Physician Decision|0
1509311|NCT00420303|4960341|P2|Overall Study|Lack of Efficacy|3
1509312|NCT00420303|4960342|P1|Overall Study|Lack of Efficacy|0
1509313|NCT00420303|4960341|P2|Overall Study|Serious Adverse Event|0
1509314|NCT00420303|4960342|P1|Overall Study|Serious Adverse Event|1
1509315|NCT00420290|4960354|P2|Overall Study|did not meet inclusion/exclusion|1
1509316|NCT00420290|4960355|P1|Overall Study|did not meet inclusion/exclusion|1
1509317|NCT00420290|4960354|P2|Overall Study|Withdrawal by Subject|2
1509318|NCT00420290|4960355|P1|Overall Study|Withdrawal by Subject|0
1509319|NCT00420290|4960354|P2|Overall Study|Adverse Event|1
1509320|NCT00420290|4960355|P1|Overall Study|Adverse Event|3
1509321|NCT00420238|4960371|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
1509322|NCT00420238|4960372|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
1509323|NCT00420238|4960371|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
1509324|NCT00420238|4960372|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
1509325|NCT00420238|4960371|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
1509326|NCT00420238|4960372|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
1509327|NCT00420238|4960371|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
1509328|NCT00420238|4960372|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
1509329|NCT00420238|4960371|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
1509330|NCT00420238|4960372|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
1509331|NCT00420238|4960371|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
1509332|NCT00420238|4960372|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
1509333|NCT00420212|4960511|P3|Overall Study|Other-Unspecified|18
1509334|NCT00420212|4960512|P2|Overall Study|Other-Unspecified|14
1509335|NCT00420212|4960513|P1|Overall Study|Other-Unspecified|21
1509336|NCT00420212|4960511|P3|Overall Study|Death|1
1509337|NCT00420212|4960512|P2|Overall Study|Death|0
1509338|NCT00420212|4960513|P1|Overall Study|Death|0
1509339|NCT00420212|4960511|P3|Overall Study|Protocol Violation|8
1509340|NCT00420212|4960512|P2|Overall Study|Protocol Violation|4
1509341|NCT00420212|4960513|P1|Overall Study|Protocol Violation|4
1509342|NCT00420212|4960511|P3|Overall Study|Physician Decision|3
1509343|NCT00420212|4960512|P2|Overall Study|Physician Decision|4
1509344|NCT00420212|4960513|P1|Overall Study|Physician Decision|4
1509345|NCT00420212|4960511|P3|Overall Study|Withdrawal by Subject|19
1509346|NCT00420212|4960512|P2|Overall Study|Withdrawal by Subject|22
1509347|NCT00420212|4960513|P1|Overall Study|Withdrawal by Subject|31
1509348|NCT00420212|4960511|P3|Overall Study|Lost to Follow-up|11
1509349|NCT00420212|4960512|P2|Overall Study|Lost to Follow-up|11
1509350|NCT00420212|4960513|P1|Overall Study|Lost to Follow-up|9
1509351|NCT00420212|4960511|P3|Overall Study|Adverse Event|36
1509352|NCT00420212|4960512|P2|Overall Study|Adverse Event|40
1509353|NCT00420212|4960513|P1|Overall Study|Adverse Event|22
1509441|NCT00419744|4960834|P2|Overall Study|Moving out of state|0
1509354|NCT00420199|4960539|P2|Overall Study|Participant no longer met study criteria|0
1509355|NCT00420199|4960540|P1|Overall Study|Participant no longer met study criteria|1
1509356|NCT00420095|4960606|P2|Overall Study|Lost to Follow-up|0
1509357|NCT00420095|4960607|P1|Overall Study|Lost to Follow-up|1
1509358|NCT00420095|4960606|P2|Overall Study|Protocol Violation|1
1509359|NCT00420095|4960607|P1|Overall Study|Protocol Violation|1
1509360|NCT00420095|4960606|P2|Overall Study|Adverse Event|0
1509361|NCT00420095|4960607|P1|Overall Study|Adverse Event|1
1509362|NCT00420056|4960625|P1|Overall Study|Objective progression or relapse|17
1509363|NCT00420004|4960665|P3|Overall Study|Sponsor Decision|1
1509364|NCT00420004|4960666|P2|Overall Study|Sponsor Decision|3
1509365|NCT00420004|4960667|P1|Overall Study|Sponsor Decision|3
1509366|NCT00420004|4960665|P3|Overall Study|Withdrawal by Subject|14
1509367|NCT00420004|4960666|P2|Overall Study|Withdrawal by Subject|42
1509368|NCT00420004|4960667|P1|Overall Study|Withdrawal by Subject|67
1509369|NCT00420004|4960665|P3|Overall Study|Protocol Violation|3
1509370|NCT00420004|4960666|P2|Overall Study|Protocol Violation|4
1509371|NCT00420004|4960667|P1|Overall Study|Protocol Violation|5
1509372|NCT00420004|4960665|P3|Overall Study|Physician Decision|2
1509373|NCT00420004|4960666|P2|Overall Study|Physician Decision|4
1509374|NCT00420004|4960667|P1|Overall Study|Physician Decision|14
1509375|NCT00420004|4960665|P3|Overall Study|Entry Criteria Not Met|0
1509376|NCT00420004|4960666|P2|Overall Study|Entry Criteria Not Met|1
1509377|NCT00420004|4960667|P1|Overall Study|Entry Criteria Not Met|0
1509378|NCT00420004|4960665|P3|Overall Study|Lost to Follow-up|10
1509379|NCT00420004|4960666|P2|Overall Study|Lost to Follow-up|12
1509380|NCT00420004|4960667|P1|Overall Study|Lost to Follow-up|31
1509381|NCT00420004|4960665|P3|Overall Study|Lack of Efficacy|1
1509382|NCT00420004|4960666|P2|Overall Study|Lack of Efficacy|4
1509383|NCT00420004|4960667|P1|Overall Study|Lack of Efficacy|5
1509384|NCT00420004|4960665|P3|Overall Study|Adverse Event|1
1509385|NCT00420004|4960666|P2|Overall Study|Adverse Event|1
1509386|NCT00420004|4960667|P1|Overall Study|Adverse Event|4
1509387|NCT00419952|4960732|P2|Overall Study|Abnormal ECG|0
1509388|NCT00419952|4960733|P1|Overall Study|Abnormal ECG|1
1509389|NCT00419952|4960732|P2|Overall Study|Diary or medication non-compliance|4
1509390|NCT00419952|4960733|P1|Overall Study|Diary or medication non-compliance|2
1509391|NCT00419952|4960732|P2|Overall Study|Occurence of 2 or more exacerbations|0
1509392|NCT00419952|4960733|P1|Overall Study|Occurence of 2 or more exacerbations|2
1509393|NCT00419952|4960732|P2|Overall Study|Intake of prohibited medication|2
1509394|NCT00419952|4960733|P1|Overall Study|Intake of prohibited medication|2
1509395|NCT00419952|4960732|P2|Overall Study|Incorrectly enrolled|3
1509396|NCT00419952|4960733|P1|Overall Study|Incorrectly enrolled|10
1509397|NCT00419952|4960732|P2|Overall Study|Physician Decision|3
1509398|NCT00419952|4960733|P1|Overall Study|Physician Decision|1
1509399|NCT00419952|4960732|P2|Overall Study|Pregnancy|2
1509400|NCT00419952|4960733|P1|Overall Study|Pregnancy|4
1509401|NCT00419952|4960732|P2|Overall Study|Protocol Violation|24
1509402|NCT00419952|4960733|P1|Overall Study|Protocol Violation|32
1509403|NCT00419952|4960732|P2|Overall Study|Lost to Follow-up|34
1509404|NCT00419952|4960733|P1|Overall Study|Lost to Follow-up|43
1509405|NCT00419952|4960732|P2|Overall Study|Withdrawal by Subject|43
1509406|NCT00419952|4960733|P1|Overall Study|Withdrawal by Subject|44
1509407|NCT00419952|4960732|P2|Overall Study|Adverse Event|10
1509408|NCT00419952|4960733|P1|Overall Study|Adverse Event|8
1509409|NCT00419926|4960767|P2|Overall Study|Death|1
1509410|NCT00419926|4960768|P1|Overall Study|Death|2
1509411|NCT00419926|4960767|P2|Overall Study|Lost to Follow-up|2
1509412|NCT00419926|4960768|P1|Overall Study|Lost to Follow-up|1
1509413|NCT00419926|4960767|P2|Overall Study|Administrative Problem|4
1509414|NCT00419926|4960768|P1|Overall Study|Administrative Problem|4
1509415|NCT00419926|4960767|P2|Overall Study|Withdrawal by Subject|3
1509416|NCT00419926|4960768|P1|Overall Study|Withdrawal by Subject|7
1509417|NCT00419770|4960784|P2|Overall Study|Withdrawal by Subject|1
1509418|NCT00419770|4960785|P1|Overall Study|Withdrawal by Subject|5
1509419|NCT00419757|4960793|P2|Overall Study|Multiple reasons|1
1509420|NCT00419757|4960794|P1|Overall Study|Multiple reasons|3
1509421|NCT00419757|4960793|P2|Overall Study|Study specific discontinuation criteria|8
1509422|NCT00419757|4960794|P1|Overall Study|Study specific discontinuation criteria|4
1509423|NCT00419757|4960793|P2|Overall Study|Protocol Violation|3
1509424|NCT00419757|4960794|P1|Overall Study|Protocol Violation|2
1509425|NCT00419757|4960793|P2|Overall Study|Withdrawal by Subject|1
1509426|NCT00419757|4960794|P1|Overall Study|Withdrawal by Subject|7
1509427|NCT00419757|4960793|P2|Overall Study|Lost to Follow-up|4
1509428|NCT00419757|4960794|P1|Overall Study|Lost to Follow-up|1
1509429|NCT00419757|4960793|P2|Overall Study|Adverse Event|4
1509430|NCT00419757|4960794|P1|Overall Study|Adverse Event|1
1509431|NCT00419744|4960833|P3|Overall Study|Incorrect medication kit dispensed|1
1509432|NCT00419744|4960834|P2|Overall Study|Incorrect medication kit dispensed|0
1509433|NCT00419744|4960835|P1|Overall Study|Incorrect medication kit dispensed|0
1509434|NCT00419744|4960833|P3|Overall Study|Spirometry mouthpiece issues|2
1509435|NCT00419744|4960834|P2|Overall Study|Spirometry mouthpiece issues|1
1509436|NCT00419744|4960835|P1|Overall Study|Spirometry mouthpiece issues|0
1509437|NCT00419744|4960833|P3|Overall Study|Physician Decision|6
1509438|NCT00419744|4960834|P2|Overall Study|Physician Decision|5
1509439|NCT00419744|4960835|P1|Overall Study|Physician Decision|10
1509440|NCT00419744|4960833|P3|Overall Study|Moving out of state|1
1509442|NCT00419744|4960835|P1|Overall Study|Moving out of state|2
1509443|NCT00419744|4960833|P3|Overall Study|Randomized in error|7
1509444|NCT00419744|4960834|P2|Overall Study|Randomized in error|6
1509445|NCT00419744|4960835|P1|Overall Study|Randomized in error|9
1509446|NCT00419744|4960833|P3|Overall Study|Protocol Violation|8
1509447|NCT00419744|4960834|P2|Overall Study|Protocol Violation|7
1509448|NCT00419744|4960835|P1|Overall Study|Protocol Violation|4
1509449|NCT00419744|4960833|P3|Overall Study|Lost to Follow-up|6
1509450|NCT00419744|4960834|P2|Overall Study|Lost to Follow-up|10
1509451|NCT00419744|4960835|P1|Overall Study|Lost to Follow-up|8
1509452|NCT00419744|4960833|P3|Overall Study|Withdrawal by Subject|52
1509453|NCT00419744|4960834|P2|Overall Study|Withdrawal by Subject|49
1509454|NCT00419744|4960835|P1|Overall Study|Withdrawal by Subject|45
1509455|NCT00419744|4960833|P3|Overall Study|Adverse Event|50
1509456|NCT00419744|4960834|P2|Overall Study|Adverse Event|40
1509457|NCT00419744|4960835|P1|Overall Study|Adverse Event|39
1509458|NCT00419393|4960877|P1|Overall Study|Other: Investigator decision|1
1509459|NCT00419393|4960877|P1|Overall Study|Other: Other health problems|1
1509460|NCT00419393|4960877|P1|Overall Study|Other: Site closure|1
1509461|NCT00419393|4960877|P1|Overall Study|Other: Subject had temporal lobectomy|1
1509462|NCT00419393|4960877|P1|Overall Study|Other: Sponsor request|3
1509463|NCT00419393|4960877|P1|Overall Study|Withdrawal by Subject|7
1509464|NCT00419393|4960877|P1|Overall Study|Protocol Violation|5
1509465|NCT00419393|4960877|P1|Overall Study|Adverse Event|5
1509466|NCT00419380|4960887|P2|Overall Study|Withdrawal by Subject|1
1509467|NCT00419380|4960888|P1|Overall Study|Withdrawal by Subject|0
1509468|NCT00419380|4960887|P2|Overall Study|Lost to Follow-up|1
1509469|NCT00419380|4960888|P1|Overall Study|Lost to Follow-up|0
1509470|NCT00419380|4960887|P2|Overall Study|Physician Decision|1
1509471|NCT00419380|4960888|P1|Overall Study|Physician Decision|0
1509472|NCT00419380|4960887|P2|Overall Study|Lack of Efficacy|7
1509473|NCT00419380|4960888|P1|Overall Study|Lack of Efficacy|1
1509474|NCT00419341|4960896|P1|Efficacy Period|Termination of study site|1
1509475|NCT00419341|4960896|P1|Efficacy Period|Non-compliance|1
1509476|NCT00419341|4960896|P1|Efficacy Period|Lost to Follow-up|1
1509477|NCT00419341|4960896|P1|Efficacy Period|Protocol Violation|1
1509478|NCT00419341|4960896|P1|Efficacy Period|Withdrawal by Subject|6
1509479|NCT00419341|4960896|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
1509480|NCT00419341|4960896|P1|Wash in/Wash Out Period|Adverse Event|2
1509481|NCT00419341|4960896|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
1509482|NCT00419263|4960931|P3|Overall Study|Withdrawal by Subject|1
1509483|NCT00419263|4960932|P2|Overall Study|Withdrawal by Subject|0
1509484|NCT00419263|4960933|P1|Overall Study|Withdrawal by Subject|0
1509485|NCT00419263|4960931|P3|Overall Study|Adverse Event|1
1509486|NCT00419263|4960932|P2|Overall Study|Adverse Event|0
1509487|NCT00419263|4960933|P1|Overall Study|Adverse Event|0
1509488|NCT00419263|4960931|P3|Overall Study|Randomized in Error, Not Treated|0
1509489|NCT00419263|4960932|P2|Overall Study|Randomized in Error, Not Treated|1
1509490|NCT00419263|4960933|P1|Overall Study|Randomized in Error, Not Treated|1
1509491|NCT00419263|4960931|P3|Overall Study|Lost to Follow-up|1
1509492|NCT00419263|4960932|P2|Overall Study|Lost to Follow-up|1
1509493|NCT00419263|4960933|P1|Overall Study|Lost to Follow-up|2
1509494|NCT00419159|4960962|P2|Overall Study|Disease progression|76
1509495|NCT00419159|4960963|P1|Overall Study|Disease progression|79
1509496|NCT00419159|4960962|P2|Overall Study|Death|2
1509497|NCT00419159|4960963|P1|Overall Study|Death|2
1509498|NCT00419159|4960962|P2|Overall Study|Lost to Follow-up|1
1509499|NCT00419159|4960963|P1|Overall Study|Lost to Follow-up|0
1509500|NCT00419159|4960962|P2|Overall Study|Withdrawal by Subject|3
1509501|NCT00419159|4960963|P1|Overall Study|Withdrawal by Subject|10
1509502|NCT00419159|4960962|P2|Overall Study|Protocol Violation|0
1509503|NCT00419159|4960963|P1|Overall Study|Protocol Violation|1
1509504|NCT00419159|4960962|P2|Overall Study|Subject's no longer requires study drug|1
1509505|NCT00419159|4960963|P1|Overall Study|Subject's no longer requires study drug|0
1509506|NCT00419159|4960962|P2|Overall Study|Abnormal laboratory value(s)|2
1509507|NCT00419159|4960963|P1|Overall Study|Abnormal laboratory value(s)|0
1509508|NCT00419159|4960962|P2|Overall Study|Adverse Event|15
1509509|NCT00419159|4960963|P1|Overall Study|Adverse Event|7
1509510|NCT00419120|4960977|P1|Long Term Follow up Period|study ongoing|10
1509511|NCT00419094|4960984|P2|Overall Study|Other: No contact for extended period|1
1509512|NCT00419094|4960985|P1|Overall Study|Other: No contact for extended period|0
1509513|NCT00419094|4960984|P2|Overall Study|Other: Patient non-compliant|1
1509514|NCT00419094|4960985|P1|Overall Study|Other: Patient non-compliant|0
1509515|NCT00419094|4960984|P2|Overall Study|Other: Error determining exit criteria|0
1509516|NCT00419094|4960985|P1|Overall Study|Other: Error determining exit criteria|1
1509517|NCT00419094|4960984|P2|Overall Study|Withdrawal of consent|5
1509518|NCT00419094|4960985|P1|Overall Study|Withdrawal of consent|1
1509519|NCT00419094|4960984|P2|Overall Study|Protocol Violation|14
1509520|NCT00419094|4960985|P1|Overall Study|Protocol Violation|1
1509521|NCT00419094|4960984|P2|Overall Study|Lost to Follow-up|2
1509522|NCT00419094|4960985|P1|Overall Study|Lost to Follow-up|0
1509523|NCT00419094|4960984|P2|Overall Study|Lack of Efficacy|0
1509524|NCT00419094|4960985|P1|Overall Study|Lack of Efficacy|1
1509525|NCT00419094|4960984|P2|Overall Study|Adverse Event|7
1509526|NCT00419094|4960985|P1|Overall Study|Adverse Event|3
1509527|NCT00419003|4960999|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
1509528|NCT00419003|4961000|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
1509529|NCT00419003|4960999|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
1509530|NCT00419003|4961000|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
1509531|NCT00418938|4961054|P2|Overall Study|Ineligibility Determined|0
1509532|NCT00418938|4961055|P1|Overall Study|Ineligibility Determined|1
1509533|NCT00418938|4961054|P2|Overall Study|On-going|1
1509534|NCT00418938|4961055|P1|Overall Study|On-going|1
1509535|NCT00418938|4961054|P2|Overall Study|Adverse Event|1
1509536|NCT00418938|4961055|P1|Overall Study|Adverse Event|1
1509537|NCT00418938|4961054|P2|Overall Study|Lost to Follow-up|3
1509538|NCT00418938|4961055|P1|Overall Study|Lost to Follow-up|1
1509539|NCT00418938|4961054|P2|Overall Study|Withdrawal by Subject|15
1509540|NCT00418938|4961055|P1|Overall Study|Withdrawal by Subject|16
1509541|NCT00418938|4961054|P2|Overall Study|Administrative decision|3
1509542|NCT00418938|4961055|P1|Overall Study|Administrative decision|3
1509543|NCT00418938|4961054|P2|Overall Study|Reimbursement|0
1509544|NCT00418938|4961055|P1|Overall Study|Reimbursement|1
1509545|NCT00418886|4961075|P2|Overall Study|randomised but no treatment received|1
1509546|NCT00418886|4961076|P1|Overall Study|randomised but no treatment received|0
1509547|NCT00418886|4961075|P2|Overall Study|withdrawn due to other reason|0
1509548|NCT00418886|4961076|P1|Overall Study|withdrawn due to other reason|1
1509549|NCT00418886|4961075|P2|Overall Study|Lost to Follow-up|6
1509550|NCT00418886|4961076|P1|Overall Study|Lost to Follow-up|4
1509551|NCT00418886|4961075|P2|Overall Study|Withdrawal by Subject|10
1509552|NCT00418886|4961076|P1|Overall Study|Withdrawal by Subject|9
1509553|NCT00418886|4961075|P2|Overall Study|Death|147
1509554|NCT00418886|4961076|P1|Overall Study|Death|122
1509555|NCT00418886|4961075|P2|Overall Study|discontinue treatment survival follow up|91
1509556|NCT00418886|4961076|P1|Overall Study|discontinue treatment survival follow up|90
1509557|NCT00418834|4961102|P2|Overall Study|Withdrawal by Subject|7
1509558|NCT00418834|4961103|P1|Overall Study|Withdrawal by Subject|3
1509559|NCT00418834|4961102|P2|Overall Study|Protocol Violation|3
1509560|NCT00418834|4961103|P1|Overall Study|Protocol Violation|4
1509561|NCT00418834|4961102|P2|Overall Study|Lost to Follow-up|1
1509562|NCT00418834|4961103|P1|Overall Study|Lost to Follow-up|0
1509563|NCT00418834|4961102|P2|Overall Study|Adverse Event|9
1509564|NCT00418834|4961103|P1|Overall Study|Adverse Event|16
1509565|NCT00418717|4961163|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
1509566|NCT00418717|4961163|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
1509567|NCT00418691|4961171|P3|Overall Study|Progressive Disease|1
1509568|NCT00418691|4961172|P2|Overall Study|Progressive Disease|0
1509569|NCT00418691|4961173|P1|Overall Study|Progressive Disease|1
1509570|NCT00418691|4961171|P3|Overall Study|Started new medication voiding entry|1
1509571|NCT00418691|4961172|P2|Overall Study|Started new medication voiding entry|0
1509572|NCT00418691|4961173|P1|Overall Study|Started new medication voiding entry|0
1509573|NCT00418691|4961171|P3|Overall Study|Lost to Follow-up|3
1509574|NCT00418691|4961172|P2|Overall Study|Lost to Follow-up|2
1509575|NCT00418691|4961173|P1|Overall Study|Lost to Follow-up|1
1509576|NCT00418665|4961184|P3|Treatment Extension|Death|1
1509577|NCT00418665|4961185|P2|Treatment Extension|Death|0
1509578|NCT00418665|4961186|P1|Treatment Extension|Death|0
1509579|NCT00418665|4961184|P3|Treatment Extension|Physician Decision|1
1509580|NCT00418665|4961185|P2|Treatment Extension|Physician Decision|2
1509581|NCT00418665|4961186|P1|Treatment Extension|Physician Decision|2
1509582|NCT00418665|4961184|P3|Treatment Extension|Requirement for alternative therapy|0
1509583|NCT00418665|4961185|P2|Treatment Extension|Requirement for alternative therapy|2
1509584|NCT00418665|4961186|P1|Treatment Extension|Requirement for alternative therapy|2
1509585|NCT00418665|4961184|P3|Treatment Extension|Withdrawal by Subject|0
1509586|NCT00418665|4961185|P2|Treatment Extension|Withdrawal by Subject|0
1509587|NCT00418665|4961186|P1|Treatment Extension|Withdrawal by Subject|1
1509588|NCT00418665|4961184|P3|Treatment Extension|Adverse Event|0
1509589|NCT00418665|4961185|P2|Treatment Extension|Adverse Event|0
1509590|NCT00418665|4961186|P1|Treatment Extension|Adverse Event|1
1509591|NCT00418665|4961184|P3|Treatment Period|Physician Decision|3
1509592|NCT00418665|4961185|P2|Treatment Period|Physician Decision|0
1509593|NCT00418665|4961186|P1|Treatment Period|Physician Decision|1
1509594|NCT00418665|4961184|P3|Treatment Period|Requirement for alternative therapy|0
1509595|NCT00418665|4961185|P2|Treatment Period|Requirement for alternative therapy|0
1509596|NCT00418665|4961186|P1|Treatment Period|Requirement for alternative therapy|1
1509597|NCT00418665|4961184|P3|Treatment Period|Withdrawal by Subject|1
1509598|NCT00418665|4961185|P2|Treatment Period|Withdrawal by Subject|3
1509599|NCT00418665|4961186|P1|Treatment Period|Withdrawal by Subject|0
1509600|NCT00418665|4961184|P3|Treatment Period|Adverse Event|0
1509601|NCT00418665|4961185|P2|Treatment Period|Adverse Event|2
1509602|NCT00418665|4961186|P1|Treatment Period|Adverse Event|2
1509603|NCT00418665|4961184|P3|Treatment Period|Ineligibility determined|0
1509604|NCT00418665|4961185|P2|Treatment Period|Ineligibility determined|1
1509605|NCT00418665|4961186|P1|Treatment Period|Ineligibility determined|1
1509606|NCT00418561|4961220|P3|Overall Study|Participant's (guardian's) decision|0
1509607|NCT00418561|4961221|P2|Overall Study|Participant's (guardian's) decision|1
1509608|NCT00418561|4961222|P1|Overall Study|Participant's (guardian's) decision|0
1509609|NCT00418522|4961292|P2|Overall Study|Randomized but did not receive treatment|4
1509610|NCT00418522|4961293|P1|Overall Study|Randomized but did not receive treatment|7
1509611|NCT00418522|4961292|P2|Overall Study|Other|23
1509612|NCT00418522|4961293|P1|Overall Study|Other|27
1509613|NCT00418522|4961292|P2|Overall Study|Withdrawal by Subject|7
1509614|NCT00418522|4961293|P1|Overall Study|Withdrawal by Subject|31
1509615|NCT00418522|4961292|P2|Overall Study|Lost to Follow-up|4
1509616|NCT00418522|4961293|P1|Overall Study|Lost to Follow-up|10
1509617|NCT00418522|4961292|P2|Overall Study|Lack of Efficacy|3
1509618|NCT00418522|4961293|P1|Overall Study|Lack of Efficacy|1
1509619|NCT00418522|4961292|P2|Overall Study|Adverse Event|1
1509620|NCT00418522|4961293|P1|Overall Study|Adverse Event|7
1509621|NCT00418379|4961340|P3|Year 5|Any other reason not above-mentioned|3
1509622|NCT00418379|4961341|P2|Year 5|Any other reason not above-mentioned|4
1509623|NCT00418379|4961342|P1|Year 5|Any other reason not above-mentioned|2
1509624|NCT00418379|4961340|P3|Year 5|Adverse Event|0
1509625|NCT00418379|4961341|P2|Year 5|Adverse Event|1
1509626|NCT00418379|4961342|P1|Year 5|Adverse Event|0
1509627|NCT00418379|4961340|P3|Year 4|Any other reason not above-mentioned|0
1509628|NCT00418379|4961341|P2|Year 4|Any other reason not above-mentioned|1
1509629|NCT00418379|4961342|P1|Year 4|Any other reason not above-mentioned|1
1509630|NCT00418379|4961340|P3|Year 4|Withdrawal by Subject|2
1509631|NCT00418379|4961341|P2|Year 4|Withdrawal by Subject|3
1509632|NCT00418379|4961342|P1|Year 4|Withdrawal by Subject|2
1509633|NCT00418379|4961340|P3|Year 4|Adverse Event|0
1509634|NCT00418379|4961341|P2|Year 4|Adverse Event|1
1509635|NCT00418379|4961342|P1|Year 4|Adverse Event|0
1509636|NCT00418379|4961340|P3|Year 3|Any other reason not above-mentioned|1
1509637|NCT00418379|4961341|P2|Year 3|Any other reason not above-mentioned|1
1509638|NCT00418379|4961342|P1|Year 3|Any other reason not above-mentioned|2
1509639|NCT00418379|4961340|P3|Year 3|Withdrawal by Subject|2
1509640|NCT00418379|4961341|P2|Year 3|Withdrawal by Subject|1
1509641|NCT00418379|4961342|P1|Year 3|Withdrawal by Subject|1
1509642|NCT00418379|4961340|P3|Year 2|Any other reason not above-mentioned|6
1509643|NCT00418379|4961341|P2|Year 2|Any other reason not above-mentioned|1
1509644|NCT00418379|4961342|P1|Year 2|Any other reason not above-mentioned|2
1509645|NCT00418379|4961340|P3|Year 2|Withdrawal by Subject|3
1509646|NCT00418379|4961341|P2|Year 2|Withdrawal by Subject|1
1509647|NCT00418379|4961342|P1|Year 2|Withdrawal by Subject|1
1509648|NCT00418379|4961340|P3|Year 2|Adverse Event|1
1509649|NCT00418379|4961341|P2|Year 2|Adverse Event|2
1509650|NCT00418379|4961342|P1|Year 2|Adverse Event|5
1509651|NCT00418379|4961340|P3|Year 1|Any other reason not above-mentioned|7
1509652|NCT00418379|4961341|P2|Year 1|Any other reason not above-mentioned|5
1509653|NCT00418379|4961342|P1|Year 1|Any other reason not above-mentioned|2
1509654|NCT00418379|4961340|P3|Year 1|Withdrawal by Subject|5
1509655|NCT00418379|4961341|P2|Year 1|Withdrawal by Subject|8
1509656|NCT00418379|4961342|P1|Year 1|Withdrawal by Subject|7
1509657|NCT00418379|4961340|P3|Year 1|Adverse Event|3
1509658|NCT00418379|4961341|P2|Year 1|Adverse Event|15
1509659|NCT00418379|4961342|P1|Year 1|Adverse Event|9
1509660|NCT00418314|4961352|P2|Overall Study|Withdrawal by Subject|2
1509661|NCT00418314|4961353|P1|Overall Study|Withdrawal by Subject|1
1509662|NCT00418184|4961383|P2|Double-blind Phase|Poor compliance|1
1509663|NCT00418184|4961384|P1|Double-blind Phase|Poor compliance|3
1509664|NCT00418184|4961383|P2|Double-blind Phase|Adverse Event|1
1509665|NCT00418184|4961384|P1|Double-blind Phase|Adverse Event|2
1509666|NCT00418184|4961383|P2|Double-blind Phase|Withdrawal by Subject|9
1509667|NCT00418184|4961384|P1|Double-blind Phase|Withdrawal by Subject|22
1509668|NCT00418145|4961392|P1|Overall Study|study terminated|6
1509669|NCT00417989|4961467|P2|Overall Study|Physician Decision|2
1509670|NCT00417989|4961468|P1|Overall Study|Physician Decision|5
1509671|NCT00417989|4961467|P2|Overall Study|Death|1
1509672|NCT00417989|4961468|P1|Overall Study|Death|0
1509673|NCT00417989|4961467|P2|Overall Study|Protocol Violation|0
1509674|NCT00417989|4961468|P1|Overall Study|Protocol Violation|1
1509675|NCT00417989|4961467|P2|Overall Study|Lost to Follow-up|6
1509676|NCT00417989|4961468|P1|Overall Study|Lost to Follow-up|1
1509677|NCT00417989|4961467|P2|Overall Study|Withdrawal by Subject|13
1509678|NCT00417989|4961468|P1|Overall Study|Withdrawal by Subject|13
1509679|NCT00417976|4961490|P1|Overall Study|Treatment -related toxicity|2
1509680|NCT00417976|4961490|P1|Overall Study|Non compliance unrelated to toxicity|1
1509681|NCT00417963|4961495|P1|Overall Study|Study device could not be deployed|3
1509682|NCT00417963|4961495|P1|Overall Study|Death|17
1509683|NCT00417963|4961495|P1|Overall Study|Withdrawal by Subject|18
1509684|NCT00417963|4961495|P1|Overall Study|Lost to Follow-up|3
1509685|NCT00417885|4961512|P1|Overall Study|Transferred to Another Sunitinib Study|2
1509686|NCT00417885|4961512|P1|Overall Study|Objective Progression or Relapse|3
1509687|NCT00417885|4961512|P1|Overall Study|Adverse Event|1
1509688|NCT00417612|4961523|P2|Overall Study|Lost to Follow-up|0
1509689|NCT00417612|4961524|P1|Overall Study|Lost to Follow-up|1
1509690|NCT00417612|4961523|P2|Overall Study|Protocol Violation|2
1509691|NCT00417612|4961524|P1|Overall Study|Protocol Violation|0
1509692|NCT00417612|4961523|P2|Overall Study|Adverse Event|0
1509693|NCT00417612|4961524|P1|Overall Study|Adverse Event|2
1509694|NCT00417612|4961523|P2|Overall Study|Errant diagnosis|1
1509695|NCT00417612|4961524|P1|Overall Study|Errant diagnosis|0
1509696|NCT00417482|4961550|P3|Phase B 2nd 16 Weeks|Death|0
1509697|NCT00417482|4961551|P2|Phase B 2nd 16 Weeks|Death|1
1509698|NCT00417482|4961552|P1|Phase B 2nd 16 Weeks|Death|1
1509699|NCT00417482|4961550|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
1509700|NCT00417482|4961551|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
1509701|NCT00417482|4961552|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
1509702|NCT00417482|4961550|P3|Phase B 2nd 16 Weeks|Adverse Event|1
1509703|NCT00417482|4961551|P2|Phase B 2nd 16 Weeks|Adverse Event|0
1509704|NCT00417482|4961552|P1|Phase B 2nd 16 Weeks|Adverse Event|0
1509705|NCT00417482|4961550|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
1509706|NCT00417482|4961551|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
1509707|NCT00417482|4961552|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
1509708|NCT00417482|4961550|P3|Phase B 1st 16 Weeks|Death|0
1509709|NCT00417482|4961551|P2|Phase B 1st 16 Weeks|Death|0
1509710|NCT00417482|4961552|P1|Phase B 1st 16 Weeks|Death|1
1509711|NCT00417482|4961550|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
1509712|NCT00417482|4961551|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
1509713|NCT00417482|4961552|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
1509714|NCT00417482|4961550|P3|Phase B 1st 16 Weeks|Adverse Event|1
1509715|NCT00417482|4961551|P2|Phase B 1st 16 Weeks|Adverse Event|0
1509716|NCT00417482|4961552|P1|Phase B 1st 16 Weeks|Adverse Event|2
1509717|NCT00417482|4961550|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
1509718|NCT00417482|4961551|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
1509719|NCT00417482|4961552|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
1509720|NCT00417248|4961591|P1|Overall Study|Lack of Efficacy|1
1509721|NCT00417248|4961591|P1|Overall Study|Death|1
1509722|NCT00417248|4961591|P1|Overall Study|Study Terminated|6
1509723|NCT00417170|4961598|P2|Overall Study|Lost to Follow-up|1
1509724|NCT00417170|4961599|P1|Overall Study|Lost to Follow-up|0
1509725|NCT00417170|4961598|P2|Overall Study|Withdrawal by Subject|1
1509726|NCT00417170|4961599|P1|Overall Study|Withdrawal by Subject|1
1509727|NCT00417170|4961598|P2|Overall Study|Adverse Event|1
1509728|NCT00417170|4961599|P1|Overall Study|Adverse Event|1
1509729|NCT00417079|4961615|P2|Overall Study|abnormal liver function tests|1
1509730|NCT00417079|4961616|P1|Overall Study|abnormal liver function tests|0
1509731|NCT00417079|4961615|P2|Overall Study|Patient unable to come to the clinic|1
1509732|NCT00417079|4961616|P1|Overall Study|Patient unable to come to the clinic|0
1509733|NCT00417079|4961615|P2|Overall Study|Withdrawal by subject's family|1
1509734|NCT00417079|4961616|P1|Overall Study|Withdrawal by subject's family|0
1509735|NCT00417079|4961615|P2|Overall Study|Screening error|1
1509736|NCT00417079|4961616|P1|Overall Study|Screening error|2
1509737|NCT00417079|4961615|P2|Overall Study|Clinical deterioration|0
1509738|NCT00417079|4961616|P1|Overall Study|Clinical deterioration|1
1509739|NCT00417079|4961615|P2|Overall Study|Non-confirmed Disease progression|1
1509740|NCT00417079|4961616|P1|Overall Study|Non-confirmed Disease progression|1
1509741|NCT00417079|4961615|P2|Overall Study|Investigator's decision|4
1509742|NCT00417079|4961616|P1|Overall Study|Investigator's decision|1
1509743|NCT00417079|4961615|P2|Overall Study|Screened failure|1
1509744|NCT00417079|4961616|P1|Overall Study|Screened failure|2
1509745|NCT00417079|4961615|P2|Overall Study|Not treated|7
1509746|NCT00417079|4961616|P1|Overall Study|Not treated|6
1509747|NCT00417079|4961615|P2|Overall Study|Withdrawal by Subject|8
1509748|NCT00417079|4961616|P1|Overall Study|Withdrawal by Subject|17
1509749|NCT00417079|4961615|P2|Overall Study|Lost to Follow-up|0
1509750|NCT00417079|4961616|P1|Overall Study|Lost to Follow-up|2
1509751|NCT00417079|4961615|P2|Overall Study|Non-compliance to protocol|1
1509752|NCT00417079|4961616|P1|Overall Study|Non-compliance to protocol|0
1509753|NCT00417079|4961615|P2|Overall Study|Adverse Event|67
1509754|NCT00417079|4961616|P1|Overall Study|Adverse Event|32
1509755|NCT00417079|4961615|P2|Overall Study|Disease progression|180
1509756|NCT00417079|4961616|P1|Overall Study|Disease progression|267
1509757|NCT00417027|4961639|P3|Overall Study|Protocol Violation|5
1509758|NCT00417027|4961640|P2|Overall Study|Protocol Violation|5
1509759|NCT00417027|4961641|P1|Overall Study|Protocol Violation|0
1509760|NCT00416949|4961667|P1|Overall Study|Patients refused to participate|5
1509761|NCT00416884|4961671|P1|Overall Study|Study terminated due to low accrual|1
1509762|NCT00416715|4961679|P1|Overall Study|Vitamin D levels not evaluable|8
1509763|NCT00416715|4961679|P1|Overall Study|Not evaluable for joint aches|7
1509764|NCT00416624|4961690|P4|Overall Study|Cancel|0
1509765|NCT00416624|4961691|P3|Overall Study|Cancel|0
1509766|NCT00416624|4961692|P2|Overall Study|Cancel|0
1509767|NCT00416624|4961693|P1|Overall Study|Cancel|1
1509768|NCT00416624|4961690|P4|Overall Study|Not Specified|5
1509769|NCT00416624|4961691|P3|Overall Study|Not Specified|5
1509770|NCT00416624|4961692|P2|Overall Study|Not Specified|11
1509771|NCT00416624|4961693|P1|Overall Study|Not Specified|8
1509772|NCT00416624|4961690|P4|Overall Study|Adverse Event|2
1509773|NCT00416624|4961691|P3|Overall Study|Adverse Event|2
1509774|NCT00416624|4961692|P2|Overall Study|Adverse Event|3
1509775|NCT00416624|4961693|P1|Overall Study|Adverse Event|8
1509776|NCT00416624|4961690|P4|Overall Study|Death|1
1509777|NCT00416624|4961691|P3|Overall Study|Death|7
1509778|NCT00416624|4961692|P2|Overall Study|Death|7
1509779|NCT00416624|4961693|P1|Overall Study|Death|4
1509780|NCT00416624|4961690|P4|Overall Study|Withdrawal by Subject|9
1509781|NCT00416624|4961691|P3|Overall Study|Withdrawal by Subject|4
1509782|NCT00416624|4961692|P2|Overall Study|Withdrawal by Subject|6
1509783|NCT00416624|4961693|P1|Overall Study|Withdrawal by Subject|1
1509784|NCT00416598|4961747|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
1509785|NCT00416598|4961747|P1|Decitabine Maintenance|Alternative treatment|2
1509786|NCT00416598|4961747|P1|Decitabine Maintenance|Progression/relapse|38
1509787|NCT00416598|4961747|P1|Decitabine Maintenance|Withdrawal by Subject|18
1509788|NCT00416598|4961747|P1|Decitabine Maintenance|Adverse Event|5
1509789|NCT00416598|4961747|P1|Induction & Intensification|Failed induction|87
1509790|NCT00416598|4961747|P1|Induction & Intensification|Relapse/progression|29
1509791|NCT00416598|4961747|P1|Induction & Intensification|Physician discretion/other medical issue|45
1509792|NCT00416598|4961747|P1|Induction & Intensification|Alternative Treatment|135
1509793|NCT00416598|4961747|P1|Induction & Intensification|Withdrawal by Subject|46
1509794|NCT00416598|4961747|P1|Induction & Intensification|Death|32
1509795|NCT00416598|4961747|P1|Induction & Intensification|Adverse Event|38
1509796|NCT00416520|4961773|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
1509797|NCT00416520|4961774|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
1509798|NCT00416520|4961775|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
1509799|NCT00416520|4961776|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
1509800|NCT00416520|4961773|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
1509801|NCT00416520|4961774|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
1509802|NCT00416520|4961775|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
1509803|NCT00416520|4961776|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
1509804|NCT00416520|4961773|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
1509805|NCT00416520|4961774|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
1509806|NCT00416520|4961775|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
1509807|NCT00416520|4961776|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
1509808|NCT00416520|4961773|P4|Open-label Period|Other Reasons|0
1509809|NCT00416520|4961774|P3|Open-label Period|Other Reasons|0
1509810|NCT00416520|4961775|P2|Open-label Period|Other Reasons|12
1509811|NCT00416520|4961776|P1|Open-label Period|Other Reasons|3
1509812|NCT00416520|4961773|P4|Open-label Period|Withdrawal by Subject|0
1509813|NCT00416520|4961774|P3|Open-label Period|Withdrawal by Subject|0
1509814|NCT00416520|4961775|P2|Open-label Period|Withdrawal by Subject|5
1509815|NCT00416520|4961776|P1|Open-label Period|Withdrawal by Subject|16
1509816|NCT00416520|4961773|P4|Open-label Period|Protocol Violation|0
1509817|NCT00416520|4961774|P3|Open-label Period|Protocol Violation|0
1509818|NCT00416520|4961775|P2|Open-label Period|Protocol Violation|3
1509819|NCT00416520|4961776|P1|Open-label Period|Protocol Violation|3
1509820|NCT00416520|4961773|P4|Open-label Period|Lack of Efficacy|0
1509821|NCT00416520|4961774|P3|Open-label Period|Lack of Efficacy|0
1509822|NCT00416520|4961775|P2|Open-label Period|Lack of Efficacy|1
1509823|NCT00416520|4961776|P1|Open-label Period|Lack of Efficacy|8
1509824|NCT00416520|4961773|P4|Open-label Period|Death|0
1509825|NCT00416520|4961774|P3|Open-label Period|Death|0
1509826|NCT00416520|4961775|P2|Open-label Period|Death|1
1509827|NCT00416520|4961776|P1|Open-label Period|Death|2
1509828|NCT00416520|4961773|P4|Open-label Period|Adverse Event|0
1509829|NCT00416520|4961774|P3|Open-label Period|Adverse Event|0
1509830|NCT00416520|4961775|P2|Open-label Period|Adverse Event|10
1509831|NCT00416520|4961776|P1|Open-label Period|Adverse Event|28
1509832|NCT00416455|4961805|P2|Overall Study|Inadequate pathology|2
1509833|NCT00416455|4961806|P1|Overall Study|Inadequate pathology|11
1509834|NCT00416455|4961805|P2|Overall Study|PET / CT poor quality|1
1509835|NCT00416455|4961806|P1|Overall Study|PET / CT poor quality|2
1509836|NCT00416455|4961805|P2|Overall Study|PET / CT not done|5
1509837|NCT00416455|4961806|P1|Overall Study|PET / CT not done|3
1509838|NCT00416312|4961818|P1|Overall Study|tumors not visible on imaging|2
1509839|NCT00416195|4961824|P2|Overall Study|Not Specified|1
1509840|NCT00416195|4961825|P1|Overall Study|Not Specified|0
1509841|NCT00416195|4961824|P2|Overall Study|Protocol Violation|1
1509842|NCT00416195|4961825|P1|Overall Study|Protocol Violation|1
1509843|NCT00416195|4961824|P2|Overall Study|Adverse Event|2
1509844|NCT00416195|4961825|P1|Overall Study|Adverse Event|1
1509845|NCT00416078|4961850|P2|Overall Study|Lost to Follow-up|2
1509846|NCT00416078|4961851|P1|Overall Study|Lost to Follow-up|4
1509847|NCT00416078|4961850|P2|Overall Study|Physician Decision|0
1509848|NCT00416078|4961851|P1|Overall Study|Physician Decision|1
1509849|NCT00416078|4961850|P2|Overall Study|Withdrawal by Subject|2
1509850|NCT00416078|4961851|P1|Overall Study|Withdrawal by Subject|3
1509851|NCT00416078|4961850|P2|Overall Study|Death|4
1509852|NCT00416078|4961851|P1|Overall Study|Death|3
1509853|NCT00415909|4961867|P1|Overall Study|Death|1
1509854|NCT00415909|4961867|P1|Overall Study|Withdrawal by Subject|2
1509855|NCT00415623|4961893|P2|Overall Study|Withdrawal by Subject|1
1509856|NCT00415623|4961894|P1|Overall Study|Withdrawal by Subject|1
1509857|NCT00415623|4961893|P2|Overall Study|Death|0
1509858|NCT00415623|4961894|P1|Overall Study|Death|1
1509859|NCT00415623|4961893|P2|Overall Study|Adverse Event|4
1509860|NCT00415623|4961894|P1|Overall Study|Adverse Event|3
1509861|NCT00415610|4961921|P3|Overall Study|Death|5
1509862|NCT00415610|4961922|P2|Overall Study|Death|2
1509863|NCT00415610|4961923|P1|Overall Study|Death|3
1509864|NCT00415597|4961943|P1|Treatment|Multiple Reasons|1
1509865|NCT00415597|4961943|P1|Treatment|Sponsor Decision|1
1509866|NCT00415597|4961943|P1|Treatment|Administrative|3
1509867|NCT00415597|4961943|P1|Treatment|Drug Screen|2
1509868|NCT00415597|4961943|P1|Treatment|Lost to Follow-up|28
1509869|NCT00415597|4961943|P1|Treatment|Withdrawal by Subject|51
1509870|NCT00415597|4961943|P1|Treatment|Physician Decision|3
1509871|NCT00415597|4961943|P1|Treatment|Protocol Violation|67
1509872|NCT00415597|4961943|P1|Treatment|Lack of Efficacy|39
1509873|NCT00415597|4961943|P1|Treatment|Adverse Event|110
1509874|NCT00415597|4961943|P1|Enrollment|Protocol Violation|1
1509875|NCT00415597|4961943|P1|Enrollment|Withdrawal by Subject|1
1509876|NCT00415532|4961951|P2|Safety Follow Up Period|Requirement for alternative therapy|1
1509877|NCT00415532|4961952|P1|Safety Follow Up Period|Requirement for alternative therapy|0
1509878|NCT00415532|4961951|P2|Safety Follow Up Period|Noncompliance|0
1509879|NCT00415532|4961952|P1|Safety Follow Up Period|Noncompliance|1
1509880|NCT00415532|4961951|P2|Safety Follow Up Period|Ineligibility determined|1
1509881|NCT00415532|4961952|P1|Safety Follow Up Period|Ineligibility determined|1
1509882|NCT00415532|4961951|P2|Safety Follow Up Period|Other|4
1509883|NCT00415532|4961952|P1|Safety Follow Up Period|Other|1
1509884|NCT00415532|4961951|P2|Safety Follow Up Period|Withdrawal by Subject|3
1509885|NCT00415532|4961952|P1|Safety Follow Up Period|Withdrawal by Subject|2
1509886|NCT00415532|4961951|P2|Safety Follow Up Period|Death|0
1509887|NCT00415532|4961952|P1|Safety Follow Up Period|Death|3
1509888|NCT00415532|4961951|P2|Safety Follow Up Period|Adverse Event|3
1509889|NCT00415532|4961952|P1|Safety Follow Up Period|Adverse Event|1
1509890|NCT00415532|4961951|P2|Treatment Period|Requirement for alternative therapy|0
1509891|NCT00415532|4961952|P1|Treatment Period|Requirement for alternative therapy|1
1509892|NCT00415532|4961951|P2|Treatment Period|Noncompliance|1
1509893|NCT00415532|4961952|P1|Treatment Period|Noncompliance|1
1509894|NCT00415532|4961951|P2|Treatment Period|Ineligibility determined|1
1509895|NCT00415532|4961952|P1|Treatment Period|Ineligibility determined|1
1509896|NCT00415532|4961951|P2|Treatment Period|Other|2
1509897|NCT00415532|4961952|P1|Treatment Period|Other|2
1509898|NCT00415532|4961951|P2|Treatment Period|Withdrawal by Subject|6
1509899|NCT00415532|4961952|P1|Treatment Period|Withdrawal by Subject|6
1509900|NCT00415532|4961951|P2|Treatment Period|Protocol Violation|0
1509901|NCT00415532|4961952|P1|Treatment Period|Protocol Violation|1
1509902|NCT00415532|4961951|P2|Treatment Period|Lost to Follow-up|1
1509903|NCT00415532|4961952|P1|Treatment Period|Lost to Follow-up|1
1509904|NCT00415532|4961951|P2|Treatment Period|Death|1
1509905|NCT00415532|4961952|P1|Treatment Period|Death|2
1509906|NCT00415532|4961951|P2|Treatment Period|Adverse Event|3
1509907|NCT00415532|4961952|P1|Treatment Period|Adverse Event|2
1509908|NCT00415519|4961974|P2|Overall Study|Patient’s convenience|0
1509909|NCT00415519|4961975|P1|Overall Study|Patient’s convenience|1
1509910|NCT00415519|4961974|P2|Overall Study|Withdrawal by Subject|0
1509911|NCT00415519|4961975|P1|Overall Study|Withdrawal by Subject|2
1509912|NCT00415519|4961974|P2|Overall Study|Adverse Event|0
1509913|NCT00415519|4961975|P1|Overall Study|Adverse Event|1
1509914|NCT00415194|4962015|P2|Overall Study|Death Due to AE (Other Causes)|15
1509915|NCT00415194|4962016|P1|Overall Study|Death Due to AE (Other Causes)|27
1509916|NCT00415194|4962015|P2|Overall Study|Death Due to Procedural Related AE|1
1509917|NCT00415194|4962016|P1|Overall Study|Death Due to Procedural Related AE|0
1509918|NCT00415194|4962015|P2|Overall Study|Death Due to Study Drug Related AE|1
1509919|NCT00415194|4962016|P1|Overall Study|Death Due to Study Drug Related AE|11
1509920|NCT00415194|4962015|P2|Overall Study|Death Due to Study Disease|29
1509921|NCT00415194|4962016|P1|Overall Study|Death Due to Study Disease|26
1509922|NCT00415194|4962015|P2|Overall Study|Withdrawal by Subject|21
1509923|NCT00415194|4962016|P1|Overall Study|Withdrawal by Subject|28
1509924|NCT00415194|4962015|P2|Overall Study|Protocol Violation|2
1509925|NCT00415194|4962016|P1|Overall Study|Protocol Violation|4
1509926|NCT00415194|4962015|P2|Overall Study|Progressive Disease|217
1509927|NCT00415194|4962016|P1|Overall Study|Progressive Disease|180
1509928|NCT00415194|4962015|P2|Overall Study|Physician Decision|16
1509929|NCT00415194|4962016|P1|Overall Study|Physician Decision|10
1509930|NCT00415194|4962015|P2|Overall Study|Lost to Follow-up|0
1509931|NCT00415194|4962016|P1|Overall Study|Lost to Follow-up|1
1509932|NCT00415194|4962015|P2|Overall Study|Entry Criteria Not Met|8
1509933|NCT00415194|4962016|P1|Overall Study|Entry Criteria Not Met|4
1509934|NCT00415194|4962015|P2|Overall Study|Adverse Event|32
1509935|NCT00415194|4962016|P1|Overall Study|Adverse Event|37
1509936|NCT00415168|4962032|P1|Overall Study|Withdrawal by Subject|6
1509937|NCT00415168|4962032|P1|Overall Study|Sponsor Decision|4
1509938|NCT00415168|4962032|P1|Overall Study|Physician Decision|13
1509939|NCT00415168|4962032|P1|Overall Study|Lost to Follow-up|3
1509940|NCT00415168|4962032|P1|Overall Study|Death|26
1509941|NCT00415051|4962042|P1|Overall Study|Protocol Violation|1
1509942|NCT00414973|4962053|P4|Overall Study|Death|0
1509943|NCT00414973|4962054|P3|Overall Study|Death|1
1509944|NCT00414973|4962055|P2|Overall Study|Death|0
1509945|NCT00414973|4962056|P1|Overall Study|Death|0
1509946|NCT00414973|4962053|P4|Overall Study|Sponsor Decision|0
1509947|NCT00414973|4962054|P3|Overall Study|Sponsor Decision|0
1509948|NCT00414973|4962055|P2|Overall Study|Sponsor Decision|0
1509949|NCT00414973|4962056|P1|Overall Study|Sponsor Decision|1
1509950|NCT00414973|4962053|P4|Overall Study|Lost to Follow-up|0
1509951|NCT00414973|4962054|P3|Overall Study|Lost to Follow-up|0
1509952|NCT00414973|4962055|P2|Overall Study|Lost to Follow-up|2
1509953|NCT00414973|4962056|P1|Overall Study|Lost to Follow-up|0
1509954|NCT00414973|4962053|P4|Overall Study|Protocol Violation|0
1509955|NCT00414973|4962054|P3|Overall Study|Protocol Violation|0
1509956|NCT00414973|4962055|P2|Overall Study|Protocol Violation|4
1509957|NCT00414973|4962056|P1|Overall Study|Protocol Violation|3
1509958|NCT00414973|4962053|P4|Overall Study|Adverse Event|0
1509959|NCT00414973|4962054|P3|Overall Study|Adverse Event|1
1509960|NCT00414973|4962055|P2|Overall Study|Adverse Event|0
1509961|NCT00414973|4962056|P1|Overall Study|Adverse Event|10
1509962|NCT00414973|4962053|P4|Overall Study|Withdrawal by Subject|0
1509963|NCT00414973|4962054|P3|Overall Study|Withdrawal by Subject|1
1509964|NCT00414973|4962055|P2|Overall Study|Withdrawal by Subject|4
1509965|NCT00414973|4962056|P1|Overall Study|Withdrawal by Subject|14
1509966|NCT00414908|4962076|P2|Overall Study|Protocol Violation|1
1509967|NCT00414908|4962077|P1|Overall Study|Protocol Violation|1
1509968|NCT00414726|4962114|P2|Overall Study|Withdrawal by Subject|1
1509969|NCT00414726|4962115|P1|Overall Study|Withdrawal by Subject|0
1509970|NCT00414661|4962150|P4|Overall Study|Other|0
1509971|NCT00414661|4962151|P3|Overall Study|Other|0
1509972|NCT00414661|4962152|P2|Overall Study|Other|3
1509973|NCT00414661|4962153|P1|Overall Study|Other|6
1509974|NCT00414661|4962150|P4|Overall Study|Withdrawal by Subject|2
1509975|NCT00414661|4962151|P3|Overall Study|Withdrawal by Subject|2
1509976|NCT00414661|4962152|P2|Overall Study|Withdrawal by Subject|2
1509977|NCT00414661|4962153|P1|Overall Study|Withdrawal by Subject|5
1509978|NCT00414661|4962150|P4|Overall Study|Lost to Follow-up|1
1509979|NCT00414661|4962151|P3|Overall Study|Lost to Follow-up|0
1509980|NCT00414661|4962152|P2|Overall Study|Lost to Follow-up|4
1509981|NCT00414661|4962153|P1|Overall Study|Lost to Follow-up|1
1509982|NCT00414661|4962150|P4|Overall Study|Death|0
1509983|NCT00414661|4962151|P3|Overall Study|Death|0
1509984|NCT00414661|4962152|P2|Overall Study|Death|5
1509985|NCT00414661|4962153|P1|Overall Study|Death|2
1509986|NCT00414609|4962198|P3|Extension Study|Death|17
1509987|NCT00414609|4962199|P2|Extension Study|Death|0
1509988|NCT00414609|4962200|P1|Extension Study|Death|0
1509989|NCT00414609|4962198|P3|Extension Study|Administrative problems|1
1509990|NCT00414609|4962199|P2|Extension Study|Administrative problems|0
1509991|NCT00414609|4962200|P1|Extension Study|Administrative problems|0
1509992|NCT00414609|4962198|P3|Extension Study|Lost to Follow-up|10
1509993|NCT00414609|4962199|P2|Extension Study|Lost to Follow-up|0
1509994|NCT00414609|4962200|P1|Extension Study|Lost to Follow-up|0
1509995|NCT00414609|4962198|P3|Extension Study|Withdrawal by Subject|13
1509996|NCT00414609|4962199|P2|Extension Study|Withdrawal by Subject|0
1509997|NCT00414609|4962200|P1|Extension Study|Withdrawal by Subject|0
1509998|NCT00414609|4962198|P3|Extension Study|Unsatisfactory therapeutic effect|2
1509999|NCT00414609|4962199|P2|Extension Study|Unsatisfactory therapeutic effect|0
1510000|NCT00414609|4962200|P1|Extension Study|Unsatisfactory therapeutic effect|0
1510001|NCT00414609|4962198|P3|Extension Study|Adverse Event|14
1510002|NCT00414609|4962199|P2|Extension Study|Adverse Event|0
1510003|NCT00414609|4962200|P1|Extension Study|Adverse Event|0
1510004|NCT00414609|4962198|P3|Core Study|Death|0
1510005|NCT00414609|4962199|P2|Core Study|Death|14
1510006|NCT00414609|4962200|P1|Core Study|Death|7
1510007|NCT00414609|4962198|P3|Core Study|Administrative problems|0
1510008|NCT00414609|4962199|P2|Core Study|Administrative problems|2
1510009|NCT00414609|4962200|P1|Core Study|Administrative problems|0
1510010|NCT00414609|4962198|P3|Core Study|Lost to Follow-up|0
1510011|NCT00414609|4962199|P2|Core Study|Lost to Follow-up|4
1510012|NCT00414609|4962200|P1|Core Study|Lost to Follow-up|7
1510013|NCT00414609|4962198|P3|Core Study|Patient withdrew consent|0
1510014|NCT00414609|4962199|P2|Core Study|Patient withdrew consent|11
1510015|NCT00414609|4962200|P1|Core Study|Patient withdrew consent|10
1510016|NCT00414609|4962198|P3|Core Study|Protocol deviation|0
1510017|NCT00414609|4962199|P2|Core Study|Protocol deviation|1
1510018|NCT00414609|4962200|P1|Core Study|Protocol deviation|0
1510019|NCT00414609|4962198|P3|Core Study|Abnormal test procedure results|0
1510020|NCT00414609|4962199|P2|Core Study|Abnormal test procedure results|1
1510021|NCT00414609|4962200|P1|Core Study|Abnormal test procedure results|1
1510022|NCT00414609|4962198|P3|Core Study|Abnormal laboratory values|0
1510023|NCT00414609|4962199|P2|Core Study|Abnormal laboratory values|1
1510024|NCT00414609|4962200|P1|Core Study|Abnormal laboratory values|0
1510025|NCT00414609|4962198|P3|Core Study|Adverse Event|0
1510026|NCT00414609|4962199|P2|Core Study|Adverse Event|11
1510027|NCT00414609|4962200|P1|Core Study|Adverse Event|9
1510028|NCT00414596|4962223|P1|Overall Study|Protocol Violation|2
1510029|NCT00414544|4962232|P1|Overall Study|Lost to Follow-up|14
1510030|NCT00414466|4962255|P4|Overall Study|Withdrawn by Sponsor|0
1510031|NCT00414466|4962256|P3|Overall Study|Withdrawn by Sponsor|0
1510032|NCT00414466|4962257|P2|Overall Study|Withdrawn by Sponsor|0
1510033|NCT00414466|4962258|P1|Overall Study|Withdrawn by Sponsor|1
1510034|NCT00414466|4962255|P4|Overall Study|Lack of Efficacy|0
1510035|NCT00414466|4962256|P3|Overall Study|Lack of Efficacy|0
1510036|NCT00414466|4962257|P2|Overall Study|Lack of Efficacy|0
1510037|NCT00414466|4962258|P1|Overall Study|Lack of Efficacy|1
1510038|NCT00414466|4962255|P4|Overall Study|Adverse Event|1
1510039|NCT00414466|4962256|P3|Overall Study|Adverse Event|1
1510040|NCT00414466|4962257|P2|Overall Study|Adverse Event|0
1510041|NCT00414466|4962258|P1|Overall Study|Adverse Event|0
1510042|NCT00414453|4962276|P1|Overall Study|Abnormal lab work|16
1510043|NCT00414440|4962324|P2|Extension Period|Not included in follow up period|8
1510044|NCT00414440|4962325|P1|Extension Period|Not included in follow up period|18
1510045|NCT00414440|4962324|P2|Extension Period|Withdrawal by Subject|7
1510046|NCT00414440|4962325|P1|Extension Period|Withdrawal by Subject|9
1510047|NCT00414440|4962324|P2|Extension Period|Death|2
1510048|NCT00414440|4962325|P1|Extension Period|Death|1
1510049|NCT00414440|4962324|P2|Extension Period|Administrative|16
1510050|NCT00414440|4962325|P1|Extension Period|Administrative|16
1510051|NCT00414440|4962324|P2|Extension Period|Other|1
1510052|NCT00414440|4962325|P1|Extension Period|Other|1
1510141|NCT00413699|4962510|P2|Overall Study|Did not meet entrance criteria|2
1510053|NCT00414440|4962324|P2|Extension Period|Did not consent to continue follow up|54
1510054|NCT00414440|4962325|P1|Extension Period|Did not consent to continue follow up|61
1510055|NCT00414440|4962324|P2|Extension Period|Lost to Follow-up|52
1510056|NCT00414440|4962325|P1|Extension Period|Lost to Follow-up|44
1510057|NCT00414440|4962324|P2|Core Period|Withdrawal by Subject|32
1510058|NCT00414440|4962325|P1|Core Period|Withdrawal by Subject|70
1510059|NCT00414388|4962339|P1|Overall Study|Adverse Event|1
1510060|NCT00414310|4962347|P2|Overall Study|Not treated|0
1510061|NCT00414310|4962348|P1|Overall Study|Not treated|1
1510062|NCT00414050|4962382|P4|Overall Study|Subject Moved|1
1510063|NCT00414050|4962383|P3|Overall Study|Subject Moved|0
1510064|NCT00414050|4962384|P2|Overall Study|Subject Moved|0
1510065|NCT00414050|4962385|P1|Overall Study|Subject Moved|0
1510066|NCT00414050|4962382|P4|Overall Study|Subject discontinued for other reason|1
1510067|NCT00414050|4962383|P3|Overall Study|Subject discontinued for other reason|2
1510068|NCT00414050|4962384|P2|Overall Study|Subject discontinued for other reason|2
1510069|NCT00414050|4962385|P1|Overall Study|Subject discontinued for other reason|1
1510070|NCT00414050|4962382|P4|Overall Study|Withdrawal by Subject|4
1510071|NCT00414050|4962383|P3|Overall Study|Withdrawal by Subject|2
1510072|NCT00414050|4962384|P2|Overall Study|Withdrawal by Subject|3
1510073|NCT00414050|4962385|P1|Overall Study|Withdrawal by Subject|5
1510074|NCT00414050|4962382|P4|Overall Study|Lost to Follow-up|1
1510075|NCT00414050|4962383|P3|Overall Study|Lost to Follow-up|1
1510076|NCT00414050|4962384|P2|Overall Study|Lost to Follow-up|2
1510077|NCT00414050|4962385|P1|Overall Study|Lost to Follow-up|2
1510078|NCT00414050|4962382|P4|Overall Study|Adverse Event|1
1510079|NCT00414050|4962383|P3|Overall Study|Adverse Event|1
1510080|NCT00414050|4962384|P2|Overall Study|Adverse Event|1
1510081|NCT00414050|4962385|P1|Overall Study|Adverse Event|1
1510082|NCT00414011|4962399|P1|Overall Study|Withdrawal by Subject|2
1510083|NCT00414011|4962399|P1|Overall Study|Physician Decision|3
1510084|NCT00413972|4962408|P4|Overall Study|Not Specified|1
1510085|NCT00413972|4962409|P3|Overall Study|Not Specified|0
1510086|NCT00413972|4962410|P2|Overall Study|Not Specified|0
1510087|NCT00413972|4962411|P1|Overall Study|Not Specified|0
1510088|NCT00413972|4962408|P4|Overall Study|Protocol Violation|0
1510089|NCT00413972|4962409|P3|Overall Study|Protocol Violation|2
1510090|NCT00413972|4962410|P2|Overall Study|Protocol Violation|0
1510091|NCT00413972|4962411|P1|Overall Study|Protocol Violation|0
1510092|NCT00413972|4962408|P4|Overall Study|Withdrawal by Subject|2
1510093|NCT00413972|4962409|P3|Overall Study|Withdrawal by Subject|7
1510094|NCT00413972|4962410|P2|Overall Study|Withdrawal by Subject|5
1510095|NCT00413972|4962411|P1|Overall Study|Withdrawal by Subject|4
1510096|NCT00413972|4962408|P4|Overall Study|Lost to Follow-up|0
1510097|NCT00413972|4962409|P3|Overall Study|Lost to Follow-up|1
1510098|NCT00413972|4962410|P2|Overall Study|Lost to Follow-up|2
1510099|NCT00413972|4962411|P1|Overall Study|Lost to Follow-up|1
1510100|NCT00413972|4962408|P4|Overall Study|Adverse Event|0
1510101|NCT00413972|4962409|P3|Overall Study|Adverse Event|0
1510102|NCT00413972|4962410|P2|Overall Study|Adverse Event|1
1510103|NCT00413972|4962411|P1|Overall Study|Adverse Event|2
1510104|NCT00413959|4962421|P1|Overall Study|Pt had only one cycle.|1
1510105|NCT00413920|4962428|P2|Overall Study|Graft Loss|3
1510106|NCT00413920|4962429|P1|Overall Study|Graft Loss|5
1510107|NCT00413920|4962428|P2|Overall Study|Death|5
1510108|NCT00413920|4962429|P1|Overall Study|Death|3
1510109|NCT00413920|4962428|P2|Overall Study|Lack of Efficacy|9
1510110|NCT00413920|4962429|P1|Overall Study|Lack of Efficacy|11
1510111|NCT00413920|4962428|P2|Overall Study|Adverse Event|11
1510112|NCT00413920|4962429|P1|Overall Study|Adverse Event|9
1510113|NCT00413894|4962444|P1|Overall Study|Other|18
1510114|NCT00413894|4962444|P1|Overall Study|Protocol Violation|11
1510115|NCT00413894|4962444|P1|Overall Study|Adverse Event|28
1510116|NCT00413894|4962444|P1|Overall Study|Hb <10 grams/deciliter|12
1510117|NCT00413894|4962444|P1|Overall Study|Administrative Reasons|1
1510118|NCT00413894|4962444|P1|Overall Study|Withdrawal by Subject|10
1510119|NCT00413777|4962461|P2|Fixed-dose Period|Withdrew Consent|1
1510120|NCT00413777|4962462|P1|Fixed-dose Period|Withdrew Consent|0
1510121|NCT00413777|4962461|P2|Fixed-dose Period|Met Withdrawal Criteria|0
1510122|NCT00413777|4962462|P1|Fixed-dose Period|Met Withdrawal Criteria|1
1510123|NCT00413777|4962461|P2|Fixed-dose Period|Adverse Event|1
1510124|NCT00413777|4962462|P1|Fixed-dose Period|Adverse Event|2
1510125|NCT00413777|4962461|P2|Fixed-dose Period|Lost to Follow-up|1
1510126|NCT00413777|4962462|P1|Fixed-dose Period|Lost to Follow-up|1
1510127|NCT00413699|4962510|P2|Overall Study|No longer willing to participate|368
1510128|NCT00413699|4962511|P1|Overall Study|No longer willing to participate|116
1510129|NCT00413699|4962510|P2|Overall Study|Missing end of study page|4
1510130|NCT00413699|4962511|P1|Overall Study|Missing end of study page|0
1510131|NCT00413699|4962510|P2|Overall Study|Adverse event not related to study drug|248
1510132|NCT00413699|4962511|P1|Overall Study|Adverse event not related to study drug|113
1510133|NCT00413699|4962510|P2|Overall Study|Adverse event related to study drug|527
1510134|NCT00413699|4962511|P1|Overall Study|Adverse event related to study drug|178
1510135|NCT00413699|4962510|P2|Overall Study|Not specified|211
1510136|NCT00413699|4962511|P1|Overall Study|Not specified|67
1510137|NCT00413699|4962510|P2|Overall Study|Study terminated by Sponsor|1
1510138|NCT00413699|4962511|P1|Overall Study|Study terminated by Sponsor|0
1510139|NCT00413699|4962510|P2|Overall Study|Medication error without adverse event|1
1510140|NCT00413699|4962511|P1|Overall Study|Medication error without adverse event|0
1510142|NCT00413699|4962511|P1|Overall Study|Did not meet entrance criteria|2
1510143|NCT00413699|4962510|P2|Overall Study|Pregnancy|8
1510144|NCT00413699|4962511|P1|Overall Study|Pregnancy|10
1510145|NCT00413699|4962510|P2|Overall Study|Protocol Violation|89
1510146|NCT00413699|4962511|P1|Overall Study|Protocol Violation|38
1510147|NCT00413699|4962510|P2|Overall Study|Lost to Follow-up|101
1510148|NCT00413699|4962511|P1|Overall Study|Lost to Follow-up|31
1510149|NCT00413699|4962510|P2|Overall Study|Lack of Efficacy|115
1510150|NCT00413699|4962511|P1|Overall Study|Lack of Efficacy|59
1510151|NCT00413699|4962510|P2|Overall Study|Death|30
1510152|NCT00413699|4962511|P1|Overall Study|Death|25
1510153|NCT00413660|4962585|P11|Post Week 12|Other|0
1510154|NCT00413660|4962586|P10|Post Week 12|Other|0
1510155|NCT00413660|4962587|P9|Post Week 12|Other|0
1510156|NCT00413660|4962588|P8|Post Week 12|Other|0
1510157|NCT00413660|4962589|P7|Post Week 12|Other|1
1510158|NCT00413660|4962590|P6|Post Week 12|Other|1
1510159|NCT00413660|4962591|P5|Post Week 12|Other|1
1510160|NCT00413660|4962592|P4|Post Week 12|Other|0
1510161|NCT00413660|4962593|P3|Post Week 12|Other|3
1510162|NCT00413660|4962594|P2|Post Week 12|Other|2
1510163|NCT00413660|4962595|P1|Post Week 12|Other|1
1510164|NCT00413660|4962585|P11|Post Week 12|Withdrawal by Subject|1
1510165|NCT00413660|4962586|P10|Post Week 12|Withdrawal by Subject|0
1510166|NCT00413660|4962587|P9|Post Week 12|Withdrawal by Subject|0
1510167|NCT00413660|4962588|P8|Post Week 12|Withdrawal by Subject|0
1510168|NCT00413660|4962589|P7|Post Week 12|Withdrawal by Subject|0
1510169|NCT00413660|4962590|P6|Post Week 12|Withdrawal by Subject|0
1510170|NCT00413660|4962591|P5|Post Week 12|Withdrawal by Subject|1
1510171|NCT00413660|4962592|P4|Post Week 12|Withdrawal by Subject|0
1510172|NCT00413660|4962593|P3|Post Week 12|Withdrawal by Subject|1
1510173|NCT00413660|4962594|P2|Post Week 12|Withdrawal by Subject|1
1510174|NCT00413660|4962595|P1|Post Week 12|Withdrawal by Subject|0
1510175|NCT00413660|4962585|P11|Post Week 12|Lost to Follow-up|0
1510176|NCT00413660|4962586|P10|Post Week 12|Lost to Follow-up|0
1510177|NCT00413660|4962587|P9|Post Week 12|Lost to Follow-up|0
1510178|NCT00413660|4962588|P8|Post Week 12|Lost to Follow-up|0
1510179|NCT00413660|4962589|P7|Post Week 12|Lost to Follow-up|0
1510180|NCT00413660|4962590|P6|Post Week 12|Lost to Follow-up|0
1510181|NCT00413660|4962591|P5|Post Week 12|Lost to Follow-up|0
1510182|NCT00413660|4962592|P4|Post Week 12|Lost to Follow-up|0
1510183|NCT00413660|4962593|P3|Post Week 12|Lost to Follow-up|1
1510184|NCT00413660|4962594|P2|Post Week 12|Lost to Follow-up|1
1510185|NCT00413660|4962595|P1|Post Week 12|Lost to Follow-up|0
1510186|NCT00413660|4962585|P11|Post Week 12|Lack of Efficacy|0
1510187|NCT00413660|4962586|P10|Post Week 12|Lack of Efficacy|1
1510188|NCT00413660|4962587|P9|Post Week 12|Lack of Efficacy|0
1510189|NCT00413660|4962588|P8|Post Week 12|Lack of Efficacy|0
1510190|NCT00413660|4962589|P7|Post Week 12|Lack of Efficacy|0
1510191|NCT00413660|4962590|P6|Post Week 12|Lack of Efficacy|0
1510192|NCT00413660|4962591|P5|Post Week 12|Lack of Efficacy|0
1510193|NCT00413660|4962592|P4|Post Week 12|Lack of Efficacy|0
1510194|NCT00413660|4962593|P3|Post Week 12|Lack of Efficacy|1
1510195|NCT00413660|4962594|P2|Post Week 12|Lack of Efficacy|0
1510196|NCT00413660|4962595|P1|Post Week 12|Lack of Efficacy|0
1510197|NCT00413660|4962585|P11|Post Week 12|Adverse Event|0
1510198|NCT00413660|4962586|P10|Post Week 12|Adverse Event|0
1510199|NCT00413660|4962587|P9|Post Week 12|Adverse Event|0
1510200|NCT00413660|4962588|P8|Post Week 12|Adverse Event|0
1510201|NCT00413660|4962589|P7|Post Week 12|Adverse Event|2
1510202|NCT00413660|4962590|P6|Post Week 12|Adverse Event|2
1510203|NCT00413660|4962591|P5|Post Week 12|Adverse Event|4
1510204|NCT00413660|4962592|P4|Post Week 12|Adverse Event|1
1510205|NCT00413660|4962593|P3|Post Week 12|Adverse Event|2
1510206|NCT00413660|4962594|P2|Post Week 12|Adverse Event|0
1510207|NCT00413660|4962595|P1|Post Week 12|Adverse Event|2
1510208|NCT00413660|4962585|P11|Up To Week 12|Other|0
1510209|NCT00413660|4962586|P10|Up To Week 12|Other|0
1510210|NCT00413660|4962587|P9|Up To Week 12|Other|0
1510211|NCT00413660|4962588|P8|Up To Week 12|Other|0
1510212|NCT00413660|4962589|P7|Up To Week 12|Other|3
1510213|NCT00413660|4962590|P6|Up To Week 12|Other|4
1510214|NCT00413660|4962591|P5|Up To Week 12|Other|2
1510215|NCT00413660|4962592|P4|Up To Week 12|Other|1
1510216|NCT00413660|4962593|P3|Up To Week 12|Other|6
1510217|NCT00413660|4962594|P2|Up To Week 12|Other|1
1510218|NCT00413660|4962595|P1|Up To Week 12|Other|3
1510219|NCT00413660|4962585|P11|Up To Week 12|Randomized, Not Treated|0
1510220|NCT00413660|4962586|P10|Up To Week 12|Randomized, Not Treated|0
1510221|NCT00413660|4962587|P9|Up To Week 12|Randomized, Not Treated|0
1510222|NCT00413660|4962588|P8|Up To Week 12|Randomized, Not Treated|0
1510223|NCT00413660|4962589|P7|Up To Week 12|Randomized, Not Treated|0
1510224|NCT00413660|4962590|P6|Up To Week 12|Randomized, Not Treated|0
1510225|NCT00413660|4962591|P5|Up To Week 12|Randomized, Not Treated|0
1510226|NCT00413660|4962592|P4|Up To Week 12|Randomized, Not Treated|1
1510227|NCT00413660|4962593|P3|Up To Week 12|Randomized, Not Treated|0
1510228|NCT00413660|4962594|P2|Up To Week 12|Randomized, Not Treated|0
1510229|NCT00413660|4962595|P1|Up To Week 12|Randomized, Not Treated|1
1510230|NCT00413660|4962585|P11|Up To Week 12|Withdrawal by Subject|0
1510231|NCT00413660|4962586|P10|Up To Week 12|Withdrawal by Subject|0
1510232|NCT00413660|4962587|P9|Up To Week 12|Withdrawal by Subject|0
1510233|NCT00413660|4962588|P8|Up To Week 12|Withdrawal by Subject|0
1510234|NCT00413660|4962589|P7|Up To Week 12|Withdrawal by Subject|2
1510235|NCT00413660|4962590|P6|Up To Week 12|Withdrawal by Subject|2
1510236|NCT00413660|4962591|P5|Up To Week 12|Withdrawal by Subject|0
1510237|NCT00413660|4962592|P4|Up To Week 12|Withdrawal by Subject|2
1510238|NCT00413660|4962593|P3|Up To Week 12|Withdrawal by Subject|0
1510239|NCT00413660|4962594|P2|Up To Week 12|Withdrawal by Subject|2
1510240|NCT00413660|4962595|P1|Up To Week 12|Withdrawal by Subject|0
1510241|NCT00413660|4962585|P11|Up To Week 12|Lost to Follow-up|0
1510242|NCT00413660|4962586|P10|Up To Week 12|Lost to Follow-up|0
1510243|NCT00413660|4962587|P9|Up To Week 12|Lost to Follow-up|0
1510244|NCT00413660|4962588|P8|Up To Week 12|Lost to Follow-up|0
1510245|NCT00413660|4962589|P7|Up To Week 12|Lost to Follow-up|0
1510246|NCT00413660|4962590|P6|Up To Week 12|Lost to Follow-up|0
1510247|NCT00413660|4962591|P5|Up To Week 12|Lost to Follow-up|1
1510248|NCT00413660|4962592|P4|Up To Week 12|Lost to Follow-up|0
1510249|NCT00413660|4962593|P3|Up To Week 12|Lost to Follow-up|0
1510250|NCT00413660|4962594|P2|Up To Week 12|Lost to Follow-up|1
1510251|NCT00413660|4962595|P1|Up To Week 12|Lost to Follow-up|0
1510252|NCT00413660|4962585|P11|Up To Week 12|Lack of Efficacy|0
1510253|NCT00413660|4962586|P10|Up To Week 12|Lack of Efficacy|0
1510254|NCT00413660|4962587|P9|Up To Week 12|Lack of Efficacy|0
1510255|NCT00413660|4962588|P8|Up To Week 12|Lack of Efficacy|0
1510256|NCT00413660|4962589|P7|Up To Week 12|Lack of Efficacy|5
1510257|NCT00413660|4962590|P6|Up To Week 12|Lack of Efficacy|0
1510258|NCT00413660|4962591|P5|Up To Week 12|Lack of Efficacy|0
1510259|NCT00413660|4962592|P4|Up To Week 12|Lack of Efficacy|0
1510260|NCT00413660|4962593|P3|Up To Week 12|Lack of Efficacy|0
1510261|NCT00413660|4962594|P2|Up To Week 12|Lack of Efficacy|0
1510262|NCT00413660|4962595|P1|Up To Week 12|Lack of Efficacy|2
1510263|NCT00413660|4962585|P11|Up To Week 12|Adverse Event|0
1510264|NCT00413660|4962586|P10|Up To Week 12|Adverse Event|0
1510265|NCT00413660|4962587|P9|Up To Week 12|Adverse Event|0
1510266|NCT00413660|4962588|P8|Up To Week 12|Adverse Event|0
1510267|NCT00413660|4962589|P7|Up To Week 12|Adverse Event|1
1510268|NCT00413660|4962590|P6|Up To Week 12|Adverse Event|4
1510269|NCT00413660|4962591|P5|Up To Week 12|Adverse Event|6
1510270|NCT00413660|4962592|P4|Up To Week 12|Adverse Event|4
1510271|NCT00413660|4962593|P3|Up To Week 12|Adverse Event|1
1510272|NCT00413660|4962594|P2|Up To Week 12|Adverse Event|3
1510273|NCT00413660|4962595|P1|Up To Week 12|Adverse Event|1
1510274|NCT00413413|4962998|P3|Double-Blind|Lost to Follow-up|2
1510275|NCT00413413|4962999|P2|Double-Blind|Lost to Follow-up|4
1510276|NCT00413413|4963000|P1|Double-Blind|Lost to Follow-up|3
1510277|NCT00413413|4962998|P3|Double-Blind|Subject withdrew consent|9
1510278|NCT00413413|4962999|P2|Double-Blind|Subject withdrew consent|6
1510279|NCT00413413|4963000|P1|Double-Blind|Subject withdrew consent|4
1510280|NCT00413413|4962998|P3|Double-Blind|Protocol deviation|1
1510281|NCT00413413|4962999|P2|Double-Blind|Protocol deviation|2
1510282|NCT00413413|4963000|P1|Double-Blind|Protocol deviation|1
1510283|NCT00413413|4962998|P3|Double-Blind|Unsatisfactory therapeutic effect|1
1510284|NCT00413413|4962999|P2|Double-Blind|Unsatisfactory therapeutic effect|2
1510285|NCT00413413|4963000|P1|Double-Blind|Unsatisfactory therapeutic effect|1
1510286|NCT00413413|4962998|P3|Double-Blind|Adverse Event|5
1510287|NCT00413413|4962999|P2|Double-Blind|Adverse Event|0
1510288|NCT00413413|4963000|P1|Double-Blind|Adverse Event|6
1510289|NCT00413413|4962998|P3|Single-Blind|Lost to Follow-up|0
1510290|NCT00413413|4962999|P2|Single-Blind|Lost to Follow-up|8
1510291|NCT00413413|4963000|P1|Single-Blind|Lost to Follow-up|0
1510292|NCT00413413|4962998|P3|Single-Blind|Withdrawal by Subject|0
1510293|NCT00413413|4962999|P2|Single-Blind|Withdrawal by Subject|27
1510294|NCT00413413|4963000|P1|Single-Blind|Withdrawal by Subject|0
1510295|NCT00413413|4962998|P3|Single-Blind|Protocol Violation|0
1510296|NCT00413413|4962999|P2|Single-Blind|Protocol Violation|16
1510297|NCT00413413|4963000|P1|Single-Blind|Protocol Violation|0
1510298|NCT00413413|4962998|P3|Single-Blind|Subject no longer requires study drug|0
1510299|NCT00413413|4962999|P2|Single-Blind|Subject no longer requires study drug|151
1510300|NCT00413413|4963000|P1|Single-Blind|Subject no longer requires study drug|0
1510301|NCT00413413|4962998|P3|Single-Blind|Lack of Efficacy|0
1510302|NCT00413413|4962999|P2|Single-Blind|Lack of Efficacy|5
1510303|NCT00413413|4963000|P1|Single-Blind|Lack of Efficacy|0
1510304|NCT00413413|4962998|P3|Single-Blind|Adverse Event|0
1510305|NCT00413413|4962999|P2|Single-Blind|Adverse Event|9
1510306|NCT00413413|4963000|P1|Single-Blind|Adverse Event|0
1510307|NCT00413374|4963053|P2|Overall Study|Surgery|0
1510308|NCT00413374|4963054|P1|Overall Study|Surgery|1
1510309|NCT00413374|4963053|P2|Overall Study|Lost to Follow-up|0
1510310|NCT00413374|4963054|P1|Overall Study|Lost to Follow-up|1
1510311|NCT00413374|4963053|P2|Overall Study|Adverse Event|0
1510312|NCT00413374|4963054|P1|Overall Study|Adverse Event|1
1510313|NCT00413374|4963053|P2|Overall Study|Ineligible due to screening criteria.|0
1510314|NCT00413374|4963054|P1|Overall Study|Ineligible due to screening criteria.|3
1510315|NCT00413283|4963085|P4|Overall Study|Not specified|0
1510316|NCT00413283|4963086|P3|Overall Study|Not specified|1
1510317|NCT00413283|4963087|P2|Overall Study|Not specified|0
1510318|NCT00413283|4963088|P1|Overall Study|Not specified|0
1510319|NCT00413283|4963085|P4|Overall Study|Requirement for alternative therapy|0
1510320|NCT00413283|4963086|P3|Overall Study|Requirement for alternative therapy|0
1510321|NCT00413283|4963087|P2|Overall Study|Requirement for alternative therapy|2
1510322|NCT00413283|4963088|P1|Overall Study|Requirement for alternative therapy|0
1510323|NCT00413283|4963085|P4|Overall Study|Protocol deviation|0
1510324|NCT00413283|4963086|P3|Overall Study|Protocol deviation|0
1510325|NCT00413283|4963087|P2|Overall Study|Protocol deviation|1
1510326|NCT00413283|4963088|P1|Overall Study|Protocol deviation|0
1510327|NCT00413283|4963085|P4|Overall Study|Ineligibility determined|1
1510328|NCT00413283|4963086|P3|Overall Study|Ineligibility determined|0
1510329|NCT00413283|4963087|P2|Overall Study|Ineligibility determined|0
1510330|NCT00413283|4963088|P1|Overall Study|Ineligibility determined|0
1510331|NCT00413283|4963085|P4|Overall Study|Adverse Event|1
1510332|NCT00413283|4963086|P3|Overall Study|Adverse Event|0
1510333|NCT00413283|4963087|P2|Overall Study|Adverse Event|0
1510334|NCT00413283|4963088|P1|Overall Study|Adverse Event|0
1510335|NCT00413283|4963085|P4|Overall Study|Death|1
1510336|NCT00413283|4963086|P3|Overall Study|Death|1
1510337|NCT00413283|4963087|P2|Overall Study|Death|0
1510338|NCT00413283|4963088|P1|Overall Study|Death|0
1510339|NCT00413283|4963085|P4|Overall Study|Withdrawal by Subject|1
1510340|NCT00413283|4963086|P3|Overall Study|Withdrawal by Subject|0
1510341|NCT00413283|4963087|P2|Overall Study|Withdrawal by Subject|0
1510342|NCT00413283|4963088|P1|Overall Study|Withdrawal by Subject|1
1510343|NCT00413244|4963120|P2|Overall Study|Withdrawal by Subject|1
1510344|NCT00413244|4963121|P1|Overall Study|Withdrawal by Subject|10
1510345|NCT00413231|4963149|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
1510346|NCT00413231|4963149|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
1510347|NCT00413231|4963149|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
1510348|NCT00413231|4963149|P1|365-day to 60-month Post Treatment|Death|36
1510349|NCT00413231|4963149|P1|30-day to 365-day Post Treatment|Death|13
1510350|NCT00413231|4963149|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
1510351|NCT00413231|4963149|P1|0 to 30-day Post Treatment|Death|5
1510352|NCT00413218|4963181|P2|Overall Study|Withdrawal by Subject|1
1510353|NCT00413218|4963182|P1|Overall Study|Withdrawal by Subject|9
1510354|NCT00413218|4963181|P2|Overall Study|Missing|0
1510355|NCT00413218|4963182|P1|Overall Study|Missing|1
1510356|NCT00413218|4963181|P2|Overall Study|Admin|14
1510357|NCT00413218|4963182|P1|Overall Study|Admin|20
1510358|NCT00413218|4963181|P2|Overall Study|Lost to Follow-up|17
1510359|NCT00413218|4963182|P1|Overall Study|Lost to Follow-up|14
1510360|NCT00413218|4963181|P2|Overall Study|Death|56
1510361|NCT00413218|4963182|P1|Overall Study|Death|57
1510362|NCT00413218|4963181|P2|Overall Study|Randomized but didn't receive study drug|8
1510363|NCT00413218|4963182|P1|Overall Study|Randomized but didn't receive study drug|2
1510364|NCT00413192|4963208|P4|Overall Study|Not treated|1
1510365|NCT00413192|4963209|P3|Overall Study|Not treated|0
1510366|NCT00413192|4963210|P2|Overall Study|Not treated|0
1510367|NCT00413192|4963211|P1|Overall Study|Not treated|0
1510368|NCT00413192|4963208|P4|Overall Study|Not specified|2
1510369|NCT00413192|4963209|P3|Overall Study|Not specified|1
1510370|NCT00413192|4963210|P2|Overall Study|Not specified|1
1510371|NCT00413192|4963211|P1|Overall Study|Not specified|5
1510372|NCT00413192|4963208|P4|Overall Study|Intercurrent death|0
1510373|NCT00413192|4963209|P3|Overall Study|Intercurrent death|0
1510374|NCT00413192|4963210|P2|Overall Study|Intercurrent death|1
1510375|NCT00413192|4963211|P1|Overall Study|Intercurrent death|0
1510376|NCT00413192|4963208|P4|Overall Study|Intercurrent illness|1
1510377|NCT00413192|4963209|P3|Overall Study|Intercurrent illness|0
1510378|NCT00413192|4963210|P2|Overall Study|Intercurrent illness|0
1510379|NCT00413192|4963211|P1|Overall Study|Intercurrent illness|0
1510380|NCT00413192|4963208|P4|Overall Study|Withdrawal by Subject|1
1510381|NCT00413192|4963209|P3|Overall Study|Withdrawal by Subject|0
1510382|NCT00413192|4963210|P2|Overall Study|Withdrawal by Subject|5
1510383|NCT00413192|4963211|P1|Overall Study|Withdrawal by Subject|3
1510384|NCT00413192|4963208|P4|Overall Study|Toxicity|2
1510385|NCT00413192|4963209|P3|Overall Study|Toxicity|2
1510386|NCT00413192|4963210|P2|Overall Study|Toxicity|2
1510387|NCT00413192|4963211|P1|Overall Study|Toxicity|3
1510388|NCT00413192|4963208|P4|Overall Study|Disease progression|25
1510389|NCT00413192|4963209|P3|Overall Study|Disease progression|16
1510390|NCT00413192|4963210|P2|Overall Study|Disease progression|31
1510391|NCT00413192|4963211|P1|Overall Study|Disease progression|26
1510392|NCT00413153|4963251|P2|Overall Study|Adverse Event|0
1510393|NCT00413153|4963252|P1|Overall Study|Adverse Event|1
1510394|NCT00413153|4963251|P2|Overall Study|Withdrawal by Subject|1
1510395|NCT00413153|4963252|P1|Overall Study|Withdrawal by Subject|1
1510396|NCT00413062|4963276|P2|Overall Study|Other reason|34
1510397|NCT00413062|4963277|P1|Overall Study|Other reason|70
1510398|NCT00413062|4963276|P2|Overall Study|Lost to Follow-up|73
1510399|NCT00413062|4963277|P1|Overall Study|Lost to Follow-up|175
1510400|NCT00413062|4963276|P2|Overall Study|Pregnancy wish|6
1510401|NCT00413062|4963277|P1|Overall Study|Pregnancy wish|17
1510402|NCT00413062|4963276|P2|Overall Study|Pregnancy|5
1510403|NCT00413062|4963277|P1|Overall Study|Pregnancy|15
1510404|NCT00413062|4963276|P2|Overall Study|Withdrawal of informed consent|36
1510405|NCT00413062|4963277|P1|Overall Study|Withdrawal of informed consent|111
1510406|NCT00413062|4963276|P2|Overall Study|Pre-treatment (serious) adverse event|0
1510407|NCT00413062|4963277|P1|Overall Study|Pre-treatment (serious) adverse event|1
1510408|NCT00413062|4963276|P2|Overall Study|Adverse event/serious adverse event|56
1510409|NCT00413062|4963277|P1|Overall Study|Adverse event/serious adverse event|289
1510410|NCT00413049|4963303|P2|Overall Study|Lack of Efficacy|0
1510411|NCT00413049|4963304|P1|Overall Study|Lack of Efficacy|1
1510412|NCT00413049|4963303|P2|Overall Study|Abnormal laboratory value(s)|0
1510413|NCT00413049|4963304|P1|Overall Study|Abnormal laboratory value(s)|1
1510414|NCT00413049|4963303|P2|Overall Study|Subject no longer requires study drug|1
1510415|NCT00413049|4963304|P1|Overall Study|Subject no longer requires study drug|0
1510416|NCT00413049|4963303|P2|Overall Study|Protocol Violation|1
1510417|NCT00413049|4963304|P1|Overall Study|Protocol Violation|3
1510418|NCT00413049|4963303|P2|Overall Study|Lost to Follow-up|3
1510419|NCT00413049|4963304|P1|Overall Study|Lost to Follow-up|2
1510420|NCT00413049|4963303|P2|Overall Study|Withdrawal by Subject|5
1510421|NCT00413049|4963304|P1|Overall Study|Withdrawal by Subject|7
1510422|NCT00413049|4963303|P2|Overall Study|Adverse Event|8
1510423|NCT00413049|4963304|P1|Overall Study|Adverse Event|10
1510424|NCT00413036|4963320|P1|Overall Study|Missing|2
1510425|NCT00413036|4963320|P1|Overall Study|Other|26
1510426|NCT00413036|4963320|P1|Overall Study|Death|9
1510427|NCT00413036|4963320|P1|Overall Study|Withdrawal by Subject|7
1510428|NCT00413036|4963320|P1|Overall Study|Lack of Efficacy|129
1510429|NCT00413036|4963320|P1|Overall Study|Adverse Event|44
1510430|NCT00413010|4963330|P2|Overall Study|Due to termination of the study|52
1510431|NCT00413010|4963331|P1|Overall Study|Due to termination of the study|54
1510432|NCT00413010|4963330|P2|Overall Study|Withdrawal by Subject|2
1510433|NCT00413010|4963331|P1|Overall Study|Withdrawal by Subject|7
1510434|NCT00413010|4963330|P2|Overall Study|Lost to Follow-up|0
1510435|NCT00413010|4963331|P1|Overall Study|Lost to Follow-up|3
1510436|NCT00413010|4963330|P2|Overall Study|Lack of Efficacy|3
1510437|NCT00413010|4963331|P1|Overall Study|Lack of Efficacy|0
1510438|NCT00413010|4963330|P2|Overall Study|Laboratory abnormality|2
1510439|NCT00413010|4963331|P1|Overall Study|Laboratory abnormality|0
1510440|NCT00413010|4963330|P2|Overall Study|Adverse Event|4
1510441|NCT00413010|4963331|P1|Overall Study|Adverse Event|8
1510442|NCT00412984|4963353|P2|Overall Study|Not Reported|12
1510443|NCT00412984|4963354|P1|Overall Study|Not Reported|11
1510444|NCT00412984|4963353|P2|Overall Study|Other Reason|92
1510445|NCT00412984|4963354|P1|Overall Study|Other Reason|80
1510446|NCT00412984|4963353|P2|Overall Study|Physician Refused to Continue Treatment|89
1510447|NCT00412984|4963354|P1|Overall Study|Physician Refused to Continue Treatment|81
1510448|NCT00412984|4963353|P2|Overall Study|Administrative Reason by Sponsor|8
1510449|NCT00412984|4963354|P1|Overall Study|Administrative Reason by Sponsor|11
1510450|NCT00412984|4963353|P2|Overall Study|Subject No Longer Meets Study Criteria|100
1510451|NCT00412984|4963354|P1|Overall Study|Subject No Longer Meets Study Criteria|87
1510452|NCT00412984|4963353|P2|Overall Study|Pregnancy|0
1510453|NCT00412984|4963354|P1|Overall Study|Pregnancy|1
1510454|NCT00412984|4963353|P2|Overall Study|Poor/Noncompliance|77
1510455|NCT00412984|4963354|P1|Overall Study|Poor/Noncompliance|57
1510456|NCT00412984|4963353|P2|Overall Study|Lost to Follow-up|39
1510457|NCT00412984|4963354|P1|Overall Study|Lost to Follow-up|51
1510458|NCT00412984|4963353|P2|Overall Study|Withdrawal by Subject|989
1510459|NCT00412984|4963354|P1|Overall Study|Withdrawal by Subject|921
1510460|NCT00412984|4963353|P2|Overall Study|Adverse Event|738
1510461|NCT00412984|4963354|P1|Overall Study|Adverse Event|679
1510462|NCT00412984|4963353|P2|Overall Study|Death|349
1510463|NCT00412984|4963354|P1|Overall Study|Death|331
1510464|NCT00412971|4963398|P2|Overall Study|Protocol Violation|1
1510465|NCT00412971|4963399|P1|Overall Study|Protocol Violation|13
1510466|NCT00412971|4963398|P2|Overall Study|Lost to Follow-up|9
1510467|NCT00412971|4963399|P1|Overall Study|Lost to Follow-up|17
1510468|NCT00412958|4963412|P4|Overall Study|Transport issue|0
1510469|NCT00412958|4963413|P3|Overall Study|Transport issue|0
1510470|NCT00412958|4963414|P2|Overall Study|Transport issue|1
1510471|NCT00412958|4963415|P1|Overall Study|Transport issue|0
1510472|NCT00412958|4963412|P4|Overall Study|Death|0
1510473|NCT00412958|4963413|P3|Overall Study|Death|0
1510474|NCT00412958|4963414|P2|Overall Study|Death|1
1510475|NCT00412958|4963415|P1|Overall Study|Death|0
1510476|NCT00412958|4963412|P4|Overall Study|Lost to Follow-up|0
1510477|NCT00412958|4963413|P3|Overall Study|Lost to Follow-up|0
1510478|NCT00412958|4963414|P2|Overall Study|Lost to Follow-up|1
1510479|NCT00412958|4963415|P1|Overall Study|Lost to Follow-up|0
1510480|NCT00412958|4963412|P4|Overall Study|Adverse Event|0
1510481|NCT00412958|4963413|P3|Overall Study|Adverse Event|0
1510482|NCT00412958|4963414|P2|Overall Study|Adverse Event|1
1510483|NCT00412958|4963415|P1|Overall Study|Adverse Event|0
1510484|NCT00412958|4963412|P4|Overall Study|Withdrawal by Subject|1
1510485|NCT00412958|4963413|P3|Overall Study|Withdrawal by Subject|0
1510486|NCT00412958|4963414|P2|Overall Study|Withdrawal by Subject|0
1510487|NCT00412958|4963415|P1|Overall Study|Withdrawal by Subject|3
1510488|NCT00412932|4963425|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
1510489|NCT00412932|4963425|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
1510490|NCT00412932|4963425|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
1510491|NCT00412932|4963425|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
1510492|NCT00412932|4963425|P1|Olmesartan 40 mg|Withdrawal by Subject|1
1510493|NCT00412932|4963425|P1|Olmesartan 40 mg|Lack of Efficacy|3
1510494|NCT00412932|4963425|P1|Olmesartan 40 mg|Adverse Event|4
1510495|NCT00412932|4963425|P1|Olmesartan (Olm) 20 mg|Other|1
1510496|NCT00412932|4963425|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
1510497|NCT00412932|4963425|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
1510498|NCT00412932|4963425|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
1510499|NCT00412932|4963425|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
1510500|NCT00412893|4963436|P2|Overall Study|Randomized but Never Received Study Drug|6
1510501|NCT00412893|4963437|P1|Overall Study|Randomized but Never Received Study Drug|5
1510502|NCT00412893|4963436|P2|Overall Study|Administrative Reason|15
1510503|NCT00412893|4963437|P1|Overall Study|Administrative Reason|12
1510504|NCT00412893|4963436|P2|Overall Study|Did Not Cooperate|9
1510505|NCT00412893|4963437|P1|Overall Study|Did Not Cooperate|12
1510506|NCT00412893|4963436|P2|Overall Study|Other Protocol Violation|6
1510507|NCT00412893|4963437|P1|Overall Study|Other Protocol Violation|10
1510508|NCT00412893|4963436|P2|Overall Study|Violation of Selection at Entry|10
1510509|NCT00412893|4963437|P1|Overall Study|Violation of Selection at Entry|17
1510510|NCT00412893|4963436|P2|Overall Study|Lost to Follow-up|1
1510511|NCT00412893|4963437|P1|Overall Study|Lost to Follow-up|2
1510512|NCT00412893|4963436|P2|Overall Study|Insufficient Therapeutic Response|23
1510513|NCT00412893|4963437|P1|Overall Study|Insufficient Therapeutic Response|39
1510514|NCT00412893|4963436|P2|Overall Study|Death|21
1510515|NCT00412893|4963437|P1|Overall Study|Death|17
1510516|NCT00412893|4963436|P2|Overall Study|Adverse Event|53
1510517|NCT00412893|4963437|P1|Overall Study|Adverse Event|31
1510518|NCT00412854|4963475|P2|Overall Study|Withdrawn for other reasons|11
1510519|NCT00412854|4963476|P1|Overall Study|Withdrawn for other reasons|13
1510520|NCT00412854|4963475|P2|Overall Study|Withdrawn due to adverse events|5
1510521|NCT00412854|4963476|P1|Overall Study|Withdrawn due to adverse events|1
1510522|NCT00412750|4963516|P3|Overall Study|Lack of Efficacy|3
1510523|NCT00412750|4963517|P2|Overall Study|Lack of Efficacy|0
1510524|NCT00412750|4963518|P1|Overall Study|Lack of Efficacy|0
1510525|NCT00412750|4963516|P3|Overall Study|Withdrawal by Subject|2
1510526|NCT00412750|4963517|P2|Overall Study|Withdrawal by Subject|1
1510527|NCT00412750|4963518|P1|Overall Study|Withdrawal by Subject|0
1510528|NCT00412750|4963516|P3|Overall Study|Lost to Follow-up|1
1510529|NCT00412750|4963517|P2|Overall Study|Lost to Follow-up|0
1510530|NCT00412750|4963518|P1|Overall Study|Lost to Follow-up|1
1510531|NCT00412750|4963516|P3|Overall Study|Adverse Event|3
1510532|NCT00412750|4963517|P2|Overall Study|Adverse Event|3
1510533|NCT00412750|4963518|P1|Overall Study|Adverse Event|8
1510534|NCT00412750|4963516|P3|Overall Study|Administrative problems|14
1510535|NCT00412750|4963517|P2|Overall Study|Administrative problems|17
1510536|NCT00412750|4963518|P1|Overall Study|Administrative problems|21
1510537|NCT00412750|4963516|P3|Overall Study|Abnormal laboratory value(s)|0
1510538|NCT00412750|4963517|P2|Overall Study|Abnormal laboratory value(s)|0
1510539|NCT00412750|4963518|P1|Overall Study|Abnormal laboratory value(s)|1
1510540|NCT00412737|4963543|P2|Overall Study|Failure to Return|2
1510541|NCT00412737|4963544|P1|Overall Study|Failure to Return|6
1510542|NCT00412737|4963543|P2|Overall Study|Refused Treatment|2
1510543|NCT00412737|4963544|P1|Overall Study|Refused Treatment|6
1510544|NCT00412737|4963543|P2|Overall Study|Adverse Event|2
1510545|NCT00412737|4963544|P1|Overall Study|Adverse Event|3
1510546|NCT00412737|4963543|P2|Overall Study|Death|0
1510547|NCT00412737|4963544|P1|Overall Study|Death|1
1510548|NCT00412607|4963562|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
1510549|NCT00412607|4963562|P1|Overall Study|Death|61
1510550|NCT00412607|4963562|P1|Overall Study|Lost to Follow-up|19
1510551|NCT00412607|4963562|P1|Overall Study|Withdrawal by Subject|9
1510552|NCT00412542|4963575|P2|Overall Study|Not Eligible|1
1510553|NCT00412542|4963576|P1|Overall Study|Not Eligible|0
1510554|NCT00412542|4963575|P2|Overall Study|Withdrawal by Subject|2
1510555|NCT00412542|4963576|P1|Overall Study|Withdrawal by Subject|0
1510556|NCT00412373|4963661|P2|Overall Study|Not Specified|2
1510557|NCT00412373|4963662|P1|Overall Study|Not Specified|2
1510558|NCT00412373|4963661|P2|Overall Study|Withdrawal by Subject|27
1510559|NCT00412373|4963662|P1|Overall Study|Withdrawal by Subject|8
1510560|NCT00412373|4963661|P2|Overall Study|Lost to Follow-up|13
1510561|NCT00412373|4963662|P1|Overall Study|Lost to Follow-up|7
1510562|NCT00412373|4963661|P2|Overall Study|Lack of Efficacy|22
1510563|NCT00412373|4963662|P1|Overall Study|Lack of Efficacy|16
1510564|NCT00412373|4963661|P2|Overall Study|Adverse Event|13
1510565|NCT00412373|4963662|P1|Overall Study|Adverse Event|8
1510566|NCT00412360|4963704|P2|Overall Study|Not Transplanted|2
1510567|NCT00412360|4963705|P1|Overall Study|Not Transplanted|1
1510568|NCT00412360|4963704|P2|Overall Study|Lost to Follow-up|1
1510569|NCT00412360|4963705|P1|Overall Study|Lost to Follow-up|0
1510570|NCT00412217|4963735|P2|Overall Study|Not Specified|1
1510571|NCT00412217|4963736|P1|Overall Study|Not Specified|1
1510572|NCT00412217|4963735|P2|Overall Study|Study Terminated by Sponsor|33
1510573|NCT00412217|4963736|P1|Overall Study|Study Terminated by Sponsor|26
1510574|NCT00412217|4963735|P2|Overall Study|Lost to Follow-up|4
1510575|NCT00412217|4963736|P1|Overall Study|Lost to Follow-up|1
1510576|NCT00412217|4963735|P2|Overall Study|Withdrawal by Subject|0
1510577|NCT00412217|4963736|P1|Overall Study|Withdrawal by Subject|2
1510578|NCT00412217|4963735|P2|Overall Study|Investigator Decision|0
1510579|NCT00412217|4963736|P1|Overall Study|Investigator Decision|1
1510580|NCT00412217|4963735|P2|Overall Study|Disease Progression|3
1510581|NCT00412217|4963736|P1|Overall Study|Disease Progression|2
1510582|NCT00412217|4963735|P2|Overall Study|Death|4
1510583|NCT00412217|4963736|P1|Overall Study|Death|5
1510584|NCT00412217|4963735|P2|Overall Study|Insufficient Data Available|3
1510585|NCT00412217|4963736|P1|Overall Study|Insufficient Data Available|8
1510586|NCT00412113|4963750|P2|Overall Study|did not receive treatment|0
1510587|NCT00412113|4963751|P1|Overall Study|did not receive treatment|1
1510588|NCT00412113|4963750|P2|Overall Study|Adverse Event|15
1510589|NCT00412113|4963751|P1|Overall Study|Adverse Event|11
1510590|NCT00412061|4963835|P2|Open Label Phase|New Cancer Therapy|1
1510591|NCT00412061|4963836|P1|Open Label Phase|New Cancer Therapy|0
1510592|NCT00412061|4963835|P2|Open Label Phase|Lost to Follow-up|2
1510593|NCT00412061|4963836|P1|Open Label Phase|Lost to Follow-up|0
1510594|NCT00412061|4963835|P2|Open Label Phase|Death|7
1510595|NCT00412061|4963836|P1|Open Label Phase|Death|0
1510596|NCT00412061|4963835|P2|Open Label Phase|Administrative Problems|13
1510597|NCT00412061|4963836|P1|Open Label Phase|Administrative Problems|0
1510598|NCT00412061|4963835|P2|Open Label Phase|Withdrawal by Subject|15
1510599|NCT00412061|4963836|P1|Open Label Phase|Withdrawal by Subject|0
1510600|NCT00412061|4963835|P2|Open Label Phase|Adverse Event|46
1510601|NCT00412061|4963836|P1|Open Label Phase|Adverse Event|0
1510602|NCT00412061|4963835|P2|Open Label Phase|Disease Progression|86
1510603|NCT00412061|4963836|P1|Open Label Phase|Disease Progression|0
1510604|NCT00412061|4963835|P2|Double Blind Phase|Lost to Follow-up|1
1510605|NCT00412061|4963836|P1|Double Blind Phase|Lost to Follow-up|0
1510606|NCT00412061|4963835|P2|Double Blind Phase|New Cander Therapy|1
1510607|NCT00412061|4963836|P1|Double Blind Phase|New Cander Therapy|1
1510608|NCT00412061|4963835|P2|Double Blind Phase|Protocol Violation|4
1510609|NCT00412061|4963836|P1|Double Blind Phase|Protocol Violation|3
1510610|NCT00412061|4963835|P2|Double Blind Phase|Death|3
1510611|NCT00412061|4963836|P1|Double Blind Phase|Death|6
1510612|NCT00412061|4963835|P2|Double Blind Phase|Withdrawal by Subject|20
1510613|NCT00412061|4963836|P1|Double Blind Phase|Withdrawal by Subject|18
1510614|NCT00412061|4963835|P2|Double Blind Phase|Final Primary Analysis|14
1510615|NCT00412061|4963836|P1|Double Blind Phase|Final Primary Analysis|26
1510616|NCT00412061|4963835|P2|Double Blind Phase|Adverse Event|16
1510617|NCT00412061|4963836|P1|Double Blind Phase|Adverse Event|61
1510618|NCT00412061|4963835|P2|Double Blind Phase|Disease Progression|154
1510619|NCT00412061|4963836|P1|Double Blind Phase|Disease Progression|101
1510620|NCT00411788|4963854|P1|Overall Study|Adverse Event|1
1510621|NCT00411788|4963854|P1|Overall Study|Protocol Violation|1
1510622|NCT00411762|4963863|P1|Overall Study|Withdrawal by Subject|5
1510623|NCT00411671|4963887|P1|Overall Study|Lost to Follow-up|3
1510624|NCT00411671|4963887|P1|Overall Study|Death|2
1510625|NCT00411671|4963887|P1|Overall Study|Adverse Event|15
1510626|NCT00411645|4963895|P2|Overall Study|Lost to Follow-up|0
1510627|NCT00411645|4963896|P1|Overall Study|Lost to Follow-up|2
1510628|NCT00411645|4963895|P2|Overall Study|Investigator/Sponsor Decision|7
1510629|NCT00411645|4963896|P1|Overall Study|Investigator/Sponsor Decision|10
1510630|NCT00411645|4963895|P2|Overall Study|Death|135
1510631|NCT00411645|4963896|P1|Overall Study|Death|56
1510632|NCT00411645|4963895|P2|Overall Study|Consent Withdrawn|22
1510633|NCT00411645|4963896|P1|Overall Study|Consent Withdrawn|13
1510634|NCT00411554|4963927|P2|Overall Study|Patient Moved|0
1510635|NCT00411554|4963928|P1|Overall Study|Patient Moved|1
1510636|NCT00411554|4963927|P2|Overall Study|Withdrawal by Subject|0
1510637|NCT00411554|4963928|P1|Overall Study|Withdrawal by Subject|3
1510638|NCT00411554|4963927|P2|Overall Study|Lack of Efficacy|5
1510639|NCT00411554|4963928|P1|Overall Study|Lack of Efficacy|2
1510640|NCT00411554|4963927|P2|Overall Study|Adverse Event|4
1510641|NCT00411554|4963928|P1|Overall Study|Adverse Event|2
1510642|NCT00411450|4963954|P1|Overall Study|Ongoing at time of data cut-off.|3
1510643|NCT00411216|4963997|P2|Overall Study|Ten participants were entered into the c|2
1510644|NCT00411216|4963998|P1|Overall Study|Ten participants were entered into the c|0
1510645|NCT00411151|4964004|P1|Overall Study|Trial prematurely closed|4
1510646|NCT00411151|4964004|P1|Overall Study|Protocol Violation|1
1510647|NCT00411151|4964004|P1|Overall Study|Lost to Follow-up|2
1510648|NCT00411151|4964004|P1|Overall Study|Withdrawal by Subject|2
1510649|NCT00411151|4964004|P1|Overall Study|Death|38
1510650|NCT00410813|4964048|P2|Overall Study|Death|2
1510651|NCT00410813|4964049|P1|Overall Study|Death|0
1510652|NCT00410813|4964048|P2|Overall Study|Ineligible|4
1510653|NCT00410813|4964049|P1|Overall Study|Ineligible|2
1510654|NCT00410813|4964048|P2|Overall Study|Not protocol specified|4
1510655|NCT00410813|4964049|P1|Overall Study|Not protocol specified|3
1510656|NCT00410813|4964048|P2|Overall Study|Progression|21
1510657|NCT00410813|4964049|P1|Overall Study|Progression|32
1510658|NCT00410813|4964048|P2|Overall Study|Adverse Event|11
1510659|NCT00410813|4964049|P1|Overall Study|Adverse Event|6
1510660|NCT00410761|4964086|P2|Overall Study|Never received randomised treatment|1
1510661|NCT00410761|4964087|P1|Overall Study|Never received randomised treatment|0
1510662|NCT00410761|4964086|P2|Overall Study|Other|9
1510663|NCT00410761|4964087|P1|Overall Study|Other|12
1510664|NCT00410761|4964086|P2|Overall Study|Withdrawal by Subject|4
1510665|NCT00410761|4964087|P1|Overall Study|Withdrawal by Subject|8
1510666|NCT00410761|4964086|P2|Overall Study|objective disease progression|55
1510667|NCT00410761|4964087|P1|Overall Study|objective disease progression|71
1510668|NCT00410761|4964086|P2|Overall Study|Adverse Event|3
1510669|NCT00410761|4964087|P1|Overall Study|Adverse Event|29
1510670|NCT00410605|4964107|P1|Overall Study|Transferred to another Institution|1
1510671|NCT00410605|4964107|P1|Overall Study|Stopped treatmen to collect stem cells|1
1510672|NCT00410605|4964107|P1|Overall Study|Started Non-Protocol Therapy|3
1510673|NCT00410605|4964107|P1|Overall Study|Withdrawal by Subject|5
1510674|NCT00410605|4964107|P1|Overall Study|Physician Decision|3
1510675|NCT00410605|4964107|P1|Overall Study|Adverse Event|12
1510676|NCT00410514|4964119|P3|Overall Study|Non-compliant with study procedures|2
1510677|NCT00410514|4964120|P2|Overall Study|Non-compliant with study procedures|0
1510678|NCT00410514|4964121|P1|Overall Study|Non-compliant with study procedures|0
1510679|NCT00410514|4964119|P3|Overall Study|Lost to Follow-up|2
1510680|NCT00410514|4964120|P2|Overall Study|Lost to Follow-up|0
1510681|NCT00410514|4964121|P1|Overall Study|Lost to Follow-up|0
1510682|NCT00410514|4964119|P3|Overall Study|Protocol Violation|1
1510683|NCT00410514|4964120|P2|Overall Study|Protocol Violation|1
1510684|NCT00410514|4964121|P1|Overall Study|Protocol Violation|0
1510685|NCT00410514|4964119|P3|Overall Study|Adverse Event|2
1510686|NCT00410514|4964120|P2|Overall Study|Adverse Event|2
1510687|NCT00410514|4964121|P1|Overall Study|Adverse Event|2
1510688|NCT00410410|4964204|P9|Open-Label Period (OL)|not specified|7
1510689|NCT00410410|4964205|P8|Open-Label Period (OL)|not specified|0
1510690|NCT00410410|4964206|P7|Open-Label Period (OL)|not specified|0
1510691|NCT00410410|4964207|P6|Open-Label Period (OL)|not specified|0
1510692|NCT00410410|4964208|P5|Open-Label Period (OL)|not specified|0
1510693|NCT00410410|4964209|P4|Open-Label Period (OL)|not specified|0
1510694|NCT00410410|4964210|P3|Open-Label Period (OL)|not specified|0
1510695|NCT00410410|4964211|P2|Open-Label Period (OL)|not specified|0
1510696|NCT00410410|4964212|P1|Open-Label Period (OL)|not specified|0
1510697|NCT00410410|4964204|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
1510698|NCT00410410|4964205|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1510699|NCT00410410|4964206|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1510700|NCT00410410|4964207|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1510701|NCT00410410|4964208|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1510702|NCT00410410|4964209|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1510703|NCT00410410|4964210|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1510704|NCT00410410|4964211|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1510705|NCT00410410|4964212|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1510706|NCT00410410|4964204|P9|Open-Label Period (OL)|Pregnancy|1
1510707|NCT00410410|4964205|P8|Open-Label Period (OL)|Pregnancy|0
1510708|NCT00410410|4964206|P7|Open-Label Period (OL)|Pregnancy|0
1510709|NCT00410410|4964207|P6|Open-Label Period (OL)|Pregnancy|0
1510710|NCT00410410|4964208|P5|Open-Label Period (OL)|Pregnancy|0
1510711|NCT00410410|4964209|P4|Open-Label Period (OL)|Pregnancy|0
1510712|NCT00410410|4964210|P3|Open-Label Period (OL)|Pregnancy|0
1510713|NCT00410410|4964211|P2|Open-Label Period (OL)|Pregnancy|0
1510714|NCT00410410|4964212|P1|Open-Label Period (OL)|Pregnancy|0
1510715|NCT00410410|4964204|P9|Open-Label Period (OL)|Withdrawal by Subject|20
1510716|NCT00410410|4964205|P8|Open-Label Period (OL)|Withdrawal by Subject|0
1510717|NCT00410410|4964206|P7|Open-Label Period (OL)|Withdrawal by Subject|0
1510718|NCT00410410|4964207|P6|Open-Label Period (OL)|Withdrawal by Subject|0
1510719|NCT00410410|4964208|P5|Open-Label Period (OL)|Withdrawal by Subject|0
1510720|NCT00410410|4964209|P4|Open-Label Period (OL)|Withdrawal by Subject|0
1510721|NCT00410410|4964210|P3|Open-Label Period (OL)|Withdrawal by Subject|0
1510722|NCT00410410|4964211|P2|Open-Label Period (OL)|Withdrawal by Subject|0
1510723|NCT00410410|4964212|P1|Open-Label Period (OL)|Withdrawal by Subject|0
1510724|NCT00410410|4964204|P9|Open-Label Period (OL)|Lost to Follow-up|4
1510725|NCT00410410|4964205|P8|Open-Label Period (OL)|Lost to Follow-up|0
1510726|NCT00410410|4964206|P7|Open-Label Period (OL)|Lost to Follow-up|0
1510727|NCT00410410|4964207|P6|Open-Label Period (OL)|Lost to Follow-up|0
1510728|NCT00410410|4964208|P5|Open-Label Period (OL)|Lost to Follow-up|0
1510729|NCT00410410|4964209|P4|Open-Label Period (OL)|Lost to Follow-up|0
1510730|NCT00410410|4964210|P3|Open-Label Period (OL)|Lost to Follow-up|0
1510731|NCT00410410|4964211|P2|Open-Label Period (OL)|Lost to Follow-up|0
1510732|NCT00410410|4964212|P1|Open-Label Period (OL)|Lost to Follow-up|0
1510733|NCT00410410|4964204|P9|Open-Label Period (OL)|Lack of Efficacy|161
1510734|NCT00410410|4964205|P8|Open-Label Period (OL)|Lack of Efficacy|0
1510735|NCT00410410|4964206|P7|Open-Label Period (OL)|Lack of Efficacy|0
1510736|NCT00410410|4964207|P6|Open-Label Period (OL)|Lack of Efficacy|0
1510737|NCT00410410|4964208|P5|Open-Label Period (OL)|Lack of Efficacy|0
1510738|NCT00410410|4964209|P4|Open-Label Period (OL)|Lack of Efficacy|0
1510739|NCT00410410|4964210|P3|Open-Label Period (OL)|Lack of Efficacy|0
1510740|NCT00410410|4964211|P2|Open-Label Period (OL)|Lack of Efficacy|0
1510741|NCT00410410|4964212|P1|Open-Label Period (OL)|Lack of Efficacy|0
1510742|NCT00410410|4964204|P9|Open-Label Period (OL)|Adverse Event|10
1510743|NCT00410410|4964205|P8|Open-Label Period (OL)|Adverse Event|0
1510744|NCT00410410|4964206|P7|Open-Label Period (OL)|Adverse Event|0
1510745|NCT00410410|4964207|P6|Open-Label Period (OL)|Adverse Event|0
1510746|NCT00410410|4964208|P5|Open-Label Period (OL)|Adverse Event|0
1510747|NCT00410410|4964209|P4|Open-Label Period (OL)|Adverse Event|0
1510748|NCT00410410|4964210|P3|Open-Label Period (OL)|Adverse Event|0
1510749|NCT00410410|4964211|P2|Open-Label Period (OL)|Adverse Event|0
1510750|NCT00410410|4964212|P1|Open-Label Period (OL)|Adverse Event|0
1510751|NCT00410410|4964204|P9|Open-Label Period (OL)|Death|1
1510752|NCT00410410|4964205|P8|Open-Label Period (OL)|Death|0
1510753|NCT00410410|4964206|P7|Open-Label Period (OL)|Death|0
1510754|NCT00410410|4964207|P6|Open-Label Period (OL)|Death|0
1510755|NCT00410410|4964208|P5|Open-Label Period (OL)|Death|0
1510756|NCT00410410|4964209|P4|Open-Label Period (OL)|Death|0
1510757|NCT00410410|4964210|P3|Open-Label Period (OL)|Death|0
1510758|NCT00410410|4964211|P2|Open-Label Period (OL)|Death|0
1510759|NCT00410410|4964212|P1|Open-Label Period (OL)|Death|0
1510760|NCT00410410|4964204|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1510761|NCT00410410|4964205|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
1510762|NCT00410410|4964206|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
1510763|NCT00410410|4964207|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1510764|NCT00410410|4964208|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1510765|NCT00410410|4964209|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1510766|NCT00410410|4964210|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1510767|NCT00410410|4964211|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1510768|NCT00410410|4964212|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1510769|NCT00410410|4964204|P9|Maintenance Period (MP)|Withdrawal by Subject|0
1510770|NCT00410410|4964205|P8|Maintenance Period (MP)|Withdrawal by Subject|1
1510771|NCT00410410|4964206|P7|Maintenance Period (MP)|Withdrawal by Subject|1
1510772|NCT00410410|4964207|P6|Maintenance Period (MP)|Withdrawal by Subject|0
1510773|NCT00410410|4964208|P5|Maintenance Period (MP)|Withdrawal by Subject|0
1510774|NCT00410410|4964209|P4|Maintenance Period (MP)|Withdrawal by Subject|0
1510775|NCT00410410|4964210|P3|Maintenance Period (MP)|Withdrawal by Subject|0
1510776|NCT00410410|4964211|P2|Maintenance Period (MP)|Withdrawal by Subject|0
1510777|NCT00410410|4964212|P1|Maintenance Period (MP)|Withdrawal by Subject|0
1510778|NCT00410410|4964204|P9|Maintenance Period (MP)|Lost to Follow-up|0
1510779|NCT00410410|4964205|P8|Maintenance Period (MP)|Lost to Follow-up|2
1510780|NCT00410410|4964206|P7|Maintenance Period (MP)|Lost to Follow-up|1
1510781|NCT00410410|4964207|P6|Maintenance Period (MP)|Lost to Follow-up|0
1510782|NCT00410410|4964208|P5|Maintenance Period (MP)|Lost to Follow-up|0
1510783|NCT00410410|4964209|P4|Maintenance Period (MP)|Lost to Follow-up|0
1510784|NCT00410410|4964210|P3|Maintenance Period (MP)|Lost to Follow-up|0
1510785|NCT00410410|4964211|P2|Maintenance Period (MP)|Lost to Follow-up|0
1510786|NCT00410410|4964212|P1|Maintenance Period (MP)|Lost to Follow-up|0
1510787|NCT00410410|4964204|P9|Maintenance Period (MP)|Lack of Efficacy|0
1510788|NCT00410410|4964205|P8|Maintenance Period (MP)|Lack of Efficacy|24
1510789|NCT00410410|4964206|P7|Maintenance Period (MP)|Lack of Efficacy|25
1510790|NCT00410410|4964207|P6|Maintenance Period (MP)|Lack of Efficacy|0
1510791|NCT00410410|4964208|P5|Maintenance Period (MP)|Lack of Efficacy|0
1510792|NCT00410410|4964209|P4|Maintenance Period (MP)|Lack of Efficacy|0
1510793|NCT00410410|4964210|P3|Maintenance Period (MP)|Lack of Efficacy|0
1510794|NCT00410410|4964211|P2|Maintenance Period (MP)|Lack of Efficacy|0
1510795|NCT00410410|4964212|P1|Maintenance Period (MP)|Lack of Efficacy|0
1510796|NCT00410410|4964204|P9|Maintenance Period (MP)|Adverse Event|0
1510797|NCT00410410|4964205|P8|Maintenance Period (MP)|Adverse Event|3
1510798|NCT00410410|4964206|P7|Maintenance Period (MP)|Adverse Event|1
1510799|NCT00410410|4964207|P6|Maintenance Period (MP)|Adverse Event|0
1510800|NCT00410410|4964208|P5|Maintenance Period (MP)|Adverse Event|0
1510801|NCT00410410|4964209|P4|Maintenance Period (MP)|Adverse Event|0
1510802|NCT00410410|4964210|P3|Maintenance Period (MP)|Adverse Event|0
1510803|NCT00410410|4964211|P2|Maintenance Period (MP)|Adverse Event|0
1510804|NCT00410410|4964212|P1|Maintenance Period (MP)|Adverse Event|0
1510805|NCT00410410|4964204|P9|Maintenance Period (MP)|Death|0
1510806|NCT00410410|4964205|P8|Maintenance Period (MP)|Death|0
1510807|NCT00410410|4964206|P7|Maintenance Period (MP)|Death|1
1510808|NCT00410410|4964207|P6|Maintenance Period (MP)|Death|0
1510809|NCT00410410|4964208|P5|Maintenance Period (MP)|Death|0
1510810|NCT00410410|4964209|P4|Maintenance Period (MP)|Death|0
1510811|NCT00410410|4964210|P3|Maintenance Period (MP)|Death|0
1510812|NCT00410410|4964211|P2|Maintenance Period (MP)|Death|0
1510813|NCT00410410|4964212|P1|Maintenance Period (MP)|Death|0
1510814|NCT00410410|4964204|P9|Induction Period (IP)|not specified|0
1510815|NCT00410410|4964205|P8|Induction Period (IP)|not specified|0
1510816|NCT00410410|4964206|P7|Induction Period (IP)|not specified|0
1510817|NCT00410410|4964207|P6|Induction Period (IP)|not specified|0
1510818|NCT00410410|4964208|P5|Induction Period (IP)|not specified|0
1510819|NCT00410410|4964209|P4|Induction Period (IP)|not specified|0
1510820|NCT00410410|4964210|P3|Induction Period (IP)|not specified|1
1510821|NCT00410410|4964211|P2|Induction Period (IP)|not specified|0
1510822|NCT00410410|4964212|P1|Induction Period (IP)|not specified|0
1510823|NCT00410410|4964204|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
1510824|NCT00410410|4964205|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
1510825|NCT00410410|4964206|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
1510826|NCT00410410|4964207|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
1510827|NCT00410410|4964208|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
1510828|NCT00410410|4964209|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
1510829|NCT00410410|4964210|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
1510830|NCT00410410|4964211|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
1510831|NCT00410410|4964212|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
1510832|NCT00410410|4964204|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1510833|NCT00410410|4964205|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1510834|NCT00410410|4964206|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1510835|NCT00410410|4964207|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1510836|NCT00410410|4964208|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1510837|NCT00410410|4964209|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1510838|NCT00410410|4964210|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
1510839|NCT00410410|4964211|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1510840|NCT00410410|4964212|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1510841|NCT00410410|4964204|P9|Induction Period (IP)|Withdrawal by Subject|0
1510842|NCT00410410|4964205|P8|Induction Period (IP)|Withdrawal by Subject|0
1510843|NCT00410410|4964206|P7|Induction Period (IP)|Withdrawal by Subject|0
1510844|NCT00410410|4964207|P6|Induction Period (IP)|Withdrawal by Subject|0
1510845|NCT00410410|4964208|P5|Induction Period (IP)|Withdrawal by Subject|2
1510846|NCT00410410|4964209|P4|Induction Period (IP)|Withdrawal by Subject|5
1510847|NCT00410410|4964210|P3|Induction Period (IP)|Withdrawal by Subject|3
1510848|NCT00410410|4964211|P2|Induction Period (IP)|Withdrawal by Subject|5
1510849|NCT00410410|4964212|P1|Induction Period (IP)|Withdrawal by Subject|3
1510850|NCT00410410|4964204|P9|Induction Period (IP)|Lost to Follow-up|0
1510851|NCT00410410|4964205|P8|Induction Period (IP)|Lost to Follow-up|0
1510852|NCT00410410|4964206|P7|Induction Period (IP)|Lost to Follow-up|0
1510853|NCT00410410|4964207|P6|Induction Period (IP)|Lost to Follow-up|1
1510854|NCT00410410|4964208|P5|Induction Period (IP)|Lost to Follow-up|0
1510855|NCT00410410|4964209|P4|Induction Period (IP)|Lost to Follow-up|3
1510856|NCT00410410|4964210|P3|Induction Period (IP)|Lost to Follow-up|2
1510857|NCT00410410|4964211|P2|Induction Period (IP)|Lost to Follow-up|2
1510858|NCT00410410|4964212|P1|Induction Period (IP)|Lost to Follow-up|2
1510859|NCT00410410|4964204|P9|Induction Period (IP)|Lack of Efficacy|0
1510860|NCT00410410|4964205|P8|Induction Period (IP)|Lack of Efficacy|0
1510861|NCT00410410|4964206|P7|Induction Period (IP)|Lack of Efficacy|0
1510862|NCT00410410|4964207|P6|Induction Period (IP)|Lack of Efficacy|7
1510863|NCT00410410|4964208|P5|Induction Period (IP)|Lack of Efficacy|7
1510864|NCT00410410|4964209|P4|Induction Period (IP)|Lack of Efficacy|8
1510865|NCT00410410|4964210|P3|Induction Period (IP)|Lack of Efficacy|8
1510866|NCT00410410|4964211|P2|Induction Period (IP)|Lack of Efficacy|24
1510867|NCT00410410|4964212|P1|Induction Period (IP)|Lack of Efficacy|26
1510868|NCT00410410|4964204|P9|Induction Period (IP)|Adverse Event|0
1510869|NCT00410410|4964205|P8|Induction Period (IP)|Adverse Event|0
1510870|NCT00410410|4964206|P7|Induction Period (IP)|Adverse Event|0
1510871|NCT00410410|4964207|P6|Induction Period (IP)|Adverse Event|0
1510872|NCT00410410|4964208|P5|Induction Period (IP)|Adverse Event|1
1510873|NCT00410410|4964209|P4|Induction Period (IP)|Adverse Event|4
1510874|NCT00410410|4964210|P3|Induction Period (IP)|Adverse Event|2
1510875|NCT00410410|4964211|P2|Induction Period (IP)|Adverse Event|4
1510876|NCT00410410|4964212|P1|Induction Period (IP)|Adverse Event|3
1510877|NCT00410410|4964204|P9|Induction Period (IP)|Death|0
1510878|NCT00410410|4964205|P8|Induction Period (IP)|Death|0
1510879|NCT00410410|4964206|P7|Induction Period (IP)|Death|0
1510880|NCT00410410|4964207|P6|Induction Period (IP)|Death|0
1510881|NCT00410410|4964208|P5|Induction Period (IP)|Death|0
1510882|NCT00410410|4964209|P4|Induction Period (IP)|Death|0
1510883|NCT00410410|4964210|P3|Induction Period (IP)|Death|0
1510884|NCT00410410|4964211|P2|Induction Period (IP)|Death|0
1510885|NCT00410410|4964212|P1|Induction Period (IP)|Death|1
1510886|NCT00410384|4964373|P3|Overall Study|Other|4
1510887|NCT00410384|4964374|P2|Overall Study|Other|8
1510888|NCT00410384|4964375|P1|Overall Study|Other|3
1510889|NCT00410384|4964373|P3|Overall Study|Physician Decision|4
1510890|NCT00410384|4964374|P2|Overall Study|Physician Decision|3
1510891|NCT00410384|4964375|P1|Overall Study|Physician Decision|3
1510892|NCT00410384|4964373|P3|Overall Study|Protocol Violation|6
1510893|NCT00410384|4964374|P2|Overall Study|Protocol Violation|6
1510894|NCT00410384|4964375|P1|Overall Study|Protocol Violation|6
1510895|NCT00410384|4964373|P3|Overall Study|Lost to Follow-up|6
1510896|NCT00410384|4964374|P2|Overall Study|Lost to Follow-up|6
1510897|NCT00410384|4964375|P1|Overall Study|Lost to Follow-up|4
1510898|NCT00410384|4964373|P3|Overall Study|Lack of Compliance|2
1510899|NCT00410384|4964374|P2|Overall Study|Lack of Compliance|2
1510900|NCT00410384|4964375|P1|Overall Study|Lack of Compliance|2
1510901|NCT00410384|4964373|P3|Overall Study|Lack of Efficacy|17
1510902|NCT00410384|4964374|P2|Overall Study|Lack of Efficacy|12
1510903|NCT00410384|4964375|P1|Overall Study|Lack of Efficacy|20
1510904|NCT00410384|4964373|P3|Overall Study|Adverse Event|23
1510905|NCT00410384|4964374|P2|Overall Study|Adverse Event|18
1510906|NCT00410384|4964375|P1|Overall Study|Adverse Event|23
1510907|NCT00410384|4964373|P3|Overall Study|Withdrawal by Subject|20
1510908|NCT00410384|4964374|P2|Overall Study|Withdrawal by Subject|17
1510909|NCT00410384|4964375|P1|Overall Study|Withdrawal by Subject|28
1510910|NCT00410202|4964448|P3|Off-treatment Follow up|Lost to Follow-up|0
1510911|NCT00410202|4964449|P2|Off-treatment Follow up|Lost to Follow-up|0
1510912|NCT00410202|4964450|P1|Off-treatment Follow up|Lost to Follow-up|1
1510913|NCT00410202|4964448|P3|Off-treatment Follow up|Follow up not required per protocol|1
1510914|NCT00410202|4964449|P2|Off-treatment Follow up|Follow up not required per protocol|0
1510915|NCT00410202|4964450|P1|Off-treatment Follow up|Follow up not required per protocol|3
1510916|NCT00410202|4964448|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
1510917|NCT00410202|4964449|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
1510918|NCT00410202|4964450|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
1510919|NCT00410202|4964448|P3|On-Treatment|Other Reason|1
1510920|NCT00410202|4964449|P2|On-Treatment|Other Reason|0
1510921|NCT00410202|4964450|P1|On-Treatment|Other Reason|0
1510922|NCT00410202|4964448|P3|On-Treatment|Withdrawal by Subject|1
1510923|NCT00410202|4964449|P2|On-Treatment|Withdrawal by Subject|1
1510924|NCT00410202|4964450|P1|On-Treatment|Withdrawal by Subject|2
1510925|NCT00410202|4964448|P3|On-Treatment|Lack of Efficacy|0
1510926|NCT00410202|4964449|P2|On-Treatment|Lack of Efficacy|4
1510927|NCT00410202|4964450|P1|On-Treatment|Lack of Efficacy|1
1510928|NCT00410202|4964448|P3|On-Treatment|Lost to Follow-up|1
1510929|NCT00410202|4964449|P2|On-Treatment|Lost to Follow-up|0
1510930|NCT00410202|4964450|P1|On-Treatment|Lost to Follow-up|1
1510931|NCT00410202|4964448|P3|On-Treatment|Death|0
1510932|NCT00410202|4964449|P2|On-Treatment|Death|0
1510933|NCT00410202|4964450|P1|On-Treatment|Death|1
1510934|NCT00410202|4964448|P3|On-Treatment|Adverse Event|2
1510935|NCT00410202|4964449|P2|On-Treatment|Adverse Event|3
1510936|NCT00410202|4964450|P1|On-Treatment|Adverse Event|1
1510937|NCT00410202|4964448|P3|On-Treatment|Continuing treatment|66
1510938|NCT00410202|4964449|P2|On-Treatment|Continuing treatment|71
1510939|NCT00410202|4964450|P1|On-Treatment|Continuing treatment|69
1510940|NCT00410163|4964537|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
1510941|NCT00410163|4964538|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
1510942|NCT00410163|4964537|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
1510943|NCT00410163|4964538|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
1510944|NCT00410163|4964537|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
1510945|NCT00410163|4964538|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
1510946|NCT00410163|4964537|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
1510947|NCT00410163|4964538|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
1510948|NCT00410163|4964537|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
1510949|NCT00410163|4964538|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
1510950|NCT00410163|4964537|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
1510951|NCT00410163|4964538|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
1510952|NCT00410163|4964537|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
1510953|NCT00410163|4964538|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
1510954|NCT00410163|4964537|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
1510955|NCT00410163|4964538|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
1510956|NCT00410163|4964537|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
1510957|NCT00410163|4964538|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
1510958|NCT00410163|4964537|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
1510959|NCT00410163|4964538|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
1510960|NCT00410163|4964537|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
1510961|NCT00410163|4964538|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
1510962|NCT00410163|4964537|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
1510963|NCT00410163|4964538|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
1510964|NCT00410163|4964537|P2|Treatment and Follow-up Phase (2 Years)|Death|1
1510965|NCT00410163|4964538|P1|Treatment and Follow-up Phase (2 Years)|Death|1
1510966|NCT00410163|4964537|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
1510967|NCT00410163|4964538|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
1510968|NCT00410124|4964591|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
1510969|NCT00410124|4964592|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
1510970|NCT00410124|4964591|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
1510971|NCT00410124|4964592|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
1510972|NCT00410124|4964591|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
1510973|NCT00410124|4964592|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
1510974|NCT00410124|4964591|P2|Extension Phase - Open Label (45 Months)|Death|10
1510975|NCT00410124|4964592|P1|Extension Phase - Open Label (45 Months)|Death|2
1510976|NCT00410124|4964591|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
1510977|NCT00410124|4964592|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
1510978|NCT00410124|4964591|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
1510979|NCT00410124|4964592|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
1510980|NCT00410124|4964591|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
1510981|NCT00410124|4964592|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
1510982|NCT00410124|4964591|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
1510983|NCT00410124|4964592|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
1510984|NCT00410124|4964591|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
1510985|NCT00410124|4964592|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
1510986|NCT00410124|4964591|P2|Core Phase Double Blind (15 Months)|Death|4
1510987|NCT00410124|4964592|P1|Core Phase Double Blind (15 Months)|Death|7
1510988|NCT00410124|4964591|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
1510989|NCT00410124|4964592|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
1510990|NCT00410124|4964591|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
1510991|NCT00410124|4964592|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
1510992|NCT00410124|4964591|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
1510993|NCT00410124|4964592|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
1510994|NCT00410124|4964591|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
1510995|NCT00410124|4964592|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
1510996|NCT00410124|4964591|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
1510997|NCT00410124|4964592|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
1510998|NCT00410124|4964591|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
1510999|NCT00410124|4964592|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
1511000|NCT00410072|4964623|P2|After Week 48 to Week 96|Withdrawal by Subject|1
1511001|NCT00410072|4964624|P1|After Week 48 to Week 96|Withdrawal by Subject|0
1511002|NCT00410072|4964623|P2|After Week 48 to Week 96|Pregnancy|2
1511003|NCT00410072|4964624|P1|After Week 48 to Week 96|Pregnancy|0
1511004|NCT00410072|4964623|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
1511005|NCT00410072|4964624|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
1511006|NCT00410072|4964623|P2|After Week 48 to Week 96|Not specified|0
1511007|NCT00410072|4964624|P1|After Week 48 to Week 96|Not specified|2
1511008|NCT00410072|4964623|P2|After Week 48 to Week 96|Lost to Follow-up|4
1511009|NCT00410072|4964624|P1|After Week 48 to Week 96|Lost to Follow-up|2
1511010|NCT00410072|4964623|P2|After Week 48 to Week 96|Lack of Efficacy|0
1511011|NCT00410072|4964624|P1|After Week 48 to Week 96|Lack of Efficacy|1
1511012|NCT00410072|4964623|P2|After Week 48 to Week 96|Death|1
1511013|NCT00410072|4964624|P1|After Week 48 to Week 96|Death|0
1511014|NCT00410072|4964623|P2|After Week 48 to Week 96|Adverse Event|2
1511015|NCT00410072|4964624|P1|After Week 48 to Week 96|Adverse Event|1
1511016|NCT00410072|4964623|P2|Day 1 to Week 48|Withdrawal by Subject|2
1511017|NCT00410072|4964624|P1|Day 1 to Week 48|Withdrawal by Subject|0
1511018|NCT00410072|4964623|P2|Day 1 to Week 48|Pregnancy|2
1511019|NCT00410072|4964624|P1|Day 1 to Week 48|Pregnancy|0
1511020|NCT00410072|4964623|P2|Day 1 to Week 48|poor compliance/noncompliance|3
1511021|NCT00410072|4964624|P1|Day 1 to Week 48|poor compliance/noncompliance|0
1511022|NCT00410072|4964623|P2|Day 1 to Week 48|Not specified|1
1511023|NCT00410072|4964624|P1|Day 1 to Week 48|Not specified|0
1511024|NCT00410072|4964623|P2|Day 1 to Week 48|Lost to Follow-up|2
1511025|NCT00410072|4964624|P1|Day 1 to Week 48|Lost to Follow-up|5
1511026|NCT00410072|4964623|P2|Day 1 to Week 48|Adverse Event|2
1511027|NCT00410072|4964624|P1|Day 1 to Week 48|Adverse Event|1
1511028|NCT00410046|4964664|P1|Overall Study|Lost to Follow-up|1
1511029|NCT00410046|4964664|P1|Overall Study|Withdrawal by Subject|1
1511030|NCT00410046|4964664|P1|Overall Study|Adverse Event|3
1511031|NCT00409838|4964695|P2|Long-term Extension Period|Pregnancy|0
1511032|NCT00409838|4964696|P1|Long-term Extension Period|Pregnancy|1
1511033|NCT00409838|4964695|P2|Long-term Extension Period|Poor compliance/noncompliance|0
1511034|NCT00409838|4964696|P1|Long-term Extension Period|Poor compliance/noncompliance|1
1511035|NCT00409838|4964695|P2|Long-term Extension Period|Withdrawal by Subject|0
1511036|NCT00409838|4964696|P1|Long-term Extension Period|Withdrawal by Subject|3
1511037|NCT00409838|4964695|P2|Long-term Extension Period|Lack of Efficacy|0
1511038|NCT00409838|4964696|P1|Long-term Extension Period|Lack of Efficacy|2
1511039|NCT00409838|4964695|P2|Long-term Extension Period|Death|0
1511040|NCT00409838|4964696|P1|Long-term Extension Period|Death|1
1511041|NCT00409838|4964695|P2|Long-term Extension Period|Adverse Event|0
1511042|NCT00409838|4964696|P1|Long-term Extension Period|Adverse Event|10
1511043|NCT00409838|4964695|P2|Short-term Period|Never Treated|0
1511044|NCT00409838|4964696|P1|Short-term Period|Never Treated|1
1511045|NCT00409838|4964695|P2|Short-term Period|Withdrawal by Subject|3
1511046|NCT00409838|4964696|P1|Short-term Period|Withdrawal by Subject|2
1511047|NCT00409838|4964695|P2|Short-term Period|Lost to Follow-up|1
1511048|NCT00409838|4964696|P1|Short-term Period|Lost to Follow-up|0
1511049|NCT00409838|4964695|P2|Short-term Period|Adverse Event|1
1511050|NCT00409838|4964696|P1|Short-term Period|Adverse Event|0
1511051|NCT00409786|4964761|P1|Overall Study|Withdrawal by Subject|3
1511052|NCT00409773|4964770|P5|Overall Study|Lack of Eligibility|1
1511053|NCT00409773|4964771|P4|Overall Study|Lack of Eligibility|0
1511054|NCT00409773|4964772|P3|Overall Study|Lack of Eligibility|0
1511055|NCT00409773|4964773|P2|Overall Study|Lack of Eligibility|0
1511056|NCT00409773|4964774|P1|Overall Study|Lack of Eligibility|0
1511057|NCT00409773|4964770|P5|Overall Study|Withdrawal by Subject|1
1511058|NCT00409773|4964771|P4|Overall Study|Withdrawal by Subject|2
1511059|NCT00409773|4964772|P3|Overall Study|Withdrawal by Subject|0
1511060|NCT00409773|4964773|P2|Overall Study|Withdrawal by Subject|0
1511061|NCT00409773|4964774|P1|Overall Study|Withdrawal by Subject|0
1511062|NCT00409773|4964770|P5|Overall Study|Protocol Violation|1
1511063|NCT00409773|4964771|P4|Overall Study|Protocol Violation|3
1511064|NCT00409773|4964772|P3|Overall Study|Protocol Violation|3
1511065|NCT00409773|4964773|P2|Overall Study|Protocol Violation|2
1511066|NCT00409773|4964774|P1|Overall Study|Protocol Violation|0
1511067|NCT00409773|4964770|P5|Overall Study|Physician Decision|0
1511068|NCT00409773|4964771|P4|Overall Study|Physician Decision|2
1511069|NCT00409773|4964772|P3|Overall Study|Physician Decision|0
1511070|NCT00409773|4964773|P2|Overall Study|Physician Decision|0
1511071|NCT00409773|4964774|P1|Overall Study|Physician Decision|0
1511072|NCT00409773|4964770|P5|Overall Study|Lost to Follow-up|1
1511073|NCT00409773|4964771|P4|Overall Study|Lost to Follow-up|3
1511074|NCT00409773|4964772|P3|Overall Study|Lost to Follow-up|2
1511075|NCT00409773|4964773|P2|Overall Study|Lost to Follow-up|1
1511076|NCT00409773|4964774|P1|Overall Study|Lost to Follow-up|6
1511077|NCT00409773|4964770|P5|Overall Study|Adverse Event|6
1511078|NCT00409773|4964771|P4|Overall Study|Adverse Event|2
1511079|NCT00409773|4964772|P3|Overall Study|Adverse Event|4
1511080|NCT00409773|4964773|P2|Overall Study|Adverse Event|4
1511081|NCT00409773|4964774|P1|Overall Study|Adverse Event|3
1511082|NCT00409747|4964856|P1|Overall Study|Withdrawal by Subject|1
1511083|NCT00409708|4964863|P2|Washout|Lost to Follow-up|3
1511084|NCT00409708|4964864|P1|Washout|Lost to Follow-up|1
1511085|NCT00409708|4964863|P2|Washout|Withdrawal by Subject|5
1511086|NCT00409708|4964864|P1|Washout|Withdrawal by Subject|11
1511087|NCT00409708|4964863|P2|Washout|Protocol Violation|1
1511088|NCT00409708|4964864|P1|Washout|Protocol Violation|0
1511089|NCT00409708|4964863|P2|Washout|Lack of Efficacy|1
1511090|NCT00409708|4964864|P1|Washout|Lack of Efficacy|9
1511091|NCT00409708|4964863|P2|Treatment|Administrative problems|0
1511092|NCT00409708|4964864|P1|Treatment|Administrative problems|5
1511093|NCT00409708|4964863|P2|Treatment|Lost to Follow-up|6
1511094|NCT00409708|4964864|P1|Treatment|Lost to Follow-up|0
1511095|NCT00409708|4964863|P2|Treatment|Withdrawal by Subject|8
1511096|NCT00409708|4964864|P1|Treatment|Withdrawal by Subject|3
1511097|NCT00409708|4964863|P2|Treatment|Protocol Violation|2
1511098|NCT00409708|4964864|P1|Treatment|Protocol Violation|6
1511099|NCT00409708|4964863|P2|Treatment|Lack of Efficacy|1
1511100|NCT00409708|4964864|P1|Treatment|Lack of Efficacy|0
1511101|NCT00409708|4964863|P2|Treatment|Abnormal test procedure result(s)|0
1511102|NCT00409708|4964864|P1|Treatment|Abnormal test procedure result(s)|1
1511103|NCT00409682|4964885|P3|EOW Double-blind Maintenance Period|Non-compliance|1
1511104|NCT00409682|4964886|P2|EOW Double-blind Maintenance Period|Non-compliance|0
1511105|NCT00409682|4964887|P1|EOW Double-blind Maintenance Period|Non-compliance|0
1511106|NCT00409682|4964885|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
1511107|NCT00409682|4964886|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
1511108|NCT00409682|4964887|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
1511109|NCT00409682|4964885|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
1511110|NCT00409682|4964886|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
1511111|NCT00409682|4964887|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
1511112|NCT00409682|4964885|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
1511113|NCT00409682|4964886|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
1511114|NCT00409682|4964887|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
1511115|NCT00409682|4964885|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
1511116|NCT00409682|4964886|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
1511117|NCT00409682|4964887|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
1511118|NCT00409682|4964885|P3|EOW Double-blind Maintenance Period|Adverse Event|12
1511119|NCT00409682|4964886|P2|EOW Double-blind Maintenance Period|Adverse Event|10
1511120|NCT00409682|4964887|P1|EOW Double-blind Maintenance Period|Adverse Event|0
1511121|NCT00409682|4964885|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
1511122|NCT00409682|4964886|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
1511123|NCT00409682|4964887|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
1511124|NCT00409682|4964885|P3|Open-label Induction Period|Protocol Violation|0
1511125|NCT00409682|4964886|P2|Open-label Induction Period|Protocol Violation|0
1511126|NCT00409682|4964887|P1|Open-label Induction Period|Protocol Violation|1
1511127|NCT00409682|4964885|P3|Open-label Induction Period|Lack of Efficacy|0
1511128|NCT00409682|4964886|P2|Open-label Induction Period|Lack of Efficacy|0
1511129|NCT00409682|4964887|P1|Open-label Induction Period|Lack of Efficacy|1
1511130|NCT00409682|4964885|P3|Open-label Induction Period|Adverse Event|0
1511131|NCT00409682|4964886|P2|Open-label Induction Period|Adverse Event|0
1511132|NCT00409682|4964887|P1|Open-label Induction Period|Adverse Event|1
1511133|NCT00409617|4964904|P1|Overall Study|Not described|14
1511134|NCT00409617|4964904|P1|Overall Study|Administrative reasons|1
1511135|NCT00409617|4964904|P1|Overall Study|Withdrawal by Subject|8
1511136|NCT00409617|4964904|P1|Overall Study|Protocol Violation|24
1511137|NCT00409617|4964904|P1|Overall Study|Lost to Follow-up|2
1511138|NCT00409617|4964904|P1|Overall Study|Lack of Efficacy|54
1511139|NCT00409617|4964904|P1|Overall Study|Adverse Event|57
1511140|NCT00409578|4964920|P4|Overall Study|Missing|1
1511141|NCT00409578|4964921|P3|Overall Study|Missing|0
1511142|NCT00409578|4964922|P2|Overall Study|Missing|1
1511143|NCT00409578|4964923|P1|Overall Study|Missing|0
1511144|NCT00409578|4964920|P4|Overall Study|Protocol Violation|1
1511145|NCT00409578|4964921|P3|Overall Study|Protocol Violation|3
1511146|NCT00409578|4964922|P2|Overall Study|Protocol Violation|2
1511147|NCT00409578|4964923|P1|Overall Study|Protocol Violation|3
1511148|NCT00409578|4964920|P4|Overall Study|Death|2
1511149|NCT00409578|4964921|P3|Overall Study|Death|4
1511150|NCT00409578|4964922|P2|Overall Study|Death|4
1511151|NCT00409578|4964923|P1|Overall Study|Death|2
1511152|NCT00409578|4964920|P4|Overall Study|Administrative problems|4
1511153|NCT00409578|4964921|P3|Overall Study|Administrative problems|2
1511154|NCT00409578|4964922|P2|Overall Study|Administrative problems|9
1511155|NCT00409578|4964923|P1|Overall Study|Administrative problems|8
1511156|NCT00409578|4964920|P4|Overall Study|Lost to Follow-up|2
1511157|NCT00409578|4964921|P3|Overall Study|Lost to Follow-up|2
1511158|NCT00409578|4964922|P2|Overall Study|Lost to Follow-up|0
1511159|NCT00409578|4964923|P1|Overall Study|Lost to Follow-up|2
1511160|NCT00409578|4964920|P4|Overall Study|Withdrawal by Subject|17
1511161|NCT00409578|4964921|P3|Overall Study|Withdrawal by Subject|16
1511162|NCT00409578|4964922|P2|Overall Study|Withdrawal by Subject|15
1511163|NCT00409578|4964923|P1|Overall Study|Withdrawal by Subject|8
1511164|NCT00409578|4964920|P4|Overall Study|Subject no longer requires study drug|1
1511165|NCT00409578|4964921|P3|Overall Study|Subject no longer requires study drug|0
1511166|NCT00409578|4964922|P2|Overall Study|Subject no longer requires study drug|0
1511167|NCT00409578|4964923|P1|Overall Study|Subject no longer requires study drug|0
1511168|NCT00409578|4964920|P4|Overall Study|Lack of Efficacy|2
1511169|NCT00409578|4964921|P3|Overall Study|Lack of Efficacy|0
1511170|NCT00409578|4964922|P2|Overall Study|Lack of Efficacy|0
1511171|NCT00409578|4964923|P1|Overall Study|Lack of Efficacy|0
1511172|NCT00409578|4964920|P4|Overall Study|Abnormal laboratory value(s)|4
1511173|NCT00409578|4964921|P3|Overall Study|Abnormal laboratory value(s)|2
1511174|NCT00409578|4964922|P2|Overall Study|Abnormal laboratory value(s)|2
1511175|NCT00409578|4964923|P1|Overall Study|Abnormal laboratory value(s)|2
1511176|NCT00409578|4964920|P4|Overall Study|Adverse Event|33
1511177|NCT00409578|4964921|P3|Overall Study|Adverse Event|25
1511178|NCT00409578|4964922|P2|Overall Study|Adverse Event|37
1511179|NCT00409578|4964923|P1|Overall Study|Adverse Event|27
1511180|NCT00409409|4964981|P2|Overall Study|Any other reason not above-mentioned|1
1511181|NCT00409409|4964982|P1|Overall Study|Any other reason not above-mentioned|0
1511182|NCT00409409|4964981|P2|Overall Study|Withdrawal by Subject|1
1511183|NCT00409409|4964982|P1|Overall Study|Withdrawal by Subject|1
1511184|NCT00409409|4964981|P2|Overall Study|Adverse Event|2
1511185|NCT00409409|4964982|P1|Overall Study|Adverse Event|7
1511186|NCT00409344|4964990|P2|Overall Study|no enrollment|0
1511187|NCT00409344|4964991|P1|Overall Study|no enrollment|0
1511188|NCT00409331|4965009|P1|Overall Study|Physician Decision|1
1511189|NCT00409188|4965031|P2|Overall Study|Ongoing at data cut-off|175
1511190|NCT00409188|4965032|P1|Overall Study|Ongoing at data cut-off|383
1511191|NCT00409175|4965048|P2|Overall Study|Liver transplantation|13
1511192|NCT00409175|4965049|P1|Overall Study|Liver transplantation|13
1511193|NCT00409175|4965048|P2|Overall Study|Negative genotype|1
1511194|NCT00409175|4965049|P1|Overall Study|Negative genotype|0
1511195|NCT00409175|4965048|P2|Overall Study|Withdrawal by Subject|2
1511196|NCT00409175|4965049|P1|Overall Study|Withdrawal by Subject|1
1511197|NCT00409175|4965048|P2|Overall Study|Adverse Event|3
1511198|NCT00409175|4965049|P1|Overall Study|Adverse Event|4
1511199|NCT00409006|4965075|P2|Overall Study|Physician Decision|2
1511200|NCT00409006|4965076|P1|Overall Study|Physician Decision|1
1511201|NCT00409006|4965075|P2|Overall Study|Withdrawal by Subject|2
1511202|NCT00409006|4965076|P1|Overall Study|Withdrawal by Subject|3
1511203|NCT00409006|4965075|P2|Overall Study|Lost to Follow-up|2
1511204|NCT00409006|4965076|P1|Overall Study|Lost to Follow-up|1
1511205|NCT00409006|4965075|P2|Overall Study|Death|6
1511206|NCT00409006|4965076|P1|Overall Study|Death|15
1511207|NCT00408993|4965092|P2|Overall Study|Withdrawal by Subject|3
1511208|NCT00408993|4965093|P1|Overall Study|Withdrawal by Subject|2
1511209|NCT00408993|4965092|P2|Overall Study|Lack of Efficacy|4
1511210|NCT00408993|4965093|P1|Overall Study|Lack of Efficacy|1
1511211|NCT00408993|4965092|P2|Overall Study|Protocol Violation|6
1511212|NCT00408993|4965093|P1|Overall Study|Protocol Violation|1
1511213|NCT00408993|4965092|P2|Overall Study|Adverse Event|4
1511214|NCT00408993|4965093|P1|Overall Study|Adverse Event|15
1511215|NCT00408928|4965125|P1|Overall Study|Infection indistinguishable from GVHD|1
1511216|NCT00408928|4965125|P1|Overall Study|Death|1
1511217|NCT00408928|4965125|P1|Overall Study|Withdrawal by Subject|1
1511218|NCT00408902|4965130|P1|Overall Study|Adverse Event|3
1511219|NCT00408902|4965130|P1|Overall Study|Lack of Efficacy|7
1511220|NCT00408876|4965140|P4|Overall Study|Physician Decision|0
1511221|NCT00408876|4965141|P3|Overall Study|Physician Decision|3
1511222|NCT00408876|4965142|P2|Overall Study|Physician Decision|0
1511223|NCT00408876|4965143|P1|Overall Study|Physician Decision|1
1511224|NCT00408876|4965140|P4|Overall Study|Protocol Violation|3
1511225|NCT00408876|4965141|P3|Overall Study|Protocol Violation|4
1511226|NCT00408876|4965142|P2|Overall Study|Protocol Violation|3
1511227|NCT00408876|4965143|P1|Overall Study|Protocol Violation|0
1511228|NCT00408876|4965140|P4|Overall Study|Lost to Follow-up|2
1511229|NCT00408876|4965141|P3|Overall Study|Lost to Follow-up|5
1511230|NCT00408876|4965142|P2|Overall Study|Lost to Follow-up|6
1511231|NCT00408876|4965143|P1|Overall Study|Lost to Follow-up|1
1511232|NCT00408876|4965140|P4|Overall Study|Lack of Efficacy|6
1511233|NCT00408876|4965141|P3|Overall Study|Lack of Efficacy|5
1511234|NCT00408876|4965142|P2|Overall Study|Lack of Efficacy|4
1511235|NCT00408876|4965143|P1|Overall Study|Lack of Efficacy|2
1511236|NCT00408876|4965140|P4|Overall Study|Withdrawal by Subject|14
1511237|NCT00408876|4965141|P3|Overall Study|Withdrawal by Subject|6
1511238|NCT00408876|4965142|P2|Overall Study|Withdrawal by Subject|6
1511239|NCT00408876|4965143|P1|Overall Study|Withdrawal by Subject|3
1511240|NCT00408876|4965140|P4|Overall Study|Adverse Event|10
1511241|NCT00408876|4965141|P3|Overall Study|Adverse Event|27
1511242|NCT00408876|4965142|P2|Overall Study|Adverse Event|17
1511243|NCT00408876|4965143|P1|Overall Study|Adverse Event|9
1511244|NCT00408694|4965393|P1|Overall Study|No protocol treatment|1
1511245|NCT00408694|4965393|P1|Overall Study|Ineligible|1
1511246|NCT00408681|4965405|P1|Overall Study|Adverse Event|7
1511247|NCT00408681|4965405|P1|Overall Study|Lack of Efficacy|2
1511248|NCT00408629|4965424|P2|Overall Study|Miscellaneous|15
1511249|NCT00408629|4965425|P1|Overall Study|Miscellaneous|11
1511250|NCT00408629|4965424|P2|Overall Study|Protocol Violation|5
1511251|NCT00408629|4965425|P1|Overall Study|Protocol Violation|1
1511252|NCT00408629|4965424|P2|Overall Study|Lack of Efficacy|73
1511253|NCT00408629|4965425|P1|Overall Study|Lack of Efficacy|63
1511254|NCT00408629|4965424|P2|Overall Study|Lost to Follow-up|1
1511255|NCT00408629|4965425|P1|Overall Study|Lost to Follow-up|1
1511256|NCT00408629|4965424|P2|Overall Study|Withdrawal by Subject|4
1511257|NCT00408629|4965425|P1|Overall Study|Withdrawal by Subject|8
1511258|NCT00408629|4965424|P2|Overall Study|Adverse Event|27
1511259|NCT00408629|4965425|P1|Overall Study|Adverse Event|13
1511260|NCT00408499|4965521|P5|Phase II- MTD Expansion|treatment delay|3
1511261|NCT00408499|4965522|P4|Phase II- MTD Expansion|treatment delay|0
1511262|NCT00408499|4965523|P3|Phase II- MTD Expansion|treatment delay|0
1511263|NCT00408499|4965524|P2|Phase II- MTD Expansion|treatment delay|0
1511264|NCT00408499|4965525|P1|Phase II- MTD Expansion|treatment delay|0
1511265|NCT00408499|4965521|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
1511266|NCT00408499|4965522|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
1511267|NCT00408499|4965523|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
1511268|NCT00408499|4965524|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
1511269|NCT00408499|4965525|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
1511270|NCT00408499|4965521|P5|Phase II- MTD Expansion|Physician Decision|1
1511271|NCT00408499|4965522|P4|Phase II- MTD Expansion|Physician Decision|0
1511272|NCT00408499|4965523|P3|Phase II- MTD Expansion|Physician Decision|0
1511273|NCT00408499|4965524|P2|Phase II- MTD Expansion|Physician Decision|0
1511274|NCT00408499|4965525|P1|Phase II- MTD Expansion|Physician Decision|0
1511275|NCT00408499|4965521|P5|Phase II- MTD Expansion|Death|2
1511276|NCT00408499|4965522|P4|Phase II- MTD Expansion|Death|0
1511277|NCT00408499|4965523|P3|Phase II- MTD Expansion|Death|0
1511278|NCT00408499|4965524|P2|Phase II- MTD Expansion|Death|0
1511279|NCT00408499|4965525|P1|Phase II- MTD Expansion|Death|0
1511280|NCT00408499|4965521|P5|Phase II- MTD Expansion|Adverse Event|9
1511281|NCT00408499|4965522|P4|Phase II- MTD Expansion|Adverse Event|0
1511282|NCT00408499|4965523|P3|Phase II- MTD Expansion|Adverse Event|0
1511283|NCT00408499|4965524|P2|Phase II- MTD Expansion|Adverse Event|0
1511284|NCT00408499|4965525|P1|Phase II- MTD Expansion|Adverse Event|0
1511285|NCT00408499|4965521|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
1511286|NCT00408499|4965522|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
1511287|NCT00408499|4965523|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
1511288|NCT00408499|4965524|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
1511289|NCT00408499|4965525|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
1511290|NCT00408499|4965521|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
1511291|NCT00408499|4965522|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
1511292|NCT00408499|4965523|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
1511293|NCT00408499|4965524|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
1511294|NCT00408499|4965525|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
1511295|NCT00408499|4965521|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
1511296|NCT00408499|4965522|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
1511297|NCT00408499|4965523|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
1511298|NCT00408499|4965524|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
1511299|NCT00408499|4965525|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
1511300|NCT00408421|4965542|P3|Treatment Re-Randomization|Withdrawal by Subject|0
1511301|NCT00408421|4965543|P2|Treatment Re-Randomization|Withdrawal by Subject|1
1511302|NCT00408421|4965544|P1|Treatment Re-Randomization|Withdrawal by Subject|2
1511303|NCT00408421|4965542|P3|Treatment Re-Randomization|Protocol Violation|0
1511304|NCT00408421|4965543|P2|Treatment Re-Randomization|Protocol Violation|1
1511305|NCT00408421|4965544|P1|Treatment Re-Randomization|Protocol Violation|1
1511306|NCT00408421|4965542|P3|Treatment Re-Randomization|Physician Decision|0
1511307|NCT00408421|4965543|P2|Treatment Re-Randomization|Physician Decision|3
1511308|NCT00408421|4965544|P1|Treatment Re-Randomization|Physician Decision|1
1511309|NCT00408421|4965542|P3|Treatment Re-Randomization|Lost to Follow-up|1
1511310|NCT00408421|4965543|P2|Treatment Re-Randomization|Lost to Follow-up|0
1511311|NCT00408421|4965544|P1|Treatment Re-Randomization|Lost to Follow-up|0
1511312|NCT00408421|4965542|P3|Treatment Re-Randomization|Lack of Efficacy|0
1511313|NCT00408421|4965543|P2|Treatment Re-Randomization|Lack of Efficacy|0
1511314|NCT00408421|4965544|P1|Treatment Re-Randomization|Lack of Efficacy|1
1511315|NCT00408421|4965542|P3|Treatment Re-Randomization|Adverse Event|4
1511316|NCT00408421|4965543|P2|Treatment Re-Randomization|Adverse Event|2
1511317|NCT00408421|4965544|P1|Treatment Re-Randomization|Adverse Event|2
1511318|NCT00408421|4965542|P3|Treatment Initial Randomization|Sponsor Decision|0
1511319|NCT00408421|4965543|P2|Treatment Initial Randomization|Sponsor Decision|0
1511320|NCT00408421|4965544|P1|Treatment Initial Randomization|Sponsor Decision|1
1511321|NCT00408421|4965542|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
1511322|NCT00408421|4965543|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
1511323|NCT00408421|4965544|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
1511324|NCT00408421|4965542|P3|Treatment Initial Randomization|Withdrawal by Subject|0
1511325|NCT00408421|4965543|P2|Treatment Initial Randomization|Withdrawal by Subject|7
1511326|NCT00408421|4965544|P1|Treatment Initial Randomization|Withdrawal by Subject|7
1511327|NCT00408421|4965542|P3|Treatment Initial Randomization|Protocol Violation|0
1511328|NCT00408421|4965543|P2|Treatment Initial Randomization|Protocol Violation|1
1511329|NCT00408421|4965544|P1|Treatment Initial Randomization|Protocol Violation|0
1511330|NCT00408421|4965542|P3|Treatment Initial Randomization|Physician Decision|0
1511331|NCT00408421|4965543|P2|Treatment Initial Randomization|Physician Decision|0
1511332|NCT00408421|4965544|P1|Treatment Initial Randomization|Physician Decision|1
1511333|NCT00408421|4965542|P3|Treatment Initial Randomization|Lost to Follow-up|0
1511334|NCT00408421|4965543|P2|Treatment Initial Randomization|Lost to Follow-up|3
1511335|NCT00408421|4965544|P1|Treatment Initial Randomization|Lost to Follow-up|0
1511336|NCT00408421|4965542|P3|Treatment Initial Randomization|Lack of Efficacy|0
1511337|NCT00408421|4965543|P2|Treatment Initial Randomization|Lack of Efficacy|2
1511338|NCT00408421|4965544|P1|Treatment Initial Randomization|Lack of Efficacy|2
1511339|NCT00408421|4965542|P3|Treatment Initial Randomization|Adverse Event|0
1511340|NCT00408421|4965543|P2|Treatment Initial Randomization|Adverse Event|9
1511341|NCT00408421|4965544|P1|Treatment Initial Randomization|Adverse Event|5
1511342|NCT00408408|4965624|P6|Overall Study|No follow up data|3
1511343|NCT00408408|4965625|P5|Overall Study|No follow up data|5
1511344|NCT00408408|4965626|P4|Overall Study|No follow up data|7
1511345|NCT00408408|4965627|P3|Overall Study|No follow up data|0
1511346|NCT00408408|4965628|P2|Overall Study|No follow up data|3
1511347|NCT00408408|4965629|P1|Overall Study|No follow up data|2
1511348|NCT00408317|4965691|P2|Second Intervention Period|Withdrawal of consent|1
1511349|NCT00408317|4965692|P1|Second Intervention Period|Withdrawal of consent|0
1511350|NCT00408317|4965691|P2|Second Intervention Period|Protocol Violation|1
1511351|NCT00408317|4965692|P1|Second Intervention Period|Protocol Violation|0
1511352|NCT00408317|4965691|P2|Second Intervention Period|Adverse Event|0
1511353|NCT00408317|4965692|P1|Second Intervention Period|Adverse Event|2
1511354|NCT00408317|4965691|P2|First Intervention Period|Adverse Event|1
1511355|NCT00408317|4965692|P1|First Intervention Period|Adverse Event|0
1511356|NCT00407797|4965735|P1|Overall Study|Withdrawal by Subject|3
1511357|NCT00407797|4965735|P1|Overall Study|Other|7
1511358|NCT00407797|4965735|P1|Overall Study|Adverse Event|6
1511359|NCT00407797|4965735|P1|Overall Study|Lost to Follow-up|2
1511360|NCT00407758|4965750|P1|Overall Study|ineligible –improper prior treatment|1
1511361|NCT00407745|4965763|P2|Overall Study|Randomized, unknown if treated|1
1511362|NCT00407745|4965764|P1|Overall Study|Randomized, unknown if treated|0
1511363|NCT00407745|4965763|P2|Overall Study|Other|0
1511364|NCT00407745|4965764|P1|Overall Study|Other|2
1511365|NCT00407745|4965763|P2|Overall Study|Adverse Event|8
1511366|NCT00407745|4965764|P1|Overall Study|Adverse Event|8
1511367|NCT00407745|4965763|P2|Overall Study|Protocol Violation|3
1511368|NCT00407745|4965764|P1|Overall Study|Protocol Violation|5
1511369|NCT00407745|4965763|P2|Overall Study|Withdrawal by Subject|3
1511370|NCT00407745|4965764|P1|Overall Study|Withdrawal by Subject|3
1511371|NCT00407745|4965763|P2|Overall Study|Lack of Efficacy|2
1511372|NCT00407745|4965764|P1|Overall Study|Lack of Efficacy|1
1511373|NCT00407563|4965850|P1|Overall Study|Patient continues on treatment|1
1511374|NCT00407550|4965860|P2|Overall Study|Insurance or Other medical condition|1
1511375|NCT00407550|4965861|P1|Overall Study|Insurance or Other medical condition|2
1511376|NCT00407550|4965860|P2|Overall Study|Death|0
1511377|NCT00407550|4965861|P1|Overall Study|Death|1
1511378|NCT00407550|4965860|P2|Overall Study|Withdrawal by Subject|2
1511379|NCT00407550|4965861|P1|Overall Study|Withdrawal by Subject|0
1511380|NCT00407550|4965860|P2|Overall Study|Adverse Event|1
1511381|NCT00407550|4965861|P1|Overall Study|Adverse Event|0
1511382|NCT00407537|4965869|P2|Overall Study|Withdrawal by Subject|16
1511383|NCT00407537|4965870|P1|Overall Study|Withdrawal by Subject|34
1511384|NCT00407537|4965869|P2|Overall Study|Other|7
1511385|NCT00407537|4965870|P1|Overall Study|Other|6
1511386|NCT00407537|4965869|P2|Overall Study|Lost to Follow-up|19
1511387|NCT00407537|4965870|P1|Overall Study|Lost to Follow-up|12
1511388|NCT00407537|4965869|P2|Overall Study|Adverse Event|0
1511389|NCT00407537|4965870|P1|Overall Study|Adverse Event|36
1511390|NCT00407537|4965869|P2|Overall Study|Death|2
1511391|NCT00407537|4965870|P1|Overall Study|Death|5
1511392|NCT00407511|4965918|P1|Overall Study|Withdrawal by Subject|4
1511393|NCT00407511|4965918|P1|Overall Study|Other|5
1511394|NCT00407511|4965918|P1|Overall Study|Lost to Follow-up|4
1511395|NCT00407511|4965918|P1|Overall Study|Adverse Event|9
1511396|NCT00407030|4965964|P3|Extension Period - up to 68 Weeks|Physician Decision|0
1511397|NCT00407030|4965965|P2|Extension Period - up to 68 Weeks|Physician Decision|2
1511398|NCT00407030|4965966|P1|Extension Period - up to 68 Weeks|Physician Decision|1
1511399|NCT00407030|4965964|P3|Extension Period - up to 68 Weeks|Patient Decision|0
1511400|NCT00407030|4965965|P2|Extension Period - up to 68 Weeks|Patient Decision|2
1511401|NCT00407030|4965966|P1|Extension Period - up to 68 Weeks|Patient Decision|1
1511402|NCT00407030|4965964|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
1511403|NCT00407030|4965965|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
1511404|NCT00407030|4965966|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
1511405|NCT00407030|4965964|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
1511406|NCT00407030|4965965|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
1511407|NCT00407030|4965966|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
1511408|NCT00407030|4965964|P3|Extension Period - up to 68 Weeks|Adverse Event|0
1511409|NCT00407030|4965965|P2|Extension Period - up to 68 Weeks|Adverse Event|0
1511410|NCT00407030|4965966|P1|Extension Period - up to 68 Weeks|Adverse Event|1
1511411|NCT00407030|4965964|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
1511412|NCT00407030|4965965|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
1511413|NCT00407030|4965966|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
1511414|NCT00407030|4965964|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
1511415|NCT00407030|4965965|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
1511416|NCT00407030|4965966|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
1511417|NCT00407030|4965964|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
1511418|NCT00407030|4965965|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
1511419|NCT00407030|4965966|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
1511420|NCT00407030|4965964|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
1511421|NCT00407030|4965965|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
1511422|NCT00407030|4965966|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
1511423|NCT00407030|4965964|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
1511424|NCT00407030|4965965|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
1511425|NCT00407030|4965966|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
1511426|NCT00407030|4965964|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
1511427|NCT00407030|4965965|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
1511428|NCT00407030|4965966|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
1511429|NCT00407030|4965964|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
1511430|NCT00407030|4965965|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
1511431|NCT00407030|4965966|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
1511432|NCT00407030|4965964|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
1511433|NCT00407030|4965965|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
1511434|NCT00407030|4965966|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
1511435|NCT00406848|4965994|P2|Overall Study|Sponsor Decision|1
1511436|NCT00406848|4965995|P1|Overall Study|Sponsor Decision|1
1511437|NCT00406848|4965994|P2|Overall Study|Physician Decision|2
1511438|NCT00406848|4965995|P1|Overall Study|Physician Decision|2
1511439|NCT00406848|4965994|P2|Overall Study|Lost to Follow-up|2
1511440|NCT00406848|4965995|P1|Overall Study|Lost to Follow-up|6
1511441|NCT00406848|4965994|P2|Overall Study|Protocol Violation|6
1511442|NCT00406848|4965995|P1|Overall Study|Protocol Violation|10
1511443|NCT00406848|4965994|P2|Overall Study|Lack of Efficacy|14
1511444|NCT00406848|4965995|P1|Overall Study|Lack of Efficacy|9
1511445|NCT00406848|4965994|P2|Overall Study|Adverse Event|7
1511446|NCT00406848|4965995|P1|Overall Study|Adverse Event|38
1511447|NCT00406848|4965994|P2|Overall Study|Withdrawal by Subject|22
1511448|NCT00406848|4965995|P1|Overall Study|Withdrawal by Subject|27
1511449|NCT00406783|4966059|P2|Overall Study|Protocol Violation|4
1511450|NCT00406783|4966060|P1|Overall Study|Protocol Violation|4
1511451|NCT00406783|4966059|P2|Overall Study|Withdrawal by Subject|4
1511452|NCT00406783|4966060|P1|Overall Study|Withdrawal by Subject|1
1511453|NCT00406783|4966059|P2|Overall Study|Lost to Follow-up|0
1511454|NCT00406783|4966060|P1|Overall Study|Lost to Follow-up|3
1511455|NCT00406783|4966059|P2|Overall Study|Treatment Failure|3
1511456|NCT00406783|4966060|P1|Overall Study|Treatment Failure|2
1511457|NCT00406783|4966059|P2|Overall Study|Adverse Event|4
1511458|NCT00406783|4966060|P1|Overall Study|Adverse Event|4
1511459|NCT00406718|4966075|P3|Overall Study|Lost to Follow-up|4
1511460|NCT00406718|4966076|P2|Overall Study|Lost to Follow-up|5
1511461|NCT00406718|4966077|P1|Overall Study|Lost to Follow-up|2
1511462|NCT00406718|4966075|P3|Overall Study|Withdrawal by Subject|4
1511463|NCT00406718|4966076|P2|Overall Study|Withdrawal by Subject|9
1511464|NCT00406718|4966077|P1|Overall Study|Withdrawal by Subject|2
1511465|NCT00406692|4966091|P1|Overall Study|Lack of Efficacy|1
1511466|NCT00406692|4966091|P1|Overall Study|Adverse Event|1
1511467|NCT00406692|4966091|P1|Overall Study|Physician Decision|1
1511468|NCT00406692|4966091|P1|Overall Study|Withdrawal by Subject|4
1511469|NCT00406653|4966101|P7|Open-Label Period|Refused followup|1
1511470|NCT00406653|4966102|P6|Open-Label Period|Refused followup|0
1511471|NCT00406653|4966103|P5|Open-Label Period|Refused followup|0
1511472|NCT00406653|4966104|P4|Open-Label Period|Refused followup|0
1511473|NCT00406653|4966105|P3|Open-Label Period|Refused followup|0
1511474|NCT00406653|4966106|P2|Open-Label Period|Refused followup|0
1511475|NCT00406653|4966107|P1|Open-Label Period|Refused followup|0
1511476|NCT00406653|4966101|P7|Open-Label Period|Discontinued by Sponsor|1
1511477|NCT00406653|4966102|P6|Open-Label Period|Discontinued by Sponsor|0
1511478|NCT00406653|4966103|P5|Open-Label Period|Discontinued by Sponsor|0
1511479|NCT00406653|4966104|P4|Open-Label Period|Discontinued by Sponsor|0
1511480|NCT00406653|4966105|P3|Open-Label Period|Discontinued by Sponsor|0
1511481|NCT00406653|4966106|P2|Open-Label Period|Discontinued by Sponsor|0
1511482|NCT00406653|4966107|P1|Open-Label Period|Discontinued by Sponsor|0
1511483|NCT00406653|4966101|P7|Open-Label Period|Declined participation but followup done|8
1511484|NCT00406653|4966102|P6|Open-Label Period|Declined participation but followup done|0
1511485|NCT00406653|4966103|P5|Open-Label Period|Declined participation but followup done|0
1511486|NCT00406653|4966104|P4|Open-Label Period|Declined participation but followup done|0
1511487|NCT00406653|4966105|P3|Open-Label Period|Declined participation but followup done|0
1511488|NCT00406653|4966106|P2|Open-Label Period|Declined participation but followup done|0
1511489|NCT00406653|4966107|P1|Open-Label Period|Declined participation but followup done|0
1511490|NCT00406653|4966101|P7|Open-Label Period|Administrative Reason By Sponsor|115
1511491|NCT00406653|4966102|P6|Open-Label Period|Administrative Reason By Sponsor|0
1511492|NCT00406653|4966103|P5|Open-Label Period|Administrative Reason By Sponsor|0
1511493|NCT00406653|4966104|P4|Open-Label Period|Administrative Reason By Sponsor|0
1511494|NCT00406653|4966105|P3|Open-Label Period|Administrative Reason By Sponsor|0
1511495|NCT00406653|4966106|P2|Open-Label Period|Administrative Reason By Sponsor|0
1511496|NCT00406653|4966107|P1|Open-Label Period|Administrative Reason By Sponsor|0
1511497|NCT00406653|4966101|P7|Open-Label Period|Pregnancy|2
1511498|NCT00406653|4966102|P6|Open-Label Period|Pregnancy|0
1511499|NCT00406653|4966103|P5|Open-Label Period|Pregnancy|0
1511500|NCT00406653|4966104|P4|Open-Label Period|Pregnancy|0
1511501|NCT00406653|4966105|P3|Open-Label Period|Pregnancy|0
1511502|NCT00406653|4966106|P2|Open-Label Period|Pregnancy|0
1511503|NCT00406653|4966107|P1|Open-Label Period|Pregnancy|0
1511504|NCT00406653|4966101|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
1511505|NCT00406653|4966102|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
1511506|NCT00406653|4966103|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
1511507|NCT00406653|4966104|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
1511508|NCT00406653|4966105|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
1511509|NCT00406653|4966106|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
1511510|NCT00406653|4966107|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
1511511|NCT00406653|4966101|P7|Open-Label Period|Withdrawal of Consent|11
1511512|NCT00406653|4966102|P6|Open-Label Period|Withdrawal of Consent|0
1511513|NCT00406653|4966103|P5|Open-Label Period|Withdrawal of Consent|0
1511514|NCT00406653|4966104|P4|Open-Label Period|Withdrawal of Consent|0
1511515|NCT00406653|4966105|P3|Open-Label Period|Withdrawal of Consent|0
1511516|NCT00406653|4966106|P2|Open-Label Period|Withdrawal of Consent|0
1511517|NCT00406653|4966107|P1|Open-Label Period|Withdrawal of Consent|0
1511518|NCT00406653|4966101|P7|Open-Label Period|Lost to Follow-up|6
1511519|NCT00406653|4966102|P6|Open-Label Period|Lost to Follow-up|0
1511520|NCT00406653|4966103|P5|Open-Label Period|Lost to Follow-up|0
1511521|NCT00406653|4966104|P4|Open-Label Period|Lost to Follow-up|0
1511522|NCT00406653|4966105|P3|Open-Label Period|Lost to Follow-up|0
1511523|NCT00406653|4966106|P2|Open-Label Period|Lost to Follow-up|0
1511524|NCT00406653|4966107|P1|Open-Label Period|Lost to Follow-up|0
1511525|NCT00406653|4966101|P7|Open-Label Period|Lack of Efficacy|160
1511526|NCT00406653|4966102|P6|Open-Label Period|Lack of Efficacy|0
1511527|NCT00406653|4966103|P5|Open-Label Period|Lack of Efficacy|0
1511528|NCT00406653|4966104|P4|Open-Label Period|Lack of Efficacy|0
1511529|NCT00406653|4966105|P3|Open-Label Period|Lack of Efficacy|0
1511530|NCT00406653|4966106|P2|Open-Label Period|Lack of Efficacy|0
1511531|NCT00406653|4966107|P1|Open-Label Period|Lack of Efficacy|0
1511532|NCT00406653|4966101|P7|Open-Label Period|Adverse Event|18
1511533|NCT00406653|4966102|P6|Open-Label Period|Adverse Event|0
1511534|NCT00406653|4966103|P5|Open-Label Period|Adverse Event|0
1511535|NCT00406653|4966104|P4|Open-Label Period|Adverse Event|0
1511536|NCT00406653|4966105|P3|Open-Label Period|Adverse Event|0
1511537|NCT00406653|4966106|P2|Open-Label Period|Adverse Event|0
1511538|NCT00406653|4966107|P1|Open-Label Period|Adverse Event|0
1511539|NCT00406653|4966101|P7|Open-Label Period|Death|1
1511540|NCT00406653|4966102|P6|Open-Label Period|Death|0
1511541|NCT00406653|4966103|P5|Open-Label Period|Death|0
1511542|NCT00406653|4966104|P4|Open-Label Period|Death|0
1511543|NCT00406653|4966105|P3|Open-Label Period|Death|0
1511544|NCT00406653|4966106|P2|Open-Label Period|Death|0
1511545|NCT00406653|4966107|P1|Open-Label Period|Death|0
1511546|NCT00406653|4966101|P7|Maintenance Period|Error in disease score evaluation|0
1511547|NCT00406653|4966102|P6|Maintenance Period|Error in disease score evaluation|0
1511548|NCT00406653|4966103|P5|Maintenance Period|Error in disease score evaluation|1
1511549|NCT00406653|4966104|P4|Maintenance Period|Error in disease score evaluation|0
1511550|NCT00406653|4966105|P3|Maintenance Period|Error in disease score evaluation|0
1511551|NCT00406653|4966106|P2|Maintenance Period|Error in disease score evaluation|0
1511552|NCT00406653|4966107|P1|Maintenance Period|Error in disease score evaluation|0
1511553|NCT00406653|4966101|P7|Maintenance Period|Administrative Reason By Sponsor|0
1511554|NCT00406653|4966102|P6|Maintenance Period|Administrative Reason By Sponsor|7
1511555|NCT00406653|4966103|P5|Maintenance Period|Administrative Reason By Sponsor|4
1511556|NCT00406653|4966104|P4|Maintenance Period|Administrative Reason By Sponsor|0
1511557|NCT00406653|4966105|P3|Maintenance Period|Administrative Reason By Sponsor|0
1511558|NCT00406653|4966106|P2|Maintenance Period|Administrative Reason By Sponsor|0
1511559|NCT00406653|4966107|P1|Maintenance Period|Administrative Reason By Sponsor|0
1511560|NCT00406653|4966101|P7|Maintenance Period|Pregnancy|0
1511561|NCT00406653|4966102|P6|Maintenance Period|Pregnancy|1
1511562|NCT00406653|4966103|P5|Maintenance Period|Pregnancy|0
1511563|NCT00406653|4966104|P4|Maintenance Period|Pregnancy|0
1511564|NCT00406653|4966105|P3|Maintenance Period|Pregnancy|0
1511565|NCT00406653|4966106|P2|Maintenance Period|Pregnancy|0
1511566|NCT00406653|4966107|P1|Maintenance Period|Pregnancy|0
1511567|NCT00406653|4966101|P7|Maintenance Period|Withdrawal of Consent|0
1511568|NCT00406653|4966102|P6|Maintenance Period|Withdrawal of Consent|0
1511569|NCT00406653|4966103|P5|Maintenance Period|Withdrawal of Consent|2
1511570|NCT00406653|4966104|P4|Maintenance Period|Withdrawal of Consent|0
1511571|NCT00406653|4966105|P3|Maintenance Period|Withdrawal of Consent|0
1511572|NCT00406653|4966106|P2|Maintenance Period|Withdrawal of Consent|0
1511573|NCT00406653|4966107|P1|Maintenance Period|Withdrawal of Consent|0
1511574|NCT00406653|4966101|P7|Maintenance Period|Lost to Follow-up|0
1511575|NCT00406653|4966102|P6|Maintenance Period|Lost to Follow-up|1
1511576|NCT00406653|4966103|P5|Maintenance Period|Lost to Follow-up|2
1511577|NCT00406653|4966104|P4|Maintenance Period|Lost to Follow-up|0
1511578|NCT00406653|4966105|P3|Maintenance Period|Lost to Follow-up|0
1511579|NCT00406653|4966106|P2|Maintenance Period|Lost to Follow-up|0
1511580|NCT00406653|4966107|P1|Maintenance Period|Lost to Follow-up|0
1511581|NCT00406653|4966101|P7|Maintenance Period|Lack of Efficacy|0
1511582|NCT00406653|4966102|P6|Maintenance Period|Lack of Efficacy|26
1511583|NCT00406653|4966103|P5|Maintenance Period|Lack of Efficacy|20
1511584|NCT00406653|4966104|P4|Maintenance Period|Lack of Efficacy|0
1511585|NCT00406653|4966105|P3|Maintenance Period|Lack of Efficacy|0
1511586|NCT00406653|4966106|P2|Maintenance Period|Lack of Efficacy|0
1511587|NCT00406653|4966107|P1|Maintenance Period|Lack of Efficacy|0
1511588|NCT00406653|4966101|P7|Maintenance Period|Adverse Event|0
1511589|NCT00406653|4966102|P6|Maintenance Period|Adverse Event|1
1511590|NCT00406653|4966103|P5|Maintenance Period|Adverse Event|1
1511591|NCT00406653|4966104|P4|Maintenance Period|Adverse Event|0
1511592|NCT00406653|4966105|P3|Maintenance Period|Adverse Event|0
1511593|NCT00406653|4966106|P2|Maintenance Period|Adverse Event|0
1511594|NCT00406653|4966107|P1|Maintenance Period|Adverse Event|0
1511595|NCT00406653|4966101|P7|Induction Period|Patient relocated|0
1511596|NCT00406653|4966102|P6|Induction Period|Patient relocated|0
1511597|NCT00406653|4966103|P5|Induction Period|Patient relocated|0
1511598|NCT00406653|4966104|P4|Induction Period|Patient relocated|0
1511599|NCT00406653|4966105|P3|Induction Period|Patient relocated|1
1511600|NCT00406653|4966106|P2|Induction Period|Patient relocated|0
1511601|NCT00406653|4966107|P1|Induction Period|Patient relocated|0
1511602|NCT00406653|4966101|P7|Induction Period|Incarcerated|0
1511603|NCT00406653|4966102|P6|Induction Period|Incarcerated|0
1511604|NCT00406653|4966103|P5|Induction Period|Incarcerated|0
1511605|NCT00406653|4966104|P4|Induction Period|Incarcerated|0
1511606|NCT00406653|4966105|P3|Induction Period|Incarcerated|1
1511607|NCT00406653|4966106|P2|Induction Period|Incarcerated|0
1511608|NCT00406653|4966107|P1|Induction Period|Incarcerated|0
1511609|NCT00406653|4966101|P7|Induction Period|Given prohibited drug|0
1511610|NCT00406653|4966102|P6|Induction Period|Given prohibited drug|0
1511611|NCT00406653|4966103|P5|Induction Period|Given prohibited drug|0
1511612|NCT00406653|4966104|P4|Induction Period|Given prohibited drug|0
1511613|NCT00406653|4966105|P3|Induction Period|Given prohibited drug|2
1511614|NCT00406653|4966106|P2|Induction Period|Given prohibited drug|1
1511615|NCT00406653|4966107|P1|Induction Period|Given prohibited drug|0
1511616|NCT00406653|4966101|P7|Induction Period|Declined participation but followup done|0
1511617|NCT00406653|4966102|P6|Induction Period|Declined participation but followup done|0
1511618|NCT00406653|4966103|P5|Induction Period|Declined participation but followup done|0
1511619|NCT00406653|4966104|P4|Induction Period|Declined participation but followup done|1
1511620|NCT00406653|4966105|P3|Induction Period|Declined participation but followup done|1
1511621|NCT00406653|4966106|P2|Induction Period|Declined participation but followup done|2
1511622|NCT00406653|4966107|P1|Induction Period|Declined participation but followup done|0
1511623|NCT00406653|4966101|P7|Induction Period|Pregnancy|0
1511624|NCT00406653|4966102|P6|Induction Period|Pregnancy|0
1511625|NCT00406653|4966103|P5|Induction Period|Pregnancy|0
1511626|NCT00406653|4966104|P4|Induction Period|Pregnancy|0
1511627|NCT00406653|4966105|P3|Induction Period|Pregnancy|0
1511628|NCT00406653|4966106|P2|Induction Period|Pregnancy|0
1511629|NCT00406653|4966107|P1|Induction Period|Pregnancy|1
1511630|NCT00406653|4966101|P7|Induction Period|Subject No Longer Meets Study Criteria|0
1511631|NCT00406653|4966102|P6|Induction Period|Subject No Longer Meets Study Criteria|0
1511632|NCT00406653|4966103|P5|Induction Period|Subject No Longer Meets Study Criteria|0
1511633|NCT00406653|4966104|P4|Induction Period|Subject No Longer Meets Study Criteria|2
1511634|NCT00406653|4966105|P3|Induction Period|Subject No Longer Meets Study Criteria|0
1511635|NCT00406653|4966106|P2|Induction Period|Subject No Longer Meets Study Criteria|0
1511636|NCT00406653|4966107|P1|Induction Period|Subject No Longer Meets Study Criteria|0
1511637|NCT00406653|4966101|P7|Induction Period|Withdrawal of Consent|0
1511638|NCT00406653|4966102|P6|Induction Period|Withdrawal of Consent|0
1511639|NCT00406653|4966103|P5|Induction Period|Withdrawal of Consent|0
1511640|NCT00406653|4966104|P4|Induction Period|Withdrawal of Consent|2
1511641|NCT00406653|4966105|P3|Induction Period|Withdrawal of Consent|1
1511642|NCT00406653|4966106|P2|Induction Period|Withdrawal of Consent|5
1511643|NCT00406653|4966107|P1|Induction Period|Withdrawal of Consent|2
1511644|NCT00406653|4966101|P7|Induction Period|Lost to Follow-up|0
1511645|NCT00406653|4966102|P6|Induction Period|Lost to Follow-up|0
1511646|NCT00406653|4966103|P5|Induction Period|Lost to Follow-up|0
1511647|NCT00406653|4966104|P4|Induction Period|Lost to Follow-up|0
1511648|NCT00406653|4966105|P3|Induction Period|Lost to Follow-up|0
1511649|NCT00406653|4966106|P2|Induction Period|Lost to Follow-up|2
1511650|NCT00406653|4966107|P1|Induction Period|Lost to Follow-up|0
1511651|NCT00406653|4966101|P7|Induction Period|Lack of Efficacy|0
1511652|NCT00406653|4966102|P6|Induction Period|Lack of Efficacy|0
1511653|NCT00406653|4966103|P5|Induction Period|Lack of Efficacy|0
1511654|NCT00406653|4966104|P4|Induction Period|Lack of Efficacy|10
1511655|NCT00406653|4966105|P3|Induction Period|Lack of Efficacy|8
1511656|NCT00406653|4966106|P2|Induction Period|Lack of Efficacy|14
1511657|NCT00406653|4966107|P1|Induction Period|Lack of Efficacy|11
1511658|NCT00406653|4966101|P7|Induction Period|Adverse Event|0
1511659|NCT00406653|4966102|P6|Induction Period|Adverse Event|0
1511660|NCT00406653|4966103|P5|Induction Period|Adverse Event|0
1511661|NCT00406653|4966104|P4|Induction Period|Adverse Event|11
1511662|NCT00406653|4966105|P3|Induction Period|Adverse Event|4
1511663|NCT00406653|4966106|P2|Induction Period|Adverse Event|10
1511664|NCT00406653|4966107|P1|Induction Period|Adverse Event|1
1511665|NCT00406640|4966188|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
1511666|NCT00406640|4966189|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
1511667|NCT00406640|4966188|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
1511668|NCT00406640|4966189|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
1511669|NCT00406640|4966188|P2|OL Extension Phase for Non-Responders|non-compliance|2
1511670|NCT00406640|4966189|P1|OL Extension Phase for Non-Responders|non-compliance|3
1511671|NCT00406640|4966188|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
1511672|NCT00406640|4966189|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
1511673|NCT00406640|4966188|P2|OL Extension Phase for Non-Responders|Physician Decision|0
1511674|NCT00406640|4966189|P1|OL Extension Phase for Non-Responders|Physician Decision|1
1511675|NCT00406640|4966188|P2|OL Extension Phase for Non-Responders|Failed to Return|0
1511676|NCT00406640|4966189|P1|OL Extension Phase for Non-Responders|Failed to Return|1
1511677|NCT00406640|4966188|P2|OL Extension Phase for Non-Responders|Adverse Event|6
1511678|NCT00406640|4966189|P1|OL Extension Phase for Non-Responders|Adverse Event|6
1511679|NCT00406640|4966188|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
1511680|NCT00406640|4966189|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
1511681|NCT00406640|4966188|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
1511682|NCT00406640|4966189|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
1511683|NCT00406640|4966188|P2|DB Continuation Phase for Responders|Protocol Violation|2
1511684|NCT00406640|4966189|P1|DB Continuation Phase for Responders|Protocol Violation|2
1511685|NCT00406640|4966188|P2|DB Continuation Phase for Responders|non-compliance|5
1511686|NCT00406640|4966189|P1|DB Continuation Phase for Responders|non-compliance|7
1511687|NCT00406640|4966188|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
1511688|NCT00406640|4966189|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
1511689|NCT00406640|4966188|P2|DB Continuation Phase for Responders|Physician Decision|3
1511690|NCT00406640|4966189|P1|DB Continuation Phase for Responders|Physician Decision|2
1511691|NCT00406640|4966188|P2|DB Continuation Phase for Responders|Failed to Return|2
1511692|NCT00406640|4966189|P1|DB Continuation Phase for Responders|Failed to Return|0
1511693|NCT00406640|4966188|P2|DB Continuation Phase for Responders|Death|0
1511694|NCT00406640|4966189|P1|DB Continuation Phase for Responders|Death|1
1511695|NCT00406640|4966188|P2|DB Continuation Phase for Responders|Adverse Event|11
1511696|NCT00406640|4966189|P1|DB Continuation Phase for Responders|Adverse Event|11
1511697|NCT00406640|4966188|P2|Acute Phase|Lack of Efficacy|3
1511698|NCT00406640|4966189|P1|Acute Phase|Lack of Efficacy|3
1511699|NCT00406640|4966188|P2|Acute Phase|Withdrawal by Subject|9
1511700|NCT00406640|4966189|P1|Acute Phase|Withdrawal by Subject|11
1511701|NCT00406640|4966188|P2|Acute Phase|Protocol Violation|2
1511702|NCT00406640|4966189|P1|Acute Phase|Protocol Violation|3
1511703|NCT00406640|4966188|P2|Acute Phase|Protocol deviation|10
1511704|NCT00406640|4966189|P1|Acute Phase|Protocol deviation|4
1511705|NCT00406640|4966188|P2|Acute Phase|Lost to Follow-up|4
1511706|NCT00406640|4966189|P1|Acute Phase|Lost to Follow-up|7
1511707|NCT00406640|4966188|P2|Acute Phase|Physician Decision|1
1511708|NCT00406640|4966189|P1|Acute Phase|Physician Decision|0
1511709|NCT00406640|4966188|P2|Acute Phase|Failed to Return|1
1511710|NCT00406640|4966189|P1|Acute Phase|Failed to Return|5
1511711|NCT00406640|4966188|P2|Acute Phase|Adverse Event|13
1511712|NCT00406640|4966189|P1|Acute Phase|Adverse Event|18
1511713|NCT00406393|4966221|P2|Overall Study|Did not undergo transplantation|1
1511714|NCT00406393|4966222|P1|Overall Study|Did not undergo transplantation|2
1511715|NCT00406367|4966252|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
1511716|NCT00406367|4966253|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
1511717|NCT00406367|4966252|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
1511718|NCT00406367|4966253|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
1511719|NCT00406367|4966252|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
1511720|NCT00406367|4966253|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
1511721|NCT00406367|4966252|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
1511722|NCT00406367|4966253|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
1511723|NCT00406367|4966252|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
1511724|NCT00406367|4966253|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
1511725|NCT00406367|4966252|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
1511726|NCT00406367|4966253|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
1511727|NCT00406367|4966252|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
1511728|NCT00406367|4966253|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
1511729|NCT00406367|4966252|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
1511730|NCT00406367|4966253|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
1511731|NCT00406367|4966252|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
1511732|NCT00406367|4966253|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
1511733|NCT00406367|4966252|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
1511734|NCT00406367|4966253|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
1511735|NCT00406367|4966252|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
1511736|NCT00406367|4966253|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
1511737|NCT00406367|4966252|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
1511738|NCT00406367|4966253|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
1511739|NCT00406354|4966268|P3|All Randomized and Treated Patients|Physician Decision|1
1511740|NCT00406354|4966269|P2|All Randomized and Treated Patients|Physician Decision|0
1511741|NCT00406354|4966270|P1|All Randomized and Treated Patients|Physician Decision|0
1511742|NCT00406354|4966268|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
1511743|NCT00406354|4966269|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
1511744|NCT00406354|4966270|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
1511745|NCT00406354|4966268|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
1511746|NCT00406354|4966269|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
1511747|NCT00406354|4966270|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
1511748|NCT00406354|4966268|P3|All Randomized and Treated Patients|Adverse Event|1
1511749|NCT00406354|4966269|P2|All Randomized and Treated Patients|Adverse Event|2
1511750|NCT00406354|4966270|P1|All Randomized and Treated Patients|Adverse Event|6
1511751|NCT00406354|4966268|P3|All Randomized and Treated Patients|Lack of Efficacy|17
1511752|NCT00406354|4966269|P2|All Randomized and Treated Patients|Lack of Efficacy|4
1511753|NCT00406354|4966270|P1|All Randomized and Treated Patients|Lack of Efficacy|7
1511754|NCT00406354|4966268|P3|All Randomized Patients|Protocol Violation|1
1511755|NCT00406354|4966269|P2|All Randomized Patients|Protocol Violation|0
1511756|NCT00406354|4966270|P1|All Randomized Patients|Protocol Violation|0
1511757|NCT00406315|4966341|P1|Overall Study|Withdrawal by Subject|30
1511758|NCT00406315|4966341|P1|Overall Study|Lost to Follow-up|21
1511759|NCT00406315|4966341|P1|Overall Study|Other|33
1511760|NCT00406315|4966341|P1|Overall Study|Lack of Efficacy|13
1511761|NCT00406315|4966341|P1|Overall Study|Laboratory Abnormality|4
1511762|NCT00406315|4966341|P1|Overall Study|Adverse Event|39
1511763|NCT00406315|4966341|P1|Overall Study|Death|1
1511764|NCT00406029|4966451|P5|Overall Study|Randomized in Error|1
1511765|NCT00406029|4966452|P4|Overall Study|Randomized in Error|3
1511766|NCT00406029|4966453|P3|Overall Study|Randomized in Error|2
1511767|NCT00406029|4966454|P2|Overall Study|Randomized in Error|0
1511768|NCT00406029|4966455|P1|Overall Study|Randomized in Error|0
1511769|NCT00406029|4966451|P5|Overall Study|Did Not Meet Eligibility Criteria|0
1511770|NCT00406029|4966452|P4|Overall Study|Did Not Meet Eligibility Criteria|0
1511771|NCT00406029|4966453|P3|Overall Study|Did Not Meet Eligibility Criteria|1
1511772|NCT00406029|4966454|P2|Overall Study|Did Not Meet Eligibility Criteria|0
1511773|NCT00406029|4966455|P1|Overall Study|Did Not Meet Eligibility Criteria|0
1511774|NCT00406029|4966451|P5|Overall Study|Protocol Violation|0
1511775|NCT00406029|4966452|P4|Overall Study|Protocol Violation|2
1511776|NCT00406029|4966453|P3|Overall Study|Protocol Violation|0
1511777|NCT00406029|4966454|P2|Overall Study|Protocol Violation|2
1511778|NCT00406029|4966455|P1|Overall Study|Protocol Violation|1
1511779|NCT00406029|4966451|P5|Overall Study|Withdrawal by Subject|0
1511780|NCT00406029|4966452|P4|Overall Study|Withdrawal by Subject|2
1511781|NCT00406029|4966453|P3|Overall Study|Withdrawal by Subject|2
1511782|NCT00406029|4966454|P2|Overall Study|Withdrawal by Subject|4
1511783|NCT00406029|4966455|P1|Overall Study|Withdrawal by Subject|3
1511784|NCT00406029|4966451|P5|Overall Study|Adverse Event|7
1511785|NCT00406029|4966452|P4|Overall Study|Adverse Event|10
1511786|NCT00406029|4966453|P3|Overall Study|Adverse Event|5
1511787|NCT00406029|4966454|P2|Overall Study|Adverse Event|2
1511788|NCT00406029|4966455|P1|Overall Study|Adverse Event|12
1511789|NCT00405964|4966559|P2|Overall Study|Protocol Violation|6
1511790|NCT00405964|4966560|P1|Overall Study|Protocol Violation|11
1511791|NCT00405964|4966559|P2|Overall Study|Withdrawal by Subject|23
1511792|NCT00405964|4966560|P1|Overall Study|Withdrawal by Subject|19
1511793|NCT00405964|4966559|P2|Overall Study|Lost to Follow-up|5
1511794|NCT00405964|4966560|P1|Overall Study|Lost to Follow-up|5
1511795|NCT00405964|4966559|P2|Overall Study|Adverse Event|16
1511796|NCT00405964|4966560|P1|Overall Study|Adverse Event|7
1511797|NCT00405964|4966559|P2|Overall Study|Treatment Failure|45
1511798|NCT00405964|4966560|P1|Overall Study|Treatment Failure|17
1511799|NCT00405912|4966582|P3|Overall Study|Lost to Follow-up|4
1511800|NCT00405912|4966583|P2|Overall Study|Lost to Follow-up|8
1511801|NCT00405912|4966584|P1|Overall Study|Lost to Follow-up|4
1511802|NCT00405912|4966582|P3|Overall Study|Withdrawal by Subject|12
1511803|NCT00405912|4966583|P2|Overall Study|Withdrawal by Subject|11
1511804|NCT00405912|4966584|P1|Overall Study|Withdrawal by Subject|12
1511805|NCT00405821|4966597|P2|Overall Study|initiated ART|8
1511806|NCT00405821|4966598|P1|Overall Study|initiated ART|9
1511807|NCT00405821|4966597|P2|Overall Study|Protocol Violation|0
1511808|NCT00405821|4966598|P1|Overall Study|Protocol Violation|1
1511809|NCT00405821|4966597|P2|Overall Study|Lost to Follow-up|7
1511810|NCT00405821|4966598|P1|Overall Study|Lost to Follow-up|7
1511811|NCT00405821|4966597|P2|Overall Study|Death|7
1511812|NCT00405821|4966598|P1|Overall Study|Death|5
1511813|NCT00405756|4966611|P3|Follow-up|Lost to Follow-up|4
1511814|NCT00405756|4966612|P2|Follow-up|Lost to Follow-up|8
1511815|NCT00405756|4966613|P1|Follow-up|Lost to Follow-up|2
1511816|NCT00405756|4966611|P3|Follow-up|Death|24
1511817|NCT00405756|4966612|P2|Follow-up|Death|31
1511818|NCT00405756|4966613|P1|Follow-up|Death|21
1511819|NCT00405756|4966611|P3|Follow-up|Ongoing in Follow-up Period|60
1511820|NCT00405756|4966612|P2|Follow-up|Ongoing in Follow-up Period|51
1511821|NCT00405756|4966613|P1|Follow-up|Ongoing in Follow-up Period|52
1511822|NCT00405756|4966611|P3|Open-label Extension|Other|7
1511823|NCT00405756|4966612|P2|Open-label Extension|Other|1
1511824|NCT00405756|4966613|P1|Open-label Extension|Other|0
1511825|NCT00405756|4966611|P3|Open-label Extension|Death|4
1511826|NCT00405756|4966612|P2|Open-label Extension|Death|2
1511827|NCT00405756|4966613|P1|Open-label Extension|Death|1
1511828|NCT00405756|4966611|P3|Open-label Extension|Withdrawal by Subject|3
1511829|NCT00405756|4966612|P2|Open-label Extension|Withdrawal by Subject|3
1511830|NCT00405756|4966613|P1|Open-label Extension|Withdrawal by Subject|2
1511831|NCT00405756|4966611|P3|Open-label Extension|Disease Progression|26
1511832|NCT00405756|4966612|P2|Open-label Extension|Disease Progression|23
1511833|NCT00405756|4966613|P1|Open-label Extension|Disease Progression|8
1511834|NCT00405756|4966611|P3|Open-label Extension|Adverse Event|7
1511835|NCT00405756|4966612|P2|Open-label Extension|Adverse Event|3
1511836|NCT00405756|4966613|P1|Open-label Extension|Adverse Event|1
1511837|NCT00405756|4966611|P3|Open-label Extension|Ongoing in Open Label Period|25
1511838|NCT00405756|4966612|P2|Open-label Extension|Ongoing in Open Label Period|15
1511839|NCT00405756|4966613|P1|Open-label Extension|Ongoing in Open Label Period|7
1511840|NCT00405756|4966611|P3|Double-blind Treatment|Not Specified|4
1511841|NCT00405756|4966612|P2|Double-blind Treatment|Not Specified|4
1511842|NCT00405756|4966613|P1|Double-blind Treatment|Not Specified|7
1511843|NCT00405756|4966611|P3|Double-blind Treatment|Protocol Violation|2
1511844|NCT00405756|4966612|P2|Double-blind Treatment|Protocol Violation|0
1511845|NCT00405756|4966613|P1|Double-blind Treatment|Protocol Violation|1
1511846|NCT00405756|4966611|P3|Double-blind Treatment|Death|4
1511847|NCT00405756|4966612|P2|Double-blind Treatment|Death|4
1511848|NCT00405756|4966613|P1|Double-blind Treatment|Death|4
1511849|NCT00405756|4966611|P3|Double-blind Treatment|Lost to Follow-up|0
1511850|NCT00405756|4966612|P2|Double-blind Treatment|Lost to Follow-up|0
1511851|NCT00405756|4966613|P1|Double-blind Treatment|Lost to Follow-up|1
1511852|NCT00405756|4966611|P3|Double-blind Treatment|Withdrawal by Subject|10
1511853|NCT00405756|4966612|P2|Double-blind Treatment|Withdrawal by Subject|9
1511854|NCT00405756|4966613|P1|Double-blind Treatment|Withdrawal by Subject|15
1511855|NCT00405756|4966611|P3|Double-blind Treatment|Lack of Efficacy|2
1511856|NCT00405756|4966612|P2|Double-blind Treatment|Lack of Efficacy|4
1511857|NCT00405756|4966613|P1|Double-blind Treatment|Lack of Efficacy|1
1511858|NCT00405756|4966611|P3|Double-blind Treatment|Disease Progression|102
1511859|NCT00405756|4966612|P2|Double-blind Treatment|Disease Progression|81
1511860|NCT00405756|4966613|P1|Double-blind Treatment|Disease Progression|47
1511861|NCT00405756|4966611|P3|Double-blind Treatment|Adverse Event|12
1511862|NCT00405756|4966612|P2|Double-blind Treatment|Adverse Event|27
1511863|NCT00405756|4966613|P1|Double-blind Treatment|Adverse Event|31
1511864|NCT00405756|4966611|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
1511865|NCT00405756|4966612|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
1511866|NCT00405756|4966613|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
1511867|NCT00405652|4966724|P1|Overall Study|Adverse Event|4
1511868|NCT00405639|4966731|P2|Overall Study|Seizure prior to receiving BNP|0
1511869|NCT00405639|4966732|P1|Overall Study|Seizure prior to receiving BNP|1
1511870|NCT00405639|4966731|P2|Overall Study|Adverse Event|0
1511871|NCT00405639|4966732|P1|Overall Study|Adverse Event|1
1511872|NCT00405639|4966731|P2|Overall Study|Withdrawal by Subject|0
1511873|NCT00405639|4966732|P1|Overall Study|Withdrawal by Subject|1
1511874|NCT00405587|4966748|P4|Overall Study|Participant not dosed|0
1511875|NCT00405587|4966749|P3|Overall Study|Participant not dosed|0
1511876|NCT00405587|4966750|P2|Overall Study|Participant not dosed|1
1511877|NCT00405587|4966751|P1|Overall Study|Participant not dosed|0
1511878|NCT00405587|4966748|P4|Overall Study|Withdrawal by Subject|2
1511879|NCT00405587|4966749|P3|Overall Study|Withdrawal by Subject|0
1511880|NCT00405587|4966750|P2|Overall Study|Withdrawal by Subject|0
1511881|NCT00405587|4966751|P1|Overall Study|Withdrawal by Subject|0
1511882|NCT00405587|4966748|P4|Overall Study|Radiation induced necrosis|0
1511883|NCT00405587|4966749|P3|Overall Study|Radiation induced necrosis|0
1511884|NCT00405587|4966750|P2|Overall Study|Radiation induced necrosis|1
1511885|NCT00405587|4966751|P1|Overall Study|Radiation induced necrosis|0
1511886|NCT00405587|4966748|P4|Overall Study|Lost to Follow-up|0
1511887|NCT00405587|4966749|P3|Overall Study|Lost to Follow-up|1
1511888|NCT00405587|4966750|P2|Overall Study|Lost to Follow-up|1
1511889|NCT00405587|4966751|P1|Overall Study|Lost to Follow-up|0
1511890|NCT00405587|4966748|P4|Overall Study|Adverse Event|0
1511891|NCT00405587|4966749|P3|Overall Study|Adverse Event|0
1511892|NCT00405587|4966750|P2|Overall Study|Adverse Event|0
1511893|NCT00405587|4966751|P1|Overall Study|Adverse Event|1
1511894|NCT00405587|4966748|P4|Overall Study|Physician Decision|0
1511895|NCT00405587|4966749|P3|Overall Study|Physician Decision|0
1511896|NCT00405587|4966750|P2|Overall Study|Physician Decision|2
1511897|NCT00405587|4966751|P1|Overall Study|Physician Decision|3
1511898|NCT00405587|4966748|P4|Overall Study|Disease Progression|17
1511899|NCT00405587|4966749|P3|Overall Study|Disease Progression|21
1511900|NCT00405587|4966750|P2|Overall Study|Disease Progression|23
1511901|NCT00405587|4966751|P1|Overall Study|Disease Progression|22
1511902|NCT00405587|4966748|P4|Overall Study|Death|1
1511903|NCT00405587|4966749|P3|Overall Study|Death|0
1511904|NCT00405587|4966750|P2|Overall Study|Death|0
1511905|NCT00405587|4966751|P1|Overall Study|Death|0
1511906|NCT00405548|4966869|P2|Overall Study|Withdrawal by Subject|0
1511907|NCT00405548|4966870|P1|Overall Study|Withdrawal by Subject|1
1511908|NCT00405548|4966869|P2|Overall Study|Venous access failed during study day|0
1511909|NCT00405548|4966870|P1|Overall Study|Venous access failed during study day|1
1511910|NCT00405548|4966869|P2|Overall Study|Unable to self-administer shots|0
1511911|NCT00405548|4966870|P1|Overall Study|Unable to self-administer shots|1
1511912|NCT00405548|4966869|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
1511913|NCT00405548|4966870|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
1511914|NCT00405548|4966869|P2|Overall Study|Cognitive Memory problems on study day|0
1511915|NCT00405548|4966870|P1|Overall Study|Cognitive Memory problems on study day|1
1511916|NCT00405392|4966901|P2|Overall Study|Other|5
1511917|NCT00405392|4966902|P1|Overall Study|Other|1
1511918|NCT00405392|4966901|P2|Overall Study|Non-compliance|1
1511919|NCT00405392|4966902|P1|Overall Study|Non-compliance|0
1511920|NCT00405392|4966901|P2|Overall Study|Data missing|0
1511921|NCT00405392|4966902|P1|Overall Study|Data missing|2
1511922|NCT00405392|4966901|P2|Overall Study|Lost to Follow-up|2
1511923|NCT00405392|4966902|P1|Overall Study|Lost to Follow-up|1
1511924|NCT00405392|4966901|P2|Overall Study|Withdrawal by Subject|3
1511925|NCT00405392|4966902|P1|Overall Study|Withdrawal by Subject|4
1511926|NCT00405392|4966901|P2|Overall Study|Did not meet Eligibility criteria|2
1511927|NCT00405392|4966902|P1|Overall Study|Did not meet Eligibility criteria|7
1511928|NCT00405392|4966901|P2|Overall Study|Adverse Event|14
1511929|NCT00405392|4966902|P1|Overall Study|Adverse Event|15
1511930|NCT00405275|4966945|P2|Overall Study|Unwilling to continue|9
1511931|NCT00405275|4966946|P1|Overall Study|Unwilling to continue|10
1511932|NCT00405275|4966945|P2|Overall Study|Withdrawal by Subject|9
1511933|NCT00405275|4966946|P1|Overall Study|Withdrawal by Subject|7
1511934|NCT00405275|4966945|P2|Overall Study|Lost to Follow-up|1
1511935|NCT00405275|4966946|P1|Overall Study|Lost to Follow-up|5
1511936|NCT00405275|4966945|P2|Overall Study|Death|0
1511937|NCT00405275|4966946|P1|Overall Study|Death|1
1511938|NCT00405067|4966955|P3|Overall Study|Lost to Follow-up|1
1511939|NCT00405067|4966956|P2|Overall Study|Lost to Follow-up|0
1511940|NCT00405067|4966957|P1|Overall Study|Lost to Follow-up|0
1511941|NCT00405067|4966955|P3|Overall Study|Adverse Event|4
1511942|NCT00405067|4966956|P2|Overall Study|Adverse Event|9
1511943|NCT00405067|4966957|P1|Overall Study|Adverse Event|4
1511944|NCT00404924|4966994|P2|Overall Study|Randomised but not received treatment|1
1511945|NCT00404924|4966995|P1|Overall Study|Randomised but not received treatment|1
1511946|NCT00404924|4966994|P2|Overall Study|Not Specified|11
1511947|NCT00404924|4966995|P1|Overall Study|Not Specified|25
1511948|NCT00404924|4966994|P2|Overall Study|Withdrawal by Subject|13
1511949|NCT00404924|4966995|P1|Overall Study|Withdrawal by Subject|26
1511950|NCT00404924|4966994|P2|Overall Study|Lost to Follow-up|1
1511951|NCT00404924|4966995|P1|Overall Study|Lost to Follow-up|1
1511952|NCT00404924|4966994|P2|Overall Study|Condition under investigation worsened|264
1511953|NCT00404924|4966995|P1|Overall Study|Condition under investigation worsened|475
1511954|NCT00404924|4966994|P2|Overall Study|Adverse Event|16
1511955|NCT00404924|4966995|P1|Overall Study|Adverse Event|75
1511956|NCT00404820|4967013|P2|Overall Study|Other|2
1511957|NCT00404820|4967014|P1|Overall Study|Other|0
1511958|NCT00404820|4967013|P2|Overall Study|Death|0
1511959|NCT00404820|4967014|P1|Overall Study|Death|1
1511960|NCT00404820|4967013|P2|Overall Study|Administrative problems|0
1511961|NCT00404820|4967014|P1|Overall Study|Administrative problems|2
1511962|NCT00404820|4967013|P2|Overall Study|Lost to Follow-up|3
1511963|NCT00404820|4967014|P1|Overall Study|Lost to Follow-up|7
1511964|NCT00404820|4967013|P2|Overall Study|Withdrawal by Subject|3
1511965|NCT00404820|4967014|P1|Overall Study|Withdrawal by Subject|5
1511966|NCT00404820|4967013|P2|Overall Study|Adverse Event|16
1511967|NCT00404820|4967014|P1|Overall Study|Adverse Event|4
1511968|NCT00404768|4967036|P4|Part C|Researcher suspended study medication|1
1511969|NCT00404768|4967037|P3|Part C|Researcher suspended study medication|0
1511970|NCT00404768|4967038|P2|Part C|Researcher suspended study medication|0
1511971|NCT00404768|4967039|P1|Part C|Researcher suspended study medication|0
1511972|NCT00404768|4967036|P4|Part C|Investigator discretion|1
1511973|NCT00404768|4967037|P3|Part C|Investigator discretion|0
1511974|NCT00404768|4967038|P2|Part C|Investigator discretion|0
1511975|NCT00404768|4967039|P1|Part C|Investigator discretion|0
1511976|NCT00404768|4967036|P4|Part C|Treatment failure|1
1511977|NCT00404768|4967037|P3|Part C|Treatment failure|0
1511978|NCT00404768|4967038|P2|Part C|Treatment failure|0
1511979|NCT00404768|4967039|P1|Part C|Treatment failure|0
1511980|NCT00404768|4967036|P4|Part C|Lack of Efficacy|2
1511981|NCT00404768|4967037|P3|Part C|Lack of Efficacy|0
1511982|NCT00404768|4967038|P2|Part C|Lack of Efficacy|0
1511983|NCT00404768|4967039|P1|Part C|Lack of Efficacy|0
1511984|NCT00404768|4967036|P4|Part C|Active labor|1
1511985|NCT00404768|4967037|P3|Part C|Active labor|0
1511986|NCT00404768|4967038|P2|Part C|Active labor|0
1511987|NCT00404768|4967039|P1|Part C|Active labor|0
1511988|NCT00404768|4967036|P4|Part C|Unsatisfactory uterine response to IP|1
1511989|NCT00404768|4967037|P3|Part C|Unsatisfactory uterine response to IP|0
1511990|NCT00404768|4967038|P2|Part C|Unsatisfactory uterine response to IP|0
1511991|NCT00404768|4967039|P1|Part C|Unsatisfactory uterine response to IP|0
1511992|NCT00404768|4967036|P4|Part C|Participant delivered baby|1
1511993|NCT00404768|4967037|P3|Part C|Participant delivered baby|0
1511994|NCT00404768|4967038|P2|Part C|Participant delivered baby|0
1511995|NCT00404768|4967039|P1|Part C|Participant delivered baby|0
1511996|NCT00404768|4967036|P4|Part C|Physician withdrew the study medication|0
1511997|NCT00404768|4967037|P3|Part C|Physician withdrew the study medication|1
1511998|NCT00404768|4967038|P2|Part C|Physician withdrew the study medication|0
1511999|NCT00404768|4967039|P1|Part C|Physician withdrew the study medication|0
1512000|NCT00404768|4967036|P4|Part C|Participant did not respond to therapy|1
1512001|NCT00404768|4967037|P3|Part C|Participant did not respond to therapy|1
1512002|NCT00404768|4967038|P2|Part C|Participant did not respond to therapy|0
1512003|NCT00404768|4967039|P1|Part C|Participant did not respond to therapy|0
1512004|NCT00404768|4967036|P4|Part C|Early withdrawal from study medication|0
1512005|NCT00404768|4967037|P3|Part C|Early withdrawal from study medication|1
1512006|NCT00404768|4967038|P2|Part C|Early withdrawal from study medication|0
1512007|NCT00404768|4967039|P1|Part C|Early withdrawal from study medication|0
1512008|NCT00404768|4967036|P4|Part C|Withdrawal by Subject|1
1512009|NCT00404768|4967037|P3|Part C|Withdrawal by Subject|2
1512010|NCT00404768|4967038|P2|Part C|Withdrawal by Subject|0
1512011|NCT00404768|4967039|P1|Part C|Withdrawal by Subject|0
1512012|NCT00404768|4967036|P4|Part C|Lost to Follow-up|1
1512013|NCT00404768|4967037|P3|Part C|Lost to Follow-up|3
1512014|NCT00404768|4967038|P2|Part C|Lost to Follow-up|0
1512015|NCT00404768|4967039|P1|Part C|Lost to Follow-up|0
1512016|NCT00404768|4967036|P4|Part C|Adverse Event|3
1512017|NCT00404768|4967037|P3|Part C|Adverse Event|0
1512018|NCT00404768|4967038|P2|Part C|Adverse Event|0
1512019|NCT00404768|4967039|P1|Part C|Adverse Event|0
1512020|NCT00404768|4967036|P4|Part A and B|Withdrawn as delivery imminemnt|0
1512021|NCT00404768|4967037|P3|Part A and B|Withdrawn as delivery imminemnt|0
1512022|NCT00404768|4967038|P2|Part A and B|Withdrawn as delivery imminemnt|1
1512023|NCT00404768|4967039|P1|Part A and B|Withdrawn as delivery imminemnt|0
1512024|NCT00404768|4967036|P4|Part A and B|Withdrawn due to labor progression|0
1512025|NCT00404768|4967037|P3|Part A and B|Withdrawn due to labor progression|0
1512026|NCT00404768|4967038|P2|Part A and B|Withdrawn due to labor progression|0
1512027|NCT00404768|4967039|P1|Part A and B|Withdrawn due to labor progression|1
1512028|NCT00404755|4967100|P1|Phase II (Escitalopram)|Lost to Follow-up|2
1512029|NCT00404755|4967100|P1|Phase I (Bupropion)|Other|1
1512030|NCT00404755|4967100|P1|Phase I (Bupropion)|Adverse Event|3
1512031|NCT00404651|4967115|P4|Overall Study|Withdrawal by Subject|6
1512032|NCT00404651|4967116|P3|Overall Study|Withdrawal by Subject|16
1512033|NCT00404651|4967117|P2|Overall Study|Withdrawal by Subject|12
1512034|NCT00404651|4967118|P1|Overall Study|Withdrawal by Subject|14
1512035|NCT00404651|4967115|P4|Overall Study|Lost to Follow-up|10
1512036|NCT00404651|4967116|P3|Overall Study|Lost to Follow-up|13
1512037|NCT00404651|4967117|P2|Overall Study|Lost to Follow-up|11
1512038|NCT00404651|4967118|P1|Overall Study|Lost to Follow-up|15
1512039|NCT00404651|4967115|P4|Overall Study|Protocol Violation|5
1512040|NCT00404651|4967116|P3|Overall Study|Protocol Violation|14
1512041|NCT00404651|4967117|P2|Overall Study|Protocol Violation|5
1512042|NCT00404651|4967118|P1|Overall Study|Protocol Violation|10
1512043|NCT00404651|4967115|P4|Overall Study|Serious Adverse Event|0
1512044|NCT00404651|4967116|P3|Overall Study|Serious Adverse Event|2
1512045|NCT00404651|4967117|P2|Overall Study|Serious Adverse Event|0
1512046|NCT00404651|4967118|P1|Overall Study|Serious Adverse Event|0
1512047|NCT00404547|4967146|P2|Overall Study|Reason not stated|6
1512048|NCT00404547|4967147|P1|Overall Study|Reason not stated|3
1512049|NCT00404547|4967146|P2|Overall Study|Other|0
1512050|NCT00404547|4967147|P1|Overall Study|Other|4
1512051|NCT00404547|4967146|P2|Overall Study|Lack of compliance|1
1512052|NCT00404547|4967147|P1|Overall Study|Lack of compliance|5
1512053|NCT00404547|4967146|P2|Overall Study|Lost to Follow-up|9
1512054|NCT00404547|4967147|P1|Overall Study|Lost to Follow-up|20
1512055|NCT00404547|4967146|P2|Overall Study|Protocol Violation|1
1512056|NCT00404547|4967147|P1|Overall Study|Protocol Violation|0
1512057|NCT00404547|4967146|P2|Overall Study|Withdrawal by Subject|2
1512058|NCT00404547|4967147|P1|Overall Study|Withdrawal by Subject|19
1512059|NCT00404547|4967146|P2|Overall Study|Adverse Event|6
1512060|NCT00404547|4967147|P1|Overall Study|Adverse Event|39
1512061|NCT00404495|4967157|P2|Overall Study|Withdrawal by Subject|0
1512062|NCT00404495|4967158|P1|Overall Study|Withdrawal by Subject|1
1512063|NCT00404495|4967157|P2|Overall Study|Not specified|0
1512064|NCT00404495|4967158|P1|Overall Study|Not specified|1
1512065|NCT00404495|4967157|P2|Overall Study|Lost to Follow-up|0
1512066|NCT00404495|4967158|P1|Overall Study|Lost to Follow-up|5
1512067|NCT00404495|4967157|P2|Overall Study|Death|11
1512068|NCT00404495|4967158|P1|Overall Study|Death|37
1512069|NCT00404352|4967177|P9|Open Label Extension (up to 36 Months)|Other|2
1512070|NCT00404352|4967178|P8|Open Label Extension (up to 36 Months)|Other|0
1512071|NCT00404352|4967179|P7|Open Label Extension (up to 36 Months)|Other|0
1512072|NCT00404352|4967180|P6|Open Label Extension (up to 36 Months)|Other|0
1512073|NCT00404352|4967181|P5|Open Label Extension (up to 36 Months)|Other|0
1512074|NCT00404352|4967182|P4|Open Label Extension (up to 36 Months)|Other|0
1512075|NCT00404352|4967183|P3|Open Label Extension (up to 36 Months)|Other|0
1512076|NCT00404352|4967184|P2|Open Label Extension (up to 36 Months)|Other|0
1512077|NCT00404352|4967185|P1|Open Label Extension (up to 36 Months)|Other|0
1512078|NCT00404352|4967177|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
1512079|NCT00404352|4967178|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
1512080|NCT00404352|4967179|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
1512081|NCT00404352|4967180|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
1512082|NCT00404352|4967181|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
1512083|NCT00404352|4967182|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
1512084|NCT00404352|4967183|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
1512085|NCT00404352|4967184|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
1512086|NCT00404352|4967185|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
1512087|NCT00404352|4967177|P9|Open Label (up to 24 Month)|Disease progression|0
1512088|NCT00404352|4967178|P8|Open Label (up to 24 Month)|Disease progression|0
1512089|NCT00404352|4967179|P7|Open Label (up to 24 Month)|Disease progression|0
1512090|NCT00404352|4967180|P6|Open Label (up to 24 Month)|Disease progression|0
1512091|NCT00404352|4967181|P5|Open Label (up to 24 Month)|Disease progression|0
1512092|NCT00404352|4967182|P4|Open Label (up to 24 Month)|Disease progression|1
1512093|NCT00404352|4967183|P3|Open Label (up to 24 Month)|Disease progression|0
1512094|NCT00404352|4967184|P2|Open Label (up to 24 Month)|Disease progression|0
1512095|NCT00404352|4967185|P1|Open Label (up to 24 Month)|Disease progression|0
1512096|NCT00404352|4967177|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
1512097|NCT00404352|4967178|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
1512098|NCT00404352|4967179|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
1512099|NCT00404352|4967180|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
1512100|NCT00404352|4967181|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
1512101|NCT00404352|4967182|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
1512102|NCT00404352|4967183|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
1512103|NCT00404352|4967184|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
1512104|NCT00404352|4967185|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
1512105|NCT00404352|4967177|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
1512106|NCT00404352|4967178|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
1512107|NCT00404352|4967179|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
1512108|NCT00404352|4967180|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
1512109|NCT00404352|4967181|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
1512110|NCT00404352|4967182|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
1512111|NCT00404352|4967183|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
1512112|NCT00404352|4967184|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
1512113|NCT00404352|4967185|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
1512114|NCT00404352|4967177|P9|Open Label (up to 24 Month)|Pregnancy|0
1512115|NCT00404352|4967178|P8|Open Label (up to 24 Month)|Pregnancy|0
1512116|NCT00404352|4967179|P7|Open Label (up to 24 Month)|Pregnancy|0
1512117|NCT00404352|4967180|P6|Open Label (up to 24 Month)|Pregnancy|1
1512118|NCT00404352|4967181|P5|Open Label (up to 24 Month)|Pregnancy|0
1512119|NCT00404352|4967182|P4|Open Label (up to 24 Month)|Pregnancy|0
1512120|NCT00404352|4967183|P3|Open Label (up to 24 Month)|Pregnancy|0
1512121|NCT00404352|4967184|P2|Open Label (up to 24 Month)|Pregnancy|0
1512122|NCT00404352|4967185|P1|Open Label (up to 24 Month)|Pregnancy|0
1512123|NCT00404352|4967177|P9|Open Label (up to 24 Month)|Adverse Event|0
1512124|NCT00404352|4967178|P8|Open Label (up to 24 Month)|Adverse Event|0
1512125|NCT00404352|4967179|P7|Open Label (up to 24 Month)|Adverse Event|0
1512126|NCT00404352|4967180|P6|Open Label (up to 24 Month)|Adverse Event|1
1512127|NCT00404352|4967181|P5|Open Label (up to 24 Month)|Adverse Event|1
1512128|NCT00404352|4967182|P4|Open Label (up to 24 Month)|Adverse Event|2
1512129|NCT00404352|4967183|P3|Open Label (up to 24 Month)|Adverse Event|0
1512130|NCT00404352|4967184|P2|Open Label (up to 24 Month)|Adverse Event|0
1512131|NCT00404352|4967185|P1|Open Label (up to 24 Month)|Adverse Event|0
1512132|NCT00404352|4967177|P9|Double Blind (up to 24 Month)|Other|0
1512133|NCT00404352|4967178|P8|Double Blind (up to 24 Month)|Other|0
1512134|NCT00404352|4967179|P7|Double Blind (up to 24 Month)|Other|0
1512135|NCT00404352|4967180|P6|Double Blind (up to 24 Month)|Other|0
1512136|NCT00404352|4967181|P5|Double Blind (up to 24 Month)|Other|0
1512137|NCT00404352|4967182|P4|Double Blind (up to 24 Month)|Other|0
1512138|NCT00404352|4967183|P3|Double Blind (up to 24 Month)|Other|0
1512139|NCT00404352|4967184|P2|Double Blind (up to 24 Month)|Other|1
1512140|NCT00404352|4967185|P1|Double Blind (up to 24 Month)|Other|0
1512141|NCT00404352|4967177|P9|Double Blind (up to 24 Month)|Physician Decision|0
1512142|NCT00404352|4967178|P8|Double Blind (up to 24 Month)|Physician Decision|0
1512143|NCT00404352|4967179|P7|Double Blind (up to 24 Month)|Physician Decision|0
1512144|NCT00404352|4967180|P6|Double Blind (up to 24 Month)|Physician Decision|0
1512145|NCT00404352|4967181|P5|Double Blind (up to 24 Month)|Physician Decision|0
1512146|NCT00404352|4967182|P4|Double Blind (up to 24 Month)|Physician Decision|0
1512147|NCT00404352|4967183|P3|Double Blind (up to 24 Month)|Physician Decision|1
1512148|NCT00404352|4967184|P2|Double Blind (up to 24 Month)|Physician Decision|0
1512149|NCT00404352|4967185|P1|Double Blind (up to 24 Month)|Physician Decision|0
1512150|NCT00404352|4967177|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
1512151|NCT00404352|4967178|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
1512152|NCT00404352|4967179|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
1512153|NCT00404352|4967180|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
1512154|NCT00404352|4967181|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
1512155|NCT00404352|4967182|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
1512156|NCT00404352|4967183|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
1512157|NCT00404352|4967184|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
1512158|NCT00404352|4967185|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
1512159|NCT00404352|4967177|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
1512160|NCT00404352|4967178|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
1512161|NCT00404352|4967179|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
1512162|NCT00404352|4967180|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
1512163|NCT00404352|4967181|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
1512164|NCT00404352|4967182|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
1512165|NCT00404352|4967183|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
1512166|NCT00404352|4967184|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
1512167|NCT00404352|4967185|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
1512168|NCT00404352|4967177|P9|Double Blind (up to 24 Month)|Poor compliance|0
1512169|NCT00404352|4967178|P8|Double Blind (up to 24 Month)|Poor compliance|0
1512170|NCT00404352|4967179|P7|Double Blind (up to 24 Month)|Poor compliance|0
1512171|NCT00404352|4967180|P6|Double Blind (up to 24 Month)|Poor compliance|0
1512172|NCT00404352|4967181|P5|Double Blind (up to 24 Month)|Poor compliance|0
1512173|NCT00404352|4967182|P4|Double Blind (up to 24 Month)|Poor compliance|0
1512174|NCT00404352|4967183|P3|Double Blind (up to 24 Month)|Poor compliance|0
1512175|NCT00404352|4967184|P2|Double Blind (up to 24 Month)|Poor compliance|0
1512176|NCT00404352|4967185|P1|Double Blind (up to 24 Month)|Poor compliance|1
1512177|NCT00404352|4967177|P9|Double Blind (up to 24 Month)|Disease progression|0
1512178|NCT00404352|4967178|P8|Double Blind (up to 24 Month)|Disease progression|0
1512179|NCT00404352|4967179|P7|Double Blind (up to 24 Month)|Disease progression|0
1512180|NCT00404352|4967180|P6|Double Blind (up to 24 Month)|Disease progression|0
1512181|NCT00404352|4967181|P5|Double Blind (up to 24 Month)|Disease progression|0
1512182|NCT00404352|4967182|P4|Double Blind (up to 24 Month)|Disease progression|0
1512183|NCT00404352|4967183|P3|Double Blind (up to 24 Month)|Disease progression|2
1512184|NCT00404352|4967184|P2|Double Blind (up to 24 Month)|Disease progression|0
1512185|NCT00404352|4967185|P1|Double Blind (up to 24 Month)|Disease progression|3
1512186|NCT00404352|4967177|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1512187|NCT00404352|4967178|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1512188|NCT00404352|4967179|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1512189|NCT00404352|4967180|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1512190|NCT00404352|4967181|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1512191|NCT00404352|4967182|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1512192|NCT00404352|4967183|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
1512193|NCT00404352|4967184|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
1512194|NCT00404352|4967185|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
1512195|NCT00404352|4967177|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
1512196|NCT00404352|4967178|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
1512197|NCT00404352|4967179|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
1512198|NCT00404352|4967180|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
1512199|NCT00404352|4967181|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
1512200|NCT00404352|4967182|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
1512201|NCT00404352|4967183|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
1512202|NCT00404352|4967184|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
1512203|NCT00404352|4967185|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
1512204|NCT00404352|4967177|P9|Double Blind (up to 24 Month)|Death|0
1512205|NCT00404352|4967178|P8|Double Blind (up to 24 Month)|Death|0
1512206|NCT00404352|4967179|P7|Double Blind (up to 24 Month)|Death|0
1512207|NCT00404352|4967180|P6|Double Blind (up to 24 Month)|Death|0
1512208|NCT00404352|4967181|P5|Double Blind (up to 24 Month)|Death|0
1512209|NCT00404352|4967182|P4|Double Blind (up to 24 Month)|Death|0
1512210|NCT00404352|4967183|P3|Double Blind (up to 24 Month)|Death|1
1512211|NCT00404352|4967184|P2|Double Blind (up to 24 Month)|Death|0
1512212|NCT00404352|4967185|P1|Double Blind (up to 24 Month)|Death|0
1512213|NCT00404352|4967177|P9|Double Blind (up to 24 Month)|Pregnancy|0
1512214|NCT00404352|4967178|P8|Double Blind (up to 24 Month)|Pregnancy|0
1512215|NCT00404352|4967179|P7|Double Blind (up to 24 Month)|Pregnancy|0
1512216|NCT00404352|4967180|P6|Double Blind (up to 24 Month)|Pregnancy|0
1512217|NCT00404352|4967181|P5|Double Blind (up to 24 Month)|Pregnancy|0
1512218|NCT00404352|4967182|P4|Double Blind (up to 24 Month)|Pregnancy|0
1512219|NCT00404352|4967183|P3|Double Blind (up to 24 Month)|Pregnancy|2
1512220|NCT00404352|4967184|P2|Double Blind (up to 24 Month)|Pregnancy|0
1512221|NCT00404352|4967185|P1|Double Blind (up to 24 Month)|Pregnancy|0
1512222|NCT00404352|4967177|P9|Double Blind (up to 24 Month)|Adverse Event|0
1512223|NCT00404352|4967178|P8|Double Blind (up to 24 Month)|Adverse Event|0
1512224|NCT00404352|4967179|P7|Double Blind (up to 24 Month)|Adverse Event|0
1512225|NCT00404352|4967180|P6|Double Blind (up to 24 Month)|Adverse Event|0
1512226|NCT00404352|4967181|P5|Double Blind (up to 24 Month)|Adverse Event|0
1512227|NCT00404352|4967182|P4|Double Blind (up to 24 Month)|Adverse Event|0
1512228|NCT00404352|4967183|P3|Double Blind (up to 24 Month)|Adverse Event|6
1512229|NCT00404352|4967184|P2|Double Blind (up to 24 Month)|Adverse Event|4
1512230|NCT00404352|4967185|P1|Double Blind (up to 24 Month)|Adverse Event|5
1512231|NCT00404248|4967220|P9|Overall Study|pts declining status|0
1512232|NCT00404248|4967221|P8|Overall Study|pts declining status|0
1512233|NCT00404248|4967222|P7|Overall Study|pts declining status|0
1512234|NCT00404248|4967223|P6|Overall Study|pts declining status|0
1512235|NCT00404248|4967224|P5|Overall Study|pts declining status|0
1512236|NCT00404248|4967225|P4|Overall Study|pts declining status|0
1512237|NCT00404248|4967226|P3|Overall Study|pts declining status|0
1512238|NCT00404248|4967227|P2|Overall Study|pts declining status|1
1512239|NCT00404248|4967228|P1|Overall Study|pts declining status|0
1512240|NCT00404092|4967263|P4|Overall Study|Adverse Event|0
1512241|NCT00404092|4967264|P3|Overall Study|Adverse Event|1
1512242|NCT00404092|4967265|P2|Overall Study|Adverse Event|0
1512243|NCT00404092|4967266|P1|Overall Study|Adverse Event|0
1512244|NCT00404092|4967263|P4|Overall Study|Death|0
1512245|NCT00404092|4967264|P3|Overall Study|Death|0
1512246|NCT00404092|4967265|P2|Overall Study|Death|0
1512247|NCT00404092|4967266|P1|Overall Study|Death|1
1512248|NCT00404079|4967282|P2|Overall Study|Lost to follow up, adverse event etc|20
1512249|NCT00404079|4967283|P1|Overall Study|Lost to follow up, adverse event etc|22
1512250|NCT00404066|4967289|P1|Overall Study|Withdrawal by Subject - Adverse event|2
1512251|NCT00404066|4967289|P1|Overall Study|Withdrawal by Subject - Pre-treatment|1
1512252|NCT00403845|4967294|P4|Treatment Period 3|Adverse Event|1
1512253|NCT00403845|4967295|P3|Treatment Period 3|Adverse Event|0
1512254|NCT00403845|4967296|P2|Treatment Period 3|Adverse Event|0
1512255|NCT00403845|4967297|P1|Treatment Period 3|Adverse Event|0
1512256|NCT00403845|4967294|P4|Treatment Period 3|Subject withdrew consent|1
1512257|NCT00403845|4967295|P3|Treatment Period 3|Subject withdrew consent|0
1512258|NCT00403845|4967296|P2|Treatment Period 3|Subject withdrew consent|0
1512259|NCT00403845|4967297|P1|Treatment Period 3|Subject withdrew consent|0
1512260|NCT00403845|4967294|P4|Treatment Period 2|Subject withdrew consent|0
1512261|NCT00403845|4967295|P3|Treatment Period 2|Subject withdrew consent|0
1512262|NCT00403845|4967296|P2|Treatment Period 2|Subject withdrew consent|0
1512263|NCT00403845|4967297|P1|Treatment Period 2|Subject withdrew consent|1
1512264|NCT00403845|4967294|P4|Treatment Period 1|Subject no longer needs study drug|1
1512265|NCT00403845|4967295|P3|Treatment Period 1|Subject no longer needs study drug|0
1512266|NCT00403845|4967296|P2|Treatment Period 1|Subject no longer needs study drug|0
1512267|NCT00403845|4967297|P1|Treatment Period 1|Subject no longer needs study drug|0
1512268|NCT00403845|4967294|P4|Treatment Period 1|Subject withdrew consent|0
1512269|NCT00403845|4967295|P3|Treatment Period 1|Subject withdrew consent|0
1512270|NCT00403845|4967296|P2|Treatment Period 1|Subject withdrew consent|0
1512271|NCT00403845|4967297|P1|Treatment Period 1|Subject withdrew consent|1
1512272|NCT00403767|4967321|P2|Overall Study|Missing/incomplete data|1
1512273|NCT00403767|4967322|P1|Overall Study|Missing/incomplete data|1
1512274|NCT00403767|4967321|P2|Overall Study|Study terminated by sponsor|69
1512275|NCT00403767|4967322|P1|Overall Study|Study terminated by sponsor|82
1512276|NCT00403767|4967321|P2|Overall Study|Clinical efficacy endpoint reached|332
1512277|NCT00403767|4967322|P1|Overall Study|Clinical efficacy endpoint reached|300
1512278|NCT00403767|4967321|P2|Overall Study|Protocol Violation|124
1512279|NCT00403767|4967322|P1|Overall Study|Protocol Violation|142
1512280|NCT00403767|4967321|P2|Overall Study|Lost to Follow-up|8
1512281|NCT00403767|4967322|P1|Overall Study|Lost to Follow-up|6
1512282|NCT00403767|4967321|P2|Overall Study|Investigator dec./not protocol-related|178
1512283|NCT00403767|4967322|P1|Overall Study|Investigator dec./not protocol-related|191
1512284|NCT00403767|4967321|P2|Overall Study|Consent withdrawn|673
1512285|NCT00403767|4967322|P1|Overall Study|Consent withdrawn|671
1512286|NCT00403767|4967321|P2|Overall Study|Non-compliant with study medication|164
1512287|NCT00403767|4967322|P1|Overall Study|Non-compliant with study medication|134
1512288|NCT00403767|4967321|P2|Overall Study|Adverse Event|919
1512289|NCT00403767|4967322|P1|Overall Study|Adverse Event|993
1512290|NCT00403754|4967346|P4|Core Treatment Period 2|Lack of Efficacy|0
1512291|NCT00403754|4967347|P3|Core Treatment Period 2|Lack of Efficacy|1
1512292|NCT00403754|4967348|P2|Core Treatment Period 2|Lack of Efficacy|0
1512293|NCT00403754|4967349|P1|Core Treatment Period 2|Lack of Efficacy|0
1512294|NCT00403754|4967346|P4|Core Treatment Period 1|Withdrawal by Subject|0
1512295|NCT00403754|4967347|P3|Core Treatment Period 1|Withdrawal by Subject|0
1512296|NCT00403754|4967348|P2|Core Treatment Period 1|Withdrawal by Subject|1
1512297|NCT00403754|4967349|P1|Core Treatment Period 1|Withdrawal by Subject|0
1512298|NCT00403585|4967376|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
1512299|NCT00403585|4967376|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
1512300|NCT00403585|4967376|P1|Initial Treatment Phase|Lost to Follow-up|2
1512301|NCT00403546|4967387|P3|Randomized Trial|Early Terminations|16
1512302|NCT00403546|4967388|P2|Randomized Trial|Early Terminations|17
1512303|NCT00403546|4967389|P1|Randomized Trial|Early Terminations|0
1512304|NCT00403546|4967387|P3|Screening Phase|Terminated Prior to Randomization|0
1512305|NCT00403546|4967388|P2|Screening Phase|Terminated Prior to Randomization|0
1512306|NCT00403546|4967389|P1|Screening Phase|Terminated Prior to Randomization|5
1512307|NCT00403546|4967387|P3|Screening Phase|Adverse Event|0
1512308|NCT00403546|4967388|P2|Screening Phase|Adverse Event|0
1512309|NCT00403546|4967389|P1|Screening Phase|Adverse Event|1
1512310|NCT00403546|4967387|P3|Screening Phase|Screening Failure|0
1512311|NCT00403546|4967388|P2|Screening Phase|Screening Failure|0
1512312|NCT00403546|4967389|P1|Screening Phase|Screening Failure|22
1512313|NCT00403546|4967387|P3|Signed Informed Consent/Open-Label|Adverse Event|0
1512314|NCT00403546|4967388|P2|Signed Informed Consent/Open-Label|Adverse Event|0
1512315|NCT00403546|4967389|P1|Signed Informed Consent/Open-Label|Adverse Event|5
1512316|NCT00403546|4967387|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
1512317|NCT00403546|4967388|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
1512318|NCT00403546|4967389|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
1512319|NCT00403546|4967387|P3|Signed Informed Consent/Open-Label|Early Termination|0
1512320|NCT00403546|4967388|P2|Signed Informed Consent/Open-Label|Early Termination|0
1512321|NCT00403546|4967389|P1|Signed Informed Consent/Open-Label|Early Termination|8
1512322|NCT00403546|4967387|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
1512323|NCT00403546|4967388|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
1512324|NCT00403546|4967389|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
1512325|NCT00403481|4967429|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
1512326|NCT00403481|4967429|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
1512327|NCT00403481|4967429|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
1512328|NCT00403481|4967429|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
1512329|NCT00403481|4967429|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
1512330|NCT00403481|4967429|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
1512331|NCT00403481|4967429|P1|Olm 40 mg|Other|1
1512332|NCT00403481|4967429|P1|Olm 40 mg|Withdrawal by Subject|1
1512333|NCT00403481|4967429|P1|Olm 40 mg|Protocol Violation|1
1512334|NCT00403481|4967429|P1|Olm 40 mg|Adverse Event|2
1512335|NCT00403481|4967429|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
1512336|NCT00403481|4967429|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
1512337|NCT00403481|4967429|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
1512338|NCT00403481|4967429|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
1512339|NCT00403455|4967444|P1|Overall Study|Withdrawal by Subject|1
1512340|NCT00403390|4967467|P2|Overall Study|non-compliant|0
1512341|NCT00403390|4967468|P1|Overall Study|non-compliant|1
1512342|NCT00403390|4967467|P2|Overall Study|samples lost|0
1512343|NCT00403390|4967468|P1|Overall Study|samples lost|1
1512344|NCT00403390|4967467|P2|Overall Study|Withdrawal by Subject|0
1512345|NCT00403390|4967468|P1|Overall Study|Withdrawal by Subject|1
1512346|NCT00403273|4967476|P2|Overall Study|pt. wanted to have a surgical procedure|1
1512347|NCT00403273|4967477|P1|Overall Study|pt. wanted to have a surgical procedure|0
1512348|NCT00403273|4967476|P2|Overall Study|Physician Decision|1
1512349|NCT00403273|4967477|P1|Overall Study|Physician Decision|0
1512350|NCT00403273|4967476|P2|Overall Study|Lost to Follow-up|2
1512351|NCT00403273|4967477|P1|Overall Study|Lost to Follow-up|3
1512352|NCT00403234|4967519|P4|Overall Study|Adverse Event|0
1512353|NCT00403234|4967520|P3|Overall Study|Adverse Event|1
1512354|NCT00403234|4967521|P2|Overall Study|Adverse Event|0
1512355|NCT00403234|4967522|P1|Overall Study|Adverse Event|1
1512356|NCT00403234|4967519|P4|Overall Study|Withdrawal by Subject|0
1512357|NCT00403234|4967520|P3|Overall Study|Withdrawal by Subject|0
1512358|NCT00403234|4967521|P2|Overall Study|Withdrawal by Subject|1
1512359|NCT00403234|4967522|P1|Overall Study|Withdrawal by Subject|0
1512360|NCT00403130|4967532|P1|Overall Study|Withdrawal by Subject|1
1512361|NCT00403130|4967532|P1|Overall Study|Lost to Follow up|1
1512362|NCT00403130|4967532|P1|Overall Study|Not Eligible|3
1512363|NCT00402987|4967585|P4|Overall Study|Lack of Efficacy|0
1512364|NCT00402987|4967586|P3|Overall Study|Lack of Efficacy|1
1512365|NCT00402987|4967587|P2|Overall Study|Lack of Efficacy|0
1512366|NCT00402987|4967588|P1|Overall Study|Lack of Efficacy|0
1512367|NCT00402831|4967760|P2|Overall Study|Non-compliance with protocol|1
1512368|NCT00402831|4967761|P1|Overall Study|Non-compliance with protocol|0
1512369|NCT00402831|4967760|P2|Overall Study|Lost to Follow-up|2
1512370|NCT00402831|4967761|P1|Overall Study|Lost to Follow-up|1
1512371|NCT00402740|4967793|P1|Overall Study|Subject disposition unknown.|1
1512372|NCT00402740|4967793|P1|Overall Study|No stent. Completed FU at 30 days.|5
1512373|NCT00402740|4967793|P1|Overall Study|Lost to Follow-up|6
1512374|NCT00402740|4967793|P1|Overall Study|Death|50
1512375|NCT00402740|4967793|P1|Overall Study|Withdrawal by Subject|18
1512376|NCT00402727|4967805|P2|Overall Study|non-compliance|1
1512377|NCT00402727|4967806|P1|Overall Study|non-compliance|0
1512378|NCT00402727|4967805|P2|Overall Study|supply problems|1
1512379|NCT00402727|4967806|P1|Overall Study|supply problems|2
1512380|NCT00402727|4967805|P2|Overall Study|Withdrawal by Subject|7
1512381|NCT00402727|4967806|P1|Overall Study|Withdrawal by Subject|3
1512382|NCT00402727|4967805|P2|Overall Study|Protocol Violation|4
1512383|NCT00402727|4967806|P1|Overall Study|Protocol Violation|0
1512384|NCT00402727|4967805|P2|Overall Study|Physician Decision|1
1512385|NCT00402727|4967806|P1|Overall Study|Physician Decision|1
1512386|NCT00402727|4967805|P2|Overall Study|Lost to Follow-up|11
1512387|NCT00402727|4967806|P1|Overall Study|Lost to Follow-up|24
1512388|NCT00402727|4967805|P2|Overall Study|Lack of Efficacy|3
1512389|NCT00402727|4967806|P1|Overall Study|Lack of Efficacy|1
1512390|NCT00402727|4967805|P2|Overall Study|Death|0
1512391|NCT00402727|4967806|P1|Overall Study|Death|1
1512392|NCT00402727|4967805|P2|Overall Study|Adverse Event|6
1512393|NCT00402727|4967806|P1|Overall Study|Adverse Event|10
1512394|NCT00402688|4967848|P3|Overall Study|Patient Left Town and Forgot Medication|1
1512395|NCT00402688|4967849|P2|Overall Study|Patient Left Town and Forgot Medication|0
1512396|NCT00402688|4967850|P1|Overall Study|Patient Left Town and Forgot Medication|0
1512397|NCT00402688|4967848|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
1512398|NCT00402688|4967849|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
1512399|NCT00402688|4967850|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
1512400|NCT00402688|4967848|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
1512401|NCT00402688|4967849|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
1512402|NCT00402688|4967850|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
1512403|NCT00402688|4967848|P3|Overall Study|Lost to Follow-up|2
1512404|NCT00402688|4967849|P2|Overall Study|Lost to Follow-up|0
1512405|NCT00402688|4967850|P1|Overall Study|Lost to Follow-up|1
1512406|NCT00402688|4967848|P3|Overall Study|Protocol Violation|1
1512407|NCT00402688|4967849|P2|Overall Study|Protocol Violation|1
1512408|NCT00402688|4967850|P1|Overall Study|Protocol Violation|1
1512409|NCT00402688|4967848|P3|Overall Study|Lack of Efficacy|5
1512410|NCT00402688|4967849|P2|Overall Study|Lack of Efficacy|4
1512411|NCT00402688|4967850|P1|Overall Study|Lack of Efficacy|4
1512412|NCT00402688|4967848|P3|Overall Study|Physician Decision|1
1512413|NCT00402688|4967849|P2|Overall Study|Physician Decision|0
1512414|NCT00402688|4967850|P1|Overall Study|Physician Decision|0
1512415|NCT00402688|4967848|P3|Overall Study|Withdrawal by Subject|1
1512416|NCT00402688|4967849|P2|Overall Study|Withdrawal by Subject|1
1512417|NCT00402688|4967850|P1|Overall Study|Withdrawal by Subject|3
1512418|NCT00402688|4967848|P3|Overall Study|Adverse Event|3
1512419|NCT00402688|4967849|P2|Overall Study|Adverse Event|9
1512420|NCT00402688|4967850|P1|Overall Study|Adverse Event|12
1512421|NCT00402649|4967873|P1|Overall Study|Withdrawal by Subject|1
1512422|NCT00402649|4967873|P1|Overall Study|Lost to Follow-up|1
1512423|NCT00402597|4967888|P5|Overall Study|reason not specified|20
1512424|NCT00402597|4967889|P4|Overall Study|reason not specified|14
1512425|NCT00402597|4967890|P3|Overall Study|reason not specified|27
1512426|NCT00402597|4967891|P2|Overall Study|reason not specified|4
1512427|NCT00402597|4967892|P1|Overall Study|reason not specified|30
1512428|NCT00402597|4967888|P5|Overall Study|Withdrawal by Subject|24
1512429|NCT00402597|4967889|P4|Overall Study|Withdrawal by Subject|15
1512430|NCT00402597|4967890|P3|Overall Study|Withdrawal by Subject|65
1512431|NCT00402597|4967891|P2|Overall Study|Withdrawal by Subject|16
1512432|NCT00402597|4967892|P1|Overall Study|Withdrawal by Subject|57
1512433|NCT00402597|4967888|P5|Overall Study|Lost to Follow-up|3
1512434|NCT00402597|4967889|P4|Overall Study|Lost to Follow-up|2
1512435|NCT00402597|4967890|P3|Overall Study|Lost to Follow-up|8
1512436|NCT00402597|4967891|P2|Overall Study|Lost to Follow-up|1
1512437|NCT00402597|4967892|P1|Overall Study|Lost to Follow-up|8
1512438|NCT00402597|4967888|P5|Overall Study|Adverse Event|71
1512439|NCT00402597|4967889|P4|Overall Study|Adverse Event|39
1512440|NCT00402597|4967890|P3|Overall Study|Adverse Event|106
1512441|NCT00402597|4967891|P2|Overall Study|Adverse Event|18
1512442|NCT00402597|4967892|P1|Overall Study|Adverse Event|81
1512443|NCT00402597|4967888|P5|Overall Study|Death|6
1512444|NCT00402597|4967889|P4|Overall Study|Death|4
1512445|NCT00402597|4967890|P3|Overall Study|Death|6
1512446|NCT00402597|4967891|P2|Overall Study|Death|7
1512447|NCT00402597|4967892|P1|Overall Study|Death|15
1512448|NCT00402363|4967933|P4|Overall Study|"Captured as Other"|2
1512449|NCT00402363|4967934|P3|Overall Study|"Captured as Other"|2
1512450|NCT00402363|4967935|P2|Overall Study|"Captured as Other"|2
1512451|NCT00402363|4967936|P1|Overall Study|"Captured as Other"|6
1512452|NCT00402363|4967933|P4|Overall Study|Lost to Follow-up|2
1512453|NCT00402363|4967934|P3|Overall Study|Lost to Follow-up|0
1512454|NCT00402363|4967935|P2|Overall Study|Lost to Follow-up|4
1512455|NCT00402363|4967936|P1|Overall Study|Lost to Follow-up|5
1512456|NCT00402363|4967933|P4|Overall Study|Protocol Violation|3
1512457|NCT00402363|4967934|P3|Overall Study|Protocol Violation|0
1512458|NCT00402363|4967935|P2|Overall Study|Protocol Violation|5
1512459|NCT00402363|4967936|P1|Overall Study|Protocol Violation|3
1512460|NCT00402363|4967933|P4|Overall Study|Withdrew Consent|1
1512461|NCT00402363|4967934|P3|Overall Study|Withdrew Consent|2
1512462|NCT00402363|4967935|P2|Overall Study|Withdrew Consent|5
1512463|NCT00402363|4967936|P1|Overall Study|Withdrew Consent|10
1512464|NCT00402363|4967933|P4|Overall Study|Adverse Event|2
1512465|NCT00402363|4967934|P3|Overall Study|Adverse Event|2
1512466|NCT00402363|4967935|P2|Overall Study|Adverse Event|14
1512467|NCT00402363|4967936|P1|Overall Study|Adverse Event|9
1512468|NCT00402337|4967999|P5|Overall Study|Other Reason|0
1512469|NCT00402337|4968000|P4|Overall Study|Other Reason|0
1512470|NCT00402337|4968001|P3|Overall Study|Other Reason|0
1512471|NCT00402337|4968002|P2|Overall Study|Other Reason|1
1512472|NCT00402337|4968003|P1|Overall Study|Other Reason|0
1512473|NCT00402337|4967999|P5|Overall Study|Physician Decision|0
1512474|NCT00402337|4968000|P4|Overall Study|Physician Decision|1
1512475|NCT00402337|4968001|P3|Overall Study|Physician Decision|0
1512476|NCT00402337|4968002|P2|Overall Study|Physician Decision|0
1512477|NCT00402337|4968003|P1|Overall Study|Physician Decision|0
1512478|NCT00402337|4967999|P5|Overall Study|Lost to Follow-up|0
1512479|NCT00402337|4968000|P4|Overall Study|Lost to Follow-up|2
1512480|NCT00402337|4968001|P3|Overall Study|Lost to Follow-up|1
1512481|NCT00402337|4968002|P2|Overall Study|Lost to Follow-up|0
1512482|NCT00402337|4968003|P1|Overall Study|Lost to Follow-up|0
1512483|NCT00402337|4967999|P5|Overall Study|Withdrawal by Subject|4
1512484|NCT00402337|4968000|P4|Overall Study|Withdrawal by Subject|6
1512485|NCT00402337|4968001|P3|Overall Study|Withdrawal by Subject|1
1512486|NCT00402337|4968002|P2|Overall Study|Withdrawal by Subject|3
1512487|NCT00402337|4968003|P1|Overall Study|Withdrawal by Subject|5
1512488|NCT00402337|4967999|P5|Overall Study|Noncompliance|2
1512489|NCT00402337|4968000|P4|Overall Study|Noncompliance|0
1512490|NCT00402337|4968001|P3|Overall Study|Noncompliance|0
1512491|NCT00402337|4968002|P2|Overall Study|Noncompliance|0
1512492|NCT00402337|4968003|P1|Overall Study|Noncompliance|0
1512493|NCT00402337|4967999|P5|Overall Study|Adverse Event|2
1512494|NCT00402337|4968000|P4|Overall Study|Adverse Event|3
1512495|NCT00402337|4968001|P3|Overall Study|Adverse Event|2
1512496|NCT00402337|4968002|P2|Overall Study|Adverse Event|2
1512497|NCT00402337|4968003|P1|Overall Study|Adverse Event|0
1512498|NCT00402324|4968042|P2|Overall Study|Death|0
1512499|NCT00402324|4968043|P1|Overall Study|Death|1
1512500|NCT00402324|4968042|P2|Overall Study|Adverse Event|4
1512501|NCT00402324|4968043|P1|Overall Study|Adverse Event|6
1512502|NCT00402324|4968042|P2|Overall Study|Lack of Efficacy|4
1512503|NCT00402324|4968043|P1|Overall Study|Lack of Efficacy|1
1512504|NCT00402324|4968042|P2|Overall Study|Sponsor Decision|5
1512505|NCT00402324|4968043|P1|Overall Study|Sponsor Decision|4
1512506|NCT00402324|4968042|P2|Overall Study|Physician Decision|4
1512507|NCT00402324|4968043|P1|Overall Study|Physician Decision|2
1512508|NCT00402324|4968042|P2|Overall Study|Withdrawal by Subject|2
1512509|NCT00402324|4968043|P1|Overall Study|Withdrawal by Subject|5
1512510|NCT00402324|4968042|P2|Overall Study|Protocol Violation|7
1512511|NCT00402324|4968043|P1|Overall Study|Protocol Violation|8
1512512|NCT00402324|4968042|P2|Overall Study|Protocol Entry Criteria Not Met|4
1512513|NCT00402324|4968043|P1|Overall Study|Protocol Entry Criteria Not Met|5
1512514|NCT00402324|4968042|P2|Overall Study|Lost to Follow-up|11
1512515|NCT00402324|4968043|P1|Overall Study|Lost to Follow-up|11
1512516|NCT00402285|4968076|P3|Overall Study|insufficient RNA quality|2
1512517|NCT00402285|4968077|P2|Overall Study|insufficient RNA quality|6
1512518|NCT00402285|4968078|P1|Overall Study|insufficient RNA quality|7
1512519|NCT00402246|4968086|P2|Overall Study|Deterioriating Condition|2
1512520|NCT00402246|4968087|P1|Overall Study|Deterioriating Condition|3
1512521|NCT00402246|4968086|P2|Overall Study|Center Closure|3
1512522|NCT00402246|4968087|P1|Overall Study|Center Closure|5
1512523|NCT00402246|4968086|P2|Overall Study|Patient's device explanted|2
1512524|NCT00402246|4968087|P1|Overall Study|Patient's device explanted|6
1512525|NCT00402246|4968086|P2|Overall Study|Heart Transplant|1
1512526|NCT00402246|4968087|P1|Overall Study|Heart Transplant|0
1512527|NCT00402246|4968086|P2|Overall Study|Insurance Issues|1
1512528|NCT00402246|4968087|P1|Overall Study|Insurance Issues|2
1512529|NCT00402246|4968086|P2|Overall Study|Missed Final Visit|2
1512530|NCT00402246|4968087|P1|Overall Study|Missed Final Visit|1
1512531|NCT00402246|4968086|P2|Overall Study|Protocol Violation|24
1512532|NCT00402246|4968087|P1|Overall Study|Protocol Violation|25
1512533|NCT00402246|4968086|P2|Overall Study|Physician Decision|26
1512534|NCT00402246|4968087|P1|Overall Study|Physician Decision|24
1512535|NCT00402246|4968086|P2|Overall Study|Withdrawal by Subject|87
1512536|NCT00402246|4968087|P1|Overall Study|Withdrawal by Subject|72
1512537|NCT00402246|4968086|P2|Overall Study|Lost to Follow-up|28
1512538|NCT00402246|4968087|P1|Overall Study|Lost to Follow-up|20
1512539|NCT00402246|4968086|P2|Overall Study|Death|58
1512540|NCT00402246|4968087|P1|Overall Study|Death|62
1512541|NCT00402233|4968121|P4|Overall Study|Worsening of other pre-existing disease|0
1512542|NCT00402233|4968122|P3|Overall Study|Worsening of other pre-existing disease|0
1512543|NCT00402233|4968123|P2|Overall Study|Worsening of other pre-existing disease|1
1512544|NCT00402233|4968124|P1|Overall Study|Worsening of other pre-existing disease|0
1512545|NCT00402233|4968121|P4|Overall Study|Worsening of disease under study|0
1512546|NCT00402233|4968122|P3|Overall Study|Worsening of disease under study|0
1512547|NCT00402233|4968123|P2|Overall Study|Worsening of disease under study|0
1512548|NCT00402233|4968124|P1|Overall Study|Worsening of disease under study|2
1512549|NCT00402233|4968121|P4|Overall Study|Withdrawal by Subject|2
1512550|NCT00402233|4968122|P3|Overall Study|Withdrawal by Subject|2
1512551|NCT00402233|4968123|P2|Overall Study|Withdrawal by Subject|1
1512552|NCT00402233|4968124|P1|Overall Study|Withdrawal by Subject|2
1512553|NCT00402233|4968121|P4|Overall Study|Protocol Violation|0
1512554|NCT00402233|4968122|P3|Overall Study|Protocol Violation|0
1512555|NCT00402233|4968123|P2|Overall Study|Protocol Violation|1
1512556|NCT00402233|4968124|P1|Overall Study|Protocol Violation|0
1512557|NCT00402233|4968121|P4|Overall Study|Adverse Event|9
1512558|NCT00402233|4968122|P3|Overall Study|Adverse Event|9
1512559|NCT00402233|4968123|P2|Overall Study|Adverse Event|7
1512560|NCT00402233|4968124|P1|Overall Study|Adverse Event|1
1512561|NCT00402168|4968159|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
1512562|NCT00402168|4968160|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
1512563|NCT00402168|4968159|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
1512564|NCT00402168|4968160|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
1512565|NCT00402168|4968159|P2|Long Term (LT)|non-specified|2
1512566|NCT00402168|4968160|P1|Long Term (LT)|non-specified|1
1512567|NCT00402168|4968159|P2|Long Term (LT)|Lack of Efficacy|2
1512568|NCT00402168|4968160|P1|Long Term (LT)|Lack of Efficacy|0
1512569|NCT00402168|4968159|P2|Long Term (LT)|Death|0
1512570|NCT00402168|4968160|P1|Long Term (LT)|Death|4
1512571|NCT00402168|4968159|P2|Long Term (LT)|Lost to Follow-up|0
1512572|NCT00402168|4968160|P1|Long Term (LT)|Lost to Follow-up|1
1512573|NCT00402168|4968159|P2|Long Term (LT)|Pregnancy|1
1512574|NCT00402168|4968160|P1|Long Term (LT)|Pregnancy|0
1512575|NCT00402168|4968159|P2|Long Term (LT)|Withdrawal by Subject|7
1512576|NCT00402168|4968160|P1|Long Term (LT)|Withdrawal by Subject|4
1512577|NCT00402168|4968159|P2|Long Term (LT)|Adverse Event|5
1512578|NCT00402168|4968160|P1|Long Term (LT)|Adverse Event|1
1512579|NCT00402168|4968159|P2|Treatment (up to 12 Months)|non-specified|1
1512580|NCT00402168|4968160|P1|Treatment (up to 12 Months)|non-specified|0
1512581|NCT00402168|4968159|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
1512582|NCT00402168|4968160|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
1512583|NCT00402168|4968159|P2|Treatment (up to 12 Months)|Death|1
1512584|NCT00402168|4968160|P1|Treatment (up to 12 Months)|Death|0
1512585|NCT00402168|4968159|P2|Randomized|Withdrawal by Subject|1
1512586|NCT00402168|4968160|P1|Randomized|Withdrawal by Subject|0
1512587|NCT00402168|4968159|P2|Randomized|Lost to Follow-up|0
1512588|NCT00402168|4968160|P1|Randomized|Lost to Follow-up|1
1512589|NCT00402103|4968217|P2|Overall Study|Administrative problems|0
1512590|NCT00402103|4968218|P1|Overall Study|Administrative problems|2
1512591|NCT00402103|4968217|P2|Overall Study|Lost to Follow-up|3
1512592|NCT00402103|4968218|P1|Overall Study|Lost to Follow-up|6
1512593|NCT00402103|4968217|P2|Overall Study|Patient withdrew consent|1
1512594|NCT00402103|4968218|P1|Overall Study|Patient withdrew consent|12
1512595|NCT00402103|4968217|P2|Overall Study|Protocol Deviation|0
1512596|NCT00402103|4968218|P1|Overall Study|Protocol Deviation|8
1512597|NCT00402103|4968217|P2|Overall Study|Condition no longer requires study drug|0
1512598|NCT00402103|4968218|P1|Overall Study|Condition no longer requires study drug|2
1512599|NCT00402103|4968217|P2|Overall Study|Unsatisfactory therapeutic effect|2
1512600|NCT00402103|4968218|P1|Overall Study|Unsatisfactory therapeutic effect|1
1512601|NCT00402103|4968217|P2|Overall Study|Adverse Event|7
1512602|NCT00402103|4968218|P1|Overall Study|Adverse Event|60
1512603|NCT00402051|4968234|P2|Overall Study|Lost to Follow-up|0
1512604|NCT00402051|4968235|P1|Overall Study|Lost to Follow-up|1
1512605|NCT00402051|4968234|P2|Overall Study|Death Due to Adverse Event|2
1512606|NCT00402051|4968235|P1|Overall Study|Death Due to Adverse Event|0
1512607|NCT00402051|4968234|P2|Overall Study|Death Due to Study Disease|1
1512608|NCT00402051|4968235|P1|Overall Study|Death Due to Study Disease|2
1512609|NCT00402051|4968234|P2|Overall Study|Death - Related to Study Drug|2
1512610|NCT00402051|4968235|P1|Overall Study|Death - Related to Study Drug|1
1512611|NCT00402051|4968234|P2|Overall Study|Withdrawal by Subject|3
1512612|NCT00402051|4968235|P1|Overall Study|Withdrawal by Subject|3
1512613|NCT00402051|4968234|P2|Overall Study|Physician Decision|3
1512614|NCT00402051|4968235|P1|Overall Study|Physician Decision|7
1512615|NCT00402051|4968234|P2|Overall Study|Adverse Event|4
1512616|NCT00402051|4968235|P1|Overall Study|Adverse Event|11
1512617|NCT00402051|4968234|P2|Overall Study|Progressive Disease|20
1512618|NCT00402051|4968235|P1|Overall Study|Progressive Disease|13
1512619|NCT00402025|4968252|P3|Overall Study|Participant Decision|1
1512620|NCT00402025|4968253|P2|Overall Study|Participant Decision|0
1512621|NCT00402025|4968254|P1|Overall Study|Participant Decision|0
1512622|NCT00402025|4968252|P3|Overall Study|Physician Decision|0
1512623|NCT00402025|4968253|P2|Overall Study|Physician Decision|1
1512624|NCT00402025|4968254|P1|Overall Study|Physician Decision|1
1512625|NCT00402025|4968252|P3|Overall Study|Disease Progression|2
1512626|NCT00402025|4968253|P2|Overall Study|Disease Progression|1
1512627|NCT00402025|4968254|P1|Overall Study|Disease Progression|1
1512628|NCT00402025|4968252|P3|Overall Study|Death|5
1512629|NCT00402025|4968253|P2|Overall Study|Death|1
1512630|NCT00402025|4968254|P1|Overall Study|Death|0
1512631|NCT00402025|4968252|P3|Overall Study|Adverse Event|2
1512632|NCT00402025|4968253|P2|Overall Study|Adverse Event|0
1512633|NCT00402025|4968254|P1|Overall Study|Adverse Event|0
1512634|NCT00401973|4968280|P3|Overall Study|Withdrawal by Subject|9
1512635|NCT00401973|4968281|P2|Overall Study|Withdrawal by Subject|12
1512636|NCT00401973|4968282|P1|Overall Study|Withdrawal by Subject|4
1512637|NCT00401973|4968280|P3|Overall Study|Sponsor Decision|0
1512638|NCT00401973|4968281|P2|Overall Study|Sponsor Decision|1
1512639|NCT00401973|4968282|P1|Overall Study|Sponsor Decision|0
1512640|NCT00401973|4968280|P3|Overall Study|Protocol Violation|3
1512641|NCT00401973|4968281|P2|Overall Study|Protocol Violation|2
1512642|NCT00401973|4968282|P1|Overall Study|Protocol Violation|1
1512643|NCT00401973|4968280|P3|Overall Study|Physician Decision|1
1512644|NCT00401973|4968281|P2|Overall Study|Physician Decision|0
1512645|NCT00401973|4968282|P1|Overall Study|Physician Decision|2
1512646|NCT00401973|4968280|P3|Overall Study|Lost to Follow-up|2
1512647|NCT00401973|4968281|P2|Overall Study|Lost to Follow-up|2
1512648|NCT00401973|4968282|P1|Overall Study|Lost to Follow-up|2
1512649|NCT00401973|4968280|P3|Overall Study|Lack of Efficacy|3
1512650|NCT00401973|4968281|P2|Overall Study|Lack of Efficacy|0
1512651|NCT00401973|4968282|P1|Overall Study|Lack of Efficacy|0
1512652|NCT00401973|4968280|P3|Overall Study|Clinical Relapse|1
1512653|NCT00401973|4968281|P2|Overall Study|Clinical Relapse|1
1512654|NCT00401973|4968282|P1|Overall Study|Clinical Relapse|0
1512655|NCT00401973|4968280|P3|Overall Study|Adverse Event|4
1512656|NCT00401973|4968281|P2|Overall Study|Adverse Event|8
1512657|NCT00401973|4968282|P1|Overall Study|Adverse Event|2
1512658|NCT00401960|4968321|P2|Overall Study|Death|0
1512659|NCT00401960|4968322|P1|Overall Study|Death|2
1512660|NCT00401960|4968321|P2|Overall Study|Lost to Follow-up|0
1512661|NCT00401960|4968322|P1|Overall Study|Lost to Follow-up|3
1512662|NCT00401843|4968352|P3|Overall Study|Received incorrect treatment|0
1512663|NCT00401843|4968353|P2|Overall Study|Received incorrect treatment|3
1512664|NCT00401843|4968354|P1|Overall Study|Received incorrect treatment|0
1512665|NCT00401843|4968352|P3|Overall Study|Randomized but not Treated|3
1512666|NCT00401843|4968353|P2|Overall Study|Randomized but not Treated|2
1512667|NCT00401843|4968354|P1|Overall Study|Randomized but not Treated|0
1512668|NCT00401843|4968352|P3|Overall Study|Withdrawal of consent to study agent|17
1512669|NCT00401843|4968353|P2|Overall Study|Withdrawal of consent to study agent|15
1512670|NCT00401843|4968354|P1|Overall Study|Withdrawal of consent to study agent|1
1512671|NCT00401843|4968352|P3|Overall Study|Withdrawal by Subject|5
1512672|NCT00401843|4968353|P2|Overall Study|Withdrawal by Subject|5
1512673|NCT00401843|4968354|P1|Overall Study|Withdrawal by Subject|1
1512674|NCT00401843|4968352|P3|Overall Study|Protocol Violation|1
1512675|NCT00401843|4968353|P2|Overall Study|Protocol Violation|0
1512676|NCT00401843|4968354|P1|Overall Study|Protocol Violation|0
1512677|NCT00401843|4968352|P3|Overall Study|Physician Decision|10
1512678|NCT00401843|4968353|P2|Overall Study|Physician Decision|16
1512679|NCT00401843|4968354|P1|Overall Study|Physician Decision|0
1512680|NCT00401843|4968352|P3|Overall Study|Other Unspecified|5
1512681|NCT00401843|4968353|P2|Overall Study|Other Unspecified|3
1512682|NCT00401843|4968354|P1|Overall Study|Other Unspecified|0
1512683|NCT00401843|4968352|P3|Overall Study|Lost to Follow-up|2
1512684|NCT00401843|4968353|P2|Overall Study|Lost to Follow-up|0
1512685|NCT00401843|4968354|P1|Overall Study|Lost to Follow-up|0
1512686|NCT00401843|4968352|P3|Overall Study|End of Study|2
1512687|NCT00401843|4968353|P2|Overall Study|End of Study|1
1512688|NCT00401843|4968354|P1|Overall Study|End of Study|1
1512689|NCT00401843|4968352|P3|Overall Study|Disease progression|49
1512690|NCT00401843|4968353|P2|Overall Study|Disease progression|60
1512691|NCT00401843|4968354|P1|Overall Study|Disease progression|10
1512692|NCT00401843|4968352|P3|Overall Study|Death|10
1512693|NCT00401843|4968353|P2|Overall Study|Death|8
1512694|NCT00401843|4968354|P1|Overall Study|Death|0
1512695|NCT00401843|4968352|P3|Overall Study|Adverse Event|27
1512696|NCT00401843|4968353|P2|Overall Study|Adverse Event|26
1512697|NCT00401843|4968354|P1|Overall Study|Adverse Event|7
1512698|NCT00401843|4968352|P3|Overall Study|Achieved Complete Response|11
1512699|NCT00401843|4968353|P2|Overall Study|Achieved Complete Response|5
1512700|NCT00401843|4968354|P1|Overall Study|Achieved Complete Response|1
1512701|NCT00401830|4968372|P2|Overall Study|Other: Personal / Family problems|0
1512702|NCT00401830|4968373|P1|Overall Study|Other: Personal / Family problems|1
1512703|NCT00401830|4968372|P2|Overall Study|Lost to Follow-up|3
1512704|NCT00401830|4968373|P1|Overall Study|Lost to Follow-up|1
1512705|NCT00401830|4968372|P2|Overall Study|Non-compliance with drug study|0
1512706|NCT00401830|4968373|P1|Overall Study|Non-compliance with drug study|1
1512707|NCT00401830|4968372|P2|Overall Study|Protocol Violation|3
1512708|NCT00401830|4968373|P1|Overall Study|Protocol Violation|3
1512709|NCT00401830|4968372|P2|Overall Study|Withdrawal by Subject|3
1512710|NCT00401830|4968373|P1|Overall Study|Withdrawal by Subject|4
1512711|NCT00401830|4968372|P2|Overall Study|Lack of Efficacy|5
1512712|NCT00401830|4968373|P1|Overall Study|Lack of Efficacy|11
1512713|NCT00401830|4968372|P2|Overall Study|Adverse Event|18
1512714|NCT00401830|4968373|P1|Overall Study|Adverse Event|10
1512715|NCT00401752|4968431|P2|Overall Study|Physician Decision|1
1512716|NCT00401752|4968432|P1|Overall Study|Physician Decision|1
1512717|NCT00401752|4968431|P2|Overall Study|Development of any exclusion criteria|2
1512718|NCT00401752|4968432|P1|Overall Study|Development of any exclusion criteria|4
1512719|NCT00401752|4968431|P2|Overall Study|Lost to Follow-up|4
1512720|NCT00401752|4968432|P1|Overall Study|Lost to Follow-up|1
1512721|NCT00401752|4968431|P2|Overall Study|Withdrawal by Subject|6
1512722|NCT00401752|4968432|P1|Overall Study|Withdrawal by Subject|2
1512723|NCT00401752|4968431|P2|Overall Study|Adverse Event|5
1512724|NCT00401752|4968432|P1|Overall Study|Adverse Event|2
1512725|NCT00401726|4968450|P2|Overall Study|Protocol Deviation|4
1512726|NCT00401726|4968451|P1|Overall Study|Protocol Deviation|9
1512727|NCT00401726|4968450|P2|Overall Study|Lack of Efficacy|6
1512728|NCT00401726|4968451|P1|Overall Study|Lack of Efficacy|4
1512729|NCT00401726|4968450|P2|Overall Study|Withdrawal by Subject|24
1512730|NCT00401726|4968451|P1|Overall Study|Withdrawal by Subject|18
1512731|NCT00401726|4968450|P2|Overall Study|Protocol Violation|3
1512732|NCT00401726|4968451|P1|Overall Study|Protocol Violation|6
1512733|NCT00401726|4968450|P2|Overall Study|Lost to Follow-up|20
1512734|NCT00401726|4968451|P1|Overall Study|Lost to Follow-up|23
1512735|NCT00401726|4968450|P2|Overall Study|Physician Decision|6
1512736|NCT00401726|4968451|P1|Overall Study|Physician Decision|3
1512737|NCT00401726|4968450|P2|Overall Study|Sponsor Request|1
1512738|NCT00401726|4968451|P1|Overall Study|Sponsor Request|0
1512739|NCT00401726|4968450|P2|Overall Study|Death|3
1512740|NCT00401726|4968451|P1|Overall Study|Death|0
1512741|NCT00401726|4968450|P2|Overall Study|Adverse Event|45
1512742|NCT00401726|4968451|P1|Overall Study|Adverse Event|34
1512743|NCT00401544|4968486|P4|Overall Study|Other|2
1512744|NCT00401544|4968487|P3|Overall Study|Other|2
1512745|NCT00401544|4968488|P2|Overall Study|Other|0
1512746|NCT00401544|4968489|P1|Overall Study|Other|0
1512747|NCT00401544|4968486|P4|Overall Study|Disease progression|0
1512748|NCT00401544|4968487|P3|Overall Study|Disease progression|0
1512749|NCT00401544|4968488|P2|Overall Study|Disease progression|1
1512750|NCT00401544|4968489|P1|Overall Study|Disease progression|0
1512751|NCT00401544|4968486|P4|Overall Study|Ineligibility determined|2
1512752|NCT00401544|4968487|P3|Overall Study|Ineligibility determined|0
1512753|NCT00401544|4968488|P2|Overall Study|Ineligibility determined|1
1512754|NCT00401544|4968489|P1|Overall Study|Ineligibility determined|0
1512755|NCT00401544|4968486|P4|Overall Study|Physician Decision|0
1512756|NCT00401544|4968487|P3|Overall Study|Physician Decision|0
1512757|NCT00401544|4968488|P2|Overall Study|Physician Decision|3
1512758|NCT00401544|4968489|P1|Overall Study|Physician Decision|1
1512759|NCT00401544|4968486|P4|Overall Study|Withdrawal by Subject|5
1512760|NCT00401544|4968487|P3|Overall Study|Withdrawal by Subject|6
1512761|NCT00401544|4968488|P2|Overall Study|Withdrawal by Subject|6
1512762|NCT00401544|4968489|P1|Overall Study|Withdrawal by Subject|7
1512763|NCT00401544|4968486|P4|Overall Study|Lost to Follow-up|1
1512764|NCT00401544|4968487|P3|Overall Study|Lost to Follow-up|1
1512765|NCT00401544|4968488|P2|Overall Study|Lost to Follow-up|0
1512766|NCT00401544|4968489|P1|Overall Study|Lost to Follow-up|2
1512767|NCT00401544|4968486|P4|Overall Study|Death|5
1512768|NCT00401544|4968487|P3|Overall Study|Death|2
1512769|NCT00401544|4968488|P2|Overall Study|Death|6
1512770|NCT00401544|4968489|P1|Overall Study|Death|3
1512771|NCT00401544|4968486|P4|Overall Study|Adverse Event|1
1512772|NCT00401544|4968487|P3|Overall Study|Adverse Event|1
1512773|NCT00401544|4968488|P2|Overall Study|Adverse Event|1
1512774|NCT00401544|4968489|P1|Overall Study|Adverse Event|5
1512775|NCT00401531|4968529|P2|Overall Study|Withdrawal by Subject|2
1512776|NCT00401531|4968530|P1|Overall Study|Withdrawal by Subject|3
1512777|NCT00401531|4968529|P2|Overall Study|Lost to Follow-up|1
1512778|NCT00401531|4968530|P1|Overall Study|Lost to Follow-up|1
1512779|NCT00401531|4968529|P2|Overall Study|Protocol Violation|7
1512780|NCT00401531|4968530|P1|Overall Study|Protocol Violation|3
1512781|NCT00401531|4968529|P2|Overall Study|Adverse Event|0
1512782|NCT00401531|4968530|P1|Overall Study|Adverse Event|2
1512783|NCT00401258|4968600|P1|Overall Study|Adverse Event|7
1512784|NCT00401245|4968615|P8|Double Blind Tapering Phase|Lack of Efficacy|0
1512785|NCT00401245|4968616|P7|Double Blind Tapering Phase|Lack of Efficacy|0
1512786|NCT00401245|4968617|P6|Double Blind Tapering Phase|Lack of Efficacy|1
1512787|NCT00401245|4968618|P5|Double Blind Tapering Phase|Lack of Efficacy|0
1512788|NCT00401245|4968619|P4|Double Blind Tapering Phase|Lack of Efficacy|0
1512789|NCT00401245|4968620|P3|Double Blind Tapering Phase|Lack of Efficacy|0
1512790|NCT00401245|4968621|P2|Double Blind Tapering Phase|Lack of Efficacy|0
1512791|NCT00401245|4968622|P1|Double Blind Tapering Phase|Lack of Efficacy|0
1512792|NCT00401245|4968615|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
1512793|NCT00401245|4968616|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
1512794|NCT00401245|4968617|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
1512795|NCT00401245|4968618|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
1512796|NCT00401245|4968619|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
1512797|NCT00401245|4968620|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
1512798|NCT00401245|4968621|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
1512799|NCT00401245|4968622|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
1512800|NCT00401245|4968615|P8|Double Blind Tapering Phase|Other|2
1512801|NCT00401245|4968616|P7|Double Blind Tapering Phase|Other|2
1512802|NCT00401245|4968617|P6|Double Blind Tapering Phase|Other|0
1512803|NCT00401245|4968618|P5|Double Blind Tapering Phase|Other|1
1512804|NCT00401245|4968619|P4|Double Blind Tapering Phase|Other|0
1512805|NCT00401245|4968620|P3|Double Blind Tapering Phase|Other|0
1512806|NCT00401245|4968621|P2|Double Blind Tapering Phase|Other|0
1512807|NCT00401245|4968622|P1|Double Blind Tapering Phase|Other|0
1512808|NCT00401245|4968615|P8|Double Blind Tapering Phase|Investigator request|1
1512809|NCT00401245|4968616|P7|Double Blind Tapering Phase|Investigator request|0
1512810|NCT00401245|4968617|P6|Double Blind Tapering Phase|Investigator request|0
1512811|NCT00401245|4968618|P5|Double Blind Tapering Phase|Investigator request|0
1512812|NCT00401245|4968619|P4|Double Blind Tapering Phase|Investigator request|0
1512813|NCT00401245|4968620|P3|Double Blind Tapering Phase|Investigator request|0
1512814|NCT00401245|4968621|P2|Double Blind Tapering Phase|Investigator request|0
1512815|NCT00401245|4968622|P1|Double Blind Tapering Phase|Investigator request|0
1512816|NCT00401245|4968615|P8|Double Blind Tapering Phase|Adverse Event|4
1512817|NCT00401245|4968616|P7|Double Blind Tapering Phase|Adverse Event|2
1512818|NCT00401245|4968617|P6|Double Blind Tapering Phase|Adverse Event|1
1512819|NCT00401245|4968618|P5|Double Blind Tapering Phase|Adverse Event|1
1512820|NCT00401245|4968619|P4|Double Blind Tapering Phase|Adverse Event|0
1512821|NCT00401245|4968620|P3|Double Blind Tapering Phase|Adverse Event|0
1512822|NCT00401245|4968621|P2|Double Blind Tapering Phase|Adverse Event|0
1512823|NCT00401245|4968622|P1|Double Blind Tapering Phase|Adverse Event|0
1512824|NCT00401245|4968615|P8|Open Label Phase|Lack of Efficacy|0
1512825|NCT00401245|4968616|P7|Open Label Phase|Lack of Efficacy|0
1512826|NCT00401245|4968617|P6|Open Label Phase|Lack of Efficacy|0
1512827|NCT00401245|4968618|P5|Open Label Phase|Lack of Efficacy|0
1512828|NCT00401245|4968619|P4|Open Label Phase|Lack of Efficacy|0
1512829|NCT00401245|4968620|P3|Open Label Phase|Lack of Efficacy|3
1512830|NCT00401245|4968621|P2|Open Label Phase|Lack of Efficacy|2
1512831|NCT00401245|4968622|P1|Open Label Phase|Lack of Efficacy|4
1512832|NCT00401245|4968615|P8|Open Label Phase|Withdrawal by Subject|0
1512833|NCT00401245|4968616|P7|Open Label Phase|Withdrawal by Subject|0
1512834|NCT00401245|4968617|P6|Open Label Phase|Withdrawal by Subject|0
1512835|NCT00401245|4968618|P5|Open Label Phase|Withdrawal by Subject|0
1512836|NCT00401245|4968619|P4|Open Label Phase|Withdrawal by Subject|1
1512837|NCT00401245|4968620|P3|Open Label Phase|Withdrawal by Subject|2
1512838|NCT00401245|4968621|P2|Open Label Phase|Withdrawal by Subject|3
1512839|NCT00401245|4968622|P1|Open Label Phase|Withdrawal by Subject|3
1512840|NCT00401245|4968615|P8|Open Label Phase|Protocol Violation|0
1512841|NCT00401245|4968616|P7|Open Label Phase|Protocol Violation|0
1512842|NCT00401245|4968617|P6|Open Label Phase|Protocol Violation|0
1512843|NCT00401245|4968618|P5|Open Label Phase|Protocol Violation|0
1512844|NCT00401245|4968619|P4|Open Label Phase|Protocol Violation|1
1512845|NCT00401245|4968620|P3|Open Label Phase|Protocol Violation|0
1512846|NCT00401245|4968621|P2|Open Label Phase|Protocol Violation|1
1512847|NCT00401245|4968622|P1|Open Label Phase|Protocol Violation|0
1512848|NCT00401245|4968615|P8|Open Label Phase|Other|0
1512849|NCT00401245|4968616|P7|Open Label Phase|Other|0
1512850|NCT00401245|4968617|P6|Open Label Phase|Other|0
1512851|NCT00401245|4968618|P5|Open Label Phase|Other|0
1512852|NCT00401245|4968619|P4|Open Label Phase|Other|8
1512853|NCT00401245|4968620|P3|Open Label Phase|Other|7
1512854|NCT00401245|4968621|P2|Open Label Phase|Other|8
1512855|NCT00401245|4968622|P1|Open Label Phase|Other|4
1512856|NCT00401245|4968615|P8|Open Label Phase|Lost to Follow-up|0
1512857|NCT00401245|4968616|P7|Open Label Phase|Lost to Follow-up|0
1512858|NCT00401245|4968617|P6|Open Label Phase|Lost to Follow-up|0
1512859|NCT00401245|4968618|P5|Open Label Phase|Lost to Follow-up|0
1512860|NCT00401245|4968619|P4|Open Label Phase|Lost to Follow-up|4
1512861|NCT00401245|4968620|P3|Open Label Phase|Lost to Follow-up|5
1512862|NCT00401245|4968621|P2|Open Label Phase|Lost to Follow-up|7
1512863|NCT00401245|4968622|P1|Open Label Phase|Lost to Follow-up|5
1512864|NCT00401245|4968615|P8|Open Label Phase|Adverse Event|0
1512865|NCT00401245|4968616|P7|Open Label Phase|Adverse Event|0
1512866|NCT00401245|4968617|P6|Open Label Phase|Adverse Event|0
1512867|NCT00401245|4968618|P5|Open Label Phase|Adverse Event|0
1512868|NCT00401245|4968619|P4|Open Label Phase|Adverse Event|7
1512869|NCT00401245|4968620|P3|Open Label Phase|Adverse Event|6
1512870|NCT00401245|4968621|P2|Open Label Phase|Adverse Event|14
1512871|NCT00401245|4968622|P1|Open Label Phase|Adverse Event|5
1512872|NCT00401245|4968615|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
1512873|NCT00401245|4968616|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
1512874|NCT00401245|4968617|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
1512875|NCT00401245|4968618|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
1512876|NCT00401245|4968619|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
1512877|NCT00401245|4968620|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
1512878|NCT00401245|4968621|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
1512879|NCT00401245|4968622|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
1512880|NCT00401245|4968615|P8|Double Blind Titration Phase|Withdrawal by Subject|0
1512881|NCT00401245|4968616|P7|Double Blind Titration Phase|Withdrawal by Subject|0
1512882|NCT00401245|4968617|P6|Double Blind Titration Phase|Withdrawal by Subject|0
1512883|NCT00401245|4968618|P5|Double Blind Titration Phase|Withdrawal by Subject|0
1512884|NCT00401245|4968619|P4|Double Blind Titration Phase|Withdrawal by Subject|2
1512885|NCT00401245|4968620|P3|Double Blind Titration Phase|Withdrawal by Subject|0
1512886|NCT00401245|4968621|P2|Double Blind Titration Phase|Withdrawal by Subject|1
1512887|NCT00401245|4968622|P1|Double Blind Titration Phase|Withdrawal by Subject|1
1512888|NCT00401245|4968615|P8|Double Blind Titration Phase|Protocol Violation|0
1512889|NCT00401245|4968616|P7|Double Blind Titration Phase|Protocol Violation|0
1512890|NCT00401245|4968617|P6|Double Blind Titration Phase|Protocol Violation|0
1512891|NCT00401245|4968618|P5|Double Blind Titration Phase|Protocol Violation|0
1512892|NCT00401245|4968619|P4|Double Blind Titration Phase|Protocol Violation|1
1512893|NCT00401245|4968620|P3|Double Blind Titration Phase|Protocol Violation|0
1512894|NCT00401245|4968621|P2|Double Blind Titration Phase|Protocol Violation|0
1512895|NCT00401245|4968622|P1|Double Blind Titration Phase|Protocol Violation|0
1512896|NCT00401245|4968615|P8|Double Blind Titration Phase|Other|0
1512897|NCT00401245|4968616|P7|Double Blind Titration Phase|Other|0
1512898|NCT00401245|4968617|P6|Double Blind Titration Phase|Other|0
1512899|NCT00401245|4968618|P5|Double Blind Titration Phase|Other|0
1512900|NCT00401245|4968619|P4|Double Blind Titration Phase|Other|0
1512901|NCT00401245|4968620|P3|Double Blind Titration Phase|Other|1
1512902|NCT00401245|4968621|P2|Double Blind Titration Phase|Other|0
1512903|NCT00401245|4968622|P1|Double Blind Titration Phase|Other|0
1512904|NCT00401245|4968615|P8|Double Blind Titration Phase|Adverse Event|0
1512905|NCT00401245|4968616|P7|Double Blind Titration Phase|Adverse Event|0
1512906|NCT00401245|4968617|P6|Double Blind Titration Phase|Adverse Event|0
1512907|NCT00401245|4968618|P5|Double Blind Titration Phase|Adverse Event|0
1512908|NCT00401245|4968619|P4|Double Blind Titration Phase|Adverse Event|12
1512909|NCT00401245|4968620|P3|Double Blind Titration Phase|Adverse Event|5
1512910|NCT00401245|4968621|P2|Double Blind Titration Phase|Adverse Event|2
1512911|NCT00401245|4968622|P1|Double Blind Titration Phase|Adverse Event|3
1512912|NCT00401193|4968690|P3|Overall Study|Other Event|2
1512913|NCT00401193|4968691|P2|Overall Study|Other Event|2
1512914|NCT00401193|4968692|P1|Overall Study|Other Event|3
1512915|NCT00401193|4968690|P3|Overall Study|Withdrawal by Subject|1
1512916|NCT00401193|4968691|P2|Overall Study|Withdrawal by Subject|0
1512917|NCT00401193|4968692|P1|Overall Study|Withdrawal by Subject|2
1512918|NCT00401193|4968690|P3|Overall Study|Lost to Follow-up|1
1512919|NCT00401193|4968691|P2|Overall Study|Lost to Follow-up|5
1512920|NCT00401193|4968692|P1|Overall Study|Lost to Follow-up|6
1512921|NCT00401193|4968690|P3|Overall Study|Protocol Violation|1
1512922|NCT00401193|4968691|P2|Overall Study|Protocol Violation|1
1512923|NCT00401193|4968692|P1|Overall Study|Protocol Violation|3
1512924|NCT00401193|4968690|P3|Overall Study|Adverse Event|1
1512925|NCT00401193|4968691|P2|Overall Study|Adverse Event|3
1512926|NCT00401193|4968692|P1|Overall Study|Adverse Event|1
1512927|NCT00400946|4968715|P5|Overall Study|Other|1
1512928|NCT00400946|4968716|P4|Overall Study|Other|0
1512929|NCT00400946|4968717|P3|Overall Study|Other|0
1512930|NCT00400946|4968718|P2|Overall Study|Other|0
1512931|NCT00400946|4968719|P1|Overall Study|Other|0
1512932|NCT00400946|4968715|P5|Overall Study|Clinical|9
1512933|NCT00400946|4968716|P4|Overall Study|Clinical|2
1512934|NCT00400946|4968717|P3|Overall Study|Clinical|0
1512935|NCT00400946|4968718|P2|Overall Study|Clinical|2
1512936|NCT00400946|4968719|P1|Overall Study|Clinical|1
1512937|NCT00400946|4968715|P5|Overall Study|Withdrawal by Subject|8
1512938|NCT00400946|4968716|P4|Overall Study|Withdrawal by Subject|5
1512939|NCT00400946|4968717|P3|Overall Study|Withdrawal by Subject|1
1512940|NCT00400946|4968718|P2|Overall Study|Withdrawal by Subject|5
1512941|NCT00400946|4968719|P1|Overall Study|Withdrawal by Subject|2
1512942|NCT00400946|4968715|P5|Overall Study|Transplant in CR1|1
1512943|NCT00400946|4968716|P4|Overall Study|Transplant in CR1|10
1512944|NCT00400946|4968717|P3|Overall Study|Transplant in CR1|0
1512945|NCT00400946|4968718|P2|Overall Study|Transplant in CR1|0
1512946|NCT00400946|4968719|P1|Overall Study|Transplant in CR1|0
1512947|NCT00400946|4968715|P5|Overall Study|Relapse|5
1512948|NCT00400946|4968716|P4|Overall Study|Relapse|1
1512949|NCT00400946|4968717|P3|Overall Study|Relapse|1
1512950|NCT00400946|4968718|P2|Overall Study|Relapse|2
1512951|NCT00400946|4968719|P1|Overall Study|Relapse|9
1512952|NCT00400946|4968715|P5|Overall Study|Remission Death|1
1512953|NCT00400946|4968716|P4|Overall Study|Remission Death|0
1512954|NCT00400946|4968717|P3|Overall Study|Remission Death|0
1512955|NCT00400946|4968718|P2|Overall Study|Remission Death|1
1512956|NCT00400946|4968719|P1|Overall Study|Remission Death|1
1512957|NCT00400946|4968715|P5|Overall Study|Lost to Follow-up|1
1512958|NCT00400946|4968716|P4|Overall Study|Lost to Follow-up|0
1512959|NCT00400946|4968717|P3|Overall Study|Lost to Follow-up|0
1512960|NCT00400946|4968718|P2|Overall Study|Lost to Follow-up|1
1512961|NCT00400946|4968719|P1|Overall Study|Lost to Follow-up|1
1512962|NCT00400946|4968715|P5|Overall Study|Induction Death|3
1512963|NCT00400946|4968716|P4|Overall Study|Induction Death|13
1512964|NCT00400946|4968717|P3|Overall Study|Induction Death|0
1512965|NCT00400946|4968718|P2|Overall Study|Induction Death|0
1512966|NCT00400946|4968719|P1|Overall Study|Induction Death|0
1512967|NCT00400946|4968715|P5|Overall Study|Induction Failure|8
1512968|NCT00400946|4968716|P4|Overall Study|Induction Failure|11
1512969|NCT00400946|4968717|P3|Overall Study|Induction Failure|0
1512970|NCT00400946|4968718|P2|Overall Study|Induction Failure|0
1512971|NCT00400946|4968719|P1|Overall Study|Induction Failure|0
1512972|NCT00400946|4968715|P5|Overall Study|Ineligible|1
1512973|NCT00400946|4968716|P4|Overall Study|Ineligible|5
1512974|NCT00400946|4968717|P3|Overall Study|Ineligible|0
1512975|NCT00400946|4968718|P2|Overall Study|Ineligible|0
1512976|NCT00400946|4968719|P1|Overall Study|Ineligible|0
1512977|NCT00400764|4968778|P5|Phase II|Withdrawal by Subject|0
1512978|NCT00400764|4968779|P4|Phase II|Withdrawal by Subject|1
1512979|NCT00400764|4968780|P3|Phase II|Withdrawal by Subject|1
1512980|NCT00400764|4968781|P2|Phase II|Withdrawal by Subject|0
1512981|NCT00400764|4968782|P1|Phase II|Withdrawal by Subject|0
1512982|NCT00400764|4968778|P5|Phase II|Patient began new, non-protocol, therapy|0
1512983|NCT00400764|4968779|P4|Phase II|Patient began new, non-protocol, therapy|0
1512984|NCT00400764|4968780|P3|Phase II|Patient began new, non-protocol, therapy|1
1512985|NCT00400764|4968781|P2|Phase II|Patient began new, non-protocol, therapy|0
1512986|NCT00400764|4968782|P1|Phase II|Patient began new, non-protocol, therapy|0
1512987|NCT00400764|4968778|P5|Phase II|Sponsor’s decision to terminate|11
1512988|NCT00400764|4968779|P4|Phase II|Sponsor’s decision to terminate|22
1512989|NCT00400764|4968780|P3|Phase II|Sponsor’s decision to terminate|18
1512990|NCT00400764|4968781|P2|Phase II|Sponsor’s decision to terminate|0
1512991|NCT00400764|4968782|P1|Phase II|Sponsor’s decision to terminate|0
1512992|NCT00400764|4968778|P5|Phase II|Physician Decision|0
1512993|NCT00400764|4968779|P4|Phase II|Physician Decision|1
1512994|NCT00400764|4968780|P3|Phase II|Physician Decision|1
1512995|NCT00400764|4968781|P2|Phase II|Physician Decision|0
1512996|NCT00400764|4968782|P1|Phase II|Physician Decision|0
1512997|NCT00400764|4968778|P5|Phase II|Lost to Follow-up|0
1512998|NCT00400764|4968779|P4|Phase II|Lost to Follow-up|0
1512999|NCT00400764|4968780|P3|Phase II|Lost to Follow-up|1
1513000|NCT00400764|4968781|P2|Phase II|Lost to Follow-up|0
1513001|NCT00400764|4968782|P1|Phase II|Lost to Follow-up|0
1513002|NCT00400764|4968778|P5|Phase II|Death|0
1513003|NCT00400764|4968779|P4|Phase II|Death|2
1513004|NCT00400764|4968780|P3|Phase II|Death|1
1513005|NCT00400764|4968781|P2|Phase II|Death|0
1513006|NCT00400764|4968782|P1|Phase II|Death|0
1513007|NCT00400764|4968778|P5|Phase Ib|Disease Progression|0
1513008|NCT00400764|4968779|P4|Phase Ib|Disease Progression|0
1513009|NCT00400764|4968780|P3|Phase Ib|Disease Progression|0
1513010|NCT00400764|4968781|P2|Phase Ib|Disease Progression|4
1513011|NCT00400764|4968782|P1|Phase Ib|Disease Progression|4
1513012|NCT00400764|4968778|P5|Phase Ib|Death|0
1513013|NCT00400764|4968779|P4|Phase Ib|Death|0
1513014|NCT00400764|4968780|P3|Phase Ib|Death|0
1513015|NCT00400764|4968781|P2|Phase Ib|Death|0
1513016|NCT00400764|4968782|P1|Phase Ib|Death|1
1513017|NCT00400764|4968778|P5|Phase Ib|Adverse Event|0
1513018|NCT00400764|4968779|P4|Phase Ib|Adverse Event|0
1513019|NCT00400764|4968780|P3|Phase Ib|Adverse Event|0
1513020|NCT00400764|4968781|P2|Phase Ib|Adverse Event|0
1513021|NCT00400764|4968782|P1|Phase Ib|Adverse Event|1
1513022|NCT00400712|4968835|P2|Overall Study|Physician Decision|4
1513023|NCT00400712|4968836|P1|Overall Study|Physician Decision|5
1513024|NCT00400712|4968835|P2|Overall Study|Withdrawal by Subject|12
1513025|NCT00400712|4968836|P1|Overall Study|Withdrawal by Subject|11
1513026|NCT00400712|4968835|P2|Overall Study|Death|0
1513027|NCT00400712|4968836|P1|Overall Study|Death|1
1513028|NCT00400569|4968871|P1|Overall Study|Death|1
1513029|NCT00400517|4968882|P1|Overall Study|Physician Decision|1
1513030|NCT00400517|4968882|P1|Overall Study|Withdrawal by Subject|1
1513031|NCT00400400|4968891|P2|Overall Study|Did not receive study drug|3
1513032|NCT00400400|4968892|P1|Overall Study|Did not receive study drug|1
1513033|NCT00400400|4968891|P2|Overall Study|Lost to Follow-up|1
1513034|NCT00400400|4968892|P1|Overall Study|Lost to Follow-up|0
1513035|NCT00400400|4968891|P2|Overall Study|Administrative Problem|0
1513036|NCT00400400|4968892|P1|Overall Study|Administrative Problem|1
1513037|NCT00400400|4968891|P2|Overall Study|Withdrawal by Subject|3
1513038|NCT00400400|4968892|P1|Overall Study|Withdrawal by Subject|1
1513039|NCT00400400|4968891|P2|Overall Study|Protocol Violation|0
1513040|NCT00400400|4968892|P1|Overall Study|Protocol Violation|2
1513041|NCT00400400|4968891|P2|Overall Study|Adverse Event|8
1513042|NCT00400400|4968892|P1|Overall Study|Adverse Event|9
1513043|NCT00400179|4968917|P2|Overall Study|Randomization error/patient ineligible|6
1513044|NCT00400179|4968918|P1|Overall Study|Randomization error/patient ineligible|1
1513045|NCT00400179|4968917|P2|Overall Study|Investigator judgment|1
1513046|NCT00400179|4968918|P1|Overall Study|Investigator judgment|0
1513047|NCT00400179|4968917|P2|Overall Study|Intercurrent illness|1
1513048|NCT00400179|4968918|P1|Overall Study|Intercurrent illness|0
1513049|NCT00400179|4968917|P2|Overall Study|Disease progression|1
1513050|NCT00400179|4968918|P1|Overall Study|Disease progression|1
1513051|NCT00400179|4968917|P2|Overall Study|Withdrew Consent|5
1513052|NCT00400179|4968918|P1|Overall Study|Withdrew Consent|1
1513053|NCT00400179|4968917|P2|Overall Study|Death|2
1513054|NCT00400179|4968918|P1|Overall Study|Death|1
1513055|NCT00400179|4968917|P2|Overall Study|Adverse Event|2
1513056|NCT00400179|4968918|P1|Overall Study|Adverse Event|2
1513057|NCT00400153|4968935|P3|Overall Study|Other reasons - not mentioned above|3
1513058|NCT00400153|4968936|P2|Overall Study|Other reasons - not mentioned above|5
1513059|NCT00400153|4968937|P1|Overall Study|Other reasons - not mentioned above|8
1513060|NCT00400153|4968935|P3|Overall Study|Withdrawal by Subject|10
1513061|NCT00400153|4968936|P2|Overall Study|Withdrawal by Subject|11
1513062|NCT00400153|4968937|P1|Overall Study|Withdrawal by Subject|12
1513063|NCT00400153|4968935|P3|Overall Study|Lost to Follow-up|4
1513064|NCT00400153|4968936|P2|Overall Study|Lost to Follow-up|1
1513065|NCT00400153|4968937|P1|Overall Study|Lost to Follow-up|2
1513066|NCT00400153|4968935|P3|Overall Study|Protocol Violation|9
1513067|NCT00400153|4968936|P2|Overall Study|Protocol Violation|4
1513068|NCT00400153|4968937|P1|Overall Study|Protocol Violation|7
1513069|NCT00400153|4968935|P3|Overall Study|AE due to other condition|15
1513070|NCT00400153|4968936|P2|Overall Study|AE due to other condition|14
1513071|NCT00400153|4968937|P1|Overall Study|AE due to other condition|3
1513072|NCT00400153|4968935|P3|Overall Study|AE due to other disease worsening|0
1513073|NCT00400153|4968936|P2|Overall Study|AE due to other disease worsening|1
1513074|NCT00400153|4968937|P1|Overall Study|AE due to other disease worsening|2
1513075|NCT00400153|4968935|P3|Overall Study|AE due to study disease worsening|20
1513076|NCT00400153|4968936|P2|Overall Study|AE due to study disease worsening|19
1513077|NCT00400153|4968937|P1|Overall Study|AE due to study disease worsening|14
1513078|NCT00399893|4969184|P2|Overall Study|Withdrawal by Subject|0
1513079|NCT00399893|4969185|P1|Overall Study|Withdrawal by Subject|1
1513080|NCT00399802|4969224|P2|Overall Study|Participant discontinued by mistake|1
1513081|NCT00399802|4969225|P1|Overall Study|Participant discontinued by mistake|0
1513082|NCT00399802|4969224|P2|Overall Study|Adverse Event|2
1513083|NCT00399802|4969225|P1|Overall Study|Adverse Event|0
1513084|NCT00399763|4969239|P2|Overall Study|Lost to Follow-up|3
1513085|NCT00399763|4969240|P1|Overall Study|Lost to Follow-up|2
1513086|NCT00399568|4969252|P2|Overall Study|Lost to Follow-up|2
1513087|NCT00399568|4969253|P1|Overall Study|Lost to Follow-up|2
1513088|NCT00399568|4969252|P2|Overall Study|Protocol non-compliance|2
1513089|NCT00399568|4969253|P1|Overall Study|Protocol non-compliance|2
1513090|NCT00399568|4969252|P2|Overall Study|Withdrawal by Subject|3
1513091|NCT00399568|4969253|P1|Overall Study|Withdrawal by Subject|7
1513092|NCT00399568|4969252|P2|Overall Study|Adverse Event|2
1513093|NCT00399568|4969253|P1|Overall Study|Adverse Event|1
1513094|NCT00399542|4969267|P2|Overall Study|Physician Decision|1
1513095|NCT00399542|4969268|P1|Overall Study|Physician Decision|0
1513096|NCT00399542|4969267|P2|Overall Study|Other|0
1513097|NCT00399542|4969268|P1|Overall Study|Other|1
1513098|NCT00399542|4969267|P2|Overall Study|Lost to Follow-up|6
1513099|NCT00399542|4969268|P1|Overall Study|Lost to Follow-up|6
1513100|NCT00399542|4969267|P2|Overall Study|Lack of Efficacy|8
1513101|NCT00399542|4969268|P1|Overall Study|Lack of Efficacy|18
1513102|NCT00399542|4969267|P2|Overall Study|Withdrawal by Subject|10
1513103|NCT00399542|4969268|P1|Overall Study|Withdrawal by Subject|28
1513104|NCT00399542|4969267|P2|Overall Study|Protocol Violation|3
1513105|NCT00399542|4969268|P1|Overall Study|Protocol Violation|13
1513106|NCT00399542|4969267|P2|Overall Study|Adverse Event|15
1513107|NCT00399542|4969268|P1|Overall Study|Adverse Event|18
1513108|NCT00399516|4969330|P1|Overall Study|Lost to Follow-up|2
1513109|NCT00399360|4969338|P4|Overall Study|Withdrawal by Subject|2
1513110|NCT00399360|4969339|P3|Overall Study|Withdrawal by Subject|0
1513111|NCT00399360|4969340|P2|Overall Study|Withdrawal by Subject|2
1513112|NCT00399360|4969341|P1|Overall Study|Withdrawal by Subject|0
1513113|NCT00399360|4969338|P4|Overall Study|Adverse Event|0
1513114|NCT00399360|4969339|P3|Overall Study|Adverse Event|1
1513115|NCT00399360|4969340|P2|Overall Study|Adverse Event|0
1513116|NCT00399360|4969341|P1|Overall Study|Adverse Event|0
1513117|NCT00399360|4969338|P4|Overall Study|Lost to Follow-up|4
1513118|NCT00399360|4969339|P3|Overall Study|Lost to Follow-up|2
1513119|NCT00399360|4969340|P2|Overall Study|Lost to Follow-up|1
1513120|NCT00399360|4969341|P1|Overall Study|Lost to Follow-up|2
1513121|NCT00399035|4969412|P3|Overall Study|Severe non-compliance with protocol|0
1513122|NCT00399035|4969413|P2|Overall Study|Severe non-compliance with protocol|1
1513123|NCT00399035|4969414|P1|Overall Study|Severe non-compliance with protocol|2
1513124|NCT00399035|4969412|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
1513125|NCT00399035|4969413|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
1513126|NCT00399035|4969414|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
1513127|NCT00399035|4969412|P3|Overall Study|Withdrawal by Subject|12
1513128|NCT00399035|4969413|P2|Overall Study|Withdrawal by Subject|15
1513129|NCT00399035|4969414|P1|Overall Study|Withdrawal by Subject|19
1513130|NCT00399035|4969412|P3|Overall Study|Lost to Follow-up|5
1513131|NCT00399035|4969413|P2|Overall Study|Lost to Follow-up|1
1513132|NCT00399035|4969414|P1|Overall Study|Lost to Follow-up|2
1513133|NCT00399035|4969412|P3|Overall Study|Death|234
1513134|NCT00399035|4969413|P2|Overall Study|Death|141
1513135|NCT00399035|4969414|P1|Overall Study|Death|289
1513136|NCT00398866|4969450|P3|Overall Study|Unable to complete requirements of study|1
1513137|NCT00398866|4969451|P2|Overall Study|Unable to complete requirements of study|1
1513138|NCT00398866|4969452|P1|Overall Study|Unable to complete requirements of study|1
1513139|NCT00398866|4969450|P3|Overall Study|Withdrawal by Subject|2
1513140|NCT00398866|4969451|P2|Overall Study|Withdrawal by Subject|1
1513141|NCT00398866|4969452|P1|Overall Study|Withdrawal by Subject|5
1513142|NCT00398866|4969450|P3|Overall Study|Lost to Follow-up|4
1513143|NCT00398866|4969451|P2|Overall Study|Lost to Follow-up|6
1513144|NCT00398866|4969452|P1|Overall Study|Lost to Follow-up|7
1513145|NCT00398866|4969450|P3|Overall Study|Lack of Efficacy|1
1513146|NCT00398866|4969451|P2|Overall Study|Lack of Efficacy|0
1513147|NCT00398866|4969452|P1|Overall Study|Lack of Efficacy|0
1513148|NCT00398866|4969450|P3|Overall Study|Adverse Event|0
1513149|NCT00398866|4969451|P2|Overall Study|Adverse Event|0
1513150|NCT00398866|4969452|P1|Overall Study|Adverse Event|1
1513151|NCT00398632|4969463|P1|Overall Study|Lack of Efficacy|1
1513152|NCT00398632|4969463|P1|Overall Study|Withdrawal by Subject|1
1513153|NCT00398567|4969471|P3|Overall Study|Protocol Violation|1
1513154|NCT00398567|4969472|P2|Overall Study|Protocol Violation|0
1513155|NCT00398567|4969473|P1|Overall Study|Protocol Violation|0
1513156|NCT00398567|4969471|P3|Overall Study|Adverse Event|2
1513157|NCT00398567|4969472|P2|Overall Study|Adverse Event|0
1513158|NCT00398567|4969473|P1|Overall Study|Adverse Event|0
1513159|NCT00398567|4969471|P3|Overall Study|Withdrawal by Subject|4
1513160|NCT00398567|4969472|P2|Overall Study|Withdrawal by Subject|0
1513161|NCT00398567|4969473|P1|Overall Study|Withdrawal by Subject|1
1513162|NCT00398567|4969471|P3|Overall Study|Disease Progression|27
1513163|NCT00398567|4969472|P2|Overall Study|Disease Progression|4
1513164|NCT00398567|4969473|P1|Overall Study|Disease Progression|3
1513165|NCT00398411|4969527|P2|Overall Study|Death|1
1513166|NCT00398411|4969528|P1|Overall Study|Death|0
1513167|NCT00398320|4969551|P1|Overall Study|Physician Decision|1
1513168|NCT00398320|4969551|P1|Overall Study|Adverse Event|4
1513169|NCT00398320|4969551|P1|Overall Study|Death|1
1513170|NCT00398216|4969564|P5|Overall Study|entrance criteria|2
1513171|NCT00398216|4969565|P4|Overall Study|entrance criteria|0
1513172|NCT00398216|4969566|P3|Overall Study|entrance criteria|0
1513173|NCT00398216|4969567|P2|Overall Study|entrance criteria|0
1513174|NCT00398216|4969568|P1|Overall Study|entrance criteria|0
1513175|NCT00398216|4969564|P5|Overall Study|administrative reasons|3
1513176|NCT00398216|4969565|P4|Overall Study|administrative reasons|3
1513177|NCT00398216|4969566|P3|Overall Study|administrative reasons|4
1513178|NCT00398216|4969567|P2|Overall Study|administrative reasons|4
1513179|NCT00398216|4969568|P1|Overall Study|administrative reasons|3
1513180|NCT00398216|4969564|P5|Overall Study|Withdrawal by Subject|2
1513181|NCT00398216|4969565|P4|Overall Study|Withdrawal by Subject|1
1513182|NCT00398216|4969566|P3|Overall Study|Withdrawal by Subject|3
1513183|NCT00398216|4969567|P2|Overall Study|Withdrawal by Subject|0
1513184|NCT00398216|4969568|P1|Overall Study|Withdrawal by Subject|1
1513185|NCT00398216|4969564|P5|Overall Study|Death|0
1513186|NCT00398216|4969565|P4|Overall Study|Death|0
1513187|NCT00398216|4969566|P3|Overall Study|Death|0
1513188|NCT00398216|4969567|P2|Overall Study|Death|3
1513189|NCT00398216|4969568|P1|Overall Study|Death|0
1513190|NCT00398216|4969564|P5|Overall Study|Lost to Follow-up|1
1513191|NCT00398216|4969565|P4|Overall Study|Lost to Follow-up|4
1513192|NCT00398216|4969566|P3|Overall Study|Lost to Follow-up|4
1513193|NCT00398216|4969567|P2|Overall Study|Lost to Follow-up|6
1513194|NCT00398216|4969568|P1|Overall Study|Lost to Follow-up|1
1513195|NCT00398216|4969564|P5|Overall Study|Protocol Violation|5
1513196|NCT00398216|4969565|P4|Overall Study|Protocol Violation|7
1513197|NCT00398216|4969566|P3|Overall Study|Protocol Violation|5
1513198|NCT00398216|4969567|P2|Overall Study|Protocol Violation|4
1513199|NCT00398216|4969568|P1|Overall Study|Protocol Violation|2
1513200|NCT00398216|4969564|P5|Overall Study|Adverse Event|2
1513201|NCT00398216|4969565|P4|Overall Study|Adverse Event|7
1513202|NCT00398216|4969566|P3|Overall Study|Adverse Event|5
1513203|NCT00398216|4969567|P2|Overall Study|Adverse Event|2
1513204|NCT00398216|4969568|P1|Overall Study|Adverse Event|4
1513205|NCT00398138|4969595|P1|Overall Study|Adverse Event|2
1513206|NCT00398112|4969600|P1|Overall Study|Death|1
1513207|NCT00398112|4969600|P1|Overall Study|Withdrawal by Subject|3
1513208|NCT00398112|4969600|P1|Overall Study|Alternative treatment|1
1513209|NCT00398112|4969600|P1|Overall Study|Disease progression|9
1513210|NCT00398112|4969600|P1|Overall Study|Adverse Event|4
1513211|NCT00398086|4969611|P3|Overall Study|Withdrawal by Subject|0
1513212|NCT00398086|4969612|P2|Overall Study|Withdrawal by Subject|7
1513213|NCT00398086|4969613|P1|Overall Study|Withdrawal by Subject|5
1513214|NCT00398086|4969611|P3|Overall Study|Physician Decision|0
1513215|NCT00398086|4969612|P2|Overall Study|Physician Decision|4
1513216|NCT00398086|4969613|P1|Overall Study|Physician Decision|1
1513217|NCT00398086|4969611|P3|Overall Study|Adverse Event|0
1513218|NCT00398086|4969612|P2|Overall Study|Adverse Event|4
1513219|NCT00398086|4969613|P1|Overall Study|Adverse Event|1
1513220|NCT00398086|4969611|P3|Overall Study|Unacceptable Toxicity|2
1513221|NCT00398086|4969612|P2|Overall Study|Unacceptable Toxicity|8
1513222|NCT00398086|4969613|P1|Overall Study|Unacceptable Toxicity|2
1513223|NCT00398073|4969647|P2|Overall Study|Withdrawal by Subject|0
1513224|NCT00398073|4969648|P1|Overall Study|Withdrawal by Subject|1
1513225|NCT00398047|4969658|P1|Overall Study|all patient progressed before completion|3
1513226|NCT00397982|4969668|P1|Overall Study|Unrelated health issues|1
1513227|NCT00397982|4969668|P1|Overall Study|noncompliance|1
1513228|NCT00397982|4969668|P1|Overall Study|Adverse Event|1
1513229|NCT00397982|4969668|P1|Overall Study|Withdrawal by Subject|1
1513230|NCT00397943|4969682|P5|Overall Study|Unspecified reasons|0
1513231|NCT00397943|4969683|P4|Overall Study|Unspecified reasons|0
1513232|NCT00397943|4969684|P3|Overall Study|Unspecified reasons|0
1513233|NCT00397943|4969685|P2|Overall Study|Unspecified reasons|9
1513234|NCT00397943|4969686|P1|Overall Study|Unspecified reasons|12
1513235|NCT00397930|4969842|P2|Overall Study|Missing data|4
1513236|NCT00397930|4969843|P1|Overall Study|Missing data|0
1513237|NCT00397930|4969842|P2|Overall Study|Withdrawal by Subject|8
1513238|NCT00397930|4969843|P1|Overall Study|Withdrawal by Subject|0
1513239|NCT00397930|4969842|P2|Overall Study|Did not want to be in control group|1
1513240|NCT00397930|4969843|P1|Overall Study|Did not want to be in control group|0
1513241|NCT00397930|4969842|P2|Overall Study|Started own yoga program|1
1513242|NCT00397930|4969843|P1|Overall Study|Started own yoga program|1
1513243|NCT00397930|4969842|P2|Overall Study|Too time-consuming|9
1513244|NCT00397930|4969843|P1|Overall Study|Too time-consuming|2
1513245|NCT00397930|4969842|P2|Overall Study|Noncompliant|2
1513246|NCT00397930|4969843|P1|Overall Study|Noncompliant|3
1513247|NCT00397930|4969842|P2|Overall Study|Unknown reasons|14
1513248|NCT00397930|4969843|P1|Overall Study|Unknown reasons|9
1513249|NCT00397930|4969842|P2|Overall Study|Other medical|4
1513250|NCT00397930|4969843|P1|Overall Study|Other medical|9
1513251|NCT00397930|4969842|P2|Overall Study|Personal reasons|8
1513252|NCT00397930|4969843|P1|Overall Study|Personal reasons|14
1513253|NCT00397891|4969858|P5|Overall Study|Withdrawal by Subject|1
1513254|NCT00397891|4969859|P4|Overall Study|Withdrawal by Subject|0
1513255|NCT00397891|4969860|P3|Overall Study|Withdrawal by Subject|0
1513256|NCT00397891|4969861|P2|Overall Study|Withdrawal by Subject|0
1513257|NCT00397891|4969862|P1|Overall Study|Withdrawal by Subject|1
1513258|NCT00397631|4969983|P2|Overall Study|protocol discontinuation criteria|4
1513259|NCT00397631|4969984|P1|Overall Study|protocol discontinuation criteria|1
1513260|NCT00397631|4969983|P2|Overall Study|Withdrawal by Subject|14
1513261|NCT00397631|4969984|P1|Overall Study|Withdrawal by Subject|7
1513262|NCT00397631|4969983|P2|Overall Study|Protocol Violation|1
1513263|NCT00397631|4969984|P1|Overall Study|Protocol Violation|0
1513264|NCT00397631|4969983|P2|Overall Study|Physician Decision|0
1513265|NCT00397631|4969984|P1|Overall Study|Physician Decision|2
1513266|NCT00397631|4969983|P2|Overall Study|Lost to Follow-up|9
1513267|NCT00397631|4969984|P1|Overall Study|Lost to Follow-up|8
1513268|NCT00397631|4969983|P2|Overall Study|Lack of Efficacy|10
1513269|NCT00397631|4969984|P1|Overall Study|Lack of Efficacy|7
1513270|NCT00397631|4969983|P2|Overall Study|Adverse Event|6
1513271|NCT00397631|4969984|P1|Overall Study|Adverse Event|5
1513272|NCT00397540|4969996|P2|Overall Study|short follow-up duration < 12 months|0
1513273|NCT00397540|4969997|P1|Overall Study|short follow-up duration < 12 months|1
1513274|NCT00397514|4970003|P1|Overall Study|poor echocardiographic windows|1
1513275|NCT00397514|4970003|P1|Overall Study|early extubation|2
1513276|NCT00397514|4970003|P1|Overall Study|Not able to capture & pace LV intraoper.|4
1513277|NCT00397514|4970003|P1|Overall Study|Pacing wire malfunction|1
1513278|NCT00397514|4970003|P1|Overall Study|Withdrawal by Subject|1
1513279|NCT00397488|4970013|P1|Overall Study|Death|1
1513280|NCT00397488|4970013|P1|Overall Study|Adverse Event|3
1513281|NCT00397488|4970013|P1|Overall Study|Withdrawal by Subject|3
1513282|NCT00397254|4970033|P2|Overall Study|Lost to Follow-up|2
1513283|NCT00397254|4970034|P1|Overall Study|Lost to Follow-up|2
1513284|NCT00397215|4970056|P4|Month 6 (Day 180)|Other|0
1513285|NCT00397215|4970057|P3|Month 6 (Day 180)|Other|3
1513286|NCT00397215|4970058|P2|Month 6 (Day 180)|Other|0
1513287|NCT00397215|4970059|P1|Month 6 (Day 180)|Other|2
1513288|NCT00397215|4970056|P4|Month 6 (Day 180)|Adverse Event|0
1513289|NCT00397215|4970057|P3|Month 6 (Day 180)|Adverse Event|2
1513290|NCT00397215|4970058|P2|Month 6 (Day 180)|Adverse Event|3
1513291|NCT00397215|4970059|P1|Month 6 (Day 180)|Adverse Event|0
1513292|NCT00397215|4970056|P4|Month 0 (Day 0)|Other|3
1513293|NCT00397215|4970057|P3|Month 0 (Day 0)|Other|3
1513294|NCT00397215|4970058|P2|Month 0 (Day 0)|Other|1
1513295|NCT00397215|4970059|P1|Month 0 (Day 0)|Other|4
1513296|NCT00397215|4970056|P4|Month 0 (Day 0)|Withdrawal by Subject|1
1513297|NCT00397215|4970057|P3|Month 0 (Day 0)|Withdrawal by Subject|3
1513298|NCT00397215|4970058|P2|Month 0 (Day 0)|Withdrawal by Subject|3
1513299|NCT00397215|4970059|P1|Month 0 (Day 0)|Withdrawal by Subject|3
1513300|NCT00397215|4970056|P4|Month 0 (Day 0)|Adverse Event|0
1513301|NCT00397215|4970057|P3|Month 0 (Day 0)|Adverse Event|0
1513302|NCT00397215|4970058|P2|Month 0 (Day 0)|Adverse Event|1
1513303|NCT00397215|4970059|P1|Month 0 (Day 0)|Adverse Event|0
1513304|NCT00397189|4970195|P2|3 Weeks Period|Other|2
1513305|NCT00397189|4970196|P1|3 Weeks Period|Other|0
1513306|NCT00397189|4970195|P2|3 Weeks Period|Protocol Violation|3
1513307|NCT00397189|4970196|P1|3 Weeks Period|Protocol Violation|0
1513308|NCT00397189|4970195|P2|3 Weeks Period|Physician Decision|2
1513309|NCT00397189|4970196|P1|3 Weeks Period|Physician Decision|0
1513310|NCT00397189|4970195|P2|3 Weeks Period|Withdrawal by Subject|9
1513311|NCT00397189|4970196|P1|3 Weeks Period|Withdrawal by Subject|13
1513312|NCT00397189|4970195|P2|3 Weeks Period|Adverse Event|2
1513313|NCT00397189|4970196|P1|3 Weeks Period|Adverse Event|3
1513314|NCT00397189|4970195|P2|3 Weeks Period|Lost to Follow-up|4
1513315|NCT00397189|4970196|P1|3 Weeks Period|Lost to Follow-up|5
1513316|NCT00397046|4970223|P4|Overall Study|Disease Progression|5
1513317|NCT00397046|4970224|P3|Overall Study|Disease Progression|10
1513318|NCT00397046|4970225|P2|Overall Study|Disease Progression|3
1513319|NCT00397046|4970226|P1|Overall Study|Disease Progression|3
1513320|NCT00397033|4970247|P3|Overall Study|Other|2
1513321|NCT00397033|4970248|P2|Overall Study|Other|5
1513322|NCT00397033|4970249|P1|Overall Study|Other|0
1513323|NCT00397033|4970247|P3|Overall Study|Withdrawal by Subject|5
1513324|NCT00397033|4970248|P2|Overall Study|Withdrawal by Subject|7
1513325|NCT00397033|4970249|P1|Overall Study|Withdrawal by Subject|12
1513326|NCT00397033|4970247|P3|Overall Study|Lost to Follow-up|3
1513327|NCT00397033|4970248|P2|Overall Study|Lost to Follow-up|3
1513328|NCT00397033|4970249|P1|Overall Study|Lost to Follow-up|3
1513329|NCT00397033|4970247|P3|Overall Study|Lack of Efficacy|9
1513330|NCT00397033|4970248|P2|Overall Study|Lack of Efficacy|12
1513331|NCT00397033|4970249|P1|Overall Study|Lack of Efficacy|22
1513332|NCT00397033|4970247|P3|Overall Study|Adverse Event|4
1513333|NCT00397033|4970248|P2|Overall Study|Adverse Event|10
1513334|NCT00397033|4970249|P1|Overall Study|Adverse Event|7
1513335|NCT00396877|4970331|P2|Overall Study|Parent(s)/guardian(s)'s request|7
1513336|NCT00396877|4970332|P1|Overall Study|Parent(s)/guardian(s)'s request|4
1513337|NCT00396877|4970331|P2|Overall Study|Lost to Follow-up|1
1513338|NCT00396877|4970332|P1|Overall Study|Lost to Follow-up|2
1513339|NCT00396812|4970342|P1|Overall Study|Physician Decision|1
1513340|NCT00396656|4970354|P2|Second Treatment Period|Adverse Event|1
1513341|NCT00396656|4970355|P1|Second Treatment Period|Adverse Event|0
1513342|NCT00396656|4970354|P2|First Treatment Period|Withdrawal by Subject|2
1513343|NCT00396656|4970355|P1|First Treatment Period|Withdrawal by Subject|0
1513344|NCT00396630|4970373|P2|Overall Study|Not vaccinated at Visit 3|3
1513345|NCT00396630|4970374|P1|Overall Study|Not vaccinated at Visit 3|3
1513346|NCT00396630|4970373|P2|Overall Study|Withdrawal by Subject|1
1513347|NCT00396630|4970374|P1|Overall Study|Withdrawal by Subject|1
1513348|NCT00396630|4970373|P2|Overall Study|Lost to Follow-up|1
1513349|NCT00396630|4970374|P1|Overall Study|Lost to Follow-up|1
1513350|NCT00396591|4970394|P1|Overall Study|Participant request|1
1513351|NCT00396591|4970394|P1|Overall Study|Adverse Event|2
1513352|NCT00396591|4970394|P1|Overall Study|Disease Progression|13
1513353|NCT00396565|4970407|P3|Overall Study|Lack of Efficacy|11
1513354|NCT00396565|4970408|P2|Overall Study|Lack of Efficacy|64
1513355|NCT00396565|4970409|P1|Overall Study|Lack of Efficacy|32
1513356|NCT00396565|4970407|P3|Overall Study|Withdrawal by Subject|1
1513357|NCT00396565|4970408|P2|Overall Study|Withdrawal by Subject|13
1513358|NCT00396565|4970409|P1|Overall Study|Withdrawal by Subject|8
1513359|NCT00396565|4970407|P3|Overall Study|Adverse Event|3
1513360|NCT00396565|4970408|P2|Overall Study|Adverse Event|13
1513361|NCT00396565|4970409|P1|Overall Study|Adverse Event|5
1513362|NCT00396565|4970407|P3|Overall Study|Physician Decision|2
1513363|NCT00396565|4970408|P2|Overall Study|Physician Decision|1
1513364|NCT00396565|4970409|P1|Overall Study|Physician Decision|3
1513365|NCT00396409|4970434|P2|Period 2 - 2008|Lost to Follow-up|1
1513366|NCT00396409|4970435|P1|Period 2 - 2008|Lost to Follow-up|3
1513367|NCT00396409|4970434|P2|Period 2 - 2008|Withdrawal by Subject|1
1513368|NCT00396409|4970435|P1|Period 2 - 2008|Withdrawal by Subject|3
1513369|NCT00396409|4970434|P2|Period 2 - 2008|Protocol Violation|0
1513370|NCT00396409|4970435|P1|Period 2 - 2008|Protocol Violation|1
1513371|NCT00396409|4970434|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
1513372|NCT00396409|4970435|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
1513373|NCT00396409|4970434|P2|Period 1 - 2007|Lost to Follow-up|3
1513374|NCT00396409|4970435|P1|Period 1 - 2007|Lost to Follow-up|2
1513375|NCT00396409|4970434|P2|Period 1 - 2007|Withdrawal by Subject|1
1513376|NCT00396409|4970435|P1|Period 1 - 2007|Withdrawal by Subject|1
1513377|NCT00396409|4970434|P2|Period 1 - 2007|Lack of Efficacy|1
1513378|NCT00396409|4970435|P1|Period 1 - 2007|Lack of Efficacy|0
1513379|NCT00396409|4970434|P2|Period 1 - 2007|Adverse Event|1
1513380|NCT00396409|4970435|P1|Period 1 - 2007|Adverse Event|0
1513381|NCT00396383|4970465|P1|Overall Study|Lost to Follow-up|1
1513382|NCT00396383|4970465|P1|Overall Study|Death|2
1513383|NCT00396331|4970478|P1|Overall Study|Death|16
1513384|NCT00396331|4970478|P1|Overall Study|Lost to Follow-up|3
1513385|NCT00396331|4970478|P1|Overall Study|Did not go on to transplant|5
1513386|NCT00396331|4970478|P1|Overall Study|Failed to mobilize - no transplant|8
1513387|NCT00396318|4970531|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
1513388|NCT00396279|4970551|P1|Overall Study|Physician Decision|1
1513389|NCT00396279|4970551|P1|Overall Study|Withdrawal by Subject|1
1513390|NCT00396279|4970551|P1|Overall Study|Disease progression|2
1513391|NCT00396279|4970551|P1|Overall Study|Ongoing in study|26
1513392|NCT00396253|4970584|P1|Overall Study|Change in eligibility status|1
1513393|NCT00396253|4970584|P1|Overall Study|Physician Decision|1
1513394|NCT00396253|4970584|P1|Overall Study|Death|3
1513395|NCT00396253|4970584|P1|Overall Study|Withdrawal by Subject|7
1513396|NCT00396253|4970584|P1|Overall Study|Protocol Violation|1
1513397|NCT00396162|4970615|P2|Overall Study|Withdrawal by Subject|3
1513398|NCT00396162|4970616|P1|Overall Study|Withdrawal by Subject|2
1513399|NCT00396136|4970628|P1|Overall Study|Study device explanted|8
1513400|NCT00396136|4970628|P1|Overall Study|Lost to Follow-up|15
1513401|NCT00396136|4970628|P1|Overall Study|Withdrawal by Subject|59
1513402|NCT00396136|4970628|P1|Overall Study|Death|43
1513403|NCT00396097|4970635|P2|Overall Study|Insufficient Clinical Response|4
1513404|NCT00396097|4970636|P1|Overall Study|Insufficient Clinical Response|1
1513405|NCT00396097|4970635|P2|Overall Study|Adverse Event|5
1513406|NCT00396097|4970636|P1|Overall Study|Adverse Event|1
1513407|NCT00396097|4970635|P2|Overall Study|Protocol Violation|6
1513408|NCT00396097|4970636|P1|Overall Study|Protocol Violation|0
1513409|NCT00396097|4970635|P2|Overall Study|Not specified|5
1513410|NCT00396097|4970636|P1|Overall Study|Not specified|3
1513411|NCT00396097|4970635|P2|Overall Study|Lost to Follow-up|9
1513412|NCT00396097|4970636|P1|Overall Study|Lost to Follow-up|4
1513413|NCT00396097|4970635|P2|Overall Study|Withdrawal by Subject|17
1513414|NCT00396097|4970636|P1|Overall Study|Withdrawal by Subject|17
1513415|NCT00396084|4970664|P6|Overall Study|Withdrawal by Subject|0
1513416|NCT00396084|4970665|P5|Overall Study|Withdrawal by Subject|0
1513417|NCT00396084|4970666|P4|Overall Study|Withdrawal by Subject|1
1513418|NCT00396084|4970667|P3|Overall Study|Withdrawal by Subject|0
1513419|NCT00396084|4970668|P2|Overall Study|Withdrawal by Subject|0
1513420|NCT00396084|4970669|P1|Overall Study|Withdrawal by Subject|0
1513421|NCT00396084|4970664|P6|Overall Study|Adverse Event|2
1513422|NCT00396084|4970665|P5|Overall Study|Adverse Event|1
1513423|NCT00396084|4970666|P4|Overall Study|Adverse Event|0
1513424|NCT00396084|4970667|P3|Overall Study|Adverse Event|0
1513425|NCT00396084|4970668|P2|Overall Study|Adverse Event|0
1513426|NCT00396084|4970669|P1|Overall Study|Adverse Event|0
1513427|NCT00395967|4970798|P1|Follow-up Period|Lost to Follow-up|1
1513428|NCT00395967|4970798|P1|Follow-up Period|Death|1
1513429|NCT00395967|4970798|P1|Treatment Period|Failed Mobilization|1
1513430|NCT00395863|4970838|P2|Overall Study|Patients did not complete both exams|3
1513431|NCT00395863|4970839|P1|Overall Study|Patients did not complete both exams|2
1513432|NCT00395850|4970874|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
1513433|NCT00395850|4970875|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
1513434|NCT00395850|4970876|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
1513435|NCT00395850|4970877|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
1513436|NCT00395850|4970874|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
1513437|NCT00395850|4970875|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
1513438|NCT00395850|4970876|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
1513439|NCT00395850|4970877|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
1513440|NCT00395850|4970874|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
1513441|NCT00395850|4970875|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
1513442|NCT00395850|4970876|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
1513443|NCT00395850|4970877|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
1513444|NCT00395850|4970874|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
1513445|NCT00395850|4970875|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
1513446|NCT00395850|4970876|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
1513447|NCT00395850|4970877|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
1513448|NCT00395850|4970874|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
1513449|NCT00395850|4970875|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
1513450|NCT00395850|4970876|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
1513451|NCT00395850|4970877|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
1513452|NCT00395850|4970874|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
1513453|NCT00395850|4970875|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
1513454|NCT00395850|4970876|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
1513455|NCT00395850|4970877|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
1513543|NCT00395512|4971028|P2|Overall Study|Withdrawal by Subject|5
1513456|NCT00395850|4970874|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
1513457|NCT00395850|4970875|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
1513458|NCT00395850|4970876|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
1513459|NCT00395850|4970877|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
1513460|NCT00395746|4970894|P3|Overall Study|Unable to visit site on schedule|0
1513461|NCT00395746|4970895|P2|Overall Study|Unable to visit site on schedule|0
1513462|NCT00395746|4970896|P1|Overall Study|Unable to visit site on schedule|1
1513463|NCT00395746|4970894|P3|Overall Study|Difficultulty in use of device|1
1513464|NCT00395746|4970895|P2|Overall Study|Difficultulty in use of device|0
1513465|NCT00395746|4970896|P1|Overall Study|Difficultulty in use of device|0
1513466|NCT00395746|4970894|P3|Overall Study|Withdrawal of consent|1
1513467|NCT00395746|4970895|P2|Overall Study|Withdrawal of consent|0
1513468|NCT00395746|4970896|P1|Overall Study|Withdrawal of consent|0
1513469|NCT00395746|4970894|P3|Overall Study|Subject decision|1
1513470|NCT00395746|4970895|P2|Overall Study|Subject decision|0
1513471|NCT00395746|4970896|P1|Overall Study|Subject decision|0
1513472|NCT00395746|4970894|P3|Overall Study|Hypoglycaemia|0
1513473|NCT00395746|4970895|P2|Overall Study|Hypoglycaemia|1
1513474|NCT00395746|4970896|P1|Overall Study|Hypoglycaemia|2
1513475|NCT00395746|4970894|P3|Overall Study|Lack of Efficacy|17
1513476|NCT00395746|4970895|P2|Overall Study|Lack of Efficacy|0
1513477|NCT00395746|4970896|P1|Overall Study|Lack of Efficacy|2
1513478|NCT00395746|4970894|P3|Overall Study|Protocol Violation|0
1513479|NCT00395746|4970895|P2|Overall Study|Protocol Violation|1
1513480|NCT00395746|4970896|P1|Overall Study|Protocol Violation|0
1513481|NCT00395746|4970894|P3|Overall Study|Adverse Event|2
1513482|NCT00395746|4970895|P2|Overall Study|Adverse Event|2
1513483|NCT00395746|4970896|P1|Overall Study|Adverse Event|5
1513484|NCT00395733|4970942|P2|Period 2|Technical problems|0
1513485|NCT00395733|4970943|P1|Period 2|Technical problems|1
1513486|NCT00395733|4970942|P2|Period 2|Adverse Event|2
1513487|NCT00395733|4970943|P1|Period 2|Adverse Event|0
1513488|NCT00395733|4970942|P2|Period 2|Protocol Violation|1
1513489|NCT00395733|4970943|P1|Period 2|Protocol Violation|0
1513490|NCT00395733|4970942|P2|Period 2|Withdrawal by Subject|2
1513491|NCT00395733|4970943|P1|Period 2|Withdrawal by Subject|1
1513492|NCT00395694|4970967|P2|Continuation Phase|Withdrawal by Subject|2
1513493|NCT00395694|4970968|P1|Continuation Phase|Withdrawal by Subject|0
1513494|NCT00395694|4970967|P2|Continuation Phase|Poor Compliance|0
1513495|NCT00395694|4970968|P1|Continuation Phase|Poor Compliance|1
1513496|NCT00395694|4970967|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
1513497|NCT00395694|4970968|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
1513498|NCT00395694|4970967|P2|Continuation Phase|Lack of Efficacy|11
1513499|NCT00395694|4970968|P1|Continuation Phase|Lack of Efficacy|12
1513500|NCT00395694|4970967|P2|Continuation Phase|Adverse Event|0
1513501|NCT00395694|4970968|P1|Continuation Phase|Adverse Event|1
1513502|NCT00395694|4970967|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
1513503|NCT00395694|4970968|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
1513504|NCT00395642|4970999|P1|Overall Study|Withdrawal by Subject|1
1513505|NCT00395642|4970999|P1|Overall Study|Physician Decision|7
1513506|NCT00395642|4970999|P1|Overall Study|Lost to Follow-up|1
1513507|NCT00395642|4970999|P1|Overall Study|Death|4
1513508|NCT00395629|4971006|P3|Extension Study|Administrative problems|1
1513509|NCT00395629|4971007|P2|Extension Study|Administrative problems|0
1513510|NCT00395629|4971008|P1|Extension Study|Administrative problems|0
1513511|NCT00395629|4971006|P3|Extension Study|Adverse Event|2
1513512|NCT00395629|4971007|P2|Extension Study|Adverse Event|0
1513513|NCT00395629|4971008|P1|Extension Study|Adverse Event|0
1513514|NCT00395629|4971006|P3|Core Study|Lost to Follow-up|1
1513515|NCT00395629|4971007|P2|Core Study|Lost to Follow-up|0
1513516|NCT00395629|4971008|P1|Core Study|Lost to Follow-up|0
1513517|NCT00395629|4971006|P3|Core Study|Withdrawal by Subject|1
1513518|NCT00395629|4971007|P2|Core Study|Withdrawal by Subject|1
1513519|NCT00395629|4971008|P1|Core Study|Withdrawal by Subject|0
1513520|NCT00395629|4971006|P3|Core Study|Protocol Violation|0
1513521|NCT00395629|4971007|P2|Core Study|Protocol Violation|0
1513522|NCT00395629|4971008|P1|Core Study|Protocol Violation|1
1513523|NCT00395629|4971006|P3|Core Study|Abnormal laboratory value(s)|1
1513524|NCT00395629|4971007|P2|Core Study|Abnormal laboratory value(s)|0
1513525|NCT00395629|4971008|P1|Core Study|Abnormal laboratory value(s)|0
1513526|NCT00395629|4971006|P3|Core Study|Adverse Event|4
1513527|NCT00395629|4971007|P2|Core Study|Adverse Event|3
1513528|NCT00395629|4971008|P1|Core Study|Adverse Event|0
1513529|NCT00395512|4971026|P4|Overall Study|Hyperglycemic Rescue|6
1513530|NCT00395512|4971027|P3|Overall Study|Hyperglycemic Rescue|4
1513531|NCT00395512|4971028|P2|Overall Study|Hyperglycemic Rescue|10
1513532|NCT00395512|4971029|P1|Overall Study|Hyperglycemic Rescue|18
1513533|NCT00395512|4971026|P4|Overall Study|Other|0
1513534|NCT00395512|4971027|P3|Overall Study|Other|0
1513535|NCT00395512|4971028|P2|Overall Study|Other|1
1513536|NCT00395512|4971029|P1|Overall Study|Other|1
1513537|NCT00395512|4971026|P4|Overall Study|Physician Decision|2
1513538|NCT00395512|4971027|P3|Overall Study|Physician Decision|2
1513539|NCT00395512|4971028|P2|Overall Study|Physician Decision|4
1513540|NCT00395512|4971029|P1|Overall Study|Physician Decision|6
1513541|NCT00395512|4971026|P4|Overall Study|Withdrawal by Subject|12
1513542|NCT00395512|4971027|P3|Overall Study|Withdrawal by Subject|5
1513544|NCT00395512|4971029|P1|Overall Study|Withdrawal by Subject|6
1513545|NCT00395512|4971026|P4|Overall Study|Lost to Follow-up|5
1513546|NCT00395512|4971027|P3|Overall Study|Lost to Follow-up|5
1513547|NCT00395512|4971028|P2|Overall Study|Lost to Follow-up|6
1513548|NCT00395512|4971029|P1|Overall Study|Lost to Follow-up|2
1513549|NCT00395512|4971026|P4|Overall Study|Protocol Violation|7
1513550|NCT00395512|4971027|P3|Overall Study|Protocol Violation|6
1513551|NCT00395512|4971028|P2|Overall Study|Protocol Violation|3
1513552|NCT00395512|4971029|P1|Overall Study|Protocol Violation|2
1513553|NCT00395512|4971026|P4|Overall Study|Adverse Event|6
1513554|NCT00395512|4971027|P3|Overall Study|Adverse Event|6
1513555|NCT00395512|4971028|P2|Overall Study|Adverse Event|8
1513556|NCT00395512|4971029|P1|Overall Study|Adverse Event|3
1513557|NCT00395486|4971201|P2|Overall Study|Lost to Follow-up|1
1513558|NCT00395486|4971202|P1|Overall Study|Lost to Follow-up|0
1513559|NCT00395486|4971201|P2|Overall Study|Withdrawal by Subject|2
1513560|NCT00395486|4971202|P1|Overall Study|Withdrawal by Subject|5
1513561|NCT00395486|4971201|P2|Overall Study|Adverse Event|2
1513562|NCT00395486|4971202|P1|Overall Study|Adverse Event|1
1513563|NCT00395460|4971232|P2|Overall Study|Withdrawal by Subject|0
1513564|NCT00395460|4971233|P1|Overall Study|Withdrawal by Subject|1
1513565|NCT00395447|4971257|P2|Overall Study|Withdrawl - Other (not subject)|17
1513566|NCT00395447|4971258|P1|Overall Study|Withdrawl - Other (not subject)|8
1513567|NCT00395447|4971257|P2|Overall Study|Withdrawal by Subject|19
1513568|NCT00395447|4971258|P1|Overall Study|Withdrawal by Subject|24
1513569|NCT00395447|4971257|P2|Overall Study|Lost to Follow-up|43
1513570|NCT00395447|4971258|P1|Overall Study|Lost to Follow-up|52
1513571|NCT00395447|4971257|P2|Overall Study|Death|32
1513572|NCT00395447|4971258|P1|Overall Study|Death|37
1513573|NCT00395343|4971266|P2|Overall Study|Other|2
1513574|NCT00395343|4971267|P1|Overall Study|Other|5
1513575|NCT00395343|4971266|P2|Overall Study|Withdrawal by Subject|12
1513576|NCT00395343|4971267|P1|Overall Study|Withdrawal by Subject|11
1513577|NCT00395343|4971266|P2|Overall Study|Protocol Violation|8
1513578|NCT00395343|4971267|P1|Overall Study|Protocol Violation|6
1513579|NCT00395343|4971266|P2|Overall Study|Physician Decision|4
1513580|NCT00395343|4971267|P1|Overall Study|Physician Decision|2
1513581|NCT00395343|4971266|P2|Overall Study|Lost to Follow-up|4
1513582|NCT00395343|4971267|P1|Overall Study|Lost to Follow-up|4
1513583|NCT00395343|4971266|P2|Overall Study|Lack of Efficacy|1
1513584|NCT00395343|4971267|P1|Overall Study|Lack of Efficacy|0
1513585|NCT00395343|4971266|P2|Overall Study|Adverse Event|5
1513586|NCT00395343|4971267|P1|Overall Study|Adverse Event|13
1513587|NCT00395304|4971285|P6|Treatment Period 3|Other|0
1513588|NCT00395304|4971286|P5|Treatment Period 3|Other|0
1513589|NCT00395304|4971287|P4|Treatment Period 3|Other|1
1513590|NCT00395304|4971288|P3|Treatment Period 3|Other|0
1513591|NCT00395304|4971289|P2|Treatment Period 3|Other|0
1513592|NCT00395304|4971290|P1|Treatment Period 3|Other|0
1513593|NCT00395304|4971285|P6|Treatment Period 3|Physician Decision|0
1513594|NCT00395304|4971286|P5|Treatment Period 3|Physician Decision|0
1513595|NCT00395304|4971287|P4|Treatment Period 3|Physician Decision|0
1513596|NCT00395304|4971288|P3|Treatment Period 3|Physician Decision|0
1513597|NCT00395304|4971289|P2|Treatment Period 3|Physician Decision|1
1513598|NCT00395304|4971290|P1|Treatment Period 3|Physician Decision|0
1513599|NCT00395304|4971285|P6|Treatment Period 3|Lost to Follow-up|0
1513600|NCT00395304|4971286|P5|Treatment Period 3|Lost to Follow-up|0
1513601|NCT00395304|4971287|P4|Treatment Period 3|Lost to Follow-up|0
1513602|NCT00395304|4971288|P3|Treatment Period 3|Lost to Follow-up|0
1513603|NCT00395304|4971289|P2|Treatment Period 3|Lost to Follow-up|1
1513604|NCT00395304|4971290|P1|Treatment Period 3|Lost to Follow-up|1
1513605|NCT00395304|4971285|P6|Treatment Period 3|Withdrawal by Subject|1
1513606|NCT00395304|4971286|P5|Treatment Period 3|Withdrawal by Subject|0
1513607|NCT00395304|4971287|P4|Treatment Period 3|Withdrawal by Subject|1
1513608|NCT00395304|4971288|P3|Treatment Period 3|Withdrawal by Subject|0
1513609|NCT00395304|4971289|P2|Treatment Period 3|Withdrawal by Subject|0
1513610|NCT00395304|4971290|P1|Treatment Period 3|Withdrawal by Subject|0
1513611|NCT00395304|4971285|P6|Treatment Period 2|Other|0
1513612|NCT00395304|4971286|P5|Treatment Period 2|Other|0
1513613|NCT00395304|4971287|P4|Treatment Period 2|Other|0
1513614|NCT00395304|4971288|P3|Treatment Period 2|Other|0
1513615|NCT00395304|4971289|P2|Treatment Period 2|Other|1
1513616|NCT00395304|4971290|P1|Treatment Period 2|Other|0
1513617|NCT00395304|4971285|P6|Treatment Period 2|Physician Decision|0
1513618|NCT00395304|4971286|P5|Treatment Period 2|Physician Decision|0
1513619|NCT00395304|4971287|P4|Treatment Period 2|Physician Decision|0
1513620|NCT00395304|4971288|P3|Treatment Period 2|Physician Decision|1
1513621|NCT00395304|4971289|P2|Treatment Period 2|Physician Decision|0
1513622|NCT00395304|4971290|P1|Treatment Period 2|Physician Decision|0
1513623|NCT00395304|4971285|P6|Treatment Period 2|Lost to Follow-up|0
1513624|NCT00395304|4971286|P5|Treatment Period 2|Lost to Follow-up|0
1513625|NCT00395304|4971287|P4|Treatment Period 2|Lost to Follow-up|0
1513626|NCT00395304|4971288|P3|Treatment Period 2|Lost to Follow-up|0
1513627|NCT00395304|4971289|P2|Treatment Period 2|Lost to Follow-up|3
1513628|NCT00395304|4971290|P1|Treatment Period 2|Lost to Follow-up|0
1513629|NCT00395304|4971285|P6|Treatment Period 2|Withdrawal by Subject|2
1513630|NCT00395304|4971286|P5|Treatment Period 2|Withdrawal by Subject|0
1513631|NCT00395304|4971287|P4|Treatment Period 2|Withdrawal by Subject|1
1513632|NCT00395304|4971288|P3|Treatment Period 2|Withdrawal by Subject|0
1513633|NCT00395304|4971289|P2|Treatment Period 2|Withdrawal by Subject|0
1513634|NCT00395304|4971290|P1|Treatment Period 2|Withdrawal by Subject|0
1513635|NCT00395304|4971285|P6|Treatment Period 1|Physician Decision|0
1513636|NCT00395304|4971286|P5|Treatment Period 1|Physician Decision|0
1513637|NCT00395304|4971287|P4|Treatment Period 1|Physician Decision|0
1513638|NCT00395304|4971288|P3|Treatment Period 1|Physician Decision|0
1513639|NCT00395304|4971289|P2|Treatment Period 1|Physician Decision|1
1513640|NCT00395304|4971290|P1|Treatment Period 1|Physician Decision|0
1513641|NCT00395304|4971285|P6|Treatment Period 1|Lost to Follow-up|1
1513642|NCT00395304|4971286|P5|Treatment Period 1|Lost to Follow-up|0
1513643|NCT00395304|4971287|P4|Treatment Period 1|Lost to Follow-up|1
1513644|NCT00395304|4971288|P3|Treatment Period 1|Lost to Follow-up|0
1513645|NCT00395304|4971289|P2|Treatment Period 1|Lost to Follow-up|0
1513646|NCT00395304|4971290|P1|Treatment Period 1|Lost to Follow-up|1
1513647|NCT00395304|4971285|P6|Treatment Period 1|Withdrawal by Subject|1
1513648|NCT00395304|4971286|P5|Treatment Period 1|Withdrawal by Subject|1
1513649|NCT00395304|4971287|P4|Treatment Period 1|Withdrawal by Subject|2
1513650|NCT00395304|4971288|P3|Treatment Period 1|Withdrawal by Subject|0
1513651|NCT00395304|4971289|P2|Treatment Period 1|Withdrawal by Subject|3
1513652|NCT00395304|4971290|P1|Treatment Period 1|Withdrawal by Subject|0
1513653|NCT00395226|4971366|P2|Overall Study|Lost to Follow-up|1
1513654|NCT00395226|4971367|P1|Overall Study|Lost to Follow-up|0
1513655|NCT00395226|4971366|P2|Overall Study|Withdrawal by Subject|1
1513656|NCT00395226|4971367|P1|Overall Study|Withdrawal by Subject|0
1513657|NCT00395226|4971366|P2|Overall Study|Adverse Event|3
1513658|NCT00395226|4971367|P1|Overall Study|Adverse Event|4
1513659|NCT00395083|4971414|P2|Overall Study|Developed another disease|3
1513660|NCT00395083|4971415|P1|Overall Study|Developed another disease|4
1513661|NCT00395083|4971414|P2|Overall Study|Withdrawal by Subject|5
1513662|NCT00395083|4971415|P1|Overall Study|Withdrawal by Subject|6
1513663|NCT00395018|4971481|P1|Off-Treatment Follow-up|Poor/non-compliance|1
1513664|NCT00395018|4971481|P1|Off-Treatment Follow-up|Lost to Follow-up|2
1513665|NCT00395018|4971481|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
1513666|NCT00395018|4971481|P1|On-Treatment|Subject no longer meets study criteria|2
1513667|NCT00395018|4971481|P1|On-Treatment|Poor/non-compliance|2
1513668|NCT00395018|4971481|P1|On-Treatment|Other Reason|2
1513669|NCT00395018|4971481|P1|On-Treatment|Death|4
1513670|NCT00394953|4971502|P2|Second Treatment Period|Not defined|8
1513671|NCT00394953|4971503|P1|Second Treatment Period|Not defined|3
1513672|NCT00394953|4971502|P2|Second Treatment Period|Renal transplant|6
1513673|NCT00394953|4971503|P1|Second Treatment Period|Renal transplant|4
1513674|NCT00394953|4971502|P2|Second Treatment Period|Lost to Follow-up|1
1513675|NCT00394953|4971503|P1|Second Treatment Period|Lost to Follow-up|0
1513676|NCT00394953|4971502|P2|Second Treatment Period|Withdrawal by Subject|3
1513677|NCT00394953|4971503|P1|Second Treatment Period|Withdrawal by Subject|3
1513678|NCT00394953|4971502|P2|Second Treatment Period|Lack of Efficacy|47
1513679|NCT00394953|4971503|P1|Second Treatment Period|Lack of Efficacy|9
1513680|NCT00394953|4971502|P2|Second Treatment Period|Death|4
1513681|NCT00394953|4971503|P1|Second Treatment Period|Death|8
1513682|NCT00394953|4971502|P2|Second Treatment Period|Adverse Event|5
1513683|NCT00394953|4971503|P1|Second Treatment Period|Adverse Event|2
1513684|NCT00394953|4971502|P2|First Treatment Period|Not defined|1
1513685|NCT00394953|4971503|P1|First Treatment Period|Not defined|4
1513686|NCT00394953|4971502|P2|First Treatment Period|Renal transplant|7
1513687|NCT00394953|4971503|P1|First Treatment Period|Renal transplant|11
1513688|NCT00394953|4971502|P2|First Treatment Period|Lost to Follow-up|1
1513689|NCT00394953|4971503|P1|First Treatment Period|Lost to Follow-up|0
1513690|NCT00394953|4971502|P2|First Treatment Period|Withdrawal by Subject|3
1513691|NCT00394953|4971503|P1|First Treatment Period|Withdrawal by Subject|6
1513692|NCT00394953|4971502|P2|First Treatment Period|Lack of Efficacy|1
1513693|NCT00394953|4971503|P1|First Treatment Period|Lack of Efficacy|1
1513694|NCT00394953|4971502|P2|First Treatment Period|Death|7
1513695|NCT00394953|4971503|P1|First Treatment Period|Death|6
1513696|NCT00394953|4971502|P2|First Treatment Period|Adverse Event|2
1513697|NCT00394953|4971503|P1|First Treatment Period|Adverse Event|1
1513698|NCT00394914|4971521|P3|Treatment Period|Did not meet protocol eligibility|1
1513699|NCT00394914|4971522|P2|Treatment Period|Did not meet protocol eligibility|1
1513700|NCT00394914|4971523|P1|Treatment Period|Did not meet protocol eligibility|0
1513701|NCT00394914|4971521|P3|Treatment Period|Noncompliance with protocol|2
1513702|NCT00394914|4971522|P2|Treatment Period|Noncompliance with protocol|3
1513703|NCT00394914|4971523|P1|Treatment Period|Noncompliance with protocol|0
1513704|NCT00394914|4971521|P3|Treatment Period|Withdrawal by Subject|2
1513705|NCT00394914|4971522|P2|Treatment Period|Withdrawal by Subject|2
1513706|NCT00394914|4971523|P1|Treatment Period|Withdrawal by Subject|0
1513707|NCT00394914|4971521|P3|Treatment Period|Lost to Follow-up|0
1513708|NCT00394914|4971522|P2|Treatment Period|Lost to Follow-up|1
1513709|NCT00394914|4971523|P1|Treatment Period|Lost to Follow-up|0
1513710|NCT00394914|4971521|P3|Treatment Period|Adverse Event|1
1513711|NCT00394914|4971522|P2|Treatment Period|Adverse Event|3
1513712|NCT00394914|4971523|P1|Treatment Period|Adverse Event|0
1513713|NCT00394901|4971551|P4|Double-blind Phase|Found not to meet entrance criteria|1
1513714|NCT00394901|4971552|P3|Double-blind Phase|Found not to meet entrance criteria|0
1513715|NCT00394901|4971553|P2|Double-blind Phase|Found not to meet entrance criteria|0
1513716|NCT00394901|4971554|P1|Double-blind Phase|Found not to meet entrance criteria|0
1513717|NCT00394901|4971551|P4|Double-blind Phase|Entry into another study was found|0
1513718|NCT00394901|4971552|P3|Double-blind Phase|Entry into another study was found|1
1513719|NCT00394901|4971553|P2|Double-blind Phase|Entry into another study was found|0
1513720|NCT00394901|4971554|P1|Double-blind Phase|Entry into another study was found|0
1513721|NCT00394901|4971551|P4|Double-blind Phase|Lack of Compliance|0
1513722|NCT00394901|4971552|P3|Double-blind Phase|Lack of Compliance|0
1513723|NCT00394901|4971553|P2|Double-blind Phase|Lack of Compliance|3
1513724|NCT00394901|4971554|P1|Double-blind Phase|Lack of Compliance|0
1513725|NCT00394901|4971551|P4|Double-blind Phase|Subject's Personal Reason|1
1513726|NCT00394901|4971552|P3|Double-blind Phase|Subject's Personal Reason|0
1513727|NCT00394901|4971553|P2|Double-blind Phase|Subject's Personal Reason|0
1513728|NCT00394901|4971554|P1|Double-blind Phase|Subject's Personal Reason|1
1513729|NCT00394901|4971551|P4|Double-blind Phase|Death|0
1513730|NCT00394901|4971552|P3|Double-blind Phase|Death|0
1513731|NCT00394901|4971553|P2|Double-blind Phase|Death|0
1513732|NCT00394901|4971554|P1|Double-blind Phase|Death|1
1513733|NCT00394901|4971551|P4|Double-blind Phase|Protocol Violation|1
1513734|NCT00394901|4971552|P3|Double-blind Phase|Protocol Violation|0
1513735|NCT00394901|4971553|P2|Double-blind Phase|Protocol Violation|0
1513736|NCT00394901|4971554|P1|Double-blind Phase|Protocol Violation|0
1513737|NCT00394901|4971551|P4|Double-blind Phase|Lost to Follow-up|1
1513738|NCT00394901|4971552|P3|Double-blind Phase|Lost to Follow-up|0
1513739|NCT00394901|4971553|P2|Double-blind Phase|Lost to Follow-up|0
1513740|NCT00394901|4971554|P1|Double-blind Phase|Lost to Follow-up|0
1513741|NCT00394901|4971551|P4|Double-blind Phase|Withdrawal by Subject|0
1513742|NCT00394901|4971552|P3|Double-blind Phase|Withdrawal by Subject|0
1513743|NCT00394901|4971553|P2|Double-blind Phase|Withdrawal by Subject|0
1513744|NCT00394901|4971554|P1|Double-blind Phase|Withdrawal by Subject|2
1513745|NCT00394901|4971551|P4|Double-blind Phase|Lack of Efficacy|3
1513746|NCT00394901|4971552|P3|Double-blind Phase|Lack of Efficacy|1
1513747|NCT00394901|4971553|P2|Double-blind Phase|Lack of Efficacy|4
1513748|NCT00394901|4971554|P1|Double-blind Phase|Lack of Efficacy|6
1513749|NCT00394901|4971551|P4|Double-blind Phase|Adverse Event|20
1513750|NCT00394901|4971552|P3|Double-blind Phase|Adverse Event|16
1513751|NCT00394901|4971553|P2|Double-blind Phase|Adverse Event|7
1513752|NCT00394901|4971554|P1|Double-blind Phase|Adverse Event|5
1513753|NCT00394901|4971551|P4|Baseline Phase|Protocol Violation|0
1513754|NCT00394901|4971552|P3|Baseline Phase|Protocol Violation|1
1513755|NCT00394901|4971553|P2|Baseline Phase|Protocol Violation|0
1513756|NCT00394901|4971554|P1|Baseline Phase|Protocol Violation|0
1513757|NCT00394836|4971797|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
1513758|NCT00394836|4971798|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
1513759|NCT00394836|4971797|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
1513760|NCT00394836|4971798|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
1513761|NCT00394836|4971797|P2|Extended Follow-up Phase (2-5 Years)|Death|1
1513762|NCT00394836|4971798|P1|Extended Follow-up Phase (2-5 Years)|Death|0
1513763|NCT00394836|4971797|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
1513764|NCT00394836|4971798|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
1513765|NCT00394836|4971797|P2|Teatment or Follow-up Phase|Non compliance|1
1513766|NCT00394836|4971798|P1|Teatment or Follow-up Phase|Non compliance|0
1513767|NCT00394836|4971797|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
1513768|NCT00394836|4971798|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
1513769|NCT00394836|4971797|P2|Teatment or Follow-up Phase|Physician Decision|1
1513770|NCT00394836|4971798|P1|Teatment or Follow-up Phase|Physician Decision|0
1513771|NCT00394836|4971797|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
1513772|NCT00394836|4971798|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
1513773|NCT00394836|4971797|P2|Teatment or Follow-up Phase|Started alternative treatment|6
1513774|NCT00394836|4971798|P1|Teatment or Follow-up Phase|Started alternative treatment|0
1513775|NCT00394836|4971797|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
1513776|NCT00394836|4971798|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
1513777|NCT00394836|4971797|P2|Teatment or Follow-up Phase|Death|1
1513778|NCT00394836|4971798|P1|Teatment or Follow-up Phase|Death|0
1513779|NCT00394836|4971797|P2|Teatment or Follow-up Phase|Patient Refusal|2
1513780|NCT00394836|4971798|P1|Teatment or Follow-up Phase|Patient Refusal|1
1513781|NCT00394836|4971797|P2|Teatment or Follow-up Phase|Disease Progression|60
1513782|NCT00394836|4971798|P1|Teatment or Follow-up Phase|Disease Progression|27
1513783|NCT00394836|4971797|P2|Teatment or Follow-up Phase|Protocol Violation|2
1513784|NCT00394836|4971798|P1|Teatment or Follow-up Phase|Protocol Violation|0
1513785|NCT00394836|4971797|P2|Teatment or Follow-up Phase|Adverse Event|2
1513786|NCT00394836|4971798|P1|Teatment or Follow-up Phase|Adverse Event|0
1513787|NCT00394771|4971844|P4|Overall Study|Not specified|0
1513788|NCT00394771|4971845|P3|Overall Study|Not specified|1
1513789|NCT00394771|4971846|P2|Overall Study|Not specified|3
1513790|NCT00394771|4971847|P1|Overall Study|Not specified|3
1513791|NCT00394771|4971844|P4|Overall Study|Lost to Follow-up|10
1513792|NCT00394771|4971845|P3|Overall Study|Lost to Follow-up|13
1513793|NCT00394771|4971846|P2|Overall Study|Lost to Follow-up|15
1513794|NCT00394771|4971847|P1|Overall Study|Lost to Follow-up|15
1513795|NCT00394771|4971844|P4|Overall Study|Participant pregnant|2
1513796|NCT00394771|4971845|P3|Overall Study|Participant pregnant|2
1513797|NCT00394771|4971846|P2|Overall Study|Participant pregnant|1
1513798|NCT00394771|4971847|P1|Overall Study|Participant pregnant|0
1513799|NCT00394771|4971844|P4|Overall Study|Adverse Event|8
1513800|NCT00394771|4971845|P3|Overall Study|Adverse Event|12
1513801|NCT00394771|4971846|P2|Overall Study|Adverse Event|5
1513802|NCT00394771|4971847|P1|Overall Study|Adverse Event|10
1513803|NCT00394771|4971844|P4|Overall Study|Withdrawal by Subject|12
1513804|NCT00394771|4971845|P3|Overall Study|Withdrawal by Subject|8
1513805|NCT00394771|4971846|P2|Overall Study|Withdrawal by Subject|6
1513806|NCT00394771|4971847|P1|Overall Study|Withdrawal by Subject|10
1513807|NCT00394771|4971844|P4|Overall Study|Protocol Violation|7
1513808|NCT00394771|4971845|P3|Overall Study|Protocol Violation|9
1513809|NCT00394771|4971846|P2|Overall Study|Protocol Violation|4
1513810|NCT00394771|4971847|P1|Overall Study|Protocol Violation|2
1513811|NCT00394771|4971844|P4|Overall Study|Did not meet protocol requirements|0
1513812|NCT00394771|4971845|P3|Overall Study|Did not meet protocol requirements|2
1513813|NCT00394771|4971846|P2|Overall Study|Did not meet protocol requirements|0
1513814|NCT00394771|4971847|P1|Overall Study|Did not meet protocol requirements|1
1513815|NCT00394706|4971917|P8|Overall Study|Lost to Follow-up|0
1513816|NCT00394706|4971918|P7|Overall Study|Lost to Follow-up|2
1513817|NCT00394706|4971919|P6|Overall Study|Lost to Follow-up|5
1513818|NCT00394706|4971920|P5|Overall Study|Lost to Follow-up|2
1513819|NCT00394706|4971921|P4|Overall Study|Lost to Follow-up|1
1513820|NCT00394706|4971922|P3|Overall Study|Lost to Follow-up|8
1513821|NCT00394706|4971923|P2|Overall Study|Lost to Follow-up|2
1513822|NCT00394706|4971924|P1|Overall Study|Lost to Follow-up|2
1513823|NCT00394706|4971917|P8|Overall Study|Withdrawal by Subject|0
1513824|NCT00394706|4971918|P7|Overall Study|Withdrawal by Subject|1
1513825|NCT00394706|4971919|P6|Overall Study|Withdrawal by Subject|2
1513826|NCT00394706|4971920|P5|Overall Study|Withdrawal by Subject|0
1513827|NCT00394706|4971921|P4|Overall Study|Withdrawal by Subject|0
1513828|NCT00394706|4971922|P3|Overall Study|Withdrawal by Subject|1
1513829|NCT00394706|4971923|P2|Overall Study|Withdrawal by Subject|0
1513830|NCT00394706|4971924|P1|Overall Study|Withdrawal by Subject|2
1513831|NCT00394654|4971956|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
1513832|NCT00394654|4971957|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
1513833|NCT00394654|4971956|P2|Overall Study|Lost to Follow-up|0
1513834|NCT00394654|4971957|P1|Overall Study|Lost to Follow-up|1
1513835|NCT00394589|4972022|P3|Overall Study|Protocol Violation|2
1513836|NCT00394589|4972023|P2|Overall Study|Protocol Violation|0
1513837|NCT00394589|4972024|P1|Overall Study|Protocol Violation|4
1513838|NCT00394589|4972022|P3|Overall Study|Lack of Efficacy|3
1513839|NCT00394589|4972023|P2|Overall Study|Lack of Efficacy|2
1513840|NCT00394589|4972024|P1|Overall Study|Lack of Efficacy|2
1513841|NCT00394589|4972022|P3|Overall Study|Adverse Event|2
1513842|NCT00394589|4972023|P2|Overall Study|Adverse Event|1
1513843|NCT00394589|4972024|P1|Overall Study|Adverse Event|2
1513844|NCT00394524|4972034|P2|Overall Study|Withdrawal by Subject|10
1513845|NCT00394524|4972035|P1|Overall Study|Withdrawal by Subject|11
1513846|NCT00394472|4972047|P2|Overall Study|Lost to Follow-up|1
1513847|NCT00394472|4972048|P1|Overall Study|Lost to Follow-up|0
1513848|NCT00394472|4972047|P2|Overall Study|Physician Decision|1
1513849|NCT00394472|4972048|P1|Overall Study|Physician Decision|0
1513850|NCT00394472|4972047|P2|Overall Study|Withdrawal by Subject|2
1513851|NCT00394472|4972048|P1|Overall Study|Withdrawal by Subject|0
1513852|NCT00394472|4972047|P2|Overall Study|Adverse Event|2
1513853|NCT00394472|4972048|P1|Overall Study|Adverse Event|4
1513854|NCT00394472|4972047|P2|Overall Study|incorrect enrolment|2
1513855|NCT00394472|4972048|P1|Overall Study|incorrect enrolment|4
1513856|NCT00394472|4972047|P2|Overall Study|Protocol Violation|3
1513857|NCT00394472|4972048|P1|Overall Study|Protocol Violation|1
1513858|NCT00394433|4972056|P1|Overall Study|Alternative Therapy|1
1513859|NCT00394433|4972056|P1|Overall Study|Adverse Event|2
1513860|NCT00394355|4972067|P4|Overall Study|Lack of Efficacy|3
1513861|NCT00394355|4972068|P3|Overall Study|Lack of Efficacy|2
1513862|NCT00394355|4972069|P2|Overall Study|Lack of Efficacy|0
1513863|NCT00394355|4972070|P1|Overall Study|Lack of Efficacy|0
1513864|NCT00394355|4972067|P4|Overall Study|Administrative|1
1513865|NCT00394355|4972068|P3|Overall Study|Administrative|1
1513866|NCT00394355|4972069|P2|Overall Study|Administrative|1
1513867|NCT00394355|4972070|P1|Overall Study|Administrative|0
1513868|NCT00394355|4972067|P4|Overall Study|Noncompliance with protocol|8
1513869|NCT00394355|4972068|P3|Overall Study|Noncompliance with protocol|10
1513870|NCT00394355|4972069|P2|Overall Study|Noncompliance with protocol|3
1513871|NCT00394355|4972070|P1|Overall Study|Noncompliance with protocol|4
1513872|NCT00394355|4972067|P4|Overall Study|Lost to Follow-up|3
1513873|NCT00394355|4972068|P3|Overall Study|Lost to Follow-up|4
1513874|NCT00394355|4972069|P2|Overall Study|Lost to Follow-up|5
1513875|NCT00394355|4972070|P1|Overall Study|Lost to Follow-up|7
1513876|NCT00394355|4972067|P4|Overall Study|Subject withdrawal - related to drug|0
1513877|NCT00394355|4972068|P3|Overall Study|Subject withdrawal - related to drug|0
1513878|NCT00394355|4972069|P2|Overall Study|Subject withdrawal - related to drug|0
1513879|NCT00394355|4972070|P1|Overall Study|Subject withdrawal - related to drug|1
1513880|NCT00394355|4972067|P4|Overall Study|Subject withdrawal - unrelated to drug|6
1513881|NCT00394355|4972068|P3|Overall Study|Subject withdrawal - unrelated to drug|10
1513882|NCT00394355|4972069|P2|Overall Study|Subject withdrawal - unrelated to drug|14
1513883|NCT00394355|4972070|P1|Overall Study|Subject withdrawal - unrelated to drug|12
1513884|NCT00394355|4972067|P4|Overall Study|Did not meet protocol eligibility|2
1513885|NCT00394355|4972068|P3|Overall Study|Did not meet protocol eligibility|4
1513886|NCT00394355|4972069|P2|Overall Study|Did not meet protocol eligibility|5
1513887|NCT00394355|4972070|P1|Overall Study|Did not meet protocol eligibility|1
1513888|NCT00394355|4972067|P4|Overall Study|Adverse Event|8
1513889|NCT00394355|4972068|P3|Overall Study|Adverse Event|7
1513890|NCT00394355|4972069|P2|Overall Study|Adverse Event|6
1513891|NCT00394355|4972070|P1|Overall Study|Adverse Event|10
1513892|NCT00394251|4972176|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
1513893|NCT00394251|4972177|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
1513894|NCT00394251|4972176|P2|Overall Study|Withdrawal by Subject|11
1513895|NCT00394251|4972177|P1|Overall Study|Withdrawal by Subject|7
1513896|NCT00394251|4972176|P2|Overall Study|Protocol Violation|1
1513897|NCT00394251|4972177|P1|Overall Study|Protocol Violation|0
1513898|NCT00394251|4972176|P2|Overall Study|Physician Decision|1
1513899|NCT00394251|4972177|P1|Overall Study|Physician Decision|1
1513900|NCT00394251|4972176|P2|Overall Study|Unacceptable Toxicity|18
1513901|NCT00394251|4972177|P1|Overall Study|Unacceptable Toxicity|20
1513902|NCT00394251|4972176|P2|Overall Study|Adverse Event|5
1513903|NCT00394251|4972177|P1|Overall Study|Adverse Event|7
1513904|NCT00394212|4972205|P2|Overall Study|Withdrawal by Subject|1
1513905|NCT00394212|4972206|P1|Overall Study|Withdrawal by Subject|4
1513906|NCT00394212|4972205|P2|Overall Study|Lost to Follow-up|0
1513907|NCT00394212|4972206|P1|Overall Study|Lost to Follow-up|3
1513908|NCT00394095|4972220|P2|Overall Study|Adverse Event|0
1513909|NCT00394095|4972221|P1|Overall Study|Adverse Event|1
1513910|NCT00394082|4972229|P1|Overall Study|Not specified|1
1513911|NCT00394082|4972229|P1|Overall Study|Withdrawal by Subject|2
1513912|NCT00394082|4972229|P1|Overall Study|Physician Decision|4
1513913|NCT00394082|4972229|P1|Overall Study|Adverse Event|4
1513914|NCT00394082|4972229|P1|Overall Study|Unacceptable toxicity|15
1513915|NCT00393939|4972251|P2|Overall Study|Not specified|45
1513916|NCT00393939|4972252|P1|Overall Study|Not specified|37
1513917|NCT00393939|4972251|P2|Overall Study|Withdrawal by Subject|7
1513918|NCT00393939|4972252|P1|Overall Study|Withdrawal by Subject|2
1513919|NCT00393939|4972251|P2|Overall Study|Objective progression or relapse|223
1513920|NCT00393939|4972252|P1|Overall Study|Objective progression or relapse|239
1513921|NCT00393939|4972251|P2|Overall Study|Sponsor|13
1513922|NCT00393939|4972252|P1|Overall Study|Sponsor|5
1513923|NCT00393939|4972251|P2|Overall Study|Death|4
1513924|NCT00393939|4972252|P1|Overall Study|Death|10
1513925|NCT00393939|4972251|P2|Overall Study|Lost to Follow-up|4
1513926|NCT00393939|4972252|P1|Overall Study|Lost to Follow-up|2
1513927|NCT00393939|4972251|P2|Overall Study|Protocol Violation|1
1513928|NCT00393939|4972252|P1|Overall Study|Protocol Violation|1
1513929|NCT00393913|4972270|P1|CPAP|TEchnical problem with CPAP|3
1513930|NCT00393913|4972270|P1|CPAP|Physician Decision|1
1513931|NCT00393913|4972270|P1|CPAP|Withdrawal by Subject|3
1513932|NCT00393913|4972270|P1|Initial Assessment|Withdrawal by Subject|16
1513933|NCT00393913|4972270|P1|Initial Assessment|diagnosed with other sleep disorder|21
1513934|NCT00393887|4972278|P2|Overall Study|Lost to Follow-up|9
1513935|NCT00393887|4972279|P1|Overall Study|Lost to Follow-up|11
1513936|NCT00393887|4972278|P2|Overall Study|Physician Decision|0
1513937|NCT00393887|4972279|P1|Overall Study|Physician Decision|5
1513938|NCT00393861|4972307|P1|Overall Study|Disease Progression|24
1513939|NCT00393861|4972307|P1|Overall Study|Adverse Event|2
1513940|NCT00393848|4972318|P4|Overall Study|Personal reasons|0
1513941|NCT00393848|4972319|P3|Overall Study|Personal reasons|2
1513942|NCT00393848|4972320|P2|Overall Study|Personal reasons|0
1513943|NCT00393848|4972321|P1|Overall Study|Personal reasons|0
1513944|NCT00393848|4972318|P4|Overall Study|Surgical schedule|1
1513945|NCT00393848|4972319|P3|Overall Study|Surgical schedule|0
1513946|NCT00393848|4972320|P2|Overall Study|Surgical schedule|0
1513947|NCT00393848|4972321|P1|Overall Study|Surgical schedule|0
1513948|NCT00393718|4972344|P2|Overall Study|Move|0
1513949|NCT00393718|4972345|P1|Overall Study|Move|1
1513950|NCT00393718|4972344|P2|Overall Study|Missed measurement|0
1513951|NCT00393718|4972345|P1|Overall Study|Missed measurement|1
1513952|NCT00393718|4972344|P2|Overall Study|Withdrawal of consent|1
1513953|NCT00393718|4972345|P1|Overall Study|Withdrawal of consent|2
1513954|NCT00393718|4972344|P2|Overall Study|Subject decision|0
1513955|NCT00393718|4972345|P1|Overall Study|Subject decision|5
1513956|NCT00393718|4972344|P2|Overall Study|Hypoglycaemia|2
1513957|NCT00393718|4972345|P1|Overall Study|Hypoglycaemia|3
1513958|NCT00393718|4972344|P2|Overall Study|Lack of Efficacy|9
1513959|NCT00393718|4972345|P1|Overall Study|Lack of Efficacy|10
1513960|NCT00393718|4972344|P2|Overall Study|Protocol Violation|2
1513961|NCT00393718|4972345|P1|Overall Study|Protocol Violation|1
1513962|NCT00393718|4972344|P2|Overall Study|Adverse Event|8
1513963|NCT00393718|4972345|P1|Overall Study|Adverse Event|20
1513964|NCT00393705|4972377|P2|Overall Study|Physician Decision|2
1513965|NCT00393705|4972378|P1|Overall Study|Physician Decision|2
1513966|NCT00393705|4972377|P2|Overall Study|Withdrawal by Subject|3
1513967|NCT00393705|4972378|P1|Overall Study|Withdrawal by Subject|5
1513968|NCT00393705|4972377|P2|Overall Study|Protocol Violation|3
1513969|NCT00393705|4972378|P1|Overall Study|Protocol Violation|4
1513970|NCT00393705|4972377|P2|Overall Study|Entry Criteria Not Met|10
1513971|NCT00393705|4972378|P1|Overall Study|Entry Criteria Not Met|10
1513972|NCT00393705|4972377|P2|Overall Study|Lost to Follow-up|2
1513973|NCT00393705|4972378|P1|Overall Study|Lost to Follow-up|2
1513974|NCT00393705|4972377|P2|Overall Study|Death|1
1513975|NCT00393705|4972378|P1|Overall Study|Death|0
1513976|NCT00393705|4972377|P2|Overall Study|Adverse Event|2
1513977|NCT00393705|4972378|P1|Overall Study|Adverse Event|0
1513978|NCT00393523|4972407|P5|Overall Study|Vaccine supply issue|0
1513979|NCT00393523|4972408|P4|Overall Study|Vaccine supply issue|0
1513980|NCT00393523|4972409|P3|Overall Study|Vaccine supply issue|1
1513981|NCT00393523|4972410|P2|Overall Study|Vaccine supply issue|0
1513982|NCT00393523|4972411|P1|Overall Study|Vaccine supply issue|0
1513983|NCT00393523|4972407|P5|Overall Study|Difficulties in specimen collection|0
1513984|NCT00393523|4972408|P4|Overall Study|Difficulties in specimen collection|0
1513985|NCT00393523|4972409|P3|Overall Study|Difficulties in specimen collection|1
1513986|NCT00393523|4972410|P2|Overall Study|Difficulties in specimen collection|0
1513987|NCT00393523|4972411|P1|Overall Study|Difficulties in specimen collection|0
1513988|NCT00393523|4972407|P5|Overall Study|Withdrawal by Subject|0
1513989|NCT00393523|4972408|P4|Overall Study|Withdrawal by Subject|3
1513990|NCT00393523|4972409|P3|Overall Study|Withdrawal by Subject|2
1513991|NCT00393523|4972410|P2|Overall Study|Withdrawal by Subject|7
1513992|NCT00393523|4972411|P1|Overall Study|Withdrawal by Subject|6
1513993|NCT00393523|4972407|P5|Overall Study|Protocol Violation|0
1513994|NCT00393523|4972408|P4|Overall Study|Protocol Violation|1
1513995|NCT00393523|4972409|P3|Overall Study|Protocol Violation|0
1513996|NCT00393523|4972410|P2|Overall Study|Protocol Violation|2
1513997|NCT00393523|4972411|P1|Overall Study|Protocol Violation|6
1513998|NCT00393523|4972407|P5|Overall Study|Lost to Follow-up|1
1513999|NCT00393523|4972408|P4|Overall Study|Lost to Follow-up|2
1514000|NCT00393523|4972409|P3|Overall Study|Lost to Follow-up|0
1514001|NCT00393523|4972410|P2|Overall Study|Lost to Follow-up|0
1514002|NCT00393523|4972411|P1|Overall Study|Lost to Follow-up|0
1514003|NCT00393510|4972428|P2|Overall Study|Physician Decision|9
1514004|NCT00393510|4972429|P1|Overall Study|Physician Decision|3
1514005|NCT00393484|4972441|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
1514006|NCT00393484|4972442|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
1514007|NCT00393484|4972441|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
1514008|NCT00393484|4972442|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
1514009|NCT00393484|4972441|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
1514010|NCT00393484|4972442|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
1514011|NCT00393484|4972441|P2|Open-label Period (Weeks 96 to 240)|Death|0
1514012|NCT00393484|4972442|P1|Open-label Period (Weeks 96 to 240)|Death|1
1514013|NCT00393484|4972441|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
1514014|NCT00393484|4972442|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
1514015|NCT00393484|4972441|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
1514016|NCT00393484|4972442|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
1514017|NCT00393484|4972441|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
1514018|NCT00393484|4972442|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
1514019|NCT00393484|4972441|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
1514020|NCT00393484|4972442|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
1514021|NCT00393484|4972441|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
1514022|NCT00393484|4972442|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
1514023|NCT00393484|4972441|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
1514024|NCT00393484|4972442|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
1514025|NCT00393458|4972478|P4|Overall Study|Subject no longer requires study drug|0
1514026|NCT00393458|4972479|P3|Overall Study|Subject no longer requires study drug|0
1514027|NCT00393458|4972480|P2|Overall Study|Subject no longer requires study drug|1
1514028|NCT00393458|4972481|P1|Overall Study|Subject no longer requires study drug|0
1514029|NCT00393458|4972478|P4|Overall Study|Abnormal test procedure result(s)|2
1514030|NCT00393458|4972479|P3|Overall Study|Abnormal test procedure result(s)|1
1514031|NCT00393458|4972480|P2|Overall Study|Abnormal test procedure result(s)|1
1514032|NCT00393458|4972481|P1|Overall Study|Abnormal test procedure result(s)|0
1514033|NCT00393458|4972478|P4|Overall Study|Death|5
1514034|NCT00393458|4972479|P3|Overall Study|Death|5
1514035|NCT00393458|4972480|P2|Overall Study|Death|1
1514036|NCT00393458|4972481|P1|Overall Study|Death|1
1514037|NCT00393458|4972478|P4|Overall Study|Abnormal laboratory value(s)|0
1514038|NCT00393458|4972479|P3|Overall Study|Abnormal laboratory value(s)|0
1514039|NCT00393458|4972480|P2|Overall Study|Abnormal laboratory value(s)|1
1514040|NCT00393458|4972481|P1|Overall Study|Abnormal laboratory value(s)|1
1514041|NCT00393458|4972478|P4|Overall Study|Lost to Follow-up|3
1514042|NCT00393458|4972479|P3|Overall Study|Lost to Follow-up|5
1514043|NCT00393458|4972480|P2|Overall Study|Lost to Follow-up|6
1514044|NCT00393458|4972481|P1|Overall Study|Lost to Follow-up|5
1514045|NCT00393458|4972478|P4|Overall Study|Administrative problems|2
1514046|NCT00393458|4972479|P3|Overall Study|Administrative problems|5
1514047|NCT00393458|4972480|P2|Overall Study|Administrative problems|8
1514048|NCT00393458|4972481|P1|Overall Study|Administrative problems|7
1514049|NCT00393458|4972478|P4|Overall Study|Protocol deviation|10
1514050|NCT00393458|4972479|P3|Overall Study|Protocol deviation|11
1514051|NCT00393458|4972480|P2|Overall Study|Protocol deviation|11
1514052|NCT00393458|4972481|P1|Overall Study|Protocol deviation|11
1514053|NCT00393458|4972478|P4|Overall Study|Unsatisfactory therapeutic effect|30
1514054|NCT00393458|4972479|P3|Overall Study|Unsatisfactory therapeutic effect|12
1514055|NCT00393458|4972480|P2|Overall Study|Unsatisfactory therapeutic effect|9
1514056|NCT00393458|4972481|P1|Overall Study|Unsatisfactory therapeutic effect|12
1514057|NCT00393458|4972478|P4|Overall Study|Subject withdrew consent|50
1514058|NCT00393458|4972479|P3|Overall Study|Subject withdrew consent|33
1514059|NCT00393458|4972480|P2|Overall Study|Subject withdrew consent|40
1514060|NCT00393458|4972481|P1|Overall Study|Subject withdrew consent|27
1514061|NCT00393458|4972478|P4|Overall Study|Adverse Event|35
1514062|NCT00393458|4972479|P3|Overall Study|Adverse Event|40
1514063|NCT00393458|4972480|P2|Overall Study|Adverse Event|24
1514064|NCT00393458|4972481|P1|Overall Study|Adverse Event|35
1514065|NCT00393367|4972508|P2|Overall Study|Withdrawal by Subject|2
1514066|NCT00393367|4972509|P1|Overall Study|Withdrawal by Subject|0
1514067|NCT00393367|4972508|P2|Overall Study|Protocol Violation|5
1514068|NCT00393367|4972509|P1|Overall Study|Protocol Violation|2
1514069|NCT00393094|4972537|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
1514070|NCT00393094|4972537|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
1514071|NCT00393042|4972548|P2|Second Intervetion|Protocol Violation|1
1514072|NCT00393042|4972549|P1|Second Intervetion|Protocol Violation|1
1514073|NCT00393042|4972548|P2|Second Intervetion|Lost to Follow-up|2
1514074|NCT00393042|4972549|P1|Second Intervetion|Lost to Follow-up|0
1514075|NCT00393042|4972548|P2|Second Intervetion|Lack of Efficacy|0
1514076|NCT00393042|4972549|P1|Second Intervetion|Lack of Efficacy|1
1514077|NCT00393042|4972548|P2|Second Intervetion|Withdrawal by Subject|2
1514078|NCT00393042|4972549|P1|Second Intervetion|Withdrawal by Subject|0
1514079|NCT00393042|4972548|P2|Second Intervetion|Adverse Event|3
1514080|NCT00393042|4972549|P1|Second Intervetion|Adverse Event|0
1514081|NCT00393042|4972548|P2|First Intervention|Adverse Event|1
1514082|NCT00393042|4972549|P1|First Intervention|Adverse Event|0
1514083|NCT00393042|4972548|P2|First Intervention|Protocol Violation|0
1514084|NCT00393042|4972549|P1|First Intervention|Protocol Violation|1
1514085|NCT00393042|4972548|P2|First Intervention|Lost to Follow-up|3
1514086|NCT00393042|4972549|P1|First Intervention|Lost to Follow-up|3
1514087|NCT00393042|4972548|P2|First Intervention|Withdrawal by Subject|2
1514088|NCT00393042|4972549|P1|First Intervention|Withdrawal by Subject|1
1514089|NCT00393029|4972621|P2|Overall Study|Not treated|1
1514090|NCT00393029|4972622|P1|Overall Study|Not treated|0
1514091|NCT00392925|4972643|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
1514092|NCT00392925|4972644|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
1514093|NCT00392925|4972645|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
1514094|NCT00392925|4972646|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
1514095|NCT00392925|4972643|P4|Randomization to Treatment Group Period|Protocol Violation|1
1514096|NCT00392925|4972644|P3|Randomization to Treatment Group Period|Protocol Violation|2
1514097|NCT00392925|4972645|P2|Randomization to Treatment Group Period|Protocol Violation|0
1514098|NCT00392925|4972646|P1|Randomization to Treatment Group Period|Protocol Violation|0
1514099|NCT00392925|4972643|P4|Randomization to Treatment Group Period|Adverse Event|5
1514100|NCT00392925|4972644|P3|Randomization to Treatment Group Period|Adverse Event|3
1514101|NCT00392925|4972645|P2|Randomization to Treatment Group Period|Adverse Event|3
1514102|NCT00392925|4972646|P1|Randomization to Treatment Group Period|Adverse Event|0
1514103|NCT00392925|4972643|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
1514104|NCT00392925|4972644|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
1514105|NCT00392925|4972645|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
1514106|NCT00392925|4972646|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
1514107|NCT00392925|4972643|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
1514108|NCT00392925|4972644|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
1514109|NCT00392925|4972645|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
1514110|NCT00392925|4972646|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
1514111|NCT00392925|4972643|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
1514112|NCT00392925|4972644|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
1514113|NCT00392925|4972645|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
1514114|NCT00392925|4972646|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
1514115|NCT00392925|4972643|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
1514116|NCT00392925|4972644|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
1514117|NCT00392925|4972645|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
1514118|NCT00392925|4972646|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
1514119|NCT00392925|4972643|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
1514120|NCT00392925|4972644|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
1514121|NCT00392925|4972645|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
1514122|NCT00392925|4972646|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
1514123|NCT00392925|4972643|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
1514124|NCT00392925|4972644|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
1514125|NCT00392925|4972645|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
1514126|NCT00392925|4972646|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
1514127|NCT00392808|4972760|P4|Overall Study|Unable to withdraw blood|2
1514128|NCT00392808|4972761|P3|Overall Study|Unable to withdraw blood|1
1514129|NCT00392808|4972762|P2|Overall Study|Unable to withdraw blood|1
1514130|NCT00392808|4972763|P1|Overall Study|Unable to withdraw blood|3
1514131|NCT00392808|4972760|P4|Overall Study|Lost to Follow-up|2
1514132|NCT00392808|4972761|P3|Overall Study|Lost to Follow-up|1
1514133|NCT00392808|4972762|P2|Overall Study|Lost to Follow-up|2
1514134|NCT00392808|4972763|P1|Overall Study|Lost to Follow-up|3
1514135|NCT00392769|4972787|P1|Overall Study|Adverse Event|1
1514136|NCT00392769|4972787|P1|Overall Study|Clinical Deterioration|9
1514137|NCT00392665|4972839|P2|Overall Study|Lost to Follow-up|1
1514138|NCT00392665|4972840|P1|Overall Study|Lost to Follow-up|1
1514139|NCT00392665|4972839|P2|Overall Study|Death|14
1514140|NCT00392665|4972840|P1|Overall Study|Death|16
1514141|NCT00392379|4972866|P2|Overall Study|Adverse Event|1
1514142|NCT00392379|4972867|P1|Overall Study|Adverse Event|1
1514143|NCT00392379|4972866|P2|Overall Study|Lost to Follow-up|9
1514144|NCT00392379|4972867|P1|Overall Study|Lost to Follow-up|4
1514145|NCT00392379|4972866|P2|Overall Study|Withdrawal by Subject|28
1514146|NCT00392379|4972867|P1|Overall Study|Withdrawal by Subject|17
1514147|NCT00392288|4972880|P3|Overall Study|Other|1
1514148|NCT00392288|4972881|P2|Overall Study|Other|4
1514149|NCT00392288|4972882|P1|Overall Study|Other|3
1514150|NCT00392288|4972880|P3|Overall Study|Parent/legal guardian withdrawal|1
1514151|NCT00392288|4972881|P2|Overall Study|Parent/legal guardian withdrawal|2
1514152|NCT00392288|4972882|P1|Overall Study|Parent/legal guardian withdrawal|1
1514153|NCT00392288|4972880|P3|Overall Study|Withdrawal by Subject|2
1514154|NCT00392288|4972881|P2|Overall Study|Withdrawal by Subject|0
1514155|NCT00392288|4972882|P1|Overall Study|Withdrawal by Subject|1
1514156|NCT00392288|4972880|P3|Overall Study|Lost to Follow-up|1
1514157|NCT00392288|4972881|P2|Overall Study|Lost to Follow-up|1
1514158|NCT00392288|4972882|P1|Overall Study|Lost to Follow-up|1
1514159|NCT00392288|4972880|P3|Overall Study|Protocol Violation|1
1514160|NCT00392288|4972881|P2|Overall Study|Protocol Violation|3
1514161|NCT00392288|4972882|P1|Overall Study|Protocol Violation|1
1514162|NCT00392288|4972880|P3|Overall Study|Lack of Efficacy|3
1514163|NCT00392288|4972881|P2|Overall Study|Lack of Efficacy|5
1514164|NCT00392288|4972882|P1|Overall Study|Lack of Efficacy|8
1514165|NCT00392288|4972880|P3|Overall Study|Adverse Event|8
1514166|NCT00392288|4972881|P2|Overall Study|Adverse Event|7
1514167|NCT00392288|4972882|P1|Overall Study|Adverse Event|17
1514168|NCT00392223|4972907|P2|Overall Study|Withdrawal by Subject|2
1514169|NCT00392223|4972908|P1|Overall Study|Withdrawal by Subject|3
1514170|NCT00392223|4972907|P2|Overall Study|Protocol Violation|3
1514171|NCT00392223|4972908|P1|Overall Study|Protocol Violation|0
1514172|NCT00392223|4972907|P2|Overall Study|Lost to Follow-up|4
1514173|NCT00392223|4972908|P1|Overall Study|Lost to Follow-up|1
1514174|NCT00392223|4972907|P2|Overall Study|Adverse Event|4
1514175|NCT00392223|4972908|P1|Overall Study|Adverse Event|5
1514176|NCT00392210|4972926|P2|First Voiding Trial|Physician Decision|2
1514177|NCT00392210|4972927|P1|First Voiding Trial|Physician Decision|2
1514178|NCT00392197|4972935|P2|Overall Study|Withdrawal by Subject|6
1514179|NCT00392197|4972936|P1|Overall Study|Withdrawal by Subject|4
1514180|NCT00392197|4972935|P2|Overall Study|Protocol Violation|5
1514181|NCT00392197|4972936|P1|Overall Study|Protocol Violation|7
1514182|NCT00392197|4972935|P2|Overall Study|Physician Decision|2
1514183|NCT00392197|4972936|P1|Overall Study|Physician Decision|3
1514184|NCT00392197|4972935|P2|Overall Study|Lost to Follow-up|1
1514185|NCT00392197|4972936|P1|Overall Study|Lost to Follow-up|0
1514186|NCT00392197|4972935|P2|Overall Study|Lack of Efficacy|4
1514187|NCT00392197|4972936|P1|Overall Study|Lack of Efficacy|3
1514188|NCT00392197|4972935|P2|Overall Study|Adverse Event|12
1514189|NCT00392197|4972936|P1|Overall Study|Adverse Event|4
1514190|NCT00392171|4972944|P1|Overall Study|Disease progression|101
1514191|NCT00392171|4972944|P1|Overall Study|Did not meet inclusion criteria|4
1514192|NCT00391976|4972955|P3|Overall Study|Positive P. aeruginosa antibody test|31
1514193|NCT00391976|4972956|P2|Overall Study|Positive P. aeruginosa antibody test|0
1514194|NCT00391976|4972957|P1|Overall Study|Positive P. aeruginosa antibody test|0
1514195|NCT00391976|4972955|P3|Overall Study|Unable to classify|1
1514196|NCT00391976|4972956|P2|Overall Study|Unable to classify|0
1514197|NCT00391976|4972957|P1|Overall Study|Unable to classify|0
1514198|NCT00391976|4972955|P3|Overall Study|Recurrence/no eradication of infection|0
1514199|NCT00391976|4972956|P2|Overall Study|Recurrence/no eradication of infection|19
1514200|NCT00391976|4972957|P1|Overall Study|Recurrence/no eradication of infection|21
1514201|NCT00391976|4972955|P3|Overall Study|Protocol deviation/violation|1
1514202|NCT00391976|4972956|P2|Overall Study|Protocol deviation/violation|2
1514203|NCT00391976|4972957|P1|Overall Study|Protocol deviation/violation|4
1514204|NCT00391976|4972955|P3|Overall Study|Inappropriate enrollment|0
1514205|NCT00391976|4972956|P2|Overall Study|Inappropriate enrollment|1
1514206|NCT00391976|4972957|P1|Overall Study|Inappropriate enrollment|1
1514207|NCT00391976|4972955|P3|Overall Study|Lost to Follow-up|0
1514208|NCT00391976|4972956|P2|Overall Study|Lost to Follow-up|2
1514209|NCT00391976|4972957|P1|Overall Study|Lost to Follow-up|1
1514210|NCT00391976|4972955|P3|Overall Study|Withdrawal of consent|1
1514211|NCT00391976|4972956|P2|Overall Study|Withdrawal of consent|1
1514212|NCT00391976|4972957|P1|Overall Study|Withdrawal of consent|0
1514213|NCT00391976|4972955|P3|Overall Study|Adverse Event|1
1514214|NCT00391976|4972956|P2|Overall Study|Adverse Event|0
1514215|NCT00391976|4972957|P1|Overall Study|Adverse Event|0
1514216|NCT00391898|4972981|P2|Overall Study|Other|10
1514217|NCT00391898|4972982|P1|Overall Study|Other|8
1514218|NCT00391898|4972981|P2|Overall Study|Adverse Event|0
1514219|NCT00391898|4972982|P1|Overall Study|Adverse Event|3
1514220|NCT00391872|4973002|P2|Overall Study|Lost to Follow-up|0
1514221|NCT00391872|4973003|P1|Overall Study|Lost to Follow-up|2
1514222|NCT00391872|4973002|P2|Overall Study|Reason unknown|4
1514223|NCT00391872|4973003|P1|Overall Study|Reason unknown|2
1514224|NCT00391872|4973002|P2|Overall Study|Withdrawal by Subject|249
1514225|NCT00391872|4973003|P1|Overall Study|Withdrawal by Subject|296
1514226|NCT00391872|4973002|P2|Overall Study|Protocol Violation|2
1514227|NCT00391872|4973003|P1|Overall Study|Protocol Violation|7
1514228|NCT00391846|4973041|P2|Overall Study|Developed study specific DC criteria|1
1514229|NCT00391846|4973042|P1|Overall Study|Developed study specific DC criteria|0
1514230|NCT00391846|4973041|P2|Overall Study|Withdrawal by Subject|3
1514231|NCT00391846|4973042|P1|Overall Study|Withdrawal by Subject|2
1514232|NCT00391846|4973041|P2|Overall Study|Did not meet the required elig. crit|2
1514233|NCT00391846|4973042|P1|Overall Study|Did not meet the required elig. crit|2
1514234|NCT00391846|4973041|P2|Overall Study|Adverse Event|1
1514235|NCT00391846|4973042|P1|Overall Study|Adverse Event|4
1514236|NCT00391807|4973062|P1|Overall Study|Various|96
1514237|NCT00391807|4973062|P1|Overall Study|Protocol Violation|20
1514238|NCT00391807|4973062|P1|Overall Study|Withdrawal by Subject|147
1514239|NCT00391807|4973062|P1|Overall Study|Lost to Follow-up|227
1514240|NCT00391807|4973062|P1|Overall Study|Pregnancy|25
1514241|NCT00391807|4973062|P1|Overall Study|Adverse Event|177
1514242|NCT00391807|4973062|P1|Overall Study|Did not receive study medication|23
1514243|NCT00391768|4973089|P7|Overall Study|Lost to Follow-up|3
1514244|NCT00391768|4973090|P6|Overall Study|Lost to Follow-up|2
1514245|NCT00391768|4973091|P5|Overall Study|Lost to Follow-up|2
1514246|NCT00391768|4973092|P4|Overall Study|Lost to Follow-up|1
1514247|NCT00391768|4973093|P3|Overall Study|Lost to Follow-up|0
1514248|NCT00391768|4973094|P2|Overall Study|Lost to Follow-up|0
1514249|NCT00391768|4973095|P1|Overall Study|Lost to Follow-up|0
1514250|NCT00391768|4973089|P7|Overall Study|Withdrawal by Subject|1
1514251|NCT00391768|4973090|P6|Overall Study|Withdrawal by Subject|1
1514252|NCT00391768|4973091|P5|Overall Study|Withdrawal by Subject|0
1514253|NCT00391768|4973092|P4|Overall Study|Withdrawal by Subject|0
1514254|NCT00391768|4973093|P3|Overall Study|Withdrawal by Subject|1
1514255|NCT00391768|4973094|P2|Overall Study|Withdrawal by Subject|0
1514256|NCT00391768|4973095|P1|Overall Study|Withdrawal by Subject|0
1514257|NCT00391625|4973182|P1|Month 50|Physician Decision|1
1514258|NCT00391625|4973182|P1|Month 14|Withdrawal by Subject|1
1514259|NCT00391586|4973235|P1|Overall Study|Death|4
1514260|NCT00391586|4973235|P1|Overall Study|Physician Decision|2
1514261|NCT00391586|4973235|P1|Overall Study|Adverse Event|5
1514262|NCT00391586|4973235|P1|Overall Study|Progressive disease|13
1514263|NCT00391391|4973272|P4|Overall Study|Withdrawal by Subject|7
1514264|NCT00391391|4973273|P3|Overall Study|Withdrawal by Subject|10
1514265|NCT00391391|4973274|P2|Overall Study|Withdrawal by Subject|4
1514266|NCT00391391|4973275|P1|Overall Study|Withdrawal by Subject|6
1514267|NCT00391391|4973272|P4|Overall Study|Protocol Violation|7
1514268|NCT00391391|4973273|P3|Overall Study|Protocol Violation|6
1514269|NCT00391391|4973274|P2|Overall Study|Protocol Violation|3
1514270|NCT00391391|4973275|P1|Overall Study|Protocol Violation|2
1514271|NCT00391391|4973272|P4|Overall Study|Lost to Follow-up|4
1514272|NCT00391391|4973273|P3|Overall Study|Lost to Follow-up|7
1514273|NCT00391391|4973274|P2|Overall Study|Lost to Follow-up|3
1514274|NCT00391391|4973275|P1|Overall Study|Lost to Follow-up|1
1514275|NCT00391391|4973272|P4|Overall Study|Adverse Event|1
1514276|NCT00391391|4973273|P3|Overall Study|Adverse Event|0
1514277|NCT00391391|4973274|P2|Overall Study|Adverse Event|0
1514278|NCT00391391|4973275|P1|Overall Study|Adverse Event|0
1514279|NCT00391274|4973320|P2|Overall Study|Death Not Study Related|1
1514280|NCT00391274|4973321|P1|Overall Study|Death Not Study Related|0
1514281|NCT00391274|4973320|P2|Overall Study|Death Due to Indeterminate Cause|0
1514282|NCT00391274|4973321|P1|Overall Study|Death Due to Indeterminate Cause|1
1514283|NCT00391274|4973320|P2|Overall Study|Death Due to Adverse Event|3
1514284|NCT00391274|4973321|P1|Overall Study|Death Due to Adverse Event|1
1514285|NCT00391274|4973320|P2|Overall Study|Withdrawal by Subject|3
1514286|NCT00391274|4973321|P1|Overall Study|Withdrawal by Subject|0
1514287|NCT00391274|4973320|P2|Overall Study|Physician Decision|2
1514288|NCT00391274|4973321|P1|Overall Study|Physician Decision|4
1514289|NCT00391274|4973320|P2|Overall Study|Lost to Follow-up|3
1514290|NCT00391274|4973321|P1|Overall Study|Lost to Follow-up|0
1514291|NCT00391274|4973320|P2|Overall Study|Death Due to Study Disease|45
1514292|NCT00391274|4973321|P1|Overall Study|Death Due to Study Disease|55
1514293|NCT00391222|4973340|P4|Period III (Double-Blind Treatment)|Other|0
1514294|NCT00391222|4973341|P3|Period III (Double-Blind Treatment)|Other|6
1514295|NCT00391222|4973342|P2|Period III (Double-Blind Treatment)|Other|1
1514296|NCT00391222|4973343|P1|Period III (Double-Blind Treatment)|Other|6
1514297|NCT00391222|4973340|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
1514298|NCT00391222|4973341|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
1514299|NCT00391222|4973342|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
1514300|NCT00391222|4973343|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
1514301|NCT00391222|4973340|P4|Period III (Double-Blind Treatment)|Pregnancy|0
1514302|NCT00391222|4973341|P3|Period III (Double-Blind Treatment)|Pregnancy|0
1514303|NCT00391222|4973342|P2|Period III (Double-Blind Treatment)|Pregnancy|2
1514304|NCT00391222|4973343|P1|Period III (Double-Blind Treatment)|Pregnancy|0
1514305|NCT00391222|4973340|P4|Period III (Double-Blind Treatment)|Adverse Event|0
1514306|NCT00391222|4973341|P3|Period III (Double-Blind Treatment)|Adverse Event|4
1514307|NCT00391222|4973342|P2|Period III (Double-Blind Treatment)|Adverse Event|2
1514308|NCT00391222|4973343|P1|Period III (Double-Blind Treatment)|Adverse Event|5
1514309|NCT00391222|4973340|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
1514310|NCT00391222|4973341|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
1514311|NCT00391222|4973342|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
1514312|NCT00391222|4973343|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
1514313|NCT00391222|4973340|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
1514314|NCT00391222|4973341|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
1514315|NCT00391222|4973342|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
1514316|NCT00391222|4973343|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
1514317|NCT00391222|4973340|P4|Period II (Open-label Risperidone LAI)|Other|24
1514318|NCT00391222|4973341|P3|Period II (Open-label Risperidone LAI)|Other|0
1514319|NCT00391222|4973342|P2|Period II (Open-label Risperidone LAI)|Other|0
1514320|NCT00391222|4973343|P1|Period II (Open-label Risperidone LAI)|Other|0
1514321|NCT00391222|4973340|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
1514322|NCT00391222|4973341|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
1514323|NCT00391222|4973342|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
1514324|NCT00391222|4973343|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
1514325|NCT00391222|4973340|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
1514326|NCT00391222|4973341|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
1514327|NCT00391222|4973342|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
1514328|NCT00391222|4973343|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
1514329|NCT00391222|4973340|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
1514330|NCT00391222|4973341|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
1514331|NCT00391222|4973342|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
1514332|NCT00391222|4973343|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
1514333|NCT00391222|4973340|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
1514334|NCT00391222|4973341|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
1514335|NCT00391222|4973342|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
1514336|NCT00391222|4973343|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
1514337|NCT00391092|4973369|P2|Overall Study|Alive in follow-up|84
1514338|NCT00391092|4973370|P1|Overall Study|Alive in follow-up|88
1514339|NCT00391092|4973369|P2|Overall Study|Alive on treatment|33
1514340|NCT00391092|4973370|P1|Overall Study|Alive on treatment|29
1514341|NCT00391092|4973369|P2|Overall Study|Lost to Follow-up|18
1514342|NCT00391092|4973370|P1|Overall Study|Lost to Follow-up|13
1514343|NCT00391092|4973369|P2|Overall Study|Death|81
1514344|NCT00391092|4973370|P1|Overall Study|Death|78
1514345|NCT00391053|4973413|P4|Overall Study|Withdrawal by Subject|1
1514346|NCT00391053|4973414|P3|Overall Study|Withdrawal by Subject|1
1514347|NCT00391053|4973415|P2|Overall Study|Withdrawal by Subject|1
1514348|NCT00391053|4973416|P1|Overall Study|Withdrawal by Subject|5
1514349|NCT00391053|4973413|P4|Overall Study|Lost to Follow-up|5
1514350|NCT00391053|4973414|P3|Overall Study|Lost to Follow-up|0
1514351|NCT00391053|4973415|P2|Overall Study|Lost to Follow-up|0
1514352|NCT00391053|4973416|P1|Overall Study|Lost to Follow-up|1
1514353|NCT00391053|4973413|P4|Overall Study|Protocol Violation|0
1514354|NCT00391053|4973414|P3|Overall Study|Protocol Violation|0
1514355|NCT00391053|4973415|P2|Overall Study|Protocol Violation|0
1514356|NCT00391053|4973416|P1|Overall Study|Protocol Violation|2
1514357|NCT00391053|4973413|P4|Overall Study|Serious Adverse Events|4
1514358|NCT00391053|4973414|P3|Overall Study|Serious Adverse Events|1
1514359|NCT00391053|4973415|P2|Overall Study|Serious Adverse Events|0
1514360|NCT00391053|4973416|P1|Overall Study|Serious Adverse Events|1
1514361|NCT00391027|4973440|P2|Overall Study|Other|3
1514362|NCT00391027|4973441|P1|Overall Study|Other|4
1514363|NCT00391027|4973440|P2|Overall Study|Withdrawal by Subject|1
1514364|NCT00391027|4973441|P1|Overall Study|Withdrawal by Subject|10
1514365|NCT00391027|4973440|P2|Overall Study|Lack of Efficacy|0
1514366|NCT00391027|4973441|P1|Overall Study|Lack of Efficacy|3
1514367|NCT00391027|4973440|P2|Overall Study|Adverse Event|8
1514368|NCT00391027|4973441|P1|Overall Study|Adverse Event|8
1514369|NCT00390884|4973481|P2|Overall Study|Withdrawal by Subject|2
1514370|NCT00390884|4973482|P1|Overall Study|Withdrawal by Subject|2
1514371|NCT00390858|4973494|P2|Overall Study|Withdrawal by Subject|4
1514372|NCT00390858|4973495|P1|Overall Study|Withdrawal by Subject|3
1514373|NCT00390858|4973494|P2|Overall Study|Lack of Efficacy|1
1514374|NCT00390858|4973495|P1|Overall Study|Lack of Efficacy|0
1514375|NCT00390858|4973494|P2|Overall Study|Adverse Event|2
1514376|NCT00390858|4973495|P1|Overall Study|Adverse Event|6
1514377|NCT00390806|4973509|P2|Overall Study|Ongoing|2
1514378|NCT00390806|4973510|P1|Overall Study|Ongoing|4
1514379|NCT00390806|4973509|P2|Overall Study|Physician Decision|1
1514380|NCT00390806|4973510|P1|Overall Study|Physician Decision|0
1514381|NCT00390806|4973509|P2|Overall Study|Death|0
1514382|NCT00390806|4973510|P1|Overall Study|Death|1
1514383|NCT00390806|4973509|P2|Overall Study|Investigator Decision|6
1514384|NCT00390806|4973510|P1|Overall Study|Investigator Decision|4
1514385|NCT00390806|4973509|P2|Overall Study|Withdrawal by Subject|15
1514386|NCT00390806|4973510|P1|Overall Study|Withdrawal by Subject|12
1514387|NCT00390806|4973509|P2|Overall Study|Protocol Violation|2
1514388|NCT00390806|4973510|P1|Overall Study|Protocol Violation|2
1514389|NCT00390806|4973509|P2|Overall Study|Lost to Follow-up|6
1514390|NCT00390806|4973510|P1|Overall Study|Lost to Follow-up|7
1514391|NCT00390780|4973578|P2|Overall Study|SAE, death|1
1514392|NCT00390780|4973579|P1|Overall Study|SAE, death|0
1514393|NCT00390780|4973578|P2|Overall Study|Investigator decision, SAE, other reason|1
1514394|NCT00390780|4973579|P1|Overall Study|Investigator decision, SAE, other reason|0
1514395|NCT00390780|4973578|P2|Overall Study|Lost to follow up and other reasons|1
1514396|NCT00390780|4973579|P1|Overall Study|Lost to follow up and other reasons|0
1514397|NCT00390780|4973578|P2|Overall Study|Inclusion criteria not satisfied|2
1514398|NCT00390780|4973579|P1|Overall Study|Inclusion criteria not satisfied|0
1514399|NCT00390780|4973578|P2|Overall Study|Withdrawal by Subject|2
1514400|NCT00390780|4973579|P1|Overall Study|Withdrawal by Subject|1
1514401|NCT00390780|4973578|P2|Overall Study|Death|3
1514402|NCT00390780|4973579|P1|Overall Study|Death|1
1514403|NCT00390780|4973578|P2|Overall Study|Adverse Event|3
1514404|NCT00390780|4973579|P1|Overall Study|Adverse Event|2
1514405|NCT00390780|4973578|P2|Overall Study|Lost to Follow-up|6
1514406|NCT00390780|4973579|P1|Overall Study|Lost to Follow-up|3
1514407|NCT00390780|4973578|P2|Overall Study|Protocol Violation|4
1514408|NCT00390780|4973579|P1|Overall Study|Protocol Violation|6
1514409|NCT00390780|4973578|P2|Overall Study|Not completed|4
1514410|NCT00390780|4973579|P1|Overall Study|Not completed|10
1514411|NCT00390689|4973612|P3|Overall Study|Investigator's judgement|0
1514412|NCT00390689|4973613|P2|Overall Study|Investigator's judgement|0
1514413|NCT00390689|4973614|P1|Overall Study|Investigator's judgement|2
1514414|NCT00390689|4973612|P3|Overall Study|Protocol Violation|0
1514415|NCT00390689|4973613|P2|Overall Study|Protocol Violation|0
1514416|NCT00390689|4973614|P1|Overall Study|Protocol Violation|1
1514417|NCT00390689|4973612|P3|Overall Study|Lack of Efficacy|1
1514418|NCT00390689|4973613|P2|Overall Study|Lack of Efficacy|0
1514419|NCT00390689|4973614|P1|Overall Study|Lack of Efficacy|0
1514420|NCT00390689|4973612|P3|Overall Study|Adverse Event|2
1514421|NCT00390689|4973613|P2|Overall Study|Adverse Event|5
1514422|NCT00390689|4973614|P1|Overall Study|Adverse Event|2
1514423|NCT00390572|4973689|P2|Overall Study|health condition|1
1514424|NCT00390572|4973690|P1|Overall Study|health condition|0
1514425|NCT00390572|4973689|P2|Overall Study|Lost to Follow-up|4
1514426|NCT00390572|4973690|P1|Overall Study|Lost to Follow-up|8
1514427|NCT00390546|4973716|P2|Overall Study|Physician Decision|5
1514428|NCT00390546|4973717|P1|Overall Study|Physician Decision|5
1514429|NCT00390546|4973716|P2|Overall Study|Renal impairment|0
1514430|NCT00390546|4973717|P1|Overall Study|Renal impairment|1
1514431|NCT00390468|4973727|P1|Overall Study|Lack of Efficacy|1
1514432|NCT00390468|4973727|P1|Overall Study|Protocol Violation|2
1514433|NCT00390455|4973733|P2|Overall Study|Other Medical Reasons|11
1514434|NCT00390455|4973734|P1|Overall Study|Other Medical Reasons|7
1514435|NCT00390455|4973733|P2|Overall Study|Alternate Treatment|1
1514436|NCT00390455|4973734|P1|Overall Study|Alternate Treatment|0
1514437|NCT00390455|4973733|P2|Overall Study|Withdrawal by Subject|8
1514438|NCT00390455|4973734|P1|Overall Study|Withdrawal by Subject|8
1514439|NCT00390455|4973733|P2|Overall Study|Adverse Event|3
1514440|NCT00390455|4973734|P1|Overall Study|Adverse Event|17
1514441|NCT00390416|4973774|P1|Overall Study|Not treated|3
1514442|NCT00390416|4973774|P1|Overall Study|Withdrawal by Subject|1
1514443|NCT00390221|4973795|P3|Overall Study|Not Specified|2
1514444|NCT00390221|4973796|P2|Overall Study|Not Specified|4
1514445|NCT00390221|4973797|P1|Overall Study|Not Specified|3
1514446|NCT00390221|4973795|P3|Overall Study|Subject Non-compliance|2
1514447|NCT00390221|4973796|P2|Overall Study|Subject Non-compliance|0
1514448|NCT00390221|4973797|P1|Overall Study|Subject Non-compliance|1
1514449|NCT00390221|4973795|P3|Overall Study|Withdrawal by Subject|7
1514450|NCT00390221|4973796|P2|Overall Study|Withdrawal by Subject|9
1514451|NCT00390221|4973797|P1|Overall Study|Withdrawal by Subject|13
1514452|NCT00390221|4973795|P3|Overall Study|Investigator Decision|1
1514453|NCT00390221|4973796|P2|Overall Study|Investigator Decision|0
1514454|NCT00390221|4973797|P1|Overall Study|Investigator Decision|0
1514455|NCT00390221|4973795|P3|Overall Study|Adverse Event|3
1514456|NCT00390221|4973796|P2|Overall Study|Adverse Event|4
1514457|NCT00390221|4973797|P1|Overall Study|Adverse Event|1
1514458|NCT00390221|4973795|P3|Overall Study|Lost to Follow-up|0
1514459|NCT00390221|4973796|P2|Overall Study|Lost to Follow-up|3
1514460|NCT00390221|4973797|P1|Overall Study|Lost to Follow-up|0
1514461|NCT00390013|4973827|P4|Phase 2 First Treatment|Withdrawal by Subject|0
1514462|NCT00390013|4973828|P3|Phase 2 First Treatment|Withdrawal by Subject|0
1514463|NCT00390013|4973829|P2|Phase 2 First Treatment|Withdrawal by Subject|1
1514464|NCT00390013|4973830|P1|Phase 2 First Treatment|Withdrawal by Subject|0
1514465|NCT00390013|4973827|P4|Phase 2 First Treatment|tired|0
1514466|NCT00390013|4973828|P3|Phase 2 First Treatment|tired|0
1514467|NCT00390013|4973829|P2|Phase 2 First Treatment|tired|0
1514468|NCT00390013|4973830|P1|Phase 2 First Treatment|tired|1
1514469|NCT00390013|4973827|P4|Phase 1|tired|1
1514470|NCT00390013|4973828|P3|Phase 1|tired|0
1514471|NCT00390013|4973829|P2|Phase 1|tired|0
1514472|NCT00390013|4973830|P1|Phase 1|tired|0
1514473|NCT00389831|4973855|P2|Overall Study|Lost to Follow-up|1
1514474|NCT00389831|4973856|P1|Overall Study|Lost to Follow-up|0
1514475|NCT00389831|4973855|P2|Overall Study|Other reasons|2
1514476|NCT00389831|4973856|P1|Overall Study|Other reasons|0
1514477|NCT00389831|4973855|P2|Overall Study|Did not receive treatment.|2
1514478|NCT00389831|4973856|P1|Overall Study|Did not receive treatment.|0
1514479|NCT00389831|4973855|P2|Overall Study|Lack of Efficacy|2
1514480|NCT00389831|4973856|P1|Overall Study|Lack of Efficacy|0
1514481|NCT00389597|4973919|P4|Overall Study|Lost to Follow-up|6
1514482|NCT00389597|4973920|P3|Overall Study|Lost to Follow-up|4
1514483|NCT00389597|4973921|P2|Overall Study|Lost to Follow-up|6
1514484|NCT00389597|4973922|P1|Overall Study|Lost to Follow-up|8
1514485|NCT00389519|4973947|P4|Treated|Reason not specified|2
1514486|NCT00389519|4973948|P3|Treated|Reason not specified|0
1514487|NCT00389519|4973949|P2|Treated|Reason not specified|1
1514488|NCT00389519|4973950|P1|Treated|Reason not specified|1
1514489|NCT00389519|4973947|P4|Treated|Adverse Event|2
1514490|NCT00389519|4973948|P3|Treated|Adverse Event|0
1514491|NCT00389519|4973949|P2|Treated|Adverse Event|0
1514492|NCT00389519|4973950|P1|Treated|Adverse Event|1
1514493|NCT00389519|4973947|P4|Randomized|Did not receive study drug|0
1514494|NCT00389519|4973948|P3|Randomized|Did not receive study drug|0
1514495|NCT00389519|4973949|P2|Randomized|Did not receive study drug|0
1514496|NCT00389519|4973950|P1|Randomized|Did not receive study drug|2
1514497|NCT00389519|4973947|P4|Placebo Run-In|Reason not specified|0
1514498|NCT00389519|4973948|P3|Placebo Run-In|Reason not specified|0
1514499|NCT00389519|4973949|P2|Placebo Run-In|Reason not specified|0
1514500|NCT00389519|4973950|P1|Placebo Run-In|Reason not specified|40
1514501|NCT00389519|4973947|P4|Placebo Run-In|Withdrawal by Subject|0
1514502|NCT00389519|4973948|P3|Placebo Run-In|Withdrawal by Subject|0
1514503|NCT00389519|4973949|P2|Placebo Run-In|Withdrawal by Subject|0
1514504|NCT00389519|4973950|P1|Placebo Run-In|Withdrawal by Subject|19
1514505|NCT00389519|4973947|P4|Placebo Run-In|Did not meet blood pressure criteria|0
1514506|NCT00389519|4973948|P3|Placebo Run-In|Did not meet blood pressure criteria|0
1514507|NCT00389519|4973949|P2|Placebo Run-In|Did not meet blood pressure criteria|0
1514508|NCT00389519|4973950|P1|Placebo Run-In|Did not meet blood pressure criteria|119
1514509|NCT00389441|4974027|P1|Overall Study|Clinical progression|1
1514510|NCT00389441|4974027|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
1514511|NCT00389441|4974027|P1|Overall Study|Objective progression or relapse|26
1514512|NCT00389441|4974027|P1|Overall Study|Global deterioration of health status|4
1514513|NCT00389441|4974027|P1|Overall Study|Protocol Violation|1
1514514|NCT00389441|4974027|P1|Overall Study|Physician Decision|1
1514515|NCT00389441|4974027|P1|Overall Study|Withdrawal by Subject|4
1514516|NCT00389441|4974027|P1|Overall Study|Lost to Follow-up|2
1514517|NCT00389441|4974027|P1|Overall Study|Death|4
1514518|NCT00389441|4974027|P1|Overall Study|Adverse Event|7
1514519|NCT00389324|4974036|P1|Subcutaneous Phase|Lost to Follow-up|1
1514520|NCT00389324|4974036|P1|Subcutaneous Phase|Withdrawal by Subject|2
1514521|NCT00389324|4974036|P1|Subcutaneous Phase|Non-compliance with study medication|2
1514522|NCT00389324|4974036|P1|Subcutaneous Phase|Adverse Event|2
1514523|NCT00389324|4974036|P1|Run-In Phase|Withdrawal by Subject|1
1514524|NCT00389324|4974036|P1|Run-In Phase|Lost to Follow-up|1
1514525|NCT00389324|4974036|P1|Run-In Phase|Adverse Event|1
1514526|NCT00389207|4974046|P3|Overall Study|Not specified|9
1514527|NCT00389207|4974047|P2|Overall Study|Not specified|23
1514528|NCT00389207|4974048|P1|Overall Study|Not specified|17
1514529|NCT00389207|4974046|P3|Overall Study|Withdrawal by Subject|11
1514530|NCT00389207|4974047|P2|Overall Study|Withdrawal by Subject|7
1514531|NCT00389207|4974048|P1|Overall Study|Withdrawal by Subject|5
1514532|NCT00389207|4974046|P3|Overall Study|Lost to Follow-up|7
1514533|NCT00389207|4974047|P2|Overall Study|Lost to Follow-up|9
1514534|NCT00389207|4974048|P1|Overall Study|Lost to Follow-up|12
1514535|NCT00389207|4974046|P3|Overall Study|Protocol Violation|4
1514536|NCT00389207|4974047|P2|Overall Study|Protocol Violation|1
1514537|NCT00389207|4974048|P1|Overall Study|Protocol Violation|3
1514538|NCT00389207|4974046|P3|Overall Study|Adverse Event|10
1514539|NCT00389207|4974047|P2|Overall Study|Adverse Event|32
1514540|NCT00389207|4974048|P1|Overall Study|Adverse Event|26
1514541|NCT00389064|4974171|P2|Overall Study|Multiple Reasons|11
1514542|NCT00389064|4974172|P1|Overall Study|Multiple Reasons|9
1514543|NCT00389064|4974171|P2|Overall Study|Protocol Violation|0
1514544|NCT00389064|4974172|P1|Overall Study|Protocol Violation|2
1514545|NCT00389064|4974171|P2|Overall Study|Lost to Follow-up|2
1514546|NCT00389064|4974172|P1|Overall Study|Lost to Follow-up|1
1514547|NCT00389064|4974171|P2|Overall Study|Physician Decision|2
1514548|NCT00389064|4974172|P1|Overall Study|Physician Decision|2
1514549|NCT00389064|4974171|P2|Overall Study|Withdrawal by Subject|27
1514550|NCT00389064|4974172|P1|Overall Study|Withdrawal by Subject|17
1514551|NCT00389064|4974171|P2|Overall Study|Lack of Efficacy|14
1514552|NCT00389064|4974172|P1|Overall Study|Lack of Efficacy|3
1514553|NCT00389064|4974171|P2|Overall Study|Adverse Event|3
1514554|NCT00389064|4974172|P1|Overall Study|Adverse Event|11
1514555|NCT00388973|4974200|P2|Overall Study|Did not complete 2-week follow-up visit|17
1514556|NCT00388973|4974201|P1|Overall Study|Did not complete 2-week follow-up visit|17
1514557|NCT00388973|4974200|P2|Overall Study|Left region|1
1514558|NCT00388973|4974201|P1|Overall Study|Left region|0
1514559|NCT00388973|4974200|P2|Overall Study|Did not complete 61 days of treatment|4
1514560|NCT00388973|4974201|P1|Overall Study|Did not complete 61 days of treatment|5
1514561|NCT00388973|4974200|P2|Overall Study|Study specific Discontinuation Criteria|1
1514562|NCT00388973|4974201|P1|Overall Study|Study specific Discontinuation Criteria|0
1514563|NCT00388973|4974200|P2|Overall Study|Withdrawal by Subject|17
1514564|NCT00388973|4974201|P1|Overall Study|Withdrawal by Subject|14
1514565|NCT00388973|4974200|P2|Overall Study|Protocol Violation|0
1514566|NCT00388973|4974201|P1|Overall Study|Protocol Violation|3
1514567|NCT00388973|4974200|P2|Overall Study|Lack of Efficacy|12
1514568|NCT00388973|4974201|P1|Overall Study|Lack of Efficacy|1
1514569|NCT00388973|4974200|P2|Overall Study|Adverse Event|6
1514570|NCT00388973|4974201|P1|Overall Study|Adverse Event|16
1514571|NCT00388947|4974221|P1|Overall Study|Protocol Violation|47
1514572|NCT00388726|4974237|P2|Overall Study|Death|2
1514573|NCT00388726|4974238|P1|Overall Study|Death|3
1514574|NCT00388726|4974237|P2|Overall Study|Physician Decision|13
1514575|NCT00388726|4974238|P1|Overall Study|Physician Decision|18
1514576|NCT00388726|4974237|P2|Overall Study|Administrative|9
1514577|NCT00388726|4974238|P1|Overall Study|Administrative|6
1514578|NCT00388726|4974237|P2|Overall Study|Withdrawal by Subject|7
1514579|NCT00388726|4974238|P1|Overall Study|Withdrawal by Subject|10
1514580|NCT00388726|4974237|P2|Overall Study|Clinical Progression|36
1514581|NCT00388726|4974238|P1|Overall Study|Clinical Progression|61
1514582|NCT00388726|4974237|P2|Overall Study|Progressive Disease|153
1514583|NCT00388726|4974238|P1|Overall Study|Progressive Disease|336
1514584|NCT00388726|4974237|P2|Overall Study|Adverse Event|24
1514585|NCT00388726|4974238|P1|Overall Study|Adverse Event|50
1514586|NCT00388674|4974252|P2|End of Study|Not Reported|1
1514587|NCT00388674|4974253|P1|End of Study|Not Reported|0
1514588|NCT00388674|4974252|P2|End of Study|No Off-Treatment Status Data|30
1514589|NCT00388674|4974253|P1|End of Study|No Off-Treatment Status Data|22
1514590|NCT00388674|4974252|P2|End of Study|Participant Withdrew Consent|673
1514591|NCT00388674|4974253|P1|End of Study|Participant Withdrew Consent|437
1514592|NCT00388674|4974252|P2|End of Study|Not Defined|214
1514593|NCT00388674|4974253|P1|End of Study|Not Defined|135
1514594|NCT00388674|4974252|P2|End of Study|Non-Study Related Comorbidities|4
1514595|NCT00388674|4974253|P1|End of Study|Non-Study Related Comorbidities|3
1514596|NCT00388674|4974252|P2|End of Study|Malignancy (Non-HCC)|1
1514597|NCT00388674|4974253|P1|End of Study|Malignancy (Non-HCC)|1
1514598|NCT00388674|4974252|P2|End of Study|Lost to Follow-up|715
1514599|NCT00388674|4974253|P1|End of Study|Lost to Follow-up|587
1514600|NCT00388674|4974252|P2|End of Study|HCC|7
1514601|NCT00388674|4974253|P1|End of Study|HCC|8
1514602|NCT00388674|4974252|P2|End of Study|HBV Disease Progression (Non-HCC)|9
1514603|NCT00388674|4974253|P1|End of Study|HBV Disease Progression (Non-HCC)|3
1514604|NCT00388674|4974252|P2|End of Study|Death|262
1514605|NCT00388674|4974253|P1|End of Study|Death|239
1514606|NCT00388674|4974252|P2|End of Study|Administrative Reason By Sponsor|253
1514607|NCT00388674|4974253|P1|End of Study|Administrative Reason By Sponsor|299
1514608|NCT00388674|4974252|P2|Initial Treatment|Not Reported|12
1514609|NCT00388674|4974253|P1|Initial Treatment|Not Reported|10
1514610|NCT00388674|4974252|P2|Initial Treatment|No Off-Treatment Status Data|13
1514611|NCT00388674|4974253|P1|Initial Treatment|No Off-Treatment Status Data|11
1514612|NCT00388674|4974252|P2|Initial Treatment|Participant Request|673
1514613|NCT00388674|4974253|P1|Initial Treatment|Participant Request|501
1514614|NCT00388674|4974252|P2|Initial Treatment|Study Drug Toxicity|92
1514615|NCT00388674|4974253|P1|Initial Treatment|Study Drug Toxicity|5
1514616|NCT00388674|4974252|P2|Initial Treatment|Pregnancy|16
1514617|NCT00388674|4974253|P1|Initial Treatment|Pregnancy|26
1514618|NCT00388674|4974252|P2|Initial Treatment|Partial or inadequate Treatment|472
1514619|NCT00388674|4974253|P1|Initial Treatment|Partial or inadequate Treatment|112
1514620|NCT00388674|4974252|P2|Initial Treatment|Not Defined|172
1514621|NCT00388674|4974253|P1|Initial Treatment|Not Defined|125
1514622|NCT00388674|4974252|P2|Initial Treatment|Non-Study related Comorbidities|4
1514623|NCT00388674|4974253|P1|Initial Treatment|Non-Study related Comorbidities|3
1514624|NCT00388674|4974252|P2|Initial Treatment|Never Treated with Study Medication|7
1514625|NCT00388674|4974253|P1|Initial Treatment|Never Treated with Study Medication|1
1514626|NCT00388674|4974252|P2|Initial Treatment|Malignancy (Non-HCC)|3
1514627|NCT00388674|4974253|P1|Initial Treatment|Malignancy (Non-HCC)|7
1514628|NCT00388674|4974252|P2|Initial Treatment|Lost to Follow-up|624
1514629|NCT00388674|4974253|P1|Initial Treatment|Lost to Follow-up|526
1514630|NCT00388674|4974252|P2|Initial Treatment|HCC|20
1514631|NCT00388674|4974253|P1|Initial Treatment|HCC|12
1514632|NCT00388674|4974252|P2|Initial Treatment|Non-HCC HBV Disease Progression|17
1514633|NCT00388674|4974253|P1|Initial Treatment|Non-HCC HBV Disease Progression|11
1514634|NCT00388674|4974252|P2|Initial Treatment|Death|216
1514635|NCT00388674|4974253|P1|Initial Treatment|Death|215
1514636|NCT00388674|4974252|P2|Initial Treatment|Adverse Event|87
1514637|NCT00388674|4974253|P1|Initial Treatment|Adverse Event|22
1514638|NCT00388674|4974252|P2|Initial Treatment|Administrative Reason by Sponsor|158
1514639|NCT00388674|4974253|P1|Initial Treatment|Administrative Reason by Sponsor|241
1514640|NCT00388583|4974271|P2|Overall Study|Did not receive vaccine|1
1514641|NCT00388583|4974272|P1|Overall Study|Did not receive vaccine|0
1514642|NCT00388583|4974271|P2|Overall Study|Serious Adverse Event|0
1514643|NCT00388583|4974272|P1|Overall Study|Serious Adverse Event|2
1514644|NCT00388583|4974271|P2|Overall Study|Withdrawal by Subject|3
1514645|NCT00388583|4974272|P1|Overall Study|Withdrawal by Subject|3
1514646|NCT00388583|4974271|P2|Overall Study|Protocol Violation|0
1514647|NCT00388583|4974272|P1|Overall Study|Protocol Violation|1
1514648|NCT00388505|4974286|P2|Overall Study|Unable to classify|3
1514649|NCT00388505|4974287|P1|Overall Study|Unable to classify|4
1514650|NCT00388505|4974286|P2|Overall Study|Protocol Violation|5
1514651|NCT00388505|4974287|P1|Overall Study|Protocol Violation|6
1514652|NCT00388505|4974286|P2|Overall Study|Administrative Reason|0
1514653|NCT00388505|4974287|P1|Overall Study|Administrative Reason|1
1514654|NCT00388505|4974286|P2|Overall Study|Inappropriate Enrollment|1
1514655|NCT00388505|4974287|P1|Overall Study|Inappropriate Enrollment|0
1514656|NCT00388505|4974286|P2|Overall Study|Lost to Follow-up|3
1514657|NCT00388505|4974287|P1|Overall Study|Lost to Follow-up|5
1514658|NCT00388505|4974286|P2|Overall Study|Withdrawal by Subject|9
1514659|NCT00388505|4974287|P1|Overall Study|Withdrawal by Subject|24
1514660|NCT00388505|4974286|P2|Overall Study|Adverse Event or Death|17
1514661|NCT00388505|4974287|P1|Overall Study|Adverse Event or Death|43
1514662|NCT00388362|4974342|P1|Remained on Study Median of 514 Days|Death|2
1514663|NCT00388362|4974342|P1|Enrolled|Withdrawal by Subject|1
1514664|NCT00388362|4974342|P1|Enrolled|Loss insurance|1
1514665|NCT00388362|4974342|P1|Enrolled|Death|1
1514666|NCT00388362|4974342|P1|Enrolled|Adverse Event|9
1514667|NCT00388362|4974342|P1|Enrolled|Ineligible|1
1514668|NCT00388349|4974347|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
1514669|NCT00388349|4974348|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
1514670|NCT00388154|4974357|P1|Overall Study|Withdrawal by Subject|1
1514671|NCT00388037|4974362|P1|Overall Study|Protocol Violation|1
1514672|NCT00387894|4974370|P1|Overall Study|Withdrawal by Subject|1
1514673|NCT00387881|4974377|P2|Overall Study|Not otherwise specified|7
1514674|NCT00387881|4974378|P1|Overall Study|Not otherwise specified|11
1514675|NCT00387881|4974377|P2|Overall Study|No opportunity to treat headache|34
1514676|NCT00387881|4974378|P1|Overall Study|No opportunity to treat headache|32
1514677|NCT00387881|4974377|P2|Overall Study|Not eligible|7
1514678|NCT00387881|4974378|P1|Overall Study|Not eligible|6
1514679|NCT00387881|4974377|P2|Overall Study|Sponsor terminated Study|1
1514680|NCT00387881|4974378|P1|Overall Study|Sponsor terminated Study|0
1514681|NCT00387881|4974377|P2|Overall Study|Withdrawal by Subject|18
1514682|NCT00387881|4974378|P1|Overall Study|Withdrawal by Subject|15
1514683|NCT00387881|4974377|P2|Overall Study|Protocol Violation|12
1514684|NCT00387881|4974378|P1|Overall Study|Protocol Violation|2
1514685|NCT00387881|4974377|P2|Overall Study|Lost to Follow-up|23
1514686|NCT00387881|4974378|P1|Overall Study|Lost to Follow-up|23
1514687|NCT00387790|4974411|P1|Overall Study|Ineligible for study|2
1514688|NCT00387790|4974411|P1|Overall Study|Withdrawal by Subject|3
1514689|NCT00387790|4974411|P1|Overall Study|Physician Decision|2
1514690|NCT00387790|4974411|P1|Overall Study|Lack of Efficacy|2
1514691|NCT00387790|4974411|P1|Overall Study|Adverse Event|5
1514692|NCT00387764|4974417|P1|Overall Study|Death|7
1514693|NCT00387764|4974417|P1|Overall Study|Other|2
1514694|NCT00387764|4974417|P1|Overall Study|Physician Decision|1
1514695|NCT00387764|4974417|P1|Overall Study|Sponsor Terminated Study|1
1514696|NCT00387764|4974417|P1|Overall Study|Withdrawal by Subject|8
1514697|NCT00387764|4974417|P1|Overall Study|Adverse Event|12
1514698|NCT00387725|4974445|P4|Overall Study|Parent/legal guardian request|1
1514699|NCT00387725|4974446|P3|Overall Study|Parent/legal guardian request|1
1514700|NCT00387725|4974447|P2|Overall Study|Parent/legal guardian request|0
1514701|NCT00387725|4974448|P1|Overall Study|Parent/legal guardian request|0
1514702|NCT00387725|4974445|P4|Overall Study|Withdrawal by Subject|0
1514703|NCT00387725|4974446|P3|Overall Study|Withdrawal by Subject|1
1514704|NCT00387725|4974447|P2|Overall Study|Withdrawal by Subject|0
1514705|NCT00387725|4974448|P1|Overall Study|Withdrawal by Subject|1
1514706|NCT00387725|4974445|P4|Overall Study|Protocol Violation|0
1514707|NCT00387725|4974446|P3|Overall Study|Protocol Violation|0
1514708|NCT00387725|4974447|P2|Overall Study|Protocol Violation|1
1514709|NCT00387725|4974448|P1|Overall Study|Protocol Violation|0
1514710|NCT00387725|4974445|P4|Overall Study|Adverse Event|1
1514711|NCT00387725|4974446|P3|Overall Study|Adverse Event|0
1514712|NCT00387725|4974447|P2|Overall Study|Adverse Event|0
1514713|NCT00387725|4974448|P1|Overall Study|Adverse Event|0
1514714|NCT00387712|4974468|P2|Overall Study|Withdrawal by Subject|12
1514715|NCT00387712|4974469|P1|Overall Study|Withdrawal by Subject|6
1514716|NCT00387712|4974468|P2|Overall Study|Lost to Follow-up|20
1514717|NCT00387712|4974469|P1|Overall Study|Lost to Follow-up|17
1514718|NCT00387712|4974468|P2|Overall Study|Physician Decision|4
1514719|NCT00387712|4974469|P1|Overall Study|Physician Decision|6
1514720|NCT00387647|4974500|P1|Overall Study|Death|18
1514721|NCT00387426|4974540|P1|Overall Study|Disease Progression|3
1514722|NCT00387426|4974540|P1|Overall Study|Toxicities|4
1514723|NCT00387426|4974540|P1|Overall Study|Lack of Response|7
1514724|NCT00387348|4974547|P3|Overall Study|Adverse Event|1
1514725|NCT00387348|4974548|P2|Overall Study|Adverse Event|0
1514726|NCT00387348|4974549|P1|Overall Study|Adverse Event|1
1514727|NCT00387348|4974547|P3|Overall Study|Withdrawal by Subject|2
1514728|NCT00387348|4974548|P2|Overall Study|Withdrawal by Subject|2
1514729|NCT00387348|4974549|P1|Overall Study|Withdrawal by Subject|0
1514730|NCT00387348|4974547|P3|Overall Study|Physician Decision|1
1514731|NCT00387348|4974548|P2|Overall Study|Physician Decision|0
1514732|NCT00387348|4974549|P1|Overall Study|Physician Decision|1
1514733|NCT00387348|4974547|P3|Overall Study|Death|0
1514734|NCT00387348|4974548|P2|Overall Study|Death|1
1514735|NCT00387348|4974549|P1|Overall Study|Death|1
1514736|NCT00387153|4974578|P1|Overall Study|Lack of Response|4
1514737|NCT00387153|4974578|P1|Overall Study|Disease Progression|3
1514738|NCT00387153|4974578|P1|Overall Study|Adverse Event|1
1514739|NCT00387127|4974584|P2|Overall Study|Sponsor Unblinded|0
1514740|NCT00387127|4974585|P1|Overall Study|Sponsor Unblinded|1
1514741|NCT00387127|4974584|P2|Overall Study|Serious Adverse Event|1
1514742|NCT00387127|4974585|P1|Overall Study|Serious Adverse Event|1
1514743|NCT00387127|4974584|P2|Overall Study|Required by Protocol Amendment #4|10
1514744|NCT00387127|4974585|P1|Overall Study|Required by Protocol Amendment #4|12
1514745|NCT00387127|4974584|P2|Overall Study|Withdrawal by Subject|2
1514746|NCT00387127|4974585|P1|Overall Study|Withdrawal by Subject|3
1514747|NCT00387127|4974584|P2|Overall Study|Physician Decision|1
1514748|NCT00387127|4974585|P1|Overall Study|Physician Decision|0
1514749|NCT00387127|4974584|P2|Overall Study|Death|16
1514750|NCT00387127|4974585|P1|Overall Study|Death|16
1514751|NCT00387127|4974584|P2|Overall Study|Lost to Follow-up|4
1514752|NCT00387127|4974585|P1|Overall Study|Lost to Follow-up|0
1514753|NCT00387088|4974627|P2|Overall Study|Other|52
1514754|NCT00387088|4974628|P1|Overall Study|Other|58
1514755|NCT00387088|4974627|P2|Overall Study|Lost to Follow-up|28
1514756|NCT00387088|4974628|P1|Overall Study|Lost to Follow-up|22
1514757|NCT00387088|4974627|P2|Overall Study|Lack of Efficacy|67
1514758|NCT00387088|4974628|P1|Overall Study|Lack of Efficacy|28
1514759|NCT00387088|4974627|P2|Overall Study|Withdrawal by Subject|35
1514760|NCT00387088|4974628|P1|Overall Study|Withdrawal by Subject|20
1514761|NCT00387088|4974627|P2|Overall Study|Protocol Violation|35
1514762|NCT00387088|4974628|P1|Overall Study|Protocol Violation|47
1514763|NCT00387088|4974627|P2|Overall Study|Adverse Event|156
1514764|NCT00387088|4974628|P1|Overall Study|Adverse Event|143
1514765|NCT00387010|4974685|P1|Treatment Period|Participant reported study drug stolen|1
1514766|NCT00387010|4974685|P1|Treatment Period|Noncompliance with study procedures|3
1514767|NCT00387010|4974685|P1|Treatment Period|Noncompliance with study medication|2
1514768|NCT00387010|4974685|P1|Treatment Period|Withdrawal by Subject|1
1514769|NCT00387010|4974685|P1|Treatment Period|Adverse Event|4
1514770|NCT00387010|4974685|P1|Dose Titration Period|Noncompliance with study procedures|7
1514771|NCT00387010|4974685|P1|Dose Titration Period|Noncompliance with study medication|8
1514772|NCT00387010|4974685|P1|Dose Titration Period|Lost to Follow-up|2
1514773|NCT00387010|4974685|P1|Dose Titration Period|Protocol Violation|1
1514774|NCT00387010|4974685|P1|Dose Titration Period|Withdrawal by Subject|3
1514775|NCT00387010|4974685|P1|Dose Titration Period|Lack of Efficacy|5
1514776|NCT00387010|4974685|P1|Dose Titration Period|Adverse Event|12
1514777|NCT00386776|4974712|P1|Overall Study|Withdrawal by Subject|8
1514778|NCT00386607|4974722|P2|Extension|Unsatisfactory therapeutic effect|1
1514779|NCT00386607|4974723|P1|Extension|Unsatisfactory therapeutic effect|0
1514780|NCT00386607|4974722|P2|Extension|Patient withdrew consent|5
1514781|NCT00386607|4974723|P1|Extension|Patient withdrew consent|0
1514782|NCT00386607|4974722|P2|Extension|Lost to Follow-up|3
1514783|NCT00386607|4974723|P1|Extension|Lost to Follow-up|0
1514784|NCT00386607|4974722|P2|Extension|Administrative problems|1
1514785|NCT00386607|4974723|P1|Extension|Administrative problems|0
1514786|NCT00386607|4974722|P2|Extension|Abnormal laboratory value(s)|1
1514787|NCT00386607|4974723|P1|Extension|Abnormal laboratory value(s)|0
1514788|NCT00386607|4974722|P2|Extension|Adverse Event|6
1514789|NCT00386607|4974723|P1|Extension|Adverse Event|0
1514790|NCT00386607|4974722|P2|Core|Protocol Deviation|0
1514791|NCT00386607|4974723|P1|Core|Protocol Deviation|6
1514792|NCT00386607|4974722|P2|Core|Administrative problems|0
1514793|NCT00386607|4974723|P1|Core|Administrative problems|1
1514794|NCT00386607|4974722|P2|Core|Lost to Follow-up|0
1514795|NCT00386607|4974723|P1|Core|Lost to Follow-up|23
1514796|NCT00386607|4974722|P2|Core|Patient withdrew consent|0
1514797|NCT00386607|4974723|P1|Core|Patient withdrew consent|15
1514798|NCT00386607|4974722|P2|Core|Condition no longer requires study drug|0
1514799|NCT00386607|4974723|P1|Core|Condition no longer requires study drug|4
1514800|NCT00386607|4974722|P2|Core|Unsatisfactory therapeutic effect|0
1514801|NCT00386607|4974723|P1|Core|Unsatisfactory therapeutic effect|23
1514802|NCT00386607|4974722|P2|Core|Abnormal laboratory value(s)|0
1514803|NCT00386607|4974723|P1|Core|Abnormal laboratory value(s)|3
1514804|NCT00386607|4974722|P2|Core|Adverse Event|0
1514805|NCT00386607|4974723|P1|Core|Adverse Event|40
1514806|NCT00386425|4974751|P3|Overall Study|Withdrawal by Subject|0
1514807|NCT00386425|4974752|P2|Overall Study|Withdrawal by Subject|1
1514808|NCT00386425|4974753|P1|Overall Study|Withdrawal by Subject|0
1514809|NCT00386425|4974751|P3|Overall Study|Physician Decision|0
1514810|NCT00386425|4974752|P2|Overall Study|Physician Decision|0
1514811|NCT00386425|4974753|P1|Overall Study|Physician Decision|3
1514812|NCT00386360|4974779|P2|Overall Study|Did not take any study medication|2
1514813|NCT00386360|4974780|P1|Overall Study|Did not take any study medication|0
1514814|NCT00386360|4974779|P2|Overall Study|Withdrawal by Subject|6
1514815|NCT00386360|4974780|P1|Overall Study|Withdrawal by Subject|3
1514816|NCT00386360|4974779|P2|Overall Study|Protocol Violation|3
1514817|NCT00386360|4974780|P1|Overall Study|Protocol Violation|0
1514818|NCT00386360|4974779|P2|Overall Study|Lost to Follow-up|2
1514819|NCT00386360|4974780|P1|Overall Study|Lost to Follow-up|0
1514820|NCT00386360|4974779|P2|Overall Study|Physician Decision|2
1514821|NCT00386360|4974780|P1|Overall Study|Physician Decision|2
1514822|NCT00386360|4974779|P2|Overall Study|Adverse Event|2
1514823|NCT00386360|4974780|P1|Overall Study|Adverse Event|4
1514908|NCT00386100|4975029|P1|Overall Study|Laboratory findings|1
1514824|NCT00386334|4974814|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
1514825|NCT00386334|4974815|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
1514826|NCT00386334|4974814|P2|Double Blind Period|Other|3
1514827|NCT00386334|4974815|P1|Double Blind Period|Other|3
1514828|NCT00386334|4974814|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
1514829|NCT00386334|4974815|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
1514830|NCT00386334|4974814|P2|Double Blind Period|Lack of Efficacy|11
1514831|NCT00386334|4974815|P1|Double Blind Period|Lack of Efficacy|20
1514832|NCT00386334|4974814|P2|Double Blind Period|Withdrawal by Subject|13
1514833|NCT00386334|4974815|P1|Double Blind Period|Withdrawal by Subject|9
1514834|NCT00386334|4974814|P2|Double Blind Period|Protocol Violation|1
1514835|NCT00386334|4974815|P1|Double Blind Period|Protocol Violation|1
1514836|NCT00386334|4974814|P2|Double Blind Period|Adverse Event|14
1514837|NCT00386334|4974815|P1|Double Blind Period|Adverse Event|9
1514838|NCT00386308|4974959|P2|Overall Study|Other Event|1
1514839|NCT00386308|4974960|P1|Overall Study|Other Event|8
1514840|NCT00386308|4974959|P2|Overall Study|Withdrawal by Subject|2
1514841|NCT00386308|4974960|P1|Overall Study|Withdrawal by Subject|6
1514842|NCT00386308|4974959|P2|Overall Study|Lost to Follow-up|6
1514843|NCT00386308|4974960|P1|Overall Study|Lost to Follow-up|10
1514844|NCT00386308|4974959|P2|Overall Study|Lack of Efficacy|2
1514845|NCT00386308|4974960|P1|Overall Study|Lack of Efficacy|0
1514846|NCT00386308|4974959|P2|Overall Study|Protocol Violation|5
1514847|NCT00386308|4974960|P1|Overall Study|Protocol Violation|2
1514848|NCT00386308|4974959|P2|Overall Study|Adverse Event|3
1514849|NCT00386308|4974960|P1|Overall Study|Adverse Event|3
1514850|NCT00386152|4975007|P3|Overall Study|Withdrawal by Subject|10
1514851|NCT00386152|4975008|P2|Overall Study|Withdrawal by Subject|6
1514852|NCT00386152|4975009|P1|Overall Study|Withdrawal by Subject|3
1514853|NCT00386152|4975007|P3|Overall Study|Protocol Violation|2
1514854|NCT00386152|4975008|P2|Overall Study|Protocol Violation|5
1514855|NCT00386152|4975009|P1|Overall Study|Protocol Violation|3
1514856|NCT00386152|4975007|P3|Overall Study|Completed chemotherapy|1
1514857|NCT00386152|4975008|P2|Overall Study|Completed chemotherapy|5
1514858|NCT00386152|4975009|P1|Overall Study|Completed chemotherapy|4
1514859|NCT00386152|4975007|P3|Overall Study|Lost to Follow-up|0
1514860|NCT00386152|4975008|P2|Overall Study|Lost to Follow-up|0
1514861|NCT00386152|4975009|P1|Overall Study|Lost to Follow-up|1
1514862|NCT00386152|4975007|P3|Overall Study|Physician Decision|4
1514863|NCT00386152|4975008|P2|Overall Study|Physician Decision|10
1514864|NCT00386152|4975009|P1|Overall Study|Physician Decision|13
1514865|NCT00386152|4975007|P3|Overall Study|Disease progression|5
1514866|NCT00386152|4975008|P2|Overall Study|Disease progression|4
1514867|NCT00386152|4975009|P1|Overall Study|Disease progression|7
1514868|NCT00386152|4975007|P3|Overall Study|Death|1
1514869|NCT00386152|4975008|P2|Overall Study|Death|0
1514870|NCT00386152|4975009|P1|Overall Study|Death|3
1514871|NCT00386152|4975007|P3|Overall Study|Chang from original chemo stratification|6
1514872|NCT00386152|4975008|P2|Overall Study|Chang from original chemo stratification|5
1514873|NCT00386152|4975009|P1|Overall Study|Chang from original chemo stratification|4
1514874|NCT00386152|4975007|P3|Overall Study|Adverse Event|4
1514875|NCT00386152|4975008|P2|Overall Study|Adverse Event|5
1514876|NCT00386152|4975009|P1|Overall Study|Adverse Event|6
1514877|NCT00386100|4975028|P2|Overall Study|Participant randomized in error|0
1514878|NCT00386100|4975029|P1|Overall Study|Participant randomized in error|1
1514879|NCT00386100|4975028|P2|Overall Study|Hb1Ac >8%|1
1514880|NCT00386100|4975029|P1|Overall Study|Hb1Ac >8%|0
1514881|NCT00386100|4975028|P2|Overall Study|Out of country for 5 months|0
1514882|NCT00386100|4975029|P1|Overall Study|Out of country for 5 months|1
1514883|NCT00386100|4975028|P2|Overall Study|Positive pregnancy test|3
1514884|NCT00386100|4975029|P1|Overall Study|Positive pregnancy test|1
1514885|NCT00386100|4975028|P2|Overall Study|Osteoporosis|1
1514886|NCT00386100|4975029|P1|Overall Study|Osteoporosis|0
1514887|NCT00386100|4975028|P2|Overall Study|7.6% bone loss|0
1514888|NCT00386100|4975029|P1|Overall Study|7.6% bone loss|1
1514889|NCT00386100|4975028|P2|Overall Study|DBP 93 mmHg at randomization|0
1514890|NCT00386100|4975029|P1|Overall Study|DBP 93 mmHg at randomization|1
1514891|NCT00386100|4975028|P2|Overall Study|Bone loss by DXA bone scan|0
1514892|NCT00386100|4975029|P1|Overall Study|Bone loss by DXA bone scan|1
1514893|NCT00386100|4975028|P2|Overall Study|Bad metabolic control & patient security|0
1514894|NCT00386100|4975029|P1|Overall Study|Bad metabolic control & patient security|1
1514895|NCT00386100|4975028|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
1514896|NCT00386100|4975029|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
1514897|NCT00386100|4975028|P2|Overall Study|Participant's PCP wanted to stop drug|0
1514898|NCT00386100|4975029|P1|Overall Study|Participant's PCP wanted to stop drug|1
1514899|NCT00386100|4975028|P2|Overall Study|Didn't meet entry criteria|1
1514900|NCT00386100|4975029|P1|Overall Study|Didn't meet entry criteria|1
1514901|NCT00386100|4975028|P2|Overall Study|Excessive bone loss vs. baseline value|1
1514902|NCT00386100|4975029|P1|Overall Study|Excessive bone loss vs. baseline value|0
1514903|NCT00386100|4975028|P2|Overall Study|Participant moving out of state|0
1514904|NCT00386100|4975029|P1|Overall Study|Participant moving out of state|2
1514905|NCT00386100|4975028|P2|Overall Study|Participant's concern due to CPK levels|0
1514906|NCT00386100|4975029|P1|Overall Study|Participant's concern due to CPK levels|1
1514907|NCT00386100|4975028|P2|Overall Study|Laboratory findings|0
1514909|NCT00386100|4975028|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
1514910|NCT00386100|4975029|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
1514911|NCT00386100|4975028|P2|Overall Study|Consecutive elevated Hba1C|0
1514912|NCT00386100|4975029|P1|Overall Study|Consecutive elevated Hba1C|1
1514913|NCT00386100|4975028|P2|Overall Study|BMD <2.5|0
1514914|NCT00386100|4975029|P1|Overall Study|BMD <2.5|1
1514915|NCT00386100|4975028|P2|Overall Study|Bone mass density (BMD) loss >6%|4
1514916|NCT00386100|4975029|P1|Overall Study|Bone mass density (BMD) loss >6%|4
1514917|NCT00386100|4975028|P2|Overall Study|Withdrawal by Subject|31
1514918|NCT00386100|4975029|P1|Overall Study|Withdrawal by Subject|32
1514919|NCT00386100|4975028|P2|Overall Study|Protocol Violation|3
1514920|NCT00386100|4975029|P1|Overall Study|Protocol Violation|5
1514921|NCT00386100|4975028|P2|Overall Study|Non-compliance|19
1514922|NCT00386100|4975029|P1|Overall Study|Non-compliance|18
1514923|NCT00386100|4975028|P2|Overall Study|Lost to Follow-up|29
1514924|NCT00386100|4975029|P1|Overall Study|Lost to Follow-up|29
1514925|NCT00386100|4975028|P2|Overall Study|Insufficient therapeutic effect|6
1514926|NCT00386100|4975029|P1|Overall Study|Insufficient therapeutic effect|30
1514927|NCT00386100|4975028|P2|Overall Study|Death|1
1514928|NCT00386100|4975029|P1|Overall Study|Death|0
1514929|NCT00386100|4975028|P2|Overall Study|Adverse Event|25
1514930|NCT00386100|4975029|P1|Overall Study|Adverse Event|15
1514931|NCT00386100|4975028|P2|Overall Study|Did not receive study medication|4
1514932|NCT00386100|4975029|P1|Overall Study|Did not receive study medication|6
1514933|NCT00386022|4975093|P2|Plus Estrogen|Adverse Event|1
1514934|NCT00386022|4975094|P1|Plus Estrogen|Adverse Event|0
1514935|NCT00386022|4975093|P2|Plus Estrogen|Lost to Follow-up|0
1514936|NCT00386022|4975094|P1|Plus Estrogen|Lost to Follow-up|2
1514937|NCT00386009|4975104|P2|Overall Study|Withdrawal by Subject|4
1514938|NCT00386009|4975105|P1|Overall Study|Withdrawal by Subject|5
1514939|NCT00386009|4975104|P2|Overall Study|Sponsor Decision|1
1514940|NCT00386009|4975105|P1|Overall Study|Sponsor Decision|1
1514941|NCT00386009|4975104|P2|Overall Study|Protocol Violation|0
1514942|NCT00386009|4975105|P1|Overall Study|Protocol Violation|1
1514943|NCT00386009|4975104|P2|Overall Study|Lost to Follow-up|1
1514944|NCT00386009|4975105|P1|Overall Study|Lost to Follow-up|1
1514945|NCT00386009|4975104|P2|Overall Study|Entry Criteria Not Met|2
1514946|NCT00386009|4975105|P1|Overall Study|Entry Criteria Not Met|0
1514947|NCT00386009|4975104|P2|Overall Study|Death|0
1514948|NCT00386009|4975105|P1|Overall Study|Death|1
1514949|NCT00386009|4975104|P2|Overall Study|Adverse Event|2
1514950|NCT00386009|4975105|P1|Overall Study|Adverse Event|0
1514951|NCT00385944|4975150|P3|2nd Maintenance Dose Period|Invalid PD Data|0
1514952|NCT00385944|4975151|P2|2nd Maintenance Dose Period|Invalid PD Data|3
1514953|NCT00385944|4975152|P1|2nd Maintenance Dose Period|Invalid PD Data|2
1514954|NCT00385944|4975150|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
1514955|NCT00385944|4975151|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
1514956|NCT00385944|4975152|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
1514957|NCT00385944|4975150|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
1514958|NCT00385944|4975151|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
1514959|NCT00385944|4975152|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
1514960|NCT00385944|4975150|P3|1st Maintenance Dose Period|Physician Decision|0
1514961|NCT00385944|4975151|P2|1st Maintenance Dose Period|Physician Decision|0
1514962|NCT00385944|4975152|P1|1st Maintenance Dose Period|Physician Decision|1
1514963|NCT00385918|4975195|P3|Intervention Phase After Randomization|Lost to Follow-up|0
1514964|NCT00385918|4975196|P2|Intervention Phase After Randomization|Lost to Follow-up|0
1514965|NCT00385918|4975197|P1|Intervention Phase After Randomization|Lost to Follow-up|1
1514966|NCT00385918|4975195|P3|Intervention Phase After Randomization|Physician Decision|0
1514967|NCT00385918|4975196|P2|Intervention Phase After Randomization|Physician Decision|0
1514968|NCT00385918|4975197|P1|Intervention Phase After Randomization|Physician Decision|1
1514969|NCT00385918|4975195|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
1514970|NCT00385918|4975196|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
1514971|NCT00385918|4975197|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
1514972|NCT00385918|4975195|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
1514973|NCT00385918|4975196|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
1514974|NCT00385918|4975197|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
1514975|NCT00385918|4975195|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
1514976|NCT00385918|4975196|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
1514977|NCT00385918|4975197|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
1514978|NCT00385918|4975195|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
1514979|NCT00385918|4975196|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
1514980|NCT00385918|4975197|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
1514981|NCT00385840|4975221|P2|Overall Study|Lost to Follow-up|13
1514982|NCT00385840|4975222|P1|Overall Study|Lost to Follow-up|3
1514983|NCT00385840|4975221|P2|Overall Study|Adverse Event|1
1514984|NCT00385840|4975222|P1|Overall Study|Adverse Event|1
1514985|NCT00385827|4975245|P3|Part 2|Other|21
1514986|NCT00385827|4975246|P2|Part 2|Other|11
1514987|NCT00385827|4975247|P1|Part 2|Other|0
1514988|NCT00385827|4975245|P3|Part 2|Randomized but not treated|2
1514989|NCT00385827|4975246|P2|Part 2|Randomized but not treated|2
1514990|NCT00385827|4975247|P1|Part 2|Randomized but not treated|0
1514991|NCT00385827|4975245|P3|Part 2|Lack of Efficacy|13
1514992|NCT00385827|4975246|P2|Part 2|Lack of Efficacy|14
1514993|NCT00385827|4975247|P1|Part 2|Lack of Efficacy|0
1514994|NCT00385827|4975245|P3|Part 2|Death|2
1514995|NCT00385827|4975246|P2|Part 2|Death|0
1514996|NCT00385827|4975247|P1|Part 2|Death|0
1514997|NCT00385827|4975245|P3|Part 2|Adverse Event|10
1514998|NCT00385827|4975246|P2|Part 2|Adverse Event|6
1514999|NCT00385827|4975247|P1|Part 2|Adverse Event|0
1515000|NCT00385827|4975245|P3|Part 1|Other|0
1515001|NCT00385827|4975246|P2|Part 1|Other|0
1515002|NCT00385827|4975247|P1|Part 1|Other|1
1515003|NCT00385827|4975245|P3|Part 1|Lack of Efficacy|0
1515004|NCT00385827|4975246|P2|Part 1|Lack of Efficacy|0
1515005|NCT00385827|4975247|P1|Part 1|Lack of Efficacy|5
1515006|NCT00385827|4975245|P3|Part 1|Death|0
1515007|NCT00385827|4975246|P2|Part 1|Death|0
1515008|NCT00385827|4975247|P1|Part 1|Death|2
1515009|NCT00385827|4975245|P3|Part 1|Adverse Event|0
1515010|NCT00385827|4975246|P2|Part 1|Adverse Event|0
1515011|NCT00385827|4975247|P1|Part 1|Adverse Event|1
1515012|NCT00385762|4975291|P1|Overall Study|Lost to Follow-up|1
1515013|NCT00385762|4975291|P1|Overall Study|Adverse Event|1
1515014|NCT00385736|4975301|P3|Safety Analysis Set|Other|4
1515015|NCT00385736|4975302|P2|Safety Analysis Set|Other|4
1515016|NCT00385736|4975303|P1|Safety Analysis Set|Other|1
1515017|NCT00385736|4975301|P3|Safety Analysis Set|Protocol Violation|6
1515018|NCT00385736|4975302|P2|Safety Analysis Set|Protocol Violation|1
1515019|NCT00385736|4975303|P1|Safety Analysis Set|Protocol Violation|2
1515020|NCT00385736|4975301|P3|Safety Analysis Set|Lack of Efficacy|31
1515021|NCT00385736|4975302|P2|Safety Analysis Set|Lack of Efficacy|16
1515022|NCT00385736|4975303|P1|Safety Analysis Set|Lack of Efficacy|38
1515023|NCT00385736|4975301|P3|Safety Analysis Set|Lost to Follow-up|2
1515024|NCT00385736|4975302|P2|Safety Analysis Set|Lost to Follow-up|2
1515025|NCT00385736|4975303|P1|Safety Analysis Set|Lost to Follow-up|0
1515026|NCT00385736|4975301|P3|Safety Analysis Set|Withdrawal by Subject|14
1515027|NCT00385736|4975302|P2|Safety Analysis Set|Withdrawal by Subject|6
1515028|NCT00385736|4975303|P1|Safety Analysis Set|Withdrawal by Subject|6
1515029|NCT00385736|4975301|P3|Safety Analysis Set|Adverse Event|23
1515030|NCT00385736|4975302|P2|Safety Analysis Set|Adverse Event|15
1515031|NCT00385736|4975303|P1|Safety Analysis Set|Adverse Event|23
1515032|NCT00385736|4975301|P3|Efficacy Analysis Set - Maintenance|Other|4
1515033|NCT00385736|4975302|P2|Efficacy Analysis Set - Maintenance|Other|4
1515034|NCT00385736|4975303|P1|Efficacy Analysis Set - Maintenance|Other|0
1515035|NCT00385736|4975301|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
1515036|NCT00385736|4975302|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
1515037|NCT00385736|4975303|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
1515038|NCT00385736|4975301|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
1515039|NCT00385736|4975302|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
1515040|NCT00385736|4975303|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
1515041|NCT00385736|4975301|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
1515042|NCT00385736|4975302|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
1515043|NCT00385736|4975303|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
1515044|NCT00385736|4975301|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
1515045|NCT00385736|4975302|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
1515046|NCT00385736|4975303|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
1515047|NCT00385736|4975301|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
1515048|NCT00385736|4975302|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
1515049|NCT00385736|4975303|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
1515050|NCT00385736|4975301|P3|Efficacy Analysis Set - Induction|Other|1
1515051|NCT00385736|4975302|P2|Efficacy Analysis Set - Induction|Other|0
1515052|NCT00385736|4975303|P1|Efficacy Analysis Set - Induction|Other|0
1515053|NCT00385736|4975301|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
1515054|NCT00385736|4975302|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
1515055|NCT00385736|4975303|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
1515056|NCT00385736|4975301|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
1515057|NCT00385736|4975302|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
1515058|NCT00385736|4975303|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
1515059|NCT00385736|4975301|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
1515060|NCT00385736|4975302|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
1515061|NCT00385736|4975303|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
1515062|NCT00385736|4975301|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
1515063|NCT00385736|4975302|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
1515064|NCT00385736|4975303|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
1515065|NCT00385736|4975301|P3|Efficacy Analysis Set - Induction|Adverse Event|4
1515066|NCT00385736|4975302|P2|Efficacy Analysis Set - Induction|Adverse Event|6
1515067|NCT00385736|4975303|P1|Efficacy Analysis Set - Induction|Adverse Event|5
1515068|NCT00385723|4975348|P3|Overall Study|Withdrawal by Subject|2
1515069|NCT00385723|4975349|P2|Overall Study|Withdrawal by Subject|0
1515070|NCT00385723|4975350|P1|Overall Study|Withdrawal by Subject|1
1515071|NCT00385723|4975348|P3|Overall Study|Lost to Follow-up|0
1515072|NCT00385723|4975349|P2|Overall Study|Lost to Follow-up|1
1515073|NCT00385723|4975350|P1|Overall Study|Lost to Follow-up|1
1515074|NCT00385684|4975364|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
1515075|NCT00385684|4975365|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
1515076|NCT00385684|4975364|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
1515077|NCT00385684|4975365|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
1515078|NCT00385684|4975364|P2|FIRST INTERVENTION OF PHASE A|Death|0
1515079|NCT00385684|4975365|P1|FIRST INTERVENTION OF PHASE A|Death|1
1515080|NCT00385671|4975374|P3|Overall Study|Withdrawal by Subject|4
1515081|NCT00385671|4975375|P2|Overall Study|Withdrawal by Subject|4
1515082|NCT00385671|4975376|P1|Overall Study|Withdrawal by Subject|4
1515083|NCT00385671|4975374|P3|Overall Study|Sponsor Decision|1
1515084|NCT00385671|4975375|P2|Overall Study|Sponsor Decision|2
1515085|NCT00385671|4975376|P1|Overall Study|Sponsor Decision|2
1515086|NCT00385671|4975374|P3|Overall Study|Protocol Violation|1
1515087|NCT00385671|4975375|P2|Overall Study|Protocol Violation|2
1515088|NCT00385671|4975376|P1|Overall Study|Protocol Violation|5
1515089|NCT00385671|4975374|P3|Overall Study|Physician Decision|2
1515090|NCT00385671|4975375|P2|Overall Study|Physician Decision|1
1515091|NCT00385671|4975376|P1|Overall Study|Physician Decision|2
1515092|NCT00385671|4975374|P3|Overall Study|Lost to Follow-up|5
1515093|NCT00385671|4975375|P2|Overall Study|Lost to Follow-up|6
1515094|NCT00385671|4975376|P1|Overall Study|Lost to Follow-up|6
1515095|NCT00385671|4975374|P3|Overall Study|Lack of Efficacy|5
1515096|NCT00385671|4975375|P2|Overall Study|Lack of Efficacy|9
1515097|NCT00385671|4975376|P1|Overall Study|Lack of Efficacy|5
1515098|NCT00385671|4975374|P3|Overall Study|Adverse Event|18
1515099|NCT00385671|4975375|P2|Overall Study|Adverse Event|27
1515100|NCT00385671|4975376|P1|Overall Study|Adverse Event|14
1515101|NCT00385593|4975532|P2|Overall Study|Incorrect randomization|1
1515102|NCT00385593|4975533|P1|Overall Study|Incorrect randomization|0
1515103|NCT00385593|4975532|P2|Overall Study|Incorrect inclusion|0
1515104|NCT00385593|4975533|P1|Overall Study|Incorrect inclusion|2
1515105|NCT00385593|4975532|P2|Overall Study|Several reasons|15
1515106|NCT00385593|4975533|P1|Overall Study|Several reasons|17
1515107|NCT00385593|4975532|P2|Overall Study|Protocol Violation|4
1515108|NCT00385593|4975533|P1|Overall Study|Protocol Violation|7
1515109|NCT00385593|4975532|P2|Overall Study|Lost to Follow-up|8
1515110|NCT00385593|4975533|P1|Overall Study|Lost to Follow-up|12
1515111|NCT00385593|4975532|P2|Overall Study|Withdrawal by Subject|7
1515112|NCT00385593|4975533|P1|Overall Study|Withdrawal by Subject|17
1515113|NCT00385593|4975532|P2|Overall Study|Adverse Event|2
1515114|NCT00385593|4975533|P1|Overall Study|Adverse Event|3
1515115|NCT00385541|4975643|P2|Overall Study|severe pain, clinician requested unblind|1
1515116|NCT00385541|4975644|P1|Overall Study|severe pain, clinician requested unblind|0
1515117|NCT00385203|4975691|P2|Overall Study|Incorrect enrollment|0
1515118|NCT00385203|4975692|P1|Overall Study|Incorrect enrollment|2
1515119|NCT00385203|4975691|P2|Overall Study|Condition under investigation worsened|3
1515120|NCT00385203|4975692|P1|Overall Study|Condition under investigation worsened|18
1515121|NCT00385203|4975691|P2|Overall Study|Death|0
1515122|NCT00385203|4975692|P1|Overall Study|Death|1
1515123|NCT00385203|4975691|P2|Overall Study|Adverse Event|4
1515124|NCT00385203|4975692|P1|Overall Study|Adverse Event|5
1515125|NCT00384956|4975780|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
1515126|NCT00384930|4975797|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
1515127|NCT00384930|4975798|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
1515128|NCT00384930|4975799|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
1515129|NCT00384930|4975800|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
1515130|NCT00384930|4975801|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
1515131|NCT00384930|4975797|P5|Overall Study|Withdrawal by Subject|16
1515132|NCT00384930|4975798|P4|Overall Study|Withdrawal by Subject|6
1515133|NCT00384930|4975799|P3|Overall Study|Withdrawal by Subject|7
1515134|NCT00384930|4975800|P2|Overall Study|Withdrawal by Subject|7
1515135|NCT00384930|4975801|P1|Overall Study|Withdrawal by Subject|9
1515136|NCT00384930|4975797|P5|Overall Study|Sponsor Decision|0
1515137|NCT00384930|4975798|P4|Overall Study|Sponsor Decision|5
1515138|NCT00384930|4975799|P3|Overall Study|Sponsor Decision|0
1515139|NCT00384930|4975800|P2|Overall Study|Sponsor Decision|4
1515140|NCT00384930|4975801|P1|Overall Study|Sponsor Decision|3
1515141|NCT00384930|4975797|P5|Overall Study|Protocol Violation|4
1515142|NCT00384930|4975798|P4|Overall Study|Protocol Violation|6
1515143|NCT00384930|4975799|P3|Overall Study|Protocol Violation|1
1515144|NCT00384930|4975800|P2|Overall Study|Protocol Violation|0
1515145|NCT00384930|4975801|P1|Overall Study|Protocol Violation|1
1515146|NCT00384930|4975797|P5|Overall Study|Physician Decision|1
1515147|NCT00384930|4975798|P4|Overall Study|Physician Decision|0
1515148|NCT00384930|4975799|P3|Overall Study|Physician Decision|1
1515149|NCT00384930|4975800|P2|Overall Study|Physician Decision|1
1515150|NCT00384930|4975801|P1|Overall Study|Physician Decision|0
1515151|NCT00384930|4975797|P5|Overall Study|Lost to Follow-up|6
1515152|NCT00384930|4975798|P4|Overall Study|Lost to Follow-up|4
1515153|NCT00384930|4975799|P3|Overall Study|Lost to Follow-up|0
1515154|NCT00384930|4975800|P2|Overall Study|Lost to Follow-up|3
1515155|NCT00384930|4975801|P1|Overall Study|Lost to Follow-up|5
1515156|NCT00384930|4975797|P5|Overall Study|Lack of Efficacy|2
1515157|NCT00384930|4975798|P4|Overall Study|Lack of Efficacy|1
1515158|NCT00384930|4975799|P3|Overall Study|Lack of Efficacy|2
1515159|NCT00384930|4975800|P2|Overall Study|Lack of Efficacy|1
1515160|NCT00384930|4975801|P1|Overall Study|Lack of Efficacy|1
1515161|NCT00384930|4975797|P5|Overall Study|Entry Criteria Not Met|4
1515162|NCT00384930|4975798|P4|Overall Study|Entry Criteria Not Met|8
1515163|NCT00384930|4975799|P3|Overall Study|Entry Criteria Not Met|7
1515164|NCT00384930|4975800|P2|Overall Study|Entry Criteria Not Met|6
1515165|NCT00384930|4975801|P1|Overall Study|Entry Criteria Not Met|2
1515166|NCT00384930|4975797|P5|Overall Study|Adverse Event|14
1515167|NCT00384930|4975798|P4|Overall Study|Adverse Event|11
1515168|NCT00384930|4975799|P3|Overall Study|Adverse Event|12
1515169|NCT00384930|4975800|P2|Overall Study|Adverse Event|4
1515170|NCT00384930|4975801|P1|Overall Study|Adverse Event|5
1515171|NCT00384397|4975911|P3|Overall Study|Withdrawal by Subject|15
1515172|NCT00384397|4975912|P2|Overall Study|Withdrawal by Subject|17
1515173|NCT00384397|4975913|P1|Overall Study|Withdrawal by Subject|14
1515174|NCT00384397|4975911|P3|Overall Study|Lost to Follow-up|3
1515175|NCT00384397|4975912|P2|Overall Study|Lost to Follow-up|13
1515176|NCT00384397|4975913|P1|Overall Study|Lost to Follow-up|11
1515177|NCT00384397|4975911|P3|Overall Study|Protocol Violation|13
1515178|NCT00384397|4975912|P2|Overall Study|Protocol Violation|15
1515179|NCT00384397|4975913|P1|Overall Study|Protocol Violation|7
1515180|NCT00384397|4975911|P3|Overall Study|Adverse Event|2
1515181|NCT00384397|4975912|P2|Overall Study|Adverse Event|1
1515182|NCT00384397|4975913|P1|Overall Study|Adverse Event|0
1515183|NCT00384332|4975932|P2|Overall Study|Lost to Follow-up|0
1515184|NCT00384332|4975933|P1|Overall Study|Lost to Follow-up|4
1515185|NCT00384293|4975943|P3|Post-randomization Period|Patient Randomized in Error|1
1515186|NCT00384293|4975944|P2|Post-randomization Period|Patient Randomized in Error|0
1515187|NCT00384293|4975945|P1|Post-randomization Period|Patient Randomized in Error|0
1515188|NCT00384293|4975943|P3|Post-randomization Period|Trial Termination|204
1515189|NCT00384293|4975944|P2|Post-randomization Period|Trial Termination|180
1515190|NCT00384293|4975945|P1|Post-randomization Period|Trial Termination|0
1515191|NCT00384293|4975943|P3|Post-randomization Period|Withdrawal by Subject|6
1515192|NCT00384293|4975944|P2|Post-randomization Period|Withdrawal by Subject|8
1515193|NCT00384293|4975945|P1|Post-randomization Period|Withdrawal by Subject|0
1515194|NCT00384293|4975943|P3|Post-randomization Period|Protocol Violation|0
1515195|NCT00384293|4975944|P2|Post-randomization Period|Protocol Violation|1
1515196|NCT00384293|4975945|P1|Post-randomization Period|Protocol Violation|0
1515197|NCT00384293|4975943|P3|Post-randomization Period|Lost to Follow-up|1
1515198|NCT00384293|4975944|P2|Post-randomization Period|Lost to Follow-up|2
1515199|NCT00384293|4975945|P1|Post-randomization Period|Lost to Follow-up|0
1515200|NCT00384293|4975943|P3|Post-randomization Period|Adverse Event|7
1515201|NCT00384293|4975944|P2|Post-randomization Period|Adverse Event|23
1515202|NCT00384293|4975945|P1|Post-randomization Period|Adverse Event|0
1515203|NCT00384293|4975943|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
1515204|NCT00384293|4975944|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
1515205|NCT00384293|4975945|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
1515206|NCT00384293|4975943|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
1515207|NCT00384293|4975944|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
1515208|NCT00384293|4975945|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
1515209|NCT00384293|4975943|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
1515210|NCT00384293|4975944|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
1515211|NCT00384293|4975945|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
1515212|NCT00384293|4975943|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
1515213|NCT00384293|4975944|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
1515214|NCT00384293|4975945|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
1515215|NCT00384293|4975943|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
1515216|NCT00384293|4975944|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
1515217|NCT00384293|4975945|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
1515218|NCT00384293|4975943|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
1515219|NCT00384293|4975944|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
1515220|NCT00384293|4975945|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
1515221|NCT00384293|4975943|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
1515222|NCT00384293|4975944|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
1515223|NCT00384293|4975945|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
1515224|NCT00384189|4975969|P4|Overall Study|Reason Not Specified|40
1515225|NCT00384189|4975970|P3|Overall Study|Reason Not Specified|58
1515226|NCT00384189|4975971|P2|Overall Study|Reason Not Specified|57
1515227|NCT00384189|4975972|P1|Overall Study|Reason Not Specified|50
1515228|NCT00384176|4976033|P3|Overall Study|Liver metastases, colon resec. planned|0
1515229|NCT00384176|4976034|P2|Overall Study|Liver metastases, colon resec. planned|0
1515230|NCT00384176|4976035|P1|Overall Study|Liver metastases, colon resec. planned|1
1515231|NCT00384176|4976033|P3|Overall Study|Physician Decision|0
1515232|NCT00384176|4976034|P2|Overall Study|Physician Decision|2
1515233|NCT00384176|4976035|P1|Overall Study|Physician Decision|0
1515234|NCT00384176|4976033|P3|Overall Study|Did not receive study treatment|1
1515235|NCT00384176|4976034|P2|Overall Study|Did not receive study treatment|1
1515236|NCT00384176|4976035|P1|Overall Study|Did not receive study treatment|0
1515237|NCT00384176|4976033|P3|Overall Study|Toxicity of treatment|0
1515238|NCT00384176|4976034|P2|Overall Study|Toxicity of treatment|0
1515239|NCT00384176|4976035|P1|Overall Study|Toxicity of treatment|1
1515240|NCT00384176|4976033|P3|Overall Study|Longer QTC as Visit 1|0
1515241|NCT00384176|4976034|P2|Overall Study|Longer QTC as Visit 1|0
1515242|NCT00384176|4976035|P1|Overall Study|Longer QTC as Visit 1|1
1515243|NCT00384176|4976033|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
1515244|NCT00384176|4976034|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
1515245|NCT00384176|4976035|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
1515246|NCT00384176|4976033|P3|Overall Study|Lost to Follow-up|4
1515247|NCT00384176|4976034|P2|Overall Study|Lost to Follow-up|18
1515248|NCT00384176|4976035|P1|Overall Study|Lost to Follow-up|16
1515249|NCT00384176|4976033|P3|Overall Study|Withdrawal by Subject|22
1515250|NCT00384176|4976034|P2|Overall Study|Withdrawal by Subject|48
1515251|NCT00384176|4976035|P1|Overall Study|Withdrawal by Subject|52
1515252|NCT00384176|4976033|P3|Overall Study|Death|105
1515253|NCT00384176|4976034|P2|Overall Study|Death|247
1515254|NCT00384176|4976035|P1|Overall Study|Death|239
1515255|NCT00384085|4976061|P3|Overall Study|Patient required surgery|0
1515256|NCT00384085|4976062|P2|Overall Study|Patient required surgery|1
1515257|NCT00384085|4976063|P1|Overall Study|Patient required surgery|0
1515258|NCT00384085|4976061|P3|Overall Study|Patient moved|1
1515259|NCT00384085|4976062|P2|Overall Study|Patient moved|0
1515260|NCT00384085|4976063|P1|Overall Study|Patient moved|1
1515261|NCT00384085|4976061|P3|Overall Study|Sponsor decision|1
1515262|NCT00384085|4976062|P2|Overall Study|Sponsor decision|2
1515263|NCT00384085|4976063|P1|Overall Study|Sponsor decision|1
1515264|NCT00384085|4976061|P3|Overall Study|Loss of site personnel|1
1515265|NCT00384085|4976062|P2|Overall Study|Loss of site personnel|0
1515266|NCT00384085|4976063|P1|Overall Study|Loss of site personnel|1
1515267|NCT00384085|4976061|P3|Overall Study|Physician Decision|0
1515268|NCT00384085|4976062|P2|Overall Study|Physician Decision|0
1515269|NCT00384085|4976063|P1|Overall Study|Physician Decision|1
1515270|NCT00384085|4976061|P3|Overall Study|Patient non-compliant|5
1515271|NCT00384085|4976062|P2|Overall Study|Patient non-compliant|4
1515272|NCT00384085|4976063|P1|Overall Study|Patient non-compliant|4
1515273|NCT00384085|4976061|P3|Overall Study|Withdrawal by Subject|29
1515274|NCT00384085|4976062|P2|Overall Study|Withdrawal by Subject|19
1515275|NCT00384085|4976063|P1|Overall Study|Withdrawal by Subject|14
1515276|NCT00384085|4976061|P3|Overall Study|Progressive Disease|0
1515277|NCT00384085|4976062|P2|Overall Study|Progressive Disease|1
1515278|NCT00384085|4976063|P1|Overall Study|Progressive Disease|0
1515279|NCT00384085|4976061|P3|Overall Study|Lost to Follow-up|10
1515280|NCT00384085|4976062|P2|Overall Study|Lost to Follow-up|9
1515281|NCT00384085|4976063|P1|Overall Study|Lost to Follow-up|9
1515282|NCT00384085|4976061|P3|Overall Study|Protocol Violation|2
1515283|NCT00384085|4976062|P2|Overall Study|Protocol Violation|2
1515284|NCT00384085|4976063|P1|Overall Study|Protocol Violation|2
1515285|NCT00384085|4976061|P3|Overall Study|No longer Requires Study Treatment|1
1515286|NCT00384085|4976062|P2|Overall Study|No longer Requires Study Treatment|0
1515287|NCT00384085|4976063|P1|Overall Study|No longer Requires Study Treatment|1
1515288|NCT00384085|4976061|P3|Overall Study|Lack of Efficacy|2
1515289|NCT00384085|4976062|P2|Overall Study|Lack of Efficacy|3
1515290|NCT00384085|4976063|P1|Overall Study|Lack of Efficacy|0
1515291|NCT00384085|4976061|P3|Overall Study|Adverse Event|4
1515292|NCT00384085|4976062|P2|Overall Study|Adverse Event|5
1515293|NCT00384085|4976063|P1|Overall Study|Adverse Event|5
1515294|NCT00384059|4976089|P2|Toddler Dose|Failed to return|1
1515295|NCT00384059|4976090|P1|Toddler Dose|Failed to return|0
1515296|NCT00384059|4976089|P2|Toddler Dose|Lost to Follow-up|1
1515297|NCT00384059|4976090|P1|Toddler Dose|Lost to Follow-up|1
1515298|NCT00384059|4976089|P2|After Infant Series|Lost to Follow-up|1
1515299|NCT00384059|4976090|P1|After Infant Series|Lost to Follow-up|0
1515300|NCT00384059|4976089|P2|After Infant Series|Physician Decision|1
1515301|NCT00384059|4976090|P1|After Infant Series|Physician Decision|0
1515302|NCT00384059|4976089|P2|After Infant Series|Adverse Event|1
1515303|NCT00384059|4976090|P1|After Infant Series|Adverse Event|0
1515304|NCT00384059|4976089|P2|After Infant Series|Failed to Return|2
1515305|NCT00384059|4976090|P1|After Infant Series|Failed to Return|0
1515306|NCT00384059|4976089|P2|After Infant Series|Withdrawal by Subject|2
1515307|NCT00384059|4976090|P1|After Infant Series|Withdrawal by Subject|2
1515308|NCT00384059|4976089|P2|After Infant Series|Protocol Violation|3
1515309|NCT00384059|4976090|P1|After Infant Series|Protocol Violation|2
1515310|NCT00384059|4976089|P2|Infant Series|Lost to Follow-up|1
1515311|NCT00384059|4976090|P1|Infant Series|Lost to Follow-up|0
1515312|NCT00384059|4976089|P2|Infant Series|Protocol Violation|2
1515313|NCT00384059|4976090|P1|Infant Series|Protocol Violation|1
1515314|NCT00384059|4976089|P2|Infant Series|Adverse Event|2
1515315|NCT00384059|4976090|P1|Infant Series|Adverse Event|1
1515316|NCT00384059|4976089|P2|Infant Series|Withdrawal by Subject|2
1515317|NCT00384059|4976090|P1|Infant Series|Withdrawal by Subject|2
1515318|NCT00384059|4976089|P2|Infant Series|Not consented|6
1515319|NCT00384059|4976090|P1|Infant Series|Not consented|2
1515320|NCT00384033|4976140|P4|Overall Study|Randomized but not treated|2
1515321|NCT00384033|4976141|P3|Overall Study|Randomized but not treated|10
1515322|NCT00384033|4976142|P2|Overall Study|Randomized but not treated|7
1515323|NCT00384033|4976143|P1|Overall Study|Randomized but not treated|3
1515324|NCT00384033|4976140|P4|Overall Study|Lack of Efficacy|1
1515325|NCT00384033|4976141|P3|Overall Study|Lack of Efficacy|3
1515326|NCT00384033|4976142|P2|Overall Study|Lack of Efficacy|3
1515327|NCT00384033|4976143|P1|Overall Study|Lack of Efficacy|7
1515328|NCT00384033|4976140|P4|Overall Study|Withdrawal by Subject|2
1515329|NCT00384033|4976141|P3|Overall Study|Withdrawal by Subject|5
1515330|NCT00384033|4976142|P2|Overall Study|Withdrawal by Subject|2
1515331|NCT00384033|4976143|P1|Overall Study|Withdrawal by Subject|6
1515332|NCT00384033|4976140|P4|Overall Study|Protocol Violation|6
1515333|NCT00384033|4976141|P3|Overall Study|Protocol Violation|5
1515334|NCT00384033|4976142|P2|Overall Study|Protocol Violation|0
1515335|NCT00384033|4976143|P1|Overall Study|Protocol Violation|5
1515336|NCT00384033|4976140|P4|Overall Study|Other|0
1515337|NCT00384033|4976141|P3|Overall Study|Other|0
1515338|NCT00384033|4976142|P2|Overall Study|Other|0
1515339|NCT00384033|4976143|P1|Overall Study|Other|2
1515340|NCT00384033|4976140|P4|Overall Study|Lost to Follow-up|7
1515341|NCT00384033|4976141|P3|Overall Study|Lost to Follow-up|7
1515342|NCT00384033|4976142|P2|Overall Study|Lost to Follow-up|12
1515343|NCT00384033|4976143|P1|Overall Study|Lost to Follow-up|6
1515344|NCT00384033|4976140|P4|Overall Study|Physician Decision|0
1515345|NCT00384033|4976141|P3|Overall Study|Physician Decision|0
1515346|NCT00384033|4976142|P2|Overall Study|Physician Decision|0
1515347|NCT00384033|4976143|P1|Overall Study|Physician Decision|1
1515348|NCT00384033|4976140|P4|Overall Study|Failed to return|2
1515349|NCT00384033|4976141|P3|Overall Study|Failed to return|2
1515350|NCT00384033|4976142|P2|Overall Study|Failed to return|3
1515351|NCT00384033|4976143|P1|Overall Study|Failed to return|1
1515352|NCT00384033|4976140|P4|Overall Study|Adverse Event|20
1515353|NCT00384033|4976141|P3|Overall Study|Adverse Event|11
1515354|NCT00384033|4976142|P2|Overall Study|Adverse Event|8
1515355|NCT00384033|4976143|P1|Overall Study|Adverse Event|10
1515356|NCT00383786|4976196|P2|Overall Study|Physician Decision|1
1515357|NCT00383786|4976197|P1|Overall Study|Physician Decision|0
1515358|NCT00383786|4976196|P2|Overall Study|Withdrawal by Subject|5
1515359|NCT00383786|4976197|P1|Overall Study|Withdrawal by Subject|2
1515360|NCT00383786|4976196|P2|Overall Study|Protocol Violation|6
1515361|NCT00383786|4976197|P1|Overall Study|Protocol Violation|2
1515362|NCT00383721|4976247|P5|26-Week Treatment Safety Extension|Administrative|0
1515363|NCT00383721|4976248|P4|26-Week Treatment Safety Extension|Administrative|1
1515364|NCT00383721|4976249|P3|26-Week Treatment Safety Extension|Administrative|3
1515365|NCT00383721|4976250|P2|26-Week Treatment Safety Extension|Administrative|2
1515366|NCT00383721|4976251|P1|26-Week Treatment Safety Extension|Administrative|1
1515367|NCT00383721|4976247|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1515368|NCT00383721|4976248|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1515369|NCT00383721|4976249|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1515370|NCT00383721|4976250|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1515371|NCT00383721|4976251|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1515372|NCT00383721|4976247|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
1515373|NCT00383721|4976248|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
1515374|NCT00383721|4976249|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1515375|NCT00383721|4976250|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1515376|NCT00383721|4976251|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
1515377|NCT00383721|4976247|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
1515378|NCT00383721|4976248|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
1515379|NCT00383721|4976249|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
1515380|NCT00383721|4976250|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
1515381|NCT00383721|4976251|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
1515382|NCT00383721|4976247|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
1515383|NCT00383721|4976248|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
1515384|NCT00383721|4976249|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
1515385|NCT00383721|4976250|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
1515386|NCT00383721|4976251|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
1515387|NCT00383721|4976247|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
1515388|NCT00383721|4976248|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
1515389|NCT00383721|4976249|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
1515390|NCT00383721|4976250|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
1515391|NCT00383721|4976251|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
1515392|NCT00383721|4976247|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
1515393|NCT00383721|4976248|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
1515394|NCT00383721|4976249|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
1515395|NCT00383721|4976250|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
1515396|NCT00383721|4976251|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
1515397|NCT00383721|4976247|P5|26-Week Treatment Safety Extension|Adverse Event|0
1515398|NCT00383721|4976248|P4|26-Week Treatment Safety Extension|Adverse Event|1
1515399|NCT00383721|4976249|P3|26-Week Treatment Safety Extension|Adverse Event|10
1515400|NCT00383721|4976250|P2|26-Week Treatment Safety Extension|Adverse Event|7
1515401|NCT00383721|4976251|P1|26-Week Treatment Safety Extension|Adverse Event|6
1515402|NCT00383721|4976247|P5|26-Week Double-Blind Treatment Period|Ongoing|0
1515403|NCT00383721|4976248|P4|26-Week Double-Blind Treatment Period|Ongoing|0
1515404|NCT00383721|4976249|P3|26-Week Double-Blind Treatment Period|Ongoing|0
1515405|NCT00383721|4976250|P2|26-Week Double-Blind Treatment Period|Ongoing|0
1515406|NCT00383721|4976251|P1|26-Week Double-Blind Treatment Period|Ongoing|1
1515407|NCT00383721|4976247|P5|26-Week Double-Blind Treatment Period|Administrative|3
1515408|NCT00383721|4976248|P4|26-Week Double-Blind Treatment Period|Administrative|3
1515409|NCT00383721|4976249|P3|26-Week Double-Blind Treatment Period|Administrative|3
1515410|NCT00383721|4976250|P2|26-Week Double-Blind Treatment Period|Administrative|3
1515411|NCT00383721|4976251|P1|26-Week Double-Blind Treatment Period|Administrative|1
1515412|NCT00383721|4976247|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
1515413|NCT00383721|4976248|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
1515414|NCT00383721|4976249|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
1515415|NCT00383721|4976250|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
1515416|NCT00383721|4976251|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
1515417|NCT00383721|4976247|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
1515418|NCT00383721|4976248|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
1515419|NCT00383721|4976249|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
1515420|NCT00383721|4976250|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
1515421|NCT00383721|4976251|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
1515422|NCT00383721|4976247|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
1515423|NCT00383721|4976248|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
1515424|NCT00383721|4976249|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
1515425|NCT00383721|4976250|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
1515426|NCT00383721|4976251|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
1515427|NCT00383721|4976247|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
1515428|NCT00383721|4976248|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
1515429|NCT00383721|4976249|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
1515430|NCT00383721|4976250|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
1515431|NCT00383721|4976251|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
1515432|NCT00383721|4976247|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
1515433|NCT00383721|4976248|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
1515434|NCT00383721|4976249|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
1515435|NCT00383721|4976250|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
1515436|NCT00383721|4976251|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
1515437|NCT00383721|4976247|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
1515438|NCT00383721|4976248|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
1515439|NCT00383721|4976249|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1515440|NCT00383721|4976250|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1515441|NCT00383721|4976251|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
1515442|NCT00383721|4976247|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
1515443|NCT00383721|4976248|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
1515444|NCT00383721|4976249|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
1515445|NCT00383721|4976250|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
1515446|NCT00383721|4976251|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
1515447|NCT00383708|4976288|P1|Co-administration Period|Adverse Event|5
1515448|NCT00383708|4976288|P1|Run-in Period|Claustrophobia|1
1515449|NCT00383708|4976288|P1|Run-in Period|Adverse Event|2
1515450|NCT00383708|4976288|P1|Run-in Period|Protocol Violation|4
1515451|NCT00383708|4976288|P1|Enrolment Through Start Treatment|Did not meet entry criteria|32
1515452|NCT00383708|4976288|P1|Enrolment Through Start Treatment|Withdrawal by Subject|1
1515453|NCT00383552|4976357|P4|Overall Study|Administrative|1
1515454|NCT00383552|4976358|P3|Overall Study|Administrative|1
1515455|NCT00383552|4976359|P2|Overall Study|Administrative|0
1515456|NCT00383552|4976360|P1|Overall Study|Administrative|1
1515457|NCT00383552|4976357|P4|Overall Study|Did not meet protocol eligibility|3
1515458|NCT00383552|4976358|P3|Overall Study|Did not meet protocol eligibility|2
1515459|NCT00383552|4976359|P2|Overall Study|Did not meet protocol eligibility|6
1515460|NCT00383552|4976360|P1|Overall Study|Did not meet protocol eligibility|8
1515461|NCT00383552|4976357|P4|Overall Study|Noncompliance with the protocol|10
1515462|NCT00383552|4976358|P3|Overall Study|Noncompliance with the protocol|8
1515463|NCT00383552|4976359|P2|Overall Study|Noncompliance with the protocol|6
1515464|NCT00383552|4976360|P1|Overall Study|Noncompliance with the protocol|11
1515465|NCT00383552|4976357|P4|Overall Study|Did not wish to continue (related)|3
1515466|NCT00383552|4976358|P3|Overall Study|Did not wish to continue (related)|2
1515467|NCT00383552|4976359|P2|Overall Study|Did not wish to continue (related)|0
1515468|NCT00383552|4976360|P1|Overall Study|Did not wish to continue (related)|1
1515469|NCT00383552|4976357|P4|Overall Study|Did not wish to continue (unrelated)|6
1515470|NCT00383552|4976358|P3|Overall Study|Did not wish to continue (unrelated)|5
1515471|NCT00383552|4976359|P2|Overall Study|Did not wish to continue (unrelated)|9
1515472|NCT00383552|4976360|P1|Overall Study|Did not wish to continue (unrelated)|4
1515473|NCT00383552|4976357|P4|Overall Study|Lost to Follow-up|1
1515474|NCT00383552|4976358|P3|Overall Study|Lost to Follow-up|5
1515475|NCT00383552|4976359|P2|Overall Study|Lost to Follow-up|1
1515476|NCT00383552|4976360|P1|Overall Study|Lost to Follow-up|0
1515477|NCT00383552|4976357|P4|Overall Study|Lack of Efficacy|42
1515478|NCT00383552|4976358|P3|Overall Study|Lack of Efficacy|29
1515479|NCT00383552|4976359|P2|Overall Study|Lack of Efficacy|13
1515480|NCT00383552|4976360|P1|Overall Study|Lack of Efficacy|4
1515481|NCT00383552|4976357|P4|Overall Study|Adverse Event|6
1515482|NCT00383552|4976358|P3|Overall Study|Adverse Event|9
1515483|NCT00383552|4976359|P2|Overall Study|Adverse Event|6
1515484|NCT00383552|4976360|P1|Overall Study|Adverse Event|7
1515485|NCT00383500|4976402|P3|Overall Study|Lost to Follow-up|2
1515486|NCT00383500|4976403|P2|Overall Study|Lost to Follow-up|0
1515487|NCT00383500|4976404|P1|Overall Study|Lost to Follow-up|0
1515488|NCT00383500|4976402|P3|Overall Study|Withdrawal by Subject|0
1515489|NCT00383500|4976403|P2|Overall Study|Withdrawal by Subject|3
1515490|NCT00383500|4976404|P1|Overall Study|Withdrawal by Subject|8
1515491|NCT00383435|4976420|P5|26-Week Treatment Safety Extension|Administrative|0
1515492|NCT00383435|4976421|P4|26-Week Treatment Safety Extension|Administrative|1
1515493|NCT00383435|4976422|P3|26-Week Treatment Safety Extension|Administrative|0
1515494|NCT00383435|4976423|P2|26-Week Treatment Safety Extension|Administrative|1
1515495|NCT00383435|4976424|P1|26-Week Treatment Safety Extension|Administrative|1
1515496|NCT00383435|4976420|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1515497|NCT00383435|4976421|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1515498|NCT00383435|4976422|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1515499|NCT00383435|4976423|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1515500|NCT00383435|4976424|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1515501|NCT00383435|4976420|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
1515502|NCT00383435|4976421|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1515503|NCT00383435|4976422|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1515504|NCT00383435|4976423|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1515505|NCT00383435|4976424|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
1515506|NCT00383435|4976420|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
1515507|NCT00383435|4976421|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
1515508|NCT00383435|4976422|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
1515509|NCT00383435|4976423|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
1515510|NCT00383435|4976424|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
1515511|NCT00383435|4976420|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
1515512|NCT00383435|4976421|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
1515513|NCT00383435|4976422|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
1515514|NCT00383435|4976423|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
1515515|NCT00383435|4976424|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
1515516|NCT00383435|4976420|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
1515517|NCT00383435|4976421|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
1515518|NCT00383435|4976422|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
1515519|NCT00383435|4976423|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
1515520|NCT00383435|4976424|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
1515521|NCT00383435|4976420|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
1515522|NCT00383435|4976421|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
1515523|NCT00383435|4976422|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
1515524|NCT00383435|4976423|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
1515525|NCT00383435|4976424|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
1515526|NCT00383435|4976420|P5|26-Week Treatment Safety Extension|Adverse Event|1
1515527|NCT00383435|4976421|P4|26-Week Treatment Safety Extension|Adverse Event|5
1515528|NCT00383435|4976422|P3|26-Week Treatment Safety Extension|Adverse Event|5
1515529|NCT00383435|4976423|P2|26-Week Treatment Safety Extension|Adverse Event|2
1515530|NCT00383435|4976424|P1|26-Week Treatment Safety Extension|Adverse Event|4
1515531|NCT00383435|4976420|P5|26-Week Double-Blind Treatment Period|Administrative|1
1515532|NCT00383435|4976421|P4|26-Week Double-Blind Treatment Period|Administrative|1
1515533|NCT00383435|4976422|P3|26-Week Double-Blind Treatment Period|Administrative|1
1515534|NCT00383435|4976423|P2|26-Week Double-Blind Treatment Period|Administrative|3
1515535|NCT00383435|4976424|P1|26-Week Double-Blind Treatment Period|Administrative|5
1515536|NCT00383435|4976420|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
1515537|NCT00383435|4976421|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
1515538|NCT00383435|4976422|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
1515539|NCT00383435|4976423|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
1515540|NCT00383435|4976424|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
1515541|NCT00383435|4976420|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
1515542|NCT00383435|4976421|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
1515543|NCT00383435|4976422|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
1515544|NCT00383435|4976423|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
1515545|NCT00383435|4976424|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
1515546|NCT00383435|4976420|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
1515547|NCT00383435|4976421|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
1515548|NCT00383435|4976422|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
1515549|NCT00383435|4976423|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
1515550|NCT00383435|4976424|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
1515551|NCT00383435|4976420|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
1515552|NCT00383435|4976421|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
1515553|NCT00383435|4976422|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
1515554|NCT00383435|4976423|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
1515555|NCT00383435|4976424|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
1515556|NCT00383435|4976420|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
1515557|NCT00383435|4976421|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
1515558|NCT00383435|4976422|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
1515559|NCT00383435|4976423|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
1515560|NCT00383435|4976424|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
1515561|NCT00383435|4976420|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
1515562|NCT00383435|4976421|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
1515563|NCT00383435|4976422|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1515564|NCT00383435|4976423|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
1515565|NCT00383435|4976424|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1515566|NCT00383435|4976420|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
1515567|NCT00383435|4976421|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
1515568|NCT00383435|4976422|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
1515569|NCT00383435|4976423|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
1515570|NCT00383435|4976424|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
1515571|NCT00383331|4976463|P2|Overall Study|Protocol Violation|1
1515572|NCT00383331|4976464|P1|Overall Study|Protocol Violation|0
1515573|NCT00383292|4976483|P3|Overall Study|Other|0
1515574|NCT00383292|4976484|P2|Overall Study|Other|0
1515575|NCT00383292|4976485|P1|Overall Study|Other|1
1515576|NCT00383292|4976483|P3|Overall Study|Withdrawal by Subject|2
1515577|NCT00383292|4976484|P2|Overall Study|Withdrawal by Subject|2
1515578|NCT00383292|4976485|P1|Overall Study|Withdrawal by Subject|3
1515579|NCT00383292|4976483|P3|Overall Study|Physician Decision|1
1515580|NCT00383292|4976484|P2|Overall Study|Physician Decision|0
1515581|NCT00383292|4976485|P1|Overall Study|Physician Decision|4
1515582|NCT00383292|4976483|P3|Overall Study|Death|3
1515583|NCT00383292|4976484|P2|Overall Study|Death|3
1515584|NCT00383292|4976485|P1|Overall Study|Death|3
1515585|NCT00383292|4976483|P3|Overall Study|Adverse Event|2
1515586|NCT00383292|4976484|P2|Overall Study|Adverse Event|1
1515587|NCT00383292|4976485|P1|Overall Study|Adverse Event|4
1515588|NCT00383240|4976526|P4|Overall Study|Administrative|0
1515589|NCT00383240|4976527|P3|Overall Study|Administrative|0
1515590|NCT00383240|4976528|P2|Overall Study|Administrative|1
1515591|NCT00383240|4976529|P1|Overall Study|Administrative|1
1515592|NCT00383240|4976526|P4|Overall Study|Did not meet protocol eligibility|3
1515593|NCT00383240|4976527|P3|Overall Study|Did not meet protocol eligibility|9
1515594|NCT00383240|4976528|P2|Overall Study|Did not meet protocol eligibility|4
1515595|NCT00383240|4976529|P1|Overall Study|Did not meet protocol eligibility|9
1515596|NCT00383240|4976526|P4|Overall Study|Protocol Violation|6
1515597|NCT00383240|4976527|P3|Overall Study|Protocol Violation|9
1515598|NCT00383240|4976528|P2|Overall Study|Protocol Violation|5
1515599|NCT00383240|4976529|P1|Overall Study|Protocol Violation|4
1515600|NCT00383240|4976526|P4|Overall Study|Withdrawal by subjects, reasons related|5
1515601|NCT00383240|4976527|P3|Overall Study|Withdrawal by subjects, reasons related|3
1515602|NCT00383240|4976528|P2|Overall Study|Withdrawal by subjects, reasons related|1
1515603|NCT00383240|4976529|P1|Overall Study|Withdrawal by subjects, reasons related|0
1515604|NCT00383240|4976526|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
1515605|NCT00383240|4976527|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
1515606|NCT00383240|4976528|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
1515607|NCT00383240|4976529|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
1515608|NCT00383240|4976526|P4|Overall Study|Lost to Follow-up|2
1515609|NCT00383240|4976527|P3|Overall Study|Lost to Follow-up|0
1515610|NCT00383240|4976528|P2|Overall Study|Lost to Follow-up|0
1515611|NCT00383240|4976529|P1|Overall Study|Lost to Follow-up|3
1515612|NCT00383240|4976526|P4|Overall Study|Treatment Failure|46
1515613|NCT00383240|4976527|P3|Overall Study|Treatment Failure|47
1515614|NCT00383240|4976528|P2|Overall Study|Treatment Failure|13
1515615|NCT00383240|4976529|P1|Overall Study|Treatment Failure|8
1515616|NCT00383240|4976526|P4|Overall Study|Adverse Event|7
1515617|NCT00383240|4976527|P3|Overall Study|Adverse Event|9
1515618|NCT00383240|4976528|P2|Overall Study|Adverse Event|6
1515619|NCT00383240|4976529|P1|Overall Study|Adverse Event|4
1515620|NCT00383162|4976560|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
1515621|NCT00383162|4976561|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
1515622|NCT00383162|4976560|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
1515623|NCT00383162|4976561|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
1515624|NCT00383162|4976560|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
1515625|NCT00383162|4976561|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
1515626|NCT00383162|4976560|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
1515627|NCT00383162|4976561|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
1515628|NCT00383162|4976560|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
1515629|NCT00383162|4976561|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
1515630|NCT00383162|4976560|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
1515631|NCT00383162|4976561|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
1515632|NCT00383162|4976560|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
1515633|NCT00383162|4976561|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
1515634|NCT00383162|4976560|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
1515635|NCT00383162|4976561|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
1515636|NCT00383162|4976560|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
1515637|NCT00383162|4976561|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
1515638|NCT00383149|4976603|P1|Overall Study|Participant Withdrew Consent|1
1515639|NCT00383149|4976603|P1|Overall Study|Request to Discontinue Treatment|4
1515640|NCT00383149|4976603|P1|Overall Study|Study Drug Toxicity|4
1515641|NCT00383149|4976603|P1|Overall Study|Other|1
1515642|NCT00383149|4976603|P1|Overall Study|Lost to Follow-up|1
1515643|NCT00383149|4976603|P1|Overall Study|Disease Progression|38
1515644|NCT00383149|4976603|P1|Overall Study|Death|2
1515645|NCT00383149|4976603|P1|Overall Study|Adverse Event not Related to Study Drug|3
1515646|NCT00383123|4976622|P2|Overall Study|Other reason|6
1515647|NCT00383123|4976623|P1|Overall Study|Other reason|10
1515648|NCT00383123|4976622|P2|Overall Study|Withdrawal by Subject|18
1515649|NCT00383123|4976623|P1|Overall Study|Withdrawal by Subject|27
1515650|NCT00383123|4976622|P2|Overall Study|Protocol Violation|1
1515651|NCT00383123|4976623|P1|Overall Study|Protocol Violation|5
1515652|NCT00383123|4976622|P2|Overall Study|Lost to Follow-up|61
1515653|NCT00383123|4976623|P1|Overall Study|Lost to Follow-up|68
1515654|NCT00383123|4976622|P2|Overall Study|Adverse Event|0
1515655|NCT00383123|4976623|P1|Overall Study|Adverse Event|1
1515656|NCT00383084|4976664|P2|Overall Study|Withdrawal by Subject|10
1515657|NCT00383084|4976665|P1|Overall Study|Withdrawal by Subject|12
1515658|NCT00383019|4976696|P2|Overall Study|Withdrawal by Subject|1
1515659|NCT00383019|4976697|P1|Overall Study|Withdrawal by Subject|0
1515660|NCT00383019|4976696|P2|Overall Study|Adverse Event|1
1515661|NCT00383019|4976697|P1|Overall Study|Adverse Event|5
1515662|NCT00382993|4976719|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
1515663|NCT00382993|4976720|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
1515664|NCT00382993|4976719|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
1515665|NCT00382993|4976720|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
1515666|NCT00382993|4976719|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
1515667|NCT00382993|4976720|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
1515668|NCT00382993|4976719|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
1515669|NCT00382993|4976720|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
1515670|NCT00382993|4976719|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
1515671|NCT00382993|4976720|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
1515672|NCT00382993|4976719|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
1515673|NCT00382993|4976720|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
1515674|NCT00382993|4976719|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
1515675|NCT00382993|4976720|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
1515676|NCT00382993|4976719|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
1515677|NCT00382993|4976720|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
1515678|NCT00382993|4976719|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
1515679|NCT00382993|4976720|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
1515680|NCT00382993|4976719|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
1515681|NCT00382993|4976720|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
1515682|NCT00382967|4976764|P2|Overall Study|Protocol Violation|1
1515683|NCT00382967|4976765|P1|Overall Study|Protocol Violation|1
1515684|NCT00382863|4976790|P2|Overall Study|Withdrawal by Subject|25
1515685|NCT00382863|4976791|P1|Overall Study|Withdrawal by Subject|5
1515686|NCT00382863|4976790|P2|Overall Study|Lost to Follow-up|2
1515687|NCT00382863|4976791|P1|Overall Study|Lost to Follow-up|1
1515688|NCT00382863|4976790|P2|Overall Study|Death|9
1515689|NCT00382863|4976791|P1|Overall Study|Death|9
1515690|NCT00382733|4976858|P5|Overall Study|Withdrawal by Subject|0
1515691|NCT00382733|4976859|P4|Overall Study|Withdrawal by Subject|0
1515692|NCT00382733|4976860|P3|Overall Study|Withdrawal by Subject|0
1515693|NCT00382733|4976861|P2|Overall Study|Withdrawal by Subject|1
1515694|NCT00382733|4976862|P1|Overall Study|Withdrawal by Subject|0
1515695|NCT00382720|4976883|P3|Overall Study|Discontinued at end of study|2
1515696|NCT00382720|4976884|P2|Overall Study|Discontinued at end of study|1
1515697|NCT00382720|4976885|P1|Overall Study|Discontinued at end of study|0
1515698|NCT00382720|4976883|P3|Overall Study|Investigator/Clinical decision|6
1515699|NCT00382720|4976884|P2|Overall Study|Investigator/Clinical decision|6
1515700|NCT00382720|4976885|P1|Overall Study|Investigator/Clinical decision|5
1515701|NCT00382720|4976883|P3|Overall Study|Good prognosis|0
1515702|NCT00382720|4976884|P2|Overall Study|Good prognosis|1
1515703|NCT00382720|4976885|P1|Overall Study|Good prognosis|0
1515704|NCT00382720|4976883|P3|Overall Study|Clinically progressive disease|0
1515705|NCT00382720|4976884|P2|Overall Study|Clinically progressive disease|1
1515706|NCT00382720|4976885|P1|Overall Study|Clinically progressive disease|0
1515707|NCT00382720|4976883|P3|Overall Study|Patient did not receive study medication|4
1515708|NCT00382720|4976884|P2|Overall Study|Patient did not receive study medication|1
1515709|NCT00382720|4976885|P1|Overall Study|Patient did not receive study medication|1
1515710|NCT00382720|4976883|P3|Overall Study|Surgery|4
1515711|NCT00382720|4976884|P2|Overall Study|Surgery|1
1515712|NCT00382720|4976885|P1|Overall Study|Surgery|1
1515713|NCT00382720|4976883|P3|Overall Study|Withdrawal by Subject|12
1515714|NCT00382720|4976884|P2|Overall Study|Withdrawal by Subject|20
1515715|NCT00382720|4976885|P1|Overall Study|Withdrawal by Subject|11
1515716|NCT00382720|4976883|P3|Overall Study|Withdrew consent|2
1515717|NCT00382720|4976884|P2|Overall Study|Withdrew consent|1
1515718|NCT00382720|4976885|P1|Overall Study|Withdrew consent|1
1515719|NCT00382720|4976883|P3|Overall Study|Progressive disease|38
1515720|NCT00382720|4976884|P2|Overall Study|Progressive disease|28
1515721|NCT00382720|4976885|P1|Overall Study|Progressive disease|37
1515722|NCT00382720|4976883|P3|Overall Study|Death|2
1515723|NCT00382720|4976884|P2|Overall Study|Death|1
1515724|NCT00382720|4976885|P1|Overall Study|Death|0
1515725|NCT00382720|4976883|P3|Overall Study|Protocol Violation|1
1515726|NCT00382720|4976884|P2|Overall Study|Protocol Violation|5
1515727|NCT00382720|4976885|P1|Overall Study|Protocol Violation|2
1515728|NCT00382720|4976883|P3|Overall Study|Adverse Event|15
1515729|NCT00382720|4976884|P2|Overall Study|Adverse Event|23
1515730|NCT00382720|4976885|P1|Overall Study|Adverse Event|21
1515731|NCT00382408|4976910|P2|Overall Study|Not specified|35
1515732|NCT00382408|4976911|P1|Overall Study|Not specified|100
1515733|NCT00382408|4976910|P2|Overall Study|Lost to Follow-up|8
1515734|NCT00382408|4976911|P1|Overall Study|Lost to Follow-up|19
1515735|NCT00382408|4976910|P2|Overall Study|Pregnancy|0
1515736|NCT00382408|4976911|P1|Overall Study|Pregnancy|2
1515737|NCT00382408|4976910|P2|Overall Study|Withdrawal by Subject|6
1515738|NCT00382408|4976911|P1|Overall Study|Withdrawal by Subject|17
1515739|NCT00382408|4976910|P2|Overall Study|Physician Decision|0
1515740|NCT00382408|4976911|P1|Overall Study|Physician Decision|1
1515741|NCT00382408|4976910|P2|Overall Study|Protocol Violation|2
1515742|NCT00382408|4976911|P1|Overall Study|Protocol Violation|2
1515743|NCT00382408|4976910|P2|Overall Study|Did not meet protocol requirement|3
1515744|NCT00382408|4976911|P1|Overall Study|Did not meet protocol requirement|3
1515745|NCT00382291|4976938|P3|Overall Study|Lack of Efficacy|1
1515746|NCT00382291|4976939|P2|Overall Study|Lack of Efficacy|0
1515747|NCT00382291|4976940|P1|Overall Study|Lack of Efficacy|0
1515748|NCT00382291|4976938|P3|Overall Study|Physician Decision|0
1515749|NCT00382291|4976939|P2|Overall Study|Physician Decision|1
1515750|NCT00382291|4976940|P1|Overall Study|Physician Decision|0
1515751|NCT00382291|4976938|P3|Overall Study|Withdrawal by Subject|0
1515752|NCT00382291|4976939|P2|Overall Study|Withdrawal by Subject|2
1515753|NCT00382291|4976940|P1|Overall Study|Withdrawal by Subject|0
1515754|NCT00382291|4976938|P3|Overall Study|Temporary study suspension|5
1515755|NCT00382291|4976939|P2|Overall Study|Temporary study suspension|2
1515756|NCT00382291|4976940|P1|Overall Study|Temporary study suspension|2
1515757|NCT00382291|4976938|P3|Overall Study|Protocol Violation|0
1515758|NCT00382291|4976939|P2|Overall Study|Protocol Violation|0
1515759|NCT00382291|4976940|P1|Overall Study|Protocol Violation|1
1515760|NCT00382291|4976938|P3|Overall Study|Adverse Event|2
1515761|NCT00382291|4976939|P2|Overall Study|Adverse Event|2
1515762|NCT00382291|4976940|P1|Overall Study|Adverse Event|1
1515763|NCT00382174|4976953|P3|Overall Study|Wounds merged|2
1515764|NCT00382174|4976954|P2|Overall Study|Wounds merged|2
1515765|NCT00382174|4976955|P1|Overall Study|Wounds merged|0
1515766|NCT00382174|4976953|P3|Overall Study|Failed to meet criteria|1
1515767|NCT00382174|4976954|P2|Overall Study|Failed to meet criteria|1
1515768|NCT00382174|4976955|P1|Overall Study|Failed to meet criteria|0
1515769|NCT00382174|4976953|P3|Overall Study|Physician Decision|2
1515770|NCT00382174|4976954|P2|Overall Study|Physician Decision|2
1515771|NCT00382174|4976955|P1|Overall Study|Physician Decision|0
1515772|NCT00382174|4976953|P3|Overall Study|Non compliance|1
1515773|NCT00382174|4976954|P2|Overall Study|Non compliance|0
1515774|NCT00382174|4976955|P1|Overall Study|Non compliance|1
1515775|NCT00382174|4976953|P3|Overall Study|Withdrawal by Subject|5
1515776|NCT00382174|4976954|P2|Overall Study|Withdrawal by Subject|4
1515777|NCT00382174|4976955|P1|Overall Study|Withdrawal by Subject|1
1515778|NCT00382174|4976953|P3|Overall Study|Adverse Event|5
1515779|NCT00382174|4976954|P2|Overall Study|Adverse Event|4
1515780|NCT00382174|4976955|P1|Overall Study|Adverse Event|1
1515781|NCT00382174|4976953|P3|Overall Study|Lost to Follow-up|5
1515782|NCT00382174|4976954|P2|Overall Study|Lost to Follow-up|4
1515783|NCT00382174|4976955|P1|Overall Study|Lost to Follow-up|1
1515784|NCT00382109|4976983|P2|Overall Study|consent withdrawal|1
1515785|NCT00382109|4976984|P1|Overall Study|consent withdrawal|0
1515786|NCT00382109|4976983|P2|Overall Study|Other|2
1515787|NCT00382109|4976984|P1|Overall Study|Other|0
1515788|NCT00382109|4976983|P2|Overall Study|ineligible|0
1515789|NCT00382109|4976984|P1|Overall Study|ineligible|2
1515790|NCT00382109|4976983|P2|Overall Study|Withdrawal by Subject|0
1515791|NCT00382109|4976984|P1|Overall Study|Withdrawal by Subject|1
1515792|NCT00382109|4976983|P2|Overall Study|Physician Decision|1
1515793|NCT00382109|4976984|P1|Overall Study|Physician Decision|6
1515794|NCT00382109|4976983|P2|Overall Study|Adverse Event|0
1515795|NCT00382109|4976984|P1|Overall Study|Adverse Event|3
1515796|NCT00382018|4977023|P4|Overall Study|Other, not protocol specified|1
1515797|NCT00382018|4977024|P3|Overall Study|Other, not protocol specified|3
1515798|NCT00382018|4977025|P2|Overall Study|Other, not protocol specified|16
1515799|NCT00382018|4977026|P1|Overall Study|Other, not protocol specified|0
1515800|NCT00382018|4977023|P4|Overall Study|Withdrawal by Subject|4
1515801|NCT00382018|4977024|P3|Overall Study|Withdrawal by Subject|3
1515802|NCT00382018|4977025|P2|Overall Study|Withdrawal by Subject|4
1515803|NCT00382018|4977026|P1|Overall Study|Withdrawal by Subject|0
1515804|NCT00382018|4977023|P4|Overall Study|Death|11
1515805|NCT00382018|4977024|P3|Overall Study|Death|7
1515806|NCT00382018|4977025|P2|Overall Study|Death|9
1515807|NCT00382018|4977026|P1|Overall Study|Death|0
1515808|NCT00382018|4977023|P4|Overall Study|Progression|43
1515809|NCT00382018|4977024|P3|Overall Study|Progression|51
1515810|NCT00382018|4977025|P2|Overall Study|Progression|136
1515811|NCT00382018|4977026|P1|Overall Study|Progression|0
1515812|NCT00381940|4977049|P1|Overall Study|Ineligible|1
1515813|NCT00381940|4977049|P1|Overall Study|Protocol Violation|1
1515814|NCT00381940|4977049|P1|Overall Study|Lack of Efficacy|3
1515815|NCT00381888|4977053|P1|Overall Study|Adverse Event|1
1515816|NCT00381888|4977053|P1|Overall Study|Surgery was cancelled|2
1515817|NCT00381888|4977053|P1|Overall Study|Had laparoscopic surgery|2
1515818|NCT00381888|4977053|P1|Overall Study|Protocol Violation|9
1515819|NCT00381888|4977053|P1|Overall Study|Physician Decision|1
1515820|NCT00381888|4977053|P1|Overall Study|Withdrawal by Subject|1
1515821|NCT00381888|4977053|P1|Overall Study|Death|1
1515822|NCT00381849|4977064|P2|Wash Out|Withdrawal by Subject|1
1515823|NCT00381849|4977065|P1|Wash Out|Withdrawal by Subject|0
1515824|NCT00381797|4977092|P5|Overall Study|Ineligible|0
1515825|NCT00381797|4977093|P4|Overall Study|Ineligible|1
1515826|NCT00381797|4977094|P3|Overall Study|Ineligible|0
1515827|NCT00381797|4977095|P2|Overall Study|Ineligible|0
1515828|NCT00381797|4977096|P1|Overall Study|Ineligible|0
1515829|NCT00381797|4977092|P5|Overall Study|Withdrawal by Subject|2
1515830|NCT00381797|4977093|P4|Overall Study|Withdrawal by Subject|0
1515831|NCT00381797|4977094|P3|Overall Study|Withdrawal by Subject|0
1515832|NCT00381797|4977095|P2|Overall Study|Withdrawal by Subject|1
1515833|NCT00381797|4977096|P1|Overall Study|Withdrawal by Subject|1
1515834|NCT00381706|4977171|P3|Overall Study|Never treated|1
1515835|NCT00381706|4977172|P2|Overall Study|Never treated|2
1515836|NCT00381706|4977173|P1|Overall Study|Never treated|7
1515837|NCT00381693|4977196|P1|Overall Study|Progression|2
1515838|NCT00381693|4977196|P1|Overall Study|Patient Choice|1
1515839|NCT00381693|4977196|P1|Overall Study|Adverse Event|4
1515840|NCT00381693|4977196|P1|Overall Study|Death|1
1515841|NCT00381680|4977205|P2|Overall Study|Ineligible|1
1515842|NCT00381680|4977206|P1|Overall Study|Ineligible|3
1515843|NCT00381680|4977205|P2|Overall Study|Other not otherwise specified|2
1515844|NCT00381680|4977206|P1|Overall Study|Other not otherwise specified|7
1515845|NCT00381680|4977205|P2|Overall Study|Progression|1
1515846|NCT00381680|4977206|P1|Overall Study|Progression|1
1515847|NCT00381680|4977205|P2|Overall Study|Induction Failure|1
1515848|NCT00381680|4977206|P1|Overall Study|Induction Failure|4
1515849|NCT00381680|4977205|P2|Overall Study|Relapse|9
1515850|NCT00381680|4977206|P1|Overall Study|Relapse|18
1515851|NCT00381680|4977205|P2|Overall Study|Stem Cell Transplant|10
1515852|NCT00381680|4977206|P1|Overall Study|Stem Cell Transplant|26
1515853|NCT00381680|4977205|P2|Overall Study|Delay initiation|0
1515854|NCT00381680|4977206|P1|Overall Study|Delay initiation|1
1515855|NCT00381680|4977205|P2|Overall Study|Secondary Malignancy|0
1515856|NCT00381680|4977206|P1|Overall Study|Secondary Malignancy|3
1515857|NCT00381680|4977205|P2|Overall Study|Alternative Therapy|5
1515858|NCT00381680|4977206|P1|Overall Study|Alternative Therapy|11
1515859|NCT00381680|4977205|P2|Overall Study|Entry onto another COG Trial|2
1515860|NCT00381680|4977206|P1|Overall Study|Entry onto another COG Trial|1
1515861|NCT00381680|4977205|P2|Overall Study|Withdrawal by Subject|1
1515862|NCT00381680|4977206|P1|Overall Study|Withdrawal by Subject|3
1515863|NCT00381680|4977205|P2|Overall Study|Physician Decision|6
1515864|NCT00381680|4977206|P1|Overall Study|Physician Decision|25
1515865|NCT00381680|4977205|P2|Overall Study|Lost to Follow-up|2
1515866|NCT00381680|4977206|P1|Overall Study|Lost to Follow-up|3
1515867|NCT00381680|4977205|P2|Overall Study|Death|7
1515868|NCT00381680|4977206|P1|Overall Study|Death|10
1515869|NCT00381680|4977205|P2|Overall Study|Adverse Event|3
1515870|NCT00381680|4977206|P1|Overall Study|Adverse Event|9
1515871|NCT00381641|4977223|P2|Overall Study|Withdrawal by Subject|2
1515872|NCT00381641|4977224|P1|Overall Study|Withdrawal by Subject|0
1515873|NCT00381615|4977257|P4|Overall Study|Protocol Violation|0
1515874|NCT00381615|4977258|P3|Overall Study|Protocol Violation|1
1515875|NCT00381615|4977259|P2|Overall Study|Protocol Violation|0
1515876|NCT00381615|4977260|P1|Overall Study|Protocol Violation|0
1515877|NCT00381615|4977257|P4|Overall Study|Lost to Follow-up|1
1515878|NCT00381615|4977258|P3|Overall Study|Lost to Follow-up|0
1515879|NCT00381615|4977259|P2|Overall Study|Lost to Follow-up|2
1515880|NCT00381615|4977260|P1|Overall Study|Lost to Follow-up|3
1515881|NCT00381615|4977257|P4|Overall Study|Withdrawal by Subject|1
1515882|NCT00381615|4977258|P3|Overall Study|Withdrawal by Subject|0
1515883|NCT00381615|4977259|P2|Overall Study|Withdrawal by Subject|3
1515884|NCT00381615|4977260|P1|Overall Study|Withdrawal by Subject|1
1515885|NCT00381563|4977312|P2|Overall Study|Protocol Violation|1
1515886|NCT00381563|4977313|P1|Overall Study|Protocol Violation|0
1515887|NCT00381563|4977312|P2|Overall Study|Lost to Follow-up|0
1515888|NCT00381563|4977313|P1|Overall Study|Lost to Follow-up|2
1515889|NCT00381563|4977312|P2|Overall Study|Withdrawal by Subject|5
1515890|NCT00381563|4977313|P1|Overall Study|Withdrawal by Subject|5
1515891|NCT00381485|4977328|P4|Double-Blind Treatment Period|Administrative|1
1515892|NCT00381485|4977329|P3|Double-Blind Treatment Period|Administrative|0
1515893|NCT00381485|4977330|P2|Double-Blind Treatment Period|Administrative|1
1515894|NCT00381485|4977331|P1|Double-Blind Treatment Period|Administrative|0
1515895|NCT00381485|4977328|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
1515896|NCT00381485|4977329|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
1515897|NCT00381485|4977330|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
1515898|NCT00381485|4977331|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
1515899|NCT00381485|4977328|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
1515900|NCT00381485|4977329|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
1515901|NCT00381485|4977330|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
1515902|NCT00381485|4977331|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
1515903|NCT00381485|4977328|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
1515904|NCT00381485|4977329|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
1515905|NCT00381485|4977330|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
1515906|NCT00381485|4977331|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
1515907|NCT00381485|4977328|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
1515908|NCT00381485|4977329|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
1515909|NCT00381485|4977330|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
1515910|NCT00381485|4977331|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
1515911|NCT00381485|4977328|P4|Double-Blind Treatment Period|Lost to Follow-up|1
1515912|NCT00381485|4977329|P3|Double-Blind Treatment Period|Lost to Follow-up|1
1515913|NCT00381485|4977330|P2|Double-Blind Treatment Period|Lost to Follow-up|0
1515914|NCT00381485|4977331|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1515915|NCT00381485|4977328|P4|Double-Blind Treatment Period|Lack of Efficacy|13
1515916|NCT00381485|4977329|P3|Double-Blind Treatment Period|Lack of Efficacy|11
1515917|NCT00381485|4977330|P2|Double-Blind Treatment Period|Lack of Efficacy|8
1515918|NCT00381485|4977331|P1|Double-Blind Treatment Period|Lack of Efficacy|0
1515919|NCT00381485|4977328|P4|Double-Blind Treatment Period|Adverse Event|5
1515920|NCT00381485|4977329|P3|Double-Blind Treatment Period|Adverse Event|2
1515921|NCT00381485|4977330|P2|Double-Blind Treatment Period|Adverse Event|2
1515922|NCT00381485|4977331|P1|Double-Blind Treatment Period|Adverse Event|0
1515923|NCT00381485|4977328|P4|Open-Label Run-In Period|Treatment failure|0
1515924|NCT00381485|4977329|P3|Open-Label Run-In Period|Treatment failure|0
1515925|NCT00381485|4977330|P2|Open-Label Run-In Period|Treatment failure|0
1515926|NCT00381485|4977331|P1|Open-Label Run-In Period|Treatment failure|1
1515927|NCT00381485|4977328|P4|Open-Label Run-In Period|Lost to Follow-up|0
1515928|NCT00381485|4977329|P3|Open-Label Run-In Period|Lost to Follow-up|0
1515929|NCT00381485|4977330|P2|Open-Label Run-In Period|Lost to Follow-up|0
1515930|NCT00381485|4977331|P1|Open-Label Run-In Period|Lost to Follow-up|3
1515931|NCT00381485|4977328|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
1515932|NCT00381485|4977329|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
1515933|NCT00381485|4977330|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
1515934|NCT00381485|4977331|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
1515935|NCT00381485|4977328|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
1515936|NCT00381485|4977329|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
1515937|NCT00381485|4977330|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
1515938|NCT00381485|4977331|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
1515939|NCT00381485|4977328|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
1515940|NCT00381485|4977329|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
1515941|NCT00381485|4977330|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
1515942|NCT00381485|4977331|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
1515943|NCT00381485|4977328|P4|Open-Label Run-In Period|Adverse Event|0
1515944|NCT00381485|4977329|P3|Open-Label Run-In Period|Adverse Event|0
1515945|NCT00381485|4977330|P2|Open-Label Run-In Period|Adverse Event|0
1515946|NCT00381485|4977331|P1|Open-Label Run-In Period|Adverse Event|9
1515947|NCT00381381|4977349|P1|Overall Study|Withdrawal by Subject|9
1515948|NCT00381381|4977349|P1|Overall Study|Lost to Follow-up|52
1515949|NCT00381381|4977349|P1|Overall Study|Adverse Event|3
1515950|NCT00381303|4977358|P2|Overall Study|Subject primary physician's decision|0
1515951|NCT00381303|4977359|P1|Overall Study|Subject primary physician's decision|1
1515952|NCT00381303|4977358|P2|Overall Study|Subject did not continue visits|0
1515953|NCT00381303|4977359|P1|Overall Study|Subject did not continue visits|1
1515954|NCT00381303|4977358|P2|Overall Study|Subject was too busy for appointments|0
1515955|NCT00381303|4977359|P1|Overall Study|Subject was too busy for appointments|1
1515956|NCT00381303|4977358|P2|Overall Study|No virologic response by week 12|0
1515957|NCT00381303|4977359|P1|Overall Study|No virologic response by week 12|1
1515958|NCT00381303|4977358|P2|Overall Study|Subject taking too many different meds|0
1515959|NCT00381303|4977359|P1|Overall Study|Subject taking too many different meds|1
1515960|NCT00381303|4977358|P2|Overall Study|Subject moved out of state|0
1515961|NCT00381303|4977359|P1|Overall Study|Subject moved out of state|2
1515962|NCT00381303|4977358|P2|Overall Study|Physician's decision to close the site|1
1515963|NCT00381303|4977359|P1|Overall Study|Physician's decision to close the site|3
1515964|NCT00381303|4977358|P2|Overall Study|Physician Decision|0
1515965|NCT00381303|4977359|P1|Overall Study|Physician Decision|1
1515966|NCT00381303|4977358|P2|Overall Study|Pregnancy|0
1515967|NCT00381303|4977359|P1|Overall Study|Pregnancy|2
1515968|NCT00381303|4977358|P2|Overall Study|Ineligible to continue the trial|1
1515969|NCT00381303|4977359|P1|Overall Study|Ineligible to continue the trial|2
1515970|NCT00381303|4977358|P2|Overall Study|Virologic failure|4
1515971|NCT00381303|4977359|P1|Overall Study|Virologic failure|6
1515972|NCT00381303|4977358|P2|Overall Study|Withdrawal by Subject|6
1515973|NCT00381303|4977359|P1|Overall Study|Withdrawal by Subject|13
1515974|NCT00381303|4977358|P2|Overall Study|Non-Adherence|6
1515975|NCT00381303|4977359|P1|Overall Study|Non-Adherence|13
1515976|NCT00381303|4977358|P2|Overall Study|AE/HIV-related event|6
1515977|NCT00381303|4977359|P1|Overall Study|AE/HIV-related event|22
1515978|NCT00381303|4977358|P2|Overall Study|Lost to Follow-up|9
1515979|NCT00381303|4977359|P1|Overall Study|Lost to Follow-up|25
1515980|NCT00381238|4977419|P1|Overall Study|Disease progression|1
1515981|NCT00381238|4977419|P1|Overall Study|Withdrew by physician|1
1515982|NCT00381238|4977419|P1|Overall Study|Lack of Efficacy|2
1515983|NCT00381238|4977419|P1|Overall Study|Withdrawal by Subject|4
1515984|NCT00381238|4977419|P1|Overall Study|Protocol Violation|1
1515985|NCT00381238|4977419|P1|Overall Study|Adverse Event|3
1515986|NCT00381095|4977435|P2|Overall Study|Adverse Event|7
1515987|NCT00381095|4977436|P1|Overall Study|Adverse Event|2
1515988|NCT00381095|4977435|P2|Overall Study|Withdrawal by Subject|3
1515989|NCT00381095|4977436|P1|Overall Study|Withdrawal by Subject|3
1515990|NCT00381095|4977435|P2|Overall Study|Protocol Violation|1
1515991|NCT00381095|4977436|P1|Overall Study|Protocol Violation|1
1515992|NCT00381095|4977435|P2|Overall Study|Other|2
1515993|NCT00381095|4977436|P1|Overall Study|Other|2
1515994|NCT00381095|4977435|P2|Overall Study|Lack of Efficacy|4
1515995|NCT00381095|4977436|P1|Overall Study|Lack of Efficacy|2
1515996|NCT00381095|4977435|P2|Overall Study|Death|4
1515997|NCT00381095|4977436|P1|Overall Study|Death|3
1515998|NCT00381043|4977468|P2|Overall Study|incarcerated|0
1515999|NCT00381043|4977469|P1|Overall Study|incarcerated|1
1516000|NCT00381043|4977468|P2|Overall Study|wanted more care|1
1516001|NCT00381043|4977469|P1|Overall Study|wanted more care|0
1516002|NCT00381043|4977468|P2|Overall Study|Withdrawal by Subject|1
1516003|NCT00381043|4977469|P1|Overall Study|Withdrawal by Subject|3
1516004|NCT00381043|4977468|P2|Overall Study|Lost to Follow-up|6
1516005|NCT00381043|4977469|P1|Overall Study|Lost to Follow-up|8
1516006|NCT00380978|4977495|P2|Overall Study|Parous patient|0
1516007|NCT00380978|4977496|P1|Overall Study|Parous patient|1
1516008|NCT00380978|4977495|P2|Overall Study|Allocation prior to analgesia request|2
1516009|NCT00380978|4977496|P1|Overall Study|Allocation prior to analgesia request|1
1516010|NCT00380978|4977495|P2|Overall Study|Wrong study envelope|2
1516011|NCT00380978|4977496|P1|Overall Study|Wrong study envelope|0
1516012|NCT00380978|4977495|P2|Overall Study|Refused allocated intervention|6
1516013|NCT00380978|4977496|P1|Overall Study|Refused allocated intervention|0
1516014|NCT00380874|4977518|P2|Overall Study|Not related to study drug|2
1516015|NCT00380874|4977519|P1|Overall Study|Not related to study drug|3
1516016|NCT00380874|4977518|P2|Overall Study|Withdrawal by Subject|1
1516017|NCT00380874|4977519|P1|Overall Study|Withdrawal by Subject|2
1516018|NCT00380874|4977518|P2|Overall Study|Death|0
1516019|NCT00380874|4977519|P1|Overall Study|Death|1
1516020|NCT00380874|4977518|P2|Overall Study|Adverse Event|7
1516021|NCT00380874|4977519|P1|Overall Study|Adverse Event|7
1516022|NCT00380718|4977544|P1|Overall Study|Death after 30-day post-therapy followup|17
1516023|NCT00380718|4977544|P1|Overall Study|Adverse Event|1
1516024|NCT00380692|4977556|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
1516025|NCT00380692|4977557|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
1516026|NCT00380692|4977556|P2|Study Period III - Open Label|Lack of Efficacy|4
1516027|NCT00380692|4977557|P1|Study Period III - Open Label|Lack of Efficacy|0
1516028|NCT00380692|4977556|P2|Study Period III - Open Label|Physician Decision|3
1516029|NCT00380692|4977557|P1|Study Period III - Open Label|Physician Decision|0
1516030|NCT00380692|4977556|P2|Study Period III - Open Label|Withdrawal by Subject|1
1516031|NCT00380692|4977557|P1|Study Period III - Open Label|Withdrawal by Subject|0
1516032|NCT00380692|4977556|P2|Study Period III - Open Label|Protocol Violation|0
1516033|NCT00380692|4977557|P1|Study Period III - Open Label|Protocol Violation|0
1516034|NCT00380692|4977556|P2|Study Period III - Open Label|Adverse Event|3
1516035|NCT00380692|4977557|P1|Study Period III - Open Label|Adverse Event|5
1516036|NCT00380692|4977556|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
1516037|NCT00380692|4977557|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
1516038|NCT00380692|4977556|P2|Study Period II - Double Blind|Lack of Efficacy|0
1516039|NCT00380692|4977557|P1|Study Period II - Double Blind|Lack of Efficacy|1
1516040|NCT00380692|4977556|P2|Study Period II - Double Blind|Physician Decision|1
1516041|NCT00380692|4977557|P1|Study Period II - Double Blind|Physician Decision|0
1516042|NCT00380692|4977556|P2|Study Period II - Double Blind|Withdrawal by Subject|0
1516043|NCT00380692|4977557|P1|Study Period II - Double Blind|Withdrawal by Subject|0
1516044|NCT00380692|4977556|P2|Study Period II - Double Blind|Protocol Violation|2
1516045|NCT00380692|4977557|P1|Study Period II - Double Blind|Protocol Violation|2
1516046|NCT00380692|4977556|P2|Study Period II - Double Blind|Adverse Event|0
1516047|NCT00380692|4977557|P1|Study Period II - Double Blind|Adverse Event|1
1516048|NCT00380588|4977605|P2|Overall Study|Physician Decision|0
1516049|NCT00380588|4977606|P1|Overall Study|Physician Decision|2
1516050|NCT00380588|4977605|P2|Overall Study|Withdrawal by Subject|3
1516051|NCT00380588|4977606|P1|Overall Study|Withdrawal by Subject|1
1516052|NCT00380588|4977605|P2|Overall Study|Adverse Event|3
1516053|NCT00380588|4977606|P1|Overall Study|Adverse Event|7
1516054|NCT00380588|4977605|P2|Overall Study|Next Cycle Not Started|0
1516055|NCT00380588|4977606|P1|Overall Study|Next Cycle Not Started|4
1516056|NCT00380588|4977605|P2|Overall Study|Unequivocal Disease Progression|34
1516057|NCT00380588|4977606|P1|Overall Study|Unequivocal Disease Progression|25
1516058|NCT00380393|4977620|P2|Month 14|Others|6
1516059|NCT00380393|4977621|P1|Month 14|Others|6
1516060|NCT00380393|4977620|P2|Month 14|Protocol Violation|0
1516061|NCT00380393|4977621|P1|Month 14|Protocol Violation|2
1516062|NCT00380393|4977620|P2|Month 14|Migrated/moved from study area|42
1516063|NCT00380393|4977621|P1|Month 14|Migrated/moved from study area|39
1516064|NCT00380393|4977620|P2|Month 14|Lost to Follow-up|1
1516065|NCT00380393|4977621|P1|Month 14|Lost to Follow-up|0
1516066|NCT00380393|4977620|P2|Month 14|Death|0
1516067|NCT00380393|4977621|P1|Month 14|Death|1
1516068|NCT00380393|4977620|P2|Month 14|Withdrawal by Subject|7
1516069|NCT00380393|4977621|P1|Month 14|Withdrawal by Subject|9
1516070|NCT00380393|4977620|P2|Month 8 (Cross-sectional Visit)|Others|4
1516071|NCT00380393|4977621|P1|Month 8 (Cross-sectional Visit)|Others|5
1516072|NCT00380393|4977620|P2|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
1516073|NCT00380393|4977621|P1|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
1516074|NCT00380393|4977620|P2|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
1516075|NCT00380393|4977621|P1|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
1516076|NCT00380393|4977620|P2|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
1516077|NCT00380393|4977621|P1|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
1516078|NCT00380393|4977620|P2|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
1516079|NCT00380393|4977621|P1|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
1516080|NCT00380367|4977669|P1|Overall Study|Withdrawal by Subject|1
1516081|NCT00380367|4977669|P1|Overall Study|Lost to Follow-up|1
1516082|NCT00380250|4977676|P2|Overall Study|Physician Decision|0
1516083|NCT00380250|4977677|P1|Overall Study|Physician Decision|1
1516084|NCT00380250|4977676|P2|Overall Study|Lost to Follow-up|5
1516085|NCT00380250|4977677|P1|Overall Study|Lost to Follow-up|14
1516086|NCT00380250|4977676|P2|Overall Study|Protocol Violation|5
1516087|NCT00380250|4977677|P1|Overall Study|Protocol Violation|15
1516088|NCT00380250|4977676|P2|Overall Study|Lack of Efficacy|8
1516089|NCT00380250|4977677|P1|Overall Study|Lack of Efficacy|10
1516090|NCT00380250|4977676|P2|Overall Study|Adverse Event|9
1516091|NCT00380250|4977677|P1|Overall Study|Adverse Event|20
1516092|NCT00380250|4977676|P2|Overall Study|Withdrawal by Subject|28
1516093|NCT00380250|4977677|P1|Overall Study|Withdrawal by Subject|39
1516094|NCT00380081|4977745|P6|Overall Study|Family Emergency|1
1516095|NCT00380081|4977746|P5|Overall Study|Family Emergency|0
1516096|NCT00380081|4977747|P4|Overall Study|Family Emergency|0
1516097|NCT00380081|4977748|P3|Overall Study|Family Emergency|0
1516098|NCT00380081|4977749|P2|Overall Study|Family Emergency|0
1516099|NCT00380081|4977750|P1|Overall Study|Family Emergency|0
1516100|NCT00380081|4977745|P6|Overall Study|Withdrawal by Subject|0
1516101|NCT00380081|4977746|P5|Overall Study|Withdrawal by Subject|1
1516102|NCT00380081|4977747|P4|Overall Study|Withdrawal by Subject|0
1516103|NCT00380081|4977748|P3|Overall Study|Withdrawal by Subject|0
1516104|NCT00380081|4977749|P2|Overall Study|Withdrawal by Subject|0
1516105|NCT00380081|4977750|P1|Overall Study|Withdrawal by Subject|0
1516106|NCT00380068|4977800|P1|Overall Study|Lack of Efficacy|5
1516107|NCT00380068|4977800|P1|Overall Study|Partipant moved away|1
1516108|NCT00380068|4977800|P1|Overall Study|Physician Decision|2
1516109|NCT00380068|4977800|P1|Overall Study|Lung transplant|3
1516110|NCT00380068|4977800|P1|Overall Study|Addition of other PAH therapeutic agent|1
1516111|NCT00380068|4977800|P1|Overall Study|Lost to Follow-up|1
1516112|NCT00380068|4977800|P1|Overall Study|Not compliant|6
1516113|NCT00380068|4977800|P1|Overall Study|Withdrawal by Subject|10
1516114|NCT00380068|4977800|P1|Overall Study|Adverse Event|40
1516115|NCT00379912|4977832|P2|Overall Study|Lack of Efficacy|0
1516116|NCT00379912|4977833|P1|Overall Study|Lack of Efficacy|1
1516117|NCT00379899|4977855|P2|Overall Study|Other|1
1516118|NCT00379899|4977856|P1|Overall Study|Other|3
1516119|NCT00379899|4977855|P2|Overall Study|Other protocol-specified criteria|4
1516120|NCT00379899|4977856|P1|Overall Study|Other protocol-specified criteria|3
1516121|NCT00379899|4977855|P2|Overall Study|Coronary artery bypass graft|1
1516122|NCT00379899|4977856|P1|Overall Study|Coronary artery bypass graft|1
1516123|NCT00379899|4977855|P2|Overall Study|Renal transplantation|4
1516124|NCT00379899|4977856|P1|Overall Study|Renal transplantation|5
1516125|NCT00379899|4977855|P2|Overall Study|Parathyroidectomy|2
1516126|NCT00379899|4977856|P1|Overall Study|Parathyroidectomy|0
1516127|NCT00379899|4977855|P2|Overall Study|Noncompliance|1
1516128|NCT00379899|4977856|P1|Overall Study|Noncompliance|1
1516129|NCT00379899|4977855|P2|Overall Study|Ineligibility determined|1
1516130|NCT00379899|4977856|P1|Overall Study|Ineligibility determined|0
1516131|NCT00379899|4977855|P2|Overall Study|Withdrawal by Subject|5
1516132|NCT00379899|4977856|P1|Overall Study|Withdrawal by Subject|5
1516133|NCT00379899|4977855|P2|Overall Study|Physician Decision|4
1516134|NCT00379899|4977856|P1|Overall Study|Physician Decision|3
1516135|NCT00379899|4977855|P2|Overall Study|Lost to Follow-up|4
1516136|NCT00379899|4977856|P1|Overall Study|Lost to Follow-up|2
1516137|NCT00379899|4977855|P2|Overall Study|Death|10
1516138|NCT00379899|4977856|P1|Overall Study|Death|10
1516139|NCT00379899|4977855|P2|Overall Study|Adverse Event|3
1516140|NCT00379899|4977856|P1|Overall Study|Adverse Event|7
1516141|NCT00379834|4977884|P1|Overall Study|Time constraints|2
1516142|NCT00379808|4978036|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
1516143|NCT00379808|4978037|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
1516144|NCT00379795|4978058|P5|Overall Study|Sponsor's decision|10
1516145|NCT00379795|4978059|P4|Overall Study|Sponsor's decision|47
1516146|NCT00379795|4978060|P3|Overall Study|Sponsor's decision|54
1516147|NCT00379795|4978061|P2|Overall Study|Sponsor's decision|17
1516148|NCT00379795|4978062|P1|Overall Study|Sponsor's decision|257
1516149|NCT00379795|4978058|P5|Overall Study|Subjects condition mandated intervention|7
1516150|NCT00379795|4978059|P4|Overall Study|Subjects condition mandated intervention|5
1516151|NCT00379795|4978060|P3|Overall Study|Subjects condition mandated intervention|7
1516152|NCT00379795|4978061|P2|Overall Study|Subjects condition mandated intervention|9
1516153|NCT00379795|4978062|P1|Overall Study|Subjects condition mandated intervention|34
1516154|NCT00379795|4978058|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
1516155|NCT00379795|4978059|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
1516156|NCT00379795|4978060|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
1516157|NCT00379795|4978061|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
1516158|NCT00379795|4978062|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
1516159|NCT00379795|4978058|P5|Overall Study|Subject non-compliance|1
1516160|NCT00379795|4978059|P4|Overall Study|Subject non-compliance|0
1516161|NCT00379795|4978060|P3|Overall Study|Subject non-compliance|0
1516162|NCT00379795|4978061|P2|Overall Study|Subject non-compliance|2
1516163|NCT00379795|4978062|P1|Overall Study|Subject non-compliance|7
1516164|NCT00379795|4978058|P5|Overall Study|Withdrawal by Subject|14
1516165|NCT00379795|4978059|P4|Overall Study|Withdrawal by Subject|7
1516166|NCT00379795|4978060|P3|Overall Study|Withdrawal by Subject|19
1516167|NCT00379795|4978061|P2|Overall Study|Withdrawal by Subject|11
1516168|NCT00379795|4978062|P1|Overall Study|Withdrawal by Subject|94
1516169|NCT00379795|4978058|P5|Overall Study|Physician Decision|2
1516170|NCT00379795|4978059|P4|Overall Study|Physician Decision|2
1516171|NCT00379795|4978060|P3|Overall Study|Physician Decision|2
1516172|NCT00379795|4978061|P2|Overall Study|Physician Decision|0
1516173|NCT00379795|4978062|P1|Overall Study|Physician Decision|25
1516174|NCT00379795|4978058|P5|Overall Study|Lost to Follow-up|4
1516175|NCT00379795|4978059|P4|Overall Study|Lost to Follow-up|1
1516176|NCT00379795|4978060|P3|Overall Study|Lost to Follow-up|2
1516177|NCT00379795|4978061|P2|Overall Study|Lost to Follow-up|1
1516178|NCT00379795|4978062|P1|Overall Study|Lost to Follow-up|8
1516179|NCT00379795|4978058|P5|Overall Study|Adverse Event|4
1516180|NCT00379795|4978059|P4|Overall Study|Adverse Event|1
1516181|NCT00379795|4978060|P3|Overall Study|Adverse Event|3
1516182|NCT00379795|4978061|P2|Overall Study|Adverse Event|3
1516183|NCT00379795|4978062|P1|Overall Study|Adverse Event|17
1516184|NCT00379795|4978058|P5|Overall Study|Death|7
1516185|NCT00379795|4978059|P4|Overall Study|Death|4
1516186|NCT00379795|4978060|P3|Overall Study|Death|6
1516187|NCT00379795|4978061|P2|Overall Study|Death|8
1516188|NCT00379795|4978062|P1|Overall Study|Death|31
1516189|NCT00379769|4978092|P6|Observational Follow-up|Unknown; Reason Not Provided|1
1516190|NCT00379769|4978093|P5|Observational Follow-up|Unknown; Reason Not Provided|1
1516191|NCT00379769|4978094|P4|Observational Follow-up|Unknown; Reason Not Provided|0
1516192|NCT00379769|4978095|P3|Observational Follow-up|Unknown; Reason Not Provided|0
1516193|NCT00379769|4978096|P2|Observational Follow-up|Unknown; Reason Not Provided|0
1516194|NCT00379769|4978097|P1|Observational Follow-up|Unknown; Reason Not Provided|0
1516195|NCT00379769|4978092|P6|Observational Follow-up|Participant Moved|1
1516196|NCT00379769|4978093|P5|Observational Follow-up|Participant Moved|0
1516197|NCT00379769|4978094|P4|Observational Follow-up|Participant Moved|0
1516198|NCT00379769|4978095|P3|Observational Follow-up|Participant Moved|0
1516199|NCT00379769|4978096|P2|Observational Follow-up|Participant Moved|0
1516200|NCT00379769|4978097|P1|Observational Follow-up|Participant Moved|0
1516201|NCT00379769|4978092|P6|Observational Follow-up|Site Closed Early|7
1516202|NCT00379769|4978093|P5|Observational Follow-up|Site Closed Early|6
1516203|NCT00379769|4978094|P4|Observational Follow-up|Site Closed Early|0
1516204|NCT00379769|4978095|P3|Observational Follow-up|Site Closed Early|0
1516205|NCT00379769|4978096|P2|Observational Follow-up|Site Closed Early|0
1516206|NCT00379769|4978097|P1|Observational Follow-up|Site Closed Early|0
1516207|NCT00379769|4978092|P6|Observational Follow-up|Physician Decision|8
1516208|NCT00379769|4978093|P5|Observational Follow-up|Physician Decision|8
1516209|NCT00379769|4978094|P4|Observational Follow-up|Physician Decision|0
1516210|NCT00379769|4978095|P3|Observational Follow-up|Physician Decision|0
1516211|NCT00379769|4978096|P2|Observational Follow-up|Physician Decision|0
1516212|NCT00379769|4978097|P1|Observational Follow-up|Physician Decision|0
1516213|NCT00379769|4978092|P6|Observational Follow-up|Entered into Another Clinical Trial|22
1516214|NCT00379769|4978093|P5|Observational Follow-up|Entered into Another Clinical Trial|18
1516215|NCT00379769|4978094|P4|Observational Follow-up|Entered into Another Clinical Trial|0
1516216|NCT00379769|4978095|P3|Observational Follow-up|Entered into Another Clinical Trial|0
1516217|NCT00379769|4978096|P2|Observational Follow-up|Entered into Another Clinical Trial|0
1516218|NCT00379769|4978097|P1|Observational Follow-up|Entered into Another Clinical Trial|0
1516219|NCT00379769|4978092|P6|Observational Follow-up|Withdrawal by Subject|12
1516303|NCT00379769|4978092|P6|Main Study|Poor compliance|0
1516220|NCT00379769|4978093|P5|Observational Follow-up|Withdrawal by Subject|12
1516221|NCT00379769|4978094|P4|Observational Follow-up|Withdrawal by Subject|0
1516222|NCT00379769|4978095|P3|Observational Follow-up|Withdrawal by Subject|0
1516223|NCT00379769|4978096|P2|Observational Follow-up|Withdrawal by Subject|0
1516224|NCT00379769|4978097|P1|Observational Follow-up|Withdrawal by Subject|0
1516225|NCT00379769|4978092|P6|Observational Follow-up|Lost to Follow-up|27
1516226|NCT00379769|4978093|P5|Observational Follow-up|Lost to Follow-up|25
1516227|NCT00379769|4978094|P4|Observational Follow-up|Lost to Follow-up|0
1516228|NCT00379769|4978095|P3|Observational Follow-up|Lost to Follow-up|0
1516229|NCT00379769|4978096|P2|Observational Follow-up|Lost to Follow-up|0
1516230|NCT00379769|4978097|P1|Observational Follow-up|Lost to Follow-up|0
1516231|NCT00379769|4978092|P6|Observational Follow-up|Adverse Event|0
1516232|NCT00379769|4978093|P5|Observational Follow-up|Adverse Event|1
1516233|NCT00379769|4978094|P4|Observational Follow-up|Adverse Event|0
1516234|NCT00379769|4978095|P3|Observational Follow-up|Adverse Event|0
1516235|NCT00379769|4978096|P2|Observational Follow-up|Adverse Event|0
1516236|NCT00379769|4978097|P1|Observational Follow-up|Adverse Event|0
1516237|NCT00379769|4978092|P6|Observational Follow-up|Death|70
1516238|NCT00379769|4978093|P5|Observational Follow-up|Death|78
1516239|NCT00379769|4978094|P4|Observational Follow-up|Death|0
1516240|NCT00379769|4978095|P3|Observational Follow-up|Death|0
1516241|NCT00379769|4978096|P2|Observational Follow-up|Death|0
1516242|NCT00379769|4978097|P1|Observational Follow-up|Death|0
1516243|NCT00379769|4978092|P6|Main Study|Reason unspecified|0
1516244|NCT00379769|4978093|P5|Main Study|Reason unspecified|0
1516245|NCT00379769|4978094|P4|Main Study|Reason unspecified|0
1516246|NCT00379769|4978095|P3|Main Study|Reason unspecified|1
1516247|NCT00379769|4978096|P2|Main Study|Reason unspecified|0
1516248|NCT00379769|4978097|P1|Main Study|Reason unspecified|0
1516249|NCT00379769|4978092|P6|Main Study|Investigator refused to log temperature|0
1516250|NCT00379769|4978093|P5|Main Study|Investigator refused to log temperature|0
1516251|NCT00379769|4978094|P4|Main Study|Investigator refused to log temperature|0
1516252|NCT00379769|4978095|P3|Main Study|Investigator refused to log temperature|1
1516253|NCT00379769|4978096|P2|Main Study|Investigator refused to log temperature|0
1516254|NCT00379769|4978097|P1|Main Study|Investigator refused to log temperature|0
1516255|NCT00379769|4978092|P6|Main Study|Risk of heart failure|0
1516256|NCT00379769|4978093|P5|Main Study|Risk of heart failure|0
1516257|NCT00379769|4978094|P4|Main Study|Risk of heart failure|0
1516258|NCT00379769|4978095|P3|Main Study|Risk of heart failure|0
1516259|NCT00379769|4978096|P2|Main Study|Risk of heart failure|1
1516260|NCT00379769|4978097|P1|Main Study|Risk of heart failure|0
1516261|NCT00379769|4978092|P6|Main Study|Personal reasons|0
1516262|NCT00379769|4978093|P5|Main Study|Personal reasons|0
1516263|NCT00379769|4978094|P4|Main Study|Personal reasons|0
1516264|NCT00379769|4978095|P3|Main Study|Personal reasons|0
1516265|NCT00379769|4978096|P2|Main Study|Personal reasons|0
1516266|NCT00379769|4978097|P1|Main Study|Personal reasons|1
1516267|NCT00379769|4978092|P6|Main Study|Participant completed study at visit 27|0
1516268|NCT00379769|4978093|P5|Main Study|Participant completed study at visit 27|0
1516269|NCT00379769|4978094|P4|Main Study|Participant completed study at visit 27|0
1516270|NCT00379769|4978095|P3|Main Study|Participant completed study at visit 27|0
1516271|NCT00379769|4978096|P2|Main Study|Participant completed study at visit 27|0
1516272|NCT00379769|4978097|P1|Main Study|Participant completed study at visit 27|1
1516273|NCT00379769|4978092|P6|Main Study|Physician Decision|0
1516274|NCT00379769|4978093|P5|Main Study|Physician Decision|0
1516275|NCT00379769|4978094|P4|Main Study|Physician Decision|1
1516276|NCT00379769|4978095|P3|Main Study|Physician Decision|1
1516277|NCT00379769|4978096|P2|Main Study|Physician Decision|2
1516278|NCT00379769|4978097|P1|Main Study|Physician Decision|2
1516279|NCT00379769|4978092|P6|Main Study|Participant did not take study drug|0
1516280|NCT00379769|4978093|P5|Main Study|Participant did not take study drug|0
1516281|NCT00379769|4978094|P4|Main Study|Participant did not take study drug|0
1516282|NCT00379769|4978095|P3|Main Study|Participant did not take study drug|1
1516283|NCT00379769|4978096|P2|Main Study|Participant did not take study drug|0
1516284|NCT00379769|4978097|P1|Main Study|Participant did not take study drug|0
1516285|NCT00379769|4978092|P6|Main Study|Entry criteria violation|0
1516286|NCT00379769|4978093|P5|Main Study|Entry criteria violation|0
1516287|NCT00379769|4978094|P4|Main Study|Entry criteria violation|1
1516288|NCT00379769|4978095|P3|Main Study|Entry criteria violation|1
1516289|NCT00379769|4978096|P2|Main Study|Entry criteria violation|0
1516290|NCT00379769|4978097|P1|Main Study|Entry criteria violation|0
1516291|NCT00379769|4978092|P6|Main Study|Site closed|0
1516292|NCT00379769|4978093|P5|Main Study|Site closed|0
1516293|NCT00379769|4978094|P4|Main Study|Site closed|8
1516294|NCT00379769|4978095|P3|Main Study|Site closed|4
1516295|NCT00379769|4978096|P2|Main Study|Site closed|4
1516296|NCT00379769|4978097|P1|Main Study|Site closed|4
1516297|NCT00379769|4978092|P6|Main Study|Prohibited glucose lowering medication|0
1516298|NCT00379769|4978093|P5|Main Study|Prohibited glucose lowering medication|0
1516299|NCT00379769|4978094|P4|Main Study|Prohibited glucose lowering medication|1
1516300|NCT00379769|4978095|P3|Main Study|Prohibited glucose lowering medication|0
1516301|NCT00379769|4978096|P2|Main Study|Prohibited glucose lowering medication|3
1516302|NCT00379769|4978097|P1|Main Study|Prohibited glucose lowering medication|0
1516304|NCT00379769|4978093|P5|Main Study|Poor compliance|0
1516305|NCT00379769|4978094|P4|Main Study|Poor compliance|1
1516306|NCT00379769|4978095|P3|Main Study|Poor compliance|2
1516307|NCT00379769|4978096|P2|Main Study|Poor compliance|2
1516308|NCT00379769|4978097|P1|Main Study|Poor compliance|3
1516309|NCT00379769|4978092|P6|Main Study|Participant moved|0
1516310|NCT00379769|4978093|P5|Main Study|Participant moved|0
1516311|NCT00379769|4978094|P4|Main Study|Participant moved|3
1516312|NCT00379769|4978095|P3|Main Study|Participant moved|3
1516313|NCT00379769|4978096|P2|Main Study|Participant moved|2
1516314|NCT00379769|4978097|P1|Main Study|Participant moved|3
1516315|NCT00379769|4978092|P6|Main Study|Moved to survival status follow-up only|0
1516316|NCT00379769|4978093|P5|Main Study|Moved to survival status follow-up only|0
1516317|NCT00379769|4978094|P4|Main Study|Moved to survival status follow-up only|36
1516318|NCT00379769|4978095|P3|Main Study|Moved to survival status follow-up only|32
1516319|NCT00379769|4978096|P2|Main Study|Moved to survival status follow-up only|25
1516320|NCT00379769|4978097|P1|Main Study|Moved to survival status follow-up only|27
1516321|NCT00379769|4978092|P6|Main Study|Withdrawal by Subject|0
1516322|NCT00379769|4978093|P5|Main Study|Withdrawal by Subject|0
1516323|NCT00379769|4978094|P4|Main Study|Withdrawal by Subject|70
1516324|NCT00379769|4978095|P3|Main Study|Withdrawal by Subject|72
1516325|NCT00379769|4978096|P2|Main Study|Withdrawal by Subject|56
1516326|NCT00379769|4978097|P1|Main Study|Withdrawal by Subject|46
1516327|NCT00379769|4978092|P6|Main Study|Lost to Follow-up|0
1516328|NCT00379769|4978093|P5|Main Study|Lost to Follow-up|0
1516329|NCT00379769|4978094|P4|Main Study|Lost to Follow-up|26
1516330|NCT00379769|4978095|P3|Main Study|Lost to Follow-up|25
1516331|NCT00379769|4978096|P2|Main Study|Lost to Follow-up|29
1516332|NCT00379769|4978097|P1|Main Study|Lost to Follow-up|29
1516333|NCT00379769|4978092|P6|Main Study|Adverse Event|0
1516334|NCT00379769|4978093|P5|Main Study|Adverse Event|0
1516335|NCT00379769|4978094|P4|Main Study|Adverse Event|11
1516336|NCT00379769|4978095|P3|Main Study|Adverse Event|10
1516337|NCT00379769|4978096|P2|Main Study|Adverse Event|8
1516338|NCT00379769|4978097|P1|Main Study|Adverse Event|5
1516339|NCT00379769|4978092|P6|Main Study|Death|0
1516340|NCT00379769|4978093|P5|Main Study|Death|0
1516341|NCT00379769|4978094|P4|Main Study|Death|72
1516342|NCT00379769|4978095|P3|Main Study|Death|54
1516343|NCT00379769|4978096|P2|Main Study|Death|67
1516344|NCT00379769|4978097|P1|Main Study|Death|57
1516345|NCT00379639|4978256|P5|Overall Study|Other|0
1516346|NCT00379639|4978257|P4|Overall Study|Other|0
1516347|NCT00379639|4978258|P3|Overall Study|Other|3
1516348|NCT00379639|4978259|P2|Overall Study|Other|0
1516349|NCT00379639|4978260|P1|Overall Study|Other|0
1516350|NCT00379639|4978256|P5|Overall Study|Lost to Follow-up|0
1516351|NCT00379639|4978257|P4|Overall Study|Lost to Follow-up|1
1516352|NCT00379639|4978258|P3|Overall Study|Lost to Follow-up|0
1516353|NCT00379639|4978259|P2|Overall Study|Lost to Follow-up|0
1516354|NCT00379639|4978260|P1|Overall Study|Lost to Follow-up|0
1516355|NCT00379639|4978256|P5|Overall Study|Adverse Event|1
1516356|NCT00379639|4978257|P4|Overall Study|Adverse Event|0
1516357|NCT00379639|4978258|P3|Overall Study|Adverse Event|1
1516358|NCT00379639|4978259|P2|Overall Study|Adverse Event|0
1516359|NCT00379639|4978260|P1|Overall Study|Adverse Event|0
1516360|NCT00379639|4978256|P5|Overall Study|Symptomatic Deterioration|1
1516361|NCT00379639|4978257|P4|Overall Study|Symptomatic Deterioration|0
1516362|NCT00379639|4978258|P3|Overall Study|Symptomatic Deterioration|1
1516363|NCT00379639|4978259|P2|Overall Study|Symptomatic Deterioration|0
1516364|NCT00379639|4978260|P1|Overall Study|Symptomatic Deterioration|0
1516365|NCT00379639|4978256|P5|Overall Study|Physician Decision|0
1516366|NCT00379639|4978257|P4|Overall Study|Physician Decision|1
1516367|NCT00379639|4978258|P3|Overall Study|Physician Decision|1
1516368|NCT00379639|4978259|P2|Overall Study|Physician Decision|2
1516369|NCT00379639|4978260|P1|Overall Study|Physician Decision|0
1516370|NCT00379639|4978256|P5|Overall Study|Disease Progression|4
1516371|NCT00379639|4978257|P4|Overall Study|Disease Progression|4
1516372|NCT00379639|4978258|P3|Overall Study|Disease Progression|3
1516373|NCT00379639|4978259|P2|Overall Study|Disease Progression|3
1516374|NCT00379639|4978260|P1|Overall Study|Disease Progression|3
1516375|NCT00379587|4978282|P1|Overall Study|Lost to Follow-up|2
1516376|NCT00379353|4978296|P2|Overall Study|Conflicting drug treatment|1
1516377|NCT00379353|4978297|P1|Overall Study|Conflicting drug treatment|0
1516378|NCT00379353|4978296|P2|Overall Study|Non-compliance|0
1516379|NCT00379353|4978297|P1|Overall Study|Non-compliance|1
1516380|NCT00379353|4978296|P2|Overall Study|Cardiac Tamponade|0
1516381|NCT00379353|4978297|P1|Overall Study|Cardiac Tamponade|1
1516382|NCT00379353|4978296|P2|Overall Study|Death|0
1516383|NCT00379353|4978297|P1|Overall Study|Death|1
1516384|NCT00379353|4978296|P2|Overall Study|Withdrawal by Subject|2
1516385|NCT00379353|4978297|P1|Overall Study|Withdrawal by Subject|5
1516386|NCT00379353|4978296|P2|Overall Study|Hospitalization|3
1516387|NCT00379353|4978297|P1|Overall Study|Hospitalization|3
1516388|NCT00379340|4978332|P5|Overall Study|Delayed nephrectomy and anaplasia|1
1516389|NCT00379340|4978333|P4|Overall Study|Delayed nephrectomy and anaplasia|1
1516390|NCT00379340|4978334|P3|Overall Study|Delayed nephrectomy and anaplasia|0
1516391|NCT00379340|4978335|P2|Overall Study|Delayed nephrectomy and anaplasia|0
1516392|NCT00379340|4978336|P1|Overall Study|Delayed nephrectomy and anaplasia|0
1516393|NCT00379340|4978332|P5|Overall Study|On more than 1 tumor therapeutic study|0
1516394|NCT00379340|4978333|P4|Overall Study|On more than 1 tumor therapeutic study|2
1516395|NCT00379340|4978334|P3|Overall Study|On more than 1 tumor therapeutic study|0
1516396|NCT00379340|4978335|P2|Overall Study|On more than 1 tumor therapeutic study|0
1516397|NCT00379340|4978336|P1|Overall Study|On more than 1 tumor therapeutic study|0
1516398|NCT00379340|4978332|P5|Overall Study|Refusal of further protocol therapy|7
1516399|NCT00379340|4978333|P4|Overall Study|Refusal of further protocol therapy|1
1516400|NCT00379340|4978334|P3|Overall Study|Refusal of further protocol therapy|1
1516401|NCT00379340|4978335|P2|Overall Study|Refusal of further protocol therapy|0
1516402|NCT00379340|4978336|P1|Overall Study|Refusal of further protocol therapy|1
1516403|NCT00379340|4978332|P5|Overall Study|Withdrawal by Subject|0
1516404|NCT00379340|4978333|P4|Overall Study|Withdrawal by Subject|1
1516405|NCT00379340|4978334|P3|Overall Study|Withdrawal by Subject|0
1516406|NCT00379340|4978335|P2|Overall Study|Withdrawal by Subject|0
1516407|NCT00379340|4978336|P1|Overall Study|Withdrawal by Subject|0
1516408|NCT00379340|4978332|P5|Overall Study|Physician Decision|3
1516409|NCT00379340|4978333|P4|Overall Study|Physician Decision|2
1516410|NCT00379340|4978334|P3|Overall Study|Physician Decision|1
1516411|NCT00379340|4978335|P2|Overall Study|Physician Decision|2
1516412|NCT00379340|4978336|P1|Overall Study|Physician Decision|6
1516413|NCT00379340|4978332|P5|Overall Study|Lack of Efficacy|3
1516414|NCT00379340|4978333|P4|Overall Study|Lack of Efficacy|4
1516415|NCT00379340|4978334|P3|Overall Study|Lack of Efficacy|0
1516416|NCT00379340|4978335|P2|Overall Study|Lack of Efficacy|1
1516417|NCT00379340|4978336|P1|Overall Study|Lack of Efficacy|6
1516418|NCT00379340|4978332|P5|Overall Study|Death|0
1516419|NCT00379340|4978333|P4|Overall Study|Death|2
1516420|NCT00379340|4978334|P3|Overall Study|Death|0
1516421|NCT00379340|4978335|P2|Overall Study|Death|0
1516422|NCT00379340|4978336|P1|Overall Study|Death|0
1516423|NCT00379288|4978353|P4|Overall Study|Administrative|1
1516424|NCT00379288|4978354|P3|Overall Study|Administrative|0
1516425|NCT00379288|4978355|P2|Overall Study|Administrative|2
1516426|NCT00379288|4978356|P1|Overall Study|Administrative|2
1516427|NCT00379288|4978353|P4|Overall Study|Did not meet protocol eligibility|2
1516428|NCT00379288|4978354|P3|Overall Study|Did not meet protocol eligibility|0
1516429|NCT00379288|4978355|P2|Overall Study|Did not meet protocol eligibility|1
1516430|NCT00379288|4978356|P1|Overall Study|Did not meet protocol eligibility|0
1516431|NCT00379288|4978353|P4|Overall Study|Noncompliance with protocol|1
1516432|NCT00379288|4978354|P3|Overall Study|Noncompliance with protocol|2
1516433|NCT00379288|4978355|P2|Overall Study|Noncompliance with protocol|6
1516434|NCT00379288|4978356|P1|Overall Study|Noncompliance with protocol|8
1516435|NCT00379288|4978353|P4|Overall Study|Subject withdrew-related to study drug|1
1516436|NCT00379288|4978354|P3|Overall Study|Subject withdrew-related to study drug|0
1516437|NCT00379288|4978355|P2|Overall Study|Subject withdrew-related to study drug|0
1516438|NCT00379288|4978356|P1|Overall Study|Subject withdrew-related to study drug|1
1516439|NCT00379288|4978353|P4|Overall Study|Subject withdrew-unrelated to study drug|2
1516440|NCT00379288|4978354|P3|Overall Study|Subject withdrew-unrelated to study drug|4
1516441|NCT00379288|4978355|P2|Overall Study|Subject withdrew-unrelated to study drug|3
1516442|NCT00379288|4978356|P1|Overall Study|Subject withdrew-unrelated to study drug|0
1516443|NCT00379288|4978353|P4|Overall Study|Lost to Follow-up|0
1516444|NCT00379288|4978354|P3|Overall Study|Lost to Follow-up|2
1516445|NCT00379288|4978355|P2|Overall Study|Lost to Follow-up|3
1516446|NCT00379288|4978356|P1|Overall Study|Lost to Follow-up|3
1516447|NCT00379288|4978353|P4|Overall Study|Treatment Failure|1
1516448|NCT00379288|4978354|P3|Overall Study|Treatment Failure|0
1516449|NCT00379288|4978355|P2|Overall Study|Treatment Failure|1
1516450|NCT00379288|4978356|P1|Overall Study|Treatment Failure|0
1516451|NCT00379288|4978353|P4|Overall Study|Adverse Event|0
1516452|NCT00379288|4978354|P3|Overall Study|Adverse Event|2
1516453|NCT00379288|4978355|P2|Overall Study|Adverse Event|6
1516454|NCT00379288|4978356|P1|Overall Study|Adverse Event|5
1516455|NCT00379236|4978368|P3|Open-label Extension|Not specified|7
1516456|NCT00379236|4978369|P2|Open-label Extension|Not specified|0
1516457|NCT00379236|4978370|P1|Open-label Extension|Not specified|0
1516458|NCT00379236|4978368|P3|Open-label Extension|Use of exclusionary medication|3
1516459|NCT00379236|4978369|P2|Open-label Extension|Use of exclusionary medication|0
1516460|NCT00379236|4978370|P1|Open-label Extension|Use of exclusionary medication|0
1516461|NCT00379236|4978368|P3|Open-label Extension|Lost to Follow-up|12
1516462|NCT00379236|4978369|P2|Open-label Extension|Lost to Follow-up|0
1516463|NCT00379236|4978370|P1|Open-label Extension|Lost to Follow-up|0
1516464|NCT00379236|4978368|P3|Open-label Extension|Withdrawal by Subject|13
1516465|NCT00379236|4978369|P2|Open-label Extension|Withdrawal by Subject|0
1516466|NCT00379236|4978370|P1|Open-label Extension|Withdrawal by Subject|0
1516467|NCT00379236|4978368|P3|Open-label Extension|Protocol Violation|7
1516468|NCT00379236|4978369|P2|Open-label Extension|Protocol Violation|0
1516469|NCT00379236|4978370|P1|Open-label Extension|Protocol Violation|0
1516470|NCT00379236|4978368|P3|Open-label Extension|Adverse Event|13
1516471|NCT00379236|4978369|P2|Open-label Extension|Adverse Event|0
1516472|NCT00379236|4978370|P1|Open-label Extension|Adverse Event|0
1516473|NCT00379236|4978368|P3|Double-blind|Data could not be retrieved|0
1516474|NCT00379236|4978369|P2|Double-blind|Data could not be retrieved|2
1516475|NCT00379236|4978370|P1|Double-blind|Data could not be retrieved|2
1516476|NCT00379236|4978368|P3|Double-blind|Not specified|0
1516477|NCT00379236|4978369|P2|Double-blind|Not specified|7
1516478|NCT00379236|4978370|P1|Double-blind|Not specified|3
1516479|NCT00379236|4978368|P3|Double-blind|Use of exclusionary medication|0
1516480|NCT00379236|4978369|P2|Double-blind|Use of exclusionary medication|2
1516481|NCT00379236|4978370|P1|Double-blind|Use of exclusionary medication|1
1516482|NCT00379236|4978368|P3|Double-blind|Lost to Follow-up|0
1516483|NCT00379236|4978369|P2|Double-blind|Lost to Follow-up|3
1516484|NCT00379236|4978370|P1|Double-blind|Lost to Follow-up|4
1516485|NCT00379236|4978368|P3|Double-blind|Withdrawal by Subject|0
1516486|NCT00379236|4978369|P2|Double-blind|Withdrawal by Subject|13
1516487|NCT00379236|4978370|P1|Double-blind|Withdrawal by Subject|12
1516488|NCT00379236|4978368|P3|Double-blind|Protocol Violation|0
1516489|NCT00379236|4978369|P2|Double-blind|Protocol Violation|3
1516490|NCT00379236|4978370|P1|Double-blind|Protocol Violation|3
1516491|NCT00379236|4978368|P3|Double-blind|Adverse Event|0
1516492|NCT00379236|4978369|P2|Double-blind|Adverse Event|6
1516493|NCT00379236|4978370|P1|Double-blind|Adverse Event|11
1516494|NCT00379210|4978415|P2|Overall Study|Withdrawal by Subject|7
1516495|NCT00379210|4978416|P1|Overall Study|Withdrawal by Subject|10
1516496|NCT00379080|4978439|P3|Overall Study|Withdrawal by Subject|0
1516497|NCT00379080|4978440|P2|Overall Study|Withdrawal by Subject|4
1516498|NCT00379080|4978441|P1|Overall Study|Withdrawal by Subject|0
1516499|NCT00378898|4978486|P2|Overall Study|Protocol Violation|1
1516500|NCT00378898|4978487|P1|Overall Study|Protocol Violation|1
1516501|NCT00378898|4978486|P2|Overall Study|Withdrawal by Subject|5
1516502|NCT00378898|4978487|P1|Overall Study|Withdrawal by Subject|10
1516503|NCT00378703|4978499|P4|Overall Study|Other|3
1516504|NCT00378703|4978500|P3|Overall Study|Other|2
1516505|NCT00378703|4978501|P2|Overall Study|Other|1
1516506|NCT00378703|4978502|P1|Overall Study|Other|1
1516507|NCT00378703|4978499|P4|Overall Study|Never started treatment|0
1516508|NCT00378703|4978500|P3|Overall Study|Never started treatment|0
1516509|NCT00378703|4978501|P2|Overall Study|Never started treatment|4
1516510|NCT00378703|4978502|P1|Overall Study|Never started treatment|1
1516511|NCT00378703|4978499|P4|Overall Study|Ineligible|7
1516512|NCT00378703|4978500|P3|Overall Study|Ineligible|7
1516513|NCT00378703|4978501|P2|Overall Study|Ineligible|7
1516514|NCT00378703|4978502|P1|Overall Study|Ineligible|4
1516515|NCT00378703|4978499|P4|Overall Study|Relocation|0
1516516|NCT00378703|4978500|P3|Overall Study|Relocation|1
1516517|NCT00378703|4978501|P2|Overall Study|Relocation|0
1516518|NCT00378703|4978502|P1|Overall Study|Relocation|0
1516519|NCT00378703|4978499|P4|Overall Study|Adverse events and progressive disease|1
1516520|NCT00378703|4978500|P3|Overall Study|Adverse events and progressive disease|0
1516521|NCT00378703|4978501|P2|Overall Study|Adverse events and progressive disease|0
1516522|NCT00378703|4978502|P1|Overall Study|Adverse events and progressive disease|0
1516523|NCT00378703|4978499|P4|Overall Study|Joint decision of physician and patient|0
1516524|NCT00378703|4978500|P3|Overall Study|Joint decision of physician and patient|0
1516525|NCT00378703|4978501|P2|Overall Study|Joint decision of physician and patient|0
1516526|NCT00378703|4978502|P1|Overall Study|Joint decision of physician and patient|1
1516527|NCT00378703|4978499|P4|Overall Study|Surgery|1
1516528|NCT00378703|4978500|P3|Overall Study|Surgery|0
1516529|NCT00378703|4978501|P2|Overall Study|Surgery|0
1516530|NCT00378703|4978502|P1|Overall Study|Surgery|1
1516531|NCT00378703|4978499|P4|Overall Study|Symptomatic deterioration|2
1516532|NCT00378703|4978500|P3|Overall Study|Symptomatic deterioration|0
1516533|NCT00378703|4978501|P2|Overall Study|Symptomatic deterioration|1
1516534|NCT00378703|4978502|P1|Overall Study|Symptomatic deterioration|0
1516535|NCT00378703|4978499|P4|Overall Study|Other complicated disease|0
1516536|NCT00378703|4978500|P3|Overall Study|Other complicated disease|2
1516537|NCT00378703|4978501|P2|Overall Study|Other complicated disease|2
1516538|NCT00378703|4978502|P1|Overall Study|Other complicated disease|0
1516539|NCT00378703|4978499|P4|Overall Study|Alternative therapy|0
1516540|NCT00378703|4978500|P3|Overall Study|Alternative therapy|0
1516541|NCT00378703|4978501|P2|Overall Study|Alternative therapy|2
1516542|NCT00378703|4978502|P1|Overall Study|Alternative therapy|4
1516543|NCT00378703|4978499|P4|Overall Study|Physician Decision|0
1516544|NCT00378703|4978500|P3|Overall Study|Physician Decision|1
1516545|NCT00378703|4978501|P2|Overall Study|Physician Decision|4
1516546|NCT00378703|4978502|P1|Overall Study|Physician Decision|1
1516547|NCT00378703|4978499|P4|Overall Study|Withdrawal by Subject|7
1516548|NCT00378703|4978500|P3|Overall Study|Withdrawal by Subject|5
1516549|NCT00378703|4978501|P2|Overall Study|Withdrawal by Subject|8
1516550|NCT00378703|4978502|P1|Overall Study|Withdrawal by Subject|4
1516551|NCT00378703|4978499|P4|Overall Study|Death|3
1516552|NCT00378703|4978500|P3|Overall Study|Death|4
1516553|NCT00378703|4978501|P2|Overall Study|Death|2
1516554|NCT00378703|4978502|P1|Overall Study|Death|2
1516555|NCT00378703|4978499|P4|Overall Study|Adverse Event|18
1516556|NCT00378703|4978500|P3|Overall Study|Adverse Event|20
1516557|NCT00378703|4978501|P2|Overall Study|Adverse Event|17
1516558|NCT00378703|4978502|P1|Overall Study|Adverse Event|11
1516559|NCT00378703|4978499|P4|Overall Study|Disease progression|49
1516560|NCT00378703|4978500|P3|Overall Study|Disease progression|48
1516561|NCT00378703|4978501|P2|Overall Study|Disease progression|43
1516562|NCT00378703|4978502|P1|Overall Study|Disease progression|59
1516563|NCT00378599|4978524|P1|Overall Study|Withdrawal by Subject|5
1516564|NCT00378599|4978524|P1|Overall Study|Treatment failure|7
1516565|NCT00378599|4978524|P1|Overall Study|Protocol Violation|2
1516566|NCT00378599|4978524|P1|Overall Study|Adverse Event|38
1516567|NCT00378573|4978528|P1|Follow-up|Withdrawal by Subject|1
1516568|NCT00378573|4978528|P1|Follow-up|Lost to Follow-up|1
1516569|NCT00378573|4978528|P1|Follow-up|Death|12
1516570|NCT00378573|4978528|P1|Treatment Period|Sponsor decision to close study|1
1516571|NCT00378573|4978528|P1|Treatment Period|Disease Progression|4
1516572|NCT00378573|4978528|P1|Treatment Period|Withdrawal by Subject|2
1516573|NCT00378573|4978528|P1|Treatment Period|Physician Decision|1
1516574|NCT00378573|4978528|P1|Treatment Period|Adverse Event|9
1516575|NCT00378560|4978536|P2|Overall Study|Laboratory test values abnormal|0
1516576|NCT00378560|4978537|P1|Overall Study|Laboratory test values abnormal|1
1516577|NCT00378560|4978536|P2|Overall Study|Pregnancy|5
1516578|NCT00378560|4978537|P1|Overall Study|Pregnancy|7
1516579|NCT00378560|4978536|P2|Overall Study|Moved|3
1516580|NCT00378560|4978537|P1|Overall Study|Moved|4
1516581|NCT00378560|4978536|P2|Overall Study|Withdrawal by Subject|21
1516582|NCT00378560|4978537|P1|Overall Study|Withdrawal by Subject|17
1516583|NCT00378560|4978536|P2|Overall Study|Protocol Violation|0
1516584|NCT00378560|4978537|P1|Overall Study|Protocol Violation|2
1516585|NCT00378560|4978536|P2|Overall Study|Lost to Follow-up|29
1516586|NCT00378560|4978537|P1|Overall Study|Lost to Follow-up|24
1516587|NCT00378560|4978536|P2|Overall Study|Adverse Event|0
1516588|NCT00378560|4978537|P1|Overall Study|Adverse Event|1
1516589|NCT00378534|4978551|P1|Overall Study|Subjects did not receive a transplant|3
1516590|NCT00378534|4978551|P1|Overall Study|Donors|57
1516591|NCT00378508|4978557|P2|Overall Study|Lost to Follow-up|0
1516592|NCT00378508|4978558|P1|Overall Study|Lost to Follow-up|1
1516593|NCT00378508|4978557|P2|Overall Study|Withdrawal by Subject|3
1516594|NCT00378508|4978558|P1|Overall Study|Withdrawal by Subject|1
1516595|NCT00378378|4978577|P3|Overall Study|Non-compliance with protocol|1
1516596|NCT00378378|4978578|P2|Overall Study|Non-compliance with protocol|0
1516597|NCT00378378|4978579|P1|Overall Study|Non-compliance with protocol|0
1516598|NCT00378378|4978577|P3|Overall Study|Treatment Failure|1
1516599|NCT00378378|4978578|P2|Overall Study|Treatment Failure|0
1516600|NCT00378378|4978579|P1|Overall Study|Treatment Failure|0
1516601|NCT00378378|4978577|P3|Overall Study|Withdrawal by Subject|0
1516602|NCT00378378|4978578|P2|Overall Study|Withdrawal by Subject|1
1516603|NCT00378378|4978579|P1|Overall Study|Withdrawal by Subject|0
1516604|NCT00378209|4978625|P1|Overall Study|Treatment delay|1
1516605|NCT00378209|4978625|P1|Overall Study|Death|1
1516606|NCT00378209|4978625|P1|Overall Study|Physician Decision|3
1516607|NCT00378209|4978625|P1|Overall Study|Initiation of non-protocol therapy|3
1516608|NCT00378209|4978625|P1|Overall Study|Adverse Event|3
1516609|NCT00378209|4978625|P1|Overall Study|Progressive disease|11
1516610|NCT00378105|4978635|P2|Overall Study|necessity to increase lenalidomide dose|1
1516611|NCT00378105|4978636|P1|Overall Study|necessity to increase lenalidomide dose|0
1516612|NCT00378105|4978635|P2|Overall Study|Going non-protocol therapy|1
1516613|NCT00378105|4978636|P1|Overall Study|Going non-protocol therapy|0
1516614|NCT00378105|4978635|P2|Overall Study|Physician Decision|2
1516615|NCT00378105|4978636|P1|Overall Study|Physician Decision|0
1516616|NCT00378105|4978635|P2|Overall Study|remain on study|11
1516617|NCT00378105|4978636|P1|Overall Study|remain on study|3
1516618|NCT00378105|4978635|P2|Overall Study|Progressive disease|3
1516619|NCT00378105|4978636|P1|Overall Study|Progressive disease|3
1516620|NCT00378105|4978635|P2|Overall Study|Going to transplant|8
1516621|NCT00378105|4978636|P1|Overall Study|Going to transplant|7
1516622|NCT00378105|4978635|P2|Overall Study|Death|0
1516623|NCT00378105|4978636|P1|Overall Study|Death|1
1516624|NCT00378105|4978635|P2|Overall Study|Withdrawal by Subject|3
1516625|NCT00378105|4978636|P1|Overall Study|Withdrawal by Subject|3
1516626|NCT00378105|4978635|P2|Overall Study|Adverse Event|1
1516627|NCT00378105|4978636|P1|Overall Study|Adverse Event|3
1516628|NCT00378079|4978648|P3|Overall Study|Lost to Follow-up|0
1516629|NCT00378079|4978649|P2|Overall Study|Lost to Follow-up|1
1516630|NCT00378079|4978650|P1|Overall Study|Lost to Follow-up|6
1516631|NCT00378014|4978672|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
1516632|NCT00378014|4978673|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
1516633|NCT00378014|4978672|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
1516634|NCT00378014|4978673|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
1516635|NCT00378014|4978672|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
1516636|NCT00378014|4978673|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
1516637|NCT00378014|4978672|P2|Extension (Month 12 to Month 59)|Administrative problems|0
1516638|NCT00378014|4978673|P1|Extension (Month 12 to Month 59)|Administrative problems|1
1516639|NCT00378014|4978672|P2|Extension (Month 12 to Month 59)|Death|2
1516640|NCT00378014|4978673|P1|Extension (Month 12 to Month 59)|Death|1
1516641|NCT00378014|4978672|P2|Extension (Month 12 to Month 59)|Adverse Event|7
1516642|NCT00378014|4978673|P1|Extension (Month 12 to Month 59)|Adverse Event|8
1516643|NCT00378014|4978672|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
1516644|NCT00378014|4978673|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
1516645|NCT00378014|4978672|P2|Core (Randomization to Month 11)|Protocol deviation|1
1516646|NCT00378014|4978673|P1|Core (Randomization to Month 11)|Protocol deviation|0
1516647|NCT00378014|4978672|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
1516648|NCT00378014|4978673|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
1516649|NCT00378014|4978672|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
1516650|NCT00378014|4978673|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
1516651|NCT00378014|4978672|P2|Core (Randomization to Month 11)|Administrative Problems|2
1516652|NCT00378014|4978673|P1|Core (Randomization to Month 11)|Administrative Problems|2
1516653|NCT00378014|4978672|P2|Core (Randomization to Month 11)|Death|3
1516654|NCT00378014|4978673|P1|Core (Randomization to Month 11)|Death|5
1516655|NCT00378014|4978672|P2|Core (Randomization to Month 11)|Graft loss|2
1516656|NCT00378014|4978673|P1|Core (Randomization to Month 11)|Graft loss|1
1516657|NCT00378014|4978672|P2|Core (Randomization to Month 11)|Adverse Event|0
1516658|NCT00378014|4978673|P1|Core (Randomization to Month 11)|Adverse Event|1
1516659|NCT00377962|4978699|P2|Extension Study: 12-24 Months|Unspecified reason|3
1516660|NCT00377962|4978700|P1|Extension Study: 12-24 Months|Unspecified reason|0
1516661|NCT00377962|4978699|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
1516662|NCT00377962|4978700|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
1516663|NCT00377962|4978699|P2|Extension Study: 12-24 Months|Adverse Event|0
1516664|NCT00377962|4978700|P1|Extension Study: 12-24 Months|Adverse Event|8
1516665|NCT00377962|4978699|P2|Extension Study: 12-24 Months|Death|1
1516666|NCT00377962|4978700|P1|Extension Study: 12-24 Months|Death|1
1516667|NCT00377962|4978699|P2|Core Study: 0-12 Months|Unspecified reasons|4
1516668|NCT00377962|4978700|P1|Core Study: 0-12 Months|Unspecified reasons|1
1516669|NCT00377962|4978699|P2|Core Study: 0-12 Months|Administrative Reason|1
1516670|NCT00377962|4978700|P1|Core Study: 0-12 Months|Administrative Reason|1
1516671|NCT00377962|4978699|P2|Core Study: 0-12 Months|Withdrew Consent|2
1516672|NCT00377962|4978700|P1|Core Study: 0-12 Months|Withdrew Consent|5
1516673|NCT00377962|4978699|P2|Core Study: 0-12 Months|Death|0
1516674|NCT00377962|4978700|P1|Core Study: 0-12 Months|Death|3
1516675|NCT00377962|4978699|P2|Core Study: 0-12 Months|Adverse Event|2
1516676|NCT00377962|4978700|P1|Core Study: 0-12 Months|Adverse Event|18
1516677|NCT00377858|4978736|P2|Overall Study|Death|3
1516678|NCT00377858|4978737|P1|Overall Study|Death|0
1516679|NCT00377858|4978736|P2|Overall Study|Sponsor Decision|2
1516680|NCT00377858|4978737|P1|Overall Study|Sponsor Decision|1
1516681|NCT00377858|4978736|P2|Overall Study|Entry Criteria Not Met|0
1516682|NCT00377858|4978737|P1|Overall Study|Entry Criteria Not Met|2
1516683|NCT00377858|4978736|P2|Overall Study|Adverse Event|1
1516684|NCT00377858|4978737|P1|Overall Study|Adverse Event|2
1516685|NCT00377858|4978736|P2|Overall Study|Protocol Violation|4
1516686|NCT00377858|4978737|P1|Overall Study|Protocol Violation|3
1516687|NCT00377858|4978736|P2|Overall Study|Physician Decision|5
1516688|NCT00377858|4978737|P1|Overall Study|Physician Decision|5
1516689|NCT00377858|4978736|P2|Overall Study|Lost to Follow-up|1
1516690|NCT00377858|4978737|P1|Overall Study|Lost to Follow-up|6
1516691|NCT00377858|4978736|P2|Overall Study|Withdrawal by Subject|11
1516692|NCT00377858|4978737|P1|Overall Study|Withdrawal by Subject|12
1516693|NCT00377819|4978790|P2|Overall Study|Protocol Violation|1
1516694|NCT00377819|4978791|P1|Overall Study|Protocol Violation|1
1516695|NCT00377819|4978790|P2|Overall Study|Lost to Follow-up|1
1516696|NCT00377819|4978791|P1|Overall Study|Lost to Follow-up|0
1516697|NCT00377819|4978790|P2|Overall Study|Death|1
1516698|NCT00377819|4978791|P1|Overall Study|Death|0
1516699|NCT00377819|4978790|P2|Overall Study|Withdrawal by Subject|4
1516700|NCT00377819|4978791|P1|Overall Study|Withdrawal by Subject|10
1516701|NCT00377819|4978790|P2|Overall Study|Adverse Event|3
1516702|NCT00377819|4978791|P1|Overall Study|Adverse Event|2
1516703|NCT00377676|4978820|P2|Overall Study|not specified|58
1516704|NCT00377676|4978821|P1|Overall Study|not specified|118
1516705|NCT00377676|4978820|P2|Overall Study|Lost to Follow-up|56
1516706|NCT00377676|4978821|P1|Overall Study|Lost to Follow-up|120
1516707|NCT00377676|4978820|P2|Overall Study|Withdrawal by Subject|72
1516708|NCT00377676|4978821|P1|Overall Study|Withdrawal by Subject|187
1516709|NCT00377676|4978820|P2|Overall Study|Death|2
1516710|NCT00377676|4978821|P1|Overall Study|Death|5
1516711|NCT00377676|4978820|P2|Overall Study|Protocol Violation|27
1516712|NCT00377676|4978821|P1|Overall Study|Protocol Violation|33
1516713|NCT00377676|4978820|P2|Overall Study|Adverse Event|107
1516714|NCT00377676|4978821|P1|Overall Study|Adverse Event|498
1516715|NCT00377637|4978837|P4|Maintenance Phase|Death|1
1516716|NCT00377637|4978838|P3|Maintenance Phase|Death|0
1516717|NCT00377637|4978839|P2|Maintenance Phase|Death|0
1516718|NCT00377637|4978840|P1|Maintenance Phase|Death|0
1516719|NCT00377637|4978837|P4|Maintenance Phase|Study medication stopped > 14 days|1
1516720|NCT00377637|4978838|P3|Maintenance Phase|Study medication stopped > 14 days|0
1516721|NCT00377637|4978839|P2|Maintenance Phase|Study medication stopped > 14 days|0
1516722|NCT00377637|4978840|P1|Maintenance Phase|Study medication stopped > 14 days|0
1516723|NCT00377637|4978837|P4|Maintenance Phase|Non-compliance|1
1516724|NCT00377637|4978838|P3|Maintenance Phase|Non-compliance|1
1516725|NCT00377637|4978839|P2|Maintenance Phase|Non-compliance|0
1516726|NCT00377637|4978840|P1|Maintenance Phase|Non-compliance|0
1516727|NCT00377637|4978837|P4|Maintenance Phase|Sponsor decision|3
1516728|NCT00377637|4978838|P3|Maintenance Phase|Sponsor decision|2
1516729|NCT00377637|4978839|P2|Maintenance Phase|Sponsor decision|0
1516730|NCT00377637|4978840|P1|Maintenance Phase|Sponsor decision|0
1516731|NCT00377637|4978837|P4|Maintenance Phase|Withdrawal by Subject|3
1516732|NCT00377637|4978838|P3|Maintenance Phase|Withdrawal by Subject|3
1516733|NCT00377637|4978839|P2|Maintenance Phase|Withdrawal by Subject|0
1516734|NCT00377637|4978840|P1|Maintenance Phase|Withdrawal by Subject|0
1516735|NCT00377637|4978837|P4|Maintenance Phase|Lost to Follow-up|1
1516736|NCT00377637|4978838|P3|Maintenance Phase|Lost to Follow-up|3
1516737|NCT00377637|4978839|P2|Maintenance Phase|Lost to Follow-up|0
1516738|NCT00377637|4978840|P1|Maintenance Phase|Lost to Follow-up|0
1516739|NCT00377637|4978837|P4|Maintenance Phase|Physician Decision|4
1516740|NCT00377637|4978838|P3|Maintenance Phase|Physician Decision|5
1516741|NCT00377637|4978839|P2|Maintenance Phase|Physician Decision|0
1516742|NCT00377637|4978840|P1|Maintenance Phase|Physician Decision|0
1516743|NCT00377637|4978837|P4|Maintenance Phase|Adverse Event|43
1516744|NCT00377637|4978838|P3|Maintenance Phase|Adverse Event|29
1516745|NCT00377637|4978839|P2|Maintenance Phase|Adverse Event|0
1516746|NCT00377637|4978840|P1|Maintenance Phase|Adverse Event|0
1516747|NCT00377637|4978837|P4|Induction Phase|Reason for withdrawal is not noted|0
1516748|NCT00377637|4978838|P3|Induction Phase|Reason for withdrawal is not noted|0
1516749|NCT00377637|4978839|P2|Induction Phase|Reason for withdrawal is not noted|0
1516750|NCT00377637|4978840|P1|Induction Phase|Reason for withdrawal is not noted|2
1516751|NCT00377637|4978837|P4|Induction Phase|Non-Compliance|0
1516752|NCT00377637|4978838|P3|Induction Phase|Non-Compliance|0
1516753|NCT00377637|4978839|P2|Induction Phase|Non-Compliance|0
1516754|NCT00377637|4978840|P1|Induction Phase|Non-Compliance|1
1516755|NCT00377637|4978837|P4|Induction Phase|Sponsor decision|0
1516756|NCT00377637|4978838|P3|Induction Phase|Sponsor decision|0
1516757|NCT00377637|4978839|P2|Induction Phase|Sponsor decision|2
1516758|NCT00377637|4978840|P1|Induction Phase|Sponsor decision|1
1516759|NCT00377637|4978837|P4|Induction Phase|Physician Decision|0
1516760|NCT00377637|4978838|P3|Induction Phase|Physician Decision|0
1516761|NCT00377637|4978839|P2|Induction Phase|Physician Decision|1
1516762|NCT00377637|4978840|P1|Induction Phase|Physician Decision|3
1516763|NCT00377637|4978837|P4|Induction Phase|Withdrawal by Subject|0
1516764|NCT00377637|4978838|P3|Induction Phase|Withdrawal by Subject|0
1516765|NCT00377637|4978839|P2|Induction Phase|Withdrawal by Subject|6
1516766|NCT00377637|4978840|P1|Induction Phase|Withdrawal by Subject|5
1516767|NCT00377637|4978837|P4|Induction Phase|Death|0
1516768|NCT00377637|4978838|P3|Induction Phase|Death|0
1516769|NCT00377637|4978839|P2|Induction Phase|Death|3
1516770|NCT00377637|4978840|P1|Induction Phase|Death|1
1516771|NCT00377637|4978837|P4|Induction Phase|Lost to Follow-up|0
1516772|NCT00377637|4978838|P3|Induction Phase|Lost to Follow-up|0
1516773|NCT00377637|4978839|P2|Induction Phase|Lost to Follow-up|1
1516774|NCT00377637|4978840|P1|Induction Phase|Lost to Follow-up|2
1516775|NCT00377637|4978837|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
1516776|NCT00377637|4978838|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
1516777|NCT00377637|4978839|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
1516778|NCT00377637|4978840|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
1516779|NCT00377637|4978837|P4|Induction Phase|Deterioration/serum creatinine|0
1516780|NCT00377637|4978838|P3|Induction Phase|Deterioration/serum creatinine|0
1516781|NCT00377637|4978839|P2|Induction Phase|Deterioration/serum creatinine|0
1516782|NCT00377637|4978840|P1|Induction Phase|Deterioration/serum creatinine|2
1516783|NCT00377637|4978837|P4|Induction Phase|Adverse Event|0
1516784|NCT00377637|4978838|P3|Induction Phase|Adverse Event|0
1516785|NCT00377637|4978839|P2|Induction Phase|Adverse Event|21
1516786|NCT00377637|4978840|P1|Induction Phase|Adverse Event|12
1516787|NCT00377520|4978915|P1|Overall Study|Ineligible (Prior radiation)|1
1516788|NCT00377455|4978920|P1|Overall Study|Withdrawal by Subject|1
1516789|NCT00377429|4978928|P1|Overall Study|Patient non-compliance|1
1516790|NCT00377429|4978928|P1|Overall Study|Physician Decision|1
1516791|NCT00377429|4978928|P1|Overall Study|Adverse Event|8
1516792|NCT00377429|4978928|P1|Overall Study|Withdrawal by Subject|5
1516793|NCT00377403|4978939|P2|Overall Study|Unable to contact for telephone intervie|7
1516794|NCT00377403|4978940|P1|Overall Study|Unable to contact for telephone intervie|4
1516795|NCT00377364|4978948|P2|Overall Study|Withdrawal by Subject|0
1516796|NCT00377364|4978949|P1|Overall Study|Withdrawal by Subject|1
1516797|NCT00377364|4978948|P2|Overall Study|Lost to Follow-up|0
1516798|NCT00377364|4978949|P1|Overall Study|Lost to Follow-up|1
1516799|NCT00377312|4978975|P2|Overall Study|Adverse Event|1
1516800|NCT00377312|4978976|P1|Overall Study|Adverse Event|1
1516801|NCT00377299|4979008|P2|Overall Study|Withdrawal by Subject|4
1516802|NCT00377299|4979009|P1|Overall Study|Withdrawal by Subject|5
1516803|NCT00377299|4979008|P2|Overall Study|Adverse Event|1
1516804|NCT00377299|4979009|P1|Overall Study|Adverse Event|0
1516805|NCT00377299|4979008|P2|Overall Study|Lost to Follow-up|19
1516806|NCT00377299|4979009|P1|Overall Study|Lost to Follow-up|14
1516807|NCT00377260|4979025|P2|Overall Study|Withdrawal by Subject|4
1516808|NCT00377260|4979026|P1|Overall Study|Withdrawal by Subject|2
1516809|NCT00377260|4979025|P2|Overall Study|Lost to Follow-up|1
1516810|NCT00377260|4979026|P1|Overall Study|Lost to Follow-up|0
1516811|NCT00377234|4979080|P2|Overall Study|Not assigned|2
1516812|NCT00377234|4979081|P1|Overall Study|Not assigned|3
1516813|NCT00377234|4979080|P2|Overall Study|Administrative|1
1516814|NCT00377234|4979081|P1|Overall Study|Administrative|2
1516815|NCT00377234|4979080|P2|Overall Study|Lost to Follow-up|2
1516816|NCT00377234|4979081|P1|Overall Study|Lost to Follow-up|4
1516817|NCT00377234|4979080|P2|Overall Study|Withdrawal by Subject|9
1516818|NCT00377234|4979081|P1|Overall Study|Withdrawal by Subject|11
1516819|NCT00377234|4979080|P2|Overall Study|Adverse Event|17
1516820|NCT00377234|4979081|P1|Overall Study|Adverse Event|14
1516821|NCT00377156|4979099|P2|Overall Study|Other|2
1516822|NCT00377156|4979100|P1|Overall Study|Other|5
1516823|NCT00377156|4979099|P2|Overall Study|Disability or language problem|1
1516824|NCT00377156|4979100|P1|Overall Study|Disability or language problem|0
1516825|NCT00377156|4979099|P2|Overall Study|Ineligible|1
1516826|NCT00377156|4979100|P1|Overall Study|Ineligible|0
1516827|NCT00377156|4979099|P2|Overall Study|Refused testing|1
1516828|NCT00377156|4979100|P1|Overall Study|Refused testing|0
1516829|NCT00377156|4979099|P2|Overall Study|Cancellation|0
1516830|NCT00377156|4979100|P1|Overall Study|Cancellation|1
1516831|NCT00377156|4979099|P2|Overall Study|Had follow-up <90 d|6
1516832|NCT00377156|4979100|P1|Overall Study|Had follow-up <90 d|3
1516833|NCT00377156|4979099|P2|Overall Study|Withdrawal by Subject|24
1516834|NCT00377156|4979100|P1|Overall Study|Withdrawal by Subject|16
1516835|NCT00377156|4979099|P2|Overall Study|Death|19
1516836|NCT00377156|4979100|P1|Overall Study|Death|23
1516837|NCT00376961|4979114|P2|Maintenance|Ineligible|3
1516838|NCT00376961|4979115|P1|Maintenance|Ineligible|0
1516839|NCT00376961|4979114|P2|Maintenance|Progression/relapse|18
1516840|NCT00376961|4979115|P1|Maintenance|Progression/relapse|0
1516841|NCT00376961|4979114|P2|Maintenance|Refusal Unrelated to Adverse Event|1
1516842|NCT00376961|4979115|P1|Maintenance|Refusal Unrelated to Adverse Event|0
1516843|NCT00376961|4979114|P2|Maintenance|Adverse Event|1
1516844|NCT00376961|4979115|P1|Maintenance|Adverse Event|0
1516845|NCT00376961|4979114|P2|Initial Registration|Ineligible|0
1516846|NCT00376961|4979115|P1|Initial Registration|Ineligible|3
1516847|NCT00376961|4979114|P2|Initial Registration|Progression/relapse|0
1516848|NCT00376961|4979115|P1|Initial Registration|Progression/relapse|1
1516849|NCT00376961|4979114|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
1516850|NCT00376961|4979115|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
1516851|NCT00376961|4979114|P2|Initial Registration|Adverse Event|0
1516852|NCT00376961|4979115|P1|Initial Registration|Adverse Event|1
1516853|NCT00376688|4979181|P1|Overall Study|Death|1
1516854|NCT00376688|4979181|P1|Overall Study|Adverse Event|3
1516855|NCT00376675|4979187|P2|Overall Study|Other Reason|7
1516856|NCT00376675|4979188|P1|Overall Study|Other Reason|1
1516857|NCT00376675|4979187|P2|Overall Study|Adverse Event|5
1516858|NCT00376675|4979188|P1|Overall Study|Adverse Event|10
1516859|NCT00376675|4979187|P2|Overall Study|Withdrawal by Subject|2
1516860|NCT00376675|4979188|P1|Overall Study|Withdrawal by Subject|9
1516861|NCT00376532|4979237|P2|Overall Study|Lack sufficient blood sample|6
1516862|NCT00376532|4979238|P1|Overall Study|Lack sufficient blood sample|6
1516863|NCT00376506|4979248|P2|Overall Study|Death|2
1516864|NCT00376506|4979249|P1|Overall Study|Death|0
1516865|NCT00376259|4979280|P2|Overall Study|Patient request|0
1516866|NCT00376259|4979281|P1|Overall Study|Patient request|1
1516867|NCT00376259|4979280|P2|Overall Study|Sponsor request - study termination|21
1516868|NCT00376259|4979281|P1|Overall Study|Sponsor request - study termination|21
1516869|NCT00376220|4979295|P2|Overall Study|Withdrawal by Subject|2
1516870|NCT00376220|4979296|P1|Overall Study|Withdrawal by Subject|3
1516871|NCT00376220|4979295|P2|Overall Study|Lost to Follow-up|10
1516872|NCT00376220|4979296|P1|Overall Study|Lost to Follow-up|7
1516873|NCT00376168|4979304|P2|Overall Study|Pregnancy|0
1516874|NCT00376168|4979305|P1|Overall Study|Pregnancy|1
1516875|NCT00376168|4979304|P2|Overall Study|Adverse Event|1
1516876|NCT00376168|4979305|P1|Overall Study|Adverse Event|1
1516877|NCT00375934|4979346|P2|Overall Study|Physician Decision|1
1516878|NCT00375934|4979347|P1|Overall Study|Physician Decision|0
1516879|NCT00375934|4979346|P2|Overall Study|Lack of Efficacy|2
1516880|NCT00375934|4979347|P1|Overall Study|Lack of Efficacy|0
1516881|NCT00375934|4979346|P2|Overall Study|Withdrawal by Subject|2
1516882|NCT00375934|4979347|P1|Overall Study|Withdrawal by Subject|2
1516883|NCT00375934|4979346|P2|Overall Study|Adverse Event|1
1516884|NCT00375934|4979347|P1|Overall Study|Adverse Event|1
1516885|NCT00375752|4979375|P2|Overall Study|Administrative Problems|1
1516886|NCT00375752|4979376|P1|Overall Study|Administrative Problems|0
1516887|NCT00375752|4979375|P2|Overall Study|Protocol Violation|2
1516888|NCT00375752|4979376|P1|Overall Study|Protocol Violation|0
1516889|NCT00375752|4979375|P2|Overall Study|Abnormal Laboratory Value(s)|1
1516890|NCT00375752|4979376|P1|Overall Study|Abnormal Laboratory Value(s)|1
1516891|NCT00375752|4979375|P2|Overall Study|Withdrawal by Subject|1
1516892|NCT00375752|4979376|P1|Overall Study|Withdrawal by Subject|6
1516893|NCT00375752|4979375|P2|Overall Study|Adverse Event|6
1516894|NCT00375752|4979376|P1|Overall Study|Adverse Event|1
1516895|NCT00375752|4979375|P2|Overall Study|Lack of Efficacy|4
1516896|NCT00375752|4979376|P1|Overall Study|Lack of Efficacy|4
1516897|NCT00375674|4979407|P2|Overall Study|Enrolled but not treated|2
1516898|NCT00375674|4979408|P1|Overall Study|Enrolled but not treated|3
1516899|NCT00375674|4979407|P2|Overall Study|Lost to Follow-up|15
1516900|NCT00375674|4979408|P1|Overall Study|Lost to Follow-up|17
1516901|NCT00375674|4979407|P2|Overall Study|Participants refused further follow-up|30
1516902|NCT00375674|4979408|P1|Overall Study|Participants refused further follow-up|31
1516903|NCT00375674|4979407|P2|Overall Study|Death|76
1516904|NCT00375674|4979408|P1|Overall Study|Death|67
1516905|NCT00375674|4979407|P2|Overall Study|Not specified|18
1516906|NCT00375674|4979408|P1|Overall Study|Not specified|26
1516907|NCT00375609|4979437|P3|Overall Study|Neurologist Wanted Pt to start Plavix|0
1516908|NCT00375609|4979438|P2|Overall Study|Neurologist Wanted Pt to start Plavix|0
1516909|NCT00375609|4979439|P1|Overall Study|Neurologist Wanted Pt to start Plavix|1
1516910|NCT00375609|4979437|P3|Overall Study|Withdrawal by Subject|0
1516911|NCT00375609|4979438|P2|Overall Study|Withdrawal by Subject|4
1516912|NCT00375609|4979439|P1|Overall Study|Withdrawal by Subject|1
1516913|NCT00375609|4979437|P3|Overall Study|Physician Decision|1
1516914|NCT00375609|4979438|P2|Overall Study|Physician Decision|0
1516915|NCT00375609|4979439|P1|Overall Study|Physician Decision|0
1516916|NCT00375609|4979437|P3|Overall Study|Lost to Follow-up|0
1516917|NCT00375609|4979438|P2|Overall Study|Lost to Follow-up|0
1516918|NCT00375609|4979439|P1|Overall Study|Lost to Follow-up|1
1516919|NCT00375609|4979437|P3|Overall Study|Adverse Event|0
1516920|NCT00375609|4979438|P2|Overall Study|Adverse Event|3
1516921|NCT00375609|4979439|P1|Overall Study|Adverse Event|0
1516922|NCT00375609|4979437|P3|Overall Study|Did not receive treatment|0
1516923|NCT00375609|4979438|P2|Overall Study|Did not receive treatment|0
1516924|NCT00375609|4979439|P1|Overall Study|Did not receive treatment|1
1516925|NCT00375518|4979455|P2|Overall Study|Death|1
1516926|NCT00375518|4979456|P1|Overall Study|Death|0
1516927|NCT00375518|4979455|P2|Overall Study|Patient Not Treated|6
1516928|NCT00375518|4979456|P1|Overall Study|Patient Not Treated|6
1516929|NCT00375518|4979455|P2|Overall Study|Withdrawal by Subject|10
1516930|NCT00375518|4979456|P1|Overall Study|Withdrawal by Subject|2
1516931|NCT00375505|4979464|P2|Overall Study|Adverse Event|2
1516932|NCT00375505|4979465|P1|Overall Study|Adverse Event|1
1516933|NCT00375492|4979509|P2|Overall Study|Withdrawal by Subject|6
1516934|NCT00375492|4979510|P1|Overall Study|Withdrawal by Subject|6
1516935|NCT00375492|4979509|P2|Overall Study|Sponsor Decision|1
1516936|NCT00375492|4979510|P1|Overall Study|Sponsor Decision|0
1516937|NCT00375492|4979509|P2|Overall Study|Protocol Violation|3
1516938|NCT00375492|4979510|P1|Overall Study|Protocol Violation|6
1516939|NCT00375492|4979509|P2|Overall Study|Physician Decision|4
1516940|NCT00375492|4979510|P1|Overall Study|Physician Decision|0
1516941|NCT00375492|4979509|P2|Overall Study|Lost to Follow-up|5
1516942|NCT00375492|4979510|P1|Overall Study|Lost to Follow-up|10
1516943|NCT00375492|4979509|P2|Overall Study|Loss of Glucose Control|1
1516944|NCT00375492|4979510|P1|Overall Study|Loss of Glucose Control|0
1516945|NCT00375492|4979509|P2|Overall Study|Entry Criteria Not Met|1
1516946|NCT00375492|4979510|P1|Overall Study|Entry Criteria Not Met|0
1516947|NCT00375492|4979509|P2|Overall Study|Adverse Event|5
1516948|NCT00375492|4979510|P1|Overall Study|Adverse Event|4
1516949|NCT00375427|4979540|P2|Overall Study|Death|10
1516950|NCT00375427|4979541|P1|Overall Study|Death|11
1516951|NCT00375427|4979540|P2|Overall Study|Administrative reasons|1
1516952|NCT00375427|4979541|P1|Overall Study|Administrative reasons|0
1516953|NCT00375427|4979540|P2|Overall Study|Lost to Follow-up|1
1516954|NCT00375427|4979541|P1|Overall Study|Lost to Follow-up|1
1516955|NCT00375427|4979540|P2|Overall Study|Withdrawal by Subject|13
1516956|NCT00375427|4979541|P1|Overall Study|Withdrawal by Subject|9
1516957|NCT00375427|4979540|P2|Overall Study|Protocol Violation|8
1516958|NCT00375427|4979541|P1|Overall Study|Protocol Violation|10
1516959|NCT00375427|4979540|P2|Overall Study|Patient no longer requires study drug|7
1516960|NCT00375427|4979541|P1|Overall Study|Patient no longer requires study drug|3
1516961|NCT00375427|4979540|P2|Overall Study|Unsatisfactory therapeutic effect|4
1516962|NCT00375427|4979541|P1|Overall Study|Unsatisfactory therapeutic effect|4
1516963|NCT00375427|4979540|P2|Overall Study|Abnormal laboratory value(s)|2
1516964|NCT00375427|4979541|P1|Overall Study|Abnormal laboratory value(s)|1
1516965|NCT00375427|4979540|P2|Overall Study|Abnormal test procedure result(s)|1
1516966|NCT00375427|4979541|P1|Overall Study|Abnormal test procedure result(s)|0
1516967|NCT00375427|4979540|P2|Overall Study|Adverse Event|27
1516968|NCT00375427|4979541|P1|Overall Study|Adverse Event|21
1516969|NCT00375219|4979566|P3|Overall Study|Withdrawal by Subject|0
1516970|NCT00375219|4979567|P2|Overall Study|Withdrawal by Subject|0
1516971|NCT00375219|4979568|P1|Overall Study|Withdrawal by Subject|1
1516972|NCT00375219|4979566|P3|Overall Study|Cord blood transplantation|0
1516973|NCT00375219|4979567|P2|Overall Study|Cord blood transplantation|0
1516974|NCT00375219|4979568|P1|Overall Study|Cord blood transplantation|1
1516975|NCT00375219|4979566|P3|Overall Study|Allograft|0
1516976|NCT00375219|4979567|P2|Overall Study|Allograft|0
1516977|NCT00375219|4979568|P1|Overall Study|Allograft|2
1516978|NCT00375219|4979566|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
1516979|NCT00375219|4979567|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
1516980|NCT00375219|4979568|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
1516981|NCT00375219|4979566|P3|Overall Study|Hematologic resistance|0
1516982|NCT00375219|4979567|P2|Overall Study|Hematologic resistance|0
1516983|NCT00375219|4979568|P1|Overall Study|Hematologic resistance|1
1516984|NCT00375219|4979566|P3|Overall Study|Death|7
1516985|NCT00375219|4979567|P2|Overall Study|Death|3
1516986|NCT00375219|4979568|P1|Overall Study|Death|4
1516987|NCT00375219|4979566|P3|Overall Study|Disease progression|12
1516988|NCT00375219|4979567|P2|Overall Study|Disease progression|9
1516989|NCT00375219|4979568|P1|Overall Study|Disease progression|18
1516990|NCT00375219|4979566|P3|Overall Study|Lost to Follow-up|0
1516991|NCT00375219|4979567|P2|Overall Study|Lost to Follow-up|1
1516992|NCT00375219|4979568|P1|Overall Study|Lost to Follow-up|1
1516993|NCT00375219|4979566|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
1516994|NCT00375219|4979567|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
1516995|NCT00375219|4979568|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
1516996|NCT00375219|4979566|P3|Overall Study|Protocol Violation|1
1516997|NCT00375219|4979567|P2|Overall Study|Protocol Violation|0
1516998|NCT00375219|4979568|P1|Overall Study|Protocol Violation|1
1516999|NCT00375219|4979566|P3|Overall Study|Adverse Event|1
1517000|NCT00375219|4979567|P2|Overall Study|Adverse Event|2
1517001|NCT00375219|4979568|P1|Overall Study|Adverse Event|8
1517002|NCT00375219|4979566|P3|Overall Study|Failure to achieve a response|0
1517003|NCT00375219|4979567|P2|Overall Study|Failure to achieve a response|2
1517004|NCT00375219|4979568|P1|Overall Study|Failure to achieve a response|16
1517005|NCT00374907|4979636|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
1517006|NCT00374907|4979637|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
1517007|NCT00374907|4979636|P2|116-Week Short-term + Long-term Period|Adverse Event|2
1517008|NCT00374907|4979637|P1|116-Week Short-term + Long-term Period|Adverse Event|0
1517009|NCT00374907|4979636|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
1517010|NCT00374907|4979637|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
1517011|NCT00374907|4979636|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
1517012|NCT00374907|4979637|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
1517013|NCT00374907|4979636|P2|12-Week Short-term Period|Subject Withdrew Consent|1
1517014|NCT00374907|4979637|P1|12-Week Short-term Period|Subject Withdrew Consent|3
1517015|NCT00374868|4979649|P1|Overall Study|Other - Not Specified|1
1517016|NCT00374868|4979649|P1|Overall Study|Death|2
1517017|NCT00374868|4979649|P1|Overall Study|Lost to Follow-up|1
1517018|NCT00374868|4979649|P1|Overall Study|Physician Decision|13
1517019|NCT00374868|4979649|P1|Overall Study|Progressive Disease|7
1517020|NCT00374868|4979649|P1|Overall Study|Adverse Event|12
1517021|NCT00374556|4979713|P2|Overall Study|excluded at baseline due to medical cond|1
1517022|NCT00374556|4979714|P1|Overall Study|excluded at baseline due to medical cond|0
1517023|NCT00374556|4979713|P2|Overall Study|Lost to Follow-up|0
1517024|NCT00374556|4979714|P1|Overall Study|Lost to Follow-up|1
1517025|NCT00374452|4979775|P2|Overall Study|Withdrawal by Subject|2
1517026|NCT00374452|4979776|P1|Overall Study|Withdrawal by Subject|0
1517027|NCT00374452|4979775|P2|Overall Study|Left clinic after intervention started|1
1517028|NCT00374452|4979776|P1|Overall Study|Left clinic after intervention started|1
1517029|NCT00374452|4979775|P2|Overall Study|Change in job role before intervention|1
1517030|NCT00374452|4979776|P1|Overall Study|Change in job role before intervention|0
1517031|NCT00374452|4979775|P2|Overall Study|Left clinic before intervention started|1
1517032|NCT00374452|4979776|P1|Overall Study|Left clinic before intervention started|4
1517033|NCT00374322|4979789|P2|Overall Study|Did Not Receive Study Medication|6
1517034|NCT00374322|4979790|P1|Overall Study|Did Not Receive Study Medication|8
1517035|NCT00374322|4979789|P2|Overall Study|Withdrew Consent During Follow-up|5
1517036|NCT00374322|4979790|P1|Overall Study|Withdrew Consent During Follow-up|0
1517037|NCT00374322|4979789|P2|Overall Study|Noncompliance with Study Requirements|1
1517038|NCT00374322|4979790|P1|Overall Study|Noncompliance with Study Requirements|0
1517039|NCT00374322|4979789|P2|Overall Study|Started Another Chemotherapy Regimen|1
1517040|NCT00374322|4979790|P1|Overall Study|Started Another Chemotherapy Regimen|0
1517041|NCT00374322|4979789|P2|Overall Study|Participant Changed Physician|0
1517042|NCT00374322|4979790|P1|Overall Study|Participant Changed Physician|1
1517043|NCT00374322|4979789|P2|Overall Study|Site Closed|2
1517044|NCT00374322|4979790|P1|Overall Study|Site Closed|2
1517045|NCT00374322|4979789|P2|Overall Study|Severe Toxicity|0
1517046|NCT00374322|4979790|P1|Overall Study|Severe Toxicity|1
1517047|NCT00374322|4979789|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
1517048|NCT00374322|4979790|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
1517049|NCT00374322|4979789|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
1517050|NCT00374322|4979790|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
1517051|NCT00374322|4979789|P2|Overall Study|Sponsor Decision|3
1517052|NCT00374322|4979790|P1|Overall Study|Sponsor Decision|2
1517053|NCT00374322|4979789|P2|Overall Study|Par. Consented to Survival FU Only|1
1517054|NCT00374322|4979790|P1|Overall Study|Par. Consented to Survival FU Only|3
1517055|NCT00374322|4979789|P2|Overall Study|Physician Decision|32
1517056|NCT00374322|4979790|P1|Overall Study|Physician Decision|36
1517057|NCT00374322|4979789|P2|Overall Study|Sponsor Terminated Study|990
1517058|NCT00374322|4979790|P1|Overall Study|Sponsor Terminated Study|866
1517059|NCT00374322|4979789|P2|Overall Study|Withdrawal by Subject|167
1517060|NCT00374322|4979790|P1|Overall Study|Withdrawal by Subject|235
1517061|NCT00374322|4979789|P2|Overall Study|Protocol Violation|3
1517062|NCT00374322|4979790|P1|Overall Study|Protocol Violation|8
1517063|NCT00374322|4979789|P2|Overall Study|Lost to Follow-up|90
1517064|NCT00374322|4979790|P1|Overall Study|Lost to Follow-up|92
1517065|NCT00374140|4979881|P1|Overall Study|Protocol Violation|1
1517066|NCT00374140|4979881|P1|Overall Study|Lost to Follow-up|1
1517067|NCT00374127|4979888|P1|Overall Study|Pregnancy|1
1517068|NCT00374127|4979888|P1|Overall Study|Protocol Violation|5
1517069|NCT00374127|4979888|P1|Overall Study|Blood could not be drawn.|2
1517070|NCT00374127|4979888|P1|Overall Study|Did not inhale during smoking procedure.|3
1517071|NCT00373958|4979937|P2|Toddler Dose|Withdrawn after infant series|25
1517072|NCT00373958|4979938|P1|Toddler Dose|Withdrawn after infant series|22
1517073|NCT00373958|4979937|P2|Toddler Dose|Protocol Violation|1
1517074|NCT00373958|4979938|P1|Toddler Dose|Protocol Violation|0
1517075|NCT00373958|4979937|P2|Toddler Dose|Failed to return|2
1517076|NCT00373958|4979938|P1|Toddler Dose|Failed to return|1
1517077|NCT00373958|4979937|P2|Toddler Dose|Withdrawal by Subject|2
1517078|NCT00373958|4979938|P1|Toddler Dose|Withdrawal by Subject|2
1517079|NCT00373958|4979937|P2|Toddler Dose|Lost to Follow-up|8
1517080|NCT00373958|4979938|P1|Toddler Dose|Lost to Follow-up|5
1517081|NCT00373958|4979937|P2|Infant Series|Physician Decision|1
1517082|NCT00373958|4979938|P1|Infant Series|Physician Decision|1
1517083|NCT00373958|4979937|P2|Infant Series|Adverse Event|1
1517084|NCT00373958|4979938|P1|Infant Series|Adverse Event|3
1517085|NCT00373958|4979937|P2|Infant Series|Consent was not received|0
1517086|NCT00373958|4979938|P1|Infant Series|Consent was not received|1
1517087|NCT00373958|4979937|P2|Infant Series|Child relocated|0
1517088|NCT00373958|4979938|P1|Infant Series|Child relocated|1
1517089|NCT00373958|4979937|P2|Infant Series|Lost Kaiser coverage|0
1517090|NCT00373958|4979938|P1|Infant Series|Lost Kaiser coverage|4
1517091|NCT00373958|4979937|P2|Infant Series|Protocol Violation|7
1517092|NCT00373958|4979938|P1|Infant Series|Protocol Violation|3
1517093|NCT00373958|4979937|P2|Infant Series|Lost to Follow-up|5
1517094|NCT00373958|4979938|P1|Infant Series|Lost to Follow-up|6
1517095|NCT00373958|4979937|P2|Infant Series|Failed to return|13
1517096|NCT00373958|4979938|P1|Infant Series|Failed to return|8
1517097|NCT00373958|4979937|P2|Infant Series|Withdrawal by Subject|15
1517098|NCT00373958|4979938|P1|Infant Series|Withdrawal by Subject|13
1517099|NCT00373880|4979986|P1|Overall Study|Protocol Violation|14
1517100|NCT00373880|4979986|P1|Overall Study|Arrested|1
1517101|NCT00373880|4979986|P1|Overall Study|Physician Decision|3
1517102|NCT00373685|4980031|P2|Overall Study|Randomized, not treated|77
1517103|NCT00373685|4980032|P1|Overall Study|Randomized, not treated|51
1517104|NCT00373685|4980031|P2|Overall Study|Final Status Unknown|4
1517105|NCT00373685|4980032|P1|Overall Study|Final Status Unknown|12
1517106|NCT00373685|4980031|P2|Overall Study|Protocol Violation|182
1517107|NCT00373685|4980032|P1|Overall Study|Protocol Violation|191
1517108|NCT00373685|4980031|P2|Overall Study|Other|146
1517109|NCT00373685|4980032|P1|Overall Study|Other|149
1517110|NCT00373685|4980031|P2|Overall Study|No longer willing to participate|352
1517111|NCT00373685|4980032|P1|Overall Study|No longer willing to participate|337
1517112|NCT00373685|4980031|P2|Overall Study|Lost to follow up|103
1517113|NCT00373685|4980032|P1|Overall Study|Lost to follow up|83
1517114|NCT00373685|4980031|P2|Overall Study|Did not meet entrance criteria|184
1517115|NCT00373685|4980032|P1|Overall Study|Did not meet entrance criteria|167
1517116|NCT00373685|4980031|P2|Overall Study|Insufficient clinical response|119
1517117|NCT00373685|4980032|P1|Overall Study|Insufficient clinical response|169
1517118|NCT00373685|4980031|P2|Overall Study|Adverse Event|253
1517119|NCT00373685|4980032|P1|Overall Study|Adverse Event|278
1517120|NCT00373685|4980031|P2|Overall Study|Death|1
1517121|NCT00373685|4980032|P1|Overall Study|Death|2
1517122|NCT00373529|4980066|P1|Overall Study|Consent violation|1
1517123|NCT00373529|4980066|P1|Overall Study|Failed independent confirmation of AML|3
1517124|NCT00373529|4980066|P1|Overall Study|Not specified|8
1517125|NCT00373529|4980066|P1|Overall Study|Need for treatment prohibited by study|1
1517126|NCT00373529|4980066|P1|Overall Study|Death|16
1517127|NCT00373529|4980066|P1|Overall Study|Disease recurrence|10
1517128|NCT00373529|4980066|P1|Overall Study|Treatment failure|36
1517129|NCT00373529|4980066|P1|Overall Study|Adverse Event|7
1517130|NCT00373529|4980066|P1|Overall Study|Withdrawal by Subject|7
1517131|NCT00373529|4980066|P1|Overall Study|Physician Decision|19
1517132|NCT00373490|4980078|P2|Overall Study|Withdrawal by Subject|1
1517133|NCT00373490|4980079|P1|Overall Study|Withdrawal by Subject|0
1517134|NCT00373490|4980078|P2|Overall Study|Lack of Efficacy|4
1517135|NCT00373490|4980079|P1|Overall Study|Lack of Efficacy|9
1517136|NCT00373490|4980078|P2|Overall Study|Adverse Event|1
1517137|NCT00373490|4980079|P1|Overall Study|Adverse Event|0
1517138|NCT00373425|4980102|P5|Overall Study|Death|0
1517139|NCT00373425|4980103|P4|Overall Study|Death|1
1517140|NCT00373425|4980104|P3|Overall Study|Death|3
1517141|NCT00373425|4980105|P2|Overall Study|Death|0
1517142|NCT00373425|4980106|P1|Overall Study|Death|7
1517143|NCT00373425|4980102|P5|Overall Study|Medical/ethical/noncompliance reason|5
1517144|NCT00373425|4980103|P4|Overall Study|Medical/ethical/noncompliance reason|2
1517145|NCT00373425|4980104|P3|Overall Study|Medical/ethical/noncompliance reason|10
1517146|NCT00373425|4980105|P2|Overall Study|Medical/ethical/noncompliance reason|9
1517147|NCT00373425|4980106|P1|Overall Study|Medical/ethical/noncompliance reason|21
1517148|NCT00373425|4980102|P5|Overall Study|Patient request|7
1517149|NCT00373425|4980103|P4|Overall Study|Patient request|6
1517150|NCT00373425|4980104|P3|Overall Study|Patient request|43
1517151|NCT00373425|4980105|P2|Overall Study|Patient request|18
1517152|NCT00373425|4980106|P1|Overall Study|Patient request|35
1517153|NCT00373425|4980102|P5|Overall Study|Adverse Event|34
1517154|NCT00373425|4980103|P4|Overall Study|Adverse Event|0
1517155|NCT00373425|4980104|P3|Overall Study|Adverse Event|59
1517156|NCT00373425|4980105|P2|Overall Study|Adverse Event|22
1517157|NCT00373425|4980106|P1|Overall Study|Adverse Event|191
1517158|NCT00373425|4980102|P5|Overall Study|Relapse of NSCLC|26
1517159|NCT00373425|4980103|P4|Overall Study|Relapse of NSCLC|2
1517160|NCT00373425|4980104|P3|Overall Study|Relapse of NSCLC|19
1517161|NCT00373425|4980105|P2|Overall Study|Relapse of NSCLC|104
1517162|NCT00373425|4980106|P1|Overall Study|Relapse of NSCLC|116
1517163|NCT00373295|4980188|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
1517164|NCT00373295|4980189|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
1517165|NCT00373295|4980190|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
1517166|NCT00373295|4980191|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
1517167|NCT00373295|4980192|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
1517168|NCT00373295|4980193|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
1517169|NCT00373256|4980214|P2|Overall Study|Study Terminated by Sponsor|13
1517170|NCT00373256|4980215|P1|Overall Study|Study Terminated by Sponsor|41
1517171|NCT00373256|4980214|P2|Overall Study|Protocol Violation|2
1517172|NCT00373256|4980215|P1|Overall Study|Protocol Violation|0
1517173|NCT00373256|4980214|P2|Overall Study|Other|107
1517174|NCT00373256|4980215|P1|Overall Study|Other|73
1517175|NCT00373256|4980214|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
1517176|NCT00373256|4980215|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
1517177|NCT00373256|4980214|P2|Overall Study|Objective Progression or Relapse|104
1517178|NCT00373256|4980215|P1|Overall Study|Objective Progression or Relapse|111
1517179|NCT00373256|4980214|P2|Overall Study|Death|8
1517180|NCT00373256|4980215|P1|Overall Study|Death|9
1517181|NCT00373256|4980214|P2|Overall Study|Lost to Follow-up|1
1517182|NCT00373256|4980215|P1|Overall Study|Lost to Follow-up|2
1517183|NCT00373256|4980214|P2|Overall Study|Adverse Event (AE)|5
1517184|NCT00373256|4980215|P1|Overall Study|Adverse Event (AE)|1
1517185|NCT00373113|4980241|P2|Overall Study|Withdrawal by Subject|15
1517186|NCT00373113|4980242|P1|Overall Study|Withdrawal by Subject|10
1517187|NCT00373113|4980241|P2|Overall Study|Protocol Violation|1
1517188|NCT00373113|4980242|P1|Overall Study|Protocol Violation|5
1517189|NCT00373113|4980241|P2|Overall Study|Other|17
1517190|NCT00373113|4980242|P1|Overall Study|Other|14
1517191|NCT00373113|4980241|P2|Overall Study|Objective progression or relapse|169
1517192|NCT00373113|4980242|P1|Overall Study|Objective progression or relapse|150
1517193|NCT00373113|4980241|P2|Overall Study|Lost to Follow-up|3
1517194|NCT00373113|4980242|P1|Overall Study|Lost to Follow-up|1
1517195|NCT00373113|4980241|P2|Overall Study|Global deterioration of health status|7
1517196|NCT00373113|4980242|P1|Overall Study|Global deterioration of health status|10
1517197|NCT00373113|4980241|P2|Overall Study|Study terminated by sponsor|1
1517198|NCT00373113|4980242|P1|Overall Study|Study terminated by sponsor|9
1517199|NCT00373113|4980241|P2|Overall Study|Adverse Event|24
1517200|NCT00373113|4980242|P1|Overall Study|Adverse Event|38
1517201|NCT00373113|4980241|P2|Overall Study|Death|7
1517202|NCT00373113|4980242|P1|Overall Study|Death|1
1517203|NCT00372996|4980264|P4|Overall Study|Not specified|7
1517204|NCT00372996|4980265|P3|Overall Study|Not specified|7
1517205|NCT00372996|4980266|P2|Overall Study|Not specified|2
1517206|NCT00372996|4980267|P1|Overall Study|Not specified|10
1517207|NCT00372996|4980264|P4|Overall Study|Study Terminated by Sponsor|0
1517208|NCT00372996|4980265|P3|Overall Study|Study Terminated by Sponsor|4
1517209|NCT00372996|4980266|P2|Overall Study|Study Terminated by Sponsor|0
1517210|NCT00372996|4980267|P1|Overall Study|Study Terminated by Sponsor|4
1517211|NCT00372996|4980264|P4|Overall Study|Withdrawal by Subject|5
1517212|NCT00372996|4980265|P3|Overall Study|Withdrawal by Subject|9
1517213|NCT00372996|4980266|P2|Overall Study|Withdrawal by Subject|6
1517214|NCT00372996|4980267|P1|Overall Study|Withdrawal by Subject|12
1517215|NCT00372996|4980264|P4|Overall Study|Lost to Follow-up|1
1517216|NCT00372996|4980265|P3|Overall Study|Lost to Follow-up|0
1517217|NCT00372996|4980266|P2|Overall Study|Lost to Follow-up|2
1517218|NCT00372996|4980267|P1|Overall Study|Lost to Follow-up|0
1517219|NCT00372996|4980264|P4|Overall Study|Death|7
1517220|NCT00372996|4980265|P3|Overall Study|Death|8
1517221|NCT00372996|4980266|P2|Overall Study|Death|4
1517222|NCT00372996|4980267|P1|Overall Study|Death|11
1517223|NCT00372775|4980352|P1|Overall Study|Not Treated|2
1517224|NCT00372775|4980352|P1|Overall Study|Not specified|1
1517225|NCT00372775|4980352|P1|Overall Study|Withdrawal by Subject|1
1517226|NCT00372775|4980352|P1|Overall Study|Global deterioration of health status|6
1517227|NCT00372775|4980352|P1|Overall Study|Objective progression or relapse|30
1517228|NCT00372775|4980352|P1|Overall Study|Death|15
1517229|NCT00372775|4980352|P1|Overall Study|Adverse Event|8
1517230|NCT00372697|4980374|P2|Overall Study|Protocol Violation|1
1517231|NCT00372697|4980375|P1|Overall Study|Protocol Violation|1
1517232|NCT00372619|4980400|P7|Overall Study|Inevaluable|0
1517233|NCT00372619|4980401|P6|Overall Study|Inevaluable|1
1517234|NCT00372619|4980402|P5|Overall Study|Inevaluable|0
1517235|NCT00372619|4980403|P4|Overall Study|Inevaluable|0
1517236|NCT00372619|4980404|P3|Overall Study|Inevaluable|0
1517237|NCT00372619|4980405|P2|Overall Study|Inevaluable|0
1517238|NCT00372619|4980406|P1|Overall Study|Inevaluable|0
1517239|NCT00372619|4980400|P7|Overall Study|Ineligible|0
1517240|NCT00372619|4980401|P6|Overall Study|Ineligible|2
1517241|NCT00372619|4980402|P5|Overall Study|Ineligible|0
1517242|NCT00372619|4980403|P4|Overall Study|Ineligible|0
1517243|NCT00372619|4980404|P3|Overall Study|Ineligible|0
1517244|NCT00372619|4980405|P2|Overall Study|Ineligible|0
1517245|NCT00372619|4980406|P1|Overall Study|Ineligible|0
1517246|NCT00372593|4980439|P3|Overall Study|Ineligible|1
1517247|NCT00372593|4980440|P2|Overall Study|Ineligible|21
1517248|NCT00372593|4980441|P1|Overall Study|Ineligible|20
1517249|NCT00372593|4980439|P3|Overall Study|Physician Decision|0
1517250|NCT00372593|4980440|P2|Overall Study|Physician Decision|41
1517251|NCT00372593|4980441|P1|Overall Study|Physician Decision|42
1517252|NCT00372593|4980439|P3|Overall Study|Lost to Follow-up|0
1517253|NCT00372593|4980440|P2|Overall Study|Lost to Follow-up|0
1517254|NCT00372593|4980441|P1|Overall Study|Lost to Follow-up|1
1517255|NCT00372593|4980439|P3|Overall Study|Lack of Efficacy|2
1517256|NCT00372593|4980440|P2|Overall Study|Lack of Efficacy|71
1517257|NCT00372593|4980441|P1|Overall Study|Lack of Efficacy|82
1517258|NCT00372593|4980439|P3|Overall Study|Death|1
1517259|NCT00372593|4980440|P2|Overall Study|Death|20
1517260|NCT00372593|4980441|P1|Overall Study|Death|16
1517261|NCT00372593|4980439|P3|Overall Study|Adverse Event|0
1517262|NCT00372593|4980440|P2|Overall Study|Adverse Event|45
1517263|NCT00372593|4980441|P1|Overall Study|Adverse Event|43
1517264|NCT00372567|4980470|P3|Phase 3 Study|study terminated by sponsor|5
1517265|NCT00372567|4980471|P2|Phase 3 Study|study terminated by sponsor|8
1517266|NCT00372567|4980472|P1|Phase 3 Study|study terminated by sponsor|13
1517267|NCT00372567|4980470|P3|Phase 3 Study|not specified|1
1517268|NCT00372567|4980471|P2|Phase 3 Study|not specified|2
1517269|NCT00372567|4980472|P1|Phase 3 Study|not specified|2
1517270|NCT00372567|4980470|P3|Phase 3 Study|Global deterioration of health status|0
1517271|NCT00372567|4980471|P2|Phase 3 Study|Global deterioration of health status|1
1517272|NCT00372567|4980472|P1|Phase 3 Study|Global deterioration of health status|0
1517273|NCT00372567|4980470|P3|Phase 3 Study|Objective progression or relapse|4
1517274|NCT00372567|4980471|P2|Phase 3 Study|Objective progression or relapse|13
1517275|NCT00372567|4980472|P1|Phase 3 Study|Objective progression or relapse|10
1517276|NCT00372567|4980470|P3|Phase 3 Study|Protocol Violation|1
1517277|NCT00372567|4980471|P2|Phase 3 Study|Protocol Violation|0
1517278|NCT00372567|4980472|P1|Phase 3 Study|Protocol Violation|0
1517279|NCT00372567|4980470|P3|Phase 3 Study|Death|0
1517280|NCT00372567|4980471|P2|Phase 3 Study|Death|1
1517281|NCT00372567|4980472|P1|Phase 3 Study|Death|1
1517282|NCT00372567|4980470|P3|Phase 3 Study|Adverse Event|1
1517283|NCT00372567|4980471|P2|Phase 3 Study|Adverse Event|1
1517284|NCT00372567|4980472|P1|Phase 3 Study|Adverse Event|5
1517285|NCT00372528|4980500|P1|Overall Study|Other|1
1517286|NCT00372528|4980500|P1|Overall Study|Study Terminated by Sponsor|18
1517287|NCT00372528|4980500|P1|Overall Study|Adverse Event|1
1517288|NCT00372528|4980500|P1|Overall Study|Lack of Efficacy|1
1517289|NCT00372489|4980505|P1|Overall Study|Sponsor Decision to Terminate Study|41
1517290|NCT00372489|4980505|P1|Overall Study|Renal transplant|6
1517291|NCT00372489|4980505|P1|Overall Study|Patient Relocation|2
1517292|NCT00372489|4980505|P1|Overall Study|Withdrawal by Subject|5
1517293|NCT00372489|4980505|P1|Overall Study|Physician Decision|3
1517294|NCT00372489|4980505|P1|Overall Study|Lost to Follow-up|3
1517295|NCT00372489|4980505|P1|Overall Study|Lack of Efficacy|1
1517296|NCT00372489|4980505|P1|Overall Study|Adverse Event|18
1517297|NCT00372424|4980509|P1|Overall Study|Enrolled, Not Treated|1
1517298|NCT00372424|4980509|P1|Overall Study|Other|7
1517299|NCT00372424|4980509|P1|Overall Study|Objective Progression or Relapse|14
1517300|NCT00372424|4980509|P1|Overall Study|Death|1
1517301|NCT00372424|4980509|P1|Overall Study|Withdrawal by Subject|1
1517302|NCT00372424|4980509|P1|Overall Study|Adverse Event|2
1517303|NCT00372411|4980523|P3|Overall Study|Adverse Event|0
1517304|NCT00372411|4980524|P2|Overall Study|Adverse Event|1
1517305|NCT00372411|4980525|P1|Overall Study|Adverse Event|1
1517306|NCT00372411|4980523|P3|Overall Study|Lost to Follow-up|1
1517307|NCT00372411|4980524|P2|Overall Study|Lost to Follow-up|1
1517308|NCT00372411|4980525|P1|Overall Study|Lost to Follow-up|1
1517309|NCT00372411|4980523|P3|Overall Study|Death|1
1517310|NCT00372411|4980524|P2|Overall Study|Death|2
1517311|NCT00372411|4980525|P1|Overall Study|Death|0
1517312|NCT00372411|4980523|P3|Overall Study|Withdrawal by Subject|1
1517313|NCT00372411|4980524|P2|Overall Study|Withdrawal by Subject|4
1517314|NCT00372411|4980525|P1|Overall Study|Withdrawal by Subject|3
1517315|NCT00372385|4980549|P4|Overall Study|Virologic Stopping Rule|0
1517316|NCT00372385|4980550|P3|Overall Study|Virologic Stopping Rule|0
1517317|NCT00372385|4980551|P2|Overall Study|Virologic Stopping Rule|0
1517318|NCT00372385|4980552|P1|Overall Study|Virologic Stopping Rule|17
1517319|NCT00372385|4980549|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
1517320|NCT00372385|4980550|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
1517321|NCT00372385|4980551|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
1517322|NCT00372385|4980552|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
1517323|NCT00372385|4980549|P4|Overall Study|No Response|0
1517324|NCT00372385|4980550|P3|Overall Study|No Response|0
1517325|NCT00372385|4980551|P2|Overall Study|No Response|1
1517326|NCT00372385|4980552|P1|Overall Study|No Response|1
1517327|NCT00372385|4980549|P4|Overall Study|Refusal of Treatment|0
1517328|NCT00372385|4980550|P3|Overall Study|Refusal of Treatment|0
1517329|NCT00372385|4980551|P2|Overall Study|Refusal of Treatment|6
1517330|NCT00372385|4980552|P1|Overall Study|Refusal of Treatment|3
1517331|NCT00372385|4980549|P4|Overall Study|Withdrawal by Subject|0
1517332|NCT00372385|4980550|P3|Overall Study|Withdrawal by Subject|0
1517333|NCT00372385|4980551|P2|Overall Study|Withdrawal by Subject|1
1517334|NCT00372385|4980552|P1|Overall Study|Withdrawal by Subject|2
1517335|NCT00372385|4980549|P4|Overall Study|Lost to Follow-up|0
1517336|NCT00372385|4980550|P3|Overall Study|Lost to Follow-up|0
1517337|NCT00372385|4980551|P2|Overall Study|Lost to Follow-up|0
1517338|NCT00372385|4980552|P1|Overall Study|Lost to Follow-up|2
1517339|NCT00372385|4980549|P4|Overall Study|Physician Decision|0
1517340|NCT00372385|4980550|P3|Overall Study|Physician Decision|0
1517341|NCT00372385|4980551|P2|Overall Study|Physician Decision|0
1517342|NCT00372385|4980552|P1|Overall Study|Physician Decision|1
1517343|NCT00372385|4980549|P4|Overall Study|Noncompliance|1
1517344|NCT00372385|4980550|P3|Overall Study|Noncompliance|1
1517345|NCT00372385|4980551|P2|Overall Study|Noncompliance|1
1517346|NCT00372385|4980552|P1|Overall Study|Noncompliance|0
1517347|NCT00372385|4980549|P4|Overall Study|Adverse Event|7
1517348|NCT00372385|4980550|P3|Overall Study|Adverse Event|9
1517349|NCT00372385|4980551|P2|Overall Study|Adverse Event|11
1517350|NCT00372385|4980552|P1|Overall Study|Adverse Event|6
1517351|NCT00372190|4980581|P2|Overall Study|Lost to Follow-up|1
1517352|NCT00372190|4980582|P1|Overall Study|Lost to Follow-up|3
1517353|NCT00372112|4980598|P4|Overall Study|Other-protocol violation|0
1517354|NCT00372112|4980599|P3|Overall Study|Other-protocol violation|1
1517355|NCT00372112|4980600|P2|Overall Study|Other-protocol violation|0
1517356|NCT00372112|4980601|P1|Overall Study|Other-protocol violation|0
1517357|NCT00372112|4980598|P4|Overall Study|Hepatitis B|0
1517358|NCT00372112|4980599|P3|Overall Study|Hepatitis B|0
1517359|NCT00372112|4980600|P2|Overall Study|Hepatitis B|0
1517360|NCT00372112|4980601|P1|Overall Study|Hepatitis B|1
1517361|NCT00372112|4980598|P4|Overall Study|PR >240 at Visit 3|1
1517362|NCT00372112|4980599|P3|Overall Study|PR >240 at Visit 3|0
1517363|NCT00372112|4980600|P2|Overall Study|PR >240 at Visit 3|0
1517364|NCT00372112|4980601|P1|Overall Study|PR >240 at Visit 3|0
1517365|NCT00372112|4980598|P4|Overall Study|Exacerbation|1
1517366|NCT00372112|4980599|P3|Overall Study|Exacerbation|0
1517367|NCT00372112|4980600|P2|Overall Study|Exacerbation|0
1517368|NCT00372112|4980601|P1|Overall Study|Exacerbation|0
1517369|NCT00372112|4980598|P4|Overall Study|Withdrawal by Subject|1
1517370|NCT00372112|4980599|P3|Overall Study|Withdrawal by Subject|2
1517371|NCT00372112|4980600|P2|Overall Study|Withdrawal by Subject|0
1517372|NCT00372112|4980601|P1|Overall Study|Withdrawal by Subject|0
1517373|NCT00372112|4980598|P4|Overall Study|Adverse Event|1
1517374|NCT00372112|4980599|P3|Overall Study|Adverse Event|1
1517375|NCT00372112|4980600|P2|Overall Study|Adverse Event|1
1517376|NCT00372112|4980601|P1|Overall Study|Adverse Event|0
1517377|NCT00372060|4980732|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
1517378|NCT00372060|4980733|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
1517379|NCT00372060|4980732|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
1517380|NCT00372060|4980733|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
1517381|NCT00372060|4980732|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
1517382|NCT00372060|4980733|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
1517383|NCT00372060|4980732|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
1517384|NCT00372060|4980733|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
1517385|NCT00372060|4980732|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
1517386|NCT00372060|4980733|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
1517387|NCT00372060|4980732|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
1517388|NCT00372060|4980733|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
1517389|NCT00371865|4980748|P2|Overall Study|Withdrawal by Subject|10
1517390|NCT00371865|4980749|P1|Overall Study|Withdrawal by Subject|12
1517391|NCT00371865|4980748|P2|Overall Study|Protocol Violation|2
1517392|NCT00371865|4980749|P1|Overall Study|Protocol Violation|3
1517393|NCT00371865|4980748|P2|Overall Study|Lack of Efficacy|2
1517394|NCT00371865|4980749|P1|Overall Study|Lack of Efficacy|0
1517395|NCT00371839|4980766|P3|Overall Study|Lost to Follow-up|2
1517396|NCT00371839|4980767|P2|Overall Study|Lost to Follow-up|3
1517397|NCT00371839|4980768|P1|Overall Study|Lost to Follow-up|6
1517398|NCT00371839|4980766|P3|Overall Study|Withdrawal by Subject|0
1517399|NCT00371839|4980767|P2|Overall Study|Withdrawal by Subject|4
1517400|NCT00371839|4980768|P1|Overall Study|Withdrawal by Subject|7
1517401|NCT00371839|4980766|P3|Overall Study|Death|0
1517402|NCT00371839|4980767|P2|Overall Study|Death|0
1517403|NCT00371839|4980768|P1|Overall Study|Death|4
1517404|NCT00371826|4980777|P3|Extension Phase (24 Months)|Administrative problems|2
1517405|NCT00371826|4980778|P2|Extension Phase (24 Months)|Administrative problems|0
1517406|NCT00371826|4980779|P1|Extension Phase (24 Months)|Administrative problems|0
1517407|NCT00371826|4980777|P3|Extension Phase (24 Months)|Subject withdrew consent|0
1517408|NCT00371826|4980778|P2|Extension Phase (24 Months)|Subject withdrew consent|2
1517409|NCT00371826|4980779|P1|Extension Phase (24 Months)|Subject withdrew consent|1
1517410|NCT00371826|4980777|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
1517411|NCT00371826|4980778|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
1517412|NCT00371826|4980779|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
1517413|NCT00371826|4980777|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
1517414|NCT00371826|4980778|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
1517415|NCT00371826|4980779|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
1517416|NCT00371826|4980777|P3|Extension Phase (24 Months)|Adverse Event|0
1517417|NCT00371826|4980778|P2|Extension Phase (24 Months)|Adverse Event|5
1517418|NCT00371826|4980779|P1|Extension Phase (24 Months)|Adverse Event|4
1517419|NCT00371826|4980777|P3|Core Phase (12 Months)|Graft Loss|0
1517420|NCT00371826|4980778|P2|Core Phase (12 Months)|Graft Loss|1
1517421|NCT00371826|4980779|P1|Core Phase (12 Months)|Graft Loss|0
1517422|NCT00371826|4980777|P3|Core Phase (12 Months)|Administrative problems|8
1517423|NCT00371826|4980778|P2|Core Phase (12 Months)|Administrative problems|0
1517424|NCT00371826|4980779|P1|Core Phase (12 Months)|Administrative problems|1
1517425|NCT00371826|4980777|P3|Core Phase (12 Months)|Subject withdrew consent|3
1517426|NCT00371826|4980778|P2|Core Phase (12 Months)|Subject withdrew consent|0
1517427|NCT00371826|4980779|P1|Core Phase (12 Months)|Subject withdrew consent|0
1517428|NCT00371826|4980777|P3|Core Phase (12 Months)|Protocol Violation|1
1517429|NCT00371826|4980778|P2|Core Phase (12 Months)|Protocol Violation|0
1517430|NCT00371826|4980779|P1|Core Phase (12 Months)|Protocol Violation|1
1517431|NCT00371826|4980777|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
1517432|NCT00371826|4980778|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
1517433|NCT00371826|4980779|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
1517434|NCT00371826|4980777|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
1517435|NCT00371826|4980778|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
1517436|NCT00371826|4980779|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
1517437|NCT00371826|4980777|P3|Core Phase (12 Months)|Adverse Event|9
1517438|NCT00371826|4980778|P2|Core Phase (12 Months)|Adverse Event|4
1517439|NCT00371826|4980779|P1|Core Phase (12 Months)|Adverse Event|15
1517440|NCT00371787|4980903|P2|Overall Study|Withdrawal by Subject|1
1517441|NCT00371787|4980904|P1|Overall Study|Withdrawal by Subject|3
1517442|NCT00371761|4980918|P2|Overall Study|Study termination|3
1517443|NCT00371761|4980919|P1|Overall Study|Study termination|4
1517444|NCT00371761|4980918|P2|Overall Study|Investigator Judgment|3
1517445|NCT00371761|4980919|P1|Overall Study|Investigator Judgment|2
1517446|NCT00371761|4980918|P2|Overall Study|Withdrawal by Subject|3
1517447|NCT00371761|4980919|P1|Overall Study|Withdrawal by Subject|1
1517448|NCT00371761|4980918|P2|Overall Study|Adverse Event|1
1517449|NCT00371761|4980919|P1|Overall Study|Adverse Event|1
1517450|NCT00371683|4980927|P2|Follow-Up Period - Randomized Patients|non-specified|12
1517451|NCT00371683|4980928|P1|Follow-Up Period - Randomized Patients|non-specified|6
1517452|NCT00371683|4980927|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
1517453|NCT00371683|4980928|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
1517454|NCT00371683|4980927|P2|Follow-Up Period - Randomized Patients|Death|2
1517455|NCT00371683|4980928|P1|Follow-Up Period - Randomized Patients|Death|0
1517456|NCT00371683|4980927|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
1517457|NCT00371683|4980928|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
1517458|NCT00371683|4980927|P2|DB Treatment Period-Randomized Patients|non-specified|8
1517459|NCT00371683|4980928|P1|DB Treatment Period-Randomized Patients|non-specified|9
1517460|NCT00371683|4980927|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
1517461|NCT00371683|4980928|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
1517462|NCT00371683|4980927|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
1517463|NCT00371683|4980928|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
1517464|NCT00371683|4980927|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
1517465|NCT00371683|4980928|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
1517466|NCT00371683|4980927|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
1517467|NCT00371683|4980928|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
1517468|NCT00371683|4980927|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
1517469|NCT00371683|4980928|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
1517470|NCT00371683|4980927|P2|DB Treatment Period-Randomized Patients|Death|1
1517471|NCT00371683|4980928|P1|DB Treatment Period-Randomized Patients|Death|1
1517472|NCT00371566|4980996|P2|Follow Up Phase|Lost to Follow-up|0
1517473|NCT00371566|4980997|P1|Follow Up Phase|Lost to Follow-up|1
1517474|NCT00371566|4980996|P2|Follow Up Phase|Physician Decision|1
1517475|NCT00371566|4980997|P1|Follow Up Phase|Physician Decision|1
1517476|NCT00371566|4980996|P2|Follow Up Phase|Withdrawal by Subject|1
1517477|NCT00371566|4980997|P1|Follow Up Phase|Withdrawal by Subject|0
1517478|NCT00371566|4980996|P2|Follow Up Phase|Disease progression|0
1517479|NCT00371566|4980997|P1|Follow Up Phase|Disease progression|1
1517480|NCT00371566|4980996|P2|Follow Up Phase|Death|5
1517481|NCT00371566|4980997|P1|Follow Up Phase|Death|0
1517482|NCT00371566|4980996|P2|Chemoradiation Phase|Death|0
1517483|NCT00371566|4980997|P1|Chemoradiation Phase|Death|2
1517484|NCT00371566|4980996|P2|Chemoradiation Phase|Progressive Disease|1
1517485|NCT00371566|4980997|P1|Chemoradiation Phase|Progressive Disease|1
1517486|NCT00371566|4980996|P2|Chemoradiation Phase|Non compliant|1
1517487|NCT00371566|4980997|P1|Chemoradiation Phase|Non compliant|0
1517488|NCT00371566|4980996|P2|Chemoradiation Phase|Withdrawal by Subject|1
1517489|NCT00371566|4980997|P1|Chemoradiation Phase|Withdrawal by Subject|0
1517490|NCT00371566|4980996|P2|Chemoradiation Phase|Physician Decision|0
1517491|NCT00371566|4980997|P1|Chemoradiation Phase|Physician Decision|2
1517492|NCT00371566|4980996|P2|Treatment Phase|Protocol Violation|1
1517493|NCT00371566|4980997|P1|Treatment Phase|Protocol Violation|0
1517494|NCT00371566|4980996|P2|Treatment Phase|Adverse Event|1
1517495|NCT00371566|4980997|P1|Treatment Phase|Adverse Event|0
1517496|NCT00371566|4980996|P2|Treatment Phase|Withdrawal by Subject|1
1517497|NCT00371566|4980997|P1|Treatment Phase|Withdrawal by Subject|0
1517498|NCT00371462|4981082|P2|Overall Study|Other|8
1517499|NCT00371462|4981083|P1|Overall Study|Other|7
1517500|NCT00371462|4981082|P2|Overall Study|Withdrawal by Subject|0
1517501|NCT00371462|4981083|P1|Overall Study|Withdrawal by Subject|1
1517502|NCT00371397|4981107|P12|Session 1|Withdrawal by Subject|0
1517503|NCT00371397|4981108|P11|Session 1|Withdrawal by Subject|0
1517504|NCT00371397|4981109|P10|Session 1|Withdrawal by Subject|0
1517505|NCT00371397|4981110|P9|Session 1|Withdrawal by Subject|0
1517506|NCT00371397|4981111|P8|Session 1|Withdrawal by Subject|1
1517507|NCT00371397|4981112|P7|Session 1|Withdrawal by Subject|0
1517508|NCT00371397|4981113|P6|Session 1|Withdrawal by Subject|0
1517509|NCT00371397|4981114|P5|Session 1|Withdrawal by Subject|0
1517510|NCT00371397|4981115|P4|Session 1|Withdrawal by Subject|0
1517511|NCT00371397|4981116|P3|Session 1|Withdrawal by Subject|0
1517512|NCT00371397|4981117|P2|Session 1|Withdrawal by Subject|0
1517513|NCT00371397|4981118|P1|Session 1|Withdrawal by Subject|1
1517514|NCT00371345|4981126|P2|Overall Study|Participant Withdrew Consent|1
1517515|NCT00371345|4981127|P1|Overall Study|Participant Withdrew Consent|0
1517516|NCT00371345|4981126|P2|Overall Study|Participant Request|1
1517517|NCT00371345|4981127|P1|Overall Study|Participant Request|1
1517518|NCT00371345|4981126|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
1517519|NCT00371345|4981127|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
1517520|NCT00371345|4981126|P2|Overall Study|Study Drug Toxicity|7
1517521|NCT00371345|4981127|P1|Overall Study|Study Drug Toxicity|1
1517522|NCT00371345|4981126|P2|Overall Study|Disease Progression|35
1517523|NCT00371345|4981127|P1|Overall Study|Disease Progression|21
1517524|NCT00371254|4981228|P2|Overall Study|Withdrawal by Subject|1
1517525|NCT00371254|4981229|P1|Overall Study|Withdrawal by Subject|0
1517526|NCT00371254|4981228|P2|Overall Study|Lost to Follow-up|1
1517527|NCT00371254|4981229|P1|Overall Study|Lost to Follow-up|0
1517528|NCT00371254|4981228|P2|Overall Study|Adverse event unrelated to study drug|1
1517529|NCT00371254|4981229|P1|Overall Study|Adverse event unrelated to study drug|0
1517530|NCT00371254|4981228|P2|Overall Study|Investigator Decision|0
1517531|NCT00371254|4981229|P1|Overall Study|Investigator Decision|2
1517532|NCT00371254|4981228|P2|Overall Study|Subject request|0
1517533|NCT00371254|4981229|P1|Overall Study|Subject request|5
1517534|NCT00371254|4981228|P2|Overall Study|Study drug toxicity|5
1517535|NCT00371254|4981229|P1|Overall Study|Study drug toxicity|3
1517536|NCT00371254|4981228|P2|Overall Study|Disease progression|13
1517537|NCT00371254|4981229|P1|Overall Study|Disease progression|13
1517538|NCT00371150|4981312|P2|Overall Study|Lost to Follow-up|2
1517539|NCT00371150|4981313|P1|Overall Study|Lost to Follow-up|3
1517540|NCT00371137|4981348|P3|Overall Study|Protocol Violation|1
1517541|NCT00371137|4981349|P2|Overall Study|Protocol Violation|1
1517542|NCT00371137|4981350|P1|Overall Study|Protocol Violation|2
1517543|NCT00371137|4981348|P3|Overall Study|Physician Decision|1
1517544|NCT00371137|4981349|P2|Overall Study|Physician Decision|1
1517545|NCT00371137|4981350|P1|Overall Study|Physician Decision|1
1517546|NCT00371137|4981348|P3|Overall Study|Sponsor Decision|2
1517547|NCT00371137|4981349|P2|Overall Study|Sponsor Decision|1
1517548|NCT00371137|4981350|P1|Overall Study|Sponsor Decision|2
1517549|NCT00371137|4981348|P3|Overall Study|Lack of Efficacy|13
1517550|NCT00371137|4981349|P2|Overall Study|Lack of Efficacy|12
1517551|NCT00371137|4981350|P1|Overall Study|Lack of Efficacy|30
1517552|NCT00371137|4981348|P3|Overall Study|Lost to Follow-up|5
1517553|NCT00371137|4981349|P2|Overall Study|Lost to Follow-up|3
1517554|NCT00371137|4981350|P1|Overall Study|Lost to Follow-up|6
1517555|NCT00371137|4981348|P3|Overall Study|Withdrawal by Subject|15
1517556|NCT00371137|4981349|P2|Overall Study|Withdrawal by Subject|10
1517557|NCT00371137|4981350|P1|Overall Study|Withdrawal by Subject|11
1517558|NCT00371137|4981348|P3|Overall Study|Adverse Event|42
1517559|NCT00371137|4981349|P2|Overall Study|Adverse Event|35
1517560|NCT00371137|4981350|P1|Overall Study|Adverse Event|20
1517561|NCT00370682|4981393|P3|Overall Study|Lost to Follow-up|1
1517562|NCT00370682|4981394|P2|Overall Study|Lost to Follow-up|1
1517563|NCT00370682|4981395|P1|Overall Study|Lost to Follow-up|0
1517564|NCT00370682|4981393|P3|Overall Study|Moved from area|0
1517565|NCT00370682|4981394|P2|Overall Study|Moved from area|2
1517566|NCT00370682|4981395|P1|Overall Study|Moved from area|0
1517567|NCT00370552|4981437|P3|Overall Study|Planned radiation for palliation|0
1517568|NCT00370552|4981438|P2|Overall Study|Planned radiation for palliation|1
1517569|NCT00370552|4981439|P1|Overall Study|Planned radiation for palliation|0
1517570|NCT00370552|4981437|P3|Overall Study|High risk of allergic reaction|0
1517571|NCT00370552|4981438|P2|Overall Study|High risk of allergic reaction|1
1517572|NCT00370552|4981439|P1|Overall Study|High risk of allergic reaction|0
1517573|NCT00370552|4981437|P3|Overall Study|Investigator decision|0
1517574|NCT00370552|4981438|P2|Overall Study|Investigator decision|1
1517575|NCT00370552|4981439|P1|Overall Study|Investigator decision|2
1517576|NCT00370552|4981437|P3|Overall Study|Physician Decision|0
1517577|NCT00370552|4981438|P2|Overall Study|Physician Decision|1
1517578|NCT00370552|4981439|P1|Overall Study|Physician Decision|1
1517579|NCT00370552|4981437|P3|Overall Study|Never treated|0
1517580|NCT00370552|4981438|P2|Overall Study|Never treated|0
1517581|NCT00370552|4981439|P1|Overall Study|Never treated|1
1517582|NCT00370552|4981437|P3|Overall Study|Still on treatment|2
1517583|NCT00370552|4981438|P2|Overall Study|Still on treatment|3
1517584|NCT00370552|4981439|P1|Overall Study|Still on treatment|1
1517585|NCT00370552|4981437|P3|Overall Study|Withdrawal by Subject|1
1517586|NCT00370552|4981438|P2|Overall Study|Withdrawal by Subject|0
1517587|NCT00370552|4981439|P1|Overall Study|Withdrawal by Subject|2
1517588|NCT00370552|4981437|P3|Overall Study|Study drug toxicity|6
1517589|NCT00370552|4981438|P2|Overall Study|Study drug toxicity|8
1517590|NCT00370552|4981439|P1|Overall Study|Study drug toxicity|11
1517591|NCT00370552|4981437|P3|Overall Study|Poor or noncompliance|1
1517592|NCT00370552|4981438|P2|Overall Study|Poor or noncompliance|0
1517593|NCT00370552|4981439|P1|Overall Study|Poor or noncompliance|0
1517594|NCT00370552|4981437|P3|Overall Study|Maximum clinical benefit|5
1517595|NCT00370552|4981438|P2|Overall Study|Maximum clinical benefit|5
1517596|NCT00370552|4981439|P1|Overall Study|Maximum clinical benefit|3
1517597|NCT00370552|4981437|P3|Overall Study|Disease progression|15
1517598|NCT00370552|4981438|P2|Overall Study|Disease progression|23
1517599|NCT00370552|4981439|P1|Overall Study|Disease progression|23
1517600|NCT00370552|4981437|P3|Overall Study|Adverse Event|2
1517601|NCT00370552|4981438|P2|Overall Study|Adverse Event|2
1517602|NCT00370552|4981439|P1|Overall Study|Adverse Event|2
1517603|NCT00370331|4981479|P2|Overall Study|Protocol Violation|1
1517604|NCT00370331|4981480|P1|Overall Study|Protocol Violation|1
1517605|NCT00370331|4981479|P2|Overall Study|Non-compliance|1
1517606|NCT00370331|4981480|P1|Overall Study|Non-compliance|0
1517607|NCT00370331|4981479|P2|Overall Study|Lack of Efficacy|1
1517608|NCT00370331|4981480|P1|Overall Study|Lack of Efficacy|0
1517609|NCT00370331|4981479|P2|Overall Study|Lost to Follow-up|3
1517610|NCT00370331|4981480|P1|Overall Study|Lost to Follow-up|0
1517611|NCT00370331|4981479|P2|Overall Study|Withdrawal by Subject|4
1517612|NCT00370331|4981480|P1|Overall Study|Withdrawal by Subject|2
1517613|NCT00370331|4981479|P2|Overall Study|Adverse Event|13
1517614|NCT00370331|4981480|P1|Overall Study|Adverse Event|4
1517615|NCT00370292|4981506|P1|Overall Study|Physician Decision|2
1517616|NCT00370292|4981506|P1|Overall Study|Adverse Event|7
1517617|NCT00370292|4981506|P1|Overall Study|Disease Progression|4
1517618|NCT00370149|4981519|P2|Overall Study|Antibiotic coated dressing placed|1
1517619|NCT00370149|4981520|P1|Overall Study|Antibiotic coated dressing placed|0
1517620|NCT00370149|4981519|P2|Overall Study|Pre-existing infection|1
1517621|NCT00370149|4981520|P1|Overall Study|Pre-existing infection|0
1517622|NCT00370149|4981519|P2|Overall Study|Catheter inserted in wrong vessel-|1
1517623|NCT00370149|4981520|P1|Overall Study|Catheter inserted in wrong vessel-|2
1517624|NCT00370149|4981519|P2|Overall Study|Protocol Violation|0
1517625|NCT00370149|4981520|P1|Overall Study|Protocol Violation|1
1517626|NCT00370149|4981519|P2|Overall Study|Physician Decision|16
1517627|NCT00370149|4981520|P1|Overall Study|Physician Decision|16
1517628|NCT00370071|4981530|P1|Overall Study|Withdrawal by Subject|2
1517629|NCT00370032|4981547|P2|Follow-up Period|Withdrawal by Subject|0
1517630|NCT00370032|4981548|P1|Follow-up Period|Withdrawal by Subject|1
1517631|NCT00370032|4981547|P2|Washout Period|Adverse Event|0
1517632|NCT00370032|4981548|P1|Washout Period|Adverse Event|1
1517633|NCT00370032|4981547|P2|Washout Period|Lost to Follow-up|1
1517634|NCT00370032|4981548|P1|Washout Period|Lost to Follow-up|0
1517635|NCT00370032|4981547|P2|Washout Period|Withdrawal by Subject|1
1517636|NCT00370032|4981548|P1|Washout Period|Withdrawal by Subject|0
1517637|NCT00370032|4981547|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
1517638|NCT00370032|4981548|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
1517639|NCT00369967|4981568|P2|Overall Study|Lost to Follow-up|12
1517640|NCT00369967|4981569|P1|Overall Study|Lost to Follow-up|23
1517641|NCT00369941|4981587|P2|Overall Study|Miscellaneous|3
1517642|NCT00369941|4981588|P1|Overall Study|Miscellaneous|3
1517643|NCT00369941|4981587|P2|Overall Study|Study Site Terminated|0
1517644|NCT00369941|4981588|P1|Overall Study|Study Site Terminated|2
1517645|NCT00369941|4981587|P2|Overall Study|Employment Interfered with Study Visits|0
1517646|NCT00369941|4981588|P1|Overall Study|Employment Interfered with Study Visits|1
1517647|NCT00369941|4981587|P2|Overall Study|Treatment with Prohibited Medication|1
1517648|NCT00369941|4981588|P1|Overall Study|Treatment with Prohibited Medication|3
1517649|NCT00369941|4981587|P2|Overall Study|Moved|5
1517650|NCT00369941|4981588|P1|Overall Study|Moved|11
1517651|NCT00369941|4981587|P2|Overall Study|Completed, Did Not Enter Extension|6
1517652|NCT00369941|4981588|P1|Overall Study|Completed, Did Not Enter Extension|5
1517653|NCT00369941|4981587|P2|Overall Study|Pregnancy|2
1517654|NCT00369941|4981588|P1|Overall Study|Pregnancy|4
1517655|NCT00369941|4981587|P2|Overall Study|Withdrawal by Subject|18
1517656|NCT00369941|4981588|P1|Overall Study|Withdrawal by Subject|5
1517657|NCT00369941|4981587|P2|Overall Study|Protocol Violation|3
1517658|NCT00369941|4981588|P1|Overall Study|Protocol Violation|5
1517659|NCT00369941|4981587|P2|Overall Study|Lost to Follow-up|22
1517660|NCT00369941|4981588|P1|Overall Study|Lost to Follow-up|12
1517661|NCT00369941|4981587|P2|Overall Study|Lack of Efficacy|10
1517662|NCT00369941|4981588|P1|Overall Study|Lack of Efficacy|6
1517663|NCT00369941|4981587|P2|Overall Study|Adverse Event|28
1517664|NCT00369941|4981588|P1|Overall Study|Adverse Event|14
1517665|NCT00369941|4981587|P2|Overall Study|Never Treated|2
1517666|NCT00369941|4981588|P1|Overall Study|Never Treated|1
1517667|NCT00369915|4981753|P2|Overall Study|W/drawl by investigators|1
1517668|NCT00369915|4981754|P1|Overall Study|W/drawl by investigators|0
1517669|NCT00369915|4981753|P2|Overall Study|Withdrawal by Subject|1
1517670|NCT00369915|4981754|P1|Overall Study|Withdrawal by Subject|4
1517671|NCT00369915|4981753|P2|Overall Study|expected side effects|1
1517672|NCT00369915|4981754|P1|Overall Study|expected side effects|2
1517673|NCT00369824|4981768|P6|Overall Study|Other|3
1517674|NCT00369824|4981769|P5|Overall Study|Other|1
1517675|NCT00369824|4981770|P4|Overall Study|Other|2
1517676|NCT00369824|4981771|P3|Overall Study|Other|0
1517677|NCT00369824|4981772|P2|Overall Study|Other|0
1517678|NCT00369824|4981773|P1|Overall Study|Other|0
1517679|NCT00369824|4981768|P6|Overall Study|Lost to Follow-up|6
1517680|NCT00369824|4981769|P5|Overall Study|Lost to Follow-up|9
1517681|NCT00369824|4981770|P4|Overall Study|Lost to Follow-up|8
1517682|NCT00369824|4981771|P3|Overall Study|Lost to Follow-up|7
1517683|NCT00369824|4981772|P2|Overall Study|Lost to Follow-up|11
1517684|NCT00369824|4981773|P1|Overall Study|Lost to Follow-up|6
1517685|NCT00369824|4981768|P6|Overall Study|Withdrawal by Subject|2
1517686|NCT00369824|4981769|P5|Overall Study|Withdrawal by Subject|6
1517687|NCT00369824|4981770|P4|Overall Study|Withdrawal by Subject|4
1517688|NCT00369824|4981771|P3|Overall Study|Withdrawal by Subject|5
1517689|NCT00369824|4981772|P2|Overall Study|Withdrawal by Subject|5
1517690|NCT00369824|4981773|P1|Overall Study|Withdrawal by Subject|9
1517691|NCT00369824|4981768|P6|Overall Study|Protocol Violation|0
1517692|NCT00369824|4981769|P5|Overall Study|Protocol Violation|1
1517693|NCT00369824|4981770|P4|Overall Study|Protocol Violation|1
1517694|NCT00369824|4981771|P3|Overall Study|Protocol Violation|0
1517695|NCT00369824|4981772|P2|Overall Study|Protocol Violation|1
1517696|NCT00369824|4981773|P1|Overall Study|Protocol Violation|0
1517697|NCT00369824|4981768|P6|Overall Study|Adverse Event|0
1517698|NCT00369824|4981769|P5|Overall Study|Adverse Event|1
1517699|NCT00369824|4981770|P4|Overall Study|Adverse Event|0
1517700|NCT00369824|4981771|P3|Overall Study|Adverse Event|0
1517701|NCT00369824|4981772|P2|Overall Study|Adverse Event|2
1517702|NCT00369824|4981773|P1|Overall Study|Adverse Event|0
1517703|NCT00369785|4981873|P2|Overall Study|Multiple reasons|5
1517704|NCT00369785|4981874|P1|Overall Study|Multiple reasons|6
1517705|NCT00369785|4981873|P2|Overall Study|Progression|4
1517706|NCT00369785|4981874|P1|Overall Study|Progression|4
1517707|NCT00369785|4981873|P2|Overall Study|Never started|2
1517708|NCT00369785|4981874|P1|Overall Study|Never started|0
1517709|NCT00369785|4981873|P2|Overall Study|Toxicity|4
1517710|NCT00369785|4981874|P1|Overall Study|Toxicity|6
1517711|NCT00369785|4981873|P2|Overall Study|Withdrawal by Subject|6
1517712|NCT00369785|4981874|P1|Overall Study|Withdrawal by Subject|7
1517713|NCT00369785|4981873|P2|Overall Study|Death|2
1517714|NCT00369785|4981874|P1|Overall Study|Death|1
1517715|NCT00369785|4981873|P2|Overall Study|Physician Decision|2
1517716|NCT00369785|4981874|P1|Overall Study|Physician Decision|3
1517717|NCT00369681|4981895|P1|Overall Study|Death|1
1517718|NCT00369668|4981905|P3|Overall Study|Lack of Efficacy|7
1517719|NCT00369668|4981906|P2|Overall Study|Lack of Efficacy|5
1517720|NCT00369668|4981907|P1|Overall Study|Lack of Efficacy|4
1517721|NCT00369655|4981921|P1|Overall Study|Refusal of further treatment|2
1517722|NCT00369577|4981951|P3|Overall Study|Withdrawal by Subject|1
1517723|NCT00369577|4981952|P2|Overall Study|Withdrawal by Subject|0
1517724|NCT00369577|4981953|P1|Overall Study|Withdrawal by Subject|0
1517725|NCT00369486|4981990|P5|34-Week Visit|Dropped|3
1517726|NCT00369486|4981991|P4|34-Week Visit|Dropped|3
1517727|NCT00369486|4981992|P3|34-Week Visit|Dropped|1
1517728|NCT00369486|4981993|P2|34-Week Visit|Dropped|1
1517729|NCT00369486|4981994|P1|34-Week Visit|Dropped|0
1517730|NCT00369486|4981990|P5|17-Week Visit|Missed visit|1
1517731|NCT00369486|4981991|P4|17-Week Visit|Missed visit|1
1517732|NCT00369486|4981992|P3|17-Week Visit|Missed visit|1
1517733|NCT00369486|4981993|P2|17-Week Visit|Missed visit|0
1517734|NCT00369486|4981994|P1|17-Week Visit|Missed visit|0
1517735|NCT00369486|4981990|P5|8-Week Visit|Dropped|0
1517736|NCT00369486|4981991|P4|8-Week Visit|Dropped|1
1517737|NCT00369486|4981992|P3|8-Week Visit|Dropped|0
1517738|NCT00369486|4981993|P2|8-Week Visit|Dropped|0
1517739|NCT00369486|4981994|P1|8-Week Visit|Dropped|0
1517740|NCT00369486|4981990|P5|8-Week Visit|Missed visit|1
1517741|NCT00369486|4981991|P4|8-Week Visit|Missed visit|0
1517742|NCT00369486|4981992|P3|8-Week Visit|Missed visit|0
1517743|NCT00369486|4981993|P2|8-Week Visit|Missed visit|1
1517744|NCT00369486|4981994|P1|8-Week Visit|Missed visit|0
1517745|NCT00369486|4981990|P5|4-Week Visit|Dropped|0
1517746|NCT00369486|4981991|P4|4-Week Visit|Dropped|0
1517747|NCT00369486|4981992|P3|4-Week Visit|Dropped|1
1517748|NCT00369486|4981993|P2|4-Week Visit|Dropped|0
1517749|NCT00369486|4981994|P1|4-Week Visit|Dropped|0
1517750|NCT00369486|4981990|P5|4-Week Visit|Missed visit|1
1517751|NCT00369486|4981991|P4|4-Week Visit|Missed visit|2
1517752|NCT00369486|4981992|P3|4-Week Visit|Missed visit|0
1517753|NCT00369486|4981993|P2|4-Week Visit|Missed visit|2
1517754|NCT00369486|4981994|P1|4-Week Visit|Missed visit|2
1517755|NCT00369382|4982033|P2|Overall Study|Other|0
1517756|NCT00369382|4982034|P1|Overall Study|Other|1
1517757|NCT00369382|4982033|P2|Overall Study|Randomized, not treated|0
1517758|NCT00369382|4982034|P1|Overall Study|Randomized, not treated|2
1517759|NCT00369382|4982033|P2|Overall Study|Withdrawal by Subject|0
1517760|NCT00369382|4982034|P1|Overall Study|Withdrawal by Subject|5
1517761|NCT00369382|4982033|P2|Overall Study|Physician Decision|1
1517762|NCT00369382|4982034|P1|Overall Study|Physician Decision|2
1517763|NCT00369382|4982033|P2|Overall Study|Death|2
1517764|NCT00369382|4982034|P1|Overall Study|Death|0
1517765|NCT00369343|4982067|P2|Open-label Phase|did not take study drug|2
1517766|NCT00369343|4982068|P1|Open-label Phase|did not take study drug|1
1517767|NCT00369343|4982067|P2|Open-label Phase|Lack of continuance tolerability|4
1517768|NCT00369343|4982068|P1|Open-label Phase|Lack of continuance tolerability|3
1517769|NCT00369343|4982067|P2|Open-label Phase|Lack of Efficacy|3
1517770|NCT00369343|4982068|P1|Open-label Phase|Lack of Efficacy|4
1517771|NCT00369343|4982067|P2|Open-label Phase|Withdrawal by Subject|6
1517772|NCT00369343|4982068|P1|Open-label Phase|Withdrawal by Subject|15
1517773|NCT00369343|4982067|P2|Open-label Phase|Protocol Violation|3
1517774|NCT00369343|4982068|P1|Open-label Phase|Protocol Violation|1
1517775|NCT00369343|4982067|P2|Open-label Phase|inadvertently reported study completers|2
1517776|NCT00369343|4982068|P1|Open-label Phase|inadvertently reported study completers|3
1517777|NCT00369343|4982067|P2|Open-label Phase|Lost to Follow-up|3
1517778|NCT00369343|4982068|P1|Open-label Phase|Lost to Follow-up|5
1517779|NCT00369343|4982067|P2|Open-label Phase|Physician Decision|0
1517780|NCT00369343|4982068|P1|Open-label Phase|Physician Decision|2
1517781|NCT00369343|4982067|P2|Open-label Phase|Failed to return|0
1517782|NCT00369343|4982068|P1|Open-label Phase|Failed to return|4
1517783|NCT00369343|4982067|P2|Open-label Phase|Adverse Event|7
1517784|NCT00369343|4982068|P1|Open-label Phase|Adverse Event|19
1517785|NCT00369343|4982067|P2|Double-blind Phase|Protocol deviation|0
1517786|NCT00369343|4982068|P1|Double-blind Phase|Protocol deviation|4
1517787|NCT00369343|4982067|P2|Double-blind Phase|Lack of Efficacy|4
1517788|NCT00369343|4982068|P1|Double-blind Phase|Lack of Efficacy|0
1517789|NCT00369343|4982067|P2|Double-blind Phase|Withdrawal by Subject|6
1517790|NCT00369343|4982068|P1|Double-blind Phase|Withdrawal by Subject|8
1517791|NCT00369343|4982067|P2|Double-blind Phase|Protocol Violation|0
1517792|NCT00369343|4982068|P1|Double-blind Phase|Protocol Violation|2
1517793|NCT00369343|4982067|P2|Double-blind Phase|Lost to Follow-up|2
1517794|NCT00369343|4982068|P1|Double-blind Phase|Lost to Follow-up|9
1517795|NCT00369343|4982067|P2|Double-blind Phase|Failed to return|0
1517796|NCT00369343|4982068|P1|Double-blind Phase|Failed to return|2
1517797|NCT00369343|4982067|P2|Double-blind Phase|Adverse Event|4
1517798|NCT00369343|4982068|P1|Double-blind Phase|Adverse Event|19
1517799|NCT00369317|4982101|P1|Overall Study|Ineligible|1
1517800|NCT00369317|4982101|P1|Overall Study|Withdrawal by Subject|8
1517801|NCT00369317|4982101|P1|Overall Study|Physician Decision|2
1517802|NCT00369317|4982101|P1|Overall Study|Lack of Efficacy|5
1517803|NCT00369317|4982101|P1|Overall Study|Death|1
1517804|NCT00369317|4982101|P1|Overall Study|Adverse Event|3
1517805|NCT00369278|4982117|P2|Overall Study|Graft loss|2
1517806|NCT00369278|4982118|P1|Overall Study|Graft loss|1
1517807|NCT00369278|4982117|P2|Overall Study|Lost to Follow-up|0
1517808|NCT00369278|4982118|P1|Overall Study|Lost to Follow-up|1
1517809|NCT00369278|4982117|P2|Overall Study|Withdrawal by Subject|2
1517810|NCT00369278|4982118|P1|Overall Study|Withdrawal by Subject|2
1517811|NCT00369278|4982117|P2|Overall Study|Protocol Violation|1
1517812|NCT00369278|4982118|P1|Overall Study|Protocol Violation|2
1517813|NCT00369278|4982117|P2|Overall Study|Unsatisfactory therapeutic effect|5
1517814|NCT00369278|4982118|P1|Overall Study|Unsatisfactory therapeutic effect|4
1517815|NCT00369278|4982117|P2|Overall Study|Adverse Event|11
1517816|NCT00369278|4982118|P1|Overall Study|Adverse Event|14
1517817|NCT00369265|4982134|P2|Overall Study|Study terminated|7
1517818|NCT00369265|4982135|P1|Overall Study|Study terminated|4
1517819|NCT00369161|4982156|P2|Overall Study|Administrative Problem|2
1517820|NCT00369161|4982157|P1|Overall Study|Administrative Problem|2
1517821|NCT00369161|4982156|P2|Overall Study|Graft loss|0
1517822|NCT00369161|4982157|P1|Overall Study|Graft loss|4
1517823|NCT00369161|4982156|P2|Overall Study|Death|2
1517824|NCT00369161|4982157|P1|Overall Study|Death|1
1517825|NCT00369161|4982156|P2|Overall Study|Withdrawal by Subject|3
1517826|NCT00369161|4982157|P1|Overall Study|Withdrawal by Subject|2
1517827|NCT00369161|4982156|P2|Overall Study|Protocol Violation|2
1517828|NCT00369161|4982157|P1|Overall Study|Protocol Violation|0
1517829|NCT00369161|4982156|P2|Overall Study|Lack of Efficacy|1
1517830|NCT00369161|4982157|P1|Overall Study|Lack of Efficacy|3
1517831|NCT00369161|4982156|P2|Overall Study|Abnormal laboratory value|1
1517832|NCT00369161|4982157|P1|Overall Study|Abnormal laboratory value|0
1517833|NCT00369161|4982156|P2|Overall Study|Adverse Event|13
1517834|NCT00369161|4982157|P1|Overall Study|Adverse Event|15
1517835|NCT00369122|4982167|P1|Overall Study|No protocol treatment|1
1517836|NCT00369122|4982167|P1|Overall Study|Ineligible|10
1517837|NCT00368992|4982174|P1|Overall Study|Not Specified|9
1517838|NCT00368992|4982174|P1|Overall Study|Death|4
1517839|NCT00368992|4982174|P1|Overall Study|Adverse Event|26
1517840|NCT00368992|4982174|P1|Overall Study|Lack of Efficacy|63
1517841|NCT00368992|4982174|P1|Overall Study|Refused treatment|3
1517842|NCT00368992|4982174|P1|Overall Study|Ineligible|5
1517843|NCT00368979|4982183|P2|Overall Study|Withdrawal by Subject|9
1517844|NCT00368979|4982184|P1|Overall Study|Withdrawal by Subject|5
1517845|NCT00368979|4982183|P2|Overall Study|Protocol Violation|1
1517846|NCT00368979|4982184|P1|Overall Study|Protocol Violation|2
1517847|NCT00368979|4982183|P2|Overall Study|Lost to Follow-up|0
1517848|NCT00368979|4982184|P1|Overall Study|Lost to Follow-up|1
1517849|NCT00368979|4982183|P2|Overall Study|Not specified|1
1517850|NCT00368979|4982184|P1|Overall Study|Not specified|3
1517851|NCT00368979|4982183|P2|Overall Study|Lack of Efficacy|3
1517852|NCT00368979|4982184|P1|Overall Study|Lack of Efficacy|5
1517853|NCT00368979|4982183|P2|Overall Study|Adverse Event|16
1517854|NCT00368979|4982184|P1|Overall Study|Adverse Event|9
1517855|NCT00368966|4982200|P2|Toddler Dose|Lost to Follow-up|2
1517856|NCT00368966|4982201|P1|Toddler Dose|Lost to Follow-up|0
1517857|NCT00368966|4982200|P2|Toddler Dose|Withdrawal by Subject|1
1517858|NCT00368966|4982201|P1|Toddler Dose|Withdrawal by Subject|1
1517859|NCT00368966|4982200|P2|After Infant|Lost to Follow-up|1
1517860|NCT00368966|4982201|P1|After Infant|Lost to Follow-up|0
1517861|NCT00368966|4982200|P2|After Infant|Death|0
1517862|NCT00368966|4982201|P1|After Infant|Death|1
1517863|NCT00368966|4982200|P2|After Infant|Withdrawal by Subject|1
1517864|NCT00368966|4982201|P1|After Infant|Withdrawal by Subject|1
1517865|NCT00368966|4982200|P2|After Infant|Adverse Event|2
1517866|NCT00368966|4982201|P1|After Infant|Adverse Event|1
1517867|NCT00368966|4982200|P2|After Infant|Failed to return|1
1517868|NCT00368966|4982201|P1|After Infant|Failed to return|3
1517869|NCT00368966|4982200|P2|Infant Series|Failed to return|0
1517870|NCT00368966|4982201|P1|Infant Series|Failed to return|1
1517871|NCT00368966|4982200|P2|Infant Series|Adverse Event|1
1517872|NCT00368966|4982201|P1|Infant Series|Adverse Event|0
1517873|NCT00368966|4982200|P2|Infant Series|Failed to meet eligibility criteria|1
1517874|NCT00368966|4982201|P1|Infant Series|Failed to meet eligibility criteria|0
1517875|NCT00368966|4982200|P2|Infant Series|Randomization error|1
1517876|NCT00368966|4982201|P1|Infant Series|Randomization error|0
1517877|NCT00368966|4982200|P2|Infant Series|Lost to Follow-up|0
1517878|NCT00368966|4982201|P1|Infant Series|Lost to Follow-up|2
1517879|NCT00368966|4982200|P2|Infant Series|Protocol Violation|1
1517880|NCT00368966|4982201|P1|Infant Series|Protocol Violation|2
1517881|NCT00368966|4982200|P2|Infant Series|Withdrawal by Subject|6
1517882|NCT00368966|4982201|P1|Infant Series|Withdrawal by Subject|11
1517883|NCT00368927|4982272|P2|Overall Study|Physician Decision|0
1517884|NCT00368927|4982273|P1|Overall Study|Physician Decision|1
1517885|NCT00368927|4982272|P2|Overall Study|Withdrawal by Subject|2
1517886|NCT00368927|4982273|P1|Overall Study|Withdrawal by Subject|1
1517887|NCT00368927|4982272|P2|Overall Study|Adverse Event|1
1517888|NCT00368927|4982273|P1|Overall Study|Adverse Event|1
1517889|NCT00368927|4982272|P2|Overall Study|Lost to Follow-up|0
1517890|NCT00368927|4982273|P1|Overall Study|Lost to Follow-up|2
1517891|NCT00368875|4982281|P2|Overall Study|Alternative Therapy|1
1517892|NCT00368875|4982282|P1|Overall Study|Alternative Therapy|1
1517893|NCT00368875|4982281|P2|Overall Study|Other Reason|2
1517894|NCT00368875|4982282|P1|Overall Study|Other Reason|0
1517895|NCT00368875|4982281|P2|Overall Study|Withdrawal by Subject|6
1517896|NCT00368875|4982282|P1|Overall Study|Withdrawal by Subject|2
1517897|NCT00368875|4982281|P2|Overall Study|Progressive disease|27
1517898|NCT00368875|4982282|P1|Overall Study|Progressive disease|3
1517899|NCT00368875|4982281|P2|Overall Study|Adverse Event|12
1517900|NCT00368875|4982282|P1|Overall Study|Adverse Event|0
1517901|NCT00368849|4982290|P2|Overall Study|Physician Decision|1
1517902|NCT00368849|4982291|P1|Overall Study|Physician Decision|0
1517903|NCT00368849|4982290|P2|Overall Study|Withdrawal by Subject|1
1517904|NCT00368849|4982291|P1|Overall Study|Withdrawal by Subject|0
1517905|NCT00368745|4982307|P2|Double-blind Treatment Period|Other|6
1517906|NCT00368745|4982308|P1|Double-blind Treatment Period|Other|7
1517907|NCT00368745|4982307|P2|Double-blind Treatment Period|Withdrawal by Subject|3
1517908|NCT00368745|4982308|P1|Double-blind Treatment Period|Withdrawal by Subject|5
1517909|NCT00368745|4982307|P2|Double-blind Treatment Period|Lost to Follow-up|0
1517910|NCT00368745|4982308|P1|Double-blind Treatment Period|Lost to Follow-up|1
1517911|NCT00368745|4982307|P2|Double-blind Treatment Period|Lack of Efficacy|16
1517912|NCT00368745|4982308|P1|Double-blind Treatment Period|Lack of Efficacy|7
1517913|NCT00368745|4982307|P2|Double-blind Treatment Period|Adverse Event|6
1517914|NCT00368745|4982308|P1|Double-blind Treatment Period|Adverse Event|6
1517915|NCT00368641|4982361|P2|Overall Study|Sponsor decision to terminate study|5
1517916|NCT00368641|4982362|P1|Overall Study|Sponsor decision to terminate study|2
1517917|NCT00368641|4982361|P2|Overall Study|Withdrawal by Subject|0
1517918|NCT00368641|4982362|P1|Overall Study|Withdrawal by Subject|1
1517919|NCT00368641|4982361|P2|Overall Study|Death|0
1517920|NCT00368641|4982362|P1|Overall Study|Death|1
1517921|NCT00368641|4982361|P2|Overall Study|Adverse Event|1
1517922|NCT00368641|4982362|P1|Overall Study|Adverse Event|2
1517923|NCT00368550|4982370|P2|Overall Study|Withdrawal by Subject|10
1517924|NCT00368550|4982371|P1|Overall Study|Withdrawal by Subject|17
1517925|NCT00368550|4982370|P2|Overall Study|Lack of Efficacy|9
1517926|NCT00368550|4982371|P1|Overall Study|Lack of Efficacy|4
1517927|NCT00368550|4982370|P2|Overall Study|Adverse Event|4
1517928|NCT00368550|4982371|P1|Overall Study|Adverse Event|7
1517929|NCT00368537|4982383|P2|Baseline Participants|Patient uncompliant|1
1517930|NCT00368537|4982384|P1|Baseline Participants|Patient uncompliant|0
1517931|NCT00368537|4982383|P2|Baseline Participants|No susceptibility|0
1517932|NCT00368537|4982384|P1|Baseline Participants|No susceptibility|1
1517933|NCT00368537|4982383|P2|Baseline Participants|Death|2
1517934|NCT00368537|4982384|P1|Baseline Participants|Death|1
1517935|NCT00368537|4982383|P2|Baseline Participants|Withdrawal by Subject|4
1517936|NCT00368537|4982384|P1|Baseline Participants|Withdrawal by Subject|6
1517937|NCT00368537|4982383|P2|Baseline Participants|Lost to Follow-up|17
1517938|NCT00368537|4982384|P1|Baseline Participants|Lost to Follow-up|16
1517939|NCT00368537|4982383|P2|Randomization|No study drug dosed|6
1517940|NCT00368537|4982384|P1|Randomization|No study drug dosed|13
1517941|NCT00368472|4982398|P1|Overall Study|Missing Final Disposition Date|1
1517942|NCT00368472|4982398|P1|Overall Study|Not Specified|32
1517943|NCT00368472|4982398|P1|Overall Study|Diary non-compliance|1
1517944|NCT00368472|4982398|P1|Overall Study|Withdrawal by Subject|40
1517945|NCT00368472|4982398|P1|Overall Study|Request of Investigator or Sponsor|3
1517946|NCT00368472|4982398|P1|Overall Study|Protocol Violation|2
1517947|NCT00368472|4982398|P1|Overall Study|Medication non-compliance|4
1517948|NCT00368472|4982398|P1|Overall Study|Adverse Event|22
1517949|NCT00368277|4982457|P2|Overall Study|Lost to Follow-up|6
1517950|NCT00368277|4982458|P1|Overall Study|Lost to Follow-up|8
1517951|NCT00368277|4982457|P2|Overall Study|Patient withdrew consent|28
1517952|NCT00368277|4982458|P1|Overall Study|Patient withdrew consent|32
1517953|NCT00368277|4982457|P2|Overall Study|Protocol deviation|0
1517954|NCT00368277|4982458|P1|Overall Study|Protocol deviation|7
1517955|NCT00368277|4982457|P2|Overall Study|Unsatisfactory therapeutic effect|24
1517956|NCT00368277|4982458|P1|Overall Study|Unsatisfactory therapeutic effect|31
1517957|NCT00368277|4982457|P2|Overall Study|Death|1
1517958|NCT00368277|4982458|P1|Overall Study|Death|2
1517959|NCT00368277|4982457|P2|Overall Study|Adverse Event|49
1517960|NCT00368277|4982458|P1|Overall Study|Adverse Event|33
1517961|NCT00368251|4982473|P3|Overall Study|AE, non-serious non-fatal|1
1517962|NCT00368251|4982474|P2|Overall Study|AE, non-serious non-fatal|0
1517963|NCT00368251|4982475|P1|Overall Study|AE, non-serious non-fatal|0
1517964|NCT00368251|4982473|P3|Overall Study|SAE, non-fatal|0
1517965|NCT00368251|4982474|P2|Overall Study|SAE, non-fatal|0
1517966|NCT00368251|4982475|P1|Overall Study|SAE, non-fatal|1
1517967|NCT00368108|4982498|P3|Overall Study|Not Specified|1
1517968|NCT00368108|4982499|P2|Overall Study|Not Specified|7
1517969|NCT00368108|4982500|P1|Overall Study|Not Specified|3
1517970|NCT00368108|4982498|P3|Overall Study|Physician Decision|1
1517971|NCT00368108|4982499|P2|Overall Study|Physician Decision|0
1517972|NCT00368108|4982500|P1|Overall Study|Physician Decision|2
1517973|NCT00368108|4982498|P3|Overall Study|Lack of Efficacy|5
1517974|NCT00368108|4982499|P2|Overall Study|Lack of Efficacy|8
1517975|NCT00368108|4982500|P1|Overall Study|Lack of Efficacy|7
1517976|NCT00368108|4982498|P3|Overall Study|Withdrawal by Subject|5
1517977|NCT00368108|4982499|P2|Overall Study|Withdrawal by Subject|3
1517978|NCT00368108|4982500|P1|Overall Study|Withdrawal by Subject|9
1517979|NCT00368108|4982498|P3|Overall Study|Protocol Violation|9
1517980|NCT00368108|4982499|P2|Overall Study|Protocol Violation|9
1517981|NCT00368108|4982500|P1|Overall Study|Protocol Violation|5
1517982|NCT00368108|4982498|P3|Overall Study|Abnormal Laboratory Value|3
1517983|NCT00368108|4982499|P2|Overall Study|Abnormal Laboratory Value|0
1517984|NCT00368108|4982500|P1|Overall Study|Abnormal Laboratory Value|0
1517985|NCT00368108|4982498|P3|Overall Study|Adverse Event|44
1517986|NCT00368108|4982499|P2|Overall Study|Adverse Event|26
1517987|NCT00368108|4982500|P1|Overall Study|Adverse Event|38
1517988|NCT00368069|4982519|P2|Overall Study|no blood sampling possible|1
1517989|NCT00368069|4982520|P1|Overall Study|no blood sampling possible|0
1517990|NCT00368069|4982519|P2|Overall Study|Withdrawal of Consent|1
1517991|NCT00368069|4982520|P1|Overall Study|Withdrawal of Consent|2
1517992|NCT00368069|4982519|P2|Overall Study|Protocol Violation|2
1517993|NCT00368069|4982520|P1|Overall Study|Protocol Violation|0
1517994|NCT00368069|4982519|P2|Overall Study|Lost to Follow-up|0
1517995|NCT00368069|4982520|P1|Overall Study|Lost to Follow-up|1
1517996|NCT00368069|4982519|P2|Overall Study|Lack of Efficacy|1
1517997|NCT00368069|4982520|P1|Overall Study|Lack of Efficacy|0
1517998|NCT00368069|4982519|P2|Overall Study|Adverse Event|2
1517999|NCT00368069|4982520|P1|Overall Study|Adverse Event|5
1518000|NCT00367991|4982538|P2|Overall Study|Adverse Event|1
1518001|NCT00367991|4982539|P1|Overall Study|Adverse Event|1
1518002|NCT00367991|4982538|P2|Overall Study|Withdrawal by Subject|1
1518003|NCT00367991|4982539|P1|Overall Study|Withdrawal by Subject|1
1518004|NCT00367835|4982557|P2|Overall Study|History of lead poisoning|1
1518005|NCT00367835|4982558|P1|Overall Study|History of lead poisoning|0
1518006|NCT00367835|4982557|P2|Overall Study|Did not respond to calls|0
1518007|NCT00367835|4982558|P1|Overall Study|Did not respond to calls|1
1518008|NCT00367835|4982557|P2|Overall Study|refused blood collection|0
1518009|NCT00367835|4982558|P1|Overall Study|refused blood collection|1
1518010|NCT00367835|4982557|P2|Overall Study|Subject in juvenile detention center|0
1518011|NCT00367835|4982558|P1|Overall Study|Subject in juvenile detention center|1
1518012|NCT00367835|4982557|P2|Overall Study|Lack of Efficacy|12
1518013|NCT00367835|4982558|P1|Overall Study|Lack of Efficacy|3
1518014|NCT00367835|4982557|P2|Overall Study|Lost to Follow-up|4
1518015|NCT00367835|4982558|P1|Overall Study|Lost to Follow-up|1
1518016|NCT00367835|4982557|P2|Overall Study|Withdrawal by Subject|6
1518017|NCT00367835|4982558|P1|Overall Study|Withdrawal by Subject|7
1518018|NCT00367835|4982557|P2|Overall Study|Protocol Violation|7
1518019|NCT00367835|4982558|P1|Overall Study|Protocol Violation|1
1518020|NCT00367835|4982557|P2|Overall Study|Adverse Event|1
1518021|NCT00367835|4982558|P1|Overall Study|Adverse Event|14
1518022|NCT00367770|4982584|P1|Overall Study|Withdrawal by Subject|1
1518023|NCT00367770|4982584|P1|Overall Study|Adverse Event|1
1518024|NCT00367744|4982592|P2|Overall Study|Lost to Follow-up|5
1518025|NCT00367744|4982593|P1|Overall Study|Lost to Follow-up|4
1518026|NCT00367640|4982622|P4|Overall Study|Any other reason not above-mentioned|4
1518027|NCT00367640|4982623|P3|Overall Study|Any other reason not above-mentioned|3
1518028|NCT00367640|4982624|P2|Overall Study|Any other reason not above-mentioned|5
1518029|NCT00367640|4982625|P1|Overall Study|Any other reason not above-mentioned|7
1518030|NCT00367640|4982622|P4|Overall Study|Withdrawal by Subject|6
1518031|NCT00367640|4982623|P3|Overall Study|Withdrawal by Subject|8
1518032|NCT00367640|4982624|P2|Overall Study|Withdrawal by Subject|11
1518033|NCT00367640|4982625|P1|Overall Study|Withdrawal by Subject|8
1518034|NCT00367640|4982622|P4|Overall Study|Adverse Event|0
1518035|NCT00367640|4982623|P3|Overall Study|Adverse Event|8
1518036|NCT00367640|4982624|P2|Overall Study|Adverse Event|6
1518037|NCT00367640|4982625|P1|Overall Study|Adverse Event|3
1518038|NCT00367484|4982641|P1|Overall Study|Lack of Efficacy|1
1518039|NCT00367484|4982641|P1|Overall Study|The choice of the patient|1
1518040|NCT00367484|4982641|P1|Overall Study|Protocol Violation|1
1518041|NCT00367484|4982641|P1|Overall Study|Lost to Follow-up|1
1518042|NCT00367484|4982641|P1|Overall Study|Travel to USA|1
1518043|NCT00367484|4982641|P1|Overall Study|Withdrew informed consent|5
1518044|NCT00367484|4982641|P1|Overall Study|Adverse Event|7
1518045|NCT00367432|4982645|P2|Second Period (up to 54 Months)|Other Reason|2
1518046|NCT00367432|4982646|P1|Second Period (up to 54 Months)|Other Reason|6
1518047|NCT00367432|4982645|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
1518048|NCT00367432|4982646|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
1518049|NCT00367432|4982645|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
1518050|NCT00367432|4982646|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
1518051|NCT00367432|4982645|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
1518052|NCT00367432|4982646|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
1518053|NCT00367432|4982645|P2|Second Period (up to 54 Months)|Adverse Event|3
1518054|NCT00367432|4982646|P1|Second Period (up to 54 Months)|Adverse Event|14
1518055|NCT00367432|4982645|P2|First Period (16 Weeks)|Other Reason|0
1518056|NCT00367432|4982646|P1|First Period (16 Weeks)|Other Reason|2
1518057|NCT00367432|4982645|P2|First Period (16 Weeks)|Withdrawal by Subject|0
1518058|NCT00367432|4982646|P1|First Period (16 Weeks)|Withdrawal by Subject|6
1518059|NCT00367432|4982645|P2|First Period (16 Weeks)|Lack of Efficacy|0
1518060|NCT00367432|4982646|P1|First Period (16 Weeks)|Lack of Efficacy|24
1518061|NCT00367432|4982645|P2|First Period (16 Weeks)|Adverse Event|0
1518062|NCT00367432|4982646|P1|First Period (16 Weeks)|Adverse Event|6
1518063|NCT00367341|4982673|P2|Overall Study|Protocol Violation|0
1518064|NCT00367341|4982674|P1|Overall Study|Protocol Violation|1
1518065|NCT00367341|4982673|P2|Overall Study|Physician Decision|0
1518066|NCT00367341|4982674|P1|Overall Study|Physician Decision|1
1518067|NCT00367237|4982684|P2|Overall Study|Protocol Violation|5
1518068|NCT00367237|4982685|P1|Overall Study|Protocol Violation|2
1518069|NCT00367237|4982684|P2|Overall Study|Withdrawal by Subject|4
1518070|NCT00367237|4982685|P1|Overall Study|Withdrawal by Subject|0
1518071|NCT00367237|4982684|P2|Overall Study|Lost to Follow-up|0
1518072|NCT00367237|4982685|P1|Overall Study|Lost to Follow-up|1
1518073|NCT00367237|4982684|P2|Overall Study|Adverse Event|2
1518074|NCT00367237|4982685|P1|Overall Study|Adverse Event|7
1518075|NCT00367133|4982694|P3|2 Years|Missed visit|4
1518076|NCT00367133|4982695|P2|2 Years|Missed visit|5
1518077|NCT00367133|4982696|P1|2 Years|Missed visit|4
1518078|NCT00367133|4982694|P3|2 Years|Dropped|33
1518079|NCT00367133|4982695|P2|2 Years|Dropped|19
1518080|NCT00367133|4982696|P1|2 Years|Dropped|34
1518081|NCT00367133|4982694|P3|2 Years|Death|12
1518082|NCT00367133|4982695|P2|2 Years|Death|12
1518083|NCT00367133|4982696|P1|2 Years|Death|20
1518084|NCT00367055|4982748|P2|Overall Study|Participant Living too Far from Hospital|1
1518085|NCT00367055|4982749|P1|Overall Study|Participant Living too Far from Hospital|0
1518086|NCT00367055|4982748|P2|Overall Study|Stopping Criterion Met|1
1518087|NCT00367055|4982749|P1|Overall Study|Stopping Criterion Met|0
1518088|NCT00367055|4982748|P2|Overall Study|Protocol Violation|1
1518089|NCT00367055|4982749|P1|Overall Study|Protocol Violation|0
1518090|NCT00367055|4982748|P2|Overall Study|Lost to Follow-up|1
1518091|NCT00367055|4982749|P1|Overall Study|Lost to Follow-up|1
1518092|NCT00367055|4982748|P2|Overall Study|Lack of Efficacy|2
1518093|NCT00367055|4982749|P1|Overall Study|Lack of Efficacy|1
1518094|NCT00367055|4982748|P2|Overall Study|Patient's Willing|2
1518095|NCT00367055|4982749|P1|Overall Study|Patient's Willing|3
1518096|NCT00367055|4982748|P2|Overall Study|Adverse Event|3
1518097|NCT00367055|4982749|P1|Overall Study|Adverse Event|6
1518098|NCT00366899|4982765|P2|Toddler Dose|Protocol Violation|0
1518099|NCT00366899|4982766|P1|Toddler Dose|Protocol Violation|1
1518100|NCT00366899|4982765|P2|Toddler Dose|Withdrawal by Subject|1
1518101|NCT00366899|4982766|P1|Toddler Dose|Withdrawal by Subject|1
1518102|NCT00366899|4982765|P2|After Infant Series|Protocol Violation|0
1518103|NCT00366899|4982766|P1|After Infant Series|Protocol Violation|1
1518104|NCT00366899|4982765|P2|After Infant Series|Adverse Event|2
1518105|NCT00366899|4982766|P1|After Infant Series|Adverse Event|1
1518106|NCT00366899|4982765|P2|After Infant Series|Withdrawal by Subject|4
1518107|NCT00366899|4982766|P1|After Infant Series|Withdrawal by Subject|1
1518108|NCT00366899|4982765|P2|After Infant Series|Lost to Follow-up|3
1518109|NCT00366899|4982766|P1|After Infant Series|Lost to Follow-up|4
1518110|NCT00366899|4982765|P2|Infant Series|Randomized but not consented|0
1518111|NCT00366899|4982766|P1|Infant Series|Randomized but not consented|1
1518112|NCT00366899|4982765|P2|Infant Series|Physician Decision|0
1518113|NCT00366899|4982766|P1|Infant Series|Physician Decision|1
1518114|NCT00366899|4982765|P2|Infant Series|Adverse Event|1
1518115|NCT00366899|4982766|P1|Infant Series|Adverse Event|0
1518116|NCT00366899|4982765|P2|Infant Series|Lost to Follow-up|2
1518117|NCT00366899|4982766|P1|Infant Series|Lost to Follow-up|0
1518118|NCT00366899|4982765|P2|Infant Series|Failed to return|1
1518119|NCT00366899|4982766|P1|Infant Series|Failed to return|1
1518120|NCT00366899|4982765|P2|Infant Series|Protocol Violation|1
1518121|NCT00366899|4982766|P1|Infant Series|Protocol Violation|2
1518122|NCT00366899|4982765|P2|Infant Series|Withdrawal by Subject|7
1518123|NCT00366899|4982766|P1|Infant Series|Withdrawal by Subject|4
1518124|NCT00366678|4982826|P3|Toddler Dose|protocol deviation|0
1518125|NCT00366678|4982827|P2|Toddler Dose|protocol deviation|0
1518126|NCT00366678|4982828|P1|Toddler Dose|protocol deviation|1
1518127|NCT00366678|4982826|P3|Toddler Dose|Withdrawal by Subject|0
1518128|NCT00366678|4982827|P2|Toddler Dose|Withdrawal by Subject|0
1518129|NCT00366678|4982828|P1|Toddler Dose|Withdrawal by Subject|1
1518130|NCT00366678|4982826|P3|Toddler Dose|Failed to return|0
1518131|NCT00366678|4982827|P2|Toddler Dose|Failed to return|0
1518132|NCT00366678|4982828|P1|Toddler Dose|Failed to return|1
1518133|NCT00366678|4982826|P3|Toddler Dose|Protocol Violation|0
1518134|NCT00366678|4982827|P2|Toddler Dose|Protocol Violation|1
1518135|NCT00366678|4982828|P1|Toddler Dose|Protocol Violation|2
1518136|NCT00366678|4982826|P3|After Infant|Protocol Violation|0
1518137|NCT00366678|4982827|P2|After Infant|Protocol Violation|0
1518138|NCT00366678|4982828|P1|After Infant|Protocol Violation|1
1518139|NCT00366678|4982826|P3|After Infant|Adverse Event|0
1518140|NCT00366678|4982827|P2|After Infant|Adverse Event|0
1518141|NCT00366678|4982828|P1|After Infant|Adverse Event|1
1518142|NCT00366678|4982826|P3|After Infant|Failed to return|0
1518143|NCT00366678|4982827|P2|After Infant|Failed to return|5
1518144|NCT00366678|4982828|P1|After Infant|Failed to return|5
1518145|NCT00366678|4982826|P3|After Infant|Lost to Follow-up|0
1518146|NCT00366678|4982827|P2|After Infant|Lost to Follow-up|1
1518147|NCT00366678|4982828|P1|After Infant|Lost to Follow-up|2
1518148|NCT00366678|4982826|P3|After Infant|Withdrawal by Subject|0
1518149|NCT00366678|4982827|P2|After Infant|Withdrawal by Subject|4
1518150|NCT00366678|4982828|P1|After Infant|Withdrawal by Subject|8
1518151|NCT00366678|4982826|P3|Infant Series|Adverse Event|0
1518152|NCT00366678|4982827|P2|Infant Series|Adverse Event|0
1518153|NCT00366678|4982828|P1|Infant Series|Adverse Event|1
1518154|NCT00366678|4982826|P3|Infant Series|Failed to return|0
1518155|NCT00366678|4982827|P2|Infant Series|Failed to return|1
1518156|NCT00366678|4982828|P1|Infant Series|Failed to return|1
1518157|NCT00366678|4982826|P3|Infant Series|Protocol Violation|0
1518158|NCT00366678|4982827|P2|Infant Series|Protocol Violation|3
1518159|NCT00366678|4982828|P1|Infant Series|Protocol Violation|4
1518160|NCT00366678|4982826|P3|Infant Series|Withdrawal by Subject|0
1518161|NCT00366678|4982827|P2|Infant Series|Withdrawal by Subject|6
1518162|NCT00366678|4982828|P1|Infant Series|Withdrawal by Subject|8
1518163|NCT00366548|4982910|P2|After Infant Series|Lost to Follow-up|0
1518164|NCT00366548|4982911|P1|After Infant Series|Lost to Follow-up|1
1518165|NCT00366548|4982910|P2|After Infant Series|Adverse Event|0
1518166|NCT00366548|4982911|P1|After Infant Series|Adverse Event|2
1518167|NCT00366548|4982910|P2|After Infant Series|Withdrawal by Subject|1
1518168|NCT00366548|4982911|P1|After Infant Series|Withdrawal by Subject|3
1518169|NCT00366548|4982910|P2|Infant Series|Withdrawal by Subject|1
1518170|NCT00366548|4982911|P1|Infant Series|Withdrawal by Subject|3
1518171|NCT00366548|4982910|P2|Infant Series|Protocol Violation|1
1518172|NCT00366548|4982911|P1|Infant Series|Protocol Violation|0
1518173|NCT00366548|4982910|P2|Infant Series|Adverse Event|3
1518174|NCT00366548|4982911|P1|Infant Series|Adverse Event|1
1518175|NCT00366535|4982947|P2|Second Phase: 12 Weeks|Withdrawal by Subject|2
1518176|NCT00366535|4982948|P1|Second Phase: 12 Weeks|Withdrawal by Subject|2
1518177|NCT00366535|4982947|P2|Second Phase: 12 Weeks|Adverse Event|1
1518178|NCT00366535|4982948|P1|Second Phase: 12 Weeks|Adverse Event|1
1518179|NCT00366535|4982947|P2|First Phase: 12 Weeks|Withdrawal by Subject|5
1518180|NCT00366535|4982948|P1|First Phase: 12 Weeks|Withdrawal by Subject|2
1518181|NCT00366535|4982947|P2|First Phase: 12 Weeks|Adverse Event|3
1518182|NCT00366535|4982948|P1|First Phase: 12 Weeks|Adverse Event|1
1518183|NCT00366457|4982962|P1|Overall Study|never began study therapy|2
1518184|NCT00366444|4982971|P2|Overall Study|Lack of Efficacy|1
1518185|NCT00366444|4982972|P1|Overall Study|Lack of Efficacy|0
1518186|NCT00366444|4982971|P2|Overall Study|Withdrawal by Subject|1
1518187|NCT00366444|4982972|P1|Overall Study|Withdrawal by Subject|1
1518188|NCT00366340|4983000|P2|Toddler Dose|Parent/legal guardian request|1
1518189|NCT00366340|4983001|P1|Toddler Dose|Parent/legal guardian request|0
1518190|NCT00366340|4983000|P2|Toddler Dose|Failed to return|0
1518191|NCT00366340|4983001|P1|Toddler Dose|Failed to return|1
1518192|NCT00366340|4983000|P2|After the Infant Series|Lost to Follow-up|1
1518193|NCT00366340|4983001|P1|After the Infant Series|Lost to Follow-up|0
1518194|NCT00366340|4983000|P2|After the Infant Series|Adverse Event|1
1518195|NCT00366340|4983001|P1|After the Infant Series|Adverse Event|0
1518196|NCT00366340|4983000|P2|After the Infant Series|Protocol Violation|2
1518197|NCT00366340|4983001|P1|After the Infant Series|Protocol Violation|2
1518198|NCT00366340|4983000|P2|After the Infant Series|Failed to return|1
1518199|NCT00366340|4983001|P1|After the Infant Series|Failed to return|0
1518200|NCT00366340|4983000|P2|After the Infant Series|Parent/legal guardian request|1
1518201|NCT00366340|4983001|P1|After the Infant Series|Parent/legal guardian request|1
1518202|NCT00366340|4983000|P2|Infant Series|Failure to return|0
1518203|NCT00366340|4983001|P1|Infant Series|Failure to return|1
1518204|NCT00366340|4983000|P2|Infant Series|Lost to Follow-up|1
1518205|NCT00366340|4983001|P1|Infant Series|Lost to Follow-up|1
1518206|NCT00366340|4983000|P2|Infant Series|Adverse Event|2
1518207|NCT00366340|4983001|P1|Infant Series|Adverse Event|0
1518208|NCT00366340|4983000|P2|Infant Series|Withdrawal by Subject|3
1518209|NCT00366340|4983001|P1|Infant Series|Withdrawal by Subject|3
1518210|NCT00366340|4983000|P2|Infant Series|Protocol Violation|4
1518211|NCT00366340|4983001|P1|Infant Series|Protocol Violation|3
1518212|NCT00366301|4983059|P4|Overall Study|Withdrawal by Subject|1
1518213|NCT00366301|4983060|P3|Overall Study|Withdrawal by Subject|1
1518214|NCT00366301|4983061|P2|Overall Study|Withdrawal by Subject|2
1518215|NCT00366301|4983062|P1|Overall Study|Withdrawal by Subject|4
1518216|NCT00366301|4983059|P4|Overall Study|Lost to Follow-up|7
1518217|NCT00366301|4983060|P3|Overall Study|Lost to Follow-up|3
1518218|NCT00366301|4983061|P2|Overall Study|Lost to Follow-up|4
1518219|NCT00366301|4983062|P1|Overall Study|Lost to Follow-up|4
1518220|NCT00366249|4983078|P2|Overall Study|Most due to osteomylitis status|20
1518221|NCT00366249|4983079|P1|Overall Study|Most due to osteomylitis status|31
1518222|NCT00366249|4983078|P2|Overall Study|Lack of Efficacy|21
1518223|NCT00366249|4983079|P1|Overall Study|Lack of Efficacy|21
1518224|NCT00366249|4983078|P2|Overall Study|Withdrawal by Subject|4
1518225|NCT00366249|4983079|P1|Overall Study|Withdrawal by Subject|18
1518226|NCT00366249|4983078|P2|Overall Study|Protocol Violation|2
1518227|NCT00366249|4983079|P1|Overall Study|Protocol Violation|1
1518228|NCT00366249|4983078|P2|Overall Study|Lost to Follow-up|0
1518229|NCT00366249|4983079|P1|Overall Study|Lost to Follow-up|2
1518230|NCT00366249|4983078|P2|Overall Study|Physician Decision|2
1518231|NCT00366249|4983079|P1|Overall Study|Physician Decision|5
1518232|NCT00366249|4983078|P2|Overall Study|Death|1
1518233|NCT00366249|4983079|P1|Overall Study|Death|0
1518234|NCT00366249|4983078|P2|Overall Study|Adverse Event|28
1518235|NCT00366249|4983079|P1|Overall Study|Adverse Event|53
1518236|NCT00365976|4983113|P2|Overall Study|Withdrawal by Subject|5
1518237|NCT00365976|4983114|P1|Overall Study|Withdrawal by Subject|1
1518238|NCT00365846|4983252|P1|Overall Study|Lost to Follow-up|1
1518239|NCT00365716|4983277|P7|Extension 2|Withdrawal by Subject|5
1518240|NCT00365716|4983278|P6|Extension 2|Withdrawal by Subject|0
1518241|NCT00365716|4983279|P5|Extension 2|Withdrawal by Subject|0
1518242|NCT00365716|4983280|P4|Extension 2|Withdrawal by Subject|0
1518243|NCT00365716|4983281|P3|Extension 2|Withdrawal by Subject|0
1518244|NCT00365716|4983282|P2|Extension 2|Withdrawal by Subject|0
1518245|NCT00365716|4983283|P1|Extension 2|Withdrawal by Subject|0
1518246|NCT00365716|4983277|P7|Extension 2|Other|3
1518247|NCT00365716|4983278|P6|Extension 2|Other|0
1518248|NCT00365716|4983279|P5|Extension 2|Other|0
1518249|NCT00365716|4983280|P4|Extension 2|Other|0
1518250|NCT00365716|4983281|P3|Extension 2|Other|0
1518251|NCT00365716|4983282|P2|Extension 2|Other|0
1518252|NCT00365716|4983283|P1|Extension 2|Other|0
1518253|NCT00365716|4983277|P7|Extension 2|Lost to Follow-up|2
1518254|NCT00365716|4983278|P6|Extension 2|Lost to Follow-up|0
1518255|NCT00365716|4983279|P5|Extension 2|Lost to Follow-up|0
1518256|NCT00365716|4983280|P4|Extension 2|Lost to Follow-up|0
1518257|NCT00365716|4983281|P3|Extension 2|Lost to Follow-up|0
1518258|NCT00365716|4983282|P2|Extension 2|Lost to Follow-up|0
1518259|NCT00365716|4983283|P1|Extension 2|Lost to Follow-up|0
1518260|NCT00365716|4983277|P7|Extension 1|Protocol Violation|0
1518261|NCT00365716|4983278|P6|Extension 1|Protocol Violation|1
1518262|NCT00365716|4983279|P5|Extension 1|Protocol Violation|0
1518263|NCT00365716|4983280|P4|Extension 1|Protocol Violation|0
1518264|NCT00365716|4983281|P3|Extension 1|Protocol Violation|0
1518265|NCT00365716|4983282|P2|Extension 1|Protocol Violation|0
1518266|NCT00365716|4983283|P1|Extension 1|Protocol Violation|0
1518267|NCT00365716|4983277|P7|Extension 1|Pregnancy|0
1518268|NCT00365716|4983278|P6|Extension 1|Pregnancy|4
1518269|NCT00365716|4983279|P5|Extension 1|Pregnancy|0
1518270|NCT00365716|4983280|P4|Extension 1|Pregnancy|0
1518271|NCT00365716|4983281|P3|Extension 1|Pregnancy|0
1518272|NCT00365716|4983282|P2|Extension 1|Pregnancy|0
1518273|NCT00365716|4983283|P1|Extension 1|Pregnancy|0
1518274|NCT00365716|4983277|P7|Extension 1|Withdrawal by Subject|0
1518275|NCT00365716|4983278|P6|Extension 1|Withdrawal by Subject|3
1518276|NCT00365716|4983279|P5|Extension 1|Withdrawal by Subject|0
1518277|NCT00365716|4983280|P4|Extension 1|Withdrawal by Subject|0
1518278|NCT00365716|4983281|P3|Extension 1|Withdrawal by Subject|0
1518279|NCT00365716|4983282|P2|Extension 1|Withdrawal by Subject|0
1518280|NCT00365716|4983283|P1|Extension 1|Withdrawal by Subject|0
1518281|NCT00365716|4983277|P7|Extension 1|Moved|0
1518282|NCT00365716|4983278|P6|Extension 1|Moved|4
1518283|NCT00365716|4983279|P5|Extension 1|Moved|0
1518284|NCT00365716|4983280|P4|Extension 1|Moved|0
1518285|NCT00365716|4983281|P3|Extension 1|Moved|0
1518286|NCT00365716|4983282|P2|Extension 1|Moved|0
1518287|NCT00365716|4983283|P1|Extension 1|Moved|0
1518288|NCT00365716|4983277|P7|Extension 1|Other|0
1518289|NCT00365716|4983278|P6|Extension 1|Other|9
1518290|NCT00365716|4983279|P5|Extension 1|Other|0
1518291|NCT00365716|4983280|P4|Extension 1|Other|0
1518292|NCT00365716|4983281|P3|Extension 1|Other|0
1518293|NCT00365716|4983282|P2|Extension 1|Other|0
1518294|NCT00365716|4983283|P1|Extension 1|Other|0
1518295|NCT00365716|4983277|P7|Extension 1|Lost to Follow-up|0
1518296|NCT00365716|4983278|P6|Extension 1|Lost to Follow-up|1
1518297|NCT00365716|4983279|P5|Extension 1|Lost to Follow-up|0
1518298|NCT00365716|4983280|P4|Extension 1|Lost to Follow-up|0
1518299|NCT00365716|4983281|P3|Extension 1|Lost to Follow-up|0
1518300|NCT00365716|4983282|P2|Extension 1|Lost to Follow-up|0
1518301|NCT00365716|4983283|P1|Extension 1|Lost to Follow-up|0
1518302|NCT00365716|4983277|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
1518303|NCT00365716|4983278|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
1518304|NCT00365716|4983279|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
1518305|NCT00365716|4983280|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
1518306|NCT00365716|4983281|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
1518307|NCT00365716|4983282|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
1518308|NCT00365716|4983283|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
1518309|NCT00365716|4983277|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1518310|NCT00365716|4983278|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1518311|NCT00365716|4983279|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1518312|NCT00365716|4983280|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1518313|NCT00365716|4983281|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
1518314|NCT00365716|4983282|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
1518315|NCT00365716|4983283|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1518316|NCT00365716|4983277|P7|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1518317|NCT00365716|4983278|P6|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1518318|NCT00365716|4983279|P5|Long Term Follow-up (Month 7 toMonth 36)|Other|1
1518319|NCT00365716|4983280|P4|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1518320|NCT00365716|4983281|P3|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1518321|NCT00365716|4983282|P2|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1518322|NCT00365716|4983283|P1|Long Term Follow-up (Month 7 toMonth 36)|Other|2
1518323|NCT00365716|4983277|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
1518324|NCT00365716|4983278|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
1518325|NCT00365716|4983279|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
1518326|NCT00365716|4983280|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
1518327|NCT00365716|4983281|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
1518328|NCT00365716|4983282|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
1518329|NCT00365716|4983283|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
1518330|NCT00365716|4983277|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
1518331|NCT00365716|4983278|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
1518332|NCT00365716|4983279|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
1518333|NCT00365716|4983280|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
1518334|NCT00365716|4983281|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
1518335|NCT00365716|4983282|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
1518336|NCT00365716|4983283|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
1518337|NCT00365716|4983277|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1518338|NCT00365716|4983278|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1518339|NCT00365716|4983279|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
1518340|NCT00365716|4983280|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
1518341|NCT00365716|4983281|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1518342|NCT00365716|4983282|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1518343|NCT00365716|4983283|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
1518344|NCT00365716|4983277|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
1518345|NCT00365716|4983278|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
1518346|NCT00365716|4983279|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
1518347|NCT00365716|4983280|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
1518348|NCT00365716|4983281|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
1518349|NCT00365716|4983282|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
1518350|NCT00365716|4983283|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
1518351|NCT00365716|4983277|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
1518352|NCT00365716|4983278|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
1518353|NCT00365716|4983279|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
1518354|NCT00365716|4983280|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
1518355|NCT00365716|4983281|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
1518356|NCT00365716|4983282|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
1518357|NCT00365716|4983283|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
1518358|NCT00365716|4983277|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
1518359|NCT00365716|4983278|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
1518360|NCT00365716|4983279|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
1518361|NCT00365716|4983280|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
1518362|NCT00365716|4983281|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
1518363|NCT00365716|4983282|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
1518364|NCT00365716|4983283|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
1518365|NCT00365716|4983277|P7|Base Study (Day 1 to Month 7)|Other|0
1518366|NCT00365716|4983278|P6|Base Study (Day 1 to Month 7)|Other|0
1518367|NCT00365716|4983279|P5|Base Study (Day 1 to Month 7)|Other|0
1518368|NCT00365716|4983280|P4|Base Study (Day 1 to Month 7)|Other|0
1518369|NCT00365716|4983281|P3|Base Study (Day 1 to Month 7)|Other|0
1518370|NCT00365716|4983282|P2|Base Study (Day 1 to Month 7)|Other|1
1518371|NCT00365716|4983283|P1|Base Study (Day 1 to Month 7)|Other|0
1518372|NCT00365716|4983277|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
1518373|NCT00365716|4983278|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
1518374|NCT00365716|4983279|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
1518375|NCT00365716|4983280|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
1518376|NCT00365716|4983281|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
1518377|NCT00365716|4983282|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
1518378|NCT00365716|4983283|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
1518379|NCT00365716|4983277|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
1518380|NCT00365716|4983278|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
1518381|NCT00365716|4983279|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
1518382|NCT00365716|4983280|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
1518383|NCT00365716|4983281|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
1518384|NCT00365716|4983282|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
1518385|NCT00365716|4983283|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
1518386|NCT00365716|4983277|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1518387|NCT00365716|4983278|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1518388|NCT00365716|4983279|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1518389|NCT00365716|4983280|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1518390|NCT00365716|4983281|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1518391|NCT00365716|4983282|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
1518392|NCT00365716|4983283|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
1518393|NCT00365547|4983304|P1|Overall Study|Withdrawal by Subject|1
1518394|NCT00365547|4983304|P1|Overall Study|Screen failure|1
1518395|NCT00365547|4983304|P1|Overall Study|Insurance did not cover Avastin|1
1518396|NCT00365508|4983314|P2|Overall Study|Lost to Follow-up|154
1518397|NCT00365508|4983315|P1|Overall Study|Lost to Follow-up|139
1518398|NCT00365456|4983323|P2|Trial Period III (12 Months)|Other|1
1518399|NCT00365456|4983324|P1|Trial Period III (12 Months)|Other|1
1518400|NCT00365456|4983323|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
1518401|NCT00365456|4983324|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
1518402|NCT00365456|4983323|P2|Trial Period III (12 Months)|Adverse Event|3
1518403|NCT00365456|4983324|P1|Trial Period III (12 Months)|Adverse Event|13
1518404|NCT00365456|4983323|P2|Trial Period II (12 Months)|Other|1
1518405|NCT00365456|4983324|P1|Trial Period II (12 Months)|Other|0
1518406|NCT00365456|4983323|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
1518407|NCT00365456|4983324|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
1518408|NCT00365456|4983323|P2|Trial Period II (12 Months)|Non-compliance|2
1518409|NCT00365456|4983324|P1|Trial Period II (12 Months)|Non-compliance|0
1518410|NCT00365456|4983323|P2|Trial Period II (12 Months)|Adverse Event|6
1518411|NCT00365456|4983324|P1|Trial Period II (12 Months)|Adverse Event|0
1518412|NCT00365456|4983323|P2|Trial Period I (12 Months)|Other|0
1518413|NCT00365456|4983324|P1|Trial Period I (12 Months)|Other|11
1518414|NCT00365456|4983323|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
1518415|NCT00365456|4983324|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
1518416|NCT00365456|4983323|P2|Trial Period I (12 Months)|Non-compliance|0
1518417|NCT00365456|4983324|P1|Trial Period I (12 Months)|Non-compliance|3
1518418|NCT00365456|4983323|P2|Trial Period I (12 Months)|Adverse Event|0
1518419|NCT00365456|4983324|P1|Trial Period I (12 Months)|Adverse Event|84
1518420|NCT00365378|4983346|P3|Extension|Other|31
1518421|NCT00365378|4983347|P2|Extension|Other|0
1518422|NCT00365378|4983348|P1|Extension|Other|0
1518423|NCT00365378|4983346|P3|Extension|Withdrawal by Subject|98
1518424|NCT00365378|4983347|P2|Extension|Withdrawal by Subject|0
1518425|NCT00365378|4983348|P1|Extension|Withdrawal by Subject|0
1518426|NCT00365378|4983346|P3|Extension|Protocol Violation|2
1518427|NCT00365378|4983347|P2|Extension|Protocol Violation|0
1518428|NCT00365378|4983348|P1|Extension|Protocol Violation|0
1518429|NCT00365378|4983346|P3|Extension|Lost to Follow-up|57
1518430|NCT00365378|4983347|P2|Extension|Lost to Follow-up|0
1518431|NCT00365378|4983348|P1|Extension|Lost to Follow-up|0
1518432|NCT00365378|4983346|P3|Extension|Moved|8
1518433|NCT00365378|4983347|P2|Extension|Moved|0
1518434|NCT00365378|4983348|P1|Extension|Moved|0
1518435|NCT00365378|4983346|P3|Extension|Adverse Event|1
1518436|NCT00365378|4983347|P2|Extension|Adverse Event|0
1518437|NCT00365378|4983348|P1|Extension|Adverse Event|0
1518438|NCT00365378|4983346|P3|Follow-up (Month 7 Though Month 48)|Other|0
1518439|NCT00365378|4983347|P2|Follow-up (Month 7 Though Month 48)|Other|21
1518440|NCT00365378|4983348|P1|Follow-up (Month 7 Though Month 48)|Other|11
1518441|NCT00365378|4983346|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
1518442|NCT00365378|4983347|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
1518443|NCT00365378|4983348|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
1518444|NCT00365378|4983346|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
1518445|NCT00365378|4983347|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
1518446|NCT00365378|4983348|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
1518447|NCT00365378|4983346|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
1518448|NCT00365378|4983347|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
1518449|NCT00365378|4983348|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
1518450|NCT00365378|4983346|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
1518451|NCT00365378|4983347|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
1518452|NCT00365378|4983348|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
1518453|NCT00365378|4983346|P3|Follow-up (Month 7 Though Month 48)|Moved|0
1518454|NCT00365378|4983347|P2|Follow-up (Month 7 Though Month 48)|Moved|5
1518455|NCT00365378|4983348|P1|Follow-up (Month 7 Though Month 48)|Moved|6
1518456|NCT00365378|4983346|P3|Vaccination (Day 1 to Month 7)|Other|0
1518457|NCT00365378|4983347|P2|Vaccination (Day 1 to Month 7)|Other|9
1518458|NCT00365378|4983348|P1|Vaccination (Day 1 to Month 7)|Other|17
1518459|NCT00365378|4983346|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
1518460|NCT00365378|4983347|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
1518461|NCT00365378|4983348|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
1518462|NCT00365378|4983346|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
1518463|NCT00365378|4983347|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
1518464|NCT00365378|4983348|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
1518465|NCT00365378|4983346|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
1518466|NCT00365378|4983347|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
1518467|NCT00365378|4983348|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
1518468|NCT00365378|4983346|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
1518469|NCT00365378|4983347|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
1518470|NCT00365378|4983348|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
1518471|NCT00365378|4983346|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
1518472|NCT00365378|4983347|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
1518473|NCT00365378|4983348|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
1518474|NCT00365378|4983346|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
1518475|NCT00365378|4983347|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
1518476|NCT00365378|4983348|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
1518477|NCT00365365|4983362|P3|Overall Study|Patient/physician decision|1
1518478|NCT00365365|4983363|P2|Overall Study|Patient/physician decision|0
1518479|NCT00365365|4983364|P1|Overall Study|Patient/physician decision|0
1518480|NCT00365365|4983362|P3|Overall Study|Second malignancy|0
1518481|NCT00365365|4983363|P2|Overall Study|Second malignancy|1
1518482|NCT00365365|4983364|P1|Overall Study|Second malignancy|0
1518483|NCT00365365|4983362|P3|Overall Study|Withdrew consent|0
1518484|NCT00365365|4983363|P2|Overall Study|Withdrew consent|1
1518485|NCT00365365|4983364|P1|Overall Study|Withdrew consent|1
1518486|NCT00365365|4983362|P3|Overall Study|New cancer|0
1518487|NCT00365365|4983363|P2|Overall Study|New cancer|0
1518488|NCT00365365|4983364|P1|Overall Study|New cancer|1
1518489|NCT00365365|4983362|P3|Overall Study|Moved|0
1518490|NCT00365365|4983363|P2|Overall Study|Moved|0
1518491|NCT00365365|4983364|P1|Overall Study|Moved|2
1518492|NCT00365365|4983362|P3|Overall Study|Adverse Event|3
1518493|NCT00365365|4983363|P2|Overall Study|Adverse Event|6
1518494|NCT00365365|4983364|P1|Overall Study|Adverse Event|6
1518495|NCT00365365|4983362|P3|Overall Study|Disease progression/relapse|7
1518496|NCT00365365|4983363|P2|Overall Study|Disease progression/relapse|6
1518497|NCT00365365|4983364|P1|Overall Study|Disease progression/relapse|9
1518498|NCT00365365|4983362|P3|Overall Study|Subject's request|1
1518499|NCT00365365|4983363|P2|Overall Study|Subject's request|13
1518500|NCT00365365|4983364|P1|Overall Study|Subject's request|11
1518501|NCT00365365|4983362|P3|Overall Study|Death|0
1518502|NCT00365365|4983363|P2|Overall Study|Death|3
1518503|NCT00365365|4983364|P1|Overall Study|Death|1
1518504|NCT00365365|4983362|P3|Overall Study|Lost to Follow-up|3
1518505|NCT00365365|4983363|P2|Overall Study|Lost to Follow-up|3
1518506|NCT00365365|4983364|P1|Overall Study|Lost to Follow-up|3
1518507|NCT00365365|4983362|P3|Overall Study|Poor compliance to protocol|0
1518508|NCT00365365|4983363|P2|Overall Study|Poor compliance to protocol|1
1518509|NCT00365365|4983364|P1|Overall Study|Poor compliance to protocol|0
1518510|NCT00365365|4983362|P3|Overall Study|Randomized but not treated|0
1518511|NCT00365365|4983363|P2|Overall Study|Randomized but not treated|2
1518512|NCT00365365|4983364|P1|Overall Study|Randomized but not treated|0
1518513|NCT00365352|4983381|P3|Overall Study|Withdrawal of Participant by Sponsor|0
1518514|NCT00365352|4983382|P2|Overall Study|Withdrawal of Participant by Sponsor|0
1518515|NCT00365352|4983383|P1|Overall Study|Withdrawal of Participant by Sponsor|1
1518516|NCT00365352|4983381|P3|Overall Study|Lost to Follow-up|0
1518517|NCT00365352|4983382|P2|Overall Study|Lost to Follow-up|1
1518518|NCT00365352|4983383|P1|Overall Study|Lost to Follow-up|1
1518519|NCT00365352|4983381|P3|Overall Study|Non-Compliance (after Randomization)|1
1518520|NCT00365352|4983382|P2|Overall Study|Non-Compliance (after Randomization)|0
1518521|NCT00365352|4983383|P1|Overall Study|Non-Compliance (after Randomization)|1
1518522|NCT00365352|4983381|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
1518523|NCT00365352|4983382|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
1518524|NCT00365352|4983383|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
1518525|NCT00365352|4983381|P3|Overall Study|Lack of Efficacy|0
1518526|NCT00365352|4983382|P2|Overall Study|Lack of Efficacy|0
1518527|NCT00365352|4983383|P1|Overall Study|Lack of Efficacy|3
1518528|NCT00365352|4983381|P3|Overall Study|Participant Withdrew Consent|4
1518529|NCT00365352|4983382|P2|Overall Study|Participant Withdrew Consent|3
1518530|NCT00365352|4983383|P1|Overall Study|Participant Withdrew Consent|8
1518531|NCT00365352|4983381|P3|Overall Study|Adverse Event|8
1518532|NCT00365352|4983382|P2|Overall Study|Adverse Event|7
1518533|NCT00365352|4983383|P1|Overall Study|Adverse Event|6
1518534|NCT00365300|4983467|P2|Double-blind Phase|Lack of Efficacy|6
1518535|NCT00365300|4983468|P1|Double-blind Phase|Lack of Efficacy|6
1518536|NCT00365300|4983467|P2|Double-blind Phase|Protocol Violation|1
1518537|NCT00365300|4983468|P1|Double-blind Phase|Protocol Violation|3
1518538|NCT00365300|4983467|P2|Double-blind Phase|Withdrawal by Subject|1
1518539|NCT00365300|4983468|P1|Double-blind Phase|Withdrawal by Subject|0
1518540|NCT00365300|4983467|P2|Double-blind Phase|Noncompliance|1
1518541|NCT00365300|4983468|P1|Double-blind Phase|Noncompliance|1
1518542|NCT00365300|4983467|P2|Double-blind Phase|Failed to return|0
1518543|NCT00365300|4983468|P1|Double-blind Phase|Failed to return|1
1518544|NCT00365300|4983467|P2|Open-label Phase|Patient skipped open label phase|0
1518545|NCT00365300|4983468|P1|Open-label Phase|Patient skipped open label phase|1
1518546|NCT00365300|4983467|P2|Open-label Phase|Lack of Efficacy|0
1518547|NCT00365300|4983468|P1|Open-label Phase|Lack of Efficacy|1
1518548|NCT00365300|4983467|P2|Open-label Phase|Protocol Violation|0
1518549|NCT00365300|4983468|P1|Open-label Phase|Protocol Violation|1
1518550|NCT00365300|4983467|P2|Open-label Phase|Parent/Legal Guardian Request|0
1518551|NCT00365300|4983468|P1|Open-label Phase|Parent/Legal Guardian Request|4
1518552|NCT00365300|4983467|P2|Open-label Phase|Noncompliance|0
1518553|NCT00365300|4983468|P1|Open-label Phase|Noncompliance|9
1518554|NCT00365300|4983467|P2|Open-label Phase|Physician Decision|0
1518555|NCT00365300|4983468|P1|Open-label Phase|Physician Decision|1
1518556|NCT00365300|4983467|P2|Open-label Phase|Failed to Return|0
1518557|NCT00365300|4983468|P1|Open-label Phase|Failed to Return|1
1518558|NCT00365300|4983467|P2|Open-label Phase|Adverse Event|0
1518559|NCT00365300|4983468|P1|Open-label Phase|Adverse Event|4
1518560|NCT00365105|4983533|P2|Overall Study|Lost to Follow-up|0
1518561|NCT00365105|4983534|P1|Overall Study|Lost to Follow-up|1
1518562|NCT00365105|4983533|P2|Overall Study|Withdrawal by Subject|1
1518563|NCT00365105|4983534|P1|Overall Study|Withdrawal by Subject|1
1518564|NCT00365105|4983533|P2|Overall Study|Protocol Violation|3
1518565|NCT00365105|4983534|P1|Overall Study|Protocol Violation|4
1518566|NCT00364923|4983570|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
1518567|NCT00364923|4983570|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
1518568|NCT00364858|4983579|P2|Overall Study|Clinical baseline issue|1
1518569|NCT00364858|4983580|P1|Overall Study|Clinical baseline issue|0
1518570|NCT00364858|4983579|P2|Overall Study|Return to Q2 regimen|1
1518571|NCT00364858|4983580|P1|Overall Study|Return to Q2 regimen|0
1518572|NCT00364858|4983579|P2|Overall Study|Non-compliant|0
1518573|NCT00364858|4983580|P1|Overall Study|Non-compliant|1
1518574|NCT00364858|4983579|P2|Overall Study|Discontinuation at baseline|0
1518575|NCT00364858|4983580|P1|Overall Study|Discontinuation at baseline|1
1518576|NCT00364858|4983579|P2|Overall Study|Clinical failure|13
1518577|NCT00364858|4983580|P1|Overall Study|Clinical failure|2
1518578|NCT00364858|4983579|P2|Overall Study|Pregnancy|1
1518579|NCT00364858|4983580|P1|Overall Study|Pregnancy|1
1518580|NCT00364858|4983579|P2|Overall Study|Withdrawal by Subject|1
1518581|NCT00364858|4983580|P1|Overall Study|Withdrawal by Subject|1
1518582|NCT00364858|4983579|P2|Overall Study|Adverse Event|5
1518583|NCT00364858|4983580|P1|Overall Study|Adverse Event|1
1518584|NCT00364845|4983595|P2|Overall Study|Death|1
1518585|NCT00364845|4983596|P1|Overall Study|Death|0
1518586|NCT00364845|4983595|P2|Overall Study|Lost to Follow-up|1
1518587|NCT00364845|4983596|P1|Overall Study|Lost to Follow-up|0
1518588|NCT00364845|4983595|P2|Overall Study|Physician Decision|8
1518589|NCT00364845|4983596|P1|Overall Study|Physician Decision|8
1518590|NCT00364845|4983595|P2|Overall Study|Withdrawal by Subject|1
1518591|NCT00364845|4983596|P1|Overall Study|Withdrawal by Subject|2
1518592|NCT00364845|4983595|P2|Overall Study|Adverse Event|0
1518593|NCT00364845|4983596|P1|Overall Study|Adverse Event|1
1518594|NCT00364832|4983617|P12|Extension Year 2|Early Withdrawals|3
1518595|NCT00364832|4983618|P11|Extension Year 2|Early Withdrawals|5
1518596|NCT00364832|4983619|P10|Extension Year 2|Early Withdrawals|5
1518597|NCT00364832|4983620|P9|Extension Year 2|Early Withdrawals|0
1518598|NCT00364832|4983621|P8|Extension Year 2|Early Withdrawals|0
1518599|NCT00364832|4983622|P7|Extension Year 2|Early Withdrawals|0
1518600|NCT00364832|4983623|P6|Extension Year 2|Early Withdrawals|0
1518601|NCT00364832|4983624|P5|Extension Year 2|Early Withdrawals|0
1518602|NCT00364832|4983625|P4|Extension Year 2|Early Withdrawals|0
1518603|NCT00364832|4983626|P3|Extension Year 2|Early Withdrawals|0
1518604|NCT00364832|4983627|P2|Extension Year 2|Early Withdrawals|0
1518605|NCT00364832|4983628|P1|Extension Year 2|Early Withdrawals|0
1518606|NCT00364832|4983617|P12|Extension Year 1|Early Withdrawals|10
1518607|NCT00364832|4983618|P11|Extension Year 1|Early Withdrawals|2
1518608|NCT00364832|4983619|P10|Extension Year 1|Early Withdrawals|4
1518609|NCT00364832|4983620|P9|Extension Year 1|Early Withdrawals|0
1518610|NCT00364832|4983621|P8|Extension Year 1|Early Withdrawals|0
1518611|NCT00364832|4983622|P7|Extension Year 1|Early Withdrawals|0
1518612|NCT00364832|4983623|P6|Extension Year 1|Early Withdrawals|0
1518613|NCT00364832|4983624|P5|Extension Year 1|Early Withdrawals|0
1518614|NCT00364832|4983625|P4|Extension Year 1|Early Withdrawals|0
1518615|NCT00364832|4983626|P3|Extension Year 1|Early Withdrawals|0
1518616|NCT00364832|4983627|P2|Extension Year 1|Early Withdrawals|0
1518617|NCT00364832|4983628|P1|Extension Year 1|Early Withdrawals|0
1518618|NCT00364832|4983617|P12|Core Period|Early Withdrawals|0
1518619|NCT00364832|4983618|P11|Core Period|Early Withdrawals|0
1518620|NCT00364832|4983619|P10|Core Period|Early Withdrawals|0
1518621|NCT00364832|4983620|P9|Core Period|Early Withdrawals|0
1518622|NCT00364832|4983621|P8|Core Period|Early Withdrawals|1
1518623|NCT00364832|4983622|P7|Core Period|Early Withdrawals|4
1518624|NCT00364832|4983623|P6|Core Period|Early Withdrawals|0
1518625|NCT00364832|4983624|P5|Core Period|Early Withdrawals|0
1518626|NCT00364832|4983625|P4|Core Period|Early Withdrawals|1
1518627|NCT00364832|4983626|P3|Core Period|Early Withdrawals|1
1518628|NCT00364832|4983627|P2|Core Period|Early Withdrawals|2
1518629|NCT00364832|4983628|P1|Core Period|Early Withdrawals|2
1518630|NCT00364793|4983693|P4|Overall Study|Withdrawal by Subject|0
1518631|NCT00364793|4983694|P3|Overall Study|Withdrawal by Subject|0
1518632|NCT00364793|4983695|P2|Overall Study|Withdrawal by Subject|1
1518633|NCT00364793|4983696|P1|Overall Study|Withdrawal by Subject|0
1518634|NCT00364793|4983693|P4|Overall Study|No longer meets criteria|1
1518635|NCT00364793|4983694|P3|Overall Study|No longer meets criteria|0
1518636|NCT00364793|4983695|P2|Overall Study|No longer meets criteria|0
1518637|NCT00364793|4983696|P1|Overall Study|No longer meets criteria|0
1518638|NCT00364793|4983693|P4|Overall Study|Poor or non-compliance|1
1518639|NCT00364793|4983694|P3|Overall Study|Poor or non-compliance|0
1518640|NCT00364793|4983695|P2|Overall Study|Poor or non-compliance|1
1518641|NCT00364793|4983696|P1|Overall Study|Poor or non-compliance|1
1518642|NCT00364793|4983693|P4|Overall Study|Lost to Follow-up|0
1518643|NCT00364793|4983694|P3|Overall Study|Lost to Follow-up|2
1518644|NCT00364793|4983695|P2|Overall Study|Lost to Follow-up|0
1518645|NCT00364793|4983696|P1|Overall Study|Lost to Follow-up|1
1518646|NCT00364793|4983693|P4|Overall Study|Lack of Efficacy|1
1518647|NCT00364793|4983694|P3|Overall Study|Lack of Efficacy|1
1518648|NCT00364793|4983695|P2|Overall Study|Lack of Efficacy|3
1518649|NCT00364793|4983696|P1|Overall Study|Lack of Efficacy|3
1518650|NCT00364793|4983693|P4|Overall Study|Death|0
1518651|NCT00364793|4983694|P3|Overall Study|Death|1
1518652|NCT00364793|4983695|P2|Overall Study|Death|0
1518653|NCT00364793|4983696|P1|Overall Study|Death|1
1518654|NCT00364793|4983693|P4|Overall Study|Adverse Event|0
1518655|NCT00364793|4983694|P3|Overall Study|Adverse Event|0
1518656|NCT00364793|4983695|P2|Overall Study|Adverse Event|0
1518657|NCT00364793|4983696|P1|Overall Study|Adverse Event|2
1518658|NCT00364611|4983832|P2|Overall Study|Receiving Liver Ablation|1
1518659|NCT00364611|4983833|P1|Overall Study|Receiving Liver Ablation|0
1518660|NCT00364611|4983832|P2|Overall Study|Presumed CR on Study|1
1518661|NCT00364611|4983833|P1|Overall Study|Presumed CR on Study|0
1518662|NCT00364611|4983832|P2|Overall Study|Found Ineligible|0
1518663|NCT00364611|4983833|P1|Overall Study|Found Ineligible|1
1518664|NCT00364611|4983832|P2|Overall Study|Investigator decision|2
1518665|NCT00364611|4983833|P1|Overall Study|Investigator decision|2
1518666|NCT00364611|4983832|P2|Overall Study|Disease Progression|8
1518667|NCT00364611|4983833|P1|Overall Study|Disease Progression|38
1518668|NCT00364611|4983832|P2|Overall Study|Participant's Request|4
1518669|NCT00364611|4983833|P1|Overall Study|Participant's Request|3
1518670|NCT00364611|4983832|P2|Overall Study|Adverse Event|4
1518671|NCT00364611|4983833|P1|Overall Study|Adverse Event|7
1518672|NCT00364611|4983832|P2|Overall Study|Did not receive study medication|1
1518673|NCT00364611|4983833|P1|Overall Study|Did not receive study medication|0
1518674|NCT00364533|4983856|P5|Overall Study|Protocol Violation|0
1518675|NCT00364533|4983857|P4|Overall Study|Protocol Violation|0
1518676|NCT00364533|4983858|P3|Overall Study|Protocol Violation|0
1518677|NCT00364533|4983859|P2|Overall Study|Protocol Violation|1
1518678|NCT00364533|4983860|P1|Overall Study|Protocol Violation|1
1518679|NCT00364533|4983856|P5|Overall Study|Non-compliance|0
1518680|NCT00364533|4983857|P4|Overall Study|Non-compliance|0
1518681|NCT00364533|4983858|P3|Overall Study|Non-compliance|0
1518682|NCT00364533|4983859|P2|Overall Study|Non-compliance|0
1518683|NCT00364533|4983860|P1|Overall Study|Non-compliance|1
1518684|NCT00364533|4983856|P5|Overall Study|Variations in drug compliance|0
1518685|NCT00364533|4983857|P4|Overall Study|Variations in drug compliance|0
1518686|NCT00364533|4983858|P3|Overall Study|Variations in drug compliance|1
1518687|NCT00364533|4983859|P2|Overall Study|Variations in drug compliance|1
1518688|NCT00364533|4983860|P1|Overall Study|Variations in drug compliance|2
1518689|NCT00364533|4983856|P5|Overall Study|Subject discharged from hospital|1
1518690|NCT00364533|4983857|P4|Overall Study|Subject discharged from hospital|3
1518691|NCT00364533|4983858|P3|Overall Study|Subject discharged from hospital|2
1518692|NCT00364533|4983859|P2|Overall Study|Subject discharged from hospital|1
1518693|NCT00364533|4983860|P1|Overall Study|Subject discharged from hospital|4
1518694|NCT00364533|4983856|P5|Overall Study|Lack of Efficacy|42
1518695|NCT00364533|4983857|P4|Overall Study|Lack of Efficacy|17
1518696|NCT00364533|4983858|P3|Overall Study|Lack of Efficacy|21
1518697|NCT00364533|4983859|P2|Overall Study|Lack of Efficacy|22
1518698|NCT00364533|4983860|P1|Overall Study|Lack of Efficacy|22
1518699|NCT00364533|4983856|P5|Overall Study|Withdrawal by Subject|6
1518700|NCT00364533|4983857|P4|Overall Study|Withdrawal by Subject|6
1518701|NCT00364533|4983858|P3|Overall Study|Withdrawal by Subject|6
1518702|NCT00364533|4983859|P2|Overall Study|Withdrawal by Subject|8
1518703|NCT00364533|4983860|P1|Overall Study|Withdrawal by Subject|4
1518704|NCT00364533|4983856|P5|Overall Study|Adverse Event|2
1518705|NCT00364533|4983857|P4|Overall Study|Adverse Event|5
1518706|NCT00364533|4983858|P3|Overall Study|Adverse Event|15
1518707|NCT00364533|4983859|P2|Overall Study|Adverse Event|7
1518708|NCT00364533|4983860|P1|Overall Study|Adverse Event|8
1518709|NCT00364351|4983893|P2|Overall Study|Randomised treatment not started|3
1518710|NCT00364351|4983894|P1|Overall Study|Randomised treatment not started|0
1518711|NCT00364351|4983893|P2|Overall Study|Patient could not travel to site|1
1518712|NCT00364351|4983894|P1|Overall Study|Patient could not travel to site|0
1518713|NCT00364351|4983893|P2|Overall Study|Investigator error|2
1518714|NCT00364351|4983894|P1|Overall Study|Investigator error|0
1518715|NCT00364351|4983893|P2|Overall Study|Poor treatment compliance|3
1518716|NCT00364351|4983894|P1|Overall Study|Poor treatment compliance|0
1518717|NCT00364351|4983893|P2|Overall Study|Sponsor decision|0
1518718|NCT00364351|4983894|P1|Overall Study|Sponsor decision|1
1518719|NCT00364351|4983893|P2|Overall Study|Incorrect enrollment|1
1518720|NCT00364351|4983894|P1|Overall Study|Incorrect enrollment|1
1518721|NCT00364351|4983893|P2|Overall Study|Withdrawal by Subject|29
1518722|NCT00364351|4983894|P1|Overall Study|Withdrawal by Subject|30
1518723|NCT00364351|4983893|P2|Overall Study|Lost to Follow-up|1
1518724|NCT00364351|4983894|P1|Overall Study|Lost to Follow-up|1
1518725|NCT00364351|4983893|P2|Overall Study|Prohibited concomitant medication|2
1518726|NCT00364351|4983894|P1|Overall Study|Prohibited concomitant medication|0
1518727|NCT00364351|4983893|P2|Overall Study|Condition under investigation worsened|497
1518728|NCT00364351|4983894|P1|Overall Study|Condition under investigation worsened|469
1518729|NCT00364351|4983893|P2|Overall Study|Adverse Event|44
1518730|NCT00364351|4983894|P1|Overall Study|Adverse Event|90
1518731|NCT00364286|4983912|P1|Overall Study|Adverse Event|2
1518732|NCT00364286|4983912|P1|Overall Study|Withdrawal by Subject|1
1518733|NCT00364182|4983919|P3|Third Intervention|Lost to Follow-up|1
1518734|NCT00364182|4983920|P2|Third Intervention|Lost to Follow-up|0
1518735|NCT00364182|4983921|P1|Third Intervention|Lost to Follow-up|0
1518736|NCT00364182|4983919|P3|Third Intervention|non-compliance|0
1518737|NCT00364182|4983920|P2|Third Intervention|non-compliance|1
1518738|NCT00364182|4983921|P1|Third Intervention|non-compliance|0
1518739|NCT00364182|4983919|P3|Second Intervention|Adverse Event|1
1518740|NCT00364182|4983920|P2|Second Intervention|Adverse Event|0
1518741|NCT00364182|4983921|P1|Second Intervention|Adverse Event|0
1518742|NCT00364182|4983919|P3|Second Intervention|Protocol Violation|0
1518743|NCT00364182|4983920|P2|Second Intervention|Protocol Violation|1
1518744|NCT00364182|4983921|P1|Second Intervention|Protocol Violation|0
1518745|NCT00364182|4983919|P3|Second Intervention|non-compliance|1
1518746|NCT00364182|4983920|P2|Second Intervention|non-compliance|1
1518747|NCT00364182|4983921|P1|Second Intervention|non-compliance|0
1518748|NCT00364182|4983919|P3|First Intervention|Withdrawal by Subject|0
1518749|NCT00364182|4983920|P2|First Intervention|Withdrawal by Subject|0
1518750|NCT00364182|4983921|P1|First Intervention|Withdrawal by Subject|2
1518751|NCT00364182|4983919|P3|First Intervention|Secondary prophylaxis|0
1518752|NCT00364182|4983920|P2|First Intervention|Secondary prophylaxis|0
1518753|NCT00364182|4983921|P1|First Intervention|Secondary prophylaxis|1
1518754|NCT00364156|4983955|P2|Overall Study|Protocol Violation|1
1518755|NCT00364156|4983956|P1|Overall Study|Protocol Violation|6
1518756|NCT00364156|4983955|P2|Overall Study|Withdrawal by Subject|80
1518757|NCT00364156|4983956|P1|Overall Study|Withdrawal by Subject|73
1518758|NCT00364130|4983964|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
1518759|NCT00364130|4983965|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
1518760|NCT00364130|4983964|P2|Intervention Period|Withdrawal by Subject|5
1518761|NCT00364130|4983965|P1|Intervention Period|Withdrawal by Subject|4
1518762|NCT00364130|4983964|P2|Intervention Period|Pregnancy|0
1518763|NCT00364130|4983965|P1|Intervention Period|Pregnancy|1
1518764|NCT00364130|4983964|P2|Intervention Period|Lost to Follow-up|3
1518765|NCT00364130|4983965|P1|Intervention Period|Lost to Follow-up|4
1518766|NCT00364013|4983987|P2|Overall Study|Ongoing|13
1518767|NCT00364013|4983988|P1|Overall Study|Ongoing|20
1518768|NCT00364013|4983987|P2|Overall Study|Other|47
1518769|NCT00364013|4983988|P1|Overall Study|Other|41
1518770|NCT00364013|4983987|P2|Overall Study|Protocol-specified criteria|6
1518771|NCT00364013|4983988|P1|Overall Study|Protocol-specified criteria|6
1518772|NCT00364013|4983987|P2|Overall Study|Lost to Follow-up|3
1518773|NCT00364013|4983988|P1|Overall Study|Lost to Follow-up|10
1518774|NCT00364013|4983987|P2|Overall Study|Physician Decision|3
1518775|NCT00364013|4983988|P1|Overall Study|Physician Decision|3
1518776|NCT00364013|4983987|P2|Overall Study|Withdrawal by Subject|18
1518777|NCT00364013|4983988|P1|Overall Study|Withdrawal by Subject|13
1518778|NCT00364013|4983987|P2|Overall Study|Adverse Event|3
1518779|NCT00364013|4983988|P1|Overall Study|Adverse Event|4
1518780|NCT00364013|4983987|P2|Overall Study|Ineligibility determined|2
1518781|NCT00364013|4983988|P1|Overall Study|Ineligibility determined|4
1518782|NCT00363896|4984016|P2|Overall Study|Other|2
1518783|NCT00363896|4984017|P1|Overall Study|Other|1
1518784|NCT00363896|4984016|P2|Overall Study|Non-fulfilment of entry criteria|0
1518785|NCT00363896|4984017|P1|Overall Study|Non-fulfilment of entry criteria|1
1518786|NCT00363896|4984016|P2|Overall Study|Lost to Follow-up|0
1518787|NCT00363896|4984017|P1|Overall Study|Lost to Follow-up|3
1518788|NCT00363896|4984016|P2|Overall Study|Protocol Violation|1
1518789|NCT00363896|4984017|P1|Overall Study|Protocol Violation|6
1518790|NCT00363896|4984016|P2|Overall Study|Lack of Efficacy|8
1518791|NCT00363896|4984017|P1|Overall Study|Lack of Efficacy|12
1518792|NCT00363896|4984016|P2|Overall Study|COPD exacerbation|7
1518793|NCT00363896|4984017|P1|Overall Study|COPD exacerbation|13
1518794|NCT00363896|4984016|P2|Overall Study|Adverse Event|13
1518795|NCT00363896|4984017|P1|Overall Study|Adverse Event|24
1518796|NCT00363896|4984016|P2|Overall Study|Withdrawal by Subject|16
1518797|NCT00363896|4984017|P1|Overall Study|Withdrawal by Subject|29
1518798|NCT00363545|4984065|P2|Overall Study|Others|0
1518799|NCT00363545|4984066|P1|Overall Study|Others|1
1518800|NCT00363545|4984065|P2|Overall Study|Lost to follow-up (complete vaccination)|17
1518801|NCT00363545|4984066|P1|Overall Study|Lost to follow-up (complete vaccination)|14
1518802|NCT00363545|4984065|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
1518803|NCT00363545|4984066|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
1518804|NCT00363545|4984065|P2|Overall Study|Migrated/moved from study area|6
1518805|NCT00363545|4984066|P1|Overall Study|Migrated/moved from study area|3
1518806|NCT00363545|4984065|P2|Overall Study|Withdrawal by Subject|15
1518807|NCT00363545|4984066|P1|Overall Study|Withdrawal by Subject|12
1518808|NCT00363545|4984065|P2|Overall Study|Serious Adverse Event|1
1518809|NCT00363545|4984066|P1|Overall Study|Serious Adverse Event|0
1518810|NCT00363480|4984084|P1|Overall Study|Participant discontinued on its own|1
1518811|NCT00363480|4984084|P1|Overall Study|Non-compliance of subject|1
1518812|NCT00363480|4984084|P1|Overall Study|Withdrawal by Subject|5
1518813|NCT00363480|4984084|P1|Overall Study|Lost to Follow-up|5
1518814|NCT00363480|4984084|P1|Overall Study|Adverse Event|4
1518815|NCT00363480|4984084|P1|Overall Study|Criteria for treatment period not fulfil|1
1518816|NCT00363467|4984104|P1|Overall Study|Physician Decision|1
1518817|NCT00363415|4984114|P2|Overall Study|Protocol Violation|4
1518818|NCT00363415|4984115|P1|Overall Study|Protocol Violation|1
1518819|NCT00363415|4984114|P2|Overall Study|Lost to Follow-up|3
1518820|NCT00363415|4984115|P1|Overall Study|Lost to Follow-up|3
1518821|NCT00363415|4984114|P2|Overall Study|Withdrawal by Subject|15
1518822|NCT00363415|4984115|P1|Overall Study|Withdrawal by Subject|9
1518823|NCT00363415|4984114|P2|Overall Study|Entry Criteria Not Met|10
1518824|NCT00363415|4984115|P1|Overall Study|Entry Criteria Not Met|11
1518825|NCT00363415|4984114|P2|Overall Study|Physician Decision|35
1518826|NCT00363415|4984115|P1|Overall Study|Physician Decision|18
1518827|NCT00363415|4984114|P2|Overall Study|Adverse Event|15
1518828|NCT00363415|4984115|P1|Overall Study|Adverse Event|24
1518829|NCT00363415|4984114|P2|Overall Study|Death|29
1518830|NCT00363415|4984115|P1|Overall Study|Death|32
1518831|NCT00363415|4984114|P2|Overall Study|Sponsor Decision|31
1518832|NCT00363415|4984115|P1|Overall Study|Sponsor Decision|67
1518833|NCT00363415|4984114|P2|Overall Study|Progressive Disease|107
1518834|NCT00363415|4984115|P1|Overall Study|Progressive Disease|196
1518835|NCT00363311|4984133|P2|Overall Study|Participant Moved to Louisiana|1
1518836|NCT00363311|4984134|P1|Overall Study|Participant Moved to Louisiana|0
1518837|NCT00363311|4984133|P2|Overall Study|Withdrawn per Instructions of Monitor|1
1518838|NCT00363311|4984134|P1|Overall Study|Withdrawn per Instructions of Monitor|0
1518839|NCT00363311|4984133|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
1518840|NCT00363311|4984134|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
1518841|NCT00363311|4984133|P2|Overall Study|Participant Moved to Another Country|0
1518842|NCT00363311|4984134|P1|Overall Study|Participant Moved to Another Country|1
1518843|NCT00363311|4984133|P2|Overall Study|Participant Opted for Treatment|0
1518844|NCT00363311|4984134|P1|Overall Study|Participant Opted for Treatment|1
1518845|NCT00363311|4984133|P2|Overall Study|Prostate Volume/PSA Doubled|0
1518846|NCT00363311|4984134|P1|Overall Study|Prostate Volume/PSA Doubled|1
1518847|NCT00363311|4984133|P2|Overall Study|Participant Refused Biopsy|0
1518848|NCT00363311|4984134|P1|Overall Study|Participant Refused Biopsy|1
1518849|NCT00363311|4984133|P2|Overall Study|Non-Compliance|1
1518850|NCT00363311|4984134|P1|Overall Study|Non-Compliance|1
1518851|NCT00363311|4984133|P2|Overall Study|Disease Progression|26
1518852|NCT00363311|4984134|P1|Overall Study|Disease Progression|46
1518853|NCT00363311|4984133|P2|Overall Study|Sponsor Terminated Study|2
1518854|NCT00363311|4984134|P1|Overall Study|Sponsor Terminated Study|2
1518855|NCT00363311|4984133|P2|Overall Study|Physician Decision|1
1518856|NCT00363311|4984134|P1|Overall Study|Physician Decision|1
1518857|NCT00363311|4984133|P2|Overall Study|Withdrawal by Subject|6
1518858|NCT00363311|4984134|P1|Overall Study|Withdrawal by Subject|12
1518859|NCT00363311|4984133|P2|Overall Study|Protocol Violation|2
1518860|NCT00363311|4984134|P1|Overall Study|Protocol Violation|1
1518861|NCT00363311|4984133|P2|Overall Study|Lost to Follow-up|0
1518862|NCT00363311|4984134|P1|Overall Study|Lost to Follow-up|3
1518863|NCT00363311|4984133|P2|Overall Study|Adverse Event|4
1518864|NCT00363311|4984134|P1|Overall Study|Adverse Event|6
1518865|NCT00363298|4984200|P2|4-week Study Continuation Phase|Lack of Efficacy|0
1518866|NCT00363298|4984201|P1|4-week Study Continuation Phase|Lack of Efficacy|1
1518867|NCT00363298|4984200|P2|First Study Week|Lack of Efficacy|5
1518868|NCT00363298|4984201|P1|First Study Week|Lack of Efficacy|6
1518869|NCT00363246|4984209|P1|Overall Study|Eligibility changed due to Hospice move|5
1518870|NCT00363246|4984209|P1|Overall Study|Subject expressed security concerns|2
1518871|NCT00363246|4984209|P1|Overall Study|Stopped using wheelchair|11
1518872|NCT00363246|4984209|P1|Overall Study|Bad health|6
1518873|NCT00363246|4984209|P1|Overall Study|Lost to Follow-up|14
1518874|NCT00363246|4984209|P1|Overall Study|Withdrawal by Subject|19
1518875|NCT00363246|4984209|P1|Overall Study|Death|40
1518876|NCT00363142|4984227|P2|Overall Study|Withdrawal by Subject|1
1518877|NCT00363142|4984228|P1|Overall Study|Withdrawal by Subject|3
1518878|NCT00363142|4984227|P2|Overall Study|Non-compliance|1
1518879|NCT00363142|4984228|P1|Overall Study|Non-compliance|1
1518880|NCT00363142|4984227|P2|Overall Study|Lost to Follow-up|0
1518881|NCT00363142|4984228|P1|Overall Study|Lost to Follow-up|1
1518882|NCT00363142|4984227|P2|Overall Study|Lack of Efficacy|1
1518883|NCT00363142|4984228|P1|Overall Study|Lack of Efficacy|0
1518884|NCT00363142|4984227|P2|Overall Study|Adverse Event|0
1518885|NCT00363142|4984228|P1|Overall Study|Adverse Event|2
1518886|NCT00363129|4984257|P2|Overall Study|Other Reasons|3
1518887|NCT00363129|4984258|P1|Overall Study|Other Reasons|6
1518888|NCT00363129|4984257|P2|Overall Study|Death|1
1518889|NCT00363129|4984258|P1|Overall Study|Death|0
1518890|NCT00363129|4984257|P2|Overall Study|Other Medical Problems|4
1518891|NCT00363129|4984258|P1|Overall Study|Other Medical Problems|2
1518892|NCT00363129|4984257|P2|Overall Study|Alternate Treatment|4
1518893|NCT00363129|4984258|P1|Overall Study|Alternate Treatment|2
1518894|NCT00363129|4984257|P2|Overall Study|Adverse Event|3
1518895|NCT00363129|4984258|P1|Overall Study|Adverse Event|8
1518896|NCT00363129|4984257|P2|Overall Study|Withdrawal by Subject|18
1518897|NCT00363129|4984258|P1|Overall Study|Withdrawal by Subject|11
1518898|NCT00363051|4984301|P2|Overall Study|Death|2
1518899|NCT00363051|4984302|P1|Overall Study|Death|3
1518900|NCT00363051|4984301|P2|Overall Study|Protocol Violation|2
1518901|NCT00363051|4984302|P1|Overall Study|Protocol Violation|0
1518902|NCT00363051|4984301|P2|Overall Study|Lost to Follow-up|1
1518903|NCT00363051|4984302|P1|Overall Study|Lost to Follow-up|0
1518904|NCT00363051|4984301|P2|Overall Study|Withdrawal by Subject|3
1518905|NCT00363051|4984302|P1|Overall Study|Withdrawal by Subject|11
1518906|NCT00363051|4984301|P2|Overall Study|New Cancer Therapy|1
1518907|NCT00363051|4984302|P1|Overall Study|New Cancer Therapy|2
1518908|NCT00363051|4984301|P2|Overall Study|Adverse Event|12
1518909|NCT00363051|4984302|P1|Overall Study|Adverse Event|21
1518910|NCT00363051|4984301|P2|Overall Study|Adminstrative problems|1
1518911|NCT00363051|4984302|P1|Overall Study|Adminstrative problems|1
1518912|NCT00362648|4984351|P4|Overall Study|Withdrawal by Subject|6
1518913|NCT00362648|4984352|P3|Overall Study|Withdrawal by Subject|2
1518914|NCT00362648|4984353|P2|Overall Study|Withdrawal by Subject|42
1518915|NCT00362648|4984354|P1|Overall Study|Withdrawal by Subject|48
1518916|NCT00362648|4984351|P4|Overall Study|Protocol Violation|2
1518917|NCT00362648|4984352|P3|Overall Study|Protocol Violation|2
1518918|NCT00362648|4984353|P2|Overall Study|Protocol Violation|2
1518919|NCT00362648|4984354|P1|Overall Study|Protocol Violation|4
1518920|NCT00362648|4984351|P4|Overall Study|Lost to Follow-up|3
1518921|NCT00362648|4984352|P3|Overall Study|Lost to Follow-up|4
1518922|NCT00362648|4984353|P2|Overall Study|Lost to Follow-up|69
1518923|NCT00362648|4984354|P1|Overall Study|Lost to Follow-up|62
1518924|NCT00362648|4984351|P4|Overall Study|Adverse Event|0
1518925|NCT00362648|4984352|P3|Overall Study|Adverse Event|1
1518926|NCT00362648|4984353|P2|Overall Study|Adverse Event|21
1518927|NCT00362648|4984354|P1|Overall Study|Adverse Event|12
1518928|NCT00362609|4984372|P2|Overall Study|Protocol Violation|1
1518929|NCT00362609|4984373|P1|Overall Study|Protocol Violation|0
1518930|NCT00362609|4984372|P2|Overall Study|Withdrawal by Subject|1
1518931|NCT00362609|4984373|P1|Overall Study|Withdrawal by Subject|0
1518932|NCT00362414|4984454|P1|Overall Study|Adverse Event|1
1518933|NCT00362414|4984454|P1|Overall Study|Death|2
1518934|NCT00362375|4984483|P2|Overall Study|Lost to Follow-up|35
1518935|NCT00362375|4984484|P1|Overall Study|Lost to Follow-up|40
1518936|NCT00362336|4984501|P3|Overall Study|Withdrawal by Subject|1
1518937|NCT00362336|4984502|P2|Overall Study|Withdrawal by Subject|3
1518938|NCT00362336|4984503|P1|Overall Study|Withdrawal by Subject|3
1518939|NCT00362336|4984501|P3|Overall Study|Lost to Follow-up|0
1518940|NCT00362336|4984502|P2|Overall Study|Lost to Follow-up|4
1518941|NCT00362336|4984503|P1|Overall Study|Lost to Follow-up|6
1518942|NCT00362336|4984501|P3|Overall Study|Protocol Violation|1
1518943|NCT00362336|4984502|P2|Overall Study|Protocol Violation|0
1518944|NCT00362336|4984503|P1|Overall Study|Protocol Violation|0
1518945|NCT00362336|4984501|P3|Overall Study|Serious Adverse Event|1
1518946|NCT00362336|4984502|P2|Overall Study|Serious Adverse Event|0
1518947|NCT00362336|4984503|P1|Overall Study|Serious Adverse Event|1
1518948|NCT00362297|4984531|P2|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|4
1518949|NCT00362297|4984532|P1|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|0
1518950|NCT00362232|4984540|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
1518951|NCT00362232|4984541|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
1518952|NCT00362232|4984540|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
1518953|NCT00362232|4984541|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
1518954|NCT00362232|4984540|P2|Follow-up (30 (+ 5) Days)|Death|1
1518955|NCT00362232|4984541|P1|Follow-up (30 (+ 5) Days)|Death|1
1518956|NCT00362232|4984540|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
1518957|NCT00362232|4984541|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
1518958|NCT00362232|4984540|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
1518959|NCT00362232|4984541|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
1518960|NCT00362232|4984540|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
1518961|NCT00362232|4984541|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
1518962|NCT00362232|4984540|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
1518963|NCT00362232|4984541|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
1518964|NCT00362232|4984540|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
1518965|NCT00362232|4984541|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
1518966|NCT00362232|4984540|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
1518967|NCT00362232|4984541|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
1518968|NCT00362232|4984540|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
1518969|NCT00362232|4984541|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
1518970|NCT00362232|4984540|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
1518971|NCT00362232|4984541|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
1518972|NCT00362232|4984540|P2|Treatment (12 +/- 2 Days)|Death|3
1518973|NCT00362232|4984541|P1|Treatment (12 +/- 2 Days)|Death|1
1518974|NCT00362232|4984540|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
1518975|NCT00362232|4984541|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
1518976|NCT00362180|4984586|P9|Treated Period|Adverse Event|0
1518977|NCT00362180|4984587|P8|Treated Period|Adverse Event|1
1518978|NCT00362180|4984588|P7|Treated Period|Adverse Event|0
1518979|NCT00362180|4984589|P6|Treated Period|Adverse Event|1
1518980|NCT00362180|4984590|P5|Treated Period|Adverse Event|0
1518981|NCT00362180|4984591|P4|Treated Period|Adverse Event|0
1518982|NCT00362180|4984592|P3|Treated Period|Adverse Event|0
1518983|NCT00362180|4984593|P2|Treated Period|Adverse Event|0
1518984|NCT00362180|4984594|P1|Treated Period|Adverse Event|0
1518985|NCT00362180|4984586|P9|Treated Period|Withdrawal by Subject|0
1518986|NCT00362180|4984587|P8|Treated Period|Withdrawal by Subject|0
1518987|NCT00362180|4984588|P7|Treated Period|Withdrawal by Subject|0
1518988|NCT00362180|4984589|P6|Treated Period|Withdrawal by Subject|0
1518989|NCT00362180|4984590|P5|Treated Period|Withdrawal by Subject|0
1518990|NCT00362180|4984591|P4|Treated Period|Withdrawal by Subject|0
1518991|NCT00362180|4984592|P3|Treated Period|Withdrawal by Subject|0
1518992|NCT00362180|4984593|P2|Treated Period|Withdrawal by Subject|0
1518993|NCT00362180|4984594|P1|Treated Period|Withdrawal by Subject|1
1518994|NCT00362115|4984666|P7|Overall Study|Other|0
1518995|NCT00362115|4984667|P6|Overall Study|Other|1
1518996|NCT00362115|4984668|P5|Overall Study|Other|0
1518997|NCT00362115|4984669|P4|Overall Study|Other|1
1518998|NCT00362115|4984670|P3|Overall Study|Other|0
1518999|NCT00362115|4984671|P2|Overall Study|Other|1
1519000|NCT00362115|4984672|P1|Overall Study|Other|0
1519001|NCT00362115|4984666|P7|Overall Study|Physician Decision|3
1519002|NCT00362115|4984667|P6|Overall Study|Physician Decision|0
1519003|NCT00362115|4984668|P5|Overall Study|Physician Decision|0
1519004|NCT00362115|4984669|P4|Overall Study|Physician Decision|0
1519005|NCT00362115|4984670|P3|Overall Study|Physician Decision|0
1519006|NCT00362115|4984671|P2|Overall Study|Physician Decision|0
1519007|NCT00362115|4984672|P1|Overall Study|Physician Decision|0
1519008|NCT00362115|4984666|P7|Overall Study|Lack of Efficacy|3
1519009|NCT00362115|4984667|P6|Overall Study|Lack of Efficacy|0
1519010|NCT00362115|4984668|P5|Overall Study|Lack of Efficacy|2
1519011|NCT00362115|4984669|P4|Overall Study|Lack of Efficacy|2
1519012|NCT00362115|4984670|P3|Overall Study|Lack of Efficacy|5
1519013|NCT00362115|4984671|P2|Overall Study|Lack of Efficacy|0
1519014|NCT00362115|4984672|P1|Overall Study|Lack of Efficacy|1
1519015|NCT00362115|4984666|P7|Overall Study|Withdrawal by Subject|4
1519016|NCT00362115|4984667|P6|Overall Study|Withdrawal by Subject|3
1519017|NCT00362115|4984668|P5|Overall Study|Withdrawal by Subject|1
1519018|NCT00362115|4984669|P4|Overall Study|Withdrawal by Subject|0
1519019|NCT00362115|4984670|P3|Overall Study|Withdrawal by Subject|1
1519020|NCT00362115|4984671|P2|Overall Study|Withdrawal by Subject|3
1519021|NCT00362115|4984672|P1|Overall Study|Withdrawal by Subject|1
1519022|NCT00362115|4984666|P7|Overall Study|Lost to Follow-up|1
1519023|NCT00362115|4984667|P6|Overall Study|Lost to Follow-up|0
1519024|NCT00362115|4984668|P5|Overall Study|Lost to Follow-up|2
1519025|NCT00362115|4984669|P4|Overall Study|Lost to Follow-up|0
1519026|NCT00362115|4984670|P3|Overall Study|Lost to Follow-up|0
1519027|NCT00362115|4984671|P2|Overall Study|Lost to Follow-up|1
1519028|NCT00362115|4984672|P1|Overall Study|Lost to Follow-up|0
1519029|NCT00362115|4984666|P7|Overall Study|Protocol Violation|0
1519030|NCT00362115|4984667|P6|Overall Study|Protocol Violation|1
1519031|NCT00362115|4984668|P5|Overall Study|Protocol Violation|0
1519032|NCT00362115|4984669|P4|Overall Study|Protocol Violation|0
1519033|NCT00362115|4984670|P3|Overall Study|Protocol Violation|0
1519034|NCT00362115|4984671|P2|Overall Study|Protocol Violation|0
1519035|NCT00362115|4984672|P1|Overall Study|Protocol Violation|0
1519036|NCT00362115|4984666|P7|Overall Study|Adverse Event|1
1519037|NCT00362115|4984667|P6|Overall Study|Adverse Event|2
1519038|NCT00362115|4984668|P5|Overall Study|Adverse Event|2
1519039|NCT00362115|4984669|P4|Overall Study|Adverse Event|1
1519040|NCT00362115|4984670|P3|Overall Study|Adverse Event|1
1519041|NCT00362115|4984671|P2|Overall Study|Adverse Event|1
1519042|NCT00362115|4984672|P1|Overall Study|Adverse Event|0
1519043|NCT00361634|4984845|P1|Overall Study|Withdrawal by Subject|1
1519044|NCT00361634|4984845|P1|Overall Study|Lost to Follow-up|1
1519045|NCT00361569|4984874|P4|Overall Study|Not specified by investigator|1
1519046|NCT00361569|4984875|P3|Overall Study|Not specified by investigator|0
1519047|NCT00361569|4984876|P2|Overall Study|Not specified by investigator|0
1519048|NCT00361569|4984877|P1|Overall Study|Not specified by investigator|2
1519049|NCT00361569|4984874|P4|Overall Study|Lost to Follow-up|2
1519050|NCT00361569|4984875|P3|Overall Study|Lost to Follow-up|3
1519051|NCT00361569|4984876|P2|Overall Study|Lost to Follow-up|3
1519052|NCT00361569|4984877|P1|Overall Study|Lost to Follow-up|2
1519053|NCT00361569|4984874|P4|Overall Study|Adverse Event|2
1519054|NCT00361569|4984875|P3|Overall Study|Adverse Event|2
1519055|NCT00361569|4984876|P2|Overall Study|Adverse Event|5
1519056|NCT00361569|4984877|P1|Overall Study|Adverse Event|3
1519057|NCT00361569|4984874|P4|Overall Study|Withdrawal by Subject|14
1519058|NCT00361569|4984875|P3|Overall Study|Withdrawal by Subject|9
1519059|NCT00361569|4984876|P2|Overall Study|Withdrawal by Subject|1
1519060|NCT00361569|4984877|P1|Overall Study|Withdrawal by Subject|2
1519061|NCT00361569|4984874|P4|Overall Study|Protocol Violation|2
1519062|NCT00361569|4984875|P3|Overall Study|Protocol Violation|4
1519063|NCT00361569|4984876|P2|Overall Study|Protocol Violation|2
1519064|NCT00361569|4984877|P1|Overall Study|Protocol Violation|3
1519065|NCT00361504|4984901|P2|Overall Study|All other|3
1519066|NCT00361504|4984902|P1|Overall Study|All other|28
1519067|NCT00361504|4984901|P2|Overall Study|Study medication non compliant|15
1519068|NCT00361504|4984902|P1|Overall Study|Study medication non compliant|42
1519069|NCT00361504|4984901|P2|Overall Study|Resolution of Pain|0
1519070|NCT00361504|4984902|P1|Overall Study|Resolution of Pain|2
1519071|NCT00361504|4984901|P2|Overall Study|Lack of Efficacy|7
1519072|NCT00361504|4984902|P1|Overall Study|Lack of Efficacy|72
1519073|NCT00361504|4984901|P2|Overall Study|Adverse Event|82
1519074|NCT00361504|4984902|P1|Overall Study|Adverse Event|203
1519075|NCT00361504|4984901|P2|Overall Study|Lost to Follow-up|7
1519076|NCT00361504|4984902|P1|Overall Study|Lost to Follow-up|40
1519077|NCT00361504|4984901|P2|Overall Study|Withdrawal by Subject|31
1519078|NCT00361504|4984902|P1|Overall Study|Withdrawal by Subject|94
1519079|NCT00361335|4984943|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
1519080|NCT00361335|4984944|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1519081|NCT00361335|4984945|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1519082|NCT00361335|4984946|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1519083|NCT00361335|4984947|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
1519084|NCT00361335|4984948|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1519085|NCT00361335|4984949|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1519086|NCT00361335|4984943|P7|SC Period: Week E0 to Week E24|Not specified|2
1519087|NCT00361335|4984944|P6|SC Period: Week E0 to Week E24|Not specified|1
1519088|NCT00361335|4984945|P5|SC Period: Week E0 to Week E24|Not specified|0
1519089|NCT00361335|4984946|P4|SC Period: Week E0 to Week E24|Not specified|1
1519090|NCT00361335|4984947|P3|SC Period: Week E0 to Week E24|Not specified|0
1519091|NCT00361335|4984948|P2|SC Period: Week E0 to Week E24|Not specified|0
1519092|NCT00361335|4984949|P1|SC Period: Week E0 to Week E24|Not specified|1
1519093|NCT00361335|4984943|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
1519094|NCT00361335|4984944|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
1519095|NCT00361335|4984945|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
1519096|NCT00361335|4984946|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
1519097|NCT00361335|4984947|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
1519098|NCT00361335|4984948|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
1519099|NCT00361335|4984949|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
1519100|NCT00361335|4984943|P7|SC Period: Week E0 to Week E24|Death|1
1519101|NCT00361335|4984944|P6|SC Period: Week E0 to Week E24|Death|0
1519102|NCT00361335|4984945|P5|SC Period: Week E0 to Week E24|Death|0
1519103|NCT00361335|4984946|P4|SC Period: Week E0 to Week E24|Death|0
1519104|NCT00361335|4984947|P3|SC Period: Week E0 to Week E24|Death|0
1519105|NCT00361335|4984948|P2|SC Period: Week E0 to Week E24|Death|0
1519106|NCT00361335|4984949|P1|SC Period: Week E0 to Week E24|Death|0
1519107|NCT00361335|4984943|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
1519108|NCT00361335|4984944|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1519109|NCT00361335|4984945|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1519110|NCT00361335|4984946|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1519111|NCT00361335|4984947|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
1519112|NCT00361335|4984948|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1519113|NCT00361335|4984949|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
1519114|NCT00361335|4984943|P7|SC Period: Week E0 to Week E24|Adverse Event|2
1519115|NCT00361335|4984944|P6|SC Period: Week E0 to Week E24|Adverse Event|0
1519116|NCT00361335|4984945|P5|SC Period: Week E0 to Week E24|Adverse Event|0
1519117|NCT00361335|4984946|P4|SC Period: Week E0 to Week E24|Adverse Event|2
1519118|NCT00361335|4984947|P3|SC Period: Week E0 to Week E24|Adverse Event|1
1519119|NCT00361335|4984948|P2|SC Period: Week E0 to Week E24|Adverse Event|2
1519120|NCT00361335|4984949|P1|SC Period: Week E0 to Week E24|Adverse Event|0
1519121|NCT00361335|4984943|P7|IV Period: Baseline to E0|Lack of Efficacy|0
1519122|NCT00361335|4984944|P6|IV Period: Baseline to E0|Lack of Efficacy|0
1519123|NCT00361335|4984945|P5|IV Period: Baseline to E0|Lack of Efficacy|8
1519124|NCT00361335|4984946|P4|IV Period: Baseline to E0|Lack of Efficacy|7
1519125|NCT00361335|4984947|P3|IV Period: Baseline to E0|Lack of Efficacy|3
1519126|NCT00361335|4984948|P2|IV Period: Baseline to E0|Lack of Efficacy|9
1519127|NCT00361335|4984949|P1|IV Period: Baseline to E0|Lack of Efficacy|5
1519128|NCT00361335|4984943|P7|IV Period: Baseline to E0|Not specified|0
1519129|NCT00361335|4984944|P6|IV Period: Baseline to E0|Not specified|0
1519130|NCT00361335|4984945|P5|IV Period: Baseline to E0|Not specified|2
1519131|NCT00361335|4984946|P4|IV Period: Baseline to E0|Not specified|3
1519132|NCT00361335|4984947|P3|IV Period: Baseline to E0|Not specified|9
1519133|NCT00361335|4984948|P2|IV Period: Baseline to E0|Not specified|9
1519134|NCT00361335|4984949|P1|IV Period: Baseline to E0|Not specified|2
1519135|NCT00361335|4984943|P7|IV Period: Baseline to E0|Worsening of RA|0
1519136|NCT00361335|4984944|P6|IV Period: Baseline to E0|Worsening of RA|0
1519137|NCT00361335|4984945|P5|IV Period: Baseline to E0|Worsening of RA|2
1519138|NCT00361335|4984946|P4|IV Period: Baseline to E0|Worsening of RA|4
1519139|NCT00361335|4984947|P3|IV Period: Baseline to E0|Worsening of RA|1
1519140|NCT00361335|4984948|P2|IV Period: Baseline to E0|Worsening of RA|5
1519141|NCT00361335|4984949|P1|IV Period: Baseline to E0|Worsening of RA|0
1519142|NCT00361335|4984943|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
1519143|NCT00361335|4984944|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
1519144|NCT00361335|4984945|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
1519145|NCT00361335|4984946|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
1519146|NCT00361335|4984947|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
1519147|NCT00361335|4984948|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
1519148|NCT00361335|4984949|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
1519149|NCT00361335|4984943|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
1519150|NCT00361335|4984944|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
1519151|NCT00361335|4984945|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
1519152|NCT00361335|4984946|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
1519153|NCT00361335|4984947|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
1519154|NCT00361335|4984948|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
1519155|NCT00361335|4984949|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
1519156|NCT00361335|4984943|P7|IV Period: Baseline to E0|Death|0
1519157|NCT00361335|4984944|P6|IV Period: Baseline to E0|Death|0
1519158|NCT00361335|4984945|P5|IV Period: Baseline to E0|Death|0
1519159|NCT00361335|4984946|P4|IV Period: Baseline to E0|Death|1
1519160|NCT00361335|4984947|P3|IV Period: Baseline to E0|Death|1
1519161|NCT00361335|4984948|P2|IV Period: Baseline to E0|Death|1
1519162|NCT00361335|4984949|P1|IV Period: Baseline to E0|Death|1
1519163|NCT00361335|4984943|P7|IV Period: Baseline to E0|Lost to Follow-up|0
1519164|NCT00361335|4984944|P6|IV Period: Baseline to E0|Lost to Follow-up|0
1519165|NCT00361335|4984945|P5|IV Period: Baseline to E0|Lost to Follow-up|2
1519166|NCT00361335|4984946|P4|IV Period: Baseline to E0|Lost to Follow-up|2
1519167|NCT00361335|4984947|P3|IV Period: Baseline to E0|Lost to Follow-up|0
1519168|NCT00361335|4984948|P2|IV Period: Baseline to E0|Lost to Follow-up|0
1519169|NCT00361335|4984949|P1|IV Period: Baseline to E0|Lost to Follow-up|1
1519170|NCT00361335|4984943|P7|IV Period: Baseline to E0|Adverse Event|0
1519171|NCT00361335|4984944|P6|IV Period: Baseline to E0|Adverse Event|0
1519172|NCT00361335|4984945|P5|IV Period: Baseline to E0|Adverse Event|8
1519173|NCT00361335|4984946|P4|IV Period: Baseline to E0|Adverse Event|9
1519174|NCT00361335|4984947|P3|IV Period: Baseline to E0|Adverse Event|5
1519175|NCT00361335|4984948|P2|IV Period: Baseline to E0|Adverse Event|4
1519176|NCT00361335|4984949|P1|IV Period: Baseline to E0|Adverse Event|9
1519177|NCT00361283|4984993|P1|Overall Study|Lost to Follow-up|27
1519178|NCT00361270|4985001|P4|Overall Study|Adverse Event|0
1519179|NCT00361270|4985002|P3|Overall Study|Adverse Event|1
1519180|NCT00361270|4985003|P2|Overall Study|Adverse Event|1
1519181|NCT00361270|4985004|P1|Overall Study|Adverse Event|0
1519182|NCT00361270|4985001|P4|Overall Study|Problems with Transportation|0
1519183|NCT00361270|4985002|P3|Overall Study|Problems with Transportation|0
1519184|NCT00361270|4985003|P2|Overall Study|Problems with Transportation|0
1519185|NCT00361270|4985004|P1|Overall Study|Problems with Transportation|4
1519186|NCT00361270|4985001|P4|Overall Study|Afraid of Hypnosis|0
1519187|NCT00361270|4985002|P3|Overall Study|Afraid of Hypnosis|0
1519188|NCT00361270|4985003|P2|Overall Study|Afraid of Hypnosis|2
1519189|NCT00361270|4985004|P1|Overall Study|Afraid of Hypnosis|1
1519190|NCT00361270|4985001|P4|Overall Study|Withdrawal by Subject|7
1519191|NCT00361270|4985002|P3|Overall Study|Withdrawal by Subject|3
1519192|NCT00361270|4985003|P2|Overall Study|Withdrawal by Subject|6
1519193|NCT00361270|4985004|P1|Overall Study|Withdrawal by Subject|6
1519194|NCT00361270|4985001|P4|Overall Study|Protocol Violation|4
1519195|NCT00361270|4985002|P3|Overall Study|Protocol Violation|5
1519196|NCT00361270|4985003|P2|Overall Study|Protocol Violation|4
1519197|NCT00361270|4985004|P1|Overall Study|Protocol Violation|9
1519198|NCT00361270|4985001|P4|Overall Study|Physician Decision|0
1519199|NCT00361270|4985002|P3|Overall Study|Physician Decision|1
1519200|NCT00361270|4985003|P2|Overall Study|Physician Decision|0
1519201|NCT00361270|4985004|P1|Overall Study|Physician Decision|0
1519202|NCT00361270|4985001|P4|Overall Study|Lost to Follow-up|0
1519203|NCT00361270|4985002|P3|Overall Study|Lost to Follow-up|0
1519204|NCT00361270|4985003|P2|Overall Study|Lost to Follow-up|1
1519205|NCT00361270|4985004|P1|Overall Study|Lost to Follow-up|4
1519206|NCT00361270|4985001|P4|Overall Study|Death|2
1519207|NCT00361270|4985002|P3|Overall Study|Death|0
1519208|NCT00361270|4985003|P2|Overall Study|Death|0
1519209|NCT00361270|4985004|P1|Overall Study|Death|0
1519210|NCT00361231|4985077|P1|Overall Study|Adverse Event|6
1519211|NCT00361231|4985077|P1|Overall Study|Withdrawal by Subject|4
1519212|NCT00361231|4985077|P1|Overall Study|Radiographic disease progression|16
1519213|NCT00361231|4985077|P1|Overall Study|Symptomatic deterioration|5
1519214|NCT00361231|4985077|P1|Overall Study|Physician Decision|3
1519215|NCT00361218|4985082|P1|Overall Study|terminated / withdrawn due to toxicity /|5
1519216|NCT00361218|4985082|P1|Overall Study|Personal Reasons|7
1519217|NCT00361218|4985082|P1|Overall Study|Lost to Follow-up|11
1519218|NCT00360698|4985161|P2|Treatment Period|Early termination by error|1
1519219|NCT00360698|4985162|P1|Treatment Period|Early termination by error|0
1519220|NCT00360698|4985161|P2|Treatment Period|Non compliance with treatment procedure|0
1519221|NCT00360698|4985162|P1|Treatment Period|Non compliance with treatment procedure|1
1519222|NCT00360698|4985161|P2|Run-In|Need of insulin with meals|1
1519223|NCT00360698|4985162|P1|Run-In|Need of insulin with meals|0
1519224|NCT00360698|4985161|P2|Run-In|Patient personal reasons|2
1519225|NCT00360698|4985162|P1|Run-In|Patient personal reasons|0
1519226|NCT00360698|4985161|P2|Run-In|Patient did not meet inclusion criteria|1
1519227|NCT00360698|4985162|P1|Run-In|Patient did not meet inclusion criteria|0
1519228|NCT00360698|4985161|P2|Run-In|Sponsor request|2
1519229|NCT00360698|4985162|P1|Run-In|Sponsor request|0
1519230|NCT00360698|4985161|P2|Run-In|Non compliance with treatment procedure|1
1519231|NCT00360698|4985162|P1|Run-In|Non compliance with treatment procedure|0
1519232|NCT00360698|4985161|P2|Run-In|Withdrawal by Subject|2
1519233|NCT00360698|4985162|P1|Run-In|Withdrawal by Subject|0
1519234|NCT00360698|4985161|P2|Run-In|Physician Decision|1
1519235|NCT00360698|4985162|P1|Run-In|Physician Decision|0
1519236|NCT00360568|4985207|P2|Overall Study|Withdrawal by Subject|3
1519237|NCT00360568|4985208|P1|Overall Study|Withdrawal by Subject|0
1519238|NCT00360568|4985207|P2|Overall Study|Lack of Efficacy|0
1519239|NCT00360568|4985208|P1|Overall Study|Lack of Efficacy|1
1519240|NCT00360568|4985207|P2|Overall Study|Adverse Event|2
1519241|NCT00360568|4985208|P1|Overall Study|Adverse Event|1
1519242|NCT00360529|4985339|P3|Overall Study|Reason discontinued not explained above|11
1519243|NCT00360529|4985340|P2|Overall Study|Reason discontinued not explained above|9
1519244|NCT00360529|4985341|P1|Overall Study|Reason discontinued not explained above|4
1519245|NCT00360529|4985339|P3|Overall Study|Lack of Efficacy|5
1519246|NCT00360529|4985340|P2|Overall Study|Lack of Efficacy|6
1519247|NCT00360529|4985341|P1|Overall Study|Lack of Efficacy|8
1519248|NCT00360529|4985339|P3|Overall Study|Withdrawal by Subject|18
1519249|NCT00360529|4985340|P2|Overall Study|Withdrawal by Subject|14
1519250|NCT00360529|4985341|P1|Overall Study|Withdrawal by Subject|22
1519251|NCT00360529|4985339|P3|Overall Study|Lost to Follow-up|13
1519252|NCT00360529|4985340|P2|Overall Study|Lost to Follow-up|10
1519253|NCT00360529|4985341|P1|Overall Study|Lost to Follow-up|14
1519254|NCT00360529|4985339|P3|Overall Study|Protocol Violation|11
1519255|NCT00360529|4985340|P2|Overall Study|Protocol Violation|3
1519256|NCT00360529|4985341|P1|Overall Study|Protocol Violation|3
1519257|NCT00360529|4985339|P3|Overall Study|Adverse Event|33
1519258|NCT00360529|4985340|P2|Overall Study|Adverse Event|23
1519259|NCT00360529|4985341|P1|Overall Study|Adverse Event|10
1519260|NCT00360490|4985369|P2|Overall Study|Withdrawal by Subject|3
1519261|NCT00360490|4985370|P1|Overall Study|Withdrawal by Subject|1
1519262|NCT00360490|4985369|P2|Overall Study|Protocol Violation|4
1519263|NCT00360490|4985370|P1|Overall Study|Protocol Violation|0
1519264|NCT00360490|4985369|P2|Overall Study|Physician Decision|1
1519265|NCT00360490|4985370|P1|Overall Study|Physician Decision|2
1519266|NCT00360490|4985369|P2|Overall Study|Lost to Follow-up|1
1519267|NCT00360490|4985370|P1|Overall Study|Lost to Follow-up|2
1519268|NCT00360490|4985369|P2|Overall Study|Adverse Event|2
1519269|NCT00360490|4985370|P1|Overall Study|Adverse Event|4
1519270|NCT00360412|4985405|P2|Overall Study|Study termination by Sponsor|469
1519271|NCT00360412|4985406|P1|Overall Study|Study termination by Sponsor|214
1519272|NCT00360412|4985405|P2|Overall Study|Not specified|6
1519273|NCT00360412|4985406|P1|Overall Study|Not specified|5
1519274|NCT00360412|4985405|P2|Overall Study|Physician Decision|4
1519275|NCT00360412|4985406|P1|Overall Study|Physician Decision|2
1519276|NCT00360412|4985405|P2|Overall Study|Lack of therapeutic efficacy|61
1519277|NCT00360412|4985406|P1|Overall Study|Lack of therapeutic efficacy|46
1519278|NCT00360412|4985405|P2|Overall Study|Patient withdrew consent|52
1519279|NCT00360412|4985406|P1|Overall Study|Patient withdrew consent|27
1519280|NCT00360412|4985405|P2|Overall Study|Protocol Violation|5
1519281|NCT00360412|4985406|P1|Overall Study|Protocol Violation|2
1519282|NCT00360412|4985405|P2|Overall Study|Adverse Event|65
1519283|NCT00360412|4985406|P1|Overall Study|Adverse Event|37
1519284|NCT00360334|4985453|P2|Overall Study|Subject decision|2
1519285|NCT00360334|4985454|P1|Overall Study|Subject decision|8
1519286|NCT00360334|4985453|P2|Overall Study|Entry criterion not met|2
1519287|NCT00360334|4985454|P1|Overall Study|Entry criterion not met|1
1519288|NCT00360334|4985453|P2|Overall Study|Lack of Efficacy|1
1519289|NCT00360334|4985454|P1|Overall Study|Lack of Efficacy|0
1519290|NCT00360334|4985453|P2|Overall Study|Physician Decision|3
1519291|NCT00360334|4985454|P1|Overall Study|Physician Decision|2
1519292|NCT00360334|4985453|P2|Overall Study|Protocol Violation|1
1519293|NCT00360334|4985454|P1|Overall Study|Protocol Violation|1
1519294|NCT00360334|4985453|P2|Overall Study|Adverse Event|4
1519295|NCT00360334|4985454|P1|Overall Study|Adverse Event|7
1519296|NCT00360308|4985517|P3|Overall Study|Study termination by sponsor|44
1519297|NCT00360308|4985518|P2|Overall Study|Study termination by sponsor|55
1519298|NCT00360308|4985519|P1|Overall Study|Study termination by sponsor|43
1519299|NCT00360308|4985517|P3|Overall Study|Not Specified|1
1519300|NCT00360308|4985518|P2|Overall Study|Not Specified|1
1519301|NCT00360308|4985519|P1|Overall Study|Not Specified|2
1519302|NCT00360308|4985517|P3|Overall Study|Lack of Efficacy|2
1519303|NCT00360308|4985518|P2|Overall Study|Lack of Efficacy|0
1519304|NCT00360308|4985519|P1|Overall Study|Lack of Efficacy|3
1519305|NCT00360308|4985517|P3|Overall Study|Withdrawal by Subject|14
1519306|NCT00360308|4985518|P2|Overall Study|Withdrawal by Subject|7
1519307|NCT00360308|4985519|P1|Overall Study|Withdrawal by Subject|11
1519308|NCT00360308|4985517|P3|Overall Study|Protocol Violation|2
1519309|NCT00360308|4985518|P2|Overall Study|Protocol Violation|1
1519310|NCT00360308|4985519|P1|Overall Study|Protocol Violation|2
1519311|NCT00360308|4985517|P3|Overall Study|Abnormal Laboratory Value(s)|0
1519312|NCT00360308|4985518|P2|Overall Study|Abnormal Laboratory Value(s)|1
1519313|NCT00360308|4985519|P1|Overall Study|Abnormal Laboratory Value(s)|0
1519314|NCT00360308|4985517|P3|Overall Study|Adverse Event|25
1519315|NCT00360308|4985518|P2|Overall Study|Adverse Event|14
1519316|NCT00360308|4985519|P1|Overall Study|Adverse Event|15
1519317|NCT00360282|4985536|P4|Second Intervention|Adverse Event|0
1519318|NCT00360282|4985537|P3|Second Intervention|Adverse Event|0
1519319|NCT00360282|4985538|P2|Second Intervention|Adverse Event|1
1519320|NCT00360282|4985539|P1|Second Intervention|Adverse Event|0
1519321|NCT00360282|4985536|P4|Washout 1-3 Weeks|Lost to Follow-up|0
1519322|NCT00360282|4985537|P3|Washout 1-3 Weeks|Lost to Follow-up|1
1519323|NCT00360282|4985538|P2|Washout 1-3 Weeks|Lost to Follow-up|0
1519324|NCT00360282|4985539|P1|Washout 1-3 Weeks|Lost to Follow-up|0
1519325|NCT00360269|4985551|P2|Overall Study|Withdrawal by Subject|1
1519326|NCT00360269|4985552|P1|Overall Study|Withdrawal by Subject|1
1519327|NCT00360269|4985551|P2|Overall Study|Adverse Event|0
1519328|NCT00360269|4985552|P1|Overall Study|Adverse Event|1
1519329|NCT00360269|4985551|P2|Overall Study|Physician Decision|2
1519330|NCT00360269|4985552|P1|Overall Study|Physician Decision|1
1519331|NCT00360269|4985551|P2|Overall Study|Lost to Follow-up|9
1519332|NCT00360269|4985552|P1|Overall Study|Lost to Follow-up|7
1519333|NCT00360230|4985594|P7|Overall Study|Death|1
1519334|NCT00360230|4985595|P6|Overall Study|Death|1
1519335|NCT00360230|4985596|P5|Overall Study|Death|0
1519336|NCT00360230|4985597|P4|Overall Study|Death|0
1519337|NCT00360230|4985598|P3|Overall Study|Death|0
1519338|NCT00360230|4985599|P2|Overall Study|Death|1
1519339|NCT00360230|4985600|P1|Overall Study|Death|0
1519340|NCT00360230|4985594|P7|Overall Study|Protocol Violation|0
1519341|NCT00360230|4985595|P6|Overall Study|Protocol Violation|1
1519342|NCT00360230|4985596|P5|Overall Study|Protocol Violation|0
1519343|NCT00360230|4985597|P4|Overall Study|Protocol Violation|0
1519344|NCT00360230|4985598|P3|Overall Study|Protocol Violation|0
1519345|NCT00360230|4985599|P2|Overall Study|Protocol Violation|0
1519346|NCT00360230|4985600|P1|Overall Study|Protocol Violation|0
1519347|NCT00360230|4985594|P7|Overall Study|Not specified|0
1519348|NCT00360230|4985595|P6|Overall Study|Not specified|0
1519349|NCT00360230|4985596|P5|Overall Study|Not specified|0
1519350|NCT00360230|4985597|P4|Overall Study|Not specified|0
1519351|NCT00360230|4985598|P3|Overall Study|Not specified|0
1519352|NCT00360230|4985599|P2|Overall Study|Not specified|0
1519353|NCT00360230|4985600|P1|Overall Study|Not specified|1
1519354|NCT00360230|4985594|P7|Overall Study|Migrated|1
1519355|NCT00360230|4985595|P6|Overall Study|Migrated|1
1519356|NCT00360230|4985596|P5|Overall Study|Migrated|4
1519357|NCT00360230|4985597|P4|Overall Study|Migrated|1
1519358|NCT00360230|4985598|P3|Overall Study|Migrated|3
1519359|NCT00360230|4985599|P2|Overall Study|Migrated|1
1519360|NCT00360230|4985600|P1|Overall Study|Migrated|4
1519361|NCT00360230|4985594|P7|Overall Study|Withdrawal by Subject|0
1519362|NCT00360230|4985595|P6|Overall Study|Withdrawal by Subject|1
1519363|NCT00360230|4985596|P5|Overall Study|Withdrawal by Subject|1
1519364|NCT00360230|4985597|P4|Overall Study|Withdrawal by Subject|1
1519365|NCT00360230|4985598|P3|Overall Study|Withdrawal by Subject|0
1519366|NCT00360230|4985599|P2|Overall Study|Withdrawal by Subject|1
1519367|NCT00360230|4985600|P1|Overall Study|Withdrawal by Subject|1
1519368|NCT00359801|4985756|P2|Overall Study|Sponsor Decision|16
1519369|NCT00359801|4985757|P1|Overall Study|Sponsor Decision|17
1519370|NCT00359801|4985756|P2|Overall Study|Final Status Unknown: missing data|4
1519371|NCT00359801|4985757|P1|Overall Study|Final Status Unknown: missing data|7
1519372|NCT00359801|4985756|P2|Overall Study|Other|46
1519373|NCT00359801|4985757|P1|Overall Study|Other|66
1519374|NCT00359801|4985756|P2|Overall Study|Withdrawal by Subject|96
1519375|NCT00359801|4985757|P1|Overall Study|Withdrawal by Subject|143
1519376|NCT00359801|4985756|P2|Overall Study|Lost to Follow-up|58
1519377|NCT00359801|4985757|P1|Overall Study|Lost to Follow-up|72
1519378|NCT00359788|4985791|P2|Overall Study|Protocol Violation|2
1519379|NCT00359788|4985792|P1|Overall Study|Protocol Violation|4
1519380|NCT00359788|4985791|P2|Overall Study|Withdrawal by Subject|1
1519381|NCT00359788|4985792|P1|Overall Study|Withdrawal by Subject|4
1519382|NCT00359788|4985791|P2|Overall Study|Lost to Follow-up|2
1519383|NCT00359788|4985792|P1|Overall Study|Lost to Follow-up|3
1519384|NCT00359788|4985791|P2|Overall Study|Lack of Efficacy|2
1519385|NCT00359788|4985792|P1|Overall Study|Lack of Efficacy|1
1519386|NCT00359788|4985791|P2|Overall Study|Adverse Event|10
1519387|NCT00359788|4985792|P1|Overall Study|Adverse Event|11
1519388|NCT00359762|4986026|P5|Period III|Subject Decision|0
1519389|NCT00359762|4986027|P4|Period III|Subject Decision|20
1519390|NCT00359762|4986028|P3|Period III|Subject Decision|8
1519391|NCT00359762|4986029|P2|Period III|Subject Decision|7
1519392|NCT00359762|4986030|P1|Period III|Subject Decision|0
1519393|NCT00359762|4986026|P5|Period III|Entry Criteria Not Met|0
1519394|NCT00359762|4986027|P4|Period III|Entry Criteria Not Met|1
1519395|NCT00359762|4986028|P3|Period III|Entry Criteria Not Met|0
1519396|NCT00359762|4986029|P2|Period III|Entry Criteria Not Met|1
1519397|NCT00359762|4986030|P1|Period III|Entry Criteria Not Met|0
1519398|NCT00359762|4986026|P5|Period III|Lost to follow up|0
1519399|NCT00359762|4986027|P4|Period III|Lost to follow up|2
1519400|NCT00359762|4986028|P3|Period III|Lost to follow up|1
1519401|NCT00359762|4986029|P2|Period III|Lost to follow up|1
1519402|NCT00359762|4986030|P1|Period III|Lost to follow up|0
1519403|NCT00359762|4986026|P5|Period III|Lack of Efficacy|0
1519404|NCT00359762|4986027|P4|Period III|Lack of Efficacy|9
1519405|NCT00359762|4986028|P3|Period III|Lack of Efficacy|5
1519406|NCT00359762|4986029|P2|Period III|Lack of Efficacy|7
1519407|NCT00359762|4986030|P1|Period III|Lack of Efficacy|0
1519408|NCT00359762|4986026|P5|Period III|Physician Decision|0
1519409|NCT00359762|4986027|P4|Period III|Physician Decision|15
1519410|NCT00359762|4986028|P3|Period III|Physician Decision|9
1519411|NCT00359762|4986029|P2|Period III|Physician Decision|5
1519412|NCT00359762|4986030|P1|Period III|Physician Decision|0
1519413|NCT00359762|4986026|P5|Period III|Adverse Event|0
1519414|NCT00359762|4986027|P4|Period III|Adverse Event|10
1519415|NCT00359762|4986028|P3|Period III|Adverse Event|4
1519416|NCT00359762|4986029|P2|Period III|Adverse Event|3
1519417|NCT00359762|4986030|P1|Period III|Adverse Event|0
1519418|NCT00359762|4986026|P5|Period III|Protocol Violation|0
1519419|NCT00359762|4986027|P4|Period III|Protocol Violation|8
1519420|NCT00359762|4986028|P3|Period III|Protocol Violation|3
1519421|NCT00359762|4986029|P2|Period III|Protocol Violation|5
1519422|NCT00359762|4986030|P1|Period III|Protocol Violation|0
1519423|NCT00359762|4986026|P5|Period II|Subject Decision|70
1519424|NCT00359762|4986027|P4|Period II|Subject Decision|0
1519425|NCT00359762|4986028|P3|Period II|Subject Decision|0
1519426|NCT00359762|4986029|P2|Period II|Subject Decision|0
1519427|NCT00359762|4986030|P1|Period II|Subject Decision|50
1519428|NCT00359762|4986026|P5|Period II|Entry Criteria Not Met|4
1519429|NCT00359762|4986027|P4|Period II|Entry Criteria Not Met|0
1519430|NCT00359762|4986028|P3|Period II|Entry Criteria Not Met|0
1519431|NCT00359762|4986029|P2|Period II|Entry Criteria Not Met|0
1519432|NCT00359762|4986030|P1|Period II|Entry Criteria Not Met|8
1519433|NCT00359762|4986026|P5|Period II|Lost to follow up|5
1519434|NCT00359762|4986027|P4|Period II|Lost to follow up|0
1519435|NCT00359762|4986028|P3|Period II|Lost to follow up|0
1519436|NCT00359762|4986029|P2|Period II|Lost to follow up|0
1519437|NCT00359762|4986030|P1|Period II|Lost to follow up|5
1519438|NCT00359762|4986026|P5|Period II|Lack of Efficacy|8
1519439|NCT00359762|4986027|P4|Period II|Lack of Efficacy|0
1519440|NCT00359762|4986028|P3|Period II|Lack of Efficacy|0
1519441|NCT00359762|4986029|P2|Period II|Lack of Efficacy|0
1519442|NCT00359762|4986030|P1|Period II|Lack of Efficacy|11
1519443|NCT00359762|4986026|P5|Period II|Death|4
1519444|NCT00359762|4986027|P4|Period II|Death|0
1519445|NCT00359762|4986028|P3|Period II|Death|0
1519446|NCT00359762|4986029|P2|Period II|Death|0
1519447|NCT00359762|4986030|P1|Period II|Death|2
1519448|NCT00359762|4986026|P5|Period II|Physician Decision|23
1519449|NCT00359762|4986027|P4|Period II|Physician Decision|0
1519450|NCT00359762|4986028|P3|Period II|Physician Decision|0
1519451|NCT00359762|4986029|P2|Period II|Physician Decision|0
1519452|NCT00359762|4986030|P1|Period II|Physician Decision|17
1519453|NCT00359762|4986026|P5|Period II|Protocol Violation|11
1519454|NCT00359762|4986027|P4|Period II|Protocol Violation|0
1519455|NCT00359762|4986028|P3|Period II|Protocol Violation|0
1519456|NCT00359762|4986029|P2|Period II|Protocol Violation|0
1519457|NCT00359762|4986030|P1|Period II|Protocol Violation|18
1519458|NCT00359762|4986026|P5|Period II|Adverse Event|49
1519459|NCT00359762|4986027|P4|Period II|Adverse Event|0
1519460|NCT00359762|4986028|P3|Period II|Adverse Event|0
1519461|NCT00359762|4986029|P2|Period II|Adverse Event|0
1519462|NCT00359762|4986030|P1|Period II|Adverse Event|17
1519463|NCT00359632|4986104|P2|Overall Study|Non-compliance with visit schedule|0
1519464|NCT00359632|4986105|P1|Overall Study|Non-compliance with visit schedule|1
1519465|NCT00359632|4986104|P2|Overall Study|Adverse Event|0
1519466|NCT00359632|4986105|P1|Overall Study|Adverse Event|1
1519467|NCT00359632|4986104|P2|Overall Study|Death|0
1519468|NCT00359632|4986105|P1|Overall Study|Death|2
1519469|NCT00359619|4986119|P7|Overall Study|Lost to Follow-up|0
1519470|NCT00359619|4986120|P6|Overall Study|Lost to Follow-up|5
1519471|NCT00359619|4986121|P5|Overall Study|Lost to Follow-up|1
1519472|NCT00359619|4986122|P4|Overall Study|Lost to Follow-up|1
1519473|NCT00359619|4986123|P3|Overall Study|Lost to Follow-up|2
1519474|NCT00359619|4986124|P2|Overall Study|Lost to Follow-up|4
1519475|NCT00359619|4986125|P1|Overall Study|Lost to Follow-up|4
1519476|NCT00359619|4986119|P7|Overall Study|Other|0
1519477|NCT00359619|4986120|P6|Overall Study|Other|0
1519478|NCT00359619|4986121|P5|Overall Study|Other|0
1519479|NCT00359619|4986122|P4|Overall Study|Other|0
1519480|NCT00359619|4986123|P3|Overall Study|Other|0
1519481|NCT00359619|4986124|P2|Overall Study|Other|0
1519482|NCT00359619|4986125|P1|Overall Study|Other|1
1519483|NCT00359619|4986119|P7|Overall Study|Withdrawal by Subject|3
1519484|NCT00359619|4986120|P6|Overall Study|Withdrawal by Subject|0
1519485|NCT00359619|4986121|P5|Overall Study|Withdrawal by Subject|2
1519486|NCT00359619|4986122|P4|Overall Study|Withdrawal by Subject|2
1519487|NCT00359619|4986123|P3|Overall Study|Withdrawal by Subject|4
1519488|NCT00359619|4986124|P2|Overall Study|Withdrawal by Subject|1
1519489|NCT00359619|4986125|P1|Overall Study|Withdrawal by Subject|3
1519490|NCT00359619|4986119|P7|Overall Study|Adverse Event|1
1519491|NCT00359619|4986120|P6|Overall Study|Adverse Event|0
1519492|NCT00359619|4986121|P5|Overall Study|Adverse Event|0
1519493|NCT00359619|4986122|P4|Overall Study|Adverse Event|0
1519494|NCT00359619|4986123|P3|Overall Study|Adverse Event|1
1519495|NCT00359619|4986124|P2|Overall Study|Adverse Event|0
1519496|NCT00359619|4986125|P1|Overall Study|Adverse Event|0
1519497|NCT00359424|4986255|P2|Overall Study|follow up not conducted|0
1519498|NCT00359424|4986256|P1|Overall Study|follow up not conducted|2
1519499|NCT00359424|4986255|P2|Overall Study|Withdrawal by Subject|2
1519500|NCT00359424|4986256|P1|Overall Study|Withdrawal by Subject|10
1519501|NCT00359424|4986255|P2|Overall Study|Lost to Follow-up|7
1519502|NCT00359424|4986256|P1|Overall Study|Lost to Follow-up|19
1519503|NCT00359424|4986255|P2|Overall Study|Death|58
1519504|NCT00359424|4986256|P1|Overall Study|Death|99
1519505|NCT00359281|4986295|P9|Overall Study|Withdrawal by Subject|0
1519506|NCT00359281|4986296|P8|Overall Study|Withdrawal by Subject|0
1519507|NCT00359281|4986297|P7|Overall Study|Withdrawal by Subject|1
1519508|NCT00359281|4986298|P6|Overall Study|Withdrawal by Subject|0
1519509|NCT00359281|4986299|P5|Overall Study|Withdrawal by Subject|0
1519510|NCT00359281|4986300|P4|Overall Study|Withdrawal by Subject|0
1519511|NCT00359281|4986301|P3|Overall Study|Withdrawal by Subject|0
1519512|NCT00359281|4986302|P2|Overall Study|Withdrawal by Subject|0
1519513|NCT00359281|4986303|P1|Overall Study|Withdrawal by Subject|0
1519514|NCT00359281|4986295|P9|Overall Study|Adverse Event|0
1519515|NCT00359281|4986296|P8|Overall Study|Adverse Event|0
1519516|NCT00359281|4986297|P7|Overall Study|Adverse Event|1
1519517|NCT00359281|4986298|P6|Overall Study|Adverse Event|0
1519518|NCT00359281|4986299|P5|Overall Study|Adverse Event|0
1519519|NCT00359281|4986300|P4|Overall Study|Adverse Event|0
1519520|NCT00359281|4986301|P3|Overall Study|Adverse Event|0
1519521|NCT00359281|4986302|P2|Overall Study|Adverse Event|0
1519522|NCT00359281|4986303|P1|Overall Study|Adverse Event|1
1519523|NCT00359073|4986366|P2|Overall Study|developed RV16 antibody|1
1519524|NCT00359073|4986367|P1|Overall Study|developed RV16 antibody|0
1519525|NCT00359073|4986366|P2|Overall Study|Eligibility criteria no longer met|0
1519526|NCT00359073|4986367|P1|Overall Study|Eligibility criteria no longer met|3
1519527|NCT00359073|4986366|P2|Overall Study|Withdrawal by Subject|1
1519528|NCT00359073|4986367|P1|Overall Study|Withdrawal by Subject|1
1519529|NCT00359021|4986379|P2|Overall Study|Pregnancy|0
1519530|NCT00359021|4986380|P1|Overall Study|Pregnancy|1
1519531|NCT00359021|4986379|P2|Overall Study|Not specified|1
1519532|NCT00359021|4986380|P1|Overall Study|Not specified|4
1519533|NCT00359021|4986379|P2|Overall Study|Lost to Follow-up|0
1519534|NCT00359021|4986380|P1|Overall Study|Lost to Follow-up|1
1519535|NCT00359021|4986379|P2|Overall Study|Withdrawal by Subject|9
1519536|NCT00359021|4986380|P1|Overall Study|Withdrawal by Subject|2
1519537|NCT00359021|4986379|P2|Overall Study|Subject Reached A Virologic Endpoint|32
1519538|NCT00359021|4986380|P1|Overall Study|Subject Reached A Virologic Endpoint|45
1519539|NCT00359021|4986379|P2|Overall Study|Subject Ineligible To Continue The Trial|0
1519540|NCT00359021|4986380|P1|Overall Study|Subject Ineligible To Continue The Trial|1
1519541|NCT00359021|4986379|P2|Overall Study|Subject Non-Compliant|2
1519542|NCT00359021|4986380|P1|Overall Study|Subject Non-Compliant|1
1519543|NCT00359021|4986379|P2|Overall Study|Adverse Event|8
1519544|NCT00359021|4986380|P1|Overall Study|Adverse Event|26
1519545|NCT00358956|4986392|P1|Overall Study|Withdrawal by Subject|1
1519546|NCT00358956|4986392|P1|Overall Study|condition under investigation worsened|4
1519547|NCT00358956|4986392|P1|Overall Study|Adverse Event|3
1519548|NCT00358917|4986404|P2|Overall Study|Unable to Continue Participation|2
1519549|NCT00358917|4986405|P1|Overall Study|Unable to Continue Participation|2
1519550|NCT00358917|4986404|P2|Overall Study|Virologic failure|8
1519551|NCT00358917|4986405|P1|Overall Study|Virologic failure|11
1519552|NCT00358917|4986404|P2|Overall Study|Death|3
1519553|NCT00358917|4986405|P1|Overall Study|Death|2
1519554|NCT00358917|4986404|P2|Overall Study|Noncompliance|11
1519555|NCT00358917|4986405|P1|Overall Study|Noncompliance|12
1519556|NCT00358917|4986404|P2|Overall Study|Lost to Follow-up|17
1519557|NCT00358917|4986405|P1|Overall Study|Lost to Follow-up|20
1519558|NCT00358917|4986404|P2|Overall Study|Withdrawal by Subject|7
1519559|NCT00358917|4986405|P1|Overall Study|Withdrawal by Subject|5
1519560|NCT00358917|4986404|P2|Overall Study|Adverse Event|21
1519561|NCT00358917|4986405|P1|Overall Study|Adverse Event|14
1519562|NCT00358826|4986423|P8|MDCT Substudy|Withdrawal by Subject|0
1519563|NCT00358826|4986424|P7|MDCT Substudy|Withdrawal by Subject|0
1519564|NCT00358826|4986425|P6|MDCT Substudy|Withdrawal by Subject|1
1519565|NCT00358826|4986426|P5|MDCT Substudy|Withdrawal by Subject|0
1519566|NCT00358826|4986427|P4|MDCT Substudy|Withdrawal by Subject|0
1519567|NCT00358826|4986428|P3|MDCT Substudy|Withdrawal by Subject|0
1519568|NCT00358826|4986429|P2|MDCT Substudy|Withdrawal by Subject|0
1519569|NCT00358826|4986430|P1|MDCT Substudy|Withdrawal by Subject|0
1519570|NCT00358826|4986423|P8|MDCT Substudy|Lost to Follow-up|0
1519571|NCT00358826|4986424|P7|MDCT Substudy|Lost to Follow-up|0
1519572|NCT00358826|4986425|P6|MDCT Substudy|Lost to Follow-up|1
1519573|NCT00358826|4986426|P5|MDCT Substudy|Lost to Follow-up|0
1519574|NCT00358826|4986427|P4|MDCT Substudy|Lost to Follow-up|0
1519575|NCT00358826|4986428|P3|MDCT Substudy|Lost to Follow-up|0
1519576|NCT00358826|4986429|P2|MDCT Substudy|Lost to Follow-up|0
1519577|NCT00358826|4986430|P1|MDCT Substudy|Lost to Follow-up|0
1519578|NCT00358826|4986423|P8|MDCT Substudy|Adverse Event|0
1519579|NCT00358826|4986424|P7|MDCT Substudy|Adverse Event|0
1519580|NCT00358826|4986425|P6|MDCT Substudy|Adverse Event|0
1519581|NCT00358826|4986426|P5|MDCT Substudy|Adverse Event|1
1519582|NCT00358826|4986427|P4|MDCT Substudy|Adverse Event|0
1519583|NCT00358826|4986428|P3|MDCT Substudy|Adverse Event|0
1519584|NCT00358826|4986429|P2|MDCT Substudy|Adverse Event|0
1519585|NCT00358826|4986430|P1|MDCT Substudy|Adverse Event|0
1519586|NCT00358826|4986423|P8|Core Study|Physician Decision|0
1519587|NCT00358826|4986424|P7|Core Study|Physician Decision|0
1519588|NCT00358826|4986425|P6|Core Study|Physician Decision|0
1519589|NCT00358826|4986426|P5|Core Study|Physician Decision|0
1519590|NCT00358826|4986427|P4|Core Study|Physician Decision|0
1519591|NCT00358826|4986428|P3|Core Study|Physician Decision|1
1519592|NCT00358826|4986429|P2|Core Study|Physician Decision|0
1519593|NCT00358826|4986430|P1|Core Study|Physician Decision|0
1519594|NCT00358826|4986423|P8|Core Study|Lost to Follow-up|0
1519595|NCT00358826|4986424|P7|Core Study|Lost to Follow-up|0
1519596|NCT00358826|4986425|P6|Core Study|Lost to Follow-up|0
1519597|NCT00358826|4986426|P5|Core Study|Lost to Follow-up|0
1519598|NCT00358826|4986427|P4|Core Study|Lost to Follow-up|1
1519599|NCT00358826|4986428|P3|Core Study|Lost to Follow-up|0
1519600|NCT00358826|4986429|P2|Core Study|Lost to Follow-up|0
1519601|NCT00358826|4986430|P1|Core Study|Lost to Follow-up|0
1519602|NCT00358826|4986423|P8|Core Study|Withdrawal by Subject|0
1519603|NCT00358826|4986424|P7|Core Study|Withdrawal by Subject|0
1519604|NCT00358826|4986425|P6|Core Study|Withdrawal by Subject|0
1519605|NCT00358826|4986426|P5|Core Study|Withdrawal by Subject|0
1519606|NCT00358826|4986427|P4|Core Study|Withdrawal by Subject|0
1519607|NCT00358826|4986428|P3|Core Study|Withdrawal by Subject|0
1519608|NCT00358826|4986429|P2|Core Study|Withdrawal by Subject|2
1519609|NCT00358826|4986430|P1|Core Study|Withdrawal by Subject|2
1519610|NCT00358826|4986423|P8|Core Study|Adverse Event|0
1519611|NCT00358826|4986424|P7|Core Study|Adverse Event|0
1519612|NCT00358826|4986425|P6|Core Study|Adverse Event|0
1519613|NCT00358826|4986426|P5|Core Study|Adverse Event|0
1519614|NCT00358826|4986427|P4|Core Study|Adverse Event|1
1519615|NCT00358826|4986428|P3|Core Study|Adverse Event|1
1519616|NCT00358826|4986429|P2|Core Study|Adverse Event|3
1519617|NCT00358826|4986430|P1|Core Study|Adverse Event|1
1519618|NCT00358670|4986497|P2|Overall Study|Administrative|125
1519619|NCT00358670|4986498|P1|Overall Study|Administrative|153
1519620|NCT00358670|4986497|P2|Overall Study|Did Not Meet Protocol Eligibility|3
1519621|NCT00358670|4986498|P1|Overall Study|Did Not Meet Protocol Eligibility|0
1519622|NCT00358670|4986497|P2|Overall Study|Protocol Defined Clinical Event|1
1519623|NCT00358670|4986498|P1|Overall Study|Protocol Defined Clinical Event|0
1519624|NCT00358670|4986497|P2|Overall Study|Withdrawal by Subject|24
1519625|NCT00358670|4986498|P1|Overall Study|Withdrawal by Subject|13
1519626|NCT00358670|4986497|P2|Overall Study|Lost to Follow-up|5
1519627|NCT00358670|4986498|P1|Overall Study|Lost to Follow-up|4
1519628|NCT00358670|4986497|P2|Overall Study|Protocol Violation|9
1519629|NCT00358670|4986498|P1|Overall Study|Protocol Violation|6
1519630|NCT00358670|4986497|P2|Overall Study|Lack of Efficacy|23
1519631|NCT00358670|4986498|P1|Overall Study|Lack of Efficacy|20
1519632|NCT00358670|4986497|P2|Overall Study|Adverse Event|29
1519633|NCT00358670|4986498|P1|Overall Study|Adverse Event|26
1519634|NCT00358644|4986512|P1|Overall Study|Patient not eligible for study|1
1519635|NCT00358644|4986512|P1|Overall Study|Physician Decision|6
1519636|NCT00358644|4986512|P1|Overall Study|Withdrawal by Subject|4
1519637|NCT00358644|4986512|P1|Overall Study|Death|11
1519638|NCT00358644|4986512|P1|Overall Study|Adverse Event|7
1519639|NCT00358644|4986512|P1|Overall Study|Progressive Disease|21
1519640|NCT00358527|4986535|P2|Overall Study|Administrative|1
1519641|NCT00358527|4986536|P1|Overall Study|Administrative|2
1519642|NCT00358527|4986535|P2|Overall Study|Non-compliance with protocol|1
1519643|NCT00358527|4986536|P1|Overall Study|Non-compliance with protocol|6
1519644|NCT00358527|4986535|P2|Overall Study|Withdrawal by Subject|1
1519645|NCT00358527|4986536|P1|Overall Study|Withdrawal by Subject|1
1519646|NCT00358527|4986535|P2|Overall Study|Adverse Event|0
1519647|NCT00358527|4986536|P1|Overall Study|Adverse Event|4
1519648|NCT00358449|4986586|P3|Overall Study|Steriod Inhaler was Increased|1
1519649|NCT00358449|4986587|P2|Overall Study|Steriod Inhaler was Increased|0
1519650|NCT00358449|4986588|P1|Overall Study|Steriod Inhaler was Increased|0
1519651|NCT00358449|4986586|P3|Overall Study|Lack of Efficacy|0
1519652|NCT00358449|4986587|P2|Overall Study|Lack of Efficacy|1
1519653|NCT00358449|4986588|P1|Overall Study|Lack of Efficacy|0
1519654|NCT00358449|4986586|P3|Overall Study|Withdrawal by Subject|0
1519655|NCT00358449|4986587|P2|Overall Study|Withdrawal by Subject|0
1519656|NCT00358449|4986588|P1|Overall Study|Withdrawal by Subject|2
1519657|NCT00358449|4986586|P3|Overall Study|Lost to Follow-up|0
1519658|NCT00358449|4986587|P2|Overall Study|Lost to Follow-up|0
1519659|NCT00358449|4986588|P1|Overall Study|Lost to Follow-up|1
1519660|NCT00358449|4986586|P3|Overall Study|Adverse Event|1
1519661|NCT00358449|4986587|P2|Overall Study|Adverse Event|0
1519662|NCT00358449|4986588|P1|Overall Study|Adverse Event|1
1519663|NCT00358436|4986691|P2|Overall Study|Other|1
1519664|NCT00358436|4986692|P1|Overall Study|Other|6
1519665|NCT00358436|4986691|P2|Overall Study|COPD exacerbation|10
1519666|NCT00358436|4986692|P1|Overall Study|COPD exacerbation|22
1519667|NCT00358436|4986691|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
1519668|NCT00358436|4986692|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
1519669|NCT00358436|4986691|P2|Overall Study|Withdrawal by Subject|17
1519670|NCT00358436|4986692|P1|Overall Study|Withdrawal by Subject|40
1519671|NCT00358436|4986691|P2|Overall Study|Protocol Violation|3
1519672|NCT00358436|4986692|P1|Overall Study|Protocol Violation|8
1519673|NCT00358436|4986691|P2|Overall Study|Lost to Follow-up|6
1519674|NCT00358436|4986692|P1|Overall Study|Lost to Follow-up|11
1519675|NCT00358436|4986691|P2|Overall Study|Lack of Efficacy|36
1519676|NCT00358436|4986692|P1|Overall Study|Lack of Efficacy|34
1519677|NCT00358436|4986691|P2|Overall Study|Adverse Event|13
1519678|NCT00358436|4986692|P1|Overall Study|Adverse Event|29
1519679|NCT00358215|4986763|P2|Overall Study|Did not receive investigational product|3
1519680|NCT00358215|4986764|P1|Overall Study|Did not receive investigational product|2
1519681|NCT00358215|4986763|P2|Overall Study|Other|14
1519682|NCT00358215|4986764|P1|Overall Study|Other|21
1519683|NCT00358215|4986763|P2|Overall Study|Pregnancy|0
1519684|NCT00358215|4986764|P1|Overall Study|Pregnancy|1
1519685|NCT00358215|4986763|P2|Overall Study|Protocol Violation|59
1519686|NCT00358215|4986764|P1|Overall Study|Protocol Violation|64
1519687|NCT00358215|4986763|P2|Overall Study|Death|281
1519688|NCT00358215|4986764|P1|Overall Study|Death|265
1519689|NCT00358215|4986763|P2|Overall Study|Lost to Follow-up|22
1519690|NCT00358215|4986764|P1|Overall Study|Lost to Follow-up|16
1519691|NCT00358215|4986763|P2|Overall Study|Physician Decision|39
1519692|NCT00358215|4986764|P1|Overall Study|Physician Decision|47
1519693|NCT00358215|4986763|P2|Overall Study|Participant request|64
1519694|NCT00358215|4986764|P1|Overall Study|Participant request|65
1519695|NCT00358215|4986763|P2|Overall Study|Withdrawal by Subject|102
1519696|NCT00358215|4986764|P1|Overall Study|Withdrawal by Subject|111
1519697|NCT00358215|4986763|P2|Overall Study|Adverse Event|65
1519698|NCT00358215|4986764|P1|Overall Study|Adverse Event|83
1519699|NCT00358215|4986763|P2|Overall Study|Ineligibility determined|3
1519700|NCT00358215|4986764|P1|Overall Study|Ineligibility determined|4
1519701|NCT00358150|4986778|P1|Overall Study|Undefined|3
1519702|NCT00358150|4986778|P1|Overall Study|Withdrawal by Subject|1
1519703|NCT00358150|4986778|P1|Overall Study|Adverse Event|3
1519704|NCT00357994|4986807|P2|Overall Study|Protocol Violation|0
1519705|NCT00357994|4986808|P1|Overall Study|Protocol Violation|1
1519706|NCT00357994|4986807|P2|Overall Study|Lack of Efficacy|1
1519707|NCT00357994|4986808|P1|Overall Study|Lack of Efficacy|0
1519708|NCT00357994|4986807|P2|Overall Study|Adverse Event|2
1519709|NCT00357994|4986808|P1|Overall Study|Adverse Event|1
1519710|NCT00357968|4986862|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
1519711|NCT00357968|4986863|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
1519712|NCT00357968|4986862|P2|First Maintenance Dose Phase|Not a PCI patient|42
1519713|NCT00357968|4986863|P1|First Maintenance Dose Phase|Not a PCI patient|47
1519714|NCT00357903|4986916|P2|Overall Study|Other|10
1519715|NCT00357903|4986917|P1|Overall Study|Other|49
1519716|NCT00357903|4986916|P2|Overall Study|Response status|9
1519717|NCT00357903|4986917|P1|Overall Study|Response status|61
1519718|NCT00357903|4986916|P2|Overall Study|Protocol issues|3
1519719|NCT00357903|4986917|P1|Overall Study|Protocol issues|14
1519720|NCT00357903|4986916|P2|Overall Study|Completed month 12 only|1
1519721|NCT00357903|4986917|P1|Overall Study|Completed month 12 only|0
1519722|NCT00357903|4986916|P2|Overall Study|Withdrawal by Subject|7
1519723|NCT00357903|4986917|P1|Overall Study|Withdrawal by Subject|57
1519724|NCT00357903|4986916|P2|Overall Study|Physician Decision|5
1519725|NCT00357903|4986917|P1|Overall Study|Physician Decision|39
1519726|NCT00357903|4986916|P2|Overall Study|Lost to Follow-up|4
1519727|NCT00357903|4986917|P1|Overall Study|Lost to Follow-up|23
1519728|NCT00357903|4986916|P2|Overall Study|Death|0
1519729|NCT00357903|4986917|P1|Overall Study|Death|33
1519730|NCT00357903|4986916|P2|Overall Study|Adverse Event|4
1519731|NCT00357903|4986917|P1|Overall Study|Adverse Event|87
1519732|NCT00357877|4986957|P2|Overall Study|Other|2
1519733|NCT00357877|4986958|P1|Overall Study|Other|0
1519734|NCT00357877|4986957|P2|Overall Study|Administrative withdrawal|1
1519735|NCT00357877|4986958|P1|Overall Study|Administrative withdrawal|1
1519736|NCT00357877|4986957|P2|Overall Study|Withdrawal by Subject|3
1519737|NCT00357877|4986958|P1|Overall Study|Withdrawal by Subject|3
1519738|NCT00357877|4986957|P2|Overall Study|Lost to Follow-up|23
1519739|NCT00357877|4986958|P1|Overall Study|Lost to Follow-up|20
1519740|NCT00357877|4986957|P2|Overall Study|Death|1
1519741|NCT00357877|4986958|P1|Overall Study|Death|2
1519742|NCT00357760|4986972|P2|Overall Study|To receive hospice care|1
1519743|NCT00357760|4986973|P1|Overall Study|To receive hospice care|0
1519744|NCT00357760|4986972|P2|Overall Study|Protocol Violation|1
1519745|NCT00357760|4986973|P1|Overall Study|Protocol Violation|0
1519746|NCT00357760|4986972|P2|Overall Study|Physician Decision|1
1519747|NCT00357760|4986973|P1|Overall Study|Physician Decision|2
1519748|NCT00357760|4986972|P2|Overall Study|Ineligible|2
1519749|NCT00357760|4986973|P1|Overall Study|Ineligible|0
1519750|NCT00357760|4986972|P2|Overall Study|Never started treatment|1
1519751|NCT00357760|4986973|P1|Overall Study|Never started treatment|2
1519752|NCT00357760|4986972|P2|Overall Study|Withdrawal by Subject|2
1519753|NCT00357760|4986973|P1|Overall Study|Withdrawal by Subject|0
1519754|NCT00357760|4986972|P2|Overall Study|Alternative therapy|0
1519755|NCT00357760|4986973|P1|Overall Study|Alternative therapy|1
1519756|NCT00357760|4986972|P2|Overall Study|Death|3
1519757|NCT00357760|4986973|P1|Overall Study|Death|0
1519758|NCT00357760|4986972|P2|Overall Study|Adverse Event|7
1519759|NCT00357760|4986973|P1|Overall Study|Adverse Event|10
1519760|NCT00357760|4986972|P2|Overall Study|Disease progression|17
1519761|NCT00357760|4986973|P1|Overall Study|Disease progression|44
1519762|NCT00357656|4986994|P2|Overall Study|Other, No surgery performed|3
1519763|NCT00357656|4986995|P1|Overall Study|Other, No surgery performed|0
1519764|NCT00357552|4987046|P1|Weeks 24 to 104|Not able to get to clinic|2
1519765|NCT00357552|4987046|P1|Weeks 24 to 104|Death|3
1519766|NCT00357552|4987046|P1|Weeks 0 to 24|Death|1
1519767|NCT00357552|4987046|P1|Screening|Did not meet eligibility criteria|84
1519768|NCT00357500|4987061|P1|Overall Study|Not Started Protocol Therapy|4
1519769|NCT00357500|4987061|P1|Overall Study|Progressive Disease|65
1519770|NCT00357500|4987061|P1|Overall Study|Withdrawal by Subject|5
1519771|NCT00357500|4987061|P1|Overall Study|Adverse Event|3
1519772|NCT00357396|4987070|P2|Overall Study|Adverse Event|0
1519773|NCT00357396|4987071|P1|Overall Study|Adverse Event|1
1519774|NCT00357370|4987079|P3|Cohort 2|Withdrawal by Subject|0
1519775|NCT00357370|4987080|P2|Cohort 2|Withdrawal by Subject|2
1519776|NCT00357370|4987081|P1|Cohort 2|Withdrawal by Subject|0
1519777|NCT00357370|4987079|P3|Cohort 2|non-compliance, not met criteria, etc|0
1519778|NCT00357370|4987080|P2|Cohort 2|non-compliance, not met criteria, etc|1
1519779|NCT00357370|4987081|P1|Cohort 2|non-compliance, not met criteria, etc|1
1519780|NCT00357370|4987079|P3|Cohort 2|Lost to Follow-up|0
1519781|NCT00357370|4987080|P2|Cohort 2|Lost to Follow-up|1
1519782|NCT00357370|4987081|P1|Cohort 2|Lost to Follow-up|0
1519783|NCT00357370|4987079|P3|Cohort 2|Adverse Event|1
1519784|NCT00357370|4987080|P2|Cohort 2|Adverse Event|1
1519785|NCT00357370|4987081|P1|Cohort 2|Adverse Event|1
1519786|NCT00357370|4987079|P3|Cohort 2|Lack of Efficacy|1
1519787|NCT00357370|4987080|P2|Cohort 2|Lack of Efficacy|2
1519788|NCT00357370|4987081|P1|Cohort 2|Lack of Efficacy|0
1519789|NCT00357110|4987127|P2|Overall Study|Early study termination|5
1519790|NCT00357110|4987128|P1|Overall Study|Early study termination|5
1519791|NCT00357097|4987136|P2|Overall Study|Increase of RLS Symptoms|1
1519792|NCT00357097|4987137|P1|Overall Study|Increase of RLS Symptoms|0
1519793|NCT00357097|4987136|P2|Overall Study|Other|1
1519794|NCT00357097|4987137|P1|Overall Study|Other|1
1519795|NCT00357097|4987136|P2|Overall Study|Met Exclusion Criteria|1
1519796|NCT00357097|4987137|P1|Overall Study|Met Exclusion Criteria|3
1519797|NCT00357097|4987136|P2|Overall Study|Lack of Efficacy|8
1519798|NCT00357097|4987137|P1|Overall Study|Lack of Efficacy|2
1519799|NCT00357097|4987136|P2|Overall Study|Non-compliance|2
1519800|NCT00357097|4987137|P1|Overall Study|Non-compliance|1
1519801|NCT00357097|4987136|P2|Overall Study|Withdrawal by Subject|7
1519802|NCT00357097|4987137|P1|Overall Study|Withdrawal by Subject|8
1519803|NCT00357097|4987136|P2|Overall Study|Adverse Event|6
1519804|NCT00357097|4987137|P1|Overall Study|Adverse Event|34
1519805|NCT00357097|4987136|P2|Overall Study|Did not meet inclusion criteria|3
1519806|NCT00357097|4987137|P1|Overall Study|Did not meet inclusion criteria|5
1519807|NCT00357006|4987191|P3|Overall Study|Withdrawal by Subject|2
1519808|NCT00357006|4987192|P2|Overall Study|Withdrawal by Subject|3
1519809|NCT00357006|4987193|P1|Overall Study|Withdrawal by Subject|1
1519810|NCT00357006|4987191|P3|Overall Study|Lost to Follow-up|1
1519811|NCT00357006|4987192|P2|Overall Study|Lost to Follow-up|2
1519812|NCT00357006|4987193|P1|Overall Study|Lost to Follow-up|1
1519813|NCT00356915|4987204|P3|Overall Study|Miscellaneous reasons|3
1519814|NCT00356915|4987205|P2|Overall Study|Miscellaneous reasons|8
1519815|NCT00356915|4987206|P1|Overall Study|Miscellaneous reasons|11
1519816|NCT00356915|4987204|P3|Overall Study|Adverse Event|8
1519817|NCT00356915|4987205|P2|Overall Study|Adverse Event|31
1519818|NCT00356915|4987206|P1|Overall Study|Adverse Event|21
1519819|NCT00356915|4987204|P3|Overall Study|Physician Decision|0
1519820|NCT00356915|4987205|P2|Overall Study|Physician Decision|2
1519821|NCT00356915|4987206|P1|Overall Study|Physician Decision|0
1519822|NCT00356915|4987204|P3|Overall Study|Administrative Decision|1
1519823|NCT00356915|4987205|P2|Overall Study|Administrative Decision|0
1519824|NCT00356915|4987206|P1|Overall Study|Administrative Decision|0
1519825|NCT00356915|4987204|P3|Overall Study|Lost to Follow-up|14
1519826|NCT00356915|4987205|P2|Overall Study|Lost to Follow-up|34
1519827|NCT00356915|4987206|P1|Overall Study|Lost to Follow-up|27
1519828|NCT00356915|4987204|P3|Overall Study|Lack of Efficacy|3
1519829|NCT00356915|4987205|P2|Overall Study|Lack of Efficacy|0
1519830|NCT00356915|4987206|P1|Overall Study|Lack of Efficacy|0
1519831|NCT00356915|4987204|P3|Overall Study|Withdrawal by Subject|10
1519832|NCT00356915|4987205|P2|Overall Study|Withdrawal by Subject|14
1519833|NCT00356915|4987206|P1|Overall Study|Withdrawal by Subject|14
1519834|NCT00356915|4987204|P3|Overall Study|Protocol Violation|2
1519835|NCT00356915|4987205|P2|Overall Study|Protocol Violation|3
1519836|NCT00356915|4987206|P1|Overall Study|Protocol Violation|2
1519837|NCT00356915|4987204|P3|Overall Study|Non compliance|1
1519838|NCT00356915|4987205|P2|Overall Study|Non compliance|2
1519839|NCT00356915|4987206|P1|Overall Study|Non compliance|1
1519840|NCT00356889|4987223|P1|Overall Study|Adverse Event|1
1519841|NCT00356889|4987223|P1|Overall Study|Protocol Violation|2
1519842|NCT00356863|4987232|P2|Overall Study|Lost to Follow-up|43
1519843|NCT00356863|4987233|P1|Overall Study|Lost to Follow-up|76
1519844|NCT00356863|4987232|P2|Overall Study|Death|32
1519845|NCT00356863|4987233|P1|Overall Study|Death|16
1519846|NCT00356811|4987259|P1|Overall Study|Site Closed during Follow-up|2
1519847|NCT00356811|4987259|P1|Overall Study|Study Is Terminating|3
1519848|NCT00356811|4987259|P1|Overall Study|Participant Could Not Make a Checkup|1
1519849|NCT00356811|4987259|P1|Overall Study|Withdrawal by Subject|6
1519850|NCT00356811|4987259|P1|Overall Study|Lost to Follow-up|2
1519851|NCT00356811|4987259|P1|Overall Study|Death|35
1519852|NCT00356759|4987274|P2|Overall Study|Intercurrent disease or persistent extre|2
1519853|NCT00356759|4987275|P1|Overall Study|Intercurrent disease or persistent extre|5
1519854|NCT00356759|4987274|P2|Overall Study|Lost to Follow-up|1
1519855|NCT00356759|4987275|P1|Overall Study|Lost to Follow-up|1
1519856|NCT00356759|4987274|P2|Overall Study|Adverse Event|3
1519857|NCT00356759|4987275|P1|Overall Study|Adverse Event|1
1519858|NCT00356759|4987274|P2|Overall Study|Withdrawal by Subject|2
1519859|NCT00356759|4987275|P1|Overall Study|Withdrawal by Subject|2
1519860|NCT00356759|4987274|P2|Overall Study|Death|2
1519861|NCT00356759|4987275|P1|Overall Study|Death|5
1519862|NCT00356603|4987293|P2|Overall Study|Other|3
1519863|NCT00356603|4987294|P1|Overall Study|Other|6
1519864|NCT00356590|4987308|P1|Overall Study|Other|52
1519865|NCT00356590|4987308|P1|Overall Study|Response status|28
1519866|NCT00356590|4987308|P1|Overall Study|Protocol issues|6
1519867|NCT00356590|4987308|P1|Overall Study|Completed month 12 only|2
1519868|NCT00356590|4987308|P1|Overall Study|Withdrawal by Subject|41
1519869|NCT00356590|4987308|P1|Overall Study|Physician Decision|46
1519870|NCT00356590|4987308|P1|Overall Study|Lost to Follow-up|35
1519871|NCT00356590|4987308|P1|Overall Study|Death|10
1519872|NCT00356590|4987308|P1|Overall Study|Adverse Event|54
1519873|NCT00356525|4987344|P4|Overall Study|Sponsor Decision|1
1519874|NCT00356525|4987345|P3|Overall Study|Sponsor Decision|0
1519875|NCT00356525|4987346|P2|Overall Study|Sponsor Decision|0
1519876|NCT00356525|4987347|P1|Overall Study|Sponsor Decision|0
1519877|NCT00356525|4987344|P4|Overall Study|Death|1
1519878|NCT00356525|4987345|P3|Overall Study|Death|0
1519879|NCT00356525|4987346|P2|Overall Study|Death|0
1519880|NCT00356525|4987347|P1|Overall Study|Death|0
1519881|NCT00356525|4987344|P4|Overall Study|Withdrawal by Subject|3
1519882|NCT00356525|4987345|P3|Overall Study|Withdrawal by Subject|0
1519883|NCT00356525|4987346|P2|Overall Study|Withdrawal by Subject|1
1519884|NCT00356525|4987347|P1|Overall Study|Withdrawal by Subject|1
1519885|NCT00356525|4987344|P4|Overall Study|Protocol Entry Criteria Not Met|0
1519886|NCT00356525|4987345|P3|Overall Study|Protocol Entry Criteria Not Met|0
1519887|NCT00356525|4987346|P2|Overall Study|Protocol Entry Criteria Not Met|0
1519888|NCT00356525|4987347|P1|Overall Study|Protocol Entry Criteria Not Met|1
1519889|NCT00356525|4987344|P4|Overall Study|Physician Decision|1
1519890|NCT00356525|4987345|P3|Overall Study|Physician Decision|2
1519891|NCT00356525|4987346|P2|Overall Study|Physician Decision|2
1519892|NCT00356525|4987347|P1|Overall Study|Physician Decision|2
1519893|NCT00356525|4987344|P4|Overall Study|Lost to Follow-up|0
1519894|NCT00356525|4987345|P3|Overall Study|Lost to Follow-up|0
1519895|NCT00356525|4987346|P2|Overall Study|Lost to Follow-up|0
1519896|NCT00356525|4987347|P1|Overall Study|Lost to Follow-up|1
1519897|NCT00356525|4987344|P4|Overall Study|Adverse Event|1
1519898|NCT00356525|4987345|P3|Overall Study|Adverse Event|1
1519899|NCT00356525|4987346|P2|Overall Study|Adverse Event|3
1519900|NCT00356525|4987347|P1|Overall Study|Adverse Event|1
1519901|NCT00356525|4987344|P4|Overall Study|Progressive Disease|2
1519902|NCT00356525|4987345|P3|Overall Study|Progressive Disease|4
1519903|NCT00356525|4987346|P2|Overall Study|Progressive Disease|5
1519904|NCT00356525|4987347|P1|Overall Study|Progressive Disease|8
1519905|NCT00356421|4987388|P2|Overall Study|Not related to study drug|3
1519906|NCT00356421|4987389|P1|Overall Study|Not related to study drug|5
1519907|NCT00356421|4987388|P2|Overall Study|Related to study drug|12
1519908|NCT00356421|4987389|P1|Overall Study|Related to study drug|15
1519909|NCT00356421|4987388|P2|Overall Study|Withdrawal by Subject|2
1519910|NCT00356421|4987389|P1|Overall Study|Withdrawal by Subject|9
1519911|NCT00356421|4987388|P2|Overall Study|Lack of Efficacy|0
1519912|NCT00356421|4987389|P1|Overall Study|Lack of Efficacy|3
1519913|NCT00356408|4987429|P1|Overall Study|Other: Subject chose commerical dosing|1
1519914|NCT00356408|4987429|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
1519915|NCT00356408|4987429|P1|Overall Study|Other: Azathioprine stopped|1
1519916|NCT00356408|4987429|P1|Overall Study|Other: Sponsor request|1
1519917|NCT00356408|4987429|P1|Overall Study|Other: Principal investigator discretion|3
1519918|NCT00356408|4987429|P1|Overall Study|Withdrawal by Subject|6
1519919|NCT00356408|4987429|P1|Overall Study|Lost to Follow-up|2
1519920|NCT00356408|4987429|P1|Overall Study|Lack of Efficacy|36
1519921|NCT00356408|4987429|P1|Overall Study|Adverse Event|9
1519922|NCT00356369|4987446|P2|Active Phase|Withdrawal by Subject|1
1519923|NCT00356369|4987447|P1|Active Phase|Withdrawal by Subject|2
1519924|NCT00356278|4987529|P3|Overall Study|Withdrawal by Subject|19
1519925|NCT00356278|4987530|P2|Overall Study|Withdrawal by Subject|15
1519926|NCT00356278|4987531|P1|Overall Study|Withdrawal by Subject|25
1519927|NCT00356265|4987569|P3|Overall Study|Withdrawal by Subject|1
1519928|NCT00356265|4987570|P2|Overall Study|Withdrawal by Subject|0
1519929|NCT00356265|4987571|P1|Overall Study|Withdrawal by Subject|0
1519930|NCT00356200|4987583|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
1519931|NCT00356200|4987584|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
1519932|NCT00356200|4987583|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
1519933|NCT00356200|4987584|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
1519934|NCT00356148|4987613|P2|Overall Study|Reoperation within 30 days|1
1519935|NCT00356148|4987614|P1|Overall Study|Reoperation within 30 days|2
1519936|NCT00356135|4987625|P3|Overall Study|Subject non-compliance|3
1519937|NCT00356135|4987626|P2|Overall Study|Subject non-compliance|1
1519938|NCT00356135|4987627|P1|Overall Study|Subject non-compliance|1
1519939|NCT00356135|4987625|P3|Overall Study|Physician Decision|1
1519940|NCT00356135|4987626|P2|Overall Study|Physician Decision|1
1519941|NCT00356135|4987627|P1|Overall Study|Physician Decision|1
1519942|NCT00356135|4987625|P3|Overall Study|Lost to Follow-up|1
1519943|NCT00356135|4987626|P2|Overall Study|Lost to Follow-up|0
1519944|NCT00356135|4987627|P1|Overall Study|Lost to Follow-up|0
1519945|NCT00356135|4987625|P3|Overall Study|Adverse Event|0
1519946|NCT00356135|4987626|P2|Overall Study|Adverse Event|0
1519947|NCT00356135|4987627|P1|Overall Study|Adverse Event|1
1519948|NCT00356135|4987625|P3|Overall Study|Protocol Violation|0
1519949|NCT00356135|4987626|P2|Overall Study|Protocol Violation|0
1519950|NCT00356135|4987627|P1|Overall Study|Protocol Violation|1
1519951|NCT00356122|4987649|P1|FOLLOW-UP|Other|2
1519952|NCT00356122|4987649|P1|FOLLOW-UP|Lost to Follow-up|2
1519953|NCT00356122|4987649|P1|FOLLOW-UP|Death|37
1519954|NCT00356122|4987649|P1|TREATMENT|Did not receive study medication|1
1519955|NCT00356122|4987649|P1|TREATMENT|Other|4
1519956|NCT00356122|4987649|P1|TREATMENT|Subject's request|4
1519957|NCT00356122|4987649|P1|TREATMENT|Adverse Event|10
1519958|NCT00356122|4987649|P1|TREATMENT|Lack of Efficacy|26
1519959|NCT00355784|4987757|P3|Overall Study|Withdrawal by Subject|2
1519960|NCT00355784|4987758|P2|Overall Study|Withdrawal by Subject|0
1519961|NCT00355784|4987759|P1|Overall Study|Withdrawal by Subject|0
1519962|NCT00355615|4987808|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
1519963|NCT00355615|4987809|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
1519964|NCT00355615|4987810|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
1519965|NCT00355615|4987811|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
1519966|NCT00355615|4987812|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
1519967|NCT00355615|4987808|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
1519968|NCT00355615|4987809|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1519969|NCT00355615|4987810|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1519970|NCT00355615|4987811|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1519971|NCT00355615|4987812|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1519972|NCT00355615|4987808|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
1519973|NCT00355615|4987809|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1519974|NCT00355615|4987810|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1519975|NCT00355615|4987811|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1519976|NCT00355615|4987812|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1519977|NCT00355615|4987808|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
1519978|NCT00355615|4987809|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
1519979|NCT00355615|4987810|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
1519980|NCT00355615|4987811|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
1519981|NCT00355615|4987812|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
1519982|NCT00355615|4987808|P5|Randomized Double Blind Period|Protocol Violation|0
1519983|NCT00355615|4987809|P4|Randomized Double Blind Period|Protocol Violation|1
1519984|NCT00355615|4987810|P3|Randomized Double Blind Period|Protocol Violation|1
1519985|NCT00355615|4987811|P2|Randomized Double Blind Period|Protocol Violation|0
1519986|NCT00355615|4987812|P1|Randomized Double Blind Period|Protocol Violation|0
1519987|NCT00355615|4987808|P5|Randomized Double Blind Period|Adverse Event|0
1519988|NCT00355615|4987809|P4|Randomized Double Blind Period|Adverse Event|0
1519989|NCT00355615|4987810|P3|Randomized Double Blind Period|Adverse Event|0
1519990|NCT00355615|4987811|P2|Randomized Double Blind Period|Adverse Event|0
1519991|NCT00355615|4987812|P1|Randomized Double Blind Period|Adverse Event|1
1519992|NCT00355472|4987871|P1|Overall Study|Physician Decision|1
1519993|NCT00355368|4987917|P2|Overall Study|cardiac arrest prior to intubation|2
1519994|NCT00355368|4987918|P1|Overall Study|cardiac arrest prior to intubation|2
1519995|NCT00355368|4987917|P2|Overall Study|Protocol Violation|7
1519996|NCT00355368|4987918|P1|Overall Study|Protocol Violation|8
1519997|NCT00355342|4987932|P2|Overall Study|Use of protocol excluded medication|1
1519998|NCT00355342|4987933|P1|Overall Study|Use of protocol excluded medication|0
1519999|NCT00355342|4987932|P2|Overall Study|Protocol Violation|1
1520000|NCT00355342|4987933|P1|Overall Study|Protocol Violation|0
1520001|NCT00355342|4987932|P2|Overall Study|Study management|1
1520002|NCT00355342|4987933|P1|Overall Study|Study management|0
1520003|NCT00355342|4987932|P2|Overall Study|Participant discontinued study drug|1
1520004|NCT00355342|4987933|P1|Overall Study|Participant discontinued study drug|0
1520005|NCT00355342|4987932|P2|Overall Study|Participant relocated|1
1520006|NCT00355342|4987933|P1|Overall Study|Participant relocated|0
1520007|NCT00355342|4987932|P2|Overall Study|Withdrawal by participant and physician|0
1520008|NCT00355342|4987933|P1|Overall Study|Withdrawal by participant and physician|1
1520009|NCT00355342|4987932|P2|Overall Study|Non-compliance with Dexa scans|0
1520010|NCT00355342|4987933|P1|Overall Study|Non-compliance with Dexa scans|1
1520011|NCT00355342|4987932|P2|Overall Study|Dispensed wrong study drug kit|0
1520012|NCT00355342|4987933|P1|Overall Study|Dispensed wrong study drug kit|1
1520013|NCT00355342|4987932|P2|Overall Study|COPD exacerbation|1
1520014|NCT00355342|4987933|P1|Overall Study|COPD exacerbation|1
1520015|NCT00355342|4987932|P2|Overall Study|Use of prohibited medication|0
1520016|NCT00355342|4987933|P1|Overall Study|Use of prohibited medication|1
1520017|NCT00355342|4987932|P2|Overall Study|Overcompliant-PI discretion|0
1520018|NCT00355342|4987933|P1|Overall Study|Overcompliant-PI discretion|1
1520019|NCT00355342|4987932|P2|Overall Study|Sponsor terminated study|2
1520020|NCT00355342|4987933|P1|Overall Study|Sponsor terminated study|2
1520021|NCT00355342|4987932|P2|Overall Study|Withdrawal by Subject|11
1520022|NCT00355342|4987933|P1|Overall Study|Withdrawal by Subject|14
1520023|NCT00355342|4987932|P2|Overall Study|Lost to Follow-up|2
1520024|NCT00355342|4987933|P1|Overall Study|Lost to Follow-up|4
1520025|NCT00355342|4987932|P2|Overall Study|Adverse Event|15
1520026|NCT00355342|4987933|P1|Overall Study|Adverse Event|13
1520027|NCT00355147|4987960|P2|Overall Study|Withdrawal by Subject|12
1520028|NCT00355147|4987961|P1|Overall Study|Withdrawal by Subject|8
1520029|NCT00355147|4987960|P2|Overall Study|Lost to Follow-up|8
1520030|NCT00355147|4987961|P1|Overall Study|Lost to Follow-up|10
1520031|NCT00355134|4987980|P5|Extension Phase|Protocol Violation|0
1520032|NCT00355134|4987981|P4|Extension Phase|Protocol Violation|1
1520033|NCT00355134|4987982|P3|Extension Phase|Protocol Violation|0
1520034|NCT00355134|4987983|P2|Extension Phase|Protocol Violation|0
1520035|NCT00355134|4987984|P1|Extension Phase|Protocol Violation|0
1520036|NCT00355134|4987980|P5|Extension Phase|Abnormal test procedure result(s)|1
1520037|NCT00355134|4987981|P4|Extension Phase|Abnormal test procedure result(s)|0
1520038|NCT00355134|4987982|P3|Extension Phase|Abnormal test procedure result(s)|0
1520039|NCT00355134|4987983|P2|Extension Phase|Abnormal test procedure result(s)|1
1520040|NCT00355134|4987984|P1|Extension Phase|Abnormal test procedure result(s)|0
1520041|NCT00355134|4987980|P5|Extension Phase|Unsatisfactory therapeutic effect|1
1520042|NCT00355134|4987981|P4|Extension Phase|Unsatisfactory therapeutic effect|0
1520043|NCT00355134|4987982|P3|Extension Phase|Unsatisfactory therapeutic effect|0
1520044|NCT00355134|4987983|P2|Extension Phase|Unsatisfactory therapeutic effect|4
1520045|NCT00355134|4987984|P1|Extension Phase|Unsatisfactory therapeutic effect|3
1520046|NCT00355134|4987980|P5|Extension Phase|Administrative problems|1
1520047|NCT00355134|4987981|P4|Extension Phase|Administrative problems|1
1520048|NCT00355134|4987982|P3|Extension Phase|Administrative problems|0
1520049|NCT00355134|4987983|P2|Extension Phase|Administrative problems|4
1520050|NCT00355134|4987984|P1|Extension Phase|Administrative problems|2
1520051|NCT00355134|4987980|P5|Extension Phase|Abnormal laboratory value(s)|2
1520052|NCT00355134|4987981|P4|Extension Phase|Abnormal laboratory value(s)|2
1520053|NCT00355134|4987982|P3|Extension Phase|Abnormal laboratory value(s)|0
1520054|NCT00355134|4987983|P2|Extension Phase|Abnormal laboratory value(s)|2
1520055|NCT00355134|4987984|P1|Extension Phase|Abnormal laboratory value(s)|4
1520056|NCT00355134|4987980|P5|Extension Phase|Lost to Follow-up|4
1520057|NCT00355134|4987981|P4|Extension Phase|Lost to Follow-up|2
1520058|NCT00355134|4987982|P3|Extension Phase|Lost to Follow-up|0
1520059|NCT00355134|4987983|P2|Extension Phase|Lost to Follow-up|6
1520060|NCT00355134|4987984|P1|Extension Phase|Lost to Follow-up|2
1520061|NCT00355134|4987980|P5|Extension Phase|Adverse Event|5
1520062|NCT00355134|4987981|P4|Extension Phase|Adverse Event|3
1520063|NCT00355134|4987982|P3|Extension Phase|Adverse Event|0
1520064|NCT00355134|4987983|P2|Extension Phase|Adverse Event|9
1520065|NCT00355134|4987984|P1|Extension Phase|Adverse Event|13
1520066|NCT00355134|4987980|P5|Extension Phase|Withdrawal by Subject|5
1520067|NCT00355134|4987981|P4|Extension Phase|Withdrawal by Subject|7
1520068|NCT00355134|4987982|P3|Extension Phase|Withdrawal by Subject|0
1520069|NCT00355134|4987983|P2|Extension Phase|Withdrawal by Subject|11
1520070|NCT00355134|4987984|P1|Extension Phase|Withdrawal by Subject|7
1520071|NCT00355134|4987980|P5|Core Phase|Condition no longer requires study drug|0
1520072|NCT00355134|4987981|P4|Core Phase|Condition no longer requires study drug|0
1520073|NCT00355134|4987982|P3|Core Phase|Condition no longer requires study drug|1
1520074|NCT00355134|4987983|P2|Core Phase|Condition no longer requires study drug|0
1520075|NCT00355134|4987984|P1|Core Phase|Condition no longer requires study drug|1
1520076|NCT00355134|4987980|P5|Core Phase|Abnormal test procedure result(s)|0
1520077|NCT00355134|4987981|P4|Core Phase|Abnormal test procedure result(s)|0
1520078|NCT00355134|4987982|P3|Core Phase|Abnormal test procedure result(s)|1
1520079|NCT00355134|4987983|P2|Core Phase|Abnormal test procedure result(s)|2
1520080|NCT00355134|4987984|P1|Core Phase|Abnormal test procedure result(s)|1
1520081|NCT00355134|4987980|P5|Core Phase|Protocol Violation|0
1520082|NCT00355134|4987981|P4|Core Phase|Protocol Violation|0
1520083|NCT00355134|4987982|P3|Core Phase|Protocol Violation|2
1520084|NCT00355134|4987983|P2|Core Phase|Protocol Violation|2
1520085|NCT00355134|4987984|P1|Core Phase|Protocol Violation|3
1520086|NCT00355134|4987980|P5|Core Phase|Administrative problems|0
1520087|NCT00355134|4987981|P4|Core Phase|Administrative problems|0
1520088|NCT00355134|4987982|P3|Core Phase|Administrative problems|5
1520089|NCT00355134|4987983|P2|Core Phase|Administrative problems|3
1520090|NCT00355134|4987984|P1|Core Phase|Administrative problems|5
1520091|NCT00355134|4987980|P5|Core Phase|Unsatisfactory therapeutic effect|0
1520092|NCT00355134|4987981|P4|Core Phase|Unsatisfactory therapeutic effect|0
1520093|NCT00355134|4987982|P3|Core Phase|Unsatisfactory therapeutic effect|17
1520094|NCT00355134|4987983|P2|Core Phase|Unsatisfactory therapeutic effect|6
1520095|NCT00355134|4987984|P1|Core Phase|Unsatisfactory therapeutic effect|10
1520096|NCT00355134|4987980|P5|Core Phase|Abnormal laboratory value(s)|0
1520097|NCT00355134|4987981|P4|Core Phase|Abnormal laboratory value(s)|0
1520098|NCT00355134|4987982|P3|Core Phase|Abnormal laboratory value(s)|2
1520099|NCT00355134|4987983|P2|Core Phase|Abnormal laboratory value(s)|14
1520100|NCT00355134|4987984|P1|Core Phase|Abnormal laboratory value(s)|19
1520101|NCT00355134|4987980|P5|Core Phase|Lost to Follow-up|0
1520102|NCT00355134|4987981|P4|Core Phase|Lost to Follow-up|0
1520103|NCT00355134|4987982|P3|Core Phase|Lost to Follow-up|21
1520104|NCT00355134|4987983|P2|Core Phase|Lost to Follow-up|13
1520105|NCT00355134|4987984|P1|Core Phase|Lost to Follow-up|17
1520106|NCT00355134|4987980|P5|Core Phase|Adverse Event|0
1520107|NCT00355134|4987981|P4|Core Phase|Adverse Event|0
1520108|NCT00355134|4987982|P3|Core Phase|Adverse Event|16
1520109|NCT00355134|4987983|P2|Core Phase|Adverse Event|22
1520110|NCT00355134|4987984|P1|Core Phase|Adverse Event|28
1520111|NCT00355134|4987980|P5|Core Phase|Withdrawal by Subject|0
1520112|NCT00355134|4987981|P4|Core Phase|Withdrawal by Subject|0
1520113|NCT00355134|4987982|P3|Core Phase|Withdrawal by Subject|35
1520114|NCT00355134|4987983|P2|Core Phase|Withdrawal by Subject|24
1520115|NCT00355134|4987984|P1|Core Phase|Withdrawal by Subject|35
1520116|NCT00355121|4988027|P3|Overall Study|Serious adverse events|0
1520117|NCT00355121|4988028|P2|Overall Study|Serious adverse events|2
1520118|NCT00355121|4988029|P1|Overall Study|Serious adverse events|0
1520119|NCT00355121|4988027|P3|Overall Study|Withdrawal by Subject|2
1520120|NCT00355121|4988028|P2|Overall Study|Withdrawal by Subject|10
1520121|NCT00355121|4988029|P1|Overall Study|Withdrawal by Subject|9
1520122|NCT00355121|4988027|P3|Overall Study|Lost to Follow-up|1
1520123|NCT00355121|4988028|P2|Overall Study|Lost to Follow-up|7
1520124|NCT00355121|4988029|P1|Overall Study|Lost to Follow-up|4
1520125|NCT00355121|4988027|P3|Overall Study|Protocol Violation|1
1520126|NCT00355121|4988028|P2|Overall Study|Protocol Violation|9
1520127|NCT00355121|4988029|P1|Overall Study|Protocol Violation|7
1520128|NCT00355121|4988027|P3|Overall Study|Adverse Event|0
1520129|NCT00355121|4988028|P2|Overall Study|Adverse Event|1
1520130|NCT00355121|4988029|P1|Overall Study|Adverse Event|0
1520131|NCT00355121|4988027|P3|Overall Study|Did not receive study vaccine|1
1520132|NCT00355121|4988028|P2|Overall Study|Did not receive study vaccine|0
1520133|NCT00355121|4988029|P1|Overall Study|Did not receive study vaccine|1
1520134|NCT00355082|4988060|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
1520135|NCT00355082|4988061|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
1520136|NCT00355082|4988062|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
1520137|NCT00355082|4988060|P3|Continuation Phase|Scheduling Error|0
1520138|NCT00355082|4988061|P2|Continuation Phase|Scheduling Error|0
1520139|NCT00355082|4988062|P1|Continuation Phase|Scheduling Error|1
1520140|NCT00355082|4988060|P3|Continuation Phase|Site Closed by Sponsor|0
1520141|NCT00355082|4988061|P2|Continuation Phase|Site Closed by Sponsor|0
1520142|NCT00355082|4988062|P1|Continuation Phase|Site Closed by Sponsor|8
1520143|NCT00355082|4988060|P3|Continuation Phase|Lack of Efficacy|0
1520144|NCT00355082|4988061|P2|Continuation Phase|Lack of Efficacy|0
1520145|NCT00355082|4988062|P1|Continuation Phase|Lack of Efficacy|5
1520146|NCT00355082|4988060|P3|Continuation Phase|Withdrawal by Subject|0
1520147|NCT00355082|4988061|P2|Continuation Phase|Withdrawal by Subject|0
1520148|NCT00355082|4988062|P1|Continuation Phase|Withdrawal by Subject|4
1520149|NCT00355082|4988060|P3|Continuation Phase|Protocol Violation|1
1520150|NCT00355082|4988061|P2|Continuation Phase|Protocol Violation|0
1520151|NCT00355082|4988062|P1|Continuation Phase|Protocol Violation|1
1520152|NCT00355082|4988060|P3|Continuation Phase|Lost to Follow-up|1
1520153|NCT00355082|4988061|P2|Continuation Phase|Lost to Follow-up|0
1520154|NCT00355082|4988062|P1|Continuation Phase|Lost to Follow-up|2
1520155|NCT00355082|4988060|P3|Continuation Phase|Adverse Event|1
1520156|NCT00355082|4988061|P2|Continuation Phase|Adverse Event|0
1520157|NCT00355082|4988062|P1|Continuation Phase|Adverse Event|2
1520158|NCT00355082|4988060|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
1520159|NCT00355082|4988061|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
1520160|NCT00355082|4988062|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
1520161|NCT00355082|4988060|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
1520162|NCT00355082|4988061|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
1520163|NCT00355082|4988062|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
1520164|NCT00355082|4988060|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
1520165|NCT00355082|4988061|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
1520166|NCT00355082|4988062|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
1520167|NCT00355082|4988060|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
1520168|NCT00355082|4988061|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
1520169|NCT00355082|4988062|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
1520170|NCT00355082|4988060|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
1520171|NCT00355082|4988061|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
1520172|NCT00355082|4988062|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
1520173|NCT00355082|4988060|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
1520174|NCT00355082|4988061|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
1520175|NCT00355082|4988062|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
1520176|NCT00355030|4988084|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
1520177|NCT00355030|4988085|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
1520178|NCT00355030|4988084|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
1520179|NCT00355030|4988085|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
1520180|NCT00355030|4988084|P2|Study Period 1 Treatment|Other|6
1520181|NCT00355030|4988085|P1|Study Period 1 Treatment|Other|2
1520182|NCT00355030|4988084|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
1520183|NCT00355030|4988085|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
1520184|NCT00355030|4988084|P2|Study Period 1 Treatment|Sponsor Decision|32
1520185|NCT00355030|4988085|P1|Study Period 1 Treatment|Sponsor Decision|34
1520186|NCT00355030|4988084|P2|Study Period 1 Treatment|Physician Decision|1
1520187|NCT00355030|4988085|P1|Study Period 1 Treatment|Physician Decision|0
1520188|NCT00355030|4988084|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
1520189|NCT00355030|4988085|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
1520190|NCT00355030|4988084|P2|Study Period 1 Treatment|Withdrawal by Subject|1
1520191|NCT00355030|4988085|P1|Study Period 1 Treatment|Withdrawal by Subject|4
1520192|NCT00355030|4988084|P2|Study Period 1 Treatment|Lost to Follow-up|0
1520193|NCT00355030|4988085|P1|Study Period 1 Treatment|Lost to Follow-up|3
1520194|NCT00355030|4988084|P2|Study Period 1 Treatment|Adverse Event|1
1520195|NCT00355030|4988085|P1|Study Period 1 Treatment|Adverse Event|1
1520196|NCT00354835|4988124|P2|Overall Study|Refusal of further therapy|8
1520197|NCT00354835|4988125|P1|Overall Study|Refusal of further therapy|3
1520198|NCT00354835|4988124|P2|Overall Study|Adverse Event|0
1520199|NCT00354835|4988125|P1|Overall Study|Adverse Event|6
1520200|NCT00354835|4988124|P2|Overall Study|Disease progression or relapse|22
1520201|NCT00354835|4988125|P1|Overall Study|Disease progression or relapse|15
1520202|NCT00354835|4988124|P2|Overall Study|Ineligible|16
1520203|NCT00354835|4988125|P1|Overall Study|Ineligible|17
1520204|NCT00354835|4988124|P2|Overall Study|Withdrawal by Subject|1
1520205|NCT00354835|4988125|P1|Overall Study|Withdrawal by Subject|2
1520206|NCT00354835|4988124|P2|Overall Study|Physician Decision|13
1520207|NCT00354835|4988125|P1|Overall Study|Physician Decision|8
1520208|NCT00354835|4988124|P2|Overall Study|Death|1
1520209|NCT00354835|4988125|P1|Overall Study|Death|1
1520210|NCT00354744|4988164|P1|Overall Study|Withdrawal by Subject|14
1520211|NCT00354744|4988164|P1|Overall Study|Physician Decision|11
1520212|NCT00354744|4988164|P1|Overall Study|Lost to Follow-up|2
1520213|NCT00354744|4988164|P1|Overall Study|Lack of Efficacy|11
1520214|NCT00354744|4988164|P1|Overall Study|Death|2
1520215|NCT00354744|4988164|P1|Overall Study|Adverse Event|2
1520216|NCT00354679|4988169|P1|Overall Study|Patient Not Treated|1
1520217|NCT00354614|4988178|P1|Overall Study|Lack of Efficacy|28
1520218|NCT00354601|4988182|P1|Overall Study|progression|1
1520219|NCT00354601|4988182|P1|Overall Study|Protocol Violation|1
1520220|NCT00354432|4988202|P4|Overall Study|Off/Toxicity|5
1520221|NCT00354432|4988203|P3|Overall Study|Off/Toxicity|5
1520222|NCT00354432|4988204|P2|Overall Study|Off/Toxicity|7
1520223|NCT00354432|4988205|P1|Overall Study|Off/Toxicity|3
1520224|NCT00354432|4988202|P4|Overall Study|Adverse Event|5
1520225|NCT00354432|4988203|P3|Overall Study|Adverse Event|5
1520226|NCT00354432|4988204|P2|Overall Study|Adverse Event|1
1520227|NCT00354432|4988205|P1|Overall Study|Adverse Event|3
1520228|NCT00354341|4988221|P2|Overall Study|Other|2
1520229|NCT00354341|4988222|P1|Overall Study|Other|1
1520230|NCT00354341|4988221|P2|Overall Study|Failure to return|1
1520231|NCT00354341|4988222|P1|Overall Study|Failure to return|0
1520232|NCT00354341|4988221|P2|Overall Study|Refused treatment|2
1520233|NCT00354341|4988222|P1|Overall Study|Refused treatment|1
1520234|NCT00354341|4988221|P2|Overall Study|Death|2
1520235|NCT00354341|4988222|P1|Overall Study|Death|0
1520236|NCT00354341|4988221|P2|Overall Study|Adverse Event|0
1520237|NCT00354341|4988222|P1|Overall Study|Adverse Event|1
1520238|NCT00354172|4988244|P1|Overall Study|Did not receive transplant|1
1520239|NCT00354159|4988264|P2|Long-term Follow-up|Study Closed|34
1520240|NCT00354159|4988265|P1|Long-term Follow-up|Study Closed|29
1520241|NCT00354159|4988264|P2|Long-term Follow-up|Death|11
1520242|NCT00354159|4988265|P1|Long-term Follow-up|Death|14
1520243|NCT00354159|4988264|P2|Long-term Follow-up|Lost to Follow-up|0
1520244|NCT00354159|4988265|P1|Long-term Follow-up|Lost to Follow-up|1
1520245|NCT00354159|4988264|P2|Long-term Follow-up|Physician Decision|122
1520246|NCT00354159|4988265|P1|Long-term Follow-up|Physician Decision|127
1520247|NCT00354159|4988264|P2|Long-term Follow-up|Withdrawal by Subject|9
1520248|NCT00354159|4988265|P1|Long-term Follow-up|Withdrawal by Subject|9
1520249|NCT00354159|4988264|P2|Randomized Study Period|Death|9
1520250|NCT00354159|4988265|P1|Randomized Study Period|Death|7
1520251|NCT00354159|4988264|P2|Randomized Study Period|Lost to Follow-up|0
1520252|NCT00354159|4988265|P1|Randomized Study Period|Lost to Follow-up|4
1520253|NCT00354159|4988264|P2|Randomized Study Period|Physician Decision|10
1520254|NCT00354159|4988265|P1|Randomized Study Period|Physician Decision|6
1520255|NCT00354159|4988264|P2|Randomized Study Period|Withdrawal by Subject|3
1520256|NCT00354159|4988265|P1|Randomized Study Period|Withdrawal by Subject|5
1520257|NCT00354107|4988308|P1|Overall Study|Withdrawal by Subject|1
1520258|NCT00354107|4988308|P1|Overall Study|Physician Decision|2
1520259|NCT00354107|4988308|P1|Overall Study|Adverse Event|2
1520260|NCT00354029|4988318|P2|Overall Study|Protocol Violation|2
1520261|NCT00354029|4988319|P1|Overall Study|Protocol Violation|4
1520262|NCT00353873|4988331|P2|Overall Study|Withdrawal by Subject|1
1520263|NCT00353873|4988332|P1|Overall Study|Withdrawal by Subject|1
1520264|NCT00353873|4988331|P2|Overall Study|Physician Decision|0
1520265|NCT00353873|4988332|P1|Overall Study|Physician Decision|2
1520266|NCT00353873|4988331|P2|Overall Study|Adverse Event|0
1520267|NCT00353873|4988332|P1|Overall Study|Adverse Event|1
1520268|NCT00353873|4988331|P2|Overall Study|Exacerbation|0
1520269|NCT00353873|4988332|P1|Overall Study|Exacerbation|1
1520270|NCT00353873|4988331|P2|Overall Study|Protocol Violation|2
1520271|NCT00353873|4988332|P1|Overall Study|Protocol Violation|1
1520272|NCT00353704|4988361|P2|Overall Study|Protocol Violation|1
1520273|NCT00353704|4988362|P1|Overall Study|Protocol Violation|3
1520274|NCT00353496|4988397|P2|Overall Study|Not otherwise specified|2
1520275|NCT00353496|4988398|P1|Overall Study|Not otherwise specified|4
1520276|NCT00353496|4988397|P2|Overall Study|Physician Decision|9
1520277|NCT00353496|4988398|P1|Overall Study|Physician Decision|6
1520278|NCT00353496|4988397|P2|Overall Study|Withdrawal by Subject|4
1520279|NCT00353496|4988398|P1|Overall Study|Withdrawal by Subject|3
1520280|NCT00353496|4988397|P2|Overall Study|Protocol Violation|2
1520281|NCT00353496|4988398|P1|Overall Study|Protocol Violation|2
1520282|NCT00353496|4988397|P2|Overall Study|Adverse Event|0
1520283|NCT00353496|4988398|P1|Overall Study|Adverse Event|1
1520284|NCT00353366|4988451|P1|Overall Study|Other|135
1520285|NCT00353366|4988451|P1|Overall Study|Adverse Event|8
1520286|NCT00353262|4988472|P1|Overall Study|Break from Chemotherapy|1
1520287|NCT00353262|4988472|P1|Overall Study|Surgery|4
1520288|NCT00353262|4988472|P1|Overall Study|Progression|1
1520289|NCT00353262|4988472|P1|Overall Study|Insufficient Therapeutic Response|13
1520290|NCT00353262|4988472|P1|Overall Study|Withdrawal by Subject|2
1520291|NCT00353262|4988472|P1|Overall Study|Adverse Event|8
1520292|NCT00352846|4988522|P2|Overall Study|Death|1
1520293|NCT00352846|4988523|P1|Overall Study|Death|0
1520294|NCT00352846|4988522|P2|Overall Study|Non-compliance|0
1520295|NCT00352846|4988523|P1|Overall Study|Non-compliance|2
1520296|NCT00352846|4988522|P2|Overall Study|Ineligible|2
1520297|NCT00352846|4988523|P1|Overall Study|Ineligible|3
1520298|NCT00352846|4988522|P2|Overall Study|Withdrawal by Subject|8
1520299|NCT00352846|4988523|P1|Overall Study|Withdrawal by Subject|3
1520300|NCT00352846|4988522|P2|Overall Study|Disease progression|2
1520301|NCT00352846|4988523|P1|Overall Study|Disease progression|0
1520302|NCT00352755|4988534|P1|Overall Study|Adverse Event|1
1520303|NCT00352755|4988534|P1|Overall Study|Physician Decision|1
1520304|NCT00352690|4988544|P2|Overall Study|Determined to be ineligible|0
1520305|NCT00352690|4988545|P1|Overall Study|Determined to be ineligible|2
1520306|NCT00352664|4988565|P2|Overall Study|Withdrawal by Subject|0
1520307|NCT00352664|4988566|P1|Overall Study|Withdrawal by Subject|7
1520308|NCT00352534|4988583|P7|Final Risk Group Assignment|Death|0
1520309|NCT00352534|4988584|P6|Final Risk Group Assignment|Death|2
1520310|NCT00352534|4988585|P5|Final Risk Group Assignment|Death|0
1520311|NCT00352534|4988586|P4|Final Risk Group Assignment|Death|0
1520312|NCT00352534|4988587|P3|Final Risk Group Assignment|Death|0
1520313|NCT00352534|4988588|P2|Final Risk Group Assignment|Death|0
1520314|NCT00352534|4988589|P1|Final Risk Group Assignment|Death|0
1520315|NCT00352534|4988583|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
1520316|NCT00352534|4988584|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1520317|NCT00352534|4988585|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1520318|NCT00352534|4988586|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1520319|NCT00352534|4988587|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1520320|NCT00352534|4988588|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1520321|NCT00352534|4988589|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1520322|NCT00352534|4988583|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
1520323|NCT00352534|4988584|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
1520324|NCT00352534|4988585|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
1520325|NCT00352534|4988586|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
1520326|NCT00352534|4988587|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
1520327|NCT00352534|4988588|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
1520328|NCT00352534|4988589|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
1520329|NCT00352534|4988583|P7|Final Risk Group Assignment|Ineligible|0
1520330|NCT00352534|4988584|P6|Final Risk Group Assignment|Ineligible|13
1520331|NCT00352534|4988585|P5|Final Risk Group Assignment|Ineligible|0
1520332|NCT00352534|4988586|P4|Final Risk Group Assignment|Ineligible|1
1520333|NCT00352534|4988587|P3|Final Risk Group Assignment|Ineligible|3
1520334|NCT00352534|4988588|P2|Final Risk Group Assignment|Ineligible|0
1520335|NCT00352534|4988589|P1|Final Risk Group Assignment|Ineligible|0
1520336|NCT00352534|4988583|P7|Final Risk Group Assignment|Withdrawal by Subject|0
1520337|NCT00352534|4988584|P6|Final Risk Group Assignment|Withdrawal by Subject|3
1520338|NCT00352534|4988585|P5|Final Risk Group Assignment|Withdrawal by Subject|0
1520339|NCT00352534|4988586|P4|Final Risk Group Assignment|Withdrawal by Subject|0
1520340|NCT00352534|4988587|P3|Final Risk Group Assignment|Withdrawal by Subject|0
1520341|NCT00352534|4988588|P2|Final Risk Group Assignment|Withdrawal by Subject|0
1520342|NCT00352534|4988589|P1|Final Risk Group Assignment|Withdrawal by Subject|0
1520343|NCT00352534|4988583|P7|Final Risk Group Assignment|Physician Decision|0
1520344|NCT00352534|4988584|P6|Final Risk Group Assignment|Physician Decision|8
1520345|NCT00352534|4988585|P5|Final Risk Group Assignment|Physician Decision|0
1520346|NCT00352534|4988586|P4|Final Risk Group Assignment|Physician Decision|0
1520347|NCT00352534|4988587|P3|Final Risk Group Assignment|Physician Decision|0
1520348|NCT00352534|4988588|P2|Final Risk Group Assignment|Physician Decision|0
1520349|NCT00352534|4988589|P1|Final Risk Group Assignment|Physician Decision|0
1520350|NCT00352534|4988583|P7|Final Risk Group Assignment|Lack of Efficacy|0
1520351|NCT00352534|4988584|P6|Final Risk Group Assignment|Lack of Efficacy|19
1520352|NCT00352534|4988585|P5|Final Risk Group Assignment|Lack of Efficacy|1
1520353|NCT00352534|4988586|P4|Final Risk Group Assignment|Lack of Efficacy|2
1520354|NCT00352534|4988587|P3|Final Risk Group Assignment|Lack of Efficacy|0
1520355|NCT00352534|4988588|P2|Final Risk Group Assignment|Lack of Efficacy|0
1520356|NCT00352534|4988589|P1|Final Risk Group Assignment|Lack of Efficacy|0
1520357|NCT00352534|4988583|P7|Initial Staging|Ineligible|0
1520358|NCT00352534|4988584|P6|Initial Staging|Ineligible|0
1520359|NCT00352534|4988585|P5|Initial Staging|Ineligible|0
1520360|NCT00352534|4988586|P4|Initial Staging|Ineligible|0
1520361|NCT00352534|4988587|P3|Initial Staging|Ineligible|0
1520362|NCT00352534|4988588|P2|Initial Staging|Ineligible|9
1520363|NCT00352534|4988589|P1|Initial Staging|Ineligible|8
1520364|NCT00352417|4988606|P2|Overall Study|Schedule Change|1
1520365|NCT00352417|4988607|P1|Overall Study|Schedule Change|2
1520366|NCT00352417|4988606|P2|Overall Study|Lost to Follow-up|0
1520367|NCT00352417|4988607|P1|Overall Study|Lost to Follow-up|1
1520368|NCT00352417|4988606|P2|Overall Study|Withdrawal by Subject|2
1520369|NCT00352417|4988607|P1|Overall Study|Withdrawal by Subject|1
1520370|NCT00352417|4988606|P2|Overall Study|Protocol Violation|2
1520371|NCT00352417|4988607|P1|Overall Study|Protocol Violation|0
1520372|NCT00352417|4988606|P2|Overall Study|Adverse Event|0
1520373|NCT00352417|4988607|P1|Overall Study|Adverse Event|1
1520374|NCT00352365|4988621|P1|Maintenance Therapy|Not eligible|4
1520375|NCT00352365|4988621|P1|Maintenance Therapy|Not protocol specified|3
1520376|NCT00352365|4988621|P1|Maintenance Therapy|Death|2
1520377|NCT00352365|4988621|P1|Maintenance Therapy|Progression/Relapse|3
1520378|NCT00352365|4988621|P1|Induction Therapy|Death before starting protocol therapy|1
1520379|NCT00352365|4988621|P1|Induction Therapy|Not eligible|3
1520380|NCT00352365|4988621|P1|Induction Therapy|Not protocol specified|1
1520381|NCT00352365|4988621|P1|Induction Therapy|Death|7
1520382|NCT00352365|4988621|P1|Induction Therapy|Progression/Relapse|8
1520383|NCT00352365|4988621|P1|Induction Therapy|Adverse Event|7
1520384|NCT00352118|4988631|P1|Overall Study|Physician Decision|4
1520385|NCT00352105|4988641|P1|Overall Study|Protocol Violation|2
1520386|NCT00352105|4988641|P1|Overall Study|Adverse Event|19
1520387|NCT00352105|4988641|P1|Overall Study|Lack of Efficacy|9
1520388|NCT00352105|4988641|P1|Overall Study|Withdrawal by Subject|5
1520389|NCT00352105|4988641|P1|Overall Study|Death|5
1520390|NCT00352053|4988652|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
1520391|NCT00352053|4988653|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
1520392|NCT00352053|4988652|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
1520393|NCT00352053|4988653|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
1520394|NCT00352053|4988652|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
1520395|NCT00352053|4988653|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
1520396|NCT00352053|4988652|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
1520397|NCT00352053|4988653|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
1520398|NCT00352053|4988652|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
1520399|NCT00352053|4988653|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
1520400|NCT00352053|4988652|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
1520401|NCT00352053|4988653|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
1520402|NCT00352053|4988652|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
1520403|NCT00352053|4988653|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
1520404|NCT00352053|4988652|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
1520405|NCT00352053|4988653|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
1520406|NCT00352053|4988652|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
1520407|NCT00352053|4988653|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
1520408|NCT00352053|4988652|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
1520409|NCT00352053|4988653|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
1520410|NCT00352053|4988652|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
1520411|NCT00352053|4988653|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
1520412|NCT00352053|4988652|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
1520413|NCT00352053|4988653|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
1520414|NCT00352053|4988652|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
1520415|NCT00352053|4988653|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
1520416|NCT00352027|4988820|P1|Overall Study|Progressive disease|3
1520417|NCT00351819|4989108|P2|Overall Study|Enrolled in another trial|1
1520418|NCT00351819|4989109|P1|Overall Study|Enrolled in another trial|0
1520419|NCT00351819|4989108|P2|Overall Study|Incarcerated|1
1520420|NCT00351819|4989109|P1|Overall Study|Incarcerated|0
1520421|NCT00351819|4989108|P2|Overall Study|Non-compliance|1
1520422|NCT00351819|4989109|P1|Overall Study|Non-compliance|0
1520423|NCT00351819|4989108|P2|Overall Study|Unprofessional behavior|0
1520424|NCT00351819|4989109|P1|Overall Study|Unprofessional behavior|1
1520425|NCT00351819|4989108|P2|Overall Study|Traumatic ankle fracture|0
1520426|NCT00351819|4989109|P1|Overall Study|Traumatic ankle fracture|1
1520427|NCT00351819|4989108|P2|Overall Study|Elevated PSA|1
1520428|NCT00351819|4989109|P1|Overall Study|Elevated PSA|1
1520429|NCT00351819|4989108|P2|Overall Study|Withdrawal by Subject|4
1520430|NCT00351819|4989109|P1|Overall Study|Withdrawal by Subject|0
1520431|NCT00351819|4989108|P2|Overall Study|Lost to Follow-up|4
1520432|NCT00351819|4989109|P1|Overall Study|Lost to Follow-up|4
1520433|NCT00351533|4989180|P2|Overall Study|Withdrawal by Subject|1
1520434|NCT00351533|4989181|P1|Overall Study|Withdrawal by Subject|0
1520435|NCT00351533|4989180|P2|Overall Study|Physician Decision|1
1520436|NCT00351533|4989181|P1|Overall Study|Physician Decision|0
1520437|NCT00351533|4989180|P2|Overall Study|Lost to Follow-up|3
1520438|NCT00351533|4989181|P1|Overall Study|Lost to Follow-up|1
1520439|NCT00351533|4989180|P2|Overall Study|Extubated before first BAL|0
1520440|NCT00351533|4989181|P1|Overall Study|Extubated before first BAL|1
1520441|NCT00351468|4989241|P1|Overall Study|Protocol Violation|3
1520442|NCT00351468|4989241|P1|Overall Study|Lost to Follow-up|4
1520443|NCT00351468|4989241|P1|Overall Study|Non-compliance|8
1520444|NCT00351468|4989241|P1|Overall Study|Lack of Efficacy|32
1520445|NCT00351468|4989241|P1|Overall Study|Various -follow up w clinical team|39
1520446|NCT00351468|4989241|P1|Overall Study|Withdrawal by Subject|39
1520447|NCT00351468|4989241|P1|Overall Study|Adverse Event|42
1520448|NCT00351377|4989265|P1|Overall Study|Unsatisfactory therapeutic effect|1
1520449|NCT00351377|4989265|P1|Overall Study|Death|1
1520450|NCT00351377|4989265|P1|Overall Study|Adverse Event|5
1520451|NCT00351351|4989279|P2|Overall Study|surgical access pbs; device issues|4
1520452|NCT00351351|4989280|P1|Overall Study|surgical access pbs; device issues|9
1520453|NCT00351273|4989306|P3|Overall Study|Lost to Follow-up|5
1520454|NCT00351273|4989307|P2|Overall Study|Lost to Follow-up|2
1520455|NCT00351273|4989308|P1|Overall Study|Lost to Follow-up|1
1520456|NCT00350870|4989336|P4|Overall Study|Physician Decision|1
1520457|NCT00350870|4989337|P3|Overall Study|Physician Decision|1
1520458|NCT00350870|4989338|P2|Overall Study|Physician Decision|0
1520459|NCT00350870|4989339|P1|Overall Study|Physician Decision|1
1520460|NCT00350870|4989336|P4|Overall Study|Withdrawal by Subject|14
1520461|NCT00350870|4989337|P3|Overall Study|Withdrawal by Subject|15
1520462|NCT00350870|4989338|P2|Overall Study|Withdrawal by Subject|17
1520463|NCT00350870|4989339|P1|Overall Study|Withdrawal by Subject|21
1520464|NCT00350844|4989353|P1|Overall Study|Lost to Follow-up|1
1520465|NCT00350792|4989357|P1|Overall Study|Lack of Efficacy|11
1520466|NCT00350792|4989357|P1|Overall Study|Physician Decision|2
1520467|NCT00350792|4989357|P1|Overall Study|Withdrawal by Subject|4
1520468|NCT00350792|4989357|P1|Overall Study|Protocol Violation|1
1520469|NCT00350792|4989357|P1|Overall Study|Death Not Study Drug Related|2
1520470|NCT00350792|4989357|P1|Overall Study|Death from Study Drug Toxicity|1
1520471|NCT00350792|4989357|P1|Overall Study|Death from Study Disease|1
1520472|NCT00350792|4989357|P1|Overall Study|Adverse Event|11
1520473|NCT00350779|4989367|P2|Overall Study|Non-compliance with study procedures|1
1520474|NCT00350779|4989368|P1|Overall Study|Non-compliance with study procedures|0
1520475|NCT00350779|4989367|P2|Overall Study|Patient Moved|1
1520476|NCT00350779|4989368|P1|Overall Study|Patient Moved|2
1520477|NCT00350779|4989367|P2|Overall Study|Withdrawal by Subject|8
1520478|NCT00350779|4989368|P1|Overall Study|Withdrawal by Subject|9
1520479|NCT00350779|4989367|P2|Overall Study|Protocol Violation|1
1520480|NCT00350779|4989368|P1|Overall Study|Protocol Violation|3
1520481|NCT00350779|4989367|P2|Overall Study|Physician Decision|4
1520482|NCT00350779|4989368|P1|Overall Study|Physician Decision|2
1520483|NCT00350779|4989367|P2|Overall Study|Lost to Follow-up|0
1520484|NCT00350779|4989368|P1|Overall Study|Lost to Follow-up|2
1520485|NCT00350779|4989367|P2|Overall Study|Lack of Efficacy|4
1520486|NCT00350779|4989368|P1|Overall Study|Lack of Efficacy|0
1520487|NCT00350779|4989367|P2|Overall Study|Adverse Event|2
1520488|NCT00350779|4989368|P1|Overall Study|Adverse Event|4
1520489|NCT00350727|4989389|P3|Phase II|Enrolled in Rollover Study|1
1520490|NCT00350727|4989390|P2|Phase II|Enrolled in Rollover Study|0
1520491|NCT00350727|4989391|P1|Phase II|Enrolled in Rollover Study|0
1520492|NCT00350727|4989389|P3|Phase II|Sponsor Terminated Study|1
1520493|NCT00350727|4989390|P2|Phase II|Sponsor Terminated Study|0
1520494|NCT00350727|4989391|P1|Phase II|Sponsor Terminated Study|0
1520495|NCT00350727|4989389|P3|Phase II|Death|2
1520496|NCT00350727|4989390|P2|Phase II|Death|0
1520497|NCT00350727|4989391|P1|Phase II|Death|0
1520498|NCT00350727|4989389|P3|Phase II|Adverse Event|1
1520499|NCT00350727|4989390|P2|Phase II|Adverse Event|1
1520500|NCT00350727|4989391|P1|Phase II|Adverse Event|0
1520501|NCT00350727|4989389|P3|Phase II|Withdrawal by Subject|1
1520502|NCT00350727|4989390|P2|Phase II|Withdrawal by Subject|2
1520503|NCT00350727|4989391|P1|Phase II|Withdrawal by Subject|0
1520504|NCT00350727|4989389|P3|Phase II|Clinical Deterioration|0
1520505|NCT00350727|4989390|P2|Phase II|Clinical Deterioration|1
1520506|NCT00350727|4989391|P1|Phase II|Clinical Deterioration|0
1520507|NCT00350727|4989389|P3|Phase II|Disease Progression|16
1520508|NCT00350727|4989390|P2|Phase II|Disease Progression|15
1520509|NCT00350727|4989391|P1|Phase II|Disease Progression|0
1520510|NCT00350727|4989389|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
1520511|NCT00350727|4989390|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
1520512|NCT00350727|4989391|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
1520513|NCT00350727|4989389|P3|Phase I: Dose Escalation|Physician Decision|0
1520514|NCT00350727|4989390|P2|Phase I: Dose Escalation|Physician Decision|0
1520515|NCT00350727|4989391|P1|Phase I: Dose Escalation|Physician Decision|1
1520516|NCT00350727|4989389|P3|Phase I: Dose Escalation|Death|0
1520517|NCT00350727|4989390|P2|Phase I: Dose Escalation|Death|0
1520518|NCT00350727|4989391|P1|Phase I: Dose Escalation|Death|1
1520519|NCT00350727|4989389|P3|Phase I: Dose Escalation|Lack of Efficacy|0
1520520|NCT00350727|4989390|P2|Phase I: Dose Escalation|Lack of Efficacy|0
1520521|NCT00350727|4989391|P1|Phase I: Dose Escalation|Lack of Efficacy|25
1520522|NCT00350727|4989389|P3|Phase I: Dose Escalation|Adverse Event|0
1520523|NCT00350727|4989390|P2|Phase I: Dose Escalation|Adverse Event|0
1520524|NCT00350727|4989391|P1|Phase I: Dose Escalation|Adverse Event|4
1520525|NCT00350636|4989535|P2|Overall Study|Other|2
1520526|NCT00350636|4989536|P1|Overall Study|Other|1
1520527|NCT00350636|4989535|P2|Overall Study|Physician Decision|2
1520528|NCT00350636|4989536|P1|Overall Study|Physician Decision|0
1520529|NCT00350636|4989535|P2|Overall Study|Lost to Follow-up|8
1520530|NCT00350636|4989536|P1|Overall Study|Lost to Follow-up|9
1520531|NCT00350636|4989535|P2|Overall Study|Withdrawal by Subject|17
1520532|NCT00350636|4989536|P1|Overall Study|Withdrawal by Subject|13
1520533|NCT00350636|4989535|P2|Overall Study|Protocol Violation|3
1520534|NCT00350636|4989536|P1|Overall Study|Protocol Violation|1
1520535|NCT00350636|4989535|P2|Overall Study|Adverse Event|13
1520536|NCT00350636|4989536|P1|Overall Study|Adverse Event|19
1520537|NCT00350623|4989555|P3|Overall Study|patient traveling outside the country|1
1520538|NCT00350623|4989556|P2|Overall Study|patient traveling outside the country|0
1520539|NCT00350623|4989557|P1|Overall Study|patient traveling outside the country|0
1520540|NCT00350623|4989555|P3|Overall Study|Withdrawal by Subject|1
1520541|NCT00350623|4989556|P2|Overall Study|Withdrawal by Subject|1
1520542|NCT00350623|4989557|P1|Overall Study|Withdrawal by Subject|0
1520543|NCT00350623|4989555|P3|Overall Study|Lost to Follow-up|4
1520544|NCT00350623|4989556|P2|Overall Study|Lost to Follow-up|3
1520545|NCT00350623|4989557|P1|Overall Study|Lost to Follow-up|8
1520546|NCT00350545|4989565|P1|Overall Study|Withdrawal by Subject|2
1520547|NCT00350519|4989584|P2|Overall Study|Withdrawal by Subject|2
1520548|NCT00350519|4989585|P1|Overall Study|Withdrawal by Subject|3
1520549|NCT00350519|4989584|P2|Overall Study|Protocol Violation|2
1520550|NCT00350519|4989585|P1|Overall Study|Protocol Violation|1
1520551|NCT00350519|4989584|P2|Overall Study|Physician Decision|1
1520552|NCT00350519|4989585|P1|Overall Study|Physician Decision|0
1520553|NCT00350519|4989584|P2|Overall Study|Death|1
1520554|NCT00350519|4989585|P1|Overall Study|Death|0
1520555|NCT00350402|4989599|P2|Overall Study|Lost to Follow-up|1
1520556|NCT00350402|4989600|P1|Overall Study|Lost to Follow-up|1
1520557|NCT00350272|4989618|P2|Open-Label 84 Week Treatment|Sponsor decision|1
1520558|NCT00350272|4989619|P1|Open-Label 84 Week Treatment|Sponsor decision|2
1520559|NCT00350272|4989618|P2|Open-Label 84 Week Treatment|Physician Decision|2
1520560|NCT00350272|4989619|P1|Open-Label 84 Week Treatment|Physician Decision|1
1520561|NCT00350272|4989618|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
1520562|NCT00350272|4989619|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
1520563|NCT00350272|4989618|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
1520564|NCT00350272|4989619|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
1520565|NCT00350272|4989618|P2|Open-Label 84 Week Treatment|Adverse Event|1
1520566|NCT00350272|4989619|P1|Open-Label 84 Week Treatment|Adverse Event|2
1520567|NCT00350272|4989618|P2|Blinded 12 Week Treatment|Sponsor decision|1
1520568|NCT00350272|4989619|P1|Blinded 12 Week Treatment|Sponsor decision|0
1520569|NCT00350272|4989618|P2|Blinded 12 Week Treatment|Physician Decision|1
1520570|NCT00350272|4989619|P1|Blinded 12 Week Treatment|Physician Decision|2
1520571|NCT00350272|4989618|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
1520572|NCT00350272|4989619|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
1520573|NCT00350272|4989618|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
1520574|NCT00350272|4989619|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
1520575|NCT00350272|4989618|P2|Blinded 12 Week Treatment|Death|0
1520576|NCT00350272|4989619|P1|Blinded 12 Week Treatment|Death|1
1520577|NCT00350272|4989618|P2|Blinded 12 Week Treatment|Adverse Event|0
1520578|NCT00350272|4989619|P1|Blinded 12 Week Treatment|Adverse Event|1
1520579|NCT00350207|4989641|P3|Overall Study|Other|1
1520580|NCT00350207|4989642|P2|Overall Study|Other|3
1520581|NCT00350207|4989643|P1|Overall Study|Other|1
1520582|NCT00350207|4989641|P3|Overall Study|Withdrawal by Subject|1
1520583|NCT00350207|4989642|P2|Overall Study|Withdrawal by Subject|1
1520584|NCT00350207|4989643|P1|Overall Study|Withdrawal by Subject|0
1520585|NCT00350207|4989641|P3|Overall Study|Lost to Follow-up|1
1520586|NCT00350207|4989642|P2|Overall Study|Lost to Follow-up|0
1520587|NCT00350207|4989643|P1|Overall Study|Lost to Follow-up|1
1520588|NCT00350207|4989641|P3|Overall Study|Lack of Efficacy|2
1520589|NCT00350207|4989642|P2|Overall Study|Lack of Efficacy|0
1520590|NCT00350207|4989643|P1|Overall Study|Lack of Efficacy|1
1520591|NCT00350207|4989641|P3|Overall Study|Adverse Event|2
1520592|NCT00350207|4989642|P2|Overall Study|Adverse Event|2
1520593|NCT00350207|4989643|P1|Overall Study|Adverse Event|5
1520594|NCT00349921|4989857|P4|First Spinal Injection|Adverse Event|0
1520595|NCT00349921|4989858|P3|First Spinal Injection|Adverse Event|1
1520596|NCT00349921|4989859|P2|First Spinal Injection|Adverse Event|0
1520597|NCT00349921|4989860|P1|First Spinal Injection|Adverse Event|0
1520598|NCT00349921|4989857|P4|First Spinal Injection|Physician Decision|0
1520599|NCT00349921|4989858|P3|First Spinal Injection|Physician Decision|0
1520600|NCT00349921|4989859|P2|First Spinal Injection|Physician Decision|0
1520601|NCT00349921|4989860|P1|First Spinal Injection|Physician Decision|1
1520602|NCT00349908|4989871|P2|Overall Study|Withdrawal by Subject|4
1520603|NCT00349908|4989872|P1|Overall Study|Withdrawal by Subject|0
1520604|NCT00349752|4989898|P2|Overall Study|Other:History of squamous cell carcinoma|0
1520605|NCT00349752|4989899|P1|Overall Study|Other:History of squamous cell carcinoma|1
1520606|NCT00349752|4989898|P2|Overall Study|Other: Inadvertently unblinded|0
1520607|NCT00349752|4989899|P1|Overall Study|Other: Inadvertently unblinded|1
1520608|NCT00349752|4989898|P2|Overall Study|Other: Ineligible|0
1520609|NCT00349752|4989899|P1|Overall Study|Other: Ineligible|1
1520610|NCT00349752|4989898|P2|Overall Study|Other: Patient's steroid use|0
1520611|NCT00349752|4989899|P1|Overall Study|Other: Patient's steroid use|1
1520612|NCT00349752|4989898|P2|Overall Study|Other: Patient stopped steroids|1
1520613|NCT00349752|4989899|P1|Overall Study|Other: Patient stopped steroids|0
1520614|NCT00349752|4989898|P2|Overall Study|Other: Non compliance|1
1520615|NCT00349752|4989899|P1|Overall Study|Other: Non compliance|0
1520616|NCT00349752|4989898|P2|Overall Study|Other: Required exclusionary medication|1
1520617|NCT00349752|4989899|P1|Overall Study|Other: Required exclusionary medication|0
1520618|NCT00349752|4989898|P2|Overall Study|Personal reasons|5
1520619|NCT00349752|4989899|P1|Overall Study|Personal reasons|6
1520620|NCT00349752|4989898|P2|Overall Study|Lost to Follow-up|2
1520621|NCT00349752|4989899|P1|Overall Study|Lost to Follow-up|4
1520622|NCT00349752|4989898|P2|Overall Study|Lack of Efficacy|42
1520623|NCT00349752|4989899|P1|Overall Study|Lack of Efficacy|37
1520624|NCT00349752|4989898|P2|Overall Study|Adverse Event|12
1520625|NCT00349752|4989899|P1|Overall Study|Adverse Event|8
1520626|NCT00349622|4989952|P2|Overall Study|Withdrawal by Subject|9
1520627|NCT00349622|4989953|P1|Overall Study|Withdrawal by Subject|5
1520628|NCT00349622|4989952|P2|Overall Study|Lost to Follow-up|1
1520629|NCT00349622|4989953|P1|Overall Study|Lost to Follow-up|5
1520630|NCT00349622|4989952|P2|Overall Study|Death|86
1520631|NCT00349622|4989953|P1|Overall Study|Death|168
1520632|NCT00349349|4989990|P3|Overall Study|New Malignancy (Bladder Cancer)|0
1520633|NCT00349349|4989991|P2|Overall Study|New Malignancy (Bladder Cancer)|1
1520634|NCT00349349|4989992|P1|Overall Study|New Malignancy (Bladder Cancer)|0
1520635|NCT00349349|4989990|P3|Overall Study|No Response|0
1520636|NCT00349349|4989991|P2|Overall Study|No Response|3
1520637|NCT00349349|4989992|P1|Overall Study|No Response|0
1520638|NCT00349349|4989990|P3|Overall Study|Physician Decision|1
1520639|NCT00349349|4989991|P2|Overall Study|Physician Decision|2
1520640|NCT00349349|4989992|P1|Overall Study|Physician Decision|1
1520641|NCT00349349|4989990|P3|Overall Study|Participant Reduced General Condition|0
1520642|NCT00349349|4989991|P2|Overall Study|Participant Reduced General Condition|1
1520643|NCT00349349|4989992|P1|Overall Study|Participant Reduced General Condition|0
1520644|NCT00349349|4989990|P3|Overall Study|Other Treatment Selected|0
1520645|NCT00349349|4989991|P2|Overall Study|Other Treatment Selected|0
1520646|NCT00349349|4989992|P1|Overall Study|Other Treatment Selected|2
1520647|NCT00349349|4989990|P3|Overall Study|Death|1
1520648|NCT00349349|4989991|P2|Overall Study|Death|10
1520649|NCT00349349|4989992|P1|Overall Study|Death|13
1520650|NCT00349349|4989990|P3|Overall Study|Withdrawn due to Disease Progression|1
1520651|NCT00349349|4989991|P2|Overall Study|Withdrawn due to Disease Progression|37
1520652|NCT00349349|4989992|P1|Overall Study|Withdrawn due to Disease Progression|27
1520653|NCT00349349|4989990|P3|Overall Study|Withdrawal by Subject|1
1520654|NCT00349349|4989991|P2|Overall Study|Withdrawal by Subject|2
1520655|NCT00349349|4989992|P1|Overall Study|Withdrawal by Subject|5
1520656|NCT00349349|4989990|P3|Overall Study|Adverse Event|2
1520657|NCT00349349|4989991|P2|Overall Study|Adverse Event|6
1520658|NCT00349349|4989992|P1|Overall Study|Adverse Event|5
1520659|NCT00348933|4990081|P1|Overall Study|Adverse Event|7
1520660|NCT00348933|4990081|P1|Overall Study|Protocol Violation|2
1520661|NCT00348933|4990081|P1|Overall Study|Lost to Follow-up|6
1520662|NCT00348933|4990081|P1|Overall Study|Withdrawal by Subject|10
1520663|NCT00348881|4990089|P2|Overall Study|Serious Adverse Event|2
1520664|NCT00348881|4990090|P1|Overall Study|Serious Adverse Event|0
1520665|NCT00348881|4990089|P2|Overall Study|Adverse Event|0
1520666|NCT00348881|4990090|P1|Overall Study|Adverse Event|2
1520667|NCT00348881|4990089|P2|Overall Study|Withdrawal by Subject|4
1520668|NCT00348881|4990090|P1|Overall Study|Withdrawal by Subject|3
1520669|NCT00348881|4990089|P2|Overall Study|Lost to Follow-up|6
1520670|NCT00348881|4990090|P1|Overall Study|Lost to Follow-up|12
1520671|NCT00348816|4990102|P1|Overall Study|Noncompliance with radiation treatment|1
1520672|NCT00348790|4990109|P1|Completed Treatment|Unable to travel to study site|1
1520673|NCT00348790|4990109|P1|Completed Treatment|Required surgery|2
1520674|NCT00348790|4990109|P1|Completed Treatment|Adverse Event|4
1520675|NCT00348790|4990109|P1|Completed Treatment|Disease progression|14
1520676|NCT00348790|4990109|P1|Completed Treatment|Withdrawal by Subject|4
1520677|NCT00348686|4990114|P1|Overall Study|Multiple Reasons|8
1520678|NCT00348686|4990114|P1|Overall Study|Lost to Follow-up|2
1520679|NCT00348686|4990114|P1|Overall Study|Protocol Violation|6
1520680|NCT00348686|4990114|P1|Overall Study|Adverse Event|5
1520681|NCT00348686|4990114|P1|Overall Study|Withdrawal by Subject|45
1520682|NCT00348673|4990131|P9|Stage 1|Randomized but not Treated|0
1520683|NCT00348673|4990132|P8|Stage 1|Randomized but not Treated|0
1520684|NCT00348673|4990133|P7|Stage 1|Randomized but not Treated|0
1520685|NCT00348673|4990134|P6|Stage 1|Randomized but not Treated|0
1520686|NCT00348673|4990135|P5|Stage 1|Randomized but not Treated|0
1520687|NCT00348673|4990136|P4|Stage 1|Randomized but not Treated|0
1520688|NCT00348673|4990137|P3|Stage 1|Randomized but not Treated|1
1520689|NCT00348673|4990138|P2|Stage 1|Randomized but not Treated|0
1520690|NCT00348673|4990139|P1|Stage 1|Randomized but not Treated|0
1520691|NCT00348556|4990186|P1|Overall Study|Adverse Event|1
1520692|NCT00348374|4990193|P2|Overall Study|randomized but did not receive treatment|7
1520693|NCT00348374|4990194|P1|Overall Study|randomized but did not receive treatment|0
1520694|NCT00348374|4990193|P2|Overall Study|ongoing at date of cutoff|1
1520695|NCT00348374|4990194|P1|Overall Study|ongoing at date of cutoff|1
1520696|NCT00348374|4990193|P2|Overall Study|Other|12
1520697|NCT00348374|4990194|P1|Overall Study|Other|11
1520698|NCT00348374|4990193|P2|Overall Study|Withdrawal by Subject|5
1520699|NCT00348374|4990194|P1|Overall Study|Withdrawal by Subject|5
1520700|NCT00348374|4990193|P2|Overall Study|Lost to Follow-up|3
1520701|NCT00348374|4990194|P1|Overall Study|Lost to Follow-up|1
1520702|NCT00348374|4990193|P2|Overall Study|Adverse Event|4
1520703|NCT00348374|4990194|P1|Overall Study|Adverse Event|1
1520704|NCT00348348|4990241|P2|Overall Study|Adverse event probably related to study|0
1520705|NCT00348348|4990242|P1|Overall Study|Adverse event probably related to study|1
1520706|NCT00348348|4990241|P2|Overall Study|Worsening of BC - Unlikely related|2
1520707|NCT00348348|4990242|P1|Overall Study|Worsening of BC - Unlikely related|1
1520708|NCT00348348|4990241|P2|Overall Study|Worsening of BC - Unrelated to study|3
1520709|NCT00348348|4990242|P1|Overall Study|Worsening of BC - Unrelated to study|0
1520710|NCT00348348|4990241|P2|Overall Study|Dissallowed Meds - possibly releated|1
1520711|NCT00348348|4990242|P1|Overall Study|Dissallowed Meds - possibly releated|1
1520712|NCT00348348|4990241|P2|Overall Study|Dissallowed Meds - unlikley related|1
1520713|NCT00348348|4990242|P1|Overall Study|Dissallowed Meds - unlikley related|1
1520714|NCT00348348|4990241|P2|Overall Study|Dissallowed Meds - unrelated to study|3
1520715|NCT00348348|4990242|P1|Overall Study|Dissallowed Meds - unrelated to study|1
1520716|NCT00348348|4990241|P2|Overall Study|Not specified|4
1520717|NCT00348348|4990242|P1|Overall Study|Not specified|7
1520718|NCT00348348|4990241|P2|Overall Study|Withdrawal by Subject|1
1520719|NCT00348348|4990242|P1|Overall Study|Withdrawal by Subject|4
1520720|NCT00348348|4990241|P2|Overall Study|Lost to Follow-up|10
1520721|NCT00348348|4990242|P1|Overall Study|Lost to Follow-up|8
1520722|NCT00348348|4990241|P2|Overall Study|Lack of Efficacy|1
1520723|NCT00348348|4990242|P1|Overall Study|Lack of Efficacy|1
1520724|NCT00348348|4990241|P2|Overall Study|Adverse event - unrelated to study drug|1
1520725|NCT00348348|4990242|P1|Overall Study|Adverse event - unrelated to study drug|0
1520726|NCT00348309|4990257|P3|Overall Study|HCV career|1
1520727|NCT00348309|4990258|P2|Overall Study|HCV career|0
1520728|NCT00348309|4990259|P1|Overall Study|HCV career|0
1520729|NCT00348309|4990257|P3|Overall Study|Cardiologist recommendations|1
1520730|NCT00348309|4990258|P2|Overall Study|Cardiologist recommendations|0
1520731|NCT00348309|4990259|P1|Overall Study|Cardiologist recommendations|0
1520732|NCT00348309|4990257|P3|Overall Study|ECG abnormal|2
1520733|NCT00348309|4990258|P2|Overall Study|ECG abnormal|0
1520734|NCT00348309|4990259|P1|Overall Study|ECG abnormal|0
1520735|NCT00348309|4990257|P3|Overall Study|Adverse event not attended|1
1520736|NCT00348309|4990258|P2|Overall Study|Adverse event not attended|0
1520737|NCT00348309|4990259|P1|Overall Study|Adverse event not attended|0
1520738|NCT00348309|4990257|P3|Overall Study|Site closure|1
1520739|NCT00348309|4990258|P2|Overall Study|Site closure|0
1520740|NCT00348309|4990259|P1|Overall Study|Site closure|0
1520741|NCT00348309|4990257|P3|Overall Study|Increased dose of Aricept|1
1520742|NCT00348309|4990258|P2|Overall Study|Increased dose of Aricept|0
1520743|NCT00348309|4990259|P1|Overall Study|Increased dose of Aricept|0
1520744|NCT00348309|4990257|P3|Overall Study|Medical Monitor decision|1
1520745|NCT00348309|4990258|P2|Overall Study|Medical Monitor decision|0
1520746|NCT00348309|4990259|P1|Overall Study|Medical Monitor decision|0
1520747|NCT00348309|4990257|P3|Overall Study|Forgot often medication|0
1520748|NCT00348309|4990258|P2|Overall Study|Forgot often medication|1
1520749|NCT00348309|4990259|P1|Overall Study|Forgot often medication|0
1520750|NCT00348309|4990257|P3|Overall Study|Sponsor refuseal|1
1520751|NCT00348309|4990258|P2|Overall Study|Sponsor refuseal|1
1520752|NCT00348309|4990259|P1|Overall Study|Sponsor refuseal|0
1520753|NCT00348309|4990257|P3|Overall Study|Participant was hospitalized|0
1520754|NCT00348309|4990258|P2|Overall Study|Participant was hospitalized|1
1520755|NCT00348309|4990259|P1|Overall Study|Participant was hospitalized|0
1520756|NCT00348309|4990257|P3|Overall Study|A foul of exclusion criteria|0
1520757|NCT00348309|4990258|P2|Overall Study|A foul of exclusion criteria|1
1520758|NCT00348309|4990259|P1|Overall Study|A foul of exclusion criteria|0
1520759|NCT00348309|4990257|P3|Overall Study|Ineffectiveness of treatment|0
1520760|NCT00348309|4990258|P2|Overall Study|Ineffectiveness of treatment|1
1520761|NCT00348309|4990259|P1|Overall Study|Ineffectiveness of treatment|0
1520762|NCT00348309|4990257|P3|Overall Study|Decision of sponsor|0
1520763|NCT00348309|4990258|P2|Overall Study|Decision of sponsor|0
1520764|NCT00348309|4990259|P1|Overall Study|Decision of sponsor|1
1520765|NCT00348309|4990257|P3|Overall Study|Participant died|1
1520766|NCT00348309|4990258|P2|Overall Study|Participant died|1
1520767|NCT00348309|4990259|P1|Overall Study|Participant died|2
1520768|NCT00348309|4990257|P3|Overall Study|Did not appear in time for Visit 3|0
1520769|NCT00348309|4990258|P2|Overall Study|Did not appear in time for Visit 3|0
1520770|NCT00348309|4990259|P1|Overall Study|Did not appear in time for Visit 3|1
1520771|NCT00348309|4990257|P3|Overall Study|Worsening of alzheimer|1
1520772|NCT00348309|4990258|P2|Overall Study|Worsening of alzheimer|0
1520773|NCT00348309|4990259|P1|Overall Study|Worsening of alzheimer|1
1520774|NCT00348309|4990257|P3|Overall Study|Cognitive and behaviour worsening|0
1520775|NCT00348309|4990258|P2|Overall Study|Cognitive and behaviour worsening|0
1520776|NCT00348309|4990259|P1|Overall Study|Cognitive and behaviour worsening|2
1520777|NCT00348309|4990257|P3|Overall Study|Worsened neurodegenerative disease|0
1520778|NCT00348309|4990258|P2|Overall Study|Worsened neurodegenerative disease|0
1520779|NCT00348309|4990259|P1|Overall Study|Worsened neurodegenerative disease|1
1520780|NCT00348309|4990257|P3|Overall Study|No disponibility of medication|0
1520781|NCT00348309|4990258|P2|Overall Study|No disponibility of medication|0
1520782|NCT00348309|4990259|P1|Overall Study|No disponibility of medication|1
1520783|NCT00348309|4990257|P3|Overall Study|Principal investigator's decision|0
1520784|NCT00348309|4990258|P2|Overall Study|Principal investigator's decision|0
1520785|NCT00348309|4990259|P1|Overall Study|Principal investigator's decision|1
1520786|NCT00348309|4990257|P3|Overall Study|PI closing medical practice|0
1520787|NCT00348309|4990258|P2|Overall Study|PI closing medical practice|0
1520788|NCT00348309|4990259|P1|Overall Study|PI closing medical practice|1
1520789|NCT00348309|4990257|P3|Overall Study|Unable to complete ET visit|0
1520790|NCT00348309|4990258|P2|Overall Study|Unable to complete ET visit|0
1520791|NCT00348309|4990259|P1|Overall Study|Unable to complete ET visit|1
1520792|NCT00348309|4990257|P3|Overall Study|Caregiver withdrawal|7
1520793|NCT00348309|4990258|P2|Overall Study|Caregiver withdrawal|0
1520794|NCT00348309|4990259|P1|Overall Study|Caregiver withdrawal|3
1520795|NCT00348309|4990257|P3|Overall Study|Use of prohibited medication|2
1520796|NCT00348309|4990258|P2|Overall Study|Use of prohibited medication|2
1520797|NCT00348309|4990259|P1|Overall Study|Use of prohibited medication|5
1520798|NCT00348309|4990257|P3|Overall Study|Caregiver sick|0
1520799|NCT00348309|4990258|P2|Overall Study|Caregiver sick|0
1520800|NCT00348309|4990259|P1|Overall Study|Caregiver sick|1
1520801|NCT00348309|4990257|P3|Overall Study|Wrong bottle allocated|0
1520802|NCT00348309|4990258|P2|Overall Study|Wrong bottle allocated|0
1520803|NCT00348309|4990259|P1|Overall Study|Wrong bottle allocated|1
1520804|NCT00348309|4990257|P3|Overall Study|Lack of insight, dementia|0
1520805|NCT00348309|4990258|P2|Overall Study|Lack of insight, dementia|0
1520806|NCT00348309|4990259|P1|Overall Study|Lack of insight, dementia|1
1520807|NCT00348309|4990257|P3|Overall Study|Death of caregiver|1
1520808|NCT00348309|4990258|P2|Overall Study|Death of caregiver|0
1520809|NCT00348309|4990259|P1|Overall Study|Death of caregiver|1
1520810|NCT00348309|4990257|P3|Overall Study|Non-compliance|8
1520811|NCT00348309|4990258|P2|Overall Study|Non-compliance|6
1520812|NCT00348309|4990259|P1|Overall Study|Non-compliance|8
1520813|NCT00348309|4990257|P3|Overall Study|Withdrawal by Subject|40
1520814|NCT00348309|4990258|P2|Overall Study|Withdrawal by Subject|37
1520815|NCT00348309|4990259|P1|Overall Study|Withdrawal by Subject|33
1520816|NCT00348309|4990257|P3|Overall Study|Protocol Violation|7
1520817|NCT00348309|4990258|P2|Overall Study|Protocol Violation|12
1520818|NCT00348309|4990259|P1|Overall Study|Protocol Violation|7
1520819|NCT00348309|4990257|P3|Overall Study|Lost to Follow-up|4
1520820|NCT00348309|4990258|P2|Overall Study|Lost to Follow-up|7
1520821|NCT00348309|4990259|P1|Overall Study|Lost to Follow-up|6
1520822|NCT00348309|4990257|P3|Overall Study|Adverse Event|63
1520823|NCT00348309|4990258|P2|Overall Study|Adverse Event|28
1520824|NCT00348309|4990259|P1|Overall Study|Adverse Event|56
1520825|NCT00348283|4990332|P2|Open Label|Sponsor decision|1
1520826|NCT00348283|4990333|P1|Open Label|Sponsor decision|0
1520827|NCT00348283|4990332|P2|Open Label|Pregnancy|1
1520828|NCT00348283|4990333|P1|Open Label|Pregnancy|0
1520829|NCT00348283|4990332|P2|Open Label|Subject moved to the United States|1
1520830|NCT00348283|4990333|P1|Open Label|Subject moved to the United States|0
1520831|NCT00348283|4990332|P2|Open Label|Administrative reasons|5
1520832|NCT00348283|4990333|P1|Open Label|Administrative reasons|0
1520833|NCT00348283|4990332|P2|Open Label|Lack of Efficacy|13
1520834|NCT00348283|4990333|P1|Open Label|Lack of Efficacy|0
1520835|NCT00348283|4990332|P2|Open Label|Lost to Follow-up|1
1520836|NCT00348283|4990333|P1|Open Label|Lost to Follow-up|0
1520837|NCT00348283|4990332|P2|Open Label|Withdrawal by Subject|4
1520838|NCT00348283|4990333|P1|Open Label|Withdrawal by Subject|0
1520839|NCT00348283|4990332|P2|Open Label|Adverse Event|8
1520840|NCT00348283|4990333|P1|Open Label|Adverse Event|0
1520841|NCT00348283|4990332|P2|Double Blind|Pregnancy|1
1520842|NCT00348283|4990333|P1|Double Blind|Pregnancy|0
1520843|NCT00348283|4990332|P2|Double Blind|Lack of Efficacy|2
1520844|NCT00348283|4990333|P1|Double Blind|Lack of Efficacy|2
1520845|NCT00348283|4990332|P2|Double Blind|Protocol Violation|1
1520846|NCT00348283|4990333|P1|Double Blind|Protocol Violation|0
1520847|NCT00348283|4990332|P2|Double Blind|Withdrawal by Subject|1
1520848|NCT00348283|4990333|P1|Double Blind|Withdrawal by Subject|1
1520849|NCT00348283|4990332|P2|Double Blind|Adverse Event|5
1520850|NCT00348283|4990333|P1|Double Blind|Adverse Event|2
1520851|NCT00348283|4990332|P2|Induction|Protocol Violation|4
1520852|NCT00348283|4990333|P1|Induction|Protocol Violation|0
1520853|NCT00348283|4990332|P2|Induction|Adverse Event|2
1520854|NCT00348283|4990333|P1|Induction|Adverse Event|0
1520855|NCT00348140|4990352|P3|Overall Study|Memory declined|1
1520856|NCT00348140|4990353|P2|Overall Study|Memory declined|0
1520857|NCT00348140|4990354|P1|Overall Study|Memory declined|0
1520858|NCT00348140|4990352|P3|Overall Study|Exclusion criteria met|1
1520859|NCT00348140|4990353|P2|Overall Study|Exclusion criteria met|0
1520860|NCT00348140|4990354|P1|Overall Study|Exclusion criteria met|0
1520861|NCT00348140|4990352|P3|Overall Study|Participant died|0
1520862|NCT00348140|4990353|P2|Overall Study|Participant died|1
1520863|NCT00348140|4990354|P1|Overall Study|Participant died|0
1520864|NCT00348140|4990352|P3|Overall Study|Abnormal ECG|3
1520865|NCT00348140|4990353|P2|Overall Study|Abnormal ECG|1
1520866|NCT00348140|4990354|P1|Overall Study|Abnormal ECG|0
1520867|NCT00348140|4990352|P3|Overall Study|Serious adverse event|0
1520868|NCT00348140|4990353|P2|Overall Study|Serious adverse event|1
1520869|NCT00348140|4990354|P1|Overall Study|Serious adverse event|0
1520870|NCT00348140|4990352|P3|Overall Study|Increased risk of cardiac infarction|0
1520871|NCT00348140|4990353|P2|Overall Study|Increased risk of cardiac infarction|1
1520872|NCT00348140|4990354|P1|Overall Study|Increased risk of cardiac infarction|0
1520873|NCT00348140|4990352|P3|Overall Study|Disease progression|5
1520874|NCT00348140|4990353|P2|Overall Study|Disease progression|2
1520875|NCT00348140|4990354|P1|Overall Study|Disease progression|1
1520876|NCT00348140|4990352|P3|Overall Study|Use of prohibited drug|2
1520877|NCT00348140|4990353|P2|Overall Study|Use of prohibited drug|0
1520878|NCT00348140|4990354|P1|Overall Study|Use of prohibited drug|1
1520879|NCT00348140|4990352|P3|Overall Study|Decided to discontinue on their own|1
1520880|NCT00348140|4990353|P2|Overall Study|Decided to discontinue on their own|4
1520881|NCT00348140|4990354|P1|Overall Study|Decided to discontinue on their own|1
1520882|NCT00348140|4990352|P3|Overall Study|Investigator decided to discontinue|4
1520883|NCT00348140|4990353|P2|Overall Study|Investigator decided to discontinue|1
1520884|NCT00348140|4990354|P1|Overall Study|Investigator decided to discontinue|4
1520885|NCT00348140|4990352|P3|Overall Study|Screen failure|0
1520886|NCT00348140|4990353|P2|Overall Study|Screen failure|0
1520887|NCT00348140|4990354|P1|Overall Study|Screen failure|1
1520888|NCT00348140|4990352|P3|Overall Study|Participant unwell|0
1520889|NCT00348140|4990353|P2|Overall Study|Participant unwell|0
1520890|NCT00348140|4990354|P1|Overall Study|Participant unwell|1
1520891|NCT00348140|4990352|P3|Overall Study|Unmet inclusion-exclusion criteria|1
1520892|NCT00348140|4990353|P2|Overall Study|Unmet inclusion-exclusion criteria|0
1520893|NCT00348140|4990354|P1|Overall Study|Unmet inclusion-exclusion criteria|1
1520894|NCT00348140|4990352|P3|Overall Study|Administration related|1
1520895|NCT00348140|4990353|P2|Overall Study|Administration related|1
1520896|NCT00348140|4990354|P1|Overall Study|Administration related|3
1520897|NCT00348140|4990352|P3|Overall Study|Efficacy related|0
1520898|NCT00348140|4990353|P2|Overall Study|Efficacy related|1
1520899|NCT00348140|4990354|P1|Overall Study|Efficacy related|1
1520900|NCT00348140|4990352|P3|Overall Study|Participant hospitalised|0
1520901|NCT00348140|4990353|P2|Overall Study|Participant hospitalised|0
1520902|NCT00348140|4990354|P1|Overall Study|Participant hospitalised|3
1520903|NCT00348140|4990352|P3|Overall Study|Caregiver related|3
1520904|NCT00348140|4990353|P2|Overall Study|Caregiver related|7
1520905|NCT00348140|4990354|P1|Overall Study|Caregiver related|4
1520906|NCT00348140|4990352|P3|Overall Study|Conditional medication increased dose|0
1520907|NCT00348140|4990353|P2|Overall Study|Conditional medication increased dose|0
1520908|NCT00348140|4990354|P1|Overall Study|Conditional medication increased dose|1
1520909|NCT00348140|4990352|P3|Overall Study|Participant at risk due to study drug|0
1520910|NCT00348140|4990353|P2|Overall Study|Participant at risk due to study drug|0
1520911|NCT00348140|4990354|P1|Overall Study|Participant at risk due to study drug|2
1520912|NCT00348140|4990352|P3|Overall Study|Non-compliance|5
1520913|NCT00348140|4990353|P2|Overall Study|Non-compliance|13
1520914|NCT00348140|4990354|P1|Overall Study|Non-compliance|8
1520915|NCT00348140|4990352|P3|Overall Study|Withdrawal by Subject|40
1520916|NCT00348140|4990353|P2|Overall Study|Withdrawal by Subject|40
1520917|NCT00348140|4990354|P1|Overall Study|Withdrawal by Subject|32
1520918|NCT00348140|4990352|P3|Overall Study|Protocol Violation|14
1520919|NCT00348140|4990353|P2|Overall Study|Protocol Violation|13
1520920|NCT00348140|4990354|P1|Overall Study|Protocol Violation|12
1520921|NCT00348140|4990352|P3|Overall Study|Lost to Follow-up|4
1520922|NCT00348140|4990353|P2|Overall Study|Lost to Follow-up|4
1520923|NCT00348140|4990354|P1|Overall Study|Lost to Follow-up|4
1520924|NCT00348140|4990352|P3|Overall Study|Adverse Event|78
1520925|NCT00348140|4990353|P2|Overall Study|Adverse Event|49
1520926|NCT00348140|4990354|P1|Overall Study|Adverse Event|46
1520927|NCT00347958|4990452|P1|Overall Study|Withdrawal by Subject|1
1520928|NCT00347958|4990452|P1|Overall Study|Protocol Violation|2
1520929|NCT00347958|4990452|P1|Overall Study|Adverse Event|1
1520930|NCT00347932|4990461|P2|Overall Study|Did not meet inclusion criteria|8
1520931|NCT00347932|4990462|P1|Overall Study|Did not meet inclusion criteria|4
1520932|NCT00347932|4990461|P2|Overall Study|Withdrawal by Subject|16
1520933|NCT00347932|4990462|P1|Overall Study|Withdrawal by Subject|10
1520934|NCT00347932|4990461|P2|Overall Study|Lost to Follow-up|9
1520935|NCT00347932|4990462|P1|Overall Study|Lost to Follow-up|10
1520936|NCT00347932|4990461|P2|Overall Study|Lack of Efficacy|14
1520937|NCT00347932|4990462|P1|Overall Study|Lack of Efficacy|3
1520938|NCT00347932|4990461|P2|Overall Study|Adverse Event|5
1520939|NCT00347932|4990462|P1|Overall Study|Adverse Event|4
1520940|NCT00347919|4990477|P3|Overall Study|Missing|2
1520941|NCT00347919|4990478|P2|Overall Study|Missing|1
1520942|NCT00347919|4990479|P1|Overall Study|Missing|2
1520943|NCT00347919|4990477|P3|Overall Study|Par. Started Other Treatment|1
1520944|NCT00347919|4990478|P2|Overall Study|Par. Started Other Treatment|1
1520945|NCT00347919|4990479|P1|Overall Study|Par. Started Other Treatment|1
1520946|NCT00347919|4990477|P3|Overall Study|Death|19
1520947|NCT00347919|4990478|P2|Overall Study|Death|42
1520948|NCT00347919|4990479|P1|Overall Study|Death|35
1520949|NCT00347919|4990477|P3|Overall Study|Sponsor terminated study|16
1520950|NCT00347919|4990478|P2|Overall Study|Sponsor terminated study|10
1520951|NCT00347919|4990479|P1|Overall Study|Sponsor terminated study|15
1520952|NCT00347919|4990477|P3|Overall Study|Physician Decision|0
1520953|NCT00347919|4990478|P2|Overall Study|Physician Decision|1
1520954|NCT00347919|4990479|P1|Overall Study|Physician Decision|1
1520955|NCT00347919|4990477|P3|Overall Study|Withdrawal by Subject|0
1520956|NCT00347919|4990478|P2|Overall Study|Withdrawal by Subject|8
1520957|NCT00347919|4990479|P1|Overall Study|Withdrawal by Subject|6
1520958|NCT00347919|4990477|P3|Overall Study|Lost to Follow-up|0
1520959|NCT00347919|4990478|P2|Overall Study|Lost to Follow-up|13
1520960|NCT00347919|4990479|P1|Overall Study|Lost to Follow-up|11
1520961|NCT00347776|4990502|P3|12 Month Follow-up|Reached endpoint|9
1520962|NCT00347776|4990503|P2|12 Month Follow-up|Reached endpoint|6
1520963|NCT00347776|4990504|P1|12 Month Follow-up|Reached endpoint|13
1520964|NCT00347776|4990502|P3|12 Month Follow-up|Death|4
1520965|NCT00347776|4990503|P2|12 Month Follow-up|Death|4
1520966|NCT00347776|4990504|P1|12 Month Follow-up|Death|3
1520967|NCT00347776|4990502|P3|12 Month Follow-up|Lost to Follow-up|6
1520968|NCT00347776|4990503|P2|12 Month Follow-up|Lost to Follow-up|6
1520969|NCT00347776|4990504|P1|12 Month Follow-up|Lost to Follow-up|7
1520970|NCT00347776|4990502|P3|6 Month Follow-up|reached endpont|15
1520971|NCT00347776|4990503|P2|6 Month Follow-up|reached endpont|12
1520972|NCT00347776|4990504|P1|6 Month Follow-up|reached endpont|20
1520973|NCT00347776|4990502|P3|6 Month Follow-up|Death|3
1520974|NCT00347776|4990503|P2|6 Month Follow-up|Death|1
1520975|NCT00347776|4990504|P1|6 Month Follow-up|Death|2
1520976|NCT00347776|4990502|P3|1.5 Month Follow-up|reached the endpoint|12
1520977|NCT00347776|4990503|P2|1.5 Month Follow-up|reached the endpoint|8
1520978|NCT00347776|4990504|P1|1.5 Month Follow-up|reached the endpoint|12
1520979|NCT00347776|4990502|P3|1.5 Month Follow-up|Death|0
1520980|NCT00347776|4990503|P2|1.5 Month Follow-up|Death|0
1520981|NCT00347776|4990504|P1|1.5 Month Follow-up|Death|2
1520982|NCT00347438|4990516|P1|Overall Study|Physician Decision|1
1520983|NCT00347438|4990516|P1|Overall Study|Withdrawal by Subject|1
1520984|NCT00347360|4990538|P15|Overall Study|Visits conflicted with new job|0
1520985|NCT00347360|4990539|P14|Overall Study|Visits conflicted with new job|0
1520986|NCT00347360|4990540|P13|Overall Study|Visits conflicted with new job|0
1520987|NCT00347360|4990541|P12|Overall Study|Visits conflicted with new job|0
1520988|NCT00347360|4990542|P11|Overall Study|Visits conflicted with new job|0
1520989|NCT00347360|4990543|P10|Overall Study|Visits conflicted with new job|0
1520990|NCT00347360|4990544|P9|Overall Study|Visits conflicted with new job|0
1520991|NCT00347360|4990545|P8|Overall Study|Visits conflicted with new job|0
1520992|NCT00347360|4990546|P7|Overall Study|Visits conflicted with new job|1
1520993|NCT00347360|4990547|P6|Overall Study|Visits conflicted with new job|0
1520994|NCT00347360|4990548|P5|Overall Study|Visits conflicted with new job|0
1520995|NCT00347360|4990549|P4|Overall Study|Visits conflicted with new job|0
1520996|NCT00347360|4990550|P3|Overall Study|Visits conflicted with new job|0
1520997|NCT00347360|4990551|P2|Overall Study|Visits conflicted with new job|0
1520998|NCT00347360|4990552|P1|Overall Study|Visits conflicted with new job|0
1520999|NCT00347360|4990538|P15|Overall Study|Subject refuse to sign updated consent|1
1521000|NCT00347360|4990539|P14|Overall Study|Subject refuse to sign updated consent|0
1521001|NCT00347360|4990540|P13|Overall Study|Subject refuse to sign updated consent|0
1521002|NCT00347360|4990541|P12|Overall Study|Subject refuse to sign updated consent|0
1521003|NCT00347360|4990542|P11|Overall Study|Subject refuse to sign updated consent|0
1521004|NCT00347360|4990543|P10|Overall Study|Subject refuse to sign updated consent|0
1521005|NCT00347360|4990544|P9|Overall Study|Subject refuse to sign updated consent|0
1521006|NCT00347360|4990545|P8|Overall Study|Subject refuse to sign updated consent|0
1521007|NCT00347360|4990546|P7|Overall Study|Subject refuse to sign updated consent|0
1521008|NCT00347360|4990547|P6|Overall Study|Subject refuse to sign updated consent|0
1521009|NCT00347360|4990548|P5|Overall Study|Subject refuse to sign updated consent|0
1521010|NCT00347360|4990549|P4|Overall Study|Subject refuse to sign updated consent|0
1521011|NCT00347360|4990550|P3|Overall Study|Subject refuse to sign updated consent|0
1521012|NCT00347360|4990551|P2|Overall Study|Subject refuse to sign updated consent|0
1521013|NCT00347360|4990552|P1|Overall Study|Subject refuse to sign updated consent|0
1521014|NCT00347360|4990538|P15|Overall Study|Subject left town, ran out of study drug|0
1521015|NCT00347360|4990539|P14|Overall Study|Subject left town, ran out of study drug|1
1521016|NCT00347360|4990540|P13|Overall Study|Subject left town, ran out of study drug|0
1521017|NCT00347360|4990541|P12|Overall Study|Subject left town, ran out of study drug|0
1521018|NCT00347360|4990542|P11|Overall Study|Subject left town, ran out of study drug|0
1521019|NCT00347360|4990543|P10|Overall Study|Subject left town, ran out of study drug|0
1521020|NCT00347360|4990544|P9|Overall Study|Subject left town, ran out of study drug|0
1521021|NCT00347360|4990545|P8|Overall Study|Subject left town, ran out of study drug|0
1521022|NCT00347360|4990546|P7|Overall Study|Subject left town, ran out of study drug|0
1521023|NCT00347360|4990547|P6|Overall Study|Subject left town, ran out of study drug|0
1521024|NCT00347360|4990548|P5|Overall Study|Subject left town, ran out of study drug|0
1521025|NCT00347360|4990549|P4|Overall Study|Subject left town, ran out of study drug|0
1521026|NCT00347360|4990550|P3|Overall Study|Subject left town, ran out of study drug|0
1521027|NCT00347360|4990551|P2|Overall Study|Subject left town, ran out of study drug|0
1521028|NCT00347360|4990552|P1|Overall Study|Subject left town, ran out of study drug|0
1521029|NCT00347360|4990538|P15|Overall Study|Prolonged duration between visits|0
1521030|NCT00347360|4990539|P14|Overall Study|Prolonged duration between visits|0
1521031|NCT00347360|4990540|P13|Overall Study|Prolonged duration between visits|1
1521032|NCT00347360|4990541|P12|Overall Study|Prolonged duration between visits|0
1521033|NCT00347360|4990542|P11|Overall Study|Prolonged duration between visits|0
1521034|NCT00347360|4990543|P10|Overall Study|Prolonged duration between visits|0
1521035|NCT00347360|4990544|P9|Overall Study|Prolonged duration between visits|0
1521036|NCT00347360|4990545|P8|Overall Study|Prolonged duration between visits|0
1521037|NCT00347360|4990546|P7|Overall Study|Prolonged duration between visits|0
1521038|NCT00347360|4990547|P6|Overall Study|Prolonged duration between visits|0
1521039|NCT00347360|4990548|P5|Overall Study|Prolonged duration between visits|0
1521040|NCT00347360|4990549|P4|Overall Study|Prolonged duration between visits|0
1521041|NCT00347360|4990550|P3|Overall Study|Prolonged duration between visits|0
1521042|NCT00347360|4990551|P2|Overall Study|Prolonged duration between visits|0
1521043|NCT00347360|4990552|P1|Overall Study|Prolonged duration between visits|0
1521044|NCT00347360|4990538|P15|Overall Study|Failed inclusion criteria #4|0
1521045|NCT00347360|4990539|P14|Overall Study|Failed inclusion criteria #4|0
1521046|NCT00347360|4990540|P13|Overall Study|Failed inclusion criteria #4|0
1521047|NCT00347360|4990541|P12|Overall Study|Failed inclusion criteria #4|1
1521048|NCT00347360|4990542|P11|Overall Study|Failed inclusion criteria #4|0
1521049|NCT00347360|4990543|P10|Overall Study|Failed inclusion criteria #4|0
1521050|NCT00347360|4990544|P9|Overall Study|Failed inclusion criteria #4|0
1521051|NCT00347360|4990545|P8|Overall Study|Failed inclusion criteria #4|0
1521052|NCT00347360|4990546|P7|Overall Study|Failed inclusion criteria #4|0
1521053|NCT00347360|4990547|P6|Overall Study|Failed inclusion criteria #4|0
1521054|NCT00347360|4990548|P5|Overall Study|Failed inclusion criteria #4|0
1521055|NCT00347360|4990549|P4|Overall Study|Failed inclusion criteria #4|0
1521056|NCT00347360|4990550|P3|Overall Study|Failed inclusion criteria #4|0
1521057|NCT00347360|4990551|P2|Overall Study|Failed inclusion criteria #4|0
1521058|NCT00347360|4990552|P1|Overall Study|Failed inclusion criteria #4|0
1521059|NCT00347360|4990538|P15|Overall Study|Randomized in error|0
1521060|NCT00347360|4990539|P14|Overall Study|Randomized in error|0
1521061|NCT00347360|4990540|P13|Overall Study|Randomized in error|0
1521062|NCT00347360|4990541|P12|Overall Study|Randomized in error|1
1521063|NCT00347360|4990542|P11|Overall Study|Randomized in error|0
1521064|NCT00347360|4990543|P10|Overall Study|Randomized in error|0
1521065|NCT00347360|4990544|P9|Overall Study|Randomized in error|0
1521066|NCT00347360|4990545|P8|Overall Study|Randomized in error|0
1521067|NCT00347360|4990546|P7|Overall Study|Randomized in error|0
1521068|NCT00347360|4990547|P6|Overall Study|Randomized in error|0
1521069|NCT00347360|4990548|P5|Overall Study|Randomized in error|0
1521070|NCT00347360|4990549|P4|Overall Study|Randomized in error|0
1521071|NCT00347360|4990550|P3|Overall Study|Randomized in error|0
1521072|NCT00347360|4990551|P2|Overall Study|Randomized in error|0
1521073|NCT00347360|4990552|P1|Overall Study|Randomized in error|0
1521074|NCT00347360|4990538|P15|Overall Study|Did not meet criteria before ABPM|0
1521075|NCT00347360|4990539|P14|Overall Study|Did not meet criteria before ABPM|0
1521076|NCT00347360|4990540|P13|Overall Study|Did not meet criteria before ABPM|0
1521077|NCT00347360|4990541|P12|Overall Study|Did not meet criteria before ABPM|0
1521078|NCT00347360|4990542|P11|Overall Study|Did not meet criteria before ABPM|1
1521079|NCT00347360|4990543|P10|Overall Study|Did not meet criteria before ABPM|0
1521080|NCT00347360|4990544|P9|Overall Study|Did not meet criteria before ABPM|0
1521081|NCT00347360|4990545|P8|Overall Study|Did not meet criteria before ABPM|0
1521082|NCT00347360|4990546|P7|Overall Study|Did not meet criteria before ABPM|0
1521083|NCT00347360|4990547|P6|Overall Study|Did not meet criteria before ABPM|0
1521084|NCT00347360|4990548|P5|Overall Study|Did not meet criteria before ABPM|0
1521085|NCT00347360|4990549|P4|Overall Study|Did not meet criteria before ABPM|0
1521086|NCT00347360|4990550|P3|Overall Study|Did not meet criteria before ABPM|0
1521087|NCT00347360|4990551|P2|Overall Study|Did not meet criteria before ABPM|0
1521088|NCT00347360|4990552|P1|Overall Study|Did not meet criteria before ABPM|0
1521089|NCT00347360|4990538|P15|Overall Study|PI recommended early withdrawal|0
1521090|NCT00347360|4990539|P14|Overall Study|PI recommended early withdrawal|0
1521091|NCT00347360|4990540|P13|Overall Study|PI recommended early withdrawal|0
1521092|NCT00347360|4990541|P12|Overall Study|PI recommended early withdrawal|0
1521093|NCT00347360|4990542|P11|Overall Study|PI recommended early withdrawal|0
1521094|NCT00347360|4990543|P10|Overall Study|PI recommended early withdrawal|1
1521095|NCT00347360|4990544|P9|Overall Study|PI recommended early withdrawal|0
1521096|NCT00347360|4990545|P8|Overall Study|PI recommended early withdrawal|0
1521097|NCT00347360|4990546|P7|Overall Study|PI recommended early withdrawal|0
1521098|NCT00347360|4990547|P6|Overall Study|PI recommended early withdrawal|0
1521099|NCT00347360|4990548|P5|Overall Study|PI recommended early withdrawal|0
1521100|NCT00347360|4990549|P4|Overall Study|PI recommended early withdrawal|0
1521101|NCT00347360|4990550|P3|Overall Study|PI recommended early withdrawal|0
1521102|NCT00347360|4990551|P2|Overall Study|PI recommended early withdrawal|0
1521103|NCT00347360|4990552|P1|Overall Study|PI recommended early withdrawal|0
1521104|NCT00347360|4990538|P15|Overall Study|Abnormal lab values|0
1521105|NCT00347360|4990539|P14|Overall Study|Abnormal lab values|0
1521106|NCT00347360|4990540|P13|Overall Study|Abnormal lab values|0
1521107|NCT00347360|4990541|P12|Overall Study|Abnormal lab values|0
1521108|NCT00347360|4990542|P11|Overall Study|Abnormal lab values|0
1521109|NCT00347360|4990543|P10|Overall Study|Abnormal lab values|0
1521110|NCT00347360|4990544|P9|Overall Study|Abnormal lab values|0
1521111|NCT00347360|4990545|P8|Overall Study|Abnormal lab values|0
1521112|NCT00347360|4990546|P7|Overall Study|Abnormal lab values|1
1521113|NCT00347360|4990547|P6|Overall Study|Abnormal lab values|0
1521114|NCT00347360|4990548|P5|Overall Study|Abnormal lab values|0
1521115|NCT00347360|4990549|P4|Overall Study|Abnormal lab values|0
1521116|NCT00347360|4990550|P3|Overall Study|Abnormal lab values|0
1521117|NCT00347360|4990551|P2|Overall Study|Abnormal lab values|0
1521118|NCT00347360|4990552|P1|Overall Study|Abnormal lab values|0
1521119|NCT00347360|4990538|P15|Overall Study|Subject did not meet end of study ABPM|0
1521120|NCT00347360|4990539|P14|Overall Study|Subject did not meet end of study ABPM|1
1521121|NCT00347360|4990540|P13|Overall Study|Subject did not meet end of study ABPM|1
1521122|NCT00347360|4990541|P12|Overall Study|Subject did not meet end of study ABPM|0
1521123|NCT00347360|4990542|P11|Overall Study|Subject did not meet end of study ABPM|1
1521124|NCT00347360|4990543|P10|Overall Study|Subject did not meet end of study ABPM|0
1521125|NCT00347360|4990544|P9|Overall Study|Subject did not meet end of study ABPM|0
1521126|NCT00347360|4990545|P8|Overall Study|Subject did not meet end of study ABPM|0
1521127|NCT00347360|4990546|P7|Overall Study|Subject did not meet end of study ABPM|1
1521128|NCT00347360|4990547|P6|Overall Study|Subject did not meet end of study ABPM|0
1521129|NCT00347360|4990548|P5|Overall Study|Subject did not meet end of study ABPM|0
1521130|NCT00347360|4990549|P4|Overall Study|Subject did not meet end of study ABPM|0
1521131|NCT00347360|4990550|P3|Overall Study|Subject did not meet end of study ABPM|0
1521132|NCT00347360|4990551|P2|Overall Study|Subject did not meet end of study ABPM|0
1521133|NCT00347360|4990552|P1|Overall Study|Subject did not meet end of study ABPM|0
1521134|NCT00347360|4990538|P15|Overall Study|P.I. recommended due to blood pressure|0
1521135|NCT00347360|4990539|P14|Overall Study|P.I. recommended due to blood pressure|0
1521136|NCT00347360|4990540|P13|Overall Study|P.I. recommended due to blood pressure|0
1521137|NCT00347360|4990541|P12|Overall Study|P.I. recommended due to blood pressure|0
1521138|NCT00347360|4990542|P11|Overall Study|P.I. recommended due to blood pressure|0
1521139|NCT00347360|4990543|P10|Overall Study|P.I. recommended due to blood pressure|0
1521140|NCT00347360|4990544|P9|Overall Study|P.I. recommended due to blood pressure|0
1521141|NCT00347360|4990545|P8|Overall Study|P.I. recommended due to blood pressure|0
1521142|NCT00347360|4990546|P7|Overall Study|P.I. recommended due to blood pressure|0
1521143|NCT00347360|4990547|P6|Overall Study|P.I. recommended due to blood pressure|0
1521144|NCT00347360|4990548|P5|Overall Study|P.I. recommended due to blood pressure|1
1521145|NCT00347360|4990549|P4|Overall Study|P.I. recommended due to blood pressure|0
1521146|NCT00347360|4990550|P3|Overall Study|P.I. recommended due to blood pressure|0
1521147|NCT00347360|4990551|P2|Overall Study|P.I. recommended due to blood pressure|0
1521148|NCT00347360|4990552|P1|Overall Study|P.I. recommended due to blood pressure|0
1521149|NCT00347360|4990538|P15|Overall Study|Per sponsors instruction|0
1521150|NCT00347360|4990539|P14|Overall Study|Per sponsors instruction|0
1521151|NCT00347360|4990540|P13|Overall Study|Per sponsors instruction|0
1521152|NCT00347360|4990541|P12|Overall Study|Per sponsors instruction|0
1521153|NCT00347360|4990542|P11|Overall Study|Per sponsors instruction|0
1521154|NCT00347360|4990543|P10|Overall Study|Per sponsors instruction|0
1521155|NCT00347360|4990544|P9|Overall Study|Per sponsors instruction|0
1521156|NCT00347360|4990545|P8|Overall Study|Per sponsors instruction|0
1521157|NCT00347360|4990546|P7|Overall Study|Per sponsors instruction|0
1521158|NCT00347360|4990547|P6|Overall Study|Per sponsors instruction|0
1521159|NCT00347360|4990548|P5|Overall Study|Per sponsors instruction|0
1521160|NCT00347360|4990549|P4|Overall Study|Per sponsors instruction|0
1521161|NCT00347360|4990550|P3|Overall Study|Per sponsors instruction|0
1521162|NCT00347360|4990551|P2|Overall Study|Per sponsors instruction|1
1521163|NCT00347360|4990552|P1|Overall Study|Per sponsors instruction|0
1521164|NCT00347360|4990538|P15|Overall Study|Reason not listed/blank|0
1521165|NCT00347360|4990539|P14|Overall Study|Reason not listed/blank|1
1521166|NCT00347360|4990540|P13|Overall Study|Reason not listed/blank|0
1521167|NCT00347360|4990541|P12|Overall Study|Reason not listed/blank|0
1521168|NCT00347360|4990542|P11|Overall Study|Reason not listed/blank|0
1521169|NCT00347360|4990543|P10|Overall Study|Reason not listed/blank|0
1521170|NCT00347360|4990544|P9|Overall Study|Reason not listed/blank|0
1521171|NCT00347360|4990545|P8|Overall Study|Reason not listed/blank|0
1521172|NCT00347360|4990546|P7|Overall Study|Reason not listed/blank|1
1521173|NCT00347360|4990547|P6|Overall Study|Reason not listed/blank|0
1521174|NCT00347360|4990548|P5|Overall Study|Reason not listed/blank|0
1521175|NCT00347360|4990549|P4|Overall Study|Reason not listed/blank|0
1521176|NCT00347360|4990550|P3|Overall Study|Reason not listed/blank|0
1521177|NCT00347360|4990551|P2|Overall Study|Reason not listed/blank|0
1521178|NCT00347360|4990552|P1|Overall Study|Reason not listed/blank|1
1521179|NCT00347360|4990538|P15|Overall Study|Lack of Efficacy|0
1521180|NCT00347360|4990539|P14|Overall Study|Lack of Efficacy|0
1521181|NCT00347360|4990540|P13|Overall Study|Lack of Efficacy|0
1521182|NCT00347360|4990541|P12|Overall Study|Lack of Efficacy|0
1521183|NCT00347360|4990542|P11|Overall Study|Lack of Efficacy|0
1521184|NCT00347360|4990543|P10|Overall Study|Lack of Efficacy|0
1521185|NCT00347360|4990544|P9|Overall Study|Lack of Efficacy|1
1521186|NCT00347360|4990545|P8|Overall Study|Lack of Efficacy|1
1521187|NCT00347360|4990546|P7|Overall Study|Lack of Efficacy|0
1521188|NCT00347360|4990547|P6|Overall Study|Lack of Efficacy|1
1521189|NCT00347360|4990548|P5|Overall Study|Lack of Efficacy|0
1521190|NCT00347360|4990549|P4|Overall Study|Lack of Efficacy|1
1521191|NCT00347360|4990550|P3|Overall Study|Lack of Efficacy|3
1521192|NCT00347360|4990551|P2|Overall Study|Lack of Efficacy|1
1521193|NCT00347360|4990552|P1|Overall Study|Lack of Efficacy|1
1521194|NCT00347360|4990538|P15|Overall Study|Withdrawal by Subject|1
1521195|NCT00347360|4990539|P14|Overall Study|Withdrawal by Subject|2
1521196|NCT00347360|4990540|P13|Overall Study|Withdrawal by Subject|4
1521197|NCT00347360|4990541|P12|Overall Study|Withdrawal by Subject|3
1521198|NCT00347360|4990542|P11|Overall Study|Withdrawal by Subject|0
1521199|NCT00347360|4990543|P10|Overall Study|Withdrawal by Subject|1
1521200|NCT00347360|4990544|P9|Overall Study|Withdrawal by Subject|1
1521201|NCT00347360|4990545|P8|Overall Study|Withdrawal by Subject|1
1521202|NCT00347360|4990546|P7|Overall Study|Withdrawal by Subject|1
1521203|NCT00347360|4990547|P6|Overall Study|Withdrawal by Subject|2
1521204|NCT00347360|4990548|P5|Overall Study|Withdrawal by Subject|1
1521205|NCT00347360|4990549|P4|Overall Study|Withdrawal by Subject|4
1521206|NCT00347360|4990550|P3|Overall Study|Withdrawal by Subject|2
1521207|NCT00347360|4990551|P2|Overall Study|Withdrawal by Subject|1
1521208|NCT00347360|4990552|P1|Overall Study|Withdrawal by Subject|0
1521209|NCT00347360|4990538|P15|Overall Study|Protocol Violation|0
1521210|NCT00347360|4990539|P14|Overall Study|Protocol Violation|1
1521211|NCT00347360|4990540|P13|Overall Study|Protocol Violation|0
1521212|NCT00347360|4990541|P12|Overall Study|Protocol Violation|0
1521213|NCT00347360|4990542|P11|Overall Study|Protocol Violation|0
1521214|NCT00347360|4990543|P10|Overall Study|Protocol Violation|2
1521215|NCT00347360|4990544|P9|Overall Study|Protocol Violation|1
1521216|NCT00347360|4990545|P8|Overall Study|Protocol Violation|0
1521217|NCT00347360|4990546|P7|Overall Study|Protocol Violation|0
1521218|NCT00347360|4990547|P6|Overall Study|Protocol Violation|2
1521219|NCT00347360|4990548|P5|Overall Study|Protocol Violation|1
1521220|NCT00347360|4990549|P4|Overall Study|Protocol Violation|2
1521221|NCT00347360|4990550|P3|Overall Study|Protocol Violation|1
1521222|NCT00347360|4990551|P2|Overall Study|Protocol Violation|3
1521223|NCT00347360|4990552|P1|Overall Study|Protocol Violation|2
1521224|NCT00347360|4990538|P15|Overall Study|Lost to Follow-up|0
1521225|NCT00347360|4990539|P14|Overall Study|Lost to Follow-up|0
1521226|NCT00347360|4990540|P13|Overall Study|Lost to Follow-up|1
1521227|NCT00347360|4990541|P12|Overall Study|Lost to Follow-up|0
1521228|NCT00347360|4990542|P11|Overall Study|Lost to Follow-up|0
1521229|NCT00347360|4990543|P10|Overall Study|Lost to Follow-up|2
1521230|NCT00347360|4990544|P9|Overall Study|Lost to Follow-up|1
1521231|NCT00347360|4990545|P8|Overall Study|Lost to Follow-up|1
1521232|NCT00347360|4990546|P7|Overall Study|Lost to Follow-up|0
1521233|NCT00347360|4990547|P6|Overall Study|Lost to Follow-up|1
1521234|NCT00347360|4990548|P5|Overall Study|Lost to Follow-up|1
1521235|NCT00347360|4990549|P4|Overall Study|Lost to Follow-up|2
1521236|NCT00347360|4990550|P3|Overall Study|Lost to Follow-up|0
1521237|NCT00347360|4990551|P2|Overall Study|Lost to Follow-up|0
1521238|NCT00347360|4990552|P1|Overall Study|Lost to Follow-up|0
1521239|NCT00347360|4990538|P15|Overall Study|Adverse Event|2
1521240|NCT00347360|4990539|P14|Overall Study|Adverse Event|2
1521241|NCT00347360|4990540|P13|Overall Study|Adverse Event|3
1521242|NCT00347360|4990541|P12|Overall Study|Adverse Event|1
1521243|NCT00347360|4990542|P11|Overall Study|Adverse Event|3
1521244|NCT00347360|4990543|P10|Overall Study|Adverse Event|3
1521245|NCT00347360|4990544|P9|Overall Study|Adverse Event|2
1521246|NCT00347360|4990545|P8|Overall Study|Adverse Event|0
1521247|NCT00347360|4990546|P7|Overall Study|Adverse Event|2
1521248|NCT00347360|4990547|P6|Overall Study|Adverse Event|2
1521249|NCT00347360|4990548|P5|Overall Study|Adverse Event|1
1521250|NCT00347360|4990549|P4|Overall Study|Adverse Event|4
1521251|NCT00347360|4990550|P3|Overall Study|Adverse Event|0
1521252|NCT00347360|4990551|P2|Overall Study|Adverse Event|2
1521253|NCT00347360|4990552|P1|Overall Study|Adverse Event|1
1521254|NCT00347269|4990740|P2|Overall Study|Death|3
1521255|NCT00347269|4990741|P1|Overall Study|Death|2
1521256|NCT00347269|4990740|P2|Overall Study|Withdrawal by Subject|38
1521257|NCT00347269|4990741|P1|Overall Study|Withdrawal by Subject|18
1521258|NCT00347269|4990740|P2|Overall Study|Lost to Follow-up|65
1521259|NCT00347269|4990741|P1|Overall Study|Lost to Follow-up|74
1521260|NCT00347009|4990756|P1|Overall Study|Serious Adverse Event|1
1521261|NCT00347009|4990756|P1|Overall Study|Increased ALT/HBV DNA|1
1521262|NCT00347009|4990756|P1|Overall Study|Insufficient Viral Suppression|3
1521263|NCT00347009|4990756|P1|Overall Study|Adverse Laboratory Experience|1
1521264|NCT00347009|4990756|P1|Overall Study|Protocol Violation|2
1521265|NCT00347009|4990756|P1|Overall Study|Lost to Follow-up|4
1521266|NCT00347009|4990756|P1|Overall Study|Physician Decision|5
1521267|NCT00347009|4990756|P1|Overall Study|Withdrawal by Subject|3
1521268|NCT00347009|4990756|P1|Overall Study|Adverse Event|6
1521269|NCT00347009|4990756|P1|Overall Study|Death|1
1521270|NCT00346775|4990777|P2|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
1521271|NCT00346775|4990778|P1|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
1521272|NCT00346775|4990777|P2|Period 1: Intervention Period 1|Protocol Violation|2
1521273|NCT00346775|4990778|P1|Period 1: Intervention Period 1|Protocol Violation|3
1521274|NCT00346775|4990777|P2|Period 1: Intervention Period 1|Lost to Follow-up|1
1521275|NCT00346775|4990778|P1|Period 1: Intervention Period 1|Lost to Follow-up|1
1521276|NCT00346697|4990790|P2|Overall Study|Lost to Follow-up|1
1521277|NCT00346697|4990791|P1|Overall Study|Lost to Follow-up|0
1521278|NCT00346632|4990827|P10|Overall Study|Not Stated|1
1521279|NCT00346632|4990828|P9|Overall Study|Not Stated|2
1521280|NCT00346632|4990829|P8|Overall Study|Not Stated|2
1521281|NCT00346632|4990830|P7|Overall Study|Not Stated|0
1521282|NCT00346632|4990831|P6|Overall Study|Not Stated|0
1521283|NCT00346632|4990832|P5|Overall Study|Not Stated|0
1521284|NCT00346632|4990833|P4|Overall Study|Not Stated|0
1521285|NCT00346632|4990834|P3|Overall Study|Not Stated|0
1521286|NCT00346632|4990835|P2|Overall Study|Not Stated|1
1521287|NCT00346632|4990836|P1|Overall Study|Not Stated|1
1521288|NCT00346632|4990827|P10|Overall Study|Switched to alternative treatment|0
1521289|NCT00346632|4990828|P9|Overall Study|Switched to alternative treatment|0
1521290|NCT00346632|4990829|P8|Overall Study|Switched to alternative treatment|0
1521291|NCT00346632|4990830|P7|Overall Study|Switched to alternative treatment|0
1521292|NCT00346632|4990831|P6|Overall Study|Switched to alternative treatment|0
1521293|NCT00346632|4990832|P5|Overall Study|Switched to alternative treatment|0
1521294|NCT00346632|4990833|P4|Overall Study|Switched to alternative treatment|0
1521295|NCT00346632|4990834|P3|Overall Study|Switched to alternative treatment|1
1521296|NCT00346632|4990835|P2|Overall Study|Switched to alternative treatment|0
1521297|NCT00346632|4990836|P1|Overall Study|Switched to alternative treatment|0
1521298|NCT00346632|4990827|P10|Overall Study|Withdrawal by Subject|0
1521299|NCT00346632|4990828|P9|Overall Study|Withdrawal by Subject|0
1521300|NCT00346632|4990829|P8|Overall Study|Withdrawal by Subject|0
1521301|NCT00346632|4990830|P7|Overall Study|Withdrawal by Subject|1
1521302|NCT00346632|4990831|P6|Overall Study|Withdrawal by Subject|0
1521303|NCT00346632|4990832|P5|Overall Study|Withdrawal by Subject|0
1521304|NCT00346632|4990833|P4|Overall Study|Withdrawal by Subject|0
1521305|NCT00346632|4990834|P3|Overall Study|Withdrawal by Subject|0
1521306|NCT00346632|4990835|P2|Overall Study|Withdrawal by Subject|0
1521307|NCT00346632|4990836|P1|Overall Study|Withdrawal by Subject|0
1521308|NCT00346632|4990827|P10|Overall Study|Protocol Violation|0
1521309|NCT00346632|4990828|P9|Overall Study|Protocol Violation|0
1521310|NCT00346632|4990829|P8|Overall Study|Protocol Violation|0
1521311|NCT00346632|4990830|P7|Overall Study|Protocol Violation|1
1521312|NCT00346632|4990831|P6|Overall Study|Protocol Violation|0
1521313|NCT00346632|4990832|P5|Overall Study|Protocol Violation|0
1521314|NCT00346632|4990833|P4|Overall Study|Protocol Violation|0
1521315|NCT00346632|4990834|P3|Overall Study|Protocol Violation|0
1521316|NCT00346632|4990835|P2|Overall Study|Protocol Violation|0
1521317|NCT00346632|4990836|P1|Overall Study|Protocol Violation|0
1521318|NCT00346632|4990827|P10|Overall Study|Death|0
1521319|NCT00346632|4990828|P9|Overall Study|Death|0
1521320|NCT00346632|4990829|P8|Overall Study|Death|0
1521321|NCT00346632|4990830|P7|Overall Study|Death|0
1521322|NCT00346632|4990831|P6|Overall Study|Death|0
1521323|NCT00346632|4990832|P5|Overall Study|Death|0
1521324|NCT00346632|4990833|P4|Overall Study|Death|0
1521325|NCT00346632|4990834|P3|Overall Study|Death|1
1521326|NCT00346632|4990835|P2|Overall Study|Death|0
1521327|NCT00346632|4990836|P1|Overall Study|Death|0
1521328|NCT00346632|4990827|P10|Overall Study|Adverse Event|0
1521329|NCT00346632|4990828|P9|Overall Study|Adverse Event|0
1521330|NCT00346632|4990829|P8|Overall Study|Adverse Event|0
1521331|NCT00346632|4990830|P7|Overall Study|Adverse Event|1
1521332|NCT00346632|4990831|P6|Overall Study|Adverse Event|1
1521333|NCT00346632|4990832|P5|Overall Study|Adverse Event|1
1521334|NCT00346632|4990833|P4|Overall Study|Adverse Event|0
1521335|NCT00346632|4990834|P3|Overall Study|Adverse Event|0
1521336|NCT00346632|4990835|P2|Overall Study|Adverse Event|0
1521337|NCT00346632|4990836|P1|Overall Study|Adverse Event|0
1521338|NCT00346632|4990827|P10|Overall Study|Progressive Disease|2
1521339|NCT00346632|4990828|P9|Overall Study|Progressive Disease|2
1521340|NCT00346632|4990829|P8|Overall Study|Progressive Disease|2
1521341|NCT00346632|4990830|P7|Overall Study|Progressive Disease|2
1521342|NCT00346632|4990831|P6|Overall Study|Progressive Disease|1
1521343|NCT00346632|4990832|P5|Overall Study|Progressive Disease|3
1521344|NCT00346632|4990833|P4|Overall Study|Progressive Disease|3
1521345|NCT00346632|4990834|P3|Overall Study|Progressive Disease|4
1521346|NCT00346632|4990835|P2|Overall Study|Progressive Disease|2
1521347|NCT00346632|4990836|P1|Overall Study|Progressive Disease|2
1521348|NCT00346398|4990986|P2|Overall Study|Withdrawal by Subject|2
1521349|NCT00346398|4990987|P1|Overall Study|Withdrawal by Subject|0
1521350|NCT00346398|4990986|P2|Overall Study|Lost to Follow-up|0
1521351|NCT00346398|4990987|P1|Overall Study|Lost to Follow-up|3
1521352|NCT00346333|4990999|P2|Overall Study|unwilling or unable to continue|8
1521353|NCT00346333|4991000|P1|Overall Study|unwilling or unable to continue|4
1521354|NCT00346333|4990999|P2|Overall Study|Death|0
1521355|NCT00346333|4991000|P1|Overall Study|Death|1
1521356|NCT00346268|4991016|P2|Overall Study|Participant refused|3
1521357|NCT00346268|4991017|P1|Overall Study|Participant refused|0
1521358|NCT00346268|4991016|P2|Overall Study|Protocol Violation|0
1521359|NCT00346268|4991017|P1|Overall Study|Protocol Violation|1
1521360|NCT00346268|4991016|P2|Overall Study|Adverse Event|0
1521361|NCT00346268|4991017|P1|Overall Study|Adverse Event|1
1521362|NCT00346216|4991052|P3|Overall Study|Missing Subject Summary Status|62
1521363|NCT00346216|4991053|P2|Overall Study|Missing Subject Summary Status|61
1521364|NCT00346216|4991054|P1|Overall Study|Missing Subject Summary Status|62
1521365|NCT00346216|4991052|P3|Overall Study|Study terminated by sponsor|8
1521366|NCT00346216|4991053|P2|Overall Study|Study terminated by sponsor|4
1521367|NCT00346216|4991054|P1|Overall Study|Study terminated by sponsor|11
1521368|NCT00346216|4991052|P3|Overall Study|Death|228
1521369|NCT00346216|4991053|P2|Overall Study|Death|192
1521370|NCT00346216|4991054|P1|Overall Study|Death|189
1521371|NCT00346216|4991052|P3|Overall Study|Does not meet entrance criteria|8
1521372|NCT00346216|4991053|P2|Overall Study|Does not meet entrance criteria|10
1521373|NCT00346216|4991054|P1|Overall Study|Does not meet entrance criteria|13
1521374|NCT00346216|4991052|P3|Overall Study|Physician Decision|59
1521375|NCT00346216|4991053|P2|Overall Study|Physician Decision|76
1521376|NCT00346216|4991054|P1|Overall Study|Physician Decision|80
1521377|NCT00346216|4991052|P3|Overall Study|Lost to Follow-up|542
1521378|NCT00346216|4991053|P2|Overall Study|Lost to Follow-up|588
1521379|NCT00346216|4991054|P1|Overall Study|Lost to Follow-up|611
1521380|NCT00346216|4991052|P3|Overall Study|Withdrawal by Subject|651
1521381|NCT00346216|4991053|P2|Overall Study|Withdrawal by Subject|692
1521382|NCT00346216|4991054|P1|Overall Study|Withdrawal by Subject|661
1521383|NCT00346216|4991052|P3|Overall Study|No longer willing to participate|585
1521384|NCT00346216|4991053|P2|Overall Study|No longer willing to participate|606
1521385|NCT00346216|4991054|P1|Overall Study|No longer willing to participate|600
1521386|NCT00346216|4991052|P3|Overall Study|Not specified|205
1521387|NCT00346216|4991053|P2|Overall Study|Not specified|231
1521388|NCT00346216|4991054|P1|Overall Study|Not specified|181
1521389|NCT00346164|4991075|P4|Overall Study|Inability to start week 16 tx on time|11
1521390|NCT00346164|4991076|P3|Overall Study|Inability to start week 16 tx on time|0
1521391|NCT00346164|4991077|P2|Overall Study|Inability to start week 16 tx on time|0
1521392|NCT00346164|4991078|P1|Overall Study|Inability to start week 16 tx on time|0
1521393|NCT00346164|4991075|P4|Overall Study|Refusal of further protocol therapy|15
1521394|NCT00346164|4991076|P3|Overall Study|Refusal of further protocol therapy|3
1521395|NCT00346164|4991077|P2|Overall Study|Refusal of further protocol therapy|1
1521396|NCT00346164|4991078|P1|Overall Study|Refusal of further protocol therapy|0
1521397|NCT00346164|4991075|P4|Overall Study|Ineligible|23
1521398|NCT00346164|4991076|P3|Overall Study|Ineligible|2
1521399|NCT00346164|4991077|P2|Overall Study|Ineligible|2
1521400|NCT00346164|4991078|P1|Overall Study|Ineligible|11
1521401|NCT00346164|4991075|P4|Overall Study|Withdrawal by Subject|0
1521402|NCT00346164|4991076|P3|Overall Study|Withdrawal by Subject|2
1521403|NCT00346164|4991077|P2|Overall Study|Withdrawal by Subject|0
1521404|NCT00346164|4991078|P1|Overall Study|Withdrawal by Subject|0
1521405|NCT00346164|4991075|P4|Overall Study|Protocol Violation|4
1521406|NCT00346164|4991076|P3|Overall Study|Protocol Violation|10
1521407|NCT00346164|4991077|P2|Overall Study|Protocol Violation|2
1521408|NCT00346164|4991078|P1|Overall Study|Protocol Violation|6
1521409|NCT00346164|4991075|P4|Overall Study|Physician Decision|27
1521410|NCT00346164|4991076|P3|Overall Study|Physician Decision|2
1521411|NCT00346164|4991077|P2|Overall Study|Physician Decision|1
1521412|NCT00346164|4991078|P1|Overall Study|Physician Decision|0
1521413|NCT00346164|4991075|P4|Overall Study|Lack of Efficacy|25
1521414|NCT00346164|4991076|P3|Overall Study|Lack of Efficacy|7
1521415|NCT00346164|4991077|P2|Overall Study|Lack of Efficacy|1
1521416|NCT00346164|4991078|P1|Overall Study|Lack of Efficacy|0
1521417|NCT00346164|4991075|P4|Overall Study|Adverse Event|1
1521418|NCT00346164|4991076|P3|Overall Study|Adverse Event|0
1521419|NCT00346164|4991077|P2|Overall Study|Adverse Event|0
1521420|NCT00346164|4991078|P1|Overall Study|Adverse Event|0
1521421|NCT00346151|4991113|P1|Overall Study|Withdrawal by Subject|3
1521422|NCT00346073|4991133|P2|Overall Study|Lost to Follow-up|24
1521423|NCT00346073|4991134|P1|Overall Study|Lost to Follow-up|39
1521424|NCT00346073|4991133|P2|Overall Study|Serious Adverse Event|0
1521425|NCT00346073|4991134|P1|Overall Study|Serious Adverse Event|2
1521426|NCT00346034|4991168|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
1521427|NCT00346034|4991168|P1|Overall Study|Patient Stopped Taking Study Drug|1
1521428|NCT00346034|4991168|P1|Overall Study|Withdrawal by Subject|13
1521429|NCT00346034|4991168|P1|Overall Study|Lack of Efficacy|8
1521430|NCT00346034|4991168|P1|Overall Study|Adverse Event|34
1521431|NCT00345878|4991208|P2|Overall Study|Other|0
1521432|NCT00345878|4991209|P1|Overall Study|Other|1
1521433|NCT00345878|4991208|P2|Overall Study|Lost to Follow-up|1
1521434|NCT00345878|4991209|P1|Overall Study|Lost to Follow-up|2
1521435|NCT00345878|4991208|P2|Overall Study|Adverse Event|0
1521436|NCT00345878|4991209|P1|Overall Study|Adverse Event|1
1521437|NCT00345839|4991227|P2|Overall Study|Lost to Follow-up|61
1521438|NCT00345839|4991228|P1|Overall Study|Lost to Follow-up|58
1521439|NCT00345839|4991227|P2|Overall Study|Withdrawal by Subject|98
1521440|NCT00345839|4991228|P1|Overall Study|Withdrawal by Subject|91
1521441|NCT00345683|4991254|P2|Overall Study|Other|2
1521442|NCT00345683|4991255|P1|Overall Study|Other|6
1521443|NCT00345683|4991254|P2|Overall Study|Lost to Follow-up|7
1521444|NCT00345683|4991255|P1|Overall Study|Lost to Follow-up|19
1521445|NCT00345631|4991278|P3|Overall Study|Other reasons|1
1521446|NCT00345631|4991279|P2|Overall Study|Other reasons|0
1521447|NCT00345631|4991280|P1|Overall Study|Other reasons|0
1521448|NCT00345631|4991278|P3|Overall Study|Lost to Follow-up|4
1521449|NCT00345631|4991279|P2|Overall Study|Lost to Follow-up|7
1521450|NCT00345631|4991280|P1|Overall Study|Lost to Follow-up|3
1521451|NCT00345631|4991278|P3|Overall Study|Adverse Event|0
1521452|NCT00345631|4991279|P2|Overall Study|Adverse Event|1
1521453|NCT00345631|4991280|P1|Overall Study|Adverse Event|0
1521454|NCT00345631|4991278|P3|Overall Study|Withdrawal by Subject|1
1521455|NCT00345631|4991279|P2|Overall Study|Withdrawal by Subject|0
1521456|NCT00345631|4991280|P1|Overall Study|Withdrawal by Subject|1
1521457|NCT00345605|4991312|P2|Arm 2, Opposite Treatment|Adverse Event|0
1521458|NCT00345605|4991313|P1|Arm 2, Opposite Treatment|Adverse Event|1
1521459|NCT00345605|4991312|P2|Arm 1|Adverse Event|1
1521460|NCT00345605|4991313|P1|Arm 1|Adverse Event|0
1521461|NCT00345592|4991333|P2|Overall Study|Withdrawal by Subject|8
1521462|NCT00345592|4991334|P1|Overall Study|Withdrawal by Subject|11
1521463|NCT00345592|4991333|P2|Overall Study|Death|16
1521464|NCT00345592|4991334|P1|Overall Study|Death|14
1521465|NCT00345579|4991342|P2|Overall Study|Other|1
1521466|NCT00345579|4991343|P1|Overall Study|Other|9
1521467|NCT00345579|4991342|P2|Overall Study|Lost to Follow-up|36
1521468|NCT00345579|4991343|P1|Overall Study|Lost to Follow-up|82
1521469|NCT00345579|4991342|P2|Overall Study|Withdrawal by Subject|17
1521470|NCT00345579|4991343|P1|Overall Study|Withdrawal by Subject|50
1521471|NCT00345579|4991342|P2|Overall Study|Protocol Violation|5
1521472|NCT00345579|4991343|P1|Overall Study|Protocol Violation|14
1521473|NCT00345579|4991342|P2|Overall Study|Adverse Event|6
1521474|NCT00345579|4991343|P1|Overall Study|Adverse Event|9
1521475|NCT00345540|4991363|P1|Overall Study|Withdrawal by Subject|1
1521476|NCT00345397|4991369|P1|Overall Study|Death|1
1521477|NCT00345293|4991407|P2|Overall Study|Withdrawal by Subject|0
1521478|NCT00345293|4991408|P1|Overall Study|Withdrawal by Subject|1
1521479|NCT00345293|4991407|P2|Overall Study|Unable to access line for sample|0
1521480|NCT00345293|4991408|P1|Overall Study|Unable to access line for sample|1
1521481|NCT00345046|4991454|P3|Overall Study|Protocol Violation|2
1521482|NCT00345046|4991455|P2|Overall Study|Protocol Violation|1
1521483|NCT00345046|4991456|P1|Overall Study|Protocol Violation|1
1521484|NCT00344968|4991486|P3|Overall Study|Other|0
1521485|NCT00344968|4991487|P2|Overall Study|Other|1
1521486|NCT00344968|4991488|P1|Overall Study|Other|0
1521487|NCT00344968|4991486|P3|Overall Study|Death|31
1521488|NCT00344968|4991487|P2|Overall Study|Death|27
1521489|NCT00344968|4991488|P1|Overall Study|Death|11
1521490|NCT00344968|4991486|P3|Overall Study|Lost to Follow-up|37
1521491|NCT00344968|4991487|P2|Overall Study|Lost to Follow-up|37
1521492|NCT00344968|4991488|P1|Overall Study|Lost to Follow-up|24
1521493|NCT00344968|4991486|P3|Overall Study|Withdrawal by Subject|27
1521494|NCT00344968|4991487|P2|Overall Study|Withdrawal by Subject|31
1521495|NCT00344968|4991488|P1|Overall Study|Withdrawal by Subject|14
1521496|NCT00344968|4991486|P3|Overall Study|Protocol Violation|5
1521497|NCT00344968|4991487|P2|Overall Study|Protocol Violation|2
1521498|NCT00344968|4991488|P1|Overall Study|Protocol Violation|2
1521499|NCT00344968|4991486|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
1521500|NCT00344968|4991487|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
1521501|NCT00344968|4991488|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
1521502|NCT00344968|4991486|P3|Overall Study|Adverse Event|15
1521503|NCT00344968|4991487|P2|Overall Study|Adverse Event|4
1521504|NCT00344968|4991488|P1|Overall Study|Adverse Event|5
1521505|NCT00344773|4991499|P1|Overall Study|Not Eligible for the study|2
1521506|NCT00344773|4991499|P1|Overall Study|Withdrawal by Subject|1
1521507|NCT00344773|4991499|P1|Overall Study|Objective Disease Progression|16
1521508|NCT00344773|4991499|P1|Overall Study|Adverse Event|2
1521509|NCT00344500|4991522|P3|Overall Study|Not Noted|0
1521510|NCT00344500|4991523|P2|Overall Study|Not Noted|3
1521511|NCT00344500|4991524|P1|Overall Study|Not Noted|1
1521512|NCT00344500|4991522|P3|Overall Study|Protocol Violation|1
1521513|NCT00344500|4991523|P2|Overall Study|Protocol Violation|7
1521514|NCT00344500|4991524|P1|Overall Study|Protocol Violation|4
1521515|NCT00344500|4991522|P3|Overall Study|Withdrawal by Subject|0
1521516|NCT00344500|4991523|P2|Overall Study|Withdrawal by Subject|10
1521517|NCT00344500|4991524|P1|Overall Study|Withdrawal by Subject|7
1521518|NCT00344500|4991522|P3|Overall Study|Lost to Follow-up|1
1521519|NCT00344500|4991523|P2|Overall Study|Lost to Follow-up|13
1521520|NCT00344500|4991524|P1|Overall Study|Lost to Follow-up|5
1521521|NCT00344500|4991522|P3|Overall Study|Adverse Event|0
1521522|NCT00344500|4991523|P2|Overall Study|Adverse Event|2
1521523|NCT00344500|4991524|P1|Overall Study|Adverse Event|6
1521524|NCT00344487|4991535|P1|Overall Study|immunologic failure|1
1521525|NCT00344461|4991539|P1|Overall Study|Withdrawal by Subject|2
1521526|NCT00344461|4991539|P1|Overall Study|Protocol Violation|6
1521527|NCT00344461|4991539|P1|Overall Study|Physician Decision|2
1521528|NCT00344461|4991539|P1|Overall Study|Lost to Follow-up|2
1521529|NCT00344461|4991539|P1|Overall Study|Lack of Efficacy|2
1521530|NCT00344461|4991539|P1|Overall Study|Death|1
1521531|NCT00344461|4991539|P1|Overall Study|Adverse Event|6
1521532|NCT00344448|4991550|P2|Open Label|Study terminated|0
1521533|NCT00344448|4991551|P1|Open Label|Study terminated|1
1521534|NCT00344448|4991550|P2|Open Label|Withdrawal by Subject|1
1521535|NCT00344448|4991551|P1|Open Label|Withdrawal by Subject|1
1521536|NCT00344448|4991550|P2|Double Blind, Placebo Controlled|Study terminated|0
1521537|NCT00344448|4991551|P1|Double Blind, Placebo Controlled|Study terminated|1
1521538|NCT00344448|4991550|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
1521539|NCT00344448|4991551|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
1521540|NCT00344448|4991550|P2|Screening|Withdrawal by Subject|1
1521541|NCT00344448|4991551|P1|Screening|Withdrawal by Subject|0
1521542|NCT00344305|4991570|P2|Overall Study|Participant was not contacted in window|1
1521543|NCT00344305|4991571|P1|Overall Study|Participant was not contacted in window|0
1521544|NCT00344305|4991570|P2|Overall Study|Lost to Follow-up|0
1521545|NCT00344305|4991571|P1|Overall Study|Lost to Follow-up|2
1521546|NCT00344032|4991621|P2|Overall Study|Physician Decision|1
1521547|NCT00344032|4991622|P1|Overall Study|Physician Decision|4
1521548|NCT00344032|4991621|P2|Overall Study|Lost to Follow-up|6
1521549|NCT00344032|4991622|P1|Overall Study|Lost to Follow-up|4
1521550|NCT00344032|4991621|P2|Overall Study|Withdrawal by Subject|2
1521551|NCT00344032|4991622|P1|Overall Study|Withdrawal by Subject|6
1521552|NCT00344032|4991621|P2|Overall Study|Adverse Event|1
1521553|NCT00344032|4991622|P1|Overall Study|Adverse Event|0
1521554|NCT00344019|4991641|P3|Overall Study|did not meet final inclusion criteria|74
1521555|NCT00344019|4991642|P2|Overall Study|did not meet final inclusion criteria|0
1521556|NCT00344019|4991643|P1|Overall Study|did not meet final inclusion criteria|0
1521557|NCT00343915|4991661|P2|Primary Study|Other|0
1521558|NCT00343915|4991662|P1|Primary Study|Other|1
1521559|NCT00343915|4991661|P2|Primary Study|Lost to Follow-up|3
1521560|NCT00343915|4991662|P1|Primary Study|Lost to Follow-up|2
1521561|NCT00343915|4991661|P2|Primary Study|Withdrawal by Subject|0
1521562|NCT00343915|4991662|P1|Primary Study|Withdrawal by Subject|1
1521563|NCT00343889|4991688|P2|Overall Study|Protocol Violation|0
1521564|NCT00343889|4991689|P1|Overall Study|Protocol Violation|1
1521565|NCT00343889|4991688|P2|Overall Study|Withdrawal by Subject|1
1521566|NCT00343889|4991689|P1|Overall Study|Withdrawal by Subject|0
1521567|NCT00343889|4991688|P2|Overall Study|Lost to Follow-up|0
1521568|NCT00343889|4991689|P1|Overall Study|Lost to Follow-up|2
1521569|NCT00343512|4991772|P1|Overall Study|Withdrawal by Subject|2
1521570|NCT00343382|4991860|P3|Overall Study|Other Reason Not Specified|4
1521571|NCT00343382|4991861|P2|Overall Study|Other Reason Not Specified|2
1521572|NCT00343382|4991862|P1|Overall Study|Other Reason Not Specified|1
1521573|NCT00343382|4991860|P3|Overall Study|Withdrawal by Subject|6
1521574|NCT00343382|4991861|P2|Overall Study|Withdrawal by Subject|2
1521575|NCT00343382|4991862|P1|Overall Study|Withdrawal by Subject|1
1521576|NCT00343382|4991860|P3|Overall Study|Adverse Event|7
1521577|NCT00343382|4991861|P2|Overall Study|Adverse Event|10
1521578|NCT00343382|4991862|P1|Overall Study|Adverse Event|2
1521579|NCT00343291|4991881|P2|Overall Study|Other|5
1521580|NCT00343291|4991882|P1|Overall Study|Other|8
1521581|NCT00343291|4991881|P2|Overall Study|Withdrawal by Subject|2
1521582|NCT00343291|4991882|P1|Overall Study|Withdrawal by Subject|0
1521583|NCT00343291|4991881|P2|Overall Study|Progressive disease|34
1521584|NCT00343291|4991882|P1|Overall Study|Progressive disease|33
1521585|NCT00343291|4991881|P2|Overall Study|Death|2
1521586|NCT00343291|4991882|P1|Overall Study|Death|3
1521587|NCT00343291|4991881|P2|Overall Study|Adverse Event|13
1521588|NCT00343291|4991882|P1|Overall Study|Adverse Event|13
1521589|NCT00343252|4991898|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
1521590|NCT00343252|4991899|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
1521591|NCT00343252|4991898|P2|18 Months (All Treated Participants)|Sponsor Decision|5
1521592|NCT00343252|4991899|P1|18 Months (All Treated Participants)|Sponsor Decision|8
1521593|NCT00343252|4991898|P2|18 Months (All Treated Participants)|Protocol Violation|3
1521594|NCT00343252|4991899|P1|18 Months (All Treated Participants)|Protocol Violation|3
1521595|NCT00343252|4991898|P2|18 Months (All Treated Participants)|Physician Decision|7
1521596|NCT00343252|4991899|P1|18 Months (All Treated Participants)|Physician Decision|4
1521597|NCT00343252|4991898|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
1521598|NCT00343252|4991899|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
1521599|NCT00343252|4991898|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
1521600|NCT00343252|4991899|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
1521601|NCT00343252|4991898|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
1521602|NCT00343252|4991899|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
1521603|NCT00343252|4991898|P2|18 Months (All Treated Participants)|Death|5
1521604|NCT00343252|4991899|P1|18 Months (All Treated Participants)|Death|4
1521605|NCT00343252|4991898|P2|18 Months (All Treated Participants)|Adverse Event|23
1521606|NCT00343252|4991899|P1|18 Months (All Treated Participants)|Adverse Event|31
1521607|NCT00343252|4991898|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
1521608|NCT00343252|4991899|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
1521609|NCT00343252|4991898|P2|12 Months (All Treated Participants)|Sponsor Decision|6
1521610|NCT00343252|4991899|P1|12 Months (All Treated Participants)|Sponsor Decision|9
1521611|NCT00343252|4991898|P2|12 Months (All Treated Participants)|Protocol Violation|2
1521612|NCT00343252|4991899|P1|12 Months (All Treated Participants)|Protocol Violation|3
1521613|NCT00343252|4991898|P2|12 Months (All Treated Participants)|Physician Decision|5
1521614|NCT00343252|4991899|P1|12 Months (All Treated Participants)|Physician Decision|4
1521615|NCT00343252|4991898|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
1521616|NCT00343252|4991899|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
1521617|NCT00343252|4991898|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
1521618|NCT00343252|4991899|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
1521619|NCT00343252|4991898|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
1521620|NCT00343252|4991899|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
1521621|NCT00343252|4991898|P2|12 Months (All Treated Participants)|Death|3
1521622|NCT00343252|4991899|P1|12 Months (All Treated Participants)|Death|3
1521623|NCT00343252|4991898|P2|12 Months (All Treated Participants)|Adverse Event|20
1521624|NCT00343252|4991899|P1|12 Months (All Treated Participants)|Adverse Event|22
1521625|NCT00343252|4991898|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
1521626|NCT00343252|4991899|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
1521627|NCT00343252|4991898|P2|6 Months (All Treated Participants)|Sponsor Decision|4
1521628|NCT00343252|4991899|P1|6 Months (All Treated Participants)|Sponsor Decision|7
1521629|NCT00343252|4991898|P2|6 Months (All Treated Participants)|Protocol Violation|2
1521630|NCT00343252|4991899|P1|6 Months (All Treated Participants)|Protocol Violation|2
1521631|NCT00343252|4991898|P2|6 Months (All Treated Participants)|Physician Decision|3
1521632|NCT00343252|4991899|P1|6 Months (All Treated Participants)|Physician Decision|1
1521633|NCT00343252|4991898|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
1521634|NCT00343252|4991899|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
1521635|NCT00343252|4991898|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
1521636|NCT00343252|4991899|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
1521637|NCT00343252|4991898|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
1521638|NCT00343252|4991899|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
1521639|NCT00343252|4991898|P2|6 Months (All Treated Participants)|Death|2
1521640|NCT00343252|4991899|P1|6 Months (All Treated Participants)|Death|0
1521641|NCT00343252|4991898|P2|6 Months (All Treated Participants)|Adverse Event|11
1521642|NCT00343252|4991899|P1|6 Months (All Treated Participants)|Adverse Event|17
1521643|NCT00342628|4991964|P3|Overall Study|moved residence|1
1521644|NCT00342628|4991965|P2|Overall Study|moved residence|1
1521645|NCT00342628|4991966|P1|Overall Study|moved residence|0
1521646|NCT00342628|4991964|P3|Overall Study|Death|0
1521647|NCT00342628|4991965|P2|Overall Study|Death|1
1521648|NCT00342628|4991966|P1|Overall Study|Death|1
1521649|NCT00342628|4991964|P3|Overall Study|Withdrawal by Subject|18
1521650|NCT00342628|4991965|P2|Overall Study|Withdrawal by Subject|19
1521651|NCT00342628|4991966|P1|Overall Study|Withdrawal by Subject|19
1521652|NCT00340834|4992032|P5|Extension Phase of Study|Death|1
1521653|NCT00340834|4992033|P4|Extension Phase of Study|Death|0
1521654|NCT00340834|4992034|P3|Extension Phase of Study|Death|0
1521655|NCT00340834|4992035|P2|Extension Phase of Study|Death|0
1521656|NCT00340834|4992036|P1|Extension Phase of Study|Death|0
1521657|NCT00340834|4992032|P5|Extension Phase of Study|Protocol Violation|0
1521658|NCT00340834|4992033|P4|Extension Phase of Study|Protocol Violation|0
1521659|NCT00340834|4992034|P3|Extension Phase of Study|Protocol Violation|0
1521660|NCT00340834|4992035|P2|Extension Phase of Study|Protocol Violation|0
1521661|NCT00340834|4992036|P1|Extension Phase of Study|Protocol Violation|3
1521662|NCT00340834|4992032|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
1521663|NCT00340834|4992033|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
1521664|NCT00340834|4992034|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
1521665|NCT00340834|4992035|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
1521666|NCT00340834|4992036|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
1521667|NCT00340834|4992032|P5|Extension Phase of Study|Administrative problems|1
1521668|NCT00340834|4992033|P4|Extension Phase of Study|Administrative problems|1
1521669|NCT00340834|4992034|P3|Extension Phase of Study|Administrative problems|0
1521670|NCT00340834|4992035|P2|Extension Phase of Study|Administrative problems|0
1521671|NCT00340834|4992036|P1|Extension Phase of Study|Administrative problems|3
1521672|NCT00340834|4992032|P5|Extension Phase of Study|Subject no longer requires study drug|2
1521673|NCT00340834|4992033|P4|Extension Phase of Study|Subject no longer requires study drug|0
1521674|NCT00340834|4992034|P3|Extension Phase of Study|Subject no longer requires study drug|0
1521675|NCT00340834|4992035|P2|Extension Phase of Study|Subject no longer requires study drug|0
1521676|NCT00340834|4992036|P1|Extension Phase of Study|Subject no longer requires study drug|4
1521677|NCT00340834|4992032|P5|Extension Phase of Study|Lost to Follow-up|3
1521678|NCT00340834|4992033|P4|Extension Phase of Study|Lost to Follow-up|2
1521679|NCT00340834|4992034|P3|Extension Phase of Study|Lost to Follow-up|0
1521680|NCT00340834|4992035|P2|Extension Phase of Study|Lost to Follow-up|1
1521681|NCT00340834|4992036|P1|Extension Phase of Study|Lost to Follow-up|1
1521682|NCT00340834|4992032|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
1521683|NCT00340834|4992033|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
1521684|NCT00340834|4992034|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
1521685|NCT00340834|4992035|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
1521686|NCT00340834|4992036|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
1521687|NCT00340834|4992032|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
1521688|NCT00340834|4992033|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
1521689|NCT00340834|4992034|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
1521690|NCT00340834|4992035|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
1521691|NCT00340834|4992036|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
1521692|NCT00340834|4992032|P5|Extension Phase of Study|Adverse Event|7
1521693|NCT00340834|4992033|P4|Extension Phase of Study|Adverse Event|19
1521694|NCT00340834|4992034|P3|Extension Phase of Study|Adverse Event|0
1521695|NCT00340834|4992035|P2|Extension Phase of Study|Adverse Event|22
1521696|NCT00340834|4992036|P1|Extension Phase of Study|Adverse Event|21
1521697|NCT00340834|4992032|P5|Extension Phase of Study|Subject withdrew consent|15
1521698|NCT00340834|4992033|P4|Extension Phase of Study|Subject withdrew consent|12
1521699|NCT00340834|4992034|P3|Extension Phase of Study|Subject withdrew consent|0
1521700|NCT00340834|4992035|P2|Extension Phase of Study|Subject withdrew consent|31
1521701|NCT00340834|4992036|P1|Extension Phase of Study|Subject withdrew consent|26
1521702|NCT00340834|4992032|P5|Extension Phase of Study|Subject did not receive study drug|0
1521703|NCT00340834|4992033|P4|Extension Phase of Study|Subject did not receive study drug|2
1521704|NCT00340834|4992034|P3|Extension Phase of Study|Subject did not receive study drug|0
1521705|NCT00340834|4992035|P2|Extension Phase of Study|Subject did not receive study drug|1
1521706|NCT00340834|4992036|P1|Extension Phase of Study|Subject did not receive study drug|0
1521707|NCT00340834|4992032|P5|Core Phase of Study|Protocol Violation|0
1521708|NCT00340834|4992033|P4|Core Phase of Study|Protocol Violation|0
1521709|NCT00340834|4992034|P3|Core Phase of Study|Protocol Violation|2
1521710|NCT00340834|4992035|P2|Core Phase of Study|Protocol Violation|0
1521711|NCT00340834|4992036|P1|Core Phase of Study|Protocol Violation|0
1521712|NCT00340834|4992032|P5|Core Phase of Study|Death|0
1521713|NCT00340834|4992033|P4|Core Phase of Study|Death|0
1521714|NCT00340834|4992034|P3|Core Phase of Study|Death|0
1521715|NCT00340834|4992035|P2|Core Phase of Study|Death|0
1521716|NCT00340834|4992036|P1|Core Phase of Study|Death|2
1521717|NCT00340834|4992032|P5|Core Phase of Study|Lost to Follow-up|0
1521718|NCT00340834|4992033|P4|Core Phase of Study|Lost to Follow-up|0
1521719|NCT00340834|4992034|P3|Core Phase of Study|Lost to Follow-up|4
1521720|NCT00340834|4992035|P2|Core Phase of Study|Lost to Follow-up|1
1521721|NCT00340834|4992036|P1|Core Phase of Study|Lost to Follow-up|1
1521722|NCT00340834|4992032|P5|Core Phase of Study|Abnormal test procedure result(s)|0
1521723|NCT00340834|4992033|P4|Core Phase of Study|Abnormal test procedure result(s)|0
1521724|NCT00340834|4992034|P3|Core Phase of Study|Abnormal test procedure result(s)|3
1521725|NCT00340834|4992035|P2|Core Phase of Study|Abnormal test procedure result(s)|3
1521726|NCT00340834|4992036|P1|Core Phase of Study|Abnormal test procedure result(s)|4
1521727|NCT00340834|4992032|P5|Core Phase of Study|Abnormal laboratory value(s)|0
1521728|NCT00340834|4992033|P4|Core Phase of Study|Abnormal laboratory value(s)|0
1521729|NCT00340834|4992034|P3|Core Phase of Study|Abnormal laboratory value(s)|1
1521730|NCT00340834|4992035|P2|Core Phase of Study|Abnormal laboratory value(s)|6
1521731|NCT00340834|4992036|P1|Core Phase of Study|Abnormal laboratory value(s)|4
1521732|NCT00340834|4992032|P5|Core Phase of Study|Lack of Efficacy|0
1521733|NCT00340834|4992033|P4|Core Phase of Study|Lack of Efficacy|0
1521734|NCT00340834|4992034|P3|Core Phase of Study|Lack of Efficacy|7
1521735|NCT00340834|4992035|P2|Core Phase of Study|Lack of Efficacy|3
1521736|NCT00340834|4992036|P1|Core Phase of Study|Lack of Efficacy|3
1521737|NCT00340834|4992032|P5|Core Phase of Study|Administrative Problems|0
1521738|NCT00340834|4992033|P4|Core Phase of Study|Administrative Problems|0
1521739|NCT00340834|4992034|P3|Core Phase of Study|Administrative Problems|7
1521740|NCT00340834|4992035|P2|Core Phase of Study|Administrative Problems|2
1521741|NCT00340834|4992036|P1|Core Phase of Study|Administrative Problems|6
1521742|NCT00340834|4992032|P5|Core Phase of Study|Withdrawal by Subject|0
1521743|NCT00340834|4992033|P4|Core Phase of Study|Withdrawal by Subject|0
1521744|NCT00340834|4992034|P3|Core Phase of Study|Withdrawal by Subject|16
1521745|NCT00340834|4992035|P2|Core Phase of Study|Withdrawal by Subject|9
1521746|NCT00340834|4992036|P1|Core Phase of Study|Withdrawal by Subject|11
1521747|NCT00340834|4992032|P5|Core Phase of Study|Adverse Event|0
1521748|NCT00340834|4992033|P4|Core Phase of Study|Adverse Event|0
1521749|NCT00340834|4992034|P3|Core Phase of Study|Adverse Event|9
1521750|NCT00340834|4992035|P2|Core Phase of Study|Adverse Event|9
1521751|NCT00340834|4992036|P1|Core Phase of Study|Adverse Event|26
1521752|NCT00340704|4992070|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
1521753|NCT00340704|4992071|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
1521754|NCT00340704|4992072|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
1521755|NCT00340704|4992073|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
1521756|NCT00340704|4992074|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1521757|NCT00340704|4992075|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1521758|NCT00340704|4992076|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1521759|NCT00340704|4992077|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1521760|NCT00340704|4992078|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1521761|NCT00340704|4992070|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1521762|NCT00340704|4992071|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1521763|NCT00340704|4992072|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1521764|NCT00340704|4992073|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
1521765|NCT00340704|4992074|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
1521766|NCT00340704|4992075|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1521767|NCT00340704|4992076|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1521768|NCT00340704|4992077|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1521769|NCT00340704|4992078|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1521770|NCT00340704|4992070|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1521771|NCT00340704|4992071|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1521772|NCT00340704|4992072|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1521773|NCT00340704|4992073|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
1521774|NCT00340704|4992074|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1521775|NCT00340704|4992075|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1521776|NCT00340704|4992076|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1521777|NCT00340704|4992077|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1521778|NCT00340704|4992078|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1521779|NCT00340704|4992070|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
1521780|NCT00340704|4992071|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
1521781|NCT00340704|4992072|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1521782|NCT00340704|4992073|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1521783|NCT00340704|4992074|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
1521784|NCT00340704|4992075|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
1521785|NCT00340704|4992076|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1521786|NCT00340704|4992077|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1521787|NCT00340704|4992078|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1521788|NCT00340704|4992070|P9|PK Study|Not treated|0
1521789|NCT00340704|4992071|P8|PK Study|Not treated|0
1521790|NCT00340704|4992072|P7|PK Study|Not treated|0
1521791|NCT00340704|4992073|P6|PK Study|Not treated|0
1521792|NCT00340704|4992074|P5|PK Study|Not treated|0
1521793|NCT00340704|4992075|P4|PK Study|Not treated|0
1521794|NCT00340704|4992076|P3|PK Study|Not treated|1
1521795|NCT00340704|4992077|P2|PK Study|Not treated|0
1521796|NCT00340704|4992078|P1|PK Study|Not treated|0
1521797|NCT00340704|4992070|P9|PK Study|Adverse Event|0
1521798|NCT00340704|4992071|P8|PK Study|Adverse Event|0
1521799|NCT00340704|4992072|P7|PK Study|Adverse Event|0
1521800|NCT00340704|4992073|P6|PK Study|Adverse Event|0
1521801|NCT00340704|4992074|P5|PK Study|Adverse Event|0
1521802|NCT00340704|4992075|P4|PK Study|Adverse Event|0
1521803|NCT00340704|4992076|P3|PK Study|Adverse Event|0
1521804|NCT00340704|4992077|P2|PK Study|Adverse Event|1
1521805|NCT00340704|4992078|P1|PK Study|Adverse Event|0
1521806|NCT00340678|4992184|P4|Overall Study|Lost to Follow-up|0
1521807|NCT00340678|4992185|P3|Overall Study|Lost to Follow-up|0
1521808|NCT00340678|4992186|P2|Overall Study|Lost to Follow-up|0
1521809|NCT00340678|4992187|P1|Overall Study|Lost to Follow-up|1
1521810|NCT00339833|4992214|P2|Overall Study|Error in data records|0
1521811|NCT00339833|4992215|P1|Overall Study|Error in data records|1
1521812|NCT00339833|4992214|P2|Overall Study|anaemia or excess drop in glycaemia|0
1521813|NCT00339833|4992215|P1|Overall Study|anaemia or excess drop in glycaemia|2
1521814|NCT00339833|4992214|P2|Overall Study|Poor venous access|2
1521815|NCT00339833|4992215|P1|Overall Study|Poor venous access|2
1521816|NCT00339833|4992214|P2|Overall Study|minor infection|1
1521817|NCT00339833|4992215|P1|Overall Study|minor infection|0
1521818|NCT00339833|4992214|P2|Overall Study|Chest pain|1
1521819|NCT00339833|4992215|P1|Overall Study|Chest pain|0
1521820|NCT00339833|4992214|P2|Overall Study|indigestion|1
1521821|NCT00339833|4992215|P1|Overall Study|indigestion|0
1521822|NCT00339833|4992214|P2|Overall Study|toothache|1
1521823|NCT00339833|4992215|P1|Overall Study|toothache|0
1521824|NCT00339833|4992214|P2|Overall Study|Withdrawal by Subject|2
1521825|NCT00339833|4992215|P1|Overall Study|Withdrawal by Subject|1
1521826|NCT00339183|4992225|P2|Overall Study|Ongoing|13
1521827|NCT00339183|4992226|P1|Overall Study|Ongoing|20
1521828|NCT00339183|4992225|P2|Overall Study|Other|40
1521829|NCT00339183|4992226|P1|Overall Study|Other|46
1521830|NCT00339183|4992225|P2|Overall Study|Missing reason|1
1521831|NCT00339183|4992226|P1|Overall Study|Missing reason|3
1521832|NCT00339183|4992225|P2|Overall Study|Protocol-specified criteria|8
1521833|NCT00339183|4992226|P1|Overall Study|Protocol-specified criteria|12
1521834|NCT00339183|4992225|P2|Overall Study|Lost to Follow-up|17
1521835|NCT00339183|4992226|P1|Overall Study|Lost to Follow-up|17
1521836|NCT00339183|4992225|P2|Overall Study|Physician Decision|4
1521837|NCT00339183|4992226|P1|Overall Study|Physician Decision|2
1521838|NCT00339183|4992225|P2|Overall Study|Withdrawal by Subject|19
1521839|NCT00339183|4992226|P1|Overall Study|Withdrawal by Subject|16
1521840|NCT00339183|4992225|P2|Overall Study|Adverse Event|3
1521841|NCT00339183|4992226|P1|Overall Study|Adverse Event|5
1521842|NCT00339144|4992255|P3|Overall Study|Participant's request to discontinuation|1
1521843|NCT00339144|4992256|P2|Overall Study|Participant's request to discontinuation|0
1521844|NCT00339144|4992257|P1|Overall Study|Participant's request to discontinuation|1
1521845|NCT00339144|4992255|P3|Overall Study|Study drug toxicity|1
1521846|NCT00339144|4992256|P2|Overall Study|Study drug toxicity|1
1521847|NCT00339144|4992257|P1|Overall Study|Study drug toxicity|3
1521848|NCT00339144|4992255|P3|Overall Study|Disease progression|2
1521849|NCT00339144|4992256|P2|Overall Study|Disease progression|2
1521850|NCT00339144|4992257|P1|Overall Study|Disease progression|5
1521851|NCT00339040|4992362|P2|Stage II|Site closing|0
1521852|NCT00339040|4992363|P1|Stage II|Site closing|2
1521853|NCT00339040|4992362|P2|Stage II|Not able to attend clinic|0
1521854|NCT00339040|4992363|P1|Stage II|Not able to attend clinic|1
1521855|NCT00339040|4992362|P2|Stage II|Protocol Violation|0
1521856|NCT00339040|4992363|P1|Stage II|Protocol Violation|3
1521857|NCT00339040|4992362|P2|Stage II|Withdrawal by Subject|2
1521858|NCT00339040|4992363|P1|Stage II|Withdrawal by Subject|1
1521859|NCT00339040|4992362|P2|Stage II|Lost to Follow-up|0
1521860|NCT00339040|4992363|P1|Stage II|Lost to Follow-up|3
1521861|NCT00339040|4992362|P2|Stage I|Protocol Violation|1
1521862|NCT00339040|4992363|P1|Stage I|Protocol Violation|1
1521863|NCT00339040|4992362|P2|Stage I|Not able to attend clinic|0
1521864|NCT00339040|4992363|P1|Stage I|Not able to attend clinic|1
1521865|NCT00338962|4992390|P4|Overall Study|Poor Compliance|0
1521866|NCT00338962|4992391|P3|Overall Study|Poor Compliance|2
1521867|NCT00338962|4992392|P2|Overall Study|Poor Compliance|0
1521868|NCT00338962|4992393|P1|Overall Study|Poor Compliance|0
1521869|NCT00338962|4992390|P4|Overall Study|Adverse Event|0
1521870|NCT00338962|4992391|P3|Overall Study|Adverse Event|2
1521871|NCT00338962|4992392|P2|Overall Study|Adverse Event|0
1521872|NCT00338962|4992393|P1|Overall Study|Adverse Event|0
1521873|NCT00338962|4992390|P4|Overall Study|Moved|0
1521874|NCT00338962|4992391|P3|Overall Study|Moved|0
1521875|NCT00338962|4992392|P2|Overall Study|Moved|1
1521876|NCT00338962|4992393|P1|Overall Study|Moved|0
1521877|NCT00338962|4992390|P4|Overall Study|Time Constraint|0
1521878|NCT00338962|4992391|P3|Overall Study|Time Constraint|0
1521879|NCT00338962|4992392|P2|Overall Study|Time Constraint|0
1521880|NCT00338962|4992393|P1|Overall Study|Time Constraint|2
1521881|NCT00338962|4992390|P4|Overall Study|No Transportation|0
1521882|NCT00338962|4992391|P3|Overall Study|No Transportation|0
1521883|NCT00338962|4992392|P2|Overall Study|No Transportation|0
1521884|NCT00338962|4992393|P1|Overall Study|No Transportation|2
1521885|NCT00338962|4992390|P4|Overall Study|Withdrawal by Subject|0
1521886|NCT00338962|4992391|P3|Overall Study|Withdrawal by Subject|0
1521887|NCT00338962|4992392|P2|Overall Study|Withdrawal by Subject|0
1521888|NCT00338962|4992393|P1|Overall Study|Withdrawal by Subject|1
1521889|NCT00338962|4992390|P4|Overall Study|Lost to Follow-up|3
1521890|NCT00338962|4992391|P3|Overall Study|Lost to Follow-up|2
1521891|NCT00338962|4992392|P2|Overall Study|Lost to Follow-up|3
1521892|NCT00338962|4992393|P1|Overall Study|Lost to Follow-up|3
1521893|NCT00338884|4992415|P1|Overall Study|Randomized But Did Not Receive Treatment|1
1521894|NCT00338884|4992415|P1|Overall Study|Lost to Follow-up|1
1521895|NCT00338884|4992415|P1|Overall Study|Withdrawal by Subject|3
1521896|NCT00338884|4992415|P1|Overall Study|Global Deterioration of Health Status|3
1521897|NCT00338884|4992415|P1|Overall Study|Other|4
1521898|NCT00338884|4992415|P1|Overall Study|Death|8
1521899|NCT00338884|4992415|P1|Overall Study|Adverse Event|14
1521900|NCT00338884|4992415|P1|Overall Study|Objective Disease Progression or Relapse|44
1521901|NCT00338806|4992449|P2|Follow-up|Lost to Follow-up|3
1521902|NCT00338806|4992450|P1|Follow-up|Lost to Follow-up|1
1521903|NCT00338806|4992449|P2|Acute Phase|Withdrawal by Subject|1
1521904|NCT00338806|4992450|P1|Acute Phase|Withdrawal by Subject|0
1521905|NCT00338741|4992512|P2|Overall Study|Lost to Follow-up|0
1521906|NCT00338741|4992513|P1|Overall Study|Lost to Follow-up|2
1521907|NCT00338455|4992544|P2|Overall Study|Physician Decision|0
1521908|NCT00338455|4992545|P1|Overall Study|Physician Decision|1
1521909|NCT00338455|4992544|P2|Overall Study|Death|1
1521910|NCT00338455|4992545|P1|Overall Study|Death|2
1521911|NCT00338286|4992559|P2|Overall Study|Other|93
1521912|NCT00338286|4992560|P1|Overall Study|Other|103
1521913|NCT00338286|4992559|P2|Overall Study|Lost to Follow-up|66
1521914|NCT00338286|4992560|P1|Overall Study|Lost to Follow-up|80
1521915|NCT00338286|4992559|P2|Overall Study|Withdrawal by Subject|54
1521916|NCT00338286|4992560|P1|Overall Study|Withdrawal by Subject|50
1521917|NCT00338104|4992577|P3|Overall Study|Protocol Violation|3
1521918|NCT00338104|4992578|P2|Overall Study|Protocol Violation|1
1521919|NCT00338104|4992579|P1|Overall Study|Protocol Violation|2
1521920|NCT00337935|4992602|P2|Overall Study|Lack of Efficacy|1
1521921|NCT00337935|4992603|P1|Overall Study|Lack of Efficacy|0
1521922|NCT00337935|4992602|P2|Overall Study|Other|1
1521923|NCT00337935|4992603|P1|Overall Study|Other|0
1521924|NCT00337935|4992602|P2|Overall Study|Withdrawal by Subject|7
1521925|NCT00337935|4992603|P1|Overall Study|Withdrawal by Subject|1
1521926|NCT00337935|4992602|P2|Overall Study|Protocol Violation|3
1521927|NCT00337935|4992603|P1|Overall Study|Protocol Violation|4
1521928|NCT00337935|4992602|P2|Overall Study|Lost to Follow-up|1
1521929|NCT00337935|4992603|P1|Overall Study|Lost to Follow-up|0
1521930|NCT00337935|4992602|P2|Overall Study|Physician Decision|1
1521931|NCT00337935|4992603|P1|Overall Study|Physician Decision|1
1521932|NCT00337935|4992602|P2|Overall Study|Death|8
1521933|NCT00337935|4992603|P1|Overall Study|Death|2
1521934|NCT00337935|4992602|P2|Overall Study|Adverse Event|5
1521935|NCT00337935|4992603|P1|Overall Study|Adverse Event|2
1521936|NCT00337818|4992616|P3|Overall Study|Lost to Follow-up|107
1521937|NCT00337818|4992617|P2|Overall Study|Lost to Follow-up|91
1521938|NCT00337818|4992618|P1|Overall Study|Lost to Follow-up|289
1521939|NCT00337779|4992640|P2|Overall Study|Death|1
1521940|NCT00337779|4992641|P1|Overall Study|Death|0
1521941|NCT00337779|4992640|P2|Overall Study|Pregnancy|2
1521942|NCT00337779|4992641|P1|Overall Study|Pregnancy|3
1521943|NCT00337779|4992640|P2|Overall Study|Adverse Event|51
1521944|NCT00337779|4992641|P1|Overall Study|Adverse Event|28
1521945|NCT00337779|4992640|P2|Overall Study|Lost to Follow-up|5
1521946|NCT00337779|4992641|P1|Overall Study|Lost to Follow-up|6
1521947|NCT00337779|4992640|P2|Overall Study|Protocol Violation|1
1521948|NCT00337779|4992641|P1|Overall Study|Protocol Violation|1
1521949|NCT00337779|4992640|P2|Overall Study|Physician Decision|6
1521950|NCT00337779|4992641|P1|Overall Study|Physician Decision|3
1521951|NCT00337779|4992640|P2|Overall Study|Sponsor decision|1
1521952|NCT00337779|4992641|P1|Overall Study|Sponsor decision|1
1521953|NCT00337779|4992640|P2|Overall Study|Withdrawal by Subject|12
1521954|NCT00337779|4992641|P1|Overall Study|Withdrawal by Subject|10
1521955|NCT00337727|4992653|P2|Overall Study|Withdrawal by Subject|5
1521956|NCT00337727|4992654|P1|Overall Study|Withdrawal by Subject|3
1521957|NCT00337727|4992653|P2|Overall Study|Protocol Violation|0
1521958|NCT00337727|4992654|P1|Overall Study|Protocol Violation|4
1521959|NCT00337727|4992653|P2|Overall Study|Physician Decision|0
1521960|NCT00337727|4992654|P1|Overall Study|Physician Decision|1
1521961|NCT00337727|4992653|P2|Overall Study|Lost to Follow-up|4
1521962|NCT00337727|4992654|P1|Overall Study|Lost to Follow-up|5
1521963|NCT00337727|4992653|P2|Overall Study|Adverse Event|3
1521964|NCT00337727|4992654|P1|Overall Study|Adverse Event|5
1521965|NCT00337675|4992665|P3|Overall Study|Trial Terminated|2
1521966|NCT00337675|4992666|P2|Overall Study|Trial Terminated|0
1521967|NCT00337675|4992667|P1|Overall Study|Trial Terminated|0
1521968|NCT00337675|4992665|P3|Overall Study|Progressive Disease|0
1521969|NCT00337675|4992666|P2|Overall Study|Progressive Disease|2
1521970|NCT00337675|4992667|P1|Overall Study|Progressive Disease|0
1521971|NCT00337675|4992665|P3|Overall Study|Withdrawal by Subject|19
1521972|NCT00337675|4992666|P2|Overall Study|Withdrawal by Subject|25
1521973|NCT00337675|4992667|P1|Overall Study|Withdrawal by Subject|25
1521974|NCT00337675|4992665|P3|Overall Study|Protocol Violation|19
1521975|NCT00337675|4992666|P2|Overall Study|Protocol Violation|24
1521976|NCT00337675|4992667|P1|Overall Study|Protocol Violation|21
1521977|NCT00337675|4992665|P3|Overall Study|Physician Decision|14
1521978|NCT00337675|4992666|P2|Overall Study|Physician Decision|17
1521979|NCT00337675|4992667|P1|Overall Study|Physician Decision|9
1521980|NCT00337675|4992665|P3|Overall Study|Lost to Follow-up|17
1521981|NCT00337675|4992666|P2|Overall Study|Lost to Follow-up|19
1521982|NCT00337675|4992667|P1|Overall Study|Lost to Follow-up|22
1521983|NCT00337675|4992665|P3|Overall Study|Lack of Efficacy|9
1521984|NCT00337675|4992666|P2|Overall Study|Lack of Efficacy|7
1521985|NCT00337675|4992667|P1|Overall Study|Lack of Efficacy|10
1521986|NCT00337675|4992665|P3|Overall Study|Adverse Event|19
1521987|NCT00337675|4992666|P2|Overall Study|Adverse Event|9
1521988|NCT00337675|4992667|P1|Overall Study|Adverse Event|10
1521989|NCT00337662|4992684|P4|Study Period III|Clinical Relapse|0
1521990|NCT00337662|4992685|P3|Study Period III|Clinical Relapse|0
1521991|NCT00337662|4992686|P2|Study Period III|Clinical Relapse|0
1521992|NCT00337662|4992687|P1|Study Period III|Clinical Relapse|1
1521993|NCT00337662|4992684|P4|Study Period III|Sponsor Decision|0
1521994|NCT00337662|4992685|P3|Study Period III|Sponsor Decision|1
1521995|NCT00337662|4992686|P2|Study Period III|Sponsor Decision|0
1521996|NCT00337662|4992687|P1|Study Period III|Sponsor Decision|1
1521997|NCT00337662|4992684|P4|Study Period III|Parent/Caregiver Decision|0
1521998|NCT00337662|4992685|P3|Study Period III|Parent/Caregiver Decision|2
1521999|NCT00337662|4992686|P2|Study Period III|Parent/Caregiver Decision|0
1522000|NCT00337662|4992687|P1|Study Period III|Parent/Caregiver Decision|0
1522001|NCT00337662|4992684|P4|Study Period III|Lack of Efficacy|0
1522002|NCT00337662|4992685|P3|Study Period III|Lack of Efficacy|2
1522003|NCT00337662|4992686|P2|Study Period III|Lack of Efficacy|4
1522004|NCT00337662|4992687|P1|Study Period III|Lack of Efficacy|4
1522005|NCT00337662|4992684|P4|Study Period III|Entry Criteria Not Met|0
1522006|NCT00337662|4992685|P3|Study Period III|Entry Criteria Not Met|3
1522007|NCT00337662|4992686|P2|Study Period III|Entry Criteria Not Met|1
1522008|NCT00337662|4992687|P1|Study Period III|Entry Criteria Not Met|4
1522009|NCT00337662|4992684|P4|Study Period III|Physician Decision|0
1522010|NCT00337662|4992685|P3|Study Period III|Physician Decision|0
1522011|NCT00337662|4992686|P2|Study Period III|Physician Decision|5
1522012|NCT00337662|4992687|P1|Study Period III|Physician Decision|6
1522013|NCT00337662|4992684|P4|Study Period III|Protocol Violation|0
1522014|NCT00337662|4992685|P3|Study Period III|Protocol Violation|2
1522015|NCT00337662|4992686|P2|Study Period III|Protocol Violation|8
1522016|NCT00337662|4992687|P1|Study Period III|Protocol Violation|3
1522017|NCT00337662|4992684|P4|Study Period III|Adverse Event|0
1522018|NCT00337662|4992685|P3|Study Period III|Adverse Event|8
1522019|NCT00337662|4992686|P2|Study Period III|Adverse Event|10
1522020|NCT00337662|4992687|P1|Study Period III|Adverse Event|9
1522021|NCT00337662|4992684|P4|Study Period III|Withdrawal by Subject|0
1522022|NCT00337662|4992685|P3|Study Period III|Withdrawal by Subject|12
1522023|NCT00337662|4992686|P2|Study Period III|Withdrawal by Subject|14
1522024|NCT00337662|4992687|P1|Study Period III|Withdrawal by Subject|18
1522025|NCT00337662|4992684|P4|Study Period III|Lost to Follow-up|0
1522026|NCT00337662|4992685|P3|Study Period III|Lost to Follow-up|14
1522027|NCT00337662|4992686|P2|Study Period III|Lost to Follow-up|16
1522028|NCT00337662|4992687|P1|Study Period III|Lost to Follow-up|14
1522029|NCT00337662|4992684|P4|Study Period II|Parent/Caregiver Decision|1
1522030|NCT00337662|4992685|P3|Study Period II|Parent/Caregiver Decision|0
1522031|NCT00337662|4992686|P2|Study Period II|Parent/Caregiver Decision|0
1522032|NCT00337662|4992687|P1|Study Period II|Parent/Caregiver Decision|0
1522033|NCT00337662|4992684|P4|Study Period II|Sponsor Decision|2
1522034|NCT00337662|4992685|P3|Study Period II|Sponsor Decision|0
1522035|NCT00337662|4992686|P2|Study Period II|Sponsor Decision|0
1522036|NCT00337662|4992687|P1|Study Period II|Sponsor Decision|0
1522037|NCT00337662|4992684|P4|Study Period II|Lack of Efficacy|7
1522038|NCT00337662|4992685|P3|Study Period II|Lack of Efficacy|0
1522039|NCT00337662|4992686|P2|Study Period II|Lack of Efficacy|0
1522040|NCT00337662|4992687|P1|Study Period II|Lack of Efficacy|0
1522041|NCT00337662|4992684|P4|Study Period II|Protocol Violation|6
1522042|NCT00337662|4992685|P3|Study Period II|Protocol Violation|0
1522043|NCT00337662|4992686|P2|Study Period II|Protocol Violation|0
1522044|NCT00337662|4992687|P1|Study Period II|Protocol Violation|0
1522045|NCT00337662|4992684|P4|Study Period II|Entry Criteria Not Met|6
1522046|NCT00337662|4992685|P3|Study Period II|Entry Criteria Not Met|0
1522047|NCT00337662|4992686|P2|Study Period II|Entry Criteria Not Met|0
1522048|NCT00337662|4992687|P1|Study Period II|Entry Criteria Not Met|0
1522049|NCT00337662|4992684|P4|Study Period II|Physician Decision|13
1522050|NCT00337662|4992685|P3|Study Period II|Physician Decision|0
1522051|NCT00337662|4992686|P2|Study Period II|Physician Decision|0
1522052|NCT00337662|4992687|P1|Study Period II|Physician Decision|0
1522053|NCT00337662|4992684|P4|Study Period II|Adverse Event|16
1522054|NCT00337662|4992685|P3|Study Period II|Adverse Event|0
1522055|NCT00337662|4992686|P2|Study Period II|Adverse Event|0
1522056|NCT00337662|4992687|P1|Study Period II|Adverse Event|0
1522057|NCT00337662|4992684|P4|Study Period II|Withdrawal by Subject|20
1522058|NCT00337662|4992685|P3|Study Period II|Withdrawal by Subject|0
1522059|NCT00337662|4992686|P2|Study Period II|Withdrawal by Subject|0
1522060|NCT00337662|4992687|P1|Study Period II|Withdrawal by Subject|0
1522061|NCT00337662|4992684|P4|Study Period II|Lost to Follow-up|35
1522062|NCT00337662|4992685|P3|Study Period II|Lost to Follow-up|0
1522063|NCT00337662|4992686|P2|Study Period II|Lost to Follow-up|0
1522064|NCT00337662|4992687|P1|Study Period II|Lost to Follow-up|0
1522065|NCT00337610|4992741|P2|Overall Study|Withdrawal by Subject|5
1522066|NCT00337610|4992742|P1|Overall Study|Withdrawal by Subject|6
1522067|NCT00337610|4992741|P2|Overall Study|Lost to Follow-up|3
1522068|NCT00337610|4992742|P1|Overall Study|Lost to Follow-up|3
1522069|NCT00337610|4992741|P2|Overall Study|Lack of Efficacy|3
1522070|NCT00337610|4992742|P1|Overall Study|Lack of Efficacy|6
1522071|NCT00337610|4992741|P2|Overall Study|Death|1
1522072|NCT00337610|4992742|P1|Overall Study|Death|0
1522073|NCT00337610|4992741|P2|Overall Study|Adverse Event|2
1522074|NCT00337610|4992742|P1|Overall Study|Adverse Event|2
1522075|NCT00337571|4992758|P4|Overall Study|High Potassium level|1
1522076|NCT00337571|4992759|P3|Overall Study|High Potassium level|0
1522077|NCT00337571|4992760|P2|Overall Study|High Potassium level|0
1522078|NCT00337571|4992761|P1|Overall Study|High Potassium level|0
1522079|NCT00337571|4992758|P4|Overall Study|No longer met study criteria|0
1522080|NCT00337571|4992759|P3|Overall Study|No longer met study criteria|0
1522081|NCT00337571|4992760|P2|Overall Study|No longer met study criteria|0
1522082|NCT00337571|4992761|P1|Overall Study|No longer met study criteria|1
1522083|NCT00337571|4992758|P4|Overall Study|Poor/noncompliance|1
1522084|NCT00337571|4992759|P3|Overall Study|Poor/noncompliance|1
1522085|NCT00337571|4992760|P2|Overall Study|Poor/noncompliance|1
1522086|NCT00337571|4992761|P1|Overall Study|Poor/noncompliance|1
1522087|NCT00337571|4992758|P4|Overall Study|Lost to Follow-up|1
1522088|NCT00337571|4992759|P3|Overall Study|Lost to Follow-up|0
1522089|NCT00337571|4992760|P2|Overall Study|Lost to Follow-up|1
1522090|NCT00337571|4992761|P1|Overall Study|Lost to Follow-up|3
1522091|NCT00337571|4992758|P4|Overall Study|Withdrawal by Subject|0
1522092|NCT00337571|4992759|P3|Overall Study|Withdrawal by Subject|1
1522093|NCT00337571|4992760|P2|Overall Study|Withdrawal by Subject|2
1522094|NCT00337571|4992761|P1|Overall Study|Withdrawal by Subject|2
1522095|NCT00337571|4992758|P4|Overall Study|Adverse Event|4
1522096|NCT00337571|4992759|P3|Overall Study|Adverse Event|8
1522097|NCT00337571|4992760|P2|Overall Study|Adverse Event|5
1522098|NCT00337571|4992761|P1|Overall Study|Adverse Event|4
1522099|NCT00337571|4992758|P4|Overall Study|Lack of Efficacy|0
1522100|NCT00337571|4992759|P3|Overall Study|Lack of Efficacy|0
1522101|NCT00337571|4992760|P2|Overall Study|Lack of Efficacy|0
1522102|NCT00337571|4992761|P1|Overall Study|Lack of Efficacy|3
1522103|NCT00337467|4992799|P1|Overall Study|Subject No Longer Met Study Criteria|2
1522104|NCT00337467|4992799|P1|Overall Study|Lost to Follow-up|2
1522105|NCT00337467|4992799|P1|Overall Study|Pregnancy|1
1522106|NCT00337467|4992799|P1|Overall Study|Subject Withdrew Consent|2
1522107|NCT00337467|4992799|P1|Overall Study|Adverse Event|3
1522108|NCT00337428|4992818|P2|Overall Study|Anorexia|0
1522109|NCT00337428|4992819|P1|Overall Study|Anorexia|1
1522110|NCT00337428|4992818|P2|Overall Study|Unwilling to Continue|0
1522111|NCT00337428|4992819|P1|Overall Study|Unwilling to Continue|1
1522112|NCT00337428|4992818|P2|Overall Study|Lack of Time|1
1522113|NCT00337428|4992819|P1|Overall Study|Lack of Time|1
1522114|NCT00337428|4992818|P2|Overall Study|Withdrawal by Subject|2
1522115|NCT00337428|4992819|P1|Overall Study|Withdrawal by Subject|1
1522116|NCT00337285|4992870|P1|Overall Study|Lack of protocol compliance|7
1522117|NCT00337285|4992870|P1|Overall Study|Physician Decision|1
1522118|NCT00337285|4992870|P1|Overall Study|Death|1
1522119|NCT00337285|4992870|P1|Overall Study|Lack of Efficacy|11
1522120|NCT00337285|4992870|P1|Overall Study|Protocol Violation|27
1522121|NCT00337285|4992870|P1|Overall Study|Adverse Event|28
1522122|NCT00337285|4992870|P1|Overall Study|Lost to Follow-up|41
1522123|NCT00337285|4992870|P1|Overall Study|Withdrawal by Subject|42
1522124|NCT00337272|4992878|P2|Withdrawal Period|Non-compliance|1
1522125|NCT00337272|4992879|P1|Withdrawal Period|Non-compliance|0
1522126|NCT00337272|4992878|P2|Treatment Period|Withdrawal by Subject|1
1522127|NCT00337272|4992879|P1|Treatment Period|Withdrawal by Subject|0
1522128|NCT00337272|4992878|P2|Treatment Period|Non-compliance|1
1522129|NCT00337272|4992879|P1|Treatment Period|Non-compliance|1
1522130|NCT00337272|4992878|P2|Screening Period (Pre-randomization)|Screen failure|0
1522131|NCT00337272|4992879|P1|Screening Period (Pre-randomization)|Screen failure|3
1522132|NCT00337272|4992878|P2|Screening Period (Pre-randomization)|Non-compliance|0
1522133|NCT00337272|4992879|P1|Screening Period (Pre-randomization)|Non-compliance|1
1522134|NCT00337272|4992878|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
1522135|NCT00337272|4992879|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
1522136|NCT00337207|4992899|P1|Overall Study|Withdrawal by Subject|3
1522137|NCT00337194|4992905|P2|Overall Study|Subsequent non-protocol therapy|1
1522138|NCT00337194|4992906|P1|Overall Study|Subsequent non-protocol therapy|3
1522139|NCT00337194|4992905|P2|Overall Study|Disease progression|2
1522140|NCT00337194|4992906|P1|Overall Study|Disease progression|1
1522141|NCT00337194|4992905|P2|Overall Study|Withdrawal by Subject|0
1522142|NCT00337194|4992906|P1|Overall Study|Withdrawal by Subject|1
1522143|NCT00337194|4992905|P2|Overall Study|Death|0
1522144|NCT00337194|4992906|P1|Overall Study|Death|2
1522145|NCT00337194|4992905|P2|Overall Study|Adverse Event|1
1522146|NCT00337194|4992906|P1|Overall Study|Adverse Event|5
1522147|NCT00337168|4992930|P1|Overall Study|Did not start therapy|1
1522148|NCT00337168|4992930|P1|Overall Study|Not protocol specified|2
1522149|NCT00337168|4992930|P1|Overall Study|Death|5
1522150|NCT00337129|4992937|P1|Overall Study|not protocol specified|1
1522151|NCT00337129|4992937|P1|Overall Study|Death|2
1522152|NCT00337129|4992937|P1|Overall Study|Lack of Efficacy|32
1522153|NCT00337129|4992937|P1|Overall Study|Withdrawal by Subject|1
1522154|NCT00337129|4992937|P1|Overall Study|Adverse Event|4
1522155|NCT00337103|4992946|P2|Overall Study|Death|0
1522156|NCT00337103|4992947|P1|Overall Study|Death|1
1522157|NCT00337103|4992946|P2|Overall Study|Lost to Follow-up|2
1522158|NCT00337103|4992947|P1|Overall Study|Lost to Follow-up|1
1522159|NCT00337103|4992946|P2|Overall Study|Entry Criteria Not Met|1
1522160|NCT00337103|4992947|P1|Overall Study|Entry Criteria Not Met|4
1522161|NCT00337103|4992946|P2|Overall Study|Not specified|6
1522162|NCT00337103|4992947|P1|Overall Study|Not specified|5
1522163|NCT00337103|4992946|P2|Overall Study|Withdrawal by Subject|5
1522164|NCT00337103|4992947|P1|Overall Study|Withdrawal by Subject|8
1522165|NCT00337103|4992946|P2|Overall Study|Physician Decision|14
1522166|NCT00337103|4992947|P1|Overall Study|Physician Decision|15
1522167|NCT00337103|4992946|P2|Overall Study|Clinical Progression|24
1522168|NCT00337103|4992947|P1|Overall Study|Clinical Progression|27
1522169|NCT00337103|4992946|P2|Overall Study|Subject Choice|27
1522170|NCT00337103|4992947|P1|Overall Study|Subject Choice|34
1522171|NCT00337103|4992946|P2|Overall Study|Adverse Event|59
1522172|NCT00337103|4992947|P1|Overall Study|Adverse Event|45
1522173|NCT00337103|4992946|P2|Overall Study|Progressive Disease|405
1522174|NCT00337103|4992947|P1|Overall Study|Progressive Disease|409
1522175|NCT00337077|4992958|P3|Overall Study|Ineligible|1
1522176|NCT00337077|4992959|P2|Overall Study|Ineligible|1
1522177|NCT00337077|4992960|P1|Overall Study|Ineligible|1
1522178|NCT00337077|4992958|P3|Overall Study|Never started treatment|0
1522179|NCT00337077|4992959|P2|Overall Study|Never started treatment|1
1522180|NCT00337077|4992960|P1|Overall Study|Never started treatment|1
1522181|NCT00337077|4992958|P3|Overall Study|Physician Decision|2
1522182|NCT00337077|4992959|P2|Overall Study|Physician Decision|4
1522183|NCT00337077|4992960|P1|Overall Study|Physician Decision|1
1522184|NCT00337077|4992958|P3|Overall Study|Alternative therapy|0
1522185|NCT00337077|4992959|P2|Overall Study|Alternative therapy|0
1522186|NCT00337077|4992960|P1|Overall Study|Alternative therapy|1
1522187|NCT00337077|4992958|P3|Overall Study|Withdrawal by Subject|2
1522188|NCT00337077|4992959|P2|Overall Study|Withdrawal by Subject|2
1522189|NCT00337077|4992960|P1|Overall Study|Withdrawal by Subject|7
1522190|NCT00337077|4992958|P3|Overall Study|Death|0
1522191|NCT00337077|4992959|P2|Overall Study|Death|1
1522192|NCT00337077|4992960|P1|Overall Study|Death|0
1522193|NCT00337077|4992958|P3|Overall Study|Adverse Event|1
1522194|NCT00337077|4992959|P2|Overall Study|Adverse Event|7
1522195|NCT00337077|4992960|P1|Overall Study|Adverse Event|7
1522196|NCT00337077|4992958|P3|Overall Study|Progressive disease|19
1522197|NCT00337077|4992959|P2|Overall Study|Progressive disease|37
1522198|NCT00337077|4992960|P1|Overall Study|Progressive disease|25
1522199|NCT00336895|4992975|P1|Overall Study|screen failed|1
1522200|NCT00336895|4992975|P1|Overall Study|Physician Decision|1
1522201|NCT00336895|4992975|P1|Overall Study|nausea and upset stomach|1
1522202|NCT00336895|4992975|P1|Overall Study|diarrhea|1
1522203|NCT00336856|4992981|P1|Overall Study|Found ineligible at time of analysis|1
1522204|NCT00336856|4992981|P1|Overall Study|Withdrawal by Subject|3
1522205|NCT00336583|4993029|P1|Overall Study|Death|1
1522206|NCT00336583|4993029|P1|Overall Study|Lost to Follow-up|1
1522207|NCT00336544|4993036|P2|Overall Study|Other|5
1522208|NCT00336544|4993037|P1|Overall Study|Other|3
1522209|NCT00336544|4993036|P2|Overall Study|Withdrawal by Subject|3
1522210|NCT00336544|4993037|P1|Overall Study|Withdrawal by Subject|4
1522211|NCT00336544|4993036|P2|Overall Study|Adverse Event|9
1522212|NCT00336544|4993037|P1|Overall Study|Adverse Event|4
1522213|NCT00336544|4993036|P2|Overall Study|Lack of Efficacy|5
1522214|NCT00336544|4993037|P1|Overall Study|Lack of Efficacy|8
1522215|NCT00336505|4993051|P2|Overall Study|Other|7
1522216|NCT00336505|4993052|P1|Overall Study|Other|7
1522217|NCT00336505|4993051|P2|Overall Study|Withdrawal by Subject|3
1522218|NCT00336505|4993052|P1|Overall Study|Withdrawal by Subject|5
1522219|NCT00336505|4993051|P2|Overall Study|Lost to Follow-up|4
1522220|NCT00336505|4993052|P1|Overall Study|Lost to Follow-up|7
1522221|NCT00336505|4993051|P2|Overall Study|Lack of Efficacy|4
1522222|NCT00336505|4993052|P1|Overall Study|Lack of Efficacy|8
1522223|NCT00336505|4993051|P2|Overall Study|Adverse Event|9
1522224|NCT00336505|4993052|P1|Overall Study|Adverse Event|10
1522225|NCT00336492|4993067|P3|Overall Study|Other|1
1522226|NCT00336492|4993068|P2|Overall Study|Other|0
1522227|NCT00336492|4993069|P1|Overall Study|Other|5
1522228|NCT00336492|4993067|P3|Overall Study|Lack of Efficacy|4
1522229|NCT00336492|4993068|P2|Overall Study|Lack of Efficacy|1
1522230|NCT00336492|4993069|P1|Overall Study|Lack of Efficacy|6
1522231|NCT00336492|4993067|P3|Overall Study|Adverse Event|6
1522232|NCT00336492|4993068|P2|Overall Study|Adverse Event|3
1522233|NCT00336492|4993069|P1|Overall Study|Adverse Event|4
1522234|NCT00336479|4993081|P4|Overall Study|Virologic Stopping Rule|0
1522235|NCT00336479|4993082|P3|Overall Study|Virologic Stopping Rule|0
1522236|NCT00336479|4993083|P2|Overall Study|Virologic Stopping Rule|0
1522237|NCT00336479|4993084|P1|Overall Study|Virologic Stopping Rule|20
1522238|NCT00336479|4993081|P4|Overall Study|Other|0
1522239|NCT00336479|4993082|P3|Overall Study|Other|1
1522240|NCT00336479|4993083|P2|Overall Study|Other|0
1522241|NCT00336479|4993084|P1|Overall Study|Other|0
1522242|NCT00336479|4993081|P4|Overall Study|Withdrawal by Subject|0
1522243|NCT00336479|4993082|P3|Overall Study|Withdrawal by Subject|3
1522244|NCT00336479|4993083|P2|Overall Study|Withdrawal by Subject|2
1522245|NCT00336479|4993084|P1|Overall Study|Withdrawal by Subject|3
1522246|NCT00336479|4993081|P4|Overall Study|Lost to Follow-up|0
1522247|NCT00336479|4993082|P3|Overall Study|Lost to Follow-up|0
1522248|NCT00336479|4993083|P2|Overall Study|Lost to Follow-up|2
1522249|NCT00336479|4993084|P1|Overall Study|Lost to Follow-up|3
1522250|NCT00336479|4993081|P4|Overall Study|Physician Decision|0
1522251|NCT00336479|4993082|P3|Overall Study|Physician Decision|1
1522252|NCT00336479|4993083|P2|Overall Study|Physician Decision|3
1522253|NCT00336479|4993084|P1|Overall Study|Physician Decision|2
1522254|NCT00336479|4993081|P4|Overall Study|Noncompliant|0
1522255|NCT00336479|4993082|P3|Overall Study|Noncompliant|3
1522256|NCT00336479|4993083|P2|Overall Study|Noncompliant|7
1522257|NCT00336479|4993084|P1|Overall Study|Noncompliant|1
1522258|NCT00336479|4993081|P4|Overall Study|Adverse Event|4
1522259|NCT00336479|4993082|P3|Overall Study|Adverse Event|18
1522260|NCT00336479|4993083|P2|Overall Study|Adverse Event|11
1522261|NCT00336479|4993084|P1|Overall Study|Adverse Event|8
1522262|NCT00336284|4993173|P2|Overall Study|Withdrawal by Physician or Subject|64
1522263|NCT00336284|4993174|P1|Overall Study|Withdrawal by Physician or Subject|102
1522264|NCT00336284|4993173|P2|Overall Study|Lost to Follow-up|61
1522265|NCT00336284|4993174|P1|Overall Study|Lost to Follow-up|82
1522266|NCT00336284|4993173|P2|Overall Study|Death|26
1522267|NCT00336284|4993174|P1|Overall Study|Death|52
1522268|NCT00335972|4993192|P2|Overall Study|not given treatments|3
1522269|NCT00335972|4993193|P1|Overall Study|not given treatments|0
1522270|NCT00335959|4993203|P1|Overall Study|Ineligible|1
1522271|NCT00335959|4993203|P1|Overall Study|Adverse Event|2
1522272|NCT00335829|4993208|P1|Overall Study|Adverse Event|1
1522273|NCT00335829|4993208|P1|Overall Study|Lost to Follow-up|1
1522274|NCT00335829|4993208|P1|Overall Study|Withdrawal by Subject|1
1522275|NCT00335777|4993222|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
1522276|NCT00335777|4993222|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
1522277|NCT00335777|4993222|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
1522278|NCT00335777|4993222|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
1522279|NCT00335777|4993222|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
1522280|NCT00335764|4993232|P5|Overall Study|wrong histology|1
1522281|NCT00335764|4993233|P4|Overall Study|wrong histology|0
1522282|NCT00335764|4993234|P3|Overall Study|wrong histology|0
1522283|NCT00335764|4993235|P2|Overall Study|wrong histology|0
1522284|NCT00335764|4993236|P1|Overall Study|wrong histology|1
1522285|NCT00335738|4993285|P2|Overall Study|Ineligible|4
1522286|NCT00335738|4993286|P1|Overall Study|Ineligible|3
1522287|NCT00335738|4993285|P2|Overall Study|Withdrawal by Subject|0
1522288|NCT00335738|4993286|P1|Overall Study|Withdrawal by Subject|2
1522289|NCT00335738|4993285|P2|Overall Study|Physician Decision|0
1522290|NCT00335738|4993286|P1|Overall Study|Physician Decision|6
1522291|NCT00335556|4993318|P6|Overall Study|Refusal of further protocol therapy|0
1522292|NCT00335556|4993319|P5|Overall Study|Refusal of further protocol therapy|0
1522293|NCT00335556|4993320|P4|Overall Study|Refusal of further protocol therapy|1
1522294|NCT00335556|4993321|P3|Overall Study|Refusal of further protocol therapy|0
1522295|NCT00335556|4993322|P2|Overall Study|Refusal of further protocol therapy|4
1522296|NCT00335556|4993323|P1|Overall Study|Refusal of further protocol therapy|0
1522297|NCT00335556|4993318|P6|Overall Study|Ineligible|0
1522298|NCT00335556|4993319|P5|Overall Study|Ineligible|0
1522299|NCT00335556|4993320|P4|Overall Study|Ineligible|0
1522300|NCT00335556|4993321|P3|Overall Study|Ineligible|0
1522301|NCT00335556|4993322|P2|Overall Study|Ineligible|0
1522302|NCT00335556|4993323|P1|Overall Study|Ineligible|2
1522303|NCT00335556|4993318|P6|Overall Study|Physician Decision|0
1522304|NCT00335556|4993319|P5|Overall Study|Physician Decision|0
1522305|NCT00335556|4993320|P4|Overall Study|Physician Decision|1
1522306|NCT00335556|4993321|P3|Overall Study|Physician Decision|2
1522307|NCT00335556|4993322|P2|Overall Study|Physician Decision|6
1522308|NCT00335556|4993323|P1|Overall Study|Physician Decision|0
1522309|NCT00335556|4993318|P6|Overall Study|Lack of Efficacy|1
1522310|NCT00335556|4993319|P5|Overall Study|Lack of Efficacy|0
1522311|NCT00335556|4993320|P4|Overall Study|Lack of Efficacy|3
1522312|NCT00335556|4993321|P3|Overall Study|Lack of Efficacy|3
1522313|NCT00335556|4993322|P2|Overall Study|Lack of Efficacy|19
1522314|NCT00335556|4993323|P1|Overall Study|Lack of Efficacy|0
1522315|NCT00335556|4993318|P6|Overall Study|Death|0
1522316|NCT00335556|4993319|P5|Overall Study|Death|1
1522317|NCT00335556|4993320|P4|Overall Study|Death|0
1522318|NCT00335556|4993321|P3|Overall Study|Death|0
1522319|NCT00335556|4993322|P2|Overall Study|Death|5
1522320|NCT00335556|4993323|P1|Overall Study|Death|0
1522321|NCT00335452|4993385|P4|Overall Study|Lost to Follow-up|2
1522322|NCT00335452|4993386|P3|Overall Study|Lost to Follow-up|1
1522323|NCT00335452|4993387|P2|Overall Study|Lost to Follow-up|3
1522324|NCT00335452|4993388|P1|Overall Study|Lost to Follow-up|2
1522325|NCT00335452|4993385|P4|Overall Study|Death|129
1522326|NCT00335452|4993386|P3|Overall Study|Death|158
1522327|NCT00335452|4993387|P2|Overall Study|Death|144
1522328|NCT00335452|4993388|P1|Overall Study|Death|156
1522329|NCT00335322|4993413|P3|Overall Study|Randomised but withdrew prior to ART sta|2
1522330|NCT00335322|4993414|P2|Overall Study|Randomised but withdrew prior to ART sta|2
1522331|NCT00335322|4993415|P1|Overall Study|Randomised but withdrew prior to ART sta|1
1522332|NCT00335153|4993460|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
1522333|NCT00335153|4993460|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
1522334|NCT00335153|4993460|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
1522335|NCT00335153|4993460|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
1522336|NCT00335153|4993460|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
1522337|NCT00335153|4993460|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
1522338|NCT00335153|4993460|P1|Nasojejunal (NJ) Test Period|Administrative|1
1522428|NCT00333866|4993679|P2|Overall Study|Other|2
1522339|NCT00335153|4993460|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
1522340|NCT00335153|4993460|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
1522341|NCT00335153|4993460|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
1522342|NCT00335140|4993497|P1|Overall Study|Ineligible|1
1522343|NCT00334958|4993503|P2|Overall Study|Not specified|2
1522344|NCT00334958|4993504|P1|Overall Study|Not specified|1
1522345|NCT00334958|4993503|P2|Overall Study|Adverse Event|12
1522346|NCT00334958|4993504|P1|Overall Study|Adverse Event|27
1522347|NCT00334958|4993503|P2|Overall Study|Withdrawal by Subject|4
1522348|NCT00334958|4993504|P1|Overall Study|Withdrawal by Subject|7
1522349|NCT00334958|4993503|P2|Overall Study|Request of the investigator or sponsor|1
1522350|NCT00334958|4993504|P1|Overall Study|Request of the investigator or sponsor|0
1522351|NCT00334958|4993503|P2|Overall Study|Protocol Violation|2
1522352|NCT00334958|4993504|P1|Overall Study|Protocol Violation|2
1522353|NCT00334958|4993503|P2|Overall Study|Medication Noncompliance|3
1522354|NCT00334958|4993504|P1|Overall Study|Medication Noncompliance|0
1522355|NCT00334893|4993518|P2|Overall Study|Not Treated|0
1522356|NCT00334893|4993519|P1|Overall Study|Not Treated|1
1522357|NCT00334815|4993529|P2|Overall Study|Physician Decision|4
1522358|NCT00334815|4993530|P1|Overall Study|Physician Decision|2
1522359|NCT00334815|4993529|P2|Overall Study|patient refused treatment|1
1522360|NCT00334815|4993530|P1|Overall Study|patient refused treatment|0
1522361|NCT00334815|4993529|P2|Overall Study|ineligible|1
1522362|NCT00334815|4993530|P1|Overall Study|ineligible|1
1522363|NCT00334815|4993529|P2|Overall Study|Progression|0
1522364|NCT00334815|4993530|P1|Overall Study|Progression|1
1522365|NCT00334815|4993529|P2|Overall Study|Death|2
1522366|NCT00334815|4993530|P1|Overall Study|Death|0
1522367|NCT00334815|4993529|P2|Overall Study|Adverse Event|2
1522368|NCT00334815|4993530|P1|Overall Study|Adverse Event|3
1522369|NCT00334802|4993544|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
1522370|NCT00334802|4993545|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
1522371|NCT00334802|4993544|P2|Overall Study|Adverse Event|3
1522372|NCT00334802|4993545|P1|Overall Study|Adverse Event|0
1522373|NCT00334802|4993544|P2|Overall Study|Withdrawal by Subject|4
1522374|NCT00334802|4993545|P1|Overall Study|Withdrawal by Subject|0
1522375|NCT00334802|4993544|P2|Overall Study|Physician Decision|0
1522376|NCT00334802|4993545|P1|Overall Study|Physician Decision|1
1522377|NCT00334802|4993544|P2|Overall Study|Patient Condition Aggrevated|0
1522378|NCT00334802|4993545|P1|Overall Study|Patient Condition Aggrevated|1
1522379|NCT00334802|4993544|P2|Overall Study|Lack of Efficacy|3
1522380|NCT00334802|4993545|P1|Overall Study|Lack of Efficacy|1
1522381|NCT00334802|4993544|P2|Overall Study|Toxicity|5
1522382|NCT00334802|4993545|P1|Overall Study|Toxicity|1
1522383|NCT00334802|4993544|P2|Overall Study|Progressive Disease|24
1522384|NCT00334802|4993545|P1|Overall Study|Progressive Disease|2
1522385|NCT00334542|4993578|P1|Overall Study|New cancer diagnosis|1
1522386|NCT00334542|4993578|P1|Overall Study|Withdrawal by Subject|1
1522387|NCT00334542|4993578|P1|Overall Study|Adverse Event|3
1522388|NCT00334295|4993583|P1|Overall Study|Patients received fewer than 3 injection|5
1522389|NCT00334282|4993593|P2|Overall Study|Death|100
1522390|NCT00334282|4993594|P1|Overall Study|Death|194
1522391|NCT00334282|4993593|P2|Overall Study|Withdrawal by Subject|3
1522392|NCT00334282|4993594|P1|Overall Study|Withdrawal by Subject|17
1522393|NCT00334282|4993593|P2|Overall Study|Lost to Follow-up|5
1522394|NCT00334282|4993594|P1|Overall Study|Lost to Follow-up|11
1522395|NCT00334113|4993625|P2|Overall Study|Withdrawal by Subject|1
1522396|NCT00334113|4993626|P1|Overall Study|Withdrawal by Subject|0
1522397|NCT00334113|4993625|P2|Overall Study|Lost to Follow-up|2
1522398|NCT00334113|4993626|P1|Overall Study|Lost to Follow-up|2
1522399|NCT00333983|4993649|P3|Overall Study|Withdrawal by Subject|1
1522400|NCT00333983|4993650|P2|Overall Study|Withdrawal by Subject|3
1522401|NCT00333983|4993651|P1|Overall Study|Withdrawal by Subject|0
1522402|NCT00333983|4993649|P3|Overall Study|Adverse Event|1
1522403|NCT00333983|4993650|P2|Overall Study|Adverse Event|1
1522404|NCT00333983|4993651|P1|Overall Study|Adverse Event|1
1522405|NCT00333983|4993649|P3|Overall Study|Lost to Follow-up|0
1522406|NCT00333983|4993650|P2|Overall Study|Lost to Follow-up|1
1522407|NCT00333983|4993651|P1|Overall Study|Lost to Follow-up|2
1522408|NCT00333970|4993661|P2|Overall Study|Withdrawal by Subject|7
1522409|NCT00333970|4993662|P1|Overall Study|Withdrawal by Subject|13
1522410|NCT00333866|4993677|P4|Overall Study|Randomized but not Treated|1
1522411|NCT00333866|4993678|P3|Overall Study|Randomized but not Treated|2
1522412|NCT00333866|4993679|P2|Overall Study|Randomized but not Treated|3
1522413|NCT00333866|4993680|P1|Overall Study|Randomized but not Treated|5
1522414|NCT00333866|4993677|P4|Overall Study|Withdrawal by Subject|9
1522415|NCT00333866|4993678|P3|Overall Study|Withdrawal by Subject|4
1522416|NCT00333866|4993679|P2|Overall Study|Withdrawal by Subject|14
1522417|NCT00333866|4993680|P1|Overall Study|Withdrawal by Subject|8
1522418|NCT00333866|4993677|P4|Overall Study|Lost to Follow-up|2
1522419|NCT00333866|4993678|P3|Overall Study|Lost to Follow-up|2
1522420|NCT00333866|4993679|P2|Overall Study|Lost to Follow-up|2
1522421|NCT00333866|4993680|P1|Overall Study|Lost to Follow-up|1
1522422|NCT00333866|4993677|P4|Overall Study|Lack of Efficacy|5
1522423|NCT00333866|4993678|P3|Overall Study|Lack of Efficacy|3
1522424|NCT00333866|4993679|P2|Overall Study|Lack of Efficacy|6
1522425|NCT00333866|4993680|P1|Overall Study|Lack of Efficacy|8
1522426|NCT00333866|4993677|P4|Overall Study|Other|2
1522427|NCT00333866|4993678|P3|Overall Study|Other|2
1522429|NCT00333866|4993680|P1|Overall Study|Other|3
1522430|NCT00333866|4993677|P4|Overall Study|Adverse Event|47
1522431|NCT00333866|4993678|P3|Overall Study|Adverse Event|38
1522432|NCT00333866|4993679|P2|Overall Study|Adverse Event|37
1522433|NCT00333866|4993680|P1|Overall Study|Adverse Event|23
1522434|NCT00333840|4993740|P4|Second-line Treatment Period|Death|9
1522435|NCT00333840|4993741|P3|Second-line Treatment Period|Death|0
1522436|NCT00333840|4993742|P2|Second-line Treatment Period|Death|0
1522437|NCT00333840|4993743|P1|Second-line Treatment Period|Death|0
1522438|NCT00333840|4993740|P4|Second-line Treatment Period|Administrative problems|7
1522439|NCT00333840|4993741|P3|Second-line Treatment Period|Administrative problems|0
1522440|NCT00333840|4993742|P2|Second-line Treatment Period|Administrative problems|0
1522441|NCT00333840|4993743|P1|Second-line Treatment Period|Administrative problems|0
1522442|NCT00333840|4993740|P4|Second-line Treatment Period|Lost to Follow-up|6
1522443|NCT00333840|4993741|P3|Second-line Treatment Period|Lost to Follow-up|0
1522444|NCT00333840|4993742|P2|Second-line Treatment Period|Lost to Follow-up|0
1522445|NCT00333840|4993743|P1|Second-line Treatment Period|Lost to Follow-up|0
1522446|NCT00333840|4993740|P4|Second-line Treatment Period|Subject withdrew consent|34
1522447|NCT00333840|4993741|P3|Second-line Treatment Period|Subject withdrew consent|0
1522448|NCT00333840|4993742|P2|Second-line Treatment Period|Subject withdrew consent|0
1522449|NCT00333840|4993743|P1|Second-line Treatment Period|Subject withdrew consent|0
1522450|NCT00333840|4993740|P4|Second-line Treatment Period|Protocol Violation|10
1522451|NCT00333840|4993741|P3|Second-line Treatment Period|Protocol Violation|1
1522452|NCT00333840|4993742|P2|Second-line Treatment Period|Protocol Violation|0
1522453|NCT00333840|4993743|P1|Second-line Treatment Period|Protocol Violation|0
1522454|NCT00333840|4993740|P4|Second-line Treatment Period|No longer required study drug|14
1522455|NCT00333840|4993741|P3|Second-line Treatment Period|No longer required study drug|1
1522456|NCT00333840|4993742|P2|Second-line Treatment Period|No longer required study drug|0
1522457|NCT00333840|4993743|P1|Second-line Treatment Period|No longer required study drug|0
1522458|NCT00333840|4993740|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
1522459|NCT00333840|4993741|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
1522460|NCT00333840|4993742|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
1522461|NCT00333840|4993743|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
1522462|NCT00333840|4993740|P4|Second-line Treatment Period|Abnormal procedure|1
1522463|NCT00333840|4993741|P3|Second-line Treatment Period|Abnormal procedure|0
1522464|NCT00333840|4993742|P2|Second-line Treatment Period|Abnormal procedure|0
1522465|NCT00333840|4993743|P1|Second-line Treatment Period|Abnormal procedure|0
1522466|NCT00333840|4993740|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
1522467|NCT00333840|4993741|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
1522468|NCT00333840|4993742|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
1522469|NCT00333840|4993743|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
1522470|NCT00333840|4993740|P4|Second-line Treatment Period|Adverse Event|34
1522471|NCT00333840|4993741|P3|Second-line Treatment Period|Adverse Event|3
1522472|NCT00333840|4993742|P2|Second-line Treatment Period|Adverse Event|0
1522473|NCT00333840|4993743|P1|Second-line Treatment Period|Adverse Event|0
1522474|NCT00333840|4993740|P4|First-line Treatment Period|Crossed over to other treatment arm|0
1522475|NCT00333840|4993741|P3|First-line Treatment Period|Crossed over to other treatment arm|0
1522476|NCT00333840|4993742|P2|First-line Treatment Period|Crossed over to other treatment arm|363
1522477|NCT00333840|4993743|P1|First-line Treatment Period|Crossed over to other treatment arm|14
1522478|NCT00333840|4993740|P4|First-line Treatment Period|Death|0
1522479|NCT00333840|4993741|P3|First-line Treatment Period|Death|0
1522480|NCT00333840|4993742|P2|First-line Treatment Period|Death|2
1522481|NCT00333840|4993743|P1|First-line Treatment Period|Death|19
1522482|NCT00333840|4993740|P4|First-line Treatment Period|Administrative problems|0
1522483|NCT00333840|4993741|P3|First-line Treatment Period|Administrative problems|0
1522484|NCT00333840|4993742|P2|First-line Treatment Period|Administrative problems|6
1522485|NCT00333840|4993743|P1|First-line Treatment Period|Administrative problems|12
1522486|NCT00333840|4993740|P4|First-line Treatment Period|Lost to Follow-up|0
1522487|NCT00333840|4993741|P3|First-line Treatment Period|Lost to Follow-up|0
1522488|NCT00333840|4993742|P2|First-line Treatment Period|Lost to Follow-up|6
1522489|NCT00333840|4993743|P1|First-line Treatment Period|Lost to Follow-up|15
1522490|NCT00333840|4993740|P4|First-line Treatment Period|Subject withdrew consent|0
1522491|NCT00333840|4993741|P3|First-line Treatment Period|Subject withdrew consent|0
1522492|NCT00333840|4993742|P2|First-line Treatment Period|Subject withdrew consent|77
1522493|NCT00333840|4993743|P1|First-line Treatment Period|Subject withdrew consent|57
1522494|NCT00333840|4993740|P4|First-line Treatment Period|Protocol Violation|0
1522495|NCT00333840|4993741|P3|First-line Treatment Period|Protocol Violation|0
1522496|NCT00333840|4993742|P2|First-line Treatment Period|Protocol Violation|17
1522497|NCT00333840|4993743|P1|First-line Treatment Period|Protocol Violation|17
1522498|NCT00333840|4993740|P4|First-line Treatment Period|No longer required study drug|0
1522499|NCT00333840|4993741|P3|First-line Treatment Period|No longer required study drug|0
1522500|NCT00333840|4993742|P2|First-line Treatment Period|No longer required study drug|8
1522501|NCT00333840|4993743|P1|First-line Treatment Period|No longer required study drug|21
1522502|NCT00333840|4993740|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
1522503|NCT00333840|4993741|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
1522504|NCT00333840|4993742|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
1522505|NCT00333840|4993743|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
1522506|NCT00333840|4993740|P4|First-line Treatment Period|Abnormal procedure|0
1522507|NCT00333840|4993741|P3|First-line Treatment Period|Abnormal procedure|0
1522508|NCT00333840|4993742|P2|First-line Treatment Period|Abnormal procedure|0
1522509|NCT00333840|4993743|P1|First-line Treatment Period|Abnormal procedure|2
1522510|NCT00333840|4993740|P4|First-line Treatment Period|Abnormal laboratory values|0
1522511|NCT00333840|4993741|P3|First-line Treatment Period|Abnormal laboratory values|0
1522512|NCT00333840|4993742|P2|First-line Treatment Period|Abnormal laboratory values|1
1522513|NCT00333840|4993743|P1|First-line Treatment Period|Abnormal laboratory values|3
1522514|NCT00333840|4993740|P4|First-line Treatment Period|Adverse Event|0
1522515|NCT00333840|4993741|P3|First-line Treatment Period|Adverse Event|0
1522516|NCT00333840|4993742|P2|First-line Treatment Period|Adverse Event|37
1522517|NCT00333840|4993743|P1|First-line Treatment Period|Adverse Event|38
1522518|NCT00333801|4993789|P2|Overall Study|Withdrawal by Subject|1
1522519|NCT00333801|4993790|P1|Overall Study|Withdrawal by Subject|0
1522520|NCT00333801|4993789|P2|Overall Study|Incarcerated|2
1522521|NCT00333801|4993790|P1|Overall Study|Incarcerated|1
1522522|NCT00333801|4993789|P2|Overall Study|Lost to Follow-up|0
1522523|NCT00333801|4993790|P1|Overall Study|Lost to Follow-up|2
1522524|NCT00333801|4993789|P2|Overall Study|Moved to another state|3
1522525|NCT00333801|4993790|P1|Overall Study|Moved to another state|5
1522526|NCT00333788|4993808|P1|Overall Study|Other: Signed consent for another study|1
1522527|NCT00333788|4993808|P1|Overall Study|Other: Physician decision|1
1522528|NCT00333788|4993808|P1|Overall Study|Other: Medical monitor decision|1
1522529|NCT00333788|4993808|P1|Overall Study|Other: Subject in need of an Entocort|1
1522530|NCT00333788|4993808|P1|Overall Study|Other: Sponsor decision|1
1522531|NCT00333788|4993808|P1|Overall Study|Other: Quality of life concern|1
1522532|NCT00333788|4993808|P1|Overall Study|Other: Investigator decision|1
1522533|NCT00333788|4993808|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
1522534|NCT00333788|4993808|P1|Overall Study|Other: Moved|2
1522535|NCT00333788|4993808|P1|Overall Study|Other: Non-compliance|2
1522536|NCT00333788|4993808|P1|Overall Study|Withdrawal by Subject|24
1522537|NCT00333788|4993808|P1|Overall Study|Lost to Follow-up|2
1522538|NCT00333788|4993808|P1|Overall Study|Lack of Efficacy|80
1522539|NCT00333788|4993808|P1|Overall Study|Adverse Event|44
1522540|NCT00333775|4993838|P3|Overall Study|Lost to Follow-up|8
1522541|NCT00333775|4993839|P2|Overall Study|Lost to Follow-up|7
1522542|NCT00333775|4993840|P1|Overall Study|Lost to Follow-up|10
1522543|NCT00333775|4993838|P3|Overall Study|In Follow−up When Study Stopped|96
1522544|NCT00333775|4993839|P2|Overall Study|In Follow−up When Study Stopped|92
1522545|NCT00333775|4993840|P1|Overall Study|In Follow−up When Study Stopped|87
1522546|NCT00333775|4993838|P3|Overall Study|Death|143
1522547|NCT00333775|4993839|P2|Overall Study|Death|149
1522548|NCT00333775|4993840|P1|Overall Study|Death|144
1522549|NCT00333619|4993879|P2|Overall Study|Lost to Follow-up|3
1522550|NCT00333619|4993880|P1|Overall Study|Lost to Follow-up|3
1522551|NCT00333619|4993879|P2|Overall Study|Withdrawal by Subject|1
1522552|NCT00333619|4993880|P1|Overall Study|Withdrawal by Subject|6
1522553|NCT00333619|4993879|P2|Overall Study|Death|6
1522554|NCT00333619|4993880|P1|Overall Study|Death|12
1522555|NCT00333359|4993898|P2|Overall Study|Withdrew before Receiving One Dose|6
1522556|NCT00333359|4993899|P1|Overall Study|Withdrew before Receiving One Dose|2
1522557|NCT00333359|4993898|P2|Overall Study|Treatment Failure|8
1522558|NCT00333359|4993899|P1|Overall Study|Treatment Failure|3
1522559|NCT00333359|4993898|P2|Overall Study|Termination or Withdrawal by Sponsor|1
1522560|NCT00333359|4993899|P1|Overall Study|Termination or Withdrawal by Sponsor|1
1522561|NCT00333359|4993898|P2|Overall Study|Lost to Follow-up|25
1522562|NCT00333359|4993899|P1|Overall Study|Lost to Follow-up|15
1522563|NCT00333359|4993898|P2|Overall Study|Protocol Non-compliance|8
1522564|NCT00333359|4993899|P1|Overall Study|Protocol Non-compliance|2
1522565|NCT00333359|4993898|P2|Overall Study|Physician Decision|2
1522566|NCT00333359|4993899|P1|Overall Study|Physician Decision|2
1522567|NCT00333359|4993898|P2|Overall Study|Withdrawal by Subject|37
1522568|NCT00333359|4993899|P1|Overall Study|Withdrawal by Subject|19
1522569|NCT00333359|4993898|P2|Overall Study|Adverse Event|35
1522570|NCT00333359|4993899|P1|Overall Study|Adverse Event|29
1522571|NCT00333229|4993942|P2|Overall Study|Lack of Efficacy|1
1522572|NCT00333229|4993943|P1|Overall Study|Lack of Efficacy|0
1522573|NCT00333138|4993960|P3|Extension Study (Month6 to End of Study)|Death|0
1522574|NCT00333138|4993961|P2|Extension Study (Month6 to End of Study)|Death|1
1522575|NCT00333138|4993962|P1|Extension Study (Month6 to End of Study)|Death|0
1522576|NCT00333138|4993960|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
1522577|NCT00333138|4993961|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
1522578|NCT00333138|4993962|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
1522579|NCT00333138|4993960|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
1522580|NCT00333138|4993961|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
1522581|NCT00333138|4993962|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
1522582|NCT00333138|4993960|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
1522583|NCT00333138|4993961|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
1522584|NCT00333138|4993962|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
1522585|NCT00333138|4993960|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
1522586|NCT00333138|4993961|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
1522587|NCT00333138|4993962|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
1522588|NCT00333138|4993960|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
1522589|NCT00333138|4993961|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
1522590|NCT00333138|4993962|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
1522591|NCT00333138|4993960|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
1522592|NCT00333138|4993961|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
1522593|NCT00333138|4993962|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
1522594|NCT00333138|4993960|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
1522595|NCT00333138|4993961|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
1522596|NCT00333138|4993962|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
1522597|NCT00333138|4993960|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
1522598|NCT00333138|4993961|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
1522599|NCT00333138|4993962|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
1522600|NCT00333138|4993960|P3|Core Study (6 Months)|Laboratory abnormality|1
1522601|NCT00333138|4993961|P2|Core Study (6 Months)|Laboratory abnormality|0
1522602|NCT00333138|4993962|P1|Core Study (6 Months)|Laboratory abnormality|0
1522603|NCT00333138|4993960|P3|Core Study (6 Months)|Protocol Violation|1
1522604|NCT00333138|4993961|P2|Core Study (6 Months)|Protocol Violation|0
1522605|NCT00333138|4993962|P1|Core Study (6 Months)|Protocol Violation|1
1522606|NCT00333138|4993960|P3|Core Study (6 Months)|Lack of Efficacy|0
1522607|NCT00333138|4993961|P2|Core Study (6 Months)|Lack of Efficacy|0
1522608|NCT00333138|4993962|P1|Core Study (6 Months)|Lack of Efficacy|1
1522609|NCT00333138|4993960|P3|Core Study (6 Months)|Withdrawal by Subject|2
1522610|NCT00333138|4993961|P2|Core Study (6 Months)|Withdrawal by Subject|1
1522611|NCT00333138|4993962|P1|Core Study (6 Months)|Withdrawal by Subject|1
1522612|NCT00333138|4993960|P3|Core Study (6 Months)|Adverse Event|8
1522613|NCT00333138|4993961|P2|Core Study (6 Months)|Adverse Event|5
1522614|NCT00333138|4993962|P1|Core Study (6 Months)|Adverse Event|4
1522615|NCT00332839|4994001|P2|Follow-up (Months 12 - 60)|Death|1
1522616|NCT00332839|4994002|P1|Follow-up (Months 12 - 60)|Death|1
1522617|NCT00332839|4994001|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
1522618|NCT00332839|4994002|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
1522619|NCT00332839|4994001|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
1522620|NCT00332839|4994002|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
1522621|NCT00332839|4994001|P2|Core (Months 0 - 12)|Adverse Event|15
1522622|NCT00332839|4994002|P1|Core (Months 0 - 12)|Adverse Event|5
1522623|NCT00332839|4994001|P2|Core (Months 0 - 12)|Protocol deviation|1
1522624|NCT00332839|4994002|P1|Core (Months 0 - 12)|Protocol deviation|1
1522625|NCT00332839|4994001|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
1522626|NCT00332839|4994002|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
1522627|NCT00332839|4994001|P2|Core (Months 0 - 12)|Administrative problems|1
1522628|NCT00332839|4994002|P1|Core (Months 0 - 12)|Administrative problems|1
1522629|NCT00332709|4994033|P2|Overall Study|Abnormal test procedure result|0
1522630|NCT00332709|4994034|P1|Overall Study|Abnormal test procedure result|1
1522631|NCT00332709|4994033|P2|Overall Study|Administrative Problems|3
1522632|NCT00332709|4994034|P1|Overall Study|Administrative Problems|0
1522633|NCT00332709|4994033|P2|Overall Study|Lost to Follow-up|0
1522634|NCT00332709|4994034|P1|Overall Study|Lost to Follow-up|2
1522635|NCT00332709|4994033|P2|Overall Study|Withdrawal by Subject|3
1522636|NCT00332709|4994034|P1|Overall Study|Withdrawal by Subject|2
1522637|NCT00332709|4994033|P2|Overall Study|Adverse Event|14
1522638|NCT00332709|4994034|P1|Overall Study|Adverse Event|11
1522639|NCT00332696|4994058|P2|Overall Study|Withdrawal by Subject|0
1522640|NCT00332696|4994059|P1|Overall Study|Withdrawal by Subject|1
1522641|NCT00332696|4994058|P2|Overall Study|Lost to Follow-up|1
1522642|NCT00332696|4994059|P1|Overall Study|Lost to Follow-up|0
1522643|NCT00332696|4994058|P2|Overall Study|Condition does not justify treatment|2
1522644|NCT00332696|4994059|P1|Overall Study|Condition does not justify treatment|0
1522645|NCT00332696|4994058|P2|Overall Study|Adverse Event|2
1522646|NCT00332696|4994059|P1|Overall Study|Adverse Event|1
1522647|NCT00332696|4994058|P2|Overall Study|Insufficient therapeutic effect|11
1522648|NCT00332696|4994059|P1|Overall Study|Insufficient therapeutic effect|4
1522649|NCT00332696|4994058|P2|Overall Study|Death|14
1522650|NCT00332696|4994059|P1|Overall Study|Death|24
1522651|NCT00332488|4994135|P3|Transfer Treatment Phase (Weeks 12 – 24)|Various|5
1522652|NCT00332488|4994136|P2|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
1522653|NCT00332488|4994137|P1|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
1522654|NCT00332488|4994135|P3|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|8
1522655|NCT00332488|4994136|P2|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
1522656|NCT00332488|4994137|P1|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
1522657|NCT00332488|4994135|P3|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|1
1522658|NCT00332488|4994136|P2|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
1522659|NCT00332488|4994137|P1|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
1522660|NCT00332488|4994135|P3|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|3
1522661|NCT00332488|4994136|P2|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
1522662|NCT00332488|4994137|P1|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
1522663|NCT00332488|4994135|P3|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|1
1522664|NCT00332488|4994136|P2|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
1522665|NCT00332488|4994137|P1|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
1522666|NCT00332488|4994135|P3|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|3
1522667|NCT00332488|4994136|P2|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
1522668|NCT00332488|4994137|P1|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
1522669|NCT00332488|4994135|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
1522670|NCT00332488|4994136|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
1522671|NCT00332488|4994137|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
1522672|NCT00332488|4994135|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
1522673|NCT00332488|4994136|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
1522674|NCT00332488|4994137|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
1522675|NCT00332488|4994135|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
1522676|NCT00332488|4994136|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
1522677|NCT00332488|4994137|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
1522678|NCT00332488|4994135|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
1522679|NCT00332488|4994136|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
1522680|NCT00332488|4994137|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
1522681|NCT00332488|4994135|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
1522682|NCT00332488|4994136|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
1522683|NCT00332488|4994137|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
1522684|NCT00332488|4994135|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
1522685|NCT00332488|4994136|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
1522686|NCT00332488|4994137|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
1522687|NCT00332462|4994149|P1|Overall Study|Graft Loss|2
1522688|NCT00332462|4994149|P1|Overall Study|Death|3
1522689|NCT00332462|4994149|P1|Overall Study|no longer requires study drug|1
1522690|NCT00332462|4994149|P1|Overall Study|Unsatisfactory therapeutic effect|4
1522691|NCT00332462|4994149|P1|Overall Study|Abnormal Lab Value|1
1522692|NCT00332462|4994149|P1|Overall Study|Adverse Event|5
1522693|NCT00332332|4994156|P1|Overall Study|Did not receive study treatment|16
1522694|NCT00332332|4994156|P1|Overall Study|Not specified|18
1522695|NCT00332332|4994156|P1|Overall Study|Disease progression|2
1522696|NCT00332332|4994156|P1|Overall Study|Noncompliance|2
1522697|NCT00332332|4994156|P1|Overall Study|Protocol deviation|4
1522698|NCT00332332|4994156|P1|Overall Study|Lost to Follow-up|3
1522699|NCT00332332|4994156|P1|Overall Study|Physician Decision|1
1522700|NCT00332332|4994156|P1|Overall Study|Withdrawal by Subject|8
1522701|NCT00332332|4994156|P1|Overall Study|Death|1
1522702|NCT00332332|4994156|P1|Overall Study|Adverse Event|13
1522703|NCT00332241|4994165|P2|Overall Study|Lost to Follow-up|1
1522704|NCT00332241|4994166|P1|Overall Study|Lost to Follow-up|4
1522705|NCT00332241|4994165|P2|Overall Study|Withdrawal by Subject|1
1522706|NCT00332241|4994166|P1|Overall Study|Withdrawal by Subject|2
1522707|NCT00332241|4994165|P2|Overall Study|Adverse Event|5
1522708|NCT00332241|4994166|P1|Overall Study|Adverse Event|3
1522709|NCT00332241|4994165|P2|Overall Study|Lack of Efficacy|1
1522710|NCT00332241|4994166|P1|Overall Study|Lack of Efficacy|6
1522711|NCT00332189|4994186|P1|Overall Study|Moved out of country|2
1522712|NCT00332189|4994186|P1|Overall Study|Lack of Efficacy|4
1522713|NCT00332189|4994186|P1|Overall Study|Withdrawal by Subject|9
1522714|NCT00332189|4994186|P1|Overall Study|Uncooperative/Noncompliant|3
1522715|NCT00332189|4994186|P1|Overall Study|Adverse Event|3
1522716|NCT00331864|4994228|P2|Overall Study|Death|0
1522717|NCT00331864|4994229|P1|Overall Study|Death|6
1522718|NCT00331864|4994228|P2|Overall Study|Administrative Problems|0
1522719|NCT00331864|4994229|P1|Overall Study|Administrative Problems|1
1522720|NCT00331864|4994228|P2|Overall Study|Lost to Follow-up|3
1522721|NCT00331864|4994229|P1|Overall Study|Lost to Follow-up|4
1522722|NCT00331864|4994228|P2|Overall Study|Withdrawal by Subject|0
1522723|NCT00331864|4994229|P1|Overall Study|Withdrawal by Subject|10
1522724|NCT00331864|4994228|P2|Overall Study|Protocol Violation|0
1522725|NCT00331864|4994229|P1|Overall Study|Protocol Violation|3
1522726|NCT00331864|4994228|P2|Overall Study|Lack of Efficacy|0
1522727|NCT00331864|4994229|P1|Overall Study|Lack of Efficacy|4
1522728|NCT00331864|4994228|P2|Overall Study|Adverse Event|1
1522729|NCT00331864|4994229|P1|Overall Study|Adverse Event|30
1522730|NCT00331799|4994248|P1|Overall Study|Sedation|1
1522731|NCT00331799|4994248|P1|Overall Study|Withdrawal by Subject|2
1522732|NCT00331773|4994254|P2|Overall Study|Protocol Violation|3
1522733|NCT00331773|4994255|P1|Overall Study|Protocol Violation|10
1522734|NCT00331773|4994254|P2|Overall Study|Withdrawal by Subject|4
1522735|NCT00331773|4994255|P1|Overall Study|Withdrawal by Subject|6
1522736|NCT00331760|4994283|P2|Overall Study|Ineligible / no protocol treatment|8
1522737|NCT00331760|4994284|P1|Overall Study|Ineligible / no protocol treatment|15
1522738|NCT00331682|4994290|P1|Overall Study|Adverse Event|1
1522739|NCT00331552|4994298|P2|Period 3: Phase II|Severe Nausea|0
1522740|NCT00331552|4994299|P1|Period 3: Phase II|Severe Nausea|1
1522741|NCT00331552|4994298|P2|Period 3: Phase II|Neurological Symptoms|0
1522742|NCT00331552|4994299|P1|Period 3: Phase II|Neurological Symptoms|1
1522743|NCT00331422|4994313|P1|Overall Study|Did not receive entire study regimen|5
1522744|NCT00331409|4994322|P1|Overall Study|Lack of Efficacy|4
1522745|NCT00331344|4994330|P9|Phase II|Death|4
1522746|NCT00331344|4994331|P8|Phase II|Death|0
1522747|NCT00331344|4994332|P7|Phase II|Death|0
1522748|NCT00331344|4994333|P6|Phase II|Death|0
1522749|NCT00331344|4994334|P5|Phase II|Death|0
1522750|NCT00331344|4994335|P4|Phase II|Death|0
1522751|NCT00331344|4994336|P3|Phase II|Death|0
1522752|NCT00331344|4994337|P2|Phase II|Death|0
1522753|NCT00331344|4994338|P1|Phase II|Death|0
1522754|NCT00331344|4994330|P9|Phase I|Adverse Event|0
1522755|NCT00331344|4994331|P8|Phase I|Adverse Event|1
1522756|NCT00331344|4994332|P7|Phase I|Adverse Event|0
1522757|NCT00331344|4994333|P6|Phase I|Adverse Event|2
1522758|NCT00331344|4994334|P5|Phase I|Adverse Event|2
1522759|NCT00331344|4994335|P4|Phase I|Adverse Event|1
1522760|NCT00331344|4994336|P3|Phase I|Adverse Event|0
1522761|NCT00331344|4994337|P2|Phase I|Adverse Event|0
1522762|NCT00331344|4994338|P1|Phase I|Adverse Event|0
1522763|NCT00331006|4994375|P1|Follow-Up Phase II|Lost to Follow-up|3
1522764|NCT00331006|4994375|P1|Follow-Up Phase I|Lost to Follow-up|1
1522765|NCT00331006|4994375|P1|Treatment Phase|Withdrawal by Subject|1
1522766|NCT00331006|4994375|P1|Screening Phase|Ineligible for treatment phase|4
1522767|NCT00331006|4994375|P1|Screening Phase|Lost to Follow-up|1
1522768|NCT00331006|4994375|P1|Screening Phase|enrollment halted|1
1522769|NCT00331006|4994375|P1|Screening Phase|Withdrawal by Subject|1
1522770|NCT00330967|4994388|P2|Overall Study|Physician Decision|9
1522771|NCT00330967|4994389|P1|Overall Study|Physician Decision|0
1522772|NCT00330967|4994388|P2|Overall Study|Withdrawal by Subject|5
1522773|NCT00330967|4994389|P1|Overall Study|Withdrawal by Subject|0
1522774|NCT00330928|4994400|P1|Overall Study|IVUS could not be performed.|1
1522775|NCT00330928|4994400|P1|Overall Study|Death|1
1522776|NCT00330928|4994400|P1|Overall Study|Physician Decision|9
1522777|NCT00330928|4994400|P1|Overall Study|Lost to Follow-up|6
1522778|NCT00330759|4994442|P2|Overall Study|Other|44
1522779|NCT00330759|4994443|P1|Overall Study|Other|36
1522780|NCT00330759|4994442|P2|Overall Study|Ineligibility determined|1
1522781|NCT00330759|4994443|P1|Overall Study|Ineligibility determined|2
1522782|NCT00330759|4994442|P2|Overall Study|Protocol deviation|2
1522783|NCT00330759|4994443|P1|Overall Study|Protocol deviation|0
1522784|NCT00330759|4994442|P2|Overall Study|Physician Decision|2
1522785|NCT00330759|4994443|P1|Overall Study|Physician Decision|1
1522786|NCT00330759|4994442|P2|Overall Study|Noncompliance|17
1522787|NCT00330759|4994443|P1|Overall Study|Noncompliance|15
1522788|NCT00330759|4994442|P2|Overall Study|Lost to Follow-up|22
1522789|NCT00330759|4994443|P1|Overall Study|Lost to Follow-up|16
1522790|NCT00330759|4994442|P2|Overall Study|Participant request|22
1522791|NCT00330759|4994443|P1|Overall Study|Participant request|31
1522792|NCT00330759|4994442|P2|Overall Study|Adverse Event|36
1522793|NCT00330759|4994443|P1|Overall Study|Adverse Event|48
1522794|NCT00330759|4994442|P2|Overall Study|Withdrawal by Subject|124
1522795|NCT00330759|4994443|P1|Overall Study|Withdrawal by Subject|143
1522796|NCT00330759|4994442|P2|Overall Study|Disease progression|126
1522797|NCT00330759|4994443|P1|Overall Study|Disease progression|104
1522798|NCT00330759|4994442|P2|Overall Study|Death|310
1522799|NCT00330759|4994443|P1|Overall Study|Death|316
1522800|NCT00330681|4994464|P2|Overall Study|Tracheotomy due to worsening of ALS|2
1522801|NCT00330681|4994465|P1|Overall Study|Tracheotomy due to worsening of ALS|1
1522802|NCT00330681|4994464|P2|Overall Study|Withdrawal by Subject|5
1522803|NCT00330681|4994465|P1|Overall Study|Withdrawal by Subject|5
1522804|NCT00330681|4994464|P2|Overall Study|Protocol Violation|1
1522805|NCT00330681|4994465|P1|Overall Study|Protocol Violation|0
1522806|NCT00330681|4994464|P2|Overall Study|Adverse Event|6
1522807|NCT00330681|4994465|P1|Overall Study|Adverse Event|3
1522808|NCT00330668|4994487|P1|Overall Study|Patient started Lupron|1
1522809|NCT00330668|4994487|P1|Overall Study|Use of exclusionary medication|1
1522810|NCT00330668|4994487|P1|Overall Study|Lack of Efficacy|1
1522811|NCT00330668|4994487|P1|Overall Study|Sponsor's decision|76
1522812|NCT00330668|4994487|P1|Overall Study|Withdrawal by Subject|20
1522813|NCT00330668|4994487|P1|Overall Study|Non-Compliance|5
1522814|NCT00330668|4994487|P1|Overall Study|Lost to Follow-up|9
1522815|NCT00330668|4994487|P1|Overall Study|Adverse Event|1
1522816|NCT00330616|4994494|P1|Overall Study|Not specified|1
1522817|NCT00330616|4994494|P1|Overall Study|Withdrawal by Subject|4
1522818|NCT00330616|4994494|P1|Overall Study|Lost to Follow-up|2
1522819|NCT00330616|4994494|P1|Overall Study|Lack of Efficacy|1
1522820|NCT00330616|4994494|P1|Overall Study|Adverse Event|13
1522821|NCT00330460|4994520|P2|Overall Study|Other|0
1522822|NCT00330460|4994521|P1|Overall Study|Other|1
1522823|NCT00330460|4994520|P2|Overall Study|Noncompliance|1
1522824|NCT00330460|4994521|P1|Overall Study|Noncompliance|2
1522825|NCT00330460|4994520|P2|Overall Study|Lost to Follow-up|3
1522826|NCT00330460|4994521|P1|Overall Study|Lost to Follow-up|8
1522827|NCT00330460|4994520|P2|Overall Study|Ineligibility determined|3
1522828|NCT00330460|4994521|P1|Overall Study|Ineligibility determined|1
1522829|NCT00330460|4994520|P2|Overall Study|Death|1
1522830|NCT00330460|4994521|P1|Overall Study|Death|1
1522831|NCT00330460|4994520|P2|Overall Study|Withdrawal by Subject|17
1522832|NCT00330460|4994521|P1|Overall Study|Withdrawal by Subject|18
1522833|NCT00330460|4994520|P2|Overall Study|Adverse Event|8
1522834|NCT00330460|4994521|P1|Overall Study|Adverse Event|10
1522835|NCT00330460|4994520|P2|Overall Study|Physician Decision|0
1522836|NCT00330460|4994521|P1|Overall Study|Physician Decision|1
1522837|NCT00330343|4994564|P1|Overall Study|Lost to Follow-up|5
1522838|NCT00330174|4994570|P2|Overall Study|Miscellaneous reasons|1
1522839|NCT00330174|4994571|P1|Overall Study|Miscellaneous reasons|7
1522840|NCT00330174|4994570|P2|Overall Study|Excessive missed visits|8
1522841|NCT00330174|4994571|P1|Overall Study|Excessive missed visits|3
1522842|NCT00330174|4994570|P2|Overall Study|Clinical deterioration|2
1522843|NCT00330174|4994571|P1|Overall Study|Clinical deterioration|1
1522844|NCT00330174|4994570|P2|Overall Study|Lost to Follow-up|1
1522845|NCT00330174|4994571|P1|Overall Study|Lost to Follow-up|4
1522846|NCT00330174|4994570|P2|Overall Study|Withdrawal by Subject|7
1522847|NCT00330174|4994571|P1|Overall Study|Withdrawal by Subject|7
1522848|NCT00329901|4994595|P3|Overall Study|Unable to classify|0
1522849|NCT00329901|4994596|P2|Overall Study|Unable to classify|2
1522850|NCT00329901|4994597|P1|Overall Study|Unable to classify|2
1522851|NCT00329901|4994595|P3|Overall Study|Protocol Violation|1
1522852|NCT00329901|4994596|P2|Overall Study|Protocol Violation|0
1522853|NCT00329901|4994597|P1|Overall Study|Protocol Violation|1
1522854|NCT00329901|4994595|P3|Overall Study|Lost to Follow-up|1
1522855|NCT00329901|4994596|P2|Overall Study|Lost to Follow-up|0
1522856|NCT00329901|4994597|P1|Overall Study|Lost to Follow-up|2
1522857|NCT00329901|4994595|P3|Overall Study|Withdrawal by Subject|2
1522858|NCT00329901|4994596|P2|Overall Study|Withdrawal by Subject|3
1522859|NCT00329901|4994597|P1|Overall Study|Withdrawal by Subject|4
1522860|NCT00329849|4994627|P2|Overall Study|Withdrawal by Subject|4
1522861|NCT00329849|4994628|P1|Overall Study|Withdrawal by Subject|6
1522862|NCT00329797|4994654|P2|Overall Study|Withdrawal by Subject|6
1522863|NCT00329797|4994655|P1|Overall Study|Withdrawal by Subject|6
1522864|NCT00329797|4994654|P2|Overall Study|Protocol Violation|0
1522865|NCT00329797|4994655|P1|Overall Study|Protocol Violation|1
1522866|NCT00329784|4994671|P4|Overall Study|Other|0
1522867|NCT00329784|4994672|P3|Overall Study|Other|0
1522868|NCT00329784|4994673|P2|Overall Study|Other|2
1522869|NCT00329784|4994674|P1|Overall Study|Other|1
1522870|NCT00329784|4994671|P4|Overall Study|Withdrawal by Subject|0
1522871|NCT00329784|4994672|P3|Overall Study|Withdrawal by Subject|0
1522872|NCT00329784|4994673|P2|Overall Study|Withdrawal by Subject|2
1522873|NCT00329784|4994674|P1|Overall Study|Withdrawal by Subject|4
1522874|NCT00329784|4994671|P4|Overall Study|Lost to Follow-up|0
1522875|NCT00329784|4994672|P3|Overall Study|Lost to Follow-up|0
1522876|NCT00329784|4994673|P2|Overall Study|Lost to Follow-up|1
1522877|NCT00329784|4994674|P1|Overall Study|Lost to Follow-up|0
1522878|NCT00329745|4994702|P2|Overall Study|Lost to Follow-up|101
1522879|NCT00329745|4994703|P1|Overall Study|Lost to Follow-up|86
1522880|NCT00329745|4994702|P2|Overall Study|Withdrawal by Subject|1
1522881|NCT00329745|4994703|P1|Overall Study|Withdrawal by Subject|0
1522882|NCT00329745|4994702|P2|Overall Study|Protocol Violation|0
1522883|NCT00329745|4994703|P1|Overall Study|Protocol Violation|1
1522884|NCT00329719|4994723|P4|Overall Study|Lost to Follow-up|1
1522885|NCT00329719|4994724|P3|Overall Study|Lost to Follow-up|0
1522886|NCT00329719|4994725|P2|Overall Study|Lost to Follow-up|0
1522887|NCT00329719|4994726|P1|Overall Study|Lost to Follow-up|0
1522888|NCT00329641|4994748|P1|Overall Study|Other reason, not protocol specified|1
1522889|NCT00329641|4994748|P1|Overall Study|Adverse Event|3
1522890|NCT00329641|4994748|P1|Overall Study|Not eligible|1
1522891|NCT00329641|4994748|P1|Overall Study|Did not start treatment|1
1522892|NCT00329602|4994757|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
1522893|NCT00329602|4994758|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
1522894|NCT00329602|4994759|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
1522895|NCT00329602|4994757|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
1522896|NCT00329602|4994758|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
1522897|NCT00329602|4994759|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
1522898|NCT00329602|4994757|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
1522899|NCT00329602|4994758|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
1522900|NCT00329602|4994759|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
1522901|NCT00329602|4994757|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
1522902|NCT00329602|4994758|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
1522903|NCT00329602|4994759|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
1522904|NCT00329602|4994757|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
1522905|NCT00329602|4994758|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
1522906|NCT00329602|4994759|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
1522907|NCT00329602|4994757|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
1522908|NCT00329602|4994758|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
1522909|NCT00329602|4994759|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
1522910|NCT00329550|4994797|P3|Overall Study|Due to Relocation|1
1522911|NCT00329550|4994798|P2|Overall Study|Due to Relocation|0
1522912|NCT00329550|4994799|P1|Overall Study|Due to Relocation|0
1522913|NCT00329550|4994797|P3|Overall Study|Withdrawal of Consent|1
1522914|NCT00329550|4994798|P2|Overall Study|Withdrawal of Consent|0
1522915|NCT00329550|4994799|P1|Overall Study|Withdrawal of Consent|1
1522916|NCT00329550|4994797|P3|Overall Study|Adverse Event|2
1522917|NCT00329550|4994798|P2|Overall Study|Adverse Event|4
1522918|NCT00329550|4994799|P1|Overall Study|Adverse Event|3
1522919|NCT00329420|4995064|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
1522920|NCT00329420|4995065|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
1522921|NCT00329420|4995066|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
1522922|NCT00329420|4995064|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
1522923|NCT00329420|4995065|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
1522924|NCT00329420|4995066|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
1522925|NCT00329420|4995064|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
1522926|NCT00329420|4995065|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
1522927|NCT00329420|4995066|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
1522928|NCT00329420|4995064|P3|Re-induction Phase|Did not respond to re-induction|7
1522929|NCT00329420|4995065|P2|Re-induction Phase|Did not respond to re-induction|5
1522930|NCT00329420|4995066|P1|Re-induction Phase|Did not respond to re-induction|6
1522931|NCT00329420|4995064|P3|Re-induction Phase|Withdrawal of Consent|1
1522932|NCT00329420|4995065|P2|Re-induction Phase|Withdrawal of Consent|0
1522933|NCT00329420|4995066|P1|Re-induction Phase|Withdrawal of Consent|0
1522934|NCT00329420|4995064|P3|Re-induction Phase|Lack of Efficacy|0
1522935|NCT00329420|4995065|P2|Re-induction Phase|Lack of Efficacy|1
1522936|NCT00329420|4995066|P1|Re-induction Phase|Lack of Efficacy|0
1522937|NCT00329407|4995445|P1|Overall Study|Withdrawal by Subject|1
1522938|NCT00329238|4995452|P2|Overall Study|Other reason (not specified)|54
1522939|NCT00329238|4995453|P1|Overall Study|Other reason (not specified)|40
1522940|NCT00329238|4995452|P2|Overall Study|Withdrawal by Subject|58
1522941|NCT00329238|4995453|P1|Overall Study|Withdrawal by Subject|64
1522942|NCT00329238|4995452|P2|Overall Study|Lost to Follow-up|6
1522943|NCT00329238|4995453|P1|Overall Study|Lost to Follow-up|2
1522944|NCT00329238|4995452|P2|Overall Study|Protocol Violation|34
1522945|NCT00329238|4995453|P1|Overall Study|Protocol Violation|23
1522946|NCT00329238|4995452|P2|Overall Study|Adverse Event|129
1522947|NCT00329238|4995453|P1|Overall Study|Adverse Event|147
1522948|NCT00329160|4995489|P1|Overall Study|Incomplete IVUS|45
1522949|NCT00329160|4995489|P1|Overall Study|Did not Receive Study Drug|1
1522950|NCT00329160|4995489|P1|Overall Study|Protocol Violation|2
1522951|NCT00329160|4995489|P1|Overall Study|Withdrawal by Subject|13
1522952|NCT00329160|4995489|P1|Overall Study|Adverse Event|27
1522953|NCT00329108|4995498|P2|Overall Study|Protocol Violation|2
1522954|NCT00329108|4995499|P1|Overall Study|Protocol Violation|0
1522955|NCT00329108|4995498|P2|Overall Study|withdrew patient after SAE resolved|0
1522956|NCT00329108|4995499|P1|Overall Study|withdrew patient after SAE resolved|1
1522957|NCT00329108|4995498|P2|Overall Study|study terminated by sponsor|0
1522958|NCT00329108|4995499|P1|Overall Study|study terminated by sponsor|1
1522959|NCT00329108|4995498|P2|Overall Study|Subject no longer willing to participate|2
1522960|NCT00329108|4995499|P1|Overall Study|Subject no longer willing to participate|2
1522961|NCT00329108|4995498|P2|Overall Study|symptomatic deterioration|1
1522962|NCT00329108|4995499|P1|Overall Study|symptomatic deterioration|1
1522963|NCT00329108|4995498|P2|Overall Study|Withdrawal by Subject|2
1522964|NCT00329108|4995499|P1|Overall Study|Withdrawal by Subject|0
1522965|NCT00329108|4995498|P2|Overall Study|Lack of Efficacy|3
1522966|NCT00329108|4995499|P1|Overall Study|Lack of Efficacy|3
1522967|NCT00329108|4995498|P2|Overall Study|Adverse Event|2
1522968|NCT00329108|4995499|P1|Overall Study|Adverse Event|2
1522969|NCT00329030|4995507|P2|Overall Study|Ineligible Pathology|1
1522970|NCT00329030|4995508|P1|Overall Study|Ineligible Pathology|1
1522971|NCT00329030|4995507|P2|Overall Study|Progressive Disease|2
1522972|NCT00329030|4995508|P1|Overall Study|Progressive Disease|6
1522973|NCT00329030|4995507|P2|Overall Study|Withdrawal by Subject|3
1522974|NCT00329030|4995508|P1|Overall Study|Withdrawal by Subject|1
1522975|NCT00328926|4995539|P3|Overall Study|Lack of ovarian response|0
1522976|NCT00328926|4995540|P2|Overall Study|Lack of ovarian response|1
1522977|NCT00328926|4995541|P1|Overall Study|Lack of ovarian response|0
1522978|NCT00328926|4995539|P3|Overall Study|In vitro fertilization treatment|1
1522979|NCT00328926|4995540|P2|Overall Study|In vitro fertilization treatment|0
1522980|NCT00328926|4995541|P1|Overall Study|In vitro fertilization treatment|0
1522981|NCT00328926|4995539|P3|Overall Study|Death|1
1522982|NCT00328926|4995540|P2|Overall Study|Death|0
1522983|NCT00328926|4995541|P1|Overall Study|Death|0
1522984|NCT00328926|4995539|P3|Overall Study|Lost to Follow-up|0
1522985|NCT00328926|4995540|P2|Overall Study|Lost to Follow-up|1
1522986|NCT00328926|4995541|P1|Overall Study|Lost to Follow-up|0
1522987|NCT00328926|4995539|P3|Overall Study|Pregnancy|0
1522988|NCT00328926|4995540|P2|Overall Study|Pregnancy|1
1522989|NCT00328926|4995541|P1|Overall Study|Pregnancy|2
1522990|NCT00328783|4995566|P1|Overall Study|Withdrawal by Subject|1
1522991|NCT00328783|4995566|P1|Overall Study|No heart in RT field|4
1522992|NCT00328783|4995566|P1|Overall Study|Could not tolerate ABC|21
1522993|NCT00328627|4995592|P12|Overall Study|Other|0
1522994|NCT00328627|4995593|P11|Overall Study|Other|1
1522995|NCT00328627|4995594|P10|Overall Study|Other|1
1522996|NCT00328627|4995595|P9|Overall Study|Other|0
1522997|NCT00328627|4995596|P8|Overall Study|Other|0
1522998|NCT00328627|4995597|P7|Overall Study|Other|1
1522999|NCT00328627|4995598|P6|Overall Study|Other|0
1523000|NCT00328627|4995599|P5|Overall Study|Other|0
1523001|NCT00328627|4995600|P4|Overall Study|Other|1
1523002|NCT00328627|4995601|P3|Overall Study|Other|0
1523003|NCT00328627|4995602|P2|Overall Study|Other|0
1523004|NCT00328627|4995603|P1|Overall Study|Other|0
1523005|NCT00328627|4995592|P12|Overall Study|Physician Decision|0
1523006|NCT00328627|4995593|P11|Overall Study|Physician Decision|1
1523007|NCT00328627|4995594|P10|Overall Study|Physician Decision|2
1523008|NCT00328627|4995595|P9|Overall Study|Physician Decision|3
1523009|NCT00328627|4995596|P8|Overall Study|Physician Decision|0
1523010|NCT00328627|4995597|P7|Overall Study|Physician Decision|1
1523011|NCT00328627|4995598|P6|Overall Study|Physician Decision|1
1523012|NCT00328627|4995599|P5|Overall Study|Physician Decision|1
1523013|NCT00328627|4995600|P4|Overall Study|Physician Decision|2
1523014|NCT00328627|4995601|P3|Overall Study|Physician Decision|1
1523015|NCT00328627|4995602|P2|Overall Study|Physician Decision|3
1523016|NCT00328627|4995603|P1|Overall Study|Physician Decision|4
1523017|NCT00328627|4995592|P12|Overall Study|Pregnancy|0
1523018|NCT00328627|4995593|P11|Overall Study|Pregnancy|0
1523019|NCT00328627|4995594|P10|Overall Study|Pregnancy|0
1523020|NCT00328627|4995595|P9|Overall Study|Pregnancy|0
1523021|NCT00328627|4995596|P8|Overall Study|Pregnancy|0
1523022|NCT00328627|4995597|P7|Overall Study|Pregnancy|0
1523023|NCT00328627|4995598|P6|Overall Study|Pregnancy|0
1523024|NCT00328627|4995599|P5|Overall Study|Pregnancy|0
1523025|NCT00328627|4995600|P4|Overall Study|Pregnancy|0
1523026|NCT00328627|4995601|P3|Overall Study|Pregnancy|0
1523027|NCT00328627|4995602|P2|Overall Study|Pregnancy|1
1523028|NCT00328627|4995603|P1|Overall Study|Pregnancy|0
1523029|NCT00328627|4995592|P12|Overall Study|Withdrawal by Subject|7
1523030|NCT00328627|4995593|P11|Overall Study|Withdrawal by Subject|2
1523031|NCT00328627|4995594|P10|Overall Study|Withdrawal by Subject|5
1523032|NCT00328627|4995595|P9|Overall Study|Withdrawal by Subject|4
1523033|NCT00328627|4995596|P8|Overall Study|Withdrawal by Subject|4
1523034|NCT00328627|4995597|P7|Overall Study|Withdrawal by Subject|4
1523035|NCT00328627|4995598|P6|Overall Study|Withdrawal by Subject|5
1523036|NCT00328627|4995599|P5|Overall Study|Withdrawal by Subject|2
1523037|NCT00328627|4995600|P4|Overall Study|Withdrawal by Subject|6
1523038|NCT00328627|4995601|P3|Overall Study|Withdrawal by Subject|5
1523039|NCT00328627|4995602|P2|Overall Study|Withdrawal by Subject|4
1523040|NCT00328627|4995603|P1|Overall Study|Withdrawal by Subject|5
1523041|NCT00328627|4995592|P12|Overall Study|Lost to Follow-up|1
1523042|NCT00328627|4995593|P11|Overall Study|Lost to Follow-up|0
1523043|NCT00328627|4995594|P10|Overall Study|Lost to Follow-up|2
1523044|NCT00328627|4995595|P9|Overall Study|Lost to Follow-up|3
1523045|NCT00328627|4995596|P8|Overall Study|Lost to Follow-up|0
1523046|NCT00328627|4995597|P7|Overall Study|Lost to Follow-up|3
1523047|NCT00328627|4995598|P6|Overall Study|Lost to Follow-up|2
1523048|NCT00328627|4995599|P5|Overall Study|Lost to Follow-up|0
1523049|NCT00328627|4995600|P4|Overall Study|Lost to Follow-up|4
1523050|NCT00328627|4995601|P3|Overall Study|Lost to Follow-up|2
1523051|NCT00328627|4995602|P2|Overall Study|Lost to Follow-up|2
1523052|NCT00328627|4995603|P1|Overall Study|Lost to Follow-up|4
1523053|NCT00328627|4995592|P12|Overall Study|Protocol Violation|2
1523054|NCT00328627|4995593|P11|Overall Study|Protocol Violation|6
1523055|NCT00328627|4995594|P10|Overall Study|Protocol Violation|4
1523056|NCT00328627|4995595|P9|Overall Study|Protocol Violation|1
1523057|NCT00328627|4995596|P8|Overall Study|Protocol Violation|2
1523058|NCT00328627|4995597|P7|Overall Study|Protocol Violation|6
1523059|NCT00328627|4995598|P6|Overall Study|Protocol Violation|5
1523060|NCT00328627|4995599|P5|Overall Study|Protocol Violation|5
1523061|NCT00328627|4995600|P4|Overall Study|Protocol Violation|8
1523062|NCT00328627|4995601|P3|Overall Study|Protocol Violation|2
1523063|NCT00328627|4995602|P2|Overall Study|Protocol Violation|2
1523064|NCT00328627|4995603|P1|Overall Study|Protocol Violation|2
1523065|NCT00328627|4995592|P12|Overall Study|Adverse Event|4
1523066|NCT00328627|4995593|P11|Overall Study|Adverse Event|5
1523067|NCT00328627|4995594|P10|Overall Study|Adverse Event|7
1523068|NCT00328627|4995595|P9|Overall Study|Adverse Event|0
1523069|NCT00328627|4995596|P8|Overall Study|Adverse Event|2
1523070|NCT00328627|4995597|P7|Overall Study|Adverse Event|1
1523071|NCT00328627|4995598|P6|Overall Study|Adverse Event|2
1523072|NCT00328627|4995599|P5|Overall Study|Adverse Event|1
1523073|NCT00328627|4995600|P4|Overall Study|Adverse Event|3
1523074|NCT00328627|4995601|P3|Overall Study|Adverse Event|2
1523075|NCT00328627|4995602|P2|Overall Study|Adverse Event|1
1523076|NCT00328627|4995603|P1|Overall Study|Adverse Event|3
1523077|NCT00328627|4995592|P12|Overall Study|Hyperglycemic Rescue|2
1523078|NCT00328627|4995593|P11|Overall Study|Hyperglycemic Rescue|3
1523079|NCT00328627|4995594|P10|Overall Study|Hyperglycemic Rescue|11
1523080|NCT00328627|4995595|P9|Overall Study|Hyperglycemic Rescue|6
1523081|NCT00328627|4995596|P8|Overall Study|Hyperglycemic Rescue|6
1523082|NCT00328627|4995597|P7|Overall Study|Hyperglycemic Rescue|19
1523083|NCT00328627|4995598|P6|Overall Study|Hyperglycemic Rescue|5
1523084|NCT00328627|4995599|P5|Overall Study|Hyperglycemic Rescue|6
1523085|NCT00328627|4995600|P4|Overall Study|Hyperglycemic Rescue|13
1523086|NCT00328627|4995601|P3|Overall Study|Hyperglycemic Rescue|16
1523087|NCT00328627|4995602|P2|Overall Study|Hyperglycemic Rescue|18
1523088|NCT00328627|4995603|P1|Overall Study|Hyperglycemic Rescue|41
1523089|NCT00328562|4997140|P1|Overall Study|Disease progression|1
1523090|NCT00328510|4997149|P2|Overall Study|Treatment changed to a single fraction|1
1523091|NCT00328510|4997150|P1|Overall Study|Treatment changed to a single fraction|1
1523092|NCT00328510|4997149|P2|Overall Study|Severe kyphosis, could not use mask|1
1523093|NCT00328510|4997150|P1|Overall Study|Severe kyphosis, could not use mask|0
1523094|NCT00328510|4997149|P2|Overall Study|Withdrawal by Subject|2
1523095|NCT00328510|4997150|P1|Overall Study|Withdrawal by Subject|4
1523096|NCT00328510|4997149|P2|Overall Study|Dentition problems, could not use frame|0
1523097|NCT00328510|4997150|P1|Overall Study|Dentition problems, could not use frame|1
1523098|NCT00328510|4997149|P2|Overall Study|Gag disorder, could not use frame|0
1523099|NCT00328510|4997150|P1|Overall Study|Gag disorder, could not use frame|4
1523100|NCT00328198|4997165|P1|Follow-up|Death|31
1523101|NCT00328198|4997165|P1|Follow-up|Lost to Follow-up|4
1523102|NCT00328198|4997165|P1|Treatment|Confirmed complete response, MRD -|3
1523103|NCT00328198|4997165|P1|Treatment|Non-compliance|1
1523104|NCT00328198|4997165|P1|Treatment|Evidence of disease progression|2
1523105|NCT00328198|4997165|P1|Treatment|Withdrawal by Subject|5
1523106|NCT00328198|4997165|P1|Treatment|Physician Decision|5
1523107|NCT00328198|4997165|P1|Treatment|Death|1
1523108|NCT00328198|4997165|P1|Treatment|Adverse Event|21
1523109|NCT00328172|4997180|P5|Overall Study|Other reason (not specified)|0
1523110|NCT00328172|4997181|P4|Overall Study|Other reason (not specified)|0
1523111|NCT00328172|4997182|P3|Overall Study|Other reason (not specified)|1
1523112|NCT00328172|4997183|P2|Overall Study|Other reason (not specified)|0
1523113|NCT00328172|4997184|P1|Overall Study|Other reason (not specified)|3
1523114|NCT00328172|4997180|P5|Overall Study|Lack of Efficacy|3
1523115|NCT00328172|4997181|P4|Overall Study|Lack of Efficacy|4
1523116|NCT00328172|4997182|P3|Overall Study|Lack of Efficacy|4
1523117|NCT00328172|4997183|P2|Overall Study|Lack of Efficacy|9
1523118|NCT00328172|4997184|P1|Overall Study|Lack of Efficacy|14
1523119|NCT00328172|4997180|P5|Overall Study|Withdrawal by Subject|0
1523120|NCT00328172|4997181|P4|Overall Study|Withdrawal by Subject|6
1523121|NCT00328172|4997182|P3|Overall Study|Withdrawal by Subject|1
1523122|NCT00328172|4997183|P2|Overall Study|Withdrawal by Subject|1
1523123|NCT00328172|4997184|P1|Overall Study|Withdrawal by Subject|1
1523124|NCT00328172|4997180|P5|Overall Study|Lost to Follow-up|1
1523125|NCT00328172|4997181|P4|Overall Study|Lost to Follow-up|1
1523126|NCT00328172|4997182|P3|Overall Study|Lost to Follow-up|2
1523127|NCT00328172|4997183|P2|Overall Study|Lost to Follow-up|1
1523128|NCT00328172|4997184|P1|Overall Study|Lost to Follow-up|1
1523129|NCT00328172|4997180|P5|Overall Study|Protocol Violation|0
1523130|NCT00328172|4997181|P4|Overall Study|Protocol Violation|0
1523131|NCT00328172|4997182|P3|Overall Study|Protocol Violation|1
1523132|NCT00328172|4997183|P2|Overall Study|Protocol Violation|1
1523133|NCT00328172|4997184|P1|Overall Study|Protocol Violation|0
1523134|NCT00328172|4997180|P5|Overall Study|Adverse Event|1
1523135|NCT00328172|4997181|P4|Overall Study|Adverse Event|2
1523136|NCT00328172|4997182|P3|Overall Study|Adverse Event|1
1523137|NCT00328172|4997183|P2|Overall Study|Adverse Event|2
1523138|NCT00328172|4997184|P1|Overall Study|Adverse Event|3
1523139|NCT00328094|4997208|P2|Overall Study|Physician Decision|3
1523140|NCT00328094|4997209|P1|Overall Study|Physician Decision|3
1523141|NCT00327717|4997243|P2|Overall Study|Withdrawal by Subject|7
1523142|NCT00327717|4997244|P1|Overall Study|Withdrawal by Subject|3
1523143|NCT00327717|4997243|P2|Overall Study|Lack of Efficacy|1
1523144|NCT00327717|4997244|P1|Overall Study|Lack of Efficacy|0
1523145|NCT00327717|4997243|P2|Overall Study|Adverse Event|6
1523146|NCT00327717|4997244|P1|Overall Study|Adverse Event|6
1523147|NCT00327470|4997270|P2|Overall Study|Death|4
1523148|NCT00327470|4997271|P1|Overall Study|Death|1
1523149|NCT00327470|4997270|P2|Overall Study|Withdrawal by Subject|12
1523150|NCT00327470|4997271|P1|Overall Study|Withdrawal by Subject|6
1523151|NCT00327470|4997270|P2|Overall Study|Lost to Follow-up|3
1523152|NCT00327470|4997271|P1|Overall Study|Lost to Follow-up|1
1523153|NCT00327470|4997270|P2|Overall Study|Other|9
1523154|NCT00327470|4997271|P1|Overall Study|Other|5
1523155|NCT00327470|4997270|P2|Overall Study|Lack of Efficacy|19
1523156|NCT00327470|4997271|P1|Overall Study|Lack of Efficacy|7
1523157|NCT00327470|4997270|P2|Overall Study|Adverse Event|14
1523158|NCT00327470|4997271|P1|Overall Study|Adverse Event|9
1523159|NCT00327470|4997270|P2|Overall Study|Randomized, but not treated|2
1523160|NCT00327470|4997271|P1|Overall Study|Randomized, but not treated|0
1523161|NCT00327444|4997291|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
1523162|NCT00327444|4997292|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
1523163|NCT00327444|4997291|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
1523164|NCT00327444|4997292|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
1523165|NCT00327444|4997291|P2|Open Label Treatment (OL) Period|Adverse Event|2
1523166|NCT00327444|4997292|P1|Open Label Treatment (OL) Period|Adverse Event|2
1523167|NCT00327444|4997291|P2|Open Label Treatment (OL) Period|Disease progression|7
1523168|NCT00327444|4997292|P1|Open Label Treatment (OL) Period|Disease progression|8
1523169|NCT00327444|4997291|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
1523170|NCT00327444|4997292|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
1523171|NCT00327444|4997291|P2|Double Blind Treatment (DB) Period|Subject request|1
1523172|NCT00327444|4997292|P1|Double Blind Treatment (DB) Period|Subject request|0
1523173|NCT00327444|4997291|P2|Double Blind Treatment (DB) Period|Adverse Event|5
1523174|NCT00327444|4997292|P1|Double Blind Treatment (DB) Period|Adverse Event|5
1523175|NCT00327444|4997291|P2|Double Blind Treatment (DB) Period|Disease progression|13
1523176|NCT00327444|4997292|P1|Double Blind Treatment (DB) Period|Disease progression|10
1523177|NCT00327340|4997310|P2|Overall Study|Adverse Event|3
1523178|NCT00327340|4997311|P1|Overall Study|Adverse Event|3
1523179|NCT00327340|4997310|P2|Overall Study|Symptomatic Disease|2
1523180|NCT00327340|4997311|P1|Overall Study|Symptomatic Disease|0
1523181|NCT00327340|4997310|P2|Overall Study|Disease Progression|19
1523182|NCT00327340|4997311|P1|Overall Study|Disease Progression|10
1523183|NCT00327340|4997310|P2|Overall Study|Physician Decision|1
1523184|NCT00327340|4997311|P1|Overall Study|Physician Decision|1
1523185|NCT00327340|4997310|P2|Overall Study|Withdrawal by Subject|5
1523186|NCT00327340|4997311|P1|Overall Study|Withdrawal by Subject|1
1523187|NCT00327171|4997325|P2|Overall Study|Other|0
1523188|NCT00327171|4997326|P1|Overall Study|Other|1
1523189|NCT00327171|4997325|P2|Overall Study|Undisclosed history of ischemia|1
1523190|NCT00327171|4997326|P1|Overall Study|Undisclosed history of ischemia|0
1523191|NCT00327171|4997325|P2|Overall Study|Clinical progression|8
1523192|NCT00327171|4997326|P1|Overall Study|Clinical progression|12
1523193|NCT00327171|4997325|P2|Overall Study|Investigator/participant request|8
1523194|NCT00327171|4997326|P1|Overall Study|Investigator/participant request|1
1523195|NCT00327171|4997325|P2|Overall Study|Disease progression/lack of efficacy|69
1523196|NCT00327171|4997326|P1|Overall Study|Disease progression/lack of efficacy|68
1523197|NCT00327171|4997325|P2|Overall Study|Adverse Event|23
1523198|NCT00327171|4997326|P1|Overall Study|Adverse Event|23
1523199|NCT00327171|4997325|P2|Overall Study|Did not receive study medication|0
1523200|NCT00327171|4997326|P1|Overall Study|Did not receive study medication|3
1523201|NCT00327015|4997358|P4|Overall Study|Administrative Reason by Sponsor|1
1523202|NCT00327015|4997359|P3|Overall Study|Administrative Reason by Sponsor|2
1523203|NCT00327015|4997360|P2|Overall Study|Administrative Reason by Sponsor|2
1523204|NCT00327015|4997361|P1|Overall Study|Administrative Reason by Sponsor|1
1523205|NCT00327015|4997358|P4|Overall Study|Pregnancy|1
1523206|NCT00327015|4997359|P3|Overall Study|Pregnancy|1
1523207|NCT00327015|4997360|P2|Overall Study|Pregnancy|2
1523208|NCT00327015|4997361|P1|Overall Study|Pregnancy|0
1523209|NCT00327015|4997358|P4|Overall Study|Death|3
1523210|NCT00327015|4997359|P3|Overall Study|Death|2
1523211|NCT00327015|4997360|P2|Overall Study|Death|2
1523212|NCT00327015|4997361|P1|Overall Study|Death|1
1523213|NCT00327015|4997358|P4|Overall Study|Physician Decision|2
1523214|NCT00327015|4997359|P3|Overall Study|Physician Decision|3
1523215|NCT00327015|4997360|P2|Overall Study|Physician Decision|1
1523216|NCT00327015|4997361|P1|Overall Study|Physician Decision|0
1523217|NCT00327015|4997358|P4|Overall Study|Poor/Noncompliance|5
1523218|NCT00327015|4997359|P3|Overall Study|Poor/Noncompliance|4
1523219|NCT00327015|4997360|P2|Overall Study|Poor/Noncompliance|8
1523220|NCT00327015|4997361|P1|Overall Study|Poor/Noncompliance|11
1523221|NCT00327015|4997358|P4|Overall Study|Subject no longer meets study criteria|7
1523222|NCT00327015|4997359|P3|Overall Study|Subject no longer meets study criteria|8
1523223|NCT00327015|4997360|P2|Overall Study|Subject no longer meets study criteria|2
1523224|NCT00327015|4997361|P1|Overall Study|Subject no longer meets study criteria|4
1523225|NCT00327015|4997358|P4|Overall Study|Adverse Event|14
1523226|NCT00327015|4997359|P3|Overall Study|Adverse Event|14
1523227|NCT00327015|4997360|P2|Overall Study|Adverse Event|10
1523228|NCT00327015|4997361|P1|Overall Study|Adverse Event|14
1523229|NCT00327015|4997358|P4|Overall Study|Lost to Follow-up|22
1523230|NCT00327015|4997359|P3|Overall Study|Lost to Follow-up|29
1523231|NCT00327015|4997360|P2|Overall Study|Lost to Follow-up|23
1523232|NCT00327015|4997361|P1|Overall Study|Lost to Follow-up|22
1523233|NCT00327015|4997358|P4|Overall Study|Withdrawal of Consent by Subject|25
1523234|NCT00327015|4997359|P3|Overall Study|Withdrawal of Consent by Subject|28
1523235|NCT00327015|4997360|P2|Overall Study|Withdrawal of Consent by Subject|24
1523236|NCT00327015|4997361|P1|Overall Study|Withdrawal of Consent by Subject|20
1523237|NCT00327015|4997358|P4|Overall Study|Lack of Efficacy|29
1523238|NCT00327015|4997359|P3|Overall Study|Lack of Efficacy|35
1523239|NCT00327015|4997360|P2|Overall Study|Lack of Efficacy|18
1523240|NCT00327015|4997361|P1|Overall Study|Lack of Efficacy|18
1523241|NCT00326963|4997403|P1|Overall Study|Administrative / other|1
1523242|NCT00326963|4997403|P1|Overall Study|Other protocol violation|1
1523243|NCT00326963|4997403|P1|Overall Study|Violation of selection criteria at entry|2
1523244|NCT00326963|4997403|P1|Overall Study|Refused treatment / did not cooperate|5
1523245|NCT00326963|4997403|P1|Overall Study|Withdrawal by Subject|10
1523246|NCT00326963|4997403|P1|Overall Study|Failure to return|10
1523247|NCT00326963|4997403|P1|Overall Study|Death|1
1523248|NCT00326963|4997403|P1|Overall Study|Injection site reaction|1
1523249|NCT00326963|4997403|P1|Overall Study|Adverse Event|2
1523250|NCT00326950|4997423|P1|Overall Study|Progressive Disease|1
1523251|NCT00326911|4997445|P2|Overall Study|Withdrawal by subject prior to treatment|1
1523252|NCT00326911|4997446|P1|Overall Study|Withdrawal by subject prior to treatment|0
1523253|NCT00326911|4997445|P2|Overall Study|Physician decision prior to treatment|0
1523254|NCT00326911|4997446|P1|Overall Study|Physician decision prior to treatment|1
1523255|NCT00326911|4997445|P2|Overall Study|Hospitalization prior to treatment|1
1523256|NCT00326911|4997446|P1|Overall Study|Hospitalization prior to treatment|0
1523257|NCT00326898|4997499|P3|Overall Study|Other/Missing/Unknown|32
1523258|NCT00326898|4997500|P2|Overall Study|Other/Missing/Unknown|28
1523259|NCT00326898|4997501|P1|Overall Study|Other/Missing/Unknown|33
1523260|NCT00326898|4997499|P3|Overall Study|Other complicating disease|4
1523261|NCT00326898|4997500|P2|Overall Study|Other complicating disease|5
1523262|NCT00326898|4997501|P1|Overall Study|Other complicating disease|5
1523263|NCT00326898|4997499|P3|Overall Study|Alternative therapy|0
1523264|NCT00326898|4997500|P2|Overall Study|Alternative therapy|0
1523265|NCT00326898|4997501|P1|Overall Study|Alternative therapy|1
1523266|NCT00326898|4997499|P3|Overall Study|Withdrawal by Subject|32
1523267|NCT00326898|4997500|P2|Overall Study|Withdrawal by Subject|128
1523268|NCT00326898|4997501|P1|Overall Study|Withdrawal by Subject|134
1523269|NCT00326898|4997499|P3|Overall Study|Death|0
1523270|NCT00326898|4997500|P2|Overall Study|Death|0
1523271|NCT00326898|4997501|P1|Overall Study|Death|2
1523272|NCT00326898|4997499|P3|Overall Study|Adverse Event|33
1523273|NCT00326898|4997500|P2|Overall Study|Adverse Event|128
1523274|NCT00326898|4997501|P1|Overall Study|Adverse Event|124
1523275|NCT00326898|4997499|P3|Overall Study|Disease progression|102
1523276|NCT00326898|4997500|P2|Overall Study|Disease progression|54
1523277|NCT00326898|4997501|P1|Overall Study|Disease progression|52
1523278|NCT00326885|4997518|P1|Overall Study|Hospice withdrew consent|2
1523279|NCT00326885|4997518|P1|Overall Study|Physician Decision|1
1523280|NCT00326885|4997518|P1|Overall Study|Withdrawal by Subject|3
1523281|NCT00326885|4997518|P1|Overall Study|Adverse Event|1
1523282|NCT00326716|4997549|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
1523283|NCT00326716|4997550|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
1523284|NCT00326716|4997551|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
1523285|NCT00326716|4997552|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
1523286|NCT00326612|4997624|P2|Overall Study|They did not have a seizure requiring tx|137
1523287|NCT00326612|4997625|P1|Overall Study|They did not have a seizure requiring tx|129
1523288|NCT00326599|4997647|P4|Overall Study|Other Unspecified Reason|1
1523289|NCT00326599|4997648|P3|Overall Study|Other Unspecified Reason|2
1523290|NCT00326599|4997649|P2|Overall Study|Other Unspecified Reason|0
1523291|NCT00326599|4997650|P1|Overall Study|Other Unspecified Reason|0
1523292|NCT00326599|4997647|P4|Overall Study|Death|2
1523293|NCT00326599|4997648|P3|Overall Study|Death|1
1523294|NCT00326599|4997649|P2|Overall Study|Death|0
1523295|NCT00326599|4997650|P1|Overall Study|Death|0
1523296|NCT00326599|4997647|P4|Overall Study|Alternate Treatment|0
1523297|NCT00326599|4997648|P3|Overall Study|Alternate Treatment|0
1523298|NCT00326599|4997649|P2|Overall Study|Alternate Treatment|0
1523299|NCT00326599|4997650|P1|Overall Study|Alternate Treatment|1
1523300|NCT00326599|4997647|P4|Overall Study|Disease Progression|11
1523301|NCT00326599|4997648|P3|Overall Study|Disease Progression|13
1523302|NCT00326599|4997649|P2|Overall Study|Disease Progression|1
1523303|NCT00326599|4997650|P1|Overall Study|Disease Progression|3
1523304|NCT00326599|4997647|P4|Overall Study|Adverse Event|3
1523305|NCT00326599|4997648|P3|Overall Study|Adverse Event|32
1523306|NCT00326599|4997649|P2|Overall Study|Adverse Event|0
1523307|NCT00326599|4997650|P1|Overall Study|Adverse Event|1
1523308|NCT00326599|4997647|P4|Overall Study|Withdrawal by Subject|2
1523309|NCT00326599|4997648|P3|Overall Study|Withdrawal by Subject|5
1523310|NCT00326599|4997649|P2|Overall Study|Withdrawal by Subject|0
1523311|NCT00326599|4997650|P1|Overall Study|Withdrawal by Subject|1
1523312|NCT00326495|4997669|P1|Overall Study|Subject off study before assessment|1
1523313|NCT00326495|4997669|P1|Overall Study|Refused further treatment|2
1523314|NCT00326495|4997669|P1|Overall Study|Disease progression before treatment|1
1523315|NCT00326495|4997669|P1|Overall Study|Switched to alternative treatment|1
1523316|NCT00326417|4997676|P4|Overall Study|Death|0
1523317|NCT00326417|4997677|P3|Overall Study|Death|0
1523318|NCT00326417|4997678|P2|Overall Study|Death|0
1523319|NCT00326417|4997679|P1|Overall Study|Death|7
1523320|NCT00326417|4997676|P4|Overall Study|Arm Closed|3
1523321|NCT00326417|4997677|P3|Overall Study|Arm Closed|0
1523322|NCT00326417|4997678|P2|Overall Study|Arm Closed|0
1523323|NCT00326417|4997679|P1|Overall Study|Arm Closed|7
1523324|NCT00326417|4997676|P4|Overall Study|Withdrawal by Subject|0
1523325|NCT00326417|4997677|P3|Overall Study|Withdrawal by Subject|1
1523326|NCT00326417|4997678|P2|Overall Study|Withdrawal by Subject|0
1523327|NCT00326417|4997679|P1|Overall Study|Withdrawal by Subject|0
1523328|NCT00326183|4997706|P2|Overall Study|Adverse Event|0
1523329|NCT00326183|4997707|P1|Overall Study|Adverse Event|1
1523330|NCT00326183|4997706|P2|Overall Study|Other|13
1523331|NCT00326183|4997707|P1|Overall Study|Other|47
1523332|NCT00326183|4997706|P2|Overall Study|Subject Moved|4
1523333|NCT00326183|4997707|P1|Overall Study|Subject Moved|7
1523334|NCT00326183|4997706|P2|Overall Study|Withdrawal by Subject|7
1523335|NCT00326183|4997707|P1|Overall Study|Withdrawal by Subject|35
1523336|NCT00326183|4997706|P2|Overall Study|Protocol Violation|3
1523337|NCT00326183|4997707|P1|Overall Study|Protocol Violation|6
1523338|NCT00326183|4997706|P2|Overall Study|Lost to Follow-up|56
1523339|NCT00326183|4997707|P1|Overall Study|Lost to Follow-up|104
1523340|NCT00326118|4997739|P2|Active Phase|Withdrawal by Subject|1
1523341|NCT00326118|4997740|P1|Active Phase|Withdrawal by Subject|4
1523342|NCT00326001|4997776|P2|Overall Study|Physician Decision|3
1523343|NCT00326001|4997777|P1|Overall Study|Physician Decision|3
1523344|NCT00326001|4997776|P2|Overall Study|Adverse Event|5
1523345|NCT00326001|4997777|P1|Overall Study|Adverse Event|4
1523346|NCT00325897|4997791|P2|Overall Study|Lost to Follow-up|13
1523347|NCT00325897|4997792|P1|Overall Study|Lost to Follow-up|12
1523348|NCT00325819|4997812|P2|Overall Study|Lost to Follow-up|3
1523349|NCT00325819|4997813|P1|Overall Study|Lost to Follow-up|3
1523350|NCT00325819|4997812|P2|Overall Study|Did not take a dose of study product|9
1523351|NCT00325819|4997813|P1|Overall Study|Did not take a dose of study product|4
1523352|NCT00325819|4997812|P2|Overall Study|Study product lost in mail|1
1523353|NCT00325819|4997813|P1|Overall Study|Study product lost in mail|2
1523354|NCT00325754|4997840|P2|Overall Study|Adverse Event|1
1523355|NCT00325754|4997841|P1|Overall Study|Adverse Event|4
1523356|NCT00325468|4997887|P5|Overall Study|site closure etc|1
1523357|NCT00325468|4997888|P4|Overall Study|site closure etc|8
1523358|NCT00325468|4997889|P3|Overall Study|site closure etc|1
1523359|NCT00325468|4997890|P2|Overall Study|site closure etc|2
1523360|NCT00325468|4997891|P1|Overall Study|site closure etc|4
1523361|NCT00325468|4997887|P5|Overall Study|Withdrawal by Subject|4
1523362|NCT00325468|4997888|P4|Overall Study|Withdrawal by Subject|14
1523363|NCT00325468|4997889|P3|Overall Study|Withdrawal by Subject|0
1523364|NCT00325468|4997890|P2|Overall Study|Withdrawal by Subject|1
1523365|NCT00325468|4997891|P1|Overall Study|Withdrawal by Subject|3
1523366|NCT00325468|4997887|P5|Overall Study|Physician Decision|0
1523367|NCT00325468|4997888|P4|Overall Study|Physician Decision|1
1523368|NCT00325468|4997889|P3|Overall Study|Physician Decision|0
1523369|NCT00325468|4997890|P2|Overall Study|Physician Decision|1
1523370|NCT00325468|4997891|P1|Overall Study|Physician Decision|1
1523371|NCT00325468|4997887|P5|Overall Study|Lost to Follow-up|2
1523372|NCT00325468|4997888|P4|Overall Study|Lost to Follow-up|2
1523373|NCT00325468|4997889|P3|Overall Study|Lost to Follow-up|1
1523374|NCT00325468|4997890|P2|Overall Study|Lost to Follow-up|0
1523375|NCT00325468|4997891|P1|Overall Study|Lost to Follow-up|0
1523376|NCT00325468|4997887|P5|Overall Study|Death|0
1523377|NCT00325468|4997888|P4|Overall Study|Death|4
1523378|NCT00325468|4997889|P3|Overall Study|Death|2
1523379|NCT00325468|4997890|P2|Overall Study|Death|0
1523380|NCT00325468|4997891|P1|Overall Study|Death|2
1523381|NCT00325468|4997887|P5|Overall Study|Adverse Event|1
1523382|NCT00325468|4997888|P4|Overall Study|Adverse Event|5
1523383|NCT00325468|4997889|P3|Overall Study|Adverse Event|0
1523384|NCT00325468|4997890|P2|Overall Study|Adverse Event|1
1523385|NCT00325468|4997891|P1|Overall Study|Adverse Event|1
1523386|NCT00325416|4997974|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
1523387|NCT00325416|4997975|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
1523388|NCT00325416|4997974|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
1523389|NCT00325416|4997975|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
1523390|NCT00325416|4997974|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
1523391|NCT00325416|4997975|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
1523392|NCT00325416|4997974|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
1523393|NCT00325416|4997975|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
1523394|NCT00325416|4997974|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
1523395|NCT00325416|4997975|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
1523396|NCT00325416|4997974|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
1523397|NCT00325416|4997975|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
1523398|NCT00325234|4998028|P2|Overall Study|Progressive Disease|37
1523399|NCT00325234|4998029|P1|Overall Study|Progressive Disease|34
1523400|NCT00325234|4998028|P2|Overall Study|Physician Decision|12
1523401|NCT00325234|4998029|P1|Overall Study|Physician Decision|17
1523402|NCT00325234|4998028|P2|Overall Study|Subject Decision|8
1523403|NCT00325234|4998029|P1|Overall Study|Subject Decision|6
1523404|NCT00325234|4998028|P2|Overall Study|Entry Criteria Not Met|2
1523405|NCT00325234|4998029|P1|Overall Study|Entry Criteria Not Met|1
1523406|NCT00325234|4998028|P2|Overall Study|Death due to Study Disease|0
1523407|NCT00325234|4998029|P1|Overall Study|Death due to Study Disease|1
1523408|NCT00325234|4998028|P2|Overall Study|Adverse Event|7
1523409|NCT00325234|4998029|P1|Overall Study|Adverse Event|10
1523410|NCT00325195|4998048|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
1523411|NCT00325195|4998049|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
1523412|NCT00325195|4998050|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
1523413|NCT00325195|4998048|P3|Received Intervention: ITT Population|Lost to Follow-up|2
1523414|NCT00325195|4998049|P2|Received Intervention: ITT Population|Lost to Follow-up|0
1523415|NCT00325195|4998050|P1|Received Intervention: ITT Population|Lost to Follow-up|0
1523416|NCT00325195|4998048|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
1523417|NCT00325195|4998049|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
1523418|NCT00325195|4998050|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
1523419|NCT00325195|4998048|P3|Received Intervention: ITT Population|Death|0
1523420|NCT00325195|4998049|P2|Received Intervention: ITT Population|Death|1
1523421|NCT00325195|4998050|P1|Received Intervention: ITT Population|Death|3
1523422|NCT00325195|4998048|P3|Received Intervention: ITT Population|Adverse Event|1
1523423|NCT00325195|4998049|P2|Received Intervention: ITT Population|Adverse Event|17
1523424|NCT00325195|4998050|P1|Received Intervention: ITT Population|Adverse Event|15
1523425|NCT00325195|4998048|P3|Randomized|Not dosed|3
1523426|NCT00325195|4998049|P2|Randomized|Not dosed|5
1523427|NCT00325195|4998050|P1|Randomized|Not dosed|5
1523428|NCT00325156|4998073|P1|Overall Study|Withdrawal by Subject|31
1523429|NCT00325156|4998073|P1|Overall Study|Other|1
1523430|NCT00325156|4998073|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
1523431|NCT00325156|4998073|P1|Overall Study|Adverse event, non-fatal|3
1523432|NCT00325156|4998073|P1|Overall Study|Migrated/moved from study area|12
1523433|NCT00325156|4998073|P1|Overall Study|Lost to follow-up (complete vaccination)|41
1523434|NCT00325156|4998073|P1|Overall Study|Protocol Violation|8
1523435|NCT00325143|4998080|P1|Overall Study|Withdrawal by Subject|8
1523436|NCT00325143|4998080|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
1523437|NCT00325143|4998080|P1|Overall Study|Migrated/moved from study area|1
1523438|NCT00325143|4998080|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
1523439|NCT00325130|4998090|P2|Overall Study|Patient Discontinued for Other|0
1523440|NCT00325130|4998091|P1|Overall Study|Patient Discontinued for Other|1
1523441|NCT00325130|4998090|P2|Overall Study|Moved|1
1523442|NCT00325130|4998091|P1|Overall Study|Moved|0
1523443|NCT00325130|4998090|P2|Overall Study|Protocol Deviation|1
1523444|NCT00325130|4998091|P1|Overall Study|Protocol Deviation|0
1523445|NCT00325130|4998090|P2|Overall Study|Withdrawal by Subject|14
1523446|NCT00325130|4998091|P1|Overall Study|Withdrawal by Subject|12
1523447|NCT00325130|4998090|P2|Overall Study|Lost to Follow-up|14
1523448|NCT00325130|4998091|P1|Overall Study|Lost to Follow-up|6
1523449|NCT00325039|4998148|P2|Overall Study|Lost to Follow-up|14
1523450|NCT00325039|4998149|P1|Overall Study|Lost to Follow-up|18
1523451|NCT00324987|4998165|P2|Overall Study|symptomatic deterioration, toxicity, etc|3
1523452|NCT00324987|4998166|P1|Overall Study|symptomatic deterioration, toxicity, etc|2
1523453|NCT00324987|4998165|P2|Overall Study|Progression|1
1523454|NCT00324987|4998166|P1|Overall Study|Progression|1
1523455|NCT00324987|4998165|P2|Overall Study|Withdrawal by Subject|1
1523456|NCT00324987|4998166|P1|Overall Study|Withdrawal by Subject|1
1523457|NCT00324987|4998165|P2|Overall Study|Adverse Event|1
1523458|NCT00324987|4998166|P1|Overall Study|Adverse Event|2
1523459|NCT00324961|4998180|P1|Overall Study|Other|2
1523460|NCT00324961|4998180|P1|Overall Study|Protocol Violation|3
1523461|NCT00324961|4998180|P1|Overall Study|Lost to Follow-up|22
1523462|NCT00324961|4998180|P1|Overall Study|Consent Withdrawn|11
1523463|NCT00324961|4998180|P1|Overall Study|Adverse Event|5
1523464|NCT00324805|4998227|P2|Overall Study|Did not start therapy|17
1523465|NCT00324805|4998228|P1|Overall Study|Did not start therapy|12
1523466|NCT00324805|4998227|P2|Overall Study|Other|2
1523467|NCT00324805|4998228|P1|Overall Study|Other|0
1523468|NCT00324805|4998227|P2|Overall Study|Other reasons|26
1523469|NCT00324805|4998228|P1|Overall Study|Other reasons|7
1523470|NCT00324805|4998227|P2|Overall Study|Other complicating disease|9
1523471|NCT00324805|4998228|P1|Overall Study|Other complicating disease|1
1523472|NCT00324805|4998227|P2|Overall Study|Alternative therapy|8
1523473|NCT00324805|4998228|P1|Overall Study|Alternative therapy|4
1523474|NCT00324805|4998227|P2|Overall Study|Death|9
1523475|NCT00324805|4998228|P1|Overall Study|Death|6
1523476|NCT00324805|4998227|P2|Overall Study|Withdrawal by Subject|174
1523477|NCT00324805|4998228|P1|Overall Study|Withdrawal by Subject|51
1523478|NCT00324805|4998227|P2|Overall Study|Progression|35
1523479|NCT00324805|4998228|P1|Overall Study|Progression|7
1523480|NCT00324805|4998227|P2|Overall Study|Adverse Event|203
1523481|NCT00324805|4998228|P1|Overall Study|Adverse Event|62
1523482|NCT00324740|4998240|P3|Overall Study|Withdrawal by Subject|1
1523483|NCT00324740|4998241|P2|Overall Study|Withdrawal by Subject|0
1523484|NCT00324740|4998242|P1|Overall Study|Withdrawal by Subject|1
1523485|NCT00324675|4998262|P2|Overall Study|Adverse Event|0
1523486|NCT00324675|4998263|P1|Overall Study|Adverse Event|1
1523487|NCT00324649|4998271|P2|Overall Study|Noncompliance|0
1523488|NCT00324649|4998272|P1|Overall Study|Noncompliance|1
1523489|NCT00324649|4998271|P2|Overall Study|Withdrawal by Subject|1
1523490|NCT00324649|4998272|P1|Overall Study|Withdrawal by Subject|0
1523491|NCT00324649|4998271|P2|Overall Study|Adverse Event|4
1523492|NCT00324649|4998272|P1|Overall Study|Adverse Event|1
1523493|NCT00324233|4998403|P2|Second Period|Protocol Violation|6
1523494|NCT00324233|4998404|P1|Second Period|Protocol Violation|4
1523495|NCT00324233|4998403|P2|Second Period|unable to insert catheter|1
1523496|NCT00324233|4998404|P1|Second Period|unable to insert catheter|1
1523497|NCT00324233|4998403|P2|First Period|unable to insert catheter|0
1523498|NCT00324233|4998404|P1|First Period|unable to insert catheter|1
1523499|NCT00324168|4998412|P2|Overall Study|Patient did not visit in f/u window|9
1523500|NCT00324168|4998413|P1|Overall Study|Patient did not visit in f/u window|6
1523501|NCT00324168|4998412|P2|Overall Study|Death|3
1523502|NCT00324168|4998413|P1|Overall Study|Death|3
1523503|NCT00324168|4998412|P2|Overall Study|Lost to Follow-up|18
1523504|NCT00324168|4998413|P1|Overall Study|Lost to Follow-up|19
1523505|NCT00324155|4998441|P2|Follow-up Phase|On-going participants still on drug|6
1523506|NCT00324155|4998442|P1|Follow-up Phase|On-going participants still on drug|11
1523507|NCT00324155|4998441|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
1523508|NCT00324155|4998442|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
1523509|NCT00324155|4998441|P2|Received Treatment in Maintenance Phase|Adverse Event|3
1523510|NCT00324155|4998442|P1|Received Treatment in Maintenance Phase|Adverse Event|0
1523511|NCT00324155|4998441|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
1523512|NCT00324155|4998442|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
1523513|NCT00324155|4998441|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
1523514|NCT00324155|4998442|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
1523515|NCT00324155|4998441|P2|Received Treatment in Maintenance Phase|Disease Progression|41
1523516|NCT00324155|4998442|P1|Received Treatment in Maintenance Phase|Disease Progression|26
1523517|NCT00324155|4998441|P2|Received Treatment in Induction Phase|Physician Decision|0
1523518|NCT00324155|4998442|P1|Received Treatment in Induction Phase|Physician Decision|2
1523519|NCT00324155|4998441|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
1523520|NCT00324155|4998442|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
1523521|NCT00324155|4998441|P2|Received Treatment in Induction Phase|Adverse Event|7
1523522|NCT00324155|4998442|P1|Received Treatment in Induction Phase|Adverse Event|6
1523523|NCT00324155|4998441|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
1523524|NCT00324155|4998442|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
1523525|NCT00324155|4998441|P2|Received Treatment in Induction Phase|Death|15
1523526|NCT00324155|4998442|P1|Received Treatment in Induction Phase|Death|8
1523527|NCT00324155|4998441|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
1523528|NCT00324155|4998442|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
1523529|NCT00324155|4998441|P2|Received Treatment in Induction Phase|Disease Progression|152
1523530|NCT00324155|4998442|P1|Received Treatment in Induction Phase|Disease Progression|88
1523531|NCT00324155|4998441|P2|Enrolled and Randomized|Lost to Follow-up|1
1523532|NCT00324155|4998442|P1|Enrolled and Randomized|Lost to Follow-up|0
1523533|NCT00324155|4998441|P2|Enrolled and Randomized|No longer met study criteria|0
1523534|NCT00324155|4998442|P1|Enrolled and Randomized|No longer met study criteria|3
1523535|NCT00324116|4998472|P1|Overall Study|Other|5
1523536|NCT00324116|4998472|P1|Overall Study|Withdrawal by Subject|5
1523537|NCT00324116|4998472|P1|Overall Study|Lack of Efficacy|17
1523538|NCT00324116|4998472|P1|Overall Study|Adverse Event|5
1523539|NCT00324038|4998484|P2|Overall Study|Other|13
1523540|NCT00324038|4998485|P1|Overall Study|Other|6
1523541|NCT00324038|4998484|P2|Overall Study|Lost to Follow-up|2
1523542|NCT00324038|4998485|P1|Overall Study|Lost to Follow-up|0
1523543|NCT00324038|4998484|P2|Overall Study|Lack of Efficacy|13
1523544|NCT00324038|4998485|P1|Overall Study|Lack of Efficacy|5
1523545|NCT00324038|4998484|P2|Overall Study|Adverse Event|23
1523546|NCT00324038|4998485|P1|Overall Study|Adverse Event|38
1523547|NCT00323882|4998496|P5|Overall Study|Not Specified|1
1523548|NCT00323882|4998497|P4|Overall Study|Not Specified|1
1523549|NCT00323882|4998498|P3|Overall Study|Not Specified|0
1523550|NCT00323882|4998499|P2|Overall Study|Not Specified|0
1523551|NCT00323882|4998500|P1|Overall Study|Not Specified|0
1523552|NCT00323882|4998496|P5|Overall Study|Lost to Follow-up|1
1523553|NCT00323882|4998497|P4|Overall Study|Lost to Follow-up|0
1523554|NCT00323882|4998498|P3|Overall Study|Lost to Follow-up|1
1523555|NCT00323882|4998499|P2|Overall Study|Lost to Follow-up|0
1523556|NCT00323882|4998500|P1|Overall Study|Lost to Follow-up|0
1523557|NCT00323882|4998496|P5|Overall Study|Death|5
1523558|NCT00323882|4998497|P4|Overall Study|Death|0
1523559|NCT00323882|4998498|P3|Overall Study|Death|1
1523560|NCT00323882|4998499|P2|Overall Study|Death|1
1523561|NCT00323882|4998500|P1|Overall Study|Death|0
1523562|NCT00323882|4998496|P5|Overall Study|Disease Progression|22
1523563|NCT00323882|4998497|P4|Overall Study|Disease Progression|5
1523564|NCT00323882|4998498|P3|Overall Study|Disease Progression|10
1523565|NCT00323882|4998499|P2|Overall Study|Disease Progression|4
1523566|NCT00323882|4998500|P1|Overall Study|Disease Progression|6
1523567|NCT00323882|4998496|P5|Overall Study|Adverse Event|3
1523568|NCT00323882|4998497|P4|Overall Study|Adverse Event|1
1523569|NCT00323882|4998498|P3|Overall Study|Adverse Event|1
1523570|NCT00323882|4998499|P2|Overall Study|Adverse Event|1
1523571|NCT00323882|4998500|P1|Overall Study|Adverse Event|2
1523572|NCT00323869|4998571|P1|Overall Study|Death|1
1523573|NCT00323622|4998627|P8|Overall Study|Death|2
1523574|NCT00323622|4998628|P7|Overall Study|Death|0
1523575|NCT00323622|4998629|P6|Overall Study|Death|0
1523576|NCT00323622|4998630|P5|Overall Study|Death|7
1523577|NCT00323622|4998631|P4|Overall Study|Death|0
1523578|NCT00323622|4998632|P3|Overall Study|Death|0
1523579|NCT00323622|4998633|P2|Overall Study|Death|1
1523580|NCT00323622|4998634|P1|Overall Study|Death|1
1523581|NCT00323622|4998627|P8|Overall Study|Other|13
1523582|NCT00323622|4998628|P7|Overall Study|Other|5
1523583|NCT00323622|4998629|P6|Overall Study|Other|74
1523584|NCT00323622|4998630|P5|Overall Study|Other|32
1523585|NCT00323622|4998631|P4|Overall Study|Other|12
1523586|NCT00323622|4998632|P3|Overall Study|Other|4
1523587|NCT00323622|4998633|P2|Overall Study|Other|91
1523588|NCT00323622|4998634|P1|Overall Study|Other|30
1523589|NCT00323609|4998676|P4|Overall Study|Other reason|9
1523590|NCT00323609|4998677|P3|Overall Study|Other reason|4
1523591|NCT00323609|4998678|P2|Overall Study|Other reason|8
1523592|NCT00323609|4998679|P1|Overall Study|Other reason|11
1523593|NCT00323609|4998676|P4|Overall Study|Logistical withdrawal|1
1523594|NCT00323609|4998677|P3|Overall Study|Logistical withdrawal|0
1523595|NCT00323609|4998678|P2|Overall Study|Logistical withdrawal|5
1523596|NCT00323609|4998679|P1|Overall Study|Logistical withdrawal|9
1523597|NCT00323609|4998676|P4|Overall Study|Unrelenting or severe back pain|0
1523598|NCT00323609|4998677|P3|Overall Study|Unrelenting or severe back pain|0
1523599|NCT00323609|4998678|P2|Overall Study|Unrelenting or severe back pain|1
1523600|NCT00323609|4998679|P1|Overall Study|Unrelenting or severe back pain|1
1523601|NCT00323609|4998676|P4|Overall Study|Sponsor discontinued trial|0
1523602|NCT00323609|4998677|P3|Overall Study|Sponsor discontinued trial|0
1523603|NCT00323609|4998678|P2|Overall Study|Sponsor discontinued trial|29
1523604|NCT00323609|4998679|P1|Overall Study|Sponsor discontinued trial|29
1523605|NCT00323609|4998676|P4|Overall Study|Other non-VCF-related medical condition|0
1523606|NCT00323609|4998677|P3|Overall Study|Other non-VCF-related medical condition|0
1523607|NCT00323609|4998678|P2|Overall Study|Other non-VCF-related medical condition|2
1523608|NCT00323609|4998679|P1|Overall Study|Other non-VCF-related medical condition|3
1523609|NCT00323609|4998676|P4|Overall Study|Withdrawal by Subject|4
1523610|NCT00323609|4998677|P3|Overall Study|Withdrawal by Subject|4
1523611|NCT00323609|4998678|P2|Overall Study|Withdrawal by Subject|23
1523612|NCT00323609|4998679|P1|Overall Study|Withdrawal by Subject|11
1523613|NCT00323609|4998676|P4|Overall Study|Physician Decision|1
1523614|NCT00323609|4998677|P3|Overall Study|Physician Decision|0
1523615|NCT00323609|4998678|P2|Overall Study|Physician Decision|0
1523616|NCT00323609|4998679|P1|Overall Study|Physician Decision|2
1523617|NCT00323609|4998676|P4|Overall Study|Lost to Follow-up|0
1523618|NCT00323609|4998677|P3|Overall Study|Lost to Follow-up|0
1523619|NCT00323609|4998678|P2|Overall Study|Lost to Follow-up|10
1523620|NCT00323609|4998679|P1|Overall Study|Lost to Follow-up|9
1523621|NCT00323609|4998676|P4|Overall Study|Death|0
1523622|NCT00323609|4998677|P3|Overall Study|Death|0
1523623|NCT00323609|4998678|P2|Overall Study|Death|21
1523624|NCT00323609|4998679|P1|Overall Study|Death|16
1523625|NCT00323557|4998715|P2|Overall Study|Physician Decision|0
1523626|NCT00323557|4998716|P1|Overall Study|Physician Decision|1
1523627|NCT00323492|4998725|P3|Study Phase 2|Protocol Violation|0
1523628|NCT00323492|4998726|P2|Study Phase 2|Protocol Violation|0
1523629|NCT00323492|4998727|P1|Study Phase 2|Protocol Violation|1
1523630|NCT00323492|4998725|P3|Study Phase 2|Noncompliance with study schedule|1
1523631|NCT00323492|4998726|P2|Study Phase 2|Noncompliance with study schedule|0
1523632|NCT00323492|4998727|P1|Study Phase 2|Noncompliance with study schedule|0
1523633|NCT00323492|4998725|P3|Study Phase 2|Withdrawal by Subject|0
1523634|NCT00323492|4998726|P2|Study Phase 2|Withdrawal by Subject|1
1523635|NCT00323492|4998727|P1|Study Phase 2|Withdrawal by Subject|0
1523636|NCT00323492|4998725|P3|Study Phase 2|Lost to Follow-up|0
1523637|NCT00323492|4998726|P2|Study Phase 2|Lost to Follow-up|0
1523638|NCT00323492|4998727|P1|Study Phase 2|Lost to Follow-up|1
1523639|NCT00323492|4998725|P3|Study Phase 2|Physician Decision|0
1523640|NCT00323492|4998726|P2|Study Phase 2|Physician Decision|0
1523641|NCT00323492|4998727|P1|Study Phase 2|Physician Decision|1
1523642|NCT00323492|4998725|P3|Study Phase 2|Adverse Event|0
1523643|NCT00323492|4998726|P2|Study Phase 2|Adverse Event|0
1523644|NCT00323492|4998727|P1|Study Phase 2|Adverse Event|1
1523645|NCT00323492|4998725|P3|Study Phase 1|Adverse Event|0
1523646|NCT00323492|4998726|P2|Study Phase 1|Adverse Event|0
1523647|NCT00323492|4998727|P1|Study Phase 1|Adverse Event|2
1523648|NCT00323479|4998758|P1|Overall Study|house moving|1
1523649|NCT00323479|4998758|P1|Overall Study|Protocol Violation|3
1523650|NCT00323479|4998758|P1|Overall Study|Withdrawal by Subject|2
1523651|NCT00323479|4998758|P1|Overall Study|Adverse Event|2
1523652|NCT00323414|4998782|P2|Overall Study|Withdrawal by Subject|1
1523653|NCT00323414|4998783|P1|Overall Study|Withdrawal by Subject|0
1523654|NCT00323310|4998805|P1|Overall Study|did not complete the 24-hr f-up visit|1
1523655|NCT00323310|4998805|P1|Overall Study|a parent refused blood draw|1
1523656|NCT00323310|4998805|P1|Overall Study|Withdrawal by Subject|1
1523657|NCT00323297|4998820|P2|Part B (Open-label)|Protocol Violation|1
1523658|NCT00323297|4998821|P1|Part B (Open-label)|Protocol Violation|0
1523659|NCT00323297|4998820|P2|Part B (Open-label)|Adverse Event|5
1523660|NCT00323297|4998821|P1|Part B (Open-label)|Adverse Event|5
1523661|NCT00323297|4998820|P2|Part B (Open-label)|Lack of Efficacy|1
1523662|NCT00323297|4998821|P1|Part B (Open-label)|Lack of Efficacy|3
1523663|NCT00323297|4998820|P2|Part B (Open-label)|Withdrawal by Subject|3
1523664|NCT00323297|4998821|P1|Part B (Open-label)|Withdrawal by Subject|1
1523665|NCT00323297|4998820|P2|Part B (Open-label)|Reason unspecified|1
1523666|NCT00323297|4998821|P1|Part B (Open-label)|Reason unspecified|0
1523667|NCT00323297|4998820|P2|Part B (Open-label)|Death|1
1523668|NCT00323297|4998821|P1|Part B (Open-label)|Death|0
1523669|NCT00323297|4998820|P2|Part A (Double Blind Randomized)|Related adverse event|2
1523670|NCT00323297|4998821|P1|Part A (Double Blind Randomized)|Related adverse event|2
1523671|NCT00323297|4998820|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
1523672|NCT00323297|4998821|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
1523673|NCT00323297|4998820|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
1523674|NCT00323297|4998821|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
1523675|NCT00323297|4998820|P2|Part A (Double Blind Randomized)|Protocol Violation|3
1523676|NCT00323297|4998821|P1|Part A (Double Blind Randomized)|Protocol Violation|1
1523677|NCT00323297|4998820|P2|Part A (Double Blind Randomized)|Death|1
1523678|NCT00323297|4998821|P1|Part A (Double Blind Randomized)|Death|0
1523679|NCT00323297|4998820|P2|Part A (Double Blind Randomized)|Reason unspecified|1
1523680|NCT00323297|4998821|P1|Part A (Double Blind Randomized)|Reason unspecified|0
1523681|NCT00323258|4998861|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
1523682|NCT00323258|4998862|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
1523683|NCT00323258|4998861|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
1523684|NCT00323258|4998862|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
1523685|NCT00323258|4998861|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
1523686|NCT00323258|4998862|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
1523687|NCT00323258|4998861|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
1523688|NCT00323258|4998862|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
1523689|NCT00323258|4998861|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
1523690|NCT00323258|4998862|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
1523691|NCT00323258|4998861|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
1523692|NCT00323258|4998862|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
1523693|NCT00323258|4998861|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
1523694|NCT00323258|4998862|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
1523695|NCT00323115|4998887|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
1523696|NCT00323115|4998887|P1|Vaccine Administration|Adverse Event|1
1523697|NCT00323063|4998894|P2|Overall Study|brain mets discovered prior to treatment|0
1523698|NCT00323063|4998895|P1|Overall Study|brain mets discovered prior to treatment|1
1523699|NCT00323063|4998894|P2|Overall Study|Adverse Event|0
1523700|NCT00323063|4998895|P1|Overall Study|Adverse Event|1
1523701|NCT00322881|4998912|P1|Overall Study|Disease Progression|2
1523702|NCT00322881|4998912|P1|Overall Study|Adverse Event|1
1523703|NCT00322881|4998912|P1|Overall Study|Death|2
1523704|NCT00322868|4998916|P1|Overall Study|disease progression|1
1523705|NCT00322842|4998941|P2|Overall Study|Death|0
1523706|NCT00322842|4998942|P1|Overall Study|Death|1
1523707|NCT00322842|4998941|P2|Overall Study|Refused transplant|0
1523708|NCT00322842|4998942|P1|Overall Study|Refused transplant|1
1523709|NCT00322842|4998941|P2|Overall Study|Lost to Follow-up|1
1523710|NCT00322842|4998942|P1|Overall Study|Lost to Follow-up|0
1523711|NCT00322842|4998941|P2|Overall Study|Withdrawal by Subject|1
1523712|NCT00322842|4998942|P1|Overall Study|Withdrawal by Subject|0
1523713|NCT00322712|4998980|P1|Overall Study|treated with bevacizumab not cetuximab|1
1523714|NCT00322621|4998984|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
1523715|NCT00322621|4998985|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
1523716|NCT00322621|4998986|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
1523717|NCT00322621|4998984|P3|Period III - Maintenance / Rescue Phase|Death|0
1523718|NCT00322621|4998985|P2|Period III - Maintenance / Rescue Phase|Death|1
1523719|NCT00322621|4998986|P1|Period III - Maintenance / Rescue Phase|Death|0
1523720|NCT00322621|4998984|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
1523721|NCT00322621|4998985|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
1523722|NCT00322621|4998986|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
1523723|NCT00322621|4998984|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
1523724|NCT00322621|4998985|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
1523725|NCT00322621|4998986|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
1523726|NCT00322621|4998984|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
1523727|NCT00322621|4998985|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
1523728|NCT00322621|4998986|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
1523729|NCT00322621|4998984|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
1523730|NCT00322621|4998985|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
1523731|NCT00322621|4998986|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
1523732|NCT00322621|4998984|P3|Period II - Acute Therapy Phase|Physician Decision|0
1523733|NCT00322621|4998985|P2|Period II - Acute Therapy Phase|Physician Decision|0
1523734|NCT00322621|4998986|P1|Period II - Acute Therapy Phase|Physician Decision|1
1523735|NCT00322621|4998984|P3|Period II - Acute Therapy Phase|Protocol Violation|0
1523736|NCT00322621|4998985|P2|Period II - Acute Therapy Phase|Protocol Violation|0
1523737|NCT00322621|4998986|P1|Period II - Acute Therapy Phase|Protocol Violation|2
1523738|NCT00322621|4998984|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
1523739|NCT00322621|4998985|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
1523740|NCT00322621|4998986|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
1523741|NCT00322621|4998984|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
1523742|NCT00322621|4998985|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
1523743|NCT00322621|4998986|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
1523744|NCT00322621|4998984|P3|Period II - Acute Therapy Phase|Adverse Event|0
1523745|NCT00322621|4998985|P2|Period II - Acute Therapy Phase|Adverse Event|0
1523746|NCT00322621|4998986|P1|Period II - Acute Therapy Phase|Adverse Event|20
1523747|NCT00322556|4999038|P1|Overall Study|Other Reason|7
1523748|NCT00322556|4999038|P1|Overall Study|Lost to Follow-up|3
1523749|NCT00322556|4999038|P1|Overall Study|Withdrawal by Subject|1
1523750|NCT00322556|4999038|P1|Overall Study|Adverse Event|1
1523751|NCT00322491|4999054|P2|Overall Study|Death|2
1523752|NCT00322491|4999055|P1|Overall Study|Death|1
1523753|NCT00322491|4999054|P2|Overall Study|Adverse Event|0
1523754|NCT00322491|4999055|P1|Overall Study|Adverse Event|1
1523755|NCT00322452|4999145|P2|Overall Study|Death|227
1523756|NCT00322452|4999146|P1|Overall Study|Death|223
1523757|NCT00322452|4999145|P2|Overall Study|Withdrawal by Subject|46
1523758|NCT00322452|4999146|P1|Overall Study|Withdrawal by Subject|19
1523759|NCT00322452|4999145|P2|Overall Study|Lost to Follow-up|2
1523760|NCT00322452|4999146|P1|Overall Study|Lost to Follow-up|5
1523761|NCT00322452|4999145|P2|Overall Study|Eligibility criteria not fulfilled|1
1523762|NCT00322452|4999146|P1|Overall Study|Eligibility criteria not fulfilled|0
1523763|NCT00322387|4999197|P2|Follow-up Period|Death|0
1523764|NCT00322387|4999198|P1|Follow-up Period|Death|1
1523765|NCT00322387|4999197|P2|Follow-up Period|Final assessment not done|3
1523766|NCT00322387|4999198|P1|Follow-up Period|Final assessment not done|1
1523767|NCT00322387|4999197|P2|Treatment Period|Adverse Event|1
1523768|NCT00322387|4999198|P1|Treatment Period|Adverse Event|0
1523769|NCT00322374|4999232|P4|Second Escalation|Study Drug Toxicity|0
1523770|NCT00322374|4999233|P3|Second Escalation|Study Drug Toxicity|1
1523771|NCT00322374|4999234|P2|Second Escalation|Study Drug Toxicity|0
1523772|NCT00322374|4999235|P1|Second Escalation|Study Drug Toxicity|0
1523773|NCT00322374|4999232|P4|Second Escalation|Physician Decision|0
1523774|NCT00322374|4999233|P3|Second Escalation|Physician Decision|5
1523775|NCT00322374|4999234|P2|Second Escalation|Physician Decision|0
1523776|NCT00322374|4999235|P1|Second Escalation|Physician Decision|0
1523777|NCT00322374|4999232|P4|First Escalation|Participant Request|0
1523778|NCT00322374|4999233|P3|First Escalation|Participant Request|0
1523779|NCT00322374|4999234|P2|First Escalation|Participant Request|1
1523780|NCT00322374|4999235|P1|First Escalation|Participant Request|0
1523781|NCT00322374|4999232|P4|First Escalation|Study Drug Toxicity|0
1523782|NCT00322374|4999233|P3|First Escalation|Study Drug Toxicity|0
1523783|NCT00322374|4999234|P2|First Escalation|Study Drug Toxicity|11
1523784|NCT00322374|4999235|P1|First Escalation|Study Drug Toxicity|0
1523785|NCT00322374|4999232|P4|First Escalation|Physician Decision|0
1523786|NCT00322374|4999233|P3|First Escalation|Physician Decision|0
1523787|NCT00322374|4999234|P2|First Escalation|Physician Decision|12
1523788|NCT00322374|4999235|P1|First Escalation|Physician Decision|0
1523789|NCT00322374|4999232|P4|First Escalation|Documented Disease Progression|0
1523790|NCT00322374|4999233|P3|First Escalation|Documented Disease Progression|0
1523791|NCT00322374|4999234|P2|First Escalation|Documented Disease Progression|6
1523792|NCT00322374|4999235|P1|First Escalation|Documented Disease Progression|0
1523793|NCT00322374|4999232|P4|Starting Dose|Study Drug Toxicity|0
1523794|NCT00322374|4999233|P3|Starting Dose|Study Drug Toxicity|0
1523795|NCT00322374|4999234|P2|Starting Dose|Study Drug Toxicity|0
1523796|NCT00322374|4999235|P1|Starting Dose|Study Drug Toxicity|4
1523797|NCT00322374|4999232|P4|Starting Dose|Physician Decision|0
1523798|NCT00322374|4999233|P3|Starting Dose|Physician Decision|0
1523799|NCT00322374|4999234|P2|Starting Dose|Physician Decision|0
1523800|NCT00322374|4999235|P1|Starting Dose|Physician Decision|2
1523801|NCT00322348|4999285|P2|Overall Study|Reasons not specified|1
1523802|NCT00322348|4999286|P1|Overall Study|Reasons not specified|5
1523803|NCT00322348|4999285|P2|Overall Study|Disease Progression|25
1523804|NCT00322348|4999286|P1|Overall Study|Disease Progression|30
1523805|NCT00322348|4999285|P2|Overall Study|Death|2
1523806|NCT00322348|4999286|P1|Overall Study|Death|0
1523807|NCT00322348|4999285|P2|Overall Study|Lost to Follow-up|0
1523808|NCT00322348|4999286|P1|Overall Study|Lost to Follow-up|1
1523809|NCT00322348|4999285|P2|Overall Study|Withdrawal by Subject|4
1523810|NCT00322348|4999286|P1|Overall Study|Withdrawal by Subject|1
1523811|NCT00322348|4999285|P2|Overall Study|Adverse Event|1
1523812|NCT00322348|4999286|P1|Overall Study|Adverse Event|0
1523813|NCT00322153|4999377|P2|Overall Study|Withdrawn for other reasons|4
1523814|NCT00322153|4999378|P1|Overall Study|Withdrawn for other reasons|5
1523815|NCT00322153|4999377|P2|Overall Study|Lost to Follow-up|4
1523816|NCT00322153|4999378|P1|Overall Study|Lost to Follow-up|5
1523817|NCT00322153|4999377|P2|Overall Study|Lack of Efficacy|3
1523818|NCT00322153|4999378|P1|Overall Study|Lack of Efficacy|8
1523819|NCT00322153|4999377|P2|Overall Study|Withdrawal by Subject|10
1523820|NCT00322153|4999378|P1|Overall Study|Withdrawal by Subject|18
1523821|NCT00322153|4999377|P2|Overall Study|Protocol Violation|14
1523822|NCT00322153|4999378|P1|Overall Study|Protocol Violation|6
1523823|NCT00322153|4999377|P2|Overall Study|Adverse Event|34
1523824|NCT00322153|4999378|P1|Overall Study|Adverse Event|21
1523825|NCT00322049|4999411|P4|Overall Study|Infected with Dengue during study|0
1523826|NCT00322049|4999412|P3|Overall Study|Infected with Dengue during study|0
1523827|NCT00322049|4999413|P2|Overall Study|Infected with Dengue during study|1
1523828|NCT00322049|4999414|P1|Overall Study|Infected with Dengue during study|0
1523829|NCT00322049|4999411|P4|Overall Study|Moved out of area|1
1523830|NCT00322049|4999412|P3|Overall Study|Moved out of area|0
1523831|NCT00322049|4999413|P2|Overall Study|Moved out of area|0
1523832|NCT00322049|4999414|P1|Overall Study|Moved out of area|0
1523833|NCT00321984|4999447|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
1523834|NCT00321984|4999448|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
1523835|NCT00321984|4999449|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
1523836|NCT00321984|4999447|P3|Overall Study|Per Investigator Request|0
1523837|NCT00321984|4999448|P2|Overall Study|Per Investigator Request|0
1523838|NCT00321984|4999449|P1|Overall Study|Per Investigator Request|1
1523839|NCT00321984|4999447|P3|Overall Study|Per Subject Request|0
1523840|NCT00321984|4999448|P2|Overall Study|Per Subject Request|0
1523841|NCT00321984|4999449|P1|Overall Study|Per Subject Request|1
1523842|NCT00321984|4999447|P3|Overall Study|Pregnancy|0
1523843|NCT00321984|4999448|P2|Overall Study|Pregnancy|1
1523844|NCT00321984|4999449|P1|Overall Study|Pregnancy|0
1523845|NCT00321984|4999447|P3|Overall Study|Noncompliant|2
1523846|NCT00321984|4999448|P2|Overall Study|Noncompliant|0
1523847|NCT00321984|4999449|P1|Overall Study|Noncompliant|0
1523848|NCT00321984|4999447|P3|Overall Study|Lack of Efficacy|3
1523849|NCT00321984|4999448|P2|Overall Study|Lack of Efficacy|1
1523850|NCT00321984|4999449|P1|Overall Study|Lack of Efficacy|3
1523851|NCT00321984|4999447|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
1523852|NCT00321984|4999448|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
1523853|NCT00321984|4999449|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
1523854|NCT00321984|4999447|P3|Overall Study|Withdrawal by Subject|5
1523855|NCT00321984|4999448|P2|Overall Study|Withdrawal by Subject|6
1523856|NCT00321984|4999449|P1|Overall Study|Withdrawal by Subject|8
1523857|NCT00321984|4999447|P3|Overall Study|Lost to Follow-up|2
1523858|NCT00321984|4999448|P2|Overall Study|Lost to Follow-up|4
1523859|NCT00321984|4999449|P1|Overall Study|Lost to Follow-up|2
1523860|NCT00321984|4999447|P3|Overall Study|Protocol Violation|1
1523861|NCT00321984|4999448|P2|Overall Study|Protocol Violation|1
1523862|NCT00321984|4999449|P1|Overall Study|Protocol Violation|0
1523863|NCT00321984|4999447|P3|Overall Study|Adverse Event|8
1523864|NCT00321984|4999448|P2|Overall Study|Adverse Event|6
1523865|NCT00321984|4999449|P1|Overall Study|Adverse Event|9
1523866|NCT00321932|4999477|P2|Overall Study|Missing data|1
1523867|NCT00321932|4999478|P1|Overall Study|Missing data|2
1523868|NCT00321932|4999477|P2|Overall Study|Early relapse|8
1523869|NCT00321932|4999478|P1|Overall Study|Early relapse|2
1523870|NCT00321932|4999477|P2|Overall Study|Withdrawal by Subject|6
1523871|NCT00321932|4999478|P1|Overall Study|Withdrawal by Subject|3
1523872|NCT00321932|4999477|P2|Overall Study|Death|6
1523873|NCT00321932|4999478|P1|Overall Study|Death|3
1523874|NCT00321919|4999502|P2|Overall Study|Other withdrawal reason|6
1523875|NCT00321919|4999503|P1|Overall Study|Other withdrawal reason|7
1523876|NCT00321919|4999502|P2|Overall Study|Failure to Return|1
1523877|NCT00321919|4999503|P1|Overall Study|Failure to Return|3
1523878|NCT00321919|4999502|P2|Overall Study|Other Protocol Violation|3
1523879|NCT00321919|4999503|P1|Overall Study|Other Protocol Violation|2
1523880|NCT00321919|4999502|P2|Overall Study|Refused Treatment|14
1523881|NCT00321919|4999503|P1|Overall Study|Refused Treatment|23
1523882|NCT00321919|4999502|P2|Overall Study|Violation of Selection Criteria at Entry|1
1523883|NCT00321919|4999503|P1|Overall Study|Violation of Selection Criteria at Entry|1
1523884|NCT00321919|4999502|P2|Overall Study|Insufficient Therapeutic Response|0
1523885|NCT00321919|4999503|P1|Overall Study|Insufficient Therapeutic Response|1
1523886|NCT00321919|4999502|P2|Overall Study|Death|17
1523887|NCT00321919|4999503|P1|Overall Study|Death|21
1523888|NCT00321919|4999502|P2|Overall Study|Adverse Event|10
1523889|NCT00321919|4999503|P1|Overall Study|Adverse Event|17
1523890|NCT00321906|4999545|P2|Overall Study|Withdrawal by Subject|4
1523891|NCT00321906|4999546|P1|Overall Study|Withdrawal by Subject|0
1523892|NCT00321906|4999545|P2|Overall Study|Lost to Follow-up|2
1523893|NCT00321906|4999546|P1|Overall Study|Lost to Follow-up|1
1523894|NCT00321906|4999545|P2|Overall Study|Death|6
1523895|NCT00321906|4999546|P1|Overall Study|Death|9
1523896|NCT00321906|4999545|P2|Overall Study|Adverse Event|44
1523897|NCT00321906|4999546|P1|Overall Study|Adverse Event|36
1523898|NCT00321893|4999568|P2|Overall Study|Adverse Event|3
1523899|NCT00321893|4999569|P1|Overall Study|Adverse Event|6
1523900|NCT00321893|4999568|P2|Overall Study|Lost to Follow-up|1
1523901|NCT00321893|4999569|P1|Overall Study|Lost to Follow-up|2
1523902|NCT00321893|4999568|P2|Overall Study|Non-Compliance/Refusal|10
1523903|NCT00321893|4999569|P1|Overall Study|Non-Compliance/Refusal|16
1523904|NCT00321854|4999583|P2|Overall Study|Other|1
1523905|NCT00321854|4999584|P1|Overall Study|Other|1
1523906|NCT00321854|4999583|P2|Overall Study|Withdrawal by Subject|17
1523907|NCT00321854|4999584|P1|Overall Study|Withdrawal by Subject|6
1523908|NCT00321854|4999583|P2|Overall Study|Lost to Follow-up|2
1523909|NCT00321854|4999584|P1|Overall Study|Lost to Follow-up|0
1523910|NCT00321854|4999583|P2|Overall Study|Protocol Violation|5
1523911|NCT00321854|4999584|P1|Overall Study|Protocol Violation|6
1523912|NCT00321854|4999583|P2|Overall Study|Lack of Efficacy|14
1523913|NCT00321854|4999584|P1|Overall Study|Lack of Efficacy|9
1523914|NCT00321854|4999583|P2|Overall Study|Adverse Event|43
1523915|NCT00321854|4999584|P1|Overall Study|Adverse Event|41
1523916|NCT00321828|4999702|P1|Overall Study|No follow up data|1
1523917|NCT00321828|4999702|P1|Overall Study|Ineligible|3
1523918|NCT00321789|4999708|P2|Overall Study|Protocol Violation|3
1523919|NCT00321789|4999709|P1|Overall Study|Protocol Violation|5
1523920|NCT00321789|4999708|P2|Overall Study|Withdrawal by Subject|6
1523921|NCT00321789|4999709|P1|Overall Study|Withdrawal by Subject|6
1523922|NCT00321789|4999708|P2|Overall Study|Lost to Follow-up|7
1523923|NCT00321789|4999709|P1|Overall Study|Lost to Follow-up|4
1523924|NCT00321763|4999741|P4|Overall Study|Lost to Follow-up|4
1523925|NCT00321763|4999742|P3|Overall Study|Lost to Follow-up|5
1523926|NCT00321763|4999743|P2|Overall Study|Lost to Follow-up|1
1523927|NCT00321763|4999744|P1|Overall Study|Lost to Follow-up|3
1523928|NCT00321763|4999741|P4|Overall Study|Withdrawal by Subject|0
1523929|NCT00321763|4999742|P3|Overall Study|Withdrawal by Subject|1
1523930|NCT00321763|4999743|P2|Overall Study|Withdrawal by Subject|0
1523931|NCT00321763|4999744|P1|Overall Study|Withdrawal by Subject|2
1523932|NCT00321763|4999741|P4|Overall Study|Adverse Event|1
1523933|NCT00321763|4999742|P3|Overall Study|Adverse Event|0
1523934|NCT00321763|4999743|P2|Overall Study|Adverse Event|1
1523935|NCT00321763|4999744|P1|Overall Study|Adverse Event|1
1523936|NCT00321737|4999804|P3|Overall Study|Subject Request/ Subject Unavailable|2
1523937|NCT00321737|4999805|P2|Overall Study|Subject Request/ Subject Unavailable|0
1523938|NCT00321737|4999806|P1|Overall Study|Subject Request/ Subject Unavailable|0
1523939|NCT00321737|4999804|P3|Overall Study|Noncompliance|0
1523940|NCT00321737|4999805|P2|Overall Study|Noncompliance|0
1523941|NCT00321737|4999806|P1|Overall Study|Noncompliance|2
1523942|NCT00321737|4999804|P3|Overall Study|Pregnancy|0
1523943|NCT00321737|4999805|P2|Overall Study|Pregnancy|2
1523944|NCT00321737|4999806|P1|Overall Study|Pregnancy|0
1523945|NCT00321737|4999804|P3|Overall Study|Therapeutic Failure|2
1523946|NCT00321737|4999805|P2|Overall Study|Therapeutic Failure|0
1523947|NCT00321737|4999806|P1|Overall Study|Therapeutic Failure|6
1523948|NCT00321737|4999804|P3|Overall Study|Possible Barrett's Esophagus|1
1523949|NCT00321737|4999805|P2|Overall Study|Possible Barrett's Esophagus|1
1523950|NCT00321737|4999806|P1|Overall Study|Possible Barrett's Esophagus|2
1523951|NCT00321737|4999804|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1523952|NCT00321737|4999805|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1523953|NCT00321737|4999806|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
1523954|NCT00321737|4999804|P3|Overall Study|Protocol Violation|1
1523955|NCT00321737|4999805|P2|Overall Study|Protocol Violation|0
1523956|NCT00321737|4999806|P1|Overall Study|Protocol Violation|0
1523957|NCT00321737|4999804|P3|Overall Study|Withdrawal by Subject|17
1523958|NCT00321737|4999805|P2|Overall Study|Withdrawal by Subject|12
1523959|NCT00321737|4999806|P1|Overall Study|Withdrawal by Subject|19
1523960|NCT00321737|4999804|P3|Overall Study|Lost to Follow-up|6
1523961|NCT00321737|4999805|P2|Overall Study|Lost to Follow-up|5
1523962|NCT00321737|4999806|P1|Overall Study|Lost to Follow-up|5
1523963|NCT00321737|4999804|P3|Overall Study|Adverse Event|6
1523964|NCT00321737|4999805|P2|Overall Study|Adverse Event|3
1523965|NCT00321737|4999806|P1|Overall Study|Adverse Event|11
1523966|NCT00321737|4999804|P3|Overall Study|Relapse of Erosive Esophagitis|19
1523967|NCT00321737|4999805|P2|Overall Study|Relapse of Erosive Esophagitis|25
1523968|NCT00321737|4999806|P1|Overall Study|Relapse of Erosive Esophagitis|76
1523969|NCT00321711|4999834|P5|Part B|Death|1
1523970|NCT00321711|4999835|P4|Part B|Death|2
1523971|NCT00321711|4999836|P3|Part B|Death|0
1523972|NCT00321711|4999837|P2|Part B|Death|0
1523973|NCT00321711|4999838|P1|Part B|Death|0
1523974|NCT00321711|4999834|P5|Part B|Physician Decision|2
1523975|NCT00321711|4999835|P4|Part B|Physician Decision|1
1523976|NCT00321711|4999836|P3|Part B|Physician Decision|0
1523977|NCT00321711|4999837|P2|Part B|Physician Decision|0
1523978|NCT00321711|4999838|P1|Part B|Physician Decision|0
1523979|NCT00321711|4999834|P5|Part B|Disease progression|0
1523980|NCT00321711|4999835|P4|Part B|Disease progression|1
1523981|NCT00321711|4999836|P3|Part B|Disease progression|0
1523982|NCT00321711|4999837|P2|Part B|Disease progression|0
1523983|NCT00321711|4999838|P1|Part B|Disease progression|0
1523984|NCT00321711|4999834|P5|Part B|Adverse Event|1
1523985|NCT00321711|4999835|P4|Part B|Adverse Event|2
1523986|NCT00321711|4999836|P3|Part B|Adverse Event|0
1523987|NCT00321711|4999837|P2|Part B|Adverse Event|0
1523988|NCT00321711|4999838|P1|Part B|Adverse Event|0
1523989|NCT00321711|4999834|P5|Part B|Noncompliance|1
1523990|NCT00321711|4999835|P4|Part B|Noncompliance|0
1523991|NCT00321711|4999836|P3|Part B|Noncompliance|0
1523992|NCT00321711|4999837|P2|Part B|Noncompliance|0
1523993|NCT00321711|4999838|P1|Part B|Noncompliance|0
1523994|NCT00321711|4999834|P5|Part A|Protocol deviation|0
1523995|NCT00321711|4999835|P4|Part A|Protocol deviation|0
1523996|NCT00321711|4999836|P3|Part A|Protocol deviation|1
1523997|NCT00321711|4999837|P2|Part A|Protocol deviation|0
1523998|NCT00321711|4999838|P1|Part A|Protocol deviation|0
1523999|NCT00321711|4999834|P5|Part A|Other|0
1524000|NCT00321711|4999835|P4|Part A|Other|0
1524001|NCT00321711|4999836|P3|Part A|Other|3
1524002|NCT00321711|4999837|P2|Part A|Other|2
1524003|NCT00321711|4999838|P1|Part A|Other|1
1524004|NCT00321711|4999834|P5|Part A|Physician Decision|0
1524005|NCT00321711|4999835|P4|Part A|Physician Decision|0
1524006|NCT00321711|4999836|P3|Part A|Physician Decision|3
1524007|NCT00321711|4999837|P2|Part A|Physician Decision|1
1524008|NCT00321711|4999838|P1|Part A|Physician Decision|0
1524009|NCT00321711|4999834|P5|Part A|Requirement for alternative therapy|0
1524010|NCT00321711|4999835|P4|Part A|Requirement for alternative therapy|0
1524011|NCT00321711|4999836|P3|Part A|Requirement for alternative therapy|1
1524012|NCT00321711|4999837|P2|Part A|Requirement for alternative therapy|2
1524013|NCT00321711|4999838|P1|Part A|Requirement for alternative therapy|0
1524014|NCT00321711|4999834|P5|Part A|Disease progression|0
1524015|NCT00321711|4999835|P4|Part A|Disease progression|0
1524016|NCT00321711|4999836|P3|Part A|Disease progression|0
1524017|NCT00321711|4999837|P2|Part A|Disease progression|1
1524018|NCT00321711|4999838|P1|Part A|Disease progression|0
1524019|NCT00321711|4999834|P5|Part A|Withdrawal by Subject|0
1524020|NCT00321711|4999835|P4|Part A|Withdrawal by Subject|0
1524021|NCT00321711|4999836|P3|Part A|Withdrawal by Subject|1
1524022|NCT00321711|4999837|P2|Part A|Withdrawal by Subject|1
1524023|NCT00321711|4999838|P1|Part A|Withdrawal by Subject|1
1524024|NCT00321711|4999834|P5|Part A|Adverse Event|0
1524025|NCT00321711|4999835|P4|Part A|Adverse Event|0
1524026|NCT00321711|4999836|P3|Part A|Adverse Event|2
1524027|NCT00321711|4999837|P2|Part A|Adverse Event|3
1524028|NCT00321711|4999838|P1|Part A|Adverse Event|3
1524029|NCT00321685|4999888|P1|Overall Study|Ineligible|2
1524030|NCT00321685|4999888|P1|Overall Study|Not start protocol therapy|2
1524031|NCT00321685|4999888|P1|Overall Study|Other|5
1524032|NCT00321685|4999888|P1|Overall Study|Complicating disese|1
1524033|NCT00321685|4999888|P1|Overall Study|Alternative therapy|1
1524034|NCT00321685|4999888|P1|Overall Study|Withdrawal by Subject|8
1524035|NCT00321685|4999888|P1|Overall Study|Death|2
1524036|NCT00321685|4999888|P1|Overall Study|Adverse Event|18
1524037|NCT00321672|4999900|P4|Overall Study|Extensive travel required for new job|0
1524038|NCT00321672|4999901|P3|Overall Study|Extensive travel required for new job|0
1524039|NCT00321672|4999902|P2|Overall Study|Extensive travel required for new job|1
1524040|NCT00321672|4999903|P1|Overall Study|Extensive travel required for new job|0
1524041|NCT00321672|4999900|P4|Overall Study|Diagnosis of testicular cancer|0
1524042|NCT00321672|4999901|P3|Overall Study|Diagnosis of testicular cancer|0
1524043|NCT00321672|4999902|P2|Overall Study|Diagnosis of testicular cancer|1
1524044|NCT00321672|4999903|P1|Overall Study|Diagnosis of testicular cancer|0
1524045|NCT00321672|4999900|P4|Overall Study|Protocol Violation|0
1524046|NCT00321672|4999901|P3|Overall Study|Protocol Violation|1
1524047|NCT00321672|4999902|P2|Overall Study|Protocol Violation|0
1524048|NCT00321672|4999903|P1|Overall Study|Protocol Violation|0
1524049|NCT00321672|4999900|P4|Overall Study|Moved out of state|0
1524050|NCT00321672|4999901|P3|Overall Study|Moved out of state|1
1524051|NCT00321672|4999902|P2|Overall Study|Moved out of state|1
1524052|NCT00321672|4999903|P1|Overall Study|Moved out of state|0
1524053|NCT00321672|4999900|P4|Overall Study|Incarcerated|0
1524054|NCT00321672|4999901|P3|Overall Study|Incarcerated|2
1524055|NCT00321672|4999902|P2|Overall Study|Incarcerated|0
1524056|NCT00321672|4999903|P1|Overall Study|Incarcerated|0
1524057|NCT00321672|4999900|P4|Overall Study|Too far to travel for visits|0
1524058|NCT00321672|4999901|P3|Overall Study|Too far to travel for visits|0
1524059|NCT00321672|4999902|P2|Overall Study|Too far to travel for visits|0
1524060|NCT00321672|4999903|P1|Overall Study|Too far to travel for visits|1
1524061|NCT00321672|4999900|P4|Overall Study|Death|0
1524062|NCT00321672|4999901|P3|Overall Study|Death|0
1524063|NCT00321672|4999902|P2|Overall Study|Death|0
1524064|NCT00321672|4999903|P1|Overall Study|Death|1
1524065|NCT00321672|4999900|P4|Overall Study|Lost to Follow-up|2
1524066|NCT00321672|4999901|P3|Overall Study|Lost to Follow-up|4
1524067|NCT00321672|4999902|P2|Overall Study|Lost to Follow-up|0
1524068|NCT00321672|4999903|P1|Overall Study|Lost to Follow-up|2
1524069|NCT00321672|4999900|P4|Overall Study|Lack of Efficacy|0
1524070|NCT00321672|4999901|P3|Overall Study|Lack of Efficacy|0
1524071|NCT00321672|4999902|P2|Overall Study|Lack of Efficacy|1
1524072|NCT00321672|4999903|P1|Overall Study|Lack of Efficacy|1
1524073|NCT00321672|4999900|P4|Overall Study|Adverse Event|0
1524074|NCT00321672|4999901|P3|Overall Study|Adverse Event|0
1524075|NCT00321672|4999902|P2|Overall Study|Adverse Event|1
1524076|NCT00321672|4999903|P1|Overall Study|Adverse Event|1
1524077|NCT00321672|4999900|P4|Overall Study|Noncompliance|0
1524078|NCT00321672|4999901|P3|Overall Study|Noncompliance|1
1524079|NCT00321672|4999902|P2|Overall Study|Noncompliance|2
1524080|NCT00321672|4999903|P1|Overall Study|Noncompliance|1
1524081|NCT00321672|4999900|P4|Overall Study|Withdrawal by Subject|0
1524082|NCT00321672|4999901|P3|Overall Study|Withdrawal by Subject|2
1524083|NCT00321672|4999902|P2|Overall Study|Withdrawal by Subject|1
1524084|NCT00321672|4999903|P1|Overall Study|Withdrawal by Subject|5
1524085|NCT00321646|4999929|P1|Neoadjuvant Chemotherapy|Disease progression|1
1524086|NCT00321646|4999929|P1|Neoadjuvant Chemotherapy|Adverse Event|2
1524087|NCT00321646|4999929|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
1524088|NCT00321620|4999936|P2|Overall Study|Other|33
1524089|NCT00321620|4999937|P1|Overall Study|Other|42
1524090|NCT00321620|4999936|P2|Overall Study|Participant request|52
1524091|NCT00321620|4999937|P1|Overall Study|Participant request|75
1524092|NCT00321620|4999936|P2|Overall Study|Ineligibility determined|3
1524093|NCT00321620|4999937|P1|Overall Study|Ineligibility determined|2
1524094|NCT00321620|4999936|P2|Overall Study|Protocol deviation|3
1524095|NCT00321620|4999937|P1|Overall Study|Protocol deviation|4
1524096|NCT00321620|4999936|P2|Overall Study|Noncompliance|7
1524097|NCT00321620|4999937|P1|Overall Study|Noncompliance|14
1524098|NCT00321620|4999936|P2|Overall Study|Physician Decision|1
1524099|NCT00321620|4999937|P1|Overall Study|Physician Decision|4
1524100|NCT00321620|4999936|P2|Overall Study|Lost to Follow-up|9
1524101|NCT00321620|4999937|P1|Overall Study|Lost to Follow-up|13
1524102|NCT00321620|4999936|P2|Overall Study|Adverse Event|56
1524103|NCT00321620|4999937|P1|Overall Study|Adverse Event|43
1524104|NCT00321620|4999936|P2|Overall Study|Disease progression|117
1524105|NCT00321620|4999937|P1|Overall Study|Disease progression|113
1524106|NCT00321620|4999936|P2|Overall Study|Withdrawal by Subject|147
1524107|NCT00321620|4999937|P1|Overall Study|Withdrawal by Subject|164
1524108|NCT00321620|4999936|P2|Overall Study|Death|294
1524109|NCT00321620|4999937|P1|Overall Study|Death|269
1524110|NCT00321464|4999967|P2|Overall Study|Other|18
1524111|NCT00321464|4999968|P1|Overall Study|Other|21
1524112|NCT00321464|4999967|P2|Overall Study|Ineligibility determined|1
1524113|NCT00321464|4999968|P1|Overall Study|Ineligibility determined|2
1524114|NCT00321464|4999967|P2|Overall Study|Protocol deviation|2
1524115|NCT00321464|4999968|P1|Overall Study|Protocol deviation|0
1524116|NCT00321464|4999967|P2|Overall Study|Lost to Follow-up|8
1524117|NCT00321464|4999968|P1|Overall Study|Lost to Follow-up|7
1524118|NCT00321464|4999967|P2|Overall Study|Noncompliance|10
1524119|NCT00321464|4999968|P1|Overall Study|Noncompliance|4
1524120|NCT00321464|4999967|P2|Overall Study|Physician Decision|14
1524121|NCT00321464|4999968|P1|Overall Study|Physician Decision|15
1524122|NCT00321464|4999967|P2|Overall Study|Adverse Event|28
1524123|NCT00321464|4999968|P1|Overall Study|Adverse Event|43
1524124|NCT00321464|4999967|P2|Overall Study|Participant request|61
1524125|NCT00321464|4999968|P1|Overall Study|Participant request|57
1524126|NCT00321464|4999967|P2|Overall Study|Withdrawal by Subject|118
1524127|NCT00321464|4999968|P1|Overall Study|Withdrawal by Subject|117
1524128|NCT00321464|4999967|P2|Overall Study|Disease progression|124
1524129|NCT00321464|4999968|P1|Overall Study|Disease progression|124
1524130|NCT00321464|4999967|P2|Overall Study|Death|174
1524131|NCT00321464|4999968|P1|Overall Study|Death|169
1524132|NCT00321373|4999981|P3|Overall Study|Other|1
1524133|NCT00321373|4999982|P2|Overall Study|Other|0
1524134|NCT00321373|4999983|P1|Overall Study|Other|0
1524135|NCT00321373|4999981|P3|Overall Study|Withdrawal by Subject|0
1524136|NCT00321373|4999982|P2|Overall Study|Withdrawal by Subject|0
1524137|NCT00321373|4999983|P1|Overall Study|Withdrawal by Subject|1
1524138|NCT00321373|4999981|P3|Overall Study|Lost to Follow-up|1
1524139|NCT00321373|4999982|P2|Overall Study|Lost to Follow-up|0
1524140|NCT00321373|4999983|P1|Overall Study|Lost to Follow-up|1
1524141|NCT00321373|4999981|P3|Overall Study|Adverse Event|1
1524142|NCT00321373|4999982|P2|Overall Study|Adverse Event|0
1524143|NCT00321373|4999983|P1|Overall Study|Adverse Event|0
1524144|NCT00320801|5000023|P4|Extension Phase|Lost to Follow-up|3
1524145|NCT00320801|5000024|P3|Extension Phase|Lost to Follow-up|0
1524146|NCT00320801|5000025|P2|Extension Phase|Lost to Follow-up|0
1524147|NCT00320801|5000026|P1|Extension Phase|Lost to Follow-up|0
1524148|NCT00320801|5000023|P4|Extension Phase|Lack of Efficacy|2
1524149|NCT00320801|5000024|P3|Extension Phase|Lack of Efficacy|0
1524150|NCT00320801|5000025|P2|Extension Phase|Lack of Efficacy|0
1524151|NCT00320801|5000026|P1|Extension Phase|Lack of Efficacy|0
1524152|NCT00320801|5000023|P4|Extension Phase|Administrative|29
1524153|NCT00320801|5000024|P3|Extension Phase|Administrative|0
1524154|NCT00320801|5000025|P2|Extension Phase|Administrative|0
1524155|NCT00320801|5000026|P1|Extension Phase|Administrative|0
1524156|NCT00320801|5000023|P4|Extension Phase|Adverse Event|8
1524157|NCT00320801|5000024|P3|Extension Phase|Adverse Event|0
1524158|NCT00320801|5000025|P2|Extension Phase|Adverse Event|0
1524159|NCT00320801|5000026|P1|Extension Phase|Adverse Event|0
1524160|NCT00320801|5000023|P4|Extension Phase|Withdrawal by Subject|6
1524161|NCT00320801|5000024|P3|Extension Phase|Withdrawal by Subject|0
1524162|NCT00320801|5000025|P2|Extension Phase|Withdrawal by Subject|0
1524163|NCT00320801|5000026|P1|Extension Phase|Withdrawal by Subject|0
1524164|NCT00320801|5000023|P4|Double-blind Phase|Lack of Efficacy|0
1524165|NCT00320801|5000024|P3|Double-blind Phase|Lack of Efficacy|1
1524166|NCT00320801|5000025|P2|Double-blind Phase|Lack of Efficacy|9
1524167|NCT00320801|5000026|P1|Double-blind Phase|Lack of Efficacy|0
1524168|NCT00320801|5000023|P4|Double-blind Phase|Administrative|0
1524169|NCT00320801|5000024|P3|Double-blind Phase|Administrative|4
1524170|NCT00320801|5000025|P2|Double-blind Phase|Administrative|0
1524171|NCT00320801|5000026|P1|Double-blind Phase|Administrative|0
1524172|NCT00320801|5000023|P4|Double-blind Phase|Adverse Event|0
1524173|NCT00320801|5000024|P3|Double-blind Phase|Adverse Event|8
1524174|NCT00320801|5000025|P2|Double-blind Phase|Adverse Event|2
1524175|NCT00320801|5000026|P1|Double-blind Phase|Adverse Event|0
1524176|NCT00320801|5000023|P4|Double-blind Phase|Withdrawal by Subject|0
1524177|NCT00320801|5000024|P3|Double-blind Phase|Withdrawal by Subject|1
1524178|NCT00320801|5000025|P2|Double-blind Phase|Withdrawal by Subject|0
1524179|NCT00320801|5000026|P1|Double-blind Phase|Withdrawal by Subject|0
1524180|NCT00320801|5000023|P4|Open-label Run-in Period|Did not qualify|0
1524181|NCT00320801|5000024|P3|Open-label Run-in Period|Did not qualify|0
1524182|NCT00320801|5000025|P2|Open-label Run-in Period|Did not qualify|0
1524183|NCT00320801|5000026|P1|Open-label Run-in Period|Did not qualify|1
1524184|NCT00320801|5000023|P4|Open-label Run-in Period|Lost to Follow-up|0
1524185|NCT00320801|5000024|P3|Open-label Run-in Period|Lost to Follow-up|0
1524186|NCT00320801|5000025|P2|Open-label Run-in Period|Lost to Follow-up|0
1524187|NCT00320801|5000026|P1|Open-label Run-in Period|Lost to Follow-up|2
1524188|NCT00320801|5000023|P4|Open-label Run-in Period|Lack of Efficacy|0
1524189|NCT00320801|5000024|P3|Open-label Run-in Period|Lack of Efficacy|0
1524190|NCT00320801|5000025|P2|Open-label Run-in Period|Lack of Efficacy|0
1524191|NCT00320801|5000026|P1|Open-label Run-in Period|Lack of Efficacy|44
1524192|NCT00320801|5000023|P4|Open-label Run-in Period|Administrative|0
1524193|NCT00320801|5000024|P3|Open-label Run-in Period|Administrative|0
1524194|NCT00320801|5000025|P2|Open-label Run-in Period|Administrative|0
1524195|NCT00320801|5000026|P1|Open-label Run-in Period|Administrative|10
1524196|NCT00320801|5000023|P4|Open-label Run-in Period|Adverse Event|0
1524197|NCT00320801|5000024|P3|Open-label Run-in Period|Adverse Event|0
1524198|NCT00320801|5000025|P2|Open-label Run-in Period|Adverse Event|0
1524199|NCT00320801|5000026|P1|Open-label Run-in Period|Adverse Event|33
1524200|NCT00320801|5000023|P4|Open-label Run-in Period|Withdrawal by Subject|0
1524201|NCT00320801|5000024|P3|Open-label Run-in Period|Withdrawal by Subject|0
1524202|NCT00320801|5000025|P2|Open-label Run-in Period|Withdrawal by Subject|0
1524203|NCT00320801|5000026|P1|Open-label Run-in Period|Withdrawal by Subject|2
1524204|NCT00320788|5000041|P5|Overall Study|Withdrawal by Subject|1
1524205|NCT00320788|5000042|P4|Overall Study|Withdrawal by Subject|3
1524206|NCT00320788|5000043|P3|Overall Study|Withdrawal by Subject|0
1524207|NCT00320788|5000044|P2|Overall Study|Withdrawal by Subject|0
1524208|NCT00320788|5000045|P1|Overall Study|Withdrawal by Subject|3
1524209|NCT00320788|5000041|P5|Overall Study|Protocol Violation|1
1524210|NCT00320788|5000042|P4|Overall Study|Protocol Violation|0
1524211|NCT00320788|5000043|P3|Overall Study|Protocol Violation|0
1524212|NCT00320788|5000044|P2|Overall Study|Protocol Violation|0
1524213|NCT00320788|5000045|P1|Overall Study|Protocol Violation|0
1524214|NCT00320788|5000041|P5|Overall Study|Physician Decision|0
1524215|NCT00320788|5000042|P4|Overall Study|Physician Decision|0
1524216|NCT00320788|5000043|P3|Overall Study|Physician Decision|0
1524217|NCT00320788|5000044|P2|Overall Study|Physician Decision|1
1524218|NCT00320788|5000045|P1|Overall Study|Physician Decision|1
1524219|NCT00320788|5000041|P5|Overall Study|Other|1
1524220|NCT00320788|5000042|P4|Overall Study|Other|1
1524221|NCT00320788|5000043|P3|Overall Study|Other|1
1524222|NCT00320788|5000044|P2|Overall Study|Other|2
1524223|NCT00320788|5000045|P1|Overall Study|Other|1
1524224|NCT00320788|5000041|P5|Overall Study|Decision by the Sponsor|1
1524225|NCT00320788|5000042|P4|Overall Study|Decision by the Sponsor|0
1524226|NCT00320788|5000043|P3|Overall Study|Decision by the Sponsor|0
1524227|NCT00320788|5000044|P2|Overall Study|Decision by the Sponsor|1
1524228|NCT00320788|5000045|P1|Overall Study|Decision by the Sponsor|1
1524229|NCT00320788|5000041|P5|Overall Study|Lost to Follow-up|0
1524230|NCT00320788|5000042|P4|Overall Study|Lost to Follow-up|0
1524231|NCT00320788|5000043|P3|Overall Study|Lost to Follow-up|1
1524232|NCT00320788|5000044|P2|Overall Study|Lost to Follow-up|2
1524233|NCT00320788|5000045|P1|Overall Study|Lost to Follow-up|0
1524234|NCT00320788|5000041|P5|Overall Study|Death|1
1524235|NCT00320788|5000042|P4|Overall Study|Death|0
1524236|NCT00320788|5000043|P3|Overall Study|Death|1
1524237|NCT00320788|5000044|P2|Overall Study|Death|0
1524238|NCT00320788|5000045|P1|Overall Study|Death|0
1524239|NCT00320788|5000041|P5|Overall Study|Adverse Event|0
1524240|NCT00320788|5000042|P4|Overall Study|Adverse Event|1
1524241|NCT00320788|5000043|P3|Overall Study|Adverse Event|0
1524242|NCT00320788|5000044|P2|Overall Study|Adverse Event|0
1524243|NCT00320788|5000045|P1|Overall Study|Adverse Event|0
1524244|NCT00320710|5000099|P3|Overall Study|Lost to Follow-up|0
1524245|NCT00320710|5000100|P2|Overall Study|Lost to Follow-up|0
1524246|NCT00320710|5000101|P1|Overall Study|Lost to Follow-up|1
1524247|NCT00320710|5000099|P3|Overall Study|Adverse Event|1
1524248|NCT00320710|5000100|P2|Overall Study|Adverse Event|14
1524249|NCT00320710|5000101|P1|Overall Study|Adverse Event|18
1524250|NCT00320710|5000099|P3|Overall Study|Abnormal laboratory value(s)|0
1524251|NCT00320710|5000100|P2|Overall Study|Abnormal laboratory value(s)|3
1524252|NCT00320710|5000101|P1|Overall Study|Abnormal laboratory value(s)|12
1524253|NCT00320710|5000099|P3|Overall Study|Abnormal test procedure result(s)|0
1524254|NCT00320710|5000100|P2|Overall Study|Abnormal test procedure result(s)|0
1524255|NCT00320710|5000101|P1|Overall Study|Abnormal test procedure result(s)|2
1524256|NCT00320710|5000099|P3|Overall Study|Protocol Violation|0
1524257|NCT00320710|5000100|P2|Overall Study|Protocol Violation|5
1524258|NCT00320710|5000101|P1|Overall Study|Protocol Violation|6
1524259|NCT00320710|5000099|P3|Overall Study|Withdrawal by Subject|1
1524260|NCT00320710|5000100|P2|Overall Study|Withdrawal by Subject|26
1524261|NCT00320710|5000101|P1|Overall Study|Withdrawal by Subject|20
1524262|NCT00320710|5000099|P3|Overall Study|Administrative problems|0
1524263|NCT00320710|5000100|P2|Overall Study|Administrative problems|2
1524264|NCT00320710|5000101|P1|Overall Study|Administrative problems|1
1524265|NCT00320710|5000099|P3|Overall Study|Death|1
1524266|NCT00320710|5000100|P2|Overall Study|Death|7
1524267|NCT00320710|5000101|P1|Overall Study|Death|10
1524268|NCT00320710|5000099|P3|Overall Study|Disease progression|2
1524269|NCT00320710|5000100|P2|Overall Study|Disease progression|19
1524270|NCT00320710|5000101|P1|Overall Study|Disease progression|24
1524271|NCT00320606|5000131|P1|Overall Study|Ongoing in study|12
1524272|NCT00320606|5000131|P1|Overall Study|Protocol Violation|1
1524273|NCT00320606|5000131|P1|Overall Study|Adverse Event|1
1524274|NCT00320593|5000137|P2|Overall Study|Withdrawal by clinical center|0
1524275|NCT00320593|5000138|P1|Overall Study|Withdrawal by clinical center|1
1524276|NCT00320593|5000137|P2|Overall Study|Withdrawal by Subject|1
1524277|NCT00320593|5000138|P1|Overall Study|Withdrawal by Subject|2
1524278|NCT00320593|5000137|P2|Overall Study|Moved to another state|0
1524279|NCT00320593|5000138|P1|Overall Study|Moved to another state|1
1524280|NCT00320593|5000137|P2|Overall Study|Lost to Follow-up|0
1524281|NCT00320593|5000138|P1|Overall Study|Lost to Follow-up|3
1524282|NCT00320541|5000162|P2|Overall Study|Protocol Entry Criterion Not Met|0
1524283|NCT00320541|5000163|P1|Overall Study|Protocol Entry Criterion Not Met|1
1524284|NCT00320541|5000162|P2|Overall Study|Death due to Adverse Event(s)|0
1524285|NCT00320541|5000163|P1|Overall Study|Death due to Adverse Event(s)|1
1524286|NCT00320541|5000162|P2|Overall Study|Death due to Study Disease|3
1524287|NCT00320541|5000163|P1|Overall Study|Death due to Study Disease|1
1524288|NCT00320541|5000162|P2|Overall Study|Sponsor Decision|1
1524289|NCT00320541|5000163|P1|Overall Study|Sponsor Decision|2
1524290|NCT00320541|5000162|P2|Overall Study|Other|4
1524291|NCT00320541|5000163|P1|Overall Study|Other|3
1524292|NCT00320541|5000162|P2|Overall Study|Physician Decision|13
1524293|NCT00320541|5000163|P1|Overall Study|Physician Decision|9
1524294|NCT00320541|5000162|P2|Overall Study|Withdrawal by Subject|16
1524295|NCT00320541|5000163|P1|Overall Study|Withdrawal by Subject|12
1524296|NCT00320541|5000162|P2|Overall Study|Protocol Violation|1
1524297|NCT00320541|5000163|P1|Overall Study|Protocol Violation|0
1524298|NCT00320541|5000162|P2|Overall Study|Adverse Event|19
1524299|NCT00320541|5000163|P1|Overall Study|Adverse Event|21
1524300|NCT00320528|5000190|P3|Study Period III|Atomoxetine Commercially Available|90
1524301|NCT00320528|5000191|P2|Study Period III|Atomoxetine Commercially Available|25
1524302|NCT00320528|5000192|P1|Study Period III|Atomoxetine Commercially Available|68
1524303|NCT00320528|5000190|P3|Study Period III|Sponsor Decision|1
1524304|NCT00320528|5000191|P2|Study Period III|Sponsor Decision|0
1524305|NCT00320528|5000192|P1|Study Period III|Sponsor Decision|0
1524306|NCT00320528|5000190|P3|Study Period III|Physician Decision|2
1524307|NCT00320528|5000191|P2|Study Period III|Physician Decision|1
1524308|NCT00320528|5000192|P1|Study Period III|Physician Decision|0
1524309|NCT00320528|5000190|P3|Study Period III|Protocol Violation|0
1524310|NCT00320528|5000191|P2|Study Period III|Protocol Violation|1
1524311|NCT00320528|5000192|P1|Study Period III|Protocol Violation|0
1524312|NCT00320528|5000190|P3|Study Period III|Parent/Caregiver Decision|11
1524313|NCT00320528|5000191|P2|Study Period III|Parent/Caregiver Decision|3
1524314|NCT00320528|5000192|P1|Study Period III|Parent/Caregiver Decision|14
1524315|NCT00320528|5000190|P3|Study Period III|Lack of Efficacy|0
1524316|NCT00320528|5000191|P2|Study Period III|Lack of Efficacy|0
1524317|NCT00320528|5000192|P1|Study Period III|Lack of Efficacy|2
1524318|NCT00320528|5000190|P3|Study Period III|Withdrawal by Subject|2
1524319|NCT00320528|5000191|P2|Study Period III|Withdrawal by Subject|1
1524320|NCT00320528|5000192|P1|Study Period III|Withdrawal by Subject|1
1524321|NCT00320528|5000190|P3|Study Period III|Lost to Follow-up|0
1524322|NCT00320528|5000191|P2|Study Period III|Lost to Follow-up|0
1524323|NCT00320528|5000192|P1|Study Period III|Lost to Follow-up|1
1524324|NCT00320528|5000190|P3|Study Period III|Adverse Event|0
1524325|NCT00320528|5000191|P2|Study Period III|Adverse Event|0
1524326|NCT00320528|5000192|P1|Study Period III|Adverse Event|1
1524327|NCT00320528|5000190|P3|Study Period II|Entry Criteria Exclusion|2
1524328|NCT00320528|5000191|P2|Study Period II|Entry Criteria Exclusion|2
1524329|NCT00320528|5000192|P1|Study Period II|Entry Criteria Exclusion|0
1524330|NCT00320528|5000190|P3|Study Period II|Withdrawal by Subject|1
1524331|NCT00320528|5000191|P2|Study Period II|Withdrawal by Subject|1
1524332|NCT00320528|5000192|P1|Study Period II|Withdrawal by Subject|0
1524333|NCT00320528|5000190|P3|Study Period II|Parent/Caregiver Decision|11
1524334|NCT00320528|5000191|P2|Study Period II|Parent/Caregiver Decision|3
1524335|NCT00320528|5000192|P1|Study Period II|Parent/Caregiver Decision|8
1524336|NCT00320528|5000190|P3|Study Period II|Adverse Event|8
1524337|NCT00320528|5000191|P2|Study Period II|Adverse Event|4
1524338|NCT00320528|5000192|P1|Study Period II|Adverse Event|3
1524339|NCT00320515|5000227|P1|Overall Study|Withdrawal by Subject|8
1524340|NCT00320515|5000227|P1|Overall Study|Physician Decision|2
1524341|NCT00320515|5000227|P1|Overall Study|Lost to Follow-up|6
1524342|NCT00320515|5000227|P1|Overall Study|Death|33
1524343|NCT00320489|5000236|P2|Overall Study|Withdrawal by Subject|41
1524344|NCT00320489|5000237|P1|Overall Study|Withdrawal by Subject|39
1524345|NCT00320489|5000236|P2|Overall Study|Sponsor Decision|3
1524346|NCT00320489|5000237|P1|Overall Study|Sponsor Decision|3
1524347|NCT00320489|5000236|P2|Overall Study|Protocol Violation|4
1524348|NCT00320489|5000237|P1|Overall Study|Protocol Violation|4
1524349|NCT00320489|5000236|P2|Overall Study|Physician Decision|8
1524350|NCT00320489|5000237|P1|Overall Study|Physician Decision|8
1524351|NCT00320489|5000236|P2|Overall Study|Lost to Follow-up|22
1524352|NCT00320489|5000237|P1|Overall Study|Lost to Follow-up|21
1524353|NCT00320489|5000236|P2|Overall Study|Lack of Efficacy|7
1524354|NCT00320489|5000237|P1|Overall Study|Lack of Efficacy|16
1524355|NCT00320489|5000236|P2|Overall Study|Entry Criteria Exclusion|4
1524356|NCT00320489|5000237|P1|Overall Study|Entry Criteria Exclusion|2
1524357|NCT00320489|5000236|P2|Overall Study|Death|2
1524358|NCT00320489|5000237|P1|Overall Study|Death|0
1524359|NCT00320489|5000236|P2|Overall Study|Clinical Relapse|20
1524360|NCT00320489|5000237|P1|Overall Study|Clinical Relapse|26
1524361|NCT00320489|5000236|P2|Overall Study|Adverse Event|25
1524362|NCT00320489|5000237|P1|Overall Study|Adverse Event|26
1524363|NCT00320424|5000293|P1|Overall Study|Other|3
1524364|NCT00320424|5000293|P1|Overall Study|Adverse Event|3
1524365|NCT00320411|5000307|P1|Overall Study|No investigational product admin.|4
1524366|NCT00320398|5000330|P2|Overall Study|Other|0
1524367|NCT00320398|5000331|P1|Overall Study|Other|1
1524368|NCT00320398|5000330|P2|Overall Study|Adverse Event|4
1524369|NCT00320398|5000331|P1|Overall Study|Adverse Event|1
1524370|NCT00320385|5000359|P2|Overall Study|Adverse Event|1
1524371|NCT00320385|5000360|P1|Overall Study|Adverse Event|0
1524372|NCT00320385|5000359|P2|Overall Study|Withdrew Consent|0
1524373|NCT00320385|5000360|P1|Overall Study|Withdrew Consent|1
1524374|NCT00320385|5000359|P2|Overall Study|Serious Adverse Event|0
1524375|NCT00320385|5000360|P1|Overall Study|Serious Adverse Event|1
1524376|NCT00320385|5000359|P2|Overall Study|Death|2
1524377|NCT00320385|5000360|P1|Overall Study|Death|1
1524378|NCT00320385|5000359|P2|Overall Study|Investigator Decision|1
1524379|NCT00320385|5000360|P1|Overall Study|Investigator Decision|0
1524380|NCT00320385|5000359|P2|Overall Study|Sponsor Terminated Study|1
1524381|NCT00320385|5000360|P1|Overall Study|Sponsor Terminated Study|2
1524382|NCT00320385|5000359|P2|Overall Study|Withdrawal by Subject|7
1524383|NCT00320385|5000360|P1|Overall Study|Withdrawal by Subject|6
1524384|NCT00320385|5000359|P2|Overall Study|Lost to Follow-up|10
1524385|NCT00320385|5000360|P1|Overall Study|Lost to Follow-up|7
1524386|NCT00320372|5000383|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
1524387|NCT00320372|5000384|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
1524388|NCT00320372|5000383|P2|Overall Study|Did not Meet (I/E)|1
1524389|NCT00320372|5000384|P1|Overall Study|Did not Meet (I/E)|3
1524390|NCT00320372|5000383|P2|Overall Study|Non-Compliance|39
1524391|NCT00320372|5000384|P1|Overall Study|Non-Compliance|40
1524392|NCT00320372|5000383|P2|Overall Study|Withdrawal by Subject|37
1524393|NCT00320372|5000384|P1|Overall Study|Withdrawal by Subject|55
1524394|NCT00320372|5000383|P2|Overall Study|Death|8
1524395|NCT00320372|5000384|P1|Overall Study|Death|7
1524396|NCT00320372|5000383|P2|Overall Study|Physician Decision|7
1524397|NCT00320372|5000384|P1|Overall Study|Physician Decision|4
1524398|NCT00320255|5000424|P6|Overall Study|Not specified|0
1524399|NCT00320255|5000425|P5|Overall Study|Not specified|0
1524400|NCT00320255|5000426|P4|Overall Study|Not specified|0
1524401|NCT00320255|5000427|P3|Overall Study|Not specified|1
1524402|NCT00320255|5000428|P2|Overall Study|Not specified|2
1524403|NCT00320255|5000429|P1|Overall Study|Not specified|3
1524404|NCT00320255|5000424|P6|Overall Study|No longer meets study criteria|0
1524405|NCT00320255|5000425|P5|Overall Study|No longer meets study criteria|0
1524406|NCT00320255|5000426|P4|Overall Study|No longer meets study criteria|1
1524407|NCT00320255|5000427|P3|Overall Study|No longer meets study criteria|0
1524408|NCT00320255|5000428|P2|Overall Study|No longer meets study criteria|0
1524409|NCT00320255|5000429|P1|Overall Study|No longer meets study criteria|0
1524410|NCT00320255|5000424|P6|Overall Study|Poor compliance/noncompliance|0
1524411|NCT00320255|5000425|P5|Overall Study|Poor compliance/noncompliance|0
1524412|NCT00320255|5000426|P4|Overall Study|Poor compliance/noncompliance|1
1524413|NCT00320255|5000427|P3|Overall Study|Poor compliance/noncompliance|0
1524414|NCT00320255|5000428|P2|Overall Study|Poor compliance/noncompliance|1
1524415|NCT00320255|5000429|P1|Overall Study|Poor compliance/noncompliance|1
1524416|NCT00320255|5000424|P6|Overall Study|Withdrawal by Subject|0
1524417|NCT00320255|5000425|P5|Overall Study|Withdrawal by Subject|0
1524418|NCT00320255|5000426|P4|Overall Study|Withdrawal by Subject|4
1524419|NCT00320255|5000427|P3|Overall Study|Withdrawal by Subject|2
1524420|NCT00320255|5000428|P2|Overall Study|Withdrawal by Subject|2
1524421|NCT00320255|5000429|P1|Overall Study|Withdrawal by Subject|1
1524422|NCT00320255|5000424|P6|Overall Study|Adverse Event|0
1524423|NCT00320255|5000425|P5|Overall Study|Adverse Event|0
1524424|NCT00320255|5000426|P4|Overall Study|Adverse Event|2
1524425|NCT00320255|5000427|P3|Overall Study|Adverse Event|3
1524426|NCT00320255|5000428|P2|Overall Study|Adverse Event|2
1524427|NCT00320255|5000429|P1|Overall Study|Adverse Event|5
1524428|NCT00320255|5000424|P6|Overall Study|Lack of Efficacy|0
1524429|NCT00320255|5000425|P5|Overall Study|Lack of Efficacy|0
1524430|NCT00320255|5000426|P4|Overall Study|Lack of Efficacy|0
1524431|NCT00320255|5000427|P3|Overall Study|Lack of Efficacy|0
1524432|NCT00320255|5000428|P2|Overall Study|Lack of Efficacy|0
1524433|NCT00320255|5000429|P1|Overall Study|Lack of Efficacy|1
1524434|NCT00320216|5000522|P5|Overall Study|Other|3
1524435|NCT00320216|5000523|P4|Overall Study|Other|1
1524436|NCT00320216|5000524|P3|Overall Study|Other|5
1524437|NCT00320216|5000525|P2|Overall Study|Other|2
1524438|NCT00320216|5000526|P1|Overall Study|Other|7
1524439|NCT00320216|5000522|P5|Overall Study|Lost to Follow-up|0
1524440|NCT00320216|5000523|P4|Overall Study|Lost to Follow-up|0
1524441|NCT00320216|5000524|P3|Overall Study|Lost to Follow-up|0
1524442|NCT00320216|5000525|P2|Overall Study|Lost to Follow-up|0
1524443|NCT00320216|5000526|P1|Overall Study|Lost to Follow-up|3
1524444|NCT00320216|5000522|P5|Overall Study|Lack of Efficacy|1
1524445|NCT00320216|5000523|P4|Overall Study|Lack of Efficacy|0
1524446|NCT00320216|5000524|P3|Overall Study|Lack of Efficacy|1
1524447|NCT00320216|5000525|P2|Overall Study|Lack of Efficacy|2
1524448|NCT00320216|5000526|P1|Overall Study|Lack of Efficacy|6
1524449|NCT00320216|5000522|P5|Overall Study|Adverse Event|2
1524450|NCT00320216|5000523|P4|Overall Study|Adverse Event|2
1524451|NCT00320216|5000524|P3|Overall Study|Adverse Event|0
1524452|NCT00320216|5000525|P2|Overall Study|Adverse Event|6
1524453|NCT00320216|5000526|P1|Overall Study|Adverse Event|0
1524454|NCT00320190|5000560|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
1524455|NCT00320190|5000561|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
1524456|NCT00320190|5000560|P2|Long-term (12-month) Extension|Lack of major molecular response|2
1524457|NCT00320190|5000561|P1|Long-term (12-month) Extension|Lack of major molecular response|1
1524458|NCT00320190|5000560|P2|Long-term (12-month) Extension|Sponsor terminated study|0
1524459|NCT00320190|5000561|P1|Long-term (12-month) Extension|Sponsor terminated study|7
1524460|NCT00320190|5000560|P2|First 12 Months|Withdrawal by Subject|1
1524461|NCT00320190|5000561|P1|First 12 Months|Withdrawal by Subject|0
1524462|NCT00320190|5000560|P2|First 12 Months|Study drug toxicity|1
1524463|NCT00320190|5000561|P1|First 12 Months|Study drug toxicity|0
1524464|NCT00320190|5000560|P2|First 12 Months|Investigator request|1
1524465|NCT00320190|5000561|P1|First 12 Months|Investigator request|0
1524466|NCT00320190|5000560|P2|First 12 Months|Adverse event unrelated to study drug|0
1524467|NCT00320190|5000561|P1|First 12 Months|Adverse event unrelated to study drug|1
1524468|NCT00320190|5000560|P2|First 12 Months|Enrollment failure|1
1524469|NCT00320190|5000561|P1|First 12 Months|Enrollment failure|0
1524470|NCT00320190|5000560|P2|First 12 Months|Lost to Follow-up|1
1524471|NCT00320190|5000561|P1|First 12 Months|Lost to Follow-up|0
1524472|NCT00320190|5000560|P2|First 12 Months|Sponsor terminated study|2
1524473|NCT00320190|5000561|P1|First 12 Months|Sponsor terminated study|2
1524474|NCT00320190|5000560|P2|First 12 Months|Completed but did not enter extension|3
1524475|NCT00320190|5000561|P1|First 12 Months|Completed but did not enter extension|5
1524476|NCT00320112|5000581|P2|Overall Study|Death|1
1524477|NCT00320112|5000582|P1|Overall Study|Death|2
1524478|NCT00320112|5000581|P2|Overall Study|Withdrawal by Subject|0
1524479|NCT00320112|5000582|P1|Overall Study|Withdrawal by Subject|3
1524480|NCT00320112|5000581|P2|Overall Study|Lost to Follow-up|4
1524481|NCT00320112|5000582|P1|Overall Study|Lost to Follow-up|3
1524482|NCT00319982|5000596|P2|Overall Study|Withdrawal by Subject|0
1524483|NCT00319982|5000597|P1|Overall Study|Withdrawal by Subject|1
1524484|NCT00319956|5000617|P2|Overall Study|Death|24
1524485|NCT00319956|5000618|P1|Overall Study|Death|20
1524486|NCT00319839|5000630|P1|Overall Study|Withdrawal by Subject|1
1524487|NCT00319839|5000630|P1|Overall Study|Adverse Event|5
1524488|NCT00319735|5000646|P1|Overall Study|Death|2
1524489|NCT00319696|5000659|P1|Overall Study|Lost to Follow-up|3
1524490|NCT00319696|5000659|P1|Overall Study|administrative|7
1524491|NCT00319696|5000659|P1|Overall Study|withdrawal of consent|14
1524492|NCT00319696|5000659|P1|Overall Study|Adverse Event|36
1524493|NCT00319592|5000696|P2|Overall Study|Physician Decision|1
1524494|NCT00319592|5000697|P1|Overall Study|Physician Decision|0
1524495|NCT00319592|5000696|P2|Overall Study|Protocol Violation|0
1524496|NCT00319592|5000697|P1|Overall Study|Protocol Violation|1
1524497|NCT00319553|5000713|P2|Overall Study|Withdrawal by Subject|1
1524498|NCT00319553|5000714|P1|Overall Study|Withdrawal by Subject|1
1524499|NCT00319553|5000713|P2|Overall Study|Lost to Follow-up|1
1524500|NCT00319553|5000714|P1|Overall Study|Lost to Follow-up|2
1524501|NCT00319553|5000713|P2|Overall Study|Protocol Violation|2
1524502|NCT00319553|5000714|P1|Overall Study|Protocol Violation|1
1524503|NCT00319501|5000728|P2|Open-label Extension Period|Withdrawal by Subject|0
1524504|NCT00319501|5000729|P1|Open-label Extension Period|Withdrawal by Subject|2
1524505|NCT00319501|5000728|P2|Open-label Extension Period|Sponsor request|0
1524506|NCT00319501|5000729|P1|Open-label Extension Period|Sponsor request|26
1524507|NCT00319501|5000728|P2|Open-label Extension Period|Principal investigator decision|0
1524508|NCT00319501|5000729|P1|Open-label Extension Period|Principal investigator decision|2
1524509|NCT00319501|5000728|P2|Open-label Extension Period|Not specified|0
1524510|NCT00319501|5000729|P1|Open-label Extension Period|Not specified|1
1524511|NCT00319501|5000728|P2|Open-label Extension Period|Did not receive treatment|0
1524512|NCT00319501|5000729|P1|Open-label Extension Period|Did not receive treatment|18
1524513|NCT00319501|5000728|P2|Open-label Extension Period|Adverse Event|0
1524514|NCT00319501|5000729|P1|Open-label Extension Period|Adverse Event|2
1524515|NCT00319501|5000728|P2|Open-label Period|Not specified|0
1524516|NCT00319501|5000729|P1|Open-label Period|Not specified|11
1524517|NCT00319501|5000728|P2|Open-label Period|Did not receive treatment|0
1524518|NCT00319501|5000729|P1|Open-label Period|Did not receive treatment|33
1524519|NCT00319501|5000728|P2|Open-label Period|Lost to Follow-up|0
1524520|NCT00319501|5000729|P1|Open-label Period|Lost to Follow-up|5
1524521|NCT00319501|5000728|P2|Open-label Period|Sponsor request|0
1524522|NCT00319501|5000729|P1|Open-label Period|Sponsor request|12
1524523|NCT00319501|5000728|P2|Open-label Period|Principal Investigator decision|0
1524524|NCT00319501|5000729|P1|Open-label Period|Principal Investigator decision|6
1524525|NCT00319501|5000728|P2|Open-label Period|Withdrawal by Subject|0
1524526|NCT00319501|5000729|P1|Open-label Period|Withdrawal by Subject|38
1524527|NCT00319501|5000728|P2|Open-label Period|Protocol Violation|0
1524528|NCT00319501|5000729|P1|Open-label Period|Protocol Violation|6
1524529|NCT00319501|5000728|P2|Open-label Period|Adverse Event|0
1524530|NCT00319501|5000729|P1|Open-label Period|Adverse Event|5
1524531|NCT00319501|5000728|P2|Double-blind Period|Did not receive treatment|29
1524532|NCT00319501|5000729|P1|Double-blind Period|Did not receive treatment|42
1524533|NCT00319501|5000728|P2|Double-blind Period|Sponsor Request|0
1524534|NCT00319501|5000729|P1|Double-blind Period|Sponsor Request|1
1524535|NCT00319501|5000728|P2|Double-blind Period|Withdrawal by Subject|3
1524536|NCT00319501|5000729|P1|Double-blind Period|Withdrawal by Subject|0
1524537|NCT00319449|5000755|P2|Overall Study|Noncompliance with the protocol|0
1524538|NCT00319449|5000756|P1|Overall Study|Noncompliance with the protocol|1
1524539|NCT00319449|5000755|P2|Overall Study|Subject did not wish to continue|0
1524540|NCT00319449|5000756|P1|Overall Study|Subject did not wish to continue|1
1524541|NCT00319436|5000768|P2|Overall Study|Withdrawal by Subject|7
1524542|NCT00319436|5000769|P1|Overall Study|Withdrawal by Subject|6
1524543|NCT00319254|5000787|P1|Overall Study|Enrolled, Not Treated|2
1524544|NCT00319254|5000787|P1|Overall Study|Lost to Follow-up|2
1524545|NCT00319254|5000787|P1|Overall Study|Death|46
1524546|NCT00319254|5000787|P1|Overall Study|Withdrawal by Subject|4
1524547|NCT00319111|5000800|P1|Overall Study|Treatment failure|1
1524548|NCT00319111|5000800|P1|Overall Study|Administrative|2
1524549|NCT00319111|5000800|P1|Overall Study|Lack of clinical improvement|4
1524550|NCT00319111|5000800|P1|Overall Study|Death|9
1524551|NCT00319111|5000800|P1|Overall Study|Withdrawal of consent|11
1524552|NCT00319111|5000800|P1|Overall Study|Adverse Event|20
1524553|NCT00319098|5000814|P2|Overall Study|Protocol Violation|1
1524554|NCT00319098|5000815|P1|Overall Study|Protocol Violation|3
1524555|NCT00319098|5000814|P2|Overall Study|Others|8
1524556|NCT00319098|5000815|P1|Overall Study|Others|33
1524557|NCT00319098|5000814|P2|Overall Study|Lost to Follow-up|13
1524558|NCT00319098|5000815|P1|Overall Study|Lost to Follow-up|37
1524559|NCT00319098|5000814|P2|Overall Study|Migrated/moved from study area|1
1524560|NCT00319098|5000815|P1|Overall Study|Migrated/moved from study area|2
1524561|NCT00319098|5000814|P2|Overall Study|Withdrawal by Subject|8
1524562|NCT00319098|5000815|P1|Overall Study|Withdrawal by Subject|37
1524563|NCT00319098|5000814|P2|Overall Study|Adverse Event|1
1524564|NCT00319098|5000815|P1|Overall Study|Adverse Event|20
1524565|NCT00319098|5000814|P2|Overall Study|Serious adverse event|0
1524566|NCT00319098|5000815|P1|Overall Study|Serious adverse event|3
1524567|NCT00319046|5000873|P1|Overall Study|administrative reason|1
1524568|NCT00319046|5000873|P1|Overall Study|withdrawal of subject's consent|7
1524569|NCT00319020|5000882|P2|Overall Study|Adverse Event|1
1524570|NCT00319020|5000883|P1|Overall Study|Adverse Event|0
1524571|NCT00319020|5000882|P2|Overall Study|Treatment failure|1
1524572|NCT00319020|5000883|P1|Overall Study|Treatment failure|0
1524573|NCT00319020|5000882|P2|Overall Study|Transplant|1
1524574|NCT00319020|5000883|P1|Overall Study|Transplant|0
1524575|NCT00319020|5000882|P2|Overall Study|Disease progression|2
1524576|NCT00319020|5000883|P1|Overall Study|Disease progression|0
1524577|NCT00319020|5000882|P2|Overall Study|Administrative reason|5
1524578|NCT00319020|5000883|P1|Overall Study|Administrative reason|0
1524579|NCT00319020|5000882|P2|Overall Study|F-1 completed but not enrolled in F-2|0
1524580|NCT00319020|5000883|P1|Overall Study|F-1 completed but not enrolled in F-2|1
1524581|NCT00319020|5000882|P2|Overall Study|Withdrawal by Subject|1
1524582|NCT00319020|5000883|P1|Overall Study|Withdrawal by Subject|4
1524583|NCT00319020|5000882|P2|Overall Study|Death|2
1524584|NCT00319020|5000883|P1|Overall Study|Death|2
1524585|NCT00318656|5000955|P2|Overall Study|Did not receive any treatment|1
1524586|NCT00318656|5000956|P1|Overall Study|Did not receive any treatment|0
1524587|NCT00318656|5000955|P2|Overall Study|Took Avandamet instead of Glim/Met|1
1524588|NCT00318656|5000956|P1|Overall Study|Took Avandamet instead of Glim/Met|0
1524589|NCT00318565|5001013|P1|Overall Study|Excluded per protocol|24
1524590|NCT00318474|5001020|P2|Overall Study|Trial terminated|7
1524591|NCT00318474|5001021|P1|Overall Study|Trial terminated|10
1524592|NCT00318474|5001020|P2|Overall Study|Post-therapy hyperflycemia|1
1524593|NCT00318474|5001021|P1|Overall Study|Post-therapy hyperflycemia|0
1524594|NCT00318474|5001020|P2|Overall Study|Fall in GFR|3
1524595|NCT00318474|5001021|P1|Overall Study|Fall in GFR|3
1524596|NCT00318474|5001020|P2|Overall Study|Withdrawal by Subject|2
1524597|NCT00318474|5001021|P1|Overall Study|Withdrawal by Subject|3
1524598|NCT00318474|5001020|P2|Overall Study|Protocol Violation|0
1524599|NCT00318474|5001021|P1|Overall Study|Protocol Violation|1
1524600|NCT00318474|5001020|P2|Overall Study|Pregnancy|2
1524601|NCT00318474|5001021|P1|Overall Study|Pregnancy|0
1524602|NCT00318474|5001020|P2|Overall Study|Lost to Follow-up|1
1524603|NCT00318474|5001021|P1|Overall Study|Lost to Follow-up|0
1524604|NCT00318474|5001020|P2|Overall Study|Adverse Event|1
1524605|NCT00318474|5001021|P1|Overall Study|Adverse Event|1
1524606|NCT00318461|5001032|P5|Open-Label Extension, 18 Months|Protocol Violation|6
1524607|NCT00318461|5001033|P4|Open-Label Extension, 18 Months|Protocol Violation|4
1524608|NCT00318461|5001034|P3|Open-Label Extension, 18 Months|Protocol Violation|3
1524609|NCT00318461|5001035|P2|Open-Label Extension, 18 Months|Protocol Violation|5
1524610|NCT00318461|5001036|P1|Open-Label Extension, 18 Months|Protocol Violation|7
1524611|NCT00318461|5001032|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
1524612|NCT00318461|5001033|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
1524613|NCT00318461|5001034|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
1524614|NCT00318461|5001035|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
1524615|NCT00318461|5001036|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
1524616|NCT00318461|5001032|P5|Open-Label Extension, 18 Months|Adverse Event|6
1524617|NCT00318461|5001033|P4|Open-Label Extension, 18 Months|Adverse Event|1
1524618|NCT00318461|5001034|P3|Open-Label Extension, 18 Months|Adverse Event|6
1524619|NCT00318461|5001035|P2|Open-Label Extension, 18 Months|Adverse Event|8
1524620|NCT00318461|5001036|P1|Open-Label Extension, 18 Months|Adverse Event|11
1524621|NCT00318461|5001032|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
1524622|NCT00318461|5001033|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
1524623|NCT00318461|5001034|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
1524624|NCT00318461|5001035|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
1524625|NCT00318461|5001036|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
1524626|NCT00318461|5001032|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
1524627|NCT00318461|5001033|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
1524628|NCT00318461|5001034|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
1524629|NCT00318461|5001035|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
1524630|NCT00318461|5001036|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
1524631|NCT00318461|5001032|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
1524632|NCT00318461|5001033|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1524633|NCT00318461|5001034|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1524634|NCT00318461|5001035|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1524635|NCT00318461|5001036|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1524636|NCT00318461|5001032|P5|Double-Blind, 6 Months|Hyperglicaemia|0
1524637|NCT00318461|5001033|P4|Double-Blind, 6 Months|Hyperglicaemia|1
1524638|NCT00318461|5001034|P3|Double-Blind, 6 Months|Hyperglicaemia|0
1524639|NCT00318461|5001035|P2|Double-Blind, 6 Months|Hyperglicaemia|0
1524640|NCT00318461|5001036|P1|Double-Blind, 6 Months|Hyperglicaemia|0
1524641|NCT00318461|5001032|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
1524642|NCT00318461|5001033|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1524643|NCT00318461|5001034|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1524644|NCT00318461|5001035|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1524645|NCT00318461|5001036|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1524646|NCT00318461|5001032|P5|Double-Blind, 6 Months|Lack of time|0
1524647|NCT00318461|5001033|P4|Double-Blind, 6 Months|Lack of time|0
1524648|NCT00318461|5001034|P3|Double-Blind, 6 Months|Lack of time|0
1524649|NCT00318461|5001035|P2|Double-Blind, 6 Months|Lack of time|0
1524650|NCT00318461|5001036|P1|Double-Blind, 6 Months|Lack of time|1
1524651|NCT00318461|5001032|P5|Double-Blind, 6 Months|Investigator decision|1
1524652|NCT00318461|5001033|P4|Double-Blind, 6 Months|Investigator decision|0
1524653|NCT00318461|5001034|P3|Double-Blind, 6 Months|Investigator decision|0
1524654|NCT00318461|5001035|P2|Double-Blind, 6 Months|Investigator decision|0
1524655|NCT00318461|5001036|P1|Double-Blind, 6 Months|Investigator decision|0
1524656|NCT00318461|5001032|P5|Double-Blind, 6 Months|Work commitment|1
1524657|NCT00318461|5001033|P4|Double-Blind, 6 Months|Work commitment|0
1524658|NCT00318461|5001034|P3|Double-Blind, 6 Months|Work commitment|0
1524659|NCT00318461|5001035|P2|Double-Blind, 6 Months|Work commitment|0
1524660|NCT00318461|5001036|P1|Double-Blind, 6 Months|Work commitment|0
1524661|NCT00318461|5001032|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
1524662|NCT00318461|5001033|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
1524663|NCT00318461|5001034|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
1524664|NCT00318461|5001035|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
1524665|NCT00318461|5001036|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
1524666|NCT00318461|5001032|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
1524667|NCT00318461|5001033|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1524668|NCT00318461|5001034|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1524669|NCT00318461|5001035|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1524670|NCT00318461|5001036|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1524671|NCT00318461|5001032|P5|Double-Blind, 6 Months|Move|0
1524672|NCT00318461|5001033|P4|Double-Blind, 6 Months|Move|0
1524673|NCT00318461|5001034|P3|Double-Blind, 6 Months|Move|0
1524674|NCT00318461|5001035|P2|Double-Blind, 6 Months|Move|1
1524675|NCT00318461|5001036|P1|Double-Blind, 6 Months|Move|0
1524676|NCT00318461|5001032|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
1524677|NCT00318461|5001033|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
1524678|NCT00318461|5001034|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
1524679|NCT00318461|5001035|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
1524680|NCT00318461|5001036|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
1524681|NCT00318461|5001032|P5|Double-Blind, 6 Months|Consent withdrawn|4
1524682|NCT00318461|5001033|P4|Double-Blind, 6 Months|Consent withdrawn|10
1524683|NCT00318461|5001034|P3|Double-Blind, 6 Months|Consent withdrawn|4
1524684|NCT00318461|5001035|P2|Double-Blind, 6 Months|Consent withdrawn|3
1524685|NCT00318461|5001036|P1|Double-Blind, 6 Months|Consent withdrawn|0
1524686|NCT00318461|5001032|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1524687|NCT00318461|5001033|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1524688|NCT00318461|5001034|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1524689|NCT00318461|5001035|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
1524690|NCT00318461|5001036|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1524691|NCT00318461|5001032|P5|Double-Blind, 6 Months|Lost to follow up|0
1524692|NCT00318461|5001033|P4|Double-Blind, 6 Months|Lost to follow up|0
1524693|NCT00318461|5001034|P3|Double-Blind, 6 Months|Lost to follow up|0
1524694|NCT00318461|5001035|P2|Double-Blind, 6 Months|Lost to follow up|1
1524695|NCT00318461|5001036|P1|Double-Blind, 6 Months|Lost to follow up|0
1524696|NCT00318461|5001032|P5|Double-Blind, 6 Months|Protocol Violation|5
1524697|NCT00318461|5001033|P4|Double-Blind, 6 Months|Protocol Violation|4
1524698|NCT00318461|5001034|P3|Double-Blind, 6 Months|Protocol Violation|4
1524699|NCT00318461|5001035|P2|Double-Blind, 6 Months|Protocol Violation|4
1524700|NCT00318461|5001036|P1|Double-Blind, 6 Months|Protocol Violation|2
1524701|NCT00318461|5001032|P5|Double-Blind, 6 Months|Lack of Efficacy|9
1524702|NCT00318461|5001033|P4|Double-Blind, 6 Months|Lack of Efficacy|29
1524703|NCT00318461|5001034|P3|Double-Blind, 6 Months|Lack of Efficacy|13
1524704|NCT00318461|5001035|P2|Double-Blind, 6 Months|Lack of Efficacy|8
1524705|NCT00318461|5001036|P1|Double-Blind, 6 Months|Lack of Efficacy|19
1524706|NCT00318461|5001032|P5|Double-Blind, 6 Months|Adverse Event|8
1524707|NCT00318461|5001033|P4|Double-Blind, 6 Months|Adverse Event|2
1524708|NCT00318461|5001034|P3|Double-Blind, 6 Months|Adverse Event|29
1524709|NCT00318461|5001035|P2|Double-Blind, 6 Months|Adverse Event|23
1524710|NCT00318461|5001036|P1|Double-Blind, 6 Months|Adverse Event|11
1524711|NCT00318370|5001135|P3|Period 3|Other|3
1524712|NCT00318370|5001136|P2|Period 3|Other|0
1524713|NCT00318370|5001137|P1|Period 3|Other|0
1524714|NCT00318370|5001135|P3|Period 3|Withdrawal by Subject|3
1524715|NCT00318370|5001136|P2|Period 3|Withdrawal by Subject|0
1524716|NCT00318370|5001137|P1|Period 3|Withdrawal by Subject|0
1524717|NCT00318370|5001135|P3|Period 3|Physician Decision|1
1524718|NCT00318370|5001136|P2|Period 3|Physician Decision|0
1524719|NCT00318370|5001137|P1|Period 3|Physician Decision|0
1524720|NCT00318370|5001135|P3|Period 3|Death|1
1524721|NCT00318370|5001136|P2|Period 3|Death|0
1524722|NCT00318370|5001137|P1|Period 3|Death|0
1524723|NCT00318370|5001135|P3|Period 3|Lack of Efficacy|24
1524724|NCT00318370|5001136|P2|Period 3|Lack of Efficacy|0
1524725|NCT00318370|5001137|P1|Period 3|Lack of Efficacy|0
1524726|NCT00318370|5001135|P3|Period 3|Adverse Event|1
1524727|NCT00318370|5001136|P2|Period 3|Adverse Event|0
1524728|NCT00318370|5001137|P1|Period 3|Adverse Event|0
1524729|NCT00318370|5001135|P3|Period 2|Other|0
1524730|NCT00318370|5001136|P2|Period 2|Other|1
1524731|NCT00318370|5001137|P1|Period 2|Other|0
1524732|NCT00318370|5001135|P3|Period 2|Withdrawal by Subject|0
1524733|NCT00318370|5001136|P2|Period 2|Withdrawal by Subject|1
1524734|NCT00318370|5001137|P1|Period 2|Withdrawal by Subject|0
1524735|NCT00318370|5001135|P3|Period 2|Physician Decision|0
1524736|NCT00318370|5001136|P2|Period 2|Physician Decision|1
1524737|NCT00318370|5001137|P1|Period 2|Physician Decision|0
1524738|NCT00318370|5001135|P3|Period 2|Lack of Efficacy|0
1524739|NCT00318370|5001136|P2|Period 2|Lack of Efficacy|5
1524740|NCT00318370|5001137|P1|Period 2|Lack of Efficacy|0
1524741|NCT00318370|5001135|P3|Period 2|Adverse Event|0
1524742|NCT00318370|5001136|P2|Period 2|Adverse Event|3
1524743|NCT00318370|5001137|P1|Period 2|Adverse Event|0
1524744|NCT00318370|5001135|P3|Period 1|Withdrawal by Subject|0
1524745|NCT00318370|5001136|P2|Period 1|Withdrawal by Subject|0
1524746|NCT00318370|5001137|P1|Period 1|Withdrawal by Subject|1
1524747|NCT00318370|5001135|P3|Period 1|Physician Decision|0
1524748|NCT00318370|5001136|P2|Period 1|Physician Decision|0
1524749|NCT00318370|5001137|P1|Period 1|Physician Decision|1
1524750|NCT00318370|5001135|P3|Period 1|Lack of Efficacy|0
1524751|NCT00318370|5001136|P2|Period 1|Lack of Efficacy|0
1524752|NCT00318370|5001137|P1|Period 1|Lack of Efficacy|5
1524753|NCT00318149|5001162|P6|Overall Study|Adverse Event|2
1524754|NCT00318149|5001163|P5|Overall Study|Adverse Event|0
1524755|NCT00318149|5001164|P4|Overall Study|Adverse Event|0
1524756|NCT00318149|5001165|P3|Overall Study|Adverse Event|0
1524757|NCT00318149|5001166|P2|Overall Study|Adverse Event|0
1524758|NCT00318149|5001167|P1|Overall Study|Adverse Event|0
1524759|NCT00317642|5001313|P2|Overall Study|AML Not Centrally Confirmed|5
1524760|NCT00317642|5001314|P1|Overall Study|AML Not Centrally Confirmed|1
1524761|NCT00317642|5001313|P2|Overall Study|Referred For Transplantation|0
1524762|NCT00317642|5001314|P1|Overall Study|Referred For Transplantation|1
1524763|NCT00317642|5001313|P2|Overall Study|Withdrawal by Subject|1
1524764|NCT00317642|5001314|P1|Overall Study|Withdrawal by Subject|0
1524765|NCT00317642|5001313|P2|Overall Study|Not Continue to Consolidation|0
1524766|NCT00317642|5001314|P1|Overall Study|Not Continue to Consolidation|2
1524767|NCT00317642|5001313|P2|Overall Study|Death|7
1524768|NCT00317642|5001314|P1|Overall Study|Death|14
1524769|NCT00317642|5001313|P2|Overall Study|Disease Recurrence|2
1524770|NCT00317642|5001314|P1|Overall Study|Disease Recurrence|1
1524771|NCT00317642|5001313|P2|Overall Study|Treatment Failure|102
1524772|NCT00317642|5001314|P1|Overall Study|Treatment Failure|56
1524773|NCT00317642|5001313|P2|Overall Study|Adverse Event|5
1524774|NCT00317642|5001314|P1|Overall Study|Adverse Event|17
1524775|NCT00317642|5001313|P2|Overall Study|Participant declined treatment|3
1524776|NCT00317642|5001314|P1|Overall Study|Participant declined treatment|14
1524777|NCT00317642|5001313|P2|Overall Study|Physician Decision|7
1524778|NCT00317642|5001314|P1|Overall Study|Physician Decision|15
1524779|NCT00317642|5001313|P2|Overall Study|Not Received Either Study Drug|3
1524780|NCT00317642|5001314|P1|Overall Study|Not Received Either Study Drug|1
1524781|NCT00317473|5001393|P6|Overall Study|Other|0
1524782|NCT00317473|5001394|P5|Overall Study|Other|0
1524783|NCT00317473|5001395|P4|Overall Study|Other|0
1524784|NCT00317473|5001396|P3|Overall Study|Other|0
1524785|NCT00317473|5001397|P2|Overall Study|Other|2
1524786|NCT00317473|5001398|P1|Overall Study|Other|0
1524787|NCT00317473|5001393|P6|Overall Study|Death|0
1524788|NCT00317473|5001394|P5|Overall Study|Death|0
1524789|NCT00317473|5001395|P4|Overall Study|Death|0
1524790|NCT00317473|5001396|P3|Overall Study|Death|0
1524791|NCT00317473|5001397|P2|Overall Study|Death|0
1524792|NCT00317473|5001398|P1|Overall Study|Death|1
1524793|NCT00317473|5001393|P6|Overall Study|Relocation|2
1524794|NCT00317473|5001394|P5|Overall Study|Relocation|5
1524795|NCT00317473|5001395|P4|Overall Study|Relocation|1
1524796|NCT00317473|5001396|P3|Overall Study|Relocation|1
1524797|NCT00317473|5001397|P2|Overall Study|Relocation|0
1524798|NCT00317473|5001398|P1|Overall Study|Relocation|1
1524799|NCT00317473|5001393|P6|Overall Study|Withdrawal by Subject|1
1524800|NCT00317473|5001394|P5|Overall Study|Withdrawal by Subject|3
1524801|NCT00317473|5001395|P4|Overall Study|Withdrawal by Subject|1
1524802|NCT00317473|5001396|P3|Overall Study|Withdrawal by Subject|2
1524803|NCT00317473|5001397|P2|Overall Study|Withdrawal by Subject|1
1524804|NCT00317473|5001398|P1|Overall Study|Withdrawal by Subject|2
1524805|NCT00317109|5001437|P2|Overall Study|Migated/moved from study area|0
1524806|NCT00317109|5001438|P1|Overall Study|Migated/moved from study area|1
1524807|NCT00317109|5001437|P2|Overall Study|Withdrawal by Subject|0
1524808|NCT00317109|5001438|P1|Overall Study|Withdrawal by Subject|2
1524809|NCT00317044|5001475|P3|Overall Study|Multiple Reasons|6
1524810|NCT00317044|5001476|P2|Overall Study|Multiple Reasons|2
1524811|NCT00317044|5001477|P1|Overall Study|Multiple Reasons|6
1524812|NCT00317044|5001475|P3|Overall Study|Lost to Follow-up|3
1524813|NCT00317044|5001476|P2|Overall Study|Lost to Follow-up|2
1524814|NCT00317044|5001477|P1|Overall Study|Lost to Follow-up|0
1524815|NCT00317044|5001475|P3|Overall Study|Withdrawal by Subject|12
1524816|NCT00317044|5001476|P2|Overall Study|Withdrawal by Subject|7
1524817|NCT00317044|5001477|P1|Overall Study|Withdrawal by Subject|10
1524818|NCT00317044|5001475|P3|Overall Study|Adverse Event|4
1524819|NCT00317044|5001476|P2|Overall Study|Adverse Event|7
1524820|NCT00317044|5001477|P1|Overall Study|Adverse Event|4
1524821|NCT00317044|5001475|P3|Overall Study|Protocol Violation|20
1524822|NCT00317044|5001476|P2|Overall Study|Protocol Violation|22
1524823|NCT00317044|5001477|P1|Overall Study|Protocol Violation|28
1524824|NCT00316914|5001523|P2|Overall Study|Missing end of treatment documentation|15
1524825|NCT00316914|5001524|P1|Overall Study|Missing end of treatment documentation|14
1524826|NCT00316914|5001523|P2|Overall Study|Other Problems|11
1524827|NCT00316914|5001524|P1|Overall Study|Other Problems|6
1524828|NCT00316914|5001523|P2|Overall Study|Adverse Event|7
1524829|NCT00316914|5001524|P1|Overall Study|Adverse Event|8
1524830|NCT00316914|5001523|P2|Overall Study|Withdrawal by Subject|3
1524831|NCT00316914|5001524|P1|Overall Study|Withdrawal by Subject|5
1524832|NCT00316888|5001554|P2|Overall Study|Not start protocol therapy|1
1524833|NCT00316888|5001555|P1|Overall Study|Not start protocol therapy|0
1524834|NCT00316888|5001554|P2|Overall Study|Withdrawal by Subject|2
1524835|NCT00316888|5001555|P1|Overall Study|Withdrawal by Subject|2
1524836|NCT00316888|5001554|P2|Overall Study|Adverse Event|5
1524837|NCT00316888|5001555|P1|Overall Study|Adverse Event|4
1524838|NCT00316719|5001577|P2|Overall Study|Consent withdrawn|0
1524839|NCT00316719|5001578|P1|Overall Study|Consent withdrawn|2
1524840|NCT00316719|5001577|P2|Overall Study|Adverse Event|6
1524841|NCT00316719|5001578|P1|Overall Study|Adverse Event|0
1524842|NCT00316706|5001604|P2|Overall Study|Lost to Follow-up|48
1524843|NCT00316706|5001605|P1|Overall Study|Lost to Follow-up|38
1524844|NCT00316693|5001621|P2|Overall Study|Other|44
1524845|NCT00316693|5001622|P1|Overall Study|Other|38
1524846|NCT00316693|5001621|P2|Overall Study|Lost to Follow-up|34
1524847|NCT00316693|5001622|P1|Overall Study|Lost to Follow-up|26
1524848|NCT00316693|5001621|P2|Overall Study|Withdrawal by Subject|6
1524849|NCT00316693|5001622|P1|Overall Study|Withdrawal by Subject|6
1524850|NCT00316693|5001621|P2|Overall Study|Protocol Violation|0
1524851|NCT00316693|5001622|P1|Overall Study|Protocol Violation|1
1524852|NCT00316693|5001621|P2|Overall Study|Adverse Event|1
1524853|NCT00316693|5001622|P1|Overall Study|Adverse Event|6
1524854|NCT00316303|5001675|P2|Overall Study|Lost to Follow-up|16
1524855|NCT00316303|5001676|P1|Overall Study|Lost to Follow-up|11
1524856|NCT00316277|5001692|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
1524857|NCT00316277|5001693|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
1524858|NCT00316277|5001692|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
1524859|NCT00316277|5001693|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
1524860|NCT00316277|5001692|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
1524861|NCT00316277|5001693|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
1524862|NCT00316277|5001692|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
1524863|NCT00316277|5001693|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
1524864|NCT00316277|5001692|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
1524865|NCT00316277|5001693|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
1524866|NCT00316264|5001714|P3|Overall Study|not specified|0
1524867|NCT00316264|5001715|P2|Overall Study|not specified|1
1524868|NCT00316264|5001716|P1|Overall Study|not specified|1
1524869|NCT00316264|5001714|P3|Overall Study|Death|0
1524870|NCT00316264|5001715|P2|Overall Study|Death|0
1524871|NCT00316264|5001716|P1|Overall Study|Death|2
1524872|NCT00316264|5001714|P3|Overall Study|Withdrawal of Consent|6
1524873|NCT00316264|5001715|P2|Overall Study|Withdrawal of Consent|5
1524874|NCT00316264|5001716|P1|Overall Study|Withdrawal of Consent|3
1524875|NCT00316264|5001714|P3|Overall Study|Lost to Follow-up|0
1524876|NCT00316264|5001715|P2|Overall Study|Lost to Follow-up|1
1524877|NCT00316264|5001716|P1|Overall Study|Lost to Follow-up|0
1524878|NCT00316225|5001784|P1|Overall Study|Death|2
1524879|NCT00316225|5001784|P1|Overall Study|Withdrawal by Subject|3
1524880|NCT00316225|5001784|P1|Overall Study|Progressive Disease|15
1524881|NCT00316225|5001784|P1|Overall Study|Physician Decision|3
1524882|NCT00316225|5001784|P1|Overall Study|Adverse Event|2
1524883|NCT00316199|5001793|P1|Overall Study|Lost to Follow-up|2
1524884|NCT00316199|5001793|P1|Overall Study|Death|8
1524885|NCT00316199|5001793|P1|Overall Study|Adverse Event|2
1524886|NCT00316186|5001801|P1|Overall Study|Other|1
1524887|NCT00316186|5001801|P1|Overall Study|Lost to Follow-up|1
1524888|NCT00316186|5001801|P1|Overall Study|Disease Progression|4
1524889|NCT00316186|5001801|P1|Overall Study|Adverse Event|6
1524890|NCT00316173|5001815|P2|Treatment Phase|Study Follow-up Stopped|34
1524891|NCT00316173|5001816|P1|Treatment Phase|Study Follow-up Stopped|0
1524892|NCT00316173|5001815|P2|Treatment Phase|Withdrawal by Subject|1
1524893|NCT00316173|5001816|P1|Treatment Phase|Withdrawal by Subject|0
1524894|NCT00316173|5001815|P2|Treatment Phase|Lost to Follow-up|3
1524895|NCT00316173|5001816|P1|Treatment Phase|Lost to Follow-up|0
1524896|NCT00316173|5001815|P2|Treatment Phase|Lack of Efficacy|3
1524897|NCT00316173|5001816|P1|Treatment Phase|Lack of Efficacy|0
1524898|NCT00316173|5001815|P2|Treatment Phase|Adverse Event|1
1524899|NCT00316173|5001816|P1|Treatment Phase|Adverse Event|0
1524900|NCT00316173|5001815|P2|Run-in Phase|Study Follow-up Stopped|0
1524901|NCT00316173|5001816|P1|Run-in Phase|Study Follow-up Stopped|5
1524902|NCT00316173|5001815|P2|Run-in Phase|Protocol Violation|0
1524903|NCT00316173|5001816|P1|Run-in Phase|Protocol Violation|1
1524904|NCT00316173|5001815|P2|Run-in Phase|Adverse Event|0
1524905|NCT00316173|5001816|P1|Run-in Phase|Adverse Event|1
1524906|NCT00316121|5001829|P2|Overall Study|Subject did not have 24 month visit|0
1524907|NCT00316121|5001830|P1|Overall Study|Subject did not have 24 month visit|1
1524908|NCT00316121|5001829|P2|Overall Study|Subject no show for visit x 3|0
1524909|NCT00316121|5001830|P1|Overall Study|Subject no show for visit x 3|1
1524910|NCT00316121|5001829|P2|Overall Study|Subject refused to return|0
1524911|NCT00316121|5001830|P1|Overall Study|Subject refused to return|1
1524912|NCT00316121|5001829|P2|Overall Study|Subject relocated|1
1524913|NCT00316121|5001830|P1|Overall Study|Subject relocated|1
1524914|NCT00316121|5001829|P2|Overall Study|Reason is missing|0
1524915|NCT00316121|5001830|P1|Overall Study|Reason is missing|1
1524916|NCT00316121|5001829|P2|Overall Study|Withdrawal by Subject|0
1524917|NCT00316121|5001830|P1|Overall Study|Withdrawal by Subject|2
1524918|NCT00316121|5001829|P2|Overall Study|Lost to Follow-up|8
1524919|NCT00316121|5001830|P1|Overall Study|Lost to Follow-up|14
1524920|NCT00316121|5001829|P2|Overall Study|Death|0
1524921|NCT00316121|5001830|P1|Overall Study|Death|1
1524922|NCT00316082|5001841|P5|Overall Study|Administrative reason by sponsor|0
1524923|NCT00316082|5001842|P4|Overall Study|Administrative reason by sponsor|0
1524924|NCT00316082|5001843|P3|Overall Study|Administrative reason by sponsor|1
1524925|NCT00316082|5001844|P2|Overall Study|Administrative reason by sponsor|0
1524926|NCT00316082|5001845|P1|Overall Study|Administrative reason by sponsor|0
1524927|NCT00316082|5001841|P5|Overall Study|Death|0
1524928|NCT00316082|5001842|P4|Overall Study|Death|0
1524929|NCT00316082|5001843|P3|Overall Study|Death|1
1524930|NCT00316082|5001844|P2|Overall Study|Death|0
1524931|NCT00316082|5001845|P1|Overall Study|Death|0
1524932|NCT00316082|5001841|P5|Overall Study|Physician Decision|1
1524933|NCT00316082|5001842|P4|Overall Study|Physician Decision|1
1524934|NCT00316082|5001843|P3|Overall Study|Physician Decision|2
1524935|NCT00316082|5001844|P2|Overall Study|Physician Decision|1
1524936|NCT00316082|5001845|P1|Overall Study|Physician Decision|1
1524937|NCT00316082|5001841|P5|Overall Study|Subject no longer meets study criteria|1
1524938|NCT00316082|5001842|P4|Overall Study|Subject no longer meets study criteria|2
1524939|NCT00316082|5001843|P3|Overall Study|Subject no longer meets study criteria|2
1524940|NCT00316082|5001844|P2|Overall Study|Subject no longer meets study criteria|1
1524941|NCT00316082|5001845|P1|Overall Study|Subject no longer meets study criteria|3
1524942|NCT00316082|5001841|P5|Overall Study|Adverse Event|3
1524943|NCT00316082|5001842|P4|Overall Study|Adverse Event|1
1524944|NCT00316082|5001843|P3|Overall Study|Adverse Event|5
1524945|NCT00316082|5001844|P2|Overall Study|Adverse Event|2
1524946|NCT00316082|5001845|P1|Overall Study|Adverse Event|4
1524947|NCT00316082|5001841|P5|Overall Study|Poor/noncompliance|4
1524948|NCT00316082|5001842|P4|Overall Study|Poor/noncompliance|1
1524949|NCT00316082|5001843|P3|Overall Study|Poor/noncompliance|4
1524950|NCT00316082|5001844|P2|Overall Study|Poor/noncompliance|1
1524951|NCT00316082|5001845|P1|Overall Study|Poor/noncompliance|6
1524952|NCT00316082|5001841|P5|Overall Study|Lost to Follow-up|6
1524953|NCT00316082|5001842|P4|Overall Study|Lost to Follow-up|8
1524954|NCT00316082|5001843|P3|Overall Study|Lost to Follow-up|7
1524955|NCT00316082|5001844|P2|Overall Study|Lost to Follow-up|6
1524956|NCT00316082|5001845|P1|Overall Study|Lost to Follow-up|7
1524957|NCT00316082|5001841|P5|Overall Study|Withdrawal of Consent by Subject|5
1524958|NCT00316082|5001842|P4|Overall Study|Withdrawal of Consent by Subject|9
1524959|NCT00316082|5001843|P3|Overall Study|Withdrawal of Consent by Subject|2
1524960|NCT00316082|5001844|P2|Overall Study|Withdrawal of Consent by Subject|8
1524961|NCT00316082|5001845|P1|Overall Study|Withdrawal of Consent by Subject|10
1524962|NCT00316082|5001841|P5|Overall Study|Lack of Efficacy|6
1524963|NCT00316082|5001842|P4|Overall Study|Lack of Efficacy|4
1524964|NCT00316082|5001843|P3|Overall Study|Lack of Efficacy|3
1524965|NCT00316082|5001844|P2|Overall Study|Lack of Efficacy|3
1524966|NCT00316082|5001845|P1|Overall Study|Lack of Efficacy|2
1524967|NCT00316017|5001876|P3|Overall Study|Protocol Violation|19
1524968|NCT00316017|5001877|P2|Overall Study|Protocol Violation|13
1524969|NCT00316017|5001878|P1|Overall Study|Protocol Violation|11
1524970|NCT00316004|5001952|P3|Overall Study|Subject was not given study fluid.|21
1524971|NCT00316004|5001953|P2|Overall Study|Subject was not given study fluid.|14
1524972|NCT00316004|5001954|P1|Overall Study|Subject was not given study fluid.|14
1524973|NCT00315731|5002025|P1|Overall Study|Death|5
1524974|NCT00315731|5002025|P1|Overall Study|Lost to Follow-up|1
1524975|NCT00315705|5002053|P1|Phase 2|Death|7
1524976|NCT00315705|5002053|P1|Phase 2|Other|1
1524977|NCT00315705|5002053|P1|Phase 2|Scheduled for transplant|8
1524978|NCT00315705|5002053|P1|Phase 2|Disease relapse|1
1524979|NCT00315705|5002053|P1|Phase 2|Failure to achieve response|3
1524980|NCT00315705|5002053|P1|Phase 2|Adverse Event|1
1524981|NCT00315705|5002053|P1|Phase 2|Physician Decision|4
1524982|NCT00315705|5002053|P1|Phase 1|Death|3
1524983|NCT00315705|5002053|P1|Phase 1|Scheduled for transplant|9
1524984|NCT00315705|5002053|P1|Phase 1|Disease relapse|4
1524985|NCT00315705|5002053|P1|Phase 1|Failure to achieve response|8
1524986|NCT00315705|5002053|P1|Phase 1|Refused further treatment|1
1524987|NCT00315458|5002114|P4|Overall Study|Did not qualify|0
1524988|NCT00315458|5002115|P3|Overall Study|Did not qualify|1
1524989|NCT00315458|5002116|P2|Overall Study|Did not qualify|0
1524990|NCT00315458|5002117|P1|Overall Study|Did not qualify|0
1524991|NCT00315458|5002114|P4|Overall Study|Lack of Efficacy|1
1524992|NCT00315458|5002115|P3|Overall Study|Lack of Efficacy|20
1524993|NCT00315458|5002116|P2|Overall Study|Lack of Efficacy|0
1524994|NCT00315458|5002117|P1|Overall Study|Lack of Efficacy|0
1524995|NCT00315458|5002114|P4|Overall Study|Withdrawal by Subject|2
1524996|NCT00315458|5002115|P3|Overall Study|Withdrawal by Subject|0
1524997|NCT00315458|5002116|P2|Overall Study|Withdrawal by Subject|3
1524998|NCT00315458|5002117|P1|Overall Study|Withdrawal by Subject|0
1524999|NCT00315458|5002114|P4|Overall Study|Lost to Follow-up|2
1525000|NCT00315458|5002115|P3|Overall Study|Lost to Follow-up|0
1525001|NCT00315458|5002116|P2|Overall Study|Lost to Follow-up|2
1525002|NCT00315458|5002117|P1|Overall Study|Lost to Follow-up|1
1525003|NCT00315458|5002114|P4|Overall Study|Adverse Event|3
1525004|NCT00315458|5002115|P3|Overall Study|Adverse Event|23
1525005|NCT00315458|5002116|P2|Overall Study|Adverse Event|4
1525006|NCT00315458|5002117|P1|Overall Study|Adverse Event|2
1525007|NCT00315458|5002114|P4|Overall Study|Administrative|21
1525008|NCT00315458|5002115|P3|Overall Study|Administrative|8
1525009|NCT00315458|5002116|P2|Overall Study|Administrative|3
1525010|NCT00315458|5002117|P1|Overall Study|Administrative|0
1525011|NCT00315445|5002130|P3|Overall Study|Other|0
1525012|NCT00315445|5002131|P2|Overall Study|Other|3
1525013|NCT00315445|5002132|P1|Overall Study|Other|1
1525014|NCT00315445|5002130|P3|Overall Study|Protocol Violation|1
1525015|NCT00315445|5002131|P2|Overall Study|Protocol Violation|0
1525016|NCT00315445|5002132|P1|Overall Study|Protocol Violation|2
1525017|NCT00315445|5002130|P3|Overall Study|Lost to Follow-up|1
1525018|NCT00315445|5002131|P2|Overall Study|Lost to Follow-up|0
1525019|NCT00315445|5002132|P1|Overall Study|Lost to Follow-up|1
1525020|NCT00315445|5002130|P3|Overall Study|Lack of Efficacy|7
1525021|NCT00315445|5002131|P2|Overall Study|Lack of Efficacy|1
1525022|NCT00315445|5002132|P1|Overall Study|Lack of Efficacy|16
1525023|NCT00315445|5002130|P3|Overall Study|Adverse Event|15
1525024|NCT00315445|5002131|P2|Overall Study|Adverse Event|12
1525025|NCT00315445|5002132|P1|Overall Study|Adverse Event|7
1525026|NCT00315055|5002422|P2|Overall Study|Lost to Follow-up|1
1525027|NCT00315055|5002423|P1|Overall Study|Lost to Follow-up|1
1525028|NCT00315055|5002422|P2|Overall Study|Protocol Violation|4
1525029|NCT00315055|5002423|P1|Overall Study|Protocol Violation|2
1525030|NCT00314951|5002441|P2|Follow-up|mITT failure|34
1525031|NCT00314951|5002442|P1|Follow-up|mITT failure|44
1525032|NCT00314951|5002441|P2|Treatment|Didn't meet criteria for mITT population|11
1525033|NCT00314951|5002442|P1|Treatment|Didn't meet criteria for mITT population|16
1525034|NCT00314808|5002452|P1|Overall Study|Withdrawal by Subject/PI without AE|4
1525035|NCT00314808|5002452|P1|Overall Study|Disease Progression without AE|4
1525036|NCT00314574|5002462|P2|Overall Study|Data unknown at database lock|1
1525037|NCT00314574|5002463|P1|Overall Study|Data unknown at database lock|0
1525038|NCT00314574|5002462|P2|Overall Study|Pregnancy|4
1525039|NCT00314574|5002463|P1|Overall Study|Pregnancy|6
1525040|NCT00314574|5002462|P2|Overall Study|Physician Decision|15
1525041|NCT00314574|5002463|P1|Overall Study|Physician Decision|22
1525042|NCT00314574|5002462|P2|Overall Study|Withdrawal by Subject|22
1525043|NCT00314574|5002463|P1|Overall Study|Withdrawal by Subject|33
1525044|NCT00314574|5002462|P2|Overall Study|Lost to Follow-up|25
1525045|NCT00314574|5002463|P1|Overall Study|Lost to Follow-up|19
1525046|NCT00314574|5002462|P2|Overall Study|Adverse Event|16
1525047|NCT00314574|5002463|P1|Overall Study|Adverse Event|11
1525048|NCT00314574|5002462|P2|Overall Study|Death|0
1525049|NCT00314574|5002463|P1|Overall Study|Death|3
1525050|NCT00314366|5002479|P2|Overall Study|not treated due to patient medical condi|0
1525051|NCT00314366|5002480|P1|Overall Study|not treated due to patient medical condi|1
1525052|NCT00314340|5002525|P1|Overall Study|lost interest|1
1525053|NCT00314327|5002531|P1|Overall Study|Withdrawal by Subject|1
1525054|NCT00314262|5002536|P1|Overall Study|Physician Decision|1
1525055|NCT00314262|5002536|P1|Overall Study|Withdrawal by Subject|2
1525056|NCT00314262|5002536|P1|Overall Study|Adverse Event|2
1525057|NCT00314249|5002544|P2|Overall Study|Non-Compliant|6
1525058|NCT00314249|5002545|P1|Overall Study|Non-Compliant|5
1525059|NCT00314249|5002544|P2|Overall Study|Withdrawn for other reasons|1
1525060|NCT00314249|5002545|P1|Overall Study|Withdrawn for other reasons|4
1525061|NCT00314249|5002544|P2|Overall Study|Physician Decision|1
1525062|NCT00314249|5002545|P1|Overall Study|Physician Decision|1
1525063|NCT00314249|5002544|P2|Overall Study|Lost to Follow-up|9
1525064|NCT00314249|5002545|P1|Overall Study|Lost to Follow-up|15
1525065|NCT00314249|5002544|P2|Overall Study|Withdrawal by Subject|28
1525066|NCT00314249|5002545|P1|Overall Study|Withdrawal by Subject|21
1525067|NCT00314249|5002544|P2|Overall Study|Lack of Efficacy|24
1525068|NCT00314249|5002545|P1|Overall Study|Lack of Efficacy|33
1525069|NCT00314249|5002544|P2|Overall Study|Adverse Event|94
1525070|NCT00314249|5002545|P1|Overall Study|Adverse Event|73
1525071|NCT00314145|5002578|P2|Overall Study|Sponsor Decision|0
1525072|NCT00314145|5002579|P1|Overall Study|Sponsor Decision|2
1525073|NCT00314145|5002578|P2|Overall Study|Protocol Violation|0
1525074|NCT00314145|5002579|P1|Overall Study|Protocol Violation|3
1525075|NCT00314145|5002578|P2|Overall Study|Adverse Event|3
1525076|NCT00314145|5002579|P1|Overall Study|Adverse Event|0
1525077|NCT00314145|5002578|P2|Overall Study|Physician Decision|4
1525078|NCT00314145|5002579|P1|Overall Study|Physician Decision|3
1525079|NCT00314145|5002578|P2|Overall Study|Lost to Follow-up|12
1525080|NCT00314145|5002579|P1|Overall Study|Lost to Follow-up|5
1525081|NCT00314145|5002578|P2|Overall Study|Withdrawal by Subject|10
1525082|NCT00314145|5002579|P1|Overall Study|Withdrawal by Subject|8
1525083|NCT00314132|5002593|P2|Overall Study|Physician Decision|0
1525084|NCT00314132|5002594|P1|Overall Study|Physician Decision|1
1525085|NCT00314132|5002593|P2|Overall Study|Adverse Event|0
1525086|NCT00314132|5002594|P1|Overall Study|Adverse Event|1
1525087|NCT00314132|5002593|P2|Overall Study|Withdrawal by Subject|5
1525088|NCT00314132|5002594|P1|Overall Study|Withdrawal by Subject|3
1525089|NCT00314132|5002593|P2|Overall Study|Lost to Follow-up|13
1525090|NCT00314132|5002594|P1|Overall Study|Lost to Follow-up|3
1525091|NCT00313911|5002615|P2|Overall Study|Did not meet age criteria|1
1525092|NCT00313911|5002616|P1|Overall Study|Did not meet age criteria|1
1525093|NCT00313911|5002615|P2|Overall Study|Withdrawal by Subject|12
1525094|NCT00313911|5002616|P1|Overall Study|Withdrawal by Subject|39
1525095|NCT00313911|5002615|P2|Overall Study|Lost to Follow-up|14
1525096|NCT00313911|5002616|P1|Overall Study|Lost to Follow-up|27
1525097|NCT00313911|5002615|P2|Overall Study|Protocol Violation|10
1525098|NCT00313911|5002616|P1|Overall Study|Protocol Violation|19
1525099|NCT00313911|5002615|P2|Overall Study|Adverse Event|3
1525100|NCT00313911|5002616|P1|Overall Study|Adverse Event|2
1525101|NCT00313911|5002615|P2|Overall Study|Serious adverse event|1
1525102|NCT00313911|5002616|P1|Overall Study|Serious adverse event|6
1525103|NCT00313846|5002630|P2|Overall Study|Administrative|3
1525104|NCT00313846|5002631|P1|Overall Study|Administrative|2
1525105|NCT00313846|5002630|P2|Overall Study|Adverse Event|8
1525106|NCT00313846|5002631|P1|Overall Study|Adverse Event|1
1525107|NCT00313846|5002630|P2|Overall Study|Withdrawal by Subject|0
1525108|NCT00313846|5002631|P1|Overall Study|Withdrawal by Subject|2
1525109|NCT00313820|5002642|P2|Pregabalin or Placebo Treatment Period|Other|3
1525110|NCT00313820|5002643|P1|Pregabalin or Placebo Treatment Period|Other|2
1525111|NCT00313820|5002642|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
1525112|NCT00313820|5002643|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
1525113|NCT00313820|5002642|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
1525114|NCT00313820|5002643|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
1525115|NCT00313820|5002642|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
1525116|NCT00313820|5002643|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
1525117|NCT00313820|5002642|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
1525118|NCT00313820|5002643|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
1525119|NCT00313820|5002642|P2|Assigned to Treatment|Other|0
1525120|NCT00313820|5002643|P1|Assigned to Treatment|Other|1
1525121|NCT00313781|5002681|P3|After Crossover|Other|18
1525122|NCT00313781|5002682|P2|After Crossover|Other|0
1525123|NCT00313781|5002683|P1|After Crossover|Other|0
1525124|NCT00313781|5002681|P3|After Crossover|Withdrawal by Subject|3
1525125|NCT00313781|5002682|P2|After Crossover|Withdrawal by Subject|0
1525126|NCT00313781|5002683|P1|After Crossover|Withdrawal by Subject|0
1525127|NCT00313781|5002681|P3|After Crossover|Death|6
1525128|NCT00313781|5002682|P2|After Crossover|Death|0
1525129|NCT00313781|5002683|P1|After Crossover|Death|0
1525130|NCT00313781|5002681|P3|Before Crossover|Randomized, not treated|0
1525131|NCT00313781|5002682|P2|Before Crossover|Randomized, not treated|0
1525132|NCT00313781|5002683|P1|Before Crossover|Randomized, not treated|5
1525133|NCT00313781|5002681|P3|Before Crossover|Crossover|0
1525134|NCT00313781|5002682|P2|Before Crossover|Crossover|37
1525135|NCT00313781|5002683|P1|Before Crossover|Crossover|0
1525136|NCT00313781|5002681|P3|Before Crossover|Other|0
1525137|NCT00313781|5002682|P2|Before Crossover|Other|30
1525138|NCT00313781|5002683|P1|Before Crossover|Other|45
1525139|NCT00313781|5002681|P3|Before Crossover|Withdrawal by Subject|0
1525140|NCT00313781|5002682|P2|Before Crossover|Withdrawal by Subject|1
1525141|NCT00313781|5002683|P1|Before Crossover|Withdrawal by Subject|3
1525142|NCT00313781|5002681|P3|Before Crossover|Lost to Follow-up|0
1525143|NCT00313781|5002682|P2|Before Crossover|Lost to Follow-up|3
1525144|NCT00313781|5002683|P1|Before Crossover|Lost to Follow-up|0
1525145|NCT00313781|5002681|P3|Before Crossover|Death|0
1525146|NCT00313781|5002682|P2|Before Crossover|Death|8
1525147|NCT00313781|5002683|P1|Before Crossover|Death|22
1525148|NCT00313716|5002723|P6|Overall Study|Withdrawal by Subject|0
1525149|NCT00313716|5002724|P5|Overall Study|Withdrawal by Subject|1
1525150|NCT00313716|5002725|P4|Overall Study|Withdrawal by Subject|0
1525151|NCT00313716|5002726|P3|Overall Study|Withdrawal by Subject|1
1525152|NCT00313716|5002727|P2|Overall Study|Withdrawal by Subject|1
1525153|NCT00313716|5002728|P1|Overall Study|Withdrawal by Subject|0
1525154|NCT00313716|5002723|P6|Overall Study|Lost to Follow-up|4
1525155|NCT00313716|5002724|P5|Overall Study|Lost to Follow-up|0
1525156|NCT00313716|5002725|P4|Overall Study|Lost to Follow-up|1
1525157|NCT00313716|5002726|P3|Overall Study|Lost to Follow-up|2
1525158|NCT00313716|5002727|P2|Overall Study|Lost to Follow-up|5
1525159|NCT00313716|5002728|P1|Overall Study|Lost to Follow-up|2
1525160|NCT00313716|5002723|P6|Overall Study|Death|9
1525161|NCT00313716|5002724|P5|Overall Study|Death|5
1525162|NCT00313716|5002725|P4|Overall Study|Death|3
1525163|NCT00313716|5002726|P3|Overall Study|Death|9
1525164|NCT00313716|5002727|P2|Overall Study|Death|2
1525165|NCT00313716|5002728|P1|Overall Study|Death|3
1525166|NCT00313703|5002755|P4|Overall Study|Lost to Follow-up|12
1525167|NCT00313703|5002756|P3|Overall Study|Lost to Follow-up|5
1525168|NCT00313703|5002757|P2|Overall Study|Lost to Follow-up|2
1525169|NCT00313703|5002758|P1|Overall Study|Lost to Follow-up|11
1525170|NCT00313612|5002774|P2|Overall Study|Patient never received treatment|1
1525171|NCT00313612|5002775|P1|Overall Study|Patient never received treatment|0
1525172|NCT00313586|5002787|P4|Overall Study|Death before starting treatment|0
1525173|NCT00313586|5002788|P3|Overall Study|Death before starting treatment|0
1525174|NCT00313586|5002789|P2|Overall Study|Death before starting treatment|0
1525175|NCT00313586|5002790|P1|Overall Study|Death before starting treatment|1
1525176|NCT00313586|5002787|P4|Overall Study|Moved|0
1525177|NCT00313586|5002788|P3|Overall Study|Moved|0
1525178|NCT00313586|5002789|P2|Overall Study|Moved|1
1525179|NCT00313586|5002790|P1|Overall Study|Moved|0
1525180|NCT00313586|5002787|P4|Overall Study|Lost insurance|0
1525181|NCT00313586|5002788|P3|Overall Study|Lost insurance|0
1525182|NCT00313586|5002789|P2|Overall Study|Lost insurance|1
1525183|NCT00313586|5002790|P1|Overall Study|Lost insurance|0
1525184|NCT00313586|5002787|P4|Overall Study|Absolute neutrophil count not recovered|0
1525185|NCT00313586|5002788|P3|Overall Study|Absolute neutrophil count not recovered|0
1525186|NCT00313586|5002789|P2|Overall Study|Absolute neutrophil count not recovered|1
1525187|NCT00313586|5002790|P1|Overall Study|Absolute neutrophil count not recovered|2
1525188|NCT00313586|5002787|P4|Overall Study|Physician Decision|0
1525189|NCT00313586|5002788|P3|Overall Study|Physician Decision|0
1525190|NCT00313586|5002789|P2|Overall Study|Physician Decision|1
1525191|NCT00313586|5002790|P1|Overall Study|Physician Decision|2
1525192|NCT00313586|5002787|P4|Overall Study|Did not achieve HI-major/better response|1
1525193|NCT00313586|5002788|P3|Overall Study|Did not achieve HI-major/better response|2
1525194|NCT00313586|5002789|P2|Overall Study|Did not achieve HI-major/better response|7
1525195|NCT00313586|5002790|P1|Overall Study|Did not achieve HI-major/better response|10
1525196|NCT00313586|5002787|P4|Overall Study|Other complicating disease|0
1525197|NCT00313586|5002788|P3|Overall Study|Other complicating disease|0
1525198|NCT00313586|5002789|P2|Overall Study|Other complicating disease|2
1525199|NCT00313586|5002790|P1|Overall Study|Other complicating disease|2
1525200|NCT00313586|5002787|P4|Overall Study|Alternative therapy|0
1525201|NCT00313586|5002788|P3|Overall Study|Alternative therapy|2
1525202|NCT00313586|5002789|P2|Overall Study|Alternative therapy|6
1525203|NCT00313586|5002790|P1|Overall Study|Alternative therapy|3
1525204|NCT00313586|5002787|P4|Overall Study|Withdrawal by Subject|2
1525205|NCT00313586|5002788|P3|Overall Study|Withdrawal by Subject|6
1525206|NCT00313586|5002789|P2|Overall Study|Withdrawal by Subject|6
1525207|NCT00313586|5002790|P1|Overall Study|Withdrawal by Subject|13
1525208|NCT00313586|5002787|P4|Overall Study|Death|7
1525209|NCT00313586|5002788|P3|Overall Study|Death|1
1525210|NCT00313586|5002789|P2|Overall Study|Death|8
1525211|NCT00313586|5002790|P1|Overall Study|Death|11
1525212|NCT00313586|5002787|P4|Overall Study|Adverse Event|10
1525213|NCT00313586|5002788|P3|Overall Study|Adverse Event|3
1525214|NCT00313586|5002789|P2|Overall Study|Adverse Event|18
1525215|NCT00313586|5002790|P1|Overall Study|Adverse Event|12
1525216|NCT00313586|5002787|P4|Overall Study|Disease progression|3
1525217|NCT00313586|5002788|P3|Overall Study|Disease progression|10
1525218|NCT00313586|5002789|P2|Overall Study|Disease progression|19
1525219|NCT00313586|5002790|P1|Overall Study|Disease progression|14
1525220|NCT00313313|5002809|P3|Overall Study|Subject No Longer Meets Study Criteria|2
1525221|NCT00313313|5002810|P2|Overall Study|Subject No Longer Meets Study Criteria|3
1525222|NCT00313313|5002811|P1|Overall Study|Subject No Longer Meets Study Criteria|0
1525223|NCT00313313|5002809|P3|Overall Study|Death|2
1525224|NCT00313313|5002810|P2|Overall Study|Death|0
1525225|NCT00313313|5002811|P1|Overall Study|Death|0
1525226|NCT00313313|5002809|P3|Overall Study|Pregnancy|0
1525227|NCT00313313|5002810|P2|Overall Study|Pregnancy|2
1525228|NCT00313313|5002811|P1|Overall Study|Pregnancy|1
1525229|NCT00313313|5002809|P3|Overall Study|Poor/Noncompliance|2
1525230|NCT00313313|5002810|P2|Overall Study|Poor/Noncompliance|6
1525231|NCT00313313|5002811|P1|Overall Study|Poor/Noncompliance|3
1525232|NCT00313313|5002809|P3|Overall Study|Physician Decision|4
1525233|NCT00313313|5002810|P2|Overall Study|Physician Decision|6
1525234|NCT00313313|5002811|P1|Overall Study|Physician Decision|2
1525235|NCT00313313|5002809|P3|Overall Study|Adverse Event|12
1525236|NCT00313313|5002810|P2|Overall Study|Adverse Event|16
1525237|NCT00313313|5002811|P1|Overall Study|Adverse Event|15
1525238|NCT00313313|5002809|P3|Overall Study|Lost to Follow-up|9
1525239|NCT00313313|5002810|P2|Overall Study|Lost to Follow-up|7
1525240|NCT00313313|5002811|P1|Overall Study|Lost to Follow-up|10
1525241|NCT00313313|5002809|P3|Overall Study|Withdrawal of consent by subject|31
1525242|NCT00313313|5002810|P2|Overall Study|Withdrawal of consent by subject|17
1525243|NCT00313313|5002811|P1|Overall Study|Withdrawal of consent by subject|18
1525244|NCT00313313|5002809|P3|Overall Study|Lack of Efficacy|20
1525245|NCT00313313|5002810|P2|Overall Study|Lack of Efficacy|9
1525246|NCT00313313|5002811|P1|Overall Study|Lack of Efficacy|14
1525247|NCT00313300|5002833|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
1525248|NCT00313300|5002834|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
1525249|NCT00313300|5002835|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
1525250|NCT00313300|5002836|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
1525251|NCT00313300|5002837|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
1525252|NCT00313300|5002833|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
1525253|NCT00313300|5002834|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
1525254|NCT00313300|5002835|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
1525255|NCT00313300|5002836|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
1525256|NCT00313300|5002837|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
1525257|NCT00313300|5002833|P5|Follow-Up(30days)-Randomized Phase B|Death|0
1525258|NCT00313300|5002834|P4|Follow-Up(30days)-Randomized Phase B|Death|0
1525259|NCT00313300|5002835|P3|Follow-Up(30days)-Randomized Phase B|Death|0
1525260|NCT00313300|5002836|P2|Follow-Up(30days)-Randomized Phase B|Death|0
1525261|NCT00313300|5002837|P1|Follow-Up(30days)-Randomized Phase B|Death|1
1525262|NCT00313300|5002833|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
1525263|NCT00313300|5002834|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
1525264|NCT00313300|5002835|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
1525265|NCT00313300|5002836|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
1525266|NCT00313300|5002837|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
1525267|NCT00313300|5002833|P5|Follow-Up(30days)-Randomized Phase A|Death|0
1525268|NCT00313300|5002834|P4|Follow-Up(30days)-Randomized Phase A|Death|0
1525269|NCT00313300|5002835|P3|Follow-Up(30days)-Randomized Phase A|Death|0
1525270|NCT00313300|5002836|P2|Follow-Up(30days)-Randomized Phase A|Death|1
1525271|NCT00313300|5002837|P1|Follow-Up(30days)-Randomized Phase A|Death|0
1525272|NCT00313300|5002833|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
1525273|NCT00313300|5002834|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
1525274|NCT00313300|5002835|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
1525275|NCT00313300|5002836|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
1525276|NCT00313300|5002837|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
1525277|NCT00313300|5002833|P5|Randomized in Phase B (26 Weeks)|non-specified|0
1525278|NCT00313300|5002834|P4|Randomized in Phase B (26 Weeks)|non-specified|0
1525279|NCT00313300|5002835|P3|Randomized in Phase B (26 Weeks)|non-specified|0
1525280|NCT00313300|5002836|P2|Randomized in Phase B (26 Weeks)|non-specified|0
1525281|NCT00313300|5002837|P1|Randomized in Phase B (26 Weeks)|non-specified|1
1525282|NCT00313300|5002833|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
1525283|NCT00313300|5002834|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
1525284|NCT00313300|5002835|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
1525285|NCT00313300|5002836|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
1525286|NCT00313300|5002837|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
1525287|NCT00313300|5002833|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
1525288|NCT00313300|5002834|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
1525289|NCT00313300|5002835|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
1525290|NCT00313300|5002836|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
1525291|NCT00313300|5002837|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
1525292|NCT00313300|5002833|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
1525293|NCT00313300|5002834|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
1525294|NCT00313300|5002835|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
1525295|NCT00313300|5002836|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
1525296|NCT00313300|5002837|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
1525297|NCT00313300|5002833|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
1525298|NCT00313300|5002834|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
1525299|NCT00313300|5002835|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
1525300|NCT00313300|5002836|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
1525301|NCT00313300|5002837|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
1525302|NCT00313300|5002833|P5|Randomized in Phase B (26 Weeks)|Death|1
1525303|NCT00313300|5002834|P4|Randomized in Phase B (26 Weeks)|Death|0
1525304|NCT00313300|5002835|P3|Randomized in Phase B (26 Weeks)|Death|1
1525305|NCT00313300|5002836|P2|Randomized in Phase B (26 Weeks)|Death|3
1525306|NCT00313300|5002837|P1|Randomized in Phase B (26 Weeks)|Death|5
1525307|NCT00313300|5002833|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
1525308|NCT00313300|5002834|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
1525309|NCT00313300|5002835|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
1525310|NCT00313300|5002836|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
1525311|NCT00313300|5002837|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
1525312|NCT00313300|5002833|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
1525313|NCT00313300|5002834|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
1525314|NCT00313300|5002835|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
1525315|NCT00313300|5002836|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
1525316|NCT00313300|5002837|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
1525317|NCT00313300|5002833|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1525318|NCT00313300|5002834|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1525319|NCT00313300|5002835|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1525320|NCT00313300|5002836|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1525321|NCT00313300|5002837|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
1525322|NCT00313300|5002833|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
1525323|NCT00313300|5002834|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
1525324|NCT00313300|5002835|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
1525325|NCT00313300|5002836|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
1525326|NCT00313300|5002837|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
1525327|NCT00313300|5002833|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
1525328|NCT00313300|5002834|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
1525329|NCT00313300|5002835|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
1525330|NCT00313300|5002836|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
1525331|NCT00313300|5002837|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
1525332|NCT00313300|5002833|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
1525333|NCT00313300|5002834|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
1525334|NCT00313300|5002835|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
1525335|NCT00313300|5002836|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
1525336|NCT00313300|5002837|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
1525337|NCT00313300|5002833|P5|Randomized in Phase A (26 Weeks)|Death|0
1525338|NCT00313300|5002834|P4|Randomized in Phase A (26 Weeks)|Death|0
1525339|NCT00313300|5002835|P3|Randomized in Phase A (26 Weeks)|Death|0
1525340|NCT00313300|5002836|P2|Randomized in Phase A (26 Weeks)|Death|4
1525341|NCT00313300|5002837|P1|Randomized in Phase A (26 Weeks)|Death|3
1525342|NCT00313300|5002833|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
1525343|NCT00313300|5002834|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
1525344|NCT00313300|5002835|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
1525345|NCT00313300|5002836|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
1525346|NCT00313300|5002837|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
1525347|NCT00313300|5002833|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
1525348|NCT00313300|5002834|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
1525349|NCT00313300|5002835|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
1525350|NCT00313300|5002836|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
1525351|NCT00313300|5002837|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
1525352|NCT00313170|5002907|P3|Overall Study|brain mets. after randomisation|1
1525353|NCT00313170|5002908|P2|Overall Study|brain mets. after randomisation|0
1525354|NCT00313170|5002909|P1|Overall Study|brain mets. after randomisation|0
1525355|NCT00313170|5002907|P3|Overall Study|dosing error|1
1525356|NCT00313170|5002908|P2|Overall Study|dosing error|0
1525357|NCT00313170|5002909|P1|Overall Study|dosing error|0
1525358|NCT00313170|5002907|P3|Overall Study|Clinical progression|0
1525359|NCT00313170|5002908|P2|Overall Study|Clinical progression|0
1525360|NCT00313170|5002909|P1|Overall Study|Clinical progression|1
1525361|NCT00313170|5002907|P3|Overall Study|Lost to Follow-up|1
1525362|NCT00313170|5002908|P2|Overall Study|Lost to Follow-up|0
1525363|NCT00313170|5002909|P1|Overall Study|Lost to Follow-up|0
1525364|NCT00313170|5002907|P3|Overall Study|Incorrect enrollment|1
1525365|NCT00313170|5002908|P2|Overall Study|Incorrect enrollment|1
1525366|NCT00313170|5002909|P1|Overall Study|Incorrect enrollment|0
1525367|NCT00313170|5002907|P3|Overall Study|Withdrawal by Subject|1
1525368|NCT00313170|5002908|P2|Overall Study|Withdrawal by Subject|1
1525369|NCT00313170|5002909|P1|Overall Study|Withdrawal by Subject|1
1525370|NCT00313170|5002907|P3|Overall Study|Disease progression|27
1525371|NCT00313170|5002908|P2|Overall Study|Disease progression|26
1525372|NCT00313170|5002909|P1|Overall Study|Disease progression|31
1525373|NCT00313170|5002907|P3|Overall Study|Adverse Event|0
1525374|NCT00313170|5002908|P2|Overall Study|Adverse Event|2
1525375|NCT00313170|5002909|P1|Overall Study|Adverse Event|2
1525376|NCT00313170|5002907|P3|Overall Study|Death|0
1525377|NCT00313170|5002908|P2|Overall Study|Death|4
1525378|NCT00313170|5002909|P1|Overall Study|Death|1
1525379|NCT00313144|5002925|P1|Overall Study|Due to termination of the study|66
1525380|NCT00313144|5002925|P1|Overall Study|Change to different product|1
1525381|NCT00313144|5002925|P1|Overall Study|Insurance (homecare provider) change|1
1525382|NCT00313144|5002925|P1|Overall Study|Liver transplant|1
1525383|NCT00313144|5002925|P1|Overall Study|Adverse event - transient|5
1525384|NCT00313144|5002925|P1|Overall Study|Physician Decision|4
1525385|NCT00313144|5002925|P1|Overall Study|Terminated by sponsor/ homecare provider|4
1525386|NCT00313144|5002925|P1|Overall Study|Withdrawal by Subject|4
1525387|NCT00313144|5002925|P1|Overall Study|Lost to Follow-up|5
1525388|NCT00313144|5002925|P1|Overall Study|Death|7
1525389|NCT00313144|5002925|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
1525390|NCT00313014|5003012|P3|Overall Study|Lack of Efficacy|16
1525391|NCT00313014|5003013|P2|Overall Study|Lack of Efficacy|25
1525392|NCT00313014|5003014|P1|Overall Study|Lack of Efficacy|52
1525393|NCT00313014|5003012|P3|Overall Study|Administrative|14
1525394|NCT00313014|5003013|P2|Overall Study|Administrative|6
1525395|NCT00313014|5003014|P1|Overall Study|Administrative|9
1525396|NCT00313014|5003012|P3|Overall Study|Lost to Follow-up|10
1525397|NCT00313014|5003013|P2|Overall Study|Lost to Follow-up|6
1525398|NCT00313014|5003014|P1|Overall Study|Lost to Follow-up|7
1525399|NCT00313014|5003012|P3|Overall Study|Adverse Event|16
1525400|NCT00313014|5003013|P2|Overall Study|Adverse Event|29
1525401|NCT00313014|5003014|P1|Overall Study|Adverse Event|14
1525402|NCT00313014|5003012|P3|Overall Study|Withdrawal by Subject|5
1525403|NCT00313014|5003013|P2|Overall Study|Withdrawal by Subject|7
1525404|NCT00313014|5003014|P1|Overall Study|Withdrawal by Subject|11
1525405|NCT00312897|5003045|P2|Overall Study|discontinued prior to getting treatment|3
1525406|NCT00312897|5003046|P1|Overall Study|discontinued prior to getting treatment|0
1525407|NCT00312897|5003045|P2|Overall Study|Pregnancy|0
1525408|NCT00312897|5003046|P1|Overall Study|Pregnancy|1
1525409|NCT00312897|5003045|P2|Overall Study|Withdrawal by Subject|3
1525410|NCT00312897|5003046|P1|Overall Study|Withdrawal by Subject|1
1525411|NCT00312897|5003045|P2|Overall Study|Physician Decision|0
1525412|NCT00312897|5003046|P1|Overall Study|Physician Decision|1
1525413|NCT00312897|5003045|P2|Overall Study|Lost to Follow-up|0
1525414|NCT00312897|5003046|P1|Overall Study|Lost to Follow-up|2
1525415|NCT00312897|5003045|P2|Overall Study|Adverse Event|0
1525416|NCT00312897|5003046|P1|Overall Study|Adverse Event|1
1525417|NCT00312858|5003071|P2|Overall Study|Other|12
1525418|NCT00312858|5003072|P1|Overall Study|Other|9
1525419|NCT00312858|5003071|P2|Overall Study|Participant Moved|10
1525420|NCT00312858|5003072|P1|Overall Study|Participant Moved|11
1525421|NCT00312858|5003071|P2|Overall Study|Withdraw by Participant|20
1525422|NCT00312858|5003072|P1|Overall Study|Withdraw by Participant|20
1525423|NCT00312858|5003071|P2|Overall Study|Protocol Violation|8
1525424|NCT00312858|5003072|P1|Overall Study|Protocol Violation|3
1525425|NCT00312858|5003071|P2|Overall Study|Lost to Follow-up|42
1525426|NCT00312858|5003072|P1|Overall Study|Lost to Follow-up|25
1525427|NCT00312858|5003071|P2|Overall Study|Adverse Event|1
1525428|NCT00312858|5003072|P1|Overall Study|Adverse Event|0
1525429|NCT00312845|5003126|P2|Overall Study|Other|5
1525430|NCT00312845|5003127|P1|Overall Study|Other|6
1525431|NCT00312845|5003126|P2|Overall Study|Lost to Follow-up|0
1525432|NCT00312845|5003127|P1|Overall Study|Lost to Follow-up|2
1525433|NCT00312845|5003126|P2|Overall Study|Disease Progression|77
1525434|NCT00312845|5003127|P1|Overall Study|Disease Progression|56
1525435|NCT00312845|5003126|P2|Overall Study|Withdrawal by Subject|6
1525436|NCT00312845|5003127|P1|Overall Study|Withdrawal by Subject|14
1525437|NCT00312845|5003126|P2|Overall Study|Death|2
1525438|NCT00312845|5003127|P1|Overall Study|Death|2
1525439|NCT00312845|5003126|P2|Overall Study|Adverse Event|5
1525440|NCT00312845|5003127|P1|Overall Study|Adverse Event|19
1525441|NCT00312728|5003135|P1|Overall Study|Other|1
1525442|NCT00312728|5003135|P1|Overall Study|Other|10
1525443|NCT00312728|5003135|P1|Overall Study|Protocol Violation|2
1525444|NCT00312728|5003135|P1|Overall Study|Required non-protocol cancer treatment|2
1525445|NCT00312728|5003135|P1|Overall Study|Withdrawal by Subject|10
1525446|NCT00312728|5003135|P1|Overall Study|Adverse Event|32
1525447|NCT00312728|5003135|P1|Overall Study|Progressive disease|53
1525448|NCT00312572|5003146|P2|Overall Study|Lack of Efficacy|2
1525449|NCT00312572|5003147|P1|Overall Study|Lack of Efficacy|1
1525450|NCT00312572|5003146|P2|Overall Study|Administrative|2
1525451|NCT00312572|5003147|P1|Overall Study|Administrative|4
1525452|NCT00312572|5003146|P2|Overall Study|Lost to Follow-up|1
1525453|NCT00312572|5003147|P1|Overall Study|Lost to Follow-up|1
1525454|NCT00312572|5003146|P2|Overall Study|Adverse Event|16
1525455|NCT00312572|5003147|P1|Overall Study|Adverse Event|10
1525456|NCT00312494|5003158|P3|Overall Study|Other|1
1525457|NCT00312494|5003159|P2|Overall Study|Other|10
1525458|NCT00312494|5003160|P1|Overall Study|Other|10
1525459|NCT00312494|5003158|P3|Overall Study|Withdrawal by Subject|10
1525460|NCT00312494|5003159|P2|Overall Study|Withdrawal by Subject|9
1525461|NCT00312494|5003160|P1|Overall Study|Withdrawal by Subject|6
1525462|NCT00312494|5003158|P3|Overall Study|Lost to Follow-up|8
1525463|NCT00312494|5003159|P2|Overall Study|Lost to Follow-up|8
1525464|NCT00312494|5003160|P1|Overall Study|Lost to Follow-up|8
1525465|NCT00312494|5003158|P3|Overall Study|Laboratory abnormality|0
1525466|NCT00312494|5003159|P2|Overall Study|Laboratory abnormality|0
1525467|NCT00312494|5003160|P1|Overall Study|Laboratory abnormality|1
1525468|NCT00312494|5003158|P3|Overall Study|Lack of Efficacy|8
1525469|NCT00312494|5003159|P2|Overall Study|Lack of Efficacy|6
1525470|NCT00312494|5003160|P1|Overall Study|Lack of Efficacy|4
1525471|NCT00312494|5003158|P3|Overall Study|Adverse Event|11
1525472|NCT00312494|5003159|P2|Overall Study|Adverse Event|15
1525473|NCT00312494|5003160|P1|Overall Study|Adverse Event|33
1525474|NCT00312494|5003158|P3|Overall Study|Randomized; not treated with study drug|5
1525475|NCT00312494|5003159|P2|Overall Study|Randomized; not treated with study drug|10
1525476|NCT00312494|5003160|P1|Overall Study|Randomized; not treated with study drug|9
1525477|NCT00312377|5003194|P2|Overall Study|Site ended participation in study|0
1525478|NCT00312377|5003195|P1|Overall Study|Site ended participation in study|1
1525479|NCT00312377|5003194|P2|Overall Study|Discontinue treatment survival follow up|200
1525480|NCT00312377|5003195|P1|Overall Study|Discontinue treatment survival follow up|202
1525481|NCT00312377|5003194|P2|Overall Study|Randomised but never received treatment|6
1525482|NCT00312377|5003195|P1|Overall Study|Randomised but never received treatment|6
1525483|NCT00312377|5003194|P2|Overall Study|Non-compliance|2
1525484|NCT00312377|5003195|P1|Overall Study|Non-compliance|0
1525485|NCT00312377|5003194|P2|Overall Study|Lost to Follow-up|12
1525486|NCT00312377|5003195|P1|Overall Study|Lost to Follow-up|9
1525487|NCT00312377|5003194|P2|Overall Study|Withdrawal by Subject|30
1525488|NCT00312377|5003195|P1|Overall Study|Withdrawal by Subject|23
1525489|NCT00312377|5003194|P2|Overall Study|Death|418
1525490|NCT00312377|5003195|P1|Overall Study|Death|403
1525491|NCT00312338|5003219|P2|Overall Study|Subsequent infection|0
1525492|NCT00312338|5003220|P1|Overall Study|Subsequent infection|2
1525493|NCT00312338|5003219|P2|Overall Study|Withdrawal by Subject|0
1525494|NCT00312338|5003220|P1|Overall Study|Withdrawal by Subject|4
1525495|NCT00312338|5003219|P2|Overall Study|Lost to Follow-up|1
1525496|NCT00312338|5003220|P1|Overall Study|Lost to Follow-up|9
1525497|NCT00312338|5003219|P2|Overall Study|Adverse Event|2
1525498|NCT00312338|5003220|P1|Overall Study|Adverse Event|7
1525499|NCT00312221|5003233|P4|Double-blind Phase|Lack of Efficacy|10
1525500|NCT00312221|5003234|P3|Double-blind Phase|Lack of Efficacy|6
1525501|NCT00312221|5003235|P2|Double-blind Phase|Lack of Efficacy|17
1525502|NCT00312221|5003236|P1|Double-blind Phase|Lack of Efficacy|0
1525503|NCT00312221|5003233|P4|Double-blind Phase|Administrative|33
1525504|NCT00312221|5003234|P3|Double-blind Phase|Administrative|37
1525505|NCT00312221|5003235|P2|Double-blind Phase|Administrative|26
1525506|NCT00312221|5003236|P1|Double-blind Phase|Administrative|0
1525507|NCT00312221|5003233|P4|Double-blind Phase|Lost to Follow-up|2
1525508|NCT00312221|5003234|P3|Double-blind Phase|Lost to Follow-up|2
1525509|NCT00312221|5003235|P2|Double-blind Phase|Lost to Follow-up|0
1525510|NCT00312221|5003236|P1|Double-blind Phase|Lost to Follow-up|0
1525511|NCT00312221|5003233|P4|Double-blind Phase|Adverse Event|18
1525512|NCT00312221|5003234|P3|Double-blind Phase|Adverse Event|19
1525513|NCT00312221|5003235|P2|Double-blind Phase|Adverse Event|10
1525514|NCT00312221|5003236|P1|Double-blind Phase|Adverse Event|0
1525515|NCT00312221|5003233|P4|Double-blind Phase|Withdrawal by Subject|7
1525516|NCT00312221|5003234|P3|Double-blind Phase|Withdrawal by Subject|8
1525517|NCT00312221|5003235|P2|Double-blind Phase|Withdrawal by Subject|6
1525518|NCT00312221|5003236|P1|Double-blind Phase|Withdrawal by Subject|0
1525519|NCT00312221|5003233|P4|Open-label Run-in Period|Did not qualify|0
1525520|NCT00312221|5003234|P3|Open-label Run-in Period|Did not qualify|0
1525521|NCT00312221|5003235|P2|Open-label Run-in Period|Did not qualify|0
1525522|NCT00312221|5003236|P1|Open-label Run-in Period|Did not qualify|5
1525523|NCT00312221|5003233|P4|Open-label Run-in Period|Lack of Efficacy|0
1525524|NCT00312221|5003234|P3|Open-label Run-in Period|Lack of Efficacy|0
1525525|NCT00312221|5003235|P2|Open-label Run-in Period|Lack of Efficacy|0
1525526|NCT00312221|5003236|P1|Open-label Run-in Period|Lack of Efficacy|102
1525527|NCT00312221|5003233|P4|Open-label Run-in Period|Administrative|0
1525528|NCT00312221|5003234|P3|Open-label Run-in Period|Administrative|0
1525529|NCT00312221|5003235|P2|Open-label Run-in Period|Administrative|0
1525530|NCT00312221|5003236|P1|Open-label Run-in Period|Administrative|42
1525531|NCT00312221|5003233|P4|Open-label Run-in Period|Lost to Follow-up|0
1525532|NCT00312221|5003234|P3|Open-label Run-in Period|Lost to Follow-up|0
1525533|NCT00312221|5003235|P2|Open-label Run-in Period|Lost to Follow-up|0
1525534|NCT00312221|5003236|P1|Open-label Run-in Period|Lost to Follow-up|5
1525535|NCT00312221|5003233|P4|Open-label Run-in Period|Adverse Event|0
1525536|NCT00312221|5003234|P3|Open-label Run-in Period|Adverse Event|0
1525537|NCT00312221|5003235|P2|Open-label Run-in Period|Adverse Event|0
1525538|NCT00312221|5003236|P1|Open-label Run-in Period|Adverse Event|74
1525539|NCT00312221|5003233|P4|Open-label Run-in Period|Withdrawal by Subject|0
1525540|NCT00312221|5003234|P3|Open-label Run-in Period|Withdrawal by Subject|0
1525541|NCT00312221|5003235|P2|Open-label Run-in Period|Withdrawal by Subject|0
1525542|NCT00312221|5003236|P1|Open-label Run-in Period|Withdrawal by Subject|6
1525543|NCT00312208|5003256|P2|Overall Study|Not specified|7
1525544|NCT00312208|5003257|P1|Overall Study|Not specified|5
1525545|NCT00312208|5003256|P2|Overall Study|Withdrawal by Subject|42
1525546|NCT00312208|5003257|P1|Overall Study|Withdrawal by Subject|53
1525547|NCT00312208|5003256|P2|Overall Study|Lost to Follow-up|5
1525548|NCT00312208|5003257|P1|Overall Study|Lost to Follow-up|3
1525549|NCT00312208|5003256|P2|Overall Study|Lack of Efficacy|4
1525550|NCT00312208|5003257|P1|Overall Study|Lack of Efficacy|7
1525551|NCT00312208|5003256|P2|Overall Study|Death|1
1525552|NCT00312208|5003257|P1|Overall Study|Death|2
1525553|NCT00312208|5003256|P2|Overall Study|Protocol Violation|3
1525554|NCT00312208|5003257|P1|Overall Study|Protocol Violation|5
1525555|NCT00312208|5003256|P2|Overall Study|Adverse Event|61
1525556|NCT00312208|5003257|P1|Overall Study|Adverse Event|97
1525557|NCT00312195|5003267|P2|Overall Study|Protocol Violation|0
1525558|NCT00312195|5003268|P1|Overall Study|Protocol Violation|1
1525559|NCT00312195|5003267|P2|Overall Study|Lost to Follow-up|0
1525560|NCT00312195|5003268|P1|Overall Study|Lost to Follow-up|1
1525561|NCT00312195|5003267|P2|Overall Study|Adverse Event|6
1525562|NCT00312195|5003268|P1|Overall Study|Adverse Event|4
1525563|NCT00311584|5003295|P2|Overall Study|ineligible|2
1525564|NCT00311584|5003296|P1|Overall Study|ineligible|2
1525565|NCT00311584|5003295|P2|Overall Study|Withdrawal by Subject|1
1525566|NCT00311584|5003296|P1|Overall Study|Withdrawal by Subject|1
1525567|NCT00311584|5003295|P2|Overall Study|Physician Decision|5
1525568|NCT00311584|5003296|P1|Overall Study|Physician Decision|4
1525569|NCT00311584|5003295|P2|Overall Study|Lack of Efficacy|15
1525570|NCT00311584|5003296|P1|Overall Study|Lack of Efficacy|12
1525571|NCT00311584|5003295|P2|Overall Study|Death|0
1525572|NCT00311584|5003296|P1|Overall Study|Death|1
1525573|NCT00311402|5003304|P2|Overall Study|IRB's rejection etc.|3
1525574|NCT00311402|5003305|P1|Overall Study|IRB's rejection etc.|10
1525575|NCT00311402|5003304|P2|Overall Study|Protocol Violation|6
1525576|NCT00311402|5003305|P1|Overall Study|Protocol Violation|7
1525577|NCT00311402|5003304|P2|Overall Study|Lack of Efficacy|42
1525578|NCT00311402|5003305|P1|Overall Study|Lack of Efficacy|58
1525579|NCT00311402|5003304|P2|Overall Study|Withdrawal by Subject|18
1525580|NCT00311402|5003305|P1|Overall Study|Withdrawal by Subject|17
1525581|NCT00311402|5003304|P2|Overall Study|Lost to Follow-up|3
1525582|NCT00311402|5003305|P1|Overall Study|Lost to Follow-up|0
1525583|NCT00311402|5003304|P2|Overall Study|Adverse Event|105
1525584|NCT00311402|5003305|P1|Overall Study|Adverse Event|118
1525585|NCT00311363|5003354|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
1525586|NCT00311363|5003355|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
1525587|NCT00311363|5003356|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
1525588|NCT00311363|5003354|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
1525589|NCT00311363|5003355|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
1525590|NCT00311363|5003356|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
1525591|NCT00311363|5003354|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
1525592|NCT00311363|5003355|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
1525593|NCT00311363|5003356|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
1525594|NCT00311363|5003354|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
1525595|NCT00311363|5003355|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
1525596|NCT00311363|5003356|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
1525597|NCT00311363|5003354|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
1525598|NCT00311363|5003355|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
1525599|NCT00311363|5003356|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
1525600|NCT00311363|5003354|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
1525601|NCT00311363|5003355|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
1525602|NCT00311363|5003356|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
1525603|NCT00311363|5003354|P3|24-Week Single-Blind Treatment Period|Death|0
1525604|NCT00311363|5003355|P2|24-Week Single-Blind Treatment Period|Death|0
1525605|NCT00311363|5003356|P1|24-Week Single-Blind Treatment Period|Death|1
1525606|NCT00311363|5003354|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
1525607|NCT00311363|5003355|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
1525608|NCT00311363|5003356|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
1525609|NCT00311363|5003354|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
1525610|NCT00311363|5003355|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
1525611|NCT00311363|5003356|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
1525612|NCT00311363|5003354|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
1525613|NCT00311363|5003355|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
1525614|NCT00311363|5003356|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
1525615|NCT00311363|5003354|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
1525616|NCT00311363|5003355|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
1525617|NCT00311363|5003356|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
1525618|NCT00311363|5003354|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
1525619|NCT00311363|5003355|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
1525620|NCT00311363|5003356|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
1525621|NCT00311363|5003354|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
1525622|NCT00311363|5003355|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
1525623|NCT00311363|5003356|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
1525624|NCT00311363|5003354|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
1525625|NCT00311363|5003355|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
1525626|NCT00311363|5003356|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
1525627|NCT00311363|5003354|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
1525628|NCT00311363|5003355|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
1525629|NCT00311363|5003356|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
1525630|NCT00311311|5003416|P2|Overall Study|Lack of ancillary assistance|1
1525631|NCT00311311|5003417|P1|Overall Study|Lack of ancillary assistance|0
1525632|NCT00311311|5003416|P2|Overall Study|Death|0
1525633|NCT00311311|5003417|P1|Overall Study|Death|1
1525634|NCT00311311|5003416|P2|Overall Study|Study Termination by Sponsor|4
1525635|NCT00311311|5003417|P1|Overall Study|Study Termination by Sponsor|3
1525636|NCT00311311|5003416|P2|Overall Study|Noncompliance|1
1525637|NCT00311311|5003417|P1|Overall Study|Noncompliance|0
1525638|NCT00311311|5003416|P2|Overall Study|Withdrawal by Subject|1
1525639|NCT00311311|5003417|P1|Overall Study|Withdrawal by Subject|1
1525640|NCT00311311|5003416|P2|Overall Study|Adverse Event|2
1525641|NCT00311311|5003417|P1|Overall Study|Adverse Event|3
1525642|NCT00311181|5003467|P1|Overall Study|Final DFTs were not obtained|96
1525643|NCT00311155|5003473|P1|Overall Study|Did not meet entry criteria|55
1525644|NCT00311155|5003473|P1|Overall Study|Withdrawal by Subject|17
1525645|NCT00311155|5003473|P1|Overall Study|Adverse Event|21
1525646|NCT00310856|5003485|P3|Overall Study|Unable to classify|0
1525647|NCT00310856|5003486|P2|Overall Study|Unable to classify|0
1525648|NCT00310856|5003487|P1|Overall Study|Unable to classify|1
1525649|NCT00310856|5003485|P3|Overall Study|Inappropriate enrollment|0
1525650|NCT00310856|5003486|P2|Overall Study|Inappropriate enrollment|1
1525651|NCT00310856|5003487|P1|Overall Study|Inappropriate enrollment|1
1525652|NCT00310856|5003485|P3|Overall Study|Lost to Follow-up|6
1525653|NCT00310856|5003486|P2|Overall Study|Lost to Follow-up|2
1525654|NCT00310856|5003487|P1|Overall Study|Lost to Follow-up|1
1525655|NCT00310856|5003485|P3|Overall Study|Withdrawal by Subject|2
1525656|NCT00310856|5003486|P2|Overall Study|Withdrawal by Subject|2
1525657|NCT00310856|5003487|P1|Overall Study|Withdrawal by Subject|2
1525658|NCT00310817|5003511|P4|Overall Study|Unable to classify|0
1525659|NCT00310817|5003512|P3|Overall Study|Unable to classify|0
1525660|NCT00310817|5003513|P2|Overall Study|Unable to classify|1
1525661|NCT00310817|5003514|P1|Overall Study|Unable to classify|3
1525662|NCT00310817|5003511|P4|Overall Study|Protocol Violation|1
1525663|NCT00310817|5003512|P3|Overall Study|Protocol Violation|1
1525664|NCT00310817|5003513|P2|Overall Study|Protocol Violation|1
1525665|NCT00310817|5003514|P1|Overall Study|Protocol Violation|1
1525666|NCT00310817|5003511|P4|Overall Study|Inappropriate Enrollment|0
1525667|NCT00310817|5003512|P3|Overall Study|Inappropriate Enrollment|1
1525668|NCT00310817|5003513|P2|Overall Study|Inappropriate Enrollment|0
1525669|NCT00310817|5003514|P1|Overall Study|Inappropriate Enrollment|1
1525670|NCT00310817|5003511|P4|Overall Study|Lost to Follow-up|0
1525671|NCT00310817|5003512|P3|Overall Study|Lost to Follow-up|0
1525672|NCT00310817|5003513|P2|Overall Study|Lost to Follow-up|1
1525673|NCT00310817|5003514|P1|Overall Study|Lost to Follow-up|2
1525674|NCT00310817|5003511|P4|Overall Study|Withdrawal by Subject|7
1525675|NCT00310817|5003512|P3|Overall Study|Withdrawal by Subject|6
1525676|NCT00310817|5003513|P2|Overall Study|Withdrawal by Subject|4
1525677|NCT00310817|5003514|P1|Overall Study|Withdrawal by Subject|1
1525678|NCT00310817|5003511|P4|Overall Study|AE or Death|0
1525679|NCT00310817|5003512|P3|Overall Study|AE or Death|0
1525680|NCT00310817|5003513|P2|Overall Study|AE or Death|1
1525681|NCT00310817|5003514|P1|Overall Study|AE or Death|3
1525682|NCT00310804|5003602|P2|Overall Study|Withdrawal by Subject|0
1525683|NCT00310804|5003603|P1|Overall Study|Withdrawal by Subject|3
1525684|NCT00310804|5003602|P2|Overall Study|Lost to Follow-up|0
1525685|NCT00310804|5003603|P1|Overall Study|Lost to Follow-up|2
1525686|NCT00310440|5003662|P2|Overall Study|Missed 12 Month Visit|4
1525687|NCT00310440|5003663|P1|Overall Study|Missed 12 Month Visit|7
1525688|NCT00310440|5003662|P2|Overall Study|Withdrawal by Subject|1
1525689|NCT00310440|5003663|P1|Overall Study|Withdrawal by Subject|2
1525690|NCT00310440|5003662|P2|Overall Study|Lost to Follow-up|8
1525691|NCT00310440|5003663|P1|Overall Study|Lost to Follow-up|17
1525692|NCT00310388|5003727|P1|Overall Study|Other|1
1525693|NCT00310388|5003727|P1|Overall Study|Missing|1
1525694|NCT00310388|5003727|P1|Overall Study|Participant retired the informed consent|1
1525695|NCT00310388|5003727|P1|Overall Study|Participant passed away|1
1525696|NCT00310388|5003727|P1|Overall Study|Due to pigmentation risk concerns|2
1525697|NCT00310388|5003727|P1|Overall Study|Ongoing SAE from parent study|1
1525698|NCT00310388|5003727|P1|Overall Study|Termination of study at sponsor request|3
1525699|NCT00310388|5003727|P1|Overall Study|Participant Immigrated to New Zealand|1
1525700|NCT00310388|5003727|P1|Overall Study|Discontinuation of study|1
1525701|NCT00310388|5003727|P1|Overall Study|Ministry of Health decision|25
1525702|NCT00310388|5003727|P1|Overall Study|Participant request|2
1525703|NCT00310388|5003727|P1|Overall Study|Participant request unrelated to study|2
1525704|NCT00310388|5003727|P1|Overall Study|Failed to return|8
1525705|NCT00310388|5003727|P1|Overall Study|Request of the sponsor|19
1525706|NCT00310388|5003727|P1|Overall Study|Physician Decision|2
1525707|NCT00310388|5003727|P1|Overall Study|ALT/AST levels above 5 times the ULN|3
1525708|NCT00310388|5003727|P1|Overall Study|Persistent ALT/AST above 3 times the ULN|3
1525709|NCT00310388|5003727|P1|Overall Study|Change in participant medical condition|3
1525710|NCT00310388|5003727|P1|Overall Study|Pregnancy|3
1525711|NCT00310388|5003727|P1|Overall Study|Protocol Violation|10
1525712|NCT00310388|5003727|P1|Overall Study|Withdrawal by Subject|97
1525713|NCT00310388|5003727|P1|Overall Study|Lack of Efficacy|56
1525714|NCT00310388|5003727|P1|Overall Study|Adverse Event|101
1525715|NCT00310375|5003765|P3|Safety Follow-up Continuation Phase|Lost to Follow-up|1
1525716|NCT00310375|5003766|P2|Safety Follow-up Continuation Phase|Lost to Follow-up|0
1525717|NCT00310375|5003767|P1|Safety Follow-up Continuation Phase|Lost to Follow-up|0
1525718|NCT00310375|5003765|P3|Primary Reporting Phase|Request of Ethics Committee|0
1525719|NCT00310375|5003766|P2|Primary Reporting Phase|Request of Ethics Committee|1
1525720|NCT00310375|5003767|P1|Primary Reporting Phase|Request of Ethics Committee|0
1525721|NCT00310375|5003765|P3|Primary Reporting Phase|Par. switched to commercial product|0
1525722|NCT00310375|5003766|P2|Primary Reporting Phase|Par. switched to commercial product|1
1525723|NCT00310375|5003767|P1|Primary Reporting Phase|Par. switched to commercial product|0
1525724|NCT00310375|5003765|P3|Primary Reporting Phase|Missed study drug for 2 months|0
1525725|NCT00310375|5003766|P2|Primary Reporting Phase|Missed study drug for 2 months|0
1525726|NCT00310375|5003767|P1|Primary Reporting Phase|Missed study drug for 2 months|1
1525727|NCT00310375|5003765|P3|Primary Reporting Phase|Site closure|0
1525728|NCT00310375|5003766|P2|Primary Reporting Phase|Site closure|0
1525729|NCT00310375|5003767|P1|Primary Reporting Phase|Site closure|3
1525730|NCT00310375|5003765|P3|Primary Reporting Phase|Missed study drug >5 days|0
1525731|NCT00310375|5003766|P2|Primary Reporting Phase|Missed study drug >5 days|0
1525732|NCT00310375|5003767|P1|Primary Reporting Phase|Missed study drug >5 days|1
1525733|NCT00310375|5003765|P3|Primary Reporting Phase|Going for temporal lobectomy|0
1525734|NCT00310375|5003766|P2|Primary Reporting Phase|Going for temporal lobectomy|0
1525735|NCT00310375|5003767|P1|Primary Reporting Phase|Going for temporal lobectomy|1
1525736|NCT00310375|5003765|P3|Primary Reporting Phase|Participant request unrelated to study|0
1525737|NCT00310375|5003766|P2|Primary Reporting Phase|Participant request unrelated to study|2
1525738|NCT00310375|5003767|P1|Primary Reporting Phase|Participant request unrelated to study|1
1525739|NCT00310375|5003765|P3|Primary Reporting Phase|Failed to return|0
1525740|NCT00310375|5003766|P2|Primary Reporting Phase|Failed to return|3
1525741|NCT00310375|5003767|P1|Primary Reporting Phase|Failed to return|1
1525742|NCT00310375|5003765|P3|Primary Reporting Phase|Request of the sponsor|0
1525743|NCT00310375|5003766|P2|Primary Reporting Phase|Request of the sponsor|2
1525744|NCT00310375|5003767|P1|Primary Reporting Phase|Request of the sponsor|2
1525745|NCT00310375|5003765|P3|Primary Reporting Phase|Physician Decision|0
1525746|NCT00310375|5003766|P2|Primary Reporting Phase|Physician Decision|3
1525747|NCT00310375|5003767|P1|Primary Reporting Phase|Physician Decision|5
1525748|NCT00310375|5003765|P3|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
1525749|NCT00310375|5003766|P2|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
1525750|NCT00310375|5003767|P1|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
1525751|NCT00310375|5003765|P3|Primary Reporting Phase|Change in Par medical condition|0
1525752|NCT00310375|5003766|P2|Primary Reporting Phase|Change in Par medical condition|0
1525753|NCT00310375|5003767|P1|Primary Reporting Phase|Change in Par medical condition|2
1525754|NCT00310375|5003765|P3|Primary Reporting Phase|Protocol Violation|0
1525755|NCT00310375|5003766|P2|Primary Reporting Phase|Protocol Violation|5
1525756|NCT00310375|5003767|P1|Primary Reporting Phase|Protocol Violation|8
1525757|NCT00310375|5003765|P3|Primary Reporting Phase|Withdrawal by Subject|0
1525758|NCT00310375|5003766|P2|Primary Reporting Phase|Withdrawal by Subject|7
1525759|NCT00310375|5003767|P1|Primary Reporting Phase|Withdrawal by Subject|10
1525760|NCT00310375|5003765|P3|Primary Reporting Phase|Pregnancy|0
1525761|NCT00310375|5003766|P2|Primary Reporting Phase|Pregnancy|2
1525762|NCT00310375|5003767|P1|Primary Reporting Phase|Pregnancy|2
1525763|NCT00310375|5003765|P3|Primary Reporting Phase|Lack of Efficacy|0
1525764|NCT00310375|5003766|P2|Primary Reporting Phase|Lack of Efficacy|19
1525765|NCT00310375|5003767|P1|Primary Reporting Phase|Lack of Efficacy|24
1525766|NCT00310375|5003765|P3|Primary Reporting Phase|Adverse Event|0
1525767|NCT00310375|5003766|P2|Primary Reporting Phase|Adverse Event|22
1525768|NCT00310375|5003767|P1|Primary Reporting Phase|Adverse Event|28
1525769|NCT00310037|5003857|P2|Overall Study|Non-protocol treatment|0
1525770|NCT00310037|5003858|P1|Overall Study|Non-protocol treatment|1
1525771|NCT00310037|5003857|P2|Overall Study|Progression|0
1525772|NCT00310037|5003858|P1|Overall Study|Progression|6
1525773|NCT00310037|5003857|P2|Overall Study|Withdrawal by Subject|3
1525774|NCT00310037|5003858|P1|Overall Study|Withdrawal by Subject|4
1525775|NCT00310037|5003857|P2|Overall Study|Adverse Event|14
1525776|NCT00310037|5003858|P1|Overall Study|Adverse Event|7
1525777|NCT00309985|5003872|P2|Overall Study|Chemotherapy discontinued only|0
1525778|NCT00309985|5003873|P1|Overall Study|Chemotherapy discontinued only|1
1525779|NCT00309985|5003872|P2|Overall Study|Non-compliance|0
1525780|NCT00309985|5003873|P1|Overall Study|Non-compliance|1
1525781|NCT00309985|5003872|P2|Overall Study|Complicating disease|0
1525782|NCT00309985|5003873|P1|Overall Study|Complicating disease|1
1525783|NCT00309985|5003872|P2|Overall Study|Never started treatment|0
1525784|NCT00309985|5003873|P1|Overall Study|Never started treatment|7
1525785|NCT00309985|5003872|P2|Overall Study|Physician Decision|0
1525786|NCT00309985|5003873|P1|Overall Study|Physician Decision|3
1525787|NCT00309985|5003872|P2|Overall Study|Withdrawal by Subject|1
1525788|NCT00309985|5003873|P1|Overall Study|Withdrawal by Subject|5
1525789|NCT00309985|5003872|P2|Overall Study|Death|0
1525790|NCT00309985|5003873|P1|Overall Study|Death|2
1525791|NCT00309985|5003872|P2|Overall Study|Adverse Event|0
1525792|NCT00309985|5003873|P1|Overall Study|Adverse Event|30
1525793|NCT00309985|5003872|P2|Overall Study|Disease progression|0
1525794|NCT00309985|5003873|P1|Overall Study|Disease progression|12
1525795|NCT00309946|5003889|P1|Overall Study|Withdrawal by Subject|1
1525796|NCT00309907|5003895|P1|Overall Study|Major infectious event|4
1525797|NCT00309907|5003895|P1|Overall Study|Ineligible|11
1525798|NCT00309907|5003895|P1|Overall Study|Physician Decision|1
1525799|NCT00309907|5003895|P1|Overall Study|Death|4
1525800|NCT00309777|5003908|P4|Overall Study|Death|0
1525801|NCT00309777|5003909|P3|Overall Study|Death|0
1525802|NCT00309777|5003910|P2|Overall Study|Death|1
1525803|NCT00309777|5003911|P1|Overall Study|Death|0
1525804|NCT00309777|5003908|P4|Overall Study|Lost to Follow-up|0
1525805|NCT00309777|5003909|P3|Overall Study|Lost to Follow-up|1
1525806|NCT00309777|5003910|P2|Overall Study|Lost to Follow-up|0
1525807|NCT00309777|5003911|P1|Overall Study|Lost to Follow-up|0
1525808|NCT00309777|5003908|P4|Overall Study|Withdrawal by Subject|2
1525809|NCT00309777|5003909|P3|Overall Study|Withdrawal by Subject|7
1525810|NCT00309777|5003910|P2|Overall Study|Withdrawal by Subject|5
1525811|NCT00309777|5003911|P1|Overall Study|Withdrawal by Subject|6
1525812|NCT00309777|5003908|P4|Overall Study|Protocol Violation|1
1525813|NCT00309777|5003909|P3|Overall Study|Protocol Violation|3
1525814|NCT00309777|5003910|P2|Overall Study|Protocol Violation|1
1525815|NCT00309777|5003911|P1|Overall Study|Protocol Violation|4
1525816|NCT00309777|5003908|P4|Overall Study|Adverse Event|1
1525817|NCT00309777|5003909|P3|Overall Study|Adverse Event|8
1525818|NCT00309777|5003910|P2|Overall Study|Adverse Event|2
1525819|NCT00309777|5003911|P1|Overall Study|Adverse Event|13
1525820|NCT00309608|5003952|P5|Overall Study|Other incl. Lack of efficacy|0
1525821|NCT00309608|5003953|P4|Overall Study|Other incl. Lack of efficacy|4
1525822|NCT00309608|5003954|P3|Overall Study|Other incl. Lack of efficacy|3
1525823|NCT00309608|5003955|P2|Overall Study|Other incl. Lack of efficacy|4
1525824|NCT00309608|5003956|P1|Overall Study|Other incl. Lack of efficacy|10
1525825|NCT00309608|5003952|P5|Overall Study|Withdrawal by Subject|0
1525826|NCT00309608|5003953|P4|Overall Study|Withdrawal by Subject|0
1525827|NCT00309608|5003954|P3|Overall Study|Withdrawal by Subject|2
1525828|NCT00309608|5003955|P2|Overall Study|Withdrawal by Subject|4
1525829|NCT00309608|5003956|P1|Overall Study|Withdrawal by Subject|1
1525830|NCT00309608|5003952|P5|Overall Study|Lost to Follow-up|1
1525831|NCT00309608|5003953|P4|Overall Study|Lost to Follow-up|0
1525832|NCT00309608|5003954|P3|Overall Study|Lost to Follow-up|2
1525833|NCT00309608|5003955|P2|Overall Study|Lost to Follow-up|0
1525834|NCT00309608|5003956|P1|Overall Study|Lost to Follow-up|0
1525835|NCT00309608|5003952|P5|Overall Study|Protocol Violation|0
1525836|NCT00309608|5003953|P4|Overall Study|Protocol Violation|0
1525837|NCT00309608|5003954|P3|Overall Study|Protocol Violation|0
1525838|NCT00309608|5003955|P2|Overall Study|Protocol Violation|0
1525839|NCT00309608|5003956|P1|Overall Study|Protocol Violation|2
1525840|NCT00309608|5003952|P5|Overall Study|Adverse Event|3
1525841|NCT00309608|5003953|P4|Overall Study|Adverse Event|2
1525842|NCT00309608|5003954|P3|Overall Study|Adverse Event|3
1525843|NCT00309608|5003955|P2|Overall Study|Adverse Event|5
1525844|NCT00309608|5003956|P1|Overall Study|Adverse Event|1
1525845|NCT00309452|5004004|P2|Overall Study|Withdrawal by Subject|0
1525846|NCT00309452|5004005|P1|Overall Study|Withdrawal by Subject|3
1525847|NCT00309387|5004033|P2|Overall Study|Lost to Follow-up|86
1525848|NCT00309387|5004034|P1|Overall Study|Lost to Follow-up|70
1525849|NCT00309387|5004033|P2|Overall Study|Death|73
1525850|NCT00309387|5004034|P1|Overall Study|Death|72
1525851|NCT00309244|5004052|P2|Overall Study|Death|1
1525852|NCT00309244|5004053|P1|Overall Study|Death|4
1525853|NCT00309244|5004052|P2|Overall Study|Randomized but not dosed|12
1525854|NCT00309244|5004053|P1|Overall Study|Randomized but not dosed|11
1525855|NCT00309244|5004052|P2|Overall Study|Various|7
1525856|NCT00309244|5004053|P1|Overall Study|Various|7
1525857|NCT00309244|5004052|P2|Overall Study|Withdrawal by Subject|32
1525858|NCT00309244|5004053|P1|Overall Study|Withdrawal by Subject|50
1525859|NCT00309244|5004052|P2|Overall Study|Protocol Violation|3
1525860|NCT00309244|5004053|P1|Overall Study|Protocol Violation|6
1525861|NCT00309244|5004052|P2|Overall Study|Physician Decision|8
1525862|NCT00309244|5004053|P1|Overall Study|Physician Decision|5
1525863|NCT00309244|5004052|P2|Overall Study|Lost to Follow-up|22
1525864|NCT00309244|5004053|P1|Overall Study|Lost to Follow-up|6
1525865|NCT00309244|5004052|P2|Overall Study|Adverse Event|12
1525866|NCT00309244|5004053|P1|Overall Study|Adverse Event|29
1525867|NCT00308997|5004075|P2|Overall Study|Unable to tolerate intervention|0
1525868|NCT00308997|5004076|P1|Overall Study|Unable to tolerate intervention|1
1525869|NCT00308997|5004075|P2|Overall Study|Subject feigned clinical data|1
1525870|NCT00308997|5004076|P1|Overall Study|Subject feigned clinical data|0
1525871|NCT00308737|5004095|P3|Overall Study|Various|8
1525872|NCT00308737|5004096|P2|Overall Study|Various|20
1525873|NCT00308737|5004097|P1|Overall Study|Various|32
1525874|NCT00308737|5004095|P3|Overall Study|Withdrawal by Subject|18
1525875|NCT00308737|5004096|P2|Overall Study|Withdrawal by Subject|166
1525876|NCT00308737|5004097|P1|Overall Study|Withdrawal by Subject|218
1525877|NCT00308737|5004095|P3|Overall Study|Protocol Violation|5
1525878|NCT00308737|5004096|P2|Overall Study|Protocol Violation|9
1525879|NCT00308737|5004097|P1|Overall Study|Protocol Violation|34
1525880|NCT00308737|5004095|P3|Overall Study|Physician Decision|1
1525881|NCT00308737|5004096|P2|Overall Study|Physician Decision|2
1525882|NCT00308737|5004097|P1|Overall Study|Physician Decision|15
1525883|NCT00308737|5004095|P3|Overall Study|Lost to Follow-up|5
1525884|NCT00308737|5004096|P2|Overall Study|Lost to Follow-up|80
1525885|NCT00308737|5004097|P1|Overall Study|Lost to Follow-up|56
1525886|NCT00308737|5004095|P3|Overall Study|Death|0
1525887|NCT00308737|5004096|P2|Overall Study|Death|3
1525888|NCT00308737|5004097|P1|Overall Study|Death|4
1525889|NCT00308737|5004095|P3|Overall Study|Adverse Event|0
1525890|NCT00308737|5004096|P2|Overall Study|Adverse Event|9
1525891|NCT00308737|5004097|P1|Overall Study|Adverse Event|104
1525892|NCT00308711|5004137|P3|Overall Study|Subject incarcerated, data not allowed|1
1525893|NCT00308711|5004138|P2|Overall Study|Subject incarcerated, data not allowed|0
1525894|NCT00308711|5004139|P1|Overall Study|Subject incarcerated, data not allowed|0
1525895|NCT00308711|5004137|P3|Overall Study|Baby not born within 7 days of treatment|2
1525896|NCT00308711|5004138|P2|Overall Study|Baby not born within 7 days of treatment|2
1525897|NCT00308711|5004139|P1|Overall Study|Baby not born within 7 days of treatment|1
1525898|NCT00308711|5004137|P3|Overall Study|Lost to Follow-up|0
1525899|NCT00308711|5004138|P2|Overall Study|Lost to Follow-up|1
1525900|NCT00308711|5004139|P1|Overall Study|Lost to Follow-up|0
1525901|NCT00308711|5004137|P3|Overall Study|Protocol Violation|1
1525902|NCT00308711|5004138|P2|Overall Study|Protocol Violation|1
1525903|NCT00308711|5004139|P1|Overall Study|Protocol Violation|0
1525904|NCT00308711|5004137|P3|Overall Study|Withdrawal by Subject|1
1525905|NCT00308711|5004138|P2|Overall Study|Withdrawal by Subject|0
1525906|NCT00308711|5004139|P1|Overall Study|Withdrawal by Subject|1
1525907|NCT00308620|5004174|P3|Overall Study|Lost to Follow-up|1
1525908|NCT00308620|5004175|P2|Overall Study|Lost to Follow-up|0
1525909|NCT00308620|5004176|P1|Overall Study|Lost to Follow-up|0
1525910|NCT00308620|5004174|P3|Overall Study|Death|0
1525911|NCT00308620|5004175|P2|Overall Study|Death|1
1525912|NCT00308620|5004176|P1|Overall Study|Death|1
1525913|NCT00308581|5004185|P3|Randomized Maintenance Phase|Unknown reason|0
1525914|NCT00308581|5004186|P2|Randomized Maintenance Phase|Unknown reason|0
1525915|NCT00308581|5004187|P1|Randomized Maintenance Phase|Unknown reason|3
1525916|NCT00308581|5004185|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
1525917|NCT00308581|5004186|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
1525918|NCT00308581|5004187|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
1525919|NCT00308581|5004185|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
1525920|NCT00308581|5004186|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
1525921|NCT00308581|5004187|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
1525922|NCT00308581|5004185|P3|Randomized Maintenance Phase|Lost to Follow-up|0
1525923|NCT00308581|5004186|P2|Randomized Maintenance Phase|Lost to Follow-up|2
1525924|NCT00308581|5004187|P1|Randomized Maintenance Phase|Lost to Follow-up|0
1525925|NCT00308581|5004185|P3|Randomized Maintenance Phase|Lack of Efficacy|0
1525926|NCT00308581|5004186|P2|Randomized Maintenance Phase|Lack of Efficacy|21
1525927|NCT00308581|5004187|P1|Randomized Maintenance Phase|Lack of Efficacy|9
1525928|NCT00308581|5004185|P3|Randomized Maintenance Phase|Adverse Event|0
1525929|NCT00308581|5004186|P2|Randomized Maintenance Phase|Adverse Event|17
1525930|NCT00308581|5004187|P1|Randomized Maintenance Phase|Adverse Event|10
1525931|NCT00308581|5004185|P3|Induction Phase|Unknown reason|3
1525932|NCT00308581|5004186|P2|Induction Phase|Unknown reason|0
1525933|NCT00308581|5004187|P1|Induction Phase|Unknown reason|0
1525934|NCT00308581|5004185|P3|Induction Phase|Withdrawal by Subject|5
1525935|NCT00308581|5004186|P2|Induction Phase|Withdrawal by Subject|0
1525936|NCT00308581|5004187|P1|Induction Phase|Withdrawal by Subject|0
1525937|NCT00308581|5004185|P3|Induction Phase|Lack of Efficacy|121
1525938|NCT00308581|5004186|P2|Induction Phase|Lack of Efficacy|0
1525939|NCT00308581|5004187|P1|Induction Phase|Lack of Efficacy|0
1525940|NCT00308581|5004185|P3|Induction Phase|Adverse Event|37
1525941|NCT00308581|5004186|P2|Induction Phase|Adverse Event|0
1525942|NCT00308581|5004187|P1|Induction Phase|Adverse Event|0
1525943|NCT00308555|5004313|P2|Overall Study|Physician Decision|0
1525944|NCT00308555|5004314|P1|Overall Study|Physician Decision|2
1525945|NCT00308555|5004313|P2|Overall Study|Withdrawal by Subject|0
1525946|NCT00308555|5004314|P1|Overall Study|Withdrawal by Subject|1
1525947|NCT00308308|5004331|P2|Overall Study|Other|0
1525948|NCT00308308|5004332|P1|Overall Study|Other|1
1525949|NCT00308308|5004331|P2|Overall Study|Randomized but not dosed|16
1525950|NCT00308308|5004332|P1|Overall Study|Randomized but not dosed|8
1525951|NCT00308308|5004331|P2|Overall Study|Various|5
1525952|NCT00308308|5004332|P1|Overall Study|Various|7
1525953|NCT00308308|5004331|P2|Overall Study|Withdrawal by Subject|19
1525954|NCT00308308|5004332|P1|Overall Study|Withdrawal by Subject|47
1525955|NCT00308308|5004331|P2|Overall Study|Protocol Violation|14
1525956|NCT00308308|5004332|P1|Overall Study|Protocol Violation|3
1525957|NCT00308308|5004331|P2|Overall Study|Physician Decision|7
1525958|NCT00308308|5004332|P1|Overall Study|Physician Decision|15
1525959|NCT00308308|5004331|P2|Overall Study|Lost to Follow-up|5
1525960|NCT00308308|5004332|P1|Overall Study|Lost to Follow-up|5
1525961|NCT00308308|5004331|P2|Overall Study|Adverse Event|2
1525962|NCT00308308|5004332|P1|Overall Study|Adverse Event|17
1525963|NCT00308139|5004367|P2|Overall Study|Other|0
1525964|NCT00308139|5004368|P1|Overall Study|Other|1
1525965|NCT00308139|5004367|P2|Overall Study|Administrative|4
1525966|NCT00308139|5004368|P1|Overall Study|Administrative|1
1525967|NCT00308139|5004367|P2|Overall Study|Loss of Glucose Control|7
1525968|NCT00308139|5004368|P1|Overall Study|Loss of Glucose Control|5
1525969|NCT00308139|5004367|P2|Overall Study|Investigator Decision|10
1525970|NCT00308139|5004368|P1|Overall Study|Investigator Decision|11
1525971|NCT00308139|5004367|P2|Overall Study|Withdrawal of Consent|42
1525972|NCT00308139|5004368|P1|Overall Study|Withdrawal of Consent|40
1525973|NCT00308139|5004367|P2|Overall Study|Protocol Violation|2
1525974|NCT00308139|5004368|P1|Overall Study|Protocol Violation|3
1525975|NCT00308139|5004367|P2|Overall Study|Lost to Follow-up|8
1525976|NCT00308139|5004368|P1|Overall Study|Lost to Follow-up|13
1525977|NCT00308139|5004367|P2|Overall Study|Adverse Event|14
1525978|NCT00308139|5004368|P1|Overall Study|Adverse Event|20
1525979|NCT00308113|5004442|P4|Overall Study|Protocol closure|1
1525980|NCT00308113|5004443|P3|Overall Study|Protocol closure|0
1525981|NCT00308113|5004444|P2|Overall Study|Protocol closure|0
1525982|NCT00308113|5004445|P1|Overall Study|Protocol closure|0
1525983|NCT00308087|5004465|P2|Overall Study|Not Specified|3
1525984|NCT00308087|5004466|P1|Overall Study|Not Specified|4
1525985|NCT00308087|5004465|P2|Overall Study|Withdrawal by Subject|1
1525986|NCT00308087|5004466|P1|Overall Study|Withdrawal by Subject|2
1525987|NCT00308087|5004465|P2|Overall Study|Study Closure|12
1525988|NCT00308087|5004466|P1|Overall Study|Study Closure|11
1525989|NCT00308087|5004465|P2|Overall Study|Progressive Disease|21
1525990|NCT00308087|5004466|P1|Overall Study|Progressive Disease|19
1525991|NCT00308074|5004482|P1|Overall Study|Withdrawal by Subject|1
1525992|NCT00307931|5004499|P1|Overall Study|Adverse Event|1
1525993|NCT00307801|5004516|P2|Overall Study|Pregnancy|1
1525994|NCT00307801|5004517|P1|Overall Study|Pregnancy|0
1525995|NCT00307801|5004516|P2|Overall Study|No reason specified|0
1525996|NCT00307801|5004517|P1|Overall Study|No reason specified|2
1525997|NCT00307801|5004516|P2|Overall Study|Protocol Violation|2
1525998|NCT00307801|5004517|P1|Overall Study|Protocol Violation|3
1525999|NCT00307801|5004516|P2|Overall Study|Frustration with e-diary|0
1526000|NCT00307801|5004517|P1|Overall Study|Frustration with e-diary|1
1526001|NCT00307801|5004516|P2|Overall Study|Lost to Follow-up, moved abroad|1
1526002|NCT00307801|5004517|P1|Overall Study|Lost to Follow-up, moved abroad|1
1526003|NCT00307801|5004516|P2|Overall Study|Lack of Efficacy|2
1526004|NCT00307801|5004517|P1|Overall Study|Lack of Efficacy|0
1526005|NCT00307801|5004516|P2|Overall Study|Wrong Randomization|0
1526006|NCT00307801|5004517|P1|Overall Study|Wrong Randomization|1
1526007|NCT00307801|5004516|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
1526008|NCT00307801|5004517|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
1526009|NCT00307801|5004516|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
1526010|NCT00307801|5004517|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
1526011|NCT00307801|5004516|P2|Overall Study|Non-compliance, not taken all tablets|2
1526012|NCT00307801|5004517|P1|Overall Study|Non-compliance, not taken all tablets|1
1526013|NCT00307801|5004516|P2|Overall Study|Withdrawal by Subject|4
1526014|NCT00307801|5004517|P1|Overall Study|Withdrawal by Subject|9
1526015|NCT00307801|5004516|P2|Overall Study|Adverse Event|4
1526016|NCT00307801|5004517|P1|Overall Study|Adverse Event|12
1526017|NCT00307736|5004629|P4|Overall Study|Withdrawal by Subject|0
1526018|NCT00307736|5004630|P3|Overall Study|Withdrawal by Subject|2
1526019|NCT00307736|5004631|P2|Overall Study|Withdrawal by Subject|0
1526020|NCT00307736|5004632|P1|Overall Study|Withdrawal by Subject|0
1526021|NCT00307736|5004629|P4|Overall Study|Adverse Event|3
1526022|NCT00307736|5004630|P3|Overall Study|Adverse Event|1
1526023|NCT00307736|5004631|P2|Overall Study|Adverse Event|0
1526024|NCT00307736|5004632|P1|Overall Study|Adverse Event|0
1526025|NCT00307684|5004643|P3|Double Blind Phase|Lack of Efficacy|0
1526026|NCT00307684|5004644|P2|Double Blind Phase|Lack of Efficacy|5
1526027|NCT00307684|5004645|P1|Double Blind Phase|Lack of Efficacy|2
1526028|NCT00307684|5004643|P3|Open Label Phase|other|6
1526029|NCT00307684|5004644|P2|Open Label Phase|other|0
1526030|NCT00307684|5004645|P1|Open Label Phase|other|0
1526031|NCT00307684|5004643|P3|Open Label Phase|non compliance|5
1526032|NCT00307684|5004644|P2|Open Label Phase|non compliance|0
1526033|NCT00307684|5004645|P1|Open Label Phase|non compliance|0
1526034|NCT00307684|5004643|P3|Open Label Phase|Lost to Follow-up|11
1526035|NCT00307684|5004644|P2|Open Label Phase|Lost to Follow-up|0
1526036|NCT00307684|5004645|P1|Open Label Phase|Lost to Follow-up|0
1526037|NCT00307684|5004643|P3|Open Label Phase|Withdrawal by Subject|15
1526038|NCT00307684|5004644|P2|Open Label Phase|Withdrawal by Subject|0
1526039|NCT00307684|5004645|P1|Open Label Phase|Withdrawal by Subject|0
1526040|NCT00307684|5004643|P3|Open Label Phase|Adverse Event|16
1526041|NCT00307684|5004644|P2|Open Label Phase|Adverse Event|0
1526042|NCT00307684|5004645|P1|Open Label Phase|Adverse Event|0
1526043|NCT00307684|5004643|P3|Open Label Phase|Lack of Efficacy|3
1526044|NCT00307684|5004644|P2|Open Label Phase|Lack of Efficacy|0
1526045|NCT00307684|5004645|P1|Open Label Phase|Lack of Efficacy|0
1526046|NCT00307489|5004673|P2|Week 48 Through Week 168|Seroconversion|0
1526047|NCT00307489|5004674|P1|Week 48 Through Week 168|Seroconversion|1
1526048|NCT00307489|5004673|P2|Week 48 Through Week 168|Lost to Follow-up|1
1526049|NCT00307489|5004674|P1|Week 48 Through Week 168|Lost to Follow-up|0
1526050|NCT00307489|5004673|P2|Week 48 Through Week 168|Death|1
1526051|NCT00307489|5004674|P1|Week 48 Through Week 168|Death|0
1526052|NCT00307489|5004673|P2|Week 48 Through Week 168|Lack of Efficacy|2
1526053|NCT00307489|5004674|P1|Week 48 Through Week 168|Lack of Efficacy|2
1526054|NCT00307489|5004673|P2|Week 48 Through Week 168|Withdrawal by Subject|2
1526055|NCT00307489|5004674|P1|Week 48 Through Week 168|Withdrawal by Subject|1
1526056|NCT00307489|5004673|P2|Week 48 Through Week 168|Physician Decision|0
1526057|NCT00307489|5004674|P1|Week 48 Through Week 168|Physician Decision|1
1526058|NCT00307489|5004673|P2|Week 48 Through Week 168|Adverse Event|0
1526059|NCT00307489|5004674|P1|Week 48 Through Week 168|Adverse Event|1
1526060|NCT00307489|5004673|P2|Baseline Through Week 48|Withdrawal by Subject|1
1526061|NCT00307489|5004674|P1|Baseline Through Week 48|Withdrawal by Subject|0
1526062|NCT00307489|5004673|P2|Baseline Through Week 48|Physician Decision|0
1526063|NCT00307489|5004674|P1|Baseline Through Week 48|Physician Decision|1
1526064|NCT00307489|5004673|P2|Baseline Through Week 48|Lost to Follow-up|1
1526065|NCT00307489|5004674|P1|Baseline Through Week 48|Lost to Follow-up|0
1526066|NCT00307437|5004719|P7|After Controlled Period|Other|28
1526067|NCT00307437|5004720|P6|After Controlled Period|Other|40
1526068|NCT00307437|5004721|P5|After Controlled Period|Other|9
1526069|NCT00307437|5004722|P4|After Controlled Period|Other|15
1526070|NCT00307437|5004723|P3|After Controlled Period|Other|0
1526071|NCT00307437|5004724|P2|After Controlled Period|Other|0
1526072|NCT00307437|5004725|P1|After Controlled Period|Other|0
1526073|NCT00307437|5004719|P7|After Controlled Period|Lost to Follow-up|18
1526074|NCT00307437|5004720|P6|After Controlled Period|Lost to Follow-up|13
1526075|NCT00307437|5004721|P5|After Controlled Period|Lost to Follow-up|12
1526076|NCT00307437|5004722|P4|After Controlled Period|Lost to Follow-up|7
1526077|NCT00307437|5004723|P3|After Controlled Period|Lost to Follow-up|0
1526078|NCT00307437|5004724|P2|After Controlled Period|Lost to Follow-up|0
1526079|NCT00307437|5004725|P1|After Controlled Period|Lost to Follow-up|0
1526080|NCT00307437|5004719|P7|After Controlled Period|Lack of Efficacy|24
1526081|NCT00307437|5004720|P6|After Controlled Period|Lack of Efficacy|37
1526082|NCT00307437|5004721|P5|After Controlled Period|Lack of Efficacy|17
1526083|NCT00307437|5004722|P4|After Controlled Period|Lack of Efficacy|15
1526084|NCT00307437|5004723|P3|After Controlled Period|Lack of Efficacy|0
1526085|NCT00307437|5004724|P2|After Controlled Period|Lack of Efficacy|0
1526086|NCT00307437|5004725|P1|After Controlled Period|Lack of Efficacy|0
1526087|NCT00307437|5004719|P7|After Controlled Period|Death|3
1526088|NCT00307437|5004720|P6|After Controlled Period|Death|1
1526089|NCT00307437|5004721|P5|After Controlled Period|Death|1
1526090|NCT00307437|5004722|P4|After Controlled Period|Death|3
1526091|NCT00307437|5004723|P3|After Controlled Period|Death|0
1526092|NCT00307437|5004724|P2|After Controlled Period|Death|0
1526093|NCT00307437|5004725|P1|After Controlled Period|Death|0
1526094|NCT00307437|5004719|P7|After Controlled Period|Adverse Event|40
1526095|NCT00307437|5004720|P6|After Controlled Period|Adverse Event|31
1526096|NCT00307437|5004721|P5|After Controlled Period|Adverse Event|16
1526097|NCT00307437|5004722|P4|After Controlled Period|Adverse Event|18
1526098|NCT00307437|5004723|P3|After Controlled Period|Adverse Event|0
1526099|NCT00307437|5004724|P2|After Controlled Period|Adverse Event|0
1526100|NCT00307437|5004725|P1|After Controlled Period|Adverse Event|0
1526101|NCT00307437|5004719|P7|Controlled Period|Other|0
1526102|NCT00307437|5004720|P6|Controlled Period|Other|0
1526103|NCT00307437|5004721|P5|Controlled Period|Other|0
1526104|NCT00307437|5004722|P4|Controlled Period|Other|0
1526105|NCT00307437|5004723|P3|Controlled Period|Other|3
1526106|NCT00307437|5004724|P2|Controlled Period|Other|1
1526107|NCT00307437|5004725|P1|Controlled Period|Other|5
1526108|NCT00307437|5004719|P7|Controlled Period|Lost to Follow-up|0
1526109|NCT00307437|5004720|P6|Controlled Period|Lost to Follow-up|0
1526110|NCT00307437|5004721|P5|Controlled Period|Lost to Follow-up|0
1526111|NCT00307437|5004722|P4|Controlled Period|Lost to Follow-up|0
1526112|NCT00307437|5004723|P3|Controlled Period|Lost to Follow-up|0
1526113|NCT00307437|5004724|P2|Controlled Period|Lost to Follow-up|3
1526114|NCT00307437|5004725|P1|Controlled Period|Lost to Follow-up|2
1526115|NCT00307437|5004719|P7|Controlled Period|Lack of Efficacy|0
1526116|NCT00307437|5004720|P6|Controlled Period|Lack of Efficacy|0
1526117|NCT00307437|5004721|P5|Controlled Period|Lack of Efficacy|0
1526118|NCT00307437|5004722|P4|Controlled Period|Lack of Efficacy|0
1526119|NCT00307437|5004723|P3|Controlled Period|Lack of Efficacy|0
1526120|NCT00307437|5004724|P2|Controlled Period|Lack of Efficacy|0
1526121|NCT00307437|5004725|P1|Controlled Period|Lack of Efficacy|2
1526122|NCT00307437|5004719|P7|Controlled Period|Death|0
1526123|NCT00307437|5004720|P6|Controlled Period|Death|0
1526124|NCT00307437|5004721|P5|Controlled Period|Death|0
1526125|NCT00307437|5004722|P4|Controlled Period|Death|0
1526126|NCT00307437|5004723|P3|Controlled Period|Death|1
1526127|NCT00307437|5004724|P2|Controlled Period|Death|0
1526128|NCT00307437|5004725|P1|Controlled Period|Death|0
1526129|NCT00307437|5004719|P7|Controlled Period|Adverse Event|0
1526130|NCT00307437|5004720|P6|Controlled Period|Adverse Event|0
1526131|NCT00307437|5004721|P5|Controlled Period|Adverse Event|0
1526132|NCT00307437|5004722|P4|Controlled Period|Adverse Event|0
1526133|NCT00307437|5004723|P3|Controlled Period|Adverse Event|5
1526134|NCT00307437|5004724|P2|Controlled Period|Adverse Event|2
1526135|NCT00307437|5004725|P1|Controlled Period|Adverse Event|7
1526136|NCT00307333|5004751|P2|Overall Study|Lost to Follow-up|3
1526137|NCT00307333|5004752|P1|Overall Study|Lost to Follow-up|11
1526138|NCT00307294|5004764|P1|Overall Study|Withdrawal by Subject|1
1526139|NCT00307164|5004773|P2|Overall Study|Lost to Follow-up|1
1526140|NCT00307164|5004774|P1|Overall Study|Lost to Follow-up|6
1526141|NCT00307164|5004773|P2|Overall Study|Not compliant with requirements|4
1526142|NCT00307164|5004774|P1|Overall Study|Not compliant with requirements|4
1526143|NCT00307164|5004773|P2|Overall Study|Withdrawal by Subject|8
1526144|NCT00307164|5004774|P1|Overall Study|Withdrawal by Subject|1
1526145|NCT00307164|5004773|P2|Overall Study|Subject/parent not able to get to clinic|1
1526146|NCT00307164|5004774|P1|Overall Study|Subject/parent not able to get to clinic|2
1526147|NCT00307164|5004773|P2|Overall Study|Severe debilitation, unable to continue|0
1526148|NCT00307164|5004774|P1|Overall Study|Severe debilitation, unable to continue|1
1526149|NCT00307164|5004773|P2|Overall Study|Death|0
1526150|NCT00307164|5004774|P1|Overall Study|Death|1
1526151|NCT00307151|5004814|P4|Overall Study|Clinic unable to contact subject|1
1526152|NCT00307151|5004815|P3|Overall Study|Clinic unable to contact subject|1
1526153|NCT00307151|5004816|P2|Overall Study|Clinic unable to contact subject|3
1526154|NCT00307151|5004817|P1|Overall Study|Clinic unable to contact subject|3
1526155|NCT00307151|5004814|P4|Overall Study|Not willing to adhere to study reqs|2
1526156|NCT00307151|5004815|P3|Overall Study|Not willing to adhere to study reqs|2
1526157|NCT00307151|5004816|P2|Overall Study|Not willing to adhere to study reqs|0
1526158|NCT00307151|5004817|P1|Overall Study|Not willing to adhere to study reqs|2
1526159|NCT00307151|5004814|P4|Overall Study|Withdrew consent|3
1526160|NCT00307151|5004815|P3|Overall Study|Withdrew consent|1
1526161|NCT00307151|5004816|P2|Overall Study|Withdrew consent|1
1526162|NCT00307151|5004817|P1|Overall Study|Withdrew consent|0
1526163|NCT00307151|5004814|P4|Overall Study|Subject unable to get to clinic|2
1526164|NCT00307151|5004815|P3|Overall Study|Subject unable to get to clinic|6
1526165|NCT00307151|5004816|P2|Overall Study|Subject unable to get to clinic|0
1526166|NCT00307151|5004817|P1|Overall Study|Subject unable to get to clinic|1
1526167|NCT00307151|5004814|P4|Overall Study|Severe debilitation, unable to continue|0
1526168|NCT00307151|5004815|P3|Overall Study|Severe debilitation, unable to continue|0
1526169|NCT00307151|5004816|P2|Overall Study|Severe debilitation, unable to continue|0
1526170|NCT00307151|5004817|P1|Overall Study|Severe debilitation, unable to continue|1
1526171|NCT00307151|5004814|P4|Overall Study|Death|3
1526172|NCT00307151|5004815|P3|Overall Study|Death|10
1526173|NCT00307151|5004816|P2|Overall Study|Death|3
1526174|NCT00307151|5004817|P1|Overall Study|Death|4
1526175|NCT00307125|5004861|P3|Pilot Phase|Withdrawal by Subject|1
1526176|NCT00307125|5004862|P2|Pilot Phase|Withdrawal by Subject|1
1526177|NCT00307125|5004863|P1|Pilot Phase|Withdrawal by Subject|0
1526178|NCT00307125|5004861|P3|Pilot Phase|Lost to Follow-up|0
1526179|NCT00307125|5004862|P2|Pilot Phase|Lost to Follow-up|1
1526180|NCT00307125|5004863|P1|Pilot Phase|Lost to Follow-up|0
1526181|NCT00307125|5004861|P3|Screening Phase|Coronary artery bypass|0
1526182|NCT00307125|5004862|P2|Screening Phase|Coronary artery bypass|0
1526183|NCT00307125|5004863|P1|Screening Phase|Coronary artery bypass|1
1526184|NCT00307125|5004861|P3|Screening Phase|AMR and treated with rituximab|0
1526185|NCT00307125|5004862|P2|Screening Phase|AMR and treated with rituximab|0
1526186|NCT00307125|5004863|P1|Screening Phase|AMR and treated with rituximab|1
1526187|NCT00307125|5004861|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
1526188|NCT00307125|5004862|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
1526189|NCT00307125|5004863|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
1526190|NCT00307125|5004861|P3|Screening Phase|Screen Error|0
1526191|NCT00307125|5004862|P2|Screening Phase|Screen Error|0
1526192|NCT00307125|5004863|P1|Screening Phase|Screen Error|1
1526193|NCT00307125|5004861|P3|Screening Phase|Ineligible|0
1526194|NCT00307125|5004862|P2|Screening Phase|Ineligible|0
1526195|NCT00307125|5004863|P1|Screening Phase|Ineligible|1
1526196|NCT00307125|5004861|P3|Screening Phase|PAK|0
1526197|NCT00307125|5004862|P2|Screening Phase|PAK|0
1526198|NCT00307125|5004863|P1|Screening Phase|PAK|1
1526199|NCT00307125|5004861|P3|Screening Phase|Malignancy|0
1526200|NCT00307125|5004862|P2|Screening Phase|Malignancy|0
1526201|NCT00307125|5004863|P1|Screening Phase|Malignancy|1
1526202|NCT00307125|5004861|P3|Screening Phase|Metastatic colon cancer|0
1526203|NCT00307125|5004862|P2|Screening Phase|Metastatic colon cancer|0
1526204|NCT00307125|5004863|P1|Screening Phase|Metastatic colon cancer|1
1526205|NCT00307125|5004861|P3|Screening Phase|Developed acute leukemia|0
1526206|NCT00307125|5004862|P2|Screening Phase|Developed acute leukemia|0
1526207|NCT00307125|5004863|P1|Screening Phase|Developed acute leukemia|1
1526208|NCT00307125|5004861|P3|Screening Phase|Try to get pregnant|0
1526209|NCT00307125|5004862|P2|Screening Phase|Try to get pregnant|0
1526210|NCT00307125|5004863|P1|Screening Phase|Try to get pregnant|1
1526211|NCT00307125|5004861|P3|Screening Phase|Ineligible for pilot|0
1526212|NCT00307125|5004862|P2|Screening Phase|Ineligible for pilot|0
1526213|NCT00307125|5004863|P1|Screening Phase|Ineligible for pilot|4
1526214|NCT00307125|5004861|P3|Screening Phase|Received Pancreas Transplant|0
1526215|NCT00307125|5004862|P2|Screening Phase|Received Pancreas Transplant|0
1526216|NCT00307125|5004863|P1|Screening Phase|Received Pancreas Transplant|8
1526217|NCT00307125|5004861|P3|Screening Phase|Moved or transferred facilities|0
1526218|NCT00307125|5004862|P2|Screening Phase|Moved or transferred facilities|0
1526219|NCT00307125|5004863|P1|Screening Phase|Moved or transferred facilities|34
1526220|NCT00307125|5004861|P3|Screening Phase|Scheduling issues/Non-compliance|0
1526221|NCT00307125|5004862|P2|Screening Phase|Scheduling issues/Non-compliance|0
1526222|NCT00307125|5004863|P1|Screening Phase|Scheduling issues/Non-compliance|55
1526223|NCT00307125|5004861|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
1526224|NCT00307125|5004862|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
1526225|NCT00307125|5004863|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
1526226|NCT00307125|5004861|P3|Screening Phase|Graft Failure|0
1526227|NCT00307125|5004862|P2|Screening Phase|Graft Failure|0
1526228|NCT00307125|5004863|P1|Screening Phase|Graft Failure|8
1526229|NCT00307125|5004861|P3|Screening Phase|Graft Loss|0
1526230|NCT00307125|5004862|P2|Screening Phase|Graft Loss|0
1526231|NCT00307125|5004863|P1|Screening Phase|Graft Loss|3
1526232|NCT00307125|5004861|P3|Screening Phase|Study Terminated|0
1526233|NCT00307125|5004862|P2|Screening Phase|Study Terminated|0
1526234|NCT00307125|5004863|P1|Screening Phase|Study Terminated|17
1526235|NCT00307125|5004861|P3|Screening Phase|Sponsor Decision|0
1526236|NCT00307125|5004862|P2|Screening Phase|Sponsor Decision|0
1526237|NCT00307125|5004863|P1|Screening Phase|Sponsor Decision|4
1526238|NCT00307125|5004861|P3|Screening Phase|Physician Decision|0
1526239|NCT00307125|5004862|P2|Screening Phase|Physician Decision|0
1526240|NCT00307125|5004863|P1|Screening Phase|Physician Decision|26
1526241|NCT00307125|5004861|P3|Screening Phase|Withdrawal by Subject|0
1526242|NCT00307125|5004862|P2|Screening Phase|Withdrawal by Subject|0
1526243|NCT00307125|5004863|P1|Screening Phase|Withdrawal by Subject|77
1526244|NCT00307125|5004861|P3|Screening Phase|Death|0
1526245|NCT00307125|5004862|P2|Screening Phase|Death|0
1526246|NCT00307125|5004863|P1|Screening Phase|Death|10
1526247|NCT00307125|5004861|P3|Screening Phase|Lost to Follow-up|0
1526248|NCT00307125|5004862|P2|Screening Phase|Lost to Follow-up|0
1526249|NCT00307125|5004863|P1|Screening Phase|Lost to Follow-up|87
1526250|NCT00307125|5004861|P3|Screening Phase|Protocol Violation|0
1526251|NCT00307125|5004862|P2|Screening Phase|Protocol Violation|0
1526252|NCT00307125|5004863|P1|Screening Phase|Protocol Violation|27
1526253|NCT00307125|5004861|P3|Screening Phase|Adverse Event|0
1526254|NCT00307125|5004862|P2|Screening Phase|Adverse Event|0
1526255|NCT00307125|5004863|P1|Screening Phase|Adverse Event|1
1526256|NCT00307086|5004885|P1|Overall Study|ineligible|5
1526257|NCT00307047|5004891|P2|Overall Study|All death, all MI, all Revascularization|16
1526258|NCT00307047|5004892|P1|Overall Study|All death, all MI, all Revascularization|27
1526259|NCT00307047|5004891|P2|Overall Study|Lost to follow-up for other reasons|1
1526260|NCT00307047|5004892|P1|Overall Study|Lost to follow-up for other reasons|0
1526261|NCT00307047|5004891|P2|Overall Study|Physician Decision|2
1526262|NCT00307047|5004892|P1|Overall Study|Physician Decision|1
1526263|NCT00307047|5004891|P2|Overall Study|Withdrawal by Subject|6
1526264|NCT00307047|5004892|P1|Overall Study|Withdrawal by Subject|6
1526265|NCT00307047|5004891|P2|Overall Study|Lost to Follow-up|24
1526266|NCT00307047|5004892|P1|Overall Study|Lost to Follow-up|35
1526267|NCT00307034|5005030|P2|Overall Study|Lost to Follow-up|3
1526268|NCT00307034|5005031|P1|Overall Study|Lost to Follow-up|0
1526269|NCT00307034|5005030|P2|Overall Study|Withdrawal by Subject|2
1526270|NCT00307034|5005031|P1|Overall Study|Withdrawal by Subject|1
1526271|NCT00307034|5005030|P2|Overall Study|Adverse Event|2
1526272|NCT00307034|5005031|P1|Overall Study|Adverse Event|1
1526273|NCT00306891|5005082|P4|Part B|Development of study specific disc crit.|1
1526274|NCT00306891|5005083|P3|Part B|Development of study specific disc crit.|0
1526275|NCT00306891|5005084|P2|Part B|Development of study specific disc crit.|0
1526276|NCT00306891|5005085|P1|Part B|Development of study specific disc crit.|0
1526277|NCT00306891|5005082|P4|Part B|Condition under investigation worsened|8
1526278|NCT00306891|5005083|P3|Part B|Condition under investigation worsened|2
1526279|NCT00306891|5005084|P2|Part B|Condition under investigation worsened|0
1526280|NCT00306891|5005085|P1|Part B|Condition under investigation worsened|0
1526281|NCT00306891|5005082|P4|Part B|Withdrawal by Subject|1
1526282|NCT00306891|5005083|P3|Part B|Withdrawal by Subject|3
1526283|NCT00306891|5005084|P2|Part B|Withdrawal by Subject|0
1526284|NCT00306891|5005085|P1|Part B|Withdrawal by Subject|0
1526285|NCT00306891|5005082|P4|Part B|Adverse Event|5
1526286|NCT00306891|5005083|P3|Part B|Adverse Event|5
1526287|NCT00306891|5005084|P2|Part B|Adverse Event|0
1526288|NCT00306891|5005085|P1|Part B|Adverse Event|0
1526289|NCT00306891|5005082|P4|Part B|Death|2
1526290|NCT00306891|5005083|P3|Part B|Death|1
1526291|NCT00306891|5005084|P2|Part B|Death|0
1526292|NCT00306891|5005085|P1|Part B|Death|0
1526293|NCT00306891|5005082|P4|Part A|QTC interval outwith elig. criteria|0
1526294|NCT00306891|5005083|P3|Part A|QTC interval outwith elig. criteria|0
1526295|NCT00306891|5005084|P2|Part A|QTC interval outwith elig. criteria|0
1526296|NCT00306891|5005085|P1|Part A|QTC interval outwith elig. criteria|1
1526297|NCT00306891|5005082|P4|Part A|Suspicion of second malignancy|0
1526298|NCT00306891|5005083|P3|Part A|Suspicion of second malignancy|0
1526299|NCT00306891|5005084|P2|Part A|Suspicion of second malignancy|1
1526300|NCT00306891|5005085|P1|Part A|Suspicion of second malignancy|0
1526301|NCT00306891|5005082|P4|Part A|Reaccumul. of ascites following drainage|0
1526302|NCT00306891|5005083|P3|Part A|Reaccumul. of ascites following drainage|0
1526303|NCT00306891|5005084|P2|Part A|Reaccumul. of ascites following drainage|1
1526304|NCT00306891|5005085|P1|Part A|Reaccumul. of ascites following drainage|0
1526305|NCT00306891|5005082|P4|Part A|Partial bowel obstruction|0
1526306|NCT00306891|5005083|P3|Part A|Partial bowel obstruction|0
1526307|NCT00306891|5005084|P2|Part A|Partial bowel obstruction|0
1526308|NCT00306891|5005085|P1|Part A|Partial bowel obstruction|1
1526309|NCT00306891|5005082|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
1526310|NCT00306891|5005083|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
1526311|NCT00306891|5005084|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
1526312|NCT00306891|5005085|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
1526313|NCT00306891|5005082|P4|Part A|Condition under investigation worsened|0
1526314|NCT00306891|5005083|P3|Part A|Condition under investigation worsened|0
1526315|NCT00306891|5005084|P2|Part A|Condition under investigation worsened|2
1526316|NCT00306891|5005085|P1|Part A|Condition under investigation worsened|2
1526317|NCT00306891|5005082|P4|Part A|Withdrawal by Subject|0
1526318|NCT00306891|5005083|P3|Part A|Withdrawal by Subject|0
1526319|NCT00306891|5005084|P2|Part A|Withdrawal by Subject|1
1526320|NCT00306891|5005085|P1|Part A|Withdrawal by Subject|1
1526321|NCT00306852|5005108|P2|Overall Study|Lost to Follow-up|24
1526322|NCT00306852|5005109|P1|Overall Study|Lost to Follow-up|15
1526323|NCT00306852|5005108|P2|Overall Study|Death|14
1526324|NCT00306852|5005109|P1|Overall Study|Death|14
1526325|NCT00306787|5005127|P2|Overall Study|Abnormal laboratory value(s)|0
1526326|NCT00306787|5005128|P1|Overall Study|Abnormal laboratory value(s)|1
1526327|NCT00306787|5005127|P2|Overall Study|Administrative problems|0
1526328|NCT00306787|5005128|P1|Overall Study|Administrative problems|4
1526329|NCT00306787|5005127|P2|Overall Study|Lost to Follow-up|6
1526330|NCT00306787|5005128|P1|Overall Study|Lost to Follow-up|9
1526331|NCT00306787|5005127|P2|Overall Study|Withdrawal by Subject|9
1526332|NCT00306787|5005128|P1|Overall Study|Withdrawal by Subject|2
1526333|NCT00306787|5005127|P2|Overall Study|Protocol Violation|10
1526334|NCT00306787|5005128|P1|Overall Study|Protocol Violation|8
1526335|NCT00306787|5005127|P2|Overall Study|Lack of Efficacy|0
1526336|NCT00306787|5005128|P1|Overall Study|Lack of Efficacy|1
1526337|NCT00306787|5005127|P2|Overall Study|Adverse Event|1
1526338|NCT00306787|5005128|P1|Overall Study|Adverse Event|1
1526339|NCT00306787|5005127|P2|Overall Study|Discontinued without taking study drug|215
1526340|NCT00306787|5005128|P1|Overall Study|Discontinued without taking study drug|208
1526341|NCT00306670|5005146|P2|Overall Study|patients recruited; Genentech, the st|2
1526342|NCT00306670|5005147|P1|Overall Study|patients recruited; Genentech, the st|0
1526343|NCT00306592|5005153|P2|Overall Study|48-week Treatment Period Ongoing|20
1526344|NCT00306592|5005154|P1|Overall Study|48-week Treatment Period Ongoing|0
1526345|NCT00306592|5005153|P2|Overall Study|Other|2
1526346|NCT00306592|5005154|P1|Overall Study|Other|1
1526347|NCT00306592|5005153|P2|Overall Study|Not Specified|10
1526348|NCT00306592|5005154|P1|Overall Study|Not Specified|5
1526349|NCT00306592|5005153|P2|Overall Study|Voluntary|6
1526350|NCT00306592|5005154|P1|Overall Study|Voluntary|10
1526351|NCT00306592|5005153|P2|Overall Study|Persistent Antibodies|3
1526352|NCT00306592|5005154|P1|Overall Study|Persistent Antibodies|6
1526353|NCT00306592|5005153|P2|Overall Study|Noncompliance|2
1526354|NCT00306592|5005154|P1|Overall Study|Noncompliance|0
1526355|NCT00306592|5005153|P2|Overall Study|Lost to Follow-up|0
1526356|NCT00306592|5005154|P1|Overall Study|Lost to Follow-up|1
1526357|NCT00306592|5005153|P2|Overall Study|Adverse Event|15
1526358|NCT00306592|5005154|P1|Overall Study|Adverse Event|8
1526359|NCT00306527|5005164|P4|Overall Study|Death|2
1526360|NCT00306527|5005165|P3|Overall Study|Death|1
1526361|NCT00306527|5005166|P2|Overall Study|Death|0
1526362|NCT00306527|5005167|P1|Overall Study|Death|1
1526363|NCT00306527|5005164|P4|Overall Study|Adverse Event|1
1526364|NCT00306527|5005165|P3|Overall Study|Adverse Event|1
1526365|NCT00306527|5005166|P2|Overall Study|Adverse Event|0
1526366|NCT00306527|5005167|P1|Overall Study|Adverse Event|0
1526367|NCT00306527|5005164|P4|Overall Study|Withdrawal by Subject|3
1526368|NCT00306527|5005165|P3|Overall Study|Withdrawal by Subject|0
1526369|NCT00306527|5005166|P2|Overall Study|Withdrawal by Subject|3
1526370|NCT00306527|5005167|P1|Overall Study|Withdrawal by Subject|2
1526371|NCT00306527|5005164|P4|Overall Study|Lost to Follow-up|0
1526372|NCT00306527|5005165|P3|Overall Study|Lost to Follow-up|3
1526373|NCT00306527|5005166|P2|Overall Study|Lost to Follow-up|4
1526374|NCT00306527|5005167|P1|Overall Study|Lost to Follow-up|3
1526375|NCT00306384|5005236|P3|Overall Study|Site closure|0
1526376|NCT00306384|5005237|P2|Overall Study|Site closure|0
1526377|NCT00306384|5005238|P1|Overall Study|Site closure|2
1526378|NCT00306384|5005236|P3|Overall Study|Other|32
1526379|NCT00306384|5005237|P2|Overall Study|Other|70
1526380|NCT00306384|5005238|P1|Overall Study|Other|80
1526381|NCT00306384|5005236|P3|Overall Study|Investigator discretion|21
1526382|NCT00306384|5005237|P2|Overall Study|Investigator discretion|31
1526383|NCT00306384|5005238|P1|Overall Study|Investigator discretion|28
1526384|NCT00306384|5005236|P3|Overall Study|Lack of Efficacy|38
1526385|NCT00306384|5005237|P2|Overall Study|Lack of Efficacy|40
1526386|NCT00306384|5005238|P1|Overall Study|Lack of Efficacy|26
1526387|NCT00306384|5005236|P3|Overall Study|Pregnancy|1
1526388|NCT00306384|5005237|P2|Overall Study|Pregnancy|1
1526389|NCT00306384|5005238|P1|Overall Study|Pregnancy|3
1526390|NCT00306384|5005236|P3|Overall Study|Study termination|1
1526391|NCT00306384|5005237|P2|Overall Study|Study termination|0
1526392|NCT00306384|5005238|P1|Overall Study|Study termination|1
1526393|NCT00306384|5005236|P3|Overall Study|Voluntary withdrawal|91
1526394|NCT00306384|5005237|P2|Overall Study|Voluntary withdrawal|187
1526395|NCT00306384|5005238|P1|Overall Study|Voluntary withdrawal|199
1526396|NCT00306384|5005236|P3|Overall Study|Lost to Follow-up|35
1526397|NCT00306384|5005237|P2|Overall Study|Lost to Follow-up|41
1526398|NCT00306384|5005238|P1|Overall Study|Lost to Follow-up|57
1526399|NCT00306384|5005236|P3|Overall Study|Major protocol deviation|18
1526400|NCT00306384|5005237|P2|Overall Study|Major protocol deviation|51
1526401|NCT00306384|5005238|P1|Overall Study|Major protocol deviation|43
1526402|NCT00306384|5005236|P3|Overall Study|Adverse Event|40
1526403|NCT00306384|5005237|P2|Overall Study|Adverse Event|87
1526404|NCT00306384|5005238|P1|Overall Study|Adverse Event|103
1526405|NCT00306293|5005270|P2|Period 2 (Day 67 to Day 126 )|Pregnancy|0
1526406|NCT00306293|5005271|P1|Period 2 (Day 67 to Day 126 )|Pregnancy|1
1526407|NCT00306293|5005270|P2|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
1526408|NCT00306293|5005271|P1|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
1526409|NCT00306293|5005270|P2|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
1526410|NCT00306293|5005271|P1|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
1526411|NCT00306293|5005270|P2|Period 2 (Day 67 to Day 126 )|Adverse Event|0
1526412|NCT00306293|5005271|P1|Period 2 (Day 67 to Day 126 )|Adverse Event|1
1526413|NCT00306293|5005270|P2|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
1526414|NCT00306293|5005271|P1|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
1526415|NCT00306293|5005270|P2|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
1526416|NCT00306293|5005271|P1|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
1526417|NCT00306293|5005270|P2|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
1526418|NCT00306293|5005271|P1|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
1526419|NCT00306293|5005270|P2|Period 1 (Day 1 to Day 60)|Adverse Event|0
1526420|NCT00306293|5005271|P1|Period 1 (Day 1 to Day 60)|Adverse Event|1
1526421|NCT00306202|5005292|P3|Overall Study|Still on treatment|0
1526422|NCT00306202|5005293|P2|Overall Study|Still on treatment|1
1526423|NCT00306202|5005294|P1|Overall Study|Still on treatment|6
1526424|NCT00306189|5005454|P4|Overall Study|Other|0
1526425|NCT00306189|5005455|P3|Overall Study|Other|0
1526426|NCT00306189|5005456|P2|Overall Study|Other|0
1526427|NCT00306189|5005457|P1|Overall Study|Other|1
1526428|NCT00306189|5005454|P4|Overall Study|Ineligibility determined|1
1526429|NCT00306189|5005455|P3|Overall Study|Ineligibility determined|1
1526430|NCT00306189|5005456|P2|Overall Study|Ineligibility determined|1
1526431|NCT00306189|5005457|P1|Overall Study|Ineligibility determined|1
1526432|NCT00306189|5005454|P4|Overall Study|Withdrawal by Subject|1
1526433|NCT00306189|5005455|P3|Overall Study|Withdrawal by Subject|8
1526434|NCT00306189|5005456|P2|Overall Study|Withdrawal by Subject|2
1526435|NCT00306189|5005457|P1|Overall Study|Withdrawal by Subject|4
1526436|NCT00306189|5005454|P4|Overall Study|Adverse Event|2
1526437|NCT00306189|5005455|P3|Overall Study|Adverse Event|2
1526438|NCT00306189|5005456|P2|Overall Study|Adverse Event|3
1526439|NCT00306189|5005457|P1|Overall Study|Adverse Event|3
1526440|NCT00306189|5005454|P4|Overall Study|Physician Decision|1
1526441|NCT00306189|5005455|P3|Overall Study|Physician Decision|0
1526442|NCT00306189|5005456|P2|Overall Study|Physician Decision|0
1526443|NCT00306189|5005457|P1|Overall Study|Physician Decision|0
1526444|NCT00305877|5005484|P2|Overall Study|Transportation issue with daily RT|1
1526445|NCT00305877|5005485|P1|Overall Study|Transportation issue with daily RT|0
1526446|NCT00305877|5005484|P2|Overall Study|Ineligible|1
1526447|NCT00305877|5005485|P1|Overall Study|Ineligible|2
1526448|NCT00305877|5005484|P2|Overall Study|Never start treatment|5
1526449|NCT00305877|5005485|P1|Overall Study|Never start treatment|2
1526450|NCT00305877|5005484|P2|Overall Study|Physician Decision|1
1526451|NCT00305877|5005485|P1|Overall Study|Physician Decision|1
1526452|NCT00305877|5005484|P2|Overall Study|Withdrawal by Subject|2
1526453|NCT00305877|5005485|P1|Overall Study|Withdrawal by Subject|4
1526454|NCT00305877|5005484|P2|Overall Study|Death|1
1526455|NCT00305877|5005485|P1|Overall Study|Death|0
1526456|NCT00305877|5005484|P2|Overall Study|Adverse Event|14
1526457|NCT00305877|5005485|P1|Overall Study|Adverse Event|9
1526458|NCT00305877|5005484|P2|Overall Study|Lack of Efficacy|9
1526459|NCT00305877|5005485|P1|Overall Study|Lack of Efficacy|6
1526460|NCT00305864|5005499|P4|Overall Study|Ineligible / No protocol treatment|13
1526461|NCT00305864|5005500|P3|Overall Study|Ineligible / No protocol treatment|1
1526462|NCT00305864|5005501|P2|Overall Study|Ineligible / No protocol treatment|1
1526463|NCT00305864|5005502|P1|Overall Study|Ineligible / No protocol treatment|0
1526464|NCT00305773|5005515|P2|Overall Study|All other reasons|2
1526465|NCT00305773|5005516|P1|Overall Study|All other reasons|3
1526466|NCT00305773|5005515|P2|Overall Study|Disease Progression|3
1526467|NCT00305773|5005516|P1|Overall Study|Disease Progression|1
1526468|NCT00305773|5005515|P2|Overall Study|Withdrawal by Subject|4
1526469|NCT00305773|5005516|P1|Overall Study|Withdrawal by Subject|1
1526470|NCT00305773|5005515|P2|Overall Study|Physician Decision|1
1526471|NCT00305773|5005516|P1|Overall Study|Physician Decision|1
1526472|NCT00305773|5005515|P2|Overall Study|Alternative Treatment|4
1526473|NCT00305773|5005516|P1|Overall Study|Alternative Treatment|4
1526474|NCT00305773|5005515|P2|Overall Study|Adverse Event|2
1526475|NCT00305773|5005516|P1|Overall Study|Adverse Event|1
1526476|NCT00305773|5005515|P2|Overall Study|Death|2
1526477|NCT00305773|5005516|P1|Overall Study|Death|3
1526478|NCT00305604|5005547|P2|Overall Study|Patient moved|0
1526479|NCT00305604|5005548|P1|Overall Study|Patient moved|1
1526480|NCT00305604|5005547|P2|Overall Study|Withdrawal by Subject|21
1526481|NCT00305604|5005548|P1|Overall Study|Withdrawal by Subject|12
1526482|NCT00305604|5005547|P2|Overall Study|Protocol Violation|1
1526483|NCT00305604|5005548|P1|Overall Study|Protocol Violation|2
1526484|NCT00305604|5005547|P2|Overall Study|Lost to Follow-up|4
1526485|NCT00305604|5005548|P1|Overall Study|Lost to Follow-up|0
1526486|NCT00305604|5005547|P2|Overall Study|Lack of Efficacy|18
1526487|NCT00305604|5005548|P1|Overall Study|Lack of Efficacy|11
1526488|NCT00305604|5005547|P2|Overall Study|Adverse Event|3
1526489|NCT00305604|5005548|P1|Overall Study|Adverse Event|6
1526490|NCT00305448|5005692|P3|Overall Study|Tumor Marker Elevation|1
1526491|NCT00305448|5005693|P2|Overall Study|Tumor Marker Elevation|0
1526492|NCT00305448|5005694|P1|Overall Study|Tumor Marker Elevation|0
1526493|NCT00305448|5005692|P3|Overall Study|Subjective Disease Progression|2
1526494|NCT00305448|5005693|P2|Overall Study|Subjective Disease Progression|2
1526495|NCT00305448|5005694|P1|Overall Study|Subjective Disease Progression|1
1526496|NCT00305448|5005692|P3|Overall Study|Disease Progression|28
1526497|NCT00305448|5005693|P2|Overall Study|Disease Progression|31
1526498|NCT00305448|5005694|P1|Overall Study|Disease Progression|27
1526499|NCT00305448|5005692|P3|Overall Study|Adverse Event|1
1526500|NCT00305448|5005693|P2|Overall Study|Adverse Event|0
1526501|NCT00305448|5005694|P1|Overall Study|Adverse Event|1
1526502|NCT00305448|5005692|P3|Overall Study|Withdrawal by Subject|1
1526503|NCT00305448|5005693|P2|Overall Study|Withdrawal by Subject|0
1526504|NCT00305448|5005694|P1|Overall Study|Withdrawal by Subject|2
1526505|NCT00305448|5005692|P3|Overall Study|Protocol Violation|0
1526506|NCT00305448|5005693|P2|Overall Study|Protocol Violation|1
1526507|NCT00305448|5005694|P1|Overall Study|Protocol Violation|0
1526508|NCT00305253|5005716|P2|Overall Study|Withdrawal by Subject|1
1526509|NCT00305253|5005717|P1|Overall Study|Withdrawal by Subject|0
1526510|NCT00305227|5005729|P2|Overall Study|Lost to Follow-up|6
1526511|NCT00305227|5005730|P1|Overall Study|Lost to Follow-up|7
1526512|NCT00305110|5005777|P1|Overall Study|Missing data|29
1526513|NCT00305058|5005788|P2|Overall Study|Missing outcome data|2
1526514|NCT00305058|5005789|P1|Overall Study|Missing outcome data|3
1526515|NCT00305058|5005788|P2|Overall Study|Missing data collection instrument|2
1526516|NCT00305058|5005789|P1|Overall Study|Missing data collection instrument|3
1526517|NCT00305058|5005788|P2|Overall Study|Participant too young|0
1526518|NCT00305058|5005789|P1|Overall Study|Participant too young|1
1526519|NCT00304954|5005805|P4|Overall Study|Adverse Event|0
1526520|NCT00304954|5005806|P3|Overall Study|Adverse Event|0
1526521|NCT00304954|5005807|P2|Overall Study|Adverse Event|0
1526522|NCT00304954|5005808|P1|Overall Study|Adverse Event|1
1526523|NCT00304954|5005805|P4|Overall Study|Withdrawal by Subject|0
1526524|NCT00304954|5005806|P3|Overall Study|Withdrawal by Subject|1
1526525|NCT00304954|5005807|P2|Overall Study|Withdrawal by Subject|0
1526526|NCT00304954|5005808|P1|Overall Study|Withdrawal by Subject|0
1526527|NCT00304915|5005828|P2|Overall Study|Withdrawal by Subject|0
1526528|NCT00304915|5005829|P1|Overall Study|Withdrawal by Subject|3
1526529|NCT00304915|5005828|P2|Overall Study|Death|5
1526530|NCT00304915|5005829|P1|Overall Study|Death|4
1526531|NCT00304915|5005828|P2|Overall Study|Lost to Follow-up|11
1526532|NCT00304915|5005829|P1|Overall Study|Lost to Follow-up|11
1526533|NCT00304356|5005855|P1|Nitazoxanide|Physician Decision|1
1526534|NCT00304356|5005855|P1|Nitazoxanide|Physician Decision|1
1526535|NCT00304356|5005855|P1|Nitazoxanide|Physician Decision|1
1526536|NCT00304356|5005855|P1|Nitazoxanide|number is 0|1
1526537|NCT00304356|5005855|P1|Nitazoxanide|Physician Decision|1
1526538|NCT00304356|5005855|P1|Nitazoxanide|Physician Decision|5
1526539|NCT00304278|5005859|P1|Overall Study|PT had medical condition preventing TX|1
1526540|NCT00304278|5005859|P1|Overall Study|lack of insurance coverage for chemoRT|1
1526541|NCT00304083|5005908|P2|Overall Study|Other|2
1526542|NCT00304083|5005909|P1|Overall Study|Other|5
1526543|NCT00304083|5005908|P2|Overall Study|Disease Progression|1
1526544|NCT00304083|5005909|P1|Overall Study|Disease Progression|5
1526545|NCT00304083|5005908|P2|Overall Study|Physician Decision|3
1526546|NCT00304083|5005909|P1|Overall Study|Physician Decision|8
1526547|NCT00304083|5005908|P2|Overall Study|Withdrawal by Subject|2
1526548|NCT00304083|5005909|P1|Overall Study|Withdrawal by Subject|4
1526549|NCT00304070|5005917|P3|Overall Study|Progressive Disease|4
1526550|NCT00304070|5005918|P2|Overall Study|Progressive Disease|7
1526551|NCT00304070|5005919|P1|Overall Study|Progressive Disease|3
1526552|NCT00304070|5005917|P3|Overall Study|Withdrawal by Subject|1
1526553|NCT00304070|5005918|P2|Overall Study|Withdrawal by Subject|0
1526554|NCT00304070|5005919|P1|Overall Study|Withdrawal by Subject|0
1526555|NCT00304070|5005917|P3|Overall Study|Physician Decision|3
1526556|NCT00304070|5005918|P2|Overall Study|Physician Decision|0
1526557|NCT00304070|5005919|P1|Overall Study|Physician Decision|0
1526558|NCT00304070|5005917|P3|Overall Study|Lost to Follow-up|1
1526559|NCT00304070|5005918|P2|Overall Study|Lost to Follow-up|0
1526560|NCT00304070|5005919|P1|Overall Study|Lost to Follow-up|0
1526561|NCT00304070|5005917|P3|Overall Study|Death|3
1526562|NCT00304070|5005918|P2|Overall Study|Death|0
1526563|NCT00304070|5005919|P1|Overall Study|Death|0
1526564|NCT00304031|5005934|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
1526565|NCT00304031|5005935|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
1526566|NCT00304031|5005936|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
1526567|NCT00304031|5005934|P3|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
1526568|NCT00304031|5005935|P2|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
1526569|NCT00304031|5005936|P1|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|37
1526570|NCT00304031|5005934|P3|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
1526571|NCT00304031|5005935|P2|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
1526572|NCT00304031|5005936|P1|Concomitant Radiation Therapy and TMZ|Other complicating disease|1
1526573|NCT00304031|5005934|P3|Concomitant Radiation Therapy and TMZ|Toxicity|0
1526574|NCT00304031|5005935|P2|Concomitant Radiation Therapy and TMZ|Toxicity|0
1526575|NCT00304031|5005936|P1|Concomitant Radiation Therapy and TMZ|Toxicity|10
1526576|NCT00304031|5005934|P3|Concomitant Radiation Therapy and TMZ|Physician preference|0
1526577|NCT00304031|5005935|P2|Concomitant Radiation Therapy and TMZ|Physician preference|0
1526578|NCT00304031|5005936|P1|Concomitant Radiation Therapy and TMZ|Physician preference|15
1526579|NCT00304031|5005934|P3|Concomitant Radiation Therapy and TMZ|Death|0
1526580|NCT00304031|5005935|P2|Concomitant Radiation Therapy and TMZ|Death|0
1526581|NCT00304031|5005936|P1|Concomitant Radiation Therapy and TMZ|Death|18
1526582|NCT00304031|5005934|P3|Concomitant Radiation Therapy and TMZ|Patient refusal|0
1526583|NCT00304031|5005935|P2|Concomitant Radiation Therapy and TMZ|Patient refusal|0
1526584|NCT00304031|5005936|P1|Concomitant Radiation Therapy and TMZ|Patient refusal|19
1526585|NCT00304031|5005934|P3|Concomitant Radiation Therapy and TMZ|Disease progression|0
1526586|NCT00304031|5005935|P2|Concomitant Radiation Therapy and TMZ|Disease progression|0
1526587|NCT00304031|5005936|P1|Concomitant Radiation Therapy and TMZ|Disease progression|48
1526588|NCT00304031|5005934|P3|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
1526589|NCT00304031|5005935|P2|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
1526590|NCT00304031|5005936|P1|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|144
1526591|NCT00304031|5005934|P3|Registration|Ineligible|0
1526592|NCT00304031|5005935|P2|Registration|Ineligible|0
1526593|NCT00304031|5005936|P1|Registration|Ineligible|48
1526594|NCT00303953|5005967|P1|Overall Study|Physician Decision|1
1526595|NCT00303953|5005967|P1|Overall Study|Lack of Efficacy|12
1526596|NCT00303953|5005967|P1|Overall Study|Adverse Event|4
1526597|NCT00303953|5005967|P1|Overall Study|Death|1
1526598|NCT00303953|5005967|P1|Overall Study|Ineligible|1
1526599|NCT00303667|5006002|P2|Overall Study|Death|4
1526600|NCT00303667|5006003|P1|Overall Study|Death|0
1526601|NCT00303628|5006027|P2|Overall Study|Other|9
1526602|NCT00303628|5006028|P1|Overall Study|Other|8
1526603|NCT00303628|5006027|P2|Overall Study|Not start protocol therapy|5
1526604|NCT00303628|5006028|P1|Overall Study|Not start protocol therapy|3
1526605|NCT00303628|5006027|P2|Overall Study|Other complicating disease|1
1526606|NCT00303628|5006028|P1|Overall Study|Other complicating disease|0
1526607|NCT00303628|5006027|P2|Overall Study|Alternative therapy|0
1526608|NCT00303628|5006028|P1|Overall Study|Alternative therapy|2
1526609|NCT00303628|5006027|P2|Overall Study|Withdrawal by Subject|20
1526610|NCT00303628|5006028|P1|Overall Study|Withdrawal by Subject|11
1526611|NCT00303628|5006027|P2|Overall Study|Death|1
1526612|NCT00303628|5006028|P1|Overall Study|Death|0
1526613|NCT00303628|5006027|P2|Overall Study|Adverse Event|36
1526614|NCT00303628|5006028|P1|Overall Study|Adverse Event|26
1526615|NCT00303628|5006027|P2|Overall Study|Disease progression|1
1526616|NCT00303628|5006028|P1|Overall Study|Disease progression|0
1526617|NCT00303602|5006046|P2|Overall Study|Protocol Violation|0
1526618|NCT00303602|5006047|P1|Overall Study|Protocol Violation|1
1526619|NCT00303602|5006046|P2|Overall Study|Noncompliance|2
1526620|NCT00303602|5006047|P1|Overall Study|Noncompliance|2
1526621|NCT00303602|5006046|P2|Overall Study|Physician Decision|1
1526622|NCT00303602|5006047|P1|Overall Study|Physician Decision|2
1526623|NCT00303602|5006046|P2|Overall Study|Protocol entry criteria not met|2
1526624|NCT00303602|5006047|P1|Overall Study|Protocol entry criteria not met|2
1526625|NCT00303602|5006046|P2|Overall Study|Lost to Follow-up|2
1526626|NCT00303602|5006047|P1|Overall Study|Lost to Follow-up|5
1526627|NCT00303602|5006046|P2|Overall Study|Withdrawal by Subject|6
1526628|NCT00303602|5006047|P1|Overall Study|Withdrawal by Subject|5
1526629|NCT00303602|5006046|P2|Overall Study|Adverse Event|2
1526630|NCT00303602|5006047|P1|Overall Study|Adverse Event|2
1526631|NCT00303485|5006093|P2|Overall Study|Withdrawal by Subject|0
1526632|NCT00303485|5006094|P1|Overall Study|Withdrawal by Subject|1
1526633|NCT00303485|5006093|P2|Overall Study|Failure to return|1
1526634|NCT00303485|5006094|P1|Overall Study|Failure to return|0
1526635|NCT00303485|5006093|P2|Overall Study|Adverse Event/Intercurrent Illness|1
1526636|NCT00303485|5006094|P1|Overall Study|Adverse Event/Intercurrent Illness|0
1526637|NCT00303472|5006125|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
1526638|NCT00303472|5006126|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
1526639|NCT00303472|5006127|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
1526640|NCT00303472|5006128|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
1526641|NCT00303472|5006129|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
1526642|NCT00303472|5006130|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
1526643|NCT00303472|5006131|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
1526644|NCT00303472|5006125|P7|Treatment Extension (Optional)|Not specified|0
1526645|NCT00303472|5006126|P6|Treatment Extension (Optional)|Not specified|0
1526646|NCT00303472|5006127|P5|Treatment Extension (Optional)|Not specified|1
1526647|NCT00303472|5006128|P4|Treatment Extension (Optional)|Not specified|2
1526648|NCT00303472|5006129|P3|Treatment Extension (Optional)|Not specified|4
1526649|NCT00303472|5006130|P2|Treatment Extension (Optional)|Not specified|2
1526650|NCT00303472|5006131|P1|Treatment Extension (Optional)|Not specified|0
1526651|NCT00303472|5006125|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
1526652|NCT00303472|5006126|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
1526653|NCT00303472|5006127|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
1526654|NCT00303472|5006128|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
1526655|NCT00303472|5006129|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
1526656|NCT00303472|5006130|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
1526657|NCT00303472|5006131|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
1526658|NCT00303472|5006125|P7|Treatment Extension (Optional)|Physician Decision|0
1526659|NCT00303472|5006126|P6|Treatment Extension (Optional)|Physician Decision|0
1526660|NCT00303472|5006127|P5|Treatment Extension (Optional)|Physician Decision|2
1526661|NCT00303472|5006128|P4|Treatment Extension (Optional)|Physician Decision|3
1526662|NCT00303472|5006129|P3|Treatment Extension (Optional)|Physician Decision|2
1526663|NCT00303472|5006130|P2|Treatment Extension (Optional)|Physician Decision|4
1526664|NCT00303472|5006131|P1|Treatment Extension (Optional)|Physician Decision|0
1526665|NCT00303472|5006125|P7|Treatment Extension (Optional)|Lost to Follow-up|0
1526666|NCT00303472|5006126|P6|Treatment Extension (Optional)|Lost to Follow-up|0
1526667|NCT00303472|5006127|P5|Treatment Extension (Optional)|Lost to Follow-up|0
1526668|NCT00303472|5006128|P4|Treatment Extension (Optional)|Lost to Follow-up|1
1526669|NCT00303472|5006129|P3|Treatment Extension (Optional)|Lost to Follow-up|0
1526670|NCT00303472|5006130|P2|Treatment Extension (Optional)|Lost to Follow-up|0
1526671|NCT00303472|5006131|P1|Treatment Extension (Optional)|Lost to Follow-up|0
1526672|NCT00303472|5006125|P7|Treatment Extension (Optional)|Death|0
1526673|NCT00303472|5006126|P6|Treatment Extension (Optional)|Death|0
1526674|NCT00303472|5006127|P5|Treatment Extension (Optional)|Death|0
1526675|NCT00303472|5006128|P4|Treatment Extension (Optional)|Death|0
1526676|NCT00303472|5006129|P3|Treatment Extension (Optional)|Death|1
1526677|NCT00303472|5006130|P2|Treatment Extension (Optional)|Death|0
1526678|NCT00303472|5006131|P1|Treatment Extension (Optional)|Death|2
1526679|NCT00303472|5006125|P7|Treatment Extension (Optional)|Adverse Event|0
1526680|NCT00303472|5006126|P6|Treatment Extension (Optional)|Adverse Event|0
1526681|NCT00303472|5006127|P5|Treatment Extension (Optional)|Adverse Event|0
1526682|NCT00303472|5006128|P4|Treatment Extension (Optional)|Adverse Event|0
1526683|NCT00303472|5006129|P3|Treatment Extension (Optional)|Adverse Event|1
1526684|NCT00303472|5006130|P2|Treatment Extension (Optional)|Adverse Event|0
1526685|NCT00303472|5006131|P1|Treatment Extension (Optional)|Adverse Event|1
1526686|NCT00303472|5006125|P7|Treatment Period|Disease Progression (to AML)|0
1526687|NCT00303472|5006126|P6|Treatment Period|Disease Progression (to AML)|0
1526688|NCT00303472|5006127|P5|Treatment Period|Disease Progression (to AML)|1
1526689|NCT00303472|5006128|P4|Treatment Period|Disease Progression (to AML)|0
1526690|NCT00303472|5006129|P3|Treatment Period|Disease Progression (to AML)|0
1526691|NCT00303472|5006130|P2|Treatment Period|Disease Progression (to AML)|0
1526692|NCT00303472|5006131|P1|Treatment Period|Disease Progression (to AML)|0
1526693|NCT00303472|5006125|P7|Treatment Period|Not specified|1
1526694|NCT00303472|5006126|P6|Treatment Period|Not specified|0
1526695|NCT00303472|5006127|P5|Treatment Period|Not specified|1
1526696|NCT00303472|5006128|P4|Treatment Period|Not specified|0
1526697|NCT00303472|5006129|P3|Treatment Period|Not specified|0
1526698|NCT00303472|5006130|P2|Treatment Period|Not specified|0
1526699|NCT00303472|5006131|P1|Treatment Period|Not specified|0
1526700|NCT00303472|5006125|P7|Treatment Period|Withdrawal by Subject|0
1526701|NCT00303472|5006126|P6|Treatment Period|Withdrawal by Subject|1
1526702|NCT00303472|5006127|P5|Treatment Period|Withdrawal by Subject|0
1526703|NCT00303472|5006128|P4|Treatment Period|Withdrawal by Subject|1
1526704|NCT00303472|5006129|P3|Treatment Period|Withdrawal by Subject|0
1526705|NCT00303472|5006130|P2|Treatment Period|Withdrawal by Subject|0
1526706|NCT00303472|5006131|P1|Treatment Period|Withdrawal by Subject|0
1526707|NCT00303472|5006125|P7|Treatment Period|Death|1
1526708|NCT00303472|5006126|P6|Treatment Period|Death|0
1526709|NCT00303472|5006127|P5|Treatment Period|Death|0
1526710|NCT00303472|5006128|P4|Treatment Period|Death|1
1526711|NCT00303472|5006129|P3|Treatment Period|Death|0
1526712|NCT00303472|5006130|P2|Treatment Period|Death|0
1526713|NCT00303472|5006131|P1|Treatment Period|Death|0
1526714|NCT00303472|5006125|P7|Treatment Period|Adverse Event|0
1526715|NCT00303472|5006126|P6|Treatment Period|Adverse Event|0
1526716|NCT00303472|5006127|P5|Treatment Period|Adverse Event|1
1526717|NCT00303472|5006128|P4|Treatment Period|Adverse Event|0
1526718|NCT00303472|5006129|P3|Treatment Period|Adverse Event|0
1526719|NCT00303472|5006130|P2|Treatment Period|Adverse Event|0
1526720|NCT00303472|5006131|P1|Treatment Period|Adverse Event|0
1526721|NCT00303459|5006191|P2|Overall Study|Lung transplantation|1
1526722|NCT00303459|5006192|P1|Overall Study|Lung transplantation|1
1526723|NCT00303459|5006191|P2|Overall Study|Decision by the investigator|7
1526724|NCT00303459|5006192|P1|Overall Study|Decision by the investigator|5
1526725|NCT00303459|5006191|P2|Overall Study|Administrative reason|7
1526726|NCT00303459|5006192|P1|Overall Study|Administrative reason|7
1526727|NCT00303459|5006191|P2|Overall Study|Lost to Follow-up|4
1526728|NCT00303459|5006192|P1|Overall Study|Lost to Follow-up|5
1526729|NCT00303459|5006191|P2|Overall Study|Withdrawal of consent|26
1526730|NCT00303459|5006192|P1|Overall Study|Withdrawal of consent|32
1526731|NCT00303459|5006191|P2|Overall Study|Death|44
1526732|NCT00303459|5006192|P1|Overall Study|Death|33
1526733|NCT00303446|5006218|P2|Overall Study|Physician Decision|1
1526734|NCT00303446|5006219|P1|Overall Study|Physician Decision|0
1526735|NCT00303446|5006218|P2|Overall Study|Death|1
1526736|NCT00303446|5006219|P1|Overall Study|Death|0
1526737|NCT00303446|5006218|P2|Overall Study|Withdrawal by Subject|2
1526738|NCT00303446|5006219|P1|Overall Study|Withdrawal by Subject|2
1526739|NCT00303329|5006255|P2|Overall Study|Stopped at end of extension 1|0
1526740|NCT00303329|5006256|P1|Overall Study|Stopped at end of extension 1|1
1526741|NCT00303329|5006255|P2|Overall Study|Stopped at end of core|9
1526742|NCT00303329|5006256|P1|Overall Study|Stopped at end of core|3
1526743|NCT00303329|5006255|P2|Overall Study|Death|12
1526744|NCT00303329|5006256|P1|Overall Study|Death|2
1526745|NCT00303329|5006255|P2|Overall Study|Administrative problems|0
1526746|NCT00303329|5006256|P1|Overall Study|Administrative problems|1
1526747|NCT00303329|5006255|P2|Overall Study|Lost to Follow-up|1
1526748|NCT00303329|5006256|P1|Overall Study|Lost to Follow-up|0
1526749|NCT00303329|5006255|P2|Overall Study|Withdrawal by Subject|15
1526750|NCT00303329|5006256|P1|Overall Study|Withdrawal by Subject|9
1526751|NCT00303329|5006255|P2|Overall Study|Protocol Violation|0
1526752|NCT00303329|5006256|P1|Overall Study|Protocol Violation|3
1526753|NCT00303329|5006255|P2|Overall Study|Condition no longer requires study drug|8
1526754|NCT00303329|5006256|P1|Overall Study|Condition no longer requires study drug|0
1526755|NCT00303329|5006255|P2|Overall Study|Unsatisfactory therapeutic effect|2
1526756|NCT00303329|5006256|P1|Overall Study|Unsatisfactory therapeutic effect|9
1526757|NCT00303329|5006255|P2|Overall Study|Abnormal Laboratory Values|1
1526758|NCT00303329|5006256|P1|Overall Study|Abnormal Laboratory Values|0
1526759|NCT00303329|5006255|P2|Overall Study|Adverse Event|14
1526760|NCT00303329|5006256|P1|Overall Study|Adverse Event|7
1526761|NCT00303316|5006270|P2|Overall Study|Withdrawal by Subject|2
1526762|NCT00303316|5006271|P1|Overall Study|Withdrawal by Subject|1
1526763|NCT00303316|5006270|P2|Overall Study|Lost to Follow-up|1
1526764|NCT00303316|5006271|P1|Overall Study|Lost to Follow-up|0
1526765|NCT00303316|5006270|P2|Overall Study|Protocol Violation|0
1526766|NCT00303316|5006271|P1|Overall Study|Protocol Violation|1
1526767|NCT00303186|5006283|P1|Overall Study|Other|52
1526768|NCT00303108|5006317|P3|Overall Study|ineligible|0
1526769|NCT00303108|5006318|P2|Overall Study|ineligible|1
1526770|NCT00303108|5006319|P1|Overall Study|ineligible|2
1526771|NCT00303108|5006317|P3|Overall Study|Failed Entry|1
1526772|NCT00303108|5006318|P2|Overall Study|Failed Entry|0
1526773|NCT00303108|5006319|P1|Overall Study|Failed Entry|1
1526774|NCT00303108|5006317|P3|Overall Study|Patient Request|8
1526775|NCT00303108|5006318|P2|Overall Study|Patient Request|2
1526776|NCT00303108|5006319|P1|Overall Study|Patient Request|4
1526777|NCT00303108|5006317|P3|Overall Study|Adverse Event|7
1526778|NCT00303108|5006318|P2|Overall Study|Adverse Event|6
1526779|NCT00303108|5006319|P1|Overall Study|Adverse Event|5
1526780|NCT00303069|5006339|P4|Overall Study|Recruitment into Army Reserves|0
1526781|NCT00303069|5006340|P3|Overall Study|Recruitment into Army Reserves|1
1526782|NCT00303069|5006341|P2|Overall Study|Recruitment into Army Reserves|0
1526783|NCT00303069|5006342|P1|Overall Study|Recruitment into Army Reserves|0
1526784|NCT00303069|5006339|P4|Overall Study|subject moved|0
1526785|NCT00303069|5006340|P3|Overall Study|subject moved|0
1526786|NCT00303069|5006341|P2|Overall Study|subject moved|0
1526787|NCT00303069|5006342|P1|Overall Study|subject moved|1
1526788|NCT00303069|5006339|P4|Overall Study|Lost to Follow-up|2
1526789|NCT00303069|5006340|P3|Overall Study|Lost to Follow-up|0
1526790|NCT00303069|5006341|P2|Overall Study|Lost to Follow-up|0
1526791|NCT00303069|5006342|P1|Overall Study|Lost to Follow-up|1
1526792|NCT00302952|5006362|P2|Overall Study|Elevated SGOT (AST) lab value|1
1526793|NCT00302952|5006363|P1|Overall Study|Elevated SGOT (AST) lab value|0
1526794|NCT00302952|5006362|P2|Overall Study|Withdrawal by Subject|3
1526795|NCT00302952|5006363|P1|Overall Study|Withdrawal by Subject|2
1526796|NCT00302952|5006362|P2|Overall Study|Physician Decision|1
1526797|NCT00302952|5006363|P1|Overall Study|Physician Decision|1
1526798|NCT00302731|5006413|P4|Overall Study|cancer unrelated to study discovered|0
1526799|NCT00302731|5006414|P3|Overall Study|cancer unrelated to study discovered|1
1526800|NCT00302731|5006415|P2|Overall Study|cancer unrelated to study discovered|0
1526801|NCT00302731|5006416|P1|Overall Study|cancer unrelated to study discovered|1
1526802|NCT00302731|5006413|P4|Overall Study|Protocol Violation|0
1526803|NCT00302731|5006414|P3|Overall Study|Protocol Violation|0
1526804|NCT00302731|5006415|P2|Overall Study|Protocol Violation|0
1526805|NCT00302731|5006416|P1|Overall Study|Protocol Violation|1
1526806|NCT00302731|5006413|P4|Overall Study|Withdrawal by Subject|0
1526807|NCT00302731|5006414|P3|Overall Study|Withdrawal by Subject|0
1526808|NCT00302731|5006415|P2|Overall Study|Withdrawal by Subject|1
1526809|NCT00302731|5006416|P1|Overall Study|Withdrawal by Subject|1
1526810|NCT00302731|5006413|P4|Overall Study|Adverse Event|0
1526811|NCT00302731|5006414|P3|Overall Study|Adverse Event|2
1526812|NCT00302731|5006415|P2|Overall Study|Adverse Event|2
1526813|NCT00302731|5006416|P1|Overall Study|Adverse Event|0
1526814|NCT00302731|5006413|P4|Overall Study|Lost to Follow-up|0
1526815|NCT00302731|5006414|P3|Overall Study|Lost to Follow-up|0
1526816|NCT00302731|5006415|P2|Overall Study|Lost to Follow-up|2
1526817|NCT00302731|5006416|P1|Overall Study|Lost to Follow-up|1
1526818|NCT00302718|5006442|P4|Overall Study|Participant left primary care setting|1
1526819|NCT00302718|5006443|P3|Overall Study|Participant left primary care setting|2
1526820|NCT00302718|5006444|P2|Overall Study|Participant left primary care setting|0
1526821|NCT00302718|5006445|P1|Overall Study|Participant left primary care setting|0
1526822|NCT00302718|5006442|P4|Overall Study|Withdrawal by Subject|0
1526823|NCT00302718|5006443|P3|Overall Study|Withdrawal by Subject|0
1526824|NCT00302718|5006444|P2|Overall Study|Withdrawal by Subject|1
1526825|NCT00302718|5006445|P1|Overall Study|Withdrawal by Subject|0
1526826|NCT00302718|5006442|P4|Overall Study|Participant left the hospital|1
1526827|NCT00302718|5006443|P3|Overall Study|Participant left the hospital|0
1526828|NCT00302718|5006444|P2|Overall Study|Participant left the hospital|0
1526829|NCT00302718|5006445|P1|Overall Study|Participant left the hospital|1
1526830|NCT00302458|5006477|P1|Overall Study|Withdrawal by Subject|1
1526831|NCT00302458|5006477|P1|Overall Study|Ineligible after screening|1
1526832|NCT00302458|5006477|P1|Overall Study|Lost to Follow-up|1
1526833|NCT00302328|5006488|P3|Overall Study|Physician Decision|0
1526834|NCT00302328|5006489|P2|Overall Study|Physician Decision|1
1526835|NCT00302328|5006490|P1|Overall Study|Physician Decision|0
1526836|NCT00302211|5006507|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1526837|NCT00302211|5006508|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
1526838|NCT00302211|5006509|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1526839|NCT00302211|5006510|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1526840|NCT00302211|5006511|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1526841|NCT00302211|5006507|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
1526842|NCT00302211|5006508|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1526843|NCT00302211|5006509|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1526844|NCT00302211|5006510|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1526845|NCT00302211|5006511|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1526846|NCT00302211|5006507|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
1526847|NCT00302211|5006508|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1526848|NCT00302211|5006509|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1526849|NCT00302211|5006510|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1526850|NCT00302211|5006511|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1526851|NCT00302211|5006507|P5|Open Label-Patients From Double-Blind|Death|1
1526852|NCT00302211|5006508|P4|Open Label-Patients From Double-Blind|Death|1
1526853|NCT00302211|5006509|P3|Open Label-Patients From Double-Blind|Death|0
1526854|NCT00302211|5006510|P2|Open Label-Patients From Double-Blind|Death|0
1526855|NCT00302211|5006511|P1|Open Label-Patients From Double-Blind|Death|0
1526856|NCT00302211|5006507|P5|Open Label-Patients From Double-Blind|Disease progression|2
1526857|NCT00302211|5006508|P4|Open Label-Patients From Double-Blind|Disease progression|1
1526858|NCT00302211|5006509|P3|Open Label-Patients From Double-Blind|Disease progression|0
1526859|NCT00302211|5006510|P2|Open Label-Patients From Double-Blind|Disease progression|0
1526860|NCT00302211|5006511|P1|Open Label-Patients From Double-Blind|Disease progression|0
1526861|NCT00302211|5006507|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
1526862|NCT00302211|5006508|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
1526863|NCT00302211|5006509|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
1526864|NCT00302211|5006510|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
1526865|NCT00302211|5006511|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
1526866|NCT00302211|5006507|P5|Open Label-Patients From Double-Blind|Adverse Event|0
1526867|NCT00302211|5006508|P4|Open Label-Patients From Double-Blind|Adverse Event|1
1526868|NCT00302211|5006509|P3|Open Label-Patients From Double-Blind|Adverse Event|0
1526869|NCT00302211|5006510|P2|Open Label-Patients From Double-Blind|Adverse Event|0
1526870|NCT00302211|5006511|P1|Open Label-Patients From Double-Blind|Adverse Event|0
1526871|NCT00302211|5006507|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
1526872|NCT00302211|5006508|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
1526873|NCT00302211|5006509|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
1526874|NCT00302211|5006510|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
1526875|NCT00302211|5006511|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
1526876|NCT00302211|5006507|P5|Double Blind Period (New Patients)|Disease progression|0
1526877|NCT00302211|5006508|P4|Double Blind Period (New Patients)|Disease progression|0
1526878|NCT00302211|5006509|P3|Double Blind Period (New Patients)|Disease progression|1
1526879|NCT00302211|5006510|P2|Double Blind Period (New Patients)|Disease progression|1
1526880|NCT00302211|5006511|P1|Double Blind Period (New Patients)|Disease progression|0
1526881|NCT00302211|5006507|P5|Double Blind Period (New Patients)|Investigator's judgement|0
1526882|NCT00302211|5006508|P4|Double Blind Period (New Patients)|Investigator's judgement|0
1526883|NCT00302211|5006509|P3|Double Blind Period (New Patients)|Investigator's judgement|0
1526884|NCT00302211|5006510|P2|Double Blind Period (New Patients)|Investigator's judgement|0
1526885|NCT00302211|5006511|P1|Double Blind Period (New Patients)|Investigator's judgement|1
1526886|NCT00302211|5006507|P5|Double Blind Period (New Patients)|Adverse Event|0
1526887|NCT00302211|5006508|P4|Double Blind Period (New Patients)|Adverse Event|0
1526888|NCT00302211|5006509|P3|Double Blind Period (New Patients)|Adverse Event|3
1526889|NCT00302211|5006510|P2|Double Blind Period (New Patients)|Adverse Event|0
1526890|NCT00302211|5006511|P1|Double Blind Period (New Patients)|Adverse Event|0
1526891|NCT00302211|5006507|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
1526892|NCT00302211|5006508|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
1526893|NCT00302211|5006509|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
1526894|NCT00302211|5006510|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
1526895|NCT00302211|5006511|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
1526896|NCT00302159|5006523|P1|Overall Study|pt started Avastin|1
1526897|NCT00302159|5006523|P1|Overall Study|pt declined before treatment started|1
1526898|NCT00302107|5006545|P2|Overall Study|Adverse Event|0
1526899|NCT00302107|5006546|P1|Overall Study|Adverse Event|1
1526900|NCT00302107|5006545|P2|Overall Study|Withdrawal by Subject|3
1526901|NCT00302107|5006546|P1|Overall Study|Withdrawal by Subject|0
1526902|NCT00302107|5006545|P2|Overall Study|Relocation|1
1526903|NCT00302107|5006546|P1|Overall Study|Relocation|0
1526904|NCT00302107|5006545|P2|Overall Study|Protocol Violation|0
1526905|NCT00302107|5006546|P1|Overall Study|Protocol Violation|1
1526906|NCT00302107|5006545|P2|Overall Study|Lost to Follow-up|5
1526907|NCT00302107|5006546|P1|Overall Study|Lost to Follow-up|6
1526908|NCT00302081|5006555|P3|Overall Study|Other|5
1526909|NCT00302081|5006556|P2|Overall Study|Other|6
1526910|NCT00302081|5006557|P1|Overall Study|Other|13
1526911|NCT00302081|5006555|P3|Overall Study|Death|0
1526912|NCT00302081|5006556|P2|Overall Study|Death|1
1526913|NCT00302081|5006557|P1|Overall Study|Death|2
1526914|NCT00302081|5006555|P3|Overall Study|Lack of Efficacy|5
1526915|NCT00302081|5006556|P2|Overall Study|Lack of Efficacy|0
1526916|NCT00302081|5006557|P1|Overall Study|Lack of Efficacy|1
1526917|NCT00302081|5006555|P3|Overall Study|Protocol Violation|2
1526918|NCT00302081|5006556|P2|Overall Study|Protocol Violation|1
1526919|NCT00302081|5006557|P1|Overall Study|Protocol Violation|5
1526920|NCT00302081|5006555|P3|Overall Study|Withdrawal by Subject|8
1526921|NCT00302081|5006556|P2|Overall Study|Withdrawal by Subject|12
1526922|NCT00302081|5006557|P1|Overall Study|Withdrawal by Subject|8
1526923|NCT00302081|5006555|P3|Overall Study|Lost to Follow-up|28
1526924|NCT00302081|5006556|P2|Overall Study|Lost to Follow-up|18
1526925|NCT00302081|5006557|P1|Overall Study|Lost to Follow-up|21
1526926|NCT00302081|5006555|P3|Overall Study|Adverse Event|4
1526927|NCT00302081|5006556|P2|Overall Study|Adverse Event|5
1526928|NCT00302081|5006557|P1|Overall Study|Adverse Event|6
1526929|NCT00302003|5006614|P1|Overall Study|Protocol Violation|1
1526930|NCT00302003|5006614|P1|Overall Study|Ineligible|9
1526931|NCT00302003|5006614|P1|Overall Study|Withdrawal by Subject|5
1526932|NCT00302003|5006614|P1|Overall Study|Physician Decision|2
1526933|NCT00302003|5006614|P1|Overall Study|Lost to Follow-up|1
1526934|NCT00302003|5006614|P1|Overall Study|Lack of Efficacy|62
1526935|NCT00301964|5006621|P1|Overall Study|Inadequate pathology|1
1526936|NCT00301964|5006621|P1|Overall Study|Wrong primary|1
1526937|NCT00301964|5006621|P1|Overall Study|Second primary|2
1526938|NCT00301834|5006642|P1|Overall Study|Death|1
1526939|NCT00301821|5006651|P1|Overall Study|Cancel|1
1526940|NCT00301821|5006651|P1|Overall Study|Ineligible|25
1526941|NCT00301808|5006658|P1|Overall Study|Lack of Efficacy|4
1526942|NCT00301808|5006658|P1|Overall Study|Death|3
1526943|NCT00301808|5006658|P1|Overall Study|Adverse Event|5
1526944|NCT00301366|5006683|P1|Overall Study|Adverse Event|1
1526945|NCT00301262|5006689|P2|Open Label Phase (OL)|Other|0
1526946|NCT00301262|5006690|P1|Open Label Phase (OL)|Other|2
1526947|NCT00301262|5006689|P2|Open Label Phase (OL)|Lost to Follow-up|2
1526948|NCT00301262|5006690|P1|Open Label Phase (OL)|Lost to Follow-up|1
1526949|NCT00301262|5006689|P2|Open Label Phase (OL)|Adverse Event|0
1526950|NCT00301262|5006690|P1|Open Label Phase (OL)|Adverse Event|1
1526951|NCT00301262|5006689|P2|Double Blind Phase (DB)|Other|4
1526952|NCT00301262|5006690|P1|Double Blind Phase (DB)|Other|1
1526953|NCT00301262|5006689|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
1526954|NCT00301262|5006690|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
1526955|NCT00301262|5006689|P2|Double Blind Phase (DB)|Lost to Follow-up|3
1526956|NCT00301262|5006690|P1|Double Blind Phase (DB)|Lost to Follow-up|3
1526957|NCT00301262|5006689|P2|Double Blind Phase (DB)|Lack of Efficacy|1
1526958|NCT00301262|5006690|P1|Double Blind Phase (DB)|Lack of Efficacy|0
1526959|NCT00301262|5006689|P2|Double Blind Phase (DB)|Adverse Event|0
1526960|NCT00301262|5006690|P1|Double Blind Phase (DB)|Adverse Event|1
1526961|NCT00301080|5006848|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1526962|NCT00301080|5006849|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1526963|NCT00301080|5006850|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1526964|NCT00301080|5006851|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1526965|NCT00301080|5006852|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
1526966|NCT00300885|5006887|P2|Follow-up|Withdrawal by Subject|25
1526967|NCT00300885|5006888|P1|Follow-up|Withdrawal by Subject|26
1526968|NCT00300885|5006887|P2|Follow-up|Lost to Follow-up|7
1526969|NCT00300885|5006888|P1|Follow-up|Lost to Follow-up|11
1526970|NCT00300885|5006887|P2|Follow-up|Death|163
1526971|NCT00300885|5006888|P1|Follow-up|Death|141
1526972|NCT00300885|5006887|P2|Treatment|Non-compliant with study medication|4
1526973|NCT00300885|5006888|P1|Treatment|Non-compliant with study medication|3
1526974|NCT00300885|5006887|P2|Treatment|Random code broken (subject died)|1
1526975|NCT00300885|5006888|P1|Treatment|Random code broken (subject died)|0
1526976|NCT00300885|5006887|P2|Treatment|Disease progression|238
1526977|NCT00300885|5006888|P1|Treatment|Disease progression|171
1526978|NCT00300885|5006887|P2|Treatment|Withdrawal by Subject|23
1526979|NCT00300885|5006888|P1|Treatment|Withdrawal by Subject|26
1526980|NCT00300885|5006887|P2|Treatment|Protocol Violation|11
1526981|NCT00300885|5006888|P1|Treatment|Protocol Violation|11
1526982|NCT00300885|5006887|P2|Treatment|Physician Decision|5
1526983|NCT00300885|5006888|P1|Treatment|Physician Decision|4
1526984|NCT00300885|5006887|P2|Treatment|Lost to Follow-up|2
1526985|NCT00300885|5006888|P1|Treatment|Lost to Follow-up|3
1526986|NCT00300885|5006887|P2|Treatment|Lack of Efficacy|1
1526987|NCT00300885|5006888|P1|Treatment|Lack of Efficacy|1
1526988|NCT00300885|5006887|P2|Treatment|Death|7
1526989|NCT00300885|5006888|P1|Treatment|Death|20
1526990|NCT00300885|5006887|P2|Treatment|Adverse Event|82
1526991|NCT00300885|5006888|P1|Treatment|Adverse Event|134
1526992|NCT00300781|5006906|P2|Overall Study|Lost to Follow-up|1
1526993|NCT00300781|5006907|P1|Overall Study|Lost to Follow-up|0
1526994|NCT00300781|5006906|P2|Overall Study|Symptomatic Deterioration|0
1526995|NCT00300781|5006907|P1|Overall Study|Symptomatic Deterioration|1
1526996|NCT00300781|5006906|P2|Overall Study|Not Recorded|1
1526997|NCT00300781|5006907|P1|Overall Study|Not Recorded|0
1526998|NCT00300781|5006906|P2|Overall Study|Physician Decision|0
1526999|NCT00300781|5006907|P1|Overall Study|Physician Decision|1
1527000|NCT00300781|5006906|P2|Overall Study|Withdrawal by Subject|2
1527001|NCT00300781|5006907|P1|Overall Study|Withdrawal by Subject|1
1527002|NCT00300781|5006906|P2|Overall Study|Adverse Event|6
1527003|NCT00300781|5006907|P1|Overall Study|Adverse Event|5
1527004|NCT00300781|5006906|P2|Overall Study|Disease Progression|52
1527005|NCT00300781|5006907|P1|Overall Study|Disease Progression|55
1527006|NCT00300755|5006922|P3|Overall Study|Protocol Violation|1
1527007|NCT00300755|5006923|P2|Overall Study|Protocol Violation|0
1527008|NCT00300755|5006924|P1|Overall Study|Protocol Violation|0
1527009|NCT00300755|5006922|P3|Overall Study|Withdrawal by Subject|0
1527010|NCT00300755|5006923|P2|Overall Study|Withdrawal by Subject|2
1527011|NCT00300755|5006924|P1|Overall Study|Withdrawal by Subject|0
1527012|NCT00300755|5006922|P3|Overall Study|Adverse Event|1
1527013|NCT00300755|5006923|P2|Overall Study|Adverse Event|2
1527014|NCT00300755|5006924|P1|Overall Study|Adverse Event|1
1527015|NCT00300495|5006958|P2|Overall Study|Protocol Violation|1
1527016|NCT00300495|5006959|P1|Overall Study|Protocol Violation|4
1527017|NCT00300365|5007226|P2|Overall Study|Adverse Event|2
1527018|NCT00300365|5007227|P1|Overall Study|Adverse Event|0
1527019|NCT00300365|5007226|P2|Overall Study|Withdrawal by Subject|0
1527020|NCT00300365|5007227|P1|Overall Study|Withdrawal by Subject|1
1527021|NCT00300365|5007226|P2|Overall Study|Physician Decision|0
1527022|NCT00300365|5007227|P1|Overall Study|Physician Decision|2
1527023|NCT00300365|5007226|P2|Overall Study|Lost to Follow-up|0
1527024|NCT00300365|5007227|P1|Overall Study|Lost to Follow-up|1
1527025|NCT00300274|5007236|P3|Overall Study|Re-transplant|1
1527026|NCT00300274|5007237|P2|Overall Study|Re-transplant|0
1527027|NCT00300274|5007238|P1|Overall Study|Re-transplant|0
1527028|NCT00300274|5007236|P3|Overall Study|Death|25
1527029|NCT00300274|5007237|P2|Overall Study|Death|20
1527030|NCT00300274|5007238|P1|Overall Study|Death|31
1527031|NCT00300274|5007236|P3|Overall Study|Lost to Follow-up|5
1527032|NCT00300274|5007237|P2|Overall Study|Lost to Follow-up|4
1527033|NCT00300274|5007238|P1|Overall Study|Lost to Follow-up|3
1527034|NCT00300274|5007236|P3|Overall Study|Withdrawal by Subject|14
1527035|NCT00300274|5007237|P2|Overall Study|Withdrawal by Subject|3
1527036|NCT00300274|5007238|P1|Overall Study|Withdrawal by Subject|12
1527037|NCT00299975|5007297|P3|Overall Study|Physician Decision|1
1527038|NCT00299975|5007298|P2|Overall Study|Physician Decision|0
1527039|NCT00299975|5007299|P1|Overall Study|Physician Decision|0
1527040|NCT00299975|5007297|P3|Overall Study|Withdrawal by Subject|3
1527041|NCT00299975|5007298|P2|Overall Study|Withdrawal by Subject|1
1527042|NCT00299975|5007299|P1|Overall Study|Withdrawal by Subject|0
1527043|NCT00299975|5007297|P3|Overall Study|Lost to Follow-up|0
1527044|NCT00299975|5007298|P2|Overall Study|Lost to Follow-up|0
1527045|NCT00299975|5007299|P1|Overall Study|Lost to Follow-up|1
1527046|NCT00299975|5007297|P3|Overall Study|Lack of Efficacy|1
1527047|NCT00299975|5007298|P2|Overall Study|Lack of Efficacy|0
1527048|NCT00299975|5007299|P1|Overall Study|Lack of Efficacy|1
1527049|NCT00299975|5007297|P3|Overall Study|Pregnancy|1
1527050|NCT00299975|5007298|P2|Overall Study|Pregnancy|0
1527051|NCT00299975|5007299|P1|Overall Study|Pregnancy|0
1527052|NCT00299975|5007297|P3|Overall Study|Adverse Event|2
1527053|NCT00299975|5007298|P2|Overall Study|Adverse Event|0
1527054|NCT00299975|5007299|P1|Overall Study|Adverse Event|1
1527055|NCT00299702|5007356|P2|Overall Study|Admin issues, sponsor decision, etc.|9
1527056|NCT00299702|5007357|P1|Overall Study|Admin issues, sponsor decision, etc.|5
1527057|NCT00299702|5007356|P2|Overall Study|Insufficient Response|3
1527058|NCT00299702|5007357|P1|Overall Study|Insufficient Response|4
1527059|NCT00299702|5007356|P2|Overall Study|Pregnancy|1
1527060|NCT00299702|5007357|P1|Overall Study|Pregnancy|0
1527061|NCT00299702|5007356|P2|Overall Study|Withdrawal by Subject|23
1527062|NCT00299702|5007357|P1|Overall Study|Withdrawal by Subject|25
1527063|NCT00299702|5007356|P2|Overall Study|Lost to Follow-up|10
1527064|NCT00299702|5007357|P1|Overall Study|Lost to Follow-up|18
1527065|NCT00299702|5007356|P2|Overall Study|Adverse Event|4
1527066|NCT00299702|5007357|P1|Overall Study|Adverse Event|0
1527067|NCT00299702|5007356|P2|Overall Study|Death|0
1527068|NCT00299702|5007357|P1|Overall Study|Death|1
1527069|NCT00299546|5007372|P3|Overall Study|Not treated|1
1527070|NCT00299546|5007373|P2|Overall Study|Not treated|1
1527071|NCT00299546|5007374|P1|Overall Study|Not treated|0
1527072|NCT00299546|5007372|P3|Overall Study|Not specified|19
1527073|NCT00299546|5007373|P2|Overall Study|Not specified|26
1527074|NCT00299546|5007374|P1|Overall Study|Not specified|24
1527075|NCT00299546|5007372|P3|Overall Study|Unsatisfactory therapeutic effect|34
1527076|NCT00299546|5007373|P2|Overall Study|Unsatisfactory therapeutic effect|39
1527077|NCT00299546|5007374|P1|Overall Study|Unsatisfactory therapeutic effect|34
1527078|NCT00299546|5007372|P3|Overall Study|Adverse Event|27
1527079|NCT00299546|5007373|P2|Overall Study|Adverse Event|22
1527080|NCT00299546|5007374|P1|Overall Study|Adverse Event|37
1527081|NCT00299546|5007372|P3|Overall Study|Lost to Follow-up|5
1527082|NCT00299546|5007373|P2|Overall Study|Lost to Follow-up|2
1527083|NCT00299546|5007374|P1|Overall Study|Lost to Follow-up|2
1527084|NCT00299546|5007372|P3|Overall Study|Death|0
1527085|NCT00299546|5007373|P2|Overall Study|Death|2
1527086|NCT00299546|5007374|P1|Overall Study|Death|3
1527087|NCT00299494|5007405|P6|Overall Study|Other - site closure|1
1527088|NCT00299494|5007406|P5|Overall Study|Other - site closure|1
1527089|NCT00299494|5007407|P4|Overall Study|Other - site closure|1
1527090|NCT00299494|5007408|P3|Overall Study|Other - site closure|0
1527091|NCT00299494|5007409|P2|Overall Study|Other - site closure|0
1527092|NCT00299494|5007410|P1|Overall Study|Other - site closure|0
1527093|NCT00299494|5007405|P6|Overall Study|Other - Unspecified|1
1527094|NCT00299494|5007406|P5|Overall Study|Other - Unspecified|3
1527095|NCT00299494|5007407|P4|Overall Study|Other - Unspecified|0
1527096|NCT00299494|5007408|P3|Overall Study|Other - Unspecified|0
1527097|NCT00299494|5007409|P2|Overall Study|Other - Unspecified|0
1527098|NCT00299494|5007410|P1|Overall Study|Other - Unspecified|0
1527099|NCT00299494|5007405|P6|Overall Study|Lost to Follow-up|1
1527100|NCT00299494|5007406|P5|Overall Study|Lost to Follow-up|3
1527101|NCT00299494|5007407|P4|Overall Study|Lost to Follow-up|0
1527102|NCT00299494|5007408|P3|Overall Study|Lost to Follow-up|0
1527103|NCT00299494|5007409|P2|Overall Study|Lost to Follow-up|0
1527104|NCT00299494|5007410|P1|Overall Study|Lost to Follow-up|0
1527105|NCT00299494|5007405|P6|Overall Study|Death|19
1527106|NCT00299494|5007406|P5|Overall Study|Death|18
1527107|NCT00299494|5007407|P4|Overall Study|Death|6
1527108|NCT00299494|5007408|P3|Overall Study|Death|4
1527109|NCT00299494|5007409|P2|Overall Study|Death|1
1527110|NCT00299494|5007410|P1|Overall Study|Death|3
1527111|NCT00299494|5007405|P6|Overall Study|Physician Decision|0
1527112|NCT00299494|5007406|P5|Overall Study|Physician Decision|1
1527113|NCT00299494|5007407|P4|Overall Study|Physician Decision|0
1527114|NCT00299494|5007408|P3|Overall Study|Physician Decision|0
1527115|NCT00299494|5007409|P2|Overall Study|Physician Decision|0
1527116|NCT00299494|5007410|P1|Overall Study|Physician Decision|0
1527117|NCT00299494|5007405|P6|Overall Study|Withdrawal by Subject|4
1527118|NCT00299494|5007406|P5|Overall Study|Withdrawal by Subject|1
1527119|NCT00299494|5007407|P4|Overall Study|Withdrawal by Subject|3
1527120|NCT00299494|5007408|P3|Overall Study|Withdrawal by Subject|0
1527121|NCT00299494|5007409|P2|Overall Study|Withdrawal by Subject|0
1527122|NCT00299494|5007410|P1|Overall Study|Withdrawal by Subject|0
1527123|NCT00299156|5007539|P3|Period 2 (Randomized)|Screen Failure|0
1527124|NCT00299156|5007540|P2|Period 2 (Randomized)|Screen Failure|1
1527125|NCT00299156|5007541|P1|Period 2 (Randomized)|Screen Failure|0
1527126|NCT00299130|5007552|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
1527127|NCT00299130|5007553|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
1527128|NCT00299130|5007554|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
1527129|NCT00299130|5007552|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
1527130|NCT00299130|5007553|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
1527131|NCT00299130|5007554|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
1527132|NCT00299130|5007552|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
1527133|NCT00299130|5007553|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
1527134|NCT00299130|5007554|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
1527135|NCT00299130|5007552|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
1527136|NCT00299130|5007553|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
1527137|NCT00299130|5007554|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
1527138|NCT00299130|5007552|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
1527139|NCT00299130|5007553|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
1527140|NCT00299130|5007554|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
1527141|NCT00299130|5007552|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
1527142|NCT00299130|5007553|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
1527143|NCT00299130|5007554|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
1527144|NCT00299130|5007552|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
1527145|NCT00299130|5007553|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
1527146|NCT00299130|5007554|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
1527147|NCT00299130|5007552|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
1527148|NCT00299130|5007553|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
1527149|NCT00299130|5007554|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
1527150|NCT00299130|5007552|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
1527151|NCT00299130|5007553|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
1527152|NCT00299130|5007554|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
1527153|NCT00299130|5007552|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
1527154|NCT00299130|5007553|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
1527155|NCT00299130|5007554|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
1527156|NCT00299130|5007552|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
1527157|NCT00299130|5007553|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
1527158|NCT00299130|5007554|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
1527159|NCT00299130|5007552|P3|Treatment Period (up to 5 Years)|Failure to Return|6
1527160|NCT00299130|5007553|P2|Treatment Period (up to 5 Years)|Failure to Return|6
1527161|NCT00299130|5007554|P1|Treatment Period (up to 5 Years)|Failure to Return|4
1527162|NCT00299130|5007552|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
1527163|NCT00299130|5007553|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
1527164|NCT00299130|5007554|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
1527165|NCT00299130|5007552|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
1527166|NCT00299130|5007553|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
1527167|NCT00299130|5007554|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
1527168|NCT00299130|5007552|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
1527169|NCT00299130|5007553|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
1527170|NCT00299130|5007554|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
1527171|NCT00299130|5007552|P3|Treatment Period (up to 5 Years)|Death|1
1527172|NCT00299130|5007553|P2|Treatment Period (up to 5 Years)|Death|3
1527173|NCT00299130|5007554|P1|Treatment Period (up to 5 Years)|Death|1
1527174|NCT00299130|5007552|P3|Treatment Period (up to 5 Years)|Adverse Event|13
1527175|NCT00299130|5007553|P2|Treatment Period (up to 5 Years)|Adverse Event|8
1527176|NCT00299130|5007554|P1|Treatment Period (up to 5 Years)|Adverse Event|13
1527177|NCT00299104|5007659|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
1527178|NCT00299104|5007660|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
1527179|NCT00299104|5007661|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
1527180|NCT00299104|5007659|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
1527181|NCT00299104|5007660|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
1527182|NCT00299104|5007661|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
1527183|NCT00299104|5007659|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
1527184|NCT00299104|5007660|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
1527185|NCT00299104|5007661|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
1527186|NCT00299104|5007659|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
1527187|NCT00299104|5007660|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
1527188|NCT00299104|5007661|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
1527189|NCT00299104|5007659|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
1527190|NCT00299104|5007660|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
1527191|NCT00299104|5007661|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
1527192|NCT00299104|5007659|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
1527193|NCT00299104|5007660|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
1527194|NCT00299104|5007661|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
1527195|NCT00299104|5007659|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
1527196|NCT00299104|5007660|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
1527197|NCT00299104|5007661|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
1527198|NCT00299104|5007659|P3|Safety Follow-Up (SFU) Period|Death|1
1527199|NCT00299104|5007660|P2|Safety Follow-Up (SFU) Period|Death|2
1527200|NCT00299104|5007661|P1|Safety Follow-Up (SFU) Period|Death|3
1527201|NCT00299104|5007659|P3|Treatment Period|Administrative reasons|137
1527202|NCT00299104|5007660|P2|Treatment Period|Administrative reasons|120
1527203|NCT00299104|5007661|P1|Treatment Period|Administrative reasons|106
1527204|NCT00299104|5007659|P3|Treatment Period|Withdrew consent|9
1527205|NCT00299104|5007660|P2|Treatment Period|Withdrew consent|19
1527206|NCT00299104|5007661|P1|Treatment Period|Withdrew consent|14
1527207|NCT00299104|5007659|P3|Treatment Period|Refused treatment|2
1527208|NCT00299104|5007660|P2|Treatment Period|Refused treatment|2
1527209|NCT00299104|5007661|P1|Treatment Period|Refused treatment|9
1527210|NCT00299104|5007659|P3|Treatment Period|Protocol Violation|0
1527211|NCT00299104|5007660|P2|Treatment Period|Protocol Violation|1
1527212|NCT00299104|5007661|P1|Treatment Period|Protocol Violation|1
1527213|NCT00299104|5007659|P3|Treatment Period|Violation of selection criteria|0
1527214|NCT00299104|5007660|P2|Treatment Period|Violation of selection criteria|2
1527215|NCT00299104|5007661|P1|Treatment Period|Violation of selection criteria|1
1527216|NCT00299104|5007659|P3|Treatment Period|Failure to return|8
1527217|NCT00299104|5007660|P2|Treatment Period|Failure to return|8
1527218|NCT00299104|5007661|P1|Treatment Period|Failure to return|9
1527219|NCT00299104|5007659|P3|Treatment Period|Insufficient therapeutic response|8
1527220|NCT00299104|5007660|P2|Treatment Period|Insufficient therapeutic response|13
1527221|NCT00299104|5007661|P1|Treatment Period|Insufficient therapeutic response|34
1527222|NCT00299104|5007659|P3|Treatment Period|Death|1
1527223|NCT00299104|5007660|P2|Treatment Period|Death|1
1527224|NCT00299104|5007661|P1|Treatment Period|Death|1
1527225|NCT00299104|5007659|P3|Treatment Period|Adverse Event|7
1527226|NCT00299104|5007660|P2|Treatment Period|Adverse Event|9
1527227|NCT00299104|5007661|P1|Treatment Period|Adverse Event|14
1527228|NCT00298896|5007771|P1|Overall Study|Assigned to treatment in error|1
1527229|NCT00298896|5007771|P1|Overall Study|Withdrawal by Subject|2
1527230|NCT00298896|5007771|P1|Overall Study|Disease Progression|41
1527231|NCT00298896|5007771|P1|Overall Study|Intercurrent Illness|1
1527232|NCT00298896|5007771|P1|Overall Study|Physician Decision|2
1527233|NCT00298896|5007771|P1|Overall Study|Death|3
1527234|NCT00298766|5007776|P1|Overall Study|Other|4
1527235|NCT00298766|5007776|P1|Overall Study|Subjects overall condition deterioration|4
1527236|NCT00298766|5007776|P1|Overall Study|Deterioration in KPS and organ function|1
1527237|NCT00298766|5007776|P1|Overall Study|Progression of amyloid markers|4
1527238|NCT00298766|5007776|P1|Overall Study|Treatment ongoing|4
1527239|NCT00298766|5007776|P1|Overall Study|Withdrawal by Subject|9
1527240|NCT00298766|5007776|P1|Overall Study|Death|2
1527241|NCT00298766|5007776|P1|Overall Study|Adverse Event|18
1527242|NCT00298740|5007785|P1|Overall Study|Withdrawal by Subject|3
1527243|NCT00298740|5007785|P1|Overall Study|Lack of Efficacy|6
1527244|NCT00298363|5007839|P3|Overall Study|Lack of Efficacy|0
1527245|NCT00298363|5007840|P2|Overall Study|Lack of Efficacy|3
1527246|NCT00298363|5007841|P1|Overall Study|Lack of Efficacy|2
1527247|NCT00298363|5007839|P3|Overall Study|Adverse Event|2
1527248|NCT00298363|5007840|P2|Overall Study|Adverse Event|2
1527249|NCT00298363|5007841|P1|Overall Study|Adverse Event|5
1527250|NCT00298363|5007839|P3|Overall Study|Withdrawal by Subject|3
1527251|NCT00298363|5007840|P2|Overall Study|Withdrawal by Subject|1
1527252|NCT00298363|5007841|P1|Overall Study|Withdrawal by Subject|5
1527253|NCT00298363|5007839|P3|Overall Study|Protocol Violation|0
1527254|NCT00298363|5007840|P2|Overall Study|Protocol Violation|1
1527255|NCT00298363|5007841|P1|Overall Study|Protocol Violation|1
1527256|NCT00298363|5007839|P3|Overall Study|Physician Decision|0
1527257|NCT00298363|5007840|P2|Overall Study|Physician Decision|1
1527258|NCT00298363|5007841|P1|Overall Study|Physician Decision|4
1527259|NCT00298363|5007839|P3|Overall Study|Lost to Follow-up|1
1527260|NCT00298363|5007840|P2|Overall Study|Lost to Follow-up|0
1527261|NCT00298363|5007841|P1|Overall Study|Lost to Follow-up|0
1527262|NCT00298272|5007999|P2|Safety Follow-up Phase|Administrative/Other Reason|1
1527263|NCT00298272|5008000|P1|Safety Follow-up Phase|Administrative/Other Reason|1
1527264|NCT00298272|5007999|P2|Safety Follow-up Phase|Withdrawal by Subject|2
1527265|NCT00298272|5008000|P1|Safety Follow-up Phase|Withdrawal by Subject|2
1527266|NCT00298272|5007999|P2|Safety Follow-up Phase|Failure to Return|1
1527267|NCT00298272|5008000|P1|Safety Follow-up Phase|Failure to Return|1
1527268|NCT00298272|5007999|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
1527269|NCT00298272|5008000|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
1527270|NCT00298272|5007999|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
1527271|NCT00298272|5008000|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
1527272|NCT00298272|5007999|P2|Open Label Retreatment Phase|Protocol Violation|1
1527273|NCT00298272|5008000|P1|Open Label Retreatment Phase|Protocol Violation|2
1527274|NCT00298272|5007999|P2|Open Label Retreatment Phase|Failure to Return|0
1527275|NCT00298272|5008000|P1|Open Label Retreatment Phase|Failure to Return|1
1527276|NCT00298272|5007999|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
1527277|NCT00298272|5008000|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
1527278|NCT00298272|5007999|P2|Open Label Retreatment Phase|Adverse Event|2
1527279|NCT00298272|5008000|P1|Open Label Retreatment Phase|Adverse Event|1
1527280|NCT00298272|5007999|P2|Double-blind Phase|Withdrawal by Subject|0
1527281|NCT00298272|5008000|P1|Double-blind Phase|Withdrawal by Subject|2
1527282|NCT00298272|5007999|P2|Double-blind Phase|Protocol Violation|0
1527283|NCT00298272|5008000|P1|Double-blind Phase|Protocol Violation|2
1527284|NCT00298272|5007999|P2|Double-blind Phase|Failure to Return|0
1527285|NCT00298272|5008000|P1|Double-blind Phase|Failure to Return|2
1527286|NCT00298272|5007999|P2|Double-blind Phase|Adverse Event|0
1527287|NCT00298272|5008000|P1|Double-blind Phase|Adverse Event|2
1527288|NCT00297830|5008065|P3|12 Month Visit|Withdrawal by Subject|0
1527289|NCT00297830|5008066|P2|12 Month Visit|Withdrawal by Subject|3
1527290|NCT00297830|5008067|P1|12 Month Visit|Withdrawal by Subject|0
1527291|NCT00297830|5008065|P3|12 Month Visit|Adverse Event|0
1527292|NCT00297830|5008066|P2|12 Month Visit|Adverse Event|3
1527293|NCT00297830|5008067|P1|12 Month Visit|Adverse Event|0
1527294|NCT00297830|5008065|P3|12 Month Visit|Lost to Follow-up|0
1527295|NCT00297830|5008066|P2|12 Month Visit|Lost to Follow-up|0
1527296|NCT00297830|5008067|P1|12 Month Visit|Lost to Follow-up|1
1527297|NCT00297830|5008065|P3|6 Month Visit|Adverse Event|0
1527298|NCT00297830|5008066|P2|6 Month Visit|Adverse Event|1
1527299|NCT00297830|5008067|P1|6 Month Visit|Adverse Event|0
1527300|NCT00297830|5008065|P3|6 Month Visit|Withdrawal by Subject|1
1527301|NCT00297830|5008066|P2|6 Month Visit|Withdrawal by Subject|1
1527302|NCT00297830|5008067|P1|6 Month Visit|Withdrawal by Subject|2
1527303|NCT00297830|5008065|P3|6 Month Visit|Death|2
1527304|NCT00297830|5008066|P2|6 Month Visit|Death|0
1527305|NCT00297830|5008067|P1|6 Month Visit|Death|1
1527306|NCT00297778|5008086|P2|Overall Study|Other|1
1527307|NCT00297778|5008087|P1|Overall Study|Other|0
1527308|NCT00297778|5008086|P2|Overall Study|Non-compliant with trial protocol|3
1527309|NCT00297778|5008087|P1|Overall Study|Non-compliant with trial protocol|0
1527310|NCT00297778|5008086|P2|Overall Study|Lack of Efficacy|1
1527311|NCT00297778|5008087|P1|Overall Study|Lack of Efficacy|2
1527312|NCT00297778|5008086|P2|Overall Study|Withdrawal by Subject|5
1527313|NCT00297778|5008087|P1|Overall Study|Withdrawal by Subject|1
1527314|NCT00297778|5008086|P2|Overall Study|Adverse Event|10
1527315|NCT00297778|5008087|P1|Overall Study|Adverse Event|16
1527316|NCT00297648|5008121|P1|Overall Study|Other: Incompliance|1
1527317|NCT00297648|5008121|P1|Overall Study|Withdrawal by Subject|3
1527318|NCT00297648|5008121|P1|Overall Study|Lost to Follow-up|1
1527319|NCT00297648|5008121|P1|Overall Study|Lack of Efficacy|18
1527320|NCT00297648|5008121|P1|Overall Study|Adverse Event|13
1527321|NCT00297492|5008167|P3|6 Month Follow-up|Lost to Follow-up|27
1527322|NCT00297492|5008168|P2|6 Month Follow-up|Lost to Follow-up|49
1527323|NCT00297492|5008169|P1|6 Month Follow-up|Lost to Follow-up|63
1527324|NCT00297492|5008167|P3|Set Quit Date|Lost to Follow-up|5
1527325|NCT00297492|5008168|P2|Set Quit Date|Lost to Follow-up|13
1527326|NCT00297492|5008169|P1|Set Quit Date|Lost to Follow-up|7
1527327|NCT00297427|5008179|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
1527328|NCT00297427|5008180|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
1527329|NCT00297427|5008179|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
1527330|NCT00297427|5008180|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
1527331|NCT00297427|5008179|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
1527332|NCT00297427|5008180|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
1527333|NCT00297427|5008179|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
1527334|NCT00297427|5008180|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
1527335|NCT00297427|5008179|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
1527336|NCT00297427|5008180|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
1527337|NCT00297427|5008179|P2|Phase 1: Initial Intervention|Death|1
1527338|NCT00297427|5008180|P1|Phase 1: Initial Intervention|Death|0
1527339|NCT00297427|5008179|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
1527340|NCT00297427|5008180|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
1527341|NCT00297427|5008179|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
1527342|NCT00297427|5008180|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
1527343|NCT00297258|5008221|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
1527344|NCT00297258|5008221|P1|Overall Study|Switch to Commercial Treatment|1
1527345|NCT00297258|5008221|P1|Overall Study|Surgery Performed on Target Lesion|1
1527346|NCT00297258|5008221|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
1527347|NCT00297258|5008221|P1|Overall Study|Deteriorization of General Condition|1
1527348|NCT00297258|5008221|P1|Overall Study|Intercurrent Death|2
1527349|NCT00297258|5008221|P1|Overall Study|Intercurrent Illness|3
1527350|NCT00297258|5008221|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
1527351|NCT00297258|5008221|P1|Overall Study|Toxicity (or Toxic Death)|10
1527352|NCT00297258|5008221|P1|Overall Study|Disease Progression, Relapse, Death|120
1527353|NCT00297232|5008240|P1|Overall Study|Other|1
1527354|NCT00297232|5008240|P1|Overall Study|No data available after Week 264|161
1527355|NCT00297232|5008240|P1|Overall Study|Did Not Enroll to Week 480|17
1527356|NCT00297232|5008240|P1|Overall Study|Did Not Enroll to Week 264|34
1527357|NCT00297232|5008240|P1|Overall Study|Investigator Withdrew From Program|19
1527358|NCT00297232|5008240|P1|Overall Study|Persistently Positive Antibodies|11
1527359|NCT00297232|5008240|P1|Overall Study|Subject Withdrew Consent|37
1527360|NCT00297232|5008240|P1|Overall Study|Subject Relocated|7
1527361|NCT00297232|5008240|P1|Overall Study|Sponsor Decision|34
1527362|NCT00297232|5008240|P1|Overall Study|Miscellaneous|5
1527363|NCT00297232|5008240|P1|Overall Study|Anti-JCV Antibody Positive|13
1527364|NCT00297232|5008240|P1|Overall Study|Fear of PML|10
1527365|NCT00297232|5008240|P1|Overall Study|Disease Progression|8
1527366|NCT00297232|5008240|P1|Overall Study|Switched to Commercial Tysabri|22
1527367|NCT00297232|5008240|P1|Overall Study|Anti-natalizumab Positive|8
1527368|NCT00297232|5008240|P1|Overall Study|Death|9
1527369|NCT00297232|5008240|P1|Overall Study|Subject was Noncompliant|9
1527370|NCT00297232|5008240|P1|Overall Study|Voluntary Withdrawal|120
1527371|NCT00297232|5008240|P1|Overall Study|Adverse Event|63
1527372|NCT00297232|5008240|P1|Overall Study|Lost to Follow-up|10
1527373|NCT00297232|5008240|P1|Overall Study|Lack of Efficacy|7
1527374|NCT00297167|5008246|P3|Second Double-blind Intervention Period|Protocol Violation|0
1527375|NCT00297167|5008247|P2|Second Double-blind Intervention Period|Protocol Violation|0
1527376|NCT00297167|5008248|P1|Second Double-blind Intervention Period|Protocol Violation|1
1527377|NCT00297167|5008246|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
1527378|NCT00297167|5008247|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
1527379|NCT00297167|5008248|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
1527380|NCT00297037|5008312|P2|Overall Study|Withdrawal by Subject|0
1527381|NCT00297037|5008313|P1|Overall Study|Withdrawal by Subject|2
1527382|NCT00296816|5008325|P1|Overall Study|ineligibility due to radiation treatment|1
1527383|NCT00296816|5008325|P1|Overall Study|Proteinuria|1
1527384|NCT00296816|5008325|P1|Overall Study|Neuropathy/patient preference|1
1527385|NCT00296816|5008325|P1|Overall Study|Urine protein/creatinine ratio delay|1
1527386|NCT00296816|5008325|P1|Overall Study|Noncompliance/decision to discontinue|1
1527387|NCT00296816|5008325|P1|Overall Study|Relocation to Florida|1
1527388|NCT00296816|5008325|P1|Overall Study|Poor performance status|1
1527389|NCT00296816|5008325|P1|Overall Study|Progression based on CA-125 (biomarker)|2
1527390|NCT00296816|5008325|P1|Overall Study|Missing for end of treatment|4
1527391|NCT00296816|5008325|P1|Overall Study|Non-compliance|1
1527392|NCT00296816|5008325|P1|Overall Study|Investigator/Participant request|5
1527393|NCT00296816|5008325|P1|Overall Study|Adverse Event|18
1527394|NCT00296816|5008325|P1|Overall Study|Disease Progression|37
1527395|NCT00296647|5008342|P5|Overall Study|Withdrawal by Subject|19
1527396|NCT00296647|5008343|P4|Overall Study|Withdrawal by Subject|16
1527397|NCT00296647|5008344|P3|Overall Study|Withdrawal by Subject|32
1527398|NCT00296647|5008345|P2|Overall Study|Withdrawal by Subject|27
1527399|NCT00296647|5008346|P1|Overall Study|Withdrawal by Subject|28
1527400|NCT00296647|5008342|P5|Overall Study|Death|1
1527401|NCT00296647|5008343|P4|Overall Study|Death|1
1527402|NCT00296647|5008344|P3|Overall Study|Death|2
1527403|NCT00296647|5008345|P2|Overall Study|Death|1
1527404|NCT00296647|5008346|P1|Overall Study|Death|4
1527405|NCT00296517|5008360|P2|Dose Level 3 - Weeks 3-12|Not specified|2
1527406|NCT00296517|5008361|P1|Dose Level 3 - Weeks 3-12|Not specified|0
1527407|NCT00296517|5008360|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
1527408|NCT00296517|5008361|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
1527409|NCT00296517|5008360|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
1527410|NCT00296517|5008361|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
1527411|NCT00296517|5008360|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
1527412|NCT00296517|5008361|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
1527413|NCT00296517|5008360|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
1527414|NCT00296517|5008361|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
1527415|NCT00296517|5008360|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
1527416|NCT00296517|5008361|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
1527417|NCT00296517|5008360|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
1527418|NCT00296517|5008361|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
1527419|NCT00296517|5008360|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
1527420|NCT00296517|5008361|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
1527421|NCT00296517|5008360|P2|Dose Level 2 - Week 2|Adverse Event|5
1527422|NCT00296517|5008361|P1|Dose Level 2 - Week 2|Adverse Event|1
1527423|NCT00296504|5008397|P9|Final Analysis|Poor Adherence|1
1527424|NCT00296504|5008398|P8|Final Analysis|Poor Adherence|0
1527425|NCT00296504|5008399|P7|Final Analysis|Poor Adherence|0
1527426|NCT00296504|5008400|P6|Final Analysis|Poor Adherence|0
1527427|NCT00296504|5008401|P5|Final Analysis|Poor Adherence|0
1527428|NCT00296504|5008402|P4|Final Analysis|Poor Adherence|0
1527429|NCT00296504|5008403|P3|Final Analysis|Poor Adherence|0
1527430|NCT00296504|5008404|P2|Final Analysis|Poor Adherence|0
1527431|NCT00296504|5008405|P1|Final Analysis|Poor Adherence|0
1527432|NCT00296504|5008397|P9|Final Analysis|Participant Moved to Another Country|1
1527433|NCT00296504|5008398|P8|Final Analysis|Participant Moved to Another Country|0
1527434|NCT00296504|5008399|P7|Final Analysis|Participant Moved to Another Country|0
1527435|NCT00296504|5008400|P6|Final Analysis|Participant Moved to Another Country|0
1527436|NCT00296504|5008401|P5|Final Analysis|Participant Moved to Another Country|0
1527437|NCT00296504|5008402|P4|Final Analysis|Participant Moved to Another Country|0
1527438|NCT00296504|5008403|P3|Final Analysis|Participant Moved to Another Country|0
1527439|NCT00296504|5008404|P2|Final Analysis|Participant Moved to Another Country|0
1527440|NCT00296504|5008405|P1|Final Analysis|Participant Moved to Another Country|0
1527441|NCT00296504|5008397|P9|Final Analysis|Tuberculosis|1
1527442|NCT00296504|5008398|P8|Final Analysis|Tuberculosis|0
1527443|NCT00296504|5008399|P7|Final Analysis|Tuberculosis|0
1527444|NCT00296504|5008400|P6|Final Analysis|Tuberculosis|0
1527445|NCT00296504|5008401|P5|Final Analysis|Tuberculosis|0
1527446|NCT00296504|5008402|P4|Final Analysis|Tuberculosis|0
1527447|NCT00296504|5008403|P3|Final Analysis|Tuberculosis|0
1527448|NCT00296504|5008404|P2|Final Analysis|Tuberculosis|0
1527449|NCT00296504|5008405|P1|Final Analysis|Tuberculosis|0
1527450|NCT00296504|5008397|P9|Final Analysis|Pregnancy|4
1527451|NCT00296504|5008398|P8|Final Analysis|Pregnancy|0
1527452|NCT00296504|5008399|P7|Final Analysis|Pregnancy|0
1527453|NCT00296504|5008400|P6|Final Analysis|Pregnancy|0
1527454|NCT00296504|5008401|P5|Final Analysis|Pregnancy|0
1527455|NCT00296504|5008402|P4|Final Analysis|Pregnancy|0
1527456|NCT00296504|5008403|P3|Final Analysis|Pregnancy|0
1527457|NCT00296504|5008404|P2|Final Analysis|Pregnancy|0
1527458|NCT00296504|5008405|P1|Final Analysis|Pregnancy|0
1527459|NCT00296504|5008397|P9|Final Analysis|Adverse Event|2
1527460|NCT00296504|5008398|P8|Final Analysis|Adverse Event|0
1527461|NCT00296504|5008399|P7|Final Analysis|Adverse Event|0
1527462|NCT00296504|5008400|P6|Final Analysis|Adverse Event|0
1527463|NCT00296504|5008401|P5|Final Analysis|Adverse Event|0
1527464|NCT00296504|5008402|P4|Final Analysis|Adverse Event|0
1527465|NCT00296504|5008403|P3|Final Analysis|Adverse Event|0
1527466|NCT00296504|5008404|P2|Final Analysis|Adverse Event|0
1527467|NCT00296504|5008405|P1|Final Analysis|Adverse Event|0
1527468|NCT00296504|5008397|P9|Final Analysis|Insufficient Viral Load Response|6
1527469|NCT00296504|5008398|P8|Final Analysis|Insufficient Viral Load Response|0
1527470|NCT00296504|5008399|P7|Final Analysis|Insufficient Viral Load Response|0
1527471|NCT00296504|5008400|P6|Final Analysis|Insufficient Viral Load Response|0
1527472|NCT00296504|5008401|P5|Final Analysis|Insufficient Viral Load Response|0
1527473|NCT00296504|5008402|P4|Final Analysis|Insufficient Viral Load Response|0
1527474|NCT00296504|5008403|P3|Final Analysis|Insufficient Viral Load Response|0
1527475|NCT00296504|5008404|P2|Final Analysis|Insufficient Viral Load Response|0
1527476|NCT00296504|5008405|P1|Final Analysis|Insufficient Viral Load Response|0
1527477|NCT00296504|5008397|P9|Final Analysis|Lost to Follow-up|5
1527478|NCT00296504|5008398|P8|Final Analysis|Lost to Follow-up|0
1527479|NCT00296504|5008399|P7|Final Analysis|Lost to Follow-up|0
1527480|NCT00296504|5008400|P6|Final Analysis|Lost to Follow-up|0
1527481|NCT00296504|5008401|P5|Final Analysis|Lost to Follow-up|0
1527482|NCT00296504|5008402|P4|Final Analysis|Lost to Follow-up|0
1527483|NCT00296504|5008403|P3|Final Analysis|Lost to Follow-up|0
1527484|NCT00296504|5008404|P2|Final Analysis|Lost to Follow-up|0
1527485|NCT00296504|5008405|P1|Final Analysis|Lost to Follow-up|0
1527486|NCT00296504|5008397|P9|Final Analysis|Withdrawal by Subject|1
1527487|NCT00296504|5008398|P8|Final Analysis|Withdrawal by Subject|0
1527488|NCT00296504|5008399|P7|Final Analysis|Withdrawal by Subject|0
1527489|NCT00296504|5008400|P6|Final Analysis|Withdrawal by Subject|0
1527490|NCT00296504|5008401|P5|Final Analysis|Withdrawal by Subject|0
1527491|NCT00296504|5008402|P4|Final Analysis|Withdrawal by Subject|0
1527492|NCT00296504|5008403|P3|Final Analysis|Withdrawal by Subject|0
1527493|NCT00296504|5008404|P2|Final Analysis|Withdrawal by Subject|0
1527494|NCT00296504|5008405|P1|Final Analysis|Withdrawal by Subject|0
1527495|NCT00296504|5008397|P9|Interim Analysis|Ongoing|0
1527496|NCT00296504|5008398|P8|Interim Analysis|Ongoing|1
1527497|NCT00296504|5008399|P7|Interim Analysis|Ongoing|30
1527498|NCT00296504|5008400|P6|Interim Analysis|Ongoing|0
1527499|NCT00296504|5008401|P5|Interim Analysis|Ongoing|0
1527500|NCT00296504|5008402|P4|Interim Analysis|Ongoing|22
1527501|NCT00296504|5008403|P3|Interim Analysis|Ongoing|16
1527502|NCT00296504|5008404|P2|Interim Analysis|Ongoing|12
1527503|NCT00296504|5008405|P1|Interim Analysis|Ongoing|32
1527504|NCT00296504|5008397|P9|Interim Analysis|Participant Needed Interferon|0
1527505|NCT00296504|5008398|P8|Interim Analysis|Participant Needed Interferon|1
1527506|NCT00296504|5008399|P7|Interim Analysis|Participant Needed Interferon|0
1527507|NCT00296504|5008400|P6|Interim Analysis|Participant Needed Interferon|0
1527508|NCT00296504|5008401|P5|Interim Analysis|Participant Needed Interferon|0
1527509|NCT00296504|5008402|P4|Interim Analysis|Participant Needed Interferon|0
1527510|NCT00296504|5008403|P3|Interim Analysis|Participant Needed Interferon|0
1527511|NCT00296504|5008404|P2|Interim Analysis|Participant Needed Interferon|0
1527512|NCT00296504|5008405|P1|Interim Analysis|Participant Needed Interferon|0
1527513|NCT00296504|5008397|P9|Interim Analysis|Study Ended|0
1527514|NCT00296504|5008398|P8|Interim Analysis|Study Ended|0
1527515|NCT00296504|5008399|P7|Interim Analysis|Study Ended|1
1527516|NCT00296504|5008400|P6|Interim Analysis|Study Ended|0
1527517|NCT00296504|5008401|P5|Interim Analysis|Study Ended|0
1527518|NCT00296504|5008402|P4|Interim Analysis|Study Ended|0
1527519|NCT00296504|5008403|P3|Interim Analysis|Study Ended|0
1527520|NCT00296504|5008404|P2|Interim Analysis|Study Ended|0
1527521|NCT00296504|5008405|P1|Interim Analysis|Study Ended|0
1527522|NCT00296504|5008397|P9|Interim Analysis|Participant Stopped HIV Medications|0
1527523|NCT00296504|5008398|P8|Interim Analysis|Participant Stopped HIV Medications|0
1527524|NCT00296504|5008399|P7|Interim Analysis|Participant Stopped HIV Medications|1
1527525|NCT00296504|5008400|P6|Interim Analysis|Participant Stopped HIV Medications|0
1527526|NCT00296504|5008401|P5|Interim Analysis|Participant Stopped HIV Medications|0
1527527|NCT00296504|5008402|P4|Interim Analysis|Participant Stopped HIV Medications|0
1527528|NCT00296504|5008403|P3|Interim Analysis|Participant Stopped HIV Medications|0
1527529|NCT00296504|5008404|P2|Interim Analysis|Participant Stopped HIV Medications|0
1527530|NCT00296504|5008405|P1|Interim Analysis|Participant Stopped HIV Medications|0
1527531|NCT00296504|5008397|P9|Interim Analysis|Physician and Participant Decision|0
1527532|NCT00296504|5008398|P8|Interim Analysis|Physician and Participant Decision|0
1527533|NCT00296504|5008399|P7|Interim Analysis|Physician and Participant Decision|0
1527534|NCT00296504|5008400|P6|Interim Analysis|Physician and Participant Decision|1
1527535|NCT00296504|5008401|P5|Interim Analysis|Physician and Participant Decision|0
1527536|NCT00296504|5008402|P4|Interim Analysis|Physician and Participant Decision|0
1527537|NCT00296504|5008403|P3|Interim Analysis|Physician and Participant Decision|0
1527538|NCT00296504|5008404|P2|Interim Analysis|Physician and Participant Decision|0
1527539|NCT00296504|5008405|P1|Interim Analysis|Physician and Participant Decision|0
1527540|NCT00296504|5008397|P9|Interim Analysis|Participant Stopped|0
1527541|NCT00296504|5008398|P8|Interim Analysis|Participant Stopped|0
1527542|NCT00296504|5008399|P7|Interim Analysis|Participant Stopped|0
1527543|NCT00296504|5008400|P6|Interim Analysis|Participant Stopped|0
1527544|NCT00296504|5008401|P5|Interim Analysis|Participant Stopped|1
1527545|NCT00296504|5008402|P4|Interim Analysis|Participant Stopped|0
1527546|NCT00296504|5008403|P3|Interim Analysis|Participant Stopped|0
1527547|NCT00296504|5008404|P2|Interim Analysis|Participant Stopped|0
1527548|NCT00296504|5008405|P1|Interim Analysis|Participant Stopped|0
1527549|NCT00296504|5008397|P9|Interim Analysis|Inclusion in Other Protocol|0
1527550|NCT00296504|5008398|P8|Interim Analysis|Inclusion in Other Protocol|0
1527551|NCT00296504|5008399|P7|Interim Analysis|Inclusion in Other Protocol|0
1527552|NCT00296504|5008400|P6|Interim Analysis|Inclusion in Other Protocol|0
1527553|NCT00296504|5008401|P5|Interim Analysis|Inclusion in Other Protocol|0
1527554|NCT00296504|5008402|P4|Interim Analysis|Inclusion in Other Protocol|1
1527555|NCT00296504|5008403|P3|Interim Analysis|Inclusion in Other Protocol|0
1527556|NCT00296504|5008404|P2|Interim Analysis|Inclusion in Other Protocol|0
1527557|NCT00296504|5008405|P1|Interim Analysis|Inclusion in Other Protocol|0
1527558|NCT00296504|5008397|P9|Interim Analysis|Missed Schedule Date|0
1527559|NCT00296504|5008398|P8|Interim Analysis|Missed Schedule Date|0
1527560|NCT00296504|5008399|P7|Interim Analysis|Missed Schedule Date|0
1527561|NCT00296504|5008400|P6|Interim Analysis|Missed Schedule Date|0
1527562|NCT00296504|5008401|P5|Interim Analysis|Missed Schedule Date|0
1527563|NCT00296504|5008402|P4|Interim Analysis|Missed Schedule Date|0
1527564|NCT00296504|5008403|P3|Interim Analysis|Missed Schedule Date|0
1527565|NCT00296504|5008404|P2|Interim Analysis|Missed Schedule Date|0
1527566|NCT00296504|5008405|P1|Interim Analysis|Missed Schedule Date|1
1527567|NCT00296504|5008397|P9|Interim Analysis|Lack of Personnel at Site|0
1527568|NCT00296504|5008398|P8|Interim Analysis|Lack of Personnel at Site|0
1527569|NCT00296504|5008399|P7|Interim Analysis|Lack of Personnel at Site|0
1527570|NCT00296504|5008400|P6|Interim Analysis|Lack of Personnel at Site|0
1527571|NCT00296504|5008401|P5|Interim Analysis|Lack of Personnel at Site|0
1527572|NCT00296504|5008402|P4|Interim Analysis|Lack of Personnel at Site|0
1527573|NCT00296504|5008403|P3|Interim Analysis|Lack of Personnel at Site|0
1527574|NCT00296504|5008404|P2|Interim Analysis|Lack of Personnel at Site|0
1527575|NCT00296504|5008405|P1|Interim Analysis|Lack of Personnel at Site|1
1527576|NCT00296504|5008397|P9|Interim Analysis|Site Closing|0
1527577|NCT00296504|5008398|P8|Interim Analysis|Site Closing|0
1527578|NCT00296504|5008399|P7|Interim Analysis|Site Closing|2
1527579|NCT00296504|5008400|P6|Interim Analysis|Site Closing|1
1527580|NCT00296504|5008401|P5|Interim Analysis|Site Closing|0
1527581|NCT00296504|5008402|P4|Interim Analysis|Site Closing|0
1527582|NCT00296504|5008403|P3|Interim Analysis|Site Closing|0
1527583|NCT00296504|5008404|P2|Interim Analysis|Site Closing|0
1527584|NCT00296504|5008405|P1|Interim Analysis|Site Closing|1
1527585|NCT00296504|5008397|P9|Interim Analysis|Non-adherence|0
1527586|NCT00296504|5008398|P8|Interim Analysis|Non-adherence|1
1527587|NCT00296504|5008399|P7|Interim Analysis|Non-adherence|0
1527588|NCT00296504|5008400|P6|Interim Analysis|Non-adherence|0
1527589|NCT00296504|5008401|P5|Interim Analysis|Non-adherence|1
1527590|NCT00296504|5008402|P4|Interim Analysis|Non-adherence|0
1527591|NCT00296504|5008403|P3|Interim Analysis|Non-adherence|0
1527592|NCT00296504|5008404|P2|Interim Analysis|Non-adherence|0
1527593|NCT00296504|5008405|P1|Interim Analysis|Non-adherence|2
1527594|NCT00296504|5008397|P9|Interim Analysis|Principle Investigator Terminated Study|0
1527595|NCT00296504|5008398|P8|Interim Analysis|Principle Investigator Terminated Study|0
1527596|NCT00296504|5008399|P7|Interim Analysis|Principle Investigator Terminated Study|0
1527597|NCT00296504|5008400|P6|Interim Analysis|Principle Investigator Terminated Study|0
1527598|NCT00296504|5008401|P5|Interim Analysis|Principle Investigator Terminated Study|0
1527599|NCT00296504|5008402|P4|Interim Analysis|Principle Investigator Terminated Study|0
1527600|NCT00296504|5008403|P3|Interim Analysis|Principle Investigator Terminated Study|1
1527601|NCT00296504|5008404|P2|Interim Analysis|Principle Investigator Terminated Study|0
1527602|NCT00296504|5008405|P1|Interim Analysis|Principle Investigator Terminated Study|0
1527603|NCT00296504|5008397|P9|Interim Analysis|Principle Investigator Discretion|0
1527604|NCT00296504|5008398|P8|Interim Analysis|Principle Investigator Discretion|0
1527605|NCT00296504|5008399|P7|Interim Analysis|Principle Investigator Discretion|0
1527606|NCT00296504|5008400|P6|Interim Analysis|Principle Investigator Discretion|0
1527607|NCT00296504|5008401|P5|Interim Analysis|Principle Investigator Discretion|0
1527608|NCT00296504|5008402|P4|Interim Analysis|Principle Investigator Discretion|1
1527609|NCT00296504|5008403|P3|Interim Analysis|Principle Investigator Discretion|1
1527610|NCT00296504|5008404|P2|Interim Analysis|Principle Investigator Discretion|0
1527611|NCT00296504|5008405|P1|Interim Analysis|Principle Investigator Discretion|2
1527612|NCT00296504|5008397|P9|Interim Analysis|Physician Decision|0
1527613|NCT00296504|5008398|P8|Interim Analysis|Physician Decision|0
1527614|NCT00296504|5008399|P7|Interim Analysis|Physician Decision|0
1527615|NCT00296504|5008400|P6|Interim Analysis|Physician Decision|0
1527616|NCT00296504|5008401|P5|Interim Analysis|Physician Decision|0
1527617|NCT00296504|5008402|P4|Interim Analysis|Physician Decision|0
1527618|NCT00296504|5008403|P3|Interim Analysis|Physician Decision|1
1527619|NCT00296504|5008404|P2|Interim Analysis|Physician Decision|0
1527620|NCT00296504|5008405|P1|Interim Analysis|Physician Decision|0
1527621|NCT00296504|5008397|P9|Interim Analysis|Resistance to FPV|0
1527622|NCT00296504|5008398|P8|Interim Analysis|Resistance to FPV|0
1527623|NCT00296504|5008399|P7|Interim Analysis|Resistance to FPV|0
1527624|NCT00296504|5008400|P6|Interim Analysis|Resistance to FPV|0
1527625|NCT00296504|5008401|P5|Interim Analysis|Resistance to FPV|0
1527626|NCT00296504|5008402|P4|Interim Analysis|Resistance to FPV|0
1527627|NCT00296504|5008403|P3|Interim Analysis|Resistance to FPV|1
1527628|NCT00296504|5008404|P2|Interim Analysis|Resistance to FPV|0
1527629|NCT00296504|5008405|P1|Interim Analysis|Resistance to FPV|0
1527630|NCT00296504|5008397|P9|Interim Analysis|Participant Was Incarcerated|0
1527631|NCT00296504|5008398|P8|Interim Analysis|Participant Was Incarcerated|0
1527632|NCT00296504|5008399|P7|Interim Analysis|Participant Was Incarcerated|0
1527633|NCT00296504|5008400|P6|Interim Analysis|Participant Was Incarcerated|0
1527634|NCT00296504|5008401|P5|Interim Analysis|Participant Was Incarcerated|0
1527635|NCT00296504|5008402|P4|Interim Analysis|Participant Was Incarcerated|0
1527636|NCT00296504|5008403|P3|Interim Analysis|Participant Was Incarcerated|1
1527637|NCT00296504|5008404|P2|Interim Analysis|Participant Was Incarcerated|0
1527638|NCT00296504|5008405|P1|Interim Analysis|Participant Was Incarcerated|2
1527639|NCT00296504|5008397|P9|Interim Analysis|Participant Moved|0
1527640|NCT00296504|5008398|P8|Interim Analysis|Participant Moved|0
1527641|NCT00296504|5008399|P7|Interim Analysis|Participant Moved|1
1527642|NCT00296504|5008400|P6|Interim Analysis|Participant Moved|1
1527643|NCT00296504|5008401|P5|Interim Analysis|Participant Moved|0
1527644|NCT00296504|5008402|P4|Interim Analysis|Participant Moved|0
1527645|NCT00296504|5008403|P3|Interim Analysis|Participant Moved|1
1527646|NCT00296504|5008404|P2|Interim Analysis|Participant Moved|0
1527647|NCT00296504|5008405|P1|Interim Analysis|Participant Moved|1
1527648|NCT00296504|5008397|P9|Interim Analysis|Participant Had Problems with Alcohol|0
1527649|NCT00296504|5008398|P8|Interim Analysis|Participant Had Problems with Alcohol|0
1527650|NCT00296504|5008399|P7|Interim Analysis|Participant Had Problems with Alcohol|0
1527651|NCT00296504|5008400|P6|Interim Analysis|Participant Had Problems with Alcohol|0
1527652|NCT00296504|5008401|P5|Interim Analysis|Participant Had Problems with Alcohol|0
1527653|NCT00296504|5008402|P4|Interim Analysis|Participant Had Problems with Alcohol|0
1527654|NCT00296504|5008403|P3|Interim Analysis|Participant Had Problems with Alcohol|1
1527655|NCT00296504|5008404|P2|Interim Analysis|Participant Had Problems with Alcohol|0
1527656|NCT00296504|5008405|P1|Interim Analysis|Participant Had Problems with Alcohol|0
1527657|NCT00296504|5008397|P9|Interim Analysis|To Simplify Treatment|0
1527658|NCT00296504|5008398|P8|Interim Analysis|To Simplify Treatment|0
1527659|NCT00296504|5008399|P7|Interim Analysis|To Simplify Treatment|2
1527660|NCT00296504|5008400|P6|Interim Analysis|To Simplify Treatment|0
1527661|NCT00296504|5008401|P5|Interim Analysis|To Simplify Treatment|0
1527662|NCT00296504|5008402|P4|Interim Analysis|To Simplify Treatment|0
1527663|NCT00296504|5008403|P3|Interim Analysis|To Simplify Treatment|1
1527664|NCT00296504|5008404|P2|Interim Analysis|To Simplify Treatment|0
1527665|NCT00296504|5008405|P1|Interim Analysis|To Simplify Treatment|0
1527666|NCT00296504|5008397|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
1527667|NCT00296504|5008398|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
1527668|NCT00296504|5008399|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
1527669|NCT00296504|5008400|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
1527670|NCT00296504|5008401|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
1527671|NCT00296504|5008402|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
1527672|NCT00296504|5008403|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
1527673|NCT00296504|5008404|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
1527674|NCT00296504|5008405|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
1527675|NCT00296504|5008397|P9|Interim Analysis|Participant Non-compliant|0
1527676|NCT00296504|5008398|P8|Interim Analysis|Participant Non-compliant|2
1527677|NCT00296504|5008399|P7|Interim Analysis|Participant Non-compliant|6
1527678|NCT00296504|5008400|P6|Interim Analysis|Participant Non-compliant|3
1527679|NCT00296504|5008401|P5|Interim Analysis|Participant Non-compliant|1
1527680|NCT00296504|5008402|P4|Interim Analysis|Participant Non-compliant|1
1527681|NCT00296504|5008403|P3|Interim Analysis|Participant Non-compliant|2
1527682|NCT00296504|5008404|P2|Interim Analysis|Participant Non-compliant|1
1527683|NCT00296504|5008405|P1|Interim Analysis|Participant Non-compliant|0
1527684|NCT00296504|5008397|P9|Interim Analysis|Death|0
1527685|NCT00296504|5008398|P8|Interim Analysis|Death|0
1527686|NCT00296504|5008399|P7|Interim Analysis|Death|0
1527687|NCT00296504|5008400|P6|Interim Analysis|Death|0
1527688|NCT00296504|5008401|P5|Interim Analysis|Death|0
1527689|NCT00296504|5008402|P4|Interim Analysis|Death|0
1527690|NCT00296504|5008403|P3|Interim Analysis|Death|3
1527691|NCT00296504|5008404|P2|Interim Analysis|Death|0
1527692|NCT00296504|5008405|P1|Interim Analysis|Death|1
1527693|NCT00296504|5008397|P9|Interim Analysis|Pregnancy|0
1527694|NCT00296504|5008398|P8|Interim Analysis|Pregnancy|1
1527695|NCT00296504|5008399|P7|Interim Analysis|Pregnancy|1
1527696|NCT00296504|5008400|P6|Interim Analysis|Pregnancy|1
1527697|NCT00296504|5008401|P5|Interim Analysis|Pregnancy|0
1527698|NCT00296504|5008402|P4|Interim Analysis|Pregnancy|2
1527699|NCT00296504|5008403|P3|Interim Analysis|Pregnancy|4
1527700|NCT00296504|5008404|P2|Interim Analysis|Pregnancy|1
1527701|NCT00296504|5008405|P1|Interim Analysis|Pregnancy|4
1527702|NCT00296504|5008397|P9|Interim Analysis|Switched to Commercially Available Drug|0
1527703|NCT00296504|5008398|P8|Interim Analysis|Switched to Commercially Available Drug|4
1527704|NCT00296504|5008399|P7|Interim Analysis|Switched to Commercially Available Drug|3
1527705|NCT00296504|5008400|P6|Interim Analysis|Switched to Commercially Available Drug|5
1527706|NCT00296504|5008401|P5|Interim Analysis|Switched to Commercially Available Drug|0
1527707|NCT00296504|5008402|P4|Interim Analysis|Switched to Commercially Available Drug|1
1527708|NCT00296504|5008403|P3|Interim Analysis|Switched to Commercially Available Drug|4
1527709|NCT00296504|5008404|P2|Interim Analysis|Switched to Commercially Available Drug|0
1527710|NCT00296504|5008405|P1|Interim Analysis|Switched to Commercially Available Drug|2
1527711|NCT00296504|5008397|P9|Interim Analysis|Insufficient CD4 Response|0
1527712|NCT00296504|5008398|P8|Interim Analysis|Insufficient CD4 Response|0
1527713|NCT00296504|5008399|P7|Interim Analysis|Insufficient CD4 Response|0
1527714|NCT00296504|5008400|P6|Interim Analysis|Insufficient CD4 Response|1
1527715|NCT00296504|5008401|P5|Interim Analysis|Insufficient CD4 Response|1
1527716|NCT00296504|5008402|P4|Interim Analysis|Insufficient CD4 Response|0
1527717|NCT00296504|5008403|P3|Interim Analysis|Insufficient CD4 Response|0
1527718|NCT00296504|5008404|P2|Interim Analysis|Insufficient CD4 Response|0
1527719|NCT00296504|5008405|P1|Interim Analysis|Insufficient CD4 Response|0
1527720|NCT00296504|5008397|P9|Interim Analysis|Protocol Violation|0
1527721|NCT00296504|5008398|P8|Interim Analysis|Protocol Violation|1
1527722|NCT00296504|5008399|P7|Interim Analysis|Protocol Violation|0
1527723|NCT00296504|5008400|P6|Interim Analysis|Protocol Violation|0
1527724|NCT00296504|5008401|P5|Interim Analysis|Protocol Violation|1
1527725|NCT00296504|5008402|P4|Interim Analysis|Protocol Violation|0
1527726|NCT00296504|5008403|P3|Interim Analysis|Protocol Violation|2
1527727|NCT00296504|5008404|P2|Interim Analysis|Protocol Violation|0
1527728|NCT00296504|5008405|P1|Interim Analysis|Protocol Violation|0
1527729|NCT00296504|5008397|P9|Interim Analysis|Adverse Event|0
1527730|NCT00296504|5008398|P8|Interim Analysis|Adverse Event|5
1527731|NCT00296504|5008399|P7|Interim Analysis|Adverse Event|4
1527732|NCT00296504|5008400|P6|Interim Analysis|Adverse Event|3
1527733|NCT00296504|5008401|P5|Interim Analysis|Adverse Event|6
1527734|NCT00296504|5008402|P4|Interim Analysis|Adverse Event|4
1527735|NCT00296504|5008403|P3|Interim Analysis|Adverse Event|13
1527736|NCT00296504|5008404|P2|Interim Analysis|Adverse Event|0
1527737|NCT00296504|5008405|P1|Interim Analysis|Adverse Event|0
1527738|NCT00296504|5008397|P9|Interim Analysis|Insufficient Viral Load Response|0
1527739|NCT00296504|5008398|P8|Interim Analysis|Insufficient Viral Load Response|24
1527740|NCT00296504|5008399|P7|Interim Analysis|Insufficient Viral Load Response|2
1527741|NCT00296504|5008400|P6|Interim Analysis|Insufficient Viral Load Response|9
1527742|NCT00296504|5008401|P5|Interim Analysis|Insufficient Viral Load Response|7
1527743|NCT00296504|5008402|P4|Interim Analysis|Insufficient Viral Load Response|2
1527744|NCT00296504|5008403|P3|Interim Analysis|Insufficient Viral Load Response|12
1527745|NCT00296504|5008404|P2|Interim Analysis|Insufficient Viral Load Response|1
1527746|NCT00296504|5008405|P1|Interim Analysis|Insufficient Viral Load Response|5
1527747|NCT00296504|5008397|P9|Interim Analysis|Clinical Progression|0
1527748|NCT00296504|5008398|P8|Interim Analysis|Clinical Progression|2
1527749|NCT00296504|5008399|P7|Interim Analysis|Clinical Progression|1
1527750|NCT00296504|5008400|P6|Interim Analysis|Clinical Progression|2
1527751|NCT00296504|5008401|P5|Interim Analysis|Clinical Progression|0
1527752|NCT00296504|5008402|P4|Interim Analysis|Clinical Progression|1
1527753|NCT00296504|5008403|P3|Interim Analysis|Clinical Progression|1
1527754|NCT00296504|5008404|P2|Interim Analysis|Clinical Progression|0
1527755|NCT00296504|5008405|P1|Interim Analysis|Clinical Progression|1
1527756|NCT00296504|5008397|P9|Interim Analysis|Lost to Follow-up|0
1527757|NCT00296504|5008398|P8|Interim Analysis|Lost to Follow-up|4
1527758|NCT00296504|5008399|P7|Interim Analysis|Lost to Follow-up|11
1527759|NCT00296504|5008400|P6|Interim Analysis|Lost to Follow-up|4
1527760|NCT00296504|5008401|P5|Interim Analysis|Lost to Follow-up|14
1527761|NCT00296504|5008402|P4|Interim Analysis|Lost to Follow-up|8
1527762|NCT00296504|5008403|P3|Interim Analysis|Lost to Follow-up|26
1527763|NCT00296504|5008404|P2|Interim Analysis|Lost to Follow-up|3
1527764|NCT00296504|5008405|P1|Interim Analysis|Lost to Follow-up|13
1527765|NCT00296504|5008397|P9|Interim Analysis|Withdrawal by Subject|0
1527766|NCT00296504|5008398|P8|Interim Analysis|Withdrawal by Subject|3
1527767|NCT00296504|5008399|P7|Interim Analysis|Withdrawal by Subject|9
1527768|NCT00296504|5008400|P6|Interim Analysis|Withdrawal by Subject|5
1527769|NCT00296504|5008401|P5|Interim Analysis|Withdrawal by Subject|5
1527770|NCT00296504|5008402|P4|Interim Analysis|Withdrawal by Subject|0
1527771|NCT00296504|5008403|P3|Interim Analysis|Withdrawal by Subject|12
1527772|NCT00296504|5008404|P2|Interim Analysis|Withdrawal by Subject|0
1527773|NCT00296504|5008405|P1|Interim Analysis|Withdrawal by Subject|8
1527774|NCT00296491|5008498|P4|Overall Study|Lost to Follow-up|0
1527775|NCT00296491|5008499|P3|Overall Study|Lost to Follow-up|2
1527776|NCT00296491|5008500|P2|Overall Study|Lost to Follow-up|2
1527777|NCT00296491|5008501|P1|Overall Study|Lost to Follow-up|0
1527778|NCT00296491|5008498|P4|Overall Study|Non-Compliance|14
1527779|NCT00296491|5008499|P3|Overall Study|Non-Compliance|10
1527780|NCT00296491|5008500|P2|Overall Study|Non-Compliance|13
1527781|NCT00296491|5008501|P1|Overall Study|Non-Compliance|12
1527782|NCT00296491|5008498|P4|Overall Study|Withdrawal by Subject|2
1527783|NCT00296491|5008499|P3|Overall Study|Withdrawal by Subject|3
1527784|NCT00296491|5008500|P2|Overall Study|Withdrawal by Subject|3
1527785|NCT00296491|5008501|P1|Overall Study|Withdrawal by Subject|7
1527786|NCT00296491|5008498|P4|Overall Study|Withdrawn due to Asthma|4
1527787|NCT00296491|5008499|P3|Overall Study|Withdrawn due to Asthma|0
1527788|NCT00296491|5008500|P2|Overall Study|Withdrawn due to Asthma|0
1527789|NCT00296491|5008501|P1|Overall Study|Withdrawn due to Asthma|0
1527790|NCT00296491|5008498|P4|Overall Study|Adverse Event|4
1527791|NCT00296491|5008499|P3|Overall Study|Adverse Event|1
1527792|NCT00296491|5008500|P2|Overall Study|Adverse Event|3
1527793|NCT00296491|5008501|P1|Overall Study|Adverse Event|1
1527794|NCT00296491|5008498|P4|Overall Study|Protocol Violation|3
1527795|NCT00296491|5008499|P3|Overall Study|Protocol Violation|2
1527796|NCT00296491|5008500|P2|Overall Study|Protocol Violation|6
1527797|NCT00296491|5008501|P1|Overall Study|Protocol Violation|4
1527798|NCT00296491|5008498|P4|Overall Study|Low Pollen Counts|16
1527799|NCT00296491|5008499|P3|Overall Study|Low Pollen Counts|25
1527800|NCT00296491|5008500|P2|Overall Study|Low Pollen Counts|26
1527801|NCT00296491|5008501|P1|Overall Study|Low Pollen Counts|18
1527802|NCT00296400|5008530|P3|Overall Study|Pregnancy|0
1527803|NCT00296400|5008531|P2|Overall Study|Pregnancy|2
1527804|NCT00296400|5008532|P1|Overall Study|Pregnancy|1
1527805|NCT00296400|5008530|P3|Overall Study|Visit 10 was performed earlier|0
1527806|NCT00296400|5008531|P2|Overall Study|Visit 10 was performed earlier|1
1527807|NCT00296400|5008532|P1|Overall Study|Visit 10 was performed earlier|0
1527808|NCT00296400|5008530|P3|Overall Study|Study specific discontinuation criteria|1
1527809|NCT00296400|5008531|P2|Overall Study|Study specific discontinuation criteria|0
1527810|NCT00296400|5008532|P1|Overall Study|Study specific discontinuation criteria|0
1527811|NCT00296400|5008530|P3|Overall Study|Lost to Follow-up|2
1527812|NCT00296400|5008531|P2|Overall Study|Lost to Follow-up|1
1527813|NCT00296400|5008532|P1|Overall Study|Lost to Follow-up|1
1527814|NCT00296400|5008530|P3|Overall Study|Protocol Violation|1
1527815|NCT00296400|5008531|P2|Overall Study|Protocol Violation|1
1527816|NCT00296400|5008532|P1|Overall Study|Protocol Violation|1
1527817|NCT00296400|5008530|P3|Overall Study|Incorrect enrollment|0
1527818|NCT00296400|5008531|P2|Overall Study|Incorrect enrollment|0
1527819|NCT00296400|5008532|P1|Overall Study|Incorrect enrollment|2
1527820|NCT00296400|5008530|P3|Overall Study|Withdrawal by Subject|2
1527821|NCT00296400|5008531|P2|Overall Study|Withdrawal by Subject|6
1527822|NCT00296400|5008532|P1|Overall Study|Withdrawal by Subject|5
1527823|NCT00296400|5008530|P3|Overall Study|Adverse Event|7
1527824|NCT00296400|5008531|P2|Overall Study|Adverse Event|7
1527825|NCT00296400|5008532|P1|Overall Study|Adverse Event|7
1527826|NCT00296374|5008756|P3|Overall Study|Not specified|1
1527827|NCT00296374|5008757|P2|Overall Study|Not specified|0
1527828|NCT00296374|5008758|P1|Overall Study|Not specified|0
1527829|NCT00296374|5008756|P3|Overall Study|Pregnancy|2
1527830|NCT00296374|5008757|P2|Overall Study|Pregnancy|0
1527831|NCT00296374|5008758|P1|Overall Study|Pregnancy|0
1527832|NCT00296374|5008756|P3|Overall Study|Nephrologist introduced ACE|0
1527833|NCT00296374|5008757|P2|Overall Study|Nephrologist introduced ACE|1
1527834|NCT00296374|5008758|P1|Overall Study|Nephrologist introduced ACE|0
1527835|NCT00296374|5008756|P3|Overall Study|Stopped drug before end of study visit|0
1527836|NCT00296374|5008757|P2|Overall Study|Stopped drug before end of study visit|1
1527837|NCT00296374|5008758|P1|Overall Study|Stopped drug before end of study visit|0
1527838|NCT00296374|5008756|P3|Overall Study|Relocated to another state|0
1527839|NCT00296374|5008757|P2|Overall Study|Relocated to another state|0
1527840|NCT00296374|5008758|P1|Overall Study|Relocated to another state|1
1527841|NCT00296374|5008756|P3|Overall Study|Lost to Follow-up|1
1527842|NCT00296374|5008757|P2|Overall Study|Lost to Follow-up|1
1527843|NCT00296374|5008758|P1|Overall Study|Lost to Follow-up|3
1527844|NCT00296374|5008756|P3|Overall Study|Protocol Violation|3
1527845|NCT00296374|5008757|P2|Overall Study|Protocol Violation|2
1527846|NCT00296374|5008758|P1|Overall Study|Protocol Violation|1
1527847|NCT00296374|5008756|P3|Overall Study|Incorrect enrollment|4
1527848|NCT00296374|5008757|P2|Overall Study|Incorrect enrollment|3
1527849|NCT00296374|5008758|P1|Overall Study|Incorrect enrollment|3
1527850|NCT00296374|5008756|P3|Overall Study|Withdrawal by Subject|11
1527851|NCT00296374|5008757|P2|Overall Study|Withdrawal by Subject|5
1527852|NCT00296374|5008758|P1|Overall Study|Withdrawal by Subject|3
1527853|NCT00296374|5008756|P3|Overall Study|Adverse Event|7
1527854|NCT00296374|5008757|P2|Overall Study|Adverse Event|10
1527855|NCT00296374|5008758|P1|Overall Study|Adverse Event|14
1527856|NCT00296335|5008981|P2|Overall Study|Physician Decision|11
1527857|NCT00296335|5008982|P1|Overall Study|Physician Decision|3
1527858|NCT00296335|5008981|P2|Overall Study|Lost to Follow-up|33
1527859|NCT00296335|5008982|P1|Overall Study|Lost to Follow-up|7
1527860|NCT00296335|5008981|P2|Overall Study|Adverse Event|27
1527861|NCT00296335|5008982|P1|Overall Study|Adverse Event|17
1527862|NCT00296335|5008981|P2|Overall Study|Recurrence|51
1527863|NCT00296335|5008982|P1|Overall Study|Recurrence|3
1527864|NCT00296244|5009022|P2|Overall Study|Underwent retransplant|1
1527865|NCT00296244|5009023|P1|Overall Study|Underwent retransplant|0
1527866|NCT00296140|5009087|P2|Overall Study|Discharge to Nursing Home|0
1527867|NCT00296140|5009088|P1|Overall Study|Discharge to Nursing Home|1
1527868|NCT00296140|5009087|P2|Overall Study|Withdrawal by Subject|0
1527869|NCT00296140|5009088|P1|Overall Study|Withdrawal by Subject|1
1527870|NCT00296140|5009087|P2|Overall Study|Lost to Follow-up|0
1527871|NCT00296140|5009088|P1|Overall Study|Lost to Follow-up|1
1527872|NCT00296036|5009100|P6|Overall Study|Protocol Violation|3
1527873|NCT00296036|5009101|P5|Overall Study|Protocol Violation|0
1527874|NCT00296036|5009102|P4|Overall Study|Protocol Violation|0
1527875|NCT00296036|5009103|P3|Overall Study|Protocol Violation|0
1527876|NCT00296036|5009104|P2|Overall Study|Protocol Violation|0
1527877|NCT00296036|5009105|P1|Overall Study|Protocol Violation|0
1527878|NCT00296036|5009100|P6|Overall Study|Withdrawal by Subject|1
1527879|NCT00296036|5009101|P5|Overall Study|Withdrawal by Subject|2
1527880|NCT00296036|5009102|P4|Overall Study|Withdrawal by Subject|1
1527881|NCT00296036|5009103|P3|Overall Study|Withdrawal by Subject|2
1527882|NCT00296036|5009104|P2|Overall Study|Withdrawal by Subject|0
1527883|NCT00296036|5009105|P1|Overall Study|Withdrawal by Subject|1
1527884|NCT00295880|5009131|P1|Overall Study|Unit randomization did not occur|1
1527885|NCT00295880|5009131|P1|Overall Study|IBMI unit could not be volume reduced|1
1527886|NCT00295854|5009145|P3|Overall Study|not specified|1
1527887|NCT00295854|5009146|P2|Overall Study|not specified|5
1527888|NCT00295854|5009147|P1|Overall Study|not specified|3
1527889|NCT00295854|5009145|P3|Overall Study|required a prohibited medication|0
1527890|NCT00295854|5009146|P2|Overall Study|required a prohibited medication|0
1527891|NCT00295854|5009147|P1|Overall Study|required a prohibited medication|1
1527892|NCT00295854|5009145|P3|Overall Study|did not continue to meet criteria|2
1527893|NCT00295854|5009146|P2|Overall Study|did not continue to meet criteria|1
1527894|NCT00295854|5009147|P1|Overall Study|did not continue to meet criteria|1
1527895|NCT00295854|5009145|P3|Overall Study|Withdrawal by Subject|4
1527896|NCT00295854|5009146|P2|Overall Study|Withdrawal by Subject|7
1527897|NCT00295854|5009147|P1|Overall Study|Withdrawal by Subject|3
1527898|NCT00295854|5009145|P3|Overall Study|Lost to Follow-up|1
1527899|NCT00295854|5009146|P2|Overall Study|Lost to Follow-up|0
1527900|NCT00295854|5009147|P1|Overall Study|Lost to Follow-up|2
1527901|NCT00295854|5009145|P3|Overall Study|Protocol Violation|1
1527902|NCT00295854|5009146|P2|Overall Study|Protocol Violation|1
1527903|NCT00295854|5009147|P1|Overall Study|Protocol Violation|1
1527904|NCT00295854|5009145|P3|Overall Study|Adverse Event|6
1527905|NCT00295854|5009146|P2|Overall Study|Adverse Event|7
1527906|NCT00295854|5009147|P1|Overall Study|Adverse Event|7
1527907|NCT00295750|5009161|P3|Overall Study|Protocol Violation|2
1527908|NCT00295750|5009162|P2|Overall Study|Protocol Violation|4
1527909|NCT00295750|5009163|P1|Overall Study|Protocol Violation|2
1527910|NCT00295750|5009161|P3|Overall Study|Withdrawal by Subject|7
1527911|NCT00295750|5009162|P2|Overall Study|Withdrawal by Subject|4
1527912|NCT00295750|5009163|P1|Overall Study|Withdrawal by Subject|9
1527913|NCT00295750|5009161|P3|Overall Study|Randomized but never received trial drug|3
1527914|NCT00295750|5009162|P2|Overall Study|Randomized but never received trial drug|3
1527915|NCT00295750|5009163|P1|Overall Study|Randomized but never received trial drug|4
1527916|NCT00295750|5009161|P3|Overall Study|Personal reasons|0
1527917|NCT00295750|5009162|P2|Overall Study|Personal reasons|1
1527918|NCT00295750|5009163|P1|Overall Study|Personal reasons|0
1527919|NCT00295750|5009161|P3|Overall Study|Disease progression|0
1527920|NCT00295750|5009162|P2|Overall Study|Disease progression|1
1527921|NCT00295750|5009163|P1|Overall Study|Disease progression|2
1527922|NCT00295750|5009161|P3|Overall Study|Trial drug errors|0
1527923|NCT00295750|5009162|P2|Overall Study|Trial drug errors|1
1527924|NCT00295750|5009163|P1|Overall Study|Trial drug errors|1
1527925|NCT00295750|5009161|P3|Overall Study|Administrative errors|5
1527926|NCT00295750|5009162|P2|Overall Study|Administrative errors|4
1527927|NCT00295750|5009163|P1|Overall Study|Administrative errors|2
1527928|NCT00295750|5009161|P3|Overall Study|Taking prohibited therapy|2
1527929|NCT00295750|5009162|P2|Overall Study|Taking prohibited therapy|3
1527930|NCT00295750|5009163|P1|Overall Study|Taking prohibited therapy|2
1527931|NCT00295750|5009161|P3|Overall Study|Lost to Follow-up|1
1527932|NCT00295750|5009162|P2|Overall Study|Lost to Follow-up|4
1527933|NCT00295750|5009163|P1|Overall Study|Lost to Follow-up|1
1527934|NCT00295750|5009161|P3|Overall Study|Lack of Efficacy|0
1527935|NCT00295750|5009162|P2|Overall Study|Lack of Efficacy|1
1527936|NCT00295750|5009163|P1|Overall Study|Lack of Efficacy|1
1527937|NCT00295750|5009161|P3|Overall Study|Adverse Event|12
1527938|NCT00295750|5009162|P2|Overall Study|Adverse Event|15
1527939|NCT00295750|5009163|P1|Overall Study|Adverse Event|19
1527940|NCT00295633|5009198|P3|Overall Study|Administrative reason by sponsor|1
1527941|NCT00295633|5009199|P2|Overall Study|Administrative reason by sponsor|0
1527942|NCT00295633|5009200|P1|Overall Study|Administrative reason by sponsor|0
1527943|NCT00295633|5009198|P3|Overall Study|Death|0
1527944|NCT00295633|5009199|P2|Overall Study|Death|1
1527945|NCT00295633|5009200|P1|Overall Study|Death|1
1527946|NCT00295633|5009198|P3|Overall Study|Subject No Longer Meets Study Criteria|3
1527947|NCT00295633|5009199|P2|Overall Study|Subject No Longer Meets Study Criteria|3
1527948|NCT00295633|5009200|P1|Overall Study|Subject No Longer Meets Study Criteria|0
1527949|NCT00295633|5009198|P3|Overall Study|Poor/Noncompliance|6
1527950|NCT00295633|5009199|P2|Overall Study|Poor/Noncompliance|2
1527951|NCT00295633|5009200|P1|Overall Study|Poor/Noncompliance|2
1527952|NCT00295633|5009198|P3|Overall Study|Physician Decision|8
1527953|NCT00295633|5009199|P2|Overall Study|Physician Decision|10
1527954|NCT00295633|5009200|P1|Overall Study|Physician Decision|9
1527955|NCT00295633|5009198|P3|Overall Study|Lost to Follow-up|7
1527956|NCT00295633|5009199|P2|Overall Study|Lost to Follow-up|11
1527957|NCT00295633|5009200|P1|Overall Study|Lost to Follow-up|6
1527958|NCT00295633|5009198|P3|Overall Study|Adverse Event|9
1527959|NCT00295633|5009199|P2|Overall Study|Adverse Event|17
1527960|NCT00295633|5009200|P1|Overall Study|Adverse Event|9
1527961|NCT00295633|5009198|P3|Overall Study|Withdrawal of consent by subject|26
1527962|NCT00295633|5009199|P2|Overall Study|Withdrawal of consent by subject|16
1527963|NCT00295633|5009200|P1|Overall Study|Withdrawal of consent by subject|16
1527964|NCT00295633|5009198|P3|Overall Study|Lack of Efficacy|16
1527965|NCT00295633|5009199|P2|Overall Study|Lack of Efficacy|7
1527966|NCT00295633|5009200|P1|Overall Study|Lack of Efficacy|19
1527967|NCT00295490|5009227|P4|Overall Study|Other|1
1527968|NCT00295490|5009228|P3|Overall Study|Other|0
1527969|NCT00295490|5009229|P2|Overall Study|Other|2
1527970|NCT00295490|5009230|P1|Overall Study|Other|0
1527971|NCT00295490|5009227|P4|Overall Study|Adverse Event|0
1527972|NCT00295490|5009228|P3|Overall Study|Adverse Event|0
1527973|NCT00295490|5009229|P2|Overall Study|Adverse Event|0
1527974|NCT00295490|5009230|P1|Overall Study|Adverse Event|1
1527975|NCT00295490|5009227|P4|Overall Study|Lost to Follow-up|0
1527976|NCT00295490|5009228|P3|Overall Study|Lost to Follow-up|1
1527977|NCT00295490|5009229|P2|Overall Study|Lost to Follow-up|0
1527978|NCT00295490|5009230|P1|Overall Study|Lost to Follow-up|0
1527979|NCT00295490|5009227|P4|Overall Study|Withdrawal by Subject|1
1527980|NCT00295490|5009228|P3|Overall Study|Withdrawal by Subject|0
1527981|NCT00295490|5009229|P2|Overall Study|Withdrawal by Subject|2
1527982|NCT00295490|5009230|P1|Overall Study|Withdrawal by Subject|0
1527983|NCT00295490|5009227|P4|Overall Study|Protocol Violation|3
1527984|NCT00295490|5009228|P3|Overall Study|Protocol Violation|3
1527985|NCT00295490|5009229|P2|Overall Study|Protocol Violation|0
1527986|NCT00295490|5009230|P1|Overall Study|Protocol Violation|0
1527987|NCT00295022|5009280|P3|Overall Study|Withdrawal by Subject|2
1527988|NCT00295022|5009281|P2|Overall Study|Withdrawal by Subject|0
1527989|NCT00295022|5009282|P1|Overall Study|Withdrawal by Subject|0
1527990|NCT00295022|5009280|P3|Overall Study|Lost to Follow-up|1
1527991|NCT00295022|5009281|P2|Overall Study|Lost to Follow-up|0
1527992|NCT00295022|5009282|P1|Overall Study|Lost to Follow-up|0
1527993|NCT00295022|5009280|P3|Overall Study|Adverse Event|2
1527994|NCT00295022|5009281|P2|Overall Study|Adverse Event|1
1527995|NCT00295022|5009282|P1|Overall Study|Adverse Event|1
1527996|NCT00294762|5009398|P2|Overall Study|Did not receive study treatment|3
1527997|NCT00294762|5009399|P1|Overall Study|Did not receive study treatment|3
1527998|NCT00294723|5009418|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
1527999|NCT00294723|5009419|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
1528000|NCT00294723|5009420|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
1528001|NCT00294723|5009418|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
1528002|NCT00294723|5009419|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
1528003|NCT00294723|5009420|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
1528004|NCT00294723|5009418|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
1528005|NCT00294723|5009419|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
1528006|NCT00294723|5009420|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
1528007|NCT00294723|5009418|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
1528008|NCT00294723|5009419|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
1528009|NCT00294723|5009420|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
1528010|NCT00294723|5009418|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
1528011|NCT00294723|5009419|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
1528012|NCT00294723|5009420|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
1528013|NCT00294723|5009418|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
1528014|NCT00294723|5009419|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
1528015|NCT00294723|5009420|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
1528016|NCT00294723|5009418|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
1528017|NCT00294723|5009419|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
1528018|NCT00294723|5009420|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
1528019|NCT00294723|5009418|P3|Open-Label Extension 52 Weeks|Adverse Event|2
1528020|NCT00294723|5009419|P2|Open-Label Extension 52 Weeks|Adverse Event|5
1528021|NCT00294723|5009420|P1|Open-Label Extension 52 Weeks|Adverse Event|5
1528022|NCT00294723|5009418|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
1528023|NCT00294723|5009419|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
1528024|NCT00294723|5009420|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
1528025|NCT00294723|5009418|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
1528026|NCT00294723|5009419|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
1528027|NCT00294723|5009420|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
1528028|NCT00294723|5009418|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
1528029|NCT00294723|5009419|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
1528030|NCT00294723|5009420|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
1528031|NCT00294723|5009418|P3|Double-Blind Period 52 Weeks|Adverse Event|15
1528032|NCT00294723|5009419|P2|Double-Blind Period 52 Weeks|Adverse Event|25
1528033|NCT00294723|5009420|P1|Double-Blind Period 52 Weeks|Adverse Event|18
1528034|NCT00294684|5009481|P2|Overall Study|Lost to Follow-up|8
1528035|NCT00294684|5009482|P1|Overall Study|Lost to Follow-up|5
1528036|NCT00294671|5009522|P2|Overall Study|Death|1
1528037|NCT00294671|5009523|P1|Overall Study|Death|0
1528038|NCT00294671|5009522|P2|Overall Study|Non-compliance|0
1528039|NCT00294671|5009523|P1|Overall Study|Non-compliance|1
1528040|NCT00294671|5009522|P2|Overall Study|Lost to Follow-up|3
1528041|NCT00294671|5009523|P1|Overall Study|Lost to Follow-up|1
1528042|NCT00294671|5009522|P2|Overall Study|Non-drug related AE|2
1528043|NCT00294671|5009523|P1|Overall Study|Non-drug related AE|3
1528044|NCT00294671|5009522|P2|Overall Study|Drug related adverse event (AE)|2
1528045|NCT00294671|5009523|P1|Overall Study|Drug related adverse event (AE)|4
1528046|NCT00294671|5009522|P2|Overall Study|Liver transplant|9
1528047|NCT00294671|5009523|P1|Overall Study|Liver transplant|7
1528048|NCT00294671|5009522|P2|Overall Study|Lack of Efficacy|23
1528049|NCT00294671|5009523|P1|Overall Study|Lack of Efficacy|11
1528050|NCT00294658|5009539|P2|Overall Study|Patient and family were not satisfied|1
1528051|NCT00294658|5009540|P1|Overall Study|Patient and family were not satisfied|0
1528052|NCT00294658|5009539|P2|Overall Study|Found to have invasive thymoma|0
1528053|NCT00294658|5009540|P1|Overall Study|Found to have invasive thymoma|1
1528054|NCT00294658|5009539|P2|Overall Study|Withdrawal by Subject|4
1528055|NCT00294658|5009540|P1|Overall Study|Withdrawal by Subject|0
1528056|NCT00294658|5009539|P2|Overall Study|Pregnancy|1
1528057|NCT00294658|5009540|P1|Overall Study|Pregnancy|0
1528058|NCT00294658|5009539|P2|Overall Study|Physician Decision|2
1528059|NCT00294658|5009540|P1|Overall Study|Physician Decision|1
1528060|NCT00294658|5009539|P2|Overall Study|Lost to Follow-up|0
1528061|NCT00294658|5009540|P1|Overall Study|Lost to Follow-up|4
1528062|NCT00294658|5009539|P2|Overall Study|Death|1
1528063|NCT00294658|5009540|P1|Overall Study|Death|0
1528064|NCT00294645|5009604|P2|Overall Study|Other|10
1528065|NCT00294645|5009605|P1|Overall Study|Other|4
1528066|NCT00294645|5009604|P2|Overall Study|Physician Decision|20
1528067|NCT00294645|5009605|P1|Overall Study|Physician Decision|15
1528068|NCT00294645|5009604|P2|Overall Study|Withdrawal by Subject|34
1528069|NCT00294645|5009605|P1|Overall Study|Withdrawal by Subject|18
1528070|NCT00294645|5009604|P2|Overall Study|Lost to Follow-up|10
1528071|NCT00294645|5009605|P1|Overall Study|Lost to Follow-up|1
1528072|NCT00294645|5009604|P2|Overall Study|Death|18
1528073|NCT00294645|5009605|P1|Overall Study|Death|10
1528074|NCT00294554|5009639|P2|Overall Study|Physician Decision|1
1528075|NCT00294554|5009640|P1|Overall Study|Physician Decision|0
1528076|NCT00294554|5009639|P2|Overall Study|Lack of Efficacy|1
1528077|NCT00294554|5009640|P1|Overall Study|Lack of Efficacy|0
1528078|NCT00294398|5009667|P2|Overall Study|Lost to Follow-up|26
1528079|NCT00294398|5009668|P1|Overall Study|Lost to Follow-up|21
1528080|NCT00294060|5009676|P1|Overall Study|Device explanted/not replaced|23
1528081|NCT00294060|5009676|P1|Overall Study|Medical condition|3
1528082|NCT00294060|5009676|P1|Overall Study|Physician Decision|797
1528083|NCT00294060|5009676|P1|Overall Study|Withdrawal by Subject|11
1528084|NCT00294060|5009676|P1|Overall Study|Lost to Follow-up|55
1528085|NCT00294060|5009676|P1|Overall Study|Other|59
1528086|NCT00294060|5009676|P1|Overall Study|Death|225
1528087|NCT00294047|5009684|P2|Month 84|No consent for Month 84 Follow-up|754
1528088|NCT00294047|5009685|P1|Month 84|No consent for Month 84 Follow-up|731
1528089|NCT00294047|5009684|P2|Month 84|Visit missed|1
1528090|NCT00294047|5009685|P1|Month 84|Visit missed|0
1528091|NCT00294047|5009684|P2|Month 84|Under investigation locally|0
1528092|NCT00294047|5009685|P1|Month 84|Under investigation locally|1
1528093|NCT00294047|5009684|P2|Month 84|Unable to reach study site|0
1528094|NCT00294047|5009685|P1|Month 84|Unable to reach study site|1
1528095|NCT00294047|5009684|P2|Month 84|Transport reimbursement delayed|1
1528096|NCT00294047|5009685|P1|Month 84|Transport reimbursement delayed|0
1528097|NCT00294047|5009684|P2|Month 84|Subject does not want male physician|0
1528098|NCT00294047|5009685|P1|Month 84|Subject does not want male physician|1
1528099|NCT00294047|5009684|P2|Month 84|Personal reason|4
1528100|NCT00294047|5009685|P1|Month 84|Personal reason|2
1528101|NCT00294047|5009684|P2|Month 84|Lack of time|1
1528102|NCT00294047|5009685|P1|Month 84|Lack of time|3
1528103|NCT00294047|5009684|P2|Month 84|Family problems|2
1528104|NCT00294047|5009685|P1|Month 84|Family problems|2
1528105|NCT00294047|5009684|P2|Month 84|Center closed, subject did not transfer|0
1528106|NCT00294047|5009685|P1|Month 84|Center closed, subject did not transfer|1
1528107|NCT00294047|5009684|P2|Month 84|Work related reasons|2
1528108|NCT00294047|5009685|P1|Month 84|Work related reasons|4
1528109|NCT00294047|5009684|P2|Month 84|Absent Cervix|0
1528110|NCT00294047|5009685|P1|Month 84|Absent Cervix|2
1528111|NCT00294047|5009684|P2|Month 84|Lost to Follow-up|190
1528112|NCT00294047|5009685|P1|Month 84|Lost to Follow-up|187
1528113|NCT00294047|5009684|P2|Month 84|Withdrawal by Subject|31
1528114|NCT00294047|5009685|P1|Month 84|Withdrawal by Subject|33
1528115|NCT00294047|5009684|P2|Month 84|Protocol Violation|1
1528116|NCT00294047|5009685|P1|Month 84|Protocol Violation|1
1528117|NCT00294047|5009684|P2|Month 84|Adverse Event|2
1528118|NCT00294047|5009685|P1|Month 84|Adverse Event|4
1528119|NCT00294047|5009684|P2|Month 48|Other|14
1528120|NCT00294047|5009685|P1|Month 48|Other|10
1528121|NCT00294047|5009684|P2|Month 48|Lost to Follow-up|287
1528122|NCT00294047|5009685|P1|Month 48|Lost to Follow-up|272
1528123|NCT00294047|5009684|P2|Month 48|Withdrawal by Subject|115
1528124|NCT00294047|5009685|P1|Month 48|Withdrawal by Subject|111
1528125|NCT00294047|5009684|P2|Month 48|Protocol Violation|4
1528126|NCT00294047|5009685|P1|Month 48|Protocol Violation|4
1528127|NCT00294047|5009684|P2|Month 48|Adverse Event|13
1528128|NCT00294047|5009685|P1|Month 48|Adverse Event|28
1528129|NCT00293813|5009790|P3|Overall Study|Noncompliance|0
1528130|NCT00293813|5009791|P2|Overall Study|Noncompliance|1
1528131|NCT00293813|5009792|P1|Overall Study|Noncompliance|0
1528132|NCT00293813|5009790|P3|Overall Study|Lost to Follow-up|3
1528133|NCT00293813|5009791|P2|Overall Study|Lost to Follow-up|2
1528134|NCT00293813|5009792|P1|Overall Study|Lost to Follow-up|3
1528135|NCT00293813|5009790|P3|Overall Study|Withdrawal by Subject|4
1528136|NCT00293813|5009791|P2|Overall Study|Withdrawal by Subject|4
1528137|NCT00293813|5009792|P1|Overall Study|Withdrawal by Subject|7
1528138|NCT00293813|5009790|P3|Overall Study|Adverse Event|1
1528139|NCT00293813|5009791|P2|Overall Study|Adverse Event|1
1528140|NCT00293813|5009792|P1|Overall Study|Adverse Event|3
1528141|NCT00293813|5009790|P3|Overall Study|Physician Decision|0
1528142|NCT00293813|5009791|P2|Overall Study|Physician Decision|1
1528143|NCT00293813|5009792|P1|Overall Study|Physician Decision|0
1528144|NCT00293722|5009803|P1|Overall Study|Other|427
1528145|NCT00293709|5009817|P1|Overall Study|Other|47
1528146|NCT00293579|5009831|P1|Overall Study|Withdrawal by Subject|1
1528147|NCT00293462|5009850|P3|Overall Study|Physician Decision|0
1528148|NCT00293462|5009851|P2|Overall Study|Physician Decision|1
1528149|NCT00293462|5009852|P1|Overall Study|Physician Decision|0
1528150|NCT00293462|5009850|P3|Overall Study|Low radiation dose in oral cavity|0
1528151|NCT00293462|5009851|P2|Overall Study|Low radiation dose in oral cavity|1
1528152|NCT00293462|5009852|P1|Overall Study|Low radiation dose in oral cavity|0
1528153|NCT00293462|5009850|P3|Overall Study|Possible Tracheostomy leakage|0
1528154|NCT00293462|5009851|P2|Overall Study|Possible Tracheostomy leakage|1
1528155|NCT00293462|5009852|P1|Overall Study|Possible Tracheostomy leakage|0
1528156|NCT00293462|5009850|P3|Overall Study|Ischemic stroke after chemotherapy|1
1528157|NCT00293462|5009851|P2|Overall Study|Ischemic stroke after chemotherapy|0
1528158|NCT00293462|5009852|P1|Overall Study|Ischemic stroke after chemotherapy|0
1528159|NCT00293462|5009850|P3|Overall Study|Blood clot after chemotherapy|1
1528160|NCT00293462|5009851|P2|Overall Study|Blood clot after chemotherapy|0
1528161|NCT00293462|5009852|P1|Overall Study|Blood clot after chemotherapy|0
1528162|NCT00293462|5009850|P3|Overall Study|Went back to his home country|1
1528163|NCT00293462|5009851|P2|Overall Study|Went back to his home country|0
1528164|NCT00293462|5009852|P1|Overall Study|Went back to his home country|0
1528165|NCT00293462|5009850|P3|Overall Study|No Show|1
1528166|NCT00293462|5009851|P2|Overall Study|No Show|0
1528167|NCT00293462|5009852|P1|Overall Study|No Show|0
1528168|NCT00293462|5009850|P3|Overall Study|Refuse Radiation Treatment|0
1528169|NCT00293462|5009851|P2|Overall Study|Refuse Radiation Treatment|0
1528170|NCT00293462|5009852|P1|Overall Study|Refuse Radiation Treatment|1
1528171|NCT00293462|5009850|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
1528172|NCT00293462|5009851|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
1528173|NCT00293462|5009852|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
1528174|NCT00293462|5009850|P3|Overall Study|Change Treatment Regimen (ineligible)|0
1528175|NCT00293462|5009851|P2|Overall Study|Change Treatment Regimen (ineligible)|0
1528176|NCT00293462|5009852|P1|Overall Study|Change Treatment Regimen (ineligible)|1
1528177|NCT00293462|5009850|P3|Overall Study|Lost to Follow-up|0
1528178|NCT00293462|5009851|P2|Overall Study|Lost to Follow-up|1
1528179|NCT00293462|5009852|P1|Overall Study|Lost to Follow-up|0
1528180|NCT00293462|5009850|P3|Overall Study|Death|0
1528181|NCT00293462|5009851|P2|Overall Study|Death|0
1528182|NCT00293462|5009852|P1|Overall Study|Death|1
1528183|NCT00293462|5009850|P3|Overall Study|Withdrawal by Subject|6
1528184|NCT00293462|5009851|P2|Overall Study|Withdrawal by Subject|3
1528185|NCT00293462|5009852|P1|Overall Study|Withdrawal by Subject|4
1528186|NCT00293397|5009871|P1|Overall Study|Death|2
1528187|NCT00293384|5009881|P1|Overall Study|Ineligible|2
1528188|NCT00293384|5009881|P1|Overall Study|Missed dosage/study drug|1
1528189|NCT00293384|5009881|P1|Overall Study|Non-compliance|2
1528190|NCT00293293|5009890|P2|Overall Study|Patient discontinued chemotherapy|1
1528191|NCT00293293|5009891|P1|Overall Study|Patient discontinued chemotherapy|0
1528192|NCT00293293|5009890|P2|Overall Study|"Patient too anxious to complete trial"|0
1528193|NCT00293293|5009891|P1|Overall Study|"Patient too anxious to complete trial"|1
1528194|NCT00293293|5009890|P2|Overall Study|Withdrawal by Subject|1
1528195|NCT00293293|5009891|P1|Overall Study|Withdrawal by Subject|1
1528196|NCT00293267|5009919|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
1528197|NCT00293267|5009920|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
1528198|NCT00293267|5009919|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
1528199|NCT00293267|5009920|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
1528200|NCT00293267|5009919|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
1528201|NCT00293267|5009920|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
1528202|NCT00293267|5009919|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
1528203|NCT00293267|5009920|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
1528204|NCT00293267|5009919|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
1528205|NCT00293267|5009920|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
1528206|NCT00293267|5009919|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
1528207|NCT00293267|5009920|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
1528208|NCT00293267|5009919|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
1528209|NCT00293267|5009920|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
1528210|NCT00293267|5009919|P2|Extension - Open-Label Week 157-240|Other Reason|1
1528211|NCT00293267|5009920|P1|Extension - Open-Label Week 157-240|Other Reason|3
1528212|NCT00293267|5009919|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
1528213|NCT00293267|5009920|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
1528214|NCT00293267|5009919|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
1528215|NCT00293267|5009920|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
1528216|NCT00293267|5009919|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
1528217|NCT00293267|5009920|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
1528218|NCT00293267|5009919|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
1528219|NCT00293267|5009920|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
1528220|NCT00293267|5009919|P2|Extension - Open-Label Week 157-240|Adverse Event|0
1528221|NCT00293267|5009920|P1|Extension - Open-Label Week 157-240|Adverse Event|5
1528222|NCT00293267|5009919|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
1528223|NCT00293267|5009920|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
1528224|NCT00293267|5009919|P2|Extension - Double-Blind Week 49-156|Other Reason|0
1528225|NCT00293267|5009920|P1|Extension - Double-Blind Week 49-156|Other Reason|7
1528226|NCT00293267|5009919|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
1528227|NCT00293267|5009920|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
1528228|NCT00293267|5009919|P2|Extension - Double-Blind Week 49-156|Death|0
1528229|NCT00293267|5009920|P1|Extension - Double-Blind Week 49-156|Death|3
1528230|NCT00293267|5009919|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
1528231|NCT00293267|5009920|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
1528232|NCT00293267|5009919|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
1528233|NCT00293267|5009920|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
1528234|NCT00293267|5009919|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
1528235|NCT00293267|5009920|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
1528236|NCT00293267|5009919|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
1528237|NCT00293267|5009920|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
1528238|NCT00293267|5009919|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
1528239|NCT00293267|5009920|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
1528240|NCT00293267|5009919|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
1528241|NCT00293267|5009920|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
1528242|NCT00293267|5009919|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
1528243|NCT00293267|5009920|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
1528244|NCT00293267|5009919|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
1528245|NCT00293267|5009920|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
1528246|NCT00293267|5009919|P2|Primary Study - Double-Blind Week 0-48|Death|3
1528247|NCT00293267|5009920|P1|Primary Study - Double-Blind Week 0-48|Death|3
1528248|NCT00293267|5009919|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
1528249|NCT00293267|5009920|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
1528250|NCT00293267|5009919|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
1528251|NCT00293267|5009920|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
1528252|NCT00293254|5009960|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
1528253|NCT00293254|5009961|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
1528254|NCT00293254|5009960|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
1528255|NCT00293254|5009961|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
1528256|NCT00293254|5009960|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
1528257|NCT00293254|5009961|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
1528258|NCT00293254|5009960|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
1528259|NCT00293254|5009961|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
1528260|NCT00293254|5009960|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
1528261|NCT00293254|5009961|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
1528262|NCT00293254|5009960|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
1528263|NCT00293254|5009961|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
1528264|NCT00293254|5009960|P2|Extension - Open-Label Week 157-240|Other Reason|0
1528265|NCT00293254|5009961|P1|Extension - Open-Label Week 157-240|Other Reason|4
1528266|NCT00293254|5009960|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
1528267|NCT00293254|5009961|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
1528268|NCT00293254|5009960|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
1528269|NCT00293254|5009961|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
1528270|NCT00293254|5009960|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
1528271|NCT00293254|5009961|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
1528272|NCT00293254|5009960|P2|Extension - Open-Label Week 157-240|Adverse Event|1
1528273|NCT00293254|5009961|P1|Extension - Open-Label Week 157-240|Adverse Event|2
1528274|NCT00293254|5009960|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
1528275|NCT00293254|5009961|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
1528276|NCT00293254|5009960|P2|Extension - Double-Blind Week 49-156|Other Reason|2
1528277|NCT00293254|5009961|P1|Extension - Double-Blind Week 49-156|Other Reason|10
1528278|NCT00293254|5009960|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
1528279|NCT00293254|5009961|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
1528280|NCT00293254|5009960|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
1528281|NCT00293254|5009961|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
1528282|NCT00293254|5009960|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
1528283|NCT00293254|5009961|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
1528284|NCT00293254|5009960|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
1528285|NCT00293254|5009961|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
1528286|NCT00293254|5009960|P2|Extension - Double-Blind Week 49-156|Death|1
1528287|NCT00293254|5009961|P1|Extension - Double-Blind Week 49-156|Death|4
1528288|NCT00293254|5009960|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
1528289|NCT00293254|5009961|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
1528290|NCT00293254|5009960|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
1528291|NCT00293254|5009961|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
1528292|NCT00293254|5009960|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
1528293|NCT00293254|5009961|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
1528294|NCT00293254|5009960|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
1528295|NCT00293254|5009961|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
1528296|NCT00293254|5009960|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
1528297|NCT00293254|5009961|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
1528298|NCT00293254|5009960|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
1528299|NCT00293254|5009961|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
1528300|NCT00293254|5009960|P2|Primary Study - Double-Blind Week 0-48|Death|2
1528301|NCT00293254|5009961|P1|Primary Study - Double-Blind Week 0-48|Death|5
1528302|NCT00293254|5009960|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
1528303|NCT00293254|5009961|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
1528304|NCT00293254|5009960|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
1528305|NCT00293254|5009961|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
1528306|NCT00293241|5010001|P2|Overall Study|Withdrawal by Subject|8
1528307|NCT00293241|5010002|P1|Overall Study|Withdrawal by Subject|4
1528308|NCT00293241|5010001|P2|Overall Study|Physician Decision|17
1528309|NCT00293241|5010002|P1|Overall Study|Physician Decision|23
1528310|NCT00293241|5010001|P2|Overall Study|Lost to Follow-up|16
1528311|NCT00293241|5010002|P1|Overall Study|Lost to Follow-up|9
1528312|NCT00293059|5010046|P2|Overall Study|missing|5
1528313|NCT00293059|5010047|P1|Overall Study|missing|3
1528314|NCT00293059|5010046|P2|Overall Study|Noncompliant - sanitary pads collection|1
1528315|NCT00293059|5010047|P1|Overall Study|Noncompliant - sanitary pads collection|0
1528316|NCT00293059|5010046|P2|Overall Study|Participant stopped study drug|0
1528317|NCT00293059|5010047|P1|Overall Study|Participant stopped study drug|1
1528318|NCT00293059|5010046|P2|Overall Study|Participant moved out of state|0
1528319|NCT00293059|5010047|P1|Overall Study|Participant moved out of state|1
1528320|NCT00293059|5010046|P2|Overall Study|Withdrawal by Subject|5
1528321|NCT00293059|5010047|P1|Overall Study|Withdrawal by Subject|11
1528322|NCT00293059|5010046|P2|Overall Study|Protocol Violation|0
1528323|NCT00293059|5010047|P1|Overall Study|Protocol Violation|2
1528324|NCT00293059|5010046|P2|Overall Study|Pregnancy|1
1528325|NCT00293059|5010047|P1|Overall Study|Pregnancy|1
1528326|NCT00293059|5010046|P2|Overall Study|Lost to Follow-up|3
1528327|NCT00293059|5010047|P1|Overall Study|Lost to Follow-up|2
1528328|NCT00293059|5010046|P2|Overall Study|Lack of Efficacy|0
1528329|NCT00293059|5010047|P1|Overall Study|Lack of Efficacy|2
1528330|NCT00293059|5010046|P2|Overall Study|Adverse Event|4
1528331|NCT00293059|5010047|P1|Overall Study|Adverse Event|12
1528332|NCT00293020|5010159|P1|Overall Study|No dose taken|1
1528333|NCT00293020|5010159|P1|Overall Study|Other Reason|22
1528334|NCT00293020|5010159|P1|Overall Study|Physician Decision|21
1528335|NCT00293020|5010159|P1|Overall Study|Protocol Violation|6
1528336|NCT00293020|5010159|P1|Overall Study|Lost to Follow-up|4
1528337|NCT00293020|5010159|P1|Overall Study|Lack of Efficacy|12
1528338|NCT00293020|5010159|P1|Overall Study|Death|32
1528339|NCT00293020|5010159|P1|Overall Study|Adverse Event|30
1528340|NCT00293020|5010159|P1|Overall Study|Withdrawal by Subject|34
1528341|NCT00292981|5010163|P1|Overall Study|Not specified|3
1528342|NCT00292981|5010163|P1|Overall Study|Withdrawal by Subject|22
1528343|NCT00292981|5010163|P1|Overall Study|Lost to Follow-up|13
1528344|NCT00292981|5010163|P1|Overall Study|Adverse Event|1
1528345|NCT00292461|5010185|P2|Overall Study|Lost to Follow-up|0
1528346|NCT00292461|5010186|P1|Overall Study|Lost to Follow-up|1
1528347|NCT00292461|5010185|P2|Overall Study|Protocol Violation|3
1528348|NCT00292461|5010186|P1|Overall Study|Protocol Violation|4
1528349|NCT00292461|5010185|P2|Overall Study|Withdrawal by Subject|1
1528350|NCT00292461|5010186|P1|Overall Study|Withdrawal by Subject|0
1528351|NCT00292461|5010185|P2|Overall Study|Lack of Efficacy|0
1528352|NCT00292461|5010186|P1|Overall Study|Lack of Efficacy|1
1528353|NCT00292461|5010185|P2|Overall Study|Adverse Event|2
1528354|NCT00292461|5010186|P1|Overall Study|Adverse Event|4
1528355|NCT00292370|5010201|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
1528356|NCT00292370|5010202|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
1528357|NCT00292370|5010203|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
1528358|NCT00292370|5010201|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
1528359|NCT00292370|5010202|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
1528360|NCT00292370|5010203|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
1528361|NCT00292370|5010201|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
1528362|NCT00292370|5010202|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
1528363|NCT00292370|5010203|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
1528364|NCT00292370|5010201|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
1528365|NCT00292370|5010202|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
1528366|NCT00292370|5010203|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
1528367|NCT00292370|5010201|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
1528368|NCT00292370|5010202|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
1528369|NCT00292370|5010203|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
1528370|NCT00292370|5010201|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
1528371|NCT00292370|5010202|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
1528372|NCT00292370|5010203|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
1528373|NCT00292318|5010212|P2|Overall Study|Study terminated by officials|1
1528374|NCT00292318|5010213|P1|Overall Study|Study terminated by officials|2
1528375|NCT00292227|5010223|P3|Patch Period|Withdrawal by Subject|1
1528376|NCT00292227|5010224|P2|Patch Period|Withdrawal by Subject|0
1528377|NCT00292227|5010225|P1|Patch Period|Withdrawal by Subject|0
1528378|NCT00292227|5010223|P3|Patch Period|Adverse Event|2
1528379|NCT00292227|5010224|P2|Patch Period|Adverse Event|0
1528380|NCT00292227|5010225|P1|Patch Period|Adverse Event|1
1528381|NCT00292188|5010307|P3|Double-Blind|Laboratory Abnormality|1
1528382|NCT00292188|5010308|P2|Double-Blind|Laboratory Abnormality|0
1528383|NCT00292188|5010309|P1|Double-Blind|Laboratory Abnormality|0
1528384|NCT00292188|5010307|P3|Double-Blind|Withdrawal by Subject|3
1528385|NCT00292188|5010308|P2|Double-Blind|Withdrawal by Subject|0
1528386|NCT00292188|5010309|P1|Double-Blind|Withdrawal by Subject|0
1528387|NCT00292188|5010307|P3|Double-Blind|Other|4
1528388|NCT00292188|5010308|P2|Double-Blind|Other|3
1528389|NCT00292188|5010309|P1|Double-Blind|Other|0
1528390|NCT00292188|5010307|P3|Double-Blind|Lost to Follow-up|0
1528391|NCT00292188|5010308|P2|Double-Blind|Lost to Follow-up|1
1528392|NCT00292188|5010309|P1|Double-Blind|Lost to Follow-up|0
1528393|NCT00292188|5010307|P3|Double-Blind|Lack of Efficacy|12
1528394|NCT00292188|5010308|P2|Double-Blind|Lack of Efficacy|2
1528395|NCT00292188|5010309|P1|Double-Blind|Lack of Efficacy|0
1528396|NCT00292188|5010307|P3|Double-Blind|Adverse Event|9
1528397|NCT00292188|5010308|P2|Double-Blind|Adverse Event|25
1528398|NCT00292188|5010309|P1|Double-Blind|Adverse Event|0
1528399|NCT00292188|5010307|P3|Single-Blind|Did not receive treatment|0
1528400|NCT00292188|5010308|P2|Single-Blind|Did not receive treatment|0
1528401|NCT00292188|5010309|P1|Single-Blind|Did not receive treatment|1
1528402|NCT00292188|5010307|P3|Single-Blind|Withdrawal by Subject|0
1528403|NCT00292188|5010308|P2|Single-Blind|Withdrawal by Subject|0
1528404|NCT00292188|5010309|P1|Single-Blind|Withdrawal by Subject|12
1528405|NCT00292188|5010307|P3|Single-Blind|Other|0
1528406|NCT00292188|5010308|P2|Single-Blind|Other|0
1528407|NCT00292188|5010309|P1|Single-Blind|Other|77
1528408|NCT00292188|5010307|P3|Single-Blind|Lost to Follow-up|0
1528409|NCT00292188|5010308|P2|Single-Blind|Lost to Follow-up|0
1528410|NCT00292188|5010309|P1|Single-Blind|Lost to Follow-up|3
1528411|NCT00292188|5010307|P3|Single-Blind|Laboratory Abnormality|0
1528412|NCT00292188|5010308|P2|Single-Blind|Laboratory Abnormality|0
1528413|NCT00292188|5010309|P1|Single-Blind|Laboratory Abnormality|5
1528414|NCT00292188|5010307|P3|Single-Blind|Lack of Efficacy|0
1528415|NCT00292188|5010308|P2|Single-Blind|Lack of Efficacy|0
1528416|NCT00292188|5010309|P1|Single-Blind|Lack of Efficacy|2
1528417|NCT00292188|5010307|P3|Single-Blind|Adverse Event|0
1528418|NCT00292188|5010308|P2|Single-Blind|Adverse Event|0
1528419|NCT00292188|5010309|P1|Single-Blind|Adverse Event|14
1528420|NCT00291642|5010426|P5|Overall Study|Intake of prohibited medication|0
1528421|NCT00291642|5010427|P4|Overall Study|Intake of prohibited medication|0
1528422|NCT00291642|5010428|P3|Overall Study|Intake of prohibited medication|0
1528423|NCT00291642|5010429|P2|Overall Study|Intake of prohibited medication|0
1528424|NCT00291642|5010430|P1|Overall Study|Intake of prohibited medication|1
1528425|NCT00291642|5010426|P5|Overall Study|Patient missed visit|0
1528426|NCT00291642|5010427|P4|Overall Study|Patient missed visit|0
1528427|NCT00291642|5010428|P3|Overall Study|Patient missed visit|1
1528428|NCT00291642|5010429|P2|Overall Study|Patient missed visit|0
1528429|NCT00291642|5010430|P1|Overall Study|Patient missed visit|0
1528430|NCT00291642|5010426|P5|Overall Study|Adverse Event|1
1528431|NCT00291642|5010427|P4|Overall Study|Adverse Event|0
1528432|NCT00291642|5010428|P3|Overall Study|Adverse Event|1
1528433|NCT00291642|5010429|P2|Overall Study|Adverse Event|0
1528434|NCT00291642|5010430|P1|Overall Study|Adverse Event|1
1528435|NCT00291577|5010482|P1|Overall Study|Lack of Efficacy|14
1528436|NCT00291577|5010482|P1|Overall Study|Withdrawal by Subject|2
1528437|NCT00291577|5010482|P1|Overall Study|Other|4
1528438|NCT00291577|5010482|P1|Overall Study|Adverse Event|1
1528439|NCT00291551|5010501|P1|Overall Study|Withdrawal by Subject|6
1528440|NCT00291551|5010501|P1|Overall Study|Death|7
1528441|NCT00291330|5010549|P2|Overall Study|Other|1
1528442|NCT00291330|5010550|P1|Overall Study|Other|3
1528443|NCT00291330|5010549|P2|Overall Study|Withdrawal by Subject|25
1528444|NCT00291330|5010550|P1|Overall Study|Withdrawal by Subject|22
1528445|NCT00291330|5010549|P2|Overall Study|Lost to Follow-up|11
1528446|NCT00291330|5010550|P1|Overall Study|Lost to Follow-up|16
1528447|NCT00291330|5010549|P2|Overall Study|Protocol Violation|20
1528448|NCT00291330|5010550|P1|Overall Study|Protocol Violation|13
1528449|NCT00291330|5010549|P2|Overall Study|Adverse Event|40
1528450|NCT00291330|5010550|P1|Overall Study|Adverse Event|47
1528451|NCT00291187|5010592|P4|Overall Study|Protocol Violation- No Drug Administered|0
1528452|NCT00291187|5010593|P3|Overall Study|Protocol Violation- No Drug Administered|1
1528453|NCT00291187|5010594|P2|Overall Study|Protocol Violation- No Drug Administered|0
1528454|NCT00291187|5010595|P1|Overall Study|Protocol Violation- No Drug Administered|0
1528455|NCT00291018|5010639|P3|Overall Study|Lost to Follow-up|18
1528456|NCT00291018|5010640|P2|Overall Study|Lost to Follow-up|4
1528457|NCT00291018|5010641|P1|Overall Study|Lost to Follow-up|3
1528458|NCT00291018|5010639|P3|Overall Study|Failures|5
1528459|NCT00291018|5010640|P2|Overall Study|Failures|12
1528460|NCT00291018|5010641|P1|Overall Study|Failures|5
1528461|NCT00291018|5010639|P3|Overall Study|Withdrawal by Subject|1
1528462|NCT00291018|5010640|P2|Overall Study|Withdrawal by Subject|8
1528463|NCT00291018|5010641|P1|Overall Study|Withdrawal by Subject|2
1528464|NCT00291018|5010639|P3|Overall Study|Death|4
1528465|NCT00291018|5010640|P2|Overall Study|Death|3
1528466|NCT00291018|5010641|P1|Overall Study|Death|3
1528467|NCT00291018|5010639|P3|Overall Study|Not Consented or Declined PAS|15
1528468|NCT00291018|5010640|P2|Overall Study|Not Consented or Declined PAS|15
1528469|NCT00291018|5010641|P1|Overall Study|Not Consented or Declined PAS|12
1528470|NCT00290888|5010681|P2|Overall Study|Physician Decision|1
1528471|NCT00290888|5010682|P1|Overall Study|Physician Decision|3
1528472|NCT00290771|5010699|P2|Overall Study|Lost to Follow-up|1
1528473|NCT00290771|5010700|P1|Overall Study|Lost to Follow-up|0
1528474|NCT00290771|5010699|P2|Overall Study|Protocol Violation|0
1528475|NCT00290771|5010700|P1|Overall Study|Protocol Violation|2
1528476|NCT00290771|5010699|P2|Overall Study|Administrative problems|1
1528477|NCT00290771|5010700|P1|Overall Study|Administrative problems|2
1528478|NCT00290771|5010699|P2|Overall Study|Withdrawal by Subject|6
1528479|NCT00290771|5010700|P1|Overall Study|Withdrawal by Subject|5
1528480|NCT00290771|5010699|P2|Overall Study|Adverse Event|6
1528481|NCT00290771|5010700|P1|Overall Study|Adverse Event|12
1528482|NCT00290771|5010699|P2|Overall Study|Death|10
1528483|NCT00290771|5010700|P1|Overall Study|Death|11
1528484|NCT00290771|5010699|P2|Overall Study|Disease progression|73
1528485|NCT00290771|5010700|P1|Overall Study|Disease progression|95
1528486|NCT00290758|5010724|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
1528487|NCT00290758|5010725|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
1528488|NCT00290758|5010724|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
1528489|NCT00290758|5010725|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
1528490|NCT00290758|5010724|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
1528491|NCT00290758|5010725|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
1528492|NCT00290758|5010724|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
1528493|NCT00290758|5010725|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
1528494|NCT00290758|5010724|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
1528495|NCT00290758|5010725|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
1528496|NCT00290758|5010724|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
1528497|NCT00290758|5010725|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
1528498|NCT00290758|5010724|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
1528499|NCT00290758|5010725|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
1528500|NCT00290758|5010724|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
1528501|NCT00290758|5010725|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
1528502|NCT00290732|5010747|P5|Overall Study|Inability to instill drug intraductally.|0
1528503|NCT00290732|5010748|P4|Overall Study|Inability to instill drug intraductally.|0
1528504|NCT00290732|5010749|P3|Overall Study|Inability to instill drug intraductally.|1
1528505|NCT00290732|5010750|P2|Overall Study|Inability to instill drug intraductally.|1
1528506|NCT00290732|5010751|P1|Overall Study|Inability to instill drug intraductally.|0
1528507|NCT00290693|5010769|P1|Overall Study|Withdrawal by Subject|2
1528508|NCT00290407|5010818|P1|Overall Study|Physician Decision|2
1528509|NCT00290290|5010850|P2|Overall Study|Underwent clean surgical procedure|12
1528510|NCT00290290|5010851|P1|Overall Study|Underwent clean surgical procedure|13
1528511|NCT00290290|5010850|P2|Overall Study|Withdrawal by Subject|2
1528512|NCT00290290|5010851|P1|Overall Study|Withdrawal by Subject|2
1528513|NCT00290290|5010850|P2|Overall Study|Death|4
1528514|NCT00290290|5010851|P1|Overall Study|Death|3
1528515|NCT00290251|5010857|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
1528516|NCT00290251|5010858|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
1528517|NCT00290251|5010859|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
1528518|NCT00290251|5010857|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
1528519|NCT00290251|5010858|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
1528520|NCT00290251|5010859|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
1528521|NCT00290251|5010857|P3|Treatment 1 (Months 1 - 3)|headache|0
1528522|NCT00290251|5010858|P2|Treatment 1 (Months 1 - 3)|headache|1
1528523|NCT00290251|5010859|P1|Treatment 1 (Months 1 - 3)|headache|0
1528524|NCT00290251|5010857|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
1528525|NCT00290251|5010858|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
1528526|NCT00290251|5010859|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
1528527|NCT00290238|5010871|P2|Overall Study|Withdrawal by Subject|13
1528528|NCT00290238|5010872|P1|Overall Study|Withdrawal by Subject|15
1528529|NCT00290238|5010871|P2|Overall Study|Lost to Follow-up|1
1528530|NCT00290238|5010872|P1|Overall Study|Lost to Follow-up|0
1528531|NCT00290238|5010871|P2|Overall Study|Study terminated|27
1528532|NCT00290238|5010872|P1|Overall Study|Study terminated|27
1528533|NCT00290186|5010897|P2|Overall Study|Withdrawal by Subject|1
1528534|NCT00290186|5010898|P1|Overall Study|Withdrawal by Subject|0
1528535|NCT00290186|5010897|P2|Overall Study|Study was terminated prior to 3-month te|1
1528536|NCT00290186|5010898|P1|Overall Study|Study was terminated prior to 3-month te|1
1528537|NCT00290186|5010897|P2|Overall Study|Lost to Follow-up|2
1528538|NCT00290186|5010898|P1|Overall Study|Lost to Follow-up|3
1528539|NCT00290186|5010897|P2|Overall Study|Adverse Event|1
1528540|NCT00290186|5010898|P1|Overall Study|Adverse Event|1
1528541|NCT00289991|5010949|P2|Overall Study|Other|14
1528542|NCT00289991|5010950|P1|Overall Study|Other|5
1528543|NCT00289991|5010949|P2|Overall Study|Withdrawal by Subject|12
1528544|NCT00289991|5010950|P1|Overall Study|Withdrawal by Subject|2
1528545|NCT00289991|5010949|P2|Overall Study|Lost to Follow-up|1
1528546|NCT00289991|5010950|P1|Overall Study|Lost to Follow-up|0
1528547|NCT00289991|5010949|P2|Overall Study|Fungal breakthrough infection|1
1528548|NCT00289991|5010950|P1|Overall Study|Fungal breakthrough infection|0
1528549|NCT00289991|5010949|P2|Overall Study|Failure of prophylaxis|1
1528550|NCT00289991|5010950|P1|Overall Study|Failure of prophylaxis|1
1528551|NCT00289991|5010949|P2|Overall Study|Adverse Event|13
1528552|NCT00289991|5010950|P1|Overall Study|Adverse Event|15
1528553|NCT00289991|5010949|P2|Overall Study|Death|38
1528554|NCT00289991|5010950|P1|Overall Study|Death|35
1528555|NCT00289978|5010975|P3|Overall Study|Death|2
1528556|NCT00289978|5010976|P2|Overall Study|Death|0
1528557|NCT00289978|5010977|P1|Overall Study|Death|1
1528558|NCT00289978|5010975|P3|Overall Study|Abnormal test procedure result(s)|1
1528559|NCT00289978|5010976|P2|Overall Study|Abnormal test procedure result(s)|1
1528560|NCT00289978|5010977|P1|Overall Study|Abnormal test procedure result(s)|2
1528561|NCT00289978|5010975|P3|Overall Study|Protocol Violation|4
1528562|NCT00289978|5010976|P2|Overall Study|Protocol Violation|5
1528563|NCT00289978|5010977|P1|Overall Study|Protocol Violation|5
1528564|NCT00289978|5010975|P3|Overall Study|Lost to Follow-up|7
1528565|NCT00289978|5010976|P2|Overall Study|Lost to Follow-up|5
1528566|NCT00289978|5010977|P1|Overall Study|Lost to Follow-up|3
1528567|NCT00289978|5010975|P3|Overall Study|Abnormal laboratory value(s)|1
1528568|NCT00289978|5010976|P2|Overall Study|Abnormal laboratory value(s)|9
1528569|NCT00289978|5010977|P1|Overall Study|Abnormal laboratory value(s)|20
1528570|NCT00289978|5010975|P3|Overall Study|Lack of Efficacy|25
1528571|NCT00289978|5010976|P2|Overall Study|Lack of Efficacy|6
1528572|NCT00289978|5010977|P1|Overall Study|Lack of Efficacy|13
1528573|NCT00289978|5010975|P3|Overall Study|Adverse Event|18
1528574|NCT00289978|5010976|P2|Overall Study|Adverse Event|13
1528575|NCT00289978|5010977|P1|Overall Study|Adverse Event|22
1528576|NCT00289978|5010975|P3|Overall Study|Withdrawal by Subject|28
1528577|NCT00289978|5010976|P2|Overall Study|Withdrawal by Subject|17
1528578|NCT00289978|5010977|P1|Overall Study|Withdrawal by Subject|31
1528579|NCT00289913|5010996|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1528580|NCT00289913|5010997|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1528581|NCT00289913|5010998|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1528582|NCT00289913|5010999|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
1528583|NCT00289913|5011000|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1528584|NCT00289913|5010996|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
1528585|NCT00289913|5010997|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1528586|NCT00289913|5010998|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1528587|NCT00289913|5010999|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1528588|NCT00289913|5011000|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1528589|NCT00289913|5010996|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1528590|NCT00289913|5010997|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1528591|NCT00289913|5010998|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
1528592|NCT00289913|5010999|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
1528593|NCT00289913|5011000|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1528594|NCT00289913|5010996|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
1528595|NCT00289913|5010997|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
1528596|NCT00289913|5010998|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
1528597|NCT00289913|5010999|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
1528598|NCT00289913|5011000|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
1528599|NCT00289913|5010996|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
1528600|NCT00289913|5010997|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1528601|NCT00289913|5010998|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1528602|NCT00289913|5010999|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1528603|NCT00289913|5011000|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1528604|NCT00289913|5010996|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1528605|NCT00289913|5010997|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
1528606|NCT00289913|5010998|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1528607|NCT00289913|5010999|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1528608|NCT00289913|5011000|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1528609|NCT00289913|5010996|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
1528610|NCT00289913|5010997|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
1528611|NCT00289913|5010998|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
1528612|NCT00289913|5010999|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
1528613|NCT00289913|5011000|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
1528614|NCT00289913|5010996|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1528615|NCT00289913|5010997|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1528616|NCT00289913|5010998|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1528617|NCT00289913|5010999|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
1528618|NCT00289913|5011000|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1528619|NCT00289913|5010996|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
1528620|NCT00289913|5010997|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1528621|NCT00289913|5010998|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1528622|NCT00289913|5010999|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1528623|NCT00289913|5011000|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1528624|NCT00289913|5010996|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
1528625|NCT00289913|5010997|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1528626|NCT00289913|5010998|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1528627|NCT00289913|5010999|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1528628|NCT00289913|5011000|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1528629|NCT00289913|5010996|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
1528630|NCT00289913|5010997|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1528631|NCT00289913|5010998|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1528632|NCT00289913|5010999|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1528633|NCT00289913|5011000|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1528634|NCT00289913|5010996|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
1528635|NCT00289913|5010997|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1528636|NCT00289913|5010998|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1528637|NCT00289913|5010999|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1528638|NCT00289913|5011000|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1528639|NCT00289913|5010996|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
1528640|NCT00289913|5010997|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1528641|NCT00289913|5010998|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1528642|NCT00289913|5010999|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1528643|NCT00289913|5011000|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1528644|NCT00289913|5010996|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1528645|NCT00289913|5010997|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1528646|NCT00289913|5010998|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1528647|NCT00289913|5010999|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1528648|NCT00289913|5011000|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
1528649|NCT00289913|5010996|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
1528650|NCT00289913|5010997|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
1528651|NCT00289913|5010998|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
1528652|NCT00289913|5010999|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
1528653|NCT00289913|5011000|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
1528654|NCT00289913|5010996|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
1528655|NCT00289913|5010997|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
1528656|NCT00289913|5010998|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
1528657|NCT00289913|5010999|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
1528658|NCT00289913|5011000|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
1528659|NCT00289913|5010996|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1528660|NCT00289913|5010997|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
1528661|NCT00289913|5010998|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
1528662|NCT00289913|5010999|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
1528663|NCT00289913|5011000|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1528664|NCT00289913|5010996|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
1528665|NCT00289913|5010997|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
1528666|NCT00289913|5010998|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
1528667|NCT00289913|5010999|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
1528668|NCT00289913|5011000|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
1528669|NCT00289913|5010996|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1528670|NCT00289913|5010997|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1528671|NCT00289913|5010998|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
1528672|NCT00289913|5010999|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1528673|NCT00289913|5011000|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
1528674|NCT00289913|5010996|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1528675|NCT00289913|5010997|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1528676|NCT00289913|5010998|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1528677|NCT00289913|5010999|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
1528678|NCT00289913|5011000|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1528679|NCT00289913|5010996|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
1528680|NCT00289913|5010997|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
1528681|NCT00289913|5010998|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
1528682|NCT00289913|5010999|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
1528683|NCT00289913|5011000|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
1528684|NCT00289913|5010996|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1528685|NCT00289913|5010997|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1528686|NCT00289913|5010998|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
1528687|NCT00289913|5010999|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1528688|NCT00289913|5011000|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1528689|NCT00289913|5010996|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
1528690|NCT00289913|5010997|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
1528691|NCT00289913|5010998|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
1528692|NCT00289913|5010999|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
1528693|NCT00289913|5011000|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
1528694|NCT00289913|5010996|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1528695|NCT00289913|5010997|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
1528696|NCT00289913|5010998|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
1528697|NCT00289913|5010999|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
1528698|NCT00289913|5011000|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1528699|NCT00289913|5010996|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
1528700|NCT00289913|5010997|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
1528701|NCT00289913|5010998|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
1528702|NCT00289913|5010999|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
1528703|NCT00289913|5011000|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
1528704|NCT00289913|5010996|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1528705|NCT00289913|5010997|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1528706|NCT00289913|5010998|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1528707|NCT00289913|5010999|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
1528708|NCT00289913|5011000|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
1528709|NCT00289913|5010996|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1528710|NCT00289913|5010997|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
1528711|NCT00289913|5010998|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1528712|NCT00289913|5010999|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1528713|NCT00289913|5011000|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1528714|NCT00289913|5010996|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
1528715|NCT00289913|5010997|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1528716|NCT00289913|5010998|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1528717|NCT00289913|5010999|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1528718|NCT00289913|5011000|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1528719|NCT00289913|5010996|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1528720|NCT00289913|5010997|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1528721|NCT00289913|5010998|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1528722|NCT00289913|5010999|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1528723|NCT00289913|5011000|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1528724|NCT00289913|5010996|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
1528725|NCT00289913|5010997|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
1528726|NCT00289913|5010998|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
1528727|NCT00289913|5010999|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
1528728|NCT00289913|5011000|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
1528729|NCT00289913|5010996|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1528730|NCT00289913|5010997|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1528731|NCT00289913|5010998|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1528732|NCT00289913|5010999|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
1528733|NCT00289913|5011000|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1528734|NCT00289900|5011031|P6|Overall Study|Not treated|0
1528735|NCT00289900|5011032|P5|Overall Study|Not treated|0
1528736|NCT00289900|5011033|P4|Overall Study|Not treated|0
1528737|NCT00289900|5011034|P3|Overall Study|Not treated|0
1528738|NCT00289900|5011035|P2|Overall Study|Not treated|1
1528739|NCT00289900|5011036|P1|Overall Study|Not treated|0
1528740|NCT00289900|5011031|P6|Overall Study|site terminated|0
1528741|NCT00289900|5011032|P5|Overall Study|site terminated|0
1528742|NCT00289900|5011033|P4|Overall Study|site terminated|0
1528743|NCT00289900|5011034|P3|Overall Study|site terminated|1
1528744|NCT00289900|5011035|P2|Overall Study|site terminated|0
1528745|NCT00289900|5011036|P1|Overall Study|site terminated|1
1528746|NCT00289900|5011031|P6|Overall Study|Protocol Violation|4
1528747|NCT00289900|5011032|P5|Overall Study|Protocol Violation|7
1528748|NCT00289900|5011033|P4|Overall Study|Protocol Violation|6
1528749|NCT00289900|5011034|P3|Overall Study|Protocol Violation|2
1528750|NCT00289900|5011035|P2|Overall Study|Protocol Violation|9
1528751|NCT00289900|5011036|P1|Overall Study|Protocol Violation|3
1528752|NCT00289900|5011031|P6|Overall Study|Withdrawal by Subject|11
1528753|NCT00289900|5011032|P5|Overall Study|Withdrawal by Subject|12
1528754|NCT00289900|5011033|P4|Overall Study|Withdrawal by Subject|18
1528755|NCT00289900|5011034|P3|Overall Study|Withdrawal by Subject|8
1528756|NCT00289900|5011035|P2|Overall Study|Withdrawal by Subject|21
1528757|NCT00289900|5011036|P1|Overall Study|Withdrawal by Subject|10
1528758|NCT00289900|5011031|P6|Overall Study|Participant moved|1
1528759|NCT00289900|5011032|P5|Overall Study|Participant moved|1
1528760|NCT00289900|5011033|P4|Overall Study|Participant moved|1
1528761|NCT00289900|5011034|P3|Overall Study|Participant moved|0
1528762|NCT00289900|5011035|P2|Overall Study|Participant moved|0
1528763|NCT00289900|5011036|P1|Overall Study|Participant moved|1
1528764|NCT00289900|5011031|P6|Overall Study|Other|0
1528765|NCT00289900|5011032|P5|Overall Study|Other|1
1528766|NCT00289900|5011033|P4|Overall Study|Other|5
1528767|NCT00289900|5011034|P3|Overall Study|Other|0
1528768|NCT00289900|5011035|P2|Overall Study|Other|0
1528769|NCT00289900|5011036|P1|Overall Study|Other|0
1528770|NCT00289900|5011031|P6|Overall Study|Participant had flushing|4
1528771|NCT00289900|5011032|P5|Overall Study|Participant had flushing|0
1528772|NCT00289900|5011033|P4|Overall Study|Participant had flushing|2
1528773|NCT00289900|5011034|P3|Overall Study|Participant had flushing|1
1528774|NCT00289900|5011035|P2|Overall Study|Participant had flushing|42
1528775|NCT00289900|5011036|P1|Overall Study|Participant had flushing|18
1528776|NCT00289900|5011031|P6|Overall Study|Lost to Follow-up|8
1528777|NCT00289900|5011032|P5|Overall Study|Lost to Follow-up|4
1528778|NCT00289900|5011033|P4|Overall Study|Lost to Follow-up|8
1528779|NCT00289900|5011034|P3|Overall Study|Lost to Follow-up|8
1528780|NCT00289900|5011035|P2|Overall Study|Lost to Follow-up|7
1528781|NCT00289900|5011036|P1|Overall Study|Lost to Follow-up|7
1528782|NCT00289900|5011031|P6|Overall Study|Adverse Event|33
1528783|NCT00289900|5011032|P5|Overall Study|Adverse Event|20
1528784|NCT00289900|5011033|P4|Overall Study|Adverse Event|19
1528785|NCT00289900|5011034|P3|Overall Study|Adverse Event|13
1528786|NCT00289900|5011035|P2|Overall Study|Adverse Event|40
1528787|NCT00289900|5011036|P1|Overall Study|Adverse Event|28
1528788|NCT00289887|5011140|P2|Overall Study|Other|3
1528789|NCT00289887|5011141|P1|Overall Study|Other|7
1528790|NCT00289887|5011140|P2|Overall Study|Withdrawal by Subject|8
1528791|NCT00289887|5011141|P1|Overall Study|Withdrawal by Subject|3
1528792|NCT00289887|5011140|P2|Overall Study|Protocol Violation|1
1528793|NCT00289887|5011141|P1|Overall Study|Protocol Violation|3
1528794|NCT00289887|5011140|P2|Overall Study|Lost to Follow-up|3
1528795|NCT00289887|5011141|P1|Overall Study|Lost to Follow-up|3
1528796|NCT00289887|5011140|P2|Overall Study|Lack of Efficacy|11
1528797|NCT00289887|5011141|P1|Overall Study|Lack of Efficacy|3
1528798|NCT00289887|5011140|P2|Overall Study|Adverse Event|3
1528799|NCT00289887|5011141|P1|Overall Study|Adverse Event|3
1528800|NCT00289874|5011159|P2|Overall Study|Did not meet eligibility|0
1528801|NCT00289874|5011160|P1|Overall Study|Did not meet eligibility|1
1528802|NCT00289874|5011159|P2|Overall Study|Protocol Violation|2
1528803|NCT00289874|5011160|P1|Overall Study|Protocol Violation|3
1528804|NCT00289874|5011159|P2|Overall Study|Lost to Follow-up|1
1528805|NCT00289874|5011160|P1|Overall Study|Lost to Follow-up|1
1528806|NCT00289874|5011159|P2|Overall Study|Adverse Event|5
1528807|NCT00289874|5011160|P1|Overall Study|Adverse Event|1
1528808|NCT00289848|5011170|P2|Overall Study|Open-Label AHA Treatment Requested|1
1528809|NCT00289848|5011171|P1|Overall Study|Open-Label AHA Treatment Requested|0
1528810|NCT00289848|5011170|P2|Overall Study|Patient Moved|2
1528811|NCT00289848|5011171|P1|Overall Study|Patient Moved|6
1528812|NCT00289848|5011170|P2|Overall Study|Withdrawal by Subject|11
1528813|NCT00289848|5011171|P1|Overall Study|Withdrawal by Subject|5
1528814|NCT00289848|5011170|P2|Overall Study|Protocol Violation|2
1528815|NCT00289848|5011171|P1|Overall Study|Protocol Violation|5
1528816|NCT00289848|5011170|P2|Overall Study|Lost to Follow-up|1
1528817|NCT00289848|5011171|P1|Overall Study|Lost to Follow-up|3
1528818|NCT00289848|5011170|P2|Overall Study|Lack of Efficacy|24
1528819|NCT00289848|5011171|P1|Overall Study|Lack of Efficacy|20
1528820|NCT00289848|5011170|P2|Overall Study|Death|0
1528821|NCT00289848|5011171|P1|Overall Study|Death|1
1528822|NCT00289848|5011170|P2|Overall Study|Adverse Event|4
1528823|NCT00289848|5011171|P1|Overall Study|Adverse Event|6
1528824|NCT00289783|5011183|P2|Fourth Dose Phase|Other|10
1528825|NCT00289783|5011184|P1|Fourth Dose Phase|Other|22
1528826|NCT00289783|5011183|P2|Fourth Dose Phase|Migration from the study area|1
1528827|NCT00289783|5011184|P1|Fourth Dose Phase|Migration from the study area|1
1528828|NCT00289783|5011183|P2|Fourth Dose Phase|Lost to Follow-up|12
1528829|NCT00289783|5011184|P1|Fourth Dose Phase|Lost to Follow-up|53
1528830|NCT00289783|5011183|P2|Fourth Dose Phase|Withdrawal by Subject|1
1528831|NCT00289783|5011184|P1|Fourth Dose Phase|Withdrawal by Subject|10
1528832|NCT00289783|5011183|P2|Fourth Dose Phase|Adverse Event|0
1528833|NCT00289783|5011184|P1|Fourth Dose Phase|Adverse Event|1
1528834|NCT00289783|5011183|P2|Primary Phase|Other|12
1528835|NCT00289783|5011184|P1|Primary Phase|Other|32
1528836|NCT00289783|5011183|P2|Primary Phase|Migration from the study area|10
1528837|NCT00289783|5011184|P1|Primary Phase|Migration from the study area|26
1528838|NCT00289783|5011183|P2|Primary Phase|Lost to Follow-up|14
1528839|NCT00289783|5011184|P1|Primary Phase|Lost to Follow-up|60
1528840|NCT00289783|5011183|P2|Primary Phase|Withdrawal by Subject|40
1528841|NCT00289783|5011184|P1|Primary Phase|Withdrawal by Subject|93
1528842|NCT00289783|5011183|P2|Primary Phase|Protocol Violation|6
1528843|NCT00289783|5011184|P1|Primary Phase|Protocol Violation|27
1528844|NCT00289783|5011183|P2|Primary Phase|Adverse Event|1
1528845|NCT00289783|5011184|P1|Primary Phase|Adverse Event|10
1528846|NCT00289770|5011362|P1|Year 15|Withdrawal by Subject|1
1528847|NCT00289536|5011420|P3|Period 3|Lost to Follow-up|1
1528848|NCT00289536|5011421|P2|Period 3|Lost to Follow-up|0
1528849|NCT00289536|5011422|P1|Period 3|Lost to Follow-up|0
1528850|NCT00289458|5011468|P3|Overall Study|Withdrawal by Subject|4
1528851|NCT00289458|5011469|P2|Overall Study|Withdrawal by Subject|2
1528852|NCT00289458|5011470|P1|Overall Study|Withdrawal by Subject|2
1528853|NCT00289458|5011468|P3|Overall Study|Physician Decision|2
1528854|NCT00289458|5011469|P2|Overall Study|Physician Decision|4
1528855|NCT00289458|5011470|P1|Overall Study|Physician Decision|3
1528856|NCT00289458|5011468|P3|Overall Study|Death|0
1528857|NCT00289458|5011469|P2|Overall Study|Death|0
1528858|NCT00289458|5011470|P1|Overall Study|Death|1
1528859|NCT00289289|5011531|P3|Overall Study|Other Exit Reason|12
1528860|NCT00289289|5011532|P2|Overall Study|Other Exit Reason|4
1528861|NCT00289289|5011533|P1|Overall Study|Other Exit Reason|6
1528862|NCT00289289|5011531|P3|Overall Study|Did not meet inclusion/exclusion|6
1528863|NCT00289289|5011532|P2|Overall Study|Did not meet inclusion/exclusion|0
1528864|NCT00289289|5011533|P1|Overall Study|Did not meet inclusion/exclusion|0
1528865|NCT00289289|5011531|P3|Overall Study|Non-study device implanted|3
1528866|NCT00289289|5011532|P2|Overall Study|Non-study device implanted|1
1528867|NCT00289289|5011533|P1|Overall Study|Non-study device implanted|2
1528868|NCT00289289|5011531|P3|Overall Study|Physician Decision|6
1528869|NCT00289289|5011532|P2|Overall Study|Physician Decision|0
1528870|NCT00289289|5011533|P1|Overall Study|Physician Decision|1
1528871|NCT00289289|5011531|P3|Overall Study|No implant attempted|1
1528872|NCT00289289|5011532|P2|Overall Study|No implant attempted|0
1528873|NCT00289289|5011533|P1|Overall Study|No implant attempted|0
1528874|NCT00289289|5011531|P3|Overall Study|Death|5
1528875|NCT00289289|5011532|P2|Overall Study|Death|2
1528876|NCT00289289|5011533|P1|Overall Study|Death|4
1528877|NCT00289289|5011531|P3|Overall Study|Lost to Follow-up|1
1528878|NCT00289289|5011532|P2|Overall Study|Lost to Follow-up|0
1528879|NCT00289289|5011533|P1|Overall Study|Lost to Follow-up|1
1528880|NCT00289289|5011531|P3|Overall Study|Withdrawal by Subject|15
1528881|NCT00289289|5011532|P2|Overall Study|Withdrawal by Subject|3
1528882|NCT00289289|5011533|P1|Overall Study|Withdrawal by Subject|5
1528883|NCT00289276|5011548|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
1528884|NCT00289276|5011549|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
1528885|NCT00289276|5011548|P2|Second Part of FAST Study (Expansion)|Death|2
1528886|NCT00289276|5011549|P1|Second Part of FAST Study (Expansion)|Death|0
1528887|NCT00289198|5011584|P2|Overall Study|Other: Impossible to come on visit|1
1528888|NCT00289198|5011585|P1|Overall Study|Other: Impossible to come on visit|0
1528889|NCT00289198|5011584|P2|Overall Study|Other: Miscalculation of the visit date|22
1528890|NCT00289198|5011585|P1|Overall Study|Other: Miscalculation of the visit date|21
1528891|NCT00289198|5011584|P2|Overall Study|Other: Unable to attend on schedule|1
1528892|NCT00289198|5011585|P1|Overall Study|Other: Unable to attend on schedule|2
1528893|NCT00289198|5011584|P2|Overall Study|Other: Physician's decision|1
1528894|NCT00289198|5011585|P1|Overall Study|Other: Physician's decision|0
1528895|NCT00289198|5011584|P2|Overall Study|Other: Low compliance|1
1528896|NCT00289198|5011585|P1|Overall Study|Other: Low compliance|0
1528897|NCT00289198|5011584|P2|Overall Study|Lack of Efficacy|0
1528898|NCT00289198|5011585|P1|Overall Study|Lack of Efficacy|2
1528899|NCT00289198|5011584|P2|Overall Study|Withdrawal by Subject|1
1528900|NCT00289198|5011585|P1|Overall Study|Withdrawal by Subject|4
1528901|NCT00289198|5011584|P2|Overall Study|Protocol Violation|1
1528902|NCT00289198|5011585|P1|Overall Study|Protocol Violation|2
1528903|NCT00289198|5011584|P2|Overall Study|Adverse Event|2
1528904|NCT00289198|5011585|P1|Overall Study|Adverse Event|0
1528905|NCT00289185|5011635|P2|Overall Study|Death|1
1528906|NCT00289185|5011636|P1|Overall Study|Death|1
1528907|NCT00289185|5011635|P2|Overall Study|Lost to Follow-up|17
1528908|NCT00289185|5011636|P1|Overall Study|Lost to Follow-up|23
1528909|NCT00289185|5011635|P2|Overall Study|Withdrawal by Subject|8
1528910|NCT00289185|5011636|P1|Overall Study|Withdrawal by Subject|4
1528911|NCT00289133|5011683|P2|Overall Study|Lost to Follow-up|115
1528912|NCT00289133|5011684|P1|Overall Study|Lost to Follow-up|92
1528913|NCT00289133|5011683|P2|Overall Study|Revision|6
1528914|NCT00289133|5011684|P1|Overall Study|Revision|8
1528915|NCT00289133|5011683|P2|Overall Study|Physician Decision|45
1528916|NCT00289133|5011684|P1|Overall Study|Physician Decision|41
1528917|NCT00289133|5011683|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
1528918|NCT00289133|5011684|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
1528919|NCT00289133|5011683|P2|Overall Study|Death|10
1528920|NCT00289133|5011684|P1|Overall Study|Death|5
1528921|NCT00289133|5011683|P2|Overall Study|Withdrawal by Subject|10
1528922|NCT00289133|5011684|P1|Overall Study|Withdrawal by Subject|9
1528923|NCT00289133|5011683|P2|Overall Study|Protocol Violation|38
1528924|NCT00289133|5011684|P1|Overall Study|Protocol Violation|32
1528925|NCT00289133|5011683|P2|Overall Study|Non-study device implanted|0
1528926|NCT00289133|5011684|P1|Overall Study|Non-study device implanted|12
1528927|NCT00289016|5011740|P1|Overall Study|Other|1
1528928|NCT00289016|5011740|P1|Overall Study|Adverse Event|1
1528929|NCT00289016|5011740|P1|Overall Study|Withdrawal by Subject|2
1528930|NCT00289016|5011740|P1|Overall Study|Unrelated Medical Condition or Accident|2
1528931|NCT00289016|5011740|P1|Overall Study|Death|2
1528932|NCT00289016|5011740|P1|Overall Study|Disease Progression|29
1528933|NCT00288912|5011752|P3|Overall Study|Withdrawal by Subject|12
1528934|NCT00288912|5011753|P2|Overall Study|Withdrawal by Subject|5
1528935|NCT00288912|5011754|P1|Overall Study|Withdrawal by Subject|4
1528936|NCT00288912|5011752|P3|Overall Study|Lost to Follow-up|9
1528937|NCT00288912|5011753|P2|Overall Study|Lost to Follow-up|6
1528938|NCT00288912|5011754|P1|Overall Study|Lost to Follow-up|9
1528939|NCT00288912|5011752|P3|Overall Study|Developed exclusion criterion|7
1528940|NCT00288912|5011753|P2|Overall Study|Developed exclusion criterion|6
1528941|NCT00288912|5011754|P1|Overall Study|Developed exclusion criterion|4
1528942|NCT00288860|5011794|P2|Overall Study|Lost to Follow-up|71
1528943|NCT00288860|5011795|P1|Overall Study|Lost to Follow-up|74
1528944|NCT00288860|5011794|P2|Overall Study|Withdrawal by Subject|15
1528945|NCT00288860|5011795|P1|Overall Study|Withdrawal by Subject|20
1528946|NCT00288860|5011794|P2|Overall Study|Death|3
1528947|NCT00288860|5011795|P1|Overall Study|Death|4
1528948|NCT00288860|5011794|P2|Overall Study|Did not complete intake|8
1528949|NCT00288860|5011795|P1|Overall Study|Did not complete intake|4
1528950|NCT00288704|5011808|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
1528951|NCT00288704|5011809|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
1528952|NCT00288704|5011810|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
1528953|NCT00288704|5011808|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
1528954|NCT00288704|5011809|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
1528955|NCT00288704|5011810|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
1528956|NCT00288704|5011808|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
1528957|NCT00288704|5011809|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
1528958|NCT00288704|5011810|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
1528959|NCT00288704|5011808|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
1528960|NCT00288704|5011809|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
1528961|NCT00288704|5011810|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
1528962|NCT00288704|5011808|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
1528963|NCT00288704|5011809|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
1528964|NCT00288704|5011810|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
1528965|NCT00288704|5011808|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
1528966|NCT00288704|5011809|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
1528967|NCT00288704|5011810|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
1528968|NCT00288704|5011808|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
1528969|NCT00288704|5011809|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
1528970|NCT00288704|5011810|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
1528971|NCT00288639|5011837|P1|Overall Study|Other|1
1528972|NCT00288639|5011837|P1|Overall Study|Withdrawal by Subject|2
1528973|NCT00288639|5011837|P1|Overall Study|Lack of Efficacy|4
1528974|NCT00288639|5011837|P1|Overall Study|Adverse Event|5
1528975|NCT00288626|5011854|P1|Overall Study|Withdrawal by Subject|4
1528976|NCT00288626|5011854|P1|Overall Study|Death|3
1528977|NCT00288587|5011888|P2|Overall Study|Severe Aortic Stenosis|0
1528978|NCT00288587|5011889|P1|Overall Study|Severe Aortic Stenosis|1
1528979|NCT00288587|5011888|P2|Overall Study|Physician Decision|2
1528980|NCT00288587|5011889|P1|Overall Study|Physician Decision|0
1528981|NCT00288587|5011888|P2|Overall Study|Adverse Event|1
1528982|NCT00288587|5011889|P1|Overall Study|Adverse Event|0
1528983|NCT00288587|5011888|P2|Overall Study|Transplant|3
1528984|NCT00288587|5011889|P1|Overall Study|Transplant|0
1528985|NCT00288587|5011888|P2|Overall Study|Death|4
1528986|NCT00288587|5011889|P1|Overall Study|Death|4
1528987|NCT00288509|5011932|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
1528988|NCT00288509|5011932|P1|Treatment Cycle 4|Physician Decision|4
1528989|NCT00288509|5011932|P1|Treatment Cycle 4|Withdrawal by Subject|3
1528990|NCT00288509|5011932|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
1528991|NCT00288509|5011932|P1|Treatment Cycle 3|Lost to Follow-up|2
1528992|NCT00288509|5011932|P1|Treatment Cycle 3|Withdrawal by Subject|1
1528993|NCT00288509|5011932|P1|Treatment Cycle 3|Lack of Efficacy|1
1528994|NCT00288509|5011932|P1|Treatment Cycle 2|Withdrawal by Subject|2
1528995|NCT00288509|5011932|P1|Treatment Cycle 2|Lack of Efficacy|1
1528996|NCT00288509|5011932|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
1528997|NCT00288509|5011932|P1|Treatment Cycle 1|Lost to Follow-up|2
1528998|NCT00288509|5011932|P1|Treatment Cycle 1|Withdrawal by Subject|1
1528999|NCT00288509|5011932|P1|Treatment Cycle 1|Lack of Efficacy|1
1529000|NCT00288509|5011932|P1|Treatment Cycle 1|Adverse Event|1
1529001|NCT00288080|5011941|P2|Overall Study|Protocol Violation|20
1529002|NCT00288080|5011942|P1|Overall Study|Protocol Violation|25
1529003|NCT00288080|5011941|P2|Overall Study|Withdrawal by Subject|3
1529004|NCT00288080|5011942|P1|Overall Study|Withdrawal by Subject|1
1529005|NCT00288054|5011964|P1|Overall Study|Not protocol specified|2
1529006|NCT00288054|5011964|P1|Overall Study|Withdrawal by Subject|1
1529007|NCT00288054|5011964|P1|Overall Study|Adverse Event|3
1529008|NCT00288054|5011964|P1|Overall Study|Lack of Efficacy|16
1529009|NCT00288054|5011964|P1|Overall Study|Protocol Violation|2
1529010|NCT00288015|5011972|P1|Follow up for Survival x 2 Years|Other|9
1529011|NCT00288015|5011972|P1|Follow up for Survival x 2 Years|Lost to Follow-up|4
1529012|NCT00288015|5011972|P1|Follow up for Survival x 2 Years|Death|13
1529013|NCT00288015|5011972|P1|Continued Bevacizumab Cycle 3+|Disease progressed|7
1529014|NCT00288015|5011972|P1|First Response Assessment|Physician Decision|2
1529015|NCT00288015|5011972|P1|First Response Assessment|Death|1
1529016|NCT00288015|5011972|P1|First Response Assessment|Withdrawal by Subject|1
1529017|NCT00288015|5011972|P1|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
1529018|NCT00288015|5011972|P1|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
1529019|NCT00287586|5012048|P2|Overall Study|Recurrent Melanoma|1
1529020|NCT00287586|5012049|P1|Overall Study|Recurrent Melanoma|0
1529021|NCT00287586|5012048|P2|Overall Study|Itchy Swollen Eyes|1
1529022|NCT00287586|5012049|P1|Overall Study|Itchy Swollen Eyes|0
1529023|NCT00287586|5012048|P2|Overall Study|Bradycardia|1
1529024|NCT00287586|5012049|P1|Overall Study|Bradycardia|0
1529025|NCT00287586|5012048|P2|Overall Study|Mood Swings and Irritability|1
1529026|NCT00287586|5012049|P1|Overall Study|Mood Swings and Irritability|0
1529027|NCT00287586|5012048|P2|Overall Study|Mastodynia and Gynecomastia|1
1529028|NCT00287586|5012049|P1|Overall Study|Mastodynia and Gynecomastia|0
1529029|NCT00287586|5012048|P2|Overall Study|Retroperitoneal Cancer|1
1529030|NCT00287586|5012049|P1|Overall Study|Retroperitoneal Cancer|0
1529031|NCT00287586|5012048|P2|Overall Study|Elevated IPSS Score|1
1529032|NCT00287586|5012049|P1|Overall Study|Elevated IPSS Score|0
1529033|NCT00287586|5012048|P2|Overall Study|Lung Cancer|2
1529034|NCT00287586|5012049|P1|Overall Study|Lung Cancer|0
1529035|NCT00287586|5012048|P2|Overall Study|Major Depression|2
1529036|NCT00287586|5012049|P1|Overall Study|Major Depression|0
1529037|NCT00287586|5012048|P2|Overall Study|Enrolled in Another Study|0
1529038|NCT00287586|5012049|P1|Overall Study|Enrolled in Another Study|1
1529039|NCT00287586|5012048|P2|Overall Study|Nonadherence|1
1529040|NCT00287586|5012049|P1|Overall Study|Nonadherence|1
1529041|NCT00287586|5012048|P2|Overall Study|Inappropriate Behaviour with Staff|0
1529042|NCT00287586|5012049|P1|Overall Study|Inappropriate Behaviour with Staff|1
1529043|NCT00287586|5012048|P2|Overall Study|Shoulder Pain|0
1529044|NCT00287586|5012049|P1|Overall Study|Shoulder Pain|1
1529045|NCT00287586|5012048|P2|Overall Study|Sleep Apnea|0
1529046|NCT00287586|5012049|P1|Overall Study|Sleep Apnea|1
1529047|NCT00287586|5012048|P2|Overall Study|Pancreatic Cancer|3
1529048|NCT00287586|5012049|P1|Overall Study|Pancreatic Cancer|1
1529049|NCT00287586|5012048|P2|Overall Study|Cognitive Impairment|0
1529050|NCT00287586|5012049|P1|Overall Study|Cognitive Impairment|1
1529051|NCT00287586|5012048|P2|Overall Study|Lower Urinary Tract Symptoms|0
1529052|NCT00287586|5012049|P1|Overall Study|Lower Urinary Tract Symptoms|1
1529053|NCT00287586|5012048|P2|Overall Study|Myocardial Infarction|0
1529054|NCT00287586|5012049|P1|Overall Study|Myocardial Infarction|1
1529055|NCT00287586|5012048|P2|Overall Study|Stroke|0
1529056|NCT00287586|5012049|P1|Overall Study|Stroke|2
1529057|NCT00287586|5012048|P2|Overall Study|Elevated Prostate Specific Antigen|0
1529058|NCT00287586|5012049|P1|Overall Study|Elevated Prostate Specific Antigen|2
1529059|NCT00287586|5012048|P2|Overall Study|Rash|0
1529060|NCT00287586|5012049|P1|Overall Study|Rash|3
1529061|NCT00287586|5012048|P2|Overall Study|Elevated Hematocrit|0
1529062|NCT00287586|5012049|P1|Overall Study|Elevated Hematocrit|3
1529063|NCT00287586|5012048|P2|Overall Study|Death|3
1529064|NCT00287586|5012049|P1|Overall Study|Death|2
1529065|NCT00287586|5012048|P2|Overall Study|Lost to Follow-up|4
1529066|NCT00287586|5012049|P1|Overall Study|Lost to Follow-up|5
1529067|NCT00287586|5012048|P2|Overall Study|Withdrew Consent|30
1529068|NCT00287586|5012049|P1|Overall Study|Withdrew Consent|19
1529069|NCT00287365|5012085|P1|Overall Study|sample not acquired|13
1529070|NCT00287118|5012107|P1|Overall Study|Not specified|7
1529071|NCT00287118|5012107|P1|Overall Study|Protocol Violation|2
1529072|NCT00287118|5012107|P1|Overall Study|Lost to Follow-up|1
1529073|NCT00287118|5012107|P1|Overall Study|Lack of Efficacy|11
1529074|NCT00287118|5012107|P1|Overall Study|Death|1
1529075|NCT00287118|5012107|P1|Overall Study|Adverse Event|30
1529076|NCT00287079|5012113|P2|Overall Study|Other|0
1529077|NCT00287079|5012114|P1|Overall Study|Other|3
1529078|NCT00287079|5012113|P2|Overall Study|Protocol Violation|0
1529079|NCT00287079|5012114|P1|Overall Study|Protocol Violation|1
1529080|NCT00287079|5012113|P2|Overall Study|Adverse Event|0
1529081|NCT00287079|5012114|P1|Overall Study|Adverse Event|5
1529082|NCT00287079|5012113|P2|Overall Study|Non-qualifying relapse|0
1529083|NCT00287079|5012114|P1|Overall Study|Non-qualifying relapse|1
1529084|NCT00287079|5012113|P2|Overall Study|Qualifying relapse|1
1529085|NCT00287079|5012114|P1|Overall Study|Qualifying relapse|12
1529086|NCT00286754|5012142|P3|Overall Study|Moved out of state|1
1529087|NCT00286754|5012143|P2|Overall Study|Moved out of state|0
1529088|NCT00286754|5012144|P1|Overall Study|Moved out of state|0
1529089|NCT00286754|5012142|P3|Overall Study|Lost to Follow-up|6
1529090|NCT00286754|5012143|P2|Overall Study|Lost to Follow-up|14
1529091|NCT00286754|5012144|P1|Overall Study|Lost to Follow-up|12
1529092|NCT00286754|5012142|P3|Overall Study|Withdrawal by Subject|0
1529093|NCT00286754|5012143|P2|Overall Study|Withdrawal by Subject|2
1529094|NCT00286754|5012144|P1|Overall Study|Withdrawal by Subject|6
1529095|NCT00286754|5012142|P3|Overall Study|Adverse Event|3
1529096|NCT00286754|5012143|P2|Overall Study|Adverse Event|2
1529097|NCT00286754|5012144|P1|Overall Study|Adverse Event|2
1529098|NCT00286494|5012199|P3|Overall Study|Protocol Violation|2
1529099|NCT00286494|5012200|P2|Overall Study|Protocol Violation|1
1529100|NCT00286494|5012201|P1|Overall Study|Protocol Violation|1
1529101|NCT00286494|5012199|P3|Overall Study|Lost to Follow-up|3
1529102|NCT00286494|5012200|P2|Overall Study|Lost to Follow-up|1
1529103|NCT00286494|5012201|P1|Overall Study|Lost to Follow-up|3
1529104|NCT00286494|5012199|P3|Overall Study|Physician Decision|1
1529105|NCT00286494|5012200|P2|Overall Study|Physician Decision|5
1529106|NCT00286494|5012201|P1|Overall Study|Physician Decision|5
1529107|NCT00286494|5012199|P3|Overall Study|Adverse Event|6
1529108|NCT00286494|5012200|P2|Overall Study|Adverse Event|8
1529109|NCT00286494|5012201|P1|Overall Study|Adverse Event|3
1529110|NCT00286494|5012199|P3|Overall Study|Withdrawal by Subject|9
1529111|NCT00286494|5012200|P2|Overall Study|Withdrawal by Subject|10
1529112|NCT00286494|5012201|P1|Overall Study|Withdrawal by Subject|2
1529113|NCT00286494|5012199|P3|Overall Study|Hyperglycemic rescue|18
1529114|NCT00286494|5012200|P2|Overall Study|Hyperglycemic rescue|19
1529115|NCT00286494|5012201|P1|Overall Study|Hyperglycemic rescue|12
1529116|NCT00286468|5012362|P3|Overall Study|Physician Decision|1
1529117|NCT00286468|5012363|P2|Overall Study|Physician Decision|2
1529118|NCT00286468|5012364|P1|Overall Study|Physician Decision|3
1529119|NCT00286468|5012362|P3|Overall Study|Withdrawal by Subject|11
1529120|NCT00286468|5012363|P2|Overall Study|Withdrawal by Subject|8
1529121|NCT00286468|5012364|P1|Overall Study|Withdrawal by Subject|3
1529122|NCT00286468|5012362|P3|Overall Study|Lost to Follow-up|2
1529123|NCT00286468|5012363|P2|Overall Study|Lost to Follow-up|1
1529124|NCT00286468|5012364|P1|Overall Study|Lost to Follow-up|1
1529125|NCT00286468|5012362|P3|Overall Study|Protocol Violation|1
1529126|NCT00286468|5012363|P2|Overall Study|Protocol Violation|3
1529127|NCT00286468|5012364|P1|Overall Study|Protocol Violation|0
1529128|NCT00286468|5012362|P3|Overall Study|Adverse Event|4
1529129|NCT00286468|5012363|P2|Overall Study|Adverse Event|6
1529130|NCT00286468|5012364|P1|Overall Study|Adverse Event|2
1529131|NCT00286468|5012362|P3|Overall Study|Hyperglycemic Rescue|31
1529132|NCT00286468|5012363|P2|Overall Study|Hyperglycemic Rescue|30
1529133|NCT00286468|5012364|P1|Overall Study|Hyperglycemic Rescue|28
1529134|NCT00286455|5012525|P3|Overall Study|Withdrawal by Subject|7
1529135|NCT00286455|5012526|P2|Overall Study|Withdrawal by Subject|8
1529136|NCT00286455|5012527|P1|Overall Study|Withdrawal by Subject|0
1529137|NCT00286455|5012525|P3|Overall Study|Participant Non-compliance|0
1529138|NCT00286455|5012526|P2|Overall Study|Participant Non-compliance|0
1529139|NCT00286455|5012527|P1|Overall Study|Participant Non-compliance|1
1529140|NCT00286455|5012525|P3|Overall Study|Protocol Violation|0
1529141|NCT00286455|5012526|P2|Overall Study|Protocol Violation|1
1529142|NCT00286455|5012527|P1|Overall Study|Protocol Violation|1
1529143|NCT00286455|5012525|P3|Overall Study|Physician Decision|2
1529144|NCT00286455|5012526|P2|Overall Study|Physician Decision|0
1529145|NCT00286455|5012527|P1|Overall Study|Physician Decision|3
1529146|NCT00286455|5012525|P3|Overall Study|Lost to Follow-up|3
1529147|NCT00286455|5012526|P2|Overall Study|Lost to Follow-up|3
1529148|NCT00286455|5012527|P1|Overall Study|Lost to Follow-up|0
1529149|NCT00286455|5012525|P3|Overall Study|Adverse Event|2
1529150|NCT00286455|5012526|P2|Overall Study|Adverse Event|3
1529151|NCT00286455|5012527|P1|Overall Study|Adverse Event|1
1529152|NCT00286455|5012525|P3|Overall Study|Hyperglycemia rescue|10
1529153|NCT00286455|5012526|P2|Overall Study|Hyperglycemia rescue|13
1529154|NCT00286455|5012527|P1|Overall Study|Hyperglycemia rescue|19
1529155|NCT00286442|5012706|P3|Overall Study|Withdrawal by Subject|2
1529156|NCT00286442|5012707|P2|Overall Study|Withdrawal by Subject|14
1529157|NCT00286442|5012708|P1|Overall Study|Withdrawal by Subject|2
1529158|NCT00286442|5012706|P3|Overall Study|Administrative Error|0
1529159|NCT00286442|5012707|P2|Overall Study|Administrative Error|1
1529160|NCT00286442|5012708|P1|Overall Study|Administrative Error|1
1529161|NCT00286442|5012706|P3|Overall Study|Physician Decision|1
1529162|NCT00286442|5012707|P2|Overall Study|Physician Decision|1
1529163|NCT00286442|5012708|P1|Overall Study|Physician Decision|1
1529164|NCT00286442|5012706|P3|Overall Study|Lost to Follow-up|1
1529165|NCT00286442|5012707|P2|Overall Study|Lost to Follow-up|2
1529166|NCT00286442|5012708|P1|Overall Study|Lost to Follow-up|5
1529167|NCT00286442|5012706|P3|Overall Study|Protocol Violation|2
1529168|NCT00286442|5012707|P2|Overall Study|Protocol Violation|4
1529169|NCT00286442|5012708|P1|Overall Study|Protocol Violation|2
1529170|NCT00286442|5012706|P3|Overall Study|Adverse Event|1
1529171|NCT00286442|5012707|P2|Overall Study|Adverse Event|6
1529172|NCT00286442|5012708|P1|Overall Study|Adverse Event|7
1529173|NCT00286442|5012706|P3|Overall Study|Hyperglycemic Rescue|25
1529174|NCT00286442|5012707|P2|Overall Study|Hyperglycemic Rescue|17
1529175|NCT00286442|5012708|P1|Overall Study|Hyperglycemic Rescue|19
1529176|NCT00286429|5012869|P3|Overall Study|Administrative Decision|0
1529177|NCT00286429|5012870|P2|Overall Study|Administrative Decision|1
1529178|NCT00286429|5012871|P1|Overall Study|Administrative Decision|0
1529179|NCT00286429|5012869|P3|Overall Study|Administrative Error|1
1529180|NCT00286429|5012870|P2|Overall Study|Administrative Error|1
1529181|NCT00286429|5012871|P1|Overall Study|Administrative Error|1
1529182|NCT00286429|5012869|P3|Overall Study|Withdrawal by Subject|6
1529183|NCT00286429|5012870|P2|Overall Study|Withdrawal by Subject|2
1529184|NCT00286429|5012871|P1|Overall Study|Withdrawal by Subject|3
1529185|NCT00286429|5012869|P3|Overall Study|Protocol Violation|4
1529186|NCT00286429|5012870|P2|Overall Study|Protocol Violation|5
1529187|NCT00286429|5012871|P1|Overall Study|Protocol Violation|3
1529188|NCT00286429|5012869|P3|Overall Study|Physician Decision|7
1529189|NCT00286429|5012870|P2|Overall Study|Physician Decision|7
1529190|NCT00286429|5012871|P1|Overall Study|Physician Decision|10
1529191|NCT00286429|5012869|P3|Overall Study|Lost to Follow-up|3
1529192|NCT00286429|5012870|P2|Overall Study|Lost to Follow-up|4
1529193|NCT00286429|5012871|P1|Overall Study|Lost to Follow-up|2
1529194|NCT00286429|5012869|P3|Overall Study|Lack of Efficacy|25
1529195|NCT00286429|5012870|P2|Overall Study|Lack of Efficacy|27
1529196|NCT00286429|5012871|P1|Overall Study|Lack of Efficacy|52
1529197|NCT00286429|5012869|P3|Overall Study|Adverse Event|6
1529198|NCT00286429|5012870|P2|Overall Study|Adverse Event|1
1529199|NCT00286429|5012871|P1|Overall Study|Adverse Event|4
1529200|NCT00286221|5012987|P4|Overall Study|Unrecognized exclusion criteria met|0
1529201|NCT00286221|5012988|P3|Overall Study|Unrecognized exclusion criteria met|0
1529202|NCT00286221|5012989|P2|Overall Study|Unrecognized exclusion criteria met|1
1529203|NCT00286221|5012990|P1|Overall Study|Unrecognized exclusion criteria met|0
1529204|NCT00286221|5012987|P4|Overall Study|Inability to trigger PCA|0
1529205|NCT00286221|5012988|P3|Overall Study|Inability to trigger PCA|0
1529206|NCT00286221|5012989|P2|Overall Study|Inability to trigger PCA|0
1529207|NCT00286221|5012990|P1|Overall Study|Inability to trigger PCA|2
1529208|NCT00286221|5012987|P4|Overall Study|Unanticipated Neurosurgical Complication|2
1529209|NCT00286221|5012988|P3|Overall Study|Unanticipated Neurosurgical Complication|3
1529210|NCT00286221|5012989|P2|Overall Study|Unanticipated Neurosurgical Complication|3
1529211|NCT00286221|5012990|P1|Overall Study|Unanticipated Neurosurgical Complication|6
1529212|NCT00286221|5012987|P4|Overall Study|Protocol Violation|4
1529213|NCT00286221|5012988|P3|Overall Study|Protocol Violation|6
1529214|NCT00286221|5012989|P2|Overall Study|Protocol Violation|1
1529215|NCT00286221|5012990|P1|Overall Study|Protocol Violation|2
1529216|NCT00286156|5013016|P3|Overall Study|AE: pneumonia|0
1529217|NCT00286156|5013017|P2|Overall Study|AE: pneumonia|0
1529218|NCT00286156|5013018|P1|Overall Study|AE: pneumonia|1
1529219|NCT00286156|5013016|P3|Overall Study|AE: nephrotic-range proteinuruia|0
1529220|NCT00286156|5013017|P2|Overall Study|AE: nephrotic-range proteinuruia|0
1529221|NCT00286156|5013018|P1|Overall Study|AE: nephrotic-range proteinuruia|1
1529222|NCT00286156|5013016|P3|Overall Study|AE: pulmonary embolus|0
1529223|NCT00286156|5013017|P2|Overall Study|AE: pulmonary embolus|1
1529224|NCT00286156|5013018|P1|Overall Study|AE: pulmonary embolus|0
1529225|NCT00286156|5013016|P3|Overall Study|Missed 12 month visit|1
1529226|NCT00286156|5013017|P2|Overall Study|Missed 12 month visit|0
1529227|NCT00286156|5013018|P1|Overall Study|Missed 12 month visit|0
1529228|NCT00286091|5013031|P2|Open-label Treatment Phase|Missing End of Study Information|1
1529229|NCT00286091|5013032|P1|Open-label Treatment Phase|Missing End of Study Information|0
1529230|NCT00286091|5013031|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
1529231|NCT00286091|5013032|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
1529232|NCT00286091|5013031|P2|Open-label Treatment Phase|Lost to Follow-up|1
1529233|NCT00286091|5013032|P1|Open-label Treatment Phase|Lost to Follow-up|0
1529234|NCT00286091|5013031|P2|Open-label Treatment Phase|Noncompliance|1
1529235|NCT00286091|5013032|P1|Open-label Treatment Phase|Noncompliance|3
1529236|NCT00286091|5013031|P2|Open-label Treatment Phase|Disease Progression|3
1529237|NCT00286091|5013032|P1|Open-label Treatment Phase|Disease Progression|9
1529238|NCT00286091|5013031|P2|Open-label Treatment Phase|Death|7
1529239|NCT00286091|5013032|P1|Open-label Treatment Phase|Death|10
1529240|NCT00286091|5013031|P2|Open-label Treatment Phase|Withdrawal by Subject|10
1529241|NCT00286091|5013032|P1|Open-label Treatment Phase|Withdrawal by Subject|14
1529242|NCT00286091|5013031|P2|Open-label Treatment Phase|Other|11
1529243|NCT00286091|5013032|P1|Open-label Treatment Phase|Other|11
1529244|NCT00286091|5013031|P2|Open-label Treatment Phase|Adverse Event|16
1529245|NCT00286091|5013032|P1|Open-label Treatment Phase|Adverse Event|5
1529246|NCT00286091|5013031|P2|Open-label Treatment Phase|Physician Decision|21
1529247|NCT00286091|5013032|P1|Open-label Treatment Phase|Physician Decision|24
1529248|NCT00286091|5013031|P2|Double-blind Treatment Phase|Ineligibility Determined|2
1529249|NCT00286091|5013032|P1|Double-blind Treatment Phase|Ineligibility Determined|1
1529250|NCT00286091|5013031|P2|Double-blind Treatment Phase|Protocol Deviation|3
1529251|NCT00286091|5013032|P1|Double-blind Treatment Phase|Protocol Deviation|1
1529252|NCT00286091|5013031|P2|Double-blind Treatment Phase|Lost to Follow-up|4
1529253|NCT00286091|5013032|P1|Double-blind Treatment Phase|Lost to Follow-up|11
1529254|NCT00286091|5013031|P2|Double-blind Treatment Phase|Noncompliance|8
1529255|NCT00286091|5013032|P1|Double-blind Treatment Phase|Noncompliance|8
1529256|NCT00286091|5013031|P2|Double-blind Treatment Phase|Administrative Decision|21
1529257|NCT00286091|5013032|P1|Double-blind Treatment Phase|Administrative Decision|20
1529258|NCT00286091|5013031|P2|Double-blind Treatment Phase|Other|33
1529259|NCT00286091|5013032|P1|Double-blind Treatment Phase|Other|25
1529260|NCT00286091|5013031|P2|Double-blind Treatment Phase|Disease Progression|35
1529261|NCT00286091|5013032|P1|Double-blind Treatment Phase|Disease Progression|22
1529262|NCT00286091|5013031|P2|Double-blind Treatment Phase|Adverse Event|40
1529263|NCT00286091|5013032|P1|Double-blind Treatment Phase|Adverse Event|28
1529264|NCT00286091|5013031|P2|Double-blind Treatment Phase|Death|65
1529265|NCT00286091|5013032|P1|Double-blind Treatment Phase|Death|58
1529266|NCT00286091|5013031|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
1529267|NCT00286091|5013032|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
1529268|NCT00286091|5013031|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
1529269|NCT00286091|5013032|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
1529270|NCT00285857|5013055|P1|Overall Study|Adverse Event|1
1529271|NCT00285857|5013055|P1|Overall Study|Inadequate initial breast cytology|1
1529272|NCT00285857|5013055|P1|Overall Study|Withdrawal by Subject|2
1529273|NCT00285818|5013068|P2|Overall Study|Lost to Follow-up|0
1529274|NCT00285818|5013069|P1|Overall Study|Lost to Follow-up|1
1529275|NCT00285818|5013068|P2|Overall Study|Withdrawal by Subject|2
1529276|NCT00285818|5013069|P1|Overall Study|Withdrawal by Subject|3
1529277|NCT00285649|5013114|P3|Overall Study|Withdrawal by Subject|2
1529278|NCT00285649|5013115|P2|Overall Study|Withdrawal by Subject|2
1529279|NCT00285649|5013116|P1|Overall Study|Withdrawal by Subject|3
1529280|NCT00285649|5013114|P3|Overall Study|Lost to Follow-up|4
1529281|NCT00285649|5013115|P2|Overall Study|Lost to Follow-up|4
1529282|NCT00285649|5013116|P1|Overall Study|Lost to Follow-up|6
1529283|NCT00285584|5013126|P2|Month 6|Lost to Follow-up|1
1529284|NCT00285584|5013127|P1|Month 6|Lost to Follow-up|0
1529285|NCT00285584|5013126|P2|Month 3|Withdrawal by Subject|0
1529286|NCT00285584|5013127|P1|Month 3|Withdrawal by Subject|1
1529287|NCT00285584|5013126|P2|Month 3|Lost to Follow-up|3
1529288|NCT00285584|5013127|P1|Month 3|Lost to Follow-up|3
1529289|NCT00285207|5013159|P2|Overall Study|non-compliance|1
1529290|NCT00285207|5013160|P1|Overall Study|non-compliance|0
1529291|NCT00285207|5013159|P2|Overall Study|Pregnancy|1
1529292|NCT00285207|5013160|P1|Overall Study|Pregnancy|1
1529293|NCT00285207|5013159|P2|Overall Study|Withdrawal by Subject|2
1529294|NCT00285207|5013160|P1|Overall Study|Withdrawal by Subject|5
1529295|NCT00285207|5013159|P2|Overall Study|Lost to Follow-up|2
1529296|NCT00285207|5013160|P1|Overall Study|Lost to Follow-up|3
1529297|NCT00285012|5013168|P2|Received Study Tx|Other|5
1529298|NCT00285012|5013169|P1|Received Study Tx|Other|5
1529299|NCT00285012|5013168|P2|Received Study Tx|Withdrawal by Subject|43
1529300|NCT00285012|5013169|P1|Received Study Tx|Withdrawal by Subject|31
1529301|NCT00285012|5013168|P2|Received Study Tx|Lost to Follow-up|31
1529302|NCT00285012|5013169|P1|Received Study Tx|Lost to Follow-up|29
1529303|NCT00285012|5013168|P2|Received Study Tx|Lack of Efficacy|3
1529304|NCT00285012|5013169|P1|Received Study Tx|Lack of Efficacy|0
1529305|NCT00285012|5013168|P2|Received Study Tx|Adverse Event|11
1529306|NCT00285012|5013169|P1|Received Study Tx|Adverse Event|5
1529307|NCT00285012|5013168|P2|Received Study Tx|Death|1
1529308|NCT00285012|5013169|P1|Received Study Tx|Death|2
1529309|NCT00285012|5013168|P2|Assigned to Study Treatment (Tx)|Other|3
1529310|NCT00285012|5013169|P1|Assigned to Study Treatment (Tx)|Other|2
1529311|NCT00284934|5013195|P2|Overall Study|Other reasons|1
1529312|NCT00284934|5013196|P1|Overall Study|Other reasons|3
1529313|NCT00284934|5013195|P2|Overall Study|Adverse Event|2
1529314|NCT00284934|5013196|P1|Overall Study|Adverse Event|1
1529315|NCT00284856|5013211|P3|Overall Study|Other|4
1529316|NCT00284856|5013212|P2|Overall Study|Other|5
1529317|NCT00284856|5013213|P1|Overall Study|Other|4
1529318|NCT00284856|5013211|P3|Overall Study|Withdrawal by Subject|18
1529319|NCT00284856|5013212|P2|Overall Study|Withdrawal by Subject|16
1529320|NCT00284856|5013213|P1|Overall Study|Withdrawal by Subject|12
1529321|NCT00284856|5013211|P3|Overall Study|Protocol Violation|5
1529322|NCT00284856|5013212|P2|Overall Study|Protocol Violation|4
1529323|NCT00284856|5013213|P1|Overall Study|Protocol Violation|5
1529324|NCT00284856|5013211|P3|Overall Study|Lost to Follow-up|22
1529325|NCT00284856|5013212|P2|Overall Study|Lost to Follow-up|21
1529326|NCT00284856|5013213|P1|Overall Study|Lost to Follow-up|25
1529327|NCT00284856|5013211|P3|Overall Study|Lack of Efficacy|8
1529328|NCT00284856|5013212|P2|Overall Study|Lack of Efficacy|1
1529329|NCT00284856|5013213|P1|Overall Study|Lack of Efficacy|2
1529330|NCT00284856|5013211|P3|Overall Study|Adverse Event|3
1529331|NCT00284856|5013212|P2|Overall Study|Adverse Event|3
1529332|NCT00284856|5013213|P1|Overall Study|Adverse Event|3
1529333|NCT00284141|5013312|P1|Overall Study|Ongoing treatment|2
1529334|NCT00284141|5013312|P1|Overall Study|Did not take study medication|2
1529335|NCT00284141|5013312|P1|Overall Study|Pneumonia|1
1529336|NCT00284141|5013312|P1|Overall Study|General decline|1
1529337|NCT00284141|5013312|P1|Overall Study|Clinical deterioration / death|2
1529338|NCT00284141|5013312|P1|Overall Study|Symptomatic / Clinical Progression|11
1529339|NCT00284141|5013312|P1|Overall Study|Participant's request|9
1529340|NCT00284141|5013312|P1|Overall Study|Adverse Event|19
1529341|NCT00284141|5013312|P1|Overall Study|Disease Progression / Lack of efficacy|51
1529342|NCT00284089|5013335|P4|Extension Phase|Withdrawal by Subject|3
1529343|NCT00284089|5013336|P3|Extension Phase|Withdrawal by Subject|1
1529344|NCT00284089|5013337|P2|Extension Phase|Withdrawal by Subject|0
1529345|NCT00284089|5013338|P1|Extension Phase|Withdrawal by Subject|0
1529346|NCT00284089|5013335|P4|Extension Phase|Protocol Violation|0
1529347|NCT00284089|5013336|P3|Extension Phase|Protocol Violation|1
1529348|NCT00284089|5013337|P2|Extension Phase|Protocol Violation|0
1529349|NCT00284089|5013338|P1|Extension Phase|Protocol Violation|0
1529350|NCT00284089|5013335|P4|Extension Phase|condition no longer requires study drug|7
1529351|NCT00284089|5013336|P3|Extension Phase|condition no longer requires study drug|2
1529352|NCT00284089|5013337|P2|Extension Phase|condition no longer requires study drug|0
1529353|NCT00284089|5013338|P1|Extension Phase|condition no longer requires study drug|2
1529354|NCT00284089|5013335|P4|Extension Phase|Adverse Event|2
1529355|NCT00284089|5013336|P3|Extension Phase|Adverse Event|2
1529356|NCT00284089|5013337|P2|Extension Phase|Adverse Event|0
1529357|NCT00284089|5013338|P1|Extension Phase|Adverse Event|0
1529358|NCT00284089|5013335|P4|Multiple Dose Phase|Death|1
1529359|NCT00284089|5013336|P3|Multiple Dose Phase|Death|1
1529360|NCT00284089|5013337|P2|Multiple Dose Phase|Death|0
1529361|NCT00284089|5013338|P1|Multiple Dose Phase|Death|0
1529362|NCT00284089|5013335|P4|Multiple Dose Phase|Withdrawal by Subject|2
1529363|NCT00284089|5013336|P3|Multiple Dose Phase|Withdrawal by Subject|1
1529364|NCT00284089|5013337|P2|Multiple Dose Phase|Withdrawal by Subject|0
1529365|NCT00284089|5013338|P1|Multiple Dose Phase|Withdrawal by Subject|0
1529366|NCT00284089|5013335|P4|Multiple Dose Phase|Protocol Violation|0
1529367|NCT00284089|5013336|P3|Multiple Dose Phase|Protocol Violation|1
1529368|NCT00284089|5013337|P2|Multiple Dose Phase|Protocol Violation|0
1529369|NCT00284089|5013338|P1|Multiple Dose Phase|Protocol Violation|0
1529370|NCT00284089|5013335|P4|Multiple Dose Phase|Adverse Event|1
1529371|NCT00284089|5013336|P3|Multiple Dose Phase|Adverse Event|1
1529372|NCT00284089|5013337|P2|Multiple Dose Phase|Adverse Event|0
1529373|NCT00284089|5013338|P1|Multiple Dose Phase|Adverse Event|1
1529374|NCT00284050|5013367|P3|Overall Study|Death|0
1529375|NCT00284050|5013368|P2|Overall Study|Death|0
1529376|NCT00284050|5013369|P1|Overall Study|Death|1
1529377|NCT00284050|5013367|P3|Overall Study|Lost to Follow-up|1
1529378|NCT00284050|5013368|P2|Overall Study|Lost to Follow-up|0
1529379|NCT00284050|5013369|P1|Overall Study|Lost to Follow-up|1
1529380|NCT00284050|5013367|P3|Overall Study|Withdrawal by Subject|2
1529381|NCT00284050|5013368|P2|Overall Study|Withdrawal by Subject|2
1529382|NCT00284050|5013369|P1|Overall Study|Withdrawal by Subject|2
1529383|NCT00284050|5013367|P3|Overall Study|Protocol Violation|2
1529384|NCT00284050|5013368|P2|Overall Study|Protocol Violation|1
1529385|NCT00284050|5013369|P1|Overall Study|Protocol Violation|0
1529386|NCT00284050|5013367|P3|Overall Study|Lack of Efficacy|3
1529387|NCT00284050|5013368|P2|Overall Study|Lack of Efficacy|1
1529388|NCT00284050|5013369|P1|Overall Study|Lack of Efficacy|0
1529389|NCT00284050|5013367|P3|Overall Study|Adverse Event|1
1529390|NCT00284050|5013368|P2|Overall Study|Adverse Event|1
1529391|NCT00284050|5013369|P1|Overall Study|Adverse Event|1
1529392|NCT00283868|5013385|P2|Overall Study|Lost to Follow-up|8
1529393|NCT00283868|5013386|P1|Overall Study|Lost to Follow-up|7
1529394|NCT00283842|5013403|P5|Overall Study|Lost to Follow-up|1
1529395|NCT00283842|5013404|P4|Overall Study|Lost to Follow-up|1
1529396|NCT00283842|5013405|P3|Overall Study|Lost to Follow-up|4
1529397|NCT00283842|5013406|P2|Overall Study|Lost to Follow-up|2
1529398|NCT00283842|5013407|P1|Overall Study|Lost to Follow-up|0
1529399|NCT00283842|5013403|P5|Overall Study|Lack of Efficacy|3
1529400|NCT00283842|5013404|P4|Overall Study|Lack of Efficacy|0
1529401|NCT00283842|5013405|P3|Overall Study|Lack of Efficacy|1
1529402|NCT00283842|5013406|P2|Overall Study|Lack of Efficacy|3
1529403|NCT00283842|5013407|P1|Overall Study|Lack of Efficacy|1
1529404|NCT00283842|5013403|P5|Overall Study|Withdrawal by Subject|4
1529405|NCT00283842|5013404|P4|Overall Study|Withdrawal by Subject|5
1529406|NCT00283842|5013405|P3|Overall Study|Withdrawal by Subject|1
1529407|NCT00283842|5013406|P2|Overall Study|Withdrawal by Subject|1
1529408|NCT00283842|5013407|P1|Overall Study|Withdrawal by Subject|2
1529409|NCT00283842|5013403|P5|Overall Study|Protocol deviation|2
1529410|NCT00283842|5013404|P4|Overall Study|Protocol deviation|0
1529411|NCT00283842|5013405|P3|Overall Study|Protocol deviation|0
1529412|NCT00283842|5013406|P2|Overall Study|Protocol deviation|0
1529413|NCT00283842|5013407|P1|Overall Study|Protocol deviation|0
1529414|NCT00283842|5013403|P5|Overall Study|Protocol Violation|0
1529415|NCT00283842|5013404|P4|Overall Study|Protocol Violation|0
1529416|NCT00283842|5013405|P3|Overall Study|Protocol Violation|4
1529417|NCT00283842|5013406|P2|Overall Study|Protocol Violation|5
1529418|NCT00283842|5013407|P1|Overall Study|Protocol Violation|1
1529419|NCT00283842|5013403|P5|Overall Study|Adverse Event|5
1529420|NCT00283842|5013404|P4|Overall Study|Adverse Event|21
1529421|NCT00283842|5013405|P3|Overall Study|Adverse Event|21
1529422|NCT00283842|5013406|P2|Overall Study|Adverse Event|7
1529423|NCT00283842|5013407|P1|Overall Study|Adverse Event|8
1529424|NCT00283803|5013439|P1|Overall Study|Withdrawal by Subject|4
1529425|NCT00283803|5013439|P1|Overall Study|Physician Decision|9
1529426|NCT00283712|5013447|P2|Overall Study|Death|1
1529427|NCT00283712|5013448|P1|Overall Study|Death|0
1529428|NCT00283686|5013486|P4|Overall Study|Less than full participation|12
1529429|NCT00283686|5013487|P3|Overall Study|Less than full participation|6
1529430|NCT00283686|5013488|P2|Overall Study|Less than full participation|9
1529431|NCT00283686|5013489|P1|Overall Study|Less than full participation|7
1529432|NCT00283686|5013486|P4|Overall Study|Lost to Follow-up|20
1529433|NCT00283686|5013487|P3|Overall Study|Lost to Follow-up|26
1529434|NCT00283686|5013488|P2|Overall Study|Lost to Follow-up|31
1529435|NCT00283686|5013489|P1|Overall Study|Lost to Follow-up|21
1529436|NCT00283686|5013486|P4|Overall Study|Death|0
1529437|NCT00283686|5013487|P3|Overall Study|Death|1
1529438|NCT00283686|5013488|P2|Overall Study|Death|1
1529439|NCT00283686|5013489|P1|Overall Study|Death|1
1529440|NCT00283595|5013533|P2|Overall Study|Withdrawal by Subject|2
1529441|NCT00283595|5013534|P1|Overall Study|Withdrawal by Subject|1
1529442|NCT00283439|5013559|P4|Overall Study|Not specified|0
1529443|NCT00283439|5013560|P3|Overall Study|Not specified|0
1529444|NCT00283439|5013561|P2|Overall Study|Not specified|0
1529445|NCT00283439|5013562|P1|Overall Study|Not specified|1
1529446|NCT00283439|5013559|P4|Overall Study|Treatment discontinued|3
1529447|NCT00283439|5013560|P3|Overall Study|Treatment discontinued|1
1529448|NCT00283439|5013561|P2|Overall Study|Treatment discontinued|2
1529449|NCT00283439|5013562|P1|Overall Study|Treatment discontinued|0
1529450|NCT00283439|5013559|P4|Overall Study|Stem cell transplant|3
1529451|NCT00283439|5013560|P3|Overall Study|Stem cell transplant|4
1529452|NCT00283439|5013561|P2|Overall Study|Stem cell transplant|6
1529453|NCT00283439|5013562|P1|Overall Study|Stem cell transplant|6
1529454|NCT00283439|5013559|P4|Overall Study|Requirement for alternative therapy|2
1529455|NCT00283439|5013560|P3|Overall Study|Requirement for alternative therapy|5
1529456|NCT00283439|5013561|P2|Overall Study|Requirement for alternative therapy|2
1529457|NCT00283439|5013562|P1|Overall Study|Requirement for alternative therapy|1
1529458|NCT00283439|5013559|P4|Overall Study|Disease progression|0
1529459|NCT00283439|5013560|P3|Overall Study|Disease progression|0
1529460|NCT00283439|5013561|P2|Overall Study|Disease progression|1
1529461|NCT00283439|5013562|P1|Overall Study|Disease progression|0
1529462|NCT00283439|5013559|P4|Overall Study|Death|0
1529463|NCT00283439|5013560|P3|Overall Study|Death|1
1529464|NCT00283439|5013561|P2|Overall Study|Death|0
1529465|NCT00283439|5013562|P1|Overall Study|Death|0
1529466|NCT00283439|5013559|P4|Overall Study|Adverse Event|1
1529467|NCT00283439|5013560|P3|Overall Study|Adverse Event|0
1529468|NCT00283439|5013561|P2|Overall Study|Adverse Event|0
1529469|NCT00283439|5013562|P1|Overall Study|Adverse Event|0
1529470|NCT00283400|5013588|P4|Overall Study|Death|0
1529471|NCT00283400|5013589|P3|Overall Study|Death|1
1529472|NCT00283400|5013590|P2|Overall Study|Death|0
1529473|NCT00283400|5013591|P1|Overall Study|Death|1
1529474|NCT00283400|5013588|P4|Overall Study|Withdrawal by Subject|0
1529475|NCT00283400|5013589|P3|Overall Study|Withdrawal by Subject|0
1529476|NCT00283400|5013590|P2|Overall Study|Withdrawal by Subject|1
1529477|NCT00283400|5013591|P1|Overall Study|Withdrawal by Subject|1
1529478|NCT00283387|5013609|P2|First Intervention|Withdrawal by Subject|1
1529479|NCT00283387|5013610|P1|First Intervention|Withdrawal by Subject|0
1529480|NCT00283387|5013609|P2|First Intervention|Subject non-compliant|1
1529481|NCT00283387|5013610|P1|First Intervention|Subject non-compliant|1
1529482|NCT00283296|5013616|P1|Overall Study|in-home trial not completed|5
1529483|NCT00283244|5013625|P3|Overall Study|Clinical deterioration|3
1529484|NCT00283244|5013626|P2|Overall Study|Clinical deterioration|3
1529485|NCT00283244|5013627|P1|Overall Study|Clinical deterioration|1
1529486|NCT00283244|5013625|P3|Overall Study|Medical illness (other complicating dz)|6
1529487|NCT00283244|5013626|P2|Overall Study|Medical illness (other complicating dz)|3
1529488|NCT00283244|5013627|P1|Overall Study|Medical illness (other complicating dz)|4
1529489|NCT00283244|5013625|P3|Overall Study|Physician Decision|1
1529490|NCT00283244|5013626|P2|Overall Study|Physician Decision|0
1529491|NCT00283244|5013627|P1|Overall Study|Physician Decision|0
1529492|NCT00283244|5013625|P3|Overall Study|Withdrawal by Subject|2
1529493|NCT00283244|5013626|P2|Overall Study|Withdrawal by Subject|2
1529494|NCT00283244|5013627|P1|Overall Study|Withdrawal by Subject|1
1529495|NCT00283244|5013625|P3|Overall Study|Lack of Efficacy|26
1529496|NCT00283244|5013626|P2|Overall Study|Lack of Efficacy|32
1529497|NCT00283244|5013627|P1|Overall Study|Lack of Efficacy|8
1529498|NCT00283244|5013625|P3|Overall Study|Death|2
1529499|NCT00283244|5013626|P2|Overall Study|Death|3
1529500|NCT00283244|5013627|P1|Overall Study|Death|4
1529501|NCT00283244|5013625|P3|Overall Study|Adverse Event|11
1529502|NCT00283244|5013626|P2|Overall Study|Adverse Event|8
1529503|NCT00283244|5013627|P1|Overall Study|Adverse Event|0
1529504|NCT00283062|5013663|P4|Overall Study|chemotherapy not completed (cycle 6)|0
1529505|NCT00283062|5013664|P3|Overall Study|chemotherapy not completed (cycle 6)|0
1529506|NCT00283062|5013665|P2|Overall Study|chemotherapy not completed (cycle 6)|0
1529507|NCT00283062|5013666|P1|Overall Study|chemotherapy not completed (cycle 6)|1
1529508|NCT00283062|5013663|P4|Overall Study|Undefined|4
1529509|NCT00283062|5013664|P3|Overall Study|Undefined|1
1529510|NCT00283062|5013665|P2|Overall Study|Undefined|1
1529511|NCT00283062|5013666|P1|Overall Study|Undefined|0
1529512|NCT00283062|5013663|P4|Overall Study|Participant did not wish to continue|0
1529513|NCT00283062|5013664|P3|Overall Study|Participant did not wish to continue|1
1529514|NCT00283062|5013665|P2|Overall Study|Participant did not wish to continue|2
1529515|NCT00283062|5013666|P1|Overall Study|Participant did not wish to continue|3
1529516|NCT00283062|5013663|P4|Overall Study|Progressive disease|0
1529517|NCT00283062|5013664|P3|Overall Study|Progressive disease|1
1529518|NCT00283062|5013665|P2|Overall Study|Progressive disease|0
1529519|NCT00283062|5013666|P1|Overall Study|Progressive disease|0
1529520|NCT00283062|5013663|P4|Overall Study|Lost to Follow-up|0
1529521|NCT00283062|5013664|P3|Overall Study|Lost to Follow-up|1
1529522|NCT00283062|5013665|P2|Overall Study|Lost to Follow-up|0
1529523|NCT00283062|5013666|P1|Overall Study|Lost to Follow-up|1
1529524|NCT00283062|5013663|P4|Overall Study|Adverse Event|0
1529525|NCT00283062|5013664|P3|Overall Study|Adverse Event|1
1529526|NCT00283062|5013665|P2|Overall Study|Adverse Event|0
1529527|NCT00283062|5013666|P1|Overall Study|Adverse Event|2
1529528|NCT00283062|5013663|P4|Overall Study|Did not receive any study medication|45
1529529|NCT00283062|5013664|P3|Overall Study|Did not receive any study medication|36
1529530|NCT00283062|5013665|P2|Overall Study|Did not receive any study medication|4
1529531|NCT00283062|5013666|P1|Overall Study|Did not receive any study medication|5
1529532|NCT00283049|5013699|P3|Overall Study|No longer requires study treatment|1
1529533|NCT00283049|5013700|P2|Overall Study|No longer requires study treatment|0
1529534|NCT00283049|5013701|P1|Overall Study|No longer requires study treatment|0
1529535|NCT00283049|5013699|P3|Overall Study|Discontinuation of Study|20
1529536|NCT00283049|5013700|P2|Overall Study|Discontinuation of Study|16
1529537|NCT00283049|5013701|P1|Overall Study|Discontinuation of Study|18
1529538|NCT00283049|5013699|P3|Overall Study|Withdrawal by Subject|19
1529539|NCT00283049|5013700|P2|Overall Study|Withdrawal by Subject|24
1529540|NCT00283049|5013701|P1|Overall Study|Withdrawal by Subject|26
1529541|NCT00283049|5013699|P3|Overall Study|Lost to Follow-up|5
1529542|NCT00283049|5013700|P2|Overall Study|Lost to Follow-up|2
1529543|NCT00283049|5013701|P1|Overall Study|Lost to Follow-up|4
1529544|NCT00283049|5013699|P3|Overall Study|Lack of Efficacy|1
1529545|NCT00283049|5013700|P2|Overall Study|Lack of Efficacy|1
1529546|NCT00283049|5013701|P1|Overall Study|Lack of Efficacy|0
1529547|NCT00283049|5013699|P3|Overall Study|Death|1
1529548|NCT00283049|5013700|P2|Overall Study|Death|1
1529549|NCT00283049|5013701|P1|Overall Study|Death|1
1529550|NCT00283049|5013699|P3|Overall Study|Protocol Violation|3
1529551|NCT00283049|5013700|P2|Overall Study|Protocol Violation|0
1529552|NCT00283049|5013701|P1|Overall Study|Protocol Violation|3
1529553|NCT00283049|5013699|P3|Overall Study|Adverse Event|4
1529554|NCT00283049|5013700|P2|Overall Study|Adverse Event|1
1529555|NCT00283049|5013701|P1|Overall Study|Adverse Event|6
1529556|NCT00282984|5013729|P2|Overall Study|Protocol Violation|0
1529557|NCT00282984|5013730|P1|Overall Study|Protocol Violation|2
1529558|NCT00282984|5013729|P2|Overall Study|in prison|1
1529559|NCT00282984|5013730|P1|Overall Study|in prison|0
1529560|NCT00282984|5013729|P2|Overall Study|lack of motivation|0
1529561|NCT00282984|5013730|P1|Overall Study|lack of motivation|1
1529562|NCT00282984|5013729|P2|Overall Study|Participant used antipsychosis meds|1
1529563|NCT00282984|5013730|P1|Overall Study|Participant used antipsychosis meds|0
1529564|NCT00282984|5013729|P2|Overall Study|Participant only allowed phone follow-up|1
1529565|NCT00282984|5013730|P1|Overall Study|Participant only allowed phone follow-up|0
1529566|NCT00282984|5013729|P2|Overall Study|Participant stopped study medication|2
1529567|NCT00282984|5013730|P1|Overall Study|Participant stopped study medication|2
1529568|NCT00282984|5013729|P2|Overall Study|Withdrawal by Participant|34
1529569|NCT00282984|5013730|P1|Overall Study|Withdrawal by Participant|22
1529570|NCT00282984|5013729|P2|Overall Study|Lost to Follow-up|10
1529571|NCT00282984|5013730|P1|Overall Study|Lost to Follow-up|14
1529572|NCT00282984|5013729|P2|Overall Study|Lack of Efficacy|2
1529573|NCT00282984|5013730|P1|Overall Study|Lack of Efficacy|0
1529574|NCT00282984|5013729|P2|Overall Study|Adverse Event|5
1529575|NCT00282984|5013730|P1|Overall Study|Adverse Event|8
1529576|NCT00282984|5013729|P2|Overall Study|Death|5
1529577|NCT00282984|5013730|P1|Overall Study|Death|2
1529578|NCT00282919|5013767|P1|Overall Study|Asymptomatic Parasitemia|2
1529579|NCT00282919|5013767|P1|Overall Study|Withdrawal by Subject|1
1529580|NCT00282919|5013767|P1|Overall Study|Lack of Efficacy|4
1529581|NCT00282867|5013782|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
1529582|NCT00282867|5013783|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
1529583|NCT00282867|5013784|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
1529584|NCT00282568|5013881|P1|Extended Treatment Period|Lost to Follow-up|2
1529585|NCT00282568|5013881|P1|Extended Treatment Period|Physician Decision|1
1529586|NCT00282568|5013881|P1|Extended Treatment Period|Non-compliance|4
1529587|NCT00282568|5013881|P1|Extended Treatment Period|Adverse Event|17
1529588|NCT00282568|5013881|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
1529589|NCT00282568|5013881|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
1529590|NCT00282464|5013907|P2|Overall Study|dropped due to missed visits|1
1529591|NCT00282464|5013908|P1|Overall Study|dropped due to missed visits|0
1529592|NCT00282464|5013907|P2|Overall Study|dispensed wrong kit|1
1529593|NCT00282464|5013908|P1|Overall Study|dispensed wrong kit|0
1529594|NCT00282464|5013907|P2|Overall Study|family crisis|1
1529595|NCT00282464|5013908|P1|Overall Study|family crisis|0
1529596|NCT00282464|5013907|P2|Overall Study|patient incarcerated|1
1529597|NCT00282464|5013908|P1|Overall Study|patient incarcerated|0
1529598|NCT00282464|5013907|P2|Overall Study|patient no show|1
1529599|NCT00282464|5013908|P1|Overall Study|patient no show|0
1529600|NCT00282464|5013907|P2|Overall Study|patient non-compliant|0
1529601|NCT00282464|5013908|P1|Overall Study|patient non-compliant|3
1529602|NCT00282464|5013907|P2|Overall Study|Patient moved|0
1529603|NCT00282464|5013908|P1|Overall Study|Patient moved|1
1529604|NCT00282464|5013907|P2|Overall Study|Protocol Violation|7
1529605|NCT00282464|5013908|P1|Overall Study|Protocol Violation|0
1529606|NCT00282464|5013907|P2|Overall Study|laboratory abnormality|2
1529607|NCT00282464|5013908|P1|Overall Study|laboratory abnormality|1
1529608|NCT00282464|5013907|P2|Overall Study|Withdrawal by Subject|10
1529609|NCT00282464|5013908|P1|Overall Study|Withdrawal by Subject|24
1529610|NCT00282464|5013907|P2|Overall Study|Lost to Follow-up|10
1529611|NCT00282464|5013908|P1|Overall Study|Lost to Follow-up|10
1529612|NCT00282464|5013907|P2|Overall Study|Lack of Efficacy|8
1529613|NCT00282464|5013908|P1|Overall Study|Lack of Efficacy|8
1529614|NCT00282464|5013907|P2|Overall Study|Adverse Event|20
1529615|NCT00282464|5013908|P1|Overall Study|Adverse Event|26
1529616|NCT00282438|5013958|P2|Overall Study|Death|1
1529617|NCT00282438|5013959|P1|Overall Study|Death|0
1529618|NCT00282438|5013958|P2|Overall Study|Lack of Efficacy|0
1529619|NCT00282438|5013959|P1|Overall Study|Lack of Efficacy|1
1529620|NCT00282412|5013969|P1|Overall Study|Death|2
1529621|NCT00282347|5013975|P2|B Cell Follow-up Period|Reason Not Specified|0
1529622|NCT00282347|5013976|P1|B Cell Follow-up Period|Reason Not Specified|2
1529623|NCT00282347|5013975|P2|B Cell Follow-up Period|Physician Decision|0
1529624|NCT00282347|5013976|P1|B Cell Follow-up Period|Physician Decision|1
1529625|NCT00282347|5013975|P2|B Cell Follow-up Period|Withdrawal by Subject|0
1529626|NCT00282347|5013976|P1|B Cell Follow-up Period|Withdrawal by Subject|2
1529627|NCT00282347|5013975|P2|Safety Follow-up Period|Protocol Deviation|2
1529628|NCT00282347|5013976|P1|Safety Follow-up Period|Protocol Deviation|0
1529629|NCT00282347|5013975|P2|Safety Follow-up Period|Physician Decision|1
1529630|NCT00282347|5013976|P1|Safety Follow-up Period|Physician Decision|1
1529631|NCT00282347|5013975|P2|Safety Follow-up Period|Withdrawal by Subject|1
1529632|NCT00282347|5013976|P1|Safety Follow-up Period|Withdrawal by Subject|2
1529633|NCT00282347|5013975|P2|Safety Follow-up Period|Lost to Follow-up|2
1529634|NCT00282347|5013976|P1|Safety Follow-up Period|Lost to Follow-up|0
1529635|NCT00282347|5013975|P2|Treatment Period|Physician Decision|1
1529636|NCT00282347|5013976|P1|Treatment Period|Physician Decision|0
1529637|NCT00282347|5013975|P2|Treatment Period|Withdrawal by Subject|3
1529638|NCT00282347|5013976|P1|Treatment Period|Withdrawal by Subject|1
1529639|NCT00282347|5013975|P2|Treatment Period|Lost to Follow-up|5
1529640|NCT00282347|5013976|P1|Treatment Period|Lost to Follow-up|2
1529641|NCT00282347|5013975|P2|Treatment Period|Death|0
1529642|NCT00282347|5013976|P1|Treatment Period|Death|2
1529643|NCT00282334|5014002|P2|Overall Study|Withdrawal by Subject|5
1529644|NCT00282334|5014003|P1|Overall Study|Withdrawal by Subject|8
1529645|NCT00282308|5014011|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
1529646|NCT00282308|5014012|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
1529647|NCT00282308|5014013|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
1529648|NCT00282308|5014011|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
1529649|NCT00282308|5014012|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
1529650|NCT00282308|5014013|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
1529651|NCT00282308|5014011|P3|Safety Follow-up Period|Lost to Follow-up|5
1529652|NCT00282308|5014012|P2|Safety Follow-up Period|Lost to Follow-up|0
1529653|NCT00282308|5014013|P1|Safety Follow-up Period|Lost to Follow-up|0
1529654|NCT00282308|5014011|P3|Safety Follow-up Period|Adverse Event|1
1529655|NCT00282308|5014012|P2|Safety Follow-up Period|Adverse Event|0
1529656|NCT00282308|5014013|P1|Safety Follow-up Period|Adverse Event|0
1529657|NCT00282308|5014011|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
1529658|NCT00282308|5014012|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
1529659|NCT00282308|5014013|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
1529660|NCT00282308|5014011|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
1529661|NCT00282308|5014012|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
1529662|NCT00282308|5014013|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
1529663|NCT00282308|5014011|P3|Optional Extension Re-treatment Period|Adverse Event|4
1529664|NCT00282308|5014012|P2|Optional Extension Re-treatment Period|Adverse Event|0
1529665|NCT00282308|5014013|P1|Optional Extension Re-treatment Period|Adverse Event|0
1529666|NCT00282308|5014011|P3|Treatment Period|Not Treated with Study Drug|0
1529667|NCT00282308|5014012|P2|Treatment Period|Not Treated with Study Drug|0
1529668|NCT00282308|5014013|P1|Treatment Period|Not Treated with Study Drug|1
1529669|NCT00282308|5014011|P3|Treatment Period|Adverse Event|0
1529670|NCT00282308|5014012|P2|Treatment Period|Adverse Event|2
1529671|NCT00282308|5014013|P1|Treatment Period|Adverse Event|0
1529672|NCT00282308|5014011|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
1529673|NCT00282308|5014012|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
1529674|NCT00282308|5014013|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
1529675|NCT00282308|5014011|P3|Treatment Period|Lost to Follow-up|0
1529676|NCT00282308|5014012|P2|Treatment Period|Lost to Follow-up|0
1529677|NCT00282308|5014013|P1|Treatment Period|Lost to Follow-up|1
1529678|NCT00282295|5014043|P3|Overall Study|Other|0
1529679|NCT00282295|5014044|P2|Overall Study|Other|1
1529680|NCT00282295|5014045|P1|Overall Study|Other|0
1529681|NCT00282295|5014043|P3|Overall Study|Lost to Follow-up|2
1529682|NCT00282295|5014044|P2|Overall Study|Lost to Follow-up|7
1529683|NCT00282295|5014045|P1|Overall Study|Lost to Follow-up|1
1529684|NCT00282295|5014043|P3|Overall Study|Withdrawal by Subject|4
1529685|NCT00282295|5014044|P2|Overall Study|Withdrawal by Subject|6
1529686|NCT00282295|5014045|P1|Overall Study|Withdrawal by Subject|2
1529687|NCT00282295|5014043|P3|Overall Study|Protocol Violation|1
1529688|NCT00282295|5014044|P2|Overall Study|Protocol Violation|2
1529689|NCT00282295|5014045|P1|Overall Study|Protocol Violation|0
1529690|NCT00282295|5014043|P3|Overall Study|Serious Adverse Events|1
1529691|NCT00282295|5014044|P2|Overall Study|Serious Adverse Events|0
1529692|NCT00282295|5014045|P1|Overall Study|Serious Adverse Events|0
1529693|NCT00282295|5014043|P3|Overall Study|Adverse Event|0
1529694|NCT00282295|5014044|P2|Overall Study|Adverse Event|1
1529695|NCT00282295|5014045|P1|Overall Study|Adverse Event|0
1529696|NCT00282256|5014100|P1|Extension Treatment Period|Adverse Event|2
1529697|NCT00282256|5014100|P1|Pharmacokinetic Treatment Period|Poor venous access|1
1529698|NCT00282243|5014121|P1|Extension Treatment Period|Physician Decision|1
1529699|NCT00282243|5014121|P1|Extension Treatment Period|Non-compliance|2
1529700|NCT00282243|5014121|P1|Extension Treatment Period|Withdrawal by Subject|4
1529701|NCT00282243|5014121|P1|Extension Treatment Period|Adverse Event|15
1529702|NCT00282243|5014121|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
1529703|NCT00282243|5014121|P1|Pharmacokinetic Treatment Period|Adverse Event|3
1529704|NCT00282152|5014147|P2|Overall Study|Withdrawal by Subject|0
1529705|NCT00282152|5014148|P1|Overall Study|Withdrawal by Subject|1
1529706|NCT00282113|5014169|P3|Overall Study|Removed at parents request|0
1529707|NCT00282113|5014170|P2|Overall Study|Removed at parents request|0
1529708|NCT00282113|5014171|P1|Overall Study|Removed at parents request|1
1529709|NCT00282087|5014185|P1|Overall Study|Death|1
1529710|NCT00282048|5014198|P1|Overall Study|Ongoing|1
1529711|NCT00282048|5014198|P1|Overall Study|Other|8
1529712|NCT00282048|5014198|P1|Overall Study|Withdrawal by Subject|1
1529713|NCT00282048|5014198|P1|Overall Study|Adverse Event|22
1529714|NCT00282048|5014198|P1|Overall Study|Lack of Efficacy|30
1529715|NCT00281957|5014212|P2|Overall Study|Refusal unrelated to adverse events|1
1529716|NCT00281957|5014213|P1|Overall Study|Refusal unrelated to adverse events|0
1529717|NCT00281957|5014212|P2|Overall Study|Did not start treatment|1
1529718|NCT00281957|5014213|P1|Overall Study|Did not start treatment|3
1529719|NCT00281957|5014212|P2|Overall Study|Not eligible|2
1529720|NCT00281957|5014213|P1|Overall Study|Not eligible|1
1529721|NCT00281957|5014212|P2|Overall Study|Not protocol specified|1
1529722|NCT00281957|5014213|P1|Overall Study|Not protocol specified|8
1529723|NCT00281957|5014212|P2|Overall Study|Progression/relapse|35
1529724|NCT00281957|5014213|P1|Overall Study|Progression/relapse|47
1529725|NCT00281957|5014212|P2|Overall Study|Death|0
1529726|NCT00281957|5014213|P1|Overall Study|Death|1
1529727|NCT00281957|5014212|P2|Overall Study|Adverse Event|2
1529728|NCT00281957|5014213|P1|Overall Study|Adverse Event|7
1529729|NCT00281840|5014287|P1|Overall Study|Complicating Disease|1
1529730|NCT00281840|5014287|P1|Overall Study|exceed maximum delay in treatment|1
1529731|NCT00281840|5014287|P1|Overall Study|Disease Progression|2
1529732|NCT00281840|5014287|P1|Overall Study|Withdrawal by Subject|3
1529733|NCT00281840|5014287|P1|Overall Study|Physician Decision|6
1529734|NCT00281840|5014287|P1|Overall Study|Adverse Event|12
1529735|NCT00281697|5014303|P2|Overall Study|Did not receive study drug|2
1529736|NCT00281697|5014304|P1|Overall Study|Did not receive study drug|3
1529737|NCT00281697|5014303|P2|Overall Study|Subject/guardian's decision to withdraw|6
1529738|NCT00281697|5014304|P1|Overall Study|Subject/guardian's decision to withdraw|33
1529739|NCT00281697|5014303|P2|Overall Study|Physician's decision to withdraw|12
1529740|NCT00281697|5014304|P1|Overall Study|Physician's decision to withdraw|15
1529741|NCT00281697|5014303|P2|Overall Study|Not specified|6
1529742|NCT00281697|5014304|P1|Overall Study|Not specified|5
1529743|NCT00281697|5014303|P2|Overall Study|Disease progression|149
1529744|NCT00281697|5014304|P1|Overall Study|Disease progression|279
1529745|NCT00281697|5014303|P2|Overall Study|Death|3
1529746|NCT00281697|5014304|P1|Overall Study|Death|8
1529747|NCT00281697|5014303|P2|Overall Study|Adverse Event|15
1529748|NCT00281697|5014304|P1|Overall Study|Adverse Event|54
1529749|NCT00281697|5014303|P2|Overall Study|> 60 days since last dose of study drug|4
1529750|NCT00281697|5014304|P1|Overall Study|> 60 days since last dose of study drug|4
1529751|NCT00281658|5014322|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
1529752|NCT00281658|5014323|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
1529753|NCT00281658|5014324|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
1529754|NCT00281658|5014322|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
1529755|NCT00281658|5014323|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
1529756|NCT00281658|5014324|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
1529757|NCT00281658|5014322|P3|Open-label Monotherapy Extension Phase|Death|97
1529758|NCT00281658|5014323|P2|Open-label Monotherapy Extension Phase|Death|0
1529759|NCT00281658|5014324|P1|Open-label Monotherapy Extension Phase|Death|0
1529760|NCT00281658|5014322|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
1529761|NCT00281658|5014323|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
1529762|NCT00281658|5014324|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
1529763|NCT00281658|5014322|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
1529764|NCT00281658|5014323|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
1529765|NCT00281658|5014324|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
1529766|NCT00281658|5014322|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
1529767|NCT00281658|5014323|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
1529768|NCT00281658|5014324|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
1529769|NCT00281658|5014322|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
1529770|NCT00281658|5014323|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
1529771|NCT00281658|5014324|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
1529772|NCT00281658|5014322|P3|Double-blind, Randomized Phase|Death|0
1529773|NCT00281658|5014323|P2|Double-blind, Randomized Phase|Death|46
1529774|NCT00281658|5014324|P1|Double-blind, Randomized Phase|Death|120
1529775|NCT00281632|5014341|P1|Overall Study|Ongoing|3
1529776|NCT00281632|5014341|P1|Overall Study|Physician Decision|1
1529777|NCT00281632|5014341|P1|Overall Study|Death|1
1529778|NCT00281632|5014341|P1|Overall Study|Disease Progression|22
1529779|NCT00281632|5014341|P1|Overall Study|Withdrawal by Subject|2
1529780|NCT00281632|5014341|P1|Overall Study|Adverse Event|7
1529781|NCT00281580|5014383|P16|Overall Study|Randomised in error; pregnancy; moving|2
1529782|NCT00281580|5014384|P15|Overall Study|Randomised in error; pregnancy; moving|1
1529783|NCT00281580|5014385|P14|Overall Study|Randomised in error; pregnancy; moving|0
1529784|NCT00281580|5014386|P13|Overall Study|Randomised in error; pregnancy; moving|2
1529785|NCT00281580|5014387|P12|Overall Study|Randomised in error; pregnancy; moving|1
1529786|NCT00281580|5014388|P11|Overall Study|Randomised in error; pregnancy; moving|1
1529787|NCT00281580|5014389|P10|Overall Study|Randomised in error; pregnancy; moving|1
1529788|NCT00281580|5014390|P9|Overall Study|Randomised in error; pregnancy; moving|2
1529789|NCT00281580|5014391|P8|Overall Study|Randomised in error; pregnancy; moving|0
1529790|NCT00281580|5014392|P7|Overall Study|Randomised in error; pregnancy; moving|1
1529791|NCT00281580|5014393|P6|Overall Study|Randomised in error; pregnancy; moving|0
1529792|NCT00281580|5014394|P5|Overall Study|Randomised in error; pregnancy; moving|0
1529793|NCT00281580|5014395|P4|Overall Study|Randomised in error; pregnancy; moving|2
1529794|NCT00281580|5014396|P3|Overall Study|Randomised in error; pregnancy; moving|0
1529795|NCT00281580|5014397|P2|Overall Study|Randomised in error; pregnancy; moving|0
1529796|NCT00281580|5014398|P1|Overall Study|Randomised in error; pregnancy; moving|0
1529797|NCT00281580|5014383|P16|Overall Study|Lost to Follow-up|0
1529798|NCT00281580|5014384|P15|Overall Study|Lost to Follow-up|0
1529799|NCT00281580|5014385|P14|Overall Study|Lost to Follow-up|0
1529800|NCT00281580|5014386|P13|Overall Study|Lost to Follow-up|1
1529801|NCT00281580|5014387|P12|Overall Study|Lost to Follow-up|0
1529802|NCT00281580|5014388|P11|Overall Study|Lost to Follow-up|1
1529803|NCT00281580|5014389|P10|Overall Study|Lost to Follow-up|1
1529804|NCT00281580|5014390|P9|Overall Study|Lost to Follow-up|2
1529805|NCT00281580|5014391|P8|Overall Study|Lost to Follow-up|1
1529806|NCT00281580|5014392|P7|Overall Study|Lost to Follow-up|0
1529807|NCT00281580|5014393|P6|Overall Study|Lost to Follow-up|1
1529808|NCT00281580|5014394|P5|Overall Study|Lost to Follow-up|0
1529809|NCT00281580|5014395|P4|Overall Study|Lost to Follow-up|3
1529810|NCT00281580|5014396|P3|Overall Study|Lost to Follow-up|0
1529811|NCT00281580|5014397|P2|Overall Study|Lost to Follow-up|0
1529812|NCT00281580|5014398|P1|Overall Study|Lost to Follow-up|0
1529813|NCT00281580|5014383|P16|Overall Study|Lack of Efficacy|0
1529814|NCT00281580|5014384|P15|Overall Study|Lack of Efficacy|1
1529815|NCT00281580|5014385|P14|Overall Study|Lack of Efficacy|2
1529816|NCT00281580|5014386|P13|Overall Study|Lack of Efficacy|0
1529817|NCT00281580|5014387|P12|Overall Study|Lack of Efficacy|1
1529818|NCT00281580|5014388|P11|Overall Study|Lack of Efficacy|0
1529819|NCT00281580|5014389|P10|Overall Study|Lack of Efficacy|0
1529820|NCT00281580|5014390|P9|Overall Study|Lack of Efficacy|0
1529821|NCT00281580|5014391|P8|Overall Study|Lack of Efficacy|0
1529822|NCT00281580|5014392|P7|Overall Study|Lack of Efficacy|0
1529823|NCT00281580|5014393|P6|Overall Study|Lack of Efficacy|0
1529824|NCT00281580|5014394|P5|Overall Study|Lack of Efficacy|2
1529825|NCT00281580|5014395|P4|Overall Study|Lack of Efficacy|6
1529826|NCT00281580|5014396|P3|Overall Study|Lack of Efficacy|1
1529827|NCT00281580|5014397|P2|Overall Study|Lack of Efficacy|1
1529828|NCT00281580|5014398|P1|Overall Study|Lack of Efficacy|2
1529829|NCT00281580|5014383|P16|Overall Study|Withdrawal by Subject|5
1529830|NCT00281580|5014384|P15|Overall Study|Withdrawal by Subject|1
1529831|NCT00281580|5014385|P14|Overall Study|Withdrawal by Subject|2
1529832|NCT00281580|5014386|P13|Overall Study|Withdrawal by Subject|2
1529833|NCT00281580|5014387|P12|Overall Study|Withdrawal by Subject|1
1529834|NCT00281580|5014388|P11|Overall Study|Withdrawal by Subject|1
1529835|NCT00281580|5014389|P10|Overall Study|Withdrawal by Subject|4
1529836|NCT00281580|5014390|P9|Overall Study|Withdrawal by Subject|1
1529837|NCT00281580|5014391|P8|Overall Study|Withdrawal by Subject|0
1529838|NCT00281580|5014392|P7|Overall Study|Withdrawal by Subject|2
1529839|NCT00281580|5014393|P6|Overall Study|Withdrawal by Subject|2
1529840|NCT00281580|5014394|P5|Overall Study|Withdrawal by Subject|1
1529841|NCT00281580|5014395|P4|Overall Study|Withdrawal by Subject|1
1529842|NCT00281580|5014396|P3|Overall Study|Withdrawal by Subject|1
1529843|NCT00281580|5014397|P2|Overall Study|Withdrawal by Subject|0
1529844|NCT00281580|5014398|P1|Overall Study|Withdrawal by Subject|3
1529845|NCT00281580|5014383|P16|Overall Study|Protocol Violation|3
1529846|NCT00281580|5014384|P15|Overall Study|Protocol Violation|1
1529847|NCT00281580|5014385|P14|Overall Study|Protocol Violation|1
1529848|NCT00281580|5014386|P13|Overall Study|Protocol Violation|0
1529849|NCT00281580|5014387|P12|Overall Study|Protocol Violation|2
1529850|NCT00281580|5014388|P11|Overall Study|Protocol Violation|1
1529851|NCT00281580|5014389|P10|Overall Study|Protocol Violation|0
1529852|NCT00281580|5014390|P9|Overall Study|Protocol Violation|2
1529853|NCT00281580|5014391|P8|Overall Study|Protocol Violation|0
1529854|NCT00281580|5014392|P7|Overall Study|Protocol Violation|1
1529855|NCT00281580|5014393|P6|Overall Study|Protocol Violation|0
1529856|NCT00281580|5014394|P5|Overall Study|Protocol Violation|0
1529857|NCT00281580|5014395|P4|Overall Study|Protocol Violation|1
1529858|NCT00281580|5014396|P3|Overall Study|Protocol Violation|1
1529859|NCT00281580|5014397|P2|Overall Study|Protocol Violation|0
1529860|NCT00281580|5014398|P1|Overall Study|Protocol Violation|0
1529861|NCT00281580|5014383|P16|Overall Study|Adverse Event|3
1529862|NCT00281580|5014384|P15|Overall Study|Adverse Event|3
1529863|NCT00281580|5014385|P14|Overall Study|Adverse Event|2
1529864|NCT00281580|5014386|P13|Overall Study|Adverse Event|8
1529865|NCT00281580|5014387|P12|Overall Study|Adverse Event|5
1529866|NCT00281580|5014388|P11|Overall Study|Adverse Event|0
1529867|NCT00281580|5014389|P10|Overall Study|Adverse Event|6
1529868|NCT00281580|5014390|P9|Overall Study|Adverse Event|1
1529869|NCT00281580|5014391|P8|Overall Study|Adverse Event|0
1529870|NCT00281580|5014392|P7|Overall Study|Adverse Event|1
1529871|NCT00281580|5014393|P6|Overall Study|Adverse Event|0
1529872|NCT00281580|5014394|P5|Overall Study|Adverse Event|1
1529873|NCT00281580|5014395|P4|Overall Study|Adverse Event|4
1529874|NCT00281580|5014396|P3|Overall Study|Adverse Event|2
1529875|NCT00281580|5014397|P2|Overall Study|Adverse Event|0
1529876|NCT00281580|5014398|P1|Overall Study|Adverse Event|2
1529877|NCT00281528|5014745|P3|Overall Study|Other|5
1529878|NCT00281528|5014746|P2|Overall Study|Other|3
1529879|NCT00281528|5014747|P1|Overall Study|Other|6
1529880|NCT00281528|5014745|P3|Overall Study|Withdrawal by Subject|7
1529881|NCT00281528|5014746|P2|Overall Study|Withdrawal by Subject|5
1529882|NCT00281528|5014747|P1|Overall Study|Withdrawal by Subject|5
1529883|NCT00281528|5014745|P3|Overall Study|Protocol Violation|1
1529884|NCT00281528|5014746|P2|Overall Study|Protocol Violation|0
1529885|NCT00281528|5014747|P1|Overall Study|Protocol Violation|1
1529886|NCT00281528|5014745|P3|Overall Study|Physician Decision|5
1529887|NCT00281528|5014746|P2|Overall Study|Physician Decision|4
1529888|NCT00281528|5014747|P1|Overall Study|Physician Decision|11
1529889|NCT00281528|5014745|P3|Overall Study|Adverse Event-unrelated to treatment|2
1529890|NCT00281528|5014746|P2|Overall Study|Adverse Event-unrelated to treatment|0
1529891|NCT00281528|5014747|P1|Overall Study|Adverse Event-unrelated to treatment|3
1529892|NCT00281528|5014745|P3|Overall Study|Unacceptable Toxicity-related to trt|32
1529893|NCT00281528|5014746|P2|Overall Study|Unacceptable Toxicity-related to trt|24
1529894|NCT00281528|5014747|P1|Overall Study|Unacceptable Toxicity-related to trt|21
1529895|NCT00281528|5014745|P3|Overall Study|Progressive Disease|27
1529896|NCT00281528|5014746|P2|Overall Study|Progressive Disease|18
1529897|NCT00281528|5014747|P1|Overall Study|Progressive Disease|28
1529898|NCT00281320|5014798|P2|Overall Study|Not specified|1
1529899|NCT00281320|5014799|P1|Overall Study|Not specified|3
1529900|NCT00281320|5014798|P2|Overall Study|Lost to Follow-up|2
1529901|NCT00281320|5014799|P1|Overall Study|Lost to Follow-up|1
1529902|NCT00281320|5014798|P2|Overall Study|Withdrawal by Subject|6
1529903|NCT00281320|5014799|P1|Overall Study|Withdrawal by Subject|5
1529904|NCT00281320|5014798|P2|Overall Study|Lack of Efficacy|3
1529905|NCT00281320|5014799|P1|Overall Study|Lack of Efficacy|4
1529906|NCT00281320|5014798|P2|Overall Study|Adverse Event|9
1529907|NCT00281320|5014799|P1|Overall Study|Adverse Event|12
1529908|NCT00281099|5014821|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
1529909|NCT00281099|5014822|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
1529910|NCT00281099|5014821|P2|Overall Study|Physician Decision|72
1529911|NCT00281099|5014822|P1|Overall Study|Physician Decision|79
1529912|NCT00281099|5014821|P2|Overall Study|Withdrawal by Subject|70
1529913|NCT00281099|5014822|P1|Overall Study|Withdrawal by Subject|65
1529914|NCT00281099|5014821|P2|Overall Study|Lost to Follow-up|19
1529915|NCT00281099|5014822|P1|Overall Study|Lost to Follow-up|10
1529916|NCT00281099|5014821|P2|Overall Study|Death|57
1529917|NCT00281099|5014822|P1|Overall Study|Death|46
1529918|NCT00280917|5014871|P4|Overall Study|Noncompliance|0
1529919|NCT00280917|5014872|P3|Overall Study|Noncompliance|2
1529920|NCT00280917|5014873|P2|Overall Study|Noncompliance|1
1529921|NCT00280917|5014874|P1|Overall Study|Noncompliance|0
1529922|NCT00280917|5014871|P4|Overall Study|Withdrawal by Subject|1
1529923|NCT00280917|5014872|P3|Overall Study|Withdrawal by Subject|0
1529924|NCT00280917|5014873|P2|Overall Study|Withdrawal by Subject|2
1529925|NCT00280917|5014874|P1|Overall Study|Withdrawal by Subject|0
1529926|NCT00280917|5014871|P4|Overall Study|Change Therapy|0
1529927|NCT00280917|5014872|P3|Overall Study|Change Therapy|0
1529928|NCT00280917|5014873|P2|Overall Study|Change Therapy|2
1529929|NCT00280917|5014874|P1|Overall Study|Change Therapy|1
1529930|NCT00280917|5014871|P4|Overall Study|Adverse Event|1
1529931|NCT00280917|5014872|P3|Overall Study|Adverse Event|4
1529932|NCT00280917|5014873|P2|Overall Study|Adverse Event|1
1529933|NCT00280917|5014874|P1|Overall Study|Adverse Event|1
1529934|NCT00280748|5014897|P1|Overall Study|Extra-cranial disease progression|1
1529935|NCT00280748|5014897|P1|Overall Study|Decline in performance|3
1529936|NCT00280735|5014907|P1|Overall Study|Intercurrent Illness|2
1529937|NCT00280735|5014907|P1|Overall Study|Withdrawal by Subject|8
1529938|NCT00280735|5014907|P1|Overall Study|Lack of Efficacy|3
1529939|NCT00280735|5014907|P1|Overall Study|Adverse Event|5
1529940|NCT00280683|5014919|P2|Overall Study|Adverse Event|1
1529941|NCT00280683|5014920|P1|Overall Study|Adverse Event|1
1529942|NCT00280683|5014919|P2|Overall Study|Withdrawal by Subject|2
1529943|NCT00280683|5014920|P1|Overall Study|Withdrawal by Subject|1
1529944|NCT00280566|5014930|P3|Period 2 Double Blind|miscellaneous|5
1529945|NCT00280566|5014931|P2|Period 2 Double Blind|miscellaneous|10
1529946|NCT00280566|5014932|P1|Period 2 Double Blind|miscellaneous|0
1529947|NCT00280566|5014930|P3|Period 2 Double Blind|Withdrawal by Subject|9
1529948|NCT00280566|5014931|P2|Period 2 Double Blind|Withdrawal by Subject|9
1529949|NCT00280566|5014932|P1|Period 2 Double Blind|Withdrawal by Subject|0
1529950|NCT00280566|5014930|P3|Period 2 Double Blind|Lost to Follow-up|6
1529951|NCT00280566|5014931|P2|Period 2 Double Blind|Lost to Follow-up|3
1529952|NCT00280566|5014932|P1|Period 2 Double Blind|Lost to Follow-up|0
1529953|NCT00280566|5014930|P3|Period 2 Double Blind|Adverse Event|15
1529954|NCT00280566|5014931|P2|Period 2 Double Blind|Adverse Event|11
1529955|NCT00280566|5014932|P1|Period 2 Double Blind|Adverse Event|0
1529956|NCT00280566|5014930|P3|Period 2 Double Blind|Laboratory Abnormality|0
1529957|NCT00280566|5014931|P2|Period 2 Double Blind|Laboratory Abnormality|1
1529958|NCT00280566|5014932|P1|Period 2 Double Blind|Laboratory Abnormality|0
1529959|NCT00280566|5014930|P3|Period 2 Double Blind|Lack of Efficacy|22
1529960|NCT00280566|5014931|P2|Period 2 Double Blind|Lack of Efficacy|9
1529961|NCT00280566|5014932|P1|Period 2 Double Blind|Lack of Efficacy|0
1529962|NCT00280566|5014930|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
1529963|NCT00280566|5014931|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
1529964|NCT00280566|5014932|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
1529965|NCT00280566|5014930|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
1529966|NCT00280566|5014931|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
1529967|NCT00280566|5014932|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
1529968|NCT00280566|5014930|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
1529969|NCT00280566|5014931|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
1529970|NCT00280566|5014932|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
1529971|NCT00280566|5014930|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
1529972|NCT00280566|5014931|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
1529973|NCT00280566|5014932|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
1529974|NCT00280566|5014930|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
1529975|NCT00280566|5014931|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
1529976|NCT00280566|5014932|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
1529977|NCT00280566|5014930|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
1529978|NCT00280566|5014931|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
1529979|NCT00280566|5014932|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
1529980|NCT00280397|5014957|P1|Overall Study|Adverse Event|1
1529981|NCT00280293|5015023|P2|Overall Study|Adverse Event|1
1529982|NCT00280293|5015024|P1|Overall Study|Adverse Event|0
1529983|NCT00280293|5015023|P2|Overall Study|Incarceration/Legal Reasons|1
1529984|NCT00280293|5015024|P1|Overall Study|Incarceration/Legal Reasons|1
1529985|NCT00280293|5015023|P2|Overall Study|Withdrawal by Subject|5
1529986|NCT00280293|5015024|P1|Overall Study|Withdrawal by Subject|3
1529987|NCT00280293|5015023|P2|Overall Study|Lost to Follow-up|12
1529988|NCT00280293|5015024|P1|Overall Study|Lost to Follow-up|14
1529989|NCT00280293|5015023|P2|Overall Study|Physician Decision|4
1529990|NCT00280293|5015024|P1|Overall Study|Physician Decision|5
1529991|NCT00280293|5015023|P2|Overall Study|Protocol Violation|0
1529992|NCT00280293|5015024|P1|Overall Study|Protocol Violation|3
1529993|NCT00280150|5015047|P4|Overall Study|Declining Performance Status|1
1529994|NCT00280150|5015048|P3|Overall Study|Declining Performance Status|0
1529995|NCT00280150|5015049|P2|Overall Study|Declining Performance Status|0
1529996|NCT00280150|5015050|P1|Overall Study|Declining Performance Status|0
1529997|NCT00280150|5015047|P4|Overall Study|Did not get consolidation therapy|0
1529998|NCT00280150|5015048|P3|Overall Study|Did not get consolidation therapy|3
1529999|NCT00280150|5015049|P2|Overall Study|Did not get consolidation therapy|0
1530000|NCT00280150|5015050|P1|Overall Study|Did not get consolidation therapy|3
1530001|NCT00280150|5015047|P4|Overall Study|Withdrawal by Subject|1
1530002|NCT00280150|5015048|P3|Overall Study|Withdrawal by Subject|0
1530003|NCT00280150|5015049|P2|Overall Study|Withdrawal by Subject|0
1530004|NCT00280150|5015050|P1|Overall Study|Withdrawal by Subject|0
1530005|NCT00280150|5015047|P4|Overall Study|Protocol Violation|1
1530006|NCT00280150|5015048|P3|Overall Study|Protocol Violation|0
1530007|NCT00280150|5015049|P2|Overall Study|Protocol Violation|0
1530008|NCT00280150|5015050|P1|Overall Study|Protocol Violation|0
1530009|NCT00280150|5015047|P4|Overall Study|Physician Decision|1
1530010|NCT00280150|5015048|P3|Overall Study|Physician Decision|0
1530011|NCT00280150|5015049|P2|Overall Study|Physician Decision|0
1530012|NCT00280150|5015050|P1|Overall Study|Physician Decision|0
1530013|NCT00280150|5015047|P4|Overall Study|Lack of Efficacy|3
1530014|NCT00280150|5015048|P3|Overall Study|Lack of Efficacy|0
1530015|NCT00280150|5015049|P2|Overall Study|Lack of Efficacy|0
1530016|NCT00280150|5015050|P1|Overall Study|Lack of Efficacy|0
1530017|NCT00280150|5015047|P4|Overall Study|Adverse Event|3
1530018|NCT00280150|5015048|P3|Overall Study|Adverse Event|2
1530019|NCT00280150|5015049|P2|Overall Study|Adverse Event|1
1530020|NCT00280150|5015050|P1|Overall Study|Adverse Event|0
1530021|NCT00280059|5015065|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
1530022|NCT00280059|5015066|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
1530023|NCT00280059|5015065|P2|Efficacy Assessment Phase|Other|8
1530024|NCT00280059|5015066|P1|Efficacy Assessment Phase|Other|7
1530025|NCT00280059|5015065|P2|Efficacy Assessment Phase|Lost to Follow-up|13
1530026|NCT00280059|5015066|P1|Efficacy Assessment Phase|Lost to Follow-up|6
1530027|NCT00280059|5015065|P2|Efficacy Assessment Phase|Lack of Efficacy|3
1530028|NCT00280059|5015066|P1|Efficacy Assessment Phase|Lack of Efficacy|19
1530029|NCT00280059|5015065|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
1530030|NCT00280059|5015066|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
1530031|NCT00280059|5015065|P2|Efficacy Assessment Phase|Adverse Event|31
1530032|NCT00280059|5015066|P1|Efficacy Assessment Phase|Adverse Event|33
1530033|NCT00280059|5015065|P2|Efficacy Assessment Phase|Death|0
1530034|NCT00280059|5015066|P1|Efficacy Assessment Phase|Death|2
1530035|NCT00279916|5015130|P2|Overall Study|Lost to Follow-up|2
1530036|NCT00279916|5015131|P1|Overall Study|Lost to Follow-up|3
1530037|NCT00279916|5015130|P2|Overall Study|Withdrawal by Subject|3
1530038|NCT00279916|5015131|P1|Overall Study|Withdrawal by Subject|4
1530039|NCT00279812|5015157|P6|Overall Study|Adverse Event|1
1530040|NCT00279812|5015158|P5|Overall Study|Adverse Event|2
1530041|NCT00279812|5015159|P4|Overall Study|Adverse Event|0
1530042|NCT00279812|5015160|P3|Overall Study|Adverse Event|1
1530043|NCT00279812|5015161|P2|Overall Study|Adverse Event|1
1530044|NCT00279812|5015162|P1|Overall Study|Adverse Event|0
1530045|NCT00279812|5015157|P6|Overall Study|Withdrawal by Subject|0
1530046|NCT00279812|5015158|P5|Overall Study|Withdrawal by Subject|0
1530047|NCT00279812|5015159|P4|Overall Study|Withdrawal by Subject|0
1530048|NCT00279812|5015160|P3|Overall Study|Withdrawal by Subject|2
1530049|NCT00279812|5015161|P2|Overall Study|Withdrawal by Subject|4
1530050|NCT00279812|5015162|P1|Overall Study|Withdrawal by Subject|0
1530051|NCT00279812|5015157|P6|Overall Study|Protocol Violation|0
1530052|NCT00279812|5015158|P5|Overall Study|Protocol Violation|1
1530053|NCT00279812|5015159|P4|Overall Study|Protocol Violation|0
1530054|NCT00279812|5015160|P3|Overall Study|Protocol Violation|0
1530055|NCT00279812|5015161|P2|Overall Study|Protocol Violation|1
1530056|NCT00279812|5015162|P1|Overall Study|Protocol Violation|1
1530057|NCT00279708|5015190|P2|Overall Study|Adverse Event|1
1530058|NCT00279708|5015191|P1|Overall Study|Adverse Event|1
1530059|NCT00279708|5015190|P2|Overall Study|Withdrawal by Subject|3
1530060|NCT00279708|5015191|P1|Overall Study|Withdrawal by Subject|2
1530061|NCT00279305|5015220|P2|Overall Study|FDA Safety Alert|1
1530062|NCT00279305|5015221|P1|Overall Study|FDA Safety Alert|4
1530063|NCT00279305|5015220|P2|Overall Study|Dificulting establishing IV|0
1530064|NCT00279305|5015221|P1|Overall Study|Dificulting establishing IV|1
1530065|NCT00279305|5015220|P2|Overall Study|Withdrawal by Subject|0
1530066|NCT00279305|5015221|P1|Overall Study|Withdrawal by Subject|2
1530067|NCT00279305|5015220|P2|Overall Study|Pregnancy|0
1530068|NCT00279305|5015221|P1|Overall Study|Pregnancy|1
1530069|NCT00279214|5015229|P2|Overall Study|Physician Decision|2
1530070|NCT00279214|5015230|P1|Overall Study|Physician Decision|3
1530071|NCT00279201|5015260|P6|Intensification Addendum|Death|0
1530072|NCT00279201|5015261|P5|Intensification Addendum|Death|1
1530073|NCT00279201|5015262|P4|Intensification Addendum|Death|0
1530074|NCT00279201|5015263|P3|Intensification Addendum|Death|0
1530075|NCT00279201|5015264|P2|Intensification Addendum|Death|0
1530076|NCT00279201|5015265|P1|Intensification Addendum|Death|0
1530077|NCT00279201|5015260|P6|Intensification Addendum|Lack of Efficacy|0
1530078|NCT00279201|5015261|P5|Intensification Addendum|Lack of Efficacy|1
1530079|NCT00279201|5015262|P4|Intensification Addendum|Lack of Efficacy|1
1530080|NCT00279201|5015263|P3|Intensification Addendum|Lack of Efficacy|0
1530081|NCT00279201|5015264|P2|Intensification Addendum|Lack of Efficacy|0
1530082|NCT00279201|5015265|P1|Intensification Addendum|Lack of Efficacy|0
1530083|NCT00279201|5015260|P6|Intensification Addendum|Entry Criteria Exclusion|0
1530084|NCT00279201|5015261|P5|Intensification Addendum|Entry Criteria Exclusion|0
1530085|NCT00279201|5015262|P4|Intensification Addendum|Entry Criteria Exclusion|0
1530086|NCT00279201|5015263|P3|Intensification Addendum|Entry Criteria Exclusion|1
1530087|NCT00279201|5015264|P2|Intensification Addendum|Entry Criteria Exclusion|0
1530088|NCT00279201|5015265|P1|Intensification Addendum|Entry Criteria Exclusion|0
1530089|NCT00279201|5015260|P6|Intensification Addendum|Sponsor Decision|1
1530090|NCT00279201|5015261|P5|Intensification Addendum|Sponsor Decision|1
1530091|NCT00279201|5015262|P4|Intensification Addendum|Sponsor Decision|0
1530092|NCT00279201|5015263|P3|Intensification Addendum|Sponsor Decision|0
1530093|NCT00279201|5015264|P2|Intensification Addendum|Sponsor Decision|0
1530094|NCT00279201|5015265|P1|Intensification Addendum|Sponsor Decision|0
1530095|NCT00279201|5015260|P6|Intensification Addendum|Physician Decision|2
1530096|NCT00279201|5015261|P5|Intensification Addendum|Physician Decision|3
1530097|NCT00279201|5015262|P4|Intensification Addendum|Physician Decision|1
1530098|NCT00279201|5015263|P3|Intensification Addendum|Physician Decision|4
1530099|NCT00279201|5015264|P2|Intensification Addendum|Physician Decision|0
1530100|NCT00279201|5015265|P1|Intensification Addendum|Physician Decision|0
1530101|NCT00279201|5015260|P6|Intensification Addendum|Adverse Event|3
1530102|NCT00279201|5015261|P5|Intensification Addendum|Adverse Event|1
1530103|NCT00279201|5015262|P4|Intensification Addendum|Adverse Event|4
1530104|NCT00279201|5015263|P3|Intensification Addendum|Adverse Event|0
1530105|NCT00279201|5015264|P2|Intensification Addendum|Adverse Event|0
1530106|NCT00279201|5015265|P1|Intensification Addendum|Adverse Event|0
1530107|NCT00279201|5015260|P6|Intensification Addendum|Protocol Violation|6
1530108|NCT00279201|5015261|P5|Intensification Addendum|Protocol Violation|6
1530109|NCT00279201|5015262|P4|Intensification Addendum|Protocol Violation|2
1530110|NCT00279201|5015263|P3|Intensification Addendum|Protocol Violation|2
1530111|NCT00279201|5015264|P2|Intensification Addendum|Protocol Violation|0
1530112|NCT00279201|5015265|P1|Intensification Addendum|Protocol Violation|0
1530113|NCT00279201|5015260|P6|Intensification Addendum|Lost to Follow-up|7
1530114|NCT00279201|5015261|P5|Intensification Addendum|Lost to Follow-up|7
1530115|NCT00279201|5015262|P4|Intensification Addendum|Lost to Follow-up|6
1530116|NCT00279201|5015263|P3|Intensification Addendum|Lost to Follow-up|4
1530117|NCT00279201|5015264|P2|Intensification Addendum|Lost to Follow-up|0
1530118|NCT00279201|5015265|P1|Intensification Addendum|Lost to Follow-up|0
1530119|NCT00279201|5015260|P6|Intensification Addendum|Withdrawal by Subject|18
1530120|NCT00279201|5015261|P5|Intensification Addendum|Withdrawal by Subject|9
1530121|NCT00279201|5015262|P4|Intensification Addendum|Withdrawal by Subject|14
1530122|NCT00279201|5015263|P3|Intensification Addendum|Withdrawal by Subject|12
1530123|NCT00279201|5015264|P2|Intensification Addendum|Withdrawal by Subject|0
1530124|NCT00279201|5015265|P1|Intensification Addendum|Withdrawal by Subject|0
1530125|NCT00279201|5015260|P6|Maintenance|HbA1c>7.5%|0
1530126|NCT00279201|5015261|P5|Maintenance|HbA1c>7.5%|0
1530127|NCT00279201|5015262|P4|Maintenance|HbA1c>7.5%|0
1530128|NCT00279201|5015263|P3|Maintenance|HbA1c>7.5%|0
1530129|NCT00279201|5015264|P2|Maintenance|HbA1c>7.5%|126
1530130|NCT00279201|5015265|P1|Maintenance|HbA1c>7.5%|123
1530131|NCT00279201|5015260|P6|Maintenance|Sponsor Decision|0
1530132|NCT00279201|5015261|P5|Maintenance|Sponsor Decision|0
1530133|NCT00279201|5015262|P4|Maintenance|Sponsor Decision|0
1530134|NCT00279201|5015263|P3|Maintenance|Sponsor Decision|0
1530135|NCT00279201|5015264|P2|Maintenance|Sponsor Decision|0
1530136|NCT00279201|5015265|P1|Maintenance|Sponsor Decision|4
1530137|NCT00279201|5015260|P6|Maintenance|Physician Decision|0
1530138|NCT00279201|5015261|P5|Maintenance|Physician Decision|0
1530139|NCT00279201|5015262|P4|Maintenance|Physician Decision|0
1530140|NCT00279201|5015263|P3|Maintenance|Physician Decision|0
1530141|NCT00279201|5015264|P2|Maintenance|Physician Decision|9
1530142|NCT00279201|5015265|P1|Maintenance|Physician Decision|9
1530143|NCT00279201|5015260|P6|Maintenance|Withdrawal by Subject|0
1530144|NCT00279201|5015261|P5|Maintenance|Withdrawal by Subject|0
1530145|NCT00279201|5015262|P4|Maintenance|Withdrawal by Subject|0
1530146|NCT00279201|5015263|P3|Maintenance|Withdrawal by Subject|0
1530147|NCT00279201|5015264|P2|Maintenance|Withdrawal by Subject|18
1530148|NCT00279201|5015265|P1|Maintenance|Withdrawal by Subject|18
1530149|NCT00279201|5015260|P6|Maintenance|Protocol Violation|0
1530150|NCT00279201|5015261|P5|Maintenance|Protocol Violation|0
1530151|NCT00279201|5015262|P4|Maintenance|Protocol Violation|0
1530152|NCT00279201|5015263|P3|Maintenance|Protocol Violation|0
1530153|NCT00279201|5015264|P2|Maintenance|Protocol Violation|24
1530154|NCT00279201|5015265|P1|Maintenance|Protocol Violation|16
1530155|NCT00279201|5015260|P6|Maintenance|Entry Criteria Exclusion|0
1530156|NCT00279201|5015261|P5|Maintenance|Entry Criteria Exclusion|0
1530157|NCT00279201|5015262|P4|Maintenance|Entry Criteria Exclusion|0
1530158|NCT00279201|5015263|P3|Maintenance|Entry Criteria Exclusion|0
1530159|NCT00279201|5015264|P2|Maintenance|Entry Criteria Exclusion|4
1530160|NCT00279201|5015265|P1|Maintenance|Entry Criteria Exclusion|1
1530161|NCT00279201|5015260|P6|Maintenance|Lost to Follow-up|0
1530162|NCT00279201|5015261|P5|Maintenance|Lost to Follow-up|0
1530163|NCT00279201|5015262|P4|Maintenance|Lost to Follow-up|0
1530164|NCT00279201|5015263|P3|Maintenance|Lost to Follow-up|0
1530165|NCT00279201|5015264|P2|Maintenance|Lost to Follow-up|13
1530166|NCT00279201|5015265|P1|Maintenance|Lost to Follow-up|17
1530167|NCT00279201|5015260|P6|Maintenance|Death|0
1530168|NCT00279201|5015261|P5|Maintenance|Death|0
1530169|NCT00279201|5015262|P4|Maintenance|Death|0
1530170|NCT00279201|5015263|P3|Maintenance|Death|0
1530171|NCT00279201|5015264|P2|Maintenance|Death|4
1530172|NCT00279201|5015265|P1|Maintenance|Death|4
1530173|NCT00279201|5015260|P6|Maintenance|Adverse Event|0
1530174|NCT00279201|5015261|P5|Maintenance|Adverse Event|0
1530175|NCT00279201|5015262|P4|Maintenance|Adverse Event|0
1530176|NCT00279201|5015263|P3|Maintenance|Adverse Event|0
1530177|NCT00279201|5015264|P2|Maintenance|Adverse Event|4
1530178|NCT00279201|5015265|P1|Maintenance|Adverse Event|4
1530179|NCT00279201|5015260|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1530180|NCT00279201|5015261|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1530181|NCT00279201|5015262|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1530182|NCT00279201|5015263|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1530183|NCT00279201|5015264|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
1530184|NCT00279201|5015265|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
1530185|NCT00279201|5015260|P6|Maintenance|Lack of Efficacy|0
1530186|NCT00279201|5015261|P5|Maintenance|Lack of Efficacy|0
1530187|NCT00279201|5015262|P4|Maintenance|Lack of Efficacy|0
1530188|NCT00279201|5015263|P3|Maintenance|Lack of Efficacy|0
1530189|NCT00279201|5015264|P2|Maintenance|Lack of Efficacy|30
1530190|NCT00279201|5015265|P1|Maintenance|Lack of Efficacy|32
1530191|NCT00279201|5015260|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
1530192|NCT00279201|5015261|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
1530193|NCT00279201|5015262|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
1530194|NCT00279201|5015263|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
1530195|NCT00279201|5015264|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
1530196|NCT00279201|5015265|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
1530197|NCT00279201|5015260|P6|Initiation|Sponsor Decision|0
1530198|NCT00279201|5015261|P5|Initiation|Sponsor Decision|0
1530199|NCT00279201|5015262|P4|Initiation|Sponsor Decision|0
1530200|NCT00279201|5015263|P3|Initiation|Sponsor Decision|0
1530201|NCT00279201|5015264|P2|Initiation|Sponsor Decision|5
1530202|NCT00279201|5015265|P1|Initiation|Sponsor Decision|13
1530203|NCT00279201|5015260|P6|Initiation|Physician Decision|0
1530204|NCT00279201|5015261|P5|Initiation|Physician Decision|0
1530205|NCT00279201|5015262|P4|Initiation|Physician Decision|0
1530206|NCT00279201|5015263|P3|Initiation|Physician Decision|0
1530207|NCT00279201|5015264|P2|Initiation|Physician Decision|18
1530208|NCT00279201|5015265|P1|Initiation|Physician Decision|15
1530209|NCT00279201|5015260|P6|Initiation|Withdrawal by Subject|0
1530210|NCT00279201|5015261|P5|Initiation|Withdrawal by Subject|0
1530211|NCT00279201|5015262|P4|Initiation|Withdrawal by Subject|0
1530212|NCT00279201|5015263|P3|Initiation|Withdrawal by Subject|0
1530213|NCT00279201|5015264|P2|Initiation|Withdrawal by Subject|41
1530214|NCT00279201|5015265|P1|Initiation|Withdrawal by Subject|35
1530215|NCT00279201|5015260|P6|Initiation|Protocol Violation|0
1530216|NCT00279201|5015261|P5|Initiation|Protocol Violation|0
1530217|NCT00279201|5015262|P4|Initiation|Protocol Violation|0
1530218|NCT00279201|5015263|P3|Initiation|Protocol Violation|0
1530219|NCT00279201|5015264|P2|Initiation|Protocol Violation|10
1530220|NCT00279201|5015265|P1|Initiation|Protocol Violation|9
1530221|NCT00279201|5015260|P6|Initiation|Entry Criteria Exclusion|0
1530222|NCT00279201|5015261|P5|Initiation|Entry Criteria Exclusion|0
1530223|NCT00279201|5015262|P4|Initiation|Entry Criteria Exclusion|0
1530224|NCT00279201|5015263|P3|Initiation|Entry Criteria Exclusion|0
1530225|NCT00279201|5015264|P2|Initiation|Entry Criteria Exclusion|9
1530226|NCT00279201|5015265|P1|Initiation|Entry Criteria Exclusion|7
1530227|NCT00279201|5015260|P6|Initiation|Lost to Follow-up|0
1530228|NCT00279201|5015261|P5|Initiation|Lost to Follow-up|0
1530229|NCT00279201|5015262|P4|Initiation|Lost to Follow-up|0
1530230|NCT00279201|5015263|P3|Initiation|Lost to Follow-up|0
1530231|NCT00279201|5015264|P2|Initiation|Lost to Follow-up|41
1530232|NCT00279201|5015265|P1|Initiation|Lost to Follow-up|42
1530233|NCT00279201|5015260|P6|Initiation|Adverse Event|0
1530234|NCT00279201|5015261|P5|Initiation|Adverse Event|0
1530235|NCT00279201|5015262|P4|Initiation|Adverse Event|0
1530236|NCT00279201|5015263|P3|Initiation|Adverse Event|0
1530237|NCT00279201|5015264|P2|Initiation|Adverse Event|15
1530238|NCT00279201|5015265|P1|Initiation|Adverse Event|6
1530239|NCT00279201|5015260|P6|Initiation|Death|0
1530240|NCT00279201|5015261|P5|Initiation|Death|0
1530241|NCT00279201|5015262|P4|Initiation|Death|0
1530242|NCT00279201|5015263|P3|Initiation|Death|0
1530243|NCT00279201|5015264|P2|Initiation|Death|5
1530244|NCT00279201|5015265|P1|Initiation|Death|1
1530245|NCT00278993|5015409|P1|Overall Study|Not Otherwise Specified|4
1530246|NCT00278993|5015409|P1|Overall Study|Physician Decision|9
1530247|NCT00278993|5015409|P1|Overall Study|Progressive Disease|65
1530248|NCT00278993|5015409|P1|Overall Study|Withdrawal by Subject|5
1530249|NCT00278993|5015409|P1|Overall Study|Adverse Event|24
1530250|NCT00278954|5015417|P1|Overall Study|Withdrawal by Subject|1
1530251|NCT00278954|5015417|P1|Overall Study|Lost to Follow-up|1
1530252|NCT00278954|5015417|P1|Overall Study|Adverse Event|3
1530253|NCT00278915|5015425|P1|Overall Study|Lack of Efficacy|1
1530254|NCT00278889|5015461|P3|Overall Study|Death|17
1530255|NCT00278889|5015462|P2|Overall Study|Death|21
1530256|NCT00278889|5015463|P1|Overall Study|Death|24
1530257|NCT00278889|5015461|P3|Overall Study|Lost to Follow-up|0
1530258|NCT00278889|5015462|P2|Overall Study|Lost to Follow-up|1
1530259|NCT00278889|5015463|P1|Overall Study|Lost to Follow-up|1
1530260|NCT00278889|5015461|P3|Overall Study|Withdrawal by Subject|3
1530261|NCT00278889|5015462|P2|Overall Study|Withdrawal by Subject|5
1530262|NCT00278889|5015463|P1|Overall Study|Withdrawal by Subject|0
1530263|NCT00278564|5015511|P1|Overall Study|Lack of Efficacy|4
1530264|NCT00278512|5015528|P2|Overall Study|Death|0
1530265|NCT00278512|5015529|P1|Overall Study|Death|1
1530266|NCT00278473|5015537|P2|Overall Study|drop out|3
1530267|NCT00278473|5015538|P1|Overall Study|drop out|4
1530268|NCT00278395|5015554|P1|Overall Study|Nonevaluable|1
1530269|NCT00278395|5015554|P1|Overall Study|Adverse Event|2
1530270|NCT00277355|5015612|P2|Overall Study|Physician Decision|0
1530271|NCT00277355|5015613|P1|Overall Study|Physician Decision|1
1530272|NCT00277355|5015612|P2|Overall Study|Death|0
1530273|NCT00277355|5015613|P1|Overall Study|Death|3
1530274|NCT00277355|5015612|P2|Overall Study|Adverse Event|0
1530275|NCT00277355|5015613|P1|Overall Study|Adverse Event|5
1530276|NCT00277355|5015612|P2|Overall Study|Lost to Follow-up|2
1530277|NCT00277355|5015613|P1|Overall Study|Lost to Follow-up|2
1530278|NCT00277355|5015612|P2|Overall Study|Withdrawal by Subject|3
1530279|NCT00277355|5015613|P1|Overall Study|Withdrawal by Subject|3
1530280|NCT00277212|5015621|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
1530281|NCT00277212|5015622|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
1530282|NCT00277212|5015623|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
1530283|NCT00277212|5015621|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
1530284|NCT00277212|5015622|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
1530285|NCT00277212|5015623|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
1530286|NCT00277212|5015621|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
1530287|NCT00277212|5015622|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
1530288|NCT00277212|5015623|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
1530289|NCT00277212|5015621|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
1530290|NCT00277212|5015622|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
1530291|NCT00277212|5015623|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
1530292|NCT00277212|5015621|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
1530293|NCT00277212|5015622|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
1530294|NCT00277212|5015623|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
1530295|NCT00277212|5015621|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
1530296|NCT00277212|5015622|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
1530297|NCT00277212|5015623|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
1530298|NCT00277212|5015621|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
1530299|NCT00277212|5015622|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
1530300|NCT00277212|5015623|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
1530301|NCT00277212|5015621|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
1530302|NCT00277212|5015622|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
1530303|NCT00277212|5015623|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
1530304|NCT00277212|5015621|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
1530305|NCT00277212|5015622|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
1530306|NCT00277212|5015623|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
1530307|NCT00277212|5015621|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
1530308|NCT00277212|5015622|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
1530309|NCT00277212|5015623|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
1530310|NCT00277212|5015621|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
1530311|NCT00277212|5015622|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
1530312|NCT00277212|5015623|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
1530313|NCT00277212|5015621|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
1530314|NCT00277212|5015622|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
1530315|NCT00277212|5015623|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
1530316|NCT00277212|5015621|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
1530317|NCT00277212|5015622|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
1530318|NCT00277212|5015623|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
1530319|NCT00277212|5015621|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
1530320|NCT00277212|5015622|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
1530321|NCT00277212|5015623|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
1530322|NCT00277212|5015621|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
1530323|NCT00277212|5015622|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
1530324|NCT00277212|5015623|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
1530325|NCT00277212|5015621|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
1530326|NCT00277212|5015622|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
1530327|NCT00277212|5015623|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
1530328|NCT00277212|5015621|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
1530329|NCT00277212|5015622|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
1530330|NCT00277212|5015623|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
1530331|NCT00277212|5015621|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
1530332|NCT00277212|5015622|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
1530333|NCT00277212|5015623|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
1530334|NCT00277095|5015661|P1|Overall Study|Physician Decision|1
1530335|NCT00277095|5015661|P1|Overall Study|Missed Follow-up|9
1530336|NCT00277095|5015661|P1|Overall Study|Lost to Follow-up|2
1530337|NCT00277095|5015661|P1|Overall Study|Explanted|7
1530338|NCT00277095|5015661|P1|Overall Study|Death|2
1530339|NCT00276744|5015670|P1|PART A|Reason unknown|98
1530340|NCT00276614|5015674|P1|Overall Study|Progression of disease under study|3
1530341|NCT00276484|5015685|P2|Overall Study|Could not take time off work|1
1530342|NCT00276484|5015686|P1|Overall Study|Could not take time off work|0
1530343|NCT00276484|5015685|P2|Overall Study|Withdrawal by Subject|3
1530344|NCT00276484|5015686|P1|Overall Study|Withdrawal by Subject|4
1530345|NCT00276484|5015685|P2|Overall Study|Protocol Violation|1
1530346|NCT00276484|5015686|P1|Overall Study|Protocol Violation|0
1530347|NCT00276484|5015685|P2|Overall Study|Lost to Follow-up|1
1530348|NCT00276484|5015686|P1|Overall Study|Lost to Follow-up|1
1530349|NCT00276484|5015685|P2|Overall Study|Adverse Event|7
1530350|NCT00276484|5015686|P1|Overall Study|Adverse Event|4
1530351|NCT00276458|5015718|P2|Overall Study|Protocol Violation|3
1530352|NCT00276458|5015719|P1|Overall Study|Protocol Violation|4
1530353|NCT00276458|5015718|P2|Overall Study|Lost to Follow-up|2
1530354|NCT00276458|5015719|P1|Overall Study|Lost to Follow-up|2
1530355|NCT00276458|5015718|P2|Overall Study|Adverse Event|2
1530356|NCT00276458|5015719|P1|Overall Study|Adverse Event|0
1530357|NCT00276419|5015753|P2|First Intervention|Withdrawal by Subject|2
1530358|NCT00276419|5015754|P1|First Intervention|Withdrawal by Subject|0
1530359|NCT00276419|5015753|P2|First Intervention|Adverse Event|0
1530360|NCT00276419|5015754|P1|First Intervention|Adverse Event|1
1530361|NCT00276380|5015797|P2|Overall Study|Abnormal aPPT Levels|1
1530362|NCT00276380|5015798|P1|Overall Study|Abnormal aPPT Levels|0
1530363|NCT00276380|5015797|P2|Overall Study|Death|3
1530364|NCT00276380|5015798|P1|Overall Study|Death|5
1530365|NCT00276380|5015797|P2|Overall Study|Withdrawal by Subject|6
1530366|NCT00276380|5015798|P1|Overall Study|Withdrawal by Subject|3
1530367|NCT00276380|5015797|P2|Overall Study|Lost to Follow-up|1
1530368|NCT00276380|5015798|P1|Overall Study|Lost to Follow-up|1
1530369|NCT00276380|5015797|P2|Overall Study|Adverse Event|3
1530370|NCT00276380|5015798|P1|Overall Study|Adverse Event|5
1530371|NCT00276159|5015853|P1|Overall Study|Did not receive all 24 doses of 852A|6
1530372|NCT00276094|5015863|P3|Overall Study|Other-Study medication lost|1
1530373|NCT00276094|5015864|P2|Overall Study|Other-Study medication lost|0
1530374|NCT00276094|5015865|P1|Overall Study|Other-Study medication lost|0
1530375|NCT00276094|5015863|P3|Overall Study|Other-Relocation|0
1530376|NCT00276094|5015864|P2|Overall Study|Other-Relocation|1
1530377|NCT00276094|5015865|P1|Overall Study|Other-Relocation|0
1530378|NCT00276094|5015863|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
1530379|NCT00276094|5015864|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
1530380|NCT00276094|5015865|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
1530381|NCT00276094|5015863|P3|Overall Study|Other-Refused follow-up visit|0
1530382|NCT00276094|5015864|P2|Overall Study|Other-Refused follow-up visit|0
1530383|NCT00276094|5015865|P1|Overall Study|Other-Refused follow-up visit|1
1530384|NCT00276094|5015863|P3|Overall Study|Other-Lack of efficacy|0
1530385|NCT00276094|5015864|P2|Overall Study|Other-Lack of efficacy|0
1530386|NCT00276094|5015865|P1|Overall Study|Other-Lack of efficacy|1
1530387|NCT00276094|5015863|P3|Overall Study|Other-Scheduled gastroplasty|0
1530388|NCT00276094|5015864|P2|Overall Study|Other-Scheduled gastroplasty|0
1530389|NCT00276094|5015865|P1|Overall Study|Other-Scheduled gastroplasty|1
1530390|NCT00276094|5015863|P3|Overall Study|Other-Subject moved out of country|0
1530391|NCT00276094|5015864|P2|Overall Study|Other-Subject moved out of country|0
1530392|NCT00276094|5015865|P1|Overall Study|Other-Subject moved out of country|1
1530393|NCT00276094|5015863|P3|Overall Study|Lost to Follow-up|4
1530394|NCT00276094|5015864|P2|Overall Study|Lost to Follow-up|6
1530395|NCT00276094|5015865|P1|Overall Study|Lost to Follow-up|8
1530396|NCT00276094|5015863|P3|Overall Study|Protocol Violation|10
1530397|NCT00276094|5015864|P2|Overall Study|Protocol Violation|7
1530398|NCT00276094|5015865|P1|Overall Study|Protocol Violation|16
1530399|NCT00276094|5015863|P3|Overall Study|Withdrawal by Subject|12
1530400|NCT00276094|5015864|P2|Overall Study|Withdrawal by Subject|14
1530401|NCT00276094|5015865|P1|Overall Study|Withdrawal by Subject|14
1530402|NCT00276094|5015863|P3|Overall Study|Adverse Event|11
1530403|NCT00276094|5015864|P2|Overall Study|Adverse Event|13
1530404|NCT00276094|5015865|P1|Overall Study|Adverse Event|15
1530405|NCT00276016|5015918|P6|Intervention 1|Withdrawal by Subject|0
1530406|NCT00276016|5015919|P5|Intervention 1|Withdrawal by Subject|0
1530407|NCT00276016|5015920|P4|Intervention 1|Withdrawal by Subject|0
1530408|NCT00276016|5015921|P3|Intervention 1|Withdrawal by Subject|0
1530409|NCT00276016|5015922|P2|Intervention 1|Withdrawal by Subject|1
1530410|NCT00276016|5015923|P1|Intervention 1|Withdrawal by Subject|0
1530411|NCT00275821|5015969|P3|Overall Study|Protocol Violation|0
1530412|NCT00275821|5015970|P2|Overall Study|Protocol Violation|1
1530413|NCT00275821|5015971|P1|Overall Study|Protocol Violation|5
1530414|NCT00275821|5015969|P3|Overall Study|Lack of Efficacy|0
1530415|NCT00275821|5015970|P2|Overall Study|Lack of Efficacy|1
1530416|NCT00275821|5015971|P1|Overall Study|Lack of Efficacy|2
1530417|NCT00275821|5015969|P3|Overall Study|Death|1
1530418|NCT00275821|5015970|P2|Overall Study|Death|2
1530419|NCT00275821|5015971|P1|Overall Study|Death|0
1530420|NCT00275821|5015969|P3|Overall Study|Lost to Follow-up|1
1530421|NCT00275821|5015970|P2|Overall Study|Lost to Follow-up|1
1530422|NCT00275821|5015971|P1|Overall Study|Lost to Follow-up|0
1530423|NCT00275821|5015969|P3|Overall Study|Withdrawal by Subject|1
1530424|NCT00275821|5015970|P2|Overall Study|Withdrawal by Subject|2
1530425|NCT00275821|5015971|P1|Overall Study|Withdrawal by Subject|0
1530426|NCT00275821|5015969|P3|Overall Study|Administrative problems|4
1530427|NCT00275821|5015970|P2|Overall Study|Administrative problems|4
1530428|NCT00275821|5015971|P1|Overall Study|Administrative problems|3
1530429|NCT00275821|5015969|P3|Overall Study|Adverse Event|5
1530430|NCT00275821|5015970|P2|Overall Study|Adverse Event|12
1530431|NCT00275821|5015971|P1|Overall Study|Adverse Event|4
1530432|NCT00275561|5015990|P2|Overall Study|Family Issues|2
1530433|NCT00275561|5015991|P1|Overall Study|Family Issues|0
1530434|NCT00275561|5015990|P2|Overall Study|Scheduling|2
1530435|NCT00275561|5015991|P1|Overall Study|Scheduling|1
1530436|NCT00275561|5015990|P2|Overall Study|Travel|1
1530437|NCT00275561|5015991|P1|Overall Study|Travel|1
1530438|NCT00275561|5015990|P2|Overall Study|Withdrawal by Subject|1
1530439|NCT00275561|5015991|P1|Overall Study|Withdrawal by Subject|0
1530440|NCT00275509|5016003|P2|Overall Study|graft thrombosis, post-operative day #8|1
1530441|NCT00275509|5016004|P1|Overall Study|graft thrombosis, post-operative day #8|0
1530442|NCT00275340|5016027|P2|Overall Study|Lost to Follow-up|4
1530443|NCT00275340|5016028|P1|Overall Study|Lost to Follow-up|2
1530444|NCT00275301|5016032|P1|Overall Study|Adverse Event|5
1530445|NCT00275262|5016051|P2|Overall Study|Started Chemotherapy|0
1530446|NCT00275262|5016052|P1|Overall Study|Started Chemotherapy|1
1530447|NCT00275262|5016051|P2|Overall Study|Death|0
1530448|NCT00275262|5016052|P1|Overall Study|Death|1
1530449|NCT00275262|5016051|P2|Overall Study|Protocol Violation|2
1530450|NCT00275262|5016052|P1|Overall Study|Protocol Violation|0
1530451|NCT00275262|5016051|P2|Overall Study|Lost to Follow-up|2
1530452|NCT00275262|5016052|P1|Overall Study|Lost to Follow-up|0
1530453|NCT00275262|5016051|P2|Overall Study|Disease progression|5
1530454|NCT00275262|5016052|P1|Overall Study|Disease progression|2
1530455|NCT00275262|5016051|P2|Overall Study|Adverse Event|0
1530456|NCT00275262|5016052|P1|Overall Study|Adverse Event|2
1530457|NCT00275028|5016066|P1|Overall Study|Physician Decision|2
1530458|NCT00275028|5016066|P1|Overall Study|Progressive Disease|30
1530459|NCT00275028|5016066|P1|Overall Study|Adverse Event|9
1530460|NCT00275028|5016066|P1|Overall Study|Withdrawal by Subject|5
1530461|NCT00275028|5016066|P1|Overall Study|Withdrew consent before treatment began|1
1530462|NCT00275002|5016073|P2|Overall Study|Adverse Event|1
1530463|NCT00275002|5016074|P1|Overall Study|Adverse Event|0
1530464|NCT00275002|5016073|P2|Overall Study|Disease progression|15
1530465|NCT00275002|5016074|P1|Overall Study|Disease progression|21
1530466|NCT00275002|5016073|P2|Overall Study|Death|0
1530467|NCT00275002|5016074|P1|Overall Study|Death|1
1530468|NCT00274937|5016082|P1|Overall Study|Progressive Disease|4
1530469|NCT00274937|5016082|P1|Overall Study|Withdrawal by Subject|6
1530470|NCT00274937|5016082|P1|Overall Study|Physician Decision|10
1530471|NCT00274924|5016092|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
1530472|NCT00274924|5016093|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
1530473|NCT00274924|5016094|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
1530474|NCT00274924|5016092|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
1530475|NCT00274924|5016093|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
1530476|NCT00274924|5016094|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
1530477|NCT00274924|5016092|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
1530478|NCT00274924|5016093|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
1530479|NCT00274924|5016094|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
1530480|NCT00274924|5016092|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
1530481|NCT00274924|5016093|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
1530482|NCT00274924|5016094|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
1530483|NCT00274924|5016092|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
1530484|NCT00274924|5016093|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
1530485|NCT00274924|5016094|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
1530486|NCT00274924|5016092|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
1530487|NCT00274924|5016093|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
1530488|NCT00274924|5016094|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
1530489|NCT00274924|5016092|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
1530490|NCT00274924|5016093|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
1530491|NCT00274924|5016094|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
1530492|NCT00274924|5016092|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
1530493|NCT00274924|5016093|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
1530494|NCT00274924|5016094|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
1530495|NCT00274924|5016092|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
1530496|NCT00274924|5016093|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
1530497|NCT00274924|5016094|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
1530498|NCT00274924|5016092|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
1530499|NCT00274924|5016093|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
1530500|NCT00274924|5016094|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
1530501|NCT00274924|5016092|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
1530502|NCT00274924|5016093|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
1530503|NCT00274924|5016094|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
1530504|NCT00274924|5016092|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
1530505|NCT00274924|5016093|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
1530506|NCT00274924|5016094|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
1530507|NCT00274924|5016092|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
1530508|NCT00274924|5016093|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
1530509|NCT00274924|5016094|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
1530510|NCT00274846|5016103|P1|Overall Study|Did not receive adequate NK cells|1
1530511|NCT00274742|5016127|P6|Overall Study|Other|0
1530512|NCT00274742|5016128|P5|Overall Study|Other|2
1530513|NCT00274742|5016129|P4|Overall Study|Other|0
1530514|NCT00274742|5016130|P3|Overall Study|Other|0
1530515|NCT00274742|5016131|P2|Overall Study|Other|3
1530516|NCT00274742|5016132|P1|Overall Study|Other|0
1530517|NCT00274742|5016127|P6|Overall Study|Disease Progression|0
1530518|NCT00274742|5016128|P5|Overall Study|Disease Progression|1
1530519|NCT00274742|5016129|P4|Overall Study|Disease Progression|0
1530520|NCT00274742|5016130|P3|Overall Study|Disease Progression|1
1530521|NCT00274742|5016131|P2|Overall Study|Disease Progression|1
1530522|NCT00274742|5016132|P1|Overall Study|Disease Progression|0
1530523|NCT00274742|5016127|P6|Overall Study|End of Study|0
1530524|NCT00274742|5016128|P5|Overall Study|End of Study|0
1530525|NCT00274742|5016129|P4|Overall Study|End of Study|1
1530526|NCT00274742|5016130|P3|Overall Study|End of Study|0
1530527|NCT00274742|5016131|P2|Overall Study|End of Study|0
1530528|NCT00274742|5016132|P1|Overall Study|End of Study|0
1530529|NCT00274742|5016127|P6|Overall Study|Lost to Follow-up|0
1530530|NCT00274742|5016128|P5|Overall Study|Lost to Follow-up|1
1530531|NCT00274742|5016129|P4|Overall Study|Lost to Follow-up|0
1530532|NCT00274742|5016130|P3|Overall Study|Lost to Follow-up|0
1530533|NCT00274742|5016131|P2|Overall Study|Lost to Follow-up|0
1530534|NCT00274742|5016132|P1|Overall Study|Lost to Follow-up|0
1530535|NCT00274742|5016127|P6|Overall Study|Adverse Event|3
1530536|NCT00274742|5016128|P5|Overall Study|Adverse Event|12
1530537|NCT00274742|5016129|P4|Overall Study|Adverse Event|4
1530538|NCT00274742|5016130|P3|Overall Study|Adverse Event|1
1530539|NCT00274742|5016131|P2|Overall Study|Adverse Event|4
1530540|NCT00274742|5016132|P1|Overall Study|Adverse Event|0
1530541|NCT00274716|5016170|P6|Phase B|Lost to Follow-up|0
1530542|NCT00274716|5016171|P5|Phase B|Lost to Follow-up|0
1530543|NCT00274716|5016172|P4|Phase B|Lost to Follow-up|0
1530544|NCT00274716|5016173|P3|Phase B|Lost to Follow-up|0
1530545|NCT00274716|5016174|P2|Phase B|Lost to Follow-up|1
1530546|NCT00274716|5016175|P1|Phase B|Lost to Follow-up|0
1530547|NCT00274716|5016170|P6|Phase B|Other non-reported reason|0
1530548|NCT00274716|5016171|P5|Phase B|Other non-reported reason|0
1530549|NCT00274716|5016172|P4|Phase B|Other non-reported reason|1
1530550|NCT00274716|5016173|P3|Phase B|Other non-reported reason|1
1530551|NCT00274716|5016174|P2|Phase B|Other non-reported reason|0
1530552|NCT00274716|5016175|P1|Phase B|Other non-reported reason|0
1530553|NCT00274716|5016170|P6|Phase B|Participant moved|0
1530554|NCT00274716|5016171|P5|Phase B|Participant moved|0
1530555|NCT00274716|5016172|P4|Phase B|Participant moved|0
1530556|NCT00274716|5016173|P3|Phase B|Participant moved|0
1530557|NCT00274716|5016174|P2|Phase B|Participant moved|0
1530558|NCT00274716|5016175|P1|Phase B|Participant moved|1
1530559|NCT00274716|5016170|P6|Phase B|Withdrawal by Subject|0
1530560|NCT00274716|5016171|P5|Phase B|Withdrawal by Subject|0
1530561|NCT00274716|5016172|P4|Phase B|Withdrawal by Subject|0
1530562|NCT00274716|5016173|P3|Phase B|Withdrawal by Subject|0
1530563|NCT00274716|5016174|P2|Phase B|Withdrawal by Subject|1
1530564|NCT00274716|5016175|P1|Phase B|Withdrawal by Subject|0
1530565|NCT00274716|5016170|P6|Phase B|Protocol Violation|0
1530566|NCT00274716|5016171|P5|Phase B|Protocol Violation|0
1530567|NCT00274716|5016172|P4|Phase B|Protocol Violation|0
1530568|NCT00274716|5016173|P3|Phase B|Protocol Violation|0
1530569|NCT00274716|5016174|P2|Phase B|Protocol Violation|2
1530570|NCT00274716|5016175|P1|Phase B|Protocol Violation|0
1530571|NCT00274716|5016170|P6|Phase B|Adverse Event|1
1530572|NCT00274716|5016171|P5|Phase B|Adverse Event|0
1530573|NCT00274716|5016172|P4|Phase B|Adverse Event|0
1530574|NCT00274716|5016173|P3|Phase B|Adverse Event|2
1530575|NCT00274716|5016174|P2|Phase B|Adverse Event|0
1530576|NCT00274716|5016175|P1|Phase B|Adverse Event|0
1530577|NCT00274716|5016170|P6|Phase A|Completed but did not enter Phase B|1
1530578|NCT00274716|5016171|P5|Phase A|Completed but did not enter Phase B|1
1530579|NCT00274716|5016172|P4|Phase A|Completed but did not enter Phase B|2
1530580|NCT00274716|5016173|P3|Phase A|Completed but did not enter Phase B|2
1530581|NCT00274716|5016174|P2|Phase A|Completed but did not enter Phase B|2
1530582|NCT00274716|5016175|P1|Phase A|Completed but did not enter Phase B|1
1530583|NCT00274716|5016170|P6|Phase A|Adverse Event|0
1530584|NCT00274716|5016171|P5|Phase A|Adverse Event|2
1530585|NCT00274716|5016172|P4|Phase A|Adverse Event|0
1530586|NCT00274716|5016173|P3|Phase A|Adverse Event|3
1530587|NCT00274716|5016174|P2|Phase A|Adverse Event|3
1530588|NCT00274716|5016175|P1|Phase A|Adverse Event|2
1530589|NCT00274716|5016170|P6|Phase A|Withdrawal by Subject|1
1530590|NCT00274716|5016171|P5|Phase A|Withdrawal by Subject|0
1530591|NCT00274716|5016172|P4|Phase A|Withdrawal by Subject|3
1530592|NCT00274716|5016173|P3|Phase A|Withdrawal by Subject|1
1530593|NCT00274716|5016174|P2|Phase A|Withdrawal by Subject|2
1530594|NCT00274716|5016175|P1|Phase A|Withdrawal by Subject|2
1530595|NCT00274716|5016170|P6|Phase A|Met criteria for discontinuation|0
1530596|NCT00274716|5016171|P5|Phase A|Met criteria for discontinuation|0
1530597|NCT00274716|5016172|P4|Phase A|Met criteria for discontinuation|0
1530598|NCT00274716|5016173|P3|Phase A|Met criteria for discontinuation|0
1530599|NCT00274716|5016174|P2|Phase A|Met criteria for discontinuation|1
1530600|NCT00274716|5016175|P1|Phase A|Met criteria for discontinuation|1
1530601|NCT00274716|5016170|P6|Phase A|Protocol Violation|0
1530602|NCT00274716|5016171|P5|Phase A|Protocol Violation|0
1530603|NCT00274716|5016172|P4|Phase A|Protocol Violation|1
1530604|NCT00274716|5016173|P3|Phase A|Protocol Violation|0
1530605|NCT00274716|5016174|P2|Phase A|Protocol Violation|0
1530606|NCT00274716|5016175|P1|Phase A|Protocol Violation|1
1530607|NCT00274716|5016170|P6|Phase A|Site Terminated|0
1530608|NCT00274716|5016171|P5|Phase A|Site Terminated|0
1530609|NCT00274716|5016172|P4|Phase A|Site Terminated|1
1530610|NCT00274716|5016173|P3|Phase A|Site Terminated|0
1530611|NCT00274716|5016174|P2|Phase A|Site Terminated|0
1530612|NCT00274716|5016175|P1|Phase A|Site Terminated|0
1530613|NCT00274716|5016170|P6|Phase A|Participant moved|1
1530614|NCT00274716|5016171|P5|Phase A|Participant moved|0
1530615|NCT00274716|5016172|P4|Phase A|Participant moved|0
1530616|NCT00274716|5016173|P3|Phase A|Participant moved|1
1530617|NCT00274716|5016174|P2|Phase A|Participant moved|0
1530618|NCT00274716|5016175|P1|Phase A|Participant moved|0
1530619|NCT00274716|5016170|P6|Phase A|Other non-reported reason|1
1530620|NCT00274716|5016171|P5|Phase A|Other non-reported reason|0
1530621|NCT00274716|5016172|P4|Phase A|Other non-reported reason|2
1530622|NCT00274716|5016173|P3|Phase A|Other non-reported reason|1
1530623|NCT00274716|5016174|P2|Phase A|Other non-reported reason|2
1530624|NCT00274716|5016175|P1|Phase A|Other non-reported reason|4
1530625|NCT00274651|5016237|P2|Overall Study|Physician Decision|7
1530626|NCT00274651|5016238|P1|Overall Study|Physician Decision|8
1530627|NCT00274651|5016237|P2|Overall Study|Withdrawal by Subject|1
1530628|NCT00274651|5016238|P1|Overall Study|Withdrawal by Subject|0
1530629|NCT00274651|5016237|P2|Overall Study|Death|3
1530630|NCT00274651|5016238|P1|Overall Study|Death|1
1530631|NCT00274651|5016237|P2|Overall Study|Lack of Efficacy|6
1530632|NCT00274651|5016238|P1|Overall Study|Lack of Efficacy|13
1530633|NCT00274651|5016237|P2|Overall Study|Adverse Event|3
1530634|NCT00274651|5016238|P1|Overall Study|Adverse Event|6
1530635|NCT00274625|5016253|P2|Overall Study|Excluded from analysis|8
1530636|NCT00274625|5016254|P1|Overall Study|Excluded from analysis|14
1530637|NCT00274625|5016253|P2|Overall Study|Lost to Follow-up|54
1530638|NCT00274625|5016254|P1|Overall Study|Lost to Follow-up|46
1530639|NCT00274469|5016262|P2|Overall Study|Reasons not specified|8
1530640|NCT00274469|5016263|P1|Overall Study|Reasons not specified|5
1530641|NCT00274469|5016262|P2|Overall Study|Withdrawal by Subject|0
1530642|NCT00274469|5016263|P1|Overall Study|Withdrawal by Subject|2
1530643|NCT00274469|5016262|P2|Overall Study|Condition under investigation worsened|38
1530644|NCT00274469|5016263|P1|Overall Study|Condition under investigation worsened|28
1530645|NCT00274469|5016262|P2|Overall Study|Adverse Event|3
1530646|NCT00274469|5016263|P1|Overall Study|Adverse Event|2
1530647|NCT00274469|5016262|P2|Overall Study|Death|1
1530648|NCT00274469|5016263|P1|Overall Study|Death|1
1530649|NCT00274456|5016281|P4|Overall Study|Withdrawal by Subject|13
1530650|NCT00274456|5016282|P3|Overall Study|Withdrawal by Subject|9
1530651|NCT00274456|5016283|P2|Overall Study|Withdrawal by Subject|13
1530652|NCT00274456|5016284|P1|Overall Study|Withdrawal by Subject|18
1530653|NCT00274456|5016281|P4|Overall Study|Lost to Follow-up|0
1530654|NCT00274456|5016282|P3|Overall Study|Lost to Follow-up|1
1530655|NCT00274456|5016283|P2|Overall Study|Lost to Follow-up|0
1530656|NCT00274456|5016284|P1|Overall Study|Lost to Follow-up|0
1530657|NCT00274456|5016281|P4|Overall Study|Physician Decision|13
1530658|NCT00274456|5016282|P3|Overall Study|Physician Decision|6
1530659|NCT00274456|5016283|P2|Overall Study|Physician Decision|5
1530660|NCT00274456|5016284|P1|Overall Study|Physician Decision|7
1530661|NCT00274456|5016281|P4|Overall Study|Adverse Event|2
1530662|NCT00274456|5016282|P3|Overall Study|Adverse Event|2
1530663|NCT00274456|5016283|P2|Overall Study|Adverse Event|1
1530664|NCT00274456|5016284|P1|Overall Study|Adverse Event|0
1530665|NCT00274456|5016281|P4|Overall Study|Unacceptable toxicity|16
1530666|NCT00274456|5016282|P3|Overall Study|Unacceptable toxicity|12
1530667|NCT00274456|5016283|P2|Overall Study|Unacceptable toxicity|5
1530668|NCT00274456|5016284|P1|Overall Study|Unacceptable toxicity|10
1530669|NCT00274456|5016281|P4|Overall Study|Still on treatment|1
1530670|NCT00274456|5016282|P3|Overall Study|Still on treatment|5
1530671|NCT00274456|5016283|P2|Overall Study|Still on treatment|3
1530672|NCT00274456|5016284|P1|Overall Study|Still on treatment|2
1530673|NCT00274287|5016326|P1|Overall Study|subject non-compliance|1
1530674|NCT00274287|5016326|P1|Overall Study|Withdrawal by Subject|1
1530675|NCT00274261|5016332|P2|Overall Study|Lost to Follow-up|75
1530676|NCT00274261|5016333|P1|Overall Study|Lost to Follow-up|106
1530677|NCT00274261|5016332|P2|Overall Study|Protocol Violation|42
1530678|NCT00274261|5016333|P1|Overall Study|Protocol Violation|71
1530679|NCT00274261|5016332|P2|Overall Study|Withdrawal by Subject|126
1530680|NCT00274261|5016333|P1|Overall Study|Withdrawal by Subject|179
1530681|NCT00274261|5016332|P2|Overall Study|Pregnancy|83
1530682|NCT00274261|5016333|P1|Overall Study|Pregnancy|114
1530683|NCT00274261|5016332|P2|Overall Study|Adverse Event|11
1530684|NCT00274261|5016333|P1|Overall Study|Adverse Event|19
1530685|NCT00273858|5016372|P1|Overall Study|Adverse Event|81
1530686|NCT00273858|5016372|P1|Overall Study|Withdrawal by Subject|21
1530687|NCT00273858|5016372|P1|Overall Study|Lost to Follow-up|101
1530688|NCT00273858|5016372|P1|Overall Study|Not completed 24 month observation time|334
1530689|NCT00273182|5016431|P1|Overall Study|Site exit, system change, 36 m FU missed|36
1530690|NCT00273182|5016431|P1|Overall Study|Device/System Explant|154
1530691|NCT00273182|5016431|P1|Overall Study|Withdrawal by Subject|257
1530692|NCT00273182|5016431|P1|Overall Study|Lost to Follow-up|88
1530693|NCT00273182|5016431|P1|Overall Study|Death|450
1530694|NCT00273052|5016441|P2|Overall Study|Worsening serum lipid levels|2
1530695|NCT00273052|5016442|P1|Overall Study|Worsening serum lipid levels|0
1530696|NCT00273052|5016441|P2|Overall Study|Not specified|0
1530697|NCT00273052|5016442|P1|Overall Study|Not specified|2
1530698|NCT00273052|5016441|P2|Overall Study|Non-Compliance|1
1530699|NCT00273052|5016442|P1|Overall Study|Non-Compliance|3
1530700|NCT00273052|5016441|P2|Overall Study|Lack of Efficacy|4
1530701|NCT00273052|5016442|P1|Overall Study|Lack of Efficacy|6
1530702|NCT00273052|5016441|P2|Overall Study|Lost to Follow-up|25
1530703|NCT00273052|5016442|P1|Overall Study|Lost to Follow-up|7
1530704|NCT00273052|5016441|P2|Overall Study|Protocol Violation|18
1530705|NCT00273052|5016442|P1|Overall Study|Protocol Violation|14
1530706|NCT00273052|5016441|P2|Overall Study|Adverse Event|19
1530707|NCT00273052|5016442|P1|Overall Study|Adverse Event|21
1530708|NCT00273052|5016441|P2|Overall Study|Withdrawal by Subject|19
1530709|NCT00273052|5016442|P1|Overall Study|Withdrawal by Subject|16
1530710|NCT00272987|5016477|P3|Overall Study|Ongoing|15
1530711|NCT00272987|5016478|P2|Overall Study|Ongoing|14
1530712|NCT00272987|5016479|P1|Overall Study|Ongoing|20
1530713|NCT00272987|5016477|P3|Overall Study|Missed >3 Visits|1
1530714|NCT00272987|5016478|P2|Overall Study|Missed >3 Visits|0
1530715|NCT00272987|5016479|P1|Overall Study|Missed >3 Visits|0
1530716|NCT00272987|5016477|P3|Overall Study|Withdrawal by Subject|3
1530717|NCT00272987|5016478|P2|Overall Study|Withdrawal by Subject|0
1530718|NCT00272987|5016479|P1|Overall Study|Withdrawal by Subject|0
1530719|NCT00272987|5016477|P3|Overall Study|Adverse Event|0
1530720|NCT00272987|5016478|P2|Overall Study|Adverse Event|0
1530721|NCT00272987|5016479|P1|Overall Study|Adverse Event|1
1530722|NCT00272961|5016543|P5|Treatment Phase: Week 3 Up to Week 12|Other|2
1530723|NCT00272961|5016544|P4|Treatment Phase: Week 3 Up to Week 12|Other|2
1530724|NCT00272961|5016545|P3|Treatment Phase: Week 3 Up to Week 12|Other|3
1530725|NCT00272961|5016546|P2|Treatment Phase: Week 3 Up to Week 12|Other|3
1530726|NCT00272961|5016547|P1|Treatment Phase: Week 3 Up to Week 12|Other|1
1530727|NCT00272961|5016543|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
1530728|NCT00272961|5016544|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
1530729|NCT00272961|5016545|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
1530730|NCT00272961|5016546|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
1530731|NCT00272961|5016547|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
1530732|NCT00272961|5016543|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
1530733|NCT00272961|5016544|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
1530734|NCT00272961|5016545|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
1530735|NCT00272961|5016546|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
1530736|NCT00272961|5016547|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
1530737|NCT00272961|5016543|P5|Placebo Run-in Phase: Up to Week 2|Other|0
1530738|NCT00272961|5016544|P4|Placebo Run-in Phase: Up to Week 2|Other|0
1530739|NCT00272961|5016545|P3|Placebo Run-in Phase: Up to Week 2|Other|0
1530740|NCT00272961|5016546|P2|Placebo Run-in Phase: Up to Week 2|Other|0
1530741|NCT00272961|5016547|P1|Placebo Run-in Phase: Up to Week 2|Other|2
1530742|NCT00272961|5016543|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1530743|NCT00272961|5016544|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1530983|NCT00269152|5017526|P1|Overall Study|Physician Decision|2
1530744|NCT00272961|5016545|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1530745|NCT00272961|5016546|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1530746|NCT00272961|5016547|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
1530747|NCT00272961|5016543|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1530748|NCT00272961|5016544|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1530749|NCT00272961|5016545|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1530750|NCT00272961|5016546|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1530751|NCT00272961|5016547|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
1530752|NCT00272961|5016543|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1530753|NCT00272961|5016544|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1530754|NCT00272961|5016545|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1530755|NCT00272961|5016546|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1530756|NCT00272961|5016547|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
1530757|NCT00272961|5016543|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1530758|NCT00272961|5016544|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1530759|NCT00272961|5016545|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1530760|NCT00272961|5016546|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1530761|NCT00272961|5016547|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
1530762|NCT00272844|5016604|P1|Overall Study|Withdrawal by Subject|5
1530763|NCT00272792|5016612|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
1530764|NCT00272792|5016613|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
1530765|NCT00272792|5016612|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
1530766|NCT00272792|5016613|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
1530767|NCT00272792|5016612|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
1530768|NCT00272792|5016613|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
1530769|NCT00272792|5016612|P2|Part 1: Responsiveness|Lost to Follow-up|0
1530770|NCT00272792|5016613|P1|Part 1: Responsiveness|Lost to Follow-up|1
1530771|NCT00272779|5016623|P2|Baseline Through Week 96|Continuing on treatment|38
1530772|NCT00272779|5016624|P1|Baseline Through Week 96|Continuing on treatment|61
1530773|NCT00272779|5016623|P2|Baseline Through Week 96|Never treated|3
1530774|NCT00272779|5016624|P1|Baseline Through Week 96|Never treated|2
1530775|NCT00272779|5016623|P2|Baseline Through Week 96|Pregnancy at Week 96|0
1530776|NCT00272779|5016624|P1|Baseline Through Week 96|Pregnancy at Week 96|1
1530777|NCT00272779|5016623|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
1530778|NCT00272779|5016624|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
1530779|NCT00272779|5016623|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
1530780|NCT00272779|5016624|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
1530781|NCT00272779|5016623|P2|Baseline Through Week 96|Changed address before Week 96|1
1530782|NCT00272779|5016624|P1|Baseline Through Week 96|Changed address before Week 96|0
1530783|NCT00272779|5016623|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
1530784|NCT00272779|5016624|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
1530785|NCT00272779|5016623|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
1530786|NCT00272779|5016624|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
1530787|NCT00272779|5016623|P2|Baseline Through Week 96|Pregnancy before Week 96|7
1530788|NCT00272779|5016624|P1|Baseline Through Week 96|Pregnancy before Week 96|5
1530789|NCT00272779|5016623|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
1530790|NCT00272779|5016624|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
1530791|NCT00272779|5016623|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
1530792|NCT00272779|5016624|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
1530793|NCT00272779|5016623|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
1530794|NCT00272779|5016624|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
1530795|NCT00272779|5016623|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
1530796|NCT00272779|5016624|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
1530797|NCT00272779|5016623|P2|Baseline Through Week 96|Death before Week 96|5
1530798|NCT00272779|5016624|P1|Baseline Through Week 96|Death before Week 96|6
1530799|NCT00272779|5016623|P2|Baseline Through Week 96|Adverse event before Week 96|22
1530800|NCT00272779|5016624|P1|Baseline Through Week 96|Adverse event before Week 96|13
1530801|NCT00272779|5016623|P2|Baseline Through Week 48|Never treated|3
1530802|NCT00272779|5016624|P1|Baseline Through Week 48|Never treated|2
1530803|NCT00272779|5016623|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
1530804|NCT00272779|5016624|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
1530805|NCT00272779|5016623|P2|Baseline Through Week 48|Continuing treatment|368
1530806|NCT00272779|5016624|P1|Baseline Through Week 48|Continuing treatment|385
1530807|NCT00272779|5016623|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
1530808|NCT00272779|5016624|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
1530809|NCT00272779|5016623|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
1530810|NCT00272779|5016624|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
1530811|NCT00272779|5016623|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
1530812|NCT00272779|5016624|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
1530813|NCT00272779|5016623|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
1530814|NCT00272779|5016624|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
1530984|NCT00269152|5017525|P2|Overall Study|Withdrawal by Subject|3
1530815|NCT00272779|5016623|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
1530816|NCT00272779|5016624|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
1530817|NCT00272779|5016623|P2|Baseline Through Week 48|Death on/after Week 48|1
1530818|NCT00272779|5016624|P1|Baseline Through Week 48|Death on/after Week 48|1
1530819|NCT00272779|5016623|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
1530820|NCT00272779|5016624|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
1530821|NCT00272779|5016623|P2|Baseline Through Week 48|Chose different site before wk 48|1
1530822|NCT00272779|5016624|P1|Baseline Through Week 48|Chose different site before wk 48|0
1530823|NCT00272779|5016623|P2|Baseline Through Week 48|Participant's decision before wk 48|1
1530824|NCT00272779|5016624|P1|Baseline Through Week 48|Participant's decision before wk 48|0
1530825|NCT00272779|5016623|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
1530826|NCT00272779|5016624|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
1530827|NCT00272779|5016623|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
1530828|NCT00272779|5016624|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
1530829|NCT00272779|5016623|P2|Baseline Through Week 48|Pregnancy before Week 48|2
1530830|NCT00272779|5016624|P1|Baseline Through Week 48|Pregnancy before Week 48|2
1530831|NCT00272779|5016623|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
1530832|NCT00272779|5016624|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
1530833|NCT00272779|5016623|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
1530834|NCT00272779|5016624|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
1530835|NCT00272779|5016623|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
1530836|NCT00272779|5016624|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
1530837|NCT00272779|5016623|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
1530838|NCT00272779|5016624|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
1530839|NCT00272779|5016623|P2|Baseline Through Week 48|Death before Week 48|4
1530840|NCT00272779|5016624|P1|Baseline Through Week 48|Death before Week 48|4
1530841|NCT00272779|5016623|P2|Baseline Through Week 48|Adverse event before Week 48|14
1530842|NCT00272779|5016624|P1|Baseline Through Week 48|Adverse event before Week 48|10
1530843|NCT00272038|5016864|P1|Overall Study|withdrew before they received 2 cycles|7
1530844|NCT00271947|5016870|P1|Overall Study|Lost to Follow-up|1
1530845|NCT00271856|5016876|P2|Overall Study|Lost to Follow-up|11
1530846|NCT00271856|5016877|P1|Overall Study|Lost to Follow-up|10
1530847|NCT00271856|5016876|P2|Overall Study|Withdrawal by Subject|7
1530848|NCT00271856|5016877|P1|Overall Study|Withdrawal by Subject|1
1530849|NCT00271817|5016896|P3|Part 2|LDL < 50 mg/dL|4
1530850|NCT00271817|5016897|P2|Part 2|LDL < 50 mg/dL|3
1530851|NCT00271817|5016898|P1|Part 2|LDL < 50 mg/dL|0
1530852|NCT00271817|5016896|P3|Part 2|Withdrawal by Subject|13
1530853|NCT00271817|5016897|P2|Part 2|Withdrawal by Subject|2
1530854|NCT00271817|5016898|P1|Part 2|Withdrawal by Subject|0
1530855|NCT00271817|5016896|P3|Part 2|Patient Moved|5
1530856|NCT00271817|5016897|P2|Part 2|Patient Moved|0
1530857|NCT00271817|5016898|P1|Part 2|Patient Moved|0
1530858|NCT00271817|5016896|P3|Part 2|Protocol Violation|5
1530859|NCT00271817|5016897|P2|Part 2|Protocol Violation|3
1530860|NCT00271817|5016898|P1|Part 2|Protocol Violation|0
1530861|NCT00271817|5016896|P3|Part 2|Lost to Follow-up|18
1530862|NCT00271817|5016897|P2|Part 2|Lost to Follow-up|6
1530863|NCT00271817|5016898|P1|Part 2|Lost to Follow-up|0
1530864|NCT00271817|5016896|P3|Part 2|Lack of Efficacy|6
1530865|NCT00271817|5016897|P2|Part 2|Lack of Efficacy|1
1530866|NCT00271817|5016898|P1|Part 2|Lack of Efficacy|0
1530867|NCT00271817|5016896|P3|Part 2|Adverse Event|33
1530868|NCT00271817|5016897|P2|Part 2|Adverse Event|17
1530869|NCT00271817|5016898|P1|Part 2|Adverse Event|0
1530870|NCT00271817|5016896|P3|Part 1|LDL < 50 mg/dL|48
1530871|NCT00271817|5016897|P2|Part 1|LDL < 50 mg/dL|4
1530872|NCT00271817|5016898|P1|Part 1|LDL < 50 mg/dL|1
1530873|NCT00271817|5016896|P3|Part 1|Withdrawal by Subject|45
1530874|NCT00271817|5016897|P2|Part 1|Withdrawal by Subject|17
1530875|NCT00271817|5016898|P1|Part 1|Withdrawal by Subject|23
1530876|NCT00271817|5016896|P3|Part 1|Patient Moved|5
1530877|NCT00271817|5016897|P2|Part 1|Patient Moved|1
1530878|NCT00271817|5016898|P1|Part 1|Patient Moved|3
1530879|NCT00271817|5016896|P3|Part 1|Protocol Violation|7
1530880|NCT00271817|5016897|P2|Part 1|Protocol Violation|4
1530881|NCT00271817|5016898|P1|Part 1|Protocol Violation|5
1530882|NCT00271817|5016896|P3|Part 1|Lost to Follow-up|24
1530883|NCT00271817|5016897|P2|Part 1|Lost to Follow-up|8
1530884|NCT00271817|5016898|P1|Part 1|Lost to Follow-up|6
1530885|NCT00271817|5016896|P3|Part 1|Adverse Event|156
1530886|NCT00271817|5016897|P2|Part 1|Adverse Event|25
1530887|NCT00271817|5016898|P1|Part 1|Adverse Event|68
1530888|NCT00271609|5016940|P2|Overall Study|Withdrawal by Subject|0
1530889|NCT00271609|5016941|P1|Overall Study|Withdrawal by Subject|2
1530890|NCT00271609|5016940|P2|Overall Study|Adverse Event|3
1530891|NCT00271609|5016941|P1|Overall Study|Adverse Event|11
1530892|NCT00271596|5016951|P2|Overall Study|Withdrawal by Subject|1
1530893|NCT00271596|5016952|P1|Overall Study|Withdrawal by Subject|0
1530894|NCT00271596|5016951|P2|Overall Study|Protocol Violation|0
1530895|NCT00271596|5016952|P1|Overall Study|Protocol Violation|1
1530896|NCT00271544|5016987|P1|Overall Study|Implant not attempted|4
1530897|NCT00271544|5016987|P1|Overall Study|Model 4196 lead not attempted|9
1530898|NCT00271544|5016987|P1|Overall Study|Subjects did not receive a 4196 lead|7
1530899|NCT00271024|5017092|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
1530900|NCT00271024|5017093|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
1530901|NCT00271024|5017094|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
1530902|NCT00271024|5017095|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
1530903|NCT00271024|5017092|P4|Overall Study|Unpleasant Reaction To Tablet|2
1530904|NCT00271024|5017093|P3|Overall Study|Unpleasant Reaction To Tablet|4
1530905|NCT00271024|5017094|P2|Overall Study|Unpleasant Reaction To Tablet|3
1530906|NCT00271024|5017095|P1|Overall Study|Unpleasant Reaction To Tablet|1
1530907|NCT00271024|5017092|P4|Overall Study|Protocol Violation|11
1530908|NCT00271024|5017093|P3|Overall Study|Protocol Violation|5
1530909|NCT00271024|5017094|P2|Overall Study|Protocol Violation|6
1530910|NCT00271024|5017095|P1|Overall Study|Protocol Violation|1
1530911|NCT00271024|5017092|P4|Overall Study|Unknown/Unspecified|4
1530912|NCT00271024|5017093|P3|Overall Study|Unknown/Unspecified|8
1530913|NCT00271024|5017094|P2|Overall Study|Unknown/Unspecified|11
1530914|NCT00271024|5017095|P1|Overall Study|Unknown/Unspecified|11
1530915|NCT00271024|5017092|P4|Overall Study|Lost Interest|3
1530916|NCT00271024|5017093|P3|Overall Study|Lost Interest|2
1530917|NCT00271024|5017094|P2|Overall Study|Lost Interest|4
1530918|NCT00271024|5017095|P1|Overall Study|Lost Interest|3
1530919|NCT00270998|5017145|P3|12 Month Follow-up|Received/desired alternate treatment|1
1530920|NCT00270998|5017146|P2|12 Month Follow-up|Received/desired alternate treatment|4
1530921|NCT00270998|5017147|P1|12 Month Follow-up|Received/desired alternate treatment|1
1530922|NCT00270998|5017145|P3|12 Month Follow-up|Personal/family health|1
1530923|NCT00270998|5017146|P2|12 Month Follow-up|Personal/family health|5
1530924|NCT00270998|5017147|P1|12 Month Follow-up|Personal/family health|0
1530925|NCT00270998|5017145|P3|12 Month Follow-up|Pessary did not fit|0
1530926|NCT00270998|5017146|P2|12 Month Follow-up|Pessary did not fit|0
1530927|NCT00270998|5017147|P1|12 Month Follow-up|Pessary did not fit|1
1530928|NCT00270998|5017145|P3|12 Month Follow-up|Withdrawal by Subject|16
1530929|NCT00270998|5017146|P2|12 Month Follow-up|Withdrawal by Subject|12
1530930|NCT00270998|5017147|P1|12 Month Follow-up|Withdrawal by Subject|7
1530931|NCT00270998|5017145|P3|12 Month Follow-up|Lack of Efficacy|3
1530932|NCT00270998|5017146|P2|12 Month Follow-up|Lack of Efficacy|4
1530933|NCT00270998|5017147|P1|12 Month Follow-up|Lack of Efficacy|5
1530934|NCT00270998|5017145|P3|3 Month Follow-up|Received/desired alternate treatment|2
1530935|NCT00270998|5017146|P2|3 Month Follow-up|Received/desired alternate treatment|5
1530936|NCT00270998|5017147|P1|3 Month Follow-up|Received/desired alternate treatment|13
1530937|NCT00270998|5017145|P3|3 Month Follow-up|Personal/family health|0
1530938|NCT00270998|5017146|P2|3 Month Follow-up|Personal/family health|1
1530939|NCT00270998|5017147|P1|3 Month Follow-up|Personal/family health|1
1530940|NCT00270998|5017145|P3|3 Month Follow-up|Pessary did not fit|0
1530941|NCT00270998|5017146|P2|3 Month Follow-up|Pessary did not fit|0
1530942|NCT00270998|5017147|P1|3 Month Follow-up|Pessary did not fit|12
1530943|NCT00270998|5017145|P3|3 Month Follow-up|Withdrawal by Subject|15
1530944|NCT00270998|5017146|P2|3 Month Follow-up|Withdrawal by Subject|14
1530945|NCT00270998|5017147|P1|3 Month Follow-up|Withdrawal by Subject|11
1530946|NCT00270998|5017145|P3|3 Month Follow-up|Lack of Efficacy|1
1530947|NCT00270998|5017146|P2|3 Month Follow-up|Lack of Efficacy|2
1530948|NCT00270998|5017147|P1|3 Month Follow-up|Lack of Efficacy|1
1530949|NCT00270998|5017145|P3|3 Month Follow-up|Adverse Event|0
1530950|NCT00270998|5017146|P2|3 Month Follow-up|Adverse Event|0
1530951|NCT00270998|5017147|P1|3 Month Follow-up|Adverse Event|1
1530952|NCT00270894|5017176|P1|Overall Study|Withdrawal by Subject|1
1530953|NCT00270894|5017176|P1|Overall Study|Adverse Event|1
1530954|NCT00270855|5017188|P2|Overall Study|Withdrawal by Subject|8
1530955|NCT00270855|5017189|P1|Overall Study|Withdrawal by Subject|8
1530956|NCT00270257|5017325|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
1530957|NCT00270257|5017326|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
1530958|NCT00270231|5017344|P2|Second Intervention|Lost to Follow-up|1
1530959|NCT00270231|5017345|P1|Second Intervention|Lost to Follow-up|0
1530960|NCT00270231|5017344|P2|Washout Period|Lost to Follow-up|0
1530961|NCT00270231|5017345|P1|Washout Period|Lost to Follow-up|1
1530962|NCT00270231|5017344|P2|First Intervention|Lost to Follow-up|1
1530963|NCT00270231|5017345|P1|First Intervention|Lost to Follow-up|1
1530964|NCT00270205|5017355|P4|Overall Study|Lost to Follow-up|1
1530965|NCT00270205|5017356|P3|Overall Study|Lost to Follow-up|0
1530966|NCT00270205|5017357|P2|Overall Study|Lost to Follow-up|0
1530967|NCT00270205|5017358|P1|Overall Study|Lost to Follow-up|1
1530968|NCT00269919|5017476|P1|Overall Study|Started but not treated|1
1530969|NCT00269919|5017476|P1|Overall Study|Other|26
1530970|NCT00269633|5017495|P2|Overall Study|Withdrawal by Subject|0
1530971|NCT00269633|5017496|P1|Overall Study|Withdrawal by Subject|1
1530972|NCT00269477|5017506|P4|Overall Study|Missed post-vaccination blood draw|0
1530973|NCT00269477|5017507|P3|Overall Study|Missed post-vaccination blood draw|0
1530974|NCT00269477|5017508|P2|Overall Study|Missed post-vaccination blood draw|1
1530975|NCT00269477|5017509|P1|Overall Study|Missed post-vaccination blood draw|0
1530976|NCT00269477|5017506|P4|Overall Study|Protocol Violation|0
1530977|NCT00269477|5017507|P3|Overall Study|Protocol Violation|1
1530978|NCT00269477|5017508|P2|Overall Study|Protocol Violation|5
1530979|NCT00269477|5017509|P1|Overall Study|Protocol Violation|5
1530980|NCT00269152|5017525|P2|Overall Study|Protocol Violation|1
1530981|NCT00269152|5017526|P1|Overall Study|Protocol Violation|0
1530982|NCT00269152|5017525|P2|Overall Study|Physician Decision|3
1530985|NCT00269152|5017526|P1|Overall Study|Withdrawal by Subject|7
1530986|NCT00269152|5017525|P2|Overall Study|Adverse Event|3
1530987|NCT00269152|5017526|P1|Overall Study|Adverse Event|9
1530988|NCT00269113|5017542|P2|Overall Study|Not specified|2
1530989|NCT00269113|5017543|P1|Overall Study|Not specified|0
1530990|NCT00269113|5017542|P2|Overall Study|Protocol Violation|5
1530991|NCT00269113|5017543|P1|Overall Study|Protocol Violation|15
1530992|NCT00269113|5017542|P2|Overall Study|Lost to Follow-up|1
1530993|NCT00269113|5017543|P1|Overall Study|Lost to Follow-up|2
1530994|NCT00269113|5017542|P2|Overall Study|Death|2
1530995|NCT00269113|5017543|P1|Overall Study|Death|6
1530996|NCT00269113|5017542|P2|Overall Study|Withdrawal by Subject|2
1530997|NCT00269113|5017543|P1|Overall Study|Withdrawal by Subject|0
1530998|NCT00269113|5017542|P2|Overall Study|Early Improvement|0
1530999|NCT00269113|5017543|P1|Overall Study|Early Improvement|2
1531000|NCT00269113|5017542|P2|Overall Study|Lack of Efficacy|18
1531001|NCT00269113|5017543|P1|Overall Study|Lack of Efficacy|35
1531002|NCT00269113|5017542|P2|Overall Study|Adverse Event|7
1531003|NCT00269113|5017543|P1|Overall Study|Adverse Event|14
1531004|NCT00268996|5017563|P2|Overall Study|Other|1
1531005|NCT00268996|5017564|P1|Overall Study|Other|1
1531006|NCT00268996|5017563|P2|Overall Study|Non-compliance|0
1531007|NCT00268996|5017564|P1|Overall Study|Non-compliance|1
1531008|NCT00268996|5017563|P2|Overall Study|Withdrawal by Subject|11
1531009|NCT00268996|5017564|P1|Overall Study|Withdrawal by Subject|5
1531010|NCT00268996|5017563|P2|Overall Study|Lost to Follow-up|1
1531011|NCT00268996|5017564|P1|Overall Study|Lost to Follow-up|3
1531012|NCT00268996|5017563|P2|Overall Study|Adverse Event|7
1531013|NCT00268996|5017564|P1|Overall Study|Adverse Event|11
1531014|NCT00268983|5017608|P2|Overall Study|Death|0
1531015|NCT00268983|5017609|P1|Overall Study|Death|3
1531016|NCT00268905|5017652|P3|Overall Study|Clinical Progression|1
1531017|NCT00268905|5017653|P2|Overall Study|Clinical Progression|4
1531018|NCT00268905|5017654|P1|Overall Study|Clinical Progression|9
1531019|NCT00268905|5017652|P3|Overall Study|Physician Decision|1
1531020|NCT00268905|5017653|P2|Overall Study|Physician Decision|0
1531021|NCT00268905|5017654|P1|Overall Study|Physician Decision|3
1531022|NCT00268905|5017652|P3|Overall Study|Progressive Disease|3
1531023|NCT00268905|5017653|P2|Overall Study|Progressive Disease|4
1531024|NCT00268905|5017654|P1|Overall Study|Progressive Disease|28
1531025|NCT00268905|5017652|P3|Overall Study|Withdrawal by Subject|3
1531026|NCT00268905|5017653|P2|Overall Study|Withdrawal by Subject|0
1531027|NCT00268905|5017654|P1|Overall Study|Withdrawal by Subject|0
1531028|NCT00268905|5017652|P3|Overall Study|Lost to Follow-up|0
1531029|NCT00268905|5017653|P2|Overall Study|Lost to Follow-up|1
1531030|NCT00268905|5017654|P1|Overall Study|Lost to Follow-up|0
1531031|NCT00268905|5017652|P3|Overall Study|Adverse Event|4
1531032|NCT00268905|5017653|P2|Overall Study|Adverse Event|0
1531033|NCT00268905|5017654|P1|Overall Study|Adverse Event|3
1531034|NCT00268892|5017671|P3|Overall Study|Trial Site Closed|2
1531035|NCT00268892|5017672|P2|Overall Study|Trial Site Closed|2
1531036|NCT00268892|5017673|P1|Overall Study|Trial Site Closed|4
1531037|NCT00268892|5017671|P3|Overall Study|Disease Progression|0
1531038|NCT00268892|5017672|P2|Overall Study|Disease Progression|1
1531039|NCT00268892|5017673|P1|Overall Study|Disease Progression|1
1531040|NCT00268892|5017671|P3|Overall Study|Protocol Violation|0
1531041|NCT00268892|5017672|P2|Overall Study|Protocol Violation|1
1531042|NCT00268892|5017673|P1|Overall Study|Protocol Violation|0
1531043|NCT00268892|5017671|P3|Overall Study|Lost to Follow-up|4
1531044|NCT00268892|5017672|P2|Overall Study|Lost to Follow-up|2
1531045|NCT00268892|5017673|P1|Overall Study|Lost to Follow-up|5
1531046|NCT00268892|5017671|P3|Overall Study|Physician Decision|0
1531047|NCT00268892|5017672|P2|Overall Study|Physician Decision|1
1531048|NCT00268892|5017673|P1|Overall Study|Physician Decision|0
1531049|NCT00268892|5017671|P3|Overall Study|Withdrawal by Subject|13
1531050|NCT00268892|5017672|P2|Overall Study|Withdrawal by Subject|15
1531051|NCT00268892|5017673|P1|Overall Study|Withdrawal by Subject|14
1531052|NCT00268892|5017671|P3|Overall Study|Lack of Efficacy|0
1531053|NCT00268892|5017672|P2|Overall Study|Lack of Efficacy|3
1531054|NCT00268892|5017673|P1|Overall Study|Lack of Efficacy|1
1531055|NCT00268892|5017671|P3|Overall Study|Adverse Event|20
1531056|NCT00268892|5017672|P2|Overall Study|Adverse Event|17
1531057|NCT00268892|5017673|P1|Overall Study|Adverse Event|14
1531058|NCT00268463|5017692|P2|Overall Study|study terminated due to low accrual|12
1531059|NCT00268463|5017693|P1|Overall Study|study terminated due to low accrual|10
1531060|NCT00268437|5017709|P1|Overall Study|Ineligible|1
1531061|NCT00268346|5017716|P2|Overall Study|Withdrawal by Subject|1
1531062|NCT00268346|5017717|P1|Overall Study|Withdrawal by Subject|0
1531063|NCT00268346|5017716|P2|Overall Study|Death|1
1531064|NCT00268346|5017717|P1|Overall Study|Death|0
1531065|NCT00268346|5017716|P2|Overall Study|Adverse Event|1
1531066|NCT00268346|5017717|P1|Overall Study|Adverse Event|0
1531067|NCT00268242|5017723|P1|Overall Study|Death|1
1531068|NCT00268203|5017732|P1|Overall Study|Completed 2 Years of Follow-up|62
1531069|NCT00268203|5017732|P1|Overall Study|Reason Not Specified|34
1531070|NCT00268203|5017732|P1|Overall Study|Death|84
1531071|NCT00268203|5017732|P1|Overall Study|Progressive Disease|359
1531072|NCT00268203|5017732|P1|Overall Study|Received Other NHL Therapy|7
1531073|NCT00268203|5017732|P1|Overall Study|Withdrawal by Subject|9
1531074|NCT00268203|5017732|P1|Overall Study|Lost to Follow-up|92
1531075|NCT00267969|5017746|P7|After Controlled Period|Not specified|25
1531076|NCT00267969|5017747|P6|After Controlled Period|Not specified|22
1531077|NCT00267969|5017748|P5|After Controlled Period|Not specified|11
1531078|NCT00267969|5017749|P4|After Controlled Period|Not specified|13
1531079|NCT00267969|5017750|P3|After Controlled Period|Not specified|0
1531080|NCT00267969|5017751|P2|After Controlled Period|Not specified|0
1531081|NCT00267969|5017752|P1|After Controlled Period|Not specified|0
1531082|NCT00267969|5017746|P7|After Controlled Period|Lost to Follow-up|10
1531083|NCT00267969|5017747|P6|After Controlled Period|Lost to Follow-up|9
1531084|NCT00267969|5017748|P5|After Controlled Period|Lost to Follow-up|8
1531085|NCT00267969|5017749|P4|After Controlled Period|Lost to Follow-up|5
1531086|NCT00267969|5017750|P3|After Controlled Period|Lost to Follow-up|0
1531087|NCT00267969|5017751|P2|After Controlled Period|Lost to Follow-up|0
1531088|NCT00267969|5017752|P1|After Controlled Period|Lost to Follow-up|0
1531089|NCT00267969|5017746|P7|After Controlled Period|Lack of Efficacy|15
1531090|NCT00267969|5017747|P6|After Controlled Period|Lack of Efficacy|28
1531091|NCT00267969|5017748|P5|After Controlled Period|Lack of Efficacy|6
1531092|NCT00267969|5017749|P4|After Controlled Period|Lack of Efficacy|10
1531093|NCT00267969|5017750|P3|After Controlled Period|Lack of Efficacy|0
1531094|NCT00267969|5017751|P2|After Controlled Period|Lack of Efficacy|0
1531095|NCT00267969|5017752|P1|After Controlled Period|Lack of Efficacy|0
1531096|NCT00267969|5017746|P7|After Controlled Period|Death|1
1531097|NCT00267969|5017747|P6|After Controlled Period|Death|0
1531098|NCT00267969|5017748|P5|After Controlled Period|Death|2
1531099|NCT00267969|5017749|P4|After Controlled Period|Death|1
1531100|NCT00267969|5017750|P3|After Controlled Period|Death|0
1531101|NCT00267969|5017751|P2|After Controlled Period|Death|0
1531102|NCT00267969|5017752|P1|After Controlled Period|Death|0
1531103|NCT00267969|5017746|P7|After Controlled Period|Adverse Event|21
1531104|NCT00267969|5017747|P6|After Controlled Period|Adverse Event|23
1531105|NCT00267969|5017748|P5|After Controlled Period|Adverse Event|8
1531106|NCT00267969|5017749|P4|After Controlled Period|Adverse Event|7
1531107|NCT00267969|5017750|P3|After Controlled Period|Adverse Event|0
1531108|NCT00267969|5017751|P2|After Controlled Period|Adverse Event|0
1531109|NCT00267969|5017752|P1|After Controlled Period|Adverse Event|0
1531110|NCT00267969|5017746|P7|Controlled Period|Not specified|0
1531111|NCT00267969|5017747|P6|Controlled Period|Not specified|0
1531112|NCT00267969|5017748|P5|Controlled Period|Not specified|0
1531113|NCT00267969|5017749|P4|Controlled Period|Not specified|0
1531114|NCT00267969|5017750|P3|Controlled Period|Not specified|6
1531115|NCT00267969|5017751|P2|Controlled Period|Not specified|1
1531116|NCT00267969|5017752|P1|Controlled Period|Not specified|2
1531117|NCT00267969|5017746|P7|Controlled Period|Randomized but not treated|0
1531118|NCT00267969|5017747|P6|Controlled Period|Randomized but not treated|0
1531119|NCT00267969|5017748|P5|Controlled Period|Randomized but not treated|0
1531120|NCT00267969|5017749|P4|Controlled Period|Randomized but not treated|0
1531121|NCT00267969|5017750|P3|Controlled Period|Randomized but not treated|1
1531122|NCT00267969|5017751|P2|Controlled Period|Randomized but not treated|0
1531123|NCT00267969|5017752|P1|Controlled Period|Randomized but not treated|0
1531124|NCT00267969|5017746|P7|Controlled Period|Lost to Follow-up|0
1531125|NCT00267969|5017747|P6|Controlled Period|Lost to Follow-up|0
1531126|NCT00267969|5017748|P5|Controlled Period|Lost to Follow-up|0
1531127|NCT00267969|5017749|P4|Controlled Period|Lost to Follow-up|0
1531128|NCT00267969|5017750|P3|Controlled Period|Lost to Follow-up|1
1531129|NCT00267969|5017751|P2|Controlled Period|Lost to Follow-up|0
1531130|NCT00267969|5017752|P1|Controlled Period|Lost to Follow-up|1
1531131|NCT00267969|5017746|P7|Controlled Period|Lack of Efficacy|0
1531132|NCT00267969|5017747|P6|Controlled Period|Lack of Efficacy|0
1531133|NCT00267969|5017748|P5|Controlled Period|Lack of Efficacy|0
1531134|NCT00267969|5017749|P4|Controlled Period|Lack of Efficacy|0
1531135|NCT00267969|5017750|P3|Controlled Period|Lack of Efficacy|1
1531136|NCT00267969|5017751|P2|Controlled Period|Lack of Efficacy|0
1531137|NCT00267969|5017752|P1|Controlled Period|Lack of Efficacy|3
1531138|NCT00267969|5017746|P7|Controlled Period|Adverse Event|0
1531139|NCT00267969|5017747|P6|Controlled Period|Adverse Event|0
1531140|NCT00267969|5017748|P5|Controlled Period|Adverse Event|0
1531141|NCT00267969|5017749|P4|Controlled Period|Adverse Event|0
1531142|NCT00267969|5017750|P3|Controlled Period|Adverse Event|2
1531143|NCT00267969|5017751|P2|Controlled Period|Adverse Event|0
1531144|NCT00267969|5017752|P1|Controlled Period|Adverse Event|6
1531145|NCT00267956|5017778|P4|After Controlled Period|Withdrew consent|0
1531146|NCT00267956|5017779|P3|After Controlled Period|Withdrew consent|1
1531147|NCT00267956|5017780|P2|After Controlled Period|Withdrew consent|0
1531148|NCT00267956|5017781|P1|After Controlled Period|Withdrew consent|0
1531149|NCT00267956|5017778|P4|After Controlled Period|Lost to Follow-up|0
1531150|NCT00267956|5017779|P3|After Controlled Period|Lost to Follow-up|1
1531151|NCT00267956|5017780|P2|After Controlled Period|Lost to Follow-up|0
1531152|NCT00267956|5017781|P1|After Controlled Period|Lost to Follow-up|0
1531153|NCT00267956|5017778|P4|After Controlled Period|Lack of Efficacy|1
1531154|NCT00267956|5017779|P3|After Controlled Period|Lack of Efficacy|1
1531155|NCT00267956|5017780|P2|After Controlled Period|Lack of Efficacy|0
1531156|NCT00267956|5017781|P1|After Controlled Period|Lack of Efficacy|0
1531157|NCT00267956|5017778|P4|After Controlled Period|Adverse Event|1
1531158|NCT00267956|5017779|P3|After Controlled Period|Adverse Event|2
1531159|NCT00267956|5017780|P2|After Controlled Period|Adverse Event|0
1531160|NCT00267956|5017781|P1|After Controlled Period|Adverse Event|0
1531161|NCT00267956|5017778|P4|Controlled Period|Withdrew consent|0
1531162|NCT00267956|5017779|P3|Controlled Period|Withdrew consent|0
1531163|NCT00267956|5017780|P2|Controlled Period|Withdrew consent|1
1531164|NCT00267956|5017781|P1|Controlled Period|Withdrew consent|3
1531165|NCT00267956|5017778|P4|Controlled Period|Lost to Follow-up|0
1531166|NCT00267956|5017779|P3|Controlled Period|Lost to Follow-up|0
1531167|NCT00267956|5017780|P2|Controlled Period|Lost to Follow-up|0
1531168|NCT00267956|5017781|P1|Controlled Period|Lost to Follow-up|2
1531169|NCT00267956|5017778|P4|Controlled Period|Lack of Efficacy|0
1531170|NCT00267956|5017779|P3|Controlled Period|Lack of Efficacy|0
1531171|NCT00267956|5017780|P2|Controlled Period|Lack of Efficacy|2
1531172|NCT00267956|5017781|P1|Controlled Period|Lack of Efficacy|4
1531173|NCT00267956|5017778|P4|Controlled Period|Adverse Event|0
1531174|NCT00267956|5017779|P3|Controlled Period|Adverse Event|0
1531175|NCT00267956|5017780|P2|Controlled Period|Adverse Event|1
1531176|NCT00267956|5017781|P1|Controlled Period|Adverse Event|4
1531177|NCT00267748|5017813|P3|Randomized Period|randomized but not treated|3
1531178|NCT00267748|5017814|P2|Randomized Period|randomized but not treated|0
1531179|NCT00267748|5017815|P1|Randomized Period|randomized but not treated|0
1531180|NCT00267748|5017813|P3|Randomized Period|Other|6
1531181|NCT00267748|5017814|P2|Randomized Period|Other|9
1531182|NCT00267748|5017815|P1|Randomized Period|Other|0
1531183|NCT00267748|5017813|P3|Randomized Period|Withdrawal by Subject|2
1531184|NCT00267748|5017814|P2|Randomized Period|Withdrawal by Subject|9
1531185|NCT00267748|5017815|P1|Randomized Period|Withdrawal by Subject|0
1531186|NCT00267748|5017813|P3|Randomized Period|Objective progression or relapse|86
1531187|NCT00267748|5017814|P2|Randomized Period|Objective progression or relapse|77
1531188|NCT00267748|5017815|P1|Randomized Period|Objective progression or relapse|0
1531189|NCT00267748|5017813|P3|Randomized Period|Lost to Follow-up|0
1531190|NCT00267748|5017814|P2|Randomized Period|Lost to Follow-up|1
1531191|NCT00267748|5017815|P1|Randomized Period|Lost to Follow-up|0
1531192|NCT00267748|5017813|P3|Randomized Period|Global deterioration of health status|7
1531193|NCT00267748|5017814|P2|Randomized Period|Global deterioration of health status|6
1531194|NCT00267748|5017815|P1|Randomized Period|Global deterioration of health status|0
1531195|NCT00267748|5017813|P3|Randomized Period|Adverse Event|25
1531196|NCT00267748|5017814|P2|Randomized Period|Adverse Event|23
1531197|NCT00267748|5017815|P1|Randomized Period|Adverse Event|0
1531198|NCT00267748|5017813|P3|Randomized Period|Death|3
1531199|NCT00267748|5017814|P2|Randomized Period|Death|2
1531200|NCT00267748|5017815|P1|Randomized Period|Death|0
1531201|NCT00267748|5017813|P3|Non-randomized Period|Other|0
1531202|NCT00267748|5017814|P2|Non-randomized Period|Other|0
1531203|NCT00267748|5017815|P1|Non-randomized Period|Other|3
1531204|NCT00267748|5017813|P3|Non-randomized Period|Participant not willing to participate|0
1531205|NCT00267748|5017814|P2|Non-randomized Period|Participant not willing to participate|0
1531206|NCT00267748|5017815|P1|Non-randomized Period|Participant not willing to participate|1
1531207|NCT00267748|5017813|P3|Non-randomized Period|Death|0
1531208|NCT00267748|5017814|P2|Non-randomized Period|Death|0
1531209|NCT00267748|5017815|P1|Non-randomized Period|Death|1
1531210|NCT00267748|5017813|P3|Non-randomized Period|Adverse Event|0
1531211|NCT00267748|5017814|P2|Non-randomized Period|Adverse Event|0
1531212|NCT00267748|5017815|P1|Non-randomized Period|Adverse Event|8
1531213|NCT00267748|5017813|P3|Non-randomized Period|Progressive disease|0
1531214|NCT00267748|5017814|P2|Non-randomized Period|Progressive disease|0
1531215|NCT00267748|5017815|P1|Non-randomized Period|Progressive disease|10
1531216|NCT00267488|5017872|P1|Overall Study|Other (Disease Progression)|1
1531217|NCT00267488|5017872|P1|Overall Study|Protocol Violation|1
1531218|NCT00267488|5017872|P1|Overall Study|Sponsor Terminated Study|9
1531219|NCT00267202|5017896|P2|Overall Study|Lost to Follow-up|0
1531220|NCT00267202|5017897|P1|Overall Study|Lost to Follow-up|3
1531221|NCT00267202|5017896|P2|Overall Study|Administrative problems|1
1531222|NCT00267202|5017897|P1|Overall Study|Administrative problems|2
1531223|NCT00267202|5017896|P2|Overall Study|Protocol Violation|3
1531224|NCT00267202|5017897|P1|Overall Study|Protocol Violation|2
1531225|NCT00267202|5017896|P2|Overall Study|Adverse Event|7
1531226|NCT00267202|5017897|P1|Overall Study|Adverse Event|13
1531227|NCT00267202|5017896|P2|Overall Study|Withdrawal by Subject|15
1531228|NCT00267202|5017897|P1|Overall Study|Withdrawal by Subject|12
1531229|NCT00267202|5017896|P2|Overall Study|Unsatisfactory therapeutic effect|8
1531230|NCT00267202|5017897|P1|Overall Study|Unsatisfactory therapeutic effect|21
1531231|NCT00267189|5017918|P2|Overall Study|Missing|0
1531232|NCT00267189|5017919|P1|Overall Study|Missing|3
1531233|NCT00267189|5017918|P2|Overall Study|Death|0
1531234|NCT00267189|5017919|P1|Overall Study|Death|1
1531235|NCT00267189|5017918|P2|Overall Study|Patient withdrew consent|1
1531236|NCT00267189|5017919|P1|Overall Study|Patient withdrew consent|1
1531237|NCT00267150|5017929|P1|Overall Study|Adverse Event|1
1531238|NCT00267098|5017953|P8|Overall Study|Sponsor withdrew subject|0
1531239|NCT00267098|5017954|P7|Overall Study|Sponsor withdrew subject|0
1531240|NCT00267098|5017955|P6|Overall Study|Sponsor withdrew subject|0
1531241|NCT00267098|5017956|P5|Overall Study|Sponsor withdrew subject|0
1531242|NCT00267098|5017957|P4|Overall Study|Sponsor withdrew subject|1
1531243|NCT00267098|5017958|P3|Overall Study|Sponsor withdrew subject|0
1531244|NCT00267098|5017959|P2|Overall Study|Sponsor withdrew subject|0
1531245|NCT00267098|5017960|P1|Overall Study|Sponsor withdrew subject|0
1531246|NCT00267098|5017953|P8|Overall Study|Subject listed for heart transplant|0
1531247|NCT00267098|5017954|P7|Overall Study|Subject listed for heart transplant|1
1531248|NCT00267098|5017955|P6|Overall Study|Subject listed for heart transplant|0
1531249|NCT00267098|5017956|P5|Overall Study|Subject listed for heart transplant|0
1531250|NCT00267098|5017957|P4|Overall Study|Subject listed for heart transplant|0
1531251|NCT00267098|5017958|P3|Overall Study|Subject listed for heart transplant|0
1531252|NCT00267098|5017959|P2|Overall Study|Subject listed for heart transplant|0
1531253|NCT00267098|5017960|P1|Overall Study|Subject listed for heart transplant|0
1531254|NCT00267098|5017953|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
1531255|NCT00267098|5017954|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
1531256|NCT00267098|5017955|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
1531257|NCT00267098|5017956|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
1531258|NCT00267098|5017957|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
1531259|NCT00267098|5017958|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
1531260|NCT00267098|5017959|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
1531261|NCT00267098|5017960|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
1531262|NCT00267098|5017953|P8|Overall Study|Explanted Medtronic device|0
1531263|NCT00267098|5017954|P7|Overall Study|Explanted Medtronic device|0
1531264|NCT00267098|5017955|P6|Overall Study|Explanted Medtronic device|0
1531265|NCT00267098|5017956|P5|Overall Study|Explanted Medtronic device|0
1531266|NCT00267098|5017957|P4|Overall Study|Explanted Medtronic device|1
1531267|NCT00267098|5017958|P3|Overall Study|Explanted Medtronic device|0
1531268|NCT00267098|5017959|P2|Overall Study|Explanted Medtronic device|0
1531269|NCT00267098|5017960|P1|Overall Study|Explanted Medtronic device|0
1531270|NCT00267098|5017953|P8|Overall Study|Site closure|0
1531271|NCT00267098|5017954|P7|Overall Study|Site closure|1
1531272|NCT00267098|5017955|P6|Overall Study|Site closure|1
1531273|NCT00267098|5017956|P5|Overall Study|Site closure|0
1531274|NCT00267098|5017957|P4|Overall Study|Site closure|1
1531275|NCT00267098|5017958|P3|Overall Study|Site closure|0
1531276|NCT00267098|5017959|P2|Overall Study|Site closure|0
1531277|NCT00267098|5017960|P1|Overall Study|Site closure|0
1531278|NCT00267098|5017953|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1531279|NCT00267098|5017954|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1531280|NCT00267098|5017955|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1531281|NCT00267098|5017956|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1531282|NCT00267098|5017957|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1531283|NCT00267098|5017958|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1531284|NCT00267098|5017959|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
1531285|NCT00267098|5017960|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1531286|NCT00267098|5017953|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1531287|NCT00267098|5017954|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1531288|NCT00267098|5017955|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1531289|NCT00267098|5017956|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
1531290|NCT00267098|5017957|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1531291|NCT00267098|5017958|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1531292|NCT00267098|5017959|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1531293|NCT00267098|5017960|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
1531294|NCT00267098|5017953|P8|Overall Study|Physician Decision|0
1531295|NCT00267098|5017954|P7|Overall Study|Physician Decision|3
1531296|NCT00267098|5017955|P6|Overall Study|Physician Decision|4
1531297|NCT00267098|5017956|P5|Overall Study|Physician Decision|5
1531298|NCT00267098|5017957|P4|Overall Study|Physician Decision|11
1531299|NCT00267098|5017958|P3|Overall Study|Physician Decision|7
1531300|NCT00267098|5017959|P2|Overall Study|Physician Decision|0
1531301|NCT00267098|5017960|P1|Overall Study|Physician Decision|5
1531302|NCT00267098|5017953|P8|Overall Study|Withdrawal by Subject|5
1531303|NCT00267098|5017954|P7|Overall Study|Withdrawal by Subject|12
1531304|NCT00267098|5017955|P6|Overall Study|Withdrawal by Subject|9
1531305|NCT00267098|5017956|P5|Overall Study|Withdrawal by Subject|12
1531306|NCT00267098|5017957|P4|Overall Study|Withdrawal by Subject|21
1531307|NCT00267098|5017958|P3|Overall Study|Withdrawal by Subject|24
1531308|NCT00267098|5017959|P2|Overall Study|Withdrawal by Subject|0
1531309|NCT00267098|5017960|P1|Overall Study|Withdrawal by Subject|8
1531310|NCT00267098|5017953|P8|Overall Study|Lost to Follow-up|1
1531311|NCT00267098|5017954|P7|Overall Study|Lost to Follow-up|1
1531312|NCT00267098|5017955|P6|Overall Study|Lost to Follow-up|3
1531313|NCT00267098|5017956|P5|Overall Study|Lost to Follow-up|2
1531314|NCT00267098|5017957|P4|Overall Study|Lost to Follow-up|5
1531315|NCT00267098|5017958|P3|Overall Study|Lost to Follow-up|6
1531316|NCT00267098|5017959|P2|Overall Study|Lost to Follow-up|0
1531317|NCT00267098|5017960|P1|Overall Study|Lost to Follow-up|0
1531318|NCT00267098|5017953|P8|Overall Study|Death|9
1531319|NCT00267098|5017954|P7|Overall Study|Death|28
1531320|NCT00267098|5017955|P6|Overall Study|Death|23
1531321|NCT00267098|5017956|P5|Overall Study|Death|14
1531322|NCT00267098|5017957|P4|Overall Study|Death|66
1531323|NCT00267098|5017958|P3|Overall Study|Death|57
1531324|NCT00267098|5017959|P2|Overall Study|Death|0
1531325|NCT00267098|5017960|P1|Overall Study|Death|0
1531326|NCT00267046|5018103|P2|Overall Study|Radiation|1
1531327|NCT00267046|5018104|P1|Overall Study|Radiation|0
1531328|NCT00267046|5018103|P2|Overall Study|Withdrawal by Subject|0
1531329|NCT00267046|5018104|P1|Overall Study|Withdrawal by Subject|1
1531330|NCT00267046|5018103|P2|Overall Study|Surgery|1
1531331|NCT00267046|5018104|P1|Overall Study|Surgery|3
1531332|NCT00267046|5018103|P2|Overall Study|Open-label palifermin|7
1531333|NCT00267046|5018104|P1|Overall Study|Open-label palifermin|2
1531334|NCT00267046|5018103|P2|Overall Study|Chemotoxicity|0
1531335|NCT00267046|5018104|P1|Overall Study|Chemotoxicity|2
1531336|NCT00267046|5018103|P2|Overall Study|Disease progression|2
1531337|NCT00267046|5018104|P1|Overall Study|Disease progression|4
1531338|NCT00267007|5018114|P2|Overall Study|Adverse Event|0
1531339|NCT00267007|5018115|P1|Overall Study|Adverse Event|1
1531340|NCT00267007|5018114|P2|Overall Study|Non-compliance|1
1531341|NCT00267007|5018115|P1|Overall Study|Non-compliance|0
1531342|NCT00267007|5018114|P2|Overall Study|Lost to Follow-up|0
1531343|NCT00267007|5018115|P1|Overall Study|Lost to Follow-up|1
1531344|NCT00267007|5018114|P2|Overall Study|Withdrawal by Subject|0
1531345|NCT00267007|5018115|P1|Overall Study|Withdrawal by Subject|6
1531346|NCT00266877|5018126|P3|Overall Study|Concomitant Radiotherapy|0
1531347|NCT00266877|5018127|P2|Overall Study|Concomitant Radiotherapy|1
1531348|NCT00266877|5018128|P1|Overall Study|Concomitant Radiotherapy|0
1531349|NCT00266877|5018126|P3|Overall Study|Hospitalization|0
1531350|NCT00266877|5018127|P2|Overall Study|Hospitalization|0
1531351|NCT00266877|5018128|P1|Overall Study|Hospitalization|1
1531352|NCT00266877|5018126|P3|Overall Study|Symptomatic Deterioration|1
1531353|NCT00266877|5018127|P2|Overall Study|Symptomatic Deterioration|3
1531354|NCT00266877|5018128|P1|Overall Study|Symptomatic Deterioration|6
1531355|NCT00266877|5018126|P3|Overall Study|Disease Progression|23
1531356|NCT00266877|5018127|P2|Overall Study|Disease Progression|37
1531357|NCT00266877|5018128|P1|Overall Study|Disease Progression|72
1531358|NCT00266877|5018126|P3|Overall Study|Withdrawal by Subject|1
1531359|NCT00266877|5018127|P2|Overall Study|Withdrawal by Subject|1
1531360|NCT00266877|5018128|P1|Overall Study|Withdrawal by Subject|3
1531361|NCT00266877|5018126|P3|Overall Study|Physician Decision|1
1531362|NCT00266877|5018127|P2|Overall Study|Physician Decision|1
1531363|NCT00266877|5018128|P1|Overall Study|Physician Decision|2
1531364|NCT00266877|5018126|P3|Overall Study|Adverse Event|1
1531365|NCT00266877|5018127|P2|Overall Study|Adverse Event|4
1531366|NCT00266877|5018128|P1|Overall Study|Adverse Event|6
1531367|NCT00266877|5018126|P3|Overall Study|Death|1
1531368|NCT00266877|5018127|P2|Overall Study|Death|1
1531369|NCT00266877|5018128|P1|Overall Study|Death|1
1531370|NCT00266864|5018147|P2|Overall Study|Withdrawal by Subject|1
1531371|NCT00266864|5018148|P1|Overall Study|Withdrawal by Subject|1
1531372|NCT00266864|5018147|P2|Overall Study|Lost to Follow-up|1
1531373|NCT00266864|5018148|P1|Overall Study|Lost to Follow-up|4
1531374|NCT00266825|5018157|P2|Completed Follow-Up|Withdrawal by Subject|5
1531375|NCT00266825|5018158|P1|Completed Follow-Up|Withdrawal by Subject|11
1531376|NCT00266825|5018157|P2|Completed Follow-Up|Lost to Follow-up|19
1531377|NCT00266825|5018158|P1|Completed Follow-Up|Lost to Follow-up|14
1531378|NCT00266812|5018184|P2|Overall Study|Discontinued before starting study drug|0
1531379|NCT00266812|5018185|P1|Overall Study|Discontinued before starting study drug|4
1531380|NCT00266812|5018184|P2|Overall Study|Withdrawal by Subject|2
1531381|NCT00266812|5018185|P1|Overall Study|Withdrawal by Subject|0
1531382|NCT00266812|5018184|P2|Overall Study|Protocol Violation|1
1531383|NCT00266812|5018185|P1|Overall Study|Protocol Violation|0
1531384|NCT00266812|5018184|P2|Overall Study|Adverse Event|1
1531385|NCT00266812|5018185|P1|Overall Study|Adverse Event|3
1531386|NCT00266812|5018184|P2|Overall Study|Death|4
1531387|NCT00266812|5018185|P1|Overall Study|Death|5
1531388|NCT00266812|5018184|P2|Overall Study|Disease Progression|3
1531389|NCT00266812|5018185|P1|Overall Study|Disease Progression|9
1531390|NCT00266695|5018208|P1|Overall Study|Withdrawal by Subject|15
1531391|NCT00266695|5018208|P1|Overall Study|Lost to Follow-up|3
1531392|NCT00266695|5018208|P1|Overall Study|Physician Decision|1
1531393|NCT00266695|5018208|P1|Overall Study|Death|9
1531394|NCT00266695|5018208|P1|Overall Study|Adverse Event|1
1531395|NCT00266656|5018220|P2|Overall Study|Parent/Caregiver Decision|2
1531396|NCT00266656|5018221|P1|Overall Study|Parent/Caregiver Decision|1
1531397|NCT00266656|5018220|P2|Overall Study|Did Not Reach Final Height|8
1531398|NCT00266656|5018221|P1|Overall Study|Did Not Reach Final Height|4
1531399|NCT00266656|5018220|P2|Overall Study|Withdrawal by Subject|2
1531400|NCT00266656|5018221|P1|Overall Study|Withdrawal by Subject|4
1531401|NCT00266656|5018220|P2|Overall Study|Lost to Follow-up|1
1531402|NCT00266656|5018221|P1|Overall Study|Lost to Follow-up|4
1531403|NCT00266656|5018220|P2|Overall Study|Death|0
1531404|NCT00266656|5018221|P1|Overall Study|Death|1
1531405|NCT00266630|5018245|P2|Overall Study|Not Specified|11
1531406|NCT00266630|5018246|P1|Overall Study|Not Specified|19
1531407|NCT00266630|5018245|P2|Overall Study|Lost to Follow-up|0
1531408|NCT00266630|5018246|P1|Overall Study|Lost to Follow-up|1
1531409|NCT00266630|5018245|P2|Overall Study|Withdrawal by Subject|2
1531410|NCT00266630|5018246|P1|Overall Study|Withdrawal by Subject|10
1531411|NCT00266630|5018245|P2|Overall Study|Physician Decision|2
1531412|NCT00266630|5018246|P1|Overall Study|Physician Decision|1
1531413|NCT00266630|5018245|P2|Overall Study|Protocol Violation|3
1531414|NCT00266630|5018246|P1|Overall Study|Protocol Violation|1
1531415|NCT00266630|5018245|P2|Overall Study|Entry Criteria not met|0
1531416|NCT00266630|5018246|P1|Overall Study|Entry Criteria not met|1
1531417|NCT00266630|5018245|P2|Overall Study|Lack of Efficacy|4
1531418|NCT00266630|5018246|P1|Overall Study|Lack of Efficacy|1
1531419|NCT00266630|5018245|P2|Overall Study|Adverse Event|6
1531420|NCT00266630|5018246|P1|Overall Study|Adverse Event|8
1531421|NCT00266409|5018288|P4|Overall Study|Other|0
1531422|NCT00266409|5018289|P3|Overall Study|Other|2
1531423|NCT00266409|5018290|P2|Overall Study|Other|4
1531424|NCT00266409|5018291|P1|Overall Study|Other|7
1531425|NCT00266409|5018288|P4|Overall Study|Protocol Violation|2
1531426|NCT00266409|5018289|P3|Overall Study|Protocol Violation|4
1531427|NCT00266409|5018290|P2|Overall Study|Protocol Violation|3
1531428|NCT00266409|5018291|P1|Overall Study|Protocol Violation|5
1531429|NCT00266409|5018288|P4|Overall Study|Withdrawal by Subject|9
1531430|NCT00266409|5018289|P3|Overall Study|Withdrawal by Subject|3
1531431|NCT00266409|5018290|P2|Overall Study|Withdrawal by Subject|10
1531432|NCT00266409|5018291|P1|Overall Study|Withdrawal by Subject|6
1531433|NCT00266409|5018288|P4|Overall Study|Lost to Follow-up|8
1531434|NCT00266409|5018289|P3|Overall Study|Lost to Follow-up|6
1531435|NCT00266409|5018290|P2|Overall Study|Lost to Follow-up|21
1531436|NCT00266409|5018291|P1|Overall Study|Lost to Follow-up|18
1531437|NCT00266409|5018288|P4|Overall Study|Adverse Event|1
1531438|NCT00266409|5018289|P3|Overall Study|Adverse Event|1
1531439|NCT00266409|5018290|P2|Overall Study|Adverse Event|2
1531440|NCT00266409|5018291|P1|Overall Study|Adverse Event|7
1531441|NCT00266409|5018288|P4|Overall Study|Lack of Efficacy|2
1531442|NCT00266409|5018289|P3|Overall Study|Lack of Efficacy|1
1531443|NCT00266409|5018290|P2|Overall Study|Lack of Efficacy|6
1531444|NCT00266409|5018291|P1|Overall Study|Lack of Efficacy|2
1531445|NCT00266227|5018579|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
1531446|NCT00266227|5018580|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
1531447|NCT00266227|5018581|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
1531448|NCT00266227|5018579|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
1531449|NCT00266227|5018580|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
1531450|NCT00266227|5018581|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
1531451|NCT00266227|5018579|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
1531452|NCT00266227|5018580|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
1531453|NCT00266227|5018581|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
1531454|NCT00266227|5018579|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
1531455|NCT00266227|5018580|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
1531456|NCT00266227|5018581|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
1531457|NCT00266227|5018579|P3|Retreatment: Week 48 to Week 72|Death|0
1531458|NCT00266227|5018580|P2|Retreatment: Week 48 to Week 72|Death|1
1531459|NCT00266227|5018581|P1|Retreatment: Week 48 to Week 72|Death|1
1531460|NCT00266227|5018579|P3|Retreatment: Up to Week 48|Pregnancy|0
1531461|NCT00266227|5018580|P2|Retreatment: Up to Week 48|Pregnancy|0
1531462|NCT00266227|5018581|P1|Retreatment: Up to Week 48|Pregnancy|1
1531463|NCT00266227|5018579|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
1531464|NCT00266227|5018580|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
1531465|NCT00266227|5018581|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
1531466|NCT00266227|5018579|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
1531467|NCT00266227|5018580|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
1531468|NCT00266227|5018581|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
1531469|NCT00266227|5018579|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
1531470|NCT00266227|5018580|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
1531471|NCT00266227|5018581|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
1531472|NCT00266227|5018579|P3|Retreatment: Up to Week 48|Adverse Event|0
1531473|NCT00266227|5018580|P2|Retreatment: Up to Week 48|Adverse Event|7
1531474|NCT00266227|5018581|P1|Retreatment: Up to Week 48|Adverse Event|7
1531475|NCT00266227|5018579|P3|Retreatment: Up to Week 48|Death|0
1531476|NCT00266227|5018580|P2|Retreatment: Up to Week 48|Death|0
1531477|NCT00266227|5018581|P1|Retreatment: Up to Week 48|Death|1
1531478|NCT00266227|5018579|P3|Initial Treatment|Pregnancy|1
1531479|NCT00266227|5018580|P2|Initial Treatment|Pregnancy|0
1531480|NCT00266227|5018581|P1|Initial Treatment|Pregnancy|0
1531481|NCT00266227|5018579|P3|Initial Treatment|Physician decision to withdraw|12
1531482|NCT00266227|5018580|P2|Initial Treatment|Physician decision to withdraw|0
1531483|NCT00266227|5018581|P1|Initial Treatment|Physician decision to withdraw|0
1531484|NCT00266227|5018579|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
1531485|NCT00266227|5018580|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
1531486|NCT00266227|5018581|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
1531487|NCT00266227|5018579|P3|Initial Treatment|Lost to Follow-up|6
1531488|NCT00266227|5018580|P2|Initial Treatment|Lost to Follow-up|0
1531489|NCT00266227|5018581|P1|Initial Treatment|Lost to Follow-up|0
1531490|NCT00266227|5018579|P3|Initial Treatment|Adverse Event|13
1531491|NCT00266227|5018580|P2|Initial Treatment|Adverse Event|0
1531492|NCT00266227|5018581|P1|Initial Treatment|Adverse Event|0
1531493|NCT00266032|5018633|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
1531494|NCT00266032|5018634|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
1531495|NCT00266032|5018635|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
1531496|NCT00266032|5018633|P3|Open-label Safety Extension|Withdrawal by Subject|12
1531497|NCT00266032|5018634|P2|Open-label Safety Extension|Withdrawal by Subject|3
1531498|NCT00266032|5018635|P1|Open-label Safety Extension|Withdrawal by Subject|19
1531499|NCT00266032|5018633|P3|Open-label Safety Extension|Protocol Violation|2
1531500|NCT00266032|5018634|P2|Open-label Safety Extension|Protocol Violation|3
1531501|NCT00266032|5018635|P1|Open-label Safety Extension|Protocol Violation|1
1531502|NCT00266032|5018633|P3|Open-label Safety Extension|Pregnancy|2
1531503|NCT00266032|5018634|P2|Open-label Safety Extension|Pregnancy|1
1531504|NCT00266032|5018635|P1|Open-label Safety Extension|Pregnancy|4
1531505|NCT00266032|5018633|P3|Open-label Safety Extension|Lost to Follow-up|4
1531506|NCT00266032|5018634|P2|Open-label Safety Extension|Lost to Follow-up|5
1531507|NCT00266032|5018635|P1|Open-label Safety Extension|Lost to Follow-up|2
1531508|NCT00266032|5018633|P3|Open-label Safety Extension|Adverse Event|4
1531509|NCT00266032|5018634|P2|Open-label Safety Extension|Adverse Event|0
1531510|NCT00266032|5018635|P1|Open-label Safety Extension|Adverse Event|5
1531511|NCT00266032|5018633|P3|Treatment|patient moved/wish for pregnancy/no need|8
1531512|NCT00266032|5018634|P2|Treatment|patient moved/wish for pregnancy/no need|5
1531513|NCT00266032|5018635|P1|Treatment|patient moved/wish for pregnancy/no need|13
1531514|NCT00266032|5018633|P3|Treatment|Withdrawal by Subject|12
1531515|NCT00266032|5018634|P2|Treatment|Withdrawal by Subject|13
1531516|NCT00266032|5018635|P1|Treatment|Withdrawal by Subject|28
1531517|NCT00266032|5018633|P3|Treatment|Protocol Violation|13
1531518|NCT00266032|5018634|P2|Treatment|Protocol Violation|14
1531519|NCT00266032|5018635|P1|Treatment|Protocol Violation|6
1531520|NCT00266032|5018633|P3|Treatment|Pregnancy|2
1531521|NCT00266032|5018634|P2|Treatment|Pregnancy|2
1531522|NCT00266032|5018635|P1|Treatment|Pregnancy|3
1531523|NCT00266032|5018633|P3|Treatment|Lost to Follow-up|2
1531524|NCT00266032|5018634|P2|Treatment|Lost to Follow-up|4
1531525|NCT00266032|5018635|P1|Treatment|Lost to Follow-up|19
1531526|NCT00266032|5018633|P3|Treatment|Adverse Event|10
1531527|NCT00266032|5018634|P2|Treatment|Adverse Event|26
1531528|NCT00266032|5018635|P1|Treatment|Adverse Event|42
1531529|NCT00265941|5018665|P2|Overall Study|Lost to Follow-up|1
1531530|NCT00265941|5018666|P1|Overall Study|Lost to Follow-up|1
1531531|NCT00265941|5018665|P2|Overall Study|Protocol Violation|25
1531532|NCT00265941|5018666|P1|Overall Study|Protocol Violation|22
1531533|NCT00265889|5018698|P1|Overall Study|Insurance denied the request|3
1531534|NCT00265889|5018698|P1|Overall Study|Protocol Violation|1
1531535|NCT00265889|5018698|P1|Overall Study|Physician Decision|1
1531536|NCT00265785|5018725|P1|Overall Study|Did not receive protocol treatment|2
1531537|NCT00265785|5018725|P1|Overall Study|Ineligible|1
1531538|NCT00265785|5018725|P1|Overall Study|Not protocol specified|2
1531539|NCT00265785|5018725|P1|Overall Study|Progression/Relapse|15
1531540|NCT00265785|5018725|P1|Overall Study|Withdrawal by Subject|3
1531541|NCT00265785|5018725|P1|Overall Study|Adverse Event|4
1531542|NCT00265759|5018738|P4|Overall Study|Discontinued due to intolerability|1
1531543|NCT00265759|5018739|P3|Overall Study|Discontinued due to intolerability|0
1531544|NCT00265759|5018740|P2|Overall Study|Discontinued due to intolerability|0
1531545|NCT00265759|5018741|P1|Overall Study|Discontinued due to intolerability|0
1531546|NCT00265759|5018738|P4|Overall Study|Bilateral disease|2
1531547|NCT00265759|5018739|P3|Overall Study|Bilateral disease|0
1531548|NCT00265759|5018740|P2|Overall Study|Bilateral disease|0
1531549|NCT00265759|5018741|P1|Overall Study|Bilateral disease|0
1531550|NCT00265759|5018738|P4|Overall Study|Ineligible|1
1531551|NCT00265759|5018739|P3|Overall Study|Ineligible|0
1531552|NCT00265759|5018740|P2|Overall Study|Ineligible|0
1531553|NCT00265759|5018741|P1|Overall Study|Ineligible|0
1531554|NCT00265759|5018738|P4|Overall Study|Cancel|3
1531555|NCT00265759|5018739|P3|Overall Study|Cancel|0
1531556|NCT00265759|5018740|P2|Overall Study|Cancel|0
1531557|NCT00265759|5018741|P1|Overall Study|Cancel|0
1531558|NCT00265759|5018738|P4|Overall Study|Withdrawal by Subject|2
1531559|NCT00265759|5018739|P3|Overall Study|Withdrawal by Subject|2
1531560|NCT00265759|5018740|P2|Overall Study|Withdrawal by Subject|1
1531561|NCT00265759|5018741|P1|Overall Study|Withdrawal by Subject|0
1531562|NCT00265395|5018808|P2|Overall Study|Administrative|1
1531563|NCT00265395|5018809|P1|Overall Study|Administrative|0
1531564|NCT00265395|5018808|P2|Overall Study|Lack of Efficacy|1
1531565|NCT00265395|5018809|P1|Overall Study|Lack of Efficacy|0
1531566|NCT00265395|5018808|P2|Overall Study|Protocol Violation|2
1531567|NCT00265395|5018809|P1|Overall Study|Protocol Violation|2
1531568|NCT00265395|5018808|P2|Overall Study|Withdrawal by Subject|6
1531569|NCT00265395|5018809|P1|Overall Study|Withdrawal by Subject|1
1531570|NCT00265395|5018808|P2|Overall Study|Lost to Follow-up|1
1531571|NCT00265395|5018809|P1|Overall Study|Lost to Follow-up|2
1531572|NCT00265395|5018808|P2|Overall Study|Adverse Event|6
1531573|NCT00265395|5018809|P1|Overall Study|Adverse Event|3
1531574|NCT00265382|5018814|P1|Overall Study|Death|1
1531575|NCT00265382|5018814|P1|Overall Study|Study terminated by sponsor|94
1531576|NCT00265382|5018814|P1|Overall Study|Withdrawal by Subject|13
1531577|NCT00265382|5018814|P1|Overall Study|Miscellaneous|6
1531578|NCT00265382|5018814|P1|Overall Study|Lack of Efficacy|6
1531579|NCT00265382|5018814|P1|Overall Study|Lost to Follow-up|3
1531580|NCT00265382|5018814|P1|Overall Study|Laboratory Abnormality|1
1531581|NCT00265382|5018814|P1|Overall Study|Adverse Event|21
1531582|NCT00265343|5018834|P2|Overall Study|Other|3
1531583|NCT00265343|5018835|P1|Overall Study|Other|8
1531584|NCT00265343|5018834|P2|Overall Study|Withdrawal by Subject|9
1531585|NCT00265343|5018835|P1|Overall Study|Withdrawal by Subject|3
1531586|NCT00265343|5018834|P2|Overall Study|Adverse Event|7
1531587|NCT00265343|5018835|P1|Overall Study|Adverse Event|10
1531588|NCT00265330|5018843|P1|Overall Study|Protocol Violation|1
1531589|NCT00265330|5018843|P1|Overall Study|Withdrew Consent|1
1531590|NCT00265330|5018843|P1|Overall Study|Principal Investigators Request|1
1531591|NCT00265330|5018843|P1|Overall Study|Site Closed by Sponsor|1
1531592|NCT00265330|5018843|P1|Overall Study|Discharged from Unit for Long Term Care|1
1531593|NCT00265330|5018843|P1|Overall Study|Began Taking Formulary Geodon|1
1531594|NCT00265330|5018843|P1|Overall Study|Family Scheduling Conflicts|1
1531595|NCT00265330|5018843|P1|Overall Study|Lack of Efficacy|4
1531596|NCT00265330|5018843|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
1531597|NCT00265330|5018843|P1|Overall Study|Withdrawal by Subject|34
1531598|NCT00265330|5018843|P1|Overall Study|Lost to Follow-up|8
1531599|NCT00265330|5018843|P1|Overall Study|Adverse Event|41
1531600|NCT00265317|5018869|P4|Phase 2|Other|1
1531601|NCT00265317|5018870|P3|Phase 2|Other|1
1531602|NCT00265317|5018871|P2|Phase 2|Other|0
1531603|NCT00265317|5018872|P1|Phase 2|Other|0
1531604|NCT00265317|5018869|P4|Phase 2|Study terminated by sponsor|0
1531605|NCT00265317|5018870|P3|Phase 2|Study terminated by sponsor|1
1531606|NCT00265317|5018871|P2|Phase 2|Study terminated by sponsor|0
1531607|NCT00265317|5018872|P1|Phase 2|Study terminated by sponsor|0
1531608|NCT00265317|5018869|P4|Phase 2|Withdrawal/other than adverse event|1
1531609|NCT00265317|5018870|P3|Phase 2|Withdrawal/other than adverse event|2
1531610|NCT00265317|5018871|P2|Phase 2|Withdrawal/other than adverse event|0
1531611|NCT00265317|5018872|P1|Phase 2|Withdrawal/other than adverse event|0
1531612|NCT00265317|5018869|P4|Phase 2|Lost to Follow-up|1
1531613|NCT00265317|5018870|P3|Phase 2|Lost to Follow-up|0
1531614|NCT00265317|5018871|P2|Phase 2|Lost to Follow-up|0
1531615|NCT00265317|5018872|P1|Phase 2|Lost to Follow-up|0
1531616|NCT00265317|5018869|P4|Phase 2|Protocol Violation|4
1531617|NCT00265317|5018870|P3|Phase 2|Protocol Violation|1
1531618|NCT00265317|5018871|P2|Phase 2|Protocol Violation|0
1531619|NCT00265317|5018872|P1|Phase 2|Protocol Violation|0
1531620|NCT00265317|5018869|P4|Phase 2|Death|15
1531621|NCT00265317|5018870|P3|Phase 2|Death|12
1531622|NCT00265317|5018871|P2|Phase 2|Death|0
1531623|NCT00265317|5018872|P1|Phase 2|Death|0
1531624|NCT00265317|5018869|P4|Phase 2|Adverse Event|5
1531625|NCT00265317|5018870|P3|Phase 2|Adverse Event|7
1531626|NCT00265317|5018871|P2|Phase 2|Adverse Event|0
1531627|NCT00265317|5018872|P1|Phase 2|Adverse Event|0
1531628|NCT00265317|5018869|P4|Phase 2|Global deterioration of health status|0
1531629|NCT00265317|5018870|P3|Phase 2|Global deterioration of health status|3
1531630|NCT00265317|5018871|P2|Phase 2|Global deterioration of health status|0
1531631|NCT00265317|5018872|P1|Phase 2|Global deterioration of health status|0
1531632|NCT00265317|5018869|P4|Phase 2|Objective progression or relapse|38
1531633|NCT00265317|5018870|P3|Phase 2|Objective progression or relapse|37
1531634|NCT00265317|5018871|P2|Phase 2|Objective progression or relapse|0
1531635|NCT00265317|5018872|P1|Phase 2|Objective progression or relapse|0
1531636|NCT00265317|5018869|P4|Lead-In|Withdrawal/other than adverse event|0
1531637|NCT00265317|5018870|P3|Lead-In|Withdrawal/other than adverse event|0
1531638|NCT00265317|5018871|P2|Lead-In|Withdrawal/other than adverse event|0
1531639|NCT00265317|5018872|P1|Lead-In|Withdrawal/other than adverse event|1
1531640|NCT00265317|5018869|P4|Lead-In|Death|0
1531641|NCT00265317|5018870|P3|Lead-In|Death|0
1531642|NCT00265317|5018871|P2|Lead-In|Death|5
1531643|NCT00265317|5018872|P1|Lead-In|Death|3
1531644|NCT00265317|5018869|P4|Lead-In|Adverse Event|0
1531645|NCT00265317|5018870|P3|Lead-In|Adverse Event|0
1531646|NCT00265317|5018871|P2|Lead-In|Adverse Event|1
1531647|NCT00265317|5018872|P1|Lead-In|Adverse Event|2
1531648|NCT00265317|5018869|P4|Lead-In|Objective progression or relapse|0
1531649|NCT00265317|5018870|P3|Lead-In|Objective progression or relapse|0
1531650|NCT00265317|5018871|P2|Lead-In|Objective progression or relapse|11
1531651|NCT00265317|5018872|P1|Lead-In|Objective progression or relapse|6
1531652|NCT00265239|5018987|P2|Overall Study|Adverse Event|1
1531653|NCT00265239|5018988|P1|Overall Study|Adverse Event|2
1531654|NCT00265122|5019010|P6|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
1531655|NCT00265122|5019011|P5|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
1531656|NCT00265122|5019012|P4|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
1531657|NCT00265122|5019013|P3|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
1531658|NCT00265122|5019014|P2|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
1531659|NCT00265122|5019015|P1|Intervention Period 2 (Weeks 8 to 28):|Not specified|4
1531660|NCT00265122|5019010|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
1531661|NCT00265122|5019011|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
1531662|NCT00265122|5019012|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
1531663|NCT00265122|5019013|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
1531664|NCT00265122|5019014|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
1531665|NCT00265122|5019015|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
1531666|NCT00265122|5019010|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
1531667|NCT00265122|5019011|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
1531668|NCT00265122|5019012|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
1531669|NCT00265122|5019013|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
1531670|NCT00265122|5019014|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
1531671|NCT00265122|5019015|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
1531672|NCT00265122|5019010|P6|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
1531673|NCT00265122|5019011|P5|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
1531674|NCT00265122|5019012|P4|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
1531675|NCT00265122|5019013|P3|Intervention Period 1 (Weeks 0 to 8):|Not specified|2
1531676|NCT00265122|5019014|P2|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
1531677|NCT00265122|5019015|P1|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
1531678|NCT00265122|5019010|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1531679|NCT00265122|5019011|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1531680|NCT00265122|5019012|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
1531681|NCT00265122|5019013|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1531682|NCT00265122|5019014|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1531683|NCT00265122|5019015|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
1531684|NCT00265122|5019010|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
1531685|NCT00265122|5019011|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
1531686|NCT00265122|5019012|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
1531687|NCT00265122|5019013|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
1531688|NCT00265122|5019014|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
1531689|NCT00265122|5019015|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
1531690|NCT00265109|5019037|P1|Overall Study|Adverse Event|1
1531691|NCT00265109|5019037|P1|Overall Study|Withdrawal by Subject|5
1531692|NCT00265096|5019044|P3|Overall Study|Not Specified|10
1531693|NCT00265096|5019045|P2|Overall Study|Not Specified|19
1531694|NCT00265096|5019046|P1|Overall Study|Not Specified|11
1531695|NCT00265096|5019044|P3|Overall Study|Unsatisfactory therapeutic effect|6
1531696|NCT00265096|5019045|P2|Overall Study|Unsatisfactory therapeutic effect|8
1531697|NCT00265096|5019046|P1|Overall Study|Unsatisfactory therapeutic effect|9
1531698|NCT00265096|5019044|P3|Overall Study|Death|2
1531699|NCT00265096|5019045|P2|Overall Study|Death|1
1531700|NCT00265096|5019046|P1|Overall Study|Death|0
1531701|NCT00265096|5019044|P3|Overall Study|Lost to Follow-up|3
1531702|NCT00265096|5019045|P2|Overall Study|Lost to Follow-up|5
1531703|NCT00265096|5019046|P1|Overall Study|Lost to Follow-up|2
1531704|NCT00265096|5019044|P3|Overall Study|Adverse Event|18
1531705|NCT00265096|5019045|P2|Overall Study|Adverse Event|18
1531706|NCT00265096|5019046|P1|Overall Study|Adverse Event|14
1531707|NCT00265083|5019078|P3|Overall Study|Not specified|9
1531708|NCT00265083|5019079|P2|Overall Study|Not specified|12
1531709|NCT00265083|5019080|P1|Overall Study|Not specified|1
1531710|NCT00265083|5019078|P3|Overall Study|Unsatisfactory therapeutic effect|14
1531711|NCT00265083|5019079|P2|Overall Study|Unsatisfactory therapeutic effect|13
1531712|NCT00265083|5019080|P1|Overall Study|Unsatisfactory therapeutic effect|8
1531713|NCT00265083|5019078|P3|Overall Study|Lost to Follow-up|4
1531714|NCT00265083|5019079|P2|Overall Study|Lost to Follow-up|4
1531715|NCT00265083|5019080|P1|Overall Study|Lost to Follow-up|3
1531716|NCT00265083|5019078|P3|Overall Study|Adverse Event|15
1531717|NCT00265083|5019079|P2|Overall Study|Adverse Event|13
1531718|NCT00265083|5019080|P1|Overall Study|Adverse Event|5
1531719|NCT00264875|5019101|P1|Overall Study|Withdrawal by Subject|7
1531720|NCT00264875|5019101|P1|Overall Study|Protocol Violation|11
1531721|NCT00264875|5019101|P1|Overall Study|Lost to Follow-up|6
1531722|NCT00264875|5019101|P1|Overall Study|Adverse Event|6
1531723|NCT00264849|5019107|P2|Overall Study|Administrative Problems|0
1531724|NCT00264849|5019108|P1|Overall Study|Administrative Problems|2
1531725|NCT00264849|5019107|P2|Overall Study|Death|1
1531726|NCT00264849|5019108|P1|Overall Study|Death|0
1531727|NCT00264849|5019107|P2|Overall Study|Lost to Follow-up|2
1531728|NCT00264849|5019108|P1|Overall Study|Lost to Follow-up|0
1531729|NCT00264849|5019107|P2|Overall Study|Lack of Efficacy|6
1531730|NCT00264849|5019108|P1|Overall Study|Lack of Efficacy|1
1531731|NCT00264849|5019107|P2|Overall Study|Protocol Violation|3
1531732|NCT00264849|5019108|P1|Overall Study|Protocol Violation|5
1531733|NCT00264849|5019107|P2|Overall Study|Withdrawal by Subject|11
1531734|NCT00264849|5019108|P1|Overall Study|Withdrawal by Subject|7
1531735|NCT00264849|5019107|P2|Overall Study|Adverse Event|2
1531736|NCT00264849|5019108|P1|Overall Study|Adverse Event|7
1531737|NCT00264810|5019142|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
1531738|NCT00264810|5019143|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
1531739|NCT00264810|5019142|P2|Open Label Evaluation Period|Death|2
1531740|NCT00264810|5019143|P1|Open Label Evaluation Period|Death|3
1531741|NCT00264810|5019142|P2|Open Label Evaluation Period|Explant due to infection|1
1531742|NCT00264810|5019143|P1|Open Label Evaluation Period|Explant due to infection|1
1531743|NCT00264810|5019142|P2|Blinded Evaluation Period|Explant due to infection|1
1531744|NCT00264810|5019143|P1|Blinded Evaluation Period|Explant due to infection|1
1531745|NCT00264810|5019142|P2|Stimulation Optimization Period|Death|1
1531746|NCT00264810|5019143|P1|Stimulation Optimization Period|Death|0
1531747|NCT00264810|5019142|P2|Stimulation Optimization Period|Withdrawal by Subject|0
1531748|NCT00264810|5019143|P1|Stimulation Optimization Period|Withdrawal by Subject|1
1531749|NCT00264810|5019142|P2|Baseline|Other|1
1531750|NCT00264810|5019143|P1|Baseline|Other|0
1531751|NCT00264810|5019142|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
1531752|NCT00264810|5019143|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
1531753|NCT00264810|5019142|P2|Baseline|Insufficient Seizure Frequency|2
1531754|NCT00264810|5019143|P1|Baseline|Insufficient Seizure Frequency|2
1531755|NCT00264810|5019142|P2|Baseline|Subject Compliance Failure|3
1531756|NCT00264810|5019143|P1|Baseline|Subject Compliance Failure|3
1531757|NCT00264810|5019142|P2|Baseline|Physician Decision|8
1531758|NCT00264810|5019143|P1|Baseline|Physician Decision|7
1531759|NCT00264810|5019142|P2|Baseline|Withdrawal by Subject|10
1531760|NCT00264810|5019143|P1|Baseline|Withdrawal by Subject|10
1531761|NCT00264797|5019153|P2|Overall Study|Other|4
1531762|NCT00264797|5019154|P1|Overall Study|Other|3
1531763|NCT00264797|5019153|P2|Overall Study|Feels treatment not necessary, not worki|1
1531764|NCT00264797|5019154|P1|Overall Study|Feels treatment not necessary, not worki|0
1531765|NCT00264797|5019153|P2|Overall Study|Pressure/advice from Outsiders|1
1531766|NCT00264797|5019154|P1|Overall Study|Pressure/advice from Outsiders|1
1531767|NCT00264797|5019153|P2|Overall Study|Incarceration|5
1531768|NCT00264797|5019154|P1|Overall Study|Incarceration|4
1531769|NCT00264797|5019153|P2|Overall Study|Practical Problems|3
1531770|NCT00264797|5019154|P1|Overall Study|Practical Problems|2
1531771|NCT00264797|5019153|P2|Overall Study|Moved from area|1
1531772|NCT00264797|5019154|P1|Overall Study|Moved from area|3
1531773|NCT00264797|5019153|P2|Overall Study|Lost to Follow-up|17
1531774|NCT00264797|5019154|P1|Overall Study|Lost to Follow-up|9
1531775|NCT00264797|5019153|P2|Overall Study|Withdrawal by Subject|11
1531776|NCT00264797|5019154|P1|Overall Study|Withdrawal by Subject|11
1531777|NCT00264576|5019176|P2|Overall Study|Lost to Follow-up|1
1531778|NCT00264576|5019177|P1|Overall Study|Lost to Follow-up|1
1531779|NCT00264550|5019201|P4|Overall Study|Not specified|9
1531780|NCT00264550|5019202|P3|Overall Study|Not specified|3
1531781|NCT00264550|5019203|P2|Overall Study|Not specified|7
1531782|NCT00264550|5019204|P1|Overall Study|Not specified|13
1531783|NCT00264550|5019201|P4|Overall Study|Discontinued oral study agent|0
1531784|NCT00264550|5019202|P3|Overall Study|Discontinued oral study agent|0
1531785|NCT00264550|5019203|P2|Overall Study|Discontinued oral study agent|1
1531786|NCT00264550|5019204|P1|Overall Study|Discontinued oral study agent|0
1531787|NCT00264550|5019201|P4|Overall Study|Unsatisfactory therapeutic effect|6
1531788|NCT00264550|5019202|P3|Overall Study|Unsatisfactory therapeutic effect|4
1531789|NCT00264550|5019203|P2|Overall Study|Unsatisfactory therapeutic effect|11
1531790|NCT00264550|5019204|P1|Overall Study|Unsatisfactory therapeutic effect|4
1531791|NCT00264550|5019201|P4|Overall Study|Adverse Event|14
1531792|NCT00264550|5019202|P3|Overall Study|Adverse Event|9
1531793|NCT00264550|5019203|P2|Overall Study|Adverse Event|18
1531794|NCT00264550|5019204|P1|Overall Study|Adverse Event|23
1531795|NCT00264550|5019201|P4|Overall Study|Lost to Follow-up|1
1531796|NCT00264550|5019202|P3|Overall Study|Lost to Follow-up|1
1531797|NCT00264550|5019203|P2|Overall Study|Lost to Follow-up|1
1531798|NCT00264550|5019204|P1|Overall Study|Lost to Follow-up|3
1531799|NCT00264550|5019201|P4|Overall Study|Death|0
1531800|NCT00264550|5019202|P3|Overall Study|Death|0
1531801|NCT00264550|5019203|P2|Overall Study|Death|3
1531802|NCT00264550|5019204|P1|Overall Study|Death|0
1531803|NCT00264537|5019243|P4|Overall Study|Not treated|0
1531804|NCT00264537|5019244|P3|Overall Study|Not treated|1
1531805|NCT00264537|5019245|P2|Overall Study|Not treated|2
1531806|NCT00264537|5019246|P1|Overall Study|Not treated|0
1531807|NCT00264537|5019243|P4|Overall Study|Not specified|11
1531808|NCT00264537|5019244|P3|Overall Study|Not specified|10
1531809|NCT00264537|5019245|P2|Overall Study|Not specified|11
1531810|NCT00264537|5019246|P1|Overall Study|Not specified|21
1531811|NCT00264537|5019243|P4|Overall Study|Unsatisfactory therapeutic effect|7
1531812|NCT00264537|5019244|P3|Overall Study|Unsatisfactory therapeutic effect|5
1531813|NCT00264537|5019245|P2|Overall Study|Unsatisfactory therapeutic effect|6
1531814|NCT00264537|5019246|P1|Overall Study|Unsatisfactory therapeutic effect|5
1531815|NCT00264537|5019243|P4|Overall Study|Adverse Event|34
1531816|NCT00264537|5019244|P3|Overall Study|Adverse Event|24
1531817|NCT00264537|5019245|P2|Overall Study|Adverse Event|32
1531818|NCT00264537|5019246|P1|Overall Study|Adverse Event|21
1531819|NCT00264537|5019243|P4|Overall Study|Lost to Follow-up|6
1531820|NCT00264537|5019244|P3|Overall Study|Lost to Follow-up|7
1531821|NCT00264537|5019245|P2|Overall Study|Lost to Follow-up|4
1531822|NCT00264537|5019246|P1|Overall Study|Lost to Follow-up|3
1531823|NCT00264537|5019243|P4|Overall Study|Death|2
1531824|NCT00264537|5019244|P3|Overall Study|Death|3
1531825|NCT00264537|5019245|P2|Overall Study|Death|3
1531826|NCT00264537|5019246|P1|Overall Study|Death|0
1531827|NCT00264498|5019278|P2|Crossover Treatment|Withdrawal by Subject|0
1531828|NCT00264498|5019279|P1|Crossover Treatment|Withdrawal by Subject|1
1531829|NCT00264498|5019278|P2|Crossover Treatment|Study closure|1
1531830|NCT00264498|5019279|P1|Crossover Treatment|Study closure|0
1531831|NCT00264498|5019278|P2|Crossover Treatment|Objective disease progression|5
1531832|NCT00264498|5019279|P1|Crossover Treatment|Objective disease progression|4
1531833|NCT00264498|5019278|P2|Crossover Treatment|Death|3
1531834|NCT00264498|5019279|P1|Crossover Treatment|Death|1
1531835|NCT00264498|5019278|P2|Randomized Treatment|Protocol Violation|0
1531836|NCT00264498|5019279|P1|Randomized Treatment|Protocol Violation|1
1531837|NCT00264498|5019278|P2|Randomized Treatment|Study Closure|0
1531838|NCT00264498|5019279|P1|Randomized Treatment|Study Closure|1
1531839|NCT00264498|5019278|P2|Randomized Treatment|Incorrectly randomized|0
1531840|NCT00264498|5019279|P1|Randomized Treatment|Incorrectly randomized|1
1531841|NCT00264498|5019278|P2|Randomized Treatment|Physician Decision|0
1531842|NCT00264498|5019279|P1|Randomized Treatment|Physician Decision|1
1531843|NCT00264498|5019278|P2|Randomized Treatment|Objective disease Progression|14
1531844|NCT00264498|5019279|P1|Randomized Treatment|Objective disease Progression|13
1531845|NCT00264498|5019278|P2|Randomized Treatment|Withdrawal by Subject|1
1531846|NCT00264498|5019279|P1|Randomized Treatment|Withdrawal by Subject|0
1531847|NCT00264498|5019278|P2|Randomized Treatment|Death|3
1531848|NCT00264498|5019279|P1|Randomized Treatment|Death|0
1531849|NCT00264303|5019302|P2|Overall Study|Various reasons listed in study report|7
1531850|NCT00264303|5019303|P1|Overall Study|Various reasons listed in study report|6
1531851|NCT00264303|5019302|P2|Overall Study|Withdrawal by Subject|3
1531852|NCT00264303|5019303|P1|Overall Study|Withdrawal by Subject|2
1531853|NCT00264303|5019302|P2|Overall Study|Lost to Follow-up|3
1531854|NCT00264303|5019303|P1|Overall Study|Lost to Follow-up|3
1531855|NCT00264303|5019302|P2|Overall Study|Lack of Efficacy|13
1531856|NCT00264303|5019303|P1|Overall Study|Lack of Efficacy|10
1531857|NCT00264303|5019302|P2|Overall Study|Adverse Event|3
1531858|NCT00264303|5019303|P1|Overall Study|Adverse Event|4
1531859|NCT00264290|5019321|P2|Intervention (8 Weeks)|Adverse Event|0
1531860|NCT00264290|5019322|P1|Intervention (8 Weeks)|Adverse Event|1
1531861|NCT00264238|5019328|P1|Overall Study|Protocol Violation|1
1531862|NCT00264147|5019340|P6|Treatment II Period|Pre-scheduled total hip replacement|1
1531863|NCT00264147|5019341|P5|Treatment II Period|Pre-scheduled total hip replacement|0
1531864|NCT00264147|5019342|P4|Treatment II Period|Pre-scheduled total hip replacement|0
1531865|NCT00264147|5019343|P3|Treatment II Period|Pre-scheduled total hip replacement|0
1531866|NCT00264147|5019344|P2|Treatment II Period|Pre-scheduled total hip replacement|0
1531867|NCT00264147|5019345|P1|Treatment II Period|Pre-scheduled total hip replacement|0
1531868|NCT00264147|5019340|P6|Treatment II Period|Withdrawal by Subject|2
1531869|NCT00264147|5019341|P5|Treatment II Period|Withdrawal by Subject|3
1531870|NCT00264147|5019342|P4|Treatment II Period|Withdrawal by Subject|0
1531871|NCT00264147|5019343|P3|Treatment II Period|Withdrawal by Subject|0
1531872|NCT00264147|5019344|P2|Treatment II Period|Withdrawal by Subject|0
1531873|NCT00264147|5019345|P1|Treatment II Period|Withdrawal by Subject|0
1531874|NCT00264147|5019340|P6|Treatment II Period|Lost to Follow-up|1
1531875|NCT00264147|5019341|P5|Treatment II Period|Lost to Follow-up|1
1531876|NCT00264147|5019342|P4|Treatment II Period|Lost to Follow-up|0
1531877|NCT00264147|5019343|P3|Treatment II Period|Lost to Follow-up|0
1531878|NCT00264147|5019344|P2|Treatment II Period|Lost to Follow-up|0
1531879|NCT00264147|5019345|P1|Treatment II Period|Lost to Follow-up|0
1531880|NCT00264147|5019340|P6|Treatment II Period|Lack of Efficacy|19
1531881|NCT00264147|5019341|P5|Treatment II Period|Lack of Efficacy|20
1531882|NCT00264147|5019342|P4|Treatment II Period|Lack of Efficacy|0
1531883|NCT00264147|5019343|P3|Treatment II Period|Lack of Efficacy|0
1531884|NCT00264147|5019344|P2|Treatment II Period|Lack of Efficacy|0
1531885|NCT00264147|5019345|P1|Treatment II Period|Lack of Efficacy|0
1531886|NCT00264147|5019340|P6|Treatment II Period|Laboratory Adverse Event|1
1531887|NCT00264147|5019341|P5|Treatment II Period|Laboratory Adverse Event|0
1531888|NCT00264147|5019342|P4|Treatment II Period|Laboratory Adverse Event|0
1531889|NCT00264147|5019343|P3|Treatment II Period|Laboratory Adverse Event|0
1531890|NCT00264147|5019344|P2|Treatment II Period|Laboratory Adverse Event|0
1531891|NCT00264147|5019345|P1|Treatment II Period|Laboratory Adverse Event|0
1531892|NCT00264147|5019340|P6|Treatment II Period|Adverse Event|9
1531893|NCT00264147|5019341|P5|Treatment II Period|Adverse Event|9
1531894|NCT00264147|5019342|P4|Treatment II Period|Adverse Event|0
1531895|NCT00264147|5019343|P3|Treatment II Period|Adverse Event|0
1531896|NCT00264147|5019344|P2|Treatment II Period|Adverse Event|0
1531897|NCT00264147|5019345|P1|Treatment II Period|Adverse Event|0
1531898|NCT00264147|5019340|P6|Treatment I Period|Reassigned to Treatment II Period|0
1531899|NCT00264147|5019341|P5|Treatment I Period|Reassigned to Treatment II Period|45
1531900|NCT00264147|5019342|P4|Treatment I Period|Reassigned to Treatment II Period|63
1531901|NCT00264147|5019343|P3|Treatment I Period|Reassigned to Treatment II Period|65
1531902|NCT00264147|5019344|P2|Treatment I Period|Reassigned to Treatment II Period|72
1531903|NCT00264147|5019345|P1|Treatment I Period|Reassigned to Treatment II Period|84
1531904|NCT00264147|5019340|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
1531905|NCT00264147|5019341|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
1531906|NCT00264147|5019342|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
1531907|NCT00264147|5019343|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
1531908|NCT00264147|5019344|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
1531909|NCT00264147|5019345|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
1531910|NCT00264147|5019340|P6|Treatment I Period|Patient out of town for an extended time|0
1531911|NCT00264147|5019341|P5|Treatment I Period|Patient out of town for an extended time|0
1531912|NCT00264147|5019342|P4|Treatment I Period|Patient out of town for an extended time|0
1531913|NCT00264147|5019343|P3|Treatment I Period|Patient out of town for an extended time|0
1531914|NCT00264147|5019344|P2|Treatment I Period|Patient out of town for an extended time|1
1531915|NCT00264147|5019345|P1|Treatment I Period|Patient out of town for an extended time|0
1531916|NCT00264147|5019340|P6|Treatment I Period|Withdrawal by Subject|0
1531917|NCT00264147|5019341|P5|Treatment I Period|Withdrawal by Subject|2
1531918|NCT00264147|5019342|P4|Treatment I Period|Withdrawal by Subject|2
1531919|NCT00264147|5019343|P3|Treatment I Period|Withdrawal by Subject|0
1531920|NCT00264147|5019344|P2|Treatment I Period|Withdrawal by Subject|0
1531921|NCT00264147|5019345|P1|Treatment I Period|Withdrawal by Subject|2
1531922|NCT00264147|5019340|P6|Treatment I Period|Protocol Violation|0
1531923|NCT00264147|5019341|P5|Treatment I Period|Protocol Violation|0
1531924|NCT00264147|5019342|P4|Treatment I Period|Protocol Violation|0
1531925|NCT00264147|5019343|P3|Treatment I Period|Protocol Violation|0
1531926|NCT00264147|5019344|P2|Treatment I Period|Protocol Violation|2
1531927|NCT00264147|5019345|P1|Treatment I Period|Protocol Violation|2
1531928|NCT00264147|5019340|P6|Treatment I Period|Lost to Follow-up|0
1531929|NCT00264147|5019341|P5|Treatment I Period|Lost to Follow-up|1
1531930|NCT00264147|5019342|P4|Treatment I Period|Lost to Follow-up|1
1531931|NCT00264147|5019343|P3|Treatment I Period|Lost to Follow-up|0
1531932|NCT00264147|5019344|P2|Treatment I Period|Lost to Follow-up|0
1531933|NCT00264147|5019345|P1|Treatment I Period|Lost to Follow-up|1
1531934|NCT00264147|5019340|P6|Treatment I Period|Lack of Efficacy|0
1531935|NCT00264147|5019341|P5|Treatment I Period|Lack of Efficacy|1
1531936|NCT00264147|5019342|P4|Treatment I Period|Lack of Efficacy|0
1531937|NCT00264147|5019343|P3|Treatment I Period|Lack of Efficacy|8
1531938|NCT00264147|5019344|P2|Treatment I Period|Lack of Efficacy|2
1531939|NCT00264147|5019345|P1|Treatment I Period|Lack of Efficacy|6
1531940|NCT00264147|5019340|P6|Treatment I Period|Laboratory Adverse Event|0
1531941|NCT00264147|5019341|P5|Treatment I Period|Laboratory Adverse Event|0
1531942|NCT00264147|5019342|P4|Treatment I Period|Laboratory Adverse Event|1
1531943|NCT00264147|5019343|P3|Treatment I Period|Laboratory Adverse Event|0
1531944|NCT00264147|5019344|P2|Treatment I Period|Laboratory Adverse Event|0
1531945|NCT00264147|5019345|P1|Treatment I Period|Laboratory Adverse Event|0
1531946|NCT00264147|5019340|P6|Treatment I Period|Adverse Event|0
1531947|NCT00264147|5019341|P5|Treatment I Period|Adverse Event|7
1531948|NCT00264147|5019342|P4|Treatment I Period|Adverse Event|5
1531949|NCT00264147|5019343|P3|Treatment I Period|Adverse Event|3
1531950|NCT00264147|5019344|P2|Treatment I Period|Adverse Event|6
1531951|NCT00264147|5019345|P1|Treatment I Period|Adverse Event|3
1531952|NCT00264004|5019388|P4|Overall Study|Not treated|2
1531953|NCT00264004|5019389|P3|Overall Study|Not treated|2
1531954|NCT00264004|5019390|P2|Overall Study|Not treated|0
1531955|NCT00264004|5019391|P1|Overall Study|Not treated|3
1531956|NCT00264004|5019388|P4|Overall Study|Cond. under inv. worsened|4
1531957|NCT00264004|5019389|P3|Overall Study|Cond. under inv. worsened|3
1531958|NCT00264004|5019390|P2|Overall Study|Cond. under inv. worsened|5
1531959|NCT00264004|5019391|P1|Overall Study|Cond. under inv. worsened|9
1531960|NCT00264004|5019388|P4|Overall Study|Development study specific disc. crit.|0
1531961|NCT00264004|5019389|P3|Overall Study|Development study specific disc. crit.|1
1531962|NCT00264004|5019390|P2|Overall Study|Development study specific disc. crit.|0
1531963|NCT00264004|5019391|P1|Overall Study|Development study specific disc. crit.|1
1531964|NCT00264004|5019388|P4|Overall Study|Not specified|3
1531965|NCT00264004|5019389|P3|Overall Study|Not specified|0
1531966|NCT00264004|5019390|P2|Overall Study|Not specified|2
1531967|NCT00264004|5019391|P1|Overall Study|Not specified|2
1531968|NCT00264004|5019388|P4|Overall Study|Withdrawal by Subject|2
1531969|NCT00264004|5019389|P3|Overall Study|Withdrawal by Subject|2
1531970|NCT00264004|5019390|P2|Overall Study|Withdrawal by Subject|1
1531971|NCT00264004|5019391|P1|Overall Study|Withdrawal by Subject|0
1531972|NCT00264004|5019388|P4|Overall Study|Adverse Event|4
1531973|NCT00264004|5019389|P3|Overall Study|Adverse Event|6
1531974|NCT00264004|5019390|P2|Overall Study|Adverse Event|3
1531975|NCT00264004|5019391|P1|Overall Study|Adverse Event|2
1531976|NCT00263887|5019419|P2|Overall Study|Lack of Efficacy|1
1531977|NCT00263887|5019420|P1|Overall Study|Lack of Efficacy|0
1531978|NCT00263887|5019419|P2|Overall Study|Disease progression|1
1531979|NCT00263887|5019420|P1|Overall Study|Disease progression|0
1531980|NCT00263887|5019419|P2|Overall Study|Adverse Event|2
1531981|NCT00263887|5019420|P1|Overall Study|Adverse Event|0
1531982|NCT00263887|5019419|P2|Overall Study|Too ill to attend visit|0
1531983|NCT00263887|5019420|P1|Overall Study|Too ill to attend visit|1
1531984|NCT00263887|5019419|P2|Overall Study|Lung transplantation|2
1531985|NCT00263887|5019420|P1|Overall Study|Lung transplantation|1
1531986|NCT00263887|5019419|P2|Overall Study|Withdrawal by Subject|1
1531987|NCT00263887|5019420|P1|Overall Study|Withdrawal by Subject|1
1531988|NCT00263757|5019428|P2|Overall Study|Adverse Event|3
1531989|NCT00263757|5019429|P1|Overall Study|Adverse Event|3
1531990|NCT00263757|5019428|P2|Overall Study|Screen failure|1
1531991|NCT00263757|5019429|P1|Overall Study|Screen failure|0
1531992|NCT00263757|5019428|P2|Overall Study|Withdrawal by Subject|4
1531993|NCT00263757|5019429|P1|Overall Study|Withdrawal by Subject|5
1531994|NCT00263666|5019441|P2|Overall Study|Withdrawal by Subject|1
1531995|NCT00263666|5019442|P1|Overall Study|Withdrawal by Subject|0
1531996|NCT00263666|5019441|P2|Overall Study|Lost to Follow-up|2
1531997|NCT00263666|5019442|P1|Overall Study|Lost to Follow-up|1
1531998|NCT00263666|5019441|P2|Overall Study|Adverse Event|8
1531999|NCT00263666|5019442|P1|Overall Study|Adverse Event|6
1532000|NCT00263328|5019496|P3|Overall Study|Adverse Event|4
1532001|NCT00263328|5019497|P2|Overall Study|Adverse Event|1
1532002|NCT00263328|5019498|P1|Overall Study|Adverse Event|1
1532003|NCT00263328|5019496|P3|Overall Study|Not specified|1
1532004|NCT00263328|5019497|P2|Overall Study|Not specified|0
1532005|NCT00263328|5019498|P1|Overall Study|Not specified|3
1532006|NCT00263328|5019496|P3|Overall Study|Withdrawal by Subject|1
1532007|NCT00263328|5019497|P2|Overall Study|Withdrawal by Subject|0
1532008|NCT00263328|5019498|P1|Overall Study|Withdrawal by Subject|3
1532009|NCT00263328|5019496|P3|Overall Study|Lost to Follow-up|0
1532010|NCT00263328|5019497|P2|Overall Study|Lost to Follow-up|1
1532011|NCT00263328|5019498|P1|Overall Study|Lost to Follow-up|1
1532012|NCT00263328|5019496|P3|Overall Study|Death|1
1532013|NCT00263328|5019497|P2|Overall Study|Death|0
1532014|NCT00263328|5019498|P1|Overall Study|Death|0
1532015|NCT00263211|5019656|P2|Overall Study|Disease Progression|1
1532016|NCT00263211|5019657|P1|Overall Study|Disease Progression|0
1532017|NCT00263211|5019656|P2|Overall Study|Protocol Violation|0
1532018|NCT00263211|5019657|P1|Overall Study|Protocol Violation|1
1532019|NCT00263211|5019656|P2|Overall Study|Withdrawal by Subject|0
1532020|NCT00263211|5019657|P1|Overall Study|Withdrawal by Subject|3
1532021|NCT00263211|5019656|P2|Overall Study|Death|0
1532022|NCT00263211|5019657|P1|Overall Study|Death|1
1532023|NCT00262951|5019708|P1|Overall Study|Off treatment for other disease|1
1532024|NCT00262951|5019708|P1|Overall Study|Alternative treatment|3
1532025|NCT00262951|5019708|P1|Overall Study|Withdrawal by Subject|1
1532026|NCT00262951|5019708|P1|Overall Study|Death|1
1532027|NCT00262951|5019708|P1|Overall Study|Adverse Event|7
1532028|NCT00262951|5019708|P1|Overall Study|Progressive disease/relapse|3
1532029|NCT00262925|5019713|P1|Overall Study|Other|1
1532030|NCT00262925|5019713|P1|Overall Study|alternative therapy|1
1532031|NCT00262925|5019713|P1|Overall Study|Death|2
1532032|NCT00262925|5019713|P1|Overall Study|Adverse Event|4
1532033|NCT00262925|5019713|P1|Overall Study|Lack of Efficacy|3
1532034|NCT00262873|5019719|P1|Overall Study|Withdrawal by Subject|5
1532035|NCT00262873|5019719|P1|Overall Study|Adverse Event|3
1532036|NCT00262860|5019730|P1|Overall Study|Adverse Event|2
1532037|NCT00262847|5019739|P3|Overall Study|Did not receive study treatment|4
1532038|NCT00262847|5019740|P2|Overall Study|Did not receive study treatment|1
1532039|NCT00262847|5019741|P1|Overall Study|Did not receive study treatment|4
1532040|NCT00262847|5019739|P3|Overall Study|Other Reasons|27
1532041|NCT00262847|5019740|P2|Overall Study|Other Reasons|88
1532042|NCT00262847|5019741|P1|Overall Study|Other Reasons|79
1532043|NCT00262847|5019739|P3|Overall Study|Concomitant disease|4
1532044|NCT00262847|5019740|P2|Overall Study|Concomitant disease|2
1532045|NCT00262847|5019741|P1|Overall Study|Concomitant disease|3
1532046|NCT00262847|5019739|P3|Overall Study|Death|11
1532047|NCT00262847|5019740|P2|Overall Study|Death|8
1532048|NCT00262847|5019741|P1|Overall Study|Death|8
1532049|NCT00262847|5019739|P3|Overall Study|Adverse Event|108
1532050|NCT00262847|5019740|P2|Overall Study|Adverse Event|88
1532051|NCT00262847|5019741|P1|Overall Study|Adverse Event|74
1532052|NCT00262847|5019739|P3|Overall Study|Patient Refusal|47
1532053|NCT00262847|5019740|P2|Overall Study|Patient Refusal|52
1532054|NCT00262847|5019741|P1|Overall Study|Patient Refusal|41
1532055|NCT00262847|5019739|P3|Overall Study|Disease Progression|195
1532056|NCT00262847|5019740|P2|Overall Study|Disease Progression|274
1532057|NCT00262847|5019741|P1|Overall Study|Disease Progression|309
1532058|NCT00262834|5019760|P2|Overall Study|Surgery delayed/tissue not collected|4
1532059|NCT00262834|5019761|P1|Overall Study|Surgery delayed/tissue not collected|1
1532060|NCT00262821|5019774|P2|Overall Study|Inevaluable - inadequate data|4
1532061|NCT00262821|5019775|P1|Overall Study|Inevaluable - inadequate data|0
1532062|NCT00262821|5019774|P2|Overall Study|Ineligible - required test not done|4
1532063|NCT00262821|5019775|P1|Overall Study|Ineligible - required test not done|1
1532064|NCT00262821|5019774|P2|Overall Study|Ineligible - elevated creatinine|2
1532065|NCT00262821|5019775|P1|Overall Study|Ineligible - elevated creatinine|0
1532066|NCT00262821|5019774|P2|Overall Study|Ineligible - inadequate pathology|3
1532067|NCT00262821|5019775|P1|Overall Study|Ineligible - inadequate pathology|1
1532068|NCT00262821|5019774|P2|Overall Study|Ineligible - wrong primary|1
1532069|NCT00262821|5019775|P1|Overall Study|Ineligible - wrong primary|0
1532070|NCT00262821|5019774|P2|Overall Study|Ineligible - wrong cell type|2
1532071|NCT00262821|5019775|P1|Overall Study|Ineligible - wrong cell type|2
1532072|NCT00262821|5019774|P2|Overall Study|Ineligible - wrong stage|3
1532073|NCT00262821|5019775|P1|Overall Study|Ineligible - wrong stage|0
1532074|NCT00262743|5019787|P2|Overall Study|Disease progression|3
1532075|NCT00262743|5019788|P1|Overall Study|Disease progression|0
1532076|NCT00262743|5019787|P2|Overall Study|Adverse Event|9
1532077|NCT00262743|5019788|P1|Overall Study|Adverse Event|0
1532078|NCT00262600|5019823|P3|Overall Study|Not Specified|62
1532079|NCT00262600|5019824|P2|Overall Study|Not Specified|59
1532080|NCT00262600|5019825|P1|Overall Study|Not Specified|58
1532081|NCT00262600|5019823|P3|Overall Study|Not Treated|24
1532082|NCT00262600|5019824|P2|Overall Study|Not Treated|17
1532083|NCT00262600|5019825|P1|Overall Study|Not Treated|32
1532084|NCT00262600|5019823|P3|Overall Study|Withdrawal by Subject|139
1532085|NCT00262600|5019824|P2|Overall Study|Withdrawal by Subject|145
1532086|NCT00262600|5019825|P1|Overall Study|Withdrawal by Subject|128
1532087|NCT00262600|5019823|P3|Overall Study|Lost to Follow-up|41
1532088|NCT00262600|5019824|P2|Overall Study|Lost to Follow-up|31
1532089|NCT00262600|5019825|P1|Overall Study|Lost to Follow-up|17
1532090|NCT00262522|5019852|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
1532091|NCT00262522|5019853|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
1532092|NCT00262522|5019854|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
1532093|NCT00262522|5019855|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
1532094|NCT00262522|5019852|P4|Study Start Through 96 Weeks|Virologic failure|0
1532095|NCT00262522|5019853|P3|Study Start Through 96 Weeks|Virologic failure|8
1532096|NCT00262522|5019854|P2|Study Start Through 96 Weeks|Virologic failure|0
1532097|NCT00262522|5019855|P1|Study Start Through 96 Weeks|Virologic failure|5
1532098|NCT00262522|5019852|P4|Study Start Through 96 Weeks|Death|0
1532099|NCT00262522|5019853|P3|Study Start Through 96 Weeks|Death|2
1532100|NCT00262522|5019854|P2|Study Start Through 96 Weeks|Death|0
1532101|NCT00262522|5019855|P1|Study Start Through 96 Weeks|Death|2
1532102|NCT00262522|5019852|P4|Study Start Through 96 Weeks|Noncompliance|0
1532103|NCT00262522|5019853|P3|Study Start Through 96 Weeks|Noncompliance|11
1532104|NCT00262522|5019854|P2|Study Start Through 96 Weeks|Noncompliance|0
1532105|NCT00262522|5019855|P1|Study Start Through 96 Weeks|Noncompliance|6
1532106|NCT00262522|5019852|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
1532107|NCT00262522|5019853|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
1532108|NCT00262522|5019854|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
1532109|NCT00262522|5019855|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
1532110|NCT00262522|5019852|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
1532111|NCT00262522|5019853|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
1532112|NCT00262522|5019854|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
1532113|NCT00262522|5019855|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
1532114|NCT00262522|5019852|P4|Study Start Through 96 Weeks|Adverse Event|0
1532115|NCT00262522|5019853|P3|Study Start Through 96 Weeks|Adverse Event|16
1532116|NCT00262522|5019854|P2|Study Start Through 96 Weeks|Adverse Event|0
1532117|NCT00262522|5019855|P1|Study Start Through 96 Weeks|Adverse Event|20
1532118|NCT00262522|5019852|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
1532119|NCT00262522|5019853|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
1532120|NCT00262522|5019854|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
1532121|NCT00262522|5019855|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
1532122|NCT00262522|5019852|P4|Study Start Through 48 Weeks|Virologic failure|0
1532123|NCT00262522|5019853|P3|Study Start Through 48 Weeks|Virologic failure|4
1532124|NCT00262522|5019854|P2|Study Start Through 48 Weeks|Virologic failure|0
1532125|NCT00262522|5019855|P1|Study Start Through 48 Weeks|Virologic failure|2
1532126|NCT00262522|5019852|P4|Study Start Through 48 Weeks|Death|0
1532127|NCT00262522|5019853|P3|Study Start Through 48 Weeks|Death|1
1532128|NCT00262522|5019854|P2|Study Start Through 48 Weeks|Death|0
1532129|NCT00262522|5019855|P1|Study Start Through 48 Weeks|Death|2
1532130|NCT00262522|5019852|P4|Study Start Through 48 Weeks|Noncompliance|0
1532131|NCT00262522|5019853|P3|Study Start Through 48 Weeks|Noncompliance|8
1532132|NCT00262522|5019854|P2|Study Start Through 48 Weeks|Noncompliance|0
1532133|NCT00262522|5019855|P1|Study Start Through 48 Weeks|Noncompliance|3
1532134|NCT00262522|5019852|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
1532135|NCT00262522|5019853|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
1532136|NCT00262522|5019854|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
1532137|NCT00262522|5019855|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
1532138|NCT00262522|5019852|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
1532139|NCT00262522|5019853|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
1532140|NCT00262522|5019854|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
1532141|NCT00262522|5019855|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
1532142|NCT00262522|5019852|P4|Study Start Through 48 Weeks|Adverse Event|0
1532143|NCT00262522|5019853|P3|Study Start Through 48 Weeks|Adverse Event|10
1532144|NCT00262522|5019854|P2|Study Start Through 48 Weeks|Adverse Event|0
1532145|NCT00262522|5019855|P1|Study Start Through 48 Weeks|Adverse Event|16
1532146|NCT00262522|5019852|P4|Study Start Through 8 Weeks|Death|0
1532147|NCT00262522|5019853|P3|Study Start Through 8 Weeks|Death|0
1532148|NCT00262522|5019854|P2|Study Start Through 8 Weeks|Death|0
1532149|NCT00262522|5019855|P1|Study Start Through 8 Weeks|Death|1
1532150|NCT00262522|5019852|P4|Study Start Through 8 Weeks|Noncompliance|2
1532151|NCT00262522|5019853|P3|Study Start Through 8 Weeks|Noncompliance|2
1532152|NCT00262522|5019854|P2|Study Start Through 8 Weeks|Noncompliance|0
1532153|NCT00262522|5019855|P1|Study Start Through 8 Weeks|Noncompliance|0
1532154|NCT00262522|5019852|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
1532155|NCT00262522|5019853|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
1532156|NCT00262522|5019854|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
1532157|NCT00262522|5019855|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
1532158|NCT00262522|5019852|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
1532159|NCT00262522|5019853|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
1532160|NCT00262522|5019854|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
1532161|NCT00262522|5019855|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
1532162|NCT00262522|5019852|P4|Study Start Through 8 Weeks|Adverse Event|1
1532163|NCT00262522|5019853|P3|Study Start Through 8 Weeks|Adverse Event|3
1532164|NCT00262522|5019854|P2|Study Start Through 8 Weeks|Adverse Event|2
1532165|NCT00262522|5019855|P1|Study Start Through 8 Weeks|Adverse Event|1
1532166|NCT00262314|5019884|P1|Overall Study|Administrative withdrawal|30
1532167|NCT00262314|5019884|P1|Overall Study|Lost to Follow-up|70
1532168|NCT00262314|5019884|P1|Overall Study|Not specified|95
1532169|NCT00262314|5019884|P1|Overall Study|Patient's decision|92
1532170|NCT00262314|5019884|P1|Overall Study|Death|12
1532171|NCT00262314|5019884|P1|Overall Study|Changing physicians|38
1532172|NCT00262301|5019902|P3|Double-blind Phase|"worsening of HAE symptoms"|0
1532173|NCT00262301|5019903|P2|Double-blind Phase|"worsening of HAE symptoms"|1
1532174|NCT00262301|5019904|P1|Double-blind Phase|"worsening of HAE symptoms"|0
1532175|NCT00262301|5019902|P3|Double-blind Phase|Lost to Follow-up|0
1532176|NCT00262301|5019903|P2|Double-blind Phase|Lost to Follow-up|0
1532177|NCT00262301|5019904|P1|Double-blind Phase|Lost to Follow-up|1
1532178|NCT00262223|5019917|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
1532179|NCT00262223|5019918|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
1532180|NCT00262223|5019917|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
1532181|NCT00262223|5019918|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
1532182|NCT00262223|5019917|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
1532183|NCT00262223|5019918|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
1532184|NCT00262223|5019917|P2|Treatment Phase|Adverse Event|2
1532185|NCT00262223|5019918|P1|Treatment Phase|Adverse Event|1
1532186|NCT00262223|5019917|P2|Treatment Phase|Withdrawal by Subject|6
1532187|NCT00262223|5019918|P1|Treatment Phase|Withdrawal by Subject|3
1532188|NCT00262119|5019929|P3|Overall Study|Death|16
1532189|NCT00262119|5019930|P2|Overall Study|Death|19
1532190|NCT00262119|5019931|P1|Overall Study|Death|20
1532191|NCT00262119|5019929|P3|Overall Study|Lost to Follow-up|42
1532192|NCT00262119|5019930|P2|Overall Study|Lost to Follow-up|51
1532193|NCT00262119|5019931|P1|Overall Study|Lost to Follow-up|38
1532194|NCT00262080|5019951|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
1532195|NCT00262080|5019952|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
1532196|NCT00262080|5019953|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
1532197|NCT00262080|5019951|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
1532198|NCT00262080|5019952|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
1532199|NCT00262080|5019953|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
1532200|NCT00262080|5019951|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
1532201|NCT00262080|5019952|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
1532202|NCT00262080|5019953|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
1532203|NCT00262080|5019951|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
1532204|NCT00262080|5019952|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
1532205|NCT00262080|5019953|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
1532206|NCT00262080|5019951|P3|Repeat Dose Treatment Period|Adverse Event|0
1532207|NCT00262080|5019952|P2|Repeat Dose Treatment Period|Adverse Event|0
1532208|NCT00262080|5019953|P1|Repeat Dose Treatment Period|Adverse Event|1
1532209|NCT00262080|5019951|P3|Double Blind Treatment Period|Lost to Follow-up|0
1532210|NCT00262080|5019952|P2|Double Blind Treatment Period|Lost to Follow-up|0
1532211|NCT00262080|5019953|P1|Double Blind Treatment Period|Lost to Follow-up|1
1532212|NCT00262067|5019973|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
1532213|NCT00262067|5019974|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
1532214|NCT00262067|5019975|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
1532215|NCT00262067|5019976|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
1532216|NCT00262067|5019973|P4|Overall Study|Sponsor's Decision to Terminate Study|0
1532217|NCT00262067|5019974|P3|Overall Study|Sponsor's Decision to Terminate Study|0
1532218|NCT00262067|5019975|P2|Overall Study|Sponsor's Decision to Terminate Study|0
1532219|NCT00262067|5019976|P1|Overall Study|Sponsor's Decision to Terminate Study|1
1532220|NCT00262067|5019973|P4|Overall Study|Lost to Follow-up|5
1532221|NCT00262067|5019974|P3|Overall Study|Lost to Follow-up|7
1532222|NCT00262067|5019975|P2|Overall Study|Lost to Follow-up|4
1532223|NCT00262067|5019976|P1|Overall Study|Lost to Follow-up|5
1532224|NCT00262067|5019973|P4|Overall Study|Death|99
1532225|NCT00262067|5019974|P3|Overall Study|Death|186
1532226|NCT00262067|5019975|P2|Overall Study|Death|89
1532227|NCT00262067|5019976|P1|Overall Study|Death|190
1532228|NCT00262041|5020010|P3|Overall Study|Unable to classify|0
1532229|NCT00262041|5020011|P2|Overall Study|Unable to classify|0
1532230|NCT00262041|5020012|P1|Overall Study|Unable to classify|1
1532231|NCT00262041|5020010|P3|Overall Study|Lost to Follow-up|5
1532232|NCT00262041|5020011|P2|Overall Study|Lost to Follow-up|1
1532233|NCT00262041|5020012|P1|Overall Study|Lost to Follow-up|1
1532234|NCT00262041|5020010|P3|Overall Study|Withdrawal by Subject|1
1532235|NCT00262041|5020011|P2|Overall Study|Withdrawal by Subject|3
1532236|NCT00262041|5020012|P1|Overall Study|Withdrawal by Subject|0
1532237|NCT00262028|5020041|P9|Overall Study|Unable to classify|1
1532238|NCT00262028|5020042|P8|Overall Study|Unable to classify|0
1532239|NCT00262028|5020043|P7|Overall Study|Unable to classify|0
1532240|NCT00262028|5020044|P6|Overall Study|Unable to classify|0
1532241|NCT00262028|5020045|P5|Overall Study|Unable to classify|0
1532242|NCT00262028|5020046|P4|Overall Study|Unable to classify|0
1532243|NCT00262028|5020047|P3|Overall Study|Unable to classify|0
1532244|NCT00262028|5020048|P2|Overall Study|Unable to classify|3
1532245|NCT00262028|5020049|P1|Overall Study|Unable to classify|0
1532246|NCT00262028|5020041|P9|Overall Study|Protocol Violation|0
1532247|NCT00262028|5020042|P8|Overall Study|Protocol Violation|0
1532248|NCT00262028|5020043|P7|Overall Study|Protocol Violation|0
1532249|NCT00262028|5020044|P6|Overall Study|Protocol Violation|0
1532250|NCT00262028|5020045|P5|Overall Study|Protocol Violation|0
1532251|NCT00262028|5020046|P4|Overall Study|Protocol Violation|1
1532252|NCT00262028|5020047|P3|Overall Study|Protocol Violation|0
1532253|NCT00262028|5020048|P2|Overall Study|Protocol Violation|0
1532254|NCT00262028|5020049|P1|Overall Study|Protocol Violation|0
1532255|NCT00262028|5020041|P9|Overall Study|Administrative Reason|10
1532256|NCT00262028|5020042|P8|Overall Study|Administrative Reason|6
1532257|NCT00262028|5020043|P7|Overall Study|Administrative Reason|4
1532258|NCT00262028|5020044|P6|Overall Study|Administrative Reason|7
1532259|NCT00262028|5020045|P5|Overall Study|Administrative Reason|6
1532260|NCT00262028|5020046|P4|Overall Study|Administrative Reason|12
1532261|NCT00262028|5020047|P3|Overall Study|Administrative Reason|9
1532262|NCT00262028|5020048|P2|Overall Study|Administrative Reason|14
1532263|NCT00262028|5020049|P1|Overall Study|Administrative Reason|11
1532264|NCT00262028|5020041|P9|Overall Study|Lost to Follow-up|6
1532265|NCT00262028|5020042|P8|Overall Study|Lost to Follow-up|5
1532266|NCT00262028|5020043|P7|Overall Study|Lost to Follow-up|3
1532267|NCT00262028|5020044|P6|Overall Study|Lost to Follow-up|3
1532268|NCT00262028|5020045|P5|Overall Study|Lost to Follow-up|4
1532269|NCT00262028|5020046|P4|Overall Study|Lost to Follow-up|5
1532270|NCT00262028|5020047|P3|Overall Study|Lost to Follow-up|5
1532271|NCT00262028|5020048|P2|Overall Study|Lost to Follow-up|7
1532272|NCT00262028|5020049|P1|Overall Study|Lost to Follow-up|7
1532273|NCT00262028|5020041|P9|Overall Study|Withdrawal by Subject|2
1532274|NCT00262028|5020042|P8|Overall Study|Withdrawal by Subject|7
1532275|NCT00262028|5020043|P7|Overall Study|Withdrawal by Subject|5
1532276|NCT00262028|5020044|P6|Overall Study|Withdrawal by Subject|3
1532277|NCT00262028|5020045|P5|Overall Study|Withdrawal by Subject|2
1532278|NCT00262028|5020046|P4|Overall Study|Withdrawal by Subject|5
1532279|NCT00262028|5020047|P3|Overall Study|Withdrawal by Subject|6
1532280|NCT00262028|5020048|P2|Overall Study|Withdrawal by Subject|3
1532281|NCT00262028|5020049|P1|Overall Study|Withdrawal by Subject|6
1532282|NCT00262002|5020111|P7|Overall Study|Unable to classify|2
1532283|NCT00262002|5020112|P6|Overall Study|Unable to classify|0
1532284|NCT00262002|5020113|P5|Overall Study|Unable to classify|0
1532285|NCT00262002|5020114|P4|Overall Study|Unable to classify|0
1532286|NCT00262002|5020115|P3|Overall Study|Unable to classify|0
1532287|NCT00262002|5020116|P2|Overall Study|Unable to classify|0
1532288|NCT00262002|5020117|P1|Overall Study|Unable to classify|0
1532289|NCT00262002|5020111|P7|Overall Study|Protocol Violation|2
1532290|NCT00262002|5020112|P6|Overall Study|Protocol Violation|3
1532291|NCT00262002|5020113|P5|Overall Study|Protocol Violation|5
1532292|NCT00262002|5020114|P4|Overall Study|Protocol Violation|2
1532293|NCT00262002|5020115|P3|Overall Study|Protocol Violation|0
1532294|NCT00262002|5020116|P2|Overall Study|Protocol Violation|2
1532295|NCT00262002|5020117|P1|Overall Study|Protocol Violation|3
1532296|NCT00262002|5020111|P7|Overall Study|Inapropriate enrollment|0
1532297|NCT00262002|5020112|P6|Overall Study|Inapropriate enrollment|0
1532298|NCT00262002|5020113|P5|Overall Study|Inapropriate enrollment|0
1532299|NCT00262002|5020114|P4|Overall Study|Inapropriate enrollment|0
1532300|NCT00262002|5020115|P3|Overall Study|Inapropriate enrollment|0
1532301|NCT00262002|5020116|P2|Overall Study|Inapropriate enrollment|1
1532302|NCT00262002|5020117|P1|Overall Study|Inapropriate enrollment|0
1532303|NCT00262002|5020111|P7|Overall Study|Lost to Follow-up|0
1532304|NCT00262002|5020112|P6|Overall Study|Lost to Follow-up|1
1532305|NCT00262002|5020113|P5|Overall Study|Lost to Follow-up|0
1532306|NCT00262002|5020114|P4|Overall Study|Lost to Follow-up|2
1532307|NCT00262002|5020115|P3|Overall Study|Lost to Follow-up|0
1532308|NCT00262002|5020116|P2|Overall Study|Lost to Follow-up|0
1532309|NCT00262002|5020117|P1|Overall Study|Lost to Follow-up|2
1532310|NCT00262002|5020111|P7|Overall Study|Withdrawal by Subject|2
1532311|NCT00262002|5020112|P6|Overall Study|Withdrawal by Subject|2
1532312|NCT00262002|5020113|P5|Overall Study|Withdrawal by Subject|2
1532313|NCT00262002|5020114|P4|Overall Study|Withdrawal by Subject|1
1532314|NCT00262002|5020115|P3|Overall Study|Withdrawal by Subject|0
1532315|NCT00262002|5020116|P2|Overall Study|Withdrawal by Subject|2
1532316|NCT00262002|5020117|P1|Overall Study|Withdrawal by Subject|4
1532317|NCT00262002|5020111|P7|Overall Study|Adverse Event|0
1532318|NCT00262002|5020112|P6|Overall Study|Adverse Event|1
1532319|NCT00262002|5020113|P5|Overall Study|Adverse Event|0
1532320|NCT00262002|5020114|P4|Overall Study|Adverse Event|0
1532321|NCT00262002|5020115|P3|Overall Study|Adverse Event|0
1532322|NCT00262002|5020116|P2|Overall Study|Adverse Event|1
1532323|NCT00262002|5020117|P1|Overall Study|Adverse Event|2
1532324|NCT00261950|5020210|P1|Overall Study|Protocol specified Criteria|11
1532325|NCT00261950|5020210|P1|Overall Study|Physician Decision|1
1532326|NCT00261950|5020210|P1|Overall Study|not specified|1
1532327|NCT00261950|5020210|P1|Overall Study|Withdrawal by Subject|5
1532328|NCT00261950|5020210|P1|Overall Study|Death|6
1532329|NCT00261950|5020210|P1|Overall Study|Lost to Follow-up|2
1532330|NCT00261846|5020235|P12|Period 2: Part 2 (Efficacy)|Extension study|1
1532331|NCT00261846|5020236|P11|Period 2: Part 2 (Efficacy)|Extension study|1
1532332|NCT00261846|5020237|P10|Period 2: Part 2 (Efficacy)|Extension study|9
1532333|NCT00261846|5020238|P9|Period 2: Part 2 (Efficacy)|Extension study|5
1532334|NCT00261846|5020239|P8|Period 2: Part 2 (Efficacy)|Extension study|9
1532335|NCT00261846|5020240|P7|Period 2: Part 2 (Efficacy)|Extension study|4
1532336|NCT00261846|5020241|P6|Period 2: Part 2 (Efficacy)|Extension study|0
1532337|NCT00261846|5020242|P5|Period 2: Part 2 (Efficacy)|Extension study|27
1532338|NCT00261846|5020243|P4|Period 2: Part 2 (Efficacy)|Extension study|61
1532339|NCT00261846|5020244|P3|Period 2: Part 2 (Efficacy)|Extension study|0
1532340|NCT00261846|5020245|P2|Period 2: Part 2 (Efficacy)|Extension study|0
1532341|NCT00261846|5020246|P1|Period 2: Part 2 (Efficacy)|Extension study|0
1532342|NCT00261846|5020235|P12|Period 2: Part 2 (Efficacy)|Death|22
1532343|NCT00261846|5020236|P11|Period 2: Part 2 (Efficacy)|Death|44
1532344|NCT00261846|5020237|P10|Period 2: Part 2 (Efficacy)|Death|30
1532345|NCT00261846|5020238|P9|Period 2: Part 2 (Efficacy)|Death|3
1532346|NCT00261846|5020239|P8|Period 2: Part 2 (Efficacy)|Death|12
1532347|NCT00261846|5020240|P7|Period 2: Part 2 (Efficacy)|Death|10
1532348|NCT00261846|5020241|P6|Period 2: Part 2 (Efficacy)|Death|1
1532349|NCT00261846|5020242|P5|Period 2: Part 2 (Efficacy)|Death|7
1532350|NCT00261846|5020243|P4|Period 2: Part 2 (Efficacy)|Death|37
1532351|NCT00261846|5020244|P3|Period 2: Part 2 (Efficacy)|Death|0
1532352|NCT00261846|5020245|P2|Period 2: Part 2 (Efficacy)|Death|0
1532353|NCT00261846|5020246|P1|Period 2: Part 2 (Efficacy)|Death|0
1532354|NCT00261846|5020235|P12|Period 2: Part 2 (Efficacy)|Other|0
1532355|NCT00261846|5020236|P11|Period 2: Part 2 (Efficacy)|Other|0
1532356|NCT00261846|5020237|P10|Period 2: Part 2 (Efficacy)|Other|4
1532357|NCT00261846|5020238|P9|Period 2: Part 2 (Efficacy)|Other|4
1532358|NCT00261846|5020239|P8|Period 2: Part 2 (Efficacy)|Other|5
1532359|NCT00261846|5020240|P7|Period 2: Part 2 (Efficacy)|Other|1
1532360|NCT00261846|5020241|P6|Period 2: Part 2 (Efficacy)|Other|0
1532361|NCT00261846|5020242|P5|Period 2: Part 2 (Efficacy)|Other|4
1532362|NCT00261846|5020243|P4|Period 2: Part 2 (Efficacy)|Other|15
1532363|NCT00261846|5020244|P3|Period 2: Part 2 (Efficacy)|Other|0
1532364|NCT00261846|5020245|P2|Period 2: Part 2 (Efficacy)|Other|0
1532365|NCT00261846|5020246|P1|Period 2: Part 2 (Efficacy)|Other|0
1532366|NCT00261846|5020235|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1532367|NCT00261846|5020236|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1532368|NCT00261846|5020237|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1532369|NCT00261846|5020238|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
1532370|NCT00261846|5020239|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1532371|NCT00261846|5020240|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1532372|NCT00261846|5020241|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1532373|NCT00261846|5020242|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1532374|NCT00261846|5020243|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
1532375|NCT00261846|5020244|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1532376|NCT00261846|5020245|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1532377|NCT00261846|5020246|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1532378|NCT00261846|5020235|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1532379|NCT00261846|5020236|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1532380|NCT00261846|5020237|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
1532381|NCT00261846|5020238|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1532382|NCT00261846|5020239|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
1532383|NCT00261846|5020240|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
1532384|NCT00261846|5020241|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
1532385|NCT00261846|5020242|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
1532386|NCT00261846|5020243|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
1532387|NCT00261846|5020244|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1532388|NCT00261846|5020245|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1532389|NCT00261846|5020246|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1532390|NCT00261846|5020235|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1532391|NCT00261846|5020236|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1532392|NCT00261846|5020237|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1532393|NCT00261846|5020238|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
1532394|NCT00261846|5020239|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1532395|NCT00261846|5020240|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1532396|NCT00261846|5020241|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1532397|NCT00261846|5020242|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1532398|NCT00261846|5020243|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
1532399|NCT00261846|5020244|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1532400|NCT00261846|5020245|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1532401|NCT00261846|5020246|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1532402|NCT00261846|5020235|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1532403|NCT00261846|5020236|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1532404|NCT00261846|5020237|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1532405|NCT00261846|5020238|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1532406|NCT00261846|5020239|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1532407|NCT00261846|5020240|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1532408|NCT00261846|5020241|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1532409|NCT00261846|5020242|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1532410|NCT00261846|5020243|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1532411|NCT00261846|5020244|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
1532412|NCT00261846|5020245|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
1532413|NCT00261846|5020246|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
1532414|NCT00261833|5020505|P2|Overall Study|Not interested in being participant|1
1532415|NCT00261833|5020506|P1|Overall Study|Not interested in being participant|0
1532416|NCT00261833|5020505|P2|Overall Study|Missing reason|0
1532417|NCT00261833|5020506|P1|Overall Study|Missing reason|1
1532418|NCT00261833|5020505|P2|Overall Study|Lung transplantation|1
1532419|NCT00261833|5020506|P1|Overall Study|Lung transplantation|1
1532420|NCT00261833|5020505|P2|Overall Study|Suspicion of pulmonary cancer|1
1532421|NCT00261833|5020506|P1|Overall Study|Suspicion of pulmonary cancer|0
1532422|NCT00261833|5020505|P2|Overall Study|Protocol Violation|1
1532423|NCT00261833|5020506|P1|Overall Study|Protocol Violation|0
1532424|NCT00261833|5020505|P2|Overall Study|Withdrawal by Subject|7
1532425|NCT00261833|5020506|P1|Overall Study|Withdrawal by Subject|5
1532426|NCT00261833|5020505|P2|Overall Study|Adverse Event|4
1532427|NCT00261833|5020506|P1|Overall Study|Adverse Event|1
1532428|NCT00261833|5020505|P2|Overall Study|Death|3
1532429|NCT00261833|5020506|P1|Overall Study|Death|1
1532430|NCT00261716|5020540|P2|Overall Study|Lost to Follow-up|2
1532431|NCT00261716|5020541|P1|Overall Study|Lost to Follow-up|0
1532432|NCT00261716|5020540|P2|Overall Study|Withdrawal by Subject|8
1532433|NCT00261716|5020541|P1|Overall Study|Withdrawal by Subject|6
1532434|NCT00261495|5020561|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1532435|NCT00261495|5020562|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
1532436|NCT00261495|5020561|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
1532437|NCT00261495|5020562|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
1532438|NCT00261495|5020561|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
1532439|NCT00261495|5020562|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
1532440|NCT00261495|5020561|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
1532441|NCT00261495|5020562|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
1532442|NCT00261495|5020561|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
1532443|NCT00261495|5020562|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
1532444|NCT00261495|5020561|P2|Extension Phase (Weeks 24 to 52)|Other|2
1532445|NCT00261495|5020562|P1|Extension Phase (Weeks 24 to 52)|Other|4
1532446|NCT00261495|5020561|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
1532447|NCT00261495|5020562|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
1532448|NCT00261495|5020561|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
1532449|NCT00261495|5020562|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
1532450|NCT00261495|5020561|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
1532451|NCT00261495|5020562|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
1532452|NCT00261495|5020561|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
1532453|NCT00261495|5020562|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
1532454|NCT00261495|5020561|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
1532455|NCT00261495|5020562|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
1532456|NCT00261495|5020561|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
1532457|NCT00261495|5020562|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
1532458|NCT00261495|5020561|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
1532459|NCT00261495|5020562|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
1532460|NCT00261495|5020561|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
1532461|NCT00261495|5020562|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
1532462|NCT00261495|5020561|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
1532463|NCT00261495|5020562|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
1532464|NCT00261495|5020561|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
1532465|NCT00261495|5020562|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
1532466|NCT00261495|5020561|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
1532467|NCT00261495|5020562|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
1532468|NCT00261495|5020561|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
1532469|NCT00261495|5020562|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
1532470|NCT00261495|5020561|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
1532471|NCT00261495|5020562|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
1532472|NCT00261495|5020561|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
1532473|NCT00261495|5020562|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
1532474|NCT00261495|5020561|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
1532475|NCT00261495|5020562|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
1532476|NCT00261443|5020726|P3|4: Extension Phase|Lost to Follow-up|0
1532477|NCT00261443|5020727|P2|4: Extension Phase|Lost to Follow-up|1
1532478|NCT00261443|5020728|P1|4: Extension Phase|Lost to Follow-up|0
1532479|NCT00261443|5020726|P3|4: Extension Phase|Withdrawal by Subject|2
1532480|NCT00261443|5020727|P2|4: Extension Phase|Withdrawal by Subject|1
1532481|NCT00261443|5020728|P1|4: Extension Phase|Withdrawal by Subject|0
1532482|NCT00261443|5020726|P3|4: Extension Phase|Adverse Event|0
1532483|NCT00261443|5020727|P2|4: Extension Phase|Adverse Event|1
1532484|NCT00261443|5020728|P1|4: Extension Phase|Adverse Event|0
1532485|NCT00261443|5020726|P3|3: Assessment of Relapse|Other Reasons|3
1532486|NCT00261443|5020727|P2|3: Assessment of Relapse|Other Reasons|4
1532487|NCT00261443|5020728|P1|3: Assessment of Relapse|Other Reasons|0
1532488|NCT00261443|5020726|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
1532489|NCT00261443|5020727|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
1532490|NCT00261443|5020728|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
1532491|NCT00261443|5020726|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
1532492|NCT00261443|5020727|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
1532493|NCT00261443|5020728|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
1532494|NCT00261443|5020726|P3|3: Assessment of Relapse|Pregnancy|1
1532495|NCT00261443|5020727|P2|3: Assessment of Relapse|Pregnancy|2
1532496|NCT00261443|5020728|P1|3: Assessment of Relapse|Pregnancy|0
1532497|NCT00261443|5020726|P3|3: Assessment of Relapse|Poor/Noncompliance|3
1532498|NCT00261443|5020727|P2|3: Assessment of Relapse|Poor/Noncompliance|5
1532499|NCT00261443|5020728|P1|3: Assessment of Relapse|Poor/Noncompliance|0
1532500|NCT00261443|5020726|P3|3: Assessment of Relapse|Lost to Follow-up|6
1532501|NCT00261443|5020727|P2|3: Assessment of Relapse|Lost to Follow-up|7
1532502|NCT00261443|5020728|P1|3: Assessment of Relapse|Lost to Follow-up|0
1532503|NCT00261443|5020726|P3|3: Assessment of Relapse|Death|1
1532504|NCT00261443|5020727|P2|3: Assessment of Relapse|Death|0
1532505|NCT00261443|5020728|P1|3: Assessment of Relapse|Death|0
1532506|NCT00261443|5020726|P3|3: Assessment of Relapse|Withdrawal by Subject|15
1532507|NCT00261443|5020727|P2|3: Assessment of Relapse|Withdrawal by Subject|14
1532508|NCT00261443|5020728|P1|3: Assessment of Relapse|Withdrawal by Subject|0
1532509|NCT00261443|5020726|P3|3: Assessment of Relapse|Adverse Event|19
1532510|NCT00261443|5020727|P2|3: Assessment of Relapse|Adverse Event|15
1532511|NCT00261443|5020728|P1|3: Assessment of Relapse|Adverse Event|0
1532512|NCT00261443|5020726|P3|3: Assessment of Relapse|Lack of Efficacy|14
1532513|NCT00261443|5020727|P2|3: Assessment of Relapse|Lack of Efficacy|31
1532514|NCT00261443|5020728|P1|3: Assessment of Relapse|Lack of Efficacy|0
1532515|NCT00261443|5020726|P3|2: Stability & Maintenance of Stability|Other Reasons|0
1532516|NCT00261443|5020727|P2|2: Stability & Maintenance of Stability|Other Reasons|0
1532517|NCT00261443|5020728|P1|2: Stability & Maintenance of Stability|Other Reasons|13
1532518|NCT00261443|5020726|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
1532519|NCT00261443|5020727|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
1532520|NCT00261443|5020728|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
1532521|NCT00261443|5020726|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
1532522|NCT00261443|5020727|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
1532523|NCT00261443|5020728|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
1532524|NCT00261443|5020726|P3|2: Stability & Maintenance of Stability|Pregnancy|0
1532525|NCT00261443|5020727|P2|2: Stability & Maintenance of Stability|Pregnancy|0
1532526|NCT00261443|5020728|P1|2: Stability & Maintenance of Stability|Pregnancy|1
1532527|NCT00261443|5020726|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
1532528|NCT00261443|5020727|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
1532529|NCT00261443|5020728|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
1532530|NCT00261443|5020726|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
1532531|NCT00261443|5020727|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
1532532|NCT00261443|5020728|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
1532533|NCT00261443|5020726|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
1532534|NCT00261443|5020727|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
1532535|NCT00261443|5020728|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
1532536|NCT00261443|5020726|P3|2: Stability & Maintenance of Stability|Adverse Event|0
1532537|NCT00261443|5020727|P2|2: Stability & Maintenance of Stability|Adverse Event|0
1532538|NCT00261443|5020728|P1|2: Stability & Maintenance of Stability|Adverse Event|93
1532539|NCT00261443|5020726|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
1532540|NCT00261443|5020727|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
1532541|NCT00261443|5020728|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
1532542|NCT00261443|5020726|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
1532543|NCT00261443|5020727|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
1532544|NCT00261443|5020728|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
1532545|NCT00261443|5020726|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
1532546|NCT00261443|5020727|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
1532547|NCT00261443|5020728|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
1532548|NCT00261443|5020726|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
1532549|NCT00261443|5020727|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
1532550|NCT00261443|5020728|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
1532551|NCT00261443|5020726|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
1532552|NCT00261443|5020727|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
1532553|NCT00261443|5020728|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
1532554|NCT00261443|5020726|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
1532555|NCT00261443|5020727|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
1532556|NCT00261443|5020728|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
1532557|NCT00261443|5020726|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
1532558|NCT00261443|5020727|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
1532559|NCT00261443|5020728|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
1532560|NCT00261443|5020726|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
1532561|NCT00261443|5020727|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
1532562|NCT00261443|5020728|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
1532563|NCT00260832|5020996|P2|Overall Study|Protocol Violation|1
1532564|NCT00260832|5020997|P1|Overall Study|Protocol Violation|3
1532565|NCT00260832|5020996|P2|Overall Study|Not Specified|7
1532566|NCT00260832|5020997|P1|Overall Study|Not Specified|10
1532567|NCT00260832|5020996|P2|Overall Study|Death|62
1532568|NCT00260832|5020997|P1|Overall Study|Death|43
1532569|NCT00260832|5020996|P2|Overall Study|Physician Decision|9
1532570|NCT00260832|5020997|P1|Overall Study|Physician Decision|15
1532571|NCT00260832|5020996|P2|Overall Study|Withdrawal by Subject|17
1532572|NCT00260832|5020997|P1|Overall Study|Withdrawal by Subject|15
1532573|NCT00260832|5020996|P2|Overall Study|Progression|96
1532574|NCT00260832|5020997|P1|Overall Study|Progression|116
1532575|NCT00260832|5020996|P2|Overall Study|Adverse Event|19
1532576|NCT00260832|5020997|P1|Overall Study|Adverse Event|26
1532577|NCT00260533|5021024|P2|Overall Study|Other|3
1532578|NCT00260533|5021025|P1|Overall Study|Other|3
1532579|NCT00260429|5021033|P2|Overall Study|scheduled hand surgery|0
1532580|NCT00260429|5021034|P1|Overall Study|scheduled hand surgery|1
1532581|NCT00260429|5021033|P2|Overall Study|failure to follow appointments|0
1532582|NCT00260429|5021034|P1|Overall Study|failure to follow appointments|1
1532583|NCT00260208|5021042|P2|Overall Study|Missing|16
1532584|NCT00260208|5021043|P1|Overall Study|Missing|18
1532585|NCT00260208|5021042|P2|Overall Study|Death|10
1532586|NCT00260208|5021043|P1|Overall Study|Death|12
1532587|NCT00260208|5021042|P2|Overall Study|Lost to Follow-up|1
1532588|NCT00260208|5021043|P1|Overall Study|Lost to Follow-up|6
1532589|NCT00260208|5021042|P2|Overall Study|Subject withdrew consent|7
1532590|NCT00260208|5021043|P1|Overall Study|Subject withdrew consent|11
1532591|NCT00260065|5021086|P1|Overall Study|Medication Noncompliance|1
1532592|NCT00260065|5021086|P1|Overall Study|Not otherwise specified|8
1532593|NCT00260065|5021086|P1|Overall Study|Physician Decision|19
1532594|NCT00260065|5021086|P1|Overall Study|Withdrawal by Subject|13
1532595|NCT00260065|5021086|P1|Overall Study|Death|13
1532596|NCT00260065|5021086|P1|Overall Study|Adverse Event|17
1532597|NCT00260065|5021086|P1|Overall Study|Progressive Disease|22
1532598|NCT00259857|5021093|P2|24 Months Treatment|Lost to Follow-up|3
1532599|NCT00259857|5021094|P1|24 Months Treatment|Lost to Follow-up|0
1532600|NCT00259857|5021093|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
1532601|NCT00259857|5021094|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
1532602|NCT00259740|5021112|P2|Overall Study|Requirement for alternative therapy|4
1532603|NCT00259740|5021113|P1|Overall Study|Requirement for alternative therapy|0
1532604|NCT00259740|5021112|P2|Overall Study|Other|0
1532605|NCT00259740|5021113|P1|Overall Study|Other|3
1532606|NCT00259740|5021112|P2|Overall Study|Ongoing|3
1532607|NCT00259740|5021113|P1|Overall Study|Ongoing|17
1532608|NCT00259740|5021112|P2|Overall Study|Disease progression|36
1532609|NCT00259740|5021113|P1|Overall Study|Disease progression|19
1532610|NCT00259740|5021112|P2|Overall Study|Death|1
1532611|NCT00259740|5021113|P1|Overall Study|Death|1
1532612|NCT00259740|5021112|P2|Overall Study|Withdrawal by Subject|6
1532613|NCT00259740|5021113|P1|Overall Study|Withdrawal by Subject|2
1532614|NCT00259740|5021112|P2|Overall Study|Adverse Event|2
1532615|NCT00259740|5021113|P1|Overall Study|Adverse Event|0
1532616|NCT00259740|5021112|P2|Overall Study|Physician Decision|1
1532617|NCT00259740|5021113|P1|Overall Study|Physician Decision|1
1532618|NCT00259649|5021123|P1|Overall Study|irregular menses|3
1532619|NCT00259649|5021123|P1|Overall Study|Lost to Follow-up|7
1532620|NCT00259610|5021131|P4|Overall Study|Serious Adverse Event|2
1532621|NCT00259610|5021132|P3|Overall Study|Serious Adverse Event|2
1532622|NCT00259610|5021133|P2|Overall Study|Serious Adverse Event|2
1532623|NCT00259610|5021134|P1|Overall Study|Serious Adverse Event|8
1532624|NCT00259610|5021131|P4|Overall Study|Adverse Event|2
1532625|NCT00259610|5021132|P3|Overall Study|Adverse Event|5
1532626|NCT00259610|5021133|P2|Overall Study|Adverse Event|4
1532627|NCT00259610|5021134|P1|Overall Study|Adverse Event|3
1532628|NCT00259610|5021131|P4|Overall Study|non medical reason|3
1532629|NCT00259610|5021132|P3|Overall Study|non medical reason|10
1532630|NCT00259610|5021133|P2|Overall Study|non medical reason|2
1532631|NCT00259610|5021134|P1|Overall Study|non medical reason|6
1532632|NCT00259610|5021131|P4|Overall Study|Death|0
1532633|NCT00259610|5021132|P3|Overall Study|Death|2
1532634|NCT00259610|5021133|P2|Overall Study|Death|1
1532635|NCT00259610|5021134|P1|Overall Study|Death|1
1532636|NCT00259610|5021131|P4|Overall Study|Physician Decision|2
1532637|NCT00259610|5021132|P3|Overall Study|Physician Decision|7
1532638|NCT00259610|5021133|P2|Overall Study|Physician Decision|4
1532639|NCT00259610|5021134|P1|Overall Study|Physician Decision|6
1532640|NCT00259610|5021131|P4|Overall Study|Lost to Follow-up|15
1532641|NCT00259610|5021132|P3|Overall Study|Lost to Follow-up|18
1532642|NCT00259610|5021133|P2|Overall Study|Lost to Follow-up|8
1532643|NCT00259610|5021134|P1|Overall Study|Lost to Follow-up|19
1532644|NCT00259610|5021131|P4|Overall Study|Withdrawal by Subject|19
1532645|NCT00259610|5021132|P3|Overall Study|Withdrawal by Subject|29
1532646|NCT00259610|5021133|P2|Overall Study|Withdrawal by Subject|25
1532647|NCT00259610|5021134|P1|Overall Study|Withdrawal by Subject|33
1532648|NCT00259298|5021148|P1|Overall Study|Physician Decision|2
1532649|NCT00259298|5021148|P1|Overall Study|Withdrawal by Subject|1
1532650|NCT00259272|5021166|P4|Overall Study|Lost to Follow-up|1
1532651|NCT00259272|5021167|P3|Overall Study|Lost to Follow-up|0
1532652|NCT00259272|5021168|P2|Overall Study|Lost to Follow-up|0
1532653|NCT00259272|5021169|P1|Overall Study|Lost to Follow-up|1
1532654|NCT00259272|5021166|P4|Overall Study|Withdrawal by Subject|7
1532655|NCT00259272|5021167|P3|Overall Study|Withdrawal by Subject|2
1532656|NCT00259272|5021168|P2|Overall Study|Withdrawal by Subject|2
1532657|NCT00259272|5021169|P1|Overall Study|Withdrawal by Subject|4
1532658|NCT00259272|5021166|P4|Overall Study|Sponsor Decision|0
1532659|NCT00259272|5021167|P3|Overall Study|Sponsor Decision|0
1532660|NCT00259272|5021168|P2|Overall Study|Sponsor Decision|1
1532661|NCT00259272|5021169|P1|Overall Study|Sponsor Decision|0
1532662|NCT00259272|5021166|P4|Overall Study|Protocol Violation|1
1532663|NCT00259272|5021167|P3|Overall Study|Protocol Violation|0
1532664|NCT00259272|5021168|P2|Overall Study|Protocol Violation|0
1532665|NCT00259272|5021169|P1|Overall Study|Protocol Violation|2
1532666|NCT00259272|5021166|P4|Overall Study|Physician Decision|3
1532667|NCT00259272|5021167|P3|Overall Study|Physician Decision|1
1532668|NCT00259272|5021168|P2|Overall Study|Physician Decision|2
1532669|NCT00259272|5021169|P1|Overall Study|Physician Decision|1
1532670|NCT00259272|5021166|P4|Overall Study|Lack of Efficacy|6
1532671|NCT00259272|5021167|P3|Overall Study|Lack of Efficacy|2
1532672|NCT00259272|5021168|P2|Overall Study|Lack of Efficacy|1
1532673|NCT00259272|5021169|P1|Overall Study|Lack of Efficacy|5
1532674|NCT00259272|5021166|P4|Overall Study|Adverse Event|3
1532675|NCT00259272|5021167|P3|Overall Study|Adverse Event|0
1532676|NCT00259272|5021168|P2|Overall Study|Adverse Event|1
1532677|NCT00259272|5021169|P1|Overall Study|Adverse Event|2
1532678|NCT00259012|5021265|P2|Overall Study|Protocol Violation|1
1532679|NCT00259012|5021266|P1|Overall Study|Protocol Violation|1
1532680|NCT00259012|5021265|P2|Overall Study|Lost to Follow-up|1
1532681|NCT00259012|5021266|P1|Overall Study|Lost to Follow-up|0
1532682|NCT00259012|5021265|P2|Overall Study|Physician Decision|1
1532683|NCT00259012|5021266|P1|Overall Study|Physician Decision|0
1532684|NCT00259012|5021265|P2|Overall Study|Withdrawal by Subject|0
1532685|NCT00259012|5021266|P1|Overall Study|Withdrawal by Subject|1
1532686|NCT00259012|5021265|P2|Overall Study|Adverse Event|1
1532687|NCT00259012|5021266|P1|Overall Study|Adverse Event|0
1532688|NCT00258895|5021306|P2|Overall Study|Withdrawal by Subject|0
1532689|NCT00258895|5021307|P1|Overall Study|Withdrawal by Subject|1
1532690|NCT00258895|5021306|P2|Overall Study|Protocol Violation|2
1532691|NCT00258895|5021307|P1|Overall Study|Protocol Violation|6
1532692|NCT00258895|5021306|P2|Overall Study|Lost to Follow-up|1
1532693|NCT00258895|5021307|P1|Overall Study|Lost to Follow-up|3
1532694|NCT00258856|5021343|P4|Overall Study|Non-compliance|1
1532695|NCT00258856|5021344|P3|Overall Study|Non-compliance|0
1532696|NCT00258856|5021345|P2|Overall Study|Non-compliance|0
1532697|NCT00258856|5021346|P1|Overall Study|Non-compliance|2
1532698|NCT00258856|5021343|P4|Overall Study|Lost to Follow-up|0
1532699|NCT00258856|5021344|P3|Overall Study|Lost to Follow-up|2
1532700|NCT00258856|5021345|P2|Overall Study|Lost to Follow-up|0
1532701|NCT00258856|5021346|P1|Overall Study|Lost to Follow-up|1
1532702|NCT00258674|5021387|P3|Overall Study|Death|34
1532703|NCT00258674|5021388|P2|Overall Study|Death|53
1532704|NCT00258674|5021389|P1|Overall Study|Death|32
1532705|NCT00258440|5021448|P3|Overall Study|Withdrawal by Subject|1
1532706|NCT00258440|5021449|P2|Overall Study|Withdrawal by Subject|0
1532707|NCT00258440|5021450|P1|Overall Study|Withdrawal by Subject|0
1532708|NCT00258154|5021483|P2|Overall Study|Patient Moved|1
1532709|NCT00258154|5021484|P1|Overall Study|Patient Moved|3
1532710|NCT00258154|5021483|P2|Overall Study|Withdrawal by Subject|4
1532711|NCT00258154|5021484|P1|Overall Study|Withdrawal by Subject|3
1532712|NCT00258154|5021483|P2|Overall Study|Protocol Violation|1
1532713|NCT00258154|5021484|P1|Overall Study|Protocol Violation|2
1532714|NCT00258154|5021483|P2|Overall Study|Lost to Follow-up|1
1532715|NCT00258154|5021484|P1|Overall Study|Lost to Follow-up|0
1532716|NCT00258154|5021483|P2|Overall Study|Adverse Event|0
1532717|NCT00258154|5021484|P1|Overall Study|Adverse Event|1
1532718|NCT00257920|5021568|P2|Period: Second Intervention|Other|1
1532719|NCT00257920|5021569|P1|Period: Second Intervention|Other|2
1532720|NCT00257920|5021568|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
1532721|NCT00257920|5021569|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
1532722|NCT00257660|5021625|P2|Overall Study|No longer wanted to do blood draws|0
1532723|NCT00257660|5021626|P1|Overall Study|No longer wanted to do blood draws|1
1532724|NCT00257660|5021625|P2|Overall Study|PI & Subject Schedule Conflicts|0
1532725|NCT00257660|5021626|P1|Overall Study|PI & Subject Schedule Conflicts|1
1532726|NCT00257660|5021625|P2|Overall Study|Lost to Follow-up|0
1532727|NCT00257660|5021626|P1|Overall Study|Lost to Follow-up|1
1532728|NCT00257660|5021625|P2|Overall Study|Withdrawal by Subject|0
1532729|NCT00257660|5021626|P1|Overall Study|Withdrawal by Subject|2
1532730|NCT00257660|5021625|P2|Overall Study|Lack of Efficacy|23
1532731|NCT00257660|5021626|P1|Overall Study|Lack of Efficacy|5
1532732|NCT00257608|5021656|P3|Post Chemotherapy Phase|Not treated|7
1532733|NCT00257608|5021657|P2|Post Chemotherapy Phase|Not treated|4
1532734|NCT00257608|5021658|P1|Post Chemotherapy Phase|Not treated|0
1532735|NCT00257608|5021656|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
1532736|NCT00257608|5021657|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
1532737|NCT00257608|5021658|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
1532738|NCT00257608|5021656|P3|Post Chemotherapy Phase|Physician Decision|11
1532739|NCT00257608|5021657|P2|Post Chemotherapy Phase|Physician Decision|8
1532740|NCT00257608|5021658|P1|Post Chemotherapy Phase|Physician Decision|0
1532741|NCT00257608|5021656|P3|Post Chemotherapy Phase|Lost to Follow-up|1
1532742|NCT00257608|5021657|P2|Post Chemotherapy Phase|Lost to Follow-up|0
1532743|NCT00257608|5021658|P1|Post Chemotherapy Phase|Lost to Follow-up|0
1532744|NCT00257608|5021656|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
1532745|NCT00257608|5021657|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
1532746|NCT00257608|5021658|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
1532747|NCT00257608|5021656|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
1532748|NCT00257608|5021657|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
1532749|NCT00257608|5021658|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
1532750|NCT00257608|5021656|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
1532751|NCT00257608|5021657|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
1532752|NCT00257608|5021658|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
1532753|NCT00257608|5021656|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
1532754|NCT00257608|5021657|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
1532755|NCT00257608|5021658|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
1532756|NCT00257608|5021656|P3|Post Chemotherapy Phase|Disease progression|168
1532757|NCT00257608|5021657|P2|Post Chemotherapy Phase|Disease progression|204
1532758|NCT00257608|5021658|P1|Post Chemotherapy Phase|Disease progression|0
1532759|NCT00257608|5021656|P3|Post Chemotherapy Phase|Adverse Event|38
1532760|NCT00257608|5021657|P2|Post Chemotherapy Phase|Adverse Event|34
1532761|NCT00257608|5021658|P1|Post Chemotherapy Phase|Adverse Event|0
1532762|NCT00257608|5021656|P3|Chemotherapy Phase|Physician Decision|0
1532763|NCT00257608|5021657|P2|Chemotherapy Phase|Physician Decision|0
1532764|NCT00257608|5021658|P1|Chemotherapy Phase|Physician Decision|28
1532765|NCT00257608|5021656|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
1532766|NCT00257608|5021657|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
1532767|NCT00257608|5021658|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
1532768|NCT00257608|5021656|P3|Chemotherapy Phase|Patient's decision to discontinue|0
1532769|NCT00257608|5021657|P2|Chemotherapy Phase|Patient's decision to discontinue|0
1532770|NCT00257608|5021658|P1|Chemotherapy Phase|Patient's decision to discontinue|35
1532771|NCT00257608|5021656|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
1532772|NCT00257608|5021657|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
1532773|NCT00257608|5021658|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
1532774|NCT00257608|5021656|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
1532775|NCT00257608|5021657|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
1532776|NCT00257608|5021658|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
1532777|NCT00257608|5021656|P3|Chemotherapy Phase|Disease progression|0
1532778|NCT00257608|5021657|P2|Chemotherapy Phase|Disease progression|0
1532779|NCT00257608|5021658|P1|Chemotherapy Phase|Disease progression|139
1532780|NCT00257608|5021656|P3|Chemotherapy Phase|Adverse Event|0
1532781|NCT00257608|5021657|P2|Chemotherapy Phase|Adverse Event|0
1532782|NCT00257608|5021658|P1|Chemotherapy Phase|Adverse Event|138
1532783|NCT00257556|5021684|P2|Overall Study|other reason|6
1532784|NCT00257556|5021685|P1|Overall Study|other reason|4
1532785|NCT00257556|5021684|P2|Overall Study|Did not meet hCG criterion|0
1532786|NCT00257556|5021685|P1|Overall Study|Did not meet hCG criterion|3
1532787|NCT00257556|5021684|P2|Overall Study|Physician Decision|0
1532788|NCT00257556|5021685|P1|Overall Study|Physician Decision|6
1532789|NCT00257556|5021684|P2|Overall Study|Adverse Event|4
1532790|NCT00257556|5021685|P1|Overall Study|Adverse Event|1
1532791|NCT00257192|5021729|P2|Overall Study|Miscellaneous|4
1532792|NCT00257192|5021730|P1|Overall Study|Miscellaneous|0
1532793|NCT00257192|5021729|P2|Overall Study|Study terminated by sponsor|0
1532794|NCT00257192|5021730|P1|Overall Study|Study terminated by sponsor|1
1532795|NCT00257192|5021729|P2|Overall Study|Randomized but not treated|1
1532796|NCT00257192|5021730|P1|Overall Study|Randomized but not treated|0
1532797|NCT00257192|5021729|P2|Overall Study|Withdrawal by Subject|2
1532798|NCT00257192|5021730|P1|Overall Study|Withdrawal by Subject|14
1532799|NCT00257192|5021729|P2|Overall Study|Insufficient clinical response|18
1532800|NCT00257192|5021730|P1|Overall Study|Insufficient clinical response|18
1532801|NCT00257192|5021729|P2|Overall Study|Lost to Follow-up|3
1532802|NCT00257192|5021730|P1|Overall Study|Lost to Follow-up|3
1532803|NCT00257192|5021729|P2|Overall Study|Laboratory abnormality|1
1532804|NCT00257192|5021730|P1|Overall Study|Laboratory abnormality|1
1532805|NCT00257192|5021729|P2|Overall Study|Adverse Event|10
1532806|NCT00257192|5021730|P1|Overall Study|Adverse Event|21
1532807|NCT00257166|5021774|P2|Overall Study|Randomized, but not treated|0
1532808|NCT00257166|5021775|P1|Overall Study|Randomized, but not treated|1
1532809|NCT00257166|5021774|P2|Overall Study|Other|21
1532810|NCT00257166|5021775|P1|Overall Study|Other|16
1532811|NCT00257166|5021774|P2|Overall Study|Withdrawal by Subject|2
1532812|NCT00257166|5021775|P1|Overall Study|Withdrawal by Subject|9
1532813|NCT00257166|5021774|P2|Overall Study|Lost to Follow-up|1
1532814|NCT00257166|5021775|P1|Overall Study|Lost to Follow-up|8
1532815|NCT00257166|5021774|P2|Overall Study|Laboratory abnormality|0
1532816|NCT00257166|5021775|P1|Overall Study|Laboratory abnormality|1
1532817|NCT00257166|5021774|P2|Overall Study|Adverse Event|13
1532818|NCT00257166|5021775|P1|Overall Study|Adverse Event|18
1532819|NCT00257010|5021787|P1|Overall Study|no headache reported|9
1532820|NCT00257010|5021787|P1|Overall Study|various|11
1532821|NCT00257010|5021787|P1|Overall Study|Adverse Event|10
1532822|NCT00257010|5021787|P1|Overall Study|Withdrawal by Subject|34
1532823|NCT00257010|5021787|P1|Overall Study|Lost to Follow-up|53
1532824|NCT00257010|5021787|P1|Overall Study|Lack of Efficacy|11
1532825|NCT00256997|5021798|P2|Overall Study|Investigator Withdrew Participant|1
1532826|NCT00256997|5021799|P1|Overall Study|Investigator Withdrew Participant|2
1532827|NCT00256997|5021798|P2|Overall Study|Participant Non-compliant|6
1532828|NCT00256997|5021799|P1|Overall Study|Participant Non-compliant|3
1532829|NCT00256997|5021798|P2|Overall Study|End of Study (As Per Sponsor)|24
1532830|NCT00256997|5021799|P1|Overall Study|End of Study (As Per Sponsor)|12
1532831|NCT00256997|5021798|P2|Overall Study|Other|8
1532832|NCT00256997|5021799|P1|Overall Study|Other|5
1532833|NCT00256997|5021798|P2|Overall Study|Started but not treated|0
1532834|NCT00256997|5021799|P1|Overall Study|Started but not treated|2
1532835|NCT00256997|5021798|P2|Overall Study|Withdrawal by Subject|3
1532836|NCT00256997|5021799|P1|Overall Study|Withdrawal by Subject|13
1532837|NCT00256997|5021798|P2|Overall Study|Lost to Follow-up|5
1532838|NCT00256997|5021799|P1|Overall Study|Lost to Follow-up|3
1532839|NCT00256997|5021798|P2|Overall Study|Adverse Event|0
1532840|NCT00256997|5021799|P1|Overall Study|Adverse Event|4
1532841|NCT00256997|5021798|P2|Overall Study|Death|0
1532842|NCT00256997|5021799|P1|Overall Study|Death|2
1532843|NCT00256997|5021798|P2|Overall Study|Lack of Efficacy|4
1532844|NCT00256997|5021799|P1|Overall Study|Lack of Efficacy|1
1532845|NCT00256997|5021798|P2|Overall Study|Protocol Violation|4
1532846|NCT00256997|5021799|P1|Overall Study|Protocol Violation|1
1532847|NCT00256867|5021841|P8|Overall Study|Withdrawal by participant|0
1532848|NCT00256867|5021842|P7|Overall Study|Withdrawal by participant|0
1532849|NCT00256867|5021843|P6|Overall Study|Withdrawal by participant|1
1532850|NCT00256867|5021844|P5|Overall Study|Withdrawal by participant|0
1532851|NCT00256867|5021845|P4|Overall Study|Withdrawal by participant|0
1532852|NCT00256867|5021846|P3|Overall Study|Withdrawal by participant|0
1532853|NCT00256867|5021847|P2|Overall Study|Withdrawal by participant|0
1532854|NCT00256867|5021848|P1|Overall Study|Withdrawal by participant|0
1532855|NCT00256867|5021841|P8|Overall Study|Participant out of assessment window|0
1532856|NCT00256867|5021842|P7|Overall Study|Participant out of assessment window|0
1532857|NCT00256867|5021843|P6|Overall Study|Participant out of assessment window|0
1532858|NCT00256867|5021844|P5|Overall Study|Participant out of assessment window|0
1532859|NCT00256867|5021845|P4|Overall Study|Participant out of assessment window|0
1532860|NCT00256867|5021846|P3|Overall Study|Participant out of assessment window|1
1532861|NCT00256867|5021847|P2|Overall Study|Participant out of assessment window|0
1532862|NCT00256867|5021848|P1|Overall Study|Participant out of assessment window|0
1532863|NCT00256867|5021841|P8|Overall Study|Participant travelled Overseas|0
1532864|NCT00256867|5021842|P7|Overall Study|Participant travelled Overseas|0
1532865|NCT00256867|5021843|P6|Overall Study|Participant travelled Overseas|0
1532866|NCT00256867|5021844|P5|Overall Study|Participant travelled Overseas|0
1532867|NCT00256867|5021845|P4|Overall Study|Participant travelled Overseas|0
1532868|NCT00256867|5021846|P3|Overall Study|Participant travelled Overseas|0
1532869|NCT00256867|5021847|P2|Overall Study|Participant travelled Overseas|1
1532870|NCT00256867|5021848|P1|Overall Study|Participant travelled Overseas|0
1532871|NCT00256867|5021841|P8|Overall Study|Non-compliance with study medication|1
1532872|NCT00256867|5021842|P7|Overall Study|Non-compliance with study medication|0
1532873|NCT00256867|5021843|P6|Overall Study|Non-compliance with study medication|0
1532874|NCT00256867|5021844|P5|Overall Study|Non-compliance with study medication|0
1532875|NCT00256867|5021845|P4|Overall Study|Non-compliance with study medication|0
1532876|NCT00256867|5021846|P3|Overall Study|Non-compliance with study medication|0
1532877|NCT00256867|5021847|P2|Overall Study|Non-compliance with study medication|0
1532878|NCT00256867|5021848|P1|Overall Study|Non-compliance with study medication|0
1532879|NCT00256867|5021841|P8|Overall Study|Investigator's Decision|0
1532880|NCT00256867|5021842|P7|Overall Study|Investigator's Decision|0
1532881|NCT00256867|5021843|P6|Overall Study|Investigator's Decision|0
1532882|NCT00256867|5021844|P5|Overall Study|Investigator's Decision|1
1532883|NCT00256867|5021845|P4|Overall Study|Investigator's Decision|0
1532884|NCT00256867|5021846|P3|Overall Study|Investigator's Decision|0
1532885|NCT00256867|5021847|P2|Overall Study|Investigator's Decision|0
1532886|NCT00256867|5021848|P1|Overall Study|Investigator's Decision|0
1532887|NCT00256867|5021841|P8|Overall Study|Glycemia over 13.3 millimole per litre|1
1532888|NCT00256867|5021842|P7|Overall Study|Glycemia over 13.3 millimole per litre|0
1532889|NCT00256867|5021843|P6|Overall Study|Glycemia over 13.3 millimole per litre|0
1532890|NCT00256867|5021844|P5|Overall Study|Glycemia over 13.3 millimole per litre|0
1532891|NCT00256867|5021845|P4|Overall Study|Glycemia over 13.3 millimole per litre|0
1532892|NCT00256867|5021846|P3|Overall Study|Glycemia over 13.3 millimole per litre|0
1532893|NCT00256867|5021847|P2|Overall Study|Glycemia over 13.3 millimole per litre|0
1532894|NCT00256867|5021848|P1|Overall Study|Glycemia over 13.3 millimole per litre|0
1532895|NCT00256867|5021841|P8|Overall Study|Fasting plasma glucose >240 mg/dL|0
1532896|NCT00256867|5021842|P7|Overall Study|Fasting plasma glucose >240 mg/dL|0
1532897|NCT00256867|5021843|P6|Overall Study|Fasting plasma glucose >240 mg/dL|0
1532898|NCT00256867|5021844|P5|Overall Study|Fasting plasma glucose >240 mg/dL|0
1532899|NCT00256867|5021845|P4|Overall Study|Fasting plasma glucose >240 mg/dL|0
1532900|NCT00256867|5021846|P3|Overall Study|Fasting plasma glucose >240 mg/dL|0
1532901|NCT00256867|5021847|P2|Overall Study|Fasting plasma glucose >240 mg/dL|1
1532902|NCT00256867|5021848|P1|Overall Study|Fasting plasma glucose >240 mg/dL|0
1532903|NCT00256867|5021841|P8|Overall Study|Withdrawal by Subject|2
1532904|NCT00256867|5021842|P7|Overall Study|Withdrawal by Subject|3
1532905|NCT00256867|5021843|P6|Overall Study|Withdrawal by Subject|2
1532906|NCT00256867|5021844|P5|Overall Study|Withdrawal by Subject|2
1532907|NCT00256867|5021845|P4|Overall Study|Withdrawal by Subject|1
1532908|NCT00256867|5021846|P3|Overall Study|Withdrawal by Subject|1
1532909|NCT00256867|5021847|P2|Overall Study|Withdrawal by Subject|0
1532910|NCT00256867|5021848|P1|Overall Study|Withdrawal by Subject|0
1532911|NCT00256867|5021841|P8|Overall Study|Protocol Violation|1
1532912|NCT00256867|5021842|P7|Overall Study|Protocol Violation|0
1532913|NCT00256867|5021843|P6|Overall Study|Protocol Violation|1
1532914|NCT00256867|5021844|P5|Overall Study|Protocol Violation|0
1532915|NCT00256867|5021845|P4|Overall Study|Protocol Violation|1
1532916|NCT00256867|5021846|P3|Overall Study|Protocol Violation|0
1532917|NCT00256867|5021847|P2|Overall Study|Protocol Violation|0
1532918|NCT00256867|5021848|P1|Overall Study|Protocol Violation|0
1532919|NCT00256867|5021841|P8|Overall Study|Lost to Follow-up|2
1532920|NCT00256867|5021842|P7|Overall Study|Lost to Follow-up|1
1532921|NCT00256867|5021843|P6|Overall Study|Lost to Follow-up|0
1532922|NCT00256867|5021844|P5|Overall Study|Lost to Follow-up|2
1532923|NCT00256867|5021845|P4|Overall Study|Lost to Follow-up|3
1532924|NCT00256867|5021846|P3|Overall Study|Lost to Follow-up|2
1532925|NCT00256867|5021847|P2|Overall Study|Lost to Follow-up|2
1532926|NCT00256867|5021848|P1|Overall Study|Lost to Follow-up|2
1532927|NCT00256867|5021841|P8|Overall Study|Adverse Event|4
1532928|NCT00256867|5021842|P7|Overall Study|Adverse Event|1
1532929|NCT00256867|5021843|P6|Overall Study|Adverse Event|2
1532930|NCT00256867|5021844|P5|Overall Study|Adverse Event|2
1532931|NCT00256867|5021845|P4|Overall Study|Adverse Event|1
1532932|NCT00256867|5021846|P3|Overall Study|Adverse Event|1
1532933|NCT00256867|5021847|P2|Overall Study|Adverse Event|1
1532934|NCT00256867|5021848|P1|Overall Study|Adverse Event|0
1532935|NCT00256750|5021935|P3|Long Term Extension (LTE; 84 Months)|Not Specified|5
1532936|NCT00256750|5021936|P2|Long Term Extension (LTE; 84 Months)|Not Specified|4
1532937|NCT00256750|5021937|P1|Long Term Extension (LTE; 84 Months)|Not Specified|5
1532938|NCT00256750|5021935|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
1532939|NCT00256750|5021936|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
1532940|NCT00256750|5021937|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
1532941|NCT00256750|5021935|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
1532942|NCT00256750|5021936|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
1532943|NCT00256750|5021937|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
1532944|NCT00256750|5021935|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
1532945|NCT00256750|5021936|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
1532946|NCT00256750|5021937|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
1532947|NCT00256750|5021935|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
1532948|NCT00256750|5021936|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
1532949|NCT00256750|5021937|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
1532950|NCT00256750|5021935|P3|Long Term Extension (LTE; 84 Months)|Death|4
1532951|NCT00256750|5021936|P2|Long Term Extension (LTE; 84 Months)|Death|4
1532952|NCT00256750|5021937|P1|Long Term Extension (LTE; 84 Months)|Death|9
1532953|NCT00256750|5021935|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
1532954|NCT00256750|5021936|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
1532955|NCT00256750|5021937|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
1532956|NCT00256750|5021935|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
1532957|NCT00256750|5021936|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
1532958|NCT00256750|5021937|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
1532959|NCT00256750|5021935|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
1532960|NCT00256750|5021936|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
1532961|NCT00256750|5021937|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
1532962|NCT00256750|5021935|P3|Post-Transplant Treated (36 Months)|Not specified|1
1532963|NCT00256750|5021936|P2|Post-Transplant Treated (36 Months)|Not specified|1
1532964|NCT00256750|5021937|P1|Post-Transplant Treated (36 Months)|Not specified|0
1532965|NCT00256750|5021935|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
1532966|NCT00256750|5021936|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
1532967|NCT00256750|5021937|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
1532968|NCT00256750|5021935|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
1532969|NCT00256750|5021936|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
1532970|NCT00256750|5021937|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
1532971|NCT00256750|5021935|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
1532972|NCT00256750|5021936|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
1532973|NCT00256750|5021937|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
1532974|NCT00256750|5021935|P3|Post-Transplant Treated (36 Months)|Death|1
1532975|NCT00256750|5021936|P2|Post-Transplant Treated (36 Months)|Death|2
1532976|NCT00256750|5021937|P1|Post-Transplant Treated (36 Months)|Death|0
1532977|NCT00256750|5021935|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
1532978|NCT00256750|5021936|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
1532979|NCT00256750|5021937|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
1532980|NCT00256750|5021935|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
1532981|NCT00256750|5021936|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
1532982|NCT00256750|5021937|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
1532983|NCT00256750|5021935|P3|Post-Transplant Treated (24 Months)|Not Specified|1
1532984|NCT00256750|5021936|P2|Post-Transplant Treated (24 Months)|Not Specified|0
1532985|NCT00256750|5021937|P1|Post-Transplant Treated (24 Months)|Not Specified|2
1532986|NCT00256750|5021935|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
1532987|NCT00256750|5021936|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
1532988|NCT00256750|5021937|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
1532989|NCT00256750|5021935|P3|Post-Transplant Treated (24 Months)|Death|0
1532990|NCT00256750|5021936|P2|Post-Transplant Treated (24 Months)|Death|0
1532991|NCT00256750|5021937|P1|Post-Transplant Treated (24 Months)|Death|3
1532992|NCT00256750|5021935|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
1532993|NCT00256750|5021936|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
1532994|NCT00256750|5021937|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
1532995|NCT00256750|5021935|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
1532996|NCT00256750|5021936|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
1532997|NCT00256750|5021937|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
1532998|NCT00256750|5021935|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
1532999|NCT00256750|5021936|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
1533000|NCT00256750|5021937|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
1533001|NCT00256750|5021935|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
1533002|NCT00256750|5021936|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
1533003|NCT00256750|5021937|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
1533004|NCT00256750|5021935|P3|Post-Transplant Treated (12 Months)|Not Specified|2
1533005|NCT00256750|5021936|P2|Post-Transplant Treated (12 Months)|Not Specified|4
1533006|NCT00256750|5021937|P1|Post-Transplant Treated (12 Months)|Not Specified|5
1533007|NCT00256750|5021935|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
1533008|NCT00256750|5021936|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
1533009|NCT00256750|5021937|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
1533010|NCT00256750|5021935|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
1533011|NCT00256750|5021936|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
1533012|NCT00256750|5021937|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
1533013|NCT00256750|5021935|P3|Post-Transplant Treated (12 Months)|Death|4
1533014|NCT00256750|5021936|P2|Post-Transplant Treated (12 Months)|Death|2
1533015|NCT00256750|5021937|P1|Post-Transplant Treated (12 Months)|Death|3
1533016|NCT00256750|5021935|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
1533017|NCT00256750|5021936|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
1533018|NCT00256750|5021937|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
1533019|NCT00256750|5021935|P3|Transplanted Pre-Treatment|Death|0
1533020|NCT00256750|5021936|P2|Transplanted Pre-Treatment|Death|0
1533021|NCT00256750|5021937|P1|Transplanted Pre-Treatment|Death|1
1533022|NCT00256750|5021935|P3|Transplanted Pre-Treatment|Not Specified|0
1533023|NCT00256750|5021936|P2|Transplanted Pre-Treatment|Not Specified|0
1533024|NCT00256750|5021937|P1|Transplanted Pre-Treatment|Not Specified|2
1533025|NCT00256750|5021935|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
1533026|NCT00256750|5021936|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
1533027|NCT00256750|5021937|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
1533028|NCT00256724|5022073|P2|Overall Study|Protocol Violation|3
1533029|NCT00256724|5022074|P1|Overall Study|Protocol Violation|3
1533030|NCT00256724|5022073|P2|Overall Study|Physician Decision|5
1533031|NCT00256724|5022074|P1|Overall Study|Physician Decision|2
1533032|NCT00256698|5022084|P2|Overall Study|Prematurely Discontinued|0
1533033|NCT00256698|5022085|P1|Overall Study|Prematurely Discontinued|1
1533034|NCT00256698|5022084|P2|Overall Study|withdrawn due to osteoporosis|0
1533035|NCT00256698|5022085|P1|Overall Study|withdrawn due to osteoporosis|1
1533036|NCT00256698|5022084|P2|Overall Study|still ongoing at data cut-off|46
1533037|NCT00256698|5022085|P1|Overall Study|still ongoing at data cut-off|41
1533038|NCT00256698|5022084|P2|Overall Study|disease progression|105
1533039|NCT00256698|5022085|P1|Overall Study|disease progression|97
1533040|NCT00256698|5022084|P2|Overall Study|Lost to Follow-up|3
1533041|NCT00256698|5022085|P1|Overall Study|Lost to Follow-up|1
1533042|NCT00256698|5022084|P2|Overall Study|Protocol Violation|5
1533043|NCT00256698|5022085|P1|Overall Study|Protocol Violation|6
1533044|NCT00256698|5022084|P2|Overall Study|Adverse Event|6
1533045|NCT00256698|5022085|P1|Overall Study|Adverse Event|13
1533046|NCT00256698|5022084|P2|Overall Study|Withdrawal by Subject|7
1533047|NCT00256698|5022085|P1|Overall Study|Withdrawal by Subject|7
1533048|NCT00256308|5022103|P1|Overall Study|Death|2
1533049|NCT00256295|5022111|P1|Overall Study|Death|1
1533050|NCT00256295|5022111|P1|Overall Study|Withdrawal by Subject|3
1533051|NCT00256282|5022117|P1|Overall Study|Physician Decision|1
1533052|NCT00256282|5022117|P1|Overall Study|Adverse Event|3
1533053|NCT00256282|5022117|P1|Overall Study|Disease progression, relapse during acti|12
1533054|NCT00256243|5022122|P1|Overall Study|Not treated|1
1533055|NCT00256243|5022122|P1|Overall Study|Death|7
1533056|NCT00256243|5022122|P1|Overall Study|Lost to Follow-up|2
1533057|NCT00256204|5022131|P4|Overall Study|Need for additional prohibited treatment|25
1533058|NCT00256204|5022132|P3|Overall Study|Need for additional prohibited treatment|27
1533059|NCT00256204|5022133|P2|Overall Study|Need for additional prohibited treatment|28
1533060|NCT00256204|5022134|P1|Overall Study|Need for additional prohibited treatment|38
1533061|NCT00256204|5022131|P4|Overall Study|Withdrawal by Subject|5
1533062|NCT00256204|5022132|P3|Overall Study|Withdrawal by Subject|7
1533063|NCT00256204|5022133|P2|Overall Study|Withdrawal by Subject|6
1533064|NCT00256204|5022134|P1|Overall Study|Withdrawal by Subject|17
1533065|NCT00256204|5022131|P4|Overall Study|Physician Decision|2
1533066|NCT00256204|5022132|P3|Overall Study|Physician Decision|1
1533067|NCT00256204|5022133|P2|Overall Study|Physician Decision|0
1533068|NCT00256204|5022134|P1|Overall Study|Physician Decision|0
1533069|NCT00256204|5022131|P4|Overall Study|Protocol Violation|1
1533070|NCT00256204|5022132|P3|Overall Study|Protocol Violation|2
1533071|NCT00256204|5022133|P2|Overall Study|Protocol Violation|0
1533072|NCT00256204|5022134|P1|Overall Study|Protocol Violation|1
1533073|NCT00256204|5022131|P4|Overall Study|Lost to Follow-up|2
1533074|NCT00256204|5022132|P3|Overall Study|Lost to Follow-up|1
1533075|NCT00256204|5022133|P2|Overall Study|Lost to Follow-up|1
1533076|NCT00256204|5022134|P1|Overall Study|Lost to Follow-up|1
1533077|NCT00256204|5022131|P4|Overall Study|Death|0
1533078|NCT00256204|5022132|P3|Overall Study|Death|0
1533079|NCT00256204|5022133|P2|Overall Study|Death|1
1533080|NCT00256204|5022134|P1|Overall Study|Death|0
1533081|NCT00256204|5022131|P4|Overall Study|Adverse Event|14
1533082|NCT00256204|5022132|P3|Overall Study|Adverse Event|16
1533083|NCT00256204|5022133|P2|Overall Study|Adverse Event|14
1533084|NCT00256204|5022134|P1|Overall Study|Adverse Event|10
1533085|NCT00256126|5022149|P2|Overall Study|Other|2
1533086|NCT00256126|5022150|P1|Overall Study|Other|1
1533087|NCT00256126|5022149|P2|Overall Study|Adverse Event|0
1533088|NCT00256126|5022150|P1|Overall Study|Adverse Event|1
1533089|NCT00255840|5022189|P2|Overall Study|Discontinued intervention|56
1533090|NCT00255840|5022190|P1|Overall Study|Discontinued intervention|53
1533091|NCT00255840|5022189|P2|Overall Study|Lost to Follow-up|14
1533092|NCT00255840|5022190|P1|Overall Study|Lost to Follow-up|10
1533093|NCT00255723|5022203|P2|Overall Study|Response Data Not Available|0
1533094|NCT00255723|5022204|P1|Overall Study|Response Data Not Available|1
1533095|NCT00255723|5022203|P2|Overall Study|Death|1
1533096|NCT00255723|5022204|P1|Overall Study|Death|0
1533097|NCT00255723|5022203|P2|Overall Study|Adverse Event|1
1533098|NCT00255723|5022204|P1|Overall Study|Adverse Event|1
1533099|NCT00255190|5022217|P2|Overall Study|Various|23
1533100|NCT00255190|5022218|P1|Overall Study|Various|4
1533101|NCT00255190|5022217|P2|Overall Study|Erosive esophagitis not healed|20
1533102|NCT00255190|5022218|P1|Overall Study|Erosive esophagitis not healed|0
1533103|NCT00255190|5022217|P2|Overall Study|Inclusion/Exclusion criteria not met|1
1533104|NCT00255190|5022218|P1|Overall Study|Inclusion/Exclusion criteria not met|0
1533105|NCT00255190|5022217|P2|Overall Study|Withdrew Consent|48
1533106|NCT00255190|5022218|P1|Overall Study|Withdrew Consent|17
1533107|NCT00255190|5022217|P2|Overall Study|Lost to Follow-up|27
1533108|NCT00255190|5022218|P1|Overall Study|Lost to Follow-up|10
1533109|NCT00255190|5022217|P2|Overall Study|Protocol Violation|2
1533110|NCT00255190|5022218|P1|Overall Study|Protocol Violation|2
1533111|NCT00255190|5022217|P2|Overall Study|Adverse Event|36
1533112|NCT00255190|5022218|P1|Overall Study|Adverse Event|17
1533113|NCT00255164|5022302|P3|Overall Study|Therapeutic Failure|3
1533114|NCT00255164|5022303|P2|Overall Study|Therapeutic Failure|2
1533115|NCT00255164|5022304|P1|Overall Study|Therapeutic Failure|11
1533116|NCT00255164|5022302|P3|Overall Study|Esophageal Stricture|1
1533117|NCT00255164|5022303|P2|Overall Study|Esophageal Stricture|0
1533118|NCT00255164|5022304|P1|Overall Study|Esophageal Stricture|0
1533119|NCT00255164|5022302|P3|Overall Study|Possible Barrett's Esophagus|8
1533120|NCT00255164|5022303|P2|Overall Study|Possible Barrett's Esophagus|3
1533121|NCT00255164|5022304|P1|Overall Study|Possible Barrett's Esophagus|1
1533122|NCT00255164|5022302|P3|Overall Study|Relapse of Erosive Esophagitis|12
1533123|NCT00255164|5022303|P2|Overall Study|Relapse of Erosive Esophagitis|16
1533124|NCT00255164|5022304|P1|Overall Study|Relapse of Erosive Esophagitis|78
1533125|NCT00255164|5022302|P3|Overall Study|Subject Request/Subject Unavailable|2
1533126|NCT00255164|5022303|P2|Overall Study|Subject Request/Subject Unavailable|1
1533127|NCT00255164|5022304|P1|Overall Study|Subject Request/Subject Unavailable|1
1533128|NCT00255164|5022302|P3|Overall Study|Noncompliance|2
1533129|NCT00255164|5022303|P2|Overall Study|Noncompliance|1
1533130|NCT00255164|5022304|P1|Overall Study|Noncompliance|0
1533131|NCT00255164|5022302|P3|Overall Study|Withdrawal by Subject|8
1533132|NCT00255164|5022303|P2|Overall Study|Withdrawal by Subject|17
1533133|NCT00255164|5022304|P1|Overall Study|Withdrawal by Subject|18
1533134|NCT00255164|5022302|P3|Overall Study|Lost to Follow-up|4
1533135|NCT00255164|5022303|P2|Overall Study|Lost to Follow-up|3
1533136|NCT00255164|5022304|P1|Overall Study|Lost to Follow-up|4
1533137|NCT00255164|5022302|P3|Overall Study|Adverse Event|9
1533138|NCT00255164|5022303|P2|Overall Study|Adverse Event|6
1533139|NCT00255164|5022304|P1|Overall Study|Adverse Event|10
1533140|NCT00255151|5022330|P3|Overall Study|Therapeutic Failure|3
1533141|NCT00255151|5022331|P2|Overall Study|Therapeutic Failure|2
1533142|NCT00255151|5022332|P1|Overall Study|Therapeutic Failure|11
1533143|NCT00255151|5022330|P3|Overall Study|Esophageal Stricture|1
1533144|NCT00255151|5022331|P2|Overall Study|Esophageal Stricture|0
1533145|NCT00255151|5022332|P1|Overall Study|Esophageal Stricture|0
1533146|NCT00255151|5022330|P3|Overall Study|Possible Barrett's Esophagus|8
1533147|NCT00255151|5022331|P2|Overall Study|Possible Barrett's Esophagus|3
1533148|NCT00255151|5022332|P1|Overall Study|Possible Barrett's Esophagus|1
1533149|NCT00255151|5022330|P3|Overall Study|Relapse of Erosive Esophagitis|12
1533150|NCT00255151|5022331|P2|Overall Study|Relapse of Erosive Esophagitis|16
1533151|NCT00255151|5022332|P1|Overall Study|Relapse of Erosive Esophagitis|78
1533152|NCT00255151|5022330|P3|Overall Study|Subject Request/Subject Unavailable|2
1533153|NCT00255151|5022331|P2|Overall Study|Subject Request/Subject Unavailable|1
1533154|NCT00255151|5022332|P1|Overall Study|Subject Request/Subject Unavailable|1
1533155|NCT00255151|5022330|P3|Overall Study|Noncompliance|2
1533156|NCT00255151|5022331|P2|Overall Study|Noncompliance|1
1533157|NCT00255151|5022332|P1|Overall Study|Noncompliance|0
1533158|NCT00255151|5022330|P3|Overall Study|Withdrawal by Subject|8
1533159|NCT00255151|5022331|P2|Overall Study|Withdrawal by Subject|17
1533160|NCT00255151|5022332|P1|Overall Study|Withdrawal by Subject|18
1533161|NCT00255151|5022330|P3|Overall Study|Lost to Follow-up|4
1533162|NCT00255151|5022331|P2|Overall Study|Lost to Follow-up|3
1533163|NCT00255151|5022332|P1|Overall Study|Lost to Follow-up|4
1533164|NCT00255151|5022330|P3|Overall Study|Adverse Event|9
1533165|NCT00255151|5022331|P2|Overall Study|Adverse Event|6
1533166|NCT00255151|5022332|P1|Overall Study|Adverse Event|10
1533167|NCT00255086|5022366|P2|Overall Study|Protocol Violation|1
1533168|NCT00255086|5022367|P1|Overall Study|Protocol Violation|1
1533169|NCT00255086|5022366|P2|Overall Study|Adverse Event|1
1533170|NCT00255086|5022367|P1|Overall Study|Adverse Event|1
1533171|NCT00255047|5022379|P4|Overall Study|Withdrawal by Subject|18
1533172|NCT00255047|5022380|P3|Overall Study|Withdrawal by Subject|25
1533173|NCT00255047|5022381|P2|Overall Study|Withdrawal by Subject|23
1533174|NCT00255047|5022382|P1|Overall Study|Withdrawal by Subject|24
1533175|NCT00255047|5022379|P4|Overall Study|Lost to Follow-up|6
1533176|NCT00255047|5022380|P3|Overall Study|Lost to Follow-up|5
1533177|NCT00255047|5022381|P2|Overall Study|Lost to Follow-up|8
1533178|NCT00255047|5022382|P1|Overall Study|Lost to Follow-up|9
1533179|NCT00255047|5022379|P4|Overall Study|Protocol Violation|20
1533180|NCT00255047|5022380|P3|Overall Study|Protocol Violation|16
1533181|NCT00255047|5022381|P2|Overall Study|Protocol Violation|13
1533182|NCT00255047|5022382|P1|Overall Study|Protocol Violation|13
1533183|NCT00255047|5022379|P4|Overall Study|Adverse Event|1
1533184|NCT00255047|5022380|P3|Overall Study|Adverse Event|2
1533185|NCT00255047|5022381|P2|Overall Study|Adverse Event|3
1533186|NCT00255047|5022382|P1|Overall Study|Adverse Event|0
1533187|NCT00255047|5022379|P4|Overall Study|Serious Adverse Events|1
1533188|NCT00255047|5022380|P3|Overall Study|Serious Adverse Events|2
1533189|NCT00255047|5022381|P2|Overall Study|Serious Adverse Events|1
1533190|NCT00255047|5022382|P1|Overall Study|Serious Adverse Events|2
1533191|NCT00255034|5022406|P2|Overall Study|Withdrawal by Subject|38
1533192|NCT00255034|5022407|P1|Overall Study|Withdrawal by Subject|15
1533193|NCT00255008|5022417|P4|Overall Study|Other|2
1533194|NCT00255008|5022418|P3|Overall Study|Other|3
1533195|NCT00255008|5022419|P2|Overall Study|Other|0
1533196|NCT00255008|5022420|P1|Overall Study|Other|7
1533197|NCT00255008|5022417|P4|Overall Study|Adverse lab experience|0
1533198|NCT00255008|5022418|P3|Overall Study|Adverse lab experience|0
1533199|NCT00255008|5022419|P2|Overall Study|Adverse lab experience|0
1533200|NCT00255008|5022420|P1|Overall Study|Adverse lab experience|1
1533201|NCT00255008|5022417|P4|Overall Study|Sponsor request|17
1533202|NCT00255008|5022418|P3|Overall Study|Sponsor request|8
1533203|NCT00255008|5022419|P2|Overall Study|Sponsor request|3
1533204|NCT00255008|5022420|P1|Overall Study|Sponsor request|18
1533205|NCT00255008|5022417|P4|Overall Study|Withdrew consent|0
1533206|NCT00255008|5022418|P3|Overall Study|Withdrew consent|2
1533207|NCT00255008|5022419|P2|Overall Study|Withdrew consent|0
1533208|NCT00255008|5022420|P1|Overall Study|Withdrew consent|0
1533209|NCT00255008|5022417|P4|Overall Study|Did not meet viral reduction criteria|1
1533210|NCT00255008|5022418|P3|Overall Study|Did not meet viral reduction criteria|0
1533211|NCT00255008|5022419|P2|Overall Study|Did not meet viral reduction criteria|5
1533212|NCT00255008|5022420|P1|Overall Study|Did not meet viral reduction criteria|4
1533213|NCT00255008|5022417|P4|Overall Study|Lost to Follow-up|2
1533214|NCT00255008|5022418|P3|Overall Study|Lost to Follow-up|1
1533215|NCT00255008|5022419|P2|Overall Study|Lost to Follow-up|0
1533216|NCT00255008|5022420|P1|Overall Study|Lost to Follow-up|1
1533217|NCT00255008|5022417|P4|Overall Study|Adverse Event|0
1533218|NCT00255008|5022418|P3|Overall Study|Adverse Event|2
1533219|NCT00255008|5022419|P2|Overall Study|Adverse Event|1
1533220|NCT00255008|5022420|P1|Overall Study|Adverse Event|1
1533221|NCT00254982|5022456|P2|Overall Study|Abnormal liver function tests|1
1533222|NCT00254982|5022457|P1|Overall Study|Abnormal liver function tests|2
1533223|NCT00254982|5022456|P2|Overall Study|Opportunistic infection|0
1533224|NCT00254982|5022457|P1|Overall Study|Opportunistic infection|1
1533225|NCT00254982|5022456|P2|Overall Study|Malignancy|2
1533226|NCT00254982|5022457|P1|Overall Study|Malignancy|0
1533227|NCT00254982|5022456|P2|Overall Study|Diagnosis of Tuberculosis|1
1533228|NCT00254982|5022457|P1|Overall Study|Diagnosis of Tuberculosis|1
1533229|NCT00254982|5022456|P2|Overall Study|Protocol deviation|1
1533230|NCT00254982|5022457|P1|Overall Study|Protocol deviation|1
1533231|NCT00254982|5022456|P2|Overall Study|Inclusion/exclusion criteria violation|2
1533232|NCT00254982|5022457|P1|Overall Study|Inclusion/exclusion criteria violation|0
1533233|NCT00254982|5022456|P2|Overall Study|Withdrawal by Subject|1
1533234|NCT00254982|5022457|P1|Overall Study|Withdrawal by Subject|1
1533235|NCT00254982|5022456|P2|Overall Study|Adverse Event|16
1533236|NCT00254982|5022457|P1|Overall Study|Adverse Event|18
1533237|NCT00254982|5022456|P2|Overall Study|Lost to Follow-up|3
1533238|NCT00254982|5022457|P1|Overall Study|Lost to Follow-up|5
1533239|NCT00254982|5022456|P2|Overall Study|Lack of Efficacy|3
1533240|NCT00254982|5022457|P1|Overall Study|Lack of Efficacy|5
1533241|NCT00254982|5022456|P2|Overall Study|Not specified|1
1533242|NCT00254982|5022457|P1|Overall Study|Not specified|2
1533243|NCT00254566|5022469|P2|Overall Study|Lost to Follow-up|2
1533244|NCT00254566|5022470|P1|Overall Study|Lost to Follow-up|7
1533245|NCT00254566|5022469|P2|Overall Study|Withdrawal by Subject|6
1533246|NCT00254566|5022470|P1|Overall Study|Withdrawal by Subject|5
1533247|NCT00254566|5022469|P2|Overall Study|Other|5
1533248|NCT00254566|5022470|P1|Overall Study|Other|1
1533249|NCT00254566|5022469|P2|Overall Study|Lack of Efficacy|9
1533250|NCT00254566|5022470|P1|Overall Study|Lack of Efficacy|12
1533251|NCT00254566|5022469|P2|Overall Study|Adverse Event|4
1533252|NCT00254566|5022470|P1|Overall Study|Adverse Event|5
1533253|NCT00254566|5022469|P2|Overall Study|Death|0
1533254|NCT00254566|5022470|P1|Overall Study|Death|1
1533255|NCT00254540|5022494|P2|Overall Study|Laboratory Test Abnormality|1
1533256|NCT00254540|5022495|P1|Overall Study|Laboratory Test Abnormality|0
1533257|NCT00254540|5022494|P2|Overall Study|Death|1
1533258|NCT00254540|5022495|P1|Overall Study|Death|0
1533259|NCT00254540|5022494|P2|Overall Study|Lack of Efficacy|13
1533260|NCT00254540|5022495|P1|Overall Study|Lack of Efficacy|13
1533261|NCT00254540|5022494|P2|Overall Study|Adverse Event|7
1533262|NCT00254540|5022495|P1|Overall Study|Adverse Event|6
1533263|NCT00254501|5022524|P2|Overall Study|Lost to Follow-up|1
1533264|NCT00254501|5022525|P1|Overall Study|Lost to Follow-up|1
1533265|NCT00254293|5022565|P7|LTE Open Label Fixed Dosing|not specified|1
1533266|NCT00254293|5022566|P6|LTE Open Label Fixed Dosing|not specified|0
1533267|NCT00254293|5022567|P5|LTE Open Label Fixed Dosing|not specified|0
1533268|NCT00254293|5022568|P4|LTE Open Label Fixed Dosing|not specified|0
1533269|NCT00254293|5022569|P3|LTE Open Label Fixed Dosing|not specified|0
1533270|NCT00254293|5022570|P2|LTE Open Label Fixed Dosing|not specified|0
1533271|NCT00254293|5022571|P1|LTE Open Label Fixed Dosing|not specified|0
1533272|NCT00254293|5022565|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
1533273|NCT00254293|5022566|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1533274|NCT00254293|5022567|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1533275|NCT00254293|5022568|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1533276|NCT00254293|5022569|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1533277|NCT00254293|5022570|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1533278|NCT00254293|5022571|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1533279|NCT00254293|5022565|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
1533280|NCT00254293|5022566|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1533281|NCT00254293|5022567|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1533282|NCT00254293|5022568|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1533283|NCT00254293|5022569|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1533284|NCT00254293|5022570|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1533285|NCT00254293|5022571|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1533286|NCT00254293|5022565|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
1533287|NCT00254293|5022566|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1533288|NCT00254293|5022567|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1533289|NCT00254293|5022568|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1533290|NCT00254293|5022569|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1533291|NCT00254293|5022570|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1533292|NCT00254293|5022571|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1533293|NCT00254293|5022565|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
1533294|NCT00254293|5022566|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1533295|NCT00254293|5022567|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1533296|NCT00254293|5022568|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1533297|NCT00254293|5022569|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1533298|NCT00254293|5022570|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1533299|NCT00254293|5022571|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1533300|NCT00254293|5022565|P7|LTE Open Label Fixed Dosing|Adverse Event|1
1533301|NCT00254293|5022566|P6|LTE Open Label Fixed Dosing|Adverse Event|0
1533302|NCT00254293|5022567|P5|LTE Open Label Fixed Dosing|Adverse Event|0
1533303|NCT00254293|5022568|P4|LTE Open Label Fixed Dosing|Adverse Event|0
1533304|NCT00254293|5022569|P3|LTE Open Label Fixed Dosing|Adverse Event|0
1533305|NCT00254293|5022570|P2|LTE Open Label Fixed Dosing|Adverse Event|0
1533306|NCT00254293|5022571|P1|LTE Open Label Fixed Dosing|Adverse Event|0
1533307|NCT00254293|5022565|P7|LTE Open Label Fixed Dosing|Death|3
1533308|NCT00254293|5022566|P6|LTE Open Label Fixed Dosing|Death|0
1533309|NCT00254293|5022567|P5|LTE Open Label Fixed Dosing|Death|0
1533310|NCT00254293|5022568|P4|LTE Open Label Fixed Dosing|Death|0
1533311|NCT00254293|5022569|P3|LTE Open Label Fixed Dosing|Death|0
1533312|NCT00254293|5022570|P2|LTE Open Label Fixed Dosing|Death|0
1533313|NCT00254293|5022571|P1|LTE Open Label Fixed Dosing|Death|0
1533314|NCT00254293|5022565|P7|LTE Open Label Variable SC Dosing|not specified|0
1533315|NCT00254293|5022566|P6|LTE Open Label Variable SC Dosing|not specified|0
1533316|NCT00254293|5022567|P5|LTE Open Label Variable SC Dosing|not specified|0
1533317|NCT00254293|5022568|P4|LTE Open Label Variable SC Dosing|not specified|0
1533318|NCT00254293|5022569|P3|LTE Open Label Variable SC Dosing|not specified|2
1533319|NCT00254293|5022570|P2|LTE Open Label Variable SC Dosing|not specified|0
1533320|NCT00254293|5022571|P1|LTE Open Label Variable SC Dosing|not specified|0
1533321|NCT00254293|5022565|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1533322|NCT00254293|5022566|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1533323|NCT00254293|5022567|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1533324|NCT00254293|5022568|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1533325|NCT00254293|5022569|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
1533326|NCT00254293|5022570|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1533327|NCT00254293|5022571|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1533328|NCT00254293|5022565|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1533329|NCT00254293|5022566|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1533330|NCT00254293|5022567|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1533331|NCT00254293|5022568|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1533332|NCT00254293|5022569|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
1533333|NCT00254293|5022570|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1533334|NCT00254293|5022571|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1533335|NCT00254293|5022565|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1533336|NCT00254293|5022566|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1533337|NCT00254293|5022567|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1533338|NCT00254293|5022568|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1533339|NCT00254293|5022569|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
1533340|NCT00254293|5022570|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1533341|NCT00254293|5022571|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1533342|NCT00254293|5022565|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1533343|NCT00254293|5022566|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1533344|NCT00254293|5022567|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
1533345|NCT00254293|5022568|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1533346|NCT00254293|5022569|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
1533347|NCT00254293|5022570|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1533348|NCT00254293|5022571|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
1533349|NCT00254293|5022565|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
1533350|NCT00254293|5022566|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
1533351|NCT00254293|5022567|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
1533352|NCT00254293|5022568|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
1533353|NCT00254293|5022569|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
1533354|NCT00254293|5022570|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
1533355|NCT00254293|5022571|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
1533356|NCT00254293|5022565|P7|LTE Open Label Variable SC Dosing|Death|0
1533357|NCT00254293|5022566|P6|LTE Open Label Variable SC Dosing|Death|0
1533358|NCT00254293|5022567|P5|LTE Open Label Variable SC Dosing|Death|0
1533359|NCT00254293|5022568|P4|LTE Open Label Variable SC Dosing|Death|0
1533360|NCT00254293|5022569|P3|LTE Open Label Variable SC Dosing|Death|1
1533361|NCT00254293|5022570|P2|LTE Open Label Variable SC Dosing|Death|0
1533362|NCT00254293|5022571|P1|LTE Open Label Variable SC Dosing|Death|0
1533363|NCT00254293|5022565|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1533364|NCT00254293|5022566|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1533365|NCT00254293|5022567|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1533366|NCT00254293|5022568|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1533367|NCT00254293|5022569|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
1533368|NCT00254293|5022570|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1533369|NCT00254293|5022571|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1533370|NCT00254293|5022565|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1533371|NCT00254293|5022566|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1533372|NCT00254293|5022567|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1533373|NCT00254293|5022568|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1533374|NCT00254293|5022569|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
1533375|NCT00254293|5022570|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1533376|NCT00254293|5022571|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1533377|NCT00254293|5022565|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1533378|NCT00254293|5022566|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1533379|NCT00254293|5022567|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1533380|NCT00254293|5022568|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
1533381|NCT00254293|5022569|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1533382|NCT00254293|5022570|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
1533383|NCT00254293|5022571|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1533384|NCT00254163|5022654|P2|Overall Study|Other|8
1533385|NCT00254163|5022655|P1|Overall Study|Other|8
1533386|NCT00254163|5022654|P2|Overall Study|Death|1
1533387|NCT00254163|5022655|P1|Overall Study|Death|0
1533388|NCT00254163|5022654|P2|Overall Study|Progressive disease|1
1533389|NCT00254163|5022655|P1|Overall Study|Progressive disease|0
1533390|NCT00254163|5022654|P2|Overall Study|Failed entry|3
1533391|NCT00254163|5022655|P1|Overall Study|Failed entry|1
1533392|NCT00254163|5022654|P2|Overall Study|Investigator request|3
1533393|NCT00254163|5022655|P1|Overall Study|Investigator request|1
1533394|NCT00254163|5022654|P2|Overall Study|Patient request/withdrew consent|4
1533395|NCT00254163|5022655|P1|Overall Study|Patient request/withdrew consent|6
1533396|NCT00254163|5022654|P2|Overall Study|Adverse Event|26
1533397|NCT00254163|5022655|P1|Overall Study|Adverse Event|29
1533398|NCT00253747|5022706|P2|Overall Study|Administrative Discharge (1), Other (2)|2
1533399|NCT00253747|5022707|P1|Overall Study|Administrative Discharge (1), Other (2)|1
1533400|NCT00253747|5022706|P2|Overall Study|Withdrawal by Subject|11
1533401|NCT00253747|5022707|P1|Overall Study|Withdrawal by Subject|10
1533402|NCT00253747|5022706|P2|Overall Study|Lost to Follow-up|14
1533403|NCT00253747|5022707|P1|Overall Study|Lost to Follow-up|13
1533404|NCT00253643|5022760|P4|Overall Study|Non-Compliance|2
1533405|NCT00253643|5022761|P3|Overall Study|Non-Compliance|0
1533406|NCT00253643|5022762|P2|Overall Study|Non-Compliance|0
1533407|NCT00253643|5022763|P1|Overall Study|Non-Compliance|0
1533408|NCT00253643|5022760|P4|Overall Study|Withdrawal by Subject|1
1533409|NCT00253643|5022761|P3|Overall Study|Withdrawal by Subject|1
1533410|NCT00253643|5022762|P2|Overall Study|Withdrawal by Subject|0
1533411|NCT00253643|5022763|P1|Overall Study|Withdrawal by Subject|0
1533412|NCT00253630|5022777|P1|Overall Study|ineligible|2
1533413|NCT00253448|5022793|P1|Overall Study|Withdrawal by Subject|1
1533414|NCT00253370|5022812|P1|Overall Study|Abdominal pain due to disease|1
1533415|NCT00253370|5022812|P1|Overall Study|Protocol Violation|1
1533416|NCT00253370|5022812|P1|Overall Study|Physician Decision|1
1533417|NCT00253370|5022812|P1|Overall Study|Non-protocol therapy|1
1533418|NCT00253370|5022812|P1|Overall Study|Withdrawal by Subject|6
1533419|NCT00253370|5022812|P1|Overall Study|Death|2
1533420|NCT00253370|5022812|P1|Overall Study|Disease progression|13
1533421|NCT00253370|5022812|P1|Overall Study|Adverse Event|18
1533422|NCT00252733|5022858|P2|Overall Study|Multiple Reasons|14
1533423|NCT00252733|5022859|P1|Overall Study|Multiple Reasons|14
1533424|NCT00252733|5022858|P2|Overall Study|Lost to Follow-up|6
1533425|NCT00252733|5022859|P1|Overall Study|Lost to Follow-up|12
1533426|NCT00252733|5022858|P2|Overall Study|Death|5
1533427|NCT00252733|5022859|P1|Overall Study|Death|7
1533428|NCT00252733|5022858|P2|Overall Study|Withdrawal by Subject|67
1533429|NCT00252733|5022859|P1|Overall Study|Withdrawal by Subject|73
1533430|NCT00252720|5022869|P2|Overall Study|Mainly patients lost to follow-up|18
1533431|NCT00252720|5022870|P1|Overall Study|Mainly patients lost to follow-up|7
1533432|NCT00252720|5022869|P2|Overall Study|Moving|42
1533433|NCT00252720|5022870|P1|Overall Study|Moving|23
1533434|NCT00252720|5022869|P2|Overall Study|Death|8
1533435|NCT00252720|5022870|P1|Overall Study|Death|7
1533436|NCT00252720|5022869|P2|Overall Study|Withdrawal by Subject|97
1533437|NCT00252720|5022870|P1|Overall Study|Withdrawal by Subject|95
1533438|NCT00252694|5022884|P2|Overall Study|Patient Moving|16
1533439|NCT00252694|5022885|P1|Overall Study|Patient Moving|17
1533440|NCT00252694|5022884|P2|Overall Study|Mostly Lost to Follow Up|13
1533441|NCT00252694|5022885|P1|Overall Study|Mostly Lost to Follow Up|8
1533442|NCT00252694|5022884|P2|Overall Study|Death|34
1533443|NCT00252694|5022885|P1|Overall Study|Death|36
1533444|NCT00252694|5022884|P2|Overall Study|Withdrawal by Subject|91
1533445|NCT00252694|5022885|P1|Overall Study|Withdrawal by Subject|83
1533446|NCT00252564|5022933|P2|Overall Study|Withdrawal by Subject|2
1533447|NCT00252564|5022934|P1|Overall Study|Withdrawal by Subject|0
1533448|NCT00252564|5022933|P2|Overall Study|Patient Request|5
1533449|NCT00252564|5022934|P1|Overall Study|Patient Request|4
1533450|NCT00252564|5022933|P2|Overall Study|Lost to Follow-up|0
1533451|NCT00252564|5022934|P1|Overall Study|Lost to Follow-up|1
1533452|NCT00252564|5022933|P2|Overall Study|Physician Decision|0
1533453|NCT00252564|5022934|P1|Overall Study|Physician Decision|1
1533454|NCT00252564|5022933|P2|Overall Study|Protocol Violation|0
1533455|NCT00252564|5022934|P1|Overall Study|Protocol Violation|0
1533456|NCT00252564|5022933|P2|Overall Study|Death|3
1533457|NCT00252564|5022934|P1|Overall Study|Death|0
1533458|NCT00252564|5022933|P2|Overall Study|Disease Progression|20
1533459|NCT00252564|5022934|P1|Overall Study|Disease Progression|14
1533460|NCT00252564|5022933|P2|Overall Study|Unrelated Complication|1
1533461|NCT00252564|5022934|P1|Overall Study|Unrelated Complication|2
1533462|NCT00252564|5022933|P2|Overall Study|Adverse Event|13
1533463|NCT00252564|5022934|P1|Overall Study|Adverse Event|17
1533464|NCT00252499|5022974|P3|Overall Study|Lost to Follow-up|0
1533465|NCT00252499|5022975|P2|Overall Study|Lost to Follow-up|0
1533466|NCT00252499|5022976|P1|Overall Study|Lost to Follow-up|1
1533467|NCT00252239|5023008|P4|Overall Study|Lost to Follow-up|0
1533468|NCT00252239|5023009|P3|Overall Study|Lost to Follow-up|2
1533469|NCT00252239|5023010|P2|Overall Study|Lost to Follow-up|0
1533470|NCT00252239|5023011|P1|Overall Study|Lost to Follow-up|0
1533471|NCT00252239|5023008|P4|Overall Study|Withdrawal by Subject|1
1533472|NCT00252239|5023009|P3|Overall Study|Withdrawal by Subject|0
1533473|NCT00252239|5023010|P2|Overall Study|Withdrawal by Subject|0
1533474|NCT00252239|5023011|P1|Overall Study|Withdrawal by Subject|1
1533475|NCT00252187|5023023|P2|Overall Study|Withdrawal by Subject|0
1533476|NCT00252187|5023024|P1|Overall Study|Withdrawal by Subject|1
1533477|NCT00252187|5023023|P2|Overall Study|Adverse Event|1
1533478|NCT00252187|5023024|P1|Overall Study|Adverse Event|3
1533479|NCT00252174|5023047|P3|Overall Study|Withdrawal by Subject|0
1533480|NCT00252174|5023048|P2|Overall Study|Withdrawal by Subject|1
1533481|NCT00252174|5023049|P1|Overall Study|Withdrawal by Subject|0
1533482|NCT00252057|5023089|P2|Overall Study|Participant previously enrolled|1
1533483|NCT00252057|5023090|P1|Overall Study|Participant previously enrolled|0
1533484|NCT00252057|5023089|P2|Overall Study|Death|2
1533485|NCT00252057|5023090|P1|Overall Study|Death|1
1533486|NCT00252057|5023089|P2|Overall Study|Withdrawal by Subject|5
1533487|NCT00252057|5023090|P1|Overall Study|Withdrawal by Subject|2
1533488|NCT00251979|5023098|P2|Overall Study|Death|5
1533489|NCT00251979|5023099|P1|Overall Study|Death|3
1533490|NCT00251979|5023098|P2|Overall Study|Lost to Follow-up|6
1533491|NCT00251979|5023099|P1|Overall Study|Lost to Follow-up|8
1533492|NCT00251979|5023098|P2|Overall Study|Withdrawal by Subject|7
1533493|NCT00251979|5023099|P1|Overall Study|Withdrawal by Subject|13
1533494|NCT00251979|5023098|P2|Overall Study|Adverse Event|17
1533495|NCT00251979|5023099|P1|Overall Study|Adverse Event|11
1533496|NCT00251979|5023098|P2|Overall Study|Protocol Violation|5
1533497|NCT00251979|5023099|P1|Overall Study|Protocol Violation|3
1533498|NCT00251927|5023131|P2|Overall Study|Study procedure non-compliance|6
1533499|NCT00251927|5023132|P1|Overall Study|Study procedure non-compliance|5
1533500|NCT00251927|5023131|P2|Overall Study|Study-specific discont. achieved|2
1533501|NCT00251927|5023132|P1|Overall Study|Study-specific discont. achieved|13
1533502|NCT00251927|5023131|P2|Overall Study|Withdrawal by Subject|25
1533503|NCT00251927|5023132|P1|Overall Study|Withdrawal by Subject|40
1533504|NCT00251927|5023131|P2|Overall Study|Pregnancy|0
1533505|NCT00251927|5023132|P1|Overall Study|Pregnancy|2
1533506|NCT00251927|5023131|P2|Overall Study|Protocol Violation|2
1533507|NCT00251927|5023132|P1|Overall Study|Protocol Violation|1
1533508|NCT00251927|5023131|P2|Overall Study|Lost to Follow-up|8
1533509|NCT00251927|5023132|P1|Overall Study|Lost to Follow-up|22
1533510|NCT00251927|5023131|P2|Overall Study|Lack of Efficacy|16
1533511|NCT00251927|5023132|P1|Overall Study|Lack of Efficacy|22
1533512|NCT00251927|5023131|P2|Overall Study|Adverse Event|15
1533513|NCT00251927|5023132|P1|Overall Study|Adverse Event|3
1533514|NCT00251758|5023184|P3|Overall Study|Per Investigator Request|0
1533515|NCT00251758|5023185|P2|Overall Study|Per Investigator Request|0
1533516|NCT00251758|5023186|P1|Overall Study|Per Investigator Request|1
1533517|NCT00251758|5023184|P3|Overall Study|Per Subject Request|1
1533518|NCT00251758|5023185|P2|Overall Study|Per Subject Request|0
1533519|NCT00251758|5023186|P1|Overall Study|Per Subject Request|0
1533520|NCT00251758|5023184|P3|Overall Study|Pregnancy|0
1533521|NCT00251758|5023185|P2|Overall Study|Pregnancy|1
1533522|NCT00251758|5023186|P1|Overall Study|Pregnancy|0
1533523|NCT00251758|5023184|P3|Overall Study|Noncompliant|2
1533524|NCT00251758|5023185|P2|Overall Study|Noncompliant|2
1533525|NCT00251758|5023186|P1|Overall Study|Noncompliant|0
1533526|NCT00251758|5023184|P3|Overall Study|Lack of Efficacy|0
1533527|NCT00251758|5023185|P2|Overall Study|Lack of Efficacy|0
1533528|NCT00251758|5023186|P1|Overall Study|Lack of Efficacy|3
1533529|NCT00251758|5023184|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
1533530|NCT00251758|5023185|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
1533531|NCT00251758|5023186|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1533532|NCT00251758|5023184|P3|Overall Study|Withdrawal by Subject|3
1533533|NCT00251758|5023185|P2|Overall Study|Withdrawal by Subject|7
1533534|NCT00251758|5023186|P1|Overall Study|Withdrawal by Subject|13
1533535|NCT00251758|5023184|P3|Overall Study|Lost to Follow-up|5
1533536|NCT00251758|5023185|P2|Overall Study|Lost to Follow-up|2
1533537|NCT00251758|5023186|P1|Overall Study|Lost to Follow-up|4
1533538|NCT00251758|5023184|P3|Overall Study|Adverse Event|11
1533539|NCT00251758|5023185|P2|Overall Study|Adverse Event|9
1533540|NCT00251758|5023186|P1|Overall Study|Adverse Event|7
1533541|NCT00251745|5023206|P3|Overall Study|Per Investigator Request|0
1533542|NCT00251745|5023207|P2|Overall Study|Per Investigator Request|0
1533543|NCT00251745|5023208|P1|Overall Study|Per Investigator Request|1
1533544|NCT00251745|5023206|P3|Overall Study|Per Subject Request|1
1533545|NCT00251745|5023207|P2|Overall Study|Per Subject Request|0
1533546|NCT00251745|5023208|P1|Overall Study|Per Subject Request|0
1533547|NCT00251745|5023206|P3|Overall Study|Pregnancy|0
1533548|NCT00251745|5023207|P2|Overall Study|Pregnancy|1
1533549|NCT00251745|5023208|P1|Overall Study|Pregnancy|0
1533550|NCT00251745|5023206|P3|Overall Study|Noncompliant|2
1533551|NCT00251745|5023207|P2|Overall Study|Noncompliant|2
1533552|NCT00251745|5023208|P1|Overall Study|Noncompliant|0
1533553|NCT00251745|5023206|P3|Overall Study|Lack of Efficacy|0
1533554|NCT00251745|5023207|P2|Overall Study|Lack of Efficacy|0
1533555|NCT00251745|5023208|P1|Overall Study|Lack of Efficacy|3
1533556|NCT00251745|5023206|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
1533557|NCT00251745|5023207|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
1533558|NCT00251745|5023208|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1533559|NCT00251745|5023206|P3|Overall Study|Withdrawal by Subject|3
1533560|NCT00251745|5023207|P2|Overall Study|Withdrawal by Subject|7
1533561|NCT00251745|5023208|P1|Overall Study|Withdrawal by Subject|13
1533562|NCT00251745|5023206|P3|Overall Study|Lost to Follow-up|5
1533563|NCT00251745|5023207|P2|Overall Study|Lost to Follow-up|2
1533564|NCT00251745|5023208|P1|Overall Study|Lost to Follow-up|4
1533565|NCT00251745|5023206|P3|Overall Study|Adverse Event|11
1533566|NCT00251745|5023207|P2|Overall Study|Adverse Event|9
1533567|NCT00251745|5023208|P1|Overall Study|Adverse Event|7
1533568|NCT00251719|5023228|P3|Overall Study|Barrett's esophagus|0
1533569|NCT00251719|5023229|P2|Overall Study|Barrett's esophagus|2
1533570|NCT00251719|5023230|P1|Overall Study|Barrett's esophagus|2
1533571|NCT00251719|5023228|P3|Overall Study|Noncompliance|1
1533572|NCT00251719|5023229|P2|Overall Study|Noncompliance|3
1533573|NCT00251719|5023230|P1|Overall Study|Noncompliance|2
1533574|NCT00251719|5023228|P3|Overall Study|Investigator decision|0
1533575|NCT00251719|5023229|P2|Overall Study|Investigator decision|1
1533576|NCT00251719|5023230|P1|Overall Study|Investigator decision|1
1533577|NCT00251719|5023228|P3|Overall Study|Inclusion/exclusion criteria not met|2
1533578|NCT00251719|5023229|P2|Overall Study|Inclusion/exclusion criteria not met|6
1533579|NCT00251719|5023230|P1|Overall Study|Inclusion/exclusion criteria not met|12
1533580|NCT00251719|5023228|P3|Overall Study|Lack of Efficacy|0
1533581|NCT00251719|5023229|P2|Overall Study|Lack of Efficacy|1
1533582|NCT00251719|5023230|P1|Overall Study|Lack of Efficacy|2
1533583|NCT00251719|5023228|P3|Overall Study|Withdrawal by Subject|11
1533584|NCT00251719|5023229|P2|Overall Study|Withdrawal by Subject|12
1533585|NCT00251719|5023230|P1|Overall Study|Withdrawal by Subject|14
1533586|NCT00251719|5023228|P3|Overall Study|Lost to Follow-up|8
1533587|NCT00251719|5023229|P2|Overall Study|Lost to Follow-up|11
1533588|NCT00251719|5023230|P1|Overall Study|Lost to Follow-up|5
1533589|NCT00251719|5023228|P3|Overall Study|Protocol Violation|1
1533590|NCT00251719|5023229|P2|Overall Study|Protocol Violation|1
1533591|NCT00251719|5023230|P1|Overall Study|Protocol Violation|1
1533592|NCT00251719|5023228|P3|Overall Study|Adverse Event|7
1533593|NCT00251719|5023229|P2|Overall Study|Adverse Event|8
1533594|NCT00251719|5023230|P1|Overall Study|Adverse Event|14
1533595|NCT00251693|5023256|P3|Overall Study|Abnormal laboratory findings|1
1533596|NCT00251693|5023257|P2|Overall Study|Abnormal laboratory findings|0
1533597|NCT00251693|5023258|P1|Overall Study|Abnormal laboratory findings|0
1533598|NCT00251693|5023256|P3|Overall Study|Subject request/subject unavailable|0
1533599|NCT00251693|5023257|P2|Overall Study|Subject request/subject unavailable|2
1533600|NCT00251693|5023258|P1|Overall Study|Subject request/subject unavailable|1
1533601|NCT00251693|5023256|P3|Overall Study|Possible Barrett's esophagus|2
1533602|NCT00251693|5023257|P2|Overall Study|Possible Barrett's esophagus|5
1533603|NCT00251693|5023258|P1|Overall Study|Possible Barrett's esophagus|3
1533604|NCT00251693|5023256|P3|Overall Study|Noncompliant|2
1533605|NCT00251693|5023257|P2|Overall Study|Noncompliant|0
1533606|NCT00251693|5023258|P1|Overall Study|Noncompliant|0
1533607|NCT00251693|5023256|P3|Overall Study|Inclusion/exclusion criteria not met|8
1533608|NCT00251693|5023257|P2|Overall Study|Inclusion/exclusion criteria not met|3
1533609|NCT00251693|5023258|P1|Overall Study|Inclusion/exclusion criteria not met|5
1533610|NCT00251693|5023256|P3|Overall Study|Lack of Efficacy|0
1533611|NCT00251693|5023257|P2|Overall Study|Lack of Efficacy|1
1533612|NCT00251693|5023258|P1|Overall Study|Lack of Efficacy|0
1533613|NCT00251693|5023256|P3|Overall Study|Withdrawal by Subject|14
1533614|NCT00251693|5023257|P2|Overall Study|Withdrawal by Subject|17
1533615|NCT00251693|5023258|P1|Overall Study|Withdrawal by Subject|11
1533616|NCT00251693|5023256|P3|Overall Study|Lost to Follow-up|8
1533617|NCT00251693|5023257|P2|Overall Study|Lost to Follow-up|7
1533618|NCT00251693|5023258|P1|Overall Study|Lost to Follow-up|12
1533619|NCT00251693|5023256|P3|Overall Study|Protocol Violation|2
1533620|NCT00251693|5023257|P2|Overall Study|Protocol Violation|0
1533621|NCT00251693|5023258|P1|Overall Study|Protocol Violation|2
1533622|NCT00251693|5023256|P3|Overall Study|Adverse Event|9
1533623|NCT00251693|5023257|P2|Overall Study|Adverse Event|9
1533624|NCT00251693|5023258|P1|Overall Study|Adverse Event|17
1533625|NCT00251641|5023283|P2|Overall Study|Switched Treatment|63
1533626|NCT00251641|5023284|P1|Overall Study|Switched Treatment|9
1533627|NCT00251641|5023283|P2|Overall Study|Did not Meet protocol Eligibility|1
1533628|NCT00251641|5023284|P1|Overall Study|Did not Meet protocol Eligibility|2
1533629|NCT00251641|5023283|P2|Overall Study|Protocol Violation|2
1533630|NCT00251641|5023284|P1|Overall Study|Protocol Violation|10
1533631|NCT00251641|5023283|P2|Overall Study|Withdrawal by Subject|8
1533632|NCT00251641|5023284|P1|Overall Study|Withdrawal by Subject|6
1533633|NCT00251641|5023283|P2|Overall Study|Lost to Follow-up|3
1533634|NCT00251641|5023284|P1|Overall Study|Lost to Follow-up|3
1533635|NCT00251641|5023283|P2|Overall Study|Progression of Disease|2
1533636|NCT00251641|5023284|P1|Overall Study|Progression of Disease|0
1533637|NCT00251641|5023283|P2|Overall Study|Lack of Efficacy|1
1533638|NCT00251641|5023284|P1|Overall Study|Lack of Efficacy|2
1533639|NCT00251641|5023283|P2|Overall Study|Adverse Event|8
1533640|NCT00251641|5023284|P1|Overall Study|Adverse Event|80
1533641|NCT00251589|5023302|P4|Overall Study|Discontinued due to progressive disease|1
1533642|NCT00251589|5023303|P3|Overall Study|Discontinued due to progressive disease|0
1533643|NCT00251589|5023304|P2|Overall Study|Discontinued due to progressive disease|1
1533644|NCT00251589|5023305|P1|Overall Study|Discontinued due to progressive disease|9
1533645|NCT00251589|5023302|P4|Overall Study|Withdrawal by Subject|0
1533646|NCT00251589|5023303|P3|Overall Study|Withdrawal by Subject|0
1533647|NCT00251589|5023304|P2|Overall Study|Withdrawal by Subject|1
1533648|NCT00251589|5023305|P1|Overall Study|Withdrawal by Subject|1
1533649|NCT00251589|5023302|P4|Overall Study|Adverse Event|1
1533650|NCT00251589|5023303|P3|Overall Study|Adverse Event|2
1533651|NCT00251589|5023304|P2|Overall Study|Adverse Event|1
1533652|NCT00251589|5023305|P1|Overall Study|Adverse Event|5
1533653|NCT00251316|5023342|P2|Overall Study|Physician Decision|3
1533654|NCT00251316|5023343|P1|Overall Study|Physician Decision|2
1533655|NCT00251004|5023382|P3|Overall Study|Graft Loss|8
1533656|NCT00251004|5023383|P2|Overall Study|Graft Loss|13
1533657|NCT00251004|5023384|P1|Overall Study|Graft Loss|12
1533658|NCT00251004|5023382|P3|Overall Study|Lost to Follow-up|1
1533659|NCT00251004|5023383|P2|Overall Study|Lost to Follow-up|2
1533660|NCT00251004|5023384|P1|Overall Study|Lost to Follow-up|1
1533661|NCT00251004|5023382|P3|Overall Study|Death|8
1533662|NCT00251004|5023383|P2|Overall Study|Death|10
1533663|NCT00251004|5023384|P1|Overall Study|Death|9
1533664|NCT00251004|5023382|P3|Overall Study|Withdrawal by Subject|14
1533665|NCT00251004|5023383|P2|Overall Study|Withdrawal by Subject|16
1533666|NCT00251004|5023384|P1|Overall Study|Withdrawal by Subject|23
1533667|NCT00250835|5023408|P1|Overall Study|Withdrawal by Subject|1
1533668|NCT00250718|5023417|P1|Overall Study|Withdrawal by Subject|1
1533669|NCT00250718|5023417|P1|Overall Study|Adverse Event|1
1533670|NCT00250718|5023417|P1|Overall Study|Death|1
1533671|NCT00250705|5023422|P1|Overall Study|Lack of Efficacy|2
1533672|NCT00250679|5023433|P3|Overall Study|various single events: hip surgery,diary|1
1533673|NCT00250679|5023434|P2|Overall Study|various single events: hip surgery,diary|1
1533674|NCT00250679|5023435|P1|Overall Study|various single events: hip surgery,diary|3
1533675|NCT00250679|5023433|P3|Overall Study|Non-compliance|0
1533676|NCT00250679|5023434|P2|Overall Study|Non-compliance|1
1533677|NCT00250679|5023435|P1|Overall Study|Non-compliance|1
1533678|NCT00250679|5023433|P3|Overall Study|Moved|0
1533679|NCT00250679|5023434|P2|Overall Study|Moved|1
1533680|NCT00250679|5023435|P1|Overall Study|Moved|1
1533681|NCT00250679|5023433|P3|Overall Study|Technical Holter issues|2
1533682|NCT00250679|5023434|P2|Overall Study|Technical Holter issues|0
1533683|NCT00250679|5023435|P1|Overall Study|Technical Holter issues|1
1533684|NCT00250679|5023433|P3|Overall Study|Lack of Efficacy|3
1533685|NCT00250679|5023434|P2|Overall Study|Lack of Efficacy|1
1533686|NCT00250679|5023435|P1|Overall Study|Lack of Efficacy|0
1533687|NCT00250679|5023433|P3|Overall Study|Does Not Meet Entry Criteria|2
1533688|NCT00250679|5023434|P2|Overall Study|Does Not Meet Entry Criteria|4
1533689|NCT00250679|5023435|P1|Overall Study|Does Not Meet Entry Criteria|1
1533690|NCT00250679|5023433|P3|Overall Study|Lost to Follow-up|2
1533691|NCT00250679|5023434|P2|Overall Study|Lost to Follow-up|4
1533692|NCT00250679|5023435|P1|Overall Study|Lost to Follow-up|3
1533693|NCT00250679|5023433|P3|Overall Study|Withdrawal by Subject|15
1533694|NCT00250679|5023434|P2|Overall Study|Withdrawal by Subject|18
1533695|NCT00250679|5023435|P1|Overall Study|Withdrawal by Subject|15
1533696|NCT00250679|5023433|P3|Overall Study|Protocol Violation|3
1533697|NCT00250679|5023434|P2|Overall Study|Protocol Violation|4
1533698|NCT00250679|5023435|P1|Overall Study|Protocol Violation|2
1533699|NCT00250679|5023433|P3|Overall Study|Adverse Event|16
1533700|NCT00250679|5023434|P2|Overall Study|Adverse Event|15
1533701|NCT00250679|5023435|P1|Overall Study|Adverse Event|12
1533702|NCT00250588|5023536|P3|Overall Study|Lost to Follow-up|13
1533703|NCT00250588|5023537|P2|Overall Study|Lost to Follow-up|13
1533704|NCT00250588|5023538|P1|Overall Study|Lost to Follow-up|6
1533705|NCT00250588|5023536|P3|Overall Study|Withdrawal by Subject|0
1533706|NCT00250588|5023537|P2|Overall Study|Withdrawal by Subject|6
1533707|NCT00250588|5023538|P1|Overall Study|Withdrawal by Subject|3
1533708|NCT00250458|5023586|P2|Overall Study|Not Specified|0
1533709|NCT00250458|5023587|P1|Overall Study|Not Specified|1
1533710|NCT00250458|5023586|P2|Overall Study|Qualifying migraine but did not treat|3
1533711|NCT00250458|5023587|P1|Overall Study|Qualifying migraine but did not treat|3
1533712|NCT00250458|5023586|P2|Overall Study|Lack of Migraine Attack|9
1533713|NCT00250458|5023587|P1|Overall Study|Lack of Migraine Attack|20
1533714|NCT00250458|5023586|P2|Overall Study|Withdrawal by Subject|2
1533715|NCT00250458|5023587|P1|Overall Study|Withdrawal by Subject|4
1533716|NCT00250458|5023586|P2|Overall Study|Protocol Violation|1
1533717|NCT00250458|5023587|P1|Overall Study|Protocol Violation|0
1533718|NCT00250458|5023586|P2|Overall Study|Lost to Follow-up|2
1533719|NCT00250458|5023587|P1|Overall Study|Lost to Follow-up|4
1533720|NCT00250432|5023597|P2|Overall Study|Pt was considered untreatable|1
1533721|NCT00250432|5023598|P1|Overall Study|Pt was considered untreatable|0
1533722|NCT00250432|5023597|P2|Overall Study|Pt died out of posttherapy report period|5
1533723|NCT00250432|5023598|P1|Overall Study|Pt died out of posttherapy report period|6
1533724|NCT00250432|5023597|P2|Overall Study|Withdrawal by Subject|2
1533725|NCT00250432|5023598|P1|Overall Study|Withdrawal by Subject|6
1533726|NCT00250432|5023597|P2|Overall Study|Protocol Violation|3
1533727|NCT00250432|5023598|P1|Overall Study|Protocol Violation|0
1533728|NCT00250432|5023597|P2|Overall Study|Patient Moved|1
1533729|NCT00250432|5023598|P1|Overall Study|Patient Moved|0
1533730|NCT00250432|5023597|P2|Overall Study|Lost to Follow-up|5
1533731|NCT00250432|5023598|P1|Overall Study|Lost to Follow-up|6
1533732|NCT00250432|5023597|P2|Overall Study|Lack of Efficacy|1
1533733|NCT00250432|5023598|P1|Overall Study|Lack of Efficacy|2
1533734|NCT00250432|5023597|P2|Overall Study|Adverse Event|29
1533735|NCT00250432|5023598|P1|Overall Study|Adverse Event|25
1533736|NCT00250276|5023610|P4|Overall Study|Lost to Follow-up|8
1533737|NCT00250276|5023611|P3|Overall Study|Lost to Follow-up|13
1533738|NCT00250276|5023612|P2|Overall Study|Lost to Follow-up|18
1533739|NCT00250276|5023613|P1|Overall Study|Lost to Follow-up|11
1533740|NCT00250276|5023610|P4|Overall Study|Migrated/moved from study area|7
1533741|NCT00250276|5023611|P3|Overall Study|Migrated/moved from study area|2
1533742|NCT00250276|5023612|P2|Overall Study|Migrated/moved from study area|0
1533743|NCT00250276|5023613|P1|Overall Study|Migrated/moved from study area|3
1533744|NCT00250276|5023610|P4|Overall Study|Withdrawal by Subject|2
1533745|NCT00250276|5023611|P3|Overall Study|Withdrawal by Subject|3
1533746|NCT00250276|5023612|P2|Overall Study|Withdrawal by Subject|2
1533747|NCT00250276|5023613|P1|Overall Study|Withdrawal by Subject|1
1533748|NCT00250276|5023610|P4|Overall Study|Protocol Violation|0
1533749|NCT00250276|5023611|P3|Overall Study|Protocol Violation|0
1533750|NCT00250276|5023612|P2|Overall Study|Protocol Violation|1
1533751|NCT00250276|5023613|P1|Overall Study|Protocol Violation|0
1533752|NCT00250276|5023610|P4|Overall Study|Non-serious Adverse Event|2
1533753|NCT00250276|5023611|P3|Overall Study|Non-serious Adverse Event|0
1533754|NCT00250276|5023612|P2|Overall Study|Non-serious Adverse Event|0
1533755|NCT00250276|5023613|P1|Overall Study|Non-serious Adverse Event|2
1533756|NCT00250276|5023610|P4|Overall Study|Serious Adverse Event|0
1533757|NCT00250276|5023611|P3|Overall Study|Serious Adverse Event|1
1533758|NCT00250276|5023612|P2|Overall Study|Serious Adverse Event|0
1533759|NCT00250276|5023613|P1|Overall Study|Serious Adverse Event|0
1533760|NCT00249873|5023693|P2|Overall Study|Thromboembolic/outcome event|122
1533761|NCT00249873|5023694|P1|Overall Study|Thromboembolic/outcome event|82
1533762|NCT00249873|5023693|P2|Overall Study|Event related to cardiac condition|21
1533763|NCT00249873|5023694|P1|Overall Study|Event related to cardiac condition|12
1533764|NCT00249873|5023693|P2|Overall Study|Surgery/ procedure|9
1533765|NCT00249873|5023694|P1|Overall Study|Surgery/ procedure|9
1533766|NCT00249873|5023693|P2|Overall Study|Study drug intolerance|0
1533767|NCT00249873|5023694|P1|Overall Study|Study drug intolerance|5
1533768|NCT00249873|5023693|P2|Overall Study|Oral anticoagulant required|157
1533769|NCT00249873|5023694|P1|Overall Study|Oral anticoagulant required|159
1533770|NCT00249873|5023693|P2|Overall Study|Angiotensin II receptor blocker required|0
1533771|NCT00249873|5023694|P1|Overall Study|Angiotensin II receptor blocker required|1
1533772|NCT00249873|5023693|P2|Overall Study|Open label clopidogrel required|42
1533773|NCT00249873|5023694|P1|Overall Study|Open label clopidogrel required|31
1533774|NCT00249873|5023693|P2|Overall Study|Physician withdrew consent|60
1533775|NCT00249873|5023694|P1|Overall Study|Physician withdrew consent|59
1533776|NCT00249873|5023693|P2|Overall Study|Patient not wish to continue after May08|4
1533777|NCT00249873|5023694|P1|Overall Study|Patient not wish to continue after May08|3
1533778|NCT00249873|5023693|P2|Overall Study|Other contraindicated medication|0
1533779|NCT00249873|5023694|P1|Overall Study|Other contraindicated medication|1
1533780|NCT00249873|5023693|P2|Overall Study|Other non serious Adverse Event|108
1533781|NCT00249873|5023694|P1|Overall Study|Other non serious Adverse Event|112
1533782|NCT00249873|5023693|P2|Overall Study|Non-compliance|46
1533783|NCT00249873|5023694|P1|Overall Study|Non-compliance|41
1533784|NCT00249873|5023693|P2|Overall Study|Minor bleeding|37
1533785|NCT00249873|5023694|P1|Overall Study|Minor bleeding|99
1533786|NCT00249873|5023693|P2|Overall Study|Lost to Follow-up|7
1533787|NCT00249873|5023694|P1|Overall Study|Lost to Follow-up|4
1533788|NCT00249873|5023693|P2|Overall Study|Withdrawal by Subject|466
1533789|NCT00249873|5023694|P1|Overall Study|Withdrawal by Subject|504
1533790|NCT00249873|5023693|P2|Overall Study|Contraindication to oral anticoagulant|8
1533791|NCT00249873|5023694|P1|Overall Study|Contraindication to oral anticoagulant|4
1533792|NCT00249873|5023693|P2|Overall Study|Qualifying condition not present|23
1533793|NCT00249873|5023694|P1|Overall Study|Qualifying condition not present|20
1533794|NCT00249873|5023693|P2|Overall Study|Other Serious Adverse Event|97
1533795|NCT00249873|5023694|P1|Overall Study|Other Serious Adverse Event|86
1533796|NCT00249873|5023693|P2|Overall Study|Serious haemorrhagic Adverse Event|30
1533797|NCT00249873|5023694|P1|Overall Study|Serious haemorrhagic Adverse Event|74
1533798|NCT00249873|5023693|P2|Overall Study|Severe allergic reaction|1
1533799|NCT00249873|5023694|P1|Overall Study|Severe allergic reaction|8
1533800|NCT00249873|5023693|P2|Overall Study|Significant thrombocytopenia|8
1533801|NCT00249873|5023694|P1|Overall Study|Significant thrombocytopenia|9
1533802|NCT00249873|5023693|P2|Overall Study|Not treated|8
1533803|NCT00249873|5023694|P1|Overall Study|Not treated|7
1533804|NCT00249834|5023714|P8|Overall Study|Protocol Violation|0
1533805|NCT00249834|5023715|P7|Overall Study|Protocol Violation|0
1533806|NCT00249834|5023716|P6|Overall Study|Protocol Violation|2
1533807|NCT00249834|5023717|P5|Overall Study|Protocol Violation|5
1533808|NCT00249834|5023718|P4|Overall Study|Protocol Violation|8
1533809|NCT00249834|5023719|P3|Overall Study|Protocol Violation|14
1533810|NCT00249834|5023720|P2|Overall Study|Protocol Violation|19
1533811|NCT00249834|5023721|P1|Overall Study|Protocol Violation|0
1533812|NCT00249834|5023714|P8|Overall Study|Failure of down-regulation|0
1533813|NCT00249834|5023715|P7|Overall Study|Failure of down-regulation|1
1533814|NCT00249834|5023716|P6|Overall Study|Failure of down-regulation|0
1533815|NCT00249834|5023717|P5|Overall Study|Failure of down-regulation|0
1533816|NCT00249834|5023718|P4|Overall Study|Failure of down-regulation|0
1533817|NCT00249834|5023719|P3|Overall Study|Failure of down-regulation|0
1533818|NCT00249834|5023720|P2|Overall Study|Failure of down-regulation|0
1533819|NCT00249834|5023721|P1|Overall Study|Failure of down-regulation|0
1533820|NCT00249834|5023714|P8|Overall Study|Ovarian stimulation failed|0
1533821|NCT00249834|5023715|P7|Overall Study|Ovarian stimulation failed|0
1533822|NCT00249834|5023716|P6|Overall Study|Ovarian stimulation failed|0
1533823|NCT00249834|5023717|P5|Overall Study|Ovarian stimulation failed|0
1533824|NCT00249834|5023718|P4|Overall Study|Ovarian stimulation failed|0
1533825|NCT00249834|5023719|P3|Overall Study|Ovarian stimulation failed|0
1533826|NCT00249834|5023720|P2|Overall Study|Ovarian stimulation failed|0
1533827|NCT00249834|5023721|P1|Overall Study|Ovarian stimulation failed|1
1533828|NCT00249821|5023770|P2|Overall Study|Technical problem|1
1533829|NCT00249821|5023771|P1|Overall Study|Technical problem|0
1533830|NCT00249808|5023791|P1|Overall Study|Did Not Provide Post-Baseline Data|11
1533831|NCT00249808|5023791|P1|Overall Study|Lack of Efficacy|52
1533832|NCT00249808|5023791|P1|Overall Study|Adverse Event|81
1533833|NCT00249808|5023791|P1|Overall Study|Lost to Follow-up|8
1533834|NCT00249808|5023791|P1|Overall Study|Protocol Violation|3
1533835|NCT00249808|5023791|P1|Overall Study|Other|27
1533836|NCT00249795|5023799|P2|Overall Study|Missing|1
1533837|NCT00249795|5023800|P1|Overall Study|Missing|0
1533838|NCT00249795|5023799|P2|Overall Study|Lost to Follow-up|2
1533839|NCT00249795|5023800|P1|Overall Study|Lost to Follow-up|0
1533840|NCT00249795|5023799|P2|Overall Study|Site not agree to continue after May08|1
1533841|NCT00249795|5023800|P1|Overall Study|Site not agree to continue after May08|1
1533842|NCT00249795|5023799|P2|Overall Study|Patient not wish to continue after May08|6
1533843|NCT00249795|5023800|P1|Overall Study|Patient not wish to continue after May08|4
1533844|NCT00249795|5023799|P2|Overall Study|Event related to cardiac condition|16
1533845|NCT00249795|5023800|P1|Overall Study|Event related to cardiac condition|17
1533846|NCT00249795|5023799|P2|Overall Study|Other contraindicated medication|1
1533847|NCT00249795|5023800|P1|Overall Study|Other contraindicated medication|1
1533848|NCT00249795|5023799|P2|Overall Study|Hypotension (non-symptomatic)|5
1533849|NCT00249795|5023800|P1|Overall Study|Hypotension (non-symptomatic)|5
1533850|NCT00249795|5023799|P2|Overall Study|Lightheadedness / dizziness|11
1533851|NCT00249795|5023800|P1|Overall Study|Lightheadedness / dizziness|15
1533852|NCT00249795|5023799|P2|Overall Study|Angiotensin II receptor blocker required|58
1533853|NCT00249795|5023800|P1|Overall Study|Angiotensin II receptor blocker required|35
1533854|NCT00249795|5023799|P2|Overall Study|Surgery / procedure|5
1533855|NCT00249795|5023800|P1|Overall Study|Surgery / procedure|4
1533856|NCT00249795|5023799|P2|Overall Study|Physician withdrew consent|63
1533857|NCT00249795|5023800|P1|Overall Study|Physician withdrew consent|71
1533858|NCT00249795|5023799|P2|Overall Study|Other adverse events (non-serious)|159
1533859|NCT00249795|5023800|P1|Overall Study|Other adverse events (non-serious)|188
1533860|NCT00249795|5023799|P2|Overall Study|Study drug intolerance|3
1533861|NCT00249795|5023800|P1|Overall Study|Study drug intolerance|3
1533862|NCT00249795|5023799|P2|Overall Study|Non-compliance|69
1533863|NCT00249795|5023800|P1|Overall Study|Non-compliance|71
1533864|NCT00249795|5023799|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
1533865|NCT00249795|5023800|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
1533866|NCT00249795|5023799|P2|Overall Study|Oral anticoagulant required|0
1533867|NCT00249795|5023800|P1|Overall Study|Oral anticoagulant required|2
1533868|NCT00249795|5023799|P2|Overall Study|Thromboembolic / outcome event|45
1533869|NCT00249795|5023800|P1|Overall Study|Thromboembolic / outcome event|39
1533870|NCT00249795|5023799|P2|Overall Study|Withdrawal by Subject|742
1533871|NCT00249795|5023800|P1|Overall Study|Withdrawal by Subject|678
1533872|NCT00249795|5023799|P2|Overall Study|Qualifying condition not present|29
1533873|NCT00249795|5023800|P1|Overall Study|Qualifying condition not present|26
1533874|NCT00249795|5023799|P2|Overall Study|Other Serious Adverse Event|93
1533875|NCT00249795|5023800|P1|Overall Study|Other Serious Adverse Event|84
1533876|NCT00249795|5023799|P2|Overall Study|Symptomatic hypotension|64
1533877|NCT00249795|5023800|P1|Overall Study|Symptomatic hypotension|127
1533878|NCT00249795|5023799|P2|Overall Study|Not treated|14
1533879|NCT00249795|5023800|P1|Overall Study|Not treated|16
1533880|NCT00249613|5023820|P2|12 Month Follow-up|Lost to Follow-up|8
1533881|NCT00249613|5023821|P1|12 Month Follow-up|Lost to Follow-up|10
1533882|NCT00249613|5023820|P2|12 Month Follow-up|Withdrawal by Subject|6
1533883|NCT00249613|5023821|P1|12 Month Follow-up|Withdrawal by Subject|6
1533884|NCT00249613|5023820|P2|12 Month Follow-up|Death|1
1533885|NCT00249613|5023821|P1|12 Month Follow-up|Death|1
1533886|NCT00249444|5023862|P2|Overall Study|life event|1
1533887|NCT00249444|5023863|P1|Overall Study|life event|0
1533888|NCT00249444|5023862|P2|Overall Study|Adverse Event|1
1533889|NCT00249444|5023863|P1|Overall Study|Adverse Event|1
1533890|NCT00249444|5023862|P2|Overall Study|non-compliant|11
1533891|NCT00249444|5023863|P1|Overall Study|non-compliant|9
1533892|NCT00249444|5023862|P2|Overall Study|Lost to Follow-up|2
1533893|NCT00249444|5023863|P1|Overall Study|Lost to Follow-up|2
1533894|NCT00249288|5023888|P2|Overall Study|Withdrawal by Subject|2
1533895|NCT00249288|5023889|P1|Overall Study|Withdrawal by Subject|2
1533896|NCT00249288|5023888|P2|Overall Study|Lost to Follow-up|3
1533897|NCT00249288|5023889|P1|Overall Study|Lost to Follow-up|3
1533898|NCT00249002|5023981|P1|Overall Study|Other|2
1533899|NCT00249002|5023981|P1|Overall Study|Study cancellation|3
1533900|NCT00249002|5023981|P1|Overall Study|Adverse Event|2
1533901|NCT00248794|5024017|P3|Overall Study|Lost to Follow-up|3
1533902|NCT00248794|5024018|P2|Overall Study|Lost to Follow-up|8
1533903|NCT00248794|5024019|P1|Overall Study|Lost to Follow-up|6
1533904|NCT00248651|5024069|P3|Overall Study|Withdrawal by Subject|32
1533905|NCT00248651|5024070|P2|Overall Study|Withdrawal by Subject|40
1533906|NCT00248651|5024071|P1|Overall Study|Withdrawal by Subject|28
1533907|NCT00248625|5024107|P2|Overall Study|Withdrawal by Subject|2
1533908|NCT00248625|5024108|P1|Overall Study|Withdrawal by Subject|0
1533909|NCT00248495|5024190|P1|Overall Study|Withdrawal by Subject|1
1533910|NCT00248287|5024201|P2|Overall Study|Other|2
1533911|NCT00248287|5024202|P1|Overall Study|Other|3
1533912|NCT00248287|5024201|P2|Overall Study|Patient Request|3
1533913|NCT00248287|5024202|P1|Overall Study|Patient Request|5
1533914|NCT00248287|5024201|P2|Overall Study|Investigator Request|3
1533915|NCT00248287|5024202|P1|Overall Study|Investigator Request|4
1533916|NCT00248287|5024201|P2|Overall Study|Lost to Follow-up|1
1533917|NCT00248287|5024202|P1|Overall Study|Lost to Follow-up|0
1533918|NCT00248287|5024201|P2|Overall Study|Death|0
1533919|NCT00248287|5024202|P1|Overall Study|Death|1
1533920|NCT00248287|5024201|P2|Overall Study|Adverse Event|10
1533921|NCT00248287|5024202|P1|Overall Study|Adverse Event|11
1533922|NCT00248170|5024216|P2|Overall Study|Protocol deviation|19
1533923|NCT00248170|5024217|P1|Overall Study|Protocol deviation|17
1533924|NCT00248170|5024216|P2|Overall Study|Abnormal laboratory values|0
1533925|NCT00248170|5024217|P1|Overall Study|Abnormal laboratory values|4
1533926|NCT00248170|5024216|P2|Overall Study|Abnormal test procedure(s) result|61
1533927|NCT00248170|5024217|P1|Overall Study|Abnormal test procedure(s) result|49
1533928|NCT00248170|5024216|P2|Overall Study|Administrative problems|25
1533929|NCT00248170|5024217|P1|Overall Study|Administrative problems|22
1533930|NCT00248170|5024216|P2|Overall Study|Adverse Event|296
1533931|NCT00248170|5024217|P1|Overall Study|Adverse Event|311
1533932|NCT00248170|5024216|P2|Overall Study|Death|47
1533933|NCT00248170|5024217|P1|Overall Study|Death|28
1533934|NCT00248170|5024216|P2|Overall Study|Disease progression|216
1533935|NCT00248170|5024217|P1|Overall Study|Disease progression|196
1533936|NCT00248170|5024216|P2|Overall Study|Lost to Follow-up|35
1533937|NCT00248170|5024217|P1|Overall Study|Lost to Follow-up|28
1533938|NCT00248170|5024216|P2|Overall Study|Protocol Violation|30
1533939|NCT00248170|5024217|P1|Overall Study|Protocol Violation|35
1533940|NCT00248170|5024216|P2|Overall Study|Withdrawal by Subject|79
1533941|NCT00248170|5024217|P1|Overall Study|Withdrawal by Subject|71
1533942|NCT00247962|5024239|P2|Overall Study|Lack of Efficacy|2
1533943|NCT00247962|5024240|P1|Overall Study|Lack of Efficacy|4
1533944|NCT00247962|5024239|P2|Overall Study|Withdrawal by Subject|2
1533945|NCT00247962|5024240|P1|Overall Study|Withdrawal by Subject|3
1533946|NCT00247962|5024239|P2|Overall Study|Protocol Violation|1
1533947|NCT00247962|5024240|P1|Overall Study|Protocol Violation|1
1533948|NCT00247962|5024239|P2|Overall Study|Physician Decision|1
1533949|NCT00247962|5024240|P1|Overall Study|Physician Decision|0
1533950|NCT00247962|5024239|P2|Overall Study|Lost to Follow-up|1
1533951|NCT00247962|5024240|P1|Overall Study|Lost to Follow-up|3
1533952|NCT00247962|5024239|P2|Overall Study|Adverse Event|12
1533953|NCT00247962|5024240|P1|Overall Study|Adverse Event|15
1533954|NCT00247676|5024248|P1|Overall Study|Withdrawal by Subject|2
1533955|NCT00247676|5024248|P1|Overall Study|Other|3
1533956|NCT00247676|5024248|P1|Overall Study|Lack of Efficacy|15
1533957|NCT00247676|5024248|P1|Overall Study|Adverse Event|11
1533958|NCT00247676|5024248|P1|Overall Study|Death|5
1533959|NCT00247611|5024293|P2|Baselined|Completed baseline only|8
1533960|NCT00247611|5024294|P1|Baselined|Completed baseline only|9
1533961|NCT00247611|5024293|P2|Baselined|Completed baseline, never placed on ARVs|5
1533962|NCT00247611|5024294|P1|Baselined|Completed baseline, never placed on ARVs|8
1533963|NCT00247416|5024312|P2|Overall Study|3 patients were found to be ineligible|2
1533964|NCT00247416|5024313|P1|Overall Study|3 patients were found to be ineligible|1
1533965|NCT00247273|5024354|P2|Overall Study|Did not take any study drug|0
1533966|NCT00247273|5024355|P1|Overall Study|Did not take any study drug|2
1533967|NCT00247273|5024354|P2|Overall Study|Withdrawal by Subject|47
1533968|NCT00247273|5024355|P1|Overall Study|Withdrawal by Subject|46
1533969|NCT00247273|5024354|P2|Overall Study|Lost to Follow-up|7
1533970|NCT00247273|5024355|P1|Overall Study|Lost to Follow-up|7
1533971|NCT00247273|5024354|P2|Overall Study|Physician Decision|3
1533972|NCT00247273|5024355|P1|Overall Study|Physician Decision|6
1533973|NCT00247273|5024354|P2|Overall Study|Adverse Event|80
1533974|NCT00247273|5024355|P1|Overall Study|Adverse Event|85
1533975|NCT00246805|5024401|P2|Phase 1|Lost to Follow-up|0
1533976|NCT00246805|5024402|P1|Phase 1|Lost to Follow-up|1
1533977|NCT00246753|5024408|P1|Overall Study|Unacceptable toxicity|2
1533978|NCT00246753|5024408|P1|Overall Study|Adverse Event|2
1533979|NCT00246753|5024408|P1|Overall Study|Physician Decision|2
1533980|NCT00246753|5024408|P1|Overall Study|Withdrawal by Subject|2
1533981|NCT00246740|5024416|P2|Initial Enrollment|Other|2
1533982|NCT00246740|5024417|P1|Initial Enrollment|Other|1
1533983|NCT00246740|5024416|P2|Initial Enrollment|Surgery schedule change|4
1533984|NCT00246740|5024417|P1|Initial Enrollment|Surgery schedule change|4
1533985|NCT00246740|5024416|P2|Initial Enrollment|Additional surgery scheduled|2
1533986|NCT00246740|5024417|P1|Initial Enrollment|Additional surgery scheduled|0
1533987|NCT00246740|5024416|P2|Initial Enrollment|Death|0
1533988|NCT00246740|5024417|P1|Initial Enrollment|Death|1
1533989|NCT00246571|5024441|P2|Overall Study|Crossover participants|74
1533990|NCT00246571|5024442|P1|Overall Study|Crossover participants|0
1533991|NCT00246571|5024441|P2|Overall Study|Laboratory abnormalities|0
1533992|NCT00246571|5024442|P1|Overall Study|Laboratory abnormalities|1
1533993|NCT00246571|5024441|P2|Overall Study|Did not meet entrance criteria|1
1533994|NCT00246571|5024442|P1|Overall Study|Did not meet entrance criteria|2
1533995|NCT00246571|5024441|P2|Overall Study|Sponsor|1
1533996|NCT00246571|5024442|P1|Overall Study|Sponsor|0
1533997|NCT00246571|5024441|P2|Overall Study|Death|3
1533998|NCT00246571|5024442|P1|Overall Study|Death|17
1533999|NCT00246571|5024441|P2|Overall Study|Lack of Efficacy|21
1534000|NCT00246571|5024442|P1|Overall Study|Lack of Efficacy|84
1534001|NCT00246571|5024441|P2|Overall Study|Withdrawal by Subject|3
1534002|NCT00246571|5024442|P1|Overall Study|Withdrawal by Subject|2
1534003|NCT00246571|5024441|P2|Overall Study|Protocol Violation|1
1534004|NCT00246571|5024442|P1|Overall Study|Protocol Violation|0
1534005|NCT00246571|5024441|P2|Overall Study|Adverse Event|0
1534006|NCT00246571|5024442|P1|Overall Study|Adverse Event|7
1534007|NCT00246376|5024494|P5|Overall Study|Lost to Follow-up|13
1534008|NCT00246376|5024495|P4|Overall Study|Lost to Follow-up|16
1534009|NCT00246376|5024496|P3|Overall Study|Lost to Follow-up|11
1534010|NCT00246376|5024497|P2|Overall Study|Lost to Follow-up|11
1534011|NCT00246376|5024498|P1|Overall Study|Lost to Follow-up|2
1534012|NCT00246376|5024494|P5|Overall Study|Adverse Event|1
1534013|NCT00246376|5024495|P4|Overall Study|Adverse Event|3
1534014|NCT00246376|5024496|P3|Overall Study|Adverse Event|1
1534015|NCT00246376|5024497|P2|Overall Study|Adverse Event|3
1534016|NCT00246376|5024498|P1|Overall Study|Adverse Event|2
1534017|NCT00246376|5024494|P5|Overall Study|Dropped/withdrew during dietary run-in|3
1534018|NCT00246376|5024495|P4|Overall Study|Dropped/withdrew during dietary run-in|7
1534019|NCT00246376|5024496|P3|Overall Study|Dropped/withdrew during dietary run-in|4
1534020|NCT00246376|5024497|P2|Overall Study|Dropped/withdrew during dietary run-in|5
1534021|NCT00246376|5024498|P1|Overall Study|Dropped/withdrew during dietary run-in|11
1534022|NCT00246337|5024549|P9|Overall Study|Reported as completing trial in error|0
1534023|NCT00246337|5024550|P8|Overall Study|Reported as completing trial in error|1
1534024|NCT00246337|5024551|P7|Overall Study|Reported as completing trial in error|0
1534025|NCT00246337|5024552|P6|Overall Study|Reported as completing trial in error|0
1534026|NCT00246337|5024553|P5|Overall Study|Reported as completing trial in error|0
1534027|NCT00246337|5024554|P4|Overall Study|Reported as completing trial in error|0
1534028|NCT00246337|5024555|P3|Overall Study|Reported as completing trial in error|0
1534029|NCT00246337|5024556|P2|Overall Study|Reported as completing trial in error|0
1534030|NCT00246337|5024557|P1|Overall Study|Reported as completing trial in error|0
1534031|NCT00246337|5024549|P9|Overall Study|Protocol Violator|0
1534032|NCT00246337|5024550|P8|Overall Study|Protocol Violator|0
1534033|NCT00246337|5024551|P7|Overall Study|Protocol Violator|0
1534034|NCT00246337|5024552|P6|Overall Study|Protocol Violator|0
1534035|NCT00246337|5024553|P5|Overall Study|Protocol Violator|0
1534036|NCT00246337|5024554|P4|Overall Study|Protocol Violator|0
1534037|NCT00246337|5024555|P3|Overall Study|Protocol Violator|0
1534038|NCT00246337|5024556|P2|Overall Study|Protocol Violator|0
1534039|NCT00246337|5024557|P1|Overall Study|Protocol Violator|1
1534040|NCT00246337|5024549|P9|Overall Study|Overwhelmed|0
1534041|NCT00246337|5024550|P8|Overall Study|Overwhelmed|0
1534042|NCT00246337|5024551|P7|Overall Study|Overwhelmed|0
1534043|NCT00246337|5024552|P6|Overall Study|Overwhelmed|1
1534044|NCT00246337|5024553|P5|Overall Study|Overwhelmed|0
1534045|NCT00246337|5024554|P4|Overall Study|Overwhelmed|0
1534046|NCT00246337|5024555|P3|Overall Study|Overwhelmed|0
1534047|NCT00246337|5024556|P2|Overall Study|Overwhelmed|0
1534048|NCT00246337|5024557|P1|Overall Study|Overwhelmed|0
1534049|NCT00246337|5024549|P9|Overall Study|Abnormal baseline lab values|4
1534050|NCT00246337|5024550|P8|Overall Study|Abnormal baseline lab values|0
1534051|NCT00246337|5024551|P7|Overall Study|Abnormal baseline lab values|2
1534052|NCT00246337|5024552|P6|Overall Study|Abnormal baseline lab values|2
1534053|NCT00246337|5024553|P5|Overall Study|Abnormal baseline lab values|0
1534054|NCT00246337|5024554|P4|Overall Study|Abnormal baseline lab values|0
1534055|NCT00246337|5024555|P3|Overall Study|Abnormal baseline lab values|2
1534056|NCT00246337|5024556|P2|Overall Study|Abnormal baseline lab values|0
1534057|NCT00246337|5024557|P1|Overall Study|Abnormal baseline lab values|7
1534058|NCT00246337|5024549|P9|Overall Study|Site Terminated|2
1534059|NCT00246337|5024550|P8|Overall Study|Site Terminated|6
1534060|NCT00246337|5024551|P7|Overall Study|Site Terminated|1
1534061|NCT00246337|5024552|P6|Overall Study|Site Terminated|7
1534062|NCT00246337|5024553|P5|Overall Study|Site Terminated|0
1534063|NCT00246337|5024554|P4|Overall Study|Site Terminated|0
1534064|NCT00246337|5024555|P3|Overall Study|Site Terminated|0
1534065|NCT00246337|5024556|P2|Overall Study|Site Terminated|0
1534066|NCT00246337|5024557|P1|Overall Study|Site Terminated|10
1534067|NCT00246337|5024549|P9|Overall Study|Lack of Qualifying Event|5
1534068|NCT00246337|5024550|P8|Overall Study|Lack of Qualifying Event|2
1534069|NCT00246337|5024551|P7|Overall Study|Lack of Qualifying Event|3
1534070|NCT00246337|5024552|P6|Overall Study|Lack of Qualifying Event|3
1534071|NCT00246337|5024553|P5|Overall Study|Lack of Qualifying Event|1
1534072|NCT00246337|5024554|P4|Overall Study|Lack of Qualifying Event|1
1534073|NCT00246337|5024555|P3|Overall Study|Lack of Qualifying Event|1
1534074|NCT00246337|5024556|P2|Overall Study|Lack of Qualifying Event|2
1534075|NCT00246337|5024557|P1|Overall Study|Lack of Qualifying Event|8
1534076|NCT00246337|5024549|P9|Overall Study|Withdrawal by Subject|0
1534077|NCT00246337|5024550|P8|Overall Study|Withdrawal by Subject|1
1534078|NCT00246337|5024551|P7|Overall Study|Withdrawal by Subject|1
1534079|NCT00246337|5024552|P6|Overall Study|Withdrawal by Subject|0
1534080|NCT00246337|5024553|P5|Overall Study|Withdrawal by Subject|0
1534081|NCT00246337|5024554|P4|Overall Study|Withdrawal by Subject|0
1534082|NCT00246337|5024555|P3|Overall Study|Withdrawal by Subject|0
1534083|NCT00246337|5024556|P2|Overall Study|Withdrawal by Subject|0
1534084|NCT00246337|5024557|P1|Overall Study|Withdrawal by Subject|2
1534085|NCT00246337|5024549|P9|Overall Study|Protocol Violation|0
1534086|NCT00246337|5024550|P8|Overall Study|Protocol Violation|1
1534087|NCT00246337|5024551|P7|Overall Study|Protocol Violation|1
1534088|NCT00246337|5024552|P6|Overall Study|Protocol Violation|0
1534089|NCT00246337|5024553|P5|Overall Study|Protocol Violation|1
1534090|NCT00246337|5024554|P4|Overall Study|Protocol Violation|0
1534091|NCT00246337|5024555|P3|Overall Study|Protocol Violation|0
1534092|NCT00246337|5024556|P2|Overall Study|Protocol Violation|0
1534093|NCT00246337|5024557|P1|Overall Study|Protocol Violation|1
1534094|NCT00246337|5024549|P9|Overall Study|Lost to Follow-up|0
1534095|NCT00246337|5024550|P8|Overall Study|Lost to Follow-up|2
1534096|NCT00246337|5024551|P7|Overall Study|Lost to Follow-up|1
1534097|NCT00246337|5024552|P6|Overall Study|Lost to Follow-up|2
1534098|NCT00246337|5024553|P5|Overall Study|Lost to Follow-up|2
1534099|NCT00246337|5024554|P4|Overall Study|Lost to Follow-up|0
1534100|NCT00246337|5024555|P3|Overall Study|Lost to Follow-up|0
1534101|NCT00246337|5024556|P2|Overall Study|Lost to Follow-up|0
1534102|NCT00246337|5024557|P1|Overall Study|Lost to Follow-up|3
1534103|NCT00246324|5024604|P1|Overall Study|Withdrawal by Subject|1
1534104|NCT00246259|5024611|P2|Overall Study|randomly assigned, not eligible for ITT|6
1534105|NCT00246259|5024612|P1|Overall Study|randomly assigned, not eligible for ITT|2
1534106|NCT00246259|5024611|P2|Overall Study|Withdrawal by Subject|1
1534107|NCT00246259|5024612|P1|Overall Study|Withdrawal by Subject|5
1534108|NCT00246259|5024611|P2|Overall Study|Lost to Follow-up|4
1534109|NCT00246259|5024612|P1|Overall Study|Lost to Follow-up|3
1534110|NCT00246259|5024611|P2|Overall Study|Adverse Event|0
1534111|NCT00246259|5024612|P1|Overall Study|Adverse Event|5
1534112|NCT00246259|5024611|P2|Overall Study|Investigator withdrew participant|0
1534113|NCT00246259|5024612|P1|Overall Study|Investigator withdrew participant|2
1534114|NCT00246259|5024611|P2|Overall Study|Lack of Efficacy|2
1534115|NCT00246259|5024612|P1|Overall Study|Lack of Efficacy|2
1534116|NCT00246259|5024611|P2|Overall Study|Participant non-compliant|9
1534117|NCT00246259|5024612|P1|Overall Study|Participant non-compliant|4
1534118|NCT00246259|5024611|P2|Overall Study|Not stable by Week 18|1
1534119|NCT00246259|5024612|P1|Overall Study|Not stable by Week 18|2
1534120|NCT00246259|5024611|P2|Overall Study|Other|3
1534121|NCT00246259|5024612|P1|Overall Study|Other|3
1534122|NCT00246090|5024646|P1|Overall Study|Not Otherwise Specified|10
1534123|NCT00246090|5024646|P1|Overall Study|Physician Decision|11
1534124|NCT00246090|5024646|P1|Overall Study|Clinical Progression|30
1534125|NCT00246090|5024646|P1|Overall Study|Progressive Disease|212
1534126|NCT00246090|5024646|P1|Overall Study|Withdrawal by Subject|7
1534127|NCT00246090|5024646|P1|Overall Study|Adverse Event|25
1534128|NCT00246025|5024655|P4|Overall Study|unsuitable medical history was found|1
1534129|NCT00246025|5024656|P3|Overall Study|unsuitable medical history was found|0
1534130|NCT00246025|5024657|P2|Overall Study|unsuitable medical history was found|0
1534131|NCT00246025|5024658|P1|Overall Study|unsuitable medical history was found|0
1534132|NCT00246025|5024655|P4|Overall Study|Withdrawal by Subject|2
1534133|NCT00246025|5024656|P3|Overall Study|Withdrawal by Subject|1
1534134|NCT00246025|5024657|P2|Overall Study|Withdrawal by Subject|0
1534135|NCT00246025|5024658|P1|Overall Study|Withdrawal by Subject|3
1534136|NCT00246025|5024655|P4|Overall Study|Adverse Event|10
1534137|NCT00246025|5024656|P3|Overall Study|Adverse Event|9
1534138|NCT00246025|5024657|P2|Overall Study|Adverse Event|9
1534139|NCT00246025|5024658|P1|Overall Study|Adverse Event|7
1534140|NCT00246012|5024717|P9|Overall Study|Randomly assigned but not treated|0
1534141|NCT00246012|5024718|P8|Overall Study|Randomly assigned but not treated|0
1534142|NCT00246012|5024719|P7|Overall Study|Randomly assigned but not treated|1
1534143|NCT00246012|5024720|P6|Overall Study|Randomly assigned but not treated|1
1534144|NCT00246012|5024721|P5|Overall Study|Randomly assigned but not treated|0
1534145|NCT00246012|5024722|P4|Overall Study|Randomly assigned but not treated|0
1534146|NCT00246012|5024723|P3|Overall Study|Randomly assigned but not treated|0
1534147|NCT00246012|5024724|P2|Overall Study|Randomly assigned but not treated|0
1534148|NCT00246012|5024725|P1|Overall Study|Randomly assigned but not treated|0
1534149|NCT00246012|5024717|P9|Overall Study|Other|0
1534150|NCT00246012|5024718|P8|Overall Study|Other|1
1534151|NCT00246012|5024719|P7|Overall Study|Other|0
1534152|NCT00246012|5024720|P6|Overall Study|Other|0
1534153|NCT00246012|5024721|P5|Overall Study|Other|0
1534154|NCT00246012|5024722|P4|Overall Study|Other|0
1534155|NCT00246012|5024723|P3|Overall Study|Other|0
1534156|NCT00246012|5024724|P2|Overall Study|Other|0
1534157|NCT00246012|5024725|P1|Overall Study|Other|0
1534158|NCT00246012|5024717|P9|Overall Study|Disease progression|26
1534159|NCT00246012|5024718|P8|Overall Study|Disease progression|27
1534160|NCT00246012|5024719|P7|Overall Study|Disease progression|30
1534161|NCT00246012|5024720|P6|Overall Study|Disease progression|25
1534162|NCT00246012|5024721|P5|Overall Study|Disease progression|3
1534163|NCT00246012|5024722|P4|Overall Study|Disease progression|3
1534164|NCT00246012|5024723|P3|Overall Study|Disease progression|2
1534165|NCT00246012|5024724|P2|Overall Study|Disease progression|1
1534166|NCT00246012|5024725|P1|Overall Study|Disease progression|3
1534167|NCT00246012|5024717|P9|Overall Study|Withdrawal by Subject|0
1534168|NCT00246012|5024718|P8|Overall Study|Withdrawal by Subject|0
1534169|NCT00246012|5024719|P7|Overall Study|Withdrawal by Subject|0
1534170|NCT00246012|5024720|P6|Overall Study|Withdrawal by Subject|1
1534171|NCT00246012|5024721|P5|Overall Study|Withdrawal by Subject|0
1534172|NCT00246012|5024722|P4|Overall Study|Withdrawal by Subject|0
1534173|NCT00246012|5024723|P3|Overall Study|Withdrawal by Subject|0
1534174|NCT00246012|5024724|P2|Overall Study|Withdrawal by Subject|0
1534175|NCT00246012|5024725|P1|Overall Study|Withdrawal by Subject|0
1534176|NCT00246012|5024717|P9|Overall Study|Adverse Event|2
1534177|NCT00246012|5024718|P8|Overall Study|Adverse Event|0
1534178|NCT00246012|5024719|P7|Overall Study|Adverse Event|0
1534179|NCT00246012|5024720|P6|Overall Study|Adverse Event|1
1534180|NCT00246012|5024721|P5|Overall Study|Adverse Event|0
1534181|NCT00246012|5024722|P4|Overall Study|Adverse Event|0
1534182|NCT00246012|5024723|P3|Overall Study|Adverse Event|0
1534183|NCT00246012|5024724|P2|Overall Study|Adverse Event|0
1534184|NCT00246012|5024725|P1|Overall Study|Adverse Event|0
1534185|NCT00245960|5024820|P2|Overall Study|Lack of Efficacy|6
1534186|NCT00245960|5024821|P1|Overall Study|Lack of Efficacy|4
1534187|NCT00245960|5024820|P2|Overall Study|Withdrawal by Subject|7
1534188|NCT00245960|5024821|P1|Overall Study|Withdrawal by Subject|5
1534189|NCT00245960|5024820|P2|Overall Study|Protocol Violation|3
1534190|NCT00245960|5024821|P1|Overall Study|Protocol Violation|4
1534191|NCT00245960|5024820|P2|Overall Study|Lost to Follow-up|2
1534192|NCT00245960|5024821|P1|Overall Study|Lost to Follow-up|2
1534193|NCT00245960|5024820|P2|Overall Study|Adverse Event|10
1534194|NCT00245960|5024821|P1|Overall Study|Adverse Event|14
1534195|NCT00245856|5024829|P2|Period Two|Withdrawal by Subject|1
1534196|NCT00245856|5024830|P1|Period Two|Withdrawal by Subject|0
1534197|NCT00245570|5024846|P6|Washout Between Periods III and IV|Adverse Event|0
1534198|NCT00245570|5024847|P5|Washout Between Periods III and IV|Adverse Event|0
1534199|NCT00245570|5024848|P4|Washout Between Periods III and IV|Adverse Event|0
1534200|NCT00245570|5024849|P3|Washout Between Periods III and IV|Adverse Event|0
1534201|NCT00245570|5024850|P2|Washout Between Periods III and IV|Adverse Event|1
1534202|NCT00245570|5024851|P1|Washout Between Periods III and IV|Adverse Event|0
1534203|NCT00245466|5024985|P3|Overall Study|Administrative reasons|0
1534204|NCT00245466|5024986|P2|Overall Study|Administrative reasons|1
1534205|NCT00245466|5024987|P1|Overall Study|Administrative reasons|0
1534206|NCT00245466|5024985|P3|Overall Study|Death|0
1534207|NCT00245466|5024986|P2|Overall Study|Death|2
1534208|NCT00245466|5024987|P1|Overall Study|Death|0
1534209|NCT00245466|5024985|P3|Overall Study|Protocol Violation|2
1534210|NCT00245466|5024986|P2|Overall Study|Protocol Violation|2
1534211|NCT00245466|5024987|P1|Overall Study|Protocol Violation|1
1534212|NCT00245466|5024985|P3|Overall Study|Disease progression|1
1534213|NCT00245466|5024986|P2|Overall Study|Disease progression|3
1534214|NCT00245466|5024987|P1|Overall Study|Disease progression|0
1534215|NCT00245466|5024985|P3|Overall Study|Lost to Follow-up|0
1534216|NCT00245466|5024986|P2|Overall Study|Lost to Follow-up|0
1534217|NCT00245466|5024987|P1|Overall Study|Lost to Follow-up|3
1534218|NCT00245466|5024985|P3|Overall Study|Withdrawal by Subject|1
1534219|NCT00245466|5024986|P2|Overall Study|Withdrawal by Subject|2
1534220|NCT00245466|5024987|P1|Overall Study|Withdrawal by Subject|2
1534221|NCT00245466|5024985|P3|Overall Study|Insufficient PSA and testosterone suppr|3
1534222|NCT00245466|5024986|P2|Overall Study|Insufficient PSA and testosterone suppr|0
1534223|NCT00245466|5024987|P1|Overall Study|Insufficient PSA and testosterone suppr|0
1534224|NCT00245466|5024985|P3|Overall Study|Insufficient testosterone suppr|21
1534225|NCT00245466|5024986|P2|Overall Study|Insufficient testosterone suppr|12
1534226|NCT00245466|5024987|P1|Overall Study|Insufficient testosterone suppr|12
1534227|NCT00245466|5024985|P3|Overall Study|Low prostate specific antigen suppr|5
1534228|NCT00245466|5024986|P2|Overall Study|Low prostate specific antigen suppr|14
1534229|NCT00245466|5024987|P1|Overall Study|Low prostate specific antigen suppr|16
1534230|NCT00245466|5024985|P3|Overall Study|Adverse Event|4
1534231|NCT00245466|5024986|P2|Overall Study|Adverse Event|8
1534232|NCT00245466|5024987|P1|Overall Study|Adverse Event|2
1534233|NCT00245102|5025030|P6|Overall Study|Clinical progression|0
1534234|NCT00245102|5025031|P5|Overall Study|Clinical progression|0
1534235|NCT00245102|5025032|P4|Overall Study|Clinical progression|0
1534236|NCT00245102|5025033|P3|Overall Study|Clinical progression|0
1534237|NCT00245102|5025034|P2|Overall Study|Clinical progression|0
1534238|NCT00245102|5025035|P1|Overall Study|Clinical progression|1
1534239|NCT00245102|5025030|P6|Overall Study|Participant needed surgery|0
1534240|NCT00245102|5025031|P5|Overall Study|Participant needed surgery|0
1534241|NCT00245102|5025032|P4|Overall Study|Participant needed surgery|0
1534242|NCT00245102|5025033|P3|Overall Study|Participant needed surgery|1
1534243|NCT00245102|5025034|P2|Overall Study|Participant needed surgery|0
1534244|NCT00245102|5025035|P1|Overall Study|Participant needed surgery|0
1534245|NCT00245102|5025030|P6|Overall Study|Decline in performance|2
1534246|NCT00245102|5025031|P5|Overall Study|Decline in performance|0
1534247|NCT00245102|5025032|P4|Overall Study|Decline in performance|1
1534248|NCT00245102|5025033|P3|Overall Study|Decline in performance|0
1534249|NCT00245102|5025034|P2|Overall Study|Decline in performance|2
1534250|NCT00245102|5025035|P1|Overall Study|Decline in performance|0
1534251|NCT00245102|5025030|P6|Overall Study|Adverse Event|2
1534252|NCT00245102|5025031|P5|Overall Study|Adverse Event|0
1534253|NCT00245102|5025032|P4|Overall Study|Adverse Event|1
1534254|NCT00245102|5025033|P3|Overall Study|Adverse Event|5
1534255|NCT00245102|5025034|P2|Overall Study|Adverse Event|2
1534256|NCT00245102|5025035|P1|Overall Study|Adverse Event|4
1534257|NCT00245102|5025030|P6|Overall Study|Death|0
1534258|NCT00245102|5025031|P5|Overall Study|Death|0
1534259|NCT00245102|5025032|P4|Overall Study|Death|1
1534260|NCT00245102|5025033|P3|Overall Study|Death|0
1534261|NCT00245102|5025034|P2|Overall Study|Death|0
1534262|NCT00245102|5025035|P1|Overall Study|Death|0
1534263|NCT00245102|5025030|P6|Overall Study|Protocol Violation|0
1534264|NCT00245102|5025031|P5|Overall Study|Protocol Violation|0
1534265|NCT00245102|5025032|P4|Overall Study|Protocol Violation|0
1534266|NCT00245102|5025033|P3|Overall Study|Protocol Violation|0
1534267|NCT00245102|5025034|P2|Overall Study|Protocol Violation|0
1534268|NCT00245102|5025035|P1|Overall Study|Protocol Violation|1
1534269|NCT00245102|5025030|P6|Overall Study|Not Treated|0
1534270|NCT00245102|5025031|P5|Overall Study|Not Treated|0
1534271|NCT00245102|5025032|P4|Overall Study|Not Treated|0
1534272|NCT00245102|5025033|P3|Overall Study|Not Treated|1
1534273|NCT00245102|5025034|P2|Overall Study|Not Treated|0
1534274|NCT00245102|5025035|P1|Overall Study|Not Treated|1
1534275|NCT00245063|5025051|P2|Overall Study|Death|0
1534276|NCT00245063|5025052|P1|Overall Study|Death|1
1534277|NCT00245063|5025051|P2|Overall Study|Adverse Event|5
1534278|NCT00245063|5025052|P1|Overall Study|Adverse Event|6
1534279|NCT00245050|5025060|P2|Overall Study|Adverse Event|2
1534280|NCT00245050|5025061|P1|Overall Study|Adverse Event|3
1534281|NCT00245037|5025069|P1|Overall Study|Death|17
1534282|NCT00245011|5025079|P1|Overall Study|Lack of Efficacy|1
1534283|NCT00244933|5025091|P1|Overall Study|Not response evaluable|2
1534284|NCT00244881|5025095|P1|Overall Study|Withdrawal by Subject|3
1534285|NCT00244855|5025103|P2|Overall Study|Withdrawal by Subject|1
1534286|NCT00244855|5025104|P1|Overall Study|Withdrawal by Subject|0
1534287|NCT00244764|5025112|P1|Overall Study|Developed Secondary Malignancy|1
1534288|NCT00244764|5025112|P1|Overall Study|Sponsor Terminated Study|2
1534289|NCT00244764|5025112|P1|Overall Study|Primary Investigator Discretion|2
1534290|NCT00244764|5025112|P1|Overall Study|Participant was Hospitalized until Death|1
1534291|NCT00244764|5025112|P1|Overall Study|Declining Performance Status|1
1534292|NCT00244764|5025112|P1|Overall Study|Off Study Medication for >21 Days|1
1534293|NCT00244764|5025112|P1|Overall Study|Death|1
1534294|NCT00244764|5025112|P1|Overall Study|Protocol Violation|2
1534295|NCT00244764|5025112|P1|Overall Study|Disease Progression|13
1534296|NCT00244764|5025112|P1|Overall Study|Withdrawal by Subject|12
1534297|NCT00244764|5025112|P1|Overall Study|Lost to Follow-up|23
1534298|NCT00244764|5025112|P1|Overall Study|Adverse Event|37
1534299|NCT00244751|5025122|P3|Overall Study|Participant randomized by mistake|1
1534300|NCT00244751|5025123|P2|Overall Study|Participant randomized by mistake|0
1534301|NCT00244751|5025124|P1|Overall Study|Participant randomized by mistake|0
1534302|NCT00244751|5025122|P3|Overall Study|Safety reasons|0
1534303|NCT00244751|5025123|P2|Overall Study|Safety reasons|1
1534304|NCT00244751|5025124|P1|Overall Study|Safety reasons|0
1534305|NCT00244751|5025122|P3|Overall Study|Lack of compliance with protocol|0
1534306|NCT00244751|5025123|P2|Overall Study|Lack of compliance with protocol|1
1534307|NCT00244751|5025124|P1|Overall Study|Lack of compliance with protocol|0
1534308|NCT00244751|5025122|P3|Overall Study|Elevated liver enzymes|0
1534309|NCT00244751|5025123|P2|Overall Study|Elevated liver enzymes|0
1534310|NCT00244751|5025124|P1|Overall Study|Elevated liver enzymes|1
1534311|NCT00244751|5025122|P3|Overall Study|Withdrawal by Subject|3
1534312|NCT00244751|5025123|P2|Overall Study|Withdrawal by Subject|5
1534313|NCT00244751|5025124|P1|Overall Study|Withdrawal by Subject|7
1534314|NCT00244751|5025122|P3|Overall Study|Protocol Violation|1
1534315|NCT00244751|5025123|P2|Overall Study|Protocol Violation|0
1534316|NCT00244751|5025124|P1|Overall Study|Protocol Violation|1
1534317|NCT00244751|5025122|P3|Overall Study|Lost to Follow-up|0
1534318|NCT00244751|5025123|P2|Overall Study|Lost to Follow-up|1
1534319|NCT00244751|5025124|P1|Overall Study|Lost to Follow-up|0
1534320|NCT00244751|5025122|P3|Overall Study|Adverse Event|5
1534321|NCT00244751|5025123|P2|Overall Study|Adverse Event|7
1534322|NCT00244751|5025124|P1|Overall Study|Adverse Event|7
1534323|NCT00244725|5025225|P4|Overall Study|Failed to follow-up|1
1534324|NCT00244725|5025226|P3|Overall Study|Failed to follow-up|1
1534325|NCT00244725|5025227|P2|Overall Study|Failed to follow-up|0
1534326|NCT00244725|5025228|P1|Overall Study|Failed to follow-up|0
1534327|NCT00244725|5025225|P4|Overall Study|Vomit|0
1534328|NCT00244725|5025226|P3|Overall Study|Vomit|1
1534329|NCT00244725|5025227|P2|Overall Study|Vomit|0
1534330|NCT00244725|5025228|P1|Overall Study|Vomit|0
1534331|NCT00244725|5025225|P4|Overall Study|Administrative reason|0
1534332|NCT00244725|5025226|P3|Overall Study|Administrative reason|1
1534333|NCT00244725|5025227|P2|Overall Study|Administrative reason|0
1534334|NCT00244725|5025228|P1|Overall Study|Administrative reason|0
1534335|NCT00244725|5025225|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
1534336|NCT00244725|5025226|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
1534337|NCT00244725|5025227|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
1534338|NCT00244725|5025228|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
1534339|NCT00244725|5025225|P4|Overall Study|Received prohibited medication|1
1534340|NCT00244725|5025226|P3|Overall Study|Received prohibited medication|0
1534341|NCT00244725|5025227|P2|Overall Study|Received prohibited medication|1
1534342|NCT00244725|5025228|P1|Overall Study|Received prohibited medication|0
1534343|NCT00244725|5025225|P4|Overall Study|Headache|0
1534344|NCT00244725|5025226|P3|Overall Study|Headache|0
1534345|NCT00244725|5025227|P2|Overall Study|Headache|1
1534346|NCT00244725|5025228|P1|Overall Study|Headache|0
1534347|NCT00244725|5025225|P4|Overall Study|Rehab Refused to allow participantion|0
1534348|NCT00244725|5025226|P3|Overall Study|Rehab Refused to allow participantion|0
1534349|NCT00244725|5025227|P2|Overall Study|Rehab Refused to allow participantion|1
1534350|NCT00244725|5025228|P1|Overall Study|Rehab Refused to allow participantion|0
1534351|NCT00244725|5025225|P4|Overall Study|Mediciation Error|0
1534352|NCT00244725|5025226|P3|Overall Study|Mediciation Error|0
1534353|NCT00244725|5025227|P2|Overall Study|Mediciation Error|1
1534354|NCT00244725|5025228|P1|Overall Study|Mediciation Error|0
1534355|NCT00244725|5025225|P4|Overall Study|Sponsor withdrew the participant|1
1534356|NCT00244725|5025226|P3|Overall Study|Sponsor withdrew the participant|0
1534357|NCT00244725|5025227|P2|Overall Study|Sponsor withdrew the participant|0
1534358|NCT00244725|5025228|P1|Overall Study|Sponsor withdrew the participant|1
1534359|NCT00244725|5025225|P4|Overall Study|Liver function test abnormality|1
1534360|NCT00244725|5025226|P3|Overall Study|Liver function test abnormality|0
1534361|NCT00244725|5025227|P2|Overall Study|Liver function test abnormality|0
1534362|NCT00244725|5025228|P1|Overall Study|Liver function test abnormality|2
1534363|NCT00244725|5025225|P4|Overall Study|Withdrwal by participant|1
1534364|NCT00244725|5025226|P3|Overall Study|Withdrwal by participant|0
1534365|NCT00244725|5025227|P2|Overall Study|Withdrwal by participant|0
1534366|NCT00244725|5025228|P1|Overall Study|Withdrwal by participant|1
1534367|NCT00244725|5025225|P4|Overall Study|Adverse Events|4
1534368|NCT00244725|5025226|P3|Overall Study|Adverse Events|4
1534369|NCT00244725|5025227|P2|Overall Study|Adverse Events|1
1534370|NCT00244725|5025228|P1|Overall Study|Adverse Events|3
1534371|NCT00244725|5025225|P4|Overall Study|Physician Decision|2
1534372|NCT00244725|5025226|P3|Overall Study|Physician Decision|1
1534373|NCT00244725|5025227|P2|Overall Study|Physician Decision|0
1534374|NCT00244725|5025228|P1|Overall Study|Physician Decision|3
1534375|NCT00244725|5025225|P4|Overall Study|Not meet treatment eligibility criteria|0
1534376|NCT00244725|5025226|P3|Overall Study|Not meet treatment eligibility criteria|0
1534377|NCT00244725|5025227|P2|Overall Study|Not meet treatment eligibility criteria|2
1534378|NCT00244725|5025228|P1|Overall Study|Not meet treatment eligibility criteria|1
1534379|NCT00244725|5025225|P4|Overall Study|Withdrawal by Subject|8
1534380|NCT00244725|5025226|P3|Overall Study|Withdrawal by Subject|7
1534381|NCT00244725|5025227|P2|Overall Study|Withdrawal by Subject|7
1534382|NCT00244725|5025228|P1|Overall Study|Withdrawal by Subject|9
1534383|NCT00244725|5025225|P4|Overall Study|Lost to Follow-up|2
1534384|NCT00244725|5025226|P3|Overall Study|Lost to Follow-up|9
1534385|NCT00244725|5025227|P2|Overall Study|Lost to Follow-up|4
1534386|NCT00244725|5025228|P1|Overall Study|Lost to Follow-up|3
1534387|NCT00244712|5025284|P2|Overall Study|Protocol Violation, disease progression|11
1534388|NCT00244712|5025285|P1|Overall Study|Protocol Violation, disease progression|13
1534389|NCT00244712|5025284|P2|Overall Study|Withdrawal by Subject|23
1534390|NCT00244712|5025285|P1|Overall Study|Withdrawal by Subject|13
1534391|NCT00244712|5025284|P2|Overall Study|Lost to Follow-up|52
1534392|NCT00244712|5025285|P1|Overall Study|Lost to Follow-up|45
1534393|NCT00244712|5025284|P2|Overall Study|Lack of Compliance|11
1534394|NCT00244712|5025285|P1|Overall Study|Lack of Compliance|10
1534395|NCT00244712|5025284|P2|Overall Study|Protocol-Defined Virologic Failure|6
1534396|NCT00244712|5025285|P1|Overall Study|Protocol-Defined Virologic Failure|8
1534397|NCT00244712|5025284|P2|Overall Study|Adverse Event|21
1534398|NCT00244712|5025285|P1|Overall Study|Adverse Event|20
1534399|NCT00244621|5025320|P3|Open-label Treatment Period|Moved abroad|1
1534400|NCT00244621|5025321|P2|Open-label Treatment Period|Moved abroad|0
1534401|NCT00244621|5025322|P1|Open-label Treatment Period|Moved abroad|0
1534402|NCT00244621|5025320|P3|Open-label Treatment Period|Adverse Event|1
1534403|NCT00244621|5025321|P2|Open-label Treatment Period|Adverse Event|0
1534404|NCT00244621|5025322|P1|Open-label Treatment Period|Adverse Event|0
1534405|NCT00244621|5025320|P3|Open-label Treatment Period|Withdrawal by Subject|0
1534406|NCT00244621|5025321|P2|Open-label Treatment Period|Withdrawal by Subject|0
1534407|NCT00244621|5025322|P1|Open-label Treatment Period|Withdrawal by Subject|1
1534408|NCT00244621|5025320|P3|Open-label Treatment Period|Lost to Follow-up|0
1534409|NCT00244621|5025321|P2|Open-label Treatment Period|Lost to Follow-up|1
1534410|NCT00244621|5025322|P1|Open-label Treatment Period|Lost to Follow-up|0
1534411|NCT00244621|5025320|P3|Double-blind Treatment Period|Multiple Reasons|1
1534412|NCT00244621|5025321|P2|Double-blind Treatment Period|Multiple Reasons|1
1534413|NCT00244621|5025322|P1|Double-blind Treatment Period|Multiple Reasons|2
1534414|NCT00244621|5025320|P3|Double-blind Treatment Period|Lack of Efficacy|0
1534415|NCT00244621|5025321|P2|Double-blind Treatment Period|Lack of Efficacy|1
1534416|NCT00244621|5025322|P1|Double-blind Treatment Period|Lack of Efficacy|0
1534417|NCT00244621|5025320|P3|Double-blind Treatment Period|Withdrawal by Subject|0
1534418|NCT00244621|5025321|P2|Double-blind Treatment Period|Withdrawal by Subject|1
1534419|NCT00244621|5025322|P1|Double-blind Treatment Period|Withdrawal by Subject|0
1534420|NCT00244621|5025320|P3|Double-blind Treatment Period|Lost to Follow-up|1
1534421|NCT00244621|5025321|P2|Double-blind Treatment Period|Lost to Follow-up|0
1534422|NCT00244621|5025322|P1|Double-blind Treatment Period|Lost to Follow-up|0
1534423|NCT00244374|5025339|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1534424|NCT00244374|5025340|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1534425|NCT00244374|5025341|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1534426|NCT00244374|5025342|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1534427|NCT00244374|5025343|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
1534428|NCT00244374|5025339|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1534429|NCT00244374|5025340|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1534430|NCT00244374|5025341|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1534431|NCT00244374|5025342|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1534432|NCT00244374|5025343|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
1534433|NCT00244374|5025339|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1534434|NCT00244374|5025340|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1534435|NCT00244374|5025341|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1534436|NCT00244374|5025342|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1534437|NCT00244374|5025343|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
1534438|NCT00244374|5025339|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1534439|NCT00244374|5025340|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1534440|NCT00244374|5025341|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1534441|NCT00244374|5025342|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1534679|NCT00242216|5025832|P2|Overall Study|no medicaiton dispensed|1
1534442|NCT00244374|5025343|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
1534443|NCT00244374|5025339|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1534444|NCT00244374|5025340|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1534445|NCT00244374|5025341|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1534446|NCT00244374|5025342|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1534447|NCT00244374|5025343|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
1534448|NCT00244374|5025339|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1534449|NCT00244374|5025340|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1534450|NCT00244374|5025341|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1534451|NCT00244374|5025342|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1534452|NCT00244374|5025343|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
1534453|NCT00244374|5025339|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1534454|NCT00244374|5025340|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1534455|NCT00244374|5025341|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1534456|NCT00244374|5025342|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1534457|NCT00244374|5025343|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
1534458|NCT00244374|5025339|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1534459|NCT00244374|5025340|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1534460|NCT00244374|5025341|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1534461|NCT00244374|5025342|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1534462|NCT00244374|5025343|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
1534463|NCT00244374|5025339|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1534464|NCT00244374|5025340|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1534465|NCT00244374|5025341|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1534466|NCT00244374|5025342|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1534467|NCT00244374|5025343|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
1534468|NCT00243932|5025399|P3|Stage 1: Dose Selection|Lost to Follow-up|0
1534469|NCT00243932|5025400|P2|Stage 1: Dose Selection|Lost to Follow-up|0
1534470|NCT00243932|5025401|P1|Stage 1: Dose Selection|Lost to Follow-up|2
1534471|NCT00243919|5025412|P3|Overall Study|Physician Decision|0
1534472|NCT00243919|5025413|P2|Overall Study|Physician Decision|1
1534473|NCT00243919|5025414|P1|Overall Study|Physician Decision|1
1534474|NCT00243919|5025412|P3|Overall Study|Administrative Error|0
1534475|NCT00243919|5025413|P2|Overall Study|Administrative Error|0
1534476|NCT00243919|5025414|P1|Overall Study|Administrative Error|1
1534477|NCT00243919|5025412|P3|Overall Study|Lost to Follow-up|3
1534478|NCT00243919|5025413|P2|Overall Study|Lost to Follow-up|7
1534479|NCT00243919|5025414|P1|Overall Study|Lost to Follow-up|6
1534480|NCT00243919|5025412|P3|Overall Study|Withdrawal by Subject|2
1534481|NCT00243919|5025413|P2|Overall Study|Withdrawal by Subject|6
1534482|NCT00243919|5025414|P1|Overall Study|Withdrawal by Subject|6
1534483|NCT00243919|5025412|P3|Overall Study|Death|6
1534484|NCT00243919|5025413|P2|Overall Study|Death|4
1534485|NCT00243919|5025414|P1|Overall Study|Death|3
1534486|NCT00243659|5025457|P2|Overall Study|Protocol Violation|2
1534487|NCT00243659|5025458|P1|Overall Study|Protocol Violation|1
1534488|NCT00243659|5025457|P2|Overall Study|Withdrawal by Subject|1
1534489|NCT00243659|5025458|P1|Overall Study|Withdrawal by Subject|1
1534490|NCT00243503|5025466|P1|Overall Study|Other|1
1534491|NCT00243503|5025466|P1|Overall Study|Death|1
1534492|NCT00243503|5025466|P1|Overall Study|Lack of Efficacy|44
1534493|NCT00243503|5025466|P1|Overall Study|Withdrawal by Subject|1
1534494|NCT00243503|5025466|P1|Overall Study|Adverse Event|11
1534495|NCT00243412|5025483|P2|Overall Study|not specified|1
1534496|NCT00243412|5025484|P1|Overall Study|not specified|1
1534497|NCT00243412|5025483|P2|Overall Study|Withdrawal by Subject|5
1534498|NCT00243412|5025484|P1|Overall Study|Withdrawal by Subject|4
1534499|NCT00243412|5025483|P2|Overall Study|Physician Decision|1
1534500|NCT00243412|5025484|P1|Overall Study|Physician Decision|1
1534501|NCT00243412|5025483|P2|Overall Study|Lost to Follow-up|1
1534502|NCT00243412|5025484|P1|Overall Study|Lost to Follow-up|0
1534503|NCT00243412|5025483|P2|Overall Study|Adverse Event|2
1534504|NCT00243412|5025484|P1|Overall Study|Adverse Event|4
1534505|NCT00243412|5025483|P2|Overall Study|Death|1
1534506|NCT00243412|5025484|P1|Overall Study|Death|0
1534507|NCT00243386|5025510|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
1534508|NCT00243386|5025511|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
1534509|NCT00243386|5025512|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
1534510|NCT00243386|5025510|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
1534511|NCT00243386|5025511|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
1534512|NCT00243386|5025512|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
1534513|NCT00243386|5025510|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
1534514|NCT00243386|5025511|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
1534515|NCT00243386|5025512|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
1534516|NCT00243386|5025510|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
1534517|NCT00243386|5025511|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
1534518|NCT00243386|5025512|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
1534519|NCT00243386|5025510|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
1534520|NCT00243386|5025511|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
1534521|NCT00243386|5025512|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
1534522|NCT00243386|5025510|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
1534523|NCT00243386|5025511|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
1534524|NCT00243386|5025512|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
1534525|NCT00243386|5025510|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
1534526|NCT00243386|5025511|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
1534527|NCT00243386|5025512|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
1534528|NCT00243386|5025510|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
1534529|NCT00243386|5025511|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
1534530|NCT00243386|5025512|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
1534531|NCT00243347|5025577|P1|Overall Study|Condition worsened|7
1534532|NCT00243347|5025577|P1|Overall Study|Withdrawal by Subject|5
1534533|NCT00243347|5025577|P1|Overall Study|Death|1
1534534|NCT00243347|5025577|P1|Overall Study|Adverse Event|2
1534535|NCT00243347|5025577|P1|Overall Study|Lack of Efficacy|4
1534536|NCT00243269|5025586|P4|Overall Study|Lost to Follow-up|3
1534537|NCT00243269|5025587|P3|Overall Study|Lost to Follow-up|1
1534538|NCT00243269|5025588|P2|Overall Study|Lost to Follow-up|0
1534539|NCT00243269|5025589|P1|Overall Study|Lost to Follow-up|1
1534540|NCT00243269|5025586|P4|Overall Study|Protocol Violation|1
1534541|NCT00243269|5025587|P3|Overall Study|Protocol Violation|0
1534542|NCT00243269|5025588|P2|Overall Study|Protocol Violation|1
1534543|NCT00243269|5025589|P1|Overall Study|Protocol Violation|2
1534544|NCT00243074|5025616|P1|Overall Study|Did not receive any treatment|1
1534545|NCT00243074|5025616|P1|Overall Study|not protocol specified|1
1534546|NCT00243074|5025616|P1|Overall Study|Death|2
1534547|NCT00243074|5025616|P1|Overall Study|Lack of Efficacy|36
1534548|NCT00243074|5025616|P1|Overall Study|Withdrawal by Subject|2
1534549|NCT00243074|5025616|P1|Overall Study|Adverse Event|6
1534550|NCT00243074|5025616|P1|Overall Study|Ineligible|6
1534551|NCT00243022|5025642|P2|Overall Study|Difficult Travel Distance|1
1534552|NCT00243022|5025643|P1|Overall Study|Difficult Travel Distance|0
1534553|NCT00243022|5025642|P2|Overall Study|Death|0
1534554|NCT00243022|5025643|P1|Overall Study|Death|1
1534555|NCT00243022|5025642|P2|Overall Study|Withdrawal by Subject|0
1534556|NCT00243022|5025643|P1|Overall Study|Withdrawal by Subject|1
1534557|NCT00242710|5025665|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
1534558|NCT00242710|5025666|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
1534559|NCT00242710|5025667|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
1534560|NCT00242710|5025668|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
1534561|NCT00242710|5025665|P4|Study Extension (up to Year 2)|Protocol Violation|1
1534562|NCT00242710|5025666|P3|Study Extension (up to Year 2)|Protocol Violation|0
1534563|NCT00242710|5025667|P2|Study Extension (up to Year 2)|Protocol Violation|2
1534564|NCT00242710|5025668|P1|Study Extension (up to Year 2)|Protocol Violation|0
1534565|NCT00242710|5025665|P4|Study Extension (up to Year 2)|Other|3
1534566|NCT00242710|5025666|P3|Study Extension (up to Year 2)|Other|4
1534567|NCT00242710|5025667|P2|Study Extension (up to Year 2)|Other|5
1534568|NCT00242710|5025668|P1|Study Extension (up to Year 2)|Other|3
1534569|NCT00242710|5025665|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
1534570|NCT00242710|5025666|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
1534571|NCT00242710|5025667|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
1534572|NCT00242710|5025668|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
1534573|NCT00242710|5025665|P4|Study Extension (up to Year 2)|Death|1
1534574|NCT00242710|5025666|P3|Study Extension (up to Year 2)|Death|0
1534575|NCT00242710|5025667|P2|Study Extension (up to Year 2)|Death|0
1534576|NCT00242710|5025668|P1|Study Extension (up to Year 2)|Death|0
1534577|NCT00242710|5025665|P4|Study Extension (up to Year 2)|Adverse Event|4
1534578|NCT00242710|5025666|P3|Study Extension (up to Year 2)|Adverse Event|2
1534579|NCT00242710|5025667|P2|Study Extension (up to Year 2)|Adverse Event|9
1534580|NCT00242710|5025668|P1|Study Extension (up to Year 2)|Adverse Event|7
1534581|NCT00242710|5025665|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
1534582|NCT00242710|5025666|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
1534583|NCT00242710|5025667|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
1534584|NCT00242710|5025668|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
1534585|NCT00242710|5025665|P4|Period Between Core Study and Extension|Protocol Violation|1
1534586|NCT00242710|5025666|P3|Period Between Core Study and Extension|Protocol Violation|2
1534587|NCT00242710|5025667|P2|Period Between Core Study and Extension|Protocol Violation|0
1534588|NCT00242710|5025668|P1|Period Between Core Study and Extension|Protocol Violation|0
1534589|NCT00242710|5025665|P4|Period Between Core Study and Extension|Extension not Available|7
1534590|NCT00242710|5025666|P3|Period Between Core Study and Extension|Extension not Available|8
1534591|NCT00242710|5025667|P2|Period Between Core Study and Extension|Extension not Available|21
1534592|NCT00242710|5025668|P1|Period Between Core Study and Extension|Extension not Available|17
1534593|NCT00242710|5025665|P4|Period Between Core Study and Extension|Other|11
1534594|NCT00242710|5025666|P3|Period Between Core Study and Extension|Other|9
1534595|NCT00242710|5025667|P2|Period Between Core Study and Extension|Other|24
1534596|NCT00242710|5025668|P1|Period Between Core Study and Extension|Other|24
1534597|NCT00242710|5025665|P4|Period Between Core Study and Extension|Physician Decision|0
1534598|NCT00242710|5025666|P3|Period Between Core Study and Extension|Physician Decision|0
1534599|NCT00242710|5025667|P2|Period Between Core Study and Extension|Physician Decision|1
1534600|NCT00242710|5025668|P1|Period Between Core Study and Extension|Physician Decision|1
1534601|NCT00242710|5025665|P4|Period Between Core Study and Extension|Adverse Event|2
1534602|NCT00242710|5025666|P3|Period Between Core Study and Extension|Adverse Event|5
1534603|NCT00242710|5025667|P2|Period Between Core Study and Extension|Adverse Event|3
1534604|NCT00242710|5025668|P1|Period Between Core Study and Extension|Adverse Event|2
1534605|NCT00242710|5025665|P4|Core Study (up to Year 1)|Randomized but not Treated|2
1534606|NCT00242710|5025666|P3|Core Study (up to Year 1)|Randomized but not Treated|4
1534607|NCT00242710|5025667|P2|Core Study (up to Year 1)|Randomized but not Treated|4
1534608|NCT00242710|5025668|P1|Core Study (up to Year 1)|Randomized but not Treated|12
1534609|NCT00242710|5025665|P4|Core Study (up to Year 1)|Lack of Efficacy|0
1534610|NCT00242710|5025666|P3|Core Study (up to Year 1)|Lack of Efficacy|0
1534611|NCT00242710|5025667|P2|Core Study (up to Year 1)|Lack of Efficacy|0
1534612|NCT00242710|5025668|P1|Core Study (up to Year 1)|Lack of Efficacy|1
1534613|NCT00242710|5025665|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
1534614|NCT00242710|5025666|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
1534615|NCT00242710|5025667|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
1534616|NCT00242710|5025668|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
1534617|NCT00242710|5025665|P4|Core Study (up to Year 1)|Protocol Violation|3
1534618|NCT00242710|5025666|P3|Core Study (up to Year 1)|Protocol Violation|1
1534619|NCT00242710|5025667|P2|Core Study (up to Year 1)|Protocol Violation|9
1534620|NCT00242710|5025668|P1|Core Study (up to Year 1)|Protocol Violation|2
1534621|NCT00242710|5025665|P4|Core Study (up to Year 1)|Other|2
1534622|NCT00242710|5025666|P3|Core Study (up to Year 1)|Other|0
1534623|NCT00242710|5025667|P2|Core Study (up to Year 1)|Other|1
1534624|NCT00242710|5025668|P1|Core Study (up to Year 1)|Other|6
1534625|NCT00242710|5025665|P4|Core Study (up to Year 1)|Lost to Follow-up|3
1534626|NCT00242710|5025666|P3|Core Study (up to Year 1)|Lost to Follow-up|7
1534627|NCT00242710|5025667|P2|Core Study (up to Year 1)|Lost to Follow-up|8
1534628|NCT00242710|5025668|P1|Core Study (up to Year 1)|Lost to Follow-up|8
1534629|NCT00242710|5025665|P4|Core Study (up to Year 1)|Physician Decision|1
1534630|NCT00242710|5025666|P3|Core Study (up to Year 1)|Physician Decision|0
1534631|NCT00242710|5025667|P2|Core Study (up to Year 1)|Physician Decision|1
1534632|NCT00242710|5025668|P1|Core Study (up to Year 1)|Physician Decision|0
1534633|NCT00242710|5025665|P4|Core Study (up to Year 1)|Death|0
1534634|NCT00242710|5025666|P3|Core Study (up to Year 1)|Death|1
1534635|NCT00242710|5025667|P2|Core Study (up to Year 1)|Death|0
1534636|NCT00242710|5025668|P1|Core Study (up to Year 1)|Death|0
1534637|NCT00242710|5025665|P4|Core Study (up to Year 1)|Adverse Event|14
1534638|NCT00242710|5025666|P3|Core Study (up to Year 1)|Adverse Event|23
1534639|NCT00242710|5025667|P2|Core Study (up to Year 1)|Adverse Event|25
1534640|NCT00242710|5025668|P1|Core Study (up to Year 1)|Adverse Event|30
1534641|NCT00242658|5025725|P2|Overall Study|Lost to Follow-up|19
1534642|NCT00242658|5025726|P1|Overall Study|Lost to Follow-up|22
1534643|NCT00242580|5025757|P3|Overall Study|Death|1
1534644|NCT00242580|5025758|P2|Overall Study|Death|2
1534645|NCT00242580|5025759|P1|Overall Study|Death|1
1534646|NCT00242580|5025757|P3|Overall Study|Lost to Follow-up|0
1534647|NCT00242580|5025758|P2|Overall Study|Lost to Follow-up|3
1534648|NCT00242580|5025759|P1|Overall Study|Lost to Follow-up|0
1534649|NCT00242580|5025757|P3|Overall Study|Subject withdrew consent|5
1534650|NCT00242580|5025758|P2|Overall Study|Subject withdrew consent|2
1534651|NCT00242580|5025759|P1|Overall Study|Subject withdrew consent|2
1534652|NCT00242580|5025757|P3|Overall Study|Protocol Violation|1
1534653|NCT00242580|5025758|P2|Overall Study|Protocol Violation|0
1534654|NCT00242580|5025759|P1|Overall Study|Protocol Violation|0
1534655|NCT00242580|5025757|P3|Overall Study|Unsatisfactory therapeutic effect|5
1534656|NCT00242580|5025758|P2|Overall Study|Unsatisfactory therapeutic effect|5
1534657|NCT00242580|5025759|P1|Overall Study|Unsatisfactory therapeutic effect|4
1534658|NCT00242580|5025757|P3|Overall Study|Adverse Event|2
1534659|NCT00242580|5025758|P2|Overall Study|Adverse Event|0
1534660|NCT00242580|5025759|P1|Overall Study|Adverse Event|3
1534661|NCT00242567|5025784|P2|Overall Study|Other|9
1534662|NCT00242567|5025785|P1|Overall Study|Other|14
1534663|NCT00242567|5025784|P2|Overall Study|Use of an inhibitor of bone resorption|2
1534664|NCT00242567|5025785|P1|Overall Study|Use of an inhibitor of bone resorption|0
1534665|NCT00242567|5025784|P2|Overall Study|Protocol Violation|12
1534666|NCT00242567|5025785|P1|Overall Study|Protocol Violation|12
1534667|NCT00242567|5025784|P2|Overall Study|Withdrawal by Subject|28
1534668|NCT00242567|5025785|P1|Overall Study|Withdrawal by Subject|33
1534669|NCT00242567|5025784|P2|Overall Study|Lost to Follow-up|19
1534670|NCT00242567|5025785|P1|Overall Study|Lost to Follow-up|9
1534671|NCT00242567|5025784|P2|Overall Study|Lack of Efficacy|2
1534672|NCT00242567|5025785|P1|Overall Study|Lack of Efficacy|2
1534673|NCT00242567|5025784|P2|Overall Study|Symptomatic deterioration|3
1534674|NCT00242567|5025785|P1|Overall Study|Symptomatic deterioration|9
1534675|NCT00242567|5025784|P2|Overall Study|Disease Progression|22
1534676|NCT00242567|5025785|P1|Overall Study|Disease Progression|17
1534677|NCT00242567|5025784|P2|Overall Study|Adverse Event|43
1534678|NCT00242567|5025785|P1|Overall Study|Adverse Event|70
1534680|NCT00242216|5025833|P1|Overall Study|no medicaiton dispensed|1
1534681|NCT00242216|5025832|P2|Overall Study|Lack of Efficacy|2
1534682|NCT00242216|5025833|P1|Overall Study|Lack of Efficacy|1
1534683|NCT00242216|5025832|P2|Overall Study|Death|2
1534684|NCT00242216|5025833|P1|Overall Study|Death|4
1534685|NCT00242216|5025832|P2|Overall Study|Lost to Follow-up|17
1534686|NCT00242216|5025833|P1|Overall Study|Lost to Follow-up|12
1534687|NCT00241839|5025871|P2|Overall Study|Adverse Event|1
1534688|NCT00241839|5025872|P1|Overall Study|Adverse Event|1
1534689|NCT00241839|5025871|P2|Overall Study|Withdrawal by Subject|17
1534690|NCT00241839|5025872|P1|Overall Study|Withdrawal by Subject|18
1534691|NCT00241644|5025888|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
1534692|NCT00241644|5025889|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
1534693|NCT00241644|5025890|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
1534694|NCT00241644|5025891|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
1534695|NCT00241644|5025888|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
1534696|NCT00241644|5025889|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
1534697|NCT00241644|5025890|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
1534698|NCT00241644|5025891|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
1534699|NCT00241644|5025888|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
1534700|NCT00241644|5025889|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
1534701|NCT00241644|5025890|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
1534702|NCT00241644|5025891|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
1534703|NCT00241644|5025888|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
1534704|NCT00241644|5025889|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
1534705|NCT00241644|5025890|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
1534706|NCT00241644|5025891|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
1534707|NCT00241644|5025888|P4|Second Efficacy Period (Year 2)|Adverse Event|20
1534708|NCT00241644|5025889|P3|Second Efficacy Period (Year 2)|Adverse Event|12
1534709|NCT00241644|5025890|P2|Second Efficacy Period (Year 2)|Adverse Event|9
1534710|NCT00241644|5025891|P1|Second Efficacy Period (Year 2)|Adverse Event|11
1534711|NCT00241644|5025888|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
1534712|NCT00241644|5025889|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
1534713|NCT00241644|5025890|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
1534714|NCT00241644|5025891|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
1534715|NCT00241644|5025888|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
1534716|NCT00241644|5025889|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
1534717|NCT00241644|5025890|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
1534718|NCT00241644|5025891|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
1534719|NCT00241644|5025888|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
1534720|NCT00241644|5025889|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
1534721|NCT00241644|5025890|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
1534722|NCT00241644|5025891|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
1534723|NCT00241644|5025888|P4|First Efficacy Period (Year 1)|Non-compliance|3
1534724|NCT00241644|5025889|P3|First Efficacy Period (Year 1)|Non-compliance|2
1534725|NCT00241644|5025890|P2|First Efficacy Period (Year 1)|Non-compliance|1
1534726|NCT00241644|5025891|P1|First Efficacy Period (Year 1)|Non-compliance|2
1534727|NCT00241644|5025888|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
1534728|NCT00241644|5025889|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
1534729|NCT00241644|5025890|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
1534730|NCT00241644|5025891|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
1534731|NCT00241644|5025888|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
1534732|NCT00241644|5025889|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
1534733|NCT00241644|5025890|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
1534734|NCT00241644|5025891|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
1534735|NCT00241644|5025888|P4|First Efficacy Period (Year 1)|Protocol Violation|8
1534736|NCT00241644|5025889|P3|First Efficacy Period (Year 1)|Protocol Violation|4
1534737|NCT00241644|5025890|P2|First Efficacy Period (Year 1)|Protocol Violation|5
1534738|NCT00241644|5025891|P1|First Efficacy Period (Year 1)|Protocol Violation|3
1534739|NCT00241644|5025888|P4|First Efficacy Period (Year 1)|Adverse Event|91
1534740|NCT00241644|5025889|P3|First Efficacy Period (Year 1)|Adverse Event|45
1534741|NCT00241644|5025890|P2|First Efficacy Period (Year 1)|Adverse Event|45
1534742|NCT00241644|5025891|P1|First Efficacy Period (Year 1)|Adverse Event|46
1534743|NCT00241358|5025976|P3|Overall Study|Determined to be not ineligible|1
1534744|NCT00241358|5025977|P2|Overall Study|Determined to be not ineligible|1
1534745|NCT00241358|5025978|P1|Overall Study|Determined to be not ineligible|0
1534746|NCT00241280|5026011|P2|Overall Study|Excessive Dryness|1
1534747|NCT00241280|5026012|P1|Overall Study|Excessive Dryness|0
1534748|NCT00241280|5026011|P2|Overall Study|Coating on Lens|0
1534749|NCT00241280|5026012|P1|Overall Study|Coating on Lens|1
1534750|NCT00241280|5026011|P2|Overall Study|History of Ocular Surgery|1
1534751|NCT00241280|5026012|P1|Overall Study|History of Ocular Surgery|0
1534752|NCT00241280|5026011|P2|Overall Study|Scheduling Conflict|2
1534753|NCT00241280|5026012|P1|Overall Study|Scheduling Conflict|0
1534754|NCT00241280|5026011|P2|Overall Study|Unacceptable Fit|1
1534755|NCT00241280|5026012|P1|Overall Study|Unacceptable Fit|0
1534756|NCT00241280|5026011|P2|Overall Study|Dispensed incorrect test article|2
1534757|NCT00241280|5026012|P1|Overall Study|Dispensed incorrect test article|1
1534758|NCT00241280|5026011|P2|Overall Study|Subject Ineligible/Dispensed|6
1534759|NCT00241280|5026012|P1|Overall Study|Subject Ineligible/Dispensed|9
1534760|NCT00241280|5026011|P2|Overall Study|Diabetic|0
1534761|NCT00241280|5026012|P1|Overall Study|Diabetic|1
1534762|NCT00241280|5026011|P2|Overall Study|Unsatisfactory Visual Response|1
1534763|NCT00241280|5026012|P1|Overall Study|Unsatisfactory Visual Response|1
1534764|NCT00241280|5026011|P2|Overall Study|Unsatisfactory Physiological Response|1
1534765|NCT00241280|5026012|P1|Overall Study|Unsatisfactory Physiological Response|1
1534766|NCT00241280|5026011|P2|Overall Study|Relocation|4
1534767|NCT00241280|5026012|P1|Overall Study|Relocation|4
1534768|NCT00241280|5026011|P2|Overall Study|Protocol Violation|10
1534769|NCT00241280|5026012|P1|Overall Study|Protocol Violation|4
1534770|NCT00241280|5026011|P2|Overall Study|Withdrawal by Subject|4
1534771|NCT00241280|5026012|P1|Overall Study|Withdrawal by Subject|7
1534772|NCT00241280|5026011|P2|Overall Study|Lost to Follow-up|8
1534773|NCT00241280|5026012|P1|Overall Study|Lost to Follow-up|5
1534774|NCT00241280|5026011|P2|Overall Study|Pregnancy|5
1534775|NCT00241280|5026012|P1|Overall Study|Pregnancy|1
1534776|NCT00241280|5026011|P2|Overall Study|Discomfort|16
1534777|NCT00241280|5026012|P1|Overall Study|Discomfort|11
1534778|NCT00241280|5026011|P2|Overall Study|Adverse Event|6
1534779|NCT00241280|5026012|P1|Overall Study|Adverse Event|2
1534780|NCT00240994|5026027|P1|Overall Study|Graft failure|1
1534781|NCT00240994|5026027|P1|Overall Study|Protocol Violation|1
1534782|NCT00240994|5026027|P1|Overall Study|Lost to Follow-up|1
1534783|NCT00240331|5026162|P2|Overall Study|Option selected by investigator|2
1534784|NCT00240331|5026163|P1|Overall Study|Option selected by investigator|1
1534785|NCT00240331|5026162|P2|Overall Study|Withdrawal by Subject|132
1534786|NCT00240331|5026163|P1|Overall Study|Withdrawal by Subject|125
1534787|NCT00240110|5026206|P2|Overall Study|Lost to Follow-up|7
1534788|NCT00240110|5026207|P1|Overall Study|Lost to Follow-up|6
1534789|NCT00240097|5026215|P1|Part II|did not continue from Part I|23
1534790|NCT00240097|5026215|P1|Part I|unevaluable|1
1534791|NCT00240097|5026215|P1|Part I|histology|1
1534792|NCT00240097|5026215|P1|Part I|Death|1
1534793|NCT00240097|5026215|P1|Part I|Adverse Event|1
1534794|NCT00240071|5026225|P1|Overall Study|Withdrawal by Subject|3
1534795|NCT00239928|5026230|P1|Overall Study|Withdrawal by Subject|2
1534796|NCT00239928|5026230|P1|Overall Study|Not need to continue study|3
1534797|NCT00239928|5026230|P1|Overall Study|Adverse Event|4
1534798|NCT00239928|5026230|P1|Overall Study|Lack of Efficacy|1
1534799|NCT00239837|5026242|P2|Overall Study|Lost to Follow-up|7
1534800|NCT00239837|5026243|P1|Overall Study|Lost to Follow-up|3
1534801|NCT00239720|5026270|P2|Overall Study|Lost to Follow-up|1
1534802|NCT00239720|5026271|P1|Overall Study|Lost to Follow-up|0
1534803|NCT00239720|5026270|P2|Overall Study|Adverse Event|0
1534804|NCT00239720|5026271|P1|Overall Study|Adverse Event|1
1534805|NCT00239681|5026279|P2|Overall Study|No information chacked on CaseReportForm|84
1534806|NCT00239681|5026280|P1|Overall Study|No information chacked on CaseReportForm|90
1534807|NCT00239681|5026279|P2|Overall Study|Physician Decision|17
1534808|NCT00239681|5026280|P1|Overall Study|Physician Decision|13
1534809|NCT00239681|5026279|P2|Overall Study|Protocol Violation|4
1534810|NCT00239681|5026280|P1|Overall Study|Protocol Violation|4
1534811|NCT00239681|5026279|P2|Overall Study|Lost to Follow-up|22
1534812|NCT00239681|5026280|P1|Overall Study|Lost to Follow-up|28
1534813|NCT00239681|5026279|P2|Overall Study|Withdrawal by Subject|489
1534814|NCT00239681|5026280|P1|Overall Study|Withdrawal by Subject|458
1534815|NCT00239681|5026279|P2|Overall Study|Adverse Event|99
1534816|NCT00239681|5026280|P1|Overall Study|Adverse Event|100
1534817|NCT00239356|5026335|P2|Overall Study|Drug available on market|2
1534818|NCT00239356|5026336|P1|Overall Study|Drug available on market|11
1534819|NCT00239356|5026335|P2|Overall Study|Administrative reason|1
1534820|NCT00239356|5026336|P1|Overall Study|Administrative reason|0
1534821|NCT00239356|5026335|P2|Overall Study|Pregnancy|0
1534822|NCT00239356|5026336|P1|Overall Study|Pregnancy|1
1534823|NCT00239356|5026335|P2|Overall Study|poor/non-compliance|0
1534824|NCT00239356|5026336|P1|Overall Study|poor/non-compliance|2
1534825|NCT00239356|5026335|P2|Overall Study|Lost to Follow-up|0
1534826|NCT00239356|5026336|P1|Overall Study|Lost to Follow-up|3
1534827|NCT00239356|5026335|P2|Overall Study|Withdrawal by Subject|6
1534828|NCT00239356|5026336|P1|Overall Study|Withdrawal by Subject|15
1534829|NCT00239356|5026335|P2|Overall Study|Adverse Event|0
1534830|NCT00239356|5026336|P1|Overall Study|Adverse Event|6
1534831|NCT00239356|5026335|P2|Overall Study|Lack of Efficacy|0
1534832|NCT00239356|5026336|P1|Overall Study|Lack of Efficacy|1
1534833|NCT00239226|5026358|P4|Overall Study|Lost to Follow-up|0
1534834|NCT00239226|5026359|P3|Overall Study|Lost to Follow-up|1
1534835|NCT00239226|5026360|P2|Overall Study|Lost to Follow-up|0
1534836|NCT00239226|5026361|P1|Overall Study|Lost to Follow-up|1
1534837|NCT00239226|5026358|P4|Overall Study|permAF during stabilization period|3
1534838|NCT00239226|5026359|P3|Overall Study|permAF during stabilization period|0
1534839|NCT00239226|5026360|P2|Overall Study|permAF during stabilization period|0
1534840|NCT00239226|5026361|P1|Overall Study|permAF during stabilization period|0
1534841|NCT00239005|5026373|P2|Overall Study|Lost to Follow-up|1
1534842|NCT00239005|5026374|P1|Overall Study|Lost to Follow-up|0
1534843|NCT00239005|5026373|P2|Overall Study|Subj. cond. no longer needs study drug|1
1534844|NCT00239005|5026374|P1|Overall Study|Subj. cond. no longer needs study drug|0
1534845|NCT00239005|5026373|P2|Overall Study|Protocol Violation|0
1534846|NCT00239005|5026374|P1|Overall Study|Protocol Violation|1
1534847|NCT00239005|5026373|P2|Overall Study|Unsatisfactory Therapeutic effect|0
1534848|NCT00239005|5026374|P1|Overall Study|Unsatisfactory Therapeutic effect|2
1534849|NCT00239005|5026373|P2|Overall Study|Withdrawal by Subject|4
1534850|NCT00239005|5026374|P1|Overall Study|Withdrawal by Subject|3
1534851|NCT00239005|5026373|P2|Overall Study|Adverse Event|6
1534852|NCT00239005|5026374|P1|Overall Study|Adverse Event|6
1534853|NCT00238433|5026390|P1|Overall Study|Death|1
1534854|NCT00238433|5026390|P1|Overall Study|Lost to Follow-up|1
1534855|NCT00238433|5026390|P1|Overall Study|Screen failure|1
1534856|NCT00238420|5026397|P2|Overall Study|Protocol Violation|1
1534857|NCT00238420|5026398|P1|Overall Study|Protocol Violation|1
1534858|NCT00238303|5026415|P3|Overall Study|Adverse Event|3
1534859|NCT00238303|5026416|P2|Overall Study|Adverse Event|1
1534860|NCT00238303|5026417|P1|Overall Study|Adverse Event|0
1534861|NCT00238303|5026415|P3|Overall Study|Poor tolerance of study treatment|1
1534862|NCT00238303|5026416|P2|Overall Study|Poor tolerance of study treatment|0
1534863|NCT00238303|5026417|P1|Overall Study|Poor tolerance of study treatment|1
1534864|NCT00238303|5026415|P3|Overall Study|Other Medical Problems|2
1534865|NCT00238303|5026416|P2|Overall Study|Other Medical Problems|0
1534866|NCT00238303|5026417|P1|Overall Study|Other Medical Problems|2
1534867|NCT00238303|5026415|P3|Overall Study|Death|1
1534868|NCT00238303|5026416|P2|Overall Study|Death|0
1534869|NCT00238303|5026417|P1|Overall Study|Death|1
1534870|NCT00238303|5026415|P3|Overall Study|Withdrawal by Subject|2
1534871|NCT00238303|5026416|P2|Overall Study|Withdrawal by Subject|1
1534872|NCT00238303|5026417|P1|Overall Study|Withdrawal by Subject|11
1534873|NCT00238264|5026434|P1|Overall Study|Ineligible|7
1534874|NCT00238264|5026434|P1|Overall Study|Withdrawal by Subject|4
1534875|NCT00238264|5026434|P1|Overall Study|Lost to Follow-up|18
1534876|NCT00238264|5026434|P1|Overall Study|Death|7
1534877|NCT00238238|5026447|P3|Overall Study|Withdrawal by Subject|0
1534878|NCT00238238|5026448|P2|Overall Study|Withdrawal by Subject|3
1534879|NCT00238238|5026449|P1|Overall Study|Withdrawal by Subject|0
1534880|NCT00238121|5026462|P2|Overall Study|Adverse Event|1
1534881|NCT00238121|5026463|P1|Overall Study|Adverse Event|2
1534882|NCT00238121|5026462|P2|Overall Study|Withdrawal by Subject|1
1534883|NCT00238121|5026463|P1|Overall Study|Withdrawal by Subject|1
1534884|NCT00237809|5026489|P4|Overall Study|Lost to Follow-up|9
1534885|NCT00237809|5026490|P3|Overall Study|Lost to Follow-up|9
1534886|NCT00237809|5026491|P2|Overall Study|Lost to Follow-up|10
1534887|NCT00237809|5026492|P1|Overall Study|Lost to Follow-up|11
1534888|NCT00237796|5026528|P2|Overall Study|Baseline and one other ILSS required|5
1534889|NCT00237796|5026529|P1|Overall Study|Baseline and one other ILSS required|10
1534890|NCT00237744|5026563|P3|Overall Study|Withdrawal by Subject|0
1534891|NCT00237744|5026564|P2|Overall Study|Withdrawal by Subject|1
1534892|NCT00237744|5026565|P1|Overall Study|Withdrawal by Subject|3
1534893|NCT00237692|5026591|P4|Overall Study|Withdrawal by Subject|4
1534894|NCT00237692|5026592|P3|Overall Study|Withdrawal by Subject|10
1534895|NCT00237692|5026593|P2|Overall Study|Withdrawal by Subject|6
1534896|NCT00237692|5026594|P1|Overall Study|Withdrawal by Subject|4
1534897|NCT00237692|5026591|P4|Overall Study|Excluded - did not meet criteria|9
1534898|NCT00237692|5026592|P3|Overall Study|Excluded - did not meet criteria|5
1534899|NCT00237692|5026593|P2|Overall Study|Excluded - did not meet criteria|3
1534900|NCT00237692|5026594|P1|Overall Study|Excluded - did not meet criteria|4
1534901|NCT00237692|5026591|P4|Overall Study|Death|3
1534902|NCT00237692|5026592|P3|Overall Study|Death|2
1534903|NCT00237692|5026593|P2|Overall Study|Death|2
1534904|NCT00237692|5026594|P1|Overall Study|Death|1
1534905|NCT00237692|5026591|P4|Overall Study|Lost to Follow-up|3
1534906|NCT00237692|5026592|P3|Overall Study|Lost to Follow-up|5
1534907|NCT00237692|5026593|P2|Overall Study|Lost to Follow-up|3
1534908|NCT00237692|5026594|P1|Overall Study|Lost to Follow-up|9
1534909|NCT00237458|5026634|P1|Overall Study|Withdrawal by Subject|1
1534910|NCT00237458|5026634|P1|Overall Study|Adverse Event|1
1534911|NCT00237458|5026634|P1|Overall Study|Lack of Efficacy|1
1534912|NCT00237185|5026652|P2|Extension|Death|1
1534913|NCT00237185|5026653|P1|Extension|Death|1
1534914|NCT00237185|5026652|P2|Extension|Administrative problems|0
1534915|NCT00237185|5026653|P1|Extension|Administrative problems|1
1534916|NCT00237185|5026652|P2|Extension|Lost to Follow-up|0
1534917|NCT00237185|5026653|P1|Extension|Lost to Follow-up|1
1534918|NCT00237185|5026652|P2|Extension|Withdrawal by Subject|2
1534919|NCT00237185|5026653|P1|Extension|Withdrawal by Subject|3
1534920|NCT00237185|5026652|P2|Extension|Condition no longer required study drug|1
1534921|NCT00237185|5026653|P1|Extension|Condition no longer required study drug|0
1534922|NCT00237185|5026652|P2|Extension|Lack of Efficacy|14
1534923|NCT00237185|5026653|P1|Extension|Lack of Efficacy|9
1534924|NCT00237185|5026652|P2|Extension|Abnormal laboratory value|1
1534925|NCT00237185|5026653|P1|Extension|Abnormal laboratory value|0
1534926|NCT00237185|5026652|P2|Extension|Adverse Event|0
1534927|NCT00237185|5026653|P1|Extension|Adverse Event|1
1534928|NCT00237185|5026652|P2|Core|Determined ineligible post randomization|0
1534929|NCT00237185|5026653|P1|Core|Determined ineligible post randomization|1
1534930|NCT00237185|5026652|P2|Core|Death|0
1534931|NCT00237185|5026653|P1|Core|Death|4
1534932|NCT00237185|5026652|P2|Core|Administrative problems|1
1534933|NCT00237185|5026653|P1|Core|Administrative problems|0
1534934|NCT00237185|5026652|P2|Core|Withdrawal by Subject|4
1534935|NCT00237185|5026653|P1|Core|Withdrawal by Subject|4
1534936|NCT00237185|5026652|P2|Core|Protocol Violation|1
1534937|NCT00237185|5026653|P1|Core|Protocol Violation|1
1534938|NCT00237185|5026652|P2|Core|Lack of Efficacy|23
1534939|NCT00237185|5026653|P1|Core|Lack of Efficacy|30
1534940|NCT00237185|5026652|P2|Core|Abnormal test procedure results|0
1534941|NCT00237185|5026653|P1|Core|Abnormal test procedure results|1
1534942|NCT00237185|5026652|P2|Core|Abnormal laboratory value|4
1534943|NCT00237185|5026653|P1|Core|Abnormal laboratory value|0
1534944|NCT00237185|5026652|P2|Core|Adverse Event|4
1534945|NCT00237185|5026653|P1|Core|Adverse Event|3
1534946|NCT00237042|5026684|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
1534947|NCT00237042|5026685|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
1534948|NCT00237042|5026686|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
1534949|NCT00237042|5026684|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
1534950|NCT00237042|5026685|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
1534951|NCT00237042|5026686|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
1534952|NCT00237042|5026684|P3|Treatment|Completed no treatment|21
1534953|NCT00237042|5026685|P2|Treatment|Completed no treatment|5
1534954|NCT00237042|5026686|P1|Treatment|Completed no treatment|5
1534955|NCT00237042|5026684|P3|Treatment|Moved out of state|1
1534956|NCT00237042|5026685|P2|Treatment|Moved out of state|1
1534957|NCT00237042|5026686|P1|Treatment|Moved out of state|1
1534958|NCT00237042|5026684|P3|Treatment|Became ineligible post-randomization|16
1534959|NCT00237042|5026685|P2|Treatment|Became ineligible post-randomization|1
1534960|NCT00237042|5026686|P1|Treatment|Became ineligible post-randomization|0
1534961|NCT00236899|5026760|P4|Overall Study|Lack of Efficacy|23
1534962|NCT00236899|5026761|P3|Overall Study|Lack of Efficacy|25
1534963|NCT00236899|5026762|P2|Overall Study|Lack of Efficacy|18
1534964|NCT00236899|5026763|P1|Overall Study|Lack of Efficacy|18
1534965|NCT00236899|5026760|P4|Overall Study|Satisfactory Response|1
1534966|NCT00236899|5026761|P3|Overall Study|Satisfactory Response|0
1534967|NCT00236899|5026762|P2|Overall Study|Satisfactory Response|0
1534968|NCT00236899|5026763|P1|Overall Study|Satisfactory Response|2
1534969|NCT00236899|5026760|P4|Overall Study|Physician Decision|6
1534970|NCT00236899|5026761|P3|Overall Study|Physician Decision|7
1534971|NCT00236899|5026762|P2|Overall Study|Physician Decision|8
1534972|NCT00236899|5026763|P1|Overall Study|Physician Decision|7
1534973|NCT00236899|5026760|P4|Overall Study|Withdrawal by Subject|2
1534974|NCT00236899|5026761|P3|Overall Study|Withdrawal by Subject|5
1534975|NCT00236899|5026762|P2|Overall Study|Withdrawal by Subject|4
1534976|NCT00236899|5026763|P1|Overall Study|Withdrawal by Subject|6
1534977|NCT00236899|5026760|P4|Overall Study|Protocol Violation|0
1534978|NCT00236899|5026761|P3|Overall Study|Protocol Violation|0
1534979|NCT00236899|5026762|P2|Overall Study|Protocol Violation|0
1534980|NCT00236899|5026763|P1|Overall Study|Protocol Violation|1
1534981|NCT00236899|5026760|P4|Overall Study|Entry Criteria Exclusion|0
1534982|NCT00236899|5026761|P3|Overall Study|Entry Criteria Exclusion|1
1534983|NCT00236899|5026762|P2|Overall Study|Entry Criteria Exclusion|1
1534984|NCT00236899|5026763|P1|Overall Study|Entry Criteria Exclusion|0
1534985|NCT00236899|5026760|P4|Overall Study|Lost to Follow-up|0
1534986|NCT00236899|5026761|P3|Overall Study|Lost to Follow-up|0
1534987|NCT00236899|5026762|P2|Overall Study|Lost to Follow-up|1
1534988|NCT00236899|5026763|P1|Overall Study|Lost to Follow-up|0
1534989|NCT00236899|5026760|P4|Overall Study|Death (Study Drug Toxicity)|0
1534990|NCT00236899|5026761|P3|Overall Study|Death (Study Drug Toxicity)|0
1534991|NCT00236899|5026762|P2|Overall Study|Death (Study Drug Toxicity)|0
1534992|NCT00236899|5026763|P1|Overall Study|Death (Study Drug Toxicity)|1
1534993|NCT00236899|5026760|P4|Overall Study|Death (Not Study Related)|0
1534994|NCT00236899|5026761|P3|Overall Study|Death (Not Study Related)|0
1534995|NCT00236899|5026762|P2|Overall Study|Death (Not Study Related)|0
1534996|NCT00236899|5026763|P1|Overall Study|Death (Not Study Related)|2
1534997|NCT00236899|5026760|P4|Overall Study|Death (Study Disease)|0
1534998|NCT00236899|5026761|P3|Overall Study|Death (Study Disease)|0
1534999|NCT00236899|5026762|P2|Overall Study|Death (Study Disease)|4
1535000|NCT00236899|5026763|P1|Overall Study|Death (Study Disease)|1
1535001|NCT00236899|5026760|P4|Overall Study|Adverse Event (Not Study Related)|7
1535002|NCT00236899|5026761|P3|Overall Study|Adverse Event (Not Study Related)|4
1535003|NCT00236899|5026762|P2|Overall Study|Adverse Event (Not Study Related)|3
1535004|NCT00236899|5026763|P1|Overall Study|Adverse Event (Not Study Related)|3
1535005|NCT00236899|5026760|P4|Overall Study|Adverse Event (Study Related)|1
1535006|NCT00236899|5026761|P3|Overall Study|Adverse Event (Study Related)|2
1535007|NCT00236899|5026762|P2|Overall Study|Adverse Event (Study Related)|1
1535008|NCT00236899|5026763|P1|Overall Study|Adverse Event (Study Related)|1
1535009|NCT00236197|5026795|P2|Overall Study|Other|2
1535010|NCT00236197|5026796|P1|Overall Study|Other|0
1535011|NCT00236197|5026795|P2|Overall Study|Medication non-compliance|2
1535012|NCT00236197|5026796|P1|Overall Study|Medication non-compliance|1
1535013|NCT00236197|5026795|P2|Overall Study|Protocol Violation|3
1535014|NCT00236197|5026796|P1|Overall Study|Protocol Violation|0
1535015|NCT00236197|5026795|P2|Overall Study|Lost to Follow-up|5
1535016|NCT00236197|5026796|P1|Overall Study|Lost to Follow-up|1
1535017|NCT00236197|5026795|P2|Overall Study|Withdrawal by Subject|2
1535018|NCT00236197|5026796|P1|Overall Study|Withdrawal by Subject|3
1535019|NCT00236184|5026804|P2|Overall Study|other|2
1535020|NCT00236184|5026805|P1|Overall Study|other|1
1535021|NCT00236184|5026804|P2|Overall Study|non-compliance with study drug|1
1535022|NCT00236184|5026805|P1|Overall Study|non-compliance with study drug|2
1535023|NCT00236184|5026804|P2|Overall Study|Protocol Violation|0
1535024|NCT00236184|5026805|P1|Overall Study|Protocol Violation|3
1535025|NCT00236184|5026804|P2|Overall Study|Withdrawal by Subject|0
1535026|NCT00236184|5026805|P1|Overall Study|Withdrawal by Subject|3
1535027|NCT00236184|5026804|P2|Overall Study|Physician Decision|1
1535028|NCT00236184|5026805|P1|Overall Study|Physician Decision|1
1535029|NCT00236184|5026804|P2|Overall Study|Lost to Follow-up|4
1535030|NCT00236184|5026805|P1|Overall Study|Lost to Follow-up|3
1535031|NCT00236184|5026804|P2|Overall Study|Lack of Efficacy|1
1535032|NCT00236184|5026805|P1|Overall Study|Lack of Efficacy|0
1535033|NCT00236184|5026804|P2|Overall Study|Adverse Event|2
1535034|NCT00236184|5026805|P1|Overall Study|Adverse Event|5
1535035|NCT00236080|5026816|P5|Overall Study|Miscellaneous|0
1535036|NCT00236080|5026817|P4|Overall Study|Miscellaneous|0
1535037|NCT00236080|5026818|P3|Overall Study|Miscellaneous|1
1535038|NCT00236080|5026819|P2|Overall Study|Miscellaneous|0
1535039|NCT00236080|5026820|P1|Overall Study|Miscellaneous|0
1535040|NCT00236080|5026816|P5|Overall Study|Withdrawal by Subject|0
1535041|NCT00236080|5026817|P4|Overall Study|Withdrawal by Subject|0
1535042|NCT00236080|5026818|P3|Overall Study|Withdrawal by Subject|0
1535043|NCT00236080|5026819|P2|Overall Study|Withdrawal by Subject|0
1535044|NCT00236080|5026820|P1|Overall Study|Withdrawal by Subject|1
1535045|NCT00236080|5026816|P5|Overall Study|Physician Decision|1
1535046|NCT00236080|5026817|P4|Overall Study|Physician Decision|1
1535047|NCT00236080|5026818|P3|Overall Study|Physician Decision|1
1535048|NCT00236080|5026819|P2|Overall Study|Physician Decision|0
1535049|NCT00236080|5026820|P1|Overall Study|Physician Decision|1
1535050|NCT00236080|5026816|P5|Overall Study|Lost to Follow-up|0
1535051|NCT00236080|5026817|P4|Overall Study|Lost to Follow-up|0
1535052|NCT00236080|5026818|P3|Overall Study|Lost to Follow-up|0
1535053|NCT00236080|5026819|P2|Overall Study|Lost to Follow-up|1
1535054|NCT00236080|5026820|P1|Overall Study|Lost to Follow-up|0
1535055|NCT00236080|5026816|P5|Overall Study|Adverse Event|0
1535056|NCT00236080|5026817|P4|Overall Study|Adverse Event|1
1535057|NCT00236080|5026818|P3|Overall Study|Adverse Event|3
1535058|NCT00236080|5026819|P2|Overall Study|Adverse Event|0
1535059|NCT00236080|5026820|P1|Overall Study|Adverse Event|0
1535060|NCT00235989|5026841|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
1535061|NCT00235989|5026842|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
1535062|NCT00235989|5026843|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
1535063|NCT00235989|5026844|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
1535064|NCT00235989|5026845|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
1535065|NCT00235989|5026846|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
1535066|NCT00235989|5026841|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
1535067|NCT00235989|5026842|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
1535068|NCT00235989|5026843|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
1535069|NCT00235989|5026844|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
1535070|NCT00235989|5026845|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
1535071|NCT00235989|5026846|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
1535072|NCT00235989|5026841|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
1535073|NCT00235989|5026842|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
1535074|NCT00235989|5026843|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
1535075|NCT00235989|5026844|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
1535076|NCT00235989|5026845|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
1535077|NCT00235989|5026846|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
1535078|NCT00235989|5026841|P6|Extension Treatment Period (ET)|Adverse Event|0
1535079|NCT00235989|5026842|P5|Extension Treatment Period (ET)|Adverse Event|0
1535080|NCT00235989|5026843|P4|Extension Treatment Period (ET)|Adverse Event|0
1535081|NCT00235989|5026844|P3|Extension Treatment Period (ET)|Adverse Event|2
1535082|NCT00235989|5026845|P2|Extension Treatment Period (ET)|Adverse Event|0
1535083|NCT00235989|5026846|P1|Extension Treatment Period (ET)|Adverse Event|3
1535084|NCT00235989|5026841|P6|Core Treatment Period (CT)|Lost to Follow-up|2
1535085|NCT00235989|5026842|P5|Core Treatment Period (CT)|Lost to Follow-up|0
1535086|NCT00235989|5026843|P4|Core Treatment Period (CT)|Lost to Follow-up|0
1535087|NCT00235989|5026844|P3|Core Treatment Period (CT)|Lost to Follow-up|0
1535088|NCT00235989|5026845|P2|Core Treatment Period (CT)|Lost to Follow-up|0
1535089|NCT00235989|5026846|P1|Core Treatment Period (CT)|Lost to Follow-up|0
1535090|NCT00235872|5026860|P1|Overall Study|Administrative reason|61
1535091|NCT00235872|5026860|P1|Overall Study|Withdrawal by Subject|50
1535092|NCT00235872|5026860|P1|Overall Study|Lost to Follow-up|1
1535093|NCT00235872|5026860|P1|Overall Study|Death|1
1535094|NCT00235872|5026860|P1|Overall Study|Adverse Event|34
1535095|NCT00235755|5026891|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
1535096|NCT00235755|5026892|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
1535097|NCT00235755|5026893|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
1535098|NCT00235755|5026891|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
1535099|NCT00235755|5026892|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
1535100|NCT00235755|5026893|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
1535101|NCT00235755|5026891|P3|12-Week Maintenance Phase|Protocol Violation|2
1535102|NCT00235755|5026892|P2|12-Week Maintenance Phase|Protocol Violation|4
1535103|NCT00235755|5026893|P1|12-Week Maintenance Phase|Protocol Violation|0
1535104|NCT00235755|5026891|P3|12-Week Maintenance Phase|Lack of Efficacy|0
1535105|NCT00235755|5026892|P2|12-Week Maintenance Phase|Lack of Efficacy|0
1535106|NCT00235755|5026893|P1|12-Week Maintenance Phase|Lack of Efficacy|5
1535107|NCT00235755|5026891|P3|12-Week Maintenance Phase|Lost to Follow-up|0
1535108|NCT00235755|5026892|P2|12-Week Maintenance Phase|Lost to Follow-up|3
1535109|NCT00235755|5026893|P1|12-Week Maintenance Phase|Lost to Follow-up|2
1535110|NCT00235755|5026891|P3|12-Week Maintenance Phase|Adverse Event|26
1535111|NCT00235755|5026892|P2|12-Week Maintenance Phase|Adverse Event|12
1535112|NCT00235755|5026893|P1|12-Week Maintenance Phase|Adverse Event|8
1535113|NCT00235755|5026891|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
1535114|NCT00235755|5026892|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
1535115|NCT00235755|5026893|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
1535116|NCT00235755|5026891|P3|4-Week Titration Phase|Randomization Occurred in Error|0
1535117|NCT00235755|5026892|P2|4-Week Titration Phase|Randomization Occurred in Error|0
1535118|NCT00235755|5026893|P1|4-Week Titration Phase|Randomization Occurred in Error|1
1535119|NCT00235755|5026891|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
1535120|NCT00235755|5026892|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
1535121|NCT00235755|5026893|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
1535122|NCT00235755|5026891|P3|4-Week Titration Phase|Withdrawal by Subject|3
1535123|NCT00235755|5026892|P2|4-Week Titration Phase|Withdrawal by Subject|2
1535124|NCT00235755|5026893|P1|4-Week Titration Phase|Withdrawal by Subject|1
1535125|NCT00235755|5026891|P3|4-Week Titration Phase|Protocol Violation|1
1535126|NCT00235755|5026892|P2|4-Week Titration Phase|Protocol Violation|2
1535127|NCT00235755|5026893|P1|4-Week Titration Phase|Protocol Violation|2
1535128|NCT00235755|5026891|P3|4-Week Titration Phase|Lost to Follow-up|1
1535129|NCT00235755|5026892|P2|4-Week Titration Phase|Lost to Follow-up|1
1535130|NCT00235755|5026893|P1|4-Week Titration Phase|Lost to Follow-up|0
1535131|NCT00235755|5026891|P3|4-Week Titration Phase|Adverse Event|20
1535132|NCT00235755|5026892|P2|4-Week Titration Phase|Adverse Event|14
1535133|NCT00235755|5026893|P1|4-Week Titration Phase|Adverse Event|6
1535134|NCT00235716|5026971|P4|Overall Study|Physician Decision|3
1535135|NCT00235716|5026972|P3|Overall Study|Physician Decision|1
1535136|NCT00235716|5026973|P2|Overall Study|Physician Decision|1
1535137|NCT00235716|5026974|P1|Overall Study|Physician Decision|0
1535138|NCT00235716|5026971|P4|Overall Study|Adverse Event|0
1535139|NCT00235716|5026972|P3|Overall Study|Adverse Event|1
1535140|NCT00235716|5026973|P2|Overall Study|Adverse Event|1
1535141|NCT00235716|5026974|P1|Overall Study|Adverse Event|1
1535142|NCT00235716|5026971|P4|Overall Study|Lost to Follow-up|10
1535143|NCT00235716|5026972|P3|Overall Study|Lost to Follow-up|14
1535144|NCT00235716|5026973|P2|Overall Study|Lost to Follow-up|7
1535145|NCT00235716|5026974|P1|Overall Study|Lost to Follow-up|12
1535146|NCT00235716|5026971|P4|Overall Study|Withdrawal by Subject|18
1535147|NCT00235716|5026972|P3|Overall Study|Withdrawal by Subject|17
1535148|NCT00235716|5026973|P2|Overall Study|Withdrawal by Subject|19
1535149|NCT00235716|5026974|P1|Overall Study|Withdrawal by Subject|23
1535150|NCT00235716|5026971|P4|Overall Study|Death|31
1535151|NCT00235716|5026972|P3|Overall Study|Death|32
1535152|NCT00235716|5026973|P2|Overall Study|Death|39
1535153|NCT00235716|5026974|P1|Overall Study|Death|26
1535154|NCT00235443|5027037|P6|Overall Study|Other reasons for premature termination|6
1535155|NCT00235443|5027038|P5|Overall Study|Other reasons for premature termination|3
1535156|NCT00235443|5027039|P4|Overall Study|Other reasons for premature termination|7
1535157|NCT00235443|5027040|P3|Overall Study|Other reasons for premature termination|6
1535158|NCT00235443|5027041|P2|Overall Study|Other reasons for premature termination|6
1535159|NCT00235443|5027042|P1|Overall Study|Other reasons for premature termination|1
1535160|NCT00235443|5027037|P6|Overall Study|Unsatisfactory compliance|0
1535161|NCT00235443|5027038|P5|Overall Study|Unsatisfactory compliance|1
1535162|NCT00235443|5027039|P4|Overall Study|Unsatisfactory compliance|4
1535163|NCT00235443|5027040|P3|Overall Study|Unsatisfactory compliance|3
1535164|NCT00235443|5027041|P2|Overall Study|Unsatisfactory compliance|2
1535165|NCT00235443|5027042|P1|Overall Study|Unsatisfactory compliance|0
1535166|NCT00235443|5027037|P6|Overall Study|Lost to Follow-up|3
1535167|NCT00235443|5027038|P5|Overall Study|Lost to Follow-up|4
1535168|NCT00235443|5027039|P4|Overall Study|Lost to Follow-up|6
1535169|NCT00235443|5027040|P3|Overall Study|Lost to Follow-up|6
1535170|NCT00235443|5027041|P2|Overall Study|Lost to Follow-up|8
1535171|NCT00235443|5027042|P1|Overall Study|Lost to Follow-up|0
1535172|NCT00235443|5027037|P6|Overall Study|Withdrawal by Subject|12
1535173|NCT00235443|5027038|P5|Overall Study|Withdrawal by Subject|10
1535174|NCT00235443|5027039|P4|Overall Study|Withdrawal by Subject|24
1535175|NCT00235443|5027040|P3|Overall Study|Withdrawal by Subject|25
1535176|NCT00235443|5027041|P2|Overall Study|Withdrawal by Subject|9
1535177|NCT00235443|5027042|P1|Overall Study|Withdrawal by Subject|3
1535178|NCT00235443|5027037|P6|Overall Study|Lack of Efficacy|9
1535179|NCT00235443|5027038|P5|Overall Study|Lack of Efficacy|2
1535180|NCT00235443|5027039|P4|Overall Study|Lack of Efficacy|12
1535181|NCT00235443|5027040|P3|Overall Study|Lack of Efficacy|5
1535182|NCT00235443|5027041|P2|Overall Study|Lack of Efficacy|1
1535183|NCT00235443|5027042|P1|Overall Study|Lack of Efficacy|0
1535184|NCT00235443|5027037|P6|Overall Study|Adverse Event|15
1535185|NCT00235443|5027038|P5|Overall Study|Adverse Event|10
1535186|NCT00235443|5027039|P4|Overall Study|Adverse Event|44
1535187|NCT00235443|5027040|P3|Overall Study|Adverse Event|17
1535188|NCT00235443|5027041|P2|Overall Study|Adverse Event|12
1535189|NCT00235443|5027042|P1|Overall Study|Adverse Event|4
1535190|NCT00235391|5027183|P6|Overall Study|Death|0
1535191|NCT00235391|5027184|P5|Overall Study|Death|0
1535192|NCT00235391|5027185|P4|Overall Study|Death|4
1535193|NCT00235391|5027186|P3|Overall Study|Death|1
1535194|NCT00235391|5027187|P2|Overall Study|Death|0
1535195|NCT00235391|5027188|P1|Overall Study|Death|0
1535196|NCT00235391|5027183|P6|Overall Study|Administrative problems|0
1535197|NCT00235391|5027184|P5|Overall Study|Administrative problems|0
1535198|NCT00235391|5027185|P4|Overall Study|Administrative problems|1
1535199|NCT00235391|5027186|P3|Overall Study|Administrative problems|0
1535200|NCT00235391|5027187|P2|Overall Study|Administrative problems|0
1535201|NCT00235391|5027188|P1|Overall Study|Administrative problems|0
1535202|NCT00235391|5027183|P6|Overall Study|Lost to Follow-up|0
1535203|NCT00235391|5027184|P5|Overall Study|Lost to Follow-up|0
1535204|NCT00235391|5027185|P4|Overall Study|Lost to Follow-up|16
1535205|NCT00235391|5027186|P3|Overall Study|Lost to Follow-up|3
1535206|NCT00235391|5027187|P2|Overall Study|Lost to Follow-up|3
1535207|NCT00235391|5027188|P1|Overall Study|Lost to Follow-up|0
1535208|NCT00235391|5027183|P6|Overall Study|Withdrawal by Subject|0
1535209|NCT00235391|5027184|P5|Overall Study|Withdrawal by Subject|5
1535210|NCT00235391|5027185|P4|Overall Study|Withdrawal by Subject|61
1535211|NCT00235391|5027186|P3|Overall Study|Withdrawal by Subject|3
1535212|NCT00235391|5027187|P2|Overall Study|Withdrawal by Subject|3
1535213|NCT00235391|5027188|P1|Overall Study|Withdrawal by Subject|2
1535214|NCT00235391|5027183|P6|Overall Study|Protocol deviation|0
1535215|NCT00235391|5027184|P5|Overall Study|Protocol deviation|0
1535216|NCT00235391|5027185|P4|Overall Study|Protocol deviation|11
1535217|NCT00235391|5027186|P3|Overall Study|Protocol deviation|1
1535218|NCT00235391|5027187|P2|Overall Study|Protocol deviation|0
1535219|NCT00235391|5027188|P1|Overall Study|Protocol deviation|0
1535220|NCT00235391|5027183|P6|Overall Study|Condition no longer requires treatment|0
1535221|NCT00235391|5027184|P5|Overall Study|Condition no longer requires treatment|1
1535222|NCT00235391|5027185|P4|Overall Study|Condition no longer requires treatment|11
1535223|NCT00235391|5027186|P3|Overall Study|Condition no longer requires treatment|0
1535224|NCT00235391|5027187|P2|Overall Study|Condition no longer requires treatment|0
1535225|NCT00235391|5027188|P1|Overall Study|Condition no longer requires treatment|3
1535226|NCT00235391|5027183|P6|Overall Study|Unsatisfactory therapeutic effect|0
1535227|NCT00235391|5027184|P5|Overall Study|Unsatisfactory therapeutic effect|0
1535228|NCT00235391|5027185|P4|Overall Study|Unsatisfactory therapeutic effect|17
1535229|NCT00235391|5027186|P3|Overall Study|Unsatisfactory therapeutic effect|2
1535230|NCT00235391|5027187|P2|Overall Study|Unsatisfactory therapeutic effect|2
1535231|NCT00235391|5027188|P1|Overall Study|Unsatisfactory therapeutic effect|0
1535232|NCT00235391|5027183|P6|Overall Study|Abnormal laboratory value(s)|2
1535233|NCT00235391|5027184|P5|Overall Study|Abnormal laboratory value(s)|1
1535234|NCT00235391|5027185|P4|Overall Study|Abnormal laboratory value(s)|27
1535235|NCT00235391|5027186|P3|Overall Study|Abnormal laboratory value(s)|4
1535236|NCT00235391|5027187|P2|Overall Study|Abnormal laboratory value(s)|5
1535237|NCT00235391|5027188|P1|Overall Study|Abnormal laboratory value(s)|3
1535238|NCT00235391|5027183|P6|Overall Study|Adverse Event|2
1535239|NCT00235391|5027184|P5|Overall Study|Adverse Event|5
1535240|NCT00235391|5027185|P4|Overall Study|Adverse Event|72
1535241|NCT00235391|5027186|P3|Overall Study|Adverse Event|10
1535242|NCT00235391|5027187|P2|Overall Study|Adverse Event|5
1535243|NCT00235391|5027188|P1|Overall Study|Adverse Event|4
1535244|NCT00235326|5027205|P2|Overall Study|Lost to Follow-up|1400
1535245|NCT00235326|5027206|P1|Overall Study|Lost to Follow-up|746
1535246|NCT00234533|5027246|P1|Overall Study|Enrolled but not treated|3
1535247|NCT00234533|5027246|P1|Overall Study|Adverse Event|2
1535248|NCT00234533|5027246|P1|Overall Study|Withdrawal by Subject|6
1535249|NCT00234494|5027265|P1|Overall Study|Protocol Violation|2
1535250|NCT00234104|5027311|P4|Overall Study|Physician Decision|2
1535251|NCT00234104|5027312|P3|Overall Study|Physician Decision|2
1535252|NCT00234104|5027313|P2|Overall Study|Physician Decision|1
1535253|NCT00234104|5027314|P1|Overall Study|Physician Decision|0
1535254|NCT00234104|5027311|P4|Overall Study|Protocol Violation|1
1535255|NCT00234104|5027312|P3|Overall Study|Protocol Violation|0
1535256|NCT00234104|5027313|P2|Overall Study|Protocol Violation|0
1535257|NCT00234104|5027314|P1|Overall Study|Protocol Violation|0
1535258|NCT00234104|5027311|P4|Overall Study|Adverse Event|5
1535259|NCT00234104|5027312|P3|Overall Study|Adverse Event|3
1535260|NCT00234104|5027313|P2|Overall Study|Adverse Event|0
1535261|NCT00234104|5027314|P1|Overall Study|Adverse Event|4
1535262|NCT00234065|5027355|P2|Overall Study|Not Classified|112
1535263|NCT00234065|5027356|P1|Overall Study|Not Classified|111
1535264|NCT00234065|5027355|P2|Overall Study|Physician Decision|22
1535265|NCT00234065|5027356|P1|Overall Study|Physician Decision|23
1535266|NCT00234065|5027355|P2|Overall Study|Withdrawal by Subject|56
1535267|NCT00234065|5027356|P1|Overall Study|Withdrawal by Subject|73
1535268|NCT00234065|5027355|P2|Overall Study|Adverse Event|166
1535269|NCT00234065|5027356|P1|Overall Study|Adverse Event|268
1535270|NCT00234039|5027372|P1|Overall Study|No Protocol Treatment Received|2
1535271|NCT00234039|5027372|P1|Overall Study|Ineligible|9
1535272|NCT00234039|5027372|P1|Overall Study|Other - Not Protocol Specified|3
1535273|NCT00234039|5027372|P1|Overall Study|Progression/relapse|34
1535274|NCT00234039|5027372|P1|Overall Study|Adverse Event|2
1535275|NCT00233987|5027379|P1|Overall Study|Ineligible|4
1535276|NCT00233987|5027379|P1|Overall Study|Eligible but No Treatment Received|2
1535277|NCT00233987|5027379|P1|Overall Study|Other - Not Protocol Specified|5
1535278|NCT00233987|5027379|P1|Overall Study|Reason Under Review|1
1535279|NCT00233987|5027379|P1|Overall Study|Lack of Efficacy|2
1535280|NCT00233987|5027379|P1|Overall Study|Withdrawal by Subject|1
1535281|NCT00233948|5027388|P6|Overall Study|Adverse Event|0
1535282|NCT00233948|5027389|P5|Overall Study|Adverse Event|0
1535283|NCT00233948|5027390|P4|Overall Study|Adverse Event|0
1535284|NCT00233948|5027391|P3|Overall Study|Adverse Event|0
1535285|NCT00233948|5027392|P2|Overall Study|Adverse Event|0
1535286|NCT00233948|5027393|P1|Overall Study|Adverse Event|1
1535287|NCT00233454|5027417|P1|Overall Study|Death|6
1535288|NCT00233402|5027424|P2|Overall Study|Lost to follow up etc|21
1535289|NCT00233402|5027425|P1|Overall Study|Lost to follow up etc|3
1535290|NCT00233402|5027424|P2|Overall Study|No Ta/T1|94
1535291|NCT00233402|5027425|P1|Overall Study|No Ta/T1|89
1535292|NCT00233402|5027424|P2|Overall Study|No pathology data|9
1535293|NCT00233402|5027425|P1|Overall Study|No pathology data|12
1535294|NCT00233324|5027440|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
1535295|NCT00233324|5027441|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
1535296|NCT00233324|5027442|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
1535297|NCT00233324|5027443|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
1535298|NCT00233324|5027440|P4|Follow up at 18-22 Months Corrected Age|Death|4
1535299|NCT00233324|5027441|P3|Follow up at 18-22 Months Corrected Age|Death|5
1535300|NCT00233324|5027442|P2|Follow up at 18-22 Months Corrected Age|Death|7
1535301|NCT00233324|5027443|P1|Follow up at 18-22 Months Corrected Age|Death|5
1535302|NCT00233324|5027440|P4|Main Study|Death|47
1535303|NCT00233324|5027441|P3|Main Study|Death|62
1535304|NCT00233324|5027442|P2|Main Study|Death|60
1535305|NCT00233324|5027443|P1|Main Study|Death|68
1535306|NCT00233064|5027497|P2|Overall Study|Moved to Dom. Republic|0
1535307|NCT00233064|5027498|P1|Overall Study|Moved to Dom. Republic|1
1535308|NCT00233064|5027497|P2|Overall Study|Protocol Violation|0
1535309|NCT00233064|5027498|P1|Overall Study|Protocol Violation|1
1535310|NCT00233064|5027497|P2|Overall Study|Relocation|1
1535311|NCT00233064|5027498|P1|Overall Study|Relocation|0
1535312|NCT00233064|5027497|P2|Overall Study|Death|1
1535313|NCT00233064|5027498|P1|Overall Study|Death|0
1535314|NCT00233064|5027497|P2|Overall Study|Withdrawal by Subject|3
1535315|NCT00233064|5027498|P1|Overall Study|Withdrawal by Subject|5
1535316|NCT00233064|5027497|P2|Overall Study|Lost to Follow-up|7
1535317|NCT00233064|5027498|P1|Overall Study|Lost to Follow-up|7
1535318|NCT00232596|5027524|P2|12-Week Maintenance Phase|Other|3
1535319|NCT00232596|5027525|P1|12-Week Maintenance Phase|Other|1
1535320|NCT00232596|5027524|P2|12-Week Maintenance Phase|Protocol Violation|1
1535321|NCT00232596|5027525|P1|12-Week Maintenance Phase|Protocol Violation|3
1535322|NCT00232596|5027524|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
1535323|NCT00232596|5027525|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
1535324|NCT00232596|5027524|P2|12-Week Maintenance Phase|Adverse Event|22
1535325|NCT00232596|5027525|P1|12-Week Maintenance Phase|Adverse Event|7
1535326|NCT00232596|5027524|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
1535327|NCT00232596|5027525|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
1535328|NCT00232596|5027524|P2|6-Week Titration Phase|Other|3
1535329|NCT00232596|5027525|P1|6-Week Titration Phase|Other|3
1535330|NCT00232596|5027524|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
1535331|NCT00232596|5027525|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
1535332|NCT00232596|5027524|P2|6-Week Titration Phase|Protocol Violation|3
1535333|NCT00232596|5027525|P1|6-Week Titration Phase|Protocol Violation|1
1535334|NCT00232596|5027524|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
1535335|NCT00232596|5027525|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
1535336|NCT00232596|5027524|P2|6-Week Titration Phase|Failed to Return|1
1535337|NCT00232596|5027525|P1|6-Week Titration Phase|Failed to Return|2
1535338|NCT00232596|5027524|P2|6-Week Titration Phase|Adverse Event|19
1535339|NCT00232596|5027525|P1|6-Week Titration Phase|Adverse Event|6
1535340|NCT00232557|5027616|P2|Overall Study|Lost to Follow-up|5
1535341|NCT00232557|5027617|P1|Overall Study|Lost to Follow-up|3
1535342|NCT00232544|5027627|P2|Overall Study|Lost to Follow-up|15
1535343|NCT00232544|5027628|P1|Overall Study|Lost to Follow-up|20
1535344|NCT00232180|5027659|P3|Open Label Phase|Randomized but not treated|1
1535345|NCT00232180|5027660|P2|Open Label Phase|Randomized but not treated|0
1535346|NCT00232180|5027661|P1|Open Label Phase|Randomized but not treated|0
1535347|NCT00232180|5027659|P3|Open Label Phase|Laboratory abnormality|10
1535348|NCT00232180|5027660|P2|Open Label Phase|Laboratory abnormality|0
1535349|NCT00232180|5027661|P1|Open Label Phase|Laboratory abnormality|0
1535350|NCT00232180|5027659|P3|Open Label Phase|Adverse Event|25
1535351|NCT00232180|5027660|P2|Open Label Phase|Adverse Event|0
1535352|NCT00232180|5027661|P1|Open Label Phase|Adverse Event|0
1535353|NCT00232180|5027659|P3|Open Label Phase|Other|16
1535354|NCT00232180|5027660|P2|Open Label Phase|Other|0
1535355|NCT00232180|5027661|P1|Open Label Phase|Other|0
1535356|NCT00232180|5027659|P3|Open Label Phase|Withdrawal by Subject|37
1535357|NCT00232180|5027660|P2|Open Label Phase|Withdrawal by Subject|0
1535358|NCT00232180|5027661|P1|Open Label Phase|Withdrawal by Subject|0
1535359|NCT00232180|5027659|P3|Open Label Phase|Study terminated by sponsor|3
1535360|NCT00232180|5027660|P2|Open Label Phase|Study terminated by sponsor|0
1535361|NCT00232180|5027661|P1|Open Label Phase|Study terminated by sponsor|0
1535362|NCT00232180|5027659|P3|Open Label Phase|Protocol Violation|3
1535363|NCT00232180|5027660|P2|Open Label Phase|Protocol Violation|0
1535364|NCT00232180|5027661|P1|Open Label Phase|Protocol Violation|0
1535365|NCT00232180|5027659|P3|Open Label Phase|Lost to Follow-up|5
1535366|NCT00232180|5027660|P2|Open Label Phase|Lost to Follow-up|0
1535367|NCT00232180|5027661|P1|Open Label Phase|Lost to Follow-up|0
1535368|NCT00232180|5027659|P3|Open Label Phase|Death|48
1535369|NCT00232180|5027660|P2|Open Label Phase|Death|0
1535370|NCT00232180|5027661|P1|Open Label Phase|Death|0
1535371|NCT00232180|5027659|P3|Double-blind (DB) Phase|Laboratory abnormality|0
1535372|NCT00232180|5027660|P2|Double-blind (DB) Phase|Laboratory abnormality|7
1535373|NCT00232180|5027661|P1|Double-blind (DB) Phase|Laboratory abnormality|6
1535374|NCT00232180|5027659|P3|Double-blind (DB) Phase|Randomized but not treated|0
1535375|NCT00232180|5027660|P2|Double-blind (DB) Phase|Randomized but not treated|4
1535376|NCT00232180|5027661|P1|Double-blind (DB) Phase|Randomized but not treated|3
1535377|NCT00232180|5027659|P3|Double-blind (DB) Phase|Other|0
1535378|NCT00232180|5027660|P2|Double-blind (DB) Phase|Other|75
1535379|NCT00232180|5027661|P1|Double-blind (DB) Phase|Other|70
1535380|NCT00232180|5027659|P3|Double-blind (DB) Phase|Adverse Event|0
1535381|NCT00232180|5027660|P2|Double-blind (DB) Phase|Adverse Event|100
1535382|NCT00232180|5027661|P1|Double-blind (DB) Phase|Adverse Event|83
1535383|NCT00232180|5027659|P3|Double-blind (DB) Phase|Protocol Violation|0
1535384|NCT00232180|5027660|P2|Double-blind (DB) Phase|Protocol Violation|21
1535385|NCT00232180|5027661|P1|Double-blind (DB) Phase|Protocol Violation|28
1535386|NCT00232180|5027659|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
1535387|NCT00232180|5027660|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
1535388|NCT00232180|5027661|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
1535389|NCT00232180|5027659|P3|Double-blind (DB) Phase|Lost to Follow-up|0
1535390|NCT00232180|5027660|P2|Double-blind (DB) Phase|Lost to Follow-up|28
1535391|NCT00232180|5027661|P1|Double-blind (DB) Phase|Lost to Follow-up|34
1535392|NCT00232180|5027659|P3|Double-blind (DB) Phase|Death|0
1535393|NCT00232180|5027660|P2|Double-blind (DB) Phase|Death|222
1535394|NCT00232180|5027661|P1|Double-blind (DB) Phase|Death|186
1535395|NCT00232141|5027706|P2|Overall Study|Withdrawal by Subject|3
1535396|NCT00232141|5027707|P1|Overall Study|Withdrawal by Subject|5
1535397|NCT00232141|5027706|P2|Overall Study|Other|10
1535398|NCT00232141|5027707|P1|Overall Study|Other|8
1535399|NCT00232141|5027706|P2|Overall Study|Lost to Follow-up|6
1535400|NCT00232141|5027707|P1|Overall Study|Lost to Follow-up|9
1535401|NCT00232141|5027706|P2|Overall Study|Lack of Efficacy|3
1535402|NCT00232141|5027707|P1|Overall Study|Lack of Efficacy|0
1535403|NCT00232141|5027706|P2|Overall Study|Adverse Event|4
1535404|NCT00232141|5027707|P1|Overall Study|Adverse Event|9
1535405|NCT00231894|5027777|P2|Overall Study|Withdrawal by Subject|1
1535406|NCT00231894|5027778|P1|Overall Study|Withdrawal by Subject|1
1535407|NCT00231816|5027802|P2|Overall Study|Not Specified|1
1535408|NCT00231816|5027803|P1|Overall Study|Not Specified|2
1535409|NCT00231816|5027802|P2|Overall Study|Withdrawal by Subject|3
1535410|NCT00231816|5027803|P1|Overall Study|Withdrawal by Subject|3
1535411|NCT00231816|5027802|P2|Overall Study|Protocol Violation|3
1535412|NCT00231816|5027803|P1|Overall Study|Protocol Violation|2
1535413|NCT00231816|5027802|P2|Overall Study|Lost to Follow-up|5
1535414|NCT00231816|5027803|P1|Overall Study|Lost to Follow-up|8
1535415|NCT00231816|5027802|P2|Overall Study|Adverse Event|0
1535416|NCT00231816|5027803|P1|Overall Study|Adverse Event|1
1535417|NCT00231777|5027818|P2|Overall Study|Other|2
1535418|NCT00231777|5027819|P1|Overall Study|Other|3
1535419|NCT00231777|5027818|P2|Overall Study|Lost to Follow-up|0
1535420|NCT00231777|5027819|P1|Overall Study|Lost to Follow-up|3
1535421|NCT00231478|5027833|P2|Overall Study|Administrative|2
1535422|NCT00231478|5027834|P1|Overall Study|Administrative|3
1535423|NCT00231478|5027833|P2|Overall Study|Adverse Event|1
1535424|NCT00231478|5027834|P1|Overall Study|Adverse Event|0
1535425|NCT00231478|5027833|P2|Overall Study|Withdrawal by Subject|0
1535426|NCT00231478|5027834|P1|Overall Study|Withdrawal by Subject|1
1535427|NCT00231478|5027833|P2|Overall Study|Refused Treatment|1
1535428|NCT00231478|5027834|P1|Overall Study|Refused Treatment|1
1535429|NCT00231478|5027833|P2|Overall Study|Protocol Violation|2
1535430|NCT00231478|5027834|P1|Overall Study|Protocol Violation|3
1535431|NCT00231465|5027846|P1|Overall Study|Did not have follow up CT scans|1
1535432|NCT00231465|5027846|P1|Overall Study|Completed only one cycle|1
1535433|NCT00231179|5027866|P2|Overall Study|Withdrawal by Subject|3
1535434|NCT00231179|5027867|P1|Overall Study|Withdrawal by Subject|3
1535435|NCT00231179|5027866|P2|Overall Study|Lost to Follow-up|21
1535436|NCT00231179|5027867|P1|Overall Study|Lost to Follow-up|21
1535437|NCT00231114|5027894|P2|Post-Treatment Period|Withdrawal by Subject|0
1535438|NCT00231114|5027895|P1|Post-Treatment Period|Withdrawal by Subject|1
1535439|NCT00231114|5027894|P2|Post-Treatment Period|Physician Decision|0
1535440|NCT00231114|5027895|P1|Post-Treatment Period|Physician Decision|1
1535441|NCT00231114|5027894|P2|Post-Treatment Period|Lost to Follow-up|1
1535442|NCT00231114|5027895|P1|Post-Treatment Period|Lost to Follow-up|6
1535443|NCT00231114|5027894|P2|Treatment Period|Death: Motor Vehicle Accident|0
1535444|NCT00231114|5027895|P1|Treatment Period|Death: Motor Vehicle Accident|1
1535445|NCT00231114|5027894|P2|Randomized|Withdrawal by Subject|3
1535446|NCT00231114|5027895|P1|Randomized|Withdrawal by Subject|6
1535447|NCT00231062|5027931|P1|Overall Study|Physician Decision|6
1535448|NCT00230971|5027939|P2|Baseline Participants|Reintervention|0
1535449|NCT00230971|5027940|P1|Baseline Participants|Reintervention|1
1535450|NCT00230971|5027939|P2|Baseline Participants|Failure to return|1
1535451|NCT00230971|5027940|P1|Baseline Participants|Failure to return|1
1535452|NCT00230971|5027939|P2|Baseline Participants|No bacteria observed|0
1535453|NCT00230971|5027940|P1|Baseline Participants|No bacteria observed|1
1535454|NCT00230971|5027939|P2|Baseline Participants|Adverse Event|0
1535455|NCT00230971|5027940|P1|Baseline Participants|Adverse Event|1
1535456|NCT00230971|5027939|P2|Baseline Participants|Withdrawal by Subject|1
1535457|NCT00230971|5027940|P1|Baseline Participants|Withdrawal by Subject|7
1535458|NCT00230971|5027939|P2|Baseline Participants|Death|5
1535459|NCT00230971|5027940|P1|Baseline Participants|Death|6
1535460|NCT00230971|5027939|P2|Baseline Participants|Lost to Follow-up|12
1535461|NCT00230971|5027940|P1|Baseline Participants|Lost to Follow-up|5
1535462|NCT00230971|5027939|P2|Randomization|No study drug administered|3
1535463|NCT00230971|5027940|P1|Randomization|No study drug administered|3
1535464|NCT00230282|5027978|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
1535465|NCT00230282|5027978|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
1535466|NCT00230282|5027978|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
1535467|NCT00230282|5027978|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
1535468|NCT00230178|5027986|P3|Overall Study|Various other reasons|4
1535469|NCT00230178|5027987|P2|Overall Study|Various other reasons|2
1535470|NCT00230178|5027988|P1|Overall Study|Various other reasons|3
1535471|NCT00230178|5027986|P3|Overall Study|Withdrawal by Subject|1
1535472|NCT00230178|5027987|P2|Overall Study|Withdrawal by Subject|0
1535473|NCT00230178|5027988|P1|Overall Study|Withdrawal by Subject|0
1535474|NCT00230178|5027986|P3|Overall Study|Adverse Event|2
1535475|NCT00230178|5027987|P2|Overall Study|Adverse Event|5
1535476|NCT00230178|5027988|P1|Overall Study|Adverse Event|1
1535477|NCT00230048|5028040|P2|Overall Study|Lost to Follow-up|18
1535478|NCT00230048|5028041|P1|Overall Study|Lost to Follow-up|13
1535479|NCT00229931|5028099|P2|Overall Study|Lost to Follow-up|2
1535480|NCT00229931|5028100|P1|Overall Study|Lost to Follow-up|3
1535481|NCT00229931|5028099|P2|Overall Study|Death|0
1535482|NCT00229931|5028100|P1|Overall Study|Death|1
1535483|NCT00229723|5028115|P7|Maintenance Phase|Other|1
1535484|NCT00229723|5028116|P6|Maintenance Phase|Other|3
1535485|NCT00229723|5028117|P5|Maintenance Phase|Other|3
1535486|NCT00229723|5028118|P4|Maintenance Phase|Other|2
1535487|NCT00229723|5028119|P3|Maintenance Phase|Other|1
1535488|NCT00229723|5028120|P2|Maintenance Phase|Other|4
1535489|NCT00229723|5028121|P1|Maintenance Phase|Other|5
1535490|NCT00229723|5028115|P7|Maintenance Phase|Severe non-compliance|0
1535491|NCT00229723|5028116|P6|Maintenance Phase|Severe non-compliance|0
1535492|NCT00229723|5028117|P5|Maintenance Phase|Severe non-compliance|1
1535493|NCT00229723|5028118|P4|Maintenance Phase|Severe non-compliance|0
1535494|NCT00229723|5028119|P3|Maintenance Phase|Severe non-compliance|0
1535495|NCT00229723|5028120|P2|Maintenance Phase|Severe non-compliance|1
1535496|NCT00229723|5028121|P1|Maintenance Phase|Severe non-compliance|3
1535497|NCT00229723|5028115|P7|Maintenance Phase|Informed consent withdrawn|0
1535498|NCT00229723|5028116|P6|Maintenance Phase|Informed consent withdrawn|1
1535499|NCT00229723|5028117|P5|Maintenance Phase|Informed consent withdrawn|1
1535500|NCT00229723|5028118|P4|Maintenance Phase|Informed consent withdrawn|1
1535501|NCT00229723|5028119|P3|Maintenance Phase|Informed consent withdrawn|0
1535502|NCT00229723|5028120|P2|Maintenance Phase|Informed consent withdrawn|0
1535503|NCT00229723|5028121|P1|Maintenance Phase|Informed consent withdrawn|1
1535504|NCT00229723|5028115|P7|Maintenance Phase|Lost to Follow-up|1
1535505|NCT00229723|5028116|P6|Maintenance Phase|Lost to Follow-up|0
1535506|NCT00229723|5028117|P5|Maintenance Phase|Lost to Follow-up|0
1535507|NCT00229723|5028118|P4|Maintenance Phase|Lost to Follow-up|2
1535508|NCT00229723|5028119|P3|Maintenance Phase|Lost to Follow-up|2
1535509|NCT00229723|5028120|P2|Maintenance Phase|Lost to Follow-up|1
1535510|NCT00229723|5028121|P1|Maintenance Phase|Lost to Follow-up|0
1535511|NCT00229723|5028115|P7|Maintenance Phase|Clinical progression|1
1535512|NCT00229723|5028116|P6|Maintenance Phase|Clinical progression|1
1535513|NCT00229723|5028117|P5|Maintenance Phase|Clinical progression|1
1535514|NCT00229723|5028118|P4|Maintenance Phase|Clinical progression|2
1535515|NCT00229723|5028119|P3|Maintenance Phase|Clinical progression|2
1535516|NCT00229723|5028120|P2|Maintenance Phase|Clinical progression|1
1535517|NCT00229723|5028121|P1|Maintenance Phase|Clinical progression|4
1535518|NCT00229723|5028115|P7|Maintenance Phase|Objective disease progression|5
1535519|NCT00229723|5028116|P6|Maintenance Phase|Objective disease progression|9
1535520|NCT00229723|5028117|P5|Maintenance Phase|Objective disease progression|2
1535521|NCT00229723|5028118|P4|Maintenance Phase|Objective disease progression|6
1535522|NCT00229723|5028119|P3|Maintenance Phase|Objective disease progression|3
1535523|NCT00229723|5028120|P2|Maintenance Phase|Objective disease progression|5
1535524|NCT00229723|5028121|P1|Maintenance Phase|Objective disease progression|5
1535525|NCT00229723|5028115|P7|Maintenance Phase|Adverse Event|2
1535526|NCT00229723|5028116|P6|Maintenance Phase|Adverse Event|5
1535527|NCT00229723|5028117|P5|Maintenance Phase|Adverse Event|7
1535528|NCT00229723|5028118|P4|Maintenance Phase|Adverse Event|4
1535529|NCT00229723|5028119|P3|Maintenance Phase|Adverse Event|1
1535530|NCT00229723|5028120|P2|Maintenance Phase|Adverse Event|2
1535531|NCT00229723|5028121|P1|Maintenance Phase|Adverse Event|7
1535532|NCT00229723|5028115|P7|Concomitant Phase|Other|0
1535533|NCT00229723|5028116|P6|Concomitant Phase|Other|2
1535534|NCT00229723|5028117|P5|Concomitant Phase|Other|0
1535535|NCT00229723|5028118|P4|Concomitant Phase|Other|1
1535536|NCT00229723|5028119|P3|Concomitant Phase|Other|1
1535537|NCT00229723|5028120|P2|Concomitant Phase|Other|0
1535538|NCT00229723|5028121|P1|Concomitant Phase|Other|3
1535539|NCT00229723|5028115|P7|Concomitant Phase|Severe non-compliance|0
1535540|NCT00229723|5028116|P6|Concomitant Phase|Severe non-compliance|0
1535541|NCT00229723|5028117|P5|Concomitant Phase|Severe non-compliance|1
1535542|NCT00229723|5028118|P4|Concomitant Phase|Severe non-compliance|0
1535543|NCT00229723|5028119|P3|Concomitant Phase|Severe non-compliance|0
1535544|NCT00229723|5028120|P2|Concomitant Phase|Severe non-compliance|1
1535545|NCT00229723|5028121|P1|Concomitant Phase|Severe non-compliance|0
1535546|NCT00229723|5028115|P7|Concomitant Phase|Informed consent withdrawn|0
1535547|NCT00229723|5028116|P6|Concomitant Phase|Informed consent withdrawn|0
1535548|NCT00229723|5028117|P5|Concomitant Phase|Informed consent withdrawn|0
1535549|NCT00229723|5028118|P4|Concomitant Phase|Informed consent withdrawn|2
1535550|NCT00229723|5028119|P3|Concomitant Phase|Informed consent withdrawn|0
1535551|NCT00229723|5028120|P2|Concomitant Phase|Informed consent withdrawn|2
1535552|NCT00229723|5028121|P1|Concomitant Phase|Informed consent withdrawn|3
1535553|NCT00229723|5028115|P7|Concomitant Phase|Lost to Follow-up|0
1535554|NCT00229723|5028116|P6|Concomitant Phase|Lost to Follow-up|0
1535555|NCT00229723|5028117|P5|Concomitant Phase|Lost to Follow-up|1
1535556|NCT00229723|5028118|P4|Concomitant Phase|Lost to Follow-up|0
1535557|NCT00229723|5028119|P3|Concomitant Phase|Lost to Follow-up|0
1535558|NCT00229723|5028120|P2|Concomitant Phase|Lost to Follow-up|0
1535559|NCT00229723|5028121|P1|Concomitant Phase|Lost to Follow-up|0
1535560|NCT00229723|5028115|P7|Concomitant Phase|Clinical progression|1
1535561|NCT00229723|5028116|P6|Concomitant Phase|Clinical progression|0
1535562|NCT00229723|5028117|P5|Concomitant Phase|Clinical progression|0
1535563|NCT00229723|5028118|P4|Concomitant Phase|Clinical progression|0
1535564|NCT00229723|5028119|P3|Concomitant Phase|Clinical progression|0
1535565|NCT00229723|5028120|P2|Concomitant Phase|Clinical progression|0
1535566|NCT00229723|5028121|P1|Concomitant Phase|Clinical progression|0
1535567|NCT00229723|5028115|P7|Concomitant Phase|Objective disease progression|0
1535568|NCT00229723|5028116|P6|Concomitant Phase|Objective disease progression|0
1535569|NCT00229723|5028117|P5|Concomitant Phase|Objective disease progression|0
1535570|NCT00229723|5028118|P4|Concomitant Phase|Objective disease progression|0
1535571|NCT00229723|5028119|P3|Concomitant Phase|Objective disease progression|0
1535572|NCT00229723|5028120|P2|Concomitant Phase|Objective disease progression|0
1535573|NCT00229723|5028121|P1|Concomitant Phase|Objective disease progression|0
1535574|NCT00229723|5028115|P7|Concomitant Phase|Adverse Event|2
1535575|NCT00229723|5028116|P6|Concomitant Phase|Adverse Event|1
1535576|NCT00229723|5028117|P5|Concomitant Phase|Adverse Event|0
1535577|NCT00229723|5028118|P4|Concomitant Phase|Adverse Event|2
1535578|NCT00229723|5028119|P3|Concomitant Phase|Adverse Event|5
1535579|NCT00229723|5028120|P2|Concomitant Phase|Adverse Event|2
1535580|NCT00229723|5028121|P1|Concomitant Phase|Adverse Event|4
1535581|NCT00229658|5028174|P2|Overall Study|Withdrawal of consent|39
1535582|NCT00229658|5028175|P1|Overall Study|Withdrawal of consent|46
1535583|NCT00229658|5028174|P2|Overall Study|Serious Adverse Event|2
1535584|NCT00229658|5028175|P1|Overall Study|Serious Adverse Event|2
1535585|NCT00229658|5028174|P2|Overall Study|Lost to Follow-up|55
1535586|NCT00229658|5028175|P1|Overall Study|Lost to Follow-up|82
1535587|NCT00229658|5028174|P2|Overall Study|Other|60
1535588|NCT00229658|5028175|P1|Overall Study|Other|80
1535589|NCT00229658|5028174|P2|Overall Study|Investigator decision|10
1535590|NCT00229658|5028175|P1|Overall Study|Investigator decision|13
1535591|NCT00229658|5028174|P2|Overall Study|Administrative|1
1535592|NCT00229658|5028175|P1|Overall Study|Administrative|2
1535593|NCT00229203|5028209|P2|Overall Study|Withdrawal by Subject|4
1535594|NCT00229203|5028210|P1|Overall Study|Withdrawal by Subject|1
1535595|NCT00229203|5028209|P2|Overall Study|Other|3
1535596|NCT00229203|5028210|P1|Overall Study|Other|3
1535597|NCT00229203|5028209|P2|Overall Study|Death|2
1535598|NCT00229203|5028210|P1|Overall Study|Death|4
1535599|NCT00229203|5028209|P2|Overall Study|Toxicity|1
1535600|NCT00229203|5028210|P1|Overall Study|Toxicity|6
1535601|NCT00229203|5028209|P2|Overall Study|Progressive disease|9
1535602|NCT00229203|5028210|P1|Overall Study|Progressive disease|18
1535603|NCT00228917|5028234|P4|Overall Study|Migrated/moved from study area|0
1535604|NCT00228917|5028235|P3|Overall Study|Migrated/moved from study area|0
1535605|NCT00228917|5028236|P2|Overall Study|Migrated/moved from study area|3
1535606|NCT00228917|5028237|P1|Overall Study|Migrated/moved from study area|0
1535607|NCT00228917|5028234|P4|Overall Study|Lost to Follow-up|0
1535608|NCT00228917|5028235|P3|Overall Study|Lost to Follow-up|0
1535609|NCT00228917|5028236|P2|Overall Study|Lost to Follow-up|0
1535610|NCT00228917|5028237|P1|Overall Study|Lost to Follow-up|1
1535611|NCT00228813|5028263|P1|Overall Study|Death|4
1535612|NCT00228566|5028269|P1|Overall Study|Miscellaneous|1
1535613|NCT00228566|5028269|P1|Overall Study|Withdrawal by Subject|4
1535614|NCT00228566|5028269|P1|Overall Study|Physician Decision|5
1535615|NCT00228566|5028269|P1|Overall Study|Lost to Follow-up|16
1535616|NCT00228566|5028269|P1|Overall Study|Lack of Efficacy|14
1535617|NCT00228566|5028269|P1|Overall Study|Adverse Event|31
1535618|NCT00228553|5028273|P1|Overall Study|Miscellaneous|46
1535619|NCT00228553|5028273|P1|Overall Study|Pregnancy|2
1535620|NCT00228553|5028273|P1|Overall Study|Withdrawal by Subject|115
1535621|NCT00228553|5028273|P1|Overall Study|Protocol Violation|6
1535622|NCT00228553|5028273|P1|Overall Study|Physician Decision|48
1535623|NCT00228553|5028273|P1|Overall Study|Lost to Follow-up|67
1535624|NCT00228553|5028273|P1|Overall Study|Lack of Efficacy|34
1535625|NCT00228553|5028273|P1|Overall Study|Adverse Event|112
1535626|NCT00228384|5028279|P2|Overall Study|Physician Decision|1
1535627|NCT00228384|5028280|P1|Overall Study|Physician Decision|0
1535628|NCT00228384|5028279|P2|Overall Study|Withdrawal by Subject|10
1535629|NCT00228384|5028280|P1|Overall Study|Withdrawal by Subject|9
1535630|NCT00228384|5028279|P2|Overall Study|Surgical Intervention (bypass)|5
1535631|NCT00228384|5028280|P1|Overall Study|Surgical Intervention (bypass)|5
1535632|NCT00228384|5028279|P2|Overall Study|Lost to Follow-up|10
1535633|NCT00228384|5028280|P1|Overall Study|Lost to Follow-up|6
1535634|NCT00228384|5028279|P2|Overall Study|Death|3
1535635|NCT00228384|5028280|P1|Overall Study|Death|9
1535636|NCT00227903|5028331|P2|Overall Study|Miscarriage|0
1535637|NCT00227903|5028332|P1|Overall Study|Miscarriage|1
1535638|NCT00227903|5028331|P2|Overall Study|Lost to Follow-up|3
1535639|NCT00227903|5028332|P1|Overall Study|Lost to Follow-up|1
1535640|NCT00227903|5028331|P2|Overall Study|Subject moved out of area|2
1535641|NCT00227903|5028332|P1|Overall Study|Subject moved out of area|1
1535642|NCT00227903|5028331|P2|Overall Study|Withdrawal by Subject|5
1535643|NCT00227903|5028332|P1|Overall Study|Withdrawal by Subject|2
1535644|NCT00227721|5028398|P1|Overall Study|On study, but never treated.|1
1535645|NCT00227591|5028402|P1|Overall Study|Withdrawal by Subject|1
1535646|NCT00227539|5028406|P1|Overall Study|Protocol Violation|1
1535647|NCT00227370|5028414|P2|Overall Study|Other reasons|1
1535648|NCT00227370|5028415|P1|Overall Study|Other reasons|2
1535649|NCT00227370|5028414|P2|Overall Study|Physician Decision|6
1535650|NCT00227370|5028415|P1|Overall Study|Physician Decision|9
1535651|NCT00227370|5028414|P2|Overall Study|Adverse Event|11
1535652|NCT00227370|5028415|P1|Overall Study|Adverse Event|6
1535653|NCT00227370|5028414|P2|Overall Study|Death|4
1535654|NCT00227370|5028415|P1|Overall Study|Death|3
1535655|NCT00227370|5028414|P2|Overall Study|Withdrawal by Subject|2
1535656|NCT00227370|5028415|P1|Overall Study|Withdrawal by Subject|1
1535657|NCT00227344|5028435|P2|Overall Study|study terminated early|5
1535658|NCT00227344|5028436|P1|Overall Study|study terminated early|12
1535659|NCT00227305|5028456|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
1535660|NCT00227305|5028456|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
1535661|NCT00227305|5028456|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
1535662|NCT00227305|5028456|P1|Overall Study|Physician Decision|3
1535663|NCT00227305|5028456|P1|Overall Study|Lack of Efficacy|7
1535664|NCT00227305|5028456|P1|Overall Study|MOVED OUT OF AREA|3
1535665|NCT00227305|5028456|P1|Overall Study|Study specific discontinuation|13
1535666|NCT00227305|5028456|P1|Overall Study|Lost to Follow-up|33
1535667|NCT00227305|5028456|P1|Overall Study|Withdrawal by Subject|42
1535668|NCT00227305|5028456|P1|Overall Study|Adverse Event|40
1535669|NCT00227266|5028473|P3|Overall Study|Excessive weight gain|2
1535670|NCT00227266|5028474|P2|Overall Study|Excessive weight gain|0
1535671|NCT00227266|5028475|P1|Overall Study|Excessive weight gain|0
1535672|NCT00227266|5028473|P3|Overall Study|Protocol Violation|1
1535673|NCT00227266|5028474|P2|Overall Study|Protocol Violation|0
1535674|NCT00227266|5028475|P1|Overall Study|Protocol Violation|1
1535675|NCT00227266|5028473|P3|Overall Study|Withdrawal by Subject|1
1535676|NCT00227266|5028474|P2|Overall Study|Withdrawal by Subject|0
1535677|NCT00227266|5028475|P1|Overall Study|Withdrawal by Subject|0
1535678|NCT00226941|5028505|P4|Overall Study|Withdrawn by investigator - unrelated AE|1
1535679|NCT00226941|5028506|P3|Overall Study|Withdrawn by investigator - unrelated AE|0
1535680|NCT00226941|5028507|P2|Overall Study|Withdrawn by investigator - unrelated AE|0
1535681|NCT00226941|5028508|P1|Overall Study|Withdrawn by investigator - unrelated AE|0
1535682|NCT00226941|5028505|P4|Overall Study|Withdrawal by subject - toxicity|1
1535683|NCT00226941|5028506|P3|Overall Study|Withdrawal by subject - toxicity|0
1535684|NCT00226941|5028507|P2|Overall Study|Withdrawal by subject - toxicity|0
1535685|NCT00226941|5028508|P1|Overall Study|Withdrawal by subject - toxicity|0
1535686|NCT00226811|5028542|P1|Overall Study|Withdrawal by Subject|2
1535687|NCT00226811|5028542|P1|Overall Study|Lack of Efficacy|55
1535688|NCT00226811|5028542|P1|Overall Study|Adverse Event|11
1535689|NCT00226811|5028542|P1|Overall Study|Death|8
1535690|NCT00226655|5028552|P1|Overall Study|Clinical deterioration|10
1535691|NCT00226655|5028552|P1|Overall Study|Physician Decision|6
1535692|NCT00226655|5028552|P1|Overall Study|Adverse Event|35
1535693|NCT00226655|5028552|P1|Overall Study|Withdrawal by Subject|15
1535694|NCT00226655|5028552|P1|Overall Study|Death|13
1535695|NCT00225758|5028591|P1|Overall Study|Adverse Event|4
1535696|NCT00225277|5028623|P2|Overall Study|Other|9
1535697|NCT00225277|5028624|P1|Overall Study|Other|7
1535698|NCT00225277|5028623|P2|Overall Study|Withdrawal by Subject|34
1535699|NCT00225277|5028624|P1|Overall Study|Withdrawal by Subject|40
1535700|NCT00225277|5028623|P2|Overall Study|Protocol Violation|3
1535701|NCT00225277|5028624|P1|Overall Study|Protocol Violation|6
1535702|NCT00225277|5028623|P2|Overall Study|Physician Decision|8
1535703|NCT00225277|5028624|P1|Overall Study|Physician Decision|6
1535704|NCT00225277|5028623|P2|Overall Study|Lost to Follow-up|6
1535705|NCT00225277|5028624|P1|Overall Study|Lost to Follow-up|4
1535706|NCT00225277|5028623|P2|Overall Study|Lack of Efficacy|1
1535707|NCT00225277|5028624|P1|Overall Study|Lack of Efficacy|4
1535708|NCT00225277|5028623|P2|Overall Study|Adverse Event|34
1535709|NCT00225277|5028624|P1|Overall Study|Adverse Event|30
1535710|NCT00225251|5028642|P2|Overall Study|Withdrawal by Subject|1
1535711|NCT00225251|5028643|P1|Overall Study|Withdrawal by Subject|1
1535712|NCT00225212|5028657|P1|Overall Study|Intercurrent illness|1
1535713|NCT00225212|5028657|P1|Overall Study|Adverse Event|2
1535714|NCT00225212|5028657|P1|Overall Study|Death|1
1535715|NCT00225212|5028657|P1|Overall Study|Disease progression|2
1535716|NCT00225147|5028666|P4|Open-label Phase|Withdrawal by Subject|6
1535717|NCT00225147|5028667|P3|Open-label Phase|Withdrawal by Subject|0
1535718|NCT00225147|5028668|P2|Open-label Phase|Withdrawal by Subject|0
1535719|NCT00225147|5028669|P1|Open-label Phase|Withdrawal by Subject|0
1535720|NCT00225147|5028666|P4|Open-label Phase|Lost to Follow-up|4
1535721|NCT00225147|5028667|P3|Open-label Phase|Lost to Follow-up|0
1535722|NCT00225147|5028668|P2|Open-label Phase|Lost to Follow-up|0
1535723|NCT00225147|5028669|P1|Open-label Phase|Lost to Follow-up|0
1535724|NCT00224874|5028716|P4|Overall Study|Withdrawal by Subject|0
1535725|NCT00224874|5028717|P3|Overall Study|Withdrawal by Subject|1
1535726|NCT00224874|5028718|P2|Overall Study|Withdrawal by Subject|0
1535727|NCT00224874|5028719|P1|Overall Study|Withdrawal by Subject|0
1535728|NCT00224770|5028764|P3|Overall Study|Lost to Follow-up|0
1535729|NCT00224770|5028765|P2|Overall Study|Lost to Follow-up|2
1535730|NCT00224770|5028766|P1|Overall Study|Lost to Follow-up|4
1535731|NCT00224484|5028801|P3|Overall Study|Reaon not specified|2
1535732|NCT00224484|5028802|P2|Overall Study|Reaon not specified|4
1535733|NCT00224484|5028803|P1|Overall Study|Reaon not specified|5
1535734|NCT00224484|5028801|P3|Overall Study|Lost to Follow-up|36
1535735|NCT00224484|5028802|P2|Overall Study|Lost to Follow-up|28
1535736|NCT00224484|5028803|P1|Overall Study|Lost to Follow-up|66
1535737|NCT00224484|5028801|P3|Overall Study|Migrated/moved from study area|5
1535738|NCT00224484|5028802|P2|Overall Study|Migrated/moved from study area|5
1535739|NCT00224484|5028803|P1|Overall Study|Migrated/moved from study area|18
1535740|NCT00224484|5028801|P3|Overall Study|Withdrawal by Subject|16
1535741|NCT00224484|5028802|P2|Overall Study|Withdrawal by Subject|18
1535742|NCT00224484|5028803|P1|Overall Study|Withdrawal by Subject|49
1535743|NCT00224484|5028801|P3|Overall Study|Protocol Violation|0
1535744|NCT00224484|5028802|P2|Overall Study|Protocol Violation|2
1535745|NCT00224484|5028803|P1|Overall Study|Protocol Violation|2
1535746|NCT00224484|5028801|P3|Overall Study|Non-Serious Adverse Event|3
1535747|NCT00224484|5028802|P2|Overall Study|Non-Serious Adverse Event|7
1535748|NCT00224484|5028803|P1|Overall Study|Non-Serious Adverse Event|5
1535749|NCT00224484|5028801|P3|Overall Study|Serious Adverse Event|0
1535750|NCT00224484|5028802|P2|Overall Study|Serious Adverse Event|1
1535751|NCT00224484|5028803|P1|Overall Study|Serious Adverse Event|1
1535752|NCT00224133|5028867|P1|Overall Study|Not specified|14
1535753|NCT00224133|5028867|P1|Overall Study|Physician Decision|1
1535754|NCT00224133|5028867|P1|Overall Study|Lost to Follow-up|21
1535755|NCT00224133|5028867|P1|Overall Study|Lack of Efficacy|58
1535756|NCT00224133|5028867|P1|Overall Study|Withdrawal by Subject|33
1535757|NCT00224133|5028867|P1|Overall Study|Protocol Violation|6
1535758|NCT00224133|5028867|P1|Overall Study|Adverse Event|93
1535759|NCT00224120|5028873|P2|Overall Study|Not specified|5
1535760|NCT00224120|5028874|P1|Overall Study|Not specified|4
1535761|NCT00224120|5028873|P2|Overall Study|Lost to Follow-up|3
1535762|NCT00224120|5028874|P1|Overall Study|Lost to Follow-up|2
1535763|NCT00224120|5028873|P2|Overall Study|Lack of Efficacy|2
1535764|NCT00224120|5028874|P1|Overall Study|Lack of Efficacy|0
1535765|NCT00224120|5028873|P2|Overall Study|Withdrawal by Subject|10
1535766|NCT00224120|5028874|P1|Overall Study|Withdrawal by Subject|5
1535767|NCT00224120|5028873|P2|Overall Study|Protocol Violation|0
1535768|NCT00224120|5028874|P1|Overall Study|Protocol Violation|1
1535769|NCT00224120|5028873|P2|Overall Study|Adverse Event|4
1535770|NCT00224120|5028874|P1|Overall Study|Adverse Event|10
1535771|NCT00224107|5028884|P2|Overall Study|Not specified|1
1535772|NCT00224107|5028885|P1|Overall Study|Not specified|1
1535773|NCT00224107|5028884|P2|Overall Study|Physician Decision|0
1535774|NCT00224107|5028885|P1|Overall Study|Physician Decision|1
1535775|NCT00224107|5028884|P2|Overall Study|Lost to Follow-up|0
1535776|NCT00224107|5028885|P1|Overall Study|Lost to Follow-up|4
1535777|NCT00224107|5028884|P2|Overall Study|Lack of Efficacy|0
1535778|NCT00224107|5028885|P1|Overall Study|Lack of Efficacy|2
1535779|NCT00224107|5028884|P2|Overall Study|Withdrawal by Subject|4
1535780|NCT00224107|5028885|P1|Overall Study|Withdrawal by Subject|1
1535781|NCT00224107|5028884|P2|Overall Study|Protocol Violation|3
1535782|NCT00224107|5028885|P1|Overall Study|Protocol Violation|2
1535783|NCT00224107|5028884|P2|Overall Study|Adverse Event|6
1535784|NCT00224107|5028885|P1|Overall Study|Adverse Event|20
1535785|NCT00224055|5028895|P2|Overall Study|Not Specified|0
1535786|NCT00224055|5028896|P1|Overall Study|Not Specified|1
1535787|NCT00224055|5028895|P2|Overall Study|Withdrawal by Subject|2
1535788|NCT00224055|5028896|P1|Overall Study|Withdrawal by Subject|0
1535789|NCT00224055|5028895|P2|Overall Study|Inclusion Violation|6
1535790|NCT00224055|5028896|P1|Overall Study|Inclusion Violation|3
1535791|NCT00224055|5028895|P2|Overall Study|Protocol Violation|1
1535792|NCT00224055|5028896|P1|Overall Study|Protocol Violation|1
1535793|NCT00224055|5028895|P2|Overall Study|Lost to Follow-up|2
1535794|NCT00224055|5028896|P1|Overall Study|Lost to Follow-up|1
1535795|NCT00224055|5028895|P2|Overall Study|Adverse Event|3
1535796|NCT00224055|5028896|P1|Overall Study|Adverse Event|9
1535797|NCT00224042|5028906|P2|Overall Study|Not specified|0
1535798|NCT00224042|5028907|P1|Overall Study|Not specified|2
1535799|NCT00224042|5028906|P2|Overall Study|Did not meet lab incusion criteria|3
1535800|NCT00224042|5028907|P1|Overall Study|Did not meet lab incusion criteria|2
1535801|NCT00224042|5028906|P2|Overall Study|Physician Decision|1
1535802|NCT00224042|5028907|P1|Overall Study|Physician Decision|0
1535803|NCT00224042|5028906|P2|Overall Study|Protocol Violation|1
1535804|NCT00224042|5028907|P1|Overall Study|Protocol Violation|0
1535805|NCT00224042|5028906|P2|Overall Study|Adverse Event|1
1535806|NCT00224042|5028907|P1|Overall Study|Adverse Event|2
1535807|NCT00224029|5028919|P1|Overall Study|Other|1
1535808|NCT00224029|5028919|P1|Overall Study|Withdrawal by Subject|4
1535809|NCT00224029|5028919|P1|Overall Study|Lost to Follow-up|1
1535810|NCT00224016|5028925|P2|Maintenance Period|Lost to Follow-up|1
1535811|NCT00224016|5028926|P1|Maintenance Period|Lost to Follow-up|0
1535812|NCT00224016|5028925|P2|Maintenance Period|Withdrawal by Subject|0
1535813|NCT00224016|5028926|P1|Maintenance Period|Withdrawal by Subject|2
1535814|NCT00224016|5028925|P2|Titration Period|Lost to Follow-up|0
1535815|NCT00224016|5028926|P1|Titration Period|Lost to Follow-up|1
1535816|NCT00224016|5028925|P2|Titration Period|Withdrawal by Subject|1
1535817|NCT00224016|5028926|P1|Titration Period|Withdrawal by Subject|0
1535818|NCT00224003|5028934|P1|Overall Study|unk|3
1535819|NCT00224003|5028934|P1|Overall Study|Withdrawal by Subject|1
1535820|NCT00224003|5028934|P1|Overall Study|Protocol Violation|2
1535821|NCT00224003|5028934|P1|Overall Study|Adverse Event|1
1535822|NCT00223977|5028941|P3|Overall Study|not specified|0
1535823|NCT00223977|5028942|P2|Overall Study|not specified|0
1535824|NCT00223977|5028943|P1|Overall Study|not specified|1
1535825|NCT00223977|5028941|P3|Overall Study|Withdrawal by Subject|2
1535826|NCT00223977|5028942|P2|Overall Study|Withdrawal by Subject|1
1535827|NCT00223977|5028943|P1|Overall Study|Withdrawal by Subject|1
1535828|NCT00223977|5028941|P3|Overall Study|Protocol Violation|1
1535829|NCT00223977|5028942|P2|Overall Study|Protocol Violation|0
1535830|NCT00223977|5028943|P1|Overall Study|Protocol Violation|0
1535831|NCT00223977|5028941|P3|Overall Study|Adverse Event|0
1535832|NCT00223977|5028942|P2|Overall Study|Adverse Event|10
1535833|NCT00223977|5028943|P1|Overall Study|Adverse Event|7
1535834|NCT00223808|5028977|P3|Overall Study|<5 hrs therapy before discharge|5
1535835|NCT00223808|5028978|P2|Overall Study|<5 hrs therapy before discharge|5
1535836|NCT00223808|5028979|P1|Overall Study|<5 hrs therapy before discharge|3
1535837|NCT00223795|5028996|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
1535838|NCT00223795|5028997|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
1535839|NCT00223795|5028996|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
1535840|NCT00223795|5028997|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
1535841|NCT00223496|5029075|P1|Overall Study|Physician Decision|2
1535842|NCT00223496|5029075|P1|Overall Study|Withdrawal by Subject|1
1535843|NCT00223496|5029075|P1|Overall Study|Lack of Efficacy|6
1535844|NCT00223496|5029075|P1|Overall Study|Lost to Follow-up|4
1535845|NCT00223496|5029075|P1|Overall Study|screen failure|9
1535846|NCT00222729|5029094|P1|Overall Study|Adverse Event|3
1535847|NCT00222105|5029101|P1|Overall Study|Death|2
1535848|NCT00222105|5029101|P1|Overall Study|Treatment delays|2
1535849|NCT00222105|5029101|P1|Overall Study|Adverse Event|8
1535850|NCT00222105|5029101|P1|Overall Study|Withdrawal by Subject|1
1535851|NCT00222105|5029101|P1|Overall Study|Removed due to wrong diagnosis|1
1535852|NCT00221195|5029122|P2|Overall Study|Lost to Follow-up|1
1535853|NCT00221195|5029123|P1|Overall Study|Lost to Follow-up|0
1535854|NCT00221195|5029122|P2|Overall Study|Death|1
1535855|NCT00221195|5029123|P1|Overall Study|Death|1
1535856|NCT00221195|5029122|P2|Overall Study|Withdrawal by Subject|1
1535857|NCT00221195|5029123|P1|Overall Study|Withdrawal by Subject|4
1535858|NCT00221104|5029145|P2|Overall Study|Others|47
1535859|NCT00221104|5029146|P1|Overall Study|Others|37
1535860|NCT00221104|5029145|P2|Overall Study|Withdrawal by Subject|29
1535861|NCT00221104|5029146|P1|Overall Study|Withdrawal by Subject|42
1535862|NCT00221104|5029145|P2|Overall Study|Protocol Violation|0
1535863|NCT00221104|5029146|P1|Overall Study|Protocol Violation|2
1535864|NCT00221104|5029145|P2|Overall Study|Physician Decision|0
1535865|NCT00221104|5029146|P1|Overall Study|Physician Decision|1
1535866|NCT00221104|5029145|P2|Overall Study|Adverse Event|0
1535867|NCT00221104|5029146|P1|Overall Study|Adverse Event|1
1535868|NCT00220805|5029179|P2|Overall Study|Develop. of choroidal neovascularization|8
1535869|NCT00220805|5029180|P1|Overall Study|Develop. of choroidal neovascularization|3
1535870|NCT00220805|5029179|P2|Overall Study|Lack of Efficacy|0
1535871|NCT00220805|5029180|P1|Overall Study|Lack of Efficacy|1
1535872|NCT00220805|5029179|P2|Overall Study|Withdrawal by Subject|0
1535873|NCT00220805|5029180|P1|Overall Study|Withdrawal by Subject|3
1535874|NCT00220805|5029179|P2|Overall Study|Adverse Event|3
1535875|NCT00220805|5029180|P1|Overall Study|Adverse Event|1
1535876|NCT00220779|5029201|P3|Overall Study|Lack of Efficacy|1
1535877|NCT00220779|5029202|P2|Overall Study|Lack of Efficacy|0
1535878|NCT00220779|5029203|P1|Overall Study|Lack of Efficacy|3
1535879|NCT00220779|5029201|P3|Overall Study|Pregnancy|2
1535880|NCT00220779|5029202|P2|Overall Study|Pregnancy|0
1535881|NCT00220779|5029203|P1|Overall Study|Pregnancy|0
1535882|NCT00220779|5029201|P3|Overall Study|Too time consuming|0
1535883|NCT00220779|5029202|P2|Overall Study|Too time consuming|0
1535884|NCT00220779|5029203|P1|Overall Study|Too time consuming|1
1535885|NCT00220779|5029201|P3|Overall Study|Non-compliance|0
1535886|NCT00220779|5029202|P2|Overall Study|Non-compliance|0
1535887|NCT00220779|5029203|P1|Overall Study|Non-compliance|1
1535888|NCT00220779|5029201|P3|Overall Study|Withdrawal by Subject|1
1535889|NCT00220779|5029202|P2|Overall Study|Withdrawal by Subject|4
1535890|NCT00220779|5029203|P1|Overall Study|Withdrawal by Subject|1
1535891|NCT00220779|5029201|P3|Overall Study|Adverse Event|0
1535892|NCT00220779|5029202|P2|Overall Study|Adverse Event|0
1535893|NCT00220779|5029203|P1|Overall Study|Adverse Event|1
1535894|NCT00220740|5029213|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
1535895|NCT00220740|5029214|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
1535896|NCT00220740|5029213|P2|Efficacy Period|Protocol Violation|0
1535897|NCT00220740|5029214|P1|Efficacy Period|Protocol Violation|1
1535898|NCT00220740|5029213|P2|Efficacy Period|Withdrawal by Subject|0
1535899|NCT00220740|5029214|P1|Efficacy Period|Withdrawal by Subject|1
1535900|NCT00220740|5029213|P2|Efficacy Period|Adverse Event|1
1535901|NCT00220740|5029214|P1|Efficacy Period|Adverse Event|1
1535902|NCT00220740|5029213|P2|Efficacy Period|Entered rescue treatment with placebo|0
1535903|NCT00220740|5029214|P1|Efficacy Period|Entered rescue treatment with placebo|23
1535904|NCT00220727|5029228|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
1535905|NCT00220727|5029229|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
1535906|NCT00220701|5029245|P2|Overall Study|Lost to Follow-up|4
1535907|NCT00220701|5029246|P1|Overall Study|Lost to Follow-up|5
1535908|NCT00220636|5029262|P1|Overall Study|Withdrawal by Subject|4
1535909|NCT00219557|5029272|P3|Phase 2|Treatment not received|3
1535910|NCT00219557|5029273|P2|Phase 2|Treatment not received|1
1535911|NCT00219557|5029274|P1|Phase 2|Treatment not received|0
1535912|NCT00219557|5029272|P3|Phase 2|Withdrawal by Subject|5
1535913|NCT00219557|5029273|P2|Phase 2|Withdrawal by Subject|9
1535914|NCT00219557|5029274|P1|Phase 2|Withdrawal by Subject|0
1535915|NCT00219557|5029272|P3|Phase 2|Other|6
1535916|NCT00219557|5029273|P2|Phase 2|Other|8
1535917|NCT00219557|5029274|P1|Phase 2|Other|0
1535918|NCT00219557|5029272|P3|Phase 2|Death|2
1535919|NCT00219557|5029273|P2|Phase 2|Death|8
1535920|NCT00219557|5029274|P1|Phase 2|Death|0
1535921|NCT00219557|5029272|P3|Phase 2|Adverse Event|2
1535922|NCT00219557|5029273|P2|Phase 2|Adverse Event|22
1535923|NCT00219557|5029274|P1|Phase 2|Adverse Event|0
1535924|NCT00219557|5029272|P3|Phase 2|Lack of Efficacy|15
1535925|NCT00219557|5029273|P2|Phase 2|Lack of Efficacy|21
1535926|NCT00219557|5029274|P1|Phase 2|Lack of Efficacy|0
1535927|NCT00219557|5029272|P3|Phase 1|Started chemotherapy at other institute|0
1535928|NCT00219557|5029273|P2|Phase 1|Started chemotherapy at other institute|0
1535929|NCT00219557|5029274|P1|Phase 1|Started chemotherapy at other institute|1
1535930|NCT00219557|5029272|P3|Phase 1|Withdrawal by Subject|0
1535931|NCT00219557|5029273|P2|Phase 1|Withdrawal by Subject|0
1535932|NCT00219557|5029274|P1|Phase 1|Withdrawal by Subject|1
1535933|NCT00219557|5029272|P3|Phase 1|Adverse Event|0
1535934|NCT00219557|5029273|P2|Phase 1|Adverse Event|0
1535935|NCT00219557|5029274|P1|Phase 1|Adverse Event|2
1535936|NCT00219557|5029272|P3|Phase 1|Lack of Efficacy|0
1535937|NCT00219557|5029273|P2|Phase 1|Lack of Efficacy|0
1535938|NCT00219557|5029274|P1|Phase 1|Lack of Efficacy|3
1535939|NCT00219544|5029302|P2|Single Blind Treatment Period|Withdrawal by Subject|0
1535940|NCT00219544|5029303|P1|Single Blind Treatment Period|Withdrawal by Subject|1
1535941|NCT00219544|5029302|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
1535942|NCT00219544|5029303|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
1535943|NCT00219544|5029302|P2|Single Blind Treatment Period|Lost to Follow-up|0
1535944|NCT00219544|5029303|P1|Single Blind Treatment Period|Lost to Follow-up|2
1535945|NCT00219544|5029302|P2|Single Blind Treatment Period|Protocol Violation|0
1535946|NCT00219544|5029303|P1|Single Blind Treatment Period|Protocol Violation|4
1535947|NCT00219544|5029302|P2|Single Blind Treatment Period|Adverse Event|0
1535948|NCT00219544|5029303|P1|Single Blind Treatment Period|Adverse Event|9
1535949|NCT00219544|5029302|P2|Single Blind Treatment Period|Lack of Efficacy|0
1535950|NCT00219544|5029303|P1|Single Blind Treatment Period|Lack of Efficacy|5
1535951|NCT00219349|5029341|P1|Escitalopram Phase|Withdrawal by Subject|3
1535952|NCT00219349|5029341|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
1535953|NCT00219349|5029341|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
1535954|NCT00219349|5029341|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
1535955|NCT00219284|5029354|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
1535956|NCT00219284|5029355|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
1535957|NCT00219284|5029354|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
1535958|NCT00219284|5029355|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
1535959|NCT00219284|5029354|P2|Extension Phase - 8 Weeks|Adverse Event|3
1535960|NCT00219284|5029355|P1|Extension Phase - 8 Weeks|Adverse Event|2
1535961|NCT00219284|5029354|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
1535962|NCT00219284|5029355|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
1535963|NCT00219284|5029354|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
1535964|NCT00219284|5029355|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
1536143|NCT00215943|5029883|P1|Overall Study|Adverse Event|3
1535965|NCT00219284|5029354|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
1535966|NCT00219284|5029355|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
1535967|NCT00219284|5029354|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
1535968|NCT00219284|5029355|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
1535969|NCT00219284|5029354|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
1535970|NCT00219284|5029355|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
1535971|NCT00219284|5029354|P2|Treatment Phase - 16 Weeks|Adverse Event|24
1535972|NCT00219284|5029355|P1|Treatment Phase - 16 Weeks|Adverse Event|26
1535973|NCT00219141|5029380|P3|Overall Study|Condition no longer requires study drug|0
1535974|NCT00219141|5029381|P2|Overall Study|Condition no longer requires study drug|0
1535975|NCT00219141|5029382|P1|Overall Study|Condition no longer requires study drug|1
1535976|NCT00219141|5029380|P3|Overall Study|Withdrawal by Subject|5
1535977|NCT00219141|5029381|P2|Overall Study|Withdrawal by Subject|3
1535978|NCT00219141|5029382|P1|Overall Study|Withdrawal by Subject|1
1535979|NCT00219141|5029380|P3|Overall Study|Protocol Violation|1
1535980|NCT00219141|5029381|P2|Overall Study|Protocol Violation|1
1535981|NCT00219141|5029382|P1|Overall Study|Protocol Violation|3
1535982|NCT00219141|5029380|P3|Overall Study|Lost to Follow-up|1
1535983|NCT00219141|5029381|P2|Overall Study|Lost to Follow-up|4
1535984|NCT00219141|5029382|P1|Overall Study|Lost to Follow-up|2
1535985|NCT00219141|5029380|P3|Overall Study|Administrative problems|0
1535986|NCT00219141|5029381|P2|Overall Study|Administrative problems|1
1535987|NCT00219141|5029382|P1|Overall Study|Administrative problems|0
1535988|NCT00219141|5029380|P3|Overall Study|Lack of Efficacy|0
1535989|NCT00219141|5029381|P2|Overall Study|Lack of Efficacy|2
1535990|NCT00219141|5029382|P1|Overall Study|Lack of Efficacy|3
1535991|NCT00219141|5029380|P3|Overall Study|Adverse Event|5
1535992|NCT00219141|5029381|P2|Overall Study|Adverse Event|10
1535993|NCT00219141|5029382|P1|Overall Study|Adverse Event|4
1535994|NCT00218634|5029428|P2|Overall Study|Lost to Follow-up|15
1535995|NCT00218634|5029429|P1|Overall Study|Lost to Follow-up|8
1535996|NCT00218543|5029449|P1|Overall Study|Adverse Event|2
1535997|NCT00218543|5029449|P1|Overall Study|Physician Decision|3
1535998|NCT00218543|5029449|P1|Overall Study|Withdrawal by Subject|1
1535999|NCT00218543|5029449|P1|Overall Study|relocated|1
1536000|NCT00218543|5029449|P1|Overall Study|Lost to Follow-up|8
1536001|NCT00218296|5029555|P2|Overall Study|Randomized but did not enter treatment|67
1536002|NCT00218296|5029556|P1|Overall Study|Randomized but did not enter treatment|66
1536003|NCT00218296|5029555|P2|Overall Study|Withdrawal by Subject|47
1536004|NCT00218296|5029556|P1|Overall Study|Withdrawal by Subject|36
1536005|NCT00218296|5029555|P2|Overall Study|Lost to Follow-up|7
1536006|NCT00218296|5029556|P1|Overall Study|Lost to Follow-up|9
1536007|NCT00217971|5029628|P2|Overall Study|non compliant|0
1536008|NCT00217971|5029629|P1|Overall Study|non compliant|1
1536009|NCT00217971|5029628|P2|Overall Study|Withdrawal by Subject|12
1536010|NCT00217971|5029629|P1|Overall Study|Withdrawal by Subject|7
1536011|NCT00217971|5029628|P2|Overall Study|Physician Decision|1
1536012|NCT00217971|5029629|P1|Overall Study|Physician Decision|0
1536013|NCT00217971|5029628|P2|Overall Study|Lost to Follow-up|19
1536014|NCT00217971|5029629|P1|Overall Study|Lost to Follow-up|15
1536015|NCT00217971|5029628|P2|Overall Study|Adverse Event|1
1536016|NCT00217971|5029629|P1|Overall Study|Adverse Event|1
1536017|NCT00217672|5029644|P2|Follow-up|Lost to Follow-up|0
1536018|NCT00217672|5029645|P1|Follow-up|Lost to Follow-up|1
1536019|NCT00217672|5029644|P2|Follow-up|Withdrawal by Subject|0
1536020|NCT00217672|5029645|P1|Follow-up|Withdrawal by Subject|4
1536021|NCT00217672|5029644|P2|Treatment|secondary malignancy|0
1536022|NCT00217672|5029645|P1|Treatment|secondary malignancy|1
1536023|NCT00217672|5029644|P2|Treatment|Death|0
1536024|NCT00217672|5029645|P1|Treatment|Death|2
1536025|NCT00217672|5029644|P2|Treatment|insurance issues|1
1536026|NCT00217672|5029645|P1|Treatment|insurance issues|1
1536027|NCT00217672|5029644|P2|Treatment|Physician Decision|0
1536028|NCT00217672|5029645|P1|Treatment|Physician Decision|6
1536029|NCT00217672|5029644|P2|Treatment|reqd treatment not permitted by protocol|0
1536030|NCT00217672|5029645|P1|Treatment|reqd treatment not permitted by protocol|6
1536031|NCT00217672|5029644|P2|Treatment|Adverse Event|2
1536032|NCT00217672|5029645|P1|Treatment|Adverse Event|18
1536033|NCT00217672|5029644|P2|Treatment|disease progression|4
1536034|NCT00217672|5029645|P1|Treatment|disease progression|33
1536035|NCT00217672|5029644|P2|Allocation|Ineligible|0
1536036|NCT00217672|5029645|P1|Allocation|Ineligible|2
1536037|NCT00217620|5029651|P1|Overall Study|Never received treatment|1
1536038|NCT00217620|5029651|P1|Overall Study|Ineligible|13
1536039|NCT00217620|5029651|P1|Overall Study|Not Protocol Specified|4
1536040|NCT00217620|5029651|P1|Overall Study|Progression|31
1536041|NCT00217620|5029651|P1|Overall Study|Adverse Event|2
1536042|NCT00217581|5029662|P1|Overall Study|Withdrawal by Subject|1
1536043|NCT00217464|5029691|P1|Overall Study|not specified|2
1536044|NCT00217464|5029691|P1|Overall Study|Progression|15
1536045|NCT00217425|5029707|P1|Overall Study|Other|4
1536046|NCT00217425|5029707|P1|Overall Study|Other complicating disease|1
1536047|NCT00217425|5029707|P1|Overall Study|Withdrawal by Subject|4
1536048|NCT00217425|5029707|P1|Overall Study|Adverse Event|8
1536049|NCT00217425|5029707|P1|Overall Study|Lack of Efficacy|13
1536050|NCT00217425|5029707|P1|Overall Study|Patient ineligible|5
1536051|NCT00217425|5029707|P1|Overall Study|Never started treatment|2
1536052|NCT00217087|5029721|P2|Overall Study|completed less than 12 months return|18
1536053|NCT00217087|5029722|P1|Overall Study|completed less than 12 months return|10
1536054|NCT00217087|5029721|P2|Overall Study|decided to have esophagectomy|2
1536055|NCT00217087|5029722|P1|Overall Study|decided to have esophagectomy|1
1536056|NCT00217022|5029736|P2|Overall Study|Withdrawal by Subject|1
1536057|NCT00217022|5029737|P1|Overall Study|Withdrawal by Subject|1
1536058|NCT00216736|5029747|P2|Overall Study|Lost to Follow-up|1
1536059|NCT00216736|5029748|P1|Overall Study|Lost to Follow-up|1
1536060|NCT00216671|5029762|P2|Overall Study|Insufficient Response Adverse Event|1
1536061|NCT00216671|5029763|P1|Overall Study|Insufficient Response Adverse Event|2
1536062|NCT00216671|5029762|P2|Overall Study|Ineligible, no efficacy data|2
1536063|NCT00216671|5029763|P1|Overall Study|Ineligible, no efficacy data|2
1536064|NCT00216671|5029762|P2|Overall Study|Patient Moved|1
1536065|NCT00216671|5029763|P1|Overall Study|Patient Moved|0
1536066|NCT00216671|5029762|P2|Overall Study|Investigator Illness|1
1536067|NCT00216671|5029763|P1|Overall Study|Investigator Illness|0
1536068|NCT00216671|5029762|P2|Overall Study|Relapse|0
1536069|NCT00216671|5029763|P1|Overall Study|Relapse|1
1536070|NCT00216671|5029762|P2|Overall Study|Protocol Violation|5
1536071|NCT00216671|5029763|P1|Overall Study|Protocol Violation|3
1536072|NCT00216671|5029762|P2|Overall Study|Physician Decision|1
1536073|NCT00216671|5029763|P1|Overall Study|Physician Decision|1
1536074|NCT00216671|5029762|P2|Overall Study|Ineligible|2
1536075|NCT00216671|5029763|P1|Overall Study|Ineligible|0
1536076|NCT00216671|5029762|P2|Overall Study|Non compliant|2
1536077|NCT00216671|5029763|P1|Overall Study|Non compliant|2
1536078|NCT00216671|5029762|P2|Overall Study|Lost to Follow-up|5
1536079|NCT00216671|5029763|P1|Overall Study|Lost to Follow-up|3
1536080|NCT00216671|5029762|P2|Overall Study|Insufficient Response|4
1536081|NCT00216671|5029763|P1|Overall Study|Insufficient Response|9
1536082|NCT00216671|5029762|P2|Overall Study|No Need to Continue Medication|1
1536083|NCT00216671|5029763|P1|Overall Study|No Need to Continue Medication|1
1536084|NCT00216671|5029762|P2|Overall Study|Refused Injections|13
1536085|NCT00216671|5029763|P1|Overall Study|Refused Injections|3
1536086|NCT00216671|5029762|P2|Overall Study|Withdrawal by Subject|2
1536087|NCT00216671|5029763|P1|Overall Study|Withdrawal by Subject|4
1536088|NCT00216671|5029762|P2|Overall Study|Pregnancy|1
1536089|NCT00216671|5029763|P1|Overall Study|Pregnancy|0
1536090|NCT00216671|5029762|P2|Overall Study|Adverse Event|9
1536091|NCT00216671|5029763|P1|Overall Study|Adverse Event|4
1536092|NCT00216476|5029781|P3|Overall Study|Patient Moved|0
1536093|NCT00216476|5029782|P2|Overall Study|Patient Moved|2
1536094|NCT00216476|5029783|P1|Overall Study|Patient Moved|2
1536095|NCT00216476|5029781|P3|Overall Study|Protocol Deviation|0
1536096|NCT00216476|5029782|P2|Overall Study|Protocol Deviation|1
1536097|NCT00216476|5029783|P1|Overall Study|Protocol Deviation|5
1536098|NCT00216476|5029781|P3|Overall Study|Administrative Reasons|0
1536099|NCT00216476|5029782|P2|Overall Study|Administrative Reasons|1
1536100|NCT00216476|5029783|P1|Overall Study|Administrative Reasons|1
1536101|NCT00216476|5029781|P3|Overall Study|Higher dose/Extra Medication Required|2
1536102|NCT00216476|5029782|P2|Overall Study|Higher dose/Extra Medication Required|0
1536103|NCT00216476|5029783|P1|Overall Study|Higher dose/Extra Medication Required|2
1536104|NCT00216476|5029781|P3|Overall Study|Non-compliance|1
1536105|NCT00216476|5029782|P2|Overall Study|Non-compliance|4
1536106|NCT00216476|5029783|P1|Overall Study|Non-compliance|0
1536107|NCT00216476|5029781|P3|Overall Study|No Further Need for Treatment|1
1536108|NCT00216476|5029782|P2|Overall Study|No Further Need for Treatment|4
1536109|NCT00216476|5029783|P1|Overall Study|No Further Need for Treatment|3
1536110|NCT00216476|5029781|P3|Overall Study|Refuses Injection|0
1536111|NCT00216476|5029782|P2|Overall Study|Refuses Injection|0
1536112|NCT00216476|5029783|P1|Overall Study|Refuses Injection|11
1536113|NCT00216476|5029781|P3|Overall Study|Other|1
1536114|NCT00216476|5029782|P2|Overall Study|Other|0
1536115|NCT00216476|5029783|P1|Overall Study|Other|0
1536116|NCT00216476|5029781|P3|Overall Study|Pregnancy|1
1536117|NCT00216476|5029782|P2|Overall Study|Pregnancy|1
1536118|NCT00216476|5029783|P1|Overall Study|Pregnancy|0
1536119|NCT00216476|5029781|P3|Overall Study|Death|0
1536120|NCT00216476|5029782|P2|Overall Study|Death|0
1536121|NCT00216476|5029783|P1|Overall Study|Death|2
1536122|NCT00216476|5029781|P3|Overall Study|Lack of Efficacy|0
1536123|NCT00216476|5029782|P2|Overall Study|Lack of Efficacy|3
1536124|NCT00216476|5029783|P1|Overall Study|Lack of Efficacy|4
1536125|NCT00216476|5029781|P3|Overall Study|Adverse Event|1
1536126|NCT00216476|5029782|P2|Overall Study|Adverse Event|10
1536127|NCT00216476|5029783|P1|Overall Study|Adverse Event|6
1536128|NCT00216476|5029781|P3|Overall Study|Lost to Follow-up|1
1536129|NCT00216476|5029782|P2|Overall Study|Lost to Follow-up|9
1536130|NCT00216476|5029783|P1|Overall Study|Lost to Follow-up|10
1536131|NCT00216476|5029781|P3|Overall Study|Withdrawal by Subject|9
1536132|NCT00216476|5029782|P2|Overall Study|Withdrawal by Subject|72
1536133|NCT00216476|5029783|P1|Overall Study|Withdrawal by Subject|59
1536134|NCT00216203|5029820|P1|Overall Study|Withdrawal by Subject|2
1536135|NCT00216086|5029850|P1|Overall Study|Social Reasons|2
1536136|NCT00216086|5029850|P1|Overall Study|Diagnosis of Metastatic Disease|1
1536137|NCT00216086|5029850|P1|Overall Study|Protocol Violation|1
1536138|NCT00215943|5029882|P2|Overall Study|Other complications|1
1536139|NCT00215943|5029883|P1|Overall Study|Other complications|3
1536140|NCT00215943|5029882|P2|Overall Study|Other disease|1
1536141|NCT00215943|5029883|P1|Overall Study|Other disease|0
1536142|NCT00215943|5029882|P2|Overall Study|Adverse Event|6
1536144|NCT00215943|5029882|P2|Overall Study|Alternate therapy|1
1536145|NCT00215943|5029883|P1|Overall Study|Alternate therapy|0
1536146|NCT00215943|5029882|P2|Overall Study|Disease Progression|5
1536147|NCT00215943|5029883|P1|Overall Study|Disease Progression|3
1536148|NCT00215683|5029908|P3|Overall Study|Intermittent therapy required|0
1536149|NCT00215683|5029909|P2|Overall Study|Intermittent therapy required|1
1536150|NCT00215683|5029910|P1|Overall Study|Intermittent therapy required|0
1536151|NCT00215683|5029908|P3|Overall Study|No study drug available|0
1536152|NCT00215683|5029909|P2|Overall Study|No study drug available|1
1536153|NCT00215683|5029910|P1|Overall Study|No study drug available|0
1536154|NCT00215683|5029908|P3|Overall Study|Difficult to attend visits|0
1536155|NCT00215683|5029909|P2|Overall Study|Difficult to attend visits|1
1536156|NCT00215683|5029910|P1|Overall Study|Difficult to attend visits|0
1536157|NCT00215683|5029908|P3|Overall Study|Physician Decision|1
1536158|NCT00215683|5029909|P2|Overall Study|Physician Decision|0
1536159|NCT00215683|5029910|P1|Overall Study|Physician Decision|0
1536160|NCT00215683|5029908|P3|Overall Study|Withdrawal by Subject|13
1536161|NCT00215683|5029909|P2|Overall Study|Withdrawal by Subject|4
1536162|NCT00215683|5029910|P1|Overall Study|Withdrawal by Subject|9
1536163|NCT00215683|5029908|P3|Overall Study|Lost to Follow-up|1
1536164|NCT00215683|5029909|P2|Overall Study|Lost to Follow-up|2
1536165|NCT00215683|5029910|P1|Overall Study|Lost to Follow-up|0
1536166|NCT00215683|5029908|P3|Overall Study|Lack of Efficacy|2
1536167|NCT00215683|5029909|P2|Overall Study|Lack of Efficacy|1
1536168|NCT00215683|5029910|P1|Overall Study|Lack of Efficacy|5
1536169|NCT00215683|5029908|P3|Overall Study|Adverse Event|15
1536170|NCT00215683|5029909|P2|Overall Study|Adverse Event|16
1536171|NCT00215683|5029910|P1|Overall Study|Adverse Event|15
1536172|NCT00215657|5029929|P8|Overall Study|Not specified|1
1536173|NCT00215657|5029930|P7|Overall Study|Not specified|6
1536174|NCT00215657|5029931|P6|Overall Study|Not specified|4
1536175|NCT00215657|5029932|P5|Overall Study|Not specified|5
1536176|NCT00215657|5029933|P4|Overall Study|Not specified|3
1536177|NCT00215657|5029934|P3|Overall Study|Not specified|2
1536178|NCT00215657|5029935|P2|Overall Study|Not specified|1
1536179|NCT00215657|5029936|P1|Overall Study|Not specified|3
1536180|NCT00215657|5029929|P8|Overall Study|Insufficient testosterone response|7
1536181|NCT00215657|5029930|P7|Overall Study|Insufficient testosterone response|4
1536182|NCT00215657|5029931|P6|Overall Study|Insufficient testosterone response|12
1536183|NCT00215657|5029932|P5|Overall Study|Insufficient testosterone response|8
1536184|NCT00215657|5029933|P4|Overall Study|Insufficient testosterone response|12
1536185|NCT00215657|5029934|P3|Overall Study|Insufficient testosterone response|1
1536186|NCT00215657|5029935|P2|Overall Study|Insufficient testosterone response|4
1536187|NCT00215657|5029936|P1|Overall Study|Insufficient testosterone response|5
1536188|NCT00215657|5029929|P8|Overall Study|Insuff prostate specific antigen resp|2
1536189|NCT00215657|5029930|P7|Overall Study|Insuff prostate specific antigen resp|3
1536190|NCT00215657|5029931|P6|Overall Study|Insuff prostate specific antigen resp|2
1536191|NCT00215657|5029932|P5|Overall Study|Insuff prostate specific antigen resp|1
1536192|NCT00215657|5029933|P4|Overall Study|Insuff prostate specific antigen resp|2
1536193|NCT00215657|5029934|P3|Overall Study|Insuff prostate specific antigen resp|2
1536194|NCT00215657|5029935|P2|Overall Study|Insuff prostate specific antigen resp|2
1536195|NCT00215657|5029936|P1|Overall Study|Insuff prostate specific antigen resp|3
1536196|NCT00215657|5029929|P8|Overall Study|Withdrawal by Subject|3
1536197|NCT00215657|5029930|P7|Overall Study|Withdrawal by Subject|10
1536198|NCT00215657|5029931|P6|Overall Study|Withdrawal by Subject|1
1536199|NCT00215657|5029932|P5|Overall Study|Withdrawal by Subject|6
1536200|NCT00215657|5029933|P4|Overall Study|Withdrawal by Subject|1
1536201|NCT00215657|5029934|P3|Overall Study|Withdrawal by Subject|3
1536202|NCT00215657|5029935|P2|Overall Study|Withdrawal by Subject|3
1536203|NCT00215657|5029936|P1|Overall Study|Withdrawal by Subject|6
1536204|NCT00215657|5029929|P8|Overall Study|Adverse Event|3
1536205|NCT00215657|5029930|P7|Overall Study|Adverse Event|0
1536206|NCT00215657|5029931|P6|Overall Study|Adverse Event|1
1536207|NCT00215657|5029932|P5|Overall Study|Adverse Event|3
1536208|NCT00215657|5029933|P4|Overall Study|Adverse Event|0
1536209|NCT00215657|5029934|P3|Overall Study|Adverse Event|3
1536210|NCT00215657|5029935|P2|Overall Study|Adverse Event|1
1536211|NCT00215657|5029936|P1|Overall Study|Adverse Event|5
1536212|NCT00215553|5029969|P7|Overall Study|Adverse Event|0
1536213|NCT00215553|5029970|P6|Overall Study|Adverse Event|6
1536214|NCT00215553|5029971|P5|Overall Study|Adverse Event|2
1536215|NCT00215553|5029972|P4|Overall Study|Adverse Event|1
1536216|NCT00215553|5029973|P3|Overall Study|Adverse Event|2
1536217|NCT00215553|5029974|P2|Overall Study|Adverse Event|1
1536218|NCT00215553|5029975|P1|Overall Study|Adverse Event|0
1536219|NCT00215540|5030008|P3|Overall Study|Withdrew from study medication|0
1536220|NCT00215540|5030009|P2|Overall Study|Withdrew from study medication|0
1536221|NCT00215540|5030010|P1|Overall Study|Withdrew from study medication|1
1536222|NCT00215150|5030045|P1|Randomization Phase Placebo|Withdrawal by Subject|1
1536223|NCT00215150|5030045|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
1536224|NCT00215150|5030045|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
1536225|NCT00215150|5030045|P1|Open Label Phase|Did not meet randomization criteria|9
1536226|NCT00215150|5030045|P1|Open Label Phase|Did not complete a post base visit|13
1536227|NCT00215150|5030045|P1|Open Label Phase|Withdrawal by Subject|1
1536228|NCT00215150|5030045|P1|Open Label Phase|Lost to Follow-up|7
1536229|NCT00215137|5030053|P3|Randomization Period|Withdrawal by Subject|0
1536230|NCT00215137|5030054|P2|Randomization Period|Withdrawal by Subject|1
1536231|NCT00215137|5030055|P1|Randomization Period|Withdrawal by Subject|0
1536232|NCT00215137|5030053|P3|Randomization Period|Lost to Follow-up|0
1536233|NCT00215137|5030054|P2|Randomization Period|Lost to Follow-up|1
1536234|NCT00215137|5030055|P1|Randomization Period|Lost to Follow-up|0
1536235|NCT00215137|5030053|P3|Open Label Escitalopram|Lack of Efficacy|0
1536236|NCT00215137|5030054|P2|Open Label Escitalopram|Lack of Efficacy|0
1536237|NCT00215137|5030055|P1|Open Label Escitalopram|Lack of Efficacy|1
1536238|NCT00214461|5030166|P4|Overall Study|Withdrawal by Subject|0
1536239|NCT00214461|5030167|P3|Overall Study|Withdrawal by Subject|1
1536240|NCT00214461|5030168|P2|Overall Study|Withdrawal by Subject|0
1536241|NCT00214461|5030169|P1|Overall Study|Withdrawal by Subject|0
1536242|NCT00214461|5030166|P4|Overall Study|Adverse Event|1
1536243|NCT00214461|5030167|P3|Overall Study|Adverse Event|1
1536244|NCT00214461|5030168|P2|Overall Study|Adverse Event|0
1536245|NCT00214461|5030169|P1|Overall Study|Adverse Event|0
1536246|NCT00214383|5030185|P2|Overall Study|Lost to Follow-up|26
1536247|NCT00214383|5030186|P1|Overall Study|Lost to Follow-up|16
1536248|NCT00214201|5030198|P2|Overall Study|Death|2
1536249|NCT00214201|5030199|P1|Overall Study|Death|0
1536250|NCT00214201|5030198|P2|Overall Study|Withdrawal by Subject|0
1536251|NCT00214201|5030199|P1|Overall Study|Withdrawal by Subject|2
1536252|NCT00214136|5030209|P1|Overall Study|Death|5
1536253|NCT00214019|5030214|P1|Overall Study|Screen Failed prior to randomization|17
1536254|NCT00214019|5030214|P1|Overall Study|Withdrawal by Subject|2
1536255|NCT00214019|5030214|P1|Overall Study|Lost to Follow-up|11
1536256|NCT00213980|5030223|P2|Overall Study|Failed to obtain all 3 DXAs|3
1536257|NCT00213980|5030224|P1|Overall Study|Failed to obtain all 3 DXAs|1
1536258|NCT00213980|5030223|P2|Overall Study|Developed ovarian cancer|0
1536259|NCT00213980|5030224|P1|Overall Study|Developed ovarian cancer|1
1536260|NCT00213980|5030223|P2|Overall Study|Disease progression|2
1536261|NCT00213980|5030224|P1|Overall Study|Disease progression|0
1536262|NCT00213980|5030223|P2|Overall Study|Adverse Event|1
1536263|NCT00213980|5030224|P1|Overall Study|Adverse Event|1
1536264|NCT00213980|5030223|P2|Overall Study|Withdrawal by Subject|1
1536265|NCT00213980|5030224|P1|Overall Study|Withdrawal by Subject|3
1536266|NCT00213148|5030253|P5|Cycle 3 (1 Month)|Other|0
1536267|NCT00213148|5030254|P4|Cycle 3 (1 Month)|Other|1
1536268|NCT00213148|5030255|P3|Cycle 3 (1 Month)|Other|1
1536269|NCT00213148|5030256|P2|Cycle 3 (1 Month)|Other|0
1536270|NCT00213148|5030257|P1|Cycle 3 (1 Month)|Other|0
1536271|NCT00213148|5030253|P5|Cycle 3 (1 Month)|Lost to Follow-up|1
1536272|NCT00213148|5030254|P4|Cycle 3 (1 Month)|Lost to Follow-up|0
1536273|NCT00213148|5030255|P3|Cycle 3 (1 Month)|Lost to Follow-up|0
1536274|NCT00213148|5030256|P2|Cycle 3 (1 Month)|Lost to Follow-up|2
1536275|NCT00213148|5030257|P1|Cycle 3 (1 Month)|Lost to Follow-up|0
1536276|NCT00213148|5030253|P5|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
1536277|NCT00213148|5030254|P4|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
1536278|NCT00213148|5030255|P3|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
1536279|NCT00213148|5030256|P2|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
1536280|NCT00213148|5030257|P1|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
1536281|NCT00213148|5030253|P5|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1536282|NCT00213148|5030254|P4|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1536283|NCT00213148|5030255|P3|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1536284|NCT00213148|5030256|P2|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1536285|NCT00213148|5030257|P1|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
1536286|NCT00213148|5030253|P5|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1536287|NCT00213148|5030254|P4|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1536288|NCT00213148|5030255|P3|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1536289|NCT00213148|5030256|P2|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
1536290|NCT00213148|5030257|P1|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1536291|NCT00213148|5030253|P5|Cycle 2 (1 Month)|Other|7
1536292|NCT00213148|5030254|P4|Cycle 2 (1 Month)|Other|8
1536293|NCT00213148|5030255|P3|Cycle 2 (1 Month)|Other|2
1536294|NCT00213148|5030256|P2|Cycle 2 (1 Month)|Other|1
1536295|NCT00213148|5030257|P1|Cycle 2 (1 Month)|Other|2
1536296|NCT00213148|5030253|P5|Cycle 2 (1 Month)|Lack of Efficacy|16
1536297|NCT00213148|5030254|P4|Cycle 2 (1 Month)|Lack of Efficacy|6
1536298|NCT00213148|5030255|P3|Cycle 2 (1 Month)|Lack of Efficacy|7
1536299|NCT00213148|5030256|P2|Cycle 2 (1 Month)|Lack of Efficacy|3
1536300|NCT00213148|5030257|P1|Cycle 2 (1 Month)|Lack of Efficacy|1
1536301|NCT00213148|5030253|P5|Cycle 2 (1 Month)|Lost to Follow-up|1
1536302|NCT00213148|5030254|P4|Cycle 2 (1 Month)|Lost to Follow-up|2
1536303|NCT00213148|5030255|P3|Cycle 2 (1 Month)|Lost to Follow-up|2
1536304|NCT00213148|5030256|P2|Cycle 2 (1 Month)|Lost to Follow-up|0
1536305|NCT00213148|5030257|P1|Cycle 2 (1 Month)|Lost to Follow-up|0
1536306|NCT00213148|5030253|P5|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
1536307|NCT00213148|5030254|P4|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
1536308|NCT00213148|5030255|P3|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
1536309|NCT00213148|5030256|P2|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
1536310|NCT00213148|5030257|P1|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
1536311|NCT00213148|5030253|P5|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
1536312|NCT00213148|5030254|P4|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1536313|NCT00213148|5030255|P3|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1536314|NCT00213148|5030256|P2|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1536315|NCT00213148|5030257|P1|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1536316|NCT00213148|5030253|P5|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1536317|NCT00213148|5030254|P4|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
1536318|NCT00213148|5030255|P3|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1536319|NCT00213148|5030256|P2|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1536320|NCT00213148|5030257|P1|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1536321|NCT00213148|5030253|P5|Cycle 1 (1 Month)|Other|7
1536322|NCT00213148|5030254|P4|Cycle 1 (1 Month)|Other|2
1536323|NCT00213148|5030255|P3|Cycle 1 (1 Month)|Other|2
1536324|NCT00213148|5030256|P2|Cycle 1 (1 Month)|Other|0
1536325|NCT00213148|5030257|P1|Cycle 1 (1 Month)|Other|3
1536326|NCT00213148|5030253|P5|Cycle 1 (1 Month)|Protocol Violation|0
1536327|NCT00213148|5030254|P4|Cycle 1 (1 Month)|Protocol Violation|0
1536328|NCT00213148|5030255|P3|Cycle 1 (1 Month)|Protocol Violation|1
1536329|NCT00213148|5030256|P2|Cycle 1 (1 Month)|Protocol Violation|0
1536330|NCT00213148|5030257|P1|Cycle 1 (1 Month)|Protocol Violation|1
1536331|NCT00213148|5030253|P5|Cycle 1 (1 Month)|Lack of Efficacy|8
1536332|NCT00213148|5030254|P4|Cycle 1 (1 Month)|Lack of Efficacy|5
1536333|NCT00213148|5030255|P3|Cycle 1 (1 Month)|Lack of Efficacy|8
1536334|NCT00213148|5030256|P2|Cycle 1 (1 Month)|Lack of Efficacy|0
1536335|NCT00213148|5030257|P1|Cycle 1 (1 Month)|Lack of Efficacy|4
1536336|NCT00213148|5030253|P5|Cycle 1 (1 Month)|Adverse Event|0
1536337|NCT00213148|5030254|P4|Cycle 1 (1 Month)|Adverse Event|0
1536338|NCT00213148|5030255|P3|Cycle 1 (1 Month)|Adverse Event|1
1536339|NCT00213148|5030256|P2|Cycle 1 (1 Month)|Adverse Event|0
1536340|NCT00213148|5030257|P1|Cycle 1 (1 Month)|Adverse Event|0
1536341|NCT00213148|5030253|P5|Cycle 1 (1 Month)|Lost to Follow-up|1
1536342|NCT00213148|5030254|P4|Cycle 1 (1 Month)|Lost to Follow-up|2
1536343|NCT00213148|5030255|P3|Cycle 1 (1 Month)|Lost to Follow-up|2
1536344|NCT00213148|5030256|P2|Cycle 1 (1 Month)|Lost to Follow-up|0
1536345|NCT00213148|5030257|P1|Cycle 1 (1 Month)|Lost to Follow-up|1
1536346|NCT00213135|5030284|P3|Overall Study|Other|15
1536347|NCT00213135|5030285|P2|Overall Study|Other|12
1536348|NCT00213135|5030286|P1|Overall Study|Other|21
1536349|NCT00213135|5030284|P3|Overall Study|Disease progression|21
1536350|NCT00213135|5030285|P2|Overall Study|Disease progression|5
1536351|NCT00213135|5030286|P1|Overall Study|Disease progression|4
1536352|NCT00213135|5030284|P3|Overall Study|Death|2
1536353|NCT00213135|5030285|P2|Overall Study|Death|1
1536354|NCT00213135|5030286|P1|Overall Study|Death|1
1536355|NCT00213135|5030284|P3|Overall Study|Protocol Violation|10
1536356|NCT00213135|5030285|P2|Overall Study|Protocol Violation|4
1536357|NCT00213135|5030286|P1|Overall Study|Protocol Violation|4
1536358|NCT00213135|5030284|P3|Overall Study|Lost to Follow-up|4
1536359|NCT00213135|5030285|P2|Overall Study|Lost to Follow-up|8
1536360|NCT00213135|5030286|P1|Overall Study|Lost to Follow-up|11
1536361|NCT00213135|5030284|P3|Overall Study|Adverse Event|5
1536362|NCT00213135|5030285|P2|Overall Study|Adverse Event|5
1536363|NCT00213135|5030286|P1|Overall Study|Adverse Event|9
1536364|NCT00212758|5030303|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
1536365|NCT00212758|5030304|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
1536366|NCT00212758|5030303|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
1536367|NCT00212758|5030304|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
1536368|NCT00212355|5030310|P1|Overall Study|A change of address|1
1536369|NCT00212355|5030310|P1|Overall Study|Withdrawal by Subject|1
1536370|NCT00212355|5030310|P1|Overall Study|Adverse Event|1
1536371|NCT00212134|5030331|P2|Phase 3 (Age 10 Years)|On Going|21
1536372|NCT00212134|5030332|P1|Phase 3 (Age 10 Years)|On Going|21
1536373|NCT00211887|5030353|P3|Overall Study|Side effects|5
1536374|NCT00211887|5030354|P2|Overall Study|Side effects|13
1536375|NCT00211887|5030355|P1|Overall Study|Side effects|19
1536376|NCT00211887|5030353|P3|Overall Study|Other medical reason|7
1536377|NCT00211887|5030354|P2|Overall Study|Other medical reason|11
1536378|NCT00211887|5030355|P1|Overall Study|Other medical reason|15
1536379|NCT00211887|5030353|P3|Overall Study|Non-medical reason|8
1536380|NCT00211887|5030354|P2|Overall Study|Non-medical reason|14
1536381|NCT00211887|5030355|P1|Overall Study|Non-medical reason|31
1536382|NCT00211887|5030353|P3|Overall Study|Lost to Follow-up|9
1536383|NCT00211887|5030354|P2|Overall Study|Lost to Follow-up|13
1536384|NCT00211887|5030355|P1|Overall Study|Lost to Follow-up|28
1536385|NCT00211887|5030353|P3|Overall Study|Death|1
1536386|NCT00211887|5030354|P2|Overall Study|Death|1
1536387|NCT00211887|5030355|P1|Overall Study|Death|1
1536388|NCT00211887|5030353|P3|Overall Study|Adverse Event|6
1536389|NCT00211887|5030354|P2|Overall Study|Adverse Event|4
1536390|NCT00211887|5030355|P1|Overall Study|Adverse Event|8
1536391|NCT00211809|5030372|P1|Overall Study|side effects|2
1536392|NCT00211809|5030372|P1|Overall Study|Pregnancy|1
1536393|NCT00211809|5030372|P1|Overall Study|Lost to Follow-up|2
1536394|NCT00211809|5030372|P1|Overall Study|Lack of Efficacy|1
1536395|NCT00211536|5030399|P2|Overall Study|Adverse Event|0
1536396|NCT00211536|5030400|P1|Overall Study|Adverse Event|2
1536397|NCT00211536|5030399|P2|Overall Study|Physician Decision|5
1536398|NCT00211536|5030400|P1|Overall Study|Physician Decision|0
1536399|NCT00211536|5030399|P2|Overall Study|Withdrawal by Subject|2
1536400|NCT00211536|5030400|P1|Overall Study|Withdrawal by Subject|2
1536401|NCT00211510|5030416|P2|Overall Study|Withdrawal by Subject|1
1536402|NCT00211510|5030417|P1|Overall Study|Withdrawal by Subject|3
1536403|NCT00211510|5030416|P2|Overall Study|Physician Decision|1
1536404|NCT00211510|5030417|P1|Overall Study|Physician Decision|3
1536405|NCT00211237|5030435|P3|12 Months|unrelated medical problem|1
1536406|NCT00211237|5030436|P2|12 Months|unrelated medical problem|0
1536407|NCT00211237|5030437|P1|12 Months|unrelated medical problem|0
1536408|NCT00211237|5030435|P3|12 Months|Withdrew|1
1536409|NCT00211237|5030436|P2|12 Months|Withdrew|0
1536410|NCT00211237|5030437|P1|12 Months|Withdrew|0
1536411|NCT00211237|5030435|P3|12 Months|Lost to Follow-up|1
1536412|NCT00211237|5030436|P2|12 Months|Lost to Follow-up|0
1536413|NCT00211237|5030437|P1|12 Months|Lost to Follow-up|1
1536414|NCT00211237|5030435|P3|12 Months|Death|3
1536415|NCT00211237|5030436|P2|12 Months|Death|2
1536416|NCT00211237|5030437|P1|12 Months|Death|8
1536417|NCT00211237|5030435|P3|6 Months|Could not comply with protocol|0
1536418|NCT00211237|5030436|P2|6 Months|Could not comply with protocol|2
1536419|NCT00211237|5030437|P1|6 Months|Could not comply with protocol|0
1536420|NCT00211237|5030435|P3|6 Months|Lost to Follow-up|0
1536421|NCT00211237|5030436|P2|6 Months|Lost to Follow-up|0
1536422|NCT00211237|5030437|P1|6 Months|Lost to Follow-up|2
1536423|NCT00211237|5030435|P3|6 Months|Death|3
1536424|NCT00211237|5030436|P2|6 Months|Death|0
1536425|NCT00211237|5030437|P1|6 Months|Death|6
1536426|NCT00211237|5030435|P3|3 Months|Non-medical problem|1
1536427|NCT00211237|5030436|P2|3 Months|Non-medical problem|0
1536428|NCT00211237|5030437|P1|3 Months|Non-medical problem|0
1536429|NCT00211237|5030435|P3|3 Months|Withdrew|0
1536430|NCT00211237|5030436|P2|3 Months|Withdrew|1
1536431|NCT00211237|5030437|P1|3 Months|Withdrew|0
1536432|NCT00211237|5030435|P3|3 Months|Could not comply with protocol|0
1536433|NCT00211237|5030436|P2|3 Months|Could not comply with protocol|0
1536434|NCT00211237|5030437|P1|3 Months|Could not comply with protocol|1
1536435|NCT00211237|5030435|P3|3 Months|Death|0
1536436|NCT00211237|5030436|P2|3 Months|Death|3
1536437|NCT00211237|5030437|P1|3 Months|Death|7
1536438|NCT00211237|5030435|P3|1 Month|Non-medical problem|0
1536439|NCT00211237|5030436|P2|1 Month|Non-medical problem|2
1536440|NCT00211237|5030437|P1|1 Month|Non-medical problem|0
1536441|NCT00211237|5030435|P3|1 Month|Additional surgery needed|0
1536442|NCT00211237|5030436|P2|1 Month|Additional surgery needed|0
1536443|NCT00211237|5030437|P1|1 Month|Additional surgery needed|1
1536444|NCT00211237|5030435|P3|1 Month|Withdrew|0
1536445|NCT00211237|5030436|P2|1 Month|Withdrew|4
1536446|NCT00211237|5030437|P1|1 Month|Withdrew|0
1536447|NCT00211237|5030435|P3|1 Month|Lost to Follow-up|0
1536448|NCT00211237|5030436|P2|1 Month|Lost to Follow-up|2
1536449|NCT00211237|5030437|P1|1 Month|Lost to Follow-up|0
1536450|NCT00211237|5030435|P3|1 Month|Death|0
1536451|NCT00211237|5030436|P2|1 Month|Death|1
1536452|NCT00211237|5030437|P1|1 Month|Death|2
1536453|NCT00211237|5030435|P3|Baseline|Refused random assignment|0
1536454|NCT00211237|5030436|P2|Baseline|Refused random assignment|0
1536455|NCT00211237|5030437|P1|Baseline|Refused random assignment|1
1536456|NCT00211237|5030435|P3|Baseline|Withdrew|0
1536457|NCT00211237|5030436|P2|Baseline|Withdrew|3
1536458|NCT00211237|5030437|P1|Baseline|Withdrew|1
1536459|NCT00211172|5030529|P2|Overall Study|Died or lost health plan eligibility|32
1536460|NCT00211172|5030530|P1|Overall Study|Died or lost health plan eligibility|39
1536461|NCT00211081|5030536|P1|Overall Study|Withdrawal by Subject|2
1536462|NCT00210639|5030548|P2|Overall Study|Not specified|12
1536463|NCT00210639|5030549|P1|Overall Study|Not specified|18
1536464|NCT00210639|5030548|P2|Overall Study|Withdrawal by Subject|1
1536465|NCT00210639|5030549|P1|Overall Study|Withdrawal by Subject|8
1536466|NCT00210639|5030548|P2|Overall Study|Lost to Follow-up|29
1536467|NCT00210639|5030549|P1|Overall Study|Lost to Follow-up|37
1536468|NCT00210626|5030557|P2|Overall Study|Not Specified|5
1536469|NCT00210626|5030558|P1|Overall Study|Not Specified|4
1536470|NCT00210626|5030557|P2|Overall Study|Sponser Request|0
1536471|NCT00210626|5030558|P1|Overall Study|Sponser Request|1
1536472|NCT00210626|5030557|P2|Overall Study|Physician Decision|2
1536473|NCT00210626|5030558|P1|Overall Study|Physician Decision|0
1536474|NCT00210626|5030557|P2|Overall Study|Withdrawal by Subject|20
1536475|NCT00210626|5030558|P1|Overall Study|Withdrawal by Subject|29
1536476|NCT00210626|5030557|P2|Overall Study|Death|0
1536477|NCT00210626|5030558|P1|Overall Study|Death|1
1536478|NCT00210626|5030557|P2|Overall Study|Lost to Follow-up|11
1536479|NCT00210626|5030558|P1|Overall Study|Lost to Follow-up|11
1536480|NCT00210626|5030557|P2|Overall Study|Protocol Violation|5
1536481|NCT00210626|5030558|P1|Overall Study|Protocol Violation|1
1536482|NCT00210626|5030557|P2|Overall Study|Adverse Event|2
1536483|NCT00210626|5030558|P1|Overall Study|Adverse Event|1
1536484|NCT00210470|5030566|P1|Overall Study|Subject did not continue to surgery|1
1536485|NCT00209560|5030572|P2|Overall Study|Lack of Efficacy|0
1536486|NCT00209560|5030573|P1|Overall Study|Lack of Efficacy|1
1536487|NCT00209339|5030592|P1|At 5 Years Follow-up|Death|1
1536488|NCT00209339|5030592|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
1536489|NCT00209339|5030592|P1|At 5 Years Follow-up|Withdrawal by Subject|2
1536490|NCT00209339|5030592|P1|At 4 Years Follow-up|Death|1
1536491|NCT00209339|5030592|P1|At 4 Years Follow-up|Withdrawal by Subject|4
1536492|NCT00209339|5030592|P1|At 3 Years Follow-up|Withdrawal by Subject|1
1536493|NCT00209339|5030592|P1|At 24 Months Follow-up|Death|1
1536494|NCT00209339|5030592|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
1536495|NCT00209339|5030592|P1|At 24 Months Follow-up|Withdrawal by Subject|4
1536496|NCT00209339|5030592|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
1536497|NCT00209339|5030592|P1|At 12 Months Follow-up|Death|1
1536498|NCT00209339|5030592|P1|At 12 Months Follow-up|Withdrawal by Subject|8
1536499|NCT00209274|5030676|P2|Overall Study|Randomized not treated (RNT)|15
1536500|NCT00209274|5030677|P1|Overall Study|Randomized not treated (RNT)|6
1536501|NCT00209274|5030676|P2|Overall Study|Withdrawal by Subject|15
1536502|NCT00209274|5030677|P1|Overall Study|Withdrawal by Subject|30
1536503|NCT00209274|5030676|P2|Overall Study|Death|15
1536504|NCT00209274|5030677|P1|Overall Study|Death|32
1536505|NCT00209274|5030676|P2|Overall Study|Missed visit|2
1536506|NCT00209274|5030677|P1|Overall Study|Missed visit|3
1536507|NCT00209170|5030997|P2|Overall Study|Lack of Efficacy|1
1536508|NCT00209170|5030998|P1|Overall Study|Lack of Efficacy|0
1536509|NCT00209170|5030997|P2|Overall Study|Withdrawal by Subject|1
1536510|NCT00209170|5030998|P1|Overall Study|Withdrawal by Subject|2
1536511|NCT00209170|5030997|P2|Overall Study|Adverse Event|1
1536512|NCT00209170|5030998|P1|Overall Study|Adverse Event|0
1536513|NCT00209131|5031006|P2|Overall Study|Lack of personnel due to turnovers.|11
1536514|NCT00209131|5031007|P1|Overall Study|Lack of personnel due to turnovers.|15
1536515|NCT00209092|5031017|P2|Overall Study|Withdrawal by Subject|0
1536516|NCT00209092|5031018|P1|Overall Study|Withdrawal by Subject|1
1536517|NCT00209092|5031017|P2|Overall Study|Adverse Event|1
1536518|NCT00209092|5031018|P1|Overall Study|Adverse Event|0
1536519|NCT00209092|5031017|P2|Overall Study|Progression of disease|1
1536520|NCT00209092|5031018|P1|Overall Study|Progression of disease|7
1536521|NCT00209027|5031028|P2|Overall Study|study terminated|0
1536522|NCT00209027|5031029|P1|Overall Study|study terminated|10
1536523|NCT00208767|5031053|P2|Overall Study|Lost to Follow-up|3
1536524|NCT00208767|5031054|P1|Overall Study|Lost to Follow-up|3
1536525|NCT00208767|5031053|P2|Overall Study|Death|0
1536526|NCT00208767|5031054|P1|Overall Study|Death|1
1536527|NCT00208767|5031053|P2|Overall Study|Withdrawal by Subject|3
1536528|NCT00208767|5031054|P1|Overall Study|Withdrawal by Subject|14
1536529|NCT00208767|5031053|P2|Overall Study|Adverse Event|1
1536530|NCT00208767|5031054|P1|Overall Study|Adverse Event|9
1536531|NCT00208325|5031082|P4|Overall Study|Mis-Randomized|0
1536532|NCT00208325|5031083|P3|Overall Study|Mis-Randomized|0
1536533|NCT00208325|5031084|P2|Overall Study|Mis-Randomized|20
1536534|NCT00208325|5031085|P1|Overall Study|Mis-Randomized|17
1536535|NCT00208325|5031082|P4|Overall Study|Other|0
1536536|NCT00208325|5031083|P3|Overall Study|Other|1
1536537|NCT00208325|5031084|P2|Overall Study|Other|1
1536538|NCT00208325|5031085|P1|Overall Study|Other|2
1536539|NCT00208325|5031082|P4|Overall Study|Does not wish to Continue in Study|2
1536540|NCT00208325|5031083|P3|Overall Study|Does not wish to Continue in Study|3
1536541|NCT00208325|5031084|P2|Overall Study|Does not wish to Continue in Study|8
1536542|NCT00208325|5031085|P1|Overall Study|Does not wish to Continue in Study|5
1536543|NCT00208325|5031082|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
1536544|NCT00208325|5031083|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
1536545|NCT00208325|5031084|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
1536546|NCT00208325|5031085|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
1536547|NCT00208325|5031082|P4|Overall Study|Lost to Follow-up|0
1536548|NCT00208325|5031083|P3|Overall Study|Lost to Follow-up|2
1536549|NCT00208325|5031084|P2|Overall Study|Lost to Follow-up|0
1536550|NCT00208325|5031085|P1|Overall Study|Lost to Follow-up|1
1536551|NCT00208325|5031082|P4|Overall Study|Revision|4
1536552|NCT00208325|5031083|P3|Overall Study|Revision|0
1536553|NCT00208325|5031084|P2|Overall Study|Revision|1
1536554|NCT00208325|5031085|P1|Overall Study|Revision|4
1536555|NCT00208325|5031082|P4|Overall Study|Withdrawal by Subject|0
1536556|NCT00208325|5031083|P3|Overall Study|Withdrawal by Subject|0
1536557|NCT00208325|5031084|P2|Overall Study|Withdrawal by Subject|1
1536558|NCT00208325|5031085|P1|Overall Study|Withdrawal by Subject|0
1536559|NCT00208325|5031082|P4|Overall Study|Death|5
1536560|NCT00208325|5031083|P3|Overall Study|Death|7
1536561|NCT00208325|5031084|P2|Overall Study|Death|19
1536562|NCT00208325|5031085|P1|Overall Study|Death|18
1536563|NCT00207740|5031220|P4|Overall Study|Not Specified|5
1536564|NCT00207740|5031221|P3|Overall Study|Not Specified|7
1536565|NCT00207740|5031222|P2|Overall Study|Not Specified|10
1536566|NCT00207740|5031223|P1|Overall Study|Not Specified|2
1536567|NCT00207740|5031220|P4|Overall Study|Sponsor Directive|21
1536568|NCT00207740|5031221|P3|Overall Study|Sponsor Directive|16
1536569|NCT00207740|5031222|P2|Overall Study|Sponsor Directive|15
1536570|NCT00207740|5031223|P1|Overall Study|Sponsor Directive|22
1536571|NCT00207740|5031220|P4|Overall Study|Death|1
1536572|NCT00207740|5031221|P3|Overall Study|Death|0
1536573|NCT00207740|5031222|P2|Overall Study|Death|0
1536574|NCT00207740|5031223|P1|Overall Study|Death|0
1536575|NCT00207740|5031220|P4|Overall Study|Lost to Follow-up|1
1536576|NCT00207740|5031221|P3|Overall Study|Lost to Follow-up|1
1536577|NCT00207740|5031222|P2|Overall Study|Lost to Follow-up|2
1536578|NCT00207740|5031223|P1|Overall Study|Lost to Follow-up|0
1536579|NCT00207740|5031220|P4|Overall Study|Unsatisfactory therapeutic effect|4
1536580|NCT00207740|5031221|P3|Overall Study|Unsatisfactory therapeutic effect|2
1536581|NCT00207740|5031222|P2|Overall Study|Unsatisfactory therapeutic effect|0
1536582|NCT00207740|5031223|P1|Overall Study|Unsatisfactory therapeutic effect|1
1536583|NCT00207740|5031220|P4|Overall Study|Adverse Event|11
1536584|NCT00207740|5031221|P3|Overall Study|Adverse Event|14
1536585|NCT00207740|5031222|P2|Overall Study|Adverse Event|14
1536586|NCT00207740|5031223|P1|Overall Study|Adverse Event|4
1536587|NCT00207727|5031269|P5|Overall Study|Not specified|33
1536588|NCT00207727|5031270|P4|Overall Study|Not specified|37
1536589|NCT00207727|5031271|P3|Overall Study|Not specified|41
1536590|NCT00207727|5031272|P2|Overall Study|Not specified|41
1536591|NCT00207727|5031273|P1|Overall Study|Not specified|38
1536592|NCT00207727|5031269|P5|Overall Study|Lost to Follow-up|0
1536593|NCT00207727|5031270|P4|Overall Study|Lost to Follow-up|0
1536594|NCT00207727|5031271|P3|Overall Study|Lost to Follow-up|0
1536595|NCT00207727|5031272|P2|Overall Study|Lost to Follow-up|1
1536596|NCT00207727|5031273|P1|Overall Study|Lost to Follow-up|0
1536597|NCT00207727|5031269|P5|Overall Study|Withdrawal by Subject|1
1536598|NCT00207727|5031270|P4|Overall Study|Withdrawal by Subject|0
1536599|NCT00207727|5031271|P3|Overall Study|Withdrawal by Subject|0
1536600|NCT00207727|5031272|P2|Overall Study|Withdrawal by Subject|0
1536601|NCT00207727|5031273|P1|Overall Study|Withdrawal by Subject|0
1536602|NCT00207714|5031300|P5|Overall Study|Other|0
1536603|NCT00207714|5031301|P4|Overall Study|Other|1
1536604|NCT00207714|5031302|P3|Overall Study|Other|5
1536605|NCT00207714|5031303|P2|Overall Study|Other|2
1536606|NCT00207714|5031304|P1|Overall Study|Other|3
1536607|NCT00207714|5031300|P5|Overall Study|Unsatisfactory therapeutic effect|4
1536608|NCT00207714|5031301|P4|Overall Study|Unsatisfactory therapeutic effect|4
1536609|NCT00207714|5031302|P3|Overall Study|Unsatisfactory therapeutic effect|1
1536610|NCT00207714|5031303|P2|Overall Study|Unsatisfactory therapeutic effect|3
1536611|NCT00207714|5031304|P1|Overall Study|Unsatisfactory therapeutic effect|5
1536612|NCT00207714|5031300|P5|Overall Study|Adverse Event|1
1536613|NCT00207714|5031301|P4|Overall Study|Adverse Event|3
1536614|NCT00207714|5031302|P3|Overall Study|Adverse Event|4
1536615|NCT00207714|5031303|P2|Overall Study|Adverse Event|2
1536616|NCT00207714|5031304|P1|Overall Study|Adverse Event|6
1536617|NCT00207142|5031326|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
1536618|NCT00207142|5031327|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
1536619|NCT00207142|5031328|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
1536620|NCT00207142|5031329|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
1536621|NCT00207142|5031326|P4|Maintenance Phase/Rescue Phase|Death|1
1536622|NCT00207142|5031327|P3|Maintenance Phase/Rescue Phase|Death|0
1536623|NCT00207142|5031328|P2|Maintenance Phase/Rescue Phase|Death|0
1536624|NCT00207142|5031329|P1|Maintenance Phase/Rescue Phase|Death|0
1536625|NCT00207142|5031326|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
1536626|NCT00207142|5031327|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
1536627|NCT00207142|5031328|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
1536628|NCT00207142|5031329|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
1536629|NCT00207142|5031326|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
1536630|NCT00207142|5031327|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
1536631|NCT00207142|5031328|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
1536632|NCT00207142|5031329|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
1536633|NCT00207142|5031326|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
1536634|NCT00207142|5031327|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
1536635|NCT00207142|5031328|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
1536636|NCT00207142|5031329|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
1536637|NCT00207142|5031326|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
1536638|NCT00207142|5031327|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
1536639|NCT00207142|5031328|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
1536640|NCT00207142|5031329|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
1536641|NCT00207142|5031326|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
1536642|NCT00207142|5031327|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
1536643|NCT00207142|5031328|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
1536644|NCT00207142|5031329|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
1536645|NCT00207142|5031326|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
1536646|NCT00207142|5031327|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
1536647|NCT00207142|5031328|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
1536648|NCT00207142|5031329|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
1536649|NCT00207142|5031326|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
1536650|NCT00207142|5031327|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
1536651|NCT00207142|5031328|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
1536652|NCT00207142|5031329|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
1536653|NCT00207142|5031326|P4|Induction Phase|Missing lab data|0
1536654|NCT00207142|5031327|P3|Induction Phase|Missing lab data|0
1536655|NCT00207142|5031328|P2|Induction Phase|Missing lab data|0
1536656|NCT00207142|5031329|P1|Induction Phase|Missing lab data|1
1536657|NCT00207142|5031326|P4|Induction Phase|Incarceration|0
1536658|NCT00207142|5031327|P3|Induction Phase|Incarceration|0
1536659|NCT00207142|5031328|P2|Induction Phase|Incarceration|0
1536660|NCT00207142|5031329|P1|Induction Phase|Incarceration|1
1536661|NCT00207142|5031326|P4|Induction Phase|Withdrawal by Subject|0
1536662|NCT00207142|5031327|P3|Induction Phase|Withdrawal by Subject|0
1536663|NCT00207142|5031328|P2|Induction Phase|Withdrawal by Subject|0
1536664|NCT00207142|5031329|P1|Induction Phase|Withdrawal by Subject|4
1536665|NCT00207142|5031326|P4|Induction Phase|Subject no longer meets study criteria|0
1536666|NCT00207142|5031327|P3|Induction Phase|Subject no longer meets study criteria|0
1536667|NCT00207142|5031328|P2|Induction Phase|Subject no longer meets study criteria|0
1536668|NCT00207142|5031329|P1|Induction Phase|Subject no longer meets study criteria|3
1536669|NCT00207142|5031326|P4|Induction Phase|Pregnancy|0
1536670|NCT00207142|5031327|P3|Induction Phase|Pregnancy|0
1536671|NCT00207142|5031328|P2|Induction Phase|Pregnancy|0
1536672|NCT00207142|5031329|P1|Induction Phase|Pregnancy|1
1536673|NCT00207142|5031326|P4|Induction Phase|Poor/noncompliance|0
1536674|NCT00207142|5031327|P3|Induction Phase|Poor/noncompliance|0
1536675|NCT00207142|5031328|P2|Induction Phase|Poor/noncompliance|0
1536676|NCT00207142|5031329|P1|Induction Phase|Poor/noncompliance|2
1536677|NCT00207142|5031326|P4|Induction Phase|Physician Decision|0
1536678|NCT00207142|5031327|P3|Induction Phase|Physician Decision|0
1536679|NCT00207142|5031328|P2|Induction Phase|Physician Decision|0
1536680|NCT00207142|5031329|P1|Induction Phase|Physician Decision|2
1536681|NCT00207142|5031326|P4|Induction Phase|Lost to Follow-up|0
1536682|NCT00207142|5031327|P3|Induction Phase|Lost to Follow-up|0
1536683|NCT00207142|5031328|P2|Induction Phase|Lost to Follow-up|0
1536684|NCT00207142|5031329|P1|Induction Phase|Lost to Follow-up|5
1536685|NCT00207142|5031326|P4|Induction Phase|Lack of Efficacy|0
1536686|NCT00207142|5031327|P3|Induction Phase|Lack of Efficacy|0
1536687|NCT00207142|5031328|P2|Induction Phase|Lack of Efficacy|0
1536688|NCT00207142|5031329|P1|Induction Phase|Lack of Efficacy|1
1536689|NCT00207142|5031326|P4|Induction Phase|Death|0
1536690|NCT00207142|5031327|P3|Induction Phase|Death|0
1536691|NCT00207142|5031328|P2|Induction Phase|Death|0
1536692|NCT00207142|5031329|P1|Induction Phase|Death|1
1536693|NCT00207142|5031326|P4|Induction Phase|Adverse Event|0
1536694|NCT00207142|5031327|P3|Induction Phase|Adverse Event|0
1536695|NCT00207142|5031328|P2|Induction Phase|Adverse Event|0
1536696|NCT00207142|5031329|P1|Induction Phase|Adverse Event|9
1536697|NCT00207090|5031366|P1|Overall Study|Physician Decision|1
1536698|NCT00207090|5031366|P1|Overall Study|Disease progression/relapse|2
1536699|NCT00207090|5031366|P1|Overall Study|Chest wall mass larger|1
1536700|NCT00207090|5031366|P1|Overall Study|Study drug toxicity|3
1536701|NCT00206726|5031395|P1|Overall Study|Withdrawal by Subject|8
1536702|NCT00206726|5031395|P1|Overall Study|Protocol Violation|1
1536703|NCT00206726|5031395|P1|Overall Study|Death|4
1536704|NCT00206726|5031395|P1|Overall Study|Adverse Event|17
1536705|NCT00206726|5031395|P1|Overall Study|Bone marrow transplant|1
1536706|NCT00206726|5031395|P1|Overall Study|Placed on new protocol|1
1536707|NCT00206726|5031395|P1|Overall Study|Progressive disease or relapsed disease|18
1536708|NCT00206726|5031395|P1|Overall Study|Delayed recovery of blood counts|1
1536709|NCT00206518|5031406|P2|Overall Study|Protocol Violation|1
1536710|NCT00206518|5031407|P1|Overall Study|Protocol Violation|1
1536711|NCT00206518|5031406|P2|Overall Study|Physician Decision|0
1536712|NCT00206518|5031407|P1|Overall Study|Physician Decision|1
1536713|NCT00206518|5031406|P2|Overall Study|Adverse Event|1
1536714|NCT00206518|5031407|P1|Overall Study|Adverse Event|2
1536715|NCT00206518|5031406|P2|Overall Study|Lack of Efficacy|4
1536716|NCT00206518|5031407|P1|Overall Study|Lack of Efficacy|6
1536717|NCT00206440|5031419|P2|Overall Study|Adverse Event|2
1536718|NCT00206440|5031420|P1|Overall Study|Adverse Event|4
1536719|NCT00206440|5031419|P2|Overall Study|Protocol Violation|2
1536720|NCT00206440|5031420|P1|Overall Study|Protocol Violation|1
1536721|NCT00206427|5031426|P1|Overall Study|Adverse Event|2
1536722|NCT00206323|5031436|P2|Overall Study|Lost to Follow-up|1
1536723|NCT00206323|5031437|P1|Overall Study|Lost to Follow-up|1
1536724|NCT00206323|5031436|P2|Overall Study|Adverse Event|1
1536725|NCT00206323|5031437|P1|Overall Study|Adverse Event|1
1536726|NCT00206323|5031436|P2|Overall Study|Lack of Efficacy|1
1536727|NCT00206323|5031437|P1|Overall Study|Lack of Efficacy|4
1536728|NCT00206102|5031445|P2|Overall Study|None of those categories|36
1536729|NCT00206102|5031446|P1|Overall Study|None of those categories|42
1536730|NCT00206102|5031445|P2|Overall Study|Study-specific discontinuation criteria|17
1536731|NCT00206102|5031446|P1|Overall Study|Study-specific discontinuation criteria|18
1536732|NCT00206102|5031445|P2|Overall Study|Withdrawal by Subject|101
1536733|NCT00206102|5031446|P1|Overall Study|Withdrawal by Subject|118
1536734|NCT00206102|5031445|P2|Overall Study|Lost to Follow-up|66
1536735|NCT00206102|5031446|P1|Overall Study|Lost to Follow-up|95
1536736|NCT00206102|5031445|P2|Overall Study|Lack of therapeutic response|11
1536737|NCT00206102|5031446|P1|Overall Study|Lack of therapeutic response|16
1536738|NCT00206102|5031445|P2|Overall Study|Protocol Violation|2
1536739|NCT00206102|5031446|P1|Overall Study|Protocol Violation|0
1536740|NCT00206102|5031445|P2|Overall Study|Adverse Event|82
1536741|NCT00206102|5031446|P1|Overall Study|Adverse Event|119
1536742|NCT00206076|5031482|P2|Overall Study|Withdrawal by Subject|1
1536743|NCT00206076|5031483|P1|Overall Study|Withdrawal by Subject|1
1536744|NCT00206076|5031482|P2|Overall Study|Physician Decision|0
1536745|NCT00206076|5031483|P1|Overall Study|Physician Decision|2
1536746|NCT00205881|5031493|P1|Overall Study|Withdrawal by Subject|16
1536747|NCT00205855|5031498|P1|Overall Study|Withdrawal by Subject|5
1536748|NCT00205855|5031498|P1|Overall Study|Only received temporary implants|16
1536749|NCT00205803|5031504|P2|Toddler Dose|Lost to Follow-up|3
1536750|NCT00205803|5031505|P1|Toddler Dose|Lost to Follow-up|2
1536751|NCT00205803|5031504|P2|After Infant Series|Other|4
1536752|NCT00205803|5031505|P1|After Infant Series|Other|10
1536753|NCT00205803|5031504|P2|After Infant Series|Withdrawal by Subject|4
1536754|NCT00205803|5031505|P1|After Infant Series|Withdrawal by Subject|1
1536755|NCT00205803|5031504|P2|After Infant Series|Physician Decision|2
1536756|NCT00205803|5031505|P1|After Infant Series|Physician Decision|3
1536757|NCT00205803|5031504|P2|After Infant Series|Lost to Follow-up|1
1536758|NCT00205803|5031505|P1|After Infant Series|Lost to Follow-up|2
1536759|NCT00205803|5031504|P2|After Infant Series|Protocol Violation|1
1536760|NCT00205803|5031505|P1|After Infant Series|Protocol Violation|1
1536761|NCT00205803|5031504|P2|After Infant Series|Adverse Event|1
1536762|NCT00205803|5031505|P1|After Infant Series|Adverse Event|1
1536763|NCT00205803|5031504|P2|Infant Series|Sponsor request|0
1536764|NCT00205803|5031505|P1|Infant Series|Sponsor request|1
1536765|NCT00205803|5031504|P2|Infant Series|Non-compliant|0
1536766|NCT00205803|5031505|P1|Infant Series|Non-compliant|1
1536767|NCT00205803|5031504|P2|Infant Series|Lost Kaiser coverage|1
1536768|NCT00205803|5031505|P1|Infant Series|Lost Kaiser coverage|0
1536769|NCT00205803|5031504|P2|Infant Series|Protocol Violation|0
1536770|NCT00205803|5031505|P1|Infant Series|Protocol Violation|1
1536771|NCT00205803|5031504|P2|Infant Series|Physician Decision|1
1536772|NCT00205803|5031505|P1|Infant Series|Physician Decision|3
1536773|NCT00205803|5031504|P2|Infant Series|Withdrawal by Subject|5
1536774|NCT00205803|5031505|P1|Infant Series|Withdrawal by Subject|2
1536775|NCT00205803|5031504|P2|Infant Series|Lost to Follow-up|4
1536776|NCT00205803|5031505|P1|Infant Series|Lost to Follow-up|10
1536777|NCT00205777|5031561|P6|Study Extension II|Enrolled but not treated|131
1536778|NCT00205777|5031562|P5|Study Extension II|Enrolled but not treated|0
1536779|NCT00205777|5031563|P4|Study Extension II|Enrolled but not treated|71
1536780|NCT00205777|5031564|P3|Study Extension II|Enrolled but not treated|0
1536781|NCT00205777|5031565|P2|Study Extension II|Enrolled but not treated|0
1536782|NCT00205777|5031566|P1|Study Extension II|Enrolled but not treated|0
1536783|NCT00205777|5031561|P6|Study Extension II|Other Event|20
1536784|NCT00205777|5031562|P5|Study Extension II|Other Event|0
1536785|NCT00205777|5031563|P4|Study Extension II|Other Event|12
1536786|NCT00205777|5031564|P3|Study Extension II|Other Event|0
1536787|NCT00205777|5031565|P2|Study Extension II|Other Event|0
1536788|NCT00205777|5031566|P1|Study Extension II|Other Event|0
1536789|NCT00205777|5031561|P6|Study Extension II|Failed to return|26
1536790|NCT00205777|5031562|P5|Study Extension II|Failed to return|0
1536791|NCT00205777|5031563|P4|Study Extension II|Failed to return|14
1536792|NCT00205777|5031564|P3|Study Extension II|Failed to return|0
1536793|NCT00205777|5031565|P2|Study Extension II|Failed to return|0
1536794|NCT00205777|5031566|P1|Study Extension II|Failed to return|0
1536795|NCT00205777|5031561|P6|Study Extension II|Lack of Efficacy|1
1536796|NCT00205777|5031562|P5|Study Extension II|Lack of Efficacy|0
1536797|NCT00205777|5031563|P4|Study Extension II|Lack of Efficacy|0
1536798|NCT00205777|5031564|P3|Study Extension II|Lack of Efficacy|0
1536799|NCT00205777|5031565|P2|Study Extension II|Lack of Efficacy|0
1536800|NCT00205777|5031566|P1|Study Extension II|Lack of Efficacy|0
1536801|NCT00205777|5031561|P6|Study Extension II|Protocol Violation|10
1536802|NCT00205777|5031562|P5|Study Extension II|Protocol Violation|0
1536803|NCT00205777|5031563|P4|Study Extension II|Protocol Violation|1
1536804|NCT00205777|5031564|P3|Study Extension II|Protocol Violation|0
1536805|NCT00205777|5031565|P2|Study Extension II|Protocol Violation|0
1536806|NCT00205777|5031566|P1|Study Extension II|Protocol Violation|0
1536807|NCT00205777|5031561|P6|Study Extension II|Withdrawal by Subject|59
1536808|NCT00205777|5031562|P5|Study Extension II|Withdrawal by Subject|0
1536809|NCT00205777|5031563|P4|Study Extension II|Withdrawal by Subject|35
1536810|NCT00205777|5031564|P3|Study Extension II|Withdrawal by Subject|0
1536811|NCT00205777|5031565|P2|Study Extension II|Withdrawal by Subject|0
1536812|NCT00205777|5031566|P1|Study Extension II|Withdrawal by Subject|0
1536813|NCT00205777|5031561|P6|Study Extension II|Death|5
1536814|NCT00205777|5031562|P5|Study Extension II|Death|0
1536815|NCT00205777|5031563|P4|Study Extension II|Death|2
1536816|NCT00205777|5031564|P3|Study Extension II|Death|0
1536817|NCT00205777|5031565|P2|Study Extension II|Death|0
1536818|NCT00205777|5031566|P1|Study Extension II|Death|0
1536819|NCT00205777|5031561|P6|Study Extension II|Adverse Event|30
1536820|NCT00205777|5031562|P5|Study Extension II|Adverse Event|0
1536821|NCT00205777|5031563|P4|Study Extension II|Adverse Event|14
1536822|NCT00205777|5031564|P3|Study Extension II|Adverse Event|0
1536823|NCT00205777|5031565|P2|Study Extension II|Adverse Event|0
1536824|NCT00205777|5031566|P1|Study Extension II|Adverse Event|0
1536825|NCT00205777|5031561|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
1536826|NCT00205777|5031562|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
1536827|NCT00205777|5031563|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
1536828|NCT00205777|5031564|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
1536829|NCT00205777|5031565|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
1536830|NCT00205777|5031566|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
1536831|NCT00205777|5031561|P6|Study Extension I|Withdrawn as per protocol|0
1536832|NCT00205777|5031562|P5|Study Extension I|Withdrawn as per protocol|0
1536833|NCT00205777|5031563|P4|Study Extension I|Withdrawn as per protocol|0
1536834|NCT00205777|5031564|P3|Study Extension I|Withdrawn as per protocol|1070
1536835|NCT00205777|5031565|P2|Study Extension I|Withdrawn as per protocol|0
1536836|NCT00205777|5031566|P1|Study Extension I|Withdrawn as per protocol|0
1536837|NCT00205777|5031561|P6|Study Extension I|Other Event|0
1536838|NCT00205777|5031562|P5|Study Extension I|Other Event|29
1536839|NCT00205777|5031563|P4|Study Extension I|Other Event|34
1536840|NCT00205777|5031564|P3|Study Extension I|Other Event|0
1536841|NCT00205777|5031565|P2|Study Extension I|Other Event|0
1536842|NCT00205777|5031566|P1|Study Extension I|Other Event|34
1536843|NCT00205777|5031561|P6|Study Extension I|Failed to return|0
1536844|NCT00205777|5031562|P5|Study Extension I|Failed to return|13
1536845|NCT00205777|5031563|P4|Study Extension I|Failed to return|17
1536846|NCT00205777|5031564|P3|Study Extension I|Failed to return|0
1536847|NCT00205777|5031565|P2|Study Extension I|Failed to return|0
1536848|NCT00205777|5031566|P1|Study Extension I|Failed to return|15
1536849|NCT00205777|5031561|P6|Study Extension I|Lack of Efficacy|0
1536850|NCT00205777|5031562|P5|Study Extension I|Lack of Efficacy|2
1536851|NCT00205777|5031563|P4|Study Extension I|Lack of Efficacy|1
1536852|NCT00205777|5031564|P3|Study Extension I|Lack of Efficacy|0
1536853|NCT00205777|5031565|P2|Study Extension I|Lack of Efficacy|0
1536854|NCT00205777|5031566|P1|Study Extension I|Lack of Efficacy|0
1536855|NCT00205777|5031561|P6|Study Extension I|Protocol Violation|0
1536856|NCT00205777|5031562|P5|Study Extension I|Protocol Violation|8
1536857|NCT00205777|5031563|P4|Study Extension I|Protocol Violation|8
1536858|NCT00205777|5031564|P3|Study Extension I|Protocol Violation|0
1536859|NCT00205777|5031565|P2|Study Extension I|Protocol Violation|0
1536860|NCT00205777|5031566|P1|Study Extension I|Protocol Violation|4
1536861|NCT00205777|5031561|P6|Study Extension I|Withdrawal by Subject|0
1536862|NCT00205777|5031562|P5|Study Extension I|Withdrawal by Subject|89
1536863|NCT00205777|5031563|P4|Study Extension I|Withdrawal by Subject|106
1536864|NCT00205777|5031564|P3|Study Extension I|Withdrawal by Subject|0
1536865|NCT00205777|5031565|P2|Study Extension I|Withdrawal by Subject|0
1536866|NCT00205777|5031566|P1|Study Extension I|Withdrawal by Subject|99
1536867|NCT00205777|5031561|P6|Study Extension I|Death|0
1536868|NCT00205777|5031562|P5|Study Extension I|Death|2
1536869|NCT00205777|5031563|P4|Study Extension I|Death|1
1536870|NCT00205777|5031564|P3|Study Extension I|Death|0
1536871|NCT00205777|5031565|P2|Study Extension I|Death|0
1536872|NCT00205777|5031566|P1|Study Extension I|Death|5
1536873|NCT00205777|5031561|P6|Study Extension I|Adverse Event|0
1536874|NCT00205777|5031562|P5|Study Extension I|Adverse Event|58
1536875|NCT00205777|5031563|P4|Study Extension I|Adverse Event|61
1536876|NCT00205777|5031564|P3|Study Extension I|Adverse Event|0
1536877|NCT00205777|5031565|P2|Study Extension I|Adverse Event|0
1536878|NCT00205777|5031566|P1|Study Extension I|Adverse Event|57
1536879|NCT00205777|5031561|P6|Completed Core Study, Entered SE I|Other Event|0
1536880|NCT00205777|5031562|P5|Completed Core Study, Entered SE I|Other Event|0
1536881|NCT00205777|5031563|P4|Completed Core Study, Entered SE I|Other Event|50
1536882|NCT00205777|5031564|P3|Completed Core Study, Entered SE I|Other Event|47
1536883|NCT00205777|5031565|P2|Completed Core Study, Entered SE I|Other Event|46
1536884|NCT00205777|5031566|P1|Completed Core Study, Entered SE I|Other Event|52
1536885|NCT00205777|5031561|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
1536886|NCT00205777|5031562|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
1536887|NCT00205777|5031563|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
1536888|NCT00205777|5031564|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
1536889|NCT00205777|5031565|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
1536890|NCT00205777|5031566|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
1536891|NCT00205777|5031561|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
1536892|NCT00205777|5031562|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
1536893|NCT00205777|5031563|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
1536894|NCT00205777|5031564|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
1536895|NCT00205777|5031565|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
1536896|NCT00205777|5031566|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
1536897|NCT00205777|5031561|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
1536898|NCT00205777|5031562|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
1536899|NCT00205777|5031563|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
1536900|NCT00205777|5031564|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
1536901|NCT00205777|5031565|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
1536902|NCT00205777|5031566|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
1536903|NCT00205777|5031561|P6|Core Study (Up to 3 Years)|Protocol Violation|0
1536904|NCT00205777|5031562|P5|Core Study (Up to 3 Years)|Protocol Violation|0
1536905|NCT00205777|5031563|P4|Core Study (Up to 3 Years)|Protocol Violation|42
1536906|NCT00205777|5031564|P3|Core Study (Up to 3 Years)|Protocol Violation|50
1536907|NCT00205777|5031565|P2|Core Study (Up to 3 Years)|Protocol Violation|55
1536908|NCT00205777|5031566|P1|Core Study (Up to 3 Years)|Protocol Violation|53
1536909|NCT00205777|5031561|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
1536910|NCT00205777|5031562|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
1536911|NCT00205777|5031563|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
1536912|NCT00205777|5031564|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
1536913|NCT00205777|5031565|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
1536914|NCT00205777|5031566|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
1536915|NCT00205777|5031561|P6|Core Study (Up to 3 Years)|Other Event|0
1536916|NCT00205777|5031562|P5|Core Study (Up to 3 Years)|Other Event|0
1536917|NCT00205777|5031563|P4|Core Study (Up to 3 Years)|Other Event|58
1536918|NCT00205777|5031564|P3|Core Study (Up to 3 Years)|Other Event|41
1536919|NCT00205777|5031565|P2|Core Study (Up to 3 Years)|Other Event|52
1536920|NCT00205777|5031566|P1|Core Study (Up to 3 Years)|Other Event|49
1536921|NCT00205777|5031561|P6|Core Study (Up to 3 Years)|Failed to return|0
1536922|NCT00205777|5031562|P5|Core Study (Up to 3 Years)|Failed to return|0
1536923|NCT00205777|5031563|P4|Core Study (Up to 3 Years)|Failed to return|27
1536924|NCT00205777|5031564|P3|Core Study (Up to 3 Years)|Failed to return|27
1536925|NCT00205777|5031565|P2|Core Study (Up to 3 Years)|Failed to return|25
1536926|NCT00205777|5031566|P1|Core Study (Up to 3 Years)|Failed to return|40
1536927|NCT00205777|5031561|P6|Core Study (Up to 3 Years)|Death|0
1536928|NCT00205777|5031562|P5|Core Study (Up to 3 Years)|Death|0
1536929|NCT00205777|5031563|P4|Core Study (Up to 3 Years)|Death|7
1536930|NCT00205777|5031564|P3|Core Study (Up to 3 Years)|Death|14
1536931|NCT00205777|5031565|P2|Core Study (Up to 3 Years)|Death|7
1536932|NCT00205777|5031566|P1|Core Study (Up to 3 Years)|Death|9
1536933|NCT00205777|5031561|P6|Core Study (Up to 3 Years)|Adverse Event|0
1536934|NCT00205777|5031562|P5|Core Study (Up to 3 Years)|Adverse Event|0
1536935|NCT00205777|5031563|P4|Core Study (Up to 3 Years)|Adverse Event|232
1536936|NCT00205777|5031564|P3|Core Study (Up to 3 Years)|Adverse Event|252
1536937|NCT00205777|5031565|P2|Core Study (Up to 3 Years)|Adverse Event|267
1536938|NCT00205777|5031566|P1|Core Study (Up to 3 Years)|Adverse Event|260
1536939|NCT00205712|5031775|P2|Overall Study|Lost to Follow-up|1
1536940|NCT00205712|5031776|P1|Overall Study|Lost to Follow-up|0
1536941|NCT00205699|5031789|P3|Overall Study|Lack of Efficacy|0
1536942|NCT00205699|5031790|P2|Overall Study|Lack of Efficacy|1
1536943|NCT00205699|5031791|P1|Overall Study|Lack of Efficacy|0
1536944|NCT00205699|5031789|P3|Overall Study|Withdrawal by Subject|1
1536945|NCT00205699|5031790|P2|Overall Study|Withdrawal by Subject|2
1536946|NCT00205699|5031791|P1|Overall Study|Withdrawal by Subject|1
1536947|NCT00205699|5031789|P3|Overall Study|Adverse Event|0
1536948|NCT00205699|5031790|P2|Overall Study|Adverse Event|0
1536949|NCT00205699|5031791|P1|Overall Study|Adverse Event|1
1536950|NCT00205699|5031789|P3|Overall Study|Lost to Follow-up|5
1536951|NCT00205699|5031790|P2|Overall Study|Lost to Follow-up|3
1536952|NCT00205699|5031791|P1|Overall Study|Lost to Follow-up|1
1536953|NCT00203996|5031885|P10|Overall Study|Scheduling issue|0
1536954|NCT00203996|5031886|P9|Overall Study|Scheduling issue|0
1536955|NCT00203996|5031887|P8|Overall Study|Scheduling issue|2
1536956|NCT00203996|5031888|P7|Overall Study|Scheduling issue|0
1536957|NCT00203996|5031889|P6|Overall Study|Scheduling issue|0
1536958|NCT00203996|5031890|P5|Overall Study|Scheduling issue|0
1536959|NCT00203996|5031891|P4|Overall Study|Scheduling issue|0
1536960|NCT00203996|5031892|P3|Overall Study|Scheduling issue|0
1536961|NCT00203996|5031893|P2|Overall Study|Scheduling issue|0
1536962|NCT00203996|5031894|P1|Overall Study|Scheduling issue|0
1536963|NCT00203996|5031885|P10|Overall Study|CPAP machine malfunction|0
1536964|NCT00203996|5031886|P9|Overall Study|CPAP machine malfunction|0
1536965|NCT00203996|5031887|P8|Overall Study|CPAP machine malfunction|0
1536966|NCT00203996|5031888|P7|Overall Study|CPAP machine malfunction|0
1536967|NCT00203996|5031889|P6|Overall Study|CPAP machine malfunction|0
1536968|NCT00203996|5031890|P5|Overall Study|CPAP machine malfunction|0
1536969|NCT00203996|5031891|P4|Overall Study|CPAP machine malfunction|1
1536970|NCT00203996|5031892|P3|Overall Study|CPAP machine malfunction|0
1536971|NCT00203996|5031893|P2|Overall Study|CPAP machine malfunction|0
1536972|NCT00203996|5031894|P1|Overall Study|CPAP machine malfunction|0
1536973|NCT00203996|5031885|P10|Overall Study|Physician Decision|1
1536974|NCT00203996|5031886|P9|Overall Study|Physician Decision|0
1536975|NCT00203996|5031887|P8|Overall Study|Physician Decision|0
1536976|NCT00203996|5031888|P7|Overall Study|Physician Decision|0
1536977|NCT00203996|5031889|P6|Overall Study|Physician Decision|0
1536978|NCT00203996|5031890|P5|Overall Study|Physician Decision|0
1536979|NCT00203996|5031891|P4|Overall Study|Physician Decision|2
1536980|NCT00203996|5031892|P3|Overall Study|Physician Decision|0
1536981|NCT00203996|5031893|P2|Overall Study|Physician Decision|0
1536982|NCT00203996|5031894|P1|Overall Study|Physician Decision|0
1536983|NCT00203996|5031885|P10|Overall Study|Protocol Violation|0
1536984|NCT00203996|5031886|P9|Overall Study|Protocol Violation|0
1536985|NCT00203996|5031887|P8|Overall Study|Protocol Violation|0
1536986|NCT00203996|5031888|P7|Overall Study|Protocol Violation|0
1536987|NCT00203996|5031889|P6|Overall Study|Protocol Violation|0
1536988|NCT00203996|5031890|P5|Overall Study|Protocol Violation|1
1536989|NCT00203996|5031891|P4|Overall Study|Protocol Violation|6
1536990|NCT00203996|5031892|P3|Overall Study|Protocol Violation|0
1536991|NCT00203996|5031893|P2|Overall Study|Protocol Violation|0
1536992|NCT00203996|5031894|P1|Overall Study|Protocol Violation|0
1536993|NCT00203996|5031885|P10|Overall Study|Lost to Follow-up|0
1536994|NCT00203996|5031886|P9|Overall Study|Lost to Follow-up|0
1536995|NCT00203996|5031887|P8|Overall Study|Lost to Follow-up|0
1536996|NCT00203996|5031888|P7|Overall Study|Lost to Follow-up|0
1536997|NCT00203996|5031889|P6|Overall Study|Lost to Follow-up|0
1536998|NCT00203996|5031890|P5|Overall Study|Lost to Follow-up|0
1536999|NCT00203996|5031891|P4|Overall Study|Lost to Follow-up|1
1537000|NCT00203996|5031892|P3|Overall Study|Lost to Follow-up|0
1537001|NCT00203996|5031893|P2|Overall Study|Lost to Follow-up|0
1537002|NCT00203996|5031894|P1|Overall Study|Lost to Follow-up|0
1537003|NCT00203892|5031961|P3|Overall Study|Death|0
1537004|NCT00203892|5031962|P2|Overall Study|Death|0
1537005|NCT00203892|5031963|P1|Overall Study|Death|1
1537006|NCT00203892|5031961|P3|Overall Study|Physician Decision|0
1537007|NCT00203892|5031962|P2|Overall Study|Physician Decision|2
1537008|NCT00203892|5031963|P1|Overall Study|Physician Decision|1
1537009|NCT00203502|5031974|P1|Overall Study|Death|1
1537010|NCT00203476|5031985|P3|Overall Study|Withdrawal by Subject|0
1537011|NCT00203476|5031986|P2|Overall Study|Withdrawal by Subject|1
1537012|NCT00203476|5031987|P1|Overall Study|Withdrawal by Subject|0
1537013|NCT00203476|5031985|P3|Overall Study|Lost to Follow-up|0
1537014|NCT00203476|5031986|P2|Overall Study|Lost to Follow-up|0
1537015|NCT00203476|5031987|P1|Overall Study|Lost to Follow-up|1
1537016|NCT00203424|5032004|P1|Follow-up Period|Lost to Follow-up|1
1537017|NCT00203424|5032004|P1|Follow-up Period|progressive disease|4
1537018|NCT00203424|5032004|P1|Follow-up Period|Withdrawal by Subject|1
1537019|NCT00203424|5032004|P1|Treatment Period|progressive disease|2
1537020|NCT00203424|5032004|P1|Treatment Period|Adverse Event|5
1537021|NCT00203424|5032004|P1|Treatment Period|Withdrawal by Subject|4
1537022|NCT00203411|5032011|P1|Follow-up|Progressive Disease|4
1537023|NCT00203307|5032020|P2|First Intervention|Adverse Event|0
1537024|NCT00203307|5032021|P1|First Intervention|Adverse Event|2
1537025|NCT00203294|5032029|P2|Overall Study|Withdrawal by Subject|13
1537026|NCT00203294|5032030|P1|Overall Study|Withdrawal by Subject|8
1537027|NCT00203268|5032036|P1|Early Treatment|Withdrawal by Subject|1
1537028|NCT00203268|5032036|P1|Early Treatment|Lost to Follow-up|1
1537029|NCT00203268|5032036|P1|Early Treatment|only treated one headache|2
1537030|NCT00203242|5032042|P1|Overall Study|Lost to Follow-up|1
1537031|NCT00203047|5032094|P2|Overall Study|Not specified|5
1537032|NCT00203047|5032095|P1|Overall Study|Not specified|5
1537033|NCT00203047|5032094|P2|Overall Study|Pregnancy|0
1537034|NCT00203047|5032095|P1|Overall Study|Pregnancy|3
1537035|NCT00203047|5032094|P2|Overall Study|Death|2
1537036|NCT00203047|5032095|P1|Overall Study|Death|1
1537037|NCT00203047|5032094|P2|Overall Study|Adverse Event|18
1537038|NCT00203047|5032095|P1|Overall Study|Adverse Event|8
1537039|NCT00203047|5032094|P2|Overall Study|Lost to Follow-up|5
1537040|NCT00203047|5032095|P1|Overall Study|Lost to Follow-up|11
1537041|NCT00203047|5032094|P2|Overall Study|Protocol Violation|0
1537042|NCT00203047|5032095|P1|Overall Study|Protocol Violation|1
1537043|NCT00203047|5032094|P2|Overall Study|Non-compliance|8
1537044|NCT00203047|5032095|P1|Overall Study|Non-compliance|4
1537045|NCT00203047|5032094|P2|Overall Study|Physician Decision|7
1537046|NCT00203047|5032095|P1|Overall Study|Physician Decision|8
1537047|NCT00203047|5032094|P2|Overall Study|Teva requested participant withdrawal|1
1537048|NCT00203047|5032095|P1|Overall Study|Teva requested participant withdrawal|1
1537049|NCT00203047|5032094|P2|Overall Study|Withdrawal by Subject|47
1537050|NCT00203047|5032095|P1|Overall Study|Withdrawal by Subject|13
1537051|NCT00203047|5032094|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
1537052|NCT00203047|5032095|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
1537053|NCT00203047|5032094|P2|Overall Study|Ongoing: in database - January 29, 2009|109
1537054|NCT00203047|5032095|P1|Overall Study|Ongoing: in database - January 29, 2009|131
1537055|NCT00202878|5032109|P2|Overall Study|Withdrawal by Subject|808
1537056|NCT00202878|5032110|P1|Overall Study|Withdrawal by Subject|795
1537057|NCT00202878|5032109|P2|Overall Study|Site Closure|36
1537058|NCT00202878|5032110|P1|Overall Study|Site Closure|39
1537059|NCT00202878|5032109|P2|Overall Study|Lost to Follow-up|49
1537060|NCT00202878|5032110|P1|Overall Study|Lost to Follow-up|44
1537061|NCT00202878|5032109|P2|Overall Study|Only Vital Status Known|356
1537062|NCT00202878|5032110|P1|Overall Study|Only Vital Status Known|357
1537063|NCT00202878|5032109|P2|Overall Study|Death|968
1537064|NCT00202878|5032110|P1|Overall Study|Death|964
1537065|NCT00202839|5032124|P2|Overall Study|Lost to Follow-up|2
1537066|NCT00202839|5032125|P1|Overall Study|Lost to Follow-up|3
1537067|NCT00202839|5032124|P2|Overall Study|Protocol Violation|1
1537068|NCT00202839|5032125|P1|Overall Study|Protocol Violation|2
1537069|NCT00202839|5032124|P2|Overall Study|Withdrawal by Subject|2
1537070|NCT00202839|5032125|P1|Overall Study|Withdrawal by Subject|6
1537071|NCT00202839|5032124|P2|Overall Study|Physician Decision|0
1537072|NCT00202839|5032125|P1|Overall Study|Physician Decision|12
1537073|NCT00202839|5032124|P2|Overall Study|Adverse Event|5
1537074|NCT00202839|5032125|P1|Overall Study|Adverse Event|1
1537075|NCT00202644|5032140|P2|Overall Study|Other|1
1537076|NCT00202644|5032141|P1|Overall Study|Other|9
1537077|NCT00202644|5032140|P2|Overall Study|Lost to Follow-up|1
1537078|NCT00202644|5032141|P1|Overall Study|Lost to Follow-up|0
1537079|NCT00202644|5032140|P2|Overall Study|Lack of Efficacy|6
1537080|NCT00202644|5032141|P1|Overall Study|Lack of Efficacy|6
1537081|NCT00202644|5032140|P2|Overall Study|Withdrawal by Subject|6
1537082|NCT00202644|5032141|P1|Overall Study|Withdrawal by Subject|8
1537083|NCT00202644|5032140|P2|Overall Study|Adverse Event|13
1537084|NCT00202644|5032141|P1|Overall Study|Adverse Event|12
1537085|NCT00201851|5032202|P3|Overall Study|Ineligible post enrollment|1
1537086|NCT00201851|5032203|P2|Overall Study|Ineligible post enrollment|1
1537087|NCT00201851|5032204|P1|Overall Study|Ineligible post enrollment|6
1537088|NCT00201851|5032202|P3|Overall Study|Lost to Follow-up|0
1537089|NCT00201851|5032203|P2|Overall Study|Lost to Follow-up|1
1537090|NCT00201851|5032204|P1|Overall Study|Lost to Follow-up|2
1537091|NCT00201643|5032276|P2|Overall Study|Withdrawal by Subject|4
1537092|NCT00201643|5032277|P1|Overall Study|Withdrawal by Subject|5
1537093|NCT00201201|5032341|P2|Overall Study|Withdrawal by Subject|5
1537094|NCT00201201|5032342|P1|Overall Study|Withdrawal by Subject|5
1537095|NCT00201201|5032341|P2|Overall Study|Death|2
1537096|NCT00201201|5032342|P1|Overall Study|Death|0
1537097|NCT00201006|5032380|P3|Overall Study|Adverse Event|1
1537098|NCT00201006|5032381|P2|Overall Study|Adverse Event|0
1537099|NCT00201006|5032382|P1|Overall Study|Adverse Event|1
1537100|NCT00201006|5032380|P3|Overall Study|Withdrawal by Subject|3
1537101|NCT00201006|5032381|P2|Overall Study|Withdrawal by Subject|2
1537102|NCT00201006|5032382|P1|Overall Study|Withdrawal by Subject|7
1537103|NCT00200967|5032392|P2|Run-out Period|Lost to Follow-up|0
1537104|NCT00200967|5032393|P1|Run-out Period|Lost to Follow-up|1
1537105|NCT00200967|5032392|P2|Second Treatment Period|Withdrawal by Subject|2
1537106|NCT00200967|5032393|P1|Second Treatment Period|Withdrawal by Subject|1
1537107|NCT00200967|5032392|P2|Wash-out Period|Lost to Follow-up|1
1537108|NCT00200967|5032393|P1|Wash-out Period|Lost to Follow-up|0
1537109|NCT00200967|5032392|P2|First Treatment Period|Pregnancy|0
1537110|NCT00200967|5032393|P1|First Treatment Period|Pregnancy|1
1537111|NCT00200967|5032392|P2|First Treatment Period|Withdrawal by Subject|1
1537112|NCT00200967|5032393|P1|First Treatment Period|Withdrawal by Subject|5
1537113|NCT00200356|5032434|P2|Overall Study|Nontreatment|0
1537114|NCT00200356|5032435|P1|Overall Study|Nontreatment|1
1537115|NCT00200356|5032434|P2|Overall Study|Protocol Violation|4
1537116|NCT00200356|5032435|P1|Overall Study|Protocol Violation|4
1537117|NCT00200356|5032434|P2|Overall Study|Lack of Efficacy|3
1537118|NCT00200356|5032435|P1|Overall Study|Lack of Efficacy|3
1537119|NCT00200057|5032502|P1|Overall Study|Death|1
1537120|NCT00200057|5032502|P1|Overall Study|Infection|1
1537121|NCT00200057|5032502|P1|Overall Study|Change in medical condition|1
1537122|NCT00200057|5032502|P1|Overall Study|Withdrawal by Subject|1
1537123|NCT00200057|5032502|P1|Overall Study|Exited due to terminal illness of PI|2
1537124|NCT00200057|5032502|P1|Overall Study|Lack of Efficacy|3
1537125|NCT00199381|5032521|P1|Overall Study|Study termination by Sponsor|323
1537126|NCT00199381|5032521|P1|Overall Study|Not including due to early termination|37
1537127|NCT00199381|5032521|P1|Overall Study|Lack of Efficacy|27
1537128|NCT00199381|5032521|P1|Overall Study|Protocol Violation|6
1537129|NCT00199381|5032521|P1|Overall Study|Adverse Event|73
1537130|NCT00199381|5032521|P1|Overall Study|Withdrawal by Subject|38
1537131|NCT00198822|5032528|P3|Overall Study|Lost to Follow-up|21
1537132|NCT00198822|5032529|P2|Overall Study|Lost to Follow-up|20
1537133|NCT00198822|5032530|P1|Overall Study|Lost to Follow-up|14
1537134|NCT00198133|5032549|P2|Overall Study|Physician Decision|0
1537135|NCT00198133|5032550|P1|Overall Study|Physician Decision|1
1537136|NCT00198133|5032549|P2|Overall Study|Withdrawal by Subject|0
1537137|NCT00198133|5032550|P1|Overall Study|Withdrawal by Subject|1
1537138|NCT00198133|5032549|P2|Overall Study|Adverse Event|3
1537139|NCT00198133|5032550|P1|Overall Study|Adverse Event|1
1537140|NCT00198133|5032549|P2|Overall Study|Disease progression|5
1537141|NCT00198133|5032550|P1|Overall Study|Disease progression|2
1537142|NCT00198029|5032593|P1|Overall Study|Withdrawal by Subject|4
1537143|NCT00197496|5032600|P2|Follow-up|Lost to Follow-up|1
1537144|NCT00197496|5032601|P1|Follow-up|Lost to Follow-up|2
1537145|NCT00197496|5032600|P2|Baseline to Discharge|Protocol Violation|1
1537146|NCT00197496|5032601|P1|Baseline to Discharge|Protocol Violation|0
1537147|NCT00197496|5032600|P2|Baseline to Discharge|Physician Decision|1
1537148|NCT00197496|5032601|P1|Baseline to Discharge|Physician Decision|0
1537149|NCT00197496|5032600|P2|Baseline to Discharge|MRSA|0
1537150|NCT00197496|5032601|P1|Baseline to Discharge|MRSA|1
1537151|NCT00197496|5032600|P2|Baseline to Discharge|not interested|0
1537152|NCT00197496|5032601|P1|Baseline to Discharge|not interested|1
1537153|NCT00197236|5032649|P3|Overall Study|Returned out of specified time window|1
1537154|NCT00197236|5032650|P2|Overall Study|Returned out of specified time window|0
1537155|NCT00197236|5032651|P1|Overall Study|Returned out of specified time window|0
1537156|NCT00197236|5032649|P3|Overall Study|Study drug/medication expiration|3
1537157|NCT00197236|5032650|P2|Overall Study|Study drug/medication expiration|0
1537158|NCT00197236|5032651|P1|Overall Study|Study drug/medication expiration|1
1537159|NCT00197236|5032649|P3|Overall Study|Withdrawal by Subject|11
1537160|NCT00197236|5032650|P2|Overall Study|Withdrawal by Subject|3
1537161|NCT00197236|5032651|P1|Overall Study|Withdrawal by Subject|7
1537162|NCT00197236|5032649|P3|Overall Study|Protocol Violation|1
1537163|NCT00197236|5032650|P2|Overall Study|Protocol Violation|0
1537164|NCT00197236|5032651|P1|Overall Study|Protocol Violation|0
1537165|NCT00197236|5032649|P3|Overall Study|Lost to Follow-up|6
1537166|NCT00197236|5032650|P2|Overall Study|Lost to Follow-up|14
1537167|NCT00197236|5032651|P1|Overall Study|Lost to Follow-up|5
1537168|NCT00197236|5032649|P3|Overall Study|Adverse Event|1
1537169|NCT00197236|5032650|P2|Overall Study|Adverse Event|0
1537170|NCT00197236|5032651|P1|Overall Study|Adverse Event|1
1537171|NCT00197106|5032738|P3|Overall Treatment Period|Withdrawal by Subject|2
1537172|NCT00197106|5032739|P2|Overall Treatment Period|Withdrawal by Subject|0
1537173|NCT00197106|5032740|P1|Overall Treatment Period|Withdrawal by Subject|0
1537174|NCT00197106|5032738|P3|Overall Treatment Period|Protocol Violation|2
1537175|NCT00197106|5032739|P2|Overall Treatment Period|Protocol Violation|0
1537176|NCT00197106|5032740|P1|Overall Treatment Period|Protocol Violation|0
1537177|NCT00197106|5032738|P3|Overall Treatment Period|Lost to Follow-up|2
1537178|NCT00197106|5032739|P2|Overall Treatment Period|Lost to Follow-up|0
1537179|NCT00197106|5032740|P1|Overall Treatment Period|Lost to Follow-up|0
1537180|NCT00197106|5032738|P3|Overall Treatment Period|Lack of Efficacy|0
1537181|NCT00197106|5032739|P2|Overall Treatment Period|Lack of Efficacy|1
1537182|NCT00197106|5032740|P1|Overall Treatment Period|Lack of Efficacy|0
1537183|NCT00197106|5032738|P3|4-Week Run-In Period|Did not meet entry criteria|0
1537184|NCT00197106|5032739|P2|4-Week Run-In Period|Did not meet entry criteria|0
1537185|NCT00197106|5032740|P1|4-Week Run-In Period|Did not meet entry criteria|99
1537186|NCT00197028|5032776|P2|Overall Study|Other|6
1537187|NCT00197028|5032777|P1|Overall Study|Other|3
1537188|NCT00197028|5032776|P2|Overall Study|Lost to Follow-up|0
1537189|NCT00197028|5032777|P1|Overall Study|Lost to Follow-up|1
1537190|NCT00197028|5032776|P2|Overall Study|Withdrawal by Subject|12
1537191|NCT00197028|5032777|P1|Overall Study|Withdrawal by Subject|8
1537192|NCT00197028|5032776|P2|Overall Study|Protocol Violation|1
1537193|NCT00197028|5032777|P1|Overall Study|Protocol Violation|2
1537194|NCT00197028|5032776|P2|Overall Study|Adverse Event|2
1537195|NCT00197028|5032777|P1|Overall Study|Adverse Event|2
1537196|NCT00197015|5032820|P3|Overall Study|Other|2
1537197|NCT00197015|5032821|P2|Overall Study|Other|3
1537198|NCT00197015|5032822|P1|Overall Study|Other|2
1537199|NCT00197015|5032820|P3|Overall Study|Lost to Follow-up|37
1537200|NCT00197015|5032821|P2|Overall Study|Lost to Follow-up|46
1537201|NCT00197015|5032822|P1|Overall Study|Lost to Follow-up|28
1537202|NCT00197015|5032820|P3|Overall Study|Withdrawal by Subject|34
1537203|NCT00197015|5032821|P2|Overall Study|Withdrawal by Subject|37
1537204|NCT00197015|5032822|P1|Overall Study|Withdrawal by Subject|17
1537205|NCT00197015|5032820|P3|Overall Study|Protocol Violation|3
1537206|NCT00197015|5032821|P2|Overall Study|Protocol Violation|3
1537207|NCT00197015|5032822|P1|Overall Study|Protocol Violation|0
1537208|NCT00197015|5032820|P3|Overall Study|Adverse Event|1
1537209|NCT00197015|5032821|P2|Overall Study|Adverse Event|0
1537210|NCT00197015|5032822|P1|Overall Study|Adverse Event|3
1537211|NCT00197002|5032881|P3|Overall Study|Others|1
1537212|NCT00197002|5032882|P2|Overall Study|Others|1
1537213|NCT00197002|5032883|P1|Overall Study|Others|3
1537214|NCT00197002|5032881|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
1537215|NCT00197002|5032882|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
1537216|NCT00197002|5032883|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
1537217|NCT00197002|5032881|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
1537218|NCT00197002|5032882|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
1537219|NCT00197002|5032883|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
1537220|NCT00197002|5032881|P3|Overall Study|Migrated/moved from study area|1
1537221|NCT00197002|5032882|P2|Overall Study|Migrated/moved from study area|5
1537222|NCT00197002|5032883|P1|Overall Study|Migrated/moved from study area|3
1537223|NCT00197002|5032881|P3|Overall Study|Withdrawal by Subject|7
1537224|NCT00197002|5032882|P2|Overall Study|Withdrawal by Subject|5
1537225|NCT00197002|5032883|P1|Overall Study|Withdrawal by Subject|9
1537226|NCT00197002|5032881|P3|Overall Study|Protocol Violation|2
1537227|NCT00197002|5032882|P2|Overall Study|Protocol Violation|0
1537228|NCT00197002|5032883|P1|Overall Study|Protocol Violation|1
1537229|NCT00197002|5032881|P3|Overall Study|Adverse Event|0
1537230|NCT00197002|5032882|P2|Overall Study|Adverse Event|1
1537231|NCT00197002|5032883|P1|Overall Study|Adverse Event|0
1537232|NCT00196976|5032934|P14|Booster Study|Lost to Follow-up|0
1537233|NCT00196976|5032935|P13|Booster Study|Lost to Follow-up|0
1537234|NCT00196976|5032936|P12|Booster Study|Lost to Follow-up|2
1537235|NCT00196976|5032937|P11|Booster Study|Lost to Follow-up|1
1537236|NCT00196976|5032938|P10|Booster Study|Lost to Follow-up|0
1537237|NCT00196976|5032939|P9|Booster Study|Lost to Follow-up|0
1537238|NCT00196976|5032940|P8|Booster Study|Lost to Follow-up|0
1537239|NCT00196976|5032941|P7|Booster Study|Lost to Follow-up|0
1537240|NCT00196976|5032942|P6|Booster Study|Lost to Follow-up|0
1537241|NCT00196976|5032943|P5|Booster Study|Lost to Follow-up|0
1537242|NCT00196976|5032944|P4|Booster Study|Lost to Follow-up|0
1537243|NCT00196976|5032945|P3|Booster Study|Lost to Follow-up|0
1537244|NCT00196976|5032946|P2|Booster Study|Lost to Follow-up|0
1537245|NCT00196976|5032947|P1|Booster Study|Lost to Follow-up|0
1537246|NCT00196976|5032934|P14|Booster Study|Withdrawal by Subject|0
1537247|NCT00196976|5032935|P13|Booster Study|Withdrawal by Subject|0
1537248|NCT00196976|5032936|P12|Booster Study|Withdrawal by Subject|0
1537249|NCT00196976|5032937|P11|Booster Study|Withdrawal by Subject|1
1537250|NCT00196976|5032938|P10|Booster Study|Withdrawal by Subject|0
1537251|NCT00196976|5032939|P9|Booster Study|Withdrawal by Subject|0
1537252|NCT00196976|5032940|P8|Booster Study|Withdrawal by Subject|0
1537253|NCT00196976|5032941|P7|Booster Study|Withdrawal by Subject|0
1537254|NCT00196976|5032942|P6|Booster Study|Withdrawal by Subject|0
1537255|NCT00196976|5032943|P5|Booster Study|Withdrawal by Subject|0
1537256|NCT00196976|5032944|P4|Booster Study|Withdrawal by Subject|0
1537257|NCT00196976|5032945|P3|Booster Study|Withdrawal by Subject|0
1537258|NCT00196976|5032946|P2|Booster Study|Withdrawal by Subject|0
1537259|NCT00196976|5032947|P1|Booster Study|Withdrawal by Subject|0
1537260|NCT00196976|5032934|P14|Primary Study|Other|0
1537261|NCT00196976|5032935|P13|Primary Study|Other|0
1537262|NCT00196976|5032936|P12|Primary Study|Other|0
1537263|NCT00196976|5032937|P11|Primary Study|Other|0
1537264|NCT00196976|5032938|P10|Primary Study|Other|0
1537265|NCT00196976|5032939|P9|Primary Study|Other|0
1537266|NCT00196976|5032940|P8|Primary Study|Other|0
1537267|NCT00196976|5032941|P7|Primary Study|Other|0
1537268|NCT00196976|5032942|P6|Primary Study|Other|0
1537269|NCT00196976|5032943|P5|Primary Study|Other|0
1537270|NCT00196976|5032944|P4|Primary Study|Other|0
1537271|NCT00196976|5032945|P3|Primary Study|Other|2
1537272|NCT00196976|5032946|P2|Primary Study|Other|0
1537273|NCT00196976|5032947|P1|Primary Study|Other|0
1537274|NCT00196976|5032934|P14|Primary Study|Lost to Follow-up|0
1537275|NCT00196976|5032935|P13|Primary Study|Lost to Follow-up|0
1537276|NCT00196976|5032936|P12|Primary Study|Lost to Follow-up|0
1537277|NCT00196976|5032937|P11|Primary Study|Lost to Follow-up|0
1537278|NCT00196976|5032938|P10|Primary Study|Lost to Follow-up|0
1537279|NCT00196976|5032939|P9|Primary Study|Lost to Follow-up|0
1537280|NCT00196976|5032940|P8|Primary Study|Lost to Follow-up|2
1537281|NCT00196976|5032941|P7|Primary Study|Lost to Follow-up|0
1537282|NCT00196976|5032942|P6|Primary Study|Lost to Follow-up|1
1537283|NCT00196976|5032943|P5|Primary Study|Lost to Follow-up|1
1537284|NCT00196976|5032944|P4|Primary Study|Lost to Follow-up|0
1537285|NCT00196976|5032945|P3|Primary Study|Lost to Follow-up|0
1537286|NCT00196976|5032946|P2|Primary Study|Lost to Follow-up|0
1537287|NCT00196976|5032947|P1|Primary Study|Lost to Follow-up|0
1537288|NCT00196976|5032934|P14|Primary Study|Withdrawal by Subject|0
1537289|NCT00196976|5032935|P13|Primary Study|Withdrawal by Subject|0
1537290|NCT00196976|5032936|P12|Primary Study|Withdrawal by Subject|0
1537291|NCT00196976|5032937|P11|Primary Study|Withdrawal by Subject|0
1537292|NCT00196976|5032938|P10|Primary Study|Withdrawal by Subject|1
1537293|NCT00196976|5032939|P9|Primary Study|Withdrawal by Subject|0
1537294|NCT00196976|5032940|P8|Primary Study|Withdrawal by Subject|0
1537295|NCT00196976|5032941|P7|Primary Study|Withdrawal by Subject|0
1537296|NCT00196976|5032942|P6|Primary Study|Withdrawal by Subject|1
1537297|NCT00196976|5032943|P5|Primary Study|Withdrawal by Subject|2
1537298|NCT00196976|5032944|P4|Primary Study|Withdrawal by Subject|1
1537299|NCT00196976|5032945|P3|Primary Study|Withdrawal by Subject|1
1537300|NCT00196976|5032946|P2|Primary Study|Withdrawal by Subject|0
1537301|NCT00196976|5032947|P1|Primary Study|Withdrawal by Subject|1
1537302|NCT00196976|5032934|P14|Primary Study|Protocol Violation|0
1537303|NCT00196976|5032935|P13|Primary Study|Protocol Violation|0
1537304|NCT00196976|5032936|P12|Primary Study|Protocol Violation|0
1537305|NCT00196976|5032937|P11|Primary Study|Protocol Violation|0
1537306|NCT00196976|5032938|P10|Primary Study|Protocol Violation|0
1537307|NCT00196976|5032939|P9|Primary Study|Protocol Violation|0
1537308|NCT00196976|5032940|P8|Primary Study|Protocol Violation|0
1537309|NCT00196976|5032941|P7|Primary Study|Protocol Violation|0
1537310|NCT00196976|5032942|P6|Primary Study|Protocol Violation|0
1537311|NCT00196976|5032943|P5|Primary Study|Protocol Violation|0
1537312|NCT00196976|5032944|P4|Primary Study|Protocol Violation|0
1537313|NCT00196976|5032945|P3|Primary Study|Protocol Violation|1
1537314|NCT00196976|5032946|P2|Primary Study|Protocol Violation|1
1537315|NCT00196976|5032947|P1|Primary Study|Protocol Violation|0
1537316|NCT00196976|5032934|P14|Primary Study|Migrated from study area|0
1537317|NCT00196976|5032935|P13|Primary Study|Migrated from study area|0
1537318|NCT00196976|5032936|P12|Primary Study|Migrated from study area|0
1537319|NCT00196976|5032937|P11|Primary Study|Migrated from study area|0
1537320|NCT00196976|5032938|P10|Primary Study|Migrated from study area|0
1537321|NCT00196976|5032939|P9|Primary Study|Migrated from study area|0
1537322|NCT00196976|5032940|P8|Primary Study|Migrated from study area|1
1537323|NCT00196976|5032941|P7|Primary Study|Migrated from study area|0
1537324|NCT00196976|5032942|P6|Primary Study|Migrated from study area|0
1537325|NCT00196976|5032943|P5|Primary Study|Migrated from study area|0
1537326|NCT00196976|5032944|P4|Primary Study|Migrated from study area|0
1537327|NCT00196976|5032945|P3|Primary Study|Migrated from study area|0
1537328|NCT00196976|5032946|P2|Primary Study|Migrated from study area|0
1537329|NCT00196976|5032947|P1|Primary Study|Migrated from study area|0
1537330|NCT00196937|5033143|P3|Overall Study|Withdrawal by Subject|3
1537331|NCT00196937|5033144|P2|Overall Study|Withdrawal by Subject|0
1537332|NCT00196937|5033145|P1|Overall Study|Withdrawal by Subject|0
1537333|NCT00196937|5033143|P3|Overall Study|Lost to Follow-up|3
1537334|NCT00196937|5033144|P2|Overall Study|Lost to Follow-up|3
1537335|NCT00196937|5033145|P1|Overall Study|Lost to Follow-up|4
1537336|NCT00196937|5033143|P3|Overall Study|Subject did not come due to holidays|0
1537337|NCT00196937|5033144|P2|Overall Study|Subject did not come due to holidays|1
1537338|NCT00196937|5033145|P1|Overall Study|Subject did not come due to holidays|3
1537339|NCT00196937|5033143|P3|Overall Study|Adverse Event|1
1537340|NCT00196937|5033144|P2|Overall Study|Adverse Event|1
1537341|NCT00196937|5033145|P1|Overall Study|Adverse Event|2
1537342|NCT00196326|5033193|P1|Overall Study|Not specified|22
1537343|NCT00196326|5033193|P1|Overall Study|Lost to Follow-up|304
1537344|NCT00196326|5033193|P1|Overall Study|Pregnancy|34
1537345|NCT00196326|5033193|P1|Overall Study|Adverse Event|253
1537346|NCT00196326|5033193|P1|Overall Study|Withdrawal by Subject|225
1537347|NCT00196326|5033193|P1|Overall Study|Physician Decision|3
1537348|NCT00196326|5033193|P1|Overall Study|Non-compliance with the protocol|81
1537349|NCT00196326|5033193|P1|Overall Study|Did not meet protocol requirements|64
1537350|NCT00196313|5033201|P2|Overall Study|Lost to Follow-up|2
1537351|NCT00196313|5033202|P1|Overall Study|Lost to Follow-up|2
1537352|NCT00196313|5033201|P2|Overall Study|Subject Pregnant|1
1537353|NCT00196313|5033202|P1|Overall Study|Subject Pregnant|1
1537354|NCT00196313|5033201|P2|Overall Study|Adverse Event|1
1537355|NCT00196313|5033202|P1|Overall Study|Adverse Event|3
1537356|NCT00196313|5033201|P2|Overall Study|Withdrawal by Subject|1
1537357|NCT00196313|5033202|P1|Overall Study|Withdrawal by Subject|3
1537358|NCT00196313|5033201|P2|Overall Study|Protocol Violation|3
1537359|NCT00196313|5033202|P1|Overall Study|Protocol Violation|2
1537360|NCT00196196|5033216|P1|Overall Study|Did not have required condition (hydroce|5
1537361|NCT00196196|5033216|P1|Overall Study|Withdrawal by Subject|2
1537362|NCT00196105|5033224|P3|Overall Study|Lost to Follow-up|7
1537363|NCT00196105|5033225|P2|Overall Study|Lost to Follow-up|5
1537364|NCT00196105|5033226|P1|Overall Study|Lost to Follow-up|4
1537365|NCT00195819|5033246|P2|Open-label|Withdrawal by Subject|5
1537366|NCT00195819|5033247|P1|Open-label|Withdrawal by Subject|0
1537367|NCT00195819|5033246|P2|Open-label|Moved|1
1537368|NCT00195819|5033247|P1|Open-label|Moved|0
1537369|NCT00195819|5033246|P2|Open-label|Protocol Violation|2
1537370|NCT00195819|5033247|P1|Open-label|Protocol Violation|0
1537371|NCT00195819|5033246|P2|Open-label|Pregnancy|1
1537372|NCT00195819|5033247|P1|Open-label|Pregnancy|0
1537373|NCT00195819|5033246|P2|Open-label|Lack of Efficacy|2
1537374|NCT00195819|5033247|P1|Open-label|Lack of Efficacy|0
1537375|NCT00195819|5033246|P2|Open-label|Adverse Event|9
1537376|NCT00195819|5033247|P1|Open-label|Adverse Event|0
1537377|NCT00195819|5033246|P2|Double-Blind|Moved|0
1537378|NCT00195819|5033247|P1|Double-Blind|Moved|1
1537379|NCT00195819|5033246|P2|Double-Blind|Withdrawal by Subject|0
1537380|NCT00195819|5033247|P1|Double-Blind|Withdrawal by Subject|1
1537381|NCT00195715|5033297|P1|Overall Study|Sponsor discretion - trial ended early|1
1537382|NCT00195715|5033297|P1|Overall Study|Sponsor discontinued trial|1
1537383|NCT00195715|5033297|P1|Overall Study|Colonic stricture|1
1537384|NCT00195715|5033297|P1|Overall Study|Ineligible|1
1537385|NCT00195715|5033297|P1|Overall Study|Increased infection rate|1
1537386|NCT00195715|5033297|P1|Overall Study|Planned surgery|2
1537387|NCT00195715|5033297|P1|Overall Study|Use of prohibited medication|2
1537388|NCT00195715|5033297|P1|Overall Study|Subject wants to get pregnant|4
1537389|NCT00195715|5033297|P1|Overall Study|Investigator's decision|2
1537390|NCT00195715|5033297|P1|Overall Study|Administrative reasons|2
1537391|NCT00195715|5033297|P1|Overall Study|Sponsor stopped study|1
1537392|NCT00195715|5033297|P1|Overall Study|Loss of response/no improvement|3
1537393|NCT00195715|5033297|P1|Overall Study|Subject choice|3
1537394|NCT00195715|5033297|P1|Overall Study|Subject started commercial Humira|5
1537395|NCT00195715|5033297|P1|Overall Study|Subject non-compliance|6
1537396|NCT00195715|5033297|P1|Overall Study|Subject moved/relocated|7
1537397|NCT00195715|5033297|P1|Overall Study|Investigative site closure|8
1537398|NCT00195715|5033297|P1|Overall Study|Pregnancy|14
1537399|NCT00195715|5033297|P1|Overall Study|Lack of Efficacy|93
1537400|NCT00195715|5033297|P1|Overall Study|Protocol Violation|13
1537401|NCT00195715|5033297|P1|Overall Study|Lost to Follow-up|27
1537402|NCT00195715|5033297|P1|Overall Study|Withdrawal by Subject|58
1537403|NCT00195715|5033297|P1|Overall Study|Adverse Event|122
1537404|NCT00195676|5033397|P1|Period R - Retreatment 16 Weeks|Other reasons|6
1537405|NCT00195676|5033397|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
1537406|NCT00195676|5033397|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
1537407|NCT00195676|5033397|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
1537408|NCT00195676|5033397|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
1537409|NCT00195676|5033397|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
1537410|NCT00195676|5033397|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
1537411|NCT00195676|5033397|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
1537412|NCT00195676|5033397|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
1537413|NCT00195676|5033397|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
1537414|NCT00195676|5033397|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
1537415|NCT00195676|5033397|P1|Period W (Withdrawal) - No Treatment|Death|2
1537416|NCT00195676|5033397|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
1537417|NCT00195676|5033397|P1|Period O - Open-label Treatment|Other reasons|68
1537418|NCT00195676|5033397|P1|Period O - Open-label Treatment|Administrative reasons|2
1537419|NCT00195676|5033397|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
1537420|NCT00195676|5033397|P1|Period O - Open-label Treatment|Protocol Violation|12
1537421|NCT00195676|5033397|P1|Period O - Open-label Treatment|Lost to Follow-up|91
1537422|NCT00195676|5033397|P1|Period O - Open-label Treatment|Lack of Efficacy|198
1537423|NCT00195676|5033397|P1|Period O - Open-label Treatment|Death|6
1537424|NCT00195676|5033397|P1|Period O - Open-label Treatment|Adverse Event|82
1537425|NCT00195663|5033411|P3|Open-Label Extension Period|Administrative reasons|13
1537426|NCT00195663|5033412|P2|Open-Label Extension Period|Administrative reasons|11
1537427|NCT00195663|5033413|P1|Open-Label Extension Period|Administrative reasons|11
1537428|NCT00195663|5033411|P3|Open-Label Extension Period|Lack of Efficacy|12
1537429|NCT00195663|5033412|P2|Open-Label Extension Period|Lack of Efficacy|6
1537430|NCT00195663|5033413|P1|Open-Label Extension Period|Lack of Efficacy|14
1537431|NCT00195663|5033411|P3|Open-Label Extension Period|Withdrawal by Subject|22
1537432|NCT00195663|5033412|P2|Open-Label Extension Period|Withdrawal by Subject|15
1537433|NCT00195663|5033413|P1|Open-Label Extension Period|Withdrawal by Subject|16
1537434|NCT00195663|5033411|P3|Open-Label Extension Period|Death|2
1537435|NCT00195663|5033412|P2|Open-Label Extension Period|Death|2
1537436|NCT00195663|5033413|P1|Open-Label Extension Period|Death|2
1537437|NCT00195663|5033411|P3|Open-Label Extension Period|Protocol Violation|4
1537438|NCT00195663|5033412|P2|Open-Label Extension Period|Protocol Violation|4
1537439|NCT00195663|5033413|P1|Open-Label Extension Period|Protocol Violation|3
1537440|NCT00195663|5033411|P3|Open-Label Extension Period|Recovery|2
1537441|NCT00195663|5033412|P2|Open-Label Extension Period|Recovery|2
1537442|NCT00195663|5033413|P1|Open-Label Extension Period|Recovery|0
1537443|NCT00195663|5033411|P3|Open-Label Extension Period|Lost to Follow-up|6
1537444|NCT00195663|5033412|P2|Open-Label Extension Period|Lost to Follow-up|2
1537445|NCT00195663|5033413|P1|Open-Label Extension Period|Lost to Follow-up|9
1537446|NCT00195663|5033411|P3|Open-Label Extension Period|Adverse Event|36
1537447|NCT00195663|5033412|P2|Open-Label Extension Period|Adverse Event|32
1537448|NCT00195663|5033413|P1|Open-Label Extension Period|Adverse Event|21
1537449|NCT00195663|5033411|P3|2-year Double-blind Treatment Period|Administrative reasons|9
1537450|NCT00195663|5033412|P2|2-year Double-blind Treatment Period|Administrative reasons|2
1537451|NCT00195663|5033413|P1|2-year Double-blind Treatment Period|Administrative reasons|3
1537452|NCT00195663|5033411|P3|2-year Double-blind Treatment Period|Recovery|1
1537453|NCT00195663|5033412|P2|2-year Double-blind Treatment Period|Recovery|0
1537454|NCT00195663|5033413|P1|2-year Double-blind Treatment Period|Recovery|1
1537455|NCT00195663|5033411|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
1537456|NCT00195663|5033412|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
1537457|NCT00195663|5033413|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
1537458|NCT00195663|5033411|P3|2-year Double-blind Treatment Period|Protocol Violation|4
1537459|NCT00195663|5033412|P2|2-year Double-blind Treatment Period|Protocol Violation|6
1537460|NCT00195663|5033413|P1|2-year Double-blind Treatment Period|Protocol Violation|6
1537461|NCT00195663|5033411|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
1537462|NCT00195663|5033412|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
1537463|NCT00195663|5033413|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
1537464|NCT00195663|5033411|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
1537465|NCT00195663|5033412|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
1537466|NCT00195663|5033413|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
1537467|NCT00195663|5033411|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
1537468|NCT00195663|5033412|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
1537469|NCT00195663|5033413|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
1537470|NCT00195663|5033411|P3|2-year Double-blind Treatment Period|Death|0
1537471|NCT00195663|5033412|P2|2-year Double-blind Treatment Period|Death|2
1537472|NCT00195663|5033413|P1|2-year Double-blind Treatment Period|Death|0
1537473|NCT00195663|5033411|P3|2-year Double-blind Treatment Period|Adverse Event|32
1537474|NCT00195663|5033412|P2|2-year Double-blind Treatment Period|Adverse Event|27
1537475|NCT00195663|5033413|P1|2-year Double-blind Treatment Period|Adverse Event|21
1537476|NCT00195650|5033507|P1|Overall Study|Administrative reasons|83
1537477|NCT00195650|5033507|P1|Overall Study|Protocol Violation|15
1537478|NCT00195650|5033507|P1|Overall Study|Death|23
1537479|NCT00195650|5033507|P1|Overall Study|Lost to Follow-up|44
1537480|NCT00195650|5033507|P1|Overall Study|Withdrawal by Subject|67
1537481|NCT00195650|5033507|P1|Overall Study|Lack of Efficacy|99
1537482|NCT00195650|5033507|P1|Overall Study|Adverse Event|194
1537483|NCT00195507|5033523|P2|Overall Study|Protocol Deviation|3
1537484|NCT00195507|5033524|P1|Overall Study|Protocol Deviation|6
1537485|NCT00195507|5033523|P2|Overall Study|Withdrawal by Subject|23
1537486|NCT00195507|5033524|P1|Overall Study|Withdrawal by Subject|16
1537487|NCT00195507|5033523|P2|Overall Study|Lack of Efficacy|67
1537488|NCT00195507|5033524|P1|Overall Study|Lack of Efficacy|40
1537489|NCT00195507|5033523|P2|Overall Study|Protocol Violation|4
1537490|NCT00195507|5033524|P1|Overall Study|Protocol Violation|5
1537491|NCT00195507|5033523|P2|Overall Study|Lost to Follow-up|2
1537492|NCT00195507|5033524|P1|Overall Study|Lost to Follow-up|3
1537493|NCT00195507|5033523|P2|Overall Study|Physician Decision|2
1537494|NCT00195507|5033524|P1|Overall Study|Physician Decision|1
1537495|NCT00195507|5033523|P2|Overall Study|Failed to Return|3
1537496|NCT00195507|5033524|P1|Overall Study|Failed to Return|4
1537497|NCT00195507|5033523|P2|Overall Study|Death|1
1537498|NCT00195507|5033524|P1|Overall Study|Death|0
1537499|NCT00195507|5033523|P2|Overall Study|Adverse Event|13
1537500|NCT00195507|5033524|P1|Overall Study|Adverse Event|24
1537501|NCT00195494|5033538|P6|Year 2|System toxicity|0
1537502|NCT00195494|5033539|P5|Year 2|System toxicity|0
1537503|NCT00195494|5033540|P4|Year 2|System toxicity|1
1537504|NCT00195494|5033541|P3|Year 2|System toxicity|0
1537505|NCT00195494|5033542|P2|Year 2|System toxicity|0
1537506|NCT00195494|5033543|P1|Year 2|System toxicity|0
1537507|NCT00195494|5033538|P6|Year 2|Withdrawal by Subject|0
1537508|NCT00195494|5033539|P5|Year 2|Withdrawal by Subject|0
1537509|NCT00195494|5033540|P4|Year 2|Withdrawal by Subject|3
1537510|NCT00195494|5033541|P3|Year 2|Withdrawal by Subject|4
1537511|NCT00195494|5033542|P2|Year 2|Withdrawal by Subject|5
1537512|NCT00195494|5033543|P1|Year 2|Withdrawal by Subject|1
1537513|NCT00195494|5033538|P6|Year 2|Physician Decision|0
1537514|NCT00195494|5033539|P5|Year 2|Physician Decision|0
1537515|NCT00195494|5033540|P4|Year 2|Physician Decision|0
1537516|NCT00195494|5033541|P3|Year 2|Physician Decision|0
1537517|NCT00195494|5033542|P2|Year 2|Physician Decision|1
1537518|NCT00195494|5033543|P1|Year 2|Physician Decision|1
1537519|NCT00195494|5033538|P6|Year 2|Protocol deviation|0
1537520|NCT00195494|5033539|P5|Year 2|Protocol deviation|0
1537521|NCT00195494|5033540|P4|Year 2|Protocol deviation|0
1537522|NCT00195494|5033541|P3|Year 2|Protocol deviation|0
1537523|NCT00195494|5033542|P2|Year 2|Protocol deviation|1
1537524|NCT00195494|5033543|P1|Year 2|Protocol deviation|0
1537525|NCT00195494|5033538|P6|Year 2|Missed >4 consecutive doses|0
1537526|NCT00195494|5033539|P5|Year 2|Missed >4 consecutive doses|0
1537527|NCT00195494|5033540|P4|Year 2|Missed >4 consecutive doses|0
1537528|NCT00195494|5033541|P3|Year 2|Missed >4 consecutive doses|1
1537529|NCT00195494|5033542|P2|Year 2|Missed >4 consecutive doses|1
1537530|NCT00195494|5033543|P1|Year 2|Missed >4 consecutive doses|1
1537531|NCT00195494|5033538|P6|Year 2|Lost to Follow-up|0
1537532|NCT00195494|5033539|P5|Year 2|Lost to Follow-up|0
1537533|NCT00195494|5033540|P4|Year 2|Lost to Follow-up|1
1537534|NCT00195494|5033541|P3|Year 2|Lost to Follow-up|1
1537535|NCT00195494|5033542|P2|Year 2|Lost to Follow-up|0
1537536|NCT00195494|5033543|P1|Year 2|Lost to Follow-up|0
1537537|NCT00195494|5033538|P6|Year 2|Compliance|0
1537538|NCT00195494|5033539|P5|Year 2|Compliance|0
1537539|NCT00195494|5033540|P4|Year 2|Compliance|2
1537540|NCT00195494|5033541|P3|Year 2|Compliance|0
1537541|NCT00195494|5033542|P2|Year 2|Compliance|0
1537542|NCT00195494|5033543|P1|Year 2|Compliance|1
1537543|NCT00195494|5033538|P6|Year 2|Lack of Efficacy|0
1537544|NCT00195494|5033539|P5|Year 2|Lack of Efficacy|0
1537545|NCT00195494|5033540|P4|Year 2|Lack of Efficacy|7
1537546|NCT00195494|5033541|P3|Year 2|Lack of Efficacy|7
1537547|NCT00195494|5033542|P2|Year 2|Lack of Efficacy|1
1537548|NCT00195494|5033543|P1|Year 2|Lack of Efficacy|0
1537549|NCT00195494|5033538|P6|Year 2|Adverse Event|0
1537550|NCT00195494|5033539|P5|Year 2|Adverse Event|0
1537551|NCT00195494|5033540|P4|Year 2|Adverse Event|9
1537552|NCT00195494|5033541|P3|Year 2|Adverse Event|5
1537553|NCT00195494|5033542|P2|Year 2|Adverse Event|7
1537554|NCT00195494|5033543|P1|Year 2|Adverse Event|3
1537555|NCT00195494|5033538|P6|Year 1|Protocol Violation|1
1537556|NCT00195494|5033539|P5|Year 1|Protocol Violation|1
1537557|NCT00195494|5033540|P4|Year 1|Protocol Violation|0
1537558|NCT00195494|5033541|P3|Year 1|Protocol Violation|0
1537559|NCT00195494|5033542|P2|Year 1|Protocol Violation|0
1537560|NCT00195494|5033543|P1|Year 1|Protocol Violation|0
1537561|NCT00195494|5033538|P6|Year 1|Withdrawal by Subject|9
1537562|NCT00195494|5033539|P5|Year 1|Withdrawal by Subject|8
1537563|NCT00195494|5033540|P4|Year 1|Withdrawal by Subject|0
1537564|NCT00195494|5033541|P3|Year 1|Withdrawal by Subject|0
1537565|NCT00195494|5033542|P2|Year 1|Withdrawal by Subject|0
1537566|NCT00195494|5033543|P1|Year 1|Withdrawal by Subject|0
1537567|NCT00195494|5033538|P6|Year 1|Physician Decision|0
1537568|NCT00195494|5033539|P5|Year 1|Physician Decision|1
1537569|NCT00195494|5033540|P4|Year 1|Physician Decision|0
1537570|NCT00195494|5033541|P3|Year 1|Physician Decision|0
1537571|NCT00195494|5033542|P2|Year 1|Physician Decision|0
1537572|NCT00195494|5033543|P1|Year 1|Physician Decision|0
1537573|NCT00195494|5033538|P6|Year 1|Protocol deviation|3
1537574|NCT00195494|5033539|P5|Year 1|Protocol deviation|2
1537575|NCT00195494|5033540|P4|Year 1|Protocol deviation|0
1537576|NCT00195494|5033541|P3|Year 1|Protocol deviation|0
1537577|NCT00195494|5033542|P2|Year 1|Protocol deviation|0
1537578|NCT00195494|5033543|P1|Year 1|Protocol deviation|0
1537579|NCT00195494|5033538|P6|Year 1|Missed >4 consecutive doses|2
1537580|NCT00195494|5033539|P5|Year 1|Missed >4 consecutive doses|3
1537581|NCT00195494|5033540|P4|Year 1|Missed >4 consecutive doses|0
1537582|NCT00195494|5033541|P3|Year 1|Missed >4 consecutive doses|0
1537583|NCT00195494|5033542|P2|Year 1|Missed >4 consecutive doses|0
1537584|NCT00195494|5033543|P1|Year 1|Missed >4 consecutive doses|0
1537585|NCT00195494|5033538|P6|Year 1|Lost to Follow-up|0
1537586|NCT00195494|5033539|P5|Year 1|Lost to Follow-up|1
1537587|NCT00195494|5033540|P4|Year 1|Lost to Follow-up|0
1537588|NCT00195494|5033541|P3|Year 1|Lost to Follow-up|0
1537589|NCT00195494|5033542|P2|Year 1|Lost to Follow-up|0
1537590|NCT00195494|5033543|P1|Year 1|Lost to Follow-up|0
1537591|NCT00195494|5033538|P6|Year 1|Compliance|1
1537592|NCT00195494|5033539|P5|Year 1|Compliance|5
1537593|NCT00195494|5033540|P4|Year 1|Compliance|0
1537594|NCT00195494|5033541|P3|Year 1|Compliance|0
1537595|NCT00195494|5033542|P2|Year 1|Compliance|0
1537596|NCT00195494|5033543|P1|Year 1|Compliance|0
1537597|NCT00195494|5033538|P6|Year 1|Lack of Efficacy|9
1537598|NCT00195494|5033539|P5|Year 1|Lack of Efficacy|24
1537599|NCT00195494|5033540|P4|Year 1|Lack of Efficacy|0
1537600|NCT00195494|5033541|P3|Year 1|Lack of Efficacy|0
1537601|NCT00195494|5033542|P2|Year 1|Lack of Efficacy|0
1537602|NCT00195494|5033543|P1|Year 1|Lack of Efficacy|0
1537603|NCT00195494|5033538|P6|Year 1|System Toxicity|1
1537604|NCT00195494|5033539|P5|Year 1|System Toxicity|0
1537605|NCT00195494|5033540|P4|Year 1|System Toxicity|0
1537606|NCT00195494|5033541|P3|Year 1|System Toxicity|0
1537607|NCT00195494|5033542|P2|Year 1|System Toxicity|0
1537608|NCT00195494|5033543|P1|Year 1|System Toxicity|0
1537609|NCT00195494|5033538|P6|Year 1|Adverse Event|27
1537610|NCT00195494|5033539|P5|Year 1|Adverse Event|34
1537611|NCT00195494|5033540|P4|Year 1|Adverse Event|0
1537612|NCT00195494|5033541|P3|Year 1|Adverse Event|0
1537613|NCT00195494|5033542|P2|Year 1|Adverse Event|0
1537614|NCT00195494|5033543|P1|Year 1|Adverse Event|0
1537615|NCT00195442|5033561|P1|Overall Study|Other|14
1537616|NCT00195442|5033561|P1|Overall Study|Poor cooperation|2
1537617|NCT00195442|5033561|P1|Overall Study|No reason specified|4
1537618|NCT00195442|5033561|P1|Overall Study|Death|7
1537619|NCT00195442|5033561|P1|Overall Study|Intermittent product shortage|21
1537620|NCT00195442|5033561|P1|Overall Study|Switch to other Factor VIII preparation|23
1537621|NCT00195442|5033561|P1|Overall Study|Lost to Follow-up|27
1537622|NCT00195442|5033561|P1|Overall Study|Less than expected therapeutic effect|38
1537623|NCT00195429|5033580|P2|Overall Study|Lost to Follow-up|0
1537624|NCT00195429|5033581|P1|Overall Study|Lost to Follow-up|1
1537625|NCT00195429|5033580|P2|Overall Study|Lack of Efficacy|1
1537626|NCT00195429|5033581|P1|Overall Study|Lack of Efficacy|2
1537627|NCT00195429|5033580|P2|Overall Study|Adverse Event|4
1537628|NCT00195429|5033581|P1|Overall Study|Adverse Event|2
1537629|NCT00195351|5033597|P2|Overall Study|Lack of Efficacy|1
1537630|NCT00195351|5033598|P1|Overall Study|Lack of Efficacy|0
1537631|NCT00195351|5033597|P2|Overall Study|Death|1
1537632|NCT00195351|5033598|P1|Overall Study|Death|3
1537633|NCT00195351|5033597|P2|Overall Study|Protocol Deviation|2
1537634|NCT00195351|5033598|P1|Overall Study|Protocol Deviation|3
1537635|NCT00195351|5033597|P2|Overall Study|Withdrawal by Subject|3
1537636|NCT00195351|5033598|P1|Overall Study|Withdrawal by Subject|6
1537637|NCT00195351|5033597|P2|Overall Study|Lost to Follow-up|9
1537638|NCT00195351|5033598|P1|Overall Study|Lost to Follow-up|9
1537639|NCT00195338|5033608|P1|Overall Study|Early closure of the site|4
1537640|NCT00195338|5033608|P1|Overall Study|Lack of Efficacy|1
1537641|NCT00195338|5033608|P1|Overall Study|Adverse Event|5
1537642|NCT00195338|5033608|P1|Overall Study|Lost to Follow-up|2
1537643|NCT00195273|5033618|P2|Overall Study|Procedural complications|3
1537644|NCT00195273|5033619|P1|Overall Study|Procedural complications|9
1537645|NCT00195273|5033618|P2|Overall Study|Lack of Efficacy|1
1537646|NCT00195273|5033619|P1|Overall Study|Lack of Efficacy|3
1537647|NCT00195273|5033618|P2|Overall Study|Protocol deviation|1
1537648|NCT00195273|5033619|P1|Overall Study|Protocol deviation|0
1537649|NCT00195273|5033618|P2|Overall Study|Adverse Event|9
1537650|NCT00195273|5033619|P1|Overall Study|Adverse Event|9
1537651|NCT00195260|5033633|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
1537652|NCT00195260|5033634|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
1537653|NCT00195260|5033635|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
1537654|NCT00195260|5033636|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1537655|NCT00195260|5033637|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1537656|NCT00195260|5033638|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1537657|NCT00195260|5033639|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1537658|NCT00195260|5033640|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1537659|NCT00195260|5033641|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1537660|NCT00195260|5033642|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1537661|NCT00195260|5033643|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1537662|NCT00195260|5033633|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
1537663|NCT00195260|5033634|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
1537664|NCT00195260|5033635|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
1537665|NCT00195260|5033636|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1537666|NCT00195260|5033637|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1537667|NCT00195260|5033638|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1537668|NCT00195260|5033639|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1537669|NCT00195260|5033640|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1537670|NCT00195260|5033641|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1537671|NCT00195260|5033642|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1537672|NCT00195260|5033643|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1537673|NCT00195260|5033633|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
1537674|NCT00195260|5033634|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
1537675|NCT00195260|5033635|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
1537676|NCT00195260|5033636|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1537677|NCT00195260|5033637|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1537678|NCT00195260|5033638|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1537679|NCT00195260|5033639|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1537680|NCT00195260|5033640|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1537681|NCT00195260|5033641|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1537682|NCT00195260|5033642|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1537683|NCT00195260|5033643|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1537684|NCT00195260|5033633|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
1537685|NCT00195260|5033634|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
1537686|NCT00195260|5033635|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
1537687|NCT00195260|5033636|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1537688|NCT00195260|5033637|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1537689|NCT00195260|5033638|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1537690|NCT00195260|5033639|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1537691|NCT00195260|5033640|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1537692|NCT00195260|5033641|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1537693|NCT00195260|5033642|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1537694|NCT00195260|5033643|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1537695|NCT00195260|5033633|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
1537696|NCT00195260|5033634|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
1537697|NCT00195260|5033635|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
1537698|NCT00195260|5033636|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
1537699|NCT00195260|5033637|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
1537700|NCT00195260|5033638|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
1537701|NCT00195260|5033639|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
1537702|NCT00195260|5033640|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
1537703|NCT00195260|5033641|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
1537704|NCT00195260|5033642|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
1537705|NCT00195260|5033643|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
1537706|NCT00195260|5033633|P11|Part 1: Dose Escalation|Disease Progression|0
1537707|NCT00195260|5033634|P10|Part 1: Dose Escalation|Disease Progression|0
1537708|NCT00195260|5033635|P9|Part 1: Dose Escalation|Disease Progression|0
1537709|NCT00195260|5033636|P8|Part 1: Dose Escalation|Disease Progression|4
1537710|NCT00195260|5033637|P7|Part 1: Dose Escalation|Disease Progression|7
1537711|NCT00195260|5033638|P6|Part 1: Dose Escalation|Disease Progression|6
1537712|NCT00195260|5033639|P5|Part 1: Dose Escalation|Disease Progression|4
1537713|NCT00195260|5033640|P4|Part 1: Dose Escalation|Disease Progression|6
1537714|NCT00195260|5033641|P3|Part 1: Dose Escalation|Disease Progression|5
1537715|NCT00195260|5033642|P2|Part 1: Dose Escalation|Disease Progression|2
1537716|NCT00195260|5033643|P1|Part 1: Dose Escalation|Disease Progression|3
1537717|NCT00195260|5033633|P11|Part 1: Dose Escalation|Death|0
1537718|NCT00195260|5033634|P10|Part 1: Dose Escalation|Death|0
1537719|NCT00195260|5033635|P9|Part 1: Dose Escalation|Death|0
1537720|NCT00195260|5033636|P8|Part 1: Dose Escalation|Death|1
1537721|NCT00195260|5033637|P7|Part 1: Dose Escalation|Death|0
1537722|NCT00195260|5033638|P6|Part 1: Dose Escalation|Death|0
1537723|NCT00195260|5033639|P5|Part 1: Dose Escalation|Death|0
1537724|NCT00195260|5033640|P4|Part 1: Dose Escalation|Death|0
1537725|NCT00195260|5033641|P3|Part 1: Dose Escalation|Death|0
1537726|NCT00195260|5033642|P2|Part 1: Dose Escalation|Death|0
1537727|NCT00195260|5033643|P1|Part 1: Dose Escalation|Death|0
1537728|NCT00195260|5033633|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
1537729|NCT00195260|5033634|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
1537730|NCT00195260|5033635|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
1537731|NCT00195260|5033636|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
1537732|NCT00195260|5033637|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
1537733|NCT00195260|5033638|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
1537734|NCT00195260|5033639|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
1537735|NCT00195260|5033640|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
1537736|NCT00195260|5033641|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
1537737|NCT00195260|5033642|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
1537738|NCT00195260|5033643|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
1537739|NCT00195260|5033633|P11|Part 1: Dose Escalation|Adverse Event|0
1537740|NCT00195260|5033634|P10|Part 1: Dose Escalation|Adverse Event|0
1537741|NCT00195260|5033635|P9|Part 1: Dose Escalation|Adverse Event|0
1537742|NCT00195260|5033636|P8|Part 1: Dose Escalation|Adverse Event|0
1537743|NCT00195260|5033637|P7|Part 1: Dose Escalation|Adverse Event|3
1537744|NCT00195260|5033638|P6|Part 1: Dose Escalation|Adverse Event|0
1537745|NCT00195260|5033639|P5|Part 1: Dose Escalation|Adverse Event|1
1537746|NCT00195260|5033640|P4|Part 1: Dose Escalation|Adverse Event|1
1537747|NCT00195260|5033641|P3|Part 1: Dose Escalation|Adverse Event|0
1537748|NCT00195260|5033642|P2|Part 1: Dose Escalation|Adverse Event|1
1537749|NCT00195260|5033643|P1|Part 1: Dose Escalation|Adverse Event|0
1537750|NCT00194792|5033830|P1|Overall Study|Withdrawal by Subject|1
1537751|NCT00194675|5033854|P2|Overall Study|Death|0
1537752|NCT00194675|5033855|P1|Overall Study|Death|1
1537753|NCT00194675|5033854|P2|Overall Study|Protocol Violation|0
1537754|NCT00194675|5033855|P1|Overall Study|Protocol Violation|1
1537755|NCT00194675|5033854|P2|Overall Study|"withdrew due to edgy feeling"|0
1537756|NCT00194675|5033855|P1|Overall Study|"withdrew due to edgy feeling"|1
1537757|NCT00194675|5033854|P2|Overall Study|lack of interest|1
1537758|NCT00194675|5033855|P1|Overall Study|lack of interest|1
1537759|NCT00194675|5033854|P2|Overall Study|Lost to Follow-up|1
1537760|NCT00194675|5033855|P1|Overall Study|Lost to Follow-up|1
1537761|NCT00194077|5033909|P2|Overall Study|Withdrawal by Subject|1
1537762|NCT00194077|5033910|P1|Overall Study|Withdrawal by Subject|1
1537763|NCT00194077|5033909|P2|Overall Study|Study nonadherence|0
1537764|NCT00194077|5033910|P1|Overall Study|Study nonadherence|1
1537765|NCT00194077|5033909|P2|Overall Study|Lack of Efficacy|29
1537766|NCT00194077|5033910|P1|Overall Study|Lack of Efficacy|22
1537767|NCT00194025|5033916|P1|Overall Study|non-adherence with study medication|4
1537768|NCT00194025|5033916|P1|Overall Study|Adverse Event|1
1537769|NCT00194012|5033931|P2|Open Label Extension (OLE)|Lack of Efficacy|0
1537770|NCT00194012|5033932|P1|Open Label Extension (OLE)|Lack of Efficacy|1
1537771|NCT00194012|5033931|P2|Open Label Extension (OLE)|Lost to Follow-up|5
1537772|NCT00194012|5033932|P1|Open Label Extension (OLE)|Lost to Follow-up|3
1537773|NCT00194012|5033931|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
1537774|NCT00194012|5033932|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
1537775|NCT00194012|5033931|P2|Open Label Extension (OLE)|Weight Gain|0
1537776|NCT00194012|5033932|P1|Open Label Extension (OLE)|Weight Gain|1
1537777|NCT00194012|5033931|P2|Randomized Phase|Oral/nasal twitching|1
1537778|NCT00194012|5033932|P1|Randomized Phase|Oral/nasal twitching|0
1537779|NCT00194012|5033931|P2|Randomized Phase|Emesis and enuresis|1
1537780|NCT00194012|5033932|P1|Randomized Phase|Emesis and enuresis|0
1537781|NCT00194012|5033931|P2|Randomized Phase|Participant reported having a rash|0
1537782|NCT00194012|5033932|P1|Randomized Phase|Participant reported having a rash|1
1537783|NCT00194012|5033931|P2|Randomized Phase|Adverse Event|1
1537784|NCT00194012|5033932|P1|Randomized Phase|Adverse Event|2
1537785|NCT00194012|5033931|P2|Randomized Phase|Withdrawal by Subject|3
1537786|NCT00194012|5033932|P1|Randomized Phase|Withdrawal by Subject|3
1537787|NCT00194012|5033931|P2|Randomized Phase|Study nonadherence|1
1537788|NCT00194012|5033932|P1|Randomized Phase|Study nonadherence|2
1537789|NCT00194012|5033931|P2|Randomized Phase|Lack of Efficacy|18
1537790|NCT00194012|5033932|P1|Randomized Phase|Lack of Efficacy|8
1537791|NCT00193609|5033968|P1|Overall Study|Adverse Event|2
1537792|NCT00193609|5033968|P1|Overall Study|Lack of Efficacy|2
1537793|NCT00193479|5033995|P1|Induction Chemotherapy|Disease Progression|1
1537794|NCT00193479|5033995|P1|Induction Chemotherapy|Adverse Event|2
1537795|NCT00193206|5034036|P1|Postoperative Therapy|Protocol Violation|1
1537796|NCT00193206|5034036|P1|Postoperative Therapy|Lack of Efficacy|1
1537797|NCT00193206|5034036|P1|Postoperative Therapy|Intercurrent Illness|2
1537798|NCT00193206|5034036|P1|Postoperative Therapy|Physician Decision|3
1537799|NCT00193206|5034036|P1|Postoperative Therapy|Withdrawal by Subject|7
1537800|NCT00193206|5034036|P1|Preoperative Therapy|False Positive Pregnancy Test|1
1537801|NCT00193206|5034036|P1|Preoperative Therapy|Withdrawal by Subject|2
1537802|NCT00193206|5034036|P1|Preoperative Therapy|Adverse Event|2
1537803|NCT00193206|5034036|P1|Preoperative Therapy|Lack of Efficacy|2
1537804|NCT00193180|5034040|P1|Overall Study|Protocol Violation|1
1537805|NCT00193180|5034040|P1|Overall Study|Adverse Event|8
1537806|NCT00193180|5034040|P1|Overall Study|Lack of Efficacy|1
1537807|NCT00193063|5034055|P1|Overall Study|Adverse Event|1
1537808|NCT00193063|5034055|P1|Overall Study|Lack of Efficacy|3
1537809|NCT00193050|5034061|P1|Adjuvant|Lack of Efficacy|2
1537810|NCT00193050|5034061|P1|Adjuvant|Intercurrent Hospitalization|3
1537811|NCT00193050|5034061|P1|Adjuvant|Physician Decision|5
1537812|NCT00193050|5034061|P1|Neoadjuvant Treatment|Adverse Event|2
1537813|NCT00193050|5034061|P1|Neoadjuvant Treatment|Physician Decision|2
1537814|NCT00193050|5034061|P1|Neoadjuvant Treatment|Intercurrent Illness|3
1537815|NCT00193050|5034061|P1|Neoadjuvant Treatment|Lack of Efficacy|2
1537816|NCT00192647|5034078|P2|Overall Study|Other/Administrative|3
1537817|NCT00192647|5034079|P1|Overall Study|Other/Administrative|5
1537818|NCT00192647|5034078|P2|Overall Study|Failure to Return|13
1537819|NCT00192647|5034079|P1|Overall Study|Failure to Return|11
1537820|NCT00192647|5034078|P2|Overall Study|Refused Treatment/Did not Cooperate|8
1537821|NCT00192647|5034079|P1|Overall Study|Refused Treatment/Did not Cooperate|10
1537822|NCT00192647|5034078|P2|Overall Study|Protocol Violation|1
1537823|NCT00192647|5034079|P1|Overall Study|Protocol Violation|3
1537824|NCT00192647|5034078|P2|Overall Study|Entry Criteria Violation|6
1537825|NCT00192647|5034079|P1|Overall Study|Entry Criteria Violation|6
1537826|NCT00192647|5034078|P2|Overall Study|Insufficient Therapeutic Response|83
1537827|NCT00192647|5034079|P1|Overall Study|Insufficient Therapeutic Response|53
1537828|NCT00192647|5034078|P2|Overall Study|Laboratory Test Abnormality|2
1537829|NCT00192647|5034079|P1|Overall Study|Laboratory Test Abnormality|4
1537830|NCT00192647|5034078|P2|Overall Study|Adverse Event|29
1537831|NCT00192647|5034079|P1|Overall Study|Adverse Event|35
1537832|NCT00192647|5034078|P2|Overall Study|Death|1
1537833|NCT00192647|5034079|P1|Overall Study|Death|1
1537834|NCT00192296|5034099|P4|Overall Study|Withdrawal by Subject|0
1537835|NCT00192296|5034100|P3|Overall Study|Withdrawal by Subject|0
1537836|NCT00192296|5034101|P2|Overall Study|Withdrawal by Subject|1
1537837|NCT00192296|5034102|P1|Overall Study|Withdrawal by Subject|0
1537838|NCT00192075|5034158|P2|Overall Study|Other|2
1537839|NCT00192075|5034159|P1|Overall Study|Other|5
1537840|NCT00192075|5034158|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
1537841|NCT00192075|5034159|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
1537842|NCT00192075|5034158|P2|Overall Study|Patient Non-Compliance|1
1537843|NCT00192075|5034159|P1|Overall Study|Patient Non-Compliance|0
1537844|NCT00192075|5034158|P2|Overall Study|Withdrawal by Subject|5
1537845|NCT00192075|5034159|P1|Overall Study|Withdrawal by Subject|5
1537846|NCT00192075|5034158|P2|Overall Study|Physician Decision|0
1537847|NCT00192075|5034159|P1|Overall Study|Physician Decision|3
1537848|NCT00192075|5034158|P2|Overall Study|Lack of Efficacy|0
1537849|NCT00192075|5034159|P1|Overall Study|Lack of Efficacy|0
1537850|NCT00192075|5034158|P2|Overall Study|Death|1
1537851|NCT00192075|5034159|P1|Overall Study|Death|0
1537852|NCT00192075|5034158|P2|Overall Study|Adverse Event|3
1537853|NCT00192075|5034159|P1|Overall Study|Adverse Event|1
1537854|NCT00192075|5034158|P2|Overall Study|Disease Progression|6
1537855|NCT00192075|5034159|P1|Overall Study|Disease Progression|23
1537856|NCT00192036|5034184|P1|Overall Study|Unknown or Not Specified|5
1537857|NCT00192036|5034184|P1|Overall Study|Death|1
1537858|NCT00192036|5034184|P1|Overall Study|Clinical Disease Progression|1
1537859|NCT00192036|5034184|P1|Overall Study|Objective Tumor Progression|4
1537860|NCT00192036|5034184|P1|Overall Study|Patient/Physician Perception|1
1537861|NCT00192036|5034184|P1|Overall Study|Adverse Event|6
1537862|NCT00192036|5034184|P1|Overall Study|Protocol Violation|3
1537863|NCT00192023|5034194|P2|Period IV - Optional Open-Label|Physician Decision|0
1537864|NCT00192023|5034195|P1|Period IV - Optional Open-Label|Physician Decision|9
1537865|NCT00192023|5034194|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
1537866|NCT00192023|5034195|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
1537867|NCT00192023|5034194|P2|Period IV - Optional Open-Label|Protocol Violation|0
1537868|NCT00192023|5034195|P1|Period IV - Optional Open-Label|Protocol Violation|1
1537869|NCT00192023|5034194|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
1537870|NCT00192023|5034195|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
1537871|NCT00192023|5034194|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
1537872|NCT00192023|5034195|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
1537873|NCT00192023|5034194|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
1537874|NCT00192023|5034195|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
1537875|NCT00192023|5034194|P2|Period IV - Optional Open-Label|Adverse Event|0
1537876|NCT00192023|5034195|P1|Period IV - Optional Open-Label|Adverse Event|6
1537877|NCT00192023|5034194|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
1537878|NCT00192023|5034195|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
1537879|NCT00192023|5034194|P2|Period III - Double-Blind|Physician Decision|0
1537880|NCT00192023|5034195|P1|Period III - Double-Blind|Physician Decision|2
1537881|NCT00192023|5034194|P2|Period III - Double-Blind|Adverse Event|0
1537882|NCT00192023|5034195|P1|Period III - Double-Blind|Adverse Event|3
1537883|NCT00191984|5034217|P1|Overall Study|Physician Decision|4
1537884|NCT00191984|5034217|P1|Overall Study|Withdrawal by Subject|7
1537885|NCT00191984|5034217|P1|Overall Study|Entry Criteria Exclusion|1
1537886|NCT00191984|5034217|P1|Overall Study|Death|2
1537887|NCT00191984|5034217|P1|Overall Study|Adverse Event|4
1537888|NCT00191984|5034217|P1|Overall Study|Disease Progression|21
1537889|NCT00191945|5034227|P2|Double-Blind Acute Treatment|Physician Decision|2
1537890|NCT00191945|5034228|P1|Double-Blind Acute Treatment|Physician Decision|0
1537891|NCT00191945|5034227|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
1537892|NCT00191945|5034228|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
1537893|NCT00191945|5034227|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
1537894|NCT00191945|5034228|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
1537895|NCT00191945|5034227|P2|Double-Blind Acute Treatment|Parent's Decision|0
1537896|NCT00191945|5034228|P1|Double-Blind Acute Treatment|Parent's Decision|3
1537897|NCT00191906|5034264|P4|Study Period III|Lack of Efficacy|0
1537898|NCT00191906|5034265|P3|Study Period III|Lack of Efficacy|0
1537899|NCT00191906|5034266|P2|Study Period III|Lack of Efficacy|3
1537900|NCT00191906|5034267|P1|Study Period III|Lack of Efficacy|3
1537901|NCT00191906|5034264|P4|Study Period III|Parent/Caregiver Decision|0
1537902|NCT00191906|5034265|P3|Study Period III|Parent/Caregiver Decision|0
1537903|NCT00191906|5034266|P2|Study Period III|Parent/Caregiver Decision|0
1537904|NCT00191906|5034267|P1|Study Period III|Parent/Caregiver Decision|1
1537905|NCT00191906|5034264|P4|Study Period III|Lost to Follow-up|0
1537906|NCT00191906|5034265|P3|Study Period III|Lost to Follow-up|0
1537907|NCT00191906|5034266|P2|Study Period III|Lost to Follow-up|1
1537908|NCT00191906|5034267|P1|Study Period III|Lost to Follow-up|0
1537909|NCT00191906|5034264|P4|Study Period III|Adverse Event|0
1537910|NCT00191906|5034265|P3|Study Period III|Adverse Event|0
1537911|NCT00191906|5034266|P2|Study Period III|Adverse Event|0
1537912|NCT00191906|5034267|P1|Study Period III|Adverse Event|1
1537913|NCT00191906|5034264|P4|Study Period II|Entry Criteria Exclusion|0
1537914|NCT00191906|5034265|P3|Study Period II|Entry Criteria Exclusion|1
1537915|NCT00191906|5034266|P2|Study Period II|Entry Criteria Exclusion|0
1537916|NCT00191906|5034267|P1|Study Period II|Entry Criteria Exclusion|0
1537917|NCT00191906|5034264|P4|Study Period II|Parent/Caregiver Decision|0
1537918|NCT00191906|5034265|P3|Study Period II|Parent/Caregiver Decision|0
1537919|NCT00191906|5034266|P2|Study Period II|Parent/Caregiver Decision|1
1537920|NCT00191906|5034267|P1|Study Period II|Parent/Caregiver Decision|0
1537921|NCT00191906|5034264|P4|Study Period II|Withdrawal by Subject|0
1537922|NCT00191906|5034265|P3|Study Period II|Withdrawal by Subject|0
1537923|NCT00191906|5034266|P2|Study Period II|Withdrawal by Subject|3
1537924|NCT00191906|5034267|P1|Study Period II|Withdrawal by Subject|0
1537925|NCT00191906|5034264|P4|Study Period II|Adverse Event|0
1537926|NCT00191906|5034265|P3|Study Period II|Adverse Event|0
1537927|NCT00191906|5034266|P2|Study Period II|Adverse Event|1
1537928|NCT00191906|5034267|P1|Study Period II|Adverse Event|0
1537929|NCT00191854|5034310|P3|Overall Study|Screen Failure|1
1537930|NCT00191854|5034311|P2|Overall Study|Screen Failure|0
1537931|NCT00191854|5034312|P1|Overall Study|Screen Failure|0
1537932|NCT00191854|5034310|P3|Overall Study|Sponsor Decision|1
1537933|NCT00191854|5034311|P2|Overall Study|Sponsor Decision|0
1537934|NCT00191854|5034312|P1|Overall Study|Sponsor Decision|0
1537935|NCT00191854|5034310|P3|Overall Study|Withdrawal by Subject|3
1537936|NCT00191854|5034311|P2|Overall Study|Withdrawal by Subject|2
1537937|NCT00191854|5034312|P1|Overall Study|Withdrawal by Subject|4
1537938|NCT00191854|5034310|P3|Overall Study|Lost to Follow-up|5
1537939|NCT00191854|5034311|P2|Overall Study|Lost to Follow-up|5
1537940|NCT00191854|5034312|P1|Overall Study|Lost to Follow-up|7
1537941|NCT00191854|5034310|P3|Overall Study|Death|29
1537942|NCT00191854|5034311|P2|Overall Study|Death|23
1537943|NCT00191854|5034312|P1|Overall Study|Death|26
1537944|NCT00191815|5034332|P1|Overall Study|Withdrawal by Subject|7
1537945|NCT00191815|5034332|P1|Overall Study|Physician Decision|2
1537946|NCT00191815|5034332|P1|Overall Study|Protocol Violation|3
1537947|NCT00191815|5034332|P1|Overall Study|Death|2
1537948|NCT00191815|5034332|P1|Overall Study|Disease progression or relapse|24
1537949|NCT00191815|5034332|P1|Overall Study|Adverse Event|2
1537950|NCT00191789|5034344|P1|Overall Study|Death - Not Study-Drug Related|1
1537951|NCT00191789|5034344|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
1537952|NCT00191789|5034344|P1|Overall Study|Death - Possibly Study Drug Related|4
1537953|NCT00191789|5034344|P1|Overall Study|Withdrawal by Subject|4
1537954|NCT00191789|5034344|P1|Overall Study|Patient/Physician: Satisfactory Response|4
1537955|NCT00191789|5034344|P1|Overall Study|Patient: Satisfactory Response|5
1537956|NCT00191789|5034344|P1|Overall Study|Adverse Event|5
1537957|NCT00191724|5034361|P5|Overall Study|Withdrawal by Subject|0
1537958|NCT00191724|5034362|P4|Overall Study|Withdrawal by Subject|1
1537959|NCT00191724|5034363|P3|Overall Study|Withdrawal by Subject|0
1537960|NCT00191724|5034364|P2|Overall Study|Withdrawal by Subject|0
1537961|NCT00191724|5034365|P1|Overall Study|Withdrawal by Subject|0
1537962|NCT00191724|5034361|P5|Overall Study|Lost to Follow-up|3
1537963|NCT00191724|5034362|P4|Overall Study|Lost to Follow-up|2
1537964|NCT00191724|5034363|P3|Overall Study|Lost to Follow-up|0
1537965|NCT00191724|5034364|P2|Overall Study|Lost to Follow-up|1
1537966|NCT00191724|5034365|P1|Overall Study|Lost to Follow-up|1
1537967|NCT00191724|5034361|P5|Overall Study|Adverse Event|0
1537968|NCT00191724|5034362|P4|Overall Study|Adverse Event|0
1537969|NCT00191724|5034363|P3|Overall Study|Adverse Event|1
1537970|NCT00191724|5034364|P2|Overall Study|Adverse Event|0
1537971|NCT00191724|5034365|P1|Overall Study|Adverse Event|0
1537972|NCT00191646|5034394|P2|Overall Study|Missing Data|11
1537973|NCT00191646|5034395|P1|Overall Study|Missing Data|18
1537974|NCT00191646|5034394|P2|Overall Study|Other|34
1537975|NCT00191646|5034395|P1|Overall Study|Other|33
1537976|NCT00191646|5034394|P2|Overall Study|Death|8
1537977|NCT00191646|5034395|P1|Overall Study|Death|6
1537978|NCT00191646|5034394|P2|Overall Study|Protocol Violation|7
1537979|NCT00191646|5034395|P1|Overall Study|Protocol Violation|5
1537980|NCT00191646|5034394|P2|Overall Study|Withdrawal by Subject|39
1537981|NCT00191646|5034395|P1|Overall Study|Withdrawal by Subject|58
1537982|NCT00191646|5034394|P2|Overall Study|Physician Decision|11
1537983|NCT00191646|5034395|P1|Overall Study|Physician Decision|20
1537984|NCT00191646|5034394|P2|Overall Study|Disease Progression|6
1537985|NCT00191646|5034395|P1|Overall Study|Disease Progression|5
1537986|NCT00191646|5034394|P2|Overall Study|Toxicity|37
1537987|NCT00191646|5034395|P1|Overall Study|Toxicity|26
1537988|NCT00191477|5034415|P2|Overall Study|Discontinued Prior to Instillation|14
1537989|NCT00191477|5034416|P1|Overall Study|Discontinued Prior to Instillation|13
1537990|NCT00191477|5034415|P2|Overall Study|Pathological Specimen Lost|0
1537991|NCT00191477|5034416|P1|Overall Study|Pathological Specimen Lost|1
1537992|NCT00191477|5034415|P2|Overall Study|Not Eligible|38
1537993|NCT00191477|5034416|P1|Overall Study|Not Eligible|41
1537994|NCT00191477|5034415|P2|Overall Study|Other|0
1537995|NCT00191477|5034416|P1|Overall Study|Other|2
1537996|NCT00191477|5034415|P2|Overall Study|Withdrawal by Subject|0
1537997|NCT00191477|5034416|P1|Overall Study|Withdrawal by Subject|2
1537998|NCT00191477|5034415|P2|Overall Study|Treatment Change|0
1537999|NCT00191477|5034416|P1|Overall Study|Treatment Change|2
1538000|NCT00191477|5034415|P2|Overall Study|Protocol Violation|1
1538001|NCT00191477|5034416|P1|Overall Study|Protocol Violation|1
1538002|NCT00191477|5034415|P2|Overall Study|Lost to Follow-up|21
1538003|NCT00191477|5034416|P1|Overall Study|Lost to Follow-up|23
1538004|NCT00191477|5034415|P2|Overall Study|Death, Other Cause|6
1538005|NCT00191477|5034416|P1|Overall Study|Death, Other Cause|3
1538006|NCT00191477|5034415|P2|Overall Study|Death, Study Disease|1
1538007|NCT00191477|5034416|P1|Overall Study|Death, Study Disease|1
1538008|NCT00191477|5034415|P2|Overall Study|Tumor Recurrence|48
1538009|NCT00191477|5034416|P1|Overall Study|Tumor Recurrence|49
1538010|NCT00191451|5034435|P3|Overall Study|Reason Not Specified|3
1538011|NCT00191451|5034436|P2|Overall Study|Reason Not Specified|1
1538012|NCT00191451|5034437|P1|Overall Study|Reason Not Specified|2
1538013|NCT00191451|5034435|P3|Overall Study|Ineligible|0
1538014|NCT00191451|5034436|P2|Overall Study|Ineligible|1
1538015|NCT00191451|5034437|P1|Overall Study|Ineligible|0
1538016|NCT00191451|5034435|P3|Overall Study|Sponsor Decision|0
1538017|NCT00191451|5034436|P2|Overall Study|Sponsor Decision|0
1538018|NCT00191451|5034437|P1|Overall Study|Sponsor Decision|1
1538019|NCT00191451|5034435|P3|Overall Study|Physician Decision|6
1538020|NCT00191451|5034436|P2|Overall Study|Physician Decision|9
1538021|NCT00191451|5034437|P1|Overall Study|Physician Decision|2
1538022|NCT00191451|5034435|P3|Overall Study|Withdrawal by Subject|5
1538023|NCT00191451|5034436|P2|Overall Study|Withdrawal by Subject|3
1538024|NCT00191451|5034437|P1|Overall Study|Withdrawal by Subject|2
1538025|NCT00191386|5034457|P1|Overall Study|Lack of Efficacy|15
1538026|NCT00191386|5034457|P1|Overall Study|Physician Decision|11
1538027|NCT00191386|5034457|P1|Overall Study|Withdrawal by Subject|96
1538028|NCT00191386|5034457|P1|Overall Study|Protocol Violation|18
1538029|NCT00191386|5034457|P1|Overall Study|Entry Criteria Exclusion|3
1538030|NCT00191386|5034457|P1|Overall Study|Lost to Follow-up|1
1538031|NCT00191386|5034457|P1|Overall Study|Adverse Event|16
1538032|NCT00191334|5034464|P1|Overall Study|Withdrawal by Subject|4
1538033|NCT00191334|5034464|P1|Overall Study|Physician Decision|1
1538034|NCT00191334|5034464|P1|Overall Study|Disease Progression or Relapse|8
1538035|NCT00191334|5034464|P1|Overall Study|Adverse Event|4
1538036|NCT00191308|5034472|P1|Overall Study|Adverse Event|1
1538037|NCT00191282|5034482|P2|Overall Study|Lost to Follow-up|31
1538038|NCT00191282|5034483|P1|Overall Study|Lost to Follow-up|24
1538039|NCT00191282|5034482|P2|Overall Study|Sponsor's decision|2
1538040|NCT00191282|5034483|P1|Overall Study|Sponsor's decision|2
1538041|NCT00191282|5034482|P2|Overall Study|Severity of outcome|5
1538042|NCT00191282|5034483|P1|Overall Study|Severity of outcome|2
1538043|NCT00191282|5034482|P2|Overall Study|Protocol Violation|12
1538044|NCT00191282|5034483|P1|Overall Study|Protocol Violation|9
1538045|NCT00191282|5034482|P2|Overall Study|Protocol entry criteria not met|9
1538046|NCT00191282|5034483|P1|Overall Study|Protocol entry criteria not met|14
1538047|NCT00191282|5034482|P2|Overall Study|Physician Decision|15
1538048|NCT00191282|5034483|P1|Overall Study|Physician Decision|18
1538049|NCT00191282|5034482|P2|Overall Study|Withdrawal by Subject|44
1538050|NCT00191282|5034483|P1|Overall Study|Withdrawal by Subject|59
1538051|NCT00191282|5034482|P2|Overall Study|Patient moved|14
1538052|NCT00191282|5034483|P1|Overall Study|Patient moved|11
1538053|NCT00191282|5034482|P2|Overall Study|Noncompliance|17
1538054|NCT00191282|5034483|P1|Overall Study|Noncompliance|14
1538055|NCT00191282|5034482|P2|Overall Study|Lack of Efficacy|6
1538056|NCT00191282|5034483|P1|Overall Study|Lack of Efficacy|11
1538057|NCT00191282|5034482|P2|Overall Study|Death|51
1538058|NCT00191282|5034483|P1|Overall Study|Death|51
1538059|NCT00191282|5034482|P2|Overall Study|Adverse Event|6
1538060|NCT00191282|5034483|P1|Overall Study|Adverse Event|5
1538061|NCT00191269|5034543|P2|Overall Study|Physician Decision|3
1538062|NCT00191269|5034544|P1|Overall Study|Physician Decision|0
1538063|NCT00191269|5034543|P2|Overall Study|Pathologic Aggrevation|1
1538064|NCT00191269|5034544|P1|Overall Study|Pathologic Aggrevation|0
1538065|NCT00191269|5034543|P2|Overall Study|Withdrawal by Subject|1
1538066|NCT00191269|5034544|P1|Overall Study|Withdrawal by Subject|0
1538067|NCT00191269|5034543|P2|Overall Study|Lack of Efficacy|5
1538068|NCT00191269|5034544|P1|Overall Study|Lack of Efficacy|1
1538069|NCT00191269|5034543|P2|Overall Study|Progression of Disease|42
1538070|NCT00191269|5034544|P1|Overall Study|Progression of Disease|4
1538071|NCT00191269|5034543|P2|Overall Study|Adverse Event|4
1538072|NCT00191269|5034544|P1|Overall Study|Adverse Event|1
1538073|NCT00191269|5034543|P2|Overall Study|Protocol Violation|2
1538074|NCT00191269|5034544|P1|Overall Study|Protocol Violation|0
1538075|NCT00191191|5034560|P2|Overall Study|Good Clinical Practice Violation|1
1538076|NCT00191191|5034561|P1|Overall Study|Good Clinical Practice Violation|0
1538077|NCT00191191|5034560|P2|Overall Study|Physician Decision|2
1538078|NCT00191191|5034561|P1|Overall Study|Physician Decision|3
1538079|NCT00191191|5034560|P2|Overall Study|Lost to Follow-up|0
1538080|NCT00191191|5034561|P1|Overall Study|Lost to Follow-up|1
1538081|NCT00191191|5034560|P2|Overall Study|Family/Caregiver Decision|7
1538082|NCT00191191|5034561|P1|Overall Study|Family/Caregiver Decision|5
1538083|NCT00191191|5034560|P2|Overall Study|Toxicity After Dose Reduction|8
1538084|NCT00191191|5034561|P1|Overall Study|Toxicity After Dose Reduction|7
1538085|NCT00191191|5034560|P2|Overall Study|Progressive Disease|72
1538086|NCT00191191|5034561|P1|Overall Study|Progressive Disease|84
1538087|NCT00191191|5034560|P2|Overall Study|Adverse Event|21
1538088|NCT00191191|5034561|P1|Overall Study|Adverse Event|11
1538089|NCT00191191|5034560|P2|Overall Study|Treated with Another Systemic Agent|1
1538090|NCT00191191|5034561|P1|Overall Study|Treated with Another Systemic Agent|1
1538091|NCT00191191|5034560|P2|Overall Study|Entry Criteria Exclusion|0
1538092|NCT00191191|5034561|P1|Overall Study|Entry Criteria Exclusion|2
1538093|NCT00191165|5034577|P2|Overall Study|Participant Moved Away|1
1538094|NCT00191165|5034578|P1|Overall Study|Participant Moved Away|0
1538095|NCT00191165|5034577|P2|Overall Study|Protocol Violation|1
1538096|NCT00191165|5034578|P1|Overall Study|Protocol Violation|0
1538097|NCT00191165|5034577|P2|Overall Study|Adverse Event|0
1538098|NCT00191165|5034578|P1|Overall Study|Adverse Event|2
1538099|NCT00191152|5034590|P2|Crossover Treatment|Not Specified|3
1538100|NCT00191152|5034591|P1|Crossover Treatment|Not Specified|4
1538101|NCT00191152|5034590|P2|Crossover Treatment|Lost to Follow-up|1
1538102|NCT00191152|5034591|P1|Crossover Treatment|Lost to Follow-up|2
1538103|NCT00191152|5034590|P2|Crossover Treatment|Withdrawal by Subject|9
1538104|NCT00191152|5034591|P1|Crossover Treatment|Withdrawal by Subject|6
1538105|NCT00191152|5034590|P2|Crossover Treatment|Physician Decision|7
1538106|NCT00191152|5034591|P1|Crossover Treatment|Physician Decision|7
1538107|NCT00191152|5034590|P2|Crossover Treatment|Adverse Event|8
1538108|NCT00191152|5034591|P1|Crossover Treatment|Adverse Event|8
1538109|NCT00191152|5034590|P2|Initial Treatment|not specified|21
1538110|NCT00191152|5034591|P1|Initial Treatment|not specified|18
1538111|NCT00191152|5034590|P2|Initial Treatment|Lost to Follow-up|6
1538112|NCT00191152|5034591|P1|Initial Treatment|Lost to Follow-up|0
1538113|NCT00191152|5034590|P2|Initial Treatment|Withdrawal by Subject|28
1538114|NCT00191152|5034591|P1|Initial Treatment|Withdrawal by Subject|40
1538115|NCT00191152|5034590|P2|Initial Treatment|Physician Decision|31
1538116|NCT00191152|5034591|P1|Initial Treatment|Physician Decision|40
1538117|NCT00191152|5034590|P2|Initial Treatment|Adverse Event|67
1538118|NCT00191152|5034591|P1|Initial Treatment|Adverse Event|43
1538119|NCT00191139|5034623|P2|Overall Study|Other|2
1538120|NCT00191139|5034624|P1|Overall Study|Other|1
1538121|NCT00191139|5034623|P2|Overall Study|Disease Progression|1
1538122|NCT00191139|5034624|P1|Overall Study|Disease Progression|0
1538123|NCT00191139|5034623|P2|Overall Study|Withdrawal by Subject|3
1538124|NCT00191139|5034624|P1|Overall Study|Withdrawal by Subject|0
1538125|NCT00191139|5034623|P2|Overall Study|Death|0
1538126|NCT00191139|5034624|P1|Overall Study|Death|2
1538127|NCT00191139|5034623|P2|Overall Study|Adverse Event|6
1538128|NCT00191139|5034624|P1|Overall Study|Adverse Event|2
1538129|NCT00191113|5034640|P2|Core Study|Death|0
1538130|NCT00191113|5034641|P1|Core Study|Death|1
1538131|NCT00191113|5034640|P2|Core Study|Lack of Efficacy|2
1538132|NCT00191113|5034641|P1|Core Study|Lack of Efficacy|0
1538133|NCT00191113|5034640|P2|Core Study|Adverse Event|2
1538134|NCT00191113|5034641|P1|Core Study|Adverse Event|0
1538135|NCT00191113|5034640|P2|Core Study|Lost to Follow-up|0
1538136|NCT00191113|5034641|P1|Core Study|Lost to Follow-up|3
1538137|NCT00191113|5034640|P2|Core Study|Protocol Violation|2
1538138|NCT00191113|5034641|P1|Core Study|Protocol Violation|6
1538139|NCT00191113|5034640|P2|Core Study|Withdrawal by Subject|9
1538140|NCT00191113|5034641|P1|Core Study|Withdrawal by Subject|25
1538141|NCT00191100|5034683|P2|Overall Study|Reason Not Specified|1
1538142|NCT00191100|5034684|P1|Overall Study|Reason Not Specified|0
1538143|NCT00191100|5034683|P2|Overall Study|Death from Other Cause|0
1538144|NCT00191100|5034684|P1|Overall Study|Death from Other Cause|1
1538145|NCT00191100|5034683|P2|Overall Study|Protocol Violation|1
1538146|NCT00191100|5034684|P1|Overall Study|Protocol Violation|1
1538147|NCT00191100|5034683|P2|Overall Study|Death from Study Drug Toxicity|0
1538148|NCT00191100|5034684|P1|Overall Study|Death from Study Drug Toxicity|2
1538149|NCT00191100|5034683|P2|Overall Study|Physician Decision|1
1538150|NCT00191100|5034684|P1|Overall Study|Physician Decision|3
1538151|NCT00191100|5034683|P2|Overall Study|Lack of Efficacy, Stable Disease|0
1538152|NCT00191100|5034684|P1|Overall Study|Lack of Efficacy, Stable Disease|1
1538153|NCT00191100|5034683|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
1538154|NCT00191100|5034684|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
1538155|NCT00191100|5034683|P2|Overall Study|Clinical Relapse|1
1538156|NCT00191100|5034684|P1|Overall Study|Clinical Relapse|2
1538157|NCT00191100|5034683|P2|Overall Study|Protocol Entry Criteria Not Met|1
1538158|NCT00191100|5034684|P1|Overall Study|Protocol Entry Criteria Not Met|2
1538159|NCT00191100|5034683|P2|Overall Study|Withdrawal by Subject|3
1538160|NCT00191100|5034684|P1|Overall Study|Withdrawal by Subject|9
1538161|NCT00191100|5034683|P2|Overall Study|Patient Moved|1
1538162|NCT00191100|5034684|P1|Overall Study|Patient Moved|0
1538163|NCT00191100|5034683|P2|Overall Study|Lost to Follow-up|0
1538164|NCT00191100|5034684|P1|Overall Study|Lost to Follow-up|2
1538165|NCT00191100|5034683|P2|Overall Study|Adverse Event|1
1538166|NCT00191100|5034684|P1|Overall Study|Adverse Event|18
1538167|NCT00190983|5034700|P1|Overall Study|Inevaluable (never treated)|2
1538168|NCT00190775|5034709|P2|Overall Study|Exclusion Criteria Met|3
1538169|NCT00190775|5034710|P1|Overall Study|Exclusion Criteria Met|1
1538170|NCT00190775|5034709|P2|Overall Study|Protocol Violation|1
1538171|NCT00190775|5034710|P1|Overall Study|Protocol Violation|0
1538172|NCT00190775|5034709|P2|Overall Study|Noncompliance|5
1538173|NCT00190775|5034710|P1|Overall Study|Noncompliance|3
1538174|NCT00190775|5034709|P2|Overall Study|Physician Decision|0
1538175|NCT00190775|5034710|P1|Overall Study|Physician Decision|3
1538176|NCT00190775|5034709|P2|Overall Study|Sponsor Decision|0
1538177|NCT00190775|5034710|P1|Overall Study|Sponsor Decision|1
1538178|NCT00190775|5034709|P2|Overall Study|Withdrawal by Subject|13
1538179|NCT00190775|5034710|P1|Overall Study|Withdrawal by Subject|24
1538180|NCT00190775|5034709|P2|Overall Study|Participant Moved|1
1538181|NCT00190775|5034710|P1|Overall Study|Participant Moved|0
1538182|NCT00190775|5034709|P2|Overall Study|Lost to Follow-up|23
1538183|NCT00190775|5034710|P1|Overall Study|Lost to Follow-up|31
1538184|NCT00190775|5034709|P2|Overall Study|Lack of Efficacy|32
1538185|NCT00190775|5034710|P1|Overall Study|Lack of Efficacy|28
1538186|NCT00190775|5034709|P2|Overall Study|Satisfactory Response|0
1538187|NCT00190775|5034710|P1|Overall Study|Satisfactory Response|1
1538188|NCT00190775|5034709|P2|Overall Study|Adverse Event|22
1538189|NCT00190775|5034710|P1|Overall Study|Adverse Event|57
1538190|NCT00190749|5034781|P2|Overall Study|Sponsor Decision|0
1538191|NCT00190749|5034782|P1|Overall Study|Sponsor Decision|1
1538192|NCT00190749|5034781|P2|Overall Study|Reason Not Specified|2
1538193|NCT00190749|5034782|P1|Overall Study|Reason Not Specified|0
1538194|NCT00190749|5034781|P2|Overall Study|Lack of Efficacy|3
1538195|NCT00190749|5034782|P1|Overall Study|Lack of Efficacy|2
1538196|NCT00190749|5034781|P2|Overall Study|Adverse Event|5
1538197|NCT00190749|5034782|P1|Overall Study|Adverse Event|0
1538198|NCT00190749|5034781|P2|Overall Study|Protocol Violation|4
1538199|NCT00190749|5034782|P1|Overall Study|Protocol Violation|5
1538200|NCT00190749|5034781|P2|Overall Study|Withdrawal by Subject|6
1538201|NCT00190749|5034782|P1|Overall Study|Withdrawal by Subject|10
1538202|NCT00190749|5034781|P2|Overall Study|Lost to Follow-up|11
1538203|NCT00190749|5034782|P1|Overall Study|Lost to Follow-up|8
1538204|NCT00190684|5034846|P1|Overall Study|Study Period V Completed|1
1538205|NCT00190684|5034846|P1|Overall Study|Study Period III Completed|103
1538206|NCT00190684|5034846|P1|Overall Study|Protocol Violation|123
1538207|NCT00190684|5034846|P1|Overall Study|Physician Decision|84
1538208|NCT00190684|5034846|P1|Overall Study|Sponsor's decision|17
1538209|NCT00190684|5034846|P1|Overall Study|Clinical relapse|67
1538210|NCT00190684|5034846|P1|Overall Study|Patient Decision|432
1538211|NCT00190684|5034846|P1|Overall Study|Patient moved|60
1538212|NCT00190684|5034846|P1|Overall Study|Lost to Follow-up|232
1538213|NCT00190684|5034846|P1|Overall Study|Lack of efficacy|204
1538214|NCT00190684|5034846|P1|Overall Study|Satisfactory response|80
1538215|NCT00190684|5034846|P1|Overall Study|Adverse Event|86
1538216|NCT00190671|5034867|P2|Overall Study|Withdrawal by Subject|2
1538217|NCT00190671|5034868|P1|Overall Study|Withdrawal by Subject|0
1538218|NCT00190671|5034867|P2|Overall Study|Protocol Violation|1
1538219|NCT00190671|5034868|P1|Overall Study|Protocol Violation|0
1538220|NCT00190671|5034867|P2|Overall Study|Death from Other Causes|2
1538221|NCT00190671|5034868|P1|Overall Study|Death from Other Causes|0
1538222|NCT00190671|5034867|P2|Overall Study|Death from Study-Drug Toxicity|2
1538223|NCT00190671|5034868|P1|Overall Study|Death from Study-Drug Toxicity|0
1538224|NCT00190671|5034867|P2|Overall Study|Clinical Relapse|1
1538225|NCT00190671|5034868|P1|Overall Study|Clinical Relapse|0
1538226|NCT00190671|5034867|P2|Overall Study|Adverse Event|2
1538227|NCT00190671|5034868|P1|Overall Study|Adverse Event|3
1538228|NCT00190671|5034867|P2|Overall Study|Death from Study Disease|1
1538229|NCT00190671|5034868|P1|Overall Study|Death from Study Disease|1
1538230|NCT00190671|5034867|P2|Overall Study|Lack of Efficacy|24
1538231|NCT00190671|5034868|P1|Overall Study|Lack of Efficacy|19
1538232|NCT00190671|5034867|P2|Overall Study|Satisfactory Response|7
1538233|NCT00190671|5034868|P1|Overall Study|Satisfactory Response|4
1538234|NCT00189540|5034888|P2|Overall Study|Death|1
1538235|NCT00189540|5034889|P1|Overall Study|Death|4
1538236|NCT00189540|5034888|P2|Overall Study|Withdrawal by Subject|0
1538237|NCT00189540|5034889|P1|Overall Study|Withdrawal by Subject|3
1538238|NCT00189488|5034907|P2|Overall Study|Other|0
1538239|NCT00189488|5034908|P1|Overall Study|Other|1
1538240|NCT00189488|5034907|P2|Overall Study|Death|8
1538241|NCT00189488|5034908|P1|Overall Study|Death|5
1538242|NCT00189488|5034907|P2|Overall Study|Administrative Decision|2
1538243|NCT00189488|5034908|P1|Overall Study|Administrative Decision|0
1538244|NCT00189488|5034907|P2|Overall Study|Disease progression|4
1538245|NCT00189488|5034908|P1|Overall Study|Disease progression|2
1538246|NCT00189488|5034907|P2|Overall Study|Withdrawal by Subject|6
1538247|NCT00189488|5034908|P1|Overall Study|Withdrawal by Subject|2
1538248|NCT00189488|5034907|P2|Overall Study|Adverse Event|1
1538249|NCT00189488|5034908|P1|Overall Study|Adverse Event|2
1538250|NCT00189488|5034907|P2|Overall Study|Protocol deviation|1
1538251|NCT00189488|5034908|P1|Overall Study|Protocol deviation|2
1538252|NCT00189488|5034907|P2|Overall Study|Ineligibility determined|0
1538253|NCT00189488|5034908|P1|Overall Study|Ineligibility determined|1
1538254|NCT00189462|5034939|P2|Overall Study|Lost to Follow-up|20
1538255|NCT00189462|5034940|P1|Overall Study|Lost to Follow-up|18
1538256|NCT00189462|5034939|P2|Overall Study|Lack of Efficacy|1
1538257|NCT00189462|5034940|P1|Overall Study|Lack of Efficacy|5
1538258|NCT00189423|5034957|P2|Overall Study|Lost to Follow-up|10
1538259|NCT00189423|5034958|P1|Overall Study|Lost to Follow-up|10
1538260|NCT00189423|5034957|P2|Overall Study|Withdrawal by Subject|9
1538261|NCT00189423|5034958|P1|Overall Study|Withdrawal by Subject|9
1538262|NCT00189423|5034957|P2|Overall Study|Death|747
1538263|NCT00189423|5034958|P1|Overall Study|Death|746
1538264|NCT00189306|5034980|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
1538265|NCT00189306|5034980|P1|Long-Term Follow-up|Lost to Follow-up|9
1538266|NCT00189306|5034980|P1|Long-Term Follow-up|Intercurrent disease|2
1538267|NCT00189306|5034980|P1|Long-Term Follow-up|Withdrawal by Subject|1
1538268|NCT00189306|5034980|P1|Long-Term Follow-up|Death|4
1538269|NCT00189306|5034980|P1|Long-Term Follow-up|Adverse Event|2
1538270|NCT00189306|5034980|P1|Posttreatment Period|Local skin reaction/sign|1
1538271|NCT00189306|5034980|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
1538272|NCT00189306|5034980|P1|Posttreatment Period|Protocol Violation|1
1538273|NCT00189306|5034980|P1|Posttreatment Period|Target lesion excised|1
1538274|NCT00189306|5034980|P1|Posttreatment Period|Noncompliance|1
1538275|NCT00189306|5034980|P1|Posttreatment Period|Withdrawal by Subject|2
1538276|NCT00189306|5034980|P1|Posttreatment Period|Death|1
1538277|NCT00189306|5034980|P1|Treatment Period|Protocol Violation|1
1538278|NCT00189306|5034980|P1|Treatment Period|Adverse Event|2
1538279|NCT00189306|5034980|P1|Treatment Period|Withdrawal by Subject|2
1538280|NCT00189202|5034985|P1|Overall Study|Physician Decision|5
1538281|NCT00187889|5035026|P2|Overall Study|Withdrawal by Subject|4
1538282|NCT00187889|5035027|P1|Overall Study|Withdrawal by Subject|6
1538283|NCT00187486|5035069|P1|Overall Study|Protocol Violation|1
1538284|NCT00187135|5035120|P6|Visit Three|Study Discontinued|6
1538285|NCT00187135|5035121|P5|Visit Three|Study Discontinued|7
1538286|NCT00187135|5035122|P4|Visit Three|Study Discontinued|7
1538287|NCT00187135|5035123|P3|Visit Three|Study Discontinued|7
1538288|NCT00187135|5035124|P2|Visit Three|Study Discontinued|6
1538289|NCT00187135|5035125|P1|Visit Three|Study Discontinued|7
1538290|NCT00187135|5035120|P6|Visit Three|Withdrawal by Subject|0
1538291|NCT00187135|5035121|P5|Visit Three|Withdrawal by Subject|0
1538292|NCT00187135|5035122|P4|Visit Three|Withdrawal by Subject|2
1538293|NCT00187135|5035123|P3|Visit Three|Withdrawal by Subject|1
1538294|NCT00187135|5035124|P2|Visit Three|Withdrawal by Subject|1
1538295|NCT00187135|5035125|P1|Visit Three|Withdrawal by Subject|0
1538296|NCT00187135|5035120|P6|Visit Three|Death|0
1538297|NCT00187135|5035121|P5|Visit Three|Death|1
1538298|NCT00187135|5035122|P4|Visit Three|Death|0
1538299|NCT00187135|5035123|P3|Visit Three|Death|1
1538300|NCT00187135|5035124|P2|Visit Three|Death|0
1538301|NCT00187135|5035125|P1|Visit Three|Death|0
1538302|NCT00187135|5035120|P6|Visit Two|Study Discontinued|6
1538303|NCT00187135|5035121|P5|Visit Two|Study Discontinued|5
1538304|NCT00187135|5035122|P4|Visit Two|Study Discontinued|7
1538305|NCT00187135|5035123|P3|Visit Two|Study Discontinued|1
1538306|NCT00187135|5035124|P2|Visit Two|Study Discontinued|2
1538307|NCT00187135|5035125|P1|Visit Two|Study Discontinued|3
1538308|NCT00187135|5035120|P6|Visit Two|Withdrawal by Subject|1
1538309|NCT00187135|5035121|P5|Visit Two|Withdrawal by Subject|1
1538310|NCT00187135|5035122|P4|Visit Two|Withdrawal by Subject|0
1538311|NCT00187135|5035123|P3|Visit Two|Withdrawal by Subject|1
1538312|NCT00187135|5035124|P2|Visit Two|Withdrawal by Subject|1
1538313|NCT00187135|5035125|P1|Visit Two|Withdrawal by Subject|1
1538314|NCT00187135|5035120|P6|Visit Two|Physician Decision|0
1538315|NCT00187135|5035121|P5|Visit Two|Physician Decision|0
1538316|NCT00187135|5035122|P4|Visit Two|Physician Decision|0
1538317|NCT00187135|5035123|P3|Visit Two|Physician Decision|0
1538318|NCT00187135|5035124|P2|Visit Two|Physician Decision|0
1538319|NCT00187135|5035125|P1|Visit Two|Physician Decision|1
1538320|NCT00187135|5035120|P6|Visit Two|Death|1
1538321|NCT00187135|5035121|P5|Visit Two|Death|0
1538322|NCT00187135|5035122|P4|Visit Two|Death|1
1538323|NCT00187135|5035123|P3|Visit Two|Death|0
1538324|NCT00187135|5035124|P2|Visit Two|Death|0
1538325|NCT00187135|5035125|P1|Visit Two|Death|0
1538326|NCT00187135|5035120|P6|Visit One|Physician Decision|1
1538327|NCT00187135|5035121|P5|Visit One|Physician Decision|0
1538328|NCT00187135|5035122|P4|Visit One|Physician Decision|0
1538329|NCT00187135|5035123|P3|Visit One|Physician Decision|0
1538330|NCT00187135|5035124|P2|Visit One|Physician Decision|1
1538331|NCT00187135|5035125|P1|Visit One|Physician Decision|3
1538332|NCT00187135|5035120|P6|Visit One|Withdrawal by Subject|1
1538333|NCT00187135|5035121|P5|Visit One|Withdrawal by Subject|0
1538334|NCT00187135|5035122|P4|Visit One|Withdrawal by Subject|0
1538335|NCT00187135|5035123|P3|Visit One|Withdrawal by Subject|0
1538336|NCT00187135|5035124|P2|Visit One|Withdrawal by Subject|0
1538337|NCT00187135|5035125|P1|Visit One|Withdrawal by Subject|1
1538338|NCT00187096|5035148|P3|Overall Study|unacceptable toxicity|1
1538339|NCT00187096|5035149|P2|Overall Study|unacceptable toxicity|0
1538340|NCT00187096|5035150|P1|Overall Study|unacceptable toxicity|0
1538341|NCT00186901|5035188|P3|Overall Study|Bone Mineral Density > 0|149
1538342|NCT00186901|5035189|P2|Overall Study|Bone Mineral Density > 0|0
1538343|NCT00186901|5035190|P1|Overall Study|Bone Mineral Density > 0|0
1538344|NCT00186901|5035188|P3|Overall Study|Limited adherence to study requirements|0
1538345|NCT00186901|5035189|P2|Overall Study|Limited adherence to study requirements|23
1538346|NCT00186901|5035190|P1|Overall Study|Limited adherence to study requirements|20
1538347|NCT00186901|5035188|P3|Overall Study|Open label|0
1538348|NCT00186901|5035189|P2|Overall Study|Open label|2
1538349|NCT00186901|5035190|P1|Overall Study|Open label|3
1538350|NCT00186901|5035188|P3|Overall Study|Withdrawal by Subject|0
1538351|NCT00186901|5035189|P2|Overall Study|Withdrawal by Subject|5
1538352|NCT00186901|5035190|P1|Overall Study|Withdrawal by Subject|4
1538353|NCT00186901|5035188|P3|Overall Study|ALL relapse or second malignancy|0
1538354|NCT00186901|5035189|P2|Overall Study|ALL relapse or second malignancy|2
1538355|NCT00186901|5035190|P1|Overall Study|ALL relapse or second malignancy|1
1538356|NCT00186901|5035188|P3|Overall Study|Bone Mineral Density dropped > 5%|0
1538357|NCT00186901|5035189|P2|Overall Study|Bone Mineral Density dropped > 5%|7
1538358|NCT00186901|5035190|P1|Overall Study|Bone Mineral Density dropped > 5%|9
1538359|NCT00186901|5035188|P3|Overall Study|Lost to Follow-up|0
1538360|NCT00186901|5035189|P2|Overall Study|Lost to Follow-up|3
1538361|NCT00186901|5035190|P1|Overall Study|Lost to Follow-up|6
1538362|NCT00186901|5035188|P3|Overall Study|Pregnancy|0
1538363|NCT00186901|5035189|P2|Overall Study|Pregnancy|3
1538364|NCT00186901|5035190|P1|Overall Study|Pregnancy|6
1538365|NCT00186888|5035230|P3|Overall Study|Relapse or progression of disease|0
1538366|NCT00186888|5035231|P2|Overall Study|Relapse or progression of disease|2
1538367|NCT00186888|5035232|P1|Overall Study|Relapse or progression of disease|4
1538368|NCT00186888|5035230|P3|Overall Study|Toxicity|0
1538369|NCT00186888|5035231|P2|Overall Study|Toxicity|1
1538370|NCT00186888|5035232|P1|Overall Study|Toxicity|0
1538371|NCT00186628|5035324|P1|Overall Study|Withdrawal by subject (before treatment)|1
1538372|NCT00186628|5035324|P1|Overall Study|Death|2
1538373|NCT00186537|5035335|P3|Overall Study|ALT > 1.5 x ULN|0
1538374|NCT00186537|5035336|P2|Overall Study|ALT > 1.5 x ULN|0
1538375|NCT00186537|5035337|P1|Overall Study|ALT > 1.5 x ULN|3
1538376|NCT00186537|5035335|P3|Overall Study|Withdrawal by Subject|3
1538377|NCT00186537|5035336|P2|Overall Study|Withdrawal by Subject|0
1538378|NCT00186537|5035337|P1|Overall Study|Withdrawal by Subject|4
1538379|NCT00186485|5035351|P1|Overall Study|Lost to Follow-up|3
1538380|NCT00186186|5035363|P1|Overall Study|Not reported as to reason|2
1538381|NCT00186186|5035363|P1|Overall Study|Withdrawal by Subject|3
1538382|NCT00186186|5035363|P1|Overall Study|Lack of Efficacy|3
1538383|NCT00186121|5035368|P1|Overall Study|Not eligible (no treatment)|1
1538384|NCT00186121|5035368|P1|Overall Study|Underwent oophorectomy (no treatment)|1
1538385|NCT00186121|5035368|P1|Overall Study|Subject withdrawal (no treatment)|1
1538386|NCT00186043|5035402|P2|Overall Study|Protocol Violation|1
1538387|NCT00186043|5035403|P1|Overall Study|Protocol Violation|2
1538388|NCT00186043|5035402|P2|Overall Study|Adverse Event|3
1538389|NCT00186043|5035403|P1|Overall Study|Adverse Event|7
1538390|NCT00186043|5035402|P2|Overall Study|Withdrawal by Subject|0
1538391|NCT00186043|5035403|P1|Overall Study|Withdrawal by Subject|1
1538392|NCT00186043|5035402|P2|Overall Study|Lost to Follow-up|6
1538393|NCT00186043|5035403|P1|Overall Study|Lost to Follow-up|4
1538394|NCT00186043|5035402|P2|Overall Study|Lack of Efficacy|3
1538395|NCT00186043|5035403|P1|Overall Study|Lack of Efficacy|1
1538396|NCT00185965|5035430|P2|Overall Study|Adverse Event|1
1538397|NCT00185965|5035431|P1|Overall Study|Adverse Event|0
1538398|NCT00185731|5035437|P1|Overall Study|Not Eligible|1
1538399|NCT00185731|5035437|P1|Overall Study|Withdrawal by Subject|1
1538400|NCT00185640|5035454|P1|Overall Study|Death|138
1538401|NCT00185640|5035454|P1|Overall Study|Withdrawal by Subject|3
1538402|NCT00185640|5035454|P1|Overall Study|Not Eligible|4
1538403|NCT00185614|5035463|P1|Inter-treatment Period|Lack of allogenic donor|1
1538404|NCT00185614|5035463|P1|Inter-treatment Period|Relapse|2
1538405|NCT00185614|5035463|P1|Inter-treatment Period|Physician Decision|1
1538406|NCT00185588|5035475|P4|Overall Study|Physician Decision|0
1538407|NCT00185588|5035476|P3|Overall Study|Physician Decision|1
1538408|NCT00185588|5035477|P2|Overall Study|Physician Decision|0
1538409|NCT00185588|5035478|P1|Overall Study|Physician Decision|0
1538410|NCT00185588|5035475|P4|Overall Study|Withdrawal by Subject|0
1538411|NCT00185588|5035476|P3|Overall Study|Withdrawal by Subject|0
1538412|NCT00185588|5035477|P2|Overall Study|Withdrawal by Subject|1
1538413|NCT00185588|5035478|P1|Overall Study|Withdrawal by Subject|0
1538414|NCT00185588|5035475|P4|Overall Study|Lost to Follow-up|2
1538415|NCT00185588|5035476|P3|Overall Study|Lost to Follow-up|1
1538416|NCT00185588|5035477|P2|Overall Study|Lost to Follow-up|0
1538417|NCT00185588|5035478|P1|Overall Study|Lost to Follow-up|0
1538418|NCT00185588|5035475|P4|Overall Study|Adverse Event|2
1538419|NCT00185588|5035476|P3|Overall Study|Adverse Event|4
1538420|NCT00185588|5035477|P2|Overall Study|Adverse Event|1
1538421|NCT00185588|5035478|P1|Overall Study|Adverse Event|3
1538422|NCT00185458|5035492|P1|HRT Phase|Withdrawal by Subject|3
1538423|NCT00185458|5035492|P1|HRT Phase|Protocol Violation|2
1538424|NCT00185458|5035492|P1|HRT Phase|Lost to Follow-up|4
1538425|NCT00185458|5035492|P1|HRT Phase|Adverse Event|18
1538426|NCT00185458|5035492|P1|Contraception Phase|Withdrawal by Subject|7
1538427|NCT00185458|5035492|P1|Contraception Phase|Physician Decision|2
1538428|NCT00185458|5035492|P1|Contraception Phase|Protocol Violation|2
1538429|NCT00185458|5035492|P1|Contraception Phase|Lost to Follow-up|10
1538430|NCT00185458|5035492|P1|Contraception Phase|Adverse Event|37
1538431|NCT00185380|5035555|P3|Overall Study|personal reason|1
1538432|NCT00185380|5035556|P2|Overall Study|personal reason|1
1538433|NCT00185380|5035557|P1|Overall Study|personal reason|6
1538434|NCT00185380|5035555|P3|Overall Study|Could not attend visits|4
1538435|NCT00185380|5035556|P2|Overall Study|Could not attend visits|0
1538436|NCT00185380|5035557|P1|Overall Study|Could not attend visits|2
1538437|NCT00185380|5035555|P3|Overall Study|No need for contraception|3
1538438|NCT00185380|5035556|P2|Overall Study|No need for contraception|3
1538439|NCT00185380|5035557|P1|Overall Study|No need for contraception|3
1538440|NCT00185380|5035555|P3|Overall Study|Planned pregnancy|12
1538441|NCT00185380|5035556|P2|Overall Study|Planned pregnancy|12
1538442|NCT00185380|5035557|P1|Overall Study|Planned pregnancy|9
1538443|NCT00185380|5035555|P3|Overall Study|Failed insertion|2
1538444|NCT00185380|5035556|P2|Overall Study|Failed insertion|1
1538445|NCT00185380|5035557|P1|Overall Study|Failed insertion|1
1538446|NCT00185380|5035555|P3|Overall Study|Withdrawal by Subject|0
1538447|NCT00185380|5035556|P2|Overall Study|Withdrawal by Subject|2
1538448|NCT00185380|5035557|P1|Overall Study|Withdrawal by Subject|1
1538449|NCT00185380|5035555|P3|Overall Study|Protocol Violation|1
1538450|NCT00185380|5035556|P2|Overall Study|Protocol Violation|2
1538451|NCT00185380|5035557|P1|Overall Study|Protocol Violation|2
1538452|NCT00185380|5035555|P3|Overall Study|Pregnancy|0
1538453|NCT00185380|5035556|P2|Overall Study|Pregnancy|4
1538454|NCT00185380|5035557|P1|Overall Study|Pregnancy|1
1538455|NCT00185380|5035555|P3|Overall Study|Lost to Follow-up|3
1538456|NCT00185380|5035556|P2|Overall Study|Lost to Follow-up|4
1538457|NCT00185380|5035557|P1|Overall Study|Lost to Follow-up|0
1538458|NCT00185380|5035555|P3|Overall Study|Adverse Event|48
1538459|NCT00185380|5035556|P2|Overall Study|Adverse Event|43
1538460|NCT00185380|5035557|P1|Overall Study|Adverse Event|41
1538461|NCT00185211|5035585|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
1538462|NCT00185211|5035586|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
1538463|NCT00185211|5035585|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
1538464|NCT00185211|5035586|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
1538465|NCT00185211|5035585|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
1538466|NCT00185211|5035586|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
1538467|NCT00185211|5035585|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
1538468|NCT00185211|5035586|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
1538469|NCT00185211|5035585|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
1538470|NCT00185211|5035586|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
1538471|NCT00185211|5035585|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
1538472|NCT00185211|5035586|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
1538473|NCT00185211|5035585|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
1538474|NCT00185211|5035586|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
1538475|NCT00185211|5035585|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
1538476|NCT00185211|5035586|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
1538477|NCT00185211|5035585|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
1538478|NCT00185211|5035586|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
1538479|NCT00185211|5035585|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
1538480|NCT00185211|5035586|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
1538481|NCT00185211|5035585|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
1538482|NCT00185211|5035586|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
1538483|NCT00185211|5035585|P2|Placebo-controlled Study (92012)|Adverse Event|0
1538484|NCT00185211|5035586|P1|Placebo-controlled Study (92012)|Adverse Event|8
1538485|NCT00184600|5035659|P3|Overall Study|Unclassified|3
1538486|NCT00184600|5035660|P2|Overall Study|Unclassified|5
1538487|NCT00184600|5035661|P1|Overall Study|Unclassified|4
1538488|NCT00184600|5035659|P3|Overall Study|Withdrawal by Subject|12
1538489|NCT00184600|5035660|P2|Overall Study|Withdrawal by Subject|28
1538490|NCT00184600|5035661|P1|Overall Study|Withdrawal by Subject|20
1538491|NCT00184600|5035659|P3|Overall Study|Protocol Violation|3
1538492|NCT00184600|5035660|P2|Overall Study|Protocol Violation|2
1538493|NCT00184600|5035661|P1|Overall Study|Protocol Violation|2
1538494|NCT00184600|5035659|P3|Overall Study|Lost to Follow-up|1
1538495|NCT00184600|5035660|P2|Overall Study|Lost to Follow-up|6
1538496|NCT00184600|5035661|P1|Overall Study|Lost to Follow-up|4
1538497|NCT00184600|5035659|P3|Overall Study|Lack of Efficacy|3
1538498|NCT00184600|5035660|P2|Overall Study|Lack of Efficacy|1
1538499|NCT00184600|5035661|P1|Overall Study|Lack of Efficacy|3
1538500|NCT00184600|5035659|P3|Overall Study|Death|7
1538501|NCT00184600|5035660|P2|Overall Study|Death|9
1538502|NCT00184600|5035661|P1|Overall Study|Death|3
1538503|NCT00184600|5035659|P3|Overall Study|Adverse Event|5
1538504|NCT00184600|5035660|P2|Overall Study|Adverse Event|0
1538505|NCT00184600|5035661|P1|Overall Study|Adverse Event|9
1538506|NCT00184093|5035752|P1|Overall Study|Withdrawal by Subject|2
1538507|NCT00184093|5035752|P1|Overall Study|Physician Decision|1
1538508|NCT00184093|5035752|P1|Overall Study|Lost to Follow-up|3
1538509|NCT00184093|5035752|P1|Overall Study|Adverse Event|3
1538510|NCT00184054|5035757|P1|Overall Study|Adverse Event|1
1538511|NCT00184028|5035762|P1|Overall Study|Non-compliance|2
1538512|NCT00184028|5035762|P1|Overall Study|Withdrawal by Subject|1
1538513|NCT00184028|5035762|P1|Overall Study|Adverse Event|2
1538514|NCT00184028|5035762|P1|Overall Study|Lack of Efficacy|4
1538515|NCT00184028|5035762|P1|Overall Study|Death|1
1538516|NCT00184002|5035767|P1|Overall Study|Withdrawal by Subject|4
1538517|NCT00184002|5035767|P1|Overall Study|Physician Decision|1
1538518|NCT00184002|5035767|P1|Overall Study|Death|3
1538519|NCT00184002|5035767|P1|Overall Study|Adverse Event|9
1538520|NCT00183872|5035793|P1|Overall Study|Drug delayed more than 28 days|2
1538521|NCT00183872|5035793|P1|Overall Study|Withdrawal by Subject|2
1538522|NCT00183872|5035793|P1|Overall Study|Adverse Event|9
1538523|NCT00183872|5035793|P1|Overall Study|Death|3
1538524|NCT00183625|5035822|P4|Overall Study|Withdrawal by Subject|14
1538525|NCT00183625|5035823|P3|Overall Study|Withdrawal by Subject|19
1538526|NCT00183625|5035824|P2|Overall Study|Withdrawal by Subject|18
1538527|NCT00183625|5035825|P1|Overall Study|Withdrawal by Subject|18
1538528|NCT00183430|5035922|P2|Overall Study|Withdrawal by Subject|0
1538529|NCT00183430|5035923|P1|Overall Study|Withdrawal by Subject|1
1538530|NCT00183430|5035922|P2|Overall Study|did not meet inclusion criteria|0
1538531|NCT00183430|5035923|P1|Overall Study|did not meet inclusion criteria|1
1538532|NCT00183430|5035922|P2|Overall Study|Lost to Follow-up|0
1538533|NCT00183430|5035923|P1|Overall Study|Lost to Follow-up|3
1538534|NCT00183430|5035922|P2|Overall Study|Adverse Event|0
1538535|NCT00183430|5035923|P1|Overall Study|Adverse Event|1
1538536|NCT00183391|5035935|P2|Block 2 - 5 Weeks|Withdrawal by Subject|2
1538537|NCT00183391|5035936|P1|Block 2 - 5 Weeks|Withdrawal by Subject|4
1538538|NCT00183391|5035935|P2|Block 1 - 5 Weeks|Withdrawal by Subject|14
1538539|NCT00183391|5035936|P1|Block 1 - 5 Weeks|Withdrawal by Subject|13
1538540|NCT00183274|5036009|P6|Phase 3: Double-Blind|Relapsed|2
1538541|NCT00183274|5036010|P5|Phase 3: Double-Blind|Relapsed|11
1538542|NCT00183274|5036011|P4|Phase 3: Double-Blind|Relapsed|1
1538543|NCT00183274|5036012|P3|Phase 3: Double-Blind|Relapsed|0
1538544|NCT00183274|5036013|P2|Phase 3: Double-Blind|Relapsed|0
1538545|NCT00183274|5036014|P1|Phase 3: Double-Blind|Relapsed|0
1538546|NCT00183274|5036009|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
1538547|NCT00183274|5036010|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
1538548|NCT00183274|5036011|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
1538549|NCT00183274|5036012|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
1538550|NCT00183274|5036013|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
1538551|NCT00183274|5036014|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
1538552|NCT00183274|5036009|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
1538553|NCT00183274|5036010|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
1538554|NCT00183274|5036011|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
1538555|NCT00183274|5036012|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
1538556|NCT00183274|5036013|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
1538557|NCT00183274|5036014|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
1538558|NCT00183274|5036009|P6|Phase 2: Double-Blind|Relapsed|0
1538559|NCT00183274|5036010|P5|Phase 2: Double-Blind|Relapsed|0
1538560|NCT00183274|5036011|P4|Phase 2: Double-Blind|Relapsed|0
1538561|NCT00183274|5036012|P3|Phase 2: Double-Blind|Relapsed|29
1538562|NCT00183274|5036013|P2|Phase 2: Double-Blind|Relapsed|8
1538563|NCT00183274|5036014|P1|Phase 2: Double-Blind|Relapsed|0
1538564|NCT00183274|5036009|P6|Phase 1: Open-Label|Other|0
1538565|NCT00183274|5036010|P5|Phase 1: Open-Label|Other|0
1538566|NCT00183274|5036011|P4|Phase 1: Open-Label|Other|0
1538567|NCT00183274|5036012|P3|Phase 1: Open-Label|Other|0
1538568|NCT00183274|5036013|P2|Phase 1: Open-Label|Other|0
1538569|NCT00183274|5036014|P1|Phase 1: Open-Label|Other|9
1538570|NCT00183274|5036009|P6|Phase 1: Open-Label|Lost to Follow-up|0
1538571|NCT00183274|5036010|P5|Phase 1: Open-Label|Lost to Follow-up|0
1538572|NCT00183274|5036011|P4|Phase 1: Open-Label|Lost to Follow-up|0
1538573|NCT00183274|5036012|P3|Phase 1: Open-Label|Lost to Follow-up|0
1538574|NCT00183274|5036013|P2|Phase 1: Open-Label|Lost to Follow-up|0
1538575|NCT00183274|5036014|P1|Phase 1: Open-Label|Lost to Follow-up|33
1538576|NCT00183274|5036009|P6|Phase 1: Open-Label|Withdrawal by Subject|0
1538577|NCT00183274|5036010|P5|Phase 1: Open-Label|Withdrawal by Subject|0
1538578|NCT00183274|5036011|P4|Phase 1: Open-Label|Withdrawal by Subject|0
1538579|NCT00183274|5036012|P3|Phase 1: Open-Label|Withdrawal by Subject|0
1538580|NCT00183274|5036013|P2|Phase 1: Open-Label|Withdrawal by Subject|0
1538581|NCT00183274|5036014|P1|Phase 1: Open-Label|Withdrawal by Subject|13
1538582|NCT00183274|5036009|P6|Phase 1: Open-Label|Protocol Violation|0
1538583|NCT00183274|5036010|P5|Phase 1: Open-Label|Protocol Violation|0
1538584|NCT00183274|5036011|P4|Phase 1: Open-Label|Protocol Violation|0
1538585|NCT00183274|5036012|P3|Phase 1: Open-Label|Protocol Violation|0
1538586|NCT00183274|5036013|P2|Phase 1: Open-Label|Protocol Violation|0
1538587|NCT00183274|5036014|P1|Phase 1: Open-Label|Protocol Violation|11
1538588|NCT00183274|5036009|P6|Phase 1: Open-Label|Lack of Efficacy|0
1538589|NCT00183274|5036010|P5|Phase 1: Open-Label|Lack of Efficacy|0
1538590|NCT00183274|5036011|P4|Phase 1: Open-Label|Lack of Efficacy|0
1538591|NCT00183274|5036012|P3|Phase 1: Open-Label|Lack of Efficacy|0
1538592|NCT00183274|5036013|P2|Phase 1: Open-Label|Lack of Efficacy|0
1538593|NCT00183274|5036014|P1|Phase 1: Open-Label|Lack of Efficacy|13
1538594|NCT00183274|5036009|P6|Phase 1: Open-Label|Adverse Event|0
1538595|NCT00183274|5036010|P5|Phase 1: Open-Label|Adverse Event|0
1538596|NCT00183274|5036011|P4|Phase 1: Open-Label|Adverse Event|0
1538597|NCT00183274|5036012|P3|Phase 1: Open-Label|Adverse Event|0
1538598|NCT00183274|5036013|P2|Phase 1: Open-Label|Adverse Event|0
1538599|NCT00183274|5036014|P1|Phase 1: Open-Label|Adverse Event|31
1538600|NCT00183248|5036031|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
1538601|NCT00183248|5036032|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
1538602|NCT00183248|5036031|P2|Overall Study|Lost to Follow-up|1
1538603|NCT00183248|5036032|P1|Overall Study|Lost to Follow-up|0
1538604|NCT00183196|5036053|P3|Overall Study|Required more intensive care|2
1538605|NCT00183196|5036054|P2|Overall Study|Required more intensive care|1
1538606|NCT00183196|5036055|P1|Overall Study|Required more intensive care|0
1538607|NCT00183196|5036053|P3|Overall Study|Legal event|1
1538608|NCT00183196|5036054|P2|Overall Study|Legal event|1
1538609|NCT00183196|5036055|P1|Overall Study|Legal event|1
1538610|NCT00183196|5036053|P3|Overall Study|Adverse Event|2
1538611|NCT00183196|5036054|P2|Overall Study|Adverse Event|2
1538612|NCT00183196|5036055|P1|Overall Study|Adverse Event|1
1538613|NCT00183196|5036053|P3|Overall Study|Withdrawal by Subject|13
1538614|NCT00183196|5036054|P2|Overall Study|Withdrawal by Subject|11
1538615|NCT00183196|5036055|P1|Overall Study|Withdrawal by Subject|18
1538616|NCT00182689|5036138|P2|Overall Study|Never received treatment|0
1538617|NCT00182689|5036139|P1|Overall Study|Never received treatment|1
1538618|NCT00182689|5036138|P2|Overall Study|Ineligible|4
1538619|NCT00182689|5036139|P1|Overall Study|Ineligible|1
1538620|NCT00182689|5036138|P2|Overall Study|not protocol specified|3
1538621|NCT00182689|5036139|P1|Overall Study|not protocol specified|0
1538622|NCT00182689|5036138|P2|Overall Study|Death|0
1538623|NCT00182689|5036139|P1|Overall Study|Death|1
1538624|NCT00182689|5036138|P2|Overall Study|Progression|29
1538625|NCT00182689|5036139|P1|Overall Study|Progression|27
1538626|NCT00182689|5036138|P2|Overall Study|Withdrawal by Subject|2
1538627|NCT00182689|5036139|P1|Overall Study|Withdrawal by Subject|2
1538628|NCT00182689|5036138|P2|Overall Study|Adverse Event|11
1538629|NCT00182689|5036139|P1|Overall Study|Adverse Event|8
1538630|NCT00182637|5036149|P1|Overall Study|Disease Progression|1
1538631|NCT00182637|5036149|P1|Overall Study|Adverse Event|2
1538632|NCT00182091|5036159|P4|Overall Study|Withdrawal by Subject|0
1538633|NCT00182091|5036160|P3|Overall Study|Withdrawal by Subject|0
1538634|NCT00182091|5036161|P2|Overall Study|Withdrawal by Subject|0
1538635|NCT00182091|5036162|P1|Overall Study|Withdrawal by Subject|1
1538636|NCT00182078|5036178|P2|Overall Study|Withdrawal by Subject|0
1538637|NCT00182078|5036179|P1|Overall Study|Withdrawal by Subject|1
1538638|NCT00181883|5036198|P1|Overall Study|Lost to Follow-up|1
1538639|NCT00181883|5036198|P1|Overall Study|Withdrawal by Subject|4
1538640|NCT00181883|5036198|P1|Overall Study|Treatment Limiting AEs|3
1538641|NCT00181883|5036198|P1|Overall Study|Lack of Efficacy|2
1538642|NCT00181844|5036202|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
1538643|NCT00181844|5036202|P1|Exposed to Study Medication|Withdrawal by Subject|1
1538644|NCT00181844|5036202|P1|Exposed to Study Medication|Non-compliance|2
1538645|NCT00181844|5036202|P1|Exposed to Study Medication|Lack of Efficacy|2
1538646|NCT00181844|5036202|P1|Exposed to Study Medication|Adverse Event|10
1538647|NCT00181844|5036202|P1|Signed Consent|Did not meet entrance criteria|7
1538648|NCT00181844|5036202|P1|Signed Consent|Withdrawal by Subject|5
1538649|NCT00181766|5036206|P1|Overall Study|non-compliance|2
1538650|NCT00181766|5036206|P1|Overall Study|Adverse Event|4
1538651|NCT00181766|5036206|P1|Overall Study|Lost to Follow-up|6
1538652|NCT00181155|5036247|P2|Overall Study|Withdrawal by Subject|0
1538653|NCT00181155|5036248|P1|Overall Study|Withdrawal by Subject|1
1538654|NCT00181155|5036247|P2|Overall Study|Physician Decision|0
1538655|NCT00181155|5036248|P1|Overall Study|Physician Decision|1
1538656|NCT00180479|5036287|P2|Overall Study|Informed consent not signed|1
1538657|NCT00180479|5036288|P1|Overall Study|Informed consent not signed|0
1538658|NCT00180479|5036287|P2|Overall Study|Withdrawal by Subject|3
1538659|NCT00180479|5036288|P1|Overall Study|Withdrawal by Subject|3
1538660|NCT00180479|5036287|P2|Overall Study|Lost to Follow-up|7
1538661|NCT00180479|5036288|P1|Overall Study|Lost to Follow-up|9
1538662|NCT00180479|5036287|P2|Overall Study|Death|2
1538663|NCT00180479|5036288|P1|Overall Study|Death|4
1538664|NCT00179959|5036398|P2|Overall Study|Withdrawal by Subject|2
1538665|NCT00179959|5036399|P1|Overall Study|Withdrawal by Subject|3
1538666|NCT00179959|5036398|P2|Overall Study|Lost to Follow-up|1
1538667|NCT00179959|5036399|P1|Overall Study|Lost to Follow-up|3
1538668|NCT00179673|5036405|P1|Overall Study|Other Observations and options|14
1538669|NCT00179673|5036405|P1|Overall Study|Death|4
1538670|NCT00179673|5036405|P1|Overall Study|Withdrawal by Subject|3
1538671|NCT00179673|5036405|P1|Overall Study|Lack of Efficacy|15
1538672|NCT00179673|5036405|P1|Overall Study|Adverse Event|7
1538673|NCT00179660|5036413|P1|Overall Study|Other - Unspecified|9
1538674|NCT00179660|5036413|P1|Overall Study|Death|3
1538675|NCT00179660|5036413|P1|Overall Study|Lost to Follow-up|1
1538676|NCT00179660|5036413|P1|Overall Study|Withdrawal by Subject|2
1538677|NCT00179660|5036413|P1|Overall Study|Lack of therapeutic effect|28
1538678|NCT00179660|5036413|P1|Overall Study|Adverse Event|7
1538679|NCT00179647|5036422|P1|Overall Study|Not specified|960
1538680|NCT00179647|5036422|P1|Overall Study|Death|94
1538681|NCT00179647|5036422|P1|Overall Study|Lost to Follow-up|4
1538682|NCT00179647|5036422|P1|Overall Study|Withdrawal by Subject|83
1538683|NCT00179647|5036422|P1|Overall Study|Lack of Efficacy|478
1538684|NCT00179647|5036422|P1|Overall Study|Adverse Event|294
1538685|NCT00179621|5036429|P4|Open-Label Period|Other|2
1538686|NCT00179621|5036430|P3|Open-Label Period|Other|1
1538687|NCT00179621|5036431|P2|Open-Label Period|Other|1
1538688|NCT00179621|5036432|P1|Open-Label Period|Other|0
1538689|NCT00179621|5036429|P4|Open-Label Period|Death|2
1538690|NCT00179621|5036430|P3|Open-Label Period|Death|1
1538691|NCT00179621|5036431|P2|Open-Label Period|Death|0
1538692|NCT00179621|5036432|P1|Open-Label Period|Death|0
1538693|NCT00179621|5036429|P4|Open-Label Period|Withdrawal by Subject|2
1538694|NCT00179621|5036430|P3|Open-Label Period|Withdrawal by Subject|2
1538695|NCT00179621|5036431|P2|Open-Label Period|Withdrawal by Subject|2
1538696|NCT00179621|5036432|P1|Open-Label Period|Withdrawal by Subject|0
1538697|NCT00179621|5036429|P4|Open-Label Period|Adverse Event|6
1538698|NCT00179621|5036430|P3|Open-Label Period|Adverse Event|5
1538699|NCT00179621|5036431|P2|Open-Label Period|Adverse Event|6
1538700|NCT00179621|5036432|P1|Open-Label Period|Adverse Event|0
1538701|NCT00179621|5036429|P4|Open-Label Period|Lack of Therapeutic Effect|31
1538702|NCT00179621|5036430|P3|Open-Label Period|Lack of Therapeutic Effect|19
1538703|NCT00179621|5036431|P2|Open-Label Period|Lack of Therapeutic Effect|19
1538704|NCT00179621|5036432|P1|Open-Label Period|Lack of Therapeutic Effect|0
1538705|NCT00179621|5036429|P4|Double-Blind Period|Other|0
1538706|NCT00179621|5036430|P3|Double-Blind Period|Other|2
1538707|NCT00179621|5036431|P2|Double-Blind Period|Other|2
1538708|NCT00179621|5036432|P1|Double-Blind Period|Other|0
1538709|NCT00179621|5036429|P4|Double-Blind Period|Protocol Violation|0
1538710|NCT00179621|5036430|P3|Double-Blind Period|Protocol Violation|0
1538711|NCT00179621|5036431|P2|Double-Blind Period|Protocol Violation|0
1538712|NCT00179621|5036432|P1|Double-Blind Period|Protocol Violation|1
1538713|NCT00179621|5036429|P4|Double-Blind Period|Death|0
1538714|NCT00179621|5036430|P3|Double-Blind Period|Death|2
1538715|NCT00179621|5036431|P2|Double-Blind Period|Death|1
1538716|NCT00179621|5036432|P1|Double-Blind Period|Death|0
1538717|NCT00179621|5036429|P4|Double-Blind Period|Withdrawal by Subject|0
1538718|NCT00179621|5036430|P3|Double-Blind Period|Withdrawal by Subject|3
1538719|NCT00179621|5036431|P2|Double-Blind Period|Withdrawal by Subject|1
1538720|NCT00179621|5036432|P1|Double-Blind Period|Withdrawal by Subject|2
1538721|NCT00179621|5036429|P4|Double-Blind Period|Adverse Event|0
1538722|NCT00179621|5036430|P3|Double-Blind Period|Adverse Event|4
1538723|NCT00179621|5036431|P2|Double-Blind Period|Adverse Event|7
1538724|NCT00179621|5036432|P1|Double-Blind Period|Adverse Event|2
1538725|NCT00179621|5036429|P4|Double-Blind Period|Lack of Therapeutic Effect|0
1538726|NCT00179621|5036430|P3|Double-Blind Period|Lack of Therapeutic Effect|19
1538727|NCT00179621|5036431|P2|Double-Blind Period|Lack of Therapeutic Effect|35
1538728|NCT00179621|5036432|P1|Double-Blind Period|Lack of Therapeutic Effect|59
1538729|NCT00179517|5036485|P2|Overall Study|Withdrawal by Subject|1
1538730|NCT00179517|5036486|P1|Overall Study|Withdrawal by Subject|2
1538731|NCT00179413|5036524|P2|Overall Study|Withdrawal by Subject|95
1538732|NCT00179413|5036525|P1|Overall Study|Withdrawal by Subject|87
1538733|NCT00179413|5036524|P2|Overall Study|Adverse Event|20
1538734|NCT00179413|5036525|P1|Overall Study|Adverse Event|38
1538735|NCT00179309|5036537|P2|Treatment|Allergy|0
1538736|NCT00179309|5036538|P1|Treatment|Allergy|1
1538737|NCT00179309|5036537|P2|Treatment|Withdrawal by Subject|2
1538738|NCT00179309|5036538|P1|Treatment|Withdrawal by Subject|1
1538739|NCT00179309|5036537|P2|Treatment|Toxicity|3
1538740|NCT00179309|5036538|P1|Treatment|Toxicity|2
1538741|NCT00178685|5036590|P3|Overall Study|Withdrawal by Subject|7
1538742|NCT00178685|5036591|P2|Overall Study|Withdrawal by Subject|14
1538743|NCT00178685|5036592|P1|Overall Study|Withdrawal by Subject|8
1538744|NCT00178685|5036590|P3|Overall Study|Lost to Follow-up|183
1538745|NCT00178685|5036591|P2|Overall Study|Lost to Follow-up|187
1538746|NCT00178685|5036592|P1|Overall Study|Lost to Follow-up|100
1538747|NCT00178685|5036590|P3|Overall Study|Death|6
1538748|NCT00178685|5036591|P2|Overall Study|Death|3
1538749|NCT00178685|5036592|P1|Overall Study|Death|3
1538750|NCT00178633|5036603|P1|Overall Study|Lost to Follow-up|6
1538751|NCT00178464|5036633|P1|Overall Study|Physician Decision|1
1538752|NCT00178464|5036633|P1|Overall Study|Withdrawal by Subject|1
1538753|NCT00178256|5036638|P4|Overall Study|Cancer progression|1
1538754|NCT00178256|5036639|P3|Overall Study|Cancer progression|0
1538755|NCT00178256|5036640|P2|Overall Study|Cancer progression|0
1538756|NCT00178256|5036641|P1|Overall Study|Cancer progression|2
1538757|NCT00178256|5036638|P4|Overall Study|Death|1
1538758|NCT00178256|5036639|P3|Overall Study|Death|0
1538759|NCT00178256|5036640|P2|Overall Study|Death|1
1538760|NCT00178256|5036641|P1|Overall Study|Death|0
1538761|NCT00178256|5036638|P4|Overall Study|Adverse Event|0
1538762|NCT00178256|5036639|P3|Overall Study|Adverse Event|0
1538763|NCT00178256|5036640|P2|Overall Study|Adverse Event|0
1538764|NCT00178256|5036641|P1|Overall Study|Adverse Event|2
1538765|NCT00178126|5036680|P2|Overall Study|did not receive intervention|6
1538766|NCT00178126|5036681|P1|Overall Study|did not receive intervention|4
1538767|NCT00178126|5036680|P2|Overall Study|Lost to Follow-up|21
1538768|NCT00178126|5036681|P1|Overall Study|Lost to Follow-up|21
1538769|NCT00177671|5036723|P2|Overall Study|Physician Decision|8
1538770|NCT00177671|5036724|P1|Overall Study|Physician Decision|12
1538771|NCT00177671|5036723|P2|Overall Study|Adverse Event|0
1538772|NCT00177671|5036724|P1|Overall Study|Adverse Event|6
1538773|NCT00177671|5036723|P2|Overall Study|medical complications|0
1538774|NCT00177671|5036724|P1|Overall Study|medical complications|2
1538775|NCT00177671|5036723|P2|Overall Study|Withdrawal by Subject|6
1538776|NCT00177671|5036724|P1|Overall Study|Withdrawal by Subject|5
1538777|NCT00177307|5036736|P1|Overall Study|Withdrawal by Subject|1
1538778|NCT00177294|5036745|P2|Overall Study|Withdrawal by Subject|5
1538779|NCT00177294|5036746|P1|Overall Study|Withdrawal by Subject|7
1538780|NCT00177216|5036760|P3|Overall Study|Withdrawal by Subject|1
1538781|NCT00177216|5036761|P2|Overall Study|Withdrawal by Subject|3
1538782|NCT00177216|5036762|P1|Overall Study|Withdrawal by Subject|6
1538783|NCT00177164|5036778|P2|Overall Study|Pregnancy|1
1538784|NCT00177164|5036779|P1|Overall Study|Pregnancy|0
1538785|NCT00177164|5036778|P2|Overall Study|Lack of Efficacy|1
1538786|NCT00177164|5036779|P1|Overall Study|Lack of Efficacy|2
1538787|NCT00177164|5036778|P2|Overall Study|discharge from hospital|0
1538788|NCT00177164|5036779|P1|Overall Study|discharge from hospital|1
1538789|NCT00177164|5036778|P2|Overall Study|Adverse Event|0
1538790|NCT00177164|5036779|P1|Overall Study|Adverse Event|1
1538791|NCT00177164|5036778|P2|Overall Study|increase in alcohol and drug use|2
1538792|NCT00177164|5036779|P1|Overall Study|increase in alcohol and drug use|1
1538793|NCT00177164|5036778|P2|Overall Study|Lost to Follow-up|5
1538794|NCT00177164|5036779|P1|Overall Study|Lost to Follow-up|4
1538795|NCT00177164|5036778|P2|Overall Study|Protocol Violation|7
1538796|NCT00177164|5036779|P1|Overall Study|Protocol Violation|0
1538797|NCT00176644|5036944|P1|Overall Study|Withdrawal by Subject|1
1538798|NCT00176605|5036957|P1|Overall Study|Withdrawal by Subject|2
1538799|NCT00176488|5036968|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
1538800|NCT00176462|5036976|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
1538801|NCT00176462|5036977|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
1538802|NCT00176462|5036976|P2|Intensive Continuation (8X8-week Cycles)|Death|0
1538803|NCT00176462|5036977|P1|Intensive Continuation (8X8-week Cycles)|Death|1
1538804|NCT00176462|5036976|P2|Consolidation (12 Weeks)|Not documented|1
1538805|NCT00176462|5036977|P1|Consolidation (12 Weeks)|Not documented|0
1538806|NCT00176462|5036976|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
1538807|NCT00176462|5036977|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
1538808|NCT00176462|5036976|P2|Consolidation (12 Weeks)|Adverse Event|1
1538809|NCT00176462|5036977|P1|Consolidation (12 Weeks)|Adverse Event|0
1538810|NCT00176462|5036976|P2|Consolidation (12 Weeks)|Patient moved to another state|1
1538811|NCT00176462|5036977|P1|Consolidation (12 Weeks)|Patient moved to another state|0
1538812|NCT00176462|5036976|P2|Induction (4 Weeks)|Lack of Efficacy|1
1538813|NCT00176462|5036977|P1|Induction (4 Weeks)|Lack of Efficacy|0
1538814|NCT00176462|5036976|P2|Induction (4 Weeks)|Death|2
1538815|NCT00176462|5036977|P1|Induction (4 Weeks)|Death|1
1538816|NCT00176462|5036976|P2|Induction (4 Weeks)|Withdrawal by Subject|2
1538817|NCT00176462|5036977|P1|Induction (4 Weeks)|Withdrawal by Subject|0
1538818|NCT00176254|5036997|P1|Overall Study|Lost to Follow-up|1
1538819|NCT00175877|5037025|P1|Overall Study|Withdrawal by subject & Other|1
1538820|NCT00175877|5037025|P1|Overall Study|AE & Other|1
1538821|NCT00175877|5037025|P1|Overall Study|Other Reason|20
1538822|NCT00175877|5037025|P1|Overall Study|Protocol Violation|15
1538823|NCT00175877|5037025|P1|Overall Study|Lack of Efficacy|26
1538824|NCT00175877|5037025|P1|Overall Study|Lost to Follow-up|9
1538825|NCT00175877|5037025|P1|Overall Study|Withdrawal by Subject|141
1538826|NCT00175877|5037025|P1|Overall Study|Adverse Event|136
1538827|NCT00175825|5037060|P4|Overall Study|Withdrawal by Subject|0
1538828|NCT00175825|5037061|P3|Overall Study|Withdrawal by Subject|0
1538829|NCT00175825|5037062|P2|Overall Study|Withdrawal by Subject|0
1538830|NCT00175825|5037063|P1|Overall Study|Withdrawal by Subject|1
1538831|NCT00175825|5037060|P4|Overall Study|Lost to Follow-up|0
1538832|NCT00175825|5037061|P3|Overall Study|Lost to Follow-up|0
1538833|NCT00175825|5037062|P2|Overall Study|Lost to Follow-up|2
1538834|NCT00175825|5037063|P1|Overall Study|Lost to Follow-up|1
1538835|NCT00175825|5037060|P4|Overall Study|Adverse Event|1
1538836|NCT00175825|5037061|P3|Overall Study|Adverse Event|1
1538837|NCT00175825|5037062|P2|Overall Study|Adverse Event|2
1538838|NCT00175825|5037063|P1|Overall Study|Adverse Event|3
1538839|NCT00175019|5037116|P3|Overall Study|Reason Not Specified|11
1538840|NCT00175019|5037117|P2|Overall Study|Reason Not Specified|34
1538841|NCT00175019|5037118|P1|Overall Study|Reason Not Specified|40
1538842|NCT00175019|5037116|P3|Overall Study|Gout Flare|0
1538843|NCT00175019|5037117|P2|Overall Study|Gout Flare|3
1538844|NCT00175019|5037118|P1|Overall Study|Gout Flare|2
1538845|NCT00175019|5037116|P3|Overall Study|Therapeutic Failure|22
1538846|NCT00175019|5037117|P2|Overall Study|Therapeutic Failure|38
1538847|NCT00175019|5037118|P1|Overall Study|Therapeutic Failure|10
1538848|NCT00175019|5037116|P3|Overall Study|Personal Reason(s)|8
1538849|NCT00175019|5037117|P2|Overall Study|Personal Reason(s)|31
1538850|NCT00175019|5037118|P1|Overall Study|Personal Reason(s)|39
1538851|NCT00175019|5037116|P3|Overall Study|Did not continue under Amendment 4|2
1538852|NCT00175019|5037117|P2|Overall Study|Did not continue under Amendment 4|1
1538853|NCT00175019|5037118|P1|Overall Study|Did not continue under Amendment 4|1
1538854|NCT00175019|5037116|P3|Overall Study|Lost to Follow-up|9
1538855|NCT00175019|5037117|P2|Overall Study|Lost to Follow-up|39
1538856|NCT00175019|5037118|P1|Overall Study|Lost to Follow-up|42
1538857|NCT00175019|5037116|P3|Overall Study|Protocol Violation|3
1538858|NCT00175019|5037117|P2|Overall Study|Protocol Violation|3
1538859|NCT00175019|5037118|P1|Overall Study|Protocol Violation|6
1538860|NCT00175019|5037116|P3|Overall Study|Adverse Event|2
1538861|NCT00175019|5037117|P2|Overall Study|Adverse Event|22
1538862|NCT00175019|5037118|P1|Overall Study|Adverse Event|54
1538863|NCT00174967|5037171|P4|Overall Study|Not Specified|0
1538864|NCT00174967|5037172|P3|Overall Study|Not Specified|0
1538865|NCT00174967|5037173|P2|Overall Study|Not Specified|1
1538866|NCT00174967|5037174|P1|Overall Study|Not Specified|0
1538867|NCT00174967|5037171|P4|Overall Study|Gout Flare|1
1538868|NCT00174967|5037172|P3|Overall Study|Gout Flare|0
1538869|NCT00174967|5037173|P2|Overall Study|Gout Flare|0
1538870|NCT00174967|5037174|P1|Overall Study|Gout Flare|0
1538871|NCT00174967|5037171|P4|Overall Study|Adverse Event|1
1538872|NCT00174967|5037172|P3|Overall Study|Adverse Event|2
1538873|NCT00174967|5037173|P2|Overall Study|Adverse Event|2
1538874|NCT00174967|5037174|P1|Overall Study|Adverse Event|1
1538875|NCT00174954|5037220|P1|Overall Study|Physician Decision|1
1538876|NCT00174954|5037220|P1|Overall Study|No tophi found in MRI|1
1538877|NCT00174954|5037220|P1|Overall Study|Adverse Event|2
1538878|NCT00174941|5037228|P4|Overall Study|Reason Not Specified|9
1538879|NCT00174941|5037229|P3|Overall Study|Reason Not Specified|2
1538880|NCT00174941|5037230|P2|Overall Study|Reason Not Specified|6
1538881|NCT00174941|5037231|P1|Overall Study|Reason Not Specified|1
1538882|NCT00174941|5037228|P4|Overall Study|Gout Flare|8
1538883|NCT00174941|5037229|P3|Overall Study|Gout Flare|4
1538884|NCT00174941|5037230|P2|Overall Study|Gout Flare|4
1538885|NCT00174941|5037231|P1|Overall Study|Gout Flare|0
1538886|NCT00174941|5037228|P4|Overall Study|Personal Reason(s)|22
1538887|NCT00174941|5037229|P3|Overall Study|Personal Reason(s)|8
1538888|NCT00174941|5037230|P2|Overall Study|Personal Reason(s)|14
1538889|NCT00174941|5037231|P1|Overall Study|Personal Reason(s)|0
1538890|NCT00174941|5037228|P4|Overall Study|Lost to Follow-up|5
1538891|NCT00174941|5037229|P3|Overall Study|Lost to Follow-up|2
1538892|NCT00174941|5037230|P2|Overall Study|Lost to Follow-up|3
1538893|NCT00174941|5037231|P1|Overall Study|Lost to Follow-up|0
1538894|NCT00174941|5037228|P4|Overall Study|Protocol Violation|1
1538895|NCT00174941|5037229|P3|Overall Study|Protocol Violation|0
1538896|NCT00174941|5037230|P2|Overall Study|Protocol Violation|1
1538897|NCT00174941|5037231|P1|Overall Study|Protocol Violation|0
1538898|NCT00174941|5037228|P4|Overall Study|Adverse Event|13
1538899|NCT00174941|5037229|P3|Overall Study|Adverse Event|2
1538900|NCT00174941|5037230|P2|Overall Study|Adverse Event|10
1538901|NCT00174941|5037231|P1|Overall Study|Adverse Event|1
1538902|NCT00174915|5037306|P5|Overall Study|Therapeutic Failure|3
1538903|NCT00174915|5037307|P4|Overall Study|Therapeutic Failure|1
1538904|NCT00174915|5037308|P3|Overall Study|Therapeutic Failure|2
1538905|NCT00174915|5037309|P2|Overall Study|Therapeutic Failure|3
1538906|NCT00174915|5037310|P1|Overall Study|Therapeutic Failure|6
1538907|NCT00174915|5037306|P5|Overall Study|Protocol Violation|3
1538908|NCT00174915|5037307|P4|Overall Study|Protocol Violation|6
1538909|NCT00174915|5037308|P3|Overall Study|Protocol Violation|3
1538910|NCT00174915|5037309|P2|Overall Study|Protocol Violation|3
1538911|NCT00174915|5037310|P1|Overall Study|Protocol Violation|6
1538912|NCT00174915|5037306|P5|Overall Study|Gout Flare|0
1538913|NCT00174915|5037307|P4|Overall Study|Gout Flare|1
1538914|NCT00174915|5037308|P3|Overall Study|Gout Flare|8
1538915|NCT00174915|5037309|P2|Overall Study|Gout Flare|6
1538916|NCT00174915|5037310|P1|Overall Study|Gout Flare|13
1538917|NCT00174915|5037306|P5|Overall Study|Other|3
1538918|NCT00174915|5037307|P4|Overall Study|Other|5
1538919|NCT00174915|5037308|P3|Overall Study|Other|6
1538920|NCT00174915|5037309|P2|Overall Study|Other|8
1538921|NCT00174915|5037310|P1|Overall Study|Other|15
1538922|NCT00174915|5037306|P5|Overall Study|Personal Reason(s)|9
1538923|NCT00174915|5037307|P4|Overall Study|Personal Reason(s)|9
1538924|NCT00174915|5037308|P3|Overall Study|Personal Reason(s)|9
1538925|NCT00174915|5037309|P2|Overall Study|Personal Reason(s)|16
1538926|NCT00174915|5037310|P1|Overall Study|Personal Reason(s)|16
1538927|NCT00174915|5037306|P5|Overall Study|Adverse Event|5
1538928|NCT00174915|5037307|P4|Overall Study|Adverse Event|18
1538929|NCT00174915|5037308|P3|Overall Study|Adverse Event|11
1538930|NCT00174915|5037309|P2|Overall Study|Adverse Event|16
1538931|NCT00174915|5037310|P1|Overall Study|Adverse Event|18
1538932|NCT00174915|5037306|P5|Overall Study|Lost to Follow-up|10
1538933|NCT00174915|5037307|P4|Overall Study|Lost to Follow-up|17
1538934|NCT00174915|5037308|P3|Overall Study|Lost to Follow-up|9
1538935|NCT00174915|5037309|P2|Overall Study|Lost to Follow-up|17
1538936|NCT00174915|5037310|P1|Overall Study|Lost to Follow-up|19
1538937|NCT00174785|5037369|P2|Overall Study|Not pre-specified/Not coded|70
1538938|NCT00174785|5037370|P1|Overall Study|Not pre-specified/Not coded|56
1538939|NCT00174785|5037369|P2|Overall Study|Family request|8
1538940|NCT00174785|5037370|P1|Overall Study|Family request|6
1538941|NCT00174785|5037369|P2|Overall Study|Other prohibited medication|3
1538942|NCT00174785|5037370|P1|Overall Study|Other prohibited medication|5
1538943|NCT00174785|5037369|P2|Overall Study|Prohibited antiarrhythmic medication|88
1538944|NCT00174785|5037370|P1|Overall Study|Prohibited antiarrhythmic medication|39
1538945|NCT00174785|5037369|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
1538946|NCT00174785|5037370|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
1538947|NCT00174785|5037369|P2|Overall Study|Withdrawal by Subject|175
1538948|NCT00174785|5037370|P1|Overall Study|Withdrawal by Subject|173
1538949|NCT00174785|5037369|P2|Overall Study|Protocol Violation|14
1538950|NCT00174785|5037370|P1|Overall Study|Protocol Violation|14
1538951|NCT00174785|5037369|P2|Overall Study|Adverse Event|191
1538952|NCT00174785|5037370|P1|Overall Study|Adverse Event|293
1538953|NCT00174460|5037386|P2|Overall Study|Withdrawal by Subject|1
1538954|NCT00174460|5037387|P1|Overall Study|Withdrawal by Subject|0
1538955|NCT00174447|5037433|P1|Overall Study|Administrative reason/Other|2
1538956|NCT00174447|5037433|P1|Overall Study|Lack of Efficacy|1
1538957|NCT00174447|5037433|P1|Overall Study|Protocol Violation|1
1538958|NCT00174447|5037433|P1|Overall Study|Withdrawal by Subject|15
1538959|NCT00174447|5037433|P1|Overall Study|Adverse Event|19
1538960|NCT00174382|5037442|P1|Overall Study|Lost to Follow-up|1
1538961|NCT00174382|5037442|P1|Overall Study|Subject felt pill not effective enough|1
1538962|NCT00174382|5037442|P1|Overall Study|Arrived early for last visit in error|1
1538963|NCT00174382|5037442|P1|Overall Study|Protocol Violation|3
1538964|NCT00174382|5037442|P1|Overall Study|Withdrawal by Subject|6
1538965|NCT00174382|5037442|P1|Overall Study|Adverse Event|19
1538966|NCT00174382|5037442|P1|Overall Study|Death|2
1538967|NCT00174291|5037461|P2|Overall Study|Withdrawal by Subject|3
1538968|NCT00174291|5037462|P1|Overall Study|Withdrawal by Subject|3
1538969|NCT00174291|5037461|P2|Overall Study|Study terminated by sponsor|0
1538970|NCT00174291|5037462|P1|Overall Study|Study terminated by sponsor|1
1538971|NCT00174291|5037461|P2|Overall Study|Protocol Violation|2
1538972|NCT00174291|5037462|P1|Overall Study|Protocol Violation|0
1538973|NCT00174291|5037461|P2|Overall Study|Lost to Follow-up|1
1538974|NCT00174291|5037462|P1|Overall Study|Lost to Follow-up|1
1538975|NCT00174265|5037492|P2|Overall Study|Other (Not specified)|10
1538976|NCT00174265|5037493|P1|Overall Study|Other (Not specified)|16
1538977|NCT00174265|5037492|P2|Overall Study|Lost to Follow-up|0
1538978|NCT00174265|5037493|P1|Overall Study|Lost to Follow-up|1
1538979|NCT00174265|5037492|P2|Overall Study|Withdrawal by Subject|5
1538980|NCT00174265|5037493|P1|Overall Study|Withdrawal by Subject|3
1538981|NCT00174265|5037492|P2|Overall Study|Lack of Efficacy|2
1538982|NCT00174265|5037493|P1|Overall Study|Lack of Efficacy|2
1538983|NCT00174265|5037492|P2|Overall Study|Adverse Event|4
1538984|NCT00174265|5037493|P1|Overall Study|Adverse Event|7
1538985|NCT00174252|5037501|P1|Overall Study|Protocol Violation|2
1538986|NCT00174187|5037536|P3|Period 2 (After 3 Years)|Other|5
1538987|NCT00174187|5037537|P2|Period 2 (After 3 Years)|Other|0
1538988|NCT00174187|5037538|P1|Period 2 (After 3 Years)|Other|0
1538989|NCT00174187|5037536|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
1538990|NCT00174187|5037537|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
1538991|NCT00174187|5037538|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
1538992|NCT00174187|5037536|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
1538993|NCT00174187|5037537|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
1538994|NCT00174187|5037538|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
1538995|NCT00174187|5037536|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
1538996|NCT00174187|5037537|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
1538997|NCT00174187|5037538|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
1538998|NCT00174187|5037536|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
1538999|NCT00174187|5037537|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
1539000|NCT00174187|5037538|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
1539001|NCT00174187|5037536|P3|Period 1 (up to 3 Years)|Other|0
1539002|NCT00174187|5037537|P2|Period 1 (up to 3 Years)|Other|1
1539003|NCT00174187|5037538|P1|Period 1 (up to 3 Years)|Other|0
1539004|NCT00174187|5037536|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
1539005|NCT00174187|5037537|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
1539006|NCT00174187|5037538|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
1539007|NCT00174187|5037536|P3|Period 1 (up to 3 Years)|Non compliance|0
1539008|NCT00174187|5037537|P2|Period 1 (up to 3 Years)|Non compliance|1
1539009|NCT00174187|5037538|P1|Period 1 (up to 3 Years)|Non compliance|0
1539010|NCT00174187|5037536|P3|Period 1 (up to 3 Years)|Serious adverse event|0
1539011|NCT00174187|5037537|P2|Period 1 (up to 3 Years)|Serious adverse event|1
1539012|NCT00174187|5037538|P1|Period 1 (up to 3 Years)|Serious adverse event|0
1539013|NCT00172185|5037603|P4|Overall Study|Withdrawal by Subject|0
1539014|NCT00172185|5037604|P3|Overall Study|Withdrawal by Subject|1
1539015|NCT00172185|5037605|P2|Overall Study|Withdrawal by Subject|0
1539016|NCT00172185|5037606|P1|Overall Study|Withdrawal by Subject|0
1539017|NCT00172185|5037603|P4|Overall Study|SPONSOR Decision|0
1539018|NCT00172185|5037604|P3|Overall Study|SPONSOR Decision|0
1539019|NCT00172185|5037605|P2|Overall Study|SPONSOR Decision|1
1539020|NCT00172185|5037606|P1|Overall Study|SPONSOR Decision|0
1539021|NCT00172185|5037603|P4|Overall Study|Physician Decision|0
1539022|NCT00172185|5037604|P3|Overall Study|Physician Decision|1
1539023|NCT00172185|5037605|P2|Overall Study|Physician Decision|0
1539024|NCT00172185|5037606|P1|Overall Study|Physician Decision|0
1539025|NCT00172185|5037603|P4|Overall Study|Adverse Event|4
1539026|NCT00172185|5037604|P3|Overall Study|Adverse Event|3
1539027|NCT00172185|5037605|P2|Overall Study|Adverse Event|1
1539028|NCT00172185|5037606|P1|Overall Study|Adverse Event|0
1539029|NCT00172042|5037622|P2|Overall Study|Death|42
1539030|NCT00172042|5037623|P1|Overall Study|Death|42
1539031|NCT00172042|5037622|P2|Overall Study|Administrative problems|10
1539032|NCT00172042|5037623|P1|Overall Study|Administrative problems|13
1539033|NCT00172042|5037622|P2|Overall Study|Lost to Follow-up|5
1539034|NCT00172042|5037623|P1|Overall Study|Lost to Follow-up|3
1539035|NCT00172042|5037622|P2|Overall Study|Withdrawal by Subject|25
1539036|NCT00172042|5037623|P1|Overall Study|Withdrawal by Subject|37
1539037|NCT00172042|5037622|P2|Overall Study|Protocol Violation|7
1539038|NCT00172042|5037623|P1|Overall Study|Protocol Violation|8
1539039|NCT00172042|5037622|P2|Overall Study|Patient no longer requires study drug|8
1539040|NCT00172042|5037623|P1|Overall Study|Patient no longer requires study drug|10
1539041|NCT00172042|5037622|P2|Overall Study|Unsatisfactory therapeutic effect|11
1539042|NCT00172042|5037623|P1|Overall Study|Unsatisfactory therapeutic effect|13
1539043|NCT00172042|5037622|P2|Overall Study|Abnormal test procedure(s)|3
1539044|NCT00172042|5037623|P1|Overall Study|Abnormal test procedure(s)|0
1539045|NCT00172042|5037622|P2|Overall Study|Abnormal laboratory value(s)|1
1539046|NCT00172042|5037623|P1|Overall Study|Abnormal laboratory value(s)|5
1539047|NCT00172042|5037622|P2|Overall Study|Adverse Event|13
1539048|NCT00172042|5037623|P1|Overall Study|Adverse Event|27
1539049|NCT00171925|5037645|P2|Overall Study|Death|2
1539050|NCT00171925|5037646|P1|Overall Study|Death|1
1539051|NCT00171925|5037645|P2|Overall Study|Administrative problems|11
1539052|NCT00171925|5037646|P1|Overall Study|Administrative problems|10
1539053|NCT00171925|5037645|P2|Overall Study|Lost to Follow-up|2
1539054|NCT00171925|5037646|P1|Overall Study|Lost to Follow-up|2
1539055|NCT00171925|5037645|P2|Overall Study|Withdrawal by Subject|9
1539056|NCT00171925|5037646|P1|Overall Study|Withdrawal by Subject|6
1539057|NCT00171925|5037645|P2|Overall Study|Protocol Violation|1
1539058|NCT00171925|5037646|P1|Overall Study|Protocol Violation|1
1539059|NCT00171925|5037645|P2|Overall Study|Adverse Event|6
1539060|NCT00171925|5037646|P1|Overall Study|Adverse Event|10
1539061|NCT00171873|5037658|P2|Overall Study|Switched to Octreotide|1
1539062|NCT00171873|5037659|P1|Overall Study|Switched to Octreotide|0
1539063|NCT00171873|5037658|P2|Overall Study|Adverse Event|0
1539064|NCT00171873|5037659|P1|Overall Study|Adverse Event|5
1539065|NCT00171873|5037658|P2|Overall Study|Withdrawal by Subject|2
1539066|NCT00171873|5037659|P1|Overall Study|Withdrawal by Subject|4
1539067|NCT00171834|5037672|P7|Overall Study|Treatment Duration Completed|0
1539068|NCT00171834|5037673|P6|Overall Study|Treatment Duration Completed|1
1539069|NCT00171834|5037674|P5|Overall Study|Treatment Duration Completed|2
1539070|NCT00171834|5037675|P4|Overall Study|Treatment Duration Completed|0
1539071|NCT00171834|5037676|P3|Overall Study|Treatment Duration Completed|1
1539072|NCT00171834|5037677|P2|Overall Study|Treatment Duration Completed|0
1539073|NCT00171834|5037678|P1|Overall Study|Treatment Duration Completed|0
1539074|NCT00171834|5037672|P7|Overall Study|Disease Progression|3
1539075|NCT00171834|5037673|P6|Overall Study|Disease Progression|18
1539076|NCT00171834|5037674|P5|Overall Study|Disease Progression|2
1539077|NCT00171834|5037675|P4|Overall Study|Disease Progression|9
1539078|NCT00171834|5037676|P3|Overall Study|Disease Progression|8
1539079|NCT00171834|5037677|P2|Overall Study|Disease Progression|8
1539080|NCT00171834|5037678|P1|Overall Study|Disease Progression|4
1539081|NCT00171834|5037672|P7|Overall Study|Death from study indication|0
1539082|NCT00171834|5037673|P6|Overall Study|Death from study indication|0
1539083|NCT00171834|5037674|P5|Overall Study|Death from study indication|1
1539084|NCT00171834|5037675|P4|Overall Study|Death from study indication|0
1539085|NCT00171834|5037676|P3|Overall Study|Death from study indication|0
1539086|NCT00171834|5037677|P2|Overall Study|Death from study indication|1
1539087|NCT00171834|5037678|P1|Overall Study|Death from study indication|0
1539088|NCT00171834|5037672|P7|Overall Study|Withdrawal by Subject|0
1539089|NCT00171834|5037673|P6|Overall Study|Withdrawal by Subject|1
1539090|NCT00171834|5037674|P5|Overall Study|Withdrawal by Subject|1
1539091|NCT00171834|5037675|P4|Overall Study|Withdrawal by Subject|1
1539092|NCT00171834|5037676|P3|Overall Study|Withdrawal by Subject|0
1539093|NCT00171834|5037677|P2|Overall Study|Withdrawal by Subject|2
1539094|NCT00171834|5037678|P1|Overall Study|Withdrawal by Subject|0
1539095|NCT00171834|5037672|P7|Overall Study|Adverse Event|1
1539096|NCT00171834|5037673|P6|Overall Study|Adverse Event|15
1539097|NCT00171834|5037674|P5|Overall Study|Adverse Event|2
1539098|NCT00171834|5037675|P4|Overall Study|Adverse Event|2
1539099|NCT00171834|5037676|P3|Overall Study|Adverse Event|3
1539100|NCT00171834|5037677|P2|Overall Study|Adverse Event|1
1539101|NCT00171834|5037678|P1|Overall Study|Adverse Event|2
1539102|NCT00171704|5037718|P2|Overall Study|Protocol Violation|1
1539103|NCT00171704|5037719|P1|Overall Study|Protocol Violation|0
1539104|NCT00171704|5037718|P2|Overall Study|Withdrawal by Subject|3
1539105|NCT00171704|5037719|P1|Overall Study|Withdrawal by Subject|1
1539106|NCT00171704|5037718|P2|Overall Study|Death|2
1539107|NCT00171704|5037719|P1|Overall Study|Death|2
1539108|NCT00171704|5037718|P2|Overall Study|Administrative Problems|1
1539109|NCT00171704|5037719|P1|Overall Study|Administrative Problems|2
1539110|NCT00171704|5037718|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
1539111|NCT00171704|5037719|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
1539112|NCT00171704|5037718|P2|Overall Study|Disease Progression|9
1539113|NCT00171704|5037719|P1|Overall Study|Disease Progression|14
1539114|NCT00171704|5037718|P2|Overall Study|Adverse Event|33
1539115|NCT00171704|5037719|P1|Overall Study|Adverse Event|24
1539116|NCT00171340|5037741|P2|Overall Study|Death|6
1539117|NCT00171340|5037742|P1|Overall Study|Death|6
1539118|NCT00171340|5037741|P2|Overall Study|Administrative Problems|2
1539119|NCT00171340|5037742|P1|Overall Study|Administrative Problems|5
1539120|NCT00171340|5037741|P2|Overall Study|No Longer Required Study Drug|1
1539121|NCT00171340|5037742|P1|Overall Study|No Longer Required Study Drug|1
1539122|NCT00171340|5037741|P2|Overall Study|Abnormal Test Procedure Results|11
1539123|NCT00171340|5037742|P1|Overall Study|Abnormal Test Procedure Results|6
1539124|NCT00171340|5037741|P2|Overall Study|Abnormal Laboratory Results|0
1539125|NCT00171340|5037742|P1|Overall Study|Abnormal Laboratory Results|2
1539126|NCT00171340|5037741|P2|Overall Study|Lost to Follow-up|5
1539127|NCT00171340|5037742|P1|Overall Study|Lost to Follow-up|0
1539128|NCT00171340|5037741|P2|Overall Study|Withdrawal by Subject|19
1539129|NCT00171340|5037742|P1|Overall Study|Withdrawal by Subject|22
1539130|NCT00171340|5037741|P2|Overall Study|Protocol Violation|8
1539131|NCT00171340|5037742|P1|Overall Study|Protocol Violation|7
1539132|NCT00171340|5037741|P2|Overall Study|Lack of Efficacy|41
1539133|NCT00171340|5037742|P1|Overall Study|Lack of Efficacy|29
1539134|NCT00171340|5037741|P2|Overall Study|Adverse Event|42
1539135|NCT00171340|5037742|P1|Overall Study|Adverse Event|46
1539136|NCT00171314|5037758|P2|Overall Study|Death|1
1539137|NCT00171314|5037759|P1|Overall Study|Death|2
1539138|NCT00171314|5037758|P2|Overall Study|Lost to Follow-up|3
1539139|NCT00171314|5037759|P1|Overall Study|Lost to Follow-up|1
1539140|NCT00171314|5037758|P2|Overall Study|Administrative Problems|3
1539141|NCT00171314|5037759|P1|Overall Study|Administrative Problems|4
1539142|NCT00171314|5037758|P2|Overall Study|Protocol Violation|7
1539143|NCT00171314|5037759|P1|Overall Study|Protocol Violation|3
1539144|NCT00171314|5037758|P2|Overall Study|Abnormal Test Procedure Results|3
1539145|NCT00171314|5037759|P1|Overall Study|Abnormal Test Procedure Results|9
1539146|NCT00171314|5037758|P2|Overall Study|Withdrawal by Subject|6
1539147|NCT00171314|5037759|P1|Overall Study|Withdrawal by Subject|9
1539148|NCT00171314|5037758|P2|Overall Study|Lack of Efficacy|14
1539149|NCT00171314|5037759|P1|Overall Study|Lack of Efficacy|19
1539150|NCT00171314|5037758|P2|Overall Study|Adverse Event|41
1539151|NCT00171314|5037759|P1|Overall Study|Adverse Event|44
1539152|NCT00171301|5037775|P2|Overall Study|Withdrawal by Subject|1
1539153|NCT00171301|5037776|P1|Overall Study|Withdrawal by Subject|0
1539154|NCT00171301|5037775|P2|Overall Study|Protocol Violation|2
1539155|NCT00171301|5037776|P1|Overall Study|Protocol Violation|0
1539156|NCT00171301|5037775|P2|Overall Study|Lost to Follow-up|2
1539157|NCT00171301|5037776|P1|Overall Study|Lost to Follow-up|6
1539158|NCT00171301|5037775|P2|Overall Study|Adverse Event|2
1539159|NCT00171301|5037776|P1|Overall Study|Adverse Event|1
1539160|NCT00171301|5037775|P2|Overall Study|Death|2
1539161|NCT00171301|5037776|P1|Overall Study|Death|1
1539162|NCT00171210|5037789|P2|Overall Study|Stopped at end of extension 1|1
1539163|NCT00171210|5037790|P1|Overall Study|Stopped at end of extension 1|0
1539164|NCT00171210|5037789|P2|Overall Study|Stopped at end of core|32
1539165|NCT00171210|5037790|P1|Overall Study|Stopped at end of core|0
1539166|NCT00171210|5037789|P2|Overall Study|Death|3
1539167|NCT00171210|5037790|P1|Overall Study|Death|2
1539168|NCT00171210|5037789|P2|Overall Study|Administrative problems|1
1539169|NCT00171210|5037790|P1|Overall Study|Administrative problems|1
1539170|NCT00171210|5037789|P2|Overall Study|Lost to Follow-up|0
1539171|NCT00171210|5037790|P1|Overall Study|Lost to Follow-up|1
1539172|NCT00171210|5037789|P2|Overall Study|Withdrawal by Subject|30
1539173|NCT00171210|5037790|P1|Overall Study|Withdrawal by Subject|32
1539174|NCT00171210|5037789|P2|Overall Study|Protocol Violation|2
1539175|NCT00171210|5037790|P1|Overall Study|Protocol Violation|0
1539176|NCT00171210|5037789|P2|Overall Study|Unsatisfactory therapeutic effect|15
1539177|NCT00171210|5037790|P1|Overall Study|Unsatisfactory therapeutic effect|11
1539178|NCT00171210|5037789|P2|Overall Study|Abnormal test procedure result(s)|1
1539179|NCT00171210|5037790|P1|Overall Study|Abnormal test procedure result(s)|0
1539180|NCT00171210|5037789|P2|Overall Study|Abnormal laboratory value(s)|3
1539181|NCT00171210|5037790|P1|Overall Study|Abnormal laboratory value(s)|6
1539182|NCT00171210|5037789|P2|Overall Study|Adverse Event|27
1539183|NCT00171210|5037790|P1|Overall Study|Adverse Event|16
1539184|NCT00171054|5037820|P2|Overall Study|Condition no longer required study drug|1
1539185|NCT00171054|5037821|P1|Overall Study|Condition no longer required study drug|0
1539186|NCT00171054|5037820|P2|Overall Study|Adverse Event|8
1539187|NCT00171054|5037821|P1|Overall Study|Adverse Event|8
1539188|NCT00171054|5037820|P2|Overall Study|Lost to Follow-up|1
1539189|NCT00171054|5037821|P1|Overall Study|Lost to Follow-up|0
1539190|NCT00171054|5037820|P2|Overall Study|Patient withdrew consent|0
1539191|NCT00171054|5037821|P1|Overall Study|Patient withdrew consent|1
1539192|NCT00171054|5037820|P2|Overall Study|Protocol Violation|2
1539193|NCT00171054|5037821|P1|Overall Study|Protocol Violation|1
1539194|NCT00170950|5037853|P2|Overall Study|Termination Data Not Recorded|22
1539195|NCT00170950|5037854|P1|Overall Study|Termination Data Not Recorded|17
1539196|NCT00170950|5037853|P2|Overall Study|Missing|1
1539197|NCT00170950|5037854|P1|Overall Study|Missing|2
1539198|NCT00170950|5037853|P2|Overall Study|Lost to Follow-up|115
1539199|NCT00170950|5037854|P1|Overall Study|Lost to Follow-up|134
1539200|NCT00170950|5037853|P2|Overall Study|Withdrawal by Subject|498
1539201|NCT00170950|5037854|P1|Overall Study|Withdrawal by Subject|496
1539202|NCT00170950|5037853|P2|Overall Study|Death|274
1539203|NCT00170950|5037854|P1|Overall Study|Death|236
1539204|NCT00170846|5037867|P3|Overall Study|Reason Missing|0
1539205|NCT00170846|5037868|P2|Overall Study|Reason Missing|1
1539206|NCT00170846|5037869|P1|Overall Study|Reason Missing|0
1539207|NCT00170846|5037867|P3|Overall Study|Death|3
1539208|NCT00170846|5037868|P2|Overall Study|Death|3
1539209|NCT00170846|5037869|P1|Overall Study|Death|0
1539210|NCT00170846|5037867|P3|Overall Study|Lost to Follow-up|2
1539211|NCT00170846|5037868|P2|Overall Study|Lost to Follow-up|3
1539212|NCT00170846|5037869|P1|Overall Study|Lost to Follow-up|6
1539213|NCT00170846|5037867|P3|Overall Study|Subject withdrew Informed Consent|8
1539214|NCT00170846|5037868|P2|Overall Study|Subject withdrew Informed Consent|12
1539215|NCT00170846|5037869|P1|Overall Study|Subject withdrew Informed Consent|5
1539216|NCT00169442|5037901|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
1539217|NCT00169442|5037902|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
1539218|NCT00169442|5037903|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
1539219|NCT00169442|5037904|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
1539220|NCT00169442|5037905|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
1539221|NCT00169442|5037906|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
1539222|NCT00169442|5037901|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
1539223|NCT00169442|5037902|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
1539224|NCT00169442|5037903|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
1539225|NCT00169442|5037904|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
1539226|NCT00169442|5037905|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
1539227|NCT00169442|5037906|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
1539228|NCT00169442|5037901|P6|Overall Study|Migrated/moved from study area|2
1539229|NCT00169442|5037902|P5|Overall Study|Migrated/moved from study area|0
1539230|NCT00169442|5037903|P4|Overall Study|Migrated/moved from study area|0
1539231|NCT00169442|5037904|P3|Overall Study|Migrated/moved from study area|0
1539232|NCT00169442|5037905|P2|Overall Study|Migrated/moved from study area|0
1539233|NCT00169442|5037906|P1|Overall Study|Migrated/moved from study area|0
1539234|NCT00169442|5037901|P6|Overall Study|Withdrawal by Subject|0
1539235|NCT00169442|5037902|P5|Overall Study|Withdrawal by Subject|0
1539236|NCT00169442|5037903|P4|Overall Study|Withdrawal by Subject|0
1539237|NCT00169442|5037904|P3|Overall Study|Withdrawal by Subject|1
1539238|NCT00169442|5037905|P2|Overall Study|Withdrawal by Subject|0
1539239|NCT00169442|5037906|P1|Overall Study|Withdrawal by Subject|0
1539240|NCT00169104|5038015|P2|Overall Study|Physician Decision|1
1539241|NCT00169104|5038016|P1|Overall Study|Physician Decision|0
1539242|NCT00169104|5038015|P2|Overall Study|Protocol Violation|1
1539243|NCT00169104|5038016|P1|Overall Study|Protocol Violation|0
1539244|NCT00169104|5038015|P2|Overall Study|Withdrawal by Subject|0
1539245|NCT00169104|5038016|P1|Overall Study|Withdrawal by Subject|2
1539246|NCT00168844|5038030|P3|Overall Study|Other|9
1539247|NCT00168844|5038031|P2|Overall Study|Other|7
1539248|NCT00168844|5038032|P1|Overall Study|Other|6
1539249|NCT00168844|5038030|P3|Overall Study|Protocol Violation|4
1539250|NCT00168844|5038031|P2|Overall Study|Protocol Violation|2
1539251|NCT00168844|5038032|P1|Overall Study|Protocol Violation|2
1539252|NCT00168844|5038030|P3|Overall Study|Withdrawal by Subject|19
1539253|NCT00168844|5038031|P2|Overall Study|Withdrawal by Subject|9
1539254|NCT00168844|5038032|P1|Overall Study|Withdrawal by Subject|12
1539255|NCT00168844|5038030|P3|Overall Study|Lost to Follow-up|11
1539256|NCT00168844|5038031|P2|Overall Study|Lost to Follow-up|5
1539257|NCT00168844|5038032|P1|Overall Study|Lost to Follow-up|4
1539258|NCT00168844|5038030|P3|Overall Study|Adverse Event|48
1539259|NCT00168844|5038031|P2|Overall Study|Adverse Event|32
1539260|NCT00168844|5038032|P1|Overall Study|Adverse Event|31
1539261|NCT00168831|5038214|P3|Overall Study|Other|6
1539262|NCT00168831|5038215|P2|Overall Study|Other|3
1539263|NCT00168831|5038216|P1|Overall Study|Other|6
1539264|NCT00168831|5038214|P3|Overall Study|Protocol Violation|11
1539265|NCT00168831|5038215|P2|Overall Study|Protocol Violation|11
1539266|NCT00168831|5038216|P1|Overall Study|Protocol Violation|6
1539267|NCT00168831|5038214|P3|Overall Study|Withdrawal by Subject|19
1539268|NCT00168831|5038215|P2|Overall Study|Withdrawal by Subject|14
1539269|NCT00168831|5038216|P1|Overall Study|Withdrawal by Subject|7
1539270|NCT00168831|5038214|P3|Overall Study|Lost to Follow-up|4
1539271|NCT00168831|5038215|P2|Overall Study|Lost to Follow-up|6
1539272|NCT00168831|5038216|P1|Overall Study|Lost to Follow-up|5
1539273|NCT00168831|5038214|P3|Overall Study|Adverse Event|74
1539274|NCT00168831|5038215|P2|Overall Study|Adverse Event|47
1539275|NCT00168831|5038216|P1|Overall Study|Adverse Event|36
1539276|NCT00168818|5038398|P3|Treatment|not specified|31
1539277|NCT00168818|5038399|P2|Treatment|not specified|29
1539278|NCT00168818|5038400|P1|Treatment|not specified|23
1539279|NCT00168818|5038398|P3|Treatment|Withdrawal by Subject|22
1539280|NCT00168818|5038399|P2|Treatment|Withdrawal by Subject|20
1539281|NCT00168818|5038400|P1|Treatment|Withdrawal by Subject|25
1539282|NCT00168818|5038398|P3|Treatment|Lost to Follow-up|1
1539283|NCT00168818|5038399|P2|Treatment|Lost to Follow-up|2
1539284|NCT00168818|5038400|P1|Treatment|Lost to Follow-up|0
1539285|NCT00168818|5038398|P3|Treatment|Protocol Violation|11
1539286|NCT00168818|5038399|P2|Treatment|Protocol Violation|11
1539287|NCT00168818|5038400|P1|Treatment|Protocol Violation|8
1539288|NCT00168818|5038398|P3|Treatment|Adverse Event|68
1539289|NCT00168818|5038399|P2|Treatment|Adverse Event|89
1539290|NCT00168818|5038400|P1|Treatment|Adverse Event|77
1539291|NCT00168818|5038398|P3|Overall Study|not specified|30
1539292|NCT00168818|5038399|P2|Overall Study|not specified|24
1539293|NCT00168818|5038400|P1|Overall Study|not specified|22
1539294|NCT00168818|5038398|P3|Overall Study|Withdrawal by Subject|37
1539295|NCT00168818|5038399|P2|Overall Study|Withdrawal by Subject|41
1539296|NCT00168818|5038400|P1|Overall Study|Withdrawal by Subject|43
1539297|NCT00168818|5038398|P3|Overall Study|Lost to Follow-up|15
1539298|NCT00168818|5038399|P2|Overall Study|Lost to Follow-up|4
1539299|NCT00168818|5038400|P1|Overall Study|Lost to Follow-up|13
1539300|NCT00168818|5038398|P3|Overall Study|Protocol Violation|11
1539301|NCT00168818|5038399|P2|Overall Study|Protocol Violation|11
1539302|NCT00168818|5038400|P1|Overall Study|Protocol Violation|16
1539303|NCT00168818|5038398|P3|Overall Study|Adverse Event|31
1539304|NCT00168818|5038399|P2|Overall Study|Adverse Event|29
1539305|NCT00168818|5038400|P1|Overall Study|Adverse Event|23
1539306|NCT00168805|5038444|P3|Treatment|not specified|17
1539307|NCT00168805|5038445|P2|Treatment|not specified|18
1539308|NCT00168805|5038446|P1|Treatment|not specified|18
1539309|NCT00168805|5038444|P3|Treatment|Withdrawal by Subject|8
1539310|NCT00168805|5038445|P2|Treatment|Withdrawal by Subject|7
1539311|NCT00168805|5038446|P1|Treatment|Withdrawal by Subject|3
1539312|NCT00168805|5038444|P3|Treatment|Protocol Violation|5
1539313|NCT00168805|5038445|P2|Treatment|Protocol Violation|5
1539314|NCT00168805|5038446|P1|Treatment|Protocol Violation|3
1539315|NCT00168805|5038444|P3|Treatment|Adverse Event|32
1539316|NCT00168805|5038445|P2|Treatment|Adverse Event|26
1539317|NCT00168805|5038446|P1|Treatment|Adverse Event|25
1539318|NCT00168805|5038444|P3|Overall Study|not specified|22
1539319|NCT00168805|5038445|P2|Overall Study|not specified|21
1539320|NCT00168805|5038446|P1|Overall Study|not specified|24
1539321|NCT00168805|5038444|P3|Overall Study|Withdrawal by Subject|21
1539322|NCT00168805|5038445|P2|Overall Study|Withdrawal by Subject|18
1539323|NCT00168805|5038446|P1|Overall Study|Withdrawal by Subject|16
1539324|NCT00168805|5038444|P3|Overall Study|Lost to Follow-up|11
1539325|NCT00168805|5038445|P2|Overall Study|Lost to Follow-up|17
1539326|NCT00168805|5038446|P1|Overall Study|Lost to Follow-up|12
1539327|NCT00168805|5038444|P3|Overall Study|Protocol Violation|8
1539328|NCT00168805|5038445|P2|Overall Study|Protocol Violation|11
1539329|NCT00168805|5038446|P1|Overall Study|Protocol Violation|12
1539330|NCT00168805|5038444|P3|Overall Study|Adverse Event|16
1539331|NCT00168805|5038445|P2|Overall Study|Adverse Event|11
1539332|NCT00168805|5038446|P1|Overall Study|Adverse Event|7
1539333|NCT00168103|5038682|P4|Overall Study|Lost to Follow-up|0
1539334|NCT00168103|5038683|P3|Overall Study|Lost to Follow-up|0
1539335|NCT00168103|5038684|P2|Overall Study|Lost to Follow-up|3
1539336|NCT00168103|5038685|P1|Overall Study|Lost to Follow-up|1
1539337|NCT00168103|5038682|P4|Overall Study|Withdrawal by Subject|0
1539338|NCT00168103|5038683|P3|Overall Study|Withdrawal by Subject|1
1539339|NCT00168103|5038684|P2|Overall Study|Withdrawal by Subject|2
1539340|NCT00168103|5038685|P1|Overall Study|Withdrawal by Subject|1
1539341|NCT00168064|5038707|P2|Overall Study|Various|3
1539342|NCT00168064|5038708|P1|Overall Study|Various|4
1539343|NCT00168064|5038707|P2|Overall Study|Subject's Best interest|2
1539344|NCT00168064|5038708|P1|Overall Study|Subject's Best interest|2
1539345|NCT00168064|5038707|P2|Overall Study|Concurrent Illness|3
1539346|NCT00168064|5038708|P1|Overall Study|Concurrent Illness|4
1539347|NCT00168064|5038707|P2|Overall Study|Non-compliance|3
1539348|NCT00168064|5038708|P1|Overall Study|Non-compliance|2
1539349|NCT00168064|5038707|P2|Overall Study|Lost to Follow-up|3
1539350|NCT00168064|5038708|P1|Overall Study|Lost to Follow-up|4
1539351|NCT00168064|5038707|P2|Overall Study|Lack of Efficacy|4
1539352|NCT00168064|5038708|P1|Overall Study|Lack of Efficacy|4
1539353|NCT00168064|5038707|P2|Overall Study|Withdrawal by Subject|4
1539354|NCT00168064|5038708|P1|Overall Study|Withdrawal by Subject|3
1539355|NCT00168064|5038707|P2|Overall Study|Adverse Event|22
1539356|NCT00168064|5038708|P1|Overall Study|Adverse Event|26
1539357|NCT00168038|5038716|P1|Overall Study|Therapy failure|1
1539358|NCT00168038|5038716|P1|Overall Study|Adverse Event|1
1539359|NCT00167778|5038728|P1|Overall Study|Withdrawal by Subject|1
1539360|NCT00167414|5038794|P1|Overall Study|Death|10
1539361|NCT00167310|5038819|P2|Overall Study|Withdrawal by Subject|7
1539362|NCT00167310|5038820|P1|Overall Study|Withdrawal by Subject|3
1539363|NCT00167310|5038819|P2|Overall Study|Protocol Violation|3
1539364|NCT00167310|5038820|P1|Overall Study|Protocol Violation|5
1539365|NCT00167245|5038830|P2|Overall Study|Drowsy|0
1539366|NCT00167245|5038831|P1|Overall Study|Drowsy|1
1539367|NCT00167245|5038830|P2|Overall Study|Incarcerated|2
1539368|NCT00167245|5038831|P1|Overall Study|Incarcerated|3
1539369|NCT00167245|5038830|P2|Overall Study|Withdrawal by Subject|8
1539370|NCT00167245|5038831|P1|Overall Study|Withdrawal by Subject|5
1539371|NCT00167245|5038830|P2|Overall Study|Lost to Follow-up|31
1539372|NCT00167245|5038831|P1|Overall Study|Lost to Follow-up|20
1539373|NCT00166712|5038881|P2|Overall Study|Physician Decision|2
1539374|NCT00166712|5038882|P1|Overall Study|Physician Decision|0
1539375|NCT00166712|5038881|P2|Overall Study|Withdrawal by Subject|2
1539376|NCT00166712|5038882|P1|Overall Study|Withdrawal by Subject|1
1539377|NCT00166712|5038881|P2|Overall Study|Adverse Event|0
1539378|NCT00166712|5038882|P1|Overall Study|Adverse Event|1
1539379|NCT00166712|5038881|P2|Overall Study|Death|1
1539380|NCT00166712|5038882|P1|Overall Study|Death|0
1539381|NCT00166517|5038899|P2|Overall Study|Withdrawal by Subject|1
1539382|NCT00166517|5038900|P1|Overall Study|Withdrawal by Subject|0
1539383|NCT00166517|5038899|P2|Overall Study|Protocol Violation|1
1539384|NCT00166517|5038900|P1|Overall Study|Protocol Violation|4
1539385|NCT00166517|5038899|P2|Overall Study|Lost to Follow-up|0
1539386|NCT00166517|5038900|P1|Overall Study|Lost to Follow-up|1
1539387|NCT00166504|5038910|P2|Overall Study|Withdrawal by Subject|0
1539388|NCT00166504|5038911|P1|Overall Study|Withdrawal by Subject|1
1539389|NCT00166504|5038910|P2|Overall Study|Lost to Follow-up|1
1539390|NCT00166504|5038911|P1|Overall Study|Lost to Follow-up|1
1539391|NCT00166504|5038910|P2|Overall Study|Adverse Event|3
1539392|NCT00166504|5038911|P1|Overall Study|Adverse Event|3
1539393|NCT00166296|5038928|P2|Overall Study|Lost to Follow-up|2
1539394|NCT00166296|5038929|P1|Overall Study|Lost to Follow-up|4
1539395|NCT00166296|5038928|P2|Overall Study|Adverse Event|4
1539396|NCT00166296|5038929|P1|Overall Study|Adverse Event|2
1539397|NCT00166296|5038928|P2|Overall Study|Withdrawal by Subject|3
1539398|NCT00166296|5038929|P1|Overall Study|Withdrawal by Subject|1
1539399|NCT00166114|5038981|P2|Overall Study|Adverse Event|1
1539400|NCT00166114|5038982|P1|Overall Study|Adverse Event|2
1539401|NCT00166114|5038981|P2|Overall Study|Withdrawal by Subject|4
1539402|NCT00166114|5038982|P1|Overall Study|Withdrawal by Subject|10
1539403|NCT00166114|5038981|P2|Overall Study|Protocol Violation|1
1539404|NCT00166114|5038982|P1|Overall Study|Protocol Violation|2
1539405|NCT00165984|5038999|P1|Overall Study|Death|15
1539406|NCT00165841|5039017|P2|Overall Study|Medication Noncompliance|1
1539407|NCT00165841|5039018|P1|Overall Study|Medication Noncompliance|1
1539408|NCT00165841|5039017|P2|Overall Study|Other|5
1539409|NCT00165841|5039018|P1|Overall Study|Other|3
1539410|NCT00165841|5039017|P2|Overall Study|Protocol Violation|8
1539411|NCT00165841|5039018|P1|Overall Study|Protocol Violation|6
1539412|NCT00165841|5039017|P2|Overall Study|Physician Decision|0
1539413|NCT00165841|5039018|P1|Overall Study|Physician Decision|1
1539414|NCT00165841|5039017|P2|Overall Study|Withdrawal by Subject|8
1539415|NCT00165841|5039018|P1|Overall Study|Withdrawal by Subject|7
1539416|NCT00165841|5039017|P2|Overall Study|Lost to Follow-up|4
1539417|NCT00165841|5039018|P1|Overall Study|Lost to Follow-up|4
1539418|NCT00165841|5039017|P2|Overall Study|Lack of Efficacy|33
1539419|NCT00165841|5039018|P1|Overall Study|Lack of Efficacy|6
1539420|NCT00165841|5039017|P2|Overall Study|Adverse Event|3
1539421|NCT00165841|5039018|P1|Overall Study|Adverse Event|2
1539422|NCT00165789|5039028|P4|Overall Study|Withdrawal by Subject|2
1539423|NCT00165789|5039029|P3|Overall Study|Withdrawal by Subject|1
1539424|NCT00165789|5039030|P2|Overall Study|Withdrawal by Subject|1
1539425|NCT00165789|5039031|P1|Overall Study|Withdrawal by Subject|0
1539426|NCT00165789|5039028|P4|Overall Study|Adverse Event|12
1539427|NCT00165789|5039029|P3|Overall Study|Adverse Event|0
1539428|NCT00165789|5039030|P2|Overall Study|Adverse Event|3
1539429|NCT00165789|5039031|P1|Overall Study|Adverse Event|0
1539430|NCT00165776|5039085|P4|Overall Study|Worsening of Cervical Dystonia|1
1539431|NCT00165776|5039086|P3|Overall Study|Worsening of Cervical Dystonia|0
1539432|NCT00165776|5039087|P2|Overall Study|Worsening of Cervical Dystonia|0
1539433|NCT00165776|5039088|P1|Overall Study|Worsening of Cervical Dystonia|0
1539434|NCT00165776|5039085|P4|Overall Study|Withdrawal by Subject|0
1539435|NCT00165776|5039086|P3|Overall Study|Withdrawal by Subject|2
1539436|NCT00165776|5039087|P2|Overall Study|Withdrawal by Subject|1
1539437|NCT00165776|5039088|P1|Overall Study|Withdrawal by Subject|4
1539438|NCT00165776|5039085|P4|Overall Study|Lack of Efficacy|1
1539439|NCT00165776|5039086|P3|Overall Study|Lack of Efficacy|0
1539440|NCT00165776|5039087|P2|Overall Study|Lack of Efficacy|0
1539441|NCT00165776|5039088|P1|Overall Study|Lack of Efficacy|0
1539442|NCT00165698|5039124|P2|Overall Study|Not Taken/Lost the medicine|2
1539443|NCT00165698|5039125|P1|Overall Study|Not Taken/Lost the medicine|1
1539444|NCT00165698|5039124|P2|Overall Study|Protocol Violation|0
1539445|NCT00165698|5039125|P1|Overall Study|Protocol Violation|1
1539446|NCT00165698|5039124|P2|Overall Study|Withdrawal by Subject|1
1539447|NCT00165698|5039125|P1|Overall Study|Withdrawal by Subject|2
1539448|NCT00165698|5039124|P2|Overall Study|Lost to Follow-up|2
1539449|NCT00165698|5039125|P1|Overall Study|Lost to Follow-up|2
1539450|NCT00165698|5039124|P2|Overall Study|Adverse Event|10
1539451|NCT00165698|5039125|P1|Overall Study|Adverse Event|2
1539452|NCT00165672|5039151|P2|Overall Study|Adverse Event|1
1539453|NCT00165672|5039152|P1|Overall Study|Adverse Event|0
1539454|NCT00165646|5039161|P3|Overall Study|Protocol Violation|0
1539455|NCT00165646|5039162|P2|Overall Study|Protocol Violation|0
1539456|NCT00165646|5039163|P1|Overall Study|Protocol Violation|1
1539457|NCT00165646|5039161|P3|Overall Study|Physician Decision|2
1539458|NCT00165646|5039162|P2|Overall Study|Physician Decision|0
1539459|NCT00165646|5039163|P1|Overall Study|Physician Decision|2
1539460|NCT00165646|5039161|P3|Overall Study|Withdrawal by Subject|1
1539461|NCT00165646|5039162|P2|Overall Study|Withdrawal by Subject|2
1539462|NCT00165646|5039163|P1|Overall Study|Withdrawal by Subject|0
1539463|NCT00165646|5039161|P3|Overall Study|Lack of Efficacy|0
1539464|NCT00165646|5039162|P2|Overall Study|Lack of Efficacy|2
1539465|NCT00165646|5039163|P1|Overall Study|Lack of Efficacy|1
1539466|NCT00165646|5039161|P3|Overall Study|Adverse Event|1
1539467|NCT00165646|5039162|P2|Overall Study|Adverse Event|1
1539468|NCT00165646|5039163|P1|Overall Study|Adverse Event|1
1539469|NCT00165503|5039171|P1|Overall Study|Unresectable|3
1539470|NCT00165503|5039171|P1|Overall Study|Lost to Follow-up|12
1539471|NCT00165503|5039171|P1|Overall Study|Death|1
1539472|NCT00163657|5039178|P3|Overall Study|Other reason|3
1539473|NCT00163657|5039179|P2|Overall Study|Other reason|1
1539474|NCT00163657|5039180|P1|Overall Study|Other reason|0
1539475|NCT00163657|5039178|P3|Overall Study|Lost to Follow-up|10
1539476|NCT00163657|5039179|P2|Overall Study|Lost to Follow-up|3
1539477|NCT00163657|5039180|P1|Overall Study|Lost to Follow-up|1
1539478|NCT00163657|5039178|P3|Overall Study|Non Compliance|0
1539479|NCT00163657|5039179|P2|Overall Study|Non Compliance|0
1539480|NCT00163657|5039180|P1|Overall Study|Non Compliance|1
1539481|NCT00163657|5039178|P3|Overall Study|Physician Decision|1
1539482|NCT00163657|5039179|P2|Overall Study|Physician Decision|1
1539483|NCT00163657|5039180|P1|Overall Study|Physician Decision|0
1539484|NCT00163657|5039178|P3|Overall Study|Withdrawal by Subject|2
1539485|NCT00163657|5039179|P2|Overall Study|Withdrawal by Subject|3
1539486|NCT00163657|5039180|P1|Overall Study|Withdrawal by Subject|2
1539487|NCT00163657|5039178|P3|Overall Study|graft loss|2
1539488|NCT00163657|5039179|P2|Overall Study|graft loss|1
1539489|NCT00163657|5039180|P1|Overall Study|graft loss|4
1539490|NCT00163657|5039178|P3|Overall Study|Death|19
1539491|NCT00163657|5039179|P2|Overall Study|Death|14
1539492|NCT00163657|5039180|P1|Overall Study|Death|12
1539493|NCT00163215|5039270|P1|Overall Study|Other|7
1539494|NCT00163215|5039270|P1|Overall Study|Withdrawal by Subject|5
1539495|NCT00163215|5039270|P1|Overall Study|Lack of Efficacy|3
1539496|NCT00163189|5039290|P1|Overall Study|Did not meet continuation criterion|16
1539497|NCT00163189|5039290|P1|Overall Study|Withdrawal by Subject|11
1539498|NCT00163189|5039290|P1|Overall Study|Study terminated by sponsor|11
1539499|NCT00163189|5039290|P1|Overall Study|Lack of Efficacy|7
1539500|NCT00163189|5039290|P1|Overall Study|Adverse Event|6
1539501|NCT00163189|5039290|P1|Overall Study|Death|3
1539502|NCT00163189|5039290|P1|Overall Study|Protocol Violation|2
1539503|NCT00163189|5039290|P1|Overall Study|Lost to Follow-up|1
1539504|NCT00163189|5039290|P1|Overall Study|Other|6
1539505|NCT00163020|5039314|P2|Overall Study|Lost to Follow-up|2
1539506|NCT00163020|5039315|P1|Overall Study|Lost to Follow-up|0
1539507|NCT00162981|5039355|P2|Overall Study|Physician Decision|0
1539508|NCT00162981|5039356|P1|Overall Study|Physician Decision|1
1539509|NCT00162981|5039355|P2|Overall Study|Withdrawal by Subject|1
1539510|NCT00162981|5039356|P1|Overall Study|Withdrawal by Subject|1
1539511|NCT00162981|5039355|P2|Overall Study|Adverse Event|5
1539512|NCT00162981|5039356|P1|Overall Study|Adverse Event|2
1539513|NCT00162942|5039372|P2|Overall Study|2 or more consecutive treatments missed|0
1539514|NCT00162942|5039373|P1|Overall Study|2 or more consecutive treatments missed|1
1539515|NCT00162942|5039372|P2|Overall Study|Flare During Active Treatment|3
1539516|NCT00162942|5039373|P1|Overall Study|Flare During Active Treatment|7
1539517|NCT00162942|5039372|P2|Overall Study|Lack of Efficacy|0
1539518|NCT00162942|5039373|P1|Overall Study|Lack of Efficacy|1
1539519|NCT00162942|5039372|P2|Overall Study|Alternate Therapy|2
1539520|NCT00162942|5039373|P1|Overall Study|Alternate Therapy|6
1539521|NCT00162942|5039372|P2|Overall Study|Enter Open-Label Study|35
1539522|NCT00162942|5039373|P1|Overall Study|Enter Open-Label Study|76
1539523|NCT00162942|5039372|P2|Overall Study|Physician Decision|0
1539524|NCT00162942|5039373|P1|Overall Study|Physician Decision|1
1539525|NCT00162942|5039372|P2|Overall Study|Withdrawal by Subject|6
1539526|NCT00162942|5039373|P1|Overall Study|Withdrawal by Subject|3
1539527|NCT00162942|5039372|P2|Overall Study|Death|0
1539528|NCT00162942|5039373|P1|Overall Study|Death|1
1539529|NCT00162942|5039372|P2|Overall Study|Adverse Event|6
1539530|NCT00162942|5039373|P1|Overall Study|Adverse Event|10
1539531|NCT00162773|5039421|P1|Overall Study|P.I, Left institution. Study terminated|22
1539532|NCT00162370|5039425|P1|Efficacy Population|Lost to Follow-up|51
1539533|NCT00162266|5039433|P4|Open-Label Period|Other Reasons|15
1539534|NCT00162266|5039434|P3|Open-Label Period|Other Reasons|0
1539535|NCT00162266|5039435|P2|Open-Label Period|Other Reasons|0
1539536|NCT00162266|5039436|P1|Open-Label Period|Other Reasons|0
1539537|NCT00162266|5039433|P4|Open-Label Period|Administrative Reason By Sponsor|9
1539538|NCT00162266|5039434|P3|Open-Label Period|Administrative Reason By Sponsor|0
1539539|NCT00162266|5039435|P2|Open-Label Period|Administrative Reason By Sponsor|0
1539540|NCT00162266|5039436|P1|Open-Label Period|Administrative Reason By Sponsor|0
1539541|NCT00162266|5039433|P4|Open-Label Period|Withdrawal by Subject|31
1539542|NCT00162266|5039434|P3|Open-Label Period|Withdrawal by Subject|0
1539543|NCT00162266|5039435|P2|Open-Label Period|Withdrawal by Subject|0
1539544|NCT00162266|5039436|P1|Open-Label Period|Withdrawal by Subject|0
1539545|NCT00162266|5039433|P4|Open-Label Period|Lost to Follow-up|3
1539546|NCT00162266|5039434|P3|Open-Label Period|Lost to Follow-up|0
1539547|NCT00162266|5039435|P2|Open-Label Period|Lost to Follow-up|0
1539548|NCT00162266|5039436|P1|Open-Label Period|Lost to Follow-up|0
1539549|NCT00162266|5039433|P4|Open-Label Period|Lack of Efficacy|26
1539550|NCT00162266|5039434|P3|Open-Label Period|Lack of Efficacy|0
1539551|NCT00162266|5039435|P2|Open-Label Period|Lack of Efficacy|0
1539552|NCT00162266|5039436|P1|Open-Label Period|Lack of Efficacy|0
1539553|NCT00162266|5039433|P4|Open-Label Period|Adverse Event|46
1539554|NCT00162266|5039434|P3|Open-Label Period|Adverse Event|0
1539555|NCT00162266|5039435|P2|Open-Label Period|Adverse Event|0
1539556|NCT00162266|5039436|P1|Open-Label Period|Adverse Event|0
1539557|NCT00162266|5039433|P4|Open-Label Period|Death|7
1539558|NCT00162266|5039434|P3|Open-Label Period|Death|0
1539559|NCT00162266|5039435|P2|Open-Label Period|Death|0
1539560|NCT00162266|5039436|P1|Open-Label Period|Death|0
1539561|NCT00162266|5039433|P4|Double-Blind Period|Withdrawal by Subject|0
1539562|NCT00162266|5039434|P3|Double-Blind Period|Withdrawal by Subject|6
1539563|NCT00162266|5039435|P2|Double-Blind Period|Withdrawal by Subject|2
1539564|NCT00162266|5039436|P1|Double-Blind Period|Withdrawal by Subject|5
1539565|NCT00162266|5039433|P4|Double-Blind Period|Lack of Efficacy|0
1539566|NCT00162266|5039434|P3|Double-Blind Period|Lack of Efficacy|30
1539567|NCT00162266|5039435|P2|Double-Blind Period|Lack of Efficacy|17
1539568|NCT00162266|5039436|P1|Double-Blind Period|Lack of Efficacy|13
1539569|NCT00162266|5039433|P4|Double-Blind Period|Other Reason|0
1539570|NCT00162266|5039434|P3|Double-Blind Period|Other Reason|1
1539571|NCT00162266|5039435|P2|Double-Blind Period|Other Reason|0
1539572|NCT00162266|5039436|P1|Double-Blind Period|Other Reason|1
1539573|NCT00162266|5039433|P4|Double-Blind Period|Lost to Follow-up|0
1539574|NCT00162266|5039434|P3|Double-Blind Period|Lost to Follow-up|0
1539575|NCT00162266|5039435|P2|Double-Blind Period|Lost to Follow-up|2
1539576|NCT00162266|5039436|P1|Double-Blind Period|Lost to Follow-up|1
1539577|NCT00162266|5039433|P4|Double-Blind Period|Death|0
1539578|NCT00162266|5039434|P3|Double-Blind Period|Death|0
1539579|NCT00162266|5039435|P2|Double-Blind Period|Death|1
1539580|NCT00162266|5039436|P1|Double-Blind Period|Death|0
1539581|NCT00162266|5039433|P4|Double-Blind Period|Adverse Event|0
1539582|NCT00162266|5039434|P3|Double-Blind Period|Adverse Event|11
1539583|NCT00162266|5039435|P2|Double-Blind Period|Adverse Event|9
1539584|NCT00162266|5039436|P1|Double-Blind Period|Adverse Event|5
1539585|NCT00162136|5039637|P1|Overall Study|Withdrawal by Subject|1
1539586|NCT00162136|5039637|P1|Overall Study|Study Drug Toxicity|4
1539587|NCT00162136|5039637|P1|Overall Study|Investigator Request|5
1539588|NCT00162136|5039637|P1|Overall Study|Disease Progression/Relapse|23
1539589|NCT00162136|5039637|P1|Overall Study|Death|1
1539590|NCT00162136|5039637|P1|Overall Study|Adverse Event|1
1539591|NCT00162123|5039669|P8|Overall Study|Follow-up only (not treated or assessed)|57
1539592|NCT00162123|5039670|P7|Overall Study|Follow-up only (not treated or assessed)|0
1539593|NCT00162123|5039671|P6|Overall Study|Follow-up only (not treated or assessed)|0
1539594|NCT00162123|5039672|P5|Overall Study|Follow-up only (not treated or assessed)|0
1539595|NCT00162123|5039673|P4|Overall Study|Follow-up only (not treated or assessed)|0
1539596|NCT00162123|5039674|P3|Overall Study|Follow-up only (not treated or assessed)|0
1539597|NCT00162123|5039675|P2|Overall Study|Follow-up only (not treated or assessed)|0
1539598|NCT00162123|5039676|P1|Overall Study|Follow-up only (not treated or assessed)|0
1539599|NCT00162123|5039669|P8|Overall Study|Tumor assessment only (not treated)|1
1539600|NCT00162123|5039670|P7|Overall Study|Tumor assessment only (not treated)|0
1539601|NCT00162123|5039671|P6|Overall Study|Tumor assessment only (not treated)|0
1539602|NCT00162123|5039672|P5|Overall Study|Tumor assessment only (not treated)|0
1539603|NCT00162123|5039673|P4|Overall Study|Tumor assessment only (not treated)|0
1539604|NCT00162123|5039674|P3|Overall Study|Tumor assessment only (not treated)|0
1539605|NCT00162123|5039675|P2|Overall Study|Tumor assessment only (not treated)|0
1539606|NCT00162123|5039676|P1|Overall Study|Tumor assessment only (not treated)|0
1539607|NCT00162123|5039669|P8|Overall Study|Physician Decision|0
1539608|NCT00162123|5039670|P7|Overall Study|Physician Decision|1
1539609|NCT00162123|5039671|P6|Overall Study|Physician Decision|1
1539610|NCT00162123|5039672|P5|Overall Study|Physician Decision|0
1539611|NCT00162123|5039673|P4|Overall Study|Physician Decision|0
1539612|NCT00162123|5039674|P3|Overall Study|Physician Decision|0
1539613|NCT00162123|5039675|P2|Overall Study|Physician Decision|2
1539614|NCT00162123|5039676|P1|Overall Study|Physician Decision|1
1539615|NCT00162123|5039669|P8|Overall Study|Not specified (after start of treatment)|0
1539616|NCT00162123|5039670|P7|Overall Study|Not specified (after start of treatment)|0
1539617|NCT00162123|5039671|P6|Overall Study|Not specified (after start of treatment)|0
1539618|NCT00162123|5039672|P5|Overall Study|Not specified (after start of treatment)|3
1539619|NCT00162123|5039673|P4|Overall Study|Not specified (after start of treatment)|0
1539620|NCT00162123|5039674|P3|Overall Study|Not specified (after start of treatment)|0
1539621|NCT00162123|5039675|P2|Overall Study|Not specified (after start of treatment)|0
1539622|NCT00162123|5039676|P1|Overall Study|Not specified (after start of treatment)|0
1539623|NCT00162123|5039669|P8|Overall Study|Not specified (before treatment)|0
1539624|NCT00162123|5039670|P7|Overall Study|Not specified (before treatment)|0
1539625|NCT00162123|5039671|P6|Overall Study|Not specified (before treatment)|1
1539626|NCT00162123|5039672|P5|Overall Study|Not specified (before treatment)|12
1539627|NCT00162123|5039673|P4|Overall Study|Not specified (before treatment)|0
1539628|NCT00162123|5039674|P3|Overall Study|Not specified (before treatment)|0
1539629|NCT00162123|5039675|P2|Overall Study|Not specified (before treatment)|0
1539630|NCT00162123|5039676|P1|Overall Study|Not specified (before treatment)|2
1539631|NCT00162123|5039669|P8|Overall Study|Adverse Event|0
1539632|NCT00162123|5039670|P7|Overall Study|Adverse Event|0
1539633|NCT00162123|5039671|P6|Overall Study|Adverse Event|0
1539634|NCT00162123|5039672|P5|Overall Study|Adverse Event|1
1539635|NCT00162123|5039673|P4|Overall Study|Adverse Event|2
1539636|NCT00162123|5039674|P3|Overall Study|Adverse Event|0
1539637|NCT00162123|5039675|P2|Overall Study|Adverse Event|2
1539638|NCT00162123|5039676|P1|Overall Study|Adverse Event|1
1539639|NCT00162123|5039669|P8|Overall Study|Deterioration without progression|0
1539640|NCT00162123|5039670|P7|Overall Study|Deterioration without progression|0
1539641|NCT00162123|5039671|P6|Overall Study|Deterioration without progression|0
1539642|NCT00162123|5039672|P5|Overall Study|Deterioration without progression|1
1539643|NCT00162123|5039673|P4|Overall Study|Deterioration without progression|0
1539644|NCT00162123|5039674|P3|Overall Study|Deterioration without progression|3
1539645|NCT00162123|5039675|P2|Overall Study|Deterioration without progression|2
1539646|NCT00162123|5039676|P1|Overall Study|Deterioration without progression|2
1539647|NCT00162123|5039669|P8|Overall Study|Withdrawal by Subject|0
1539648|NCT00162123|5039670|P7|Overall Study|Withdrawal by Subject|1
1539649|NCT00162123|5039671|P6|Overall Study|Withdrawal by Subject|2
1539650|NCT00162123|5039672|P5|Overall Study|Withdrawal by Subject|1
1539651|NCT00162123|5039673|P4|Overall Study|Withdrawal by Subject|1
1539652|NCT00162123|5039674|P3|Overall Study|Withdrawal by Subject|2
1539653|NCT00162123|5039675|P2|Overall Study|Withdrawal by Subject|0
1539654|NCT00162123|5039676|P1|Overall Study|Withdrawal by Subject|2
1539655|NCT00162123|5039669|P8|Overall Study|Death|0
1539656|NCT00162123|5039670|P7|Overall Study|Death|0
1539657|NCT00162123|5039671|P6|Overall Study|Death|1
1539658|NCT00162123|5039672|P5|Overall Study|Death|1
1539659|NCT00162123|5039673|P4|Overall Study|Death|1
1539660|NCT00162123|5039674|P3|Overall Study|Death|1
1539661|NCT00162123|5039675|P2|Overall Study|Death|3
1539662|NCT00162123|5039676|P1|Overall Study|Death|3
1539663|NCT00162123|5039669|P8|Overall Study|Study drug toxicity|0
1539664|NCT00162123|5039670|P7|Overall Study|Study drug toxicity|1
1539665|NCT00162123|5039671|P6|Overall Study|Study drug toxicity|1
1539666|NCT00162123|5039672|P5|Overall Study|Study drug toxicity|4
1539667|NCT00162123|5039673|P4|Overall Study|Study drug toxicity|0
1539668|NCT00162123|5039674|P3|Overall Study|Study drug toxicity|5
1539669|NCT00162123|5039675|P2|Overall Study|Study drug toxicity|1
1539670|NCT00162123|5039676|P1|Overall Study|Study drug toxicity|6
1539671|NCT00162123|5039669|P8|Overall Study|Disease progression|0
1539672|NCT00162123|5039670|P7|Overall Study|Disease progression|1
1539673|NCT00162123|5039671|P6|Overall Study|Disease progression|3
1539674|NCT00162123|5039672|P5|Overall Study|Disease progression|8
1539675|NCT00162123|5039673|P4|Overall Study|Disease progression|4
1539676|NCT00162123|5039674|P3|Overall Study|Disease progression|10
1539677|NCT00162123|5039675|P2|Overall Study|Disease progression|19
1539678|NCT00162123|5039676|P1|Overall Study|Disease progression|27
1539679|NCT00162097|5039709|P4|Overall Study|Participant no longer met study criteria|1
1539680|NCT00162097|5039710|P3|Overall Study|Participant no longer met study criteria|0
1539681|NCT00162097|5039711|P2|Overall Study|Participant no longer met study criteria|0
1539682|NCT00162097|5039712|P1|Overall Study|Participant no longer met study criteria|0
1539683|NCT00162032|5039774|P2|Overall Study|Reason not specified|0
1539684|NCT00162032|5039775|P1|Overall Study|Reason not specified|1
1539685|NCT00162032|5039774|P2|Overall Study|Lost to Follow-up|2
1539686|NCT00162032|5039775|P1|Overall Study|Lost to Follow-up|4
1539687|NCT00161616|5039785|P2|Overall Study|Protocol deviation|0
1539688|NCT00161616|5039786|P1|Overall Study|Protocol deviation|1
1539689|NCT00161616|5039785|P2|Overall Study|Lost to Follow-up|13
1539690|NCT00161616|5039786|P1|Overall Study|Lost to Follow-up|17
1539691|NCT00161616|5039785|P2|Overall Study|Death|1
1539692|NCT00161616|5039786|P1|Overall Study|Death|1
1539693|NCT00161616|5039785|P2|Overall Study|Physician Decision|0
1539694|NCT00161616|5039786|P1|Overall Study|Physician Decision|1
1539695|NCT00161616|5039785|P2|Overall Study|Withdrawal by Subject|5
1539696|NCT00161616|5039786|P1|Overall Study|Withdrawal by Subject|6
1539697|NCT00161213|5039818|P1|Overall Study|Evaluable for toxicity but not response|1
1539698|NCT00161213|5039818|P1|Overall Study|Withdrawal by Subject|1
1539699|NCT00160706|5039825|P1|Overall Study|Other Reason|11
1539700|NCT00160706|5039825|P1|Overall Study|Lack of Efficacy and Other|1
1539701|NCT00160706|5039825|P1|Overall Study|Lack of Efficacy|42
1539702|NCT00160706|5039825|P1|Overall Study|Lost to Follow-up and Other|1
1539703|NCT00160706|5039825|P1|Overall Study|Lost to Follow-up|4
1539704|NCT00160706|5039825|P1|Overall Study|Physician Decision and Other|3
1539705|NCT00160706|5039825|P1|Overall Study|Physician Decision|10
1539706|NCT00160706|5039825|P1|Overall Study|Withdrawal by Subject and Other|12
1539707|NCT00160706|5039825|P1|Overall Study|Withdrawal by Subject|41
1539708|NCT00160706|5039825|P1|Overall Study|Protocol Violation|3
1539709|NCT00160706|5039825|P1|Overall Study|Adverse Event and Other Reason|105
1539710|NCT00160706|5039825|P1|Overall Study|Adverse Event|53
1539711|NCT00160693|5039837|P1|Overall Study|Study terminated by sponsor|15
1539712|NCT00160693|5039837|P1|Overall Study|Withdrawal by Subject|54
1539713|NCT00160693|5039837|P1|Overall Study|Lost to Follow-up|15
1539714|NCT00160693|5039837|P1|Overall Study|Protocol Violation|24
1539715|NCT00160693|5039837|P1|Overall Study|Lack of Efficacy|30
1539716|NCT00160693|5039837|P1|Overall Study|Adverse Event|97
1539717|NCT00160641|5039854|P1|Overall Study|Other|9
1539718|NCT00160641|5039854|P1|Overall Study|Protocol Violation|3
1539719|NCT00160641|5039854|P1|Overall Study|Lack of Efficacy|12
1539720|NCT00160641|5039854|P1|Overall Study|Lost to Follow-up|8
1539721|NCT00160641|5039854|P1|Overall Study|Withdrawal by Subject|87
1539722|NCT00160641|5039854|P1|Overall Study|Adverse Event|102
1539723|NCT00160563|5039888|P3|Overall Study|Missing reason|0
1539724|NCT00160563|5039889|P2|Overall Study|Missing reason|1
1539725|NCT00160563|5039890|P1|Overall Study|Missing reason|0
1539726|NCT00160563|5039888|P3|Overall Study|Other (listed in the study report)|81
1539727|NCT00160563|5039889|P2|Overall Study|Other (listed in the study report)|40
1539728|NCT00160563|5039890|P1|Overall Study|Other (listed in the study report)|48
1539729|NCT00160563|5039888|P3|Overall Study|Withdrawal by Subject|3
1539730|NCT00160563|5039889|P2|Overall Study|Withdrawal by Subject|2
1539731|NCT00160563|5039890|P1|Overall Study|Withdrawal by Subject|1
1539732|NCT00160563|5039888|P3|Overall Study|Protocol Violation|3
1539733|NCT00160563|5039889|P2|Overall Study|Protocol Violation|0
1539734|NCT00160563|5039890|P1|Overall Study|Protocol Violation|0
1539735|NCT00160563|5039888|P3|Overall Study|Lost to Follow-up|2
1539736|NCT00160563|5039889|P2|Overall Study|Lost to Follow-up|1
1539737|NCT00160563|5039890|P1|Overall Study|Lost to Follow-up|1
1539738|NCT00160563|5039888|P3|Overall Study|Adverse Event|1
1539739|NCT00160563|5039889|P2|Overall Study|Adverse Event|1
1539740|NCT00160563|5039890|P1|Overall Study|Adverse Event|1
1539741|NCT00160524|5039902|P1|Overall Study|Other|20
1539742|NCT00160524|5039902|P1|Overall Study|Lack of Efficacy and Other|1
1539743|NCT00160524|5039902|P1|Overall Study|Lack of Efficacy|21
1539744|NCT00160524|5039902|P1|Overall Study|Lost to Follow-up and Other|1
1539745|NCT00160524|5039902|P1|Overall Study|Lost to Follow-up|13
1539746|NCT00160524|5039902|P1|Overall Study|Physician Decision and Other|6
1539747|NCT00160524|5039902|P1|Overall Study|Physician Decision|27
1539748|NCT00160524|5039902|P1|Overall Study|Withdrawal by Subject and Other|17
1539749|NCT00160524|5039902|P1|Overall Study|Withdrawal by Subject|141
1539750|NCT00160524|5039902|P1|Overall Study|Protocol Violation and Other|2
1539751|NCT00160524|5039902|P1|Overall Study|Protocol Violation|16
1539752|NCT00160524|5039902|P1|Overall Study|Adverse Event and Other|94
1539753|NCT00160524|5039902|P1|Overall Study|Adverse Event|119
1539754|NCT00160251|5039919|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
1539755|NCT00160251|5039920|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1539756|NCT00160251|5039921|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1539757|NCT00160251|5039922|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1539758|NCT00160251|5039923|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1539759|NCT00160251|5039924|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1539760|NCT00160251|5039925|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1539761|NCT00160251|5039926|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1539762|NCT00160251|5039919|P8|Post-amendment 2|Lack of Efficacy|24
1539763|NCT00160251|5039920|P7|Post-amendment 2|Lack of Efficacy|0
1539764|NCT00160251|5039921|P6|Post-amendment 2|Lack of Efficacy|0
1539765|NCT00160251|5039922|P5|Post-amendment 2|Lack of Efficacy|0
1539766|NCT00160251|5039923|P4|Post-amendment 2|Lack of Efficacy|0
1539767|NCT00160251|5039924|P3|Post-amendment 2|Lack of Efficacy|0
1539768|NCT00160251|5039925|P2|Post-amendment 2|Lack of Efficacy|0
1539769|NCT00160251|5039926|P1|Post-amendment 2|Lack of Efficacy|0
1539770|NCT00160251|5039919|P8|Post-amendment 2|Adverse Event|20
1539771|NCT00160251|5039920|P7|Post-amendment 2|Adverse Event|0
1539772|NCT00160251|5039921|P6|Post-amendment 2|Adverse Event|0
1539773|NCT00160251|5039922|P5|Post-amendment 2|Adverse Event|0
1539774|NCT00160251|5039923|P4|Post-amendment 2|Adverse Event|0
1539775|NCT00160251|5039924|P3|Post-amendment 2|Adverse Event|0
1539776|NCT00160251|5039925|P2|Post-amendment 2|Adverse Event|0
1539777|NCT00160251|5039926|P1|Post-amendment 2|Adverse Event|0
1539778|NCT00160251|5039919|P8|Prior to Amendment 2|Completed Treatment Phase|0
1539779|NCT00160251|5039920|P7|Prior to Amendment 2|Completed Treatment Phase|0
1539780|NCT00160251|5039921|P6|Prior to Amendment 2|Completed Treatment Phase|23
1539781|NCT00160251|5039922|P5|Prior to Amendment 2|Completed Treatment Phase|0
1539782|NCT00160251|5039923|P4|Prior to Amendment 2|Completed Treatment Phase|0
1539783|NCT00160251|5039924|P3|Prior to Amendment 2|Completed Treatment Phase|0
1539784|NCT00160251|5039925|P2|Prior to Amendment 2|Completed Treatment Phase|0
1539785|NCT00160251|5039926|P1|Prior to Amendment 2|Completed Treatment Phase|3
1539786|NCT00160251|5039919|P8|Prior to Amendment 2|Noncompliance with protocol|0
1539787|NCT00160251|5039920|P7|Prior to Amendment 2|Noncompliance with protocol|0
1539788|NCT00160251|5039921|P6|Prior to Amendment 2|Noncompliance with protocol|0
1539789|NCT00160251|5039922|P5|Prior to Amendment 2|Noncompliance with protocol|0
1539790|NCT00160251|5039923|P4|Prior to Amendment 2|Noncompliance with protocol|0
1539791|NCT00160251|5039924|P3|Prior to Amendment 2|Noncompliance with protocol|0
1539792|NCT00160251|5039925|P2|Prior to Amendment 2|Noncompliance with protocol|0
1539793|NCT00160251|5039926|P1|Prior to Amendment 2|Noncompliance with protocol|1
1539794|NCT00160251|5039919|P8|Prior to Amendment 2|Withdrawal by Subject|0
1539795|NCT00160251|5039920|P7|Prior to Amendment 2|Withdrawal by Subject|3
1539796|NCT00160251|5039921|P6|Prior to Amendment 2|Withdrawal by Subject|3
1539797|NCT00160251|5039922|P5|Prior to Amendment 2|Withdrawal by Subject|2
1539798|NCT00160251|5039923|P4|Prior to Amendment 2|Withdrawal by Subject|4
1539799|NCT00160251|5039924|P3|Prior to Amendment 2|Withdrawal by Subject|3
1539800|NCT00160251|5039925|P2|Prior to Amendment 2|Withdrawal by Subject|1
1539801|NCT00160251|5039926|P1|Prior to Amendment 2|Withdrawal by Subject|3
1539802|NCT00160251|5039919|P8|Prior to Amendment 2|Lost to Follow-up|0
1539803|NCT00160251|5039920|P7|Prior to Amendment 2|Lost to Follow-up|0
1539804|NCT00160251|5039921|P6|Prior to Amendment 2|Lost to Follow-up|1
1539805|NCT00160251|5039922|P5|Prior to Amendment 2|Lost to Follow-up|1
1539806|NCT00160251|5039923|P4|Prior to Amendment 2|Lost to Follow-up|0
1539807|NCT00160251|5039924|P3|Prior to Amendment 2|Lost to Follow-up|1
1539808|NCT00160251|5039925|P2|Prior to Amendment 2|Lost to Follow-up|0
1539809|NCT00160251|5039926|P1|Prior to Amendment 2|Lost to Follow-up|0
1539810|NCT00160251|5039919|P8|Prior to Amendment 2|Lack of Efficacy|0
1539811|NCT00160251|5039920|P7|Prior to Amendment 2|Lack of Efficacy|0
1539812|NCT00160251|5039921|P6|Prior to Amendment 2|Lack of Efficacy|55
1539813|NCT00160251|5039922|P5|Prior to Amendment 2|Lack of Efficacy|24
1539814|NCT00160251|5039923|P4|Prior to Amendment 2|Lack of Efficacy|35
1539815|NCT00160251|5039924|P3|Prior to Amendment 2|Lack of Efficacy|37
1539816|NCT00160251|5039925|P2|Prior to Amendment 2|Lack of Efficacy|4
1539817|NCT00160251|5039926|P1|Prior to Amendment 2|Lack of Efficacy|0
1539818|NCT00160251|5039919|P8|Prior to Amendment 2|Adverse Event|0
1539819|NCT00160251|5039920|P7|Prior to Amendment 2|Adverse Event|1
1539820|NCT00160251|5039921|P6|Prior to Amendment 2|Adverse Event|1
1539821|NCT00160251|5039922|P5|Prior to Amendment 2|Adverse Event|1
1539822|NCT00160251|5039923|P4|Prior to Amendment 2|Adverse Event|1
1539823|NCT00160251|5039924|P3|Prior to Amendment 2|Adverse Event|3
1539824|NCT00160251|5039925|P2|Prior to Amendment 2|Adverse Event|1
1539825|NCT00160251|5039926|P1|Prior to Amendment 2|Adverse Event|2
1539826|NCT00160199|5040002|P2|Overall Study|Protocol Violation|8
1539827|NCT00160199|5040003|P1|Overall Study|Protocol Violation|8
1539828|NCT00160199|5040002|P2|Overall Study|Administrative|1
1539829|NCT00160199|5040003|P1|Overall Study|Administrative|0
1539830|NCT00160199|5040002|P2|Overall Study|Withdrawal by Subject|6
1539831|NCT00160199|5040003|P1|Overall Study|Withdrawal by Subject|4
1539832|NCT00160199|5040002|P2|Overall Study|Lost to Follow-up|7
1539833|NCT00160199|5040003|P1|Overall Study|Lost to Follow-up|7
1539834|NCT00160199|5040002|P2|Overall Study|Lack of Efficacy|1
1539835|NCT00160199|5040003|P1|Overall Study|Lack of Efficacy|0
1539836|NCT00160199|5040002|P2|Overall Study|Adverse Event|14
1539837|NCT00160199|5040003|P1|Overall Study|Adverse Event|5
1539838|NCT00159913|5040060|P4|Overall Study|Protocol Violation|0
1539839|NCT00159913|5040061|P3|Overall Study|Protocol Violation|1
1539840|NCT00159913|5040062|P2|Overall Study|Protocol Violation|0
1539841|NCT00159913|5040063|P1|Overall Study|Protocol Violation|1
1539842|NCT00159913|5040060|P4|Overall Study|Lost to Follow-up|1
1539843|NCT00159913|5040061|P3|Overall Study|Lost to Follow-up|0
1539844|NCT00159913|5040062|P2|Overall Study|Lost to Follow-up|0
1539845|NCT00159913|5040063|P1|Overall Study|Lost to Follow-up|0
1539846|NCT00159913|5040060|P4|Overall Study|Withdrawal by Subject|1
1539847|NCT00159913|5040061|P3|Overall Study|Withdrawal by Subject|0
1539848|NCT00159913|5040062|P2|Overall Study|Withdrawal by Subject|0
1539849|NCT00159913|5040063|P1|Overall Study|Withdrawal by Subject|0
1539850|NCT00159913|5040060|P4|Overall Study|Adverse Event|0
1539851|NCT00159913|5040061|P3|Overall Study|Adverse Event|1
1539852|NCT00159913|5040062|P2|Overall Study|Adverse Event|0
1539853|NCT00159913|5040063|P1|Overall Study|Adverse Event|1
1539854|NCT00159874|5040137|P7|Overall Study|Pregnancy|0
1539855|NCT00159874|5040138|P6|Overall Study|Pregnancy|0
1539856|NCT00159874|5040139|P5|Overall Study|Pregnancy|0
1539857|NCT00159874|5040140|P4|Overall Study|Pregnancy|0
1539858|NCT00159874|5040141|P3|Overall Study|Pregnancy|0
1539859|NCT00159874|5040142|P2|Overall Study|Pregnancy|1
1539860|NCT00159874|5040143|P1|Overall Study|Pregnancy|1
1539861|NCT00159874|5040137|P7|Overall Study|Withdrawal by Subject|1
1539862|NCT00159874|5040138|P6|Overall Study|Withdrawal by Subject|2
1539863|NCT00159874|5040139|P5|Overall Study|Withdrawal by Subject|3
1539864|NCT00159874|5040140|P4|Overall Study|Withdrawal by Subject|4
1539865|NCT00159874|5040141|P3|Overall Study|Withdrawal by Subject|8
1539866|NCT00159874|5040142|P2|Overall Study|Withdrawal by Subject|6
1539867|NCT00159874|5040143|P1|Overall Study|Withdrawal by Subject|2
1539868|NCT00159874|5040137|P7|Overall Study|Death|0
1539869|NCT00159874|5040138|P6|Overall Study|Death|2
1539870|NCT00159874|5040139|P5|Overall Study|Death|1
1539871|NCT00159874|5040140|P4|Overall Study|Death|0
1539872|NCT00159874|5040141|P3|Overall Study|Death|15
1539873|NCT00159874|5040142|P2|Overall Study|Death|8
1539874|NCT00159874|5040143|P1|Overall Study|Death|3
1539875|NCT00159874|5040137|P7|Overall Study|Protocol Violation|0
1539876|NCT00159874|5040138|P6|Overall Study|Protocol Violation|0
1539877|NCT00159874|5040139|P5|Overall Study|Protocol Violation|0
1539878|NCT00159874|5040140|P4|Overall Study|Protocol Violation|0
1539879|NCT00159874|5040141|P3|Overall Study|Protocol Violation|2
1539880|NCT00159874|5040142|P2|Overall Study|Protocol Violation|5
1539881|NCT00159874|5040143|P1|Overall Study|Protocol Violation|0
1539882|NCT00159874|5040137|P7|Overall Study|Not specified|3
1539883|NCT00159874|5040138|P6|Overall Study|Not specified|1
1539884|NCT00159874|5040139|P5|Overall Study|Not specified|2
1539885|NCT00159874|5040140|P4|Overall Study|Not specified|0
1539886|NCT00159874|5040141|P3|Overall Study|Not specified|8
1539887|NCT00159874|5040142|P2|Overall Study|Not specified|8
1539888|NCT00159874|5040143|P1|Overall Study|Not specified|8
1539889|NCT00159874|5040137|P7|Overall Study|Lost to Follow-up|1
1539890|NCT00159874|5040138|P6|Overall Study|Lost to Follow-up|2
1539891|NCT00159874|5040139|P5|Overall Study|Lost to Follow-up|1
1539892|NCT00159874|5040140|P4|Overall Study|Lost to Follow-up|0
1539893|NCT00159874|5040141|P3|Overall Study|Lost to Follow-up|3
1539894|NCT00159874|5040142|P2|Overall Study|Lost to Follow-up|0
1539895|NCT00159874|5040143|P1|Overall Study|Lost to Follow-up|1
1539896|NCT00159874|5040137|P7|Overall Study|Lack of Efficacy|0
1539897|NCT00159874|5040138|P6|Overall Study|Lack of Efficacy|3
1539898|NCT00159874|5040139|P5|Overall Study|Lack of Efficacy|0
1539899|NCT00159874|5040140|P4|Overall Study|Lack of Efficacy|1
1539900|NCT00159874|5040141|P3|Overall Study|Lack of Efficacy|1
1539901|NCT00159874|5040142|P2|Overall Study|Lack of Efficacy|0
1539902|NCT00159874|5040143|P1|Overall Study|Lack of Efficacy|2
1539903|NCT00159874|5040137|P7|Overall Study|Does Not Meet Entrance Criteria|0
1539904|NCT00159874|5040138|P6|Overall Study|Does Not Meet Entrance Criteria|0
1539905|NCT00159874|5040139|P5|Overall Study|Does Not Meet Entrance Criteria|0
1539906|NCT00159874|5040140|P4|Overall Study|Does Not Meet Entrance Criteria|0
1539907|NCT00159874|5040141|P3|Overall Study|Does Not Meet Entrance Criteria|1
1539908|NCT00159874|5040142|P2|Overall Study|Does Not Meet Entrance Criteria|0
1539909|NCT00159874|5040143|P1|Overall Study|Does Not Meet Entrance Criteria|1
1539910|NCT00159874|5040137|P7|Overall Study|Adverse Event|0
1539911|NCT00159874|5040138|P6|Overall Study|Adverse Event|2
1539912|NCT00159874|5040139|P5|Overall Study|Adverse Event|1
1539913|NCT00159874|5040140|P4|Overall Study|Adverse Event|1
1539914|NCT00159874|5040141|P3|Overall Study|Adverse Event|5
1539915|NCT00159874|5040142|P2|Overall Study|Adverse Event|2
1539916|NCT00159874|5040143|P1|Overall Study|Adverse Event|2
1539917|NCT00159861|5040313|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
1539918|NCT00159861|5040314|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
1539919|NCT00159861|5040313|P2|Extension Study - up to 3 Years|Reason Unspecified|19
1539920|NCT00159861|5040314|P1|Extension Study - up to 3 Years|Reason Unspecified|12
1539921|NCT00159861|5040313|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
1539922|NCT00159861|5040314|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
1539923|NCT00159861|5040313|P2|Extension Study - up to 3 Years|Adverse Event|14
1539924|NCT00159861|5040314|P1|Extension Study - up to 3 Years|Adverse Event|14
1539925|NCT00159861|5040313|P2|Extension Study - up to 3 Years|Death|28
1539926|NCT00159861|5040314|P1|Extension Study - up to 3 Years|Death|24
1539927|NCT00159861|5040313|P2|Core Study - 16 Weeks|Randomized but not Treated|0
1539928|NCT00159861|5040314|P1|Core Study - 16 Weeks|Randomized but not Treated|2
1539929|NCT00159861|5040313|P2|Core Study - 16 Weeks|Subject Defaulted|0
1539930|NCT00159861|5040314|P1|Core Study - 16 Weeks|Subject Defaulted|1
1539931|NCT00159861|5040313|P2|Core Study - 16 Weeks|Reason Unspecified|3
1539932|NCT00159861|5040314|P1|Core Study - 16 Weeks|Reason Unspecified|5
1539933|NCT00159861|5040313|P2|Core Study - 16 Weeks|Lack of Efficacy|3
1539934|NCT00159861|5040314|P1|Core Study - 16 Weeks|Lack of Efficacy|2
1539935|NCT00159861|5040313|P2|Core Study - 16 Weeks|Adverse Event|6
1539936|NCT00159861|5040314|P1|Core Study - 16 Weeks|Adverse Event|12
1539937|NCT00159861|5040313|P2|Core Study - 16 Weeks|Death|0
1539938|NCT00159861|5040314|P1|Core Study - 16 Weeks|Death|3
1539939|NCT00159822|5040335|P1|Post-treatment Follow-up Period|Reason unspecified|1
1539940|NCT00159822|5040335|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
1539941|NCT00159822|5040335|P1|Post-treatment Follow-up Period|Death|1
1539942|NCT00159822|5040335|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
1539943|NCT00159822|5040335|P1|Voriconazole Treatment Period|Lost to Follow-up|2
1539944|NCT00159822|5040335|P1|Voriconazole Treatment Period|Protocol Violation|2
1539945|NCT00159822|5040335|P1|Voriconazole Treatment Period|Death|4
1539946|NCT00159822|5040335|P1|Voriconazole Treatment Period|Adverse Event|9
1539947|NCT00159822|5040335|P1|Voriconazole Treatment Period|Lack of Efficacy|3
1539948|NCT00159783|5040353|P3|Overall Study|not specified|4
1539949|NCT00159783|5040354|P2|Overall Study|not specified|2
1539950|NCT00159783|5040355|P1|Overall Study|not specified|0
1539951|NCT00159783|5040353|P3|Overall Study|Lost to Follow-up|11
1539952|NCT00159783|5040354|P2|Overall Study|Lost to Follow-up|5
1539953|NCT00159783|5040355|P1|Overall Study|Lost to Follow-up|6
1539954|NCT00159783|5040353|P3|Overall Study|Withdrawal by Subject|12
1539955|NCT00159783|5040354|P2|Overall Study|Withdrawal by Subject|11
1539956|NCT00159783|5040355|P1|Overall Study|Withdrawal by Subject|7
1539957|NCT00159783|5040353|P3|Overall Study|Lack of Efficacy|3
1539958|NCT00159783|5040354|P2|Overall Study|Lack of Efficacy|2
1539959|NCT00159783|5040355|P1|Overall Study|Lack of Efficacy|1
1539960|NCT00159783|5040353|P3|Overall Study|Adverse Event|9
1539961|NCT00159783|5040354|P2|Overall Study|Adverse Event|7
1539962|NCT00159783|5040355|P1|Overall Study|Adverse Event|5
1539963|NCT00159432|5040385|P1|Overall Study|Lack of Efficacy|8
1539964|NCT00159432|5040385|P1|Overall Study|Death|1
1539965|NCT00159432|5040385|P1|Overall Study|Adverse Event|1
1539966|NCT00158756|5040412|P5|Overall Study|Serious adverse event|0
1539967|NCT00158756|5040413|P4|Overall Study|Serious adverse event|0
1539968|NCT00158756|5040414|P3|Overall Study|Serious adverse event|1
1539969|NCT00158756|5040415|P2|Overall Study|Serious adverse event|0
1539970|NCT00158756|5040416|P1|Overall Study|Serious adverse event|0
1539971|NCT00158756|5040412|P5|Overall Study|Adverse Event|0
1539972|NCT00158756|5040413|P4|Overall Study|Adverse Event|0
1539973|NCT00158756|5040414|P3|Overall Study|Adverse Event|1
1539974|NCT00158756|5040415|P2|Overall Study|Adverse Event|0
1539975|NCT00158756|5040416|P1|Overall Study|Adverse Event|0
1539976|NCT00158756|5040412|P5|Overall Study|Withdrawal by Subject|3
1539977|NCT00158756|5040413|P4|Overall Study|Withdrawal by Subject|1
1539978|NCT00158756|5040414|P3|Overall Study|Withdrawal by Subject|6
1539979|NCT00158756|5040415|P2|Overall Study|Withdrawal by Subject|0
1539980|NCT00158756|5040416|P1|Overall Study|Withdrawal by Subject|5
1539981|NCT00158600|5040522|P2|Overall Study|Withdrawal by Subject|2
1539982|NCT00158600|5040523|P1|Overall Study|Withdrawal by Subject|2
1539983|NCT00158600|5040522|P2|Overall Study|Death|0
1539984|NCT00158600|5040523|P1|Overall Study|Death|1
1539985|NCT00158600|5040522|P2|Overall Study|Adverse Event|1
1539986|NCT00158600|5040523|P1|Overall Study|Adverse Event|2
1539987|NCT00158600|5040522|P2|Overall Study|unable to commit time to study|1
1539988|NCT00158600|5040523|P1|Overall Study|unable to commit time to study|0
1539989|NCT00158262|5040548|P2|Overall Study|Lost to Follow-up|1
1539990|NCT00158262|5040549|P1|Overall Study|Lost to Follow-up|1
1539991|NCT00158184|5040610|P2|Overall Study|Adverse Event|1
1539992|NCT00158184|5040611|P1|Overall Study|Adverse Event|1
1539993|NCT00158184|5040610|P2|Overall Study|failed for follow unit/study rules|0
1539994|NCT00158184|5040611|P1|Overall Study|failed for follow unit/study rules|2
1539995|NCT00158184|5040610|P2|Overall Study|personal issues|1
1539996|NCT00158184|5040611|P1|Overall Study|personal issues|3
1539997|NCT00158054|5040621|P2|Overall Study|Unavailable for follow up|3
1539998|NCT00158054|5040622|P1|Overall Study|Unavailable for follow up|7
1539999|NCT00158054|5040621|P2|Overall Study|Refused to continue|0
1540000|NCT00158054|5040622|P1|Overall Study|Refused to continue|3
1540001|NCT00157950|5040636|P2|Overall Study|Death|0
1540002|NCT00157950|5040637|P1|Overall Study|Death|1
1540003|NCT00157820|5040654|P3|2nd 8 Months|Premature cross-over|9
1540004|NCT00157820|5040655|P2|2nd 8 Months|Premature cross-over|7
1540005|NCT00157820|5040656|P1|2nd 8 Months|Premature cross-over|1
1540006|NCT00157820|5040654|P3|2nd 8 Months|Lost to Follow-up|2
1540007|NCT00157820|5040655|P2|2nd 8 Months|Lost to Follow-up|5
1540008|NCT00157820|5040656|P1|2nd 8 Months|Lost to Follow-up|1
1540009|NCT00157820|5040654|P3|2nd 8 Months|Death|3
1540010|NCT00157820|5040655|P2|2nd 8 Months|Death|1
1540011|NCT00157820|5040656|P1|2nd 8 Months|Death|3
1540012|NCT00157820|5040654|P3|1st 8 Month|Premature cross-over|2
1540013|NCT00157820|5040655|P2|1st 8 Month|Premature cross-over|2
1540014|NCT00157820|5040656|P1|1st 8 Month|Premature cross-over|0
1540015|NCT00157820|5040654|P3|1st 8 Month|Lost to Follow-up|1
1540016|NCT00157820|5040655|P2|1st 8 Month|Lost to Follow-up|2
1540017|NCT00157820|5040656|P1|1st 8 Month|Lost to Follow-up|1
1540018|NCT00157820|5040654|P3|1st 8 Month|Death|3
1540019|NCT00157820|5040655|P2|1st 8 Month|Death|8
1540020|NCT00157820|5040656|P1|1st 8 Month|Death|7
1540021|NCT00157820|5040654|P3|Randomized|Protocol Violation|2
1540022|NCT00157820|5040655|P2|Randomized|Protocol Violation|1
1540023|NCT00157820|5040656|P1|Randomized|Protocol Violation|2
1540024|NCT00157820|5040654|P3|Randomized|Withdrawal by Subject|3
1540025|NCT00157820|5040655|P2|Randomized|Withdrawal by Subject|2
1540026|NCT00157820|5040656|P1|Randomized|Withdrawal by Subject|1
1540027|NCT00157820|5040654|P3|Randomized|Physician Decision|3
1540028|NCT00157820|5040655|P2|Randomized|Physician Decision|2
1540029|NCT00157820|5040656|P1|Randomized|Physician Decision|4
1540030|NCT00157755|5040669|P6|Overall Study|Study completion|2
1540031|NCT00157755|5040670|P5|Overall Study|Study completion|1
1540032|NCT00157755|5040671|P4|Overall Study|Study completion|0
1540033|NCT00157755|5040672|P3|Overall Study|Study completion|0
1540034|NCT00157755|5040673|P2|Overall Study|Study completion|0
1540035|NCT00157755|5040674|P1|Overall Study|Study completion|0
1540036|NCT00157755|5040669|P6|Overall Study|Subject non-compliance|1
1540037|NCT00157755|5040670|P5|Overall Study|Subject non-compliance|0
1540038|NCT00157755|5040671|P4|Overall Study|Subject non-compliance|0
1540039|NCT00157755|5040672|P3|Overall Study|Subject non-compliance|0
1540040|NCT00157755|5040673|P2|Overall Study|Subject non-compliance|0
1540041|NCT00157755|5040674|P1|Overall Study|Subject non-compliance|0
1540042|NCT00157755|5040669|P6|Overall Study|Study site closure|0
1540043|NCT00157755|5040670|P5|Overall Study|Study site closure|0
1540044|NCT00157755|5040671|P4|Overall Study|Study site closure|0
1540045|NCT00157755|5040672|P3|Overall Study|Study site closure|0
1540046|NCT00157755|5040673|P2|Overall Study|Study site closure|1
1540047|NCT00157755|5040674|P1|Overall Study|Study site closure|0
1540048|NCT00157755|5040669|P6|Overall Study|Medical reason|0
1540049|NCT00157755|5040670|P5|Overall Study|Medical reason|0
1540050|NCT00157755|5040671|P4|Overall Study|Medical reason|1
1540051|NCT00157755|5040672|P3|Overall Study|Medical reason|1
1540052|NCT00157755|5040673|P2|Overall Study|Medical reason|0
1540053|NCT00157755|5040674|P1|Overall Study|Medical reason|0
1540054|NCT00157755|5040669|P6|Overall Study|Explant due to infection|0
1540055|NCT00157755|5040670|P5|Overall Study|Explant due to infection|0
1540056|NCT00157755|5040671|P4|Overall Study|Explant due to infection|0
1540057|NCT00157755|5040672|P3|Overall Study|Explant due to infection|1
1540058|NCT00157755|5040673|P2|Overall Study|Explant due to infection|0
1540059|NCT00157755|5040674|P1|Overall Study|Explant due to infection|0
1540060|NCT00157755|5040669|P6|Overall Study|Withdrawal by Subject|2
1540061|NCT00157755|5040670|P5|Overall Study|Withdrawal by Subject|1
1540062|NCT00157755|5040671|P4|Overall Study|Withdrawal by Subject|1
1540063|NCT00157755|5040672|P3|Overall Study|Withdrawal by Subject|1
1540064|NCT00157755|5040673|P2|Overall Study|Withdrawal by Subject|0
1540065|NCT00157755|5040674|P1|Overall Study|Withdrawal by Subject|0
1540066|NCT00157755|5040669|P6|Overall Study|Lost to Follow-up|0
1540067|NCT00157755|5040670|P5|Overall Study|Lost to Follow-up|0
1540068|NCT00157755|5040671|P4|Overall Study|Lost to Follow-up|0
1540069|NCT00157755|5040672|P3|Overall Study|Lost to Follow-up|1
1540070|NCT00157755|5040673|P2|Overall Study|Lost to Follow-up|0
1540071|NCT00157755|5040674|P1|Overall Study|Lost to Follow-up|0
1540072|NCT00157755|5040669|P6|Overall Study|Death|0
1540073|NCT00157755|5040670|P5|Overall Study|Death|0
1540074|NCT00157755|5040671|P4|Overall Study|Death|2
1540075|NCT00157755|5040672|P3|Overall Study|Death|3
1540076|NCT00157755|5040673|P2|Overall Study|Death|3
1540077|NCT00157755|5040674|P1|Overall Study|Death|2
1540078|NCT00157248|5040710|P4|Overall Study|site closures, subject moving|9
1540079|NCT00157248|5040711|P3|Overall Study|site closures, subject moving|3
1540080|NCT00157248|5040712|P2|Overall Study|site closures, subject moving|7
1540081|NCT00157248|5040713|P1|Overall Study|site closures, subject moving|7
1540082|NCT00157248|5040710|P4|Overall Study|Withdrawal by Subject|3
1540083|NCT00157248|5040711|P3|Overall Study|Withdrawal by Subject|3
1540084|NCT00157248|5040712|P2|Overall Study|Withdrawal by Subject|4
1540085|NCT00157248|5040713|P1|Overall Study|Withdrawal by Subject|1
1540086|NCT00157248|5040710|P4|Overall Study|Lost to Follow-up|0
1540087|NCT00157248|5040711|P3|Overall Study|Lost to Follow-up|0
1540088|NCT00157248|5040712|P2|Overall Study|Lost to Follow-up|1
1540089|NCT00157248|5040713|P1|Overall Study|Lost to Follow-up|0
1540090|NCT00157248|5040710|P4|Overall Study|Protocol Violation|2
1540091|NCT00157248|5040711|P3|Overall Study|Protocol Violation|2
1540092|NCT00157248|5040712|P2|Overall Study|Protocol Violation|0
1540093|NCT00157248|5040713|P1|Overall Study|Protocol Violation|4
1540094|NCT00157248|5040710|P4|Overall Study|Adverse Event|33
1540095|NCT00157248|5040711|P3|Overall Study|Adverse Event|13
1540096|NCT00157248|5040712|P2|Overall Study|Adverse Event|25
1540097|NCT00157248|5040713|P1|Overall Study|Adverse Event|36
1540098|NCT00157209|5040819|P2|Overall Study|Ongoing at data cut-off|0
1540099|NCT00157209|5040820|P1|Overall Study|Ongoing at data cut-off|10
1540100|NCT00157196|5040834|P1|Overall Study|Ongoing at data cut-off|9
1540101|NCT00157157|5040840|P1|Overall Study|Inclusion not met- baseline FVIII value|1
1540102|NCT00157157|5040840|P1|Overall Study|Met exclusion criteria|1
1540103|NCT00157157|5040840|P1|Overall Study|Enrolled in another study|1
1540104|NCT00157157|5040840|P1|Overall Study|Lost to Follow-up|1
1540105|NCT00157157|5040840|P1|Overall Study|Physician Decision|1
1540106|NCT00157157|5040840|P1|Overall Study|Withdrawal by Subject|6
1540107|NCT00157014|5040867|P4|Overall Study|Withdrawal by Subject|0
1540108|NCT00157014|5040868|P3|Overall Study|Withdrawal by Subject|0
1540109|NCT00157014|5040869|P2|Overall Study|Withdrawal by Subject|0
1540110|NCT00157014|5040870|P1|Overall Study|Withdrawal by Subject|1
1540111|NCT00157014|5040867|P4|Overall Study|Patient would not receive transplant|0
1540112|NCT00157014|5040868|P3|Overall Study|Patient would not receive transplant|0
1540113|NCT00157014|5040869|P2|Overall Study|Patient would not receive transplant|1
1540114|NCT00157014|5040870|P1|Overall Study|Patient would not receive transplant|0
1540115|NCT00157014|5040867|P4|Overall Study|Patient unable to return in nursing home|0
1540116|NCT00157014|5040868|P3|Overall Study|Patient unable to return in nursing home|0
1540117|NCT00157014|5040869|P2|Overall Study|Patient unable to return in nursing home|0
1540118|NCT00157014|5040870|P1|Overall Study|Patient unable to return in nursing home|1
1540119|NCT00157014|5040867|P4|Overall Study|Patient withdrawn by investigator|0
1540120|NCT00157014|5040868|P3|Overall Study|Patient withdrawn by investigator|0
1540121|NCT00157014|5040869|P2|Overall Study|Patient withdrawn by investigator|0
1540122|NCT00157014|5040870|P1|Overall Study|Patient withdrawn by investigator|1
1540123|NCT00157014|5040867|P4|Overall Study|Medications withdrawn on family request|0
1540124|NCT00157014|5040868|P3|Overall Study|Medications withdrawn on family request|0
1540125|NCT00157014|5040869|P2|Overall Study|Medications withdrawn on family request|1
1540126|NCT00157014|5040870|P1|Overall Study|Medications withdrawn on family request|0
1540127|NCT00157014|5040867|P4|Overall Study|Physician Decision|0
1540128|NCT00157014|5040868|P3|Overall Study|Physician Decision|0
1540129|NCT00157014|5040869|P2|Overall Study|Physician Decision|1
1540130|NCT00157014|5040870|P1|Overall Study|Physician Decision|0
1540131|NCT00157014|5040867|P4|Overall Study|Death|1
1540132|NCT00157014|5040868|P3|Overall Study|Death|1
1540133|NCT00157014|5040869|P2|Overall Study|Death|2
1540134|NCT00157014|5040870|P1|Overall Study|Death|4
1540135|NCT00156819|5040986|P3|Overall Study|Lost to Follow-up|3
1540136|NCT00156819|5040987|P2|Overall Study|Lost to Follow-up|1
1540137|NCT00156819|5040988|P1|Overall Study|Lost to Follow-up|1
1540138|NCT00156533|5041005|P4|Overall Study|Failed Screening|1
1540139|NCT00156533|5041006|P3|Overall Study|Failed Screening|1
1540140|NCT00156533|5041007|P2|Overall Study|Failed Screening|0
1540141|NCT00156533|5041008|P1|Overall Study|Failed Screening|1
1540142|NCT00156533|5041005|P4|Overall Study|Withdrawal by Subject|1
1540143|NCT00156533|5041006|P3|Overall Study|Withdrawal by Subject|0
1540144|NCT00156533|5041007|P2|Overall Study|Withdrawal by Subject|0
1540145|NCT00156533|5041008|P1|Overall Study|Withdrawal by Subject|1
1540146|NCT00156533|5041005|P4|Overall Study|Withdrawn - Medication Expiration|0
1540147|NCT00156533|5041006|P3|Overall Study|Withdrawn - Medication Expiration|1
1540148|NCT00156533|5041007|P2|Overall Study|Withdrawn - Medication Expiration|2
1540149|NCT00156533|5041008|P1|Overall Study|Withdrawn - Medication Expiration|0
1540150|NCT00156065|5041042|P3|Overall Study|Other|3
1540151|NCT00156065|5041043|P2|Overall Study|Other|9
1540152|NCT00156065|5041044|P1|Overall Study|Other|2
1540153|NCT00156065|5041042|P3|Overall Study|Lost to Follow-up|1
1540154|NCT00156065|5041043|P2|Overall Study|Lost to Follow-up|7
1540155|NCT00156065|5041044|P1|Overall Study|Lost to Follow-up|5
1540156|NCT00156065|5041042|P3|Overall Study|Withdrawal by Subject|16
1540157|NCT00156065|5041043|P2|Overall Study|Withdrawal by Subject|26
1540158|NCT00156065|5041044|P1|Overall Study|Withdrawal by Subject|13
1540159|NCT00156065|5041042|P3|Overall Study|Lack of Efficacy|3
1540160|NCT00156065|5041043|P2|Overall Study|Lack of Efficacy|9
1540161|NCT00156065|5041044|P1|Overall Study|Lack of Efficacy|2
1540162|NCT00156065|5041042|P3|Overall Study|Adverse Event|4
1540163|NCT00156065|5041043|P2|Overall Study|Adverse Event|11
1540164|NCT00156065|5041044|P1|Overall Study|Adverse Event|8
1540165|NCT00156065|5041042|P3|Overall Study|Enrolled But Never Received Treatment|0
1540166|NCT00156065|5041043|P2|Overall Study|Enrolled But Never Received Treatment|1
1540167|NCT00156065|5041044|P1|Overall Study|Enrolled But Never Received Treatment|1
1540168|NCT00154375|5041078|P2|Overall Study|Suspected progression of disease|30
1540169|NCT00154375|5041079|P1|Overall Study|Suspected progression of disease|44
1540170|NCT00154375|5041078|P2|Overall Study|Protocol Violation|1
1540171|NCT00154375|5041079|P1|Overall Study|Protocol Violation|0
1540172|NCT00154375|5041078|P2|Overall Study|Abnormal laboratory value(s)|2
1540173|NCT00154375|5041079|P1|Overall Study|Abnormal laboratory value(s)|0
1540174|NCT00154375|5041078|P2|Overall Study|Lost to Follow-up|1
1540175|NCT00154375|5041079|P1|Overall Study|Lost to Follow-up|2
1540176|NCT00154375|5041078|P2|Overall Study|Study drug no longer required|3
1540177|NCT00154375|5041079|P1|Overall Study|Study drug no longer required|5
1540178|NCT00154375|5041078|P2|Overall Study|Death|13
1540179|NCT00154375|5041079|P1|Overall Study|Death|5
1540180|NCT00154375|5041078|P2|Overall Study|Withdrawal by Subject|10
1540181|NCT00154375|5041079|P1|Overall Study|Withdrawal by Subject|14
1540182|NCT00154375|5041078|P2|Overall Study|Adverse Event|20
1540183|NCT00154375|5041079|P1|Overall Study|Adverse Event|18
1540184|NCT00154375|5041078|P2|Overall Study|Unsatisfactory therapeutic effect|26
1540185|NCT00154375|5041079|P1|Overall Study|Unsatisfactory therapeutic effect|25
1540186|NCT00154310|5041090|P2|Overall Study|Death|1
1540187|NCT00154310|5041091|P1|Overall Study|Death|0
1540188|NCT00154310|5041090|P2|Overall Study|Administrative problems|1
1540189|NCT00154310|5041091|P1|Overall Study|Administrative problems|0
1540190|NCT00154310|5041090|P2|Overall Study|Lost to Follow-up|8
1540191|NCT00154310|5041091|P1|Overall Study|Lost to Follow-up|0
1540192|NCT00154310|5041090|P2|Overall Study|Withdrawal by Subject|3
1540193|NCT00154310|5041091|P1|Overall Study|Withdrawal by Subject|9
1540194|NCT00154310|5041090|P2|Overall Study|Protocol Violation|2
1540195|NCT00154310|5041091|P1|Overall Study|Protocol Violation|4
1540196|NCT00154310|5041090|P2|Overall Study|Lack of Efficacy|4
1540197|NCT00154310|5041091|P1|Overall Study|Lack of Efficacy|5
1540198|NCT00154310|5041090|P2|Overall Study|Adverse Event|9
1540199|NCT00154310|5041091|P1|Overall Study|Adverse Event|19
1540200|NCT00154297|5041107|P2|Overall Study|Lost to Follow-up|0
1540201|NCT00154297|5041108|P1|Overall Study|Lost to Follow-up|3
1540202|NCT00154297|5041107|P2|Overall Study|Withdrawal by Subject|5
1540203|NCT00154297|5041108|P1|Overall Study|Withdrawal by Subject|0
1540204|NCT00154297|5041107|P2|Overall Study|Death|2
1540205|NCT00154297|5041108|P1|Overall Study|Death|5
1540206|NCT00154284|5041126|P2|Overall Study|Protocol Violation|1
1540207|NCT00154284|5041127|P1|Overall Study|Protocol Violation|0
1540208|NCT00154284|5041126|P2|Overall Study|Lack of Efficacy|2
1540209|NCT00154284|5041127|P1|Overall Study|Lack of Efficacy|1
1540210|NCT00154284|5041126|P2|Overall Study|Abnormal laboratory value(s)|1
1540211|NCT00154284|5041127|P1|Overall Study|Abnormal laboratory value(s)|0
1540212|NCT00154284|5041126|P2|Overall Study|Adverse Event|9
1540213|NCT00154284|5041127|P1|Overall Study|Adverse Event|6
1540214|NCT00154102|5041141|P2|Overall Study|investigational study phase ongoing|2
1540215|NCT00154102|5041142|P1|Overall Study|investigational study phase ongoing|7
1540216|NCT00154063|5041178|P2|Overall Study|Not specified|3
1540217|NCT00154063|5041179|P1|Overall Study|Not specified|3
1540218|NCT00154063|5041178|P2|Overall Study|Withdrawal by Subject|9
1540219|NCT00154063|5041179|P1|Overall Study|Withdrawal by Subject|4
1540220|NCT00154063|5041178|P2|Overall Study|Investigator or Sponsor Request|1
1540221|NCT00154063|5041179|P1|Overall Study|Investigator or Sponsor Request|0
1540222|NCT00154063|5041178|P2|Overall Study|Protocol Violation|1
1540223|NCT00154063|5041179|P1|Overall Study|Protocol Violation|1
1540224|NCT00154063|5041178|P2|Overall Study|Adverse Event|8
1540225|NCT00154063|5041179|P1|Overall Study|Adverse Event|4
1540226|NCT00153920|5041241|P1|Overall Study|Progressive Disease before Trt|1
1540227|NCT00153920|5041241|P1|Overall Study|Withdrawal of Consent before Trt|1
1540228|NCT00153920|5041241|P1|Overall Study|Non-Protocol Therapy|1
1540229|NCT00153920|5041241|P1|Overall Study|Withdrawal by Subject|1
1540230|NCT00153920|5041241|P1|Overall Study|Death|2
1540231|NCT00153920|5041241|P1|Overall Study|Lack of Response|3
1540232|NCT00153920|5041241|P1|Overall Study|Physician Decision|3
1540233|NCT00153920|5041241|P1|Overall Study|Progressive Disease|9
1540234|NCT00153920|5041241|P1|Overall Study|Adverse Event|9
1540235|NCT00153816|5041256|P6|Overall Study|Follow-up exam done, histology missing|2
1540236|NCT00153816|5041257|P5|Overall Study|Follow-up exam done, histology missing|1
1540237|NCT00153816|5041258|P4|Overall Study|Follow-up exam done, histology missing|3
1540238|NCT00153816|5041259|P3|Overall Study|Follow-up exam done, histology missing|3
1540239|NCT00153816|5041260|P2|Overall Study|Follow-up exam done, histology missing|3
1540240|NCT00153816|5041261|P1|Overall Study|Follow-up exam done, histology missing|2
1540241|NCT00153816|5041256|P6|Overall Study|Follow-up exam not done|9
1540242|NCT00153816|5041257|P5|Overall Study|Follow-up exam not done|8
1540243|NCT00153816|5041258|P4|Overall Study|Follow-up exam not done|10
1540244|NCT00153816|5041259|P3|Overall Study|Follow-up exam not done|11
1540245|NCT00153816|5041260|P2|Overall Study|Follow-up exam not done|7
1540246|NCT00153816|5041261|P1|Overall Study|Follow-up exam not done|8
1540247|NCT00153816|5041256|P6|Overall Study|Withdrawal by Subject|5
1540248|NCT00153816|5041257|P5|Overall Study|Withdrawal by Subject|1
1540249|NCT00153816|5041258|P4|Overall Study|Withdrawal by Subject|4
1540250|NCT00153816|5041259|P3|Overall Study|Withdrawal by Subject|9
1540251|NCT00153816|5041260|P2|Overall Study|Withdrawal by Subject|9
1540252|NCT00153816|5041261|P1|Overall Study|Withdrawal by Subject|9
1540253|NCT00153816|5041256|P6|Overall Study|Lost to Follow-up|9
1540254|NCT00153816|5041257|P5|Overall Study|Lost to Follow-up|7
1540255|NCT00153816|5041258|P4|Overall Study|Lost to Follow-up|8
1540256|NCT00153816|5041259|P3|Overall Study|Lost to Follow-up|5
1540257|NCT00153816|5041260|P2|Overall Study|Lost to Follow-up|8
1540258|NCT00153816|5041261|P1|Overall Study|Lost to Follow-up|7
1540259|NCT00153816|5041256|P6|Overall Study|Death|2
1540260|NCT00153816|5041257|P5|Overall Study|Death|0
1540261|NCT00153816|5041258|P4|Overall Study|Death|6
1540262|NCT00153816|5041259|P3|Overall Study|Death|4
1540263|NCT00153816|5041260|P2|Overall Study|Death|5
1540264|NCT00153816|5041261|P1|Overall Study|Death|6
1540265|NCT00153101|5041316|P5|Overall Study|Withdrawal by Subject|5
1540266|NCT00153101|5041317|P4|Overall Study|Withdrawal by Subject|3
1540267|NCT00153101|5041318|P3|Overall Study|Withdrawal by Subject|3
1540268|NCT00153101|5041319|P2|Overall Study|Withdrawal by Subject|4
1540269|NCT00153101|5041320|P1|Overall Study|Withdrawal by Subject|3
1540270|NCT00153101|5041316|P5|Overall Study|Lost to Follow-up|5
1540271|NCT00153101|5041317|P4|Overall Study|Lost to Follow-up|5
1540272|NCT00153101|5041318|P3|Overall Study|Lost to Follow-up|12
1540273|NCT00153101|5041319|P2|Overall Study|Lost to Follow-up|14
1540274|NCT00153101|5041320|P1|Overall Study|Lost to Follow-up|14
1540275|NCT00153062|5041428|P4|Overall Study|Other|0
1540276|NCT00153062|5041429|P3|Overall Study|Other|1
1540277|NCT00153062|5041430|P2|Overall Study|Other|0
1540278|NCT00153062|5041431|P1|Overall Study|Other|0
1540279|NCT00153062|5041428|P4|Overall Study|No disposition data available|1
1540280|NCT00153062|5041429|P3|Overall Study|No disposition data available|1
1540281|NCT00153062|5041430|P2|Overall Study|No disposition data available|1
1540282|NCT00153062|5041431|P1|Overall Study|No disposition data available|1
1540283|NCT00153062|5041428|P4|Overall Study|Protocol Violation|1
1540284|NCT00153062|5041429|P3|Overall Study|Protocol Violation|1
1540285|NCT00153062|5041430|P2|Overall Study|Protocol Violation|2
1540286|NCT00153062|5041431|P1|Overall Study|Protocol Violation|0
1540287|NCT00153062|5041428|P4|Overall Study|Adverse Event|0
1540288|NCT00153062|5041429|P3|Overall Study|Adverse Event|1
1540289|NCT00153062|5041430|P2|Overall Study|Adverse Event|1
1540290|NCT00153062|5041431|P1|Overall Study|Adverse Event|0
1540291|NCT00153062|5041428|P4|Overall Study|Lost to Follow-up|16
1540292|NCT00153062|5041429|P3|Overall Study|Lost to Follow-up|15
1540293|NCT00153062|5041430|P2|Overall Study|Lost to Follow-up|20
1540294|NCT00153062|5041431|P1|Overall Study|Lost to Follow-up|12
1540295|NCT00153062|5041428|P4|Overall Study|Withdrawal by Subject|28
1540296|NCT00153062|5041429|P3|Overall Study|Withdrawal by Subject|27
1540297|NCT00153062|5041430|P2|Overall Study|Withdrawal by Subject|30
1540298|NCT00153062|5041431|P1|Overall Study|Withdrawal by Subject|14
1540299|NCT00153062|5041428|P4|Overall Study|Death|365
1540300|NCT00153062|5041429|P3|Overall Study|Death|369
1540301|NCT00153062|5041430|P2|Overall Study|Death|352
1540302|NCT00153062|5041431|P1|Overall Study|Death|360
1540303|NCT00152971|5041450|P3|Treatment|not specified|10
1540304|NCT00152971|5041451|P2|Treatment|not specified|11
1540305|NCT00152971|5041452|P1|Treatment|not specified|9
1540306|NCT00152971|5041450|P3|Treatment|Withdrawal by Subject|5
1540307|NCT00152971|5041451|P2|Treatment|Withdrawal by Subject|4
1540308|NCT00152971|5041452|P1|Treatment|Withdrawal by Subject|4
1540309|NCT00152971|5041450|P3|Treatment|Lost to Follow-up|1
1540310|NCT00152971|5041451|P2|Treatment|Lost to Follow-up|2
1540311|NCT00152971|5041452|P1|Treatment|Lost to Follow-up|1
1540312|NCT00152971|5041450|P3|Treatment|Protocol Violation|10
1540313|NCT00152971|5041451|P2|Treatment|Protocol Violation|6
1540314|NCT00152971|5041452|P1|Treatment|Protocol Violation|8
1540315|NCT00152971|5041450|P3|Treatment|Adverse Event|54
1540316|NCT00152971|5041451|P2|Treatment|Adverse Event|40
1540317|NCT00152971|5041452|P1|Treatment|Adverse Event|49
1540318|NCT00152971|5041450|P3|Overall Study|not specified|5
1540319|NCT00152971|5041451|P2|Overall Study|not specified|5
1540320|NCT00152971|5041452|P1|Overall Study|not specified|3
1540321|NCT00152971|5041450|P3|Overall Study|Withdrawal by Subject|14
1540322|NCT00152971|5041451|P2|Overall Study|Withdrawal by Subject|8
1540323|NCT00152971|5041452|P1|Overall Study|Withdrawal by Subject|9
1540324|NCT00152971|5041450|P3|Overall Study|Lost to Follow-up|13
1540325|NCT00152971|5041451|P2|Overall Study|Lost to Follow-up|14
1540326|NCT00152971|5041452|P1|Overall Study|Lost to Follow-up|17
1540327|NCT00152971|5041450|P3|Overall Study|Protocol Violation|8
1540328|NCT00152971|5041451|P2|Overall Study|Protocol Violation|11
1540329|NCT00152971|5041452|P1|Overall Study|Protocol Violation|10
1540330|NCT00152971|5041450|P3|Overall Study|Adverse Event|9
1540331|NCT00152971|5041451|P2|Overall Study|Adverse Event|10
1540332|NCT00152971|5041452|P1|Overall Study|Adverse Event|12
1540333|NCT00152763|5041488|P4|Overall Study|Lost to Follow-up|13
1540334|NCT00152763|5041489|P3|Overall Study|Lost to Follow-up|2
1540335|NCT00152763|5041490|P2|Overall Study|Lost to Follow-up|4
1540336|NCT00152763|5041491|P1|Overall Study|Lost to Follow-up|6
1540337|NCT00152763|5041488|P4|Overall Study|Death|1
1540338|NCT00152763|5041489|P3|Overall Study|Death|2
1540339|NCT00152763|5041490|P2|Overall Study|Death|1
1540340|NCT00152763|5041491|P1|Overall Study|Death|4
1540341|NCT00152516|5041607|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
1540342|NCT00152516|5041607|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
1540343|NCT00152516|5041607|P1|Overall Study|Other: Moved Out Of State|1
1540344|NCT00152516|5041607|P1|Overall Study|Other: Primary Care Physician's Decision|1
1540345|NCT00152516|5041607|P1|Overall Study|Other: Non-Compliance|2
1540346|NCT00152516|5041607|P1|Overall Study|Other: Parents Withdrew Consent|2
1540347|NCT00152516|5041607|P1|Overall Study|Other: Given Commercial Drug in Error|2
1540348|NCT00152516|5041607|P1|Overall Study|Other: Mother Refused To Cooperate|1
1540349|NCT00152516|5041607|P1|Overall Study|Protocol Violation|3
1540350|NCT00152516|5041607|P1|Overall Study|Withdrawal by Subject|8
1540351|NCT00152516|5041607|P1|Overall Study|Lost to Follow-up|5
1540352|NCT00152516|5041607|P1|Overall Study|Lack and Loss of Efficacy|30
1540353|NCT00152516|5041607|P1|Overall Study|Adverse Event|18
1540354|NCT00152009|5041635|P4|Overall Study|Sponsor's decision|3
1540355|NCT00152009|5041636|P3|Overall Study|Sponsor's decision|1
1540356|NCT00152009|5041637|P2|Overall Study|Sponsor's decision|3
1540357|NCT00152009|5041638|P1|Overall Study|Sponsor's decision|3
1540358|NCT00152009|5041635|P4|Overall Study|ECG abnormalities|1
1540359|NCT00152009|5041636|P3|Overall Study|ECG abnormalities|2
1540360|NCT00152009|5041637|P2|Overall Study|ECG abnormalities|2
1540361|NCT00152009|5041638|P1|Overall Study|ECG abnormalities|2
1540362|NCT00152009|5041635|P4|Overall Study|Lack of Efficacy|15
1540363|NCT00152009|5041636|P3|Overall Study|Lack of Efficacy|7
1540364|NCT00152009|5041637|P2|Overall Study|Lack of Efficacy|6
1540365|NCT00152009|5041638|P1|Overall Study|Lack of Efficacy|8
1540366|NCT00152009|5041635|P4|Overall Study|Lost to Follow-up|3
1540367|NCT00152009|5041636|P3|Overall Study|Lost to Follow-up|3
1540368|NCT00152009|5041637|P2|Overall Study|Lost to Follow-up|4
1540369|NCT00152009|5041638|P1|Overall Study|Lost to Follow-up|2
1540370|NCT00152009|5041635|P4|Overall Study|Withdrawal by Subject|9
1540371|NCT00152009|5041636|P3|Overall Study|Withdrawal by Subject|4
1540372|NCT00152009|5041637|P2|Overall Study|Withdrawal by Subject|3
1540373|NCT00152009|5041638|P1|Overall Study|Withdrawal by Subject|2
1540374|NCT00152009|5041635|P4|Overall Study|Protocol Violation|1
1540375|NCT00152009|5041636|P3|Overall Study|Protocol Violation|0
1540376|NCT00152009|5041637|P2|Overall Study|Protocol Violation|0
1540377|NCT00152009|5041638|P1|Overall Study|Protocol Violation|3
1540378|NCT00152009|5041635|P4|Overall Study|Adverse Event|1
1540379|NCT00152009|5041636|P3|Overall Study|Adverse Event|20
1540380|NCT00152009|5041637|P2|Overall Study|Adverse Event|13
1540381|NCT00152009|5041638|P1|Overall Study|Adverse Event|9
1540382|NCT00151996|5041670|P2|Overall Study|Sponsor's decision|2
1540383|NCT00151996|5041671|P1|Overall Study|Sponsor's decision|0
1540384|NCT00151996|5041670|P2|Overall Study|Protocol Violation|2
1540385|NCT00151996|5041671|P1|Overall Study|Protocol Violation|1
1540386|NCT00151996|5041670|P2|Overall Study|Withdrawal by Subject|1
1540387|NCT00151996|5041671|P1|Overall Study|Withdrawal by Subject|1
1540388|NCT00151996|5041670|P2|Overall Study|Adverse Event|2
1540389|NCT00151996|5041671|P1|Overall Study|Adverse Event|3
1540390|NCT00151892|5041687|P2|Overall Study|Lack of study medication at center|1
1540391|NCT00151892|5041688|P1|Overall Study|Lack of study medication at center|0
1540392|NCT00151892|5041687|P2|Overall Study|Used prohibited corticosteroids|0
1540393|NCT00151892|5041688|P1|Overall Study|Used prohibited corticosteroids|1
1540394|NCT00151892|5041687|P2|Overall Study|Did not return for a visit|0
1540395|NCT00151892|5041688|P1|Overall Study|Did not return for a visit|1
1540396|NCT00151892|5041687|P2|Overall Study|Pregnancy|1
1540397|NCT00151892|5041688|P1|Overall Study|Pregnancy|0
1540398|NCT00151892|5041687|P2|Overall Study|Non-compliance|1
1540399|NCT00151892|5041688|P1|Overall Study|Non-compliance|0
1540400|NCT00151892|5041687|P2|Overall Study|Protocol Violation|3
1540401|NCT00151892|5041688|P1|Overall Study|Protocol Violation|3
1540402|NCT00151892|5041687|P2|Overall Study|Adverse Event|3
1540403|NCT00151892|5041688|P1|Overall Study|Adverse Event|6
1540404|NCT00151892|5041687|P2|Overall Study|Lost to Follow-up|10
1540405|NCT00151892|5041688|P1|Overall Study|Lost to Follow-up|5
1540406|NCT00151892|5041687|P2|Overall Study|Patient request|7
1540407|NCT00151892|5041688|P1|Overall Study|Patient request|10
1540408|NCT00151892|5041687|P2|Overall Study|Lack of Efficacy|57
1540409|NCT00151892|5041688|P1|Overall Study|Lack of Efficacy|50
1540410|NCT00151775|5041733|P12|Period 4: Open Label|Protocol Violation|0
1540411|NCT00151775|5041734|P11|Period 4: Open Label|Protocol Violation|0
1540412|NCT00151775|5041735|P10|Period 4: Open Label|Protocol Violation|0
1540413|NCT00151775|5041736|P9|Period 4: Open Label|Protocol Violation|0
1540414|NCT00151775|5041737|P8|Period 4: Open Label|Protocol Violation|0
1540415|NCT00151775|5041738|P7|Period 4: Open Label|Protocol Violation|0
1540416|NCT00151775|5041739|P6|Period 4: Open Label|Protocol Violation|0
1540417|NCT00151775|5041740|P5|Period 4: Open Label|Protocol Violation|1
1540418|NCT00151775|5041741|P4|Period 4: Open Label|Protocol Violation|0
1540419|NCT00151775|5041742|P3|Period 4: Open Label|Protocol Violation|0
1540420|NCT00151775|5041743|P2|Period 4: Open Label|Protocol Violation|0
1540421|NCT00151775|5041744|P1|Period 4: Open Label|Protocol Violation|0
1540422|NCT00151775|5041733|P12|Period 4: Open Label|Physician Decision|0
1540423|NCT00151775|5041734|P11|Period 4: Open Label|Physician Decision|0
1540424|NCT00151775|5041735|P10|Period 4: Open Label|Physician Decision|2
1540425|NCT00151775|5041736|P9|Period 4: Open Label|Physician Decision|0
1540426|NCT00151775|5041737|P8|Period 4: Open Label|Physician Decision|0
1540427|NCT00151775|5041738|P7|Period 4: Open Label|Physician Decision|0
1540428|NCT00151775|5041739|P6|Period 4: Open Label|Physician Decision|0
1540429|NCT00151775|5041740|P5|Period 4: Open Label|Physician Decision|0
1540430|NCT00151775|5041741|P4|Period 4: Open Label|Physician Decision|0
1540431|NCT00151775|5041742|P3|Period 4: Open Label|Physician Decision|0
1540432|NCT00151775|5041743|P2|Period 4: Open Label|Physician Decision|0
1540433|NCT00151775|5041744|P1|Period 4: Open Label|Physician Decision|0
1540434|NCT00151775|5041733|P12|Period 4: Open Label|Other|0
1540435|NCT00151775|5041734|P11|Period 4: Open Label|Other|0
1540436|NCT00151775|5041735|P10|Period 4: Open Label|Other|3
1540437|NCT00151775|5041736|P9|Period 4: Open Label|Other|0
1540438|NCT00151775|5041737|P8|Period 4: Open Label|Other|0
1540439|NCT00151775|5041738|P7|Period 4: Open Label|Other|0
1540440|NCT00151775|5041739|P6|Period 4: Open Label|Other|0
1540441|NCT00151775|5041740|P5|Period 4: Open Label|Other|1
1540442|NCT00151775|5041741|P4|Period 4: Open Label|Other|0
1540443|NCT00151775|5041742|P3|Period 4: Open Label|Other|0
1540444|NCT00151775|5041743|P2|Period 4: Open Label|Other|0
1540445|NCT00151775|5041744|P1|Period 4: Open Label|Other|0
1540446|NCT00151775|5041733|P12|Period 4: Open Label|Non-compliance with protocol|0
1540447|NCT00151775|5041734|P11|Period 4: Open Label|Non-compliance with protocol|0
1540448|NCT00151775|5041735|P10|Period 4: Open Label|Non-compliance with protocol|4
1540449|NCT00151775|5041736|P9|Period 4: Open Label|Non-compliance with protocol|0
1540450|NCT00151775|5041737|P8|Period 4: Open Label|Non-compliance with protocol|0
1540451|NCT00151775|5041738|P7|Period 4: Open Label|Non-compliance with protocol|0
1540452|NCT00151775|5041739|P6|Period 4: Open Label|Non-compliance with protocol|0
1540453|NCT00151775|5041740|P5|Period 4: Open Label|Non-compliance with protocol|4
1540454|NCT00151775|5041741|P4|Period 4: Open Label|Non-compliance with protocol|0
1540455|NCT00151775|5041742|P3|Period 4: Open Label|Non-compliance with protocol|0
1540456|NCT00151775|5041743|P2|Period 4: Open Label|Non-compliance with protocol|0
1540457|NCT00151775|5041744|P1|Period 4: Open Label|Non-compliance with protocol|0
1540458|NCT00151775|5041733|P12|Period 4: Open Label|Lost to Follow-up|0
1540459|NCT00151775|5041734|P11|Period 4: Open Label|Lost to Follow-up|0
1540460|NCT00151775|5041735|P10|Period 4: Open Label|Lost to Follow-up|7
1540461|NCT00151775|5041736|P9|Period 4: Open Label|Lost to Follow-up|0
1540462|NCT00151775|5041737|P8|Period 4: Open Label|Lost to Follow-up|0
1540463|NCT00151775|5041738|P7|Period 4: Open Label|Lost to Follow-up|0
1540464|NCT00151775|5041739|P6|Period 4: Open Label|Lost to Follow-up|0
1540465|NCT00151775|5041740|P5|Period 4: Open Label|Lost to Follow-up|17
1540466|NCT00151775|5041741|P4|Period 4: Open Label|Lost to Follow-up|0
1540467|NCT00151775|5041742|P3|Period 4: Open Label|Lost to Follow-up|0
1540468|NCT00151775|5041743|P2|Period 4: Open Label|Lost to Follow-up|0
1540469|NCT00151775|5041744|P1|Period 4: Open Label|Lost to Follow-up|0
1540470|NCT00151775|5041733|P12|Period 4: Open Label|Adverse Event|0
1540471|NCT00151775|5041734|P11|Period 4: Open Label|Adverse Event|0
1540472|NCT00151775|5041735|P10|Period 4: Open Label|Adverse Event|2
1540473|NCT00151775|5041736|P9|Period 4: Open Label|Adverse Event|0
1540474|NCT00151775|5041737|P8|Period 4: Open Label|Adverse Event|0
1540475|NCT00151775|5041738|P7|Period 4: Open Label|Adverse Event|0
1540476|NCT00151775|5041739|P6|Period 4: Open Label|Adverse Event|0
1540477|NCT00151775|5041740|P5|Period 4: Open Label|Adverse Event|1
1540478|NCT00151775|5041741|P4|Period 4: Open Label|Adverse Event|0
1540479|NCT00151775|5041742|P3|Period 4: Open Label|Adverse Event|0
1540480|NCT00151775|5041743|P2|Period 4: Open Label|Adverse Event|0
1540481|NCT00151775|5041744|P1|Period 4: Open Label|Adverse Event|0
1540482|NCT00151775|5041733|P12|Period 4: Open Label|Withdrawal by Subject|0
1540483|NCT00151775|5041734|P11|Period 4: Open Label|Withdrawal by Subject|0
1540484|NCT00151775|5041735|P10|Period 4: Open Label|Withdrawal by Subject|2
1540485|NCT00151775|5041736|P9|Period 4: Open Label|Withdrawal by Subject|0
1540486|NCT00151775|5041737|P8|Period 4: Open Label|Withdrawal by Subject|0
1540487|NCT00151775|5041738|P7|Period 4: Open Label|Withdrawal by Subject|0
1540488|NCT00151775|5041739|P6|Period 4: Open Label|Withdrawal by Subject|0
1540489|NCT00151775|5041740|P5|Period 4: Open Label|Withdrawal by Subject|5
1540490|NCT00151775|5041741|P4|Period 4: Open Label|Withdrawal by Subject|0
1540491|NCT00151775|5041742|P3|Period 4: Open Label|Withdrawal by Subject|0
1540492|NCT00151775|5041743|P2|Period 4: Open Label|Withdrawal by Subject|0
1540493|NCT00151775|5041744|P1|Period 4: Open Label|Withdrawal by Subject|0
1540494|NCT00151775|5041733|P12|Period 4: Open Label|Increased blood pressure|0
1540495|NCT00151775|5041734|P11|Period 4: Open Label|Increased blood pressure|0
1540496|NCT00151775|5041735|P10|Period 4: Open Label|Increased blood pressure|1
1540497|NCT00151775|5041736|P9|Period 4: Open Label|Increased blood pressure|0
1540498|NCT00151775|5041737|P8|Period 4: Open Label|Increased blood pressure|0
1540499|NCT00151775|5041738|P7|Period 4: Open Label|Increased blood pressure|0
1540500|NCT00151775|5041739|P6|Period 4: Open Label|Increased blood pressure|0
1540501|NCT00151775|5041740|P5|Period 4: Open Label|Increased blood pressure|1
1540502|NCT00151775|5041741|P4|Period 4: Open Label|Increased blood pressure|0
1540503|NCT00151775|5041742|P3|Period 4: Open Label|Increased blood pressure|0
1540504|NCT00151775|5041743|P2|Period 4: Open Label|Increased blood pressure|0
1540505|NCT00151775|5041744|P1|Period 4: Open Label|Increased blood pressure|0
1540506|NCT00151775|5041733|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
1540507|NCT00151775|5041734|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1540508|NCT00151775|5041735|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1540509|NCT00151775|5041736|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1540510|NCT00151775|5041737|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1540511|NCT00151775|5041738|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1540512|NCT00151775|5041739|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1540513|NCT00151775|5041740|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1540514|NCT00151775|5041741|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1540515|NCT00151775|5041742|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1540516|NCT00151775|5041743|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1540517|NCT00151775|5041744|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1540518|NCT00151775|5041733|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1540519|NCT00151775|5041734|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1540520|NCT00151775|5041735|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1540521|NCT00151775|5041736|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1540522|NCT00151775|5041737|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1540523|NCT00151775|5041738|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1540524|NCT00151775|5041739|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1540525|NCT00151775|5041740|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1540526|NCT00151775|5041741|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1540527|NCT00151775|5041742|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
1540528|NCT00151775|5041743|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1540529|NCT00151775|5041744|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1540530|NCT00151775|5041733|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
1540531|NCT00151775|5041734|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
1540532|NCT00151775|5041735|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
1540533|NCT00151775|5041736|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
1540534|NCT00151775|5041737|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
1540535|NCT00151775|5041738|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
1540536|NCT00151775|5041739|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
1540537|NCT00151775|5041740|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
1540538|NCT00151775|5041741|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
1540539|NCT00151775|5041742|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
1540540|NCT00151775|5041743|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
1540541|NCT00151775|5041744|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
1540542|NCT00151775|5041733|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1540543|NCT00151775|5041734|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1540544|NCT00151775|5041735|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1540545|NCT00151775|5041736|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1540546|NCT00151775|5041737|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1540547|NCT00151775|5041738|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
1540548|NCT00151775|5041739|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1540549|NCT00151775|5041740|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1540550|NCT00151775|5041741|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1540551|NCT00151775|5041742|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1540552|NCT00151775|5041743|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1540553|NCT00151775|5041744|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1540554|NCT00151775|5041733|P12|Period 3: Double-blind, Withdrawal|Other|0
1540555|NCT00151775|5041734|P11|Period 3: Double-blind, Withdrawal|Other|0
1540556|NCT00151775|5041735|P10|Period 3: Double-blind, Withdrawal|Other|0
1540557|NCT00151775|5041736|P9|Period 3: Double-blind, Withdrawal|Other|0
1540558|NCT00151775|5041737|P8|Period 3: Double-blind, Withdrawal|Other|1
1540559|NCT00151775|5041738|P7|Period 3: Double-blind, Withdrawal|Other|0
1540560|NCT00151775|5041739|P6|Period 3: Double-blind, Withdrawal|Other|0
1540561|NCT00151775|5041740|P5|Period 3: Double-blind, Withdrawal|Other|0
1540562|NCT00151775|5041741|P4|Period 3: Double-blind, Withdrawal|Other|0
1540563|NCT00151775|5041742|P3|Period 3: Double-blind, Withdrawal|Other|1
1540564|NCT00151775|5041743|P2|Period 3: Double-blind, Withdrawal|Other|0
1540565|NCT00151775|5041744|P1|Period 3: Double-blind, Withdrawal|Other|0
1540566|NCT00151775|5041733|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1540567|NCT00151775|5041734|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1540568|NCT00151775|5041735|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1540569|NCT00151775|5041736|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1540570|NCT00151775|5041737|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1540571|NCT00151775|5041738|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1540572|NCT00151775|5041739|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
1540729|NCT00150618|5041926|P1|Overall Study|No study meds|0
1540573|NCT00151775|5041740|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1540574|NCT00151775|5041741|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1540575|NCT00151775|5041742|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1540576|NCT00151775|5041743|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1540577|NCT00151775|5041744|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1540578|NCT00151775|5041733|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1540579|NCT00151775|5041734|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1540580|NCT00151775|5041735|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1540581|NCT00151775|5041736|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1540582|NCT00151775|5041737|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1540583|NCT00151775|5041738|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
1540584|NCT00151775|5041739|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1540585|NCT00151775|5041740|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1540586|NCT00151775|5041741|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1540587|NCT00151775|5041742|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1540588|NCT00151775|5041743|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1540589|NCT00151775|5041744|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1540590|NCT00151775|5041733|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
1540591|NCT00151775|5041734|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
1540592|NCT00151775|5041735|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
1540593|NCT00151775|5041736|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
1540594|NCT00151775|5041737|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
1540595|NCT00151775|5041738|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
1540596|NCT00151775|5041739|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
1540597|NCT00151775|5041740|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
1540598|NCT00151775|5041741|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
1540599|NCT00151775|5041742|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
1540600|NCT00151775|5041743|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
1540601|NCT00151775|5041744|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
1540602|NCT00151775|5041733|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
1540603|NCT00151775|5041734|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
1540604|NCT00151775|5041735|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
1540605|NCT00151775|5041736|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
1540606|NCT00151775|5041737|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
1540607|NCT00151775|5041738|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
1540608|NCT00151775|5041739|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
1540609|NCT00151775|5041740|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
1540610|NCT00151775|5041741|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
1540611|NCT00151775|5041742|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
1540612|NCT00151775|5041743|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
1540613|NCT00151775|5041744|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
1540614|NCT00151775|5041733|P12|Period 2 - Double-Blind Dose Response|Other|0
1540615|NCT00151775|5041734|P11|Period 2 - Double-Blind Dose Response|Other|0
1540616|NCT00151775|5041735|P10|Period 2 - Double-Blind Dose Response|Other|0
1540617|NCT00151775|5041736|P9|Period 2 - Double-Blind Dose Response|Other|0
1540618|NCT00151775|5041737|P8|Period 2 - Double-Blind Dose Response|Other|0
1540619|NCT00151775|5041738|P7|Period 2 - Double-Blind Dose Response|Other|1
1540620|NCT00151775|5041739|P6|Period 2 - Double-Blind Dose Response|Other|0
1540621|NCT00151775|5041740|P5|Period 2 - Double-Blind Dose Response|Other|0
1540622|NCT00151775|5041741|P4|Period 2 - Double-Blind Dose Response|Other|0
1540623|NCT00151775|5041742|P3|Period 2 - Double-Blind Dose Response|Other|0
1540624|NCT00151775|5041743|P2|Period 2 - Double-Blind Dose Response|Other|0
1540625|NCT00151775|5041744|P1|Period 2 - Double-Blind Dose Response|Other|0
1540626|NCT00151775|5041733|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1540627|NCT00151775|5041734|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1540628|NCT00151775|5041735|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1540629|NCT00151775|5041736|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1540630|NCT00151775|5041737|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1540631|NCT00151775|5041738|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1540632|NCT00151775|5041739|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1540633|NCT00151775|5041740|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1540634|NCT00151775|5041741|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1540635|NCT00151775|5041742|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1540636|NCT00151775|5041743|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
1540637|NCT00151775|5041744|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1540638|NCT00151775|5041733|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1540639|NCT00151775|5041734|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
1540640|NCT00151775|5041735|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1540641|NCT00151775|5041736|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1540642|NCT00151775|5041737|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1540643|NCT00151775|5041738|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
1540644|NCT00151775|5041739|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1540645|NCT00151775|5041740|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1540646|NCT00151775|5041741|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1540647|NCT00151775|5041742|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1540648|NCT00151775|5041743|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1540649|NCT00151775|5041744|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
1540650|NCT00151775|5041733|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
1540651|NCT00151775|5041734|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
1540652|NCT00151775|5041735|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
1540653|NCT00151775|5041736|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
1540654|NCT00151775|5041737|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
1540655|NCT00151775|5041738|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
1540656|NCT00151775|5041739|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
1540657|NCT00151775|5041740|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
1540658|NCT00151775|5041741|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
1540659|NCT00151775|5041742|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
1540660|NCT00151775|5041743|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
1540661|NCT00151775|5041744|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
1540662|NCT00151476|5041788|P2|FAP Analyzed Subjects|Other study participation|1
1540663|NCT00151476|5041789|P1|FAP Analyzed Subjects|Other study participation|0
1540664|NCT00151476|5041788|P2|FAP Analyzed Subjects|Lost to Follow-up|2
1540665|NCT00151476|5041789|P1|FAP Analyzed Subjects|Lost to Follow-up|0
1540666|NCT00151476|5041788|P2|FAP Identified Subjects|Protocol Violation|1
1540667|NCT00151476|5041789|P1|FAP Identified Subjects|Protocol Violation|0
1540668|NCT00151411|5041846|P2|Overall Study|Pregnancy|4
1540669|NCT00151411|5041847|P1|Overall Study|Pregnancy|0
1540670|NCT00151411|5041846|P2|Overall Study|Adverse Event|0
1540671|NCT00151411|5041847|P1|Overall Study|Adverse Event|6
1540672|NCT00151411|5041846|P2|Overall Study|Withdrawal by Subject|20
1540673|NCT00151411|5041847|P1|Overall Study|Withdrawal by Subject|12
1540674|NCT00151411|5041846|P2|Overall Study|Lost to Follow-up|19
1540675|NCT00151411|5041847|P1|Overall Study|Lost to Follow-up|15
1540676|NCT00151372|5041859|P2|Overall Study|Withdrawal by Subject|7
1540677|NCT00151372|5041860|P1|Overall Study|Withdrawal by Subject|7
1540678|NCT00151372|5041859|P2|Overall Study|Too sick medically to continue|6
1540679|NCT00151372|5041860|P1|Overall Study|Too sick medically to continue|5
1540680|NCT00151372|5041859|P2|Overall Study|Lost to Follow-up|5
1540681|NCT00151372|5041860|P1|Overall Study|Lost to Follow-up|5
1540682|NCT00151372|5041859|P2|Overall Study|Death|11
1540683|NCT00151372|5041860|P1|Overall Study|Death|12
1540684|NCT00151281|5041875|P1|Overall Study|Not evaluable|3
1540685|NCT00150969|5041884|P2|24-48 Month Extension|Other Reason|91
1540686|NCT00150969|5041885|P1|24-48 Month Extension|Other Reason|81
1540687|NCT00150969|5041884|P2|24-48 Month Extension|Adverse Event|3
1540688|NCT00150969|5041885|P1|24-48 Month Extension|Adverse Event|1
1540689|NCT00150969|5041884|P2|24-48 Month Extension|Lack of Efficacy|1
1540690|NCT00150969|5041885|P1|24-48 Month Extension|Lack of Efficacy|0
1540691|NCT00150969|5041884|P2|24-48 Month Extension|Withdrawal by Subject|5
1540692|NCT00150969|5041885|P1|24-48 Month Extension|Withdrawal by Subject|6
1540693|NCT00150969|5041884|P2|24 Month Main Study|Withdrawal by Subject|4
1540694|NCT00150969|5041885|P1|24 Month Main Study|Withdrawal by Subject|7
1540695|NCT00150969|5041884|P2|24 Month Main Study|Protocol Violation|2
1540696|NCT00150969|5041885|P1|24 Month Main Study|Protocol Violation|4
1540697|NCT00150969|5041884|P2|24 Month Main Study|Lost to Follow-up|2
1540698|NCT00150969|5041885|P1|24 Month Main Study|Lost to Follow-up|3
1540699|NCT00150969|5041884|P2|24 Month Main Study|Lack of Efficacy|8
1540700|NCT00150969|5041885|P1|24 Month Main Study|Lack of Efficacy|1
1540701|NCT00150969|5041884|P2|24 Month Main Study|Death|1
1540702|NCT00150969|5041885|P1|24 Month Main Study|Death|1
1540703|NCT00150969|5041884|P2|24 Month Main Study|Adverse Event|4
1540704|NCT00150969|5041885|P1|24 Month Main Study|Adverse Event|3
1540705|NCT00150618|5041922|P5|Overall Study|Sponsor's decision|0
1540706|NCT00150618|5041923|P4|Overall Study|Sponsor's decision|1
1540707|NCT00150618|5041924|P3|Overall Study|Sponsor's decision|0
1540708|NCT00150618|5041925|P2|Overall Study|Sponsor's decision|0
1540709|NCT00150618|5041926|P1|Overall Study|Sponsor's decision|0
1540710|NCT00150618|5041922|P5|Overall Study|Abnormal ECG|0
1540711|NCT00150618|5041923|P4|Overall Study|Abnormal ECG|0
1540712|NCT00150618|5041924|P3|Overall Study|Abnormal ECG|0
1540713|NCT00150618|5041925|P2|Overall Study|Abnormal ECG|0
1540714|NCT00150618|5041926|P1|Overall Study|Abnormal ECG|1
1540715|NCT00150618|5041922|P5|Overall Study|Lack of compliance|1
1540716|NCT00150618|5041923|P4|Overall Study|Lack of compliance|0
1540717|NCT00150618|5041924|P3|Overall Study|Lack of compliance|1
1540718|NCT00150618|5041925|P2|Overall Study|Lack of compliance|1
1540719|NCT00150618|5041926|P1|Overall Study|Lack of compliance|2
1540720|NCT00150618|5041922|P5|Overall Study|Physician Decision|1
1540721|NCT00150618|5041923|P4|Overall Study|Physician Decision|0
1540722|NCT00150618|5041924|P3|Overall Study|Physician Decision|0
1540723|NCT00150618|5041925|P2|Overall Study|Physician Decision|2
1540724|NCT00150618|5041926|P1|Overall Study|Physician Decision|0
1540725|NCT00150618|5041922|P5|Overall Study|No study meds|2
1540726|NCT00150618|5041923|P4|Overall Study|No study meds|0
1540727|NCT00150618|5041924|P3|Overall Study|No study meds|0
1540728|NCT00150618|5041925|P2|Overall Study|No study meds|0
1540730|NCT00150618|5041922|P5|Overall Study|Lack of Efficacy|6
1540731|NCT00150618|5041923|P4|Overall Study|Lack of Efficacy|4
1540732|NCT00150618|5041924|P3|Overall Study|Lack of Efficacy|7
1540733|NCT00150618|5041925|P2|Overall Study|Lack of Efficacy|4
1540734|NCT00150618|5041926|P1|Overall Study|Lack of Efficacy|1
1540735|NCT00150618|5041922|P5|Overall Study|Protocol Violation|1
1540736|NCT00150618|5041923|P4|Overall Study|Protocol Violation|0
1540737|NCT00150618|5041924|P3|Overall Study|Protocol Violation|0
1540738|NCT00150618|5041925|P2|Overall Study|Protocol Violation|0
1540739|NCT00150618|5041926|P1|Overall Study|Protocol Violation|1
1540740|NCT00150618|5041922|P5|Overall Study|Lost to Follow-up|4
1540741|NCT00150618|5041923|P4|Overall Study|Lost to Follow-up|8
1540742|NCT00150618|5041924|P3|Overall Study|Lost to Follow-up|5
1540743|NCT00150618|5041925|P2|Overall Study|Lost to Follow-up|1
1540744|NCT00150618|5041926|P1|Overall Study|Lost to Follow-up|4
1540745|NCT00150618|5041922|P5|Overall Study|Withdrawal by Subject|5
1540746|NCT00150618|5041923|P4|Overall Study|Withdrawal by Subject|4
1540747|NCT00150618|5041924|P3|Overall Study|Withdrawal by Subject|8
1540748|NCT00150618|5041925|P2|Overall Study|Withdrawal by Subject|8
1540749|NCT00150618|5041926|P1|Overall Study|Withdrawal by Subject|6
1540750|NCT00150618|5041922|P5|Overall Study|Adverse Event|5
1540751|NCT00150618|5041923|P4|Overall Study|Adverse Event|9
1540752|NCT00150618|5041924|P3|Overall Study|Adverse Event|6
1540753|NCT00150618|5041925|P2|Overall Study|Adverse Event|2
1540754|NCT00150618|5041926|P1|Overall Study|Adverse Event|2
1540755|NCT00150592|5041960|P2|Overall Study|Non-compliance|0
1540756|NCT00150592|5041961|P1|Overall Study|Non-compliance|1
1540757|NCT00150592|5041960|P2|Overall Study|Withdrawal by Subject|2
1540758|NCT00150592|5041961|P1|Overall Study|Withdrawal by Subject|1
1540759|NCT00150592|5041960|P2|Overall Study|Protocol Violation|0
1540760|NCT00150592|5041961|P1|Overall Study|Protocol Violation|1
1540761|NCT00150592|5041960|P2|Overall Study|Adverse Event|1
1540762|NCT00150592|5041961|P1|Overall Study|Adverse Event|4
1540763|NCT00150462|5041992|P11|Overall Study|Other|1
1540764|NCT00150462|5041993|P10|Overall Study|Other|1
1540765|NCT00150462|5041994|P9|Overall Study|Other|0
1540766|NCT00150462|5041995|P8|Overall Study|Other|0
1540767|NCT00150462|5041996|P7|Overall Study|Other|0
1540768|NCT00150462|5041997|P6|Overall Study|Other|0
1540769|NCT00150462|5041998|P5|Overall Study|Other|0
1540770|NCT00150462|5041999|P4|Overall Study|Other|0
1540771|NCT00150462|5042000|P3|Overall Study|Other|0
1540772|NCT00150462|5042001|P2|Overall Study|Other|0
1540773|NCT00150462|5042002|P1|Overall Study|Other|0
1540774|NCT00150462|5041992|P11|Overall Study|Physician Decision|0
1540775|NCT00150462|5041993|P10|Overall Study|Physician Decision|0
1540776|NCT00150462|5041994|P9|Overall Study|Physician Decision|0
1540777|NCT00150462|5041995|P8|Overall Study|Physician Decision|0
1540778|NCT00150462|5041996|P7|Overall Study|Physician Decision|0
1540779|NCT00150462|5041997|P6|Overall Study|Physician Decision|0
1540780|NCT00150462|5041998|P5|Overall Study|Physician Decision|0
1540781|NCT00150462|5041999|P4|Overall Study|Physician Decision|1
1540782|NCT00150462|5042000|P3|Overall Study|Physician Decision|1
1540783|NCT00150462|5042001|P2|Overall Study|Physician Decision|0
1540784|NCT00150462|5042002|P1|Overall Study|Physician Decision|0
1540785|NCT00150462|5041992|P11|Overall Study|Adverse Event|0
1540786|NCT00150462|5041993|P10|Overall Study|Adverse Event|1
1540787|NCT00150462|5041994|P9|Overall Study|Adverse Event|0
1540788|NCT00150462|5041995|P8|Overall Study|Adverse Event|2
1540789|NCT00150462|5041996|P7|Overall Study|Adverse Event|0
1540790|NCT00150462|5041997|P6|Overall Study|Adverse Event|0
1540791|NCT00150462|5041998|P5|Overall Study|Adverse Event|0
1540792|NCT00150462|5041999|P4|Overall Study|Adverse Event|1
1540793|NCT00150462|5042000|P3|Overall Study|Adverse Event|0
1540794|NCT00150462|5042001|P2|Overall Study|Adverse Event|0
1540795|NCT00150462|5042002|P1|Overall Study|Adverse Event|0
1540796|NCT00150462|5041992|P11|Overall Study|Death|0
1540797|NCT00150462|5041993|P10|Overall Study|Death|0
1540798|NCT00150462|5041994|P9|Overall Study|Death|1
1540799|NCT00150462|5041995|P8|Overall Study|Death|0
1540800|NCT00150462|5041996|P7|Overall Study|Death|0
1540801|NCT00150462|5041997|P6|Overall Study|Death|0
1540802|NCT00150462|5041998|P5|Overall Study|Death|0
1540803|NCT00150462|5041999|P4|Overall Study|Death|0
1540804|NCT00150462|5042000|P3|Overall Study|Death|0
1540805|NCT00150462|5042001|P2|Overall Study|Death|1
1540806|NCT00150462|5042002|P1|Overall Study|Death|0
1540807|NCT00150462|5041992|P11|Overall Study|Withdrawal by Subject|0
1540808|NCT00150462|5041993|P10|Overall Study|Withdrawal by Subject|1
1540809|NCT00150462|5041994|P9|Overall Study|Withdrawal by Subject|0
1540810|NCT00150462|5041995|P8|Overall Study|Withdrawal by Subject|1
1540811|NCT00150462|5041996|P7|Overall Study|Withdrawal by Subject|0
1540812|NCT00150462|5041997|P6|Overall Study|Withdrawal by Subject|2
1540813|NCT00150462|5041998|P5|Overall Study|Withdrawal by Subject|1
1540814|NCT00150462|5041999|P4|Overall Study|Withdrawal by Subject|0
1540815|NCT00150462|5042000|P3|Overall Study|Withdrawal by Subject|1
1540816|NCT00150462|5042001|P2|Overall Study|Withdrawal by Subject|1
1540817|NCT00150462|5042002|P1|Overall Study|Withdrawal by Subject|0
1540818|NCT00150462|5041992|P11|Overall Study|Disease Progression or Relapse|2
1540819|NCT00150462|5041993|P10|Overall Study|Disease Progression or Relapse|3
1540820|NCT00150462|5041994|P9|Overall Study|Disease Progression or Relapse|5
1540821|NCT00150462|5041995|P8|Overall Study|Disease Progression or Relapse|5
1540822|NCT00150462|5041996|P7|Overall Study|Disease Progression or Relapse|3
1540823|NCT00150462|5041997|P6|Overall Study|Disease Progression or Relapse|2
1540824|NCT00150462|5041998|P5|Overall Study|Disease Progression or Relapse|2
1540825|NCT00150462|5041999|P4|Overall Study|Disease Progression or Relapse|1
1540826|NCT00150462|5042000|P3|Overall Study|Disease Progression or Relapse|2
1540827|NCT00150462|5042001|P2|Overall Study|Disease Progression or Relapse|1
1540828|NCT00150462|5042002|P1|Overall Study|Disease Progression or Relapse|3
1540829|NCT00150345|5042112|P2|Overall Study|Other|14
1540830|NCT00150345|5042113|P1|Overall Study|Other|12
1540831|NCT00150345|5042112|P2|Overall Study|Laboratory abnormality|2
1540832|NCT00150345|5042113|P1|Overall Study|Laboratory abnormality|1
1540833|NCT00150345|5042112|P2|Overall Study|Withdrawal by Subject|4
1540834|NCT00150345|5042113|P1|Overall Study|Withdrawal by Subject|3
1540835|NCT00150345|5042112|P2|Overall Study|Lack of Efficacy|4
1540836|NCT00150345|5042113|P1|Overall Study|Lack of Efficacy|5
1540837|NCT00150345|5042112|P2|Overall Study|Adverse Event|6
1540838|NCT00150345|5042113|P1|Overall Study|Adverse Event|8
1540839|NCT00150345|5042112|P2|Overall Study|Death|2
1540840|NCT00150345|5042113|P1|Overall Study|Death|5
1540841|NCT00150176|5042177|P2|Overall Study|OTHER|13
1540842|NCT00150176|5042178|P1|Overall Study|OTHER|11
1540843|NCT00150176|5042177|P2|Overall Study|Lost to Follow-up|3
1540844|NCT00150176|5042178|P1|Overall Study|Lost to Follow-up|3
1540845|NCT00150176|5042177|P2|Overall Study|Withdrawal by Subject|12
1540846|NCT00150176|5042178|P1|Overall Study|Withdrawal by Subject|19
1540847|NCT00150176|5042177|P2|Overall Study|Relapse/Impending relapse, non-AE|39
1540848|NCT00150176|5042178|P1|Overall Study|Relapse/Impending relapse, non-AE|10
1540849|NCT00150176|5042177|P2|Overall Study|Adverse Event|53
1540850|NCT00150176|5042178|P1|Overall Study|Adverse Event|16
1540851|NCT00149994|5042189|P2|Overall Study|Protocol Violation|1
1540852|NCT00149994|5042190|P1|Overall Study|Protocol Violation|0
1540853|NCT00149994|5042189|P2|Overall Study|Administrative problems:|0
1540854|NCT00149994|5042190|P1|Overall Study|Administrative problems:|1
1540855|NCT00149890|5042198|P2|Overall Study|Graft Loss|1
1540856|NCT00149890|5042199|P1|Overall Study|Graft Loss|2
1540857|NCT00149890|5042198|P2|Overall Study|Lost to Follow-up|0
1540858|NCT00149890|5042199|P1|Overall Study|Lost to Follow-up|1
1540859|NCT00149890|5042198|P2|Overall Study|Protocol Violation|0
1540860|NCT00149890|5042199|P1|Overall Study|Protocol Violation|1
1540861|NCT00149890|5042198|P2|Overall Study|Lack of Efficacy|9
1540862|NCT00149890|5042199|P1|Overall Study|Lack of Efficacy|8
1540863|NCT00149890|5042198|P2|Overall Study|Adverse Event|8
1540864|NCT00149890|5042199|P1|Overall Study|Adverse Event|1
1540865|NCT00149825|5042219|P2|Overall Study|Other|0
1540866|NCT00149825|5042220|P1|Overall Study|Other|1
1540867|NCT00149825|5042219|P2|Overall Study|Not liking insomnia therapy|0
1540868|NCT00149825|5042220|P1|Overall Study|Not liking insomnia therapy|1
1540869|NCT00149825|5042219|P2|Overall Study|Time commitments|1
1540870|NCT00149825|5042220|P1|Overall Study|Time commitments|2
1540871|NCT00149825|5042219|P2|Overall Study|Intolerance to medication side effects|2
1540872|NCT00149825|5042220|P1|Overall Study|Intolerance to medication side effects|1
1540873|NCT00149747|5042248|P2|Overall Study|Withdrawal by Subject|3
1540874|NCT00149747|5042249|P1|Overall Study|Withdrawal by Subject|3
1540875|NCT00149747|5042248|P2|Overall Study|Death|0
1540876|NCT00149747|5042249|P1|Overall Study|Death|1
1540877|NCT00149630|5042295|P2|Overall Study|Adverse Event|0
1540878|NCT00149630|5042296|P1|Overall Study|Adverse Event|2
1540879|NCT00149630|5042295|P2|Overall Study|Treatment Programs|5
1540880|NCT00149630|5042296|P1|Overall Study|Treatment Programs|4
1540881|NCT00149630|5042295|P2|Overall Study|Incarceration|0
1540882|NCT00149630|5042296|P1|Overall Study|Incarceration|2
1540883|NCT00149396|5042306|P1|Overall Study|other treatment|5
1540884|NCT00149396|5042306|P1|Overall Study|Subject noncompliance|2
1540885|NCT00149396|5042306|P1|Overall Study|Withdrawal by Subject|1
1540886|NCT00149396|5042306|P1|Overall Study|Death|15
1540887|NCT00149214|5042376|P2|Overall Study|Progressive Disease|3
1540888|NCT00149214|5042377|P1|Overall Study|Progressive Disease|7
1540889|NCT00149214|5042376|P2|Overall Study|Sponsor Decision|1
1540890|NCT00149214|5042377|P1|Overall Study|Sponsor Decision|0
1540891|NCT00149214|5042376|P2|Overall Study|Physician Decision|3
1540892|NCT00149214|5042377|P1|Overall Study|Physician Decision|3
1540893|NCT00149214|5042376|P2|Overall Study|Withdrawal by Subject|1
1540894|NCT00149214|5042377|P1|Overall Study|Withdrawal by Subject|4
1540895|NCT00149214|5042376|P2|Overall Study|Adverse Event|9
1540896|NCT00149214|5042377|P1|Overall Study|Adverse Event|12
1540897|NCT00148759|5042425|P2|Overall Study|Lost to Follow-up|0
1540898|NCT00148759|5042426|P1|Overall Study|Lost to Follow-up|1
1540899|NCT00148759|5042425|P2|Overall Study|Withdrawal by Subject|1
1540900|NCT00148759|5042426|P1|Overall Study|Withdrawal by Subject|1
1540901|NCT00148343|5042454|P2|Overall Study|Physician Decision|4
1540902|NCT00148343|5042455|P1|Overall Study|Physician Decision|3
1540903|NCT00148343|5042454|P2|Overall Study|Withdrawal by Subject|7
1540904|NCT00148343|5042455|P1|Overall Study|Withdrawal by Subject|12
1540905|NCT00148317|5042469|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
1540906|NCT00148317|5042469|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
1540907|NCT00148317|5042469|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
1540908|NCT00148122|5042476|P1|Overall Study|Withdrawal by Subject|2
1540909|NCT00148109|5042484|P2|Overall Study|Withdrawal by Subject|0
1540910|NCT00148109|5042485|P1|Overall Study|Withdrawal by Subject|2
1540911|NCT00148109|5042484|P2|Overall Study|Adverse Event|2
1540912|NCT00148109|5042485|P1|Overall Study|Adverse Event|0
1540913|NCT00148109|5042484|P2|Overall Study|Lack of Efficacy|18
1540914|NCT00148109|5042485|P1|Overall Study|Lack of Efficacy|10
1540915|NCT00147823|5042501|P2|Overall Study|Did not receive vitoss due to infection|2
1540916|NCT00147823|5042502|P1|Overall Study|Did not receive vitoss due to infection|6
1540917|NCT00147823|5042501|P2|Overall Study|Withdrawal by Subject|1
1540918|NCT00147823|5042502|P1|Overall Study|Withdrawal by Subject|0
1540919|NCT00147823|5042501|P2|Overall Study|Physician Decision|0
1540920|NCT00147823|5042502|P1|Overall Study|Physician Decision|1
1540921|NCT00147823|5042501|P2|Overall Study|Lost to Follow-up|12
1540922|NCT00147823|5042502|P1|Overall Study|Lost to Follow-up|6
1540923|NCT00147745|5042533|P3|Overall Study|Withdrawal by Subject|0
1540924|NCT00147745|5042534|P2|Overall Study|Withdrawal by Subject|0
1540925|NCT00147745|5042535|P1|Overall Study|Withdrawal by Subject|1
1540926|NCT00147537|5042557|P11|Phase 2|Randomized but not treated|1
1540927|NCT00147537|5042558|P10|Phase 2|Randomized but not treated|1
1540928|NCT00147537|5042559|P9|Phase 2|Randomized but not treated|0
1540929|NCT00147537|5042560|P8|Phase 2|Randomized but not treated|0
1540930|NCT00147537|5042561|P7|Phase 2|Randomized but not treated|0
1540931|NCT00147537|5042562|P6|Phase 2|Randomized but not treated|0
1540932|NCT00147537|5042563|P5|Phase 2|Randomized but not treated|0
1540933|NCT00147537|5042564|P4|Phase 2|Randomized but not treated|0
1540934|NCT00147537|5042565|P3|Phase 2|Randomized but not treated|0
1540935|NCT00147537|5042566|P2|Phase 2|Randomized but not treated|0
1540936|NCT00147537|5042567|P1|Phase 2|Randomized but not treated|0
1540937|NCT00147537|5042557|P11|Phase 2|Withdrawal by Subject|4
1540938|NCT00147537|5042558|P10|Phase 2|Withdrawal by Subject|16
1540939|NCT00147537|5042559|P9|Phase 2|Withdrawal by Subject|0
1540940|NCT00147537|5042560|P8|Phase 2|Withdrawal by Subject|0
1540941|NCT00147537|5042561|P7|Phase 2|Withdrawal by Subject|0
1540942|NCT00147537|5042562|P6|Phase 2|Withdrawal by Subject|0
1540943|NCT00147537|5042563|P5|Phase 2|Withdrawal by Subject|0
1540944|NCT00147537|5042564|P4|Phase 2|Withdrawal by Subject|0
1540945|NCT00147537|5042565|P3|Phase 2|Withdrawal by Subject|0
1540946|NCT00147537|5042566|P2|Phase 2|Withdrawal by Subject|0
1540947|NCT00147537|5042567|P1|Phase 2|Withdrawal by Subject|0
1540948|NCT00147537|5042557|P11|Phase 2|Other|12
1540949|NCT00147537|5042558|P10|Phase 2|Other|47
1540950|NCT00147537|5042559|P9|Phase 2|Other|0
1540951|NCT00147537|5042560|P8|Phase 2|Other|0
1540952|NCT00147537|5042561|P7|Phase 2|Other|0
1540953|NCT00147537|5042562|P6|Phase 2|Other|0
1540954|NCT00147537|5042563|P5|Phase 2|Other|0
1540955|NCT00147537|5042564|P4|Phase 2|Other|0
1540956|NCT00147537|5042565|P3|Phase 2|Other|0
1540957|NCT00147537|5042566|P2|Phase 2|Other|0
1540958|NCT00147537|5042567|P1|Phase 2|Other|0
1540959|NCT00147537|5042557|P11|Phase 2|Lost to Follow-up|4
1540960|NCT00147537|5042558|P10|Phase 2|Lost to Follow-up|12
1540961|NCT00147537|5042559|P9|Phase 2|Lost to Follow-up|0
1540962|NCT00147537|5042560|P8|Phase 2|Lost to Follow-up|0
1540963|NCT00147537|5042561|P7|Phase 2|Lost to Follow-up|0
1540964|NCT00147537|5042562|P6|Phase 2|Lost to Follow-up|0
1540965|NCT00147537|5042563|P5|Phase 2|Lost to Follow-up|0
1540966|NCT00147537|5042564|P4|Phase 2|Lost to Follow-up|0
1540967|NCT00147537|5042565|P3|Phase 2|Lost to Follow-up|0
1540968|NCT00147537|5042566|P2|Phase 2|Lost to Follow-up|0
1540969|NCT00147537|5042567|P1|Phase 2|Lost to Follow-up|0
1540970|NCT00147537|5042557|P11|Phase 2|Death|31
1540971|NCT00147537|5042558|P10|Phase 2|Death|85
1540972|NCT00147537|5042559|P9|Phase 2|Death|0
1540973|NCT00147537|5042560|P8|Phase 2|Death|0
1540974|NCT00147537|5042561|P7|Phase 2|Death|0
1540975|NCT00147537|5042562|P6|Phase 2|Death|0
1540976|NCT00147537|5042563|P5|Phase 2|Death|0
1540977|NCT00147537|5042564|P4|Phase 2|Death|0
1540978|NCT00147537|5042565|P3|Phase 2|Death|0
1540979|NCT00147537|5042566|P2|Phase 2|Death|0
1540980|NCT00147537|5042567|P1|Phase 2|Death|0
1540981|NCT00147537|5042557|P11|Phase 1b|Randomized but not treated|0
1540982|NCT00147537|5042558|P10|Phase 1b|Randomized but not treated|0
1540983|NCT00147537|5042559|P9|Phase 1b|Randomized but not treated|1
1540984|NCT00147537|5042560|P8|Phase 1b|Randomized but not treated|0
1540985|NCT00147537|5042561|P7|Phase 1b|Randomized but not treated|1
1540986|NCT00147537|5042562|P6|Phase 1b|Randomized but not treated|0
1540987|NCT00147537|5042563|P5|Phase 1b|Randomized but not treated|0
1540988|NCT00147537|5042564|P4|Phase 1b|Randomized but not treated|0
1540989|NCT00147537|5042565|P3|Phase 1b|Randomized but not treated|0
1540990|NCT00147537|5042566|P2|Phase 1b|Randomized but not treated|0
1540991|NCT00147537|5042567|P1|Phase 1b|Randomized but not treated|0
1540992|NCT00147537|5042557|P11|Phase 1b|Withdrawal by Subject|0
1540993|NCT00147537|5042558|P10|Phase 1b|Withdrawal by Subject|0
1540994|NCT00147537|5042559|P9|Phase 1b|Withdrawal by Subject|2
1540995|NCT00147537|5042560|P8|Phase 1b|Withdrawal by Subject|0
1540996|NCT00147537|5042561|P7|Phase 1b|Withdrawal by Subject|0
1540997|NCT00147537|5042562|P6|Phase 1b|Withdrawal by Subject|0
1540998|NCT00147537|5042563|P5|Phase 1b|Withdrawal by Subject|0
1540999|NCT00147537|5042564|P4|Phase 1b|Withdrawal by Subject|0
1541000|NCT00147537|5042565|P3|Phase 1b|Withdrawal by Subject|0
1541001|NCT00147537|5042566|P2|Phase 1b|Withdrawal by Subject|0
1541002|NCT00147537|5042567|P1|Phase 1b|Withdrawal by Subject|0
1541003|NCT00147537|5042557|P11|Phase 1b|Other|0
1541004|NCT00147537|5042558|P10|Phase 1b|Other|0
1541005|NCT00147537|5042559|P9|Phase 1b|Other|4
1541006|NCT00147537|5042560|P8|Phase 1b|Other|4
1541007|NCT00147537|5042561|P7|Phase 1b|Other|14
1541008|NCT00147537|5042562|P6|Phase 1b|Other|1
1541009|NCT00147537|5042563|P5|Phase 1b|Other|1
1541010|NCT00147537|5042564|P4|Phase 1b|Other|1
1541011|NCT00147537|5042565|P3|Phase 1b|Other|2
1541012|NCT00147537|5042566|P2|Phase 1b|Other|0
1541013|NCT00147537|5042567|P1|Phase 1b|Other|0
1541014|NCT00147537|5042557|P11|Phase 1b|Lost to Follow-up|0
1541015|NCT00147537|5042558|P10|Phase 1b|Lost to Follow-up|0
1541016|NCT00147537|5042559|P9|Phase 1b|Lost to Follow-up|1
1541017|NCT00147537|5042560|P8|Phase 1b|Lost to Follow-up|0
1541018|NCT00147537|5042561|P7|Phase 1b|Lost to Follow-up|2
1541019|NCT00147537|5042562|P6|Phase 1b|Lost to Follow-up|0
1541020|NCT00147537|5042563|P5|Phase 1b|Lost to Follow-up|0
1541021|NCT00147537|5042564|P4|Phase 1b|Lost to Follow-up|0
1541022|NCT00147537|5042565|P3|Phase 1b|Lost to Follow-up|0
1541023|NCT00147537|5042566|P2|Phase 1b|Lost to Follow-up|1
1541024|NCT00147537|5042567|P1|Phase 1b|Lost to Follow-up|2
1541025|NCT00147537|5042557|P11|Phase 1b|Death|0
1541026|NCT00147537|5042558|P10|Phase 1b|Death|0
1541027|NCT00147537|5042559|P9|Phase 1b|Death|9
1541028|NCT00147537|5042560|P8|Phase 1b|Death|3
1541029|NCT00147537|5042561|P7|Phase 1b|Death|1
1541030|NCT00147537|5042562|P6|Phase 1b|Death|2
1541031|NCT00147537|5042563|P5|Phase 1b|Death|2
1541032|NCT00147537|5042564|P4|Phase 1b|Death|1
1541033|NCT00147537|5042565|P3|Phase 1b|Death|2
1541034|NCT00147537|5042566|P2|Phase 1b|Death|1
1541035|NCT00147537|5042567|P1|Phase 1b|Death|0
1541036|NCT00147498|5042750|P4|Overall Study|Other|3
1541037|NCT00147498|5042751|P3|Overall Study|Other|3
1541038|NCT00147498|5042752|P2|Overall Study|Other|1
1541039|NCT00147498|5042753|P1|Overall Study|Other|1
1541040|NCT00147498|5042750|P4|Overall Study|Participant defaulted|3
1541041|NCT00147498|5042751|P3|Overall Study|Participant defaulted|4
1541042|NCT00147498|5042752|P2|Overall Study|Participant defaulted|1
1541043|NCT00147498|5042753|P1|Overall Study|Participant defaulted|0
1541044|NCT00147498|5042750|P4|Overall Study|Laboratory abnormality|0
1541045|NCT00147498|5042751|P3|Overall Study|Laboratory abnormality|2
1541046|NCT00147498|5042752|P2|Overall Study|Laboratory abnormality|0
1541047|NCT00147498|5042753|P1|Overall Study|Laboratory abnormality|0
1541048|NCT00147498|5042750|P4|Overall Study|Lack of Efficacy|8
1541049|NCT00147498|5042751|P3|Overall Study|Lack of Efficacy|1
1541050|NCT00147498|5042752|P2|Overall Study|Lack of Efficacy|1
1541051|NCT00147498|5042753|P1|Overall Study|Lack of Efficacy|1
1541052|NCT00147498|5042750|P4|Overall Study|Adverse Event|3
1541053|NCT00147498|5042751|P3|Overall Study|Adverse Event|7
1541054|NCT00147498|5042752|P2|Overall Study|Adverse Event|6
1541055|NCT00147498|5042753|P1|Overall Study|Adverse Event|1
1541056|NCT00147238|5042877|P1|Overall Study|Inevaluable|8
1541057|NCT00147225|5042887|P6|Overall Study|Chemotherapy Changed|1
1541058|NCT00147225|5042888|P5|Overall Study|Chemotherapy Changed|0
1541059|NCT00147225|5042889|P4|Overall Study|Chemotherapy Changed|0
1541060|NCT00147225|5042890|P3|Overall Study|Chemotherapy Changed|0
1541061|NCT00147225|5042891|P2|Overall Study|Chemotherapy Changed|0
1541062|NCT00147225|5042892|P1|Overall Study|Chemotherapy Changed|0
1541063|NCT00147225|5042887|P6|Overall Study|Screen Failure|0
1541064|NCT00147225|5042888|P5|Overall Study|Screen Failure|1
1541065|NCT00147225|5042889|P4|Overall Study|Screen Failure|0
1541066|NCT00147225|5042890|P3|Overall Study|Screen Failure|0
1541067|NCT00147225|5042891|P2|Overall Study|Screen Failure|0
1541068|NCT00147225|5042892|P1|Overall Study|Screen Failure|0
1541069|NCT00147225|5042887|P6|Overall Study|Adverse Event|0
1541070|NCT00147225|5042888|P5|Overall Study|Adverse Event|0
1541071|NCT00147225|5042889|P4|Overall Study|Adverse Event|1
1541072|NCT00147225|5042890|P3|Overall Study|Adverse Event|1
1541073|NCT00147225|5042891|P2|Overall Study|Adverse Event|0
1541074|NCT00147225|5042892|P1|Overall Study|Adverse Event|0
1541075|NCT00147225|5042887|P6|Overall Study|Withdrawal by Subject|1
1541076|NCT00147225|5042888|P5|Overall Study|Withdrawal by Subject|0
1541077|NCT00147225|5042889|P4|Overall Study|Withdrawal by Subject|0
1541078|NCT00147225|5042890|P3|Overall Study|Withdrawal by Subject|1
1541079|NCT00147225|5042891|P2|Overall Study|Withdrawal by Subject|0
1541080|NCT00147225|5042892|P1|Overall Study|Withdrawal by Subject|1
1541081|NCT00146848|5042995|P3|Post-randomization|Withdrawn|27
1541082|NCT00146848|5042996|P2|Post-randomization|Withdrawn|32
1541083|NCT00146848|5042997|P1|Post-randomization|Withdrawn|26
1541084|NCT00146848|5042995|P3|Post-randomization|Lost to Follow-up|12
1541085|NCT00146848|5042996|P2|Post-randomization|Lost to Follow-up|15
1541086|NCT00146848|5042997|P1|Post-randomization|Lost to Follow-up|12
1541087|NCT00146848|5042995|P3|Pre-randomization|Withdrawal by Subject|0
1541088|NCT00146848|5042996|P2|Pre-randomization|Withdrawal by Subject|0
1541089|NCT00146848|5042997|P1|Pre-randomization|Withdrawal by Subject|40
1541090|NCT00146848|5042995|P3|Pre-randomization|Protocol Violation|0
1541091|NCT00146848|5042996|P2|Pre-randomization|Protocol Violation|0
1541092|NCT00146848|5042997|P1|Pre-randomization|Protocol Violation|172
1541093|NCT00146848|5042995|P3|Pre-randomization|Physician Decision|0
1541094|NCT00146848|5042996|P2|Pre-randomization|Physician Decision|0
1541095|NCT00146848|5042997|P1|Pre-randomization|Physician Decision|8
1541096|NCT00146848|5042995|P3|Pre-randomization|Lost to Follow-up|0
1541097|NCT00146848|5042996|P2|Pre-randomization|Lost to Follow-up|0
1541098|NCT00146848|5042997|P1|Pre-randomization|Lost to Follow-up|70
1541099|NCT00146848|5042995|P3|Pre-randomization|Death|0
1541100|NCT00146848|5042996|P2|Pre-randomization|Death|0
1541101|NCT00146848|5042997|P1|Pre-randomization|Death|19
1541102|NCT00146770|5043013|P2|Overall Study|Withdrawal by Subject|0
1541103|NCT00146770|5043014|P1|Overall Study|Withdrawal by Subject|2
1541104|NCT00146770|5043013|P2|Overall Study|Pregnancy|0
1541105|NCT00146770|5043014|P1|Overall Study|Pregnancy|1
1541106|NCT00146770|5043013|P2|Overall Study|Adverse Event|0
1541107|NCT00146770|5043014|P1|Overall Study|Adverse Event|2
1541108|NCT00146757|5043032|P2|Overall Study|Adverse Event|0
1541109|NCT00146757|5043033|P1|Overall Study|Adverse Event|1
1541110|NCT00146757|5043032|P2|Overall Study|Death|0
1541111|NCT00146757|5043033|P1|Overall Study|Death|1
1541112|NCT00146640|5043052|P2|Overall Study|Non-Medical Reasons|4
1541113|NCT00146640|5043053|P1|Overall Study|Non-Medical Reasons|8
1541114|NCT00146640|5043052|P2|Overall Study|Medical Reasons|0
1541115|NCT00146640|5043053|P1|Overall Study|Medical Reasons|3
1541116|NCT00146640|5043052|P2|Overall Study|Adverse Event|10
1541117|NCT00146640|5043053|P1|Overall Study|Adverse Event|12
1541118|NCT00146328|5043076|P3|Overall Study|Interaction with other medication|1
1541119|NCT00146328|5043077|P2|Overall Study|Interaction with other medication|0
1541120|NCT00146328|5043078|P1|Overall Study|Interaction with other medication|2
1541121|NCT00146328|5043076|P3|Overall Study|Moved|0
1541122|NCT00146328|5043077|P2|Overall Study|Moved|0
1541123|NCT00146328|5043078|P1|Overall Study|Moved|2
1541124|NCT00146328|5043076|P3|Overall Study|Death|1
1541125|NCT00146328|5043077|P2|Overall Study|Death|1
1541126|NCT00146328|5043078|P1|Overall Study|Death|0
1541127|NCT00146328|5043076|P3|Overall Study|Enroll into other trial|2
1541128|NCT00146328|5043077|P2|Overall Study|Enroll into other trial|4
1541129|NCT00146328|5043078|P1|Overall Study|Enroll into other trial|2
1541130|NCT00146328|5043076|P3|Overall Study|Patient decision to end|6
1541131|NCT00146328|5043077|P2|Overall Study|Patient decision to end|1
1541132|NCT00146328|5043078|P1|Overall Study|Patient decision to end|0
1541133|NCT00146328|5043076|P3|Overall Study|Trial ended/site closed|19
1541134|NCT00146328|5043077|P2|Overall Study|Trial ended/site closed|2
1541135|NCT00146328|5043078|P1|Overall Study|Trial ended/site closed|8
1541136|NCT00146328|5043076|P3|Overall Study|Virologic Failure/lack of efficacy|142
1541137|NCT00146328|5043077|P2|Overall Study|Virologic Failure/lack of efficacy|72
1541138|NCT00146328|5043078|P1|Overall Study|Virologic Failure/lack of efficacy|54
1541139|NCT00146328|5043076|P3|Overall Study|Withdrawal by Subject|22
1541140|NCT00146328|5043077|P2|Overall Study|Withdrawal by Subject|16
1541141|NCT00146328|5043078|P1|Overall Study|Withdrawal by Subject|16
1541142|NCT00146328|5043076|P3|Overall Study|Lost to Follow-up|7
1541143|NCT00146328|5043077|P2|Overall Study|Lost to Follow-up|4
1541144|NCT00146328|5043078|P1|Overall Study|Lost to Follow-up|7
1541145|NCT00146328|5043076|P3|Overall Study|Protocol Violation|12
1541146|NCT00146328|5043077|P2|Overall Study|Protocol Violation|6
1541147|NCT00146328|5043078|P1|Overall Study|Protocol Violation|11
1541148|NCT00146328|5043076|P3|Overall Study|Adverse Event|79
1541149|NCT00146328|5043077|P2|Overall Study|Adverse Event|48
1541150|NCT00146328|5043078|P1|Overall Study|Adverse Event|39
1541151|NCT00146172|5043169|P8|Overall Study|Symptomatic Deterioration|2
1541152|NCT00146172|5043170|P7|Overall Study|Symptomatic Deterioration|0
1541153|NCT00146172|5043171|P6|Overall Study|Symptomatic Deterioration|2
1541154|NCT00146172|5043172|P5|Overall Study|Symptomatic Deterioration|1
1541155|NCT00146172|5043173|P4|Overall Study|Symptomatic Deterioration|0
1541156|NCT00146172|5043174|P3|Overall Study|Symptomatic Deterioration|1
1541157|NCT00146172|5043175|P2|Overall Study|Symptomatic Deterioration|0
1541158|NCT00146172|5043176|P1|Overall Study|Symptomatic Deterioration|1
1541159|NCT00146172|5043169|P8|Overall Study|Withdrawal by Subject|4
1541160|NCT00146172|5043170|P7|Overall Study|Withdrawal by Subject|1
1541161|NCT00146172|5043171|P6|Overall Study|Withdrawal by Subject|1
1541162|NCT00146172|5043172|P5|Overall Study|Withdrawal by Subject|0
1541163|NCT00146172|5043173|P4|Overall Study|Withdrawal by Subject|0
1541164|NCT00146172|5043174|P3|Overall Study|Withdrawal by Subject|0
1541165|NCT00146172|5043175|P2|Overall Study|Withdrawal by Subject|0
1541166|NCT00146172|5043176|P1|Overall Study|Withdrawal by Subject|0
1541167|NCT00146172|5043169|P8|Overall Study|Physician Decision|1
1541168|NCT00146172|5043170|P7|Overall Study|Physician Decision|0
1541169|NCT00146172|5043171|P6|Overall Study|Physician Decision|0
1541170|NCT00146172|5043172|P5|Overall Study|Physician Decision|0
1541171|NCT00146172|5043173|P4|Overall Study|Physician Decision|0
1541172|NCT00146172|5043174|P3|Overall Study|Physician Decision|0
1541173|NCT00146172|5043175|P2|Overall Study|Physician Decision|0
1541174|NCT00146172|5043176|P1|Overall Study|Physician Decision|0
1541175|NCT00146172|5043169|P8|Overall Study|Death|0
1541176|NCT00146172|5043170|P7|Overall Study|Death|1
1541177|NCT00146172|5043171|P6|Overall Study|Death|0
1541178|NCT00146172|5043172|P5|Overall Study|Death|0
1541179|NCT00146172|5043173|P4|Overall Study|Death|0
1541180|NCT00146172|5043174|P3|Overall Study|Death|0
1541181|NCT00146172|5043175|P2|Overall Study|Death|0
1541182|NCT00146172|5043176|P1|Overall Study|Death|0
1541183|NCT00146172|5043169|P8|Overall Study|Disease Progression|22
1541184|NCT00146172|5043170|P7|Overall Study|Disease Progression|1
1541185|NCT00146172|5043171|P6|Overall Study|Disease Progression|2
1541186|NCT00146172|5043172|P5|Overall Study|Disease Progression|2
1541187|NCT00146172|5043173|P4|Overall Study|Disease Progression|5
1541188|NCT00146172|5043174|P3|Overall Study|Disease Progression|2
1541189|NCT00146172|5043175|P2|Overall Study|Disease Progression|4
1541190|NCT00146172|5043176|P1|Overall Study|Disease Progression|2
1541191|NCT00146172|5043169|P8|Overall Study|Lost to Follow-up|1
1541192|NCT00146172|5043170|P7|Overall Study|Lost to Follow-up|0
1541193|NCT00146172|5043171|P6|Overall Study|Lost to Follow-up|0
1541194|NCT00146172|5043172|P5|Overall Study|Lost to Follow-up|0
1541195|NCT00146172|5043173|P4|Overall Study|Lost to Follow-up|0
1541196|NCT00146172|5043174|P3|Overall Study|Lost to Follow-up|0
1541197|NCT00146172|5043175|P2|Overall Study|Lost to Follow-up|0
1541198|NCT00146172|5043176|P1|Overall Study|Lost to Follow-up|0
1541199|NCT00146172|5043169|P8|Overall Study|Adverse Event|10
1541200|NCT00146172|5043170|P7|Overall Study|Adverse Event|3
1541201|NCT00146172|5043171|P6|Overall Study|Adverse Event|2
1541202|NCT00146172|5043172|P5|Overall Study|Adverse Event|0
1541203|NCT00146172|5043173|P4|Overall Study|Adverse Event|1
1541204|NCT00146172|5043174|P3|Overall Study|Adverse Event|1
1541205|NCT00146172|5043175|P2|Overall Study|Adverse Event|0
1541206|NCT00146172|5043176|P1|Overall Study|Adverse Event|0
1541207|NCT00145795|5043210|P2|Overall Study|Adverse Event|0
1541208|NCT00145795|5043211|P1|Overall Study|Adverse Event|1
1541209|NCT00145626|5043246|P1|Overall Study|Withdrawal by Subject|1
1541210|NCT00145626|5043246|P1|Overall Study|Death|1
1541211|NCT00145626|5043246|P1|Overall Study|Turned 2 years old before treatment|1
1541212|NCT00145626|5043246|P1|Overall Study|Did not have NK infusions|2
1541213|NCT00145600|5043292|P4|Overall Study|Withdrawal by Subject|1
1541214|NCT00145600|5043293|P3|Overall Study|Withdrawal by Subject|0
1541215|NCT00145600|5043294|P2|Overall Study|Withdrawal by Subject|2
1541216|NCT00145600|5043295|P1|Overall Study|Withdrawal by Subject|1
1541217|NCT00145600|5043292|P4|Overall Study|Noncompliance|0
1541218|NCT00145600|5043293|P3|Overall Study|Noncompliance|0
1541219|NCT00145600|5043294|P2|Overall Study|Noncompliance|0
1541220|NCT00145600|5043295|P1|Overall Study|Noncompliance|1
1541221|NCT00145600|5043292|P4|Overall Study|Lost to Follow-up|4
1541222|NCT00145600|5043293|P3|Overall Study|Lost to Follow-up|2
1541223|NCT00145600|5043294|P2|Overall Study|Lost to Follow-up|6
1541224|NCT00145600|5043295|P1|Overall Study|Lost to Follow-up|2
1541225|NCT00145600|5043292|P4|Overall Study|Ineligible|5
1541226|NCT00145600|5043293|P3|Overall Study|Ineligible|1
1541227|NCT00145600|5043294|P2|Overall Study|Ineligible|0
1541228|NCT00145600|5043295|P1|Overall Study|Ineligible|3
1541229|NCT00145600|5043292|P4|Overall Study|Death|6
1541230|NCT00145600|5043293|P3|Overall Study|Death|2
1541231|NCT00145600|5043294|P2|Overall Study|Death|2
1541232|NCT00145600|5043295|P1|Overall Study|Death|1
1541233|NCT00145574|5043419|P3|Open Label Long-term Extension|required restricted medicine|1
1541234|NCT00145574|5043420|P2|Open Label Long-term Extension|required restricted medicine|0
1541235|NCT00145574|5043421|P1|Open Label Long-term Extension|required restricted medicine|0
1541236|NCT00145574|5043419|P3|Open Label Long-term Extension|Withdrawal by Subject|4
1541237|NCT00145574|5043420|P2|Open Label Long-term Extension|Withdrawal by Subject|0
1541238|NCT00145574|5043421|P1|Open Label Long-term Extension|Withdrawal by Subject|0
1541239|NCT00145574|5043419|P3|Open Label Long-term Extension|Lost to Follow-up|1
1541240|NCT00145574|5043420|P2|Open Label Long-term Extension|Lost to Follow-up|0
1541241|NCT00145574|5043421|P1|Open Label Long-term Extension|Lost to Follow-up|0
1541242|NCT00145574|5043419|P3|Open Label Long-term Extension|Adverse Event|5
1541243|NCT00145574|5043420|P2|Open Label Long-term Extension|Adverse Event|0
1541244|NCT00145574|5043421|P1|Open Label Long-term Extension|Adverse Event|0
1541245|NCT00145574|5043419|P3|Double Blind|required restricted medicine|0
1541246|NCT00145574|5043420|P2|Double Blind|required restricted medicine|1
1541247|NCT00145574|5043421|P1|Double Blind|required restricted medicine|0
1541248|NCT00145574|5043419|P3|Double Blind|Withdrawal by Subject|1
1541249|NCT00145574|5043420|P2|Double Blind|Withdrawal by Subject|1
1541250|NCT00145574|5043421|P1|Double Blind|Withdrawal by Subject|1
1541251|NCT00145574|5043419|P3|Double Blind|Adverse Event|1
1541252|NCT00145574|5043420|P2|Double Blind|Adverse Event|3
1541253|NCT00145574|5043421|P1|Double Blind|Adverse Event|0
1541254|NCT00145509|5043478|P2|Overall Study|Reason not provided|1
1541255|NCT00145509|5043479|P1|Overall Study|Reason not provided|2
1541256|NCT00145509|5043478|P2|Overall Study|Withdrew Consent|7
1541257|NCT00145509|5043479|P1|Overall Study|Withdrew Consent|2
1541258|NCT00145509|5043478|P2|Overall Study|Lost to Follow-up|9
1541259|NCT00145509|5043479|P1|Overall Study|Lost to Follow-up|5
1541260|NCT00145509|5043478|P2|Overall Study|Lack of Efficacy|1
1541261|NCT00145509|5043479|P1|Overall Study|Lack of Efficacy|3
1541262|NCT00145509|5043478|P2|Overall Study|Adverse Event|3
1541263|NCT00145509|5043479|P1|Overall Study|Adverse Event|10
1541264|NCT00145496|5043493|P2|Overall Study|Other|13
1541265|NCT00145496|5043494|P1|Overall Study|Other|25
1541266|NCT00145496|5043493|P2|Overall Study|Lost to Follow-up|5
1541267|NCT00145496|5043494|P1|Overall Study|Lost to Follow-up|12
1541268|NCT00145496|5043493|P2|Overall Study|Withdrawal by Subject|26
1541269|NCT00145496|5043494|P1|Overall Study|Withdrawal by Subject|32
1541270|NCT00145496|5043493|P2|Overall Study|Lack of Efficacy|7
1541271|NCT00145496|5043494|P1|Overall Study|Lack of Efficacy|12
1541272|NCT00145496|5043493|P2|Overall Study|Adverse Event|30
1541273|NCT00145496|5043494|P1|Overall Study|Adverse Event|42
1541274|NCT00145327|5043514|P3|Overall Study|Missing – not stated|1
1541275|NCT00145327|5043515|P2|Overall Study|Missing – not stated|0
1541276|NCT00145327|5043516|P1|Overall Study|Missing – not stated|1
1541277|NCT00145327|5043514|P3|Overall Study|Abnormal laboratory value(s)|2
1541278|NCT00145327|5043515|P2|Overall Study|Abnormal laboratory value(s)|0
1541279|NCT00145327|5043516|P1|Overall Study|Abnormal laboratory value(s)|1
1541280|NCT00145327|5043514|P3|Overall Study|Protocol Violation|2
1541281|NCT00145327|5043515|P2|Overall Study|Protocol Violation|0
1541282|NCT00145327|5043516|P1|Overall Study|Protocol Violation|2
1541283|NCT00145327|5043514|P3|Overall Study|Administrative problems|13
1541284|NCT00145327|5043515|P2|Overall Study|Administrative problems|9
1541285|NCT00145327|5043516|P1|Overall Study|Administrative problems|12
1541286|NCT00145327|5043514|P3|Overall Study|Lost to Follow-up|14
1541287|NCT00145327|5043515|P2|Overall Study|Lost to Follow-up|14
1541288|NCT00145327|5043516|P1|Overall Study|Lost to Follow-up|9
1541289|NCT00145327|5043514|P3|Overall Study|Adverse Event|22
1541290|NCT00145327|5043515|P2|Overall Study|Adverse Event|11
1541291|NCT00145327|5043516|P1|Overall Study|Adverse Event|14
1541292|NCT00145327|5043514|P3|Overall Study|Death|30
1541293|NCT00145327|5043515|P2|Overall Study|Death|18
1541294|NCT00145327|5043516|P1|Overall Study|Death|26
1541295|NCT00145327|5043514|P3|Overall Study|Withdrawal by Subject|164
1541296|NCT00145327|5043515|P2|Overall Study|Withdrawal by Subject|72
1541297|NCT00145327|5043516|P1|Overall Study|Withdrawal by Subject|77
1541298|NCT00145119|5043615|P1|Overall Study|Death|45
1541299|NCT00144781|5043633|P4|Overall Study|Non-compliant|0
1541300|NCT00144781|5043634|P3|Overall Study|Non-compliant|0
1541301|NCT00144781|5043635|P2|Overall Study|Non-compliant|1
1541302|NCT00144781|5043636|P1|Overall Study|Non-compliant|0
1541303|NCT00144781|5043633|P4|Overall Study|Adverse Event|0
1541304|NCT00144781|5043634|P3|Overall Study|Adverse Event|0
1541305|NCT00144781|5043635|P2|Overall Study|Adverse Event|1
1541306|NCT00144781|5043636|P1|Overall Study|Adverse Event|0
1541307|NCT00144339|5043665|P2|Overall Study|Other|60
1541308|NCT00144339|5043666|P1|Overall Study|Other|58
1541309|NCT00144339|5043665|P2|Overall Study|Lost to Follow-up|64
1541310|NCT00144339|5043666|P1|Overall Study|Lost to Follow-up|76
1541311|NCT00144339|5043665|P2|Overall Study|Withdrawal by Subject|300
1541312|NCT00144339|5043666|P1|Overall Study|Withdrawal by Subject|403
1541313|NCT00144339|5043665|P2|Overall Study|Protocol Violation|48
1541314|NCT00144339|5043666|P1|Overall Study|Protocol Violation|75
1541315|NCT00144339|5043665|P2|Overall Study|Adverse Event|627
1541316|NCT00144339|5043666|P1|Overall Study|Adverse Event|746
1541317|NCT00144300|5043874|P2|Overall Study|Other reason (not specified)|3
1541318|NCT00144300|5043875|P1|Overall Study|Other reason (not specified)|1
1541319|NCT00144300|5043874|P2|Overall Study|Withdrawal by Subject|6
1541320|NCT00144300|5043875|P1|Overall Study|Withdrawal by Subject|6
1541321|NCT00144300|5043874|P2|Overall Study|Lost to Follow-up|0
1541322|NCT00144300|5043875|P1|Overall Study|Lost to Follow-up|3
1541323|NCT00144300|5043874|P2|Overall Study|Protocol Violation|3
1541324|NCT00144300|5043875|P1|Overall Study|Protocol Violation|1
1541325|NCT00144300|5043874|P2|Overall Study|Adverse Event|16
1541326|NCT00144300|5043875|P1|Overall Study|Adverse Event|18
1541327|NCT00144170|5043923|P2|Overall Study|Other reason not defined above|316
1541328|NCT00144170|5043924|P1|Overall Study|Other reason not defined above|211
1541329|NCT00144170|5043923|P2|Overall Study|Withdrawal by Subject|13
1541330|NCT00144170|5043924|P1|Overall Study|Withdrawal by Subject|29
1541331|NCT00144170|5043923|P2|Overall Study|Lost to Follow-up|10
1541332|NCT00144170|5043924|P1|Overall Study|Lost to Follow-up|5
1541333|NCT00144170|5043923|P2|Overall Study|Protocol Violation|16
1541334|NCT00144170|5043924|P1|Overall Study|Protocol Violation|23
1541335|NCT00144170|5043923|P2|Overall Study|Adverse Event|41
1541336|NCT00144170|5043924|P1|Overall Study|Adverse Event|84
1541337|NCT00144027|5044114|P2|Overall Study|did not complete baseline assessment|6
1541338|NCT00144027|5044115|P1|Overall Study|did not complete baseline assessment|0
1541339|NCT00144027|5044114|P2|Overall Study|Withdrawal by Subject|2
1541340|NCT00144027|5044115|P1|Overall Study|Withdrawal by Subject|2
1541341|NCT00144027|5044114|P2|Overall Study|Lost to Follow-up|3
1541342|NCT00144027|5044115|P1|Overall Study|Lost to Follow-up|1
1541343|NCT00143598|5044145|P2|Overall Study|Death|36
1541344|NCT00143598|5044146|P1|Overall Study|Death|36
1541345|NCT00143598|5044145|P2|Overall Study|Withdrawal by Subject|37
1541346|NCT00143598|5044146|P1|Overall Study|Withdrawal by Subject|33
1541347|NCT00143598|5044145|P2|Overall Study|Lost to Follow-up|21
1541348|NCT00143598|5044146|P1|Overall Study|Lost to Follow-up|23
1541349|NCT00143507|5044160|P2|Overall Study|Withdrawn by sponsor's decision|3
1541350|NCT00143507|5044161|P1|Overall Study|Withdrawn by sponsor's decision|0
1541351|NCT00143507|5044160|P2|Overall Study|Lost to Follow-up|0
1541352|NCT00143507|5044161|P1|Overall Study|Lost to Follow-up|1
1541353|NCT00143507|5044160|P2|Overall Study|Withdrawal by Subject|102
1541354|NCT00143507|5044161|P1|Overall Study|Withdrawal by Subject|114
1541355|NCT00143507|5044160|P2|Overall Study|Death|547
1541356|NCT00143507|5044161|P1|Overall Study|Death|572
1541357|NCT00143455|5044195|P4|Cohort 2|Randomized But Not Treated|1
1541358|NCT00143455|5044196|P3|Cohort 2|Randomized But Not Treated|1
1541359|NCT00143455|5044197|P2|Cohort 2|Randomized But Not Treated|0
1541360|NCT00143455|5044198|P1|Cohort 2|Randomized But Not Treated|0
1541361|NCT00143455|5044195|P4|Cohort 2|Other|6
1541362|NCT00143455|5044196|P3|Cohort 2|Other|7
1541363|NCT00143455|5044197|P2|Cohort 2|Other|0
1541364|NCT00143455|5044198|P1|Cohort 2|Other|0
1541365|NCT00143455|5044195|P4|Cohort 2|Withdrawal by Subject|12
1541366|NCT00143455|5044196|P3|Cohort 2|Withdrawal by Subject|13
1541367|NCT00143455|5044197|P2|Cohort 2|Withdrawal by Subject|0
1541368|NCT00143455|5044198|P1|Cohort 2|Withdrawal by Subject|0
1541369|NCT00143455|5044195|P4|Cohort 2|Progressive Disease|27
1541370|NCT00143455|5044196|P3|Cohort 2|Progressive Disease|20
1541371|NCT00143455|5044197|P2|Cohort 2|Progressive Disease|0
1541372|NCT00143455|5044198|P1|Cohort 2|Progressive Disease|0
1541373|NCT00143455|5044195|P4|Cohort 2|Death|12
1541374|NCT00143455|5044196|P3|Cohort 2|Death|20
1541375|NCT00143455|5044197|P2|Cohort 2|Death|0
1541376|NCT00143455|5044198|P1|Cohort 2|Death|0
1541377|NCT00143455|5044195|P4|Cohort 2|Lost to Follow-up|4
1541378|NCT00143455|5044196|P3|Cohort 2|Lost to Follow-up|1
1541379|NCT00143455|5044197|P2|Cohort 2|Lost to Follow-up|0
1541380|NCT00143455|5044198|P1|Cohort 2|Lost to Follow-up|0
1541381|NCT00143455|5044195|P4|Cohort 2|Protocol Violation|1
1541382|NCT00143455|5044196|P3|Cohort 2|Protocol Violation|1
1541383|NCT00143455|5044197|P2|Cohort 2|Protocol Violation|0
1541384|NCT00143455|5044198|P1|Cohort 2|Protocol Violation|0
1541385|NCT00143455|5044195|P4|Cohort 2|No Longer Required Study Treatment|0
1541386|NCT00143455|5044196|P3|Cohort 2|No Longer Required Study Treatment|1
1541387|NCT00143455|5044197|P2|Cohort 2|No Longer Required Study Treatment|0
1541388|NCT00143455|5044198|P1|Cohort 2|No Longer Required Study Treatment|0
1541389|NCT00143455|5044195|P4|Cohort 2|Adverse Event|30
1541390|NCT00143455|5044196|P3|Cohort 2|Adverse Event|42
1541391|NCT00143455|5044197|P2|Cohort 2|Adverse Event|0
1541392|NCT00143455|5044198|P1|Cohort 2|Adverse Event|0
1541393|NCT00143455|5044195|P4|Cohort 1|Randomized But Not Treated|0
1541394|NCT00143455|5044196|P3|Cohort 1|Randomized But Not Treated|0
1541395|NCT00143455|5044197|P2|Cohort 1|Randomized But Not Treated|1
1541396|NCT00143455|5044198|P1|Cohort 1|Randomized But Not Treated|0
1541397|NCT00143455|5044195|P4|Cohort 1|Withdrawal by Subject|0
1541398|NCT00143455|5044196|P3|Cohort 1|Withdrawal by Subject|0
1541399|NCT00143455|5044197|P2|Cohort 1|Withdrawal by Subject|4
1541400|NCT00143455|5044198|P1|Cohort 1|Withdrawal by Subject|1
1541401|NCT00143455|5044195|P4|Cohort 1|Progressive Disease|0
1541402|NCT00143455|5044196|P3|Cohort 1|Progressive Disease|0
1541403|NCT00143455|5044197|P2|Cohort 1|Progressive Disease|6
1541404|NCT00143455|5044198|P1|Cohort 1|Progressive Disease|0
1541405|NCT00143455|5044195|P4|Cohort 1|Death|0
1541406|NCT00143455|5044196|P3|Cohort 1|Death|0
1541407|NCT00143455|5044197|P2|Cohort 1|Death|2
1541408|NCT00143455|5044198|P1|Cohort 1|Death|5
1541409|NCT00143455|5044195|P4|Cohort 1|Adverse Event|0
1541410|NCT00143455|5044196|P3|Cohort 1|Adverse Event|0
1541411|NCT00143455|5044197|P2|Cohort 1|Adverse Event|4
1541412|NCT00143455|5044198|P1|Cohort 1|Adverse Event|8
1541413|NCT00143403|5044232|P2|Overall Study|Randomized Not Treated|8
1541414|NCT00143403|5044233|P1|Overall Study|Randomized Not Treated|7
1541415|NCT00143403|5044232|P2|Overall Study|specified by site|9
1541416|NCT00143403|5044233|P1|Overall Study|specified by site|4
1541417|NCT00143403|5044232|P2|Overall Study|Protocol Violation|2
1541418|NCT00143403|5044233|P1|Overall Study|Protocol Violation|2
1541419|NCT00143403|5044232|P2|Overall Study|Relapse|7
1541420|NCT00143403|5044233|P1|Overall Study|Relapse|15
1541421|NCT00143403|5044232|P2|Overall Study|Withdrawal by Subject|12
1541422|NCT00143403|5044233|P1|Overall Study|Withdrawal by Subject|3
1541423|NCT00143403|5044232|P2|Overall Study|Death|0
1541424|NCT00143403|5044233|P1|Overall Study|Death|1
1541425|NCT00143403|5044232|P2|Overall Study|Adverse Event|8
1541426|NCT00143403|5044233|P1|Overall Study|Adverse Event|3
1541427|NCT00143390|5044243|P2|Overall Study|Other|2
1541428|NCT00143390|5044244|P1|Overall Study|Other|1
1541429|NCT00143390|5044243|P2|Overall Study|Adverse Event|8
1541430|NCT00143390|5044244|P1|Overall Study|Adverse Event|9
1541431|NCT00143390|5044243|P2|Overall Study|Study termination|15
1541432|NCT00143390|5044244|P1|Overall Study|Study termination|10
1541433|NCT00143390|5044243|P2|Overall Study|Protocol Violation|0
1541434|NCT00143390|5044244|P1|Overall Study|Protocol Violation|2
1541435|NCT00143390|5044243|P2|Overall Study|Progressive disease|115
1541436|NCT00143390|5044244|P1|Overall Study|Progressive disease|119
1541437|NCT00143390|5044243|P2|Overall Study|Withdrawal by Subject|4
1541438|NCT00143390|5044244|P1|Overall Study|Withdrawal by Subject|4
1541439|NCT00143390|5044243|P2|Overall Study|Not meeting entry criteria|5
1541440|NCT00143390|5044244|P1|Overall Study|Not meeting entry criteria|2
1541441|NCT00143390|5044243|P2|Overall Study|Death|0
1541442|NCT00143390|5044244|P1|Overall Study|Death|2
1541443|NCT00143312|5044260|P1|Overall Study|Withdrawal by Subject|1
1541444|NCT00143312|5044260|P1|Overall Study|Other|1
1541445|NCT00143312|5044260|P1|Overall Study|Lost to Follow-up|1
1541446|NCT00143312|5044260|P1|Overall Study|Adverse Event|2
1541447|NCT00143312|5044260|P1|Overall Study|Death|11
1541448|NCT00143247|5044270|P1|Overall Study|Other|12
1541449|NCT00143247|5044270|P1|Overall Study|following inaccurate lab adverse event|1
1541450|NCT00143247|5044270|P1|Overall Study|Lost to Follow-up|12
1541451|NCT00143247|5044270|P1|Overall Study|Protocol Violation|15
1541452|NCT00143247|5044270|P1|Overall Study|Study terminated by sponsor|31
1541453|NCT00143247|5044270|P1|Overall Study|Withdrawal by Subject|55
1541454|NCT00143247|5044270|P1|Overall Study|Lack of Efficacy|3
1541455|NCT00143247|5044270|P1|Overall Study|Adverse Event|19
1541456|NCT00143247|5044270|P1|Overall Study|Death|8
1541457|NCT00142935|5044287|P3|Overall Study|Death|1
1541458|NCT00142935|5044288|P2|Overall Study|Death|2
1541459|NCT00142935|5044289|P1|Overall Study|Death|0
1541460|NCT00142935|5044287|P3|Overall Study|Lost to Follow-up|5
1541461|NCT00142935|5044288|P2|Overall Study|Lost to Follow-up|5
1541462|NCT00142935|5044289|P1|Overall Study|Lost to Follow-up|2
1541463|NCT00142935|5044287|P3|Overall Study|Other reason|1
1541464|NCT00142935|5044288|P2|Overall Study|Other reason|1
1541465|NCT00142935|5044289|P1|Overall Study|Other reason|1
1541466|NCT00142909|5044314|P2|Medications Begin|Withdrawal by Subject|0
1541467|NCT00142909|5044315|P1|Medications Begin|Withdrawal by Subject|2
1541468|NCT00142909|5044314|P2|Medications Begin|Withdrawal by Subject|3
1541469|NCT00142909|5044315|P1|Medications Begin|Withdrawal by Subject|5
1541470|NCT00142909|5044314|P2|Medications Begin|Protocol Violation|0
1541471|NCT00142909|5044315|P1|Medications Begin|Protocol Violation|2
1541472|NCT00142909|5044314|P2|Randomization|Various Reasons|10
1541473|NCT00142909|5044315|P1|Randomization|Various Reasons|7
1541474|NCT00142792|5044351|P3|Overall Study|No category|1
1541475|NCT00142792|5044352|P2|Overall Study|No category|2
1541476|NCT00142792|5044353|P1|Overall Study|No category|1
1541477|NCT00142792|5044351|P3|Overall Study|Lost to Follow-up|7
1541478|NCT00142792|5044352|P2|Overall Study|Lost to Follow-up|11
1541479|NCT00142792|5044353|P1|Overall Study|Lost to Follow-up|8
1541480|NCT00142792|5044351|P3|Overall Study|Withdrawal by Subject|3
1541481|NCT00142792|5044352|P2|Overall Study|Withdrawal by Subject|2
1541482|NCT00142792|5044353|P1|Overall Study|Withdrawal by Subject|3
1541483|NCT00142792|5044351|P3|Overall Study|Death|1
1541484|NCT00142792|5044352|P2|Overall Study|Death|0
1541485|NCT00142792|5044353|P1|Overall Study|Death|0
1541486|NCT00142415|5044388|P6|Overall Study|Physician Decision|2
1541487|NCT00142415|5044389|P5|Overall Study|Physician Decision|1
1541488|NCT00142415|5044390|P4|Overall Study|Physician Decision|0
1541489|NCT00142415|5044391|P3|Overall Study|Physician Decision|0
1541490|NCT00142415|5044392|P2|Overall Study|Physician Decision|0
1541491|NCT00142415|5044393|P1|Overall Study|Physician Decision|0
1541492|NCT00142298|5044431|P10|Overall Study|Treatment Failure|0
1541493|NCT00142298|5044432|P9|Overall Study|Treatment Failure|0
1541494|NCT00142298|5044433|P8|Overall Study|Treatment Failure|0
1541495|NCT00142298|5044434|P7|Overall Study|Treatment Failure|2
1541496|NCT00142298|5044435|P6|Overall Study|Treatment Failure|2
1541497|NCT00142298|5044436|P5|Overall Study|Treatment Failure|0
1541498|NCT00142298|5044437|P4|Overall Study|Treatment Failure|0
1541499|NCT00142298|5044438|P3|Overall Study|Treatment Failure|0
1541500|NCT00142298|5044439|P2|Overall Study|Treatment Failure|0
1541501|NCT00142298|5044440|P1|Overall Study|Treatment Failure|0
1541502|NCT00142298|5044431|P10|Overall Study|Lost to Follow-up|0
1541503|NCT00142298|5044432|P9|Overall Study|Lost to Follow-up|0
1541504|NCT00142298|5044433|P8|Overall Study|Lost to Follow-up|0
1541505|NCT00142298|5044434|P7|Overall Study|Lost to Follow-up|2
1541506|NCT00142298|5044435|P6|Overall Study|Lost to Follow-up|0
1541507|NCT00142298|5044436|P5|Overall Study|Lost to Follow-up|0
1541508|NCT00142298|5044437|P4|Overall Study|Lost to Follow-up|0
1541509|NCT00142298|5044438|P3|Overall Study|Lost to Follow-up|0
1541510|NCT00142298|5044439|P2|Overall Study|Lost to Follow-up|0
1541511|NCT00142298|5044440|P1|Overall Study|Lost to Follow-up|0
1541512|NCT00142298|5044431|P10|Overall Study|Other- not specified|0
1541513|NCT00142298|5044432|P9|Overall Study|Other- not specified|0
1541514|NCT00142298|5044433|P8|Overall Study|Other- not specified|0
1541515|NCT00142298|5044434|P7|Overall Study|Other- not specified|0
1541516|NCT00142298|5044435|P6|Overall Study|Other- not specified|0
1541517|NCT00142298|5044436|P5|Overall Study|Other- not specified|0
1541518|NCT00142298|5044437|P4|Overall Study|Other- not specified|1
1541519|NCT00142298|5044438|P3|Overall Study|Other- not specified|0
1541520|NCT00142298|5044439|P2|Overall Study|Other- not specified|3
1541521|NCT00142298|5044440|P1|Overall Study|Other- not specified|0
1541522|NCT00142298|5044431|P10|Overall Study|Virologic breakthrough|0
1541523|NCT00142298|5044432|P9|Overall Study|Virologic breakthrough|0
1541524|NCT00142298|5044433|P8|Overall Study|Virologic breakthrough|0
1541525|NCT00142298|5044434|P7|Overall Study|Virologic breakthrough|3
1541526|NCT00142298|5044435|P6|Overall Study|Virologic breakthrough|3
1541527|NCT00142298|5044436|P5|Overall Study|Virologic breakthrough|2
1541528|NCT00142298|5044437|P4|Overall Study|Virologic breakthrough|7
1541529|NCT00142298|5044438|P3|Overall Study|Virologic breakthrough|9
1541530|NCT00142298|5044439|P2|Overall Study|Virologic breakthrough|23
1541531|NCT00142298|5044440|P1|Overall Study|Virologic breakthrough|19
1541532|NCT00142298|5044431|P10|Overall Study|Pregnancy|0
1541533|NCT00142298|5044432|P9|Overall Study|Pregnancy|1
1541534|NCT00142298|5044433|P8|Overall Study|Pregnancy|0
1541535|NCT00142298|5044434|P7|Overall Study|Pregnancy|0
1541536|NCT00142298|5044435|P6|Overall Study|Pregnancy|0
1541537|NCT00142298|5044436|P5|Overall Study|Pregnancy|0
1541538|NCT00142298|5044437|P4|Overall Study|Pregnancy|3
1541539|NCT00142298|5044438|P3|Overall Study|Pregnancy|2
1541540|NCT00142298|5044439|P2|Overall Study|Pregnancy|4
1541541|NCT00142298|5044440|P1|Overall Study|Pregnancy|4
1541542|NCT00142298|5044431|P10|Overall Study|Patient, Investigator,or Sponsor request|0
1541543|NCT00142298|5044432|P9|Overall Study|Patient, Investigator,or Sponsor request|1
1541544|NCT00142298|5044433|P8|Overall Study|Patient, Investigator,or Sponsor request|4
1541545|NCT00142298|5044434|P7|Overall Study|Patient, Investigator,or Sponsor request|1
1541546|NCT00142298|5044435|P6|Overall Study|Patient, Investigator,or Sponsor request|3
1541547|NCT00142298|5044436|P5|Overall Study|Patient, Investigator,or Sponsor request|4
1541548|NCT00142298|5044437|P4|Overall Study|Patient, Investigator,or Sponsor request|51
1541549|NCT00142298|5044438|P3|Overall Study|Patient, Investigator,or Sponsor request|11
1541550|NCT00142298|5044439|P2|Overall Study|Patient, Investigator,or Sponsor request|60
1541551|NCT00142298|5044440|P1|Overall Study|Patient, Investigator,or Sponsor request|66
1541552|NCT00142298|5044431|P10|Overall Study|Non-compliance|0
1541553|NCT00142298|5044432|P9|Overall Study|Non-compliance|3
1541554|NCT00142298|5044433|P8|Overall Study|Non-compliance|3
1541555|NCT00142298|5044434|P7|Overall Study|Non-compliance|0
1541556|NCT00142298|5044435|P6|Overall Study|Non-compliance|0
1541557|NCT00142298|5044436|P5|Overall Study|Non-compliance|1
1541558|NCT00142298|5044437|P4|Overall Study|Non-compliance|6
1541559|NCT00142298|5044438|P3|Overall Study|Non-compliance|0
1541560|NCT00142298|5044439|P2|Overall Study|Non-compliance|13
1541561|NCT00142298|5044440|P1|Overall Study|Non-compliance|15
1541562|NCT00142298|5044431|P10|Overall Study|Lack of Efficacy|0
1541563|NCT00142298|5044432|P9|Overall Study|Lack of Efficacy|0
1541564|NCT00142298|5044433|P8|Overall Study|Lack of Efficacy|1
1541565|NCT00142298|5044434|P7|Overall Study|Lack of Efficacy|0
1541566|NCT00142298|5044435|P6|Overall Study|Lack of Efficacy|0
1541567|NCT00142298|5044436|P5|Overall Study|Lack of Efficacy|1
1541568|NCT00142298|5044437|P4|Overall Study|Lack of Efficacy|12
1541569|NCT00142298|5044438|P3|Overall Study|Lack of Efficacy|9
1541570|NCT00142298|5044439|P2|Overall Study|Lack of Efficacy|62
1541571|NCT00142298|5044440|P1|Overall Study|Lack of Efficacy|44
1541572|NCT00142298|5044431|P10|Overall Study|Death|0
1541573|NCT00142298|5044432|P9|Overall Study|Death|0
1541574|NCT00142298|5044433|P8|Overall Study|Death|0
1541575|NCT00142298|5044434|P7|Overall Study|Death|0
1541576|NCT00142298|5044435|P6|Overall Study|Death|6
1541577|NCT00142298|5044436|P5|Overall Study|Death|0
1541578|NCT00142298|5044437|P4|Overall Study|Death|0
1541579|NCT00142298|5044438|P3|Overall Study|Death|1
1541580|NCT00142298|5044439|P2|Overall Study|Death|1
1541581|NCT00142298|5044440|P1|Overall Study|Death|1
1541582|NCT00142298|5044431|P10|Overall Study|Clinical disease progression|0
1541583|NCT00142298|5044432|P9|Overall Study|Clinical disease progression|0
1541584|NCT00142298|5044433|P8|Overall Study|Clinical disease progression|0
1541585|NCT00142298|5044434|P7|Overall Study|Clinical disease progression|0
1541586|NCT00142298|5044435|P6|Overall Study|Clinical disease progression|0
1541587|NCT00142298|5044436|P5|Overall Study|Clinical disease progression|0
1541588|NCT00142298|5044437|P4|Overall Study|Clinical disease progression|0
1541589|NCT00142298|5044438|P3|Overall Study|Clinical disease progression|0
1541590|NCT00142298|5044439|P2|Overall Study|Clinical disease progression|0
1541591|NCT00142298|5044440|P1|Overall Study|Clinical disease progression|1
1541592|NCT00142298|5044431|P10|Overall Study|Adverse Event|0
1541593|NCT00142298|5044432|P9|Overall Study|Adverse Event|0
1541594|NCT00142298|5044433|P8|Overall Study|Adverse Event|0
1541595|NCT00142298|5044434|P7|Overall Study|Adverse Event|0
1541596|NCT00142298|5044435|P6|Overall Study|Adverse Event|2
1541597|NCT00142298|5044436|P5|Overall Study|Adverse Event|2
1541598|NCT00142298|5044437|P4|Overall Study|Adverse Event|5
1541599|NCT00142298|5044438|P3|Overall Study|Adverse Event|1
1541600|NCT00142298|5044439|P2|Overall Study|Adverse Event|10
1541601|NCT00142298|5044440|P1|Overall Study|Adverse Event|10
1541602|NCT00141921|5044474|P1|Overall Study|Other|8
1541603|NCT00141921|5044474|P1|Overall Study|Ineligibility Determined|2
1541604|NCT00141921|5044474|P1|Overall Study|Pregnancy|4
1541605|NCT00141921|5044474|P1|Overall Study|Administrative Decision|2
1541606|NCT00141921|5044474|P1|Overall Study|Adverse Event|5
1541607|NCT00141921|5044474|P1|Overall Study|Protocol Deviation|7
1541608|NCT00141921|5044474|P1|Overall Study|Disease Progression|7
1541609|NCT00141921|5044474|P1|Overall Study|Noncompliance|17
1541610|NCT00141921|5044474|P1|Overall Study|Lost to Follow-up|19
1541611|NCT00141921|5044474|P1|Overall Study|Withdrawal by Subject|42
1541612|NCT00141921|5044474|P1|Overall Study|Remain on Study|28
1541613|NCT00141817|5044500|P4|Overall Study|Parent request|0
1541614|NCT00141817|5044501|P3|Overall Study|Parent request|0
1541615|NCT00141817|5044502|P2|Overall Study|Parent request|0
1541616|NCT00141817|5044503|P1|Overall Study|Parent request|1
1541617|NCT00141817|5044500|P4|Overall Study|Protocol Violation|0
1541618|NCT00141817|5044501|P3|Overall Study|Protocol Violation|1
1541619|NCT00141817|5044502|P2|Overall Study|Protocol Violation|0
1541620|NCT00141817|5044503|P1|Overall Study|Protocol Violation|0
1541621|NCT00141778|5044544|P3|Started Study Medication|Chest Discomfort|1
1541622|NCT00141778|5044545|P2|Started Study Medication|Chest Discomfort|0
1541623|NCT00141778|5044546|P1|Started Study Medication|Chest Discomfort|0
1541624|NCT00141778|5044544|P3|Started Study Medication|Difficulty Swallowing|0
1541625|NCT00141778|5044545|P2|Started Study Medication|Difficulty Swallowing|1
1541626|NCT00141778|5044546|P1|Started Study Medication|Difficulty Swallowing|0
1541627|NCT00141778|5044544|P3|Started Study Medication|Withdrawal by Subject|0
1541628|NCT00141778|5044545|P2|Started Study Medication|Withdrawal by Subject|2
1541629|NCT00141778|5044546|P1|Started Study Medication|Withdrawal by Subject|0
1541630|NCT00141778|5044544|P3|Started Study Medication|Met safety criteria for discontinuation|3
1541631|NCT00141778|5044545|P2|Started Study Medication|Met safety criteria for discontinuation|4
1541632|NCT00141778|5044546|P1|Started Study Medication|Met safety criteria for discontinuation|2
1541633|NCT00141778|5044544|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
1541634|NCT00141778|5044545|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
1541635|NCT00141778|5044546|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
1541636|NCT00141726|5044599|P1|Overall Study|Completed <50% Scheduled Dosing|3
1541637|NCT00141518|5044607|P3|Overall Study|Lack of Efficacy|0
1541638|NCT00141518|5044608|P2|Overall Study|Lack of Efficacy|0
1541639|NCT00141518|5044609|P1|Overall Study|Lack of Efficacy|5
1541640|NCT00141518|5044607|P3|Overall Study|Protocol Violation|2
1541641|NCT00141518|5044608|P2|Overall Study|Protocol Violation|1
1541642|NCT00141518|5044609|P1|Overall Study|Protocol Violation|1
1541643|NCT00141518|5044607|P3|Overall Study|Withdrawal by Subject|2
1541644|NCT00141518|5044608|P2|Overall Study|Withdrawal by Subject|0
1541645|NCT00141518|5044609|P1|Overall Study|Withdrawal by Subject|2
1541646|NCT00141518|5044607|P3|Overall Study|Adverse Event|2
1541647|NCT00141518|5044608|P2|Overall Study|Adverse Event|5
1541648|NCT00141518|5044609|P1|Overall Study|Adverse Event|7
1541649|NCT00141518|5044607|P3|Overall Study|Withdrew Consent Prior to Treatment|0
1541650|NCT00141518|5044608|P2|Overall Study|Withdrew Consent Prior to Treatment|0
1541651|NCT00141518|5044609|P1|Overall Study|Withdrew Consent Prior to Treatment|1
1541652|NCT00141453|5044798|P2|Overall Study|Protocol Violation|5
1541653|NCT00141453|5044799|P1|Overall Study|Protocol Violation|6
1541654|NCT00141297|5044813|P10|Overall Study|Transitioned|0
1541655|NCT00141297|5044814|P9|Overall Study|Transitioned|0
1541656|NCT00141297|5044815|P8|Overall Study|Transitioned|0
1541657|NCT00141297|5044816|P7|Overall Study|Transitioned|0
1541658|NCT00141297|5044817|P6|Overall Study|Transitioned|0
1541659|NCT00141297|5044818|P5|Overall Study|Transitioned|1
1541660|NCT00141297|5044819|P4|Overall Study|Transitioned|0
1541661|NCT00141297|5044820|P3|Overall Study|Transitioned|0
1541662|NCT00141297|5044821|P2|Overall Study|Transitioned|0
1541663|NCT00141297|5044822|P1|Overall Study|Transitioned|0
1541664|NCT00141297|5044813|P10|Overall Study|Progressive Disease|6
1541665|NCT00141297|5044814|P9|Overall Study|Progressive Disease|15
1541666|NCT00141297|5044815|P8|Overall Study|Progressive Disease|3
1541667|NCT00141297|5044816|P7|Overall Study|Progressive Disease|3
1541668|NCT00141297|5044817|P6|Overall Study|Progressive Disease|2
1541669|NCT00141297|5044818|P5|Overall Study|Progressive Disease|15
1541670|NCT00141297|5044819|P4|Overall Study|Progressive Disease|2
1541671|NCT00141297|5044820|P3|Overall Study|Progressive Disease|6
1541672|NCT00141297|5044821|P2|Overall Study|Progressive Disease|3
1541673|NCT00141297|5044822|P1|Overall Study|Progressive Disease|2
1541674|NCT00141297|5044813|P10|Overall Study|Other|0
1541675|NCT00141297|5044814|P9|Overall Study|Other|2
1541676|NCT00141297|5044815|P8|Overall Study|Other|0
1541677|NCT00141297|5044816|P7|Overall Study|Other|0
1541678|NCT00141297|5044817|P6|Overall Study|Other|0
1541679|NCT00141297|5044818|P5|Overall Study|Other|5
1541680|NCT00141297|5044819|P4|Overall Study|Other|1
1541681|NCT00141297|5044820|P3|Overall Study|Other|0
1541682|NCT00141297|5044821|P2|Overall Study|Other|0
1541683|NCT00141297|5044822|P1|Overall Study|Other|0
1541684|NCT00141297|5044813|P10|Overall Study|Withdrawal by Subject|0
1541685|NCT00141297|5044814|P9|Overall Study|Withdrawal by Subject|1
1541686|NCT00141297|5044815|P8|Overall Study|Withdrawal by Subject|0
1541687|NCT00141297|5044816|P7|Overall Study|Withdrawal by Subject|0
1541688|NCT00141297|5044817|P6|Overall Study|Withdrawal by Subject|0
1541689|NCT00141297|5044818|P5|Overall Study|Withdrawal by Subject|0
1541690|NCT00141297|5044819|P4|Overall Study|Withdrawal by Subject|0
1541691|NCT00141297|5044820|P3|Overall Study|Withdrawal by Subject|0
1541692|NCT00141297|5044821|P2|Overall Study|Withdrawal by Subject|0
1541693|NCT00141297|5044822|P1|Overall Study|Withdrawal by Subject|0
1541694|NCT00141297|5044813|P10|Overall Study|Death|0
1541695|NCT00141297|5044814|P9|Overall Study|Death|1
1541696|NCT00141297|5044815|P8|Overall Study|Death|0
1541697|NCT00141297|5044816|P7|Overall Study|Death|0
1541698|NCT00141297|5044817|P6|Overall Study|Death|0
1541699|NCT00141297|5044818|P5|Overall Study|Death|0
1541700|NCT00141297|5044819|P4|Overall Study|Death|0
1541701|NCT00141297|5044820|P3|Overall Study|Death|0
1541702|NCT00141297|5044821|P2|Overall Study|Death|0
1541703|NCT00141297|5044822|P1|Overall Study|Death|1
1541704|NCT00141297|5044813|P10|Overall Study|Adverse Event|0
1541705|NCT00141297|5044814|P9|Overall Study|Adverse Event|1
1541706|NCT00141297|5044815|P8|Overall Study|Adverse Event|1
1541707|NCT00141297|5044816|P7|Overall Study|Adverse Event|0
1541708|NCT00141297|5044817|P6|Overall Study|Adverse Event|1
1541709|NCT00141297|5044818|P5|Overall Study|Adverse Event|1
1541710|NCT00141297|5044819|P4|Overall Study|Adverse Event|0
1541711|NCT00141297|5044820|P3|Overall Study|Adverse Event|1
1541712|NCT00141297|5044821|P2|Overall Study|Adverse Event|0
1541713|NCT00141297|5044822|P1|Overall Study|Adverse Event|0
1541714|NCT00141271|5045100|P3|Overall Study|Other|5
1541715|NCT00141271|5045101|P2|Overall Study|Other|12
1541716|NCT00141271|5045102|P1|Overall Study|Other|11
1541717|NCT00141271|5045100|P3|Overall Study|Withdrawal by Subject|10
1541718|NCT00141271|5045101|P2|Overall Study|Withdrawal by Subject|9
1541719|NCT00141271|5045102|P1|Overall Study|Withdrawal by Subject|14
1541720|NCT00141271|5045100|P3|Overall Study|Lost to Follow-up|21
1541721|NCT00141271|5045101|P2|Overall Study|Lost to Follow-up|15
1541722|NCT00141271|5045102|P1|Overall Study|Lost to Follow-up|15
1541723|NCT00141271|5045100|P3|Overall Study|Lack of Efficacy|3
1541724|NCT00141271|5045101|P2|Overall Study|Lack of Efficacy|7
1541725|NCT00141271|5045102|P1|Overall Study|Lack of Efficacy|7
1541726|NCT00141271|5045100|P3|Overall Study|Laboratory Abnormality|1
1541727|NCT00141271|5045101|P2|Overall Study|Laboratory Abnormality|1
1541728|NCT00141271|5045102|P1|Overall Study|Laboratory Abnormality|2
1541729|NCT00141271|5045100|P3|Overall Study|Adverse Event|17
1541730|NCT00141271|5045101|P2|Overall Study|Adverse Event|19
1541731|NCT00141271|5045102|P1|Overall Study|Adverse Event|31
1541732|NCT00141219|5045223|P2|Overall Study|Withdrawal by Subject|2
1541733|NCT00141219|5045224|P1|Overall Study|Withdrawal by Subject|6
1541734|NCT00141219|5045223|P2|Overall Study|Lack of Efficacy|4
1541735|NCT00141219|5045224|P1|Overall Study|Lack of Efficacy|5
1541736|NCT00141219|5045223|P2|Overall Study|Adverse Event|6
1541737|NCT00141219|5045224|P1|Overall Study|Adverse Event|8
1541738|NCT00141219|5045223|P2|Overall Study|Protocol violations|4
1541739|NCT00141219|5045224|P1|Overall Study|Protocol violations|5
1541740|NCT00141102|5045281|P2|Overall Study|Death|2
1541741|NCT00141102|5045282|P1|Overall Study|Death|2
1541742|NCT00141102|5045281|P2|Overall Study|Randomized But Did Not Receive Treatment|9
1541743|NCT00141102|5045282|P1|Overall Study|Randomized But Did Not Receive Treatment|15
1541744|NCT00141102|5045281|P2|Overall Study|Withdrawal by Subject|142
1541745|NCT00141102|5045282|P1|Overall Study|Withdrawal by Subject|112
1541746|NCT00141102|5045281|P2|Overall Study|Other|76
1541747|NCT00141102|5045282|P1|Overall Study|Other|87
1541748|NCT00141102|5045281|P2|Overall Study|Lost to Follow-up|32
1541749|NCT00141102|5045282|P1|Overall Study|Lost to Follow-up|29
1541750|NCT00141102|5045281|P2|Overall Study|Lack of Efficacy|26
1541751|NCT00141102|5045282|P1|Overall Study|Lack of Efficacy|21
1541752|NCT00141102|5045281|P2|Overall Study|Laboratory Abnormality|33
1541753|NCT00141102|5045282|P1|Overall Study|Laboratory Abnormality|9
1541754|NCT00141102|5045281|P2|Overall Study|Adverse Event|305
1541755|NCT00141102|5045282|P1|Overall Study|Adverse Event|233
1541756|NCT00141037|5045322|P2|Overall Study|Graft Failure|4
1541757|NCT00141037|5045323|P1|Overall Study|Graft Failure|3
1541758|NCT00141037|5045322|P2|Overall Study|Moved from area|7
1541759|NCT00141037|5045323|P1|Overall Study|Moved from area|1
1541760|NCT00141037|5045322|P2|Overall Study|Other|1
1541761|NCT00141037|5045323|P1|Overall Study|Other|0
1541762|NCT00141037|5045322|P2|Overall Study|Withdrawal by Subject|1
1541763|NCT00141037|5045323|P1|Overall Study|Withdrawal by Subject|2
1541764|NCT00141037|5045322|P2|Overall Study|Protocol Violation|2
1541765|NCT00141037|5045323|P1|Overall Study|Protocol Violation|0
1541766|NCT00141037|5045322|P2|Overall Study|Lost to Follow-up|1
1541767|NCT00141037|5045323|P1|Overall Study|Lost to Follow-up|3
1541768|NCT00141037|5045322|P2|Overall Study|Physician Decision|2
1541769|NCT00141037|5045323|P1|Overall Study|Physician Decision|1
1541770|NCT00140426|5045358|P2|Overall Study|Withdrawal by Subject|3
1541771|NCT00140426|5045359|P1|Overall Study|Withdrawal by Subject|0
1541772|NCT00140413|5045392|P2|Overall Study|Withdrawal by Subject|0
1541773|NCT00140413|5045393|P1|Overall Study|Withdrawal by Subject|2
1541774|NCT00140413|5045392|P2|Overall Study|Lost to Follow-up|0
1541775|NCT00140413|5045393|P1|Overall Study|Lost to Follow-up|1
1541776|NCT00140140|5045453|P3|Overall Study|Physician Decision|0
1541777|NCT00140140|5045454|P2|Overall Study|Physician Decision|1
1541778|NCT00140140|5045455|P1|Overall Study|Physician Decision|1
1541779|NCT00140140|5045453|P3|Overall Study|Unacceptable toxicity|2
1541780|NCT00140140|5045454|P2|Overall Study|Unacceptable toxicity|1
1541781|NCT00140140|5045455|P1|Overall Study|Unacceptable toxicity|1
1541782|NCT00139776|5045505|P4|Period III|Withdrawal by Subject|21
1541783|NCT00139776|5045506|P3|Period III|Withdrawal by Subject|16
1541784|NCT00139776|5045507|P2|Period III|Withdrawal by Subject|0
1541785|NCT00139776|5045508|P1|Period III|Withdrawal by Subject|0
1541786|NCT00139776|5045505|P4|Period III|Lost to Follow-up|4
1541787|NCT00139776|5045506|P3|Period III|Lost to Follow-up|5
1541788|NCT00139776|5045507|P2|Period III|Lost to Follow-up|0
1541789|NCT00139776|5045508|P1|Period III|Lost to Follow-up|0
1541790|NCT00139776|5045505|P4|Period III|Lack of Efficacy|24
1541791|NCT00139776|5045506|P3|Period III|Lack of Efficacy|10
1541792|NCT00139776|5045507|P2|Period III|Lack of Efficacy|0
1541793|NCT00139776|5045508|P1|Period III|Lack of Efficacy|0
1541794|NCT00139776|5045505|P4|Period III|Other|34
1541795|NCT00139776|5045506|P3|Period III|Other|23
1541796|NCT00139776|5045507|P2|Period III|Other|0
1541797|NCT00139776|5045508|P1|Period III|Other|0
1541798|NCT00139776|5045505|P4|Period III|Adverse Event|23
1541799|NCT00139776|5045506|P3|Period III|Adverse Event|22
1541800|NCT00139776|5045507|P2|Period III|Adverse Event|0
1541801|NCT00139776|5045508|P1|Period III|Adverse Event|0
1541802|NCT00139776|5045505|P4|Period II|Not Randomized into Period III|0
1541803|NCT00139776|5045506|P3|Period II|Not Randomized into Period III|0
1541804|NCT00139776|5045507|P2|Period II|Not Randomized into Period III|322
1541805|NCT00139776|5045508|P1|Period II|Not Randomized into Period III|0
1541806|NCT00139776|5045505|P4|Period I|Did not enter Period II|0
1541807|NCT00139776|5045506|P3|Period I|Did not enter Period II|0
1541808|NCT00139776|5045507|P2|Period I|Did not enter Period II|0
1541809|NCT00139776|5045508|P1|Period I|Did not enter Period II|575
1541810|NCT00139737|5045543|P1|Overall Study|Screened, Not Treated|13
1541811|NCT00139737|5045543|P1|Overall Study|Did Not Meet Entrance Criteria|1
1541812|NCT00139737|5045543|P1|Overall Study|Withdrew During Screening Phase|8
1541813|NCT00139737|5045543|P1|Overall Study|Protocol Violation|18
1541814|NCT00139737|5045543|P1|Overall Study|Laboratory Abnormality|2
1541815|NCT00139737|5045543|P1|Overall Study|Death|3
1541816|NCT00139737|5045543|P1|Overall Study|Lost to Follow-up|8
1541817|NCT00139737|5045543|P1|Overall Study|Lack of Efficacy|40
1541818|NCT00139737|5045543|P1|Overall Study|Adverse Event|58
1541819|NCT00139737|5045543|P1|Overall Study|Withdrawal by Subject|190
1541820|NCT00139659|5045549|P2|Overall Study|Withdrawal by Subject|10
1541821|NCT00139659|5045550|P1|Overall Study|Withdrawal by Subject|14
1541822|NCT00139659|5045549|P2|Overall Study|Reason not Specified|3
1541823|NCT00139659|5045550|P1|Overall Study|Reason not Specified|6
1541824|NCT00139659|5045549|P2|Overall Study|Lost to Follow-up|3
1541825|NCT00139659|5045550|P1|Overall Study|Lost to Follow-up|7
1541826|NCT00139659|5045549|P2|Overall Study|Lack of Efficacy|1
1541827|NCT00139659|5045550|P1|Overall Study|Lack of Efficacy|1
1541828|NCT00139659|5045549|P2|Overall Study|Adverse Event|1
1541829|NCT00139659|5045550|P1|Overall Study|Adverse Event|12
1541830|NCT00139477|5045628|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
1541831|NCT00139477|5045629|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
1541832|NCT00139477|5045628|P2|Second Intervention -6Months to 12Months|Relocation|0
1541833|NCT00139477|5045629|P1|Second Intervention -6Months to 12Months|Relocation|1
1541834|NCT00139477|5045628|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
1541835|NCT00139477|5045629|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
1541836|NCT00139477|5045628|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
1541837|NCT00139477|5045629|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
1541838|NCT00139477|5045628|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
1541839|NCT00139477|5045629|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
1541840|NCT00139477|5045628|P2|First Intervention -Baseline to 6Months|Relocation|2
1541841|NCT00139477|5045629|P1|First Intervention -Baseline to 6Months|Relocation|1
1541842|NCT00139477|5045628|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
1541843|NCT00139477|5045629|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
1541844|NCT00138671|5045651|P2|Overall Study|Other|3
1541845|NCT00138671|5045652|P1|Overall Study|Other|3
1541846|NCT00138671|5045651|P2|Overall Study|Withdrawal by Subject|5
1541847|NCT00138671|5045652|P1|Overall Study|Withdrawal by Subject|3
1541848|NCT00138671|5045651|P2|Overall Study|Lost to Follow-up|2
1541849|NCT00138671|5045652|P1|Overall Study|Lost to Follow-up|1
1541850|NCT00138671|5045651|P2|Overall Study|Adverse Event|3
1541851|NCT00138671|5045652|P1|Overall Study|Adverse Event|6
1541852|NCT00138671|5045651|P2|Overall Study|Death|3
1541853|NCT00138671|5045652|P1|Overall Study|Death|0
1541854|NCT00138658|5045702|P1|Overall Study|Withdrawal by Subject|5
1541855|NCT00138658|5045702|P1|Overall Study|Physician Decision|11
1541856|NCT00138658|5045702|P1|Overall Study|Disease Progression|21
1541857|NCT00138658|5045702|P1|Overall Study|Death|1
1541858|NCT00138658|5045702|P1|Overall Study|Adverse Event|23
1541859|NCT00138424|5045725|P4|Overall Study|Physician Decision|0
1541860|NCT00138424|5045726|P3|Overall Study|Physician Decision|0
1541861|NCT00138424|5045727|P2|Overall Study|Physician Decision|1
1541862|NCT00138424|5045728|P1|Overall Study|Physician Decision|0
1541863|NCT00138151|5045811|P1|Overall Study|Physician Decision|1
1541864|NCT00138151|5045811|P1|Overall Study|Withdrawal by Subject|3
1541865|NCT00138073|5045821|P1|Overall Study|lack of resources|55
1541866|NCT00137631|5045862|P2|Overall Study|Lost to Follow-up|41
1541867|NCT00137631|5045863|P1|Overall Study|Lost to Follow-up|37
1541868|NCT00137449|5045879|P2|Overall Study|Withdrawal by Subject|1
1541869|NCT00137449|5045880|P1|Overall Study|Withdrawal by Subject|1
1541870|NCT00137449|5045879|P2|Overall Study|Adverse Event|1
1541871|NCT00137449|5045880|P1|Overall Study|Adverse Event|3
1541872|NCT00137449|5045879|P2|Overall Study|Death|3
1541873|NCT00137449|5045880|P1|Overall Study|Death|4
1541874|NCT00137449|5045879|P2|Overall Study|Disease Progression|13
1541875|NCT00137449|5045880|P1|Overall Study|Disease Progression|8
1541876|NCT00137436|5045917|P1|Overall Study|Other|5
1541877|NCT00137436|5045917|P1|Overall Study|Withdrawal by Subject|6
1541878|NCT00137436|5045917|P1|Overall Study|Lack of Efficacy|17
1541879|NCT00137436|5045917|P1|Overall Study|Death|2
1541880|NCT00137436|5045917|P1|Overall Study|Adverse Event|13
1541881|NCT00137423|5045936|P2|Overall Study|Death|1
1541882|NCT00137423|5045937|P1|Overall Study|Death|0
1541883|NCT00137423|5045936|P2|Overall Study|Lack of Efficacy|33
1541884|NCT00137423|5045937|P1|Overall Study|Lack of Efficacy|31
1541885|NCT00137423|5045936|P2|Overall Study|consent withdrawn|1
1541886|NCT00137423|5045937|P1|Overall Study|consent withdrawn|1
1541887|NCT00137423|5045936|P2|Overall Study|Adverse Event|9
1541888|NCT00137423|5045937|P1|Overall Study|Adverse Event|7
1541889|NCT00137267|5045974|P2|Overall Study|Lost to Follow-up|21
1541890|NCT00137267|5045975|P1|Overall Study|Lost to Follow-up|15
1541891|NCT00137111|5045987|P4|Total Therapy|Non Compliance|0
1541892|NCT00137111|5045988|P3|Total Therapy|Non Compliance|0
1541893|NCT00137111|5045989|P2|Total Therapy|Non Compliance|0
1541894|NCT00137111|5045990|P1|Total Therapy|Non Compliance|5
1541895|NCT00137111|5045987|P4|Total Therapy|Death|0
1541896|NCT00137111|5045988|P3|Total Therapy|Death|0
1541897|NCT00137111|5045989|P2|Total Therapy|Death|0
1541898|NCT00137111|5045990|P1|Total Therapy|Death|35
1541899|NCT00137046|5046004|P2|Overall Study|Withdrew prior to study treatment|1
1541900|NCT00137046|5046005|P1|Overall Study|Withdrew prior to study treatment|1
1541901|NCT00137046|5046004|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
1541902|NCT00137046|5046005|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
1541903|NCT00137046|5046004|P2|Overall Study|Withdrawal by Subject|42
1541904|NCT00137046|5046005|P1|Overall Study|Withdrawal by Subject|33
1541905|NCT00137046|5046004|P2|Overall Study|Other|19
1541906|NCT00137046|5046005|P1|Overall Study|Other|23
1541907|NCT00137046|5046004|P2|Overall Study|Lost to Follow-up|24
1541908|NCT00137046|5046005|P1|Overall Study|Lost to Follow-up|8
1541909|NCT00137046|5046004|P2|Overall Study|Lack of Efficacy|1
1541910|NCT00137046|5046005|P1|Overall Study|Lack of Efficacy|13
1541911|NCT00137046|5046004|P2|Overall Study|Laboratory Abnormality|0
1541912|NCT00137046|5046005|P1|Overall Study|Laboratory Abnormality|2
1541913|NCT00137046|5046004|P2|Overall Study|Adverse Event|5
1541914|NCT00137046|5046005|P1|Overall Study|Adverse Event|16
1541915|NCT00137046|5046004|P2|Overall Study|Death|1
1541916|NCT00137046|5046005|P1|Overall Study|Death|2
1541917|NCT00136955|5046053|P1|Overall Study|Incl. prog. disease, protocol violation|12
1541918|NCT00136955|5046053|P1|Overall Study|Withdrawal by Subject|2
1541919|NCT00136955|5046053|P1|Overall Study|Lost to Follow-up|1
1541920|NCT00136955|5046053|P1|Overall Study|Adverse Event|8
1541921|NCT00136916|5046062|P2|Overall Study|Discontinued in follow up period|0
1541922|NCT00136916|5046063|P1|Overall Study|Discontinued in follow up period|3
1541923|NCT00136916|5046062|P2|Overall Study|Other|24
1541924|NCT00136916|5046063|P1|Overall Study|Other|22
1541925|NCT00136916|5046062|P2|Overall Study|Withdrawal by Subject|46
1541926|NCT00136916|5046063|P1|Overall Study|Withdrawal by Subject|44
1541927|NCT00136916|5046062|P2|Overall Study|Lost to Follow-up|14
1541928|NCT00136916|5046063|P1|Overall Study|Lost to Follow-up|12
1541929|NCT00136916|5046062|P2|Overall Study|Lack of Efficacy|3
1541930|NCT00136916|5046063|P1|Overall Study|Lack of Efficacy|13
1541931|NCT00136916|5046062|P2|Overall Study|Laboratory abnormality|1
1541932|NCT00136916|5046063|P1|Overall Study|Laboratory abnormality|0
1541933|NCT00136916|5046062|P2|Overall Study|Adverse Event|8
1541934|NCT00136916|5046063|P1|Overall Study|Adverse Event|27
1541935|NCT00136916|5046062|P2|Overall Study|Death|3
1541936|NCT00136916|5046063|P1|Overall Study|Death|1
1541937|NCT00136916|5046062|P2|Overall Study|Never received study treatment|5
1541938|NCT00136916|5046063|P1|Overall Study|Never received study treatment|3
1541939|NCT00136357|5046167|P2|Overall Study|Withdrawal by Subject|2
1541940|NCT00136357|5046168|P1|Overall Study|Withdrawal by Subject|3
1541941|NCT00136318|5046176|P2|Overall Study|Withdrawal by Subject|2
1541942|NCT00136318|5046177|P1|Overall Study|Withdrawal by Subject|2
1541943|NCT00136318|5046176|P2|Overall Study|Adverse Event|5
1541944|NCT00136318|5046177|P1|Overall Study|Adverse Event|5
1541945|NCT00136084|5046204|P2|Overall Study|Withdrawal by Subject|1
1541946|NCT00136084|5046205|P1|Overall Study|Withdrawal by Subject|5
1541947|NCT00136084|5046204|P2|Overall Study|No Response|2
1541948|NCT00136084|5046205|P1|Overall Study|No Response|1
1541949|NCT00136084|5046204|P2|Overall Study|Lost to Follow-up|0
1541950|NCT00136084|5046205|P1|Overall Study|Lost to Follow-up|2
1541951|NCT00136084|5046204|P2|Overall Study|Relapse|23
1541952|NCT00136084|5046205|P1|Overall Study|Relapse|20
1541953|NCT00136084|5046204|P2|Overall Study|Unacceptable toxicity|11
1541954|NCT00136084|5046205|P1|Overall Study|Unacceptable toxicity|8
1541955|NCT00136084|5046204|P2|Overall Study|Death|5
1541956|NCT00136084|5046205|P1|Overall Study|Death|12
1541957|NCT00135694|5046242|P3|Overall Study|Ineligible for Random assignment|0
1541958|NCT00135694|5046243|P2|Overall Study|Ineligible for Random assignment|0
1541959|NCT00135694|5046244|P1|Overall Study|Ineligible for Random assignment|42
1541960|NCT00135694|5046242|P3|Overall Study|Hepatitis C related reasons|0
1541961|NCT00135694|5046243|P2|Overall Study|Hepatitis C related reasons|1
1541962|NCT00135694|5046244|P1|Overall Study|Hepatitis C related reasons|39
1541963|NCT00135694|5046242|P3|Overall Study|Protocol Violation|0
1541964|NCT00135694|5046243|P2|Overall Study|Protocol Violation|1
1541965|NCT00135694|5046244|P1|Overall Study|Protocol Violation|19
1541966|NCT00135694|5046242|P3|Overall Study|Withdrawal by Subject|4
1541967|NCT00135694|5046243|P2|Overall Study|Withdrawal by Subject|7
1541968|NCT00135694|5046244|P1|Overall Study|Withdrawal by Subject|41
1541969|NCT00135694|5046242|P3|Overall Study|Lost to Follow-up|1
1541970|NCT00135694|5046243|P2|Overall Study|Lost to Follow-up|7
1541971|NCT00135694|5046244|P1|Overall Study|Lost to Follow-up|8
1541972|NCT00135694|5046242|P3|Overall Study|Death|2
1541973|NCT00135694|5046243|P2|Overall Study|Death|1
1541974|NCT00135694|5046244|P1|Overall Study|Death|14
1541975|NCT00135694|5046242|P3|Overall Study|Adverse Event|0
1541976|NCT00135694|5046243|P2|Overall Study|Adverse Event|4
1541977|NCT00135694|5046244|P1|Overall Study|Adverse Event|17
1541978|NCT00135356|5046264|P2|Overall Study|Withdrawal by Subject|4
1541979|NCT00135356|5046265|P1|Overall Study|Withdrawal by Subject|2
1541980|NCT00135356|5046264|P2|Overall Study|No longer meets study criteria|0
1541981|NCT00135356|5046265|P1|Overall Study|No longer meets study criteria|2
1541982|NCT00135356|5046264|P2|Overall Study|Poor/noncompliance|1
1541983|NCT00135356|5046265|P1|Overall Study|Poor/noncompliance|1
1541984|NCT00135356|5046264|P2|Overall Study|Change in antiviral regimen|1
1541985|NCT00135356|5046265|P1|Overall Study|Change in antiviral regimen|0
1541986|NCT00135356|5046264|P2|Overall Study|Surgery for abdominal fat|0
1541987|NCT00135356|5046265|P1|Overall Study|Surgery for abdominal fat|1
1541988|NCT00135356|5046264|P2|Overall Study|Lost to Follow-up|1
1541989|NCT00135356|5046265|P1|Overall Study|Lost to Follow-up|3
1541990|NCT00135356|5046264|P2|Overall Study|Lack of Efficacy|0
1541991|NCT00135356|5046265|P1|Overall Study|Lack of Efficacy|2
1541992|NCT00135356|5046264|P2|Overall Study|Adverse Event|2
1541993|NCT00135356|5046265|P1|Overall Study|Adverse Event|6
1541994|NCT00135330|5046308|P3|Overall Study|Sponsor Decision|0
1541995|NCT00135330|5046309|P2|Overall Study|Sponsor Decision|1
1541996|NCT00135330|5046310|P1|Overall Study|Sponsor Decision|0
1541997|NCT00135330|5046308|P3|Overall Study|Patient Decision|4
1541998|NCT00135330|5046309|P2|Overall Study|Patient Decision|1
1541999|NCT00135330|5046310|P1|Overall Study|Patient Decision|5
1542000|NCT00135330|5046308|P3|Overall Study|Protocol Violation|3
1542001|NCT00135330|5046309|P2|Overall Study|Protocol Violation|3
1542002|NCT00135330|5046310|P1|Overall Study|Protocol Violation|4
1542003|NCT00135330|5046308|P3|Overall Study|Physician Decision|0
1542004|NCT00135330|5046309|P2|Overall Study|Physician Decision|1
1542005|NCT00135330|5046310|P1|Overall Study|Physician Decision|1
1542006|NCT00135330|5046308|P3|Overall Study|Lost to Follow-up|3
1542007|NCT00135330|5046309|P2|Overall Study|Lost to Follow-up|2
1542008|NCT00135330|5046310|P1|Overall Study|Lost to Follow-up|0
1542009|NCT00135330|5046308|P3|Overall Study|Adverse Event|1
1542010|NCT00135330|5046309|P2|Overall Study|Adverse Event|5
1542011|NCT00135330|5046310|P1|Overall Study|Adverse Event|2
1542012|NCT00134901|5046409|P2|Overall Study|discontinued intervention|10
1542013|NCT00134901|5046410|P1|Overall Study|discontinued intervention|12
1542014|NCT00134901|5046409|P2|Overall Study|Lost to Follow-up|5
1542015|NCT00134901|5046410|P1|Overall Study|Lost to Follow-up|5
1542016|NCT00134784|5046422|P4|Overall Study|Withdrawal by Subject|1
1542017|NCT00134784|5046423|P3|Overall Study|Withdrawal by Subject|2
1542018|NCT00134784|5046424|P2|Overall Study|Withdrawal by Subject|2
1542019|NCT00134784|5046425|P1|Overall Study|Withdrawal by Subject|2
1542020|NCT00134719|5046435|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
1542021|NCT00134719|5046436|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
1542022|NCT00134719|5046437|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
1542023|NCT00134719|5046435|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
1542024|NCT00134719|5046436|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
1542025|NCT00134719|5046437|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
1542026|NCT00134719|5046435|P3|Primary Vaccination Phase|Lost to Follow-up|3
1542027|NCT00134719|5046436|P2|Primary Vaccination Phase|Lost to Follow-up|3
1542028|NCT00134719|5046437|P1|Primary Vaccination Phase|Lost to Follow-up|7
1542029|NCT00134719|5046435|P3|Primary Vaccination Phase|Withdrawal by Subject|2
1542030|NCT00134719|5046436|P2|Primary Vaccination Phase|Withdrawal by Subject|3
1542031|NCT00134719|5046437|P1|Primary Vaccination Phase|Withdrawal by Subject|2
1542032|NCT00134719|5046435|P3|Primary Vaccination Phase|Protocol Violation|0
1542033|NCT00134719|5046436|P2|Primary Vaccination Phase|Protocol Violation|0
1542034|NCT00134719|5046437|P1|Primary Vaccination Phase|Protocol Violation|1
1542035|NCT00134719|5046435|P3|Primary Vaccination Phase|Adverse Event|0
1542036|NCT00134719|5046436|P2|Primary Vaccination Phase|Adverse Event|0
1542037|NCT00134719|5046437|P1|Primary Vaccination Phase|Adverse Event|4
1542038|NCT00134563|5046568|P3|Overall Study|Reason other than above|5
1542039|NCT00134563|5046569|P2|Overall Study|Reason other than above|2
1542040|NCT00134563|5046570|P1|Overall Study|Reason other than above|0
1542041|NCT00134563|5046568|P3|Overall Study|did not wish to continue|26
1542042|NCT00134563|5046569|P2|Overall Study|did not wish to continue|32
1542043|NCT00134563|5046570|P1|Overall Study|did not wish to continue|33
1542044|NCT00134563|5046568|P3|Overall Study|progressive disease|2
1542045|NCT00134563|5046569|P2|Overall Study|progressive disease|4
1542046|NCT00134563|5046570|P1|Overall Study|progressive disease|11
1542047|NCT00134563|5046568|P3|Overall Study|Lost to Follow-up|2
1542048|NCT00134563|5046569|P2|Overall Study|Lost to Follow-up|0
1542049|NCT00134563|5046570|P1|Overall Study|Lost to Follow-up|4
1542050|NCT00134563|5046568|P3|Overall Study|Protocol Violation|5
1542051|NCT00134563|5046569|P2|Overall Study|Protocol Violation|2
1542052|NCT00134563|5046570|P1|Overall Study|Protocol Violation|3
1542053|NCT00134563|5046568|P3|Overall Study|Lack of Efficacy|17
1542054|NCT00134563|5046569|P2|Overall Study|Lack of Efficacy|14
1542055|NCT00134563|5046570|P1|Overall Study|Lack of Efficacy|24
1542056|NCT00134563|5046568|P3|Overall Study|Adverse Event|38
1542057|NCT00134563|5046569|P2|Overall Study|Adverse Event|37
1542058|NCT00134563|5046570|P1|Overall Study|Adverse Event|29
1542059|NCT00134563|5046568|P3|Overall Study|Not treated due to protocol violation|1
1542060|NCT00134563|5046569|P2|Overall Study|Not treated due to protocol violation|1
1542061|NCT00134563|5046570|P1|Overall Study|Not treated due to protocol violation|0
1542062|NCT00134056|5046633|P2|Eligible for Protocol Assigned Treatment|Not specified|56
1542063|NCT00134056|5046634|P1|Eligible for Protocol Assigned Treatment|Not specified|55
1542064|NCT00134056|5046633|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
1542065|NCT00134056|5046634|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
1542066|NCT00134056|5046633|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
1542067|NCT00134056|5046634|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
1542068|NCT00134056|5046633|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
1542069|NCT00134056|5046634|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
1542070|NCT00134056|5046633|P2|Randomization|Not eligible for assigned treatment|20
1542071|NCT00134056|5046634|P1|Randomization|Not eligible for assigned treatment|22
1542072|NCT00133952|5046709|P2|Overall Study|Sponsor Decision|1
1542073|NCT00133952|5046710|P1|Overall Study|Sponsor Decision|0
1542074|NCT00133952|5046709|P2|Overall Study|Physician Decision|3
1542075|NCT00133952|5046710|P1|Overall Study|Physician Decision|4
1542076|NCT00133952|5046709|P2|Overall Study|Withdrawal by Subject|4
1542077|NCT00133952|5046710|P1|Overall Study|Withdrawal by Subject|20
1542078|NCT00133952|5046709|P2|Overall Study|Protocol Violation|1
1542079|NCT00133952|5046710|P1|Overall Study|Protocol Violation|1
1542080|NCT00133952|5046709|P2|Overall Study|Protocol Entry Criteria Exclusion|1
1542081|NCT00133952|5046710|P1|Overall Study|Protocol Entry Criteria Exclusion|4
1542082|NCT00133952|5046709|P2|Overall Study|Lost to Follow-up|14
1542083|NCT00133952|5046710|P1|Overall Study|Lost to Follow-up|9
1542084|NCT00133952|5046709|P2|Overall Study|Death|2
1542085|NCT00133952|5046710|P1|Overall Study|Death|3
1542086|NCT00133952|5046709|P2|Overall Study|Adverse Event|2
1542087|NCT00133952|5046710|P1|Overall Study|Adverse Event|1
1542088|NCT00133705|5046741|P2|Overall Study|Withdrawal by Subject|3
1542089|NCT00133705|5046742|P1|Overall Study|Withdrawal by Subject|2
1542090|NCT00132873|5046868|P1|Overall Study|Planned Pregnancy|1
1542091|NCT00132873|5046868|P1|Overall Study|Withdrawal by Subject|3
1542092|NCT00132873|5046868|P1|Overall Study|Lack of Efficacy|1
1542093|NCT00132873|5046868|P1|Overall Study|Lost to Follow-up|1
1542094|NCT00132873|5046868|P1|Overall Study|Adverse Event|3
1542095|NCT00132808|5046876|P3|Stratum II|Withdrawal by Subject|6
1542096|NCT00132808|5046877|P2|Stratum II|Withdrawal by Subject|9
1542097|NCT00132808|5046878|P1|Stratum II|Withdrawal by Subject|4
1542098|NCT00132808|5046876|P3|Stratum II|Protocol Violation|1
1542099|NCT00132808|5046877|P2|Stratum II|Protocol Violation|2
1542100|NCT00132808|5046878|P1|Stratum II|Protocol Violation|0
1542101|NCT00132808|5046876|P3|Stratum II|Lost to Follow-up|1
1542102|NCT00132808|5046877|P2|Stratum II|Lost to Follow-up|2
1542103|NCT00132808|5046878|P1|Stratum II|Lost to Follow-up|2
1542104|NCT00132808|5046876|P3|Stratum II|Death|0
1542105|NCT00132808|5046877|P2|Stratum II|Death|0
1542106|NCT00132808|5046878|P1|Stratum II|Death|1
1542107|NCT00132808|5046876|P3|Stratum II|Adverse Event|1
1542108|NCT00132808|5046877|P2|Stratum II|Adverse Event|2
1542109|NCT00132808|5046878|P1|Stratum II|Adverse Event|1
1542110|NCT00132808|5046876|P3|Stratum I|Abnormal test procedure result (s)|1
1542111|NCT00132808|5046877|P2|Stratum I|Abnormal test procedure result (s)|0
1542112|NCT00132808|5046878|P1|Stratum I|Abnormal test procedure result (s)|0
1542113|NCT00132808|5046876|P3|Stratum I|Withdrawal by Subject|3
1542114|NCT00132808|5046877|P2|Stratum I|Withdrawal by Subject|7
1542115|NCT00132808|5046878|P1|Stratum I|Withdrawal by Subject|4
1542116|NCT00132808|5046876|P3|Stratum I|Lost to Follow-up|1
1542117|NCT00132808|5046877|P2|Stratum I|Lost to Follow-up|4
1542118|NCT00132808|5046878|P1|Stratum I|Lost to Follow-up|3
1542119|NCT00132808|5046876|P3|Stratum I|Adverse Event|0
1542120|NCT00132808|5046877|P2|Stratum I|Adverse Event|1
1542121|NCT00132808|5046878|P1|Stratum I|Adverse Event|2
1542122|NCT00132769|5046903|P2|Overall Study|Protocol Violation|1
1542123|NCT00132769|5046904|P1|Overall Study|Protocol Violation|1
1542124|NCT00132769|5046903|P2|Overall Study|Adverse Event|1
1542125|NCT00132769|5046904|P1|Overall Study|Adverse Event|2
1542126|NCT00132769|5046903|P2|Overall Study|Lack of Efficacy|6
1542127|NCT00132769|5046904|P1|Overall Study|Lack of Efficacy|7
1542128|NCT00132769|5046903|P2|Overall Study|Withdrawal by Subject|3
1542129|NCT00132769|5046904|P1|Overall Study|Withdrawal by Subject|1
1542130|NCT00132730|5046930|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
1542131|NCT00132730|5046931|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
1542132|NCT00132730|5046932|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
1542133|NCT00132730|5046933|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
1542134|NCT00132730|5046934|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
1542135|NCT00132730|5046935|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
1542136|NCT00132730|5046930|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
1542137|NCT00132730|5046931|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
1542138|NCT00132730|5046932|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
1542139|NCT00132730|5046933|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
1542140|NCT00132730|5046934|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
1542141|NCT00132730|5046935|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
1542142|NCT00132730|5046930|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1542143|NCT00132730|5046931|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
1542144|NCT00132730|5046932|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1542145|NCT00132730|5046933|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1542146|NCT00132730|5046934|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1542147|NCT00132730|5046935|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1542148|NCT00132730|5046930|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1542149|NCT00132730|5046931|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
1542150|NCT00132730|5046932|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1542151|NCT00132730|5046933|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1542152|NCT00132730|5046934|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1542153|NCT00132730|5046935|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1542154|NCT00132730|5046930|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
1542155|NCT00132730|5046931|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
1542156|NCT00132730|5046932|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
1542157|NCT00132730|5046933|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
1542158|NCT00132730|5046934|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
1542159|NCT00132730|5046935|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
1542160|NCT00132730|5046930|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
1542161|NCT00132730|5046931|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
1542162|NCT00132730|5046932|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
1542163|NCT00132730|5046933|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
1542164|NCT00132730|5046934|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
1542165|NCT00132730|5046935|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
1542166|NCT00132730|5046930|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1542167|NCT00132730|5046931|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1542168|NCT00132730|5046932|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
1542169|NCT00132730|5046933|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1542170|NCT00132730|5046934|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1542171|NCT00132730|5046935|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1542172|NCT00132730|5046930|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1542173|NCT00132730|5046931|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1542174|NCT00132730|5046932|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
1542175|NCT00132730|5046933|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
1542176|NCT00132730|5046934|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1542177|NCT00132730|5046935|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1542178|NCT00132730|5046930|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
1542179|NCT00132730|5046931|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
1542180|NCT00132730|5046932|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
1542181|NCT00132730|5046933|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
1542182|NCT00132730|5046934|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
1542183|NCT00132730|5046935|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
1542184|NCT00132730|5046930|P6|Period II - 12-week Treatment (Base)|Other reasons|0
1542185|NCT00132730|5046931|P5|Period II - 12-week Treatment (Base)|Other reasons|0
1542186|NCT00132730|5046932|P4|Period II - 12-week Treatment (Base)|Other reasons|13
1542187|NCT00132730|5046933|P3|Period II - 12-week Treatment (Base)|Other reasons|9
1542188|NCT00132730|5046934|P2|Period II - 12-week Treatment (Base)|Other reasons|10
1542189|NCT00132730|5046935|P1|Period II - 12-week Treatment (Base)|Other reasons|11
1542190|NCT00132730|5046930|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1542191|NCT00132730|5046931|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1542192|NCT00132730|5046932|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1542193|NCT00132730|5046933|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1542194|NCT00132730|5046934|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
1542195|NCT00132730|5046935|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
1542196|NCT00132730|5046930|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
1542197|NCT00132730|5046931|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
1542198|NCT00132730|5046932|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
1542199|NCT00132730|5046933|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
1542200|NCT00132730|5046934|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
1542201|NCT00132730|5046935|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
1542202|NCT00132691|5046979|P2|Overall Study|Death|0
1542203|NCT00132691|5046980|P1|Overall Study|Death|2
1542204|NCT00132691|5046979|P2|Overall Study|Missed 2-year visit|4
1542205|NCT00132691|5046980|P1|Overall Study|Missed 2-year visit|4
1542206|NCT00132691|5046979|P2|Overall Study|Lost to Follow-up|8
1542207|NCT00132691|5046980|P1|Overall Study|Lost to Follow-up|5
1542208|NCT00132678|5047020|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
1542209|NCT00132678|5047021|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
1542210|NCT00132678|5047022|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
1542211|NCT00132678|5047020|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
1542212|NCT00132678|5047021|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
1542213|NCT00132678|5047022|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
1542214|NCT00132678|5047020|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
1542215|NCT00132678|5047021|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
1542216|NCT00132678|5047022|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
1542217|NCT00132678|5047020|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
1542218|NCT00132678|5047021|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
1542219|NCT00132678|5047022|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
1542220|NCT00132678|5047020|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
1542221|NCT00132678|5047021|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
1542222|NCT00132678|5047022|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
1542223|NCT00132678|5047020|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
1542224|NCT00132678|5047021|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
1542225|NCT00132678|5047022|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
1542226|NCT00132678|5047020|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
1542227|NCT00132678|5047021|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
1542228|NCT00132678|5047022|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
1542229|NCT00132678|5047020|P3|Period III (Open-Label Stabilization)|Pregnancy|0
1542230|NCT00132678|5047021|P2|Period III (Open-Label Stabilization)|Pregnancy|0
1542231|NCT00132678|5047022|P1|Period III (Open-Label Stabilization)|Pregnancy|2
1542232|NCT00132678|5047020|P3|Period III (Open-Label Stabilization)|Physician Decision|0
1542233|NCT00132678|5047021|P2|Period III (Open-Label Stabilization)|Physician Decision|0
1542234|NCT00132678|5047022|P1|Period III (Open-Label Stabilization)|Physician Decision|1
1542235|NCT00132678|5047020|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
1542236|NCT00132678|5047021|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
1542237|NCT00132678|5047022|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
1542238|NCT00132678|5047020|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
1542239|NCT00132678|5047021|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
1542240|NCT00132678|5047022|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
1542241|NCT00132678|5047020|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
1542242|NCT00132678|5047021|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
1542243|NCT00132678|5047022|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
1542244|NCT00132678|5047020|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
1542245|NCT00132678|5047021|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
1542246|NCT00132678|5047022|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
1542247|NCT00132678|5047020|P3|Period III (Open-Label Stabilization)|Non responder|0
1542248|NCT00132678|5047021|P2|Period III (Open-Label Stabilization)|Non responder|0
1542249|NCT00132678|5047022|P1|Period III (Open-Label Stabilization)|Non responder|107
1542250|NCT00132678|5047020|P3|Period III (Open-Label Stabilization)|Adverse Event|0
1542251|NCT00132678|5047021|P2|Period III (Open-Label Stabilization)|Adverse Event|0
1542252|NCT00132678|5047022|P1|Period III (Open-Label Stabilization)|Adverse Event|12
1542253|NCT00132678|5047020|P3|Period III (Open-Label Stabilization)|Death|0
1542254|NCT00132678|5047021|P2|Period III (Open-Label Stabilization)|Death|0
1542255|NCT00132678|5047022|P1|Period III (Open-Label Stabilization)|Death|2
1542256|NCT00132678|5047020|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
1542257|NCT00132678|5047021|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
1542258|NCT00132678|5047022|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
1542259|NCT00132678|5047020|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
1542260|NCT00132678|5047021|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
1542261|NCT00132678|5047022|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
1542262|NCT00132678|5047020|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
1542263|NCT00132678|5047021|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
1542264|NCT00132678|5047022|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
1542265|NCT00132678|5047020|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
1542266|NCT00132678|5047021|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
1542267|NCT00132678|5047022|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
1542268|NCT00132678|5047020|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
1542269|NCT00132678|5047021|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
1542270|NCT00132678|5047022|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
1542271|NCT00132678|5047020|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
1542272|NCT00132678|5047021|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
1542273|NCT00132678|5047022|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
1542274|NCT00132678|5047020|P3|Period II (Open-Label Oral Risperidone)|Death|1
1542275|NCT00132678|5047021|P2|Period II (Open-Label Oral Risperidone)|Death|0
1542276|NCT00132678|5047022|P1|Period II (Open-Label Oral Risperidone)|Death|0
1542277|NCT00132496|5047036|P2|Overall Study|Physician Decision|0
1542278|NCT00132496|5047037|P1|Overall Study|Physician Decision|1
1542279|NCT00132496|5047036|P2|Overall Study|Withdrawal by Subject|2
1542280|NCT00132496|5047037|P1|Overall Study|Withdrawal by Subject|1
1542281|NCT00132314|5047045|P2|Overall Study|Refused intervention at baseline|7
1542282|NCT00132314|5047046|P1|Overall Study|Refused intervention at baseline|2
1542283|NCT00132314|5047045|P2|Overall Study|Lacked SSN|3
1542284|NCT00132314|5047046|P1|Overall Study|Lacked SSN|1
1542285|NCT00132314|5047045|P2|Overall Study|Lost to Follow-up|62
1542286|NCT00132314|5047046|P1|Overall Study|Lost to Follow-up|70
1542287|NCT00132301|5047056|P2|Overall Study|Excluded by Data Monitoring Committee|0
1542288|NCT00132301|5047057|P1|Overall Study|Excluded by Data Monitoring Committee|1
1542289|NCT00132301|5047056|P2|Overall Study|Other|1
1542290|NCT00132301|5047057|P1|Overall Study|Other|1
1542291|NCT00132301|5047056|P2|Overall Study|Lost to Follow-up|3
1542292|NCT00132301|5047057|P1|Overall Study|Lost to Follow-up|5
1542293|NCT00132301|5047056|P2|Overall Study|Physician Decision|1
1542294|NCT00132301|5047057|P1|Overall Study|Physician Decision|1
1542295|NCT00132301|5047056|P2|Overall Study|Withdrawal by Subject|2
1542296|NCT00132301|5047057|P1|Overall Study|Withdrawal by Subject|5
1542297|NCT00132301|5047056|P2|Overall Study|Death|6
1542298|NCT00132301|5047057|P1|Overall Study|Death|7
1542299|NCT00132132|5047065|P2|Overall Study|Lost to Follow-up|2
1542300|NCT00132132|5047066|P1|Overall Study|Lost to Follow-up|7
1542301|NCT00132028|5047074|P1|Overall Study|Physician Decision|3
1542302|NCT00132028|5047074|P1|Overall Study|not eligible|2
1542303|NCT00132028|5047074|P1|Overall Study|Withdrawal by Subject|2
1542304|NCT00132028|5047074|P1|Overall Study|Lack of Efficacy|11
1542305|NCT00132028|5047074|P1|Overall Study|Death|2
1542306|NCT00132028|5047074|P1|Overall Study|Adverse Event|7
1542307|NCT00131937|5047086|P1|Overall Study|Alternative therapy|1
1542308|NCT00131937|5047086|P1|Overall Study|Disease Progression|7
1542309|NCT00131937|5047086|P1|Overall Study|Physician Decision|1
1542310|NCT00131937|5047086|P1|Overall Study|Withdrawal by Subject|2
1542311|NCT00131937|5047086|P1|Overall Study|Adverse Event|3
1542312|NCT00131911|5047094|P2|Overall Study|Withdrawal by Subject|0
1542313|NCT00131911|5047095|P1|Overall Study|Withdrawal by Subject|1
1542314|NCT00131664|5047165|P6|Second Period (Additional Drug Added)|Administrative reasons|0
1542315|NCT00131664|5047166|P5|Second Period (Additional Drug Added)|Administrative reasons|1
1542316|NCT00131664|5047167|P4|Second Period (Additional Drug Added)|Administrative reasons|0
1542317|NCT00131664|5047168|P3|Second Period (Additional Drug Added)|Administrative reasons|0
1542318|NCT00131664|5047169|P2|Second Period (Additional Drug Added)|Administrative reasons|2
1542319|NCT00131664|5047170|P1|Second Period (Additional Drug Added)|Administrative reasons|4
1542320|NCT00131664|5047165|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1542321|NCT00131664|5047166|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1542322|NCT00131664|5047167|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
1542323|NCT00131664|5047168|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1542324|NCT00131664|5047169|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1542325|NCT00131664|5047170|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1542326|NCT00131664|5047165|P6|Second Period (Additional Drug Added)|Adverse Event|1
1542327|NCT00131664|5047166|P5|Second Period (Additional Drug Added)|Adverse Event|0
1542328|NCT00131664|5047167|P4|Second Period (Additional Drug Added)|Adverse Event|0
1542329|NCT00131664|5047168|P3|Second Period (Additional Drug Added)|Adverse Event|0
1542330|NCT00131664|5047169|P2|Second Period (Additional Drug Added)|Adverse Event|1
1542331|NCT00131664|5047170|P1|Second Period (Additional Drug Added)|Adverse Event|0
1542332|NCT00131664|5047165|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1542333|NCT00131664|5047166|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1542334|NCT00131664|5047167|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1542335|NCT00131664|5047168|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1542336|NCT00131664|5047169|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1542337|NCT00131664|5047170|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
1542338|NCT00131664|5047165|P6|Second Period (Additional Drug Added)|Protocol Violation|0
1542339|NCT00131664|5047166|P5|Second Period (Additional Drug Added)|Protocol Violation|0
1542340|NCT00131664|5047167|P4|Second Period (Additional Drug Added)|Protocol Violation|0
1542341|NCT00131664|5047168|P3|Second Period (Additional Drug Added)|Protocol Violation|1
1542342|NCT00131664|5047169|P2|Second Period (Additional Drug Added)|Protocol Violation|1
1542343|NCT00131664|5047170|P1|Second Period (Additional Drug Added)|Protocol Violation|0
1542344|NCT00131664|5047165|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
1542345|NCT00131664|5047166|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
1542346|NCT00131664|5047167|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
1542347|NCT00131664|5047168|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
1542348|NCT00131664|5047169|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
1542349|NCT00131664|5047170|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
1542350|NCT00131664|5047165|P6|First Period (First 6 Months)|Administrative reasons|0
1542351|NCT00131664|5047166|P5|First Period (First 6 Months)|Administrative reasons|0
1542352|NCT00131664|5047167|P4|First Period (First 6 Months)|Administrative reasons|0
1542353|NCT00131664|5047168|P3|First Period (First 6 Months)|Administrative reasons|5
1542354|NCT00131664|5047169|P2|First Period (First 6 Months)|Administrative reasons|0
1542355|NCT00131664|5047170|P1|First Period (First 6 Months)|Administrative reasons|2
1542356|NCT00131664|5047165|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1542357|NCT00131664|5047166|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1542358|NCT00131664|5047167|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1542359|NCT00131664|5047168|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1542360|NCT00131664|5047169|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
1542361|NCT00131664|5047170|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
1542362|NCT00131664|5047165|P6|First Period (First 6 Months)|Adverse Event|0
1542363|NCT00131664|5047166|P5|First Period (First 6 Months)|Adverse Event|0
1542364|NCT00131664|5047167|P4|First Period (First 6 Months)|Adverse Event|0
1542365|NCT00131664|5047168|P3|First Period (First 6 Months)|Adverse Event|5
1542366|NCT00131664|5047169|P2|First Period (First 6 Months)|Adverse Event|4
1542367|NCT00131664|5047170|P1|First Period (First 6 Months)|Adverse Event|9
1542368|NCT00131664|5047165|P6|First Period (First 6 Months)|Withdrawal by Subject|0
1542369|NCT00131664|5047166|P5|First Period (First 6 Months)|Withdrawal by Subject|0
1542370|NCT00131664|5047167|P4|First Period (First 6 Months)|Withdrawal by Subject|0
1542371|NCT00131664|5047168|P3|First Period (First 6 Months)|Withdrawal by Subject|2
1542372|NCT00131664|5047169|P2|First Period (First 6 Months)|Withdrawal by Subject|6
1542373|NCT00131664|5047170|P1|First Period (First 6 Months)|Withdrawal by Subject|4
1542374|NCT00131664|5047165|P6|First Period (First 6 Months)|Protocol Violation|0
1542375|NCT00131664|5047166|P5|First Period (First 6 Months)|Protocol Violation|0
1542376|NCT00131664|5047167|P4|First Period (First 6 Months)|Protocol Violation|0
1542377|NCT00131664|5047168|P3|First Period (First 6 Months)|Protocol Violation|1
1542378|NCT00131664|5047169|P2|First Period (First 6 Months)|Protocol Violation|2
1542379|NCT00131664|5047170|P1|First Period (First 6 Months)|Protocol Violation|2
1542380|NCT00131664|5047165|P6|First Period (First 6 Months)|Death|0
1542381|NCT00131664|5047166|P5|First Period (First 6 Months)|Death|0
1542382|NCT00131664|5047167|P4|First Period (First 6 Months)|Death|0
1542383|NCT00131664|5047168|P3|First Period (First 6 Months)|Death|0
1542384|NCT00131664|5047169|P2|First Period (First 6 Months)|Death|1
1542385|NCT00131664|5047170|P1|First Period (First 6 Months)|Death|0
1542386|NCT00131664|5047165|P6|First Period (First 6 Months)|Lost to Follow-up|0
1542387|NCT00131664|5047166|P5|First Period (First 6 Months)|Lost to Follow-up|0
1542388|NCT00131664|5047167|P4|First Period (First 6 Months)|Lost to Follow-up|0
1542389|NCT00131664|5047168|P3|First Period (First 6 Months)|Lost to Follow-up|3
1542390|NCT00131664|5047169|P2|First Period (First 6 Months)|Lost to Follow-up|3
1542391|NCT00131664|5047170|P1|First Period (First 6 Months)|Lost to Follow-up|7
1542392|NCT00131508|5047242|P2|Overall Study|Withdrawal by Subject|2
1542393|NCT00131508|5047243|P1|Overall Study|Withdrawal by Subject|1
1542394|NCT00131508|5047242|P2|Overall Study|Non-Compliance|4
1542395|NCT00131508|5047243|P1|Overall Study|Non-Compliance|2
1542396|NCT00131508|5047242|P2|Overall Study|Disease progression|2
1542397|NCT00131508|5047243|P1|Overall Study|Disease progression|0
1542398|NCT00131352|5047305|P2|Repeat Treatment Period|Other|0
1542399|NCT00131352|5047306|P1|Repeat Treatment Period|Other|1
1542400|NCT00131352|5047305|P2|Repeat Treatment Period|Adverse Event|0
1542401|NCT00131352|5047306|P1|Repeat Treatment Period|Adverse Event|1
1542402|NCT00131352|5047305|P2|Initial Treatment Period|Other|2
1542403|NCT00131352|5047306|P1|Initial Treatment Period|Other|0
1542404|NCT00131352|5047305|P2|Initial Treatment Period|Lack of Efficacy|4
1542405|NCT00131352|5047306|P1|Initial Treatment Period|Lack of Efficacy|6
1542406|NCT00131352|5047305|P2|Initial Treatment Period|Withdrawal by Subject|1
1542407|NCT00131352|5047306|P1|Initial Treatment Period|Withdrawal by Subject|1
1542408|NCT00131352|5047305|P2|Initial Treatment Period|Non-compliant|2
1542409|NCT00131352|5047306|P1|Initial Treatment Period|Non-compliant|1
1542410|NCT00131352|5047305|P2|Initial Treatment Period|Adverse Event|3
1542411|NCT00131352|5047306|P1|Initial Treatment Period|Adverse Event|1
1542412|NCT00131248|5047328|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
1542413|NCT00131248|5047329|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
1542414|NCT00130832|5047346|P2|Overall Study|Other|3
1542415|NCT00130832|5047347|P1|Overall Study|Other|0
1542416|NCT00130832|5047346|P2|Overall Study|Moved|2
1542417|NCT00130832|5047347|P1|Overall Study|Moved|2
1542418|NCT00130832|5047346|P2|Overall Study|Withdrawal by Subject|1
1542419|NCT00130832|5047347|P1|Overall Study|Withdrawal by Subject|6
1542420|NCT00130832|5047346|P2|Overall Study|Protocol Violation|8
1542421|NCT00130832|5047347|P1|Overall Study|Protocol Violation|6
1542422|NCT00130832|5047346|P2|Overall Study|Lost to Follow-up|2
1542423|NCT00130832|5047347|P1|Overall Study|Lost to Follow-up|1
1542424|NCT00130832|5047346|P2|Overall Study|Adverse Event|1
1542425|NCT00130832|5047347|P1|Overall Study|Adverse Event|1
1542426|NCT00130793|5047359|P2|Overall Study|Withdrew consent|0
1542427|NCT00130793|5047360|P1|Overall Study|Withdrew consent|2
1542428|NCT00130793|5047359|P2|Overall Study|Lost to Follow-up|4
1542429|NCT00130793|5047360|P1|Overall Study|Lost to Follow-up|1
1542430|NCT00130728|5047381|P2|Overall Study|Withdrawal by Subject|2
1542431|NCT00130728|5047382|P1|Overall Study|Withdrawal by Subject|0
1542432|NCT00130728|5047381|P2|Overall Study|Lost to Follow-up|0
1542433|NCT00130728|5047382|P1|Overall Study|Lost to Follow-up|4
1542434|NCT00130728|5047381|P2|Overall Study|Death|211
1542435|NCT00130728|5047382|P1|Overall Study|Death|207
1542436|NCT00130689|5047394|P1|Overall Study|Ineligible|6
1542437|NCT00130689|5047394|P1|Overall Study|Withdrawal by Subject|3
1542438|NCT00130689|5047394|P1|Overall Study|Clinical Deterioration|4
1542439|NCT00130689|5047394|P1|Overall Study|Death|1
1542440|NCT00130689|5047394|P1|Overall Study|Progressive Disease|29
1542441|NCT00130637|5047398|P1|Overall Study|Withdrawal by Subject|1
1542442|NCT00130637|5047398|P1|Overall Study|Adverse Event|2
1542443|NCT00130520|5047403|P1|Overall Study|Did not meet re-treatment criteria|1
1542444|NCT00130520|5047403|P1|Overall Study|Protocol non-compliance|1
1542445|NCT00130520|5047403|P1|Overall Study|Disease Progression|23
1542446|NCT00130520|5047403|P1|Overall Study|Withdrawal by Subject|1
1542447|NCT00130520|5047403|P1|Overall Study|Physician Decision|1
1542448|NCT00130520|5047403|P1|Overall Study|Death|1
1542449|NCT00130520|5047403|P1|Overall Study|Adverse Event|11
1542450|NCT00130286|5047413|P4|Overall Study|Missing lab specimens|0
1542451|NCT00130286|5047414|P3|Overall Study|Missing lab specimens|0
1542452|NCT00130286|5047415|P2|Overall Study|Missing lab specimens|2
1542453|NCT00130286|5047416|P1|Overall Study|Missing lab specimens|0
1542454|NCT00130286|5047413|P4|Overall Study|Adverse Event|0
1542455|NCT00130286|5047414|P3|Overall Study|Adverse Event|2
1542456|NCT00130286|5047415|P2|Overall Study|Adverse Event|0
1542457|NCT00130286|5047416|P1|Overall Study|Adverse Event|0
1542458|NCT00130286|5047413|P4|Overall Study|Withdrawal by Subject|2
1542459|NCT00130286|5047414|P3|Overall Study|Withdrawal by Subject|2
1542460|NCT00130286|5047415|P2|Overall Study|Withdrawal by Subject|1
1542461|NCT00130286|5047416|P1|Overall Study|Withdrawal by Subject|0
1542462|NCT00130247|5047436|P2|Overall Study|Not compliant with DOT|2
1542463|NCT00130247|5047437|P1|Overall Study|Not compliant with DOT|0
1542464|NCT00130247|5047436|P2|Overall Study|Post-randomization exclusion|2
1542465|NCT00130247|5047437|P1|Overall Study|Post-randomization exclusion|1
1542466|NCT00130247|5047436|P2|Overall Study|Pregnancy|0
1542467|NCT00130247|5047437|P1|Overall Study|Pregnancy|1
1542468|NCT00130208|5047455|P2|Washout Period (8 Weeks)|Other|1
1542469|NCT00130208|5047456|P1|Washout Period (8 Weeks)|Other|1
1542470|NCT00130208|5047455|P2|Washout Period (8 Weeks)|Lost to Follow-up|1
1542471|NCT00130208|5047456|P1|Washout Period (8 Weeks)|Lost to Follow-up|0
1542472|NCT00130208|5047455|P2|Washout Period (8 Weeks)|Withdrawal by Subject|4
1542473|NCT00130208|5047456|P1|Washout Period (8 Weeks)|Withdrawal by Subject|2
1542474|NCT00130208|5047455|P2|Washout Period (8 Weeks)|Adverse Event|6
1542475|NCT00130208|5047456|P1|Washout Period (8 Weeks)|Adverse Event|3
1542476|NCT00130208|5047455|P2|Maintenance Period (26 Weeks)|Other|1
1542477|NCT00130208|5047456|P1|Maintenance Period (26 Weeks)|Other|1
1542478|NCT00130208|5047455|P2|Maintenance Period (26 Weeks)|Lost to Follow-up|4
1542479|NCT00130208|5047456|P1|Maintenance Period (26 Weeks)|Lost to Follow-up|5
1542480|NCT00130208|5047455|P2|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
1542481|NCT00130208|5047456|P1|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
1542482|NCT00130208|5047455|P2|Maintenance Period (26 Weeks)|Physician Decision|2
1542483|NCT00130208|5047456|P1|Maintenance Period (26 Weeks)|Physician Decision|0
1542484|NCT00130208|5047455|P2|Maintenance Period (26 Weeks)|Adverse Event|12
1542485|NCT00130208|5047456|P1|Maintenance Period (26 Weeks)|Adverse Event|10
1542486|NCT00130039|5047492|P2|Overall Study|clinical events without follow up MRI|4
1542487|NCT00130039|5047493|P1|Overall Study|clinical events without follow up MRI|5
1542488|NCT00130039|5047492|P2|Overall Study|Physician Decision|0
1542489|NCT00130039|5047493|P1|Overall Study|Physician Decision|3
1542490|NCT00130039|5047492|P2|Overall Study|Adverse Event|2
1542491|NCT00130039|5047493|P1|Overall Study|Adverse Event|4
1542492|NCT00130039|5047492|P2|Overall Study|Lost to Follow-up|1
1542493|NCT00130039|5047493|P1|Overall Study|Lost to Follow-up|3
1542494|NCT00130039|5047492|P2|Overall Study|Withdrawal by Subject|11
1542495|NCT00130039|5047493|P1|Overall Study|Withdrawal by Subject|15
1542496|NCT00129974|5047509|P1|Overall Study|Other|1
1542497|NCT00129961|5047516|P2|Overall Study|Missing Record|1
1542498|NCT00129961|5047517|P1|Overall Study|Missing Record|0
1542499|NCT00129961|5047516|P2|Overall Study|Withdrawal by Subject|1
1542500|NCT00129961|5047517|P1|Overall Study|Withdrawal by Subject|2
1542501|NCT00129961|5047516|P2|Overall Study|Physician Decision|0
1542502|NCT00129961|5047517|P1|Overall Study|Physician Decision|1
1542503|NCT00129961|5047516|P2|Overall Study|Withdrawal by Sponsor|20
1542504|NCT00129961|5047517|P1|Overall Study|Withdrawal by Sponsor|14
1542505|NCT00129961|5047516|P2|Overall Study|Death|1
1542506|NCT00129961|5047517|P1|Overall Study|Death|1
1542507|NCT00129961|5047516|P2|Overall Study|Adverse Event|0
1542508|NCT00129961|5047517|P1|Overall Study|Adverse Event|1
1542509|NCT00129766|5047553|P2|Overall Study|Lost to Follow-up|21
1542510|NCT00129766|5047554|P1|Overall Study|Lost to Follow-up|26
1542511|NCT00129766|5047553|P2|Overall Study|Withdrawal of consent|30
1542512|NCT00129766|5047554|P1|Overall Study|Withdrawal of consent|31
1542513|NCT00129766|5047553|P2|Overall Study|Death|8
1542514|NCT00129766|5047554|P1|Overall Study|Death|3
1542515|NCT00129623|5047600|P2|Overall Study|Uncertainty to return|1
1542516|NCT00129623|5047601|P1|Overall Study|Uncertainty to return|0
1542517|NCT00129623|5047600|P2|Overall Study|Relocated job out of state|0
1542518|NCT00129623|5047601|P1|Overall Study|Relocated job out of state|1
1542519|NCT00129623|5047600|P2|Overall Study|Failure to Return|1
1542520|NCT00129623|5047601|P1|Overall Study|Failure to Return|1
1542521|NCT00129623|5047600|P2|Overall Study|Refused Treatment|3
1542522|NCT00129623|5047601|P1|Overall Study|Refused Treatment|5
1542523|NCT00129623|5047600|P2|Overall Study|Adverse Event|7
1542524|NCT00129623|5047601|P1|Overall Study|Adverse Event|3
1542525|NCT00129545|5047626|P3|Overall Study|Device not implanted|0
1542526|NCT00129545|5047627|P2|Overall Study|Device not implanted|61
1542527|NCT00129545|5047628|P1|Overall Study|Device not implanted|16
1542528|NCT00129545|5047626|P3|Overall Study|Physician Decision|10
1542529|NCT00129545|5047627|P2|Overall Study|Physician Decision|3
1542530|NCT00129545|5047628|P1|Overall Study|Physician Decision|0
1542531|NCT00129545|5047626|P3|Overall Study|Lost to Follow-up|13
1542532|NCT00129545|5047627|P2|Overall Study|Lost to Follow-up|22
1542533|NCT00129545|5047628|P1|Overall Study|Lost to Follow-up|2
1542534|NCT00129545|5047626|P3|Overall Study|Withdrawal by Subject|44
1542535|NCT00129545|5047627|P2|Overall Study|Withdrawal by Subject|18
1542536|NCT00129545|5047628|P1|Overall Study|Withdrawal by Subject|3
1542537|NCT00129545|5047626|P3|Overall Study|Death|44
1542538|NCT00129545|5047627|P2|Overall Study|Death|60
1542539|NCT00129545|5047628|P1|Overall Study|Death|5
1542540|NCT00129467|5047649|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
1542541|NCT00129467|5047650|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
1542542|NCT00129467|5047649|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
1542543|NCT00129467|5047650|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
1542544|NCT00129467|5047649|P2|Received Intervention|Dizzyness, fatigue|1
1542545|NCT00129467|5047650|P1|Received Intervention|Dizzyness, fatigue|0
1542546|NCT00129467|5047649|P2|Received Intervention|Intolerance to citalopram|1
1542547|NCT00129467|5047650|P1|Received Intervention|Intolerance to citalopram|0
1542548|NCT00129467|5047649|P2|Received Intervention|Nausea|0
1542549|NCT00129467|5047650|P1|Received Intervention|Nausea|1
1542550|NCT00129467|5047649|P2|Received Intervention|Withdrawal by Subject|0
1542551|NCT00129467|5047650|P1|Received Intervention|Withdrawal by Subject|1
1542552|NCT00129467|5047649|P2|Received Intervention|Delirium|0
1542553|NCT00129467|5047650|P1|Received Intervention|Delirium|2
1542554|NCT00129467|5047649|P2|Received Intervention|Cardiac SAE (hypertension)|1
1542555|NCT00129467|5047650|P1|Received Intervention|Cardiac SAE (hypertension)|1
1542556|NCT00129467|5047649|P2|Received Intervention|Death|1
1542557|NCT00129467|5047650|P1|Received Intervention|Death|1
1542558|NCT00129402|5047681|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
1542708|NCT00129129|5047819|P4|Fourth Dose Phase|Migration from study area|0
1542559|NCT00129402|5047682|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1542560|NCT00129402|5047683|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1542561|NCT00129402|5047684|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1542562|NCT00129402|5047685|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1542563|NCT00129402|5047686|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1542564|NCT00129402|5047687|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1542565|NCT00129402|5047681|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
1542566|NCT00129402|5047682|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1542567|NCT00129402|5047683|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1542568|NCT00129402|5047684|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1542569|NCT00129402|5047685|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1542570|NCT00129402|5047686|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1542571|NCT00129402|5047687|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1542572|NCT00129402|5047681|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
1542573|NCT00129402|5047682|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1542574|NCT00129402|5047683|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1542575|NCT00129402|5047684|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1542576|NCT00129402|5047685|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1542577|NCT00129402|5047686|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1542578|NCT00129402|5047687|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1542579|NCT00129402|5047681|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
1542580|NCT00129402|5047682|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1542581|NCT00129402|5047683|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1542582|NCT00129402|5047684|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1542583|NCT00129402|5047685|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1542584|NCT00129402|5047686|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1542585|NCT00129402|5047687|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1542586|NCT00129402|5047681|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1542587|NCT00129402|5047682|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
1542588|NCT00129402|5047683|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1542589|NCT00129402|5047684|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1542590|NCT00129402|5047685|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
1542591|NCT00129402|5047686|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1542592|NCT00129402|5047687|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1542593|NCT00129402|5047681|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1542594|NCT00129402|5047682|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
1542595|NCT00129402|5047683|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1542596|NCT00129402|5047684|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1542597|NCT00129402|5047685|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
1542598|NCT00129402|5047686|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1542599|NCT00129402|5047687|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1542600|NCT00129402|5047681|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1542601|NCT00129402|5047682|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1542602|NCT00129402|5047683|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1542603|NCT00129402|5047684|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1542604|NCT00129402|5047685|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
1542605|NCT00129402|5047686|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1542606|NCT00129402|5047687|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1542607|NCT00129402|5047681|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1542608|NCT00129402|5047682|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
1542609|NCT00129402|5047683|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1542610|NCT00129402|5047684|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1542611|NCT00129402|5047685|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
1542612|NCT00129402|5047686|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1542613|NCT00129402|5047687|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1542614|NCT00129402|5047681|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1542615|NCT00129402|5047682|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1542616|NCT00129402|5047683|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1542617|NCT00129402|5047684|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1542618|NCT00129402|5047685|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
1542619|NCT00129402|5047686|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1542620|NCT00129402|5047687|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1542621|NCT00129402|5047681|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1542622|NCT00129402|5047682|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1542623|NCT00129402|5047683|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
1542624|NCT00129402|5047684|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1542625|NCT00129402|5047685|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
1542626|NCT00129402|5047686|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1542627|NCT00129402|5047687|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1542628|NCT00129402|5047681|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1542629|NCT00129402|5047682|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1542630|NCT00129402|5047683|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1542631|NCT00129402|5047684|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
1542632|NCT00129402|5047685|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1542633|NCT00129402|5047686|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1542634|NCT00129402|5047687|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1542635|NCT00129402|5047681|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1542636|NCT00129402|5047682|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
1542637|NCT00129402|5047683|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1542638|NCT00129402|5047684|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1542639|NCT00129402|5047685|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1542640|NCT00129402|5047686|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1542641|NCT00129402|5047687|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1542642|NCT00129402|5047681|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1542643|NCT00129402|5047682|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
1542644|NCT00129402|5047683|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1542645|NCT00129402|5047684|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1542646|NCT00129402|5047685|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
1542647|NCT00129402|5047686|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
1542648|NCT00129402|5047687|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1542649|NCT00129311|5047706|P2|Overall Study|Withdrawal by Subject|19
1542650|NCT00129311|5047707|P1|Overall Study|Withdrawal by Subject|12
1542651|NCT00129272|5047736|P2|Overall Study|Withdrawal by Subject|11
1542652|NCT00129272|5047737|P1|Overall Study|Withdrawal by Subject|5
1542653|NCT00129272|5047736|P2|Overall Study|Lost to Follow-up|11
1542654|NCT00129272|5047737|P1|Overall Study|Lost to Follow-up|12
1542655|NCT00129259|5047747|P2|Overall Study|Only available minimal phone assessments|1
1542656|NCT00129259|5047748|P1|Overall Study|Only available minimal phone assessments|0
1542657|NCT00129259|5047747|P2|Overall Study|Withdrawal by Subject|1
1542658|NCT00129259|5047748|P1|Overall Study|Withdrawal by Subject|2
1542659|NCT00129259|5047747|P2|Overall Study|Lost to Follow-up|1
1542660|NCT00129259|5047748|P1|Overall Study|Lost to Follow-up|1
1542661|NCT00129220|5047776|P3|Study Period III|Reason Not Specified|2
1542662|NCT00129220|5047777|P2|Study Period III|Reason Not Specified|0
1542663|NCT00129220|5047778|P1|Study Period III|Reason Not Specified|9
1542664|NCT00129220|5047776|P3|Study Period III|Sponsor Decision|0
1542665|NCT00129220|5047777|P2|Study Period III|Sponsor Decision|0
1542666|NCT00129220|5047778|P1|Study Period III|Sponsor Decision|1
1542667|NCT00129220|5047776|P3|Study Period III|Withdrawal by Subject|3
1542668|NCT00129220|5047777|P2|Study Period III|Withdrawal by Subject|0
1542669|NCT00129220|5047778|P1|Study Period III|Withdrawal by Subject|1
1542670|NCT00129220|5047776|P3|Study Period III|Protocol Violation|2
1542671|NCT00129220|5047777|P2|Study Period III|Protocol Violation|1
1542672|NCT00129220|5047778|P1|Study Period III|Protocol Violation|1
1542673|NCT00129220|5047776|P3|Study Period III|Adverse Event|3
1542674|NCT00129220|5047777|P2|Study Period III|Adverse Event|0
1542675|NCT00129220|5047778|P1|Study Period III|Adverse Event|1
1542676|NCT00129220|5047776|P3|Study Period II|Reason Not Specified|5
1542677|NCT00129220|5047777|P2|Study Period II|Reason Not Specified|0
1542678|NCT00129220|5047778|P1|Study Period II|Reason Not Specified|2
1542679|NCT00129220|5047776|P3|Study Period II|Withdrawal by Subject|4
1542680|NCT00129220|5047777|P2|Study Period II|Withdrawal by Subject|3
1542681|NCT00129220|5047778|P1|Study Period II|Withdrawal by Subject|1
1542682|NCT00129220|5047776|P3|Study Period II|Physician Decision|0
1542683|NCT00129220|5047777|P2|Study Period II|Physician Decision|1
1542684|NCT00129220|5047778|P1|Study Period II|Physician Decision|0
1542685|NCT00129220|5047776|P3|Study Period II|Protocol Violation|1
1542686|NCT00129220|5047777|P2|Study Period II|Protocol Violation|2
1542687|NCT00129220|5047778|P1|Study Period II|Protocol Violation|4
1542688|NCT00129220|5047776|P3|Study Period II|Entry Criteria Not Met|2
1542689|NCT00129220|5047777|P2|Study Period II|Entry Criteria Not Met|0
1542690|NCT00129220|5047778|P1|Study Period II|Entry Criteria Not Met|2
1542691|NCT00129220|5047776|P3|Study Period II|Lack of Efficacy|28
1542692|NCT00129220|5047777|P2|Study Period II|Lack of Efficacy|1
1542693|NCT00129220|5047778|P1|Study Period II|Lack of Efficacy|15
1542694|NCT00129220|5047776|P3|Study Period II|Adverse Event|7
1542695|NCT00129220|5047777|P2|Study Period II|Adverse Event|5
1542696|NCT00129220|5047778|P1|Study Period II|Adverse Event|9
1542697|NCT00129129|5047818|P5|Fourth Dose Phase|Protocol Violation|0
1542698|NCT00129129|5047819|P4|Fourth Dose Phase|Protocol Violation|1
1542699|NCT00129129|5047820|P3|Fourth Dose Phase|Protocol Violation|0
1542700|NCT00129129|5047821|P2|Fourth Dose Phase|Protocol Violation|0
1542701|NCT00129129|5047822|P1|Fourth Dose Phase|Protocol Violation|0
1542702|NCT00129129|5047818|P5|Fourth Dose Phase|Other|1
1542703|NCT00129129|5047819|P4|Fourth Dose Phase|Other|1
1542704|NCT00129129|5047820|P3|Fourth Dose Phase|Other|0
1542705|NCT00129129|5047821|P2|Fourth Dose Phase|Other|0
1542706|NCT00129129|5047822|P1|Fourth Dose Phase|Other|0
1542707|NCT00129129|5047818|P5|Fourth Dose Phase|Migration from study area|2
1542709|NCT00129129|5047820|P3|Fourth Dose Phase|Migration from study area|0
1542710|NCT00129129|5047821|P2|Fourth Dose Phase|Migration from study area|0
1542711|NCT00129129|5047822|P1|Fourth Dose Phase|Migration from study area|0
1542712|NCT00129129|5047818|P5|Fourth Dose Phase|Withdrawal by Subject|1
1542713|NCT00129129|5047819|P4|Fourth Dose Phase|Withdrawal by Subject|0
1542714|NCT00129129|5047820|P3|Fourth Dose Phase|Withdrawal by Subject|0
1542715|NCT00129129|5047821|P2|Fourth Dose Phase|Withdrawal by Subject|0
1542716|NCT00129129|5047822|P1|Fourth Dose Phase|Withdrawal by Subject|0
1542717|NCT00129129|5047818|P5|Fourth Dose Phase|Lost to Follow-up|2
1542718|NCT00129129|5047819|P4|Fourth Dose Phase|Lost to Follow-up|2
1542719|NCT00129129|5047820|P3|Fourth Dose Phase|Lost to Follow-up|0
1542720|NCT00129129|5047821|P2|Fourth Dose Phase|Lost to Follow-up|0
1542721|NCT00129129|5047822|P1|Fourth Dose Phase|Lost to Follow-up|4
1542722|NCT00129129|5047818|P5|Primary Phase|Other|0
1542723|NCT00129129|5047819|P4|Primary Phase|Other|0
1542724|NCT00129129|5047820|P3|Primary Phase|Other|0
1542725|NCT00129129|5047821|P2|Primary Phase|Other|5
1542726|NCT00129129|5047822|P1|Primary Phase|Other|2
1542727|NCT00129129|5047818|P5|Primary Phase|Lost to Follow-up|0
1542728|NCT00129129|5047819|P4|Primary Phase|Lost to Follow-up|0
1542729|NCT00129129|5047820|P3|Primary Phase|Lost to Follow-up|0
1542730|NCT00129129|5047821|P2|Primary Phase|Lost to Follow-up|6
1542731|NCT00129129|5047822|P1|Primary Phase|Lost to Follow-up|8
1542732|NCT00129129|5047818|P5|Primary Phase|Migration from study area|0
1542733|NCT00129129|5047819|P4|Primary Phase|Migration from study area|0
1542734|NCT00129129|5047820|P3|Primary Phase|Migration from study area|0
1542735|NCT00129129|5047821|P2|Primary Phase|Migration from study area|3
1542736|NCT00129129|5047822|P1|Primary Phase|Migration from study area|1
1542737|NCT00129129|5047818|P5|Primary Phase|Withdrawal by Subject|0
1542738|NCT00129129|5047819|P4|Primary Phase|Withdrawal by Subject|0
1542739|NCT00129129|5047820|P3|Primary Phase|Withdrawal by Subject|0
1542740|NCT00129129|5047821|P2|Primary Phase|Withdrawal by Subject|10
1542741|NCT00129129|5047822|P1|Primary Phase|Withdrawal by Subject|12
1542742|NCT00129129|5047818|P5|Primary Phase|Adverse Event|0
1542743|NCT00129129|5047819|P4|Primary Phase|Adverse Event|0
1542744|NCT00129129|5047820|P3|Primary Phase|Adverse Event|0
1542745|NCT00129129|5047821|P2|Primary Phase|Adverse Event|1
1542746|NCT00129129|5047822|P1|Primary Phase|Adverse Event|2
1542747|NCT00129116|5048029|P5|Booster Phase|Lost to Follow-up|1
1542748|NCT00129116|5048030|P4|Booster Phase|Lost to Follow-up|0
1542749|NCT00129116|5048031|P3|Booster Phase|Lost to Follow-up|0
1542750|NCT00129116|5048032|P2|Booster Phase|Lost to Follow-up|0
1542751|NCT00129116|5048033|P1|Booster Phase|Lost to Follow-up|2
1542752|NCT00129116|5048029|P5|Primary Phase|Other|0
1542753|NCT00129116|5048030|P4|Primary Phase|Other|0
1542754|NCT00129116|5048031|P3|Primary Phase|Other|1
1542755|NCT00129116|5048032|P2|Primary Phase|Other|0
1542756|NCT00129116|5048033|P1|Primary Phase|Other|0
1542757|NCT00129116|5048029|P5|Primary Phase|Withdrawal by Subject|0
1542758|NCT00129116|5048030|P4|Primary Phase|Withdrawal by Subject|0
1542759|NCT00129116|5048031|P3|Primary Phase|Withdrawal by Subject|0
1542760|NCT00129116|5048032|P2|Primary Phase|Withdrawal by Subject|1
1542761|NCT00129116|5048033|P1|Primary Phase|Withdrawal by Subject|0
1542762|NCT00129116|5048029|P5|Primary Phase|Adverse Event|0
1542763|NCT00129116|5048030|P4|Primary Phase|Adverse Event|0
1542764|NCT00129116|5048031|P3|Primary Phase|Adverse Event|0
1542765|NCT00129116|5048032|P2|Primary Phase|Adverse Event|1
1542766|NCT00129116|5048033|P1|Primary Phase|Adverse Event|1
1542767|NCT00129116|5048029|P5|Primary Phase|Protocol Violation|0
1542768|NCT00129116|5048030|P4|Primary Phase|Protocol Violation|0
1542769|NCT00129116|5048031|P3|Primary Phase|Protocol Violation|0
1542770|NCT00129116|5048032|P2|Primary Phase|Protocol Violation|1
1542771|NCT00129116|5048033|P1|Primary Phase|Protocol Violation|0
1542772|NCT00129116|5048029|P5|Primary Phase|Lost to Follow-up|1
1542773|NCT00129116|5048030|P4|Primary Phase|Lost to Follow-up|1
1542774|NCT00129116|5048031|P3|Primary Phase|Lost to Follow-up|0
1542775|NCT00129116|5048032|P2|Primary Phase|Lost to Follow-up|1
1542776|NCT00129116|5048033|P1|Primary Phase|Lost to Follow-up|1
1542777|NCT00128830|5048317|P1|Overall Study|Other|9
1542778|NCT00128830|5048317|P1|Overall Study|Discontinued or ineligible for study|2
1542779|NCT00128830|5048317|P1|Overall Study|Non-compliant|4
1542780|NCT00128830|5048317|P1|Overall Study|Reached a virologic endpoint|29
1542781|NCT00128830|5048317|P1|Overall Study|Lost to Follow-up|4
1542782|NCT00128830|5048317|P1|Overall Study|Withdrawal by Subject|14
1542783|NCT00128830|5048317|P1|Overall Study|Adverse Event|10
1542784|NCT00128661|5048359|P2|Overall Study|Other|8
1542785|NCT00128661|5048360|P1|Overall Study|Other|7
1542786|NCT00128661|5048359|P2|Overall Study|Withdrawal by Subject|232
1542787|NCT00128661|5048360|P1|Overall Study|Withdrawal by Subject|243
1542788|NCT00128661|5048359|P2|Overall Study|Lost to Follow-up|7
1542789|NCT00128661|5048360|P1|Overall Study|Lost to Follow-up|10
1542790|NCT00128661|5048359|P2|Overall Study|Adverse Event|11
1542791|NCT00128661|5048360|P1|Overall Study|Adverse Event|14
1542792|NCT00128492|5048406|P2|Overall Study|Pregnancy|1
1542793|NCT00128492|5048407|P1|Overall Study|Pregnancy|0
1542794|NCT00128492|5048406|P2|Overall Study|Withdrawal by Subject|5
1542795|NCT00128492|5048407|P1|Overall Study|Withdrawal by Subject|3
1542796|NCT00128492|5048406|P2|Overall Study|Personal or administrative|22
1542797|NCT00128492|5048407|P1|Overall Study|Personal or administrative|10
1542798|NCT00128492|5048406|P2|Overall Study|Noncompliance|5
1542799|NCT00128492|5048407|P1|Overall Study|Noncompliance|0
1542800|NCT00128492|5048406|P2|Overall Study|Lost to Follow-up|5
1542801|NCT00128492|5048407|P1|Overall Study|Lost to Follow-up|1
1542802|NCT00128492|5048406|P2|Overall Study|Death|0
1542803|NCT00128492|5048407|P1|Overall Study|Death|1
1542804|NCT00128492|5048406|P2|Overall Study|AE related to study|4
1542805|NCT00128492|5048407|P1|Overall Study|AE related to study|1
1542806|NCT00128492|5048406|P2|Overall Study|Study drug intolerance (AE)|8
1542807|NCT00128492|5048407|P1|Overall Study|Study drug intolerance (AE)|2
1542808|NCT00128492|5048406|P2|Overall Study|AE unrelated to study|9
1542809|NCT00128492|5048407|P1|Overall Study|AE unrelated to study|2
1542810|NCT00128206|5048564|P2|Overall Study|Adverse Event|2
1542811|NCT00128206|5048565|P1|Overall Study|Adverse Event|0
1542812|NCT00128206|5048564|P2|Overall Study|Lost to Follow-up|118
1542813|NCT00128206|5048565|P1|Overall Study|Lost to Follow-up|137
1542814|NCT00127933|5048857|P2|Overall Study|Randomized but not dosed|0
1542815|NCT00127933|5048858|P1|Overall Study|Randomized but not dosed|1
1542816|NCT00127855|5048879|P5|Primary Vaccination Course|Other|1
1542817|NCT00127855|5048880|P4|Primary Vaccination Course|Other|0
1542818|NCT00127855|5048881|P3|Primary Vaccination Course|Other|0
1542819|NCT00127855|5048882|P2|Primary Vaccination Course|Other|0
1542820|NCT00127855|5048883|P1|Primary Vaccination Course|Other|0
1542821|NCT00127855|5048879|P5|Primary Vaccination Course|Lost to Follow-up|2
1542822|NCT00127855|5048880|P4|Primary Vaccination Course|Lost to Follow-up|0
1542823|NCT00127855|5048881|P3|Primary Vaccination Course|Lost to Follow-up|1
1542824|NCT00127855|5048882|P2|Primary Vaccination Course|Lost to Follow-up|1
1542825|NCT00127855|5048883|P1|Primary Vaccination Course|Lost to Follow-up|1
1542826|NCT00127855|5048879|P5|Primary Vaccination Course|Withdrawal by Subject|1
1542827|NCT00127855|5048880|P4|Primary Vaccination Course|Withdrawal by Subject|0
1542828|NCT00127855|5048881|P3|Primary Vaccination Course|Withdrawal by Subject|0
1542829|NCT00127855|5048882|P2|Primary Vaccination Course|Withdrawal by Subject|0
1542830|NCT00127855|5048883|P1|Primary Vaccination Course|Withdrawal by Subject|1
1542831|NCT00127855|5048879|P5|Primary Vaccination Course|Adverse Event|0
1542832|NCT00127855|5048880|P4|Primary Vaccination Course|Adverse Event|0
1542833|NCT00127855|5048881|P3|Primary Vaccination Course|Adverse Event|1
1542834|NCT00127855|5048882|P2|Primary Vaccination Course|Adverse Event|0
1542835|NCT00127855|5048883|P1|Primary Vaccination Course|Adverse Event|0
1542836|NCT00127842|5049065|P1|Overall Study|Other|5
1542837|NCT00127842|5049065|P1|Overall Study|Protocol Violation|1
1542838|NCT00127842|5049065|P1|Overall Study|Noncompliance|2
1542839|NCT00127842|5049065|P1|Overall Study|Lack of Efficacy|12
1542840|NCT00127842|5049065|P1|Overall Study|Lost to Follow-up|1
1542841|NCT00127842|5049065|P1|Overall Study|Withdrawal by Subject|3
1542842|NCT00127842|5049065|P1|Overall Study|Adverse Event|15
1542843|NCT00127803|5049083|P4|Overall Study|Lost to Follow-up|1
1542844|NCT00127803|5049084|P3|Overall Study|Lost to Follow-up|0
1542845|NCT00127803|5049085|P2|Overall Study|Lost to Follow-up|0
1542846|NCT00127803|5049086|P1|Overall Study|Lost to Follow-up|0
1542847|NCT00127803|5049083|P4|Overall Study|Withdrawal by Subject|0
1542848|NCT00127803|5049084|P3|Overall Study|Withdrawal by Subject|0
1542849|NCT00127803|5049085|P2|Overall Study|Withdrawal by Subject|0
1542850|NCT00127803|5049086|P1|Overall Study|Withdrawal by Subject|1
1542851|NCT00127803|5049083|P4|Overall Study|Adverse Event|0
1542852|NCT00127803|5049084|P3|Overall Study|Adverse Event|0
1542853|NCT00127803|5049085|P2|Overall Study|Adverse Event|0
1542854|NCT00127803|5049086|P1|Overall Study|Adverse Event|2
1542855|NCT00127712|5049135|P2|Overall Study|Lack of GI access to continue|0
1542856|NCT00127712|5049136|P1|Overall Study|Lack of GI access to continue|2
1542857|NCT00127712|5049135|P2|Overall Study|Adverse Event|0
1542858|NCT00127712|5049136|P1|Overall Study|Adverse Event|3
1542859|NCT00127660|5049152|P4|Overall Study|Protocol Violation|0
1542860|NCT00127660|5049153|P3|Overall Study|Protocol Violation|5
1542861|NCT00127660|5049154|P2|Overall Study|Protocol Violation|3
1542862|NCT00127660|5049155|P1|Overall Study|Protocol Violation|3
1542863|NCT00127413|5049203|P4|Overall Study|Lost to Follow-up|2
1542864|NCT00127413|5049204|P3|Overall Study|Lost to Follow-up|8
1542865|NCT00127413|5049205|P2|Overall Study|Lost to Follow-up|4
1542866|NCT00127413|5049206|P1|Overall Study|Lost to Follow-up|6
1542867|NCT00127192|5049249|P5|Overall Study|Adverse event in pre-treatment period|0
1542868|NCT00127192|5049250|P4|Overall Study|Adverse event in pre-treatment period|0
1542869|NCT00127192|5049251|P3|Overall Study|Adverse event in pre-treatment period|0
1542870|NCT00127192|5049252|P2|Overall Study|Adverse event in pre-treatment period|0
1542871|NCT00127192|5049253|P1|Overall Study|Adverse event in pre-treatment period|1
1542872|NCT00127192|5049249|P5|Overall Study|Withdrawal by Subject|3
1542873|NCT00127192|5049250|P4|Overall Study|Withdrawal by Subject|0
1542874|NCT00127192|5049251|P3|Overall Study|Withdrawal by Subject|1
1542875|NCT00127192|5049252|P2|Overall Study|Withdrawal by Subject|0
1542876|NCT00127192|5049253|P1|Overall Study|Withdrawal by Subject|0
1542877|NCT00127192|5049249|P5|Overall Study|Lack of Efficacy|2
1542878|NCT00127192|5049250|P4|Overall Study|Lack of Efficacy|0
1542879|NCT00127192|5049251|P3|Overall Study|Lack of Efficacy|0
1542880|NCT00127192|5049252|P2|Overall Study|Lack of Efficacy|0
1542881|NCT00127192|5049253|P1|Overall Study|Lack of Efficacy|2
1542882|NCT00127192|5049249|P5|Overall Study|Adverse Event|0
1542883|NCT00127192|5049250|P4|Overall Study|Adverse Event|1
1542884|NCT00127192|5049251|P3|Overall Study|Adverse Event|1
1542885|NCT00127192|5049252|P2|Overall Study|Adverse Event|1
1542886|NCT00127192|5049253|P1|Overall Study|Adverse Event|0
1542887|NCT00127166|5049277|P2|Period II|Patient did not perform Visit 6 exercise|0
1542888|NCT00127166|5049278|P1|Period II|Patient did not perform Visit 6 exercise|1
1542889|NCT00127166|5049277|P2|Period II|Withdrawal by Subject|0
1542890|NCT00127166|5049278|P1|Period II|Withdrawal by Subject|2
1542891|NCT00127166|5049277|P2|Washout Period|Patient did not meet inclusion criteria|1
1542892|NCT00127166|5049278|P1|Washout Period|Patient did not meet inclusion criteria|0
1542893|NCT00127166|5049277|P2|Period I|Patient did not meet inclusion criteria|0
1542894|NCT00127166|5049278|P1|Period I|Patient did not meet inclusion criteria|1
1542895|NCT00127166|5049277|P2|Period I|Withdrawal by Subject|0
1542896|NCT00127166|5049278|P1|Period I|Withdrawal by Subject|2
1542897|NCT00127166|5049277|P2|Period I|Protocol Violation|2
1542898|NCT00127166|5049278|P1|Period I|Protocol Violation|0
1542899|NCT00127101|5049298|P6|Continuation Phase|Withdrawal by Subject|1
1542900|NCT00127101|5049299|P5|Continuation Phase|Withdrawal by Subject|2
1542901|NCT00127101|5049300|P4|Continuation Phase|Withdrawal by Subject|0
1542902|NCT00127101|5049301|P3|Continuation Phase|Withdrawal by Subject|1
1542903|NCT00127101|5049302|P2|Continuation Phase|Withdrawal by Subject|0
1542904|NCT00127101|5049303|P1|Continuation Phase|Withdrawal by Subject|0
1542905|NCT00127101|5049298|P6|Continuation Phase|Lack of Efficacy|1
1542906|NCT00127101|5049299|P5|Continuation Phase|Lack of Efficacy|0
1542907|NCT00127101|5049300|P4|Continuation Phase|Lack of Efficacy|0
1542908|NCT00127101|5049301|P3|Continuation Phase|Lack of Efficacy|0
1542909|NCT00127101|5049302|P2|Continuation Phase|Lack of Efficacy|0
1542910|NCT00127101|5049303|P1|Continuation Phase|Lack of Efficacy|0
1542911|NCT00127101|5049298|P6|Continuation Phase|Adverse Event|1
1542912|NCT00127101|5049299|P5|Continuation Phase|Adverse Event|1
1542913|NCT00127101|5049300|P4|Continuation Phase|Adverse Event|0
1542914|NCT00127101|5049301|P3|Continuation Phase|Adverse Event|0
1542915|NCT00127101|5049302|P2|Continuation Phase|Adverse Event|0
1542916|NCT00127101|5049303|P1|Continuation Phase|Adverse Event|0
1542917|NCT00127101|5049298|P6|Base Protocol|Withdrawal by Subject|1
1542918|NCT00127101|5049299|P5|Base Protocol|Withdrawal by Subject|0
1542919|NCT00127101|5049300|P4|Base Protocol|Withdrawal by Subject|0
1542920|NCT00127101|5049301|P3|Base Protocol|Withdrawal by Subject|1
1542921|NCT00127101|5049302|P2|Base Protocol|Withdrawal by Subject|2
1542922|NCT00127101|5049303|P1|Base Protocol|Withdrawal by Subject|1
1542923|NCT00127101|5049298|P6|Base Protocol|Lack of Efficacy|0
1542924|NCT00127101|5049299|P5|Base Protocol|Lack of Efficacy|2
1542925|NCT00127101|5049300|P4|Base Protocol|Lack of Efficacy|0
1542926|NCT00127101|5049301|P3|Base Protocol|Lack of Efficacy|0
1542927|NCT00127101|5049302|P2|Base Protocol|Lack of Efficacy|0
1542928|NCT00127101|5049303|P1|Base Protocol|Lack of Efficacy|1
1542929|NCT00127101|5049298|P6|Base Protocol|Adverse Event|0
1542930|NCT00127101|5049299|P5|Base Protocol|Adverse Event|0
1542931|NCT00127101|5049300|P4|Base Protocol|Adverse Event|0
1542932|NCT00127101|5049301|P3|Base Protocol|Adverse Event|1
1542933|NCT00127101|5049302|P2|Base Protocol|Adverse Event|2
1542934|NCT00127101|5049303|P1|Base Protocol|Adverse Event|0
1542935|NCT00127036|5049325|P2|Overall Study|Screen Failure|0
1542936|NCT00127036|5049326|P1|Overall Study|Screen Failure|2
1542937|NCT00127036|5049325|P2|Overall Study|Insufficient Data for Analysis|11
1542938|NCT00127036|5049326|P1|Overall Study|Insufficient Data for Analysis|6
1542939|NCT00126776|5049338|P2|Overall Study|follow up complete on all patients|0
1542940|NCT00126776|5049339|P1|Overall Study|follow up complete on all patients|0
1542941|NCT00126659|5049388|P3|Overall Study|Adverse Event|2
1542942|NCT00126659|5049389|P2|Overall Study|Adverse Event|0
1542943|NCT00126659|5049390|P1|Overall Study|Adverse Event|0
1542944|NCT00126594|5049398|P2|Overall Study|Disease Progression|24
1542945|NCT00126594|5049399|P1|Overall Study|Disease Progression|29
1542946|NCT00126594|5049398|P2|Overall Study|Non-compliance|1
1542947|NCT00126594|5049399|P1|Overall Study|Non-compliance|0
1542948|NCT00126594|5049398|P2|Overall Study|Adverse Event|5
1542949|NCT00126594|5049399|P1|Overall Study|Adverse Event|7
1542950|NCT00126594|5049398|P2|Overall Study|Physician Decision|3
1542951|NCT00126594|5049399|P1|Overall Study|Physician Decision|1
1542952|NCT00126594|5049398|P2|Overall Study|Withdrawal by Subject|4
1542953|NCT00126594|5049399|P1|Overall Study|Withdrawal by Subject|0
1542954|NCT00126594|5049398|P2|Overall Study|Ineligible|0
1542955|NCT00126594|5049399|P1|Overall Study|Ineligible|2
1542956|NCT00126581|5049416|P2|Overall Study|Other illness/MD discretion|4
1542957|NCT00126581|5049417|P1|Overall Study|Other illness/MD discretion|3
1542958|NCT00126581|5049416|P2|Overall Study|Alternative therapy|3
1542959|NCT00126581|5049417|P1|Overall Study|Alternative therapy|3
1542960|NCT00126581|5049416|P2|Overall Study|Withdrawal by Subject|4
1542961|NCT00126581|5049417|P1|Overall Study|Withdrawal by Subject|1
1542962|NCT00126581|5049416|P2|Overall Study|Death|2
1542963|NCT00126581|5049417|P1|Overall Study|Death|3
1542964|NCT00126581|5049416|P2|Overall Study|Adverse Event|7
1542965|NCT00126581|5049417|P1|Overall Study|Adverse Event|3
1542966|NCT00126568|5049437|P1|Overall Study|Death|2
1542967|NCT00126555|5049444|P1|Overall Study|Progressive Disease|3
1542968|NCT00126555|5049444|P1|Overall Study|Adverse Event|2
1542969|NCT00126555|5049444|P1|Overall Study|Withdrawal by Subject|1
1542970|NCT00126503|5049460|P2|Overall Study|Physician Decision|1
1542971|NCT00126503|5049461|P1|Overall Study|Physician Decision|2
1542972|NCT00126503|5049460|P2|Overall Study|non-compliant|0
1542973|NCT00126503|5049461|P1|Overall Study|non-compliant|1
1542974|NCT00126503|5049460|P2|Overall Study|Adverse Event|3
1542975|NCT00126503|5049461|P1|Overall Study|Adverse Event|13
1542976|NCT00126503|5049460|P2|Overall Study|Death|0
1542977|NCT00126503|5049461|P1|Overall Study|Death|3
1542978|NCT00126503|5049460|P2|Overall Study|other complicating disease|1
1542979|NCT00126503|5049461|P1|Overall Study|other complicating disease|4
1542980|NCT00126503|5049460|P2|Overall Study|alternative therapy|1
1542981|NCT00126503|5049461|P1|Overall Study|alternative therapy|1
1542982|NCT00126503|5049460|P2|Overall Study|Withdrawal by Subject|1
1542983|NCT00126503|5049461|P1|Overall Study|Withdrawal by Subject|0
1542984|NCT00126503|5049460|P2|Overall Study|disease progression|14
1542985|NCT00126503|5049461|P1|Overall Study|disease progression|23
1542986|NCT00126490|5049473|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
1542987|NCT00126438|5049483|P2|Overall Study|Withdrawal by Subject|2
1542988|NCT00126438|5049484|P1|Overall Study|Withdrawal by Subject|3
1542989|NCT00126438|5049483|P2|Overall Study|Protocol Violation|8
1542990|NCT00126438|5049484|P1|Overall Study|Protocol Violation|8
1542991|NCT00126438|5049483|P2|Overall Study|Lost to Follow-up|0
1542992|NCT00126438|5049484|P1|Overall Study|Lost to Follow-up|22
1542993|NCT00126438|5049483|P2|Overall Study|Withdrawal due to adverse event|0
1542994|NCT00126438|5049484|P1|Overall Study|Withdrawal due to adverse event|1
1542995|NCT00126425|5049492|P2|Overall Study|Other|0
1542996|NCT00126425|5049493|P1|Overall Study|Other|5
1542997|NCT00126425|5049492|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
1542998|NCT00126425|5049493|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
1542999|NCT00126425|5049492|P2|Overall Study|Adverse Event|0
1543000|NCT00126425|5049493|P1|Overall Study|Adverse Event|1
1543001|NCT00126425|5049492|P2|Overall Study|Protocol Violation|6
1543002|NCT00126425|5049493|P1|Overall Study|Protocol Violation|9
1543003|NCT00126425|5049492|P2|Overall Study|Lost to Follow-up|4
1543004|NCT00126425|5049493|P1|Overall Study|Lost to Follow-up|8
1543005|NCT00126425|5049492|P2|Overall Study|Withdrawal by Subject|1
1543006|NCT00126425|5049493|P1|Overall Study|Withdrawal by Subject|17
1543007|NCT00126191|5049501|P2|Overall Study|Death|1
1543008|NCT00126191|5049502|P1|Overall Study|Death|0
1543009|NCT00126191|5049501|P2|Overall Study|Physician Decision|1
1543010|NCT00126191|5049502|P1|Overall Study|Physician Decision|0
1543011|NCT00126126|5049512|P2|Overall Study|Lost to Follow-up|2
1543012|NCT00126126|5049513|P1|Overall Study|Lost to Follow-up|0
1543013|NCT00125268|5049646|P2|Overall Study|Withdrawal by Subject|1
1543014|NCT00125268|5049647|P1|Overall Study|Withdrawal by Subject|1
1543015|NCT00125242|5049659|P2|Overall Study|did not qualify|2
1543016|NCT00125242|5049660|P1|Overall Study|did not qualify|7
1543017|NCT00125190|5049665|P1|Overall Study|Non-compliance|2
1543018|NCT00125190|5049665|P1|Overall Study|other|1
1543019|NCT00125190|5049665|P1|Overall Study|Patient/Parent Decision|7
1543020|NCT00125190|5049665|P1|Overall Study|Lost to Follow-up|4
1543021|NCT00125190|5049665|P1|Overall Study|Adverse Event|1
1543022|NCT00125164|5049683|P4|Overall Study|Withdrawal by Subject|1
1543023|NCT00125164|5049684|P3|Overall Study|Withdrawal by Subject|1
1543024|NCT00125164|5049685|P2|Overall Study|Withdrawal by Subject|0
1543025|NCT00125164|5049686|P1|Overall Study|Withdrawal by Subject|2
1543026|NCT00125164|5049683|P4|Overall Study|Lost to Follow-up|1
1543027|NCT00125164|5049684|P3|Overall Study|Lost to Follow-up|1
1543028|NCT00125164|5049685|P2|Overall Study|Lost to Follow-up|0
1543029|NCT00125164|5049686|P1|Overall Study|Lost to Follow-up|0
1543030|NCT00125164|5049683|P4|Overall Study|Adverse Event|4
1543031|NCT00125164|5049684|P3|Overall Study|Adverse Event|2
1543032|NCT00125164|5049685|P2|Overall Study|Adverse Event|0
1543033|NCT00125164|5049686|P1|Overall Study|Adverse Event|0
1543034|NCT00125138|5049740|P4|Overall Study|Sponsor decision-pt moved to assist care|1
1543035|NCT00125138|5049741|P3|Overall Study|Sponsor decision-pt moved to assist care|0
1543036|NCT00125138|5049742|P2|Overall Study|Sponsor decision-pt moved to assist care|0
1543037|NCT00125138|5049743|P1|Overall Study|Sponsor decision-pt moved to assist care|0
1543038|NCT00125138|5049740|P4|Overall Study|Lack of Efficacy|1
1543039|NCT00125138|5049741|P3|Overall Study|Lack of Efficacy|0
1543040|NCT00125138|5049742|P2|Overall Study|Lack of Efficacy|0
1543041|NCT00125138|5049743|P1|Overall Study|Lack of Efficacy|0
1543042|NCT00125138|5049740|P4|Overall Study|Withdrawal by Subject|1
1543043|NCT00125138|5049741|P3|Overall Study|Withdrawal by Subject|1
1543044|NCT00125138|5049742|P2|Overall Study|Withdrawal by Subject|3
1543045|NCT00125138|5049743|P1|Overall Study|Withdrawal by Subject|2
1543046|NCT00125138|5049740|P4|Overall Study|Adverse Event|2
1543047|NCT00125138|5049741|P3|Overall Study|Adverse Event|3
1543048|NCT00125138|5049742|P2|Overall Study|Adverse Event|0
1543049|NCT00125138|5049743|P1|Overall Study|Adverse Event|1
1543050|NCT00124982|5049792|P3|Long-term Period|Neurologist Recommendation|1
1543051|NCT00124982|5049793|P2|Long-term Period|Neurologist Recommendation|0
1543052|NCT00124982|5049794|P1|Long-term Period|Neurologist Recommendation|0
1543053|NCT00124982|5049792|P3|Long-term Period|Administrative Reason by Sponsor|1
1543054|NCT00124982|5049793|P2|Long-term Period|Administrative Reason by Sponsor|0
1543055|NCT00124982|5049794|P1|Long-term Period|Administrative Reason by Sponsor|0
1543056|NCT00124982|5049792|P3|Long-term Period|Poor/Non-compliance|2
1543057|NCT00124982|5049793|P2|Long-term Period|Poor/Non-compliance|0
1543058|NCT00124982|5049794|P1|Long-term Period|Poor/Non-compliance|0
1543059|NCT00124982|5049792|P3|Long-term Period|Pregnancy|1
1543060|NCT00124982|5049793|P2|Long-term Period|Pregnancy|0
1543061|NCT00124982|5049794|P1|Long-term Period|Pregnancy|0
1543062|NCT00124982|5049792|P3|Long-term Period|Withdrawal by Subject|16
1543063|NCT00124982|5049793|P2|Long-term Period|Withdrawal by Subject|0
1543064|NCT00124982|5049794|P1|Long-term Period|Withdrawal by Subject|0
1543065|NCT00124982|5049792|P3|Long-term Period|Lost to Follow-up|4
1543066|NCT00124982|5049793|P2|Long-term Period|Lost to Follow-up|0
1543067|NCT00124982|5049794|P1|Long-term Period|Lost to Follow-up|0
1543068|NCT00124982|5049792|P3|Long-term Period|Lack of Efficacy|46
1543069|NCT00124982|5049793|P2|Long-term Period|Lack of Efficacy|0
1543070|NCT00124982|5049794|P1|Long-term Period|Lack of Efficacy|0
1543071|NCT00124982|5049792|P3|Long-term Period|Adverse Event|17
1543072|NCT00124982|5049793|P2|Long-term Period|Adverse Event|0
1543073|NCT00124982|5049794|P1|Long-term Period|Adverse Event|0
1543074|NCT00124982|5049792|P3|Long-term Period|Death|1
1543075|NCT00124982|5049793|P2|Long-term Period|Death|0
1543076|NCT00124982|5049794|P1|Long-term Period|Death|0
1543077|NCT00124982|5049792|P3|Short-term Period|Participant Had Lymphopenia|0
1543078|NCT00124982|5049793|P2|Short-term Period|Participant Had Lymphopenia|0
1543079|NCT00124982|5049794|P1|Short-term Period|Participant Had Lymphopenia|1
1543080|NCT00124982|5049792|P3|Short-term Period|Investigator Decision-No Specific AE|0
1543081|NCT00124982|5049793|P2|Short-term Period|Investigator Decision-No Specific AE|0
1543082|NCT00124982|5049794|P1|Short-term Period|Investigator Decision-No Specific AE|1
1543083|NCT00124982|5049792|P3|Short-term Period|Participant Chose Own Doctor|0
1543084|NCT00124982|5049793|P2|Short-term Period|Participant Chose Own Doctor|1
1543085|NCT00124982|5049794|P1|Short-term Period|Participant Chose Own Doctor|0
1543086|NCT00124982|5049792|P3|Short-term Period|Participant Decision|0
1543087|NCT00124982|5049793|P2|Short-term Period|Participant Decision|0
1543088|NCT00124982|5049794|P1|Short-term Period|Participant Decision|1
1543089|NCT00124982|5049792|P3|Short-term Period|No Longer Meets Study Criteria|0
1543090|NCT00124982|5049793|P2|Short-term Period|No Longer Meets Study Criteria|2
1543091|NCT00124982|5049794|P1|Short-term Period|No Longer Meets Study Criteria|1
1543092|NCT00124982|5049792|P3|Short-term Period|Poor/Non-compliance|0
1543093|NCT00124982|5049793|P2|Short-term Period|Poor/Non-compliance|1
1543094|NCT00124982|5049794|P1|Short-term Period|Poor/Non-compliance|3
1543095|NCT00124982|5049792|P3|Short-term Period|Withdrawal of Consent|0
1543096|NCT00124982|5049793|P2|Short-term Period|Withdrawal of Consent|9
1543097|NCT00124982|5049794|P1|Short-term Period|Withdrawal of Consent|7
1543098|NCT00124982|5049792|P3|Short-term Period|Lost to Follow-up|0
1543099|NCT00124982|5049793|P2|Short-term Period|Lost to Follow-up|5
1543100|NCT00124982|5049794|P1|Short-term Period|Lost to Follow-up|8
1543101|NCT00124982|5049792|P3|Short-term Period|Lack of Efficacy|0
1543102|NCT00124982|5049793|P2|Short-term Period|Lack of Efficacy|73
1543103|NCT00124982|5049794|P1|Short-term Period|Lack of Efficacy|32
1543104|NCT00124982|5049792|P3|Short-term Period|Adverse Event|0
1543105|NCT00124982|5049793|P2|Short-term Period|Adverse Event|22
1543106|NCT00124982|5049794|P1|Short-term Period|Adverse Event|17
1543107|NCT00124982|5049792|P3|Short-term Period|Death|0
1543108|NCT00124982|5049793|P2|Short-term Period|Death|1
1543109|NCT00124982|5049794|P1|Short-term Period|Death|1
1543110|NCT00124943|5049876|P4|Phase II|Withdrawal by Subject|2
1543111|NCT00124943|5049877|P3|Phase II|Withdrawal by Subject|0
1543112|NCT00124943|5049878|P2|Phase II|Withdrawal by Subject|0
1543113|NCT00124943|5049879|P1|Phase II|Withdrawal by Subject|0
1543114|NCT00124943|5049876|P4|Phase II|Lost to Follow-up|1
1543115|NCT00124943|5049877|P3|Phase II|Lost to Follow-up|0
1543116|NCT00124943|5049878|P2|Phase II|Lost to Follow-up|0
1543117|NCT00124943|5049879|P1|Phase II|Lost to Follow-up|0
1543118|NCT00124943|5049876|P4|Phase II|Protocol Violation|1
1543119|NCT00124943|5049877|P3|Phase II|Protocol Violation|0
1543120|NCT00124943|5049878|P2|Phase II|Protocol Violation|0
1543121|NCT00124943|5049879|P1|Phase II|Protocol Violation|0
1543122|NCT00124943|5049876|P4|Phase II|Adverse Event|1
1543123|NCT00124943|5049877|P3|Phase II|Adverse Event|0
1543124|NCT00124943|5049878|P2|Phase II|Adverse Event|2
1543125|NCT00124943|5049879|P1|Phase II|Adverse Event|0
1543126|NCT00124748|5049919|P2|Overall Study|Death|3
1543127|NCT00124748|5049920|P1|Overall Study|Death|1
1543128|NCT00124748|5049919|P2|Overall Study|Administrative Problem(Study Terminated)|174
1543129|NCT00124748|5049920|P1|Overall Study|Administrative Problem(Study Terminated)|101
1543130|NCT00124748|5049919|P2|Overall Study|Lost to Follow-up|7
1543131|NCT00124748|5049920|P1|Overall Study|Lost to Follow-up|2
1543132|NCT00124748|5049919|P2|Overall Study|Withdrawal by Subject|15
1543133|NCT00124748|5049920|P1|Overall Study|Withdrawal by Subject|5
1543134|NCT00124748|5049919|P2|Overall Study|Protocol Violation|1
1543135|NCT00124748|5049920|P1|Overall Study|Protocol Violation|3
1543136|NCT00124748|5049919|P2|Overall Study|No longer requires study drug|1
1543137|NCT00124748|5049920|P1|Overall Study|No longer requires study drug|1
1543138|NCT00124748|5049919|P2|Overall Study|Lack of Efficacy|41
1543139|NCT00124748|5049920|P1|Overall Study|Lack of Efficacy|20
1543140|NCT00124748|5049919|P2|Overall Study|Abnormal Procedure|1
1543141|NCT00124748|5049920|P1|Overall Study|Abnormal Procedure|0
1543142|NCT00124748|5049919|P2|Overall Study|Abnormal laboratory Value|2
1543143|NCT00124748|5049920|P1|Overall Study|Abnormal laboratory Value|2
1543144|NCT00124748|5049919|P2|Overall Study|Adverse Event|39
1543145|NCT00124748|5049920|P1|Overall Study|Adverse Event|8
1543146|NCT00124709|5050027|P2|Overall Study|Lost to Follow-up|120
1543147|NCT00124709|5050028|P1|Overall Study|Lost to Follow-up|114
1543148|NCT00124709|5050027|P2|Overall Study|Withdrawal by Subject|136
1543149|NCT00124709|5050028|P1|Overall Study|Withdrawal by Subject|127
1543150|NCT00124709|5050027|P2|Overall Study|Protocol Violation|5
1543151|NCT00124709|5050028|P1|Overall Study|Protocol Violation|3
1543152|NCT00124709|5050027|P2|Overall Study|Lack of Efficacy|10
1543153|NCT00124709|5050028|P1|Overall Study|Lack of Efficacy|5
1543154|NCT00124709|5050027|P2|Overall Study|Adverse Event|0
1543155|NCT00124709|5050028|P1|Overall Study|Adverse Event|3
1543156|NCT00124709|5050027|P2|Overall Study|Randomized but did not take medication|1
1543157|NCT00124709|5050028|P1|Overall Study|Randomized but did not take medication|3
1543158|NCT00124657|5050045|P3|Overall Study|Intercurrent illness|0
1543159|NCT00124657|5050046|P2|Overall Study|Intercurrent illness|0
1543160|NCT00124657|5050047|P1|Overall Study|Intercurrent illness|1
1543161|NCT00124657|5050045|P3|Overall Study|Progressive disease|27
1543162|NCT00124657|5050046|P2|Overall Study|Progressive disease|5
1543163|NCT00124657|5050047|P1|Overall Study|Progressive disease|14
1543164|NCT00124657|5050045|P3|Overall Study|Non-compliance|4
1543165|NCT00124657|5050046|P2|Overall Study|Non-compliance|0
1543166|NCT00124657|5050047|P1|Overall Study|Non-compliance|1
1543167|NCT00124657|5050045|P3|Overall Study|Toxicity|1
1543168|NCT00124657|5050046|P2|Overall Study|Toxicity|0
1543169|NCT00124657|5050047|P1|Overall Study|Toxicity|0
1543170|NCT00124618|5050082|P1|Overall Study|Ineligible|1
1543171|NCT00124462|5050097|P2|Overall Study|Device fitting, n=2, other hlth issues|1
1543172|NCT00124462|5050098|P1|Overall Study|Device fitting, n=2, other hlth issues|1
1543173|NCT00124462|5050097|P2|Overall Study|Withdrawal by Subject|5
1543174|NCT00124462|5050098|P1|Overall Study|Withdrawal by Subject|4
1543175|NCT00124462|5050097|P2|Overall Study|Physician Decision|4
1543176|NCT00124462|5050098|P1|Overall Study|Physician Decision|3
1543177|NCT00124462|5050097|P2|Overall Study|Lost to Follow-up|3
1543178|NCT00124462|5050098|P1|Overall Study|Lost to Follow-up|3
1543179|NCT00124449|5050108|P2|18-Month Untreated Observation Period|Relocated|0
1543180|NCT00124449|5050109|P1|18-Month Untreated Observation Period|Relocated|1
1543181|NCT00124449|5050108|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
1543182|NCT00124449|5050109|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
1543183|NCT00124449|5050108|P2|18-Month Untreated Observation Period|Pregnancy|0
1543184|NCT00124449|5050109|P1|18-Month Untreated Observation Period|Pregnancy|1
1543185|NCT00124449|5050108|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
1543186|NCT00124449|5050109|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
1543187|NCT00124449|5050108|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
1543188|NCT00124449|5050109|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
1543189|NCT00124449|5050108|P2|18-Month Untreated Observation Period|Adverse Event|1
1543190|NCT00124449|5050109|P1|18-Month Untreated Observation Period|Adverse Event|0
1543191|NCT00124449|5050108|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
1543192|NCT00124449|5050109|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
1543193|NCT00124449|5050108|P2|6-month Double-Blind Treatment Period|Sponsor request|1
1543194|NCT00124449|5050109|P1|6-month Double-Blind Treatment Period|Sponsor request|0
1543195|NCT00124449|5050108|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
1543196|NCT00124449|5050109|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
1543197|NCT00124449|5050108|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
1543198|NCT00124449|5050109|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
1543199|NCT00124449|5050108|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
1543200|NCT00124449|5050109|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
1543201|NCT00124449|5050108|P2|6-month Double-Blind Treatment Period|Adverse Event|0
1543202|NCT00124449|5050109|P1|6-month Double-Blind Treatment Period|Adverse Event|1
1543203|NCT00124072|5050163|P4|Overall Study|Death|480
1543204|NCT00124072|5050164|P3|Overall Study|Death|471
1543205|NCT00124072|5050165|P2|Overall Study|Death|484
1543206|NCT00124072|5050166|P1|Overall Study|Death|499
1543207|NCT00124072|5050163|P4|Overall Study|Lost to Follow-up for Morbidity|18
1543208|NCT00124072|5050164|P3|Overall Study|Lost to Follow-up for Morbidity|19
1543209|NCT00124072|5050165|P2|Overall Study|Lost to Follow-up for Morbidity|25
1543210|NCT00124072|5050166|P1|Overall Study|Lost to Follow-up for Morbidity|15
1543211|NCT00124072|5050163|P4|Overall Study|Lost to Follow-up for Mortality|2
1543212|NCT00124072|5050164|P3|Overall Study|Lost to Follow-up for Mortality|2
1543213|NCT00124072|5050165|P2|Overall Study|Lost to Follow-up for Mortality|3
1543214|NCT00124072|5050166|P1|Overall Study|Lost to Follow-up for Mortality|0
1543215|NCT00124020|5050178|P2|Overall Study|Transfer to another hospital|0
1543216|NCT00124020|5050179|P1|Overall Study|Transfer to another hospital|2
1543217|NCT00124020|5050178|P2|Overall Study|Other|1
1543218|NCT00124020|5050179|P1|Overall Study|Other|1
1543219|NCT00124020|5050178|P2|Overall Study|Lost to Follow-up|8
1543220|NCT00124020|5050179|P1|Overall Study|Lost to Follow-up|5
1543221|NCT00124020|5050178|P2|Overall Study|Withdrawal by Subject|11
1543222|NCT00124020|5050179|P1|Overall Study|Withdrawal by Subject|13
1543223|NCT00124020|5050178|P2|Overall Study|Death|71
1543224|NCT00124020|5050179|P1|Overall Study|Death|67
1543225|NCT00123955|5050187|P2|Overall Study|Death|1
1543226|NCT00123955|5050188|P1|Overall Study|Death|0
1543227|NCT00123955|5050187|P2|Overall Study|Withdrawal by Subject|3
1543228|NCT00123955|5050188|P1|Overall Study|Withdrawal by Subject|4
1543229|NCT00123955|5050187|P2|Overall Study|Adverse Event|0
1543230|NCT00123955|5050188|P1|Overall Study|Adverse Event|1
1543231|NCT00123734|5050200|P1|Overall Study|Withdrawal by Subject|1
1543232|NCT00123734|5050200|P1|Overall Study|Dropout|1
1543233|NCT00123734|5050200|P1|Overall Study|Lost to Follow-up|3
1543234|NCT00123734|5050200|P1|Overall Study|Death|3
1543235|NCT00123487|5050285|P2|Treated With Study Drug|Unknown (case report form lost)|1
1543236|NCT00123487|5050286|P1|Treated With Study Drug|Unknown (case report form lost)|0
1543237|NCT00123487|5050285|P2|Treated With Study Drug|Withdrawal by Subject|13
1543238|NCT00123487|5050286|P1|Treated With Study Drug|Withdrawal by Subject|11
1543239|NCT00123487|5050285|P2|Treated With Study Drug|Study Drug Toxicity|80
1543240|NCT00123487|5050286|P1|Treated With Study Drug|Study Drug Toxicity|62
1543241|NCT00123487|5050285|P2|Treated With Study Drug|Not Specified|58
1543242|NCT00123487|5050286|P1|Treated With Study Drug|Not Specified|59
1543243|NCT00123487|5050285|P2|Treated With Study Drug|Physician Decision|9
1543244|NCT00123487|5050286|P1|Treated With Study Drug|Physician Decision|8
1543245|NCT00123487|5050285|P2|Treated With Study Drug|Disease Progression|122
1543246|NCT00123487|5050286|P1|Treated With Study Drug|Disease Progression|141
1543247|NCT00123487|5050285|P2|Treated With Study Drug|Adverse Event|22
1543248|NCT00123487|5050286|P1|Treated With Study Drug|Adverse Event|23
1543249|NCT00123487|5050285|P2|Randomized|SAE prior to starting treatment|0
1543250|NCT00123487|5050286|P1|Randomized|SAE prior to starting treatment|1
1543251|NCT00123487|5050285|P2|Randomized|Death prior to starting treatment|1
1543252|NCT00123487|5050286|P1|Randomized|Death prior to starting treatment|0
1543253|NCT00123474|5050330|P4|As Treated at Study Closure|Withdrawal by Subject|16
1543254|NCT00123474|5050331|P3|As Treated at Study Closure|Withdrawal by Subject|18
1543255|NCT00123474|5050332|P2|As Treated at Study Closure|Withdrawal by Subject|19
1543256|NCT00123474|5050333|P1|As Treated at Study Closure|Withdrawal by Subject|14
1543257|NCT00123474|5050330|P4|As Treated at Study Closure|Study Drug Toxicity|51
1543258|NCT00123474|5050331|P3|As Treated at Study Closure|Study Drug Toxicity|45
1543259|NCT00123474|5050332|P2|As Treated at Study Closure|Study Drug Toxicity|45
1543260|NCT00123474|5050333|P1|As Treated at Study Closure|Study Drug Toxicity|39
1543261|NCT00123474|5050330|P4|As Treated at Study Closure|non-specified|60
1543262|NCT00123474|5050331|P3|As Treated at Study Closure|non-specified|57
1543263|NCT00123474|5050332|P2|As Treated at Study Closure|non-specified|47
1543264|NCT00123474|5050333|P1|As Treated at Study Closure|non-specified|54
1543265|NCT00123474|5050330|P4|As Treated at Study Closure|Investigator Request|5
1543266|NCT00123474|5050331|P3|As Treated at Study Closure|Investigator Request|7
1543267|NCT00123474|5050332|P2|As Treated at Study Closure|Investigator Request|6
1543268|NCT00123474|5050333|P1|As Treated at Study Closure|Investigator Request|12
1543269|NCT00123474|5050330|P4|As Treated at Study Closure|Disease Progression|27
1543270|NCT00123474|5050331|P3|As Treated at Study Closure|Disease Progression|29
1543271|NCT00123474|5050332|P2|As Treated at Study Closure|Disease Progression|42
1543272|NCT00123474|5050333|P1|As Treated at Study Closure|Disease Progression|35
1543273|NCT00123474|5050330|P4|As Treated at Study Closure|Adverse Event|8
1543274|NCT00123474|5050331|P3|As Treated at Study Closure|Adverse Event|10
1543275|NCT00123474|5050332|P2|As Treated at Study Closure|Adverse Event|4
1543276|NCT00123474|5050333|P1|As Treated at Study Closure|Adverse Event|10
1543277|NCT00123474|5050330|P4|As Treated at Study Closure|not reported when site closed|0
1543278|NCT00123474|5050331|P3|As Treated at Study Closure|not reported when site closed|1
1543279|NCT00123474|5050332|P2|As Treated at Study Closure|not reported when site closed|0
1543280|NCT00123474|5050333|P1|As Treated at Study Closure|not reported when site closed|1
1543281|NCT00123474|5050330|P4|Randomized to Treatment|Randomized, never treated|1
1543282|NCT00123474|5050331|P3|Randomized to Treatment|Randomized, never treated|2
1543283|NCT00123474|5050332|P2|Randomized to Treatment|Randomized, never treated|4
1543284|NCT00123474|5050333|P1|Randomized to Treatment|Randomized, never treated|1
1543285|NCT00123422|5050427|P3|Overall Study|Lost to Follow-up|2
1543286|NCT00123422|5050428|P2|Overall Study|Lost to Follow-up|2
1543287|NCT00123422|5050429|P1|Overall Study|Lost to Follow-up|1
1543288|NCT00123422|5050427|P3|Overall Study|Withdrawal by Subject|2
1543289|NCT00123422|5050428|P2|Overall Study|Withdrawal by Subject|2
1543290|NCT00123422|5050429|P1|Overall Study|Withdrawal by Subject|1
1543291|NCT00123422|5050427|P3|Overall Study|Physician Decision|6
1543292|NCT00123422|5050428|P2|Overall Study|Physician Decision|2
1543293|NCT00123422|5050429|P1|Overall Study|Physician Decision|2
1543294|NCT00122980|5050480|P2|Overall Study|Study termination|35
1543295|NCT00122980|5050481|P1|Overall Study|Study termination|27
1543296|NCT00122980|5050480|P2|Overall Study|Adjudicated stroke (study endpoint)|0
1543297|NCT00122980|5050481|P1|Overall Study|Adjudicated stroke (study endpoint)|7
1543298|NCT00122980|5050480|P2|Overall Study|Withdrawal by Subject|3
1543299|NCT00122980|5050481|P1|Overall Study|Withdrawal by Subject|2
1543300|NCT00122980|5050480|P2|Overall Study|Protocol Violation|1
1543301|NCT00122980|5050481|P1|Overall Study|Protocol Violation|5
1543302|NCT00122980|5050480|P2|Overall Study|Physician Decision|0
1543303|NCT00122980|5050481|P1|Overall Study|Physician Decision|2
1543304|NCT00122980|5050480|P2|Overall Study|Death|1
1543305|NCT00122980|5050481|P1|Overall Study|Death|0
1543306|NCT00122954|5050505|P2|Overall Study|Protocol Violation|1
1543307|NCT00122954|5050506|P1|Overall Study|Protocol Violation|0
1543308|NCT00122954|5050505|P2|Overall Study|Withdrawal by Subject|2
1543309|NCT00122954|5050506|P1|Overall Study|Withdrawal by Subject|2
1543310|NCT00122681|5050516|P2|Overall Study|Personal reasons|147
1543311|NCT00122681|5050517|P1|Overall Study|Personal reasons|150
1543312|NCT00122681|5050516|P2|Overall Study|Withdrawal by Subject|251
1543313|NCT00122681|5050517|P1|Overall Study|Withdrawal by Subject|257
1543314|NCT00122681|5050516|P2|Overall Study|Protocol Violation|10
1543315|NCT00122681|5050517|P1|Overall Study|Protocol Violation|7
1543316|NCT00122681|5050516|P2|Overall Study|Lost to Follow-up|1097
1543317|NCT00122681|5050517|P1|Overall Study|Lost to Follow-up|1080
1543318|NCT00122681|5050516|P2|Overall Study|Adverse Event|16
1543319|NCT00122681|5050517|P1|Overall Study|Adverse Event|20
1543320|NCT00122460|5050591|P2|Overall Study|investigational study phase ongoing|1
1543321|NCT00122460|5050592|P1|Overall Study|investigational study phase ongoing|7
1543322|NCT00122382|5050641|P3|Open-Label Study|Withdrawal of Consent|4
1543323|NCT00122382|5050642|P2|Open-Label Study|Withdrawal of Consent|0
1543324|NCT00122382|5050643|P1|Open-Label Study|Withdrawal of Consent|0
1543325|NCT00122382|5050641|P3|Open-Label Study|Poor/Non-Compliance|1
1543326|NCT00122382|5050642|P2|Open-Label Study|Poor/Non-Compliance|0
1543327|NCT00122382|5050643|P1|Open-Label Study|Poor/Non-Compliance|0
1543328|NCT00122382|5050641|P3|Open-Label Study|Pregnancy|2
1543329|NCT00122382|5050642|P2|Open-Label Study|Pregnancy|0
1543330|NCT00122382|5050643|P1|Open-Label Study|Pregnancy|0
1543331|NCT00122382|5050641|P3|Open-Label Study|Lost to Follow-up|3
1543332|NCT00122382|5050642|P2|Open-Label Study|Lost to Follow-up|0
1543333|NCT00122382|5050643|P1|Open-Label Study|Lost to Follow-up|0
1543334|NCT00122382|5050641|P3|Open-Label Study|Lack of Efficacy|3
1543335|NCT00122382|5050642|P2|Open-Label Study|Lack of Efficacy|0
1543336|NCT00122382|5050643|P1|Open-Label Study|Lack of Efficacy|0
1543337|NCT00122382|5050641|P3|Open-Label Study|Death|2
1543338|NCT00122382|5050642|P2|Open-Label Study|Death|0
1543339|NCT00122382|5050643|P1|Open-Label Study|Death|0
1543340|NCT00122382|5050641|P3|Open-Label Study|Adverse Event|11
1543341|NCT00122382|5050642|P2|Open-Label Study|Adverse Event|0
1543342|NCT00122382|5050643|P1|Open-Label Study|Adverse Event|0
1543343|NCT00122382|5050641|P3|Double-Blind Study|Randomized but not treated|0
1543344|NCT00122382|5050642|P2|Double-Blind Study|Randomized but not treated|2
1543345|NCT00122382|5050643|P1|Double-Blind Study|Randomized but not treated|0
1543346|NCT00122382|5050641|P3|Double-Blind Study|Methotrexate Discontinued|0
1543347|NCT00122382|5050642|P2|Double-Blind Study|Methotrexate Discontinued|1
1543348|NCT00122382|5050643|P1|Double-Blind Study|Methotrexate Discontinued|0
1543349|NCT00122382|5050641|P3|Double-Blind Study|Protocol Violation|0
1543350|NCT00122382|5050642|P2|Double-Blind Study|Protocol Violation|0
1543351|NCT00122382|5050643|P1|Double-Blind Study|Protocol Violation|1
1543352|NCT00122382|5050641|P3|Double-Blind Study|Withdrawal of Consent|0
1543353|NCT00122382|5050642|P2|Double-Blind Study|Withdrawal of Consent|3
1543354|NCT00122382|5050643|P1|Double-Blind Study|Withdrawal of Consent|7
1543355|NCT00122382|5050641|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
1543356|NCT00122382|5050642|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
1543357|NCT00122382|5050643|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
1543358|NCT00122382|5050641|P3|Double-Blind Study|Pregnancy|0
1543359|NCT00122382|5050642|P2|Double-Blind Study|Pregnancy|0
1543360|NCT00122382|5050643|P1|Double-Blind Study|Pregnancy|2
1543361|NCT00122382|5050641|P3|Double-Blind Study|Lost to Follow-up|0
1543362|NCT00122382|5050642|P2|Double-Blind Study|Lost to Follow-up|1
1543363|NCT00122382|5050643|P1|Double-Blind Study|Lost to Follow-up|2
1543364|NCT00122382|5050641|P3|Double-Blind Study|Lack of Efficacy|0
1543365|NCT00122382|5050642|P2|Double-Blind Study|Lack of Efficacy|8
1543366|NCT00122382|5050643|P1|Double-Blind Study|Lack of Efficacy|0
1543367|NCT00122382|5050641|P3|Double-Blind Study|Death|0
1543368|NCT00122382|5050642|P2|Double-Blind Study|Death|2
1543369|NCT00122382|5050643|P1|Double-Blind Study|Death|2
1543370|NCT00122382|5050641|P3|Double-Blind Study|Adverse Event|0
1543371|NCT00122382|5050642|P2|Double-Blind Study|Adverse Event|11
1543372|NCT00122382|5050643|P1|Double-Blind Study|Adverse Event|9
1543373|NCT00122317|5050787|P1|Overall Study|Withdrawal by Subject|1
1543374|NCT00122317|5050787|P1|Overall Study|patient non-compliance|1
1543375|NCT00122317|5050787|P1|Overall Study|Physician Decision|2
1543376|NCT00122317|5050787|P1|Overall Study|Adverse Event|4
1543377|NCT00122317|5050787|P1|Overall Study|Death|3
1543378|NCT00122187|5050796|P2|Overall Study|Withdrew because of resource limitations|2
1543379|NCT00122187|5050797|P1|Overall Study|Withdrew because of resource limitations|2
1543380|NCT00122135|5050811|P2|Overall Study|Withdrawal by Subject|0
1543381|NCT00122135|5050812|P1|Overall Study|Withdrawal by Subject|3
1543382|NCT00122109|5050820|P2|Overall Study|Did not meet criteria|7
1543383|NCT00122109|5050821|P1|Overall Study|Did not meet criteria|6
1543384|NCT00121719|5050885|P14|Overall Study|Continuing/ongoing patients|0
1543385|NCT00121719|5050886|P13|Overall Study|Continuing/ongoing patients|3
1543386|NCT00121719|5050887|P12|Overall Study|Continuing/ongoing patients|1
1543387|NCT00121719|5050888|P11|Overall Study|Continuing/ongoing patients|1
1543388|NCT00121719|5050889|P10|Overall Study|Continuing/ongoing patients|0
1543389|NCT00121719|5050890|P9|Overall Study|Continuing/ongoing patients|0
1543390|NCT00121719|5050891|P8|Overall Study|Continuing/ongoing patients|1
1543391|NCT00121719|5050892|P7|Overall Study|Continuing/ongoing patients|0
1543392|NCT00121719|5050893|P6|Overall Study|Continuing/ongoing patients|0
1543393|NCT00121719|5050894|P5|Overall Study|Continuing/ongoing patients|0
1543394|NCT00121719|5050895|P4|Overall Study|Continuing/ongoing patients|0
1543395|NCT00121719|5050896|P3|Overall Study|Continuing/ongoing patients|0
1543396|NCT00121719|5050897|P2|Overall Study|Continuing/ongoing patients|0
1543397|NCT00121719|5050898|P1|Overall Study|Continuing/ongoing patients|0
1543398|NCT00121719|5050885|P14|Overall Study|Not specified|1
1543399|NCT00121719|5050886|P13|Overall Study|Not specified|1
1543400|NCT00121719|5050887|P12|Overall Study|Not specified|0
1543401|NCT00121719|5050888|P11|Overall Study|Not specified|0
1543402|NCT00121719|5050889|P10|Overall Study|Not specified|0
1543403|NCT00121719|5050890|P9|Overall Study|Not specified|1
1543404|NCT00121719|5050891|P8|Overall Study|Not specified|0
1543405|NCT00121719|5050892|P7|Overall Study|Not specified|1
1543406|NCT00121719|5050893|P6|Overall Study|Not specified|0
1543407|NCT00121719|5050894|P5|Overall Study|Not specified|0
1543408|NCT00121719|5050895|P4|Overall Study|Not specified|1
1543409|NCT00121719|5050896|P3|Overall Study|Not specified|1
1543410|NCT00121719|5050897|P2|Overall Study|Not specified|0
1543411|NCT00121719|5050898|P1|Overall Study|Not specified|0
1543412|NCT00121719|5050885|P14|Overall Study|Physician Decision|0
1543413|NCT00121719|5050886|P13|Overall Study|Physician Decision|1
1543414|NCT00121719|5050887|P12|Overall Study|Physician Decision|0
1543415|NCT00121719|5050888|P11|Overall Study|Physician Decision|0
1543416|NCT00121719|5050889|P10|Overall Study|Physician Decision|0
1543417|NCT00121719|5050890|P9|Overall Study|Physician Decision|0
1543418|NCT00121719|5050891|P8|Overall Study|Physician Decision|0
1543419|NCT00121719|5050892|P7|Overall Study|Physician Decision|0
1543420|NCT00121719|5050893|P6|Overall Study|Physician Decision|0
1543421|NCT00121719|5050894|P5|Overall Study|Physician Decision|0
1543422|NCT00121719|5050895|P4|Overall Study|Physician Decision|0
1543423|NCT00121719|5050896|P3|Overall Study|Physician Decision|0
1543424|NCT00121719|5050897|P2|Overall Study|Physician Decision|1
1543425|NCT00121719|5050898|P1|Overall Study|Physician Decision|0
1543426|NCT00121719|5050885|P14|Overall Study|Clinical deterioration|2
1543427|NCT00121719|5050886|P13|Overall Study|Clinical deterioration|2
1543428|NCT00121719|5050887|P12|Overall Study|Clinical deterioration|1
1543429|NCT00121719|5050888|P11|Overall Study|Clinical deterioration|0
1543430|NCT00121719|5050889|P10|Overall Study|Clinical deterioration|2
1543431|NCT00121719|5050890|P9|Overall Study|Clinical deterioration|2
1543432|NCT00121719|5050891|P8|Overall Study|Clinical deterioration|1
1543433|NCT00121719|5050892|P7|Overall Study|Clinical deterioration|2
1543434|NCT00121719|5050893|P6|Overall Study|Clinical deterioration|0
1543435|NCT00121719|5050894|P5|Overall Study|Clinical deterioration|1
1543436|NCT00121719|5050895|P4|Overall Study|Clinical deterioration|0
1543437|NCT00121719|5050896|P3|Overall Study|Clinical deterioration|1
1543438|NCT00121719|5050897|P2|Overall Study|Clinical deterioration|1
1543439|NCT00121719|5050898|P1|Overall Study|Clinical deterioration|0
1543440|NCT00121719|5050885|P14|Overall Study|Progressive disease|4
1543441|NCT00121719|5050886|P13|Overall Study|Progressive disease|13
1543442|NCT00121719|5050887|P12|Overall Study|Progressive disease|3
1543443|NCT00121719|5050888|P11|Overall Study|Progressive disease|4
1543444|NCT00121719|5050889|P10|Overall Study|Progressive disease|1
1543445|NCT00121719|5050890|P9|Overall Study|Progressive disease|3
1543446|NCT00121719|5050891|P8|Overall Study|Progressive disease|5
1543447|NCT00121719|5050892|P7|Overall Study|Progressive disease|7
1543448|NCT00121719|5050893|P6|Overall Study|Progressive disease|1
1543449|NCT00121719|5050894|P5|Overall Study|Progressive disease|2
1543450|NCT00121719|5050895|P4|Overall Study|Progressive disease|2
1543451|NCT00121719|5050896|P3|Overall Study|Progressive disease|0
1543452|NCT00121719|5050897|P2|Overall Study|Progressive disease|1
1543453|NCT00121719|5050898|P1|Overall Study|Progressive disease|2
1543454|NCT00121719|5050885|P14|Overall Study|Withdrawal by Subject|0
1543455|NCT00121719|5050886|P13|Overall Study|Withdrawal by Subject|0
1543456|NCT00121719|5050887|P12|Overall Study|Withdrawal by Subject|0
1543457|NCT00121719|5050888|P11|Overall Study|Withdrawal by Subject|0
1543458|NCT00121719|5050889|P10|Overall Study|Withdrawal by Subject|0
1543459|NCT00121719|5050890|P9|Overall Study|Withdrawal by Subject|0
1543460|NCT00121719|5050891|P8|Overall Study|Withdrawal by Subject|0
1543461|NCT00121719|5050892|P7|Overall Study|Withdrawal by Subject|0
1543462|NCT00121719|5050893|P6|Overall Study|Withdrawal by Subject|0
1543463|NCT00121719|5050894|P5|Overall Study|Withdrawal by Subject|0
1543464|NCT00121719|5050895|P4|Overall Study|Withdrawal by Subject|0
1543465|NCT00121719|5050896|P3|Overall Study|Withdrawal by Subject|0
1543466|NCT00121719|5050897|P2|Overall Study|Withdrawal by Subject|0
1543467|NCT00121719|5050898|P1|Overall Study|Withdrawal by Subject|1
1543468|NCT00121719|5050885|P14|Overall Study|Protocol deviation|0
1543469|NCT00121719|5050886|P13|Overall Study|Protocol deviation|0
1543470|NCT00121719|5050887|P12|Overall Study|Protocol deviation|0
1543471|NCT00121719|5050888|P11|Overall Study|Protocol deviation|0
1543472|NCT00121719|5050889|P10|Overall Study|Protocol deviation|0
1543473|NCT00121719|5050890|P9|Overall Study|Protocol deviation|0
1543474|NCT00121719|5050891|P8|Overall Study|Protocol deviation|0
1543475|NCT00121719|5050892|P7|Overall Study|Protocol deviation|0
1543476|NCT00121719|5050893|P6|Overall Study|Protocol deviation|0
1543477|NCT00121719|5050894|P5|Overall Study|Protocol deviation|0
1543478|NCT00121719|5050895|P4|Overall Study|Protocol deviation|0
1543479|NCT00121719|5050896|P3|Overall Study|Protocol deviation|1
1543480|NCT00121719|5050897|P2|Overall Study|Protocol deviation|0
1543481|NCT00121719|5050898|P1|Overall Study|Protocol deviation|0
1543482|NCT00121719|5050885|P14|Overall Study|Abnormal laboratory value|0
1543483|NCT00121719|5050886|P13|Overall Study|Abnormal laboratory value|1
1543484|NCT00121719|5050887|P12|Overall Study|Abnormal laboratory value|0
1543485|NCT00121719|5050888|P11|Overall Study|Abnormal laboratory value|0
1543486|NCT00121719|5050889|P10|Overall Study|Abnormal laboratory value|0
1543487|NCT00121719|5050890|P9|Overall Study|Abnormal laboratory value|0
1543488|NCT00121719|5050891|P8|Overall Study|Abnormal laboratory value|1
1543489|NCT00121719|5050892|P7|Overall Study|Abnormal laboratory value|0
1543490|NCT00121719|5050893|P6|Overall Study|Abnormal laboratory value|0
1543491|NCT00121719|5050894|P5|Overall Study|Abnormal laboratory value|0
1543492|NCT00121719|5050895|P4|Overall Study|Abnormal laboratory value|0
1543493|NCT00121719|5050896|P3|Overall Study|Abnormal laboratory value|0
1543494|NCT00121719|5050897|P2|Overall Study|Abnormal laboratory value|1
1543495|NCT00121719|5050898|P1|Overall Study|Abnormal laboratory value|1
1543496|NCT00121719|5050885|P14|Overall Study|Adverse Event|0
1543497|NCT00121719|5050886|P13|Overall Study|Adverse Event|3
1543498|NCT00121719|5050887|P12|Overall Study|Adverse Event|0
1543499|NCT00121719|5050888|P11|Overall Study|Adverse Event|1
1543500|NCT00121719|5050889|P10|Overall Study|Adverse Event|0
1543501|NCT00121719|5050890|P9|Overall Study|Adverse Event|0
1543502|NCT00121719|5050891|P8|Overall Study|Adverse Event|1
1543503|NCT00121719|5050892|P7|Overall Study|Adverse Event|2
1543504|NCT00121719|5050893|P6|Overall Study|Adverse Event|2
1543505|NCT00121719|5050894|P5|Overall Study|Adverse Event|0
1543506|NCT00121719|5050895|P4|Overall Study|Adverse Event|0
1543507|NCT00121719|5050896|P3|Overall Study|Adverse Event|1
1543508|NCT00121719|5050897|P2|Overall Study|Adverse Event|0
1543509|NCT00121719|5050898|P1|Overall Study|Adverse Event|0
1543510|NCT00121667|5051075|P4|Short Term (ST) + Long Term (LT) Period|Death|2
1543511|NCT00121667|5051076|P3|Short Term (ST) + Long Term (LT) Period|Death|0
1543512|NCT00121667|5051077|P2|Short Term (ST) + Long Term (LT) Period|Death|0
1543513|NCT00121667|5051078|P1|Short Term (ST) + Long Term (LT) Period|Death|1
1543514|NCT00121667|5051075|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
1543515|NCT00121667|5051076|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
1543516|NCT00121667|5051077|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
1543517|NCT00121667|5051078|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
1543518|NCT00121667|5051075|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
1543519|NCT00121667|5051076|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
1543520|NCT00121667|5051077|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
1543521|NCT00121667|5051078|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
1543522|NCT00121667|5051075|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
1543523|NCT00121667|5051076|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
1543524|NCT00121667|5051077|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
1543525|NCT00121667|5051078|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
1543526|NCT00121667|5051075|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
1543527|NCT00121667|5051076|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
1543528|NCT00121667|5051077|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
1543529|NCT00121667|5051078|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
1543530|NCT00121667|5051075|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
1543531|NCT00121667|5051076|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
1543532|NCT00121667|5051077|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
1543533|NCT00121667|5051078|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
1543534|NCT00121667|5051075|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
1543535|NCT00121667|5051076|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
1543536|NCT00121667|5051077|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
1543537|NCT00121667|5051078|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
1543538|NCT00121667|5051075|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
1543539|NCT00121667|5051076|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
1543540|NCT00121667|5051077|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
1543541|NCT00121667|5051078|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
1543542|NCT00121667|5051075|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
1543543|NCT00121667|5051076|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
1543544|NCT00121667|5051077|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
1543545|NCT00121667|5051078|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
1543546|NCT00121667|5051075|P4|Short Term (ST) Period|Pregnancy|1
1543547|NCT00121667|5051076|P3|Short Term (ST) Period|Pregnancy|0
1543548|NCT00121667|5051077|P2|Short Term (ST) Period|Pregnancy|0
1543549|NCT00121667|5051078|P1|Short Term (ST) Period|Pregnancy|0
1543550|NCT00121667|5051075|P4|Short Term (ST) Period|Death|1
1543551|NCT00121667|5051076|P3|Short Term (ST) Period|Death|0
1543552|NCT00121667|5051077|P2|Short Term (ST) Period|Death|0
1543553|NCT00121667|5051078|P1|Short Term (ST) Period|Death|0
1543554|NCT00121667|5051075|P4|Short Term (ST) Period|Other Reason|0
1543555|NCT00121667|5051076|P3|Short Term (ST) Period|Other Reason|0
1543556|NCT00121667|5051077|P2|Short Term (ST) Period|Other Reason|0
1543557|NCT00121667|5051078|P1|Short Term (ST) Period|Other Reason|3
1543558|NCT00121667|5051075|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
1543559|NCT00121667|5051076|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
1543560|NCT00121667|5051077|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
1543561|NCT00121667|5051078|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
1543562|NCT00121667|5051075|P4|Short Term (ST) Period|Poor / Non-compliance|2
1543563|NCT00121667|5051076|P3|Short Term (ST) Period|Poor / Non-compliance|1
1543564|NCT00121667|5051077|P2|Short Term (ST) Period|Poor / Non-compliance|1
1543565|NCT00121667|5051078|P1|Short Term (ST) Period|Poor / Non-compliance|0
1543566|NCT00121667|5051075|P4|Short Term (ST) Period|Lost to Follow-up|3
1543567|NCT00121667|5051076|P3|Short Term (ST) Period|Lost to Follow-up|4
1543568|NCT00121667|5051077|P2|Short Term (ST) Period|Lost to Follow-up|4
1543569|NCT00121667|5051078|P1|Short Term (ST) Period|Lost to Follow-up|3
1543570|NCT00121667|5051075|P4|Short Term (ST) Period|Adverse Event|3
1543571|NCT00121667|5051076|P3|Short Term (ST) Period|Adverse Event|5
1543572|NCT00121667|5051077|P2|Short Term (ST) Period|Adverse Event|6
1543573|NCT00121667|5051078|P1|Short Term (ST) Period|Adverse Event|5
1543574|NCT00121667|5051075|P4|Short Term (ST) Period|Subject Withdrew Consent|11
1543575|NCT00121667|5051076|P3|Short Term (ST) Period|Subject Withdrew Consent|4
1543576|NCT00121667|5051077|P2|Short Term (ST) Period|Subject Withdrew Consent|13
1543577|NCT00121667|5051078|P1|Short Term (ST) Period|Subject Withdrew Consent|8
1543578|NCT00121667|5051075|P4|Short Term (ST) Period|Lack of Efficacy|44
1543579|NCT00121667|5051076|P3|Short Term (ST) Period|Lack of Efficacy|27
1543580|NCT00121667|5051077|P2|Short Term (ST) Period|Lack of Efficacy|22
1543581|NCT00121667|5051078|P1|Short Term (ST) Period|Lack of Efficacy|25
1543582|NCT00121641|5051176|P5|48-month Short Term + Long Term Period|Other Reason|1
1543583|NCT00121641|5051177|P4|48-month Short Term + Long Term Period|Other Reason|0
1543584|NCT00121641|5051178|P3|48-month Short Term + Long Term Period|Other Reason|2
1543585|NCT00121641|5051179|P2|48-month Short Term + Long Term Period|Other Reason|3
1543586|NCT00121641|5051180|P1|48-month Short Term + Long Term Period|Other Reason|5
1543587|NCT00121641|5051176|P5|48-month Short Term + Long Term Period|Missing|0
1543588|NCT00121641|5051177|P4|48-month Short Term + Long Term Period|Missing|0
1543589|NCT00121641|5051178|P3|48-month Short Term + Long Term Period|Missing|1
1543590|NCT00121641|5051179|P2|48-month Short Term + Long Term Period|Missing|0
1543591|NCT00121641|5051180|P1|48-month Short Term + Long Term Period|Missing|0
1543592|NCT00121641|5051176|P5|48-month Short Term + Long Term Period|Death|0
1543593|NCT00121641|5051177|P4|48-month Short Term + Long Term Period|Death|1
1543594|NCT00121641|5051178|P3|48-month Short Term + Long Term Period|Death|0
1543595|NCT00121641|5051179|P2|48-month Short Term + Long Term Period|Death|0
1543596|NCT00121641|5051180|P1|48-month Short Term + Long Term Period|Death|0
1543597|NCT00121641|5051176|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
1543598|NCT00121641|5051177|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
1543599|NCT00121641|5051178|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
1543600|NCT00121641|5051179|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
1543601|NCT00121641|5051180|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
1543602|NCT00121641|5051176|P5|48-month Short Term + Long Term Period|Pregnancy|0
1543603|NCT00121641|5051177|P4|48-month Short Term + Long Term Period|Pregnancy|1
1543604|NCT00121641|5051178|P3|48-month Short Term + Long Term Period|Pregnancy|0
1543605|NCT00121641|5051179|P2|48-month Short Term + Long Term Period|Pregnancy|1
1543606|NCT00121641|5051180|P1|48-month Short Term + Long Term Period|Pregnancy|0
1543607|NCT00121641|5051176|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
1543608|NCT00121641|5051177|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
1543609|NCT00121641|5051178|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
1543610|NCT00121641|5051179|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
1543611|NCT00121641|5051180|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
1543612|NCT00121641|5051176|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
1543613|NCT00121641|5051177|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
1543614|NCT00121641|5051178|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
1543615|NCT00121641|5051179|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
1543616|NCT00121641|5051180|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
1543617|NCT00121641|5051176|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
1543618|NCT00121641|5051177|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
1543619|NCT00121641|5051178|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
1543620|NCT00121641|5051179|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
1543621|NCT00121641|5051180|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
1543622|NCT00121641|5051176|P5|48-month Short Term + Long Term Period|Adverse Event|5
1543623|NCT00121641|5051177|P4|48-month Short Term + Long Term Period|Adverse Event|5
1543624|NCT00121641|5051178|P3|48-month Short Term + Long Term Period|Adverse Event|10
1543625|NCT00121641|5051179|P2|48-month Short Term + Long Term Period|Adverse Event|10
1543626|NCT00121641|5051180|P1|48-month Short Term + Long Term Period|Adverse Event|9
1543627|NCT00121641|5051176|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
1543628|NCT00121641|5051177|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
1543629|NCT00121641|5051178|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
1543630|NCT00121641|5051179|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
1543631|NCT00121641|5051180|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
1543632|NCT00121641|5051176|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
1543633|NCT00121641|5051177|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
1543634|NCT00121641|5051178|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
1543635|NCT00121641|5051179|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
1543636|NCT00121641|5051180|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
1543637|NCT00121641|5051176|P5|24-week Short-term Treatment Period|Other Reason|0
1543638|NCT00121641|5051177|P4|24-week Short-term Treatment Period|Other Reason|0
1543639|NCT00121641|5051178|P3|24-week Short-term Treatment Period|Other Reason|0
1543640|NCT00121641|5051179|P2|24-week Short-term Treatment Period|Other Reason|0
1543641|NCT00121641|5051180|P1|24-week Short-term Treatment Period|Other Reason|1
1543642|NCT00121641|5051176|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
1543643|NCT00121641|5051177|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
1543644|NCT00121641|5051178|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
1543645|NCT00121641|5051179|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
1543646|NCT00121641|5051180|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
1543647|NCT00121641|5051176|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
1543648|NCT00121641|5051177|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
1543649|NCT00121641|5051178|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
1543650|NCT00121641|5051179|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
1543651|NCT00121641|5051180|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
1543652|NCT00121641|5051176|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
1543653|NCT00121641|5051177|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
1543654|NCT00121641|5051178|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
1543655|NCT00121641|5051179|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
1543656|NCT00121641|5051180|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
1543657|NCT00121641|5051176|P5|24-week Short-term Treatment Period|Adverse Event|2
1543658|NCT00121641|5051177|P4|24-week Short-term Treatment Period|Adverse Event|0
1543659|NCT00121641|5051178|P3|24-week Short-term Treatment Period|Adverse Event|4
1543660|NCT00121641|5051179|P2|24-week Short-term Treatment Period|Adverse Event|3
1543661|NCT00121641|5051180|P1|24-week Short-term Treatment Period|Adverse Event|3
1543662|NCT00121641|5051176|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
1543663|NCT00121641|5051177|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
1543664|NCT00121641|5051178|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
1543665|NCT00121641|5051179|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
1543666|NCT00121641|5051180|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
1543667|NCT00121641|5051176|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
1543668|NCT00121641|5051177|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
1543669|NCT00121641|5051178|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
1543670|NCT00121641|5051179|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
1543671|NCT00121641|5051180|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
1543672|NCT00121485|5051293|P2|Overall Study|Crossover|2
1543673|NCT00121485|5051294|P1|Overall Study|Crossover|0
1543674|NCT00121485|5051293|P2|Overall Study|Not implanted|5
1543675|NCT00121485|5051294|P1|Overall Study|Not implanted|1
1543676|NCT00121238|5051339|P1|Overall Study|Protocol Violation|2
1543677|NCT00121238|5051339|P1|Overall Study|disease progression before intervention|1
1543678|NCT00121199|5051351|P1|Overall Study|Ineligible|9
1543679|NCT00121199|5051351|P1|Overall Study|Other - Not Protocol Specified|3
1543680|NCT00121199|5051351|P1|Overall Study|Death|3
1543681|NCT00121199|5051351|P1|Overall Study|Progression/Relapse|1
1543682|NCT00121199|5051351|P1|Overall Study|Refusal Unrelated to Adverse Event|1
1543683|NCT00121199|5051351|P1|Overall Study|Adverse Event|11
1543684|NCT00121134|5051395|P4|Overall Study|Patient Personal Reasons|0
1543685|NCT00121134|5051396|P3|Overall Study|Patient Personal Reasons|0
1543686|NCT00121134|5051397|P2|Overall Study|Patient Personal Reasons|1
1543687|NCT00121134|5051398|P1|Overall Study|Patient Personal Reasons|0
1543688|NCT00121134|5051395|P4|Overall Study|Intercurrent Illness|1
1543689|NCT00121134|5051396|P3|Overall Study|Intercurrent Illness|0
1543690|NCT00121134|5051397|P2|Overall Study|Intercurrent Illness|0
1543691|NCT00121134|5051398|P1|Overall Study|Intercurrent Illness|0
1543692|NCT00121134|5051395|P4|Overall Study|Treatment Delay|0
1543693|NCT00121134|5051396|P3|Overall Study|Treatment Delay|0
1543694|NCT00121134|5051397|P2|Overall Study|Treatment Delay|0
1543695|NCT00121134|5051398|P1|Overall Study|Treatment Delay|1
1543696|NCT00121134|5051395|P4|Overall Study|Physician Decision|1
1543697|NCT00121134|5051396|P3|Overall Study|Physician Decision|4
1543698|NCT00121134|5051397|P2|Overall Study|Physician Decision|4
1543699|NCT00121134|5051398|P1|Overall Study|Physician Decision|6
1543700|NCT00121134|5051395|P4|Overall Study|Toxicity|5
1543701|NCT00121134|5051396|P3|Overall Study|Toxicity|13
1543702|NCT00121134|5051397|P2|Overall Study|Toxicity|7
1543703|NCT00121134|5051398|P1|Overall Study|Toxicity|4
1543704|NCT00121134|5051395|P4|Overall Study|Progression of Disease|2
1543705|NCT00121134|5051396|P3|Overall Study|Progression of Disease|4
1543706|NCT00121134|5051397|P2|Overall Study|Progression of Disease|3
1543707|NCT00121134|5051398|P1|Overall Study|Progression of Disease|5
1543708|NCT00120874|5051410|P2|Overall Study|Death|1
1543709|NCT00120874|5051411|P1|Overall Study|Death|0
1543710|NCT00120627|5051449|P2|Overall Study|Withdrawal by Subject|5
1543711|NCT00120627|5051450|P1|Overall Study|Withdrawal by Subject|5
1543712|NCT00120406|5051501|P2|Overall Study|patient moved but has not withdrawn|1
1543713|NCT00120406|5051502|P1|Overall Study|patient moved but has not withdrawn|0
1543714|NCT00120406|5051501|P2|Overall Study|received non-study stent|2
1543715|NCT00120406|5051502|P1|Overall Study|received non-study stent|0
1543716|NCT00120406|5051501|P2|Overall Study|Lost to Follow-up|2
1543717|NCT00120406|5051502|P1|Overall Study|Lost to Follow-up|5
1543718|NCT00120406|5051501|P2|Overall Study|Withdrawal by Subject|7
1543719|NCT00120406|5051502|P1|Overall Study|Withdrawal by Subject|5
1543720|NCT00120406|5051501|P2|Overall Study|Death|4
1543721|NCT00120406|5051502|P1|Overall Study|Death|9
1543722|NCT00120289|5051512|P2|Overall Study|Withdrawal by Subject|13
1543723|NCT00120289|5051513|P1|Overall Study|Withdrawal by Subject|14
1543724|NCT00120289|5051512|P2|Overall Study|Lost to Follow-up|14
1543725|NCT00120289|5051513|P1|Overall Study|Lost to Follow-up|11
1543726|NCT00120289|5051512|P2|Overall Study|Death|82
1543727|NCT00120289|5051513|P1|Overall Study|Death|96
1543728|NCT00120250|5051525|P2|Overall Study|Protocol Violation|1
1543729|NCT00120250|5051526|P1|Overall Study|Protocol Violation|0
1543730|NCT00120250|5051525|P2|Overall Study|Lost to Follow-up|1
1543731|NCT00120250|5051526|P1|Overall Study|Lost to Follow-up|1
1543732|NCT00120042|5051542|P3|Overall Study|all completed protocl|0
1543733|NCT00120042|5051543|P2|Overall Study|all completed protocl|0
1543734|NCT00120042|5051544|P1|Overall Study|all completed protocl|0
1543735|NCT00119678|5051567|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
1543736|NCT00119678|5051568|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
1543737|NCT00119678|5051567|P2|Open-label Treatment Period|Pregnancy|0
1543738|NCT00119678|5051568|P1|Open-label Treatment Period|Pregnancy|1
1543739|NCT00119678|5051567|P2|Open-label Treatment Period|Participants not meeting study criteria|0
1543740|NCT00119678|5051568|P1|Open-label Treatment Period|Participants not meeting study criteria|2
1543741|NCT00119678|5051567|P2|Open-label Treatment Period|Participant withdrew consent|0
1543742|NCT00119678|5051568|P1|Open-label Treatment Period|Participant withdrew consent|4
1543743|NCT00119678|5051567|P2|Open-label Treatment Period|Lost to Follow-up|0
1543744|NCT00119678|5051568|P1|Open-label Treatment Period|Lost to Follow-up|3
1543745|NCT00119678|5051567|P2|Open-label Treatment Period|Lack of Efficacy|0
1543746|NCT00119678|5051568|P1|Open-label Treatment Period|Lack of Efficacy|9
1543747|NCT00119678|5051567|P2|Open-label Treatment Period|Adverse Event|0
1543748|NCT00119678|5051568|P1|Open-label Treatment Period|Adverse Event|3
1543749|NCT00119678|5051567|P2|Open-label Treatment Period|Death|0
1543750|NCT00119678|5051568|P1|Open-label Treatment Period|Death|1
1543751|NCT00119678|5051567|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
1543752|NCT00119678|5051568|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
1543753|NCT00119678|5051567|P2|Double-blind Treatment Period|Not treated|2
1543754|NCT00119678|5051568|P1|Double-blind Treatment Period|Not treated|1
1543755|NCT00119678|5051567|P2|Double-blind Treatment Period|Pregnancy|2
1543756|NCT00119678|5051568|P1|Double-blind Treatment Period|Pregnancy|0
1543757|NCT00119678|5051567|P2|Double-blind Treatment Period|Poor/Non-compliance|0
1543758|NCT00119678|5051568|P1|Double-blind Treatment Period|Poor/Non-compliance|3
1543759|NCT00119678|5051567|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
1543760|NCT00119678|5051568|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
1543761|NCT00119678|5051567|P2|Double-blind Treatment Period|Participant withdrew consent|4
1543762|NCT00119678|5051568|P1|Double-blind Treatment Period|Participant withdrew consent|4
1543763|NCT00119678|5051567|P2|Double-blind Treatment Period|Lost to Follow-up|2
1543764|NCT00119678|5051568|P1|Double-blind Treatment Period|Lost to Follow-up|1
1543765|NCT00119678|5051567|P2|Double-blind Treatment Period|Lack of Efficacy|12
1543766|NCT00119678|5051568|P1|Double-blind Treatment Period|Lack of Efficacy|21
1543767|NCT00119678|5051567|P2|Double-blind Treatment Period|Adverse Event|1
1543768|NCT00119678|5051568|P1|Double-blind Treatment Period|Adverse Event|7
1543769|NCT00119678|5051567|P2|Double-blind Treatment Period|Death|0
1543770|NCT00119678|5051568|P1|Double-blind Treatment Period|Death|1
1543771|NCT00119405|5051614|P1|Overall Study|Withdrawal by Subject|1
1543772|NCT00119379|5051628|P2|Overall Study|Adverse Event|1
1543773|NCT00119379|5051629|P1|Overall Study|Adverse Event|4
1543774|NCT00119262|5051647|P2|Overall Study|others|5
1543775|NCT00119262|5051648|P1|Overall Study|others|0
1543776|NCT00119262|5051647|P2|Overall Study|ineligble|2
1543777|NCT00119262|5051648|P1|Overall Study|ineligble|1
1543778|NCT00119262|5051647|P2|Overall Study|other disease|2
1543779|NCT00119262|5051648|P1|Overall Study|other disease|0
1543780|NCT00119262|5051647|P2|Overall Study|Adverse Event|35
1543781|NCT00119262|5051648|P1|Overall Study|Adverse Event|33
1543782|NCT00119262|5051647|P2|Overall Study|Withdrawal by Subject|11
1543783|NCT00119262|5051648|P1|Overall Study|Withdrawal by Subject|12
1543784|NCT00119262|5051647|P2|Overall Study|Lack of Efficacy|3
1543785|NCT00119262|5051648|P1|Overall Study|Lack of Efficacy|0
1543786|NCT00119015|5051685|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
1543787|NCT00119015|5051686|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
1543788|NCT00119015|5051687|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
1543789|NCT00118911|5051703|P2|Overall Study|Withdrawal by Subject|5
1543790|NCT00118911|5051704|P1|Overall Study|Withdrawal by Subject|2
1543791|NCT00118898|5051716|P4|Overall Study|Not able to get to clinic|40
1543792|NCT00118898|5051717|P3|Overall Study|Not able to get to clinic|31
1543793|NCT00118898|5051718|P2|Overall Study|Not able to get to clinic|43
1543794|NCT00118898|5051719|P1|Overall Study|Not able to get to clinic|34
1543795|NCT00118898|5051716|P4|Overall Study|Not compliant with requirements|11
1543796|NCT00118898|5051717|P3|Overall Study|Not compliant with requirements|11
1543797|NCT00118898|5051718|P2|Overall Study|Not compliant with requirements|13
1543798|NCT00118898|5051719|P1|Overall Study|Not compliant with requirements|11
1543799|NCT00118898|5051716|P4|Overall Study|Severe debilitation|4
1543800|NCT00118898|5051717|P3|Overall Study|Severe debilitation|6
1543801|NCT00118898|5051718|P2|Overall Study|Severe debilitation|4
1543802|NCT00118898|5051719|P1|Overall Study|Severe debilitation|1
1543803|NCT00118898|5051716|P4|Overall Study|Site Closure|37
1543804|NCT00118898|5051717|P3|Overall Study|Site Closure|28
1543805|NCT00118898|5051718|P2|Overall Study|Site Closure|31
1543806|NCT00118898|5051719|P1|Overall Study|Site Closure|33
1543807|NCT00118898|5051716|P4|Overall Study|Withdrawal by Subject|8
1543808|NCT00118898|5051717|P3|Overall Study|Withdrawal by Subject|8
1543809|NCT00118898|5051718|P2|Overall Study|Withdrawal by Subject|5
1543810|NCT00118898|5051719|P1|Overall Study|Withdrawal by Subject|10
1543811|NCT00118898|5051716|P4|Overall Study|Lost to Follow-up|33
1543812|NCT00118898|5051717|P3|Overall Study|Lost to Follow-up|33
1543813|NCT00118898|5051718|P2|Overall Study|Lost to Follow-up|34
1543814|NCT00118898|5051719|P1|Overall Study|Lost to Follow-up|26
1543815|NCT00118898|5051716|P4|Overall Study|Death|8
1543816|NCT00118898|5051717|P3|Overall Study|Death|6
1543817|NCT00118898|5051718|P2|Overall Study|Death|11
1543818|NCT00118898|5051719|P1|Overall Study|Death|6
1543819|NCT00118703|5051845|P2|Overall Study|Lost to Follow-up|2
1543820|NCT00118703|5051846|P1|Overall Study|Lost to Follow-up|1
1543821|NCT00118703|5051845|P2|Overall Study|Withdrawal by Subject|5
1543822|NCT00118703|5051846|P1|Overall Study|Withdrawal by Subject|2
1543823|NCT00118703|5051845|P2|Overall Study|Participant took two different treatment|1
1543824|NCT00118703|5051846|P1|Overall Study|Participant took two different treatment|0
1543825|NCT00118703|5051845|P2|Overall Study|Adverse Event|1
1543826|NCT00118703|5051846|P1|Overall Study|Adverse Event|1
1543827|NCT00118703|5051845|P2|Overall Study|Protocol Violation|0
1543828|NCT00118703|5051846|P1|Overall Study|Protocol Violation|1
1543829|NCT00118482|5051943|P2|Overall Study|Withdrawal by Subject|22
1543830|NCT00118482|5051944|P1|Overall Study|Withdrawal by Subject|23
1543831|NCT00118482|5051943|P2|Overall Study|Lost to Follow-up|7
1543832|NCT00118482|5051944|P1|Overall Study|Lost to Follow-up|7
1543833|NCT00118430|5051955|P3|Overall Study|Lost to Follow-up|28
1543834|NCT00118430|5051956|P2|Overall Study|Lost to Follow-up|22
1543835|NCT00118430|5051957|P1|Overall Study|Lost to Follow-up|15
1543836|NCT00118430|5051955|P3|Overall Study|Withdrawal by Subject|0
1543837|NCT00118430|5051956|P2|Overall Study|Withdrawal by Subject|2
1543838|NCT00118430|5051957|P1|Overall Study|Withdrawal by Subject|6
1543839|NCT00118417|5051972|P2|Phase II (Weeks 6 to 12)|Remission|2
1543840|NCT00118417|5051973|P1|Phase II (Weeks 6 to 12)|Remission|1
1543841|NCT00118417|5051972|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
1543842|NCT00118417|5051973|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
1543843|NCT00118417|5051972|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
1543844|NCT00118417|5051973|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
1543845|NCT00118417|5051972|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
1543846|NCT00118417|5051973|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
1543847|NCT00118417|5051972|P2|Phase I (Weeks 0 to 6)|Remission|0
1543848|NCT00118417|5051973|P1|Phase I (Weeks 0 to 6)|Remission|8
1543849|NCT00118287|5052117|P1|Overall Study|Muscle pain|1
1543850|NCT00118287|5052117|P1|Overall Study|Intracranial haemorrhage|1
1543851|NCT00118157|5052137|P1|Overall Study|Withdrawal by Subject|2
1543852|NCT00118157|5052137|P1|Overall Study|Death|8
1543853|NCT00118157|5052137|P1|Overall Study|Adverse Event|2
1543854|NCT00118092|5052155|P1|Overall Study|Protocol Violation|1
1543855|NCT00118092|5052155|P1|Overall Study|Withdrawal by Subject|1
1543856|NCT00118040|5052173|P3|Overall Study|Other|1
1543857|NCT00118040|5052174|P2|Overall Study|Other|0
1543858|NCT00118040|5052175|P1|Overall Study|Other|0
1543859|NCT00118040|5052173|P3|Overall Study|Non-Compliant Participant|2
1543860|NCT00118040|5052174|P2|Overall Study|Non-Compliant Participant|1
1543861|NCT00118040|5052175|P1|Overall Study|Non-Compliant Participant|1
1543862|NCT00118040|5052173|P3|Overall Study|Medical Contraindication|1
1543863|NCT00118040|5052174|P2|Overall Study|Medical Contraindication|0
1543864|NCT00118040|5052175|P1|Overall Study|Medical Contraindication|0
1543865|NCT00118040|5052173|P3|Overall Study|Withdrawal by Subject|2
1543866|NCT00118040|5052174|P2|Overall Study|Withdrawal by Subject|0
1543867|NCT00118040|5052175|P1|Overall Study|Withdrawal by Subject|0
1543868|NCT00118040|5052173|P3|Overall Study|Adverse Event|0
1543869|NCT00118040|5052174|P2|Overall Study|Adverse Event|1
1543870|NCT00118040|5052175|P1|Overall Study|Adverse Event|0
1543871|NCT00117988|5052236|P1|Overall Study|Adverse Event|1
1543872|NCT00117988|5052236|P1|Overall Study|Death|3
1543873|NCT00117949|5052259|P4|Overall Study|Hepatic abnormalities|1
1543874|NCT00117949|5052260|P3|Overall Study|Hepatic abnormalities|0
1543875|NCT00117949|5052261|P2|Overall Study|Hepatic abnormalities|1
1543876|NCT00117949|5052262|P1|Overall Study|Hepatic abnormalities|0
1543877|NCT00117949|5052259|P4|Overall Study|PSA reduction <=50%|4
1543878|NCT00117949|5052260|P3|Overall Study|PSA reduction <=50%|2
1543879|NCT00117949|5052261|P2|Overall Study|PSA reduction <=50%|2
1543880|NCT00117949|5052262|P1|Overall Study|PSA reduction <=50%|0
1543881|NCT00117949|5052259|P4|Overall Study|PSA increase >=10ng/mL|0
1543882|NCT00117949|5052260|P3|Overall Study|PSA increase >=10ng/mL|1
1543883|NCT00117949|5052261|P2|Overall Study|PSA increase >=10ng/mL|1
1543884|NCT00117949|5052262|P1|Overall Study|PSA increase >=10ng/mL|0
1543885|NCT00117949|5052259|P4|Overall Study|Prostate-specific antigen increase >=25%|2
1543886|NCT00117949|5052260|P3|Overall Study|Prostate-specific antigen increase >=25%|1
1543887|NCT00117949|5052261|P2|Overall Study|Prostate-specific antigen increase >=25%|1
1543888|NCT00117949|5052262|P1|Overall Study|Prostate-specific antigen increase >=25%|0
1543889|NCT00117949|5052259|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
1543890|NCT00117949|5052260|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
1543891|NCT00117949|5052261|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
1543892|NCT00117949|5052262|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
1543893|NCT00117949|5052259|P4|Overall Study|Testosterone >1.0 ng/mL|15
1543894|NCT00117949|5052260|P3|Overall Study|Testosterone >1.0 ng/mL|17
1543895|NCT00117949|5052261|P2|Overall Study|Testosterone >1.0 ng/mL|18
1543896|NCT00117949|5052262|P1|Overall Study|Testosterone >1.0 ng/mL|10
1543897|NCT00117845|5052296|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
1543898|NCT00117793|5052314|P1|Overall Study|Withdrawal by Subject|12
1543899|NCT00117676|5052337|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
1543900|NCT00117676|5052338|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
1543901|NCT00117676|5052337|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
1543902|NCT00117676|5052338|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
1543903|NCT00117676|5052337|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
1543904|NCT00117676|5052338|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
1543905|NCT00117676|5052337|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
1543906|NCT00117676|5052338|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
1543907|NCT00117676|5052337|P2|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|1
1543908|NCT00117676|5052338|P1|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|0
1543909|NCT00117676|5052337|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
1543910|NCT00117676|5052338|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
1543911|NCT00117676|5052337|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
1543912|NCT00117676|5052338|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
1543913|NCT00117676|5052337|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
1543914|NCT00117676|5052338|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
1543915|NCT00117676|5052337|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
1543916|NCT00117676|5052338|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
1543917|NCT00117676|5052337|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
1543918|NCT00117676|5052338|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
1543919|NCT00117676|5052337|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
1543920|NCT00117676|5052338|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
1543921|NCT00117676|5052337|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
1543922|NCT00117676|5052338|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
1543923|NCT00117676|5052337|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
1543924|NCT00117676|5052338|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
1543925|NCT00117676|5052337|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
1543926|NCT00117676|5052338|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
1543927|NCT00117676|5052337|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
1543928|NCT00117676|5052338|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
1543929|NCT00117676|5052337|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
1543930|NCT00117676|5052338|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
1543931|NCT00117676|5052337|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
1543932|NCT00117676|5052338|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
1543933|NCT00117676|5052337|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
1543934|NCT00117676|5052338|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
1543935|NCT00117676|5052337|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
1543936|NCT00117676|5052338|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
1543937|NCT00117676|5052337|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
1543938|NCT00117676|5052338|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
1543939|NCT00117676|5052337|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
1543940|NCT00117676|5052338|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
1543941|NCT00117676|5052337|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
1543942|NCT00117676|5052338|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
1543943|NCT00117676|5052337|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
1543944|NCT00117676|5052338|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
1543945|NCT00117676|5052337|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
1543946|NCT00117676|5052338|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
1543947|NCT00117676|5052337|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
1543948|NCT00117676|5052338|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
1543949|NCT00117676|5052337|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
1543950|NCT00117676|5052338|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
1543951|NCT00117676|5052337|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
1543952|NCT00117676|5052338|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
1543953|NCT00117676|5052337|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
1543954|NCT00117676|5052338|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
1543955|NCT00117676|5052337|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
1543956|NCT00117676|5052338|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
1543957|NCT00117676|5052337|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
1543958|NCT00117676|5052338|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
1543959|NCT00117676|5052337|P2|Double-blind Period Through Week 48|Withdrew Consent|1
1543960|NCT00117676|5052338|P1|Double-blind Period Through Week 48|Withdrew Consent|0
1543961|NCT00117676|5052337|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
1543962|NCT00117676|5052338|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
1543963|NCT00117676|5052337|P2|Double-blind Period Through Week 48|Protocol Violation|1
1543964|NCT00117676|5052338|P1|Double-blind Period Through Week 48|Protocol Violation|0
1543965|NCT00117676|5052337|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
1543966|NCT00117676|5052338|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
1543967|NCT00117676|5052337|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
1543968|NCT00117676|5052338|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
1543969|NCT00117637|5052427|P2|Second Intervention (Period 2)|reason not reported|0
1543970|NCT00117637|5052428|P1|Second Intervention (Period 2)|reason not reported|1
1543971|NCT00117637|5052427|P2|Second Intervention (Period 2)|non compliant with study medication|1
1543972|NCT00117637|5052428|P1|Second Intervention (Period 2)|non compliant with study medication|1
1543973|NCT00117637|5052427|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
1543974|NCT00117637|5052428|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
1543975|NCT00117637|5052427|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
1543976|NCT00117637|5052428|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
1543977|NCT00117637|5052427|P2|Second Intervention (Period 2)|Protocol Violation|0
1543978|NCT00117637|5052428|P1|Second Intervention (Period 2)|Protocol Violation|1
1543979|NCT00117637|5052427|P2|Second Intervention (Period 2)|Lost to Follow-up|0
1543980|NCT00117637|5052428|P1|Second Intervention (Period 2)|Lost to Follow-up|1
1543981|NCT00117637|5052427|P2|Second Intervention (Period 2)|Adverse Event|9
1543982|NCT00117637|5052428|P1|Second Intervention (Period 2)|Adverse Event|0
1543983|NCT00117637|5052427|P2|First Intervention (Period 1)|reason not reported|1
1543984|NCT00117637|5052428|P1|First Intervention (Period 1)|reason not reported|0
1543985|NCT00117637|5052427|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
1543986|NCT00117637|5052428|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
1543987|NCT00117637|5052427|P2|First Intervention (Period 1)|protocol driven decision point|0
1543988|NCT00117637|5052428|P1|First Intervention (Period 1)|protocol driven decision point|1
1543989|NCT00117637|5052427|P2|First Intervention (Period 1)|study terminated by the sponsor|1
1543990|NCT00117637|5052428|P1|First Intervention (Period 1)|study terminated by the sponsor|3
1543991|NCT00117637|5052427|P2|First Intervention (Period 1)|Withdrawal by Subject|4
1543992|NCT00117637|5052428|P1|First Intervention (Period 1)|Withdrawal by Subject|2
1543993|NCT00117637|5052427|P2|First Intervention (Period 1)|Protocol Violation|0
1543994|NCT00117637|5052428|P1|First Intervention (Period 1)|Protocol Violation|1
1543995|NCT00117637|5052427|P2|First Intervention (Period 1)|Lost to Follow-up|2
1543996|NCT00117637|5052428|P1|First Intervention (Period 1)|Lost to Follow-up|0
1543997|NCT00117637|5052427|P2|First Intervention (Period 1)|Adverse Event|16
1543998|NCT00117637|5052428|P1|First Intervention (Period 1)|Adverse Event|11
1543999|NCT00117598|5052503|P5|After Treament Cross Over|Other|2
1544000|NCT00117598|5052504|P4|After Treament Cross Over|Other|1
1544001|NCT00117598|5052505|P3|After Treament Cross Over|Other|0
1544002|NCT00117598|5052506|P2|After Treament Cross Over|Other|0
1544003|NCT00117598|5052507|P1|After Treament Cross Over|Other|0
1544004|NCT00117598|5052503|P5|After Treament Cross Over|Withdrawal by Subject|0
1544005|NCT00117598|5052504|P4|After Treament Cross Over|Withdrawal by Subject|1
1544006|NCT00117598|5052505|P3|After Treament Cross Over|Withdrawal by Subject|0
1544007|NCT00117598|5052506|P2|After Treament Cross Over|Withdrawal by Subject|0
1544008|NCT00117598|5052507|P1|After Treament Cross Over|Withdrawal by Subject|0
1544009|NCT00117598|5052503|P5|After Treament Cross Over|Death|2
1544010|NCT00117598|5052504|P4|After Treament Cross Over|Death|1
1544011|NCT00117598|5052505|P3|After Treament Cross Over|Death|0
1544012|NCT00117598|5052506|P2|After Treament Cross Over|Death|0
1544013|NCT00117598|5052507|P1|After Treament Cross Over|Death|0
1544014|NCT00117598|5052503|P5|Prior to Treatment Cross Over|Other|0
1544015|NCT00117598|5052504|P4|Prior to Treatment Cross Over|Other|0
1544016|NCT00117598|5052505|P3|Prior to Treatment Cross Over|Other|9
1544017|NCT00117598|5052506|P2|Prior to Treatment Cross Over|Other|9
1544018|NCT00117598|5052507|P1|Prior to Treatment Cross Over|Other|15
1544019|NCT00117598|5052503|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
1544020|NCT00117598|5052504|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
1544021|NCT00117598|5052505|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
1544022|NCT00117598|5052506|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
1544023|NCT00117598|5052507|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
1544024|NCT00117598|5052503|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
1544025|NCT00117598|5052504|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
1544026|NCT00117598|5052505|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
1544027|NCT00117598|5052506|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
1544028|NCT00117598|5052507|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
1544029|NCT00117598|5052503|P5|Prior to Treatment Cross Over|Death|0
1544030|NCT00117598|5052504|P4|Prior to Treatment Cross Over|Death|0
1544031|NCT00117598|5052505|P3|Prior to Treatment Cross Over|Death|37
1544032|NCT00117598|5052506|P2|Prior to Treatment Cross Over|Death|41
1544033|NCT00117598|5052507|P1|Prior to Treatment Cross Over|Death|40
1544034|NCT00117572|5052541|P2|Overall Study|Protocol Violation|0
1544035|NCT00117572|5052542|P1|Overall Study|Protocol Violation|1
1544036|NCT00117572|5052541|P2|Overall Study|Withdrawal by Subject|3
1544037|NCT00117572|5052542|P1|Overall Study|Withdrawal by Subject|3
1544038|NCT00117572|5052541|P2|Overall Study|Site withdrew before starting treatment|3
1544039|NCT00117572|5052542|P1|Overall Study|Site withdrew before starting treatment|2
1544040|NCT00117338|5052583|P2|Overall Study|Lack of Efficacy|1
1544041|NCT00117338|5052584|P1|Overall Study|Lack of Efficacy|0
1544042|NCT00117338|5052583|P2|Overall Study|Did not meet Inclusion Criteria|0
1544043|NCT00117338|5052584|P1|Overall Study|Did not meet Inclusion Criteria|1
1544044|NCT00117338|5052583|P2|Overall Study|Withdrawal by Subject|0
1544045|NCT00117338|5052584|P1|Overall Study|Withdrawal by Subject|1
1544046|NCT00117338|5052583|P2|Overall Study|Protocol Violation|2
1544047|NCT00117338|5052584|P1|Overall Study|Protocol Violation|3
1544048|NCT00117338|5052583|P2|Overall Study|Adverse Event|1
1544049|NCT00117338|5052584|P1|Overall Study|Adverse Event|0
1544050|NCT00117325|5052604|P2|Overall Study|Admisnitrative|0
1544051|NCT00117325|5052605|P1|Overall Study|Admisnitrative|1
1544052|NCT00117325|5052604|P2|Overall Study|Early termination|1
1544053|NCT00117325|5052605|P1|Overall Study|Early termination|1
1544054|NCT00117325|5052604|P2|Overall Study|Use of prohibited medicine|2
1544055|NCT00117325|5052605|P1|Overall Study|Use of prohibited medicine|1
1544056|NCT00117325|5052604|P2|Overall Study|Lack of Efficacy|0
1544057|NCT00117325|5052605|P1|Overall Study|Lack of Efficacy|1
1544058|NCT00117325|5052604|P2|Overall Study|Withdrawal by Subject|2
1544059|NCT00117325|5052605|P1|Overall Study|Withdrawal by Subject|3
1544060|NCT00117325|5052604|P2|Overall Study|Protocol Violation|3
1544061|NCT00117325|5052605|P1|Overall Study|Protocol Violation|2
1544062|NCT00117325|5052604|P2|Overall Study|Lost to Follow-up|1
1544063|NCT00117325|5052605|P1|Overall Study|Lost to Follow-up|1
1544064|NCT00117325|5052604|P2|Overall Study|Adverse Event|3
1544065|NCT00117325|5052605|P1|Overall Study|Adverse Event|3
1544066|NCT00117312|5052637|P4|Overall Study|Withdrawal by Subject|0
1544067|NCT00117312|5052638|P3|Overall Study|Withdrawal by Subject|0
1544068|NCT00117312|5052639|P2|Overall Study|Withdrawal by Subject|2
1544069|NCT00117312|5052640|P1|Overall Study|Withdrawal by Subject|0
1544070|NCT00117312|5052637|P4|Overall Study|Hepatic abnormality|1
1544071|NCT00117312|5052638|P3|Overall Study|Hepatic abnormality|0
1544072|NCT00117312|5052639|P2|Overall Study|Hepatic abnormality|1
1544073|NCT00117312|5052640|P1|Overall Study|Hepatic abnormality|0
1544074|NCT00117312|5052637|P4|Overall Study|PSA increase >= 10ng/mL|0
1544075|NCT00117312|5052638|P3|Overall Study|PSA increase >= 10ng/mL|1
1544076|NCT00117312|5052639|P2|Overall Study|PSA increase >= 10ng/mL|1
1544077|NCT00117312|5052640|P1|Overall Study|PSA increase >= 10ng/mL|0
1544078|NCT00117312|5052637|P4|Overall Study|PSA decrease <=50%|4
1544079|NCT00117312|5052638|P3|Overall Study|PSA decrease <=50%|2
1544080|NCT00117312|5052639|P2|Overall Study|PSA decrease <=50%|2
1544081|NCT00117312|5052640|P1|Overall Study|PSA decrease <=50%|0
1544082|NCT00117312|5052637|P4|Overall Study|Protocol Violation|0
1544083|NCT00117312|5052638|P3|Overall Study|Protocol Violation|3
1544084|NCT00117312|5052639|P2|Overall Study|Protocol Violation|1
1544085|NCT00117312|5052640|P1|Overall Study|Protocol Violation|0
1544086|NCT00117312|5052637|P4|Overall Study|Adverse Event|0
1544087|NCT00117312|5052638|P3|Overall Study|Adverse Event|0
1544088|NCT00117312|5052639|P2|Overall Study|Adverse Event|2
1544089|NCT00117312|5052640|P1|Overall Study|Adverse Event|0
1544090|NCT00117312|5052637|P4|Overall Study|Patient choice|1
1544091|NCT00117312|5052638|P3|Overall Study|Patient choice|2
1544092|NCT00117312|5052639|P2|Overall Study|Patient choice|0
1544093|NCT00117312|5052640|P1|Overall Study|Patient choice|0
1544094|NCT00117312|5052637|P4|Overall Study|Not specified|1
1544095|NCT00117312|5052638|P3|Overall Study|Not specified|3
1544096|NCT00117312|5052639|P2|Overall Study|Not specified|1
1544097|NCT00117312|5052640|P1|Overall Study|Not specified|0
1544098|NCT00117312|5052637|P4|Overall Study|Prostate-specific antigen increase >=25%|3
1544099|NCT00117312|5052638|P3|Overall Study|Prostate-specific antigen increase >=25%|5
1544100|NCT00117312|5052639|P2|Overall Study|Prostate-specific antigen increase >=25%|1
1544101|NCT00117312|5052640|P1|Overall Study|Prostate-specific antigen increase >=25%|0
1544102|NCT00117312|5052637|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
1544103|NCT00117312|5052638|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
1544104|NCT00117312|5052639|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
1544105|NCT00117312|5052640|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
1544106|NCT00117312|5052637|P4|Overall Study|Testosterone >1.0 ng/mL|9
1544107|NCT00117312|5052638|P3|Overall Study|Testosterone >1.0 ng/mL|5
1544108|NCT00117312|5052639|P2|Overall Study|Testosterone >1.0 ng/mL|9
1544109|NCT00117312|5052640|P1|Overall Study|Testosterone >1.0 ng/mL|9
1544110|NCT00117286|5052656|P2|Overall Study|Research site closing|2
1544111|NCT00117286|5052657|P1|Overall Study|Research site closing|0
1544112|NCT00117286|5052656|P2|Overall Study|Lack of Efficacy|1
1544113|NCT00117286|5052657|P1|Overall Study|Lack of Efficacy|2
1544114|NCT00117286|5052656|P2|Overall Study|Physician Decision|7
1544115|NCT00117286|5052657|P1|Overall Study|Physician Decision|3
1544116|NCT00117286|5052656|P2|Overall Study|Withdrawal by Subject|2
1544117|NCT00117286|5052657|P1|Overall Study|Withdrawal by Subject|6
1544118|NCT00117286|5052656|P2|Overall Study|Protocol Violation|3
1544119|NCT00117286|5052657|P1|Overall Study|Protocol Violation|3
1544120|NCT00117286|5052656|P2|Overall Study|Lost to Follow-up|0
1544121|NCT00117286|5052657|P1|Overall Study|Lost to Follow-up|2
1544122|NCT00117286|5052656|P2|Overall Study|Adverse Event|6
1544123|NCT00117286|5052657|P1|Overall Study|Adverse Event|12
1544124|NCT00117156|5052665|P1|Overall Study|Trt for Pre-Exist Second Primary|1
1544125|NCT00117156|5052665|P1|Overall Study|Physician Decision|1
1544126|NCT00117156|5052665|P1|Overall Study|Adverse Event|9
1544127|NCT00116844|5052684|P2|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
1544128|NCT00116844|5052685|P1|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
1544129|NCT00116844|5052684|P2|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
1544130|NCT00116844|5052685|P1|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
1544131|NCT00116844|5052684|P2|Period 1: Treatment Period 2 (60 Days)|Other|2
1544132|NCT00116844|5052685|P1|Period 1: Treatment Period 2 (60 Days)|Other|0
1544133|NCT00116844|5052684|P2|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
1544134|NCT00116844|5052685|P1|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
1544135|NCT00116844|5052684|P2|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
1544136|NCT00116844|5052685|P1|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
1544137|NCT00116844|5052684|P2|Period 1: Treatment Period 1 (60 Days)|Other|1
1544138|NCT00116844|5052685|P1|Period 1: Treatment Period 1 (60 Days)|Other|1
1544139|NCT00116844|5052684|P2|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
1544140|NCT00116844|5052685|P1|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
1544141|NCT00116844|5052684|P2|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
1544142|NCT00116844|5052685|P1|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
1544143|NCT00116844|5052684|P2|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
1544144|NCT00116844|5052685|P1|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
1544145|NCT00116831|5052703|P2|Overall Study|Missing data for participant|0
1544146|NCT00116831|5052704|P1|Overall Study|Missing data for participant|1
1544147|NCT00116831|5052703|P2|Overall Study|Insufficient therapeutic effect|1
1544148|NCT00116831|5052704|P1|Overall Study|Insufficient therapeutic effect|0
1544149|NCT00116831|5052703|P2|Overall Study|Withdrawal by Subject|32
1544150|NCT00116831|5052704|P1|Overall Study|Withdrawal by Subject|32
1544151|NCT00116831|5052703|P2|Overall Study|Withdrawn investigational product|0
1544152|NCT00116831|5052704|P1|Overall Study|Withdrawn investigational product|1
1544153|NCT00116831|5052703|P2|Overall Study|Low haemoglobin on screening|0
1544154|NCT00116831|5052704|P1|Overall Study|Low haemoglobin on screening|1
1544155|NCT00116831|5052703|P2|Overall Study|Hypoglycaemic events|0
1544156|NCT00116831|5052704|P1|Overall Study|Hypoglycaemic events|1
1544157|NCT00116831|5052703|P2|Overall Study|Protocol Violation|6
1544158|NCT00116831|5052704|P1|Overall Study|Protocol Violation|3
1544159|NCT00116831|5052703|P2|Overall Study|Lost to Follow-up|6
1544160|NCT00116831|5052704|P1|Overall Study|Lost to Follow-up|8
1544161|NCT00116831|5052703|P2|Overall Study|Baseline IVUS determined unevaluable|11
1544162|NCT00116831|5052704|P1|Overall Study|Baseline IVUS determined unevaluable|12
1544163|NCT00116831|5052703|P2|Overall Study|Adverse Event|16
1544164|NCT00116831|5052704|P1|Overall Study|Adverse Event|14
1544165|NCT00116805|5052782|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
1544166|NCT00116805|5052783|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
1544167|NCT00116805|5052782|P2|Open-label Period Weeks 433 - 480|Investigator’s Discretion|0
1544168|NCT00116805|5052783|P1|Open-label Period Weeks 433 - 480|Investigator’s Discretion|1
1544169|NCT00116805|5052782|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
1544170|NCT00116805|5052783|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
1544171|NCT00116805|5052782|P2|Open-label Period Weeks 385 - 432|Investigator’s Discretion|0
1544172|NCT00116805|5052783|P1|Open-label Period Weeks 385 - 432|Investigator’s Discretion|1
1544173|NCT00116805|5052782|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
1544174|NCT00116805|5052783|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
1544175|NCT00116805|5052782|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
1544176|NCT00116805|5052783|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
1544177|NCT00116805|5052782|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
1544178|NCT00116805|5052783|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
1544179|NCT00116805|5052782|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
1544180|NCT00116805|5052783|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
1544181|NCT00116805|5052782|P2|Open-label Period Weeks 337 - 384|Completed Study|0
1544182|NCT00116805|5052783|P1|Open-label Period Weeks 337 - 384|Completed Study|1
1544183|NCT00116805|5052782|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
1544184|NCT00116805|5052783|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
1544185|NCT00116805|5052782|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
1544186|NCT00116805|5052783|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
1544187|NCT00116805|5052782|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
1544188|NCT00116805|5052783|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
1544189|NCT00116805|5052782|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
1544190|NCT00116805|5052783|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
1544191|NCT00116805|5052782|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
1544192|NCT00116805|5052783|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
1544193|NCT00116805|5052782|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
1544194|NCT00116805|5052783|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
1544195|NCT00116805|5052782|P2|Open-label Period Weeks 289 - 336|Completed Study|1
1544196|NCT00116805|5052783|P1|Open-label Period Weeks 289 - 336|Completed Study|0
1544197|NCT00116805|5052782|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
1544198|NCT00116805|5052783|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
1544199|NCT00116805|5052782|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
1544200|NCT00116805|5052783|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
1544201|NCT00116805|5052782|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
1544202|NCT00116805|5052783|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
1544203|NCT00116805|5052782|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
1544204|NCT00116805|5052783|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
1544205|NCT00116805|5052782|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
1544206|NCT00116805|5052783|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
1544207|NCT00116805|5052782|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
1544208|NCT00116805|5052783|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
1544209|NCT00116805|5052782|P2|Open-label Period Weeks 193 - 240|Completed Study|1
1544210|NCT00116805|5052783|P1|Open-label Period Weeks 193 - 240|Completed Study|0
1544211|NCT00116805|5052782|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
1544212|NCT00116805|5052783|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
1544213|NCT00116805|5052782|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
1544214|NCT00116805|5052783|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
1544215|NCT00116805|5052782|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
1544216|NCT00116805|5052783|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
1544217|NCT00116805|5052782|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
1544218|NCT00116805|5052783|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
1544219|NCT00116805|5052782|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
1544220|NCT00116805|5052783|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
1544221|NCT00116805|5052782|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
1544222|NCT00116805|5052783|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
1544223|NCT00116805|5052782|P2|Open-label Period Weeks 145 - 192|Completed Study|1
1544224|NCT00116805|5052783|P1|Open-label Period Weeks 145 - 192|Completed Study|1
1544225|NCT00116805|5052782|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
1544226|NCT00116805|5052783|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
1544227|NCT00116805|5052782|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
1544228|NCT00116805|5052783|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
1544229|NCT00116805|5052782|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
1544230|NCT00116805|5052783|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
1544231|NCT00116805|5052782|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
1544232|NCT00116805|5052783|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
1544233|NCT00116805|5052782|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
1544234|NCT00116805|5052783|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
1544235|NCT00116805|5052782|P2|Open-label Period Weeks 97 - 144|Completed Study|0
1544236|NCT00116805|5052783|P1|Open-label Period Weeks 97 - 144|Completed Study|1
1544237|NCT00116805|5052782|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
1544238|NCT00116805|5052783|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
1544239|NCT00116805|5052782|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
1544240|NCT00116805|5052783|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
1544241|NCT00116805|5052782|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
1544242|NCT00116805|5052783|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
1544243|NCT00116805|5052782|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
1544244|NCT00116805|5052783|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
1544245|NCT00116805|5052782|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
1544246|NCT00116805|5052783|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
1544247|NCT00116805|5052782|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
1544248|NCT00116805|5052783|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
1544249|NCT00116805|5052782|P2|Double-blind Period Through Week 48|Withdrew Consent|2
1544250|NCT00116805|5052783|P1|Double-blind Period Through Week 48|Withdrew Consent|4
1544251|NCT00116805|5052782|P2|Double-blind Period Through Week 48|Protocol Violation|1
1544252|NCT00116805|5052783|P1|Double-blind Period Through Week 48|Protocol Violation|1
1544253|NCT00116805|5052782|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
1544254|NCT00116805|5052783|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
1544255|NCT00116779|5052876|P2|Overall Study|Elevated PSA levels|2
1544256|NCT00116779|5052877|P1|Overall Study|Elevated PSA levels|2
1544257|NCT00116779|5052876|P2|Overall Study|Physician Decision|1
1544258|NCT00116779|5052877|P1|Overall Study|Physician Decision|3
1544259|NCT00116779|5052876|P2|Overall Study|Inadequate testosterone suppression|9
1544260|NCT00116779|5052877|P1|Overall Study|Inadequate testosterone suppression|7
1544261|NCT00116779|5052876|P2|Overall Study|Withdrawal by Subject|1
1544262|NCT00116779|5052877|P1|Overall Study|Withdrawal by Subject|4
1544263|NCT00116779|5052876|P2|Overall Study|Protocol Violation|4
1544264|NCT00116779|5052877|P1|Overall Study|Protocol Violation|1
1544265|NCT00116779|5052876|P2|Overall Study|Adverse Event|2
1544266|NCT00116779|5052877|P1|Overall Study|Adverse Event|4
1544267|NCT00116753|5052910|P3|Overall Study|Dosing Error|0
1544268|NCT00116753|5052911|P2|Overall Study|Dosing Error|1
1544269|NCT00116753|5052912|P1|Overall Study|Dosing Error|0
1544270|NCT00116753|5052910|P3|Overall Study|Progressive Parkinson's Disease|0
1544271|NCT00116753|5052911|P2|Overall Study|Progressive Parkinson's Disease|0
1544272|NCT00116753|5052912|P1|Overall Study|Progressive Parkinson's Disease|1
1544273|NCT00116753|5052910|P3|Overall Study|Abnormal Echocardiogram|1
1544274|NCT00116753|5052911|P2|Overall Study|Abnormal Echocardiogram|0
1544275|NCT00116753|5052912|P1|Overall Study|Abnormal Echocardiogram|0
1544276|NCT00116753|5052910|P3|Overall Study|Disease Progression|3
1544277|NCT00116753|5052911|P2|Overall Study|Disease Progression|4
1544278|NCT00116753|5052912|P1|Overall Study|Disease Progression|3
1544279|NCT00116753|5052910|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
1544280|NCT00116753|5052911|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
1544281|NCT00116753|5052912|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
1544282|NCT00116753|5052910|P3|Overall Study|Protocol Violation|1
1544283|NCT00116753|5052911|P2|Overall Study|Protocol Violation|0
1544284|NCT00116753|5052912|P1|Overall Study|Protocol Violation|0
1544285|NCT00116753|5052910|P3|Overall Study|Lost to Follow-up|1
1544286|NCT00116753|5052911|P2|Overall Study|Lost to Follow-up|2
1544287|NCT00116753|5052912|P1|Overall Study|Lost to Follow-up|0
1544288|NCT00116753|5052910|P3|Overall Study|Withdrawal by Subject|8
1544289|NCT00116753|5052911|P2|Overall Study|Withdrawal by Subject|12
1544290|NCT00116753|5052912|P1|Overall Study|Withdrawal by Subject|11
1544291|NCT00116753|5052910|P3|Overall Study|Adverse Event|7
1544292|NCT00116753|5052911|P2|Overall Study|Adverse Event|10
1544293|NCT00116753|5052912|P1|Overall Study|Adverse Event|16
1544294|NCT00116688|5052934|P2|Overall Study|Other|0
1544295|NCT00116688|5052935|P1|Overall Study|Other|11
1544296|NCT00116688|5052934|P2|Overall Study|Pregnancy|0
1544297|NCT00116688|5052935|P1|Overall Study|Pregnancy|1
1544298|NCT00116688|5052934|P2|Overall Study|Protocol-specified criteria|0
1544299|NCT00116688|5052935|P1|Overall Study|Protocol-specified criteria|3
1544300|NCT00116688|5052934|P2|Overall Study|Death|0
1544301|NCT00116688|5052935|P1|Overall Study|Death|15
1544302|NCT00116688|5052934|P2|Overall Study|Lost to Follow-up|0
1544303|NCT00116688|5052935|P1|Overall Study|Lost to Follow-up|3
1544304|NCT00116688|5052934|P2|Overall Study|Physician Decision|0
1544305|NCT00116688|5052935|P1|Overall Study|Physician Decision|7
1544306|NCT00116688|5052934|P2|Overall Study|Requirement for alternative therapy|1
1544307|NCT00116688|5052935|P1|Overall Study|Requirement for alternative therapy|11
1544308|NCT00116688|5052934|P2|Overall Study|Withdrawal by Subject|2
1544309|NCT00116688|5052935|P1|Overall Study|Withdrawal by Subject|26
1544310|NCT00116688|5052934|P2|Overall Study|Adverse Event|0
1544311|NCT00116688|5052935|P1|Overall Study|Adverse Event|11
1544312|NCT00116688|5052934|P2|Overall Study|Noncompliance|1
1544313|NCT00116688|5052935|P1|Overall Study|Noncompliance|3
1544314|NCT00116688|5052934|P2|Overall Study|Protocol deviation|0
1544315|NCT00116688|5052935|P1|Overall Study|Protocol deviation|1
1544316|NCT00116649|5052950|P1|Overall Study|Protocol Specified|7
1544317|NCT00116649|5052950|P1|Overall Study|Various Reasons|18
1544318|NCT00116649|5052950|P1|Overall Study|Local Skin Reaction|9
1544319|NCT00116649|5052950|P1|Overall Study|Withdrawal by Subject|68
1544320|NCT00116649|5052950|P1|Overall Study|Lost to Follow-up|32
1544321|NCT00116649|5052950|P1|Overall Study|Lack of Efficacy|1
1544322|NCT00116649|5052950|P1|Overall Study|Adverse Event|20
1544323|NCT00116428|5052957|P2|Overall Study|Did not meet inclusion criteria|0
1544324|NCT00116428|5052958|P1|Overall Study|Did not meet inclusion criteria|1
1544325|NCT00116428|5052957|P2|Overall Study|Withdrawal by Subject|5
1544326|NCT00116428|5052958|P1|Overall Study|Withdrawal by Subject|2
1544327|NCT00116272|5052976|P2|Overall Study|Lost to Follow-up|6
1544328|NCT00116272|5052977|P1|Overall Study|Lost to Follow-up|11
1544329|NCT00116168|5053046|P4|Overall Study|Lost to Follow-up|0
1544330|NCT00116168|5053047|P3|Overall Study|Lost to Follow-up|0
1544331|NCT00116168|5053048|P2|Overall Study|Lost to Follow-up|5
1544332|NCT00116168|5053049|P1|Overall Study|Lost to Follow-up|6
1544333|NCT00115934|5053113|P2|Overall Study|Did not receive intervention|2
1544334|NCT00115934|5053114|P1|Overall Study|Did not receive intervention|3
1544335|NCT00115934|5053113|P2|Overall Study|Lost to Follow-up|0
1544336|NCT00115934|5053114|P1|Overall Study|Lost to Follow-up|1
1544337|NCT00115804|5053163|P1|Overall Study|Adverse Event|2
1544338|NCT00115765|5053178|P4|Overall Study|Not specified|2
1544339|NCT00115765|5053179|P3|Overall Study|Not specified|9
1544340|NCT00115765|5053180|P2|Overall Study|Not specified|12
1544341|NCT00115765|5053181|P1|Overall Study|Not specified|6
1544342|NCT00115765|5053178|P4|Overall Study|Lost to Follow-up|1
1544343|NCT00115765|5053179|P3|Overall Study|Lost to Follow-up|18
1544344|NCT00115765|5053180|P2|Overall Study|Lost to Follow-up|20
1544345|NCT00115765|5053181|P1|Overall Study|Lost to Follow-up|3
1544346|NCT00115765|5053178|P4|Overall Study|Physician Decision|13
1544347|NCT00115765|5053179|P3|Overall Study|Physician Decision|18
1544348|NCT00115765|5053180|P2|Overall Study|Physician Decision|15
1544349|NCT00115765|5053181|P1|Overall Study|Physician Decision|4
1544350|NCT00115765|5053178|P4|Overall Study|Withdrawal by Subject|15
1544351|NCT00115765|5053179|P3|Overall Study|Withdrawal by Subject|76
1544352|NCT00115765|5053180|P2|Overall Study|Withdrawal by Subject|53
1544353|NCT00115765|5053181|P1|Overall Study|Withdrawal by Subject|22
1544354|NCT00115739|5053219|P1|Overall Study|Lost to Follow-up|3
1544355|NCT00115349|5053228|P2|Overall Study|Study closed due to low enrollment.|9
1544356|NCT00115349|5053229|P1|Overall Study|Study closed due to low enrollment.|11
1544357|NCT00115063|5053250|P2|Overall Study|Death|0
1544358|NCT00115063|5053251|P1|Overall Study|Death|1
1544359|NCT00115063|5053250|P2|Overall Study|Lost to Follow-up|104
1544360|NCT00115063|5053251|P1|Overall Study|Lost to Follow-up|98
1544361|NCT00114972|5053269|P2|Overall Study|Lost to Follow-up|5
1544362|NCT00114972|5053270|P1|Overall Study|Lost to Follow-up|8
1544363|NCT00114972|5053269|P2|Overall Study|Withdrawal by Subject|7
1544364|NCT00114972|5053270|P1|Overall Study|Withdrawal by Subject|40
1544365|NCT00114959|5053290|P1|Overall Study|Death|1
1544366|NCT00114959|5053290|P1|Overall Study|Physician Decision|1
1544367|NCT00114959|5053290|P1|Overall Study|Lack of Efficacy|6
1544368|NCT00114777|5053300|P3|Long-Term Extension to Month 84|Not Specified|2
1544369|NCT00114777|5053301|P2|Long-Term Extension to Month 84|Not Specified|0
1544370|NCT00114777|5053302|P1|Long-Term Extension to Month 84|Not Specified|2
1544371|NCT00114777|5053300|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
1544372|NCT00114777|5053301|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
1544373|NCT00114777|5053302|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
1544374|NCT00114777|5053300|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
1544375|NCT00114777|5053301|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
1544376|NCT00114777|5053302|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
1544377|NCT00114777|5053300|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
1544378|NCT00114777|5053301|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
1544379|NCT00114777|5053302|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
1544380|NCT00114777|5053300|P3|Long-Term Extension to Month 84|Adverse Event|7
1544381|NCT00114777|5053301|P2|Long-Term Extension to Month 84|Adverse Event|14
1544382|NCT00114777|5053302|P1|Long-Term Extension to Month 84|Adverse Event|15
1544383|NCT00114777|5053300|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
1544384|NCT00114777|5053301|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
1544385|NCT00114777|5053302|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
1544386|NCT00114777|5053300|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
1544387|NCT00114777|5053301|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
1544388|NCT00114777|5053302|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
1544389|NCT00114777|5053300|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
1544390|NCT00114777|5053301|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
1544391|NCT00114777|5053302|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
1544392|NCT00114777|5053300|P3|Long-Term Extension to Month 84|Death|7
1544393|NCT00114777|5053301|P2|Long-Term Extension to Month 84|Death|13
1544394|NCT00114777|5053302|P1|Long-Term Extension to Month 84|Death|8
1544395|NCT00114777|5053300|P3|Randomization to Month 36|Not Specified|12
1544396|NCT00114777|5053301|P2|Randomization to Month 36|Not Specified|3
1544397|NCT00114777|5053302|P1|Randomization to Month 36|Not Specified|9
1544398|NCT00114777|5053300|P3|Randomization to Month 36|Withdrawal by Subject|5
1544399|NCT00114777|5053301|P2|Randomization to Month 36|Withdrawal by Subject|4
1544400|NCT00114777|5053302|P1|Randomization to Month 36|Withdrawal by Subject|3
1544401|NCT00114777|5053300|P3|Randomization to Month 36|Adverse Event|44
1544402|NCT00114777|5053301|P2|Randomization to Month 36|Adverse Event|35
1544403|NCT00114777|5053302|P1|Randomization to Month 36|Adverse Event|34
1544404|NCT00114777|5053300|P3|Randomization to Month 36|Poor or Non-Compliance|1
1544405|NCT00114777|5053301|P2|Randomization to Month 36|Poor or Non-Compliance|0
1544406|NCT00114777|5053302|P1|Randomization to Month 36|Poor or Non-Compliance|0
1544407|NCT00114777|5053300|P3|Randomization to Month 36|Lack of Efficacy|17
1544408|NCT00114777|5053301|P2|Randomization to Month 36|Lack of Efficacy|15
1544409|NCT00114777|5053302|P1|Randomization to Month 36|Lack of Efficacy|19
1544410|NCT00114777|5053300|P3|Randomization to Month 36|No Longer Met Study Criteria|2
1544411|NCT00114777|5053301|P2|Randomization to Month 36|No Longer Met Study Criteria|0
1544412|NCT00114777|5053302|P1|Randomization to Month 36|No Longer Met Study Criteria|0
1544413|NCT00114777|5053300|P3|Randomization to Month 36|Death|3
1544414|NCT00114777|5053301|P2|Randomization to Month 36|Death|4
1544415|NCT00114777|5053302|P1|Randomization to Month 36|Death|10
1544416|NCT00114738|5053376|P3|Screening for Randomization|Other|0
1544417|NCT00114738|5053377|P2|Screening for Randomization|Other|0
1544418|NCT00114738|5053378|P1|Screening for Randomization|Other|1
1544419|NCT00114738|5053376|P3|Screening for Randomization|CNS Hemorrhage|0
1544420|NCT00114738|5053377|P2|Screening for Randomization|CNS Hemorrhage|0
1544421|NCT00114738|5053378|P1|Screening for Randomization|CNS Hemorrhage|1
1544422|NCT00114738|5053376|P3|Screening for Randomization|Progressive disease|0
1544423|NCT00114738|5053377|P2|Screening for Randomization|Progressive disease|0
1544424|NCT00114738|5053378|P1|Screening for Randomization|Progressive disease|2
1544425|NCT00114738|5053376|P3|Screening for Randomization|Neuropathy|0
1544426|NCT00114738|5053377|P2|Screening for Randomization|Neuropathy|0
1544427|NCT00114738|5053378|P1|Screening for Randomization|Neuropathy|17
1544428|NCT00114738|5053376|P3|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
1544429|NCT00114738|5053377|P2|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
1544430|NCT00114738|5053378|P1|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
1544431|NCT00114738|5053376|P3|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
1544432|NCT00114738|5053377|P2|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
1544433|NCT00114738|5053378|P1|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
1544434|NCT00114634|5053391|P1|Overall Study|failure to return forms|3
1544435|NCT00114530|5053407|P2|Overall Study|Ineligible|0
1544436|NCT00114530|5053408|P1|Overall Study|Ineligible|1
1544437|NCT00114530|5053407|P2|Overall Study|Subject decision after endpoint failure|1
1544438|NCT00114530|5053408|P1|Overall Study|Subject decision after endpoint failure|0
1544439|NCT00114530|5053407|P2|Overall Study|Breast Cancer|0
1544440|NCT00114530|5053408|P1|Overall Study|Breast Cancer|1
1544441|NCT00114530|5053407|P2|Overall Study|Withdrawal by Subject|6
1544442|NCT00114530|5053408|P1|Overall Study|Withdrawal by Subject|2
1544443|NCT00114530|5053407|P2|Overall Study|Physician Decision|1
1544444|NCT00114530|5053408|P1|Overall Study|Physician Decision|1
1544445|NCT00114530|5053407|P2|Overall Study|Lost to Follow-up|1
1544446|NCT00114530|5053408|P1|Overall Study|Lost to Follow-up|1
1544447|NCT00114530|5053407|P2|Overall Study|Death|11
1544448|NCT00114530|5053408|P1|Overall Study|Death|3
1544449|NCT00114244|5053545|P2|Overall Study|Withdrawal by Subject|2
1544450|NCT00114244|5053546|P1|Overall Study|Withdrawal by Subject|0
1544451|NCT00114244|5053545|P2|Overall Study|Adverse Event|5
1544452|NCT00114244|5053546|P1|Overall Study|Adverse Event|2
1544453|NCT00114231|5053558|P2|Overall Study|Biopsy done after registration|0
1544454|NCT00114231|5053559|P1|Overall Study|Biopsy done after registration|1
1544455|NCT00114231|5053558|P2|Overall Study|No Absolute Neutrophil Count|0
1544456|NCT00114231|5053559|P1|Overall Study|No Absolute Neutrophil Count|2
1544457|NCT00114231|5053558|P2|Overall Study|Tumor fixed on digital exam|1
1544458|NCT00114231|5053559|P1|Overall Study|Tumor fixed on digital exam|0
1544459|NCT00114231|5053558|P2|Overall Study|Tumor size > 4cm|0
1544460|NCT00114231|5053559|P1|Overall Study|Tumor size > 4cm|1
1544461|NCT00114231|5053558|P2|Overall Study|Low creatinine clearance|1
1544462|NCT00114231|5053559|P1|Overall Study|Low creatinine clearance|0
1544463|NCT00114231|5053558|P2|Overall Study|No adenocarcinoma|0
1544464|NCT00114231|5053559|P1|Overall Study|No adenocarcinoma|1
1544465|NCT00114231|5053558|P2|Overall Study|Suspected metastatic disease|0
1544466|NCT00114231|5053559|P1|Overall Study|Suspected metastatic disease|1
1544467|NCT00114231|5053558|P2|Overall Study|QARC requirement not met|0
1544468|NCT00114231|5053559|P1|Overall Study|QARC requirement not met|1
1544469|NCT00114231|5053558|P2|Overall Study|No consent|0
1544470|NCT00114231|5053559|P1|Overall Study|No consent|2
1544471|NCT00114166|5053570|P2|Overall Study|Wrong primary|1
1544472|NCT00114166|5053571|P1|Overall Study|Wrong primary|0
1544473|NCT00114140|5053581|P1|Overall Study|Protocol Violation|7
1544474|NCT00114127|5053595|P2|Overall Study|Withdrawal by Subject|3
1544475|NCT00114127|5053596|P1|Overall Study|Withdrawal by Subject|1
1544476|NCT00114127|5053595|P2|Overall Study|Lost to Follow-up|0
1544477|NCT00114127|5053596|P1|Overall Study|Lost to Follow-up|1
1544478|NCT00114127|5053595|P2|Overall Study|Adverse Event|1
1544479|NCT00114127|5053596|P1|Overall Study|Adverse Event|2
1544480|NCT00113919|5053619|P1|Overall Study|Death|6
1544481|NCT00113919|5053619|P1|Overall Study|Physician Decision|8
1544482|NCT00113841|5053687|P2|Overall Study|Non-compliant|0
1544483|NCT00113841|5053688|P1|Overall Study|Non-compliant|1
1544484|NCT00113841|5053687|P2|Overall Study|Disease progression|2
1544485|NCT00113841|5053688|P1|Overall Study|Disease progression|0
1544486|NCT00113763|5053696|P2|Overall Study|Ongoing|0
1544487|NCT00113763|5053697|P1|Overall Study|Ongoing|1
1544488|NCT00113763|5053696|P2|Overall Study|Non-compliance|0
1544489|NCT00113763|5053697|P1|Overall Study|Non-compliance|1
1544490|NCT00113763|5053696|P2|Overall Study|Not specified|6
1544491|NCT00113763|5053697|P1|Overall Study|Not specified|27
1544492|NCT00113763|5053696|P2|Overall Study|Withdrawal by Subject|4
1544493|NCT00113763|5053697|P1|Overall Study|Withdrawal by Subject|1
1544494|NCT00113763|5053696|P2|Overall Study|Lost to Follow-up|0
1544495|NCT00113763|5053697|P1|Overall Study|Lost to Follow-up|10
1544496|NCT00113763|5053696|P2|Overall Study|Disease Progression|14
1544497|NCT00113763|5053697|P1|Overall Study|Disease Progression|28
1544498|NCT00113763|5053696|P2|Overall Study|Adverse Event|2
1544499|NCT00113763|5053697|P1|Overall Study|Adverse Event|5
1544500|NCT00113607|5053723|P2|Overall Study|Other|32
1544501|NCT00113607|5053724|P1|Overall Study|Other|43
1544502|NCT00113607|5053723|P2|Overall Study|Complete Response (Confirmed)|24
1544503|NCT00113607|5053724|P1|Overall Study|Complete Response (Confirmed)|14
1544504|NCT00113607|5053723|P2|Overall Study|Disease Progression|142
1544505|NCT00113607|5053724|P1|Overall Study|Disease Progression|180
1544506|NCT00113607|5053723|P2|Overall Study|Lost to Follow-up|2
1544507|NCT00113607|5053724|P1|Overall Study|Lost to Follow-up|0
1544508|NCT00113607|5053723|P2|Overall Study|Withdrawal by Subject|58
1544509|NCT00113607|5053724|P1|Overall Study|Withdrawal by Subject|50
1544510|NCT00113607|5053723|P2|Overall Study|Death|8
1544511|NCT00113607|5053724|P1|Overall Study|Death|8
1544512|NCT00113607|5053723|P2|Overall Study|Adverse Event|71
1544513|NCT00113607|5053724|P1|Overall Study|Adverse Event|40
1544514|NCT00113568|5053738|P1|Overall Study|Other|112
1544515|NCT00113568|5053738|P1|Overall Study|Withdrawal by Subject|117
1544516|NCT00113568|5053738|P1|Overall Study|Protocol Violation|32
1544517|NCT00113568|5053738|P1|Overall Study|Lost to Follow-up|156
1544518|NCT00113568|5053738|P1|Overall Study|Lack of Efficacy|30
1544519|NCT00113568|5053738|P1|Overall Study|Death|1
1544520|NCT00113568|5053738|P1|Overall Study|Adverse Event|97
1544521|NCT00113555|5053750|P1|Overall Study|Lost to Follow-up|8
1544522|NCT00113555|5053750|P1|Overall Study|Missed Followup|4
1544523|NCT00113555|5053750|P1|Overall Study|Death|1
1544524|NCT00113555|5053750|P1|Overall Study|Permanently Explanted|7
1544525|NCT00113555|5053750|P1|Overall Study|Baseline Failure|59
1544526|NCT00113529|5053760|P1|Overall Study|Withdrawal by Subject|4
1544527|NCT00113529|5053760|P1|Overall Study|Decision of sponsor|6
1544528|NCT00113529|5053760|P1|Overall Study|Lack of Efficacy|20
1544529|NCT00113529|5053760|P1|Overall Study|Adverse Event|4
1544530|NCT00113516|5053793|P2|Part 2|Ongoing|1
1544531|NCT00113516|5053794|P1|Part 2|Ongoing|0
1544532|NCT00113516|5053793|P2|Part 2|Laboratory Abnormality|1
1544533|NCT00113516|5053794|P1|Part 2|Laboratory Abnormality|0
1544534|NCT00113516|5053793|P2|Part 2|Other|3
1544535|NCT00113516|5053794|P1|Part 2|Other|0
1544536|NCT00113516|5053793|P2|Part 2|Withdrawal by Subject|3
1544537|NCT00113516|5053794|P1|Part 2|Withdrawal by Subject|0
1544538|NCT00113516|5053793|P2|Part 2|Lack of Efficacy|37
1544539|NCT00113516|5053794|P1|Part 2|Lack of Efficacy|0
1544540|NCT00113516|5053793|P2|Part 2|Death|5
1544541|NCT00113516|5053794|P1|Part 2|Death|0
1544542|NCT00113516|5053793|P2|Part 2|Adverse Event|16
1544543|NCT00113516|5053794|P1|Part 2|Adverse Event|0
1544544|NCT00113516|5053793|P2|Part 1|Missing|0
1544545|NCT00113516|5053794|P1|Part 1|Missing|65
1544546|NCT00113516|5053793|P2|Part 1|Ongoing|0
1544547|NCT00113516|5053794|P1|Part 1|Ongoing|1
1544548|NCT00113516|5053793|P2|Part 1|Laboratory Abnormality|0
1544549|NCT00113516|5053794|P1|Part 1|Laboratory Abnormality|1
1544550|NCT00113516|5053793|P2|Part 1|Did Not Meet Entrance Criteria|0
1544551|NCT00113516|5053794|P1|Part 1|Did Not Meet Entrance Criteria|1
1544552|NCT00113516|5053793|P2|Part 1|Lack of Efficacy|0
1544553|NCT00113516|5053794|P1|Part 1|Lack of Efficacy|2
1544554|NCT00113516|5053793|P2|Part 1|Withdrawal by Subject|0
1544555|NCT00113516|5053794|P1|Part 1|Withdrawal by Subject|2
1544556|NCT00113516|5053793|P2|Part 1|Other|0
1544557|NCT00113516|5053794|P1|Part 1|Other|3
1544558|NCT00113516|5053793|P2|Part 1|Death|0
1544559|NCT00113516|5053794|P1|Part 1|Death|3
1544560|NCT00113516|5053793|P2|Part 1|Adverse Event|0
1544561|NCT00113516|5053794|P1|Part 1|Adverse Event|6
1544562|NCT00113490|5053837|P2|Overall Study|Lost to Follow-up|0
1544563|NCT00113490|5053838|P1|Overall Study|Lost to Follow-up|1
1544564|NCT00113490|5053837|P2|Overall Study|Withdrawal by Subject|3
1544565|NCT00113490|5053838|P1|Overall Study|Withdrawal by Subject|1
1544566|NCT00113399|5053871|P2|Overall Study|Other|1
1544567|NCT00113399|5053872|P1|Overall Study|Other|0
1544568|NCT00113399|5053871|P2|Overall Study|Complete Response|1
1544569|NCT00113399|5053872|P1|Overall Study|Complete Response|0
1544570|NCT00113399|5053871|P2|Overall Study|Withdrawal by Subject|2
1544571|NCT00113399|5053872|P1|Overall Study|Withdrawal by Subject|1
1544572|NCT00113399|5053871|P2|Overall Study|Death|1
1544573|NCT00113399|5053872|P1|Overall Study|Death|1
1544574|NCT00113386|5053880|P2|Overall Study|Unknown - Lost to Follow-Up|1
1544575|NCT00113386|5053881|P1|Overall Study|Unknown - Lost to Follow-Up|2
1544576|NCT00113386|5053880|P2|Overall Study|Ineligible|2
1544577|NCT00113386|5053881|P1|Overall Study|Ineligible|1
1544578|NCT00113386|5053880|P2|Overall Study|Toxicity|0
1544579|NCT00113386|5053881|P1|Overall Study|Toxicity|3
1544580|NCT00113386|5053880|P2|Overall Study|Physician Decision|1
1544581|NCT00113386|5053881|P1|Overall Study|Physician Decision|0
1544582|NCT00113386|5053880|P2|Overall Study|Withdrawal by Subject|0
1544583|NCT00113386|5053881|P1|Overall Study|Withdrawal by Subject|1
1544584|NCT00113373|5053887|P1|Overall Study|Never Treated|1
1544585|NCT00113373|5053887|P1|Overall Study|Ineligible: second primary|1
1544586|NCT00113373|5053887|P1|Overall Study|Ineligible: wrong primary|1
1544587|NCT00113360|5053902|P1|Overall Study|Did not meet eligibility criteria|3
1544588|NCT00113360|5053902|P1|Overall Study|Subject required surgery|1
1544589|NCT00113360|5053902|P1|Overall Study|Adverse Event|3
1544590|NCT00113295|5053916|P2|Overall Study|Unrelated Medical Illness|0
1544591|NCT00113295|5053917|P1|Overall Study|Unrelated Medical Illness|1
1544592|NCT00113295|5053916|P2|Overall Study|Adverse Event|1
1544593|NCT00113295|5053917|P1|Overall Study|Adverse Event|4
1544594|NCT00113269|5053936|P4|Overall Study|Unable to return for follow up|0
1544595|NCT00113269|5053937|P3|Overall Study|Unable to return for follow up|0
1544596|NCT00113269|5053938|P2|Overall Study|Unable to return for follow up|1
1544597|NCT00113269|5053939|P1|Overall Study|Unable to return for follow up|2
1544598|NCT00113269|5053936|P4|Overall Study|Did not meet eligibility criteria|1
1544599|NCT00113269|5053937|P3|Overall Study|Did not meet eligibility criteria|0
1544600|NCT00113269|5053938|P2|Overall Study|Did not meet eligibility criteria|0
1544601|NCT00113269|5053939|P1|Overall Study|Did not meet eligibility criteria|1
1544602|NCT00113269|5053936|P4|Overall Study|Withdrew consent, Prednisone initiated|1
1544603|NCT00113269|5053937|P3|Overall Study|Withdrew consent, Prednisone initiated|0
1544604|NCT00113269|5053938|P2|Overall Study|Withdrew consent, Prednisone initiated|0
1544605|NCT00113269|5053939|P1|Overall Study|Withdrew consent, Prednisone initiated|0
1544606|NCT00113269|5053936|P4|Overall Study|Received pancreas transplant|2
1544607|NCT00113269|5053937|P3|Overall Study|Received pancreas transplant|0
1544608|NCT00113269|5053938|P2|Overall Study|Received pancreas transplant|0
1544609|NCT00113269|5053939|P1|Overall Study|Received pancreas transplant|0
1544610|NCT00113269|5053936|P4|Overall Study|Moved|3
1544611|NCT00113269|5053937|P3|Overall Study|Moved|0
1544612|NCT00113269|5053938|P2|Overall Study|Moved|1
1544613|NCT00113269|5053939|P1|Overall Study|Moved|0
1544614|NCT00113269|5053936|P4|Overall Study|Discontinued due to rejection|0
1544615|NCT00113269|5053937|P3|Overall Study|Discontinued due to rejection|1
1544616|NCT00113269|5053938|P2|Overall Study|Discontinued due to rejection|0
1544617|NCT00113269|5053939|P1|Overall Study|Discontinued due to rejection|0
1544618|NCT00113269|5053936|P4|Overall Study|Sponsor elected to discontinue patient|1
1544619|NCT00113269|5053937|P3|Overall Study|Sponsor elected to discontinue patient|0
1544620|NCT00113269|5053938|P2|Overall Study|Sponsor elected to discontinue patient|0
1544621|NCT00113269|5053939|P1|Overall Study|Sponsor elected to discontinue patient|1
1544622|NCT00113269|5053936|P4|Overall Study|Lost to Follow-up|3
1544623|NCT00113269|5053937|P3|Overall Study|Lost to Follow-up|6
1544624|NCT00113269|5053938|P2|Overall Study|Lost to Follow-up|3
1544625|NCT00113269|5053939|P1|Overall Study|Lost to Follow-up|2
1544626|NCT00113269|5053936|P4|Overall Study|Protocol Violation|2
1544627|NCT00113269|5053937|P3|Overall Study|Protocol Violation|4
1544628|NCT00113269|5053938|P2|Overall Study|Protocol Violation|0
1544629|NCT00113269|5053939|P1|Overall Study|Protocol Violation|1
1544630|NCT00113269|5053936|P4|Overall Study|Graft loss|9
1544631|NCT00113269|5053937|P3|Overall Study|Graft loss|4
1544632|NCT00113269|5053938|P2|Overall Study|Graft loss|6
1544633|NCT00113269|5053939|P1|Overall Study|Graft loss|6
1544634|NCT00113269|5053936|P4|Overall Study|Withdrawal by Subject|2
1544635|NCT00113269|5053937|P3|Overall Study|Withdrawal by Subject|4
1544636|NCT00113269|5053938|P2|Overall Study|Withdrawal by Subject|3
1544637|NCT00113269|5053939|P1|Overall Study|Withdrawal by Subject|4
1544638|NCT00113269|5053936|P4|Overall Study|Adverse Event|7
1544639|NCT00113269|5053937|P3|Overall Study|Adverse Event|11
1544640|NCT00113269|5053938|P2|Overall Study|Adverse Event|7
1544641|NCT00113269|5053939|P1|Overall Study|Adverse Event|2
1544642|NCT00113269|5053936|P4|Overall Study|Did not meet eligibility – pre-treatment|2
1544643|NCT00113269|5053937|P3|Overall Study|Did not meet eligibility – pre-treatment|0
1544644|NCT00113269|5053938|P2|Overall Study|Did not meet eligibility – pre-treatment|0
1544645|NCT00113269|5053939|P1|Overall Study|Did not meet eligibility – pre-treatment|0
1544646|NCT00113269|5053936|P4|Overall Study|Death in operating room|1
1544647|NCT00113269|5053937|P3|Overall Study|Death in operating room|0
1544648|NCT00113269|5053938|P2|Overall Study|Death in operating room|0
1544649|NCT00113269|5053939|P1|Overall Study|Death in operating room|0
1544650|NCT00113269|5053936|P4|Overall Study|Early graft loss, technical|0
1544651|NCT00113269|5053937|P3|Overall Study|Early graft loss, technical|2
1544652|NCT00113269|5053938|P2|Overall Study|Early graft loss, technical|0
1544653|NCT00113269|5053939|P1|Overall Study|Early graft loss, technical|0
1544654|NCT00113269|5053936|P4|Overall Study|Not transplanted, recipient issues|4
1544655|NCT00113269|5053937|P3|Overall Study|Not transplanted, recipient issues|7
1544656|NCT00113269|5053938|P2|Overall Study|Not transplanted, recipient issues|1
1544657|NCT00113269|5053939|P1|Overall Study|Not transplanted, recipient issues|2
1544658|NCT00113269|5053936|P4|Overall Study|Not transplanted, donor issues|2
1544659|NCT00113269|5053937|P3|Overall Study|Not transplanted, donor issues|2
1544660|NCT00113269|5053938|P2|Overall Study|Not transplanted, donor issues|0
1544661|NCT00113269|5053939|P1|Overall Study|Not transplanted, donor issues|4
1544662|NCT00113087|5053999|P2|Overall Study|Family or MD withdrew subject|5
1544663|NCT00113087|5054000|P1|Overall Study|Family or MD withdrew subject|10
1544664|NCT00113087|5053999|P2|Overall Study|Death or Transplant|16
1544665|NCT00113087|5054000|P1|Overall Study|Death or Transplant|14
1544666|NCT00112957|5054071|P1|Overall Study|Physician Decision|1
1544667|NCT00112957|5054071|P1|Overall Study|Progressive disease|18
1544668|NCT00112905|5054111|P1|Overall Study|performance status was deteiorating|1
1544669|NCT00112905|5054111|P1|Overall Study|Alternative treatment|1
1544670|NCT00112905|5054111|P1|Overall Study|Ineligibility|5
1544671|NCT00112905|5054111|P1|Overall Study|Death|1
1544672|NCT00112905|5054111|P1|Overall Study|Adverse Event|4
1544673|NCT00112866|5054120|P2|Overall Study|did not start treatment post-op|2
1544674|NCT00112866|5054121|P1|Overall Study|did not start treatment post-op|1
1544675|NCT00112866|5054120|P2|Overall Study|Protocol Violation|0
1544676|NCT00112866|5054121|P1|Overall Study|Protocol Violation|1
1544677|NCT00112840|5054143|P3|Overall Study|Protocol Violation|5
1544678|NCT00112840|5054144|P2|Overall Study|Protocol Violation|0
1544679|NCT00112840|5054145|P1|Overall Study|Protocol Violation|0
1544680|NCT00112840|5054143|P3|Overall Study|Withdrawal by Subject|1
1544681|NCT00112840|5054144|P2|Overall Study|Withdrawal by Subject|0
1544682|NCT00112840|5054145|P1|Overall Study|Withdrawal by Subject|1
1544683|NCT00112840|5054143|P3|Overall Study|Physician Decision|0
1544684|NCT00112840|5054144|P2|Overall Study|Physician Decision|0
1544685|NCT00112840|5054145|P1|Overall Study|Physician Decision|1
1544686|NCT00112736|5054164|P2|Overall Study|1 pt never had had RX due rapid decline|0
1544687|NCT00112736|5054165|P1|Overall Study|1 pt never had had RX due rapid decline|1
1544688|NCT00112489|5054222|P1|Overall Study|Ineligible|7
1544689|NCT00112489|5054222|P1|Overall Study|Patient never treated|2
1544690|NCT00112489|5054222|P1|Overall Study|Other, Not Specified|9
1544691|NCT00112489|5054222|P1|Overall Study|Death|2
1544692|NCT00112489|5054222|P1|Overall Study|Adverse Event|12
1544693|NCT00112489|5054222|P1|Overall Study|Refused further treatment|8
1544694|NCT00112463|5054226|P1|Overall Study|Never started treatment|2
1544695|NCT00112463|5054226|P1|Overall Study|Withdrawal by Subject|2
1544696|NCT00112463|5054226|P1|Overall Study|Toxicity|3
1544697|NCT00112463|5054226|P1|Overall Study|Second Primary|1
1544698|NCT00112463|5054226|P1|Overall Study|Progression|30
1544699|NCT00112463|5054226|P1|Overall Study|Physician Decision|1
1544700|NCT00112437|5054238|P26|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
1544701|NCT00112437|5054239|P25|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544702|NCT00112437|5054240|P24|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
1544703|NCT00112437|5054241|P23|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
1544704|NCT00112437|5054242|P22|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544705|NCT00112437|5054243|P21|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544706|NCT00112437|5054244|P20|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544707|NCT00112437|5054245|P19|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544708|NCT00112437|5054246|P18|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544709|NCT00112437|5054247|P17|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544710|NCT00112437|5054248|P16|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544711|NCT00112437|5054249|P15|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544712|NCT00112437|5054250|P14|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544713|NCT00112437|5054251|P13|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544714|NCT00112437|5054252|P12|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544715|NCT00112437|5054253|P11|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544716|NCT00112437|5054254|P10|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544717|NCT00112437|5054255|P9|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544718|NCT00112437|5054256|P8|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544719|NCT00112437|5054257|P7|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544720|NCT00112437|5054258|P6|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544721|NCT00112437|5054259|P5|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544722|NCT00112437|5054260|P4|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544723|NCT00112437|5054261|P3|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544724|NCT00112437|5054262|P2|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544725|NCT00112437|5054263|P1|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1544726|NCT00112437|5054238|P26|Years 6-10 (60-Month Extension)|Physician Decision|0
1544727|NCT00112437|5054239|P25|Years 6-10 (60-Month Extension)|Physician Decision|0
1544728|NCT00112437|5054240|P24|Years 6-10 (60-Month Extension)|Physician Decision|2
1544729|NCT00112437|5054241|P23|Years 6-10 (60-Month Extension)|Physician Decision|0
1544730|NCT00112437|5054242|P22|Years 6-10 (60-Month Extension)|Physician Decision|0
1544731|NCT00112437|5054243|P21|Years 6-10 (60-Month Extension)|Physician Decision|0
1544732|NCT00112437|5054244|P20|Years 6-10 (60-Month Extension)|Physician Decision|0
1544733|NCT00112437|5054245|P19|Years 6-10 (60-Month Extension)|Physician Decision|0
1544734|NCT00112437|5054246|P18|Years 6-10 (60-Month Extension)|Physician Decision|0
1544735|NCT00112437|5054247|P17|Years 6-10 (60-Month Extension)|Physician Decision|0
1544736|NCT00112437|5054248|P16|Years 6-10 (60-Month Extension)|Physician Decision|0
1544737|NCT00112437|5054249|P15|Years 6-10 (60-Month Extension)|Physician Decision|0
1544738|NCT00112437|5054250|P14|Years 6-10 (60-Month Extension)|Physician Decision|0
1544739|NCT00112437|5054251|P13|Years 6-10 (60-Month Extension)|Physician Decision|0
1544740|NCT00112437|5054252|P12|Years 6-10 (60-Month Extension)|Physician Decision|0
1544741|NCT00112437|5054253|P11|Years 6-10 (60-Month Extension)|Physician Decision|0
1544742|NCT00112437|5054254|P10|Years 6-10 (60-Month Extension)|Physician Decision|0
1544743|NCT00112437|5054255|P9|Years 6-10 (60-Month Extension)|Physician Decision|0
1544744|NCT00112437|5054256|P8|Years 6-10 (60-Month Extension)|Physician Decision|0
1544745|NCT00112437|5054257|P7|Years 6-10 (60-Month Extension)|Physician Decision|0
1544746|NCT00112437|5054258|P6|Years 6-10 (60-Month Extension)|Physician Decision|0
1544747|NCT00112437|5054259|P5|Years 6-10 (60-Month Extension)|Physician Decision|0
1544748|NCT00112437|5054260|P4|Years 6-10 (60-Month Extension)|Physician Decision|0
1544749|NCT00112437|5054261|P3|Years 6-10 (60-Month Extension)|Physician Decision|0
1544750|NCT00112437|5054262|P2|Years 6-10 (60-Month Extension)|Physician Decision|0
1544751|NCT00112437|5054263|P1|Years 6-10 (60-Month Extension)|Physician Decision|0
1544752|NCT00112437|5054238|P26|Years 6-10 (60-Month Extension)|Other|0
1544753|NCT00112437|5054239|P25|Years 6-10 (60-Month Extension)|Other|1
1544754|NCT00112437|5054240|P24|Years 6-10 (60-Month Extension)|Other|0
1544755|NCT00112437|5054241|P23|Years 6-10 (60-Month Extension)|Other|0
1544756|NCT00112437|5054242|P22|Years 6-10 (60-Month Extension)|Other|0
1544757|NCT00112437|5054243|P21|Years 6-10 (60-Month Extension)|Other|0
1544758|NCT00112437|5054244|P20|Years 6-10 (60-Month Extension)|Other|0
1544759|NCT00112437|5054245|P19|Years 6-10 (60-Month Extension)|Other|0
1544760|NCT00112437|5054246|P18|Years 6-10 (60-Month Extension)|Other|0
1544761|NCT00112437|5054247|P17|Years 6-10 (60-Month Extension)|Other|0
1544762|NCT00112437|5054248|P16|Years 6-10 (60-Month Extension)|Other|0
1544763|NCT00112437|5054249|P15|Years 6-10 (60-Month Extension)|Other|0
1544764|NCT00112437|5054250|P14|Years 6-10 (60-Month Extension)|Other|0
1544765|NCT00112437|5054251|P13|Years 6-10 (60-Month Extension)|Other|0
1544766|NCT00112437|5054252|P12|Years 6-10 (60-Month Extension)|Other|0
1544767|NCT00112437|5054253|P11|Years 6-10 (60-Month Extension)|Other|0
1544768|NCT00112437|5054254|P10|Years 6-10 (60-Month Extension)|Other|0
1544769|NCT00112437|5054255|P9|Years 6-10 (60-Month Extension)|Other|0
1544770|NCT00112437|5054256|P8|Years 6-10 (60-Month Extension)|Other|0
1544771|NCT00112437|5054257|P7|Years 6-10 (60-Month Extension)|Other|0
1544772|NCT00112437|5054258|P6|Years 6-10 (60-Month Extension)|Other|0
1544773|NCT00112437|5054259|P5|Years 6-10 (60-Month Extension)|Other|0
1544774|NCT00112437|5054260|P4|Years 6-10 (60-Month Extension)|Other|0
1544775|NCT00112437|5054261|P3|Years 6-10 (60-Month Extension)|Other|0
1544776|NCT00112437|5054262|P2|Years 6-10 (60-Month Extension)|Other|0
1544777|NCT00112437|5054263|P1|Years 6-10 (60-Month Extension)|Other|0
1544778|NCT00112437|5054238|P26|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
1544930|NCT00112437|5054260|P4|Years 4-5 (24-Month Extension)|Adverse Event|0
1544779|NCT00112437|5054239|P25|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544780|NCT00112437|5054240|P24|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544781|NCT00112437|5054241|P23|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544782|NCT00112437|5054242|P22|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544783|NCT00112437|5054243|P21|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544784|NCT00112437|5054244|P20|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544785|NCT00112437|5054245|P19|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544786|NCT00112437|5054246|P18|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544787|NCT00112437|5054247|P17|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544788|NCT00112437|5054248|P16|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544789|NCT00112437|5054249|P15|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544790|NCT00112437|5054250|P14|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544791|NCT00112437|5054251|P13|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544792|NCT00112437|5054252|P12|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544793|NCT00112437|5054253|P11|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544794|NCT00112437|5054254|P10|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544795|NCT00112437|5054255|P9|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544796|NCT00112437|5054256|P8|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544797|NCT00112437|5054257|P7|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544798|NCT00112437|5054258|P6|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544799|NCT00112437|5054259|P5|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544800|NCT00112437|5054260|P4|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544801|NCT00112437|5054261|P3|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544802|NCT00112437|5054262|P2|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544803|NCT00112437|5054263|P1|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1544804|NCT00112437|5054238|P26|Years 6-10 (60-Month Extension)|Death|0
1544805|NCT00112437|5054239|P25|Years 6-10 (60-Month Extension)|Death|0
1544806|NCT00112437|5054240|P24|Years 6-10 (60-Month Extension)|Death|2
1544807|NCT00112437|5054241|P23|Years 6-10 (60-Month Extension)|Death|0
1544808|NCT00112437|5054242|P22|Years 6-10 (60-Month Extension)|Death|0
1544809|NCT00112437|5054243|P21|Years 6-10 (60-Month Extension)|Death|0
1544810|NCT00112437|5054244|P20|Years 6-10 (60-Month Extension)|Death|0
1544811|NCT00112437|5054245|P19|Years 6-10 (60-Month Extension)|Death|0
1544812|NCT00112437|5054246|P18|Years 6-10 (60-Month Extension)|Death|0
1544813|NCT00112437|5054247|P17|Years 6-10 (60-Month Extension)|Death|0
1544814|NCT00112437|5054248|P16|Years 6-10 (60-Month Extension)|Death|0
1544815|NCT00112437|5054249|P15|Years 6-10 (60-Month Extension)|Death|0
1544816|NCT00112437|5054250|P14|Years 6-10 (60-Month Extension)|Death|0
1544817|NCT00112437|5054251|P13|Years 6-10 (60-Month Extension)|Death|0
1544818|NCT00112437|5054252|P12|Years 6-10 (60-Month Extension)|Death|0
1544819|NCT00112437|5054253|P11|Years 6-10 (60-Month Extension)|Death|0
1544820|NCT00112437|5054254|P10|Years 6-10 (60-Month Extension)|Death|0
1544821|NCT00112437|5054255|P9|Years 6-10 (60-Month Extension)|Death|0
1544822|NCT00112437|5054256|P8|Years 6-10 (60-Month Extension)|Death|0
1544823|NCT00112437|5054257|P7|Years 6-10 (60-Month Extension)|Death|0
1544824|NCT00112437|5054258|P6|Years 6-10 (60-Month Extension)|Death|0
1544825|NCT00112437|5054259|P5|Years 6-10 (60-Month Extension)|Death|0
1544826|NCT00112437|5054260|P4|Years 6-10 (60-Month Extension)|Death|0
1544827|NCT00112437|5054261|P3|Years 6-10 (60-Month Extension)|Death|0
1544828|NCT00112437|5054262|P2|Years 6-10 (60-Month Extension)|Death|0
1544829|NCT00112437|5054263|P1|Years 6-10 (60-Month Extension)|Death|0
1544830|NCT00112437|5054238|P26|Years 6-10 (60-Month Extension)|Adverse Event|1
1544831|NCT00112437|5054239|P25|Years 6-10 (60-Month Extension)|Adverse Event|0
1544832|NCT00112437|5054240|P24|Years 6-10 (60-Month Extension)|Adverse Event|2
1544833|NCT00112437|5054241|P23|Years 6-10 (60-Month Extension)|Adverse Event|1
1544834|NCT00112437|5054242|P22|Years 6-10 (60-Month Extension)|Adverse Event|0
1544835|NCT00112437|5054243|P21|Years 6-10 (60-Month Extension)|Adverse Event|0
1544836|NCT00112437|5054244|P20|Years 6-10 (60-Month Extension)|Adverse Event|0
1544837|NCT00112437|5054245|P19|Years 6-10 (60-Month Extension)|Adverse Event|0
1544838|NCT00112437|5054246|P18|Years 6-10 (60-Month Extension)|Adverse Event|0
1544839|NCT00112437|5054247|P17|Years 6-10 (60-Month Extension)|Adverse Event|0
1544840|NCT00112437|5054248|P16|Years 6-10 (60-Month Extension)|Adverse Event|0
1544841|NCT00112437|5054249|P15|Years 6-10 (60-Month Extension)|Adverse Event|0
1544842|NCT00112437|5054250|P14|Years 6-10 (60-Month Extension)|Adverse Event|0
1544843|NCT00112437|5054251|P13|Years 6-10 (60-Month Extension)|Adverse Event|0
1544844|NCT00112437|5054252|P12|Years 6-10 (60-Month Extension)|Adverse Event|0
1544845|NCT00112437|5054253|P11|Years 6-10 (60-Month Extension)|Adverse Event|0
1544846|NCT00112437|5054254|P10|Years 6-10 (60-Month Extension)|Adverse Event|0
1544847|NCT00112437|5054255|P9|Years 6-10 (60-Month Extension)|Adverse Event|0
1544848|NCT00112437|5054256|P8|Years 6-10 (60-Month Extension)|Adverse Event|0
1544849|NCT00112437|5054257|P7|Years 6-10 (60-Month Extension)|Adverse Event|0
1544850|NCT00112437|5054258|P6|Years 6-10 (60-Month Extension)|Adverse Event|0
1544851|NCT00112437|5054259|P5|Years 6-10 (60-Month Extension)|Adverse Event|0
1544852|NCT00112437|5054260|P4|Years 6-10 (60-Month Extension)|Adverse Event|0
1544853|NCT00112437|5054261|P3|Years 6-10 (60-Month Extension)|Adverse Event|0
1544854|NCT00112437|5054262|P2|Years 6-10 (60-Month Extension)|Adverse Event|0
1544855|NCT00112437|5054263|P1|Years 6-10 (60-Month Extension)|Adverse Event|0
1544856|NCT00112437|5054238|P26|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544857|NCT00112437|5054239|P25|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544858|NCT00112437|5054240|P24|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544859|NCT00112437|5054241|P23|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544860|NCT00112437|5054242|P22|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
1544861|NCT00112437|5054243|P21|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
1544862|NCT00112437|5054244|P20|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544863|NCT00112437|5054245|P19|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544864|NCT00112437|5054246|P18|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544865|NCT00112437|5054247|P17|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544866|NCT00112437|5054248|P16|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544867|NCT00112437|5054249|P15|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544868|NCT00112437|5054250|P14|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544869|NCT00112437|5054251|P13|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544870|NCT00112437|5054252|P12|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544871|NCT00112437|5054253|P11|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544872|NCT00112437|5054254|P10|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544873|NCT00112437|5054255|P9|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544874|NCT00112437|5054256|P8|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544875|NCT00112437|5054257|P7|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544876|NCT00112437|5054258|P6|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544877|NCT00112437|5054259|P5|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544878|NCT00112437|5054260|P4|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544879|NCT00112437|5054261|P3|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544880|NCT00112437|5054262|P2|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544881|NCT00112437|5054263|P1|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1544882|NCT00112437|5054238|P26|Years 4-5 (24-Month Extension)|Participant moved|0
1544883|NCT00112437|5054239|P25|Years 4-5 (24-Month Extension)|Participant moved|0
1544884|NCT00112437|5054240|P24|Years 4-5 (24-Month Extension)|Participant moved|0
1544885|NCT00112437|5054241|P23|Years 4-5 (24-Month Extension)|Participant moved|0
1544886|NCT00112437|5054242|P22|Years 4-5 (24-Month Extension)|Participant moved|1
1544887|NCT00112437|5054243|P21|Years 4-5 (24-Month Extension)|Participant moved|0
1544888|NCT00112437|5054244|P20|Years 4-5 (24-Month Extension)|Participant moved|0
1544889|NCT00112437|5054245|P19|Years 4-5 (24-Month Extension)|Participant moved|0
1544890|NCT00112437|5054246|P18|Years 4-5 (24-Month Extension)|Participant moved|0
1544891|NCT00112437|5054247|P17|Years 4-5 (24-Month Extension)|Participant moved|0
1544892|NCT00112437|5054248|P16|Years 4-5 (24-Month Extension)|Participant moved|0
1544893|NCT00112437|5054249|P15|Years 4-5 (24-Month Extension)|Participant moved|0
1544894|NCT00112437|5054250|P14|Years 4-5 (24-Month Extension)|Participant moved|0
1544895|NCT00112437|5054251|P13|Years 4-5 (24-Month Extension)|Participant moved|0
1544896|NCT00112437|5054252|P12|Years 4-5 (24-Month Extension)|Participant moved|0
1544897|NCT00112437|5054253|P11|Years 4-5 (24-Month Extension)|Participant moved|0
1544898|NCT00112437|5054254|P10|Years 4-5 (24-Month Extension)|Participant moved|0
1544899|NCT00112437|5054255|P9|Years 4-5 (24-Month Extension)|Participant moved|0
1544900|NCT00112437|5054256|P8|Years 4-5 (24-Month Extension)|Participant moved|0
1544901|NCT00112437|5054257|P7|Years 4-5 (24-Month Extension)|Participant moved|0
1544902|NCT00112437|5054258|P6|Years 4-5 (24-Month Extension)|Participant moved|0
1544903|NCT00112437|5054259|P5|Years 4-5 (24-Month Extension)|Participant moved|0
1544904|NCT00112437|5054260|P4|Years 4-5 (24-Month Extension)|Participant moved|0
1544905|NCT00112437|5054261|P3|Years 4-5 (24-Month Extension)|Participant moved|0
1544906|NCT00112437|5054262|P2|Years 4-5 (24-Month Extension)|Participant moved|0
1544907|NCT00112437|5054263|P1|Years 4-5 (24-Month Extension)|Participant moved|0
1544908|NCT00112437|5054238|P26|Years 4-5 (24-Month Extension)|Adverse Event|0
1544909|NCT00112437|5054239|P25|Years 4-5 (24-Month Extension)|Adverse Event|0
1544910|NCT00112437|5054240|P24|Years 4-5 (24-Month Extension)|Adverse Event|0
1544911|NCT00112437|5054241|P23|Years 4-5 (24-Month Extension)|Adverse Event|0
1544912|NCT00112437|5054242|P22|Years 4-5 (24-Month Extension)|Adverse Event|4
1544913|NCT00112437|5054243|P21|Years 4-5 (24-Month Extension)|Adverse Event|0
1544914|NCT00112437|5054244|P20|Years 4-5 (24-Month Extension)|Adverse Event|0
1544915|NCT00112437|5054245|P19|Years 4-5 (24-Month Extension)|Adverse Event|0
1544916|NCT00112437|5054246|P18|Years 4-5 (24-Month Extension)|Adverse Event|0
1544917|NCT00112437|5054247|P17|Years 4-5 (24-Month Extension)|Adverse Event|0
1544918|NCT00112437|5054248|P16|Years 4-5 (24-Month Extension)|Adverse Event|0
1544919|NCT00112437|5054249|P15|Years 4-5 (24-Month Extension)|Adverse Event|0
1544920|NCT00112437|5054250|P14|Years 4-5 (24-Month Extension)|Adverse Event|0
1544921|NCT00112437|5054251|P13|Years 4-5 (24-Month Extension)|Adverse Event|0
1544922|NCT00112437|5054252|P12|Years 4-5 (24-Month Extension)|Adverse Event|0
1544923|NCT00112437|5054253|P11|Years 4-5 (24-Month Extension)|Adverse Event|0
1544924|NCT00112437|5054254|P10|Years 4-5 (24-Month Extension)|Adverse Event|0
1544925|NCT00112437|5054255|P9|Years 4-5 (24-Month Extension)|Adverse Event|0
1544926|NCT00112437|5054256|P8|Years 4-5 (24-Month Extension)|Adverse Event|0
1544927|NCT00112437|5054257|P7|Years 4-5 (24-Month Extension)|Adverse Event|0
1544928|NCT00112437|5054258|P6|Years 4-5 (24-Month Extension)|Adverse Event|0
1544929|NCT00112437|5054259|P5|Years 4-5 (24-Month Extension)|Adverse Event|0
1544931|NCT00112437|5054261|P3|Years 4-5 (24-Month Extension)|Adverse Event|0
1544932|NCT00112437|5054262|P2|Years 4-5 (24-Month Extension)|Adverse Event|0
1544933|NCT00112437|5054263|P1|Years 4-5 (24-Month Extension)|Adverse Event|0
1544934|NCT00112437|5054238|P26|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544935|NCT00112437|5054239|P25|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544936|NCT00112437|5054240|P24|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544937|NCT00112437|5054241|P23|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544938|NCT00112437|5054242|P22|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544939|NCT00112437|5054243|P21|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
1544940|NCT00112437|5054244|P20|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544941|NCT00112437|5054245|P19|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544942|NCT00112437|5054246|P18|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544943|NCT00112437|5054247|P17|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544944|NCT00112437|5054248|P16|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544945|NCT00112437|5054249|P15|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544946|NCT00112437|5054250|P14|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544947|NCT00112437|5054251|P13|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544948|NCT00112437|5054252|P12|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544949|NCT00112437|5054253|P11|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544950|NCT00112437|5054254|P10|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544951|NCT00112437|5054255|P9|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544952|NCT00112437|5054256|P8|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544953|NCT00112437|5054257|P7|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544954|NCT00112437|5054258|P6|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544955|NCT00112437|5054259|P5|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544956|NCT00112437|5054260|P4|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544957|NCT00112437|5054261|P3|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544958|NCT00112437|5054262|P2|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544959|NCT00112437|5054263|P1|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1544960|NCT00112437|5054238|P26|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544961|NCT00112437|5054239|P25|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544962|NCT00112437|5054240|P24|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544963|NCT00112437|5054241|P23|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544964|NCT00112437|5054242|P22|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
1544965|NCT00112437|5054243|P21|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
1544966|NCT00112437|5054244|P20|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544967|NCT00112437|5054245|P19|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544968|NCT00112437|5054246|P18|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544969|NCT00112437|5054247|P17|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544970|NCT00112437|5054248|P16|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544971|NCT00112437|5054249|P15|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544972|NCT00112437|5054250|P14|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544973|NCT00112437|5054251|P13|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544974|NCT00112437|5054252|P12|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544975|NCT00112437|5054253|P11|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544976|NCT00112437|5054254|P10|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544977|NCT00112437|5054255|P9|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544978|NCT00112437|5054256|P8|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544979|NCT00112437|5054257|P7|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544980|NCT00112437|5054258|P6|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544981|NCT00112437|5054259|P5|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544982|NCT00112437|5054260|P4|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544983|NCT00112437|5054261|P3|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544984|NCT00112437|5054262|P2|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544985|NCT00112437|5054263|P1|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1544986|NCT00112437|5054238|P26|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1544987|NCT00112437|5054239|P25|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1544988|NCT00112437|5054240|P24|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1544989|NCT00112437|5054241|P23|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1544990|NCT00112437|5054242|P22|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1544991|NCT00112437|5054243|P21|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1544992|NCT00112437|5054244|P20|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1544993|NCT00112437|5054245|P19|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1544994|NCT00112437|5054246|P18|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1544995|NCT00112437|5054247|P17|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1544996|NCT00112437|5054248|P16|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1544997|NCT00112437|5054249|P15|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1544998|NCT00112437|5054250|P14|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1544999|NCT00112437|5054251|P13|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1545152|NCT00112437|5054248|P16|Year 2 (12-Month Extension)|Moved|0
1545000|NCT00112437|5054252|P12|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
1545001|NCT00112437|5054253|P11|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
1545002|NCT00112437|5054254|P10|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1545003|NCT00112437|5054255|P9|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1545004|NCT00112437|5054256|P8|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1545005|NCT00112437|5054257|P7|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1545006|NCT00112437|5054258|P6|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1545007|NCT00112437|5054259|P5|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1545008|NCT00112437|5054260|P4|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1545009|NCT00112437|5054261|P3|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1545010|NCT00112437|5054262|P2|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1545011|NCT00112437|5054263|P1|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1545012|NCT00112437|5054238|P26|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545013|NCT00112437|5054239|P25|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545014|NCT00112437|5054240|P24|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545015|NCT00112437|5054241|P23|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545016|NCT00112437|5054242|P22|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545017|NCT00112437|5054243|P21|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545018|NCT00112437|5054244|P20|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545019|NCT00112437|5054245|P19|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545020|NCT00112437|5054246|P18|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545021|NCT00112437|5054247|P17|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545022|NCT00112437|5054248|P16|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545023|NCT00112437|5054249|P15|Year 3 (12-Month Extension)|Withdrawal by Subject|1
1545024|NCT00112437|5054250|P14|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545025|NCT00112437|5054251|P13|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545026|NCT00112437|5054252|P12|Year 3 (12-Month Extension)|Withdrawal by Subject|3
1545027|NCT00112437|5054253|P11|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545028|NCT00112437|5054254|P10|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545029|NCT00112437|5054255|P9|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545030|NCT00112437|5054256|P8|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545031|NCT00112437|5054257|P7|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545032|NCT00112437|5054258|P6|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545033|NCT00112437|5054259|P5|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545034|NCT00112437|5054260|P4|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545035|NCT00112437|5054261|P3|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545036|NCT00112437|5054262|P2|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545037|NCT00112437|5054263|P1|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1545038|NCT00112437|5054238|P26|Year 3 (12-Month Extension)|Protocol Violation|0
1545039|NCT00112437|5054239|P25|Year 3 (12-Month Extension)|Protocol Violation|0
1545040|NCT00112437|5054240|P24|Year 3 (12-Month Extension)|Protocol Violation|0
1545041|NCT00112437|5054241|P23|Year 3 (12-Month Extension)|Protocol Violation|0
1545042|NCT00112437|5054242|P22|Year 3 (12-Month Extension)|Protocol Violation|0
1545043|NCT00112437|5054243|P21|Year 3 (12-Month Extension)|Protocol Violation|0
1545044|NCT00112437|5054244|P20|Year 3 (12-Month Extension)|Protocol Violation|0
1545045|NCT00112437|5054245|P19|Year 3 (12-Month Extension)|Protocol Violation|0
1545046|NCT00112437|5054246|P18|Year 3 (12-Month Extension)|Protocol Violation|0
1545047|NCT00112437|5054247|P17|Year 3 (12-Month Extension)|Protocol Violation|0
1545048|NCT00112437|5054248|P16|Year 3 (12-Month Extension)|Protocol Violation|1
1545049|NCT00112437|5054249|P15|Year 3 (12-Month Extension)|Protocol Violation|0
1545050|NCT00112437|5054250|P14|Year 3 (12-Month Extension)|Protocol Violation|0
1545051|NCT00112437|5054251|P13|Year 3 (12-Month Extension)|Protocol Violation|0
1545052|NCT00112437|5054252|P12|Year 3 (12-Month Extension)|Protocol Violation|0
1545053|NCT00112437|5054253|P11|Year 3 (12-Month Extension)|Protocol Violation|0
1545054|NCT00112437|5054254|P10|Year 3 (12-Month Extension)|Protocol Violation|0
1545055|NCT00112437|5054255|P9|Year 3 (12-Month Extension)|Protocol Violation|0
1545056|NCT00112437|5054256|P8|Year 3 (12-Month Extension)|Protocol Violation|0
1545057|NCT00112437|5054257|P7|Year 3 (12-Month Extension)|Protocol Violation|0
1545058|NCT00112437|5054258|P6|Year 3 (12-Month Extension)|Protocol Violation|0
1545059|NCT00112437|5054259|P5|Year 3 (12-Month Extension)|Protocol Violation|0
1545060|NCT00112437|5054260|P4|Year 3 (12-Month Extension)|Protocol Violation|0
1545061|NCT00112437|5054261|P3|Year 3 (12-Month Extension)|Protocol Violation|0
1545062|NCT00112437|5054262|P2|Year 3 (12-Month Extension)|Protocol Violation|0
1545063|NCT00112437|5054263|P1|Year 3 (12-Month Extension)|Protocol Violation|0
1545064|NCT00112437|5054238|P26|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545065|NCT00112437|5054239|P25|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545066|NCT00112437|5054240|P24|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545067|NCT00112437|5054241|P23|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545068|NCT00112437|5054242|P22|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545069|NCT00112437|5054243|P21|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545070|NCT00112437|5054244|P20|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545071|NCT00112437|5054245|P19|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545072|NCT00112437|5054246|P18|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545073|NCT00112437|5054247|P17|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545074|NCT00112437|5054248|P16|Year 3 (12-Month Extension)|Lost to Follow-up|1
1545075|NCT00112437|5054249|P15|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545076|NCT00112437|5054250|P14|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545077|NCT00112437|5054251|P13|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545078|NCT00112437|5054252|P12|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545079|NCT00112437|5054253|P11|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545080|NCT00112437|5054254|P10|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545081|NCT00112437|5054255|P9|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545082|NCT00112437|5054256|P8|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545083|NCT00112437|5054257|P7|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545084|NCT00112437|5054258|P6|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545085|NCT00112437|5054259|P5|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545086|NCT00112437|5054260|P4|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545087|NCT00112437|5054261|P3|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545088|NCT00112437|5054262|P2|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545089|NCT00112437|5054263|P1|Year 3 (12-Month Extension)|Lost to Follow-up|0
1545090|NCT00112437|5054238|P26|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545091|NCT00112437|5054239|P25|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545092|NCT00112437|5054240|P24|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545093|NCT00112437|5054241|P23|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545094|NCT00112437|5054242|P22|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545095|NCT00112437|5054243|P21|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545096|NCT00112437|5054244|P20|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545097|NCT00112437|5054245|P19|Year 3 (12-Month Extension)|Lack of Efficacy|2
1545098|NCT00112437|5054246|P18|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545099|NCT00112437|5054247|P17|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545100|NCT00112437|5054248|P16|Year 3 (12-Month Extension)|Lack of Efficacy|1
1545101|NCT00112437|5054249|P15|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545102|NCT00112437|5054250|P14|Year 3 (12-Month Extension)|Lack of Efficacy|1
1545103|NCT00112437|5054251|P13|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545104|NCT00112437|5054252|P12|Year 3 (12-Month Extension)|Lack of Efficacy|1
1545105|NCT00112437|5054253|P11|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545106|NCT00112437|5054254|P10|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545107|NCT00112437|5054255|P9|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545108|NCT00112437|5054256|P8|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545109|NCT00112437|5054257|P7|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545110|NCT00112437|5054258|P6|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545111|NCT00112437|5054259|P5|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545112|NCT00112437|5054260|P4|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545113|NCT00112437|5054261|P3|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545114|NCT00112437|5054262|P2|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545115|NCT00112437|5054263|P1|Year 3 (12-Month Extension)|Lack of Efficacy|0
1545116|NCT00112437|5054238|P26|Year 3 (12-Month Extension)|Adverse Event|0
1545117|NCT00112437|5054239|P25|Year 3 (12-Month Extension)|Adverse Event|0
1545118|NCT00112437|5054240|P24|Year 3 (12-Month Extension)|Adverse Event|0
1545119|NCT00112437|5054241|P23|Year 3 (12-Month Extension)|Adverse Event|0
1545120|NCT00112437|5054242|P22|Year 3 (12-Month Extension)|Adverse Event|0
1545121|NCT00112437|5054243|P21|Year 3 (12-Month Extension)|Adverse Event|0
1545122|NCT00112437|5054244|P20|Year 3 (12-Month Extension)|Adverse Event|1
1545123|NCT00112437|5054245|P19|Year 3 (12-Month Extension)|Adverse Event|0
1545124|NCT00112437|5054246|P18|Year 3 (12-Month Extension)|Adverse Event|1
1545125|NCT00112437|5054247|P17|Year 3 (12-Month Extension)|Adverse Event|3
1545126|NCT00112437|5054248|P16|Year 3 (12-Month Extension)|Adverse Event|1
1545127|NCT00112437|5054249|P15|Year 3 (12-Month Extension)|Adverse Event|0
1545128|NCT00112437|5054250|P14|Year 3 (12-Month Extension)|Adverse Event|0
1545129|NCT00112437|5054251|P13|Year 3 (12-Month Extension)|Adverse Event|0
1545130|NCT00112437|5054252|P12|Year 3 (12-Month Extension)|Adverse Event|0
1545131|NCT00112437|5054253|P11|Year 3 (12-Month Extension)|Adverse Event|1
1545132|NCT00112437|5054254|P10|Year 3 (12-Month Extension)|Adverse Event|0
1545133|NCT00112437|5054255|P9|Year 3 (12-Month Extension)|Adverse Event|0
1545134|NCT00112437|5054256|P8|Year 3 (12-Month Extension)|Adverse Event|0
1545135|NCT00112437|5054257|P7|Year 3 (12-Month Extension)|Adverse Event|0
1545136|NCT00112437|5054258|P6|Year 3 (12-Month Extension)|Adverse Event|0
1545137|NCT00112437|5054259|P5|Year 3 (12-Month Extension)|Adverse Event|0
1545138|NCT00112437|5054260|P4|Year 3 (12-Month Extension)|Adverse Event|0
1545139|NCT00112437|5054261|P3|Year 3 (12-Month Extension)|Adverse Event|0
1545140|NCT00112437|5054262|P2|Year 3 (12-Month Extension)|Adverse Event|0
1545141|NCT00112437|5054263|P1|Year 3 (12-Month Extension)|Adverse Event|0
1545142|NCT00112437|5054238|P26|Year 2 (12-Month Extension)|Moved|0
1545143|NCT00112437|5054239|P25|Year 2 (12-Month Extension)|Moved|0
1545144|NCT00112437|5054240|P24|Year 2 (12-Month Extension)|Moved|0
1545145|NCT00112437|5054241|P23|Year 2 (12-Month Extension)|Moved|0
1545146|NCT00112437|5054242|P22|Year 2 (12-Month Extension)|Moved|0
1545147|NCT00112437|5054243|P21|Year 2 (12-Month Extension)|Moved|0
1545148|NCT00112437|5054244|P20|Year 2 (12-Month Extension)|Moved|0
1545149|NCT00112437|5054245|P19|Year 2 (12-Month Extension)|Moved|0
1545150|NCT00112437|5054246|P18|Year 2 (12-Month Extension)|Moved|0
1545151|NCT00112437|5054247|P17|Year 2 (12-Month Extension)|Moved|0
1545153|NCT00112437|5054249|P15|Year 2 (12-Month Extension)|Moved|0
1545154|NCT00112437|5054250|P14|Year 2 (12-Month Extension)|Moved|0
1545155|NCT00112437|5054251|P13|Year 2 (12-Month Extension)|Moved|0
1545156|NCT00112437|5054252|P12|Year 2 (12-Month Extension)|Moved|0
1545157|NCT00112437|5054253|P11|Year 2 (12-Month Extension)|Moved|0
1545158|NCT00112437|5054254|P10|Year 2 (12-Month Extension)|Moved|1
1545159|NCT00112437|5054255|P9|Year 2 (12-Month Extension)|Moved|0
1545160|NCT00112437|5054256|P8|Year 2 (12-Month Extension)|Moved|0
1545161|NCT00112437|5054257|P7|Year 2 (12-Month Extension)|Moved|0
1545162|NCT00112437|5054258|P6|Year 2 (12-Month Extension)|Moved|0
1545163|NCT00112437|5054259|P5|Year 2 (12-Month Extension)|Moved|0
1545164|NCT00112437|5054260|P4|Year 2 (12-Month Extension)|Moved|0
1545165|NCT00112437|5054261|P3|Year 2 (12-Month Extension)|Moved|0
1545166|NCT00112437|5054262|P2|Year 2 (12-Month Extension)|Moved|0
1545167|NCT00112437|5054263|P1|Year 2 (12-Month Extension)|Moved|0
1545168|NCT00112437|5054238|P26|Year 2 (12-Month Extension)|patient was out of windows|0
1545169|NCT00112437|5054239|P25|Year 2 (12-Month Extension)|patient was out of windows|0
1545170|NCT00112437|5054240|P24|Year 2 (12-Month Extension)|patient was out of windows|0
1545171|NCT00112437|5054241|P23|Year 2 (12-Month Extension)|patient was out of windows|0
1545172|NCT00112437|5054242|P22|Year 2 (12-Month Extension)|patient was out of windows|0
1545173|NCT00112437|5054243|P21|Year 2 (12-Month Extension)|patient was out of windows|0
1545174|NCT00112437|5054244|P20|Year 2 (12-Month Extension)|patient was out of windows|0
1545175|NCT00112437|5054245|P19|Year 2 (12-Month Extension)|patient was out of windows|0
1545176|NCT00112437|5054246|P18|Year 2 (12-Month Extension)|patient was out of windows|0
1545177|NCT00112437|5054247|P17|Year 2 (12-Month Extension)|patient was out of windows|0
1545178|NCT00112437|5054248|P16|Year 2 (12-Month Extension)|patient was out of windows|0
1545179|NCT00112437|5054249|P15|Year 2 (12-Month Extension)|patient was out of windows|0
1545180|NCT00112437|5054250|P14|Year 2 (12-Month Extension)|patient was out of windows|0
1545181|NCT00112437|5054251|P13|Year 2 (12-Month Extension)|patient was out of windows|0
1545182|NCT00112437|5054252|P12|Year 2 (12-Month Extension)|patient was out of windows|0
1545183|NCT00112437|5054253|P11|Year 2 (12-Month Extension)|patient was out of windows|0
1545184|NCT00112437|5054254|P10|Year 2 (12-Month Extension)|patient was out of windows|1
1545185|NCT00112437|5054255|P9|Year 2 (12-Month Extension)|patient was out of windows|0
1545186|NCT00112437|5054256|P8|Year 2 (12-Month Extension)|patient was out of windows|0
1545187|NCT00112437|5054257|P7|Year 2 (12-Month Extension)|patient was out of windows|0
1545188|NCT00112437|5054258|P6|Year 2 (12-Month Extension)|patient was out of windows|0
1545189|NCT00112437|5054259|P5|Year 2 (12-Month Extension)|patient was out of windows|0
1545190|NCT00112437|5054260|P4|Year 2 (12-Month Extension)|patient was out of windows|0
1545191|NCT00112437|5054261|P3|Year 2 (12-Month Extension)|patient was out of windows|0
1545192|NCT00112437|5054262|P2|Year 2 (12-Month Extension)|patient was out of windows|0
1545193|NCT00112437|5054263|P1|Year 2 (12-Month Extension)|patient was out of windows|0
1545194|NCT00112437|5054238|P26|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545195|NCT00112437|5054239|P25|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545196|NCT00112437|5054240|P24|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545197|NCT00112437|5054241|P23|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545198|NCT00112437|5054242|P22|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545199|NCT00112437|5054243|P21|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545200|NCT00112437|5054244|P20|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545201|NCT00112437|5054245|P19|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545202|NCT00112437|5054246|P18|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545203|NCT00112437|5054247|P17|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545204|NCT00112437|5054248|P16|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545205|NCT00112437|5054249|P15|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545206|NCT00112437|5054250|P14|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545207|NCT00112437|5054251|P13|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545208|NCT00112437|5054252|P12|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545209|NCT00112437|5054253|P11|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545210|NCT00112437|5054254|P10|Year 2 (12-Month Extension)|Patient stopped taking medication|1
1545211|NCT00112437|5054255|P9|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545212|NCT00112437|5054256|P8|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545213|NCT00112437|5054257|P7|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545214|NCT00112437|5054258|P6|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545215|NCT00112437|5054259|P5|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545216|NCT00112437|5054260|P4|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545217|NCT00112437|5054261|P3|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545218|NCT00112437|5054262|P2|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545219|NCT00112437|5054263|P1|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1545220|NCT00112437|5054238|P26|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545221|NCT00112437|5054239|P25|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545222|NCT00112437|5054240|P24|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545223|NCT00112437|5054241|P23|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545224|NCT00112437|5054242|P22|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545225|NCT00112437|5054243|P21|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545226|NCT00112437|5054244|P20|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545227|NCT00112437|5054245|P19|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545228|NCT00112437|5054246|P18|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545229|NCT00112437|5054247|P17|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545230|NCT00112437|5054248|P16|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545231|NCT00112437|5054249|P15|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545232|NCT00112437|5054250|P14|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545233|NCT00112437|5054251|P13|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545234|NCT00112437|5054252|P12|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545235|NCT00112437|5054253|P11|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545236|NCT00112437|5054254|P10|Year 2 (12-Month Extension)|Withdrawal by Subject|1
1545237|NCT00112437|5054255|P9|Year 2 (12-Month Extension)|Withdrawal by Subject|4
1545238|NCT00112437|5054256|P8|Year 2 (12-Month Extension)|Withdrawal by Subject|2
1545239|NCT00112437|5054257|P7|Year 2 (12-Month Extension)|Withdrawal by Subject|1
1545240|NCT00112437|5054258|P6|Year 2 (12-Month Extension)|Withdrawal by Subject|1
1545241|NCT00112437|5054259|P5|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545242|NCT00112437|5054260|P4|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545243|NCT00112437|5054261|P3|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545244|NCT00112437|5054262|P2|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545245|NCT00112437|5054263|P1|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1545246|NCT00112437|5054238|P26|Year 2 (12-Month Extension)|Protocol Violation|0
1545247|NCT00112437|5054239|P25|Year 2 (12-Month Extension)|Protocol Violation|0
1545248|NCT00112437|5054240|P24|Year 2 (12-Month Extension)|Protocol Violation|0
1545249|NCT00112437|5054241|P23|Year 2 (12-Month Extension)|Protocol Violation|0
1545250|NCT00112437|5054242|P22|Year 2 (12-Month Extension)|Protocol Violation|0
1545251|NCT00112437|5054243|P21|Year 2 (12-Month Extension)|Protocol Violation|0
1545252|NCT00112437|5054244|P20|Year 2 (12-Month Extension)|Protocol Violation|0
1545253|NCT00112437|5054245|P19|Year 2 (12-Month Extension)|Protocol Violation|0
1545254|NCT00112437|5054246|P18|Year 2 (12-Month Extension)|Protocol Violation|0
1545255|NCT00112437|5054247|P17|Year 2 (12-Month Extension)|Protocol Violation|0
1545256|NCT00112437|5054248|P16|Year 2 (12-Month Extension)|Protocol Violation|0
1545257|NCT00112437|5054249|P15|Year 2 (12-Month Extension)|Protocol Violation|0
1545258|NCT00112437|5054250|P14|Year 2 (12-Month Extension)|Protocol Violation|0
1545259|NCT00112437|5054251|P13|Year 2 (12-Month Extension)|Protocol Violation|0
1545260|NCT00112437|5054252|P12|Year 2 (12-Month Extension)|Protocol Violation|0
1545261|NCT00112437|5054253|P11|Year 2 (12-Month Extension)|Protocol Violation|0
1545262|NCT00112437|5054254|P10|Year 2 (12-Month Extension)|Protocol Violation|0
1545263|NCT00112437|5054255|P9|Year 2 (12-Month Extension)|Protocol Violation|1
1545264|NCT00112437|5054256|P8|Year 2 (12-Month Extension)|Protocol Violation|0
1545265|NCT00112437|5054257|P7|Year 2 (12-Month Extension)|Protocol Violation|0
1545266|NCT00112437|5054258|P6|Year 2 (12-Month Extension)|Protocol Violation|0
1545267|NCT00112437|5054259|P5|Year 2 (12-Month Extension)|Protocol Violation|0
1545268|NCT00112437|5054260|P4|Year 2 (12-Month Extension)|Protocol Violation|0
1545269|NCT00112437|5054261|P3|Year 2 (12-Month Extension)|Protocol Violation|0
1545270|NCT00112437|5054262|P2|Year 2 (12-Month Extension)|Protocol Violation|0
1545271|NCT00112437|5054263|P1|Year 2 (12-Month Extension)|Protocol Violation|0
1545272|NCT00112437|5054238|P26|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545273|NCT00112437|5054239|P25|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545274|NCT00112437|5054240|P24|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545275|NCT00112437|5054241|P23|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545276|NCT00112437|5054242|P22|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545277|NCT00112437|5054243|P21|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545278|NCT00112437|5054244|P20|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545279|NCT00112437|5054245|P19|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545280|NCT00112437|5054246|P18|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545281|NCT00112437|5054247|P17|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545282|NCT00112437|5054248|P16|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545283|NCT00112437|5054249|P15|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545284|NCT00112437|5054250|P14|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545285|NCT00112437|5054251|P13|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545286|NCT00112437|5054252|P12|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545287|NCT00112437|5054253|P11|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545288|NCT00112437|5054254|P10|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545289|NCT00112437|5054255|P9|Year 2 (12-Month Extension)|Lost to Follow-up|1
1545290|NCT00112437|5054256|P8|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545291|NCT00112437|5054257|P7|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545292|NCT00112437|5054258|P6|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545293|NCT00112437|5054259|P5|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545294|NCT00112437|5054260|P4|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545295|NCT00112437|5054261|P3|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545296|NCT00112437|5054262|P2|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545297|NCT00112437|5054263|P1|Year 2 (12-Month Extension)|Lost to Follow-up|0
1545298|NCT00112437|5054238|P26|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545299|NCT00112437|5054239|P25|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545300|NCT00112437|5054240|P24|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545301|NCT00112437|5054241|P23|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545302|NCT00112437|5054242|P22|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545303|NCT00112437|5054243|P21|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545304|NCT00112437|5054244|P20|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545305|NCT00112437|5054245|P19|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545306|NCT00112437|5054246|P18|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545307|NCT00112437|5054247|P17|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545308|NCT00112437|5054248|P16|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545309|NCT00112437|5054249|P15|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545310|NCT00112437|5054250|P14|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545311|NCT00112437|5054251|P13|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545312|NCT00112437|5054252|P12|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545313|NCT00112437|5054253|P11|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545314|NCT00112437|5054254|P10|Year 2 (12-Month Extension)|Lack of Efficacy|2
1545315|NCT00112437|5054255|P9|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545316|NCT00112437|5054256|P8|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545317|NCT00112437|5054257|P7|Year 2 (12-Month Extension)|Lack of Efficacy|6
1545318|NCT00112437|5054258|P6|Year 2 (12-Month Extension)|Lack of Efficacy|1
1545319|NCT00112437|5054259|P5|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545320|NCT00112437|5054260|P4|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545321|NCT00112437|5054261|P3|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545322|NCT00112437|5054262|P2|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545323|NCT00112437|5054263|P1|Year 2 (12-Month Extension)|Lack of Efficacy|0
1545324|NCT00112437|5054238|P26|Year 2 (12-Month Extension)|Adverse Event|0
1545325|NCT00112437|5054239|P25|Year 2 (12-Month Extension)|Adverse Event|0
1545326|NCT00112437|5054240|P24|Year 2 (12-Month Extension)|Adverse Event|0
1545327|NCT00112437|5054241|P23|Year 2 (12-Month Extension)|Adverse Event|0
1545328|NCT00112437|5054242|P22|Year 2 (12-Month Extension)|Adverse Event|0
1545329|NCT00112437|5054243|P21|Year 2 (12-Month Extension)|Adverse Event|0
1545330|NCT00112437|5054244|P20|Year 2 (12-Month Extension)|Adverse Event|0
1545331|NCT00112437|5054245|P19|Year 2 (12-Month Extension)|Adverse Event|0
1545332|NCT00112437|5054246|P18|Year 2 (12-Month Extension)|Adverse Event|0
1545333|NCT00112437|5054247|P17|Year 2 (12-Month Extension)|Adverse Event|0
1545334|NCT00112437|5054248|P16|Year 2 (12-Month Extension)|Adverse Event|0
1545335|NCT00112437|5054249|P15|Year 2 (12-Month Extension)|Adverse Event|0
1545336|NCT00112437|5054250|P14|Year 2 (12-Month Extension)|Adverse Event|0
1545337|NCT00112437|5054251|P13|Year 2 (12-Month Extension)|Adverse Event|0
1545338|NCT00112437|5054252|P12|Year 2 (12-Month Extension)|Adverse Event|0
1545339|NCT00112437|5054253|P11|Year 2 (12-Month Extension)|Adverse Event|0
1545340|NCT00112437|5054254|P10|Year 2 (12-Month Extension)|Adverse Event|7
1545341|NCT00112437|5054255|P9|Year 2 (12-Month Extension)|Adverse Event|1
1545342|NCT00112437|5054256|P8|Year 2 (12-Month Extension)|Adverse Event|6
1545343|NCT00112437|5054257|P7|Year 2 (12-Month Extension)|Adverse Event|2
1545344|NCT00112437|5054258|P6|Year 2 (12-Month Extension)|Adverse Event|1
1545345|NCT00112437|5054259|P5|Year 2 (12-Month Extension)|Adverse Event|0
1545346|NCT00112437|5054260|P4|Year 2 (12-Month Extension)|Adverse Event|0
1545347|NCT00112437|5054261|P3|Year 2 (12-Month Extension)|Adverse Event|0
1545348|NCT00112437|5054262|P2|Year 2 (12-Month Extension)|Adverse Event|0
1545349|NCT00112437|5054263|P1|Year 2 (12-Month Extension)|Adverse Event|0
1545350|NCT00112437|5054238|P26|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545351|NCT00112437|5054239|P25|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545352|NCT00112437|5054240|P24|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545353|NCT00112437|5054241|P23|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545354|NCT00112437|5054242|P22|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545355|NCT00112437|5054243|P21|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545356|NCT00112437|5054244|P20|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545357|NCT00112437|5054245|P19|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545358|NCT00112437|5054246|P18|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545359|NCT00112437|5054247|P17|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545360|NCT00112437|5054248|P16|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545361|NCT00112437|5054249|P15|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545362|NCT00112437|5054250|P14|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545363|NCT00112437|5054251|P13|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545364|NCT00112437|5054252|P12|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545365|NCT00112437|5054253|P11|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545366|NCT00112437|5054254|P10|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545367|NCT00112437|5054255|P9|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545368|NCT00112437|5054256|P8|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545369|NCT00112437|5054257|P7|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545370|NCT00112437|5054258|P6|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545371|NCT00112437|5054259|P5|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
1545372|NCT00112437|5054260|P4|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545373|NCT00112437|5054261|P3|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545374|NCT00112437|5054262|P2|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545375|NCT00112437|5054263|P1|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1545376|NCT00112437|5054238|P26|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545377|NCT00112437|5054239|P25|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545378|NCT00112437|5054240|P24|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545379|NCT00112437|5054241|P23|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545380|NCT00112437|5054242|P22|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545381|NCT00112437|5054243|P21|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545382|NCT00112437|5054244|P20|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545383|NCT00112437|5054245|P19|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545384|NCT00112437|5054246|P18|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545385|NCT00112437|5054247|P17|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545386|NCT00112437|5054248|P16|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545387|NCT00112437|5054249|P15|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545388|NCT00112437|5054250|P14|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545389|NCT00112437|5054251|P13|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545390|NCT00112437|5054252|P12|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545391|NCT00112437|5054253|P11|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545392|NCT00112437|5054254|P10|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545393|NCT00112437|5054255|P9|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545394|NCT00112437|5054256|P8|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545395|NCT00112437|5054257|P7|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545396|NCT00112437|5054258|P6|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545397|NCT00112437|5054259|P5|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545398|NCT00112437|5054260|P4|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
1545399|NCT00112437|5054261|P3|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545400|NCT00112437|5054262|P2|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545401|NCT00112437|5054263|P1|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1545402|NCT00112437|5054238|P26|Year 1 (12-Month Base Study)|moved|0
1545403|NCT00112437|5054239|P25|Year 1 (12-Month Base Study)|moved|0
1545404|NCT00112437|5054240|P24|Year 1 (12-Month Base Study)|moved|0
1545405|NCT00112437|5054241|P23|Year 1 (12-Month Base Study)|moved|0
1545406|NCT00112437|5054242|P22|Year 1 (12-Month Base Study)|moved|0
1545407|NCT00112437|5054243|P21|Year 1 (12-Month Base Study)|moved|0
1545408|NCT00112437|5054244|P20|Year 1 (12-Month Base Study)|moved|0
1545409|NCT00112437|5054245|P19|Year 1 (12-Month Base Study)|moved|0
1545410|NCT00112437|5054246|P18|Year 1 (12-Month Base Study)|moved|0
1545411|NCT00112437|5054247|P17|Year 1 (12-Month Base Study)|moved|0
1545412|NCT00112437|5054248|P16|Year 1 (12-Month Base Study)|moved|0
1545413|NCT00112437|5054249|P15|Year 1 (12-Month Base Study)|moved|0
1545414|NCT00112437|5054250|P14|Year 1 (12-Month Base Study)|moved|0
1545415|NCT00112437|5054251|P13|Year 1 (12-Month Base Study)|moved|0
1545416|NCT00112437|5054252|P12|Year 1 (12-Month Base Study)|moved|0
1545417|NCT00112437|5054253|P11|Year 1 (12-Month Base Study)|moved|0
1545418|NCT00112437|5054254|P10|Year 1 (12-Month Base Study)|moved|0
1545419|NCT00112437|5054255|P9|Year 1 (12-Month Base Study)|moved|0
1545420|NCT00112437|5054256|P8|Year 1 (12-Month Base Study)|moved|0
1545421|NCT00112437|5054257|P7|Year 1 (12-Month Base Study)|moved|0
1545422|NCT00112437|5054258|P6|Year 1 (12-Month Base Study)|moved|0
1545423|NCT00112437|5054259|P5|Year 1 (12-Month Base Study)|moved|0
1545424|NCT00112437|5054260|P4|Year 1 (12-Month Base Study)|moved|0
1545425|NCT00112437|5054261|P3|Year 1 (12-Month Base Study)|moved|1
1545426|NCT00112437|5054262|P2|Year 1 (12-Month Base Study)|moved|1
1545427|NCT00112437|5054263|P1|Year 1 (12-Month Base Study)|moved|0
1545428|NCT00112437|5054238|P26|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545429|NCT00112437|5054239|P25|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545430|NCT00112437|5054240|P24|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545431|NCT00112437|5054241|P23|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545432|NCT00112437|5054242|P22|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545433|NCT00112437|5054243|P21|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545434|NCT00112437|5054244|P20|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545435|NCT00112437|5054245|P19|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545436|NCT00112437|5054246|P18|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545437|NCT00112437|5054247|P17|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545438|NCT00112437|5054248|P16|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545439|NCT00112437|5054249|P15|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545440|NCT00112437|5054250|P14|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545441|NCT00112437|5054251|P13|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545442|NCT00112437|5054252|P12|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545443|NCT00112437|5054253|P11|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545444|NCT00112437|5054254|P10|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545445|NCT00112437|5054255|P9|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545446|NCT00112437|5054256|P8|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545447|NCT00112437|5054257|P7|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545448|NCT00112437|5054258|P6|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1545449|NCT00112437|5054259|P5|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
1545450|NCT00112437|5054260|P4|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
1545451|NCT00112437|5054261|P3|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
1545452|NCT00112437|5054262|P2|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
1545453|NCT00112437|5054263|P1|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
1545454|NCT00112437|5054238|P26|Year 1 (12-Month Base Study)|Protocol Violation|0
1545455|NCT00112437|5054239|P25|Year 1 (12-Month Base Study)|Protocol Violation|0
1545456|NCT00112437|5054240|P24|Year 1 (12-Month Base Study)|Protocol Violation|0
1545457|NCT00112437|5054241|P23|Year 1 (12-Month Base Study)|Protocol Violation|0
1545458|NCT00112437|5054242|P22|Year 1 (12-Month Base Study)|Protocol Violation|0
1545459|NCT00112437|5054243|P21|Year 1 (12-Month Base Study)|Protocol Violation|0
1545460|NCT00112437|5054244|P20|Year 1 (12-Month Base Study)|Protocol Violation|0
1545461|NCT00112437|5054245|P19|Year 1 (12-Month Base Study)|Protocol Violation|0
1545462|NCT00112437|5054246|P18|Year 1 (12-Month Base Study)|Protocol Violation|0
1545463|NCT00112437|5054247|P17|Year 1 (12-Month Base Study)|Protocol Violation|0
1545464|NCT00112437|5054248|P16|Year 1 (12-Month Base Study)|Protocol Violation|0
1545465|NCT00112437|5054249|P15|Year 1 (12-Month Base Study)|Protocol Violation|0
1545466|NCT00112437|5054250|P14|Year 1 (12-Month Base Study)|Protocol Violation|0
1545467|NCT00112437|5054251|P13|Year 1 (12-Month Base Study)|Protocol Violation|0
1545468|NCT00112437|5054252|P12|Year 1 (12-Month Base Study)|Protocol Violation|0
1545469|NCT00112437|5054253|P11|Year 1 (12-Month Base Study)|Protocol Violation|0
1545470|NCT00112437|5054254|P10|Year 1 (12-Month Base Study)|Protocol Violation|0
1545471|NCT00112437|5054255|P9|Year 1 (12-Month Base Study)|Protocol Violation|0
1545472|NCT00112437|5054256|P8|Year 1 (12-Month Base Study)|Protocol Violation|0
1545473|NCT00112437|5054257|P7|Year 1 (12-Month Base Study)|Protocol Violation|0
1545474|NCT00112437|5054258|P6|Year 1 (12-Month Base Study)|Protocol Violation|0
1545475|NCT00112437|5054259|P5|Year 1 (12-Month Base Study)|Protocol Violation|1
1545476|NCT00112437|5054260|P4|Year 1 (12-Month Base Study)|Protocol Violation|1
1545477|NCT00112437|5054261|P3|Year 1 (12-Month Base Study)|Protocol Violation|3
1545478|NCT00112437|5054262|P2|Year 1 (12-Month Base Study)|Protocol Violation|0
1545479|NCT00112437|5054263|P1|Year 1 (12-Month Base Study)|Protocol Violation|1
1545480|NCT00112437|5054238|P26|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545481|NCT00112437|5054239|P25|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545482|NCT00112437|5054240|P24|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545483|NCT00112437|5054241|P23|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545484|NCT00112437|5054242|P22|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545485|NCT00112437|5054243|P21|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545486|NCT00112437|5054244|P20|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545487|NCT00112437|5054245|P19|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545488|NCT00112437|5054246|P18|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545489|NCT00112437|5054247|P17|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545490|NCT00112437|5054248|P16|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545491|NCT00112437|5054249|P15|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545492|NCT00112437|5054250|P14|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545493|NCT00112437|5054251|P13|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545494|NCT00112437|5054252|P12|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545495|NCT00112437|5054253|P11|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545496|NCT00112437|5054254|P10|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545497|NCT00112437|5054255|P9|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545498|NCT00112437|5054256|P8|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545499|NCT00112437|5054257|P7|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545500|NCT00112437|5054258|P6|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545501|NCT00112437|5054259|P5|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545502|NCT00112437|5054260|P4|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545503|NCT00112437|5054261|P3|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545504|NCT00112437|5054262|P2|Year 1 (12-Month Base Study)|Lost to Follow-up|1
1545505|NCT00112437|5054263|P1|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1545506|NCT00112437|5054238|P26|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545507|NCT00112437|5054239|P25|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545508|NCT00112437|5054240|P24|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545509|NCT00112437|5054241|P23|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545510|NCT00112437|5054242|P22|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545511|NCT00112437|5054243|P21|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545512|NCT00112437|5054244|P20|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545513|NCT00112437|5054245|P19|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545514|NCT00112437|5054246|P18|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545515|NCT00112437|5054247|P17|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545516|NCT00112437|5054248|P16|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545517|NCT00112437|5054249|P15|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545518|NCT00112437|5054250|P14|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545519|NCT00112437|5054251|P13|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545520|NCT00112437|5054252|P12|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545521|NCT00112437|5054253|P11|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545522|NCT00112437|5054254|P10|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545523|NCT00112437|5054255|P9|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545524|NCT00112437|5054256|P8|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545525|NCT00112437|5054257|P7|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545526|NCT00112437|5054258|P6|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545527|NCT00112437|5054259|P5|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545528|NCT00112437|5054260|P4|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545529|NCT00112437|5054261|P3|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545530|NCT00112437|5054262|P2|Year 1 (12-Month Base Study)|Lack of Efficacy|1
1545531|NCT00112437|5054263|P1|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1545532|NCT00112437|5054238|P26|Year 1 (12-Month Base Study)|Adverse Event|0
1545533|NCT00112437|5054239|P25|Year 1 (12-Month Base Study)|Adverse Event|0
1545534|NCT00112437|5054240|P24|Year 1 (12-Month Base Study)|Adverse Event|0
1545535|NCT00112437|5054241|P23|Year 1 (12-Month Base Study)|Adverse Event|0
1545536|NCT00112437|5054242|P22|Year 1 (12-Month Base Study)|Adverse Event|0
1545537|NCT00112437|5054243|P21|Year 1 (12-Month Base Study)|Adverse Event|0
1545538|NCT00112437|5054244|P20|Year 1 (12-Month Base Study)|Adverse Event|0
1545539|NCT00112437|5054245|P19|Year 1 (12-Month Base Study)|Adverse Event|0
1545540|NCT00112437|5054246|P18|Year 1 (12-Month Base Study)|Adverse Event|0
1545541|NCT00112437|5054247|P17|Year 1 (12-Month Base Study)|Adverse Event|0
1545542|NCT00112437|5054248|P16|Year 1 (12-Month Base Study)|Adverse Event|0
1545543|NCT00112437|5054249|P15|Year 1 (12-Month Base Study)|Adverse Event|0
1545544|NCT00112437|5054250|P14|Year 1 (12-Month Base Study)|Adverse Event|0
1545545|NCT00112437|5054251|P13|Year 1 (12-Month Base Study)|Adverse Event|0
1545546|NCT00112437|5054252|P12|Year 1 (12-Month Base Study)|Adverse Event|0
1545547|NCT00112437|5054253|P11|Year 1 (12-Month Base Study)|Adverse Event|0
1545548|NCT00112437|5054254|P10|Year 1 (12-Month Base Study)|Adverse Event|0
1545549|NCT00112437|5054255|P9|Year 1 (12-Month Base Study)|Adverse Event|0
1545550|NCT00112437|5054256|P8|Year 1 (12-Month Base Study)|Adverse Event|0
1545551|NCT00112437|5054257|P7|Year 1 (12-Month Base Study)|Adverse Event|0
1545552|NCT00112437|5054258|P6|Year 1 (12-Month Base Study)|Adverse Event|0
1545553|NCT00112437|5054259|P5|Year 1 (12-Month Base Study)|Adverse Event|3
1545554|NCT00112437|5054260|P4|Year 1 (12-Month Base Study)|Adverse Event|4
1545555|NCT00112437|5054261|P3|Year 1 (12-Month Base Study)|Adverse Event|6
1545556|NCT00112437|5054262|P2|Year 1 (12-Month Base Study)|Adverse Event|10
1545557|NCT00112437|5054263|P1|Year 1 (12-Month Base Study)|Adverse Event|9
1545558|NCT00112385|5054543|P2|Overall Study|Withdrawal by Subject|1
1545559|NCT00112385|5054544|P1|Overall Study|Withdrawal by Subject|0
1545560|NCT00112385|5054543|P2|Overall Study|Lost to Follow-up|0
1545561|NCT00112385|5054544|P1|Overall Study|Lost to Follow-up|1
1545562|NCT00112359|5054634|P2|Overall Study|Other|0
1545563|NCT00112359|5054635|P1|Overall Study|Other|3
1545564|NCT00112359|5054634|P2|Overall Study|Personal/administrative|1
1545565|NCT00112359|5054635|P1|Overall Study|Personal/administrative|1
1545566|NCT00112359|5054634|P2|Overall Study|Lost to Follow-up|1
1545567|NCT00112359|5054635|P1|Overall Study|Lost to Follow-up|0
1545568|NCT00112359|5054634|P2|Overall Study|Related adverse event|3
1545569|NCT00112359|5054635|P1|Overall Study|Related adverse event|5
1545570|NCT00112359|5054634|P2|Overall Study|Trial drug intolerance (adverse event)|0
1545571|NCT00112359|5054635|P1|Overall Study|Trial drug intolerance (adverse event)|2
1545572|NCT00112359|5054634|P2|Overall Study|Unrelated adverse event|8
1545573|NCT00112359|5054635|P1|Overall Study|Unrelated adverse event|16
1545574|NCT00112294|5054661|P2|Overall Study|Still on study|0
1545575|NCT00112294|5054662|P1|Overall Study|Still on study|5
1545576|NCT00112047|5054885|P2|Atripla Phase|Not specified|1
1545577|NCT00112047|5054886|P1|Atripla Phase|Not specified|3
1545578|NCT00112047|5054885|P2|Atripla Phase|Non-compliance|0
1545579|NCT00112047|5054886|P1|Atripla Phase|Non-compliance|1
1545580|NCT00112047|5054885|P2|Atripla Phase|Sub-optimal virological response|1
1545581|NCT00112047|5054886|P1|Atripla Phase|Sub-optimal virological response|0
1545582|NCT00112047|5054885|P2|Atripla Phase|Withdrew consent|7
1545583|NCT00112047|5054886|P1|Atripla Phase|Withdrew consent|7
1545584|NCT00112047|5054885|P2|Atripla Phase|Death|2
1545585|NCT00112047|5054886|P1|Atripla Phase|Death|0
1545586|NCT00112047|5054885|P2|Atripla Phase|Pregnancy|1
1545587|NCT00112047|5054886|P1|Atripla Phase|Pregnancy|0
1545588|NCT00112047|5054885|P2|Atripla Phase|Lost to Follow-up|7
1545589|NCT00112047|5054886|P1|Atripla Phase|Lost to Follow-up|5
1545590|NCT00112047|5054885|P2|Atripla Phase|Adverse Event|1
1545591|NCT00112047|5054886|P1|Atripla Phase|Adverse Event|2
1545592|NCT00112047|5054885|P2|Randomized Phase|High Hepatitis B DNA|1
1545593|NCT00112047|5054886|P1|Randomized Phase|High Hepatitis B DNA|0
1545594|NCT00112047|5054885|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
1545595|NCT00112047|5054886|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
1545596|NCT00112047|5054885|P2|Randomized Phase|Moved out of State|1
1545597|NCT00112047|5054886|P1|Randomized Phase|Moved out of State|0
1545598|NCT00112047|5054885|P2|Randomized Phase|Incarceration|2
1545599|NCT00112047|5054886|P1|Randomized Phase|Incarceration|3
1545600|NCT00112047|5054885|P2|Randomized Phase|Inability to swallow pills|1
1545601|NCT00112047|5054886|P1|Randomized Phase|Inability to swallow pills|0
1545602|NCT00112047|5054885|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
1545603|NCT00112047|5054886|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
1545604|NCT00112047|5054885|P2|Randomized Phase|Death|3
1545605|NCT00112047|5054886|P1|Randomized Phase|Death|1
1545606|NCT00112047|5054885|P2|Randomized Phase|Pregnancy|1
1545607|NCT00112047|5054886|P1|Randomized Phase|Pregnancy|3
1545608|NCT00112047|5054885|P2|Randomized Phase|Protocol Violation|0
1545609|NCT00112047|5054886|P1|Randomized Phase|Protocol Violation|2
1545610|NCT00112047|5054885|P2|Randomized Phase|Noncompliance|4
1545611|NCT00112047|5054886|P1|Randomized Phase|Noncompliance|8
1545612|NCT00112047|5054885|P2|Randomized Phase|Sub-optimal virological response|13
1545613|NCT00112047|5054886|P1|Randomized Phase|Sub-optimal virological response|3
1545614|NCT00112047|5054885|P2|Randomized Phase|Withrawal of consent|18
1545615|NCT00112047|5054886|P1|Randomized Phase|Withrawal of consent|10
1545616|NCT00112047|5054885|P2|Randomized Phase|Adverse Event|10
1545617|NCT00112047|5054886|P1|Randomized Phase|Adverse Event|10
1545618|NCT00112047|5054885|P2|Randomized Phase|Lost to Follow-up|33
1545619|NCT00112047|5054886|P1|Randomized Phase|Lost to Follow-up|26
1545620|NCT00111917|5054986|P2|Overall Study|Withdrawal by Subject|1
1545621|NCT00111917|5054987|P1|Overall Study|Withdrawal by Subject|1
1545622|NCT00111839|5055002|P3|Overall Study|Randomized but Not Treated|2
1545623|NCT00111839|5055003|P2|Overall Study|Randomized but Not Treated|0
1545624|NCT00111839|5055004|P1|Overall Study|Randomized but Not Treated|0
1545625|NCT00111839|5055002|P3|Overall Study|Other|3
1545626|NCT00111839|5055003|P2|Overall Study|Other|3
1545627|NCT00111839|5055004|P1|Overall Study|Other|6
1545628|NCT00111839|5055002|P3|Overall Study|Logistical Constraint|0
1545629|NCT00111839|5055003|P2|Overall Study|Logistical Constraint|0
1545630|NCT00111839|5055004|P1|Overall Study|Logistical Constraint|1
1545631|NCT00111839|5055002|P3|Overall Study|Lost to Follow-up|0
1545632|NCT00111839|5055003|P2|Overall Study|Lost to Follow-up|0
1545633|NCT00111839|5055004|P1|Overall Study|Lost to Follow-up|1
1545634|NCT00111839|5055002|P3|Overall Study|Withdrawal by Subject|2
1545635|NCT00111839|5055003|P2|Overall Study|Withdrawal by Subject|2
1545636|NCT00111839|5055004|P1|Overall Study|Withdrawal by Subject|2
1545637|NCT00111839|5055002|P3|Overall Study|Death|6
1545638|NCT00111839|5055003|P2|Overall Study|Death|1
1545639|NCT00111839|5055004|P1|Overall Study|Death|1
1545640|NCT00111839|5055002|P3|Overall Study|Protocol Violation|2
1545641|NCT00111839|5055003|P2|Overall Study|Protocol Violation|4
1545642|NCT00111839|5055004|P1|Overall Study|Protocol Violation|2
1545643|NCT00111839|5055002|P3|Overall Study|Adverse Event|1
1545644|NCT00111839|5055003|P2|Overall Study|Adverse Event|3
1545645|NCT00111839|5055004|P1|Overall Study|Adverse Event|5
1545646|NCT00111839|5055002|P3|Overall Study|Disease Progression|33
1545647|NCT00111839|5055003|P2|Overall Study|Disease Progression|33
1545648|NCT00111839|5055004|P1|Overall Study|Disease Progression|30
1545649|NCT00111813|5055024|P6|Overall Study|Not specified|0
1545650|NCT00111813|5055025|P5|Overall Study|Not specified|0
1545651|NCT00111813|5055026|P4|Overall Study|Not specified|0
1545652|NCT00111813|5055027|P3|Overall Study|Not specified|1
1545653|NCT00111813|5055028|P2|Overall Study|Not specified|0
1545654|NCT00111813|5055029|P1|Overall Study|Not specified|0
1545655|NCT00111813|5055024|P6|Overall Study|Lack of Efficacy|1
1545656|NCT00111813|5055025|P5|Overall Study|Lack of Efficacy|0
1545657|NCT00111813|5055026|P4|Overall Study|Lack of Efficacy|0
1545658|NCT00111813|5055027|P3|Overall Study|Lack of Efficacy|0
1545659|NCT00111813|5055028|P2|Overall Study|Lack of Efficacy|0
1545660|NCT00111813|5055029|P1|Overall Study|Lack of Efficacy|0
1545661|NCT00111813|5055024|P6|Overall Study|Progressive disease|3
1545662|NCT00111813|5055025|P5|Overall Study|Progressive disease|4
1545663|NCT00111813|5055026|P4|Overall Study|Progressive disease|3
1545664|NCT00111813|5055027|P3|Overall Study|Progressive disease|5
1545665|NCT00111813|5055028|P2|Overall Study|Progressive disease|1
1545666|NCT00111813|5055029|P1|Overall Study|Progressive disease|2
1545667|NCT00111813|5055024|P6|Overall Study|Adverse Event|2
1545668|NCT00111813|5055025|P5|Overall Study|Adverse Event|2
1545669|NCT00111813|5055026|P4|Overall Study|Adverse Event|2
1545670|NCT00111813|5055027|P3|Overall Study|Adverse Event|4
1545671|NCT00111813|5055028|P2|Overall Study|Adverse Event|2
1545672|NCT00111813|5055029|P1|Overall Study|Adverse Event|1
1545673|NCT00111800|5055068|P6|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1545674|NCT00111800|5055069|P5|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1545675|NCT00111800|5055070|P4|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1545676|NCT00111800|5055071|P3|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
1545677|NCT00111800|5055072|P2|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1545678|NCT00111800|5055073|P1|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1545679|NCT00111800|5055068|P6|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1545680|NCT00111800|5055069|P5|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1545681|NCT00111800|5055070|P4|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1545682|NCT00111800|5055071|P3|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
1545683|NCT00111800|5055072|P2|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1545684|NCT00111800|5055073|P1|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1545685|NCT00111800|5055068|P6|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1545686|NCT00111800|5055069|P5|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1545687|NCT00111800|5055070|P4|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1545688|NCT00111800|5055071|P3|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1545689|NCT00111800|5055072|P2|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
1545690|NCT00111800|5055073|P1|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1545909|NCT00110890|5055317|P2|Overall Study|Ineligibility determined|0
1545691|NCT00111800|5055068|P6|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1545692|NCT00111800|5055069|P5|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1545693|NCT00111800|5055070|P4|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1545694|NCT00111800|5055071|P3|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
1545695|NCT00111800|5055072|P2|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1545696|NCT00111800|5055073|P1|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1545697|NCT00111800|5055068|P6|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1545698|NCT00111800|5055069|P5|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
1545699|NCT00111800|5055070|P4|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1545700|NCT00111800|5055071|P3|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1545701|NCT00111800|5055072|P2|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
1545702|NCT00111800|5055073|P1|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1545703|NCT00111800|5055068|P6|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
1545704|NCT00111800|5055069|P5|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
1545705|NCT00111800|5055070|P4|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
1545706|NCT00111800|5055071|P3|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
1545707|NCT00111800|5055072|P2|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
1545708|NCT00111800|5055073|P1|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
1545709|NCT00111800|5055068|P6|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1545710|NCT00111800|5055069|P5|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1545711|NCT00111800|5055070|P4|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1545712|NCT00111800|5055071|P3|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
1545713|NCT00111800|5055072|P2|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
1545714|NCT00111800|5055073|P1|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1545715|NCT00111800|5055068|P6|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
1545716|NCT00111800|5055069|P5|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
1545717|NCT00111800|5055070|P4|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
1545718|NCT00111800|5055071|P3|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
1545719|NCT00111800|5055072|P2|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
1545720|NCT00111800|5055073|P1|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
1545721|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
1545722|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1545723|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1545724|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1545725|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1545726|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1545727|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1545728|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
1545729|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1545730|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1545731|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1545732|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1545733|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1545734|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
1545735|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1545736|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1545737|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1545738|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1545739|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1545740|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1545741|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
1545742|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1545743|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1545744|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1545745|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1545746|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1545747|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
1545748|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1545749|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1545750|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1545751|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1545752|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1545753|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1545754|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1545755|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
1545756|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1545757|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1545910|NCT00110890|5055318|P1|Overall Study|Ineligibility determined|3
1545758|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1545759|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1545760|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1545761|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
1545762|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1545763|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1545764|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1545765|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1545766|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1545767|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
1545768|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1545769|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1545770|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1545771|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1545772|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1545773|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
1545774|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1545775|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1545776|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1545777|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1545778|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1545779|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1545780|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
1545781|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1545782|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1545783|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1545784|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1545785|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
1545786|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
1545787|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
1545788|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
1545789|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
1545790|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
1545791|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
1545792|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
1545793|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1545794|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
1545795|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1545796|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1545797|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1545798|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
1545799|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1545800|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1545801|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
1545802|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1545803|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1545804|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
1545805|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
1545806|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
1545807|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
1545808|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
1545809|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
1545810|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
1545811|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
1545812|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
1545813|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
1545814|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
1545815|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
1545816|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
1545817|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
1545818|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
1545819|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
1545820|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
1545821|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
1545822|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
1545823|NCT00111800|5055068|P6|Period 1: Main Phase (12 Weeks)|Adverse Event|0
1545824|NCT00111800|5055069|P5|Period 1: Main Phase (12 Weeks)|Adverse Event|1
1545825|NCT00111800|5055070|P4|Period 1: Main Phase (12 Weeks)|Adverse Event|0
1545826|NCT00111800|5055071|P3|Period 1: Main Phase (12 Weeks)|Adverse Event|0
1545827|NCT00111800|5055072|P2|Period 1: Main Phase (12 Weeks)|Adverse Event|4
1545828|NCT00111800|5055073|P1|Period 1: Main Phase (12 Weeks)|Adverse Event|5
1545829|NCT00111761|5055243|P2|Part 2|Other|0
1545830|NCT00111761|5055244|P1|Part 2|Other|1
1545831|NCT00111761|5055243|P2|Part 2|Protocol-specified criteria|0
1545832|NCT00111761|5055244|P1|Part 2|Protocol-specified criteria|1
1545833|NCT00111761|5055243|P2|Part 2|Disease progression|0
1545834|NCT00111761|5055244|P1|Part 2|Disease progression|3
1545835|NCT00111761|5055243|P2|Part 2|Death|0
1545836|NCT00111761|5055244|P1|Part 2|Death|1
1545837|NCT00111761|5055243|P2|Part 2|Physician Decision|0
1545838|NCT00111761|5055244|P1|Part 2|Physician Decision|1
1545839|NCT00111761|5055243|P2|Part 2|Adverse Event|0
1545840|NCT00111761|5055244|P1|Part 2|Adverse Event|1
1545841|NCT00111761|5055243|P2|Part 1|Withdrawal by Subject|1
1545842|NCT00111761|5055244|P1|Part 1|Withdrawal by Subject|0
1545843|NCT00111761|5055243|P2|Part 1|Other|1
1545844|NCT00111761|5055244|P1|Part 1|Other|0
1545845|NCT00111761|5055243|P2|Part 1|Death|2
1545846|NCT00111761|5055244|P1|Part 1|Death|0
1545847|NCT00111761|5055243|P2|Part 1|Physician Decision|1
1545848|NCT00111761|5055244|P1|Part 1|Physician Decision|0
1545849|NCT00111007|5055273|P2|Long Term Follow-up|Missing|3
1545850|NCT00111007|5055274|P1|Long Term Follow-up|Missing|10
1545851|NCT00111007|5055273|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
1545852|NCT00111007|5055274|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
1545853|NCT00111007|5055273|P2|Long Term Follow-up|Withdrawal by Subject|1
1545854|NCT00111007|5055274|P1|Long Term Follow-up|Withdrawal by Subject|0
1545855|NCT00111007|5055273|P2|Long Term Follow-up|Lost to Follow-up|1
1545856|NCT00111007|5055274|P1|Long Term Follow-up|Lost to Follow-up|1
1545857|NCT00111007|5055273|P2|Long Term Follow-up|Death|39
1545858|NCT00111007|5055274|P1|Long Term Follow-up|Death|34
1545859|NCT00111007|5055273|P2|Active Follow-up|Disease progression/recurrence/relapse|2
1545860|NCT00111007|5055274|P1|Active Follow-up|Disease progression/recurrence/relapse|3
1545861|NCT00111007|5055273|P2|Active Follow-up|Death|0
1545862|NCT00111007|5055274|P1|Active Follow-up|Death|2
1545863|NCT00111007|5055273|P2|Active Follow-up|Adverse Event|0
1545864|NCT00111007|5055274|P1|Active Follow-up|Adverse Event|1
1545865|NCT00111007|5055273|P2|Double-blind (DB) Treatment|Primary reason with other category|1
1545866|NCT00111007|5055274|P1|Double-blind (DB) Treatment|Primary reason with other category|0
1545867|NCT00111007|5055273|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
1545868|NCT00111007|5055274|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
1545869|NCT00111007|5055273|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
1545870|NCT00111007|5055274|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
1545871|NCT00111007|5055273|P2|Double-blind (DB) Treatment|Relapse|0
1545872|NCT00111007|5055274|P1|Double-blind (DB) Treatment|Relapse|1
1545873|NCT00111007|5055273|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
1545874|NCT00111007|5055274|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
1545875|NCT00111007|5055273|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
1545876|NCT00111007|5055274|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
1545877|NCT00111007|5055273|P2|Double-blind (DB) Treatment|Protocol Violation|1
1545878|NCT00111007|5055274|P1|Double-blind (DB) Treatment|Protocol Violation|0
1545879|NCT00111007|5055273|P2|Double-blind (DB) Treatment|Death|2
1545880|NCT00111007|5055274|P1|Double-blind (DB) Treatment|Death|5
1545881|NCT00111007|5055273|P2|Double-blind (DB) Treatment|Adverse Event|4
1545882|NCT00111007|5055274|P1|Double-blind (DB) Treatment|Adverse Event|12
1545883|NCT00110994|5055290|P2|Long Term Follow-up|Death|17
1545884|NCT00110994|5055291|P1|Long Term Follow-up|Death|19
1545885|NCT00110994|5055290|P2|Active Follow-up|Other reasons|2
1545886|NCT00110994|5055291|P1|Active Follow-up|Other reasons|0
1545887|NCT00110994|5055290|P2|Active Follow-up|Disease progression/recurrence/replace|0
1545888|NCT00110994|5055291|P1|Active Follow-up|Disease progression/recurrence/replace|1
1545889|NCT00110994|5055290|P2|Double-blind (DB) Treatment|other reasons|3
1545890|NCT00110994|5055291|P1|Double-blind (DB) Treatment|other reasons|2
1545891|NCT00110994|5055290|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
1545892|NCT00110994|5055291|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
1545893|NCT00110994|5055290|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
1545894|NCT00110994|5055291|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
1545895|NCT00110994|5055290|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
1545896|NCT00110994|5055291|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
1545897|NCT00110994|5055290|P2|Double-blind (DB) Treatment|Death|0
1545898|NCT00110994|5055291|P1|Double-blind (DB) Treatment|Death|1
1545899|NCT00110994|5055290|P2|Double-blind (DB) Treatment|Adverse Event|0
1545900|NCT00110994|5055291|P1|Double-blind (DB) Treatment|Adverse Event|3
1545901|NCT00110890|5055317|P2|Overall Study|Did not enter follow-up phase|4
1545902|NCT00110890|5055318|P1|Overall Study|Did not enter follow-up phase|10
1545903|NCT00110890|5055317|P2|Overall Study|Parathyroidectomy|1
1545904|NCT00110890|5055318|P1|Overall Study|Parathyroidectomy|0
1545905|NCT00110890|5055317|P2|Overall Study|Disease progression|1
1545906|NCT00110890|5055318|P1|Overall Study|Disease progression|0
1545907|NCT00110890|5055317|P2|Overall Study|Requirement for alternative therapy|1
1545908|NCT00110890|5055318|P1|Overall Study|Requirement for alternative therapy|0
1545911|NCT00110890|5055317|P2|Overall Study|Other|23
1545912|NCT00110890|5055318|P1|Overall Study|Other|34
1545913|NCT00110890|5055317|P2|Overall Study|Invest. Product Commercially Available|110
1545914|NCT00110890|5055318|P1|Overall Study|Invest. Product Commercially Available|217
1545915|NCT00110890|5055317|P2|Overall Study|Kidney Transplant|12
1545916|NCT00110890|5055318|P1|Overall Study|Kidney Transplant|16
1545917|NCT00110890|5055317|P2|Overall Study|Noncompliance|0
1545918|NCT00110890|5055318|P1|Overall Study|Noncompliance|10
1545919|NCT00110890|5055317|P2|Overall Study|Protocol Deviation|0
1545920|NCT00110890|5055318|P1|Overall Study|Protocol Deviation|1
1545921|NCT00110890|5055317|P2|Overall Study|Withdrawal by Subject|5
1545922|NCT00110890|5055318|P1|Overall Study|Withdrawal by Subject|17
1545923|NCT00110890|5055317|P2|Overall Study|Physician Decision|5
1545924|NCT00110890|5055318|P1|Overall Study|Physician Decision|4
1545925|NCT00110890|5055317|P2|Overall Study|Lost to Follow-up|1
1545926|NCT00110890|5055318|P1|Overall Study|Lost to Follow-up|3
1545927|NCT00110890|5055317|P2|Overall Study|Death|9
1545928|NCT00110890|5055318|P1|Overall Study|Death|16
1545929|NCT00110890|5055317|P2|Overall Study|Adverse Event|7
1545930|NCT00110890|5055318|P1|Overall Study|Adverse Event|30
1545931|NCT00110812|5055335|P3|Extended Follow-up|Lost to Follow-up|1
1545932|NCT00110812|5055336|P2|Extended Follow-up|Lost to Follow-up|3
1545933|NCT00110812|5055337|P1|Extended Follow-up|Lost to Follow-up|1
1545934|NCT00110812|5055335|P3|Extended Follow-up|Withdrawal by Subject|0
1545935|NCT00110812|5055336|P2|Extended Follow-up|Withdrawal by Subject|1
1545936|NCT00110812|5055337|P1|Extended Follow-up|Withdrawal by Subject|0
1545937|NCT00110812|5055335|P3|Extended Follow-up|Death|3
1545938|NCT00110812|5055336|P2|Extended Follow-up|Death|0
1545939|NCT00110812|5055337|P1|Extended Follow-up|Death|1
1545940|NCT00110812|5055335|P3|Main Study|Lost to Follow-up|10
1545941|NCT00110812|5055336|P2|Main Study|Lost to Follow-up|11
1545942|NCT00110812|5055337|P1|Main Study|Lost to Follow-up|8
1545943|NCT00110812|5055335|P3|Main Study|Withdrawal by Subject|1
1545944|NCT00110812|5055336|P2|Main Study|Withdrawal by Subject|0
1545945|NCT00110812|5055337|P1|Main Study|Withdrawal by Subject|0
1545946|NCT00110812|5055335|P3|Main Study|Death|2
1545947|NCT00110812|5055336|P2|Main Study|Death|0
1545948|NCT00110812|5055337|P1|Main Study|Death|0
1545949|NCT00110617|5055382|P2|Overall Study|Did not receive study drug|12
1545950|NCT00110617|5055383|P1|Overall Study|Did not receive study drug|0
1545951|NCT00110617|5055382|P2|Overall Study|Death|1
1545952|NCT00110617|5055383|P1|Overall Study|Death|1
1545953|NCT00110617|5055382|P2|Overall Study|Administrative problems|5
1545954|NCT00110617|5055383|P1|Overall Study|Administrative problems|6
1545955|NCT00110617|5055382|P2|Overall Study|Lost to Follow-up|1
1545956|NCT00110617|5055383|P1|Overall Study|Lost to Follow-up|9
1545957|NCT00110617|5055382|P2|Overall Study|Withdrawal by Subject|4
1545958|NCT00110617|5055383|P1|Overall Study|Withdrawal by Subject|10
1545959|NCT00110617|5055382|P2|Overall Study|Protocol Violation|0
1545960|NCT00110617|5055383|P1|Overall Study|Protocol Violation|5
1545961|NCT00110617|5055382|P2|Overall Study|Patient no longer requires study drug|0
1545962|NCT00110617|5055383|P1|Overall Study|Patient no longer requires study drug|1
1545963|NCT00110617|5055382|P2|Overall Study|Lack of Efficacy|0
1545964|NCT00110617|5055383|P1|Overall Study|Lack of Efficacy|1
1545965|NCT00110617|5055382|P2|Overall Study|Abnormal Laboratory Value|2
1545966|NCT00110617|5055383|P1|Overall Study|Abnormal Laboratory Value|4
1545967|NCT00110617|5055382|P2|Overall Study|Adverse Event|4
1545968|NCT00110617|5055383|P1|Overall Study|Adverse Event|2
1545969|NCT00110396|5055500|P1|Overall Study|Patient is to be administered copaxone|1
1545970|NCT00110396|5055500|P1|Overall Study|The patient has refused to visit site|1
1545971|NCT00110396|5055500|P1|Overall Study|The patient has refused|2
1545972|NCT00110396|5055500|P1|Overall Study|Patient refused to come back|1
1545973|NCT00110396|5055500|P1|Overall Study|Protocol Violation|2
1545974|NCT00110396|5055500|P1|Overall Study|Pregnancy (Protocol violation)|2
1545975|NCT00110396|5055500|P1|Overall Study|Pregnancy|1
1545976|NCT00110396|5055500|P1|Overall Study|Participation in MS vaccine study|1
1545977|NCT00110396|5055500|P1|Overall Study|Patient's decision|1
1545978|NCT00110396|5055500|P1|Overall Study|Patient will|1
1545979|NCT00110396|5055500|P1|Overall Study|Patient refused to participate|1
1545980|NCT00110396|5055500|P1|Overall Study|Patient refused to continue|1
1545981|NCT00110396|5055500|P1|Overall Study|Patient non-compliance|1
1545982|NCT00110396|5055500|P1|Overall Study|Decided not to continue treatment|1
1545983|NCT00110396|5055500|P1|Overall Study|Lack of Efficacy|1
1545984|NCT00110396|5055500|P1|Overall Study|Initiated mitoxantrone therapy|1
1545985|NCT00110396|5055500|P1|Overall Study|Administration of plasmapheresis|1
1545986|NCT00110396|5055500|P1|Overall Study|Lost to Follow-up|1
1545987|NCT00110396|5055500|P1|Overall Study|Adverse Event|15
1545988|NCT00110357|5055508|P2|Overall Study|Withdrawal by Subject|1
1545989|NCT00110357|5055509|P1|Overall Study|Withdrawal by Subject|3
1545990|NCT00110357|5055508|P2|Overall Study|Study Drug Toxicity|3
1545991|NCT00110357|5055509|P1|Overall Study|Study Drug Toxicity|1
1545992|NCT00110357|5055508|P2|Overall Study|Study Closure|0
1545993|NCT00110357|5055509|P1|Overall Study|Study Closure|1
1545994|NCT00110357|5055508|P2|Overall Study|Disease progression/relapse|15
1545995|NCT00110357|5055509|P1|Overall Study|Disease progression/relapse|20
1545996|NCT00110357|5055508|P2|Overall Study|Deterioration without progression|0
1545997|NCT00110357|5055509|P1|Overall Study|Deterioration without progression|2
1545998|NCT00110305|5055597|P2|Overall Study|Other|2
1545999|NCT00110305|5055598|P1|Overall Study|Other|8
1546000|NCT00110305|5055597|P2|Overall Study|Lost to Follow-up|3
1546001|NCT00110305|5055598|P1|Overall Study|Lost to Follow-up|20
1546002|NCT00110305|5055597|P2|Overall Study|Withdrawal by Subject|7
1546003|NCT00110305|5055598|P1|Overall Study|Withdrawal by Subject|7
1546004|NCT00110305|5055597|P2|Overall Study|Protocol Violation|1
1546005|NCT00110305|5055598|P1|Overall Study|Protocol Violation|0
1546006|NCT00110305|5055597|P2|Overall Study|Subject Reached A Virologic Endpoint|3
1546007|NCT00110305|5055598|P1|Overall Study|Subject Reached A Virologic Endpoint|21
1546008|NCT00110305|5055597|P2|Overall Study|Subject Ineligible To Continue The Trial|1
1546009|NCT00110305|5055598|P1|Overall Study|Subject Ineligible To Continue The Trial|2
1546010|NCT00110305|5055597|P2|Overall Study|Subject Non-Compliant|2
1546011|NCT00110305|5055598|P1|Overall Study|Subject Non-Compliant|9
1546012|NCT00110305|5055597|P2|Overall Study|Sponsors Decision|0
1546013|NCT00110305|5055598|P1|Overall Study|Sponsors Decision|1
1546014|NCT00110305|5055597|P2|Overall Study|Adverse Event|13
1546015|NCT00110305|5055598|P1|Overall Study|Adverse Event|46
1546016|NCT00110214|5055651|P2|Overall Study|Other (not specified)|75
1546017|NCT00110214|5055652|P1|Overall Study|Other (not specified)|61
1546018|NCT00110214|5055651|P2|Overall Study|Refused further treatment|65
1546019|NCT00110214|5055652|P1|Overall Study|Refused further treatment|52
1546020|NCT00110214|5055651|P2|Overall Study|Adverse Event|192
1546021|NCT00110214|5055652|P1|Overall Study|Adverse Event|115
1546022|NCT00110214|5055651|P2|Overall Study|Disease progression or death|151
1546023|NCT00110214|5055652|P1|Overall Study|Disease progression or death|260
1546024|NCT00110214|5055651|P2|Overall Study|Never started treatment|20
1546025|NCT00110214|5055652|P1|Overall Study|Never started treatment|21
1546026|NCT00110149|5055664|P1|Overall Study|Physician Decision|3
1546027|NCT00110084|5055678|P1|Overall Study|Other|2
1546028|NCT00110084|5055678|P1|Overall Study|Intercurrent Illness|1
1546029|NCT00110084|5055678|P1|Overall Study|Alternate Therapy|5
1546030|NCT00110084|5055678|P1|Overall Study|Patient Refusal|10
1546031|NCT00110084|5055678|P1|Overall Study|Death|1
1546032|NCT00110084|5055678|P1|Overall Study|Adverse Event|9
1546033|NCT00110019|5055687|P2|Overall Study|other reasons|30
1546034|NCT00110019|5055688|P1|Overall Study|other reasons|22
1546035|NCT00110019|5055687|P2|Overall Study|Not start protocol therapy|16
1546036|NCT00110019|5055688|P1|Overall Study|Not start protocol therapy|17
1546037|NCT00110019|5055687|P2|Overall Study|symptom deterioration|16
1546038|NCT00110019|5055688|P1|Overall Study|symptom deterioration|13
1546039|NCT00110019|5055687|P2|Overall Study|complicating disease|1
1546040|NCT00110019|5055688|P1|Overall Study|complicating disease|1
1546041|NCT00110019|5055687|P2|Overall Study|alternative therapy|1
1546042|NCT00110019|5055688|P1|Overall Study|alternative therapy|5
1546043|NCT00110019|5055687|P2|Overall Study|Withdrawal by Subject|9
1546044|NCT00110019|5055688|P1|Overall Study|Withdrawal by Subject|21
1546045|NCT00110019|5055687|P2|Overall Study|Death|15
1546046|NCT00110019|5055688|P1|Overall Study|Death|13
1546047|NCT00110019|5055687|P2|Overall Study|Adverse Event|40
1546048|NCT00110019|5055688|P1|Overall Study|Adverse Event|61
1546049|NCT00110019|5055687|P2|Overall Study|Lack of Efficacy|285
1546050|NCT00110019|5055688|P1|Overall Study|Lack of Efficacy|253
1546051|NCT00109967|5055700|P2|Overall Study|Death|2
1546052|NCT00109967|5055701|P1|Overall Study|Death|0
1546053|NCT00109967|5055700|P2|Overall Study|Physician Decision|3
1546054|NCT00109967|5055701|P1|Overall Study|Physician Decision|1
1546055|NCT00109967|5055700|P2|Overall Study|Withdrawal by Subject|0
1546056|NCT00109967|5055701|P1|Overall Study|Withdrawal by Subject|5
1546057|NCT00109967|5055700|P2|Overall Study|Adverse Event|1
1546058|NCT00109967|5055701|P1|Overall Study|Adverse Event|12
1546059|NCT00109967|5055700|P2|Overall Study|Cancel Prior to Treatment|0
1546060|NCT00109967|5055701|P1|Overall Study|Cancel Prior to Treatment|2
1546061|NCT00109928|5055715|P1|Overall Study|not eligible|1
1546062|NCT00109928|5055715|P1|Overall Study|not protocol specified|2
1546063|NCT00109928|5055715|P1|Overall Study|Death|2
1546064|NCT00109928|5055715|P1|Overall Study|Progression|6
1546065|NCT00109928|5055715|P1|Overall Study|Adverse Event|2
1546066|NCT00109850|5055732|P1|Overall Study|Ineligible|1
1546067|NCT00109850|5055732|P1|Overall Study|Death|2
1546068|NCT00109850|5055732|P1|Overall Study|Adverse Event|1
1546069|NCT00109837|5055739|P1|Overall Study|Ineligible|1
1546070|NCT00109837|5055739|P1|Overall Study|Not treated|1
1546071|NCT00109837|5055739|P1|Overall Study|BCR/ABL+ or Ph+|17
1546072|NCT00109837|5055739|P1|Overall Study|Death|1
1546073|NCT00109837|5055739|P1|Overall Study|Refusal unrelated to adverse effects|1
1546074|NCT00109837|5055739|P1|Overall Study|Adverse Event|2
1546075|NCT00109772|5055749|P2|Open-label Extension|not specified|10
1546076|NCT00109772|5055750|P1|Open-label Extension|not specified|4
1546077|NCT00109772|5055749|P2|Open-label Extension|Protocol Violation|2
1546078|NCT00109772|5055750|P1|Open-label Extension|Protocol Violation|2
1546079|NCT00109772|5055749|P2|Open-label Extension|Death|1
1546080|NCT00109772|5055750|P1|Open-label Extension|Death|0
1546081|NCT00109772|5055749|P2|Open-label Extension|Lost to Follow-up|0
1546082|NCT00109772|5055750|P1|Open-label Extension|Lost to Follow-up|1
1546083|NCT00109772|5055749|P2|Open-label Extension|Withdrawal by Subject|6
1546084|NCT00109772|5055750|P1|Open-label Extension|Withdrawal by Subject|9
1546085|NCT00109772|5055749|P2|Open-label Extension|Lack of Efficacy|11
1546086|NCT00109772|5055750|P1|Open-label Extension|Lack of Efficacy|19
1546087|NCT00109772|5055749|P2|Open-label Extension|Adverse Event|19
1546088|NCT00109772|5055750|P1|Open-label Extension|Adverse Event|10
1546089|NCT00109772|5055749|P2|Double-blind Treatment|Withdrew prior to treatment|1
1546090|NCT00109772|5055750|P1|Double-blind Treatment|Withdrew prior to treatment|3
1546091|NCT00109772|5055749|P2|Double-blind Treatment|not specified|4
1546092|NCT00109772|5055750|P1|Double-blind Treatment|not specified|0
1546093|NCT00109772|5055749|P2|Double-blind Treatment|Protocol Violation|1
1546094|NCT00109772|5055750|P1|Double-blind Treatment|Protocol Violation|0
1546095|NCT00109772|5055749|P2|Double-blind Treatment|Lost to Follow-up|3
1546096|NCT00109772|5055750|P1|Double-blind Treatment|Lost to Follow-up|2
1546097|NCT00109772|5055749|P2|Double-blind Treatment|Withdrawal by Subject|1
1546098|NCT00109772|5055750|P1|Double-blind Treatment|Withdrawal by Subject|2
1546099|NCT00109772|5055749|P2|Double-blind Treatment|Lack of Efficacy|0
1546100|NCT00109772|5055750|P1|Double-blind Treatment|Lack of Efficacy|1
1546101|NCT00109772|5055749|P2|Double-blind Treatment|Adverse Event|5
1546102|NCT00109772|5055750|P1|Double-blind Treatment|Adverse Event|14
1546103|NCT00109733|5055790|P2|Overall Study|Could not commit time for study|1
1546104|NCT00109733|5055791|P1|Overall Study|Could not commit time for study|1
1546105|NCT00109733|5055790|P2|Overall Study|Non-compliant|1
1546106|NCT00109733|5055791|P1|Overall Study|Non-compliant|0
1546107|NCT00109733|5055790|P2|Overall Study|Stopped taking study drug|1
1546108|NCT00109733|5055791|P1|Overall Study|Stopped taking study drug|1
1546109|NCT00109733|5055790|P2|Overall Study|Protocol Violation|1
1546110|NCT00109733|5055791|P1|Overall Study|Protocol Violation|0
1546111|NCT00109590|5055808|P3|Overall Study|Never Started Treatment|3
1546112|NCT00109590|5055809|P2|Overall Study|Never Started Treatment|2
1546113|NCT00109590|5055810|P1|Overall Study|Never Started Treatment|1
1546114|NCT00109590|5055808|P3|Overall Study|Lost to Follow-up|1
1546115|NCT00109590|5055809|P2|Overall Study|Lost to Follow-up|0
1546116|NCT00109590|5055810|P1|Overall Study|Lost to Follow-up|1
1546117|NCT00109577|5055852|P2|Overall Study|Withdrawal by Subject|3
1546118|NCT00109577|5055853|P1|Overall Study|Withdrawal by Subject|3
1546119|NCT00109343|5055884|P3|Overall Study|Other|1
1546120|NCT00109343|5055885|P2|Overall Study|Other|2
1546121|NCT00109343|5055886|P1|Overall Study|Other|5
1546122|NCT00109343|5055884|P3|Overall Study|Subject Moved|1
1546123|NCT00109343|5055885|P2|Overall Study|Subject Moved|2
1546124|NCT00109343|5055886|P1|Overall Study|Subject Moved|6
1546125|NCT00109343|5055884|P3|Overall Study|Withdrawal by Subject|10
1546126|NCT00109343|5055885|P2|Overall Study|Withdrawal by Subject|11
1546127|NCT00109343|5055886|P1|Overall Study|Withdrawal by Subject|15
1546128|NCT00109343|5055884|P3|Overall Study|Protocol Violation|2
1546129|NCT00109343|5055885|P2|Overall Study|Protocol Violation|2
1546130|NCT00109343|5055886|P1|Overall Study|Protocol Violation|1
1546131|NCT00109343|5055884|P3|Overall Study|Lost to Follow-up|14
1546132|NCT00109343|5055885|P2|Overall Study|Lost to Follow-up|20
1546133|NCT00109343|5055886|P1|Overall Study|Lost to Follow-up|35
1546134|NCT00109343|5055884|P3|Overall Study|Lack of Efficacy|0
1546135|NCT00109343|5055885|P2|Overall Study|Lack of Efficacy|0
1546136|NCT00109343|5055886|P1|Overall Study|Lack of Efficacy|1
1546137|NCT00109343|5055884|P3|Overall Study|Adverse Event|2
1546138|NCT00109343|5055885|P2|Overall Study|Adverse Event|0
1546139|NCT00109343|5055886|P1|Overall Study|Adverse Event|1
1546140|NCT00109031|5055931|P4|Overall Study|Protocol Violation|0
1546141|NCT00109031|5055932|P3|Overall Study|Protocol Violation|1
1546142|NCT00109031|5055933|P2|Overall Study|Protocol Violation|0
1546143|NCT00109031|5055934|P1|Overall Study|Protocol Violation|0
1546144|NCT00109031|5055931|P4|Overall Study|Physician Decision|0
1546145|NCT00109031|5055932|P3|Overall Study|Physician Decision|0
1546146|NCT00109031|5055933|P2|Overall Study|Physician Decision|1
1546147|NCT00109031|5055934|P1|Overall Study|Physician Decision|0
1546148|NCT00109031|5055931|P4|Overall Study|Withdrawal by Subject|0
1546149|NCT00109031|5055932|P3|Overall Study|Withdrawal by Subject|0
1546150|NCT00109031|5055933|P2|Overall Study|Withdrawal by Subject|1
1546151|NCT00109031|5055934|P1|Overall Study|Withdrawal by Subject|0
1546152|NCT00109031|5055931|P4|Overall Study|Adverse Event|0
1546153|NCT00109031|5055932|P3|Overall Study|Adverse Event|1
1546154|NCT00109031|5055933|P2|Overall Study|Adverse Event|0
1546155|NCT00109031|5055934|P1|Overall Study|Adverse Event|0
1546156|NCT00108953|5055985|P2|Follow-up|Study terminated by sponsor|6
1546157|NCT00108953|5055986|P1|Follow-up|Study terminated by sponsor|10
1546158|NCT00108953|5055985|P2|Follow-up|Lost to Follow-up|1
1546159|NCT00108953|5055986|P1|Follow-up|Lost to Follow-up|1
1546160|NCT00108953|5055985|P2|Follow-up|Death|26
1546161|NCT00108953|5055986|P1|Follow-up|Death|18
1546162|NCT00108862|5056008|P2|Overall Study|Lost to Follow-up|19
1546163|NCT00108862|5056009|P1|Overall Study|Lost to Follow-up|27
1546164|NCT00108862|5056008|P2|Overall Study|Withdrawal by Subject|6
1546165|NCT00108862|5056009|P1|Overall Study|Withdrawal by Subject|10
1546166|NCT00108862|5056008|P2|Overall Study|Death|37
1546167|NCT00108862|5056009|P1|Overall Study|Death|31
1546168|NCT00108732|5056037|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
1546169|NCT00108732|5056037|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
1546170|NCT00108732|5056037|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
1546171|NCT00108732|5056037|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
1546172|NCT00108732|5056037|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
1546173|NCT00108732|5056037|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
1546174|NCT00108732|5056037|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
1546175|NCT00108628|5056046|P2|Overall Study|Death|0
1546176|NCT00108628|5056047|P1|Overall Study|Death|1
1546177|NCT00108628|5056046|P2|Overall Study|Lack of Efficacy|1
1546178|NCT00108628|5056047|P1|Overall Study|Lack of Efficacy|2
1546179|NCT00108628|5056046|P2|Overall Study|Withdrawal by Subject|9
1546180|NCT00108628|5056047|P1|Overall Study|Withdrawal by Subject|17
1546181|NCT00108485|5056097|P2|Overall Study|Lost to Follow-up|2
1546182|NCT00108485|5056098|P1|Overall Study|Lost to Follow-up|0
1546183|NCT00108485|5056097|P2|Overall Study|Withdrawal by Subject|0
1546184|NCT00108485|5056098|P1|Overall Study|Withdrawal by Subject|3
1546185|NCT00108433|5056106|P2|Overall Study|Other|14
1546186|NCT00108433|5056107|P1|Overall Study|Other|14
1546187|NCT00108433|5056106|P2|Overall Study|Adverse Event|1
1546188|NCT00108433|5056107|P1|Overall Study|Adverse Event|3
1546189|NCT00108433|5056106|P2|Overall Study|Death|0
1546190|NCT00108433|5056107|P1|Overall Study|Death|3
1546191|NCT00108433|5056106|P2|Overall Study|Lack of Efficacy|2
1546192|NCT00108433|5056107|P1|Overall Study|Lack of Efficacy|1
1546193|NCT00108355|5056123|P2|Overall Study|Loculated ascites, limiting paracentesis|1
1546194|NCT00108355|5056124|P1|Overall Study|Loculated ascites, limiting paracentesis|1
1546195|NCT00108355|5056123|P2|Overall Study|Peritonitis at index paracentesis|1
1546196|NCT00108355|5056124|P1|Overall Study|Peritonitis at index paracentesis|1
1546197|NCT00108160|5056173|P2|Overall Study|Protocol Violation|5
1546198|NCT00108160|5056174|P1|Overall Study|Protocol Violation|9
1546199|NCT00108160|5056173|P2|Overall Study|Withdrawal by Subject|2
1546200|NCT00108160|5056174|P1|Overall Study|Withdrawal by Subject|4
1546201|NCT00108160|5056173|P2|Overall Study|Death|2
1546202|NCT00108160|5056174|P1|Overall Study|Death|1
1546203|NCT00108160|5056173|P2|Overall Study|Lost to Follow-up|12
1546204|NCT00108160|5056174|P1|Overall Study|Lost to Follow-up|25
1546205|NCT00108082|5056187|P3|Overall Study|Blood Pressure Not Controlled|0
1546206|NCT00108082|5056188|P2|Overall Study|Blood Pressure Not Controlled|0
1546207|NCT00108082|5056189|P1|Overall Study|Blood Pressure Not Controlled|1
1546208|NCT00108082|5056187|P3|Overall Study|Investigator Not at Site|0
1546209|NCT00108082|5056188|P2|Overall Study|Investigator Not at Site|0
1546210|NCT00108082|5056189|P1|Overall Study|Investigator Not at Site|1
1546211|NCT00108082|5056187|P3|Overall Study|Subject Left Site Location|0
1546212|NCT00108082|5056188|P2|Overall Study|Subject Left Site Location|0
1546213|NCT00108082|5056189|P1|Overall Study|Subject Left Site Location|1
1546214|NCT00108082|5056187|P3|Overall Study|Study Medication Not Tapered|0
1546215|NCT00108082|5056188|P2|Overall Study|Study Medication Not Tapered|1
1546216|NCT00108082|5056189|P1|Overall Study|Study Medication Not Tapered|0
1546217|NCT00108082|5056187|P3|Overall Study|Protocol Amendment|0
1546218|NCT00108082|5056188|P2|Overall Study|Protocol Amendment|1
1546219|NCT00108082|5056189|P1|Overall Study|Protocol Amendment|0
1546220|NCT00108082|5056187|P3|Overall Study|Site Closed Study|0
1546221|NCT00108082|5056188|P2|Overall Study|Site Closed Study|2
1546222|NCT00108082|5056189|P1|Overall Study|Site Closed Study|0
1546223|NCT00108082|5056187|P3|Overall Study|Stopped Study Medication|1
1546224|NCT00108082|5056188|P2|Overall Study|Stopped Study Medication|0
1546225|NCT00108082|5056189|P1|Overall Study|Stopped Study Medication|0
1546226|NCT00108082|5056187|P3|Overall Study|Non-compliance|2
1546227|NCT00108082|5056188|P2|Overall Study|Non-compliance|0
1546228|NCT00108082|5056189|P1|Overall Study|Non-compliance|1
1546229|NCT00108082|5056187|P3|Overall Study|Incorrectly Randomized|2
1546230|NCT00108082|5056188|P2|Overall Study|Incorrectly Randomized|0
1546231|NCT00108082|5056189|P1|Overall Study|Incorrectly Randomized|0
1546232|NCT00108082|5056187|P3|Overall Study|Woman of Child-bearing Potential|2
1546233|NCT00108082|5056188|P2|Overall Study|Woman of Child-bearing Potential|0
1546234|NCT00108082|5056189|P1|Overall Study|Woman of Child-bearing Potential|2
1546235|NCT00108082|5056187|P3|Overall Study|Amendment 4: > Month 12|5
1546236|NCT00108082|5056188|P2|Overall Study|Amendment 4: > Month 12|7
1546237|NCT00108082|5056189|P1|Overall Study|Amendment 4: > Month 12|5
1546238|NCT00108082|5056187|P3|Overall Study|Lack of Efficacy|2
1546239|NCT00108082|5056188|P2|Overall Study|Lack of Efficacy|1
1546240|NCT00108082|5056189|P1|Overall Study|Lack of Efficacy|3
1546241|NCT00108082|5056187|P3|Overall Study|Protocol Violation|0
1546242|NCT00108082|5056188|P2|Overall Study|Protocol Violation|2
1546243|NCT00108082|5056189|P1|Overall Study|Protocol Violation|1
1546244|NCT00108082|5056187|P3|Overall Study|Consent Withdrawn|5
1546245|NCT00108082|5056188|P2|Overall Study|Consent Withdrawn|3
1546246|NCT00108082|5056189|P1|Overall Study|Consent Withdrawn|3
1546247|NCT00108082|5056187|P3|Overall Study|Lost to Follow-up|7
1546248|NCT00108082|5056188|P2|Overall Study|Lost to Follow-up|3
1546249|NCT00108082|5056189|P1|Overall Study|Lost to Follow-up|6
1546250|NCT00108082|5056187|P3|Overall Study|Adverse Event|17
1546251|NCT00108082|5056188|P2|Overall Study|Adverse Event|12
1546252|NCT00108082|5056189|P1|Overall Study|Adverse Event|14
1546253|NCT00108069|5056238|P2|Overall Study|Progessive disease|11
1546254|NCT00108069|5056239|P1|Overall Study|Progessive disease|27
1546255|NCT00108069|5056238|P2|Overall Study|Death|0
1546256|NCT00108069|5056239|P1|Overall Study|Death|1
1546257|NCT00108069|5056238|P2|Overall Study|Withdrawal by Subject|0
1546258|NCT00108069|5056239|P1|Overall Study|Withdrawal by Subject|1
1546259|NCT00108069|5056238|P2|Overall Study|Adverse Event|1
1546260|NCT00108069|5056239|P1|Overall Study|Adverse Event|1
1546261|NCT00108069|5056238|P2|Overall Study|Never rec'd study drug|1
1546262|NCT00108069|5056239|P1|Overall Study|Never rec'd study drug|0
1546263|NCT00107991|5056253|P1|18-Week Post Treatment Assessment|Adverse Event|2
1546264|NCT00107991|5056253|P1|12 Week Treatment Period|Incarcerated|1
1546265|NCT00107991|5056253|P1|12 Week Treatment Period|Protocol Violation|1
1546266|NCT00107991|5056253|P1|12 Week Treatment Period|Adverse Event|1
1546267|NCT00107991|5056253|P1|12 Week Treatment Period|Lack of Efficacy|2
1546268|NCT00107991|5056253|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
1546269|NCT00107991|5056253|P1|Eligibility Assessment|chronic uncontrolled asthma|1
1546270|NCT00107991|5056253|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
1546271|NCT00107991|5056253|P1|Eligibility Assessment|Abnormal labs|2
1546272|NCT00107991|5056253|P1|Eligibility Assessment|Positive purified protein derivative|4
1546273|NCT00107991|5056253|P1|Eligibility Assessment|Unwilling to participate|7
1546274|NCT00107991|5056253|P1|Eligibility Assessment|Disease not severe enough|7
1546275|NCT00107978|5056263|P2|Overall Study|Other|4
1546276|NCT00107978|5056264|P1|Overall Study|Other|5
1546277|NCT00107978|5056263|P2|Overall Study|Protocol Violation|1
1546278|NCT00107978|5056264|P1|Overall Study|Protocol Violation|0
1546279|NCT00107978|5056263|P2|Overall Study|Withdrawal by Subject|9
1546280|NCT00107978|5056264|P1|Overall Study|Withdrawal by Subject|4
1546281|NCT00107978|5056263|P2|Overall Study|Lost to Follow-up|28
1546282|NCT00107978|5056264|P1|Overall Study|Lost to Follow-up|20
1546283|NCT00107978|5056263|P2|Overall Study|Death|3
1546284|NCT00107978|5056264|P1|Overall Study|Death|3
1546285|NCT00107978|5056263|P2|Overall Study|Adverse Event|5
1546286|NCT00107978|5056264|P1|Overall Study|Adverse Event|1
1546287|NCT00107952|5056272|P2|Overall Study|Never received study treatment|6
1546288|NCT00107952|5056273|P1|Overall Study|Never received study treatment|9
1546289|NCT00107952|5056272|P2|Overall Study|Other|5
1546290|NCT00107952|5056273|P1|Overall Study|Other|2
1546291|NCT00107952|5056272|P2|Overall Study|Withdrawal by Subject|6
1546292|NCT00107952|5056273|P1|Overall Study|Withdrawal by Subject|9
1546293|NCT00107952|5056272|P2|Overall Study|Lost to Follow-up|3
1546294|NCT00107952|5056273|P1|Overall Study|Lost to Follow-up|0
1546295|NCT00107952|5056272|P2|Overall Study|Death|61
1546296|NCT00107952|5056273|P1|Overall Study|Death|75
1546297|NCT00107900|5056285|P6|Overall Study|Administrative Reasons|0
1546298|NCT00107900|5056286|P5|Overall Study|Administrative Reasons|2
1546299|NCT00107900|5056287|P4|Overall Study|Administrative Reasons|2
1546300|NCT00107900|5056288|P3|Overall Study|Administrative Reasons|2
1546301|NCT00107900|5056289|P2|Overall Study|Administrative Reasons|0
1546302|NCT00107900|5056290|P1|Overall Study|Administrative Reasons|1
1546303|NCT00107900|5056285|P6|Overall Study|Withdrawal by Subject|1
1546304|NCT00107900|5056286|P5|Overall Study|Withdrawal by Subject|1
1546305|NCT00107900|5056287|P4|Overall Study|Withdrawal by Subject|0
1546306|NCT00107900|5056288|P3|Overall Study|Withdrawal by Subject|5
1546307|NCT00107900|5056289|P2|Overall Study|Withdrawal by Subject|0
1546308|NCT00107900|5056290|P1|Overall Study|Withdrawal by Subject|1
1546309|NCT00107900|5056285|P6|Overall Study|Protocol Violation|0
1546310|NCT00107900|5056286|P5|Overall Study|Protocol Violation|7
1546311|NCT00107900|5056287|P4|Overall Study|Protocol Violation|5
1546312|NCT00107900|5056288|P3|Overall Study|Protocol Violation|5
1546313|NCT00107900|5056289|P2|Overall Study|Protocol Violation|0
1546314|NCT00107900|5056290|P1|Overall Study|Protocol Violation|1
1546315|NCT00107900|5056285|P6|Overall Study|Lost to Follow-up|5
1546316|NCT00107900|5056286|P5|Overall Study|Lost to Follow-up|5
1546317|NCT00107900|5056287|P4|Overall Study|Lost to Follow-up|2
1546318|NCT00107900|5056288|P3|Overall Study|Lost to Follow-up|3
1546319|NCT00107900|5056289|P2|Overall Study|Lost to Follow-up|1
1546320|NCT00107900|5056290|P1|Overall Study|Lost to Follow-up|4
1546321|NCT00107900|5056285|P6|Overall Study|Death|0
1546322|NCT00107900|5056286|P5|Overall Study|Death|1
1546323|NCT00107900|5056287|P4|Overall Study|Death|0
1546324|NCT00107900|5056288|P3|Overall Study|Death|0
1546325|NCT00107900|5056289|P2|Overall Study|Death|0
1546326|NCT00107900|5056290|P1|Overall Study|Death|0
1546327|NCT00107900|5056285|P6|Overall Study|Adverse Event|3
1546328|NCT00107900|5056286|P5|Overall Study|Adverse Event|5
1546329|NCT00107900|5056287|P4|Overall Study|Adverse Event|3
1546330|NCT00107900|5056288|P3|Overall Study|Adverse Event|10
1546331|NCT00107900|5056289|P2|Overall Study|Adverse Event|2
1546332|NCT00107900|5056290|P1|Overall Study|Adverse Event|3
1546333|NCT00107783|5056324|P2|Overall Study|Second hip replacement|1
1546334|NCT00107783|5056325|P1|Overall Study|Second hip replacement|1
1546335|NCT00107783|5056324|P2|Overall Study|Withdrawal by Subject|0
1546336|NCT00107783|5056325|P1|Overall Study|Withdrawal by Subject|2
1546337|NCT00107783|5056324|P2|Overall Study|Death|1
1546338|NCT00107783|5056325|P1|Overall Study|Death|0
1546339|NCT00107783|5056324|P2|Overall Study|Adverse Event|2
1546340|NCT00107783|5056325|P1|Overall Study|Adverse Event|0
1546341|NCT00107653|5056360|P2|Overall Study|Administrative Reasons|3
1546342|NCT00107653|5056361|P1|Overall Study|Administrative Reasons|3
1546343|NCT00107653|5056360|P2|Overall Study|Lost to Follow-up|5
1546344|NCT00107653|5056361|P1|Overall Study|Lost to Follow-up|13
1546345|NCT00107653|5056360|P2|Overall Study|Withdrawal by Subject|13
1546346|NCT00107653|5056361|P1|Overall Study|Withdrawal by Subject|12
1546347|NCT00107653|5056360|P2|Overall Study|Protocol Violation|0
1546348|NCT00107653|5056361|P1|Overall Study|Protocol Violation|1
1546349|NCT00107653|5056360|P2|Overall Study|Violation of Selection Criteria at Entry|1
1546350|NCT00107653|5056361|P1|Overall Study|Violation of Selection Criteria at Entry|1
1546351|NCT00107653|5056360|P2|Overall Study|Insufficient Therapeutic Response|11
1546352|NCT00107653|5056361|P1|Overall Study|Insufficient Therapeutic Response|25
1546353|NCT00107653|5056360|P2|Overall Study|Adverse Event|43
1546354|NCT00107653|5056361|P1|Overall Study|Adverse Event|24
1546355|NCT00107614|5056407|P1|Overall Study|Death|2
1546356|NCT00107614|5056407|P1|Overall Study|Physician Decision|10
1546357|NCT00107380|5056438|P1|Overall Study|Ineligible|2
1546358|NCT00107380|5056438|P1|Overall Study|Other - not protocol specified|7
1546359|NCT00107380|5056438|P1|Overall Study|Death|3
1546360|NCT00107380|5056438|P1|Overall Study|Progression/relapse|4
1546361|NCT00107380|5056438|P1|Overall Study|Refusal Unrelated to Adverse Event|7
1546362|NCT00107380|5056438|P1|Overall Study|Adverse Event|7
1546363|NCT00107315|5056444|P1|Overall Study|Withdrawal by Subject|2
1546364|NCT00107315|5056444|P1|Overall Study|Adverse Event|4
1546365|NCT00107315|5056444|P1|Overall Study|Disease Progression|9
1546366|NCT00107276|5056451|P1|Overall Study|Ineligible|16
1546367|NCT00107276|5056451|P1|Overall Study|Death|1
1546368|NCT00107276|5056451|P1|Overall Study|Patient refusal|1
1546369|NCT00107276|5056451|P1|Overall Study|M.D. decision|2
1546370|NCT00107276|5056451|P1|Overall Study|Adverse Event|6
1546371|NCT00107276|5056451|P1|Overall Study|Progression|46
1546372|NCT00107198|5056457|P1|Overall Study|Ineligible|5
1546373|NCT00107198|5056457|P1|Overall Study|Withdrawal by Subject|6
1546374|NCT00107198|5056457|P1|Overall Study|Protocol Violation|1
1546375|NCT00107198|5056457|P1|Overall Study|Lost to Follow-up|12
1546376|NCT00107198|5056457|P1|Overall Study|Lack of Efficacy|28
1546377|NCT00107172|5056467|P2|Overall Study|Other Reason|3
1546378|NCT00107172|5056468|P1|Overall Study|Other Reason|4
1546379|NCT00107172|5056467|P2|Overall Study|Death|2
1546380|NCT00107172|5056468|P1|Overall Study|Death|0
1546381|NCT00107172|5056467|P2|Overall Study|Withdrawal by Subject|0
1546382|NCT00107172|5056468|P1|Overall Study|Withdrawal by Subject|1
1546383|NCT00107120|5056498|P2|Overall Study|death of parent|1
1546384|NCT00107120|5056499|P1|Overall Study|death of parent|0
1546385|NCT00107120|5056498|P2|Overall Study|moving away from site|1
1546386|NCT00107120|5056499|P1|Overall Study|moving away from site|1
1546387|NCT00107120|5056498|P2|Overall Study|Pregnancy|1
1546388|NCT00107120|5056499|P1|Overall Study|Pregnancy|0
1546389|NCT00107120|5056498|P2|Overall Study|Lost to Follow-up|6
1546390|NCT00107120|5056499|P1|Overall Study|Lost to Follow-up|8
1546391|NCT00107120|5056498|P2|Overall Study|Withdrawal by Subject|9
1546392|NCT00107120|5056499|P1|Overall Study|Withdrawal by Subject|8
1546393|NCT00107120|5056498|P2|Overall Study|Protocol Violation|0
1546394|NCT00107120|5056499|P1|Overall Study|Protocol Violation|3
1546395|NCT00107120|5056498|P2|Overall Study|Lack of Efficacy|5
1546396|NCT00107120|5056499|P1|Overall Study|Lack of Efficacy|5
1546397|NCT00107120|5056498|P2|Overall Study|Adverse Event|1
1546398|NCT00107120|5056499|P1|Overall Study|Adverse Event|4
1546399|NCT00107042|5056511|P2|Overall Study|Disallowed medications|2
1546400|NCT00107042|5056512|P1|Overall Study|Disallowed medications|0
1546401|NCT00107042|5056511|P2|Overall Study|vaccinated outside window|1
1546402|NCT00107042|5056512|P1|Overall Study|vaccinated outside window|1
1546403|NCT00107042|5056511|P2|Overall Study|Inadvertent enrollment|1
1546404|NCT00107042|5056512|P1|Overall Study|Inadvertent enrollment|0
1546405|NCT00107042|5056511|P2|Overall Study|Pregnancy|1
1546406|NCT00107042|5056512|P1|Overall Study|Pregnancy|1
1546407|NCT00107042|5056511|P2|Overall Study|Moved out of area|3
1546408|NCT00107042|5056512|P1|Overall Study|Moved out of area|5
1546409|NCT00107042|5056511|P2|Overall Study|Withdrawal by Subject|1
1546410|NCT00107042|5056512|P1|Overall Study|Withdrawal by Subject|6
1546411|NCT00107042|5056511|P2|Overall Study|Lost to Follow-up|7
1546412|NCT00107042|5056512|P1|Overall Study|Lost to Follow-up|9
1546413|NCT00106964|5056578|P3|Overall Study|Required disallowed medication|0
1546414|NCT00106964|5056579|P2|Overall Study|Required disallowed medication|1
1546415|NCT00106964|5056580|P1|Overall Study|Required disallowed medication|0
1546416|NCT00106964|5056578|P3|Overall Study|Did not meet eligibility criteria|2
1546417|NCT00106964|5056579|P2|Overall Study|Did not meet eligibility criteria|2
1546418|NCT00106964|5056580|P1|Overall Study|Did not meet eligibility criteria|0
1546419|NCT00106964|5056578|P3|Overall Study|Failure to adhere|0
1546420|NCT00106964|5056579|P2|Overall Study|Failure to adhere|0
1546421|NCT00106964|5056580|P1|Overall Study|Failure to adhere|2
1546422|NCT00106964|5056578|P3|Overall Study|Site Funding Terminated|1
1546423|NCT00106964|5056579|P2|Overall Study|Site Funding Terminated|1
1546424|NCT00106964|5056580|P1|Overall Study|Site Funding Terminated|0
1546425|NCT00106964|5056578|P3|Overall Study|Incarceration|0
1546426|NCT00106964|5056579|P2|Overall Study|Incarceration|1
1546427|NCT00106964|5056580|P1|Overall Study|Incarceration|0
1546428|NCT00106964|5056578|P3|Overall Study|Death|0
1546429|NCT00106964|5056579|P2|Overall Study|Death|1
1546430|NCT00106964|5056580|P1|Overall Study|Death|1
1546431|NCT00106964|5056578|P3|Overall Study|Pregnancy|2
1546432|NCT00106964|5056579|P2|Overall Study|Pregnancy|3
1546433|NCT00106964|5056580|P1|Overall Study|Pregnancy|2
1546434|NCT00106964|5056578|P3|Overall Study|Lost to Follow-up|2
1546435|NCT00106964|5056579|P2|Overall Study|Lost to Follow-up|6
1546436|NCT00106964|5056580|P1|Overall Study|Lost to Follow-up|8
1546437|NCT00106704|5056675|P2|Overall Study|Laboratory test|1
1546438|NCT00106704|5056676|P1|Overall Study|Laboratory test|1
1546439|NCT00106704|5056675|P2|Overall Study|Unable to re-enter US|0
1546440|NCT00106704|5056676|P1|Overall Study|Unable to re-enter US|1
1546441|NCT00106704|5056675|P2|Overall Study|Patient Received Glycemic Medication|41
1546442|NCT00106704|5056676|P1|Overall Study|Patient Received Glycemic Medication|22
1546443|NCT00106704|5056675|P2|Overall Study|Planned major surgery|0
1546444|NCT00106704|5056676|P1|Overall Study|Planned major surgery|1
1546445|NCT00106704|5056675|P2|Overall Study|Site terminated|1
1546446|NCT00106704|5056676|P1|Overall Study|Site terminated|0
1546447|NCT00106704|5056675|P2|Overall Study|Patient moved|0
1546448|NCT00106704|5056676|P1|Overall Study|Patient moved|1
1546449|NCT00106704|5056675|P2|Overall Study|Withdrawal by Subject|21
1546450|NCT00106704|5056676|P1|Overall Study|Withdrawal by Subject|14
1546451|NCT00106704|5056675|P2|Overall Study|Protocol Violation|7
1546452|NCT00106704|5056676|P1|Overall Study|Protocol Violation|4
1546453|NCT00106704|5056675|P2|Overall Study|Pregnancy|0
1546454|NCT00106704|5056676|P1|Overall Study|Pregnancy|1
1546455|NCT00106704|5056675|P2|Overall Study|Lost to Follow-up|3
1546456|NCT00106704|5056676|P1|Overall Study|Lost to Follow-up|7
1546457|NCT00106704|5056675|P2|Overall Study|Lack of Efficacy|69
1546458|NCT00106704|5056676|P1|Overall Study|Lack of Efficacy|67
1546459|NCT00106704|5056675|P2|Overall Study|Death|1
1546460|NCT00106704|5056676|P1|Overall Study|Death|2
1546461|NCT00106704|5056675|P2|Overall Study|Adverse Event|7
1546462|NCT00106704|5056676|P1|Overall Study|Adverse Event|10
1546463|NCT00106639|5056687|P3|Overall Study|Participant defaulted|1
1546464|NCT00106639|5056688|P2|Overall Study|Participant defaulted|1
1546465|NCT00106639|5056689|P1|Overall Study|Participant defaulted|0
1546466|NCT00106639|5056687|P3|Overall Study|Withdrawal by Subject|0
1546467|NCT00106639|5056688|P2|Overall Study|Withdrawal by Subject|1
1546468|NCT00106639|5056689|P1|Overall Study|Withdrawal by Subject|0
1546469|NCT00106639|5056687|P3|Overall Study|Protocol Violation|0
1546470|NCT00106639|5056688|P2|Overall Study|Protocol Violation|1
1546471|NCT00106639|5056689|P1|Overall Study|Protocol Violation|0
1546472|NCT00106639|5056687|P3|Overall Study|Adverse Event|1
1546473|NCT00106639|5056688|P2|Overall Study|Adverse Event|4
1546474|NCT00106639|5056689|P1|Overall Study|Adverse Event|3
1546475|NCT00106626|5056816|P4|Overall Study|> 14 day delay in therapy start|0
1546476|NCT00106626|5056817|P3|Overall Study|> 14 day delay in therapy start|0
1546477|NCT00106626|5056818|P2|Overall Study|> 14 day delay in therapy start|1
1546478|NCT00106626|5056819|P1|Overall Study|> 14 day delay in therapy start|0
1546479|NCT00106626|5056816|P4|Overall Study|Received radiation on new therapy|0
1546480|NCT00106626|5056817|P3|Overall Study|Received radiation on new therapy|0
1546481|NCT00106626|5056818|P2|Overall Study|Received radiation on new therapy|0
1546482|NCT00106626|5056819|P1|Overall Study|Received radiation on new therapy|1
1546483|NCT00106626|5056816|P4|Overall Study|Progressive Disease|10
1546484|NCT00106626|5056817|P3|Overall Study|Progressive Disease|9
1546485|NCT00106626|5056818|P2|Overall Study|Progressive Disease|1
1546486|NCT00106626|5056819|P1|Overall Study|Progressive Disease|4
1546487|NCT00106626|5056816|P4|Overall Study|Adverse Event|3
1546488|NCT00106626|5056817|P3|Overall Study|Adverse Event|3
1546489|NCT00106626|5056818|P2|Overall Study|Adverse Event|4
1546490|NCT00106626|5056819|P1|Overall Study|Adverse Event|5
1546491|NCT00106353|5057164|P7|Part 2|Physician Decision|0
1546492|NCT00106353|5057165|P6|Part 2|Physician Decision|1
1546493|NCT00106353|5057166|P5|Part 2|Physician Decision|0
1546494|NCT00106353|5057167|P4|Part 2|Physician Decision|0
1546495|NCT00106353|5057168|P3|Part 2|Physician Decision|0
1546496|NCT00106353|5057169|P2|Part 2|Physician Decision|0
1546497|NCT00106353|5057170|P1|Part 2|Physician Decision|0
1546498|NCT00106353|5057164|P7|Part 2|Withdrawal by Subject|0
1546499|NCT00106353|5057165|P6|Part 2|Withdrawal by Subject|0
1546500|NCT00106353|5057166|P5|Part 2|Withdrawal by Subject|1
1546501|NCT00106353|5057167|P4|Part 2|Withdrawal by Subject|0
1546502|NCT00106353|5057168|P3|Part 2|Withdrawal by Subject|0
1546503|NCT00106353|5057169|P2|Part 2|Withdrawal by Subject|0
1546504|NCT00106353|5057170|P1|Part 2|Withdrawal by Subject|0
1546505|NCT00106353|5057164|P7|Part 2|Other|1
1546506|NCT00106353|5057165|P6|Part 2|Other|1
1546507|NCT00106353|5057166|P5|Part 2|Other|1
1546508|NCT00106353|5057167|P4|Part 2|Other|0
1546509|NCT00106353|5057168|P3|Part 2|Other|0
1546510|NCT00106353|5057169|P2|Part 2|Other|0
1546511|NCT00106353|5057170|P1|Part 2|Other|0
1546512|NCT00106353|5057164|P7|Part 2|Adverse Event|1
1546513|NCT00106353|5057165|P6|Part 2|Adverse Event|2
1546514|NCT00106353|5057166|P5|Part 2|Adverse Event|0
1546515|NCT00106353|5057167|P4|Part 2|Adverse Event|0
1546516|NCT00106353|5057168|P3|Part 2|Adverse Event|0
1546517|NCT00106353|5057169|P2|Part 2|Adverse Event|0
1546518|NCT00106353|5057170|P1|Part 2|Adverse Event|0
1546519|NCT00106353|5057164|P7|Part 2|Symptomatic deterioration|0
1546520|NCT00106353|5057165|P6|Part 2|Symptomatic deterioration|0
1546521|NCT00106353|5057166|P5|Part 2|Symptomatic deterioration|3
1546522|NCT00106353|5057167|P4|Part 2|Symptomatic deterioration|0
1546523|NCT00106353|5057168|P3|Part 2|Symptomatic deterioration|0
1546524|NCT00106353|5057169|P2|Part 2|Symptomatic deterioration|0
1546525|NCT00106353|5057170|P1|Part 2|Symptomatic deterioration|0
1546526|NCT00106353|5057164|P7|Part 2|Death|1
1546527|NCT00106353|5057165|P6|Part 2|Death|0
1546528|NCT00106353|5057166|P5|Part 2|Death|3
1546529|NCT00106353|5057167|P4|Part 2|Death|0
1546530|NCT00106353|5057168|P3|Part 2|Death|0
1546531|NCT00106353|5057169|P2|Part 2|Death|0
1546532|NCT00106353|5057170|P1|Part 2|Death|0
1546533|NCT00106353|5057164|P7|Part 2|Disease progression|13
1546534|NCT00106353|5057165|P6|Part 2|Disease progression|14
1546535|NCT00106353|5057166|P5|Part 2|Disease progression|8
1546536|NCT00106353|5057167|P4|Part 2|Disease progression|0
1546537|NCT00106353|5057168|P3|Part 2|Disease progression|0
1546538|NCT00106353|5057169|P2|Part 2|Disease progression|0
1546539|NCT00106353|5057170|P1|Part 2|Disease progression|0
1546540|NCT00106353|5057164|P7|Part 1|Adverse Event|0
1546541|NCT00106353|5057165|P6|Part 1|Adverse Event|0
1546542|NCT00106353|5057166|P5|Part 1|Adverse Event|0
1546543|NCT00106353|5057167|P4|Part 1|Adverse Event|1
1546544|NCT00106353|5057168|P3|Part 1|Adverse Event|0
1546545|NCT00106353|5057169|P2|Part 1|Adverse Event|0
1546546|NCT00106353|5057170|P1|Part 1|Adverse Event|0
1546547|NCT00106353|5057164|P7|Part 1|Entered follow-up phase|0
1546548|NCT00106353|5057165|P6|Part 1|Entered follow-up phase|0
1546549|NCT00106353|5057166|P5|Part 1|Entered follow-up phase|0
1546550|NCT00106353|5057167|P4|Part 1|Entered follow-up phase|1
1546551|NCT00106353|5057168|P3|Part 1|Entered follow-up phase|0
1546552|NCT00106353|5057169|P2|Part 1|Entered follow-up phase|1
1546553|NCT00106353|5057170|P1|Part 1|Entered follow-up phase|1
1546554|NCT00106353|5057164|P7|Part 1|Symptomatic deterioration|0
1546555|NCT00106353|5057165|P6|Part 1|Symptomatic deterioration|0
1546556|NCT00106353|5057166|P5|Part 1|Symptomatic deterioration|0
1546557|NCT00106353|5057167|P4|Part 1|Symptomatic deterioration|0
1546558|NCT00106353|5057168|P3|Part 1|Symptomatic deterioration|1
1546559|NCT00106353|5057169|P2|Part 1|Symptomatic deterioration|0
1546560|NCT00106353|5057170|P1|Part 1|Symptomatic deterioration|0
1546561|NCT00106353|5057164|P7|Part 1|Withdrawal by Subject|0
1546562|NCT00106353|5057165|P6|Part 1|Withdrawal by Subject|0
1546563|NCT00106353|5057166|P5|Part 1|Withdrawal by Subject|0
1546564|NCT00106353|5057167|P4|Part 1|Withdrawal by Subject|2
1546565|NCT00106353|5057168|P3|Part 1|Withdrawal by Subject|1
1546566|NCT00106353|5057169|P2|Part 1|Withdrawal by Subject|0
1546567|NCT00106353|5057170|P1|Part 1|Withdrawal by Subject|0
1546568|NCT00106353|5057164|P7|Part 1|Disease progression|0
1546569|NCT00106353|5057165|P6|Part 1|Disease progression|0
1546570|NCT00106353|5057166|P5|Part 1|Disease progression|0
1546571|NCT00106353|5057167|P4|Part 1|Disease progression|3
1546572|NCT00106353|5057168|P3|Part 1|Disease progression|1
1546573|NCT00106353|5057169|P2|Part 1|Disease progression|4
1546574|NCT00106353|5057170|P1|Part 1|Disease progression|3
1546575|NCT00106249|5057297|P2|Overall Study|Lost to Follow-up|2
1546576|NCT00106249|5057298|P1|Overall Study|Lost to Follow-up|3
1546577|NCT00106184|5057310|P2|Overall Study|Withdrawal by Subject|2
1546578|NCT00106184|5057311|P1|Overall Study|Withdrawal by Subject|3
1546579|NCT00106080|5057353|P2|Overall Study|Withdrew/Loss to follow-up|27
1546580|NCT00106080|5057354|P1|Overall Study|Withdrew/Loss to follow-up|43
1546581|NCT00106028|5057364|P2|Overall Study|Lost to Follow-up|1
1546582|NCT00106028|5057365|P1|Overall Study|Lost to Follow-up|0
1546583|NCT00106028|5057364|P2|Overall Study|Withdrawal by Subject|8
1546584|NCT00106028|5057365|P1|Overall Study|Withdrawal by Subject|2
1546585|NCT00106028|5057364|P2|Overall Study|Protocol Violation|1
1546586|NCT00106028|5057365|P1|Overall Study|Protocol Violation|1
1546587|NCT00106028|5057364|P2|Overall Study|Adverse Event|2
1546588|NCT00106028|5057365|P1|Overall Study|Adverse Event|3
1546589|NCT00106002|5057459|P1|Overall Study|Ineligible after Registration|1
1546590|NCT00106002|5057459|P1|Overall Study|Did not take any study drug|1
1546591|NCT00105989|5057467|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
1546592|NCT00105989|5057468|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
1546593|NCT00105989|5057467|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
1546594|NCT00105989|5057468|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
1546595|NCT00105989|5057467|P2|Maintenance - Double-Blind:Week 34-86|Death|0
1546596|NCT00105989|5057468|P1|Maintenance - Double-Blind:Week 34-86|Death|0
1546597|NCT00105989|5057467|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
1546598|NCT00105989|5057468|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
1546599|NCT00105989|5057467|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
1546600|NCT00105989|5057468|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
1546601|NCT00105989|5057467|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
1546602|NCT00105989|5057468|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
1546603|NCT00105989|5057467|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
1546604|NCT00105989|5057468|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
1546605|NCT00105989|5057467|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
1546606|NCT00105989|5057468|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
1546607|NCT00105989|5057467|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
1546608|NCT00105989|5057468|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
1546609|NCT00105989|5057467|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
1546610|NCT00105989|5057468|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
1546611|NCT00105989|5057467|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
1546612|NCT00105989|5057468|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
1546613|NCT00105989|5057467|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
1546614|NCT00105989|5057468|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
1546615|NCT00105989|5057467|P2|Continuation - Open Label:Week 10-34|Death|0
1546616|NCT00105989|5057468|P1|Continuation - Open Label:Week 10-34|Death|0
1546617|NCT00105989|5057467|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
1546618|NCT00105989|5057468|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
1546619|NCT00105989|5057467|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
1546620|NCT00105989|5057468|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
1546621|NCT00105989|5057467|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
1546622|NCT00105989|5057468|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
1546623|NCT00105989|5057467|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
1546624|NCT00105989|5057468|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
1546625|NCT00105989|5057467|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
1546626|NCT00105989|5057468|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
1546627|NCT00105989|5057467|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
1546628|NCT00105989|5057468|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
1546629|NCT00105989|5057467|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
1546630|NCT00105989|5057468|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
1546631|NCT00105989|5057467|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
1546632|NCT00105989|5057468|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
1546633|NCT00105989|5057467|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
1546634|NCT00105989|5057468|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
1546635|NCT00105989|5057467|P2|Acute - Open Label: Week 0-10|Death|0
1546636|NCT00105989|5057468|P1|Acute - Open Label: Week 0-10|Death|1
1546637|NCT00105989|5057467|P2|Acute - Open Label: Week 0-10|Physician Decision|0
1546638|NCT00105989|5057468|P1|Acute - Open Label: Week 0-10|Physician Decision|0
1546639|NCT00105989|5057467|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
1546640|NCT00105989|5057468|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
1546641|NCT00105989|5057467|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
1546642|NCT00105989|5057468|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
1546643|NCT00105989|5057467|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
1546644|NCT00105989|5057468|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
1546645|NCT00105989|5057467|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
1546646|NCT00105989|5057468|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
1546647|NCT00105989|5057467|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
1546648|NCT00105989|5057468|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
1546649|NCT00105989|5057467|P2|Acute - Open Label: Week 0-10|Adverse Event|0
1546650|NCT00105989|5057468|P1|Acute - Open Label: Week 0-10|Adverse Event|33
1546651|NCT00105586|5057584|P2|Overall Study|Physician Decision|13
1546652|NCT00105586|5057585|P1|Overall Study|Physician Decision|13
1546653|NCT00105586|5057584|P2|Overall Study|Adverse Event|3
1546654|NCT00105586|5057585|P1|Overall Study|Adverse Event|4
1546655|NCT00105560|5057593|P1|Overall Study|Lost to Follow-up|1
1546656|NCT00105534|5057615|P2|Overall Study|Other Reason|2
1546657|NCT00105534|5057616|P1|Overall Study|Other Reason|0
1546658|NCT00105534|5057615|P2|Overall Study|Treatment unmasked|0
1546659|NCT00105534|5057616|P1|Overall Study|Treatment unmasked|1
1546660|NCT00105534|5057615|P2|Overall Study|Lack of Efficacy|15
1546661|NCT00105534|5057616|P1|Overall Study|Lack of Efficacy|7
1546662|NCT00105534|5057615|P2|Overall Study|Lost to Follow-up|1
1546663|NCT00105534|5057616|P1|Overall Study|Lost to Follow-up|5
1546664|NCT00105534|5057615|P2|Overall Study|Withdrawal by Subject|6
1546665|NCT00105534|5057616|P1|Overall Study|Withdrawal by Subject|6
1546666|NCT00105534|5057615|P2|Overall Study|Protocol Violation|4
1546667|NCT00105534|5057616|P1|Overall Study|Protocol Violation|1
1546668|NCT00105534|5057615|P2|Overall Study|Adverse Event|5
1546669|NCT00105534|5057616|P1|Overall Study|Adverse Event|2
1546670|NCT00105521|5057628|P4|Overall Study|Lost to Follow-up|0
1546671|NCT00105521|5057629|P3|Overall Study|Lost to Follow-up|0
1546672|NCT00105521|5057630|P2|Overall Study|Lost to Follow-up|1
1546673|NCT00105521|5057631|P1|Overall Study|Lost to Follow-up|0
1546674|NCT00105521|5057628|P4|Overall Study|Protocol Violation|4
1546675|NCT00105521|5057629|P3|Overall Study|Protocol Violation|4
1546676|NCT00105521|5057630|P2|Overall Study|Protocol Violation|5
1546677|NCT00105521|5057631|P1|Overall Study|Protocol Violation|3
1546678|NCT00105521|5057628|P4|Overall Study|Lack of Efficacy|1
1546679|NCT00105521|5057629|P3|Overall Study|Lack of Efficacy|0
1546680|NCT00105521|5057630|P2|Overall Study|Lack of Efficacy|0
1546681|NCT00105521|5057631|P1|Overall Study|Lack of Efficacy|0
1546682|NCT00105521|5057628|P4|Overall Study|Withdrawal by Subject|4
1546683|NCT00105521|5057629|P3|Overall Study|Withdrawal by Subject|1
1546684|NCT00105521|5057630|P2|Overall Study|Withdrawal by Subject|0
1546685|NCT00105521|5057631|P1|Overall Study|Withdrawal by Subject|1
1546686|NCT00105521|5057628|P4|Overall Study|Adverse Event|8
1546687|NCT00105521|5057629|P3|Overall Study|Adverse Event|10
1546688|NCT00105521|5057630|P2|Overall Study|Adverse Event|4
1546689|NCT00105521|5057631|P1|Overall Study|Adverse Event|10
1546690|NCT00105521|5057628|P4|Overall Study|Other|0
1546691|NCT00105521|5057629|P3|Overall Study|Other|2
1546692|NCT00105521|5057630|P2|Overall Study|Other|1
1546693|NCT00105521|5057631|P1|Overall Study|Other|1
1546694|NCT00105508|5057655|P2|Overall Study|Other|9
1546695|NCT00105508|5057656|P1|Overall Study|Other|8
1546696|NCT00105508|5057655|P2|Overall Study|Protocol Violation|2
1546697|NCT00105508|5057656|P1|Overall Study|Protocol Violation|1
1546698|NCT00105508|5057655|P2|Overall Study|Lost to Follow-up|0
1546699|NCT00105508|5057656|P1|Overall Study|Lost to Follow-up|3
1546700|NCT00105508|5057655|P2|Overall Study|Withdrawal by Subject|6
1546701|NCT00105508|5057656|P1|Overall Study|Withdrawal by Subject|10
1546702|NCT00105508|5057655|P2|Overall Study|Insufficient Efficacy|0
1546703|NCT00105508|5057656|P1|Overall Study|Insufficient Efficacy|1
1546704|NCT00105508|5057655|P2|Overall Study|Adverse Event|19
1546705|NCT00105508|5057656|P1|Overall Study|Adverse Event|16
1546706|NCT00105508|5057655|P2|Overall Study|Prephase Dropout|0
1546707|NCT00105508|5057656|P1|Overall Study|Prephase Dropout|1
1546708|NCT00105482|5057670|P2|Overall Study|Withdrawn by PI|1
1546709|NCT00105482|5057671|P1|Overall Study|Withdrawn by PI|1
1546710|NCT00105482|5057670|P2|Overall Study|Scheduling Conflict|3
1546711|NCT00105482|5057671|P1|Overall Study|Scheduling Conflict|2
1546712|NCT00105482|5057670|P2|Overall Study|Lost Interest|32
1546713|NCT00105482|5057671|P1|Overall Study|Lost Interest|29
1546714|NCT00105482|5057670|P2|Overall Study|Withdrawal by Subject|1
1546715|NCT00105482|5057671|P1|Overall Study|Withdrawal by Subject|0
1546716|NCT00105482|5057670|P2|Overall Study|Lost to Follow-up|17
1546717|NCT00105482|5057671|P1|Overall Study|Lost to Follow-up|26
1546718|NCT00105482|5057670|P2|Overall Study|Adverse Event|1
1546719|NCT00105482|5057671|P1|Overall Study|Adverse Event|1
1546720|NCT00105469|5057687|P2|Overall Study|Other Reason|0
1546721|NCT00105469|5057688|P1|Overall Study|Other Reason|4
1546722|NCT00105469|5057687|P2|Overall Study|Lack of Efficacy|0
1546723|NCT00105469|5057688|P1|Overall Study|Lack of Efficacy|2
1546724|NCT00105469|5057687|P2|Overall Study|Lost to Follow-up|0
1546725|NCT00105469|5057688|P1|Overall Study|Lost to Follow-up|1
1546726|NCT00105469|5057687|P2|Overall Study|Withdrawal by Subject|3
1546727|NCT00105469|5057688|P1|Overall Study|Withdrawal by Subject|2
1546728|NCT00105469|5057687|P2|Overall Study|Protocol Violation|0
1546729|NCT00105469|5057688|P1|Overall Study|Protocol Violation|4
1546730|NCT00105469|5057687|P2|Overall Study|Adverse Event|8
1546731|NCT00105469|5057688|P1|Overall Study|Adverse Event|9
1546732|NCT00105443|5057698|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
1546733|NCT00105443|5057699|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
1546734|NCT00105443|5057700|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
1546735|NCT00105443|5057701|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
1546736|NCT00105443|5057698|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
1546737|NCT00105443|5057699|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
1546738|NCT00105443|5057700|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
1546739|NCT00105443|5057701|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
1546740|NCT00105443|5057698|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
1546741|NCT00105443|5057699|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
1546742|NCT00105443|5057700|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
1546743|NCT00105443|5057701|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
1546744|NCT00105443|5057698|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
1546745|NCT00105443|5057699|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
1546746|NCT00105443|5057700|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
1546747|NCT00105443|5057701|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
1546748|NCT00105443|5057698|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
1546749|NCT00105443|5057699|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
1546750|NCT00105443|5057700|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
1546751|NCT00105443|5057701|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
1546752|NCT00105443|5057698|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
1546753|NCT00105443|5057699|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
1546754|NCT00105443|5057700|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
1546755|NCT00105443|5057701|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
1546756|NCT00105443|5057698|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
1546757|NCT00105443|5057699|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
1546758|NCT00105443|5057700|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
1546759|NCT00105443|5057701|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
1546760|NCT00105443|5057698|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
1546761|NCT00105443|5057699|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
1546762|NCT00105443|5057700|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
1546763|NCT00105443|5057701|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
1546764|NCT00105443|5057698|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
1546765|NCT00105443|5057699|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
1546766|NCT00105443|5057700|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
1546767|NCT00105443|5057701|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
1546768|NCT00105443|5057698|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
1546769|NCT00105443|5057699|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
1546770|NCT00105443|5057700|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
1546771|NCT00105443|5057701|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
1546772|NCT00105443|5057698|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
1546773|NCT00105443|5057699|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
1546774|NCT00105443|5057700|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
1546775|NCT00105443|5057701|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
1546776|NCT00105443|5057698|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
1546777|NCT00105443|5057699|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
1546778|NCT00105443|5057700|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
1546779|NCT00105443|5057701|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
1546780|NCT00105443|5057698|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
1546781|NCT00105443|5057699|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
1546782|NCT00105443|5057700|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
1546783|NCT00105443|5057701|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
1546784|NCT00105443|5057698|P4|Follow-up and/or Open Label Nexavar|Death|4
1546785|NCT00105443|5057699|P3|Follow-up and/or Open Label Nexavar|Death|219
1546786|NCT00105443|5057700|P2|Follow-up and/or Open Label Nexavar|Death|7
1546787|NCT00105443|5057701|P1|Follow-up and/or Open Label Nexavar|Death|180
1546788|NCT00105443|5057698|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
1546789|NCT00105443|5057699|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
1546790|NCT00105443|5057700|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
1546791|NCT00105443|5057701|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
1546792|NCT00105443|5057698|P4|Double-Blind Treatment|Physician Decision|0
1546793|NCT00105443|5057699|P3|Double-Blind Treatment|Physician Decision|2
1546794|NCT00105443|5057700|P2|Double-Blind Treatment|Physician Decision|0
1546795|NCT00105443|5057701|P1|Double-Blind Treatment|Physician Decision|1
1546796|NCT00105443|5057698|P4|Double-Blind Treatment|Withdrawal by Subject|0
1546797|NCT00105443|5057699|P3|Double-Blind Treatment|Withdrawal by Subject|7
1546798|NCT00105443|5057700|P2|Double-Blind Treatment|Withdrawal by Subject|0
1546799|NCT00105443|5057701|P1|Double-Blind Treatment|Withdrawal by Subject|8
1546800|NCT00105443|5057698|P4|Double-Blind Treatment|Lost to Follow-up|0
1546801|NCT00105443|5057699|P3|Double-Blind Treatment|Lost to Follow-up|1
1546802|NCT00105443|5057700|P2|Double-Blind Treatment|Lost to Follow-up|0
1546803|NCT00105443|5057701|P1|Double-Blind Treatment|Lost to Follow-up|0
1546804|NCT00105443|5057698|P4|Double-Blind Treatment|Adverse Event|0
1546805|NCT00105443|5057699|P3|Double-Blind Treatment|Adverse Event|0
1546806|NCT00105443|5057700|P2|Double-Blind Treatment|Adverse Event|0
1546807|NCT00105443|5057701|P1|Double-Blind Treatment|Adverse Event|1
1546808|NCT00105235|5057728|P1|Overall Study|Withdrawal by Subject|2
1546809|NCT00105235|5057728|P1|Overall Study|Physician Decision|1
1546810|NCT00105235|5057728|P1|Overall Study|Death|4
1546811|NCT00105196|5057741|P2|Overall Study|Subject became unblinded|1
1546812|NCT00105196|5057742|P1|Overall Study|Subject became unblinded|0
1546813|NCT00105196|5057741|P2|Overall Study|marijuana use|1
1546814|NCT00105196|5057742|P1|Overall Study|marijuana use|0
1546815|NCT00105196|5057741|P2|Overall Study|pending surgery|1
1546816|NCT00105196|5057742|P1|Overall Study|pending surgery|0
1546817|NCT00105196|5057741|P2|Overall Study|Protocol Violation|2
1546818|NCT00105196|5057742|P1|Overall Study|Protocol Violation|5
1546819|NCT00105196|5057741|P2|Overall Study|Poor/noncompliance|4
1546820|NCT00105196|5057742|P1|Overall Study|Poor/noncompliance|3
1546821|NCT00105196|5057741|P2|Overall Study|Lost to Follow-up|2
1546822|NCT00105196|5057742|P1|Overall Study|Lost to Follow-up|3
1546823|NCT00105196|5057741|P2|Overall Study|Withdrawal by Subject|6
1546824|NCT00105196|5057742|P1|Overall Study|Withdrawal by Subject|6
1546825|NCT00105196|5057741|P2|Overall Study|Adverse Event|3
1546826|NCT00105196|5057742|P1|Overall Study|Adverse Event|11
1546827|NCT00105196|5057741|P2|Overall Study|Lack of Efficacy|3
1546828|NCT00105196|5057742|P1|Overall Study|Lack of Efficacy|2
1546829|NCT00105183|5057765|P3|Overall Study|Other reason|0
1546830|NCT00105183|5057766|P2|Overall Study|Other reason|2
1546831|NCT00105183|5057767|P1|Overall Study|Other reason|1
1546832|NCT00105183|5057765|P3|Overall Study|Lost to Follow-up|1
1546833|NCT00105183|5057766|P2|Overall Study|Lost to Follow-up|1
1546834|NCT00105183|5057767|P1|Overall Study|Lost to Follow-up|0
1546835|NCT00105183|5057765|P3|Overall Study|Physician Decision|3
1546836|NCT00105183|5057766|P2|Overall Study|Physician Decision|2
1546837|NCT00105183|5057767|P1|Overall Study|Physician Decision|1
1546838|NCT00105183|5057765|P3|Overall Study|Withdrawal by Subject|4
1546839|NCT00105183|5057766|P2|Overall Study|Withdrawal by Subject|1
1546840|NCT00105183|5057767|P1|Overall Study|Withdrawal by Subject|1
1546841|NCT00105183|5057765|P3|Overall Study|Death|15
1546842|NCT00105183|5057766|P2|Overall Study|Death|13
1546843|NCT00105183|5057767|P1|Overall Study|Death|19
1546844|NCT00105157|5057803|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
1546845|NCT00105157|5057804|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
1546846|NCT00105157|5057805|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
1546847|NCT00105157|5057806|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
1546848|NCT00105157|5057803|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
1546849|NCT00105157|5057804|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
1546850|NCT00105157|5057805|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
1546851|NCT00105157|5057806|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
1546852|NCT00105157|5057803|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
1546853|NCT00105157|5057804|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
1546854|NCT00105157|5057805|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
1546855|NCT00105157|5057806|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
1546856|NCT00105157|5057803|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
1546857|NCT00105157|5057804|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
1546858|NCT00105157|5057805|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
1546859|NCT00105157|5057806|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
1546860|NCT00105157|5057803|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
1546861|NCT00105157|5057804|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
1546862|NCT00105157|5057805|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
1546863|NCT00105157|5057806|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
1546864|NCT00105157|5057803|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
1546865|NCT00105157|5057804|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
1546866|NCT00105157|5057805|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
1546867|NCT00105157|5057806|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
1546868|NCT00105157|5057803|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
1546869|NCT00105157|5057804|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
1546870|NCT00105157|5057805|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
1546871|NCT00105157|5057806|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
1546872|NCT00105157|5057803|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
1546873|NCT00105157|5057804|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
1546874|NCT00105157|5057805|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
1546875|NCT00105157|5057806|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
1546876|NCT00105157|5057803|P4|Open-Label Continuation of DB|Lost to Follow-up|0
1546877|NCT00105157|5057804|P3|Open-Label Continuation of DB|Lost to Follow-up|1
1546878|NCT00105157|5057805|P2|Open-Label Continuation of DB|Lost to Follow-up|1
1546879|NCT00105157|5057806|P1|Open-Label Continuation of DB|Lost to Follow-up|1
1546880|NCT00105157|5057803|P4|Open-Label Continuation of DB|Lack of Efficacy|1
1546881|NCT00105157|5057804|P3|Open-Label Continuation of DB|Lack of Efficacy|3
1546882|NCT00105157|5057805|P2|Open-Label Continuation of DB|Lack of Efficacy|4
1546883|NCT00105157|5057806|P1|Open-Label Continuation of DB|Lack of Efficacy|1
1546884|NCT00105157|5057803|P4|Open-Label Continuation of DB|Adverse Event|0
1546885|NCT00105157|5057804|P3|Open-Label Continuation of DB|Adverse Event|0
1546886|NCT00105157|5057805|P2|Open-Label Continuation of DB|Adverse Event|1
1546887|NCT00105157|5057806|P1|Open-Label Continuation of DB|Adverse Event|3
1546888|NCT00105157|5057803|P4|Double-Blind (DB)|Lack of Efficacy|38
1546889|NCT00105157|5057804|P3|Double-Blind (DB)|Lack of Efficacy|11
1546890|NCT00105157|5057805|P2|Double-Blind (DB)|Lack of Efficacy|14
1546891|NCT00105157|5057806|P1|Double-Blind (DB)|Lack of Efficacy|11
1546892|NCT00105157|5057803|P4|Double-Blind (DB)|Adverse Event|1
1546893|NCT00105157|5057804|P3|Double-Blind (DB)|Adverse Event|1
1546894|NCT00105157|5057805|P2|Double-Blind (DB)|Adverse Event|0
1546895|NCT00105157|5057806|P1|Double-Blind (DB)|Adverse Event|2
1546896|NCT00105157|5057803|P4|Double-Blind (DB)|Never Treated|0
1546897|NCT00105157|5057804|P3|Double-Blind (DB)|Never Treated|0
1546898|NCT00105157|5057805|P2|Double-Blind (DB)|Never Treated|0
1546899|NCT00105157|5057806|P1|Double-Blind (DB)|Never Treated|1
1546900|NCT00105079|5058000|P2|Overall Study|not specified|1
1546901|NCT00105079|5058001|P1|Overall Study|not specified|3
1546902|NCT00105079|5058000|P2|Overall Study|Protocol Violation|0
1546903|NCT00105079|5058001|P1|Overall Study|Protocol Violation|1
1546904|NCT00105079|5058000|P2|Overall Study|Violation of selection criteria at entry|2
1546905|NCT00105079|5058001|P1|Overall Study|Violation of selection criteria at entry|0
1546906|NCT00105079|5058000|P2|Overall Study|Refused treatment|4
1546907|NCT00105079|5058001|P1|Overall Study|Refused treatment|6
1546908|NCT00105079|5058000|P2|Overall Study|Lack of Efficacy|3
1546909|NCT00105079|5058001|P1|Overall Study|Lack of Efficacy|9
1546910|NCT00105079|5058000|P2|Overall Study|Lost to Follow-up|12
1546911|NCT00105079|5058001|P1|Overall Study|Lost to Follow-up|12
1546912|NCT00105079|5058000|P2|Overall Study|Death|1
1546913|NCT00105079|5058001|P1|Overall Study|Death|3
1546914|NCT00105079|5058000|P2|Overall Study|Adverse Event|12
1546915|NCT00105079|5058001|P1|Overall Study|Adverse Event|5
1546916|NCT00105066|5058019|P2|Overall Study|Adverse Event|5
1546917|NCT00105066|5058020|P1|Overall Study|Adverse Event|2
1546918|NCT00104884|5058098|P1|Overall Study|Disease progression|4
1546919|NCT00104871|5058102|P1|Overall Study|Not evaluable|1
1546920|NCT00104728|5058107|P1|Overall Study|screen failures|19
1546921|NCT00104650|5058115|P3|Follow-up Period|Other|0
1546922|NCT00104650|5058116|P2|Follow-up Period|Other|1
1546923|NCT00104650|5058117|P1|Follow-up Period|Other|0
1546924|NCT00104650|5058115|P3|Follow-up Period|Lost to Follow-up|2
1546925|NCT00104650|5058116|P2|Follow-up Period|Lost to Follow-up|1
1546926|NCT00104650|5058117|P1|Follow-up Period|Lost to Follow-up|0
1546927|NCT00104650|5058115|P3|Follow-up Period|Disease progression|0
1546928|NCT00104650|5058116|P2|Follow-up Period|Disease progression|1
1546929|NCT00104650|5058117|P1|Follow-up Period|Disease progression|3
1546930|NCT00104650|5058115|P3|Follow-up Period|Death|4
1546931|NCT00104650|5058116|P2|Follow-up Period|Death|6
1546932|NCT00104650|5058117|P1|Follow-up Period|Death|6
1546933|NCT00104650|5058115|P3|Follow-up Period|Withdrawal by Subject|3
1546934|NCT00104650|5058116|P2|Follow-up Period|Withdrawal by Subject|3
1546935|NCT00104650|5058117|P1|Follow-up Period|Withdrawal by Subject|0
1546936|NCT00104650|5058115|P3|Follow-up Period|Adverse Event|1
1546937|NCT00104650|5058116|P2|Follow-up Period|Adverse Event|0
1546938|NCT00104650|5058117|P1|Follow-up Period|Adverse Event|1
1546939|NCT00104650|5058115|P3|Follow-up Period|Physician Decision|0
1546940|NCT00104650|5058116|P2|Follow-up Period|Physician Decision|1
1546941|NCT00104650|5058117|P1|Follow-up Period|Physician Decision|1
1546942|NCT00104650|5058115|P3|Treatment Period (25 Weeks)|Protocol deviation|0
1546943|NCT00104650|5058116|P2|Treatment Period (25 Weeks)|Protocol deviation|1
1546944|NCT00104650|5058117|P1|Treatment Period (25 Weeks)|Protocol deviation|0
1546945|NCT00104650|5058115|P3|Treatment Period (25 Weeks)|Other|0
1546946|NCT00104650|5058116|P2|Treatment Period (25 Weeks)|Other|0
1546947|NCT00104650|5058117|P1|Treatment Period (25 Weeks)|Other|1
1546948|NCT00104650|5058115|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
1546949|NCT00104650|5058116|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
1546950|NCT00104650|5058117|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
1546951|NCT00104650|5058115|P3|Treatment Period (25 Weeks)|Disease progression|2
1546952|NCT00104650|5058116|P2|Treatment Period (25 Weeks)|Disease progression|3
1546953|NCT00104650|5058117|P1|Treatment Period (25 Weeks)|Disease progression|2
1546954|NCT00104650|5058115|P3|Treatment Period (25 Weeks)|Death|6
1546955|NCT00104650|5058116|P2|Treatment Period (25 Weeks)|Death|5
1546956|NCT00104650|5058117|P1|Treatment Period (25 Weeks)|Death|7
1546957|NCT00104650|5058115|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
1546958|NCT00104650|5058116|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
1546959|NCT00104650|5058117|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
1546960|NCT00104650|5058115|P3|Treatment Period (25 Weeks)|Physician Decision|1
1546961|NCT00104650|5058116|P2|Treatment Period (25 Weeks)|Physician Decision|0
1546962|NCT00104650|5058117|P1|Treatment Period (25 Weeks)|Physician Decision|0
1546963|NCT00104637|5058149|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
1546964|NCT00104637|5058150|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
1546965|NCT00104572|5058179|P3|Overall Study|Withdrawal by Subject|0
1546966|NCT00104572|5058180|P2|Overall Study|Withdrawal by Subject|3
1546967|NCT00104572|5058181|P1|Overall Study|Withdrawal by Subject|3
1546968|NCT00104520|5058191|P2|Overall Study|Other|5
1546969|NCT00104520|5058192|P1|Overall Study|Other|1
1546970|NCT00104520|5058191|P2|Overall Study|Personal/administrative|1
1546971|NCT00104520|5058192|P1|Overall Study|Personal/administrative|1
1546972|NCT00104520|5058191|P2|Overall Study|Noncompliance|2
1546973|NCT00104520|5058192|P1|Overall Study|Noncompliance|0
1546974|NCT00104520|5058191|P2|Overall Study|Lost to Follow-up|0
1546975|NCT00104520|5058192|P1|Overall Study|Lost to Follow-up|1
1546976|NCT00104520|5058191|P2|Overall Study|Related adverse event|15
1546977|NCT00104520|5058192|P1|Overall Study|Related adverse event|13
1546978|NCT00104520|5058191|P2|Overall Study|Study drug intolerance|1
1546979|NCT00104520|5058192|P1|Overall Study|Study drug intolerance|0
1546980|NCT00104520|5058191|P2|Overall Study|Unrelated adverse event|47
1546981|NCT00104520|5058192|P1|Overall Study|Unrelated adverse event|34
1546982|NCT00104416|5058212|P5|Continuation Phase|Non-compliance|1
1546983|NCT00104416|5058213|P4|Continuation Phase|Non-compliance|0
1546984|NCT00104416|5058214|P3|Continuation Phase|Non-compliance|0
1546985|NCT00104416|5058215|P2|Continuation Phase|Non-compliance|0
1546986|NCT00104416|5058216|P1|Continuation Phase|Non-compliance|0
1546987|NCT00104416|5058212|P5|Continuation Phase|Pregnancy|0
1546988|NCT00104416|5058213|P4|Continuation Phase|Pregnancy|1
1546989|NCT00104416|5058214|P3|Continuation Phase|Pregnancy|1
1546990|NCT00104416|5058215|P2|Continuation Phase|Pregnancy|0
1546991|NCT00104416|5058216|P1|Continuation Phase|Pregnancy|0
1546992|NCT00104416|5058212|P5|Continuation Phase|Withdrawal by Subject|1
1546993|NCT00104416|5058213|P4|Continuation Phase|Withdrawal by Subject|1
1546994|NCT00104416|5058214|P3|Continuation Phase|Withdrawal by Subject|2
1546995|NCT00104416|5058215|P2|Continuation Phase|Withdrawal by Subject|0
1546996|NCT00104416|5058216|P1|Continuation Phase|Withdrawal by Subject|0
1546997|NCT00104416|5058212|P5|Continuation Phase|Lost to Follow-up|1
1546998|NCT00104416|5058213|P4|Continuation Phase|Lost to Follow-up|0
1546999|NCT00104416|5058214|P3|Continuation Phase|Lost to Follow-up|1
1547000|NCT00104416|5058215|P2|Continuation Phase|Lost to Follow-up|0
1547001|NCT00104416|5058216|P1|Continuation Phase|Lost to Follow-up|0
1547002|NCT00104416|5058212|P5|Continuation Phase|Adverse Event|2
1547003|NCT00104416|5058213|P4|Continuation Phase|Adverse Event|0
1547004|NCT00104416|5058214|P3|Continuation Phase|Adverse Event|2
1547005|NCT00104416|5058215|P2|Continuation Phase|Adverse Event|0
1547006|NCT00104416|5058216|P1|Continuation Phase|Adverse Event|0
1547007|NCT00104416|5058212|P5|Double-Blind Phase|Participant Did Not Take Drug|0
1547008|NCT00104416|5058213|P4|Double-Blind Phase|Participant Did Not Take Drug|0
1547009|NCT00104416|5058214|P3|Double-Blind Phase|Participant Did Not Take Drug|0
1547010|NCT00104416|5058215|P2|Double-Blind Phase|Participant Did Not Take Drug|4
1547011|NCT00104416|5058216|P1|Double-Blind Phase|Participant Did Not Take Drug|3
1547012|NCT00104416|5058212|P5|Double-Blind Phase|Pregnancy|0
1547013|NCT00104416|5058213|P4|Double-Blind Phase|Pregnancy|0
1547014|NCT00104416|5058214|P3|Double-Blind Phase|Pregnancy|0
1547015|NCT00104416|5058215|P2|Double-Blind Phase|Pregnancy|0
1547016|NCT00104416|5058216|P1|Double-Blind Phase|Pregnancy|1
1547017|NCT00104416|5058212|P5|Double-Blind Phase|Withdrawal by Subject|0
1547018|NCT00104416|5058213|P4|Double-Blind Phase|Withdrawal by Subject|0
1547019|NCT00104416|5058214|P3|Double-Blind Phase|Withdrawal by Subject|0
1547020|NCT00104416|5058215|P2|Double-Blind Phase|Withdrawal by Subject|3
1547021|NCT00104416|5058216|P1|Double-Blind Phase|Withdrawal by Subject|2
1547022|NCT00104416|5058212|P5|Double-Blind Phase|Protocol Violation|0
1547023|NCT00104416|5058213|P4|Double-Blind Phase|Protocol Violation|0
1547024|NCT00104416|5058214|P3|Double-Blind Phase|Protocol Violation|0
1547025|NCT00104416|5058215|P2|Double-Blind Phase|Protocol Violation|1
1547026|NCT00104416|5058216|P1|Double-Blind Phase|Protocol Violation|0
1547027|NCT00104416|5058212|P5|Double-Blind Phase|Lost to Follow-up|0
1547028|NCT00104416|5058213|P4|Double-Blind Phase|Lost to Follow-up|0
1547029|NCT00104416|5058214|P3|Double-Blind Phase|Lost to Follow-up|0
1547030|NCT00104416|5058215|P2|Double-Blind Phase|Lost to Follow-up|1
1547031|NCT00104416|5058216|P1|Double-Blind Phase|Lost to Follow-up|0
1547032|NCT00104416|5058212|P5|Double-Blind Phase|Adverse Event|0
1547033|NCT00104416|5058213|P4|Double-Blind Phase|Adverse Event|0
1547034|NCT00104416|5058214|P3|Double-Blind Phase|Adverse Event|0
1547035|NCT00104416|5058215|P2|Double-Blind Phase|Adverse Event|1
1547036|NCT00104416|5058216|P1|Double-Blind Phase|Adverse Event|2
1547037|NCT00104299|5058261|P2|Overall Study|To have renal transplant|0
1547038|NCT00104299|5058262|P1|Overall Study|To have renal transplant|1
1547039|NCT00104299|5058261|P2|Overall Study|Physician Decision|1
1547040|NCT00104299|5058262|P1|Overall Study|Physician Decision|1
1547041|NCT00104299|5058261|P2|Overall Study|Withdrawal by Subject|6
1547042|NCT00104299|5058262|P1|Overall Study|Withdrawal by Subject|2
1547043|NCT00104299|5058261|P2|Overall Study|Death|2
1547044|NCT00104299|5058262|P1|Overall Study|Death|2
1547045|NCT00104299|5058261|P2|Overall Study|Adverse Event|1
1547046|NCT00104299|5058262|P1|Overall Study|Adverse Event|3
1547047|NCT00104247|5058284|P2|Overall Study|Noncompliant with dosing|1
1547048|NCT00104247|5058285|P1|Overall Study|Noncompliant with dosing|0
1547049|NCT00104247|5058284|P2|Overall Study|Withdrawal by Subject|0
1547050|NCT00104247|5058285|P1|Overall Study|Withdrawal by Subject|1
1547051|NCT00104104|5058304|P2|Overall Study|Death|6
1547052|NCT00104104|5058305|P1|Overall Study|Death|9
1547053|NCT00104104|5058304|P2|Overall Study|Administrative problems|13
1547054|NCT00104104|5058305|P1|Overall Study|Administrative problems|12
1547055|NCT00104104|5058304|P2|Overall Study|Lost to Follow-up|7
1547056|NCT00104104|5058305|P1|Overall Study|Lost to Follow-up|3
1547057|NCT00104104|5058304|P2|Overall Study|Withdrawal by Subject|15
1547058|NCT00104104|5058305|P1|Overall Study|Withdrawal by Subject|11
1547059|NCT00104104|5058304|P2|Overall Study|Protocol Violation|2
1547060|NCT00104104|5058305|P1|Overall Study|Protocol Violation|5
1547061|NCT00104104|5058304|P2|Overall Study|Condition no longer requires study drug|4
1547062|NCT00104104|5058305|P1|Overall Study|Condition no longer requires study drug|7
1547063|NCT00104104|5058304|P2|Overall Study|Lack of Efficacy|3
1547064|NCT00104104|5058305|P1|Overall Study|Lack of Efficacy|0
1547065|NCT00104104|5058304|P2|Overall Study|Abnormal laboratory value(s)|14
1547066|NCT00104104|5058305|P1|Overall Study|Abnormal laboratory value(s)|20
1547067|NCT00104104|5058304|P2|Overall Study|Adverse Event|8
1547068|NCT00104104|5058305|P1|Overall Study|Adverse Event|8
1547069|NCT00104052|5058319|P1|Overall Study|Discontinuation unrelated to treatment|2
1547070|NCT00104052|5058319|P1|Overall Study|Lack of Efficacy|26
1547071|NCT00104052|5058319|P1|Overall Study|Adverse Event|1
1547072|NCT00103857|5058330|P7|50-Week Extension Study|reason unspecified|0
1547073|NCT00103857|5058331|P6|50-Week Extension Study|reason unspecified|0
1547074|NCT00103857|5058332|P5|50-Week Extension Study|reason unspecified|1
1547075|NCT00103857|5058333|P4|50-Week Extension Study|reason unspecified|0
1547076|NCT00103857|5058334|P3|50-Week Extension Study|reason unspecified|0
1547077|NCT00103857|5058335|P2|50-Week Extension Study|reason unspecified|0
1547078|NCT00103857|5058336|P1|50-Week Extension Study|reason unspecified|0
1547079|NCT00103857|5058330|P7|50-Week Extension Study|patient scheduled for elective surgery|0
1547080|NCT00103857|5058331|P6|50-Week Extension Study|patient scheduled for elective surgery|0
1547081|NCT00103857|5058332|P5|50-Week Extension Study|patient scheduled for elective surgery|0
1547082|NCT00103857|5058333|P4|50-Week Extension Study|patient scheduled for elective surgery|0
1547083|NCT00103857|5058334|P3|50-Week Extension Study|patient scheduled for elective surgery|1
1547084|NCT00103857|5058335|P2|50-Week Extension Study|patient scheduled for elective surgery|0
1547085|NCT00103857|5058336|P1|50-Week Extension Study|patient scheduled for elective surgery|0
1547086|NCT00103857|5058330|P7|50-Week Extension Study|patient moved|0
1547087|NCT00103857|5058331|P6|50-Week Extension Study|patient moved|0
1547088|NCT00103857|5058332|P5|50-Week Extension Study|patient moved|0
1547089|NCT00103857|5058333|P4|50-Week Extension Study|patient moved|2
1547090|NCT00103857|5058334|P3|50-Week Extension Study|patient moved|1
1547091|NCT00103857|5058335|P2|50-Week Extension Study|patient moved|0
1547092|NCT00103857|5058336|P1|50-Week Extension Study|patient moved|0
1547093|NCT00103857|5058330|P7|50-Week Extension Study|non-compliance with study procedures|0
1547094|NCT00103857|5058331|P6|50-Week Extension Study|non-compliance with study procedures|0
1547095|NCT00103857|5058332|P5|50-Week Extension Study|non-compliance with study procedures|1
1547096|NCT00103857|5058333|P4|50-Week Extension Study|non-compliance with study procedures|1
1547097|NCT00103857|5058334|P3|50-Week Extension Study|non-compliance with study procedures|0
1547098|NCT00103857|5058335|P2|50-Week Extension Study|non-compliance with study procedures|0
1547099|NCT00103857|5058336|P1|50-Week Extension Study|non-compliance with study procedures|1
1547100|NCT00103857|5058330|P7|50-Week Extension Study|protocol discontinuation criteria|0
1547101|NCT00103857|5058331|P6|50-Week Extension Study|protocol discontinuation criteria|3
1547102|NCT00103857|5058332|P5|50-Week Extension Study|protocol discontinuation criteria|3
1547103|NCT00103857|5058333|P4|50-Week Extension Study|protocol discontinuation criteria|2
1547104|NCT00103857|5058334|P3|50-Week Extension Study|protocol discontinuation criteria|3
1547105|NCT00103857|5058335|P2|50-Week Extension Study|protocol discontinuation criteria|2
1547106|NCT00103857|5058336|P1|50-Week Extension Study|protocol discontinuation criteria|2
1547107|NCT00103857|5058330|P7|50-Week Extension Study|Withdrawal by Subject|0
1547108|NCT00103857|5058331|P6|50-Week Extension Study|Withdrawal by Subject|3
1547109|NCT00103857|5058332|P5|50-Week Extension Study|Withdrawal by Subject|3
1547110|NCT00103857|5058333|P4|50-Week Extension Study|Withdrawal by Subject|8
1547111|NCT00103857|5058334|P3|50-Week Extension Study|Withdrawal by Subject|2
1547112|NCT00103857|5058335|P2|50-Week Extension Study|Withdrawal by Subject|5
1547113|NCT00103857|5058336|P1|50-Week Extension Study|Withdrawal by Subject|2
1547114|NCT00103857|5058330|P7|50-Week Extension Study|Protocol Violation|0
1547115|NCT00103857|5058331|P6|50-Week Extension Study|Protocol Violation|1
1547116|NCT00103857|5058332|P5|50-Week Extension Study|Protocol Violation|0
1547117|NCT00103857|5058333|P4|50-Week Extension Study|Protocol Violation|2
1547118|NCT00103857|5058334|P3|50-Week Extension Study|Protocol Violation|1
1547119|NCT00103857|5058335|P2|50-Week Extension Study|Protocol Violation|1
1547120|NCT00103857|5058336|P1|50-Week Extension Study|Protocol Violation|1
1547121|NCT00103857|5058330|P7|50-Week Extension Study|Pregnancy|0
1547122|NCT00103857|5058331|P6|50-Week Extension Study|Pregnancy|0
1547123|NCT00103857|5058332|P5|50-Week Extension Study|Pregnancy|1
1547124|NCT00103857|5058333|P4|50-Week Extension Study|Pregnancy|0
1547125|NCT00103857|5058334|P3|50-Week Extension Study|Pregnancy|1
1547126|NCT00103857|5058335|P2|50-Week Extension Study|Pregnancy|0
1547127|NCT00103857|5058336|P1|50-Week Extension Study|Pregnancy|0
1547128|NCT00103857|5058330|P7|50-Week Extension Study|Physician Decision|0
1547129|NCT00103857|5058331|P6|50-Week Extension Study|Physician Decision|0
1547130|NCT00103857|5058332|P5|50-Week Extension Study|Physician Decision|0
1547131|NCT00103857|5058333|P4|50-Week Extension Study|Physician Decision|0
1547132|NCT00103857|5058334|P3|50-Week Extension Study|Physician Decision|1
1547133|NCT00103857|5058335|P2|50-Week Extension Study|Physician Decision|1
1547134|NCT00103857|5058336|P1|50-Week Extension Study|Physician Decision|0
1547135|NCT00103857|5058330|P7|50-Week Extension Study|Lost to Follow-up|0
1547136|NCT00103857|5058331|P6|50-Week Extension Study|Lost to Follow-up|3
1547137|NCT00103857|5058332|P5|50-Week Extension Study|Lost to Follow-up|3
1547138|NCT00103857|5058333|P4|50-Week Extension Study|Lost to Follow-up|4
1547139|NCT00103857|5058334|P3|50-Week Extension Study|Lost to Follow-up|1
1547140|NCT00103857|5058335|P2|50-Week Extension Study|Lost to Follow-up|0
1547141|NCT00103857|5058336|P1|50-Week Extension Study|Lost to Follow-up|4
1547142|NCT00103857|5058330|P7|50-Week Extension Study|Lack of Efficacy|0
1547143|NCT00103857|5058331|P6|50-Week Extension Study|Lack of Efficacy|8
1547144|NCT00103857|5058332|P5|50-Week Extension Study|Lack of Efficacy|8
1547145|NCT00103857|5058333|P4|50-Week Extension Study|Lack of Efficacy|16
1547146|NCT00103857|5058334|P3|50-Week Extension Study|Lack of Efficacy|13
1547147|NCT00103857|5058335|P2|50-Week Extension Study|Lack of Efficacy|15
1547148|NCT00103857|5058336|P1|50-Week Extension Study|Lack of Efficacy|26
1547149|NCT00103857|5058330|P7|50-Week Extension Study|Death|0
1547150|NCT00103857|5058331|P6|50-Week Extension Study|Death|1
1547151|NCT00103857|5058332|P5|50-Week Extension Study|Death|0
1547152|NCT00103857|5058333|P4|50-Week Extension Study|Death|1
1547153|NCT00103857|5058334|P3|50-Week Extension Study|Death|0
1547154|NCT00103857|5058335|P2|50-Week Extension Study|Death|0
1547155|NCT00103857|5058336|P1|50-Week Extension Study|Death|0
1547156|NCT00103857|5058330|P7|50-Week Extension Study|Adverse Event|0
1547157|NCT00103857|5058331|P6|50-Week Extension Study|Adverse Event|1
1547158|NCT00103857|5058332|P5|50-Week Extension Study|Adverse Event|1
1547159|NCT00103857|5058333|P4|50-Week Extension Study|Adverse Event|0
1547160|NCT00103857|5058334|P3|50-Week Extension Study|Adverse Event|2
1547161|NCT00103857|5058335|P2|50-Week Extension Study|Adverse Event|3
1547162|NCT00103857|5058336|P1|50-Week Extension Study|Adverse Event|2
1547163|NCT00103857|5058330|P7|54-Week Base Study|patient intolerance to rescue therapy|0
1547164|NCT00103857|5058331|P6|54-Week Base Study|patient intolerance to rescue therapy|0
1547165|NCT00103857|5058332|P5|54-Week Base Study|patient intolerance to rescue therapy|0
1547166|NCT00103857|5058333|P4|54-Week Base Study|patient intolerance to rescue therapy|0
1547167|NCT00103857|5058334|P3|54-Week Base Study|patient intolerance to rescue therapy|0
1547168|NCT00103857|5058335|P2|54-Week Base Study|patient intolerance to rescue therapy|0
1547169|NCT00103857|5058336|P1|54-Week Base Study|patient intolerance to rescue therapy|1
1547170|NCT00103857|5058330|P7|54-Week Base Study|site error|0
1547171|NCT00103857|5058331|P6|54-Week Base Study|site error|1
1547172|NCT00103857|5058332|P5|54-Week Base Study|site error|0
1547173|NCT00103857|5058333|P4|54-Week Base Study|site error|0
1547174|NCT00103857|5058334|P3|54-Week Base Study|site error|0
1547175|NCT00103857|5058335|P2|54-Week Base Study|site error|0
1547176|NCT00103857|5058336|P1|54-Week Base Study|site error|0
1547177|NCT00103857|5058330|P7|54-Week Base Study|laboratory reporting error|0
1547178|NCT00103857|5058331|P6|54-Week Base Study|laboratory reporting error|0
1547179|NCT00103857|5058332|P5|54-Week Base Study|laboratory reporting error|1
1547180|NCT00103857|5058333|P4|54-Week Base Study|laboratory reporting error|0
1547181|NCT00103857|5058334|P3|54-Week Base Study|laboratory reporting error|0
1547182|NCT00103857|5058335|P2|54-Week Base Study|laboratory reporting error|0
1547183|NCT00103857|5058336|P1|54-Week Base Study|laboratory reporting error|0
1547184|NCT00103857|5058330|P7|54-Week Base Study|patient incarcerated|0
1547185|NCT00103857|5058331|P6|54-Week Base Study|patient incarcerated|1
1547186|NCT00103857|5058332|P5|54-Week Base Study|patient incarcerated|1
1547187|NCT00103857|5058333|P4|54-Week Base Study|patient incarcerated|0
1547188|NCT00103857|5058334|P3|54-Week Base Study|patient incarcerated|0
1547189|NCT00103857|5058335|P2|54-Week Base Study|patient incarcerated|0
1547190|NCT00103857|5058336|P1|54-Week Base Study|patient incarcerated|0
1547191|NCT00103857|5058330|P7|54-Week Base Study|non-compliance with study procedures|0
1547192|NCT00103857|5058331|P6|54-Week Base Study|non-compliance with study procedures|2
1547193|NCT00103857|5058332|P5|54-Week Base Study|non-compliance with study procedures|0
1547194|NCT00103857|5058333|P4|54-Week Base Study|non-compliance with study procedures|0
1547195|NCT00103857|5058334|P3|54-Week Base Study|non-compliance with study procedures|0
1547196|NCT00103857|5058335|P2|54-Week Base Study|non-compliance with study procedures|2
1547197|NCT00103857|5058336|P1|54-Week Base Study|non-compliance with study procedures|1
1547198|NCT00103857|5058330|P7|54-Week Base Study|patient moved|0
1547199|NCT00103857|5058331|P6|54-Week Base Study|patient moved|1
1547200|NCT00103857|5058332|P5|54-Week Base Study|patient moved|3
1547201|NCT00103857|5058333|P4|54-Week Base Study|patient moved|2
1547202|NCT00103857|5058334|P3|54-Week Base Study|patient moved|1
1547203|NCT00103857|5058335|P2|54-Week Base Study|patient moved|1
1547204|NCT00103857|5058336|P1|54-Week Base Study|patient moved|0
1547205|NCT00103857|5058330|P7|54-Week Base Study|protocol discontinuation criteria|5
1547206|NCT00103857|5058331|P6|54-Week Base Study|protocol discontinuation criteria|3
1547207|NCT00103857|5058332|P5|54-Week Base Study|protocol discontinuation criteria|5
1547208|NCT00103857|5058333|P4|54-Week Base Study|protocol discontinuation criteria|6
1547209|NCT00103857|5058334|P3|54-Week Base Study|protocol discontinuation criteria|2
1547210|NCT00103857|5058335|P2|54-Week Base Study|protocol discontinuation criteria|5
1547211|NCT00103857|5058336|P1|54-Week Base Study|protocol discontinuation criteria|2
1547212|NCT00103857|5058330|P7|54-Week Base Study|Withdrawal by Subject|4
1547213|NCT00103857|5058331|P6|54-Week Base Study|Withdrawal by Subject|15
1547214|NCT00103857|5058332|P5|54-Week Base Study|Withdrawal by Subject|10
1547215|NCT00103857|5058333|P4|54-Week Base Study|Withdrawal by Subject|15
1547216|NCT00103857|5058334|P3|54-Week Base Study|Withdrawal by Subject|16
1547217|NCT00103857|5058335|P2|54-Week Base Study|Withdrawal by Subject|16
1547218|NCT00103857|5058336|P1|54-Week Base Study|Withdrawal by Subject|17
1547219|NCT00103857|5058330|P7|54-Week Base Study|Protocol Violation|3
1547220|NCT00103857|5058331|P6|54-Week Base Study|Protocol Violation|3
1547221|NCT00103857|5058332|P5|54-Week Base Study|Protocol Violation|0
1547222|NCT00103857|5058333|P4|54-Week Base Study|Protocol Violation|4
1547223|NCT00103857|5058334|P3|54-Week Base Study|Protocol Violation|2
1547224|NCT00103857|5058335|P2|54-Week Base Study|Protocol Violation|4
1547225|NCT00103857|5058336|P1|54-Week Base Study|Protocol Violation|6
1547226|NCT00103857|5058330|P7|54-Week Base Study|Pregnancy|1
1547227|NCT00103857|5058331|P6|54-Week Base Study|Pregnancy|0
1547228|NCT00103857|5058332|P5|54-Week Base Study|Pregnancy|1
1547229|NCT00103857|5058333|P4|54-Week Base Study|Pregnancy|0
1547230|NCT00103857|5058334|P3|54-Week Base Study|Pregnancy|0
1547231|NCT00103857|5058335|P2|54-Week Base Study|Pregnancy|0
1547232|NCT00103857|5058336|P1|54-Week Base Study|Pregnancy|1
1547233|NCT00103857|5058330|P7|54-Week Base Study|Physician Decision|0
1547234|NCT00103857|5058331|P6|54-Week Base Study|Physician Decision|0
1547235|NCT00103857|5058332|P5|54-Week Base Study|Physician Decision|1
1547236|NCT00103857|5058333|P4|54-Week Base Study|Physician Decision|0
1547237|NCT00103857|5058334|P3|54-Week Base Study|Physician Decision|0
1547238|NCT00103857|5058335|P2|54-Week Base Study|Physician Decision|1
1547239|NCT00103857|5058336|P1|54-Week Base Study|Physician Decision|1
1547240|NCT00103857|5058330|P7|54-Week Base Study|Lost to Follow-up|3
1547241|NCT00103857|5058331|P6|54-Week Base Study|Lost to Follow-up|9
1547242|NCT00103857|5058332|P5|54-Week Base Study|Lost to Follow-up|10
1547243|NCT00103857|5058333|P4|54-Week Base Study|Lost to Follow-up|5
1547244|NCT00103857|5058334|P3|54-Week Base Study|Lost to Follow-up|7
1547245|NCT00103857|5058335|P2|54-Week Base Study|Lost to Follow-up|4
1547246|NCT00103857|5058336|P1|54-Week Base Study|Lost to Follow-up|5
1547247|NCT00103857|5058330|P7|54-Week Base Study|Lack of Efficacy|19
1547248|NCT00103857|5058331|P6|54-Week Base Study|Lack of Efficacy|14
1547249|NCT00103857|5058332|P5|54-Week Base Study|Lack of Efficacy|3
1547250|NCT00103857|5058333|P4|54-Week Base Study|Lack of Efficacy|4
1547251|NCT00103857|5058334|P3|54-Week Base Study|Lack of Efficacy|8
1547252|NCT00103857|5058335|P2|54-Week Base Study|Lack of Efficacy|14
1547253|NCT00103857|5058336|P1|54-Week Base Study|Lack of Efficacy|11
1547254|NCT00103857|5058330|P7|54-Week Base Study|Death|0
1547255|NCT00103857|5058331|P6|54-Week Base Study|Death|1
1547256|NCT00103857|5058332|P5|54-Week Base Study|Death|1
1547257|NCT00103857|5058333|P4|54-Week Base Study|Death|0
1547258|NCT00103857|5058334|P3|54-Week Base Study|Death|0
1547259|NCT00103857|5058335|P2|54-Week Base Study|Death|0
1547260|NCT00103857|5058336|P1|54-Week Base Study|Death|0
1547261|NCT00103857|5058330|P7|54-Week Base Study|Adverse Event|3
1547262|NCT00103857|5058331|P6|54-Week Base Study|Adverse Event|11
1547263|NCT00103857|5058332|P5|54-Week Base Study|Adverse Event|5
1547264|NCT00103857|5058333|P4|54-Week Base Study|Adverse Event|6
1547265|NCT00103857|5058334|P3|54-Week Base Study|Adverse Event|11
1547266|NCT00103857|5058335|P2|54-Week Base Study|Adverse Event|9
1547267|NCT00103857|5058336|P1|54-Week Base Study|Adverse Event|12
1547268|NCT00103740|5058435|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
1547357|NCT00103285|5058545|P3|Response Assignment|Withdrawal by Subject|1
1547269|NCT00103740|5058436|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
1547270|NCT00103740|5058435|P2|Period 2 - Extended Observation Period|Death|2
1547271|NCT00103740|5058436|P1|Period 2 - Extended Observation Period|Death|6
1547272|NCT00103740|5058435|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
1547273|NCT00103740|5058436|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
1547274|NCT00103740|5058435|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
1547275|NCT00103740|5058436|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
1547276|NCT00103740|5058435|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
1547277|NCT00103740|5058436|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
1547278|NCT00103740|5058435|P2|Period 1 - Core|Patient withdrew consent|2
1547279|NCT00103740|5058436|P1|Period 1 - Core|Patient withdrew consent|3
1547280|NCT00103740|5058435|P2|Period 1 - Core|Protocol Violation|2
1547281|NCT00103740|5058436|P1|Period 1 - Core|Protocol Violation|3
1547282|NCT00103740|5058435|P2|Period 1 - Core|Adverse Event|0
1547283|NCT00103740|5058436|P1|Period 1 - Core|Adverse Event|1
1547284|NCT00103662|5058464|P2|Overall Study|Intercurrent illness|0
1547285|NCT00103662|5058465|P1|Overall Study|Intercurrent illness|1
1547286|NCT00103662|5058464|P2|Overall Study|Failed mobilization|4
1547287|NCT00103662|5058465|P1|Overall Study|Failed mobilization|0
1547288|NCT00103662|5058464|P2|Overall Study|Other|9
1547289|NCT00103662|5058465|P1|Overall Study|Other|6
1547290|NCT00103662|5058464|P2|Overall Study|Lost to Follow-up|1
1547291|NCT00103662|5058465|P1|Overall Study|Lost to Follow-up|0
1547292|NCT00103662|5058464|P2|Overall Study|Elective Withdrawal|5
1547293|NCT00103662|5058465|P1|Overall Study|Elective Withdrawal|5
1547294|NCT00103662|5058464|P2|Overall Study|Death|7
1547295|NCT00103662|5058465|P1|Overall Study|Death|7
1547296|NCT00103662|5058464|P2|Overall Study|Entered Rescue Procedure|7
1547297|NCT00103662|5058465|P1|Overall Study|Entered Rescue Procedure|0
1547298|NCT00103610|5058491|P2|Overall Study|Noncompliance|1
1547299|NCT00103610|5058492|P1|Overall Study|Noncompliance|0
1547300|NCT00103610|5058491|P2|Overall Study|Failed mobilization|5
1547301|NCT00103610|5058492|P1|Overall Study|Failed mobilization|1
1547302|NCT00103610|5058491|P2|Overall Study|Other|7
1547303|NCT00103610|5058492|P1|Overall Study|Other|2
1547304|NCT00103610|5058491|P2|Overall Study|Adverse Event|2
1547305|NCT00103610|5058492|P1|Overall Study|Adverse Event|2
1547306|NCT00103610|5058491|P2|Overall Study|Lost to Follow-up|1
1547307|NCT00103610|5058492|P1|Overall Study|Lost to Follow-up|3
1547308|NCT00103610|5058491|P2|Overall Study|Elective Withdrawal|0
1547309|NCT00103610|5058492|P1|Overall Study|Elective Withdrawal|4
1547310|NCT00103610|5058491|P2|Overall Study|Death|12
1547311|NCT00103610|5058492|P1|Overall Study|Death|16
1547312|NCT00103610|5058491|P2|Overall Study|Entered Rescue Procedure|52
1547313|NCT00103610|5058492|P1|Overall Study|Entered Rescue Procedure|10
1547314|NCT00103506|5058516|P2|Overall Study|Withdrawal by Subject|21
1547315|NCT00103506|5058517|P1|Overall Study|Withdrawal by Subject|18
1547316|NCT00103506|5058516|P2|Overall Study|Lost to Follow-up|13
1547317|NCT00103506|5058517|P1|Overall Study|Lost to Follow-up|13
1547318|NCT00103506|5058516|P2|Overall Study|Death|253
1547319|NCT00103506|5058517|P1|Overall Study|Death|257
1547320|NCT00103506|5058516|P2|Overall Study|Study closed by sponsor|37
1547321|NCT00103506|5058517|P1|Overall Study|Study closed by sponsor|34
1547322|NCT00103311|5058529|P2|Overall Study|Adverse Event|0
1547323|NCT00103311|5058530|P1|Overall Study|Adverse Event|1
1547324|NCT00103311|5058529|P2|Overall Study|Withdrawal by Subject|1
1547325|NCT00103311|5058530|P1|Overall Study|Withdrawal by Subject|2
1547326|NCT00103311|5058529|P2|Overall Study|Lost to Follow-up|0
1547327|NCT00103311|5058530|P1|Overall Study|Lost to Follow-up|1
1547328|NCT00103285|5058540|P8|Response Assignment|Other|53
1547329|NCT00103285|5058541|P7|Response Assignment|Other|11
1547330|NCT00103285|5058542|P6|Response Assignment|Other|17
1547331|NCT00103285|5058543|P5|Response Assignment|Other|37
1547332|NCT00103285|5058544|P4|Response Assignment|Other|38
1547333|NCT00103285|5058545|P3|Response Assignment|Other|48
1547334|NCT00103285|5058546|P2|Response Assignment|Other|30
1547335|NCT00103285|5058547|P1|Response Assignment|Other|0
1547336|NCT00103285|5058540|P8|Response Assignment|Refusal|10
1547337|NCT00103285|5058541|P7|Response Assignment|Refusal|30
1547338|NCT00103285|5058542|P6|Response Assignment|Refusal|15
1547339|NCT00103285|5058543|P5|Response Assignment|Refusal|25
1547340|NCT00103285|5058544|P4|Response Assignment|Refusal|3
1547341|NCT00103285|5058545|P3|Response Assignment|Refusal|5
1547342|NCT00103285|5058546|P2|Response Assignment|Refusal|53
1547343|NCT00103285|5058547|P1|Response Assignment|Refusal|0
1547344|NCT00103285|5058540|P8|Response Assignment|Ineligible|5
1547345|NCT00103285|5058541|P7|Response Assignment|Ineligible|1
1547346|NCT00103285|5058542|P6|Response Assignment|Ineligible|3
1547347|NCT00103285|5058543|P5|Response Assignment|Ineligible|0
1547348|NCT00103285|5058544|P4|Response Assignment|Ineligible|2
1547349|NCT00103285|5058545|P3|Response Assignment|Ineligible|6
1547350|NCT00103285|5058546|P2|Response Assignment|Ineligible|8
1547351|NCT00103285|5058547|P1|Response Assignment|Ineligible|0
1547352|NCT00103285|5058540|P8|Response Assignment|Withdrawal by Subject|2
1547353|NCT00103285|5058541|P7|Response Assignment|Withdrawal by Subject|0
1547354|NCT00103285|5058542|P6|Response Assignment|Withdrawal by Subject|2
1547355|NCT00103285|5058543|P5|Response Assignment|Withdrawal by Subject|2
1547356|NCT00103285|5058544|P4|Response Assignment|Withdrawal by Subject|1
1547358|NCT00103285|5058546|P2|Response Assignment|Withdrawal by Subject|4
1547359|NCT00103285|5058547|P1|Response Assignment|Withdrawal by Subject|0
1547360|NCT00103285|5058540|P8|Response Assignment|Protocol Violation|0
1547361|NCT00103285|5058541|P7|Response Assignment|Protocol Violation|0
1547362|NCT00103285|5058542|P6|Response Assignment|Protocol Violation|0
1547363|NCT00103285|5058543|P5|Response Assignment|Protocol Violation|0
1547364|NCT00103285|5058544|P4|Response Assignment|Protocol Violation|0
1547365|NCT00103285|5058545|P3|Response Assignment|Protocol Violation|0
1547366|NCT00103285|5058546|P2|Response Assignment|Protocol Violation|2
1547367|NCT00103285|5058547|P1|Response Assignment|Protocol Violation|0
1547368|NCT00103285|5058540|P8|Response Assignment|Physician Decision|35
1547369|NCT00103285|5058541|P7|Response Assignment|Physician Decision|4
1547370|NCT00103285|5058542|P6|Response Assignment|Physician Decision|7
1547371|NCT00103285|5058543|P5|Response Assignment|Physician Decision|13
1547372|NCT00103285|5058544|P4|Response Assignment|Physician Decision|9
1547373|NCT00103285|5058545|P3|Response Assignment|Physician Decision|14
1547374|NCT00103285|5058546|P2|Response Assignment|Physician Decision|13
1547375|NCT00103285|5058547|P1|Response Assignment|Physician Decision|0
1547376|NCT00103285|5058540|P8|Response Assignment|Lost to Follow-up|5
1547377|NCT00103285|5058541|P7|Response Assignment|Lost to Follow-up|2
1547378|NCT00103285|5058542|P6|Response Assignment|Lost to Follow-up|2
1547379|NCT00103285|5058543|P5|Response Assignment|Lost to Follow-up|1
1547380|NCT00103285|5058544|P4|Response Assignment|Lost to Follow-up|5
1547381|NCT00103285|5058545|P3|Response Assignment|Lost to Follow-up|5
1547382|NCT00103285|5058546|P2|Response Assignment|Lost to Follow-up|9
1547383|NCT00103285|5058547|P1|Response Assignment|Lost to Follow-up|0
1547384|NCT00103285|5058540|P8|Response Assignment|Death|8
1547385|NCT00103285|5058541|P7|Response Assignment|Death|0
1547386|NCT00103285|5058542|P6|Response Assignment|Death|1
1547387|NCT00103285|5058543|P5|Response Assignment|Death|3
1547388|NCT00103285|5058544|P4|Response Assignment|Death|2
1547389|NCT00103285|5058545|P3|Response Assignment|Death|2
1547390|NCT00103285|5058546|P2|Response Assignment|Death|5
1547391|NCT00103285|5058547|P1|Response Assignment|Death|0
1547392|NCT00103285|5058540|P8|Response Assignment|Adverse Event|2
1547393|NCT00103285|5058541|P7|Response Assignment|Adverse Event|1
1547394|NCT00103285|5058542|P6|Response Assignment|Adverse Event|1
1547395|NCT00103285|5058543|P5|Response Assignment|Adverse Event|3
1547396|NCT00103285|5058544|P4|Response Assignment|Adverse Event|2
1547397|NCT00103285|5058545|P3|Response Assignment|Adverse Event|3
1547398|NCT00103285|5058546|P2|Response Assignment|Adverse Event|8
1547399|NCT00103285|5058547|P1|Response Assignment|Adverse Event|0
1547400|NCT00103285|5058540|P8|Induction|Other|0
1547401|NCT00103285|5058541|P7|Induction|Other|0
1547402|NCT00103285|5058542|P6|Induction|Other|0
1547403|NCT00103285|5058543|P5|Induction|Other|0
1547404|NCT00103285|5058544|P4|Induction|Other|0
1547405|NCT00103285|5058545|P3|Induction|Other|0
1547406|NCT00103285|5058546|P2|Induction|Other|0
1547407|NCT00103285|5058547|P1|Induction|Other|258
1547408|NCT00103285|5058540|P8|Induction|Refusal|0
1547409|NCT00103285|5058541|P7|Induction|Refusal|0
1547410|NCT00103285|5058542|P6|Induction|Refusal|0
1547411|NCT00103285|5058543|P5|Induction|Refusal|0
1547412|NCT00103285|5058544|P4|Induction|Refusal|0
1547413|NCT00103285|5058545|P3|Induction|Refusal|0
1547414|NCT00103285|5058546|P2|Induction|Refusal|0
1547415|NCT00103285|5058547|P1|Induction|Refusal|906
1547416|NCT00103285|5058540|P8|Induction|Ineligible|0
1547417|NCT00103285|5058541|P7|Induction|Ineligible|0
1547418|NCT00103285|5058542|P6|Induction|Ineligible|0
1547419|NCT00103285|5058543|P5|Induction|Ineligible|0
1547420|NCT00103285|5058544|P4|Induction|Ineligible|0
1547421|NCT00103285|5058545|P3|Induction|Ineligible|0
1547422|NCT00103285|5058546|P2|Induction|Ineligible|0
1547423|NCT00103285|5058547|P1|Induction|Ineligible|43
1547424|NCT00103285|5058540|P8|Induction|Withdrawal by Subject|0
1547425|NCT00103285|5058541|P7|Induction|Withdrawal by Subject|0
1547426|NCT00103285|5058542|P6|Induction|Withdrawal by Subject|0
1547427|NCT00103285|5058543|P5|Induction|Withdrawal by Subject|0
1547428|NCT00103285|5058544|P4|Induction|Withdrawal by Subject|0
1547429|NCT00103285|5058545|P3|Induction|Withdrawal by Subject|0
1547430|NCT00103285|5058546|P2|Induction|Withdrawal by Subject|0
1547431|NCT00103285|5058547|P1|Induction|Withdrawal by Subject|1
1547432|NCT00103285|5058540|P8|Induction|Physician Decision|0
1547433|NCT00103285|5058541|P7|Induction|Physician Decision|0
1547434|NCT00103285|5058542|P6|Induction|Physician Decision|0
1547435|NCT00103285|5058543|P5|Induction|Physician Decision|0
1547436|NCT00103285|5058544|P4|Induction|Physician Decision|0
1547437|NCT00103285|5058545|P3|Induction|Physician Decision|0
1547438|NCT00103285|5058546|P2|Induction|Physician Decision|0
1547439|NCT00103285|5058547|P1|Induction|Physician Decision|103
1547440|NCT00103285|5058540|P8|Induction|Death|0
1547441|NCT00103285|5058541|P7|Induction|Death|0
1547442|NCT00103285|5058542|P6|Induction|Death|0
1547443|NCT00103285|5058543|P5|Induction|Death|0
1547444|NCT00103285|5058544|P4|Induction|Death|0
1547445|NCT00103285|5058545|P3|Induction|Death|0
1547446|NCT00103285|5058546|P2|Induction|Death|0
1547447|NCT00103285|5058547|P1|Induction|Death|24
1547448|NCT00103285|5058540|P8|Induction|Adverse Event|0
1547449|NCT00103285|5058541|P7|Induction|Adverse Event|0
1547450|NCT00103285|5058542|P6|Induction|Adverse Event|0
1547451|NCT00103285|5058543|P5|Induction|Adverse Event|0
1547452|NCT00103285|5058544|P4|Induction|Adverse Event|0
1547453|NCT00103285|5058545|P3|Induction|Adverse Event|0
1547454|NCT00103285|5058546|P2|Induction|Adverse Event|0
1547455|NCT00103285|5058547|P1|Induction|Adverse Event|14
1547456|NCT00103259|5058576|P2|Overall Study|ineligible/no protocol therapy|6
1547457|NCT00103259|5058577|P1|Overall Study|ineligible/no protocol therapy|4
1547458|NCT00103259|5058576|P2|Overall Study|other (reasons were not specified)|1
1547459|NCT00103259|5058577|P1|Overall Study|other (reasons were not specified)|2
1547460|NCT00103259|5058576|P2|Overall Study|alternative therapy|0
1547461|NCT00103259|5058577|P1|Overall Study|alternative therapy|1
1547462|NCT00103259|5058576|P2|Overall Study|Withdrawal by Subject|3
1547463|NCT00103259|5058577|P1|Overall Study|Withdrawal by Subject|2
1547464|NCT00103259|5058576|P2|Overall Study|Death|2
1547465|NCT00103259|5058577|P1|Overall Study|Death|3
1547466|NCT00103207|5058589|P1|Overall Study|Diagnosis of BAC not confirmed|27
1547467|NCT00103207|5058589|P1|Overall Study|Ineligible|4
1547468|NCT00103207|5058589|P1|Overall Study|Other complicating disease|1
1547469|NCT00103207|5058589|P1|Overall Study|Withdrawal by Subject|2
1547470|NCT00103207|5058589|P1|Overall Study|Death|1
1547471|NCT00103207|5058589|P1|Overall Study|Adverse Event|3
1547472|NCT00103142|5058608|P2|Overall Study|Progression of disease|1
1547473|NCT00103142|5058609|P1|Overall Study|Progression of disease|2
1547474|NCT00103142|5058608|P2|Overall Study|Adverse Event|0
1547475|NCT00103142|5058609|P1|Overall Study|Adverse Event|1
1547476|NCT00103012|5058625|P3|Overall Study|Subject non-compliant with medications|1
1547477|NCT00103012|5058626|P2|Overall Study|Subject non-compliant with medications|0
1547478|NCT00103012|5058627|P1|Overall Study|Subject non-compliant with medications|0
1547479|NCT00103012|5058625|P3|Overall Study|Adverse Event|1
1547480|NCT00103012|5058626|P2|Overall Study|Adverse Event|0
1547481|NCT00103012|5058627|P1|Overall Study|Adverse Event|0
1547482|NCT00103012|5058625|P3|Overall Study|Pregnancy|0
1547483|NCT00103012|5058626|P2|Overall Study|Pregnancy|0
1547484|NCT00103012|5058627|P1|Overall Study|Pregnancy|1
1547485|NCT00103012|5058625|P3|Overall Study|Withdrawal by Subject|2
1547486|NCT00103012|5058626|P2|Overall Study|Withdrawal by Subject|1
1547487|NCT00103012|5058627|P1|Overall Study|Withdrawal by Subject|2
1547488|NCT00102804|5058637|P2|Overall Study|Alive, Receiving Treatment|2
1547489|NCT00102804|5058638|P1|Overall Study|Alive, Receiving Treatment|7
1547490|NCT00102804|5058637|P2|Overall Study|Sponsor Decision|0
1547491|NCT00102804|5058638|P1|Overall Study|Sponsor Decision|1
1547492|NCT00102804|5058637|P2|Overall Study|Satisfactory Response|0
1547493|NCT00102804|5058638|P1|Overall Study|Satisfactory Response|2
1547494|NCT00102804|5058637|P2|Overall Study|Protocol Violation|1
1547495|NCT00102804|5058638|P1|Overall Study|Protocol Violation|2
1547496|NCT00102804|5058637|P2|Overall Study|Lost to Follow-up|1
1547497|NCT00102804|5058638|P1|Overall Study|Lost to Follow-up|4
1547498|NCT00102804|5058637|P2|Overall Study|Enrollment Criteria Not Met|0
1547499|NCT00102804|5058638|P1|Overall Study|Enrollment Criteria Not Met|6
1547500|NCT00102804|5058637|P2|Overall Study|Death|6
1547501|NCT00102804|5058638|P1|Overall Study|Death|5
1547502|NCT00102804|5058637|P2|Overall Study|Physician Decision|6
1547503|NCT00102804|5058638|P1|Overall Study|Physician Decision|24
1547504|NCT00102804|5058637|P2|Overall Study|Adverse Event|3
1547505|NCT00102804|5058638|P1|Overall Study|Adverse Event|37
1547506|NCT00102804|5058637|P2|Overall Study|Withdrawal by Subject|7
1547507|NCT00102804|5058638|P1|Overall Study|Withdrawal by Subject|46
1547508|NCT00102804|5058637|P2|Overall Study|Progressive Disease (PD)|196
1547509|NCT00102804|5058638|P1|Overall Study|Progressive Disease (PD)|307
1547510|NCT00102687|5058659|P5|Maintenance Period|Death|1
1547511|NCT00102687|5058660|P4|Maintenance Period|Death|1
1547512|NCT00102687|5058661|P3|Maintenance Period|Death|0
1547513|NCT00102687|5058662|P2|Maintenance Period|Death|0
1547514|NCT00102687|5058663|P1|Maintenance Period|Death|0
1547515|NCT00102687|5058659|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
1547516|NCT00102687|5058660|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
1547517|NCT00102687|5058661|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
1547518|NCT00102687|5058662|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
1547519|NCT00102687|5058663|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
1547520|NCT00102687|5058659|P5|Maintenance Period|Sponsor decision|0
1547521|NCT00102687|5058660|P4|Maintenance Period|Sponsor decision|0
1547522|NCT00102687|5058661|P3|Maintenance Period|Sponsor decision|0
1547523|NCT00102687|5058662|P2|Maintenance Period|Sponsor decision|0
1547524|NCT00102687|5058663|P1|Maintenance Period|Sponsor decision|0
1547525|NCT00102687|5058659|P5|Maintenance Period|Physician Decision|4
1547526|NCT00102687|5058660|P4|Maintenance Period|Physician Decision|0
1547527|NCT00102687|5058661|P3|Maintenance Period|Physician Decision|3
1547528|NCT00102687|5058662|P2|Maintenance Period|Physician Decision|2
1547529|NCT00102687|5058663|P1|Maintenance Period|Physician Decision|1
1547530|NCT00102687|5058659|P5|Maintenance Period|Protocol Violation|0
1547531|NCT00102687|5058660|P4|Maintenance Period|Protocol Violation|0
1547532|NCT00102687|5058661|P3|Maintenance Period|Protocol Violation|0
1547533|NCT00102687|5058662|P2|Maintenance Period|Protocol Violation|0
1547534|NCT00102687|5058663|P1|Maintenance Period|Protocol Violation|0
1547535|NCT00102687|5058659|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
1547536|NCT00102687|5058660|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
1547625|NCT00102063|5058808|P2|Overall Study|Withdrawal by Subject|12
1547537|NCT00102687|5058661|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
1547538|NCT00102687|5058662|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
1547539|NCT00102687|5058663|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
1547540|NCT00102687|5058659|P5|Maintenance Period|Adverse Event|3
1547541|NCT00102687|5058660|P4|Maintenance Period|Adverse Event|1
1547542|NCT00102687|5058661|P3|Maintenance Period|Adverse Event|0
1547543|NCT00102687|5058662|P2|Maintenance Period|Adverse Event|0
1547544|NCT00102687|5058663|P1|Maintenance Period|Adverse Event|1
1547545|NCT00102687|5058659|P5|Maintenance Period|Withdrawal by Subject|1
1547546|NCT00102687|5058660|P4|Maintenance Period|Withdrawal by Subject|3
1547547|NCT00102687|5058661|P3|Maintenance Period|Withdrawal by Subject|2
1547548|NCT00102687|5058662|P2|Maintenance Period|Withdrawal by Subject|0
1547549|NCT00102687|5058663|P1|Maintenance Period|Withdrawal by Subject|4
1547550|NCT00102687|5058659|P5|Initial Period|Death|0
1547551|NCT00102687|5058660|P4|Initial Period|Death|0
1547552|NCT00102687|5058661|P3|Initial Period|Death|1
1547553|NCT00102687|5058662|P2|Initial Period|Death|1
1547554|NCT00102687|5058663|P1|Initial Period|Death|1
1547555|NCT00102687|5058659|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
1547556|NCT00102687|5058660|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
1547557|NCT00102687|5058661|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
1547558|NCT00102687|5058662|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
1547559|NCT00102687|5058663|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
1547560|NCT00102687|5058659|P5|Initial Period|Sponsor's decision|0
1547561|NCT00102687|5058660|P4|Initial Period|Sponsor's decision|0
1547562|NCT00102687|5058661|P3|Initial Period|Sponsor's decision|1
1547563|NCT00102687|5058662|P2|Initial Period|Sponsor's decision|1
1547564|NCT00102687|5058663|P1|Initial Period|Sponsor's decision|0
1547565|NCT00102687|5058659|P5|Initial Period|Physician Decision|0
1547566|NCT00102687|5058660|P4|Initial Period|Physician Decision|0
1547567|NCT00102687|5058661|P3|Initial Period|Physician Decision|6
1547568|NCT00102687|5058662|P2|Initial Period|Physician Decision|9
1547569|NCT00102687|5058663|P1|Initial Period|Physician Decision|2
1547570|NCT00102687|5058659|P5|Initial Period|Protocol Violation|0
1547571|NCT00102687|5058660|P4|Initial Period|Protocol Violation|0
1547572|NCT00102687|5058661|P3|Initial Period|Protocol Violation|2
1547573|NCT00102687|5058662|P2|Initial Period|Protocol Violation|0
1547574|NCT00102687|5058663|P1|Initial Period|Protocol Violation|0
1547575|NCT00102687|5058659|P5|Initial Period|Transformation to AML (blast > 30%)|0
1547576|NCT00102687|5058660|P4|Initial Period|Transformation to AML (blast > 30%)|0
1547577|NCT00102687|5058661|P3|Initial Period|Transformation to AML (blast > 30%)|0
1547578|NCT00102687|5058662|P2|Initial Period|Transformation to AML (blast > 30%)|3
1547579|NCT00102687|5058663|P1|Initial Period|Transformation to AML (blast > 30%)|1
1547580|NCT00102687|5058659|P5|Initial Period|Adverse Event|0
1547581|NCT00102687|5058660|P4|Initial Period|Adverse Event|0
1547582|NCT00102687|5058661|P3|Initial Period|Adverse Event|9
1547583|NCT00102687|5058662|P2|Initial Period|Adverse Event|7
1547584|NCT00102687|5058663|P1|Initial Period|Adverse Event|4
1547585|NCT00102687|5058659|P5|Initial Period|Withdrawal by Subject|0
1547586|NCT00102687|5058660|P4|Initial Period|Withdrawal by Subject|0
1547587|NCT00102687|5058661|P3|Initial Period|Withdrawal by Subject|5
1547588|NCT00102687|5058662|P2|Initial Period|Withdrawal by Subject|3
1547589|NCT00102687|5058663|P1|Initial Period|Withdrawal by Subject|6
1547590|NCT00102596|5058727|P2|Part A|Adverse Event|0
1547591|NCT00102596|5058728|P1|Part A|Adverse Event|1
1547592|NCT00102596|5058727|P2|Part A|Screen failures|0
1547593|NCT00102596|5058728|P1|Part A|Screen failures|6
1547594|NCT00102531|5058739|P2|Overall Study|Physician Decision|1
1547595|NCT00102531|5058740|P1|Overall Study|Physician Decision|0
1547596|NCT00102531|5058739|P2|Overall Study|Disease Progression|9
1547597|NCT00102531|5058740|P1|Overall Study|Disease Progression|5
1547598|NCT00102531|5058739|P2|Overall Study|Adverse Event|1
1547599|NCT00102531|5058740|P1|Overall Study|Adverse Event|0
1547600|NCT00102440|5058755|P3|Overall Study|Protocol Violation|1
1547601|NCT00102440|5058756|P2|Overall Study|Protocol Violation|2
1547602|NCT00102440|5058757|P1|Overall Study|Protocol Violation|7
1547603|NCT00102440|5058755|P3|Overall Study|Other|14
1547604|NCT00102440|5058756|P2|Overall Study|Other|14
1547605|NCT00102440|5058757|P1|Overall Study|Other|11
1547606|NCT00102440|5058755|P3|Overall Study|Personal Reason(s)|13
1547607|NCT00102440|5058756|P2|Overall Study|Personal Reason(s)|13
1547608|NCT00102440|5058757|P1|Overall Study|Personal Reason(s)|19
1547609|NCT00102440|5058755|P3|Overall Study|Gout Flare|9
1547610|NCT00102440|5058756|P2|Overall Study|Gout Flare|28
1547611|NCT00102440|5058757|P1|Overall Study|Gout Flare|10
1547612|NCT00102440|5058755|P3|Overall Study|Adverse Event|8
1547613|NCT00102440|5058756|P2|Overall Study|Adverse Event|23
1547614|NCT00102440|5058757|P1|Overall Study|Adverse Event|16
1547615|NCT00102440|5058755|P3|Overall Study|Lost to Follow-up|21
1547616|NCT00102440|5058756|P2|Overall Study|Lost to Follow-up|18
1547617|NCT00102440|5058757|P1|Overall Study|Lost to Follow-up|25
1547618|NCT00102063|5058807|P3|Overall Study|Protocol Violation|1
1547619|NCT00102063|5058808|P2|Overall Study|Protocol Violation|1
1547620|NCT00102063|5058809|P1|Overall Study|Protocol Violation|0
1547621|NCT00102063|5058807|P3|Overall Study|Lost to Follow-up|1
1547622|NCT00102063|5058808|P2|Overall Study|Lost to Follow-up|0
1547623|NCT00102063|5058809|P1|Overall Study|Lost to Follow-up|0
1547624|NCT00102063|5058807|P3|Overall Study|Withdrawal by Subject|5
1547626|NCT00102063|5058809|P1|Overall Study|Withdrawal by Subject|4
1547627|NCT00102063|5058807|P3|Overall Study|Adverse Event|2
1547628|NCT00102063|5058808|P2|Overall Study|Adverse Event|4
1547629|NCT00102063|5058809|P1|Overall Study|Adverse Event|7
1547630|NCT00102063|5058807|P3|Overall Study|Lack of Efficacy|1
1547631|NCT00102063|5058808|P2|Overall Study|Lack of Efficacy|1
1547632|NCT00102063|5058809|P1|Overall Study|Lack of Efficacy|5
1547633|NCT00101907|5058867|P6|Overall Study|Withdrawal by Subject|0
1547634|NCT00101907|5058868|P5|Overall Study|Withdrawal by Subject|1
1547635|NCT00101907|5058869|P4|Overall Study|Withdrawal by Subject|0
1547636|NCT00101907|5058870|P3|Overall Study|Withdrawal by Subject|1
1547637|NCT00101907|5058871|P2|Overall Study|Withdrawal by Subject|0
1547638|NCT00101907|5058872|P1|Overall Study|Withdrawal by Subject|1
1547639|NCT00101907|5058867|P6|Overall Study|Physician Decision|0
1547640|NCT00101907|5058868|P5|Overall Study|Physician Decision|1
1547641|NCT00101907|5058869|P4|Overall Study|Physician Decision|1
1547642|NCT00101907|5058870|P3|Overall Study|Physician Decision|0
1547643|NCT00101907|5058871|P2|Overall Study|Physician Decision|0
1547644|NCT00101907|5058872|P1|Overall Study|Physician Decision|0
1547645|NCT00101907|5058867|P6|Overall Study|Death|0
1547646|NCT00101907|5058868|P5|Overall Study|Death|3
1547647|NCT00101907|5058869|P4|Overall Study|Death|0
1547648|NCT00101907|5058870|P3|Overall Study|Death|0
1547649|NCT00101907|5058871|P2|Overall Study|Death|1
1547650|NCT00101907|5058872|P1|Overall Study|Death|0
1547651|NCT00101907|5058867|P6|Overall Study|Adverse Event|0
1547652|NCT00101907|5058868|P5|Overall Study|Adverse Event|0
1547653|NCT00101907|5058869|P4|Overall Study|Adverse Event|0
1547654|NCT00101907|5058870|P3|Overall Study|Adverse Event|0
1547655|NCT00101907|5058871|P2|Overall Study|Adverse Event|0
1547656|NCT00101907|5058872|P1|Overall Study|Adverse Event|1
1547657|NCT00101868|5058914|P2|Overall Study|Lost to Follow-up|13
1547658|NCT00101868|5058915|P1|Overall Study|Lost to Follow-up|8
1547659|NCT00101868|5058914|P2|Overall Study|Protocol Violation|0
1547660|NCT00101868|5058915|P1|Overall Study|Protocol Violation|3
1547661|NCT00101868|5058914|P2|Overall Study|Withdrawal by Subject|9
1547662|NCT00101868|5058915|P1|Overall Study|Withdrawal by Subject|8
1547663|NCT00101868|5058914|P2|Overall Study|Death|10
1547664|NCT00101868|5058915|P1|Overall Study|Death|10
1547665|NCT00101686|5058985|P10|Overall Study|Withdrawal by Subject|9
1547666|NCT00101686|5058986|P9|Overall Study|Withdrawal by Subject|8
1547667|NCT00101686|5058987|P8|Overall Study|Withdrawal by Subject|7
1547668|NCT00101686|5058988|P7|Overall Study|Withdrawal by Subject|7
1547669|NCT00101686|5058989|P6|Overall Study|Withdrawal by Subject|7
1547670|NCT00101686|5058990|P5|Overall Study|Withdrawal by Subject|8
1547671|NCT00101686|5058991|P4|Overall Study|Withdrawal by Subject|8
1547672|NCT00101686|5058992|P3|Overall Study|Withdrawal by Subject|6
1547673|NCT00101686|5058993|P2|Overall Study|Withdrawal by Subject|8
1547674|NCT00101686|5058994|P1|Overall Study|Withdrawal by Subject|9
1547675|NCT00101686|5058985|P10|Overall Study|Other|3
1547676|NCT00101686|5058986|P9|Overall Study|Other|3
1547677|NCT00101686|5058987|P8|Overall Study|Other|5
1547678|NCT00101686|5058988|P7|Overall Study|Other|1
1547679|NCT00101686|5058989|P6|Overall Study|Other|12
1547680|NCT00101686|5058990|P5|Overall Study|Other|2
1547681|NCT00101686|5058991|P4|Overall Study|Other|6
1547682|NCT00101686|5058992|P3|Overall Study|Other|1
1547683|NCT00101686|5058993|P2|Overall Study|Other|4
1547684|NCT00101686|5058994|P1|Overall Study|Other|1
1547685|NCT00101686|5058985|P10|Overall Study|Physician Decision|1
1547686|NCT00101686|5058986|P9|Overall Study|Physician Decision|1
1547687|NCT00101686|5058987|P8|Overall Study|Physician Decision|5
1547688|NCT00101686|5058988|P7|Overall Study|Physician Decision|5
1547689|NCT00101686|5058989|P6|Overall Study|Physician Decision|9
1547690|NCT00101686|5058990|P5|Overall Study|Physician Decision|8
1547691|NCT00101686|5058991|P4|Overall Study|Physician Decision|7
1547692|NCT00101686|5058992|P3|Overall Study|Physician Decision|6
1547693|NCT00101686|5058993|P2|Overall Study|Physician Decision|13
1547694|NCT00101686|5058994|P1|Overall Study|Physician Decision|10
1547695|NCT00101686|5058985|P10|Overall Study|intercurrent non-cancer related illness|1
1547696|NCT00101686|5058986|P9|Overall Study|intercurrent non-cancer related illness|1
1547697|NCT00101686|5058987|P8|Overall Study|intercurrent non-cancer related illness|0
1547698|NCT00101686|5058988|P7|Overall Study|intercurrent non-cancer related illness|1
1547699|NCT00101686|5058989|P6|Overall Study|intercurrent non-cancer related illness|3
1547700|NCT00101686|5058990|P5|Overall Study|intercurrent non-cancer related illness|1
1547701|NCT00101686|5058991|P4|Overall Study|intercurrent non-cancer related illness|0
1547702|NCT00101686|5058992|P3|Overall Study|intercurrent non-cancer related illness|2
1547703|NCT00101686|5058993|P2|Overall Study|intercurrent non-cancer related illness|0
1547704|NCT00101686|5058994|P1|Overall Study|intercurrent non-cancer related illness|0
1547705|NCT00101686|5058985|P10|Overall Study|Randomized but did not receive treament|1
1547706|NCT00101686|5058986|P9|Overall Study|Randomized but did not receive treament|0
1547707|NCT00101686|5058987|P8|Overall Study|Randomized but did not receive treament|1
1547708|NCT00101686|5058988|P7|Overall Study|Randomized but did not receive treament|0
1547709|NCT00101686|5058989|P6|Overall Study|Randomized but did not receive treament|2
1547710|NCT00101686|5058990|P5|Overall Study|Randomized but did not receive treament|2
1547711|NCT00101686|5058991|P4|Overall Study|Randomized but did not receive treament|2
1547712|NCT00101686|5058992|P3|Overall Study|Randomized but did not receive treament|2
1547713|NCT00101686|5058993|P2|Overall Study|Randomized but did not receive treament|6
1547714|NCT00101686|5058994|P1|Overall Study|Randomized but did not receive treament|1
1547715|NCT00101686|5058985|P10|Overall Study|unacceptable toxicity|4
1547716|NCT00101686|5058986|P9|Overall Study|unacceptable toxicity|1
1547717|NCT00101686|5058987|P8|Overall Study|unacceptable toxicity|2
1547718|NCT00101686|5058988|P7|Overall Study|unacceptable toxicity|4
1547719|NCT00101686|5058989|P6|Overall Study|unacceptable toxicity|10
1547720|NCT00101686|5058990|P5|Overall Study|unacceptable toxicity|16
1547721|NCT00101686|5058991|P4|Overall Study|unacceptable toxicity|6
1547722|NCT00101686|5058992|P3|Overall Study|unacceptable toxicity|10
1547723|NCT00101686|5058993|P2|Overall Study|unacceptable toxicity|9
1547724|NCT00101686|5058994|P1|Overall Study|unacceptable toxicity|3
1547725|NCT00101686|5058985|P10|Overall Study|>3 week delay treatment due toxicity|0
1547726|NCT00101686|5058986|P9|Overall Study|>3 week delay treatment due toxicity|3
1547727|NCT00101686|5058987|P8|Overall Study|>3 week delay treatment due toxicity|1
1547728|NCT00101686|5058988|P7|Overall Study|>3 week delay treatment due toxicity|2
1547729|NCT00101686|5058989|P6|Overall Study|>3 week delay treatment due toxicity|3
1547730|NCT00101686|5058990|P5|Overall Study|>3 week delay treatment due toxicity|7
1547731|NCT00101686|5058991|P4|Overall Study|>3 week delay treatment due toxicity|2
1547732|NCT00101686|5058992|P3|Overall Study|>3 week delay treatment due toxicity|1
1547733|NCT00101686|5058993|P2|Overall Study|>3 week delay treatment due toxicity|2
1547734|NCT00101686|5058994|P1|Overall Study|>3 week delay treatment due toxicity|6
1547735|NCT00101686|5058985|P10|Overall Study|initiation other anti-cancer treatment|3
1547736|NCT00101686|5058986|P9|Overall Study|initiation other anti-cancer treatment|3
1547737|NCT00101686|5058987|P8|Overall Study|initiation other anti-cancer treatment|2
1547738|NCT00101686|5058988|P7|Overall Study|initiation other anti-cancer treatment|2
1547739|NCT00101686|5058989|P6|Overall Study|initiation other anti-cancer treatment|1
1547740|NCT00101686|5058990|P5|Overall Study|initiation other anti-cancer treatment|1
1547741|NCT00101686|5058991|P4|Overall Study|initiation other anti-cancer treatment|3
1547742|NCT00101686|5058992|P3|Overall Study|initiation other anti-cancer treatment|4
1547743|NCT00101686|5058993|P2|Overall Study|initiation other anti-cancer treatment|3
1547744|NCT00101686|5058994|P1|Overall Study|initiation other anti-cancer treatment|4
1547745|NCT00101686|5058985|P10|Overall Study|Progressive Disease|8
1547746|NCT00101686|5058986|P9|Overall Study|Progressive Disease|10
1547747|NCT00101686|5058987|P8|Overall Study|Progressive Disease|7
1547748|NCT00101686|5058988|P7|Overall Study|Progressive Disease|5
1547749|NCT00101686|5058989|P6|Overall Study|Progressive Disease|25
1547750|NCT00101686|5058990|P5|Overall Study|Progressive Disease|28
1547751|NCT00101686|5058991|P4|Overall Study|Progressive Disease|38
1547752|NCT00101686|5058992|P3|Overall Study|Progressive Disease|37
1547753|NCT00101686|5058993|P2|Overall Study|Progressive Disease|28
1547754|NCT00101686|5058994|P1|Overall Study|Progressive Disease|37
1547755|NCT00101582|5059111|P2|Overall Study|Other|1
1547756|NCT00101582|5059112|P1|Overall Study|Other|0
1547757|NCT00101582|5059111|P2|Overall Study|Death|5
1547758|NCT00101582|5059112|P1|Overall Study|Death|3
1547759|NCT00101582|5059111|P2|Overall Study|Physician Decision|0
1547760|NCT00101582|5059112|P1|Overall Study|Physician Decision|1
1547761|NCT00101582|5059111|P2|Overall Study|Withdrawal by Subject|4
1547762|NCT00101582|5059112|P1|Overall Study|Withdrawal by Subject|6
1547763|NCT00101582|5059111|P2|Overall Study|Adverse Event|4
1547764|NCT00101582|5059112|P1|Overall Study|Adverse Event|1
1547765|NCT00101582|5059111|P2|Overall Study|Ineligibility determined|1
1547766|NCT00101582|5059112|P1|Overall Study|Ineligibility determined|0
1547767|NCT00101452|5059135|P3|Overall Study|Other|12
1547768|NCT00101452|5059136|P2|Overall Study|Other|16
1547769|NCT00101452|5059137|P1|Overall Study|Other|15
1547770|NCT00101452|5059135|P3|Overall Study|Protocol Violation|3
1547771|NCT00101452|5059136|P2|Overall Study|Protocol Violation|1
1547772|NCT00101452|5059137|P1|Overall Study|Protocol Violation|2
1547773|NCT00101452|5059135|P3|Overall Study|Physician Decision|2
1547774|NCT00101452|5059136|P2|Overall Study|Physician Decision|3
1547775|NCT00101452|5059137|P1|Overall Study|Physician Decision|0
1547776|NCT00101452|5059135|P3|Overall Study|Baseline Fail|2
1547777|NCT00101452|5059136|P2|Overall Study|Baseline Fail|1
1547778|NCT00101452|5059137|P1|Overall Study|Baseline Fail|2
1547779|NCT00101452|5059135|P3|Overall Study|Withdrawal by Subject|9
1547780|NCT00101452|5059136|P2|Overall Study|Withdrawal by Subject|14
1547781|NCT00101452|5059137|P1|Overall Study|Withdrawal by Subject|10
1547782|NCT00101452|5059135|P3|Overall Study|Lost to Follow-up|14
1547783|NCT00101452|5059136|P2|Overall Study|Lost to Follow-up|8
1547784|NCT00101452|5059137|P1|Overall Study|Lost to Follow-up|13
1547785|NCT00101452|5059135|P3|Overall Study|Adverse Event|1
1547786|NCT00101452|5059136|P2|Overall Study|Adverse Event|0
1547787|NCT00101452|5059137|P1|Overall Study|Adverse Event|2
1547788|NCT00101439|5059151|P2|Period 2|Withdrawal by Subject|2
1547789|NCT00101439|5059152|P1|Period 2|Withdrawal by Subject|0
1547790|NCT00101400|5059168|P1|Survival Follow-Up|Alive|7
1547791|NCT00101283|5059188|P2|Overall Study|Prostate Cancer Recurrence|1
1547792|NCT00101283|5059189|P1|Overall Study|Prostate Cancer Recurrence|0
1547793|NCT00101283|5059188|P2|Overall Study|Insurance Refusal|1
1547794|NCT00101283|5059189|P1|Overall Study|Insurance Refusal|0
1547795|NCT00101283|5059188|P2|Overall Study|Withdrawal by Subject|1
1547796|NCT00101283|5059189|P1|Overall Study|Withdrawal by Subject|0
1547797|NCT00101192|5059199|P1|Overall Study|Inevaluable|1
1547798|NCT00101192|5059199|P1|Overall Study|Ineligible|6
1547799|NCT00101166|5059203|P1|Overall Study|progressive disease|10
1547800|NCT00101101|5059211|P1|Overall Study|never received vaccine|20
1547801|NCT00100932|5059234|P2|Overall Study|Not specified|2
1547802|NCT00100932|5059235|P1|Overall Study|Not specified|5
1547803|NCT00100932|5059234|P2|Overall Study|Physician Decision|5
1547804|NCT00100932|5059235|P1|Overall Study|Physician Decision|7
1547805|NCT00100932|5059234|P2|Overall Study|Progressive Disease|18
1547806|NCT00100932|5059235|P1|Overall Study|Progressive Disease|44
1547807|NCT00100932|5059234|P2|Overall Study|Withdrawal by Subject|0
1547808|NCT00100932|5059235|P1|Overall Study|Withdrawal by Subject|6
1547809|NCT00100932|5059234|P2|Overall Study|Adverse Event|2
1547810|NCT00100932|5059235|P1|Overall Study|Adverse Event|11
1547811|NCT00100815|5059250|P1|Overall Study|not specified|3
1547812|NCT00100815|5059250|P1|Overall Study|Death|4
1547813|NCT00100815|5059250|P1|Overall Study|Adverse Event|18
1547814|NCT00100815|5059250|P1|Overall Study|Progression|24
1547815|NCT00100802|5059258|P1|Overall Study|Ineligible|12
1547816|NCT00100802|5059258|P1|Overall Study|Withdrawal by Subject|5
1547817|NCT00100802|5059258|P1|Overall Study|Protocol Violation|1
1547818|NCT00100802|5059258|P1|Overall Study|Physician Decision|5
1547819|NCT00100802|5059258|P1|Overall Study|Lack of Efficacy|47
1547820|NCT00100802|5059258|P1|Overall Study|Death|1
1547821|NCT00100802|5059258|P1|Overall Study|Adverse Event|9
1547822|NCT00100789|5059263|P1|Overall Study|Never received treatment|1
1547823|NCT00100789|5059263|P1|Overall Study|Ineligible|3
1547824|NCT00100789|5059263|P1|Overall Study|Not protocol specified|5
1547825|NCT00100789|5059263|P1|Overall Study|Death|2
1547826|NCT00100789|5059263|P1|Overall Study|Progression/relapse|42
1547827|NCT00100789|5059263|P1|Overall Study|Withdrawal by Subject|1
1547828|NCT00100789|5059263|P1|Overall Study|Adverse Event|10
1547829|NCT00100178|5059338|P3|Overall Study|Physician Decision|3
1547830|NCT00100178|5059339|P2|Overall Study|Physician Decision|1
1547831|NCT00100178|5059340|P1|Overall Study|Physician Decision|6
1547832|NCT00100178|5059338|P3|Overall Study|Withdrawal by Subject|1
1547833|NCT00100178|5059339|P2|Overall Study|Withdrawal by Subject|1
1547834|NCT00100178|5059340|P1|Overall Study|Withdrawal by Subject|1
1547835|NCT00100178|5059338|P3|Overall Study|Adverse Event|1
1547836|NCT00100178|5059339|P2|Overall Study|Adverse Event|2
1547837|NCT00100178|5059340|P1|Overall Study|Adverse Event|2
1547838|NCT00100178|5059338|P3|Overall Study|Lost to Follow-up|5
1547839|NCT00100178|5059339|P2|Overall Study|Lost to Follow-up|6
1547840|NCT00100178|5059340|P1|Overall Study|Lost to Follow-up|0
1547841|NCT00100048|5059353|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1547842|NCT00100048|5059354|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1547843|NCT00100048|5059355|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
1547844|NCT00100048|5059356|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1547845|NCT00100048|5059357|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1547846|NCT00100048|5059358|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1547847|NCT00100048|5059353|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
1547848|NCT00100048|5059354|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
1547849|NCT00100048|5059355|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
1547850|NCT00100048|5059356|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
1547851|NCT00100048|5059357|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
1547852|NCT00100048|5059358|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
1547853|NCT00100048|5059353|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
1547854|NCT00100048|5059354|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
1547855|NCT00100048|5059355|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
1547856|NCT00100048|5059356|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
1547857|NCT00100048|5059357|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
1547858|NCT00100048|5059358|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
1547859|NCT00100048|5059353|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
1547860|NCT00100048|5059354|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
1547861|NCT00100048|5059355|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
1547862|NCT00100048|5059356|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
1547863|NCT00100048|5059357|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
1547864|NCT00100048|5059358|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
1547865|NCT00100048|5059353|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
1547866|NCT00100048|5059354|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
1547867|NCT00100048|5059355|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
1547868|NCT00100048|5059356|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
1547869|NCT00100048|5059357|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
1547870|NCT00100048|5059358|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
1547871|NCT00100048|5059353|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
1547872|NCT00100048|5059354|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
1547873|NCT00100048|5059355|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
1547874|NCT00100048|5059356|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
1547875|NCT00100048|5059357|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
1547876|NCT00100048|5059358|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
1547877|NCT00100048|5059353|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
1547878|NCT00100048|5059354|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
1547879|NCT00100048|5059355|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
1547880|NCT00100048|5059356|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
1547881|NCT00100048|5059357|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
1547882|NCT00100048|5059358|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
1547883|NCT00100048|5059353|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
1547884|NCT00100048|5059354|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
1547885|NCT00100048|5059355|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
1547886|NCT00100048|5059356|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
1547887|NCT00100048|5059357|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
1547888|NCT00100048|5059358|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
1547889|NCT00099983|5059467|P2|Overall Study|Other issue|0
1547890|NCT00099983|5059468|P1|Overall Study|Other issue|1
1547891|NCT00099983|5059467|P2|Overall Study|Intolerant of burden of visits|1
1547892|NCT00099983|5059468|P1|Overall Study|Intolerant of burden of visits|0
1547893|NCT00099983|5059467|P2|Overall Study|Incarcerated|1
1547894|NCT00099983|5059468|P1|Overall Study|Incarcerated|0
1547895|NCT00099983|5059467|P2|Overall Study|Other psychiatric problem|0
1547896|NCT00099983|5059468|P1|Overall Study|Other psychiatric problem|1
1547897|NCT00099983|5059467|P2|Overall Study|Moved|0
1547898|NCT00099983|5059468|P1|Overall Study|Moved|1
1547899|NCT00099983|5059467|P2|Overall Study|Unable to return for appointments|1
1547900|NCT00099983|5059468|P1|Overall Study|Unable to return for appointments|1
1547901|NCT00099983|5059467|P2|Overall Study|Lack of Efficacy|1
1547902|NCT00099983|5059468|P1|Overall Study|Lack of Efficacy|0
1547903|NCT00099983|5059467|P2|Overall Study|Adverse Event|1
1547904|NCT00099983|5059468|P1|Overall Study|Adverse Event|1
1547905|NCT00099983|5059467|P2|Overall Study|Withdrawal by Subject|2
1547906|NCT00099983|5059468|P1|Overall Study|Withdrawal by Subject|3
1547907|NCT00099983|5059467|P2|Overall Study|Missing Source Documents|15
1547908|NCT00099983|5059468|P1|Overall Study|Missing Source Documents|14
1547909|NCT00099983|5059467|P2|Overall Study|Lost to Follow-up|3
1547910|NCT00099983|5059468|P1|Overall Study|Lost to Follow-up|2
1547911|NCT00099632|5059480|P6|Overall Study|Protocol Violation|1
1547912|NCT00099632|5059481|P5|Overall Study|Protocol Violation|0
1547913|NCT00099632|5059482|P4|Overall Study|Protocol Violation|0
1547914|NCT00099632|5059483|P3|Overall Study|Protocol Violation|0
1547915|NCT00099632|5059484|P2|Overall Study|Protocol Violation|0
1547916|NCT00099632|5059485|P1|Overall Study|Protocol Violation|0
1547917|NCT00099632|5059480|P6|Overall Study|Withdrawal by Subject|1
1547918|NCT00099632|5059481|P5|Overall Study|Withdrawal by Subject|0
1547919|NCT00099632|5059482|P4|Overall Study|Withdrawal by Subject|0
1547920|NCT00099632|5059483|P3|Overall Study|Withdrawal by Subject|0
1547921|NCT00099632|5059484|P2|Overall Study|Withdrawal by Subject|1
1547922|NCT00099632|5059485|P1|Overall Study|Withdrawal by Subject|0
1547923|NCT00099632|5059480|P6|Overall Study|Lost to Follow-up|0
1547924|NCT00099632|5059481|P5|Overall Study|Lost to Follow-up|1
1547925|NCT00099632|5059482|P4|Overall Study|Lost to Follow-up|1
1547926|NCT00099632|5059483|P3|Overall Study|Lost to Follow-up|3
1547927|NCT00099632|5059484|P2|Overall Study|Lost to Follow-up|0
1547928|NCT00099632|5059485|P1|Overall Study|Lost to Follow-up|1
1547929|NCT00099437|5059525|P2|Overall Study|Ongoing in FU but not on treatment|45
1547930|NCT00099437|5059526|P1|Overall Study|Ongoing in FU but not on treatment|37
1547931|NCT00099437|5059525|P2|Overall Study|Withdrawal by Subject|10
1547932|NCT00099437|5059526|P1|Overall Study|Withdrawal by Subject|6
1547933|NCT00099437|5059525|P2|Overall Study|Death|261
1547934|NCT00099437|5059526|P1|Overall Study|Death|293
1547935|NCT00099437|5059525|P2|Overall Study|Lost to Follow-up|33
1547936|NCT00099437|5059526|P1|Overall Study|Lost to Follow-up|30
1547937|NCT00099359|5059549|P3|Overall Study|moved out of area|4
1547938|NCT00099359|5059550|P2|Overall Study|moved out of area|7
1547939|NCT00099359|5059551|P1|Overall Study|moved out of area|9
1547940|NCT00099359|5059549|P3|Overall Study|Lost to Follow-up|24
1547941|NCT00099359|5059550|P2|Overall Study|Lost to Follow-up|24
1547942|NCT00099359|5059551|P1|Overall Study|Lost to Follow-up|15
1547943|NCT00099359|5059549|P3|Overall Study|Withdrawal by Subject|23
1547944|NCT00099359|5059550|P2|Overall Study|Withdrawal by Subject|19
1547945|NCT00099359|5059551|P1|Overall Study|Withdrawal by Subject|19
1547946|NCT00099359|5059549|P3|Overall Study|Death|17
1547947|NCT00099359|5059550|P2|Overall Study|Death|15
1547948|NCT00099359|5059551|P1|Overall Study|Death|11
1547949|NCT00099268|5059574|P2|Overall Study|Death|1
1547950|NCT00099268|5059575|P1|Overall Study|Death|3
1547951|NCT00099268|5059574|P2|Overall Study|Administrative problems|4
1547952|NCT00099268|5059575|P1|Overall Study|Administrative problems|4
1547953|NCT00099268|5059574|P2|Overall Study|Lack of Efficacy|18
1547954|NCT00099268|5059575|P1|Overall Study|Lack of Efficacy|5
1547955|NCT00099268|5059574|P2|Overall Study|Lost to Follow-up|4
1547956|NCT00099268|5059575|P1|Overall Study|Lost to Follow-up|6
1547957|NCT00099268|5059574|P2|Overall Study|Protocol Violation|8
1547958|NCT00099268|5059575|P1|Overall Study|Protocol Violation|9
1547959|NCT00099268|5059574|P2|Overall Study|Adverse Event|19
1547960|NCT00099268|5059575|P1|Overall Study|Adverse Event|19
1547961|NCT00099268|5059574|P2|Overall Study|Withdrawal by Subject|28
1547962|NCT00099268|5059575|P1|Overall Study|Withdrawal by Subject|46
1547963|NCT00098865|5059615|P1|Overall Study|Alternative Therapy|1
1547964|NCT00098865|5059615|P1|Overall Study|Adverse Event|2
1547965|NCT00098865|5059615|P1|Overall Study|Progressive Disease|6
1547966|NCT00098839|5059623|P2|Overall Study|Ineligible|0
1547967|NCT00098839|5059624|P1|Overall Study|Ineligible|2
1547968|NCT00098839|5059623|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
1547969|NCT00098839|5059624|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
1547970|NCT00098839|5059623|P2|Overall Study|Relapse|3
1547971|NCT00098839|5059624|P1|Overall Study|Relapse|6
1547972|NCT00098839|5059623|P2|Overall Study|Refusal of further protocol therapy|1
1547973|NCT00098839|5059624|P1|Overall Study|Refusal of further protocol therapy|3
1547974|NCT00098839|5059623|P2|Overall Study|Withdrawal by Subject|0
1547975|NCT00098839|5059624|P1|Overall Study|Withdrawal by Subject|1
1547976|NCT00098839|5059623|P2|Overall Study|Physician Decision|14
1547977|NCT00098839|5059624|P1|Overall Study|Physician Decision|4
1547978|NCT00098839|5059623|P2|Overall Study|Death|2
1547979|NCT00098839|5059624|P1|Overall Study|Death|1
1547980|NCT00098839|5059623|P2|Overall Study|Adverse Event|2
1547981|NCT00098839|5059624|P1|Overall Study|Adverse Event|5
1547982|NCT00098813|5059635|P1|Overall Study|Reversal of RAI resistance|1
1547983|NCT00098813|5059635|P1|Overall Study|Other complicating disease|1
1547984|NCT00098813|5059635|P1|Overall Study|Progression of Disease|1
1547985|NCT00098813|5059635|P1|Overall Study|Withdrawal by Subject|7
1547986|NCT00098813|5059635|P1|Overall Study|Protocol Violation|1
1547987|NCT00098813|5059635|P1|Overall Study|Death|8
1547988|NCT00098787|5059642|P3|Overall Study|Other|9
1547989|NCT00098787|5059643|P2|Overall Study|Other|6
1547990|NCT00098787|5059644|P1|Overall Study|Other|7
1547991|NCT00098787|5059642|P3|Overall Study|Alternative therapy|13
1547992|NCT00098787|5059643|P2|Overall Study|Alternative therapy|13
1547993|NCT00098787|5059644|P1|Overall Study|Alternative therapy|8
1547994|NCT00098787|5059642|P3|Overall Study|Withdrawal by Subject|6
1547995|NCT00098787|5059643|P2|Overall Study|Withdrawal by Subject|12
1547996|NCT00098787|5059644|P1|Overall Study|Withdrawal by Subject|4
1547997|NCT00098787|5059642|P3|Overall Study|Death|0
1547998|NCT00098787|5059643|P2|Overall Study|Death|1
1547999|NCT00098787|5059644|P1|Overall Study|Death|6
1548000|NCT00098787|5059642|P3|Overall Study|Adverse Event|8
1548001|NCT00098787|5059643|P2|Overall Study|Adverse Event|17
1548002|NCT00098787|5059644|P1|Overall Study|Adverse Event|8
1548003|NCT00098787|5059642|P3|Overall Study|Disease progression|23
1548004|NCT00098787|5059643|P2|Overall Study|Disease progression|17
1548005|NCT00098787|5059644|P1|Overall Study|Disease progression|28
1548006|NCT00098787|5059642|P3|Overall Study|Ineligible|3
1548007|NCT00098787|5059643|P2|Overall Study|Ineligible|7
1548008|NCT00098787|5059644|P1|Overall Study|Ineligible|9
1548009|NCT00098787|5059642|P3|Overall Study|Never started treatment|1
1548010|NCT00098787|5059643|P2|Overall Study|Never started treatment|2
1548011|NCT00098787|5059644|P1|Overall Study|Never started treatment|3
1548012|NCT00098774|5059658|P1|Overall Study|Physician Decision|2
1548013|NCT00098774|5059658|P1|Overall Study|Failed (to respond) during induction|4
1548014|NCT00098774|5059658|P1|Overall Study|Withdrawal by Subject|1
1548015|NCT00098774|5059658|P1|Overall Study|Disease Progression|9
1548016|NCT00098774|5059658|P1|Overall Study|Adverse Event|2
1548017|NCT00098748|5059668|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
1548018|NCT00098748|5059669|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
1548019|NCT00098748|5059670|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
1548020|NCT00098748|5059668|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
1548021|NCT00098748|5059669|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
1548022|NCT00098748|5059670|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
1548023|NCT00098748|5059668|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
1548024|NCT00098748|5059669|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
1548025|NCT00098748|5059670|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
1548026|NCT00098748|5059668|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
1548027|NCT00098748|5059669|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
1548028|NCT00098748|5059670|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
1548029|NCT00098748|5059668|P3|Continued on Open-Label Treatment|Adverse Event|0
1548030|NCT00098748|5059669|P2|Continued on Open-Label Treatment|Adverse Event|1
1548031|NCT00098748|5059670|P1|Continued on Open-Label Treatment|Adverse Event|0
1548032|NCT00098748|5059668|P3|Received Study Treatment|Subject defaulted|4
1548033|NCT00098748|5059669|P2|Received Study Treatment|Subject defaulted|4
1548034|NCT00098748|5059670|P1|Received Study Treatment|Subject defaulted|3
1548035|NCT00098748|5059668|P3|Received Study Treatment|Other|6
1548036|NCT00098748|5059669|P2|Received Study Treatment|Other|2
1548037|NCT00098748|5059670|P1|Received Study Treatment|Other|2
1548038|NCT00098748|5059668|P3|Received Study Treatment|Lack of Efficacy|27
1548039|NCT00098748|5059669|P2|Received Study Treatment|Lack of Efficacy|27
1548040|NCT00098748|5059670|P1|Received Study Treatment|Lack of Efficacy|40
1548041|NCT00098748|5059668|P3|Received Study Treatment|Adverse Event|5
1548042|NCT00098748|5059669|P2|Received Study Treatment|Adverse Event|2
1548043|NCT00098748|5059670|P1|Received Study Treatment|Adverse Event|1
1548044|NCT00098748|5059668|P3|Received Study Treatment|Death|2
1548045|NCT00098748|5059669|P2|Received Study Treatment|Death|1
1548046|NCT00098748|5059670|P1|Received Study Treatment|Death|2
1548047|NCT00098748|5059668|P3|Assigned to Study Treatment|Randomized, but not treated|2
1548048|NCT00098748|5059669|P2|Assigned to Study Treatment|Randomized, but not treated|2
1548049|NCT00098748|5059670|P1|Assigned to Study Treatment|Randomized, but not treated|0
1548050|NCT00098722|5059726|P7|Observation Phase|Other|10
1548051|NCT00098722|5059727|P6|Observation Phase|Other|21
1548052|NCT00098722|5059728|P5|Observation Phase|Other|0
1548053|NCT00098722|5059729|P4|Observation Phase|Other|0
1548054|NCT00098722|5059730|P3|Observation Phase|Other|0
1548055|NCT00098722|5059731|P2|Observation Phase|Other|0
1548056|NCT00098722|5059732|P1|Observation Phase|Other|0
1548057|NCT00098722|5059726|P7|Observation Phase|Participant defaulted|4
1548058|NCT00098722|5059727|P6|Observation Phase|Participant defaulted|17
1548059|NCT00098722|5059728|P5|Observation Phase|Participant defaulted|0
1548060|NCT00098722|5059729|P4|Observation Phase|Participant defaulted|0
1548061|NCT00098722|5059730|P3|Observation Phase|Participant defaulted|0
1548062|NCT00098722|5059731|P2|Observation Phase|Participant defaulted|0
1548063|NCT00098722|5059732|P1|Observation Phase|Participant defaulted|0
1548064|NCT00098722|5059726|P7|Observation Phase|Lack of Efficacy|0
1548065|NCT00098722|5059727|P6|Observation Phase|Lack of Efficacy|2
1548066|NCT00098722|5059728|P5|Observation Phase|Lack of Efficacy|0
1548067|NCT00098722|5059729|P4|Observation Phase|Lack of Efficacy|0
1548068|NCT00098722|5059730|P3|Observation Phase|Lack of Efficacy|0
1548069|NCT00098722|5059731|P2|Observation Phase|Lack of Efficacy|0
1548070|NCT00098722|5059732|P1|Observation Phase|Lack of Efficacy|0
1548071|NCT00098722|5059726|P7|Observation Phase|Death|3
1548072|NCT00098722|5059727|P6|Observation Phase|Death|5
1548073|NCT00098722|5059728|P5|Observation Phase|Death|0
1548074|NCT00098722|5059729|P4|Observation Phase|Death|0
1548075|NCT00098722|5059730|P3|Observation Phase|Death|0
1548076|NCT00098722|5059731|P2|Observation Phase|Death|0
1548077|NCT00098722|5059732|P1|Observation Phase|Death|0
1548078|NCT00098722|5059726|P7|Open Label Phase|Other|0
1548079|NCT00098722|5059727|P6|Open Label Phase|Other|0
1548080|NCT00098722|5059728|P5|Open Label Phase|Other|0
1548081|NCT00098722|5059729|P4|Open Label Phase|Other|18
1548082|NCT00098722|5059730|P3|Open Label Phase|Other|0
1548083|NCT00098722|5059731|P2|Open Label Phase|Other|0
1548084|NCT00098722|5059732|P1|Open Label Phase|Other|0
1548085|NCT00098722|5059726|P7|Open Label Phase|Ongoing at cut-off date|0
1548086|NCT00098722|5059727|P6|Open Label Phase|Ongoing at cut-off date|0
1548087|NCT00098722|5059728|P5|Open Label Phase|Ongoing at cut-off date|50
1548088|NCT00098722|5059729|P4|Open Label Phase|Ongoing at cut-off date|220
1548089|NCT00098722|5059730|P3|Open Label Phase|Ongoing at cut-off date|0
1548090|NCT00098722|5059731|P2|Open Label Phase|Ongoing at cut-off date|0
1548091|NCT00098722|5059732|P1|Open Label Phase|Ongoing at cut-off date|0
1548092|NCT00098722|5059726|P7|Open Label Phase|Participant defaulted|0
1548093|NCT00098722|5059727|P6|Open Label Phase|Participant defaulted|0
1548094|NCT00098722|5059728|P5|Open Label Phase|Participant defaulted|0
1548095|NCT00098722|5059729|P4|Open Label Phase|Participant defaulted|18
1548096|NCT00098722|5059730|P3|Open Label Phase|Participant defaulted|0
1548097|NCT00098722|5059731|P2|Open Label Phase|Participant defaulted|0
1548098|NCT00098722|5059732|P1|Open Label Phase|Participant defaulted|0
1548099|NCT00098722|5059726|P7|Open Label Phase|Pregnancy|0
1548100|NCT00098722|5059727|P6|Open Label Phase|Pregnancy|0
1548101|NCT00098722|5059728|P5|Open Label Phase|Pregnancy|0
1548102|NCT00098722|5059729|P4|Open Label Phase|Pregnancy|1
1548103|NCT00098722|5059730|P3|Open Label Phase|Pregnancy|0
1548104|NCT00098722|5059731|P2|Open Label Phase|Pregnancy|0
1548105|NCT00098722|5059732|P1|Open Label Phase|Pregnancy|0
1548106|NCT00098722|5059726|P7|Open Label Phase|Lack of Efficacy|0
1548107|NCT00098722|5059727|P6|Open Label Phase|Lack of Efficacy|0
1548108|NCT00098722|5059728|P5|Open Label Phase|Lack of Efficacy|0
1548109|NCT00098722|5059729|P4|Open Label Phase|Lack of Efficacy|8
1548110|NCT00098722|5059730|P3|Open Label Phase|Lack of Efficacy|0
1548111|NCT00098722|5059731|P2|Open Label Phase|Lack of Efficacy|0
1548112|NCT00098722|5059732|P1|Open Label Phase|Lack of Efficacy|0
1548113|NCT00098722|5059726|P7|Open Label Phase|Death|0
1548114|NCT00098722|5059727|P6|Open Label Phase|Death|0
1548115|NCT00098722|5059728|P5|Open Label Phase|Death|0
1548116|NCT00098722|5059729|P4|Open Label Phase|Death|2
1548117|NCT00098722|5059730|P3|Open Label Phase|Death|0
1548118|NCT00098722|5059731|P2|Open Label Phase|Death|0
1548119|NCT00098722|5059732|P1|Open Label Phase|Death|0
1548120|NCT00098722|5059726|P7|Open Label Phase|Adverse Event|0
1548121|NCT00098722|5059727|P6|Open Label Phase|Adverse Event|0
1548122|NCT00098722|5059728|P5|Open Label Phase|Adverse Event|0
1548123|NCT00098722|5059729|P4|Open Label Phase|Adverse Event|5
1548124|NCT00098722|5059730|P3|Open Label Phase|Adverse Event|0
1548125|NCT00098722|5059731|P2|Open Label Phase|Adverse Event|0
1548126|NCT00098722|5059732|P1|Open Label Phase|Adverse Event|0
1548127|NCT00098722|5059726|P7|Double Blind Phase|Other|0
1548128|NCT00098722|5059727|P6|Double Blind Phase|Other|0
1548129|NCT00098722|5059728|P5|Double Blind Phase|Other|0
1548130|NCT00098722|5059729|P4|Double Blind Phase|Other|0
1548131|NCT00098722|5059730|P3|Double Blind Phase|Other|7
1548132|NCT00098722|5059731|P2|Double Blind Phase|Other|8
1548133|NCT00098722|5059732|P1|Double Blind Phase|Other|7
1548134|NCT00098722|5059726|P7|Double Blind Phase|Ongoing at cut-off date|0
1548135|NCT00098722|5059727|P6|Double Blind Phase|Ongoing at cut-off date|0
1548136|NCT00098722|5059728|P5|Double Blind Phase|Ongoing at cut-off date|0
1548137|NCT00098722|5059729|P4|Double Blind Phase|Ongoing at cut-off date|0
1548138|NCT00098722|5059730|P3|Double Blind Phase|Ongoing at cut-off date|57
1548139|NCT00098722|5059731|P2|Double Blind Phase|Ongoing at cut-off date|137
1548140|NCT00098722|5059732|P1|Double Blind Phase|Ongoing at cut-off date|128
1548141|NCT00098722|5059726|P7|Double Blind Phase|Randomized, not treated|0
1548142|NCT00098722|5059727|P6|Double Blind Phase|Randomized, not treated|0
1548143|NCT00098722|5059728|P5|Double Blind Phase|Randomized, not treated|0
1548144|NCT00098722|5059729|P4|Double Blind Phase|Randomized, not treated|0
1548145|NCT00098722|5059730|P3|Double Blind Phase|Randomized, not treated|3
1548146|NCT00098722|5059731|P2|Double Blind Phase|Randomized, not treated|3
1548147|NCT00098722|5059732|P1|Double Blind Phase|Randomized, not treated|4
1548148|NCT00098722|5059726|P7|Double Blind Phase|Pregnancy|0
1548149|NCT00098722|5059727|P6|Double Blind Phase|Pregnancy|0
1548150|NCT00098722|5059728|P5|Double Blind Phase|Pregnancy|0
1548151|NCT00098722|5059729|P4|Double Blind Phase|Pregnancy|0
1548152|NCT00098722|5059730|P3|Double Blind Phase|Pregnancy|0
1548153|NCT00098722|5059731|P2|Double Blind Phase|Pregnancy|0
1548154|NCT00098722|5059732|P1|Double Blind Phase|Pregnancy|1
1548155|NCT00098722|5059726|P7|Double Blind Phase|Participant defaulted|0
1548156|NCT00098722|5059727|P6|Double Blind Phase|Participant defaulted|0
1548157|NCT00098722|5059728|P5|Double Blind Phase|Participant defaulted|0
1548158|NCT00098722|5059729|P4|Double Blind Phase|Participant defaulted|0
1548159|NCT00098722|5059730|P3|Double Blind Phase|Participant defaulted|9
1548160|NCT00098722|5059731|P2|Double Blind Phase|Participant defaulted|11
1548161|NCT00098722|5059732|P1|Double Blind Phase|Participant defaulted|16
1548162|NCT00098722|5059726|P7|Double Blind Phase|Lack of Efficacy|0
1548163|NCT00098722|5059727|P6|Double Blind Phase|Lack of Efficacy|0
1548164|NCT00098722|5059728|P5|Double Blind Phase|Lack of Efficacy|0
1548165|NCT00098722|5059729|P4|Double Blind Phase|Lack of Efficacy|0
1548166|NCT00098722|5059730|P3|Double Blind Phase|Lack of Efficacy|15
1548167|NCT00098722|5059731|P2|Double Blind Phase|Lack of Efficacy|23
1548168|NCT00098722|5059732|P1|Double Blind Phase|Lack of Efficacy|21
1548169|NCT00098722|5059726|P7|Double Blind Phase|Death|0
1548170|NCT00098722|5059727|P6|Double Blind Phase|Death|0
1548171|NCT00098722|5059728|P5|Double Blind Phase|Death|0
1548172|NCT00098722|5059729|P4|Double Blind Phase|Death|0
1548173|NCT00098722|5059730|P3|Double Blind Phase|Death|0
1548174|NCT00098722|5059731|P2|Double Blind Phase|Death|5
1548175|NCT00098722|5059732|P1|Double Blind Phase|Death|2
1548176|NCT00098722|5059726|P7|Double Blind Phase|Adverse Event|0
1548177|NCT00098722|5059727|P6|Double Blind Phase|Adverse Event|0
1548178|NCT00098722|5059728|P5|Double Blind Phase|Adverse Event|0
1548179|NCT00098722|5059729|P4|Double Blind Phase|Adverse Event|0
1548180|NCT00098722|5059730|P3|Double Blind Phase|Adverse Event|3
1548181|NCT00098722|5059731|P2|Double Blind Phase|Adverse Event|7
1548182|NCT00098722|5059732|P1|Double Blind Phase|Adverse Event|7
1548183|NCT00098475|5059806|P4|Step 2|Never started treatment|0
1548184|NCT00098475|5059807|P3|Step 2|Never started treatment|0
1548185|NCT00098475|5059808|P2|Step 2|Never started treatment|1
1548186|NCT00098475|5059809|P1|Step 2|Never started treatment|1
1548187|NCT00098475|5059806|P4|Step 2|Alternative therapy|0
1548188|NCT00098475|5059807|P3|Step 2|Alternative therapy|0
1548189|NCT00098475|5059808|P2|Step 2|Alternative therapy|2
1548190|NCT00098475|5059809|P1|Step 2|Alternative therapy|1
1548191|NCT00098475|5059806|P4|Step 2|Physician Decision|0
1548192|NCT00098475|5059807|P3|Step 2|Physician Decision|0
1548193|NCT00098475|5059808|P2|Step 2|Physician Decision|1
1548194|NCT00098475|5059809|P1|Step 2|Physician Decision|0
1548195|NCT00098475|5059806|P4|Step 2|Withdrawal by Subject|0
1548196|NCT00098475|5059807|P3|Step 2|Withdrawal by Subject|0
1548197|NCT00098475|5059808|P2|Step 2|Withdrawal by Subject|2
1548198|NCT00098475|5059809|P1|Step 2|Withdrawal by Subject|0
1548199|NCT00098475|5059806|P4|Step 2|Adverse Event|0
1548200|NCT00098475|5059807|P3|Step 2|Adverse Event|0
1548201|NCT00098475|5059808|P2|Step 2|Adverse Event|0
1548202|NCT00098475|5059809|P1|Step 2|Adverse Event|2
1548203|NCT00098475|5059806|P4|Step 2|Disease progression|0
1548204|NCT00098475|5059807|P3|Step 2|Disease progression|0
1548205|NCT00098475|5059808|P2|Step 2|Disease progression|4
1548206|NCT00098475|5059809|P1|Step 2|Disease progression|1
1548207|NCT00098475|5059806|P4|Step 1|Not documented|0
1548208|NCT00098475|5059807|P3|Step 1|Not documented|0
1548209|NCT00098475|5059808|P2|Step 1|Not documented|1
1548210|NCT00098475|5059809|P1|Step 1|Not documented|0
1548211|NCT00098475|5059806|P4|Step 1|Patient fell with fracture|0
1548212|NCT00098475|5059807|P3|Step 1|Patient fell with fracture|0
1548213|NCT00098475|5059808|P2|Step 1|Patient fell with fracture|0
1548214|NCT00098475|5059809|P1|Step 1|Patient fell with fracture|1
1548215|NCT00098475|5059806|P4|Step 1|Misinterpretation of lab data|0
1548216|NCT00098475|5059807|P3|Step 1|Misinterpretation of lab data|0
1548217|NCT00098475|5059808|P2|Step 1|Misinterpretation of lab data|1
1548218|NCT00098475|5059809|P1|Step 1|Misinterpretation of lab data|0
1548219|NCT00098475|5059806|P4|Step 1|Criteria to continue treatment not met|0
1548220|NCT00098475|5059807|P3|Step 1|Criteria to continue treatment not met|0
1548221|NCT00098475|5059808|P2|Step 1|Criteria to continue treatment not met|1
1548222|NCT00098475|5059809|P1|Step 1|Criteria to continue treatment not met|0
1548223|NCT00098475|5059806|P4|Step 1|Referred to other physicians|0
1548224|NCT00098475|5059807|P3|Step 1|Referred to other physicians|0
1548225|NCT00098475|5059808|P2|Step 1|Referred to other physicians|1
1548226|NCT00098475|5059809|P1|Step 1|Referred to other physicians|0
1548227|NCT00098475|5059806|P4|Step 1|Rising paraprotein|0
1548228|NCT00098475|5059807|P3|Step 1|Rising paraprotein|0
1548229|NCT00098475|5059808|P2|Step 1|Rising paraprotein|1
1548230|NCT00098475|5059809|P1|Step 1|Rising paraprotein|0
1548231|NCT00098475|5059806|P4|Step 1|Insurance issue|0
1548232|NCT00098475|5059807|P3|Step 1|Insurance issue|0
1548233|NCT00098475|5059808|P2|Step 1|Insurance issue|1
1548234|NCT00098475|5059809|P1|Step 1|Insurance issue|0
1548235|NCT00098475|5059806|P4|Step 1|Declining performance status|0
1548236|NCT00098475|5059807|P3|Step 1|Declining performance status|0
1548237|NCT00098475|5059808|P2|Step 1|Declining performance status|1
1548238|NCT00098475|5059809|P1|Step 1|Declining performance status|0
1548239|NCT00098475|5059806|P4|Step 1|Off treatment for > specified timeframe|0
1548240|NCT00098475|5059807|P3|Step 1|Off treatment for > specified timeframe|0
1548241|NCT00098475|5059808|P2|Step 1|Off treatment for > specified timeframe|1
1548242|NCT00098475|5059809|P1|Step 1|Off treatment for > specified timeframe|1
1548243|NCT00098475|5059806|P4|Step 1|Incorrect disease assessment|0
1548244|NCT00098475|5059807|P3|Step 1|Incorrect disease assessment|0
1548245|NCT00098475|5059808|P2|Step 1|Incorrect disease assessment|0
1548246|NCT00098475|5059809|P1|Step 1|Incorrect disease assessment|2
1548247|NCT00098475|5059806|P4|Step 1|Both patient and physician's decision|0
1548248|NCT00098475|5059807|P3|Step 1|Both patient and physician's decision|0
1548249|NCT00098475|5059808|P2|Step 1|Both patient and physician's decision|1
1548250|NCT00098475|5059809|P1|Step 1|Both patient and physician's decision|2
1548251|NCT00098475|5059806|P4|Step 1|Cannot comply due to other tx|0
1548252|NCT00098475|5059807|P3|Step 1|Cannot comply due to other tx|0
1548253|NCT00098475|5059808|P2|Step 1|Cannot comply due to other tx|1
1548254|NCT00098475|5059809|P1|Step 1|Cannot comply due to other tx|0
1548255|NCT00098475|5059806|P4|Step 1|Complications|0
1548256|NCT00098475|5059807|P3|Step 1|Complications|0
1548257|NCT00098475|5059808|P2|Step 1|Complications|0
1548258|NCT00098475|5059809|P1|Step 1|Complications|1
1548259|NCT00098475|5059806|P4|Step 1|Knee surgery|0
1548260|NCT00098475|5059807|P3|Step 1|Knee surgery|0
1548261|NCT00098475|5059808|P2|Step 1|Knee surgery|0
1548262|NCT00098475|5059809|P1|Step 1|Knee surgery|1
1548263|NCT00098475|5059806|P4|Step 1|Still on treatment as of this analysis|0
1548264|NCT00098475|5059807|P3|Step 1|Still on treatment as of this analysis|0
1548265|NCT00098475|5059808|P2|Step 1|Still on treatment as of this analysis|27
1548266|NCT00098475|5059809|P1|Step 1|Still on treatment as of this analysis|14
1548267|NCT00098475|5059806|P4|Step 1|Never started treatment|0
1548268|NCT00098475|5059807|P3|Step 1|Never started treatment|0
1548269|NCT00098475|5059808|P2|Step 1|Never started treatment|2
1548270|NCT00098475|5059809|P1|Step 1|Never started treatment|0
1548271|NCT00098475|5059806|P4|Step 1|Other disease|0
1548272|NCT00098475|5059807|P3|Step 1|Other disease|1
1548273|NCT00098475|5059808|P2|Step 1|Other disease|1
1548274|NCT00098475|5059809|P1|Step 1|Other disease|2
1548275|NCT00098475|5059806|P4|Step 1|Alternative therapy|0
1548276|NCT00098475|5059807|P3|Step 1|Alternative therapy|1
1548277|NCT00098475|5059808|P2|Step 1|Alternative therapy|43
1548278|NCT00098475|5059809|P1|Step 1|Alternative therapy|31
1548279|NCT00098475|5059806|P4|Step 1|Physician Decision|0
1548280|NCT00098475|5059807|P3|Step 1|Physician Decision|0
1548281|NCT00098475|5059808|P2|Step 1|Physician Decision|2
1548282|NCT00098475|5059809|P1|Step 1|Physician Decision|5
1548283|NCT00098475|5059806|P4|Step 1|Withdrawal by Subject|0
1548284|NCT00098475|5059807|P3|Step 1|Withdrawal by Subject|0
1548285|NCT00098475|5059808|P2|Step 1|Withdrawal by Subject|11
1548286|NCT00098475|5059809|P1|Step 1|Withdrawal by Subject|14
1548287|NCT00098475|5059806|P4|Step 1|Death|1
1548288|NCT00098475|5059807|P3|Step 1|Death|0
1548289|NCT00098475|5059808|P2|Step 1|Death|5
1548290|NCT00098475|5059809|P1|Step 1|Death|8
1548291|NCT00098475|5059806|P4|Step 1|Adverse Event|1
1548292|NCT00098475|5059807|P3|Step 1|Adverse Event|0
1548293|NCT00098475|5059808|P2|Step 1|Adverse Event|37
1548294|NCT00098475|5059809|P1|Step 1|Adverse Event|56
1548295|NCT00098475|5059806|P4|Step 1|Progressive disease|1
1548296|NCT00098475|5059807|P3|Step 1|Progressive disease|2
1548297|NCT00098475|5059808|P2|Step 1|Progressive disease|35
1548298|NCT00098475|5059809|P1|Step 1|Progressive disease|33
1548299|NCT00098345|5059846|P1|Overall Study|progression|4
1548300|NCT00098345|5059846|P1|Overall Study|Withdrawal by Subject|2
1548301|NCT00098345|5059846|P1|Overall Study|Adverse Event|7
1548302|NCT00098306|5059859|P7|Observational Phase|Un-specified|4
1548303|NCT00098306|5059860|P6|Observational Phase|Un-specified|7
1548304|NCT00098306|5059861|P5|Observational Phase|Un-specified|0
1548305|NCT00098306|5059862|P4|Observational Phase|Un-specified|0
1548306|NCT00098306|5059863|P3|Observational Phase|Un-specified|0
1548307|NCT00098306|5059864|P2|Observational Phase|Un-specified|0
1548308|NCT00098306|5059865|P1|Observational Phase|Un-specified|0
1548309|NCT00098306|5059859|P7|Observational Phase|Participant defaulted|18
1548310|NCT00098306|5059860|P6|Observational Phase|Participant defaulted|34
1548311|NCT00098306|5059861|P5|Observational Phase|Participant defaulted|0
1548312|NCT00098306|5059862|P4|Observational Phase|Participant defaulted|0
1548313|NCT00098306|5059863|P3|Observational Phase|Participant defaulted|0
1548314|NCT00098306|5059864|P2|Observational Phase|Participant defaulted|0
1548315|NCT00098306|5059865|P1|Observational Phase|Participant defaulted|0
1548316|NCT00098306|5059859|P7|Observational Phase|Death|4
1548317|NCT00098306|5059860|P6|Observational Phase|Death|5
1548318|NCT00098306|5059861|P5|Observational Phase|Death|0
1548319|NCT00098306|5059862|P4|Observational Phase|Death|0
1548320|NCT00098306|5059863|P3|Observational Phase|Death|0
1548321|NCT00098306|5059864|P2|Observational Phase|Death|0
1548322|NCT00098306|5059865|P1|Observational Phase|Death|0
1548323|NCT00098306|5059859|P7|Open Label|Ongoing at cut-off date|0
1548324|NCT00098306|5059860|P6|Open Label|Ongoing at cut-off date|0
1548325|NCT00098306|5059861|P5|Open Label|Ongoing at cut-off date|62
1548326|NCT00098306|5059862|P4|Open Label|Ongoing at cut-off date|269
1548327|NCT00098306|5059863|P3|Open Label|Ongoing at cut-off date|0
1548328|NCT00098306|5059864|P2|Open Label|Ongoing at cut-off date|0
1548329|NCT00098306|5059865|P1|Open Label|Ongoing at cut-off date|0
1548330|NCT00098306|5059859|P7|Open Label|Un-specified|0
1548331|NCT00098306|5059860|P6|Open Label|Un-specified|0
1548332|NCT00098306|5059861|P5|Open Label|Un-specified|0
1548333|NCT00098306|5059862|P4|Open Label|Un-specified|15
1548334|NCT00098306|5059863|P3|Open Label|Un-specified|0
1548335|NCT00098306|5059864|P2|Open Label|Un-specified|0
1548336|NCT00098306|5059865|P1|Open Label|Un-specified|0
1548337|NCT00098306|5059859|P7|Open Label|Participant defaulted|0
1548338|NCT00098306|5059860|P6|Open Label|Participant defaulted|0
1548339|NCT00098306|5059861|P5|Open Label|Participant defaulted|0
1548340|NCT00098306|5059862|P4|Open Label|Participant defaulted|24
1548341|NCT00098306|5059863|P3|Open Label|Participant defaulted|0
1548342|NCT00098306|5059864|P2|Open Label|Participant defaulted|0
1548343|NCT00098306|5059865|P1|Open Label|Participant defaulted|0
1548344|NCT00098306|5059859|P7|Open Label|Death|0
1548345|NCT00098306|5059860|P6|Open Label|Death|0
1548346|NCT00098306|5059861|P5|Open Label|Death|0
1548347|NCT00098306|5059862|P4|Open Label|Death|4
1548348|NCT00098306|5059863|P3|Open Label|Death|0
1548349|NCT00098306|5059864|P2|Open Label|Death|0
1548350|NCT00098306|5059865|P1|Open Label|Death|0
1548351|NCT00098306|5059859|P7|Open Label|Adverse Event|0
1548352|NCT00098306|5059860|P6|Open Label|Adverse Event|0
1548353|NCT00098306|5059861|P5|Open Label|Adverse Event|0
1548354|NCT00098306|5059862|P4|Open Label|Adverse Event|2
1548355|NCT00098306|5059863|P3|Open Label|Adverse Event|0
1548356|NCT00098306|5059864|P2|Open Label|Adverse Event|0
1548357|NCT00098306|5059865|P1|Open Label|Adverse Event|0
1548358|NCT00098306|5059859|P7|Open Label|Lack of Efficacy|0
1548359|NCT00098306|5059860|P6|Open Label|Lack of Efficacy|0
1548360|NCT00098306|5059861|P5|Open Label|Lack of Efficacy|0
1548361|NCT00098306|5059862|P4|Open Label|Lack of Efficacy|13
1548362|NCT00098306|5059863|P3|Open Label|Lack of Efficacy|0
1548363|NCT00098306|5059864|P2|Open Label|Lack of Efficacy|0
1548364|NCT00098306|5059865|P1|Open Label|Lack of Efficacy|0
1548365|NCT00098306|5059859|P7|Double Blind|Un-specified|0
1548366|NCT00098306|5059860|P6|Double Blind|Un-specified|0
1548367|NCT00098306|5059861|P5|Double Blind|Un-specified|0
1548368|NCT00098306|5059862|P4|Double Blind|Un-specified|0
1548369|NCT00098306|5059863|P3|Double Blind|Un-specified|11
1548370|NCT00098306|5059864|P2|Double Blind|Un-specified|3
1548371|NCT00098306|5059865|P1|Double Blind|Un-specified|7
1548372|NCT00098306|5059859|P7|Double Blind|Participant defaulted|0
1548373|NCT00098306|5059860|P6|Double Blind|Participant defaulted|0
1548374|NCT00098306|5059861|P5|Double Blind|Participant defaulted|0
1548375|NCT00098306|5059862|P4|Double Blind|Participant defaulted|0
1548376|NCT00098306|5059863|P3|Double Blind|Participant defaulted|11
1548377|NCT00098306|5059864|P2|Double Blind|Participant defaulted|18
1548378|NCT00098306|5059865|P1|Double Blind|Participant defaulted|19
1548379|NCT00098306|5059859|P7|Double Blind|Death|0
1548380|NCT00098306|5059860|P6|Double Blind|Death|0
1548381|NCT00098306|5059861|P5|Double Blind|Death|0
1548382|NCT00098306|5059862|P4|Double Blind|Death|0
1548383|NCT00098306|5059863|P3|Double Blind|Death|1
1548384|NCT00098306|5059864|P2|Double Blind|Death|4
1548385|NCT00098306|5059865|P1|Double Blind|Death|1
1548386|NCT00098306|5059859|P7|Double Blind|Lack of Efficacy|0
1548387|NCT00098306|5059860|P6|Double Blind|Lack of Efficacy|0
1548388|NCT00098306|5059861|P5|Double Blind|Lack of Efficacy|0
1548389|NCT00098306|5059862|P4|Double Blind|Lack of Efficacy|0
1548390|NCT00098306|5059863|P3|Double Blind|Lack of Efficacy|17
1548391|NCT00098306|5059864|P2|Double Blind|Lack of Efficacy|34
1548392|NCT00098306|5059865|P1|Double Blind|Lack of Efficacy|43
1548393|NCT00098306|5059859|P7|Double Blind|Adverse Event|0
1548394|NCT00098306|5059860|P6|Double Blind|Adverse Event|0
1548395|NCT00098306|5059861|P5|Double Blind|Adverse Event|0
1548396|NCT00098306|5059862|P4|Double Blind|Adverse Event|0
1548397|NCT00098306|5059863|P3|Double Blind|Adverse Event|6
1548398|NCT00098306|5059864|P2|Double Blind|Adverse Event|10
1548399|NCT00098306|5059865|P1|Double Blind|Adverse Event|11
1548400|NCT00098306|5059859|P7|Double Blind|Ongoing at cut-off date|0
1548401|NCT00098306|5059860|P6|Double Blind|Ongoing at cut-off date|0
1548402|NCT00098306|5059861|P5|Double Blind|Ongoing at cut-off date|0
1548403|NCT00098306|5059862|P4|Double Blind|Ongoing at cut-off date|0
1548404|NCT00098306|5059863|P3|Double Blind|Ongoing at cut-off date|72
1548405|NCT00098306|5059864|P2|Double Blind|Ongoing at cut-off date|166
1548406|NCT00098306|5059865|P1|Double Blind|Ongoing at cut-off date|151
1548407|NCT00098306|5059859|P7|Double Blind|Randomized, not treated|0
1548408|NCT00098306|5059860|P6|Double Blind|Randomized, not treated|0
1548409|NCT00098306|5059861|P5|Double Blind|Randomized, not treated|0
1548410|NCT00098306|5059862|P4|Double Blind|Randomized, not treated|0
1548411|NCT00098306|5059863|P3|Double Blind|Randomized, not treated|2
1548412|NCT00098306|5059864|P2|Double Blind|Randomized, not treated|5
1548413|NCT00098306|5059865|P1|Double Blind|Randomized, not treated|9
1548414|NCT00098293|5059931|P5|Supplemental Phase (SP)|Other|22
1548415|NCT00098293|5059932|P4|Supplemental Phase (SP)|Other|0
1548416|NCT00098293|5059933|P3|Supplemental Phase (SP)|Other|0
1548417|NCT00098293|5059934|P2|Supplemental Phase (SP)|Other|0
1548418|NCT00098293|5059935|P1|Supplemental Phase (SP)|Other|0
1548419|NCT00098293|5059931|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
1548420|NCT00098293|5059932|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
1548421|NCT00098293|5059933|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
1548422|NCT00098293|5059934|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
1548423|NCT00098293|5059935|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
1548424|NCT00098293|5059931|P5|Supplemental Phase (SP)|Lost to Follow-up|2
1548425|NCT00098293|5059932|P4|Supplemental Phase (SP)|Lost to Follow-up|0
1548426|NCT00098293|5059933|P3|Supplemental Phase (SP)|Lost to Follow-up|0
1548427|NCT00098293|5059934|P2|Supplemental Phase (SP)|Lost to Follow-up|0
1548428|NCT00098293|5059935|P1|Supplemental Phase (SP)|Lost to Follow-up|0
1548429|NCT00098293|5059931|P5|Supplemental Phase (SP)|Death|1
1548430|NCT00098293|5059932|P4|Supplemental Phase (SP)|Death|0
1548431|NCT00098293|5059933|P3|Supplemental Phase (SP)|Death|0
1548432|NCT00098293|5059934|P2|Supplemental Phase (SP)|Death|0
1548433|NCT00098293|5059935|P1|Supplemental Phase (SP)|Death|0
1548434|NCT00098293|5059931|P5|Open-label (OL) Phase|Death|0
1548435|NCT00098293|5059932|P4|Open-label (OL) Phase|Death|0
1548436|NCT00098293|5059933|P3|Open-label (OL) Phase|Death|3
1548437|NCT00098293|5059934|P2|Open-label (OL) Phase|Death|2
1548438|NCT00098293|5059935|P1|Open-label (OL) Phase|Death|0
1548439|NCT00098293|5059931|P5|Open-label (OL) Phase|Participant Defaulted|0
1548440|NCT00098293|5059932|P4|Open-label (OL) Phase|Participant Defaulted|20
1548441|NCT00098293|5059933|P3|Open-label (OL) Phase|Participant Defaulted|16
1548442|NCT00098293|5059934|P2|Open-label (OL) Phase|Participant Defaulted|6
1548443|NCT00098293|5059935|P1|Open-label (OL) Phase|Participant Defaulted|0
1548444|NCT00098293|5059931|P5|Open-label (OL) Phase|Protocol Violation|0
1548445|NCT00098293|5059932|P4|Open-label (OL) Phase|Protocol Violation|16
1548446|NCT00098293|5059933|P3|Open-label (OL) Phase|Protocol Violation|13
1548447|NCT00098293|5059934|P2|Open-label (OL) Phase|Protocol Violation|6
1548448|NCT00098293|5059935|P1|Open-label (OL) Phase|Protocol Violation|0
1548449|NCT00098293|5059931|P5|Open-label (OL) Phase|Pregnancy|0
1548450|NCT00098293|5059932|P4|Open-label (OL) Phase|Pregnancy|3
1548451|NCT00098293|5059933|P3|Open-label (OL) Phase|Pregnancy|0
1548452|NCT00098293|5059934|P2|Open-label (OL) Phase|Pregnancy|1
1548453|NCT00098293|5059935|P1|Open-label (OL) Phase|Pregnancy|0
1548454|NCT00098293|5059931|P5|Open-label (OL) Phase|Lack of Efficacy|0
1548455|NCT00098293|5059932|P4|Open-label (OL) Phase|Lack of Efficacy|20
1548456|NCT00098293|5059933|P3|Open-label (OL) Phase|Lack of Efficacy|2
1548457|NCT00098293|5059934|P2|Open-label (OL) Phase|Lack of Efficacy|7
1548458|NCT00098293|5059935|P1|Open-label (OL) Phase|Lack of Efficacy|0
1548459|NCT00098293|5059931|P5|Open-label (OL) Phase|Adverse Event|0
1548460|NCT00098293|5059932|P4|Open-label (OL) Phase|Adverse Event|6
1548461|NCT00098293|5059933|P3|Open-label (OL) Phase|Adverse Event|7
1548462|NCT00098293|5059934|P2|Open-label (OL) Phase|Adverse Event|3
1548463|NCT00098293|5059935|P1|Open-label (OL) Phase|Adverse Event|0
1548464|NCT00098293|5059931|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1548465|NCT00098293|5059932|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1548466|NCT00098293|5059933|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
1548467|NCT00098293|5059934|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1548468|NCT00098293|5059935|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1548469|NCT00098293|5059931|P5|Double-blind (DB) Phase|Terminated by sponsor|0
1548470|NCT00098293|5059932|P4|Double-blind (DB) Phase|Terminated by sponsor|0
1548471|NCT00098293|5059933|P3|Double-blind (DB) Phase|Terminated by sponsor|0
1548472|NCT00098293|5059934|P2|Double-blind (DB) Phase|Terminated by sponsor|0
1548473|NCT00098293|5059935|P1|Double-blind (DB) Phase|Terminated by sponsor|135
1548474|NCT00098293|5059931|P5|Double-blind (DB) Phase|Protocol Violation|0
1548475|NCT00098293|5059932|P4|Double-blind (DB) Phase|Protocol Violation|0
1548476|NCT00098293|5059933|P3|Double-blind (DB) Phase|Protocol Violation|22
1548477|NCT00098293|5059934|P2|Double-blind (DB) Phase|Protocol Violation|18
1548478|NCT00098293|5059935|P1|Double-blind (DB) Phase|Protocol Violation|2
1548479|NCT00098293|5059931|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
1548480|NCT00098293|5059932|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
1548481|NCT00098293|5059933|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
1548482|NCT00098293|5059934|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
1548483|NCT00098293|5059935|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
1548484|NCT00098293|5059931|P5|Double-blind (DB) Phase|Death|0
1548485|NCT00098293|5059932|P4|Double-blind (DB) Phase|Death|0
1548486|NCT00098293|5059933|P3|Double-blind (DB) Phase|Death|2
1548487|NCT00098293|5059934|P2|Double-blind (DB) Phase|Death|2
1548488|NCT00098293|5059935|P1|Double-blind (DB) Phase|Death|1
1548489|NCT00098293|5059931|P5|Double-blind (DB) Phase|Lack of Efficacy|0
1548490|NCT00098293|5059932|P4|Double-blind (DB) Phase|Lack of Efficacy|0
1548491|NCT00098293|5059933|P3|Double-blind (DB) Phase|Lack of Efficacy|30
1548492|NCT00098293|5059934|P2|Double-blind (DB) Phase|Lack of Efficacy|64
1548493|NCT00098293|5059935|P1|Double-blind (DB) Phase|Lack of Efficacy|11
1548494|NCT00098293|5059931|P5|Double-blind (DB) Phase|Participant Defaulted|0
1548495|NCT00098293|5059932|P4|Double-blind (DB) Phase|Participant Defaulted|0
1548496|NCT00098293|5059933|P3|Double-blind (DB) Phase|Participant Defaulted|36
1548497|NCT00098293|5059934|P2|Double-blind (DB) Phase|Participant Defaulted|40
1548498|NCT00098293|5059935|P1|Double-blind (DB) Phase|Participant Defaulted|11
1548499|NCT00098293|5059931|P5|Double-blind (DB) Phase|Pregnancy|0
1548500|NCT00098293|5059932|P4|Double-blind (DB) Phase|Pregnancy|0
1548501|NCT00098293|5059933|P3|Double-blind (DB) Phase|Pregnancy|9
1548502|NCT00098293|5059934|P2|Double-blind (DB) Phase|Pregnancy|7
1548503|NCT00098293|5059935|P1|Double-blind (DB) Phase|Pregnancy|0
1548504|NCT00098293|5059931|P5|Double-blind (DB) Phase|Adverse Event|0
1548505|NCT00098293|5059932|P4|Double-blind (DB) Phase|Adverse Event|0
1548506|NCT00098293|5059933|P3|Double-blind (DB) Phase|Adverse Event|60
1548507|NCT00098293|5059934|P2|Double-blind (DB) Phase|Adverse Event|27
1548508|NCT00098293|5059935|P1|Double-blind (DB) Phase|Adverse Event|14
1548509|NCT00098254|5059988|P1|Overall Study|Death|1
1548510|NCT00098254|5059988|P1|Overall Study|Adverse Event|2
1548511|NCT00098020|5060054|P1|Overall Study|Low epidermal growth factor receptor|1
1548512|NCT00098020|5060054|P1|Overall Study|Low urine PCR|1
1548513|NCT00098020|5060054|P1|Overall Study|elevated liver enzymes|1
1548514|NCT00098020|5060054|P1|Overall Study|Lost to Follow-up|1
1548515|NCT00098020|5060054|P1|Overall Study|Adverse Event|2
1548516|NCT00097981|5060061|P2|Overall Study|Other|13
1548517|NCT00097981|5060062|P1|Overall Study|Other|19
1548518|NCT00097981|5060061|P2|Overall Study|Transplant planned|27
1548519|NCT00097981|5060062|P1|Overall Study|Transplant planned|28
1548520|NCT00097981|5060061|P2|Overall Study|Disease Progression|2
1548521|NCT00097981|5060062|P1|Overall Study|Disease Progression|8
1548522|NCT00097981|5060061|P2|Overall Study|Physician Decision|1
1548523|NCT00097981|5060062|P1|Overall Study|Physician Decision|7
1548524|NCT00097981|5060061|P2|Overall Study|Death|4
1548525|NCT00097981|5060062|P1|Overall Study|Death|2
1548526|NCT00097981|5060061|P2|Overall Study|Protocol Violation|1
1548527|NCT00097981|5060062|P1|Overall Study|Protocol Violation|1
1548528|NCT00097981|5060061|P2|Overall Study|Withdrawal by Subject|8
1548529|NCT00097981|5060062|P1|Overall Study|Withdrawal by Subject|10
1548530|NCT00097981|5060061|P2|Overall Study|Adverse Event|44
1548531|NCT00097981|5060062|P1|Overall Study|Adverse Event|31
1548532|NCT00097786|5060084|P4|Overall Study|lost to follow-up for all-cause death|310
1548533|NCT00097786|5060085|P3|Overall Study|lost to follow-up for all-cause death|313
1548534|NCT00097786|5060086|P2|Overall Study|lost to follow-up for all-cause death|292
1548535|NCT00097786|5060087|P1|Overall Study|lost to follow-up for all-cause death|296
1548536|NCT00097773|5060109|P4|Overall Study|Other|0
1548537|NCT00097773|5060110|P3|Overall Study|Other|2
1548538|NCT00097773|5060111|P2|Overall Study|Other|0
1548539|NCT00097773|5060112|P1|Overall Study|Other|1
1548540|NCT00097773|5060109|P4|Overall Study|Adverse Event|0
1548541|NCT00097773|5060110|P3|Overall Study|Adverse Event|0
1548542|NCT00097773|5060111|P2|Overall Study|Adverse Event|1
1548543|NCT00097773|5060112|P1|Overall Study|Adverse Event|0
1548544|NCT00097773|5060109|P4|Overall Study|Withdrawal by Subject|1
1548545|NCT00097773|5060110|P3|Overall Study|Withdrawal by Subject|3
1548546|NCT00097773|5060111|P2|Overall Study|Withdrawal by Subject|3
1548547|NCT00097773|5060112|P1|Overall Study|Withdrawal by Subject|3
1548548|NCT00097773|5060109|P4|Overall Study|Physician Decision|1
1548549|NCT00097773|5060110|P3|Overall Study|Physician Decision|3
1548550|NCT00097773|5060111|P2|Overall Study|Physician Decision|2
1548551|NCT00097773|5060112|P1|Overall Study|Physician Decision|2
1548552|NCT00097773|5060109|P4|Overall Study|Lost to Follow-up|1
1548553|NCT00097773|5060110|P3|Overall Study|Lost to Follow-up|0
1548554|NCT00097773|5060111|P2|Overall Study|Lost to Follow-up|2
1548555|NCT00097773|5060112|P1|Overall Study|Lost to Follow-up|2
1548556|NCT00097721|5060132|P2|Overall Study|Reason not given|1
1548557|NCT00097721|5060133|P1|Overall Study|Reason not given|1
1548558|NCT00097721|5060132|P2|Overall Study|Physician Decision|3
1548559|NCT00097721|5060133|P1|Overall Study|Physician Decision|1
1548560|NCT00097721|5060132|P2|Overall Study|Progressive Disease|27
1548561|NCT00097721|5060133|P1|Overall Study|Progressive Disease|55
1548562|NCT00097721|5060132|P2|Overall Study|Withdrawal by Subject|1
1548563|NCT00097721|5060133|P1|Overall Study|Withdrawal by Subject|6
1548564|NCT00097721|5060132|P2|Overall Study|Adverse Event|1
1548565|NCT00097721|5060133|P1|Overall Study|Adverse Event|8
1548566|NCT00097591|5060183|P2|Overall Study|Other|3
1548567|NCT00097591|5060184|P1|Overall Study|Other|0
1548568|NCT00097591|5060183|P2|Overall Study|Lost to follow up|10
1548569|NCT00097591|5060184|P1|Overall Study|Lost to follow up|6
1548570|NCT00097591|5060183|P2|Overall Study|Unable to attend termination visit|51
1548571|NCT00097591|5060184|P1|Overall Study|Unable to attend termination visit|53
1548572|NCT00097591|5060183|P2|Overall Study|Less than 6 months on study drug|7
1548573|NCT00097591|5060184|P1|Overall Study|Less than 6 months on study drug|9
1548574|NCT00097591|5060183|P2|Overall Study|Withdrawal of consent|323
1548575|NCT00097591|5060184|P1|Overall Study|Withdrawal of consent|342
1548576|NCT00097539|5060207|P7|Overall Study|Reason not Specified|2
1548577|NCT00097539|5060208|P6|Overall Study|Reason not Specified|40
1548578|NCT00097539|5060209|P5|Overall Study|Reason not Specified|11
1548579|NCT00097539|5060210|P4|Overall Study|Reason not Specified|21
1548580|NCT00097539|5060211|P3|Overall Study|Reason not Specified|53
1548581|NCT00097539|5060212|P2|Overall Study|Reason not Specified|49
1548582|NCT00097539|5060213|P1|Overall Study|Reason not Specified|111
1548583|NCT00097539|5060207|P7|Overall Study|Reasons Other Than Above|34
1548584|NCT00097539|5060208|P6|Overall Study|Reasons Other Than Above|1244
1548585|NCT00097539|5060209|P5|Overall Study|Reasons Other Than Above|361
1548586|NCT00097539|5060210|P4|Overall Study|Reasons Other Than Above|692
1548587|NCT00097539|5060211|P3|Overall Study|Reasons Other Than Above|1757
1548588|NCT00097539|5060212|P2|Overall Study|Reasons Other Than Above|1382
1548589|NCT00097539|5060213|P1|Overall Study|Reasons Other Than Above|3602
1548590|NCT00097539|5060207|P7|Overall Study|Death|0
1548591|NCT00097539|5060208|P6|Overall Study|Death|3
1548592|NCT00097539|5060209|P5|Overall Study|Death|1
1548593|NCT00097539|5060210|P4|Overall Study|Death|0
1548594|NCT00097539|5060211|P3|Overall Study|Death|0
1548595|NCT00097539|5060212|P2|Overall Study|Death|7
1548596|NCT00097539|5060213|P1|Overall Study|Death|2
1548597|NCT00097539|5060207|P7|Overall Study|Adverse Event|1
1548598|NCT00097539|5060208|P6|Overall Study|Adverse Event|59
1548599|NCT00097539|5060209|P5|Overall Study|Adverse Event|30
1548600|NCT00097539|5060210|P4|Overall Study|Adverse Event|27
1548601|NCT00097539|5060211|P3|Overall Study|Adverse Event|37
1548602|NCT00097539|5060212|P2|Overall Study|Adverse Event|133
1548603|NCT00097539|5060213|P1|Overall Study|Adverse Event|78
1548604|NCT00097539|5060207|P7|Overall Study|Lack of Efficacy|5
1548605|NCT00097539|5060208|P6|Overall Study|Lack of Efficacy|228
1548606|NCT00097539|5060209|P5|Overall Study|Lack of Efficacy|45
1548607|NCT00097539|5060210|P4|Overall Study|Lack of Efficacy|105
1548608|NCT00097539|5060211|P3|Overall Study|Lack of Efficacy|202
1548609|NCT00097539|5060212|P2|Overall Study|Lack of Efficacy|122
1548610|NCT00097539|5060213|P1|Overall Study|Lack of Efficacy|249
1548611|NCT00097539|5060207|P7|Overall Study|Participant Non-compliant|18
1548612|NCT00097539|5060208|P6|Overall Study|Participant Non-compliant|543
1548613|NCT00097539|5060209|P5|Overall Study|Participant Non-compliant|136
1548614|NCT00097539|5060210|P4|Overall Study|Participant Non-compliant|353
1548615|NCT00097539|5060211|P3|Overall Study|Participant Non-compliant|1067
1548616|NCT00097539|5060212|P2|Overall Study|Participant Non-compliant|567
1548617|NCT00097539|5060213|P1|Overall Study|Participant Non-compliant|2140
1548618|NCT00097539|5060207|P7|Overall Study|Withdrawal by Subject|3
1548619|NCT00097539|5060208|P6|Overall Study|Withdrawal by Subject|229
1548620|NCT00097539|5060209|P5|Overall Study|Withdrawal by Subject|68
1548621|NCT00097539|5060210|P4|Overall Study|Withdrawal by Subject|217
1548622|NCT00097539|5060211|P3|Overall Study|Withdrawal by Subject|346
1548623|NCT00097539|5060212|P2|Overall Study|Withdrawal by Subject|323
1548624|NCT00097539|5060213|P1|Overall Study|Withdrawal by Subject|925
1548625|NCT00097539|5060207|P7|Overall Study|Status Unknown (Or no final evaluation)|108
1548626|NCT00097539|5060208|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
1548627|NCT00097539|5060209|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
1548628|NCT00097539|5060210|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
1548629|NCT00097539|5060211|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
1548630|NCT00097539|5060212|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
1548631|NCT00097539|5060213|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
1548632|NCT00097500|5060259|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
1548633|NCT00097500|5060260|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
1548634|NCT00097500|5060259|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
1548635|NCT00097500|5060260|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
1548636|NCT00097500|5060259|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
1548637|NCT00097500|5060260|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
1548638|NCT00097500|5060259|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
1548639|NCT00097500|5060260|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
1548640|NCT00097500|5060259|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
1548641|NCT00097500|5060260|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
1548642|NCT00097500|5060259|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
1548643|NCT00097500|5060260|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
1548644|NCT00097500|5060259|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
1548645|NCT00097500|5060260|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
1548646|NCT00097370|5060291|P1|Stage 3|Lost to Follow-up|1
1548647|NCT00097370|5060291|P1|Stage 3|Sponsor Terminated Study|52
1548648|NCT00097370|5060291|P1|Stage 3|Lack of Efficacy|1
1548649|NCT00097370|5060291|P1|Stage 3|Withdrawal by Subject|3
1548650|NCT00097370|5060291|P1|Stage 3|Adverse Event|2
1548651|NCT00097370|5060291|P1|Stage 2|Lost to Follow-up|1
1548652|NCT00097370|5060291|P1|Stage 2|Sponsor Terminated Study|2
1548653|NCT00097370|5060291|P1|Stage 2|Pregnancy|1
1548654|NCT00097370|5060291|P1|Stage 2|Lack of Efficacy|3
1548655|NCT00097370|5060291|P1|Stage 2|Withdrawal by Subject|1
1548656|NCT00097370|5060291|P1|Stage 2|Adverse Event|5
1548657|NCT00097370|5060291|P1|Stage 1|Lack of Efficacy|2
1548658|NCT00097370|5060291|P1|Stage 1|Withdrawal by Subject|1
1548659|NCT00097370|5060291|P1|Stage 1|Adverse Event|3
1548660|NCT00096993|5060325|P2|Overall Study|Other unspecified|1
1548661|NCT00096993|5060326|P1|Overall Study|Other unspecified|1
1548662|NCT00096993|5060325|P2|Overall Study|Non-compliance|1
1548663|NCT00096993|5060326|P1|Overall Study|Non-compliance|0
1548664|NCT00096993|5060325|P2|Overall Study|Physician Decision|1
1548665|NCT00096993|5060326|P1|Overall Study|Physician Decision|2
1548666|NCT00096993|5060325|P2|Overall Study|Subject's decision|1
1548667|NCT00096993|5060326|P1|Overall Study|Subject's decision|3
1548668|NCT00096993|5060325|P2|Overall Study|Adverse Event|8
1548669|NCT00096993|5060326|P1|Overall Study|Adverse Event|2
1548670|NCT00096993|5060325|P2|Overall Study|Disease progression|53
1548671|NCT00096993|5060326|P1|Overall Study|Disease progression|56
1548672|NCT00096993|5060325|P2|Overall Study|Death|0
1548673|NCT00096993|5060326|P1|Overall Study|Death|1
1548674|NCT00096954|5060342|P2|Overall Study|Lost to Follow-up|5
1548675|NCT00096954|5060343|P1|Overall Study|Lost to Follow-up|8
1548676|NCT00096954|5060342|P2|Overall Study|Non-compliance|3
1548677|NCT00096954|5060343|P1|Overall Study|Non-compliance|0
1548678|NCT00096954|5060342|P2|Overall Study|Initiation of immunotherapy|0
1548679|NCT00096954|5060343|P1|Overall Study|Initiation of immunotherapy|1
1548680|NCT00096954|5060342|P2|Overall Study|Pregnancy|1
1548681|NCT00096954|5060343|P1|Overall Study|Pregnancy|1
1548682|NCT00096954|5060342|P2|Overall Study|Sponsors Decision|1
1548683|NCT00096954|5060343|P1|Overall Study|Sponsors Decision|1
1548684|NCT00096954|5060342|P2|Overall Study|Physician Decision|1
1548685|NCT00096954|5060343|P1|Overall Study|Physician Decision|1
1548686|NCT00096954|5060342|P2|Overall Study|Withdrawal by Subject|8
1548687|NCT00096954|5060343|P1|Overall Study|Withdrawal by Subject|9
1548688|NCT00096954|5060342|P2|Overall Study|Adverse Event|1
1548689|NCT00096954|5060343|P1|Overall Study|Adverse Event|3
1548690|NCT00096941|5060355|P1|Overall Study|disease progression|3
1548691|NCT00096785|5060362|P2|Overall Study|Relocated|0
1548692|NCT00096785|5060363|P1|Overall Study|Relocated|1
1548693|NCT00096785|5060362|P2|Overall Study|Withdrawal by Subject|1
1548694|NCT00096785|5060363|P1|Overall Study|Withdrawal by Subject|0
1548695|NCT00096785|5060362|P2|Overall Study|Lost to Follow-up|0
1548696|NCT00096785|5060363|P1|Overall Study|Lost to Follow-up|1
1548697|NCT00096538|5060392|P1|Overall Study|Withdrawal by Subject|1
1548698|NCT00096486|5060400|P4|Overall Study|Not Treated|1
1548699|NCT00096486|5060401|P3|Overall Study|Not Treated|1
1548700|NCT00096486|5060402|P2|Overall Study|Not Treated|0
1548701|NCT00096486|5060403|P1|Overall Study|Not Treated|0
1548702|NCT00096486|5060400|P4|Overall Study|Withdrawal by Subject|1
1548703|NCT00096486|5060401|P3|Overall Study|Withdrawal by Subject|1
1548704|NCT00096486|5060402|P2|Overall Study|Withdrawal by Subject|0
1548705|NCT00096486|5060403|P1|Overall Study|Withdrawal by Subject|0
1548706|NCT00096447|5060422|P1|Overall Study|Never treated|1
1548707|NCT00096382|5060438|P2|Overall Study|Death during treatment|0
1548708|NCT00096382|5060439|P1|Overall Study|Death during treatment|1
1548709|NCT00096382|5060438|P2|Overall Study|Not treated|0
1548710|NCT00096382|5060439|P1|Overall Study|Not treated|1
1548711|NCT00096356|5060449|P2|Overall Study|multiple reasons|18
1548712|NCT00096356|5060450|P1|Overall Study|multiple reasons|10
1548713|NCT00096356|5060449|P2|Overall Study|Lack of Efficacy|0
1548714|NCT00096356|5060450|P1|Overall Study|Lack of Efficacy|1
1548715|NCT00096356|5060449|P2|Overall Study|Withdrawal by Subject|23
1548716|NCT00096356|5060450|P1|Overall Study|Withdrawal by Subject|17
1548717|NCT00096356|5060449|P2|Overall Study|Physician Decision|3
1548718|NCT00096356|5060450|P1|Overall Study|Physician Decision|5
1548719|NCT00096356|5060449|P2|Overall Study|Adverse Event|9
1548720|NCT00096356|5060450|P1|Overall Study|Adverse Event|11
1548721|NCT00096278|5060462|P2|Overall Study|Patient not at risk for primary endpoint|2
1548722|NCT00096278|5060463|P1|Overall Study|Patient not at risk for primary endpoint|3
1548723|NCT00096278|5060462|P2|Overall Study|No follow-up data|18
1548724|NCT00096278|5060463|P1|Overall Study|No follow-up data|15
1548725|NCT00096265|5060472|P3|Overall Study|Ineligible|0
1548726|NCT00096265|5060473|P2|Overall Study|Ineligible|0
1548727|NCT00096265|5060474|P1|Overall Study|Ineligible|1
1548728|NCT00096226|5060500|P1|Overall Study|Surgery but inadequate nodal sampling|1
1548729|NCT00096226|5060500|P1|Overall Study|Surgical restaging not performed|13
1548730|NCT00096226|5060500|P1|Overall Study|Protocol treatment not started|1
1548731|NCT00096226|5060500|P1|Overall Study|Ineligible|2
1548732|NCT00096200|5060507|P3|Overall Study|Ineligible pathology|0
1548733|NCT00096200|5060508|P2|Overall Study|Ineligible pathology|1
1548734|NCT00096200|5060509|P1|Overall Study|Ineligible pathology|0
1548735|NCT00096200|5060507|P3|Overall Study|Withdrawal by Subject|0
1548736|NCT00096200|5060508|P2|Overall Study|Withdrawal by Subject|2
1548737|NCT00096200|5060509|P1|Overall Study|Withdrawal by Subject|1
1548738|NCT00096200|5060507|P3|Overall Study|Adverse Event|0
1548739|NCT00096200|5060508|P2|Overall Study|Adverse Event|4
1548740|NCT00096200|5060509|P1|Overall Study|Adverse Event|0
1548741|NCT00096174|5060517|P1|Overall Study|other reason|8
1548742|NCT00096174|5060517|P1|Overall Study|Ineligible|6
1548743|NCT00096174|5060517|P1|Overall Study|Not started protocol therapy|3
1548744|NCT00096174|5060517|P1|Overall Study|Withdrawal by Subject|15
1548745|NCT00096174|5060517|P1|Overall Study|Death|6
1548746|NCT00096174|5060517|P1|Overall Study|Adverse Event|15
1548747|NCT00096174|5060517|P1|Overall Study|Lack of Efficacy|9
1548748|NCT00096135|5060562|P2|Overall Study|Ineligible|0
1548749|NCT00096135|5060563|P1|Overall Study|Ineligible|2
1548750|NCT00096135|5060562|P2|Overall Study|Other, specify|3
1548751|NCT00096135|5060563|P1|Overall Study|Other, specify|15
1548752|NCT00096135|5060562|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
1548753|NCT00096135|5060563|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
1548754|NCT00096135|5060562|P2|Overall Study|Refusal of further protocol therapy|1
1548755|NCT00096135|5060563|P1|Overall Study|Refusal of further protocol therapy|4
1548756|NCT00096135|5060562|P2|Overall Study|Physician Decision|4
1548757|NCT00096135|5060563|P1|Overall Study|Physician Decision|20
1548758|NCT00096044|5060579|P1|Overall Study|Disease Progression|4
1548759|NCT00096044|5060579|P1|Overall Study|Adverse Event|21
1548760|NCT00096044|5060579|P1|Overall Study|Withdrawal by Subject|9
1548761|NCT00096031|5060588|P1|Overall Study|Not protocol specified|5
1548762|NCT00096031|5060588|P1|Overall Study|Ineligible|8
1548763|NCT00096031|5060588|P1|Overall Study|Withdrawal by Subject|1
1548764|NCT00096031|5060588|P1|Overall Study|Death|4
1548765|NCT00096031|5060588|P1|Overall Study|Lack of Efficacy|42
1548766|NCT00096031|5060588|P1|Overall Study|Adverse Event|3
1548767|NCT00096018|5060596|P2|Overall Study|Miscellaneous|1
1548768|NCT00096018|5060597|P1|Overall Study|Miscellaneous|2
1548769|NCT00096018|5060596|P2|Overall Study|Withdrawal by Subject|2
1548770|NCT00096018|5060597|P1|Overall Study|Withdrawal by Subject|0
1548771|NCT00096018|5060596|P2|Overall Study|Death|1
1548772|NCT00096018|5060597|P1|Overall Study|Death|0
1548773|NCT00096018|5060596|P2|Overall Study|Adverse Event|5
1548774|NCT00096018|5060597|P1|Overall Study|Adverse Event|0
1548775|NCT00096018|5060596|P2|Overall Study|Miscellaneous (not treated)|2
1548776|NCT00096018|5060597|P1|Overall Study|Miscellaneous (not treated)|0
1548777|NCT00096018|5060596|P2|Overall Study|Became Ineligible (not treated)|3
1548778|NCT00096018|5060597|P1|Overall Study|Became Ineligible (not treated)|0
1548779|NCT00095979|5060605|P1|Overall Study|Ineligible: Second primary cancer site|2
1548780|NCT00095940|5060623|P9|Lapatinib Continuation/Phase II|Adverse Event|0
1548781|NCT00095940|5060624|P8|Lapatinib Continuation/Phase II|Adverse Event|1
1548782|NCT00095940|5060625|P7|Lapatinib Continuation/Phase II|Adverse Event|0
1548783|NCT00095940|5060626|P6|Lapatinib Continuation/Phase II|Adverse Event|0
1548784|NCT00095940|5060627|P5|Lapatinib Continuation/Phase II|Adverse Event|0
1548785|NCT00095940|5060628|P4|Lapatinib Continuation/Phase II|Adverse Event|0
1548786|NCT00095940|5060629|P3|Lapatinib Continuation/Phase II|Adverse Event|0
1548787|NCT00095940|5060630|P2|Lapatinib Continuation/Phase II|Adverse Event|0
1548788|NCT00095940|5060631|P1|Lapatinib Continuation/Phase II|Adverse Event|0
1548789|NCT00095940|5060623|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1548790|NCT00095940|5060624|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1548791|NCT00095940|5060625|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1548792|NCT00095940|5060626|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1548793|NCT00095940|5060627|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1548794|NCT00095940|5060628|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1548795|NCT00095940|5060629|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1548796|NCT00095940|5060630|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1548797|NCT00095940|5060631|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1548798|NCT00095940|5060623|P9|Lapatinib Continuation/Phase II|Disease Progression|12
1548799|NCT00095940|5060624|P8|Lapatinib Continuation/Phase II|Disease Progression|1
1548800|NCT00095940|5060625|P7|Lapatinib Continuation/Phase II|Disease Progression|2
1548801|NCT00095940|5060626|P6|Lapatinib Continuation/Phase II|Disease Progression|13
1548802|NCT00095940|5060627|P5|Lapatinib Continuation/Phase II|Disease Progression|0
1548803|NCT00095940|5060628|P4|Lapatinib Continuation/Phase II|Disease Progression|0
1548804|NCT00095940|5060629|P3|Lapatinib Continuation/Phase II|Disease Progression|15
1548805|NCT00095940|5060630|P2|Lapatinib Continuation/Phase II|Disease Progression|1
1548806|NCT00095940|5060631|P1|Lapatinib Continuation/Phase II|Disease Progression|1
1548807|NCT00095836|5060664|P1|Overall Study|Death|2
1548808|NCT00095836|5060664|P1|Overall Study|Adverse Event|1
1548809|NCT00095836|5060664|P1|Overall Study|Lost to Follow-up|1
1548810|NCT00095628|5060694|P1|Overall Study|Disease progression prior to treatment|1
1548811|NCT00095576|5060705|P2|Overall Study|Subject moved|36
1548812|NCT00095576|5060706|P1|Overall Study|Subject moved|30
1548813|NCT00095576|5060705|P2|Overall Study|Site terminated|67
1548814|NCT00095576|5060706|P1|Overall Study|Site terminated|75
1548815|NCT00095576|5060705|P2|Overall Study|Option to switch to a rollover study|1099
1548816|NCT00095576|5060706|P1|Overall Study|Option to switch to a rollover study|1097
1548817|NCT00095576|5060705|P2|Overall Study|Withdrawal by Subject|47
1548818|NCT00095576|5060706|P1|Overall Study|Withdrawal by Subject|34
1548819|NCT00095576|5060705|P2|Overall Study|Protocol Violation|0
1548820|NCT00095576|5060706|P1|Overall Study|Protocol Violation|1
1548821|NCT00095576|5060705|P2|Overall Study|Lost to Follow-up|229
1548822|NCT00095576|5060706|P1|Overall Study|Lost to Follow-up|233
1548823|NCT00095576|5060705|P2|Overall Study|Adverse Event|3
1548824|NCT00095576|5060706|P1|Overall Study|Adverse Event|5
1548825|NCT00095498|5060730|P3|Overall Study|Requirement for alternative therapy|2
1548826|NCT00095498|5060731|P2|Overall Study|Requirement for alternative therapy|0
1548827|NCT00095498|5060732|P1|Overall Study|Requirement for alternative therapy|1
1548828|NCT00095498|5060730|P3|Overall Study|Protocol Violation|1
1548829|NCT00095498|5060731|P2|Overall Study|Protocol Violation|0
1548830|NCT00095498|5060732|P1|Overall Study|Protocol Violation|0
1548831|NCT00095498|5060730|P3|Overall Study|Other|6
1548832|NCT00095498|5060731|P2|Overall Study|Other|7
1548833|NCT00095498|5060732|P1|Overall Study|Other|6
1548834|NCT00095498|5060730|P3|Overall Study|Noncompliance|1
1548835|NCT00095498|5060731|P2|Overall Study|Noncompliance|0
1548836|NCT00095498|5060732|P1|Overall Study|Noncompliance|1
1548837|NCT00095498|5060730|P3|Overall Study|Lost to Follow-up|2
1548838|NCT00095498|5060731|P2|Overall Study|Lost to Follow-up|1
1548839|NCT00095498|5060732|P1|Overall Study|Lost to Follow-up|1
1548840|NCT00095498|5060730|P3|Overall Study|Ineligibility determined|2
1548841|NCT00095498|5060731|P2|Overall Study|Ineligibility determined|0
1548842|NCT00095498|5060732|P1|Overall Study|Ineligibility determined|3
1548843|NCT00095498|5060730|P3|Overall Study|Disease progression|1
1548844|NCT00095498|5060731|P2|Overall Study|Disease progression|1
1548845|NCT00095498|5060732|P1|Overall Study|Disease progression|0
1548846|NCT00095498|5060730|P3|Overall Study|Withdrawal by Subject|15
1548847|NCT00095498|5060731|P2|Overall Study|Withdrawal by Subject|16
1548848|NCT00095498|5060732|P1|Overall Study|Withdrawal by Subject|15
1548849|NCT00095498|5060730|P3|Overall Study|Adverse Event|1
1548850|NCT00095498|5060731|P2|Overall Study|Adverse Event|0
1548851|NCT00095498|5060732|P1|Overall Study|Adverse Event|1
1548852|NCT00095498|5060730|P3|Overall Study|Physician Decision|8
1548853|NCT00095498|5060731|P2|Overall Study|Physician Decision|10
1548854|NCT00095498|5060732|P1|Overall Study|Physician Decision|9
1548855|NCT00095303|5061159|P2|Follow Up Study|Lost to Follow-up|58
1548856|NCT00095303|5061160|P1|Follow Up Study|Lost to Follow-up|59
1548857|NCT00095303|5061159|P2|Main Study|Lost to Follow-up|87
1548858|NCT00095303|5061160|P1|Main Study|Lost to Follow-up|91
1548859|NCT00095238|5061228|P2|Overall Study|Other Reasons|88
1548860|NCT00095238|5061229|P1|Overall Study|Other Reasons|87
1548861|NCT00095238|5061228|P2|Overall Study|Missing|0
1548862|NCT00095238|5061229|P1|Overall Study|Missing|1
1548863|NCT00095238|5061228|P2|Overall Study|Study terminated by sponsor|1
1548864|NCT00095238|5061229|P1|Overall Study|Study terminated by sponsor|0
1548865|NCT00095238|5061228|P2|Overall Study|No longer met study criteria|5
1548866|NCT00095238|5061229|P1|Overall Study|No longer met study criteria|4
1548867|NCT00095238|5061228|P2|Overall Study|Noncompliance|45
1548868|NCT00095238|5061229|P1|Overall Study|Noncompliance|44
1548869|NCT00095238|5061228|P2|Overall Study|Lost to Follow-up|24
1548870|NCT00095238|5061229|P1|Overall Study|Lost to Follow-up|19
1548871|NCT00095238|5061228|P2|Overall Study|Death|170
1548872|NCT00095238|5061229|P1|Overall Study|Death|154
1548873|NCT00095238|5061228|P2|Overall Study|Subject Withdrew Consent|223
1548874|NCT00095238|5061229|P1|Overall Study|Subject Withdrew Consent|208
1548875|NCT00095238|5061228|P2|Overall Study|Adverse Event|287
1548876|NCT00095238|5061229|P1|Overall Study|Adverse Event|331
1548877|NCT00095238|5061228|P2|Overall Study|Lack of Efficacy|9
1548878|NCT00095238|5061229|P1|Overall Study|Lack of Efficacy|9
1548879|NCT00095212|5061291|P2|Overall Study|Withdrawal by Subject|3
1548880|NCT00095212|5061292|P1|Overall Study|Withdrawal by Subject|1
1548881|NCT00095199|5061322|P4|Overall Study|Data inadvertently lost by site|0
1548882|NCT00095199|5061323|P3|Overall Study|Data inadvertently lost by site|0
1548883|NCT00095199|5061324|P2|Overall Study|Data inadvertently lost by site|0
1548884|NCT00095199|5061325|P1|Overall Study|Data inadvertently lost by site|1
1548885|NCT00095199|5061322|P4|Overall Study|Primary tumor removed in other surgery|0
1548886|NCT00095199|5061323|P3|Overall Study|Primary tumor removed in other surgery|0
1548887|NCT00095199|5061324|P2|Overall Study|Primary tumor removed in other surgery|1
1548888|NCT00095199|5061325|P1|Overall Study|Primary tumor removed in other surgery|0
1548889|NCT00095199|5061322|P4|Overall Study|Started radiotherapy regimen|0
1548890|NCT00095199|5061323|P3|Overall Study|Started radiotherapy regimen|0
1548891|NCT00095199|5061324|P2|Overall Study|Started radiotherapy regimen|1
1548892|NCT00095199|5061325|P1|Overall Study|Started radiotherapy regimen|0
1548893|NCT00095199|5061322|P4|Overall Study|Started Palliative Radiotherapy|0
1548894|NCT00095199|5061323|P3|Overall Study|Started Palliative Radiotherapy|0
1548895|NCT00095199|5061324|P2|Overall Study|Started Palliative Radiotherapy|0
1548896|NCT00095199|5061325|P1|Overall Study|Started Palliative Radiotherapy|1
1548897|NCT00095199|5061322|P4|Overall Study|Not eligible|1
1548898|NCT00095199|5061323|P3|Overall Study|Not eligible|0
1548899|NCT00095199|5061324|P2|Overall Study|Not eligible|7
1548900|NCT00095199|5061325|P1|Overall Study|Not eligible|1
1548901|NCT00095199|5061322|P4|Overall Study|Physician Decision|1
1548902|NCT00095199|5061323|P3|Overall Study|Physician Decision|1
1548903|NCT00095199|5061324|P2|Overall Study|Physician Decision|6
1548904|NCT00095199|5061325|P1|Overall Study|Physician Decision|5
1548905|NCT00095199|5061322|P4|Overall Study|Surgery needed could not start in 7 days|0
1548906|NCT00095199|5061323|P3|Overall Study|Surgery needed could not start in 7 days|1
1548907|NCT00095199|5061324|P2|Overall Study|Surgery needed could not start in 7 days|0
1548908|NCT00095199|5061325|P1|Overall Study|Surgery needed could not start in 7 days|0
1548909|NCT00095199|5061322|P4|Overall Study|Liver function test results elevated|1
1548910|NCT00095199|5061323|P3|Overall Study|Liver function test results elevated|1
1548911|NCT00095199|5061324|P2|Overall Study|Liver function test results elevated|0
1548912|NCT00095199|5061325|P1|Overall Study|Liver function test results elevated|0
1548913|NCT00095199|5061322|P4|Overall Study|Protocol Violation|0
1548914|NCT00095199|5061323|P3|Overall Study|Protocol Violation|2
1548915|NCT00095199|5061324|P2|Overall Study|Protocol Violation|4
1548916|NCT00095199|5061325|P1|Overall Study|Protocol Violation|4
1548917|NCT00095199|5061322|P4|Overall Study|Withdrawal by Subject|22
1548918|NCT00095199|5061323|P3|Overall Study|Withdrawal by Subject|13
1548919|NCT00095199|5061324|P2|Overall Study|Withdrawal by Subject|16
1548920|NCT00095199|5061325|P1|Overall Study|Withdrawal by Subject|21
1548921|NCT00095199|5061322|P4|Overall Study|Death|9
1548922|NCT00095199|5061323|P3|Overall Study|Death|11
1548923|NCT00095199|5061324|P2|Overall Study|Death|6
1548924|NCT00095199|5061325|P1|Overall Study|Death|10
1548925|NCT00095199|5061322|P4|Overall Study|Progressive disease|98
1548926|NCT00095199|5061323|P3|Overall Study|Progressive disease|105
1548927|NCT00095199|5061324|P2|Overall Study|Progressive disease|179
1548928|NCT00095199|5061325|P1|Overall Study|Progressive disease|213
1548929|NCT00095199|5061322|P4|Overall Study|Adverse Event|11
1548930|NCT00095199|5061323|P3|Overall Study|Adverse Event|26
1548931|NCT00095199|5061324|P2|Overall Study|Adverse Event|22
1548932|NCT00095199|5061325|P1|Overall Study|Adverse Event|40
1548933|NCT00095173|5061363|P6|Open-Label Extension Phase (Period C)|Not Specified|8
1548934|NCT00095173|5061364|P5|Open-Label Extension Phase (Period C)|Not Specified|6
1548935|NCT00095173|5061365|P4|Open-Label Extension Phase (Period C)|Not Specified|4
1548936|NCT00095173|5061366|P3|Open-Label Extension Phase (Period C)|Not Specified|0
1548937|NCT00095173|5061367|P2|Open-Label Extension Phase (Period C)|Not Specified|0
1548938|NCT00095173|5061368|P1|Open-Label Extension Phase (Period C)|Not Specified|0
1548939|NCT00095173|5061363|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
1548940|NCT00095173|5061364|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
1548941|NCT00095173|5061365|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
1548942|NCT00095173|5061366|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
1548943|NCT00095173|5061367|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
1548944|NCT00095173|5061368|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
1548945|NCT00095173|5061363|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
1548946|NCT00095173|5061364|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
1548947|NCT00095173|5061365|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1548948|NCT00095173|5061366|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1548949|NCT00095173|5061367|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1548950|NCT00095173|5061368|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1548951|NCT00095173|5061363|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
1548952|NCT00095173|5061364|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
1548953|NCT00095173|5061365|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1548954|NCT00095173|5061366|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1548955|NCT00095173|5061367|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1548956|NCT00095173|5061368|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1548957|NCT00095173|5061363|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1548958|NCT00095173|5061364|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
1548959|NCT00095173|5061365|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
1548960|NCT00095173|5061366|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1548961|NCT00095173|5061367|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1548962|NCT00095173|5061368|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1548963|NCT00095173|5061363|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
1548964|NCT00095173|5061364|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
1548965|NCT00095173|5061365|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
1548966|NCT00095173|5061366|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
1548967|NCT00095173|5061367|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
1548968|NCT00095173|5061368|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
1548969|NCT00095173|5061363|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
1548970|NCT00095173|5061364|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
1548971|NCT00095173|5061365|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
1548972|NCT00095173|5061366|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
1548973|NCT00095173|5061367|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
1548974|NCT00095173|5061368|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
1548975|NCT00095173|5061363|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
1548976|NCT00095173|5061364|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
1548977|NCT00095173|5061365|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
1548978|NCT00095173|5061366|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
1548979|NCT00095173|5061367|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
1548980|NCT00095173|5061368|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
1548981|NCT00095173|5061363|P6|Open-Label Extension Phase (Period C)|Death|1
1548982|NCT00095173|5061364|P5|Open-Label Extension Phase (Period C)|Death|0
1548983|NCT00095173|5061365|P4|Open-Label Extension Phase (Period C)|Death|0
1548984|NCT00095173|5061366|P3|Open-Label Extension Phase (Period C)|Death|0
1548985|NCT00095173|5061367|P2|Open-Label Extension Phase (Period C)|Death|0
1548986|NCT00095173|5061368|P1|Open-Label Extension Phase (Period C)|Death|0
1548987|NCT00095173|5061363|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1548988|NCT00095173|5061364|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1548989|NCT00095173|5061365|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1548990|NCT00095173|5061366|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1548991|NCT00095173|5061367|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
1548992|NCT00095173|5061368|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1548993|NCT00095173|5061363|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
1548994|NCT00095173|5061364|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
1548995|NCT00095173|5061365|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
1548996|NCT00095173|5061366|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
1548997|NCT00095173|5061367|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
1548998|NCT00095173|5061368|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
1548999|NCT00095173|5061363|P6|Open-Label Lead-In Phase (Period A)|Not specified|0
1549000|NCT00095173|5061364|P5|Open-Label Lead-In Phase (Period A)|Not specified|0
1549001|NCT00095173|5061365|P4|Open-Label Lead-In Phase (Period A)|Not specified|0
1549002|NCT00095173|5061366|P3|Open-Label Lead-In Phase (Period A)|Not specified|0
1549003|NCT00095173|5061367|P2|Open-Label Lead-In Phase (Period A)|Not specified|0
1549004|NCT00095173|5061368|P1|Open-Label Lead-In Phase (Period A)|Not specified|1
1549005|NCT00095173|5061363|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1549006|NCT00095173|5061364|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1549007|NCT00095173|5061365|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1549008|NCT00095173|5061366|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1549009|NCT00095173|5061367|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1549010|NCT00095173|5061368|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
1549011|NCT00095173|5061363|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1549012|NCT00095173|5061364|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1549013|NCT00095173|5061365|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1549014|NCT00095173|5061366|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1549015|NCT00095173|5061367|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1549016|NCT00095173|5061368|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
1549017|NCT00095173|5061363|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1549018|NCT00095173|5061364|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1549019|NCT00095173|5061365|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1549020|NCT00095173|5061366|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1549021|NCT00095173|5061367|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1549022|NCT00095173|5061368|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
1549023|NCT00095147|5061406|P5|Long-term Extension Period|Leaving country|1
1549024|NCT00095147|5061407|P4|Long-term Extension Period|Leaving country|0
1549025|NCT00095147|5061408|P3|Long-term Extension Period|Leaving country|0
1549026|NCT00095147|5061409|P2|Long-term Extension Period|Leaving country|0
1549027|NCT00095147|5061410|P1|Long-term Extension Period|Leaving country|0
1549028|NCT00095147|5061406|P5|Long-term Extension Period|Participant chose to use Revellex|1
1549029|NCT00095147|5061407|P4|Long-term Extension Period|Participant chose to use Revellex|0
1549030|NCT00095147|5061408|P3|Long-term Extension Period|Participant chose to use Revellex|0
1549031|NCT00095147|5061409|P2|Long-term Extension Period|Participant chose to use Revellex|0
1549032|NCT00095147|5061410|P1|Long-term Extension Period|Participant chose to use Revellex|0
1549033|NCT00095147|5061406|P5|Long-term Extension Period|No longer meets study criteria|1
1549034|NCT00095147|5061407|P4|Long-term Extension Period|No longer meets study criteria|0
1549035|NCT00095147|5061408|P3|Long-term Extension Period|No longer meets study criteria|0
1549036|NCT00095147|5061409|P2|Long-term Extension Period|No longer meets study criteria|0
1549037|NCT00095147|5061410|P1|Long-term Extension Period|No longer meets study criteria|0
1549038|NCT00095147|5061406|P5|Long-term Extension Period|Pregnancy|1
1549039|NCT00095147|5061407|P4|Long-term Extension Period|Pregnancy|0
1549040|NCT00095147|5061408|P3|Long-term Extension Period|Pregnancy|0
1549041|NCT00095147|5061409|P2|Long-term Extension Period|Pregnancy|0
1549042|NCT00095147|5061410|P1|Long-term Extension Period|Pregnancy|0
1549043|NCT00095147|5061406|P5|Long-term Extension Period|Withdrawal of consent|12
1549044|NCT00095147|5061407|P4|Long-term Extension Period|Withdrawal of consent|0
1549045|NCT00095147|5061408|P3|Long-term Extension Period|Withdrawal of consent|0
1549046|NCT00095147|5061409|P2|Long-term Extension Period|Withdrawal of consent|0
1549047|NCT00095147|5061410|P1|Long-term Extension Period|Withdrawal of consent|0
1549048|NCT00095147|5061406|P5|Long-term Extension Period|Lost to Follow-up|6
1549049|NCT00095147|5061407|P4|Long-term Extension Period|Lost to Follow-up|0
1549050|NCT00095147|5061408|P3|Long-term Extension Period|Lost to Follow-up|0
1549051|NCT00095147|5061409|P2|Long-term Extension Period|Lost to Follow-up|0
1549052|NCT00095147|5061410|P1|Long-term Extension Period|Lost to Follow-up|0
1549053|NCT00095147|5061406|P5|Long-term Extension Period|Lack of Efficacy|9
1549054|NCT00095147|5061407|P4|Long-term Extension Period|Lack of Efficacy|0
1549055|NCT00095147|5061408|P3|Long-term Extension Period|Lack of Efficacy|0
1549056|NCT00095147|5061409|P2|Long-term Extension Period|Lack of Efficacy|0
1549057|NCT00095147|5061410|P1|Long-term Extension Period|Lack of Efficacy|0
1549058|NCT00095147|5061406|P5|Long-term Extension Period|Adverse Event|11
1549059|NCT00095147|5061407|P4|Long-term Extension Period|Adverse Event|0
1549060|NCT00095147|5061408|P3|Long-term Extension Period|Adverse Event|0
1549061|NCT00095147|5061409|P2|Long-term Extension Period|Adverse Event|0
1549062|NCT00095147|5061410|P1|Long-term Extension Period|Adverse Event|0
1549063|NCT00095147|5061406|P5|Long-term Extension Period|Death|3
1549064|NCT00095147|5061407|P4|Long-term Extension Period|Death|0
1549065|NCT00095147|5061408|P3|Long-term Extension Period|Death|0
1549066|NCT00095147|5061409|P2|Long-term Extension Period|Death|0
1549067|NCT00095147|5061410|P1|Long-term Extension Period|Death|0
1549068|NCT00095147|5061406|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
1549069|NCT00095147|5061407|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
1549070|NCT00095147|5061408|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
1549071|NCT00095147|5061409|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
1549072|NCT00095147|5061410|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
1549073|NCT00095147|5061406|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
1549074|NCT00095147|5061407|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
1549075|NCT00095147|5061408|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
1549076|NCT00095147|5061409|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
1549077|NCT00095147|5061410|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
1549078|NCT00095147|5061406|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
1549079|NCT00095147|5061407|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
1549080|NCT00095147|5061408|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
1549081|NCT00095147|5061409|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
1549082|NCT00095147|5061410|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
1549083|NCT00095147|5061406|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
1549084|NCT00095147|5061407|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
1549085|NCT00095147|5061408|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
1549086|NCT00095147|5061409|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
1549087|NCT00095147|5061410|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
1549088|NCT00095147|5061406|P5|Double-blind Period 2 (Days 198-365)|Death|0
1549089|NCT00095147|5061407|P4|Double-blind Period 2 (Days 198-365)|Death|1
1549090|NCT00095147|5061408|P3|Double-blind Period 2 (Days 198-365)|Death|0
1549091|NCT00095147|5061409|P2|Double-blind Period 2 (Days 198-365)|Death|1
1549092|NCT00095147|5061410|P1|Double-blind Period 2 (Days 198-365)|Death|0
1549093|NCT00095147|5061406|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
1549094|NCT00095147|5061407|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
1549095|NCT00095147|5061408|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
1549096|NCT00095147|5061409|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
1549097|NCT00095147|5061410|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
1549098|NCT00095147|5061406|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
1549099|NCT00095147|5061407|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
1549100|NCT00095147|5061408|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
1549101|NCT00095147|5061409|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
1549102|NCT00095147|5061410|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
1549103|NCT00095147|5061406|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
1549104|NCT00095147|5061407|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
1549105|NCT00095147|5061408|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
1549106|NCT00095147|5061409|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
1549107|NCT00095147|5061410|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
1549108|NCT00095147|5061406|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
1549109|NCT00095147|5061407|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
1549110|NCT00095147|5061408|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
1549111|NCT00095147|5061409|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
1549112|NCT00095147|5061410|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
1549113|NCT00095147|5061406|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
1549114|NCT00095147|5061407|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
1549115|NCT00095147|5061408|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
1549116|NCT00095147|5061409|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
1549117|NCT00095147|5061410|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
1549118|NCT00095147|5061406|P5|Double-blind Period 1 (Days 1-197)|Death|0
1549119|NCT00095147|5061407|P4|Double-blind Period 1 (Days 1-197)|Death|0
1549120|NCT00095147|5061408|P3|Double-blind Period 1 (Days 1-197)|Death|0
1549121|NCT00095147|5061409|P2|Double-blind Period 1 (Days 1-197)|Death|0
1549122|NCT00095147|5061410|P1|Double-blind Period 1 (Days 1-197)|Death|1
1549123|NCT00095121|5061605|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
1549124|NCT00095121|5061606|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
1549125|NCT00095121|5061605|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
1549126|NCT00095121|5061606|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
1549127|NCT00095056|5061652|P2|Phase B (Weeks 12-54)|Protocol Violation|1
1549128|NCT00095056|5061653|P1|Phase B (Weeks 12-54)|Protocol Violation|0
1549129|NCT00095056|5061652|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
1549130|NCT00095056|5061653|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
1549131|NCT00095056|5061652|P2|Phase B (Weeks 12-54)|Death|1
1549132|NCT00095056|5061653|P1|Phase B (Weeks 12-54)|Death|3
1549133|NCT00095056|5061652|P2|Phase B (Weeks 12-54)|Patient Moved|0
1549134|NCT00095056|5061653|P1|Phase B (Weeks 12-54)|Patient Moved|1
1549135|NCT00095056|5061652|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
1549136|NCT00095056|5061653|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
1549137|NCT00095056|5061652|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
1549138|NCT00095056|5061653|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
1549139|NCT00095056|5061652|P2|Phase B (Weeks 12-54)|Adverse Event|2
1549140|NCT00095056|5061653|P1|Phase B (Weeks 12-54)|Adverse Event|2
1549141|NCT00095056|5061652|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
1549142|NCT00095056|5061653|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
1549143|NCT00095056|5061652|P2|Phase A (Weeks 0-12)|Death|0
1549144|NCT00095056|5061653|P1|Phase A (Weeks 0-12)|Death|1
1549145|NCT00095056|5061652|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
1549146|NCT00095056|5061653|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
1549147|NCT00095056|5061652|P2|Phase A (Weeks 0-12)|Adverse Event|1
1549148|NCT00095056|5061653|P1|Phase A (Weeks 0-12)|Adverse Event|1
1549149|NCT00094887|5061763|P2|Overall Study|Physician Decision|2
1549150|NCT00094887|5061764|P1|Overall Study|Physician Decision|2
1549151|NCT00094887|5061763|P2|Overall Study|Family emergency, Subject noncompliance|4
1549152|NCT00094887|5061764|P1|Overall Study|Family emergency, Subject noncompliance|3
1549153|NCT00094861|5061772|P2|Overall Study|Other|0
1549154|NCT00094861|5061773|P1|Overall Study|Other|3
1549155|NCT00094861|5061772|P2|Overall Study|Death|2
1549156|NCT00094861|5061773|P1|Overall Study|Death|4
1549157|NCT00094861|5061772|P2|Overall Study|Lost to Follow-up|1
1549158|NCT00094861|5061773|P1|Overall Study|Lost to Follow-up|0
1549159|NCT00094861|5061772|P2|Overall Study|Physician Decision|1
1549160|NCT00094861|5061773|P1|Overall Study|Physician Decision|1
1549161|NCT00094861|5061772|P2|Overall Study|Withdrawal by Subject|3
1549162|NCT00094861|5061773|P1|Overall Study|Withdrawal by Subject|5
1549163|NCT00094861|5061772|P2|Overall Study|Adverse Event|2
1549164|NCT00094861|5061773|P1|Overall Study|Adverse Event|5
1549165|NCT00094835|5061800|P7|Overall Study|Other|0
1549166|NCT00094835|5061801|P6|Overall Study|Other|0
1549167|NCT00094835|5061802|P5|Overall Study|Other|0
1549168|NCT00094835|5061803|P4|Overall Study|Other|1
1549169|NCT00094835|5061804|P3|Overall Study|Other|1
1549170|NCT00094835|5061805|P2|Overall Study|Other|1
1549171|NCT00094835|5061806|P1|Overall Study|Other|1
1549172|NCT00094835|5061800|P7|Overall Study|Non-compliance|1
1549173|NCT00094835|5061801|P6|Overall Study|Non-compliance|2
1549174|NCT00094835|5061802|P5|Overall Study|Non-compliance|2
1549175|NCT00094835|5061803|P4|Overall Study|Non-compliance|0
1549176|NCT00094835|5061804|P3|Overall Study|Non-compliance|2
1549177|NCT00094835|5061805|P2|Overall Study|Non-compliance|2
1549178|NCT00094835|5061806|P1|Overall Study|Non-compliance|1
1549179|NCT00094835|5061800|P7|Overall Study|Death|0
1549180|NCT00094835|5061801|P6|Overall Study|Death|0
1549181|NCT00094835|5061802|P5|Overall Study|Death|1
1549182|NCT00094835|5061803|P4|Overall Study|Death|0
1549183|NCT00094835|5061804|P3|Overall Study|Death|0
1549184|NCT00094835|5061805|P2|Overall Study|Death|0
1549185|NCT00094835|5061806|P1|Overall Study|Death|1
1549186|NCT00094835|5061800|P7|Overall Study|Lost to Follow-up|0
1549187|NCT00094835|5061801|P6|Overall Study|Lost to Follow-up|0
1549188|NCT00094835|5061802|P5|Overall Study|Lost to Follow-up|1
1549189|NCT00094835|5061803|P4|Overall Study|Lost to Follow-up|0
1549190|NCT00094835|5061804|P3|Overall Study|Lost to Follow-up|0
1549191|NCT00094835|5061805|P2|Overall Study|Lost to Follow-up|0
1549192|NCT00094835|5061806|P1|Overall Study|Lost to Follow-up|0
1549193|NCT00094835|5061800|P7|Overall Study|Withdrawal by Subject|1
1549194|NCT00094835|5061801|P6|Overall Study|Withdrawal by Subject|0
1549195|NCT00094835|5061802|P5|Overall Study|Withdrawal by Subject|0
1549196|NCT00094835|5061803|P4|Overall Study|Withdrawal by Subject|0
1549197|NCT00094835|5061804|P3|Overall Study|Withdrawal by Subject|0
1549198|NCT00094835|5061805|P2|Overall Study|Withdrawal by Subject|0
1549199|NCT00094835|5061806|P1|Overall Study|Withdrawal by Subject|0
1549200|NCT00094835|5061800|P7|Overall Study|Physician Decision|0
1549201|NCT00094835|5061801|P6|Overall Study|Physician Decision|1
1549202|NCT00094835|5061802|P5|Overall Study|Physician Decision|0
1549203|NCT00094835|5061803|P4|Overall Study|Physician Decision|0
1549204|NCT00094835|5061804|P3|Overall Study|Physician Decision|0
1549205|NCT00094835|5061805|P2|Overall Study|Physician Decision|0
1549206|NCT00094835|5061806|P1|Overall Study|Physician Decision|1
1549207|NCT00094809|5061884|P2|Overall Study|Other|1
1549208|NCT00094809|5061885|P1|Overall Study|Other|1
1549209|NCT00094809|5061884|P2|Overall Study|Study drug not received|8
1549210|NCT00094809|5061885|P1|Overall Study|Study drug not received|2
1549211|NCT00094809|5061884|P2|Overall Study|Informed consent signed after treatment|0
1549212|NCT00094809|5061885|P1|Overall Study|Informed consent signed after treatment|1
1549213|NCT00094809|5061884|P2|Overall Study|Other|4
1549214|NCT00094809|5061885|P1|Overall Study|Other|2
1549215|NCT00094809|5061884|P2|Overall Study|Protocol-specified criteria|1
1549216|NCT00094809|5061885|P1|Overall Study|Protocol-specified criteria|1
1549217|NCT00094809|5061884|P2|Overall Study|Death|25
1549218|NCT00094809|5061885|P1|Overall Study|Death|19
1549219|NCT00094809|5061884|P2|Overall Study|Lost to Follow-up|6
1549220|NCT00094809|5061885|P1|Overall Study|Lost to Follow-up|6
1549221|NCT00094809|5061884|P2|Overall Study|Physician Decision|5
1549222|NCT00094809|5061885|P1|Overall Study|Physician Decision|3
1549223|NCT00094809|5061884|P2|Overall Study|Disease progression|3
1549224|NCT00094809|5061885|P1|Overall Study|Disease progression|3
1549225|NCT00094809|5061884|P2|Overall Study|Withdrawal by Subject|9
1549226|NCT00094809|5061885|P1|Overall Study|Withdrawal by Subject|8
1549227|NCT00094809|5061884|P2|Overall Study|Adverse Event|1
1549228|NCT00094809|5061885|P1|Overall Study|Adverse Event|3
1549229|NCT00094809|5061884|P2|Overall Study|Noncompliance|0
1549230|NCT00094809|5061885|P1|Overall Study|Noncompliance|1
1549231|NCT00094809|5061884|P2|Overall Study|Protocol deviation|2
1549232|NCT00094809|5061885|P1|Overall Study|Protocol deviation|2
1549233|NCT00094770|5061911|P2|Year 2 (Week 0 to Week 104)|Other|23
1549234|NCT00094770|5061912|P1|Year 2 (Week 0 to Week 104)|Other|15
1549235|NCT00094770|5061911|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
1549236|NCT00094770|5061912|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
1549237|NCT00094770|5061911|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
1549238|NCT00094770|5061912|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
1549239|NCT00094770|5061911|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
1549240|NCT00094770|5061912|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
1549241|NCT00094770|5061911|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
1549242|NCT00094770|5061912|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
1549243|NCT00094770|5061911|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
1549244|NCT00094770|5061912|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
1549245|NCT00094770|5061911|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
1549246|NCT00094770|5061912|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
1549247|NCT00094770|5061911|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
1549248|NCT00094770|5061912|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
1549249|NCT00094770|5061911|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
1549250|NCT00094770|5061912|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
1549251|NCT00094770|5061911|P2|Year 1 ( Week 0 to Week 52)|Other|11
1549252|NCT00094770|5061912|P1|Year 1 ( Week 0 to Week 52)|Other|10
1549253|NCT00094770|5061911|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
1549254|NCT00094770|5061912|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
1549255|NCT00094770|5061911|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
1549256|NCT00094770|5061912|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
1549257|NCT00094770|5061911|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
1549258|NCT00094770|5061912|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
1549259|NCT00094770|5061911|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
1549260|NCT00094770|5061912|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
1549261|NCT00094770|5061911|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
1549262|NCT00094770|5061912|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
1549263|NCT00094770|5061911|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
1549264|NCT00094770|5061912|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
1549265|NCT00094770|5061911|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
1549266|NCT00094770|5061912|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
1549267|NCT00094770|5061911|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
1549268|NCT00094770|5061912|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
1549269|NCT00094757|5061943|P3|Overall Study|Protocol specified discontinuation|0
1549270|NCT00094757|5061944|P2|Overall Study|Protocol specified discontinuation|3
1549271|NCT00094757|5061945|P1|Overall Study|Protocol specified discontinuation|1
1549272|NCT00094757|5061943|P3|Overall Study|Other|1
1549273|NCT00094757|5061944|P2|Overall Study|Other|3
1549274|NCT00094757|5061945|P1|Overall Study|Other|3
1549275|NCT00094757|5061943|P3|Overall Study|Withdrawal by Subject|5
1549276|NCT00094757|5061944|P2|Overall Study|Withdrawal by Subject|21
1549277|NCT00094757|5061945|P1|Overall Study|Withdrawal by Subject|14
1549278|NCT00094757|5061943|P3|Overall Study|Protocol Violation|3
1549279|NCT00094757|5061944|P2|Overall Study|Protocol Violation|5
1549280|NCT00094757|5061945|P1|Overall Study|Protocol Violation|8
1549281|NCT00094757|5061943|P3|Overall Study|Patient Moved|1
1549282|NCT00094757|5061944|P2|Overall Study|Patient Moved|1
1549283|NCT00094757|5061945|P1|Overall Study|Patient Moved|2
1549284|NCT00094757|5061943|P3|Overall Study|Lost to Follow-up|6
1549285|NCT00094757|5061944|P2|Overall Study|Lost to Follow-up|5
1549286|NCT00094757|5061945|P1|Overall Study|Lost to Follow-up|3
1549287|NCT00094757|5061943|P3|Overall Study|Lack of Efficacy|8
1549288|NCT00094757|5061944|P2|Overall Study|Lack of Efficacy|15
1549289|NCT00094757|5061945|P1|Overall Study|Lack of Efficacy|11
1549290|NCT00094757|5061943|P3|Overall Study|Adverse Event|6
1549291|NCT00094757|5061944|P2|Overall Study|Adverse Event|9
1549292|NCT00094757|5061945|P1|Overall Study|Adverse Event|11
1549293|NCT00094653|5061965|P3|Overall Study|Protocol Violation|1
1549294|NCT00094653|5061966|P2|Overall Study|Protocol Violation|0
1549295|NCT00094653|5061967|P1|Overall Study|Protocol Violation|0
1549296|NCT00094653|5061965|P3|Overall Study|Lost to Follow-up|1
1549297|NCT00094653|5061966|P2|Overall Study|Lost to Follow-up|2
1549298|NCT00094653|5061967|P1|Overall Study|Lost to Follow-up|3
1549299|NCT00094653|5061965|P3|Overall Study|Not specified|2
1549300|NCT00094653|5061966|P2|Overall Study|Not specified|2
1549301|NCT00094653|5061967|P1|Overall Study|Not specified|2
1549302|NCT00094653|5061965|P3|Overall Study|Subject Withdrew Consent|3
1549303|NCT00094653|5061966|P2|Overall Study|Subject Withdrew Consent|2
1549304|NCT00094653|5061967|P1|Overall Study|Subject Withdrew Consent|10
1549305|NCT00094653|5061965|P3|Overall Study|Death|119
1549306|NCT00094653|5061966|P2|Overall Study|Death|100
1549307|NCT00094653|5061967|P1|Overall Study|Death|306
1549308|NCT00094575|5062030|P2|Overall Study|Death|146
1549309|NCT00094575|5062031|P1|Overall Study|Death|146
1549310|NCT00094536|5062051|P1|Treatment and Follow-up|Unable to attend visits|1
1549311|NCT00094536|5062051|P1|Treatment and Follow-up|Subject non-compliance|9
1549312|NCT00094536|5062051|P1|Treatment and Follow-up|Withdrawal by Subject|1
1549313|NCT00094536|5062051|P1|Treatment and Follow-up|Lost to Follow-up|7
1549314|NCT00094536|5062051|P1|Treatment and Follow-up|Lack of Efficacy|9
1549315|NCT00094536|5062051|P1|Treatment and Follow-up|Adverse Event|4
1549316|NCT00094536|5062051|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
1549317|NCT00094458|5062075|P6|OLE: Open-Label Extension|Patient decision|0
1549318|NCT00094458|5062076|P5|OLE: Open-Label Extension|Patient decision|1
1549319|NCT00094458|5062077|P4|OLE: Open-Label Extension|Patient decision|0
1549320|NCT00094458|5062078|P3|OLE: Open-Label Extension|Patient decision|0
1549321|NCT00094458|5062079|P2|OLE: Open-Label Extension|Patient decision|0
1549322|NCT00094458|5062080|P1|OLE: Open-Label Extension|Patient decision|0
1549323|NCT00094458|5062075|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1549324|NCT00094458|5062076|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
1549325|NCT00094458|5062077|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
1549326|NCT00094458|5062078|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1549327|NCT00094458|5062079|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1549328|NCT00094458|5062080|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1549329|NCT00094458|5062075|P6|OLE: Open-Label Extension|Adverse Event|4
1549330|NCT00094458|5062076|P5|OLE: Open-Label Extension|Adverse Event|3
1549331|NCT00094458|5062077|P4|OLE: Open-Label Extension|Adverse Event|0
1549332|NCT00094458|5062078|P3|OLE: Open-Label Extension|Adverse Event|0
1549333|NCT00094458|5062079|P2|OLE: Open-Label Extension|Adverse Event|0
1549334|NCT00094458|5062080|P1|OLE: Open-Label Extension|Adverse Event|0
1549335|NCT00094458|5062075|P6|Study Extension: Week 30 Through Week 50|Other|0
1549336|NCT00094458|5062076|P5|Study Extension: Week 30 Through Week 50|Other|0
1549337|NCT00094458|5062077|P4|Study Extension: Week 30 Through Week 50|Other|0
1549338|NCT00094458|5062078|P3|Study Extension: Week 30 Through Week 50|Other|3
1549339|NCT00094458|5062079|P2|Study Extension: Week 30 Through Week 50|Other|2
1549340|NCT00094458|5062080|P1|Study Extension: Week 30 Through Week 50|Other|1
1549341|NCT00094458|5062075|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
1549342|NCT00094458|5062076|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
1549343|NCT00094458|5062077|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
1549344|NCT00094458|5062078|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
1549345|NCT00094458|5062079|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
1549346|NCT00094458|5062080|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
1549347|NCT00094458|5062075|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1549348|NCT00094458|5062076|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1549349|NCT00094458|5062077|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1549350|NCT00094458|5062078|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
1549351|NCT00094458|5062079|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1549352|NCT00094458|5062080|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
1549353|NCT00094458|5062075|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
1549354|NCT00094458|5062076|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
1549355|NCT00094458|5062077|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
1549356|NCT00094458|5062078|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
1549357|NCT00094458|5062079|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
1549358|NCT00094458|5062080|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
1549359|NCT00094458|5062075|P6|Main Study: Through Week 30|Other|0
1549360|NCT00094458|5062076|P5|Main Study: Through Week 30|Other|0
1549361|NCT00094458|5062077|P4|Main Study: Through Week 30|Other|0
1549362|NCT00094458|5062078|P3|Main Study: Through Week 30|Other|9
1549363|NCT00094458|5062079|P2|Main Study: Through Week 30|Other|16
1549364|NCT00094458|5062080|P1|Main Study: Through Week 30|Other|19
1549365|NCT00094458|5062075|P6|Main Study: Through Week 30|Death|0
1549366|NCT00094458|5062076|P5|Main Study: Through Week 30|Death|0
1549367|NCT00094458|5062077|P4|Main Study: Through Week 30|Death|0
1549368|NCT00094458|5062078|P3|Main Study: Through Week 30|Death|0
1549369|NCT00094458|5062079|P2|Main Study: Through Week 30|Death|0
1549370|NCT00094458|5062080|P1|Main Study: Through Week 30|Death|1
1549371|NCT00094458|5062075|P6|Main Study: Through Week 30|Adverse Event|0
1549372|NCT00094458|5062076|P5|Main Study: Through Week 30|Adverse Event|0
1549373|NCT00094458|5062077|P4|Main Study: Through Week 30|Adverse Event|0
1549374|NCT00094458|5062078|P3|Main Study: Through Week 30|Adverse Event|28
1549375|NCT00094458|5062079|P2|Main Study: Through Week 30|Adverse Event|20
1549376|NCT00094458|5062080|P1|Main Study: Through Week 30|Adverse Event|38
1549377|NCT00094458|5062075|P6|Main Study: Through Week 30|Withdrawal by Subject|0
1549378|NCT00094458|5062076|P5|Main Study: Through Week 30|Withdrawal by Subject|0
1549379|NCT00094458|5062077|P4|Main Study: Through Week 30|Withdrawal by Subject|0
1549380|NCT00094458|5062078|P3|Main Study: Through Week 30|Withdrawal by Subject|7
1549381|NCT00094458|5062079|P2|Main Study: Through Week 30|Withdrawal by Subject|9
1549382|NCT00094458|5062080|P1|Main Study: Through Week 30|Withdrawal by Subject|18
1549383|NCT00094458|5062075|P6|Main Study: Through Week 30|Lost to Follow-up|0
1549384|NCT00094458|5062076|P5|Main Study: Through Week 30|Lost to Follow-up|0
1549385|NCT00094458|5062077|P4|Main Study: Through Week 30|Lost to Follow-up|0
1549386|NCT00094458|5062078|P3|Main Study: Through Week 30|Lost to Follow-up|2
1549387|NCT00094458|5062079|P2|Main Study: Through Week 30|Lost to Follow-up|5
1549388|NCT00094458|5062080|P1|Main Study: Through Week 30|Lost to Follow-up|5
1549389|NCT00094458|5062075|P6|Main Study: Through Week 30|Eligibility criteria not met|0
1549390|NCT00094458|5062076|P5|Main Study: Through Week 30|Eligibility criteria not met|0
1549391|NCT00094458|5062077|P4|Main Study: Through Week 30|Eligibility criteria not met|0
1549392|NCT00094458|5062078|P3|Main Study: Through Week 30|Eligibility criteria not met|2
1549393|NCT00094458|5062079|P2|Main Study: Through Week 30|Eligibility criteria not met|8
1549394|NCT00094458|5062080|P1|Main Study: Through Week 30|Eligibility criteria not met|3
1549395|NCT00094328|5062118|P1|Overall Study|Lost to Follow-up|1
1549396|NCT00094302|5062132|P2|Overall Study|Death|246
1549397|NCT00094302|5062133|P1|Overall Study|Death|266
1549398|NCT00094302|5062132|P2|Overall Study|Withdrawal by Subject|111
1549399|NCT00094302|5062133|P1|Overall Study|Withdrawal by Subject|103
1549400|NCT00094302|5062132|P2|Overall Study|Physician Decision|8
1549401|NCT00094302|5062133|P1|Overall Study|Physician Decision|5
1549402|NCT00094302|5062132|P2|Overall Study|Lost to Follow-up|41
1549403|NCT00094302|5062133|P1|Overall Study|Lost to Follow-up|43
1549404|NCT00094172|5062189|P2|Overall Study|Started other MS therapy due to disease|0
1549405|NCT00094172|5062190|P1|Overall Study|Started other MS therapy due to disease|1
1549406|NCT00094172|5062189|P2|Overall Study|Primary endpoint met.|0
1549407|NCT00094172|5062190|P1|Overall Study|Primary endpoint met.|1
1549408|NCT00094172|5062189|P2|Overall Study|Withdrawal by Subject|5
1549409|NCT00094172|5062190|P1|Overall Study|Withdrawal by Subject|10
1549410|NCT00094172|5062189|P2|Overall Study|Protocol Violation|1
1549411|NCT00094172|5062190|P1|Overall Study|Protocol Violation|0
1549412|NCT00094172|5062189|P2|Overall Study|Lost to Follow-up|0
1549413|NCT00094172|5062190|P1|Overall Study|Lost to Follow-up|2
1549414|NCT00094172|5062189|P2|Overall Study|Adverse Event|1
1549415|NCT00094172|5062190|P1|Overall Study|Adverse Event|0
1549416|NCT00094107|5062200|P1|Overall Study|Withdrawal due to Disease Progression|1
1549417|NCT00094107|5062200|P1|Overall Study|Adverse Event|3
1549418|NCT00094107|5062200|P1|Overall Study|Death|5
1549419|NCT00094107|5062200|P1|Overall Study|Lack of Efficacy|23
1549420|NCT00094094|5062209|P1|Overall Study|Adverse Event|7
1549421|NCT00094094|5062209|P1|Overall Study|Lack of Efficacy|23
1549422|NCT00094094|5062209|P1|Overall Study|Death|2
1549423|NCT00094055|5062218|P1|Overall Study|Withdrawal by Subject|9
1549424|NCT00094055|5062218|P1|Overall Study|roll-over to another study|14
1549425|NCT00094055|5062218|P1|Overall Study|clinical progression|1
1549426|NCT00094055|5062218|P1|Overall Study|progressive disease|2
1549427|NCT00094055|5062218|P1|Overall Study|Lost to Follow-up|2
1549428|NCT00094055|5062218|P1|Overall Study|Lack of Efficacy|17
1549429|NCT00094055|5062218|P1|Overall Study|Death|4
1549430|NCT00094055|5062218|P1|Overall Study|Adverse Event|11
1549431|NCT00093808|5062238|P1|Overall Study|Protocol Violation|1
1549432|NCT00093808|5062238|P1|Overall Study|Cancel participation before receiving tx|1
1549433|NCT00093795|5062248|P3|Overall Study|No follow up data|17
1549434|NCT00093795|5062249|P2|Overall Study|No follow up data|16
1549435|NCT00093795|5062250|P1|Overall Study|No follow up data|20
1549436|NCT00093496|5062295|P2|Overall Study|Protocol Violation|3
1549437|NCT00093496|5062296|P1|Overall Study|Protocol Violation|1
1549438|NCT00093470|5062309|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
1549439|NCT00093470|5062310|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
1549440|NCT00093470|5062309|P2|Overall Study|Never started treatment|0
1549441|NCT00093470|5062310|P1|Overall Study|Never started treatment|1
1549442|NCT00093470|5062309|P2|Overall Study|Physician Decision|0
1549443|NCT00093470|5062310|P1|Overall Study|Physician Decision|2
1549444|NCT00093470|5062309|P2|Overall Study|Other complicating disease|0
1549445|NCT00093470|5062310|P1|Overall Study|Other complicating disease|3
1549446|NCT00093470|5062309|P2|Overall Study|Alternative therapy|0
1549447|NCT00093470|5062310|P1|Overall Study|Alternative therapy|2
1549448|NCT00093470|5062309|P2|Overall Study|Withdrawal by Subject|0
1549449|NCT00093470|5062310|P1|Overall Study|Withdrawal by Subject|8
1549450|NCT00093470|5062309|P2|Overall Study|Death|0
1549451|NCT00093470|5062310|P1|Overall Study|Death|2
1549452|NCT00093470|5062309|P2|Overall Study|Adverse Event|0
1549453|NCT00093470|5062310|P1|Overall Study|Adverse Event|15
1549454|NCT00093470|5062309|P2|Overall Study|Disease progression|0
1549455|NCT00093470|5062310|P1|Overall Study|Disease progression|39
1549456|NCT00093145|5062324|P1|Overall Study|Other|1
1549457|NCT00093145|5062324|P1|Overall Study|Withdrawal by Subject|9
1549458|NCT00093145|5062324|P1|Overall Study|Physician Decision|5
1549459|NCT00093145|5062324|P1|Overall Study|Unacceptable Toxicity Only|2
1549460|NCT00093015|5062366|P2|Overall Study|Death|385
1549461|NCT00093015|5062367|P1|Overall Study|Death|375
1549462|NCT00093015|5062366|P2|Overall Study|Lost to Follow-up|108
1549463|NCT00093015|5062367|P1|Overall Study|Lost to Follow-up|96
1549464|NCT00093015|5062366|P2|Overall Study|Withdrawal by Subject|171
1549465|NCT00093015|5062367|P1|Overall Study|Withdrawal by Subject|194
1549466|NCT00092677|5062395|P2|Overall Study|Adminstrative|9
1549467|NCT00092677|5062396|P1|Overall Study|Adminstrative|5
1549468|NCT00092677|5062395|P2|Overall Study|Lost to Follow-up|2
1549469|NCT00092677|5062396|P1|Overall Study|Lost to Follow-up|0
1549470|NCT00092547|5062440|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
1549471|NCT00092547|5062441|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
1549472|NCT00092547|5062442|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
1549473|NCT00092547|5062440|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
1549474|NCT00092547|5062441|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
1549475|NCT00092547|5062442|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
1549476|NCT00092547|5062440|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
1549477|NCT00092547|5062441|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
1549478|NCT00092547|5062442|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
1549479|NCT00092547|5062440|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
1549480|NCT00092547|5062441|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
1549481|NCT00092547|5062442|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
1549482|NCT00092547|5062440|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
1549483|NCT00092547|5062441|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
1549484|NCT00092547|5062442|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
1549485|NCT00092547|5062440|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
1549486|NCT00092547|5062441|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
1549487|NCT00092547|5062442|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
1549488|NCT00092547|5062440|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
1549489|NCT00092547|5062441|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
1549490|NCT00092547|5062442|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
1549491|NCT00092547|5062440|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
1549492|NCT00092547|5062441|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
1549493|NCT00092547|5062442|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
1549494|NCT00092547|5062440|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
1549495|NCT00092547|5062441|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
1549496|NCT00092547|5062442|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
1549497|NCT00092547|5062440|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
1549498|NCT00092547|5062441|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
1549499|NCT00092547|5062442|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
1549500|NCT00092547|5062440|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
1549501|NCT00092547|5062441|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
1549502|NCT00092547|5062442|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
1549503|NCT00092547|5062440|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
1549504|NCT00092547|5062441|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
1549505|NCT00092547|5062442|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
1549506|NCT00092547|5062440|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
1549507|NCT00092547|5062441|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
1549508|NCT00092547|5062442|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
1549509|NCT00092547|5062440|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
1549510|NCT00092547|5062441|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
1549511|NCT00092547|5062442|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
1549512|NCT00092547|5062440|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
1549513|NCT00092547|5062441|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
1549514|NCT00092547|5062442|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
1549515|NCT00092547|5062440|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
1549516|NCT00092547|5062441|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
1549517|NCT00092547|5062442|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
1549518|NCT00092547|5062440|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
1549519|NCT00092547|5062441|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
1549520|NCT00092547|5062442|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
1549521|NCT00092547|5062440|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
1549522|NCT00092547|5062441|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
1549523|NCT00092547|5062442|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
1549524|NCT00092547|5062440|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
1549525|NCT00092547|5062441|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
1549526|NCT00092547|5062442|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
1549527|NCT00092547|5062440|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
1549528|NCT00092547|5062441|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
1549529|NCT00092547|5062442|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
1549530|NCT00092547|5062440|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
1549531|NCT00092547|5062441|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
1549532|NCT00092547|5062442|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
1549533|NCT00092534|5062486|P3|Extension Study|Protocol Deviation|15
1549534|NCT00092534|5062487|P2|Extension Study|Protocol Deviation|0
1549535|NCT00092534|5062488|P1|Extension Study|Protocol Deviation|0
1549536|NCT00092534|5062486|P3|Extension Study|Study Ended|29
1549537|NCT00092534|5062487|P2|Extension Study|Study Ended|0
1549538|NCT00092534|5062488|P1|Extension Study|Study Ended|0
1549539|NCT00092534|5062486|P3|Extension Study|Site Closed|21
1549540|NCT00092534|5062487|P2|Extension Study|Site Closed|0
1549541|NCT00092534|5062488|P1|Extension Study|Site Closed|0
1549542|NCT00092534|5062486|P3|Extension Study|Travel|2
1549543|NCT00092534|5062487|P2|Extension Study|Travel|0
1549544|NCT00092534|5062488|P1|Extension Study|Travel|0
1549545|NCT00092534|5062486|P3|Extension Study|Moved|6
1549546|NCT00092534|5062487|P2|Extension Study|Moved|0
1549547|NCT00092534|5062488|P1|Extension Study|Moved|0
1549548|NCT00092534|5062486|P3|Extension Study|Withdrawal by Subject|18
1549549|NCT00092534|5062487|P2|Extension Study|Withdrawal by Subject|0
1549550|NCT00092534|5062488|P1|Extension Study|Withdrawal by Subject|0
1549551|NCT00092534|5062486|P3|Extension Study|Pregnancy|12
1549552|NCT00092534|5062487|P2|Extension Study|Pregnancy|0
1549553|NCT00092534|5062488|P1|Extension Study|Pregnancy|0
1549554|NCT00092534|5062486|P3|Extension Study|Physician Decision|1
1549555|NCT00092534|5062487|P2|Extension Study|Physician Decision|0
1549556|NCT00092534|5062488|P1|Extension Study|Physician Decision|0
1549557|NCT00092534|5062486|P3|Extension Study|Lost to Follow-up|41
1549558|NCT00092534|5062487|P2|Extension Study|Lost to Follow-up|0
1549559|NCT00092534|5062488|P1|Extension Study|Lost to Follow-up|0
1549560|NCT00092534|5062486|P3|Base Study Follow Up Period|Subjects in extension|0
1549561|NCT00092534|5062487|P2|Base Study Follow Up Period|Subjects in extension|371
1549562|NCT00092534|5062488|P1|Base Study Follow Up Period|Subjects in extension|15
1549563|NCT00092534|5062486|P3|Base Study Follow Up Period|Subjects continuing|0
1549564|NCT00092534|5062487|P2|Base Study Follow Up Period|Subjects continuing|31
1549565|NCT00092534|5062488|P1|Base Study Follow Up Period|Subjects continuing|27
1549566|NCT00092534|5062486|P3|Base Study Follow Up Period|Site Closed|0
1549567|NCT00092534|5062487|P2|Base Study Follow Up Period|Site Closed|2
1549568|NCT00092534|5062488|P1|Base Study Follow Up Period|Site Closed|0
1549569|NCT00092534|5062486|P3|Base Study Follow Up Period|Travel|0
1549570|NCT00092534|5062487|P2|Base Study Follow Up Period|Travel|7
1549571|NCT00092534|5062488|P1|Base Study Follow Up Period|Travel|10
1549572|NCT00092534|5062486|P3|Base Study Follow Up Period|Moved|0
1549573|NCT00092534|5062487|P2|Base Study Follow Up Period|Moved|58
1549574|NCT00092534|5062488|P1|Base Study Follow Up Period|Moved|62
1549575|NCT00092534|5062486|P3|Base Study Follow Up Period|Withdrawal by Subject|0
1549576|NCT00092534|5062487|P2|Base Study Follow Up Period|Withdrawal by Subject|62
1549577|NCT00092534|5062488|P1|Base Study Follow Up Period|Withdrawal by Subject|71
1549578|NCT00092534|5062486|P3|Base Study Follow Up Period|Protocol Violation|0
1549579|NCT00092534|5062487|P2|Base Study Follow Up Period|Protocol Violation|2
1549580|NCT00092534|5062488|P1|Base Study Follow Up Period|Protocol Violation|1
1549581|NCT00092534|5062486|P3|Base Study Follow Up Period|Pregnancy|0
1549582|NCT00092534|5062487|P2|Base Study Follow Up Period|Pregnancy|10
1549583|NCT00092534|5062488|P1|Base Study Follow Up Period|Pregnancy|6
1549584|NCT00092534|5062486|P3|Base Study Follow Up Period|Lost to Follow-up|0
1549585|NCT00092534|5062487|P2|Base Study Follow Up Period|Lost to Follow-up|146
1549586|NCT00092534|5062488|P1|Base Study Follow Up Period|Lost to Follow-up|120
1549587|NCT00092534|5062486|P3|Base Study Follow Up Period|Death|0
1549588|NCT00092534|5062487|P2|Base Study Follow Up Period|Death|1
1549589|NCT00092534|5062488|P1|Base Study Follow Up Period|Death|2
1549590|NCT00092534|5062486|P3|Base Study Follow Up Period|Adverse Event|0
1549591|NCT00092534|5062487|P2|Base Study Follow Up Period|Adverse Event|4
1549592|NCT00092534|5062488|P1|Base Study Follow Up Period|Adverse Event|2
1549593|NCT00092534|5062486|P3|Base Study Vaccination Period|Site Closed|0
1549594|NCT00092534|5062487|P2|Base Study Vaccination Period|Site Closed|1
1549595|NCT00092534|5062488|P1|Base Study Vaccination Period|Site Closed|0
1549596|NCT00092534|5062486|P3|Base Study Vaccination Period|Travel|0
1549597|NCT00092534|5062487|P2|Base Study Vaccination Period|Travel|0
1549598|NCT00092534|5062488|P1|Base Study Vaccination Period|Travel|1
1549599|NCT00092534|5062486|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
1549600|NCT00092534|5062487|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
1549601|NCT00092534|5062488|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
1549602|NCT00092534|5062486|P3|Base Study Vaccination Period|Moved|0
1549603|NCT00092534|5062487|P2|Base Study Vaccination Period|Moved|12
1549604|NCT00092534|5062488|P1|Base Study Vaccination Period|Moved|14
1549605|NCT00092534|5062486|P3|Base Study Vaccination Period|Withdrawal by Subject|0
1549606|NCT00092534|5062487|P2|Base Study Vaccination Period|Withdrawal by Subject|58
1549607|NCT00092534|5062488|P1|Base Study Vaccination Period|Withdrawal by Subject|85
1549608|NCT00092534|5062486|P3|Base Study Vaccination Period|Protocol Violation|0
1549609|NCT00092534|5062487|P2|Base Study Vaccination Period|Protocol Violation|1
1549610|NCT00092534|5062488|P1|Base Study Vaccination Period|Protocol Violation|2
1549611|NCT00092534|5062486|P3|Base Study Vaccination Period|Pregnancy|0
1549612|NCT00092534|5062487|P2|Base Study Vaccination Period|Pregnancy|7
1549613|NCT00092534|5062488|P1|Base Study Vaccination Period|Pregnancy|9
1549614|NCT00092534|5062486|P3|Base Study Vaccination Period|Physician Decision|0
1549615|NCT00092534|5062487|P2|Base Study Vaccination Period|Physician Decision|0
1549616|NCT00092534|5062488|P1|Base Study Vaccination Period|Physician Decision|1
1549617|NCT00092534|5062486|P3|Base Study Vaccination Period|Lost to Follow-up|0
1549618|NCT00092534|5062487|P2|Base Study Vaccination Period|Lost to Follow-up|37
1549619|NCT00092534|5062488|P1|Base Study Vaccination Period|Lost to Follow-up|41
1549620|NCT00092534|5062486|P3|Base Study Vaccination Period|Death|0
1549621|NCT00092534|5062487|P2|Base Study Vaccination Period|Death|4
1549622|NCT00092534|5062488|P1|Base Study Vaccination Period|Death|5
1549623|NCT00092534|5062486|P3|Base Study Vaccination Period|Adverse Event|0
1549624|NCT00092534|5062487|P2|Base Study Vaccination Period|Adverse Event|1
1549625|NCT00092534|5062488|P1|Base Study Vaccination Period|Adverse Event|3
1549626|NCT00092534|5062486|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
1549627|NCT00092534|5062487|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
1549628|NCT00092534|5062488|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
1549629|NCT00092521|5062506|P4|Extension Study (Group 4)|Unable/unwilling to return|25
1549630|NCT00092521|5062507|P3|Extension Study (Group 4)|Unable/unwilling to return|0
1549631|NCT00092521|5062508|P2|Extension Study (Group 4)|Unable/unwilling to return|0
1549632|NCT00092521|5062509|P1|Extension Study (Group 4)|Unable/unwilling to return|0
1549633|NCT00092521|5062506|P4|Extension Study (Group 4)|Site Terminated|4
1549634|NCT00092521|5062507|P3|Extension Study (Group 4)|Site Terminated|0
1549635|NCT00092521|5062508|P2|Extension Study (Group 4)|Site Terminated|0
1549636|NCT00092521|5062509|P1|Extension Study (Group 4)|Site Terminated|0
1549637|NCT00092521|5062506|P4|Extension Study (Group 4)|Moved|16
1549638|NCT00092521|5062507|P3|Extension Study (Group 4)|Moved|0
1549639|NCT00092521|5062508|P2|Extension Study (Group 4)|Moved|0
1549640|NCT00092521|5062509|P1|Extension Study (Group 4)|Moved|0
1549641|NCT00092521|5062506|P4|Extension Study (Group 4)|Withdrawal by Subject|46
1549642|NCT00092521|5062507|P3|Extension Study (Group 4)|Withdrawal by Subject|0
1549643|NCT00092521|5062508|P2|Extension Study (Group 4)|Withdrawal by Subject|0
1549644|NCT00092521|5062509|P1|Extension Study (Group 4)|Withdrawal by Subject|0
1549645|NCT00092521|5062506|P4|Extension Study (Group 4)|Protocol Violation|2
1549646|NCT00092521|5062507|P3|Extension Study (Group 4)|Protocol Violation|0
1549647|NCT00092521|5062508|P2|Extension Study (Group 4)|Protocol Violation|0
1549648|NCT00092521|5062509|P1|Extension Study (Group 4)|Protocol Violation|0
1549649|NCT00092521|5062506|P4|Extension Study (Group 4)|Pregnancy|4
1549650|NCT00092521|5062507|P3|Extension Study (Group 4)|Pregnancy|0
1549651|NCT00092521|5062508|P2|Extension Study (Group 4)|Pregnancy|0
1549652|NCT00092521|5062509|P1|Extension Study (Group 4)|Pregnancy|0
1549653|NCT00092521|5062506|P4|Extension Study (Group 4)|Lost to Follow-up|87
1549654|NCT00092521|5062507|P3|Extension Study (Group 4)|Lost to Follow-up|0
1549655|NCT00092521|5062508|P2|Extension Study (Group 4)|Lost to Follow-up|0
1549656|NCT00092521|5062509|P1|Extension Study (Group 4)|Lost to Follow-up|0
1549657|NCT00092521|5062506|P4|Extension Study (Group 4)|Adverse Event|2
1549658|NCT00092521|5062507|P3|Extension Study (Group 4)|Adverse Event|0
1549659|NCT00092521|5062508|P2|Extension Study (Group 4)|Adverse Event|0
1549660|NCT00092521|5062509|P1|Extension Study (Group 4)|Adverse Event|0
1549661|NCT00092521|5062506|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
1549662|NCT00092521|5062507|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
1549663|NCT00092521|5062508|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
1549664|NCT00092521|5062509|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
1549665|NCT00092521|5062506|P4|Follow-Up (After Month 7)|Visits Compressed|0
1549666|NCT00092521|5062507|P3|Follow-Up (After Month 7)|Visits Compressed|5
1549667|NCT00092521|5062508|P2|Follow-Up (After Month 7)|Visits Compressed|0
1549668|NCT00092521|5062509|P1|Follow-Up (After Month 7)|Visits Compressed|5
1549669|NCT00092521|5062506|P4|Follow-Up (After Month 7)|Travel|0
1549670|NCT00092521|5062507|P3|Follow-Up (After Month 7)|Travel|0
1549671|NCT00092521|5062508|P2|Follow-Up (After Month 7)|Travel|0
1549672|NCT00092521|5062509|P1|Follow-Up (After Month 7)|Travel|2
1549673|NCT00092521|5062506|P4|Follow-Up (After Month 7)|Site Terminated|0
1549674|NCT00092521|5062507|P3|Follow-Up (After Month 7)|Site Terminated|3
1549675|NCT00092521|5062508|P2|Follow-Up (After Month 7)|Site Terminated|0
1549676|NCT00092521|5062509|P1|Follow-Up (After Month 7)|Site Terminated|3
1549677|NCT00092521|5062506|P4|Follow-Up (After Month 7)|Moved|0
1549678|NCT00092521|5062507|P3|Follow-Up (After Month 7)|Moved|28
1549679|NCT00092521|5062508|P2|Follow-Up (After Month 7)|Moved|2
1549680|NCT00092521|5062509|P1|Follow-Up (After Month 7)|Moved|32
1549681|NCT00092521|5062506|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
1549682|NCT00092521|5062507|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
1549683|NCT00092521|5062508|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
1549684|NCT00092521|5062509|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
1549685|NCT00092521|5062506|P4|Follow-Up (After Month 7)|Protocol Violation|0
1549686|NCT00092521|5062507|P3|Follow-Up (After Month 7)|Protocol Violation|5
1549687|NCT00092521|5062508|P2|Follow-Up (After Month 7)|Protocol Violation|1
1549688|NCT00092521|5062509|P1|Follow-Up (After Month 7)|Protocol Violation|1
1549689|NCT00092521|5062506|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
1549690|NCT00092521|5062507|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
1549691|NCT00092521|5062508|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
1549692|NCT00092521|5062509|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
1549693|NCT00092521|5062506|P4|Follow-Up (After Month 7)|Death|0
1549694|NCT00092521|5062507|P3|Follow-Up (After Month 7)|Death|1
1549695|NCT00092521|5062508|P2|Follow-Up (After Month 7)|Death|0
1549696|NCT00092521|5062509|P1|Follow-Up (After Month 7)|Death|2
1549697|NCT00092521|5062506|P4|Follow-Up (After Month 7)|Adverse Event|0
1549698|NCT00092521|5062507|P3|Follow-Up (After Month 7)|Adverse Event|0
1549699|NCT00092521|5062508|P2|Follow-Up (After Month 7)|Adverse Event|0
1549700|NCT00092521|5062509|P1|Follow-Up (After Month 7)|Adverse Event|1
1549701|NCT00092521|5062506|P4|Follow-Up (After Month 7)|Subjects in Extension|0
1549702|NCT00092521|5062507|P3|Follow-Up (After Month 7)|Subjects in Extension|412
1549703|NCT00092521|5062508|P2|Follow-Up (After Month 7)|Subjects in Extension|109
1549704|NCT00092521|5062509|P1|Follow-Up (After Month 7)|Subjects in Extension|13
1549705|NCT00092521|5062506|P4|Follow-Up (After Month 7)|Subjects Continuing|0
1549706|NCT00092521|5062507|P3|Follow-Up (After Month 7)|Subjects Continuing|35
1549707|NCT00092521|5062508|P2|Follow-Up (After Month 7)|Subjects Continuing|4
1549708|NCT00092521|5062509|P1|Follow-Up (After Month 7)|Subjects Continuing|34
1549709|NCT00092521|5062506|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
1549710|NCT00092521|5062507|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
1549711|NCT00092521|5062508|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
1549712|NCT00092521|5062509|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
1549713|NCT00092521|5062506|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
1549714|NCT00092521|5062507|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
1549715|NCT00092521|5062508|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
1549716|NCT00092521|5062509|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
1549717|NCT00092521|5062506|P4|Vaccination (Day 1 Through Month 7)|Moved|0
1549718|NCT00092521|5062507|P3|Vaccination (Day 1 Through Month 7)|Moved|18
1549719|NCT00092521|5062508|P2|Vaccination (Day 1 Through Month 7)|Moved|1
1549720|NCT00092521|5062509|P1|Vaccination (Day 1 Through Month 7)|Moved|14
1549721|NCT00092521|5062506|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
1549722|NCT00092521|5062507|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
1549723|NCT00092521|5062508|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
1549724|NCT00092521|5062509|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
1549725|NCT00092521|5062506|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
1549726|NCT00092521|5062507|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
1549727|NCT00092521|5062508|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
1549728|NCT00092521|5062509|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
1549729|NCT00092521|5062506|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
1549730|NCT00092521|5062507|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
1549731|NCT00092521|5062508|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
1549732|NCT00092521|5062509|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
1549733|NCT00092521|5062506|P4|Vaccination (Day 1 Through Month 7)|Death|0
1549734|NCT00092521|5062507|P3|Vaccination (Day 1 Through Month 7)|Death|1
1549735|NCT00092521|5062508|P2|Vaccination (Day 1 Through Month 7)|Death|0
1549736|NCT00092521|5062509|P1|Vaccination (Day 1 Through Month 7)|Death|0
1549737|NCT00092521|5062506|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
1549738|NCT00092521|5062507|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
1549739|NCT00092521|5062508|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
1549740|NCT00092521|5062509|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
1549741|NCT00092521|5062506|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
1549742|NCT00092521|5062507|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
1549743|NCT00092521|5062508|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
1549744|NCT00092521|5062509|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
1549745|NCT00092495|5062523|P5|Base Study Follow-up Period|Withdrawal by Subject|0
1549746|NCT00092495|5062524|P4|Base Study Follow-up Period|Withdrawal by Subject|0
1549747|NCT00092495|5062525|P3|Base Study Follow-up Period|Withdrawal by Subject|0
1549748|NCT00092495|5062526|P2|Base Study Follow-up Period|Withdrawal by Subject|0
1549749|NCT00092495|5062527|P1|Base Study Follow-up Period|Withdrawal by Subject|2
1549750|NCT00092495|5062523|P5|Base Study Follow-up Period|Lost to Follow-up|0
1549751|NCT00092495|5062524|P4|Base Study Follow-up Period|Lost to Follow-up|12
1549752|NCT00092495|5062525|P3|Base Study Follow-up Period|Lost to Follow-up|3
1549753|NCT00092495|5062526|P2|Base Study Follow-up Period|Lost to Follow-up|3
1549754|NCT00092495|5062527|P1|Base Study Follow-up Period|Lost to Follow-up|1
1549755|NCT00092495|5062523|P5|Base Study Follow-up Period|Extended|0
1549756|NCT00092495|5062524|P4|Base Study Follow-up Period|Extended|2
1549757|NCT00092495|5062525|P3|Base Study Follow-up Period|Extended|1
1549758|NCT00092495|5062526|P2|Base Study Follow-up Period|Extended|0
1549759|NCT00092495|5062527|P1|Base Study Follow-up Period|Extended|0
1549760|NCT00092495|5062523|P5|Base Study Vaccination Period|Withdrawal by Subject|0
1549761|NCT00092495|5062524|P4|Base Study Vaccination Period|Withdrawal by Subject|25
1549762|NCT00092495|5062525|P3|Base Study Vaccination Period|Withdrawal by Subject|14
1549763|NCT00092495|5062526|P2|Base Study Vaccination Period|Withdrawal by Subject|10
1549764|NCT00092495|5062527|P1|Base Study Vaccination Period|Withdrawal by Subject|9
1549765|NCT00092495|5062523|P5|Base Study Vaccination Period|Protocol Violation|0
1549766|NCT00092495|5062524|P4|Base Study Vaccination Period|Protocol Violation|0
1549767|NCT00092495|5062525|P3|Base Study Vaccination Period|Protocol Violation|0
1549768|NCT00092495|5062526|P2|Base Study Vaccination Period|Protocol Violation|0
1549769|NCT00092495|5062527|P1|Base Study Vaccination Period|Protocol Violation|1
1549770|NCT00092495|5062523|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
1549771|NCT00092495|5062524|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
1549772|NCT00092495|5062525|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
1549773|NCT00092495|5062526|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
1549774|NCT00092495|5062527|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
1549775|NCT00092495|5062523|P5|Base Study Vaccination Period|Pregnancy|0
1549776|NCT00092495|5062524|P4|Base Study Vaccination Period|Pregnancy|0
1549777|NCT00092495|5062525|P3|Base Study Vaccination Period|Pregnancy|0
1549778|NCT00092495|5062526|P2|Base Study Vaccination Period|Pregnancy|0
1549779|NCT00092495|5062527|P1|Base Study Vaccination Period|Pregnancy|2
1549780|NCT00092495|5062523|P5|Base Study Vaccination Period|Other|0
1549781|NCT00092495|5062524|P4|Base Study Vaccination Period|Other|2
1549782|NCT00092495|5062525|P3|Base Study Vaccination Period|Other|0
1549783|NCT00092495|5062526|P2|Base Study Vaccination Period|Other|1
1549784|NCT00092495|5062527|P1|Base Study Vaccination Period|Other|1
1549785|NCT00092495|5062523|P5|Base Study Vaccination Period|Moved|0
1549786|NCT00092495|5062524|P4|Base Study Vaccination Period|Moved|2
1549787|NCT00092495|5062525|P3|Base Study Vaccination Period|Moved|2
1549788|NCT00092495|5062526|P2|Base Study Vaccination Period|Moved|1
1549789|NCT00092495|5062527|P1|Base Study Vaccination Period|Moved|3
1549790|NCT00092495|5062523|P5|Base Study Vaccination Period|Lost to Follow-up|0
1549791|NCT00092495|5062524|P4|Base Study Vaccination Period|Lost to Follow-up|36
1549792|NCT00092495|5062525|P3|Base Study Vaccination Period|Lost to Follow-up|11
1549793|NCT00092495|5062526|P2|Base Study Vaccination Period|Lost to Follow-up|6
1549794|NCT00092495|5062527|P1|Base Study Vaccination Period|Lost to Follow-up|16
1549795|NCT00092495|5062523|P5|Base Study Vaccination Period|Adverse Event|0
1549796|NCT00092495|5062524|P4|Base Study Vaccination Period|Adverse Event|3
1549797|NCT00092495|5062525|P3|Base Study Vaccination Period|Adverse Event|0
1549798|NCT00092495|5062526|P2|Base Study Vaccination Period|Adverse Event|0
1549799|NCT00092495|5062527|P1|Base Study Vaccination Period|Adverse Event|1
1549800|NCT00092495|5062523|P5|Base Study Vaccination Period|*Pregnancy|0
1549801|NCT00092495|5062524|P4|Base Study Vaccination Period|*Pregnancy|7
1549802|NCT00092495|5062525|P3|Base Study Vaccination Period|*Pregnancy|5
1549803|NCT00092495|5062526|P2|Base Study Vaccination Period|*Pregnancy|2
1549804|NCT00092495|5062527|P1|Base Study Vaccination Period|*Pregnancy|0
1549805|NCT00092495|5062523|P5|Base Study Vaccination Period|*Other reasons|0
1549806|NCT00092495|5062524|P4|Base Study Vaccination Period|*Other reasons|1
1549807|NCT00092495|5062525|P3|Base Study Vaccination Period|*Other reasons|0
1549808|NCT00092495|5062526|P2|Base Study Vaccination Period|*Other reasons|0
1549809|NCT00092495|5062527|P1|Base Study Vaccination Period|*Other reasons|1
1549810|NCT00092495|5062523|P5|Base Study Vaccination Period|*Clinical AE|0
1549811|NCT00092495|5062524|P4|Base Study Vaccination Period|*Clinical AE|2
1549812|NCT00092495|5062525|P3|Base Study Vaccination Period|*Clinical AE|1
1549813|NCT00092495|5062526|P2|Base Study Vaccination Period|*Clinical AE|0
1549814|NCT00092495|5062527|P1|Base Study Vaccination Period|*Clinical AE|1
1549815|NCT00092495|5062523|P5|Base Study Vaccination Period|Extended|0
1549816|NCT00092495|5062524|P4|Base Study Vaccination Period|Extended|1
1549817|NCT00092495|5062525|P3|Base Study Vaccination Period|Extended|0
1549818|NCT00092495|5062526|P2|Base Study Vaccination Period|Extended|0
1549819|NCT00092495|5062527|P1|Base Study Vaccination Period|Extended|0
1549820|NCT00092495|5062523|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
1549821|NCT00092495|5062524|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
1549822|NCT00092495|5062525|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
1549823|NCT00092495|5062526|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
1549824|NCT00092495|5062527|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
1549825|NCT00092456|5062593|P4|Overall Study|Not Specified|0
1549826|NCT00092456|5062594|P3|Overall Study|Not Specified|3
1549827|NCT00092456|5062595|P2|Overall Study|Not Specified|2
1549828|NCT00092456|5062596|P1|Overall Study|Not Specified|4
1549829|NCT00092456|5062593|P4|Overall Study|Moved|1
1549830|NCT00092456|5062594|P3|Overall Study|Moved|0
1549831|NCT00092456|5062595|P2|Overall Study|Moved|1
1549832|NCT00092456|5062596|P1|Overall Study|Moved|1
1549833|NCT00092456|5062593|P4|Overall Study|Withdrawal by Subject|6
1549834|NCT00092456|5062594|P3|Overall Study|Withdrawal by Subject|16
1549835|NCT00092456|5062595|P2|Overall Study|Withdrawal by Subject|5
1549836|NCT00092456|5062596|P1|Overall Study|Withdrawal by Subject|13
1549837|NCT00092456|5062593|P4|Overall Study|Protocol Violation|6
1549838|NCT00092456|5062594|P3|Overall Study|Protocol Violation|8
1549839|NCT00092456|5062595|P2|Overall Study|Protocol Violation|7
1549840|NCT00092456|5062596|P1|Overall Study|Protocol Violation|5
1549841|NCT00092456|5062593|P4|Overall Study|Lost to Follow-up|2
1549842|NCT00092456|5062594|P3|Overall Study|Lost to Follow-up|1
1549843|NCT00092456|5062595|P2|Overall Study|Lost to Follow-up|2
1549844|NCT00092456|5062596|P1|Overall Study|Lost to Follow-up|2
1549845|NCT00092456|5062593|P4|Overall Study|Adverse Event|1
1549846|NCT00092456|5062594|P3|Overall Study|Adverse Event|1
1549847|NCT00092456|5062595|P2|Overall Study|Adverse Event|0
1549848|NCT00092456|5062596|P1|Overall Study|Adverse Event|0
1549849|NCT00092443|5062644|P2|Overall Study|Not Specified|13
1549850|NCT00092443|5062645|P1|Overall Study|Not Specified|17
1549851|NCT00092443|5062644|P2|Overall Study|Moved|5
1549852|NCT00092443|5062645|P1|Overall Study|Moved|5
1549853|NCT00092443|5062644|P2|Overall Study|Withdrawal by Subject|11
1549854|NCT00092443|5062645|P1|Overall Study|Withdrawal by Subject|9
1549855|NCT00092443|5062644|P2|Overall Study|Protocol Violation|9
1549856|NCT00092443|5062645|P1|Overall Study|Protocol Violation|11
1549857|NCT00092443|5062644|P2|Overall Study|Lost to Follow-up|3
1549858|NCT00092443|5062645|P1|Overall Study|Lost to Follow-up|7
1549859|NCT00092443|5062644|P2|Overall Study|Adverse Event|13
1549860|NCT00092443|5062645|P1|Overall Study|Adverse Event|9
1549861|NCT00092417|5062663|P2|Overall Study|Not Specified|0
1549862|NCT00092417|5062664|P1|Overall Study|Not Specified|1
1549863|NCT00092417|5062663|P2|Overall Study|Withdrawal by Subject|1
1549864|NCT00092417|5062664|P1|Overall Study|Withdrawal by Subject|2
1549865|NCT00092417|5062663|P2|Overall Study|Lost to Follow-up|0
1549866|NCT00092417|5062664|P1|Overall Study|Lost to Follow-up|2
1549867|NCT00092131|5062678|P2|Treatment Period II|Adverse Event|1
1549868|NCT00092131|5062679|P1|Treatment Period II|Adverse Event|0
1549869|NCT00092131|5062678|P2|Treatment Period I|Adverse Event|0
1549870|NCT00092131|5062679|P1|Treatment Period I|Adverse Event|1
1549871|NCT00092118|5062709|P2|Overall Study|Not Specified|5
1549872|NCT00092118|5062710|P1|Overall Study|Not Specified|6
1549873|NCT00092118|5062709|P2|Overall Study|Withdrawal by Subject|10
1549874|NCT00092118|5062710|P1|Overall Study|Withdrawal by Subject|4
1549875|NCT00092118|5062709|P2|Overall Study|Protocol Violation|25
1549876|NCT00092118|5062710|P1|Overall Study|Protocol Violation|23
1549877|NCT00092118|5062709|P2|Overall Study|Lost to Follow-up|3
1549878|NCT00092118|5062710|P1|Overall Study|Lost to Follow-up|4
1549879|NCT00092118|5062709|P2|Overall Study|Lack of Efficacy|14
1549880|NCT00092118|5062710|P1|Overall Study|Lack of Efficacy|12
1549881|NCT00092118|5062709|P2|Overall Study|Adverse Event|32
1549882|NCT00092118|5062710|P1|Overall Study|Adverse Event|35
1549883|NCT00091949|5062744|P2|Overall Study|Lost to Follow-up|41
1549884|NCT00091949|5062745|P1|Overall Study|Lost to Follow-up|58
1549885|NCT00091949|5062744|P2|Overall Study|Withdrawal by Subject|110
1549886|NCT00091949|5062745|P1|Overall Study|Withdrawal by Subject|117
1549887|NCT00091832|5062769|P6|Overall Study|Protocol Violation|1
1549888|NCT00091832|5062770|P5|Overall Study|Protocol Violation|0
1549889|NCT00091832|5062771|P4|Overall Study|Protocol Violation|0
1549890|NCT00091832|5062772|P3|Overall Study|Protocol Violation|1
1549891|NCT00091832|5062773|P2|Overall Study|Protocol Violation|0
1549892|NCT00091832|5062774|P1|Overall Study|Protocol Violation|0
1549893|NCT00091832|5062769|P6|Overall Study|Other|0
1549894|NCT00091832|5062770|P5|Overall Study|Other|0
1549895|NCT00091832|5062771|P4|Overall Study|Other|0
1549896|NCT00091832|5062772|P3|Overall Study|Other|2
1549897|NCT00091832|5062773|P2|Overall Study|Other|1
1549898|NCT00091832|5062774|P1|Overall Study|Other|0
1549899|NCT00091832|5062769|P6|Overall Study|Noncompliance|0
1549900|NCT00091832|5062770|P5|Overall Study|Noncompliance|0
1549901|NCT00091832|5062771|P4|Overall Study|Noncompliance|0
1549902|NCT00091832|5062772|P3|Overall Study|Noncompliance|0
1549903|NCT00091832|5062773|P2|Overall Study|Noncompliance|1
1549904|NCT00091832|5062774|P1|Overall Study|Noncompliance|0
1549905|NCT00091832|5062769|P6|Overall Study|Lost to Follow-up|1
1549906|NCT00091832|5062770|P5|Overall Study|Lost to Follow-up|2
1549907|NCT00091832|5062771|P4|Overall Study|Lost to Follow-up|3
1549908|NCT00091832|5062772|P3|Overall Study|Lost to Follow-up|3
1549909|NCT00091832|5062773|P2|Overall Study|Lost to Follow-up|0
1549910|NCT00091832|5062774|P1|Overall Study|Lost to Follow-up|1
1549911|NCT00091832|5062769|P6|Overall Study|Ineligibility Determined|0
1549912|NCT00091832|5062770|P5|Overall Study|Ineligibility Determined|1
1549913|NCT00091832|5062771|P4|Overall Study|Ineligibility Determined|0
1549914|NCT00091832|5062772|P3|Overall Study|Ineligibility Determined|1
1549915|NCT00091832|5062773|P2|Overall Study|Ineligibility Determined|0
1549916|NCT00091832|5062774|P1|Overall Study|Ineligibility Determined|0
1549917|NCT00091832|5062769|P6|Overall Study|Disease Progression|2
1549918|NCT00091832|5062770|P5|Overall Study|Disease Progression|1
1549919|NCT00091832|5062771|P4|Overall Study|Disease Progression|1
1549920|NCT00091832|5062772|P3|Overall Study|Disease Progression|0
1549921|NCT00091832|5062773|P2|Overall Study|Disease Progression|0
1549922|NCT00091832|5062774|P1|Overall Study|Disease Progression|2
1549923|NCT00091832|5062769|P6|Overall Study|Death|6
1549924|NCT00091832|5062770|P5|Overall Study|Death|5
1549925|NCT00091832|5062771|P4|Overall Study|Death|8
1549926|NCT00091832|5062772|P3|Overall Study|Death|5
1549927|NCT00091832|5062773|P2|Overall Study|Death|4
1549928|NCT00091832|5062774|P1|Overall Study|Death|6
1549929|NCT00091832|5062769|P6|Overall Study|Withdrawal by Subject|1
1549930|NCT00091832|5062770|P5|Overall Study|Withdrawal by Subject|3
1549931|NCT00091832|5062771|P4|Overall Study|Withdrawal by Subject|1
1549932|NCT00091832|5062772|P3|Overall Study|Withdrawal by Subject|0
1549933|NCT00091832|5062773|P2|Overall Study|Withdrawal by Subject|5
1549934|NCT00091832|5062774|P1|Overall Study|Withdrawal by Subject|4
1549935|NCT00091832|5062769|P6|Overall Study|Adverse Event|0
1549936|NCT00091832|5062770|P5|Overall Study|Adverse Event|3
1549937|NCT00091832|5062771|P4|Overall Study|Adverse Event|1
1549938|NCT00091832|5062772|P3|Overall Study|Adverse Event|0
1549939|NCT00091832|5062773|P2|Overall Study|Adverse Event|0
1549940|NCT00091832|5062774|P1|Overall Study|Adverse Event|0
1549941|NCT00091832|5062769|P6|Overall Study|Physician Decision|0
1549942|NCT00091832|5062770|P5|Overall Study|Physician Decision|0
1549943|NCT00091832|5062771|P4|Overall Study|Physician Decision|0
1549944|NCT00091832|5062772|P3|Overall Study|Physician Decision|0
1549945|NCT00091832|5062773|P2|Overall Study|Physician Decision|0
1549946|NCT00091832|5062774|P1|Overall Study|Physician Decision|1
1549947|NCT00091819|5062892|P2|Overall Study|Never received study treatment|4
1549948|NCT00091819|5062893|P1|Overall Study|Never received study treatment|3
1549949|NCT00091819|5062892|P2|Overall Study|Other|3
1549950|NCT00091819|5062893|P1|Overall Study|Other|2
1549951|NCT00091819|5062892|P2|Overall Study|Protocol Violation|2
1549952|NCT00091819|5062893|P1|Overall Study|Protocol Violation|1
1549953|NCT00091819|5062892|P2|Overall Study|Withdrawal by Subject|8
1549954|NCT00091819|5062893|P1|Overall Study|Withdrawal by Subject|5
1549955|NCT00091819|5062892|P2|Overall Study|Lost to Follow-up|23
1549956|NCT00091819|5062893|P1|Overall Study|Lost to Follow-up|26
1549957|NCT00091819|5062892|P2|Overall Study|Death|5
1549958|NCT00091819|5062893|P1|Overall Study|Death|4
1549959|NCT00091819|5062892|P2|Overall Study|Adverse Event|1
1549960|NCT00091819|5062893|P1|Overall Study|Adverse Event|1
1549961|NCT00091793|5062901|P2|Overall Study|Other|0
1549962|NCT00091793|5062902|P1|Overall Study|Other|2
1549963|NCT00091793|5062901|P2|Overall Study|Noncompliance|0
1549964|NCT00091793|5062902|P1|Overall Study|Noncompliance|2
1549965|NCT00091793|5062901|P2|Overall Study|Lost to Follow-up|5
1549966|NCT00091793|5062902|P1|Overall Study|Lost to Follow-up|7
1549967|NCT00091793|5062901|P2|Overall Study|Ineligibility determined|0
1549968|NCT00091793|5062902|P1|Overall Study|Ineligibility determined|2
1549969|NCT00091793|5062901|P2|Overall Study|Withdrawal by Subject|15
1549970|NCT00091793|5062902|P1|Overall Study|Withdrawal by Subject|10
1549971|NCT00091793|5062901|P2|Overall Study|Adverse Event|2
1549972|NCT00091793|5062902|P1|Overall Study|Adverse Event|1
1549973|NCT00091572|5062926|P2|Overall Study|Toxicity (Related AE)|9
1549974|NCT00091572|5062927|P1|Overall Study|Toxicity (Related AE)|53
1549975|NCT00091572|5062926|P2|Overall Study|Major Protocol Violation|0
1549976|NCT00091572|5062927|P1|Overall Study|Major Protocol Violation|2
1549977|NCT00091572|5062926|P2|Overall Study|Ongoing (still on treatment)|12
1549978|NCT00091572|5062927|P1|Overall Study|Ongoing (still on treatment)|8
1549979|NCT00091572|5062926|P2|Overall Study|Other Reason|13
1549980|NCT00091572|5062927|P1|Overall Study|Other Reason|6
1549981|NCT00091572|5062926|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
1549982|NCT00091572|5062927|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
1549983|NCT00091572|5062926|P2|Overall Study|Death not due to malignancy/toxicity|3
1549984|NCT00091572|5062927|P1|Overall Study|Death not due to malignancy/toxicity|1
1549985|NCT00091572|5062926|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
1549986|NCT00091572|5062927|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
1549987|NCT00091572|5062926|P2|Overall Study|Lost to Follow-up|1
1549988|NCT00091572|5062927|P1|Overall Study|Lost to Follow-up|1
1549989|NCT00091442|5062958|P2|Overall Study|Not Specified|6
1549990|NCT00091442|5062959|P1|Overall Study|Not Specified|2
1549991|NCT00091442|5062958|P2|Overall Study|Lost to Follow-up|3
1549992|NCT00091442|5062959|P1|Overall Study|Lost to Follow-up|1
1549993|NCT00091442|5062958|P2|Overall Study|Death|7
1549994|NCT00091442|5062959|P1|Overall Study|Death|9
1549995|NCT00091442|5062958|P2|Overall Study|2cycles therapy beyond Complete response|16
1549996|NCT00091442|5062959|P1|Overall Study|2cycles therapy beyond Complete response|9
1549997|NCT00091442|5062958|P2|Overall Study|Adverse Event|48
1549998|NCT00091442|5062959|P1|Overall Study|Adverse Event|29
1549999|NCT00091442|5062958|P2|Overall Study|Withdrawal by Subject|46
1550000|NCT00091442|5062959|P1|Overall Study|Withdrawal by Subject|38
1550001|NCT00091442|5062958|P2|Overall Study|Physician Decision|58
1550002|NCT00091442|5062959|P1|Overall Study|Physician Decision|61
1550003|NCT00091442|5062958|P2|Overall Study|Progressive Disease|189
1550004|NCT00091442|5062959|P1|Overall Study|Progressive Disease|220
1550005|NCT00091390|5062969|P1|Overall Study|Protocol Violation|2
1550006|NCT00091390|5062969|P1|Overall Study|Withdrawal by Subject|2
1550007|NCT00091169|5062987|P2|Overall Study|Not start protocol therapy|17
1550008|NCT00091169|5062988|P1|Overall Study|Not start protocol therapy|26
1550009|NCT00091169|5062987|P2|Overall Study|Other|4
1550010|NCT00091169|5062988|P1|Overall Study|Other|3
1550011|NCT00091169|5062987|P2|Overall Study|Withdrawal by Subject|13
1550012|NCT00091169|5062988|P1|Overall Study|Withdrawal by Subject|10
1550013|NCT00091169|5062987|P2|Overall Study|Death|1
1550014|NCT00091169|5062988|P1|Overall Study|Death|4
1550015|NCT00091169|5062987|P2|Overall Study|Adverse Event|17
1550016|NCT00091169|5062988|P1|Overall Study|Adverse Event|11
1550017|NCT00091169|5062987|P2|Overall Study|Disease progression|1
1550018|NCT00091169|5062988|P1|Overall Study|Disease progression|3
1550019|NCT00091026|5063006|P2|Overall Study|Unknown-never received treatment|1
1550020|NCT00091026|5063007|P1|Overall Study|Unknown-never received treatment|0
1550021|NCT00091026|5063006|P2|Overall Study|Patient withdrew and never received trea|2
1550022|NCT00091026|5063007|P1|Overall Study|Patient withdrew and never received trea|0
1550023|NCT00091026|5063006|P2|Overall Study|Patient deemed non eligible-never receiv|0
1550024|NCT00091026|5063007|P1|Overall Study|Patient deemed non eligible-never receiv|1
1550025|NCT00090987|5063017|P1|Overall Study|Incarcerated|1
1550026|NCT00090987|5063017|P1|Overall Study|Non-compliance|4
1550027|NCT00090987|5063017|P1|Overall Study|alternative therapy|1
1550028|NCT00090987|5063017|P1|Overall Study|Withdrawal by Subject|3
1550029|NCT00090987|5063017|P1|Overall Study|Lack of Efficacy|7
1550030|NCT00090987|5063017|P1|Overall Study|Adverse Event|5
1550031|NCT00090857|5063030|P2|Overall Study|Adverse Event|2
1550032|NCT00090857|5063031|P1|Overall Study|Adverse Event|2
1550033|NCT00090857|5063030|P2|Overall Study|Withdrawal by Subject|0
1550034|NCT00090857|5063031|P1|Overall Study|Withdrawal by Subject|2
1550035|NCT00090857|5063030|P2|Overall Study|Lost to Follow-up|1
1550036|NCT00090857|5063031|P1|Overall Study|Lost to Follow-up|0
1550037|NCT00090779|5063070|P2|Step 3|Off extended study due to study closure|3
1550038|NCT00090779|5063071|P1|Step 3|Off extended study due to study closure|4
1550039|NCT00090779|5063070|P2|Step 3|Initiation of ART and off extended study|2
1550040|NCT00090779|5063071|P1|Step 3|Initiation of ART and off extended study|3
1550041|NCT00090779|5063070|P2|Step 2|Non-compliance to study requirements|1
1550042|NCT00090779|5063071|P1|Step 2|Non-compliance to study requirements|0
1550043|NCT00090779|5063070|P2|Step 2|Subject relocated|1
1550044|NCT00090779|5063071|P1|Step 2|Subject relocated|0
1550045|NCT00090779|5063070|P2|Step 2|Off study per study closure|16
1550046|NCT00090779|5063071|P1|Step 2|Off study per study closure|6
1550047|NCT00090779|5063070|P2|Step 1|Subject relocated|8
1550048|NCT00090779|5063071|P1|Step 1|Subject relocated|2
1550049|NCT00090779|5063070|P2|Step 1|Non-compliance to study requirements|1
1550050|NCT00090779|5063071|P1|Step 1|Non-compliance to study requirements|0
1550051|NCT00090779|5063070|P2|Step 1|Pregnancy|0
1550052|NCT00090779|5063071|P1|Step 1|Pregnancy|1
1550053|NCT00090779|5063070|P2|Step 1|Physician Decision|0
1550054|NCT00090779|5063071|P1|Step 1|Physician Decision|1
1550055|NCT00090779|5063070|P2|Step 1|Death|2
1550056|NCT00090779|5063071|P1|Step 1|Death|0
1550057|NCT00090779|5063070|P2|Step 1|Lost to Follow-up|2
1550058|NCT00090779|5063071|P1|Step 1|Lost to Follow-up|3
1550059|NCT00090779|5063070|P2|Step 1|Withdrawal by Subject|2
1550060|NCT00090779|5063071|P1|Step 1|Withdrawal by Subject|4
1550061|NCT00090766|5063095|P3|Overall Study|Lost to Follow-up|2
1550062|NCT00090766|5063096|P2|Overall Study|Lost to Follow-up|0
1550063|NCT00090766|5063097|P1|Overall Study|Lost to Follow-up|2
1550064|NCT00090766|5063095|P3|Overall Study|Admin|0
1550065|NCT00090766|5063096|P2|Overall Study|Admin|2
1550066|NCT00090766|5063097|P1|Overall Study|Admin|0
1550067|NCT00090766|5063095|P3|Overall Study|Death|0
1550068|NCT00090766|5063096|P2|Overall Study|Death|0
1550069|NCT00090766|5063097|P1|Overall Study|Death|1
1550070|NCT00090766|5063095|P3|Overall Study|Nephrectomy Planned|1
1550071|NCT00090766|5063096|P2|Overall Study|Nephrectomy Planned|0
1550072|NCT00090766|5063097|P1|Overall Study|Nephrectomy Planned|0
1550073|NCT00090753|5063139|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
1550074|NCT00090753|5063140|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
1550075|NCT00090753|5063139|P2|Extended Treatment Period|Mircera Commercialization|93
1550076|NCT00090753|5063140|P1|Extended Treatment Period|Mircera Commercialization|188
1550077|NCT00090753|5063139|P2|Extended Treatment Period|Renal Transplant|12
1550078|NCT00090753|5063140|P1|Extended Treatment Period|Renal Transplant|15
1550079|NCT00090753|5063139|P2|Extended Treatment Period|Lost to Follow-up|1
1550080|NCT00090753|5063140|P1|Extended Treatment Period|Lost to Follow-up|3
1550081|NCT00090753|5063139|P2|Extended Treatment Period|Refused Treatment|12
1550082|NCT00090753|5063140|P1|Extended Treatment Period|Refused Treatment|18
1550083|NCT00090753|5063139|P2|Extended Treatment Period|Lack of Efficacy|0
1550084|NCT00090753|5063140|P1|Extended Treatment Period|Lack of Efficacy|1
1550085|NCT00090753|5063139|P2|Extended Treatment Period|Death|30
1550086|NCT00090753|5063140|P1|Extended Treatment Period|Death|58
1550087|NCT00090753|5063139|P2|Extended Treatment Period|Adverse Event|0
1550088|NCT00090753|5063140|P1|Extended Treatment Period|Adverse Event|11
1550089|NCT00090753|5063139|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
1550090|NCT00090753|5063140|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
1550091|NCT00090753|5063139|P2|First Treatment Period|Mircera Commercialization|0
1550092|NCT00090753|5063140|P1|First Treatment Period|Mircera Commercialization|1
1550093|NCT00090753|5063139|P2|First Treatment Period|Renal Transplant|50
1550094|NCT00090753|5063140|P1|First Treatment Period|Renal Transplant|70
1550095|NCT00090753|5063139|P2|First Treatment Period|Lost to Follow-up|4
1550096|NCT00090753|5063140|P1|First Treatment Period|Lost to Follow-up|4
1550097|NCT00090753|5063139|P2|First Treatment Period|Refused Treatment|25
1550098|NCT00090753|5063140|P1|First Treatment Period|Refused Treatment|32
1550099|NCT00090753|5063139|P2|First Treatment Period|Lack of Efficacy|1
1550100|NCT00090753|5063140|P1|First Treatment Period|Lack of Efficacy|2
1550101|NCT00090753|5063139|P2|First Treatment Period|Death|62
1550102|NCT00090753|5063140|P1|First Treatment Period|Death|88
1550103|NCT00090753|5063139|P2|First Treatment Period|Adverse Event|8
1550104|NCT00090753|5063140|P1|First Treatment Period|Adverse Event|20
1550105|NCT00090610|5063150|P2|Overall Study|Withdrawal by Subject|1
1550106|NCT00090610|5063151|P1|Overall Study|Withdrawal by Subject|1
1550107|NCT00090584|5063167|P2|Baseline to 8 Months|Lost to Follow-up|41
1550108|NCT00090584|5063168|P1|Baseline to 8 Months|Lost to Follow-up|44
1550109|NCT00090584|5063167|P2|Baseline to 10 Weeks|Lost to Follow-up|12
1550110|NCT00090584|5063168|P1|Baseline to 10 Weeks|Lost to Follow-up|15
1550111|NCT00090519|5063200|P2|Overall Study|Sponsor Decision|1
1550112|NCT00090519|5063201|P1|Overall Study|Sponsor Decision|3
1550113|NCT00090519|5063200|P2|Overall Study|Physician Decision|3
1550114|NCT00090519|5063201|P1|Overall Study|Physician Decision|2
1550115|NCT00090519|5063200|P2|Overall Study|Withdrawal by Subject|29
1550116|NCT00090519|5063201|P1|Overall Study|Withdrawal by Subject|28
1550117|NCT00090519|5063200|P2|Overall Study|Lost to Follow-up|29
1550118|NCT00090519|5063201|P1|Overall Study|Lost to Follow-up|26
1550119|NCT00090519|5063200|P2|Overall Study|Death|9
1550120|NCT00090519|5063201|P1|Overall Study|Death|9
1550121|NCT00090519|5063200|P2|Overall Study|Adverse Event|4
1550122|NCT00090519|5063201|P1|Overall Study|Adverse Event|5
1550123|NCT00090493|5063225|P1|Overall Study|Physician Decision|2
1550124|NCT00090363|5063232|P3|Overall Study|Continuing on study off treatment|16
1550125|NCT00090363|5063233|P2|Overall Study|Continuing on study off treatment|13
1550126|NCT00090363|5063234|P1|Overall Study|Continuing on study off treatment|14
1550127|NCT00090363|5063232|P3|Overall Study|Reasons not specified|1
1550128|NCT00090363|5063233|P2|Overall Study|Reasons not specified|1
1550129|NCT00090363|5063234|P1|Overall Study|Reasons not specified|2
1550130|NCT00090363|5063232|P3|Overall Study|Consent expired|9
1550131|NCT00090363|5063233|P2|Overall Study|Consent expired|10
1550132|NCT00090363|5063234|P1|Overall Study|Consent expired|7
1550133|NCT00090363|5063232|P3|Overall Study|Eligibility criteria not fulfilled|1
1550134|NCT00090363|5063233|P2|Overall Study|Eligibility criteria not fulfilled|0
1550135|NCT00090363|5063234|P1|Overall Study|Eligibility criteria not fulfilled|0
1550136|NCT00090363|5063232|P3|Overall Study|Study-specific discontinuation criteria|62
1550137|NCT00090363|5063233|P2|Overall Study|Study-specific discontinuation criteria|74
1550138|NCT00090363|5063234|P1|Overall Study|Study-specific discontinuation criteria|75
1550139|NCT00090363|5063232|P3|Overall Study|Withdrawal by Subject|6
1550140|NCT00090363|5063233|P2|Overall Study|Withdrawal by Subject|7
1550141|NCT00090363|5063234|P1|Overall Study|Withdrawal by Subject|7
1550142|NCT00090363|5063232|P3|Overall Study|Lost to Follow-up|1
1550143|NCT00090363|5063233|P2|Overall Study|Lost to Follow-up|2
1550144|NCT00090363|5063234|P1|Overall Study|Lost to Follow-up|1
1550145|NCT00090545|5063256|P2|Overall Study|Adverse Event|2
1550146|NCT00090545|5063257|P1|Overall Study|Adverse Event|0
1550147|NCT00090545|5063256|P2|Overall Study|Death|1
1550148|NCT00090545|5063257|P1|Overall Study|Death|0
1550149|NCT00090545|5063256|P2|Overall Study|Refused further treatment|4
1550150|NCT00090545|5063257|P1|Overall Study|Refused further treatment|1
1550151|NCT00090545|5063256|P2|Overall Study|Disease progression on study|17
1550152|NCT00090545|5063257|P1|Overall Study|Disease progression on study|21
1550153|NCT00090285|5063277|P6|Long-term Follow-up (EXT2)|Physician Decision|5
1550154|NCT00090285|5063278|P5|Long-term Follow-up (EXT2)|Physician Decision|6
1550155|NCT00090285|5063279|P4|Long-term Follow-up (EXT2)|Physician Decision|0
1550156|NCT00090285|5063280|P3|Long-term Follow-up (EXT2)|Physician Decision|0
1550157|NCT00090285|5063281|P2|Long-term Follow-up (EXT2)|Physician Decision|0
1550158|NCT00090285|5063282|P1|Long-term Follow-up (EXT2)|Physician Decision|0
1550159|NCT00090285|5063277|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
1550160|NCT00090285|5063278|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
1550161|NCT00090285|5063279|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1550162|NCT00090285|5063280|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1550163|NCT00090285|5063281|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1550164|NCT00090285|5063282|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1550165|NCT00090285|5063277|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|143
1550166|NCT00090285|5063278|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|156
1550167|NCT00090285|5063279|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1550168|NCT00090285|5063280|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1550169|NCT00090285|5063281|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1550170|NCT00090285|5063282|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1550171|NCT00090285|5063277|P6|Long-term Follow-up (EXT2)|Adverse Event|2
1550172|NCT00090285|5063278|P5|Long-term Follow-up (EXT2)|Adverse Event|5
1550173|NCT00090285|5063279|P4|Long-term Follow-up (EXT2)|Adverse Event|0
1550174|NCT00090285|5063280|P3|Long-term Follow-up (EXT2)|Adverse Event|0
1550175|NCT00090285|5063281|P2|Long-term Follow-up (EXT2)|Adverse Event|0
1550176|NCT00090285|5063282|P1|Long-term Follow-up (EXT2)|Adverse Event|0
1550177|NCT00090285|5063277|P6|Extension 1|Moved|0
1550178|NCT00090285|5063278|P5|Extension 1|Moved|0
1550179|NCT00090285|5063279|P4|Extension 1|Moved|0
1550180|NCT00090285|5063280|P3|Extension 1|Moved|3
1550181|NCT00090285|5063281|P2|Extension 1|Moved|0
1550182|NCT00090285|5063282|P1|Extension 1|Moved|0
1550183|NCT00090285|5063277|P6|Extension 1|Other|0
1550184|NCT00090285|5063278|P5|Extension 1|Other|0
1550185|NCT00090285|5063279|P4|Extension 1|Other|0
1550186|NCT00090285|5063280|P3|Extension 1|Other|4
1550187|NCT00090285|5063281|P2|Extension 1|Other|0
1550188|NCT00090285|5063282|P1|Extension 1|Other|0
1550189|NCT00090285|5063277|P6|Extension 1|Withdrawal by Subject|0
1550190|NCT00090285|5063278|P5|Extension 1|Withdrawal by Subject|0
1550191|NCT00090285|5063279|P4|Extension 1|Withdrawal by Subject|1
1550192|NCT00090285|5063280|P3|Extension 1|Withdrawal by Subject|13
1550193|NCT00090285|5063281|P2|Extension 1|Withdrawal by Subject|0
1550194|NCT00090285|5063282|P1|Extension 1|Withdrawal by Subject|0
1550195|NCT00090285|5063277|P6|Extension 1|Lost to Follow-up|0
1550196|NCT00090285|5063278|P5|Extension 1|Lost to Follow-up|0
1550197|NCT00090285|5063279|P4|Extension 1|Lost to Follow-up|0
1550198|NCT00090285|5063280|P3|Extension 1|Lost to Follow-up|35
1550199|NCT00090285|5063281|P2|Extension 1|Lost to Follow-up|0
1550200|NCT00090285|5063282|P1|Extension 1|Lost to Follow-up|0
1550201|NCT00090285|5063277|P6|Extension 1|Adverse Event|0
1550202|NCT00090285|5063278|P5|Extension 1|Adverse Event|0
1550203|NCT00090285|5063279|P4|Extension 1|Adverse Event|0
1550204|NCT00090285|5063280|P3|Extension 1|Adverse Event|2
1550205|NCT00090285|5063281|P2|Extension 1|Adverse Event|0
1550206|NCT00090285|5063282|P1|Extension 1|Adverse Event|0
1550207|NCT00090285|5063277|P6|Base Study Follow-up Period|Subject Incarcerated|0
1550208|NCT00090285|5063278|P5|Base Study Follow-up Period|Subject Incarcerated|0
1550209|NCT00090285|5063279|P4|Base Study Follow-up Period|Subject Incarcerated|0
1550210|NCT00090285|5063280|P3|Base Study Follow-up Period|Subject Incarcerated|0
1550211|NCT00090285|5063281|P2|Base Study Follow-up Period|Subject Incarcerated|2
1550212|NCT00090285|5063282|P1|Base Study Follow-up Period|Subject Incarcerated|0
1550213|NCT00090285|5063277|P6|Base Study Follow-up Period|Uncooperative|0
1550214|NCT00090285|5063278|P5|Base Study Follow-up Period|Uncooperative|0
1550215|NCT00090285|5063279|P4|Base Study Follow-up Period|Uncooperative|0
1550216|NCT00090285|5063280|P3|Base Study Follow-up Period|Uncooperative|0
1550217|NCT00090285|5063281|P2|Base Study Follow-up Period|Uncooperative|4
1550218|NCT00090285|5063282|P1|Base Study Follow-up Period|Uncooperative|3
1550219|NCT00090285|5063277|P6|Base Study Follow-up Period|Protocol Violation|0
1550220|NCT00090285|5063278|P5|Base Study Follow-up Period|Protocol Violation|0
1550221|NCT00090285|5063279|P4|Base Study Follow-up Period|Protocol Violation|0
1550222|NCT00090285|5063280|P3|Base Study Follow-up Period|Protocol Violation|0
1550223|NCT00090285|5063281|P2|Base Study Follow-up Period|Protocol Violation|0
1550224|NCT00090285|5063282|P1|Base Study Follow-up Period|Protocol Violation|1
1550225|NCT00090285|5063277|P6|Base Study Follow-up Period|Other|0
1550226|NCT00090285|5063278|P5|Base Study Follow-up Period|Other|0
1550227|NCT00090285|5063279|P4|Base Study Follow-up Period|Other|0
1550228|NCT00090285|5063280|P3|Base Study Follow-up Period|Other|0
1550229|NCT00090285|5063281|P2|Base Study Follow-up Period|Other|0
1550230|NCT00090285|5063282|P1|Base Study Follow-up Period|Other|2
1550231|NCT00090285|5063277|P6|Base Study Follow-up Period|Moved|0
1550232|NCT00090285|5063278|P5|Base Study Follow-up Period|Moved|0
1550233|NCT00090285|5063279|P4|Base Study Follow-up Period|Moved|0
1550234|NCT00090285|5063280|P3|Base Study Follow-up Period|Moved|0
1550235|NCT00090285|5063281|P2|Base Study Follow-up Period|Moved|36
1550236|NCT00090285|5063282|P1|Base Study Follow-up Period|Moved|41
1550237|NCT00090285|5063277|P6|Base Study Follow-up Period|Withdrawal by Subject|0
1550238|NCT00090285|5063278|P5|Base Study Follow-up Period|Withdrawal by Subject|0
1550239|NCT00090285|5063279|P4|Base Study Follow-up Period|Withdrawal by Subject|0
1550240|NCT00090285|5063280|P3|Base Study Follow-up Period|Withdrawal by Subject|0
1550241|NCT00090285|5063281|P2|Base Study Follow-up Period|Withdrawal by Subject|64
1550242|NCT00090285|5063282|P1|Base Study Follow-up Period|Withdrawal by Subject|53
1550243|NCT00090285|5063277|P6|Base Study Follow-up Period|Lost to Follow-up|0
1550244|NCT00090285|5063278|P5|Base Study Follow-up Period|Lost to Follow-up|0
1550245|NCT00090285|5063279|P4|Base Study Follow-up Period|Lost to Follow-up|0
1550246|NCT00090285|5063280|P3|Base Study Follow-up Period|Lost to Follow-up|0
1550247|NCT00090285|5063281|P2|Base Study Follow-up Period|Lost to Follow-up|226
1550248|NCT00090285|5063282|P1|Base Study Follow-up Period|Lost to Follow-up|232
1550249|NCT00090285|5063277|P6|Base Study Follow-up Period|Adverse Event|0
1550250|NCT00090285|5063278|P5|Base Study Follow-up Period|Adverse Event|0
1550251|NCT00090285|5063279|P4|Base Study Follow-up Period|Adverse Event|0
1550252|NCT00090285|5063280|P3|Base Study Follow-up Period|Adverse Event|0
1550253|NCT00090285|5063281|P2|Base Study Follow-up Period|Adverse Event|10
1550254|NCT00090285|5063282|P1|Base Study Follow-up Period|Adverse Event|3
1550255|NCT00090285|5063277|P6|Base Study Vaccination Period|HIV positive|0
1550256|NCT00090285|5063278|P5|Base Study Vaccination Period|HIV positive|0
1550257|NCT00090285|5063279|P4|Base Study Vaccination Period|HIV positive|0
1550258|NCT00090285|5063280|P3|Base Study Vaccination Period|HIV positive|0
1550259|NCT00090285|5063281|P2|Base Study Vaccination Period|HIV positive|1
1550260|NCT00090285|5063282|P1|Base Study Vaccination Period|HIV positive|1
1550261|NCT00090285|5063277|P6|Base Study Vaccination Period|Subject Incarcerated|0
1550262|NCT00090285|5063278|P5|Base Study Vaccination Period|Subject Incarcerated|0
1550263|NCT00090285|5063279|P4|Base Study Vaccination Period|Subject Incarcerated|0
1550264|NCT00090285|5063280|P3|Base Study Vaccination Period|Subject Incarcerated|0
1550265|NCT00090285|5063281|P2|Base Study Vaccination Period|Subject Incarcerated|2
1550266|NCT00090285|5063282|P1|Base Study Vaccination Period|Subject Incarcerated|2
1550267|NCT00090285|5063277|P6|Base Study Vaccination Period|Other|0
1550268|NCT00090285|5063278|P5|Base Study Vaccination Period|Other|0
1550269|NCT00090285|5063279|P4|Base Study Vaccination Period|Other|0
1550270|NCT00090285|5063280|P3|Base Study Vaccination Period|Other|0
1550271|NCT00090285|5063281|P2|Base Study Vaccination Period|Other|2
1550272|NCT00090285|5063282|P1|Base Study Vaccination Period|Other|2
1550273|NCT00090285|5063277|P6|Base Study Vaccination Period|Site Terminated|0
1550274|NCT00090285|5063278|P5|Base Study Vaccination Period|Site Terminated|0
1550275|NCT00090285|5063279|P4|Base Study Vaccination Period|Site Terminated|0
1550276|NCT00090285|5063280|P3|Base Study Vaccination Period|Site Terminated|0
1550277|NCT00090285|5063281|P2|Base Study Vaccination Period|Site Terminated|0
1550278|NCT00090285|5063282|P1|Base Study Vaccination Period|Site Terminated|1
1550279|NCT00090285|5063277|P6|Base Study Vaccination Period|Moved|0
1550280|NCT00090285|5063278|P5|Base Study Vaccination Period|Moved|0
1550281|NCT00090285|5063279|P4|Base Study Vaccination Period|Moved|0
1550282|NCT00090285|5063280|P3|Base Study Vaccination Period|Moved|0
1550283|NCT00090285|5063281|P2|Base Study Vaccination Period|Moved|21
1550284|NCT00090285|5063282|P1|Base Study Vaccination Period|Moved|20
1550285|NCT00090285|5063277|P6|Base Study Vaccination Period|Uncooperative|0
1550286|NCT00090285|5063278|P5|Base Study Vaccination Period|Uncooperative|0
1550287|NCT00090285|5063279|P4|Base Study Vaccination Period|Uncooperative|0
1550288|NCT00090285|5063280|P3|Base Study Vaccination Period|Uncooperative|0
1550289|NCT00090285|5063281|P2|Base Study Vaccination Period|Uncooperative|2
1550290|NCT00090285|5063282|P1|Base Study Vaccination Period|Uncooperative|2
1550291|NCT00090285|5063277|P6|Base Study Vaccination Period|Withdrawal by Subject|0
1550292|NCT00090285|5063278|P5|Base Study Vaccination Period|Withdrawal by Subject|0
1550293|NCT00090285|5063279|P4|Base Study Vaccination Period|Withdrawal by Subject|0
1550294|NCT00090285|5063280|P3|Base Study Vaccination Period|Withdrawal by Subject|0
1550295|NCT00090285|5063281|P2|Base Study Vaccination Period|Withdrawal by Subject|69
1550296|NCT00090285|5063282|P1|Base Study Vaccination Period|Withdrawal by Subject|64
1550297|NCT00090285|5063277|P6|Base Study Vaccination Period|Protocol Violation|0
1550298|NCT00090285|5063278|P5|Base Study Vaccination Period|Protocol Violation|0
1550299|NCT00090285|5063279|P4|Base Study Vaccination Period|Protocol Violation|0
1550300|NCT00090285|5063280|P3|Base Study Vaccination Period|Protocol Violation|0
1550301|NCT00090285|5063281|P2|Base Study Vaccination Period|Protocol Violation|3
1550302|NCT00090285|5063282|P1|Base Study Vaccination Period|Protocol Violation|2
1550303|NCT00090285|5063277|P6|Base Study Vaccination Period|Lost to Follow-up|0
1550304|NCT00090285|5063278|P5|Base Study Vaccination Period|Lost to Follow-up|0
1550305|NCT00090285|5063279|P4|Base Study Vaccination Period|Lost to Follow-up|0
1550306|NCT00090285|5063280|P3|Base Study Vaccination Period|Lost to Follow-up|0
1550307|NCT00090285|5063281|P2|Base Study Vaccination Period|Lost to Follow-up|112
1550308|NCT00090285|5063282|P1|Base Study Vaccination Period|Lost to Follow-up|111
1550309|NCT00090285|5063277|P6|Base Study Vaccination Period|Adverse Event|0
1550310|NCT00090285|5063278|P5|Base Study Vaccination Period|Adverse Event|0
1550311|NCT00090285|5063279|P4|Base Study Vaccination Period|Adverse Event|0
1550312|NCT00090285|5063280|P3|Base Study Vaccination Period|Adverse Event|0
1550313|NCT00090285|5063281|P2|Base Study Vaccination Period|Adverse Event|4
1550314|NCT00090285|5063282|P1|Base Study Vaccination Period|Adverse Event|2
1550315|NCT00090285|5063277|P6|Base Study Vaccination Period|Randomized Not Vaccinated|0
1550316|NCT00090285|5063278|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
1550317|NCT00090285|5063279|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
1550318|NCT00090285|5063280|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
1550319|NCT00090285|5063281|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
1550320|NCT00090285|5063282|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
1550321|NCT00090259|5063319|P2|Overall Study|Investigator site closed|7
1550322|NCT00090259|5063320|P1|Overall Study|Investigator site closed|11
1550323|NCT00090259|5063319|P2|Overall Study|Withdrawal by Subject|15
1550324|NCT00090259|5063320|P1|Overall Study|Withdrawal by Subject|21
1550325|NCT00090259|5063319|P2|Overall Study|Lost to Follow-up|26
1550326|NCT00090259|5063320|P1|Overall Study|Lost to Follow-up|30
1550327|NCT00090233|5063336|P2|Overall Study|Data not available at data cut-off point|1563
1550328|NCT00090233|5063337|P1|Overall Study|Data not available at data cut-off point|1552
1550329|NCT00090233|5063336|P2|Overall Study|Not Specified|1160
1550330|NCT00090233|5063337|P1|Overall Study|Not Specified|1211
1550331|NCT00090233|5063336|P2|Overall Study|Moved|189
1550332|NCT00090233|5063337|P1|Overall Study|Moved|203
1550333|NCT00090233|5063336|P2|Overall Study|Withdrawal by Subject|211
1550334|NCT00090233|5063337|P1|Overall Study|Withdrawal by Subject|182
1550335|NCT00090233|5063336|P2|Overall Study|Protocol Violation|1022
1550336|NCT00090233|5063337|P1|Overall Study|Protocol Violation|960
1550337|NCT00090233|5063336|P2|Overall Study|Lost to Follow-up|95
1550338|NCT00090233|5063337|P1|Overall Study|Lost to Follow-up|68
1550339|NCT00090233|5063336|P2|Overall Study|Adverse Event|198
1550340|NCT00090233|5063337|P1|Overall Study|Adverse Event|214
1550341|NCT00090233|5063336|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
1550342|NCT00090233|5063337|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
1550343|NCT00090220|5063361|P6|Long-term Follow-up (EXT2)|Other|0
1550344|NCT00090220|5063362|P5|Long-term Follow-up (EXT2)|Other|1
1550345|NCT00090220|5063363|P4|Long-term Follow-up (EXT2)|Other|0
1550346|NCT00090220|5063364|P3|Long-term Follow-up (EXT2)|Other|0
1550347|NCT00090220|5063365|P2|Long-term Follow-up (EXT2)|Other|0
1550348|NCT00090220|5063366|P1|Long-term Follow-up (EXT2)|Other|0
1550349|NCT00090220|5063361|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
1550350|NCT00090220|5063362|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
1550351|NCT00090220|5063363|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1550352|NCT00090220|5063364|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1550353|NCT00090220|5063365|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1550354|NCT00090220|5063366|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1550355|NCT00090220|5063361|P6|Long-term Follow-up (EXT2)|Death|1
1550356|NCT00090220|5063362|P5|Long-term Follow-up (EXT2)|Death|1
1550357|NCT00090220|5063363|P4|Long-term Follow-up (EXT2)|Death|0
1550358|NCT00090220|5063364|P3|Long-term Follow-up (EXT2)|Death|0
1550359|NCT00090220|5063365|P2|Long-term Follow-up (EXT2)|Death|0
1550360|NCT00090220|5063366|P1|Long-term Follow-up (EXT2)|Death|0
1550361|NCT00090220|5063361|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
1550362|NCT00090220|5063362|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
1550363|NCT00090220|5063363|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1550364|NCT00090220|5063364|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1550365|NCT00090220|5063365|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1550366|NCT00090220|5063366|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1550367|NCT00090220|5063361|P6|Extension 1 (EXT1)|Other reason|0
1550368|NCT00090220|5063362|P5|Extension 1 (EXT1)|Other reason|0
1550369|NCT00090220|5063363|P4|Extension 1 (EXT1)|Other reason|0
1550370|NCT00090220|5063364|P3|Extension 1 (EXT1)|Other reason|2
1550371|NCT00090220|5063365|P2|Extension 1 (EXT1)|Other reason|0
1550372|NCT00090220|5063366|P1|Extension 1 (EXT1)|Other reason|0
1550373|NCT00090220|5063361|P6|Extension 1 (EXT1)|Protocol Violation|0
1550374|NCT00090220|5063362|P5|Extension 1 (EXT1)|Protocol Violation|0
1550375|NCT00090220|5063363|P4|Extension 1 (EXT1)|Protocol Violation|1
1550376|NCT00090220|5063364|P3|Extension 1 (EXT1)|Protocol Violation|0
1550377|NCT00090220|5063365|P2|Extension 1 (EXT1)|Protocol Violation|0
1550378|NCT00090220|5063366|P1|Extension 1 (EXT1)|Protocol Violation|0
1550379|NCT00090220|5063361|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
1550380|NCT00090220|5063362|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
1550381|NCT00090220|5063363|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
1550382|NCT00090220|5063364|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
1550383|NCT00090220|5063365|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
1550384|NCT00090220|5063366|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
1550385|NCT00090220|5063361|P6|Extension 1 (EXT1)|Moved|0
1550386|NCT00090220|5063362|P5|Extension 1 (EXT1)|Moved|0
1550387|NCT00090220|5063363|P4|Extension 1 (EXT1)|Moved|1
1550388|NCT00090220|5063364|P3|Extension 1 (EXT1)|Moved|2
1550389|NCT00090220|5063365|P2|Extension 1 (EXT1)|Moved|0
1550390|NCT00090220|5063366|P1|Extension 1 (EXT1)|Moved|0
1550391|NCT00090220|5063361|P6|Extension 1 (EXT1)|Lost to Follow-up|0
1550392|NCT00090220|5063362|P5|Extension 1 (EXT1)|Lost to Follow-up|0
1550393|NCT00090220|5063363|P4|Extension 1 (EXT1)|Lost to Follow-up|0
1550394|NCT00090220|5063364|P3|Extension 1 (EXT1)|Lost to Follow-up|22
1550395|NCT00090220|5063365|P2|Extension 1 (EXT1)|Lost to Follow-up|0
1550396|NCT00090220|5063366|P1|Extension 1 (EXT1)|Lost to Follow-up|0
1550397|NCT00090220|5063361|P6|Extension 1 (EXT1)|Adverse Event|0
1550398|NCT00090220|5063362|P5|Extension 1 (EXT1)|Adverse Event|0
1550399|NCT00090220|5063363|P4|Extension 1 (EXT1)|Adverse Event|0
1550400|NCT00090220|5063364|P3|Extension 1 (EXT1)|Adverse Event|4
1550401|NCT00090220|5063365|P2|Extension 1 (EXT1)|Adverse Event|0
1550402|NCT00090220|5063366|P1|Extension 1 (EXT1)|Adverse Event|0
1550403|NCT00090220|5063361|P6|Base Study Follow-up Period|Other|0
1550404|NCT00090220|5063362|P5|Base Study Follow-up Period|Other|0
1550405|NCT00090220|5063363|P4|Base Study Follow-up Period|Other|0
1550406|NCT00090220|5063364|P3|Base Study Follow-up Period|Other|0
1550407|NCT00090220|5063365|P2|Base Study Follow-up Period|Other|21
1550408|NCT00090220|5063366|P1|Base Study Follow-up Period|Other|19
1550409|NCT00090220|5063361|P6|Base Study Follow-up Period|Patient Moved|0
1550410|NCT00090220|5063362|P5|Base Study Follow-up Period|Patient Moved|0
1550411|NCT00090220|5063363|P4|Base Study Follow-up Period|Patient Moved|0
1550412|NCT00090220|5063364|P3|Base Study Follow-up Period|Patient Moved|0
1550413|NCT00090220|5063365|P2|Base Study Follow-up Period|Patient Moved|28
1550414|NCT00090220|5063366|P1|Base Study Follow-up Period|Patient Moved|20
1550415|NCT00090220|5063361|P6|Base Study Follow-up Period|Withdrawal by Subject|0
1550416|NCT00090220|5063362|P5|Base Study Follow-up Period|Withdrawal by Subject|0
1550417|NCT00090220|5063363|P4|Base Study Follow-up Period|Withdrawal by Subject|0
1550418|NCT00090220|5063364|P3|Base Study Follow-up Period|Withdrawal by Subject|0
1550419|NCT00090220|5063365|P2|Base Study Follow-up Period|Withdrawal by Subject|36
1550420|NCT00090220|5063366|P1|Base Study Follow-up Period|Withdrawal by Subject|27
1550421|NCT00090220|5063361|P6|Base Study Follow-up Period|Lost to Follow-up|0
1550422|NCT00090220|5063362|P5|Base Study Follow-up Period|Lost to Follow-up|0
1550423|NCT00090220|5063363|P4|Base Study Follow-up Period|Lost to Follow-up|0
1550424|NCT00090220|5063364|P3|Base Study Follow-up Period|Lost to Follow-up|0
1550425|NCT00090220|5063365|P2|Base Study Follow-up Period|Lost to Follow-up|78
1550426|NCT00090220|5063366|P1|Base Study Follow-up Period|Lost to Follow-up|88
1550427|NCT00090220|5063361|P6|Base Study Follow-up Period|Adverse Event|0
1550428|NCT00090220|5063362|P5|Base Study Follow-up Period|Adverse Event|0
1550429|NCT00090220|5063363|P4|Base Study Follow-up Period|Adverse Event|0
1550430|NCT00090220|5063364|P3|Base Study Follow-up Period|Adverse Event|0
1550431|NCT00090220|5063365|P2|Base Study Follow-up Period|Adverse Event|1
1550432|NCT00090220|5063366|P1|Base Study Follow-up Period|Adverse Event|6
1550433|NCT00090220|5063361|P6|Base Study Vaccination Period|Other|0
1550434|NCT00090220|5063362|P5|Base Study Vaccination Period|Other|0
1550435|NCT00090220|5063363|P4|Base Study Vaccination Period|Other|0
1550436|NCT00090220|5063364|P3|Base Study Vaccination Period|Other|0
1550437|NCT00090220|5063365|P2|Base Study Vaccination Period|Other|4
1550438|NCT00090220|5063366|P1|Base Study Vaccination Period|Other|4
1550439|NCT00090220|5063361|P6|Base Study Vaccination Period|Patient Moved|0
1550440|NCT00090220|5063362|P5|Base Study Vaccination Period|Patient Moved|0
1550441|NCT00090220|5063363|P4|Base Study Vaccination Period|Patient Moved|0
1550442|NCT00090220|5063364|P3|Base Study Vaccination Period|Patient Moved|0
1550443|NCT00090220|5063365|P2|Base Study Vaccination Period|Patient Moved|2
1550444|NCT00090220|5063366|P1|Base Study Vaccination Period|Patient Moved|6
1550445|NCT00090220|5063361|P6|Base Study Vaccination Period|Withdrawal by Subject|0
1550446|NCT00090220|5063362|P5|Base Study Vaccination Period|Withdrawal by Subject|0
1550447|NCT00090220|5063363|P4|Base Study Vaccination Period|Withdrawal by Subject|0
1550448|NCT00090220|5063364|P3|Base Study Vaccination Period|Withdrawal by Subject|0
1550449|NCT00090220|5063365|P2|Base Study Vaccination Period|Withdrawal by Subject|27
1550450|NCT00090220|5063366|P1|Base Study Vaccination Period|Withdrawal by Subject|23
1550451|NCT00090220|5063361|P6|Base Study Vaccination Period|Lost to Follow-up|0
1550452|NCT00090220|5063362|P5|Base Study Vaccination Period|Lost to Follow-up|0
1550453|NCT00090220|5063363|P4|Base Study Vaccination Period|Lost to Follow-up|0
1550454|NCT00090220|5063364|P3|Base Study Vaccination Period|Lost to Follow-up|0
1550455|NCT00090220|5063365|P2|Base Study Vaccination Period|Lost to Follow-up|28
1550456|NCT00090220|5063366|P1|Base Study Vaccination Period|Lost to Follow-up|24
1550457|NCT00090220|5063361|P6|Base Study Vaccination Period|Adverse Event|0
1550458|NCT00090220|5063362|P5|Base Study Vaccination Period|Adverse Event|0
1550459|NCT00090220|5063363|P4|Base Study Vaccination Period|Adverse Event|0
1550460|NCT00090220|5063364|P3|Base Study Vaccination Period|Adverse Event|0
1550461|NCT00090220|5063365|P2|Base Study Vaccination Period|Adverse Event|1
1550462|NCT00090220|5063366|P1|Base Study Vaccination Period|Adverse Event|6
1550463|NCT00090220|5063361|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
1550464|NCT00090220|5063362|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
1550465|NCT00090220|5063363|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
1550466|NCT00090220|5063364|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
1550467|NCT00090220|5063365|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
1550468|NCT00090220|5063366|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
1550469|NCT00090402|5063461|P3|Overall Study|stopped taking study medication|1
1550470|NCT00090402|5063462|P2|Overall Study|stopped taking study medication|0
1550471|NCT00090402|5063463|P1|Overall Study|stopped taking study medication|1
1550472|NCT00090402|5063461|P3|Overall Study|subject moved|0
1550473|NCT00090402|5063462|P2|Overall Study|subject moved|1
1550474|NCT00090402|5063463|P1|Overall Study|subject moved|0
1550475|NCT00090402|5063461|P3|Overall Study|Death|0
1550476|NCT00090402|5063462|P2|Overall Study|Death|1
1550477|NCT00090402|5063463|P1|Overall Study|Death|1
1550478|NCT00090142|5063477|P2|Treatment Period II|Not Specified|0
1550479|NCT00090142|5063478|P1|Treatment Period II|Not Specified|1
1550480|NCT00090142|5063477|P2|Treatment Period I|Not Specified|1
1550481|NCT00090142|5063478|P1|Treatment Period I|Not Specified|0
1550482|NCT00090142|5063477|P2|Treatment Period I|Withdrawal by Subject|0
1550483|NCT00090142|5063478|P1|Treatment Period I|Withdrawal by Subject|2
1550484|NCT00090142|5063477|P2|Treatment Period I|Protocol Violation|0
1550485|NCT00090142|5063478|P1|Treatment Period I|Protocol Violation|2
1550486|NCT00090142|5063477|P2|Treatment Period I|Lost to Follow-up|2
1550487|NCT00090142|5063478|P1|Treatment Period I|Lost to Follow-up|1
1550488|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Other|0
1550489|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Other|1
1550490|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Other|0
1550491|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Jailed|0
1550492|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Jailed|1
1550493|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Jailed|0
1550494|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
1550495|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
1550496|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
1550497|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Depression|0
1550498|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Depression|1
1550499|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Depression|0
1550500|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
1550501|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
1550502|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
1550503|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
1550504|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
1550505|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
1550506|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Back Pain|0
1550507|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Back Pain|1
1550508|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Back Pain|0
1550509|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
1550510|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
1550511|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
1550512|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
1550513|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
1550514|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
1550515|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
1550516|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
1550517|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
1550518|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Gyneomastia|0
1550519|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Gyneomastia|0
1550520|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Gyneomastia|1
1550521|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Death|1
1550522|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Death|0
1550523|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Death|1
1550524|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
1550525|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
1550526|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
1550527|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Enrollment Error|2
1550528|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Enrollment Error|0
1550529|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Enrollment Error|1
1550530|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Loss of Libido|0
1550531|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Loss of Libido|0
1550532|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Loss of Libido|1
1550533|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
1550534|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
1550535|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
1550536|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
1550537|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
1550538|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
1550539|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
1550540|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
1550541|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
1550542|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
1550543|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
1550544|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
1550545|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Participant relocated|1
1550546|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Participant relocated|3
1550547|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Participant relocated|2
1550548|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
1550549|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
1550550|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
1550551|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Loss of Contact|2
1550552|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Loss of Contact|0
1550553|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Loss of Contact|4
1550554|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
1550555|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
1550556|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
1550557|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
1550558|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
1550559|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
1550560|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Protocol Violation|17
1550561|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Protocol Violation|18
1550562|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Protocol Violation|18
1550563|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
1550564|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
1550565|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
1550566|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
1550567|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
1550568|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
1550569|NCT00090103|5063509|P3|16-Week Safety Follow-up Period|Adverse Event|44
1550570|NCT00090103|5063510|P2|16-Week Safety Follow-up Period|Adverse Event|39
1550571|NCT00090103|5063511|P1|16-Week Safety Follow-up Period|Adverse Event|34
1550572|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
1550573|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
1550574|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
1550575|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
1550576|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
1550577|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
1550578|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
1550579|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
1550580|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
1550581|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
1550582|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
1550583|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
1550584|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
1550585|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
1550586|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
1550587|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
1550588|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
1550589|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
1550590|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
1550591|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
1550592|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
1550593|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
1550594|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
1550595|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
1550596|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
1550597|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
1550598|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
1550599|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
1550600|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
1550601|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
1550602|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
1550603|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
1550604|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
1550605|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
1550606|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
1550607|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
1550608|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
1550609|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
1550610|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
1550611|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
1550612|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
1550613|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
1550614|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
1550615|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
1550616|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
1550617|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
1550618|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
1550619|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
1550620|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
1550621|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
1550622|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
1550623|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
1550624|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
1550625|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
1550626|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
1550627|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
1550628|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
1550629|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
1550630|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
1550631|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
1550632|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
1550633|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
1550634|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
1550635|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
1550636|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
1550637|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
1550638|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
1550639|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
1550640|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
1550641|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
1550642|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
1550643|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
1550644|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
1550645|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
1550646|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
1550647|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
1550648|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
1550649|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
1550650|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
1550651|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
1550652|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
1550653|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
1550654|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
1550655|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
1550656|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
1550657|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
1550658|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
1550659|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
1550660|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
1550661|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
1550662|NCT00090103|5063509|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
1550663|NCT00090103|5063510|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
1550664|NCT00090103|5063511|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
1550665|NCT00089999|5063677|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
1550666|NCT00089999|5063678|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
1550667|NCT00089999|5063677|P2|Overall Study|Patient Underwent Surgery|0
1550668|NCT00089999|5063678|P1|Overall Study|Patient Underwent Surgery|2
1550669|NCT00089999|5063677|P2|Overall Study|Physician Decision|2
1550670|NCT00089999|5063678|P1|Overall Study|Physician Decision|2
1550671|NCT00089999|5063677|P2|Overall Study|Clinical Progression|2
1550672|NCT00089999|5063678|P1|Overall Study|Clinical Progression|1
1550673|NCT00089999|5063677|P2|Overall Study|Poor General Condition|0
1550674|NCT00089999|5063678|P1|Overall Study|Poor General Condition|1
1550675|NCT00089999|5063677|P2|Overall Study|Death|3
1550676|NCT00089999|5063678|P1|Overall Study|Death|3
1550677|NCT00089999|5063677|P2|Overall Study|Symptomatic Progression of Cancer|5
1550678|NCT00089999|5063678|P1|Overall Study|Symptomatic Progression of Cancer|2
1550679|NCT00089999|5063677|P2|Overall Study|Radiological Progression of Cancer|44
1550680|NCT00089999|5063678|P1|Overall Study|Radiological Progression of Cancer|52
1550681|NCT00089999|5063677|P2|Overall Study|Lost to Follow-up|1
1550682|NCT00089999|5063678|P1|Overall Study|Lost to Follow-up|2
1550683|NCT00089999|5063677|P2|Overall Study|Withdrawal by Subject|4
1550684|NCT00089999|5063678|P1|Overall Study|Withdrawal by Subject|0
1550685|NCT00089999|5063677|P2|Overall Study|Adverse Event|7
1550686|NCT00089999|5063678|P1|Overall Study|Adverse Event|4
1550687|NCT00089986|5063701|P3|Overall Study|Withdrawal by Subject|2
1550688|NCT00089986|5063702|P2|Overall Study|Withdrawal by Subject|6
1550689|NCT00089986|5063703|P1|Overall Study|Withdrawal by Subject|3
1550690|NCT00089986|5063701|P3|Overall Study|Do not resuscitate (DNR)|1
1550691|NCT00089986|5063702|P2|Overall Study|Do not resuscitate (DNR)|0
1550692|NCT00089986|5063703|P1|Overall Study|Do not resuscitate (DNR)|0
1550693|NCT00089986|5063701|P3|Overall Study|Family decision|0
1550694|NCT00089986|5063702|P2|Overall Study|Family decision|1
1550695|NCT00089986|5063703|P1|Overall Study|Family decision|0
1550696|NCT00089986|5063701|P3|Overall Study|Enrollment in another study|0
1550697|NCT00089986|5063702|P2|Overall Study|Enrollment in another study|1
1550698|NCT00089986|5063703|P1|Overall Study|Enrollment in another study|0
1550699|NCT00089986|5063701|P3|Overall Study|Investigator decision to withdrew|0
1550700|NCT00089986|5063702|P2|Overall Study|Investigator decision to withdrew|1
1550701|NCT00089986|5063703|P1|Overall Study|Investigator decision to withdrew|0
1550702|NCT00089986|5063701|P3|Overall Study|Hemohlobin stopping rule|0
1550703|NCT00089986|5063702|P2|Overall Study|Hemohlobin stopping rule|1
1550704|NCT00089986|5063703|P1|Overall Study|Hemohlobin stopping rule|0
1550705|NCT00089986|5063701|P3|Overall Study|Subject withdrew but agreed follow up|0
1550706|NCT00089986|5063702|P2|Overall Study|Subject withdrew but agreed follow up|2
1550707|NCT00089986|5063703|P1|Overall Study|Subject withdrew but agreed follow up|1
1550708|NCT00089986|5063701|P3|Overall Study|Patient transferred to another hospital|0
1550709|NCT00089986|5063702|P2|Overall Study|Patient transferred to another hospital|1
1550710|NCT00089986|5063703|P1|Overall Study|Patient transferred to another hospital|2
1550711|NCT00089986|5063701|P3|Overall Study|Protocol Violation|0
1550712|NCT00089986|5063702|P2|Overall Study|Protocol Violation|1
1550713|NCT00089986|5063703|P1|Overall Study|Protocol Violation|0
1550714|NCT00089986|5063701|P3|Overall Study|Lost to Follow-up|1
1550715|NCT00089986|5063702|P2|Overall Study|Lost to Follow-up|1
1550716|NCT00089986|5063703|P1|Overall Study|Lost to Follow-up|3
1550717|NCT00089986|5063701|P3|Overall Study|Adverse Event|6
1550718|NCT00089986|5063702|P2|Overall Study|Adverse Event|9
1550719|NCT00089986|5063703|P1|Overall Study|Adverse Event|6
1550720|NCT00089973|5063720|P1|Overall Study|Death|1
1550721|NCT00089973|5063720|P1|Overall Study|Disease progression|45
1550722|NCT00089973|5063720|P1|Overall Study|Withdrawal by Subject|1
1550723|NCT00089973|5063720|P1|Overall Study|Adverse Event|3
1550724|NCT00089895|5063735|P2|Overall Study|Missing|2
1550725|NCT00089895|5063736|P1|Overall Study|Missing|4
1550726|NCT00089895|5063735|P2|Overall Study|Not otherwise specified|8
1550727|NCT00089895|5063736|P1|Overall Study|Not otherwise specified|4
1550728|NCT00089895|5063735|P2|Overall Study|Exclusion criteria met|6
1550729|NCT00089895|5063736|P1|Overall Study|Exclusion criteria met|6
1550730|NCT00089895|5063735|P2|Overall Study|Physician Decision|7
1550731|NCT00089895|5063736|P1|Overall Study|Physician Decision|3
1550732|NCT00089895|5063735|P2|Overall Study|Bleeding|2
1550733|NCT00089895|5063736|P1|Overall Study|Bleeding|0
1550734|NCT00089895|5063735|P2|Overall Study|Surgery|1
1550735|NCT00089895|5063736|P1|Overall Study|Surgery|0
1550736|NCT00089895|5063735|P2|Overall Study|Technical reason|2
1550737|NCT00089895|5063736|P1|Overall Study|Technical reason|7
1550738|NCT00089895|5063735|P2|Overall Study|Consent Withdrawn|14
1550739|NCT00089895|5063736|P1|Overall Study|Consent Withdrawn|11
1550740|NCT00089843|5063748|P4|Overall Study|Physician Decision|1
1550741|NCT00089843|5063749|P3|Overall Study|Physician Decision|0
1550742|NCT00089843|5063750|P2|Overall Study|Physician Decision|0
1550743|NCT00089843|5063751|P1|Overall Study|Physician Decision|1
1550744|NCT00089843|5063748|P4|Overall Study|Withdrawal by Subject|6
1550745|NCT00089843|5063749|P3|Overall Study|Withdrawal by Subject|5
1550746|NCT00089843|5063750|P2|Overall Study|Withdrawal by Subject|4
1550747|NCT00089843|5063751|P1|Overall Study|Withdrawal by Subject|1
1550748|NCT00089791|5063763|P2|Overall Study|Requirement for alternative therapy|4
1550749|NCT00089791|5063764|P1|Overall Study|Requirement for alternative therapy|7
1550750|NCT00089791|5063763|P2|Overall Study|Protocol deviation|10
1550751|NCT00089791|5063764|P1|Overall Study|Protocol deviation|12
1550752|NCT00089791|5063763|P2|Overall Study|Other|32
1550753|NCT00089791|5063764|P1|Overall Study|Other|20
1550754|NCT00089791|5063763|P2|Overall Study|Noncompliance|13
1550755|NCT00089791|5063764|P1|Overall Study|Noncompliance|17
1550756|NCT00089791|5063763|P2|Overall Study|Lost to Follow-up|57
1550757|NCT00089791|5063764|P1|Overall Study|Lost to Follow-up|57
1550758|NCT00089791|5063763|P2|Overall Study|Ineligibility determined|9
1550759|NCT00089791|5063764|P1|Overall Study|Ineligibility determined|12
1550760|NCT00089791|5063763|P2|Overall Study|Disease progression|3
1550761|NCT00089791|5063764|P1|Overall Study|Disease progression|7
1550762|NCT00089791|5063763|P2|Overall Study|Death|62
1550763|NCT00089791|5063764|P1|Overall Study|Death|78
1550764|NCT00089791|5063763|P2|Overall Study|Withdrawal by Subject|344
1550765|NCT00089791|5063764|P1|Overall Study|Withdrawal by Subject|403
1550766|NCT00089791|5063763|P2|Overall Study|Adverse Event|93
1550767|NCT00089791|5063764|P1|Overall Study|Adverse Event|81
1550768|NCT00089791|5063763|P2|Overall Study|Physician Decision|3
1550769|NCT00089791|5063764|P1|Overall Study|Physician Decision|6
1550770|NCT00089778|5063798|P3|Overall Study|Protocol Violation|1
1550771|NCT00089778|5063799|P2|Overall Study|Protocol Violation|0
1550772|NCT00089778|5063800|P1|Overall Study|Protocol Violation|0
1550773|NCT00089674|5063813|P2|Overall Study|Requirement for alternative therapy|4
1550774|NCT00089674|5063814|P1|Overall Study|Requirement for alternative therapy|14
1550775|NCT00089674|5063813|P2|Overall Study|Other|9
1550776|NCT00089674|5063814|P1|Overall Study|Other|5
1550777|NCT00089674|5063813|P2|Overall Study|Noncompliance|3
1550778|NCT00089674|5063814|P1|Overall Study|Noncompliance|7
1550779|NCT00089674|5063813|P2|Overall Study|Lost to Follow-up|17
1550780|NCT00089674|5063814|P1|Overall Study|Lost to Follow-up|21
1550781|NCT00089674|5063813|P2|Overall Study|Ineligibility determined|10
1550782|NCT00089674|5063814|P1|Overall Study|Ineligibility determined|8
1550783|NCT00089674|5063813|P2|Overall Study|Disease progression|23
1550784|NCT00089674|5063814|P1|Overall Study|Disease progression|21
1550785|NCT00089674|5063813|P2|Overall Study|Death|43
1550786|NCT00089674|5063814|P1|Overall Study|Death|43
1550787|NCT00089674|5063813|P2|Overall Study|Withdrawal by Subject|127
1550788|NCT00089674|5063814|P1|Overall Study|Withdrawal by Subject|143
1550789|NCT00089674|5063813|P2|Overall Study|Adverse Event|29
1550790|NCT00089674|5063814|P1|Overall Study|Adverse Event|23
1550791|NCT00089674|5063813|P2|Overall Study|Physician Decision|2
1550792|NCT00089674|5063814|P1|Overall Study|Physician Decision|4
1550793|NCT00089661|5063840|P2|Overall Study|Other|1
1550794|NCT00089661|5063841|P1|Overall Study|Other|2
1550795|NCT00089661|5063840|P2|Overall Study|Noncompliance|4
1550796|NCT00089661|5063841|P1|Overall Study|Noncompliance|2
1550797|NCT00089661|5063840|P2|Overall Study|Ineligibility determined|4
1550798|NCT00089661|5063841|P1|Overall Study|Ineligibility determined|4
1550799|NCT00089661|5063840|P2|Overall Study|Disease progression|3
1550800|NCT00089661|5063841|P1|Overall Study|Disease progression|1
1550801|NCT00089661|5063840|P2|Overall Study|Withdrawal by Subject|9
1550802|NCT00089661|5063841|P1|Overall Study|Withdrawal by Subject|11
1550803|NCT00089661|5063840|P2|Overall Study|Lost to Follow-up|3
1550804|NCT00089661|5063841|P1|Overall Study|Lost to Follow-up|0
1550805|NCT00089661|5063840|P2|Overall Study|Death|0
1550806|NCT00089661|5063841|P1|Overall Study|Death|1
1550807|NCT00089661|5063840|P2|Overall Study|Adverse Event|2
1550808|NCT00089661|5063841|P1|Overall Study|Adverse Event|0
1550809|NCT00089648|5063857|P1|Overall Study|Lack of Efficacy|33
1550810|NCT00089648|5063857|P1|Overall Study|Withdrawal by Subject|1
1550811|NCT00089648|5063857|P1|Overall Study|Adverse Event|7
1550812|NCT00089635|5063873|P1|Overall Study|Not specified|2
1550813|NCT00089635|5063873|P1|Overall Study|Ineligibility determined|1
1550814|NCT00089635|5063873|P1|Overall Study|Withdrawal by Subject|6
1550815|NCT00089635|5063873|P1|Overall Study|Lost to Follow-up|3
1550816|NCT00089635|5063873|P1|Overall Study|Disease Progression|12
1550817|NCT00089635|5063873|P1|Overall Study|Death|17
1550818|NCT00089635|5063873|P1|Overall Study|Adverse Event|2
1550819|NCT00089583|5063887|P2|Overall Study|Participant Incarcerated|1
1550820|NCT00089583|5063888|P1|Overall Study|Participant Incarcerated|0
1550821|NCT00089583|5063887|P2|Overall Study|Necessity to Use Prohibited Drug|0
1550822|NCT00089583|5063888|P1|Overall Study|Necessity to Use Prohibited Drug|1
1550823|NCT00089583|5063887|P2|Overall Study|Start of Disallowed Medication|1
1550824|NCT00089583|5063888|P1|Overall Study|Start of Disallowed Medication|0
1550825|NCT00089583|5063887|P2|Overall Study|Principal Investigator Decision|10
1550826|NCT00089583|5063888|P1|Overall Study|Principal Investigator Decision|0
1550827|NCT00089583|5063887|P2|Overall Study|Protocol Violation|3
1550828|NCT00089583|5063888|P1|Overall Study|Protocol Violation|0
1550829|NCT00089583|5063887|P2|Overall Study|Reason Not Provided|1
1550830|NCT00089583|5063888|P1|Overall Study|Reason Not Provided|0
1550831|NCT00089583|5063887|P2|Overall Study|Participant Management Criteria Met|1
1550832|NCT00089583|5063888|P1|Overall Study|Participant Management Criteria Met|0
1550833|NCT00089583|5063887|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
1550834|NCT00089583|5063888|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
1550835|NCT00089583|5063887|P2|Overall Study|Non-Compliance|4
1550836|NCT00089583|5063888|P1|Overall Study|Non-Compliance|0
1550837|NCT00089583|5063887|P2|Overall Study|Participant Refused Study Medication|2
1550838|NCT00089583|5063888|P1|Overall Study|Participant Refused Study Medication|0
1550839|NCT00089583|5063887|P2|Overall Study|Participant (Par) Didn't Take Medication|0
1550840|NCT00089583|5063888|P1|Overall Study|Participant (Par) Didn't Take Medication|1
1550841|NCT00089583|5063887|P2|Overall Study|Withdrawal by Subject|4
1550842|NCT00089583|5063888|P1|Overall Study|Withdrawal by Subject|0
1550843|NCT00089583|5063887|P2|Overall Study|Insufficient Viral Load Response|5
1550844|NCT00089583|5063888|P1|Overall Study|Insufficient Viral Load Response|5
1550845|NCT00089583|5063887|P2|Overall Study|Adverse Event|3
1550846|NCT00089583|5063888|P1|Overall Study|Adverse Event|0
1550847|NCT00089609|5063982|P2|Overall Study|Withdrawal by Subject|1
1550848|NCT00089609|5063983|P1|Overall Study|Withdrawal by Subject|3
1550849|NCT00089544|5064002|P2|Overall Study|Ineligible|0
1550850|NCT00089544|5064003|P1|Overall Study|Ineligible|1
1550851|NCT00089505|5064017|P4|Overall Study|Protocol Violation|0
1550852|NCT00089505|5064018|P3|Overall Study|Protocol Violation|1
1550853|NCT00089505|5064019|P2|Overall Study|Protocol Violation|0
1550854|NCT00089505|5064020|P1|Overall Study|Protocol Violation|0
1550855|NCT00089505|5064017|P4|Overall Study|Physician Decision|0
1550856|NCT00089505|5064018|P3|Overall Study|Physician Decision|0
1550857|NCT00089505|5064019|P2|Overall Study|Physician Decision|0
1550858|NCT00089505|5064020|P1|Overall Study|Physician Decision|1
1550859|NCT00089505|5064017|P4|Overall Study|Lost to Follow-up|7
1550860|NCT00089505|5064018|P3|Overall Study|Lost to Follow-up|9
1550861|NCT00089505|5064019|P2|Overall Study|Lost to Follow-up|1
1550862|NCT00089505|5064020|P1|Overall Study|Lost to Follow-up|1
1550863|NCT00089505|5064017|P4|Overall Study|Withdrawal by Subject|6
1550864|NCT00089505|5064018|P3|Overall Study|Withdrawal by Subject|6
1550865|NCT00089505|5064019|P2|Overall Study|Withdrawal by Subject|0
1550866|NCT00089505|5064020|P1|Overall Study|Withdrawal by Subject|3
1550867|NCT00089505|5064017|P4|Overall Study|Death|8
1550868|NCT00089505|5064018|P3|Overall Study|Death|5
1550869|NCT00089505|5064019|P2|Overall Study|Death|1
1550870|NCT00089505|5064020|P1|Overall Study|Death|4
1550871|NCT00089479|5064064|P2|Overall Study|Lost to Follow-up|107
1550872|NCT00089479|5064065|P1|Overall Study|Lost to Follow-up|137
1550873|NCT00089479|5064064|P2|Overall Study|Withdrawal by Subject|107
1550874|NCT00089479|5064065|P1|Overall Study|Withdrawal by Subject|86
1550875|NCT00089479|5064064|P2|Overall Study|Death|75
1550876|NCT00089479|5064065|P1|Overall Study|Death|108
1550877|NCT00089297|5064108|P1|Overall Study|Non-compliance|1
1550878|NCT00089297|5064108|P1|Overall Study|IRB approval not ready|1
1550879|NCT00089297|5064108|P1|Overall Study|Secondary malignancy|1
1550880|NCT00089297|5064108|P1|Overall Study|Ineligible|11
1550881|NCT00089297|5064108|P1|Overall Study|Disease progression|2
1550882|NCT00089297|5064108|P1|Overall Study|Withdrawal by Subject|12
1550883|NCT00089297|5064108|P1|Overall Study|Death|1
1550884|NCT00089297|5064108|P1|Overall Study|Adverse Event|9
1550885|NCT00089141|5064117|P2|Overall Study|Termination of trial|24
1550886|NCT00089141|5064118|P1|Overall Study|Termination of trial|18
1550887|NCT00089076|5064154|P1|Overall Study|Progression|7
1550888|NCT00089076|5064154|P1|Overall Study|Withdrawal by Subject|2
1550889|NCT00089076|5064154|P1|Overall Study|Alternate Therapy|1
1550890|NCT00088907|5064206|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
1550891|NCT00088907|5064207|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
1550892|NCT00088907|5064206|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
1550893|NCT00088907|5064207|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
1550894|NCT00088907|5064206|P2|Single Gefitinib Treatment (Step 2)|Death|0
1550895|NCT00088907|5064207|P1|Single Gefitinib Treatment (Step 2)|Death|1
1550896|NCT00088907|5064206|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
1550897|NCT00088907|5064207|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
1550898|NCT00088907|5064206|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
1550899|NCT00088907|5064207|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
1550900|NCT00088907|5064206|P2|Randomized Study (Step 1)|unknown/not specify|13
1550901|NCT00088907|5064207|P1|Randomized Study (Step 1)|unknown/not specify|24
1550902|NCT00088907|5064206|P2|Randomized Study (Step 1)|complicating disease|1
1550903|NCT00088907|5064207|P1|Randomized Study (Step 1)|complicating disease|3
1550904|NCT00088907|5064206|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
1550905|NCT00088907|5064207|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
1550906|NCT00088907|5064206|P2|Randomized Study (Step 1)|Death|12
1550907|NCT00088907|5064207|P1|Randomized Study (Step 1)|Death|11
1550908|NCT00088907|5064206|P2|Randomized Study (Step 1)|Adverse Event|19
1550909|NCT00088907|5064207|P1|Randomized Study (Step 1)|Adverse Event|14
1550910|NCT00088907|5064206|P2|Randomized Study (Step 1)|Lack of Efficacy|62
1550911|NCT00088907|5064207|P1|Randomized Study (Step 1)|Lack of Efficacy|55
1550912|NCT00088881|5064218|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
1550913|NCT00088881|5064218|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
1550914|NCT00088881|5064218|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
1550915|NCT00088881|5064218|P1|Step 1 - R-CHOP|Physician Decision|1
1550916|NCT00088881|5064218|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
1550917|NCT00088881|5064218|P1|Step 1 - R-CHOP|Adverse Event|1
1550918|NCT00088881|5064218|P1|Step 1 - R-CHOP|Patient ineligible|9
1550919|NCT00088829|5064227|P1|Overall Study|PI left institution and study was close|22
1550920|NCT00088595|5064250|P1|Overall Study|New Cancer Therapy|2
1550921|NCT00088595|5064250|P1|Overall Study|Ongoing (After Core)|7
1550922|NCT00088595|5064250|P1|Overall Study|Withdrawal by Subject|8
1550923|NCT00088595|5064250|P1|Overall Study|Adverse Event|11
1550924|NCT00088530|5064268|P2|Overall Study|Patient never treated|0
1550925|NCT00088530|5064269|P1|Overall Study|Patient never treated|1
1550926|NCT00088530|5064268|P2|Overall Study|Sponsor decision|1
1550927|NCT00088530|5064269|P1|Overall Study|Sponsor decision|0
1550928|NCT00088530|5064268|P2|Overall Study|Physician Decision|0
1550929|NCT00088530|5064269|P1|Overall Study|Physician Decision|2
1550930|NCT00088530|5064268|P2|Overall Study|Lost to Follow-up|0
1550931|NCT00088530|5064269|P1|Overall Study|Lost to Follow-up|2
1550932|NCT00088530|5064268|P2|Overall Study|Withdrawal by Subject|5
1550933|NCT00088530|5064269|P1|Overall Study|Withdrawal by Subject|2
1550934|NCT00088530|5064268|P2|Overall Study|Adverse Event|9
1550935|NCT00088530|5064269|P1|Overall Study|Adverse Event|15
1550936|NCT00088530|5064268|P2|Overall Study|Progressive/Relapsed Disease|39
1550937|NCT00088530|5064269|P1|Overall Study|Progressive/Relapsed Disease|28
1550938|NCT00088465|5064281|P1|Overall Study|Death|11
1550939|NCT00088465|5064281|P1|Overall Study|Protocol Violation|17
1550940|NCT00088465|5064281|P1|Overall Study|Lack of Efficacy|27
1550941|NCT00088465|5064281|P1|Overall Study|Sponsor Decision|37
1550942|NCT00088465|5064281|P1|Overall Study|Physician Decision|45
1550943|NCT00088465|5064281|P1|Overall Study|Lost to Follow-up|57
1550944|NCT00088465|5064281|P1|Overall Study|Adverse Event|77
1550945|NCT00088465|5064281|P1|Overall Study|Withdrawal by Subject|290
1550946|NCT00088374|5064304|P1|Overall Study|patient received <1 cycle only of 17AAG|1
1550947|NCT00088374|5064304|P1|Overall Study|patient did not receive any 17AAG|1
1550948|NCT00088166|5064324|P2|Overall Study|Withdrawal by Subject|5
1550949|NCT00088166|5064325|P1|Overall Study|Withdrawal by Subject|5
1550950|NCT00088166|5064324|P2|Overall Study|Patient deterioration|39
1550951|NCT00088166|5064325|P1|Overall Study|Patient deterioration|29
1550952|NCT00088166|5064324|P2|Overall Study|Protocol Violation|5
1550953|NCT00088166|5064325|P1|Overall Study|Protocol Violation|1
1550954|NCT00088166|5064324|P2|Overall Study|Physician Decision|1
1550955|NCT00088166|5064325|P1|Overall Study|Physician Decision|4
1550956|NCT00088166|5064324|P2|Overall Study|Lost to Follow-up|1
1550957|NCT00088166|5064325|P1|Overall Study|Lost to Follow-up|0
1550958|NCT00088166|5064324|P2|Overall Study|Death|1
1550959|NCT00088166|5064325|P1|Overall Study|Death|3
1550960|NCT00088166|5064324|P2|Overall Study|Adverse Event|9
1550961|NCT00088166|5064325|P1|Overall Study|Adverse Event|11
1550962|NCT00088153|5064349|P2|Overall Study|Lost to Follow-up|12
1550963|NCT00088153|5064350|P1|Overall Study|Lost to Follow-up|11
1550964|NCT00088153|5064349|P2|Overall Study|Withdrawal by Subject|10
1550965|NCT00088153|5064350|P1|Overall Study|Withdrawal by Subject|10
1550966|NCT00088153|5064349|P2|Overall Study|Physician Decision|3
1550967|NCT00088153|5064350|P1|Overall Study|Physician Decision|3
1550968|NCT00087698|5064360|P1|Overall Study|Protocol Violation|1
1550969|NCT00087698|5064360|P1|Overall Study|Death from Study Drug Toxicity|2
1550970|NCT00087698|5064360|P1|Overall Study|Death from Study Disease|2
1550971|NCT00087698|5064360|P1|Overall Study|Clinical Relapse|1
1550972|NCT00087698|5064360|P1|Overall Study|Protocol Entry Criteria Not Met|2
1550973|NCT00087698|5064360|P1|Overall Study|Lack of Efficacy, Physician Perception|3
1550974|NCT00087698|5064360|P1|Overall Study|Withdrawal by Subject|4
1550975|NCT00087698|5064360|P1|Overall Study|Adverse Event|4
1550976|NCT00087698|5064360|P1|Overall Study|Death from Other Causes|3
1550977|NCT00087698|5064360|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
1550978|NCT00087685|5064369|P1|Overall Study|Withdrawal by Subject|3
1550979|NCT00087685|5064369|P1|Overall Study|Progressive Disease|5
1550980|NCT00087685|5064369|P1|Overall Study|Non-Compliance|1
1550981|NCT00087685|5064369|P1|Overall Study|Adverse Event|5
1550982|NCT00087646|5064382|P4|Overall Study|Violation of Selection Criteria at Entry|1
1550983|NCT00087646|5064383|P3|Overall Study|Violation of Selection Criteria at Entry|0
1550984|NCT00087646|5064384|P2|Overall Study|Violation of Selection Criteria at Entry|0
1550985|NCT00087646|5064385|P1|Overall Study|Violation of Selection Criteria at Entry|1
1550986|NCT00087646|5064382|P4|Overall Study|Other Protocol Violation|0
1550987|NCT00087646|5064383|P3|Overall Study|Other Protocol Violation|0
1550988|NCT00087646|5064384|P2|Overall Study|Other Protocol Violation|1
1550989|NCT00087646|5064385|P1|Overall Study|Other Protocol Violation|3
1550990|NCT00087646|5064382|P4|Overall Study|Administrative/Other|2
1550991|NCT00087646|5064383|P3|Overall Study|Administrative/Other|1
1550992|NCT00087646|5064384|P2|Overall Study|Administrative/Other|1
1550993|NCT00087646|5064385|P1|Overall Study|Administrative/Other|6
1550994|NCT00087646|5064382|P4|Overall Study|Failure to Return|3
1550995|NCT00087646|5064383|P3|Overall Study|Failure to Return|2
1550996|NCT00087646|5064384|P2|Overall Study|Failure to Return|2
1550997|NCT00087646|5064385|P1|Overall Study|Failure to Return|5
1550998|NCT00087646|5064382|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
1550999|NCT00087646|5064383|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
1551000|NCT00087646|5064384|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
1551001|NCT00087646|5064385|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
1551002|NCT00087646|5064382|P4|Overall Study|Insufficient therapeutic response|51
1551003|NCT00087646|5064383|P3|Overall Study|Insufficient therapeutic response|38
1551004|NCT00087646|5064384|P2|Overall Study|Insufficient therapeutic response|24
1551005|NCT00087646|5064385|P1|Overall Study|Insufficient therapeutic response|64
1551006|NCT00087646|5064382|P4|Overall Study|Withdrawal by Subject|2
1551007|NCT00087646|5064383|P3|Overall Study|Withdrawal by Subject|2
1551008|NCT00087646|5064384|P2|Overall Study|Withdrawal by Subject|1
1551009|NCT00087646|5064385|P1|Overall Study|Withdrawal by Subject|6
1551010|NCT00087646|5064382|P4|Overall Study|Death|0
1551011|NCT00087646|5064383|P3|Overall Study|Death|0
1551012|NCT00087646|5064384|P2|Overall Study|Death|1
1551013|NCT00087646|5064385|P1|Overall Study|Death|0
1551014|NCT00087646|5064382|P4|Overall Study|Adverse Event|20
1551015|NCT00087646|5064383|P3|Overall Study|Adverse Event|18
1551016|NCT00087646|5064384|P2|Overall Study|Adverse Event|6
1551017|NCT00087646|5064385|P1|Overall Study|Adverse Event|37
1551018|NCT00087607|5064424|P2|Overall Study|Violation of Selection Criteria at Entry|1
1551019|NCT00087607|5064425|P1|Overall Study|Violation of Selection Criteria at Entry|0
1551020|NCT00087607|5064424|P2|Overall Study|Other Protocol Violation|2
1551021|NCT00087607|5064425|P1|Overall Study|Other Protocol Violation|5
1551022|NCT00087607|5064424|P2|Overall Study|Refused Treatment|7
1551023|NCT00087607|5064425|P1|Overall Study|Refused Treatment|5
1551024|NCT00087607|5064424|P2|Overall Study|Administrative|12
1551025|NCT00087607|5064425|P1|Overall Study|Administrative|12
1551026|NCT00087607|5064424|P2|Overall Study|Withdrew Consent|16
1551027|NCT00087607|5064425|P1|Overall Study|Withdrew Consent|12
1551028|NCT00087607|5064424|P2|Overall Study|Failure to return|17
1551029|NCT00087607|5064425|P1|Overall Study|Failure to return|21
1551030|NCT00087607|5064424|P2|Overall Study|Insufficient Therapeutic Response|42
1551031|NCT00087607|5064425|P1|Overall Study|Insufficient Therapeutic Response|53
1551032|NCT00087607|5064424|P2|Overall Study|Death|1
1551033|NCT00087607|5064425|P1|Overall Study|Death|0
1551034|NCT00087607|5064424|P2|Overall Study|Adverse Event|24
1551035|NCT00087607|5064425|P1|Overall Study|Adverse Event|14
1551036|NCT00087594|5064465|P2|Overall Study|Lack of Efficacy|5
1551037|NCT00087594|5064466|P1|Overall Study|Lack of Efficacy|2
1551038|NCT00087594|5064465|P2|Overall Study|Withdrawal by Subject|2
1551039|NCT00087594|5064466|P1|Overall Study|Withdrawal by Subject|4
1551040|NCT00087594|5064465|P2|Overall Study|Lost to Follow-up|2
1551041|NCT00087594|5064466|P1|Overall Study|Lost to Follow-up|0
1551042|NCT00087594|5064465|P2|Overall Study|Adverse Event|3
1551043|NCT00087594|5064466|P1|Overall Study|Adverse Event|2
1551044|NCT00087568|5064500|P2|Overall Study|Lack of Efficacy|1
1551045|NCT00087568|5064501|P1|Overall Study|Lack of Efficacy|24
1551046|NCT00087568|5064500|P2|Overall Study|Lost to Follow-up|0
1551047|NCT00087568|5064501|P1|Overall Study|Lost to Follow-up|1
1551048|NCT00087568|5064500|P2|Overall Study|Withdrawal by Subject|1
1551049|NCT00087568|5064501|P1|Overall Study|Withdrawal by Subject|1
1551050|NCT00087568|5064500|P2|Overall Study|Adverse Event|0
1551051|NCT00087568|5064501|P1|Overall Study|Adverse Event|4
1551052|NCT00087555|5064528|P3|Overall Study|Patient wanted to go back on Med|0
1551053|NCT00087555|5064529|P2|Overall Study|Patient wanted to go back on Med|0
1551054|NCT00087555|5064530|P1|Overall Study|Patient wanted to go back on Med|1
1551055|NCT00087555|5064528|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
1551056|NCT00087555|5064529|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
1551057|NCT00087555|5064530|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
1551058|NCT00087555|5064528|P3|Overall Study|Non Compliance|1
1551059|NCT00087555|5064529|P2|Overall Study|Non Compliance|0
1551060|NCT00087555|5064530|P1|Overall Study|Non Compliance|0
1551061|NCT00087555|5064528|P3|Overall Study|Lack of Efficacy|1
1551062|NCT00087555|5064529|P2|Overall Study|Lack of Efficacy|0
1551063|NCT00087555|5064530|P1|Overall Study|Lack of Efficacy|2
1551064|NCT00087555|5064528|P3|Overall Study|Withdrawal by Subject|1
1551065|NCT00087555|5064529|P2|Overall Study|Withdrawal by Subject|2
1551066|NCT00087555|5064530|P1|Overall Study|Withdrawal by Subject|3
1551067|NCT00087555|5064528|P3|Overall Study|Pregnancy|1
1551068|NCT00087555|5064529|P2|Overall Study|Pregnancy|1
1551069|NCT00087555|5064530|P1|Overall Study|Pregnancy|0
1551070|NCT00087555|5064528|P3|Overall Study|Screen Failure|0
1551071|NCT00087555|5064529|P2|Overall Study|Screen Failure|1
1551072|NCT00087555|5064530|P1|Overall Study|Screen Failure|1
1551073|NCT00087555|5064528|P3|Overall Study|Protocol Violation|2
1551074|NCT00087555|5064529|P2|Overall Study|Protocol Violation|0
1551075|NCT00087555|5064530|P1|Overall Study|Protocol Violation|0
1551076|NCT00087555|5064528|P3|Overall Study|Non - Compliance|0
1551077|NCT00087555|5064529|P2|Overall Study|Non - Compliance|0
1551078|NCT00087555|5064530|P1|Overall Study|Non - Compliance|1
1551079|NCT00087555|5064528|P3|Overall Study|Lost to Follow-up|1
1551080|NCT00087555|5064529|P2|Overall Study|Lost to Follow-up|1
1551081|NCT00087555|5064530|P1|Overall Study|Lost to Follow-up|0
1551082|NCT00087555|5064528|P3|Overall Study|Adverse Event|14
1551083|NCT00087555|5064529|P2|Overall Study|Adverse Event|6
1551084|NCT00087555|5064530|P1|Overall Study|Adverse Event|3
1551085|NCT00087529|5064540|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
1551086|NCT00087529|5064541|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
1551087|NCT00087529|5064540|P2|Overall Study|Disease Progression|4
1551088|NCT00087529|5064541|P1|Overall Study|Disease Progression|5
1551089|NCT00087529|5064540|P2|Overall Study|Participant Noncompliance|1
1551090|NCT00087529|5064541|P1|Overall Study|Participant Noncompliance|0
1551091|NCT00087529|5064540|P2|Overall Study|Initiation of Excluded Therapy|1
1551092|NCT00087529|5064541|P1|Overall Study|Initiation of Excluded Therapy|0
1551093|NCT00087529|5064540|P2|Overall Study|Physician Decision|8
1551094|NCT00087529|5064541|P1|Overall Study|Physician Decision|4
1551095|NCT00087529|5064540|P2|Overall Study|Participant Decision|37
1551096|NCT00087529|5064541|P1|Overall Study|Participant Decision|14
1551097|NCT00087529|5064540|P2|Overall Study|Lost to Follow-up|3
1551098|NCT00087529|5064541|P1|Overall Study|Lost to Follow-up|2
1551099|NCT00087529|5064540|P2|Overall Study|Pregnancy|1
1551100|NCT00087529|5064541|P1|Overall Study|Pregnancy|0
1551101|NCT00087529|5064540|P2|Overall Study|Adverse Event|8
1551102|NCT00087529|5064541|P1|Overall Study|Adverse Event|0
1551103|NCT00087529|5064540|P2|Overall Study|Death|0
1551104|NCT00087529|5064541|P1|Overall Study|Death|1
1551105|NCT00087516|5064556|P4|Overall Study|Other|0
1551106|NCT00087516|5064557|P3|Overall Study|Other|1
1551107|NCT00087516|5064558|P2|Overall Study|Other|0
1551108|NCT00087516|5064559|P1|Overall Study|Other|0
1551109|NCT00087516|5064556|P4|Overall Study|Recommendation of Primary Care Physician|1
1551110|NCT00087516|5064557|P3|Overall Study|Recommendation of Primary Care Physician|0
1551111|NCT00087516|5064558|P2|Overall Study|Recommendation of Primary Care Physician|0
1551112|NCT00087516|5064559|P1|Overall Study|Recommendation of Primary Care Physician|0
1551113|NCT00087516|5064556|P4|Overall Study|Patient was non-compliant|0
1551114|NCT00087516|5064557|P3|Overall Study|Patient was non-compliant|0
1551115|NCT00087516|5064558|P2|Overall Study|Patient was non-compliant|1
1551116|NCT00087516|5064559|P1|Overall Study|Patient was non-compliant|3
1551117|NCT00087516|5064556|P4|Overall Study|Patient moved|0
1551118|NCT00087516|5064557|P3|Overall Study|Patient moved|1
1551119|NCT00087516|5064558|P2|Overall Study|Patient moved|2
1551120|NCT00087516|5064559|P1|Overall Study|Patient moved|3
1551121|NCT00087516|5064556|P4|Overall Study|Protocol specified discontinuation|26
1551122|NCT00087516|5064557|P3|Overall Study|Protocol specified discontinuation|33
1551123|NCT00087516|5064558|P2|Overall Study|Protocol specified discontinuation|33
1551124|NCT00087516|5064559|P1|Overall Study|Protocol specified discontinuation|35
1551125|NCT00087516|5064556|P4|Overall Study|Site terminated|0
1551126|NCT00087516|5064557|P3|Overall Study|Site terminated|1
1551127|NCT00087516|5064558|P2|Overall Study|Site terminated|2
1551128|NCT00087516|5064559|P1|Overall Study|Site terminated|0
1551129|NCT00087516|5064556|P4|Overall Study|Withdrawal by Subject|12
1551130|NCT00087516|5064557|P3|Overall Study|Withdrawal by Subject|11
1551131|NCT00087516|5064558|P2|Overall Study|Withdrawal by Subject|27
1551132|NCT00087516|5064559|P1|Overall Study|Withdrawal by Subject|16
1551133|NCT00087516|5064556|P4|Overall Study|Protocol Violation|6
1551134|NCT00087516|5064557|P3|Overall Study|Protocol Violation|3
1551135|NCT00087516|5064558|P2|Overall Study|Protocol Violation|8
1551136|NCT00087516|5064559|P1|Overall Study|Protocol Violation|4
1551137|NCT00087516|5064556|P4|Overall Study|Lost to Follow-up|5
1551138|NCT00087516|5064557|P3|Overall Study|Lost to Follow-up|5
1551139|NCT00087516|5064558|P2|Overall Study|Lost to Follow-up|6
1551140|NCT00087516|5064559|P1|Overall Study|Lost to Follow-up|8
1551141|NCT00087516|5064556|P4|Overall Study|Lack of Efficacy|29
1551142|NCT00087516|5064557|P3|Overall Study|Lack of Efficacy|39
1551143|NCT00087516|5064558|P2|Overall Study|Lack of Efficacy|80
1551144|NCT00087516|5064559|P1|Overall Study|Lack of Efficacy|82
1551145|NCT00087516|5064556|P4|Overall Study|Adverse Event|6
1551146|NCT00087516|5064557|P3|Overall Study|Adverse Event|3
1551147|NCT00087516|5064558|P2|Overall Study|Adverse Event|10
1551148|NCT00087516|5064559|P1|Overall Study|Adverse Event|10
1551149|NCT00087490|5064588|P2|Overall Study|Randomized but not treated|18
1551150|NCT00087490|5064589|P1|Overall Study|Randomized but not treated|7
1551151|NCT00087490|5064588|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
1551152|NCT00087490|5064589|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
1551153|NCT00087490|5064588|P2|Overall Study|Protocol Violation or (/) Unspecified|201
1551154|NCT00087490|5064589|P1|Overall Study|Protocol Violation or (/) Unspecified|214
1551155|NCT00087490|5064588|P2|Overall Study|Lack of Efficacy|2
1551156|NCT00087490|5064589|P1|Overall Study|Lack of Efficacy|0
1551157|NCT00087490|5064588|P2|Overall Study|Adverse Event|8
1551158|NCT00087490|5064589|P1|Overall Study|Adverse Event|3
1551159|NCT00087490|5064588|P2|Overall Study|Death|4
1551160|NCT00087490|5064589|P1|Overall Study|Death|6
1551161|NCT00087438|5064623|P1|Overall Study|Ineligible / No protocol treatment|4
1551162|NCT00087152|5064627|P1|Overall Study|Ineligible|6
1551163|NCT00087139|5064636|P3|Overall Study|Extradural disease|1
1551164|NCT00087139|5064637|P2|Overall Study|Extradural disease|0
1551165|NCT00087139|5064638|P1|Overall Study|Extradural disease|0
1551166|NCT00087139|5064636|P3|Overall Study|Response achieved|0
1551167|NCT00087139|5064637|P2|Overall Study|Response achieved|1
1551168|NCT00087139|5064638|P1|Overall Study|Response achieved|0
1551169|NCT00087139|5064636|P3|Overall Study|Use of coumadin|0
1551170|NCT00087139|5064637|P2|Overall Study|Use of coumadin|0
1551171|NCT00087139|5064638|P1|Overall Study|Use of coumadin|1
1551172|NCT00087139|5064636|P3|Overall Study|Symptomatic deterioration|3
1551173|NCT00087139|5064637|P2|Overall Study|Symptomatic deterioration|1
1551174|NCT00087139|5064638|P1|Overall Study|Symptomatic deterioration|1
1551175|NCT00087139|5064636|P3|Overall Study|Ineligible|4
1551176|NCT00087139|5064637|P2|Overall Study|Ineligible|7
1551177|NCT00087139|5064638|P1|Overall Study|Ineligible|4
1551178|NCT00087139|5064636|P3|Overall Study|Disease progression|12
1551179|NCT00087139|5064637|P2|Overall Study|Disease progression|19
1551180|NCT00087139|5064638|P1|Overall Study|Disease progression|9
1551181|NCT00087139|5064636|P3|Overall Study|Physician Decision|1
1551182|NCT00087139|5064637|P2|Overall Study|Physician Decision|1
1551183|NCT00087139|5064638|P1|Overall Study|Physician Decision|1
1551184|NCT00087139|5064636|P3|Overall Study|Withdrawal by Subject|2
1551185|NCT00087139|5064637|P2|Overall Study|Withdrawal by Subject|2
1551186|NCT00087139|5064638|P1|Overall Study|Withdrawal by Subject|3
1551187|NCT00087139|5064636|P3|Overall Study|Death|0
1551188|NCT00087139|5064637|P2|Overall Study|Death|1
1551189|NCT00087139|5064638|P1|Overall Study|Death|2
1551190|NCT00087139|5064636|P3|Overall Study|Adverse Event|13
1551191|NCT00087139|5064637|P2|Overall Study|Adverse Event|17
1551192|NCT00087139|5064638|P1|Overall Study|Adverse Event|18
1551193|NCT00086996|5064653|P1|Overall Study|not eligible|5
1551194|NCT00086996|5064653|P1|Overall Study|not specified|6
1551195|NCT00086996|5064653|P1|Overall Study|Withdrawal by Subject|13
1551196|NCT00086996|5064653|P1|Overall Study|progression/relapse|7
1551197|NCT00086996|5064653|P1|Overall Study|Death|4
1551198|NCT00086996|5064653|P1|Overall Study|Adverse Event|29
1551199|NCT00086684|5064675|P3|Overall Study|Not specified|3
1551200|NCT00086684|5064676|P2|Overall Study|Not specified|2
1551201|NCT00086684|5064677|P1|Overall Study|Not specified|4
1551202|NCT00086684|5064675|P3|Overall Study|WITHDRAWAL OF CONSENT|5
1551203|NCT00086684|5064676|P2|Overall Study|WITHDRAWAL OF CONSENT|7
1551204|NCT00086684|5064677|P1|Overall Study|WITHDRAWAL OF CONSENT|5
1551205|NCT00086684|5064675|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
1551206|NCT00086684|5064676|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
1551207|NCT00086684|5064677|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
1551208|NCT00086684|5064675|P3|Overall Study|NONCOMPLIANCE|6
1551209|NCT00086684|5064676|P2|Overall Study|NONCOMPLIANCE|7
1551210|NCT00086684|5064677|P1|Overall Study|NONCOMPLIANCE|5
1551211|NCT00086684|5064675|P3|Overall Study|Withdrawal by Subject|10
1551212|NCT00086684|5064676|P2|Overall Study|Withdrawal by Subject|4
1551213|NCT00086684|5064677|P1|Overall Study|Withdrawal by Subject|0
1551214|NCT00086684|5064675|P3|Overall Study|Protocol Violation|0
1551215|NCT00086684|5064676|P2|Overall Study|Protocol Violation|3
1551216|NCT00086684|5064677|P1|Overall Study|Protocol Violation|8
1551217|NCT00086684|5064675|P3|Overall Study|Lost to Follow-up|10
1551218|NCT00086684|5064676|P2|Overall Study|Lost to Follow-up|8
1551219|NCT00086684|5064677|P1|Overall Study|Lost to Follow-up|15
1551220|NCT00086684|5064675|P3|Overall Study|Lack of Efficacy|5
1551221|NCT00086684|5064676|P2|Overall Study|Lack of Efficacy|6
1551222|NCT00086684|5064677|P1|Overall Study|Lack of Efficacy|6
1551223|NCT00086684|5064675|P3|Overall Study|Adverse Event|14
1551224|NCT00086684|5064676|P2|Overall Study|Adverse Event|17
1551225|NCT00086684|5064677|P1|Overall Study|Adverse Event|12
1551226|NCT00086619|5064690|P2|Overall Study|Protocol Violation|1
1551227|NCT00086619|5064691|P1|Overall Study|Protocol Violation|1
1551228|NCT00086619|5064690|P2|Overall Study|Adverse Event|10
1551229|NCT00086619|5064691|P1|Overall Study|Adverse Event|8
1551230|NCT00086619|5064690|P2|Overall Study|Withdrawal by Subject|6
1551231|NCT00086619|5064691|P1|Overall Study|Withdrawal by Subject|6
1551232|NCT00086580|5064701|P2|Observation Period|Not specified|7
1551233|NCT00086580|5064702|P1|Observation Period|Not specified|8
1551234|NCT00086580|5064701|P2|Observation Period|Death|55
1551235|NCT00086580|5064702|P1|Observation Period|Death|33
1551236|NCT00086580|5064701|P2|Observation Period|Withdrawal by Subject|2
1551237|NCT00086580|5064702|P1|Observation Period|Withdrawal by Subject|4
1551238|NCT00086580|5064701|P2|Observation Period|Unable to comply with protocol|1
1551239|NCT00086580|5064702|P1|Observation Period|Unable to comply with protocol|1
1551240|NCT00086580|5064701|P2|Follow-up Period|Not specified|6
1551241|NCT00086580|5064702|P1|Follow-up Period|Not specified|7
1551242|NCT00086580|5064701|P2|Follow-up Period|Death|7
1551243|NCT00086580|5064702|P1|Follow-up Period|Death|13
1551244|NCT00086580|5064701|P2|Follow-up Period|AE - not related|0
1551245|NCT00086580|5064702|P1|Follow-up Period|AE - not related|1
1551246|NCT00086580|5064701|P2|Follow-up Period|Physician Decision|1
1551247|NCT00086580|5064702|P1|Follow-up Period|Physician Decision|0
1551248|NCT00086580|5064701|P2|Follow-up Period|Withdrawal by Subject|6
1551249|NCT00086580|5064702|P1|Follow-up Period|Withdrawal by Subject|6
1551250|NCT00086580|5064701|P2|Follow-up Period|Unable to comply with protocol|0
1551251|NCT00086580|5064702|P1|Follow-up Period|Unable to comply with protocol|5
1551252|NCT00086580|5064701|P2|Follow-up Period|Disease progression|99
1551253|NCT00086580|5064702|P1|Follow-up Period|Disease progression|72
1551254|NCT00086580|5064701|P2|Treatment Period|Not specified|3
1551255|NCT00086580|5064702|P1|Treatment Period|Not specified|5
1551256|NCT00086580|5064701|P2|Treatment Period|Death|7
1551257|NCT00086580|5064702|P1|Treatment Period|Death|5
1551258|NCT00086580|5064701|P2|Treatment Period|Anemia or thrombocytopenia|4
1551259|NCT00086580|5064702|P1|Treatment Period|Anemia or thrombocytopenia|1
1551260|NCT00086580|5064701|P2|Treatment Period|Toxicity - treatment related|15
1551261|NCT00086580|5064702|P1|Treatment Period|Toxicity - treatment related|15
1551262|NCT00086580|5064701|P2|Treatment Period|AE - not treatment related|7
1551263|NCT00086580|5064702|P1|Treatment Period|AE - not treatment related|7
1551264|NCT00086580|5064701|P2|Treatment Period|Physician Decision|7
1551265|NCT00086580|5064702|P1|Treatment Period|Physician Decision|13
1551266|NCT00086580|5064701|P2|Treatment Period|Withdrawal by Subject|8
1551267|NCT00086580|5064702|P1|Treatment Period|Withdrawal by Subject|7
1551268|NCT00086580|5064701|P2|Treatment Period|Unable to comply with protocol|1
1551269|NCT00086580|5064702|P1|Treatment Period|Unable to comply with protocol|3
1551270|NCT00086580|5064701|P2|Treatment Period|Disease progression|8
1551271|NCT00086580|5064702|P1|Treatment Period|Disease progression|9
1551272|NCT00086411|5064750|P4|Overall Study|Lost to Follow-up|12
1551273|NCT00086411|5064751|P3|Overall Study|Lost to Follow-up|13
1551274|NCT00086411|5064752|P2|Overall Study|Lost to Follow-up|11
1551275|NCT00086411|5064753|P1|Overall Study|Lost to Follow-up|11
1551276|NCT00086385|5064767|P4|Overall Study|Death|1
1551277|NCT00086385|5064768|P3|Overall Study|Death|1
1551278|NCT00086385|5064769|P2|Overall Study|Death|2
1551279|NCT00086385|5064770|P1|Overall Study|Death|2
1551280|NCT00086515|5064782|P2|Phase B (Weeks 24-104)|Discontinued in error|0
1551281|NCT00086515|5064783|P1|Phase B (Weeks 24-104)|Discontinued in error|1
1551282|NCT00086515|5064782|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
1551283|NCT00086515|5064783|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
1551284|NCT00086515|5064782|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
1551285|NCT00086515|5064783|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
1551286|NCT00086515|5064782|P2|Phase B (Weeks 24-104)|Patient Died|1
1551287|NCT00086515|5064783|P1|Phase B (Weeks 24-104)|Patient Died|3
1551288|NCT00086515|5064782|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
1551289|NCT00086515|5064783|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
1551290|NCT00086515|5064782|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
1551291|NCT00086515|5064783|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
1551292|NCT00086515|5064782|P2|Phase B (Weeks 24-104)|Patient Moved|2
1551293|NCT00086515|5064783|P1|Phase B (Weeks 24-104)|Patient Moved|2
1551294|NCT00086515|5064782|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
1551295|NCT00086515|5064783|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
1551296|NCT00086515|5064782|P2|Phase B (Weeks 24-104)|Protocol Violation|0
1551297|NCT00086515|5064783|P1|Phase B (Weeks 24-104)|Protocol Violation|1
1551298|NCT00086515|5064782|P2|Phase B (Weeks 24-104)|Physician Decision|0
1551299|NCT00086515|5064783|P1|Phase B (Weeks 24-104)|Physician Decision|3
1551300|NCT00086515|5064782|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
1551301|NCT00086515|5064783|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
1551302|NCT00086515|5064782|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
1551303|NCT00086515|5064783|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
1551304|NCT00086515|5064782|P2|Phase B (Weeks 24-104)|Adverse Event|10
1551305|NCT00086515|5064783|P1|Phase B (Weeks 24-104)|Adverse Event|16
1551306|NCT00086515|5064782|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
1551307|NCT00086515|5064783|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
1551308|NCT00086515|5064782|P2|Phase A to Phase B Transition Period|Poor compliance|0
1551309|NCT00086515|5064783|P1|Phase A to Phase B Transition Period|Poor compliance|1
1551310|NCT00086515|5064782|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
1551311|NCT00086515|5064783|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
1551312|NCT00086515|5064782|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
1551313|NCT00086515|5064783|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
1551314|NCT00086515|5064782|P2|Phase A to Phase B Transition Period|Protocol Violation|1
1551315|NCT00086515|5064783|P1|Phase A to Phase B Transition Period|Protocol Violation|0
1551316|NCT00086515|5064782|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
1551317|NCT00086515|5064783|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
1551318|NCT00086515|5064782|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
1551319|NCT00086515|5064783|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
1551320|NCT00086515|5064782|P2|Phase A to Phase B Transition Period|Adverse Event|1
1551321|NCT00086515|5064783|P1|Phase A to Phase B Transition Period|Adverse Event|2
1551322|NCT00086515|5064782|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
1551323|NCT00086515|5064783|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
1551324|NCT00086515|5064782|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
1551325|NCT00086515|5064783|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
1551326|NCT00086515|5064782|P2|Phase A (Weeks 0-24)|Poor compliance|0
1551327|NCT00086515|5064783|P1|Phase A (Weeks 0-24)|Poor compliance|1
1551328|NCT00086515|5064782|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
1551329|NCT00086515|5064783|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
1551330|NCT00086515|5064782|P2|Phase A (Weeks 0-24)|Patient Moved|3
1551331|NCT00086515|5064783|P1|Phase A (Weeks 0-24)|Patient Moved|2
1551332|NCT00086515|5064782|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
1551333|NCT00086515|5064783|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
1551334|NCT00086515|5064782|P2|Phase A (Weeks 0-24)|Protocol Violation|1
1551335|NCT00086515|5064783|P1|Phase A (Weeks 0-24)|Protocol Violation|3
1551336|NCT00086515|5064782|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
1551337|NCT00086515|5064783|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
1551338|NCT00086515|5064782|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
1551339|NCT00086515|5064783|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
1551340|NCT00086515|5064782|P2|Phase A (Weeks 0-24)|Adverse Event|9
1551341|NCT00086515|5064783|P1|Phase A (Weeks 0-24)|Adverse Event|17
1551342|NCT00086502|5064795|P2|Overall Study|Patient Accidentally Unblinded|0
1551343|NCT00086502|5064796|P1|Overall Study|Patient Accidentally Unblinded|1
1551344|NCT00086502|5064795|P2|Overall Study|Protocol Discontinuation Criteria|3
1551345|NCT00086502|5064796|P1|Overall Study|Protocol Discontinuation Criteria|1
1551346|NCT00086502|5064795|P2|Overall Study|Patient Moved|1
1551347|NCT00086502|5064796|P1|Overall Study|Patient Moved|1
1551348|NCT00086502|5064795|P2|Overall Study|Withdrawal by Subject|6
1551349|NCT00086502|5064796|P1|Overall Study|Withdrawal by Subject|5
1551350|NCT00086502|5064795|P2|Overall Study|Protocol Violation|3
1551351|NCT00086502|5064796|P1|Overall Study|Protocol Violation|3
1551352|NCT00086502|5064795|P2|Overall Study|Pregnancy|1
1551353|NCT00086502|5064796|P1|Overall Study|Pregnancy|0
1551354|NCT00086502|5064795|P2|Overall Study|Physician Decision|1
1551355|NCT00086502|5064796|P1|Overall Study|Physician Decision|1
1551356|NCT00086502|5064795|P2|Overall Study|Lost to Follow-up|1
1551357|NCT00086502|5064796|P1|Overall Study|Lost to Follow-up|3
1551358|NCT00086502|5064795|P2|Overall Study|Lack of Efficacy|2
1551359|NCT00086502|5064796|P1|Overall Study|Lack of Efficacy|0
1551360|NCT00086502|5064795|P2|Overall Study|Adverse Event|2
1551361|NCT00086502|5064796|P1|Overall Study|Adverse Event|11
1551362|NCT00086346|5064821|P2|Patients Dosed With Test Article|Lack of Efficacy|0
1551363|NCT00086346|5064822|P1|Patients Dosed With Test Article|Lack of Efficacy|11
1551364|NCT00086346|5064821|P2|Patients Dosed With Test Article|Protocol Violation|3
1551365|NCT00086346|5064822|P1|Patients Dosed With Test Article|Protocol Violation|11
1551366|NCT00086346|5064821|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
1551367|NCT00086346|5064822|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
1551368|NCT00086346|5064821|P2|Patients Dosed With Test Article|Nonmedical event|3
1551369|NCT00086346|5064822|P1|Patients Dosed With Test Article|Nonmedical event|7
1551370|NCT00086346|5064821|P2|Patients Dosed With Test Article|Lost to Follow-up|3
1551371|NCT00086346|5064822|P1|Patients Dosed With Test Article|Lost to Follow-up|1
1551372|NCT00086346|5064821|P2|Patients Dosed With Test Article|Adverse Event|11
1551373|NCT00086346|5064822|P1|Patients Dosed With Test Article|Adverse Event|94
1551374|NCT00086346|5064821|P2|Randomization|Did not receive test article|4
1551375|NCT00086346|5064822|P1|Randomization|Did not receive test article|4
1551376|NCT00086281|5064849|P15|Phase 2|Adverse Event|0
1551377|NCT00086281|5064850|P14|Phase 2|Adverse Event|1
1551378|NCT00086281|5064851|P13|Phase 2|Adverse Event|1
1551379|NCT00086281|5064852|P12|Phase 2|Adverse Event|0
1551380|NCT00086281|5064853|P11|Phase 2|Adverse Event|0
1551381|NCT00086281|5064854|P10|Phase 2|Adverse Event|0
1551382|NCT00086281|5064855|P9|Phase 2|Adverse Event|0
1551383|NCT00086281|5064856|P8|Phase 2|Adverse Event|0
1551384|NCT00086281|5064857|P7|Phase 2|Adverse Event|0
1551385|NCT00086281|5064858|P6|Phase 2|Adverse Event|0
1551386|NCT00086281|5064859|P5|Phase 2|Adverse Event|0
1551387|NCT00086281|5064860|P4|Phase 2|Adverse Event|0
1551388|NCT00086281|5064861|P3|Phase 2|Adverse Event|0
1551389|NCT00086281|5064862|P2|Phase 2|Adverse Event|0
1551390|NCT00086281|5064863|P1|Phase 2|Adverse Event|0
1551391|NCT00086281|5064849|P15|Phase 1|Serious Adverse Event|1
1551392|NCT00086281|5064850|P14|Phase 1|Serious Adverse Event|0
1551393|NCT00086281|5064851|P13|Phase 1|Serious Adverse Event|0
1551394|NCT00086281|5064852|P12|Phase 1|Serious Adverse Event|0
1551395|NCT00086281|5064853|P11|Phase 1|Serious Adverse Event|0
1551396|NCT00086281|5064854|P10|Phase 1|Serious Adverse Event|0
1551397|NCT00086281|5064855|P9|Phase 1|Serious Adverse Event|0
1551398|NCT00086281|5064856|P8|Phase 1|Serious Adverse Event|0
1551399|NCT00086281|5064857|P7|Phase 1|Serious Adverse Event|0
1551400|NCT00086281|5064858|P6|Phase 1|Serious Adverse Event|0
1551401|NCT00086281|5064859|P5|Phase 1|Serious Adverse Event|0
1551402|NCT00086281|5064860|P4|Phase 1|Serious Adverse Event|0
1551403|NCT00086281|5064861|P3|Phase 1|Serious Adverse Event|0
1551404|NCT00086281|5064862|P2|Phase 1|Serious Adverse Event|0
1551405|NCT00086281|5064863|P1|Phase 1|Serious Adverse Event|0
1551406|NCT00086281|5064849|P15|Phase 1|Protocol Violation|0
1551407|NCT00086281|5064850|P14|Phase 1|Protocol Violation|0
1551408|NCT00086281|5064851|P13|Phase 1|Protocol Violation|0
1551409|NCT00086281|5064852|P12|Phase 1|Protocol Violation|0
1551410|NCT00086281|5064853|P11|Phase 1|Protocol Violation|1
1551411|NCT00086281|5064854|P10|Phase 1|Protocol Violation|0
1551412|NCT00086281|5064855|P9|Phase 1|Protocol Violation|0
1551413|NCT00086281|5064856|P8|Phase 1|Protocol Violation|0
1551414|NCT00086281|5064857|P7|Phase 1|Protocol Violation|0
1551415|NCT00086281|5064858|P6|Phase 1|Protocol Violation|0
1551416|NCT00086281|5064859|P5|Phase 1|Protocol Violation|0
1551417|NCT00086281|5064860|P4|Phase 1|Protocol Violation|0
1551418|NCT00086281|5064861|P3|Phase 1|Protocol Violation|0
1551419|NCT00086281|5064862|P2|Phase 1|Protocol Violation|0
1551420|NCT00086281|5064863|P1|Phase 1|Protocol Violation|0
1551421|NCT00086281|5064849|P15|Phase 1|Adverse Event|2
1551422|NCT00086281|5064850|P14|Phase 1|Adverse Event|1
1551423|NCT00086281|5064851|P13|Phase 1|Adverse Event|1
1551424|NCT00086281|5064852|P12|Phase 1|Adverse Event|1
1551425|NCT00086281|5064853|P11|Phase 1|Adverse Event|2
1551426|NCT00086281|5064854|P10|Phase 1|Adverse Event|1
1551427|NCT00086281|5064855|P9|Phase 1|Adverse Event|0
1551428|NCT00086281|5064856|P8|Phase 1|Adverse Event|0
1551429|NCT00086281|5064857|P7|Phase 1|Adverse Event|0
1551430|NCT00086281|5064858|P6|Phase 1|Adverse Event|0
1551431|NCT00086281|5064859|P5|Phase 1|Adverse Event|0
1551432|NCT00086281|5064860|P4|Phase 1|Adverse Event|0
1551433|NCT00086281|5064861|P3|Phase 1|Adverse Event|0
1551434|NCT00086281|5064862|P2|Phase 1|Adverse Event|0
1551435|NCT00086281|5064863|P1|Phase 1|Adverse Event|0
1551436|NCT00086307|5064876|P3|Overall Study|Withdrawal by Subject|2
1551437|NCT00086307|5064877|P2|Overall Study|Withdrawal by Subject|0
1551438|NCT00086307|5064878|P1|Overall Study|Withdrawal by Subject|0
1551439|NCT00086307|5064876|P3|Overall Study|Fatigue and difficulty falling asleep|1
1551440|NCT00086307|5064877|P2|Overall Study|Fatigue and difficulty falling asleep|0
1551441|NCT00086307|5064878|P1|Overall Study|Fatigue and difficulty falling asleep|0
1551442|NCT00086307|5064876|P3|Overall Study|Suicidal ideation|1
1551443|NCT00086307|5064877|P2|Overall Study|Suicidal ideation|0
1551444|NCT00086307|5064878|P1|Overall Study|Suicidal ideation|0
1551445|NCT00086307|5064876|P3|Overall Study|Constipation and sleepiness|1
1551446|NCT00086307|5064877|P2|Overall Study|Constipation and sleepiness|0
1551447|NCT00086307|5064878|P1|Overall Study|Constipation and sleepiness|0
1551448|NCT00086307|5064876|P3|Overall Study|Nausea and headaches|1
1551449|NCT00086307|5064877|P2|Overall Study|Nausea and headaches|0
1551450|NCT00086307|5064878|P1|Overall Study|Nausea and headaches|0
1551451|NCT00086307|5064876|P3|Overall Study|Shortness of breath and muscle spasms|0
1551452|NCT00086307|5064877|P2|Overall Study|Shortness of breath and muscle spasms|0
1551453|NCT00086307|5064878|P1|Overall Study|Shortness of breath and muscle spasms|1
1551454|NCT00086307|5064876|P3|Overall Study|Lack of Efficacy|2
1551455|NCT00086307|5064877|P2|Overall Study|Lack of Efficacy|1
1551456|NCT00086307|5064878|P1|Overall Study|Lack of Efficacy|1
1551457|NCT00086190|5064889|P3|Overall Study|Worsening depression|2
1551458|NCT00086190|5064890|P2|Overall Study|Worsening depression|0
1551459|NCT00086190|5064891|P1|Overall Study|Worsening depression|0
1551460|NCT00086190|5064889|P3|Overall Study|Moved|0
1551461|NCT00086190|5064890|P2|Overall Study|Moved|0
1551462|NCT00086190|5064891|P1|Overall Study|Moved|1
1551463|NCT00086190|5064889|P3|Overall Study|Protocol Violation|0
1551464|NCT00086190|5064890|P2|Overall Study|Protocol Violation|0
1551465|NCT00086190|5064891|P1|Overall Study|Protocol Violation|1
1551466|NCT00086190|5064889|P3|Overall Study|Withdrawal by Subject|2
1551467|NCT00086190|5064890|P2|Overall Study|Withdrawal by Subject|2
1551468|NCT00086190|5064891|P1|Overall Study|Withdrawal by Subject|0
1551469|NCT00086190|5064889|P3|Overall Study|Adverse Event|2
1551470|NCT00086190|5064890|P2|Overall Study|Adverse Event|2
1551471|NCT00086190|5064891|P1|Overall Study|Adverse Event|6
1551472|NCT00086047|5064960|P2|Overall Study|Physician Decision|1
1551473|NCT00086047|5064961|P1|Overall Study|Physician Decision|0
1551474|NCT00086047|5064960|P2|Overall Study|Lost to Follow-up|6
1551475|NCT00086047|5064961|P1|Overall Study|Lost to Follow-up|7
1551476|NCT00085917|5064969|P2|Overall Study|Adverse Event|3
1551477|NCT00085917|5064970|P1|Overall Study|Adverse Event|4
1551478|NCT00085735|5064999|P6|Overall Study|Pt transferred to inst w/out study open|0
1551479|NCT00085735|5065000|P5|Overall Study|Pt transferred to inst w/out study open|0
1551480|NCT00085735|5065001|P4|Overall Study|Pt transferred to inst w/out study open|0
1551481|NCT00085735|5065002|P3|Overall Study|Pt transferred to inst w/out study open|0
1551482|NCT00085735|5065003|P2|Overall Study|Pt transferred to inst w/out study open|0
1551483|NCT00085735|5065004|P1|Overall Study|Pt transferred to inst w/out study open|1
1551484|NCT00085735|5064999|P6|Overall Study|Reason not documented|0
1551485|NCT00085735|5065000|P5|Overall Study|Reason not documented|1
1551486|NCT00085735|5065001|P4|Overall Study|Reason not documented|0
1551487|NCT00085735|5065002|P3|Overall Study|Reason not documented|1
1551488|NCT00085735|5065003|P2|Overall Study|Reason not documented|0
1551489|NCT00085735|5065004|P1|Overall Study|Reason not documented|1
1551490|NCT00085735|5064999|P6|Overall Study|Excess residual disease|4
1551491|NCT00085735|5065000|P5|Overall Study|Excess residual disease|1
1551492|NCT00085735|5065001|P4|Overall Study|Excess residual disease|1
1551493|NCT00085735|5065002|P3|Overall Study|Excess residual disease|1
1551494|NCT00085735|5065003|P2|Overall Study|Excess residual disease|2
1551495|NCT00085735|5065004|P1|Overall Study|Excess residual disease|2
1551496|NCT00085735|5064999|P6|Overall Study|Patient ineligible|8
1551497|NCT00085735|5065000|P5|Overall Study|Patient ineligible|17
1551498|NCT00085735|5065001|P4|Overall Study|Patient ineligible|7
1551499|NCT00085735|5065002|P3|Overall Study|Patient ineligible|3
1551500|NCT00085735|5065003|P2|Overall Study|Patient ineligible|0
1551501|NCT00085735|5065004|P1|Overall Study|Patient ineligible|1
1551502|NCT00085735|5064999|P6|Overall Study|Withdrawal by Subject|8
1551503|NCT00085735|5065000|P5|Overall Study|Withdrawal by Subject|7
1551504|NCT00085735|5065001|P4|Overall Study|Withdrawal by Subject|5
1551505|NCT00085735|5065002|P3|Overall Study|Withdrawal by Subject|4
1551506|NCT00085735|5065003|P2|Overall Study|Withdrawal by Subject|0
1551507|NCT00085735|5065004|P1|Overall Study|Withdrawal by Subject|1
1551508|NCT00085735|5064999|P6|Overall Study|Protocol Violation|0
1551509|NCT00085735|5065000|P5|Overall Study|Protocol Violation|0
1551510|NCT00085735|5065001|P4|Overall Study|Protocol Violation|0
1551511|NCT00085735|5065002|P3|Overall Study|Protocol Violation|0
1551512|NCT00085735|5065003|P2|Overall Study|Protocol Violation|0
1551513|NCT00085735|5065004|P1|Overall Study|Protocol Violation|1
1551514|NCT00085735|5064999|P6|Overall Study|Physician Decision|8
1551515|NCT00085735|5065000|P5|Overall Study|Physician Decision|11
1551516|NCT00085735|5065001|P4|Overall Study|Physician Decision|3
1551517|NCT00085735|5065002|P3|Overall Study|Physician Decision|2
1551518|NCT00085735|5065003|P2|Overall Study|Physician Decision|3
1551519|NCT00085735|5065004|P1|Overall Study|Physician Decision|2
1551520|NCT00085735|5064999|P6|Overall Study|Lost to Follow-up|0
1551521|NCT00085735|5065000|P5|Overall Study|Lost to Follow-up|1
1551522|NCT00085735|5065001|P4|Overall Study|Lost to Follow-up|0
1551523|NCT00085735|5065002|P3|Overall Study|Lost to Follow-up|0
1551524|NCT00085735|5065003|P2|Overall Study|Lost to Follow-up|1
1551525|NCT00085735|5065004|P1|Overall Study|Lost to Follow-up|0
1551526|NCT00085735|5064999|P6|Overall Study|Lack of Efficacy|3
1551527|NCT00085735|5065000|P5|Overall Study|Lack of Efficacy|4
1551528|NCT00085735|5065001|P4|Overall Study|Lack of Efficacy|3
1551529|NCT00085735|5065002|P3|Overall Study|Lack of Efficacy|6
1551530|NCT00085735|5065003|P2|Overall Study|Lack of Efficacy|4
1551531|NCT00085735|5065004|P1|Overall Study|Lack of Efficacy|2
1551532|NCT00085735|5064999|P6|Overall Study|Adverse Event|0
1551533|NCT00085735|5065000|P5|Overall Study|Adverse Event|0
1551534|NCT00085735|5065001|P4|Overall Study|Adverse Event|0
1551535|NCT00085735|5065002|P3|Overall Study|Adverse Event|0
1551536|NCT00085735|5065003|P2|Overall Study|Adverse Event|0
1551537|NCT00085735|5065004|P1|Overall Study|Adverse Event|1
1551538|NCT00085709|5065032|P2|Overall Study|Withdrawal by Subject|1
1551539|NCT00085709|5065033|P1|Overall Study|Withdrawal by Subject|2
1551540|NCT00085709|5065032|P2|Overall Study|Not eligible|19
1551541|NCT00085709|5065033|P1|Overall Study|Not eligible|19
1551542|NCT00085709|5065032|P2|Overall Study|Not protocol specified|22
1551543|NCT00085709|5065033|P1|Overall Study|Not protocol specified|12
1551544|NCT00085709|5065032|P2|Overall Study|Progression|4
1551545|NCT00085709|5065033|P1|Overall Study|Progression|3
1551546|NCT00085709|5065032|P2|Overall Study|Refusal unrelated to adverse events|2
1551547|NCT00085709|5065033|P1|Overall Study|Refusal unrelated to adverse events|1
1551548|NCT00085709|5065032|P2|Overall Study|Death|2
1551549|NCT00085709|5065033|P1|Overall Study|Death|8
1551550|NCT00085709|5065032|P2|Overall Study|Adverse Event|0
1551551|NCT00085709|5065033|P1|Overall Study|Adverse Event|8
1551552|NCT00085644|5065049|P3|Open-Label Period|Personal reason|4
1551553|NCT00085644|5065050|P2|Open-Label Period|Personal reason|0
1551554|NCT00085644|5065051|P1|Open-Label Period|Personal reason|0
1551555|NCT00085644|5065049|P3|Open-Label Period|Protocol Violation|4
1551556|NCT00085644|5065050|P2|Open-Label Period|Protocol Violation|0
1551557|NCT00085644|5065051|P1|Open-Label Period|Protocol Violation|0
1551558|NCT00085644|5065049|P3|Open-Label Period|Contemplating pregnancy|3
1551559|NCT00085644|5065050|P2|Open-Label Period|Contemplating pregnancy|0
1551560|NCT00085644|5065051|P1|Open-Label Period|Contemplating pregnancy|0
1551561|NCT00085644|5065049|P3|Open-Label Period|Pregnancy|3
1551562|NCT00085644|5065050|P2|Open-Label Period|Pregnancy|0
1551563|NCT00085644|5065051|P1|Open-Label Period|Pregnancy|0
1551564|NCT00085644|5065049|P3|Open-Label Period|Lack of Efficacy|15
1551565|NCT00085644|5065050|P2|Open-Label Period|Lack of Efficacy|0
1551566|NCT00085644|5065051|P1|Open-Label Period|Lack of Efficacy|0
1551567|NCT00085644|5065049|P3|Open-Label Period|Lost to Follow-up|13
1551568|NCT00085644|5065050|P2|Open-Label Period|Lost to Follow-up|0
1551569|NCT00085644|5065051|P1|Open-Label Period|Lost to Follow-up|0
1551570|NCT00085644|5065049|P3|Open-Label Period|Withdrawal by Subject|29
1551571|NCT00085644|5065050|P2|Open-Label Period|Withdrawal by Subject|0
1551572|NCT00085644|5065051|P1|Open-Label Period|Withdrawal by Subject|0
1551573|NCT00085644|5065049|P3|Open-Label Period|Adverse Event|38
1551574|NCT00085644|5065050|P2|Open-Label Period|Adverse Event|0
1551575|NCT00085644|5065051|P1|Open-Label Period|Adverse Event|0
1551576|NCT00085644|5065049|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
1551577|NCT00085644|5065050|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
1551578|NCT00085644|5065051|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
1551579|NCT00085644|5065049|P3|Double-Blind Period|Contemplating pregnancy|0
1551580|NCT00085644|5065050|P2|Double-Blind Period|Contemplating pregnancy|0
1551581|NCT00085644|5065051|P1|Double-Blind Period|Contemplating pregnancy|1
1551582|NCT00085644|5065049|P3|Double-Blind Period|Lack/loss of efficacy|0
1551583|NCT00085644|5065050|P2|Double-Blind Period|Lack/loss of efficacy|2
1551584|NCT00085644|5065051|P1|Double-Blind Period|Lack/loss of efficacy|2
1551585|NCT00085644|5065049|P3|Double-Blind Period|Lost to Follow-up|0
1551586|NCT00085644|5065050|P2|Double-Blind Period|Lost to Follow-up|1
1551587|NCT00085644|5065051|P1|Double-Blind Period|Lost to Follow-up|2
1551588|NCT00085644|5065049|P3|Double-Blind Period|Withdrawal by Subject|0
1551589|NCT00085644|5065050|P2|Double-Blind Period|Withdrawal by Subject|0
1551590|NCT00085644|5065051|P1|Double-Blind Period|Withdrawal by Subject|3
1551591|NCT00085644|5065049|P3|Double-Blind Period|Adverse Event|0
1551592|NCT00085644|5065050|P2|Double-Blind Period|Adverse Event|2
1551593|NCT00085644|5065051|P1|Double-Blind Period|Adverse Event|5
1551594|NCT00085631|5065092|P3|Overall Study|Missing Data|7
1551595|NCT00085631|5065093|P2|Overall Study|Missing Data|11
1551596|NCT00085631|5065094|P1|Overall Study|Missing Data|4
1551597|NCT00085566|5065104|P3|Overall Study|Clinical progression|1
1551598|NCT00085566|5065105|P2|Overall Study|Clinical progression|0
1551599|NCT00085566|5065106|P1|Overall Study|Clinical progression|0
1551600|NCT00085566|5065104|P3|Overall Study|Patient Not treated|3
1551601|NCT00085566|5065105|P2|Overall Study|Patient Not treated|0
1551602|NCT00085566|5065106|P1|Overall Study|Patient Not treated|0
1551603|NCT00085566|5065104|P3|Overall Study|Adverse Event|10
1551604|NCT00085566|5065105|P2|Overall Study|Adverse Event|0
1551605|NCT00085566|5065106|P1|Overall Study|Adverse Event|0
1551606|NCT00085540|5065116|P2|Overall Study|Protocol Violation|1
1551607|NCT00085540|5065117|P1|Overall Study|Protocol Violation|0
1551608|NCT00085540|5065116|P2|Overall Study|Withdrawal by Subject|1
1551609|NCT00085540|5065117|P1|Overall Study|Withdrawal by Subject|0
1551610|NCT00085423|5065129|P1|Overall Study|screen failure|1
1551611|NCT00085423|5065129|P1|Overall Study|Withdrawal by Subject|1
1551612|NCT00085202|5065175|P2|Overall Study|Progressive disease|11
1551613|NCT00085202|5065176|P1|Overall Study|Progressive disease|1
1551614|NCT00085202|5065175|P2|Overall Study|Physician Decision|1
1551615|NCT00085202|5065176|P1|Overall Study|Physician Decision|4
1551616|NCT00085202|5065175|P2|Overall Study|Withdrawal by Subject|1
1551617|NCT00085202|5065176|P1|Overall Study|Withdrawal by Subject|2
1551618|NCT00085202|5065175|P2|Overall Study|Non-specified|5
1551619|NCT00085202|5065176|P1|Overall Study|Non-specified|3
1551620|NCT00085202|5065175|P2|Overall Study|Excessive toxicity|5
1551621|NCT00085202|5065176|P1|Overall Study|Excessive toxicity|6
1551622|NCT00085202|5065175|P2|Overall Study|Bone involvement confirmed by bone scan|1
1551623|NCT00085202|5065176|P1|Overall Study|Bone involvement confirmed by bone scan|0
1551624|NCT00085202|5065175|P2|Overall Study|Still on therapy|0
1551625|NCT00085202|5065176|P1|Overall Study|Still on therapy|2
1551626|NCT00085098|5065197|P2|Overall Study|Ineligible|1
1551627|NCT00085098|5065198|P1|Overall Study|Ineligible|1
1551628|NCT00085098|5065197|P2|Overall Study|Withdrawal by Subject|1
1551629|NCT00085098|5065198|P1|Overall Study|Withdrawal by Subject|0
1551630|NCT00084864|5065208|P4|Overall Study|Adverse Event|0
1551631|NCT00084864|5065209|P3|Overall Study|Adverse Event|0
1551632|NCT00084864|5065210|P2|Overall Study|Adverse Event|0
1551633|NCT00084864|5065211|P1|Overall Study|Adverse Event|1
1551634|NCT00084838|5065237|P1|Overall Study|Ineligible|4
1551635|NCT00084838|5065237|P1|Overall Study|Pt Non-Compliance|1
1551636|NCT00084838|5065237|P1|Overall Study|Progressive Disease|4
1551637|NCT00084838|5065237|P1|Overall Study|Withdrawal by Subject|1
1551638|NCT00084838|5065237|P1|Overall Study|Adverse Event|2
1551639|NCT00084838|5065237|P1|Overall Study|Death|1
1551640|NCT00084747|5065259|P1|Overall Study|Withdrawal by Subject|2
1551641|NCT00084747|5065259|P1|Overall Study|Death|3
1551642|NCT00084747|5065259|P1|Overall Study|Relapsed|8
1551643|NCT00084682|5065264|P1|Overall Study|Withdrawal by Subject|1
1551644|NCT00084617|5065268|P1|Overall Study|Protocol Violation|1
1551645|NCT00084617|5065268|P1|Overall Study|Lack of Efficacy|1
1551646|NCT00084617|5065268|P1|Overall Study|Withdrawal by Subject|7
1551647|NCT00084487|5065274|P1|Overall Study|Death|1
1551648|NCT00084318|5065318|P2|Overall Study|No protocol treatment|0
1551649|NCT00084318|5065319|P1|Overall Study|No protocol treatment|2
1551650|NCT00084318|5065318|P2|Overall Study|Protocol Violation|11
1551651|NCT00084318|5065319|P1|Overall Study|Protocol Violation|15
1551652|NCT00084318|5065318|P2|Overall Study|Withdrawal by Subject|2
1551653|NCT00084318|5065319|P1|Overall Study|Withdrawal by Subject|5
1551654|NCT00084266|5065337|P2|Overall Study|Randomized not treated|20
1551655|NCT00084266|5065338|P1|Overall Study|Randomized not treated|21
1551656|NCT00084266|5065337|P2|Overall Study|Other|344
1551657|NCT00084266|5065338|P1|Overall Study|Other|360
1551658|NCT00084266|5065337|P2|Overall Study|Participant not willing to participate|8
1551659|NCT00084266|5065338|P1|Overall Study|Participant not willing to participate|3
1551660|NCT00084266|5065337|P2|Overall Study|Lost to Follow-up|3
1551661|NCT00084266|5065338|P1|Overall Study|Lost to Follow-up|5
1551662|NCT00084266|5065337|P2|Overall Study|Lack of Efficacy|4
1551663|NCT00084266|5065338|P1|Overall Study|Lack of Efficacy|2
1551664|NCT00084266|5065337|P2|Overall Study|Adverse Event|5
1551665|NCT00084266|5065338|P1|Overall Study|Adverse Event|8
1551666|NCT00084266|5065337|P2|Overall Study|Death|39
1551667|NCT00084266|5065338|P1|Overall Study|Death|42
1551668|NCT00084136|5065375|P3|NRTI Comparison|Not reason above|0
1551669|NCT00084136|5065376|P2|NRTI Comparison|Not reason above|0
1551670|NCT00084136|5065377|P1|NRTI Comparison|Not reason above|1
1551671|NCT00084136|5065375|P3|NRTI Comparison|Clinic site closed|14
1551672|NCT00084136|5065376|P2|NRTI Comparison|Clinic site closed|0
1551673|NCT00084136|5065377|P1|NRTI Comparison|Clinic site closed|12
1551674|NCT00084136|5065375|P3|NRTI Comparison|Withdrawal by Subject|38
1551675|NCT00084136|5065376|P2|NRTI Comparison|Withdrawal by Subject|0
1551676|NCT00084136|5065377|P1|NRTI Comparison|Withdrawal by Subject|54
1551677|NCT00084136|5065375|P3|NRTI Comparison|Lost to Follow-up|12
1551678|NCT00084136|5065376|P2|NRTI Comparison|Lost to Follow-up|0
1551679|NCT00084136|5065377|P1|NRTI Comparison|Lost to Follow-up|14
1551680|NCT00084136|5065375|P3|NRTI Comparison|Death|18
1551681|NCT00084136|5065376|P2|NRTI Comparison|Death|0
1551682|NCT00084136|5065377|P1|NRTI Comparison|Death|20
1551683|NCT00084136|5065375|P3|PI Comparison|Clinic site closed|0
1551684|NCT00084136|5065376|P2|PI Comparison|Clinic site closed|0
1551685|NCT00084136|5065377|P1|PI Comparison|Clinic site closed|1
1551686|NCT00084136|5065375|P3|PI Comparison|Withdrawal by Subject|0
1551687|NCT00084136|5065376|P2|PI Comparison|Withdrawal by Subject|30
1551688|NCT00084136|5065377|P1|PI Comparison|Withdrawal by Subject|33
1551689|NCT00084136|5065375|P3|PI Comparison|Lost to Follow-up|0
1551690|NCT00084136|5065376|P2|PI Comparison|Lost to Follow-up|8
1551691|NCT00084136|5065377|P1|PI Comparison|Lost to Follow-up|11
1551692|NCT00084136|5065375|P3|PI Comparison|Death|0
1551693|NCT00084136|5065376|P2|PI Comparison|Death|9
1551694|NCT00084136|5065377|P1|PI Comparison|Death|10
1551695|NCT00084084|5065436|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
1551696|NCT00084084|5065436|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
1551697|NCT00083915|5065446|P2|Overall Study|Insurance issues|1
1551698|NCT00083915|5065447|P1|Overall Study|Insurance issues|1
1551699|NCT00083915|5065446|P2|Overall Study|No response|1
1551700|NCT00083915|5065447|P1|Overall Study|No response|3
1551701|NCT00083915|5065446|P2|Overall Study|Failure to collect|0
1551702|NCT00083915|5065447|P1|Overall Study|Failure to collect|3
1551703|NCT00083915|5065446|P2|Overall Study|disease progression|23
1551704|NCT00083915|5065447|P1|Overall Study|disease progression|18
1551705|NCT00083915|5065446|P2|Overall Study|Withdrawal by Subject|3
1551706|NCT00083915|5065447|P1|Overall Study|Withdrawal by Subject|8
1551707|NCT00083915|5065446|P2|Overall Study|Physician Decision|6
1551708|NCT00083915|5065447|P1|Overall Study|Physician Decision|11
1551709|NCT00083915|5065446|P2|Overall Study|Death|3
1551710|NCT00083915|5065447|P1|Overall Study|Death|6
1551711|NCT00083889|5065455|P2|Overall Study|Crossover to SU011248|25
1551712|NCT00083889|5065456|P1|Overall Study|Crossover to SU011248|0
1551713|NCT00083889|5065455|P2|Overall Study|Completed on marketed sunitinub|0
1551714|NCT00083889|5065456|P1|Overall Study|Completed on marketed sunitinub|3
1551715|NCT00083889|5065455|P2|Overall Study|Randomized: did not take study drug|15
1551716|NCT00083889|5065456|P1|Overall Study|Randomized: did not take study drug|0
1551717|NCT00083889|5065455|P2|Overall Study|Decision of sponsor|4
1551718|NCT00083889|5065456|P1|Overall Study|Decision of sponsor|32
1551719|NCT00083889|5065455|P2|Overall Study|Lack of Efficacy|219
1551720|NCT00083889|5065456|P1|Overall Study|Lack of Efficacy|240
1551721|NCT00083889|5065455|P2|Overall Study|Withdrawal by Subject|24
1551722|NCT00083889|5065456|P1|Overall Study|Withdrawal by Subject|22
1551723|NCT00083889|5065455|P2|Overall Study|Protocol Violation|2
1551724|NCT00083889|5065456|P1|Overall Study|Protocol Violation|2
1551725|NCT00083889|5065455|P2|Overall Study|Adverse Event|86
1551726|NCT00083889|5065456|P1|Overall Study|Adverse Event|76
1551727|NCT00083759|5065514|P2|Overall Study|Other|13
1551728|NCT00083759|5065515|P1|Overall Study|Other|14
1551729|NCT00083759|5065514|P2|Overall Study|Sponsor's Discretion|29
1551730|NCT00083759|5065515|P1|Overall Study|Sponsor's Discretion|28
1551731|NCT00083759|5065514|P2|Overall Study|Non-Compliance|0
1551732|NCT00083759|5065515|P1|Overall Study|Non-Compliance|1
1551733|NCT00083759|5065514|P2|Overall Study|Subject Withdrew Consent|2
1551734|NCT00083759|5065515|P1|Overall Study|Subject Withdrew Consent|2
1551735|NCT00083759|5065514|P2|Overall Study|Inadequate Therapeutic Response|35
1551736|NCT00083759|5065515|P1|Overall Study|Inadequate Therapeutic Response|32
1551737|NCT00083759|5065514|P2|Overall Study|Death|1
1551738|NCT00083759|5065515|P1|Overall Study|Death|1
1551739|NCT00083759|5065514|P2|Overall Study|Lost to Follow-up|0
1551740|NCT00083759|5065515|P1|Overall Study|Lost to Follow-up|1
1551741|NCT00083759|5065514|P2|Overall Study|Adverse Event|3
1551742|NCT00083759|5065515|P1|Overall Study|Adverse Event|5
1551743|NCT00083616|5065533|P1|Overall Study|Other|6
1551744|NCT00083616|5065533|P1|Overall Study|Non-compliance|1
1551745|NCT00083616|5065533|P1|Overall Study|Ineligibility determined|2
1551746|NCT00083616|5065533|P1|Overall Study|Withdrawal by Subject|3
1551747|NCT00083616|5065533|P1|Overall Study|Physician Decision|2
1551748|NCT00083616|5065533|P1|Overall Study|Lost to Follow-up|1
1551749|NCT00083616|5065533|P1|Overall Study|Disease Progression|16
1551750|NCT00082888|5065558|P1|Overall Study|Still receiving treatment|4
1551751|NCT00082888|5065558|P1|Overall Study|Other Medical Problems|2
1551752|NCT00082888|5065558|P1|Overall Study|Alternate Treatment|1
1551753|NCT00082888|5065558|P1|Overall Study|Withdrawal by Subject|9
1551754|NCT00082888|5065558|P1|Overall Study|Adverse Event|4
1551755|NCT00082888|5065558|P1|Overall Study|Death|2
1551756|NCT00082810|5065562|P1|Overall Study|Withdrawal by Subject|4
1551757|NCT00082810|5065562|P1|Overall Study|Progressive disease|24
1551758|NCT00082810|5065562|P1|Overall Study|Adverse Event|3
1551759|NCT00082758|5065572|P3|Overall Study|Protocol Violation|0
1551760|NCT00082758|5065573|P2|Overall Study|Protocol Violation|1
1551761|NCT00082758|5065574|P1|Overall Study|Protocol Violation|0
1551762|NCT00082758|5065572|P3|Overall Study|Withdrawal by Subject|0
1551763|NCT00082758|5065573|P2|Overall Study|Withdrawal by Subject|0
1551764|NCT00082758|5065574|P1|Overall Study|Withdrawal by Subject|3
1551765|NCT00082758|5065572|P3|Overall Study|Physician Decision|0
1551766|NCT00082758|5065573|P2|Overall Study|Physician Decision|1
1551767|NCT00082758|5065574|P1|Overall Study|Physician Decision|0
1551768|NCT00082758|5065572|P3|Overall Study|Lack of Efficacy|0
1551769|NCT00082758|5065573|P2|Overall Study|Lack of Efficacy|13
1551770|NCT00082758|5065574|P1|Overall Study|Lack of Efficacy|12
1551771|NCT00082758|5065572|P3|Overall Study|Adverse Event|0
1551772|NCT00082758|5065573|P2|Overall Study|Adverse Event|2
1551773|NCT00082758|5065574|P1|Overall Study|Adverse Event|0
1551774|NCT00083226|5065582|P1|Overall Study|ineligible or not receiving treatment|4
1551775|NCT00083226|5065582|P1|Overall Study|Other|2
1551776|NCT00083226|5065582|P1|Overall Study|Withdrawal by Subject|4
1551777|NCT00083226|5065582|P1|Overall Study|Death|4
1551778|NCT00083226|5065582|P1|Overall Study|Adverse Event|9
1551779|NCT00083226|5065582|P1|Overall Study|Lack of Efficacy|19
1551780|NCT00082628|5065626|P5|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
1551781|NCT00082628|5065627|P4|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
1551782|NCT00082628|5065628|P3|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
1551783|NCT00082628|5065629|P2|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
1551784|NCT00082628|5065630|P1|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
1551785|NCT00082628|5065626|P5|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1551786|NCT00082628|5065627|P4|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
1551787|NCT00082628|5065628|P3|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1551788|NCT00082628|5065629|P2|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1551789|NCT00082628|5065630|P1|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1551790|NCT00082628|5065626|P5|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
1551791|NCT00082628|5065627|P4|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1551792|NCT00082628|5065628|P3|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1551793|NCT00082628|5065629|P2|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1551794|NCT00082628|5065630|P1|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1551795|NCT00082628|5065626|P5|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
1551796|NCT00082628|5065627|P4|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
1551797|NCT00082628|5065628|P3|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
1551798|NCT00082628|5065629|P2|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
1551799|NCT00082628|5065630|P1|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
1551800|NCT00082628|5065626|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
1551801|NCT00082628|5065627|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
1551802|NCT00082628|5065628|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
1551803|NCT00082628|5065629|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
1551804|NCT00082628|5065630|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
1551805|NCT00082628|5065626|P5|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
1551806|NCT00082628|5065627|P4|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
1551807|NCT00082628|5065628|P3|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
1551808|NCT00082628|5065629|P2|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
1551809|NCT00082628|5065630|P1|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
1551810|NCT00082628|5065626|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1551811|NCT00082628|5065627|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1551812|NCT00082628|5065628|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1551813|NCT00082628|5065629|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
1551814|NCT00082628|5065630|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1551815|NCT00082433|5065650|P2|Overall Study|Impending surgery|1
1551816|NCT00082433|5065651|P1|Overall Study|Impending surgery|0
1551817|NCT00082433|5065650|P2|Overall Study|New primary cancer|0
1551818|NCT00082433|5065651|P1|Overall Study|New primary cancer|1
1551819|NCT00082433|5065650|P2|Overall Study|Noncompliance|1
1551820|NCT00082433|5065651|P1|Overall Study|Noncompliance|2
1551821|NCT00082433|5065650|P2|Overall Study|Ineligible|1
1551822|NCT00082433|5065651|P1|Overall Study|Ineligible|2
1551823|NCT00082433|5065650|P2|Overall Study|Not Treated|11
1551824|NCT00082433|5065651|P1|Overall Study|Not Treated|12
1551825|NCT00082433|5065650|P2|Overall Study|Still On Treatment|1
1551826|NCT00082433|5065651|P1|Overall Study|Still On Treatment|2
1551827|NCT00082433|5065650|P2|Overall Study|Withdrawal by Subject|30
1551828|NCT00082433|5065651|P1|Overall Study|Withdrawal by Subject|55
1551829|NCT00082433|5065650|P2|Overall Study|Study Drug Toxicity|66
1551830|NCT00082433|5065651|P1|Overall Study|Study Drug Toxicity|179
1551831|NCT00082433|5065650|P2|Overall Study|Lost to Follow-up|2
1551832|NCT00082433|5065651|P1|Overall Study|Lost to Follow-up|1
1551833|NCT00082433|5065650|P2|Overall Study|Physician Decision|61
1551834|NCT00082433|5065651|P1|Overall Study|Physician Decision|50
1551835|NCT00082433|5065650|P2|Overall Study|Disease Progression/Relapse|388
1551836|NCT00082433|5065651|P1|Overall Study|Disease Progression/Relapse|270
1551837|NCT00082433|5065650|P2|Overall Study|Death|18
1551838|NCT00082433|5065651|P1|Overall Study|Death|8
1551839|NCT00082433|5065650|P2|Overall Study|Adverse Event|17
1551840|NCT00082433|5065651|P1|Overall Study|Adverse Event|12
1551841|NCT00082381|5065671|P2|Overall Study|Loss of Glucose Control|0
1551842|NCT00082381|5065672|P1|Overall Study|Loss of Glucose Control|4
1551843|NCT00082381|5065671|P2|Overall Study|Protocol Violation|11
1551844|NCT00082381|5065672|P1|Overall Study|Protocol Violation|10
1551845|NCT00082381|5065671|P2|Overall Study|Physician Decision|2
1551846|NCT00082381|5065672|P1|Overall Study|Physician Decision|1
1551847|NCT00082381|5065671|P2|Overall Study|Patient Decision|4
1551848|NCT00082381|5065672|P1|Overall Study|Patient Decision|8
1551849|NCT00082381|5065671|P2|Overall Study|Lost to Follow-up|7
1551850|NCT00082381|5065672|P1|Overall Study|Lost to Follow-up|5
1551851|NCT00082381|5065671|P2|Overall Study|Adverse Event|2
1551852|NCT00082381|5065672|P1|Overall Study|Adverse Event|27
1551853|NCT00082407|5065692|P2|Overall Study|Lost to Follow-up|3
1551854|NCT00082407|5065693|P1|Overall Study|Lost to Follow-up|0
1551855|NCT00082407|5065692|P2|Overall Study|Death|1
1551856|NCT00082407|5065693|P1|Overall Study|Death|2
1551857|NCT00082407|5065692|P2|Overall Study|Loss of Glucose Control|2
1551858|NCT00082407|5065693|P1|Overall Study|Loss of Glucose Control|2
1551859|NCT00082407|5065692|P2|Overall Study|Physician Decision|3
1551860|NCT00082407|5065693|P1|Overall Study|Physician Decision|5
1551861|NCT00082407|5065692|P2|Overall Study|Patient Decision|6
1551862|NCT00082407|5065693|P1|Overall Study|Patient Decision|13
1551863|NCT00082407|5065692|P2|Overall Study|Protocol Violation|12
1551864|NCT00082407|5065693|P1|Overall Study|Protocol Violation|14
1551865|NCT00082407|5065692|P2|Overall Study|Adverse Event|0
1551866|NCT00082407|5065693|P1|Overall Study|Adverse Event|20
1551867|NCT00082368|5065711|P1|Overall Study|Not treated-pt had poor IV access|1
1551868|NCT00082355|5065716|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
1551869|NCT00082355|5065716|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
1551870|NCT00082355|5065716|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
1551871|NCT00082173|5065750|P2|Overall Study|Culture negative or resistant at baselin|6
1551872|NCT00082173|5065751|P1|Overall Study|Culture negative or resistant at baselin|5
1551873|NCT00082173|5065750|P2|Overall Study|Adverse Event|0
1551874|NCT00082173|5065751|P1|Overall Study|Adverse Event|1
1551875|NCT00082173|5065750|P2|Overall Study|Lost to Follow-up|0
1551876|NCT00082173|5065751|P1|Overall Study|Lost to Follow-up|1
1551877|NCT00082173|5065750|P2|Overall Study|Withdrawal by Subject|5
1551878|NCT00082173|5065751|P1|Overall Study|Withdrawal by Subject|3
1551879|NCT00081770|5065791|P3|Overall Study|Not Specified|8
1551880|NCT00081770|5065792|P2|Overall Study|Not Specified|7
1551881|NCT00081770|5065793|P1|Overall Study|Not Specified|2
1551882|NCT00081770|5065791|P3|Overall Study|Administrative|1
1551883|NCT00081770|5065792|P2|Overall Study|Administrative|0
1551884|NCT00081770|5065793|P1|Overall Study|Administrative|1
1551885|NCT00081770|5065791|P3|Overall Study|Did not meet protocol eligibility|3
1551886|NCT00081770|5065792|P2|Overall Study|Did not meet protocol eligibility|0
1551887|NCT00081770|5065793|P1|Overall Study|Did not meet protocol eligibility|2
1551888|NCT00081770|5065791|P3|Overall Study|Withdrawal by Subject|42
1551889|NCT00081770|5065792|P2|Overall Study|Withdrawal by Subject|40
1551890|NCT00081770|5065793|P1|Overall Study|Withdrawal by Subject|45
1551891|NCT00081770|5065791|P3|Overall Study|Protocol Violation|10
1551892|NCT00081770|5065792|P2|Overall Study|Protocol Violation|10
1551893|NCT00081770|5065793|P1|Overall Study|Protocol Violation|15
1551894|NCT00081770|5065791|P3|Overall Study|Lost to Follow-up|45
1551895|NCT00081770|5065792|P2|Overall Study|Lost to Follow-up|34
1551896|NCT00081770|5065793|P1|Overall Study|Lost to Follow-up|45
1551897|NCT00081770|5065791|P3|Overall Study|Lack of Efficacy|211
1551898|NCT00081770|5065792|P2|Overall Study|Lack of Efficacy|357
1551899|NCT00081770|5065793|P1|Overall Study|Lack of Efficacy|262
1551900|NCT00081770|5065791|P3|Overall Study|Adverse Event|136
1551901|NCT00081770|5065792|P2|Overall Study|Adverse Event|98
1551902|NCT00081770|5065793|P1|Overall Study|Adverse Event|130
1551903|NCT00081731|5065812|P2|Overall Study|scientific integrity issue|8
1551904|NCT00081731|5065813|P1|Overall Study|scientific integrity issue|8
1551905|NCT00081653|5065833|P2|Overall Study|Loss of bone mass|2
1551906|NCT00081653|5065834|P1|Overall Study|Loss of bone mass|0
1551907|NCT00081653|5065833|P2|Overall Study|Participant leaving country|0
1551908|NCT00081653|5065834|P1|Overall Study|Participant leaving country|1
1551909|NCT00081653|5065833|P2|Overall Study|Bone loss|0
1551910|NCT00081653|5065834|P1|Overall Study|Bone loss|2
1551911|NCT00081653|5065833|P2|Overall Study|Low bone mineral density|0
1551912|NCT00081653|5065834|P1|Overall Study|Low bone mineral density|1
1551913|NCT00081653|5065833|P2|Overall Study|Refused Treatment|14
1551914|NCT00081653|5065834|P1|Overall Study|Refused Treatment|18
1551915|NCT00081653|5065833|P2|Overall Study|Lost to Follow-up|4
1551916|NCT00081653|5065834|P1|Overall Study|Lost to Follow-up|2
1551917|NCT00081653|5065833|P2|Overall Study|Adverse Event|17
1551918|NCT00081653|5065834|P1|Overall Study|Adverse Event|23
1551919|NCT00081497|5065852|P2|Overall Study|Non-compliance|1
1551920|NCT00081497|5065853|P1|Overall Study|Non-compliance|0
1551921|NCT00081497|5065852|P2|Overall Study|Withdrawal by Subject|0
1551922|NCT00081497|5065853|P1|Overall Study|Withdrawal by Subject|1
1551923|NCT00081497|5065852|P2|Overall Study|Death|1
1551924|NCT00081497|5065853|P1|Overall Study|Death|0
1551925|NCT00081497|5065852|P2|Overall Study|Adverse Event|0
1551926|NCT00081497|5065853|P1|Overall Study|Adverse Event|2
1551927|NCT00081458|5065871|P3|Overall Study|Randomized but not dosed|1
1551928|NCT00081458|5065872|P2|Overall Study|Randomized but not dosed|0
1551929|NCT00081458|5065873|P1|Overall Study|Randomized but not dosed|0
1551930|NCT00081458|5065871|P3|Overall Study|Withdrawal by Subject|1
1551931|NCT00081458|5065872|P2|Overall Study|Withdrawal by Subject|3
1551932|NCT00081458|5065873|P1|Overall Study|Withdrawal by Subject|0
1551933|NCT00081458|5065871|P3|Overall Study|Adverse Event|2
1551934|NCT00081458|5065872|P2|Overall Study|Adverse Event|5
1551935|NCT00081458|5065873|P1|Overall Study|Adverse Event|1
1551936|NCT00081289|5065929|P2|Overall Study|Ineligible / no protocol treatment|4
1551937|NCT00081289|5065930|P1|Overall Study|Ineligible / no protocol treatment|3
1551938|NCT00081289|5065929|P2|Overall Study|Accrued prior to chemotherapy amendment|17
1551939|NCT00081289|5065930|P1|Overall Study|Accrued prior to chemotherapy amendment|18
1551940|NCT00081263|5065938|P2|Overall Study|Inadequate data|10
1551941|NCT00081263|5065939|P1|Overall Study|Inadequate data|5
1551942|NCT00081263|5065938|P2|Overall Study|Never treated|5
1551943|NCT00081263|5065939|P1|Overall Study|Never treated|4
1551944|NCT00081263|5065938|P2|Overall Study|Inadequate pathology|1
1551945|NCT00081263|5065939|P1|Overall Study|Inadequate pathology|0
1551946|NCT00081263|5065938|P2|Overall Study|improper pre-protocol therapy|1
1551947|NCT00081263|5065939|P1|Overall Study|improper pre-protocol therapy|0
1551948|NCT00081263|5065938|P2|Overall Study|wrong cell type|5
1551949|NCT00081263|5065939|P1|Overall Study|wrong cell type|7
1551950|NCT00081263|5065938|P2|Overall Study|clerical error|0
1551951|NCT00081263|5065939|P1|Overall Study|clerical error|1
1551952|NCT00081159|5065949|P2|Overall Study|Lost to Follow-up|1
1551953|NCT00081159|5065950|P1|Overall Study|Lost to Follow-up|2
1551954|NCT00081159|5065949|P2|Overall Study|Myelosuppression prior to treatment|1
1551955|NCT00081159|5065950|P1|Overall Study|Myelosuppression prior to treatment|0
1551956|NCT00081159|5065949|P2|Overall Study|Withdrawal by Subject|3
1551957|NCT00081159|5065950|P1|Overall Study|Withdrawal by Subject|0
1551958|NCT00080938|5065960|P1|Overall Study|Ineligible|4
1551959|NCT00080938|5065960|P1|Overall Study|Not started protocol therapy|1
1551960|NCT00080938|5065960|P1|Overall Study|other disease|1
1551961|NCT00080938|5065960|P1|Overall Study|Lack of Efficacy|7
1551962|NCT00080938|5065960|P1|Overall Study|Death|2
1551963|NCT00080938|5065960|P1|Overall Study|Withdrawal by Subject|6
1551964|NCT00080938|5065960|P1|Overall Study|Adverse Event|3
1551965|NCT00080899|5065976|P1|Overall Study|Adverse Event|1
1551966|NCT00080483|5065988|P2|Overall Study|Physician Decision|1
1551967|NCT00080483|5065989|P1|Overall Study|Physician Decision|1
1551968|NCT00080483|5065988|P2|Overall Study|Lost to Follow-up|1
1551969|NCT00080483|5065989|P1|Overall Study|Lost to Follow-up|1
1551970|NCT00002525|5065997|P2|Overall Study|Never start protocol therapy|0
1551971|NCT00002525|5065998|P1|Overall Study|Never start protocol therapy|8
1551972|NCT00002525|5065997|P2|Overall Study|Other|0
1551973|NCT00002525|5065998|P1|Overall Study|Other|26
1551974|NCT00002525|5065997|P2|Overall Study|Error|0
1551975|NCT00002525|5065998|P1|Overall Study|Error|6
1551976|NCT00002525|5065997|P2|Overall Study|Duke's A, B1, D disease|0
1551977|NCT00002525|5065998|P1|Overall Study|Duke's A, B1, D disease|92
1551978|NCT00002525|5065997|P2|Overall Study|Other complicating disease|0
1551979|NCT00002525|5065998|P1|Overall Study|Other complicating disease|1
1551980|NCT00002525|5065997|P2|Overall Study|Start non-protocol therapy|0
1551981|NCT00002525|5065998|P1|Overall Study|Start non-protocol therapy|1
1551982|NCT00002525|5065997|P2|Overall Study|Withdrawal by Subject|0
1551983|NCT00002525|5065998|P1|Overall Study|Withdrawal by Subject|11
1551984|NCT00002525|5065997|P2|Overall Study|Death|0
1551985|NCT00002525|5065998|P1|Overall Study|Death|5
1551986|NCT00002525|5065997|P2|Overall Study|Adverse Event|0
1551987|NCT00002525|5065998|P1|Overall Study|Adverse Event|36
1551988|NCT00080301|5066025|P2|Overall Study|Still on Treatment as of CSR date|1
1551989|NCT00080301|5066026|P1|Overall Study|Still on Treatment as of CSR date|0
1551990|NCT00080301|5066025|P2|Overall Study|Randomized but Never Treated|10
1551991|NCT00080301|5066026|P1|Overall Study|Randomized but Never Treated|5
1551992|NCT00080288|5066046|P2|Overall Study|Miscellaneous|11
1551993|NCT00080288|5066047|P1|Overall Study|Miscellaneous|11
1551994|NCT00080288|5066046|P2|Overall Study|Withdrawal by Subject|16
1551995|NCT00080288|5066047|P1|Overall Study|Withdrawal by Subject|3
1551996|NCT00080288|5066046|P2|Overall Study|Physician Decision|2
1551997|NCT00080288|5066047|P1|Overall Study|Physician Decision|6
1551998|NCT00080288|5066046|P2|Overall Study|Lost to Follow-up|5
1551999|NCT00080288|5066047|P1|Overall Study|Lost to Follow-up|3
1552000|NCT00080288|5066046|P2|Overall Study|Adverse Event|4
1552001|NCT00080288|5066047|P1|Overall Study|Adverse Event|7
1552002|NCT00080223|5066055|P1|Overall Study|Physician Decision|1
1552003|NCT00080223|5066055|P1|Overall Study|Participant unwilling to continue|2
1552004|NCT00080223|5066055|P1|Overall Study|Non-compliance With Study Treatment|7
1552005|NCT00080223|5066055|P1|Overall Study|Lung Transplantation|9
1552006|NCT00080223|5066055|P1|Overall Study|Withdrawal by Subject|13
1552007|NCT00080223|5066055|P1|Overall Study|Death|21
1552008|NCT00080223|5066055|P1|Overall Study|Adverse Event|23
1552009|NCT00002540|5066065|P2|Overall Study|Refused Screen (Prostate Screening)|2433
1552010|NCT00002540|5066066|P1|Overall Study|Refused Screen (Prostate Screening)|0
1552011|NCT00002540|5066065|P2|Overall Study|Refused ASU (Control)|0
1552012|NCT00002540|5066066|P1|Overall Study|Refused ASU (Control)|597
1552013|NCT00002540|5066065|P2|Overall Study|Died Before ASU (Control)|0
1552014|NCT00002540|5066066|P1|Overall Study|Died Before ASU (Control)|202
1552015|NCT00002540|5066065|P2|Overall Study|Died Before Randomization|6
1552016|NCT00002540|5066066|P1|Overall Study|Died Before Randomization|2
1552017|NCT00002540|5066065|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
1552018|NCT00002540|5066066|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
1552019|NCT00080119|5066096|P4|Overall Study|Lost to Follow-up|14
1552020|NCT00080119|5066097|P3|Overall Study|Lost to Follow-up|19
1552021|NCT00080119|5066098|P2|Overall Study|Lost to Follow-up|19
1552022|NCT00080119|5066099|P1|Overall Study|Lost to Follow-up|16
1552023|NCT00080119|5066096|P4|Overall Study|Unwilling to adhere to study requirement|1
1552024|NCT00080119|5066097|P3|Overall Study|Unwilling to adhere to study requirement|5
1552025|NCT00080119|5066098|P2|Overall Study|Unwilling to adhere to study requirement|2
1552026|NCT00080119|5066099|P1|Overall Study|Unwilling to adhere to study requirement|3
1552027|NCT00080119|5066096|P4|Overall Study|Consent withdrawn|6
1552028|NCT00080119|5066097|P3|Overall Study|Consent withdrawn|4
1552029|NCT00080119|5066098|P2|Overall Study|Consent withdrawn|17
1552030|NCT00080119|5066099|P1|Overall Study|Consent withdrawn|13
1552031|NCT00080119|5066096|P4|Overall Study|Unable to get to clinic|1
1552032|NCT00080119|5066097|P3|Overall Study|Unable to get to clinic|7
1552033|NCT00080119|5066098|P2|Overall Study|Unable to get to clinic|24
1552034|NCT00080119|5066099|P1|Overall Study|Unable to get to clinic|24
1552035|NCT00080119|5066096|P4|Overall Study|Discontinued because of study closure|141
1552036|NCT00080119|5066097|P3|Overall Study|Discontinued because of study closure|130
1552037|NCT00080119|5066098|P2|Overall Study|Discontinued because of study closure|0
1552038|NCT00080119|5066099|P1|Overall Study|Discontinued because of study closure|0
1552039|NCT00079937|5066133|P2|Overall Study|Administrative problems|11
1552040|NCT00079937|5066134|P1|Overall Study|Administrative problems|22
1552041|NCT00079937|5066133|P2|Overall Study|Lost to Follow-up|5
1552042|NCT00079937|5066134|P1|Overall Study|Lost to Follow-up|12
1552043|NCT00079937|5066133|P2|Overall Study|Withdrawal by Subject|7
1552044|NCT00079937|5066134|P1|Overall Study|Withdrawal by Subject|21
1552045|NCT00079937|5066133|P2|Overall Study|Protocol Violation|6
1552046|NCT00079937|5066134|P1|Overall Study|Protocol Violation|8
1552047|NCT00079937|5066133|P2|Overall Study|Subject no longer requires study drug|0
1552048|NCT00079937|5066134|P1|Overall Study|Subject no longer requires study drug|3
1552049|NCT00079937|5066133|P2|Overall Study|Unsatisfactory therapeutic effect|2
1552050|NCT00079937|5066134|P1|Overall Study|Unsatisfactory therapeutic effect|1
1552051|NCT00079937|5066133|P2|Overall Study|Adverse Event|1
1552052|NCT00079937|5066134|P1|Overall Study|Adverse Event|2
1552053|NCT00009737|5066152|P2|Overall Study|Administrative/Other Reasons|1
1552054|NCT00009737|5066153|P1|Overall Study|Administrative/Other Reasons|7
1552055|NCT00009737|5066152|P2|Overall Study|Lost to Follow-up|1
1552056|NCT00009737|5066153|P1|Overall Study|Lost to Follow-up|1
1552057|NCT00009737|5066152|P2|Overall Study|Refused Treatment|16
1552058|NCT00009737|5066153|P1|Overall Study|Refused Treatment|15
1552059|NCT00009737|5066152|P2|Overall Study|Other Protocol Violation|0
1552060|NCT00009737|5066153|P1|Overall Study|Other Protocol Violation|1
1552061|NCT00009737|5066152|P2|Overall Study|Violation of Selection Criteria at Entry|9
1552062|NCT00009737|5066153|P1|Overall Study|Violation of Selection Criteria at Entry|13
1552063|NCT00009737|5066152|P2|Overall Study|Lack of Efficacy|15
1552064|NCT00009737|5066153|P1|Overall Study|Lack of Efficacy|17
1552065|NCT00009737|5066152|P2|Overall Study|Death|6
1552066|NCT00009737|5066153|P1|Overall Study|Death|4
1552067|NCT00009737|5066152|P2|Overall Study|Adverse Event|75
1552068|NCT00009737|5066153|P1|Overall Study|Adverse Event|112
1552069|NCT00079781|5066172|P3|Follow-up Period|Death|1
1552070|NCT00079781|5066173|P2|Follow-up Period|Death|0
1552071|NCT00079781|5066174|P1|Follow-up Period|Death|0
1552072|NCT00079781|5066172|P3|Follow-up Period|Lost to Follow-up|0
1552073|NCT00079781|5066173|P2|Follow-up Period|Lost to Follow-up|0
1552074|NCT00079781|5066174|P1|Follow-up Period|Lost to Follow-up|1
1552075|NCT00079781|5066172|P3|Follow-up Period|Withdrawal by Subject|1
1552076|NCT00079781|5066173|P2|Follow-up Period|Withdrawal by Subject|0
1552077|NCT00079781|5066174|P1|Follow-up Period|Withdrawal by Subject|3
1552078|NCT00079781|5066172|P3|Pre-implant Period|Did not meet I/E criteria|1
1552079|NCT00079781|5066173|P2|Pre-implant Period|Did not meet I/E criteria|1
1552080|NCT00079781|5066174|P1|Pre-implant Period|Did not meet I/E criteria|1
1552081|NCT00079781|5066172|P3|Pre-implant Period|Withdrawal by Subject|0
1552082|NCT00079781|5066173|P2|Pre-implant Period|Withdrawal by Subject|0
1552083|NCT00079781|5066174|P1|Pre-implant Period|Withdrawal by Subject|2
1552084|NCT00079677|5066183|P2|Overall Study|Miscellaneous|0
1552085|NCT00079677|5066184|P1|Overall Study|Miscellaneous|2
1552086|NCT00079677|5066183|P2|Overall Study|Withdrawal by Subject|3
1552087|NCT00079677|5066184|P1|Overall Study|Withdrawal by Subject|5
1552088|NCT00079677|5066183|P2|Overall Study|Protocol Violation|3
1552089|NCT00079677|5066184|P1|Overall Study|Protocol Violation|2
1552090|NCT00079677|5066183|P2|Overall Study|Physician Decision|0
1552091|NCT00079677|5066184|P1|Overall Study|Physician Decision|3
1552092|NCT00079677|5066183|P2|Overall Study|Lost to Follow-up|2
1552093|NCT00079677|5066184|P1|Overall Study|Lost to Follow-up|2
1552094|NCT00079677|5066183|P2|Overall Study|Lack of Efficacy|0
1552095|NCT00079677|5066184|P1|Overall Study|Lack of Efficacy|1
1552096|NCT00079677|5066183|P2|Overall Study|Adverse Event|6
1552097|NCT00079677|5066184|P1|Overall Study|Adverse Event|5
1552098|NCT00079417|5066200|P1|Overall Study|ineligible|1
1552099|NCT00079417|5066200|P1|Overall Study|Tumor requires non-protocol radiotherapy|2
1552100|NCT00079417|5066200|P1|Overall Study|Tumor requires non-protocol chemotherapy|1
1552101|NCT00079417|5066200|P1|Overall Study|Physician Decision|5
1552102|NCT00079391|5066204|P1|Overall Study|Withdrawal by Subject|1
1552103|NCT00079339|5066216|P3|Overall Study|Disease progression|2
1552104|NCT00079339|5066217|P2|Overall Study|Disease progression|28
1552105|NCT00079339|5066218|P1|Overall Study|Disease progression|3
1552106|NCT00079339|5066216|P3|Overall Study|Withdrawal by Subject|1
1552107|NCT00079339|5066217|P2|Overall Study|Withdrawal by Subject|4
1552108|NCT00079339|5066218|P1|Overall Study|Withdrawal by Subject|0
1552109|NCT00079339|5066216|P3|Overall Study|Non-compliance|1
1552110|NCT00079339|5066217|P2|Overall Study|Non-compliance|0
1552111|NCT00079339|5066218|P1|Overall Study|Non-compliance|0
1552112|NCT00079339|5066216|P3|Overall Study|Death|0
1552113|NCT00079339|5066217|P2|Overall Study|Death|0
1552114|NCT00079339|5066218|P1|Overall Study|Death|1
1552115|NCT00079339|5066216|P3|Overall Study|Adverse Event|2
1552116|NCT00079339|5066217|P2|Overall Study|Adverse Event|7
1552117|NCT00079339|5066218|P1|Overall Study|Adverse Event|1
1552118|NCT00079274|5066249|P7|Overall Study|Not Specified|0
1552119|NCT00079274|5066250|P6|Overall Study|Not Specified|2
1552120|NCT00079274|5066251|P5|Overall Study|Not Specified|1
1552121|NCT00079274|5066252|P4|Overall Study|Not Specified|55
1552122|NCT00079274|5066253|P3|Overall Study|Not Specified|5
1552123|NCT00079274|5066254|P2|Overall Study|Not Specified|7
1552124|NCT00079274|5066255|P1|Overall Study|Not Specified|43
1552125|NCT00079274|5066249|P7|Overall Study|Cytogenetic resistance|0
1552126|NCT00079274|5066250|P6|Overall Study|Cytogenetic resistance|0
1552127|NCT00079274|5066251|P5|Overall Study|Cytogenetic resistance|0
1552128|NCT00079274|5066252|P4|Overall Study|Cytogenetic resistance|2
1552129|NCT00079274|5066253|P3|Overall Study|Cytogenetic resistance|0
1552130|NCT00079274|5066254|P2|Overall Study|Cytogenetic resistance|0
1552131|NCT00079274|5066255|P1|Overall Study|Cytogenetic resistance|0
1552132|NCT00079274|5066249|P7|Overall Study|Death|0
1552133|NCT00079274|5066250|P6|Overall Study|Death|0
1552134|NCT00079274|5066251|P5|Overall Study|Death|0
1552135|NCT00079274|5066252|P4|Overall Study|Death|15
1552136|NCT00079274|5066253|P3|Overall Study|Death|1
1552137|NCT00079274|5066254|P2|Overall Study|Death|0
1552138|NCT00079274|5066255|P1|Overall Study|Death|4
1552139|NCT00079274|5066249|P7|Overall Study|Other Medical Problems|0
1552140|NCT00079274|5066250|P6|Overall Study|Other Medical Problems|0
1552141|NCT00079274|5066251|P5|Overall Study|Other Medical Problems|0
1552142|NCT00079274|5066252|P4|Overall Study|Other Medical Problems|7
1552143|NCT00079274|5066253|P3|Overall Study|Other Medical Problems|0
1552144|NCT00079274|5066254|P2|Overall Study|Other Medical Problems|1
1552145|NCT00079274|5066255|P1|Overall Study|Other Medical Problems|6
1552146|NCT00079274|5066249|P7|Overall Study|Alternate Treatment|0
1552147|NCT00079274|5066250|P6|Overall Study|Alternate Treatment|0
1552148|NCT00079274|5066251|P5|Overall Study|Alternate Treatment|0
1552149|NCT00079274|5066252|P4|Overall Study|Alternate Treatment|3
1552150|NCT00079274|5066253|P3|Overall Study|Alternate Treatment|0
1552151|NCT00079274|5066254|P2|Overall Study|Alternate Treatment|1
1552152|NCT00079274|5066255|P1|Overall Study|Alternate Treatment|6
1552153|NCT00079274|5066249|P7|Overall Study|Recurrence|0
1552154|NCT00079274|5066250|P6|Overall Study|Recurrence|2
1552155|NCT00079274|5066251|P5|Overall Study|Recurrence|0
1552156|NCT00079274|5066252|P4|Overall Study|Recurrence|15
1552157|NCT00079274|5066253|P3|Overall Study|Recurrence|1
1552158|NCT00079274|5066254|P2|Overall Study|Recurrence|0
1552159|NCT00079274|5066255|P1|Overall Study|Recurrence|21
1552160|NCT00079274|5066249|P7|Overall Study|Adverse Event|0
1552161|NCT00079274|5066250|P6|Overall Study|Adverse Event|8
1552162|NCT00079274|5066251|P5|Overall Study|Adverse Event|7
1552163|NCT00079274|5066252|P4|Overall Study|Adverse Event|184
1552164|NCT00079274|5066253|P3|Overall Study|Adverse Event|8
1552165|NCT00079274|5066254|P2|Overall Study|Adverse Event|8
1552166|NCT00079274|5066255|P1|Overall Study|Adverse Event|130
1552167|NCT00079274|5066249|P7|Overall Study|Withdrawal by Subject|0
1552168|NCT00079274|5066250|P6|Overall Study|Withdrawal by Subject|8
1552169|NCT00079274|5066251|P5|Overall Study|Withdrawal by Subject|7
1552170|NCT00079274|5066252|P4|Overall Study|Withdrawal by Subject|163
1552171|NCT00079274|5066253|P3|Overall Study|Withdrawal by Subject|12
1552172|NCT00079274|5066254|P2|Overall Study|Withdrawal by Subject|10
1552173|NCT00079274|5066255|P1|Overall Study|Withdrawal by Subject|111
1552174|NCT00079183|5066268|P1|Overall Study|Specimen collection non-compliance|1
1552175|NCT00079183|5066268|P1|Overall Study|Study medication non-compliance|2
1552176|NCT00079183|5066268|P1|Overall Study|Withdrawal by Subject|4
1552177|NCT00079040|5066283|P1|Overall Study|Ineligible|1
1552178|NCT00079040|5066283|P1|Overall Study|Withdrew before treatment|1
1552179|NCT00078949|5066306|P4|Maintenance|No treated|3
1552180|NCT00078949|5066307|P3|Maintenance|No treated|3
1552181|NCT00078949|5066308|P2|Maintenance|No treated|0
1552182|NCT00078949|5066309|P1|Maintenance|No treated|0
1552183|NCT00078949|5066306|P4|Salvage|No treated|0
1552184|NCT00078949|5066307|P3|Salvage|No treated|0
1552185|NCT00078949|5066308|P2|Salvage|No treated|5
1552186|NCT00078949|5066309|P1|Salvage|No treated|4
1552187|NCT00078767|5066323|P2|Overall Study|Withdrawal by Subject|1
1552188|NCT00078767|5066324|P1|Overall Study|Withdrawal by Subject|1
1552189|NCT00005947|5066371|P2|Overall Study|Site Closure|0
1552190|NCT00005947|5066372|P1|Overall Study|Site Closure|1
1552191|NCT00005947|5066371|P2|Overall Study|Patient Refused to Continue|1
1552192|NCT00005947|5066372|P1|Overall Study|Patient Refused to Continue|2
1552193|NCT00005947|5066371|P2|Overall Study|Death|40
1552194|NCT00005947|5066372|P1|Overall Study|Death|54
1552195|NCT00002597|5066408|P2|Overall Study|Withdrawal by Subject|6
1552196|NCT00002597|5066409|P1|Overall Study|Withdrawal by Subject|7
1552197|NCT00002597|5066408|P2|Overall Study|Protocol Violation|17
1552198|NCT00002597|5066409|P1|Overall Study|Protocol Violation|19
1552199|NCT00078377|5066434|P3|Overall Study|Miscellaneous|1
1552200|NCT00078377|5066435|P2|Overall Study|Miscellaneous|6
1552201|NCT00078377|5066436|P1|Overall Study|Miscellaneous|2
1552202|NCT00078377|5066434|P3|Overall Study|Withdrawal by Subject|4
1552203|NCT00078377|5066435|P2|Overall Study|Withdrawal by Subject|4
1552204|NCT00078377|5066436|P1|Overall Study|Withdrawal by Subject|3
1552205|NCT00078377|5066434|P3|Overall Study|Physician Decision|0
1552206|NCT00078377|5066435|P2|Overall Study|Physician Decision|0
1552207|NCT00078377|5066436|P1|Overall Study|Physician Decision|2
1552208|NCT00078377|5066434|P3|Overall Study|Lost to Follow-up|1
1552209|NCT00078377|5066435|P2|Overall Study|Lost to Follow-up|1
1552210|NCT00078377|5066436|P1|Overall Study|Lost to Follow-up|0
1552211|NCT00078377|5066434|P3|Overall Study|Lack of Efficacy|2
1552212|NCT00078377|5066435|P2|Overall Study|Lack of Efficacy|0
1552213|NCT00078377|5066436|P1|Overall Study|Lack of Efficacy|2
1552214|NCT00078377|5066434|P3|Overall Study|Adverse Event|1
1552215|NCT00078377|5066435|P2|Overall Study|Adverse Event|5
1552216|NCT00078377|5066436|P1|Overall Study|Adverse Event|2
1552217|NCT00078338|5066451|P2|Overall Study|Subjects randomized, but not treated|3
1552218|NCT00078338|5066452|P1|Overall Study|Subjects randomized, but not treated|3
1552219|NCT00078338|5066451|P2|Overall Study|Other|16
1552220|NCT00078338|5066452|P1|Overall Study|Other|28
1552221|NCT00078338|5066451|P2|Overall Study|Disease Progression|7
1552222|NCT00078338|5066452|P1|Overall Study|Disease Progression|4
1552223|NCT00078338|5066451|P2|Overall Study|Protocol Violation|2
1552224|NCT00078338|5066452|P1|Overall Study|Protocol Violation|2
1552225|NCT00078338|5066451|P2|Overall Study|Lost to Follow-up|2
1552226|NCT00078338|5066452|P1|Overall Study|Lost to Follow-up|17
1552227|NCT00078338|5066451|P2|Overall Study|Adverse Event|24
1552228|NCT00078338|5066452|P1|Overall Study|Adverse Event|31
1552229|NCT00078325|5066545|P3|Overall Study|Miscellaneous|1
1552230|NCT00078325|5066546|P2|Overall Study|Miscellaneous|1
1552231|NCT00078325|5066547|P1|Overall Study|Miscellaneous|1
1552232|NCT00078325|5066545|P3|Overall Study|Physician Decision|1
1552233|NCT00078325|5066546|P2|Overall Study|Physician Decision|0
1552234|NCT00078325|5066547|P1|Overall Study|Physician Decision|2
1552235|NCT00078325|5066545|P3|Overall Study|Lost to Follow-up|1
1552236|NCT00078325|5066546|P2|Overall Study|Lost to Follow-up|1
1552237|NCT00078325|5066547|P1|Overall Study|Lost to Follow-up|0
1552238|NCT00078325|5066545|P3|Overall Study|Withdrawal by Subject|3
1552239|NCT00078325|5066546|P2|Overall Study|Withdrawal by Subject|5
1552240|NCT00078325|5066547|P1|Overall Study|Withdrawal by Subject|1
1552241|NCT00078325|5066545|P3|Overall Study|Protocol Violation|0
1552242|NCT00078325|5066546|P2|Overall Study|Protocol Violation|2
1552243|NCT00078325|5066547|P1|Overall Study|Protocol Violation|2
1552244|NCT00078325|5066545|P3|Overall Study|Adverse Event|5
1552245|NCT00078325|5066546|P2|Overall Study|Adverse Event|10
1552246|NCT00078325|5066547|P1|Overall Study|Adverse Event|15
1552247|NCT00078312|5066558|P1|Overall Study|Miscellaneous|33
1552248|NCT00078312|5066558|P1|Overall Study|Withdrawal by Subject|33
1552249|NCT00078312|5066558|P1|Overall Study|Protocol Violation|3
1552250|NCT00078312|5066558|P1|Overall Study|Physician Decision|9
1552251|NCT00078312|5066558|P1|Overall Study|Lost to Follow-up|41
1552252|NCT00078312|5066558|P1|Overall Study|Lack of Efficacy|15
1552253|NCT00078312|5066558|P1|Overall Study|Adverse Event|43
1552254|NCT00077974|5066573|P1|Overall Study|Decision of Sponsor|2
1552255|NCT00077974|5066573|P1|Overall Study|Lack of Efficacy|76
1552256|NCT00077974|5066573|P1|Overall Study|Withdrawal by Subject|3
1552257|NCT00077974|5066573|P1|Overall Study|Protocol Violation|1
1552258|NCT00077974|5066573|P1|Overall Study|Adverse Event|22
1552259|NCT00077857|5066590|P2|Overall Study|Other|13
1552260|NCT00077857|5066591|P1|Overall Study|Other|15
1552261|NCT00077857|5066590|P2|Overall Study|Failure to return|5
1552262|NCT00077857|5066591|P1|Overall Study|Failure to return|5
1552263|NCT00077857|5066590|P2|Overall Study|Refused treatment|21
1552264|NCT00077857|5066591|P1|Overall Study|Refused treatment|29
1552265|NCT00077857|5066590|P2|Overall Study|Other protocol violation|1
1552266|NCT00077857|5066591|P1|Overall Study|Other protocol violation|0
1552267|NCT00077857|5066590|P2|Overall Study|Violation of selection criteria at entry|1
1552268|NCT00077857|5066591|P1|Overall Study|Violation of selection criteria at entry|3
1552269|NCT00077857|5066590|P2|Overall Study|Insufficient therapeutic response|128
1552270|NCT00077857|5066591|P1|Overall Study|Insufficient therapeutic response|112
1552271|NCT00077857|5066590|P2|Overall Study|Death|3
1552272|NCT00077857|5066591|P1|Overall Study|Death|7
1552273|NCT00077857|5066590|P2|Overall Study|Adverse Event|32
1552274|NCT00077857|5066591|P1|Overall Study|Adverse Event|30
1552275|NCT00077766|5066611|P2|Overall Study|Participants Vacation|1
1552276|NCT00077766|5066612|P1|Overall Study|Participants Vacation|2
1552277|NCT00077766|5066611|P2|Overall Study|Stop Dialysis|1
1552278|NCT00077766|5066612|P1|Overall Study|Stop Dialysis|0
1552279|NCT00077766|5066611|P2|Overall Study|Started Nocturnal Dialysis|1
1552280|NCT00077766|5066612|P1|Overall Study|Started Nocturnal Dialysis|0
1552281|NCT00077766|5066611|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
1552282|NCT00077766|5066612|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
1552283|NCT00077766|5066611|P2|Overall Study|Dialysis|1
1552284|NCT00077766|5066612|P1|Overall Study|Dialysis|0
1552285|NCT00077766|5066611|P2|Overall Study|Dialysis Discontinued|0
1552286|NCT00077766|5066612|P1|Overall Study|Dialysis Discontinued|1
1552287|NCT00077766|5066611|P2|Overall Study|Participant's decision|0
1552288|NCT00077766|5066612|P1|Overall Study|Participant's decision|1
1552289|NCT00077766|5066611|P2|Overall Study|Investigators Discretion|0
1552290|NCT00077766|5066612|P1|Overall Study|Investigators Discretion|1
1552291|NCT00077766|5066611|P2|Overall Study|Transplantation|1
1552292|NCT00077766|5066612|P1|Overall Study|Transplantation|5
1552293|NCT00077766|5066611|P2|Overall Study|Kidney Transplantation|5
1552294|NCT00077766|5066612|P1|Overall Study|Kidney Transplantation|9
1552295|NCT00077766|5066611|P2|Overall Study|Protocol Violation|0
1552296|NCT00077766|5066612|P1|Overall Study|Protocol Violation|1
1552297|NCT00077766|5066611|P2|Overall Study|Lost to Follow-up|0
1552298|NCT00077766|5066612|P1|Overall Study|Lost to Follow-up|2
1552299|NCT00077766|5066611|P2|Overall Study|Death|10
1552300|NCT00077766|5066612|P1|Overall Study|Death|12
1552301|NCT00077766|5066611|P2|Overall Study|Withdrawal by Subject|3
1552302|NCT00077766|5066612|P1|Overall Study|Withdrawal by Subject|4
1552303|NCT00077766|5066611|P2|Overall Study|Adverse Event|1
1552304|NCT00077766|5066612|P1|Overall Study|Adverse Event|1
1552305|NCT00077675|5066637|P2|Overall Study|Never received study treatment|3
1552306|NCT00077675|5066638|P1|Overall Study|Never received study treatment|3
1552307|NCT00077675|5066637|P2|Overall Study|Other|1
1552308|NCT00077675|5066638|P1|Overall Study|Other|0
1552309|NCT00077675|5066637|P2|Overall Study|Withdrawal by Subject|0
1552310|NCT00077675|5066638|P1|Overall Study|Withdrawal by Subject|1
1552311|NCT00077675|5066637|P2|Overall Study|Lost to Follow-up|3
1552312|NCT00077675|5066638|P1|Overall Study|Lost to Follow-up|6
1552313|NCT00077675|5066637|P2|Overall Study|Adverse Event|2
1552314|NCT00077675|5066638|P1|Overall Study|Adverse Event|1
1552315|NCT00077649|5066648|P4|Overall Study|Randomized but never dosed|0
1552316|NCT00077649|5066649|P3|Overall Study|Randomized but never dosed|0
1552317|NCT00077649|5066650|P2|Overall Study|Randomized but never dosed|0
1552318|NCT00077649|5066651|P1|Overall Study|Randomized but never dosed|1
1552319|NCT00077649|5066648|P4|Overall Study|Abnormality of Laboratory Test|2
1552320|NCT00077649|5066649|P3|Overall Study|Abnormality of Laboratory Test|1
1552321|NCT00077649|5066650|P2|Overall Study|Abnormality of Laboratory Test|2
1552322|NCT00077649|5066651|P1|Overall Study|Abnormality of Laboratory Test|1
1552323|NCT00077649|5066648|P4|Overall Study|Lost to Follow-up|2
1552324|NCT00077649|5066649|P3|Overall Study|Lost to Follow-up|3
1552325|NCT00077649|5066650|P2|Overall Study|Lost to Follow-up|2
1552326|NCT00077649|5066651|P1|Overall Study|Lost to Follow-up|2
1552327|NCT00077649|5066648|P4|Overall Study|Withdrawal by Subject|2
1552328|NCT00077649|5066649|P3|Overall Study|Withdrawal by Subject|1
1552329|NCT00077649|5066650|P2|Overall Study|Withdrawal by Subject|1
1552330|NCT00077649|5066651|P1|Overall Study|Withdrawal by Subject|0
1552331|NCT00077649|5066648|P4|Overall Study|Lack of Efficacy|2
1552332|NCT00077649|5066649|P3|Overall Study|Lack of Efficacy|3
1552333|NCT00077649|5066650|P2|Overall Study|Lack of Efficacy|3
1552334|NCT00077649|5066651|P1|Overall Study|Lack of Efficacy|5
1552335|NCT00077649|5066648|P4|Overall Study|Adverse Event|9
1552336|NCT00077649|5066649|P3|Overall Study|Adverse Event|7
1552337|NCT00077649|5066650|P2|Overall Study|Adverse Event|1
1552338|NCT00077649|5066651|P1|Overall Study|Adverse Event|5
1552339|NCT00077636|5066699|P2|Overall Study|Abnormality Of Laboratory Test|2
1552340|NCT00077636|5066700|P1|Overall Study|Abnormality Of Laboratory Test|3
1552341|NCT00077636|5066699|P2|Overall Study|Lost to Follow-up|18
1552342|NCT00077636|5066700|P1|Overall Study|Lost to Follow-up|10
1552343|NCT00077636|5066699|P2|Overall Study|Protocol Violation|2
1552344|NCT00077636|5066700|P1|Overall Study|Protocol Violation|0
1552345|NCT00077636|5066699|P2|Overall Study|Adverse Event|34
1552346|NCT00077636|5066700|P1|Overall Study|Adverse Event|17
1552347|NCT00077636|5066699|P2|Overall Study|Withdrawal by Subject|2
1552348|NCT00077636|5066700|P1|Overall Study|Withdrawal by Subject|2
1552349|NCT00077636|5066699|P2|Overall Study|Admin|3
1552350|NCT00077636|5066700|P1|Overall Study|Admin|3
1552351|NCT00077636|5066699|P2|Overall Study|Refused Treatment|31
1552352|NCT00077636|5066700|P1|Overall Study|Refused Treatment|9
1552353|NCT00077623|5066721|P3|Overall Study|Failure to return|0
1552354|NCT00077623|5066722|P2|Overall Study|Failure to return|0
1552355|NCT00077623|5066723|P1|Overall Study|Failure to return|1
1552356|NCT00077623|5066721|P3|Overall Study|Death|11
1552357|NCT00077623|5066722|P2|Overall Study|Death|18
1552358|NCT00077623|5066723|P1|Overall Study|Death|12
1552359|NCT00077623|5066721|P3|Overall Study|Insufficient therapeutic response|0
1552360|NCT00077623|5066722|P2|Overall Study|Insufficient therapeutic response|0
1552361|NCT00077623|5066723|P1|Overall Study|Insufficient therapeutic response|2
1552362|NCT00077623|5066721|P3|Overall Study|Other-Non safety reason|19
1552363|NCT00077623|5066722|P2|Overall Study|Other-Non safety reason|15
1552364|NCT00077623|5066723|P1|Overall Study|Other-Non safety reason|18
1552365|NCT00077623|5066721|P3|Overall Study|Withdrawal by Subject|1
1552366|NCT00077623|5066722|P2|Overall Study|Withdrawal by Subject|10
1552367|NCT00077623|5066723|P1|Overall Study|Withdrawal by Subject|2
1552368|NCT00077623|5066721|P3|Overall Study|Adverse Event|1
1552369|NCT00077623|5066722|P2|Overall Study|Adverse Event|0
1552370|NCT00077623|5066723|P1|Overall Study|Adverse Event|1
1552371|NCT00077610|5066758|P3|Overall Study|Sponsors decision to withdraw|1
1552372|NCT00077610|5066759|P2|Overall Study|Sponsors decision to withdraw|0
1552373|NCT00077610|5066760|P1|Overall Study|Sponsors decision to withdraw|0
1552374|NCT00077610|5066758|P3|Overall Study|Financial issues|0
1552375|NCT00077610|5066759|P2|Overall Study|Financial issues|1
1552376|NCT00077610|5066760|P1|Overall Study|Financial issues|0
1552377|NCT00077610|5066758|P3|Overall Study|Relocation|5
1552378|NCT00077610|5066759|P2|Overall Study|Relocation|8
1552379|NCT00077610|5066760|P1|Overall Study|Relocation|0
1552380|NCT00077610|5066758|P3|Overall Study|Change in dialysis modality|0
1552381|NCT00077610|5066759|P2|Overall Study|Change in dialysis modality|0
1552382|NCT00077610|5066760|P1|Overall Study|Change in dialysis modality|1
1552383|NCT00077610|5066758|P3|Overall Study|Transfer to other center for surgery|0
1552384|NCT00077610|5066759|P2|Overall Study|Transfer to other center for surgery|0
1552385|NCT00077610|5066760|P1|Overall Study|Transfer to other center for surgery|1
1552386|NCT00077610|5066758|P3|Overall Study|Transfer to satellite unit|0
1552387|NCT00077610|5066759|P2|Overall Study|Transfer to satellite unit|0
1552388|NCT00077610|5066760|P1|Overall Study|Transfer to satellite unit|1
1552389|NCT00077610|5066758|P3|Overall Study|Transferred to nursing home|1
1552390|NCT00077610|5066759|P2|Overall Study|Transferred to nursing home|0
1552391|NCT00077610|5066760|P1|Overall Study|Transferred to nursing home|0
1552392|NCT00077610|5066758|P3|Overall Study|Transferred to other unit|1
1552393|NCT00077610|5066759|P2|Overall Study|Transferred to other unit|0
1552394|NCT00077610|5066760|P1|Overall Study|Transferred to other unit|0
1552395|NCT00077610|5066758|P3|Overall Study|Given Epogen in hospital|0
1552396|NCT00077610|5066759|P2|Overall Study|Given Epogen in hospital|0
1552397|NCT00077610|5066760|P1|Overall Study|Given Epogen in hospital|1
1552398|NCT00077610|5066758|P3|Overall Study|Worsening of health condition|0
1552399|NCT00077610|5066759|P2|Overall Study|Worsening of health condition|1
1552400|NCT00077610|5066760|P1|Overall Study|Worsening of health condition|1
1552401|NCT00077610|5066758|P3|Overall Study|Principal Investigator's decision|1
1552402|NCT00077610|5066759|P2|Overall Study|Principal Investigator's decision|0
1552403|NCT00077610|5066760|P1|Overall Study|Principal Investigator's decision|1
1552404|NCT00077610|5066758|P3|Overall Study|Multiple blood transfusions|1
1552405|NCT00077610|5066759|P2|Overall Study|Multiple blood transfusions|0
1552406|NCT00077610|5066760|P1|Overall Study|Multiple blood transfusions|0
1552407|NCT00077610|5066758|P3|Overall Study|Insufficient Therapeutic Response|0
1552408|NCT00077610|5066759|P2|Overall Study|Insufficient Therapeutic Response|0
1552409|NCT00077610|5066760|P1|Overall Study|Insufficient Therapeutic Response|1
1552410|NCT00077610|5066758|P3|Overall Study|Withdrew from dialysis care|3
1552411|NCT00077610|5066759|P2|Overall Study|Withdrew from dialysis care|0
1552412|NCT00077610|5066760|P1|Overall Study|Withdrew from dialysis care|5
1552413|NCT00077610|5066758|P3|Overall Study|Renal transplant|11
1552414|NCT00077610|5066759|P2|Overall Study|Renal transplant|15
1552415|NCT00077610|5066760|P1|Overall Study|Renal transplant|12
1552416|NCT00077610|5066758|P3|Overall Study|Death|13
1552417|NCT00077610|5066759|P2|Overall Study|Death|13
1552418|NCT00077610|5066760|P1|Overall Study|Death|17
1552419|NCT00077610|5066758|P3|Overall Study|Withdrawal by Subject|6
1552420|NCT00077610|5066759|P2|Overall Study|Withdrawal by Subject|10
1552421|NCT00077610|5066760|P1|Overall Study|Withdrawal by Subject|4
1552422|NCT00077610|5066758|P3|Overall Study|Lost to Follow-up|2
1552423|NCT00077610|5066759|P2|Overall Study|Lost to Follow-up|1
1552424|NCT00077610|5066760|P1|Overall Study|Lost to Follow-up|0
1552425|NCT00077610|5066758|P3|Overall Study|Adverse Event|1
1552426|NCT00077610|5066759|P2|Overall Study|Adverse Event|7
1552427|NCT00077610|5066760|P1|Overall Study|Adverse Event|9
1552428|NCT00077376|5066789|P1|Overall Study|Insurance ran out|1
1552429|NCT00077376|5066789|P1|Overall Study|Surgery|1
1552430|NCT00077376|5066789|P1|Overall Study|Symptomatic deterioration|1
1552431|NCT00077376|5066789|P1|Overall Study|Still on treatment|1
1552432|NCT00077376|5066789|P1|Overall Study|Complicating disease|1
1552433|NCT00077376|5066789|P1|Overall Study|Alternative therapy|5
1552434|NCT00077376|5066789|P1|Overall Study|Physician Decision|1
1552435|NCT00077376|5066789|P1|Overall Study|Death|1
1552436|NCT00077376|5066789|P1|Overall Study|Withdrawal by Subject|2
1552437|NCT00077376|5066789|P1|Overall Study|Adverse Event|8
1552438|NCT00077207|5066800|P1|Overall Study|Ineligible|1
1552439|NCT00077207|5066800|P1|Overall Study|Withdrawal by Subject|6
1552440|NCT00077207|5066800|P1|Overall Study|Physician Decision|6
1552441|NCT00077207|5066800|P1|Overall Study|Lack of Efficacy|12
1552442|NCT00077207|5066800|P1|Overall Study|Adverse Event|5
1552443|NCT00077064|5066812|P2|Overall Study|Patient refusal|2
1552444|NCT00077064|5066813|P1|Overall Study|Patient refusal|0
1552445|NCT00077064|5066812|P2|Overall Study|Adverse Event|4
1552446|NCT00077064|5066813|P1|Overall Study|Adverse Event|0
1552447|NCT00076999|5066829|P5|Overall Study|Other reason (not specified)|13
1552448|NCT00076999|5066830|P4|Overall Study|Other reason (not specified)|1
1552449|NCT00076999|5066831|P3|Overall Study|Other reason (not specified)|4
1552450|NCT00076999|5066832|P2|Overall Study|Other reason (not specified)|8
1552451|NCT00076999|5066833|P1|Overall Study|Other reason (not specified)|8
1552452|NCT00076999|5066829|P5|Overall Study|Withdrawal by Subject|1
1552453|NCT00076999|5066830|P4|Overall Study|Withdrawal by Subject|0
1552454|NCT00076999|5066831|P3|Overall Study|Withdrawal by Subject|3
1552455|NCT00076999|5066832|P2|Overall Study|Withdrawal by Subject|4
1552456|NCT00076999|5066833|P1|Overall Study|Withdrawal by Subject|0
1552457|NCT00076999|5066829|P5|Overall Study|Lost to Follow-up|0
1552458|NCT00076999|5066830|P4|Overall Study|Lost to Follow-up|0
1552459|NCT00076999|5066831|P3|Overall Study|Lost to Follow-up|0
1552460|NCT00076999|5066832|P2|Overall Study|Lost to Follow-up|1
1552461|NCT00076999|5066833|P1|Overall Study|Lost to Follow-up|2
1552462|NCT00076999|5066829|P5|Overall Study|Protocol Violation|9
1552463|NCT00076999|5066830|P4|Overall Study|Protocol Violation|0
1552464|NCT00076999|5066831|P3|Overall Study|Protocol Violation|4
1552465|NCT00076999|5066832|P2|Overall Study|Protocol Violation|3
1552466|NCT00076999|5066833|P1|Overall Study|Protocol Violation|0
1552467|NCT00076999|5066829|P5|Overall Study|Adverse Event|2
1552468|NCT00076999|5066830|P4|Overall Study|Adverse Event|0
1552469|NCT00076999|5066831|P3|Overall Study|Adverse Event|6
1552470|NCT00076999|5066832|P2|Overall Study|Adverse Event|8
1552471|NCT00076999|5066833|P1|Overall Study|Adverse Event|2
1552472|NCT00003222|5066952|P2|Overall Study|Physician Decision|1
1552473|NCT00003222|5066953|P1|Overall Study|Physician Decision|0
1552474|NCT00076804|5066965|P2|Overall Study|Early study Closure|32
1552475|NCT00076804|5066966|P1|Overall Study|Early study Closure|32
1552476|NCT00076804|5066965|P2|Overall Study|Withdrawal by Subject|8
1552477|NCT00076804|5066966|P1|Overall Study|Withdrawal by Subject|10
1552478|NCT00076804|5066965|P2|Overall Study|Lost to Follow-up|9
1552479|NCT00076804|5066966|P1|Overall Study|Lost to Follow-up|9
1552480|NCT00076804|5066965|P2|Overall Study|Death|20
1552481|NCT00076804|5066966|P1|Overall Study|Death|9
1552482|NCT00076752|5066978|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
1552483|NCT00076752|5066978|P1|Overall Study|Death|2
1552484|NCT00076570|5067024|P2|Overall Study|Drug intolerance|8
1552485|NCT00076570|5067025|P1|Overall Study|Drug intolerance|8
1552486|NCT00003298|5067033|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
1552487|NCT00003298|5067033|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
1552488|NCT00003298|5067033|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
1552489|NCT00003298|5067033|P1|Step 2 (Adjuvant Therapy)|Death|1
1552490|NCT00003298|5067033|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
1552491|NCT00003298|5067033|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
1552492|NCT00003298|5067033|P1|Re-register to Step 2 After Surgery|Reason unknown|1
1552493|NCT00003298|5067033|P1|Re-register to Step 2 After Surgery|Other complications|2
1552494|NCT00003298|5067033|P1|Re-register to Step 2 After Surgery|Positive margins|5
1552495|NCT00003298|5067033|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
1552496|NCT00003298|5067033|P1|Surgery|Unevaluable and off study|2
1552497|NCT00003298|5067033|P1|Surgery|Progression before surgery|2
1552498|NCT00003298|5067033|P1|Surgery|Unresectable at surgery|3
1552499|NCT00003298|5067033|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
1552500|NCT00003298|5067033|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
1552501|NCT00076336|5067043|P2|Overall Study|Treatment failure|5
1552502|NCT00076336|5067044|P1|Overall Study|Treatment failure|4
1552503|NCT00076336|5067043|P2|Overall Study|Virologic Breakthrough|16
1552504|NCT00076336|5067044|P1|Overall Study|Virologic Breakthrough|14
1552505|NCT00076336|5067043|P2|Overall Study|Liver Transplantation|3
1552506|NCT00076336|5067044|P1|Overall Study|Liver Transplantation|3
1552507|NCT00076336|5067043|P2|Overall Study|Patient, Investigator, Sponsor request|6
1552508|NCT00076336|5067044|P1|Overall Study|Patient, Investigator, Sponsor request|8
1552509|NCT00076336|5067043|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
1552510|NCT00076336|5067044|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
1552511|NCT00076336|5067043|P2|Overall Study|Non-Compliance|0
1552512|NCT00076336|5067044|P1|Overall Study|Non-Compliance|2
1552513|NCT00076336|5067043|P2|Overall Study|Lost to Follow-up|4
1552514|NCT00076336|5067044|P1|Overall Study|Lost to Follow-up|4
1552515|NCT00076336|5067043|P2|Overall Study|Adverse Event|4
1552516|NCT00076336|5067044|P1|Overall Study|Adverse Event|4
1552517|NCT00076336|5067043|P2|Overall Study|Death|17
1552518|NCT00076336|5067044|P1|Overall Study|Death|13
1552519|NCT00076102|5067097|P1|Overall Study|refusal of further therapy|2
1552520|NCT00076102|5067097|P1|Overall Study|plexiform neurofibroma surgery|1
1552521|NCT00076102|5067097|P1|Overall Study|Progression in pre-existing brain tumor|1
1552522|NCT00076102|5067097|P1|Overall Study|Clinical progression|1
1552523|NCT00076024|5067125|P4|Phase 2, Open-label|Other|2
1552524|NCT00076024|5067126|P3|Phase 2, Open-label|Other|0
1552525|NCT00076024|5067127|P2|Phase 2, Open-label|Other|0
1552526|NCT00076024|5067128|P1|Phase 2, Open-label|Other|0
1552527|NCT00076024|5067125|P4|Phase 2, Open-label|Withdrawal by Subject|1
1552528|NCT00076024|5067126|P3|Phase 2, Open-label|Withdrawal by Subject|0
1552529|NCT00076024|5067127|P2|Phase 2, Open-label|Withdrawal by Subject|0
1552530|NCT00076024|5067128|P1|Phase 2, Open-label|Withdrawal by Subject|0
1552531|NCT00076024|5067125|P4|Phase 2, Open-label|Lack of Efficacy|11
1552532|NCT00076024|5067126|P3|Phase 2, Open-label|Lack of Efficacy|0
1552533|NCT00076024|5067127|P2|Phase 2, Open-label|Lack of Efficacy|0
1552534|NCT00076024|5067128|P1|Phase 2, Open-label|Lack of Efficacy|0
1552535|NCT00076024|5067125|P4|Phase 2, Open-label|Adverse Event|2
1552536|NCT00076024|5067126|P3|Phase 2, Open-label|Adverse Event|0
1552537|NCT00076024|5067127|P2|Phase 2, Open-label|Adverse Event|0
1552538|NCT00076024|5067128|P1|Phase 2, Open-label|Adverse Event|0
1552539|NCT00076024|5067125|P4|Phase 2, Double-blind|Randomized but not treated|0
1552540|NCT00076024|5067126|P3|Phase 2, Double-blind|Randomized but not treated|0
1552541|NCT00076024|5067127|P2|Phase 2, Double-blind|Randomized but not treated|1
1552542|NCT00076024|5067128|P1|Phase 2, Double-blind|Randomized but not treated|0
1552543|NCT00076024|5067125|P4|Phase 2, Double-blind|Un-specified|0
1552544|NCT00076024|5067126|P3|Phase 2, Double-blind|Un-specified|6
1552545|NCT00076024|5067127|P2|Phase 2, Double-blind|Un-specified|14
1552546|NCT00076024|5067128|P1|Phase 2, Double-blind|Un-specified|0
1552547|NCT00076024|5067125|P4|Phase 2, Double-blind|Adverse Event|0
1552548|NCT00076024|5067126|P3|Phase 2, Double-blind|Adverse Event|6
1552549|NCT00076024|5067127|P2|Phase 2, Double-blind|Adverse Event|25
1552550|NCT00076024|5067128|P1|Phase 2, Double-blind|Adverse Event|0
1552551|NCT00076024|5067125|P4|Phase 2, Double-blind|Withdrawal by Subject|0
1552552|NCT00076024|5067126|P3|Phase 2, Double-blind|Withdrawal by Subject|4
1552553|NCT00076024|5067127|P2|Phase 2, Double-blind|Withdrawal by Subject|13
1552554|NCT00076024|5067128|P1|Phase 2, Double-blind|Withdrawal by Subject|0
1552555|NCT00076024|5067125|P4|Phase 2, Double-blind|Lack of Efficacy|0
1552556|NCT00076024|5067126|P3|Phase 2, Double-blind|Lack of Efficacy|40
1552557|NCT00076024|5067127|P2|Phase 2, Double-blind|Lack of Efficacy|59
1552558|NCT00076024|5067128|P1|Phase 2, Double-blind|Lack of Efficacy|0
1552559|NCT00076024|5067125|P4|Phase 1, Lead-in|Clinical progression|0
1552560|NCT00076024|5067126|P3|Phase 1, Lead-in|Clinical progression|0
1552561|NCT00076024|5067127|P2|Phase 1, Lead-in|Clinical progression|0
1552562|NCT00076024|5067128|P1|Phase 1, Lead-in|Clinical progression|1
1552563|NCT00076024|5067125|P4|Phase 1, Lead-in|Adverse Event|0
1552564|NCT00076024|5067126|P3|Phase 1, Lead-in|Adverse Event|0
1552565|NCT00076024|5067127|P2|Phase 1, Lead-in|Adverse Event|0
1552566|NCT00076024|5067128|P1|Phase 1, Lead-in|Adverse Event|1
1552567|NCT00076024|5067125|P4|Phase 1, Lead-in|Lack of Efficacy|0
1552568|NCT00076024|5067126|P3|Phase 1, Lead-in|Lack of Efficacy|0
1552569|NCT00076024|5067127|P2|Phase 1, Lead-in|Lack of Efficacy|0
1552570|NCT00076024|5067128|P1|Phase 1, Lead-in|Lack of Efficacy|4
1552571|NCT00076011|5067142|P1|Overall Study|Ongoing|1
1552572|NCT00076011|5067142|P1|Overall Study|Other|11
1552573|NCT00076011|5067142|P1|Overall Study|Study terminated by sponsor|3
1552574|NCT00076011|5067142|P1|Overall Study|Withdrawal by Subject|1
1552575|NCT00076011|5067142|P1|Overall Study|Lack of Efficacy|25
1552576|NCT00076011|5067142|P1|Overall Study|Adverse Event|10
1552577|NCT00076011|5067142|P1|Overall Study|Death|1
1552578|NCT00075946|5067154|P5|Overall Study|Other|0
1552579|NCT00075946|5067155|P4|Overall Study|Other|2
1552580|NCT00075946|5067156|P3|Overall Study|Other|0
1552581|NCT00075946|5067157|P2|Overall Study|Other|13
1552582|NCT00075946|5067158|P1|Overall Study|Other|5
1552583|NCT00075946|5067154|P5|Overall Study|Time to progression less than 6 months|0
1552584|NCT00075946|5067155|P4|Overall Study|Time to progression less than 6 months|3
1552585|NCT00075946|5067156|P3|Overall Study|Time to progression less than 6 months|8
1552586|NCT00075946|5067157|P2|Overall Study|Time to progression less than 6 months|30
1552587|NCT00075946|5067158|P1|Overall Study|Time to progression less than 6 months|15
1552588|NCT00075946|5067154|P5|Overall Study|No response to retreatment|0
1552589|NCT00075946|5067155|P4|Overall Study|No response to retreatment|0
1552590|NCT00075946|5067156|P3|Overall Study|No response to retreatment|2
1552591|NCT00075946|5067157|P2|Overall Study|No response to retreatment|0
1552592|NCT00075946|5067158|P1|Overall Study|No response to retreatment|23
1552593|NCT00075946|5067154|P5|Overall Study|Other complicating disease|0
1552594|NCT00075946|5067155|P4|Overall Study|Other complicating disease|4
1552595|NCT00075946|5067156|P3|Overall Study|Other complicating disease|1
1552596|NCT00075946|5067157|P2|Overall Study|Other complicating disease|13
1552597|NCT00075946|5067158|P1|Overall Study|Other complicating disease|7
1552598|NCT00075946|5067154|P5|Overall Study|Alternative therapy|0
1552599|NCT00075946|5067155|P4|Overall Study|Alternative therapy|0
1552600|NCT00075946|5067156|P3|Overall Study|Alternative therapy|5
1552601|NCT00075946|5067157|P2|Overall Study|Alternative therapy|2
1552602|NCT00075946|5067158|P1|Overall Study|Alternative therapy|16
1552603|NCT00075946|5067154|P5|Overall Study|Withdrawal by Subject|0
1552604|NCT00075946|5067155|P4|Overall Study|Withdrawal by Subject|9
1552605|NCT00075946|5067156|P3|Overall Study|Withdrawal by Subject|4
1552606|NCT00075946|5067157|P2|Overall Study|Withdrawal by Subject|58
1552607|NCT00075946|5067158|P1|Overall Study|Withdrawal by Subject|23
1552608|NCT00075946|5067154|P5|Overall Study|Death|0
1552609|NCT00075946|5067155|P4|Overall Study|Death|0
1552610|NCT00075946|5067156|P3|Overall Study|Death|0
1552611|NCT00075946|5067157|P2|Overall Study|Death|1
1552612|NCT00075946|5067158|P1|Overall Study|Death|0
1552613|NCT00075946|5067154|P5|Overall Study|Adverse Event|0
1552614|NCT00075946|5067155|P4|Overall Study|Adverse Event|2
1552615|NCT00075946|5067156|P3|Overall Study|Adverse Event|0
1552616|NCT00075946|5067157|P2|Overall Study|Adverse Event|10
1552617|NCT00075946|5067158|P1|Overall Study|Adverse Event|2
1552618|NCT00075946|5067154|P5|Overall Study|Still on treatment at time of analysis|0
1552619|NCT00075946|5067155|P4|Overall Study|Still on treatment at time of analysis|9
1552620|NCT00075946|5067156|P3|Overall Study|Still on treatment at time of analysis|3
1552621|NCT00075946|5067157|P2|Overall Study|Still on treatment at time of analysis|19
1552622|NCT00075946|5067158|P1|Overall Study|Still on treatment at time of analysis|52
1552623|NCT00075946|5067154|P5|Overall Study|Incorrectly randomized (no response)|0
1552624|NCT00075946|5067155|P4|Overall Study|Incorrectly randomized (no response)|1
1552625|NCT00075946|5067156|P3|Overall Study|Incorrectly randomized (no response)|5
1552626|NCT00075946|5067157|P2|Overall Study|Incorrectly randomized (no response)|5
1552627|NCT00075946|5067158|P1|Overall Study|Incorrectly randomized (no response)|5
1552628|NCT00075946|5067154|P5|Overall Study|Did not achieve response after induction|182
1552629|NCT00075946|5067155|P4|Overall Study|Did not achieve response after induction|0
1552630|NCT00075946|5067156|P3|Overall Study|Did not achieve response after induction|0
1552631|NCT00075946|5067157|P2|Overall Study|Did not achieve response after induction|0
1552632|NCT00075946|5067158|P1|Overall Study|Did not achieve response after induction|0
1552633|NCT00075946|5067154|P5|Overall Study|Path ineligible: undetermined histology|6
1552634|NCT00075946|5067155|P4|Overall Study|Path ineligible: undetermined histology|0
1552635|NCT00075946|5067156|P3|Overall Study|Path ineligible: undetermined histology|0
1552636|NCT00075946|5067157|P2|Overall Study|Path ineligible: undetermined histology|0
1552637|NCT00075946|5067158|P1|Overall Study|Path ineligible: undetermined histology|0
1552638|NCT00075881|5067173|P1|Overall Study|never start protocol therapy|1
1552639|NCT00075881|5067173|P1|Overall Study|Ineligible|1
1552640|NCT00075881|5067173|P1|Overall Study|missing data|2
1552641|NCT00075881|5067173|P1|Overall Study|other|4
1552642|NCT00075881|5067173|P1|Overall Study|other complicating disease|3
1552643|NCT00075881|5067173|P1|Overall Study|Protocol Violation|4
1552644|NCT00075881|5067173|P1|Overall Study|Withdrawal by Subject|2
1552645|NCT00075881|5067173|P1|Overall Study|Death|1
1552646|NCT00075881|5067173|P1|Overall Study|Adverse Event|7
1552647|NCT00075881|5067173|P1|Overall Study|Lack of Efficacy|18
1552648|NCT00075816|5067217|P2|Overall Study|Did not undergo transplantation|11
1552649|NCT00075816|5067218|P1|Overall Study|Did not undergo transplantation|14
1552650|NCT00075764|5067287|P2|Overall Study|Under review|1
1552651|NCT00075764|5067288|P1|Overall Study|Under review|0
1552652|NCT00075764|5067287|P2|Overall Study|Not protocol specified|19
1552653|NCT00075764|5067288|P1|Overall Study|Not protocol specified|27
1552654|NCT00075764|5067287|P2|Overall Study|Delinquent|2
1552655|NCT00075764|5067288|P1|Overall Study|Delinquent|4
1552656|NCT00075764|5067287|P2|Overall Study|Still on treatment|15
1552657|NCT00075764|5067288|P1|Overall Study|Still on treatment|8
1552658|NCT00075764|5067287|P2|Overall Study|Progression|274
1552659|NCT00075764|5067288|P1|Overall Study|Progression|269
1552660|NCT00075764|5067287|P2|Overall Study|Withdrawal by Subject|18
1552661|NCT00075764|5067288|P1|Overall Study|Withdrawal by Subject|28
1552662|NCT00075764|5067287|P2|Overall Study|Death|8
1552663|NCT00075764|5067288|P1|Overall Study|Death|4
1552664|NCT00075764|5067287|P2|Overall Study|Adverse Event|12
1552665|NCT00075764|5067288|P1|Overall Study|Adverse Event|5
1552666|NCT00075725|5067312|P12|Overall Study|Pt incarcerated|0
1552667|NCT00075725|5067313|P11|Overall Study|Pt incarcerated|0
1552668|NCT00075725|5067314|P10|Overall Study|Pt incarcerated|0
1552669|NCT00075725|5067315|P9|Overall Study|Pt incarcerated|0
1552670|NCT00075725|5067316|P8|Overall Study|Pt incarcerated|1
1552671|NCT00075725|5067317|P7|Overall Study|Pt incarcerated|0
1552672|NCT00075725|5067318|P6|Overall Study|Pt incarcerated|0
1552673|NCT00075725|5067319|P5|Overall Study|Pt incarcerated|0
1552674|NCT00075725|5067320|P4|Overall Study|Pt incarcerated|0
1552675|NCT00075725|5067321|P3|Overall Study|Pt incarcerated|0
1552676|NCT00075725|5067322|P2|Overall Study|Pt incarcerated|0
1552677|NCT00075725|5067323|P1|Overall Study|Pt incarcerated|0
1552678|NCT00075725|5067312|P12|Overall Study|Pt care terminated due to pt behavior|0
1552679|NCT00075725|5067313|P11|Overall Study|Pt care terminated due to pt behavior|0
1552680|NCT00075725|5067314|P10|Overall Study|Pt care terminated due to pt behavior|0
1552681|NCT00075725|5067315|P9|Overall Study|Pt care terminated due to pt behavior|0
1552682|NCT00075725|5067316|P8|Overall Study|Pt care terminated due to pt behavior|1
1552683|NCT00075725|5067317|P7|Overall Study|Pt care terminated due to pt behavior|0
1552684|NCT00075725|5067318|P6|Overall Study|Pt care terminated due to pt behavior|0
1552685|NCT00075725|5067319|P5|Overall Study|Pt care terminated due to pt behavior|0
1552686|NCT00075725|5067320|P4|Overall Study|Pt care terminated due to pt behavior|0
1552687|NCT00075725|5067321|P3|Overall Study|Pt care terminated due to pt behavior|0
1552688|NCT00075725|5067322|P2|Overall Study|Pt care terminated due to pt behavior|0
1552689|NCT00075725|5067323|P1|Overall Study|Pt care terminated due to pt behavior|0
1552690|NCT00075725|5067312|P12|Overall Study|Other complications|0
1552691|NCT00075725|5067313|P11|Overall Study|Other complications|0
1552692|NCT00075725|5067314|P10|Overall Study|Other complications|0
1552693|NCT00075725|5067315|P9|Overall Study|Other complications|0
1552694|NCT00075725|5067316|P8|Overall Study|Other complications|0
1552695|NCT00075725|5067317|P7|Overall Study|Other complications|0
1552696|NCT00075725|5067318|P6|Overall Study|Other complications|1
1552697|NCT00075725|5067319|P5|Overall Study|Other complications|0
1552698|NCT00075725|5067320|P4|Overall Study|Other complications|0
1552699|NCT00075725|5067321|P3|Overall Study|Other complications|0
1552700|NCT00075725|5067322|P2|Overall Study|Other complications|0
1552701|NCT00075725|5067323|P1|Overall Study|Other complications|0
1552702|NCT00075725|5067312|P12|Overall Study|Study Closure|0
1552703|NCT00075725|5067313|P11|Overall Study|Study Closure|0
1552704|NCT00075725|5067314|P10|Overall Study|Study Closure|0
1552705|NCT00075725|5067315|P9|Overall Study|Study Closure|0
1552706|NCT00075725|5067316|P8|Overall Study|Study Closure|1
1552707|NCT00075725|5067317|P7|Overall Study|Study Closure|0
1552708|NCT00075725|5067318|P6|Overall Study|Study Closure|3
1552709|NCT00075725|5067319|P5|Overall Study|Study Closure|1
1552710|NCT00075725|5067320|P4|Overall Study|Study Closure|0
1552711|NCT00075725|5067321|P3|Overall Study|Study Closure|0
1552712|NCT00075725|5067322|P2|Overall Study|Study Closure|0
1552713|NCT00075725|5067323|P1|Overall Study|Study Closure|1
1552714|NCT00075725|5067312|P12|Overall Study|Institution Terminated|0
1552715|NCT00075725|5067313|P11|Overall Study|Institution Terminated|0
1552716|NCT00075725|5067314|P10|Overall Study|Institution Terminated|0
1552717|NCT00075725|5067315|P9|Overall Study|Institution Terminated|0
1552718|NCT00075725|5067316|P8|Overall Study|Institution Terminated|3
1552719|NCT00075725|5067317|P7|Overall Study|Institution Terminated|0
1552720|NCT00075725|5067318|P6|Overall Study|Institution Terminated|0
1552721|NCT00075725|5067319|P5|Overall Study|Institution Terminated|1
1552722|NCT00075725|5067320|P4|Overall Study|Institution Terminated|0
1552723|NCT00075725|5067321|P3|Overall Study|Institution Terminated|0
1552724|NCT00075725|5067322|P2|Overall Study|Institution Terminated|0
1552725|NCT00075725|5067323|P1|Overall Study|Institution Terminated|0
1552726|NCT00075725|5067312|P12|Overall Study|Pt relocated|0
1552727|NCT00075725|5067313|P11|Overall Study|Pt relocated|0
1552728|NCT00075725|5067314|P10|Overall Study|Pt relocated|0
1552729|NCT00075725|5067315|P9|Overall Study|Pt relocated|1
1552730|NCT00075725|5067316|P8|Overall Study|Pt relocated|2
1552731|NCT00075725|5067317|P7|Overall Study|Pt relocated|1
1552732|NCT00075725|5067318|P6|Overall Study|Pt relocated|1
1552733|NCT00075725|5067319|P5|Overall Study|Pt relocated|0
1552734|NCT00075725|5067320|P4|Overall Study|Pt relocated|2
1552735|NCT00075725|5067321|P3|Overall Study|Pt relocated|0
1552736|NCT00075725|5067322|P2|Overall Study|Pt relocated|0
1552737|NCT00075725|5067323|P1|Overall Study|Pt relocated|0
1552738|NCT00075725|5067312|P12|Overall Study|Pt received additional steroids|0
1552739|NCT00075725|5067313|P11|Overall Study|Pt received additional steroids|0
1552740|NCT00075725|5067314|P10|Overall Study|Pt received additional steroids|0
1552741|NCT00075725|5067315|P9|Overall Study|Pt received additional steroids|0
1552742|NCT00075725|5067316|P8|Overall Study|Pt received additional steroids|0
1552743|NCT00075725|5067317|P7|Overall Study|Pt received additional steroids|0
1552744|NCT00075725|5067318|P6|Overall Study|Pt received additional steroids|0
1552745|NCT00075725|5067319|P5|Overall Study|Pt received additional steroids|0
1552746|NCT00075725|5067320|P4|Overall Study|Pt received additional steroids|1
1552747|NCT00075725|5067321|P3|Overall Study|Pt received additional steroids|0
1552748|NCT00075725|5067322|P2|Overall Study|Pt received additional steroids|0
1552749|NCT00075725|5067323|P1|Overall Study|Pt received additional steroids|0
1552750|NCT00075725|5067312|P12|Overall Study|Pt went to transplant|0
1552751|NCT00075725|5067313|P11|Overall Study|Pt went to transplant|0
1552752|NCT00075725|5067314|P10|Overall Study|Pt went to transplant|0
1552753|NCT00075725|5067315|P9|Overall Study|Pt went to transplant|0
1552754|NCT00075725|5067316|P8|Overall Study|Pt went to transplant|0
1552755|NCT00075725|5067317|P7|Overall Study|Pt went to transplant|0
1552756|NCT00075725|5067318|P6|Overall Study|Pt went to transplant|1
1552757|NCT00075725|5067319|P5|Overall Study|Pt went to transplant|0
1552758|NCT00075725|5067320|P4|Overall Study|Pt went to transplant|1
1552759|NCT00075725|5067321|P3|Overall Study|Pt went to transplant|0
1552760|NCT00075725|5067322|P2|Overall Study|Pt went to transplant|0
1552761|NCT00075725|5067323|P1|Overall Study|Pt went to transplant|0
1552762|NCT00075725|5067312|P12|Overall Study|specimen(s) not submitted|0
1552763|NCT00075725|5067313|P11|Overall Study|specimen(s) not submitted|0
1552764|NCT00075725|5067314|P10|Overall Study|specimen(s) not submitted|0
1552765|NCT00075725|5067315|P9|Overall Study|specimen(s) not submitted|0
1552766|NCT00075725|5067316|P8|Overall Study|specimen(s) not submitted|0
1552767|NCT00075725|5067317|P7|Overall Study|specimen(s) not submitted|0
1552768|NCT00075725|5067318|P6|Overall Study|specimen(s) not submitted|0
1552769|NCT00075725|5067319|P5|Overall Study|specimen(s) not submitted|0
1552770|NCT00075725|5067320|P4|Overall Study|specimen(s) not submitted|0
1552771|NCT00075725|5067321|P3|Overall Study|specimen(s) not submitted|2
1552772|NCT00075725|5067322|P2|Overall Study|specimen(s) not submitted|0
1552773|NCT00075725|5067323|P1|Overall Study|specimen(s) not submitted|0
1552774|NCT00075725|5067312|P12|Overall Study|Unsuccessful institutional transfer|0
1553029|NCT00075582|5067421|P1|Overall Study|Withdrawal by Subject|2
1552775|NCT00075725|5067313|P11|Overall Study|Unsuccessful institutional transfer|0
1552776|NCT00075725|5067314|P10|Overall Study|Unsuccessful institutional transfer|1
1552777|NCT00075725|5067315|P9|Overall Study|Unsuccessful institutional transfer|0
1552778|NCT00075725|5067316|P8|Overall Study|Unsuccessful institutional transfer|0
1552779|NCT00075725|5067317|P7|Overall Study|Unsuccessful institutional transfer|0
1552780|NCT00075725|5067318|P6|Overall Study|Unsuccessful institutional transfer|0
1552781|NCT00075725|5067319|P5|Overall Study|Unsuccessful institutional transfer|0
1552782|NCT00075725|5067320|P4|Overall Study|Unsuccessful institutional transfer|0
1552783|NCT00075725|5067321|P3|Overall Study|Unsuccessful institutional transfer|2
1552784|NCT00075725|5067322|P2|Overall Study|Unsuccessful institutional transfer|0
1552785|NCT00075725|5067323|P1|Overall Study|Unsuccessful institutional transfer|0
1552786|NCT00075725|5067312|P12|Overall Study|Clinic chart lost unable to recreate|0
1552787|NCT00075725|5067313|P11|Overall Study|Clinic chart lost unable to recreate|0
1552788|NCT00075725|5067314|P10|Overall Study|Clinic chart lost unable to recreate|0
1552789|NCT00075725|5067315|P9|Overall Study|Clinic chart lost unable to recreate|0
1552790|NCT00075725|5067316|P8|Overall Study|Clinic chart lost unable to recreate|0
1552791|NCT00075725|5067317|P7|Overall Study|Clinic chart lost unable to recreate|0
1552792|NCT00075725|5067318|P6|Overall Study|Clinic chart lost unable to recreate|0
1552793|NCT00075725|5067319|P5|Overall Study|Clinic chart lost unable to recreate|0
1552794|NCT00075725|5067320|P4|Overall Study|Clinic chart lost unable to recreate|0
1552795|NCT00075725|5067321|P3|Overall Study|Clinic chart lost unable to recreate|1
1552796|NCT00075725|5067322|P2|Overall Study|Clinic chart lost unable to recreate|0
1552797|NCT00075725|5067323|P1|Overall Study|Clinic chart lost unable to recreate|0
1552798|NCT00075725|5067312|P12|Overall Study|Pt trying to find a BM donor|0
1552799|NCT00075725|5067313|P11|Overall Study|Pt trying to find a BM donor|0
1552800|NCT00075725|5067314|P10|Overall Study|Pt trying to find a BM donor|0
1552801|NCT00075725|5067315|P9|Overall Study|Pt trying to find a BM donor|0
1552802|NCT00075725|5067316|P8|Overall Study|Pt trying to find a BM donor|0
1552803|NCT00075725|5067317|P7|Overall Study|Pt trying to find a BM donor|0
1552804|NCT00075725|5067318|P6|Overall Study|Pt trying to find a BM donor|0
1552805|NCT00075725|5067319|P5|Overall Study|Pt trying to find a BM donor|0
1552806|NCT00075725|5067320|P4|Overall Study|Pt trying to find a BM donor|0
1552807|NCT00075725|5067321|P3|Overall Study|Pt trying to find a BM donor|0
1552808|NCT00075725|5067322|P2|Overall Study|Pt trying to find a BM donor|1
1552809|NCT00075725|5067323|P1|Overall Study|Pt trying to find a BM donor|0
1552810|NCT00075725|5067312|P12|Overall Study|Other|3
1552811|NCT00075725|5067313|P11|Overall Study|Other|0
1552812|NCT00075725|5067314|P10|Overall Study|Other|1
1552813|NCT00075725|5067315|P9|Overall Study|Other|2
1552814|NCT00075725|5067316|P8|Overall Study|Other|9
1552815|NCT00075725|5067317|P7|Overall Study|Other|2
1552816|NCT00075725|5067318|P6|Overall Study|Other|4
1552817|NCT00075725|5067319|P5|Overall Study|Other|1
1552818|NCT00075725|5067320|P4|Overall Study|Other|1
1552819|NCT00075725|5067321|P3|Overall Study|Other|1
1552820|NCT00075725|5067322|P2|Overall Study|Other|2
1552821|NCT00075725|5067323|P1|Overall Study|Other|4
1552822|NCT00075725|5067312|P12|Overall Study|Inevaluable|0
1552823|NCT00075725|5067313|P11|Overall Study|Inevaluable|1
1552824|NCT00075725|5067314|P10|Overall Study|Inevaluable|0
1552825|NCT00075725|5067315|P9|Overall Study|Inevaluable|2
1552826|NCT00075725|5067316|P8|Overall Study|Inevaluable|11
1552827|NCT00075725|5067317|P7|Overall Study|Inevaluable|1
1552828|NCT00075725|5067318|P6|Overall Study|Inevaluable|9
1552829|NCT00075725|5067319|P5|Overall Study|Inevaluable|2
1552830|NCT00075725|5067320|P4|Overall Study|Inevaluable|2
1552831|NCT00075725|5067321|P3|Overall Study|Inevaluable|4
1552832|NCT00075725|5067322|P2|Overall Study|Inevaluable|1
1552833|NCT00075725|5067323|P1|Overall Study|Inevaluable|1
1552834|NCT00075725|5067312|P12|Overall Study|Pt has very high risk ALL characteristic|3
1552835|NCT00075725|5067313|P11|Overall Study|Pt has very high risk ALL characteristic|0
1552836|NCT00075725|5067314|P10|Overall Study|Pt has very high risk ALL characteristic|1
1552837|NCT00075725|5067315|P9|Overall Study|Pt has very high risk ALL characteristic|29
1552838|NCT00075725|5067316|P8|Overall Study|Pt has very high risk ALL characteristic|74
1552839|NCT00075725|5067317|P7|Overall Study|Pt has very high risk ALL characteristic|23
1552840|NCT00075725|5067318|P6|Overall Study|Pt has very high risk ALL characteristic|75
1552841|NCT00075725|5067319|P5|Overall Study|Pt has very high risk ALL characteristic|11
1552842|NCT00075725|5067320|P4|Overall Study|Pt has very high risk ALL characteristic|18
1552843|NCT00075725|5067321|P3|Overall Study|Pt has very high risk ALL characteristic|26
1552844|NCT00075725|5067322|P2|Overall Study|Pt has very high risk ALL characteristic|11
1552845|NCT00075725|5067323|P1|Overall Study|Pt has very high risk ALL characteristic|15
1552846|NCT00075725|5067312|P12|Overall Study|MRD positive after extended ind|0
1552847|NCT00075725|5067313|P11|Overall Study|MRD positive after extended ind|0
1552848|NCT00075725|5067314|P10|Overall Study|MRD positive after extended ind|0
1552849|NCT00075725|5067315|P9|Overall Study|MRD positive after extended ind|0
1552850|NCT00075725|5067316|P8|Overall Study|MRD positive after extended ind|1
1552851|NCT00075725|5067317|P7|Overall Study|MRD positive after extended ind|0
1552852|NCT00075725|5067318|P6|Overall Study|MRD positive after extended ind|2
1552853|NCT00075725|5067319|P5|Overall Study|MRD positive after extended ind|1
1552854|NCT00075725|5067320|P4|Overall Study|MRD positive after extended ind|0
1552855|NCT00075725|5067321|P3|Overall Study|MRD positive after extended ind|1
1552856|NCT00075725|5067322|P2|Overall Study|MRD positive after extended ind|1
1552857|NCT00075725|5067323|P1|Overall Study|MRD positive after extended ind|0
1552858|NCT00075725|5067312|P12|Overall Study|Insurance issues|0
1552859|NCT00075725|5067313|P11|Overall Study|Insurance issues|0
1552860|NCT00075725|5067314|P10|Overall Study|Insurance issues|0
1552861|NCT00075725|5067315|P9|Overall Study|Insurance issues|0
1552862|NCT00075725|5067316|P8|Overall Study|Insurance issues|1
1552863|NCT00075725|5067317|P7|Overall Study|Insurance issues|0
1552864|NCT00075725|5067318|P6|Overall Study|Insurance issues|1
1552865|NCT00075725|5067319|P5|Overall Study|Insurance issues|1
1552866|NCT00075725|5067320|P4|Overall Study|Insurance issues|1
1552867|NCT00075725|5067321|P3|Overall Study|Insurance issues|0
1552868|NCT00075725|5067322|P2|Overall Study|Insurance issues|1
1552869|NCT00075725|5067323|P1|Overall Study|Insurance issues|0
1552870|NCT00075725|5067312|P12|Overall Study|Pt age out of range for treatment|0
1552871|NCT00075725|5067313|P11|Overall Study|Pt age out of range for treatment|0
1552872|NCT00075725|5067314|P10|Overall Study|Pt age out of range for treatment|0
1552873|NCT00075725|5067315|P9|Overall Study|Pt age out of range for treatment|0
1552874|NCT00075725|5067316|P8|Overall Study|Pt age out of range for treatment|1
1552875|NCT00075725|5067317|P7|Overall Study|Pt age out of range for treatment|0
1552876|NCT00075725|5067318|P6|Overall Study|Pt age out of range for treatment|1
1552877|NCT00075725|5067319|P5|Overall Study|Pt age out of range for treatment|0
1552878|NCT00075725|5067320|P4|Overall Study|Pt age out of range for treatment|0
1552879|NCT00075725|5067321|P3|Overall Study|Pt age out of range for treatment|0
1552880|NCT00075725|5067322|P2|Overall Study|Pt age out of range for treatment|1
1552881|NCT00075725|5067323|P1|Overall Study|Pt age out of range for treatment|0
1552882|NCT00075725|5067312|P12|Overall Study|Pt non compliant with therapy|0
1552883|NCT00075725|5067313|P11|Overall Study|Pt non compliant with therapy|0
1552884|NCT00075725|5067314|P10|Overall Study|Pt non compliant with therapy|0
1552885|NCT00075725|5067315|P9|Overall Study|Pt non compliant with therapy|3
1552886|NCT00075725|5067316|P8|Overall Study|Pt non compliant with therapy|5
1552887|NCT00075725|5067317|P7|Overall Study|Pt non compliant with therapy|2
1552888|NCT00075725|5067318|P6|Overall Study|Pt non compliant with therapy|14
1552889|NCT00075725|5067319|P5|Overall Study|Pt non compliant with therapy|2
1552890|NCT00075725|5067320|P4|Overall Study|Pt non compliant with therapy|0
1552891|NCT00075725|5067321|P3|Overall Study|Pt non compliant with therapy|1
1552892|NCT00075725|5067322|P2|Overall Study|Pt non compliant with therapy|1
1552893|NCT00075725|5067323|P1|Overall Study|Pt non compliant with therapy|2
1552894|NCT00075725|5067312|P12|Overall Study|Pt/Guardian refused RT therapy|0
1552895|NCT00075725|5067313|P11|Overall Study|Pt/Guardian refused RT therapy|0
1552896|NCT00075725|5067314|P10|Overall Study|Pt/Guardian refused RT therapy|0
1552897|NCT00075725|5067315|P9|Overall Study|Pt/Guardian refused RT therapy|0
1552898|NCT00075725|5067316|P8|Overall Study|Pt/Guardian refused RT therapy|0
1552899|NCT00075725|5067317|P7|Overall Study|Pt/Guardian refused RT therapy|0
1552900|NCT00075725|5067318|P6|Overall Study|Pt/Guardian refused RT therapy|0
1552901|NCT00075725|5067319|P5|Overall Study|Pt/Guardian refused RT therapy|1
1552902|NCT00075725|5067320|P4|Overall Study|Pt/Guardian refused RT therapy|2
1552903|NCT00075725|5067321|P3|Overall Study|Pt/Guardian refused RT therapy|1
1552904|NCT00075725|5067322|P2|Overall Study|Pt/Guardian refused RT therapy|0
1552905|NCT00075725|5067323|P1|Overall Study|Pt/Guardian refused RT therapy|1
1552906|NCT00075725|5067312|P12|Overall Study|Ineligible or wrong diagnosis|4
1552907|NCT00075725|5067313|P11|Overall Study|Ineligible or wrong diagnosis|2
1552908|NCT00075725|5067314|P10|Overall Study|Ineligible or wrong diagnosis|1
1552909|NCT00075725|5067315|P9|Overall Study|Ineligible or wrong diagnosis|10
1552910|NCT00075725|5067316|P8|Overall Study|Ineligible or wrong diagnosis|9
1552911|NCT00075725|5067317|P7|Overall Study|Ineligible or wrong diagnosis|6
1552912|NCT00075725|5067318|P6|Overall Study|Ineligible or wrong diagnosis|17
1552913|NCT00075725|5067319|P5|Overall Study|Ineligible or wrong diagnosis|3
1552914|NCT00075725|5067320|P4|Overall Study|Ineligible or wrong diagnosis|10
1552915|NCT00075725|5067321|P3|Overall Study|Ineligible or wrong diagnosis|3
1552916|NCT00075725|5067322|P2|Overall Study|Ineligible or wrong diagnosis|3
1552917|NCT00075725|5067323|P1|Overall Study|Ineligible or wrong diagnosis|8
1552918|NCT00075725|5067312|P12|Overall Study|Patient off treatment|0
1552919|NCT00075725|5067313|P11|Overall Study|Patient off treatment|0
1552920|NCT00075725|5067314|P10|Overall Study|Patient off treatment|0
1552921|NCT00075725|5067315|P9|Overall Study|Patient off treatment|1
1552922|NCT00075725|5067316|P8|Overall Study|Patient off treatment|2
1552923|NCT00075725|5067317|P7|Overall Study|Patient off treatment|0
1552924|NCT00075725|5067318|P6|Overall Study|Patient off treatment|0
1552925|NCT00075725|5067319|P5|Overall Study|Patient off treatment|1
1552926|NCT00075725|5067320|P4|Overall Study|Patient off treatment|2
1552927|NCT00075725|5067321|P3|Overall Study|Patient off treatment|1
1552928|NCT00075725|5067322|P2|Overall Study|Patient off treatment|0
1552929|NCT00075725|5067323|P1|Overall Study|Patient off treatment|0
1552930|NCT00075725|5067312|P12|Overall Study|Disease Progression, all other reasons|5
1552931|NCT00075725|5067313|P11|Overall Study|Disease Progression, all other reasons|0
1552932|NCT00075725|5067314|P10|Overall Study|Disease Progression, all other reasons|4
1552933|NCT00075725|5067315|P9|Overall Study|Disease Progression, all other reasons|21
1552934|NCT00075725|5067316|P8|Overall Study|Disease Progression, all other reasons|46
1552935|NCT00075725|5067317|P7|Overall Study|Disease Progression, all other reasons|20
1552936|NCT00075725|5067318|P6|Overall Study|Disease Progression, all other reasons|59
1552937|NCT00075725|5067319|P5|Overall Study|Disease Progression, all other reasons|21
1552938|NCT00075725|5067320|P4|Overall Study|Disease Progression, all other reasons|6
1552939|NCT00075725|5067321|P3|Overall Study|Disease Progression, all other reasons|33
1552940|NCT00075725|5067322|P2|Overall Study|Disease Progression, all other reasons|5
1552941|NCT00075725|5067323|P1|Overall Study|Disease Progression, all other reasons|17
1552942|NCT00075725|5067312|P12|Overall Study|Withdrawal by Subject|0
1552943|NCT00075725|5067313|P11|Overall Study|Withdrawal by Subject|0
1552944|NCT00075725|5067314|P10|Overall Study|Withdrawal by Subject|2
1552945|NCT00075725|5067315|P9|Overall Study|Withdrawal by Subject|10
1552946|NCT00075725|5067316|P8|Overall Study|Withdrawal by Subject|31
1552947|NCT00075725|5067317|P7|Overall Study|Withdrawal by Subject|7
1552948|NCT00075725|5067318|P6|Overall Study|Withdrawal by Subject|27
1552949|NCT00075725|5067319|P5|Overall Study|Withdrawal by Subject|6
1552950|NCT00075725|5067320|P4|Overall Study|Withdrawal by Subject|10
1552951|NCT00075725|5067321|P3|Overall Study|Withdrawal by Subject|6
1552952|NCT00075725|5067322|P2|Overall Study|Withdrawal by Subject|3
1552953|NCT00075725|5067323|P1|Overall Study|Withdrawal by Subject|12
1552954|NCT00075725|5067312|P12|Overall Study|Protocol Violation|1
1552955|NCT00075725|5067313|P11|Overall Study|Protocol Violation|0
1552956|NCT00075725|5067314|P10|Overall Study|Protocol Violation|0
1552957|NCT00075725|5067315|P9|Overall Study|Protocol Violation|3
1552958|NCT00075725|5067316|P8|Overall Study|Protocol Violation|2
1552959|NCT00075725|5067317|P7|Overall Study|Protocol Violation|1
1552960|NCT00075725|5067318|P6|Overall Study|Protocol Violation|2
1552961|NCT00075725|5067319|P5|Overall Study|Protocol Violation|3
1552962|NCT00075725|5067320|P4|Overall Study|Protocol Violation|3
1552963|NCT00075725|5067321|P3|Overall Study|Protocol Violation|0
1552964|NCT00075725|5067322|P2|Overall Study|Protocol Violation|1
1552965|NCT00075725|5067323|P1|Overall Study|Protocol Violation|1
1552966|NCT00075725|5067312|P12|Overall Study|Pregnancy|0
1552967|NCT00075725|5067313|P11|Overall Study|Pregnancy|0
1552968|NCT00075725|5067314|P10|Overall Study|Pregnancy|0
1552969|NCT00075725|5067315|P9|Overall Study|Pregnancy|0
1552970|NCT00075725|5067316|P8|Overall Study|Pregnancy|1
1552971|NCT00075725|5067317|P7|Overall Study|Pregnancy|0
1552972|NCT00075725|5067318|P6|Overall Study|Pregnancy|1
1552973|NCT00075725|5067319|P5|Overall Study|Pregnancy|0
1552974|NCT00075725|5067320|P4|Overall Study|Pregnancy|0
1552975|NCT00075725|5067321|P3|Overall Study|Pregnancy|0
1552976|NCT00075725|5067322|P2|Overall Study|Pregnancy|0
1552977|NCT00075725|5067323|P1|Overall Study|Pregnancy|0
1552978|NCT00075725|5067312|P12|Overall Study|Physician Decision|0
1552979|NCT00075725|5067313|P11|Overall Study|Physician Decision|1
1552980|NCT00075725|5067314|P10|Overall Study|Physician Decision|0
1552981|NCT00075725|5067315|P9|Overall Study|Physician Decision|5
1552982|NCT00075725|5067316|P8|Overall Study|Physician Decision|17
1552983|NCT00075725|5067317|P7|Overall Study|Physician Decision|3
1552984|NCT00075725|5067318|P6|Overall Study|Physician Decision|19
1552985|NCT00075725|5067319|P5|Overall Study|Physician Decision|4
1552986|NCT00075725|5067320|P4|Overall Study|Physician Decision|8
1552987|NCT00075725|5067321|P3|Overall Study|Physician Decision|5
1552988|NCT00075725|5067322|P2|Overall Study|Physician Decision|6
1552989|NCT00075725|5067323|P1|Overall Study|Physician Decision|2
1552990|NCT00075725|5067312|P12|Overall Study|Lost to Follow-up|0
1552991|NCT00075725|5067313|P11|Overall Study|Lost to Follow-up|0
1552992|NCT00075725|5067314|P10|Overall Study|Lost to Follow-up|0
1552993|NCT00075725|5067315|P9|Overall Study|Lost to Follow-up|1
1552994|NCT00075725|5067316|P8|Overall Study|Lost to Follow-up|4
1552995|NCT00075725|5067317|P7|Overall Study|Lost to Follow-up|2
1552996|NCT00075725|5067318|P6|Overall Study|Lost to Follow-up|13
1552997|NCT00075725|5067319|P5|Overall Study|Lost to Follow-up|0
1552998|NCT00075725|5067320|P4|Overall Study|Lost to Follow-up|1
1552999|NCT00075725|5067321|P3|Overall Study|Lost to Follow-up|4
1553000|NCT00075725|5067322|P2|Overall Study|Lost to Follow-up|1
1553001|NCT00075725|5067323|P1|Overall Study|Lost to Follow-up|1
1553002|NCT00075725|5067312|P12|Overall Study|Death|0
1553003|NCT00075725|5067313|P11|Overall Study|Death|3
1553004|NCT00075725|5067314|P10|Overall Study|Death|4
1553005|NCT00075725|5067315|P9|Overall Study|Death|14
1553006|NCT00075725|5067316|P8|Overall Study|Death|22
1553007|NCT00075725|5067317|P7|Overall Study|Death|4
1553008|NCT00075725|5067318|P6|Overall Study|Death|25
1553009|NCT00075725|5067319|P5|Overall Study|Death|3
1553010|NCT00075725|5067320|P4|Overall Study|Death|2
1553011|NCT00075725|5067321|P3|Overall Study|Death|10
1553012|NCT00075725|5067322|P2|Overall Study|Death|5
1553013|NCT00075725|5067323|P1|Overall Study|Death|3
1553014|NCT00075725|5067312|P12|Overall Study|Adverse Event|2
1553015|NCT00075725|5067313|P11|Overall Study|Adverse Event|2
1553016|NCT00075725|5067314|P10|Overall Study|Adverse Event|4
1553017|NCT00075725|5067315|P9|Overall Study|Adverse Event|15
1553018|NCT00075725|5067316|P8|Overall Study|Adverse Event|51
1553019|NCT00075725|5067317|P7|Overall Study|Adverse Event|3
1553020|NCT00075725|5067318|P6|Overall Study|Adverse Event|38
1553021|NCT00075725|5067319|P5|Overall Study|Adverse Event|4
1553022|NCT00075725|5067320|P4|Overall Study|Adverse Event|8
1553023|NCT00075725|5067321|P3|Overall Study|Adverse Event|20
1553024|NCT00075725|5067322|P2|Overall Study|Adverse Event|6
1553025|NCT00075725|5067323|P1|Overall Study|Adverse Event|6
1553026|NCT00075582|5067420|P2|Overall Study|Ineligible for study|16
1553027|NCT00075582|5067421|P1|Overall Study|Ineligible for study|36
1553028|NCT00075582|5067420|P2|Overall Study|Withdrawal by Subject|2
1553030|NCT00075582|5067420|P2|Overall Study|Physician Decision|8
1553031|NCT00075582|5067421|P1|Overall Study|Physician Decision|5
1553032|NCT00075582|5067420|P2|Overall Study|Lack of Efficacy|8
1553033|NCT00075582|5067421|P1|Overall Study|Lack of Efficacy|4
1553034|NCT00075582|5067420|P2|Overall Study|Adverse Event|1
1553035|NCT00075582|5067421|P1|Overall Study|Adverse Event|3
1553036|NCT00075504|5067431|P2|Overall Study|Withdrawal by Subject|7
1553037|NCT00075504|5067432|P1|Overall Study|Withdrawal by Subject|9
1553038|NCT00075478|5067444|P2|Overall Study|Physician Decision|1
1553039|NCT00075478|5067445|P1|Overall Study|Physician Decision|0
1553040|NCT00075478|5067444|P2|Overall Study|not eligible|0
1553041|NCT00075478|5067445|P1|Overall Study|not eligible|1
1553042|NCT00075400|5067465|P1|Overall Study|Never treated|2
1553043|NCT00075400|5067465|P1|Overall Study|Ineligible: wrong primary|1
1553044|NCT00075270|5067486|P2|Overall Study|Missing|13
1553045|NCT00075270|5067487|P1|Overall Study|Missing|26
1553046|NCT00075270|5067486|P2|Overall Study|Other/Unknown|5
1553047|NCT00075270|5067487|P1|Overall Study|Other/Unknown|9
1553048|NCT00075270|5067486|P2|Overall Study|Death|215
1553049|NCT00075270|5067487|P1|Overall Study|Death|198
1553050|NCT00075270|5067486|P2|Overall Study|Protocol Violation|2
1553051|NCT00075270|5067487|P1|Overall Study|Protocol Violation|0
1553052|NCT00075270|5067486|P2|Overall Study|Lost to Follow-up|28
1553053|NCT00075270|5067487|P1|Overall Study|Lost to Follow-up|25
1553054|NCT00075270|5067486|P2|Overall Study|Withdrawal by Subject|21
1553055|NCT00075270|5067487|P1|Overall Study|Withdrawal by Subject|28
1553056|NCT00075218|5067533|P3|Open-Label Treatment|enrolled in a separate continuation|9
1553057|NCT00075218|5067534|P2|Open-Label Treatment|enrolled in a separate continuation|0
1553058|NCT00075218|5067535|P1|Open-Label Treatment|enrolled in a separate continuation|0
1553059|NCT00075218|5067533|P3|Open-Label Treatment|Protocol Violation|1
1553060|NCT00075218|5067534|P2|Open-Label Treatment|Protocol Violation|0
1553061|NCT00075218|5067535|P1|Open-Label Treatment|Protocol Violation|0
1553062|NCT00075218|5067533|P3|Open-Label Treatment|Decision of Sponsor|8
1553063|NCT00075218|5067534|P2|Open-Label Treatment|Decision of Sponsor|0
1553064|NCT00075218|5067535|P1|Open-Label Treatment|Decision of Sponsor|0
1553065|NCT00075218|5067533|P3|Open-Label Treatment|Withdrawal by Subject|12
1553066|NCT00075218|5067534|P2|Open-Label Treatment|Withdrawal by Subject|0
1553067|NCT00075218|5067535|P1|Open-Label Treatment|Withdrawal by Subject|0
1553068|NCT00075218|5067533|P3|Open-Label Treatment|Adverse Event|51
1553069|NCT00075218|5067534|P2|Open-Label Treatment|Adverse Event|0
1553070|NCT00075218|5067535|P1|Open-Label Treatment|Adverse Event|0
1553071|NCT00075218|5067533|P3|Open-Label Treatment|Lack of Efficacy|174
1553072|NCT00075218|5067534|P2|Open-Label Treatment|Lack of Efficacy|0
1553073|NCT00075218|5067535|P1|Open-Label Treatment|Lack of Efficacy|0
1553074|NCT00075218|5067533|P3|Double-Blind Treatment|No study medication taken|0
1553075|NCT00075218|5067534|P2|Double-Blind Treatment|No study medication taken|0
1553076|NCT00075218|5067535|P1|Double-Blind Treatment|No study medication taken|2
1553077|NCT00075218|5067533|P3|Double-Blind Treatment|Decision of Sponsor|0
1553078|NCT00075218|5067534|P2|Double-Blind Treatment|Decision of Sponsor|1
1553079|NCT00075218|5067535|P1|Double-Blind Treatment|Decision of Sponsor|0
1553080|NCT00075218|5067533|P3|Double-Blind Treatment|Lack of Efficacy|0
1553081|NCT00075218|5067534|P2|Double-Blind Treatment|Lack of Efficacy|6
1553082|NCT00075218|5067535|P1|Double-Blind Treatment|Lack of Efficacy|58
1553083|NCT00075218|5067533|P3|Double-Blind Treatment|Lost to Follow-up|0
1553084|NCT00075218|5067534|P2|Double-Blind Treatment|Lost to Follow-up|0
1553085|NCT00075218|5067535|P1|Double-Blind Treatment|Lost to Follow-up|1
1553086|NCT00075218|5067533|P3|Double-Blind Treatment|Withdrawal by Subject|0
1553087|NCT00075218|5067534|P2|Double-Blind Treatment|Withdrawal by Subject|4
1553088|NCT00075218|5067535|P1|Double-Blind Treatment|Withdrawal by Subject|7
1553089|NCT00075218|5067533|P3|Double-Blind Treatment|Adverse Event|0
1553090|NCT00075218|5067534|P2|Double-Blind Treatment|Adverse Event|4
1553091|NCT00075218|5067535|P1|Double-Blind Treatment|Adverse Event|23
1553092|NCT00075023|5067584|P2|Pilot Study|Withdrawal by Subject|0
1553093|NCT00075023|5067585|P1|Pilot Study|Withdrawal by Subject|1
1553094|NCT00075023|5067584|P2|Pilot Study|Physician Decision|2
1553095|NCT00075023|5067585|P1|Pilot Study|Physician Decision|1
1553096|NCT00074984|5067594|P2|Overall Study|Patient Withdrawn Per Protocol|3
1553097|NCT00074984|5067595|P1|Overall Study|Patient Withdrawn Per Protocol|0
1553098|NCT00074984|5067594|P2|Overall Study|Withdrawal by Subject|3
1553099|NCT00074984|5067595|P1|Overall Study|Withdrawal by Subject|2
1553100|NCT00074984|5067594|P2|Overall Study|Death|2
1553101|NCT00074984|5067595|P1|Overall Study|Death|1
1553102|NCT00074958|5067610|P1|Overall Study|Adverse Event|1
1553103|NCT00074711|5067651|P2|Overall Study|Participant stopped study drug|6
1553104|NCT00074711|5067652|P1|Overall Study|Participant stopped study drug|4
1553105|NCT00074711|5067651|P2|Overall Study|Lost to Follow-up|8
1553106|NCT00074711|5067652|P1|Overall Study|Lost to Follow-up|10
1553107|NCT00074711|5067651|P2|Overall Study|Withdrawal by Subject|1
1553108|NCT00074711|5067652|P1|Overall Study|Withdrawal by Subject|1
1553109|NCT00074581|5067670|P2|Overall Study|Other|19
1553110|NCT00074581|5067671|P1|Overall Study|Other|14
1553111|NCT00074581|5067670|P2|Overall Study|Ended relationship w. index participant|106
1553112|NCT00074581|5067671|P1|Overall Study|Ended relationship w. index participant|117
1553113|NCT00074581|5067670|P2|Overall Study|Lost to Follow-up|11
1553114|NCT00074581|5067671|P1|Overall Study|Lost to Follow-up|16
1553115|NCT00074581|5067670|P2|Overall Study|Were withdrawn by investigator|2
1553116|NCT00074581|5067671|P1|Overall Study|Were withdrawn by investigator|5
1553117|NCT00074581|5067670|P2|Overall Study|Relocated|9
1553118|NCT00074581|5067671|P1|Overall Study|Relocated|14
1553119|NCT00074581|5067670|P2|Overall Study|Unable to adhere to visit schedule|14
1553120|NCT00074581|5067671|P1|Overall Study|Unable to adhere to visit schedule|13
1553121|NCT00074581|5067670|P2|Overall Study|Withdrawal by Subject|49
1553122|NCT00074581|5067671|P1|Overall Study|Withdrawal by Subject|50
1553123|NCT00074581|5067670|P2|Overall Study|Death|16
1553124|NCT00074581|5067671|P1|Overall Study|Death|15
1553125|NCT00074412|5067681|P2|Overall Study|Lost to Follow-up|58
1553126|NCT00074412|5067682|P1|Overall Study|Lost to Follow-up|52
1553127|NCT00074412|5067681|P2|Overall Study|Death|26
1553128|NCT00074412|5067682|P1|Overall Study|Death|30
1553129|NCT00074152|5067730|P2|Overall Study|Lack of Efficacy|24
1553130|NCT00074152|5067731|P1|Overall Study|Lack of Efficacy|34
1553131|NCT00074152|5067730|P2|Overall Study|Death|9
1553132|NCT00074152|5067731|P1|Overall Study|Death|21
1553133|NCT00073983|5067748|P1|Overall Study|not evaluable|1
1553134|NCT00073918|5067769|P1|Overall Study|Eligibility requirement not met-low CD20|1
1553135|NCT00073918|5067769|P1|Overall Study|Rapid disease progression|2
1553136|NCT00073918|5067769|P1|Overall Study|Eligibility requirement not met - HAMA+|1
1553137|NCT00073528|5067778|P2|Overall Study|Ongoing|344
1553138|NCT00073528|5067779|P1|Overall Study|Ongoing|349
1553139|NCT00073528|5067778|P2|Overall Study|Non-compliance|1
1553140|NCT00073528|5067779|P1|Overall Study|Non-compliance|0
1553141|NCT00073528|5067778|P2|Overall Study|Enrolled in Error|1
1553142|NCT00073528|5067779|P1|Overall Study|Enrolled in Error|0
1553143|NCT00073528|5067778|P2|Overall Study|Participant Was Unblinded|1
1553144|NCT00073528|5067779|P1|Overall Study|Participant Was Unblinded|0
1553145|NCT00073528|5067778|P2|Overall Study|Progressive Disease|1
1553146|NCT00073528|5067779|P1|Overall Study|Progressive Disease|0
1553147|NCT00073528|5067778|P2|Overall Study|Randomized in Error; Not Treated|0
1553148|NCT00073528|5067779|P1|Overall Study|Randomized in Error; Not Treated|2
1553149|NCT00073528|5067778|P2|Overall Study|Mastectomy Intervention|0
1553150|NCT00073528|5067779|P1|Overall Study|Mastectomy Intervention|1
1553151|NCT00073528|5067778|P2|Overall Study|Death|238
1553152|NCT00073528|5067779|P1|Overall Study|Death|229
1553153|NCT00073528|5067778|P2|Overall Study|Protocol Violation|5
1553154|NCT00073528|5067779|P1|Overall Study|Protocol Violation|3
1553155|NCT00073528|5067778|P2|Overall Study|Lost to Follow-up|22
1553156|NCT00073528|5067779|P1|Overall Study|Lost to Follow-up|26
1553157|NCT00073528|5067778|P2|Overall Study|Withdrawal by Subject|29
1553158|NCT00073528|5067779|P1|Overall Study|Withdrawal by Subject|34
1553159|NCT00073307|5067868|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
1553160|NCT00073307|5067869|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
1553161|NCT00073307|5067870|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
1553162|NCT00073307|5067868|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
1553163|NCT00073307|5067869|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
1553164|NCT00073307|5067870|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
1553165|NCT00073307|5067868|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
1553166|NCT00073307|5067869|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
1553167|NCT00073307|5067870|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
1553168|NCT00073307|5067868|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
1553169|NCT00073307|5067869|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
1553170|NCT00073307|5067870|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
1553171|NCT00073307|5067868|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
1553172|NCT00073307|5067869|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
1553173|NCT00073307|5067870|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
1553174|NCT00073307|5067868|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
1553175|NCT00073307|5067869|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
1553176|NCT00073307|5067870|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
1553177|NCT00073307|5067868|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
1553178|NCT00073307|5067869|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
1553179|NCT00073307|5067870|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
1553180|NCT00073307|5067868|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
1553181|NCT00073307|5067869|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
1553182|NCT00073307|5067870|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
1553183|NCT00073307|5067868|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
1553184|NCT00073307|5067869|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
1553185|NCT00073307|5067870|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
1553186|NCT00073307|5067868|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
1553187|NCT00073307|5067869|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
1553188|NCT00073307|5067870|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
1553189|NCT00073307|5067868|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
1553190|NCT00073307|5067869|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
1553191|NCT00073307|5067870|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
1553192|NCT00073307|5067868|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
1553193|NCT00073307|5067869|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
1553194|NCT00073307|5067870|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
1553195|NCT00073307|5067868|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
1553196|NCT00073307|5067869|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
1553197|NCT00073307|5067870|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
1553198|NCT00073307|5067868|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
1553199|NCT00073307|5067869|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
1553200|NCT00073307|5067870|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
1553201|NCT00073307|5067868|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
1553202|NCT00073307|5067869|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
1553203|NCT00073307|5067870|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
1553204|NCT00073307|5067868|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
1553205|NCT00073307|5067869|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
1553206|NCT00073307|5067870|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
1553207|NCT00073307|5067868|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
1553208|NCT00073307|5067869|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
1553209|NCT00073307|5067870|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
1553210|NCT00073307|5067868|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
1553211|NCT00073307|5067869|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
1553212|NCT00073307|5067870|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
1553213|NCT00073307|5067868|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
1553214|NCT00073307|5067869|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
1553215|NCT00073307|5067870|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
1553216|NCT00073021|5067901|P2|Overall Study|Lack of Efficacy|5
1553217|NCT00073021|5067902|P1|Overall Study|Lack of Efficacy|11
1553218|NCT00073021|5067901|P2|Overall Study|Physician Decision|1
1553219|NCT00073021|5067902|P1|Overall Study|Physician Decision|3
1553220|NCT00073021|5067901|P2|Overall Study|Withdrawal by Subject|5
1553221|NCT00073021|5067902|P1|Overall Study|Withdrawal by Subject|6
1553222|NCT00073021|5067901|P2|Overall Study|Adverse Event|4
1553223|NCT00073021|5067902|P1|Overall Study|Adverse Event|4
1553224|NCT00073021|5067901|P2|Overall Study|Protocol Violation|1
1553225|NCT00073021|5067902|P1|Overall Study|Protocol Violation|2
1553226|NCT00073008|5067932|P2|Overall Study|"Other selected on Case Report Form"|5
1553227|NCT00073008|5067933|P1|Overall Study|"Other selected on Case Report Form"|7
1553228|NCT00073008|5067932|P2|Overall Study|Death|47
1553229|NCT00073008|5067933|P1|Overall Study|Death|46
1553230|NCT00073008|5067932|P2|Overall Study|Lost to Follow-up|3
1553231|NCT00073008|5067933|P1|Overall Study|Lost to Follow-up|1
1553232|NCT00073008|5067932|P2|Overall Study|Withdrawal by Subject|2
1553233|NCT00073008|5067933|P1|Overall Study|Withdrawal by Subject|2
1553234|NCT00073008|5067932|P2|Overall Study|Missing|6
1553235|NCT00073008|5067933|P1|Overall Study|Missing|6
1553236|NCT00072475|5067972|P1|Overall Study|Patient/Investigator Decision|4
1553237|NCT00072475|5067972|P1|Overall Study|Withdrawal by Subject|46
1553238|NCT00072475|5067972|P1|Overall Study|Death|3
1553239|NCT00072475|5067972|P1|Overall Study|Adverse Event|44
1553240|NCT00072293|5067989|P2|Overall Study|Withdrawal by Subject|1
1553241|NCT00072293|5067990|P1|Overall Study|Withdrawal by Subject|0
1553242|NCT00072293|5067989|P2|Overall Study|Lost to Follow-up|1
1553243|NCT00072293|5067990|P1|Overall Study|Lost to Follow-up|1
1553244|NCT00072280|5068002|P2|Follow-up|Early termination of study|2
1553245|NCT00072280|5068003|P1|Follow-up|Early termination of study|2
1553246|NCT00072280|5068002|P2|Treatment|Found ineligible|2
1553247|NCT00072280|5068003|P1|Treatment|Found ineligible|1
1553248|NCT00072189|5068008|P1|Overall Study|Withdrawal by Subject|1
1553249|NCT00072176|5068016|P2|Overall Study|Protocol Violation|1
1553250|NCT00072176|5068017|P1|Overall Study|Protocol Violation|0
1553251|NCT00072176|5068016|P2|Overall Study|Withdrawal by Subject|0
1553252|NCT00072176|5068017|P1|Overall Study|Withdrawal by Subject|1
1553253|NCT00071981|5068029|P4|Overall Study|others (not specified in the study)|0
1553254|NCT00071981|5068030|P3|Overall Study|others (not specified in the study)|2
1553255|NCT00071981|5068031|P2|Overall Study|others (not specified in the study)|2
1553256|NCT00071981|5068032|P1|Overall Study|others (not specified in the study)|0
1553257|NCT00071981|5068029|P4|Overall Study|No protocol therapy|0
1553258|NCT00071981|5068030|P3|Overall Study|No protocol therapy|1
1553259|NCT00071981|5068031|P2|Overall Study|No protocol therapy|5
1553260|NCT00071981|5068032|P1|Overall Study|No protocol therapy|2
1553261|NCT00071981|5068029|P4|Overall Study|Withdrawal by Subject|0
1553262|NCT00071981|5068030|P3|Overall Study|Withdrawal by Subject|0
1553263|NCT00071981|5068031|P2|Overall Study|Withdrawal by Subject|1
1553264|NCT00071981|5068032|P1|Overall Study|Withdrawal by Subject|3
1553265|NCT00071981|5068029|P4|Overall Study|Death|1
1553266|NCT00071981|5068030|P3|Overall Study|Death|1
1553267|NCT00071981|5068031|P2|Overall Study|Death|0
1553268|NCT00071981|5068032|P1|Overall Study|Death|0
1553269|NCT00071981|5068029|P4|Overall Study|Adverse Event|1
1553270|NCT00071981|5068030|P3|Overall Study|Adverse Event|3
1553271|NCT00071981|5068031|P2|Overall Study|Adverse Event|4
1553272|NCT00071981|5068032|P1|Overall Study|Adverse Event|4
1553273|NCT00071981|5068029|P4|Overall Study|Lack of Efficacy|43
1553274|NCT00071981|5068030|P3|Overall Study|Lack of Efficacy|30
1553275|NCT00071981|5068031|P2|Overall Study|Lack of Efficacy|29
1553276|NCT00071981|5068032|P1|Overall Study|Lack of Efficacy|37
1553277|NCT00071812|5068075|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
1553278|NCT00071812|5068076|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
1553279|NCT00071812|5068077|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
1553280|NCT00071812|5068078|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
1553281|NCT00071812|5068075|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
1553282|NCT00071812|5068076|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1553283|NCT00071812|5068077|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1553284|NCT00071812|5068078|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1553285|NCT00071812|5068075|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
1553286|NCT00071812|5068076|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
1553287|NCT00071812|5068077|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
1553288|NCT00071812|5068078|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
1553289|NCT00071812|5068075|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
1553290|NCT00071812|5068076|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
1553291|NCT00071812|5068077|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
1553292|NCT00071812|5068078|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
1553293|NCT00071812|5068075|P4|24-Week Open-Label Extension Period|Adverse Event|7
1553294|NCT00071812|5068076|P3|24-Week Open-Label Extension Period|Adverse Event|0
1553295|NCT00071812|5068077|P2|24-Week Open-Label Extension Period|Adverse Event|0
1553296|NCT00071812|5068078|P1|24-Week Open-Label Extension Period|Adverse Event|0
1553297|NCT00071812|5068075|P4|24-Week Double-Blind Period|Protocol Violation|1
1553298|NCT00071812|5068076|P3|24-Week Double-Blind Period|Protocol Violation|0
1553299|NCT00071812|5068077|P2|24-Week Double-Blind Period|Protocol Violation|0
1553300|NCT00071812|5068078|P1|24-Week Double-Blind Period|Protocol Violation|0
1553301|NCT00071812|5068075|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
1553302|NCT00071812|5068076|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
1553303|NCT00071812|5068077|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
1553304|NCT00071812|5068078|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
1553305|NCT00071812|5068075|P4|24-Week Double-Blind Period|Lost to Follow-up|0
1553306|NCT00071812|5068076|P3|24-Week Double-Blind Period|Lost to Follow-up|1
1553307|NCT00071812|5068077|P2|24-Week Double-Blind Period|Lost to Follow-up|1
1553308|NCT00071812|5068078|P1|24-Week Double-Blind Period|Lost to Follow-up|0
1553309|NCT00071812|5068075|P4|24-Week Double-Blind Period|Lack of Efficacy|1
1553310|NCT00071812|5068076|P3|24-Week Double-Blind Period|Lack of Efficacy|2
1553311|NCT00071812|5068077|P2|24-Week Double-Blind Period|Lack of Efficacy|1
1553312|NCT00071812|5068078|P1|24-Week Double-Blind Period|Lack of Efficacy|3
1553313|NCT00071812|5068075|P4|24-Week Double-Blind Period|Adverse Event|4
1553314|NCT00071812|5068076|P3|24-Week Double-Blind Period|Adverse Event|4
1553315|NCT00071812|5068077|P2|24-Week Double-Blind Period|Adverse Event|3
1553316|NCT00071812|5068078|P1|24-Week Double-Blind Period|Adverse Event|2
1553317|NCT00071799|5068120|P2|Overall Study|Not Documented|2
1553318|NCT00071799|5068121|P1|Overall Study|Not Documented|0
1553319|NCT00071799|5068120|P2|Overall Study|Different Central+Local Pathology Review|1
1553320|NCT00071799|5068121|P1|Overall Study|Different Central+Local Pathology Review|0
1553321|NCT00071799|5068120|P2|Overall Study|Disease Progression|20
1553322|NCT00071799|5068121|P1|Overall Study|Disease Progression|23
1553323|NCT00071799|5068120|P2|Overall Study|Lack of Efficacy|18
1553324|NCT00071799|5068121|P1|Overall Study|Lack of Efficacy|11
1553325|NCT00071799|5068120|P2|Overall Study|Physician Decision|2
1553326|NCT00071799|5068121|P1|Overall Study|Physician Decision|0
1553327|NCT00071799|5068120|P2|Overall Study|Withdrawal by Subject|37
1553328|NCT00071799|5068121|P1|Overall Study|Withdrawal by Subject|15
1553329|NCT00071799|5068120|P2|Overall Study|Lost to Follow-up|1
1553330|NCT00071799|5068121|P1|Overall Study|Lost to Follow-up|1
1553331|NCT00071799|5068120|P2|Overall Study|Protocol Violation|7
1553332|NCT00071799|5068121|P1|Overall Study|Protocol Violation|1
1553333|NCT00071799|5068120|P2|Overall Study|Adverse Event|10
1553334|NCT00071799|5068121|P1|Overall Study|Adverse Event|19
1553335|NCT00071760|5068174|P1|Overall Study|Ongoing|25
1553336|NCT00071760|5068174|P1|Overall Study|Study Team Rec./Resistance|1
1553337|NCT00071760|5068174|P1|Overall Study|Investigator's Recommendation (Rec.)|4
1553338|NCT00071760|5068174|P1|Overall Study|Relocation|1
1553339|NCT00071760|5068174|P1|Overall Study|Unavailability of RTV|8
1553340|NCT00071760|5068174|P1|Overall Study|Pulmonary Tuberculosis|1
1553341|NCT00071760|5068174|P1|Overall Study|Insufficient Viral Load Response|3
1553342|NCT00071760|5068174|P1|Overall Study|Withdrawal by Subject|3
1553343|NCT00071760|5068174|P1|Overall Study|Protocol Violation|1
1553344|NCT00071760|5068174|P1|Overall Study|Lost to Follow-up|4
1553345|NCT00071760|5068174|P1|Overall Study|Adverse Event|3
1553346|NCT00071513|5068254|P2|Follow-up Assessment|Withdrawal by Subject|6
1553347|NCT00071513|5068255|P1|Follow-up Assessment|Withdrawal by Subject|6
1553348|NCT00071513|5068254|P2|Intervention Component|Withdrawal by Subject|3
1553349|NCT00071513|5068255|P1|Intervention Component|Withdrawal by Subject|2
1553350|NCT00071487|5068267|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
1553351|NCT00071487|5068268|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
1553352|NCT00071487|5068269|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
1553353|NCT00071487|5068270|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
1553354|NCT00071487|5068267|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
1553355|NCT00071487|5068268|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
1553356|NCT00071487|5068269|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
1553357|NCT00071487|5068270|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
1553358|NCT00071487|5068267|P4|24-Week Open-Label Extension Period|Pregnancy|1
1553359|NCT00071487|5068268|P3|24-Week Open-Label Extension Period|Pregnancy|0
1553360|NCT00071487|5068269|P2|24-Week Open-Label Extension Period|Pregnancy|0
1553361|NCT00071487|5068270|P1|24-Week Open-Label Extension Period|Pregnancy|0
1553362|NCT00071487|5068267|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
1553363|NCT00071487|5068268|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1553364|NCT00071487|5068269|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1553365|NCT00071487|5068270|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1553366|NCT00071487|5068267|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
1553367|NCT00071487|5068268|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
1553368|NCT00071487|5068269|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
1553369|NCT00071487|5068270|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
1553370|NCT00071487|5068267|P4|24-Week Open-Label Extension Period|Adverse Event|6
1553371|NCT00071487|5068268|P3|24-Week Open-Label Extension Period|Adverse Event|1
1553372|NCT00071487|5068269|P2|24-Week Open-Label Extension Period|Adverse Event|0
1553373|NCT00071487|5068270|P1|24-Week Open-Label Extension Period|Adverse Event|0
1553374|NCT00071487|5068267|P4|52-Week Double-Blind Period|Lack of Compliance|3
1553375|NCT00071487|5068268|P3|52-Week Double-Blind Period|Lack of Compliance|3
1553376|NCT00071487|5068269|P2|52-Week Double-Blind Period|Lack of Compliance|3
1553377|NCT00071487|5068270|P1|52-Week Double-Blind Period|Lack of Compliance|6
1553378|NCT00071487|5068267|P4|52-Week Double-Blind Period|Death|0
1553379|NCT00071487|5068268|P3|52-Week Double-Blind Period|Death|0
1553380|NCT00071487|5068269|P2|52-Week Double-Blind Period|Death|1
1553381|NCT00071487|5068270|P1|52-Week Double-Blind Period|Death|0
1553382|NCT00071487|5068267|P4|52-Week Double-Blind Period|Protocol Violation|0
1553383|NCT00071487|5068268|P3|52-Week Double-Blind Period|Protocol Violation|1
1553384|NCT00071487|5068269|P2|52-Week Double-Blind Period|Protocol Violation|1
1553385|NCT00071487|5068270|P1|52-Week Double-Blind Period|Protocol Violation|0
1553386|NCT00071487|5068267|P4|52-Week Double-Blind Period|Pregnancy|0
1553387|NCT00071487|5068268|P3|52-Week Double-Blind Period|Pregnancy|0
1553388|NCT00071487|5068269|P2|52-Week Double-Blind Period|Pregnancy|1
1553389|NCT00071487|5068270|P1|52-Week Double-Blind Period|Pregnancy|0
1553390|NCT00071487|5068267|P4|52-Week Double-Blind Period|Lost to Follow-up|2
1553391|NCT00071487|5068268|P3|52-Week Double-Blind Period|Lost to Follow-up|2
1553392|NCT00071487|5068269|P2|52-Week Double-Blind Period|Lost to Follow-up|0
1553393|NCT00071487|5068270|P1|52-Week Double-Blind Period|Lost to Follow-up|0
1553394|NCT00071487|5068267|P4|52-Week Double-Blind Period|Physician Decision|0
1553395|NCT00071487|5068268|P3|52-Week Double-Blind Period|Physician Decision|0
1553396|NCT00071487|5068269|P2|52-Week Double-Blind Period|Physician Decision|0
1553397|NCT00071487|5068270|P1|52-Week Double-Blind Period|Physician Decision|1
1553398|NCT00071487|5068267|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
1553399|NCT00071487|5068268|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
1553400|NCT00071487|5068269|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
1553401|NCT00071487|5068270|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
1553402|NCT00071487|5068267|P4|52-Week Double-Blind Period|Lack of Efficacy|1
1553403|NCT00071487|5068268|P3|52-Week Double-Blind Period|Lack of Efficacy|0
1553404|NCT00071487|5068269|P2|52-Week Double-Blind Period|Lack of Efficacy|2
1553405|NCT00071487|5068270|P1|52-Week Double-Blind Period|Lack of Efficacy|1
1553406|NCT00071487|5068267|P4|52-Week Double-Blind Period|Adverse Event|8
1553407|NCT00071487|5068268|P3|52-Week Double-Blind Period|Adverse Event|4
1553408|NCT00071487|5068269|P2|52-Week Double-Blind Period|Adverse Event|8
1553409|NCT00071487|5068270|P1|52-Week Double-Blind Period|Adverse Event|5
1553410|NCT00071396|5068314|P1|Overall Study|Physician Decision|2
1553411|NCT00071396|5068314|P1|Overall Study|Withdrawal by Subject|1
1553412|NCT00071110|5068320|P2|Overall Study|Protocol Violation|4
1553413|NCT00071110|5068321|P1|Overall Study|Protocol Violation|0
1553414|NCT00071032|5068335|P2|Overall Study|Missing Primary Outcome|1
1553415|NCT00071032|5068336|P1|Overall Study|Missing Primary Outcome|0
1553416|NCT00071032|5068335|P2|Overall Study|Withdrawal by Subject|6
1553417|NCT00071032|5068336|P1|Overall Study|Withdrawal by Subject|8
1553418|NCT00071032|5068335|P2|Overall Study|Lost to Follow-up|1
1553419|NCT00071032|5068336|P1|Overall Study|Lost to Follow-up|1
1553420|NCT00071006|5068344|P1|Overall Study|Other|3
1553421|NCT00071006|5068344|P1|Overall Study|Withdrawal by Subject|1
1553422|NCT00071006|5068344|P1|Overall Study|Adverse Event|1
1553423|NCT00071006|5068344|P1|Overall Study|Lack of Efficacy|7
1553424|NCT00070941|5068357|P3|Overall Study|Adverse Event|4
1553425|NCT00070941|5068358|P2|Overall Study|Adverse Event|8
1553426|NCT00070941|5068359|P1|Overall Study|Adverse Event|10
1553427|NCT00071058|5068367|P1|Overall Study|brain tumor-removed from study|1
1553428|NCT00003907|5068374|P2|Overall Study|ineligible or not treated|2
1553429|NCT00003907|5068375|P1|Overall Study|ineligible or not treated|2
1553430|NCT00003907|5068374|P2|Overall Study|Not specified|3
1553431|NCT00003907|5068375|P1|Overall Study|Not specified|1
1553432|NCT00003907|5068374|P2|Overall Study|Complicating disease|0
1553433|NCT00003907|5068375|P1|Overall Study|Complicating disease|1
1553434|NCT00003907|5068374|P2|Overall Study|Progressive disease|4
1553435|NCT00003907|5068375|P1|Overall Study|Progressive disease|4
1553436|NCT00003907|5068374|P2|Overall Study|Withdrawal by Subject|3
1553437|NCT00003907|5068375|P1|Overall Study|Withdrawal by Subject|1
1553438|NCT00003907|5068374|P2|Overall Study|Death|0
1553439|NCT00003907|5068375|P1|Overall Study|Death|2
1553440|NCT00003907|5068374|P2|Overall Study|Adverse Event|11
1553441|NCT00003907|5068375|P1|Overall Study|Adverse Event|2
1553442|NCT00070564|5068391|P6|Overall Study|Not reported|0
1553443|NCT00070564|5068392|P5|Overall Study|Not reported|1
1553444|NCT00070564|5068393|P4|Overall Study|Not reported|0
1553445|NCT00070564|5068394|P3|Overall Study|Not reported|0
1553446|NCT00070564|5068395|P2|Overall Study|Not reported|0
1553447|NCT00070564|5068396|P1|Overall Study|Not reported|0
1553448|NCT00070564|5068391|P6|Overall Study|Withdrawal by Subject|8
1553449|NCT00070564|5068392|P5|Overall Study|Withdrawal by Subject|8
1553450|NCT00070564|5068393|P4|Overall Study|Withdrawal by Subject|30
1553451|NCT00070564|5068394|P3|Overall Study|Withdrawal by Subject|23
1553452|NCT00070564|5068395|P2|Overall Study|Withdrawal by Subject|37
1553453|NCT00070564|5068396|P1|Overall Study|Withdrawal by Subject|26
1553454|NCT00070564|5068391|P6|Overall Study|Other, not protocol specified|7
1553455|NCT00070564|5068392|P5|Overall Study|Other, not protocol specified|6
1553456|NCT00070564|5068393|P4|Overall Study|Other, not protocol specified|19
1553457|NCT00070564|5068394|P3|Overall Study|Other, not protocol specified|14
1553458|NCT00070564|5068395|P2|Overall Study|Other, not protocol specified|15
1553459|NCT00070564|5068396|P1|Overall Study|Other, not protocol specified|17
1553460|NCT00070564|5068391|P6|Overall Study|Death|1
1553461|NCT00070564|5068392|P5|Overall Study|Death|0
1553462|NCT00070564|5068393|P4|Overall Study|Death|3
1553463|NCT00070564|5068394|P3|Overall Study|Death|5
1553464|NCT00070564|5068395|P2|Overall Study|Death|1
1553465|NCT00070564|5068396|P1|Overall Study|Death|4
1553466|NCT00070564|5068391|P6|Overall Study|Adverse Event|36
1553467|NCT00070564|5068392|P5|Overall Study|Adverse Event|63
1553468|NCT00070564|5068393|P4|Overall Study|Adverse Event|108
1553469|NCT00070564|5068394|P3|Overall Study|Adverse Event|120
1553470|NCT00070564|5068395|P2|Overall Study|Adverse Event|142
1553471|NCT00070564|5068396|P1|Overall Study|Adverse Event|150
1553472|NCT00070564|5068391|P6|Overall Study|Delinquent|0
1553473|NCT00070564|5068392|P5|Overall Study|Delinquent|0
1553474|NCT00070564|5068393|P4|Overall Study|Delinquent|0
1553475|NCT00070564|5068394|P3|Overall Study|Delinquent|2
1553476|NCT00070564|5068395|P2|Overall Study|Delinquent|4
1553477|NCT00070564|5068396|P1|Overall Study|Delinquent|1
1553478|NCT00070564|5068391|P6|Overall Study|Progression|0
1553479|NCT00070564|5068392|P5|Overall Study|Progression|1
1553480|NCT00070564|5068393|P4|Overall Study|Progression|7
1553481|NCT00070564|5068394|P3|Overall Study|Progression|7
1553482|NCT00070564|5068395|P2|Overall Study|Progression|4
1553483|NCT00070564|5068396|P1|Overall Study|Progression|2
1553484|NCT00070499|5068450|P4|Overall Study|Not eligible|2
1553485|NCT00070499|5068451|P3|Overall Study|Not eligible|3
1553486|NCT00070499|5068452|P2|Overall Study|Not eligible|5
1553487|NCT00070499|5068453|P1|Overall Study|Not eligible|2
1553488|NCT00070499|5068450|P4|Overall Study|Did not start treatment|2
1553489|NCT00070499|5068451|P3|Overall Study|Did not start treatment|0
1553490|NCT00070499|5068452|P2|Overall Study|Did not start treatment|0
1553491|NCT00070499|5068453|P1|Overall Study|Did not start treatment|1
1553492|NCT00070499|5068450|P4|Overall Study|Still on protocol treatment|57
1553493|NCT00070499|5068451|P3|Overall Study|Still on protocol treatment|79
1553494|NCT00070499|5068452|P2|Overall Study|Still on protocol treatment|4
1553495|NCT00070499|5068453|P1|Overall Study|Still on protocol treatment|10
1553496|NCT00070499|5068450|P4|Overall Study|Other - not protocol specified|20
1553497|NCT00070499|5068451|P3|Overall Study|Other - not protocol specified|12
1553498|NCT00070499|5068452|P2|Overall Study|Other - not protocol specified|3
1553499|NCT00070499|5068453|P1|Overall Study|Other - not protocol specified|7
1553500|NCT00070499|5068450|P4|Overall Study|Death|2
1553501|NCT00070499|5068451|P3|Overall Study|Death|1
1553502|NCT00070499|5068452|P2|Overall Study|Death|1
1553503|NCT00070499|5068453|P1|Overall Study|Death|1
1553504|NCT00070499|5068450|P4|Overall Study|Progression/relapse|4
1553505|NCT00070499|5068451|P3|Overall Study|Progression/relapse|1
1553506|NCT00070499|5068452|P2|Overall Study|Progression/relapse|2
1553507|NCT00070499|5068453|P1|Overall Study|Progression/relapse|4
1553508|NCT00070499|5068450|P4|Overall Study|Refusal unrelated to adverse effects|8
1553509|NCT00070499|5068451|P3|Overall Study|Refusal unrelated to adverse effects|5
1553510|NCT00070499|5068452|P2|Overall Study|Refusal unrelated to adverse effects|5
1553511|NCT00070499|5068453|P1|Overall Study|Refusal unrelated to adverse effects|7
1553512|NCT00070499|5068450|P4|Overall Study|Adverse Event|15
1553513|NCT00070499|5068451|P3|Overall Study|Adverse Event|19
1553514|NCT00070499|5068452|P2|Overall Study|Adverse Event|6
1553515|NCT00070499|5068453|P1|Overall Study|Adverse Event|6
1553516|NCT00070317|5068479|P1|Overall Study|Ineligible-Inadequate pathology|6
1553517|NCT00070317|5068479|P1|Overall Study|Ineligible-Improper prior treatment|2
1553518|NCT00070317|5068479|P1|Overall Study|Ineligible required test not done|1
1553519|NCT00070317|5068479|P1|Overall Study|Ineligible Wrong Cell type/primary/stage|3
1553520|NCT00070317|5068479|P1|Overall Study|Inevaluable (Never Treated)|1
1553521|NCT00070291|5068484|P1|Step 2|Adverse Event|1
1553522|NCT00070291|5068484|P1|Step 1|Adverse Event|1
1553523|NCT00070291|5068484|P1|Step 1|Withdrawal by Subject|1
1553524|NCT00070109|5068500|P5|Overall Study|removed from prot thpy prior to chemo|0
1553525|NCT00070109|5068501|P4|Overall Study|removed from prot thpy prior to chemo|1
1553526|NCT00070109|5068502|P3|Overall Study|removed from prot thpy prior to chemo|0
1553527|NCT00070109|5068503|P2|Overall Study|removed from prot thpy prior to chemo|0
1553528|NCT00070109|5068504|P1|Overall Study|removed from prot thpy prior to chemo|0
1553529|NCT00070109|5068500|P5|Overall Study|Adverse Event|2
1553530|NCT00070109|5068501|P4|Overall Study|Adverse Event|4
1553531|NCT00070109|5068502|P3|Overall Study|Adverse Event|2
1553532|NCT00070109|5068503|P2|Overall Study|Adverse Event|0
1553533|NCT00070109|5068504|P1|Overall Study|Adverse Event|0
1553534|NCT00070109|5068500|P5|Overall Study|Withdrawal by Subject|0
1553535|NCT00070109|5068501|P4|Overall Study|Withdrawal by Subject|0
1553536|NCT00070109|5068502|P3|Overall Study|Withdrawal by Subject|1
1553537|NCT00070109|5068503|P2|Overall Study|Withdrawal by Subject|1
1553538|NCT00070109|5068504|P1|Overall Study|Withdrawal by Subject|0
1553539|NCT00070109|5068500|P5|Overall Study|Physician Decision|0
1553540|NCT00070109|5068501|P4|Overall Study|Physician Decision|0
1553541|NCT00070109|5068502|P3|Overall Study|Physician Decision|0
1553542|NCT00070109|5068503|P2|Overall Study|Physician Decision|0
1553543|NCT00070109|5068504|P1|Overall Study|Physician Decision|1
1553544|NCT00070109|5068500|P5|Overall Study|Lack of Efficacy|5
1553545|NCT00070109|5068501|P4|Overall Study|Lack of Efficacy|15
1553546|NCT00070109|5068502|P3|Overall Study|Lack of Efficacy|5
1553547|NCT00070109|5068503|P2|Overall Study|Lack of Efficacy|4
1553548|NCT00070109|5068504|P1|Overall Study|Lack of Efficacy|6
1553549|NCT00070109|5068500|P5|Overall Study|Death|1
1553550|NCT00070109|5068501|P4|Overall Study|Death|0
1553551|NCT00070109|5068502|P3|Overall Study|Death|0
1553552|NCT00070109|5068503|P2|Overall Study|Death|1
1553553|NCT00070109|5068504|P1|Overall Study|Death|1
1553554|NCT00070018|5068517|P1|Overall Study|Withdrawal by Subject|1
1553555|NCT00070018|5068517|P1|Overall Study|Lack of Efficacy|1
1553556|NCT00070018|5068517|P1|Overall Study|Adverse Event|2
1553557|NCT00069953|5068521|P1|Overall Study|Protocol Violation|2
1553558|NCT00069784|5068527|P2|Overall Study|Other|0
1553559|NCT00069784|5068528|P1|Overall Study|Other|17
1553560|NCT00069784|5068527|P2|Overall Study|Withdrawal by Subject|0
1553561|NCT00069784|5068528|P1|Overall Study|Withdrawal by Subject|1090
1553562|NCT00069784|5068527|P2|Overall Study|Adverse Event|0
1553563|NCT00069784|5068528|P1|Overall Study|Adverse Event|105
1553564|NCT00069823|5068548|P2|Overall Study|Did not have follow-up diary cards|3
1553565|NCT00069823|5068549|P1|Overall Study|Did not have follow-up diary cards|6
1553566|NCT00069641|5068592|P3|Overall Study|Death|1
1553567|NCT00069641|5068593|P2|Overall Study|Death|0
1553568|NCT00069641|5068594|P1|Overall Study|Death|1
1553569|NCT00069277|5068619|P1|Overall Study|Physician Decision|2
1553570|NCT00069277|5068619|P1|Overall Study|Progressive Disease|15
1553571|NCT00069277|5068619|P1|Overall Study|Withdrawal by Subject|1
1553572|NCT00069277|5068619|P1|Overall Study|Adverse Event|3
1553573|NCT00069264|5068623|P1|Overall Study|Discon Therapy|3
1553574|NCT00069264|5068623|P1|Overall Study|Withdrawal by Subject|3
1553575|NCT00069264|5068623|P1|Overall Study|Progressive Disease|23
1553576|NCT00069264|5068623|P1|Overall Study|Adverse Event|3
1553577|NCT00069238|5068651|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
1553578|NCT00069238|5068652|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
1553579|NCT00069238|5068653|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
1553580|NCT00069238|5068651|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
1553581|NCT00069238|5068652|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
1553582|NCT00069238|5068653|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
1553583|NCT00069238|5068651|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
1553584|NCT00069238|5068652|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
1553585|NCT00069238|5068653|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
1553586|NCT00069121|5068661|P2|Overall Study|Lost to Follow-up|57
1553587|NCT00069121|5068662|P1|Overall Study|Lost to Follow-up|57
1553588|NCT00069121|5068661|P2|Overall Study|Withdrawal by Subject|22
1553589|NCT00069121|5068662|P1|Overall Study|Withdrawal by Subject|20
1553590|NCT00069121|5068661|P2|Overall Study|Death|197
1553591|NCT00069121|5068662|P1|Overall Study|Death|225
1553592|NCT00069108|5068684|P2|Overall Study|Refused treatment|10
1553593|NCT00069108|5068685|P1|Overall Study|Refused treatment|5
1553594|NCT00069108|5068684|P2|Overall Study|Violation criteria|4
1553595|NCT00069108|5068685|P1|Overall Study|Violation criteria|1
1553596|NCT00069108|5068684|P2|Overall Study|Insufficient therapy|144
1553597|NCT00069108|5068685|P1|Overall Study|Insufficient therapy|117
1553598|NCT00069108|5068684|P2|Overall Study|Administration|4
1553599|NCT00069108|5068685|P1|Overall Study|Administration|15
1553600|NCT00069108|5068684|P2|Overall Study|Death|6
1553601|NCT00069108|5068685|P1|Overall Study|Death|6
1553602|NCT00069108|5068684|P2|Overall Study|Adverse Event|42
1553603|NCT00069108|5068685|P1|Overall Study|Adverse Event|64
1553604|NCT00069108|5068684|P2|Overall Study|Withdrawal by Subject|9
1553605|NCT00069108|5068685|P1|Overall Study|Withdrawal by Subject|5
1553606|NCT00069095|5068717|P6|Follow-up Phase|Death|101
1553607|NCT00069095|5068718|P5|Follow-up Phase|Death|92
1553608|NCT00069095|5068719|P4|Follow-up Phase|Death|112
1553609|NCT00069095|5068720|P3|Follow-up Phase|Death|120
1553610|NCT00069095|5068721|P2|Follow-up Phase|Death|206
1553611|NCT00069095|5068722|P1|Follow-up Phase|Death|174
1553612|NCT00069095|5068717|P6|Post-study Treatment Phase|Investigator decision|1
1553613|NCT00069095|5068718|P5|Post-study Treatment Phase|Investigator decision|0
1553762|NCT00069095|5068717|P6|Primary Treatment Phase|Adverse Event|101
1553614|NCT00069095|5068719|P4|Post-study Treatment Phase|Investigator decision|0
1553615|NCT00069095|5068720|P3|Post-study Treatment Phase|Investigator decision|0
1553616|NCT00069095|5068721|P2|Post-study Treatment Phase|Investigator decision|0
1553617|NCT00069095|5068722|P1|Post-study Treatment Phase|Investigator decision|0
1553618|NCT00069095|5068717|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1553619|NCT00069095|5068718|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
1553620|NCT00069095|5068719|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1553621|NCT00069095|5068720|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1553622|NCT00069095|5068721|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1553623|NCT00069095|5068722|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1553624|NCT00069095|5068717|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
1553625|NCT00069095|5068718|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
1553626|NCT00069095|5068719|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
1553627|NCT00069095|5068720|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
1553628|NCT00069095|5068721|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
1553629|NCT00069095|5068722|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
1553630|NCT00069095|5068717|P6|Post-study Treatment Phase|Participant had progressive disease|0
1553631|NCT00069095|5068718|P5|Post-study Treatment Phase|Participant had progressive disease|1
1553632|NCT00069095|5068719|P4|Post-study Treatment Phase|Participant had progressive disease|0
1553633|NCT00069095|5068720|P3|Post-study Treatment Phase|Participant had progressive disease|0
1553634|NCT00069095|5068721|P2|Post-study Treatment Phase|Participant had progressive disease|0
1553635|NCT00069095|5068722|P1|Post-study Treatment Phase|Participant had progressive disease|0
1553636|NCT00069095|5068717|P6|Post-study Treatment Phase|Death|0
1553637|NCT00069095|5068718|P5|Post-study Treatment Phase|Death|1
1553638|NCT00069095|5068719|P4|Post-study Treatment Phase|Death|0
1553639|NCT00069095|5068720|P3|Post-study Treatment Phase|Death|0
1553640|NCT00069095|5068721|P2|Post-study Treatment Phase|Death|0
1553641|NCT00069095|5068722|P1|Post-study Treatment Phase|Death|0
1553642|NCT00069095|5068717|P6|Post-study Treatment Phase|Surgery|0
1553643|NCT00069095|5068718|P5|Post-study Treatment Phase|Surgery|1
1553644|NCT00069095|5068719|P4|Post-study Treatment Phase|Surgery|1
1553645|NCT00069095|5068720|P3|Post-study Treatment Phase|Surgery|0
1553646|NCT00069095|5068721|P2|Post-study Treatment Phase|Surgery|0
1553647|NCT00069095|5068722|P1|Post-study Treatment Phase|Surgery|0
1553648|NCT00069095|5068717|P6|Post-study Treatment Phase|Participant completed treatment|0
1553649|NCT00069095|5068718|P5|Post-study Treatment Phase|Participant completed treatment|0
1553650|NCT00069095|5068719|P4|Post-study Treatment Phase|Participant completed treatment|1
1553651|NCT00069095|5068720|P3|Post-study Treatment Phase|Participant completed treatment|0
1553652|NCT00069095|5068721|P2|Post-study Treatment Phase|Participant completed treatment|0
1553653|NCT00069095|5068722|P1|Post-study Treatment Phase|Participant completed treatment|0
1553654|NCT00069095|5068717|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
1553655|NCT00069095|5068718|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
1553656|NCT00069095|5068719|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
1553657|NCT00069095|5068720|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
1553658|NCT00069095|5068721|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
1553659|NCT00069095|5068722|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
1553660|NCT00069095|5068717|P6|Post-study Treatment Phase|Participant will start new treatment|0
1553661|NCT00069095|5068718|P5|Post-study Treatment Phase|Participant will start new treatment|0
1553662|NCT00069095|5068719|P4|Post-study Treatment Phase|Participant will start new treatment|0
1553663|NCT00069095|5068720|P3|Post-study Treatment Phase|Participant will start new treatment|1
1553664|NCT00069095|5068721|P2|Post-study Treatment Phase|Participant will start new treatment|0
1553665|NCT00069095|5068722|P1|Post-study Treatment Phase|Participant will start new treatment|0
1553666|NCT00069095|5068717|P6|Post-study Treatment Phase|Participant withdrew consent|0
1553667|NCT00069095|5068718|P5|Post-study Treatment Phase|Participant withdrew consent|0
1553668|NCT00069095|5068719|P4|Post-study Treatment Phase|Participant withdrew consent|0
1553669|NCT00069095|5068720|P3|Post-study Treatment Phase|Participant withdrew consent|1
1553670|NCT00069095|5068721|P2|Post-study Treatment Phase|Participant withdrew consent|0
1553671|NCT00069095|5068722|P1|Post-study Treatment Phase|Participant withdrew consent|0
1553672|NCT00069095|5068717|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
1553673|NCT00069095|5068718|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
1553674|NCT00069095|5068719|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
1553675|NCT00069095|5068720|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
1553676|NCT00069095|5068721|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
1553677|NCT00069095|5068722|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
1553678|NCT00069095|5068717|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
1553679|NCT00069095|5068718|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
1553680|NCT00069095|5068719|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
1553681|NCT00069095|5068720|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
1553682|NCT00069095|5068721|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
1553683|NCT00069095|5068722|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
1553684|NCT00069095|5068717|P6|Post-study Treatment Phase|Participant had complete response|0
1553685|NCT00069095|5068718|P5|Post-study Treatment Phase|Participant had complete response|0
1553686|NCT00069095|5068719|P4|Post-study Treatment Phase|Participant had complete response|0
1553687|NCT00069095|5068720|P3|Post-study Treatment Phase|Participant had complete response|0
1553688|NCT00069095|5068721|P2|Post-study Treatment Phase|Participant had complete response|1
1553689|NCT00069095|5068722|P1|Post-study Treatment Phase|Participant had complete response|1
1553690|NCT00069095|5068717|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
1553691|NCT00069095|5068718|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1553692|NCT00069095|5068719|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1553693|NCT00069095|5068720|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1553694|NCT00069095|5068721|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1553695|NCT00069095|5068722|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
1553696|NCT00069095|5068717|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
1553697|NCT00069095|5068718|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
1553698|NCT00069095|5068719|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
1553699|NCT00069095|5068720|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
1553700|NCT00069095|5068721|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
1553701|NCT00069095|5068722|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
1553702|NCT00069095|5068717|P6|Post-study Treatment Phase|Eligible for surgery|0
1553703|NCT00069095|5068718|P5|Post-study Treatment Phase|Eligible for surgery|0
1553704|NCT00069095|5068719|P4|Post-study Treatment Phase|Eligible for surgery|0
1553705|NCT00069095|5068720|P3|Post-study Treatment Phase|Eligible for surgery|0
1553706|NCT00069095|5068721|P2|Post-study Treatment Phase|Eligible for surgery|0
1553707|NCT00069095|5068722|P1|Post-study Treatment Phase|Eligible for surgery|2
1553708|NCT00069095|5068717|P6|Post-study Treatment Phase|Adverse Event|1
1553709|NCT00069095|5068718|P5|Post-study Treatment Phase|Adverse Event|5
1553710|NCT00069095|5068719|P4|Post-study Treatment Phase|Adverse Event|0
1553711|NCT00069095|5068720|P3|Post-study Treatment Phase|Adverse Event|1
1553712|NCT00069095|5068721|P2|Post-study Treatment Phase|Adverse Event|3
1553713|NCT00069095|5068722|P1|Post-study Treatment Phase|Adverse Event|2
1553714|NCT00069095|5068717|P6|Post-study Treatment Phase|Missing reason|17
1553715|NCT00069095|5068718|P5|Post-study Treatment Phase|Missing reason|18
1553716|NCT00069095|5068719|P4|Post-study Treatment Phase|Missing reason|8
1553717|NCT00069095|5068720|P3|Post-study Treatment Phase|Missing reason|12
1553718|NCT00069095|5068721|P2|Post-study Treatment Phase|Missing reason|3
1553719|NCT00069095|5068722|P1|Post-study Treatment Phase|Missing reason|1
1553720|NCT00069095|5068717|P6|Primary Treatment Phase|Violation criteria|5
1553721|NCT00069095|5068718|P5|Primary Treatment Phase|Violation criteria|1
1553722|NCT00069095|5068719|P4|Primary Treatment Phase|Violation criteria|3
1553723|NCT00069095|5068720|P3|Primary Treatment Phase|Violation criteria|4
1553724|NCT00069095|5068721|P2|Primary Treatment Phase|Violation criteria|2
1553725|NCT00069095|5068722|P1|Primary Treatment Phase|Violation criteria|0
1553726|NCT00069095|5068717|P6|Primary Treatment Phase|Other Violation|1
1553727|NCT00069095|5068718|P5|Primary Treatment Phase|Other Violation|0
1553728|NCT00069095|5068719|P4|Primary Treatment Phase|Other Violation|1
1553729|NCT00069095|5068720|P3|Primary Treatment Phase|Other Violation|1
1553730|NCT00069095|5068721|P2|Primary Treatment Phase|Other Violation|1
1553731|NCT00069095|5068722|P1|Primary Treatment Phase|Other Violation|0
1553732|NCT00069095|5068717|P6|Primary Treatment Phase|Withdrew|9
1553733|NCT00069095|5068718|P5|Primary Treatment Phase|Withdrew|4
1553734|NCT00069095|5068719|P4|Primary Treatment Phase|Withdrew|2
1553735|NCT00069095|5068720|P3|Primary Treatment Phase|Withdrew|8
1553736|NCT00069095|5068721|P2|Primary Treatment Phase|Withdrew|3
1553737|NCT00069095|5068722|P1|Primary Treatment Phase|Withdrew|2
1553738|NCT00069095|5068717|P6|Primary Treatment Phase|Refused treatment|27
1553739|NCT00069095|5068718|P5|Primary Treatment Phase|Refused treatment|24
1553740|NCT00069095|5068719|P4|Primary Treatment Phase|Refused treatment|31
1553741|NCT00069095|5068720|P3|Primary Treatment Phase|Refused treatment|17
1553742|NCT00069095|5068721|P2|Primary Treatment Phase|Refused treatment|26
1553743|NCT00069095|5068722|P1|Primary Treatment Phase|Refused treatment|15
1553744|NCT00069095|5068717|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
1553745|NCT00069095|5068718|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
1553746|NCT00069095|5068719|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
1553747|NCT00069095|5068720|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
1553748|NCT00069095|5068721|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
1553749|NCT00069095|5068722|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
1553750|NCT00069095|5068717|P6|Primary Treatment Phase|Failure to return|2
1553751|NCT00069095|5068718|P5|Primary Treatment Phase|Failure to return|0
1553752|NCT00069095|5068719|P4|Primary Treatment Phase|Failure to return|0
1553753|NCT00069095|5068720|P3|Primary Treatment Phase|Failure to return|0
1553754|NCT00069095|5068721|P2|Primary Treatment Phase|Failure to return|5
1553755|NCT00069095|5068722|P1|Primary Treatment Phase|Failure to return|5
1553756|NCT00069095|5068717|P6|Primary Treatment Phase|Death|8
1553757|NCT00069095|5068718|P5|Primary Treatment Phase|Death|8
1553758|NCT00069095|5068719|P4|Primary Treatment Phase|Death|5
1553759|NCT00069095|5068720|P3|Primary Treatment Phase|Death|2
1553760|NCT00069095|5068721|P2|Primary Treatment Phase|Death|8
1553761|NCT00069095|5068722|P1|Primary Treatment Phase|Death|14
1553763|NCT00069095|5068718|P5|Primary Treatment Phase|Adverse Event|109
1553764|NCT00069095|5068719|P4|Primary Treatment Phase|Adverse Event|72
1553765|NCT00069095|5068720|P3|Primary Treatment Phase|Adverse Event|71
1553766|NCT00069095|5068721|P2|Primary Treatment Phase|Adverse Event|92
1553767|NCT00069095|5068722|P1|Primary Treatment Phase|Adverse Event|99
1553768|NCT00069095|5068717|P6|Primary Treatment Phase|Admin/Other|42
1553769|NCT00069095|5068718|P5|Primary Treatment Phase|Admin/Other|48
1553770|NCT00069095|5068719|P4|Primary Treatment Phase|Admin/Other|45
1553771|NCT00069095|5068720|P3|Primary Treatment Phase|Admin/Other|31
1553772|NCT00069095|5068721|P2|Primary Treatment Phase|Admin/Other|38
1553773|NCT00069095|5068722|P1|Primary Treatment Phase|Admin/Other|29
1553774|NCT00069095|5068717|P6|Primary Treatment Phase|Ongoing|4
1553775|NCT00069095|5068718|P5|Primary Treatment Phase|Ongoing|7
1553776|NCT00069095|5068719|P4|Primary Treatment Phase|Ongoing|7
1553777|NCT00069095|5068720|P3|Primary Treatment Phase|Ongoing|5
1553778|NCT00069095|5068721|P2|Primary Treatment Phase|Ongoing|0
1553779|NCT00069095|5068722|P1|Primary Treatment Phase|Ongoing|0
1553780|NCT00068822|5068792|P2|First Randomized Intervention|Lost to Follow-up|2
1553781|NCT00068822|5068793|P1|First Randomized Intervention|Lost to Follow-up|1
1553782|NCT00068601|5068826|P2|Overall Study|Missing primary outcome data|34
1553783|NCT00068601|5068827|P1|Overall Study|Missing primary outcome data|30
1553784|NCT00068601|5068826|P2|Overall Study|Lost to Follow-up|2
1553785|NCT00068601|5068827|P1|Overall Study|Lost to Follow-up|3
1553786|NCT00068601|5068826|P2|Overall Study|Death|3
1553787|NCT00068601|5068827|P1|Overall Study|Death|11
1553788|NCT00068601|5068826|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
1553789|NCT00068601|5068827|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
1553790|NCT00068601|5068826|P2|Overall Study|Not evaluable: withdrew consent|4
1553791|NCT00068601|5068827|P1|Overall Study|Not evaluable: withdrew consent|5
1553792|NCT00068601|5068826|P2|Overall Study|Ineligible|13
1553793|NCT00068601|5068827|P1|Overall Study|Ineligible|11
1553794|NCT00068588|5068840|P3|Overall Study|Poor KPS|1
1553795|NCT00068588|5068841|P2|Overall Study|Poor KPS|0
1553796|NCT00068588|5068842|P1|Overall Study|Poor KPS|0
1553797|NCT00068588|5068840|P3|Overall Study|Withdrawal by Subject|1
1553798|NCT00068588|5068841|P2|Overall Study|Withdrawal by Subject|0
1553799|NCT00068588|5068842|P1|Overall Study|Withdrawal by Subject|0
1553800|NCT00068588|5068840|P3|Overall Study|Adverse Event|2
1553801|NCT00068588|5068841|P2|Overall Study|Adverse Event|0
1553802|NCT00068588|5068842|P1|Overall Study|Adverse Event|0
1553803|NCT00068445|5068858|P2|Treatment|Other (Specifics not available)|5
1553804|NCT00068445|5068859|P1|Treatment|Other (Specifics not available)|9
1553805|NCT00068445|5068858|P2|Treatment|Adverse Event|1
1553806|NCT00068445|5068859|P1|Treatment|Adverse Event|7
1553807|NCT00068445|5068858|P2|Treatment|Refused Further Treatment|10
1553808|NCT00068445|5068859|P1|Treatment|Refused Further Treatment|13
1553809|NCT00068445|5068858|P2|Randomization|Ineligible|1
1553810|NCT00068445|5068859|P1|Randomization|Ineligible|1
1553811|NCT00068445|5068858|P2|Randomization|Cancel|3
1553812|NCT00068445|5068859|P1|Randomization|Cancel|1
1553813|NCT00068419|5068883|P1|Overall Study|Ineligible|11
1553814|NCT00068419|5068883|P1|Overall Study|Withdrawal by Subject|14
1553815|NCT00068419|5068883|P1|Overall Study|Physician Decision|7
1553816|NCT00068419|5068883|P1|Overall Study|Lost to Follow-up|1
1553817|NCT00068419|5068883|P1|Overall Study|Lack of Efficacy|24
1553818|NCT00068419|5068883|P1|Overall Study|Adverse Event|3
1553819|NCT00068406|5068887|P1|Overall Study|Ineligible-Inadequate Pathology|2
1553820|NCT00068406|5068887|P1|Overall Study|Ineligible-improper pre-protocol treatm|1
1553821|NCT00068393|5068892|P1|Overall Study|Quality of life worsening|1
1553822|NCT00068393|5068892|P1|Overall Study|Alternative treatment|1
1553823|NCT00068393|5068892|P1|Overall Study|Withdrawal by Subject|3
1553824|NCT00068393|5068892|P1|Overall Study|Death|3
1553825|NCT00068393|5068892|P1|Overall Study|Adverse Event|2
1553826|NCT00068380|5068898|P1|Overall Study|Adverse Event|2
1553827|NCT00068380|5068898|P1|Overall Study|Withdrawal by Subject|3
1553828|NCT00068250|5068942|P4|Phase I: Dose Level 2|Protocol Violation|0
1553829|NCT00068250|5068943|P3|Phase I: Dose Level 2|Protocol Violation|0
1553830|NCT00068250|5068944|P2|Phase I: Dose Level 2|Protocol Violation|1
1553831|NCT00068250|5068945|P1|Phase I: Dose Level 2|Protocol Violation|0
1553832|NCT00068237|5068955|P1|Overall Study|No protocol treatment received|2
1553833|NCT00068237|5068955|P1|Overall Study|Ineligible|3
1553834|NCT00068107|5068959|P1|Overall Study|Withdrawal by Subject|1
1553835|NCT00068107|5068959|P1|Overall Study|Death|2
1553836|NCT00068107|5068959|P1|Overall Study|end-stage renal disease|6
1553837|NCT00067990|5068972|P2|Overall Study|Withdrawal by Subject|12
1553838|NCT00067990|5068973|P1|Overall Study|Withdrawal by Subject|4
1553839|NCT00067990|5068972|P2|Overall Study|ESRD, Non IF/TA|3
1553840|NCT00067990|5068973|P1|Overall Study|ESRD, Non IF/TA|1
1553841|NCT00067990|5068972|P2|Overall Study|Death|7
1553842|NCT00067990|5068973|P1|Overall Study|Death|5
1553843|NCT00067470|5068996|P2|Overall Study|Withdrawal by Subject|1
1553844|NCT00067470|5068997|P1|Overall Study|Withdrawal by Subject|0
1553845|NCT00066807|5069060|P2|Overall Study|Study was terminated early|15
1553846|NCT00066807|5069061|P1|Overall Study|Study was terminated early|14
1553847|NCT00066742|5069086|P1|Consolidation Chemotherapy|Ineligible|2
1553848|NCT00066742|5069086|P1|Consolidation Chemotherapy|not protocol specified|1
1553849|NCT00066742|5069086|P1|Induction Chemoradiotherapy|Ineligible|3
1553938|NCT00065507|5069288|P1|Overall Study|Lost to Follow-up|3
1553850|NCT00066742|5069086|P1|Induction Chemoradiotherapy|not protocol specified|2
1553851|NCT00066742|5069086|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
1553852|NCT00066742|5069086|P1|Induction Chemoradiotherapy|Adverse Event|21
1553853|NCT00066742|5069086|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
1553854|NCT00066703|5069095|P2|Overall Study|Treatment ongoing|311
1553855|NCT00066703|5069096|P1|Overall Study|Treatment ongoing|346
1553856|NCT00066703|5069095|P2|Overall Study|Withdrawal by Subject|63
1553857|NCT00066703|5069096|P1|Overall Study|Withdrawal by Subject|38
1553858|NCT00066703|5069095|P2|Overall Study|Lost to Follow-up|28
1553859|NCT00066703|5069096|P1|Overall Study|Lost to Follow-up|31
1553860|NCT00066703|5069095|P2|Overall Study|Lack of Efficacy|69
1553861|NCT00066703|5069096|P1|Overall Study|Lack of Efficacy|114
1553862|NCT00066703|5069095|P2|Overall Study|Death|0
1553863|NCT00066703|5069096|P1|Overall Study|Death|3
1553864|NCT00066703|5069095|P2|Overall Study|Adverse Event|111
1553865|NCT00066703|5069096|P1|Overall Study|Adverse Event|80
1553866|NCT00066690|5069109|P3|Overall Study|Treatment Ongoing|282
1553867|NCT00066690|5069110|P2|Overall Study|Treatment Ongoing|278
1553868|NCT00066690|5069111|P1|Overall Study|Treatment Ongoing|246
1553869|NCT00066690|5069109|P3|Overall Study|Withdrawal by Subject|49
1553870|NCT00066690|5069110|P2|Overall Study|Withdrawal by Subject|55
1553871|NCT00066690|5069111|P1|Overall Study|Withdrawal by Subject|50
1553872|NCT00066690|5069109|P3|Overall Study|Lost to Follow-up|29
1553873|NCT00066690|5069110|P2|Overall Study|Lost to Follow-up|21
1553874|NCT00066690|5069111|P1|Overall Study|Lost to Follow-up|40
1553875|NCT00066690|5069109|P3|Overall Study|Lack of Efficacy|76
1553876|NCT00066690|5069110|P2|Overall Study|Lack of Efficacy|110
1553877|NCT00066690|5069111|P1|Overall Study|Lack of Efficacy|114
1553878|NCT00066690|5069109|P3|Overall Study|Death|2
1553879|NCT00066690|5069110|P2|Overall Study|Death|0
1553880|NCT00066690|5069111|P1|Overall Study|Death|3
1553881|NCT00066690|5069109|P3|Overall Study|Adverse Event|126
1553882|NCT00066690|5069110|P2|Overall Study|Adverse Event|58
1553883|NCT00066690|5069111|P1|Overall Study|Adverse Event|145
1553884|NCT00066573|5069127|P2|Overall Study|Did not received protocol treatment|28
1553885|NCT00066573|5069128|P1|Overall Study|Did not received protocol treatment|28
1553886|NCT00066469|5069140|P1|Overall Study|ineligible|1
1553887|NCT00066469|5069140|P1|Overall Study|Withdrawal by Subject|1
1553888|NCT00066469|5069140|P1|Overall Study|Physician Decision|1
1553889|NCT00066469|5069140|P1|Overall Study|Lost to Follow-up|1
1553890|NCT00066469|5069140|P1|Overall Study|Lack of Efficacy|9
1553891|NCT00066469|5069140|P1|Overall Study|Death|3
1553892|NCT00066365|5069146|P2|Overall Study|Ineligible|2
1553893|NCT00066365|5069147|P1|Overall Study|Ineligible|4
1553894|NCT00066365|5069146|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
1553895|NCT00066365|5069147|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
1553896|NCT00066365|5069146|P2|Overall Study|Physician Decision|0
1553897|NCT00066365|5069147|P1|Overall Study|Physician Decision|1
1553898|NCT00066365|5069146|P2|Overall Study|Lack of Efficacy|12
1553899|NCT00066365|5069147|P1|Overall Study|Lack of Efficacy|15
1553900|NCT00066365|5069146|P2|Overall Study|Adverse Event|0
1553901|NCT00066365|5069147|P1|Overall Study|Adverse Event|1
1553902|NCT00066222|5069175|P1|Overall Study|No protocol treatment received|1
1553903|NCT00066170|5069188|P4|Overall Study|Other|0
1553904|NCT00066170|5069189|P3|Overall Study|Other|2
1553905|NCT00066170|5069190|P2|Overall Study|Other|5
1553906|NCT00066170|5069191|P1|Overall Study|Other|1
1553907|NCT00066170|5069188|P4|Overall Study|Protocol Violation|0
1553908|NCT00066170|5069189|P3|Overall Study|Protocol Violation|0
1553909|NCT00066170|5069190|P2|Overall Study|Protocol Violation|0
1553910|NCT00066170|5069191|P1|Overall Study|Protocol Violation|3
1553911|NCT00066170|5069188|P4|Overall Study|Non-Compliance with Trial Medicine|1
1553912|NCT00066170|5069189|P3|Overall Study|Non-Compliance with Trial Medicine|0
1553913|NCT00066170|5069190|P2|Overall Study|Non-Compliance with Trial Medicine|0
1553914|NCT00066170|5069191|P1|Overall Study|Non-Compliance with Trial Medicine|1
1553915|NCT00066170|5069188|P4|Overall Study|Lost to Follow-up|0
1553916|NCT00066170|5069189|P3|Overall Study|Lost to Follow-up|0
1553917|NCT00066170|5069190|P2|Overall Study|Lost to Follow-up|1
1553918|NCT00066170|5069191|P1|Overall Study|Lost to Follow-up|0
1553919|NCT00066170|5069188|P4|Overall Study|Serious Adverse Event|1
1553920|NCT00066170|5069189|P3|Overall Study|Serious Adverse Event|1
1553921|NCT00066170|5069190|P2|Overall Study|Serious Adverse Event|0
1553922|NCT00066170|5069191|P1|Overall Study|Serious Adverse Event|0
1553923|NCT00066170|5069188|P4|Overall Study|Adverse Event|7
1553924|NCT00066170|5069189|P3|Overall Study|Adverse Event|1
1553925|NCT00066170|5069190|P2|Overall Study|Adverse Event|4
1553926|NCT00066170|5069191|P1|Overall Study|Adverse Event|2
1553927|NCT00066066|5069204|P6|Overall Study|Lost to Follow-up|5
1553928|NCT00066066|5069205|P5|Overall Study|Lost to Follow-up|3
1553929|NCT00066066|5069206|P4|Overall Study|Lost to Follow-up|4
1553930|NCT00066066|5069207|P3|Overall Study|Lost to Follow-up|7
1553931|NCT00066066|5069208|P2|Overall Study|Lost to Follow-up|4
1553932|NCT00066066|5069209|P1|Overall Study|Lost to Follow-up|6
1553933|NCT00065507|5069287|P2|Overall Study|Subject No Longer Meets Study Criteria|0
1553934|NCT00065507|5069288|P1|Overall Study|Subject No Longer Meets Study Criteria|1
1553935|NCT00065507|5069287|P2|Overall Study|Subject Withdrew Consent|1
1553936|NCT00065507|5069288|P1|Overall Study|Subject Withdrew Consent|2
1553937|NCT00065507|5069287|P2|Overall Study|Lost to Follow-up|0
1553939|NCT00065507|5069287|P2|Overall Study|Poor/Non-compliance|2
1553940|NCT00065507|5069288|P1|Overall Study|Poor/Non-compliance|3
1553941|NCT00065507|5069287|P2|Overall Study|Lack of Efficacy|6
1553942|NCT00065507|5069288|P1|Overall Study|Lack of Efficacy|0
1553943|NCT00065507|5069287|P2|Overall Study|Adverse Event|3
1553944|NCT00065507|5069288|P1|Overall Study|Adverse Event|4
1553945|NCT00065507|5069287|P2|Overall Study|Death|17
1553946|NCT00065507|5069288|P1|Overall Study|Death|16
1553947|NCT00065468|5069353|P3|Overall Study|Other|18
1553948|NCT00065468|5069354|P2|Overall Study|Other|24
1553949|NCT00065468|5069355|P1|Overall Study|Other|14
1553950|NCT00065468|5069353|P3|Overall Study|Disease progression|1
1553951|NCT00065468|5069354|P2|Overall Study|Disease progression|0
1553952|NCT00065468|5069355|P1|Overall Study|Disease progression|0
1553953|NCT00065468|5069353|P3|Overall Study|Discontinuation of study by Sponsor|13
1553954|NCT00065468|5069354|P2|Overall Study|Discontinuation of study by Sponsor|9
1553955|NCT00065468|5069355|P1|Overall Study|Discontinuation of study by Sponsor|13
1553956|NCT00065468|5069353|P3|Overall Study|Lost to Follow-up|2
1553957|NCT00065468|5069354|P2|Overall Study|Lost to Follow-up|3
1553958|NCT00065468|5069355|P1|Overall Study|Lost to Follow-up|5
1553959|NCT00065468|5069353|P3|Overall Study|Withdrawal by Subject|5
1553960|NCT00065468|5069354|P2|Overall Study|Withdrawal by Subject|4
1553961|NCT00065468|5069355|P1|Overall Study|Withdrawal by Subject|3
1553962|NCT00065468|5069353|P3|Overall Study|Death|171
1553963|NCT00065468|5069354|P2|Overall Study|Death|169
1553964|NCT00065468|5069355|P1|Overall Study|Death|172
1553965|NCT00065442|5069386|P2|Overall Study|Withdrawal by Subject|9
1553966|NCT00065442|5069387|P1|Overall Study|Withdrawal by Subject|3
1553967|NCT00065442|5069386|P2|Overall Study|Death|210
1553968|NCT00065442|5069387|P1|Overall Study|Death|121
1553969|NCT00065442|5069386|P2|Overall Study|Lost to Follow-up|1
1553970|NCT00065442|5069387|P1|Overall Study|Lost to Follow-up|1
1553971|NCT00065429|5069402|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1553972|NCT00065429|5069403|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1553973|NCT00065429|5069404|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
1553974|NCT00065429|5069405|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1553975|NCT00065429|5069406|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1553976|NCT00065429|5069407|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1553977|NCT00065429|5069408|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1553978|NCT00065429|5069402|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1553979|NCT00065429|5069403|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1553980|NCT00065429|5069404|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
1553981|NCT00065429|5069405|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1553982|NCT00065429|5069406|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1553983|NCT00065429|5069407|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1553984|NCT00065429|5069408|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1553985|NCT00065429|5069402|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
1553986|NCT00065429|5069403|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
1553987|NCT00065429|5069404|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
1553988|NCT00065429|5069405|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
1553989|NCT00065429|5069406|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
1553990|NCT00065429|5069407|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
1553991|NCT00065429|5069408|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
1553992|NCT00065429|5069402|P7|Phase I - May 2001 - Oct 2002|Death|0
1553993|NCT00065429|5069403|P6|Phase I - May 2001 - Oct 2002|Death|0
1553994|NCT00065429|5069404|P5|Phase I - May 2001 - Oct 2002|Death|1
1553995|NCT00065429|5069405|P4|Phase I - May 2001 - Oct 2002|Death|0
1553996|NCT00065429|5069406|P3|Phase I - May 2001 - Oct 2002|Death|0
1553997|NCT00065429|5069407|P2|Phase I - May 2001 - Oct 2002|Death|0
1553998|NCT00065429|5069408|P1|Phase I - May 2001 - Oct 2002|Death|0
1553999|NCT00065429|5069402|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
1554000|NCT00065429|5069403|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
1554001|NCT00065429|5069404|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
1554002|NCT00065429|5069405|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
1554003|NCT00065429|5069406|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
1554004|NCT00065429|5069407|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
1554005|NCT00065429|5069408|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
1554006|NCT00065429|5069402|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1554007|NCT00065429|5069403|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1554008|NCT00065429|5069404|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1554009|NCT00065429|5069405|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1554010|NCT00065429|5069406|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
1554011|NCT00065429|5069407|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1554012|NCT00065429|5069408|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1554013|NCT00065429|5069402|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1554014|NCT00065429|5069403|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
1554015|NCT00065429|5069404|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1554016|NCT00065429|5069405|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1554017|NCT00065429|5069406|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1554018|NCT00065429|5069407|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1554019|NCT00065429|5069408|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1554020|NCT00065260|5069422|P2|Overall Study|Death|1
1554021|NCT00065260|5069423|P1|Overall Study|Death|0
1554022|NCT00065156|5069429|P1|Overall Study|Secondary Malign Disease|1
1554023|NCT00065156|5069429|P1|Overall Study|Loss of Response|1
1554024|NCT00065156|5069429|P1|Overall Study|Non-Compliance|2
1554025|NCT00065156|5069429|P1|Overall Study|Investigator Decision|2
1554026|NCT00065156|5069429|P1|Overall Study|Disease Progression|7
1554027|NCT00065156|5069429|P1|Overall Study|Study Closed by Sponsor|2
1554028|NCT00065156|5069429|P1|Overall Study|Death|11
1554029|NCT00065156|5069429|P1|Overall Study|Lost to Follow-up|1
1554030|NCT00065156|5069429|P1|Overall Study|Withdrawal by Subject|8
1554031|NCT00065156|5069429|P1|Overall Study|Lack of Efficacy|52
1554032|NCT00065156|5069429|P1|Overall Study|Adverse Event|37
1554033|NCT00065065|5069446|P2|Overall Study|Other|2
1554034|NCT00065065|5069447|P1|Overall Study|Other|2
1554035|NCT00065065|5069446|P2|Overall Study|Lack of Efficacy|11
1554036|NCT00065065|5069447|P1|Overall Study|Lack of Efficacy|4
1554037|NCT00065065|5069446|P2|Overall Study|Withdrawal by Subject|5
1554038|NCT00065065|5069447|P1|Overall Study|Withdrawal by Subject|1
1554039|NCT00065065|5069446|P2|Overall Study|Adverse Event|2
1554040|NCT00065065|5069447|P1|Overall Study|Adverse Event|3
1554041|NCT00003895|5069459|P2|Overall Study|Withdrawal by Subject|3
1554042|NCT00003895|5069460|P1|Overall Study|Withdrawal by Subject|0
1554043|NCT00003895|5069459|P2|Overall Study|Patient Vacation|0
1554044|NCT00003895|5069460|P1|Overall Study|Patient Vacation|2
1554045|NCT00003895|5069459|P2|Overall Study|Lack of Efficacy|1
1554046|NCT00003895|5069460|P1|Overall Study|Lack of Efficacy|1
1554047|NCT00003895|5069459|P2|Overall Study|Adverse Event|0
1554048|NCT00003895|5069460|P1|Overall Study|Adverse Event|4
1554049|NCT00064987|5069468|P2|Overall Study|Physician Decision|0
1554050|NCT00064987|5069469|P1|Overall Study|Physician Decision|3
1554051|NCT00064753|5069500|P2|Overall Study|Lost to Follow-up|235
1554052|NCT00064753|5069501|P1|Overall Study|Lost to Follow-up|225
1554053|NCT00064753|5069500|P2|Overall Study|Withdrawal by Subject|171
1554054|NCT00064753|5069501|P1|Overall Study|Withdrawal by Subject|198
1554055|NCT00064753|5069500|P2|Overall Study|Death|242
1554056|NCT00064753|5069501|P1|Overall Study|Death|251
1554057|NCT00064792|5069531|P2|Overall Study|Adverse Event|0
1554058|NCT00064792|5069532|P1|Overall Study|Adverse Event|3
1554059|NCT00064792|5069531|P2|Overall Study|Withdrawal by Subject|0
1554060|NCT00064792|5069532|P1|Overall Study|Withdrawal by Subject|2
1554061|NCT00064701|5069543|P3|Clinical Continuation Phase|Patient opted out|1
1554062|NCT00064701|5069544|P2|Clinical Continuation Phase|Patient opted out|0
1554063|NCT00064701|5069545|P1|Clinical Continuation Phase|Patient opted out|0
1554064|NCT00064701|5069543|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
1554065|NCT00064701|5069544|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
1554066|NCT00064701|5069545|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
1554067|NCT00064701|5069543|P3|Clinical Continuation Phase|Discharged to nursing home|0
1554068|NCT00064701|5069544|P2|Clinical Continuation Phase|Discharged to nursing home|1
1554069|NCT00064701|5069545|P1|Clinical Continuation Phase|Discharged to nursing home|0
1554070|NCT00064701|5069543|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
1554071|NCT00064701|5069544|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
1554072|NCT00064701|5069545|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
1554073|NCT00064701|5069543|P3|Clinical Continuation Phase|Pancreas transplant|0
1554074|NCT00064701|5069544|P2|Clinical Continuation Phase|Pancreas transplant|0
1554075|NCT00064701|5069545|P1|Clinical Continuation Phase|Pancreas transplant|1
1554076|NCT00064701|5069543|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
1554077|NCT00064701|5069544|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
1554078|NCT00064701|5069545|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
1554079|NCT00064701|5069543|P3|Clinical Continuation Phase|Physician Decision|0
1554080|NCT00064701|5069544|P2|Clinical Continuation Phase|Physician Decision|3
1554081|NCT00064701|5069545|P1|Clinical Continuation Phase|Physician Decision|1
1554082|NCT00064701|5069543|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
1554083|NCT00064701|5069544|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
1554084|NCT00064701|5069545|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
1554085|NCT00064701|5069543|P3|Clinical Continuation Phase|Sponsor discontinued study|79
1554086|NCT00064701|5069544|P2|Clinical Continuation Phase|Sponsor discontinued study|129
1554087|NCT00064701|5069545|P1|Clinical Continuation Phase|Sponsor discontinued study|113
1554088|NCT00064701|5069543|P3|Clinical Continuation Phase|Rejection|2
1554089|NCT00064701|5069544|P2|Clinical Continuation Phase|Rejection|2
1554090|NCT00064701|5069545|P1|Clinical Continuation Phase|Rejection|1
1554091|NCT00064701|5069543|P3|Clinical Continuation Phase|Graft Failure|2
1554092|NCT00064701|5069544|P2|Clinical Continuation Phase|Graft Failure|5
1554093|NCT00064701|5069545|P1|Clinical Continuation Phase|Graft Failure|5
1554094|NCT00064701|5069543|P3|Clinical Continuation Phase|Lost to Follow-up|6
1554095|NCT00064701|5069544|P2|Clinical Continuation Phase|Lost to Follow-up|3
1554096|NCT00064701|5069545|P1|Clinical Continuation Phase|Lost to Follow-up|6
1554097|NCT00064701|5069543|P3|Clinical Continuation Phase|Withdrawal by Subject|22
1554098|NCT00064701|5069544|P2|Clinical Continuation Phase|Withdrawal by Subject|3
1554099|NCT00064701|5069545|P1|Clinical Continuation Phase|Withdrawal by Subject|22
1554100|NCT00064701|5069543|P3|Clinical Continuation Phase|Non-compliance|7
1554101|NCT00064701|5069544|P2|Clinical Continuation Phase|Non-compliance|6
1554102|NCT00064701|5069545|P1|Clinical Continuation Phase|Non-compliance|8
1554103|NCT00064701|5069543|P3|Clinical Continuation Phase|Adverse Event|14
1554104|NCT00064701|5069544|P2|Clinical Continuation Phase|Adverse Event|21
1554105|NCT00064701|5069545|P1|Clinical Continuation Phase|Adverse Event|12
1554106|NCT00064701|5069543|P3|One Year Post-transplant|Pancreas transplant|1
1554107|NCT00064701|5069544|P2|One Year Post-transplant|Pancreas transplant|0
1554108|NCT00064701|5069545|P1|One Year Post-transplant|Pancreas transplant|0
1554109|NCT00064701|5069543|P3|One Year Post-transplant|Poor absorption|0
1554110|NCT00064701|5069544|P2|One Year Post-transplant|Poor absorption|1
1554111|NCT00064701|5069545|P1|One Year Post-transplant|Poor absorption|0
1554112|NCT00064701|5069543|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
1554113|NCT00064701|5069544|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
1554114|NCT00064701|5069545|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
1554115|NCT00064701|5069543|P3|One Year Post-transplant|Incorrect study drug dispensed|0
1554116|NCT00064701|5069544|P2|One Year Post-transplant|Incorrect study drug dispensed|1
1554117|NCT00064701|5069545|P1|One Year Post-transplant|Incorrect study drug dispensed|0
1554118|NCT00064701|5069543|P3|One Year Post-transplant|Acute tubular necrosis|0
1554119|NCT00064701|5069544|P2|One Year Post-transplant|Acute tubular necrosis|0
1554120|NCT00064701|5069545|P1|One Year Post-transplant|Acute tubular necrosis|1
1554121|NCT00064701|5069543|P3|One Year Post-transplant|Converted to rapamycin|0
1554122|NCT00064701|5069544|P2|One Year Post-transplant|Converted to rapamycin|0
1554123|NCT00064701|5069545|P1|One Year Post-transplant|Converted to rapamycin|1
1554124|NCT00064701|5069543|P3|One Year Post-transplant|Lost to Follow-up|0
1554125|NCT00064701|5069544|P2|One Year Post-transplant|Lost to Follow-up|0
1554126|NCT00064701|5069545|P1|One Year Post-transplant|Lost to Follow-up|1
1554127|NCT00064701|5069543|P3|One Year Post-transplant|Withdrawal by Subject|1
1554128|NCT00064701|5069544|P2|One Year Post-transplant|Withdrawal by Subject|4
1554129|NCT00064701|5069545|P1|One Year Post-transplant|Withdrawal by Subject|0
1554130|NCT00064701|5069543|P3|One Year Post-transplant|Graft Failure|1
1554131|NCT00064701|5069544|P2|One Year Post-transplant|Graft Failure|2
1554132|NCT00064701|5069545|P1|One Year Post-transplant|Graft Failure|3
1554133|NCT00064701|5069543|P3|One Year Post-transplant|Non-compliance|5
1554134|NCT00064701|5069544|P2|One Year Post-transplant|Non-compliance|2
1554135|NCT00064701|5069545|P1|One Year Post-transplant|Non-compliance|4
1554136|NCT00064701|5069543|P3|One Year Post-transplant|Rejection|16
1554137|NCT00064701|5069544|P2|One Year Post-transplant|Rejection|1
1554138|NCT00064701|5069545|P1|One Year Post-transplant|Rejection|0
1554139|NCT00064701|5069543|P3|One Year Post-transplant|Adverse Event|37
1554140|NCT00064701|5069544|P2|One Year Post-transplant|Adverse Event|19
1554141|NCT00064701|5069545|P1|One Year Post-transplant|Adverse Event|23
1554142|NCT00064701|5069543|P3|One Year Post-transplant|Did not receive study drug|11
1554143|NCT00064701|5069544|P2|One Year Post-transplant|Did not receive study drug|12
1554144|NCT00064701|5069545|P1|One Year Post-transplant|Did not receive study drug|7
1554145|NCT00064662|5069597|P2|Overall Study|Administratively withdrawn|2
1554146|NCT00064662|5069598|P1|Overall Study|Administratively withdrawn|2
1554147|NCT00064662|5069597|P2|Overall Study|Withdrawal by Subject|14
1554148|NCT00064662|5069598|P1|Overall Study|Withdrawal by Subject|14
1554149|NCT00064662|5069597|P2|Overall Study|Lost to Follow-up|44
1554150|NCT00064662|5069598|P1|Overall Study|Lost to Follow-up|57
1554151|NCT00064662|5069597|P2|Overall Study|Death|1
1554152|NCT00064662|5069598|P1|Overall Study|Death|1
1554153|NCT00064350|5069609|P3|Cross-Over|Other|0
1554154|NCT00064350|5069610|P2|Cross-Over|Other|2
1554155|NCT00064350|5069611|P1|Cross-Over|Other|0
1554156|NCT00064350|5069609|P3|Cross-Over|Ineligible or never started treatment|0
1554157|NCT00064350|5069610|P2|Cross-Over|Ineligible or never started treatment|6
1554158|NCT00064350|5069611|P1|Cross-Over|Ineligible or never started treatment|3
1554159|NCT00064350|5069609|P3|Cross-Over|Withdrawal by Subject|0
1554160|NCT00064350|5069610|P2|Cross-Over|Withdrawal by Subject|2
1554161|NCT00064350|5069611|P1|Cross-Over|Withdrawal by Subject|2
1554162|NCT00064350|5069609|P3|Cross-Over|Death|0
1554163|NCT00064350|5069610|P2|Cross-Over|Death|3
1554164|NCT00064350|5069611|P1|Cross-Over|Death|1
1554165|NCT00064350|5069609|P3|Cross-Over|Adverse Event|0
1554166|NCT00064350|5069610|P2|Cross-Over|Adverse Event|1
1554167|NCT00064350|5069611|P1|Cross-Over|Adverse Event|0
1554168|NCT00064350|5069609|P3|Randomization|Other|0
1554169|NCT00064350|5069610|P2|Randomization|Other|0
1554170|NCT00064350|5069611|P1|Randomization|Other|5
1554171|NCT00064350|5069609|P3|Randomization|Ineligible or never started treatment|0
1554172|NCT00064350|5069610|P2|Randomization|Ineligible or never started treatment|15
1554173|NCT00064350|5069611|P1|Randomization|Ineligible or never started treatment|9
1554174|NCT00064350|5069609|P3|Randomization|Withdrawal by Subject|0
1554175|NCT00064350|5069610|P2|Randomization|Withdrawal by Subject|0
1554176|NCT00064350|5069611|P1|Randomization|Withdrawal by Subject|1
1554177|NCT00064350|5069609|P3|Randomization|Death|0
1554178|NCT00064350|5069610|P2|Randomization|Death|0
1554179|NCT00064350|5069611|P1|Randomization|Death|3
1554180|NCT00064350|5069609|P3|Randomization|Adverse Event|0
1554181|NCT00064350|5069610|P2|Randomization|Adverse Event|3
1554182|NCT00064350|5069611|P1|Randomization|Adverse Event|8
1554183|NCT00064350|5069609|P3|Induction Treatment|Other|13
1554184|NCT00064350|5069610|P2|Induction Treatment|Other|0
1554185|NCT00064350|5069611|P1|Induction Treatment|Other|0
1554186|NCT00064350|5069609|P3|Induction Treatment|Ineligible or never started treatment|34
1554187|NCT00064350|5069610|P2|Induction Treatment|Ineligible or never started treatment|6
1554188|NCT00064350|5069611|P1|Induction Treatment|Ineligible or never started treatment|3
1554189|NCT00064350|5069609|P3|Induction Treatment|Withdrawal by Subject|21
1554190|NCT00064350|5069610|P2|Induction Treatment|Withdrawal by Subject|0
1554191|NCT00064350|5069611|P1|Induction Treatment|Withdrawal by Subject|0
1554192|NCT00064350|5069609|P3|Induction Treatment|Death|9
1554193|NCT00064350|5069610|P2|Induction Treatment|Death|0
1554194|NCT00064350|5069611|P1|Induction Treatment|Death|0
1554195|NCT00064350|5069609|P3|Induction Treatment|Adverse Event|49
1554196|NCT00064350|5069610|P2|Induction Treatment|Adverse Event|2
1554197|NCT00064350|5069611|P1|Induction Treatment|Adverse Event|0
1554198|NCT00064350|5069609|P3|Induction Treatment|Disease Progression|110
1554199|NCT00064350|5069610|P2|Induction Treatment|Disease Progression|1
1554200|NCT00064350|5069611|P1|Induction Treatment|Disease Progression|5
1554201|NCT00064337|5069626|P1|Maintenance|Death|1
1554202|NCT00064337|5069626|P1|Maintenance|Not protocol-specified|2
1554203|NCT00064337|5069626|P1|Maintenance|On treatment at time of analysis|2
1554204|NCT00064337|5069626|P1|Maintenance|Progression|2
1554205|NCT00064337|5069626|P1|Maintenance|Adverse Event|3
1554206|NCT00064337|5069626|P1|Transplant|Progression|2
1554207|NCT00064337|5069626|P1|Transplant|Patient Refusal|2
1554208|NCT00064337|5069626|P1|Transplant|Death|3
1554209|NCT00064337|5069626|P1|Transplant|Not protocol-specified|5
1554210|NCT00064337|5069626|P1|Transplant|Adverse Event|9
1554211|NCT00064337|5069626|P1|PBSCC or Induction/PBSCC|Death|2
1554212|NCT00064337|5069626|P1|PBSCC or Induction/PBSCC|Patient Refusal|2
1554213|NCT00064337|5069626|P1|PBSCC or Induction/PBSCC|Progression|3
1554214|NCT00064337|5069626|P1|PBSCC or Induction/PBSCC|Adverse Event|6
1554215|NCT00064337|5069626|P1|PBSCC or Induction/PBSCC|Not protocol-specified|7
1554216|NCT00064298|5069635|P2|Overall Study|Disease Progression|1
1554217|NCT00064298|5069636|P1|Overall Study|Disease Progression|2
1554218|NCT00064298|5069635|P2|Overall Study|Death|1
1554219|NCT00064298|5069636|P1|Overall Study|Death|0
1554220|NCT00064298|5069635|P2|Overall Study|Lost to Follow-up|2
1554221|NCT00064298|5069636|P1|Overall Study|Lost to Follow-up|2
1554222|NCT00064298|5069635|P2|Overall Study|Withdrawal by Subject|1
1554223|NCT00064298|5069636|P1|Overall Study|Withdrawal by Subject|2
1554224|NCT00064259|5069644|P4|Overall Study|Adverse Event|1
1554225|NCT00064259|5069645|P3|Overall Study|Adverse Event|0
1554226|NCT00064259|5069646|P2|Overall Study|Adverse Event|0
1554227|NCT00064259|5069647|P1|Overall Study|Adverse Event|1
1554228|NCT00064077|5069655|P4|Overall Study|Other reasons|2
1554229|NCT00064077|5069656|P3|Overall Study|Other reasons|1
1554230|NCT00064077|5069657|P2|Overall Study|Other reasons|2
1554231|NCT00064077|5069658|P1|Overall Study|Other reasons|2
1554232|NCT00064077|5069655|P4|Overall Study|No tumor|0
1554233|NCT00064077|5069656|P3|Overall Study|No tumor|1
1554234|NCT00064077|5069657|P2|Overall Study|No tumor|0
1554235|NCT00064077|5069658|P1|Overall Study|No tumor|0
1554236|NCT00064077|5069655|P4|Overall Study|No surgery|0
1554237|NCT00064077|5069656|P3|Overall Study|No surgery|1
1554238|NCT00064077|5069657|P2|Overall Study|No surgery|0
1554239|NCT00064077|5069658|P1|Overall Study|No surgery|0
1554240|NCT00064077|5069655|P4|Overall Study|Pathology|4
1554241|NCT00064077|5069656|P3|Overall Study|Pathology|3
1554242|NCT00064077|5069657|P2|Overall Study|Pathology|7
1554243|NCT00064077|5069658|P1|Overall Study|Pathology|10
1554244|NCT00064077|5069655|P4|Overall Study|Poor risk|1
1554245|NCT00064077|5069656|P3|Overall Study|Poor risk|1
1554246|NCT00064077|5069657|P2|Overall Study|Poor risk|0
1554247|NCT00064077|5069658|P1|Overall Study|Poor risk|2
1554248|NCT00064077|5069655|P4|Overall Study|Improper prior treatment|0
1554249|NCT00064077|5069656|P3|Overall Study|Improper prior treatment|0
1554250|NCT00064077|5069657|P2|Overall Study|Improper prior treatment|0
1554251|NCT00064077|5069658|P1|Overall Study|Improper prior treatment|1
1554252|NCT00064025|5069702|P1|Overall Study|Inevaluable|3
1554253|NCT00064025|5069702|P1|Overall Study|Ineligible|4
1554254|NCT00063999|5069711|P2|Overall Study|Ineligible|24
1554255|NCT00063999|5069712|P1|Overall Study|Ineligible|44
1554256|NCT00063999|5069711|P2|Overall Study|Withdrawal by Subject|0
1554257|NCT00063999|5069712|P1|Overall Study|Withdrawal by Subject|1
1554258|NCT00063986|5069728|P1|Overall Study|Intra-operatively ineligible|4
1554259|NCT00063986|5069728|P1|Overall Study|Ineligible|1
1554260|NCT00063986|5069728|P1|Overall Study|Withdrawal by Subject|1
1554261|NCT00063934|5069740|P1|Overall Study|Ineligible|1
1554262|NCT00063258|5069845|P2|Overall Study|Lack of Efficacy|0
1554263|NCT00063258|5069846|P1|Overall Study|Lack of Efficacy|2
1554264|NCT00063258|5069845|P2|Overall Study|Physician Decision|0
1554265|NCT00063258|5069846|P1|Overall Study|Physician Decision|2
1554266|NCT00063154|5069852|P1|Overall Study|Did not receive treatment|8
1554267|NCT00063154|5069852|P1|Overall Study|Reason unspecified|1
1554268|NCT00063154|5069852|P1|Overall Study|Death|3
1554269|NCT00063154|5069852|P1|Overall Study|Physician Decision|10
1554270|NCT00063154|5069852|P1|Overall Study|Adverse Event|2
1554271|NCT00063154|5069852|P1|Overall Study|Disease progression|27
1554272|NCT00062751|5069878|P5|Overall Study|Death|0
1554273|NCT00062751|5069879|P4|Overall Study|Death|0
1554274|NCT00062751|5069880|P3|Overall Study|Death|1
1554275|NCT00062751|5069881|P2|Overall Study|Death|0
1554276|NCT00062751|5069882|P1|Overall Study|Death|1
1554277|NCT00062751|5069878|P5|Overall Study|Symptomatic deterioration|1
1554278|NCT00062751|5069879|P4|Overall Study|Symptomatic deterioration|0
1554279|NCT00062751|5069880|P3|Overall Study|Symptomatic deterioration|0
1554280|NCT00062751|5069881|P2|Overall Study|Symptomatic deterioration|1
1554281|NCT00062751|5069882|P1|Overall Study|Symptomatic deterioration|1
1554282|NCT00062751|5069878|P5|Overall Study|Withdrawal by Subject|0
1554283|NCT00062751|5069879|P4|Overall Study|Withdrawal by Subject|1
1554284|NCT00062751|5069880|P3|Overall Study|Withdrawal by Subject|2
1554285|NCT00062751|5069881|P2|Overall Study|Withdrawal by Subject|2
1554286|NCT00062751|5069882|P1|Overall Study|Withdrawal by Subject|1
1554287|NCT00062751|5069878|P5|Overall Study|Other|1
1554288|NCT00062751|5069879|P4|Overall Study|Other|0
1554289|NCT00062751|5069880|P3|Overall Study|Other|1
1554290|NCT00062751|5069881|P2|Overall Study|Other|3
1554291|NCT00062751|5069882|P1|Overall Study|Other|2
1554292|NCT00062751|5069878|P5|Overall Study|Adverse Event|2
1554293|NCT00062751|5069879|P4|Overall Study|Adverse Event|2
1554294|NCT00062751|5069880|P3|Overall Study|Adverse Event|2
1554295|NCT00062751|5069881|P2|Overall Study|Adverse Event|7
1554296|NCT00062751|5069882|P1|Overall Study|Adverse Event|4
1554297|NCT00062751|5069878|P5|Overall Study|Disease progression|2
1554298|NCT00062751|5069879|P4|Overall Study|Disease progression|2
1554299|NCT00062751|5069880|P3|Overall Study|Disease progression|24
1554300|NCT00062751|5069881|P2|Overall Study|Disease progression|17
1554301|NCT00062751|5069882|P1|Overall Study|Disease progression|24
1554302|NCT00062647|5069968|P2|Overall Study|Never received study treatment|1
1554303|NCT00062647|5069969|P1|Overall Study|Never received study treatment|1
1554304|NCT00062647|5069968|P2|Overall Study|Other|4
1554305|NCT00062647|5069969|P1|Overall Study|Other|4
1554306|NCT00062647|5069968|P2|Overall Study|Failed continuation criteria|2
1554307|NCT00062647|5069969|P1|Overall Study|Failed continuation criteria|4
1554308|NCT00062647|5069968|P2|Overall Study|Lost to Follow-up|2
1554309|NCT00062647|5069969|P1|Overall Study|Lost to Follow-up|1
1554310|NCT00062647|5069968|P2|Overall Study|Protocol Violation|0
1554311|NCT00062647|5069969|P1|Overall Study|Protocol Violation|1
1554312|NCT00062647|5069968|P2|Overall Study|Withdrawal by Subject|1
1554313|NCT00062647|5069969|P1|Overall Study|Withdrawal by Subject|2
1554314|NCT00062647|5069968|P2|Overall Study|Adverse Event|1
1554315|NCT00062647|5069969|P1|Overall Study|Adverse Event|1
1554316|NCT00062647|5069968|P2|Overall Study|Death|2
1554317|NCT00062647|5069969|P1|Overall Study|Death|2
1554318|NCT00062439|5069975|P1|Consolidation Chemotherapy|Adverse Event|2
1554319|NCT00062439|5069975|P1|Surgery|Adverse Event|2
1554320|NCT00062439|5069975|P1|Surgery|Death|1
1554321|NCT00062439|5069975|P1|Surgery|Physician Decision|4
1554322|NCT00062439|5069975|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
1554323|NCT00062439|5069975|P1|Post Chemoradiation Assessment|Physician Decision|1
1554324|NCT00062439|5069975|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
1554325|NCT00062439|5069975|P1|Post Chemoradiation Assessment|Disease progression|2
1554326|NCT00062439|5069975|P1|Post Chemoradiation Assessment|Death|1
1554327|NCT00062439|5069975|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
1554328|NCT00062439|5069975|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
1554329|NCT00062439|5069975|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
1554330|NCT00062439|5069975|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
1554331|NCT00062374|5069987|P1|Overall Study|Not treated|12
1554332|NCT00062010|5069992|P1|Overall Study|Ineligible|3
1554333|NCT00061945|5070000|P2|Course IV: Alemtuzumab|Early exits|15
1554334|NCT00061945|5070001|P1|Course IV: Alemtuzumab|Early exits|6
1554335|NCT00061945|5070000|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
1554336|NCT00061945|5070001|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
1554337|NCT00061945|5070000|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
1554338|NCT00061945|5070001|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
1554339|NCT00061945|5070000|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
1554340|NCT00061945|5070001|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
1554341|NCT00061932|5070011|P2|Overall Study|Withdrawal by Subject|4
1554342|NCT00061932|5070012|P1|Overall Study|Withdrawal by Subject|13
1554343|NCT00061633|5070025|P2|Overall Study|Never received study treatment|2
1554344|NCT00061633|5070026|P1|Overall Study|Never received study treatment|0
1554345|NCT00061633|5070025|P2|Overall Study|Other|1
1554346|NCT00061633|5070026|P1|Overall Study|Other|1
1554347|NCT00061633|5070025|P2|Overall Study|Lost to Follow-up|4
1554348|NCT00061633|5070026|P1|Overall Study|Lost to Follow-up|1
1554349|NCT00061633|5070025|P2|Overall Study|Withdrawal by Subject|2
1554350|NCT00061633|5070026|P1|Overall Study|Withdrawal by Subject|2
1554351|NCT00061633|5070025|P2|Overall Study|Adverse Event|2
1554352|NCT00061633|5070026|P1|Overall Study|Adverse Event|1
1554353|NCT00061048|5070051|P1|Overall Study|disease progression|20
1554354|NCT00061048|5070051|P1|Overall Study|Adverse Event|2
1554355|NCT00060944|5070061|P2|Overall Study|randomized but not treated|4
1554356|NCT00060944|5070062|P1|Overall Study|randomized but not treated|6
1554357|NCT00060944|5070061|P2|Overall Study|Not specified|4
1554358|NCT00060944|5070062|P1|Overall Study|Not specified|2
1554359|NCT00060944|5070061|P2|Overall Study|Treatment Switch|13
1554360|NCT00060944|5070062|P1|Overall Study|Treatment Switch|0
1554361|NCT00060944|5070061|P2|Overall Study|Subject Ineligible To Continue|1
1554362|NCT00060944|5070062|P1|Overall Study|Subject Ineligible To Continue|2
1554363|NCT00060944|5070061|P2|Overall Study|Lost to Follow-up|0
1554364|NCT00060944|5070062|P1|Overall Study|Lost to Follow-up|1
1554365|NCT00060944|5070061|P2|Overall Study|Disease Progression|94
1554366|NCT00060944|5070062|P1|Overall Study|Disease Progression|93
1554367|NCT00060944|5070061|P2|Overall Study|Withdrawal by Subject|5
1554368|NCT00060944|5070062|P1|Overall Study|Withdrawal by Subject|18
1554369|NCT00060944|5070061|P2|Overall Study|Death|3
1554370|NCT00060944|5070062|P1|Overall Study|Death|2
1554371|NCT00060944|5070061|P2|Overall Study|Adverse Event|10
1554372|NCT00060944|5070062|P1|Overall Study|Adverse Event|12
1554373|NCT00060840|5070078|P2|Overall Study|Other|0
1554374|NCT00060840|5070079|P1|Overall Study|Other|1
1554375|NCT00060840|5070078|P2|Overall Study|Physician Decision|0
1554376|NCT00060840|5070079|P1|Overall Study|Physician Decision|1
1554377|NCT00060840|5070078|P2|Overall Study|Subinvestigator unavailable|1
1554378|NCT00060840|5070079|P1|Overall Study|Subinvestigator unavailable|0
1554379|NCT00060840|5070078|P2|Overall Study|Withdrawal by Subject|1
1554380|NCT00060840|5070079|P1|Overall Study|Withdrawal by Subject|0
1554381|NCT00060840|5070078|P2|Overall Study|Death|1
1554382|NCT00060840|5070079|P1|Overall Study|Death|0
1554383|NCT00060840|5070078|P2|Overall Study|Change in surgical plan|6
1554384|NCT00060840|5070079|P1|Overall Study|Change in surgical plan|2
1554385|NCT00059839|5070132|P2|Overall Study|Ineligible|3
1554386|NCT00059839|5070133|P1|Overall Study|Ineligible|1
1554387|NCT00059839|5070132|P2|Overall Study|Withdrawal by Subject|6
1554388|NCT00059839|5070133|P1|Overall Study|Withdrawal by Subject|1
1554389|NCT00059839|5070132|P2|Overall Study|Physician Decision|2
1554390|NCT00059839|5070133|P1|Overall Study|Physician Decision|1
1554391|NCT00059839|5070132|P2|Overall Study|Lost to Follow-up|0
1554392|NCT00059839|5070133|P1|Overall Study|Lost to Follow-up|2
1554393|NCT00059839|5070132|P2|Overall Study|Lack of Efficacy|5
1554394|NCT00059839|5070133|P1|Overall Study|Lack of Efficacy|6
1554395|NCT00059839|5070132|P2|Overall Study|Death|1
1554396|NCT00059839|5070133|P1|Overall Study|Death|1
1554397|NCT00059787|5070139|P1|Overall Study|Other|4
1554398|NCT00059787|5070139|P1|Overall Study|ineligible|1
1554399|NCT00059787|5070139|P1|Overall Study|disease progression|2
1554400|NCT00059787|5070139|P1|Overall Study|Adverse Event|13
1554401|NCT00059332|5070190|P2|Overall Study|Lost to Follow-up|1
1554402|NCT00059332|5070191|P1|Overall Study|Lost to Follow-up|1
1554403|NCT00059332|5070190|P2|Overall Study|Withdrawal by Subject|1
1554404|NCT00059332|5070191|P1|Overall Study|Withdrawal by Subject|2
1554405|NCT00059215|5070217|P4|Overall Study|Physician Decision|1
1554406|NCT00059215|5070218|P3|Overall Study|Physician Decision|1
1554407|NCT00059215|5070219|P2|Overall Study|Physician Decision|2
1554408|NCT00059215|5070220|P1|Overall Study|Physician Decision|1
1554409|NCT00059215|5070217|P4|Overall Study|Protocol entry criteria not met|2
1554410|NCT00059215|5070218|P3|Overall Study|Protocol entry criteria not met|0
1554411|NCT00059215|5070219|P2|Overall Study|Protocol entry criteria not met|1
1554412|NCT00059215|5070220|P1|Overall Study|Protocol entry criteria not met|1
1554413|NCT00059215|5070217|P4|Overall Study|Protocol Violation|0
1554414|NCT00059215|5070218|P3|Overall Study|Protocol Violation|1
1554415|NCT00059215|5070219|P2|Overall Study|Protocol Violation|0
1554416|NCT00059215|5070220|P1|Overall Study|Protocol Violation|1
1554417|NCT00059215|5070217|P4|Overall Study|Withdrawal by Subject|3
1554418|NCT00059215|5070218|P3|Overall Study|Withdrawal by Subject|1
1554419|NCT00059215|5070219|P2|Overall Study|Withdrawal by Subject|4
1554420|NCT00059215|5070220|P1|Overall Study|Withdrawal by Subject|4
1554421|NCT00059215|5070217|P4|Overall Study|Lost to Follow-up|0
1554422|NCT00059215|5070218|P3|Overall Study|Lost to Follow-up|0
1554423|NCT00059215|5070219|P2|Overall Study|Lost to Follow-up|2
1554424|NCT00059215|5070220|P1|Overall Study|Lost to Follow-up|1
1554425|NCT00059215|5070217|P4|Overall Study|Death|0
1554426|NCT00059215|5070218|P3|Overall Study|Death|3
1554427|NCT00059215|5070219|P2|Overall Study|Death|0
1554428|NCT00059215|5070220|P1|Overall Study|Death|0
1554429|NCT00059215|5070217|P4|Overall Study|Adverse Event|9
1554430|NCT00059215|5070218|P3|Overall Study|Adverse Event|9
1554431|NCT00059215|5070219|P2|Overall Study|Adverse Event|5
1554432|NCT00059215|5070220|P1|Overall Study|Adverse Event|5
1554433|NCT00058825|5070257|P1|Overall Study|Death|3
1554434|NCT00058825|5070257|P1|Overall Study|Graft Failure|5
1554435|NCT00058825|5070257|P1|Overall Study|Progressive Disease|5
1554436|NCT00058825|5070257|P1|Overall Study|Relapse|9
1554437|NCT00058552|5070273|P2|Overall Study|Clinical disease progression|4
1554438|NCT00058552|5070274|P1|Overall Study|Clinical disease progression|0
1554439|NCT00058552|5070273|P2|Overall Study|Physician Decision|5
1554440|NCT00058552|5070274|P1|Overall Study|Physician Decision|2
1554441|NCT00058552|5070273|P2|Overall Study|Withdrawal by Subject|5
1554442|NCT00058552|5070274|P1|Overall Study|Withdrawal by Subject|3
1554443|NCT00058552|5070273|P2|Overall Study|Adverse Event|2
1554444|NCT00058552|5070274|P1|Overall Study|Adverse Event|4
1554445|NCT00058552|5070273|P2|Overall Study|Disease progression|44
1554446|NCT00058552|5070274|P1|Overall Study|Disease progression|52
1554447|NCT00058552|5070273|P2|Overall Study|Died prior to receiving treatment|2
1554448|NCT00058552|5070274|P1|Overall Study|Died prior to receiving treatment|4
1554449|NCT00058539|5070292|P1|Overall Study|Death|1
1554450|NCT00058539|5070292|P1|Overall Study|Physician Decision|9
1554451|NCT00058539|5070292|P1|Overall Study|Withdrawal by Subject|5
1554452|NCT00058539|5070292|P1|Overall Study|Adverse Event|3
1554453|NCT00058539|5070292|P1|Overall Study|Disease progression|24
1554454|NCT00058214|5070319|P1|Overall Study|Adverse Event|1
1554455|NCT00058123|5070324|P1|Overall Study|Received >3 prior treatments|1
1554456|NCT00058123|5070324|P1|Overall Study|Wrong histology|9
1554457|NCT00058058|5070331|P1|Overall Study|Poor positioning, illness,pain|3
1554458|NCT00058058|5070331|P1|Overall Study|technical issues|6
1554459|NCT00058058|5070331|P1|Overall Study|Claustrophobic|5
1554460|NCT00058058|5070331|P1|Overall Study|Ineligible|20
1554461|NCT00058058|5070331|P1|Overall Study|Withdrawal by Subject|4
1554462|NCT00057954|5070356|P1|Overall Study|Disease progression|1
1554463|NCT00057954|5070356|P1|Overall Study|Death|1
1554464|NCT00057941|5070364|P2|Overall Study|Ineligible|5
1554465|NCT00057941|5070365|P1|Overall Study|Ineligible|2
1554466|NCT00057941|5070364|P2|Overall Study|insurance, symptomatic deterioration|3
1554467|NCT00057941|5070365|P1|Overall Study|insurance, symptomatic deterioration|1
1554468|NCT00057941|5070364|P2|Overall Study|still on treatment|1
1554469|NCT00057941|5070365|P1|Overall Study|still on treatment|3
1554470|NCT00057941|5070364|P2|Overall Study|Withdrawal by Subject|1
1554471|NCT00057941|5070365|P1|Overall Study|Withdrawal by Subject|6
1554472|NCT00057941|5070364|P2|Overall Study|Lack of Efficacy|53
1554473|NCT00057941|5070365|P1|Overall Study|Lack of Efficacy|54
1554474|NCT00057941|5070364|P2|Overall Study|Adverse Event|9
1554475|NCT00057941|5070365|P1|Overall Study|Adverse Event|7
1554476|NCT00057941|5070364|P2|Overall Study|Death|2
1554477|NCT00057941|5070365|P1|Overall Study|Death|1
1554478|NCT00057876|5070373|P2|Overall Study|other complicating disease|0
1554479|NCT00057876|5070374|P1|Overall Study|other complicating disease|1
1554480|NCT00057876|5070373|P2|Overall Study|other reason|2
1554481|NCT00057876|5070374|P1|Overall Study|other reason|2
1554482|NCT00057876|5070373|P2|Overall Study|Ineligible|2
1554483|NCT00057876|5070374|P1|Overall Study|Ineligible|1
1554484|NCT00057876|5070373|P2|Overall Study|Lack of Efficacy|8
1554485|NCT00057876|5070374|P1|Overall Study|Lack of Efficacy|10
1554486|NCT00057876|5070373|P2|Overall Study|Withdrawal by Subject|6
1554487|NCT00057876|5070374|P1|Overall Study|Withdrawal by Subject|5
1554488|NCT00057876|5070373|P2|Overall Study|Death|1
1554489|NCT00057876|5070374|P1|Overall Study|Death|2
1554490|NCT00057876|5070373|P2|Overall Study|Adverse Event|8
1554491|NCT00057876|5070374|P1|Overall Study|Adverse Event|8
1554492|NCT00057863|5070384|P1|Overall Study|Withdrawal by Subject|2
1554493|NCT00057863|5070384|P1|Overall Study|Death|1
1554494|NCT00057837|5070393|P2|Overall Study|Never started treatment|1
1554495|NCT00057837|5070394|P1|Overall Study|Never started treatment|1
1554496|NCT00057837|5070393|P2|Overall Study|Ineligible|3
1554497|NCT00057837|5070394|P1|Overall Study|Ineligible|3
1554498|NCT00057837|5070393|P2|Overall Study|Physician Decision|0
1554499|NCT00057837|5070394|P1|Overall Study|Physician Decision|1
1554500|NCT00057837|5070393|P2|Overall Study|Other complicating disease|1
1554501|NCT00057837|5070394|P1|Overall Study|Other complicating disease|2
1554502|NCT00057837|5070393|P2|Overall Study|Alternative therapy|1
1554503|NCT00057837|5070394|P1|Overall Study|Alternative therapy|0
1554504|NCT00057837|5070393|P2|Overall Study|Withdrawal by Subject|3
1554505|NCT00057837|5070394|P1|Overall Study|Withdrawal by Subject|5
1554506|NCT00057837|5070393|P2|Overall Study|Death|4
1554507|NCT00057837|5070394|P1|Overall Study|Death|5
1554508|NCT00057837|5070393|P2|Overall Study|Adverse Event|12
1554509|NCT00057837|5070394|P1|Overall Study|Adverse Event|2
1554510|NCT00057837|5070393|P2|Overall Study|Progression/relapse|14
1554511|NCT00057837|5070394|P1|Overall Study|Progression/relapse|12
1554512|NCT00057811|5070406|P2|Overall Study|Inevaluable|2
1554513|NCT00057811|5070407|P1|Overall Study|Inevaluable|1
1554514|NCT00057811|5070406|P2|Overall Study|Ineligible|2
1554515|NCT00057811|5070407|P1|Overall Study|Ineligible|4
1554516|NCT00057811|5070406|P2|Overall Study|Withdrawal by Subject|4
1554517|NCT00057811|5070407|P1|Overall Study|Withdrawal by Subject|3
1554518|NCT00057811|5070406|P2|Overall Study|Physician Decision|0
1554519|NCT00057811|5070407|P1|Overall Study|Physician Decision|1
1554520|NCT00057811|5070406|P2|Overall Study|Lack of Efficacy|4
1554521|NCT00057811|5070407|P1|Overall Study|Lack of Efficacy|1
1554522|NCT00057746|5070426|P3|Overall Study|Withdrawal by Subject|1
1554523|NCT00057746|5070427|P2|Overall Study|Withdrawal by Subject|0
1554524|NCT00057746|5070428|P1|Overall Study|Withdrawal by Subject|0
1554525|NCT00023673|5070439|P4|Overall Study|Patient withdrew consent|1
1554526|NCT00023673|5070440|P3|Overall Study|Patient withdrew consent|0
1554527|NCT00023673|5070441|P2|Overall Study|Patient withdrew consent|0
1554528|NCT00023673|5070442|P1|Overall Study|Patient withdrew consent|0
1554529|NCT00023673|5070439|P4|Overall Study|Ineligible / no protocol treatment|1
1554530|NCT00023673|5070440|P3|Overall Study|Ineligible / no protocol treatment|0
1554531|NCT00023673|5070441|P2|Overall Study|Ineligible / no protocol treatment|0
1554532|NCT00023673|5070442|P1|Overall Study|Ineligible / no protocol treatment|0
1554533|NCT00057330|5070506|P2|Overall Study|Other|206
1554534|NCT00057330|5070507|P1|Overall Study|Other|260
1554535|NCT00057330|5070506|P2|Overall Study|Physician Decision|0
1554536|NCT00057330|5070507|P1|Overall Study|Physician Decision|1
1554537|NCT00057330|5070506|P2|Overall Study|Lost to Follow-up|617
1554538|NCT00057330|5070507|P1|Overall Study|Lost to Follow-up|745
1554539|NCT00057330|5070506|P2|Overall Study|Withdrawal by Subject|84
1554540|NCT00057330|5070507|P1|Overall Study|Withdrawal by Subject|115
1554541|NCT00057330|5070506|P2|Overall Study|Protocol Violation|1
1554542|NCT00057330|5070507|P1|Overall Study|Protocol Violation|1
1554543|NCT00057330|5070506|P2|Overall Study|Death|0
1554544|NCT00057330|5070507|P1|Overall Study|Death|1
1554545|NCT00057330|5070506|P2|Overall Study|Adverse Event|12
1554546|NCT00057330|5070507|P1|Overall Study|Adverse Event|9
1554547|NCT00056862|5070537|P2|Overall Study|Protocol Violation|0
1554548|NCT00056862|5070538|P1|Overall Study|Protocol Violation|1
1554549|NCT00056407|5070596|P2|Overall Study|Missing|34
1554550|NCT00056407|5070597|P1|Overall Study|Missing|25
1554551|NCT00056407|5070596|P2|Overall Study|"Listed as Other on Case Report Form"|60
1554552|NCT00056407|5070597|P1|Overall Study|"Listed as Other on Case Report Form"|98
1554553|NCT00056407|5070596|P2|Overall Study|Diagnosed with Prostate Cancer|166
1554554|NCT00056407|5070597|P1|Overall Study|Diagnosed with Prostate Cancer|202
1554555|NCT00056407|5070596|P2|Overall Study|Protocol Violation|95
1554556|NCT00056407|5070597|P1|Overall Study|Protocol Violation|104
1554557|NCT00056407|5070596|P2|Overall Study|Lost to Follow-up|113
1554558|NCT00056407|5070597|P1|Overall Study|Lost to Follow-up|123
1554559|NCT00056407|5070596|P2|Overall Study|Withdrawal by Subject|361
1554560|NCT00056407|5070597|P1|Overall Study|Withdrawal by Subject|377
1554561|NCT00056407|5070596|P2|Overall Study|Adverse Event|364
1554562|NCT00056407|5070597|P1|Overall Study|Adverse Event|282
1554563|NCT00056316|5070655|P2|Overall Study|Death/NH placement of pt|1
1554564|NCT00056316|5070656|P1|Overall Study|Death/NH placement of pt|1
1554565|NCT00056316|5070655|P2|Overall Study|Withdrawal by Subject|2
1554566|NCT00056316|5070656|P1|Overall Study|Withdrawal by Subject|2
1554567|NCT00056160|5070670|P2|Final Follow-up|Adverse Event|0
1554568|NCT00056160|5070671|P1|Final Follow-up|Adverse Event|1
1554569|NCT00056160|5070670|P2|Final Follow-up|Transferred into RevAssist Program|0
1554570|NCT00056160|5070671|P1|Final Follow-up|Transferred into RevAssist Program|2
1554571|NCT00056160|5070670|P2|Final Follow-up|Transferred into expanded access study.|0
1554572|NCT00056160|5070671|P1|Final Follow-up|Transferred into expanded access study.|3
1554573|NCT00056160|5070670|P2|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|0
1554574|NCT00056160|5070671|P1|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|21
1554575|NCT00056160|5070670|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
1554576|NCT00056160|5070671|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
1554577|NCT00056160|5070670|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
1554578|NCT00056160|5070671|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
1554579|NCT00056160|5070670|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
1554580|NCT00056160|5070671|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
1554581|NCT00056160|5070670|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
1554582|NCT00056160|5070671|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
1554583|NCT00056160|5070670|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
1554584|NCT00056160|5070671|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
1554585|NCT00056160|5070670|P2|Up to Unblinding (07 Jun 2005)|Not specified|7
1554586|NCT00056160|5070671|P1|Up to Unblinding (07 Jun 2005)|Not specified|8
1554587|NCT00056160|5070670|P2|Up to Unblinding (07 Jun 2005)|Death|1
1554588|NCT00056160|5070671|P1|Up to Unblinding (07 Jun 2005)|Death|2
1554589|NCT00056160|5070670|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
1554590|NCT00056160|5070671|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
1554591|NCT00056160|5070670|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
1554592|NCT00056160|5070671|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
1554593|NCT00056160|5070670|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
1554594|NCT00056160|5070671|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
1554595|NCT00056160|5070670|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
1554596|NCT00056160|5070671|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
1554597|NCT00055601|5070694|P2|Overall Study|No protocol treatment received|1
1554598|NCT00055601|5070695|P1|Overall Study|No protocol treatment received|1
1554599|NCT00055601|5070694|P2|Overall Study|Protocol Violation|1
1554600|NCT00055601|5070695|P1|Overall Study|Protocol Violation|1
1554601|NCT00055497|5070709|P4|Overall Study|Other|11
1554602|NCT00055497|5070710|P3|Overall Study|Other|0
1554603|NCT00055497|5070711|P2|Overall Study|Other|0
1554604|NCT00055497|5070712|P1|Overall Study|Other|0
1554605|NCT00055497|5070709|P4|Overall Study|Administrative Reasons|1
1554606|NCT00055497|5070710|P3|Overall Study|Administrative Reasons|0
1554607|NCT00055497|5070711|P2|Overall Study|Administrative Reasons|0
1554608|NCT00055497|5070712|P1|Overall Study|Administrative Reasons|0
1554609|NCT00055497|5070709|P4|Overall Study|Lack of Efficacy|27
1554610|NCT00055497|5070710|P3|Overall Study|Lack of Efficacy|0
1554611|NCT00055497|5070711|P2|Overall Study|Lack of Efficacy|0
1554612|NCT00055497|5070712|P1|Overall Study|Lack of Efficacy|1
1554613|NCT00055497|5070709|P4|Overall Study|Protocol Violation|3
1554614|NCT00055497|5070710|P3|Overall Study|Protocol Violation|0
1554615|NCT00055497|5070711|P2|Overall Study|Protocol Violation|0
1554616|NCT00055497|5070712|P1|Overall Study|Protocol Violation|0
1554617|NCT00055497|5070709|P4|Overall Study|Lost to Follow-up|5
1554618|NCT00055497|5070710|P3|Overall Study|Lost to Follow-up|0
1554619|NCT00055497|5070711|P2|Overall Study|Lost to Follow-up|1
1554620|NCT00055497|5070712|P1|Overall Study|Lost to Follow-up|0
1554621|NCT00055497|5070709|P4|Overall Study|Withdrawal by Subject|15
1554622|NCT00055497|5070710|P3|Overall Study|Withdrawal by Subject|1
1554623|NCT00055497|5070711|P2|Overall Study|Withdrawal by Subject|1
1554624|NCT00055497|5070712|P1|Overall Study|Withdrawal by Subject|3
1554625|NCT00055497|5070709|P4|Overall Study|Adverse Event|28
1554626|NCT00055497|5070710|P3|Overall Study|Adverse Event|1
1554627|NCT00055497|5070711|P2|Overall Study|Adverse Event|1
1554628|NCT00055497|5070712|P1|Overall Study|Adverse Event|1
1554629|NCT00055471|5070757|P3|Period 1: Dose Escalation Period|Disease progression|0
1554630|NCT00055471|5070758|P2|Period 1: Dose Escalation Period|Disease progression|1
1554631|NCT00055471|5070759|P1|Period 1: Dose Escalation Period|Disease progression|0
1554632|NCT00055471|5070757|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
1554633|NCT00055471|5070758|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
1554634|NCT00055471|5070759|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
1554635|NCT00055471|5070757|P3|Period 1: Dose Escalation Period|Adverse Event|2
1554636|NCT00055471|5070758|P2|Period 1: Dose Escalation Period|Adverse Event|1
1554637|NCT00055471|5070759|P1|Period 1: Dose Escalation Period|Adverse Event|0
1554638|NCT00054717|5070814|P2|Overall Study|Other reason not defined above|217
1554639|NCT00054717|5070815|P1|Overall Study|Other reason not defined above|117
1554640|NCT00054717|5070814|P2|Overall Study|Withdrawal by Subject|20
1554641|NCT00054717|5070815|P1|Overall Study|Withdrawal by Subject|32
1554642|NCT00054717|5070814|P2|Overall Study|Lost to Follow-up|13
1554643|NCT00054717|5070815|P1|Overall Study|Lost to Follow-up|23
1554644|NCT00054717|5070814|P2|Overall Study|Protocol Violation|19
1554645|NCT00054717|5070815|P1|Overall Study|Protocol Violation|18
1554646|NCT00054717|5070814|P2|Overall Study|Adverse Event|22
1554647|NCT00054717|5070815|P1|Overall Study|Adverse Event|70
1554648|NCT00054717|5070814|P2|Overall Study|Randomized but not treated|8
1554649|NCT00054717|5070815|P1|Overall Study|Randomized but not treated|2
1554650|NCT00054704|5071003|P2|Overall Study|Lost to Follow-up|0
1554651|NCT00054704|5071004|P1|Overall Study|Lost to Follow-up|1
1554652|NCT00054704|5071003|P2|Overall Study|Adverse Event|2
1554653|NCT00054704|5071004|P1|Overall Study|Adverse Event|3
1554654|NCT00054704|5071003|P2|Overall Study|Lack of Efficacy|3
1554655|NCT00054704|5071004|P1|Overall Study|Lack of Efficacy|1
1554656|NCT00054691|5071010|P1|Overall Study|Noncompliant|1
1554657|NCT00054691|5071010|P1|Overall Study|Unmeasurable Disease|2
1554658|NCT00054639|5071024|P1|Overall Study|Physician Decision|1
1554659|NCT00054639|5071024|P1|Overall Study|Lack of Efficacy|1
1554660|NCT00054327|5071057|P6|Overall Study|Engraftment failure|0
1554661|NCT00054327|5071058|P5|Overall Study|Engraftment failure|0
1554662|NCT00054327|5071059|P4|Overall Study|Engraftment failure|0
1554663|NCT00054327|5071060|P3|Overall Study|Engraftment failure|0
1554664|NCT00054327|5071061|P2|Overall Study|Engraftment failure|0
1554665|NCT00054327|5071062|P1|Overall Study|Engraftment failure|1
1554666|NCT00054275|5071100|P1|Overall Study|Physician Decision|1
1554667|NCT00054275|5071100|P1|Overall Study|Progressive disease in cycle 1|1
1554668|NCT00054275|5071100|P1|Overall Study|Adverse Event|5
1554669|NCT00054275|5071100|P1|Overall Study|Withdrawal by Subject|4
1554670|NCT00054132|5071106|P1|Overall Study|Not Treated|1
1554671|NCT00053898|5071125|P2|Overall Study|Follow-up from telephone contact only|1
1554672|NCT00053898|5071126|P1|Overall Study|Follow-up from telephone contact only|5
1554673|NCT00053898|5071125|P2|Overall Study|No follow-up data from any source|12
1554674|NCT00053898|5071126|P1|Overall Study|No follow-up data from any source|9
1554675|NCT00053846|5071150|P2|Overall Study|Pills too large|1
1554676|NCT00053846|5071151|P1|Overall Study|Pills too large|0
1554677|NCT00053846|5071150|P2|Overall Study|Quit due to side effects|3
1554678|NCT00053846|5071151|P1|Overall Study|Quit due to side effects|1
1554679|NCT00053846|5071150|P2|Overall Study|Did not return data|2
1554680|NCT00053846|5071151|P1|Overall Study|Did not return data|1
1554681|NCT00053846|5071150|P2|Overall Study|Became ineligible|1
1554682|NCT00053846|5071151|P1|Overall Study|Became ineligible|3
1554683|NCT00053846|5071150|P2|Overall Study|Expired|0
1554684|NCT00053846|5071151|P1|Overall Study|Expired|5
1554685|NCT00053846|5071150|P2|Overall Study|Became too ill|7
1554686|NCT00053846|5071151|P1|Overall Study|Became too ill|8
1554687|NCT00053846|5071150|P2|Overall Study|Changed mind|13
1554688|NCT00053846|5071151|P1|Overall Study|Changed mind|8
1554689|NCT00053417|5071310|P4|Overall Study|Lost to Follow-up|0
1554690|NCT00053417|5071311|P3|Overall Study|Lost to Follow-up|0
1554691|NCT00053417|5071312|P2|Overall Study|Lost to Follow-up|1
1554692|NCT00053417|5071313|P1|Overall Study|Lost to Follow-up|1
1554693|NCT00053417|5071310|P4|Overall Study|Withdrawal by Subject|0
1554694|NCT00053417|5071311|P3|Overall Study|Withdrawal by Subject|0
1554695|NCT00053417|5071312|P2|Overall Study|Withdrawal by Subject|1
1554696|NCT00053417|5071313|P1|Overall Study|Withdrawal by Subject|0
1554697|NCT00053417|5071310|P4|Overall Study|Non-Compliance|1
1554698|NCT00053417|5071311|P3|Overall Study|Non-Compliance|0
1554699|NCT00053417|5071312|P2|Overall Study|Non-Compliance|0
1554700|NCT00053417|5071313|P1|Overall Study|Non-Compliance|0
1554701|NCT00053417|5071310|P4|Overall Study|Adverse Event|5
1554702|NCT00053417|5071311|P3|Overall Study|Adverse Event|1
1554703|NCT00053417|5071312|P2|Overall Study|Adverse Event|0
1554704|NCT00053417|5071313|P1|Overall Study|Adverse Event|1
1554705|NCT00053365|5071323|P1|Overall Study|Never treated|4
1554706|NCT00053365|5071323|P1|Overall Study|Platinum-sensitive interval >12 months|1
1554707|NCT00053365|5071323|P1|Overall Study|Incorrect cell type|1
1554708|NCT00053352|5071332|P2|Overall Study|Disease at new site|0
1554709|NCT00053352|5071333|P1|Overall Study|Disease at new site|1
1554710|NCT00053352|5071332|P2|Overall Study|Ineligible|8
1554711|NCT00053352|5071333|P1|Overall Study|Ineligible|8
1554712|NCT00053352|5071332|P2|Overall Study|Withdrawal by Subject|0
1554713|NCT00053352|5071333|P1|Overall Study|Withdrawal by Subject|1
1554714|NCT00053352|5071332|P2|Overall Study|Physician Decision|1
1554715|NCT00053352|5071333|P1|Overall Study|Physician Decision|11
1554716|NCT00053352|5071332|P2|Overall Study|Lost to Follow-up|1
1554717|NCT00053352|5071333|P1|Overall Study|Lost to Follow-up|0
1554718|NCT00003830|5071349|P2|Overall Study|Sentinel node positive patients|793
1554719|NCT00003830|5071350|P1|Overall Study|Sentinel node positive patients|829
1554720|NCT00003830|5071349|P2|Overall Study|No follow up data|0
1554721|NCT00003830|5071350|P1|Overall Study|No follow up data|3
1554722|NCT00052962|5071376|P2|Overall Study|Not randomized/not evaluable|0
1554723|NCT00052962|5071377|P1|Overall Study|Not randomized/not evaluable|1
1554724|NCT00052962|5071376|P2|Overall Study|Not evaluable|2
1554725|NCT00052962|5071377|P1|Overall Study|Not evaluable|0
1554726|NCT00052715|5071396|P1|Overall Study|wrong histology|1
1554727|NCT00049543|5071412|P2|Overall Study|still on treatment|9
1554728|NCT00049543|5071413|P1|Overall Study|still on treatment|2
1554729|NCT00049530|5071423|P1|Overall Study|ineligible|3
1554730|NCT00049530|5071423|P1|Overall Study|symptomatic deterioration|1
1554731|NCT00049530|5071423|P1|Overall Study|Death|1
1554732|NCT00049530|5071423|P1|Overall Study|Adverse Event|2
1554733|NCT00049530|5071423|P1|Overall Study|Lack of Efficacy|25
1554734|NCT00049517|5071432|P6|Conditioning/Transplant|Reasons not reported|5
1554735|NCT00049517|5071433|P5|Conditioning/Transplant|Reasons not reported|5
1554736|NCT00049517|5071434|P4|Conditioning/Transplant|Reasons not reported|15
1554737|NCT00049517|5071435|P3|Conditioning/Transplant|Reasons not reported|18
1554738|NCT00049517|5071436|P2|Conditioning/Transplant|Reasons not reported|31
1554739|NCT00049517|5071437|P1|Conditioning/Transplant|Reasons not reported|25
1554740|NCT00049517|5071432|P6|Conditioning/Transplant|Other complicating disease|1
1554741|NCT00049517|5071433|P5|Conditioning/Transplant|Other complicating disease|0
1554742|NCT00049517|5071434|P4|Conditioning/Transplant|Other complicating disease|4
1554743|NCT00049517|5071435|P3|Conditioning/Transplant|Other complicating disease|0
1554744|NCT00049517|5071436|P2|Conditioning/Transplant|Other complicating disease|0
1554745|NCT00049517|5071437|P1|Conditioning/Transplant|Other complicating disease|2
1554746|NCT00049517|5071432|P6|Conditioning/Transplant|Alternative therapy|0
1554747|NCT00049517|5071433|P5|Conditioning/Transplant|Alternative therapy|1
1554748|NCT00049517|5071434|P4|Conditioning/Transplant|Alternative therapy|1
1554749|NCT00049517|5071435|P3|Conditioning/Transplant|Alternative therapy|2
1554750|NCT00049517|5071436|P2|Conditioning/Transplant|Alternative therapy|4
1554751|NCT00049517|5071437|P1|Conditioning/Transplant|Alternative therapy|4
1554752|NCT00049517|5071432|P6|Conditioning/Transplant|Withdrawal by Subject|0
1554753|NCT00049517|5071433|P5|Conditioning/Transplant|Withdrawal by Subject|0
1554754|NCT00049517|5071434|P4|Conditioning/Transplant|Withdrawal by Subject|7
1554755|NCT00049517|5071435|P3|Conditioning/Transplant|Withdrawal by Subject|4
1554756|NCT00049517|5071436|P2|Conditioning/Transplant|Withdrawal by Subject|8
1554757|NCT00049517|5071437|P1|Conditioning/Transplant|Withdrawal by Subject|4
1554758|NCT00049517|5071432|P6|Conditioning/Transplant|Death|0
1554759|NCT00049517|5071433|P5|Conditioning/Transplant|Death|0
1554760|NCT00049517|5071434|P4|Conditioning/Transplant|Death|2
1554761|NCT00049517|5071435|P3|Conditioning/Transplant|Death|0
1554762|NCT00049517|5071436|P2|Conditioning/Transplant|Death|0
1554763|NCT00049517|5071437|P1|Conditioning/Transplant|Death|1
1554764|NCT00049517|5071432|P6|Conditioning/Transplant|Adverse Event|0
1554765|NCT00049517|5071433|P5|Conditioning/Transplant|Adverse Event|0
1554766|NCT00049517|5071434|P4|Conditioning/Transplant|Adverse Event|8
1554767|NCT00049517|5071435|P3|Conditioning/Transplant|Adverse Event|4
1554768|NCT00049517|5071436|P2|Conditioning/Transplant|Adverse Event|1
1554769|NCT00049517|5071437|P1|Conditioning/Transplant|Adverse Event|2
1554770|NCT00049517|5071432|P6|Conditioning/Transplant|Disease progression|0
1554771|NCT00049517|5071433|P5|Conditioning/Transplant|Disease progression|0
1554772|NCT00049517|5071434|P4|Conditioning/Transplant|Disease progression|6
1554773|NCT00049517|5071435|P3|Conditioning/Transplant|Disease progression|10
1554774|NCT00049517|5071436|P2|Conditioning/Transplant|Disease progression|6
1554775|NCT00049517|5071437|P1|Conditioning/Transplant|Disease progression|14
1554776|NCT00049517|5071432|P6|Induction|Reasons not reported|25
1554777|NCT00049517|5071433|P5|Induction|Reasons not reported|22
1554778|NCT00049517|5071434|P4|Induction|Reasons not reported|0
1554779|NCT00049517|5071435|P3|Induction|Reasons not reported|0
1554780|NCT00049517|5071436|P2|Induction|Reasons not reported|0
1554781|NCT00049517|5071437|P1|Induction|Reasons not reported|0
1554782|NCT00049517|5071432|P6|Induction|Other complicating disease|0
1554783|NCT00049517|5071433|P5|Induction|Other complicating disease|3
1554784|NCT00049517|5071434|P4|Induction|Other complicating disease|0
1554785|NCT00049517|5071435|P3|Induction|Other complicating disease|0
1554786|NCT00049517|5071436|P2|Induction|Other complicating disease|0
1554787|NCT00049517|5071437|P1|Induction|Other complicating disease|0
1554788|NCT00049517|5071432|P6|Induction|Alternative therapy|2
1554789|NCT00049517|5071433|P5|Induction|Alternative therapy|2
1554790|NCT00049517|5071434|P4|Induction|Alternative therapy|0
1554791|NCT00049517|5071435|P3|Induction|Alternative therapy|0
1554792|NCT00049517|5071436|P2|Induction|Alternative therapy|0
1554793|NCT00049517|5071437|P1|Induction|Alternative therapy|0
1554794|NCT00049517|5071432|P6|Induction|Withdrawal by Subject|3
1554795|NCT00049517|5071433|P5|Induction|Withdrawal by Subject|1
1554796|NCT00049517|5071434|P4|Induction|Withdrawal by Subject|0
1554797|NCT00049517|5071435|P3|Induction|Withdrawal by Subject|0
1554798|NCT00049517|5071436|P2|Induction|Withdrawal by Subject|0
1554799|NCT00049517|5071437|P1|Induction|Withdrawal by Subject|0
1554800|NCT00049517|5071432|P6|Induction|Death|6
1554801|NCT00049517|5071433|P5|Induction|Death|9
1554802|NCT00049517|5071434|P4|Induction|Death|0
1554803|NCT00049517|5071435|P3|Induction|Death|0
1554804|NCT00049517|5071436|P2|Induction|Death|0
1554805|NCT00049517|5071437|P1|Induction|Death|0
1554806|NCT00049517|5071432|P6|Induction|Adverse Event|7
1554807|NCT00049517|5071433|P5|Induction|Adverse Event|5
1554808|NCT00049517|5071434|P4|Induction|Adverse Event|0
1554809|NCT00049517|5071435|P3|Induction|Adverse Event|0
1554810|NCT00049517|5071436|P2|Induction|Adverse Event|0
1554811|NCT00049517|5071437|P1|Induction|Adverse Event|0
1554812|NCT00049517|5071432|P6|Induction|Disease progression|11
1554813|NCT00049517|5071433|P5|Induction|Disease progression|18
1554814|NCT00049517|5071434|P4|Induction|Disease progression|0
1554815|NCT00049517|5071435|P3|Induction|Disease progression|0
1554816|NCT00049517|5071436|P2|Induction|Disease progression|0
1554817|NCT00049517|5071437|P1|Induction|Disease progression|0
1554818|NCT00049322|5071455|P2|Overall Study|refused angio|3
1554819|NCT00049322|5071456|P1|Overall Study|refused angio|0
1554820|NCT00049322|5071455|P2|Overall Study|Adverse Event|0
1554821|NCT00049322|5071456|P1|Overall Study|Adverse Event|1
1554822|NCT00049322|5071455|P2|Overall Study|disease burden|3
1554823|NCT00049322|5071456|P1|Overall Study|disease burden|0
1554824|NCT00049257|5071468|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
1554825|NCT00049257|5071468|P1|Carboplatin, Paclitaxel|Death|2
1554826|NCT00049257|5071468|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
1554827|NCT00049257|5071468|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
1554828|NCT00049127|5071480|P5|Overall Study|Withdrawal by Subject|0
1554829|NCT00049127|5071481|P4|Overall Study|Withdrawal by Subject|0
1554830|NCT00049127|5071482|P3|Overall Study|Withdrawal by Subject|1
1554831|NCT00049127|5071483|P2|Overall Study|Withdrawal by Subject|0
1554832|NCT00049127|5071484|P1|Overall Study|Withdrawal by Subject|0
1554833|NCT00048997|5071522|P2|Overall Study|Withdrawal by Subject|1
1554834|NCT00048997|5071523|P1|Overall Study|Withdrawal by Subject|6
1554835|NCT00048997|5071522|P2|Overall Study|Protocol Violation|2
1554836|NCT00048997|5071523|P1|Overall Study|Protocol Violation|7
1554837|NCT00047385|5071546|P2|Overall Study|Eligible for screening but had no screen|492
1554838|NCT00047385|5071547|P1|Overall Study|Eligible for screening but had no screen|260
1554839|NCT00047385|5071546|P2|Overall Study|Lung Cancer diagnosed before screening|3
1554840|NCT00047385|5071547|P1|Overall Study|Lung Cancer diagnosed before screening|5
1554841|NCT00047385|5071546|P2|Overall Study|Death before any screening|5
1554842|NCT00047385|5071547|P1|Overall Study|Death before any screening|2
1554843|NCT00047320|5071565|P1|Overall Study|Ineligible|2
1554844|NCT00047320|5071565|P1|Overall Study|Withdrawal by Subject|9
1554845|NCT00047320|5071565|P1|Overall Study|Physician Decision|8
1554846|NCT00047320|5071565|P1|Overall Study|Lost to Follow-up|1
1554847|NCT00047320|5071565|P1|Overall Study|Lack of Efficacy|8
1554848|NCT00047008|5071576|P2|Overall Study|Ineligible|8
1554849|NCT00047008|5071577|P1|Overall Study|Ineligible|9
1554850|NCT00047008|5071576|P2|Overall Study|Withdrawn consent|3
1554851|NCT00047008|5071577|P1|Overall Study|Withdrawn consent|2
1554852|NCT00046930|5071585|P2|Overall Study|Ineligible|4
1554853|NCT00046930|5071586|P1|Overall Study|Ineligible|12
1554854|NCT00046891|5071601|P2|Overall Study|Adverse Event|5
1554855|NCT00046891|5071602|P1|Overall Study|Adverse Event|5
1554856|NCT00046891|5071601|P2|Overall Study|Withdrawal by Subject|15
1554857|NCT00046891|5071602|P1|Overall Study|Withdrawal by Subject|18
1554858|NCT00046891|5071601|P2|Overall Study|Ineligible|1
1554859|NCT00046891|5071602|P1|Overall Study|Ineligible|1
1554860|NCT00046891|5071601|P2|Overall Study|Cancels|9
1554861|NCT00046891|5071602|P1|Overall Study|Cancels|5
1554862|NCT00046839|5071622|P2|Overall Study|Withdrawal of consent|0
1554863|NCT00046839|5071623|P1|Overall Study|Withdrawal of consent|1
1554864|NCT00046839|5071622|P2|Overall Study|Ineligible / No protocol treatment|2
1554865|NCT00046839|5071623|P1|Overall Study|Ineligible / No protocol treatment|0
1554866|NCT00045734|5071630|P1|Overall Study|Protocol Violation|1
1554867|NCT00045708|5071645|P3|Phase 1|early progressive disease|0
1554868|NCT00045708|5071646|P2|Phase 1|early progressive disease|1
1554869|NCT00045708|5071647|P1|Phase 1|early progressive disease|0
1554870|NCT00045630|5071672|P1|Overall Study|Ineligible|2
1554871|NCT00045630|5071672|P1|Overall Study|Death|1
1554872|NCT00045630|5071672|P1|Overall Study|Progression/relapse|1
1554873|NCT00045630|5071672|P1|Overall Study|Refusal unrelated to adverse event|1
1554874|NCT00045630|5071672|P1|Overall Study|Adverse Event|1
1554875|NCT00045305|5071691|P1|Overall Study|site error|2
1554876|NCT00045305|5071691|P1|Overall Study|Death|3
1554877|NCT00045305|5071691|P1|Overall Study|Adverse Event|3
1554878|NCT00045305|5071691|P1|Overall Study|Lack of Efficacy|6
1554879|NCT00045162|5071702|P2|Overall Study|Not specified|16
1554880|NCT00045162|5071703|P1|Overall Study|Not specified|21
1554881|NCT00045162|5071702|P2|Overall Study|Withdrawal by Subject|3
1554882|NCT00045162|5071703|P1|Overall Study|Withdrawal by Subject|5
1554883|NCT00045162|5071702|P2|Overall Study|Death|10
1554884|NCT00045162|5071703|P1|Overall Study|Death|10
1554885|NCT00045162|5071702|P2|Overall Study|Lack of Efficacy|29
1554886|NCT00045162|5071703|P1|Overall Study|Lack of Efficacy|32
1554887|NCT00045162|5071702|P2|Overall Study|Adverse Event|50
1554888|NCT00045162|5071703|P1|Overall Study|Adverse Event|55
1554889|NCT00045162|5071702|P2|Overall Study|Not treated|2
1554890|NCT00045162|5071703|P1|Overall Study|Not treated|7
1554891|NCT00045162|5071702|P2|Overall Study|Ineligible|8
1554892|NCT00045162|5071703|P1|Overall Study|Ineligible|12
1554893|NCT00045110|5071718|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
1554894|NCT00045110|5071719|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
1554895|NCT00045110|5071720|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
1554896|NCT00045110|5071718|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
1554897|NCT00045110|5071719|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
1554898|NCT00045110|5071720|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
1554899|NCT00045110|5071718|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
1554900|NCT00045110|5071719|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
1554901|NCT00045110|5071720|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
1554902|NCT00045032|5071769|P3|Overall Study|Not Specified|105
1554903|NCT00045032|5071770|P2|Overall Study|Not Specified|84
1554904|NCT00045032|5071771|P1|Overall Study|Not Specified|93
1554905|NCT00045032|5071769|P3|Overall Study|Failure to Return|61
1554906|NCT00045032|5071770|P2|Overall Study|Failure to Return|62
1554907|NCT00045032|5071771|P1|Overall Study|Failure to Return|57
1554908|NCT00045032|5071769|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
1554909|NCT00045032|5071770|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
1554910|NCT00045032|5071771|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
1554911|NCT00045032|5071769|P3|Overall Study|Other Protocol Violation|1
1554912|NCT00045032|5071770|P2|Overall Study|Other Protocol Violation|0
1554913|NCT00045032|5071771|P1|Overall Study|Other Protocol Violation|2
1554914|NCT00045032|5071769|P3|Overall Study|Violation of Selection Criteria at Entry|6
1554915|NCT00045032|5071770|P2|Overall Study|Violation of Selection Criteria at Entry|6
1554916|NCT00045032|5071771|P1|Overall Study|Violation of Selection Criteria at Entry|3
1554917|NCT00045032|5071769|P3|Overall Study|Insufficient Therapeutic Response|445
1554918|NCT00045032|5071770|P2|Overall Study|Insufficient Therapeutic Response|437
1554919|NCT00045032|5071771|P1|Overall Study|Insufficient Therapeutic Response|542
1554920|NCT00045032|5071769|P3|Overall Study|Death|17
1554921|NCT00045032|5071770|P2|Overall Study|Death|24
1554922|NCT00045032|5071771|P1|Overall Study|Death|22
1554923|NCT00045032|5071769|P3|Overall Study|Adverse Event/Intercurrent Illness|7
1554924|NCT00045032|5071770|P2|Overall Study|Adverse Event/Intercurrent Illness|2
1554925|NCT00045032|5071771|P1|Overall Study|Adverse Event/Intercurrent Illness|2
1554926|NCT00042991|5071905|P7|Overall Study|Alternative Therapy|0
1554927|NCT00042991|5071906|P6|Overall Study|Alternative Therapy|0
1554928|NCT00042991|5071907|P5|Overall Study|Alternative Therapy|1
1554929|NCT00042991|5071908|P4|Overall Study|Alternative Therapy|0
1554930|NCT00042991|5071909|P3|Overall Study|Alternative Therapy|0
1554931|NCT00042991|5071910|P2|Overall Study|Alternative Therapy|0
1554932|NCT00042991|5071911|P1|Overall Study|Alternative Therapy|0
1554933|NCT00042991|5071905|P7|Overall Study|Disease Progression|2
1554934|NCT00042991|5071906|P6|Overall Study|Disease Progression|4
1554935|NCT00042991|5071907|P5|Overall Study|Disease Progression|1
1554936|NCT00042991|5071908|P4|Overall Study|Disease Progression|2
1554937|NCT00042991|5071909|P3|Overall Study|Disease Progression|2
1554938|NCT00042991|5071910|P2|Overall Study|Disease Progression|29
1554939|NCT00042991|5071911|P1|Overall Study|Disease Progression|5
1554940|NCT00042991|5071905|P7|Overall Study|Withdrawal by Subject|0
1554941|NCT00042991|5071906|P6|Overall Study|Withdrawal by Subject|0
1554942|NCT00042991|5071907|P5|Overall Study|Withdrawal by Subject|1
1554943|NCT00042991|5071908|P4|Overall Study|Withdrawal by Subject|0
1554944|NCT00042991|5071909|P3|Overall Study|Withdrawal by Subject|2
1554945|NCT00042991|5071910|P2|Overall Study|Withdrawal by Subject|7
1554946|NCT00042991|5071911|P1|Overall Study|Withdrawal by Subject|0
1554947|NCT00042991|5071905|P7|Overall Study|Adverse Event|0
1554948|NCT00042991|5071906|P6|Overall Study|Adverse Event|1
1554949|NCT00042991|5071907|P5|Overall Study|Adverse Event|0
1554950|NCT00042991|5071908|P4|Overall Study|Adverse Event|0
1554951|NCT00042991|5071909|P3|Overall Study|Adverse Event|2
1554952|NCT00042991|5071910|P2|Overall Study|Adverse Event|4
1554953|NCT00042991|5071911|P1|Overall Study|Adverse Event|1
1554954|NCT00042939|5071954|P2|Overall Study|Did not start treatment|1
1554955|NCT00042939|5071955|P1|Overall Study|Did not start treatment|2
1554956|NCT00042939|5071954|P2|Overall Study|Treatment break > 4 weeks|1
1554957|NCT00042939|5071955|P1|Overall Study|Treatment break > 4 weeks|0
1554958|NCT00042939|5071954|P2|Overall Study|Still on treatment|0
1554959|NCT00042939|5071955|P1|Overall Study|Still on treatment|1
1554960|NCT00042939|5071954|P2|Overall Study|Patient non-compliance|0
1554961|NCT00042939|5071955|P1|Overall Study|Patient non-compliance|1
1554962|NCT00042939|5071954|P2|Overall Study|Rising ca 19-9|0
1554963|NCT00042939|5071955|P1|Overall Study|Rising ca 19-9|1
1554964|NCT00042939|5071954|P2|Overall Study|QOL diminished|0
1554965|NCT00042939|5071955|P1|Overall Study|QOL diminished|1
1554966|NCT00042939|5071954|P2|Overall Study|Deterioration of health|4
1554967|NCT00042939|5071955|P1|Overall Study|Deterioration of health|3
1554968|NCT00042939|5071954|P2|Overall Study|Ineligible|2
1554969|NCT00042939|5071955|P1|Overall Study|Ineligible|2
1554970|NCT00042939|5071954|P2|Overall Study|Other disease|0
1554971|NCT00042939|5071955|P1|Overall Study|Other disease|1
1554972|NCT00042939|5071954|P2|Overall Study|Withdrawal by Subject|4
1554973|NCT00042939|5071955|P1|Overall Study|Withdrawal by Subject|3
1554974|NCT00042939|5071954|P2|Overall Study|Death|2
1554975|NCT00042939|5071955|P1|Overall Study|Death|3
1554976|NCT00042939|5071954|P2|Overall Study|Adverse Event|7
1554977|NCT00042939|5071955|P1|Overall Study|Adverse Event|6
1554978|NCT00041132|5071969|P1|Overall Study|Physician Decision|2
1554979|NCT00041132|5071969|P1|Overall Study|Withdrawal by Subject|1
1554980|NCT00041132|5071969|P1|Overall Study|Not Eligible|7
1554981|NCT00041132|5071969|P1|Overall Study|Death|1
1554982|NCT00041132|5071969|P1|Overall Study|Adverse Event|19
1554983|NCT00041080|5072004|P2|Overall Study|Ineligible|0
1554984|NCT00041080|5072005|P1|Overall Study|Ineligible|1
1554985|NCT00041080|5072004|P2|Overall Study|Did not start therapy|1
1554986|NCT00041080|5072005|P1|Overall Study|Did not start therapy|1
1554987|NCT00041080|5072004|P2|Overall Study|Concommitant Illness/Other|2
1554988|NCT00041080|5072005|P1|Overall Study|Concommitant Illness/Other|1
1554989|NCT00041080|5072004|P2|Overall Study|Withdrawal by Subject|6
1554990|NCT00041080|5072005|P1|Overall Study|Withdrawal by Subject|6
1554991|NCT00041080|5072004|P2|Overall Study|Adverse Event|1
1554992|NCT00041080|5072005|P1|Overall Study|Adverse Event|21
1554993|NCT00041067|5072011|P1|Overall Study|Ineligible|2
1554994|NCT00041067|5072011|P1|Overall Study|Other reasons|23
1554995|NCT00041067|5072011|P1|Overall Study|Patient refusal|12
1554996|NCT00041067|5072011|P1|Overall Study|Progression|19
1554997|NCT00041067|5072011|P1|Overall Study|Adverse Event|20
1554998|NCT00040742|5072078|P4|Overall Study|Other medical|5
1554999|NCT00040742|5072079|P3|Overall Study|Other medical|5
1555000|NCT00040742|5072080|P2|Overall Study|Other medical|5
1555001|NCT00040742|5072081|P1|Overall Study|Other medical|7
1555002|NCT00040742|5072078|P4|Overall Study|Incomplete Forms|5
1555003|NCT00040742|5072079|P3|Overall Study|Incomplete Forms|4
1555004|NCT00040742|5072080|P2|Overall Study|Incomplete Forms|10
1555005|NCT00040742|5072081|P1|Overall Study|Incomplete Forms|6
1555006|NCT00040742|5072078|P4|Overall Study|Chemotoxicity|2
1555007|NCT00040742|5072079|P3|Overall Study|Chemotoxicity|5
1555008|NCT00040742|5072080|P2|Overall Study|Chemotoxicity|3
1555009|NCT00040742|5072081|P1|Overall Study|Chemotoxicity|4
1555010|NCT00040742|5072078|P4|Overall Study|Withdrawal by Subject|13
1555011|NCT00040742|5072079|P3|Overall Study|Withdrawal by Subject|10
1555012|NCT00040742|5072080|P2|Overall Study|Withdrawal by Subject|15
1555013|NCT00040742|5072081|P1|Overall Study|Withdrawal by Subject|7
1555014|NCT00040742|5072078|P4|Overall Study|Adverse Event|9
1555015|NCT00040742|5072079|P3|Overall Study|Adverse Event|21
1555016|NCT00040742|5072080|P2|Overall Study|Adverse Event|16
1555017|NCT00040742|5072081|P1|Overall Study|Adverse Event|15
1555018|NCT00040742|5072078|P4|Overall Study|Death|0
1555019|NCT00040742|5072079|P3|Overall Study|Death|1
1555020|NCT00040742|5072080|P2|Overall Study|Death|0
1555021|NCT00040742|5072081|P1|Overall Study|Death|0
1555022|NCT00039377|5072095|P4|Initial Registration|Withdrawal by Subject|0
1555023|NCT00039377|5072096|P3|Initial Registration|Withdrawal by Subject|0
1555024|NCT00039377|5072097|P2|Initial Registration|Withdrawal by Subject|0
1555025|NCT00039377|5072098|P1|Initial Registration|Withdrawal by Subject|3
1555026|NCT00039377|5072095|P4|Initial Registration|Received non-protocol therapy|0
1555027|NCT00039377|5072096|P3|Initial Registration|Received non-protocol therapy|0
1555028|NCT00039377|5072097|P2|Initial Registration|Received non-protocol therapy|0
1555029|NCT00039377|5072098|P1|Initial Registration|Received non-protocol therapy|11
1555030|NCT00039377|5072095|P4|Initial Registration|Relapsed|0
1555031|NCT00039377|5072096|P3|Initial Registration|Relapsed|0
1555032|NCT00039377|5072097|P2|Initial Registration|Relapsed|0
1555033|NCT00039377|5072098|P1|Initial Registration|Relapsed|6
1555034|NCT00039377|5072095|P4|Initial Registration|Adverse Event|0
1555035|NCT00039377|5072096|P3|Initial Registration|Adverse Event|0
1555036|NCT00039377|5072097|P2|Initial Registration|Adverse Event|0
1555037|NCT00039377|5072098|P1|Initial Registration|Adverse Event|2
1555038|NCT00039130|5072114|P1|Overall Study|Physician Decision|3
1555039|NCT00039130|5072114|P1|Overall Study|Subsequent treatment|2
1555040|NCT00039130|5072114|P1|Overall Study|Progression|2
1555041|NCT00039130|5072114|P1|Overall Study|Withdrawal by Subject|3
1555042|NCT00039130|5072114|P1|Overall Study|Death|9
1555043|NCT00039130|5072114|P1|Overall Study|Adverse Event|11
1555044|NCT00033657|5072128|P2|Adjuvant Chemotherapy|Other|2
1555045|NCT00033657|5072129|P1|Adjuvant Chemotherapy|Other|0
1555046|NCT00033657|5072128|P2|Adjuvant Chemotherapy|alternative therapy|0
1555047|NCT00033657|5072129|P1|Adjuvant Chemotherapy|alternative therapy|1
1555048|NCT00033657|5072128|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
1555049|NCT00033657|5072129|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
1555050|NCT00033657|5072128|P2|Adjuvant Chemotherapy|Death|1
1555051|NCT00033657|5072129|P1|Adjuvant Chemotherapy|Death|2
1555052|NCT00033657|5072128|P2|Adjuvant Chemotherapy|Adverse Event|10
1555053|NCT00033657|5072129|P1|Adjuvant Chemotherapy|Adverse Event|7
1555054|NCT00033657|5072128|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
1555055|NCT00033657|5072129|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
1555056|NCT00033657|5072128|P2|Surgical Resection|not complete resection|3
1555057|NCT00033657|5072129|P1|Surgical Resection|not complete resection|0
1555058|NCT00033657|5072128|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
1555059|NCT00033657|5072129|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
1555060|NCT00033657|5072128|P2|Neoadjuvant Chemotherapy|Ineligible|4
1555061|NCT00033657|5072129|P1|Neoadjuvant Chemotherapy|Ineligible|8
1555062|NCT00033657|5072128|P2|Neoadjuvant Chemotherapy|other complicating disease|1
1555063|NCT00033657|5072129|P1|Neoadjuvant Chemotherapy|other complicating disease|0
1555064|NCT00033657|5072128|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
1555065|NCT00033657|5072129|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
1555066|NCT00033657|5072128|P2|Neoadjuvant Chemotherapy|Death|1
1555067|NCT00033657|5072129|P1|Neoadjuvant Chemotherapy|Death|1
1555068|NCT00033657|5072128|P2|Neoadjuvant Chemotherapy|Adverse Event|2
1555069|NCT00033657|5072129|P1|Neoadjuvant Chemotherapy|Adverse Event|0
1555070|NCT00033657|5072128|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
1555071|NCT00033657|5072129|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
1555072|NCT00033631|5072143|P2|Overall Study|Withdrawal by Subject|4
1555073|NCT00033631|5072144|P1|Overall Study|Withdrawal by Subject|4
1555074|NCT00033631|5072143|P2|Overall Study|Protocol Violation|11
1555075|NCT00033631|5072144|P1|Overall Study|Protocol Violation|14
1555076|NCT00033540|5072162|P1|Overall Study|Never received treatment|2
1555077|NCT00033540|5072162|P1|Overall Study|Ineligible|3
1555078|NCT00033540|5072162|P1|Overall Study|Not specified|5
1555079|NCT00033540|5072162|P1|Overall Study|Withdrawal by Subject|6
1555080|NCT00033540|5072162|P1|Overall Study|Progression|26
1555081|NCT00033540|5072162|P1|Overall Study|Death|1
1555082|NCT00033540|5072162|P1|Overall Study|Adverse Event|14
1555083|NCT00033514|5072172|P2|Overall Study|Withdrawal by Subject|3
1555084|NCT00033514|5072173|P1|Overall Study|Withdrawal by Subject|0
1555085|NCT00033514|5072172|P2|Overall Study|Lost to Follow-up|1
1555086|NCT00033514|5072173|P1|Overall Study|Lost to Follow-up|1
1555087|NCT00033371|5072183|P2|Overall Study|Disease Progression|1
1555088|NCT00033371|5072184|P1|Overall Study|Disease Progression|0
1555089|NCT00033371|5072183|P2|Overall Study|Withdrawal by Subject|3
1555090|NCT00033371|5072184|P1|Overall Study|Withdrawal by Subject|3
1555091|NCT00033371|5072183|P2|Overall Study|Lost to Follow-up|1
1555092|NCT00033371|5072184|P1|Overall Study|Lost to Follow-up|2
1555093|NCT00033371|5072183|P2|Overall Study|Adverse Event|5
1555094|NCT00033371|5072184|P1|Overall Study|Adverse Event|1
1555095|NCT00033293|5072192|P2|Overall Study|Treatment refused|6
1555096|NCT00033293|5072193|P1|Overall Study|Treatment refused|0
1555097|NCT00033293|5072192|P2|Overall Study|Could not be weaned from steroid therapy|1
1555098|NCT00033293|5072193|P1|Overall Study|Could not be weaned from steroid therapy|1
1555099|NCT00033293|5072192|P2|Overall Study|Withdrawal by Subject|0
1555100|NCT00033293|5072193|P1|Overall Study|Withdrawal by Subject|1
1555101|NCT00033293|5072192|P2|Overall Study|Physician Decision|1
1555102|NCT00033293|5072193|P1|Overall Study|Physician Decision|3
1555103|NCT00033293|5072192|P2|Overall Study|Lost to Follow-up|1
1555104|NCT00033293|5072193|P1|Overall Study|Lost to Follow-up|0
1555105|NCT00033293|5072192|P2|Overall Study|Lack of Efficacy|8
1555106|NCT00033293|5072193|P1|Overall Study|Lack of Efficacy|5
1555107|NCT00033293|5072192|P2|Overall Study|Death|1
1555108|NCT00033293|5072193|P1|Overall Study|Death|0
1555109|NCT00031694|5072211|P1|Overall Study|Withdrawal by Subject|5
1555110|NCT00031694|5072211|P1|Overall Study|Death|2
1555111|NCT00031694|5072211|P1|Overall Study|Adverse Event|12
1555112|NCT00030901|5072217|P3|Randomization|Ineligible|14
1555113|NCT00030901|5072218|P2|Randomization|Ineligible|15
1555114|NCT00030901|5072219|P1|Randomization|Ineligible|0
1555115|NCT00030901|5072217|P3|Randomization|Other|33
1555116|NCT00030901|5072218|P2|Randomization|Other|36
1555117|NCT00030901|5072219|P1|Randomization|Other|0
1555118|NCT00030901|5072217|P3|Randomization|Death|3
1555119|NCT00030901|5072218|P2|Randomization|Death|1
1555120|NCT00030901|5072219|P1|Randomization|Death|0
1555121|NCT00030901|5072217|P3|Randomization|Progression/Relapse|21
1555122|NCT00030901|5072218|P2|Randomization|Progression/Relapse|22
1555123|NCT00030901|5072219|P1|Randomization|Progression/Relapse|0
1555124|NCT00030901|5072217|P3|Randomization|Refusal Unrelated to Adverse Event|10
1555125|NCT00030901|5072218|P2|Randomization|Refusal Unrelated to Adverse Event|16
1555126|NCT00030901|5072219|P1|Randomization|Refusal Unrelated to Adverse Event|0
1555127|NCT00030901|5072217|P3|Randomization|Adverse Event|7
1555128|NCT00030901|5072218|P2|Randomization|Adverse Event|11
1555129|NCT00030901|5072219|P1|Randomization|Adverse Event|0
1555130|NCT00030901|5072217|P3|Initial Registration|Ineligible|0
1555131|NCT00030901|5072218|P2|Initial Registration|Ineligible|0
1555132|NCT00030901|5072219|P1|Initial Registration|Ineligible|167
1555133|NCT00030823|5072227|P1|Overall Study|Withdrawal by Subject|1
1555134|NCT00028769|5072235|P1|Overall Study|Not Analyzable|1
1555135|NCT00028769|5072235|P1|Overall Study|Ineligible|5
1555136|NCT00028769|5072235|P1|Overall Study|Other - Not Protocol Specified|1
1555137|NCT00028769|5072235|P1|Overall Study|Progression or Death|31
1555138|NCT00028769|5072235|P1|Overall Study|Refusal Unrelated to Adverse Events|1
1555139|NCT00028769|5072235|P1|Overall Study|Adverse Event|2
1555140|NCT00028002|5072241|P1|Overall Study|Ineligible|8
1555141|NCT00028002|5072241|P1|Overall Study|Withdrawal by Subject|3
1555142|NCT00027846|5072251|P3|Overall Study|Neuraxis dissemination during/after ther|5
1555143|NCT00027846|5072252|P2|Overall Study|Neuraxis dissemination during/after ther|2
1555144|NCT00027846|5072253|P1|Overall Study|Neuraxis dissemination during/after ther|0
1555145|NCT00027846|5072251|P3|Overall Study|Entry into another COG therapeutic study|2
1555146|NCT00027846|5072252|P2|Overall Study|Entry into another COG therapeutic study|5
1555147|NCT00027846|5072253|P1|Overall Study|Entry into another COG therapeutic study|0
1555148|NCT00027846|5072251|P3|Overall Study|Ineligible for study|14
1555149|NCT00027846|5072252|P2|Overall Study|Ineligible for study|6
1555150|NCT00027846|5072253|P1|Overall Study|Ineligible for study|2
1555151|NCT00027846|5072251|P3|Overall Study|Withdrawal by Subject|7
1555152|NCT00027846|5072252|P2|Overall Study|Withdrawal by Subject|14
1555153|NCT00027846|5072253|P1|Overall Study|Withdrawal by Subject|0
1555154|NCT00027846|5072251|P3|Overall Study|Lost to Follow-up|9
1555155|NCT00027846|5072252|P2|Overall Study|Lost to Follow-up|41
1555156|NCT00027846|5072253|P1|Overall Study|Lost to Follow-up|0
1555157|NCT00027560|5072271|P1|Overall Study|Withdrawal by Subject|1
1555158|NCT00026494|5072284|P4|Overall Study|Clinical progression|0
1555159|NCT00026494|5072285|P3|Overall Study|Clinical progression|3
1555160|NCT00026494|5072286|P2|Overall Study|Clinical progression|0
1555161|NCT00026494|5072287|P1|Overall Study|Clinical progression|0
1555162|NCT00026494|5072284|P4|Overall Study|Patient not treated|0
1555163|NCT00026494|5072285|P3|Overall Study|Patient not treated|2
1555164|NCT00026494|5072286|P2|Overall Study|Patient not treated|0
1555165|NCT00026494|5072287|P1|Overall Study|Patient not treated|0
1555166|NCT00026494|5072284|P4|Overall Study|Patient non-compliance|0
1555167|NCT00026494|5072285|P3|Overall Study|Patient non-compliance|0
1555168|NCT00026494|5072286|P2|Overall Study|Patient non-compliance|0
1555169|NCT00026494|5072287|P1|Overall Study|Patient non-compliance|1
1555170|NCT00026494|5072284|P4|Overall Study|Withdrawal by Subject|0
1555171|NCT00026494|5072285|P3|Overall Study|Withdrawal by Subject|1
1555172|NCT00026494|5072286|P2|Overall Study|Withdrawal by Subject|0
1555173|NCT00026494|5072287|P1|Overall Study|Withdrawal by Subject|1
1555174|NCT00026312|5072299|P2|Overall Study|Refusal by patient/parent/guardian|59
1555175|NCT00026312|5072300|P1|Overall Study|Refusal by patient/parent/guardian|8
1555176|NCT00026312|5072299|P2|Overall Study|Entry onto another COG study|1
1555177|NCT00026312|5072300|P1|Overall Study|Entry onto another COG study|0
1555178|NCT00026312|5072299|P2|Overall Study|Ineligible|5
1555179|NCT00026312|5072300|P1|Overall Study|Ineligible|4
1555180|NCT00026312|5072299|P2|Overall Study|Withdrawal by Subject|6
1555181|NCT00026312|5072300|P1|Overall Study|Withdrawal by Subject|1
1555182|NCT00026312|5072299|P2|Overall Study|Protocol Violation|3
1555183|NCT00026312|5072300|P1|Overall Study|Protocol Violation|0
1555184|NCT00026312|5072299|P2|Overall Study|Physician Decision|37
1555185|NCT00026312|5072300|P1|Overall Study|Physician Decision|1
1555186|NCT00026312|5072299|P2|Overall Study|Lost to Follow-up|5
1555187|NCT00026312|5072300|P1|Overall Study|Lost to Follow-up|0
1555188|NCT00026312|5072299|P2|Overall Study|Lack of Efficacy|114
1555189|NCT00026312|5072300|P1|Overall Study|Lack of Efficacy|19
1555190|NCT00026312|5072299|P2|Overall Study|Death|7
1555191|NCT00026312|5072300|P1|Overall Study|Death|1
1555192|NCT00026312|5072299|P2|Overall Study|Adverse Event|32
1555193|NCT00026312|5072300|P1|Overall Study|Adverse Event|0
1555194|NCT00026208|5072339|P2|Overall Study|Complications of auto accident|0
1555195|NCT00026208|5072340|P1|Overall Study|Complications of auto accident|1
1555196|NCT00025662|5072358|P1|Overall Study|Technical failure of manipulation|1
1555197|NCT00025662|5072358|P1|Overall Study|Withdrawal by Subject|2
1555198|NCT00025506|5072366|P1|Overall Study|Never Treated|2
1555199|NCT00025506|5072366|P1|Overall Study|Ineligible: inadequate pathology|2
1555200|NCT00025506|5072366|P1|Overall Study|Ineligible: wrong cell type|5
1555201|NCT00025506|5072366|P1|Overall Study|Ineligible: clerical error|1
1555202|NCT00025259|5072387|P7|Overall Study|Adverse Event|0
1555203|NCT00025259|5072388|P6|Overall Study|Adverse Event|0
1555204|NCT00025259|5072389|P5|Overall Study|Adverse Event|0
1555205|NCT00025259|5072390|P4|Overall Study|Adverse Event|0
1555206|NCT00025259|5072391|P3|Overall Study|Adverse Event|0
1555207|NCT00025259|5072392|P2|Overall Study|Adverse Event|0
1555208|NCT00025259|5072393|P1|Overall Study|Adverse Event|1
1555209|NCT00025259|5072387|P7|Overall Study|Randomization error|2
1555210|NCT00025259|5072388|P6|Overall Study|Randomization error|7
1555211|NCT00025259|5072389|P5|Overall Study|Randomization error|1
1555212|NCT00025259|5072390|P4|Overall Study|Randomization error|0
1555213|NCT00025259|5072391|P3|Overall Study|Randomization error|0
1555214|NCT00025259|5072392|P2|Overall Study|Randomization error|0
1555215|NCT00025259|5072393|P1|Overall Study|Randomization error|1
1555216|NCT00025259|5072387|P7|Overall Study|Ineligible|1
1555217|NCT00025259|5072388|P6|Overall Study|Ineligible|0
1555218|NCT00025259|5072389|P5|Overall Study|Ineligible|6
1555219|NCT00025259|5072390|P4|Overall Study|Ineligible|0
1555220|NCT00025259|5072391|P3|Overall Study|Ineligible|0
1555221|NCT00025259|5072392|P2|Overall Study|Ineligible|1
1555222|NCT00025259|5072393|P1|Overall Study|Ineligible|14
1555223|NCT00025259|5072387|P7|Overall Study|Withdrawal by Subject|3
1555224|NCT00025259|5072388|P6|Overall Study|Withdrawal by Subject|8
1555225|NCT00025259|5072389|P5|Overall Study|Withdrawal by Subject|11
1555226|NCT00025259|5072390|P4|Overall Study|Withdrawal by Subject|14
1555227|NCT00025259|5072391|P3|Overall Study|Withdrawal by Subject|6
1555228|NCT00025259|5072392|P2|Overall Study|Withdrawal by Subject|27
1555229|NCT00025259|5072393|P1|Overall Study|Withdrawal by Subject|9
1555230|NCT00025259|5072387|P7|Overall Study|Protocol Violation|3
1555231|NCT00025259|5072388|P6|Overall Study|Protocol Violation|1
1555232|NCT00025259|5072389|P5|Overall Study|Protocol Violation|2
1555233|NCT00025259|5072390|P4|Overall Study|Protocol Violation|1
1555234|NCT00025259|5072391|P3|Overall Study|Protocol Violation|2
1555235|NCT00025259|5072392|P2|Overall Study|Protocol Violation|2
1555236|NCT00025259|5072393|P1|Overall Study|Protocol Violation|3
1555237|NCT00025259|5072387|P7|Overall Study|Physician Decision|1
1555238|NCT00025259|5072388|P6|Overall Study|Physician Decision|2
1555239|NCT00025259|5072389|P5|Overall Study|Physician Decision|4
1555240|NCT00025259|5072390|P4|Overall Study|Physician Decision|5
1555241|NCT00025259|5072391|P3|Overall Study|Physician Decision|0
1555242|NCT00025259|5072392|P2|Overall Study|Physician Decision|1
1555243|NCT00025259|5072393|P1|Overall Study|Physician Decision|12
1555244|NCT00025259|5072387|P7|Overall Study|Lost to Follow-up|1
1555245|NCT00025259|5072388|P6|Overall Study|Lost to Follow-up|3
1555246|NCT00025259|5072389|P5|Overall Study|Lost to Follow-up|1
1555247|NCT00025259|5072390|P4|Overall Study|Lost to Follow-up|13
1555248|NCT00025259|5072391|P3|Overall Study|Lost to Follow-up|13
1555249|NCT00025259|5072392|P2|Overall Study|Lost to Follow-up|9
1555250|NCT00025259|5072393|P1|Overall Study|Lost to Follow-up|2
1555251|NCT00025259|5072387|P7|Overall Study|Lack of Efficacy|38
1555252|NCT00025259|5072388|P6|Overall Study|Lack of Efficacy|30
1555253|NCT00025259|5072389|P5|Overall Study|Lack of Efficacy|11
1555254|NCT00025259|5072390|P4|Overall Study|Lack of Efficacy|78
1555255|NCT00025259|5072391|P3|Overall Study|Lack of Efficacy|60
1555256|NCT00025259|5072392|P2|Overall Study|Lack of Efficacy|46
1555257|NCT00025259|5072393|P1|Overall Study|Lack of Efficacy|2
1555258|NCT00025259|5072387|P7|Overall Study|Death|2
1555259|NCT00025259|5072388|P6|Overall Study|Death|1
1555260|NCT00025259|5072389|P5|Overall Study|Death|0
1555261|NCT00025259|5072390|P4|Overall Study|Death|3
1555262|NCT00025259|5072391|P3|Overall Study|Death|0
1555263|NCT00025259|5072392|P2|Overall Study|Death|3
1555264|NCT00025259|5072393|P1|Overall Study|Death|1
1555265|NCT00025233|5072429|P1|Overall Study|Never treated|1
1555266|NCT00025233|5072429|P1|Overall Study|Ineligible: improper prior treatment|1
1555267|NCT00025233|5072429|P1|Overall Study|Ineligible: wrong primary|1
1555268|NCT00025233|5072429|P1|Overall Study|Ineligible: wrong cell type|1
1555269|NCT00025155|5072444|P1|Overall Study|Ineligible: Second primary cancer site|1
1555270|NCT00025155|5072444|P1|Overall Study|Ineligible: Wrong primary cancer site|1
1555271|NCT00024258|5072455|P1|Overall Study|Disease Progression|8
1555272|NCT00024258|5072455|P1|Overall Study|Withdrawal by Subject|1
1555273|NCT00024167|5072462|P2|Overall Study|Death|47
1555274|NCT00024167|5072463|P1|Overall Study|Death|53
1555275|NCT00023764|5072487|P1|Overall Study|delay in obtaining staging images|1
1555276|NCT00023764|5072487|P1|Overall Study|patient received other treatment|1
1555277|NCT00023764|5072487|P1|Overall Study|Progression of disease|6
1555278|NCT00023764|5072487|P1|Overall Study|Withdrawal by Subject|1
1555279|NCT00023764|5072487|P1|Overall Study|Adverse Event|4
1555280|NCT00023764|5072487|P1|Overall Study|Other|1
1555281|NCT00023712|5072494|P2|Overall Study|Never treated|1
1555282|NCT00023712|5072495|P1|Overall Study|Never treated|1
1555283|NCT00023712|5072494|P2|Overall Study|Not platinum sensitive|0
1555284|NCT00023712|5072495|P1|Overall Study|Not platinum sensitive|1
1555285|NCT00022698|5072519|P2|Overall Study|Administrative /other|7
1555286|NCT00022698|5072520|P1|Overall Study|Administrative /other|1
1555287|NCT00022698|5072519|P2|Overall Study|Insufficient therapeutic response|14
1555288|NCT00022698|5072520|P1|Overall Study|Insufficient therapeutic response|2
1555289|NCT00022698|5072519|P2|Overall Study|Refused treatment|2
1555290|NCT00022698|5072520|P1|Overall Study|Refused treatment|0
1555291|NCT00022698|5072519|P2|Overall Study|Failure to return|1
1555292|NCT00022698|5072520|P1|Overall Study|Failure to return|0
1555293|NCT00022698|5072519|P2|Overall Study|Death|2
1555294|NCT00022698|5072520|P1|Overall Study|Death|0
1555295|NCT00022698|5072519|P2|Overall Study|Adverse Event|9
1555296|NCT00022698|5072520|P1|Overall Study|Adverse Event|5
1555297|NCT00022672|5072545|P2|Extension Phase|Other|1
1555298|NCT00022672|5072546|P1|Extension Phase|Other|1
1555299|NCT00022672|5072545|P2|Extension Phase|Refused Treatment|2
1555300|NCT00022672|5072546|P1|Extension Phase|Refused Treatment|0
1555301|NCT00022672|5072545|P2|Extension Phase|Insufficient Therapeutic Response|44
1555302|NCT00022672|5072546|P1|Extension Phase|Insufficient Therapeutic Response|1
1555303|NCT00022672|5072545|P2|Extension Phase|Death|1
1555304|NCT00022672|5072546|P1|Extension Phase|Death|0
1555305|NCT00022672|5072545|P2|Extension Phase|Adverse Event|3
1555306|NCT00022672|5072546|P1|Extension Phase|Adverse Event|1
1555307|NCT00022672|5072545|P2|Main Phase: 24 Months|Other|0
1555308|NCT00022672|5072546|P1|Main Phase: 24 Months|Other|1
1555309|NCT00022672|5072545|P2|Main Phase: 24 Months|Failure to Return|1
1555310|NCT00022672|5072546|P1|Main Phase: 24 Months|Failure to Return|1
1555311|NCT00022672|5072545|P2|Main Phase: 24 Months|Refused Treatment|4
1555312|NCT00022672|5072546|P1|Main Phase: 24 Months|Refused Treatment|3
1555313|NCT00022672|5072545|P2|Main Phase: 24 Months|Other Protocol Violation|0
1555314|NCT00022672|5072546|P1|Main Phase: 24 Months|Other Protocol Violation|1
1555315|NCT00022672|5072545|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
1555316|NCT00022672|5072546|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
1555317|NCT00022672|5072545|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
1555318|NCT00022672|5072546|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
1555319|NCT00022672|5072545|P2|Main Phase: 24 Months|Death|3
1555320|NCT00022672|5072546|P1|Main Phase: 24 Months|Death|0
1555321|NCT00022672|5072545|P2|Main Phase: 24 Months|Adverse Event|0
1555322|NCT00022672|5072546|P1|Main Phase: 24 Months|Adverse Event|6
1555323|NCT00022659|5072579|P1|Overall Study|Never treated|1
1555324|NCT00022659|5072579|P1|Overall Study|Ineligible: wrong primary|1
1555325|NCT00022633|5072592|P2|Overall Study|Ineligible|0
1555326|NCT00022633|5072593|P1|Overall Study|Ineligible|4
1555327|NCT00022633|5072592|P2|Overall Study|Other - not protocol specified|2
1555328|NCT00022633|5072593|P1|Overall Study|Other - not protocol specified|3
1555329|NCT00022633|5072592|P2|Overall Study|Death|0
1555330|NCT00022633|5072593|P1|Overall Study|Death|4
1555331|NCT00022633|5072592|P2|Overall Study|Progression/relapse|2
1555332|NCT00022633|5072593|P1|Overall Study|Progression/relapse|9
1555333|NCT00022633|5072592|P2|Overall Study|Refusal unrelated to adverse event|0
1555334|NCT00022633|5072593|P1|Overall Study|Refusal unrelated to adverse event|1
1555335|NCT00022633|5072592|P2|Overall Study|Adverse Event|1
1555336|NCT00022633|5072593|P1|Overall Study|Adverse Event|11
1555337|NCT00022516|5072606|P2|Overall Study|Incomplete documentation|27
1555338|NCT00022516|5072607|P1|Overall Study|Incomplete documentation|0
1555339|NCT00022516|5072606|P2|Overall Study|Withdrawal by Subject|113
1555340|NCT00022516|5072607|P1|Overall Study|Withdrawal by Subject|2
1555341|NCT00022516|5072606|P2|Overall Study|Protocol Violation|3
1555342|NCT00022516|5072607|P1|Overall Study|Protocol Violation|1
1555343|NCT00022516|5072606|P2|Overall Study|Physician Decision|1
1555344|NCT00022516|5072607|P1|Overall Study|Physician Decision|0
1555345|NCT00022516|5072606|P2|Overall Study|Lack of Efficacy|27
1555346|NCT00022516|5072607|P1|Overall Study|Lack of Efficacy|0
1555347|NCT00022516|5072606|P2|Overall Study|Adverse Event|59
1555348|NCT00022516|5072607|P1|Overall Study|Adverse Event|0
1555349|NCT00021255|5072626|P3|Overall Study|Randomized but not treated|18
1555350|NCT00021255|5072627|P2|Overall Study|Randomized but not treated|2
1555351|NCT00021255|5072628|P1|Overall Study|Randomized but not treated|28
1555352|NCT00021255|5072626|P3|Overall Study|Missing|13
1555353|NCT00021255|5072627|P2|Overall Study|Missing|27
1555354|NCT00021255|5072628|P1|Overall Study|Missing|0
1555355|NCT00021255|5072626|P3|Overall Study|Other than specified above|19
1555356|NCT00021255|5072627|P2|Overall Study|Other than specified above|38
1555357|NCT00021255|5072628|P1|Overall Study|Other than specified above|0
1555358|NCT00021255|5072626|P3|Overall Study|Protocol Violation|0
1555359|NCT00021255|5072627|P2|Overall Study|Protocol Violation|2
1555360|NCT00021255|5072628|P1|Overall Study|Protocol Violation|0
1555361|NCT00021255|5072626|P3|Overall Study|Adverse Event|18
1555362|NCT00021255|5072627|P2|Overall Study|Adverse Event|30
1555363|NCT00021255|5072628|P1|Overall Study|Adverse Event|46
1555364|NCT00021255|5072626|P3|Overall Study|Herceptin toxicity|6
1555365|NCT00021255|5072627|P2|Overall Study|Herceptin toxicity|22
1555366|NCT00021255|5072628|P1|Overall Study|Herceptin toxicity|0
1555367|NCT00021255|5072626|P3|Overall Study|Cardiac toxicity|32
1555368|NCT00021255|5072627|P2|Overall Study|Cardiac toxicity|61
1555369|NCT00021255|5072628|P1|Overall Study|Cardiac toxicity|0
1555370|NCT00021255|5072626|P3|Overall Study|Lost to Follow-up|3
1555371|NCT00021255|5072627|P2|Overall Study|Lost to Follow-up|2
1555372|NCT00021255|5072628|P1|Overall Study|Lost to Follow-up|0
1555373|NCT00021255|5072626|P3|Overall Study|Withdrawal by Subject|26
1555374|NCT00021255|5072627|P2|Overall Study|Withdrawal by Subject|64
1555375|NCT00021255|5072628|P1|Overall Study|Withdrawal by Subject|41
1555376|NCT00021255|5072626|P3|Overall Study|Second primary malignancy|1
1555377|NCT00021255|5072627|P2|Overall Study|Second primary malignancy|4
1555378|NCT00021255|5072628|P1|Overall Study|Second primary malignancy|0
1555379|NCT00021255|5072626|P3|Overall Study|Breast cancer relapse|11
1555380|NCT00021255|5072627|P2|Overall Study|Breast cancer relapse|18
1555381|NCT00021255|5072628|P1|Overall Study|Breast cancer relapse|5
1555382|NCT00021255|5072626|P3|Overall Study|Death|2
1555383|NCT00021255|5072627|P2|Overall Study|Death|0
1555384|NCT00021255|5072628|P1|Overall Study|Death|1
1555385|NCT00021229|5072645|P3|Overall Study|Punctate hemmorrhage post RT|0
1555386|NCT00021229|5072646|P2|Overall Study|Punctate hemmorrhage post RT|0
1555387|NCT00021229|5072647|P1|Overall Study|Punctate hemmorrhage post RT|2
1555388|NCT00021229|5072645|P3|Overall Study|Physician Decision|1
1555389|NCT00021229|5072646|P2|Overall Study|Physician Decision|0
1555390|NCT00021229|5072647|P1|Overall Study|Physician Decision|0
1555391|NCT00021229|5072645|P3|Overall Study|Protocol Violation|0
1555392|NCT00021229|5072646|P2|Overall Study|Protocol Violation|1
1555393|NCT00021229|5072647|P1|Overall Study|Protocol Violation|1
1555394|NCT00021229|5072645|P3|Overall Study|Progressive Disease|12
1555395|NCT00021229|5072646|P2|Overall Study|Progressive Disease|19
1555396|NCT00021229|5072647|P1|Overall Study|Progressive Disease|15
1555397|NCT00021229|5072645|P3|Overall Study|Withdrawal by Subject|1
1555398|NCT00021229|5072646|P2|Overall Study|Withdrawal by Subject|7
1555399|NCT00021229|5072647|P1|Overall Study|Withdrawal by Subject|7
1555400|NCT00021229|5072645|P3|Overall Study|Death|0
1555401|NCT00021229|5072646|P2|Overall Study|Death|1
1555402|NCT00021229|5072647|P1|Overall Study|Death|0
1555403|NCT00021229|5072645|P3|Overall Study|Adverse Event|2
1555404|NCT00021229|5072646|P2|Overall Study|Adverse Event|5
1555405|NCT00021229|5072647|P1|Overall Study|Adverse Event|10
1555406|NCT00019604|5072702|P1|Overall Study|Details for other not available|4
1555407|NCT00019604|5072702|P1|Overall Study|Unable to evaluate|1
1555408|NCT00019604|5072702|P1|Overall Study|Too much disease|1
1555409|NCT00019604|5072702|P1|Overall Study|Pt going to immunotherapy study|1
1555410|NCT00019604|5072702|P1|Overall Study|Started new chemo regimen|1
1555411|NCT00019604|5072702|P1|Overall Study|Resectable disease|1
1555412|NCT00019604|5072702|P1|Overall Study|Non compliant|1
1555413|NCT00019604|5072702|P1|Overall Study|Non compliant on systemic CH|1
1555414|NCT00019604|5072702|P1|Overall Study|Move to a different study|1
1555415|NCT00019604|5072702|P1|Overall Study|Going to have liver transplant|1
1555416|NCT00019604|5072702|P1|Overall Study|Carcinoid tumor, not treatable|1
1555417|NCT00019604|5072702|P1|Overall Study|Refused treatment|1
1555418|NCT00019604|5072702|P1|Overall Study|Progressive disease|23
1555419|NCT00019604|5072702|P1|Overall Study|Death|1
1555420|NCT00016354|5072725|P8|Overall Study|Lack of Efficacy|1
1555421|NCT00016354|5072726|P7|Overall Study|Lack of Efficacy|0
1555422|NCT00016354|5072727|P6|Overall Study|Lack of Efficacy|0
1555423|NCT00016354|5072728|P5|Overall Study|Lack of Efficacy|0
1555424|NCT00016354|5072729|P4|Overall Study|Lack of Efficacy|0
1555425|NCT00016354|5072730|P3|Overall Study|Lack of Efficacy|0
1555426|NCT00016354|5072731|P2|Overall Study|Lack of Efficacy|0
1555427|NCT00016354|5072732|P1|Overall Study|Lack of Efficacy|0
1555428|NCT00014495|5072746|P4|Overall Study|Clinical deterioration|1
1555429|NCT00014495|5072747|P3|Overall Study|Clinical deterioration|0
1555430|NCT00014495|5072748|P2|Overall Study|Clinical deterioration|0
1555431|NCT00014495|5072749|P1|Overall Study|Clinical deterioration|0
1555432|NCT00014495|5072746|P4|Overall Study|Death|0
1555433|NCT00014495|5072747|P3|Overall Study|Death|1
1555434|NCT00014495|5072748|P2|Overall Study|Death|0
1555435|NCT00014495|5072749|P1|Overall Study|Death|0
1555436|NCT00012012|5072799|P2|Overall Study|Withdrawal by Subject|2
1555437|NCT00012012|5072800|P1|Overall Study|Withdrawal by Subject|0
1555438|NCT00012012|5072799|P2|Overall Study|Protocol Violation|1
1555439|NCT00012012|5072800|P1|Overall Study|Protocol Violation|1
1555440|NCT00010257|5072829|P2|Overall Study|Withdrawal by Subject|0
1555441|NCT00010257|5072830|P1|Overall Study|Withdrawal by Subject|1
1555442|NCT00009945|5072840|P2|Overall Study|no follow up data|5
1555443|NCT00009945|5072841|P1|Overall Study|no follow up data|7
1555444|NCT00008385|5072857|P2|Overall Study|Not start protocol therapy|175
1555445|NCT00008385|5072858|P1|Overall Study|Not start protocol therapy|44
1555446|NCT00008385|5072857|P2|Overall Study|Not specified|212
1555447|NCT00008385|5072858|P1|Overall Study|Not specified|105
1555448|NCT00008385|5072857|P2|Overall Study|Maximum dose reached|2
1555449|NCT00008385|5072858|P1|Overall Study|Maximum dose reached|0
1555450|NCT00008385|5072857|P2|Overall Study|Other complicating disease|30
1555451|NCT00008385|5072858|P1|Overall Study|Other complicating disease|17
1555452|NCT00008385|5072857|P2|Overall Study|Start non-protocol therapy|1
1555453|NCT00008385|5072858|P1|Overall Study|Start non-protocol therapy|3
1555454|NCT00008385|5072857|P2|Overall Study|Withdrawal by Subject|157
1555455|NCT00008385|5072858|P1|Overall Study|Withdrawal by Subject|67
1555456|NCT00008385|5072857|P2|Overall Study|Death|18
1555457|NCT00008385|5072858|P1|Overall Study|Death|12
1555458|NCT00008385|5072857|P2|Overall Study|Adverse Event|20
1555459|NCT00008385|5072858|P1|Overall Study|Adverse Event|8
1555460|NCT00008385|5072857|P2|Overall Study|Progressive disease|117
1555461|NCT00008385|5072858|P1|Overall Study|Progressive disease|52
1555462|NCT00008385|5072857|P2|Overall Study|Off treatment reasons not reported|70
1555463|NCT00008385|5072858|P1|Overall Study|Off treatment reasons not reported|79
1555464|NCT00008138|5072868|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
1555465|NCT00008138|5072868|P1|Post-Cytoreduction Chemotherapy|Progression|1
1555466|NCT00008138|5072868|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
1555467|NCT00008138|5072868|P1|Interval Debulking|Withdrawal by Subject|2
1555468|NCT00008138|5072868|P1|Neoadjuvant Chemotherapy|not protocol specified|8
1555469|NCT00008138|5072868|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
1555470|NCT00008138|5072868|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
1555471|NCT00008138|5072868|P1|Neoadjuvant Chemotherapy|Adverse Event|3
1555472|NCT00006916|5072874|P1|Overall Study|Complication of device insertion|1
1555473|NCT00006916|5072874|P1|Overall Study|Device not inserted|4
1555474|NCT00006903|5072880|P3|Overall Study|Ineligible|2
1555475|NCT00006903|5072881|P2|Overall Study|Ineligible|1
1555476|NCT00006903|5072882|P1|Overall Study|Ineligible|10
1555477|NCT00006903|5072880|P3|Overall Study|Patient never treated|1
1555478|NCT00006903|5072881|P2|Overall Study|Patient never treated|0
1555479|NCT00006903|5072882|P1|Overall Study|Patient never treated|0
1555480|NCT00006903|5072880|P3|Overall Study|Death|0
1555481|NCT00006903|5072881|P2|Overall Study|Death|1
1555482|NCT00006903|5072882|P1|Overall Study|Death|0
1555483|NCT00006903|5072880|P3|Overall Study|Adverse Event|1
1555484|NCT00006903|5072881|P2|Overall Study|Adverse Event|0
1555485|NCT00006903|5072882|P1|Overall Study|Adverse Event|0
1555486|NCT00006903|5072880|P3|Overall Study|Refused further treatment|1
1555487|NCT00006903|5072881|P2|Overall Study|Refused further treatment|2
1555488|NCT00006903|5072882|P1|Overall Study|Refused further treatment|0
1555489|NCT00006903|5072880|P3|Overall Study|Still receiving treatment|1
1555490|NCT00006903|5072881|P2|Overall Study|Still receiving treatment|0
1555491|NCT00006903|5072882|P1|Overall Study|Still receiving treatment|0
1555492|NCT00006721|5072895|P3|Overall Study|Eligible but no Treatment Received|0
1555493|NCT00006721|5072896|P2|Overall Study|Eligible but no Treatment Received|0
1555494|NCT00006721|5072897|P1|Overall Study|Eligible but no Treatment Received|1
1555495|NCT00006721|5072895|P3|Overall Study|Ineligible|10
1555496|NCT00006721|5072896|P2|Overall Study|Ineligible|12
1555497|NCT00006721|5072897|P1|Overall Study|Ineligible|2
1555498|NCT00006721|5072895|P3|Overall Study|Other - Not Protocol Specified|7
1555499|NCT00006721|5072896|P2|Overall Study|Other - Not Protocol Specified|7
1555500|NCT00006721|5072897|P1|Overall Study|Other - Not Protocol Specified|0
1555501|NCT00006721|5072895|P3|Overall Study|Death|2
1555502|NCT00006721|5072896|P2|Overall Study|Death|1
1555503|NCT00006721|5072897|P1|Overall Study|Death|0
1555504|NCT00006721|5072895|P3|Overall Study|Progression/Relapse|2
1555505|NCT00006721|5072896|P2|Overall Study|Progression/Relapse|1
1555506|NCT00006721|5072897|P1|Overall Study|Progression/Relapse|0
1555507|NCT00006721|5072895|P3|Overall Study|Refusal Unrelated to Adverse Event|8
1555508|NCT00006721|5072896|P2|Overall Study|Refusal Unrelated to Adverse Event|0
1555509|NCT00006721|5072897|P1|Overall Study|Refusal Unrelated to Adverse Event|1
1555510|NCT00006721|5072895|P3|Overall Study|Adverse Event|4
1555511|NCT00006721|5072896|P2|Overall Study|Adverse Event|4
1555512|NCT00006721|5072897|P1|Overall Study|Adverse Event|0
1555513|NCT00006478|5072915|P1|Overall Study|Physician Decision|6
1555514|NCT00006478|5072915|P1|Overall Study|Vaccine could not be produced|1
1555515|NCT00006392|5072923|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
1555516|NCT00006392|5072924|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
1555517|NCT00006392|5072925|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
1555518|NCT00006392|5072926|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
1555519|NCT00006392|5072923|P4|Overall Study|Ineligible|5
1555520|NCT00006392|5072924|P3|Overall Study|Ineligible|5
1555521|NCT00006392|5072925|P2|Overall Study|Ineligible|3
1555522|NCT00006392|5072926|P1|Overall Study|Ineligible|11
1555523|NCT00006389|5072956|P1|Overall Study|Adverse Event|1
1555524|NCT00006237|5072973|P2|Overall Study|Not protocol specified|5
1555525|NCT00006237|5072974|P1|Overall Study|Not protocol specified|14
1555526|NCT00006237|5072973|P2|Overall Study|Withdrawal by Subject|1
1555527|NCT00006237|5072974|P1|Overall Study|Withdrawal by Subject|0
1555528|NCT00006237|5072973|P2|Overall Study|Not eligible|20
1555529|NCT00006237|5072974|P1|Overall Study|Not eligible|9
1555530|NCT00006237|5072973|P2|Overall Study|Progression/relapse|2
1555531|NCT00006237|5072974|P1|Overall Study|Progression/relapse|54
1555532|NCT00006237|5072973|P2|Overall Study|Refusal unrelated to adverse effects|4
1555533|NCT00006237|5072974|P1|Overall Study|Refusal unrelated to adverse effects|8
1555534|NCT00006237|5072973|P2|Overall Study|Death|0
1555535|NCT00006237|5072974|P1|Overall Study|Death|1
1555536|NCT00006237|5072973|P2|Overall Study|Adverse Event|29
1555537|NCT00006237|5072974|P1|Overall Study|Adverse Event|39
1555538|NCT00006011|5073011|P3|Overall Study|Ineligible|9
1555539|NCT00006011|5073012|P2|Overall Study|Ineligible|16
1555540|NCT00006011|5073013|P1|Overall Study|Ineligible|18
1555541|NCT00006011|5073011|P3|Overall Study|Not specified|5
1555542|NCT00006011|5073012|P2|Overall Study|Not specified|2
1555543|NCT00006011|5073013|P1|Overall Study|Not specified|4
1555544|NCT00006011|5073011|P3|Overall Study|Death|2
1555545|NCT00006011|5073012|P2|Overall Study|Death|1
1555546|NCT00006011|5073013|P1|Overall Study|Death|0
1555547|NCT00006011|5073011|P3|Overall Study|Adverse Event|5
1555548|NCT00006011|5073012|P2|Overall Study|Adverse Event|39
1555549|NCT00006011|5073013|P1|Overall Study|Adverse Event|15
1555550|NCT00006011|5073011|P3|Overall Study|Refused further treatment|26
1555551|NCT00006011|5073012|P2|Overall Study|Refused further treatment|13
1555552|NCT00006011|5073013|P1|Overall Study|Refused further treatment|15
1555553|NCT00006011|5073011|P3|Overall Study|Disease progression|26
1555554|NCT00006011|5073012|P2|Overall Study|Disease progression|6
1555555|NCT00006011|5073013|P1|Overall Study|Disease progression|13
1555556|NCT00005957|5073021|P2|Overall Study|Crossover to the other arm|19
1555557|NCT00005957|5073022|P1|Overall Study|Crossover to the other arm|5
1555558|NCT00005957|5073021|P2|Overall Study|No treated|9
1555559|NCT00005957|5073022|P1|Overall Study|No treated|3
1555560|NCT00005879|5073032|P2|Overall Study|Withdrawal by Subject|10
1555561|NCT00005879|5073033|P1|Overall Study|Withdrawal by Subject|8
1555562|NCT00005047|5073056|P4|Overall Study|Lack of Efficacy|0
1555563|NCT00005047|5073057|P3|Overall Study|Lack of Efficacy|0
1555564|NCT00005047|5073058|P2|Overall Study|Lack of Efficacy|0
1555565|NCT00005047|5073059|P1|Overall Study|Lack of Efficacy|1
1555566|NCT00005047|5073056|P4|Overall Study|Lost to Follow-up|0
1555567|NCT00005047|5073057|P3|Overall Study|Lost to Follow-up|0
1555568|NCT00005047|5073058|P2|Overall Study|Lost to Follow-up|0
1555569|NCT00005047|5073059|P1|Overall Study|Lost to Follow-up|1
1555570|NCT00005047|5073056|P4|Overall Study|Adverse Event|0
1555571|NCT00005047|5073057|P3|Overall Study|Adverse Event|0
1555572|NCT00005047|5073058|P2|Overall Study|Adverse Event|0
1555573|NCT00005047|5073059|P1|Overall Study|Adverse Event|5
1555574|NCT00005047|5073056|P4|Overall Study|Withdrawal by Subject|0
1555575|NCT00005047|5073057|P3|Overall Study|Withdrawal by Subject|0
1555576|NCT00005047|5073058|P2|Overall Study|Withdrawal by Subject|0
1555577|NCT00005047|5073059|P1|Overall Study|Withdrawal by Subject|12
1555578|NCT00005044|5073075|P2|Overall Study|No protocol treatment|1
1555579|NCT00005044|5073076|P1|Overall Study|No protocol treatment|0
1555580|NCT00005044|5073075|P2|Overall Study|Withdrawal by Subject|5
1555581|NCT00005044|5073076|P1|Overall Study|Withdrawal by Subject|1
1555582|NCT00005044|5073075|P2|Overall Study|Protocol Violation|46
1555583|NCT00005044|5073076|P1|Overall Study|Protocol Violation|37
1555584|NCT00004888|5073096|P2|Overall Study|Toxic death|0
1555585|NCT00004888|5073097|P1|Overall Study|Toxic death|1
1555586|NCT00004888|5073096|P2|Overall Study|Death without progressive disease|1
1555587|NCT00004888|5073097|P1|Overall Study|Death without progressive disease|0
1555588|NCT00004888|5073096|P2|Overall Study|Progressive Disease|9
1555589|NCT00004888|5073097|P1|Overall Study|Progressive Disease|4
1555590|NCT00004888|5073096|P2|Overall Study|Physician Decision|1
1555591|NCT00004888|5073097|P1|Overall Study|Physician Decision|1
1555592|NCT00004888|5073096|P2|Overall Study|Withdrawal by Subject|3
1555593|NCT00004888|5073097|P1|Overall Study|Withdrawal by Subject|0
1555594|NCT00004888|5073096|P2|Overall Study|Adverse Event|10
1555595|NCT00004888|5073097|P1|Overall Study|Adverse Event|5
1555596|NCT00004859|5073115|P2|Overall Study|Not specified|21
1555597|NCT00004859|5073116|P1|Overall Study|Not specified|13
1555598|NCT00004859|5073115|P2|Overall Study|missing data|11
1555599|NCT00004859|5073116|P1|Overall Study|missing data|14
1555600|NCT00004859|5073115|P2|Overall Study|error|1
1555601|NCT00004859|5073116|P1|Overall Study|error|3
1555602|NCT00004859|5073115|P2|Overall Study|other disease|3
1555603|NCT00004859|5073116|P1|Overall Study|other disease|0
1555604|NCT00004859|5073115|P2|Overall Study|Protocol Violation|2
1555605|NCT00004859|5073116|P1|Overall Study|Protocol Violation|2
1555606|NCT00004859|5073115|P2|Overall Study|Withdrawal by Subject|33
1555607|NCT00004859|5073116|P1|Overall Study|Withdrawal by Subject|7
1555608|NCT00004859|5073115|P2|Overall Study|Death|5
1555609|NCT00004859|5073116|P1|Overall Study|Death|5
1555610|NCT00004859|5073115|P2|Overall Study|Adverse Event|93
1555611|NCT00004859|5073116|P1|Overall Study|Adverse Event|31
1555612|NCT00004859|5073115|P2|Overall Study|Lack of Efficacy|113
1555613|NCT00004859|5073116|P1|Overall Study|Lack of Efficacy|43
1555614|NCT00004259|5073130|P4|Overall Study|Withdrawal by Subject|0
1555615|NCT00004259|5073131|P3|Overall Study|Withdrawal by Subject|0
1555616|NCT00004259|5073132|P2|Overall Study|Withdrawal by Subject|2
1555617|NCT00004259|5073133|P1|Overall Study|Withdrawal by Subject|0
1555618|NCT00004259|5073130|P4|Overall Study|Protocol Violation|0
1555619|NCT00004259|5073131|P3|Overall Study|Protocol Violation|0
1555620|NCT00004259|5073132|P2|Overall Study|Protocol Violation|2
1555621|NCT00004259|5073133|P1|Overall Study|Protocol Violation|1
1555622|NCT00004228|5073154|P7|Overall Study|ineligible|5
1555623|NCT00004228|5073155|P6|Overall Study|ineligible|2
1555624|NCT00004228|5073156|P5|Overall Study|ineligible|1
1555625|NCT00004228|5073157|P4|Overall Study|ineligible|1
1555626|NCT00004228|5073158|P3|Overall Study|ineligible|4
1555627|NCT00004228|5073159|P2|Overall Study|ineligible|2
1555628|NCT00004228|5073160|P1|Overall Study|ineligible|4
1555629|NCT00004228|5073154|P7|Overall Study|Other|0
1555630|NCT00004228|5073155|P6|Overall Study|Other|0
1555631|NCT00004228|5073156|P5|Overall Study|Other|0
1555632|NCT00004228|5073157|P4|Overall Study|Other|0
1555633|NCT00004228|5073158|P3|Overall Study|Other|1
1555634|NCT00004228|5073159|P2|Overall Study|Other|0
1555635|NCT00004228|5073160|P1|Overall Study|Other|0
1555636|NCT00004228|5073154|P7|Overall Study|Withdrawal by Subject|2
1555637|NCT00004228|5073155|P6|Overall Study|Withdrawal by Subject|1
1555638|NCT00004228|5073156|P5|Overall Study|Withdrawal by Subject|2
1555639|NCT00004228|5073157|P4|Overall Study|Withdrawal by Subject|0
1555640|NCT00004228|5073158|P3|Overall Study|Withdrawal by Subject|1
1555641|NCT00004228|5073159|P2|Overall Study|Withdrawal by Subject|0
1555642|NCT00004228|5073160|P1|Overall Study|Withdrawal by Subject|3
1555643|NCT00004228|5073154|P7|Overall Study|Protocol Violation|0
1555644|NCT00004228|5073155|P6|Overall Study|Protocol Violation|2
1555645|NCT00004228|5073156|P5|Overall Study|Protocol Violation|1
1555646|NCT00004228|5073157|P4|Overall Study|Protocol Violation|1
1555647|NCT00004228|5073158|P3|Overall Study|Protocol Violation|2
1555648|NCT00004228|5073159|P2|Overall Study|Protocol Violation|5
1555649|NCT00004228|5073160|P1|Overall Study|Protocol Violation|0
1555650|NCT00004228|5073154|P7|Overall Study|Physician Decision|1
1555651|NCT00004228|5073155|P6|Overall Study|Physician Decision|1
1555652|NCT00004228|5073156|P5|Overall Study|Physician Decision|1
1555653|NCT00004228|5073157|P4|Overall Study|Physician Decision|2
1555654|NCT00004228|5073158|P3|Overall Study|Physician Decision|3
1555655|NCT00004228|5073159|P2|Overall Study|Physician Decision|0
1555656|NCT00004228|5073160|P1|Overall Study|Physician Decision|1
1555657|NCT00004228|5073154|P7|Overall Study|Lost to Follow-up|0
1555658|NCT00004228|5073155|P6|Overall Study|Lost to Follow-up|0
1555659|NCT00004228|5073156|P5|Overall Study|Lost to Follow-up|0
1555660|NCT00004228|5073157|P4|Overall Study|Lost to Follow-up|0
1555661|NCT00004228|5073158|P3|Overall Study|Lost to Follow-up|1
1555662|NCT00004228|5073159|P2|Overall Study|Lost to Follow-up|0
1555663|NCT00004228|5073160|P1|Overall Study|Lost to Follow-up|0
1555664|NCT00004228|5073154|P7|Overall Study|Lack of Efficacy|4
1555665|NCT00004228|5073155|P6|Overall Study|Lack of Efficacy|8
1555666|NCT00004228|5073156|P5|Overall Study|Lack of Efficacy|9
1555667|NCT00004228|5073157|P4|Overall Study|Lack of Efficacy|3
1555668|NCT00004228|5073158|P3|Overall Study|Lack of Efficacy|5
1555669|NCT00004228|5073159|P2|Overall Study|Lack of Efficacy|6
1555670|NCT00004228|5073160|P1|Overall Study|Lack of Efficacy|1
1555671|NCT00004228|5073154|P7|Overall Study|Death|0
1555672|NCT00004228|5073155|P6|Overall Study|Death|0
1555673|NCT00004228|5073156|P5|Overall Study|Death|1
1555674|NCT00004228|5073157|P4|Overall Study|Death|0
1555675|NCT00004228|5073158|P3|Overall Study|Death|2
1555676|NCT00004228|5073159|P2|Overall Study|Death|1
1555677|NCT00004228|5073160|P1|Overall Study|Death|0
1555678|NCT00004228|5073154|P7|Overall Study|Adverse Event|0
1555679|NCT00004228|5073155|P6|Overall Study|Adverse Event|0
1555680|NCT00004228|5073156|P5|Overall Study|Adverse Event|1
1555681|NCT00004228|5073157|P4|Overall Study|Adverse Event|0
1555682|NCT00004228|5073158|P3|Overall Study|Adverse Event|0
1555683|NCT00004228|5073159|P2|Overall Study|Adverse Event|1
1555684|NCT00004228|5073160|P1|Overall Study|Adverse Event|0
1555685|NCT00003901|5073226|P1|Overall Study|Medical problems|6
1555686|NCT00003901|5073226|P1|Overall Study|Chest X-Ray not done prior registration|1
1555687|NCT00003901|5073226|P1|Overall Study|CT Scan not within protocol requirement|2
1555688|NCT00003901|5073226|P1|Overall Study|Ineligible|6
1555689|NCT00003901|5073226|P1|Overall Study|Withdrawal by Subject|1
1555690|NCT00003901|5073226|P1|Overall Study|Adverse Event|1
1555691|NCT00003896|5073237|P1|Overall Study|ineligible|5
1555692|NCT00003896|5073237|P1|Overall Study|not protocol specified|3
1555693|NCT00003896|5073237|P1|Overall Study|Death|3
1555694|NCT00003896|5073237|P1|Overall Study|Lack of Efficacy|1
1555695|NCT00003896|5073237|P1|Overall Study|Withdrawal by Subject|1
1555696|NCT00003896|5073237|P1|Overall Study|Adverse Event|16
1555697|NCT00003875|5073243|P1|Overall Study|Screen Failed|1
1555698|NCT00003869|5073252|P2|Overall Study|Alternative treatmnt, medical problems|4
1555699|NCT00003869|5073253|P1|Overall Study|Alternative treatmnt, medical problems|5
1555700|NCT00003869|5073252|P2|Overall Study|Death|2
1555701|NCT00003869|5073253|P1|Overall Study|Death|1
1555702|NCT00003869|5073252|P2|Overall Study|Withdrawal by Subject|3
1555703|NCT00003869|5073253|P1|Overall Study|Withdrawal by Subject|21
1555704|NCT00003869|5073252|P2|Overall Study|Adverse Event|3
1555705|NCT00003869|5073253|P1|Overall Study|Adverse Event|14
1555706|NCT00003782|5073279|P3|Overall Study|No follow up data|26
1555707|NCT00003782|5073280|P2|Overall Study|No follow up data|31
1555708|NCT00003782|5073281|P1|Overall Study|No follow up data|30
1555709|NCT00003702|5073291|P2|Overall Study|Inadequate documentation of disease|3
1555710|NCT00003702|5073292|P1|Overall Study|Inadequate documentation of disease|1
1555711|NCT00003702|5073291|P2|Overall Study|WHO score > 6|1
1555712|NCT00003702|5073292|P1|Overall Study|WHO score > 6|2
1555713|NCT00003702|5073291|P2|Overall Study|Did not meet criteria for persistence|5
1555714|NCT00003702|5073292|P1|Overall Study|Did not meet criteria for persistence|8
1555715|NCT00003702|5073291|P2|Overall Study|Ineligible cell types|2
1555716|NCT00003702|5073292|P1|Overall Study|Ineligible cell types|2
1555717|NCT00003659|5073301|P1|Overall Study|Withdrawal by Subject|3
1555718|NCT00003641|5073309|P2|Overall Study|Never started interferon|12
1555719|NCT00003641|5073310|P1|Overall Study|Never started interferon|567
1555720|NCT00003641|5073309|P2|Overall Study|Should not receive interferon therapy|0
1555721|NCT00003641|5073310|P1|Overall Study|Should not receive interferon therapy|2
1555722|NCT00003641|5073309|P2|Overall Study|Unknown/missing|22
1555723|NCT00003641|5073310|P1|Overall Study|Unknown/missing|0
1555724|NCT00003641|5073309|P2|Overall Study|Disease progression|2
1555725|NCT00003641|5073310|P1|Overall Study|Disease progression|0
1555726|NCT00003641|5073309|P2|Overall Study|Adverse Event|38
1555727|NCT00003641|5073310|P1|Overall Study|Adverse Event|0
1555728|NCT00003641|5073309|P2|Overall Study|Withdrawal by Subject|100
1555729|NCT00003641|5073310|P1|Overall Study|Withdrawal by Subject|0
1555730|NCT00003631|5073321|P3|Overall Study|Evaluable for toxicity only|2
1555731|NCT00003631|5073322|P2|Overall Study|Evaluable for toxicity only|0
1555732|NCT00003631|5073323|P1|Overall Study|Evaluable for toxicity only|0
1555733|NCT00003631|5073321|P3|Overall Study|Death|1
1555734|NCT00003631|5073322|P2|Overall Study|Death|0
1555735|NCT00003631|5073323|P1|Overall Study|Death|0
1555736|NCT00003631|5073321|P3|Overall Study|Adverse Event|5
1555737|NCT00003631|5073322|P2|Overall Study|Adverse Event|1
1555738|NCT00003631|5073323|P1|Overall Study|Adverse Event|1
1555739|NCT00003631|5073321|P3|Overall Study|Protocol Violation|0
1555740|NCT00003631|5073322|P2|Overall Study|Protocol Violation|0
1555741|NCT00003631|5073323|P1|Overall Study|Protocol Violation|1
1555742|NCT00003631|5073321|P3|Overall Study|Patient not treated|1
1555743|NCT00003631|5073322|P2|Overall Study|Patient not treated|0
1555744|NCT00003631|5073323|P1|Overall Study|Patient not treated|1
1555745|NCT00003590|5073331|P1|Overall Study|Physician Decision|1
1555746|NCT00003590|5073331|P1|Overall Study|Death|1
1555747|NCT00003590|5073331|P1|Overall Study|Lack of Efficacy|11
1555748|NCT00003590|5073331|P1|Overall Study|Withdrawal by Subject|1
1555749|NCT00003590|5073331|P1|Overall Study|Adverse Event|7
1555750|NCT00003590|5073331|P1|Overall Study|Ineligible Patient|1
1555751|NCT00003537|5073336|P1|Overall Study|Not evalauable|1
1555752|NCT00003535|5073341|P1|Overall Study|Not evaluable|5
1555753|NCT00003483|5073346|P1|Overall Study|Not evaluable|1
1555754|NCT00003479|5073351|P1|Overall Study|Not evaluable|3
1555755|NCT00003477|5073356|P1|Overall Study|Not evalauable|4
1555756|NCT00003476|5073361|P1|Overall Study|Not evaluable|1
1555757|NCT00003475|5073366|P1|Overall Study|Not evaluable|13
1555758|NCT00003474|5073371|P1|Overall Study|Not Evaluable|14
1555759|NCT00003473|5073376|P1|Overall Study|Three patients were not evaluable.|3
1555760|NCT00003472|5073381|P1|Overall Study|Not evaluable|3
1555761|NCT00003471|5073386|P1|Overall Study|Not evaluable|4
1555762|NCT00003470|5073391|P1|Overall Study|Not evaluable|6
1555763|NCT00003458|5073416|P1|Overall Study|Not evaluable|4
1555764|NCT00003457|5073421|P1|Overall Study|Not evaluable|9
1555765|NCT00003456|5073426|P1|Overall Study|Not evaluable|8
1555766|NCT00003389|5073438|P2|Overall Study|Ineligible|27
1555767|NCT00003389|5073439|P1|Overall Study|Ineligible|33
1555768|NCT00003389|5073438|P2|Overall Study|Off-treatment reason missing|21
1555769|NCT00003389|5073439|P1|Overall Study|Off-treatment reason missing|31
1555770|NCT00003389|5073438|P2|Overall Study|Complicating disease|0
1555771|NCT00003389|5073439|P1|Overall Study|Complicating disease|1
1555772|NCT00003389|5073438|P2|Overall Study|Alternative therapy|1
1555773|NCT00003389|5073439|P1|Overall Study|Alternative therapy|2
1555774|NCT00003389|5073438|P2|Overall Study|Withdrawal by Subject|5
1555775|NCT00003389|5073439|P1|Overall Study|Withdrawal by Subject|12
1555776|NCT00003389|5073438|P2|Overall Study|Death|3
1555777|NCT00003389|5073439|P1|Overall Study|Death|0
1555778|NCT00003389|5073438|P2|Overall Study|Adverse Event|2
1555779|NCT00003389|5073439|P1|Overall Study|Adverse Event|13
1555780|NCT00003389|5073438|P2|Overall Study|Disease progression|1
1555781|NCT00003389|5073439|P1|Overall Study|Disease progression|6
1555782|NCT00003377|5073454|P5|Period II|Ureteral stent complications|1
1555783|NCT00003377|5073455|P4|Period II|Ureteral stent complications|0
1555784|NCT00003377|5073456|P3|Period II|Ureteral stent complications|0
1555785|NCT00003377|5073457|P2|Period II|Ureteral stent complications|0
1555786|NCT00003377|5073458|P1|Period II|Ureteral stent complications|0
1555787|NCT00003377|5073454|P5|Period I|Dose Limiting Toxicity(DLT)|0
1555788|NCT00003377|5073455|P4|Period I|Dose Limiting Toxicity(DLT)|1
1555789|NCT00003377|5073456|P3|Period I|Dose Limiting Toxicity(DLT)|1
1555790|NCT00003377|5073457|P2|Period I|Dose Limiting Toxicity(DLT)|0
1555791|NCT00003377|5073458|P1|Period I|Dose Limiting Toxicity(DLT)|0
1555792|NCT00003199|5073472|P1|Overall Study|Screen fail|15
1555793|NCT00003199|5073472|P1|Overall Study|Lack of insurance clearance|2
1555794|NCT00003199|5073472|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
1555795|NCT00003138|5073480|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
1555796|NCT00003138|5073481|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
1555797|NCT00003138|5073480|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
1555798|NCT00003138|5073481|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
1555799|NCT00003138|5073480|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
1555800|NCT00003138|5073481|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
1555801|NCT00003138|5073480|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
1555802|NCT00003138|5073481|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
1555803|NCT00003138|5073480|P2|Step 1|Never started treatment|0
1555804|NCT00003138|5073481|P1|Step 1|Never started treatment|1
1555805|NCT00003138|5073480|P2|Step 1|Reasons off treatment not documented|57
1555806|NCT00003138|5073481|P1|Step 1|Reasons off treatment not documented|60
1555807|NCT00002931|5073498|P1|Overall Study|rapidly progressing disease during|2
1555808|NCT00002874|5073506|P2|Overall Study|Protocol Violation|34
1555809|NCT00002874|5073507|P1|Overall Study|Protocol Violation|44
1555810|NCT00002874|5073506|P2|Overall Study|Withdrawal by Subject|1
1555811|NCT00002874|5073507|P1|Overall Study|Withdrawal by Subject|1
1555812|NCT00002850|5073532|P3|Overall Study|Withdrawal by Subject|0
1555813|NCT00002850|5073533|P2|Overall Study|Withdrawal by Subject|1
1555814|NCT00002850|5073534|P1|Overall Study|Withdrawal by Subject|0
1555815|NCT00002850|5073532|P3|Overall Study|Protocol Violation|1
1555816|NCT00002850|5073533|P2|Overall Study|Protocol Violation|0
1555817|NCT00002850|5073534|P1|Overall Study|Protocol Violation|1
1555818|NCT00002850|5073532|P3|Overall Study|Death|3
1555819|NCT00002850|5073533|P2|Overall Study|Death|1
1555820|NCT00002850|5073534|P1|Overall Study|Death|4
1555821|NCT00002842|5073542|P1|Overall Study|ineligible for surgical resection|27
1555822|NCT00002766|5073548|P2|Overall Study|Protocol Violation|0
1555823|NCT00002766|5073549|P1|Overall Study|Protocol Violation|1
1555824|NCT00002766|5073548|P2|Overall Study|Adverse Event|1
1555825|NCT00002766|5073549|P1|Overall Study|Adverse Event|1
1555826|NCT00002766|5073548|P2|Overall Study|Patient Not Treated|2
1555827|NCT00002766|5073549|P1|Overall Study|Patient Not Treated|1
1555828|NCT00002766|5073548|P2|Overall Study|Withdrawal by Subject|1
1555829|NCT00002766|5073549|P1|Overall Study|Withdrawal by Subject|0
1555830|NCT00002651|5073557|P3|Consolidation and Randomization|not eligible|112
1555831|NCT00002651|5073558|P2|Consolidation and Randomization|not eligible|102
1555832|NCT00002651|5073559|P1|Consolidation and Randomization|not eligible|0
1555833|NCT00002651|5073557|P3|Consolidation and Randomization|not specified|313
1555834|NCT00002651|5073558|P2|Consolidation and Randomization|not specified|314
1555835|NCT00002651|5073559|P1|Consolidation and Randomization|not specified|0
1555836|NCT00002651|5073557|P3|Consolidation and Randomization|Death|48
1555837|NCT00002651|5073558|P2|Consolidation and Randomization|Death|38
1555838|NCT00002651|5073559|P1|Consolidation and Randomization|Death|0
1555839|NCT00002651|5073557|P3|Consolidation and Randomization|Progression/relapse|298
1555840|NCT00002651|5073558|P2|Consolidation and Randomization|Progression/relapse|295
1555841|NCT00002651|5073559|P1|Consolidation and Randomization|Progression/relapse|0
1555842|NCT00002651|5073557|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
1555843|NCT00002651|5073558|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
1555844|NCT00002651|5073559|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
1555845|NCT00002651|5073557|P3|Consolidation and Randomization|Adverse Event|14
1555846|NCT00002651|5073558|P2|Consolidation and Randomization|Adverse Event|36
1555847|NCT00002651|5073559|P1|Consolidation and Randomization|Adverse Event|0
1555848|NCT00002651|5073557|P3|Induction|not eligible|0
1555849|NCT00002651|5073558|P2|Induction|not eligible|0
1555850|NCT00002651|5073559|P1|Induction|not eligible|90
1555851|NCT00002651|5073557|P3|Induction|not specified|0
1555852|NCT00002651|5073558|P2|Induction|not specified|0
1555853|NCT00002651|5073559|P1|Induction|not specified|823
1555854|NCT00002651|5073557|P3|Induction|Death|0
1555855|NCT00002651|5073558|P2|Induction|Death|0
1555856|NCT00002651|5073559|P1|Induction|Death|62
1555857|NCT00002651|5073557|P3|Induction|Progression/relapse|0
1555858|NCT00002651|5073558|P2|Induction|Progression/relapse|0
1555859|NCT00002651|5073559|P1|Induction|Progression/relapse|274
1555860|NCT00002651|5073557|P3|Induction|Refusal unrelated to adverse event|0
1555861|NCT00002651|5073558|P2|Induction|Refusal unrelated to adverse event|0
1555862|NCT00002651|5073559|P1|Induction|Refusal unrelated to adverse event|50
1555863|NCT00002651|5073557|P3|Induction|Adverse Event|0
1555864|NCT00002651|5073558|P2|Induction|Adverse Event|0
1555865|NCT00002651|5073559|P1|Induction|Adverse Event|44
1555866|NCT00002558|5073577|P2|Overall Study|Withdrawal by Subject|1
1555867|NCT00002558|5073578|P1|Overall Study|Withdrawal by Subject|0
1555868|NCT00051636|5073603|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
1555869|NCT00051636|5073604|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
1555870|NCT00051636|5073603|P2|Period 2- Extended Observation Period|Death|5
1555871|NCT00051636|5073604|P1|Period 2- Extended Observation Period|Death|4
1555872|NCT00051636|5073603|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
1555873|NCT00051636|5073604|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
1555874|NCT00051636|5073603|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
1555875|NCT00051636|5073604|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
1555876|NCT00051636|5073603|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
1555877|NCT00051636|5073604|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
1555878|NCT00051636|5073603|P2|Period 1 - Core|Lost to Follow-up|2
1555879|NCT00051636|5073604|P1|Period 1 - Core|Lost to Follow-up|0
1555880|NCT00051636|5073603|P2|Period 1 - Core|Withdrawal by Subject|2
1555881|NCT00051636|5073604|P1|Period 1 - Core|Withdrawal by Subject|1
1555882|NCT00051636|5073603|P2|Period 1 - Core|Protocol Violation|0
1555883|NCT00051636|5073604|P1|Period 1 - Core|Protocol Violation|1
1555884|NCT00051636|5073603|P2|Period 1 - Core|Adverse Event|2
1555885|NCT00051636|5073604|P1|Period 1 - Core|Adverse Event|2
1555886|NCT00051558|5073632|P2|Overall Study|Physician Decision|0
1555887|NCT00051558|5073633|P1|Overall Study|Physician Decision|5
1555888|NCT00051558|5073632|P2|Overall Study|Significant Lab Value|0
1555889|NCT00051558|5073633|P1|Overall Study|Significant Lab Value|2
1555890|NCT00051558|5073632|P2|Overall Study|Other|1
1555891|NCT00051558|5073633|P1|Overall Study|Other|2
1555892|NCT00051558|5073632|P2|Overall Study|Sponsor Decision|1
1555893|NCT00051558|5073633|P1|Overall Study|Sponsor Decision|6
1555894|NCT00051558|5073632|P2|Overall Study|Protocol Entry Criteria Unmet|2
1555895|NCT00051558|5073633|P1|Overall Study|Protocol Entry Criteria Unmet|1
1555896|NCT00051558|5073632|P2|Overall Study|Protocol Violation|4
1555897|NCT00051558|5073633|P1|Overall Study|Protocol Violation|3
1555898|NCT00051558|5073632|P2|Overall Study|Lost to Follow-up|13
1555899|NCT00051558|5073633|P1|Overall Study|Lost to Follow-up|4
1555900|NCT00051558|5073632|P2|Overall Study|Death|15
1555901|NCT00051558|5073633|P1|Overall Study|Death|9
1555902|NCT00051558|5073632|P2|Overall Study|Withdrawal by Subject|42
1555903|NCT00051558|5073633|P1|Overall Study|Withdrawal by Subject|29
1555904|NCT00051558|5073632|P2|Overall Study|Adverse Event|18
1555905|NCT00051558|5073633|P1|Overall Study|Adverse Event|30
1555906|NCT00051363|5073669|P2|Overall Study|Excluded Pre-Randomization|5
1555907|NCT00051363|5073670|P1|Overall Study|Excluded Pre-Randomization|2
1555908|NCT00051363|5073669|P2|Overall Study|Death|2
1555909|NCT00051363|5073670|P1|Overall Study|Death|2
1555910|NCT00051363|5073669|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
1555911|NCT00051363|5073670|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
1555912|NCT00051363|5073669|P2|Overall Study|Dropped Post-Rand for Any Reason|126
1555913|NCT00051363|5073670|P1|Overall Study|Dropped Post-Rand for Any Reason|102
1555914|NCT00051025|5073710|P2|Overall Study|Death|1
1555915|NCT00051025|5073711|P1|Overall Study|Death|0
1555916|NCT00051025|5073710|P2|Overall Study|Withdrawal by Subject|1
1555917|NCT00051025|5073711|P1|Overall Study|Withdrawal by Subject|0
1555918|NCT00051025|5073710|P2|Overall Study|Adverse Event|1
1555919|NCT00051025|5073711|P1|Overall Study|Adverse Event|1
1555920|NCT00051025|5073710|P2|Overall Study|Progressive Disease|1
1555921|NCT00051025|5073711|P1|Overall Study|Progressive Disease|1
1555922|NCT00050960|5073725|P2|Overall Study|Death|15
1555923|NCT00050960|5073726|P1|Overall Study|Death|13
1555924|NCT00050960|5073725|P2|Overall Study|Non-compliance|1
1555925|NCT00050960|5073726|P1|Overall Study|Non-compliance|3
1555926|NCT00050960|5073725|P2|Overall Study|Administrative|46
1555927|NCT00050960|5073726|P1|Overall Study|Administrative|31
1555928|NCT00050960|5073725|P2|Overall Study|Withdrawal by Subject|18
1555929|NCT00050960|5073726|P1|Overall Study|Withdrawal by Subject|23
1555930|NCT00050960|5073725|P2|Overall Study|Lost to Follow-up|1
1555931|NCT00050960|5073726|P1|Overall Study|Lost to Follow-up|0
1555932|NCT00050960|5073725|P2|Overall Study|Adverse Event|61
1555933|NCT00050960|5073726|P1|Overall Study|Adverse Event|62
1555934|NCT00050960|5073725|P2|Overall Study|Complete Response|2
1555935|NCT00050960|5073726|P1|Overall Study|Complete Response|0
1555936|NCT00050960|5073725|P2|Overall Study|Partial Response|19
1555937|NCT00050960|5073726|P1|Overall Study|Partial Response|14
1555938|NCT00050960|5073725|P2|Overall Study|Stable Disease|48
1555939|NCT00050960|5073726|P1|Overall Study|Stable Disease|19
1555940|NCT00050960|5073725|P2|Overall Study|Progressive Disease|93
1555941|NCT00050960|5073726|P1|Overall Study|Progressive Disease|137
1555942|NCT00050778|5073735|P3|Overall Study|Familial and personal reasons|0
1555943|NCT00050778|5073736|P2|Overall Study|Familial and personal reasons|0
1555944|NCT00050778|5073737|P1|Overall Study|Familial and personal reasons|1
1555945|NCT00050778|5073735|P3|Overall Study|Randomized but not treated|2
1555946|NCT00050778|5073736|P2|Overall Study|Randomized but not treated|5
1555947|NCT00050778|5073737|P1|Overall Study|Randomized but not treated|4
1555948|NCT00050778|5073735|P3|Overall Study|Withdrawal by Subject|4
1555949|NCT00050778|5073736|P2|Overall Study|Withdrawal by Subject|8
1555950|NCT00050778|5073737|P1|Overall Study|Withdrawal by Subject|6
1555951|NCT00050778|5073735|P3|Overall Study|Protocol Violation|1
1555952|NCT00050778|5073736|P2|Overall Study|Protocol Violation|0
1555953|NCT00050778|5073737|P1|Overall Study|Protocol Violation|2
1555954|NCT00050778|5073735|P3|Overall Study|Physician Decision|2
1555955|NCT00050778|5073736|P2|Overall Study|Physician Decision|0
1555956|NCT00050778|5073737|P1|Overall Study|Physician Decision|3
1555957|NCT00050778|5073735|P3|Overall Study|Lost to Follow-up|4
1555958|NCT00050778|5073736|P2|Overall Study|Lost to Follow-up|2
1555959|NCT00050778|5073737|P1|Overall Study|Lost to Follow-up|0
1555960|NCT00050778|5073735|P3|Overall Study|Lack of Efficacy|2
1555961|NCT00050778|5073736|P2|Overall Study|Lack of Efficacy|2
1555962|NCT00050778|5073737|P1|Overall Study|Lack of Efficacy|16
1555963|NCT00050778|5073735|P3|Overall Study|Death|1
1555964|NCT00050778|5073736|P2|Overall Study|Death|1
1555965|NCT00050778|5073737|P1|Overall Study|Death|0
1555966|NCT00050778|5073735|P3|Overall Study|Adverse Event|2
1555967|NCT00050778|5073736|P2|Overall Study|Adverse Event|3
1555968|NCT00050778|5073737|P1|Overall Study|Adverse Event|13
1555969|NCT00050622|5073763|P1|Overall Study|Adverse Event|1
1555970|NCT00050167|5073801|P2|Overall Study|not eligible not invasive|1
1555971|NCT00050167|5073802|P1|Overall Study|not eligible not invasive|1
1555972|NCT00050011|5073835|P2|Overall Study|Unknown - Reason is missing|2
1555973|NCT00050011|5073836|P1|Overall Study|Unknown - Reason is missing|0
1555974|NCT00050011|5073835|P2|Overall Study|Death|4
1555975|NCT00050011|5073836|P1|Overall Study|Death|7
1555976|NCT00050011|5073835|P2|Overall Study|Administrative problems|6
1555977|NCT00050011|5073836|P1|Overall Study|Administrative problems|10
1555978|NCT00050011|5073835|P2|Overall Study|Lost to Follow-up|9
1555979|NCT00050011|5073836|P1|Overall Study|Lost to Follow-up|7
1555980|NCT00050011|5073835|P2|Overall Study|Withdrawal by Subject|26
1555981|NCT00050011|5073836|P1|Overall Study|Withdrawal by Subject|34
1555982|NCT00050011|5073835|P2|Overall Study|Protocol Violation|10
1555983|NCT00050011|5073836|P1|Overall Study|Protocol Violation|4
1555984|NCT00050011|5073835|P2|Overall Study|Participant condition no longer required|0
1555985|NCT00050011|5073836|P1|Overall Study|Participant condition no longer required|1
1555986|NCT00050011|5073835|P2|Overall Study|Lack of Efficacy|21
1555987|NCT00050011|5073836|P1|Overall Study|Lack of Efficacy|16
1555988|NCT00050011|5073835|P2|Overall Study|Abnormal test procedure results|1
1555989|NCT00050011|5073836|P1|Overall Study|Abnormal test procedure results|0
1555990|NCT00050011|5073835|P2|Overall Study|Abnormal laboratory value(s)|1
1555991|NCT00050011|5073836|P1|Overall Study|Abnormal laboratory value(s)|1
1555992|NCT00050011|5073835|P2|Overall Study|Adverse Event|46
1555993|NCT00050011|5073836|P1|Overall Study|Adverse Event|41
1555994|NCT00049842|5073858|P2|Follow-up Phase|Not specified|4
1555995|NCT00049842|5073859|P1|Follow-up Phase|Not specified|1
1555996|NCT00049842|5073858|P2|Follow-up Phase|Adverse Event|1
1555997|NCT00049842|5073859|P1|Follow-up Phase|Adverse Event|6
1555998|NCT00049842|5073858|P2|Treatment Phase|Did not meet protocol eligibility|1
1555999|NCT00049842|5073859|P1|Treatment Phase|Did not meet protocol eligibility|0
1556000|NCT00049842|5073858|P2|Treatment Phase|Administrative|3
1556001|NCT00049842|5073859|P1|Treatment Phase|Administrative|0
1556002|NCT00049842|5073858|P2|Treatment Phase|Lost to Follow-up|8
1556003|NCT00049842|5073859|P1|Treatment Phase|Lost to Follow-up|4
1556004|NCT00049842|5073858|P2|Treatment Phase|Non-compliance with protocol|8
1556005|NCT00049842|5073859|P1|Treatment Phase|Non-compliance with protocol|7
1556006|NCT00049842|5073858|P2|Treatment Phase|Withdrawal by Subject|46
1556007|NCT00049842|5073859|P1|Treatment Phase|Withdrawal by Subject|35
1556008|NCT00049842|5073858|P2|Treatment Phase|Adverse Event|12
1556009|NCT00049842|5073859|P1|Treatment Phase|Adverse Event|47
1556010|NCT00048932|5073877|P3|Open Label Period (OL)|Participant Surgery|1
1556011|NCT00048932|5073878|P2|Open Label Period (OL)|Participant Surgery|0
1556012|NCT00048932|5073879|P1|Open Label Period (OL)|Participant Surgery|0
1556013|NCT00048932|5073877|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
1556014|NCT00048932|5073878|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
1556015|NCT00048932|5073879|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
1556016|NCT00048932|5073877|P3|Open Label Period (OL)|Site Staff Issues|2
1556017|NCT00048932|5073878|P2|Open Label Period (OL)|Site Staff Issues|0
1556018|NCT00048932|5073879|P1|Open Label Period (OL)|Site Staff Issues|0
1556019|NCT00048932|5073877|P3|Open Label Period (OL)|Investigator Decision|4
1556020|NCT00048932|5073878|P2|Open Label Period (OL)|Investigator Decision|0
1556021|NCT00048932|5073879|P1|Open Label Period (OL)|Investigator Decision|0
1556022|NCT00048932|5073877|P3|Open Label Period (OL)|Medication Lost Efficacy|1
1556023|NCT00048932|5073878|P2|Open Label Period (OL)|Medication Lost Efficacy|0
1556024|NCT00048932|5073879|P1|Open Label Period (OL)|Medication Lost Efficacy|0
1556025|NCT00048932|5073877|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
1556026|NCT00048932|5073878|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
1556027|NCT00048932|5073879|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
1556028|NCT00048932|5073877|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
1556029|NCT00048932|5073878|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
1556030|NCT00048932|5073879|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
1556031|NCT00048932|5073877|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
1556032|NCT00048932|5073878|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
1556033|NCT00048932|5073879|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
1556034|NCT00048932|5073877|P3|Open Label Period (OL)|Patient Decision|4
1556035|NCT00048932|5073878|P2|Open Label Period (OL)|Patient Decision|0
1556036|NCT00048932|5073879|P1|Open Label Period (OL)|Patient Decision|0
1556037|NCT00048932|5073877|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
1556038|NCT00048932|5073878|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
1556039|NCT00048932|5073879|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
1556040|NCT00048932|5073877|P3|Open Label Period (OL)|Trial Terminated|1
1556041|NCT00048932|5073878|P2|Open Label Period (OL)|Trial Terminated|0
1556042|NCT00048932|5073879|P1|Open Label Period (OL)|Trial Terminated|0
1556043|NCT00048932|5073877|P3|Open Label Period (OL)|Site Closure|3
1556044|NCT00048932|5073878|P2|Open Label Period (OL)|Site Closure|0
1556045|NCT00048932|5073879|P1|Open Label Period (OL)|Site Closure|0
1556046|NCT00048932|5073877|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
1556047|NCT00048932|5073878|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
1556048|NCT00048932|5073879|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
1556049|NCT00048932|5073877|P3|Open Label Period (OL)|Participant Relocated|6
1556050|NCT00048932|5073878|P2|Open Label Period (OL)|Participant Relocated|0
1556051|NCT00048932|5073879|P1|Open Label Period (OL)|Participant Relocated|0
1556052|NCT00048932|5073877|P3|Open Label Period (OL)|Participant Transportation Issues|1
1556053|NCT00048932|5073878|P2|Open Label Period (OL)|Participant Transportation Issues|0
1556054|NCT00048932|5073879|P1|Open Label Period (OL)|Participant Transportation Issues|0
1556055|NCT00048932|5073877|P3|Open Label Period (OL)|Investigator Retiring|2
1556056|NCT00048932|5073878|P2|Open Label Period (OL)|Investigator Retiring|0
1556057|NCT00048932|5073879|P1|Open Label Period (OL)|Investigator Retiring|0
1556058|NCT00048932|5073877|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
1556059|NCT00048932|5073878|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
1556060|NCT00048932|5073879|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
1556061|NCT00048932|5073877|P3|Open Label Period (OL)|Pregnancy|6
1556062|NCT00048932|5073878|P2|Open Label Period (OL)|Pregnancy|0
1556063|NCT00048932|5073879|P1|Open Label Period (OL)|Pregnancy|0
1556064|NCT00048932|5073877|P3|Open Label Period (OL)|Poor/Non-Compliance|13
1556065|NCT00048932|5073878|P2|Open Label Period (OL)|Poor/Non-Compliance|0
1556066|NCT00048932|5073879|P1|Open Label Period (OL)|Poor/Non-Compliance|0
1556067|NCT00048932|5073877|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
1556068|NCT00048932|5073878|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
1556069|NCT00048932|5073879|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
1556070|NCT00048932|5073877|P3|Open Label Period (OL)|Withdrawal by Subject|117
1556071|NCT00048932|5073878|P2|Open Label Period (OL)|Withdrawal by Subject|0
1556072|NCT00048932|5073879|P1|Open Label Period (OL)|Withdrawal by Subject|0
1556073|NCT00048932|5073877|P3|Open Label Period (OL)|Lost to Follow-up|27
1556074|NCT00048932|5073878|P2|Open Label Period (OL)|Lost to Follow-up|0
1556075|NCT00048932|5073879|P1|Open Label Period (OL)|Lost to Follow-up|0
1556076|NCT00048932|5073877|P3|Open Label Period (OL)|Lack of Efficacy|81
1556077|NCT00048932|5073878|P2|Open Label Period (OL)|Lack of Efficacy|0
1556078|NCT00048932|5073879|P1|Open Label Period (OL)|Lack of Efficacy|0
1556079|NCT00048932|5073877|P3|Open Label Period (OL)|Adverse Event|103
1556080|NCT00048932|5073878|P2|Open Label Period (OL)|Adverse Event|0
1556081|NCT00048932|5073879|P1|Open Label Period (OL)|Adverse Event|0
1556082|NCT00048932|5073877|P3|Open Label Period (OL)|Death|25
1556083|NCT00048932|5073878|P2|Open Label Period (OL)|Death|0
1556084|NCT00048932|5073879|P1|Open Label Period (OL)|Death|0
1556085|NCT00048932|5073877|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
1556086|NCT00048932|5073878|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
1556087|NCT00048932|5073879|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
1556088|NCT00048932|5073877|P3|Double Blind Period (DB)|Withdrawal by Subject|0
1556089|NCT00048932|5073878|P2|Double Blind Period (DB)|Withdrawal by Subject|10
1556090|NCT00048932|5073879|P1|Double Blind Period (DB)|Withdrawal by Subject|24
1556091|NCT00048932|5073877|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
1556092|NCT00048932|5073878|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
1556093|NCT00048932|5073879|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
1556094|NCT00048932|5073877|P3|Double Blind Period (DB)|Pregnancy|0
1556095|NCT00048932|5073878|P2|Double Blind Period (DB)|Pregnancy|0
1556096|NCT00048932|5073879|P1|Double Blind Period (DB)|Pregnancy|1
1556097|NCT00048932|5073877|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
1556098|NCT00048932|5073878|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
1556099|NCT00048932|5073879|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
1556100|NCT00048932|5073877|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
1556101|NCT00048932|5073878|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
1556102|NCT00048932|5073879|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
1556103|NCT00048932|5073877|P3|Double Blind Period (DB)|Relocation|0
1556104|NCT00048932|5073878|P2|Double Blind Period (DB)|Relocation|0
1556105|NCT00048932|5073879|P1|Double Blind Period (DB)|Relocation|1
1556106|NCT00048932|5073877|P3|Double Blind Period (DB)|Lost to Follow-up|0
1556107|NCT00048932|5073878|P2|Double Blind Period (DB)|Lost to Follow-up|4
1556108|NCT00048932|5073879|P1|Double Blind Period (DB)|Lost to Follow-up|3
1556109|NCT00048932|5073877|P3|Double Blind Period (DB)|Lack of Efficacy|0
1556110|NCT00048932|5073878|P2|Double Blind Period (DB)|Lack of Efficacy|44
1556111|NCT00048932|5073879|P1|Double Blind Period (DB)|Lack of Efficacy|26
1556112|NCT00048932|5073877|P3|Double Blind Period (DB)|Death|0
1556113|NCT00048932|5073878|P2|Double Blind Period (DB)|Death|3
1556114|NCT00048932|5073879|P1|Double Blind Period (DB)|Death|5
1556115|NCT00048932|5073877|P3|Double Blind Period (DB)|Adverse Event|0
1556116|NCT00048932|5073878|P2|Double Blind Period (DB)|Adverse Event|19
1556117|NCT00048932|5073879|P1|Double Blind Period (DB)|Adverse Event|51
1556118|NCT00048932|5073877|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
1556119|NCT00048932|5073878|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
1556120|NCT00048932|5073879|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
1556121|NCT00048581|5073921|P3|Open-Label Period|Study Ended By Sponsor|1
1556122|NCT00048581|5073922|P2|Open-Label Period|Study Ended By Sponsor|0
1556123|NCT00048581|5073923|P1|Open-Label Period|Study Ended By Sponsor|0
1556124|NCT00048581|5073921|P3|Open-Label Period|Primary Investigator Retired|2
1556125|NCT00048581|5073922|P2|Open-Label Period|Primary Investigator Retired|0
1556126|NCT00048581|5073923|P1|Open-Label Period|Primary Investigator Retired|0
1556127|NCT00048581|5073921|P3|Open-Label Period|Problem With Transportation To Site|1
1556128|NCT00048581|5073922|P2|Open-Label Period|Problem With Transportation To Site|0
1556129|NCT00048581|5073923|P1|Open-Label Period|Problem With Transportation To Site|0
1556130|NCT00048581|5073921|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
1556131|NCT00048581|5073922|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
1556132|NCT00048581|5073923|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
1556133|NCT00048581|5073921|P3|Open-Label Period|Study Site Closure|2
1556134|NCT00048581|5073922|P2|Open-Label Period|Study Site Closure|0
1556135|NCT00048581|5073923|P1|Open-Label Period|Study Site Closure|0
1556136|NCT00048581|5073921|P3|Open-Label Period|Pregnancy|7
1556137|NCT00048581|5073922|P2|Open-Label Period|Pregnancy|0
1556138|NCT00048581|5073923|P1|Open-Label Period|Pregnancy|0
1556139|NCT00048581|5073921|P3|Open-Label Period|Poor/Non-compliance|5
1556140|NCT00048581|5073922|P2|Open-Label Period|Poor/Non-compliance|0
1556141|NCT00048581|5073923|P1|Open-Label Period|Poor/Non-compliance|0
1556142|NCT00048581|5073921|P3|Open-Label Period|No Longer Meets Study Criteria|2
1556143|NCT00048581|5073922|P2|Open-Label Period|No Longer Meets Study Criteria|0
1556144|NCT00048581|5073923|P1|Open-Label Period|No Longer Meets Study Criteria|0
1556145|NCT00048581|5073921|P3|Open-Label Period|Withdrawal by Subject|20
1556146|NCT00048581|5073922|P2|Open-Label Period|Withdrawal by Subject|0
1556147|NCT00048581|5073923|P1|Open-Label Period|Withdrawal by Subject|0
1556148|NCT00048581|5073921|P3|Open-Label Period|Lost to Follow-up|14
1556149|NCT00048581|5073922|P2|Open-Label Period|Lost to Follow-up|0
1556150|NCT00048581|5073923|P1|Open-Label Period|Lost to Follow-up|0
1556151|NCT00048581|5073921|P3|Open-Label Period|Lack of Efficacy|69
1556152|NCT00048581|5073922|P2|Open-Label Period|Lack of Efficacy|0
1556153|NCT00048581|5073923|P1|Open-Label Period|Lack of Efficacy|0
1556154|NCT00048581|5073921|P3|Open-Label Period|Adverse Event|37
1556155|NCT00048581|5073922|P2|Open-Label Period|Adverse Event|0
1556156|NCT00048581|5073923|P1|Open-Label Period|Adverse Event|0
1556157|NCT00048581|5073921|P3|Open-Label Period|Death|4
1556158|NCT00048581|5073922|P2|Open-Label Period|Death|0
1556159|NCT00048581|5073923|P1|Open-Label Period|Death|0
1556160|NCT00048581|5073921|P3|Double-Blind Period|Investigator Decision|0
1556161|NCT00048581|5073922|P2|Double-Blind Period|Investigator Decision|0
1556162|NCT00048581|5073923|P1|Double-Blind Period|Investigator Decision|1
1556163|NCT00048581|5073921|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
1556164|NCT00048581|5073922|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
1556165|NCT00048581|5073923|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
1556166|NCT00048581|5073921|P3|Double-Blind Period|Withdrawal by Subject|0
1556167|NCT00048581|5073922|P2|Double-Blind Period|Withdrawal by Subject|2
1556168|NCT00048581|5073923|P1|Double-Blind Period|Withdrawal by Subject|5
1556169|NCT00048581|5073921|P3|Double-Blind Period|Lost to Follow-up|0
1556170|NCT00048581|5073922|P2|Double-Blind Period|Lost to Follow-up|0
1556171|NCT00048581|5073923|P1|Double-Blind Period|Lost to Follow-up|5
1556172|NCT00048581|5073921|P3|Double-Blind Period|Lack of Efficacy|0
1556173|NCT00048581|5073922|P2|Double-Blind Period|Lack of Efficacy|27
1556174|NCT00048581|5073923|P1|Double-Blind Period|Lack of Efficacy|14
1556175|NCT00048581|5073921|P3|Double-Blind Period|Adverse Event|0
1556176|NCT00048581|5073922|P2|Double-Blind Period|Adverse Event|5
1556177|NCT00048581|5073923|P1|Double-Blind Period|Adverse Event|9
1556178|NCT00048568|5074090|P3|Open-Label Period|Lost to Follow-up|7
1556179|NCT00048568|5074091|P2|Open-Label Period|Lost to Follow-up|0
1556180|NCT00048568|5074092|P1|Open-Label Period|Lost to Follow-up|0
1556181|NCT00048568|5074090|P3|Open-Label Period|Unknown Reasons|25
1556182|NCT00048568|5074091|P2|Open-Label Period|Unknown Reasons|0
1556183|NCT00048568|5074092|P1|Open-Label Period|Unknown Reasons|0
1556184|NCT00048568|5074090|P3|Open-Label Period|Administrative Decision By Sponsor|1
1556185|NCT00048568|5074091|P2|Open-Label Period|Administrative Decision By Sponsor|0
1556186|NCT00048568|5074092|P1|Open-Label Period|Administrative Decision By Sponsor|0
1556187|NCT00048568|5074090|P3|Open-Label Period|No Longer Met Study Criteria|2
1556188|NCT00048568|5074091|P2|Open-Label Period|No Longer Met Study Criteria|0
1556189|NCT00048568|5074092|P1|Open-Label Period|No Longer Met Study Criteria|0
1556190|NCT00048568|5074090|P3|Open-Label Period|Pregnancy|5
1556191|NCT00048568|5074091|P2|Open-Label Period|Pregnancy|0
1556192|NCT00048568|5074092|P1|Open-Label Period|Pregnancy|0
1556193|NCT00048568|5074090|P3|Open-Label Period|Withdrawal by Subject|26
1556194|NCT00048568|5074091|P2|Open-Label Period|Withdrawal by Subject|0
1556195|NCT00048568|5074092|P1|Open-Label Period|Withdrawal by Subject|0
1556196|NCT00048568|5074090|P3|Open-Label Period|Lack of Efficacy|32
1556197|NCT00048568|5074091|P2|Open-Label Period|Lack of Efficacy|0
1556198|NCT00048568|5074092|P1|Open-Label Period|Lack of Efficacy|0
1556199|NCT00048568|5074090|P3|Open-Label Period|Adverse Event|49
1556200|NCT00048568|5074091|P2|Open-Label Period|Adverse Event|0
1556201|NCT00048568|5074092|P1|Open-Label Period|Adverse Event|0
1556202|NCT00048568|5074090|P3|Open-Label Period|Death|13
1556203|NCT00048568|5074091|P2|Open-Label Period|Death|0
1556204|NCT00048568|5074092|P1|Open-Label Period|Death|0
1556205|NCT00048568|5074090|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
1556206|NCT00048568|5074091|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
1556207|NCT00048568|5074092|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
1556208|NCT00048568|5074090|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
1556209|NCT00048568|5074091|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
1556210|NCT00048568|5074092|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
1556211|NCT00048568|5074090|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
1556212|NCT00048568|5074091|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
1556213|NCT00048568|5074092|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
1556214|NCT00048568|5074090|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
1556215|NCT00048568|5074091|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
1556216|NCT00048568|5074092|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
1556217|NCT00048568|5074090|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
1556218|NCT00048568|5074091|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
1556219|NCT00048568|5074092|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
1556220|NCT00048568|5074090|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
1556221|NCT00048568|5074091|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
1556222|NCT00048568|5074092|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
1556223|NCT00048568|5074090|P3|Double-Blind Period Days 170 to 365|Death|0
1556224|NCT00048568|5074091|P2|Double-Blind Period Days 170 to 365|Death|1
1556225|NCT00048568|5074092|P1|Double-Blind Period Days 170 to 365|Death|1
1556226|NCT00048568|5074090|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
1556227|NCT00048568|5074091|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
1556228|NCT00048568|5074092|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
1556229|NCT00048568|5074090|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
1556230|NCT00048568|5074091|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
1556231|NCT00048568|5074092|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
1556232|NCT00048568|5074090|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
1556233|NCT00048568|5074091|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
1556234|NCT00048568|5074092|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
1556235|NCT00048568|5074090|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
1556236|NCT00048568|5074091|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
1556237|NCT00048568|5074092|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
1556238|NCT00048568|5074090|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
1556239|NCT00048568|5074091|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
1556240|NCT00048568|5074092|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
1556241|NCT00048724|5074397|P2|Overall Study|Administrative|1
1556242|NCT00048724|5074398|P1|Overall Study|Administrative|1
1556243|NCT00048724|5074397|P2|Overall Study|Did Not Meet Protocol Eligibility|2
1556244|NCT00048724|5074398|P1|Overall Study|Did Not Meet Protocol Eligibility|2
1556245|NCT00048724|5074397|P2|Overall Study|Noncompliance With Protocol|12
1556246|NCT00048724|5074398|P1|Overall Study|Noncompliance With Protocol|4
1556247|NCT00048724|5074397|P2|Overall Study|Protocol-defined Clinical Event|32
1556248|NCT00048724|5074398|P1|Overall Study|Protocol-defined Clinical Event|17
1556249|NCT00048724|5074397|P2|Overall Study|Lost to Follow-up|5
1556250|NCT00048724|5074398|P1|Overall Study|Lost to Follow-up|5
1556251|NCT00048724|5074397|P2|Overall Study|Withdrawal by Subject|54
1556252|NCT00048724|5074398|P1|Overall Study|Withdrawal by Subject|34
1556253|NCT00048724|5074397|P2|Overall Study|Adverse Event|12
1556254|NCT00048724|5074398|P1|Overall Study|Adverse Event|53
1556255|NCT00048542|5074410|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
1556256|NCT00048542|5074411|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
1556257|NCT00048542|5074412|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1556258|NCT00048542|5074413|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1556259|NCT00048542|5074414|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1556260|NCT00048542|5074415|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1556261|NCT00048542|5074416|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1556262|NCT00048542|5074417|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1556263|NCT00048542|5074410|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
1556264|NCT00048542|5074411|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
1556265|NCT00048542|5074412|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1556266|NCT00048542|5074413|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1556267|NCT00048542|5074414|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1556268|NCT00048542|5074415|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1556269|NCT00048542|5074416|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1556343|NCT00048542|5074410|P8|Double-Blind Phase|Randomized in error|0
1556270|NCT00048542|5074417|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1556271|NCT00048542|5074410|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
1556272|NCT00048542|5074411|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
1556273|NCT00048542|5074412|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1556274|NCT00048542|5074413|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1556275|NCT00048542|5074414|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1556276|NCT00048542|5074415|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1556277|NCT00048542|5074416|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1556278|NCT00048542|5074417|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1556279|NCT00048542|5074410|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
1556280|NCT00048542|5074411|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
1556281|NCT00048542|5074412|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1556282|NCT00048542|5074413|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1556283|NCT00048542|5074414|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1556284|NCT00048542|5074415|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1556285|NCT00048542|5074416|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1556286|NCT00048542|5074417|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1556287|NCT00048542|5074410|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
1556288|NCT00048542|5074411|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
1556289|NCT00048542|5074412|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1556290|NCT00048542|5074413|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1556291|NCT00048542|5074414|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1556292|NCT00048542|5074415|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1556293|NCT00048542|5074416|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1556294|NCT00048542|5074417|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1556295|NCT00048542|5074410|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
1556296|NCT00048542|5074411|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
1556297|NCT00048542|5074412|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1556298|NCT00048542|5074413|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1556299|NCT00048542|5074414|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1556300|NCT00048542|5074415|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1556301|NCT00048542|5074416|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1556302|NCT00048542|5074417|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1556303|NCT00048542|5074410|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
1556304|NCT00048542|5074411|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
1556305|NCT00048542|5074412|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
1556306|NCT00048542|5074413|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
1556307|NCT00048542|5074414|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
1556308|NCT00048542|5074415|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
1556309|NCT00048542|5074416|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
1556310|NCT00048542|5074417|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
1556311|NCT00048542|5074410|P8|Open-Label Extension BSA Phase|Adverse Event|0
1556312|NCT00048542|5074411|P7|Open-Label Extension BSA Phase|Adverse Event|0
1556313|NCT00048542|5074412|P6|Open-Label Extension BSA Phase|Adverse Event|1
1556314|NCT00048542|5074413|P5|Open-Label Extension BSA Phase|Adverse Event|1
1556315|NCT00048542|5074414|P4|Open-Label Extension BSA Phase|Adverse Event|0
1556316|NCT00048542|5074415|P3|Open-Label Extension BSA Phase|Adverse Event|0
1556317|NCT00048542|5074416|P2|Open-Label Extension BSA Phase|Adverse Event|0
1556318|NCT00048542|5074417|P1|Open-Label Extension BSA Phase|Adverse Event|0
1556319|NCT00048542|5074410|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
1556320|NCT00048542|5074411|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
1556321|NCT00048542|5074412|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
1556322|NCT00048542|5074413|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
1556323|NCT00048542|5074414|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
1556324|NCT00048542|5074415|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
1556325|NCT00048542|5074416|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
1556326|NCT00048542|5074417|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
1556327|NCT00048542|5074410|P8|Open-Label Extension BSA Phase|Protocol Violation|0
1556328|NCT00048542|5074411|P7|Open-Label Extension BSA Phase|Protocol Violation|0
1556329|NCT00048542|5074412|P6|Open-Label Extension BSA Phase|Protocol Violation|1
1556330|NCT00048542|5074413|P5|Open-Label Extension BSA Phase|Protocol Violation|0
1556331|NCT00048542|5074414|P4|Open-Label Extension BSA Phase|Protocol Violation|0
1556332|NCT00048542|5074415|P3|Open-Label Extension BSA Phase|Protocol Violation|0
1556333|NCT00048542|5074416|P2|Open-Label Extension BSA Phase|Protocol Violation|0
1556334|NCT00048542|5074417|P1|Open-Label Extension BSA Phase|Protocol Violation|0
1556335|NCT00048542|5074410|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1556336|NCT00048542|5074411|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1556337|NCT00048542|5074412|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
1556338|NCT00048542|5074413|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
1556339|NCT00048542|5074414|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1556340|NCT00048542|5074415|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1556341|NCT00048542|5074416|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1556342|NCT00048542|5074417|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1556344|NCT00048542|5074411|P7|Double-Blind Phase|Randomized in error|0
1556345|NCT00048542|5074412|P6|Double-Blind Phase|Randomized in error|0
1556346|NCT00048542|5074413|P5|Double-Blind Phase|Randomized in error|0
1556347|NCT00048542|5074414|P4|Double-Blind Phase|Randomized in error|0
1556348|NCT00048542|5074415|P3|Double-Blind Phase|Randomized in error|0
1556349|NCT00048542|5074416|P2|Double-Blind Phase|Randomized in error|0
1556350|NCT00048542|5074417|P1|Double-Blind Phase|Randomized in error|1
1556351|NCT00048542|5074410|P8|Double-Blind Phase|Sponsor request or decision|0
1556352|NCT00048542|5074411|P7|Double-Blind Phase|Sponsor request or decision|0
1556353|NCT00048542|5074412|P6|Double-Blind Phase|Sponsor request or decision|0
1556354|NCT00048542|5074413|P5|Double-Blind Phase|Sponsor request or decision|0
1556355|NCT00048542|5074414|P4|Double-Blind Phase|Sponsor request or decision|0
1556356|NCT00048542|5074415|P3|Double-Blind Phase|Sponsor request or decision|0
1556357|NCT00048542|5074416|P2|Double-Blind Phase|Sponsor request or decision|0
1556358|NCT00048542|5074417|P1|Double-Blind Phase|Sponsor request or decision|2
1556359|NCT00048542|5074410|P8|Double-Blind Phase|Protocol Violation|0
1556360|NCT00048542|5074411|P7|Double-Blind Phase|Protocol Violation|0
1556361|NCT00048542|5074412|P6|Double-Blind Phase|Protocol Violation|0
1556362|NCT00048542|5074413|P5|Double-Blind Phase|Protocol Violation|0
1556363|NCT00048542|5074414|P4|Double-Blind Phase|Protocol Violation|0
1556364|NCT00048542|5074415|P3|Double-Blind Phase|Protocol Violation|1
1556365|NCT00048542|5074416|P2|Double-Blind Phase|Protocol Violation|0
1556366|NCT00048542|5074417|P1|Double-Blind Phase|Protocol Violation|0
1556367|NCT00048542|5074410|P8|Double-Blind Phase|Withdrawal by Subject|0
1556368|NCT00048542|5074411|P7|Double-Blind Phase|Withdrawal by Subject|0
1556369|NCT00048542|5074412|P6|Double-Blind Phase|Withdrawal by Subject|0
1556370|NCT00048542|5074413|P5|Double-Blind Phase|Withdrawal by Subject|0
1556371|NCT00048542|5074414|P4|Double-Blind Phase|Withdrawal by Subject|0
1556372|NCT00048542|5074415|P3|Double-Blind Phase|Withdrawal by Subject|0
1556373|NCT00048542|5074416|P2|Double-Blind Phase|Withdrawal by Subject|1
1556374|NCT00048542|5074417|P1|Double-Blind Phase|Withdrawal by Subject|0
1556375|NCT00048347|5074483|P1|Overall Study|Screen failure|2
1556376|NCT00048165|5074489|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
1556377|NCT00048165|5074490|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
1556378|NCT00048165|5074489|P2|Completed 12 Months Study|Death|1
1556379|NCT00048165|5074490|P1|Completed 12 Months Study|Death|2
1556380|NCT00048165|5074489|P2|Completed 12 Months Study|Administration/Other|2
1556381|NCT00048165|5074490|P1|Completed 12 Months Study|Administration/Other|0
1556382|NCT00048165|5074489|P2|Completed 6 Months Study|Did not receive study drug|6
1556383|NCT00048165|5074490|P1|Completed 6 Months Study|Did not receive study drug|6
1556384|NCT00048165|5074489|P2|Completed 6 Months Study|Violation criteria|2
1556385|NCT00048165|5074490|P1|Completed 6 Months Study|Violation criteria|0
1556386|NCT00048165|5074489|P2|Completed 6 Months Study|Refused treatment|5
1556387|NCT00048165|5074490|P1|Completed 6 Months Study|Refused treatment|5
1556388|NCT00048165|5074489|P2|Completed 6 Months Study|Other violation|6
1556389|NCT00048165|5074490|P1|Completed 6 Months Study|Other violation|4
1556390|NCT00048165|5074489|P2|Completed 6 Months Study|Insufficient therapy|4
1556391|NCT00048165|5074490|P1|Completed 6 Months Study|Insufficient therapy|1
1556392|NCT00048165|5074489|P2|Completed 6 Months Study|Death|6
1556393|NCT00048165|5074490|P1|Completed 6 Months Study|Death|12
1556394|NCT00048165|5074489|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
1556395|NCT00048165|5074490|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
1556396|NCT00048165|5074489|P2|Completed 6 Months Study|Abnormality of laboratory test|0
1556397|NCT00048165|5074490|P1|Completed 6 Months Study|Abnormality of laboratory test|1
1556398|NCT00048165|5074489|P2|Completed 6 Months Study|Administration/Other|8
1556399|NCT00048165|5074490|P1|Completed 6 Months Study|Administration/Other|8
1556400|NCT00048074|5074525|P3|Overall Study|Social reasons|0
1556401|NCT00048074|5074526|P2|Overall Study|Social reasons|0
1556402|NCT00048074|5074527|P1|Overall Study|Social reasons|1
1556403|NCT00048074|5074525|P3|Overall Study|Out of station|1
1556404|NCT00048074|5074526|P2|Overall Study|Out of station|1
1556405|NCT00048074|5074527|P1|Overall Study|Out of station|0
1556406|NCT00048074|5074525|P3|Overall Study|Poor compliance|0
1556407|NCT00048074|5074526|P2|Overall Study|Poor compliance|1
1556408|NCT00048074|5074527|P1|Overall Study|Poor compliance|0
1556409|NCT00048074|5074525|P3|Overall Study|Husband ill|0
1556410|NCT00048074|5074526|P2|Overall Study|Husband ill|1
1556411|NCT00048074|5074527|P1|Overall Study|Husband ill|0
1556412|NCT00048074|5074525|P3|Overall Study|Study participation was terminated|0
1556413|NCT00048074|5074526|P2|Overall Study|Study participation was terminated|1
1556414|NCT00048074|5074527|P1|Overall Study|Study participation was terminated|0
1556415|NCT00048074|5074525|P3|Overall Study|Protocol Violation|0
1556416|NCT00048074|5074526|P2|Overall Study|Protocol Violation|3
1556417|NCT00048074|5074527|P1|Overall Study|Protocol Violation|1
1556418|NCT00048074|5074525|P3|Overall Study|Withdrawal by Subject|35
1556419|NCT00048074|5074526|P2|Overall Study|Withdrawal by Subject|30
1556420|NCT00048074|5074527|P1|Overall Study|Withdrawal by Subject|28
1556421|NCT00048074|5074525|P3|Overall Study|Lost to Follow-up|6
1556422|NCT00048074|5074526|P2|Overall Study|Lost to Follow-up|6
1556423|NCT00048074|5074527|P1|Overall Study|Lost to Follow-up|2
1556424|NCT00048074|5074525|P3|Overall Study|Death|2
1556425|NCT00048074|5074526|P2|Overall Study|Death|3
1556426|NCT00048074|5074527|P1|Overall Study|Death|3
1556427|NCT00048074|5074525|P3|Overall Study|Adverse Event|53
1556428|NCT00048074|5074526|P2|Overall Study|Adverse Event|41
1556429|NCT00048074|5074527|P1|Overall Study|Adverse Event|46
1556430|NCT00048061|5074584|P4|Overall Study|Early improvement|0
1556431|NCT00048061|5074585|P3|Overall Study|Early improvement|3
1556432|NCT00048061|5074586|P2|Overall Study|Early improvement|5
1556433|NCT00048061|5074587|P1|Overall Study|Early improvement|6
1556434|NCT00048061|5074584|P4|Overall Study|Did not follow-up|5
1556435|NCT00048061|5074585|P3|Overall Study|Did not follow-up|4
1556436|NCT00048061|5074586|P2|Overall Study|Did not follow-up|5
1556437|NCT00048061|5074587|P1|Overall Study|Did not follow-up|5
1556438|NCT00048061|5074584|P4|Overall Study|Withdrawal by Subject|32
1556439|NCT00048061|5074585|P3|Overall Study|Withdrawal by Subject|29
1556440|NCT00048061|5074586|P2|Overall Study|Withdrawal by Subject|29
1556441|NCT00048061|5074587|P1|Overall Study|Withdrawal by Subject|20
1556442|NCT00048061|5074584|P4|Overall Study|Lost to Follow-up|5
1556443|NCT00048061|5074585|P3|Overall Study|Lost to Follow-up|4
1556444|NCT00048061|5074586|P2|Overall Study|Lost to Follow-up|2
1556445|NCT00048061|5074587|P1|Overall Study|Lost to Follow-up|3
1556446|NCT00048061|5074584|P4|Overall Study|Adverse Event|37
1556447|NCT00048061|5074585|P3|Overall Study|Adverse Event|44
1556448|NCT00048061|5074586|P2|Overall Study|Adverse Event|32
1556449|NCT00048061|5074587|P1|Overall Study|Adverse Event|41
1556450|NCT00048048|5074666|P12|Extension Year 2|Early withdrawals|2
1556451|NCT00048048|5074667|P11|Extension Year 2|Early withdrawals|4
1556452|NCT00048048|5074668|P10|Extension Year 2|Early withdrawals|0
1556453|NCT00048048|5074669|P9|Extension Year 2|Early withdrawals|0
1556454|NCT00048048|5074670|P8|Extension Year 2|Early withdrawals|0
1556455|NCT00048048|5074671|P7|Extension Year 2|Early withdrawals|0
1556456|NCT00048048|5074672|P6|Extension Year 2|Early withdrawals|0
1556457|NCT00048048|5074673|P5|Extension Year 2|Early withdrawals|0
1556458|NCT00048048|5074674|P4|Extension Year 2|Early withdrawals|0
1556459|NCT00048048|5074675|P3|Extension Year 2|Early withdrawals|0
1556460|NCT00048048|5074676|P2|Extension Year 2|Early withdrawals|0
1556461|NCT00048048|5074677|P1|Extension Year 2|Early withdrawals|0
1556462|NCT00048048|5074666|P12|Extension Year 1|Early withdrawals|4
1556463|NCT00048048|5074667|P11|Extension Year 1|Early withdrawals|2
1556464|NCT00048048|5074668|P10|Extension Year 1|Early withdrawals|2
1556465|NCT00048048|5074669|P9|Extension Year 1|Early withdrawals|0
1556466|NCT00048048|5074670|P8|Extension Year 1|Early withdrawals|0
1556467|NCT00048048|5074671|P7|Extension Year 1|Early withdrawals|0
1556468|NCT00048048|5074672|P6|Extension Year 1|Early withdrawals|0
1556469|NCT00048048|5074673|P5|Extension Year 1|Early withdrawals|0
1556470|NCT00048048|5074674|P4|Extension Year 1|Early withdrawals|0
1556471|NCT00048048|5074675|P3|Extension Year 1|Early withdrawals|0
1556472|NCT00048048|5074676|P2|Extension Year 1|Early withdrawals|0
1556473|NCT00048048|5074677|P1|Extension Year 1|Early withdrawals|0
1556474|NCT00048048|5074666|P12|Core Treatment|Adverse Event|0
1556475|NCT00048048|5074667|P11|Core Treatment|Adverse Event|0
1556476|NCT00048048|5074668|P10|Core Treatment|Adverse Event|0
1556477|NCT00048048|5074669|P9|Core Treatment|Adverse Event|0
1556478|NCT00048048|5074670|P8|Core Treatment|Adverse Event|1
1556479|NCT00048048|5074671|P7|Core Treatment|Adverse Event|0
1556480|NCT00048048|5074672|P6|Core Treatment|Adverse Event|0
1556481|NCT00048048|5074673|P5|Core Treatment|Adverse Event|0
1556482|NCT00048048|5074674|P4|Core Treatment|Adverse Event|0
1556483|NCT00048048|5074675|P3|Core Treatment|Adverse Event|0
1556484|NCT00048048|5074676|P2|Core Treatment|Adverse Event|0
1556485|NCT00048048|5074677|P1|Core Treatment|Adverse Event|0
1556486|NCT00048048|5074666|P12|Core Treatment|Withdrawal by Subject|0
1556487|NCT00048048|5074667|P11|Core Treatment|Withdrawal by Subject|0
1556488|NCT00048048|5074668|P10|Core Treatment|Withdrawal by Subject|0
1556489|NCT00048048|5074669|P9|Core Treatment|Withdrawal by Subject|0
1556490|NCT00048048|5074670|P8|Core Treatment|Withdrawal by Subject|0
1556491|NCT00048048|5074671|P7|Core Treatment|Withdrawal by Subject|0
1556492|NCT00048048|5074672|P6|Core Treatment|Withdrawal by Subject|0
1556493|NCT00048048|5074673|P5|Core Treatment|Withdrawal by Subject|0
1556494|NCT00048048|5074674|P4|Core Treatment|Withdrawal by Subject|0
1556495|NCT00048048|5074675|P3|Core Treatment|Withdrawal by Subject|1
1556496|NCT00048048|5074676|P2|Core Treatment|Withdrawal by Subject|0
1556497|NCT00048048|5074677|P1|Core Treatment|Withdrawal by Subject|0
1556498|NCT00048035|5074733|P8|Extension Year 2|Early Withdrawals|3
1556499|NCT00048035|5074734|P7|Extension Year 2|Early Withdrawals|3
1556500|NCT00048035|5074735|P6|Extension Year 2|Early Withdrawals|0
1556501|NCT00048035|5074736|P5|Extension Year 2|Early Withdrawals|0
1556502|NCT00048035|5074737|P4|Extension Year 2|Early Withdrawals|0
1556503|NCT00048035|5074738|P3|Extension Year 2|Early Withdrawals|0
1556504|NCT00048035|5074739|P2|Extension Year 2|Early Withdrawals|0
1556505|NCT00048035|5074740|P1|Extension Year 2|Early Withdrawals|0
1556506|NCT00048035|5074733|P8|Extension Year 1|Early Withdrawals|11
1556507|NCT00048035|5074734|P7|Extension Year 1|Early Withdrawals|11
1556508|NCT00048035|5074735|P6|Extension Year 1|Early Withdrawals|0
1556509|NCT00048035|5074736|P5|Extension Year 1|Early Withdrawals|0
1556510|NCT00048035|5074737|P4|Extension Year 1|Early Withdrawals|0
1556511|NCT00048035|5074738|P3|Extension Year 1|Early Withdrawals|0
1556512|NCT00048035|5074739|P2|Extension Year 1|Early Withdrawals|0
1556513|NCT00048035|5074740|P1|Extension Year 1|Early Withdrawals|0
1556514|NCT00048035|5074733|P8|Core Period|Early Withdrawals|0
1556515|NCT00048035|5074734|P7|Core Period|Early Withdrawals|0
1556516|NCT00048035|5074735|P6|Core Period|Early Withdrawals|1
1556517|NCT00048035|5074736|P5|Core Period|Early Withdrawals|1
1556518|NCT00048035|5074737|P4|Core Period|Early Withdrawals|1
1556519|NCT00048035|5074738|P3|Core Period|Early Withdrawals|1
1556520|NCT00048035|5074739|P2|Core Period|Early Withdrawals|2
1556521|NCT00048035|5074740|P1|Core Period|Early Withdrawals|4
1556522|NCT00047879|5074778|P2|Overall Study|Progressive disease|3
1556523|NCT00047879|5074779|P1|Overall Study|Progressive disease|4
1556524|NCT00047463|5074815|P2|Overall Study|Withdrawal by Subject|3
1556525|NCT00047463|5074816|P1|Overall Study|Withdrawal by Subject|0
1556526|NCT00045942|5074933|P9|PKC412A2104E2|Death|0
1556527|NCT00045942|5074934|P8|PKC412A2104E2|Death|0
1556528|NCT00045942|5074935|P7|PKC412A2104E2|Death|2
1556529|NCT00045942|5074936|P6|PKC412A2104E2|Death|1
1556530|NCT00045942|5074937|P5|PKC412A2104E2|Death|0
1556531|NCT00045942|5074938|P4|PKC412A2104E2|Death|0
1556532|NCT00045942|5074939|P3|PKC412A2104E2|Death|0
1556533|NCT00045942|5074940|P2|PKC412A2104E2|Death|0
1556534|NCT00045942|5074941|P1|PKC412A2104E2|Death|0
1556535|NCT00045942|5074933|P9|PKC412A2104E2|Adverse Event|0
1556536|NCT00045942|5074934|P8|PKC412A2104E2|Adverse Event|1
1556537|NCT00045942|5074935|P7|PKC412A2104E2|Adverse Event|3
1556538|NCT00045942|5074936|P6|PKC412A2104E2|Adverse Event|4
1556539|NCT00045942|5074937|P5|PKC412A2104E2|Adverse Event|0
1556540|NCT00045942|5074938|P4|PKC412A2104E2|Adverse Event|0
1556541|NCT00045942|5074939|P3|PKC412A2104E2|Adverse Event|0
1556542|NCT00045942|5074940|P2|PKC412A2104E2|Adverse Event|0
1556543|NCT00045942|5074941|P1|PKC412A2104E2|Adverse Event|0
1556544|NCT00045942|5074933|P9|PKC412A2104E2|Lack of Efficacy|6
1556545|NCT00045942|5074934|P8|PKC412A2104E2|Lack of Efficacy|2
1556546|NCT00045942|5074935|P7|PKC412A2104E2|Lack of Efficacy|2
1556547|NCT00045942|5074936|P6|PKC412A2104E2|Lack of Efficacy|3
1556548|NCT00045942|5074937|P5|PKC412A2104E2|Lack of Efficacy|0
1556549|NCT00045942|5074938|P4|PKC412A2104E2|Lack of Efficacy|0
1556550|NCT00045942|5074939|P3|PKC412A2104E2|Lack of Efficacy|0
1556551|NCT00045942|5074940|P2|PKC412A2104E2|Lack of Efficacy|0
1556552|NCT00045942|5074941|P1|PKC412A2104E2|Lack of Efficacy|0
1556553|NCT00045942|5074933|P9|PKC412A2104E2|Withdrawal by Subject|0
1556554|NCT00045942|5074934|P8|PKC412A2104E2|Withdrawal by Subject|1
1556555|NCT00045942|5074935|P7|PKC412A2104E2|Withdrawal by Subject|0
1556556|NCT00045942|5074936|P6|PKC412A2104E2|Withdrawal by Subject|1
1556557|NCT00045942|5074937|P5|PKC412A2104E2|Withdrawal by Subject|0
1556558|NCT00045942|5074938|P4|PKC412A2104E2|Withdrawal by Subject|0
1556559|NCT00045942|5074939|P3|PKC412A2104E2|Withdrawal by Subject|0
1556560|NCT00045942|5074940|P2|PKC412A2104E2|Withdrawal by Subject|0
1556561|NCT00045942|5074941|P1|PKC412A2104E2|Withdrawal by Subject|0
1556562|NCT00045942|5074933|P9|PKC412A2104E2|Lost to Follow-up|0
1556563|NCT00045942|5074934|P8|PKC412A2104E2|Lost to Follow-up|3
1556564|NCT00045942|5074935|P7|PKC412A2104E2|Lost to Follow-up|0
1556565|NCT00045942|5074936|P6|PKC412A2104E2|Lost to Follow-up|0
1556566|NCT00045942|5074937|P5|PKC412A2104E2|Lost to Follow-up|0
1556567|NCT00045942|5074938|P4|PKC412A2104E2|Lost to Follow-up|0
1556568|NCT00045942|5074939|P3|PKC412A2104E2|Lost to Follow-up|0
1556569|NCT00045942|5074940|P2|PKC412A2104E2|Lost to Follow-up|0
1556570|NCT00045942|5074941|P1|PKC412A2104E2|Lost to Follow-up|0
1556571|NCT00045942|5074933|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1556572|NCT00045942|5074934|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1556573|NCT00045942|5074935|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1556574|NCT00045942|5074936|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1556575|NCT00045942|5074937|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1556576|NCT00045942|5074938|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
1556577|NCT00045942|5074939|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
1556578|NCT00045942|5074940|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1556579|NCT00045942|5074941|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1556580|NCT00045942|5074933|P9|PKC412A2104E1|Death|0
1556581|NCT00045942|5074934|P8|PKC412A2104E1|Death|0
1556582|NCT00045942|5074935|P7|PKC412A2104E1|Death|0
1556583|NCT00045942|5074936|P6|PKC412A2104E1|Death|0
1556584|NCT00045942|5074937|P5|PKC412A2104E1|Death|1
1556585|NCT00045942|5074938|P4|PKC412A2104E1|Death|1
1556586|NCT00045942|5074939|P3|PKC412A2104E1|Death|1
1556587|NCT00045942|5074940|P2|PKC412A2104E1|Death|4
1556588|NCT00045942|5074941|P1|PKC412A2104E1|Death|0
1556589|NCT00045942|5074933|P9|PKC412A2104E1|Adverse Event|0
1556590|NCT00045942|5074934|P8|PKC412A2104E1|Adverse Event|0
1556591|NCT00045942|5074935|P7|PKC412A2104E1|Adverse Event|0
1556592|NCT00045942|5074936|P6|PKC412A2104E1|Adverse Event|0
1556593|NCT00045942|5074937|P5|PKC412A2104E1|Adverse Event|6
1556594|NCT00045942|5074938|P4|PKC412A2104E1|Adverse Event|3
1556595|NCT00045942|5074939|P3|PKC412A2104E1|Adverse Event|1
1556596|NCT00045942|5074940|P2|PKC412A2104E1|Adverse Event|1
1556597|NCT00045942|5074941|P1|PKC412A2104E1|Adverse Event|0
1556598|NCT00045942|5074933|P9|PKC412A2104E1|Abnormal laboratory value|0
1556599|NCT00045942|5074934|P8|PKC412A2104E1|Abnormal laboratory value|0
1556600|NCT00045942|5074935|P7|PKC412A2104E1|Abnormal laboratory value|0
1556601|NCT00045942|5074936|P6|PKC412A2104E1|Abnormal laboratory value|0
1556602|NCT00045942|5074937|P5|PKC412A2104E1|Abnormal laboratory value|0
1556603|NCT00045942|5074938|P4|PKC412A2104E1|Abnormal laboratory value|0
1556604|NCT00045942|5074939|P3|PKC412A2104E1|Abnormal laboratory value|0
1556605|NCT00045942|5074940|P2|PKC412A2104E1|Abnormal laboratory value|1
1556606|NCT00045942|5074941|P1|PKC412A2104E1|Abnormal laboratory value|0
1556607|NCT00045942|5074933|P9|PKC412A2104E1|Lack of Efficacy|0
1556608|NCT00045942|5074934|P8|PKC412A2104E1|Lack of Efficacy|0
1556609|NCT00045942|5074935|P7|PKC412A2104E1|Lack of Efficacy|0
1556610|NCT00045942|5074936|P6|PKC412A2104E1|Lack of Efficacy|0
1556611|NCT00045942|5074937|P5|PKC412A2104E1|Lack of Efficacy|17
1556612|NCT00045942|5074938|P4|PKC412A2104E1|Lack of Efficacy|23
1556613|NCT00045942|5074939|P3|PKC412A2104E1|Lack of Efficacy|11
1556614|NCT00045942|5074940|P2|PKC412A2104E1|Lack of Efficacy|11
1556615|NCT00045942|5074941|P1|PKC412A2104E1|Lack of Efficacy|0
1556616|NCT00045942|5074933|P9|PKC412A2104E1|Condition no longer requires study drug|0
1556617|NCT00045942|5074934|P8|PKC412A2104E1|Condition no longer requires study drug|0
1556618|NCT00045942|5074935|P7|PKC412A2104E1|Condition no longer requires study drug|0
1556619|NCT00045942|5074936|P6|PKC412A2104E1|Condition no longer requires study drug|0
1556620|NCT00045942|5074937|P5|PKC412A2104E1|Condition no longer requires study drug|1
1556621|NCT00045942|5074938|P4|PKC412A2104E1|Condition no longer requires study drug|0
1556622|NCT00045942|5074939|P3|PKC412A2104E1|Condition no longer requires study drug|1
1556623|NCT00045942|5074940|P2|PKC412A2104E1|Condition no longer requires study drug|1
1556624|NCT00045942|5074941|P1|PKC412A2104E1|Condition no longer requires study drug|0
1556625|NCT00045942|5074933|P9|PKC412A2104E1|Withdrawal by Subject|0
1556626|NCT00045942|5074934|P8|PKC412A2104E1|Withdrawal by Subject|0
1556627|NCT00045942|5074935|P7|PKC412A2104E1|Withdrawal by Subject|0
1556628|NCT00045942|5074936|P6|PKC412A2104E1|Withdrawal by Subject|0
1556629|NCT00045942|5074937|P5|PKC412A2104E1|Withdrawal by Subject|2
1556630|NCT00045942|5074938|P4|PKC412A2104E1|Withdrawal by Subject|5
1556631|NCT00045942|5074939|P3|PKC412A2104E1|Withdrawal by Subject|2
1556632|NCT00045942|5074940|P2|PKC412A2104E1|Withdrawal by Subject|0
1556633|NCT00045942|5074941|P1|PKC412A2104E1|Withdrawal by Subject|0
1556634|NCT00045942|5074933|P9|PKC412A2104 (Core)|Death|0
1556635|NCT00045942|5074934|P8|PKC412A2104 (Core)|Death|0
1556636|NCT00045942|5074935|P7|PKC412A2104 (Core)|Death|0
1556637|NCT00045942|5074936|P6|PKC412A2104 (Core)|Death|0
1556638|NCT00045942|5074937|P5|PKC412A2104 (Core)|Death|0
1556639|NCT00045942|5074938|P4|PKC412A2104 (Core)|Death|0
1556640|NCT00045942|5074939|P3|PKC412A2104 (Core)|Death|0
1556641|NCT00045942|5074940|P2|PKC412A2104 (Core)|Death|0
1556642|NCT00045942|5074941|P1|PKC412A2104 (Core)|Death|1
1556643|NCT00045942|5074933|P9|PKC412A2104 (Core)|Lack of Efficacy|0
1556644|NCT00045942|5074934|P8|PKC412A2104 (Core)|Lack of Efficacy|0
1556645|NCT00045942|5074935|P7|PKC412A2104 (Core)|Lack of Efficacy|0
1556646|NCT00045942|5074936|P6|PKC412A2104 (Core)|Lack of Efficacy|0
1556647|NCT00045942|5074937|P5|PKC412A2104 (Core)|Lack of Efficacy|0
1556648|NCT00045942|5074938|P4|PKC412A2104 (Core)|Lack of Efficacy|0
1556649|NCT00045942|5074939|P3|PKC412A2104 (Core)|Lack of Efficacy|0
1556650|NCT00045942|5074940|P2|PKC412A2104 (Core)|Lack of Efficacy|0
1556651|NCT00045942|5074941|P1|PKC412A2104 (Core)|Lack of Efficacy|13
1556652|NCT00045942|5074933|P9|PKC412A2104 (Core)|Adverse Event|0
1556653|NCT00045942|5074934|P8|PKC412A2104 (Core)|Adverse Event|0
1556654|NCT00045942|5074935|P7|PKC412A2104 (Core)|Adverse Event|0
1556655|NCT00045942|5074936|P6|PKC412A2104 (Core)|Adverse Event|0
1556656|NCT00045942|5074937|P5|PKC412A2104 (Core)|Adverse Event|0
1556657|NCT00045942|5074938|P4|PKC412A2104 (Core)|Adverse Event|0
1556658|NCT00045942|5074939|P3|PKC412A2104 (Core)|Adverse Event|0
1556659|NCT00045942|5074940|P2|PKC412A2104 (Core)|Adverse Event|0
1556660|NCT00045942|5074941|P1|PKC412A2104 (Core)|Adverse Event|5
1556661|NCT00045942|5074933|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
1556662|NCT00045942|5074934|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
1556663|NCT00045942|5074935|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
1556664|NCT00045942|5074936|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
1556665|NCT00045942|5074937|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
1556666|NCT00045942|5074938|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
1556667|NCT00045942|5074939|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
1556668|NCT00045942|5074940|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
1556669|NCT00045942|5074941|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
1556670|NCT00044512|5075030|P1|Follow Up|Lost to Follow-up|2
1556671|NCT00044213|5075045|P4|Overall Study|Lost to Follow-up|4
1556672|NCT00044213|5075046|P3|Overall Study|Lost to Follow-up|5
1556673|NCT00044213|5075047|P2|Overall Study|Lost to Follow-up|5
1556674|NCT00044213|5075048|P1|Overall Study|Lost to Follow-up|8
1556675|NCT00044213|5075045|P4|Overall Study|Death|49
1556676|NCT00044213|5075046|P3|Overall Study|Death|42
1556677|NCT00044213|5075047|P2|Overall Study|Death|42
1556678|NCT00044213|5075048|P1|Overall Study|Death|42
1556679|NCT00044213|5075045|P4|Overall Study|Withdrawal by Subject|83
1556680|NCT00044213|5075046|P3|Overall Study|Withdrawal by Subject|91
1556681|NCT00044213|5075047|P2|Overall Study|Withdrawal by Subject|65
1556682|NCT00044213|5075048|P1|Overall Study|Withdrawal by Subject|50
1556683|NCT00044083|5075113|P2|Second Intervention (One Week) Patients|Withdrawal by Subject|1
1556684|NCT00044083|5075114|P1|Second Intervention (One Week) Patients|Withdrawal by Subject|0
1556685|NCT00044083|5075113|P2|First Intervention (One Week) Patients|Used illegal drug|0
1556686|NCT00044083|5075114|P1|First Intervention (One Week) Patients|Used illegal drug|1
1556687|NCT00044083|5075113|P2|First Intervention (One Week) Patients|Not follow directions|2
1556688|NCT00044083|5075114|P1|First Intervention (One Week) Patients|Not follow directions|0
1556689|NCT00044083|5075113|P2|First Intervention (One Week)- HV's|Abnormal MRI|1
1556690|NCT00044083|5075114|P1|First Intervention (One Week)- HV's|Abnormal MRI|0
1556781|NCT00043186|5075196|P7|Overall Study|Physician Decision|0
1556691|NCT00044083|5075113|P2|First Intervention (One Week)- HV's|Used illegal drugs|0
1556692|NCT00044083|5075114|P1|First Intervention (One Week)- HV's|Used illegal drugs|1
1556693|NCT00044083|5075113|P2|First Intervention (One Week)- HV's|Pregnancy|0
1556694|NCT00044083|5075114|P1|First Intervention (One Week)- HV's|Pregnancy|1
1556695|NCT00044083|5075113|P2|First Intervention (One Week)- HV's|Withdrawal by Subject|3
1556696|NCT00044083|5075114|P1|First Intervention (One Week)- HV's|Withdrawal by Subject|5
1556697|NCT00044083|5075113|P2|First Intervention (One Week)- HV's|Not follow directions|2
1556698|NCT00044083|5075114|P1|First Intervention (One Week)- HV's|Not follow directions|2
1556699|NCT00044083|5075113|P2|First Intervention (One Week)- HV's|Adverse Event|0
1556700|NCT00044083|5075114|P1|First Intervention (One Week)- HV's|Adverse Event|1
1556701|NCT00043979|5075152|P3|Period 1|recipient with progressive disease|3
1556702|NCT00043979|5075153|P2|Period 1|recipient with progressive disease|4
1556703|NCT00043979|5075154|P1|Period 1|recipient with progressive disease|7
1556704|NCT00043550|5075175|P3|Overall Study|Withdrawal by Subject|20
1556705|NCT00043550|5075176|P2|Overall Study|Withdrawal by Subject|12
1556706|NCT00043550|5075177|P1|Overall Study|Withdrawal by Subject|22
1556707|NCT00043186|5075194|P9|Overall Study|Other|0
1556708|NCT00043186|5075195|P8|Overall Study|Other|0
1556709|NCT00043186|5075196|P7|Overall Study|Other|0
1556710|NCT00043186|5075197|P6|Overall Study|Other|0
1556711|NCT00043186|5075198|P5|Overall Study|Other|0
1556712|NCT00043186|5075199|P4|Overall Study|Other|1
1556713|NCT00043186|5075200|P3|Overall Study|Other|1
1556714|NCT00043186|5075201|P2|Overall Study|Other|0
1556715|NCT00043186|5075202|P1|Overall Study|Other|0
1556716|NCT00043186|5075194|P9|Overall Study|Noncompliance|0
1556717|NCT00043186|5075195|P8|Overall Study|Noncompliance|0
1556718|NCT00043186|5075196|P7|Overall Study|Noncompliance|0
1556719|NCT00043186|5075197|P6|Overall Study|Noncompliance|0
1556720|NCT00043186|5075198|P5|Overall Study|Noncompliance|0
1556721|NCT00043186|5075199|P4|Overall Study|Noncompliance|1
1556722|NCT00043186|5075200|P3|Overall Study|Noncompliance|1
1556723|NCT00043186|5075201|P2|Overall Study|Noncompliance|0
1556724|NCT00043186|5075202|P1|Overall Study|Noncompliance|0
1556725|NCT00043186|5075194|P9|Overall Study|Lost to Follow-up|2
1556726|NCT00043186|5075195|P8|Overall Study|Lost to Follow-up|1
1556727|NCT00043186|5075196|P7|Overall Study|Lost to Follow-up|1
1556728|NCT00043186|5075197|P6|Overall Study|Lost to Follow-up|1
1556729|NCT00043186|5075198|P5|Overall Study|Lost to Follow-up|1
1556730|NCT00043186|5075199|P4|Overall Study|Lost to Follow-up|1
1556731|NCT00043186|5075200|P3|Overall Study|Lost to Follow-up|1
1556732|NCT00043186|5075201|P2|Overall Study|Lost to Follow-up|5
1556733|NCT00043186|5075202|P1|Overall Study|Lost to Follow-up|3
1556734|NCT00043186|5075194|P9|Overall Study|Ineligibility determined|1
1556735|NCT00043186|5075195|P8|Overall Study|Ineligibility determined|0
1556736|NCT00043186|5075196|P7|Overall Study|Ineligibility determined|0
1556737|NCT00043186|5075197|P6|Overall Study|Ineligibility determined|0
1556738|NCT00043186|5075198|P5|Overall Study|Ineligibility determined|0
1556739|NCT00043186|5075199|P4|Overall Study|Ineligibility determined|0
1556740|NCT00043186|5075200|P3|Overall Study|Ineligibility determined|0
1556741|NCT00043186|5075201|P2|Overall Study|Ineligibility determined|0
1556742|NCT00043186|5075202|P1|Overall Study|Ineligibility determined|0
1556743|NCT00043186|5075194|P9|Overall Study|Disease progression|0
1556744|NCT00043186|5075195|P8|Overall Study|Disease progression|4
1556745|NCT00043186|5075196|P7|Overall Study|Disease progression|0
1556746|NCT00043186|5075197|P6|Overall Study|Disease progression|0
1556747|NCT00043186|5075198|P5|Overall Study|Disease progression|0
1556748|NCT00043186|5075199|P4|Overall Study|Disease progression|3
1556749|NCT00043186|5075200|P3|Overall Study|Disease progression|0
1556750|NCT00043186|5075201|P2|Overall Study|Disease progression|0
1556751|NCT00043186|5075202|P1|Overall Study|Disease progression|1
1556752|NCT00043186|5075194|P9|Overall Study|Death|0
1556753|NCT00043186|5075195|P8|Overall Study|Death|0
1556754|NCT00043186|5075196|P7|Overall Study|Death|2
1556755|NCT00043186|5075197|P6|Overall Study|Death|0
1556756|NCT00043186|5075198|P5|Overall Study|Death|0
1556757|NCT00043186|5075199|P4|Overall Study|Death|0
1556758|NCT00043186|5075200|P3|Overall Study|Death|1
1556759|NCT00043186|5075201|P2|Overall Study|Death|0
1556760|NCT00043186|5075202|P1|Overall Study|Death|0
1556761|NCT00043186|5075194|P9|Overall Study|Withdrawal by Subject|10
1556762|NCT00043186|5075195|P8|Overall Study|Withdrawal by Subject|9
1556763|NCT00043186|5075196|P7|Overall Study|Withdrawal by Subject|12
1556764|NCT00043186|5075197|P6|Overall Study|Withdrawal by Subject|6
1556765|NCT00043186|5075198|P5|Overall Study|Withdrawal by Subject|14
1556766|NCT00043186|5075199|P4|Overall Study|Withdrawal by Subject|13
1556767|NCT00043186|5075200|P3|Overall Study|Withdrawal by Subject|11
1556768|NCT00043186|5075201|P2|Overall Study|Withdrawal by Subject|8
1556769|NCT00043186|5075202|P1|Overall Study|Withdrawal by Subject|11
1556770|NCT00043186|5075194|P9|Overall Study|Adverse Event|3
1556771|NCT00043186|5075195|P8|Overall Study|Adverse Event|1
1556772|NCT00043186|5075196|P7|Overall Study|Adverse Event|2
1556773|NCT00043186|5075197|P6|Overall Study|Adverse Event|1
1556774|NCT00043186|5075198|P5|Overall Study|Adverse Event|2
1556775|NCT00043186|5075199|P4|Overall Study|Adverse Event|3
1556776|NCT00043186|5075200|P3|Overall Study|Adverse Event|2
1556777|NCT00043186|5075201|P2|Overall Study|Adverse Event|2
1556778|NCT00043186|5075202|P1|Overall Study|Adverse Event|2
1556779|NCT00043186|5075194|P9|Overall Study|Physician Decision|1
1556780|NCT00043186|5075195|P8|Overall Study|Physician Decision|1
1556782|NCT00043186|5075197|P6|Overall Study|Physician Decision|0
1556783|NCT00043186|5075198|P5|Overall Study|Physician Decision|1
1556784|NCT00043186|5075199|P4|Overall Study|Physician Decision|0
1556785|NCT00043186|5075200|P3|Overall Study|Physician Decision|3
1556786|NCT00043186|5075201|P2|Overall Study|Physician Decision|0
1556787|NCT00043186|5075202|P1|Overall Study|Physician Decision|0
1556788|NCT00042432|5075530|P2|Overall Study|Other|0
1556789|NCT00042432|5075531|P1|Overall Study|Other|2
1556790|NCT00042432|5075530|P2|Overall Study|Initiation of maintenance dialysis|1
1556791|NCT00042432|5075531|P1|Overall Study|Initiation of maintenance dialysis|1
1556792|NCT00042432|5075530|P2|Overall Study|Ineligibility determined|0
1556793|NCT00042432|5075531|P1|Overall Study|Ineligibility determined|1
1556794|NCT00042432|5075530|P2|Overall Study|Death|2
1556795|NCT00042432|5075531|P1|Overall Study|Death|0
1556796|NCT00042432|5075530|P2|Overall Study|Withdrawal by Subject|3
1556797|NCT00042432|5075531|P1|Overall Study|Withdrawal by Subject|1
1556798|NCT00042432|5075530|P2|Overall Study|Adverse Event|1
1556799|NCT00042432|5075531|P1|Overall Study|Adverse Event|4
1556800|NCT00041756|5075584|P5|Overall Study|Data Monitoring Committee Recommendation|21
1556801|NCT00041756|5075585|P4|Overall Study|Data Monitoring Committee Recommendation|0
1556802|NCT00041756|5075586|P3|Overall Study|Data Monitoring Committee Recommendation|0
1556803|NCT00041756|5075587|P2|Overall Study|Data Monitoring Committee Recommendation|0
1556804|NCT00041756|5075588|P1|Overall Study|Data Monitoring Committee Recommendation|0
1556805|NCT00041756|5075584|P5|Overall Study|Unable to meet protocol criteria|1
1556806|NCT00041756|5075585|P4|Overall Study|Unable to meet protocol criteria|0
1556807|NCT00041756|5075586|P3|Overall Study|Unable to meet protocol criteria|1
1556808|NCT00041756|5075587|P2|Overall Study|Unable to meet protocol criteria|0
1556809|NCT00041756|5075588|P1|Overall Study|Unable to meet protocol criteria|0
1556810|NCT00041756|5075584|P5|Overall Study|Lost to Follow-up|0
1556811|NCT00041756|5075585|P4|Overall Study|Lost to Follow-up|1
1556812|NCT00041756|5075586|P3|Overall Study|Lost to Follow-up|0
1556813|NCT00041756|5075587|P2|Overall Study|Lost to Follow-up|1
1556814|NCT00041756|5075588|P1|Overall Study|Lost to Follow-up|0
1556815|NCT00041756|5075584|P5|Overall Study|Withdrawal by Subject|3
1556816|NCT00041756|5075585|P4|Overall Study|Withdrawal by Subject|2
1556817|NCT00041756|5075586|P3|Overall Study|Withdrawal by Subject|4
1556818|NCT00041756|5075587|P2|Overall Study|Withdrawal by Subject|3
1556819|NCT00041756|5075588|P1|Overall Study|Withdrawal by Subject|3
1556820|NCT00041756|5075584|P5|Overall Study|Protocol Violation|1
1556821|NCT00041756|5075585|P4|Overall Study|Protocol Violation|2
1556822|NCT00041756|5075586|P3|Overall Study|Protocol Violation|2
1556823|NCT00041756|5075587|P2|Overall Study|Protocol Violation|1
1556824|NCT00041756|5075588|P1|Overall Study|Protocol Violation|1
1556825|NCT00041756|5075584|P5|Overall Study|Adverse Event|34
1556826|NCT00041756|5075585|P4|Overall Study|Adverse Event|11
1556827|NCT00041756|5075586|P3|Overall Study|Adverse Event|6
1556828|NCT00041756|5075587|P2|Overall Study|Adverse Event|10
1556829|NCT00041756|5075588|P1|Overall Study|Adverse Event|4
1556830|NCT00041470|5075616|P1|Overall Study|Loss of Funding|38
1556831|NCT00040664|5075621|P4|Overall Study|Non-viability of oral suspension|0
1556832|NCT00040664|5075622|P3|Overall Study|Non-viability of oral suspension|1
1556833|NCT00040664|5075623|P2|Overall Study|Non-viability of oral suspension|0
1556834|NCT00040664|5075624|P1|Overall Study|Non-viability of oral suspension|1
1556835|NCT00040664|5075621|P4|Overall Study|Change of formulation|0
1556836|NCT00040664|5075622|P3|Overall Study|Change of formulation|0
1556837|NCT00040664|5075623|P2|Overall Study|Change of formulation|2
1556838|NCT00040664|5075624|P1|Overall Study|Change of formulation|2
1556839|NCT00040664|5075621|P4|Overall Study|Pharmacokinetic target not achieved|1
1556840|NCT00040664|5075622|P3|Overall Study|Pharmacokinetic target not achieved|0
1556841|NCT00040664|5075623|P2|Overall Study|Pharmacokinetic target not achieved|1
1556842|NCT00040664|5075624|P1|Overall Study|Pharmacokinetic target not achieved|2
1556843|NCT00040664|5075621|P4|Overall Study|Poor taste|0
1556844|NCT00040664|5075622|P3|Overall Study|Poor taste|2
1556845|NCT00040664|5075623|P2|Overall Study|Poor taste|0
1556846|NCT00040664|5075624|P1|Overall Study|Poor taste|2
1556847|NCT00040664|5075621|P4|Overall Study|Medication adherence/compliance problems|5
1556848|NCT00040664|5075622|P3|Overall Study|Medication adherence/compliance problems|1
1556849|NCT00040664|5075623|P2|Overall Study|Medication adherence/compliance problems|2
1556850|NCT00040664|5075624|P1|Overall Study|Medication adherence/compliance problems|8
1556851|NCT00040664|5075621|P4|Overall Study|Pregnancy|3
1556852|NCT00040664|5075622|P3|Overall Study|Pregnancy|0
1556853|NCT00040664|5075623|P2|Overall Study|Pregnancy|0
1556854|NCT00040664|5075624|P1|Overall Study|Pregnancy|3
1556855|NCT00040664|5075621|P4|Overall Study|Withdrawal by Subject|4
1556856|NCT00040664|5075622|P3|Overall Study|Withdrawal by Subject|3
1556857|NCT00040664|5075623|P2|Overall Study|Withdrawal by Subject|0
1556858|NCT00040664|5075624|P1|Overall Study|Withdrawal by Subject|7
1556859|NCT00040664|5075621|P4|Overall Study|Protocol Violation|1
1556860|NCT00040664|5075622|P3|Overall Study|Protocol Violation|0
1556861|NCT00040664|5075623|P2|Overall Study|Protocol Violation|1
1556862|NCT00040664|5075624|P1|Overall Study|Protocol Violation|2
1556863|NCT00040664|5075621|P4|Overall Study|Lost to Follow-up|2
1556864|NCT00040664|5075622|P3|Overall Study|Lost to Follow-up|0
1556865|NCT00040664|5075623|P2|Overall Study|Lost to Follow-up|2
1556866|NCT00040664|5075624|P1|Overall Study|Lost to Follow-up|4
1556867|NCT00040664|5075621|P4|Overall Study|Insufficient CD4 response|0
1556868|NCT00040664|5075622|P3|Overall Study|Insufficient CD4 response|1
1556869|NCT00040664|5075623|P2|Overall Study|Insufficient CD4 response|0
1556870|NCT00040664|5075624|P1|Overall Study|Insufficient CD4 response|1
1556871|NCT00040664|5075621|P4|Overall Study|Lack of Efficacy|4
1556872|NCT00040664|5075622|P3|Overall Study|Lack of Efficacy|3
1556873|NCT00040664|5075623|P2|Overall Study|Lack of Efficacy|2
1556874|NCT00040664|5075624|P1|Overall Study|Lack of Efficacy|9
1556875|NCT00040664|5075621|P4|Overall Study|Adverse Event|7
1556876|NCT00040664|5075622|P3|Overall Study|Adverse Event|2
1556877|NCT00040664|5075623|P2|Overall Study|Adverse Event|3
1556878|NCT00040664|5075624|P1|Overall Study|Adverse Event|12
1556879|NCT00040365|5075690|P1|Overall Study|Lost to Follow-up|3
1556880|NCT00040365|5075690|P1|Overall Study|Progressive disease|7
1556881|NCT00040365|5075690|P1|Overall Study|Death|1
1556882|NCT00039871|5075699|P1|Overall Study|Never entered follow-up|7
1556883|NCT00039871|5075699|P1|Overall Study|Discontinued at Week 12 per protocol|1061
1556884|NCT00039871|5075699|P1|Overall Study|Administrative|1
1556885|NCT00039871|5075699|P1|Overall Study|Did not meet eligibility criteria|11
1556886|NCT00039871|5075699|P1|Overall Study|Withdrawal by Subject|97
1556887|NCT00039871|5075699|P1|Overall Study|Protocol Violation|24
1556888|NCT00039871|5075699|P1|Overall Study|Lost to Follow-up|18
1556889|NCT00039871|5075699|P1|Overall Study|Adverse Event|165
1556890|NCT00039741|5075709|P4|Overall Study|Missed final visit|2
1556891|NCT00039741|5075710|P3|Overall Study|Missed final visit|2
1556892|NCT00039741|5075711|P2|Overall Study|Missed final visit|1
1556893|NCT00039741|5075712|P1|Overall Study|Missed final visit|2
1556894|NCT00039741|5075709|P4|Overall Study|Withdrew consent|1
1556895|NCT00039741|5075710|P3|Overall Study|Withdrew consent|0
1556896|NCT00039741|5075711|P2|Overall Study|Withdrew consent|5
1556897|NCT00039741|5075712|P1|Overall Study|Withdrew consent|0
1556898|NCT00039741|5075709|P4|Overall Study|Non-compliance with protocol|0
1556899|NCT00039741|5075710|P3|Overall Study|Non-compliance with protocol|1
1556900|NCT00039741|5075711|P2|Overall Study|Non-compliance with protocol|0
1556901|NCT00039741|5075712|P1|Overall Study|Non-compliance with protocol|1
1556902|NCT00039741|5075709|P4|Overall Study|Moved|6
1556903|NCT00039741|5075710|P3|Overall Study|Moved|3
1556904|NCT00039741|5075711|P2|Overall Study|Moved|2
1556905|NCT00039741|5075712|P1|Overall Study|Moved|3
1556906|NCT00039741|5075709|P4|Overall Study|Not able to get to clinic|3
1556907|NCT00039741|5075710|P3|Overall Study|Not able to get to clinic|0
1556908|NCT00039741|5075711|P2|Overall Study|Not able to get to clinic|2
1556909|NCT00039741|5075712|P1|Overall Study|Not able to get to clinic|5
1556910|NCT00039741|5075709|P4|Overall Study|Confounding medical condition|0
1556911|NCT00039741|5075710|P3|Overall Study|Confounding medical condition|0
1556912|NCT00039741|5075711|P2|Overall Study|Confounding medical condition|0
1556913|NCT00039741|5075712|P1|Overall Study|Confounding medical condition|1
1556914|NCT00039741|5075709|P4|Overall Study|Lost to Follow-up|2
1556915|NCT00039741|5075710|P3|Overall Study|Lost to Follow-up|5
1556916|NCT00039741|5075711|P2|Overall Study|Lost to Follow-up|1
1556917|NCT00039741|5075712|P1|Overall Study|Lost to Follow-up|3
1556918|NCT00039741|5075709|P4|Overall Study|Death|0
1556919|NCT00039741|5075710|P3|Overall Study|Death|0
1556920|NCT00039741|5075711|P2|Overall Study|Death|1
1556921|NCT00039741|5075712|P1|Overall Study|Death|0
1556922|NCT00038948|5075756|P2|Overall Study|Lack of Efficacy|6
1556923|NCT00038948|5075757|P1|Overall Study|Lack of Efficacy|3
1556924|NCT00038948|5075756|P2|Overall Study|Protocol Violation|7
1556925|NCT00038948|5075757|P1|Overall Study|Protocol Violation|3
1556926|NCT00038948|5075756|P2|Overall Study|Withdrawal by Subject|10
1556927|NCT00038948|5075757|P1|Overall Study|Withdrawal by Subject|23
1556928|NCT00038948|5075756|P2|Overall Study|Nonmedical event|7
1556929|NCT00038948|5075757|P1|Overall Study|Nonmedical event|5
1556930|NCT00038948|5075756|P2|Overall Study|Lost to Follow-up|4
1556931|NCT00038948|5075757|P1|Overall Study|Lost to Follow-up|4
1556932|NCT00038948|5075756|P2|Overall Study|Adverse Event|43
1556933|NCT00038948|5075757|P1|Overall Study|Adverse Event|131
1556934|NCT00038467|5075797|P2|Overall Study|Other|28
1556935|NCT00038467|5075798|P1|Overall Study|Other|26
1556936|NCT00038467|5075797|P2|Overall Study|Randomized, but not treated|35
1556937|NCT00038467|5075798|P1|Overall Study|Randomized, but not treated|31
1556938|NCT00038467|5075797|P2|Overall Study|Recurrence|179
1556939|NCT00038467|5075798|P1|Overall Study|Recurrence|109
1556940|NCT00038467|5075797|P2|Overall Study|Lost to Follow-up|10
1556941|NCT00038467|5075798|P1|Overall Study|Lost to Follow-up|15
1556942|NCT00038467|5075797|P2|Overall Study|Death|16
1556943|NCT00038467|5075798|P1|Overall Study|Death|22
1556944|NCT00038467|5075797|P2|Overall Study|Protocol Violation|22
1556945|NCT00038467|5075798|P1|Overall Study|Protocol Violation|19
1556946|NCT00038467|5075797|P2|Overall Study|Withdrawal by Subject|107
1556947|NCT00038467|5075798|P1|Overall Study|Withdrawal by Subject|150
1556948|NCT00038467|5075797|P2|Overall Study|Adverse Event|145
1556949|NCT00038467|5075798|P1|Overall Study|Adverse Event|170
1556950|NCT00038103|5075860|P2|Overall Study|Randomized/never treated|0
1556951|NCT00038103|5075861|P1|Overall Study|Randomized/never treated|2
1556952|NCT00038103|5075860|P2|Overall Study|Sponsor Decision|1
1556953|NCT00038103|5075861|P1|Overall Study|Sponsor Decision|0
1556954|NCT00038103|5075860|P2|Overall Study|Protocol Violation|2
1556955|NCT00038103|5075861|P1|Overall Study|Protocol Violation|0
1556956|NCT00038103|5075860|P2|Overall Study|Lost to Follow-up|3
1556957|NCT00038103|5075861|P1|Overall Study|Lost to Follow-up|0
1556958|NCT00038103|5075860|P2|Overall Study|Withdrawal by Subject|3
1556959|NCT00038103|5075861|P1|Overall Study|Withdrawal by Subject|0
1556960|NCT00038103|5075860|P2|Overall Study|Lack of Efficacy|41
1556961|NCT00038103|5075861|P1|Overall Study|Lack of Efficacy|48
1556962|NCT00038103|5075860|P2|Overall Study|Adverse Event|6
1556963|NCT00038103|5075861|P1|Overall Study|Adverse Event|5
1556964|NCT00037830|5075884|P3|Overall Study|Unrelated Medical Problem|0
1556965|NCT00037830|5075885|P2|Overall Study|Unrelated Medical Problem|0
1556966|NCT00037830|5075886|P1|Overall Study|Unrelated Medical Problem|2
1556967|NCT00037830|5075884|P3|Overall Study|Protocol Violation|0
1556968|NCT00037830|5075885|P2|Overall Study|Protocol Violation|2
1556969|NCT00037830|5075886|P1|Overall Study|Protocol Violation|2
1556970|NCT00037830|5075884|P3|Overall Study|Withdrawal by Subject|1
1556971|NCT00037830|5075885|P2|Overall Study|Withdrawal by Subject|5
1556972|NCT00037830|5075886|P1|Overall Study|Withdrawal by Subject|4
1556973|NCT00037830|5075884|P3|Overall Study|Adverse Event|0
1556974|NCT00037830|5075885|P2|Overall Study|Adverse Event|0
1556975|NCT00037830|5075886|P1|Overall Study|Adverse Event|2
1556976|NCT00036270|5075918|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
1556977|NCT00036270|5075919|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
1556978|NCT00036270|5075918|P2|Study Treatment to 5 Year Report|Too early switch|103
1556979|NCT00036270|5075919|P1|Study Treatment to 5 Year Report|Too early switch|0
1556980|NCT00036270|5075918|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
1556981|NCT00036270|5075919|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
1556982|NCT00036270|5075918|P2|Study Treatment to 5 Year Report|Protocol Violation|91
1556983|NCT00036270|5075919|P1|Study Treatment to 5 Year Report|Protocol Violation|23
1556984|NCT00036270|5075918|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
1556985|NCT00036270|5075919|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
1556986|NCT00036270|5075918|P2|Study Treatment to 5 Year Report|Treatment refusal|208
1556987|NCT00036270|5075919|P1|Study Treatment to 5 Year Report|Treatment refusal|113
1556988|NCT00036270|5075918|P2|Study Treatment to 5 Year Report|Other|288
1556989|NCT00036270|5075919|P1|Study Treatment to 5 Year Report|Other|277
1556990|NCT00036270|5075918|P2|Study Treatment to 5 Year Report|Adverse Event|782
1556991|NCT00036270|5075919|P1|Study Treatment to 5 Year Report|Adverse Event|501
1556992|NCT00036270|5075918|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
1556993|NCT00036270|5075919|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
1556994|NCT00036270|5075918|P2|Study Treatment to 5 Year Report|Ongoing|736
1556995|NCT00036270|5075919|P1|Study Treatment to 5 Year Report|Ongoing|1081
1556996|NCT00036270|5075918|P2|Randomized to Study Treatment|Withdrawal by Subject|7
1556997|NCT00036270|5075919|P1|Randomized to Study Treatment|Withdrawal by Subject|6
1556998|NCT00035932|5075938|P3|Overall Study|Lack of Efficacy|28
1556999|NCT00035932|5075939|P2|Overall Study|Lack of Efficacy|33
1557000|NCT00035932|5075940|P1|Overall Study|Lack of Efficacy|33
1557001|NCT00035932|5075938|P3|Overall Study|Study Termination by Sponsor|0
1557002|NCT00035932|5075939|P2|Overall Study|Study Termination by Sponsor|0
1557003|NCT00035932|5075940|P1|Overall Study|Study Termination by Sponsor|1
1557004|NCT00035932|5075938|P3|Overall Study|Withdrawal by Subject|0
1557005|NCT00035932|5075939|P2|Overall Study|Withdrawal by Subject|5
1557006|NCT00035932|5075940|P1|Overall Study|Withdrawal by Subject|1
1557007|NCT00035932|5075938|P3|Overall Study|Protocol Violation While on Study|2
1557008|NCT00035932|5075939|P2|Overall Study|Protocol Violation While on Study|1
1557009|NCT00035932|5075940|P1|Overall Study|Protocol Violation While on Study|0
1557010|NCT00035932|5075938|P3|Overall Study|Noncompliance|6
1557011|NCT00035932|5075939|P2|Overall Study|Noncompliance|7
1557012|NCT00035932|5075940|P1|Overall Study|Noncompliance|6
1557013|NCT00035932|5075938|P3|Overall Study|Lost to Follow-up|3
1557014|NCT00035932|5075939|P2|Overall Study|Lost to Follow-up|4
1557015|NCT00035932|5075940|P1|Overall Study|Lost to Follow-up|4
1557016|NCT00035932|5075938|P3|Overall Study|Disease Progression / Relapse|0
1557017|NCT00035932|5075939|P2|Overall Study|Disease Progression / Relapse|1
1557018|NCT00035932|5075940|P1|Overall Study|Disease Progression / Relapse|1
1557019|NCT00035932|5075938|P3|Overall Study|Death|1
1557020|NCT00035932|5075939|P2|Overall Study|Death|0
1557021|NCT00035932|5075940|P1|Overall Study|Death|0
1557022|NCT00035932|5075938|P3|Overall Study|Adverse Event|9
1557023|NCT00035932|5075939|P2|Overall Study|Adverse Event|9
1557024|NCT00035932|5075940|P1|Overall Study|Adverse Event|10
1557025|NCT00035815|5076066|P2|Overall Study|Withdrawal by Subject|11
1557026|NCT00035815|5076067|P1|Overall Study|Withdrawal by Subject|17
1557027|NCT00035555|5076080|P3|Overall Study|Received cyclosporin in error|1
1557028|NCT00035555|5076081|P2|Overall Study|Received cyclosporin in error|0
1557029|NCT00035555|5076082|P1|Overall Study|Received cyclosporin in error|0
1557030|NCT00035555|5076080|P3|Overall Study|Investigator deemed not a good candidate|1
1557031|NCT00035555|5076081|P2|Overall Study|Investigator deemed not a good candidate|0
1557032|NCT00035555|5076082|P1|Overall Study|Investigator deemed not a good candidate|0
1557033|NCT00035555|5076080|P3|Overall Study|Withdrawal by Subject|2
1557034|NCT00035555|5076081|P2|Overall Study|Withdrawal by Subject|0
1557035|NCT00035555|5076082|P1|Overall Study|Withdrawal by Subject|2
1557036|NCT00035555|5076080|P3|Overall Study|Treatment failure/lack of efficacy|3
1557037|NCT00035555|5076081|P2|Overall Study|Treatment failure/lack of efficacy|5
1557038|NCT00035555|5076082|P1|Overall Study|Treatment failure/lack of efficacy|7
1557039|NCT00035555|5076080|P3|Overall Study|Prohibited medication|0
1557040|NCT00035555|5076081|P2|Overall Study|Prohibited medication|1
1557041|NCT00035555|5076082|P1|Overall Study|Prohibited medication|1
1557042|NCT00035555|5076080|P3|Overall Study|Noncompliance|1
1557043|NCT00035555|5076081|P2|Overall Study|Noncompliance|1
1557044|NCT00035555|5076082|P1|Overall Study|Noncompliance|0
1557045|NCT00035555|5076080|P3|Overall Study|Lost to Follow-up|1
1557046|NCT00035555|5076081|P2|Overall Study|Lost to Follow-up|0
1557047|NCT00035555|5076082|P1|Overall Study|Lost to Follow-up|0
1557048|NCT00035555|5076080|P3|Overall Study|Death|2
1557049|NCT00035555|5076081|P2|Overall Study|Death|0
1557050|NCT00035555|5076082|P1|Overall Study|Death|0
1557051|NCT00035555|5076080|P3|Overall Study|Allograft loss|2
1557052|NCT00035555|5076081|P2|Overall Study|Allograft loss|1
1557053|NCT00035555|5076082|P1|Overall Study|Allograft loss|1
1557054|NCT00035555|5076080|P3|Overall Study|Adverse Event|9
1557055|NCT00035555|5076081|P2|Overall Study|Adverse Event|8
1557056|NCT00035555|5076082|P1|Overall Study|Adverse Event|5
1557057|NCT00032487|5076166|P2|Overall Study|Had other reason|12
1557058|NCT00032487|5076167|P1|Overall Study|Had other reason|12
1557059|NCT00032487|5076166|P2|Overall Study|Lost to Follow-up|58
1557060|NCT00032487|5076167|P1|Overall Study|Lost to Follow-up|57
1557061|NCT00032487|5076166|P2|Overall Study|Adverse Event|7
1557062|NCT00032487|5076167|P1|Overall Study|Adverse Event|3
1557063|NCT00032487|5076166|P2|Overall Study|Withdrawal by Subject|43
1557064|NCT00032487|5076167|P1|Overall Study|Withdrawal by Subject|67
1557065|NCT00031551|5076177|P2|Overall Study|Withdrew due to chemotherapy effects|0
1557066|NCT00031551|5076178|P1|Overall Study|Withdrew due to chemotherapy effects|2
1557067|NCT00031486|5076190|P2|Overall Study|Other|1
1557068|NCT00031486|5076191|P1|Overall Study|Other|1
1557069|NCT00031486|5076190|P2|Overall Study|Did not meet eligibility requirement|1
1557070|NCT00031486|5076191|P1|Overall Study|Did not meet eligibility requirement|2
1557071|NCT00031486|5076190|P2|Overall Study|Non-compliant|4
1557072|NCT00031486|5076191|P1|Overall Study|Non-compliant|0
1557073|NCT00031486|5076190|P2|Overall Study|Death|3
1557074|NCT00031486|5076191|P1|Overall Study|Death|0
1557075|NCT00031486|5076190|P2|Overall Study|Withdrawal by Subject|2
1557076|NCT00031486|5076191|P1|Overall Study|Withdrawal by Subject|3
1557077|NCT00031486|5076190|P2|Overall Study|Lost to Follow-up|1
1557078|NCT00031486|5076191|P1|Overall Study|Lost to Follow-up|0
1557079|NCT00031486|5076190|P2|Overall Study|Adverse Event|0
1557080|NCT00031486|5076191|P1|Overall Study|Adverse Event|1
1557081|NCT00031460|5076217|P2|Overall Study|Confirmed unevaluable|1
1557082|NCT00031460|5076218|P1|Overall Study|Confirmed unevaluable|0
1557083|NCT00031460|5076217|P2|Overall Study|Disruption of blinded drug supply|0
1557084|NCT00031460|5076218|P1|Overall Study|Disruption of blinded drug supply|2
1557085|NCT00031460|5076217|P2|Overall Study|Reactivation of Disease|9
1557086|NCT00031460|5076218|P1|Overall Study|Reactivation of Disease|5
1557087|NCT00031460|5076217|P2|Overall Study|Death|1
1557088|NCT00031460|5076218|P1|Overall Study|Death|0
1557089|NCT00031460|5076217|P2|Overall Study|Non-Compliant|1
1557090|NCT00031460|5076218|P1|Overall Study|Non-Compliant|1
1557091|NCT00031460|5076217|P2|Overall Study|Withdrawal by Subject|1
1557092|NCT00031460|5076218|P1|Overall Study|Withdrawal by Subject|1
1557093|NCT00031460|5076217|P2|Overall Study|Lost to Follow-up|1
1557094|NCT00031460|5076218|P1|Overall Study|Lost to Follow-up|0
1557095|NCT00031447|5076232|P2|Overall Study|Disruption of blinded study drug supply|4
1557096|NCT00031447|5076233|P1|Overall Study|Disruption of blinded study drug supply|7
1557097|NCT00031447|5076232|P2|Overall Study|Re-activation of Disease|1
1557098|NCT00031447|5076233|P1|Overall Study|Re-activation of Disease|2
1557099|NCT00031447|5076232|P2|Overall Study|Non-compliant|1
1557100|NCT00031447|5076233|P1|Overall Study|Non-compliant|1
1557101|NCT00031447|5076232|P2|Overall Study|Lost to Follow-up|1
1557102|NCT00031447|5076233|P1|Overall Study|Lost to Follow-up|0
1557103|NCT00029146|5076308|P2|Overall Study|Lost to Follow-up|1
1557104|NCT00029146|5076309|P1|Overall Study|Lost to Follow-up|2
1557105|NCT00027378|5076360|P2|Overall Study|Physician Decision|3
1557106|NCT00027378|5076361|P1|Overall Study|Physician Decision|0
1557107|NCT00027027|5076374|P5|Overall Study|Withdrawal by Subject|1
1557108|NCT00027027|5076375|P4|Overall Study|Withdrawal by Subject|0
1557109|NCT00027027|5076376|P3|Overall Study|Withdrawal by Subject|0
1557110|NCT00027027|5076377|P2|Overall Study|Withdrawal by Subject|0
1557111|NCT00027027|5076378|P1|Overall Study|Withdrawal by Subject|0
1557112|NCT00027027|5076374|P5|Overall Study|Physician Decision Due To PD|5
1557113|NCT00027027|5076375|P4|Overall Study|Physician Decision Due To PD|3
1557114|NCT00027027|5076376|P3|Overall Study|Physician Decision Due To PD|2
1557115|NCT00027027|5076377|P2|Overall Study|Physician Decision Due To PD|3
1557116|NCT00027027|5076378|P1|Overall Study|Physician Decision Due To PD|2
1557117|NCT00027027|5076374|P5|Overall Study|PD Requiring Surgery|0
1557118|NCT00027027|5076375|P4|Overall Study|PD Requiring Surgery|0
1557119|NCT00027027|5076376|P3|Overall Study|PD Requiring Surgery|1
1557120|NCT00027027|5076377|P2|Overall Study|PD Requiring Surgery|0
1557121|NCT00027027|5076378|P1|Overall Study|PD Requiring Surgery|0
1557122|NCT00027027|5076374|P5|Overall Study|Clinical Symptoms Progression not PD|0
1557123|NCT00027027|5076375|P4|Overall Study|Clinical Symptoms Progression not PD|0
1557124|NCT00027027|5076376|P3|Overall Study|Clinical Symptoms Progression not PD|0
1557125|NCT00027027|5076377|P2|Overall Study|Clinical Symptoms Progression not PD|0
1557126|NCT00027027|5076378|P1|Overall Study|Clinical Symptoms Progression not PD|1
1557127|NCT00027027|5076374|P5|Overall Study|Admitted for Signs of PD|1
1557128|NCT00027027|5076375|P4|Overall Study|Admitted for Signs of PD|0
1557129|NCT00027027|5076376|P3|Overall Study|Admitted for Signs of PD|0
1557130|NCT00027027|5076377|P2|Overall Study|Admitted for Signs of PD|0
1557131|NCT00027027|5076378|P1|Overall Study|Admitted for Signs of PD|0
1557132|NCT00027027|5076374|P5|Overall Study|Adverse Event|1
1557133|NCT00027027|5076375|P4|Overall Study|Adverse Event|0
1557134|NCT00027027|5076376|P3|Overall Study|Adverse Event|1
1557135|NCT00027027|5076377|P2|Overall Study|Adverse Event|0
1557136|NCT00027027|5076378|P1|Overall Study|Adverse Event|0
1557137|NCT00025883|5076425|P1|Overall Study|didn't reach 6 months of Metreleptin|10
1557138|NCT00025883|5076425|P1|Overall Study|Adverse Event|1
1557139|NCT00025883|5076425|P1|Overall Study|Death|1
1557140|NCT00025883|5076425|P1|Overall Study|no baseline data|1
1557141|NCT00025883|5076425|P1|Overall Study|had atypical progeriod lipodystrophy|4
1557142|NCT00023595|5076437|P5|10 Year Follow up|Lost to Follow-up|0
1557143|NCT00023595|5076438|P4|10 Year Follow up|Lost to Follow-up|0
1557144|NCT00023595|5076439|P3|10 Year Follow up|Lost to Follow-up|3
1557145|NCT00023595|5076440|P2|10 Year Follow up|Lost to Follow-up|10
1557146|NCT00023595|5076441|P1|10 Year Follow up|Lost to Follow-up|12
1557147|NCT00023595|5076437|P5|5 Year Follow up|Lost to Follow-up|3
1557148|NCT00023595|5076438|P4|5 Year Follow up|Lost to Follow-up|7
1557149|NCT00023595|5076439|P3|5 Year Follow up|Lost to Follow-up|1
1557150|NCT00023595|5076440|P2|5 Year Follow up|Lost to Follow-up|2
1557151|NCT00023595|5076441|P1|5 Year Follow up|Lost to Follow-up|2
1557152|NCT00023452|5076652|P2|Overall Study|Other|69
1557153|NCT00023452|5076653|P1|Overall Study|Other|204
1557154|NCT00023452|5076652|P2|Overall Study|Pregnant|20
1557155|NCT00023452|5076653|P1|Overall Study|Pregnant|53
1557156|NCT00023452|5076652|P2|Overall Study|Refused Treatment (continued follow-up)|224
1557157|NCT00023452|5076653|P1|Overall Study|Refused Treatment (continued follow-up)|225
1557158|NCT00023452|5076652|P2|Overall Study|Physician Decision|21
1557159|NCT00023452|5076653|P1|Overall Study|Physician Decision|49
1557160|NCT00023452|5076652|P2|Overall Study|Lost to Follow-up|60
1557161|NCT00023452|5076653|P1|Overall Study|Lost to Follow-up|293
1557162|NCT00023452|5076652|P2|Overall Study|Adverse Event|196
1557163|NCT00023452|5076653|P1|Overall Study|Adverse Event|139
1557164|NCT00023452|5076652|P2|Overall Study|Withdrawal by Subject|54
1557165|NCT00023452|5076653|P1|Overall Study|Withdrawal by Subject|66
1557166|NCT00023452|5076652|P2|Overall Study|Death|0
1557167|NCT00023452|5076653|P1|Overall Study|Death|2
1557168|NCT00023452|5076652|P2|Overall Study|Out of Window|69
1557169|NCT00023452|5076653|P1|Overall Study|Out of Window|129
1557170|NCT00023452|5076652|P2|Overall Study|Ineligible for Study|159
1557171|NCT00023452|5076653|P1|Overall Study|Ineligible for Study|163
1557172|NCT00023322|5076677|P1|Overall Study|Lost to Follow-up|1
1557173|NCT00022763|5076701|P2|Overall Study|Admin|2
1557174|NCT00022763|5076702|P1|Overall Study|Admin|3
1557175|NCT00022763|5076701|P2|Overall Study|Insufficient Therapy|0
1557176|NCT00022763|5076702|P1|Overall Study|Insufficient Therapy|1
1557177|NCT00022763|5076701|P2|Overall Study|Withdrawal by Subject|7
1557178|NCT00022763|5076702|P1|Overall Study|Withdrawal by Subject|4
1557179|NCT00022763|5076701|P2|Overall Study|Lost to Follow-up|3
1557180|NCT00022763|5076702|P1|Overall Study|Lost to Follow-up|0
1557181|NCT00022763|5076701|P2|Overall Study|Death|1
1557182|NCT00022763|5076702|P1|Overall Study|Death|0
1557183|NCT00022763|5076701|P2|Overall Study|Injection Site Reactions|2
1557184|NCT00022763|5076702|P1|Overall Study|Injection Site Reactions|0
1557185|NCT00022763|5076701|P2|Overall Study|Adverse Event|2
1557186|NCT00022763|5076702|P1|Overall Study|Adverse Event|1
1557187|NCT00014911|5076744|P1|Overall Study|Immunosuppression-related Side Effects|1
1557188|NCT00014911|5076744|P1|Overall Study|Unknown Reasons|2
1557189|NCT00014911|5076744|P1|Overall Study|Withdrawal by Subject|6
1557190|NCT00014911|5076744|P1|Overall Study|Lost to Follow-up|1
1557191|NCT00014911|5076744|P1|Overall Study|Adverse Event|1
1557192|NCT00006604|5076760|P17|Overall Study|Other Reason|0
1557193|NCT00006604|5076761|P16|Overall Study|Other Reason|0
1557194|NCT00006604|5076762|P15|Overall Study|Other Reason|0
1557195|NCT00006604|5076763|P14|Overall Study|Other Reason|0
1557196|NCT00006604|5076764|P13|Overall Study|Other Reason|0
1557197|NCT00006604|5076765|P12|Overall Study|Other Reason|0
1557198|NCT00006604|5076766|P11|Overall Study|Other Reason|0
1557199|NCT00006604|5076767|P10|Overall Study|Other Reason|1
1557200|NCT00006604|5076768|P9|Overall Study|Other Reason|0
1557201|NCT00006604|5076769|P8|Overall Study|Other Reason|0
1557202|NCT00006604|5076770|P7|Overall Study|Other Reason|0
1557203|NCT00006604|5076771|P6|Overall Study|Other Reason|1
1557204|NCT00006604|5076772|P5|Overall Study|Other Reason|0
1557205|NCT00006604|5076773|P4|Overall Study|Other Reason|0
1557206|NCT00006604|5076774|P3|Overall Study|Other Reason|0
1557207|NCT00006604|5076775|P2|Overall Study|Other Reason|0
1557208|NCT00006604|5076776|P1|Overall Study|Other Reason|0
1557209|NCT00006604|5076760|P17|Overall Study|Lost to Follow-up|3
1557210|NCT00006604|5076761|P16|Overall Study|Lost to Follow-up|1
1557211|NCT00006604|5076762|P15|Overall Study|Lost to Follow-up|0
1557212|NCT00006604|5076763|P14|Overall Study|Lost to Follow-up|0
1557213|NCT00006604|5076764|P13|Overall Study|Lost to Follow-up|0
1557214|NCT00006604|5076765|P12|Overall Study|Lost to Follow-up|0
1557215|NCT00006604|5076766|P11|Overall Study|Lost to Follow-up|0
1557216|NCT00006604|5076767|P10|Overall Study|Lost to Follow-up|2
1557217|NCT00006604|5076768|P9|Overall Study|Lost to Follow-up|0
1557218|NCT00006604|5076769|P8|Overall Study|Lost to Follow-up|1
1557219|NCT00006604|5076770|P7|Overall Study|Lost to Follow-up|0
1557220|NCT00006604|5076771|P6|Overall Study|Lost to Follow-up|0
1557221|NCT00006604|5076772|P5|Overall Study|Lost to Follow-up|0
1557222|NCT00006604|5076773|P4|Overall Study|Lost to Follow-up|0
1557223|NCT00006604|5076774|P3|Overall Study|Lost to Follow-up|0
1557224|NCT00006604|5076775|P2|Overall Study|Lost to Follow-up|0
1557225|NCT00006604|5076776|P1|Overall Study|Lost to Follow-up|0
1557226|NCT00006604|5076760|P17|Overall Study|Subj/parent not willing to adhere to req|4
1557227|NCT00006604|5076761|P16|Overall Study|Subj/parent not willing to adhere to req|3
1557228|NCT00006604|5076762|P15|Overall Study|Subj/parent not willing to adhere to req|3
1557229|NCT00006604|5076763|P14|Overall Study|Subj/parent not willing to adhere to req|2
1557230|NCT00006604|5076764|P13|Overall Study|Subj/parent not willing to adhere to req|0
1557231|NCT00006604|5076765|P12|Overall Study|Subj/parent not willing to adhere to req|0
1557232|NCT00006604|5076766|P11|Overall Study|Subj/parent not willing to adhere to req|3
1557233|NCT00006604|5076767|P10|Overall Study|Subj/parent not willing to adhere to req|6
1557234|NCT00006604|5076768|P9|Overall Study|Subj/parent not willing to adhere to req|0
1557235|NCT00006604|5076769|P8|Overall Study|Subj/parent not willing to adhere to req|1
1557236|NCT00006604|5076770|P7|Overall Study|Subj/parent not willing to adhere to req|3
1557237|NCT00006604|5076771|P6|Overall Study|Subj/parent not willing to adhere to req|0
1557238|NCT00006604|5076772|P5|Overall Study|Subj/parent not willing to adhere to req|0
1557239|NCT00006604|5076773|P4|Overall Study|Subj/parent not willing to adhere to req|3
1557240|NCT00006604|5076774|P3|Overall Study|Subj/parent not willing to adhere to req|1
1557241|NCT00006604|5076775|P2|Overall Study|Subj/parent not willing to adhere to req|0
1557242|NCT00006604|5076776|P1|Overall Study|Subj/parent not willing to adhere to req|0
1557243|NCT00006604|5076760|P17|Overall Study|Withdrawal by Subject|1
1557244|NCT00006604|5076761|P16|Overall Study|Withdrawal by Subject|0
1557245|NCT00006604|5076762|P15|Overall Study|Withdrawal by Subject|1
1557246|NCT00006604|5076763|P14|Overall Study|Withdrawal by Subject|2
1557247|NCT00006604|5076764|P13|Overall Study|Withdrawal by Subject|1
1557248|NCT00006604|5076765|P12|Overall Study|Withdrawal by Subject|0
1557249|NCT00006604|5076766|P11|Overall Study|Withdrawal by Subject|2
1557250|NCT00006604|5076767|P10|Overall Study|Withdrawal by Subject|3
1557251|NCT00006604|5076768|P9|Overall Study|Withdrawal by Subject|1
1557252|NCT00006604|5076769|P8|Overall Study|Withdrawal by Subject|0
1557253|NCT00006604|5076770|P7|Overall Study|Withdrawal by Subject|2
1557254|NCT00006604|5076771|P6|Overall Study|Withdrawal by Subject|2
1557255|NCT00006604|5076772|P5|Overall Study|Withdrawal by Subject|1
1557256|NCT00006604|5076773|P4|Overall Study|Withdrawal by Subject|0
1557257|NCT00006604|5076774|P3|Overall Study|Withdrawal by Subject|2
1557258|NCT00006604|5076775|P2|Overall Study|Withdrawal by Subject|0
1557259|NCT00006604|5076776|P1|Overall Study|Withdrawal by Subject|1
1557260|NCT00006604|5076760|P17|Overall Study|Site closing|1
1557261|NCT00006604|5076761|P16|Overall Study|Site closing|0
1557262|NCT00006604|5076762|P15|Overall Study|Site closing|0
1557263|NCT00006604|5076763|P14|Overall Study|Site closing|1
1557264|NCT00006604|5076764|P13|Overall Study|Site closing|1
1557265|NCT00006604|5076765|P12|Overall Study|Site closing|1
1557266|NCT00006604|5076766|P11|Overall Study|Site closing|0
1557267|NCT00006604|5076767|P10|Overall Study|Site closing|0
1557268|NCT00006604|5076768|P9|Overall Study|Site closing|0
1557269|NCT00006604|5076769|P8|Overall Study|Site closing|1
1557270|NCT00006604|5076770|P7|Overall Study|Site closing|0
1557271|NCT00006604|5076771|P6|Overall Study|Site closing|0
1557272|NCT00006604|5076772|P5|Overall Study|Site closing|0
1557273|NCT00006604|5076773|P4|Overall Study|Site closing|1
1557274|NCT00006604|5076774|P3|Overall Study|Site closing|1
1557275|NCT00006604|5076775|P2|Overall Study|Site closing|0
1557276|NCT00006604|5076776|P1|Overall Study|Site closing|0
1557277|NCT00006604|5076760|P17|Overall Study|Subj/Parent not able to get to clinic|0
1557278|NCT00006604|5076761|P16|Overall Study|Subj/Parent not able to get to clinic|0
1557279|NCT00006604|5076762|P15|Overall Study|Subj/Parent not able to get to clinic|3
1557280|NCT00006604|5076763|P14|Overall Study|Subj/Parent not able to get to clinic|1
1557281|NCT00006604|5076764|P13|Overall Study|Subj/Parent not able to get to clinic|1
1557282|NCT00006604|5076765|P12|Overall Study|Subj/Parent not able to get to clinic|1
1557283|NCT00006604|5076766|P11|Overall Study|Subj/Parent not able to get to clinic|2
1557284|NCT00006604|5076767|P10|Overall Study|Subj/Parent not able to get to clinic|1
1557285|NCT00006604|5076768|P9|Overall Study|Subj/Parent not able to get to clinic|0
1557286|NCT00006604|5076769|P8|Overall Study|Subj/Parent not able to get to clinic|0
1557287|NCT00006604|5076770|P7|Overall Study|Subj/Parent not able to get to clinic|1
1557288|NCT00006604|5076771|P6|Overall Study|Subj/Parent not able to get to clinic|0
1557289|NCT00006604|5076772|P5|Overall Study|Subj/Parent not able to get to clinic|1
1557290|NCT00006604|5076773|P4|Overall Study|Subj/Parent not able to get to clinic|1
1557291|NCT00006604|5076774|P3|Overall Study|Subj/Parent not able to get to clinic|0
1557292|NCT00006604|5076775|P2|Overall Study|Subj/Parent not able to get to clinic|0
1557293|NCT00006604|5076776|P1|Overall Study|Subj/Parent not able to get to clinic|0
1557294|NCT00006604|5076760|P17|Overall Study|Severe debilitation, unable to continue|0
1557295|NCT00006604|5076761|P16|Overall Study|Severe debilitation, unable to continue|0
1557296|NCT00006604|5076762|P15|Overall Study|Severe debilitation, unable to continue|2
1557297|NCT00006604|5076763|P14|Overall Study|Severe debilitation, unable to continue|0
1557298|NCT00006604|5076764|P13|Overall Study|Severe debilitation, unable to continue|1
1557299|NCT00006604|5076765|P12|Overall Study|Severe debilitation, unable to continue|2
1557300|NCT00006604|5076766|P11|Overall Study|Severe debilitation, unable to continue|0
1557301|NCT00006604|5076767|P10|Overall Study|Severe debilitation, unable to continue|5
1557302|NCT00006604|5076768|P9|Overall Study|Severe debilitation, unable to continue|0
1557303|NCT00006604|5076769|P8|Overall Study|Severe debilitation, unable to continue|0
1557304|NCT00006604|5076770|P7|Overall Study|Severe debilitation, unable to continue|3
1557305|NCT00006604|5076771|P6|Overall Study|Severe debilitation, unable to continue|0
1557306|NCT00006604|5076772|P5|Overall Study|Severe debilitation, unable to continue|0
1557307|NCT00006604|5076773|P4|Overall Study|Severe debilitation, unable to continue|0
1557308|NCT00006604|5076774|P3|Overall Study|Severe debilitation, unable to continue|0
1557309|NCT00006604|5076775|P2|Overall Study|Severe debilitation, unable to continue|0
1557310|NCT00006604|5076776|P1|Overall Study|Severe debilitation, unable to continue|0
1557311|NCT00006604|5076760|P17|Overall Study|Death|0
1557312|NCT00006604|5076761|P16|Overall Study|Death|0
1557313|NCT00006604|5076762|P15|Overall Study|Death|0
1557314|NCT00006604|5076763|P14|Overall Study|Death|0
1557315|NCT00006604|5076764|P13|Overall Study|Death|0
1557316|NCT00006604|5076765|P12|Overall Study|Death|1
1557317|NCT00006604|5076766|P11|Overall Study|Death|1
1557318|NCT00006604|5076767|P10|Overall Study|Death|1
1557319|NCT00006604|5076768|P9|Overall Study|Death|0
1557320|NCT00006604|5076769|P8|Overall Study|Death|0
1557321|NCT00006604|5076770|P7|Overall Study|Death|0
1557322|NCT00006604|5076771|P6|Overall Study|Death|0
1557323|NCT00006604|5076772|P5|Overall Study|Death|0
1557324|NCT00006604|5076773|P4|Overall Study|Death|0
1557325|NCT00006604|5076774|P3|Overall Study|Death|0
1557326|NCT00006604|5076775|P2|Overall Study|Death|0
1557327|NCT00006604|5076776|P1|Overall Study|Death|0
1557328|NCT00006604|5076760|P17|Overall Study|Randomization entry error-no RX, no FU|0
1557329|NCT00006604|5076761|P16|Overall Study|Randomization entry error-no RX, no FU|0
1557330|NCT00006604|5076762|P15|Overall Study|Randomization entry error-no RX, no FU|0
1557331|NCT00006604|5076763|P14|Overall Study|Randomization entry error-no RX, no FU|0
1557332|NCT00006604|5076764|P13|Overall Study|Randomization entry error-no RX, no FU|0
1557333|NCT00006604|5076765|P12|Overall Study|Randomization entry error-no RX, no FU|1
1557334|NCT00006604|5076766|P11|Overall Study|Randomization entry error-no RX, no FU|0
1557335|NCT00006604|5076767|P10|Overall Study|Randomization entry error-no RX, no FU|0
1557336|NCT00006604|5076768|P9|Overall Study|Randomization entry error-no RX, no FU|0
1557337|NCT00006604|5076769|P8|Overall Study|Randomization entry error-no RX, no FU|0
1557338|NCT00006604|5076770|P7|Overall Study|Randomization entry error-no RX, no FU|0
1557339|NCT00006604|5076771|P6|Overall Study|Randomization entry error-no RX, no FU|0
1557340|NCT00006604|5076772|P5|Overall Study|Randomization entry error-no RX, no FU|0
1557341|NCT00006604|5076773|P4|Overall Study|Randomization entry error-no RX, no FU|0
1557342|NCT00006604|5076774|P3|Overall Study|Randomization entry error-no RX, no FU|0
1557343|NCT00006604|5076775|P2|Overall Study|Randomization entry error-no RX, no FU|0
1557344|NCT00006604|5076776|P1|Overall Study|Randomization entry error-no RX, no FU|0
1557345|NCT00006604|5076760|P17|Overall Study|Met study objective - no further FU|0
1557346|NCT00006604|5076761|P16|Overall Study|Met study objective - no further FU|1
1557347|NCT00006604|5076762|P15|Overall Study|Met study objective - no further FU|1
1557348|NCT00006604|5076763|P14|Overall Study|Met study objective - no further FU|0
1557349|NCT00006604|5076764|P13|Overall Study|Met study objective - no further FU|0
1557350|NCT00006604|5076765|P12|Overall Study|Met study objective - no further FU|0
1557351|NCT00006604|5076766|P11|Overall Study|Met study objective - no further FU|0
1557352|NCT00006604|5076767|P10|Overall Study|Met study objective - no further FU|0
1557353|NCT00006604|5076768|P9|Overall Study|Met study objective - no further FU|0
1557354|NCT00006604|5076769|P8|Overall Study|Met study objective - no further FU|0
1557355|NCT00006604|5076770|P7|Overall Study|Met study objective - no further FU|0
1557356|NCT00006604|5076771|P6|Overall Study|Met study objective - no further FU|0
1557357|NCT00006604|5076772|P5|Overall Study|Met study objective - no further FU|0
1557358|NCT00006604|5076773|P4|Overall Study|Met study objective - no further FU|0
1557359|NCT00006604|5076774|P3|Overall Study|Met study objective - no further FU|0
1557360|NCT00006604|5076775|P2|Overall Study|Met study objective - no further FU|0
1557361|NCT00006604|5076776|P1|Overall Study|Met study objective - no further FU|1
1557362|NCT00004978|5076892|P2|Overall Study|site closure - not in analysis cohort|20
1557363|NCT00004978|5076893|P1|Overall Study|site closure - not in analysis cohort|19
1557364|NCT00004978|5076892|P2|Overall Study|Withdrawal by Subject|26
1557365|NCT00004978|5076893|P1|Overall Study|Withdrawal by Subject|17
1557366|NCT00004978|5076892|P2|Overall Study|Lost to Follow-up|108
1557367|NCT00004978|5076893|P1|Overall Study|Lost to Follow-up|101
1557368|NCT00004978|5076892|P2|Overall Study|Death|116
1557369|NCT00004978|5076893|P1|Overall Study|Death|107
1557370|NCT00021541|5076919|P2|Period 2-crossover|Pts that did not progress|3
1557371|NCT00021541|5076920|P1|Period 2-crossover|Pts that did not progress|2
1557372|NCT00021541|5076919|P2|Period 2-crossover|non-adherence|0
1557373|NCT00021541|5076920|P1|Period 2-crossover|non-adherence|1
1557374|NCT00021541|5076919|P2|Period 2-crossover|Adverse Event|2
1557375|NCT00021541|5076920|P1|Period 2-crossover|Adverse Event|2
1557376|NCT00021541|5076919|P2|Period 2-crossover|Withdrawal by Subject|4
1557377|NCT00021541|5076920|P1|Period 2-crossover|Withdrawal by Subject|3
1557378|NCT00021541|5076919|P2|Period 2-crossover|refused phase B|2
1557379|NCT00021541|5076920|P1|Period 2-crossover|refused phase B|2
1557380|NCT00021541|5076919|P2|Period 1-First Treatment|Ineligible|2
1557381|NCT00021541|5076920|P1|Period 1-First Treatment|Ineligible|0
1557382|NCT00021541|5076919|P2|Period 1-First Treatment|Pts that did not progress|2
1557383|NCT00021541|5076920|P1|Period 1-First Treatment|Pts that did not progress|2
1557384|NCT00021541|5076919|P2|Period 1-First Treatment|Death|0
1557385|NCT00021541|5076920|P1|Period 1-First Treatment|Death|1
1557386|NCT00021541|5076919|P2|Period 1-First Treatment|non-adherence|0
1557387|NCT00021541|5076920|P1|Period 1-First Treatment|non-adherence|3
1557388|NCT00021541|5076919|P2|Period 1-First Treatment|Adverse Event|1
1557389|NCT00021541|5076920|P1|Period 1-First Treatment|Adverse Event|2
1557390|NCT00021541|5076919|P2|Period 1-First Treatment|Withdrawal by Subject|3
1557391|NCT00021541|5076920|P1|Period 1-First Treatment|Withdrawal by Subject|3
1557392|NCT00015457|5076934|P2|Second Intervention|Withdrawal by Subject|0
1557393|NCT00015457|5076935|P1|Second Intervention|Withdrawal by Subject|1
1557394|NCT00015457|5076934|P2|First Intervention|Lack of Efficacy|1
1557395|NCT00015457|5076935|P1|First Intervention|Lack of Efficacy|0
1557396|NCT00015457|5076934|P2|First Intervention|Adverse Event|2
1557397|NCT00015457|5076935|P1|First Intervention|Adverse Event|0
1557398|NCT00013611|5076945|P2|Overall Study|Lost to Follow-up|100
1557399|NCT00013611|5076946|P1|Overall Study|Lost to Follow-up|91
1557400|NCT00010803|5076964|P2|Overall Study|Withdrawal by Subject|98
1557401|NCT00010803|5076965|P1|Overall Study|Withdrawal by Subject|97
1557402|NCT00007475|5076992|P4|Overall Study|Adverse Event|0
1557403|NCT00007475|5076993|P3|Overall Study|Adverse Event|0
1557404|NCT00007475|5076994|P2|Overall Study|Adverse Event|0
1557405|NCT00007475|5076995|P1|Overall Study|Adverse Event|3
1557406|NCT00007475|5076992|P4|Overall Study|Withdrawal by Subject|0
1557407|NCT00007475|5076993|P3|Overall Study|Withdrawal by Subject|0
1557408|NCT00007475|5076994|P2|Overall Study|Withdrawal by Subject|0
1557409|NCT00007475|5076995|P1|Overall Study|Withdrawal by Subject|1
1557410|NCT00007345|5077017|P2|Overall Study|Death on study|1
1557411|NCT00007345|5077018|P1|Overall Study|Death on study|1
1557412|NCT00007345|5077017|P2|Overall Study|Intercurrent illness|0
1557413|NCT00007345|5077018|P1|Overall Study|Intercurrent illness|1
1557414|NCT00007345|5077017|P2|Overall Study|Switched to alternative treatment|3
1557415|NCT00007345|5077018|P1|Overall Study|Switched to alternative treatment|0
1557416|NCT00007345|5077017|P2|Overall Study|Refused further treatment|7
1557417|NCT00007345|5077018|P1|Overall Study|Refused further treatment|0
1557418|NCT00006489|5077040|P4|Overall Study|Death|1
1557419|NCT00006489|5077041|P3|Overall Study|Death|0
1557420|NCT00006489|5077042|P2|Overall Study|Death|0
1557421|NCT00006489|5077043|P1|Overall Study|Death|0
1557422|NCT00006489|5077040|P4|Overall Study|Scheduling Conflict|1
1557423|NCT00006489|5077041|P3|Overall Study|Scheduling Conflict|2
1557424|NCT00006489|5077042|P2|Overall Study|Scheduling Conflict|3
1557425|NCT00006489|5077043|P1|Overall Study|Scheduling Conflict|0
1557426|NCT00006489|5077040|P4|Overall Study|Withdrawal by Subject|6
1557427|NCT00006489|5077041|P3|Overall Study|Withdrawal by Subject|9
1557428|NCT00006489|5077042|P2|Overall Study|Withdrawal by Subject|9
1557429|NCT00006489|5077043|P1|Overall Study|Withdrawal by Subject|10
1557430|NCT00006489|5077040|P4|Overall Study|Adverse Event|3
1557431|NCT00006489|5077041|P3|Overall Study|Adverse Event|4
1557432|NCT00006489|5077042|P2|Overall Study|Adverse Event|2
1557433|NCT00006489|5077043|P1|Overall Study|Adverse Event|3
1557434|NCT00006409|5077067|P6|Post-3 Year Intervention|Protocol Violation|62
1557435|NCT00006409|5077068|P5|Post-3 Year Intervention|Protocol Violation|62
1557436|NCT00006409|5077069|P4|Post-3 Year Intervention|Protocol Violation|0
1557437|NCT00006409|5077070|P3|Post-3 Year Intervention|Protocol Violation|0
1557438|NCT00006409|5077071|P2|Post-3 Year Intervention|Protocol Violation|0
1557439|NCT00006409|5077072|P1|Post-3 Year Intervention|Protocol Violation|0
1557440|NCT00006409|5077067|P6|Post-2 Year Intervention|Protocol Violation|0
1557441|NCT00006409|5077068|P5|Post-2 Year Intervention|Protocol Violation|0
1557442|NCT00006409|5077069|P4|Post-2 Year Intervention|Protocol Violation|168
1557443|NCT00006409|5077070|P3|Post-2 Year Intervention|Protocol Violation|251
1557444|NCT00006409|5077071|P2|Post-2 Year Intervention|Protocol Violation|0
1557445|NCT00006409|5077072|P1|Post-2 Year Intervention|Protocol Violation|0
1557446|NCT00006409|5077067|P6|Baseline|Protocol Violation|0
1557447|NCT00006409|5077068|P5|Baseline|Protocol Violation|0
1557448|NCT00006409|5077069|P4|Baseline|Protocol Violation|0
1557449|NCT00006409|5077070|P3|Baseline|Protocol Violation|0
1557450|NCT00006409|5077071|P2|Baseline|Protocol Violation|70
1557451|NCT00006409|5077072|P1|Baseline|Protocol Violation|48
1557452|NCT00006305|5077096|P4|Overall Study|Withdrawal by Subject|14
1557453|NCT00006305|5077097|P3|Overall Study|Withdrawal by Subject|15
1557454|NCT00006305|5077098|P2|Overall Study|Withdrawal by Subject|10
1557455|NCT00006305|5077099|P1|Overall Study|Withdrawal by Subject|17
1557456|NCT00006289|5077115|P2|Second Intervention (5 Weeks)|Protocol Violation|1
1557457|NCT00006289|5077116|P1|Second Intervention (5 Weeks)|Protocol Violation|1
1557458|NCT00006289|5077115|P2|First Intervention (5 Weeks)|Adverse Event|0
1557459|NCT00006289|5077116|P1|First Intervention (5 Weeks)|Adverse Event|1
1557460|NCT00006184|5077134|P2|Overall Study|Death|0
1557461|NCT00006184|5077135|P1|Overall Study|Death|1
1557462|NCT00006164|5077186|P2|Overall Study|Withdrew or lost to follow-up|81
1557463|NCT00006164|5077187|P1|Overall Study|Withdrew or lost to follow-up|70
1557464|NCT00005937|5077230|P1|Overall Study|Lack of Efficacy|5
1557465|NCT00005908|5077234|P2|Overall Study|Withdrawal by Subject|0
1557466|NCT00005908|5077235|P1|Overall Study|Withdrawal by Subject|1
1557467|NCT00005906|5077244|P1|Overall Study|Lack of Efficacy|3
1557468|NCT00004980|5077288|P2|Overall Study|Physician Decision|1
1557469|NCT00004980|5077289|P1|Overall Study|Physician Decision|0
1557470|NCT00004980|5077288|P2|Overall Study|memory difficulties|1
1557471|NCT00004980|5077289|P1|Overall Study|memory difficulties|1
1557472|NCT00004980|5077288|P2|Overall Study|Withdrawal by Subject|0
1557473|NCT00004980|5077289|P1|Overall Study|Withdrawal by Subject|1
1557474|NCT00004732|5077303|P2|Overall Study|Lost to Follow-up|47
1557475|NCT00004732|5077304|P1|Overall Study|Lost to Follow-up|33
1557476|NCT00004732|5077303|P2|Overall Study|Withdrawal by Subject|64
1557477|NCT00004732|5077304|P1|Overall Study|Withdrawal by Subject|36
1557478|NCT00004635|5077314|P2|Period Two|discrepancy in data entry|1
1557479|NCT00004635|5077315|P1|Period Two|discrepancy in data entry|0
1557480|NCT00004635|5077314|P2|Period Two|Lost to Follow-up|0
1557481|NCT00004635|5077315|P1|Period Two|Lost to Follow-up|1
1557482|NCT00004635|5077314|P2|Period Two|secondary malignancy|1
1557483|NCT00004635|5077315|P1|Period Two|secondary malignancy|1
1557484|NCT00004635|5077314|P2|Period Two|travel issues|1
1557485|NCT00004635|5077315|P1|Period Two|travel issues|0
1557486|NCT00004635|5077314|P2|Period Two|health problem|1
1557487|NCT00004635|5077315|P1|Period Two|health problem|1
1557488|NCT00004635|5077314|P2|Period Two|refused|2
1557489|NCT00004635|5077315|P1|Period Two|refused|0
1557490|NCT00004635|5077314|P2|Period Two|Adverse Event|0
1557491|NCT00004635|5077315|P1|Period Two|Adverse Event|1
1557492|NCT00004635|5077314|P2|Period Two|progression|3
1557493|NCT00004635|5077315|P1|Period Two|progression|2
1557494|NCT00004635|5077314|P2|Period One|discrepancy in data entry|1
1557495|NCT00004635|5077315|P1|Period One|discrepancy in data entry|0
1557496|NCT00004635|5077314|P2|Period One|health problem|1
1557497|NCT00004635|5077315|P1|Period One|health problem|0
1557498|NCT00004635|5077314|P2|Period One|progressed|2
1557499|NCT00004635|5077315|P1|Period One|progressed|0
1557500|NCT00004635|5077314|P2|Period One|second malignancy|0
1557501|NCT00004635|5077315|P1|Period One|second malignancy|1
1557502|NCT00004635|5077314|P2|Period One|PSA did not go <5 ng/mL|0
1557503|NCT00004635|5077315|P1|Period One|PSA did not go <5 ng/mL|1
1557504|NCT00004635|5077314|P2|Period One|Protocol Violation|0
1557505|NCT00004635|5077315|P1|Period One|Protocol Violation|1
1557506|NCT00004635|5077314|P2|Period One|Withdrawal by Subject|1
1557507|NCT00004635|5077315|P1|Period One|Withdrawal by Subject|1
1557508|NCT00004635|5077314|P2|Period One|refused|1
1557509|NCT00004635|5077315|P1|Period One|refused|2
1557510|NCT00004563|5077327|P2|Overall Study|Death|3
1557511|NCT00004563|5077328|P1|Overall Study|Death|2
1557512|NCT00004563|5077327|P2|Overall Study|Lack of Efficacy|5
1557513|NCT00004563|5077328|P1|Overall Study|Lack of Efficacy|3
1557514|NCT00004563|5077327|P2|Overall Study|Withdrawal by Subject|16
1557515|NCT00004563|5077328|P1|Overall Study|Withdrawal by Subject|20
1557516|NCT00004562|5077340|P2|Overall Study|Lost to Follow-up|91
1557517|NCT00004562|5077341|P1|Overall Study|Lost to Follow-up|102
1557518|NCT00001962|5077382|P1|Overall Study|Adverse Event|1
1557519|NCT00001962|5077382|P1|Overall Study|Lost to Follow-up|2
1557520|NCT00001962|5077382|P1|Overall Study|Death|1
1557521|NCT00001962|5077382|P1|Overall Study|Lack of Accrual|6
1557522|NCT00001962|5077382|P1|Overall Study|Lack of Efficacy|18
1557523|NCT00001959|5077386|P1|Overall Study|non-compliance|1
1557524|NCT00001959|5077386|P1|Overall Study|disabling sedation|1
1557525|NCT00001959|5077386|P1|Overall Study|newly diagnosed colon cancer|1
1557526|NCT00001941|5077392|P5|Overall Study|not treated- rapidly progressing disease|1
1557527|NCT00001941|5077393|P4|Overall Study|not treated- rapidly progressing disease|0
1557528|NCT00001941|5077394|P3|Overall Study|not treated- rapidly progressing disease|0
1557529|NCT00001941|5077395|P2|Overall Study|not treated- rapidly progressing disease|0
1557530|NCT00001941|5077396|P1|Overall Study|not treated- rapidly progressing disease|0
1557531|NCT00001832|5077428|P15|Treatment Period|Not treated|0
1557532|NCT00001832|5077429|P14|Treatment Period|Not treated|0
1557533|NCT00001832|5077430|P13|Treatment Period|Not treated|0
1557534|NCT00001832|5077431|P12|Treatment Period|Not treated|0
1557535|NCT00001832|5077432|P11|Treatment Period|Not treated|0
1557536|NCT00001832|5077433|P10|Treatment Period|Not treated|0
1557537|NCT00001832|5077434|P9|Treatment Period|Not treated|0
1557538|NCT00001832|5077435|P8|Treatment Period|Not treated|1
1557539|NCT00001832|5077436|P7|Treatment Period|Not treated|0
1557540|NCT00001832|5077437|P6|Treatment Period|Not treated|0
1557541|NCT00001832|5077438|P5|Treatment Period|Not treated|0
1557542|NCT00001832|5077439|P4|Treatment Period|Not treated|0
1557543|NCT00001832|5077440|P3|Treatment Period|Not treated|0
1557544|NCT00001832|5077441|P2|Treatment Period|Not treated|0
1557545|NCT00001832|5077442|P1|Treatment Period|Not treated|0
1557546|NCT00001832|5077428|P15|Treatment Period|Death during treatment|0
1557547|NCT00001832|5077429|P14|Treatment Period|Death during treatment|0
1557548|NCT00001832|5077430|P13|Treatment Period|Death during treatment|0
1557549|NCT00001832|5077431|P12|Treatment Period|Death during treatment|0
1557550|NCT00001832|5077432|P11|Treatment Period|Death during treatment|0
1557551|NCT00001832|5077433|P10|Treatment Period|Death during treatment|0
1557552|NCT00001832|5077434|P9|Treatment Period|Death during treatment|0
1557553|NCT00001832|5077435|P8|Treatment Period|Death during treatment|0
1557554|NCT00001832|5077436|P7|Treatment Period|Death during treatment|0
1557555|NCT00001832|5077437|P6|Treatment Period|Death during treatment|1
1557556|NCT00001832|5077438|P5|Treatment Period|Death during treatment|0
1557557|NCT00001832|5077439|P4|Treatment Period|Death during treatment|0
1557558|NCT00001832|5077440|P3|Treatment Period|Death during treatment|0
1557559|NCT00001832|5077441|P2|Treatment Period|Death during treatment|0
1557560|NCT00001832|5077442|P1|Treatment Period|Death during treatment|0
1557561|NCT00001832|5077428|P15|Apheresis Period|not able to manufacture treatment cells|0
1557562|NCT00001832|5077429|P14|Apheresis Period|not able to manufacture treatment cells|0
1557563|NCT00001832|5077430|P13|Apheresis Period|not able to manufacture treatment cells|0
1557564|NCT00001832|5077431|P12|Apheresis Period|not able to manufacture treatment cells|0
1557565|NCT00001832|5077432|P11|Apheresis Period|not able to manufacture treatment cells|0
1557566|NCT00001832|5077433|P10|Apheresis Period|not able to manufacture treatment cells|0
1557567|NCT00001832|5077434|P9|Apheresis Period|not able to manufacture treatment cells|0
1557568|NCT00001832|5077435|P8|Apheresis Period|not able to manufacture treatment cells|0
1557569|NCT00001832|5077436|P7|Apheresis Period|not able to manufacture treatment cells|0
1557570|NCT00001832|5077437|P6|Apheresis Period|not able to manufacture treatment cells|0
1557571|NCT00001832|5077438|P5|Apheresis Period|not able to manufacture treatment cells|0
1557572|NCT00001832|5077439|P4|Apheresis Period|not able to manufacture treatment cells|0
1557573|NCT00001832|5077440|P3|Apheresis Period|not able to manufacture treatment cells|0
1557574|NCT00001832|5077441|P2|Apheresis Period|not able to manufacture treatment cells|0
1557575|NCT00001832|5077442|P1|Apheresis Period|not able to manufacture treatment cells|60
1557576|NCT00001723|5077488|P2|Overall Study|medication intolerance|2
1557577|NCT00001723|5077489|P1|Overall Study|medication intolerance|1
1557578|NCT00001723|5077488|P2|Overall Study|Lost to Follow-up|2
1557579|NCT00001723|5077489|P1|Overall Study|Lost to Follow-up|2
1557580|NCT00001723|5077488|P2|Overall Study|Lack of family interest|5
1557581|NCT00001723|5077489|P1|Overall Study|Lack of family interest|4
1557582|NCT00001723|5077488|P2|Overall Study|Lack of Efficacy|7
1557583|NCT00001723|5077489|P1|Overall Study|Lack of Efficacy|6
1557584|NCT00001703|5077505|P1|Overall Study|recurrent disease|2
1557585|NCT00001703|5077505|P1|Overall Study|No evidence of disease|1
1557586|NCT00001703|5077505|P1|Overall Study|progressed disease|2
1557587|NCT00001596|5077543|P2|Overall Study|Adverse Event|0
1557588|NCT00001596|5077544|P1|Overall Study|Adverse Event|1
1557589|NCT00001596|5077543|P2|Overall Study|Study Termination|9
1557590|NCT00001596|5077544|P1|Overall Study|Study Termination|12
1557591|NCT00001596|5077543|P2|Overall Study|Withdrawal by Subject|1
1557592|NCT00001596|5077544|P1|Overall Study|Withdrawal by Subject|3
1557593|NCT00001596|5077543|P2|Overall Study|Death|0
1557594|NCT00001596|5077544|P1|Overall Study|Death|1
1557595|NCT00001575|5077575|P1|Overall Study|Withdrawn/deaths|23
1557596|NCT00001575|5077575|P1|Overall Study|Screening failures-Ph I portion|22
1557597|NCT00001566|5077581|P1|Overall Study|unable to complete initial apheresis|1
1557598|NCT00001566|5077581|P1|Overall Study|Lost to Follow-up|1
1557599|NCT00001566|5077581|P1|Overall Study|Death|13
1557600|NCT00001566|5077581|P1|Overall Study|stopped after C3 due to symptomatic PD|1
1557601|NCT00001566|5077581|P1|Overall Study|patients' choice to discontinue protocol|3
1557602|NCT00001262|5077617|P3|Overall Study|Withdrawal by Subject|0
1557603|NCT00001262|5077618|P2|Overall Study|Withdrawal by Subject|3
1557604|NCT00001262|5077619|P1|Overall Study|Withdrawal by Subject|0
1557605|NCT00001262|5077617|P3|Overall Study|Death|0
1557606|NCT00001262|5077618|P2|Overall Study|Death|11
1557607|NCT00001262|5077619|P1|Overall Study|Death|10
1557608|NCT00001213|5077645|P1|Overall Study|Death|18
1557609|NCT00000378|5077656|P2|Overall Study|Lack of Efficacy|14
1557610|NCT00000378|5077657|P1|Overall Study|Lack of Efficacy|16
1557611|NCT00000620|5077674|P8|Overall Study|missed closeout visit|16
1557612|NCT00000620|5077675|P7|Overall Study|missed closeout visit|13
1557613|NCT00000620|5077676|P6|Overall Study|missed closeout visit|28
1557614|NCT00000620|5077677|P5|Overall Study|missed closeout visit|26
1557615|NCT00000620|5077678|P4|Overall Study|missed closeout visit|11
1557616|NCT00000620|5077679|P3|Overall Study|missed closeout visit|16
1557617|NCT00000620|5077680|P2|Overall Study|missed closeout visit|28
1557618|NCT00000620|5077681|P1|Overall Study|missed closeout visit|22
1557619|NCT00000620|5077674|P8|Overall Study|Withdrawal by Subject|21
1557620|NCT00000620|5077675|P7|Overall Study|Withdrawal by Subject|32
1557621|NCT00000620|5077676|P6|Overall Study|Withdrawal by Subject|32
1557622|NCT00000620|5077677|P5|Overall Study|Withdrawal by Subject|30
1557623|NCT00000620|5077678|P4|Overall Study|Withdrawal by Subject|27
1557624|NCT00000620|5077679|P3|Overall Study|Withdrawal by Subject|28
1557625|NCT00000620|5077680|P2|Overall Study|Withdrawal by Subject|27
1557626|NCT00000620|5077681|P1|Overall Study|Withdrawal by Subject|40
1557627|NCT00000620|5077674|P8|Overall Study|Lost to Follow-up|14
1557628|NCT00000620|5077675|P7|Overall Study|Lost to Follow-up|13
1557629|NCT00000620|5077676|P6|Overall Study|Lost to Follow-up|15
1557630|NCT00000620|5077677|P5|Overall Study|Lost to Follow-up|15
1557631|NCT00000620|5077678|P4|Overall Study|Lost to Follow-up|14
1557632|NCT00000620|5077679|P3|Overall Study|Lost to Follow-up|14
1557633|NCT00000620|5077680|P2|Overall Study|Lost to Follow-up|14
1557634|NCT00000620|5077681|P1|Overall Study|Lost to Follow-up|14
1557635|NCT00000620|5077674|P8|Overall Study|Death|95
1557636|NCT00000620|5077675|P7|Overall Study|Death|91
1557637|NCT00000620|5077676|P6|Overall Study|Death|77
1557638|NCT00000620|5077677|P5|Overall Study|Death|64
1557639|NCT00000620|5077678|P4|Overall Study|Death|126
1557640|NCT00000620|5077679|P3|Overall Study|Death|112
1557641|NCT00000620|5077680|P2|Overall Study|Death|67
1557642|NCT00000620|5077681|P1|Overall Study|Death|86
1557643|NCT00004412|5077765|P3|Randomized Period|Moved to Crossover Period|0
1557644|NCT00004412|5077766|P2|Randomized Period|Moved to Crossover Period|0
1557645|NCT00004412|5077767|P1|Randomized Period|Moved to Crossover Period|3
1557646|NCT00000135|5077808|P2|Overall Study|Death|14
1557647|NCT00000135|5077809|P1|Overall Study|Death|27
